----------------------------------------------------------------------------
        CALIPHO group at the SIB - Swiss Institute of Bioinformatics
        Geneva, Switzerland
----------------------------------------------------------------------------

 Description: Cellosaurus: a knowledge resource on cell lines
 Version: 54.0
 Last update: 27-November-2025

----------------------------------------------------------------------------
    _____     _ _
   / ____|   | | |
  | |     ___| | | ___  ___  __ _ _   _ _ __ _   _ ___
  | |    / _ \ | |/ _ \/ __|/ _` | | | | '__| | | / __|
  | |___|  __/ | | (_) \__ \ (_| | |_| | |  | |_| \__ \
   \_____\___|_|_|\___/|___/\__,_|\__,_|_|   \__,_|___/


 Licensing information: we have chosen to apply the Creative Commons
 Attribution 4.0 International (CC BY 4.0) license to Cellosaurus
 (https://creativecommons.org/licenses/by/4.0/). This means that you are
 free to copy and redistribute Cellosaurus in any medium or format.
 You can remix, transform, and build upon Cellosaurus for any purpose,
 even commercially. You must give appropriate credit, provide a link to
 the license, and indicate if changes were made.

 For any questions regarding Cellosaurus, contact us at:
 mailto:cellosaurus@sib.swiss

 Format of data file:

 ---------  ------------------------------  -----------------------
 Line code  Content                         Occurrence in an entry
 ---------  ------------------------------  -----------------------
 ID         Identifier (cell line name)     Once; starts an entry
 AC         Accession (CVCL_xxxx)           Once
 AS         Secondary accession(s)          Optional; once
 SY         Synonyms                        Optional; once
 DR         Cross-references                Optional; once or more
 RX         References identifiers          Optional: once or more
 WW         Web pages                       Optional; once or more
 CC         Comments                        Optional; once or more
 ST         STR profile data                Optional; twice or more
 DI         Diseases                        Optional; once or more
 OX         Species of origin               Once or more
 HI         Hierarchy                       Optional; once or more
 OI         Originate from same individual  Optional; once or more
 SX         Sex of cell                     Optional; once
 AG         Age of donor at sampling        Optional; once
 CA         Category                        Once
 DT         Date (entry history)            Once
 //         Terminator                      Once; ends an entry

____________________________________________________________________________
ID   #132 PC3-1-SC-E8
AC   CVCL_B0T9
SY   Z48-5MG-70
DR   Wikidata; Q108819335
RX   Patent=EP0501779A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10564.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P47712; Human PLA2G4A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   #132 PL12 SC-D1
AC   CVCL_B0T8
SY   Z48-5MG-63
DR   Wikidata; Q108819336
RX   Patent=EP0501779A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10563.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P47712; Human PLA2G4A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   #15310-LN
AC   CVCL_E548
SY   15310-LN; TER461; TER-461; Ter 461; TER479; TER-479; Ter 479; Extract 519
DR   dbMHC; 48439
DR   ECACC; 94050311
DR   IHW; IHW09326
DR   IPD-IMGT/HLA; 10074
DR   Wikidata; Q54398957
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/360cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/370cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; French Canadian.
CC   HLA typing: A*03,25; B*37:01:01:01,47:01:01:03; C*06; DPA1*01; DPB1*04:01:01; DQA1*01:01:01:01,01:03:01; DQB1*05:01:01;06:03:01:02; DRB1*01:01:01,14:17; DRB3*01:01 (IPD-IMGT/HLA=10074).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94050311; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   #16-15
AC   CVCL_KA96
DR   RCB; RCB4635
DR   Wikidata; Q54422067
RX   PubMed=25400923;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q5T5X7; Human BEND3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   #31
AC   CVCL_F0A0
DR   ABCD; ABCD_BF024
RX   Patent=US10253105;
RX   PubMed=33347385;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; O60603; Human TLR2.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   #40a
AC   CVCL_IW91
DR   Wikidata; Q54422071
RX   PubMed=28159921;
CC   Characteristics: Established from parent cell line after two passages in the peritoneal cavity of C57BL/6 mice (PubMed=28159921).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IW90 ! 40
SX   Male
AG   1-2M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 6
//
ID   #48
AC   CVCL_F0A1
RX   PubMed=33347385;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   #490
AC   CVCL_B375
SY   490; Mab 7; Mab7
DR   CLO; CLO_0001018
DR   ATCC; HB-12029
DR   Wikidata; Q54422073
RX   Patent=US5616470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12029.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Cronartium ribicola antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   #822
AC   CVCL_X345
SY   822; Mab 13; Mab13
DR   ATCC; HB-12030
DR   Wikidata; Q54422076
RX   Patent=US5616470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12030.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Cronartium ribicola antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   #G65G
AC   CVCL_C4ZN
DR   Wikidata; Q116047768
RX   PubMed=11394529;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10683; Rat Gal.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   #W7079
AC   CVCL_E549
SY   #W7079 REM; REMUS; W7079
DR   dbMHC; 48440
DR   ECACC; 94022552
DR   IHW; IHW09223
DR   IPD-IMGT/HLA; 11548
DR   Wikidata; Q54480892
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:06; B*40:01:02:01,67:01:01; C*03,07; DPB1*04:01,05:01 (IPD-IMGT/HLA=11548).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   (BF1) 8A3.31
AC   CVCL_G217
DR   CLO; CLO_0001019
DR   ATCC; HB-9283
DR   Wikidata; Q54422077
RX   Patent=US4845026;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9283.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42).
CC   Discontinued: ATCC; HB-9283; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   (L)PC6
AC   CVCL_VG99
DR   TKG; TKG 0732
DR   Wikidata; Q53869506
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): TKG=TKG 0732
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   +/+ (A)
AC   CVCL_6479
DR   CLO; CLO_0001020
DR   ATCC; CRL-6470
DR   Wikidata; Q54481857
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6470; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   +/+ (B)
AC   CVCL_6480
DR   CLO; CLO_0001021
DR   ATCC; CRL-6471
DR   Wikidata; Q54481859
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6471; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   +/+ (C)
AC   CVCL_S361
DR   ATCC; CRL-6472
DR   Wikidata; Q54481860
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6472; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   +/+ Li
AC   CVCL_4977
DR   CLO; CLO_0001022
DR   ATCC; CRL-6467
DR   Wikidata; Q54481861
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-340.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6467; true.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   +/+ MGT
AC   CVCL_3627
DR   CLO; CLO_0001023
DR   ATCC; CRL-6468
DR   Wikidata; Q54399824
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   +/+ SCT
AC   CVCL_3628
DR   CLO; CLO_0001024
DR   ATCC; CRL-6469
DR   Wikidata; Q54481866
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   0.57
AC   CVCL_WM09
DR   Wikidata; Q93293951
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=821777;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   0.5alpha
AC   CVCL_B5B3
SY   0.5 alpha
DR   Wikidata; Q110429629
RX   PubMed=2422659;
RX   PubMed=2476442;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03381; Human T-cell leukemia virus 1 (HTLV-1) env (Note=AA 21-312 = gp46/SU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   00-143
AC   CVCL_D1GY
DR   Wikidata; Q127378545
RX   PubMed=11733348;
RX   PubMed=21447744;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=11733348; PubMed=21447744).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   00136
AC   CVCL_E557
SY   136
DR   dbMHC; 48441
DR   ECACC; 94071418
DR   IHW; IHW09279
DR   IPD-IMGT/HLA; 10002
DR   Wikidata; Q54481868
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native North American.
CC   HLA typing: A*02; B*40:05,48:01; C*03:04,08; DPB1*04:01,14:01; DQB1*03;04:02; DRB1*04:10,14:06; DRB3*01,01 (IPD-IMGT/HLA=10002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   0138F-1
AC   CVCL_ZB51
DR   Wikidata; Q98110377
RX   PubMed=32151953;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   0162D
AC   CVCL_VG31
DR   SKIP; SKIP001331
DR   Wikidata; Q54399825
RX   PubMed=26740656;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   0165D
AC   CVCL_VG32
DR   SKIP; SKIP001332
DR   Wikidata; Q54399827
RX   PubMed=26740656;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   017-PC-A
AC   CVCL_ZW87
SY   PC-A
DR   Wikidata; Q102111939
RX   PubMed=27109637;
CC   Characteristics: hESC-derived mesenchymal progenitor (PubMed=27109637).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B854 ! ESI-017
SX   Female
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   017-PC-M
AC   CVCL_ZW88
SY   PC-M
DR   Wikidata; Q102111940
RX   PubMed=27109637;
CC   Characteristics: hESC-derived pericyte-like cell.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Pericyte; CL=CL_0000669.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZW87 ! 017-PC-A
SX   Female
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   017-PC-O
AC   CVCL_ZW89
SY   PC-O
DR   Wikidata; Q102111941
RX   PubMed=27109637;
CC   Characteristics: hESC-derived osteogenic progenitor (PubMed=27109637).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZW87 ! 017-PC-A
SX   Female
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   01Abic immortal clone #2
AC   CVCL_D2Y7
DR   Wikidata; Q127378546
RX   PubMed=21798090;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2Y8 ! 01Abic immortal clone #6
SX   Male
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 6
//
ID   01Abic immortal clone #6
AC   CVCL_D2Y8
DR   Wikidata; Q127378547
RX   PubMed=21798090;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2Y7 ! 01Abic immortal clone #2
SX   Male
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 6
//
ID   0225-02Sp
AC   CVCL_XB90
DR   CCRID; 4201PAT-CCTCC00348
DR   Wikidata; Q93293979
RX   Patent=CN102433305B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201028.
CC   Population: Chinese.
CC   Doubling time: 40.32 hours (Patent=CN102433305B).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   022HU-NSO
AC   CVCL_6494
DR   CLO; CLO_0001025
DR   ATCC; CRL-11177
DR   Wikidata; Q54399830
CC   Discontinued: ATCC; CRL-11177; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   0274F-1
AC   CVCL_ZB52
DR   Wikidata; Q98110378
RX   PubMed=32151953;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_ZB53 ! 0274F-2
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   0274F-2
AC   CVCL_ZB53
DR   Wikidata; Q98110379
RX   PubMed=32151953;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_ZB52 ! 0274F-1
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   03-01 fibroblast
AC   CVCL_A2TJ
DR   Wikidata; Q105505720
RX   PubMed=23160490;
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-01 iPS #2
AC   CVCL_A2UI
SY   03-01#2
DR   GEO; GSM1019353
DR   Wikidata; Q105505724
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TJ ! 03-01 fibroblast
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-01 iPS #3
AC   CVCL_A2UJ
SY   03-01#3
DR   GEO; GSM1019354
DR   Wikidata; Q105505726
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TJ ! 03-01 fibroblast
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-01 iPS #4
AC   CVCL_A2UK
SY   03-01#4
DR   GEO; GSM1019355
DR   Wikidata; Q105505729
RX   PubMed=23160490;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TJ ! 03-01 fibroblast
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-01 iPS #9
AC   CVCL_A2UL
SY   03-01#9
DR   GEO; GSM1019356
DR   Wikidata; Q105505734
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TJ ! 03-01 fibroblast
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-02 fibroblast
AC   CVCL_A2TK
DR   Wikidata; Q105505737
RX   PubMed=23160490;
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-02 iPS #2B
AC   CVCL_A2UM
SY   03-02#2B
DR   GEO; GSM1019360
DR   Wikidata; Q105505740
RX   PubMed=23160490;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TK ! 03-02 fibroblast
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-02 iPS #5
AC   CVCL_A2UN
SY   03-02#5
DR   GEO; GSM1019358
DR   Wikidata; Q105505744
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TK ! 03-02 fibroblast
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-02 iPS #8
AC   CVCL_A2UP
SY   03-02#8
DR   GEO; GSM1019359
DR   Wikidata; Q105505748
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TK ! 03-02 fibroblast
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-02 iPS #9
AC   CVCL_A2UQ
SY   03-02#9
DR   GEO; GSM1019357
DR   Wikidata; Q105505750
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TK ! 03-02 fibroblast
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-03 fibroblast
AC   CVCL_A2TL
DR   Wikidata; Q105505752
RX   PubMed=23160490;
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-03 iPS #2
AC   CVCL_A2UR
SY   03-03#2
DR   GEO; GSM1019350
DR   Wikidata; Q105505755
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TL ! 03-03 fibroblast
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-03 iPS #3
AC   CVCL_A2US
SY   03-03#3
DR   GEO; GSM1019351
DR   Wikidata; Q105505760
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TL ! 03-03 fibroblast
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-03 iPS #4
AC   CVCL_A2UT
SY   03-03#4
DR   GEO; GSM1019352
DR   Wikidata; Q105505766
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TL ! 03-03 fibroblast
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-04 fibroblast
AC   CVCL_A2TM
DR   Wikidata; Q105505770
RX   PubMed=23160490;
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-04 iPS #1
AC   CVCL_A2UU
SY   03-04#1
DR   GEO; GSM1019362
DR   Wikidata; Q105505771
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TM ! 03-04 fibroblast
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-04 iPS #3
AC   CVCL_A2UV
SY   03-04#3
DR   GEO; GSM1019363
DR   Wikidata; Q105505775
RX   PubMed=23160490;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TM ! 03-04 fibroblast
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-04 iPS #5
AC   CVCL_A2UW
SY   03-04#5
DR   GEO; GSM1019364
DR   Wikidata; Q105505779
RX   PubMed=23160490;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TM ! 03-04 fibroblast
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   03-04 iPS #6
AC   CVCL_A2UX
SY   03-04#6
DR   GEO; GSM1019361
DR   Wikidata; Q105505781
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TM ! 03-04 fibroblast
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   0308
AC   CVCL_IP58
SY   0308-GSC; GSC-0308
DR   BTO; BTO_0006002
DR   Wikidata; Q54423216
RX   PubMed=23307328;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   031M-CUMC/INSERM
AC   CVCL_IJ15
SY   031M
DR   Wikidata; Q54399831
RX   PubMed=27789403;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   0342 mel
AC   CVCL_C7W5
DR   Wikidata; Q123030190
RX   PubMed=22207316;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   0363M-1
AC   CVCL_YZ96
DR   Wikidata; Q98110380
RX   PubMed=32151953;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_YZ97 ! 0363M-2
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   0363M-2
AC   CVCL_YZ97
DR   Wikidata; Q98110436
RX   PubMed=32151953;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_YZ96 ! 0363M-1
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   0467.3
AC   CVCL_A6HV
DR   Wikidata; Q107113125
RX   PubMed=3365703;
RX   PubMed=6286839;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J105 ! GM00467
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   04T036
AC   CVCL_WU68
DR   ArrayExpress; E-MTAB-5625
DR   Wikidata; Q93294007
RX   PubMed=16737911;
RX   PubMed=29279323;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, right upper lobe; UBERON=UBERON_0002170.
DI   NCIt; C45540; Lung sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 5
//
ID   051407cb
AC   CVCL_V362
SY   970615NSB
DR   IPD-IMGT/HLA; 14462
DR   Wikidata; Q54481883
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,11:29; B*18:01,07:02; C*06:02,07:02; DQB1*03:01,06:02; DRB1*11:04,15:01; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=14462).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   059-1.100.5
AC   CVCL_C4MD
DR   Wikidata; Q116047769
RX   Patent=US11155632;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   059-1.11.1
AC   CVCL_C4ME
DR   Wikidata; Q116047770
RX   Patent=US11155632;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   059-1.20.1
AC   CVCL_C4MF
DR   Wikidata; Q116047771
RX   Patent=US11155632;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   059-1.30.1
AC   CVCL_C4MG
DR   Wikidata; Q116047772
RX   Patent=US11155632;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   059-1.43.1
AC   CVCL_C4MH
DR   Wikidata; Q116047773
RX   Patent=US11155632;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   059-1.51.2
AC   CVCL_C4MI
DR   Wikidata; Q116047774
RX   Patent=US11155632;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   059-1.82.1
AC   CVCL_C4MJ
DR   Wikidata; Q116047775
RX   Patent=US11155632;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   066
AC   CVCL_Y448
DR   ATCC; CRL-6287
DR   Wikidata; Q54481884
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6287; true.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   066MD-CUMC/INSERM
AC   CVCL_IJ16
SY   066MD
DR   Wikidata; Q54399832
RX   PubMed=27789403;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   07-01 fibroblast
AC   CVCL_A2YX
DR   Wikidata; Q105505785
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   07-01 iPS #1
AC   CVCL_A2YY
SY   07-01#1; i07-01#1
DR   SKIP; SKIP001214
DR   Wikidata; Q105505788
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2YX ! 07-01 fibroblast
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   07-01 iPS #2
AC   CVCL_A2YZ
SY   07-01#2; i07-01#2
DR   SKIP; SKIP001215
DR   Wikidata; Q105505792
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2YX ! 07-01 fibroblast
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   07-01 iPS #4
AC   CVCL_A2ZA
SY   07-01#4; i07-01#4
DR   SKIP; SKIP001216
DR   Wikidata; Q105505794
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2YX ! 07-01 fibroblast
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   07-02 fibroblast
AC   CVCL_A4QY
DR   Wikidata; Q105505797
RX   PubMed=26186191;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   07-02 iPS #10
AC   CVCL_A4RB
SY   07-02#10; i07-02#10
DR   SKIP; SKIP001219
DR   Wikidata; Q105505802
RX   PubMed=26186191;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QY ! 07-02 fibroblast
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   07-02 iPS #3
AC   CVCL_A4QZ
SY   07-02#3; i07-02#3
DR   SKIP; SKIP001217
DR   Wikidata; Q105505805
RX   PubMed=26186191;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QY ! 07-02 fibroblast
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   07-02 iPS #5
AC   CVCL_A4RA
SY   07-02#5; i07-02#5
DR   SKIP; SKIP001218
DR   Wikidata; Q105505807
RX   PubMed=26186191;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QY ! 07-02 fibroblast
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   07-03 fibroblast
AC   CVCL_A2ZB
DR   Wikidata; Q105505812
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   07-03 iPS #3
AC   CVCL_A2ZC
SY   07-03#3; i07-03#3
DR   SKIP; SKIP001208
DR   Wikidata; Q105505816
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZB ! 07-03 fibroblast
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   07-03 iPS #7
AC   CVCL_A2ZD
SY   07-03#7; i07-03#7
DR   SKIP; SKIP001209
DR   Wikidata; Q105505821
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZB ! 07-03 fibroblast
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   07-03 iPS #9
AC   CVCL_A2ZE
SY   07-03#9; i07-03#9
DR   SKIP; SKIP001210
DR   Wikidata; Q105505825
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZB ! 07-03 fibroblast
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   07-4D
AC   CVCL_J077
DR   ECACC; 91121239
DR   Wikidata; Q54423218
RX   PubMed=2277091;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P33545; Bovine DSC2.
CC   Monoclonal antibody target: UniProtKB; Q28060; Bovine DSC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   07-S-0025#0100
AC   CVCL_6G61
DR   IPD-IMGT/HLA; 12636
DR   Wikidata; Q54481891
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,24:32; B*38:01,58:01; DQB1*04:02,06:09; DRB1*13,08:01 (IPD-IMGT/HLA=12636).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   0822
AC   CVCL_IP59
SY   0822-GSC; GSC-0822
DR   BTO; BTO_0006003
DR   Wikidata; Q54423219
RX   PubMed=23307328;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   0840-FusionRed
AC   CVCL_B6YG
DR   Wikidata; Q111732586
RX   PubMed=34972712;
CC   Genetic integration: Method=Transfection; Gene=FPbase; S6A7A; FusionRed (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Pitbull Terrier; VBO=VBO_0200054.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_ZV59 ! TihoDProCarc/TCC0840
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   0846-FusionRed
AC   CVCL_B6YH
DR   Wikidata; Q111732587
RX   PubMed=34972712;
CC   Genetic integration: Method=Transfection; Gene=FPbase; S6A7A; FusionRed (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: German Roughhaired Pointer; VBO=VBO_0200575.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_ZV54 ! TihoDProAdcarc0846
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   090727 LQT3/BrS g1
AC   CVCL_T913
DR   SKIP; SKIP000214
DR   Wikidata; Q54423220
CC   Discontinued: SKIP; SKIP000214; probable.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T914 ! 090727 LQT3/BrS g2
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   090727 LQT3/BrS g2
AC   CVCL_T914
DR   SKIP; SKIP000215
DR   Wikidata; Q54423221
CC   Discontinued: SKIP; SKIP000215; probable.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T913 ! 090727 LQT3/BrS g1
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   09097B
AC   CVCL_VG29
DR   SKIP; SKIP001329
DR   Wikidata; Q54399834
RX   PubMed=26740656;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   09097C
AC   CVCL_VG25
DR   SKIP; SKIP001325
DR   Wikidata; Q54399836
RX   PubMed=26740656;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012602; Zygosity=Unspecified (PubMed=26740656).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84652; Costello syndrome
DI   ORDO; Orphanet_3071; Costello syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   1-10 [Mouse hybridoma against mouse Rnf2]
AC   CVCL_C5A0
DR   Wikidata; Q116047776
RX   PubMed=11289226;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CQJ4; Mouse Rnf2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1-10 [Mouse hybridoma against ouabain]
AC   CVCL_B0PX
DR   Wikidata; Q108819337
RX   Patent=US7348412;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-812.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   1-10-1
AC   CVCL_B6WZ
DR   CCRID; 4201PAT-CCTCC00723
DR   Wikidata; Q111732588
RX   Patent=CN105132381B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201599.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human high density lipoprotein (HDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   1-10F-8A
AC   CVCL_F1E9
DR   ABCD; ABCD_BF050
RX   PubMed=11035793;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_33128; C60 fullerene (Buckminsterfullerene).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1-11
AC   CVCL_C0WE
DR   Wikidata; Q114245350
RX   PubMed=18021259;
RX   PubMed=18181171;
RX   PubMed=20931341;
CC   Characteristics: Derived from a progenitor/stem cell present in the periodontal ligament and may be very useful for studying the biology and regeneration of periodontium (PubMed=18181171).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0WC ! STPLF-fF
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   1-11A
AC   CVCL_C0E0
DR   Wikidata; Q112926879
DR   Ximbio; 160684
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UY09; Human CEACAM20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   1-12
AC   CVCL_B3Y8
DR   Wikidata; Q110429631
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1-17
AC   CVCL_C0WF
DR   Wikidata; Q114245351
RX   PubMed=18021259;
RX   PubMed=33604904;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0WC ! STPLF-fF
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   1-185-37
AC   CVCL_C5PU
DR   ABCD; ABCD_AE758
DR   Wikidata; Q116047777
RX   PubMed=1280761;
RX   PubMed=3500505;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P02708; Human CHRNA1 (Note=Also reacts with Torpedo).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5PV ! 1-187-29
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   1-187-29
AC   CVCL_C5PV
DR   ABCD; ABCD_AE757
DR   Wikidata; Q116047778
RX   PubMed=1280761;
RX   PubMed=3500505;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P02708; Human CHRNA1 (Note=Also reacts with Torpedo).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5PU ! 1-185-37
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   1-19-1
AC   CVCL_XI59
DR   CCRID; 4201PAT-CCTCC00713
DR   Wikidata; Q93294081
RX   Patent=CN105132377B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201589.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   1-1A4
AC   CVCL_DB54
DR   Wikidata; Q54423222
DR   Ximbio; 151022
RX   PubMed=9309427;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   1-1D5
AC   CVCL_DB55
DR   Wikidata; Q54423223
DR   Ximbio; 151023
RX   PubMed=9309427;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   1-1ras1000
AC   CVCL_8653
DR   JCRB; JCRB1355
DR   Wikidata; Q54423224
RX   PubMed=8634088;
RX   PubMed=27844419;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00531.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J646 ! BALB/3T3 A31-1-1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1-1src
AC   CVCL_8654
DR   JCRB; JCRB1357
DR   Wikidata; Q54423225
RX   PubMed=8634088;
RX   PubMed=27844419;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00532.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00524; Rous sarcoma virus subgroup A (strain Schmidt-Ruppin) v-Src.
CC   Transformant: v-Src.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J646 ! BALB/3T3 A31-1-1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   1-2
AC   CVCL_B3Y9
DR   Wikidata; Q110429633
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1-2322-455
AC   CVCL_C1J3
SY   1-2322
DR   Wikidata; Q114245352
RX   Patent=WO2009052400A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8024.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P80188; Human LCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   1-24
AC   CVCL_C0WG
DR   Wikidata; Q114309976
RX   PubMed=18181171;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0WC ! STPLF-fF
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   1-26-1
AC   CVCL_C5HH
DR   Wikidata; Q116047779
RX   PubMed=21529295;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P15920; Mouse Atp6v0a2.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1-29-7
AC   CVCL_Y308
DR   ATCC; HB-63
DR   Wikidata; Q54423226
RX   PubMed=6968779;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human IgA.
CC   Discontinued: ATCC; HB-63; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   1-35-1
AC   CVCL_B6X0
DR   CCRID; 4201PAT-CCTCC00722
DR   Wikidata; Q111732589
RX   Patent=CN105132381B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201598.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human high density lipoprotein (HDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   1-4
AC   CVCL_C0WH
DR   Wikidata; Q114310033
RX   PubMed=18181171;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0WC ! STPLF-fF
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   1-5-2
AC   CVCL_XI60
DR   CCRID; 4201PAT-CCTCC00712
DR   Wikidata; Q93296642
RX   Patent=CN105132377B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201588.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   1-5c-4
AC   CVCL_2260
SY   Clone 1-5c-4; Clone 1-5c-4 WKD of Chang Conjunctiva; Wong-Kilbourne derivative of Chang conjunctiva; ChWK
DR   CLO; CLO_0002500
DR   CLO; CLO_0002501
DR   CLDB; cl793
DR   CLDB; cl794
DR   CLDB; cl795
DR   ATCC; CCL-20.2
DR   BioSample; SAMN03151673
DR   ECACC; 88021103
DR   IZSLER; BS CL 93
DR   KCLB; 10020.2
DR   Wikidata; Q54399838
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=19630270;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=20143388). Originally thought to originate from the conjunctiva of a child.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00298.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-20.2; KCLB=10020.2
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   1-6
AC   CVCL_B3YA
DR   Wikidata; Q110429635
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1-7
AC   CVCL_C8TZ
DR   Wikidata; Q123030191
RX   Patent=EP0259585B1;
RX   PubMed=2426355;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06734; Human FCER2/CD23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   1-8
AC   CVCL_T367
DR   CLO; CLO_0050510
DR   RCB; RCB1374
DR   Wikidata; Q54399841
RX   PubMed=8973332;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   1-87
AC   CVCL_D231
DR   cancercelllines; CVCL_D231
DR   ChEMBL-Cells; CHEMBL3307800
DR   ChEMBL-Targets; CHEMBL612272
DR   Cosmic; 889083
DR   Cosmic; 946049
DR   Cosmic; 1066155
DR   PubChem_Cell_line; CVCL_D231
DR   Wikidata; Q54423231
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9538136;
RX   PubMed=16105816;
RX   PubMed=17511773;
CC   Population: Japanese.
CC   HLA typing: A*02:07,11:01; B*46:01,54:01; C*01:02 (PubMed=9178645).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=In 10% of cells (PubMed=16105816).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   1-9
AC   CVCL_B3YB
DR   Wikidata; Q110429637
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1-903-430
AC   CVCL_C1J4
SY   1-903
DR   Wikidata; Q114310034
RX   Patent=WO2009052400A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8026.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P80188; Human LCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   1-A2
AC   CVCL_9V12
DR   Wikidata; Q54423232
RX   DOI=10.1007/978-1-4684-4949-5_8;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human herpesvirus 3 (HHV-3).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W179 ! SBC-H20
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   1-A5
AC   CVCL_D4XN
DR   Wikidata; Q127378549
RX   PubMed=2569807;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q7TDB3; Foot-and-mouth disease virus Asia 1 (isolate Vaccine IND 63/72) genome polyprotein (Note=AA 724-934 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   1-B1
AC   CVCL_D4XP
DR   Wikidata; Q127378550
RX   PubMed=2569807;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q7TDB3; Foot-and-mouth disease virus Asia 1 (isolate Vaccine IND 63/72) genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   1-F10
AC   CVCL_XB14
DR   Wikidata; Q93296655
RX   Patent=CN103045541A;
RX   PubMed=23746246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012139.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05413; Human FABP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   1-H4
AC   CVCL_XD10
DR   Wikidata; Q93296658
RX   PubMed=23746246;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05413; Human FABP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   1-LN
AC   CVCL_L211
SY   1LN; 1-LN-PC-3-1A; 1LN-PC31A
DR   BTO; BTO_0005352
DR   cancercelllines; CVCL_L211
DR   IARC_TP53; 2305
DR   Wikidata; Q54399843
RX   PubMed=4007233;
RX   PubMed=8510267;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   1-NKAD3
AC   CVCL_D4B2
DR   Wikidata; Q127378551
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Doubling time: 40 +- 10 hours (PubMed=37087860).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MZCS-0430.
OX   NCBI_TaxID=1051664; ! Nothobranchius kadleci (African annual killifish)
SX   Sex unspecified
AG   Diapause III embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   1.1
AC   CVCL_C5WS
DR   Wikidata; Q116047780
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1.11
AC   CVCL_C8GH
DR   Wikidata; Q123030192
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   From: Jaffee, Elizabeth Marion; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   HLA typing: A*02,66; B*01,18; C*07 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   1.18
AC   CVCL_C8GI
DR   Wikidata; Q123030193
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   From: Jaffee, Elizabeth Marion; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   HLA typing: A*01,24; B*07,08; C*07 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   1.1ASML
AC   CVCL_LC22
SY   A2.6
DR   Wikidata; Q54423234
RX   PubMed=2228320;
RX   PubMed=2917359;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26051; Rat Cd44 (Note=Isoform V6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 4
//
ID   1.1B4
AC   CVCL_1778
DR   CCRID; 5301HUM-KCB15017YJ
DR   ECACC; 10012801
DR   KCB; KCB 2015017YJ
DR   Wikidata; Q54423235
RX   Patent=US20040005702;
RX   PubMed=21515691;
RX   PubMed=23985558;
RX   PubMed=34341375;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be an hybrid cell line obtained by electrofusion of a primary culture of human pancreatic islets with the PANC-1 but found to contain rat DNA (ECACC=10012801; PubMed=34341375).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00599.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00112811.
CC   Characteristics: Insulin secreting.
CC   Doubling time: 23 +- 1.7 hours (PubMed=21515691); ~20 hours (ECACC=10012801).
CC   Discontinued: ECACC; 10012801; true.
ST   Source(s): ECACC=10012801; Patent=US20040005702
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0480 ! PANC-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   1.1E7
AC   CVCL_2257
DR   ECACC; 10070101
DR   Wikidata; Q54423236
RX   Patent=US20040005702;
RX   PubMed=21515691;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be an hybrid cell line obtained by electrofusion of a primary culture of human pancreatic islets with the PANC-1 but found to contain rat DNA (ECACC=10070101).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00600.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3523.
CC   Characteristics: Insulin secreting.
CC   Doubling time: 23 +- 1.9 hours (PubMed=21515691); ~23 hours (ECACC=10070101).
CC   Discontinued: ECACC; 10070101; true.
ST   Source(s): ECACC=10070101; Patent=US20040005702
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0480 ! PANC-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   1.24
AC   CVCL_C8GJ
DR   Wikidata; Q123030194
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   From: Jaffee, Elizabeth Marion; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   HLA typing: A*01,02; B*39,63; C*01,07 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   1.26
AC   CVCL_C8GK
DR   Wikidata; Q123030195
RX   PubMed=18698046;
CC   From: Jaffee, Elizabeth Marion; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   1.2B4
AC   CVCL_2258
DR   CancerTools; 161633
DR   ECACC; 10070103
DR   Wikidata; Q54399845
RX   Patent=US20040005702;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3524.
CC   Characteristics: Insulin secreting.
CC   Characteristics: Produced by electrofusion of HuP-T3 with a primary culture of human pancreatic islets.
CC   Doubling time: ~20 hours (ECACC=10070103).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4071_4072insGATT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (from parent cell line).
ST   Source(s): ECACC=10070103; Patent=US20040005702
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D18S51: 16,17
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 10,14
ST   D7S820: 12
ST   D8S1179: 15
ST   FGA: 21,22
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1299 ! HuP-T3
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   1.2C7
AC   CVCL_AP65
DR   Coriell; WC00053
DR   Wikidata; Q54423237
RX   PubMed=1530795;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03460; Influenza B virus (strain B/Lee/1940) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00053; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 5
//
ID   1.4E7
AC   CVCL_2259
DR   CancerTools; 161632
DR   ECACC; 10070102
DR   Wikidata; Q54423238
RX   Patent=US20040005702;
RX   PubMed=21515691;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3525.
CC   Characteristics: Insulin secreting.
CC   Characteristics: Produced by electrofusion of PANC-1 with a primary culture of human pancreatic islets.
CC   Doubling time: 26 +- 1.5 hours (PubMed=21515691); ~26 hours (ECACC=10070102).
ST   Source(s): ECACC=10070102; Patent=US20040005702
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   1.51
AC   CVCL_D7DF
RX   PubMed=12354868;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q47952; Haemophilus ducreyi (strain 35000HP / ATCC 700724) hgbA (Note=Also reacts with all other strains of H.ducreyi).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   1.59
AC   CVCL_WM10
DR   Wikidata; Q93296673
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=821777;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   1.5A9
AC   CVCL_AP64
DR   Coriell; WC00052
DR   Wikidata; Q54423239
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03460; Influenza B virus (strain B/Lee/1940) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00052; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 5
//
ID   1.82
AC   CVCL_E2SL
RX   PubMed=18212073;
RX   PubMed=25897604;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; G1UBB6; Haemophilus ducreyi (strain 35000HP / ATCC 700724) dsrA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1.90.6
AC   CVCL_KR63
SY   1.90
DR   ATCC; HB-8336
DR   Wikidata; Q54423240
RX   Patent=US4650676;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8336.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella merozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   1.A16
AC   CVCL_E4F6
RX   PubMed=19305140;
CC   Omics: Variations; SNP array analysis.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0334 ! Hs 766T
HI   CVCL_1635 ! Panc 03.27
CA   Hybrid cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   1.A18
AC   CVCL_E4F7
RX   PubMed=19305140;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0334 ! Hs 766T
HI   CVCL_1635 ! Panc 03.27
CA   Hybrid cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1.A21
AC   CVCL_E4F8
RX   PubMed=19305140;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0334 ! Hs 766T
HI   CVCL_1635 ! Panc 03.27
CA   Hybrid cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1.B6
AC   CVCL_E4F9
RX   PubMed=19305140;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0334 ! Hs 766T
HI   CVCL_1635 ! Panc 03.27
CA   Hybrid cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1/2Pea
AC   CVCL_LB75
DR   Wikidata; Q54399844
RX   PubMed=25708088;
RX   PubMed=27936237;
CC   Group: Marsupial cell line.
CC   Characteristics: Originates from DFT1 strain 2.
DI   NCIt; C176223; Devil facial tumor disease 1
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_LB76 ! 1426
OI   CVCL_LB77 ! 2112
OI   CVCL_LB78 ! 4906
OI   CVCL_LB79 ! C5065
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   1/39
AC   CVCL_XX77
DR   ABCD; ABCD_AK426
DR   Wikidata; Q93296677
RX   DOI=10.24450/journals/abrep.2019.e59;
RX   PubMed=10519007;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Dictyostelium discoideum antigen in Golgi compartment.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   10(AAT) Clone A
AC   CVCL_U069
DR   ECACC; 02043015
DR   Wikidata; Q54423249
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   10-1.D.2
AC   CVCL_B376
SY   10.1.D2
DR   CLO; CLO_0001027
DR   ATCC; TIB-165
DR   Wikidata; Q54423241
RX   PubMed=6601145;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P21855; Mouse Cd72.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   10-15
AC   CVCL_D1H0
SY   NMC1015
DR   BioGRID_ORCS_Cell_line; 793
DR   Wikidata; Q127378552
RX   PubMed=23604113;
RX   PubMed=24736545;
RX   PubMed=30135075;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=23604113; PubMed=24736545).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   10-2
AC   CVCL_B6X1
DR   CCRID; 4201PAT-CCTCC00720
DR   Wikidata; Q111732590
RX   Patent=CN105132382A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201596.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08727; Human KRT19 (Note=AA 301-400 = CYFRA21-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   10-2.16
AC   CVCL_B377
DR   CLO; CLO_0001028
DR   ATCC; TIB-93
DR   Wikidata; Q54423242
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   10-25
AC   CVCL_C3VW
DR   ABCD; ABCD_AE165
DR   Wikidata; Q116047781
RX   PubMed=2104617;
RX   PubMed=3821741;
RX   PubMed=3930950;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10-3.6.2
AC   CVCL_B378
DR   CLO; CLO_0001029
DR   ATCC; TIB-92
DR   Wikidata; Q54423245
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   10-4A
AC   CVCL_B7UW
DR   GEO; GSM4711503
DR   GEO; GSM4711504
DR   GEO; GSM4711505
DR   GEO; GSM4711506
DR   Wikidata; Q112926880
RX   PubMed=33162897;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=33162897).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Alveolar type 2 fibroblast; CL=CL_4028006.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   12-14W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   10-4A(BFP)
AC   CVCL_B7UX
SY   10-4ABFP
DR   Wikidata; Q112926881
RX   PubMed=33162897;
CC   Characteristics: Using CRISPR/Cas9 a T2A-TagBFP-NLS construct was introduced at the C-terminus of Acta2 (PubMed=33162897).
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Alveolar type 2 fibroblast; CL=CL_4028006.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B7UW ! 10-4A
SX   Male
AG   12-14W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   10.014 pRSV-T
AC   CVCL_6341
SY   10.014; HCE-T; Human Corneal Epithelial cells-Transfected
DR   CLO; CLO_0001026
DR   ATCC; CRL-11515
DR   BioSample; SAMN03471338
DR   Wikidata; Q54399847
RX   Patent=US5672498;
RX   PubMed=9143482;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/10-014-prsv-t-atcc-crl-11515-growth-and-morphology
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11515.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Discontinued: ATCC; CRL-11515; true.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
ST   Source(s): ATCC=CRL-11515
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 8,13
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   10.1
AC   CVCL_C5WT
DR   Wikidata; Q116047784
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10.1.1
AC   CVCL_D3RD
DR   DSHB; 10-1-1
DR   Wikidata; Q127378553
RX   PubMed=8432973;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q91Z28; Mouse Clca3a1.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   10.11.3.9.2.3
AC   CVCL_D2Q9
DR   Wikidata; Q127378554
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   10.16.1
AC   CVCL_D3UW
DR   Wikidata; Q127378555
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   10.2
AC   CVCL_A9KM
SY   HB 10.2
DR   CCRID; 4201PAT-CCTCC00046
DR   Wikidata; Q108819338
RX   Patent=US6010902;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10269.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   10.2.8.2.3
AC   CVCL_D2Q8
DR   Wikidata; Q127378556
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   10.84.2
AC   CVCL_J168
SY   10.84
DR   ATCC; HB-8387
DR   Wikidata; Q54423247
RX   Patent=US4650676;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8387.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella merozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   10/12SN
AC   CVCL_D7ED
RX   PubMed=1612780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 65/83 kDa heterodimeric antigen on ocular melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   10/16
AC   CVCL_C7IX
SY   10/16.4.3
DR   Wikidata; Q123030196
RX   PubMed=3411286;
RX   PubMed=3488262;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   10/78
AC   CVCL_KS99
DR   Wikidata; Q54423248
RX   PubMed=8921942;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27471; Rat Klrb1a/Cd161a.
CC   Monoclonal antibody target: UniProtKB; A4KWA1; Rat Klrb1b/Cd161b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   10/8
AC   CVCL_C7IY
SY   10/8.1.4
DR   Wikidata; Q123030197
RX   PubMed=3102254;
RX   PubMed=3411286;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   10/9CRC1
AC   CVCL_8478
SY   MPC 10/9CRC1
DR   BTO; BTO_0004581
DR   Wikidata; Q54399848
RX   PubMed=15860353;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97306; Nf1.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
CC   Breed/subspecies: C57BL/6 x 129S2/SvPas.
DI   NCIt; C134960; Mouse adrenal gland pheochromocytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   100-1#16
AC   CVCL_T867
SY   100-1 #16
DR   GEO; GSM898296
DR   SKIP; SKIP000192
DR   Wikidata; Q54399849
RX   PubMed=22848530;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T866 ! 100-1#8
SX   Female
AG   106Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   100-1#8
AC   CVCL_T866
SY   100-1 #8
DR   SKIP; SKIP000191
DR   Wikidata; Q54399850
RX   PubMed=22848530;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T867 ! 100-1#16
SX   Female
AG   106Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   100-2#1
AC   CVCL_T868
SY   100-2 #1
DR   SKIP; SKIP000193
DR   SKIP; SKIP001017
DR   Wikidata; Q54399853
RX   PubMed=22848530;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   109Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   100-310
AC   CVCL_N280
DR   ATCC; HB-11028
DR   Wikidata; Q54481983
RX   Patent=US5565356;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11028.
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   1000T
AC   CVCL_A1ZY
DR   Wikidata; Q105505829
RX   PubMed=3032416;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   100213 LQT2 theta10
AC   CVCL_T915
DR   SKIP; SKIP000217
DR   Wikidata; Q54481984
CC   Discontinued: SKIP; SKIP000217; probable.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T916 ! 100213 LQT2 theta4
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   100213 LQT2 theta4
AC   CVCL_T916
DR   SKIP; SKIP000216
DR   Wikidata; Q54481987
CC   Discontinued: SKIP; SKIP000216; probable.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T915 ! 100213 LQT2 theta10
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   1003-pK4 clone 8129
AC   CVCL_B5N3
DR   Wikidata; Q111732591
RX   PubMed=2153146;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5MX ! C17-S1 clone 1003
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   10049
AC   CVCL_F1YF
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg1362Ter (c.4084C>T); ClinVar=VCV000000344; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Glu162Lys (c.484G>A); Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   10063349
AC   CVCL_6G62
DR   IPD-IMGT/HLA; 12650
DR   Wikidata; Q54399854
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:MT,68:01:01; B*07:BD,40:JV; DQB1*06:04,03:BG; DRB1*04:04,13:02 (IPD-IMGT/HLA=12650).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   1007P
AC   CVCL_WM18
DR   Cosmic; 852194
DR   Wikidata; Q93296715
RX   PubMed=15195137;
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 6
//
ID   10092
AC   CVCL_F1YG
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   101-87T
AC   CVCL_A2AA
DR   Wikidata; Q105505833
RX   PubMed=3165706;
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   10101
AC   CVCL_E3EB
CC   Population: Caucasian, not Hispanic.
CC   Doubling time: 42-48 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser2557Phe (c.7670C>T); ClinVar=VCV000827187; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.5005+1G>A; ClinVar=VCV000859032; Zygosity=Unspecified; Note=Splice donor mutation (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Ser614Phe (c.1841C>T); Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; c.-14-1G>A; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7217; MPL; Simple; c.1565+5C>T; ClinVar=VCV000135564; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:15979; TP63; Simple; p.Gln257Glu (c.769C>G); Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.His1135Tyr (c.3403C>T); ClinVar=VCV001442116; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Jenkins, Russell William.
CC   Derived from site: Metastatic; Pelvis, hypodermis; UBERON=UBERON_0002355+UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   1011-mel
AC   CVCL_7942
SY   1011-MEL; 1011 mel; 1011mel; 1011; Mel 1011
DR   cancercelllines; CVCL_7942
DR   CGH-DB; 9292-4
DR   Cosmic; 876687
DR   Cosmic; 905206
DR   Wikidata; Q54481991
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   1013
AC   CVCL_B3UR
DR   Wikidata; Q110429639
RX   PubMed=30567931;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   1013-4FA
AC   CVCL_A9M5
SY   1013 iPSC; ND-1; hiPSC-1
DR   Wikidata; Q102111942
RX   PubMed=25303535;
RX   PubMed=27163171;
RX   PubMed=30661993;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   1013L
AC   CVCL_4806
SY   1013-L; 1013 L
DR   Cosmic; 721372
DR   Wikidata; Q54399855
RX   CelloPub=CLPUB00698;
RX   PubMed=2744886;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=14518029;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200527/http://capcelllines.ca:80/details.asp?id=78
CC   Karyotypic information: Hypertriploid (CelloPub=CLPUB00698).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=14518029
ST   Amelogenin: X
ST   D13S317: 11,12
ST   D18S51: 19
ST   D21S11: 31,32.2
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 8,15
ST   FGA: 20,25
ST   vWA: 15
DI   NCIt; C39898; Primary prostate urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   10164
AC   CVCL_F1YH
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1016T
AC   CVCL_6G35
DR   Wikidata; Q54481994
RX   PubMed=748774;
RX   PubMed=6244232;
CC   Doubling time: 44 hours (PubMed=748774).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   10170
AC   CVCL_F1YI
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:18505; RNF43; Simple; p.Thr714Ile (c.2141C>T); Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Asn (c.658T>A); ClinVar=VCV000376688; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1019SeVF
AC   CVCL_A9M3
SY   T1D-1
DR   Wikidata; Q102111943
RX   PubMed=27163171;
RX   PubMed=30661993;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   101A
AC   CVCL_J815
DR   Wikidata; Q54481998
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   101E5.13
AC   CVCL_E7QE
DR   ABCD; ABCD_BE632
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1020A1
AC   CVCL_UP42
DR   Wikidata; Q93296726
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP41 ! 1020A3
OI   CVCL_UP40 ! 1020A12
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   1020A12
AC   CVCL_UP40
DR   Wikidata; Q93296727
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Doubling time: 30.3 hours (PubMed=24399248).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP42 ! 1020A1
OI   CVCL_UP41 ! 1020A3
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   1020A3
AC   CVCL_UP41
DR   Wikidata; Q93296729
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP42 ! 1020A1
OI   CVCL_UP40 ! 1020A12
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   1021-4F-B DiPS
AC   CVCL_A9L1
DR   Wikidata; Q102113398
RX   PubMed=23861493;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   10214
AC   CVCL_F1YJ
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   10222
AC   CVCL_F1YK
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1023F10
AC   CVCL_B0G3
DR   Wikidata; Q108819339
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4507.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1023SevF
AC   CVCL_A9M6
SY   ND-3
DR   Wikidata; Q102113402
RX   PubMed=27163171;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   1024-4F-A-DiPS
AC   CVCL_A9L2
DR   Wikidata; Q102113404
RX   PubMed=23861493;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   10249M
AC   CVCL_WM48
DR   cancercelllines; CVCL_WM48
DR   Cosmic; 852222
DR   Wikidata; Q93296732
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   1026-3F-A MODY iPS
AC   CVCL_A9L3
SY   MODY-1
DR   Wikidata; Q102113406
RX   PubMed=23861493;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9L4 ! 1026-3F-C MODY iPS
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   1026-3F-C MODY iPS
AC   CVCL_A9L4
SY   1026-3FC; MODY-2
DR   Wikidata; Q102113407
RX   PubMed=23861493;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9L3 ! 1026-3F-A MODY iPS
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   10266
AC   CVCL_F1YL
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1027-3F-C-DiPS
AC   CVCL_A9L5
DR   Wikidata; Q102113408
RX   PubMed=23861493;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   1027B3
AC   CVCL_RY14
DR   Wikidata; Q54399857
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Doubling time: 29.37 hours (PubMed=24399248).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY15 ! 1027B4
OI   CVCL_RY16 ! 1027B6
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1027B4
AC   CVCL_RY15
DR   Wikidata; Q54399859
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY14 ! 1027B3
OI   CVCL_RY16 ! 1027B6
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1027B6
AC   CVCL_RY16
DR   Wikidata; Q54399862
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Doubling time: 29.05 hours (PubMed=24399248).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY14 ! 1027B3
OI   CVCL_RY15 ! 1027B4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1028-3F-A-DiPS
AC   CVCL_A9L6
DR   Wikidata; Q102113409
RX   PubMed=23861493;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   102G11.23
AC   CVCL_E7QF
DR   ABCD; ABCD_BE638
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   103-LCL
AC   CVCL_6751
DR   CLO; CLO_0050492
DR   BioSample; SAMN03472055
DR   RCB; RCB2082
DR   TKG; TKG 0614
DR   Wikidata; Q54399863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2082; TKG=TKG 0614
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   103.2
AC   CVCL_XH59
DR   Wikidata; Q93296754
RX   Patent=US10716838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4403.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00481; Human BTN3A1/CD277.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   1031SeVA
AC   CVCL_A9M2
SY   T1D-2
DR   Wikidata; Q102113410
RX   PubMed=27163171;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   10326
AC   CVCL_C8Z0
DR   Wikidata; Q123030198
RX   PubMed=17934517;
RX   PubMed=21447744;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1104; BRD3 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD3-NUTM1, BRD3-NUT; Note=BRD3 exon 15 fused to NUTM1 exon 2 (PubMed=17934517; PubMed=29348827).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   10378
AC   CVCL_F1YM
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1039A1
AC   CVCL_RL23
DR   SKIP; SKIP001337
DR   Wikidata; Q54399864
RX   PubMed=25662444;
RX   PubMed=26997644;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   103B2
AC   CVCL_B0LL
SY   103B2/9E10
DR   Wikidata; Q108819340
RX   Patent=US5763274;
RX   PubMed=9763543;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2221.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q04900; Human CD164.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   104-2
AC   CVCL_B3QI
DR   Wikidata; Q110429641
RX   CelloPub=CLPUB00656;
RX   PubMed=6220106;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/anti-cd45-2-mouse-monoclonal-antibody-clone-104-2
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2003-077.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45 (Note=Isoform Ly5.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   10417
AC   CVCL_F1YN
CC   Miscellaneous: Cell line information from personal communication of Xie, Hong-Yan.
CC   Derived from site: Metastatic; Lung, left lower lobe; UBERON=UBERON_0008953.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1041SeVF
AC   CVCL_A9M4
SY   T1D-3
DR   Wikidata; Q102113411
RX   PubMed=27163171;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   104C1
AC   CVCL_2267
SY   104-C1
DR   CLO; CLO_0001030
DR   ATCC; CRL-1405
DR   CCRID; 1102MAM-NIFDC00046
DR   CCRID; 4201MAM-CCTCC00116
DR   CCTCC; GDC0116
DR   ECACC; 90110524
DR   JCRB; JCRB9036
DR   Wikidata; Q54482014
RX   PubMed=1116142;
RX   PubMed=1260765;
RX   PubMed=32226606;
CC   Virology: Susceptible to infection and early propagation by guinea pig adenovirus (GPAdV) (PubMed=32226606).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Sex unspecified
AG   43FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   10538P
AC   CVCL_WM22
DR   cancercelllines; CVCL_WM22
DR   Cosmic; 852198
DR   Wikidata; Q93296773
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   105A5
AC   CVCL_B0LM
DR   Wikidata; Q108819341
RX   Patent=WO1997007204A1;
RX   PubMed=9763543;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2222.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q04900; Human CD164.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   105AJ
AC   CVCL_M609
DR   Wikidata; Q54399865
RX   PubMed=8689636;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M605 ! 105KC
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   105AJ1.1
AC   CVCL_M610
DR   Wikidata; Q54399868
RX   PubMed=8689636;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M609 ! 105AJ
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   105AJ3.1
AC   CVCL_M611
DR   Wikidata; Q54399869
RX   PubMed=8689636;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M609 ! 105AJ
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   105AJ5.1
AC   CVCL_M612
DR   Wikidata; Q54399870
RX   PubMed=8689636;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M609 ! 105AJ
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   105KC
AC   CVCL_M605
SY   105 KC; KC
DR   EFO; EFO_0006354
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03470879
DR   EGA; EGAS00001000610
DR   PharmacoDB; 105KC_1_2019
DR   Wikidata; Q54399871
RX   PubMed=2045389;
RX   PubMed=10906887;
RX   PubMed=12354749;
RX   PubMed=16039953;
RX   PubMed=25485619;
RX   PubMed=25877200;
CC   Doubling time: 36 hours (PubMed=16039953).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile established at MicroSynth from personal communication of Muff, Roman.
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
ST   Source(s): Microsynth; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8 (Microsynth)
ST   D13S317: 8,11 (PubMed=25877200)
ST   D16S539: 9,12,14 (PubMed=25877200)
ST   D16S539: 9,14 (Microsynth)
ST   D18S51: 15,16 (Microsynth)
ST   D18S51: 15,19 (PubMed=25877200)
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 10,13
ST   D8S1179: 13,16
ST   FGA: 21,23 (PubMed=25877200)
ST   FGA: 23 (Microsynth)
ST   Penta D: 13
ST   Penta E: 5,20
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   105MA
AC   CVCL_ZT98
SY   105 MAnchester
DR   Wikidata; Q98110437
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
RX   PubMed=9681890;
CC   Senescence: Senesces at 34 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 7
//
ID   106.3
AC   CVCL_B0CS
DR   ATCC; HB-12044
DR   Wikidata; Q108819342
RX   Patent=US6162902;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12044.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1061 mel
AC   CVCL_C7W6
DR   Wikidata; Q123030199
RX   PubMed=22207316;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   1066
AC   CVCL_E424
SY   DUGE
DR   dbMHC; 48442
DR   ECACC; 94071403
DR   IHW; IHW09340
DR   IPD-IMGT/HLA; 10022
DR   Wikidata; Q54482028
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: DRB1*08:04:01 (IPD-IMGT/HLA=10022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   1067 mel
AC   CVCL_C7W7
DR   Wikidata; Q123030200
RX   PubMed=22207316;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   106A10
AC   CVCL_B0D4
SY   106A10-2
DR   ATCC; HB-10789
DR   Wikidata; Q108819343
RX   Patent=US4938948;
RX   PubMed=1715033;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10789.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10060.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer 55 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1072F
AC   CVCL_6G38
DR   Wikidata; Q54482030
RX   PubMed=6244232;
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   1074-mel
AC   CVCL_GR77
SY   1074-MEL; 1074 mel; 1074mel; 1074MEL
DR   cancercelllines; CVCL_GR77
DR   Cosmic; 2759878
DR   TOKU-E; 4036
DR   Wikidata; Q54399872
RX   PubMed=8537970;
RX   PubMed=15661905;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000376368; Zygosity=Unspecified (PubMed=15661905).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   107B6.61
AC   CVCL_E7QD
DR   ABCD; ABCD_BE637
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   107C3
AC   CVCL_RB02
DR   Wikidata; Q54482034
RX   PubMed=1116142;
RX   PubMed=1260765;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Sex unspecified
AG   43FD
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   107D2.44
AC   CVCL_E7QA
DR   ABCD; ABCD_BE634
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   107E2
AC   CVCL_C5HI
DR   Wikidata; Q116047785
RX   PubMed=21529295;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9JL12; Mouse Tcirg1.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1083-17-1A
AC   CVCL_B0T4
SY   17-1A; CO17-1A
DR   ABCD; ABCD_AC851
DR   Wikidata; Q108819344
RX   PubMed=94699;
RX   PubMed=286328;
RX   PubMed=6933502;
RX   PubMed=9806108;
CC   Biotechnology: Was used to produce the monoclonal antibody Edrecolomab (Panorex) which was evaluated as a therapeutic agent against stage III colorectal carcinoma. Was never approved by FDA but was used in Germany in 1995.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   1083933x
AC   CVCL_JD58
SY   31704; 32399; TER321; TER-321; Ter 321; TER396; TER-396; Ter-396; Ter 396
DR   IPD-IMGT/HLA; 11975
DR   Wikidata; Q54399873
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/327cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24,32; B*14,18; C*07,08; DPB1*02:01:02,03:01:01; DQA1*02:01,05:05; DQB1*02:02,03:01:01; DRB1*07:01:01,13:11:01; DRB3*02:02:01; DRB4*01:01:01:01 (IPD-IMGT/HLA=11975).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   10843566
AC   CVCL_JD19
SY   TER305; TER-305; Ter 305; TER358; TER-358; Ter 358; TER440; TER-440; Ter-440; Ter 440
DR   IPD-IMGT/HLA; 10025
DR   Wikidata; Q54399875
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/350cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caucasian.
CC   HLA typing: A*02,03; B*07,35; DPB1*02:01,03:01; DQA1*01:05,03:02; DQB1*05:01,03:03; DRB1*10:01,13:20; DRB3*01:01 (IPD-IMGT/HLA=10025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   1088-mel
AC   CVCL_8029
SY   1088-MEL; 1088 Mel; 1088 mel; 1088
DR   Cosmic; 876702
DR   Wikidata; Q54482041
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   108CC15
AC   CVCL_0464
SY   NG108-15; NG-108-15; NG 108-15; NG10815
DR   BTO; BTO_0000942
DR   CLO; CLO_0008162
DR   MCCL; MCC:0000361
DR   CLDB; cl3691
DR   ATCC; HB-12317
DR   CCRID; 1101ETC-PUMC000017
DR   CCRID; 3101ETCHYB51
DR   CCRID; 3101MOUSCSP5390
DR   CCRID; 4201MOU-CCTCC00170
DR   CCTCC; GDC0170
DR   ChEMBL-Cells; CHEMBL3308514
DR   ChEMBL-Targets; CHEMBL613828
DR   ECACC; 08062516
DR   ECACC; 88112302
DR   FCS-free; 240-17-488-3-4-12
DR   KCB; KCB 92029YJ
DR   Lonza; 968
DR   PubChem_Cell_line; CVCL_0464
DR   TKG; TKG 0726
DR   TOKU-E; 2752
DR   Wikidata; Q27870067
RX   PubMed=16829;
RX   PubMed=193191;
RX   PubMed=2985920;
WW   Info; NCBI; -; https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=129386&lvl=3
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-214.html
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12317.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1970 ! C6-BU-1
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 26
//
ID   108CC5
AC   CVCL_4076
SY   NG108-5; NG 108-5
DR   ECACC; 08062521
DR   Wikidata; Q54482047
RX   PubMed=16829;
RX   PubMed=591572;
RX   PubMed=598387;
RX   PubMed=2985920;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1970 ! C6-BU-1
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   108CC5-BU
AC   CVCL_4077
DR   ECACC; 08062566
DR   Wikidata; Q54482050
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   108CC5-BU-5
AC   CVCL_4078
DR   ECACC; 08062567
DR   Wikidata; Q54482051
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   108CC5-BU-8
AC   CVCL_4079
DR   ECACC; 08062569
DR   Wikidata; Q54482054
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   108CC5-TG-1
AC   CVCL_4082
DR   ECACC; 08062543
DR   Wikidata; Q54482056
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   108CC5-TG-2
AC   CVCL_4083
DR   ECACC; 08062544
DR   Wikidata; Q54482058
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   108CC5-TG-3
AC   CVCL_4084
DR   ECACC; 08062545
DR   Wikidata; Q54482059
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   108CC5-TG-4
AC   CVCL_4085
DR   ECACC; 08062546
DR   Wikidata; Q54482061
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   108CC5T-BU-1
AC   CVCL_4080
DR   ECACC; 08062570
DR   Wikidata; Q54482063
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   108CC5T-BU-4
AC   CVCL_4081
DR   ECACC; 08062571
DR   Wikidata; Q54482065
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4076 ! 108CC5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   108F10.710
AC   CVCL_E7QB
DR   ABCD; ABCD_BE635
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   108Z
AC   CVCL_UT49
SY   108-Z
DR   Wikidata; Q93296966
RX   PubMed=18001719;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   109-87T
AC   CVCL_A2AB
DR   Wikidata; Q105505836
RX   PubMed=3165706;
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   10913246
AC   CVCL_JD60
SY   30692; Extract 395
DR   IPD-IMGT/HLA; 13006
DR   Wikidata; Q54399878
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/327cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caucasian.
CC   HLA typing: A*32,03:11N; B*07,40; C*07:AWNZ,15:AJA; DQA1*01,03; DQB1*06:US,03:JV; DRB1*04:01,15:01; DRB4*01; DRB5*01 (IPD-IMGT/HLA=13006).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   1096
AC   CVCL_B3US
DR   Wikidata; Q110429644
RX   PubMed=30567931;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   109E11.6
AC   CVCL_E7QG
DR   ABCD; ABCD_BE639
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   109MA
AC   CVCL_ZT99
SY   109 MAnchester
DR   Wikidata; Q98125017
RX   PubMed=9649131;
CC   Senescence: Senesces at 64 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180Lys (c.538G>A); ClinVar=VCV000245711; Zygosity=Heterozygous (PubMed=9649131).
CC   Donor information: At sampling donor was not affected with Li-Fraumeni syndrome.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   10A4E11
AC   CVCL_B4ZY
DR   Wikidata; Q110429647
RX   PubMed=24702659;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   10A5H3
AC   CVCL_B4ZZ
DR   Wikidata; Q110429649
RX   PubMed=24702659;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   10A5H5
AC   CVCL_B5A0
DR   Wikidata; Q110429651
RX   PubMed=24702659;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   10A6 [Mouse hybridoma against B.germanica Bla g 1]
AC   CVCL_C3WX
DR   Wikidata; Q116047786
RX   PubMed=1993811;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UAM5; Blattella germanica allergen Bla g 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10A6 [Mouse hybridoma against G.vaginalis vaginolysin]
AC   CVCL_C5AI
DR   Wikidata; Q116047787
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10A6 [Mouse hybridoma against MTPS]
AC   CVCL_C4CZ
DR   ABCD; ABCD_AQ818
DR   Wikidata; Q116047788
RX   PubMed=31243995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10B/2C
AC   CVCL_C4PR
DR   Wikidata; Q116047789
RX   PubMed=16633832;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Schistosoma haematobium soluble egg antigen (SEA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10B10
AC   CVCL_6819
DR   cancercelllines; CVCL_6819
DR   Wikidata; Q54399879
RX   PubMed=12543551;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=10B10
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:98476; Pig IL12RB2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   10B11
AC   CVCL_XJ51
DR   CCRID; 4201PAT-CCTCC00702
DR   Wikidata; Q93296984
RX   DOI=10.17352/jvi.000020;
RX   Patent=CN104928258B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201578.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Canine parvovirus (isolate AV298).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   10B12
AC   CVCL_C5VL
DR   ABCD; ABCD_AJ076
DR   Wikidata; Q116047790
RX   PubMed=29302006;
RX   PubMed=29950717;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A5K736; Plasmodium vivax (strain Salvador I) reticulocyte binding protein 2b (RBP2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   10B1A2
AC   CVCL_A0VD
DR   Wikidata; Q108819345
RX   Patent=CN107299085B;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   10B5
AC   CVCL_F1V7
RX   PubMed=3805735;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   10B5.B4
AC   CVCL_B7CJ
DR   Wikidata; Q112926882
RX   Patent=US7807791;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8900.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   10B6
AC   CVCL_C5AJ
DR   Wikidata; Q116047791
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10B6D1
AC   CVCL_B5A1
DR   Wikidata; Q110429653
RX   PubMed=24702659;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   10B7 [Mouse hybridoma against chicken ACHE]
AC   CVCL_E8C4
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P36196; Chicken ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   10B7 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N6
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   10B8
AC   CVCL_C4D0
DR   Wikidata; Q116047792
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10B9
AC   CVCL_B379
DR   CLO; CLO_0001031
DR   ATCC; HB-172
DR   Wikidata; Q54554890
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=3901396;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on endothelial cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 7
//
ID   10B9-B6
AC   CVCL_C3TX
SY   10B9 B6
DR   Wikidata; Q116047793
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10B9-F6
AC   CVCL_C3TY
SY   10B9 F6; 10B9 F6 A12; 10B9
DR   ABCD; ABCD_AD584
DR   Wikidata; Q116047794
RX   PubMed=2442247;
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10B9.E8
AC   CVCL_B7CK
DR   Wikidata; Q112926883
RX   Patent=US7807791;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8901.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   10C11
AC   CVCL_C4FE
DR   ABCD; ABCD_AE298
DR   Wikidata; Q116047795
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10C3
AC   CVCL_C6MT
DR   ABCD; ABCD_AE847
DR   Wikidata; Q116047796
RX   PubMed=2555519;
RX   PubMed=6361525;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10C4.1.3
AC   CVCL_H997
DR   CLO; CLO_0001032
DR   ATCC; HB-11029
DR   Wikidata; Q54554891
RX   Patent=US5578704;
RX   Patent=US5652110;
RX   PubMed=7683273;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11029.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   10C4D5
AC   CVCL_B5A2
DR   Wikidata; Q110429655
RX   PubMed=24702659;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   10C5.6
AC   CVCL_C9FP
DR   ABCD; ABCD_AK558
DR   Wikidata; Q123030202
RX   Patent=US8231877;
RX   PubMed=9631008;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was developed into a therapeutic mAB known as Zanolimumab to be used in the treatment of rheumatoid arthritis, psoriasis, melanoma and cutaneous and peripheral T-cell lymphoma.
CC   Doubling time: 19 hours (PubMed=9631008).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   10C7 [Mouse hybridoma against CMV UL18]
AC   CVCL_D146
DR   CLO; CLO_0001033
DR   ATCC; CRL-2430
DR   Wikidata; Q54554892
RX   PubMed=9420246;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08560; Human cytomegalovirus glycoprotein UL18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   10C7 [Mouse hybridoma against human KIF20B]
AC   CVCL_E8P2
SY   KIF20B(10C7)
RX   PubMed=31260385;
RX   PubMed=31403911;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96Q89; Human KIF20B (Note=Immunized with the peptide 1772-QPKRAKRKLYTSEISS-1787).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   10C8
AC   CVCL_VI25
DR   BEI_Resources; MRA-253
DR   Wikidata; Q54554893
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   10C9 [Human lymphoma]
AC   CVCL_R704
SY   10-C9
DR   Wikidata; Q54554894
RX   Patent=US5108920;
RX   PubMed=8111047;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10236.
CC   Characteristics: Secretes IgM kappa (PubMed=8111047).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C8286; AIDS-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   10C9 [Mouse hybridoma against aflatoxins]
AC   CVCL_A0NZ
DR   Wikidata; Q108819346
RX   PubMed=19231357;
RX   PubMed=22548609;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   10C9 [Mouse hybridoma against ciguatoxin CTX3C]
AC   CVCL_C4DF
DR   ABCD; ABCD_AG730
DR   Wikidata; Q116047797
RX   PubMed=12812503;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_61277; Ciguatoxin CTX3C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10C9 [Mouse hybridoma against Drosophila lmb]
AC   CVCL_A6LF
DR   DSHB; 10C9-anti-late-bloomer
DR   Wikidata; Q107113126
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q24188; Drosophila melanogaster lbm.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   10C9-2G7
AC   CVCL_E5NT
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   10F4-2A9
AC   CVCL_E5P1
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   10CM
AC   CVCL_VJ83
SY   10 CM
DR   cancercelllines; CVCL_VJ83
DR   Cosmic; 2543722
DR   Wikidata; Q93297029
RX   PubMed=26744134;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val569Ala (c.1706T>C); Zygosity=Unspecified (PubMed=26744134).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg440Ter (c.1318C>T); ClinVar=VCV000230673; Zygosity=Unspecified (PubMed=26744134).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=26744134).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   10d
AC   CVCL_C5HT
DR   Wikidata; Q116047798
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10D2F6
AC   CVCL_G563
DR   CLO; CLO_0001034
DR   ATCC; HB-11103
DR   Wikidata; Q54554895
RX   Patent=US5556947;
RX   Patent=WO1994004659A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11103.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen expressed on antigen stimulated T cells and some T cell derived cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   10D3
AC   CVCL_D5GL
DR   DSHB; 10D3-anti-wrapper
DR   Wikidata; Q127378557
RX   PubMed=9856456;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9W260; Drosophila melanogaster wrapper.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   10D3G2
AC   CVCL_B5A3
DR   Wikidata; Q110429657
RX   PubMed=24702659;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   10D4
AC   CVCL_B4HA
SY   10D4-1-1-1-2
DR   ABCD; ABCD_AU119
DR   Wikidata; Q110429659
RX   Patent=US8846047;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5435.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   10E2 [Mouse embryo]
AC   CVCL_Y303
DR   Wikidata; Q54554896
RX   PubMed=6248199;
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y304 ! BLP
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 7
//
ID   10E2 [Mouse hybridoma against alprenolol]
AC   CVCL_C3XF
DR   Wikidata; Q116047799
RX   PubMed=3125254;
RX   PubMed=3701062;
RX   PubMed=6747296;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10E3-17
AC   CVCL_C6XJ
DR   ABCD; ABCD_AN748
DR   ABCD; ABCD_AN749
DR   ABCD; ABCD_AN750
DR   Wikidata; Q123030203
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   10E4
AC   CVCL_A0HG
DR   Wikidata; Q108819347
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   10E5
AC   CVCL_G016
DR   CLO; CLO_0001035
DR   ATCC; HB-8513
DR   Wikidata; Q54554897
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8513.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   10E9
AC   CVCL_C5F4
DR   Wikidata; Q116047800
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10F10 [Mouse hybridoma against human TNF]
AC   CVCL_F1V8
RX   PubMed=3805735;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   10F10 [Mouse hybridoma against oleanolic acid]
AC   CVCL_XE21
DR   Wikidata; Q93297057
RX   PubMed=15490328;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_37659; Oleanolic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 5
//
ID   10F10-C1-B8
AC   CVCL_C5DG
DR   Wikidata; Q116047801
RX   PubMed=22149279;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P18507; Human GABRG2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10F11.B2.C3
AC   CVCL_IV59
SY   10F11
DR   Wikidata; Q54554898
RX   Patent=US8022175;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8333.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Newcastle disease virus P protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   10F2-13
AC   CVCL_C6XK
DR   ABCD; ABCD_AN751
DR   ABCD; ABCD_AN752
DR   ABCD; ABCD_AN753
DR   Wikidata; Q123030204
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   10F4-2F2
AC   CVCL_E5SL
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   10F5
AC   CVCL_XA96
DR   Wikidata; Q93297072
RX   PubMed=23750481;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5T2D2; Human TREML2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   10F7 [Mouse hybridoma against influenza A HA]
AC   CVCL_A0UJ
DR   CCRID; 4201PAT-CCTCC00182
DR   Wikidata; Q108819348
RX   Patent=CN101220097A;
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200608.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   10F7 [Mouse hybridoma against phOX]
AC   CVCL_C4FF
DR   Wikidata; Q116047802
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10F7-38
AC   CVCL_B4JT
DR   Wikidata; Q110429661
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11357.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   10F7MN
AC   CVCL_G564
SY   10F7
DR   CLO; CLO_0001036
DR   ATCC; HB-8162
DR   Wikidata; Q54554899
RX   Patent=US4767710;
RX   PubMed=6197636;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8162.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=Recognizes both M and N blood group antigens).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   10F8
AC   CVCL_C5FX
DR   Wikidata; Q116047803
RX   PubMed=9839680;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P58604; Cupiennius salei toxin CSTX-9/CSTX-7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10F8A
AC   CVCL_C7IA
DR   Wikidata; Q123030205
RX   PubMed=9683260;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   10G10
AC   CVCL_C4EU
DR   ABCD; ABCD_AE286
DR   Wikidata; Q116047804
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   10G10.15.16
AC   CVCL_LH44
DR   Wikidata; Q54554900
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6033.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   10G2
AC   CVCL_XC16
DR   Wikidata; Q93297092
RX   PubMed=3579267;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_7719; Ochratoxin A (OTA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   10G4
AC   CVCL_U285
SY   AFB200810G4
DR   CCRID; 4201PAT-CCTCC00337
DR   Wikidata; Q54554901
RX   Patent=US8841419;
RX   PubMed=19231357;
RX   PubMed=22548609;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201016.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   10G5
AC   CVCL_C5AK
DR   Wikidata; Q116047806
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10H
AC   CVCL_N538
SY   H10A12
DR   CLO; CLO_0050298
DR   RCB; RCB0705
DR   Wikidata; Q54554902
RX   PubMed=6206890;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61151; Poly-ADP-D-ribose (Poly(adenosine diphosphate ribose)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   10H-2
AC   CVCL_N539
DR   CLO; CLO_0050283
DR   RCB; RCB1142
DR   Wikidata; Q54554903
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61151; Poly-ADP-D-ribose (Poly(adenosine diphosphate ribose)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N538 ! 10H
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 6
//
ID   10H2-C6
AC   CVCL_C3TZ
SY   10H2 C6
DR   Wikidata; Q116047807
RX   PubMed=2442247;
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10H2.12.1
AC   CVCL_H998
SY   10H2
DR   CLO; CLO_0001037
DR   ATCC; HB-11494
DR   Wikidata; Q54554904
RX   Patent=US5440021;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11494.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P25025; Human CXCR2/IL8RB/CD182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   10H2.2F12
AC   CVCL_B0W0
SY   <CSF-1R>10H2.2F12
DR   Wikidata; Q108819349
RX   Patent=US10336830;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07333; Human CSF1R/CD115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   10H3
AC   CVCL_C4JH
DR   Wikidata; Q116047808
RX   PubMed=33652529;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3C0R7; Chicken IL7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   10H4
AC   CVCL_XJ52
DR   CCRID; 4201PAT-CCTCC00703
DR   Wikidata; Q93297131
RX   DOI=10.17352/jvi.000020;
RX   Patent=CN104928258B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201579.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Canine parvovirus (isolate AV298) (Note=Also reacts with other isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   10K26-12A1
AC   CVCL_F1G0
RX   PubMed=6341819;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   10K44-7A1
AC   CVCL_F1G1
RX   PubMed=6341819;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   10P12
AC   CVCL_6481
DR   CLO; CLO_0001038
DR   ATCC; CRL-2036
DR   Wikidata; Q54554905
RX   PubMed=2998805;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/cAn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 13
//
ID   10P2
AC   CVCL_6482
DR   CLO; CLO_0001039
DR   ATCC; CRL-2034
DR   BCRC; 60316
DR   Wikidata; Q54554906
RX   PubMed=2998805;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/cAn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   10P8
AC   CVCL_0E96
DR   ATCC; CRL-2035
DR   Wikidata; Q54554907
RX   PubMed=2998805;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Discontinued: ATCC; CRL-2035; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/cAn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 11
//
ID   11 029
AC   CVCL_A0XD
DR   Wikidata; Q108819350
RX   PubMed=33251771;
CC   Doubling time: 6.6 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   11 030
AC   CVCL_A0XE
DR   Wikidata; Q108819351
RX   PubMed=33251771;
CC   Doubling time: 1.8 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   11 045
AC   CVCL_A0XF
DR   Wikidata; Q108819352
RX   PubMed=33251771;
CC   Doubling time: 2.3 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   11 068
AC   CVCL_A0XG
DR   Wikidata; Q108819353
RX   PubMed=33251771;
CC   Doubling time: 3.5 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   11 091
AC   CVCL_A0XH
DR   Wikidata; Q108819354
RX   PubMed=33251771;
CC   Doubling time: 13.4 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left fronto-parietal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   11-11H-10G
AC   CVCL_F0D9
RX   PubMed=2915127;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human IgG3 allotype G3M T.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   11-18
AC   CVCL_6659
AS   CVCL_A596
SY   II-18
DR   CLO; CLO_0050051
DR   BioSample; SAMN03472059
DR   cancercelllines; CVCL_6659
DR   Cell_Model_Passport; SIDM01637
DR   CGH-DB; 201-1
DR   CGH-DB; 9163-4
DR   Cosmic; 889084
DR   Cosmic; 946048
DR   Cosmic; 1066156
DR   Cosmic; 1239901
DR   Cosmic; 1336877
DR   Cosmic; 1656892
DR   Cosmic; 1731372
DR   Cosmic; 2125265
DR   IARC_TP53; 28444
DR   RCB; RCB2093
DR   TKG; TKG 0177
DR   Wikidata; Q54897419
RX   PubMed=9023415;
RX   PubMed=9538136;
RX   PubMed=14581340;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=22313637;
RX   PubMed=22815900;
RX   PubMed=38639832;
CC   Population: Japanese and Micro.
CC   HLA typing: A*02:01,24:02; B*52:01,54:01; C*01:02,12:01 (PubMed=9023415).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Unspecified (PubMed=20557307).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2093; TKG=TKG 0177
ST   Amelogenin: X
ST   CSF1PO: 7,12 (RCB=RCB2093)
ST   CSF1PO: 12 (TKG=TKG 0177)
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   11-18-ER1-7
AC   CVCL_D856
SY   11-18/ER1-7
DR   cancercelllines; CVCL_D856
DR   Cosmic; 1731373
DR   Wikidata; Q54554908
RX   PubMed=22815900;
CC   Population: Japanese and Micro.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6659 ! 11-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   11-18-ER2-1
AC   CVCL_D857
SY   11-18/ER2-1
DR   cancercelllines; CVCL_D857
DR   Cosmic; 1731374
DR   Wikidata; Q54554909
RX   PubMed=22815900;
CC   Population: Japanese and Micro.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6659 ! 11-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   11-18-GEF10-1
AC   CVCL_D776
SY   11-18/GEF10-1
DR   cancercelllines; CVCL_D776
DR   Cosmic; 1731375
DR   Wikidata; Q54554910
RX   PubMed=22815900;
CC   Population: Japanese and Micro.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6659 ! 11-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   11-18-GEF20-1
AC   CVCL_D777
SY   11-18/GEF20-1
DR   cancercelllines; CVCL_D777
DR   Cosmic; 1731376
DR   Wikidata; Q54554911
RX   PubMed=22815900;
CC   Population: Japanese and Micro.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6659 ! 11-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   11-18/R
AC   CVCL_S745
SY   11-18R; 11-18/ER
DR   cancercelllines; CVCL_S745
DR   Cosmic; 1890459
DR   Wikidata; Q54554912
RX   PubMed=22773810;
CC   Population: Japanese and Micro.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=22773810).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6659 ! 11-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   11-1H
AC   CVCL_C0E1
DR   Wikidata; Q112926884
DR   Ximbio; 153378
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13688; Human CEACAM1/CD66a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   11-26c
AC   CVCL_9138
DR   CLO; CLO_0001043
DR   ATCC; HB-250
DR   Wikidata; Q54554914
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse IgD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   11-4
AC   CVCL_2819
DR   ECACC; 11033102
DR   Wikidata; Q54399881
CC   Population: African American.
CC   Characteristics: Transfected with a firefly luciferase reporter gene under the control of the HSV-thymidine kinase promoter (ECACC=11033102).
CC   Characteristics: Used to evaluate the non-specific transcriptional activity of chemicals (ECACC=11033102).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=11033102
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   11-4.1
AC   CVCL_G219
DR   CLO; CLO_0001044
DR   ATCC; TIB-95
DR   Wikidata; Q54554915
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   11-5.2.1.9
AC   CVCL_G189
DR   CLO; CLO_0001045
DR   ATCC; TIB-94
DR   ECACC; 89050905
DR   Wikidata; Q54554916
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   11-5F
AC   CVCL_J078
DR   ECACC; 91121236
DR   Wikidata; Q54554917
RX   PubMed=3323433;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01107; Bovine DSC1.
CC   Monoclonal antibody target: UniProtKB; P33545; Bovine DSC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   11-9-1-4
AC   CVCL_5948
SY   11.9.14; BT-549Gal3
DR   BTO; BTO_0002603
DR   cancercelllines; CVCL_5948
DR   Wikidata; Q54399883
RX   PubMed=9561029;
RX   PubMed=21552935;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6563; LGALS3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 26
//
ID   11-A6
AC   CVCL_D4XQ
DR   Wikidata; Q127378558
RX   PubMed=2569807;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q7TDB3; Foot-and-mouth disease virus Asia 1 (isolate Vaccine IND 63/72) genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   11-C2
AC   CVCL_D4XR
DR   Wikidata; Q127378559
RX   PubMed=2569807;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q7TDB3; Foot-and-mouth disease virus Asia 1 (isolate Vaccine IND 63/72) genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   11-C5
AC   CVCL_D4XS
DR   Wikidata; Q127378560
RX   PubMed=2569807;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q7TDB3; Foot-and-mouth disease virus Asia 1 (isolate Vaccine IND 63/72) genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   11-D3
AC   CVCL_D4XT
DR   Wikidata; Q127378561
RX   PubMed=2569807;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q7TDB3; Foot-and-mouth disease virus Asia 1 (isolate Vaccine IND 63/72) genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   11-YX-1
AC   CVCL_WG97
DR   cancercelllines; CVCL_WG97
DR   Wikidata; Q93297249
RX   PubMed=9561029;
RX   PubMed=21552935;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6563; LGALS3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 13
//
ID   11/32
AC   CVCL_C7IZ
SY   11/32.2.1.1
DR   ABCD; ABCD_AE857
DR   Wikidata; Q123030206
RX   PubMed=3102254;
RX   PubMed=3411286;
RX   PubMed=3488262;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
CC   Monoclonal antibody target: ChEBI; CHEBI_30154; 5beta-pregnane-3,20-dione.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   11/34
AC   CVCL_C7J0
SY   11/34.4.2.2
DR   Wikidata; Q123030207
RX   PubMed=3411286;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
CC   Monoclonal antibody target: ChEBI; CHEBI_16076; 11alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   11/64
AC   CVCL_C7J1
SY   11/64.3.7
DR   Wikidata; Q123030208
RX   PubMed=3411286;
RX   PubMed=3488262;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
CC   Monoclonal antibody target: ChEBI; CHEBI_30154; 5beta-pregnane-3,20-dione.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   11/9
AC   CVCL_A6LE
SY   #11/9
DR   Wikidata; Q107113127
RX   PubMed=33271925;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   11.9
AC   CVCL_N790
DR   ATCC; CRL-2705
DR   Wikidata; Q54554919
CC   Discontinued: ATCC; CRL-2705; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   110-5
AC   CVCL_J035
DR   CLO; CLO_0001040
DR   ATCC; HB-8984
DR   Wikidata; Q54554920
RX   Patent=US5180663;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8984.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04745; Human AMY1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   110-87T
AC   CVCL_A2AC
DR   Wikidata; Q105505839
RX   PubMed=3165706;
RX   PubMed=10545285;
RX   PubMed=14978140;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   110119B
AC   CVCL_VG30
DR   SKIP; SKIP001330
DR   Wikidata; Q54399885
RX   PubMed=26740656;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   110131C
AC   CVCL_VG27
DR   SKIP; SKIP001327
DR   Wikidata; Q54399887
RX   PubMed=26740656;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012602; Zygosity=Unspecified (PubMed=26740656).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84652; Costello syndrome
DI   ORDO; Orphanet_3071; Costello syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   110150C
AC   CVCL_VG26
DR   SKIP; SKIP001326
DR   Wikidata; Q54399987
RX   PubMed=26740656;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012602; Zygosity=Unspecified (PubMed=26740656).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84652; Costello syndrome
DI   ORDO; Orphanet_3071; Costello syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   1102-mel
AC   CVCL_8030
SY   1102-MEL; 1102 mel; 1102mel; 1102; Mel-1102; MEL1102
DR   BTO; BTO_0002947
DR   cancercelllines; CVCL_8030
DR   CGH-DB; 9293-4
DR   Cosmic; 905207
DR   Cosmic; 972280
DR   ESTDAB; ESTDAB-046
DR   GEO; GSM218054
DR   Progenetix; CVCL_8030
DR   Wikidata; Q54554922
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=15467732;
RX   PubMed=15592718;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02:01,24:02; B*15:01:01:01,55:01; C*03:02; DPB1*04:02,06:01; DQB1*06:02,03:01:01; DRB1*15:01,04:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=15467732).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-046
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D3S1358: 16,18
ST   D7S820: 10
ST   FGA: 22,23.2
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   11028
AC   CVCL_L307
DR   Wikidata; Q54399988
RX   PubMed=169374;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
CC   Breed/subspecies: Saint Bernard; VBO=VBO_0201160.
DI   NCIt; C128195; Canine sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   11031
AC   CVCL_L308
DR   Wikidata; Q54399989
RX   PubMed=169374;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Saint Bernard; VBO=VBO_0201160.
DI   NCIt; C128195; Canine sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   1106-mel
AC   CVCL_GR78
SY   1106 mel; 1106mel; 1106MEL
DR   Cosmic; 2759880
DR   TOKU-E; 4037
DR   Wikidata; Q54399991
RX   PubMed=8537970;
RX   PubMed=15661905;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Unspecified (PubMed=15661905).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   11060
AC   CVCL_C9CM
SY   NMC 11060
DR   Wikidata; Q123030209
RX   PubMed=20871596;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=20871596).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   29Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   1107F-HA
AC   CVCL_G344
DR   TKG; TKG 0303
DR   Wikidata; Q54554924
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mycoplasma bovis BCG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   110BH3
AC   CVCL_A9EC
SY   HB 110-BH3
DR   CCRID; 4201PAT-CCTCC00110
DR   Wikidata; Q108819355
RX   Patent=WO1994026923A1;
RX   PubMed=7511819;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11345.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P14174; Human MIF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   110MA
AC   CVCL_ZU00
SY   110 Manchester
DR   Wikidata; Q98125018
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 53 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180Lys (c.538G>A); ClinVar=VCV000245711; Zygosity=Heterozygous (PubMed=8794843; PubMed=9018113; PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   111 BLCL
AC   CVCL_E341
DR   ECACC; 94031620
DR   Wikidata; Q54399992
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1116-56-2
AC   CVCL_B0T5
DR   Wikidata; Q108819356
RX   PubMed=94699;
RX   PubMed=286328;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   11169540
AC   CVCL_JE03
SY   33941; Extract 374
DR   IPD-IMGT/HLA; 14058
DR   Wikidata; Q54399993
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,23:01; B*44:03,40:14:03; C*03:04,04:01; DPA1*01:CG; DPB1*02:01,03:AMYJ; DQA1*01:BF,05; DQB1*03:01,06:04; DRB1*13:02,11:APYW; DRB3*02,03 (IPD-IMGT/HLA=14058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   1116NS-19-9
AC   CVCL_G218
SY   1116-NS-19-9; 1116 NS 19-9; 1116-NS-19
DR   CLO; CLO_0001041
DR   AddexBio; C0033006/4982
DR   ATCC; HB-8059
DR   Wikidata; Q54554927
RX   Patent=US4471057;
RX   PubMed=94699;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8059.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   1116NS-3d
AC   CVCL_7233
SY   3d6
DR   CLO; CLO_0001042
DR   ATCC; CRL-8019
DR   Wikidata; Q54554928
RX   Patent=US4349528;
RX   PubMed=94699;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8019.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   111A3
AC   CVCL_J079
DR   ECACC; 85062504
DR   Wikidata; Q54554929
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J061 ! 53B3
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   1120C12
AC   CVCL_RY17
DR   Wikidata; Q54554930
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY18 ! 1120C6
OI   CVCL_RY19 ! 1120C7
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1120C6
AC   CVCL_RY18
DR   Wikidata; Q54554931
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY19 ! 1120C7
OI   CVCL_RY17 ! 1120C12
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1120C7
AC   CVCL_RY19
DR   Wikidata; Q54554932
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY18 ! 1120C6
OI   CVCL_RY17 ! 1120C12
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1121A1
AC   CVCL_JB56
DR   Wikidata; Q54399994
RX   PubMed=27641649;
CC   Group: Non-human primate cell line.
CC   Donor information: Established from an animal with an homozygous MHC haplotype.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   1123-mel
AC   CVCL_S406
SY   1123-MEL; 1123
DR   Wikidata; Q54554934
RX   PubMed=8027550;
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=10754339;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*24,28 (PubMed=9670966).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   1123C1-G
AC   CVCL_JB57
DR   Wikidata; Q54399997
RX   PubMed=26905198;
RX   PubMed=28855509;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from an animal with an homozygous Mafa-HT1 MHC haplotype.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   1125
AC   CVCL_E425
DR   dbMHC; 48443
DR   IHW; IHW09313
DR   IPD-IMGT/HLA; 10032
DR   Wikidata; Q54554935
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DQA1*05:01; DQB1*03:01; DRB1*13:04; DRB3*02 (IPD-IMGT/HLA=10032).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   1127
AC   CVCL_E426
SY   FUEA
DR   dbMHC; 48444
DR   ECACC; 94071413
DR   IHW; IHW09342
DR   IPD-IMGT/HLA; 10033
DR   Wikidata; Q54554936
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: DRB1*08:04:01 (IPD-IMGT/HLA=10033).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   1135A1
AC   CVCL_VH34
DR   Wikidata; Q54399998
RX   PubMed=28855509;
CC   Group: Non-human primate cell line.
CC   Donor information: Established from an animal with an homozygous Mafa-HT4 MHC haplotype.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   11365
AC   CVCL_VQ88
DR   ArrayExpress; E-TABM-348
DR   GEO; GSE7889
DR   Lonza; 1383
DR   Wikidata; Q93297406
RX   PubMed=17668008;
RX   PubMed=19815620;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K14ac.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   113F1
AC   CVCL_J910
DR   ATCC; HB-8490
DR   Wikidata; Q54580995
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US5629197;
RX   PubMed=1715033;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8490.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human breast/ovarian cancer 55 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   114-50D4
AC   CVCL_J548
DR   Wikidata; Q54580997
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8925.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01128; Woolly monkey sarcoma virus v-sis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   114-50G2
AC   CVCL_J549
DR   Wikidata; Q54581000
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8926.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01128; Woolly monkey sarcoma virus v-sis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   114-87T
AC   CVCL_A2AD
DR   Wikidata; Q105505843
RX   PubMed=3165706;
RX   PubMed=10545285;
RX   PubMed=14978140;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   1141 mel
AC   CVCL_C7UB
DR   Wikidata; Q123030210
RX   PubMed=22207316;
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   1143-mel
AC   CVCL_8031
SY   1143-MEL; 1143 mel; 1143
DR   Cosmic; 876688
DR   Wikidata; Q54581001
RX   PubMed=8027550;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,11 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   1147F1
AC   CVCL_B7D9
DR   Wikidata; Q112926885
RX   PubMed=28233934;
RX   PubMed=28858313;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   1156492+
AC   CVCL_JD06
SY   28144; Extract 437; Extract 594
DR   IPD-IMGT/HLA; 14069
DR   Wikidata; Q54581003
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/338cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/377cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caucasian.
CC   HLA typing: A*02:01; B*07:03,44; C*03:04,05:GS; DQA1*01:BF; DQB1*06:09,06:US; DRB1*13:02,15:ZF; DRB3*03:01; DRB5*01 (IPD-IMGT/HLA=14069).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   1156D15
AC   CVCL_RY20
DR   Wikidata; Q54581005
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY21 ! 1156D2
OI   CVCL_RY22 ! 1156D5
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1156D2
AC   CVCL_RY21
DR   Wikidata; Q54581006
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY22 ! 1156D5
OI   CVCL_RY20 ! 1156D15
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1156D5
AC   CVCL_RY22
DR   Wikidata; Q54581008
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY21 ! 1156D2
OI   CVCL_RY20 ! 1156D15
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   1156QE/8
AC   CVCL_2262
SY   1156QE; 11156-Q-E; 1156Q
DR   ECACC; 06072609
DR   Wikidata; Q54581009
RX   PubMed=6169654;
RX   PubMed=6244232;
RX   PubMed=7471097;
RX   PubMed=14762065;
CC   Omics: Variations; CNV analysis.
ST   Source(s): ECACC=06072609
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 11,14
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   116
AC   CVCL_G220
SY   Anti PDGF hybridoma #116
DR   CLO; CLO_0001046
DR   ATCC; HB-9367
DR   Wikidata; Q54581012
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9367.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   116-13.1
AC   CVCL_G221
DR   CLO; CLO_0001047
DR   ATCC; HB-129
DR   Wikidata; Q54581014
RX   CelloPub=CLPUB00656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   116.4
AC   CVCL_D5L5
SY   116
DR   Wikidata; Q127378562
RX   PubMed=6821395;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse IgG of all subclasses.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   11684232
AC   CVCL_JE04
SY   TER288; TER-288; Ter 288
DR   IPD-IMGT/HLA; 12179
DR   Wikidata; Q54581015
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,25:01; B*40:01,18; C*03:04,12:03; DPB1*04:01; DQA1*03:03,05:05; DQB1*03:01; DRB1*04:01,13:14:01; DRB3*02:02; DRB4*01:03 (IPD-IMGT/HLA=12179).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   117-13
AC   CVCL_T730
SY   AD117m
DR   CLO; CLO_0050316
DR   RCB; RCB0998
DR   Wikidata; Q54581017
RX   DOI=10.1267/ahc.26.515;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_17292; Lactotetraosylceramide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 7
//
ID   117.1
AC   CVCL_0H96
DR   Wikidata; Q54581020
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4567.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   1173-mel
AC   CVCL_A1DT
SY   1173-MEL
DR   Wikidata; Q102113412
RX   PubMed=8027550;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   1174
AC   CVCL_DI59
DR   cancercelllines; CVCL_DI59
DR   GEO; GSM560316
DR   Progenetix; CVCL_DI59
DR   Wikidata; Q54581022
RX   PubMed=21168406;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 6
//
ID   1174-mel
AC   CVCL_GR79
SY   1174-MEL; 1174 mel; 1174mel; 1174MEL
DR   Cosmic; 2759879
DR   TOKU-E; 4038
DR   Wikidata; Q54581023
RX   PubMed=8537970;
RX   PubMed=15661905;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser31Ter (c.92C>G); Zygosity=Unspecified (PubMed=15661905).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   117F9
AC   CVCL_D3Q9
DR   Wikidata; Q127378563
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB (Note=Recognizes reduced carboxymethylated ovalbumin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   1180
AC   CVCL_E427
SY   HOEA
DR   dbMHC; 48445
DR   IHW; IHW09343
DR   IPD-IMGT/HLA; 10034
DR   Wikidata; Q54581024
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DQA1*01; DQB1*05; DRB1*11:01:02,12 (IPD-IMGT/HLA=10034).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   1180-mel
AC   CVCL_GR80
SY   1180-MEL; 1180mel; 1180MEL
DR   Cosmic; 2759881
DR   TOKU-E; 4039
DR   Wikidata; Q54581027
RX   PubMed=8537970;
RX   PubMed=15661905;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Unspecified (PubMed=15661905).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   1181
AC   CVCL_E428
SY   HOVI
DR   dbMHC; 48446
DR   ECACC; 94071414
DR   IHW; IHW09345
DR   IPD-IMGT/HLA; 10035
DR   Wikidata; Q54581028
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: DRB1*13:03:01 (IPD-IMGT/HLA=10035).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   1181N1
AC   CVCL_D317
SY   118MG-1181N1
DR   cancercelllines; CVCL_D317
DR   Cell_Model_Passport; SIDM01941
DR   Wikidata; Q54581030
RX   PubMed=4337530;
CC   Problematic cell line: Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0633 ! U-118MG
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   1182-1
AC   CVCL_Z895
DR   FlyBase_Cell_line; FBtc9000017
DR   Wikidata; Q54581033
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=2515901;
RX   PubMed=6421610;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   1182-4D
AC   CVCL_ZW02
SY   1182-4 Diploid
DR   Wikidata; Q102113413
RX   CelloPub=CLPUB00568;
RX   PubMed=3084259;
RX   PubMed=32456186;
CC   Group: Insect cell line.
CC   Characteristics: Constitutively lacks centrioles (CelloPub=CLPUB00568; PubMed=3084259).
CC   Karyotypic information: Diploid karyotype.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z708 ! 1182-4H
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   1182-4H
AC   CVCL_Z708
SY   1182-4; 1182-4 Haploid
DR   EFO; EFO_0005648
DR   DGRC; 177
DR   ENCODE; ENCBS601OHH
DR   FlyBase_Cell_line; FBtc0000177
DR   GEO; GSM409470
DR   GEO; GSM409471
DR   GEO; GSM409472
DR   Wikidata; Q54581034
RX   CelloPub=CLPUB00568;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=98714;
RX   PubMed=2515901;
RX   PubMed=6421610;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
RX   PubMed=32456186;
CC   Group: Insect cell line.
CC   Group: Haploid karyotype cell line.
CC   Part of: modENCODE project cell lines.
CC   Characteristics: Constitutively lacks centrioles (CelloPub=CLPUB00568; PubMed=2515901; PubMed=32456186).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   1182-5
AC   CVCL_Z896
DR   FlyBase_Cell_line; FBtc9000018
DR   Wikidata; Q54581037
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=2515901;
RX   PubMed=6421610;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   1182-6
AC   CVCL_Z897
DR   FlyBase_Cell_line; FBtc9000019
DR   Wikidata; Q54581040
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=2515901;
RX   PubMed=6421610;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   1182-7b
AC   CVCL_Z898
DR   FlyBase_Cell_line; FBtc9000020
DR   Wikidata; Q54581042
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=2515901;
RX   PubMed=6421610;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   1182-mel
AC   CVCL_8032
SY   1182-MEL; 1182 mel; 1182
DR   BTO; BTO_0002964
DR   cancercelllines; CVCL_8032
DR   GEO; GSM218058
DR   GEO; GSM1092562
DR   Progenetix; CVCL_8032
DR   Wikidata; Q54581043
RX   PubMed=8027550;
RX   PubMed=10048982;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,11 (PubMed=10048982).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   11829109
AC   CVCL_JD49
SY   36136; Extract 410; Extract 598
DR   IPD-IMGT/HLA; 13009
DR   Wikidata; Q54581046
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/331cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/378cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,68; B*08:19N,40; C*03:04,07:DBKP; DPA1*01:CG; DPB1*04:UR,04:AGGH; DQA1*03,05; DQB1*02:01,03:JV; DRB1*03:NNN,04:DPJ; DRB3*01; DRB4*01 (IPD-IMGT/HLA=13009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   1183
AC   CVCL_E429
SY   HODO
DR   dbMHC; 48447
DR   IHW; IHW09344
DR   IPD-IMGT/HLA; 10036
DR   Wikidata; Q54581047
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DQA1*01:05; DRB1*13:03:01 (IPD-IMGT/HLA=10036).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   1184
AC   CVCL_2263
DR   CLO; CLO_0001048
DR   CLDB; cl2
DR   ECACC; 90011883
DR   Wikidata; Q54581050
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=90011883
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E260 ! MRC-5 CV1
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   11845457
AC   CVCL_JC42
SY   35577; TER387; TER-387; Ter 387; TER497; TER-497; Ter-497; Ter 497; Extract 381
DR   IPD-IMGT/HLA; 14053
DR   Wikidata; Q54581052
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/324cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/378cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24; B*15:01,57:01:01; C*03:11:02,06:02; DPA1*01:CG; DPB1*02:01,04:01/94:01; DQA1*01:01; DQB1*05:01; DRB1*01:01,01:03 (IPD-IMGT/HLA=14053).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   119-87T
AC   CVCL_A2AE
DR   Wikidata; Q105505849
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor and lung cancer type from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   1195-mel
AC   CVCL_8033
SY   1195-MEL; 1195 mel; 1195
DR   cancercelllines; CVCL_8033
DR   Cosmic; 876689
DR   GEO; GSM218057
DR   Progenetix; CVCL_8033
DR   Wikidata; Q54581053
RX   PubMed=8027550;
RX   PubMed=10048982;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,24 (PubMed=10048982).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   1196a
AC   CVCL_ZJ39
SY   C3 iPSC
DR   Wikidata; Q98125019
RX   PubMed=25116795;
RX   PubMed=26626176;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   1199-mel
AC   CVCL_8034
SY   1199-MEL; 1199 mel; 1199
DR   Cosmic; 876690
DR   Wikidata; Q54581055
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   119D11
AC   CVCL_D3QA
DR   Wikidata; Q127378564
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB (Note=Recognizes reduced carboxymethylated ovalbumin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   11a
AC   CVCL_8987
SY   iPS-11a; hiPS-11a; hiPS 11a; IPS cell line 11a; iPS11a
DR   EFO; EFO_0007099
DR   ENCODE; ENCBS549SAW
DR   ENCODE; ENCBS620GSG
DR   GEO; GSM537693
DR   GEO; GSM537694
DR   GEO; GSM621719
DR   GEO; GSM637778
DR   SKIP; SKIP004340
DR   Wikidata; Q54581058
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=21368825;
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8988 ! 11b
OI   CVCL_8989 ! 11c
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   11A
AC   CVCL_C8MV
DR   Wikidata; Q123030211
RX   PubMed=22224459;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   11A-A11
AC   CVCL_WZ66
SY   HB 11A-A11
DR   CCRID; 4201PAT-CCTCC00003
DR   Wikidata; Q93297632
RX   Patent=US5156977;
RX   PubMed=2940429;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85031401.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01161; Rat Nppa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   11A10
AC   CVCL_B3R5
DR   Wikidata; Q110429664
RX   Patent=CN105017419B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10585.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q14980; Human NUMA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   11A11
AC   CVCL_E2QV
RX   PubMed=26301932;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   11A7
AC   CVCL_XF01
DR   CCRID; 4201PAT-CCTCC00518
DR   Wikidata; Q93297634
RX   Patent=CN104610452B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014187.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01151; Human CD83.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   11A8
AC   CVCL_A0AN
DR   Wikidata; Q108819357
RX   PubMed=15034010;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   11A9
AC   CVCL_B6FT
DR   Wikidata; Q111732592
RX   PubMed=7765788;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   11B
AC   CVCL_S151
DR   Wikidata; Q54581059
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Doubling time: 1.6 days (DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Arlee 12; VBO=VBO_0017491.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   11b
AC   CVCL_8988
SY   iPS-11b; hiPS-11b; hiPS 11b; iPS11b
DR   EFO; EFO_0007100
DR   ENCODE; ENCBS473MEX
DR   GEO; GSM621715
DR   GEO; GSM637779
DR   SKIP; SKIP004341
DR   Wikidata; Q54581062
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=21368825;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8987 ! 11a
OI   CVCL_8989 ! 11c
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   11B11
AC   CVCL_9139
SY   11 B 11; BSF-1
DR   CLO; CLO_0001049
DR   ABCD; ABCD_AF263
DR   ATCC; HB-188
DR   BCRJ; 0001
DR   Wikidata; Q54581064
RX   PubMed=2582266;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07750; Mouse Il4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   11B5
AC   CVCL_B6VT
DR   Wikidata; Q111732593
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   11B6
AC   CVCL_E4A4
DR   ABCD; ABCD_AQ346
RX   PubMed=15247158;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P20151; Human KLK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   11B7501
AC   CVCL_0E75
DR   ATCC; CRL-1940
DR   Wikidata; Q54581065
RX   PubMed=20116412;
CC   Discontinued: ATCC; CRL-1940; true.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C134963; Seal lymphoma
OX   NCBI_TaxID=9720; ! Phoca vitulina (Harbor seal)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 6
//
ID   11BD-2E11-2
AC   CVCL_LC04
DR   Wikidata; Q54581067
RX   Patent=US7175846;
RX   Patent=US7488475;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5643.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   11c
AC   CVCL_8989
SY   iPS-11c; hiPS-11c; hiPS 11c
DR   EFO; EFO_0007101
DR   ENCODE; ENCBS312LLV
DR   GEO; GSM637780
DR   GEO; GSM670073
DR   SKIP; SKIP004342
DR   Wikidata; Q54581069
RX   PubMed=21293464;
RX   PubMed=21295703;
CC   From: Harvard University; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8987 ! 11a
OI   CVCL_8988 ! 11b
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   11C11B11
AC   CVCL_A0JN
DR   Wikidata; Q108819358
RX   Patent=US4863851;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9226.
CC   Registration: Upjohn Culture Collection; UC HB-20.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08118; Human MSMB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   11C7
AC   CVCL_C6MU
DR   ABCD; ABCD_AE849
DR   Wikidata; Q116047809
RX   PubMed=2555519;
RX   PubMed=6361525;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
CC   Misspelling: 11CF; PubMed=6361525.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   11C9
AC   CVCL_C8JX
DR   Wikidata; Q123030212
RX   PubMed=30978883;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78576; Aflatoxin M1 (AFM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   11CM
AC   CVCL_VJ84
SY   11 CM
DR   cancercelllines; CVCL_VJ84
DR   Cosmic; 2543723
DR   Wikidata; Q93297688
RX   PubMed=26744134;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26744134).
CC   Sequence variation: Mutation; HGNC; HGNC:7105; MITF; Simple; p.Leu117Phe (c.349C>T); Zygosity=Unspecified (PubMed=26744134).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   11D12
AC   CVCL_B0FU
DR   Wikidata; Q108819359
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4116.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   11D7
AC   CVCL_C4Z5
DR   Wikidata; Q116047810
RX   PubMed=11461664;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8BN78; Mouse Zbtb33 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   11E10
AC   CVCL_E958
DR   CLO; CLO_0001050
DR   ATCC; CRL-1907
DR   Wikidata; Q54581070
RX   PubMed=3053764;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09385; Bacteriophage 933W Shiga-like toxin 2 subunit A (stxA2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   11E12
AC   CVCL_C5A3
DR   ABCD; ABCD_AN897
DR   Wikidata; Q116047811
RX   Patent=US10421807;
CC   Monoclonal antibody isotype: IgG1+IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; C7G0W1; Dog IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   11E2
AC   CVCL_F1Y5
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   11E4
AC   CVCL_C5ED
DR   Wikidata; Q116047812
RX   PubMed=22008075;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6NTJ3; Xenopus laevis greatwall (mastl).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   11E6-7
AC   CVCL_E3ZW
RX   PubMed=10438974;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
CC   Monoclonal antibody target: ChEBI; CHEBI_28544; Digitoxin.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   11E9
AC   CVCL_E1H0
RX   PubMed=34271063;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; H8XX39; Chicken IFNK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   11F11 [Mouse hybridoma against chicken IFNK]
AC   CVCL_E1H1
RX   PubMed=34271063;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; H8XX39; Chicken IFNK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   11F11 [Mouse hybridoma against phage 933W stxA2]
AC   CVCL_E959
DR   CLO; CLO_0001051
DR   ATCC; CRL-1908
DR   Wikidata; Q54581146
RX   PubMed=3053764;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09385; Bacteriophage 933W Shiga-like toxin 2 subunit A (stxA2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 6
//
ID   11F4
AC   CVCL_XJ53
DR   Wikidata; Q93297710
RX   PubMed=27222007;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   11F6
AC   CVCL_E1H2
RX   PubMed=34271063;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; H8XX39; Chicken IFNK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   11F9
AC   CVCL_E1H5
RX   PubMed=30596381;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6A2H4; Chicken IL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   11G1
AC   CVCL_C4K3
DR   Wikidata; Q116047813
RX   PubMed=33497732;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QG57; Chicken CCL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   11G11
AC   CVCL_C4FG
DR   Wikidata; Q116047814
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   11G3
AC   CVCL_C4EV
DR   ABCD; ABCD_AE291
DR   Wikidata; Q116047816
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   11G5
AC   CVCL_B6VU
DR   Wikidata; Q111732595
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   11G5G1B11
AC   CVCL_B0NQ
SY   11G5
DR   ATCC; HB-11861
DR   Wikidata; Q108819360
RX   Patent=US6441143;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11861.
CC   Monoclonal antibody isotype: IgG1+IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   11G7
AC   CVCL_B0U7
DR   Wikidata; Q108819361
RX   Patent=US7759465;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5014.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60603; Human TLR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   11H1
AC   CVCL_F0VK
RX   DOI=10.3389/fddsv.2022.1093153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14114; Human LRP8 (Note=Immunized with AA 47-65).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   11H1.5B2
AC   CVCL_F0VL
DR   ABCD; ABCD_BF034
RX   DOI=10.3389/fddsv.2022.1093153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14114; Human LRP8 (Note=Immunized with AA 47-65).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F0VK ! 11H1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   11H4.4
AC   CVCL_N022
DR   Wikidata; Q54581148
RX   Patent=US9555107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7315.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9GZX6; Human IL22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 9
//
ID   11H4-1C7
AC   CVCL_A5DE
DR   Wikidata; Q107113128
RX   Patent=US6358737;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12397.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse osteocyte antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 4
//
ID   11H8
AC   CVCL_E7SH
RX   PubMed=1379786;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   11H9 [Mouse hybridoma against human CA9]
AC   CVCL_C7HY
DR   Wikidata; Q123030213
RX   PubMed=34806527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16790; Human CA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   11H9 [Mouse hybridoma against human DPP4]
AC   CVCL_C7IB
DR   Wikidata; Q123030214
RX   PubMed=9683260;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   11P0-1
AC   CVCL_6551
DR   CLO; CLO_0001052
DR   ATCC; CRL-2037
DR   Wikidata; Q54581149
RX   PubMed=2998805;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/cAn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   11R2F8.9
AC   CVCL_XC71
SY   HB 11R2F8; OM2
DR   ATCC; HB-10398
DR   CCRID; 4201PAT-CCTCC00084
DR   Wikidata; Q93297774
RX   Patent=US5907033;
RX   PubMed=1379836;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10398.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13725; Human OSM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   11Z
AC   CVCL_0Q72
SY   11-Z; Z11
DR   Wikidata; Q54581151
RX   PubMed=11696444;
RX   PubMed=18001719;
RX   PubMed=32106286;
CC   Doubling time: 39 hours (PubMed=11696444).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=32106286
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 9
ST   D18S51: 16,18
ST   D19S433: 12,13
ST   D21S11: 29,33.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   TH01: 9,10
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   12 040
AC   CVCL_A0XI
DR   Wikidata; Q108819362
RX   PubMed=33251771;
CC   Doubling time: 6.7 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 041
AC   CVCL_A0XJ
DR   Wikidata; Q108819363
RX   PubMed=33251771;
CC   Doubling time: 2.2 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 046
AC   CVCL_A0XK
DR   Wikidata; Q108819364
RX   PubMed=33251771;
CC   Doubling time: 10.3 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, right temporo-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 058
AC   CVCL_A0XL
DR   Wikidata; Q108819365
RX   PubMed=33251771;
CC   Doubling time: 8.5 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 059
AC   CVCL_A0XM
DR   Wikidata; Q108819366
RX   PubMed=33251771;
CC   Doubling time: 5.8 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 060
AC   CVCL_A0XN
DR   Wikidata; Q108819367
RX   PubMed=33251771;
CC   Doubling time: 6.6 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 073
AC   CVCL_A0XP
DR   Wikidata; Q108819369
RX   PubMed=33251771;
CC   Doubling time: 4.2 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 075
AC   CVCL_A0XQ
DR   Wikidata; Q108819370
RX   PubMed=33251771;
CC   Doubling time: 13.6 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12 079
AC   CVCL_A0XR
DR   Wikidata; Q108819371
RX   PubMed=33251771;
CC   Doubling time: 2.3 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   12-120-94/6
AC   CVCL_YA92
SY   12-120-94
DR   DSHB; 12-120-94-6
DR   Wikidata; Q93297781
RX   PubMed=2408765;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08796; Dictyostelium discoideum csaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   12-1B6
AC   CVCL_J713
DR   CLO; CLO_0050363
DR   RCB; RCB0870
DR   Wikidata; Q54581152
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   12-2-2S (clone 5F11)
AC   CVCL_G565
DR   CLO; CLO_0001058
DR   ATCC; HB-50
DR   Wikidata; Q54581153
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   12-24
AC   CVCL_D6TR
RX   PubMed=6432681;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse Ig lambda light chains (Note=Reacts with free and bound lambda chains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   12-40
AC   CVCL_C3VX
DR   ABCD; ABCD_AE162
DR   Wikidata; Q116047817
RX   PubMed=2104617;
RX   PubMed=3821741;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   12-A-3
AC   CVCL_6760
DR   CLO; CLO_0001064
DR   ATCC; CRL-6476
DR   Wikidata; Q54581154
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-6476; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   12.1 [Mouse hybridoma against human CD6]
AC   CVCL_G222
DR   CLO; CLO_0001053
DR   ATCC; HB-228
DR   Wikidata; Q54581156
RX   PubMed=6790625;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   12.1 [Mouse hybridoma against human ENOX2]
AC   CVCL_B0US
DR   ATCC; PTA-4206
DR   Wikidata; Q108819372
RX   Patent=US7053188;
RX   PubMed=11941450;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4206.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q16206; Human ENOX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   12.1.3
AC   CVCL_E3YW
SY   12.1
RX   PubMed=2453831;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q04620; Plasmodium berghei (strain Anka) Pbs21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   12.2
AC   CVCL_A0AR
DR   Wikidata; Q108819373
RX   PubMed=15802267;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q95460; Human MR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   12.4F
AC   CVCL_C8HG
DR   Wikidata; Q123030215
RX   PubMed=10477271;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97769; Prnp (Note=With p.Asn180Thr, p.Asn186Thr and p.Ser231_Gly254del = aglycosyl recPrP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein (Note=With p.Glu126Gly = R1176E1A).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8H6 ! CHOL761h
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   12.5
AC   CVCL_B0UT
DR   Wikidata; Q108819374
RX   Patent=US7053188;
RX   PubMed=11941450;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q16206; Human ENOX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   12/101
AC   CVCL_B7QK
DR   DSHB; 12-101
DR   Wikidata; Q112926886
RX   PubMed=3446476;
RX   PubMed=6366572;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Notophthalmus viridescens 102 kda protein in adult muscles.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 30-01-24; Version: 4
//
ID   12/44
AC   CVCL_G753
DR   CLO; CLO_0001054
DR   ATCC; HB-9070
DR   Wikidata; Q54581159
RX   Patent=US4680258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9070.
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   12/49
AC   CVCL_G762
DR   CLO; CLO_0001055
DR   ATCC; HB-9071
DR   Wikidata; Q54581161
RX   Patent=US4680258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9071.
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   120-16
AC   CVCL_F0AG
RX   PubMed=2326277;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 512-856 = gp41).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   120.545
AC   CVCL_D5ZP
DR   Wikidata; Q127378565
RX   PubMed=17575147;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9UHE8; Human STEAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   1201C1
AC   CVCL_LJ37
SY   HPS0379
DR   GEO; GSM2064338
DR   RCB; HPS0379
DR   SKIP; SKIP005892
DR   Wikidata; Q54581162
RX   PubMed=27642008;
RX   PubMed=29179815;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DQ ! 1205D1
OI   CVCL_LJ38 ! 1210B2
OI   CVCL_LJ39 ! 1231A3
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   1205-4
AC   CVCL_E4CK
RX   PubMed=28817799;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1205A
AC   CVCL_UP44
DR   Wikidata; Q93297822
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP45 ! 1205B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   1205B
AC   CVCL_UP45
DR   Wikidata; Q93297826
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP44 ! 1205A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   1205D1
AC   CVCL_A3DQ
SY   HPS0380
DR   RCB; HPS0380
DR   Wikidata; Q105505852
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ37 ! 1201C1
OI   CVCL_LJ38 ! 1210B2
OI   CVCL_LJ39 ! 1231A3
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   1205Lu
AC   CVCL_5239
SY   1205-Lu; 1205 Lu; WM 1205LU; WM-1205LU; WM1205Lu; WM1205; LU1205; Lu1205; WC00058
DR   BTO; BTO_0005011
DR   CLO; CLO_0001056
DR   EFO; EFO_0002810
DR   ATCC; CRL-2812
DR   BioSample; SAMN03471797
DR   cancercelllines; CVCL_5239
DR   Cell_Model_Passport; SIDM00972
DR   Coriell; WC00058
DR   Cosmic; 686410
DR   Cosmic; 905861
DR   Cosmic; 972275
DR   Cosmic; 1155274
DR   Cosmic; 1155554
DR   Cosmic; 1187583
DR   Cosmic; 1303026
DR   Cosmic; 1507616
DR   ESTDAB; ESTDAB-067
DR   GEO; GSM109020
DR   GEO; GSM109021
DR   GEO; GSM188067
DR   GEO; GSM188119
DR   GEO; GSM188192
DR   GEO; GSM188207
DR   GEO; GSM188218
DR   GEO; GSM188283
DR   GEO; GSM188292
DR   GEO; GSM952578
DR   LINCS_LDP; LCL-1236
DR   Lonza; 900
DR   PRIDE; PXD004343
DR   Progenetix; CVCL_5239
DR   Rockland; 51603
DR   SKY/M-FISH/CGH; 4946
DR   Wikidata; Q54581163
RX   DOI=10.4172/1948-5956.1000196;
RX   DOI=10.4172/1948-5956.1000401;
RX   PubMed=2068080;
RX   PubMed=8342600;
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=18790768;
RX   PubMed=25950383;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
WW   Provider; Rockland; 51603; https://web.archive.org/web/20170706193814/http://www.rockland-inc.com/Product.aspx?id=51603
CC   Problematic cell line: Partially contaminated. The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which was distributed by Rockland (DOI=10.4172/1948-5956.1000401).
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00483.
CC   Population: Caucasian.
CC   Characteristics: Established from serial passaging of the parent cell line through immune deficient mice and harvesting lung metastasis.
CC   HLA typing: A*01:01,29:01; B*35:01,57:01; C*06:02,04:01:01; DPB1*04:01,04:01; DQB1*03:01:01,03:01:01; DRB1*11:03:01,11:03:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Unspecified (Wistar).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X,Y->X, D16S539: 11,12->10,12, D7S820: 10,12->10, D8S1179: 11,12,14->12,14 and vWA: 16,17->17.
CC   Discontinued: ATCC; CRL-2812; true.
CC   Discontinued: Coriell; WC00058; probable.
CC   Discontinued: Rockland; 51603; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-2812; ESTDAB=ESTDAB-067; Wistar
ST   Amelogenin: X (Wistar)
ST   Amelogenin: X,Y (ATCC=CRL-2812; ESTDAB=ESTDAB-067)
ST   CSF1PO: 11
ST   D13S317: 8,14
ST   D16S539: 10,12 (Wistar)
ST   D16S539: 12 (ATCC=CRL-2812)
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 10 (Wistar)
ST   D7S820: 10,12 (ATCC=CRL-2812; ESTDAB=ESTDAB-067)
ST   D8S1179: 12,14
ST   FGA: 20,21
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8787 ! WM793
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   1207
AC   CVCL_VL59
DR   Wikidata; Q93297837
RX   PubMed=9139855;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   120816CT
AC   CVCL_ZW84
DR   Wikidata; Q102113414
RX   Patent=US20190153386;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-124321.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Somatic stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   120G8
AC   CVCL_B5N5
DR   Wikidata; Q111732596
RX   PubMed=14662846;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8R2Q8; Mouse Bst2/Cd317.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   120H7
AC   CVCL_B0D5
DR   Wikidata; Q108819375
RX   Patent=US4938948;
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10790.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10061.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   120MA
AC   CVCL_ZU01
SY   120 MAnchester
DR   Wikidata; Q98125020
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 33 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   121-15B10
AC   CVCL_J550
DR   Wikidata; Q54581165
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8954.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   121-19B10
AC   CVCL_E960
DR   CLO; CLO_0001057
DR   ATCC; CRL-2652
DR   Wikidata; Q54581167
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8955.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   121-1F9
AC   CVCL_J551
DR   Wikidata; Q54581170
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8948.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   121-3H5
AC   CVCL_J552
DR   Wikidata; Q54581172
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8949.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   121-4F8
AC   CVCL_J553
DR   Wikidata; Q54581175
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8950.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   121-5E5
AC   CVCL_J554
DR   Wikidata; Q54581176
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8951.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   121-8D8
AC   CVCL_J555
DR   Wikidata; Q54581177
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8956.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   121-9E5
AC   CVCL_J556
DR   Wikidata; Q54581178
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8953.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   121-9G10
AC   CVCL_J557
DR   Wikidata; Q54581180
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8952.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   1210B2
AC   CVCL_LJ38
SY   HPS4293
DR   GEO; GSM2064336
DR   RCB; HPS4293
DR   Wikidata; Q54581182
RX   PubMed=27642008;
RX   PubMed=29179815;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ37 ! 1201C1
OI   CVCL_A3DQ ! 1205D1
OI   CVCL_LJ39 ! 1231A3
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   1218E
AC   CVCL_C524
SY   HT-D
DR   Wikidata; Q54581183
RX   PubMed=6169654;
RX   PubMed=7471097;
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   1221
AC   CVCL_2264
DR   CLO; CLO_0001009
DR   CLDB; cl3
DR   ECACC; 90011873
DR   Wikidata; Q54581186
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=90011873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   1228
AC   CVCL_IP60
SY   1228-GSC; GSC-1228
DR   BTO; BTO_0006004
DR   Wikidata; Q54581187
RX   PubMed=23307328;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   122F9
AC   CVCL_B6FU
DR   Wikidata; Q111732597
RX   PubMed=7765788;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   123-10
AC   CVCL_E961
DR   CLO; CLO_0001059
DR   ATCC; CRL-1707
DR   Wikidata; Q54581189
RX   PubMed=6090455;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P10443; Escherichia coli polC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 6
//
ID   123-28
AC   CVCL_E962
DR   CLO; CLO_0001060
DR   ATCC; CRL-1713
DR   Wikidata; Q54581190
RX   PubMed=3040763;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06710; Escherichia coli dnaX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 6
//
ID   123-353-1
AC   CVCL_YA93
DR   DSHB; 123-353-1
DR   Wikidata; Q93297964
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08796; Dictyostelium discoideum csaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   123.7
AC   CVCL_0109
DR   MCCL; MCC:0000000
DR   Wikidata; Q54581191
RX   PubMed=1645738;
RX   PubMed=1651325;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   1231A3
AC   CVCL_LJ39
SY   HPS0381; KUIMSi012-A
DR   GEO; GSM2064337
DR   hPSCreg; KUIMSi012-A
DR   RCB; HPS0381
DR   Wikidata; Q54581193
RX   PubMed=27642008;
RX   PubMed=28233934;
RX   PubMed=28858313;
RX   PubMed=35176664;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35176664
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D21S11: 31
ST   D3S1358: 14,15
ST   D5S818: 13,14
ST   D7S820: 9,10
ST   D8S1179: 13,17
ST   FGA: 24,25
ST   Penta D: 2.2,13
ST   Penta E: 12,14
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ37 ! 1201C1
OI   CVCL_A3DQ ! 1205D1
OI   CVCL_LJ38 ! 1210B2
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   12370
AC   CVCL_JY27
DR   cancercelllines; CVCL_JY27
DR   Wikidata; Q54581195
RX   PubMed=25862976;
RX   PubMed=31150822;
CC   Doubling time: 6-9 days (PubMed=25862976).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Pro (c.578A>C); ClinVar=VCV000376612; Zygosity=Unspecified (PubMed=25862976; PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D1S1656: 17.3
ST   D21S11: 28,29
ST   D2S1338: 19,23
ST   D3S1358: 14,17
ST   D5S818: 10,11
ST   D6S1043: 13
ST   D7S820: 7,8
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 7,9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   123MA
AC   CVCL_ZU02
SY   123 MAnchester
DR   Wikidata; Q98125021
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 14 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   124-11-2
AC   CVCL_A0ID
SY   #124-11-2
DR   Wikidata; Q108819376
RX   Patent=US8178100;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00142.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02778; Human CXCL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1242B
AC   CVCL_C525
DR   Wikidata; Q54581196
RX   PubMed=7471097;
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   1246
AC   CVCL_S884
DR   Wikidata; Q54581197
RX   DOI=10.1007/978-3-642-69290-1_52;
CC   Characteristics: Insulin dependent (DOI=10.1007/978-3-642-69290-1_52).
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 9
//
ID   1246-3A
AC   CVCL_S885
DR   Wikidata; Q54581199
RX   DOI=10.1007/978-3-642-69290-1_52;
RX   PubMed=2663884;
RX   PubMed=3045808;
CC   Characteristics: Has lost the insulin dependence of the parent cell line (DOI=10.1007/978-3-642-69290-1_52).
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S884 ! 1246
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 9
//
ID   1249
AC   CVCL_E430
SY   DHOL
DR   dbMHC; 48448
DR   IHW; IHW09339
DR   IPD-IMGT/HLA; 10046
DR   Wikidata; Q54581200
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DQA1*01:02,02:01; DQB1*05:01,02; DRB1*11:01:02,07:01; DRB3*02:02 (IPD-IMGT/HLA=10046).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   124BR
AC   CVCL_ZT33
SY   124 BRighton
DR   Wikidata; Q98125022
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   124MA
AC   CVCL_ZU03
SY   124 Manchester
DR   Wikidata; Q98125023
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 27 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (PubMed=8794843; PubMed=9018113; PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   125-27
AC   CVCL_C8JP
DR   Wikidata; Q123030216
RX   PubMed=3040763;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06710; Escherichia coli dnaX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   1255-B7
AC   CVCL_U954
SY   1255/B7
DR   ATCC; CRL-6604
DR   Wikidata; Q54581201
RX   PubMed=4330168;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Discontinued: ATCC; CRL-6604; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 8
//
ID   1255O
AC   CVCL_C526
SY   1255-O
DR   Wikidata; Q54581204
RX   PubMed=7471097;
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   1259-mel
AC   CVCL_GR81
SY   1259-MEL; 1259mel; 1259MEL
DR   Cosmic; 2759882
DR   TOKU-E; 4040
DR   Wikidata; Q54581206
RX   PubMed=8537970;
RX   PubMed=15661905;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Unspecified (PubMed=15661905).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   125A8-1-11
AC   CVCL_C5QX
SY   125A8
DR   Wikidata; Q116047818
RX   PubMed=2449607;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   125M10AA
AC   CVCL_B0VE
SY   M10
DR   Wikidata; Q108819377
RX   Patent=US7579187;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10107.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   125M165DAAA
AC   CVCL_B0VF
SY   M165
DR   Wikidata; Q108819378
RX   Patent=US7579187;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10106.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   125M96ABA
AC   CVCL_B0VG
SY   M96
DR   Wikidata; Q108819379
RX   Patent=US7579187;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10108.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   125MA
AC   CVCL_ZU04
SY   125 MAnchester
DR   Wikidata; Q98125024
RX   PubMed=9649131;
CC   Senescence: Senesces at 15 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   125N26F6AA
AC   CVCL_B0VH
SY   N26
DR   Wikidata; Q108819380
RX   Patent=US7579187;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10109.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   125Q47BA
AC   CVCL_B0VI
SY   Q47
DR   Wikidata; Q108819381
RX   Patent=US7579187;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10104.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   125Q54AAAA
AC   CVCL_B0VJ
SY   Q54
DR   Wikidata; Q108819382
RX   Patent=US7579187;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10105.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   125R5AAAA
AC   CVCL_B0VK
SY   R5
DR   Wikidata; Q108819383
RX   Patent=US7579187;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10103.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   126 BLCL
AC   CVCL_E342
DR   ECACC; 94031621
DR   Wikidata; Q54581208
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   126-13
AC   CVCL_F1CD
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   126-13D
AC   CVCL_F1CE
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CD ! 126-13
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   126-50
AC   CVCL_A2WW
DR   Wikidata; Q105505856
RX   Patent=US5731189;
RX   PubMed=2072448;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: HIV-1 protein gp41.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   126-6
AC   CVCL_9V02
DR   Wikidata; Q54581209
RX   Patent=US5731189;
RX   PubMed=2072448;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10037.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: HIV-1 protein gp41.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   1262T
AC   CVCL_E5K9
RX   PubMed=9331573;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1263A18
AC   CVCL_B7DC
DR   Wikidata; Q112926887
RX   PubMed=28233934;
RX   PubMed=28858313;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   126BR
AC   CVCL_ZT34
SY   126 BRighton
DR   Wikidata; Q98125025
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   126MA
AC   CVCL_ZU05
SY   126 MAnchester
DR   Wikidata; Q98125027
RX   PubMed=9018113;
RX   PubMed=9649131;
RX   PubMed=9681890;
CC   Senescence: Senesces at 53 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 7
//
ID   127 BLCL
AC   CVCL_E343
DR   ECACC; 94031622
DR   Wikidata; Q54581211
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   127-24C7
AC   CVCL_J558
DR   Wikidata; Q54581294
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8965.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   127-24E11
AC   CVCL_J559
DR   Wikidata; Q54581295
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8966.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   127-38G2
AC   CVCL_J560
DR   Wikidata; Q54581297
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8967.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   127-42C11
AC   CVCL_J561
SY   127-42C11.SCRF35.4; SCRF 35.4
DR   Wikidata; Q54581300
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9561.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   127-50D12
AC   CVCL_J562
DR   Wikidata; Q54581301
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8969.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   127-50D4
AC   CVCL_J563
DR   Wikidata; Q54581306
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8968.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   127-53F8
AC   CVCL_J564
DR   Wikidata; Q54581308
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8970.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   127-60F3
AC   CVCL_J565
DR   Wikidata; Q54581309
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8971.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00542; Feline sarcoma virus (strain Gardner-Arnstein) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   1273/99
AC   CVCL_N588
SY   1273-99; 127399; 1273
DR   cancercelllines; CVCL_N588
DR   Cell_Model_Passport; SIDM01315
DR   Cosmic; 2307723
DR   DepMap; ACH-001270
DR   Wikidata; Q54581310
RX   PubMed=12097301;
RX   PubMed=24726063;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (PubMed=12097301; DepMap=ACH-001270).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   1274A15
AC   CVCL_B7DE
DR   Wikidata; Q112926890
RX   PubMed=28233934;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7DI ! 783E2
OI   CVCL_B7DF ! 1274A8
OI   CVCL_B7DK ! PD12-1
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   1274A8
AC   CVCL_B7DF
DR   Wikidata; Q112926893
RX   PubMed=28233934;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7DI ! 783E2
OI   CVCL_B7DE ! 1274A15
OI   CVCL_B7DK ! PD12-1
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   1275A2
AC   CVCL_B7DG
DR   Wikidata; Q112926895
RX   PubMed=28233934;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7DH ! 1275A3
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   1275A3
AC   CVCL_B7DH
DR   Wikidata; Q112926899
RX   PubMed=28233934;
RX   PubMed=28858313;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7DG ! 1275A2
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   1278-mel
AC   CVCL_8035
SY   1278-MEL; 1278 mel; 1278
DR   Wikidata; Q54581311
RX   PubMed=8027550;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*11,28 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   127A
AC   CVCL_J037
DR   ATCC; HB-11905
DR   Wikidata; Q54581313
RX   Patent=US5773293;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11905.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; D3ZP29; Rat Icam4/Cd242.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   127BR
AC   CVCL_ZT35
SY   127 BRighton
DR   Wikidata; Q98125076
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   127H
AC   CVCL_J036
DR   CLO; CLO_0001061
DR   ATCC; HB-11911
DR   Wikidata; Q54581314
RX   Patent=US5773293;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11911.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; D3ZP29; Rat Icam4/Cd242.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   127TAg
AC   CVCL_6759
DR   CLO; CLO_0001062
DR   ATCC; CRL-2817
DR   Kerafast; ENH118-FP
DR   Wikidata; Q54581315
RX   PubMed=12882965;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104288; Pms2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   128-2
AC   CVCL_J861
DR   Wikidata; Q54581317
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   128-88T
AC   CVCL_A2AG
DR   Wikidata; Q105505858
RX   PubMed=11929836;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age at sampling from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   1280-mel
AC   CVCL_8036
SY   1280-MEL; 1280 mel; 1280
DR   Cosmic; 876691
DR   Wikidata; Q54581320
RX   PubMed=10048982;
RX   PubMed=10754339;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   12827878
AC   CVCL_JC97
SY   TER303; TER-303; Ter 303; TER379; TER-379; Ter 379; TER454; TER-454; Ter 454
DR   IPD-IMGT/HLA; 10049
DR   Wikidata; Q54581323
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/357cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01; B*57; DPB1*06:01,09:01; DQA1*02:01,05:01; DQB1*02:01,03:03; DRB1*03:01,07:04; DRB3*01:01; DRB4*01:03:01:02N (IPD-IMGT/HLA=10049).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   1283.Lu
AC   CVCL_S461
DR   ATCC; CRL-6297
DR   Wikidata; Q54581325
CC   Group: Non-human primate cell line.
CC   Discontinued: ATCC; CRL-6297; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9489; ! Leontocebus nigricollis (Black-mantled tamarin)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   1286-mel
AC   CVCL_8037
SY   1286-MEL; 1286 mel; 1286
DR   Wikidata; Q54581326
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,29 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   128BR
AC   CVCL_ZN50
SY   128 BRighton
DR   Wikidata; Q98125077
RX   PubMed=1372096;
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN24 ! LB146
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   1287-mel
AC   CVCL_8038
SY   1287-MEL; 1287 mel; 1287
DR   Wikidata; Q54581329
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   129 BLCL
AC   CVCL_E344
DR   ECACC; 94031623
DR   Wikidata; Q54581332
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   129 Nu 5002-1 Tu
AC   CVCL_4807
DR   Wikidata; Q54581333
RX   PubMed=9044828;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200634/http://capcelllines.ca:80/details.asp?id=105
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4844 ! HPV-18-C1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   129 Nu 5010-5 Tu
AC   CVCL_4808
DR   Wikidata; Q54581336
RX   PubMed=9044828;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200643/http://capcelllines.ca:80/details.asp?id=108
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4844 ! HPV-18-C1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   129-CUMC/UF
AC   CVCL_IJ17
DR   Wikidata; Q54581337
RX   PubMed=27789403;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   1290-2
AC   CVCL_RW69
DR   BTO; BTO_0002962
DR   Wikidata; Q54581341
RX   PubMed=16585582;
CC   Miscellaneous: Only mentioned as a melanoma cell line in PubMed=16585582. Could be a subline of 1290-mel (Cellosaurus=CVCL_7943).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   1290-mel
AC   CVCL_7943
SY   1290-MEL; 1290 mel; 1290; MG-1290; 1290-MEL p14; 1290p14
DR   cancercelllines; CVCL_7943
DR   Cosmic; 876682
DR   Cosmic; 877280
DR   Cosmic; 1042622
DR   GEO; GSM218047
DR   GEO; GSM218048
DR   GEO; GSM1092557
DR   Progenetix; CVCL_7943
DR   Wikidata; Q54581338
RX   PubMed=16470173;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DN ! 888-EBV
OI   CVCL_4632 ! 888-mel
OI   CVCL_DI11 ! 1858-mel a
OI   CVCL_DI12 ! 1858-mel b
OI   CVCL_DI13 ! 1858-mel c
OI   CVCL_DI14 ! 1936-mel
OI   CVCL_DI15 ! 1962-mel
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   129A3/1
AC   CVCL_J039
DR   CLO; CLO_0001063
DR   ATCC; HB-8087
DR   IZSLER; BS Hy 33
DR   Wikidata; Q54581342
RX   Patent=US4416866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8087.
CC   Monoclonal antibody isotype: IgA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   129BR
AC   CVCL_ZT36
SY   129 BRighton
DR   Wikidata; Q98125078
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   129fc-1
AC   CVCL_F044
DR   RCB; AES0043
DR   RCB; RCB2192
DR   SKIP; SKIP001656
DR   Wikidata; Q54581344
CC   Discontinued: RCB; RCB2192; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   129fc-2
AC   CVCL_F045
DR   RCB; AES0044
DR   RCB; RCB2193
DR   SKIP; SKIP001657
DR   Wikidata; Q54581346
CC   Discontinued: RCB; RCB2193; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   12A-NFUD3
AC   CVCL_D4B4
DR   Wikidata; Q127378566
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: MZM-0410.
OX   NCBI_TaxID=105023; ! Nothobranchius furzeri (Turquoise killifish)
SX   Sex unspecified
AG   Diapause III embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   12A07-A10
AC   CVCL_B0LP
DR   Wikidata; Q108819385
RX   Patent=US8940534;
RX   Patent=WO2009156155A1;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2695.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Extraembryonic membrane; UBERON=UBERON_0005631.
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   12A1
AC   CVCL_E8NT
RX   Patent=WO2024196162A1;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UXX9; Human RSPO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   12A11
AC   CVCL_F0H9
SY   mu12A11
DR   ABCD; ABCD_AL479
RX   Patent=US10730953;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   12A5B7
AC   CVCL_G566
DR   CLO; CLO_0001065
DR   ATCC; HB-8328
DR   Wikidata; Q54581347
RX   Patent=US4595654;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8328.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02745; Human C1QA.
CC   Monoclonal antibody target: UniProtKB; P02746; Human C1QB.
CC   Monoclonal antibody target: UniProtKB; P02747; Human C1QC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   12A7
AC   CVCL_D5YQ
DR   DSHB; 12A7
DR   Wikidata; Q127378567
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q9VVX3; Drosophila melanogaster fz2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   12B2
AC   CVCL_C4JV
DR   Wikidata; Q116047819
RX   PubMed=35688031;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; D8UWD9; Chicken CSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   12B2E1
AC   CVCL_A0VE
DR   CCRID; 4201PAT-CCTCC01051
DR   Wikidata; Q108819386
RX   Patent=CN107299085B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201761.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   12B3
AC   CVCL_E6K2
RX   PubMed=10712664;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   12B4
AC   CVCL_E5QA
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   12C1
AC   CVCL_C3VV
DR   ABCD; ABCD_AW648
DR   Wikidata; Q116047820
RX   PubMed=28152387;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_193573; Isomiroestrol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   12C2 [Mouse hybridoma against bovine NEFL]
AC   CVCL_C5D9
DR   Wikidata; Q116047821
RX   PubMed=11991817;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02548; Bovine NEFL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   12C2 [Mouse hybridoma against T-2 mycotoxin]
AC   CVCL_C5EZ
DR   Wikidata; Q116047822
RX   PubMed=3919640;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9381; T-2 mycotoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   12C3
AC   CVCL_E5M9
RX   PubMed=26889021;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11258; Vaccinia virus protein OPG154 (A27L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   12C4
AC   CVCL_C4EW
DR   Wikidata; Q116047823
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   12C4G12
AC   CVCL_E3A1
RX   PubMed=26771404;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0N9P2C3; Porcine epidemic diarrhea virus (strain HN1303) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   12C6
AC   CVCL_VG83
DR   ATCC; HB-173
DR   Wikidata; Q54581349
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=3901396;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on endothelial cells.
CC   Discontinued: ATCC; HB-173; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   12C6c
AC   CVCL_C2JG
DR   DSHB; 12C6c
DR   Wikidata; Q114310036
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_189550; FLAG peptide (DYKDDDDK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   12C7
AC   CVCL_B6VV
DR   Wikidata; Q111732598
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   12C9
AC   CVCL_VI26
DR   BEI_Resources; MRA-254
DR   Wikidata; Q54581351
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   12CFBE22o-
AC   CVCL_IN59
DR   Wikidata; Q54581352
RX   PubMed=1375758;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 7
//
ID   12D4
AC   CVCL_C6MV
DR   ABCD; ABCD_AE848
DR   Wikidata; Q116047824
RX   PubMed=2555519;
RX   PubMed=6361525;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   12D7
AC   CVCL_W647
DR   BEI_Resources; ARP-11411
DR   cancercelllines; CVCL_W647
DR   Wikidata; Q54581354
RX   PubMed=10698967;
CC   Population: Caucasian.
CC   Characteristics: Clone highly expressing CD4 (BEI_Resources=ARP-11411).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6244 ! CEM A3.01
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   12D7-MDR1
AC   CVCL_A9MA
DR   cancercelllines; CVCL_A9MA
DR   Wikidata; Q108819387
RX   PubMed=10698967;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W647 ! 12D7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   12D7-MDR1-IRES-DHFR
AC   CVCL_E3GD
SY   12D7-pHMIDwt
RX   PubMed=10698967;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W647 ! 12D7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   12D7-MDR1mt-IRES-DHFR
AC   CVCL_E3GE
SY   12D7-pHMIDmt
RX   PubMed=10698967;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1 (Note=With p.Asp555Asn).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W647 ! 12D7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   12D7-NEO
AC   CVCL_E3GC
RX   PubMed=10698967;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for 12D7-MDR1 (Cellosaurus=CVCL_A9MA), 12D7-MDR1-IRES-DHFR (Cellosaurus=CVCL_E3GD) and 12D7-MDR1mt-IRES-DHFR (Cellosaurus=CVCL_E3GE) (PubMed=10698967).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W647 ! 12D7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   12E1
AC   CVCL_C5AL
DR   Wikidata; Q116047825
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   12E3B
AC   CVCL_C7IC
DR   Wikidata; Q123030217
RX   PubMed=9683260;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   12F11
AC   CVCL_B6VW
DR   Wikidata; Q111732599
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   12G10
AC   CVCL_C4EX
DR   ABCD; ABCD_AE293
DR   Wikidata; Q116047826
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   12G2
AC   CVCL_E5M6
RX   PubMed=26889021;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11258; Vaccinia virus protein OPG154 (A27L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   12G5 [Mouse hybridoma against C.neoformans polysaccharide]
AC   CVCL_F1Y7
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   12G5 [Mouse hybridoma against human CXCR4]
AC   CVCL_ZX77
DR   Wikidata; Q102113416
RX   PubMed=8929542;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P61073; Human CXCR4/CD184.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 4
//
ID   12G7
AC   CVCL_C4Z6
DR   Wikidata; Q116047827
RX   PubMed=11461664;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8BN78; Mouse Zbtb33 (Note=Also reacts with human, dog, hamster, monkey, rat and chicken).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   12G9
AC   CVCL_E5Q9
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   12H1.B1
AC   CVCL_B7CL
DR   Wikidata; Q112926902
RX   Patent=US7807791;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8902.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   12H11
AC   CVCL_A0TW
DR   CCRID; 4201PAT-CCTCC00526
DR   Wikidata; Q108819389
RX   Patent=CN104726412A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014196.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05413; Human FABP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   12H4.11.3
AC   CVCL_LH45
DR   Wikidata; Q54581355
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6034.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 5
//
ID   12H5
AC   CVCL_A6RG
DR   Wikidata; Q107113129
RX   PubMed=2384664;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01137; Human TGFB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   12H6G1
AC   CVCL_A0VF
DR   CCRID; 4201PAT-CCTCC01052
DR   Wikidata; Q108819390
RX   Patent=CN107299085B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201762.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   12H8
AC   CVCL_C7HZ
DR   Wikidata; Q123030218
RX   PubMed=34806527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16790; Human CA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   12H8-B11
AC   CVCL_D5JM
DR   Wikidata; Q127378568
RX   PubMed=23479511;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   12H9
AC   CVCL_C4Z7
DR   Wikidata; Q116047828
RX   PubMed=11461664;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8BN78; Mouse Zbtb33 (Note=Also reacts with human, dog, hamster, monkey and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   12MBr-6
AC   CVCL_6342
SY   12MBr6
DR   CLO; CLO_0001066
DR   ATCC; CRL-1576
DR   IZSLER; BS CL 216
DR   Wikidata; Q54581358
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   DOI=10.1016/B978-012361946-4/50009-0;
CC   Group: Non-human primate cell line.
CC   Senescence: Senesces at ~23 PDL (ATCC=CRL-1576).
CC   Discontinued: IZSLER; BS CL 216; probable.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
AG   2-3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   12R13D7.2
AC   CVCL_XC72
SY   HB 12R13D7; OM3
DR   ATCC; HB-10396
DR   CCRID; 4201PAT-CCTCC00083
DR   Wikidata; Q93298212
RX   Patent=US5907033;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10396.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13725; Human OSM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   12S
AC   CVCL_0F17
SY   Clone 12S
DR   Wikidata; Q54581359
RX   PubMed=2843357;
CC   Doubling time: ~36 hours (PubMed=2843357).
CC   Transformant: Adenovirus E1A.
CC   Derived from site: In situ; Fetal thyroid gland; UBERON=UBERON_0003091.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   12Z
AC   CVCL_0Q73
SY   12z; 12-Z; Z12; Z-12; Z12 Eo; EEC12Z
DR   BTO; BTO_0005656
DR   ABM; T0764
DR   Cosmic; 1432838
DR   Millipore; SCC443
DR   Wikidata; Q54581361
RX   PubMed=11696444;
RX   PubMed=18001719;
RX   PubMed=24502583;
RX   PubMed=26199416;
RX   PubMed=32106286;
CC   Doubling time: 31 hours (PubMed=11696444).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=32106286
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 13
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 10
ST   FGA: 23,24
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 17
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 19
//
ID   12Z-GFP
AC   CVCL_UT50
DR   Wikidata; Q93298221
RX   PubMed=26199416;
CC   Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0Q73 ! 12Z
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   13 019
AC   CVCL_A0XS
DR   Wikidata; Q108819391
RX   PubMed=33251771;
CC   Doubling time: 1.6 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   13 025
AC   CVCL_A0XT
DR   Wikidata; Q108819392
RX   PubMed=33251771;
CC   Doubling time: 4.7 days (PubMed=33251771).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   13-2
AC   CVCL_B6X2
DR   CCRID; 4201PAT-CCTCC00721
DR   Wikidata; Q111732600
RX   Patent=CN105132382A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201597.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08727; Human KRT19 (Note=AA 301-400 = CYFRA21-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   13-5-9-6-2
AC   CVCL_J044
SY   13-5'9'6'2
DR   CLO; CLO_0001075
DR   ATCC; HB-8934
DR   IZSLER; BS Hy 57
DR   Wikidata; Q54581363
RX   Patent=US4790987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8934.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08492; Human parainfluenza 3 virus (strain Wash/47885/57) Hemagglutinin-neuraminidase (HN).
CC   Discontinued: IZSLER; BS Hy 57; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   13-975-157
AC   CVCL_A9RC
SY   HCV 13-975-157
DR   ATCC; HB-10608
DR   Wikidata; Q102113417
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10608.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1-150 = Core protein p21).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   13-9B
AC   CVCL_C527
DR   BTO; BTO_0006012
DR   Wikidata; Q54581364
RX   PubMed=12485491;
CC   Problematic cell line: Contaminated. Parent cell line (SUNE1) has been shown to be an hybrid of HeLa and a cell line of unknown origin.
CC   Omics: Transcriptomics; Microarray.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6946 ! SUNE1
CA   Hybrid cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   13.1
AC   CVCL_C5WU
DR   Wikidata; Q116047829
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   13.1.15
AC   CVCL_E3YX
SY   13.1
DR   ABCD; ABCD_AF728
RX   PubMed=2453831;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q04620; Plasmodium berghei (strain Anka) Pbs21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   13.4.4
AC   CVCL_E7QI
DR   ABCD; ABCD_BE641
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   13.90.2
AC   CVCL_J045
SY   13.90
DR   CLO; CLO_0001067
DR   ATCC; HB-8337
DR   Wikidata; Q54581367
RX   Patent=US4650676;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8337.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Eimeria tenella merozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   130 BLCL
AC   CVCL_E345
DR   ECACC; 94031624
DR   Wikidata; Q54581444
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   130-3-F7-5
AC   CVCL_J042
SY   CO-301; CO301
DR   CLO; CLO_0001068
DR   ATCC; HB-8326
DR   Wikidata; Q54581447
RX   Patent=US4607009;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8326.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_59440; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcNAc (Lewis B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   130-80-2
AC   CVCL_6F35
DR   ABCD; ABCD_AN707
DR   DSHB; 130-80-2
DR   Wikidata; Q54581448
RX   PubMed=2307702;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P21837; Dictyostelium discoideum cryS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 8
//
ID   1300-mel
AC   CVCL_8039
SY   1300-MEL; 1300 mel; 1300
DR   Cosmic; 876703
DR   Wikidata; Q54581449
RX   PubMed=8027550;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,24 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   13008
AC   CVCL_WH15
DR   Wikidata; Q93298250
RX   PubMed=28283079;
DI   NCIt; C158784; Canine granular cell tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   1301
AC   CVCL_2265
DR   CLO; CLO_0001010
DR   CLDB; cl5401
DR   cancercelllines; CVCL_2265
DR   Cosmic; 2402466
DR   ECACC; 01051619
DR   IARC_TP53; 21147
DR   ICLC; HTL01004
DR   NCBI_Iran; C512
DR   Wikidata; Q54581450
RX   PubMed=223921;
RX   PubMed=9685479;
CC   Population: Caucasian.
CC   Characteristics: Has unusually long telomeres.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ICLC=HTL01004
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9
ST   D16S539: 10,13
ST   D21S11: 30,32.2,33.2
ST   D5S818: 12,14,15
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 29
//
ID   1301-U1
AC   CVCL_IS05
DR   cancercelllines; CVCL_IS05
DR   Wikidata; Q54581453
RX   PubMed=9685479;
CC   Population: Caucasian.
CC   Characteristics: Has unusually long telomeres (PubMed=9685479).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2265 ! 1301
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 18
//
ID   1301-U2
AC   CVCL_IS06
DR   cancercelllines; CVCL_IS06
DR   Wikidata; Q54581455
RX   PubMed=9685479;
CC   Population: Caucasian.
CC   Characteristics: Has unusually long telomeres (PubMed=9685479).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2265 ! 1301
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 18
//
ID   13020
AC   CVCL_WH16
DR   Wikidata; Q93298262
RX   PubMed=28283079;
DI   NCIt; C158783; Canine gastrointestinal stromal tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   13041452
AC   CVCL_JC71
SY   Extract 257; Extract 506; Extract 593
DR   IPD-IMGT/HLA; 10066
DR   Wikidata; Q54581457
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/355cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/377cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,02:24; B*07:02,37:01; C*06:02,07:02; DQA1*01,02:01; DQB1*02,05; DRB1*07,10:01 (IPD-IMGT/HLA=10066).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   1306
AC   CVCL_2266
DR   CLO; CLO_0001011
DR   CLDB; cl4
DR   ECACC; 90011887
DR   Wikidata; Q54581459
RX   PubMed=3110595;
CC   Population: Puerto Rican.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ECACC=90011887
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7297 ! GM00637
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   1308-mel
AC   CVCL_A1DQ
SY   1308-MEL
DR   Wikidata; Q102113418
RX   PubMed=8027550;
RX   PubMed=9670966;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*11,24 (PubMed=9670966).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   1308.1
AC   CVCL_L903
DR   Wikidata; Q54581462
RX   PubMed=8500519;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   130BR
AC   CVCL_ZT37
SY   130 BRighton
DR   Wikidata; Q98125079
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   130C3/2B/8
AC   CVCL_J040
DR   CLO; CLO_0001069
DR   ATCC; HB-8088
DR   IZSLER; BS Hy 58
DR   Wikidata; Q54581465
RX   Patent=US4416866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8088.
CC   Monoclonal antibody isotype: IgG1.
CC   Discontinued: IZSLER; BS Hy 58; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   130MA
AC   CVCL_ZU06
SY   130 MAnchester
DR   Wikidata; Q98125080
RX   PubMed=9649131;
CC   Senescence: Senesces at 18 PDL (PubMed=9649131).
CC   Donor information: Established from an unaffected member of a Li-Fraumeni syndrome family.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   131 BLCL
AC   CVCL_E346
DR   ECACC; 94031625
DR   Wikidata; Q54581466
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   131-94H4
AC   CVCL_E963
DR   CLO; CLO_0001070
DR   ATCC; CRL-2739
DR   Wikidata; Q54581468
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9003.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   131.2F8.5.9
AC   CVCL_J991
SY   5.9; CHIR-5.9
DR   Wikidata; Q54581470
RX   Patent=US8333970;
RX   Patent=US20070098718;
RX   Patent=US20070218060;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5542.
CC   Registration: Chiron Master Culture Collection; CMCC 12047 (CMCC #12047).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   1317-mel
AC   CVCL_8040
SY   1317-MEL; 1317 mel; 1317
DR   Cosmic; 876692
DR   Wikidata; Q54581472
RX   PubMed=8027550;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   131BR
AC   CVCL_ZT38
SY   131 BRighton
DR   Wikidata; Q98125081
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   131C3
AC   CVCL_C2EW
DR   Wikidata; Q114310342
RX   PubMed=9410886;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02545; Human LMNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   131MA
AC   CVCL_ZU07
SY   131 Manchester
DR   Wikidata; Q98125083
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 23 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=9018113; PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   132-11
AC   CVCL_F1CF
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   132-11A
AC   CVCL_F1CG
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CF ! 132-11
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   132-13
AC   CVCL_F1CH
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse 100 kDa cell surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   132-18
AC   CVCL_F1CI
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   132-18A
AC   CVCL_F1CJ
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CI ! 132-18
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   132-1C8
AC   CVCL_E964
DR   CLO; CLO_0001071
DR   ATCC; CRL-2737
DR   Wikidata; Q54581474
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8927.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 10
//
ID   132-7C9
AC   CVCL_J566
DR   Wikidata; Q54581477
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8924.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   1321N1
AC   CVCL_0110
SY   1321-N1; 1321 N1
DR   BTO; BTO_0003605
DR   CLO; CLO_0001072
DR   MCCL; MCC:0000001
DR   CLDB; cl5
DR   BioSample; SAMN03471026
DR   cancercelllines; CVCL_0110
DR   Cell_Model_Passport; SIDM01967
DR   DepMap; ACH-001000
DR   ECACC; 86030402
DR   GEO; GSM827421
DR   GEO; GSM886835
DR   GEO; GSM887898
DR   GEO; GSM1374373
DR   GEO; GSM3034453
DR   GEO; GSM3034454
DR   GEO; GSM3034455
DR   GEO; GSM3034456
DR   GEO; GSM3034457
DR   GEO; GSM3034458
DR   IARC_TP53; 21148
DR   IZSLER; BS TCL 109
DR   LINCS_LDP; LCL-1393
DR   NCBI_Iran; C118
DR   PharmacoDB; 1321N1_2_2019
DR   Progenetix; CVCL_0110
DR   Wikidata; Q54581478
RX   PubMed=17254797;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=29887596;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/1321n1/
CC   Problematic cell line: Contaminated. Grand-parent cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.06%; Native American=0%; East Asian, North=1.62%; East Asian, South=0%; South Asian=0%; European, North=96.5%; European, South=0.81% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ECACC=86030402; IZSLER=BS TCL 109; PubMed=17254797; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11 (PubMed=17254797)
ST   CSF1PO: 11,12 (ECACC=86030402; IZSLER=BS TCL 109; PubMed=25877200)
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 27 (PubMed=17254797)
ST   D21S11: 27,32.2 (IZSLER=BS TCL 109; PubMed=25877200)
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 14,15
ST   FGA: 18,23,24
ST   Penta D: 10,13
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D317 ! 1181N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   1321N1 (+Galpha16) AequoScreen
AC   CVCL_5I82
DR   cancercelllines; CVCL_5I82
DR   Revvity/PerkinElmer; ES-000-A28
DR   Wikidata; Q54581482
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   1321N1 AequoScreen
AC   CVCL_5I83
DR   cancercelllines; CVCL_5I83
DR   Revvity/PerkinElmer; ES-000-A27
DR   Wikidata; Q54581484
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   1321N1 MRTFA KO
AC   CVCL_C3IQ
SY   1321N1-MRTFA KO
DR   cancercelllines; CVCL_C3IQ
DR   GEO; GSM3034465
DR   GEO; GSM3034466
DR   GEO; GSM3034467
DR   GEO; GSM3034468
DR   GEO; GSM3034469
DR   GEO; GSM3034470
DR   Wikidata; Q114310343
RX   PubMed=29887596;
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14334; MRTFA.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   1321N1 P2RY1 Gq
AC   CVCL_KU48
DR   cancercelllines; CVCL_KU48
DR   DiscoverX; 95-1018C6
DR   Wikidata; Q54581486
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8539; P2RY1.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   1321N1 RHOA KO
AC   CVCL_C3IR
SY   1321N1-Rho KO
DR   cancercelllines; CVCL_C3IR
DR   GEO; GSM3034471
DR   GEO; GSM3034472
DR   Wikidata; Q114310344
RX   PubMed=29887596;
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:667; RHOA.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   1321N1 YAP1 KO
AC   CVCL_C3IS
SY   1321N1-YAP KO
DR   cancercelllines; CVCL_C3IS
DR   GEO; GSM3034459
DR   GEO; GSM3034460
DR   GEO; GSM3034461
DR   GEO; GSM3034462
DR   GEO; GSM3034463
DR   GEO; GSM3034464
DR   Wikidata; Q114310345
RX   PubMed=29887596;
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   1321N1-HA-P2Y1
AC   CVCL_ZD90
DR   cancercelllines; CVCL_ZD90
DR   Kerafast; ENC018
DR   Wikidata; Q98125085
RX   PubMed=8733591;
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8539; P2RY1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   1321N1-HA-P2Y11
AC   CVCL_ZD94
DR   cancercelllines; CVCL_ZD94
DR   Kerafast; ENC022
DR   Wikidata; Q98125086
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8540; P2RY11 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   1321N1-HA-P2Y12
AC   CVCL_ZD95
DR   cancercelllines; CVCL_ZD95
DR   Kerafast; ENC023
DR   Wikidata; Q98125087
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18124; P2RY12 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   1321N1-HA-P2Y13
AC   CVCL_ZD96
DR   cancercelllines; CVCL_ZD96
DR   Kerafast; ENC024
DR   Wikidata; Q98125088
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4537; P2RY13 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Kerafast; ENC024; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   1321N1-HA-P2Y14
AC   CVCL_ZD97
DR   cancercelllines; CVCL_ZD97
DR   Kerafast; ENC025
DR   Wikidata; Q98125089
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16442; P2RY14 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Kerafast; ENC025; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   1321N1-HA-P2Y2
AC   CVCL_ZD91
DR   cancercelllines; CVCL_ZD91
DR   Kerafast; ENC019
DR   Wikidata; Q98125090
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8541; P2RY2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Kerafast; ENC019; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   1321N1-HA-P2Y4
AC   CVCL_ZD92
DR   ABM; T6191
DR   cancercelllines; CVCL_ZD92
DR   Kerafast; ENC020
DR   Wikidata; Q98125091
RX   PubMed=10779375;
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8542; P2RY4 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   1321N1-HA-P2Y6
AC   CVCL_ZD93
DR   cancercelllines; CVCL_ZD93
DR   Kerafast; ENC021
DR   Wikidata; Q98125092
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8543; P2RY6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Kerafast; ENC021; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   1321N1-MFSD1-KO-c12
AC   CVCL_D4EB
SY   CE0579-U
DR   Wikidata; Q127378569
WW   Info; RESOLUTE; CE0579-U; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25874; MFSD1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-MFSD1-KO-c5
AC   CVCL_D4EC
SY   CE0578-Q
DR   Wikidata; Q127378570
WW   Info; RESOLUTE; CE0578-Q; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25874; MFSD1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-NIPAL3-KO-c1
AC   CVCL_D4ED
SY   CE0776-S
DR   Wikidata; Q127378572
WW   Info; RESOLUTE; CE0776-S; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25233; NIPAL3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-NIPAL3-KO-c3
AC   CVCL_D4EE
SY   CE0779-N
DR   Wikidata; Q127378573
WW   Info; RESOLUTE; CE0779-N; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25233; NIPAL3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-NPC1-KO-c10
AC   CVCL_D4EF
SY   CE077B-Z
DR   Wikidata; Q127378574
WW   Info; RESOLUTE; CE077B-Z; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-NPC1-KO-c8
AC   CVCL_D4EG
SY   CE077C-P
DR   Wikidata; Q127378575
WW   Info; RESOLUTE; CE077C-P; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC16A11-KO-c17
AC   CVCL_D4EH
SY   CE04FF-8
DR   Wikidata; Q127378576
WW   Info; RESOLUTE; CE04FF-8; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23093; SLC16A11.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC16A11-KO-c8
AC   CVCL_D4EI
SY   CE04FE-K
DR   Wikidata; Q127378577
WW   Info; RESOLUTE; CE04FE-K; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23093; SLC16A11.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC16A2-KO-c3
AC   CVCL_D4EJ
SY   CE05BE-C
DR   Wikidata; Q127378578
WW   Info; RESOLUTE; CE05BE-C; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10923; SLC16A2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC16A2-KO-c6
AC   CVCL_D4EK
SY   CE05PB-1
DR   Wikidata; Q127378580
WW   Info; RESOLUTE; CE05PB-1; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10923; SLC16A2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC17A7-KO-c13
AC   CVCL_D4EL
SY   CE0619-E
DR   Wikidata; Q127378581
WW   Info; RESOLUTE; CE0619-E; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16704; SLC17A7.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC17A7-KO-c16
AC   CVCL_D4EM
SY   CE061A-B
DR   Wikidata; Q127378582
WW   Info; RESOLUTE; CE061A-B; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16704; SLC17A7.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC22A4-KO-c10
AC   CVCL_D4EN
SY   CE04M6-V
DR   Wikidata; Q127378583
WW   Info; RESOLUTE; CE04M6-V; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10968; SLC22A4.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC22A4-KO-c11
AC   CVCL_D4EP
SY   CE04M7-N
DR   Wikidata; Q127378584
WW   Info; RESOLUTE; CE04M7-N; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10968; SLC22A4.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC23A3-KO-c6
AC   CVCL_D4EQ
SY   CE04SB-Y
DR   Wikidata; Q127378585
WW   Info; RESOLUTE; CE04SB-Y; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20601; SLC23A3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC23A3-KO-c7
AC   CVCL_D4ER
SY   CE04SC-3
DR   Wikidata; Q127378586
WW   Info; RESOLUTE; CE04SC-3; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20601; SLC23A3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC24A5-KO-c4
AC   CVCL_D4ES
SY   CE057A-0
DR   Wikidata; Q127378587
WW   Info; RESOLUTE; CE057A-0; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20611; SLC24A5.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC25A21-KO-c13
AC   CVCL_D4ET
SY   CE07EB-6
DR   Wikidata; Q127378588
WW   Info; RESOLUTE; CE07EB-6; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14411; SLC25A21.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC25A21-KO-c7
AC   CVCL_D4EU
SY   CE04F0-C
DR   Wikidata; Q127378589
WW   Info; RESOLUTE; CE04F0-C; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14411; SLC25A21.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC26A10-KO-c2
AC   CVCL_D4EV
SY   CE06SC-7
DR   Wikidata; Q127378590
WW   Info; RESOLUTE; CE06SC-7; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14470; SLC26A10P.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC26A10-KO-c5
AC   CVCL_D4EW
SY   CE06SE-Q
DR   Wikidata; Q127378591
WW   Info; RESOLUTE; CE06SE-Q; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14470; SLC26A10P.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC26A2-KO-c3
AC   CVCL_D4EX
SY   CE05BS-0
DR   Wikidata; Q127378592
WW   Info; RESOLUTE; CE05BS-0; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10994; SLC26A2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC26A2-KO-c7
AC   CVCL_D4EY
SY   CE05RF-1
DR   Wikidata; Q127378593
WW   Info; RESOLUTE; CE05RF-1; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10994; SLC26A2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC2A10-KO-c11
AC   CVCL_D4EZ
SY   CE05BN-7
DR   Wikidata; Q127378594
WW   Info; RESOLUTE; CE05BN-7; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13444; SLC2A10.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC2A10-KO-c6
AC   CVCL_D4F0
SY   CE05RH-E
DR   Wikidata; Q127378595
WW   Info; RESOLUTE; CE05RH-E; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13444; SLC2A10.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC2A3-KO-c18
AC   CVCL_D4F1
SY   CE07EG-8
DR   Wikidata; Q127378596
WW   Info; RESOLUTE; CE07EG-8; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11007; SLC2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC2A3-KO-c21
AC   CVCL_D4F2
SY   CE07EH-A
DR   Wikidata; Q127378597
WW   Info; RESOLUTE; CE07EH-A; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11007; SLC2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC2A3-KO-c4
AC   CVCL_D4F3
SY   CE05BH-W
DR   Wikidata; Q127378598
WW   Info; RESOLUTE; CE05BH-W; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11007; SLC2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC35F5-KO-c10
AC   CVCL_D4F4
SY   CE0570-R
DR   Wikidata; Q127378599
WW   Info; RESOLUTE; CE0570-R; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23617; SLC35F5.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC35F5-KO-c11
AC   CVCL_D4F5
SY   CE0571-C
DR   Wikidata; Q127378600
WW   Info; RESOLUTE; CE0571-C; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23617; SLC35F5.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC35G2-KO-c11
AC   CVCL_D4F6
SY   CE04SF-T
DR   Wikidata; Q127378601
WW   Info; RESOLUTE; CE04SF-T; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28480; SLC35G2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC35G2-KO-c13
AC   CVCL_D4F7
SY   CE05RR-0
DR   Wikidata; Q127378602
WW   Info; RESOLUTE; CE05RR-0; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28480; SLC35G2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC37A2-KO-c3
AC   CVCL_D4F8
SY   CE05H8-2
DR   Wikidata; Q127378603
WW   Info; RESOLUTE; CE05H8-2; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20644; SLC37A2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC37A2-KO-c7
AC   CVCL_D4F9
SY   CE05H9-4
DR   Wikidata; Q127378604
WW   Info; RESOLUTE; CE05H9-4; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20644; SLC37A2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC43A3-KO-c3
AC   CVCL_D4FA
SY   CE057B-6
DR   Wikidata; Q127378607
WW   Info; RESOLUTE; CE057B-6; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17466; SLC43A3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC43A3-KO-c6
AC   CVCL_D4FB
SY   CE057E-4
DR   Wikidata; Q127378609
WW   Info; RESOLUTE; CE057E-4; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17466; SLC43A3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC4A8-KO-c4
AC   CVCL_D4FC
SY   CE0573-1
DR   Wikidata; Q127378611
WW   Info; RESOLUTE; CE0573-1; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11034; SLC4A8.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC4A8-KO-c6
AC   CVCL_D4FD
SY   CE0574-W
DR   Wikidata; Q127378612
WW   Info; RESOLUTE; CE0574-W; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11034; SLC4A8.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC6A9-KO-c3
AC   CVCL_D4FE
SY   CE057H-A
DR   Wikidata; Q127378613
WW   Info; RESOLUTE; CE057H-A; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11056; SLC6A9.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC6A9-KO-c5
AC   CVCL_D4FF
SY   CE057M-G
DR   Wikidata; Q127378614
WW   Info; RESOLUTE; CE057M-G; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11056; SLC6A9.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC8A1-KO-c4
AC   CVCL_D4FG
SY   CE05AV-8
DR   Wikidata; Q127378615
WW   Info; RESOLUTE; CE05AV-8; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11068; SLC8A1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC8A1-KO-c7
AC   CVCL_D4FH
SY   CE05AW-A
DR   Wikidata; Q127378616
WW   Info; RESOLUTE; CE05AW-A; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11068; SLC8A1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC9A9-KO-c10
AC   CVCL_D4FI
SY   CE05AX-X
DR   Wikidata; Q127378617
WW   Info; RESOLUTE; CE05AX-X; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20653; SLC9A9.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SLC9A9-KO-c6
AC   CVCL_D4FJ
SY   CE05B0-Y
DR   Wikidata; Q127378618
WW   Info; RESOLUTE; CE05B0-Y; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20653; SLC9A9.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SV2A-KO-c14
AC   CVCL_D4FK
SY   CE0610-N
DR   Wikidata; Q127378619
WW   Info; RESOLUTE; CE0610-N; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20566; SV2A.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-SV2A-KO-c17
AC   CVCL_D4FL
SY   CE0611-H
DR   Wikidata; Q127378620
WW   Info; RESOLUTE; CE0611-H; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20566; SV2A.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-TUSC3-KO-c10
AC   CVCL_D4FM
SY   CE05T5-Y
DR   Wikidata; Q127378621
WW   Info; RESOLUTE; CE05T5-Y; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30242; TUSC3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-TUSC3-KO-c4
AC   CVCL_D4FN
SY   CE05B5-S
DR   Wikidata; Q127378622
WW   Info; RESOLUTE; CE05B5-S; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30242; TUSC3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-UCP2-KO-c3
AC   CVCL_D4FP
SY   CE05GA-X
DR   Wikidata; Q127378623
WW   Info; RESOLUTE; CE05GA-X; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-UCP2-KO-c5
AC   CVCL_D4FQ
SY   CE05GC-Y
DR   Wikidata; Q127378624
WW   Info; RESOLUTE; CE05GC-Y; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-UCP3-KO-c13
AC   CVCL_D4FR
SY   CE07H7-Z
DR   Wikidata; Q127378625
WW   Info; RESOLUTE; CE07H7-Z; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12519; UCP3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1-UCP3-KO-c16
AC   CVCL_D4FS
SY   CE07H9-R
DR   Wikidata; Q127378626
WW   Info; RESOLUTE; CE07H9-R; https://re-solute.eu/resources/reagents
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12519; UCP3.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   1321N1/Cas9-hyg
AC   CVCL_C9F6
DR   GeneCopoeia; SL576
DR   Wikidata; Q123030220
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL576).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   1321N1/FFAR1
AC   CVCL_KT02
SY   ValiScreen human Free Fatty Acid Receptor 1 (FFA1,GPR40) cell line
DR   cancercelllines; CVCL_KT02
DR   Revvity/PerkinElmer; ES-652-C
DR   Wikidata; Q54581487
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4498; FFAR1.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   1321N1/P2Y1
AC   CVCL_H355
DR   cancercelllines; CVCL_H355
DR   GenScript; M00250
DR   Wikidata; Q54581489
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8539; P2RY1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 21
//
ID   1321N1/P2Y11
AC   CVCL_H356
DR   cancercelllines; CVCL_H356
DR   GenScript; M00298
DR   Wikidata; Q54581492
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8540; P2RY11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   1321N1/P2Y12/Galpha15
AC   CVCL_H357
DR   cancercelllines; CVCL_H357
DR   GenScript; M00261
DR   Wikidata; Q54581495
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18124; P2RY12.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 23
//
ID   1321N1/P2Y2
AC   CVCL_H358
DR   cancercelllines; CVCL_H358
DR   GenScript; M00318
DR   Wikidata; Q54581496
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8541; P2RY2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   1321N1/P2Y4
AC   CVCL_H359
DR   cancercelllines; CVCL_H359
DR   GenScript; M00297
DR   Wikidata; Q54581497
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8542; P2RY4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   1321N1/P2Y6
AC   CVCL_H360
DR   cancercelllines; CVCL_H360
DR   GenScript; M00346
DR   Wikidata; Q54581501
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8543; P2RY6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   1328-1-8094
AC   CVCL_JC08
DR   IHW; IHW01202
DR   Wikidata; Q54581503
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-1-8099
AC   CVCL_JC09
DR   IHW; IHW01204
DR   Wikidata; Q54581505
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-1-8100
AC   CVCL_JC10
DR   IHW; IHW01205
DR   Wikidata; Q54581508
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8097
AC   CVCL_JC11
DR   IHW; IHW01207
DR   Wikidata; Q54581510
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8103
AC   CVCL_JC12
DR   IHW; IHW01209
DR   Wikidata; Q54581512
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8104
AC   CVCL_JC13
DR   IHW; IHW01210
DR   Wikidata; Q54581514
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8105
AC   CVCL_JC14
DR   IHW; IHW01211
DR   Wikidata; Q54581517
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8106
AC   CVCL_JC15
DR   IHW; IHW01212
DR   Wikidata; Q54581519
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8107
AC   CVCL_JC16
DR   IHW; IHW01213
DR   Wikidata; Q54581521
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8108
AC   CVCL_JC17
DR   IHW; IHW01214
DR   Wikidata; Q54581523
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8109
AC   CVCL_JC18
DR   IHW; IHW01215
DR   Wikidata; Q54581525
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8110
AC   CVCL_JC19
DR   IHW; IHW01216
DR   Wikidata; Q54581526
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8139
AC   CVCL_JC20
DR   IHW; IHW01217
DR   Wikidata; Q54581585
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1328-8140
AC   CVCL_JC21
DR   IHW; IHW01218
DR   Wikidata; Q54581589
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   132BR
AC   CVCL_ZT39
SY   132 BRighton
DR   Wikidata; Q98125093
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   132C4A/4
AC   CVCL_J041
DR   CLO; CLO_0001073
DR   ATCC; HB-8086
DR   Wikidata; Q54581591
RX   Patent=US4416866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8086.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   132P1
AC   CVCL_LL63
DR   Wikidata; Q54581594
RX   PubMed=29029509;
CC   Doubling time: 22 hours (PubMed=29029509).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   132P1 CD44+/CD90+
AC   CVCL_LL64
DR   Wikidata; Q54581595
RX   PubMed=29029509;
CC   Characteristics: Subpopulation of 132P1 derived according to the CD44/CD90 status using magnetic bead based separation (PubMed=29029509).
CC   Doubling time: 30 hours (PubMed=29029509).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LL63 ! 132P1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   132P1 CD44+/CD90-
AC   CVCL_LL65
DR   Wikidata; Q54581596
RX   PubMed=29029509;
CC   Characteristics: Subpopulation of 132P1 derived according to the CD44/CD90 status using magnetic bead based separation.
CC   Doubling time: 30 hours (PubMed=29029509).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LL63 ! 132P1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   132P1 CD44-/CD90+
AC   CVCL_LM70
DR   Wikidata; Q54581597
RX   PubMed=29029509;
CC   Characteristics: Subpopulation of 132P1 derived according to the CD44/CD90 status using magnetic bead based separation (PubMed=29029509).
CC   Doubling time: 26 hours (PubMed=29029509).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LL63 ! 132P1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   132P1 CD44-/CD90-
AC   CVCL_LM71
DR   Wikidata; Q54581600
RX   PubMed=29029509;
CC   Characteristics: Subpopulation of 132P1 derived according to the CD44/CD90 status using magnetic bead based separation (PubMed=29029509).
CC   Doubling time: 34 hours (PubMed=29029509).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LL63 ! 132P1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   133
AC   CVCL_J918
SY   Anti PDGF hybridoma #133
DR   ATCC; HB-9357
DR   Wikidata; Q54581603
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9357.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   133 BLCL
AC   CVCL_E347
DR   ECACC; 94031626
DR   Wikidata; Q54581604
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   133-10F6
AC   CVCL_E965
SY   133-10F06
DR   CLO; CLO_0001074
DR   ATCC; CRL-2738
DR   Wikidata; Q54581608
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9077.
CC   Monoclonal antibody isotype: IgG1+IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 12
//
ID   133-13
AC   CVCL_F1CK
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse 100 kDa cell surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   133-1E10
AC   CVCL_J567
DR   Wikidata; Q54581609
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8888.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   133-4
AC   CVCL_F1CL
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse 100 kDa cell surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   133-6C10
AC   CVCL_J568
DR   Wikidata; Q54581610
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8897.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   1335-mel
AC   CVCL_Z019
SY   1335-MEL; 1335
DR   Cosmic; 876693
DR   Wikidata; Q54581612
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   13363
AC   CVCL_JY28
DR   Wikidata; Q54581614
RX   PubMed=25862976;
RX   PubMed=31150822;
CC   Doubling time: 2-3 days (PubMed=25862976).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr170del (c.508_510delACG); Zygosity=Unspecified (PubMed=25862976; PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 19,24
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 14,18
ST   D19S433: 13,14.2
ST   D1S1656: 15,16.3
ST   D21S11: 30,30.2
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 25
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JY32 ! 15233_nov
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   1338-mel
AC   CVCL_A1DR
SY   1338-MEL; 1338
DR   Wikidata; Q102113419
RX   PubMed=9670966;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*24,31 (PubMed=9670966).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   133A2
AC   CVCL_C2EV
DR   Wikidata; Q114310346
RX   PubMed=7769007;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P02545; Human LMNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   133B
AC   CVCL_J917
DR   Wikidata; Q54581615
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02710; Tetronarce californica chrna1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   133BR
AC   CVCL_ZT40
SY   133 BRighton
DR   Wikidata; Q98125094
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   134.6
AC   CVCL_C5WV
DR   Wikidata; Q116047830
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1340-1371
AC   CVCL_JB95
DR   IHW; IHW01189
DR   Wikidata; Q54581618
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8209
AC   CVCL_JB96
DR   IHW; IHW01190
DR   Wikidata; Q54581620
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8283
AC   CVCL_JB97
DR   IHW; IHW01191
DR   Wikidata; Q54581621
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8284
AC   CVCL_JB98
DR   IHW; IHW01192
DR   Wikidata; Q54581623
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8285
AC   CVCL_JB99
DR   IHW; IHW01193
DR   Wikidata; Q54581626
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8286
AC   CVCL_JC00
DR   IHW; IHW01194
DR   Wikidata; Q54581628
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8305
AC   CVCL_JC01
DR   IHW; IHW01195
DR   Wikidata; Q54581631
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8306
AC   CVCL_JC02
DR   IHW; IHW01196
DR   Wikidata; Q54581633
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8307
AC   CVCL_JC03
DR   IHW; IHW01197
DR   Wikidata; Q54581635
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8308
AC   CVCL_JC04
DR   IHW; IHW01198
DR   Wikidata; Q54581638
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8309
AC   CVCL_JC05
DR   IHW; IHW01199
DR   Wikidata; Q54581639
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8336
AC   CVCL_JC06
DR   IHW; IHW01200
DR   Wikidata; Q54581640
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1340-8392
AC   CVCL_JC07
DR   IHW; IHW01201
DR   Wikidata; Q54581642
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   1345-8333
AC   CVCL_JC22
DR   IHW; IHW01219
DR   Wikidata; Q54581644
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1345-8334
AC   CVCL_JC23
DR   IHW; IHW01220
DR   Wikidata; Q54581646
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   134BR
AC   CVCL_ZT41
SY   134 BRighton
DR   Wikidata; Q98125095
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   135-10
AC   CVCL_F1CM
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-10A
AC   CVCL_F1CN
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CM ! 135-10
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-10B
AC   CVCL_F1CP
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CM ! 135-10
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-11
AC   CVCL_F1CQ
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse 100 kDa cell surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-13
AC   CVCL_F1CR
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-13A
AC   CVCL_F1CS
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CR ! 135-13
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-13B
AC   CVCL_F1CT
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CR ! 135-13
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-13C
AC   CVCL_F1CU
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q61739; Mouse ITGA6/CD49f (Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F1CR ! 135-13
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-14
AC   CVCL_F1CV
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse 100 kDa cell surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-4
AC   CVCL_F1CW
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse 100 kDa cell surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   135-6
AC   CVCL_F1CX
RX   PubMed=6167348;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse 100 kDa cell surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1351-mel
AC   CVCL_A1DS
SY   1351-MEL
DR   Wikidata; Q102113420
RX   PubMed=9670966;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,03; B*08,47; C*06,07 (PubMed=9670966).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   1352-mel
AC   CVCL_Z020
SY   1352-MEL; 1352
DR   Cosmic; 876694
DR   Wikidata; Q54581648
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   1354-8472
AC   CVCL_JC24
DR   IHW; IHW01221
DR   Wikidata; Q54581650
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1354-8476
AC   CVCL_JC25
DR   IHW; IHW01222
DR   Wikidata; Q54581652
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   1359-mel
AC   CVCL_8041
SY   1359-MEL; 1359 mel; 1359; Mel-1359
DR   cancercelllines; CVCL_8041
DR   Cosmic; 2163791
DR   ESTDAB; ESTDAB-047
DR   Wikidata; Q54581654
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01:01; B*08:01,40:01; C*07:01:01,03:04; DPB1*04:01,01:01:01; DQB1*03:01:01,02:01; DRB1*03:01:01,04:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-047
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8
ST   FGA: 20
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   135BR
AC   CVCL_ZT42
SY   135 BRighton
DR   Wikidata; Q98125097
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   135D5-1-12
AC   CVCL_C5QY
SY   135D5
DR   Wikidata; Q116047831
RX   PubMed=2449607;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   135MA
AC   CVCL_ZU08
SY   135 Manchester
DR   Wikidata; Q98125098
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 74 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (PubMed=9018113; PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   136-13
AC   CVCL_E2ZZ
RX   PubMed=11556707;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Potato virus Y (strain Tunisian PVYo) coat protein (CP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   136-2
AC   CVCL_W281
DR   cancercelllines; CVCL_W281
DR   Cosmic; 1418452
DR   IARC_TP53; 10953
DR   Wikidata; Q54581655
RX   PubMed=3402430;
RX   PubMed=10070891;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Arg (c.737T>G); ClinVar=VCV000127822; Zygosity=Unspecified (PubMed=10070891).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   136-3
AC   CVCL_C5N5
DR   Wikidata; Q116047832
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1362-mel
AC   CVCL_S560
SY   1362-MEL; 1362 mel; 1362mel; 1362
DR   cancercelllines; CVCL_S560
DR   CGH-DB; 9294-4
DR   Cosmic; 905208
DR   Wikidata; Q54581657
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,25 (PubMed=9670966).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   1363-EBV
AC   CVCL_WY45
DR   Wikidata; Q93298687
RX   PubMed=19581576;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8042 ! 1363-mel
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 6
//
ID   1363-mel
AC   CVCL_8042
SY   1363-MEL; 1363 mel; 1363
DR   Cosmic; 876704
DR   Wikidata; Q54581660
RX   PubMed=10048982;
RX   PubMed=19581576;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY45 ! 1363-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   13699
AC   CVCL_JY29
DR   Wikidata; Q54581662
RX   PubMed=25862976;
RX   PubMed=31150822;
CC   Doubling time: 2-3 days (PubMed=25862976).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg333Valfs*12 (c.997delC); ClinVar=VCV002113651; Zygosity=Unspecified (PubMed=25862976; PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 16,17
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 13,16
ST   D19S433: 14
ST   D1S1656: 11,18.3
ST   D21S11: 31,31.2
ST   D2S1338: 18,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 12,22
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 11,13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   136MA
AC   CVCL_ZU09
SY   136 MAnchester
DR   Wikidata; Q98125099
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 24 PDL (PubMed=9649131).
CC   Donor information: Established from an unaffected member of a Li-Fraumeni syndrome family.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   137-2-1
AC   CVCL_A0IE
SY   #137-2-1
DR   Wikidata; Q108819393
RX   Patent=US8178100;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00145.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02778; Human CXCL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   137-26
AC   CVCL_KR87
SY   Mab 137-26
DR   Wikidata; Q54581663
RX   PubMed=12869020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01031; Human C5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   13703390
AC   CVCL_JD63
SY   39157; Extract 382
DR   IPD-IMGT/HLA; 14033
DR   Wikidata; Q54581743
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/324cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BAJC; B*39:04,15:11:01; C*03:03,07:02; DPA1*01:CG,02:02; DPB1*02:02,05:01/38:01/63:01/97:01; DQA1*03; DQB1*03:03; DRB1*09:01; DRB4*01 (IPD-IMGT/HLA=14033).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   1375-4f1
AC   CVCL_DP69
DR   GEO; GSM1040262
DR   GEO; GSM1040332
DR   Wikidata; Q54581744
RX   PubMed=24259714;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3YA ! HDF1375
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   1376-mel
AC   CVCL_8043
SY   1376-MEL; 1376 mel; 1376
DR   Cosmic; 876695
DR   Wikidata; Q54581746
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   13762 MAT B III
AC   CVCL_3475
SY   13762 Mat B III; 13762-MAT-B-III; MAT 13762; 13762; MatB 13762; Mat B-III; Mat B III; MatB
DR   CLO; CLO_0001076
DR   ATCC; CRL-1666
DR   BCRC; 60520
DR   ChEMBL-Cells; CHEMBL3308080
DR   ChEMBL-Targets; CHEMBL613867
DR   IZSLER; BS TCL 168
DR   PubChem_Cell_line; CVCL_3475
DR   Wikidata; Q54581749
RX   PubMed=1997182;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-392.html
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   1377-4f1
AC   CVCL_DP70
DR   GEO; GSM1040263
DR   GEO; GSM1040333
DR   Wikidata; Q54581750
RX   PubMed=24259714;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3XZ ! HDF1377
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   13781
AC   CVCL_WY90
DR   cancercelllines; CVCL_WY90
DR   Wikidata; Q93298749
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr2515Ile (c.7544C>T); ClinVar=VCV000038102; Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D12S391: 20
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13,15
ST   D1S1656: 13,14
ST   D21S11: 28,30
ST   D2S1338: 20,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D6S1043: 11,20
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 14
ST   TH01: 6,9
ST   TPOX: 9,12
ST   vWA: 14
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   137BR
AC   CVCL_ZT43
SY   137 BRighton
DR   Wikidata; Q98125100
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   1381B1
AC   CVCL_UP46
DR   Wikidata; Q93298751
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   1383-mel
AC   CVCL_8044
SY   1383-MEL; 1383 mel; 1383
DR   BTO; BTO_0002948
DR   Cosmic; 876696
DR   Wikidata; Q54581752
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,24 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   1383D2
AC   CVCL_UP38
SY   HPS1005
DR   RCB; HPS1005
DR   Wikidata; Q93298761
RX   Patent=US20200407693;
RX   PubMed=28453617;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Asian.
CC   HLA typing: A*02:07,32:01; B*15:02,51:01; C*08:01;14:02; DQA1*03:03,06:01; DQB1*03:01,03:02; DRB1*04:05,12:01 (PubMed=30853558).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP39 ! 1383D6
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   1383D2-B2M-KO #1
AC   CVCL_C1FK
SY   1383D2-B2M-#1
DR   Wikidata; Q114310347
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   Population: Asian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UP38 ! 1383D2
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   1383D2-B2M-KO #2
AC   CVCL_C1FL
DR   Wikidata; Q114310348
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   Population: Asian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UP38 ! 1383D2
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   1383D6
AC   CVCL_UP39
SY   HPS1006; BRCi014-A
DR   hPSCreg; BRCi014-A
DR   RCB; HPS1006
DR   Wikidata; Q93298765
RX   PubMed=28453617;
RX   PubMed=34087992;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP38 ! 1383D2
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   1387T
AC   CVCL_ZT90
DR   Wikidata; Q98125102
RX   PubMed=7779715;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   1388-mel
AC   CVCL_8045
SY   1388-MEL; 1388 mel; 1388
DR   Wikidata; Q54581753
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   138BR
AC   CVCL_ZT44
SY   138 BRighton
DR   Wikidata; Q98125103
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   138D
AC   CVCL_5446
DR   ECACC; 93090808
DR   Wikidata; Q54581755
RX   PubMed=8795574;
CC   Doubling time: ~60 hours (Note=At 7th passage) (PubMed=8795574).
CC   Discontinued: ECACC; 93090808; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   138MA
AC   CVCL_ZT87
SY   138 Manchester
DR   Wikidata; Q98125104
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 47 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (PubMed=8794843; PubMed=9018113; PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT86 ! 21MA
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   139-CUMC/UF
AC   CVCL_IJ18
DR   Wikidata; Q54581757
RX   PubMed=27789403;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   1390-mel
AC   CVCL_8046
SY   1390-MEL; 1390 mel; 1390
DR   Cosmic; 876697
DR   Wikidata; Q54581760
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,02 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   1390B1
AC   CVCL_UP47
DR   Wikidata; Q93298801
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP48 ! 1390C1
OI   CVCL_UP49 ! 1390G3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   1390C1
AC   CVCL_UP48
DR   Wikidata; Q93298803
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP47 ! 1390B1
OI   CVCL_UP49 ! 1390G3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   1390G3
AC   CVCL_UP49
DR   Wikidata; Q93298807
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP47 ! 1390B1
OI   CVCL_UP48 ! 1390C1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   1390G3 AGVT (XX)
AC   CVCL_YE15
SY   1390G3 AGVT(TFAP2C-EGFP;DDX4/hVH-DDX4)
DR   Wikidata; Q93298811
RX   PubMed=30237246;
CC   Characteristics: Using TALEN a 2A-tdTomato construct was inserted at the C-terminal end of DDX4 (DDX4/hVH-tdTomato = VT) as well as a 2A-EGFP construct (TFAP2C-p2A-EGFP =AG) at the C-terminal end of TFAP2C.
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UP49 ! 1390G3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   13914_1
AC   CVCL_JY30
SY   13914
DR   cancercelllines; CVCL_JY30
DR   Wikidata; Q54581762
RX   PubMed=25862976;
RX   PubMed=31150822;
CC   Doubling time: 6-9 days (PubMed=25862976).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu1161Phefs*3 (c.3481_3491delGAAGATACTAG); ClinVar=VCV000017684; Zygosity=Homozygous (PubMed=25862976; PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met340Serfs*2 (c.1019_1028del10); Zygosity=Unspecified (PubMed=25862976; PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 20
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14,14.2
ST   D1S1656: 14,17.3
ST   D21S11: 30
ST   D2S1338: 19,25
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D6S1043: 11,19
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   13923M
AC   CVCL_WM36
DR   Cosmic; 852211
DR   Wikidata; Q93298830
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   13976036
AC   CVCL_JC64
SY   TER382; TER-382; Ter 382; TER469; TER-469; Ter 469
DR   IPD-IMGT/HLA; 12582
DR   Wikidata; Q54581765
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/365cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,29; B*08,45:01; C*06,07; DPB1*04:01:01,04:02; DQA1*01:03,03:03; DQB1*03:01:01,06:03; DRB1*04:01:01,13:10; DRB3*01:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=12582).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   139A
AC   CVCL_J802
DR   Wikidata; Q54581767
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02710; Tetronarce californica chrna1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   139BR
AC   CVCL_ZT45
SY   139 BRighton
DR   Wikidata; Q98125105
RX   PubMed=1672363;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   13A3
AC   CVCL_F1WW
RX   Patent=US12312403;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   13A4
AC   CVCL_E8UI
RX   PubMed=1958138;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00855; Dermatophagoides farinae mite group 2 allergen Der f 2 (DERF2) (Note=Also reacts with D.pteronyssinus Der p 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   13B11 [Mouse hybridoma against A.aegypti]
AC   CVCL_VI27
DR   BEI_Resources; MRA-255
DR   Wikidata; Q54581769
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female salivary glands median and distal lateral lobes and ovaries.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 4
//
ID   13B11 [Mouse hybridoma against chicken IL10]
AC   CVCL_E1H6
RX   PubMed=30596381;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6A2H4; Chicken IL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   13B7
AC   CVCL_C5QC
DR   Wikidata; Q116047833
RX   PubMed=10995307;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_82644; Ractopamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   13B9
AC   CVCL_E8NU
DR   ABCD; ABCD_BF013
RX   Patent=WO2024196162A1;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UXX9; Human RSPO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   13C1
AC   CVCL_L104
DR   ATCC; CRL-8796
DR   Wikidata; Q54581770
RX   Patent=US4834975;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8796.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 5.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   13C2
AC   CVCL_B6VX
DR   Wikidata; Q111732601
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   13C4
AC   CVCL_4466
DR   CLO; CLO_0001077
DR   CLDB; cl5137
DR   ATCC; CRL-1794
DR   ECACC; 95032701
DR   IZSLER; BS Hy 42
DR   Wikidata; Q54581772
RX   PubMed=3905611;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7BQ98; Shigella dysenteriae stxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   13C9
AC   CVCL_C4JP
DR   Wikidata; Q116047834
RX   PubMed=35973349;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A1EA95; Chicken IL7R/CD127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   13CB-1
AC   CVCL_9Q47
DR   Wikidata; Q54581774
RX   PubMed=186420;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
OI   CVCL_9Q48 ! 8CB-1
OI   CVCL_4087 ! 26CB-1
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   13D1
AC   CVCL_C4K4
DR   Wikidata; Q116047835
RX   PubMed=33497732;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QG57; Chicken CCL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   13D10
AC   CVCL_T729
DR   CLO; CLO_0050350
DR   RCB; RCB1923
DR   Wikidata; Q54581775
RX   DOI=10.1508/cytologia.68.271;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Lygodium japonicum strain an-1 basal apparatus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   13D11
AC   CVCL_E2ZA
RX   PubMed=26788906;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   13D4 [Mouse hybridoma against influenza A HA]
AC   CVCL_XB98
DR   CCRID; 4201PAT-CCTCC00212
DR   Wikidata; Q93298910
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200721.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   13D4 [Mouse hybridoma against phOX]
AC   CVCL_C4EY
DR   ABCD; ABCD_AE287
DR   Wikidata; Q116047836
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   13D8
AC   CVCL_WZ64
DR   CCRID; 4201PAT-CCTCC00151
DR   Wikidata; Q93298912
RX   Patent=US9428554;
RX   PubMed=15780737;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200114.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q81871; Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) secreted protein ORF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 6
//
ID   13F1
AC   CVCL_F1XW
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   13F10
AC   CVCL_VI28
DR   BEI_Resources; MRA-256
DR   Wikidata; Q54581778
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands basal lamina.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   13F3
AC   CVCL_UR36
DR   ATCC; CRL-3422
DR   Wikidata; Q93298923
RX   PubMed=21383057;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9D659; Mouse Vsir.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 5
//
ID   13F7.B6.A7
AC   CVCL_IV60
SY   13F7
DR   Wikidata; Q54581780
RX   Patent=US8022175;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8331.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Newcastle disease virus HN protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   13G3
AC   CVCL_C4JM
DR   Wikidata; Q116047837
RX   PubMed=33497732;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8QG57; Chicken CCL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   13G4
AC   CVCL_B6VY
DR   Wikidata; Q111732602
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   13G5-52
AC   CVCL_B4JU
DR   Wikidata; Q110429666
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11358.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   13G5-57
AC   CVCL_B4JV
DR   Wikidata; Q110429669
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11359.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   13G7
AC   CVCL_C4FH
DR   Wikidata; Q116047839
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   13G9
AC   CVCL_C5MF
DR   Wikidata; Q116047840
RX   PubMed=17600495;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O08901; Mouse Bub1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   13H11
AC   CVCL_F1ZC
DR   ABCD; ABCD_BF054
RX   PubMed=17942537;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   13H3
AC   CVCL_F0V9
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   14-012-8-1
AC   CVCL_F251
SY   14.012.8.1
DR   CLO; CLO_0001078
DR   CLDB; cl8
DR   Wikidata; Q54581784
RX   PubMed=208448;
RX   PubMed=214606;
RX   PubMed=4355928;
CC   Transformant: NCBI_TaxID; 10298; Human herpesvirus 1 (HHV-1) (Note=Strain 14-012).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   14-1.6
AC   CVCL_C4UP
SY   Clone 14-1.6
DR   Wikidata; Q116047841
RX   PubMed=6233013;
CC   Characteristics: Recognizes the terpolymer Glu60-Ala30-Tyr10, known as GAT.
CC   Characteristics: IL2 dependent.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U28 ! L.14
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   14-1350-210
AC   CVCL_A9RE
SY   HCV 14-1350-210
DR   Wikidata; Q102113421
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10602.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1-150 = Core protein p21).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   14-153-234
AC   CVCL_A9RD
SY   HCV 14-153-234
DR   ATCC; HB-10604
DR   Wikidata; Q102113423
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10604.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1-150 = Core protein p21).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   14-4-4S
AC   CVCL_G569
DR   CLO; CLO_0001090
DR   ATCC; HB-32
DR   IZSLER; BS Hy 59
DR   NCBI_Iran; H137
DR   Wikidata; Q54581783
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Discontinued: IZSLER; BS Hy 59; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   14-NKAD3
AC   CVCL_D4B5
DR   Wikidata; Q127378627
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MZCS-0430.
OX   NCBI_TaxID=1051664; ! Nothobranchius kadleci (African annual killifish)
SX   Sex unspecified
AG   Diapause III embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   14.1 [Mouse hybridoma against human FCAR]
AC   CVCL_XY41
SY   14A8
DR   Wikidata; Q93298960
RX   Patent=US7192582;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24071; Human FCAR/CD89.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   14.1 [Mouse hybridoma against levan]
AC   CVCL_C5WW
DR   Wikidata; Q116047843
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   14.12.1
AC   CVCL_E7Q9
DR   ABCD; ABCD_BE633
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   14.15.5
AC   CVCL_E7QC
DR   ABCD; ABCD_BE636
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   14.18
AC   CVCL_KR88
SY   ch 14.18
DR   Wikidata; Q54581785
RX   PubMed=2720646;
RX   PubMed=3100030;
CC   Characteristics: Because it binds and kills neuroblastoma cells, was used to develop dinutuximab which is used in a clinical setting.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 4
//
ID   14.2.9
AC   CVCL_E7QH
DR   ABCD; ABCD_BE640
RX   PubMed=19428559;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61653; Pneumococcal C-polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   14.6b.1
AC   CVCL_D3UX
DR   ABCD; ABCD_AE244
DR   Wikidata; Q127378628
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   14.7.1
AC   CVCL_D3UY
DR   Wikidata; Q127378629
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   14.8
AC   CVCL_9140
DR   CLO; CLO_0001079
DR   ATCC; TIB-164
DR   Wikidata; Q54581787
RX   PubMed=6975314;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   14.G2a
AC   CVCL_KR89
SY   14G2a
DR   Wikidata; Q54581788
RX   PubMed=2720646;
CC   Characteristics: Isotype switched derivative of 14.18.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_KR88 ! 14.18
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 5
//
ID   140-1
AC   CVCL_XX85
DR   CCRID; 4201PAT-CCTCC00249
DR   Wikidata; Q93298992
RX   Patent=CN101477126A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200823.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Hepatitis C virus core protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   140-2
AC   CVCL_XX86
DR   Wikidata; Q93298996
RX   Patent=CN101477126A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200824.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Hepatitis C virus core protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   1402P
AC   CVCL_WM21
DR   cancercelllines; CVCL_WM21
DR   Cosmic; 852197
DR   IARC_TP53; 20610
DR   Wikidata; Q93298999
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236His (c.706T>C); ClinVar=VCV000216469; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM25 ! 1402R
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   1402R
AC   CVCL_WM25
DR   cancercelllines; CVCL_WM25
DR   Wikidata; Q93299004
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236His (c.706T>C); ClinVar=VCV000216469; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM21 ! 1402P
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   140A7
AC   CVCL_B0D6
DR   Wikidata; Q108819394
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10798.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10069.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human breast cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   140BR
AC   CVCL_ZT46
SY   140 BRighton
DR   Wikidata; Q98125106
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   141-32
AC   CVCL_A7YG
DR   BEI_Resources; MRA-454
DR   Wikidata; Q107113131
RX   PubMed=10816526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium sp. thrombospondin-related anonymous protein (TRAP) (Note=Immunized with a synthetic peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T277 ! MOPC-21
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   141-LCL
AC   CVCL_6752
DR   CLO; CLO_0051013
DR   BioSample; SAMN03472056
DR   RCB; RCB2083
DR   TKG; TKG 0611
DR   Wikidata; Q54581792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2083; TKG=TKG 0611
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   141-LCL-MUC1
AC   CVCL_8071
DR   CLO; CLO_0051014
DR   RCB; RCB2541
DR   TKG; TKG 0499
DR   TKG; TKG 0634
DR   Wikidata; Q54581794
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: TKG; TKG 0499; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2541; TKG=TKG 0634
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6752 ! 141-LCL
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   1410 KG7
AC   CVCL_G567
DR   CLO; CLO_0001080
DR   ATCC; HB-43
DR   Wikidata; Q54581796
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human IgG heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   1411H
AC   CVCL_2268
SY   1411HP
DR   ChEMBL-Cells; CHEMBL3988421
DR   Cosmic; 2077184
DR   Cosmic; 2439937
DR   Cosmic; 2806395
DR   ECACC; 06011805
DR   PubChem_Cell_line; CVCL_2268
DR   Wikidata; Q54581797
RX   PubMed=2581684;
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L942 ! 1411HRQmet
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   1411HRQmet
AC   CVCL_L942
DR   Wikidata; Q54581799
RX   PubMed=2581684;
CC   Derived from site: Metastatic; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2268 ! 1411H
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   14169
AC   CVCL_C9CL
DR   Wikidata; Q123030221
RX   PubMed=24736545;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 15 fused to NUTM1 exon 2 (PubMed=24736545).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   141BR
AC   CVCL_ZT47
SY   141 BRighton
DR   Wikidata; Q98125107
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   141MA
AC   CVCL_ZU10
SY   141 MAnchester
DR   Wikidata; Q98125108
RX   PubMed=9649131;
CC   Senescence: Senesces at 17 PDL (PubMed=9649131).
CC   Donor information: Established from an unaffected member of a Li-Fraumeni syndrome family.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   141PF11
AC   CVCL_G568
DR   CLO; CLO_0001081
DR   ATCC; HB-45
DR   Wikidata; Q54581800
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   142-24E5
AC   CVCL_E966
SY   1/24-24E05; 1/24E05; 142-24E05; SCRF 35.1
DR   CLO; CLO_0001082
DR   ATCC; CRL-2649
DR   Wikidata; Q54581801
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8679.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   1420
AC   CVCL_E5KB
SY   mAb 1420
RX   Patent=US7510844;
RX   Patent=US8969531;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7304.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P33681; Human CD80.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1426
AC   CVCL_LB76
DR   Wikidata; Q54581804
RX   PubMed=23479617;
RX   PubMed=27936237;
CC   Group: Marsupial cell line.
DI   NCIt; C176223; Devil facial tumor disease 1
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_LB75 ! 1/2Pea
OI   CVCL_LB77 ! 2112
OI   CVCL_LB78 ! 4906
OI   CVCL_LB79 ! C5065
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   142BR
AC   CVCL_2269
SY   142 BRighton
DR   CLO; CLO_0001083
DR   CLDB; cl9
DR   ECACC; 90011806
DR   Wikidata; Q54581806
RX   PubMed=1672363;
RX   PubMed=16714754;
RX   PubMed=18079351;
RX   PubMed=19179371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   142BRneo
AC   CVCL_ZN26
DR   Wikidata; Q98125109
RX   PubMed=16714754;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2269 ! 142BR
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   143-2-A6-11
AC   CVCL_J043
SY   CO-431; CO431
DR   CLO; CLO_0001086
DR   ATCC; HB-8325
DR   Wikidata; Q54581807
RX   Patent=US4607009;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8325.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_59440; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcNAc (Lewis B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   143-4-2
AC   CVCL_E967
DR   CLO; CLO_0001087
DR   ATCC; CRL-1970
DR   Wikidata; Q54581808
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   143.98.2
AC   CVCL_3476
DR   CLO; CLO_0001085
DR   ATCC; CRL-11226
DR   cancercelllines; CVCL_3476
DR   Wikidata; Q54581811
RX   Patent=US5543297;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11226.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-11226; true.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-11226
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   14362M
AC   CVCL_WM42
DR   cancercelllines; CVCL_WM42
DR   Cosmic; 852217
DR   IARC_TP53; 20614
DR   Wikidata; Q93299102
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   143B
AC   CVCL_2270
SY   143b; 143 B; 143B TK-; 143B.TK-; 143BTK-; 143TK-; HOS-143B; HOS-143b; GM05887; GM05887A
DR   BTO; BTO_0003167
DR   CLO; CLO_0001084
DR   CLO; CLO_0001088
DR   CLO; CLO_0024221
DR   EFO; EFO_0006355
DR   CLDB; cl10
DR   CLDB; cl11
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-8303
DR   BCRC; 60439
DR   BioGRID_ORCS_Cell_line; 315
DR   BioSample; SAMN03471904
DR   cancercelllines; CVCL_2270
DR   CCRID; 1101HUM-PUMC000363
DR   CCRID; 4201HUM-CCTCC00076
DR   CCTCC; GDC0076
DR   Cell_Model_Passport; SIDM00804
DR   ChEMBL-Cells; CHEMBL3307382
DR   ChEMBL-Targets; CHEMBL614508
DR   CLS; 305232
DR   Coriell; GM05887
DR   Cosmic; 1074398
DR   Cosmic; 1529910
DR   Cosmic; 2009541
DR   DepMap; ACH-001001
DR   ECACC; 91112502
DR   EGA; EGAS00001000610
DR   GEO; GSM320829
DR   GEO; GSM879206
DR   GEO; GSM886836
DR   GEO; GSM887899
DR   GEO; GSM1914980
DR   GEO; GSM1914981
DR   GEO; GSM1914982
DR   GEO; GSM1914983
DR   GEO; GSM1915018
DR   GEO; GSM1915019
DR   GEO; GSM1915020
DR   GEO; GSM1915021
DR   GEO; GSM1915022
DR   GEO; GSM2635309
DR   GEO; GSM2635310
DR   IARC_TP53; 21149
DR   IARC_TP53; 27023
DR   IZSLER; BS TCL 77
DR   LINCS_LDP; LCL-1417
DR   Lonza; 136
DR   PharmacoDB; 143B_3_2019
DR   PRIDE; PXD002425
DR   Progenetix; CVCL_2270
DR   PubChem_Cell_line; CVCL_2270
DR   TOKU-E; 132
DR   Wikidata; Q54581813
RX   CelloPub=CLPUB00447;
RX   PubMed=2233717;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=22460905;
RX   PubMed=23144859;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26320182;
RX   PubMed=26589293;
RX   PubMed=26852163;
RX   PubMed=29334376;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=36480329;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/1/cell-lines-detail-310.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8303.
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=21519327).
CC   HLA typing: A*02:11,02:11; B*52:01,52:01; C*12:02,12:02; DQB1*05:02,05:02; DRB1*15:02,16:05 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (DepMap=ACH-001001).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (DepMap=ACH-001001).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (PubMed=19787792; DepMap=ACH-001001).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=4.02%; South Asian=37%; European, North=0%; European, South=58.98% (PubMed=30894373).
CC   Caution: Could be identical to HTK- (Cellosaurus=CVCL_2522).
CC   Misspelling: I43B; Cosmic=1529910.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-8303; BCRC=60439; CCRID; CLS=305232; ECACC=91112502; IZSLER=BS TCL 77; PubMed=19787792; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 13 (ATCC=CRL-8303; BCRC=60439; CCRID; CLS=305232; ECACC=91112502; IZSLER=BS TCL 77; PubMed=25877200)
ST   D5S818: 13,14 (PubMed=19787792)
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   SE33: 21
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18 (ATCC=CRL-8303; BCRC=60439; CCRID; CLS=305232; ECACC=91112502; IZSLER=BS TCL 77; PubMed=25877200)
ST   vWA: 18,19 (PubMed=19787792)
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   143B pML BK TK
AC   CVCL_3477
SY   143B PML BK TK
DR   CLO; CLO_0001089
DR   ATCC; CRL-8304
DR   cancercelllines; CVCL_3477
DR   LINCS_LDP; LCL-1418
DR   Wikidata; Q54581908
RX   Patent=US4562155;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8304.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-8304
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   143B rho-0 EtBr
AC   CVCL_ZL52
DR   cancercelllines; CVCL_ZL52
DR   PRIDE; PXD002425
DR   Wikidata; Q98125110
RX   PubMed=20188060;
RX   PubMed=26852163;
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Obtained by growth of parental cell line with ethidium bromide.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   143B rho-0#25
AC   CVCL_XF76
DR   cancercelllines; CVCL_XF76
DR   Kerafast; ESA106
DR   Wikidata; Q93299114
RX   PubMed=27136098;
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Produced by transient transfection with plasmid pMA4008 encoding HSV-1 UL12.5M185 protein, which damages mtDNA by an unknown mechanism (PubMed=27136098).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   143B-GFP-HK2
AC   CVCL_C0Q7
DR   cancercelllines; CVCL_C0Q7
DR   Wikidata; Q112926904
RX   PubMed=35609998;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pCMV6-AC-HK2-GFP construct that contains HK2 c-terminally tagged with turbo-GFP (PubMed=35609998).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4923; HK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   143B.206
AC   CVCL_U923
SY   143B206; 143-B306; 143B/206; 143B.206 rho0; 143B-206rho0; 143B/206 rho0; 143B206 rho(0); 143B206 rho-zero; 206rho0
DR   cancercelllines; CVCL_U923
DR   Wikidata; Q54581911
RX   PubMed=2814477;
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0) (PubMed=2814477).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   143BR
AC   CVCL_ZT48
SY   143 BRighton
DR   Wikidata; Q98125112
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   143BTK-
AC   CVCL_9W36
SY   143B/TK^(-)neo^(R)
DR   CLO; CLO_0050098
DR   cancercelllines; CVCL_9W36
DR   FANTOM5_SSTAR; 10510-107D6
DR   RCB; RCB0701
DR   Wikidata; Q54581910
RX   PubMed=3413074;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): RCB=RCB0701
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 19
//
ID   14433_1
AC   CVCL_JY31
SY   14433
DR   cancercelllines; CVCL_JY31
DR   Wikidata; Q54581913
RX   PubMed=25862976;
RX   PubMed=31150822;
CC   Doubling time: 2-3 days (PubMed=25862976).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2853Ter (c.8557A>T); ClinVar=VCV000372573; Zygosity=Homozygous (PubMed=25862976; PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=25862976; PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 14,15
ST   D1S1656: 12,19.3
ST   D21S11: 29,30
ST   D2S1338: 22
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 20
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 9,10
ST   Penta E: 14
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 14
//
ID   14464M
AC   CVCL_WM31
DR   cancercelllines; CVCL_WM31
DR   Cosmic; 852206
DR   Wikidata; Q93299133
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   144BR
AC   CVCL_8779
SY   144 BRighton
DR   Wikidata; Q54581917
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2551 ! LB173
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   145 BLCL
AC   CVCL_E348
DR   ECACC; 94031627
DR   Wikidata; Q54581918
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   HLA typing: A*03,30; B*07,13; C*06,07 (ECACC=94031627).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   145-2C11
AC   CVCL_7234
SY   2C11
DR   CLO; CLO_0001091
DR   ABCD; ABCD_AF106
DR   ATCC; CRL-1975
DR   BCRJ; 0002
DR   CCRID; 1101MOU-PUMC000211
DR   KCLB; 21975
DR   Wikidata; Q54581920
RX   PubMed=2950524;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P22646; Mouse Cd3e.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   14513382
AC   CVCL_JC32
SY   TER523; TER-523; Ter-523; Ter 523; Extract 481
DR   IPD-IMGT/HLA; 14032
DR   Wikidata; Q54581921
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/1CX391.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01/02:20/02:53N/02:64/02:66/02:67,25; B*38:01,15:78; C*12:03,03:04; DPA1*01:CG; DPB1*06:01/64:01,04:01; DQA1*03,01:DF; DQB1*05:01,03:02; DRB1*04:01,10:01; DRB4*01 (IPD-IMGT/HLA=14032).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   1455
AC   CVCL_UT96
DR   IARC_TP53; 24519
DR   Wikidata; Q93299157
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 48 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   145BR
AC   CVCL_ZT49
SY   145 BRighton
DR   Wikidata; Q98125113
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   146-03E04
AC   CVCL_E968
SY   146-3E4
DR   CLO; CLO_0001092
DR   ATCC; CRL-2650
DR   Wikidata; Q54581924
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8997.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   146-17A3
AC   CVCL_J569
DR   Wikidata; Q54581925
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8998.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   146-8D11
AC   CVCL_J570
DR   Wikidata; Q54581927
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8999.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   1461T
AC   CVCL_ZT91
DR   Wikidata; Q98125114
RX   PubMed=7779715;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   146BR
AC   CVCL_ZT50
SY   146 BRighton
DR   Wikidata; Q98125267
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   146MA
AC   CVCL_ZU11
SY   146 MAnchester
DR   Wikidata; Q98125268
RX   PubMed=9649131;
CC   Senescence: Senesces at 13 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   1464R
AC   CVCL_E5ZF
DR   ABM; T0746
RX   PubMed=28707715;
WW   Provider; Cosmo Bio; PMC-RNSCL-C; https://www.cosmobiousa.com/pages/cell-cell-culture-products/rat-neuronal-stem-cell-line-1464r
CC   Characteristics: In the presence of retinoic acid, the cells may differentiate to TuJ1-positive neurons and to GFAP-positive astrocytes or O4-positive oligodendrocytes (ABM=T0746).
CC   Derived from site: In situ; Brainstem; UBERON=UBERON_0002298.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   12W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   147 BLCL
AC   CVCL_E349
DR   ECACC; 94031688
DR   Wikidata; Q54581928
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   147-67C6
AC   CVCL_E969
DR   CLO; CLO_0001093
DR   ATCC; CRL-2654
DR   Wikidata; Q54581929
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9278.
CC   Monoclonal antibody isotype: IgG1+IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   1471.1 [Mouse hybridoma against levan]
AC   CVCL_C5WX
DR   Wikidata; Q116047844
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1471.1 [Mouse mammary carcinoma]
AC   CVCL_WY43
DR   Wikidata; Q93299188
RX   PubMed=2550796;
RX   PubMed=9712407;
CC   Characteristics: Transfected with the pMMTV-CAT plasmid.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   1479-mel
AC   CVCL_8047
SY   1479-MEL; 1479 mel; 1479; Mel-1479
DR   cancercelllines; CVCL_8047
DR   Cosmic; 2163792
DR   ESTDAB; ESTDAB-048
DR   Wikidata; Q54581931
RX   PubMed=10048982;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,03 (PubMed=10048982).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Asp464_Tyr467del (c.1392_1403del); Zygosity=Unspecified (PubMed=23851445).
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-048
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,13
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   147A
AC   CVCL_J803
DR   Wikidata; Q54581934
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
CC   Monoclonal antibody target: UniProtKB; P02714; Tetronarce californica chrng.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   147BR
AC   CVCL_B4IE
SY   147 BRighton
DR   Wikidata; Q110429671
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   148 BLCL
AC   CVCL_E350
DR   ECACC; 94031628
DR   Wikidata; Q54581935
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1488-4f1
AC   CVCL_DP72
SY   1488-4F1
DR   GEO; GSM1040265
DR   GEO; GSM1040335
DR   GEO; GSM1899763
DR   Wikidata; Q54581936
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3XX ! HDF1488
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   148BR
AC   CVCL_B4IF
SY   148 BRighton
DR   Wikidata; Q110429674
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   149 BLCL
AC   CVCL_E351
DR   ECACC; 94031629
DR   Wikidata; Q54581939
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1495-mel
AC   CVCL_8048
SY   1495-MEL; 1495 mel; 1495
DR   Wikidata; Q54581940
RX   PubMed=10048982;
RX   PubMed=10754339;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,03 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   149BR
AC   CVCL_2271
SY   149 BRighton
DR   CLO; CLO_0001094
DR   CLDB; cl12
DR   ECACC; 90011807
DR   Wikidata; Q54581941
RX   PubMed=1372096;
RX   PubMed=1672363;
RX   PubMed=8609460;
RX   PubMed=16714754;
RX   PubMed=18079351;
CC   Doubling time: 46 hours (PubMed=8609460).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2552 ! LB182
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   149RCa
AC   CVCL_VF96
DR   ABM; T8331
DR   cancercelllines; CVCL_VF96
DR   Cosmic; 2806956
DR   Wikidata; Q54581943
RX   PubMed=28344882;
RX   PubMed=29880898;
CC   Population: Chinese.
CC   Doubling time: 26.75 hours (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Ser25Ter (c.74C>G); Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Val (c.38G>T); ClinVar=VCV000180848; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=29880898).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Penis; UBERON=UBERON_0000989.
ST   Source(s): PubMed=28344882; PubMed=29880898
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL37 ! 149RM
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   149RM
AC   CVCL_VL37
DR   ABM; T8330
DR   cancercelllines; CVCL_VL37
DR   Cosmic; 2806957
DR   Wikidata; Q93299258
RX   PubMed=29880898;
CC   Population: Chinese.
CC   Doubling time: 26.39 hours (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Val (c.38G>T); ClinVar=VCV000180848; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=29880898).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Scrotum; UBERON=UBERON_0001300.
ST   Source(s): PubMed=29880898
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF96 ! 149RCa
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   14A-NFUD3
AC   CVCL_D4B6
DR   Wikidata; Q127378630
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Doubling time: 31 +- 6 hours (PubMed=37087860).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: MZM-0410.
OX   NCBI_TaxID=105023; ! Nothobranchius furzeri (Turquoise killifish)
SX   Sex unspecified
AG   Diapause III embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   14A12
AC   CVCL_F1Y4
RX   PubMed=1583327;
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   14A12G11
AC   CVCL_A0VG
DR   Wikidata; Q108819395
RX   Patent=CN107299085B;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   14A2.H1
AC   CVCL_C4BE
DR   Wikidata; Q116047845
RX   PubMed=1958484;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   14A3
AC   CVCL_KB80
DR   Wikidata; Q54581944
RX   PubMed=2447167;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04823; Rat Il3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   14A8-85
AC   CVCL_B4JW
DR   Wikidata; Q110429677
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11360.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   14B1
AC   CVCL_C4JQ
DR   Wikidata; Q116047846
RX   PubMed=35973349;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A1EA95; Chicken IL7R/CD127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   14B2
AC   CVCL_ZN81
DR   Wikidata; Q98125269
RX   PubMed=6593712;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04062; Human GBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   14C1
AC   CVCL_WZ52
SY   HLCL 14C1
DR   CCRID; 4201PAT-CCTCC00016
DR   Wikidata; Q93299266
RX   Patent=GB2192185A;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P72151; Pseudomonas aeruginosa B-type flagellin (fliC).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   14C12
AC   CVCL_LB96
SY   14 C12
DR   Wikidata; Q54581946
RX   Patent=US7582296;
RX   PubMed=14670927;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 5878CB.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B02C11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   14C2
AC   CVCL_J021
DR   ATCC; HB-8515
DR   Wikidata; Q54581948
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8515.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   14C3
AC   CVCL_C3XG
DR   ABCD; ABCD_AE864
DR   Wikidata; Q116047847
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   14C7
AC   CVCL_C4EZ
DR   Wikidata; Q116047848
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   14C8
AC   CVCL_B6VZ
DR   Wikidata; Q111732604
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   14D10
AC   CVCL_C7ID
DR   Wikidata; Q123030222
RX   PubMed=9683260;
RX   PubMed=24502396;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized YS110 (YSCMA) therapeutic antibody which is in clinical trials for the treatment of malignant mesothelioma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   14D2
AC   CVCL_E5MD
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   14D2.D6
AC   CVCL_C4QG
DR   Wikidata; Q116047849
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62898; Rat Cycs.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   14D7
AC   CVCL_B5CR
DR   Wikidata; Q110429679
RX   PubMed=14733492;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_6964; Molinate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   14E3
AC   CVCL_E7S7
RX   PubMed=2845894;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q0PL25; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   14E4
AC   CVCL_XF02
DR   CCRID; 4201PAT-CCTCC00519
DR   Wikidata; Q93299283
RX   Patent=CN104610452B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014188.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01151; Human CD83.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   14E5
AC   CVCL_J046
DR   CLO; CLO_0001095
DR   ATCC; HB-174
DR   Wikidata; Q54581949
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=3901396;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on endothelial cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   14F
AC   CVCL_B380
DR   Wikidata; Q54581950
RX   PubMed=2981238;
RX   PubMed=6693503;
CC   Doubling time: 20 hours (PubMed=2981238).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B420 ! MBA-14
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   14F10 [Mouse hybridoma against phOX]
AC   CVCL_C4F0
DR   Wikidata; Q116047850
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   14F10 [Mouse hybridoma against TGEV N]
AC   CVCL_E7S8
RX   PubMed=2845894;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q0PL25; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   14F7
AC   CVCL_XI29
DR   Wikidata; Q93299302
RX   Patent=US6429295;
RX   PubMed=10952412;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 98101901.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_144806; N-glycolylneuraminyllactosylceramide (GM3(NeuGc); HD3 ganglioside).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   14F8
AC   CVCL_C4JW
DR   Wikidata; Q116047851
RX   PubMed=35688031;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; D8UWD9; Chicken CSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   14G9
AC   CVCL_E7S9
RX   PubMed=2845894;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q0PL25; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   14H9
AC   CVCL_C4JX
DR   Wikidata; Q116047852
RX   PubMed=35688031;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; D8UWD9; Chicken CSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   14M
AC   CVCL_B381
DR   Wikidata; Q54581952
RX   PubMed=2981238;
RX   PubMed=6693503;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B420 ! MBA-14
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   14M1
AC   CVCL_B382
DR   Wikidata; Q54581954
RX   PubMed=2981238;
RX   PubMed=6693503;
CC   Doubling time: 15 hours (PubMed=2981238).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B420 ! MBA-14
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   15-1
AC   CVCL_E2ZW
RX   PubMed=11556707;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Potato virus Y (strain Tunisian PVYo) cytoplasmic inclusion protein (CI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   15-1-5P
AC   CVCL_J064
DR   CLO; CLO_0001098
DR   ATCC; HB-53
DR   Wikidata; Q54581955
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   15-23-3
AC   CVCL_D5JZ
SY   233
DR   Wikidata; Q127378631
RX   PubMed=6787586;
CC   Characteristics: Produced from the fusion of the myeloma cell line with mouse fetal liver cell, thus exhibiting several phenotypic characteristics of immature B lymphocytes. This hybridoma produces, but does not secrete IgM chain. No light chain is produced (PubMed=6787586).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   15-3-1S
AC   CVCL_G570
DR   CLO; CLO_0001101
DR   ATCC; HB-13
DR   Wikidata; Q54581956
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   15-5-5S
AC   CVCL_D290
SY   15.5.5S
DR   CLO; CLO_0001103
DR   ATCC; HB-24
DR   BCRJ; 0003
DR   Wikidata; Q54581957
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   15-56-1
AC   CVCL_D5K0
SY   561
DR   Wikidata; Q127378632
RX   PubMed=6787586;
CC   Characteristics: Produced from the fusion of the myeloma cell line with mouse fetal liver cell. Does not exhibit phenotypic characteristics of immature B lymphocytes (PubMed=6787586).
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   15-79-2
AC   CVCL_J080
DR   CLO; CLO_0001105
DR   ATCC; HB-34
DR   Wikidata; Q54581959
CC   Characteristics: Produced from the fusion of the myeloma cell line with mouse fetal liver cell, thus exhibiting several phenotypic characteristics of immature B lymphocytes. This hybridoma produces, but does not secrete IgM chain. No light chain is produced (ATCC=HB-34).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 7
//
ID   15-79-6
AC   CVCL_D5K1
SY   796
DR   Wikidata; Q127378633
RX   PubMed=6787586;
CC   Characteristics: Produced from the fusion of the myeloma cell line with mouse fetal liver cell, thus exhibiting several phenotypic characteristics of immature B lymphocytes. This hybridoma produces, but does not secrete IgM chain. No light chain is produced (PubMed=6787586).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   15-8-6-5
AC   CVCL_D5K2
SY   865
DR   Wikidata; Q127378635
RX   PubMed=6787586;
CC   Characteristics: Produced from the fusion of the myeloma cell line with mouse fetal liver cell, thus exhibiting several phenotypic characteristics of immature B lymphocytes. This hybridoma produces, but does not secrete IgM chain. No light chain is produced (PubMed=6787586).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   15/0
AC   CVCL_E8B8
RX   DOI=10.1016/B978-012442710-5.50265-3;
RX   PubMed=7620321;
RX   PubMed=9914916;
RX   PubMed=19273061;
WW   Provider; URMC; -; https://www.urmc.rochester.edu/microbiology-immunology/research/xenopus-laevis/models/cell-lines
CC   Group: Amphibian cell line.
CC   Characteristics: Does not express MHC class I or MHC class II molecules (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Tumorigenic in larval and adult syngeneic hosts (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Displays a dual B-cell and T-cell phenotype (PubMed=9914916).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: LG-15.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   15/40
AC   CVCL_E8B9
RX   DOI=10.1016/B978-012442710-5.50265-3;
RX   PubMed=7620321;
RX   PubMed=9914916;
RX   PubMed=19273061;
WW   Provider; URMC; -; https://www.urmc.rochester.edu/microbiology-immunology/research/xenopus-laevis/models/cell-lines
CC   Group: Amphibian cell line.
CC   Characteristics: Expresses low level of MHC class I and MHC class II molecules (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Tumorigenic in larval and adult syngeneic hosts (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Displays a dual B-cell and T-cell phenotype (PubMed=9914916).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: LG-15.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   15.84.4
AC   CVCL_J169
SY   15.84
DR   ATCC; HB-8335
DR   Wikidata; Q54581962
RX   Patent=US4650676;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8335.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella merozoite antigen (Note=Also reacts with other Eimeria species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   150 BLCL
AC   CVCL_E352
DR   ECACC; 94031630
DR   Wikidata; Q54581963
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   150-5
AC   CVCL_D2QA
DR   Wikidata; Q127378636
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   150057
AC   CVCL_A1VU
SY   150,057
DR   cancercelllines; CVCL_A1VU
DR   Wikidata; Q105505861
RX   PubMed=33143664;
CC   Population: Chinese.
CC   Doubling time: 91.7 +- 12.7 hours (Note=At 10th passage), 76.2 +- 6.7 hours (Note=At 26th passage), 70.4 +- 14.0 hours (Note=At 41th passage) (PubMed=33143664).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gln1330Ter (c.3988C>T); Zygosity=Heterozygous (PubMed=33143664).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Ala281Thr (c.841G>A); ClinVar=VCV002187391; Zygosity=Heterozygous (PubMed=33143664).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=33143664
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   1507.2
AC   CVCL_1Y71
SY   S1507-2
DR   Wikidata; Q54581966
RX   PubMed=21695156;
RX   PubMed=23437333;
RX   PubMed=28556483;
ST   Source(s): PubMed=28556483
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 12
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 18,23
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 15
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 5
//
ID   151 BLCL
AC   CVCL_E353
DR   ECACC; 94031631
DR   Wikidata; Q54581970
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   151-5-G2-12
AC   CVCL_J081
SY   CO-512; CO512
DR   CLO; CLO_0001096
DR   ATCC; HB-8322
DR   Wikidata; Q54581972
RX   Patent=US4607009;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8322.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
CC   Monoclonal antibody target: ChEBI; CHEBI_59440; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcNAc (Lewis B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   151-5-G3-5
AC   CVCL_J082
SY   CO-513; CO513
DR   CLO; CLO_0001097
DR   ATCC; HB-8323
DR   Wikidata; Q54581973
RX   Patent=US4607009;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8323.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
CC   Monoclonal antibody target: ChEBI; CHEBI_59440; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcNAc (Lewis B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   151-6-A7-9
AC   CVCL_J083
SY   CO-514; CO514
DR   CLO; CLO_0001099
DR   ATCC; HB-8324
DR   Wikidata; Q54581974
RX   Patent=US4607009;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8324.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   151-7
AC   CVCL_D2QB
DR   Wikidata; Q127378637
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   1510-CPTX
AC   CVCL_4809
DR   Wikidata; Q54582059
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200537/http://capcelllines.ca:80/details.asp?id=87
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DX ! 1510-EBV
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   1510-EBV
AC   CVCL_A1DX
SY   1510 EBV; 1510EBV
DR   Wikidata; Q102113424
RX   PubMed=9759882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4809 ! 1510-CPTX
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   1512-CPTX
AC   CVCL_4810
DR   Wikidata; Q54582061
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200728/http://capcelllines.ca:80/details.asp?id=92
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4811 ! 1512-normal
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1512-normal
AC   CVCL_4811
DR   Wikidata; Q54582063
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200542/http://capcelllines.ca:80/details.asp?id=88
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4810 ! 1512-CPTX
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1519-CPTX
AC   CVCL_4812
DR   Wikidata; Q54582064
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200739/http://capcelllines.ca:80/details.asp?id=94
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4813 ! 1519-normal
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1519-normal
AC   CVCL_4813
DR   Wikidata; Q54582065
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200734/http://capcelllines.ca:80/details.asp?id=93
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4812 ! 1519-CPTX
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   151BR
AC   CVCL_ZT51
SY   151 BRighton
DR   Wikidata; Q98125271
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   151TAg
AC   CVCL_6343
DR   CLO; CLO_0001100
DR   ATCC; CRL-2823
DR   Kerafast; ENH119-FP
DR   Wikidata; Q54582069
RX   PubMed=12882965;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104288; Pms2.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   152-6D11
AC   CVCL_J572
SY   152-06D11
DR   ATCC; CRL-2665
DR   Wikidata; Q54582070
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8996.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P68272; Feline leukemia virus v-Myc.
CC   Discontinued: ATCC; CRL-2665; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 9
//
ID   1520-mel
AC   CVCL_8049
SY   1520-MEL; 1520 mel; 1520
DR   Wikidata; Q54582073
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,29 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   15233_nov
AC   CVCL_JY32
SY   15233
DR   Wikidata; Q54582074
RX   PubMed=25862976;
RX   PubMed=31150822;
CC   Doubling time: 6-9 days (PubMed=25862976).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr170del (c.508_510delACG); Zygosity=Unspecified (PubMed=25862976; PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 19,24
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 14,18
ST   D19S433: 13,14.2
ST   D1S1656: 15,16.3
ST   D21S11: 30,30.2
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 25
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JY28 ! 13363
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   152BR
AC   CVCL_ZT52
SY   152 BRighton
DR   Wikidata; Q98125273
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   153.8E2.D10.D6.12.12
AC   CVCL_J992
SY   153.8E2D10D6.12.12; 12.12; CHIR-12.12
DR   ABCD; ABCD_AC977
DR   Wikidata; Q54582075
RX   Patent=US8333970;
RX   Patent=US20070098718;
RX   Patent=US20070218060;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5543.
CC   Registration: Chiron Master Culture Collection; CMCC 12056 (CMCC #12056).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   15303MN clone 2
AC   CVCL_B4I6
SY   WT clone 2
DR   Wikidata; Q110429683
RX   PubMed=33567244;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_B4I7 ! 15303MN clone 3
SX   Male
AG   2M
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   15303MN clone 3
AC   CVCL_B4I7
SY   WT clone 3
DR   Wikidata; Q110429686
RX   PubMed=33567244;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_B4I6 ! 15303MN clone 2
SX   Male
AG   2M
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   1532-CPTX-1
AC   CVCL_4814
SY   1532-CP1TX; CPTX-1532; 1532T
DR   Wikidata; Q54582076
RX   PubMed=9041206;
RX   PubMed=10913677;
RX   PubMed=16235240;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200553/http://capcelllines.ca:80/details.asp?id=96
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4815 ! 1532-CPTX-2
OI   CVCL_4816 ! 1532-normal
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   1532-CPTX-2
AC   CVCL_4815
SY   1532-CP2TX
DR   Wikidata; Q54582077
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200558/http://capcelllines.ca:80/details.asp?id=97
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4814 ! 1532-CPTX-1
OI   CVCL_4816 ! 1532-normal
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1532-normal
AC   CVCL_4816
SY   NPTX-1532
DR   Wikidata; Q54582080
RX   PubMed=9041206;
RX   PubMed=22275356;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200734/http://capcelllines.ca:80/details.asp?id=95
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4814 ! 1532-CPTX-1
OI   CVCL_4815 ! 1532-CPTX-2
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1535-CPTX-1
AC   CVCL_4817
SY   1535-CP1TX; 1535T
DR   Wikidata; Q54582082
RX   PubMed=9041206;
RX   PubMed=10913677;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153350/http://capcelllines.ca:80/details.asp?id=100
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4818 ! 1535-CPTX-2
OI   CVCL_4819 ! 1535-normal prostate
OI   CVCL_4820 ! 1535-seminal vesicle
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1535-CPTX-2
AC   CVCL_4818
SY   1535-CP2TX
DR   Wikidata; Q54582083
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200623/http://capcelllines.ca:80/details.asp?id=101
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4817 ! 1535-CPTX-1
OI   CVCL_4819 ! 1535-normal prostate
OI   CVCL_4820 ! 1535-seminal vesicle
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1535-normal prostate
AC   CVCL_4819
SY   1535N
DR   Wikidata; Q54582084
RX   PubMed=9041206;
RX   PubMed=10913677;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200749/http://capcelllines.ca:80/details.asp?id=98
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4817 ! 1535-CPTX-1
OI   CVCL_4818 ! 1535-CPTX-2
OI   CVCL_4820 ! 1535-seminal vesicle
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1535-seminal vesicle
AC   CVCL_4820
DR   Wikidata; Q54582086
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200804/http://capcelllines.ca:80/details.asp?id=99
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Seminal vesicle; UBERON=UBERON_0000998.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4817 ! 1535-CPTX-1
OI   CVCL_4818 ! 1535-CPTX-2
OI   CVCL_4819 ! 1535-normal prostate
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   15392M
AC   CVCL_WM29
DR   cancercelllines; CVCL_WM29
DR   Cosmic; 852204
DR   Wikidata; Q93299559
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   153BR
AC   CVCL_2272
SY   153 BRighton
DR   CLO; CLO_0001102
DR   CLDB; cl13
DR   ECACC; 90011808
DR   Wikidata; Q54582091
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ECACC=90011808
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2553 ! LB185
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   1542-CPTX-1
AC   CVCL_4821
SY   1542-CP1TX; 1542T
DR   Wikidata; Q54582092
RX   PubMed=9041206;
RX   PubMed=10913677;
RX   PubMed=16235240;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200804/http://capcelllines.ca:80/details.asp?id=99
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4822 ! 1542-CPTX-2
OI   CVCL_4823 ! 1542-CPTX-3
OI   CVCL_4824 ! 1542-normal
OI   CVCL_4825 ! 1542-seminal vesicle
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1542-CPTX-2
AC   CVCL_4822
SY   1542-CP2TX
DR   Wikidata; Q54582095
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200804/http://capcelllines.ca:80/details.asp?id=99
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4821 ! 1542-CPTX-1
OI   CVCL_4823 ! 1542-CPTX-3
OI   CVCL_4824 ! 1542-normal
OI   CVCL_4825 ! 1542-seminal vesicle
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1542-CPTX-3
AC   CVCL_4823
SY   1542-CP3TX
DR   Wikidata; Q54582096
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200804/http://capcelllines.ca:80/details.asp?id=99
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4821 ! 1542-CPTX-1
OI   CVCL_4822 ! 1542-CPTX-2
OI   CVCL_4824 ! 1542-normal
OI   CVCL_4825 ! 1542-seminal vesicle
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1542-normal
AC   CVCL_4824
DR   Wikidata; Q54582098
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200628/http://capcelllines.ca:80/details.asp?id=102
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4821 ! 1542-CPTX-1
OI   CVCL_4822 ! 1542-CPTX-2
OI   CVCL_4823 ! 1542-CPTX-3
OI   CVCL_4825 ! 1542-seminal vesicle
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   1542-seminal vesicle
AC   CVCL_4825
DR   Wikidata; Q54582101
RX   PubMed=9041206;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200457/http://capcelllines.ca:80/details.asp?id=103
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Seminal vesicle; UBERON=UBERON_0000998.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4821 ! 1542-CPTX-1
OI   CVCL_4822 ! 1542-CPTX-2
OI   CVCL_4823 ! 1542-CPTX-3
OI   CVCL_4824 ! 1542-normal
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   154BR
AC   CVCL_VJ26
SY   154 BRighton
DR   Wikidata; Q93299619
RX   PubMed=1672363;
RX   PubMed=2400879;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   154MA
AC   CVCL_ZU12
SY   154 MAnchester
DR   Wikidata; Q98125274
RX   PubMed=9649131;
CC   Senescence: Senesces at 35 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   155
AC   CVCL_J919
SY   Anti PDGF hybridoma #155
DR   ATCC; HB-9354
DR   Wikidata; Q54582102
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9354.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   155-11C7
AC   CVCL_J573
DR   Wikidata; Q54582104
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8976.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P68272; Feline leukemia virus v-Myc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   155-8G1
AC   CVCL_J574
DR   Wikidata; Q54582107
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9001.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P68272; Feline leukemia virus v-Myc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   155-9F6
AC   CVCL_J575
DR   Wikidata; Q54582108
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9000.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P68272; Feline leukemia virus v-Myc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   155BR
AC   CVCL_2273
SY   155 BRighton
DR   CLO; CLO_0001104
DR   CLDB; cl16
DR   ECACC; 90011809
DR   Wikidata; Q54582110
RX   PubMed=1372096;
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ID ! LB188
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   155MA
AC   CVCL_ZU13
SY   155 MAnchester
DR   Wikidata; Q98125276
RX   PubMed=9649131;
CC   Senescence: Senesces at 14 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   156 BLCL
AC   CVCL_E354
DR   ECACC; 94031633
DR   Wikidata; Q54582112
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1563
AC   CVCL_E431
SY   CDUA
DR   dbMHC; 48449
DR   ECACC; 94071415
DR   IHW; IHW09337
DR   IPD-IMGT/HLA; 10075
DR   Wikidata; Q54582114
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DPB1*01:01:01,04:02; DRB1*03:02:01 (IPD-IMGT/HLA=10075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071415; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   1568
AC   CVCL_E432
SY   LJAC
DR   dbMHC; 48450
DR   IHW; IHW09346
DR   IPD-IMGT/HLA; 10077
DR   Wikidata; Q54582115
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*30,34; B*42,71; DRB1*01:02:01 (IPD-IMGT/HLA=10077).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   1568M
AC   CVCL_WM58
DR   cancercelllines; CVCL_WM58
DR   Cosmic; 852232
DR   Wikidata; Q93299682
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   156BR
AC   CVCL_ZT53
SY   156 BRighton
DR   Wikidata; Q98125277
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   156MA
AC   CVCL_ZU14
SY   156 MAnchester
DR   Wikidata; Q98125278
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 17 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   157748
AC   CVCL_V363
DR   IPD-IMGT/HLA; 14465
DR   Wikidata; Q54582118
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,26; B*35,44; C*04,05; DQB1*03:01,03:02; DRB1*04:60,11:04:01; DRB3*02:02; DRB4*01:03 (IPD-IMGT/HLA=14465).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   1579
AC   CVCL_B3UT
DR   Wikidata; Q110429689
RX   PubMed=30567931;
RX   PubMed=32011687;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; p.Thr383Ilefs*13 (c.1148delC); ClinVar=VCV000005225; Zygosity=Heterozygous (PubMed=32011687).
CC   Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; c.1663-2137C>T (chr8:g.87618576G>A); ClinVar=VCV000635823; Zygosity=Heterozygous; Note=Incorporates cryptic exon 14b (PubMed=32011687).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   157MA
AC   CVCL_ZU15
SY   157 MAnchester
DR   Wikidata; Q98125279
RX   PubMed=9649131;
CC   Senescence: Senesces at 9 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   158 BLCL
AC   CVCL_E355
DR   ECACC; 94031635
DR   Wikidata; Q54582119
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   158.2
AC   CVCL_9141
SY   MA158.2
DR   CLO; CLO_0001106
DR   ATCC; HB-8466
DR   Wikidata; Q54582121
RX   Patent=US4701408;
RX   PubMed=6379646;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8466.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse antigen on activated macrophages.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   1580
AC   CVCL_B3UU
DR   Wikidata; Q110429692
RX   PubMed=30567931;
RX   PubMed=32011687;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; p.Thr383Ilefs*13 (c.1148delC); ClinVar=VCV000005225; Zygosity=Heterozygous (PubMed=32011687).
CC   Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; c.1663-2137C>T (chr8:g.87618576G>A); ClinVar=VCV000635823; Zygosity=Heterozygous; Note=Incorporates cryptic exon 14b (PubMed=32011687).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   1580WU
AC   CVCL_M136
SY   Wu-1580
DR   Cosmic; 2362659
DR   Wikidata; Q54582122
RX   PubMed=15793295;
RX   PubMed=22976800;
RX   PubMed=27498314;
RX   PubMed=27812533;
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   1581
AC   CVCL_B3UV
DR   Wikidata; Q110429695
RX   PubMed=30567931;
RX   PubMed=32011687;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; c.1663-2137C>T (chr8:g.87618576G>A); ClinVar=VCV000635823; Zygosity=Heterozygous; Note=Incorporates cryptic exon 14b (PubMed=32011687).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   1582
AC   CVCL_B3UW
DR   Wikidata; Q110429698
RX   PubMed=30567931;
RX   PubMed=32011687;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   15876
AC   CVCL_WY92
DR   Wikidata; Q93299715
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu137Aspfs*9 (c.409_416del7); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D12S391: 18,23
ST   D13S317: 12
ST   D16S539: 11,15
ST   D18S51: 14
ST   D19S433: 16.2
ST   D1S1656: 17
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 18
ST   D5S818: 11
ST   D6S1043: 12,19
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY93 ! 16106
OI   CVCL_WY94 ! 17066
OI   CVCL_WY95 ! 17201
OI   CVCL_WY96 ! 17268
OI   CVCL_WY97 ! EB0405
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   159-183-10
AC   CVCL_D3SK
DR   DSHB; 159-183-10
DR   Wikidata; Q127378638
RX   PubMed=8130037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P34119; Dictyostelium discoideum psmA4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   159-2
AC   CVCL_IT51
DR   PRIDE; PXD000589
DR   Wikidata; Q54582125
RX   PubMed=22170606;
RX   PubMed=25894527;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   159-291-1
AC   CVCL_D3SI
DR   DSHB; 159-291-1
DR   Wikidata; Q127378639
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24005; Dictyostelium discoideum abpB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   1590
AC   CVCL_WJ10
DR   CCRID; 4201HUM-CCTCC00046
DR   CCTCC; GDC0046
DR   Wikidata; Q93299725
RX   PubMed=21965729;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   159BR
AC   CVCL_ZT54
SY   159 BRighton
DR   Wikidata; Q98125280
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   159MA
AC   CVCL_ZU16
SY   159 MAnchester
DR   Wikidata; Q98125281
RX   PubMed=9649131;
CC   Senescence: Senesces at 19 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   15b
AC   CVCL_8990
SY   iPS-15b; hiPS-15b; hiPS 15b
DR   EFO; EFO_0007102
DR   ENCODE; ENCBS196IDK
DR   ENCODE; ENCBS201ENZ
DR   ENCODE; ENCBS448IJH
DR   GEO; GSM537687
DR   GEO; GSM537690
DR   GEO; GSM537691
DR   GEO; GSM537692
DR   GEO; GSM537696
DR   GEO; GSM621433
DR   GEO; GSM621444
DR   GEO; GSM621557
DR   GEO; GSM621721
DR   GEO; GSM637781
DR   GEO; GSM772767
DR   SKIP; SKIP004427
DR   Wikidata; Q54582126
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   15B2
AC   CVCL_J020
DR   CLO; CLO_0001107
DR   Wikidata; Q54582127
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8510.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   15B3
AC   CVCL_IQ41
DR   Wikidata; Q54582131
RX   Patent=US7259246;
RX   PubMed=9363892;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2298.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Specifically recognizes infectious PrP(Sc)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   15C12
AC   CVCL_A6LK
DR   Wikidata; Q107113132
RX   Patent=WO1992017608A1;
RX   PubMed=2007622;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   15C6 [Mouse hybridoma against C.neoformans polysaccharide]
AC   CVCL_F1YB
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgA, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   15C6 [Mouse hybridoma against murid herpesvirus 1 m144]
AC   CVCL_D147
DR   CLO; CLO_0001108
DR   ATCC; CRL-2431
DR   Wikidata; Q54582132
RX   PubMed=9420246;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; D3XDW6; Murid herpesvirus 1 MHC class I-like protein m144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   15C6 [Mouse/rat hybridoma against mouse Cd1d1]
AC   CVCL_9142
DR   CLO; CLO_0001109
DR   ATCC; HB-326
DR   Wikidata; Q54582170
RX   PubMed=9531266;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   15C9
AC   CVCL_0H97
DR   ATCC; PTA-5106
DR   Wikidata; Q54582171
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5106.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   15E11
AC   CVCL_E8UJ
RX   PubMed=1958138;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00855; Dermatophagoides farinae mite group 2 allergen Der f 2 (DERF2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   15E3/53
AC   CVCL_VI48
DR   BEI_Resources; MRA-879
DR   Wikidata; Q54582172
RX   PubMed=1574088;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) merozoite surface protein 1 (MSP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   15F1.5
AC   CVCL_D5B0
DR   Wikidata; Q127378641
RX   PubMed=7518977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dog canine leukocyte-associated antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   15F10
AC   CVCL_E8V4
SY   15F10.3C9
RX   Patent=US8624002;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_15551; Prostaglandin E2 (PGE2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   15F12F8
AC   CVCL_D3RP
DR   DSHB; 15F12F8
DR   Wikidata; Q127378642
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   15F3-1
AC   CVCL_J084
SY   15F3
DR   CLO; CLO_0001110
DR   ATCC; HB-47
DR   Wikidata; Q54582173
RX   PubMed=6285749;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17763; Dengue virus type 1 genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 5
//
ID   15F7
AC   CVCL_9143
DR   CLO; CLO_0001111
DR   ATCC; HB-322
DR   Wikidata; Q54582175
RX   PubMed=9531266;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   15F9
AC   CVCL_E1H7
RX   PubMed=30596381;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6A2H4; Chicken IL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   15G7
AC   CVCL_A6LL
DR   Wikidata; Q107113135
RX   Patent=WO1992017608A1;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   15H6
AC   CVCL_C5F0
DR   Wikidata; Q116047853
RX   PubMed=3919640;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9381; T-2 mycotoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   15II-NFUD2
AC   CVCL_D4B9
DR   Wikidata; Q127378643
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Doubling time: 34 +- 3 hours (PubMed=37087860).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MZM-0410.
OX   NCBI_TaxID=105023; ! Nothobranchius furzeri (Turquoise killifish)
SX   Sex unspecified
AG   Diapause II embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   15P-1
AC   CVCL_6552
DR   CLO; CLO_0001112
DR   ATCC; CRL-2618
DR   CCRID; 1101MOU-PUMC000271
DR   CCRID; 3101MOUSCSP501
DR   CLS; 305191
DR   Wikidata; Q54582176
RX   PubMed=8393161;
RX   PubMed=15541572;
RX   PubMed=23891577;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   15PC3
AC   CVCL_D647
SY   15PC-3
DR   BTO; BTO_0002220
DR   Wikidata; Q54582179
RX   PubMed=11929820;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   16-1
AC   CVCL_E8GI
RX   PubMed=30362927;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Z7; Human COLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   16-1-11N
AC   CVCL_J085
DR   CLO; CLO_0001114
DR   ATCC; HB-16
DR   Wikidata; Q54582181
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   16-1-2N
AC   CVCL_J086
DR   CLO; CLO_0001115
DR   ATCC; HB-14
DR   Wikidata; Q54582182
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   16-10A1
AC   CVCL_8937
DR   CLO; CLO_0001113
DR   ATCC; HB-301
DR   Wikidata; Q54582183
RX   PubMed=1373896;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q00609; Mouse Cd80.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   16-12
AC   CVCL_E8GN
RX   PubMed=30362927;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Z7; Human COLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   16-13
AC   CVCL_E8GP
RX   PubMed=30362927;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Z7; Human COLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   16-23
AC   CVCL_U054
DR   ECACC; 99043001
DR   Wikidata; Q54582185
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   16-3
AC   CVCL_E8GJ
RX   PubMed=30362927;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Z7; Human COLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   16-3-1N
AC   CVCL_J089
DR   CLO; CLO_0001119
DR   ATCC; HB-25
DR   Wikidata; Q54582187
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   16-3-22S
AC   CVCL_G571
DR   CLO; CLO_0001120
DR   ATCC; HB-5
DR   Wikidata; Q54582189
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   16-4
AC   CVCL_E8GK
RX   PubMed=30362927;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Z7; Human COLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   16-46
AC   CVCL_F1HR
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   16-46-4-8
AC   CVCL_F1HS
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1HR ! 16-46
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   16-46-6-46
AC   CVCL_F1HT
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1HR ! 16-46
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   16-5
AC   CVCL_E8GL
RX   PubMed=30362927;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Z7; Human COLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   16-7
AC   CVCL_E8GM
RX   PubMed=30362927;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Z7; Human COLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   16-8
AC   CVCL_J270
DR   JCRB; JCRB0013
DR   Wikidata; Q54582191
RX   PubMed=6675779;
CC   Doubling time: 19 hours (Note=Lot 102997) (JCRB=JCRB0013).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   16.4.12E
AC   CVCL_D3UZ
DR   ABCD; ABCD_AE272
DR   Wikidata; Q127378644
RX   PubMed=2464028;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with KLH coupled isomaltohexose (KLH-IM6)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   160 BLCL
AC   CVCL_E356
DR   ECACC; 94031636
DR   Wikidata; Q54582193
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   160BR
AC   CVCL_ZT55
SY   160 BRighton
DR   Wikidata; Q98125283
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   160CT8531
AC   CVCL_XD98
DR   Wikidata; Q93299789
RX   Patent=US9273127;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201153.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O75832; Human PSMD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   160MA
AC   CVCL_ZT83
SY   160 MAnchester
DR   Wikidata; Q98125284
RX   PubMed=8649785;
RX   PubMed=9649131;
CC   Population: Indian.
CC   Senescence: Senesces at 17 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu344Pro (c.1031T>C); ClinVar=VCV000012375; Zygosity=Heterozygous (PubMed=9649131).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT84 ! 161MA-F
OI   CVCL_ZT85 ! 161MA-M
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   161 BLCL
AC   CVCL_E357
DR   ECACC; 94031637
DR   Wikidata; Q54582195
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   16106
AC   CVCL_WY93
DR   Wikidata; Q93299797
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu137Aspfs*9 (c.409_416del7); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D12S391: 18,23
ST   D13S317: 12
ST   D16S539: 11,15
ST   D18S51: 14
ST   D19S433: 16.2
ST   D1S1656: 17,18
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D6S1043: 12,19
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY92 ! 15876
OI   CVCL_WY94 ! 17066
OI   CVCL_WY95 ! 17201
OI   CVCL_WY96 ! 17268
OI   CVCL_WY97 ! EB0405
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   1613F12
AC   CVCL_B0FT
DR   Wikidata; Q108819396
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4505.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1614G5
AC   CVCL_B0G4
DR   Wikidata; Q108819397
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4519.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1616-EB
AC   CVCL_F949
DR   RCB; RCB1931
DR   TKG; TKG 0613
DR   Wikidata; Q54582198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: RCB; RCB1931; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0613
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   1616-MUC1
AC   CVCL_F950
DR   RCB; RCB1877
DR   TKG; TKG 0612
DR   Wikidata; Q54582199
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: RCB; RCB1877; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0612
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F949 ! 1616-EB
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   1618-K
AC   CVCL_S505
SY   1618K
DR   DepMap; ACH-001437
DR   DSMZ; ACC-752
DR   DSMZCellDive; ACC-752
DR   Wikidata; Q54582201
RX   CelloPub=CLPUB00009;
RX   PubMed=11416159;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~40 hours (DSMZ=ACC-752).
CC   Caution: This cell line is said to originate from a 'primary retroperitoneal embryonal carcinoma'. The current view is that retroperitoneal embryonal carcinoma is a metastatic form of testicular embryonal carcinoma.
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): DepMap=ACH-001437; DSMZ=ACC-752; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 10,19
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 17,25
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 7
ST   D8S1179: 13,14 (DepMap=ACH-001437; PubMed=11416159)
ST   D8S1179: 14 (DSMZ=ACC-752)
ST   FGA: 20
ST   Penta D: 15
ST   Penta E: 5,17
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 15
//
ID   161BR
AC   CVCL_2274
SY   161-Br; 161 BR; 161 BRighton
DR   CLO; CLO_0001116
DR   CLDB; cl17
DR   ECACC; 90011810
DR   Wikidata; Q54582204
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ECACC=90011810
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11
ST   D5S818: 9,11
ST   D7S820: 8,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   161CT7112
AC   CVCL_XD99
DR   Wikidata; Q93299822
RX   Patent=US9273127;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201154.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O75832; Human PSMD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   161MA-F
AC   CVCL_ZT84
SY   161 MAnchester-F
DR   Wikidata; Q98125286
RX   PubMed=8649785;
RX   PubMed=9649131;
CC   Population: Indian.
CC   Senescence: Senesces at 19 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu344Pro (c.1031T>C); ClinVar=VCV000012375; Zygosity=Hemizygous (PubMed=8649785; PubMed=9649131).
CC   Derived from site: In situ; Mesentery; UBERON=UBERON_0002095.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT83 ! 160MA
OI   CVCL_ZT85 ! 161MA-M
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   161MA-M
AC   CVCL_ZT85
SY   161 MAnchester-M
DR   Wikidata; Q98125287
RX   PubMed=8649785;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu344Pro (c.1031T>C); ClinVar=VCV000012375; Zygosity=Heterozygous (PubMed=8649785).
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   NCIt; C27904; Retroperitoneal leiomyosarcoma
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT83 ! 160MA
OI   CVCL_ZT84 ! 161MA-F
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   162
AC   CVCL_J920
SY   Anti PDGF hybridoma #162
DR   ATCC; HB-9356
DR   Wikidata; Q54582205
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9356.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   162-21.2
AC   CVCL_J087
SY   Anti-Trop-1
DR   CLO; CLO_0001117
DR   ATCC; HB-241
DR   Wikidata; Q54582206
RX   PubMed=7029529;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   162-46.2
AC   CVCL_J088
SY   Anti-Trop-2
DR   CLO; CLO_0001118
DR   ATCC; HB-187
DR   Wikidata; Q54582207
RX   PubMed=7029529;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   162MA
AC   CVCL_ZU17
SY   162 MAnchester
DR   Wikidata; Q98125288
RX   PubMed=9649131;
CC   Senescence: Senesces at 26 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   163 BLCL
AC   CVCL_E358
DR   ECACC; 94031638
DR   Wikidata; Q54582210
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   163-93
AC   CVCL_B0P6
SY   mAb163-93
DR   Wikidata; Q108819398
RX   Patent=WO1999055735A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12699.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99062; Human CSF3R.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   16396M
AC   CVCL_WM57
DR   cancercelllines; CVCL_WM57
DR   Cosmic; 852231
DR   IARC_TP53; 20616
DR   Wikidata; Q93299831
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Colon; UBERON=UBERON_0001155.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   163MA
AC   CVCL_ZU18
SY   163 Manchester
DR   Wikidata; Q98125290
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 70 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (PubMed=9018113; PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   164 BLCL
AC   CVCL_E359
DR   ECACC; 94031639
DR   Wikidata; Q54582212
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   164 Msar FE
AC   CVCL_C8HK
DR   Wikidata; Q123030223
RX   Patent=RU2796351;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 804D.
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21613; Mouse spindle cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   164-3F3
AC   CVCL_J576
DR   ATCC; CRL-2736
DR   Wikidata; Q54582213
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9040.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00538; Moloney murine sarcoma virus v-Mos.
CC   Discontinued: ATCC; CRL-2736; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 9
//
ID   16471
AC   CVCL_WY99
DR   cancercelllines; CVCL_WY99
DR   Wikidata; Q93299835
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Trp2626Cys (c.7878G>C); ClinVar=VCV000038125; Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr253Pro (c.757A>C); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 21,25
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 21
ST   D19S433: 14
ST   D1S1656: 16.3,17.3
ST   D21S11: 28,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 10,11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   164BR
AC   CVCL_ZT56
SY   164 BRighton
DR   Wikidata; Q98125291
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 13,15
ST   D21S11: 30,31
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   TH01: 9.3
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   164MA
AC   CVCL_ZU19
SY   164 MAnchester
DR   Wikidata; Q98125292
RX   PubMed=9649131;
CC   Senescence: Senesces at 58 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Heterozygous (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   164T2
AC   CVCL_8099
DR   BTO; BTO_0002972
DR   Wikidata; Q54582214
RX   PubMed=9427718;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C57BL/Ka.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   165-28E7
AC   CVCL_0F07
SY   SCRF 354
DR   ATCC; CRL-2735
DR   Wikidata; Q54582215
RX   Patent=US5858670;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00538; Moloney murine sarcoma virus v-Mos.
CC   Discontinued: ATCC; CRL-2735; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 5
//
ID   165-34E4
AC   CVCL_J577
DR   Wikidata; Q54582217
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9279.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00538; Moloney murine sarcoma virus v-Mos.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   1657
AC   CVCL_ZD41
DR   Wikidata; Q98125293
RX   PubMed=8105609;
RX   PubMed=12920029;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   165BR
AC   CVCL_ZT57
SY   165 BRighton
DR   Wikidata; Q98125294
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D21S11: 28,30
ST   D8S1179: 11,12
ST   FGA: 21,22
ST   TH01: 6,9.3
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   165TOR
AC   CVCL_ZP21
DR   Wikidata; Q98125295
RX   PubMed=17273966;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:3433; ERCC1; Simple; p.Gln158Ter (c.472C>T); ClinVar=VCV000016777; Zygosity=Heterozygous (PubMed=17273966).
CC   Sequence variation: Mutation; HGNC; HGNC:3433; ERCC1; Simple; p.Phe231Leu (c.693C>G); ClinVar=VCV000016778; Zygosity=Heterozygous (PubMed=17273966).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173104; Cerebrooculofacioskeletal syndrome 4
DI   ORDO; Orphanet_1466; COFS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   166
AC   CVCL_E4YL
DR   GEO; GSM7036154
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=37296104;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   166 BLCL
AC   CVCL_E360
DR   ECACC; 94031640
DR   Wikidata; Q54582219
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   166-32
AC   CVCL_B0NC
DR   ATCC; HB-12476
DR   Wikidata; Q108819399
RX   Patent=US6956107;
RX   PubMed=10456004;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12476.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized Fab antigen binding domain of the therapeutic antibody lampalizumab (FCFD4514S; RG7417) which was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00746; Human CFD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   166-ME SK
AC   CVCL_3478
DR   CLO; CLO_0001121
DR   ATCC; CRL-1533
DR   BioSample; SAMN03473643
DR   Wikidata; Q54582220
CC   Population: African American.
CC   Senescence: Senesces at 16 PDL (ATCC=CRL-1533).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1533
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 8,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 15,19
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   16610D9
AC   CVCL_0111
DR   MCCL; MCC:0000002
DR   Wikidata; Q54582221
RX   PubMed=10587351;
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   166T
AC   CVCL_A2AF
DR   Wikidata; Q105505866
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor and lung cancer type from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   167 BLCL
AC   CVCL_E361
DR   ECACC; 94031641
DR   Wikidata; Q54582223
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   167-1
AC   CVCL_D2QC
DR   Wikidata; Q127378645
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   167.2
AC   CVCL_V058
DR   CLO; CLO_0001004
DR   CLDB; cl20
DR   IHW; 11w 8126
DR   Wikidata; Q54582224
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   167.4G5.3
AC   CVCL_F0VW
RX   PubMed=2347598;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_18132; Phosphocholine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1670
AC   CVCL_DF12
SY   #1670
DR   Wikidata; Q54582225
RX   PubMed=195090;
RX   PubMed=226983;
RX   PubMed=4633909;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
DI   NCIt; C134959; Marmoset lymphoma
OX   NCBI_TaxID=9521; ! Saimiri sciureus (Common squirrel monkey)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   168
AC   CVCL_0I84
SY   Line 168
DR   Wikidata; Q54582226
RX   PubMed=210930;
RX   PubMed=2413152;
RX   PubMed=3426919;
RX   PubMed=3940214;
RX   PubMed=6677618;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_W343 ! 410.4
OI   CVCL_9722 ! 66 [Mouse mammary tumor]
OI   CVCL_0I87 ! 67 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   168 BLCL
AC   CVCL_E362
DR   ECACC; 94031642
DR   Wikidata; Q54582227
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   168.6
AC   CVCL_C5WY
DR   Wikidata; Q116047854
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1682A
AC   CVCL_F665
SY   1682-A
DR   BTO; BTO_0004320
DR   Wikidata; Q54582229
RX   PubMed=16322250;
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   1685M
AC   CVCL_A1EB
DR   Wikidata; Q102113425
RX   PubMed=6100171;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   1687-4f2
AC   CVCL_DP74
SY   1687-4F2
DR   GEO; GSM1040267
DR   GEO; GSM1040337
DR   GEO; GSM1899764
DR   Wikidata; Q54582232
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   168A51-2
AC   CVCL_A0AE
DR   BEI_Resources; ARP-1316
DR   Wikidata; Q108819400
RX   CelloPub=CLPUB00645;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   168A51-42
AC   CVCL_A0AF
DR   BEI_Resources; ARP-1318
DR   Wikidata; Q108819401
RX   CelloPub=CLPUB00645;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   168B17-46-34
AC   CVCL_A0AA
DR   BEI_Resources; ARP-1312
DR   Wikidata; Q108819402
RX   CelloPub=CLPUB00645;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   168B17-46-50
AC   CVCL_A0AB
DR   BEI_Resources; ARP-1313
DR   Wikidata; Q108819403
RX   CelloPub=CLPUB00645;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   168B17-46-70
AC   CVCL_A0AC
DR   BEI_Resources; ARP-1314
DR   Wikidata; Q108819404
RX   CelloPub=CLPUB00645;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   168B17-46-92
AC   CVCL_A0AD
DR   BEI_Resources; ARP-1315
DR   Wikidata; Q108819405
RX   CelloPub=CLPUB00645;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   168FAR
AC   CVCL_0I85
DR   Wikidata; Q54582234
RX   PubMed=3940214;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0I84 ! 168
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   168FARN
AC   CVCL_0I86
DR   Wikidata; Q54582299
RX   PubMed=1540948;
RX   PubMed=1993557;
RX   PubMed=15671244;
CC   Characteristics: Non-metastatic.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0I85 ! 168FAR
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   169-3
AC   CVCL_C5N6
DR   Wikidata; Q116047855
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   169-477-5
AC   CVCL_YA91
DR   ABCD; ABCD_AJ156
DR   DSHB; 169-477-5
DR   Wikidata; Q93299878
RX   DOI=10.24450/journals/abrep.2019.e50;
RX   DOI=10.24450/journals/abrep.2019.e51;
RX   PubMed=7698984;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0CE95; Dictyostelium discoideum talA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 6
//
ID   169-90-2
AC   CVCL_D3SJ
DR   DSHB; 169-90-2
DR   Wikidata; Q127378646
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24005; Dictyostelium discoideum abpB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   169A [Human embryonal carcinoma]
AC   CVCL_0B41
DR   Cosmic; 2163759
DR   Wikidata; Q54582301
RX   PubMed=24812411;
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   169A [Mouse hybridoma against human ITGAD]
AC   CVCL_B0NS
DR   ATCC; HB-11907
DR   Wikidata; Q108819406
RX   Patent=US5728533;
RX   PubMed=8777714;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11907.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13349; Human ITGAD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   169B
AC   CVCL_B0NT
DR   ATCC; HB-11906
DR   Wikidata; Q108819407
RX   Patent=US5728533;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11906.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13349; Human ITGAD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   169MA
AC   CVCL_ZU20
SY   169 MAnchester
DR   Wikidata; Q98125297
RX   PubMed=9649131;
CC   Senescence: Senesces at 11 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   16A3
AC   CVCL_A0HH
DR   Wikidata; Q108819408
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   16B
AC   CVCL_N540
DR   Wikidata; Q54582303
RX   PubMed=6206890;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_61151; Poly-ADP-D-ribose (Poly(adenosine diphosphate ribose)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 7
//
ID   16B2B1
AC   CVCL_D3RQ
DR   DSHB; 16B2B1
DR   Wikidata; Q127378647
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   16B3
AC   CVCL_ZN82
DR   Wikidata; Q98125298
RX   PubMed=6593712;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04062; Human GBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   16B5
AC   CVCL_VI29
DR   BEI_Resources; MRA-257
DR   Wikidata; Q54582304
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   16B8
AC   CVCL_E2ZE
RX   PubMed=26788906;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   16C11
AC   CVCL_B5CS
DR   Wikidata; Q110429700
RX   PubMed=14733492;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_6964; Molinate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   16C3
AC   CVCL_C4FI
DR   Wikidata; Q116047856
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   16C7
AC   CVCL_0H98
DR   Wikidata; Q54582307
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5107.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   16D17
AC   CVCL_WZ65
DR   Wikidata; Q93299900
RX   Patent=US9428554;
RX   PubMed=15780737;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200115.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q81871; Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) secreted protein ORF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 5
//
ID   16D3-C1
AC   CVCL_XH56
DR   Wikidata; Q93299903
RX   Patent=US9127065;
RX   PubMed=23479511;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4486.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 02-05-24; Version: 5
//
ID   16D4B
AC   CVCL_C7IE
DR   Wikidata; Q123030224
RX   PubMed=9683260;
RX   PubMed=24502396;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   16D6-3
AC   CVCL_CW59
DR   Wikidata; Q54582308
RX   PubMed=25897609;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02776; Human PF4/CXCL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   16E6
AC   CVCL_F1XJ
RX   PubMed=3905611;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7BQ98; Shigella dysenteriae stxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   16F7
AC   CVCL_C5C0
DR   Wikidata; Q116047857
RX   PubMed=23098299;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P36952; Human SERPINB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   16F9
AC   CVCL_B0X6
DR   Wikidata; Q108819409
RX   PubMed=23342681;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_B0WT ! 1C10 [Mouse/sheep heteromyeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   16G11
AC   CVCL_F0VA
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1+IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   16G9
AC   CVCL_WL75
DR   FCS-free; 45-26-257-1-4-3
DR   Wikidata; Q93299911
RX   PubMed=17604361;
RX   PubMed=19299727;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P02253; Bovine HIST1H1C (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   16H3
AC   CVCL_E970
DR   CLO; CLO_0001122
DR   ATCC; CRL-2385
DR   Wikidata; Q54582310
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   16H9
AC   CVCL_0H99
DR   Wikidata; Q54582311
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5108.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   16HBE14o-
AC   CVCL_0112
SY   16-HBE14o; 16HBE140; 16-HBEo; 16HBEo-; 16-HBE; 16HBE
DR   BTO; BTO_0002734
DR   MCCL; MCC:0000003
DR   ArrayExpress; E-MTAB-4194
DR   ChEMBL-Cells; CHEMBL4295404
DR   ChEMBL-Targets; CHEMBL4296395
DR   CLS; 305234
DR   Millipore; SCC150
DR   PRIDE; PXD006933
DR   PubChem_Cell_line; CVCL_0112
DR   TOKU-E; 4023
DR   Wikidata; Q54582314
RX   PubMed=1282304;
RX   PubMed=7507342;
RX   PubMed=9614386;
RX   PubMed=10498856;
RX   PubMed=12711171;
RX   PubMed=15463957;
RX   PubMed=18441018;
RX   PubMed=28970102;
WW   Info; Dartmouth; -; https://web.archive.org/web/20190126194809/http://www.dartmouth.edu/~cysfib/cell-lines.html
CC   Characteristics: Widely used to model barrier function of the airway epithelium and to study respiratory ion transport as well as the function of CFTR (Millipore=SCC150).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC150
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 28,30.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   16M3F10
AC   CVCL_8938
DR   CLO; CLO_0001123
DR   ATCC; HB-8363
DR   Wikidata; Q54582315
RX   Patent=US4689299;
RX   PubMed=6607295;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8363.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00588; Corynephage beta diphtheria toxin.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   16Q
AC   CVCL_T481
SY   LSQC-16Q
DR   Wikidata; Q54582317
RX   PubMed=67703;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   17-1
AC   CVCL_J862
DR   Wikidata; Q54582318
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   17-14-C1
AC   CVCL_D3C2
DR   Wikidata; Q127378648
RX   PubMed=25772471;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous; Note=By ZFN (PubMed=25772471).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=25772471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN85 ! CF iPSC clone 17
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   17-3-3S
AC   CVCL_G572
DR   CLO; CLO_0001130
DR   ATCC; HB-6
DR   Wikidata; Q54582319
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   17-4-3
AC   CVCL_B0VU
DR   Wikidata; Q108819410
RX   Patent=US9676843;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2925.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   17-5-3-10
AC   CVCL_D5K3
SY   310
DR   Wikidata; Q127378649
RX   PubMed=6787586;
CC   Characteristics: Produced from the fusion of the myeloma cell line with mouse fetal liver cell, thus exhibiting several phenotypic characteristics of immature B lymphocytes. This hybridoma produces, but does not secrete IgM chain. No light chain is produced (PubMed=6787586).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   17-71
AC   CVCL_0B18
SY   1771
DR   GEO; GSM1974773
DR   Wikidata; Q54582320
RX   PubMed=3594482;
RX   PubMed=22236332;
RX   PubMed=23365669;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 24 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:39270; CIC; Simple; p.Pro1551fs (c.4650_4653delCCCT); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231
ST   Dog FHC2054: 147,151
ST   Dog FHC2079: 271
ST   Dog PEZ1: 119,127
ST   Dog PEZ3: 119,139 (PubMed=31175136)
ST   Dog PEZ3: 139 (PubMed=27197945)
ST   Dog PEZ5: 103
ST   Dog PEZ6: 183,191
ST   Dog PEZ8: 236,249
ST   Dog PEZ12: 274,277
ST   Dog PEZ20: 180,192
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   17-9-C1
AC   CVCL_D3C3
DR   Wikidata; Q127378650
RX   PubMed=25772471;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous; Note=By ZFN (PubMed=25772471).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=25772471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN85 ! CF iPSC clone 17
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   17-94
AC   CVCL_D704
SY   17.94; 17,94
DR   cancercelllines; CVCL_D704
DR   CancerTools; 153333
DR   Cosmic; 1716565
DR   DSMZ; ACC-741
DR   DSMZCellDive; ACC-741
DR   ECACC; 17100502
DR   Wikidata; Q54582323
DR   Ximbio; 153333
RX   PubMed=22749038;
CC   Doubling time: ~1 week (DSMZ=ACC-741).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=22749038).
CC   Discontinued: ECACC; 17100502; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-741; ECACC=17100502
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 14,17
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 7,11 (ECACC=17100502)
ST   Penta E: 11 (DSMZ=ACC-741)
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   17-Cl1
AC   CVCL_VT75
SY   17-CL1; 17cl1; 17CL1; 17 Cl 1; 17 clone 1
DR   BEI_Resources; NR-53719
DR   Wikidata; Q93300182
RX   PubMed=4564284;
RX   PubMed=12441076;
RX   PubMed=21538303;
CC   Virology: Used for cultivation of murine coronaviruses, including murine hepatitis virus (PubMed=21538303).
CC   Virology: Infection by mouse hepatitis virus (MHV) results in apoptotic cell death (PubMed=12441076).
CC   Misspelling: 17C11; Note=Occasionally.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   17-G4
AC   CVCL_0F00
DR   ATCC; CRL-2574
DR   Wikidata; Q54582325
RX   PubMed=9067641;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P18428; Human LBP.
CC   Discontinued: ATCC; CRL-2574; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 6
//
ID   17.9.7
AC   CVCL_E3YY
SY   17.9
RX   PubMed=2453831;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04620; Plasmodium berghei (strain Anka) Pbs21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   17/14
AC   CVCL_J097
DR   CLO; CLO_0001124
DR   ATCC; HB-8153
DR   Wikidata; Q54582326
RX   Patent=US4521510;
RX   Patent=US4524025;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8153.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28177; Theophylline.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   170 BLCL
AC   CVCL_E363
DR   ECACC; 94031643
DR   Wikidata; Q54582328
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   170-MG-BA
AC   CVCL_LM81
SY   170MGBA
DR   DepMap; ACH-002680
DR   DSMZ; ACC-804
DR   DSMZCellDive; ACC-804
DR   Wikidata; Q54582330
RX   PubMed=30509096;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 24 hours (PubMed=30509096); ~40-60 hours (DSMZ=ACC-804).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-002680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Thr (c.832C>A); ClinVar=VCV000376643; Zygosity=Homozygous (DepMap=ACH-002680).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): DSMZ=ACC-804
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 31,31.2
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   Penta D: 11,12
ST   Penta E: 17
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   1704
AC   CVCL_RW70
DR   BTO; BTO_0002963
DR   Wikidata; Q54582333
RX   PubMed=16585582;
CC   Miscellaneous: Only mentioned as a melanoma cell line in PubMed=16585582.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   17066
AC   CVCL_WY94
DR   Wikidata; Q93299997
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu137Aspfs*9 (c.409_416del7); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D12S391: 18,23
ST   D13S317: 12
ST   D16S539: 11,15
ST   D18S51: 14
ST   D19S433: 16.2
ST   D1S1656: 17
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D6S1043: 12,19
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY92 ! 15876
OI   CVCL_WY93 ! 16106
OI   CVCL_WY95 ! 17201
OI   CVCL_WY96 ! 17268
OI   CVCL_WY97 ! EB0405
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   170BR
AC   CVCL_ZT58
SY   170 BRighton
DR   Wikidata; Q98125299
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   170MA
AC   CVCL_ZU21
SY   170 MAnchester
DR   Wikidata; Q98125300
RX   PubMed=9649131;
CC   Senescence: Senesces at 17 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   171-10E5
AC   CVCL_J544
DR   Wikidata; Q54582334
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9098.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00535; Avian erythroblastosis virus v-erbB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   171-11B9
AC   CVCL_E971
DR   CLO; CLO_0001125
DR   ATCC; CRL-2661
DR   Wikidata; Q54582335
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9117.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00535; Avian erythroblastosis virus v-erbB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   171-19B10
AC   CVCL_J546
DR   Wikidata; Q54582337
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9097.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00535; Avian erythroblastosis virus v-erbB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   171-337-2
AC   CVCL_D3SL
SY   171-337
DR   DSHB; 171-337
DR   Wikidata; Q127378651
RX   PubMed=8130037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P34120; Dictyostelium discoideum psmA7.
CC   Caution: Wrongly indicated in some web sites to recognize psmA5, but this hybridoma was raised against D.discoideum component 5 (Dd5) which is psmA7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   171-4
AC   CVCL_G573
DR   CLO; CLO_0001126
DR   ATCC; HB-296
DR   Wikidata; Q54582338
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   17142
AC   CVCL_WZ00
DR   cancercelllines; CVCL_WZ00
DR   Wikidata; Q93300011
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Phe (c.583A>T); ClinVar=VCV000376617; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20,22
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 12,13
ST   D1S1656: 12,14
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D6S1043: 11
ST   D7S820: 9,13
ST   D8S1179: 10,14
ST   FGA: 19
ST   Penta D: 10
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ01 ! 17249
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   171BR
AC   CVCL_8778
SY   171-Br; 171 BRighton
DR   CLO; CLO_0001127
DR   CLDB; cl21
DR   ECACC; 90011811
DR   Wikidata; Q54582339
RX   PubMed=1672363;
RX   PubMed=18079351;
CC   Discontinued: ECACC; 90011811; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   172-12A4
AC   CVCL_E972
DR   CLO; CLO_0001128
DR   ATCC; CRL-2660
DR   Wikidata; Q54582341
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9005.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00535; Avian erythroblastosis virus v-erbB (Note=Also react with human EGFR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   172-12G7
AC   CVCL_J578
DR   Wikidata; Q54582343
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9004.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00535; Avian erythroblastosis virus v-erbB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   172-3
AC   CVCL_C5N7
DR   Wikidata; Q116047858
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   17201
AC   CVCL_WY95
DR   Wikidata; Q93300030
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu137Aspfs*9 (c.409_416del7); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D12S391: 18,23
ST   D13S317: 12
ST   D16S539: 11,15
ST   D18S51: 14
ST   D19S433: 16.2
ST   D1S1656: 17
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D6S1043: 12,18
ST   D7S820: 12,13
ST   D8S1179: 14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY92 ! 15876
OI   CVCL_WY93 ! 16106
OI   CVCL_WY94 ! 17066
OI   CVCL_WY96 ! 17268
OI   CVCL_WY97 ! EB0405
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   17249
AC   CVCL_WZ01
DR   cancercelllines; CVCL_WZ01
DR   Wikidata; Q93300034
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Phe (c.583A>T); ClinVar=VCV000376617; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20,22
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 12,13
ST   D1S1656: 12,14
ST   D21S11: 28,29
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D6S1043: 11
ST   D7S820: 9,13
ST   D8S1179: 10,14
ST   FGA: 19
ST   Penta D: 10,13
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ00 ! 17142
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   17268
AC   CVCL_WY96
DR   Wikidata; Q93300036
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu137Aspfs*9 (c.409_416del7); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D12S391: 18,23
ST   D13S317: 12
ST   D16S539: 11,15
ST   D18S51: 14
ST   D19S433: 16.2
ST   D1S1656: 17
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D6S1043: 12,19
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY92 ! 15876
OI   CVCL_WY93 ! 16106
OI   CVCL_WY94 ! 17066
OI   CVCL_WY95 ! 17201
OI   CVCL_WY97 ! EB0405
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   172MA
AC   CVCL_ZU22
SY   172 MAnchester
DR   Wikidata; Q98125302
RX   PubMed=9649131;
CC   Senescence: Senesces at 26 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000142536; Zygosity=Hemizygous (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   173-185-1
AC   CVCL_A9G8
DR   ABCD; ABCD_AN704
DR   Wikidata; Q102113426
RX   PubMed=1310316;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Dictyostelium discoideum common antigen 1 (CA1), a sulfated carbohydrate epitope.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   173-1C11
AC   CVCL_E973
DR   CLO; CLO_0001129
DR   ATCC; CRL-2659
DR   Wikidata; Q54582344
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8894.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00535; Avian erythroblastosis virus v-erbB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   173-8D2
AC   CVCL_J579
DR   Wikidata; Q54582347
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8896.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00535; Avian erythroblastosis virus v-erbB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   17330
AC   CVCL_WZ02
DR   Wikidata; Q93300055
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly226Serfs*21 (c.673-1_698del27ins48); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,22
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 16,18
ST   D19S433: 15
ST   D1S1656: 16,17
ST   D21S11: 29
ST   D2S1338: 21,24
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D6S1043: 11,18
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   17399
AC   CVCL_WZ03
DR   Wikidata; Q93300058
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Glufs*18 (c.834_853del20); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 18,21
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13,16.2,17.2
ST   D1S1656: 11
ST   D21S11: 30,30.2
ST   D2S1338: 17,21
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D6S1043: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 7,18
ST   TH01: 6,9.3
ST   TPOX: 10
ST   vWA: 16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   173E
AC   CVCL_J038
DR   ATCC; HB-11912
DR   Wikidata; Q54582349
RX   Patent=US5773293;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11912.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q14773; Human ICAM4/CD242.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   173TOR
AC   CVCL_DB99
SY   GM21645
DR   CLO; CLO_0013966
DR   Coriell; GM21645
DR   Wikidata; Q54852048
RX   PubMed=17273966;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:3433; ERCC1; Simple; p.Phe231Leu (c.693C>G); ClinVar=VCV000016778; Zygosity=Heterozygous (PubMed=17273966).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   174-24-11
AC   CVCL_B0P7
SY   mAb174-24-11
DR   Wikidata; Q108819411
RX   Patent=WO1999055735A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12700.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99062; Human CSF3R.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1742
AC   CVCL_ZD42
DR   Wikidata; Q98125303
RX   PubMed=8105609;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   17457
AC   CVCL_WZ06
DR   cancercelllines; CVCL_WZ06
DR   Wikidata; Q93300067
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D19S433: 14
ST   D1S1656: 10,17.3
ST   D21S11: 33.2
ST   D2S1338: 18,24
ST   D3S1358: 17,20
ST   D5S818: 12,13
ST   D6S1043: 18,19
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21.2
ST   Penta D: 9,10
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ05 ! 8714
OI   CVCL_WZ07 ! EK_R1
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   17480
AC   CVCL_WZ08
DR   cancercelllines; CVCL_WZ08
DR   Wikidata; Q93300070
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys3326Ter (c.9976A>T) (10204A>T); ClinVar=VCV000038266; Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 17,23
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D1S1656: 13,15.3
ST   D21S11: 28
ST   D2S1338: 16,17
ST   D3S1358: 14
ST   D5S818: 11
ST   D6S1043: 11,17
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ09 ! 8715
OI   CVCL_WZ10 ! 8716
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   174BR
AC   CVCL_2275
SY   174 BRighton
DR   CLO; CLO_0001131
DR   CLDB; cl22
DR   ECACC; 90011895
DR   Wikidata; Q54582350
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   174MA
AC   CVCL_ZU24
SY   174 MAnchester
DR   Wikidata; Q98125304
RX   PubMed=9649131;
CC   Senescence: Senesces at 6 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   174TOR
AC   CVCL_ZP23
DR   Wikidata; Q98125305
RX   PubMed=17273966;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:3433; ERCC1; Simple; p.Gln158Ter (c.472C>T); ClinVar=VCV000016777; Zygosity=Heterozygous (PubMed=17273966).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   175-62
AC   CVCL_W643
SY   MAb 175-62
DR   Wikidata; Q54582352
RX   Patent=US8911735;
RX   PubMed=12869020;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1553.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06681; Human C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   175.2
AC   CVCL_C5WZ
DR   Wikidata; Q116047859
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   175BR
AC   CVCL_2276
SY   175 BRighton
DR   CLO; CLO_0001132
DR   CLDB; cl23
DR   ECACC; 90011863
DR   Wikidata; Q54582354
RX   PubMed=23093295;
CC   Donor information: Established from the non-affected skin biopsy from an individual with multiple tumours of independent histological origin (PubMed=23093295).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   176-15
AC   CVCL_D2QD
DR   Wikidata; Q127378652
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   176-2-5
AC   CVCL_6F36
DR   DSHB; 176-2-5
DR   Wikidata; Q54582356
RX   PubMed=1661669;
RX   PubMed=8380174;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27133; Dictyostelium discoideum corA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 7
//
ID   176-3-6
AC   CVCL_YA08
DR   ABCD; ABCD_AK425
DR   DSHB; 176-3-6
DR   Wikidata; Q93300106
RX   PubMed=8380174;
RX   PubMed=9704504;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P27133; Dictyostelium discoideum corA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   1764EGFP
AC   CVCL_E6EJ
RX   PubMed=15172493;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1764EL
AC   CVCL_LJ51
DR   Wikidata; Q54582360
RX   PubMed=15172493;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E6EJ ! 1764EGFP
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   1765-92
AC   CVCL_S817
SY   MLS 1765-92; MLS-1765; MLS1765
DR   Cosmic; 1672268
DR   Cosmic; 2307720
DR   Wikidata; Q54582361
RX   PubMed=16983332;
RX   PubMed=20515481;
RX   PubMed=24726063;
RX   PubMed=25393000;
RX   PubMed=27270875;
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=27270875).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=27270875).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   17697M
AC   CVCL_WM37
DR   cancercelllines; CVCL_WM37
DR   Cosmic; 852212
DR   IARC_TP53; 20612
DR   Wikidata; Q93300125
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   176MA
AC   CVCL_ZU25
SY   176 MAnchester
DR   Wikidata; Q98125306
RX   PubMed=9649131;
CC   Senescence: Senesces at 38 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   177-1
AC   CVCL_D2QE
DR   Wikidata; Q127378653
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   1777N Pr
AC   CVCL_A1EA
SY   1777N-Pr; 1777N-Primary
DR   Wikidata; Q102113427
RX   CelloPub=CLPUB00578;
RX   PubMed=6100171;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2277 ! 1777N Rpmet
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   1777N Rpmet
AC   CVCL_2277
SY   1777N RpMet; 1777N RPMET; 1777N-RP met; 1777N-Rp; 1777N; 1777N Retroperitoneal Metastasis
DR   Cosmic; 2077189
DR   Cosmic; 2439938
DR   Cosmic; 2806396
DR   DepMap; ACH-001438
DR   ECACC; 06011801
DR   Wikidata; Q54582362
RX   CelloPub=CLPUB00578;
RX   PubMed=6100171;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Derived from site: In situ; Retroperitoneal lymph node; UBERON=UBERON_0035371.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1EA ! 1777N Pr
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   177E6
AC   CVCL_A0JD
DR   Wikidata; Q108819412
RX   PubMed=11267782;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Salmonella enteritidis subserogroup OD1 lipopolysaccharide (LPS) O:9 antigen (Note=Also reacts with subserogroup OD3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1780D2.6
AC   CVCL_C4U7
DR   Wikidata; Q116047860
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1783
AC   CVCL_U758
DR   Cosmic; 802250
DR   Wikidata; Q54582364
RX   PubMed=9671307;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   178H11
AC   CVCL_A0JE
DR   Wikidata; Q108819413
RX   PubMed=11267782;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Salmonella enteritidis subserogroup OD1 lipopolysaccharide (LPS) O:9 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   179-2
AC   CVCL_C5N8
DR   Wikidata; Q116047861
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   17933/00
AC   CVCL_JD54
SY   Extract 404
DR   IPD-IMGT/HLA; 12640
DR   Wikidata; Q54582365
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/329cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,24:33; B*27:06,51:06; C*03,12; DQB1*05:01,05:02; DRB1*15:02,12:02 (IPD-IMGT/HLA=12640).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   1795/4A
AC   CVCL_AX27
SY   1795-4A
DR   Cosmic; 2361370
DR   Wikidata; Q54582366
RX   PubMed=8547074;
DI   NCIt; C70649; T-cell chronic lymphocytic leukemia
DI   ORDO; Orphanet_86871; T-cell prolymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 4
//
ID   17978
AC   CVCL_WZ13
DR   cancercelllines; CVCL_WZ13
DR   Wikidata; Q93300152
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 15,23
ST   D13S317: 10
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D1S1656: 12,14
ST   D21S11: 29,33.2
ST   D2S1338: 19,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 17
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 25
ST   Penta D: 9,10
ST   Penta E: 16,17
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   17a
AC   CVCL_8991
SY   iPS-17a; hiPS-17a; hiPS 17a; iPS17a
DR   EFO; EFO_0007103
DR   ENCODE; ENCBS868JUD
DR   GEO; GSM621699
DR   GEO; GSM637782
DR   SKIP; SKIP004344
DR   Wikidata; Q54582436
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=21368825;
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8992 ! 17b
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   17A10-2-2
AC   CVCL_YK88
DR   Wikidata; Q93300163
RX   Patent=US8546093;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00204.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07944; Staphylococcus aureus beta-lactam-inducible penicillin-binding protein (PBP2a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   17aba
AC   CVCL_J090
DR   CLO; CLO_0001133
DR   ATCC; HB-248
DR   Wikidata; Q54582438
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   17b
AC   CVCL_8992
SY   iPS-17b; hiPS-17b; hiPS 17b; iPS17b
DR   EFO; EFO_0007104
DR   ENCODE; ENCBS041ZVO
DR   GEO; GSM621714
DR   GEO; GSM637783
DR   GEO; GSM670062
DR   GEO; GSM670067
DR   SKIP; SKIP004343
DR   Wikidata; Q54582439
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=21368825;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8991 ! 17a
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   17B6
AC   CVCL_C4FJ
DR   Wikidata; Q116047862
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   17c
AC   CVCL_C5HU
DR   Wikidata; Q116047863
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   17C1
AC   CVCL_C3XH
DR   ABCD; ABCD_AE865
DR   Wikidata; Q116047864
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   17C3
AC   CVCL_F1WX
RX   Patent=US12312403;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   17C8
AC   CVCL_F1WY
RX   Patent=US12312403;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   17CM98
AC   CVCL_0C82
DR   GEO; GSM1974774
DR   Wikidata; Q54582441
RX   PubMed=15965647;
RX   PubMed=22901430;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 22 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:42422; KIT; Simple; p.Val558_Glu560del (c.1673_1681delTTGTTGAGG); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231
ST   Dog FHC2054: 156
ST   Dog FHC2079: 271
ST   Dog PEZ1: 127
ST   Dog PEZ3: 121,131
ST   Dog PEZ5: 107
ST   Dog PEZ6: 176
ST   Dog PEZ8: 236,240
ST   Dog PEZ12: 270,274
ST   Dog PEZ20: 176
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   17D
AC   CVCL_G088
DR   CLO; CLO_0001134
DR   ATCC; HB-262
DR   ECACC; 91060551
DR   Wikidata; Q54582442
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05542; Sheep CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   17D4
AC   CVCL_VI30
DR   BEI_Resources; MRA-258
DR   Wikidata; Q54582443
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands basal lamina, ovaries and midgut tissue.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   17E4-D6
AC   CVCL_B5A6
SY   17E4
DR   Wikidata; Q110429703
RX   Patent=WO1997024141A1;
RX   PubMed=9988333;
CC   Group: Malaria research cell line.
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   17E9
AC   CVCL_C5MG
DR   Wikidata; Q116047865
RX   PubMed=17600495;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O08901; Mouse Bub1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   17F4.F4
AC   CVCL_IV61
SY   17F4
DR   Wikidata; Q54582445
RX   Patent=US8022175;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8332.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Newcastle disease virus HN protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   17F9
AC   CVCL_B6W0
DR   Wikidata; Q111732605
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   17G1
AC   CVCL_DN54
DR   Wikidata; Q54582448
RX   PubMed=18158780;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   17H23
AC   CVCL_B5Z1
DR   Wikidata; Q111732606
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2. Recognizes other salmonid alphavirus (SAV) E2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   17II-NFUD2
AC   CVCL_D4BA
DR   Wikidata; Q127378654
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Doubling time: 29 +- 4 hours (PubMed=37087860).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MZM-0410.
OX   NCBI_TaxID=105023; ! Nothobranchius furzeri (Turquoise killifish)
SX   Sex unspecified
AG   Diapause II embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   18-1
AC   CVCL_B6X3
DR   CCRID; 4201PAT-CCTCC00717
DR   Wikidata; Q111732607
RX   Patent=CN105132383A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201593.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   18-2-3
AC   CVCL_C3VY
DR   ABCD; ABCD_AE278
DR   Wikidata; Q116047866
RX   PubMed=2494173;
RX   PubMed=6348779;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   18-26-4
AC   CVCL_0E27
DR   ATCC; CRL-2486
DR   Wikidata; Q54582450
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 3H5-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   18-5
AC   CVCL_E2ZX
RX   PubMed=11556707;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Potato virus Y (strain Tunisian PVYo) cytoplasmic inclusion protein (CI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   18-8
AC   CVCL_GR72
SY   BM18-8
DR   Wikidata; Q54582451
RX   PubMed=200369;
RX   PubMed=222460;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   18-81
AC   CVCL_GR73
DR   Wikidata; Q54582452
RX   PubMed=222460;
RX   PubMed=6322175;
RX   PubMed=6787596;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR72 ! 18-8
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   18-9B10
AC   CVCL_J580
DR   Wikidata; Q54582454
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8800.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   18.1
AC   CVCL_C5X0
DR   ABCD; ABCD_AE621
DR   Wikidata; Q116047867
RX   PubMed=1602134;
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   18/1
AC   CVCL_A0PY
DR   Wikidata; Q108819414
RX   PubMed=2146321;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00746; Human CFD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   18/20PAC2
AC   CVCL_DB46
DR   ATCC; HB-7
DR   Wikidata; Q54582456
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Discontinued: ATCC; HB-7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   1802.2
AC   CVCL_C5X1
DR   Wikidata; Q116047868
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   18031 BLCL
AC   CVCL_F1BR
RX   PubMed=10600031;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   180BR
AC   CVCL_2278
AS   CVCL_7643
SY   180 BRighton; GM16088
DR   BTO; BTO_0004314
DR   CLO; CLO_0001135
DR   CLO; CLO_0018771
DR   CLDB; cl24
DR   Coriell; GM16088
DR   ECACC; 90011862
DR   Wikidata; Q54582457
RX   PubMed=2400879;
RX   PubMed=7882314;
RX   PubMed=8609460;
RX   PubMed=9426062;
RX   PubMed=10395545;
RX   PubMed=15574327;
RX   PubMed=19896956;
CC   Characteristics: Radiosensitive cell line defective in DSB repair.
CC   Doubling time: 57 hours (PubMed=8609460).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg278His (c.833G>A); ClinVar=VCV000007675; Zygosity=Unspecified (PubMed=10395545).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   180BRhTERT
AC   CVCL_WX36
SY   180BRhT
DR   Wikidata; Q93300273
RX   PubMed=19056826;
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg278His (c.833G>A); ClinVar=VCV000007675; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2278 ! 180BR
SX   Male
AG   15Y
CA   Telomerase immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   180BRneo
AC   CVCL_F226
SY   180BR neo; GM16089
DR   CLO; CLO_0018859
DR   Coriell; GM16089
DR   Wikidata; Q54582458
RX   PubMed=10395545;
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg278His (c.833G>A); ClinVar=VCV000007675; Zygosity=Unspecified (PubMed=10395545).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2278 ! 180BR
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   180D
AC   CVCL_5447
DR   ECACC; 93090809
DR   Wikidata; Q54582460
RX   PubMed=8795574;
CC   Doubling time: ~74 hours (Note=At 17th passage) (PubMed=8795574).
CC   Discontinued: ECACC; 93090809; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   180N
AC   CVCL_E4YM
DR   GEO; GSM7036155
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=37296104;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   180T
AC   CVCL_A2AH
DR   Wikidata; Q105505869
RX   PubMed=14978140;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor and lung cancer type from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   181-D
AC   CVCL_F0AZ
RX   PubMed=2072448;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 512-856 = gp41).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   182-D1106-055
AC   CVCL_A6KQ
SY   37G11
DR   Wikidata; Q107113137
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2737.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-056
AC   CVCL_A6KR
SY   37H8
DR   Wikidata; Q107113138
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2738.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-057
AC   CVCL_A6KS
SY   38G5
DR   Wikidata; Q107113139
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2739.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-058
AC   CVCL_A6KT
SY   38H3
DR   Wikidata; Q107113140
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2740.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-059
AC   CVCL_A6KU
SY   39F11
DR   Wikidata; Q107113141
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2741.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-061
AC   CVCL_A6LA
SY   42E12
DR   Wikidata; Q107113142
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2748.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-062
AC   CVCL_A6KV
SY   43A11
DR   Wikidata; Q107113143
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2742.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-067
AC   CVCL_A6KW
SY   61C2
DR   Wikidata; Q107113144
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2743.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-279
AC   CVCL_A6LB
SY   125E1
DR   Wikidata; Q107113145
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2808.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-294
AC   CVCL_A6LC
SY   163E12
DR   Wikidata; Q107113147
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2809.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D1106-362
AC   CVCL_A6LD
SY   175D10
DR   Wikidata; Q107113149
RX   Patent=US10314890;
RX   Patent=US10738108;
RX   PubMed=19047087;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2810.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized IMAB362 (claudiximab; zolbetuximab) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D758-035
AC   CVCL_A6KX
SY   26B5
DR   Wikidata; Q107113150
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2745.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D758-036
AC   CVCL_A6KY
SY   26D12
DR   Wikidata; Q107113151
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2746.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-D758-040
AC   CVCL_A6KZ
SY   28D10
DR   Wikidata; Q107113153
RX   Patent=US10314890;
RX   Patent=US10738108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2747.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   182-PF SK
AC   CVCL_3479
DR   CLO; CLO_0001136
DR   ATCC; CRL-1532
DR   BioSample; SAMN03473642
DR   Wikidata; Q54582464
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (ATCC=CRL-1532).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1532
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 12
ST   D5S818: 9,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   182.1
AC   CVCL_V059
DR   CLO; CLO_0001005
DR   CLDB; cl26
DR   IHW; 11w 8127
DR   Wikidata; Q54582462
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   183 BLCL
AC   CVCL_E364
DR   ECACC; 94031648
DR   Wikidata; Q54582465
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   183-1
AC   CVCL_J863
DR   Wikidata; Q54582467
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   183-H12-5C
AC   CVCL_A0AG
DR   BEI_Resources; ARP-1513
DR   Wikidata; Q108819415
RX   PubMed=1404602;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03347; HIV-1 isolate BH10 gag (Note=AA 133-363 = p24).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   1835_iPS1
AC   CVCL_RA96
DR   BioSample; SAMN03856501
DR   GEO; GSM1820080
DR   Wikidata; Q54582469
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D873 ! GM01835
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   1835_iPS2
AC   CVCL_RA97
DR   BioSample; SAMN03856502
DR   GEO; GSM1820081
DR   Wikidata; Q54582470
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D873 ! GM01835
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   184
AC   CVCL_K049
SY   HMEC-184; HMEC 184; HMEC184
DR   EFO; EFO_0001190
DR   GEO; GSM200748
DR   GEO; GSM200749
DR   GEO; GSM200754
DR   GEO; GSM200755
DR   GEO; GSM200756
DR   GEO; GSM200757
DR   Wikidata; Q54582473
RX   PubMed=8504475;
RX   PubMed=9398663;
RX   PubMed=9671407;
RX   PubMed=10739701;
RX   PubMed=16849555;
WW   Info; -; -; https://hmec.lbl.gov/mreview.htm
CC   Senescence: Senesces at ~80 PDL (PubMed=9398663).
CC   Doubling time: 2.5 days (PubMed=9671407).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   184-hTERT
AC   CVCL_K053
SY   184-hTert; 184hTERT
DR   EFO; EFO_0009375
DR   Lonza; 1661
DR   Wikidata; Q54582475
RX   PubMed=17395154;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K049 ! 184
SX   Female
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   1847AD
AC   CVCL_C9BN
DR   Wikidata; Q123030225
RX   PubMed=6372095;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9724 ! A1847
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   18483
AC   CVCL_WZ14
DR   cancercelllines; CVCL_WZ14
DR   Wikidata; Q93300349
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D12S391: 23
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 12,14
ST   D1S1656: 12
ST   D21S11: 27,33.2
ST   D2S1338: 23
ST   D3S1358: 11,17
ST   D5S818: 11,12
ST   D6S1043: 12,16
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 10,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   184A1
AC   CVCL_3040
AS   CVCL_8222
SY   184 A1; H184A1
DR   CLO; CLO_0001137
DR   EFO; EFO_0022348
DR   ATCC; CRL-8798
DR   BioSample; SAMN03471210
DR   cancercelllines; CVCL_3040
DR   DepMap; ACH-002319
DR   GEO; GSM350522
DR   GEO; GSM843436
DR   GEO; GSM845393
DR   GEO; GSM1172844
DR   GEO; GSM1172932
DR   IZSLER; BS CL 178
DR   LINCS_HMS; 51088
DR   LINCS_LDP; LCL-2080
DR   PharmacoDB; 184A1_4_2019
DR   Progenetix; CVCL_3040
DR   Wikidata; Q54582476
RX   DOI=10.1007/978-1-4612-0411-4_26;
RX   Patent=US4808532;
RX   PubMed=2702624;
RX   PubMed=3857588;
RX   PubMed=8504475;
RX   PubMed=9398663;
RX   PubMed=9671407;
RX   PubMed=12661003;
RX   PubMed=19582160;
RX   PubMed=24176112;
RX   PubMed=25960936;
RX   PubMed=28196595;
RX   PubMed=28889351;
WW   Info; -; -; https://hmec.lbl.gov/mreview.htm
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8798.
CC   Doubling time: 58.07 hours (JWGray panel).
CC   HLA typing: A*02:01,02:01; B*18:01,18:01; C*07:01,07:01 (PubMed=25960936).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-8798; IZSLER=BS CL 178; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 19,22
ST   Penta D: 12,13
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K049 ! 184
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   184A1N4
AC   CVCL_9665
SY   A1N4
DR   BTO; BTO_0002179
DR   Wikidata; Q54582477
RX   DOI=10.1007/978-1-4612-0411-4_26;
RX   PubMed=3293776;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3040 ! 184A1
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   184A1N4-H
AC   CVCL_IQ01
SY   A1N4-H; 184A1N4-ras
DR   Wikidata; Q54582479
RX   PubMed=3293776;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9665 ! 184A1N4
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   184A1N4-T
AC   CVCL_IQ02
SY   A1N4-T
DR   Wikidata; Q54582480
RX   PubMed=3293776;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9665 ! 184A1N4
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   184A1N4-TH
AC   CVCL_IQ03
SY   A1N4-TH; 184A1N4-T-ras
DR   Wikidata; Q54582482
RX   DOI=10.1007/978-1-4612-0411-4_26;
RX   PubMed=1638679;
RX   PubMed=3293776;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9665 ! 184A1N4
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   184B5
AC   CVCL_4688
AS   CVCL_B387; CVCL_Y092
SY   184-B5; B5/589; B5-589; H184B5
DR   BTO; BTO_0002180
DR   CLO; CLO_0001138
DR   EFO; EFO_0022376
DR   ATCC; CRL-8799
DR   BioSample; SAMN03471211
DR   ChEMBL-Cells; CHEMBL4295444
DR   ChEMBL-Targets; CHEMBL4296396
DR   DepMap; ACH-001827
DR   GEO; GSM1172845
DR   GEO; GSM1172933
DR   IZSLER; BS CL 170
DR   LINCS_HMS; 50576
DR   LINCS_LDP; LCL-2081
DR   PharmacoDB; 184B5_5_2019
DR   PubChem_Cell_line; CVCL_4688
DR   Wikidata; Q54582483
RX   DOI=10.1007/978-1-4612-0411-4_10;
RX   DOI=10.1007/978-1-4612-0411-4_26;
RX   Patent=US4808532;
RX   PubMed=2702624;
RX   PubMed=3857588;
RX   PubMed=8504475;
RX   PubMed=9303071;
RX   PubMed=9398663;
RX   PubMed=9671407;
RX   PubMed=24176112;
RX   PubMed=25960936;
RX   PubMed=28196595;
RX   PubMed=28889351;
WW   Info; -; -; https://hmec.lbl.gov/mreview.htm
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8799.
CC   Doubling time: 56.15 hours (JWGray panel).
CC   HLA typing: A*02:01,02:01; B*18:01,50:01; C*06:02,07:01; DQB1*06:04,06:04 (PubMed=25960936).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-8799; DepMap=ACH-001827; IZSLER=BS CL 170; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 19,22
ST   Penta D: 12,13
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K049 ! 184
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   184E6E7
AC   CVCL_B0AX
DR   Wikidata; Q108819416
RX   PubMed=10739701;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K049 ! 184
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   18507
AC   CVCL_WZ15
DR   Wikidata; Q93300397
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser185Metfs*68 (c.535_551dup17); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D12S391: 18.3,23
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 12,14
ST   D1S1656: 16,16.3
ST   D21S11: 29
ST   D2S1338: 16,18
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D6S1043: 12,17
ST   D7S820: 8
ST   D8S1179: 10,13
ST   FGA: 21,22
ST   Penta D: 10,12
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   1858-mel a
AC   CVCL_DI11
SY   1858-MEL a; 1858-MEL a (Fragment)
DR   cancercelllines; CVCL_DI11
DR   Cosmic; 1042624
DR   GEO; GSM218060
DR   Progenetix; CVCL_DI11
DR   Wikidata; Q54582484
RX   PubMed=16470173;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Right flank, hypodermis; UBERON=UBERON_0000180+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DN ! 888-EBV
OI   CVCL_4632 ! 888-mel
OI   CVCL_7943 ! 1290-mel
OI   CVCL_DI12 ! 1858-mel b
OI   CVCL_DI13 ! 1858-mel c
OI   CVCL_DI14 ! 1936-mel
OI   CVCL_DI15 ! 1962-mel
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   1858-mel b
AC   CVCL_DI12
SY   1858-MEL b; 1858-MEL b (Medimachine)
DR   cancercelllines; CVCL_DI12
DR   GEO; GSM218050
DR   Progenetix; CVCL_DI12
DR   Wikidata; Q54582488
RX   PubMed=16470173;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Right flank, hypodermis; UBERON=UBERON_0000180+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DN ! 888-EBV
OI   CVCL_4632 ! 888-mel
OI   CVCL_7943 ! 1290-mel
OI   CVCL_DI11 ! 1858-mel a
OI   CVCL_DI13 ! 1858-mel c
OI   CVCL_DI14 ! 1936-mel
OI   CVCL_DI15 ! 1962-mel
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   1858-mel c
AC   CVCL_DI13
SY   1858-MEL c; 1858-MEL c (Wash)
DR   cancercelllines; CVCL_DI13
DR   GEO; GSM218059
DR   Progenetix; CVCL_DI13
DR   Wikidata; Q54582490
RX   PubMed=16470173;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Right flank, hypodermis; UBERON=UBERON_0000180+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DN ! 888-EBV
OI   CVCL_4632 ! 888-mel
OI   CVCL_7943 ! 1290-mel
OI   CVCL_DI11 ! 1858-mel a
OI   CVCL_DI12 ! 1858-mel b
OI   CVCL_DI14 ! 1936-mel
OI   CVCL_DI15 ! 1962-mel
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   18588M
AC   CVCL_WM47
DR   cancercelllines; CVCL_WM47
DR   Cosmic; 852221
DR   Wikidata; Q93300423
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   186-NWT
AC   CVCL_KB78
DR   Wikidata; Q54582493
RX   PubMed=6426784;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   18605
AC   CVCL_WZ16
DR   cancercelllines; CVCL_WZ16
DR   Wikidata; Q93300434
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu188Trpfs*3 (c.560_672del); Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 23
ST   D13S317: 11
ST   D16S539: 13,14
ST   D18S51: 15,16
ST   D19S433: 14,16
ST   D1S1656: 12,18.3
ST   D21S11: 29,30
ST   D2S1338: 20,25
ST   D3S1358: 14,18
ST   D5S818: 13
ST   D6S1043: 15
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   18656M
AC   CVCL_WM30
DR   cancercelllines; CVCL_WM30
DR   Cosmic; 852205
DR   Wikidata; Q93300436
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   187-1
AC   CVCL_J864
DR   Wikidata; Q54582496
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   187.1
AC   CVCL_9144
SY   187
DR   CLO; CLO_0001139
DR   ATCC; HB-58
DR   Wikidata; Q54582497
RX   PubMed=6438237;
RX   PubMed=6821395;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse Ig kappa light chains.
CC   Caution: Isotype is wrongly indicated as IgG2c in PubMed 6821395.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 7
//
ID   187.10
AC   CVCL_D5LI
DR   Wikidata; Q127378655
RX   PubMed=6438237;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9144 ! 187.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   1872T
AC   CVCL_ZT92
SY   1872
DR   Wikidata; Q98125308
RX   PubMed=2259385;
RX   PubMed=7779715;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   18732M
AC   CVCL_WM39
DR   cancercelllines; CVCL_WM39
DR   Cosmic; 852214
DR   Wikidata; Q93300451
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   1873T
AC   CVCL_ZT93
DR   Wikidata; Q98125311
RX   PubMed=7779715;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Heterozygous (PubMed=7779715).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   18a
AC   CVCL_8993
SY   iPS-18a; hiPS-18a; hiPS 18a
DR   EFO; EFO_0007105
DR   ENCODE; ENCBS424LHN
DR   ENCODE; ENCBS463LFL
DR   GEO; GSM637784
DR   GEO; GSM772935
DR   GEO; GSM773023
DR   GEO; GSM773024
DR   GEO; GSM773027
DR   GEO; GSM773028
DR   GEO; GSM773029
DR   GEO; GSM773030
DR   GEO; GSM773033
DR   SKIP; SKIP004428
DR   Wikidata; Q54582499
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8994 ! 18b
OI   CVCL_8995 ! 18c
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   18A4
AC   CVCL_XF03
DR   CCRID; 4201PAT-CCTCC00270
DR   Wikidata; Q93300463
RX   Patent=CN101519649B;
RX   Patent=US9574012;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200902.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O95994; Human AGR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   18b
AC   CVCL_8994
SY   iPS-18b; IPS cell line 18b; hiPS 18b; HVRDi006-A
DR   EFO; EFO_0007106
DR   BioSamples; SAMEA12775557
DR   ENCODE; ENCBS799NIQ
DR   ENCODE; ENCBS869TCU
DR   GEO; GSM621411
DR   GEO; GSM621695
DR   GEO; GSM637785
DR   GEO; GSM981284
DR   hPSCreg; HVRDi006-A
DR   SKIP; SKIP004430
DR   Wikidata; Q54582501
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8993 ! 18a
OI   CVCL_8995 ! 18c
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   18B10.C7
AC   CVCL_XX97
SY   18B10.C7(3)
DR   Wikidata; Q93300477
RX   Patent=US7820797;
RX   PubMed=20305658;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9341.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_28009; N-acetyl-beta-D-glucosamine (Note=In beta-O-glycosidic linkage to serine and threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   18B6 [Mouse hybridoma against G.vaginalis vaginolysin]
AC   CVCL_C5AM
DR   Wikidata; Q116047869
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   18B6 [Mouse hybridoma against mAB RHD5]
AC   CVCL_XI33
DR   Wikidata; Q93300482
RX   Patent=US8110190;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3559.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody RHD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   18B8
AC   CVCL_WS75
DR   Wikidata; Q93300486
RX   PubMed=3858858;
RX   PubMed=3949793;
RX   PubMed=6166002;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78438; Alpha-N-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine(3-) (Ganglioside GT3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 4
//
ID   18c
AC   CVCL_8995
SY   iPS-18c; hiPS 18c
DR   EFO; EFO_0007107
DR   ENCODE; ENCBS101JWL
DR   ENCODE; ENCBS182TVB
DR   ENCODE; ENCBS184AWY
DR   ENCODE; ENCBS223PPW
DR   ENCODE; ENCBS391PLF
DR   ENCODE; ENCBS529YKY
DR   ENCODE; ENCBS841ZKV
DR   ENCODE; ENCBS851LMU
DR   ENCODE; ENCBS954GPE
DR   GEO; GSM537671
DR   GEO; GSM537674
DR   GEO; GSM537675
DR   GEO; GSM537676
DR   GEO; GSM537677
DR   GEO; GSM537678
DR   GEO; GSM621407
DR   GEO; GSM621564
DR   GEO; GSM621725
DR   GEO; GSM637786
DR   GEO; GSM981285
DR   SKIP; SKIP004429
DR   Wikidata; Q54582504
RX   PubMed=21293464;
RX   PubMed=21295703;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8993 ! 18a
OI   CVCL_8994 ! 18b
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   18C2.8.3
AC   CVCL_J098
DR   CLO; CLO_0001140
DR   ATCC; HB-9571
DR   Wikidata; Q54582506
RX   Patent=US5194593;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9571.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   18D5
AC   CVCL_VI31
DR   BEI_Resources; MRA-259
DR   Wikidata; Q54582592
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands, ovaries and midgut tissue (Note=Also reacts with Culex pipiens salivary glands).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   18E12
AC   CVCL_VI32
DR   BEI_Resources; MRA-260
DR   Wikidata; Q54582593
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes and ovaries (Note=Also reacts with Culex pipiens salivary glands).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   18E9.G3.D7
AC   CVCL_IV62
SY   18E9
DR   Wikidata; Q54582595
RX   Patent=US8022175;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8334.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Newcastle disease virus HN protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   18F4
AC   CVCL_F0VB
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   18FR22
AC   CVCL_WY62
SY   18 days Foie de Rat at 22th passage
DR   Wikidata; Q93300526
RX   PubMed=282624;
RX   PubMed=4467909;
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   18G8 [Mouse hybridoma against D.farinae Der f 2]
AC   CVCL_E8UK
RX   PubMed=1958138;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00855; Dermatophagoides farinae mite group 2 allergen Der f 2 (DERF2) (Note=Also reacts with D.pteronyssinus Der p 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   18G8 [Mouse hybridoma against phOX]
AC   CVCL_C4F1
DR   ABCD; ABCD_AE283
DR   Wikidata; Q116047870
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   18G9
AC   CVCL_F1XZ
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   18H3A
AC   CVCL_C7IF
DR   Wikidata; Q123030226
RX   PubMed=9683260;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   18Nco
AC   CVCL_IP99
SY   HFK-18Nco; HF-18Nco; HF-18NcoI
DR   Wikidata; Q54582599
RX   DOI=10.1007/978-1-4612-0411-4_17;
RX   PubMed=2556677;
RX   PubMed=7684560;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 8
//
ID   18T-iPSC
AC   CVCL_VK55
DR   Wikidata; Q93300538
RX   PubMed=29862150;
CC   From: Key Laboratory for Rare Disease Research of Shandong Province; Jinan; China.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 6
//
ID   19-7
AC   CVCL_J271
DR   JCRB; JCRB0014
DR   Wikidata; Q54582600
RX   PubMed=6675779;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   19.1.2
AC   CVCL_D3V0
DR   Wikidata; Q127378656
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   19.2.1
AC   CVCL_C5RC
DR   Wikidata; Q116047871
RX   PubMed=20068083;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized enavatuzumab (PDL192) therapeutic antibody used in the treatment of solid tumors.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   19.22.1
AC   CVCL_D3V1
DR   Wikidata; Q127378657
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   19/178C1
AC   CVCL_VS73
DR   ATCC; HB-8
DR   Wikidata; Q93300547
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
CC   Discontinued: ATCC; HB-8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   1904.2
AC   CVCL_C5X2
DR   Wikidata; Q116047872
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   190F2A6
AC   CVCL_D3RR
DR   Wikidata; Q127378658
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   191
AC   CVCL_J921
SY   Anti PDGF hybridoma #191
DR   ATCC; HB-9368
DR   Wikidata; Q54582602
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9368.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   191D8G12
AC   CVCL_D3RS
DR   Wikidata; Q127378659
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   192B
AC   CVCL_7930
SY   192 B
DR   Wikidata; Q54582603
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RX   PubMed=66978;
RX   PubMed=748774;
RX   PubMed=944089;
RX   PubMed=6244232;
CC   Doubling time: 20 hours (PubMed=66978; PubMed=748774).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   192B6D6
AC   CVCL_D3RT
DR   Wikidata; Q127378660
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   192B6D8
AC   CVCL_D3RU
DR   Wikidata; Q127378661
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   192C
AC   CVCL_B0KZ
DR   Wikidata; Q108819417
RX   CelloPub=CLPUB00648;
RX   Patent=US5770447;
RX   PubMed=10787403;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1392; CACNA1E.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1402; CACNB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13806; Rabbit CACNA2D1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0KY ! 34893 2L
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   193 BLCL
AC   CVCL_E365
DR   ECACC; 94031649
DR   Wikidata; Q54582605
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1936-mel
AC   CVCL_DI14
SY   1936-MEL; 1936-MEL (Medimachine); MG-1936
DR   cancercelllines; CVCL_DI14
DR   Cosmic; 1042625
DR   GEO; GSM218049
DR   Progenetix; CVCL_DI14
DR   Wikidata; Q54582607
RX   PubMed=16470173;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Right chest wall, hypodermis; UBERON=UBERON_0016435+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DN ! 888-EBV
OI   CVCL_4632 ! 888-mel
OI   CVCL_7943 ! 1290-mel
OI   CVCL_DI11 ! 1858-mel a
OI   CVCL_DI12 ! 1858-mel b
OI   CVCL_DI13 ! 1858-mel c
OI   CVCL_DI15 ! 1962-mel
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   1939-3G5
AC   CVCL_G574
SY   3G5
DR   CLO; CLO_0001141
DR   ATCC; HB-8133
DR   Wikidata; Q54582609
RX   Patent=US4514498;
RX   PubMed=7047388;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8133.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Treponema pallidum (strain Nichols).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   1939-8G2
AC   CVCL_G575
SY   8G2
DR   CLO; CLO_0001142
DR   ATCC; HB-8134
DR   Wikidata; Q54582611
RX   Patent=US4514498;
RX   PubMed=7047388;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8134.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Treponema pallidum (strain Nichols).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   193E11E5B11
AC   CVCL_D3RV
SY   193E11E5
DR   DSHB; 193E11E5B11
DR   Wikidata; Q127378662
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   193F10C8C11
AC   CVCL_D3RW
SY   193F10C8
DR   DSHB; 193F10C8C11
DR   Wikidata; Q127378663
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   193F9C5
AC   CVCL_D3RX
DR   Wikidata; Q127378664
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   193G2E10
AC   CVCL_D3RY
DR   Wikidata; Q127378665
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   194 BLCL
AC   CVCL_E366
DR   ECACC; 94031650
DR   Wikidata; Q54582613
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   194-62-7
AC   CVCL_A9H0
DR   ABCD; ABCD_AN706
DR   Wikidata; Q102113428
RX   PubMed=8559803;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P27133; Dictyostelium discoideum corA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   19418
AC   CVCL_JD33
SY   Extract 348; Extract 459
DR   IPD-IMGT/HLA; 10089
DR   Wikidata; Q54582614
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/343cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26:01,32:01; B*45:01,27:08; C*06:02; DQA1*02:01,05; DQB1*02:02,03; DRB1*07,11; DRB3*02; DRB4*01 (IPD-IMGT/HLA=10089).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   1955-91
AC   CVCL_S815
SY   1955/91; MLS 1955-91
DR   Cosmic; 1105000
DR   Cosmic; 1105010
DR   Wikidata; Q54582616
RX   PubMed=1283316;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   195D2E12
AC   CVCL_D3RZ
DR   Wikidata; Q127378666
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   195D2G12
AC   CVCL_D3S0
DR   Wikidata; Q127378667
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   196 BLCL
AC   CVCL_E367
DR   ECACC; 94031651
DR   Wikidata; Q54582618
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1962-mel
AC   CVCL_DI15
SY   1962-MEL; MG-1962
DR   cancercelllines; CVCL_DI15
DR   Cosmic; 1042626
DR   GEO; GSM218045
DR   Progenetix; CVCL_DI15
DR   Wikidata; Q54582619
RX   PubMed=16470173;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Right breast, hypodermis; UBERON=UBERON_0000310+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DN ! 888-EBV
OI   CVCL_4632 ! 888-mel
OI   CVCL_7943 ! 1290-mel
OI   CVCL_DI11 ! 1858-mel a
OI   CVCL_DI12 ! 1858-mel b
OI   CVCL_DI13 ! 1858-mel c
OI   CVCL_DI14 ! 1936-mel
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   196D2D5
AC   CVCL_D3S1
DR   Wikidata; Q127378668
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   196F5F6
AC   CVCL_D3S2
DR   Wikidata; Q127378669
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   196G10G11
AC   CVCL_D3S3
DR   Wikidata; Q127378670
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   196G5D9
AC   CVCL_D3S4
DR   Wikidata; Q127378671
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   196hT
AC   CVCL_C6VV
SY   hTERT-hMSCs
DR   Wikidata; Q123030227
RX   Patent=WO2013186264A1;
RX   PubMed=24561906;
CC   Characteristics: Transduced with a lentiviral vector containing hTERT and eGFP respectively under the control of the CMV and EF1a promoters (PubMed=24561906).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): PubMed=24561906
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 12
ST   D18S51: 12,17
ST   D21S11: 30,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 10,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   197 BLCL
AC   CVCL_E368
DR   ECACC; 94031652
DR   Wikidata; Q54582620
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1970C3
AC   CVCL_D3FK
DR   ABM; T0769
DR   Wikidata; Q127378672
RX   PubMed=29238976;
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   197D10H5
AC   CVCL_D3S5
DR   Wikidata; Q127378673
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   198
AC   CVCL_J922
SY   Anti PDGF hybridoma #198
DR   ATCC; HB-9369
DR   Wikidata; Q54582622
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9369.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   198B11H2
AC   CVCL_D3S6
DR   Wikidata; Q127378674
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   198E9E10
AC   CVCL_D3S7
DR   Wikidata; Q127378675
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   198F7C6
AC   CVCL_D3S8
DR   Wikidata; Q127378676
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   198H11H2
AC   CVCL_D3S9
DR   Wikidata; Q127378677
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   198VI
AC   CVCL_ZQ82
SY   198 VIllejuif
DR   Wikidata; Q98125316
RX   PubMed=9415314;
RX   PubMed=14688028;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   199 BLCL
AC   CVCL_E369
DR   ECACC; 94031653
DR   Wikidata; Q54582624
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   1996
AC   CVCL_ZD43
DR   Wikidata; Q98125319
RX   PubMed=8105609;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   19A-NFUD3
AC   CVCL_D4B7
DR   Wikidata; Q127378678
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Doubling time: 27 +- 7 hours (PubMed=37087860).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: MZM-0410.
OX   NCBI_TaxID=105023; ! Nothobranchius furzeri (Turquoise killifish)
SX   Sex unspecified
AG   Diapause III embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   19A2
AC   CVCL_VI33
DR   BEI_Resources; MRA-261
DR   Wikidata; Q54582626
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes (Note=Also reacts with Culex pipiens salivary glands).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   19B3
AC   CVCL_KB81
DR   Wikidata; Q54582629
RX   PubMed=2447167;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04823; Rat Il3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   19BR
AC   CVCL_ZP92
SY   19 BRighton
DR   Wikidata; Q98125322
RX   PubMed=837385;
RX   PubMed=1214825;
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   19C5
AC   CVCL_C5EE
DR   Wikidata; Q116047873
RX   PubMed=22008075;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6NTJ3; Xenopus laevis greatwall (mastl).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   19C9
AC   CVCL_E8V5
SY   19C9.4B10
RX   Patent=US8624002;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_15551; Prostaglandin E2 (PGE2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   19D07
AC   CVCL_C5A4
DR   ABCD; ABCD_AN898
DR   Wikidata; Q116047874
RX   Patent=US10421807;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; C7G0W1; Dog IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   19E11
AC   CVCL_C4FK
DR   Wikidata; Q116047875
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   19f
AC   CVCL_WR49
DR   Wikidata; Q93300682
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24704492).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   19F3
AC   CVCL_B5Z2
DR   Wikidata; Q111732608
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1-561`= mRNA-capping enzyme nsP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   19F8
AC   CVCL_9145
DR   CLO; CLO_0001143
DR   ATCC; HB-321
DR   Wikidata; Q54582630
RX   PubMed=9531266;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   19g
AC   CVCL_C5HV
DR   Wikidata; Q116047876
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   19G4
AC   CVCL_0E07
DR   ATCC; CRL-2432
DR   Wikidata; Q54582631
RX   PubMed=9420246;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; D3XDW6; Murid herpesvirus 1 MHC class I-like protein m144.
CC   Discontinued: ATCC; CRL-2432; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   19G7-C10
AC   CVCL_B5A4
SY   19G7
DR   Wikidata; Q110429705
RX   Patent=WO1997024141A1;
RX   PubMed=9988333;
CC   Group: Malaria research cell line.
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
ID   19G8 [Mouse hybridoma against S.dysenteriae stxB]
AC   CVCL_F1XK
RX   PubMed=3905611;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7BQ98; Shigella dysenteriae stxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   19G8 [Mouse hybridoma against X.laevis mastl]
AC   CVCL_C5EF
DR   Wikidata; Q116047877
RX   PubMed=22008075;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6NTJ3; Xenopus laevis greatwall (mastl).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 3
//
ID   19H8dc1
AC   CVCL_A7XU
DR   Wikidata; Q107113154
RX   PubMed=7838184;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04934; Plasmodium falciparum (isolate Camp / Malaysia) merozoite surface protein 1 (MSP1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   19KW
AC   CVCL_HA39
DR   Wikidata; Q54582634
RX   PubMed=9237802;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   19L3
AC   CVCL_RX90
DR   SKIP; SKIP001354
DR   Wikidata; Q54582636
RX   PubMed=27594586;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ala469Thr (c.1405G>A) (p.Ala152Thr, c.454G>A); ClinVar=VCV000323645; Zygosity=Unspecified (PubMed=27594586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RX91 ! 19L4
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   19L4
AC   CVCL_RX91
DR   SKIP; SKIP001355
DR   Wikidata; Q54582639
RX   PubMed=27594586;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ala469Thr (c.1405G>A) (p.Ala152Thr, c.454G>A); ClinVar=VCV000323645; Zygosity=Unspecified (PubMed=27594586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RX90 ! 19L3
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   19X14
AC   CVCL_V060
SY   19 X 14
DR   CLO; CLO_0001144
DR   CLDB; cl27
DR   IHW; 11w 8010
DR   Wikidata; Q54582641
RX   PubMed=1692821;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*26).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   1A-3187
AC   CVCL_A0HV
DR   Wikidata; Q108819418
RX   Patent=US10308709;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1A-4246
AC   CVCL_A0HW
DR   Wikidata; Q108819419
RX   Patent=US10308709;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1A1 [Human LCL]
AC   CVCL_F1ER
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a HIV-1 infected patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1A1 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1ES
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1ER ! 1A1 [Human LCL]
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1A1 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BE
DR   Wikidata; Q116047878
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   1A1 [Mouse hybridoma against L.mesenteroides zwf]
AC   CVCL_E3AT
RX   PubMed=2437192;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11411; Leuconostoc mesenteroides glucose-6-phosphate 1-dehydrogenase (zwf).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1A1-1D7
AC   CVCL_C3MR
SY   1A1 1D7
DR   Wikidata; Q116047879
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   1A1-2
AC   CVCL_D2QZ
DR   Wikidata; Q127378679
RX   PubMed=37095139;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A9YUA6; Cat PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   1A1/B2
AC   CVCL_A0HF
SY   1A1 / B2; IMB-649
DR   Wikidata; Q108819420
RX   Patent=RU2143488;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Opisthorchis felineus 105 Kda excretory-secretory antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1A10 [Mouse hybridoma against dog mammary carcinoma]
AC   CVCL_C1GD
DR   Wikidata; Q114310350
RX   PubMed=8578680;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Dog antigen on mammary carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   1A10 [Mouse hybridoma against human GYPA]
AC   CVCL_E8P6
RX   PubMed=31486711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1A11
AC   CVCL_E2SI
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1A12
AC   CVCL_C3TE
DR   Wikidata; Q116047880
RX   PubMed=16305964;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02008; Human HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1A12-2A4
AC   CVCL_C3MS
SY   1A12 2A4
DR   Wikidata; Q116047881
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   1A2
AC   CVCL_3480
DR   CLO; CLO_0001146
DR   EFO; EFO_0002094
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-8119
DR   BioSample; SAMN03471192
DR   ECACC; 93031502
DR   IGRhCellID; 1A2
DR   Wikidata; Q54582644
RX   Patent=US4834975;
RX   Patent=US5662905;
RX   PubMed=20215515;
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8119.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-8119; true.
CC   Discontinued: ECACC; 93031502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8119
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D870 ! GM01500
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   1A2 [Rat glioma]
AC   CVCL_Y001
SY   1A2(R)
DR   ECACC; 93040129
DR   Wikidata; Q54582645
RX   PubMed=221002;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Discontinued: ECACC; 93040129; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 10
//
ID   1A245.6
AC   CVCL_LC05
DR   Wikidata; Q54582646
RX   Patent=US7175846;
RX   Patent=US7431923;
RX   Patent=US7488475;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4889.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   1A3 [Mouse hybridoma against HeLa]
AC   CVCL_J099
DR   CLO; CLO_0001145
DR   ATCC; HB-8563
DR   BCRC; 60406
DR   Wikidata; Q54582647
RX   Patent=US4618585;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8563.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on cancer cell line HeLa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   1A3 [Mouse hybridoma against human AURKA]
AC   CVCL_A7EZ
DR   Wikidata; Q107113156
RX   PubMed=18707550;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14965; Human AURKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1A3 [Mouse hybridoma against SVA VP2]
AC   CVCL_B5YL
DR   Wikidata; Q111732610
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   1A3.1
AC   CVCL_J100
DR   CLO; CLO_0001147
DR   ATCC; CRL-1961
DR   Wikidata; Q54582649
RX   PubMed=2592009;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Giardia muris trophozoite surface antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   1A3.1.1
AC   CVCL_U720
SY   anti-FcRH4-1A3
DR   Wikidata; Q54582651
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6339.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96PJ5; Human FCRL4/CD307d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   1A3.3.13
AC   CVCL_H999
DR   CLO; CLO_0001148
DR   ATCC; HB-11894
DR   Wikidata; Q54582653
RX   Patent=US5646036;
RX   Patent=US5686292;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11894.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   1A3G4
AC   CVCL_D5YS
DR   DSHB; 1A3G4
DR   Wikidata; Q127378680
RX   PubMed=27791132;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9VVX3; Drosophila melanogaster fz2 (Note=Immunized with the extracellular domain = AA 22-114).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   1A4 [Mouse hybridoma against CDV H]
AC   CVCL_E7DY
RX   PubMed=28472594;
RX   PubMed=28636501;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; D2JYB5; Canine distemper virus (strain Snyder Hill) hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1A4 [Mouse hybridoma against human AXL]
AC   CVCL_B0FV
DR   Wikidata; Q108819421
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3947.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   1A4 [Mouse hybridoma against human SAT1]
AC   CVCL_E6JN
RX   PubMed=27228136;
RX   PubMed=27328064;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21673; Human SAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1A4A8
AC   CVCL_E4JR
RX   PubMed=24237073;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9HBJ0; Human PLAC1 (Note=Immunized with AA 166-177).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   1A5 [Mouse hybridoma against CDV hemagglutinin]
AC   CVCL_A3CD
DR   Wikidata; Q105505871
RX   PubMed=25644427;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Canine distemper virus isolate NJ01 hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   1A5 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QN
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1A5 [Mouse hybridoma against imazethapyr]
AC   CVCL_B5CT
DR   Wikidata; Q110429707
RX   Patent=EP1043336A2;
RX   PubMed=12033799;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_82022; Imazethapyr (Pursuit) (Note=Also recognizes imazaquin, imazamethabenz-methyl and imazapic).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   1A5 [Mouse hybridoma against SVA VP3]
AC   CVCL_B5YM
DR   Wikidata; Q111732611
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 435-673 = Capsid protein VP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   1A5-2C9
AC   CVCL_E5NH
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1A6 [Mouse hybridoma against human lymphocytes]
AC   CVCL_E4DM
RX   PubMed=2785080;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on lymphocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   1A6 [Mouse hybridoma against mitragynine]
AC   CVCL_B6LV
DR   Wikidata; Q112127960
RX   PubMed=25216455;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_6956; Mitragynine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   1A6 [Mouse hybridoma against PCV2 Cap]
AC   CVCL_C3PI
DR   CCRID; 4201PAT-CCTCC02136
DR   Wikidata; Q116047882
RX   Patent=CN114958776B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2022151.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O56129; Porcine circovirus 2 (PCV2) caspid protein (Cap).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   1A6H14
AC   CVCL_C5D4
DR   Wikidata; Q116047883
RX   Patent=US10259884;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14907; Human TAX1BP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1A7
AC   CVCL_A6RP
DR   Wikidata; Q107113158
RX   Patent=US7517967;
RX   PubMed=9456440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11786.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 14.G2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1A8 [Mouse hybridoma against D.pteronyssinus Der p 21]
AC   CVCL_E5SQ
RX   PubMed=38646484;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2L7C5; Dermatophagoides pteronyssinus allergen Der p 21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1A8 [Mouse T-cell hybridoma]
AC   CVCL_U273
SY   LBRM-33-1A8
DR   ATCC; HB-8090
DR   Wikidata; Q54582659
RX   Patent=US4473642;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8090.
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_K174 ! LBRM-33
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   1A81
AC   CVCL_J225
DR   TKG; TKG 0349
DR   Wikidata; Q54582660
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   1A8C3C10
AC   CVCL_U274
SY   LBRM-33-1A8C3C10; IA8C3C10
DR   Wikidata; Q54582661
RX   Patent=US4473642;
RX   PubMed=6971310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8089.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U273 ! 1A8 [Mouse T-cell hybridoma]
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   1A9 [Mouse hybridoma against forskolin]
AC   CVCL_B6FV
DR   Wikidata; Q111732613
RX   PubMed=7765788;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   1A9 [Mouse hybridoma against human GYPA]
AC   CVCL_E8P7
RX   PubMed=31486711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1A9 [Mouse hybridoma against M.rotundus 104 kDa spore protein]
AC   CVCL_B0UF
DR   Wikidata; Q109348062
RX   DOI=10.1046/j.1365-2761.2002.00372.x;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Myxobolus rotundus 104 kDa spore protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1A9 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HB
SY   1A9-1-2-1-4
DR   Wikidata; Q110429712
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1A9/CP10
AC   CVCL_B7S4
DR   cancercelllines; CVCL_B7S4
DR   Wikidata; Q112926905
RX   PubMed=1348364;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H619 ! A2780-1A9
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   1A9/T80
AC   CVCL_CZ93
SY   1A9 T80; 1A9T80
DR   cancercelllines; CVCL_CZ93
DR   GEO; GSM95438
DR   Progenetix; CVCL_CZ93
DR   Wikidata; Q54582666
RX   PubMed=16382445;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H619 ! A2780-1A9
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   1A9PTX10
AC   CVCL_H620
SY   1A9/PTX10; 1A9/ptx-10; 1A9/Ptx-10; PTX10
DR   cancercelllines; CVCL_H620
DR   ChEMBL-Cells; CHEMBL3307629
DR   ChEMBL-Targets; CHEMBL614509
DR   PubChem_Cell_line; CVCL_H620
DR   Wikidata; Q54582753
RX   PubMed=9202030;
RX   PubMed=10871860;
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/e7fac129-74ae-48d1-ab1c-9f087b79ddd7
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: IA9-PTX10; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H619 ! A2780-1A9
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 24
//
ID   1A9PTX15
AC   CVCL_H622
SY   PTX15
DR   cancercelllines; CVCL_H622
DR   Wikidata; Q54582754
RX   PubMed=10871860;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H619 ! A2780-1A9
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   1A9PTX22
AC   CVCL_H621
SY   1A9/PTX22; 1A9/ptx-22; 1A9/Ptx-22; PTX22
DR   cancercelllines; CVCL_H621
DR   ChEMBL-Cells; CHEMBL3308076
DR   ChEMBL-Targets; CHEMBL613858
DR   PubChem_Cell_line; CVCL_H621
DR   Wikidata; Q54582757
RX   PubMed=9202030;
RX   PubMed=10871860;
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/e7fac129-74ae-48d1-ab1c-9f087b79ddd7
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H619 ! A2780-1A9
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 22
//
ID   1AA4
AC   CVCL_B3NH
DR   Wikidata; Q110429714
RX   Patent=WO2022166353A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.20288.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9F6Z8; Acinetobacter baumannii beta-lactamase IMP-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   1AG2
AC   CVCL_B7HK
DR   Wikidata; Q112926906
RX   DOI=10.1080/09712119.2002.9706389;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   1AG8
AC   CVCL_B7HL
DR   Wikidata; Q112926907
RX   DOI=10.1080/09712119.2002.9706389;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   1B-3246
AC   CVCL_A0HX
DR   Wikidata; Q108819423
RX   Patent=US10308709;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1B-3440
AC   CVCL_A0HY
DR   Wikidata; Q108819424
RX   Patent=US10308709;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1B-4863
AC   CVCL_A0HZ
DR   Wikidata; Q108819425
RX   Patent=US10308709;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1B-4971
AC   CVCL_A0IA
DR   Wikidata; Q108819426
RX   Patent=US10308709;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1B1 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FC
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1B1 [Mouse hybridoma against human HAMP]
AC   CVCL_E3Z3
RX   Patent=US10239941;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P81172; Human HAMP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   1B1 [Mouse hybridoma against trans-resveratrol]
AC   CVCL_B6IP
DR   Wikidata; Q111732614
RX   Patent=US9547001;
RX   PubMed=23244325;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-122.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_45713; Trans-resveratrol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   1B1 [Mouse/rat hybridoma against mouse Nr5a1]
AC   CVCL_E7DQ
RX   PubMed=19382844;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P33242; Mouse Nr5a1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1B1.1
AC   CVCL_J714
DR   Wikidata; Q54582758
RX   PubMed=2592009;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Giardia muris trophozoite surface antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   1B10
AC   CVCL_N504
DR   Wikidata; Q54582760
RX   DOI=10.1007/BF01404820;
RX   PubMed=8133033;
RX   PubMed=8988857;
CC   Group: Fish cell line.
CC   Characteristics: Secretes IgM.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   1B10-1D1
AC   CVCL_C3MT
SY   1B10 1D1
DR   Wikidata; Q116047884
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   1B11-2E3
AC   CVCL_C3MU
SY   1B11 2E3
DR   Wikidata; Q116047886
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   1B11E4B11
AC   CVCL_XH52
DR   Wikidata; Q93300913
RX   Patent=US9611320;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4373.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01350; Human GAST.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   1B12 [Mouse hybridoma against human CD14]
AC   CVCL_A8EN
DR   TKG; TKG 0764
DR   Wikidata; Q107113160
RX   PubMed=23203928;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   1B12 [Mouse hybridoma against human TPT1]
AC   CVCL_E9DJ
RX   PubMed=21466289;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13693; Human TPT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1B12 [Mouse hybridoma against influenza A HA]
AC   CVCL_C3MV
DR   Wikidata; Q116047887
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   1B2 [Mouse hybridoma against D.farinae Der f 2]
AC   CVCL_E8UL
RX   PubMed=1958138;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00855; Dermatophagoides farinae mite group 2 allergen Der f 2 (DERF2) (Note=Also reacts with D.pteronyssinus Der p 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1B2 [Mouse hybridoma against ZEBOV NP]
AC   CVCL_B6LD
DR   Wikidata; Q111732615
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   Patent=RU2395576;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18272; Zaire ebolavirus (strain Mayinga-76) nucleoprotein (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   1B2 [Mouse hybridoma against goose parvovirus NS1]
AC   CVCL_C5CE
DR   Wikidata; Q116047888
RX   PubMed=22509917;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I1VWH1; Goose parvovirus non-structural protein 1 (NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1B2 [Mouse hybridoma against human CD59]
AC   CVCL_D6VB
RX   PubMed=1374058;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P13987; Human CD59.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1B2 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QP
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1B2 [Mouse hybridoma against pig BST2]
AC   CVCL_E6J1
RX   PubMed=27148642;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A287A9J8; Pig BST2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1B2 [Mouse hybridoma against piperacillin]
AC   CVCL_C8MU
DR   Wikidata; Q123030228
RX   DOI=10.1016/j.jfca.2023.105180;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_8232; Piperacillin (Pipracil; PIP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   1B2-1B7
AC   CVCL_J101
SY   1B2
DR   CLO; CLO_0001150
DR   ATCC; TIB-189
DR   Wikidata; Q54582762
RX   PubMed=7287743;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Terminal N-acetyllactosamine of glycosphingolipids.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   1B2A3
AC   CVCL_G576
DR   CLO; CLO_0001151
DR   ATCC; CRL-1965
DR   IZSLER; BS Hy 52
DR   Wikidata; Q54582764
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17452; Pasteurella multocida toxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   1B2C6
AC   CVCL_U822
DR   CLO; CLO_0050258
DR   BioSample; SAMN03472239
DR   FANTOM5_SSTAR; 10604-108F1
DR   RCB; RCB0795
DR   Wikidata; Q54582767
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
ST   Source(s): RCB=RCB0795
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U823 ! 1C3D3
OI   CVCL_U824 ! 1C3IKEI
OI   CVCL_U825 ! 2C6 [Human fetal pancreas]
SX   Sex unspecified
AG   19FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   1B2E12
AC   CVCL_U322
SY   1B2-E12
DR   ATCC; HB-8144
DR   Wikidata; Q54582768
RX   Patent=US4724211;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8144.
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   1B3 [Mouse hybridoma against aconitine-type alkaloids]
AC   CVCL_B6IY
DR   Wikidata; Q111732616
RX   PubMed=18471491;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_2430; Aconitine.
CC   Monoclonal antibody target: ChEBI; CHEBI_5831; Hypaconitine.
CC   Monoclonal antibody target: ChEBI; CHEBI_6089; Jesaconitine.
CC   Monoclonal antibody target: ChEBI; CHEBI_6773; Mesaconitine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   1B3 [Mouse hybridoma against human BSG]
AC   CVCL_XC82
DR   Wikidata; Q93300952
RX   PubMed=16704305;
RX   PubMed=17444954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   1B3-18
AC   CVCL_E3ZX
SY   1B3
DR   ABCD; ABCD_AO854
RX   PubMed=10438974;
RX   PubMed=15971203;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
CC   Monoclonal antibody target: ChEBI; CHEBI_28544; Digitoxin.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1B4 [Mouse hybridoma against fibrin D-dimer]
AC   CVCL_C4A8
DR   Wikidata; Q116047889
RX   PubMed=30763351;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fibrin D-dimer (Note=Also reacts strongly with fibrinogen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1B4 [Mouse hybridoma against human MMP3]
AC   CVCL_XG93
DR   Wikidata; Q93300956
RX   PubMed=9824606;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08254; Human MMP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   1B4 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MH
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1B4A11D11
AC   CVCL_XH50
DR   Wikidata; Q93300958
RX   Patent=US9611320;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4371.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01350; Human GAST.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   1B5 [Mouse hybridoma against dog CD274]
AC   CVCL_F0H2
RX   Patent=US12252536;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog PDL1/CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1B5 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HI
DR   Wikidata; Q108819427
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   1B5A5
AC   CVCL_E6JM
RX   PubMed=27172290;
RX   PubMed=27328063;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P40199; Human CEACAM6/CD66c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   1B5 [Mouse myogenic]
AC   CVCL_B5J2
DR   Wikidata; Q111732617
RX   PubMed=9472035;
RX   PubMed=9472036;
CC   Characteristics: Can be induced to differentiate into noncontractile multinucleated myotubes (PubMed=9472036).
CC   Doubling time: ~18-24 hours (PubMed=9472036).
CC   Knockout cell: Method=KO mouse; MGI; MGI:99659; Ryr1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97275; Myod1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
CC   Breed/subspecies: 129SV ry1(53).
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   1B6
AC   CVCL_F1V1
RX   PubMed=9521144;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0A4G2; Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) pneumococcal surface adhesin A (psaA) (Note: Immunized with serotype 22F psaA but recognizes 22 capsular serotypes, does not recognize serotype 16F).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1B6A11F2
AC   CVCL_XH51
DR   Wikidata; Q93300962
RX   Patent=US9611320;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4372.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01350; Human GAST.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   1B7
AC   CVCL_C4JI
DR   Wikidata; Q116047890
RX   PubMed=33652529;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3C0R7; Chicken IL7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1B7.11
AC   CVCL_J102
DR   CLO; CLO_0001152
DR   ATCC; TIB-191
DR   Wikidata; Q54582771
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53067; 2,4,6-trinitrophenyl group (TNP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   1B71B4
AC   CVCL_XE81
SY   IB7IB4; D-IB7IB4
DR   CCRID; 4201PAT-CCTCC01206
DR   Wikidata; Q93300973
RX   PubMed=30576715;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q52UN8; Cyprinid herpesvirus 3 major capsid protein (ORF92).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   1B8 [Human hybridoma against D.pteronyssinus Der p 2]
AC   CVCL_E8UE
RX   PubMed=32907999;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG40 ! HMMA2.5
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1B8 [Mouse hybridoma against chicken SELENOW]
AC   CVCL_C5D0
DR   Wikidata; Q116047891
RX   PubMed=22149284;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; D0EYG3; Chicken SELENOW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   1B8-F11
AC   CVCL_G089
DR   CLO; CLO_0001153
DR   ATCC; CRL-1852
DR   ECACC; 95022202
DR   Wikidata; Q54582774
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0CK30; Bovine herpesvirus 1.1 gD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   1B8A2
AC   CVCL_A3BY
DR   CCRID; 4201PAT-CCTCC01648
DR   Wikidata; Q105505874
RX   Patent=CN111925992B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202095.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00755; Human WNT7A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   1B9
AC   CVCL_E4QZ
RX   DOI=10.1007/BF01577135;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BH3
AC   CVCL_B3P9
DR   Wikidata; Q110429717
RX   Patent=CN105154409B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10494.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A1Z0H6; Pseudomonas fluorescens (strain G2) 3-phosphoshikimate 1-carboxyvinyltransferase (aroA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 4
//
ID   1BR.3.G
AC   CVCL_2280
SY   1BR.3-G; 1BR3.G; 1BR.3GPT; 1BR.3gpt
DR   BTO; BTO_0004971
DR   CLO; CLO_0001154
DR   CLDB; cl28
DR   ECACC; 90020507
DR   Wikidata; Q54582777
RX   PubMed=2903889;
RX   PubMed=3002824;
RX   PubMed=11416159;
RX   PubMed=16714754;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 12,14
ST   D21S11: 30
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 9.3
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2279 ! 1BR3
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   1BR.3.GN
AC   CVCL_2281
SY   1BR3.GN
DR   CLO; CLO_0001155
DR   CLDB; cl29
DR   ChEMBL-Cells; CHEMBL4295462
DR   ChEMBL-Targets; CHEMBL4296397
DR   ECACC; 90020509
DR   PubChem_Cell_line; CVCL_2281
DR   Wikidata; Q54582779
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2280 ! 1BR.3.G
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   1BR.3.N
AC   CVCL_2282
SY   1BR3.N; 1BR.3N; 1BR.3NEO; 1BR.3neo; 1BR3neo; 1BRneo
DR   CLO; CLO_0001156
DR   CLDB; cl30
DR   ECACC; 90020508
DR   Wikidata; Q54582781
RX   PubMed=1549511;
RX   PubMed=2903889;
RX   PubMed=7519740;
RX   PubMed=11416159;
RX   PubMed=12604777;
RX   PubMed=16714754;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ECACC=90020508; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 9,12
ST   D16S539: 12,14
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2279 ! 1BR3
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   1BR3
AC   CVCL_2279
SY   1BR.3; 1.BR3; 1BR; 1Br; 1 BRighton
DR   CLO; CLO_0001157
DR   EFO; EFO_0022560
DR   CLDB; cl31
DR   ECACC; 90011801
DR   Wikidata; Q54582783
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=837385;
RX   PubMed=1196376;
RX   PubMed=1214825;
RX   PubMed=1372096;
RX   PubMed=2400879;
RX   PubMed=2903889;
RX   PubMed=2973075;
RX   PubMed=6408472;
RX   PubMed=6600729;
RX   PubMed=7067035;
RX   PubMed=7360141;
RX   PubMed=7471106;
RX   PubMed=7882314;
RX   PubMed=8609460;
RX   PubMed=8823375;
RX   PubMed=10022907;
RX   PubMed=10987302;
RX   PubMed=11219864;
RX   PubMed=11416159;
RX   PubMed=12082606;
RX   PubMed=12604777;
RX   PubMed=15130666;
RX   PubMed=15574327;
RX   PubMed=16714754;
RX   PubMed=19179371;
CC   Doubling time: 24 hours (PubMed=8609460).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 12,14
ST   D21S11: 30
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 6,9.3
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 21
//
ID   1BR3-hTERT
AC   CVCL_E3V7
RX   PubMed=35902118;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2279 ! 1BR3
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT ARID2 KO 1
AC   CVCL_E3V8
SY   1BR ARID2 KO1; 1BR3-hTERT knockout for ARID2 clone 1; 1BR3-hTERT knockout for ARID2 clone A1
DR   CancerTools; 161853
RX   PubMed=35902118;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT ARID2 KO 2
AC   CVCL_E3V9
SY   1BR ARID2 KO2; 1BR3-hTERT knockout for ARID2 clone 2; 1BR3-hTERT knockout for ARID2 clone A2
DR   CancerTools; 161854
RX   PubMed=35902118;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT ARID2 KO 9
AC   CVCL_E3VA
SY   1BR ARID2 KO9; 1BR3-hTERT knockout for ARID2 clone 9; 1BR3-hTERT knockout for ARID2 clone A9
DR   CancerTools; 161855
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT PBRM1 KO 10
AC   CVCL_E3VF
SY   1BR PBRM1 KO10; 1BR3-hTERT knockout for PBRM1 clone 10
DR   CancerTools; 161852
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT PBRM1 KO 2
AC   CVCL_E5FG
SY   1BR PBRM1 KO2; 1BR3-hTERT knockout for PBRM1 clone 2
DR   CancerTools; 161847
RX   PubMed=35902118;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1BR3-hTERT PBRM1 KO 3
AC   CVCL_E3VB
SY   1BR PBRM1 KO3; 1BR3-hTERT knockout for PBRM1 clone 3
DR   CancerTools; 161848
RX   PubMed=35902118;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT PBRM1 KO 4
AC   CVCL_E3VC
SY   1BR PBRM1 KO4; 1BR3-hTERT knockout for PBRM1 clone 4
DR   CancerTools; 161849
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT PBRM1 KO 5
AC   CVCL_E3VD
SY   1BR PBRM1 KO5; 1BR3-hTERT knockout for PBRM1 clone 5
DR   CancerTools; 161850
RX   PubMed=35902118;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1BR3-hTERT PBRM1 KO 5 + EV
AC   CVCL_E3WF
SY   1BR3 PBRM1 KO5 + EV
DR   CancerTools; 161871
RX   PubMed=35902118;
CC   Characteristics: Transduced with an empty TRIPz-neo construct. Control cell line for 1BR3-hTERT PBRM1 KO 5 + PBRM1 (Cellosaurus=CVCL_E3WE) (PubMed=35902118).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3VD ! 1BR3-hTERT PBRM1 KO 5
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   1BR3-hTERT PBRM1 KO 5 + PBRM1
AC   CVCL_E3WE
SY   1BR3 PBRM1 KO5 + PBRM1
DR   CancerTools; 161870
RX   PubMed=35902118;
CC   Characteristics: PBRM1 is expressed upon doxycycline induction (PubMed=35902118).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3VD ! 1BR3-hTERT PBRM1 KO 5
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   1BR3-hTERT PBRM1 KO 6
AC   CVCL_E3VE
SY   1BR PBRM1 KO6; 1BR3-hTERT knockout for PBRM1 clone 6
DR   CancerTools; 161851
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3V7 ! 1BR3-hTERT
SX   Male
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1C1 [Human LCL]
AC   CVCL_4T75
DR   Wikidata; Q54582785
RX   Patent=US5662905;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8941.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotypes 3 and 7.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 12
//
ID   1C1 [Mouse hybridoma against artemisinin/artesunate]
AC   CVCL_B6GI
DR   Wikidata; Q111732618
RX   PubMed=17611929;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_223316; (+)-artemisinin.
CC   Monoclonal antibody target: ChEBI; CHEBI_63918; Artesunate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   1C1 [Mouse hybridoma against chicken ACHE]
AC   CVCL_E8C3
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36196; Chicken ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1C1 [Mouse hybridoma against ZEBOV VP40]
AC   CVCL_B6LE
DR   Wikidata; Q111732619
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   Patent=RU2395577;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q05128; Zaire ebolavirus (strain Mayinga-76) matrix protein VP40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   1C1 [Mouse hybridoma against FeLV gp70]
AC   CVCL_B0VL
DR   Wikidata; Q108819428
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   1C1 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA00
DR   Wikidata; Q93301031
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9398.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 5
//
ID   1C10 [Mouse hybridoma against A.aegypti salivary glands]
AC   CVCL_VI24
DR   BEI_Resources; MRA-248
DR   Wikidata; Q54582788
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female salivary glands median and distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   1C10 [Mouse hybridoma against aflatoxin G1]
AC   CVCL_A0PA
DR   Wikidata; Q108819429
RX   PubMed=19239370;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   1C10 [Mouse hybridoma against HNK-1]
AC   CVCL_C2X6
DR   DSHB; 1C10
DR   Wikidata; Q114310351
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   1C10 [Mouse hybridoma against human MBL2]
AC   CVCL_B0JW
DR   Wikidata; Q108819430
RX   Patent=WO2000035483A1;
RX   PubMed=10793066;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P11226; Human MBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1C10 [Mouse hybridoma against pig EDN1]
AC   CVCL_F0V4
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1C10 [Mouse/sheep heteromyeloma]
AC   CVCL_B0WT
DR   Wikidata; Q108819431
RX   PubMed=23342681;
CC   Group: Hybridoma fusion partner cell line.
CC   From: Bioventix, Ltd; Farnham; United Kingdom.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   1C11 [Mouse hybridoma against aflatoxins]
AC   CVCL_A0PB
DR   CCRID; 4201PAT-CCTCC00343
DR   Wikidata; Q108819432
RX   Patent=CN101993855B;
RX   Patent=CN103116024B;
RX   PubMed=19231357;
RX   PubMed=22548609;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201013.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   1C11 [Mouse hybridoma against Drosophila fz]
AC   CVCL_D5YR
DR   DSHB; 1C11
DR   Wikidata; Q127378681
RX   PubMed=8199049;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P18537; Drosophila melanogaster fz.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   1C11 [Mouse hybridoma against FIV p24]
AC   CVCL_B0WJ
DR   Wikidata; Q108819433
RX   PubMed=1848596;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16087; Feline immunodeficiency virus (isolate Petaluma) (FIV) gag (Note=AA 136-357 = p24).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   1C11 [Mouse hybridoma against HIV-1 antigens]
AC   CVCL_U279
DR   Wikidata; Q54582790
RX   Patent=US4904581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9115.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: HIV-1 antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U276 ! 3D8
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   1C11 [Mouse hybridoma against human HSPA9]
AC   CVCL_E7QM
RX   PubMed=28719245;
RX   PubMed=28806154;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P38646; Human HSPA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1C11 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5F2
DR   Wikidata; Q116047892
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1C11 [Mouse teratocarcinoma]
AC   CVCL_B5MU
DR   Wikidata; Q111732620
RX   PubMed=2155426;
CC   Characteristics: Tumorigenic in syngeneic mice (PubMed=2155426).
CC   Characteristics: Presents two states: an immature phenotype (1C11 precursor) and a more differentiated state (1C11*). After induction by Bt2cAMP and cyclohexanecarboxylate, 1C11* cells extend neurites and express neural markers such as NCAM1, synaptophysin and [Met5]enkephalin in >95% of the clonal population (PubMed=2155426).
CC   Doubling time: 20 hours (PubMed=2155426).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5MT ! F9K4b2
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   1C11-2G9
AC   CVCL_E5NQ
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1C12 [Mouse hybridoma against FeLV p15E]
AC   CVCL_B0VM
DR   Wikidata; Q108819434
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 446-625 = p15E/TM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   1C12 [Mouse hybridoma against SVA VP2]
AC   CVCL_B5YN
DR   Wikidata; Q111732621
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   1C12 [Mouse hybridoma against T.annulata macroschizonts]
AC   CVCL_B6PA
DR   Wikidata; Q111732622
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with sporozoites).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   1C1H11
AC   CVCL_A0UU
DR   CCRID; 4201PAT-CCTCC01003
DR   Wikidata; Q108819435
RX   Patent=CN107299085B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201758.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1C2 [Mouse hybridoma against paclitaxel]
AC   CVCL_E3ZD
DR   ABCD; ABCD_AJ806
RX   PubMed=30389640;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1C2 [Mouse hybridoma against SVA VP1]
AC   CVCL_B5YP
DR   Wikidata; Q111732623
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   1C2 [Mouse hybridoma against WSSV]
AC   CVCL_F1BM
RX   DOI=10.1577/1548-8667(1999)011<0017:POMAMA>2.0.CO;2;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: White spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1C3 [Mouse hybridoma against C.perfringens pfo]
AC   CVCL_E4QX
RX   DOI=10.1007/BF01577135;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1C3 [Mouse hybridoma against Dabie bandavirus N]
AC   CVCL_C1M2
DR   Wikidata; Q114310352
RX   PubMed=35835158;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; V5XK21; Dabie bandavirus nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 4
//
ID   1C3 [Mouse hybridoma against human HFE]
AC   CVCL_D148
DR   CLO; CLO_0001158
DR   ATCC; CRL-2441
DR   Wikidata; Q54582791
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   1C3 [Mouse hybridoma against human HMGB1]
AC   CVCL_B4HC
SY   1C3-1-1-1-1
DR   Wikidata; Q110429719
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1C3D3
AC   CVCL_U823
DR   CLO; CLO_0050259
DR   FANTOM5_SSTAR; 10605-108F2
DR   RCB; RCB0796
DR   Wikidata; Q54582794
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
ST   Source(s): RCB=RCB0796
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U822 ! 1B2C6
OI   CVCL_U824 ! 1C3IKEI
OI   CVCL_U825 ! 2C6 [Human fetal pancreas]
SX   Sex unspecified
AG   19FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   1C3IKEI
AC   CVCL_U824
SY   1C3 IKEI
DR   CLO; CLO_0050257
DR   FANTOM5_SSTAR; 10606-108F3
DR   RCB; RCB0797
DR   Wikidata; Q54582796
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
ST   Source(s): RCB=RCB0797
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U822 ! 1B2C6
OI   CVCL_U823 ! 1C3D3
OI   CVCL_U825 ! 2C6 [Human fetal pancreas]
SX   Sex unspecified
AG   19FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   1C4
AC   CVCL_E8PN
RX   PubMed=32004438;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q05320; Zaire ebolavirus (strain Mayinga-76) GP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1C5 [Mouse hybridoma against human MIF]
AC   CVCL_IQ47
DR   Wikidata; Q54582799
RX   Patent=EP0162812B1;
RX   PubMed=3527953;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-316.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14174; Human MIF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   1C5 [Mouse hybridoma against human UBA1]
AC   CVCL_LB81
DR   Wikidata; Q54582801
RX   PubMed=1376922;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P22314; Human UBA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   1C5 [Mouse hybridoma against Pseudomonas P.J. 874 hpd]
AC   CVCL_B7CN
DR   Wikidata; Q112926908
RX   Patent=US8153132;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10312.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P80064; Pseudomonas sp. (strain P.J. 874) 4-hydroxyphenylpyruvate dioxygenase (hpd) (Note=With p.Gly335Trp).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   1C6 [Mouse hybridoma against ZEBOV VP35]
AC   CVCL_B6LJ
SY   IC6
DR   Wikidata; Q111732624
RX   PubMed=12800775;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q05127; Zaire ebolavirus (strain Mayinga-76) polymerase cofactor VP35.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   1C6 [Mouse hybridoma against human IL37]
AC   CVCL_B6BX
DR   Wikidata; Q111732625
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   1C6 [Mouse hybridoma against M.tuberculosis Ag85A]
AC   CVCL_XJ54
DR   Wikidata; Q93301090
RX   PubMed=28713817;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P9WQP3; Mycobacterium tuberculosis diacylglycerol acyltransferase/mycolyltransferase Ag85A (fbpA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   1C6.5
AC   CVCL_A0CF
DR   Wikidata; Q108819436
RX   PubMed=8438567;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P20881; HIV-2 isolate ST vpx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1C7 [Mouse hybridoma against CDV hemagglutinin]
AC   CVCL_A3CG
DR   Wikidata; Q105505877
RX   PubMed=25644427;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Canine distemper virus isolate NJ01 hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   1C7 [Mouse hybridoma against L.japonicum basal apparatus]
AC   CVCL_T731
DR   CLO; CLO_0050349
DR   RCB; RCB1922
DR   Wikidata; Q54582804
RX   DOI=10.1508/cytologia.68.271;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Lygodium japonicum strain an-1 basal apparatus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   1C7 [Mouse hybridoma against M.honghuensis polar filament]
AC   CVCL_B0UD
DR   CCRID; 4201PAT-CCTCC00434
DR   Wikidata; Q108819437
RX   Patent=CN103880954B;
RX   PubMed=26758653;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013188.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Myxobolus honghuensis 130/180 kDa polar filament protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   1C7 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5F3
DR   Wikidata; Q116047893
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1C7 [Mouse hybridoma against T.annulata macroschizonts]
AC   CVCL_B6P6
DR   Wikidata; Q111732626
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   1C8 [Mouse hybridoma against aflatoxin G1]
AC   CVCL_A0PC
SY   AFG20081C8
DR   CCRID; 4201PAT-CCTCC00338
DR   Wikidata; Q108819438
RX   Patent=CN102719405B;
RX   PubMed=19239370;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201017.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   1C8 [Mouse hybridoma against N.fowleri NfCPB-L]
AC   CVCL_B3MV
DR   Wikidata; Q110429721
RX   PubMed=28919331;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; X5D911; Naegleria fowleri cathepsin B-like (NfCPB-L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1C8-2B11
AC   CVCL_E8PS
RX   PubMed=32311306;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1C9 [Mouse ESC]
AC   CVCL_C695
SY   Lexicon ES cell line 1C9
DR   BTO; BTO_0004751
DR   MMRRC; MMRRC:029773-UCD
DR   Wikidata; Q54582806
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S5/SvEvBrd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C696 ! Lex-1
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   1C9 [Mouse hybridoma against human FGF1]
AC   CVCL_E3ZF
DR   ABCD; ABCD_AJ814
RX   PubMed=21360642;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P05230; Human FGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1C9 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N9
DR   ABCD; ABCD_AE967
RX   PubMed=7705409;
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1C9H6F2C1
AC   CVCL_WZ74
DR   Wikidata; Q93301111
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   1CB4
AC   CVCL_CZ91
DR   Wikidata; Q54582808
RX   PubMed=3882896;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on membranous organelles.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   1Cc8
AC   CVCL_L893
SY   1CC8; SCC-1CC8; SC8
DR   Wikidata; Q54582811
RX   PubMed=18297114;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7707 ! UM-SCC-1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 20
//
ID   1CE1
AC   CVCL_E3EP
RX   PubMed=10022441;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR (Note=Immunized AA 1-289 = TSHR-289).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1D1
AC   CVCL_A0RW
DR   Wikidata; Q108819439
RX   Patent=US5710255;
RX   PubMed=7510760;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1D10
AC   CVCL_B6BY
DR   Wikidata; Q111732627
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   1D10(AAT) Clone 8D10
AC   CVCL_U070
SY   1D10(ATT) Clone A6
DR   ECACC; 02043018
DR   Wikidata; Q54582812
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   1D11
AC   CVCL_B6TQ
DR   Wikidata; Q111732628
RX   PubMed=34171554;
CC   Characteristics: Using CRISPR/Cas9 GFP was inserted in the C region of the Ig light chain V12.41/J4/C (PubMed=34171554).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6TP ! 1E1 [Mouse hybridoma against influenza D HE]
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   1D11.16.8
AC   CVCL_J162
SY   1D11.16; 1D11
DR   CLO; CLO_0001160
DR   ATCC; HB-9849
DR   Wikidata; Q54582814
RX   Patent=US5571714;
RX   PubMed=2537357;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9849.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18341; Bovine TGFB1 (Note=Also reacts with human, mouse, rat and many other species).
CC   Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2 (Note=Also reacts with human, mouse, rat and many other species).
CC   Monoclonal antibody target: UniProtKB; A6QP91; Bovine TGFB3 (Note=Also reacts with human, mouse, rat and many other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   1D12-1D5
AC   CVCL_C3MW
SY   1D12 1D5
DR   Wikidata; Q116047894
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   1D12-B5
AC   CVCL_XK19
DR   CCRID; 4201PAT-CCTCC00274
DR   Wikidata; Q93301144
RX   Patent=CN101570577B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200906.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: 3-[4-(O,O-dimethylphosphorothioyloxy)phenyl]-1-propionic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   1D2 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HJ
DR   Wikidata; Q108819440
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1D2 [Mouse hybridoma against imazethapyr]
AC   CVCL_B5CU
DR   Wikidata; Q110429723
RX   Patent=EP1043336A2;
RX   PubMed=12033799;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_82022; Imazethapyr (Pursuit) (Note=Also recognizes imazamox, imazamethabenz-methyl and imazapic).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   1D2 [Mouse hybridoma against WSSV]
AC   CVCL_F1BN
RX   DOI=10.1577/1548-8667(1999)011<0017:POMAMA>2.0.CO;2;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: White spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1D3 [Mouse hybridoma against aflatoxins]
AC   CVCL_A0PD
DR   Wikidata; Q108819441
RX   PubMed=19231357;
RX   PubMed=22548609;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   1D3 [Mouse hybridoma against bovine CYCS]
AC   CVCL_E5SJ
RX   PubMed=10090746;
RX   PubMed=36378644;
WW   Info; -; -; https://phys.org/news/2023-03-scientists-resurrect-dead-antibody-protein.html
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62894; Bovine CYCS (Note=Recognizes a conformational change that happens early in apoptosis and in necrosis. Also reacts with mouse and rat).
CC   Anecdotal: Because of the loss of this hybridoma, a new recombinant mAB (R1D3) was created de novo using the sequence of remaining stocks of the mAB 1D3 (PubMed=36378644).
CC   Miscellaneous: This hybridoma was lost in a defective liquid nitrogen tank (PubMed=36378644).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1D3 [Mouse hybridoma against chicken TSC22D3]
AC   CVCL_E7QW
RX   PubMed=28806151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q06AW4; Chicken TSC22D3/GILZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1D3 [Mouse hybridoma against human IFNAR2]
AC   CVCL_F1WN
RX   Patent=US20030018174;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12428.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48551; Human IFNAR2.
CC   Caution: Patent wrongly indicate the registration number as HP 12428.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1D3 [Mouse hybridoma against human neutrophils]
AC   CVCL_WI92
DR   CCRID; 4201PAT-CCTCC00019
DR   Wikidata; Q93301146
RX   Patent=US4931395;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9445.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on neutrophils.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   1D3 [Rat hybridoma against mouse Itgb1]
AC   CVCL_9146
DR   CLO; CLO_0001161
DR   ATCC; HB-305
DR   Wikidata; Q54582818
RX   PubMed=8566073;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09055; Mouse Itgb1/Cd29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   1D3B8
AC   CVCL_A9KG
DR   Wikidata; Q108819442
RX   Patent=US9249216;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del; SNAP25(197)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   1D4 [Mouse hybridoma against B.germanica Bla g 2]
AC   CVCL_C3WY
DR   Wikidata; Q116047895
RX   PubMed=1993811;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54958; Blattella germanica aspartic protease Bla g 2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1D4 [Mouse hybridoma against Drosophila fas2]
AC   CVCL_A6LG
DR   DSHB; 1D4-anti-Fascicli-II
DR   Wikidata; Q107113162
RX   PubMed=8461134;
RX   PubMed=8513498;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P34082; Drosophila melanogaster fas2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   1D4 [Mouse hybridoma against human AZGP1]
AC   CVCL_KR68
DR   Wikidata; Q54582820
RX   PubMed=9114041;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25311; Human AZGP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   1D4 [Mouse hybridoma against human herpesvirus 1 p40]
AC   CVCL_J163
DR   CLO; CLO_0001162
DR   ATCC; HB-8068
DR   IZSLER; BS Hy 7
DR   Wikidata; Q54582823
RX   Patent=US4430437;
RX   PubMed=91687;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8068.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10210; Human herpesvirus 1 (HHV-1) capsid scaffolding protein (p40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   1D4 [Mouse hybridoma against human IL37]
AC   CVCL_B6BZ
DR   Wikidata; Q111732629
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   1D4 [Mouse hybridoma against human TG]
AC   CVCL_C0PL
DR   Wikidata; Q112926909
RX   DOI=10.1016/B978-0-7506-0421-5.50083-0;
RX   PubMed=4006972;
WW   Provider; KCL; -; http://kcl.testtechnologypublisher.com/technology/7244
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01266; Human TG.
CC   Caution: Incorrectly indicated as producing an IgG1 mAb in KCL technology transfer data sheet.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 4
//
ID   1D4 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TF
DR   Wikidata; Q111732630
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   1D4 [Mouse hybridoma against parathion]
AC   CVCL_C5A8
DR   Wikidata; Q116047896
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1D4 iPS
AC   CVCL_IT49
DR   GEO; GSM344761
DR   GEO; GSM344762
DR   Wikidata; Q54582824
RX   PubMed=18371336;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_IT48 ! 2D4 iPS
SX   Female
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   1D5 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4SV
DR   Wikidata; Q116047897
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   1D5 [Mouse hybridoma against TMUV prM]
AC   CVCL_E7DE
RX   PubMed=28409665;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0C6DUM8; Tembusu virus (strain TMUV-YY1Du) genome polyprotein (Note=Protein prM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1D5 [Mouse hybridoma against WSSV]
AC   CVCL_F1BP
RX   DOI=10.1577/1548-8667(1999)011<0017:POMAMA>2.0.CO;2;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: White spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1D5-3B-7
AC   CVCL_B6FZ
DR   ABCD; ABCD_AJ798
DR   Wikidata; Q111732631
RX   PubMed=14737589;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16118; Berberine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   1D5H12F1A7
AC   CVCL_WZ75
DR   Wikidata; Q93301184
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   1D6 [Mouse hybridoma against human CD81]
AC   CVCL_E5KD
WW   Provider; Stanford OTL; S98-059; https://stanford.resoluteinnovation.com/technologies/S98-059_1d6-mab-reacting-with-human-cd81
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P60033; Human CD81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1D6 [Mouse hybridoma against O.viverrini Ov-TSP-2]
AC   CVCL_A0HD
DR   Wikidata; Q108819443
RX   PubMed=34358156;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; M1G6I5; Opisthorchis viverrini tetraspanin 2A (Ov-TSP-2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   1D6-3-8
AC   CVCL_B6RY
SY   1D6
DR   Wikidata; Q111732632
RX   PubMed=10501468;
RX   PubMed=14500745;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04757; Rat Chrna3 (Note=Recognizes AA 206-217).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   1D6.3.8
AC   CVCL_U721
SY   anti-FcRH1,2-1D6
DR   Wikidata; Q54582825
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6334.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96LA6; Human FCRL1/CD307a.
CC   Monoclonal antibody target: UniProtKB; Q96LA5; Human FCRL2/CD307b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   1D7 [Human/mouse hybridoma against HIV-1 p24]
AC   CVCL_F1FM
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03366; HIV-1 isolate BH10 env (Note=AA 133-363 = p24).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1D7 [Mouse hybridoma against human GOLM1]
AC   CVCL_E2ZS
RX   PubMed=27088654;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1D7 [Mouse hybridoma against phthalate]
AC   CVCL_D5L0
DR   Wikidata; Q127378682
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   1D7-H11
AC   CVCL_E2S3
RX   PubMed=26090597;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A125YR49; Toxoplasma gondii (strain ATCC 50611 / Me49) H(+)-exporting diphosphatase (TgVP1) (Note=Also reacts with Plasmodium berghei).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1D8 [Mouse hybridoma against human KLK6]
AC   CVCL_E2ZM
RX   PubMed=26492623;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92876; Human KLK6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1D8 [Mouse hybridoma against human LRRK2]
AC   CVCL_E9E1
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/1D8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5S007; Human LRRK2 (Note=Immunized with 904-VKKKSNSISVGEFY-917 with phosphorylated p.Ser910. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1D8 [Mouse hybridoma against pig IgA]
AC   CVCL_E2ZJ
RX   PubMed=26683177;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pig IgA (Note=Recognizes secretory IgA = sIgA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1D8-A6
AC   CVCL_E8UN
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1D8-C4
AC   CVCL_E8UP
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1D8G8
AC   CVCL_E7QL
RX   PubMed=21707361;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human BCR/ABL1 out-of-frame fusion protein (Bcr/Abl-OOF).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1D9 [Mouse hybridoma against HIV-1 isolate HXB2 tat]
AC   CVCL_A0CE
SY   1D9D5
DR   BEI_Resources; ARP-7383
DR   Wikidata; Q108819444
RX   PubMed=8743086;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04608; HIV-1 isolate HXB2 tat.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   1D9 [Mouse hybridoma against human GP5]
AC   CVCL_E5F6
RX   PubMed=7900083;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P40197; Human GP5/CD42d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   1D9 [Mouse hybridoma against N.fowleri NfCPB-L]
AC   CVCL_B3MW
DR   Wikidata; Q110429725
RX   PubMed=28919331;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; X5D911; Naegleria fowleri cathepsin B-like (NfCPB-L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   1D9 [Mouse hybridoma against zearalenone]
AC   CVCL_C5NQ
DR   Wikidata; Q116047898
RX   PubMed=24465616;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1DE8
AC   CVCL_B7HM
DR   Wikidata; Q112926910
RX   DOI=10.1080/09712119.2002.9706389;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   1E1 [Mouse hybridoma against G.vaginalis vaginolysin]
AC   CVCL_C5AN
DR   Wikidata; Q116047899
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1E1 [Mouse hybridoma against human CD14]
AC   CVCL_A8EP
DR   TKG; TKG 0763
DR   Wikidata; Q107113163
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   1E1 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TP
DR   Wikidata; Q111732633
RX   PubMed=30179314;
RX   PubMed=34171554;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   1E10 [Mouse hybridoma against aflatoxins]
AC   CVCL_A0PE
DR   Wikidata; Q108819445
RX   PubMed=22548609;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 5
//
ID   1E10 [Mouse hybridoma against GXM]
AC   CVCL_F1Y0
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM) (Note=Immunized with C.neoformans serotype A (ATCC 24064)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1E10.16.4
AC   CVCL_B0E8
SY   1E10
DR   Wikidata; Q108819446
RX   Patent=US7744881;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3359.
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1E11 [Mouse hybridoma against human CD83]
AC   CVCL_C5ET
DR   Wikidata; Q116047900
RX   PubMed=21707366;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01151; Human CD83.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1E11 [Mouse hybridoma against T.annulata macroschizonts]
AC   CVCL_B6PC
DR   Wikidata; Q111732635
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with sporozoites).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   1E11.15
AC   CVCL_C9FQ
DR   Wikidata; Q123030229
RX   Patent=US8231877;
RX   PubMed=9631008;
CC   Doubling time: 16 hours (PubMed=9631008).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   1E12
AC   CVCL_A8EQ
DR   TKG; TKG 0762
DR   Wikidata; Q107113164
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   1E12-E6
AC   CVCL_E8UQ
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1E12b
AC   CVCL_B0V0
DR   Wikidata; Q108819447
RX   Patent=WO2021138378A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-126149.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140691; Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) (Stage-specific embryonic antigen-3; SSEA-3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   1E2 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QQ
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1E2 [Mouse hybridoma against influenza D HE CRISPR/Cas9 edited]
AC   CVCL_B6TR
DR   Wikidata; Q111732636
RX   PubMed=34171554;
CC   Characteristics: Using CRISPR/Cas9 a bovine herpesvirus type 1 glycoprotein E (BoHV1gE)-GFP fusion was inserted in the C region of the Ig light chain V12.41/J4/C (PubMed=34171554).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q08101; Bovine herpesvirus 1 envelope glycoprotein E (gE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6TP ! 1E1 [Mouse hybridoma against influenza D HE]
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   1E2 [Mouse hybridoma against HIV-1 antigens]
AC   CVCL_U275
DR   Wikidata; Q54582826
RX   Patent=US4904581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9100.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: HIV-1 antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   1E2 [Mouse hybridoma against human AZGP1]
AC   CVCL_KR69
DR   Wikidata; Q54582827
RX   PubMed=9114041;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25311; Human AZGP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   1E2-1D11
AC   CVCL_A6AF
DR   Wikidata; Q107113166
RX   CelloPub=CLPUB00608;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1E2-2B8
AC   CVCL_A6AG
DR   Wikidata; Q107113167
RX   CelloPub=CLPUB00608;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1E2-2C9
AC   CVCL_A6AH
DR   Wikidata; Q107113170
RX   CelloPub=CLPUB00608;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1E3 [Mouse hybridoma against human MPO]
AC   CVCL_E2YZ
RX   PubMed=26978734;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1E3 [Mouse hybridoma against Pari-ICR]
AC   CVCL_VR48
DR   Wikidata; Q93301216
RX   PubMed=30243716;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on breast cancer cell line Pari-ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 5
//
ID   1E4
AC   CVCL_C8MX
DR   Wikidata; Q123030230
RX   PubMed=33502396;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_149836; Tigecycline (Tygacil).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   1E4-1C2
AC   CVCL_A6AE
DR   Wikidata; Q107113172
RX   CelloPub=CLPUB00608;
RX   PubMed=17035092;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1E4-1D9
AC   CVCL_A6AD
DR   Wikidata; Q107113173
RX   PubMed=28321273;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1E5 [Mouse hybridoma against amantadine]
AC   CVCL_B6WA
DR   Wikidata; Q111732637
RX   Patent=CN105112376A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10865.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_2618; Amantadine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   1E5 [Mouse hybridoma against human RB1]
AC   CVCL_A0RX
DR   Wikidata; Q108819448
RX   Patent=US5710255;
RX   PubMed=7510760;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   1E5 [Mouse hybridoma against parathion]
AC   CVCL_C5A9
DR   Wikidata; Q116047901
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1E6H5
AC   CVCL_C4ZW
DR   Wikidata; Q116047902
RX   PubMed=11304405;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6LEG8; Glycine max calmodulin (SCaM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   1E7 [Mouse hybridoma against human IL1-activated endothelial cells]
AC   CVCL_J153
DR   Wikidata; Q54582829
RX   Patent=US5011778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10136.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on IL1-activated endothelial cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   1E7 [Mouse hybridoma against mouse Celf3]
AC   CVCL_A7DJ
DR   RCB; RCB4684
DR   Wikidata; Q107113174
RX   PubMed=25145264;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8CIN6; Mouse Celf3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1E7 [Mouse hybridoma against S.pneumoniae psaA]
AC   CVCL_F1V2
SY   1E7A3D7C2
RX   PubMed=2229341;
RX   PubMed=9521144;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0A4G2; Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) pneumococcal surface adhesin A (psaA) (Note: Immunized with serotype R36A psaA but recognizes 23 capsular serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1E7 [Mouse hybridoma against SVA VP1]
AC   CVCL_B5YQ
DR   Wikidata; Q111732638
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   1E7(GC) Clone B
AC   CVCL_U071
DR   ECACC; 02043020
DR   Wikidata; Q54582832
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02774; Human GC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   1E8 [Human leukemia]
AC   CVCL_L811
DR   BioSample; SAMN06481104
DR   cancercelllines; CVCL_L811
DR   Wikidata; Q54582833
RX   PubMed=7528218;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (BLIN-1) has been shown to be a NALM-6 derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00169.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV002900866; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8173 ! BLIN-1
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 29
//
ID   1E8 [Mouse hybridoma against chicken MPZ]
AC   CVCL_D141
DR   BCRJ; 0004
DR   Wikidata; Q54582835
RX   PubMed=1720625;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P37301; Chicken MPZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   1E8 [Mouse hybridoma against human DSCs]
AC   CVCL_WT33
SY   IE8
DR   Wikidata; Q93301251
RX   PubMed=7550995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on dendritically shapped cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 4
//
ID   1E8 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5NA
DR   ABCD; ABCD_AE973
RX   PubMed=7705409;
RX   PubMed=8955180;
RX   PubMed=10090746;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1E8.33
AC   CVCL_E7Q8
DR   ABCD; ABCD_BE631
RX   PubMed=22322826;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12107; Human COL11A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1E8H3
AC   CVCL_XI66
DR   CCRID; 4201PAT-CCTCC00697
DR   Wikidata; Q93301254
RX   Patent=CN105017403B;
RX   Patent=CN105021825B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201565.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96EV8; Human DTNBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   1E9
AC   CVCL_B6MF
DR   Wikidata; Q111732639
RX   PubMed=35539281;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_2622; Amarogentin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   1E9.28.1
AC   CVCL_E3ZS
RX   PubMed=2137649;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P21589; Human NT5E/CD73.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1E9A4A4
AC   CVCL_XH55
DR   Wikidata; Q93301256
RX   Patent=US9611320;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4376.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01350; Human GAST.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   1F1 [Mouse hybridoma against human ACP5]
AC   CVCL_B0XL
DR   Wikidata; Q108819449
RX   PubMed=7586523;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1F1 [Mouse hybridoma against human CD14]
AC   CVCL_A8ER
DR   TKG; TKG 0761
DR   Wikidata; Q107113175
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   1F1 [Mouse hybridoma against human TRPC1]
AC   CVCL_E9E2
DR   ABCD; ABCD_AW920
RX   PubMed=14530267;
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/1F1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P48995; Human TRPC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1F10 [Mouse hybridoma against chicken HMGB1]
AC   CVCL_E7Q0
RX   PubMed=28570826;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9YH06; Chicken HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1F10 [Mouse hybridoma against CoA]
AC   CVCL_B6W9
SY   1F10/B11
DR   Wikidata; Q111732640
RX   DOI=10.7124/bc.0008DF;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_15346; Coenzyme A (CoA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   1F10 [Mouse hybridoma against pig IgA]
AC   CVCL_E2ZK
RX   PubMed=26683177;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pig IgA (Note=Recognizes secretory IgA = sIgA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1F10 [Mouse hybridoma against S.mansoni]
AC   CVCL_F1DM
RX   PubMed=4020141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Schistosoma mansoni 22 kDa surface antigen of cercariae, schistosomula and lung worms.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1F10 (M.2)
AC   CVCL_F1DN
SY   M.2
RX   PubMed=4020141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Schistosoma mansoni 22 kDa surface antigen of cercariae, schistosomula and lung worms.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1DM ! 1F10 [Mouse hybridoma against S.mansoni]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1F11 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1EW
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1F11 [Mouse hybridoma against human SPP1]
AC   CVCL_0H91
DR   Wikidata; Q54582878
RX   Patent=US8399207;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11448.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   1F11 [Mouse hybridoma against pig IgA]
AC   CVCL_E2ZL
RX   PubMed=26683177;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pig IgA (Note=Recognizes secretory IgA = sIgA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1F11E5
AC   CVCL_B0H5
DR   ABCD; ABCD_AI189
DR   Wikidata; Q108819450
RX   Patent=US6291652;
RX   PubMed=22037470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2846.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 5
//
ID   1F12
AC   CVCL_F1YQ
RX   PubMed=8120399;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P12449; HIV-2 isolate SBLISY env (Note=AA 22-503 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1F2 [Mouse hybridoma against phage 933W stxA2]
AC   CVCL_XX87
DR   CCRID; 4201PAT-CCTCC00248
DR   Wikidata; Q93301264
RX   Patent=CN101357942B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200822.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09385; Bacteriophage 933W Shiga-like toxin 2 subunit A (stxA2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   1F2 [Mouse hybridoma against T.annulata macroschizonts]
AC   CVCL_B6P9
DR   Wikidata; Q111732641
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with Theileria parva).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   1F2D2
AC   CVCL_XW98
DR   CCRID; 4201PAT-CCTCC01044
DR   Wikidata; Q93301267
RX   Patent=CN106967689B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201750.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07307; Human ASGR2 (Note=Isoform sH2a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 7
//
ID   1F3 [Mouse hybridoma against human IFNAR2]
AC   CVCL_F1WP
RX   Patent=US20030018174;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12426.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48551; Human IFNAR2.
CC   Caution: Patent wrongly indicate the registration number as HP 12426.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1F3 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4SW
DR   Wikidata; Q116047903
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   1F3 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ76
DR   Wikidata; Q93301270
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   1F38
AC   CVCL_XV42
DR   CCRID; 4201PAT-CCTCC00992
DR   Wikidata; Q93301272
RX   Patent=CN107177557B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016220.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05413; Human FABP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   1F4
AC   CVCL_B6G0
DR   Wikidata; Q111732642
RX   Patent=JP2002069100A;
RX   PubMed=19003395;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_67987; Ginsenoside Rg1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   1F42E31FG7
AC   CVCL_XI30
DR   Wikidata; Q93301274
RX   PubMed=3148605;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_144806; N-glycolylneuraminyllactosylceramide (GM3(NeuGc); HD3 ganglioside).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   1F5 [Mouse hybridoma against human MS4A1]
AC   CVCL_D142
DR   CLO; CLO_0001163
DR   ABCD; ABCD_AH978
DR   ATCC; HB-9645
DR   BCRC; 60427
DR   BCRJ; 0005
DR   Wikidata; Q54582879
RX   Patent=US4975278;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9645.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   1F5 [Mouse hybridoma against SVA VP1]
AC   CVCL_B5YR
DR   Wikidata; Q111732643
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   1F5.D1
AC   CVCL_C4QH
DR   ABCD; ABCD_AE780
DR   Wikidata; Q116047904
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00004; Horse CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1F5.D6
AC   CVCL_XX98
SY   1F5.D6(14)
DR   Wikidata; Q93301281
RX   Patent=US7820797;
RX   PubMed=20305658;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9339.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_28009; N-acetyl-beta-D-glucosamine (Note=In beta-O-glycosidic linkage to serine and threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   1F6
AC   CVCL_E6JS
DR   ABCD; ABCD_AE977
RX   PubMed=8618905;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00021; Columba livia CYC (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1F6-1B7
AC   CVCL_E5NX
SY   1F6-1C10
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1F6C8
AC   CVCL_C6M6
DR   Wikidata; Q116047905
RX   Patent=CN114773456B;
RX   PubMed=36445388;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O64255; Mycobacterium phage D29 Gp63 (Note=AA 45-78 = PK34).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   1F7 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FH
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1F7 [Mouse hybridoma against human TF]
AC   CVCL_JX61
DR   Wikidata; Q54582880
RX   PubMed=14678650;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JX60 ! SpEBr-5
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 4
//
ID   1F8
AC   CVCL_YN74
DR   Wikidata; Q93301291
RX   PubMed=20443708;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   1F8G5D6D2
AC   CVCL_WZ77
DR   Wikidata; Q93301293
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   1F9-C6
AC   CVCL_E8UR
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1F9.1.1
AC   CVCL_U722
SY   anti-FcRH1-1F9
DR   Wikidata; Q54582882
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6332.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96LA6; Human FCRL1/CD307a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   1G1
AC   CVCL_1929
DR   DSMZ; ACC-424
DR   DSMZCellDive; ACC-424
DR   Wikidata; Q54582883
RX   PubMed=9208228;
CC   Doubling time: ~30 hours (DSMZ=ACC-424).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chicken dorsal retina cytoplasmic membranes (1G1 antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   1G10 [Mouse hybridoma against HIV-1 rev]
AC   CVCL_A0CA
DR   Wikidata; Q108819451
RX   PubMed=8107211;
RX   PubMed=9305730;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1G10 [Mouse hybridoma against pig SIGLEC10]
AC   CVCL_C3VH
DR   Wikidata; Q116047907
RX   PubMed=28742001;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A068F110; Pig SIGLEC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1G10 [Mouse/rat hybridoma against mouse Cd80]
AC   CVCL_9147
DR   CLO; CLO_0001165
DR   ATCC; CRL-2223
DR   Wikidata; Q54582885
RX   PubMed=7509723;
RX   PubMed=7510738;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00609; Mouse Cd80.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   1G10.1.5
AC   CVCL_J986
DR   Wikidata; Q54582888
RX   Patent=US20080171036;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4297.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   1G11
AC   CVCL_B3R4
DR   Wikidata; Q110429728
RX   PubMed=9301641;
RX   PubMed=32093740;
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
CC   Breed/subspecies: C57BL/6NCrLBR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 5
//
ID   1G11.14.7
AC   CVCL_B0E9
SY   1G11
DR   Wikidata; Q108819452
RX   Patent=US7744881;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3361.
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1G12
AC   CVCL_J164
DR   CLO; CLO_0001166
DR   ATCC; CRL-2827
DR   Wikidata; Q54582889
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   1G1.9
AC   CVCL_C9FR
DR   Wikidata; Q123030231
RX   Patent=US8231877;
RX   PubMed=9631008;
CC   Doubling time: 12 hours (PubMed=9631008).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   1G1.E9
AC   CVCL_C4QI
DR   ABCD; ABCD_AE777
DR   Wikidata; Q116047908
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00004; Horse CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1G2 [Human hybrid]
AC   CVCL_6345
SY   HKB11 clone 1G2; MSB7241
DR   CLO; CLO_0001167
DR   ATCC; CRL-13005
DR   BioSample; SAMN03471349
DR   Wikidata; Q54582892
RX   Patent=US6136599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-87.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6014; IL4 (Note=With p.Thr37Asp and p.Arg145Glu = IL-4SA).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
ST   Source(s): ATCC=CRL-13005
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9,12
ST   D7S820: 8,11,12
ST   TH01: 7,9,9.3
ST   TPOX: 11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3712 ! HKB-11
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   1G2 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FI
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1G2 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5NB
DR   ABCD; ABCD_AE968
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1G3 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0JZ
DR   ATCC; HB-12489
DR   Wikidata; Q108819453
RX   Patent=US6150508;
RX   PubMed=9817391;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12489.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1G3 [Mouse hybridoma against rat Fcgrt]
AC   CVCL_D149
DR   CLO; CLO_0001168
DR   ATCC; CRL-2434
DR   Wikidata; Q54582893
RX   PubMed=7889418;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13599; Rat Fcgrt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   1G2 [Mouse hybridoma against TMUV prM]
AC   CVCL_E7DG
RX   PubMed=28409665;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0C6DUM8; Tembusu virus (strain TMUV-YY1Du) genome polyprotein (Note=Protein prM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1G2F8
AC   CVCL_F0IX
DR   ECACC; 21043001
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P95829; Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) dnaK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1G3.E3
AC   CVCL_C4QJ
DR   ABCD; ABCD_AE775
DR   Wikidata; Q116047909
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62894; Bovine CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1G4 [Mouse hybridoma against C.botulinum botA]
AC   CVCL_B0X5
DR   Wikidata; Q108819454
RX   PubMed=23342681;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_B0WT ! 1C10 [Mouse/sheep heteromyeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   1G4 [Mouse hybridoma against chicken CSF1]
AC   CVCL_C4JY
DR   Wikidata; Q116047910
RX   PubMed=35688031;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; D8UWD9; Chicken CSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1G4 [Mouse hybridoma against zearalenone]
AC   CVCL_E2SU
RX   PubMed=23837984;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   1G5 [Human Jurkat derivative]
AC   CVCL_X694
DR   BEI_Resources; ARP-1819
DR   cancercelllines; CVCL_X694
DR   Wikidata; Q54582896
RX   PubMed=8018390;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 20
//
ID   1G5 [Mouse hybridoma against abrin-A]
AC   CVCL_E4BZ
RX   PubMed=21870856;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11140; Abrus precatorius abrin-A (Note=AA 262-528 = B chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1G5 [Mouse hybridoma against CDV F]
AC   CVCL_E7DZ
RX   PubMed=28472594;
RX   PubMed=28636501;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; D2JYB4; Canine distemper virus (strain Snyder Hill) fusion glycoprotein (F).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1G5 [Mouse hybridoma against chicken IL7R]
AC   CVCL_C4JR
DR   Wikidata; Q116047911
RX   PubMed=35973349;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A1EA95; Chicken IL7R/CD127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1G5 [Mouse hybridoma against human RB1]
AC   CVCL_A0RY
DR   Wikidata; Q108819455
RX   Patent=US5710255;
RX   PubMed=7510760;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1G6 [Mouse hybridoma against saikosaponin A]
AC   CVCL_B6G4
DR   Wikidata; Q111732644
RX   PubMed=14709901;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   1G6 [Mouse hybridoma against vaccinia A27L]
AC   CVCL_E5M5
RX   PubMed=26889021;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11258; Vaccinia virus protein OPG154 (A27L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1G6-D7
AC   CVCL_E9E8
RX   PubMed=27721406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07900; Human HSP90AA1 (Note=Immunized with AA 236-350).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1G7 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FJ
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1G7 [Mouse hybridoma against C.livia CYC]
AC   CVCL_E6JT
RX   PubMed=8618905;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00021; Columba livia CYC (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1G7 [Mouse hybridoma against HIV-1 rev]
AC   CVCL_A0CB
DR   BEI_Resources; ARP-7382
DR   Wikidata; Q108819456
RX   PubMed=8107211;
RX   PubMed=9305730;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   1G7 [Mouse hybridoma against human GYPA]
AC   CVCL_E8P8
RX   PubMed=31486711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   1G7 [Mouse hybridoma against I.punctatus Ig light chains]
AC   CVCL_B7G9
SY   1G7-3
DR   Wikidata; Q112926911
RX   PubMed=6421929;
RX   PubMed=6813154;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Ictalurus punctatus Ig light chains F-type.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 4
//
ID   1G7 [Mouse hybridoma against phOX]
AC   CVCL_C4FL
DR   ABCD; ABCD_AE297
DR   Wikidata; Q116047912
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1G7-2
AC   CVCL_B0U4
DR   Wikidata; Q108819457
RX   Patent=EP0479454A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10540.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   1G8 [Ictalurus]
AC   CVCL_5384
SY   IG8
DR   CLO; CLO_0001169
DR   ATCC; CRL-2756
DR   Wikidata; Q54582897
RX   PubMed=8799617;
RX   PubMed=8988857;
RX   PubMed=11687262;
RX   PubMed=18572245;
RX   PubMed=18824023;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   1G8 [Mouse hybridoma against human PSCA]
AC   CVCL_B0TN
DR   Wikidata; Q108819458
RX   Patent=US8524460;
RX   PubMed=10713670;
RX   PubMed=11226295;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12612.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1G9
AC   CVCL_B0K0
SY   1G93C4
DR   ATCC; HB-12495
DR   Wikidata; Q108819459
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12495.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1H
AC   CVCL_J416
DR   Wikidata; Q54582898
RX   PubMed=11437454;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084.
CC   Breed/subspecies: FVB/N Nkx2.5-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   1H1
AC   CVCL_B6M8
DR   ABCD; ABCD_AJ805
DR   Wikidata; Q111732920
RX   PubMed=28187468;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_6949; Miroestrol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   1H10
AC   CVCL_XF04
DR   CCRID; 4201PAT-CCTCC00517
DR   Wikidata; Q93301353
RX   Patent=CN104610452B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014186.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01151; Human CD83.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   1H10-6
AC   CVCL_J165
SY   1H10
DR   CLO; CLO_0001170
DR   ATCC; HB-48
DR   Wikidata; Q54582901
RX   PubMed=6285749;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09866; Dengue virus type 4 genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 6
//
ID   1H11 [Mouse hybridoma against human COL1A2]
AC   CVCL_J166
DR   CLO; CLO_0001171
DR   ATCC; HB-10611
DR   Wikidata; Q54582903
RX   Patent=US5300434;
RX   Patent=US5677198;
RX   PubMed=1466251;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10611.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08123; Human COL1A2 (Note=Recognizes cross-linked N-telopeptides "QYDGKGVG" where K is involved in trivalent cross-linking).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   1H11 [Mouse hybridoma against M.marinum 56 kDa antigen]
AC   CVCL_C5HJ
DR   Wikidata; Q116047913
RX   PubMed=11172985;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mycobacterium marinum 56 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1H11 [Mouse hybridoma against methyl-alpha-D-mannopyranoside]
AC   CVCL_C5E5
DR   ABCD; ABCD_AI430
DR   Wikidata; Q116047914
RX   PubMed=15585860;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_43943; Methyl alpha-D-mannoside (Methyl alpha-D-mannopyranoside).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   1H11 [Mouse hybridoma against spring viremia of carp G]
AC   CVCL_D6U6
RX   DOI=10.1089/mab.2014.0059;
RX   PubMed=25358003;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q91DS0; Spring viremia of carp virus G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   1H12
AC   CVCL_C4A9
DR   Wikidata; Q116047915
RX   PubMed=30763351;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fibrin D-dimer (Note=Also reacts strongly with fibrinogen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1H2
AC   CVCL_XC18
DR   Wikidata; Q93301372
RX   Patent=CN103215231B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201329.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_7719; Ochratoxin A (OTA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 5
//
ID   1H2-2C6
AC   CVCL_C8LL
DR   Wikidata; Q123030232
RX   PubMed=35158128;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_92386; Xylazine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   1H3
AC   CVCL_G577
DR   CLO; CLO_0001172
DR   ATCC; HB-284
DR   Wikidata; Q54582904
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   1H4
AC   CVCL_C3T9
DR   Wikidata; Q116047916
RX   PubMed=9790073;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92934; Human BAD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1H5 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1EV
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   1H5 [Mouse hybridoma against thebaine]
AC   CVCL_B6GA
DR   Wikidata; Q111732646
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
ID   1H5.25.9
AC   CVCL_B0EB
SY   1H5
DR   Wikidata; Q108819460
RX   Patent=US20110002933;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12695.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   1H5D7E3
AC   CVCL_C5CD
DR   Wikidata; Q116047917
RX   PubMed=22509918;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P21554; Human CNR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1H6 [Mouse hybridoma against chicken IL7]
AC   CVCL_C4JJ
DR   Wikidata; Q116047918
RX   PubMed=33652529;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3C0R7; Chicken IL7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   1H6 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ78
DR   Wikidata; Q93301384
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   1H7
AC   CVCL_C5E6
DR   ABCD; ABCD_AI427
DR   Wikidata; Q116047919
RX   PubMed=15585860;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_43943; Methyl alpha-D-mannoside (Methyl alpha-D-mannopyranoside).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   1H7-4B
AC   CVCL_C0E2
DR   Wikidata; Q112926912
DR   Ximbio; 153324
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P40199; Human CEACAM6/CD66c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   1H7G10D10F7
AC   CVCL_WZ79
DR   Wikidata; Q93301388
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   1H8 [Mouse hybridoma against human BMSC]
AC   CVCL_A7TU
DR   Wikidata; Q107113176
RX   DOI=10.4110/in.2001.1.1.14;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 80 kDa protein on bone marrow stromal cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   1H8 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ80
DR   Wikidata; Q93301391
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   1H8 [Mouse hybridoma against sheep IgG]
AC   CVCL_B6KY
DR   Wikidata; Q111732647
RX   Patent=RU2377298;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 73.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Sheep IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   1H9 [Mouse hybridoma against cadmium]
AC   CVCL_C4AZ
DR   ABCD; ABCD_AI801
DR   CCRID; 4201PAT-CCTCC00650
DR   Wikidata; Q116047920
RX   Patent=CN104762268B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201521.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_48775; Cadmium(2+).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   1H9 [Mouse hybridoma against L.mesenteroides zwf]
AC   CVCL_E3AU
RX   PubMed=2437192;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11411; Leuconostoc mesenteroides glucose-6-phosphate 1-dehydrogenase (zwf).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1HAEo-
AC   CVCL_0113
SY   1HAEo; 1HAEo(-)
DR   BTO; BTO_0002636
DR   EFO; EFO_0022561
DR   MCCL; MCC:0000004
DR   Millipore; SCC152
DR   Wikidata; Q54582906
RX   PubMed=1282914;
RX   PubMed=15463957;
CC   Characteristics: Useful model for the study of epithelial ion transport, secretion and biochemistry (Millipore=SCC152).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, tracheobronchial epithelium; UBERON=UBERON_0008397.
CC   Cell type: Epithelial cell of tracheobronchial tree; CL=CL_0002202.
ST   Source(s): Millipore=SCC152
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 12,13
ST   D18S51: 11,18
ST   D21S11: 30,32
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 9,11
ST   Penta E: 15,19
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   1HB
AC   CVCL_J417
DR   Wikidata; Q54582908
RX   PubMed=11437454;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084.
CC   Breed/subspecies: FVB/N Nkx2.5-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   1hFT.1.6D4.1C8
AC   CVCL_B0UW
SY   PIP
DR   Wikidata; Q108819461
RX   Patent=US7405061;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4220.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Mullerian duct-derived epithelial cell antigen PIPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   1II-NFUD2
AC   CVCL_D4B8
DR   Wikidata; Q127378683
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: MZM-0410.
OX   NCBI_TaxID=105023; ! Nothobranchius furzeri (Turquoise killifish)
SX   Sex unspecified
AG   Diapause II embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   1L12
AC   CVCL_RY05
SY   Sporadic FTD iPSC #12
DR   Wikidata; Q54582909
RX   PubMed=23063362;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY07 ! 1L9
OI   CVCL_RY06 ! 1L23
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   1L23
AC   CVCL_RY06
SY   Sporadic FTD iPSC #23
DR   Wikidata; Q54582910
RX   PubMed=23063362;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY07 ! 1L9
OI   CVCL_RY05 ! 1L12
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   1L9
AC   CVCL_RY07
SY   Sporadic FTD iPSC #9
DR   Wikidata; Q54582912
RX   PubMed=23063362;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY05 ! 1L12
OI   CVCL_RY06 ! 1L23
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   1LMF-h-iPS 1
AC   CVCL_E5KI
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KJ ! 1LMF-h-iPS 2
OI   CVCL_E5KK ! 1LMF-h-iPS 3
OI   CVCL_E5KL ! 1LMF-h-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1LMF-h-iPS 2
AC   CVCL_E5KJ
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KI ! 1LMF-h-iPS 1
OI   CVCL_E5KK ! 1LMF-h-iPS 3
OI   CVCL_E5KL ! 1LMF-h-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1LMF-h-iPS 3
AC   CVCL_E5KK
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KI ! 1LMF-h-iPS 1
OI   CVCL_E5KJ ! 1LMF-h-iPS 2
OI   CVCL_E5KL ! 1LMF-h-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1LMF-h-iPS 4
AC   CVCL_E5KL
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KI ! 1LMF-h-iPS 1
OI   CVCL_E5KJ ! 1LMF-h-iPS 2
OI   CVCL_E5KK ! 1LMF-h-iPS 3
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1LMF-o-iPS 1
AC   CVCL_E5KM
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KN ! 1LMF-o-iPS 2
OI   CVCL_E5KP ! 1LMF-o-iPS 3
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1LMF-o-iPS 2
AC   CVCL_E5KN
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KM ! 1LMF-o-iPS 1
OI   CVCL_E5KP ! 1LMF-o-iPS 3
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1LMF-o-iPS 3
AC   CVCL_E5KP
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KM ! 1LMF-o-iPS 1
OI   CVCL_E5KN ! 1LMF-o-iPS 2
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   1LN-8
AC   CVCL_LC06
SY   1LN8
DR   Wikidata; Q54582913
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2693.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   1N8
AC   CVCL_E2YT
DR   ABCD; ABCD_AV465
RX   PubMed=24555938;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; B3GRV0; Morbillivirus canis (strain CDV3) N protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   1P10.2
AC   CVCL_E4A1
RX   PubMed=14675102;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   1R [Mouse L cells]
AC   CVCL_DD99
DR   Wikidata; Q54582915
RX   PubMed=69325;
RX   PubMed=4309885;
RX   PubMed=4516198;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   1R [Rat embryo fibroblast]
AC   CVCL_B6QW
DR   Wikidata; Q111732648
RX   PubMed=2655894;
RX   PubMed=3028610;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   1R10F11.34.16
AC   CVCL_XC70
SY   HB 1R10F11; OM1
DR   ATCC; HB-10397
DR   CCRID; 4201PAT-CCTCC00082
DR   Wikidata; Q93301455
RX   Patent=US5907033;
RX   PubMed=1379836;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10397.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13725; Human OSM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   1SOD1-4
AC   CVCL_ZY45
DR   Wikidata; Q102113429
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His47Arg (c.140A>G) (H46R); ClinVar=VCV000014764; Zygosity=Unspecified (PubMed=30127392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY46 ! 1SOD1-6
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   1SOD1-6
AC   CVCL_ZY46
DR   Wikidata; Q102113430
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His47Arg (c.140A>G) (H46R); ClinVar=VCV000014764; Zygosity=Unspecified (PubMed=30127392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY45 ! 1SOD1-4
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   2-108
AC   CVCL_E5PB
SY   mAb 2-108
RX   PubMed=26974561;
RX   PubMed=27097072;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q99075; Human HBEGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2-115-19
AC   CVCL_C5PW
DR   ABCD; ABCD_AE756
DR   Wikidata; Q116047921
RX   PubMed=1280761;
RX   PubMed=3500505;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P02708; Human CHRNA1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5PX ! 2-115-58
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   2-115-58
AC   CVCL_C5PX
DR   Wikidata; Q116047922
RX   PubMed=1280761;
RX   PubMed=3500505;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody TR63.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5PW ! 2-115-19
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   2-13
AC   CVCL_B3YC
DR   Wikidata; Q110429730
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   2-14
AC   CVCL_C3VZ
DR   Wikidata; Q116047923
RX   CelloPub=CLPUB00724;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2-179-E11
AC   CVCL_J659
SY   2.179.E11
DR   ECACC; 92030602
DR   NCBI_Iran; H128
DR   Wikidata; Q54582919
RX   PubMed=2439440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   2-189-H-1
AC   CVCL_A9NH
DR   CCRID; 4201PAT-CCTCC00758
DR   Wikidata; Q108819462
RX   Patent=CN106046162B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015160.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2-1D5
AC   CVCL_9V13
DR   Wikidata; Q54582920
RX   DOI=10.1007/978-1-4684-4949-5_8;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Human herpesvirus 3 (HHV-3).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W179 ! SBC-H20
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   2-2 [Chlorocebus aethiops]
AC   CVCL_T341
DR   CLO; CLO_0050507
DR   RCB; RCB1375
DR   Wikidata; Q54582922
RX   PubMed=8973332;
CC   Group: Non-human primate cell line.
CC   Characteristics: 35 copies of CAG-loxP-neo-pA-loxP-LacZ were tandemly inserted. Cre will delete neo-pA and induce LacZ (RCB=RCB1375).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   2-2 [Mouse hybridoma against human ENO2]
AC   CVCL_B6WX
DR   CCRID; 4201PAT-CCTCC00727
DR   Wikidata; Q111732650
RX   Patent=CN105132380B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015104.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P09104; Human ENO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   2-2 [Mouse hybridoma against human IL26]
AC   CVCL_C7I5
DR   Wikidata; Q123030233
RX   Patent=JP7061750;
RX   PubMed=31397631;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE P-02580.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NPH9; Human IL26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   2-2 [Mouse hybridoma against human TCN2]
AC   CVCL_B3YD
DR   Wikidata; Q110429732
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   2-21
AC   CVCL_C3W0
DR   Wikidata; Q116047924
RX   CelloPub=CLPUB00724;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2-23
AC   CVCL_C0WI
DR   Wikidata; Q114310353
RX   PubMed=28681925;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0WC ! STPLF-fF
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   2-27
AC   CVCL_C3W1
DR   Wikidata; Q116047925
RX   CelloPub=CLPUB00724;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2-27-Ad
AC   CVCL_IY39
SY   2-27 Ad
DR   Wikidata; Q54582924
RX   CelloPub=CLPUB00384;
RX   PubMed=6310010;
RX   PubMed=6324641;
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   2-3
AC   CVCL_C3W2
DR   Wikidata; Q116047926
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2-40
AC   CVCL_C3W3
DR   Wikidata; Q116047927
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2-44
AC   CVCL_C3W4
DR   Wikidata; Q116047928
RX   CelloPub=CLPUB00724;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1+IgM, kappa+lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
CC   Miscellaneous: This hybridoma secretes IgG1 and IgM heavy chains and kappa and lambda light chains but which heavy chain is linked to which light chain is not indicated in CelloPub=CLPUB00724 and PubMed=6434941.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   2-6
AC   CVCL_B3YE
DR   Wikidata; Q110429736
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   2-7
AC   CVCL_T366
DR   CLO; CLO_0050509
DR   RCB; RCB1376
DR   Wikidata; Q54582925
RX   PubMed=8973332;
CC   Group: Non-human primate cell line.
CC   Characteristics: A copy of CAG-loxP-neo-pA-loxP-LacZ was inserted. Cre will delete neo-pA and induce LacZ (RCB=RCB1376).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   2-9
AC   CVCL_C3W5
DR   Wikidata; Q116047929
RX   CelloPub=CLPUB00724;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2.03.7
AC   CVCL_J167
SY   2.03
DR   CLO; CLO_0001174
DR   ATCC; HB-8389
DR   Wikidata; Q54582928
RX   Patent=US4650676;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8389.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Eimeria tenella merozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   2.040 pRSV-T
AC   CVCL_6346
SY   2.040
DR   CLO; CLO_0001175
DR   ATCC; CRL-3606
DR   ATCC; CRL-11516
DR   BioSample; SAMN03471339
DR   Wikidata; Q54582929
RX   Patent=US5672498;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11516.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Discontinued: ATCC; CRL-11516; true.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
ST   Source(s): ATCC=CRL-3606
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9.3,10
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   2.1
AC   CVCL_C5X3
DR   Wikidata; Q116047930
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2.12.1
AC   CVCL_ZW78
SY   LN 15846
DR   Wikidata; Q102113431
RX   Patent=US9234041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2792.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   2.13.2
AC   CVCL_ZW79
SY   LN 15842
DR   Wikidata; Q102113432
RX   Patent=US9234041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2788.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   2.14.3
AC   CVCL_ZW80
SY   LN 15844
DR   Wikidata; Q102113433
RX   Patent=US9234041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2790.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   2.28 M1
AC   CVCL_J174
SY   A2,28M1
DR   CLO; CLO_0001177
DR   ATCC; HB-166
DR   Wikidata; Q54582932
RX   PubMed=1377666;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J171 ! Sp2/08A2
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   2.29
AC   CVCL_A0AL
DR   Wikidata; Q108819463
RX   PubMed=15941912;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95944; Human NCR2/CD336.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2.31.1
AC   CVCL_D2Q2
DR   ABCD; ABCD_AE107
DR   Wikidata; Q127378684
RX   PubMed=1698868;
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   2.43
AC   CVCL_7235
DR   CLO; CLO_0001178
DR   ATCC; TIB-210
DR   BCRC; 60473
DR   IZSLER; BS Hy 53
DR   Wikidata; Q54582935
RX   PubMed=6184304;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 14
//
ID   2.4G2
AC   CVCL_9148
DR   CLO; CLO_0001179
DR   ATCC; HB-197
DR   BCRJ; 0006
DR   Wikidata; Q54582936
RX   PubMed=90108;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08508; Mouse Fcgr3/Cd16.
CC   Monoclonal antibody target: UniProtKB; P08101; Mouse Fcgr2/Cd32.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   2.7.1G.10
AC   CVCL_F0VU
RX   PubMed=2312131;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human CEA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2.B2
AC   CVCL_E4FA
SY   2B2
RX   PubMed=19305140;
CC   Omics: Variations; SNP array analysis.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0334 ! Hs 766T
HI   CVCL_1635 ! Panc 03.27
CA   Hybrid cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   2:1
AC   CVCL_C5DA
DR   Wikidata; Q116047931
RX   PubMed=11991817;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F7ED68; Macaca mulatta NEFL (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2/10SN
AC   CVCL_D7EE
RX   PubMed=1612780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 44 kDa monomeric antigen on ocular melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2/11
AC   CVCL_A1YJ
SY   2.11
DR   Wikidata; Q105505879
RX   PubMed=19276180;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 63.5 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   2/165
AC   CVCL_XY71
DR   Wikidata; Q93301531
RX   PubMed=10519007;
RX   PubMed=10769206;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q1ZXQ8; Dictyostelium discoideum mtaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   2/24
AC   CVCL_D6VA
RX   PubMed=1374058;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13987; Human CD59.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   20
AC   CVCL_J923
SY   Anti PDGF hybridoma #20
DR   Wikidata; Q54582937
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9355.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   20-10-5S
AC   CVCL_G578
DR   CLO; CLO_0001183
DR   ATCC; HB-23
DR   Wikidata; Q54582939
RX   PubMed=6174608;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   20-121-1
AC   CVCL_YA94
DR   DSHB; 20-121-1
DR   Wikidata; Q93301543
RX   PubMed=2408765;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08796; Dictyostelium discoideum csaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   20-17-3
AC   CVCL_C3W6
DR   Wikidata; Q116047933
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20-19-1
AC   CVCL_C3W7
DR   Wikidata; Q116047934
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20-20-3
AC   CVCL_C3W8
DR   Wikidata; Q116047935
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20-3
AC   CVCL_C7I6
DR   Wikidata; Q123030234
RX   Patent=JP7061750;
RX   PubMed=31397631;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE P-02578.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NPH9; Human IL26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   20-4-4
AC   CVCL_C3W9
DR   Wikidata; Q116047936
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20-53-1
AC   CVCL_YA95
DR   DSHB; 20-53-1
DR   Wikidata; Q93301545
RX   PubMed=2408765;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08796; Dictyostelium discoideum csaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   20-6-3
AC   CVCL_C3WA
DR   Wikidata; Q116047937
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20-8-4S
AC   CVCL_G579
DR   CLO; CLO_0001189
DR   ATCC; HB-11
DR   Wikidata; Q54582943
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   20.1 [Mouse hybridoma against human BTN3A1]
AC   CVCL_XH60
DR   Wikidata; Q93301552
RX   Patent=US10716838;
RX   PubMed=15259006;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4401.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00481; Human BTN3A1/CD277.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   20.1 [Mouse hybridoma against levan]
AC   CVCL_C5X4
DR   Wikidata; Q116047938
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20.27 (SBU-T6, anti-CD1)
AC   CVCL_T975
DR   ECACC; 93070779
DR   Wikidata; Q54582944
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   20.3
AC   CVCL_J620
SY   TAb 250; Tab 250
DR   CLO; CLO_0001180
DR   ATCC; CRL-2655
DR   ATCC; HB-10646
DR   Wikidata; Q54582947
RX   Patent=US6884418;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10646.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   20.6.5
AC   CVCL_D659
DR   BCRJ; 0007
DR   Wikidata; Q54582949
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-beta 2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   20.76
AC   CVCL_M026
DR   ECACC; 93100510
DR   Wikidata; Q54583034
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   20/05-3A4-26-16
AC   CVCL_B0GJ
SY   20/05-3A4; 3A4
DR   Wikidata; Q108819464
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121103.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   20/05-3A4-26-16-Clone 5
AC   CVCL_B0GK
DR   Wikidata; Q108819465
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08041903.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B0GJ ! 20/05-3A4-26-16
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   200 BLCL
AC   CVCL_E370
DR   ECACC; 94031654
DR   Wikidata; Q54583035
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   200-3-G6-4
AC   CVCL_J511
SY   20.4; ME20.4
DR   CLO; CLO_0001181
DR   ATCC; HB-8737
DR   Wikidata; Q54583038
RX   Patent=US4786593;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8737.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08138; Human NGFR/CD271.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   2004
AC   CVCL_U759
DR   Cosmic; 802248
DR   GEO; GSM3145595
DR   GEO; GSM3145685
DR   PharmacoDB; 2004_6_2019
DR   Wikidata; Q54583040
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   2006042530
AC   CVCL_V364
DR   IPD-IMGT/HLA; 14457
DR   Wikidata; Q54583042
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02:01:01,33:03:01; B*15:07,58:13; C*03:02,03:03:01; DPA1*01:03:01,02:02:02; DPB1*02:01:02,05:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:09; DRB1*04:03:01,13:02:01; DRB3*03:01:01; DRB4*01:03:01 (IPD-IMGT/HLA=14457).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   2008/C13*5.25
AC   CVCL_0114
SY   2008/C13_5_25; 2008/c13*5.25; OV 2008/C13*5.25; OV2008/C13; 2008C13; 2008 C-13; C13; 2008/C13.R; ME180C13
DR   BTO; BTO_0003989
DR   MCCL; MCC:0000005
DR   BioSample; SAMN03151842
DR   BioSample; SAMN06481105
DR   cancercelllines; CVCL_0114
DR   ChEMBL-Cells; CHEMBL3308686
DR   ChEMBL-Targets; CHEMBL614863
DR   Cosmic; 948294
DR   Cosmic; 1479983
DR   GEO; GSM711717
DR   GEO; GSM851911
DR   NCBI_Iran; C446
DR   PRIDE; PXD003668
DR   PubChem_Cell_line; CVCL_0114
DR   Wikidata; Q54583043
RX   PubMed=22710073;
RX   PubMed=27561551;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative (PubMed=22710073).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00522.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 15.2
ST   D21S11: 30,31
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0473 ! OV-2008
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   200D
AC   CVCL_5448
DR   CLO; CLO_0001182
DR   CLDB; cl34
DR   ECACC; 93092101
DR   Wikidata; Q54583044
RX   PubMed=8795574;
CC   Doubling time: ~52 hours (Note=At 7th passage) (PubMed=8795574).
CC   Discontinued: ECACC; 93092101; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   200F9
AC   CVCL_B0D7
DR   Wikidata; Q108819466
RX   Patent=US4938948;
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10791.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10062.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   201 BLCL
AC   CVCL_E371
DR   ECACC; 94031655
DR   Wikidata; Q54583045
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   201.3
AC   CVCL_B0CT
DR   Wikidata; Q108819467
RX   Patent=US6162902;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12045.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   201-45E9
AC   CVCL_J316
DR   CLO; CLO_0001184
DR   ATCC; CRL-2670
DR   Wikidata; Q54583046
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   2012 [Human B-cell IHW]
AC   CVCL_E433
SY   WELA
DR   dbMHC; 48451
DR   ECACC; 94071416
DR   IHW; IHW09347
DR   IPD-IMGT/HLA; 10095
DR   Wikidata; Q54583048
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: DQA1*01:03:01:01,01:04:01:01; DQB1*06:03:01; DRB1*13:01; DRB3*01:01 (IPD-IMGT/HLA=10095).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   2012 [Mouse liver]
AC   CVCL_U402
DR   Wikidata; Q54583049
RX   PubMed=8639765;
RX   PubMed=9108096;
RX   PubMed=9192756;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   2013
AC   CVCL_G029
SY   WEWI
DR   IPD-IMGT/HLA; 10096
DR   Wikidata; Q54583050
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQA1*01:02,01:04:01; DQB1*06:05:01; DRB1*13:02; DRB3*03:01 (IPD-IMGT/HLA=10096).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   2018
AC   CVCL_6553
DR   CLO; CLO_0001185
DR   ATCC; CRL-10907
DR   Wikidata; Q54583054
RX   Patent=US5621090;
RX   PubMed=8639765;
RX   PubMed=9108096;
RX   PubMed=9192756;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10907.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-10907; true.
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   201B1
AC   CVCL_A062
SY   201-B1; KUIFMSi004-A
DR   BioSamples; SAMEA7996629
DR   hPSCreg; KUIFMSi004-A
DR   SKIP; SKIP001160
DR   SKIP; SKIP002369
DR   Wikidata; Q54583056
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10
ST   Penta E: 7,19
ST   TH01: 5
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 18
//
ID   201B2
AC   CVCL_A063
SY   201-B2; KUIFMSi004-D; vWT-201B2
DR   GEO; GSM1040248
DR   GEO; GSM1040318
DR   hPSCreg; KUIFMSi004-D
DR   SKIP; SKIP000536
DR   SKIP; SKIP001161
DR   SKIP; SKIP002370
DR   Wikidata; Q54583058
RX   PubMed=18035408;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10
ST   Penta E: 7,19
ST   TH01: 5
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   201B3
AC   CVCL_A064
SY   201-B3; KUIFMSi004-E
DR   hPSCreg; KUIFMSi004-E
DR   SKIP; SKIP001162
DR   SKIP; SKIP002371
DR   Wikidata; Q54583060
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10
ST   Penta E: 7,19
ST   TH01: 5
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   201B6
AC   CVCL_A065
SY   201-B6; KUIFMSi004-B
DR   GEO; GSM1040249
DR   GEO; GSM1040319
DR   GEO; GSM1489217
DR   GEO; GSM1489422
DR   hPSCreg; KUIFMSi004-B
DR   SKIP; SKIP001163
DR   SKIP; SKIP002372
DR   Wikidata; Q54583061
RX   PubMed=18035408;
RX   PubMed=21098095;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=24399248;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Doubling time: 28.97 hours (PubMed=24399248).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10
ST   Penta E: 7,19
ST   TH01: 5
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   201B7
AC   CVCL_A324
SY   201-B7; 201B7-WT; 201B-7; KYOU-DXR0109B; KUIFMSi004-C; vWT-201B7; HiPS201B7; HPS0063; B7
DR   ATCC; ACS-1023
DR   BioSamples; SAMEA7996628
DR   GEO; GSM241846
DR   GEO; GSM608015
DR   GEO; GSM608028
DR   GEO; GSM701542
DR   GEO; GSM1040250
DR   GEO; GSM1040320
DR   GEO; GSM1489218
DR   GEO; GSM1489423
DR   GEO; GSM2265470
DR   GEO; GSM2265471
DR   GEO; GSM2592201
DR   GEO; GSM2592202
DR   GEO; GSM2802521
DR   GEO; GSM2802522
DR   GEO; GSM3239683
DR   GEO; GSM3239684
DR   hPSCreg; KUIFMSi004-C
DR   PRIDE; PXD000071
DR   RCB; HPS0001
DR   RCB; HPS0063
DR   SKIP; SKIP000001
DR   SKIP; SKIP000537
DR   SKIP; SKIP002373
DR   SKIP; SKIP004667
DR   Wikidata; Q27554318
RX   PubMed=18035408;
RX   PubMed=19956543;
RX   PubMed=21098095;
RX   PubMed=21460823;
RX   PubMed=21637780;
RX   PubMed=21900357;
RX   PubMed=22056147;
RX   PubMed=22802639;
RX   PubMed=22848530;
RX   PubMed=23039195;
RX   PubMed=23210603;
RX   PubMed=24259714;
RX   PubMed=24399248;
RX   PubMed=24935155;
RX   PubMed=26626025;
RX   PubMed=27476965;
RX   PubMed=27806289;
RX   PubMed=28453617;
RX   PubMed=28587749;
RX   PubMed=29179815;
RX   PubMed=30127392;
RX   PubMed=32034090;
RX   PubMed=34287353;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Doubling time: 26.90 hours (PubMed=24399248).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: RCB; HPS0001; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10
ST   Penta E: 7,19
ST   TH01: 5
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   201B7 PITX2-EGFP knockin hiPSC clone 8-2
AC   CVCL_ZE48
DR   Wikidata; Q98125325
RX   PubMed=32034090;
CC   Population: Caucasian.
CC   Characteristics: Using TALEN an IRES2 (2A)-EGFP-SV40 poly(A)-neo cassette was inserted at the 3'end of PITX2.
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A324 ! 201B7
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   201B7-R334W
AC   CVCL_A4IP
DR   Wikidata; Q105505882
RX   PubMed=28587749;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple_edited; p.Arg334Trp (c.1000C>T) (p.Arg307Trp, c.919C>T); ClinVar=VCV000004696; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28587749).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A324 ! 201B7
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   201T
AC   CVCL_X481
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X481
DR   Cell_Model_Passport; SIDM00055
DR   Cosmic; 910550
DR   Cosmic-CLP; 1287381
DR   DepMap; ACH-002089
DR   EGA; EGAS00001000978
DR   GDSC; 1287381
DR   GEO; GSM827492
DR   GEO; GSM1669564
DR   PharmacoDB; 201T_7_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_X481
DR   Wikidata; Q54583071
RX   PubMed=9816093;
RX   PubMed=9816140;
RX   PubMed=10545285;
RX   PubMed=15735034;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Population: African American.
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Ala (c.721T>G); ClinVar=VCV000376665; Zygosity=Homozygous (Cosmic-CLP=1287381; DepMap=ACH-002089).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=88.81%; Native American=0%; East Asian, North=2.58%; East Asian, South=0%; South Asian=0%; European, North=3.06%; European, South=5.55% (PubMed=30894373).
CC   Miscellaneous: Age of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1287381
ST   Amelogenin: X,Y
ST   CSF1PO: 7,13
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 6,8
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 25
//
ID   202 BLCL
AC   CVCL_E372
DR   ECACC; 94031656
DR   Wikidata; Q54583073
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   202-11A8
AC   CVCL_J317
SY   202-11AB
DR   CLO; CLO_0001186
DR   ATCC; CRL-2669
DR   Wikidata; Q54583075
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8895.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00526; Rous sarcoma virus subgroup C (strain Prague) v-Src.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   202-9D10
AC   CVCL_J581
DR   Wikidata; Q54583077
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8900.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00526; Rous sarcoma virus subgroup C (strain Prague) v-Src.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   202002
AC   CVCL_E434
DR   dbMHC; 48452
DR   IHW; IHW09395
DR   IPD-IMGT/HLA; 25999
DR   Wikidata; Q54583078
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01:01:01,03:02; B*08:01; C*07; DRB1*04:08; DRB4*01:03:01:01 (IPD-IMGT/HLA=25999).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   203 BLCL
AC   CVCL_E373
DR   ECACC; 94031657
DR   Wikidata; Q54583080
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   203-6F5
AC   CVCL_J582
DR   Wikidata; Q54583083
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8899.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00524; Rous sarcoma virus subgroup A (strain Schmidt-Ruppin) v-Src.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   203-7D10
AC   CVCL_J543
SY   203-07D10
DR   CLO; CLO_0001187
DR   ATCC; CRL-2651
DR   Wikidata; Q54583084
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8898.
CC   Monoclonal antibody isotype: IgG2a+IgG2b.
CC   Monoclonal antibody target: UniProtKB; P00524; Rous sarcoma virus subgroup A (strain Schmidt-Ruppin) v-Src.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   203-glioma
AC   CVCL_S828
SY   203 glioma; 203G
DR   Wikidata; Q54583086
RX   PubMed=6603902;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21962; Mouse glial tumours of uncertain origin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 7
//
ID   203B6
AC   CVCL_C4B8
DR   ABCD; ABCD_AP987
DR   Wikidata; Q116047939
RX   Patent=US8697855;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3920.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   203E1H5
AC   CVCL_A0NR
SY   203 E1H5; 203E1
DR   Wikidata; Q108819468
RX   Patent=US20210079099;
RX   PubMed=31159419;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3318.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   203E2
AC   CVCL_B0D8
DR   Wikidata; Q108819469
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10799.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10070.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   203E3
AC   CVCL_A0NT
DR   Wikidata; Q108819470
RX   PubMed=31159419;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   204-3
AC   CVCL_J865
DR   Wikidata; Q54583087
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   204-4
AC   CVCL_J571
DR   CLO; CLO_0001188
DR   ATCC; HB-185
DR   Wikidata; Q54583091
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   2041
AC   CVCL_E435
SY   BLJU
DR   dbMHC; 48453
DR   ECACC; 94071408
DR   IHW; IHW09336
DR   IPD-IMGT/HLA; 10097
DR   Wikidata; Q54583092
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*02,19; B*44,50; DQA1*04:01:01; DQB1*04:02:01,06:02:01; DRB1*03:02:01 (IPD-IMGT/HLA=10097).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   2044L
AC   CVCL_C520
DR   Wikidata; Q54583094
RX   PubMed=7471097;
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   2048-EBV
AC   CVCL_WY46
DR   Wikidata; Q93301809
RX   PubMed=19581576;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY47 ! 2048-mel
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 6
//
ID   2048-mel
AC   CVCL_WY47
DR   Wikidata; Q93301812
RX   PubMed=19581576;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY46 ! 2048-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   204C5E12
AC   CVCL_F0GV
RX   Patent=US10973915;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279.
CC   Miscellaneous: As the immunized splenic B-cells are from H2L2 transgenic mice the produced mAB is a chimeric Ig having human variable domain and rat constant region.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   204F4
AC   CVCL_B0D9
DR   ATCC; HB-10800
DR   Wikidata; Q108819471
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10800.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10071.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   205 BLCL
AC   CVCL_E374
DR   ECACC; 94031659
DR   Wikidata; Q54583096
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   205AD2
AC   CVCL_A9ED
DR   Wikidata; Q108819472
RX   Patent=WO1994026923A1;
RX   PubMed=7511819;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14174; Human MIF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   205BR
AC   CVCL_ZN49
SY   205 BRighton
DR   Wikidata; Q98125328
RX   PubMed=1372096;
RX   PubMed=10022907;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN25 ! LB102
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   205D12G12
AC   CVCL_D3SA
DR   Wikidata; Q127378685
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   205H8
AC   CVCL_C4B9
DR   ABCD; ABCD_AP984
DR   Wikidata; Q116047940
RX   Patent=US8697855;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3921.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2061H
AC   CVCL_C521
SY   HT-H
DR   EFO; EFO_0022498
DR   Wikidata; Q54583099
RX   PubMed=7471097;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   207
AC   CVCL_D0VB
DR   Wikidata; Q123030235
RX   PubMed=6684957;
CC   From: Wood, Stephen; Department of Medical Genetics, University of British Columbia; Vancouver; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   207,B-4
AC   CVCL_E7Q6
DR   ABCD; ABCD_AE749
RX   PubMed=10722576;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Neisseria meningitidis (strain 188/87) porA (Note=Reacts with serosubtype 1.7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   20706M
AC   CVCL_WM50
DR   cancercelllines; CVCL_WM50
DR   Cosmic; 852224
DR   Wikidata; Q93301832
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   207TAg
AC   CVCL_ZD84
DR   Kerafast; ENH121-FP
DR   Wikidata; Q98125332
CC   Knockout cell: Method=KO mouse; MGI; MGI:109352; Ung.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   208-2
AC   CVCL_J866
DR   Wikidata; Q54583101
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   208,D-5
AC   CVCL_E7Q7
DR   ABCD; ABCD_AE750
RX   PubMed=10722576;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Neisseria meningitidis (strain 188/87) porA (Note=Reacts with serosubtype 1.7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   20842M1
AC   CVCL_WM26
DR   cancercelllines; CVCL_WM26
DR   Cosmic; 852201
DR   Wikidata; Q93301842
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Ser (c.1789_1790delCTinsTC); ClinVar=VCV000375942; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM46 ! 20842M2
OI   CVCL_WM19 ! 20842P
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   20842M2
AC   CVCL_WM46
DR   cancercelllines; CVCL_WM46
DR   Cosmic; 852220
DR   Wikidata; Q93301846
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Ser (c.1789_1790delCTinsTC); ClinVar=VCV000375942; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly187Ser (c.559G>A); ClinVar=VCV000840399; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM26 ! 20842M1
OI   CVCL_WM19 ! 20842P
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   20842P
AC   CVCL_WM19
DR   cancercelllines; CVCL_WM19
DR   Cosmic; 852195
DR   IARC_TP53; 20609
DR   Wikidata; Q93301849
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Ser (c.1789_1790delCTinsTC); ClinVar=VCV000375942; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly187Ser (c.559G>A); ClinVar=VCV000840399; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM26 ! 20842M1
OI   CVCL_WM46 ! 20842M2
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   208F
AC   CVCL_4086
DR   CLO; CLO_0001190
DR   CLDB; cl36
DR   ECACC; 85103116
DR   Wikidata; Q54583103
RX   PubMed=228482;
RX   PubMed=3533793;
RX   PubMed=6526015;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-76.html
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   208F MMCV-transformed clone F311-13
AC   CVCL_E5TM
SY   F311-13
RX   PubMed=6526015;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P12523; Avian retrovirus OK10 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: Recombinant Murine myc-containing virus (MMCVneo OK-10 v-myc).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4086 ! 208F
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   208F MMCV-transformed clone FL5A
AC   CVCL_E5TN
SY   FL5A
RX   PubMed=6526015;
CC   Characteristics: Highly transformed by MMCV (PubMed=6526015).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P12523; Avian retrovirus OK10 v-Myc.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: Recombinant Murine myc-containing virus (MMCV OK-10 v-myc).
CC   Misspelling: FL4A; PubMed=6526015; Note=In table III.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4086 ! 208F
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   208F MMCV-transformed clone FS1A
AC   CVCL_E5TP
SY   FS1A
RX   PubMed=6526015;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P12523; Avian retrovirus OK10 v-Myc.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: Recombinant Murine myc-containing virus (MMCV OK-10 v-myc).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4086 ! 208F
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   208F MMCV-transformed clone FS4C
AC   CVCL_E5TQ
SY   FS4C
RX   PubMed=6526015;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P12523; Avian retrovirus OK10 v-Myc.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: Recombinant Murine myc-containing virus (MMCV OK-10 v-myc).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4086 ! 208F
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   209/MDCT
AC   CVCL_CZ90
SY   209/Mouse Distal Convoluted Tubule
DR   ATCC; CRL-3250
DR   Wikidata; Q54583105
RX   PubMed=1322939;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Kidney, distal convoluted tubule; UBERON=UBERON_0001292.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   44-55D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   2094
AC   CVCL_E436
SY   CRJC
DR   dbMHC; 48454
DR   ECACC; 94071412
DR   IHW; IHW09338
DR   IPD-IMGT/HLA; 10098
DR   Wikidata; Q54583107
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: DPB1*01:01:01,03:01; DQA1*01:02:01,03:02; DQB1*05:02,02:01; DRB1*11:04:02,09:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=10098).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   2097.2
AC   CVCL_C5X5
SY   2097
DR   Wikidata; Q116047942
RX   PubMed=1602134;
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20A11
AC   CVCL_XB99
DR   CCRID; 4201PAT-CCTCC00207
DR   Wikidata; Q93301868
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200638.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 6
//
ID   20b
AC   CVCL_8996
SY   iPS-20b; hiPS-20b; hiPS 20b
DR   EFO; EFO_0007108
DR   ENCODE; ENCBS206WTA
DR   ENCODE; ENCBS364SXM
DR   ENCODE; ENCBS391JPU
DR   ENCODE; ENCBS606XXJ
DR   ENCODE; ENCBS760MYS
DR   ENCODE; ENCBS939PXA
DR   GEO; GSM637787
DR   GEO; GSM772804
DR   GEO; GSM772841
DR   GEO; GSM772842
DR   GEO; GSM772843
DR   GEO; GSM772844
DR   GEO; GSM772845
DR   GEO; GSM772846
DR   GEO; GSM772847
DR   GEO; GSM772848
DR   GEO; GSM981286
DR   SKIP; SKIP004431
DR   Wikidata; Q54583110
RX   PubMed=21293464;
RX   PubMed=21295703;
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   20B10
AC   CVCL_E2ZB
RX   PubMed=26788906;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   20B5
AC   CVCL_F1Y9
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   20B6
AC   CVCL_VI34
DR   BEI_Resources; MRA-262
DR   Wikidata; Q54583112
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes (Note=Also reacts with Anopheles gambiae and Culex pipiens salivary glands).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   20B8
AC   CVCL_6347
DR   CLO; CLO_0001191
DR   ATCC; CRL-12582
DR   BioSample; SAMN03471346
DR   Wikidata; Q54583114
RX   Patent=US6358703;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12582.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3546; F8 (Note=With p.Ser765_Asn1658del = BDD-FVIII).
CC   Discontinued: ATCC; CRL-12582; true.
ST   Source(s): ATCC=CRL-12582
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9,12
ST   D7S820: 10,11
ST   TH01: 7,9,9.3
ST   TPOX: 6,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3712 ! HKB-11
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   20C2
AC   CVCL_9149
SY   4H12:20C2.G6.C9
DR   CLO; CLO_0001192
DR   ATCC; CRL-2382
DR   Wikidata; Q54583116
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29459; Human IL12A.
CC   Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   20C5
AC   CVCL_F1Y8
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   20E5
AC   CVCL_C5AP
DR   Wikidata; Q116047943
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   20E8
AC   CVCL_C5AQ
DR   Wikidata; Q116047944
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   20G12
AC   CVCL_VI35
DR   BEI_Resources; MRA-264
DR   Wikidata; Q54583205
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female salivary glands distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   20G3-2
AC   CVCL_B0U1
DR   Wikidata; Q108819473
RX   Patent=EP0479454A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10541.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   20G8
AC   CVCL_VI36
DR   BEI_Resources; MRA-263
DR   Wikidata; Q54583206
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes and ovaries (Note=Also reacts with Culex pipiens salivary glands).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   20G9
AC   CVCL_C4F2
DR   ABCD; ABCD_AE292
DR   Wikidata; Q116047945
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   20H11
AC   CVCL_6348
DR   CLO; CLO_0001193
DR   ATCC; CRL-9300
DR   BioSample; SAMN03471215
DR   Wikidata; Q54583208
RX   Patent=GB2192185A;
RX   Patent=US4834976;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9300.
CC   Doubling time: ~24-36 hours (ATCC=CRL-9300).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P72151; Pseudomonas aeruginosa B-type flagellin (fliC).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-9300
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 18,20
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 12,15
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   20H2
AC   CVCL_9150
DR   CLO; CLO_0001194
DR   ATCC; HB-323
DR   Wikidata; Q54583211
RX   PubMed=9531266;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   20II-NFUD2
AC   CVCL_D4BB
DR   Wikidata; Q127378686
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: MZM-0410.
OX   NCBI_TaxID=105023; ! Nothobranchius furzeri (Turquoise killifish)
SX   Sex unspecified
AG   Diapause II embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   21-96-3
AC   CVCL_A9H1
DR   ABCD; ABCD_AN708
DR   Wikidata; Q102113435
RX   PubMed=2945827;
RX   PubMed=16453425;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08799; Dictyostelium discoideum mhcA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   2102EP
AC   CVCL_C522
SY   2102Ep; 2102 Ep; 2,102 Ep
DR   BTO; BTO_0005287
DR   EFO; EFO_0002957
DR   Cosmic; 2077185
DR   Cosmic; 2163762
DR   PRIDE; PXD030251
DR   Wikidata; Q54583213
RX   PubMed=6169654;
RX   PubMed=7095898;
RX   PubMed=7471097;
RX   PubMed=17284651;
RX   PubMed=20428235;
RX   PubMed=24812411;
RX   PubMed=35084545;
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C523 ! 2102ER
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   2102EP-R
AC   CVCL_C0QK
DR   PRIDE; PXD030251
DR   Wikidata; Q112926913
RX   PubMed=35084545;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C522 ! 2102EP
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   2102ER
AC   CVCL_C523
DR   Wikidata; Q54583214
RX   PubMed=7471097;
CC   Derived from site: In situ; Retroperitoneal lymph node; UBERON=UBERON_0035371.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C522 ! 2102EP
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   2106LN
AC   CVCL_M068
DR   CLS; 300166
DR   Wikidata; Q54583215
RX   PubMed=21684623;
CC   Population: Caucasian.
CC   Discontinued: CLS; 300166; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CLS=300166; PubMed=21684623
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10
ST   D16S539: 8,11
ST   D5S818: 11,14
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M069 ! 2106T
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 17
//
ID   2106T
AC   CVCL_M069
DR   CLS; 300165
DR   Wikidata; Q54583218
RX   PubMed=21684623;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=300165; PubMed=21684623
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11 (PubMed=21684623)
ST   CSF1PO: 11 (CLS=300165)
ST   D13S317: 10
ST   D16S539: 8,11
ST   D18S51: 12,13
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11,14 (PubMed=21684623)
ST   D5S818: 14 (CLS=300165)
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M068 ! 2106LN
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 14
//
ID   210TAg
AC   CVCL_ZD85
DR   Kerafast; ENH122-FP
DR   Wikidata; Q98125336
CC   Knockout cell: Method=KO mouse; MGI; MGI:109352; Ung.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   211 BLCL
AC   CVCL_E375
DR   ECACC; 94031660
DR   Wikidata; Q54583220
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   211-LCL
AC   CVCL_8069
DR   CLO; CLO_0051017
DR   BioSample; SAMN03471957
DR   RCB; RCB2288
DR   TKG; TKG 0616
DR   Wikidata; Q54583221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2288; TKG=TKG 0616
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 8,10
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   211-LCL-MUC1
AC   CVCL_8070
DR   CLO; CLO_0050079
DR   RCB; RCB1876
DR   TKG; TKG 0615
DR   Wikidata; Q54583223
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1876; TKG=TKG 0615
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 8,10
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8069 ! 211-LCL
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   2112
AC   CVCL_LB77
DR   Wikidata; Q54583225
RX   PubMed=25708088;
CC   Group: Marsupial cell line.
CC   Characteristics: Originates from DFT1 strain 2.
DI   NCIt; C176223; Devil facial tumor disease 1
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_LB75 ! 1/2Pea
OI   CVCL_LB76 ! 1426
OI   CVCL_LB78 ! 4906
OI   CVCL_LB79 ! C5065
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   211A
AC   CVCL_U658
SY   Line 211A
DR   Wikidata; Q54583227
RX   Patent=US7232899;
RX   PubMed=9634089;
CC   Group: Adenovirus packaging cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12194.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P11818; Human adenovirus C serotype 5 fiber protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   211B
AC   CVCL_U659
SY   Line 211B
DR   Wikidata; Q54583229
RX   Patent=US7232899;
RX   PubMed=9634089;
CC   Group: Adenovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P11818; Human adenovirus C serotype 5 fiber protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   211F3
AC   CVCL_C4BA
DR   ABCD; ABCD_AP986
DR   Wikidata; Q116047946
RX   Patent=US8697855;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3918.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   211R
AC   CVCL_U660
SY   Line 211R
DR   Wikidata; Q54583232
RX   Patent=US7232899;
RX   PubMed=9634089;
CC   Group: Adenovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P11818; Human adenovirus C serotype 5 fiber protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   212
AC   CVCL_F1E3
RX   PubMed=3594482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dog 29 kDa protein from lymphocytes (Note=Immunized against 17-71 (Cellosaurus=CVCL_0B18) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   212 BLCL
AC   CVCL_E376
DR   ECACC; 94031661
DR   Wikidata; Q54583233
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   212BR
AC   CVCL_ZT59
SY   212 BRighton
DR   Wikidata; Q98125337
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 11,15
ST   D21S11: 27,33.2
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   TH01: 6,8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   213 BLCL
AC   CVCL_E377
DR   ECACC; 94031662
DR   Wikidata; Q54583235
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   2130 mel
AC   CVCL_C7UC
DR   Wikidata; Q123030236
RX   PubMed=22207316;
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   214 BLCL
AC   CVCL_E378
DR   ECACC; 94031663
DR   Wikidata; Q54583237
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   214B2
AC   CVCL_C4BB
DR   ABCD; ABCD_AP985
DR   Wikidata; Q116047947
RX   Patent=US8697855;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3919.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   214BR
AC   CVCL_ZT60
SY   214 BRighton
DR   Wikidata; Q98125340
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 15,19
ST   D21S11: 27,30
ST   D8S1179: 12,14
ST   FGA: 24
ST   TH01: 8,9.3
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   215
AC   CVCL_F1E4
RX   PubMed=3594482;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Dog 29 kDa protein from lymphocytes (Note=Immunized against 17-71 (Cellosaurus=CVCL_0B18) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   215 BLCL
AC   CVCL_E379
DR   ECACC; 94031664
DR   Wikidata; Q54583239
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   215-2
AC   CVCL_J867
DR   Wikidata; Q54583240
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   21545M
AC   CVCL_WM55
DR   cancercelllines; CVCL_WM55
DR   Cosmic; 852229
DR   Wikidata; Q93302060
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   2158
AC   CVCL_F1ZA
RX   PubMed=24478429;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q1PHM9; HIV-1 (strain CAP45) env (Note=AA 33-492 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   215BR
AC   CVCL_ZT61
SY   215 BRighton
DR   Wikidata; Q98125343
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D21S11: 32.2,33.2
ST   D8S1179: 12,13
ST   TH01: 6,7
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   216 BLCL
AC   CVCL_E380
DR   ECACC; 94031665
DR   Wikidata; Q54583241
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   216-1
AC   CVCL_F1E5
RX   PubMed=3594482;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Dog lymphoma cell lines (Note=Immunized against c17-71 (Cellosaurus=CVCL_0B18) cell line. Also reacts with a number of human, dog and rat cells and cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2161A4
AC   CVCL_C3DE
DR   Wikidata; Q114310354
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161B1
AC   CVCL_C3DF
DR   Wikidata; Q114310355
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161C1
AC   CVCL_C3DG
DR   Wikidata; Q114310357
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161D2
AC   CVCL_C3DH
DR   Wikidata; Q114310358
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161D3
AC   CVCL_C3DI
DR   Wikidata; Q114310359
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161D4
AC   CVCL_C3DJ
DR   Wikidata; Q114310360
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161D7
AC   CVCL_C3DK
DR   Wikidata; Q114310361
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161E1
AC   CVCL_C3DL
DR   Wikidata; Q114310362
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161F8
AC   CVCL_C3DM
DR   Wikidata; Q114310363
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161F9
AC   CVCL_C3DN
DR   Wikidata; Q114310395
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161G11
AC   CVCL_C3DP
DR   Wikidata; Q114310396
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161G7
AC   CVCL_C3DQ
DR   Wikidata; Q114310397
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161G8
AC   CVCL_C3DR
DR   Wikidata; Q114310398
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161H2
AC   CVCL_C3DS
DR   Wikidata; Q114310399
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161H3
AC   CVCL_C3DT
DR   Wikidata; Q114310400
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2161H8
AC   CVCL_C3DU
DR   Wikidata; Q114310401
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2163A1
AC   CVCL_C3DV
DR   Wikidata; Q114310402
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2163C3
AC   CVCL_C3DW
DR   Wikidata; Q114310403
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2163D7
AC   CVCL_C3DX
DR   Wikidata; Q114310404
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2163F4
AC   CVCL_C3DY
DR   Wikidata; Q114310405
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2163H4
AC   CVCL_C3DZ
DR   Wikidata; Q114310406
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2164A2
AC   CVCL_C3E0
DR   Wikidata; Q114310407
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2164A7
AC   CVCL_C3E1
DR   Wikidata; Q114310408
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2164B6
AC   CVCL_C3E2
DR   Wikidata; Q114310409
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2164C3
AC   CVCL_C3E3
DR   Wikidata; Q114310411
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2164G7
AC   CVCL_C3E4
DR   Wikidata; Q114310412
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2164H5
AC   CVCL_C3E5
DR   Wikidata; Q114310413
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2164H9
AC   CVCL_C3E6
DR   Wikidata; Q114310414
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2166G2
AC   CVCL_C3E7
DR   Wikidata; Q114310415
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2166G4
AC   CVCL_C3E8
DR   Wikidata; Q114310416
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   21690
AC   CVCL_JD32
SY   TER290; TER-290; Ter 290; TER310; TER-310; Ter 310; TER428; TER-428; Ter 428
DR   IPD-IMGT/HLA; 12011
DR   Wikidata; Q54583242
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/343cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,29; B*18,44; C*05:01,07; DPB1*02:01; DQA1*01:01,05:05; DQB1*05:01,03:01; DRB1*01:03,11:29; DRB3*02:02 (IPD-IMGT/HLA=12011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   2172A2
AC   CVCL_C3E9
DR   Wikidata; Q114310417
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172B12
AC   CVCL_C3EA
DR   Wikidata; Q114310418
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172B5
AC   CVCL_C3EB
DR   Wikidata; Q114310419
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172C10
AC   CVCL_C3EC
DR   Wikidata; Q114310420
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172C12
AC   CVCL_C3ED
DR   Wikidata; Q114310421
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172C2
AC   CVCL_C3EE
DR   Wikidata; Q114310422
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172C3
AC   CVCL_C3EF
DR   Wikidata; Q114310423
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172D12
AC   CVCL_C3EG
DR   Wikidata; Q114310424
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172D6
AC   CVCL_C3EH
DR   Wikidata; Q114310425
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172E8
AC   CVCL_C3EI
DR   Wikidata; Q114310426
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172E9
AC   CVCL_C3EJ
DR   Wikidata; Q114310427
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172F11
AC   CVCL_C3EK
DR   Wikidata; Q114310429
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172F4
AC   CVCL_C3EL
DR   Wikidata; Q114310430
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172G3
AC   CVCL_C3EM
DR   Wikidata; Q114310431
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172G4
AC   CVCL_C3EN
DR   Wikidata; Q114310432
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172G6
AC   CVCL_C3EP
DR   Wikidata; Q114310433
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172H12
AC   CVCL_C3EQ
DR   Wikidata; Q114310434
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2172H6
AC   CVCL_C3ER
DR   Wikidata; Q114310435
RX   PubMed=24386429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   21768M
AC   CVCL_WM54
DR   Cosmic; 852228
DR   Wikidata; Q93302082
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   218A
AC   CVCL_0B42
DR   Cosmic; 2163760
DR   Wikidata; Q54583245
RX   PubMed=9620551;
RX   PubMed=24812411;
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   219
AC   CVCL_G580
SY   Anti PDGF hybridoma #219
DR   CLO; CLO_0001195
DR   ATCC; HB-9371
DR   Wikidata; Q54583247
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9371.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   219 BLCL
AC   CVCL_E381
DR   ECACC; 94031666
DR   Wikidata; Q54583249
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   219.5
AC   CVCL_E3Z0
RX   PubMed=3514459;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04933; Plasmodium falciparum (isolate Wellcome) MSP1 (Note=143 KdA and 132 KdA polypeptides located in rhoptry).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   219F3
AC   CVCL_B0DA
DR   Wikidata; Q108819474
RX   Patent=US4938948;
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10801.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10072.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   21a
AC   CVCL_C5HW
DR   Wikidata; Q116047948
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   21A5
AC   CVCL_C5AR
DR   Wikidata; Q116047949
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   21A7.B12.F8
AC   CVCL_IV63
SY   21A7
DR   Wikidata; Q54583251
RX   Patent=US8022175;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8641.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Newcastle disease virus HN protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   21B7
AC   CVCL_B6W1
DR   Wikidata; Q111732651
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   21B8
AC   CVCL_0U24
SY   HLCL 21B8
DR   ATCC; CRL-9301
DR   CCRID; 4201PAT-CCTCC00015
DR   Wikidata; Q54583253
RX   Patent=GB2192185A;
RX   Patent=US4834976;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9301.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21184; Pseudomonas aeruginosa A-type flagellin (fliC).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   21D2
AC   CVCL_F1Y3
RX   PubMed=1583327;
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   21D4
AC   CVCL_C5EV
DR   Wikidata; Q116047952
RX   PubMed=16029427;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276 (Note=Isoform 2IgB7-H3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   21D7
AC   CVCL_B6W2
DR   Wikidata; Q111732652
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   21E11
AC   CVCL_E8V1
DR   ABCD; ABCD_AA484
RX   PubMed=17374540;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08169; Apis mellifera hyaluronidase (allergen Api m 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   21f
AC   CVCL_C5HX
DR   Wikidata; Q116047953
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   21F4
AC   CVCL_B6W3
DR   Wikidata; Q111732653
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   21G8F11
AC   CVCL_F0GW
RX   Patent=US10973915;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279 (Note=Also reacts with M.fascicularis).
CC   Miscellaneous: As the immunized splenic B-cells are from H2L2 transgenic mice the produced mAB is a chimeric Ig having human variable domain and rat constant region.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   21H1
AC   CVCL_A0HK
DR   Wikidata; Q108819475
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   21H3
AC   CVCL_DB42
DR   Wikidata; Q54583254
RX   Patent=WO1990008185A1;
RX   PubMed=2717936;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9970.
CC   Characteristics: Produces a catalytic monoclonal antibody that acts as a lipase.
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   21M18
AC   CVCL_A4BK
DR   Wikidata; Q105505888
RX   Patent=US9376497;
RX   PubMed=19664991;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8670.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized demcizumab (OMP-21M18) therapeutic antibody.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NR61; Human DLL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 6
//
ID   21MA
AC   CVCL_ZT86
SY   21 Manchester
DR   Wikidata; Q98125347
RX   PubMed=9649131;
CC   Senescence: Senesces at 44 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT87 ! 138MA
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   21MT-1
AC   CVCL_7931
SY   21-MT-1; 21MT1
DR   Cell_Model_Passport; SIDM01902
DR   DepMap; ACH-002400
DR   GEO; GSM1172846
DR   GEO; GSM1172934
DR   GEO; GSM3145619
DR   GEO; GSM3145686
DR   IARC_TP53; 21720
DR   LINCS_HMS; 51107
DR   LINCS_LDP; LCL-2110
DR   PharmacoDB; 21MT1_8_2019
DR   Wikidata; Q54583256
RX   DOI=10.1007/978-1-4612-0411-4_18;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1977518;
RX   PubMed=7923592;
RX   PubMed=8482634;
RX   PubMed=20458274;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC   Doubling time: 36.8 +- 0.6 hours (Note=In alpha H&E medium), 42.3 +- 4.7 hours (Note=In D medium) (PubMed=8482634); 44.91 hours (JWGray panel).
CC   HLA typing: A*31:01,26:01; B*38:01,35:02; C*04:01,12:03; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*04:02,04:02 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser33Phefs*9 (c.96_97insT); Zygosity=Unspecified (PubMed=7923592).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7932 ! 21MT-2
OI   CVCL_7933 ! 21NT
OI   CVCL_7934 ! 21PT
OI   CVCL_IP81 ! H16F1
OI   CVCL_IP82 ! H16N-2
OI   CVCL_IP83 ! H16N-3
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   21MT-2
AC   CVCL_7932
SY   21-MT-2; 21MT2
DR   Cell_Model_Passport; SIDM01901
DR   DepMap; ACH-002401
DR   GEO; GSM1172847
DR   GEO; GSM1172935
DR   GEO; GSM3145620
DR   GEO; GSM3145687
DR   IARC_TP53; 21721
DR   PharmacoDB; 21MT2_9_2019
DR   Wikidata; Q54583258
RX   DOI=10.1007/978-1-4612-0411-4_18;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1977518;
RX   PubMed=7923592;
RX   PubMed=8482634;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC   Doubling time: 42.0 +- 2.5 hours (Note=In alpha H&E medium), 42.3 +- 4.7 hours (Note=In D medium) (PubMed=8482634).
CC   HLA typing: A*26:01,31:01; B*35:02,38:01; C*04:01,12:03; DRB1*04:03,04:03 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser33Phefs*9 (c.96_97insT); Zygosity=Unspecified (PubMed=7923592).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7931 ! 21MT-1
OI   CVCL_7933 ! 21NT
OI   CVCL_7934 ! 21PT
OI   CVCL_IP81 ! H16F1
OI   CVCL_IP82 ! H16N-2
OI   CVCL_IP83 ! H16N-3
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   21NT
AC   CVCL_7933
SY   21 NT
DR   cancercelllines; CVCL_7933
DR   Cell_Model_Passport; SIDM01912
DR   DepMap; ACH-002399
DR   GEO; GSM1172848
DR   GEO; GSM1172936
DR   GEO; GSM1664566
DR   GEO; GSM3145617
DR   GEO; GSM3145688
DR   IARC_TP53; 21719
DR   LINCS_HMS; 51108
DR   PharmacoDB; 21NT_10_2019
DR   Progenetix; CVCL_7933
DR   Wikidata; Q54583260
RX   DOI=10.1007/978-1-4612-0411-4_18;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1977518;
RX   PubMed=7923592;
RX   PubMed=8482634;
RX   PubMed=20458274;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC   Doubling time: 31.4 +- 2.6 hours (Note=In alpha H&E medium), 38.6 +- 2.9 hours (Note=In D medium) (PubMed=8482634); 46.38 hours (JWGray panel).
CC   HLA typing: A*26:01,31:01; B*35:02,38:01; C*04:01,12:03; DRB1*04:03,04:03 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser33Phefs*9 (c.96_97insT); Zygosity=Unspecified (PubMed=7923592).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7931 ! 21MT-1
OI   CVCL_7932 ! 21MT-2
OI   CVCL_7934 ! 21PT
OI   CVCL_IP81 ! H16F1
OI   CVCL_IP82 ! H16N-2
OI   CVCL_IP83 ! H16N-3
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   21PT
AC   CVCL_7934
SY   21 PT
DR   Cell_Model_Passport; SIDM01900
DR   GEO; GSM1172849
DR   GEO; GSM1172937
DR   GEO; GSM3145618
DR   GEO; GSM3145689
DR   IARC_TP53; 3288
DR   LINCS_HMS; 51109
DR   PharmacoDB; 21PT_11_2019
DR   Wikidata; Q54583263
RX   DOI=10.1007/978-1-4612-0411-4_18;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1977518;
RX   PubMed=7923592;
RX   PubMed=8482634;
RX   PubMed=20458274;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Characteristics: 21PT is non-tumorigenic whereas 21NT and 21MT-1/21-MT-2 cause tumors in the nude mice system.
CC   Doubling time: 35.5 +- 1.1 hours (Note=In alpha H&E medium), 42.3 +- 4.7 hours (Note=In D medium) (PubMed=8482634); 35.70 hours (JWGray panel).
CC   HLA typing: A*31:01,26:01; B*35:02,38:01; C*04:01,12:03; DRB1*04:03,04:03 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser33Phefs*9 (c.96_97insT); Zygosity=Unspecified (PubMed=7923592).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7931 ! 21MT-1
OI   CVCL_7932 ! 21MT-2
OI   CVCL_7933 ! 21NT
OI   CVCL_IP81 ! H16F1
OI   CVCL_IP82 ! H16N-2
OI   CVCL_IP83 ! H16N-3
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   22
AC   CVCL_WT45
SY   M22; Hybridoma for mAB 22
DR   ATCC; HB-12147
DR   Wikidata; Q93302144
RX   Patent=US4954617;
RX   Patent=US5833985;
RX   PubMed=2474608;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12147.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12314; Human FCGR1A/CD64.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   22-1
AC   CVCL_E2ZY
DR   ABCD; ABCD_AJ190
DR   ABCD; ABCD_AJ191
RX   PubMed=11556707;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Potato virus Y (strain Tunisian PVYo) nuclear inclusion protein a (NIa).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   22/18
AC   CVCL_B7QL
DR   DSHB; 22-18
DR   Wikidata; Q112926915
RX   PubMed=3446476;
RX   PubMed=6366572;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Notophthalmus viridescens blastemal cells specific antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 30-01-24; Version: 4
//
ID   220 BLCL
AC   CVCL_E382
DR   ECACC; 94031667
DR   Wikidata; Q54583264
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   221-1-1
AC   CVCL_YA09
DR   Wikidata; Q93302151
RX   PubMed=9276759;
RX   PubMed=9394012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O15706; Dictyostelium discoideum vacA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   221-135-1
AC   CVCL_XY64
DR   Wikidata; Q93302153
RX   PubMed=9428745;
RX   PubMed=9704504;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q86IA3; Dictyostelium discoideum pdi1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   221-342-5
AC   CVCL_YA10
DR   ABCD; ABCD_AJ514
DR   Wikidata; Q93302156
RX   DOI=10.24450/journals/abrep.2019.e45;
RX   DOI=10.24450/journals/abrep.2019.e49;
RX   PubMed=9704504;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Dictyostelium discoideum common antigen 1 (CA1), a sulfated carbohydrate epitope.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   221-35-2
AC   CVCL_YA11
DR   ABCD; ABCD_AJ520
DR   Wikidata; Q93302160
RX   DOI=10.24450/journals/abrep.2019.e46;
RX   DOI=10.24450/journals/abrep.2019.e47;
RX   PubMed=9394012;
RX   PubMed=9704504;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P54647; Dictyostelium discoideum vatA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   221-42-1
AC   CVCL_A9H2
DR   ABCD; ABCD_AN703
DR   Wikidata; Q102113436
RX   PubMed=9428745;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q86IA3; Dictyostelium discoideum pdi1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   221-64-1
AC   CVCL_YA12
DR   ABCD; ABCD_AK567
DR   Wikidata; Q93302163
RX   PubMed=9428745;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q86IA3; Dictyostelium discoideum pdi1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   2211
AC   CVCL_F248
DR   CLO; CLO_0001012
DR   CLDB; cl37
DR   Wikidata; Q54583266
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 6
//
ID   2211M
AC   CVCL_WM38
DR   cancercelllines; CVCL_WM38
DR   Cosmic; 852213
DR   IARC_TP53; 20613
DR   Wikidata; Q93302168
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro246Ser (c.737C>T); Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380_381CC>TT); Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   2214 ERKOb
AC   CVCL_E8CY
RX   PubMed=19013153;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109392; Esr2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: B6.129-Esr2tm1Unc (ESKO-beta).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   222
AC   CVCL_1T15
DR   BTO; BTO_0004035
DR   BioSample; SAMN03151885
DR   cancercelllines; CVCL_1T15
DR   IARC_TP53; 5549
DR   Wikidata; Q54583269
RX   PubMed=1918981;
RX   PubMed=2227544;
RX   PubMed=8557231;
RX   PubMed=9554442;
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PA-1 derivative (PubMed=22710073). Originally thought to be an ovarian carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00454.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro316Pro (c.948C>T); ClinVar=VCV000750727; Zygosity=Heterozygous (PubMed=8557231).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0479 ! PA-1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 21
//
ID   222 BLCL
AC   CVCL_E383
DR   ECACC; 94031669
DR   Wikidata; Q54583270
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   222-35C8
AC   CVCL_J583
DR   Wikidata; Q54583271
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9052.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04628; Human WNT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   2221 ERKOa
AC   CVCL_E8CZ
RX   PubMed=19013153;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1352467; Esr1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: B6.129-Esr1tm1Ksk (ERKO-alpha).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   222TR
AC   CVCL_1T16
DR   cancercelllines; CVCL_1T16
DR   Wikidata; Q54583273
RX   PubMed=1918981;
CC   Problematic cell line: Contaminated. Parent cell line (222) has been shown to be a PA-1 derivative.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro316Pro (c.948C>T); ClinVar=VCV000750727; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1T15 ! 222
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   223 BLCL
AC   CVCL_E384
DR   ECACC; 94031670
DR   Wikidata; Q54583274
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   2231 ERKOa
AC   CVCL_E8D0
RX   PubMed=19013153;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1352467; Esr1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: B6.129-Esr1tm1Ksk (ERKO-alpha).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   223G6B5
AC   CVCL_F0GX
RX   Patent=US10973915;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279 (Note=Also reacts with M.fascicularis).
CC   Miscellaneous: As the immunized splenic B-cells are from H2L2 transgenic mice the produced mAB is a chimeric Ig having human variable domain and rat constant region.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   224 BLCL
AC   CVCL_E385
DR   ECACC; 94031671
DR   Wikidata; Q54583276
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   HLA typing: A*02:03; B*:07,38; C*07; DQB1*01,03; DRB1*09,13 (ECACC=94031671).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   224-1A6-A1
AC   CVCL_KB79
DR   Wikidata; Q54583357
RX   PubMed=7039768;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P13590; Chicken NCAM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   224-256-2
AC   CVCL_YA96
DR   ABCD; ABCD_AJ515
DR   DSHB; 224-256-2
DR   Wikidata; Q93302180
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54648; Dictyostelium discoideum vatC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   224-236-1
AC   CVCL_YB05
DR   ABCD; ABCD_AK423
DR   DSHB; 224-236-1
DR   Wikidata; Q93302181
RX   DOI=10.24450/journals/abrep.2019.e54;
RX   DOI=10.24450/journals/abrep.2019.e55;
RX   PubMed=9276758;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07830; Dictyostelium discoideum act1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   2242-1
AC   CVCL_E4CJ
RX   PubMed=28817799;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4CF ! 2242-5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   2242-5
AC   CVCL_E4CF
RX   PubMed=33558651;
RX   PubMed=36202854;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4CJ ! 2242-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   225
AC   CVCL_J594
SY   m225; M225
DR   CLO; CLO_0001196
DR   ABCD; ABCD_AC967
DR   ATCC; HB-8508
DR   Wikidata; Q54583360
RX   Patent=US4943533;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8508.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the chimeric (mouse/human) Erbitux (cetuximab) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J593 ! NS-1-503
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 8
//
ID   225 BLCL
AC   CVCL_E386
DR   ECACC; 94031675
DR   Wikidata; Q54583362
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   225.28S
AC   CVCL_B5AB
DR   Wikidata; Q110429738
RX   PubMed=7033148;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   225-1
AC   CVCL_J868
DR   Wikidata; Q54583365
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   225-G11
AC   CVCL_F957
DR   TKG; TKG 0608
DR   Wikidata; Q54583366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: TKG; TKG 0608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26883; Sjogren syndrome
DI   ORDO; Orphanet_289390; Primary Sjogren syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   2254-62.2
AC   CVCL_6349
DR   CLO; CLO_0001197
DR   ATCC; CRL-8544
DR   BCRC; 60184
DR   Wikidata; Q54583367
RX   Patent=US5668108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8544.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3546; F8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-8544; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   225C7
AC   CVCL_DP91
DR   GEO; GSM1040269
DR   GEO; GSM1040339
DR   Wikidata; Q54583368
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP65 ! HDF1419
SX   Female
AG   5-6M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   226C3A7
AC   CVCL_F0GY
RX   Patent=US10973915;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279.
CC   Miscellaneous: As the immunized splenic B-cells are from H2L2 transgenic mice the produced mAB is a chimeric Ig having human variable domain and rat constant region.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   226H
AC   CVCL_J621
DR   CLO; CLO_0001198
DR   ATCC; HB-12592
DR   Wikidata; Q54583370
RX   Patent=US6251395;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12592.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9QYE7; Rat Itgad/Cd11d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   227 BLCL
AC   CVCL_E387
DR   ECACC; 94031673
DR   Wikidata; Q54583371
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   227-341-4
AC   CVCL_CW45
DR   ABCD; ABCD_AN705
DR   DSHB; 227-341-4
DR   Wikidata; Q54583372
RX   PubMed=9230077;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0CE94; Dictyostelium discoideum talA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   228A
AC   CVCL_0B43
DR   cancercelllines; CVCL_0B43
DR   Cosmic; 2163761
DR   Wikidata; Q54583373
RX   PubMed=9620551;
RX   PubMed=24812411;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly279Glu (c.836G>A); ClinVar=VCV000419454; Zygosity=Unspecified (PubMed=9620551).
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   228BR
AC   CVCL_ZT62
SY   228 BRighton
DR   Wikidata; Q98125350
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 11,19
ST   D21S11: 27,32.2
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   TH01: 6,8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   22B
AC   CVCL_UT48
SY   22-B; ESC22B
DR   Wikidata; Q93302224
RX   PubMed=11696444;
RX   PubMed=18001719;
RX   PubMed=26199416;
RX   PubMed=32106286;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   22B-RFP
AC   CVCL_UT51
DR   Wikidata; Q93302226
RX   PubMed=26199416;
CC   Genetic integration: Method=Transduction; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT48 ! 22B
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   22B12B2
AC   CVCL_D3SB
DR   DSHB; 22B12B2
DR   Wikidata; Q127378687
RX   PubMed=1696825;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7V3; Escherichia coli rpsC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   22C4
AC   CVCL_C3XI
DR   Wikidata; Q116047954
RX   PubMed=3125254;
RX   PubMed=3701062;
RX   PubMed=6747296;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   22D1
AC   CVCL_0F11
DR   ATCC; CRL-2841
DR   Wikidata; Q54583375
RX   PubMed=14694198;
CC   Doubling time: 12 hours (ATCC=CRL-2841).
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q8CJ91; Mouse Cd209b.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   22D6
AC   CVCL_H534
SY   22-D6
DR   Wikidata; Q54583376
RX   PubMed=6277505;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   22F.Li
AC   CVCL_2H35
DR   ATCC; CRL-6530
DR   Wikidata; Q54583378
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6530; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   22H6
AC   CVCL_D2PX
DR   Wikidata; Q127378688
RX   PubMed=1418418;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Rat cytotrophoblast antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   22H7
AC   CVCL_E8V2
RX   PubMed=17374540;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08169; Apis mellifera hyaluronidase (allergen Api m 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   22H8-84
AC   CVCL_B4JX
DR   Wikidata; Q110429740
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11361.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   22MA
AC   CVCL_ZU26
SY   22 MAnchester
DR   Wikidata; Q98125353
RX   PubMed=9649131;
CC   Senescence: Senesces at 22 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   22Rv1
AC   CVCL_1045
SY   22RV1; 22Rv-1; 22rV1; CWR-22rv1; CWR22-Rv1; CWR22R-V1; CWR22-R1; CWR22Rv1; CWR22R
DR   BTO; BTO_0002999
DR   CLO; CLO_0001199
DR   CLO; CLO_0001200
DR   EFO; EFO_0002095
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2505
DR   BCRC; 60545
DR   BioGRID_ORCS_Cell_line; 821
DR   BioSample; SAMN03471600
DR   BioSample; SAMN03472052
DR   BioSample; SAMN05292447
DR   BioSample; SAMN07710012
DR   BioSample; SAMN07710013
DR   BioSample; SAMN07710014
DR   BioSample; SAMN07710015
DR   BioSample; SAMN07710016
DR   BioSample; SAMN07710017
DR   BioSample; SAMN07710018
DR   BioSample; SAMN10988315
DR   cancercelllines; CVCL_1045
DR   CCRID; 3101HUMSCSP5022
DR   CCRID; 3101HUMTCHu100
DR   CCRID; 4201HUM-CCTCC00288
DR   CCRID; 5301HUM-KCB07031YJ
DR   CCTCC; GDC0288
DR   Cell_Model_Passport; SIDM00499
DR   ChEMBL-Cells; CHEMBL3308004
DR   ChEMBL-Targets; CHEMBL612657
DR   CLS; 305037
DR   Cosmic; 924100
DR   Cosmic; 1028699
DR   Cosmic; 1071480
DR   Cosmic; 1075276
DR   Cosmic; 1172629
DR   Cosmic; 1330911
DR   Cosmic; 1689707
DR   Cosmic; 1995323
DR   Cosmic; 2537791
DR   Cosmic; 2580126
DR   Cosmic; 2651766
DR   Cosmic; 2669170
DR   Cosmic-CLP; 924100
DR   DepMap; ACH-000956
DR   DSMZ; ACC-438
DR   DSMZCellDive; ACC-438
DR   ECACC; 05092802
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS070BKF
DR   ENCODE; ENCBS383WOY
DR   ENCODE; ENCBS596KKM
DR   ENCODE; ENCBS626QQL
DR   ENCODE; ENCBS737IZN
DR   ENCODE; ENCBS822DIG
DR   GDSC; 924100
DR   GEO; GSM91926
DR   GEO; GSM525793
DR   GEO; GSM648815
DR   GEO; GSM827396
DR   GEO; GSM886837
DR   GEO; GSM887900
DR   GEO; GSM1374375
DR   GEO; GSM1633317
DR   GEO; GSM1633318
DR   GEO; GSM1633319
DR   GEO; GSM1669565
DR   GEO; GSM3145592
DR   GEO; GSM3145703
DR   IARC_TP53; 18887
DR   IGRhCellID; 22Rv1
DR   KCB; KCB 200731YJ
DR   LiGeA; CCLE_229
DR   LINCS_LDP; LCL-1145
DR   Lonza; 1442
DR   PharmacoDB; 22RV1_12_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1045
DR   PubChem_Cell_line; CVCL_1045
DR   Ubigene; YC-C012
DR   Wikidata; Q54583380
RX   CelloPub=CLPUB00698;
RX   DOI=10.5897/IJBMBR2013.0154;
RX   PubMed=10462204;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=15486987;
RX   PubMed=19403664;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21248069;
RX   PubMed=22460905;
RX   PubMed=23117885;
RX   PubMed=23671654;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27271795;
RX   PubMed=27397505;
RX   PubMed=28145883;
RX   PubMed=28928128;
RX   PubMed=30629668;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31006810;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38892296;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200709/http://capcelllines.ca:80/details.asp?id=53
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544528
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-524.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Virology: Contains at least 10 integrated copies of xenotropic murine leukemia virus-related virus (XMRV) genome and produces a high titer of the virus (PubMed=19403664; PubMed=30629668).
CC   Doubling time: ~49 hours (PubMed=10462204); 55 hours (PubMed=25984343); 63 hours (Note=From cell counting), 94 hours (Note=From absorbance) (DOI=10.5897/IJBMBR2013.0154); ~40 hours (ATCC=CRL-2505); 40-60 hours (DSMZ=ACC-438); ~41 hours (PBCF); 24.07 hours (JWGray panel).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=23671654; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (DepMap=ACH-000956).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (Cosmic-CLP=924100; DepMap=ACH-000956).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (Cosmic-CLP=924100; DepMap=ACH-000956).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (Cosmic-CLP=924100; DepMap=ACH-000956).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (PubMed=14518029; ATCC=CRL-2505; Cosmic-CLP=924100; DepMap=ACH-000956).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.89%; Native American=0.23%; East Asian, North=0.52%; East Asian, South=0%; South Asian=0.27%; European, North=67.46%; European, South=30.62% (PubMed=30894373).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): ATCC=CRL-2505; CLS=305037; Cosmic-CLP=924100; DSMZ=ACC-438; ECACC=05092802; PubMed=14518029; PubMed=25877200; PubMed=27271795; PubMed=31006810; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 13,14,15
ST   D12S391: 18,25
ST   D13S317: 8,9,12 (PubMed=14518029)
ST   D13S317: 9,12 (CLS=305037; DSMZ=ACC-438; PubMed=25877200; PubMed=27271795; PubMed=31006810; Technion Genomics Center)
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D1S1656: 17,18,19
ST   D21S11: 30
ST   D22S1045: 15
ST   D2S1338: 17,18
ST   D2S441: 11,12
ST   D3S1358: 14,15 (PubMed=14518029)
ST   D3S1358: 15 (CLS=305037; DSMZ=ACC-438; PubMed=25877200; PubMed=27271795; Technion Genomics Center)
ST   D5S818: 11,12 (Cosmic-CLP=924100; ECACC=05092802; PubMed=31006810)
ST   D5S818: 11,12,13 (ATCC=CRL-2505; DSMZ=ACC-438; PubMed=14518029; Technion Genomics Center)
ST   D5S818: 11,13 (CLS=305037; PubMed=25877200; PubMed=27271795)
ST   D6S1043: 16
ST   D7S820: 9,10,11 (ATCC=CRL-2505; CLS=305037; DSMZ=ACC-438; PubMed=25877200; PubMed=27271795; Technion Genomics Center)
ST   D7S820: 10,11 (Cosmic-CLP=924100; ECACC=05092802; PubMed=14518029; PubMed=31006810)
ST   D8S1179: 12,13,14 (ATCC=CRL-2505; DSMZ=ACC-438; PubMed=14518029; PubMed=27271795; Technion Genomics Center)
ST   D8S1179: 13,14 (CLS=305037; PubMed=25877200)
ST   DYS391: 11
ST   FGA: 19,23 (CLS=305037)
ST   FGA: 20,23 (ATCC=CRL-2505; DSMZ=ACC-438; PubMed=25877200; PubMed=27271795; Technion Genomics Center)
ST   Penta D: 9,12
ST   Penta E: 5,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,15,20,21 (DSMZ=ACC-438)
ST   vWA: 15,20,21 (PubMed=14518029)
ST   vWA: 15,21 (ATCC=CRL-2505; CLS=305037; Cosmic-CLP=924100; ECACC=05092802; PubMed=25877200; PubMed=27271795; PubMed=31006810; Technion Genomics Center)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3967 ! CWR22
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   22Rv1 CHD7 KO clone 2A2
AC   CVCL_E8SC
SY   22Rv1-CHD7-KO-2A2
DR   KYinno; KC-4252
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20626; CHD7.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   22Rv1-CHD7 KO clone 1C2
AC   CVCL_E8SD
SY   22Rv1 CHD7-KO-1C2
DR   KYinno; KC-4253
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20626; CHD7.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   22Rv1 R
AC   CVCL_4Y35
DR   cancercelllines; CVCL_4Y35
DR   Wikidata; Q54583382
RX   PubMed=21982118;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   22Rv1-CabR1
AC   CVCL_A6PG
DR   cancercelllines; CVCL_A6PG
DR   Wikidata; Q107113178
RX   PubMed=31799745;
CC   Population: Caucasian.
CC   Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745).
CC   Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   22Rv1-CabR2
AC   CVCL_A6PH
DR   cancercelllines; CVCL_A6PH
DR   Wikidata; Q107113179
RX   PubMed=31799745;
CC   Population: Caucasian.
CC   Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745).
CC   Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   22RV1-EGFP
AC   CVCL_C8WA
DR   Ubigene; YC-C012-EGFP-P
DR   Wikidata; Q123030237
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   22RV1-Luc
AC   CVCL_C8UT
DR   Ubigene; YC-C012-Luc-P
DR   Wikidata; Q123030238
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   22Rv1-SL
AC   CVCL_WZ28
SY   Stem-Like 22Rv1; 22Rv1-Stem Like
DR   cancercelllines; CVCL_WZ28
DR   GEO; GSM1633320
DR   GEO; GSM1633321
DR   GEO; GSM1633322
DR   Wikidata; Q93302231
RX   PubMed=28145883;
CC   Population: Caucasian.
CC   Characteristics: Reprogrammed to, maintained and propagated as cancer stem-like cells (CSCs) by growth in androgen-free neural/neural crest (N/NC) stem medium.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 11
//
ID   22Rv1-undup1
AC   CVCL_ZC64
DR   cancercelllines; CVCL_ZC64
DR   Kerafast; EMN025-FP
DR   Wikidata; Q98125354
RX   PubMed=28928128;
CC   Population: Caucasian.
CC   Characteristics: The 35Kb tandem duplication of exons 2b-3-CE1-3 of AR that drives the expression of AR variant 7 (ARv7) was corrected using TALEN (PubMed=28928128).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   22Rv1-undup2
AC   CVCL_ZC65
DR   cancercelllines; CVCL_ZC65
DR   Kerafast; EMN026-FP
DR   Wikidata; Q98125355
RX   PubMed=28928128;
CC   Population: Caucasian.
CC   Characteristics: The 35Kb tandem duplication of exons 2b-3-CE1-3 of AR that drives the expression of AR variant 7 (ARv7) was corrected using TALEN (PubMed=28928128).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   22Rv1-undup3
AC   CVCL_ZC66
DR   cancercelllines; CVCL_ZC66
DR   Kerafast; EMN027-FP
DR   Wikidata; Q98125356
RX   PubMed=28928128;
CC   Population: Caucasian.
CC   Characteristics: The 35Kb tandem duplication of exons 2b-3-CE1-3 of AR that drives the expression of AR variant 7 (ARv7) was corrected using TALEN (PubMed=28928128).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   22RV1rYM155_300nM
AC   CVCL_RS39
SY   22RV1rYM155(300nM)
DR   cancercelllines; CVCL_RS39
DR   Wikidata; Q54583385
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_139608; Sepantronium bromide (YM155).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   23 ScCr
AC   CVCL_3634
SY   10ScNCr/23
DR   CLO; CLO_0001201
DR   ATCC; CRL-2751
DR   Wikidata; Q54583387
RX   PubMed=12183533;
CC   Characteristics: Not responsive to LPS signaling. Maintains responsiveness to bacterial pathogen signaling through alternative TLRs, such as TLR2 (for example S. aureus LTA stimulation) (PubMed=12183533).
CC   Sequence variation: Gene deletion; MGI; MGI:96824; Tlr4; Zygosity=Homozygous (PubMed=12183533).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/10ScN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   23-1
AC   CVCL_B6WG
DR   CCRID; 4201PAT-CCTCC00718
DR   Wikidata; Q111732654
RX   Patent=CN105132378B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201594.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   23-132-27
AC   CVCL_YB03
DR   DSHB; 23-132-27
DR   Wikidata; Q93302239
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02599; Dictyostelium discoideum calA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   23-57-137
AC   CVCL_E3Z4
RX   PubMed=8352067;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   23-57-137-1
AC   CVCL_E3Z5
DR   ABCD; ABCD_AF797
RX   PubMed=19346515;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3Z4 ! 23-57-137
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   23-57-154
AC   CVCL_E3Z6
RX   PubMed=8352067;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   23/05-4C6-29-3
AC   CVCL_B0GL
SY   23/05-4C6; 4C6
DR   Wikidata; Q108819476
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121104.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   23/05-4C6-29-3-Clone 5
AC   CVCL_B0GM
DR   Wikidata; Q108819477
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08041904.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B0GL ! 23/05-4C6-29-3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   23.10.36
AC   CVCL_C3TI
DR   Wikidata; Q116047955
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BN13; Babesia bovis merozoite surface antigen 1 (MSA-1) (Bo42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   23.28.57.108
AC   CVCL_C3TJ
SY   23.28.57
DR   Wikidata; Q116047956
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10116.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Babesia bovis merozoite 16 kDa surface antigen (Bo16).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   23.3.16
AC   CVCL_C3TK
DR   Wikidata; Q116047957
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BN13; Babesia bovis merozoite surface antigen 1 (MSA-1) (Bo42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   23.38.120.8
AC   CVCL_C3TL
SY   23.38.120
DR   Wikidata; Q116047958
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10111.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q17115; Babesia bovis 60 kDa merozoite surface protein rap-1 (Bv60).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   23.53.116
AC   CVCL_C3TM
DR   Wikidata; Q116047959
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q17115; Babesia bovis 60 kDa merozoite surface protein rap-1 (Bv60).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   23.70.174.83
AC   CVCL_C3TN
SY   23.70.174
DR   Wikidata; Q116047960
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10114.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Babesia bovis merozoite 44 kDa surface antigen (Bo44).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   23.8.34.24
AC   CVCL_C3TP
SY   23.8.34
DR   Wikidata; Q116047961
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10113.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; A7ASX3; Babesia bovis spherical body protein 2 (SBP2) (Bo225).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   230 BLCL
AC   CVCL_E388
DR   ECACC; 94031674
DR   Wikidata; Q54583389
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   230699
AC   CVCL_E437
SY   Extract 149; Extract 198; Extract 478
DR   dbMHC; 48455
DR   IHW; IHW09370
DR   IPD-IMGT/HLA; 25981
DR   Wikidata; Q54583390
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/348cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:06,24:02:01:01; B*07:02:01,51:03; C*07:02,14:02:01; DPB1*04:02,05:01; DQA1*01:01,03; DQB1*04:01,05:01:01; DRB1*01:01:01,04:05:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=25981).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   230C
AC   CVCL_J804
DR   Wikidata; Q54583392
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P02712; Tetronarce californica chrnb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   231
AC   CVCL_F1E6
RX   PubMed=3594482;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Dog lymphoma cell lines (Note=Immunized against 17-71 (Cellosaurus=CVCL_0B18) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   23132/87
AC   CVCL_1046
SY   23132-87; 2313287; St 23132; St23132; 23132
DR   CLO; CLO_0001202
DR   EFO; EFO_0006528
DR   CLDB; cl38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 822
DR   BioSample; SAMN03470944
DR   BioSample; SAMN03473375
DR   BioSample; SAMN10988573
DR   cancercelllines; CVCL_1046
DR   Cell_Model_Passport; SIDM00980
DR   ChEMBL-Cells; CHEMBL3308702
DR   ChEMBL-Targets; CHEMBL1075382
DR   Cosmic; 910924
DR   Cosmic; 1995324
DR   Cosmic; 2484956
DR   Cosmic-CLP; 910924
DR   DepMap; ACH-000948
DR   DSMZ; ACC-201
DR   DSMZCellDive; ACC-201
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910924
DR   GEO; GSM827572
DR   GEO; GSM886838
DR   GEO; GSM887901
DR   GEO; GSM1374371
DR   GEO; GSM1374372
DR   GEO; GSM1669566
DR   IARC_TP53; 21150
DR   LiGeA; CCLE_415
DR   LINCS_LDP; LCL-1532
DR   PharmacoDB; 2313287_13_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1046
DR   PubChem_Cell_line; CVCL_1046
DR   Wikidata; Q54583395
RX   PubMed=8100658;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 30-32 hours (PubMed=8100658); ~50 hours (DSMZ=ACC-201).
CC   HLA typing: A*25:01,25:01; B*18:01,18:01; C*12:03,12:03; DQB1*05:01,05:01; DRB1*03:17,11:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.42%; Native American=0.35%; East Asian, North=1.75%; East Asian, South=0%; South Asian=0%; European, North=54.5%; European, South=39.98% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): Cosmic-CLP=910924; DSMZ=ACC-201; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 8,9,10 (DSMZ=ACC-201; PubMed=25877200)
ST   CSF1PO: 9,10 (Cosmic-CLP=910924)
ST   D13S317: 11,12
ST   D16S539: 11,13,14 (PubMed=25877200)
ST   D16S539: 11,14 (Cosmic-CLP=910924; DSMZ=ACC-201)
ST   D18S51: 12,13
ST   D19S433: 12,13
ST   D21S11: 28,31.2
ST   D2S1338: 17,19,20 (PubMed=25877200)
ST   D2S1338: 17,20 (DSMZ=ACC-201)
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 9.3,12 (PubMed=25877200)
ST   D7S820: 10,12,13 (Cosmic-CLP=910924; DSMZ=ACC-201)
ST   D8S1179: 11,12,13,15 (PubMed=25877200)
ST   D8S1179: 11,12,15 (DSMZ=ACC-201)
ST   FGA: 20,21,22 (DSMZ=ACC-201)
ST   FGA: 21,22 (PubMed=25877200)
ST   Penta D: 9,12
ST   Penta E: 6,16
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 15,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   232
AC   CVCL_G581
SY   Anti PDGF hybridoma #232
DR   CLO; CLO_0001203
DR   ATCC; HB-9372
DR   Wikidata; Q54583396
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9372.
CC   Monoclonal antibody isotype: IgG2b (Patent=US5175255); IgG2a (ATCC=HB-9372).
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   232-238-10
AC   CVCL_XY65
DR   DSHB; 232-238-10
DR   Wikidata; Q93302270
RX   PubMed=8752217;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q550R2; Dictyostelium discoideum ctxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   232-A4
AC   CVCL_Y556
SY   232 A4-LCL; 232A4
DR   DSMZ; ACC-774
DR   DSMZCellDive; ACC-774
DR   Wikidata; Q54583397
RX   PubMed=8127151;
RX   PubMed=23297799;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-774).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-774
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 28,33.2
ST   D2S1338: 17,19
ST   D3S1358: 14,15
ST   D5S818: 10
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 10,12
ST   Penta E: 14
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y436 ! 232-B4
SX   Male
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 11
//
ID   232-B4
AC   CVCL_Y436
SY   232 B4-CLL; 232B4
DR   NCBI_Iran; C545
DR   Wikidata; Q54583399
RX   PubMed=8127151;
RX   PubMed=23297799;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: 2J2-B4; NCBI_Iran=C545.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y556 ! 232-A4
SX   Male
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   233 BLCL
AC   CVCL_E389
DR   ECACC; 11061001
DR   Wikidata; Q54583402
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   234
AC   CVCL_F1E7
RX   PubMed=3594482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dog 36 kDa protein from lymphoma cell lines (Note=Immunized against 17-71 (Cellosaurus=CVCL_0B18) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   234 BLCL
AC   CVCL_E390
DR   ECACC; 94031676
DR   Wikidata; Q54583404
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   234H11E8
AC   CVCL_A0NS
SY   234 H11E8
DR   Wikidata; Q108819478
RX   Patent=US20210079099;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3319.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   235-1
AC   CVCL_U363
DR   Wikidata; Q54583406
RX   PubMed=6433612;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_2117 ! MMQ
SX   Sex unspecified
AG   5D
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   236L
AC   CVCL_J622
DR   CLO; CLO_0001204
DR   ATCC; HB-12593
DR   Wikidata; Q54583409
RX   Patent=US6251395;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12593.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9QYE7; Rat Itgad/Cd11d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   239 BLCL
AC   CVCL_E391
DR   ECACC; 94031678
DR   Wikidata; Q54583412
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   239T
AC   CVCL_A2AI
DR   Wikidata; Q105505891
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   23a-14G9
AC   CVCL_B0UV
DR   Wikidata; Q108819479
RX   Patent=US7772374;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6004.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Bacillus anthracis spore specific antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   23A-5-21S
AC   CVCL_G582
DR   CLO; CLO_0001205
DR   ATCC; HB-36
DR   Wikidata; Q54583415
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   23A2
AC   CVCL_C5AS
DR   Wikidata; Q116047962
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   23A3dc1
AC   CVCL_A7XV
DR   Wikidata; Q107113180
RX   PubMed=7838184;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp / Malaysia) apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   23B2
AC   CVCL_S152
DR   Wikidata; Q54583416
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Arlee 12; VBO=VBO_0017491.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   23B4
AC   CVCL_B6W4
DR   Wikidata; Q111732656
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   23B6
AC   CVCL_9151
DR   CLO; CLO_0001206
DR   Wikidata; Q54583417
RX   Patent=US4758511;
RX   PubMed=3873067;
RX   PubMed=6979575;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8521.
CC   Characteristics: T-cell hybridoma. Produces IgE-binding protein (Iap).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   23C27
AC   CVCL_VS01
DR   Wikidata; Q93302314
RX   PubMed=30735882;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Characteristics: AQP1-GFP reporter cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:633; AQP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ06 ! 585A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   23C7
AC   CVCL_A6LH
DR   DSHB; 23C7-anti-wit
DR   Wikidata; Q107113181
RX   PubMed=11856529;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; M9PE88; Drosophila melanogaster wit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   23CLN
AC   CVCL_6530
DR   CLO; CLO_0001207
DR   CLO; CLO_0050472
DR   CLDB; cl39
DR   ECACC; 94042257
DR   RCB; RCB0179
DR   Wikidata; Q54583418
WW   Info; RCB; -; https://cell.brc.riken.jp/en/announcement/23cln
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of bovine origin but found to be a porcine cell line (see Riken web site).
CC   Discontinued: ECACC; 94042257; true.
CC   Discontinued: RCB; RCB0179; true.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   23D7
AC   CVCL_B0LS
DR   Wikidata; Q108819480
RX   PubMed=16714576;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 36-302 = A chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   23E9E7
AC   CVCL_D3SC
DR   DSHB; 23E9E7
DR   Wikidata; Q127378689
RX   PubMed=1696825;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7V3; Escherichia coli rpsC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   23F2G
AC   CVCL_4W87
DR   ATCC; HB-11081
DR   Wikidata; Q54583420
RX   Patent=US5854070;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11081.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   23G3
AC   CVCL_ZC47
DR   Wikidata; Q98125357
RX   PubMed=1717839;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   23G4
AC   CVCL_F0VC
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   23M-D9
AC   CVCL_WZ67
SY   HB 23M-D9
DR   CCRID; 4201PAT-CCTCC00004
DR   Wikidata; Q93302319
RX   Patent=US5156977;
RX   PubMed=2957546;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85031402.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01160; Human NPPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   24-2-3
AC   CVCL_B0VV
DR   Wikidata; Q108819481
RX   Patent=US9676843;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2926.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   24-210-2
AC   CVCL_YA97
DR   DSHB; 24-210-2
DR   Wikidata; Q93302321
RX   PubMed=2408765;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08796; Dictyostelium discoideum csaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   24/04-10B4-24-8
AC   CVCL_B0GF
SY   24/04-10B4; 10B4
DR   Wikidata; Q108819482
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121101.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   24/04-10B4-24-8-FACS 9-5
AC   CVCL_B0GG
DR   Wikidata; Q108819483
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08042901.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B0GF ! 24/04-10B4-24-8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   24.1
AC   CVCL_F1WV
RX   Patent=US7494650;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4893; HGF (Note=With a C-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7261 ! EcR-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   240-13D10
AC   CVCL_E974
DR   CLO; CLO_0001208
DR   ATCC; CRL-2672
DR   Wikidata; Q54583423
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9144.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00527; Y73 avian sarcoma virus v-Yes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   240-D
AC   CVCL_F0AX
RX   PubMed=2072448;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 512-856 = gp41).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   240A
AC   CVCL_J805
DR   Wikidata; Q54583424
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   240E-W
AC   CVCL_Z068
DR   Wikidata; Q54583426
RX   Patent=US10377814;
RX   PubMed=21633632;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
DI   NCIt; C133738; Rabbit plasmacytoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_J972 ! 240E1-1-2
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   240E-W2
AC   CVCL_Z069
DR   Wikidata; Q54583429
RX   Patent=US10377814;
RX   PubMed=21633632;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
DI   NCIt; C133738; Rabbit plasmacytoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z068 ! 240E-W
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   240E1-1
AC   CVCL_J971
SY   240E1; 240E-1
DR   Wikidata; Q54583430
RX   Patent=US5675063;
RX   PubMed=7568130;
RX   PubMed=21633632;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11872.
DI   NCIt; C133738; Rabbit plasmacytoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   240E1-1-2
AC   CVCL_J972
SY   240E 1-1-2; 240E-1-1-2
DR   Wikidata; Q54583501
RX   Patent=US5675063;
RX   PubMed=7568130;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11870.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
DI   NCIt; C133738; Rabbit plasmacytoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_J971 ! 240E1-1
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   241-10C10
AC   CVCL_0F05
DR   ATCC; CRL-2671
DR   Wikidata; Q54583503
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00527; Y73 avian sarcoma virus v-Yes.
CC   Discontinued: ATCC; CRL-2671; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 4
//
ID   241-36-2
AC   CVCL_XY66
DR   Wikidata; Q93302336
RX   PubMed=8752217;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q54HG2; Dictyostelium discoideum ctxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   241-438-1
AC   CVCL_XY67
DR   DSHB; 241-438-1
DR   Wikidata; Q93302338
RX   PubMed=8752217;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q54HG2; Dictyostelium discoideum ctxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   24131
AC   CVCL_JC62
SY   30063; TER369; TER-369; Ter 369; TER443; TER-443; Ter 443; TER474; TER-474; Ter 474
DR   IPD-IMGT/HLA; 12578
DR   Wikidata; Q54583504
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/351cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/367cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,02; B*44,40; C*05:01,02:02; DPB1*02:01:02,04:01:01; DQA1*01:03,04:01:01; DQB1*04:02,06:03; DRB1*08:16,13:01:01; DRB3*01:01 (IPD-IMGT/HLA=12578).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   242 BLCL
AC   CVCL_E392
DR   ECACC; 94031680
DR   Wikidata; Q54583505
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   2427T
AC   CVCL_M070
DR   CLS; 300167
DR   Wikidata; Q54583507
RX   PubMed=21684623;
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,68:01:02; B*07:02:01,51:01:01; C*07:02:01,15:02:01; DPB1*03:01:01,04:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRB1*04:04:01,11:01:01 (CLS=300167).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=300167; PubMed=21684623
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 14
//
ID   243
AC   CVCL_D570
DR   Wikidata; Q54583510
RX   PubMed=16357141;
CC   Characteristics: Produces IgA lambda.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   243H1
AC   CVCL_C102
SY   KUIFMSi009-A
DR   hPSCreg; KUIFMSi009-A
DR   SKIP; SKIP001170
DR   SKIP; SKIP002374
DR   Wikidata; Q54583511
RX   PubMed=18035408;
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast-like synoviocyte; CL=CL_0002301.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 5,12
ST   TH01: 5,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C103 ! 243H7
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   243H7
AC   CVCL_C103
SY   KUIFMSi009-B
DR   hPSCreg; KUIFMSi009-B
DR   SKIP; SKIP001171
DR   SKIP; SKIP002375
DR   Wikidata; Q54583513
RX   PubMed=18035408;
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast-like synoviocyte; CL=CL_0002301.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 5,12
ST   TH01: 5,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C102 ! 243H1
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   243L1
AC   CVCL_WI30
DR   Wikidata; Q93302366
RX   PubMed=2425031;
RX   PubMed=9032273;
CC   Group: Bird cell line.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   245 BLCL
AC   CVCL_E393
DR   ECACC; 94031681
DR   Wikidata; Q54583514
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   245A
AC   CVCL_J806
DR   Wikidata; Q54583516
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   245E7
AC   CVCL_J904
DR   ATCC; HB-8489
DR   Wikidata; Q54583518
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8489.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   246 BLCL
AC   CVCL_E394
DR   ECACC; 94031682
DR   Wikidata; Q54583519
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   246-D
AC   CVCL_F0AY
RX   PubMed=2072448;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 512-856 = gp41).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   246B1
AC   CVCL_C237
DR   SKIP; SKIP001164
DR   Wikidata; Q54583520
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   246B2
AC   CVCL_C238
DR   SKIP; SKIP001165
DR   Wikidata; Q54583523
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   246B3
AC   CVCL_C239
DR   SKIP; SKIP001166
DR   Wikidata; Q54583524
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   246B4
AC   CVCL_C240
DR   SKIP; SKIP001169
DR   Wikidata; Q54583525
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   246B5
AC   CVCL_C241
DR   SKIP; SKIP001167
DR   Wikidata; Q54583527
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   246B6
AC   CVCL_C242
DR   SKIP; SKIP001168
DR   Wikidata; Q54583528
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   246G1
AC   CVCL_C243
SY   KUIFMSi011-A
DR   GEO; GSM1040270
DR   GEO; GSM1040340
DR   GEO; GSM1489424
DR   hPSCreg; KUIFMSi011-A
DR   SKIP; SKIP001155
DR   SKIP; SKIP002376
DR   Wikidata; Q54583529
RX   PubMed=18035408;
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D21S11: 28
ST   D3S1358: 13,15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   246G3
AC   CVCL_C244
SY   KUIFMSi011-B
DR   hPSCreg; KUIFMSi011-B
DR   SKIP; SKIP001156
DR   SKIP; SKIP002377
DR   Wikidata; Q54583532
RX   PubMed=18035408;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D21S11: 28
ST   D3S1358: 13,15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   246G4
AC   CVCL_C245
SY   KUIFMSi011-C
DR   hPSCreg; KUIFMSi011-C
DR   SKIP; SKIP001157
DR   SKIP; SKIP002378
DR   Wikidata; Q54583535
RX   PubMed=18035408;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D21S11: 28
ST   D3S1358: 13,15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   246G5
AC   CVCL_C246
SY   KUIFMSi011-D
DR   hPSCreg; KUIFMSi011-D
DR   SKIP; SKIP001158
DR   SKIP; SKIP002379
DR   Wikidata; Q54583536
RX   PubMed=18035408;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D21S11: 28
ST   D3S1358: 13,15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   246G6
AC   CVCL_C247
SY   KUIFMSi011-E
DR   hPSCreg; KUIFMSi011-E
DR   SKIP; SKIP001159
DR   SKIP; SKIP002380
DR   Wikidata; Q54583537
RX   PubMed=18035408;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=18035408
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D21S11: 28
ST   D3S1358: 13,15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   247 BLCL
AC   CVCL_E395
DR   ECACC; 94031683
DR   Wikidata; Q54583539
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   2474/90
AC   CVCL_9556
SY   St 2474; St2474
DR   BioSample; SAMN03151783
DR   cancercelllines; CVCL_9556
DR   Wikidata; Q54583541
RX   PubMed=8100658;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 60 year old male patient with a gastric carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00107.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   2498
AC   CVCL_ZR63
DR   Wikidata; Q98125358
RX   PubMed=6403037;
RX   PubMed=6492896;
RX   PubMed=7059984;
RX   PubMed=7163956;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   249F8
AC   CVCL_F1VB
RX   Patent=WO1992012252A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3197.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Selected for resistance to: ChEBI; CHEBI_83970; Cardiac glycoside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   249L4
AC   CVCL_L025
DR   Wikidata; Q54583542
RX   PubMed=2425031;
RX   PubMed=9032273;
RX   PubMed=9834055;
CC   Group: Bird cell line.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   24a
AC   CVCL_C5HY
DR   Wikidata; Q116047963
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   24A11
AC   CVCL_E7SA
RX   PubMed=2845894;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q0PL25; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   24B>Ras attP-G1-CloneF3
AC   CVCL_C7G8
SY   24BG1-F3
DR   DGRC; 325
DR   FlyBase_Cell_line; FBtc0000325
DR   Wikidata; Q123030239
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: how(24B)-Gal4 driving UAS-RasV12 with an attP flanked cassette for RMCE and co-expression of GFP.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Embryonic muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_XF51 ! 24B>Ras attP GFP-L1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   24B>Ras attP-G1-CloneG1
AC   CVCL_C7G7
SY   24BG1-G1
DR   DGRC; 324
DR   FlyBase_Cell_line; FBtc0000324
DR   Wikidata; Q123030240
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: how(24B)-Gal4 driving UAS-RasV12 with an attP flanked cassette for RMCE and co-expression of GFP.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Embryonic muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_XF51 ! 24B>Ras attP GFP-L1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   24B>Ras attP GFP-L1
AC   CVCL_XF51
SY   24B-G1; 24B-G1 attP; 24BG1
DR   DGRC; 283
DR   FlyBase_Cell_line; FBtc0000283
DR   Wikidata; Q93302501
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: how(24B)-Gal4 driving UAS-RasV12 with an attP flanked cassette for RMCE and co-expression of GFP.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Embryonic muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   24B>Ras attP-L5
AC   CVCL_XF52
SY   24B-5; 24B-5 attP; 24B5
DR   DGRC; 284
DR   FlyBase_Cell_line; FBtc0000284
DR   Wikidata; Q93302505
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: how(24B)-Gal4 driving UAS-RasV12 with an attP flanked cassette for RMCE.
CC   Derived from site: In situ; Embryonic muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 8
//
ID   24B>Ras attP-L5-CloneB8
AC   CVCL_C7G6
SY   24B5-B8
DR   DGRC; 323
DR   FlyBase_Cell_line; FBtc0000323
DR   Wikidata; Q123030241
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: how(24B)-Gal4 driving UAS-RasV12 with an attP flanked cassette for RMCE.
CC   Derived from site: In situ; Embryonic muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_XF52 ! 24B>Ras attP-L5
SX   Sex unspecified
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   24B11
AC   CVCL_B0LT
DR   Wikidata; Q108819484
RX   PubMed=16714577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 315-576 = B chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   24B12
AC   CVCL_C5EG
DR   Wikidata; Q116047964
RX   PubMed=22008075;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6NTJ3; Xenopus laevis greatwall (mastl).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   24BC
AC   CVCL_S153
DR   Wikidata; Q54583543
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Doubling time: 1.8 days (DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Arlee 12; VBO=VBO_0017491.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   24C2
AC   CVCL_F0VD
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   24D3-2
AC   CVCL_B0U2
DR   Wikidata; Q108819485
RX   Patent=EP0479454A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10542.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   24E6
AC   CVCL_A0JF
DR   Wikidata; Q108819486
RX   PubMed=1283092;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   24F12
AC   CVCL_F0VE
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   24F2
AC   CVCL_E8V3
RX   PubMed=17374540;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08169; Apis mellifera hyaluronidase (allergen Api m 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   24G3
AC   CVCL_F1F2
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   24G5
AC   CVCL_C5EH
DR   Wikidata; Q116047965
RX   PubMed=22008075;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6NTJ3; Xenopus laevis greatwall (mastl).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   24H7
AC   CVCL_B6W5
DR   Wikidata; Q111732657
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   24HM
AC   CVCL_A4QC
DR   SKIP; SKIP000888
DR   Wikidata; Q105505895
CC   From: Okano, Hideyuki; Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   24IA2E2E10D5
AC   CVCL_G583
SY   24IA2
DR   CLO; CLO_0001209
DR   ATCC; HB-8049
DR   Wikidata; Q54583544
RX   Patent=US4713325;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8049.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P10262; Feline leukemia virus gag (Note=AA 198-445 = p27/p30).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   25-32
AC   CVCL_J715
DR   ECACC; 91060546
DR   Wikidata; Q54583546
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; W5QBV7; Sheep CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   25-5-16S
AC   CVCL_G584
DR   CLO; CLO_0001211
DR   ATCC; HB-37
DR   Wikidata; Q54583549
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   25-9-17S
AC   CVCL_D660
SY   25.9.17S
DR   BCRJ; 0008
DR   Wikidata; Q54583552
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   25-9-17S II
AC   CVCL_G335
DR   CLO; CLO_0001212
DR   ATCC; HB-26
DR   Wikidata; Q54583553
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D660 ! 25-9-17S
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   25-9-3S
AC   CVCL_G585
DR   CLO; CLO_0001213
DR   ATCC; HB-38
DR   Wikidata; Q54583556
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   25/1506
AC   CVCL_E438
DR   dbMHC; 48456
DR   IHW; IHW09252
DR   IPD-IMGT/HLA; 10112
DR   Wikidata; Q54583559
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01,66:01; B*07,35; DPB1*02:01:02,14:01 (IPD-IMGT/HLA=10112).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   250 MK
AC   CVCL_A4ZY
SY   250MK
DR   BTO; BTO_0006200
DR   Wikidata; Q107113182
RX   PubMed=19773443;
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   250-30
AC   CVCL_A7YF
DR   BEI_Resources; MRA-453
DR   Wikidata; Q107113184
RX   PubMed=10816526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium sp. thrombospondin-related anonymous protein (TRAP) (Note=Immunized with a synthetic peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T277 ! MOPC-21
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   250-9G06
AC   CVCL_J584
DR   Wikidata; Q54583560
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9260.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00531; Avian retrovirus MH2 v-Mil.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   250BR
AC   CVCL_ZN21
SY   250 BRighton
DR   Wikidata; Q98125360
RX   PubMed=10022907;
RX   PubMed=11841555;
RX   PubMed=15572672;
RX   PubMed=16714754;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   251 BLCL
AC   CVCL_E396
DR   ECACC; 94031685
DR   Wikidata; Q54583561
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   251BR
AC   CVCL_ZN22
SY   251 BRighton
DR   Wikidata; Q98125361
RX   PubMed=16714754;
RX   PubMed=18079351;
RX   PubMed=19179371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   252 BLCL
AC   CVCL_E397
DR   ECACC; 94031686
DR   Wikidata; Q54583562
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   252-234-2
AC   CVCL_XY68
DR   DSHB; 252-234-2
DR   Wikidata; Q93302591
RX   PubMed=11726513;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q23858; Dictyostelium discoideum crtA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   2525T
AC   CVCL_ZT94
SY   2525
DR   Wikidata; Q98125362
RX   PubMed=2259385;
RX   PubMed=7779715;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   25368 mel
AC   CVCL_C7W8
DR   Wikidata; Q123030242
RX   PubMed=22207316;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   253D
AC   CVCL_5449
DR   CLO; CLO_0001210
DR   CLDB; cl41
DR   ECACC; 93090807
DR   Wikidata; Q54583564
RX   PubMed=8795574;
CC   Doubling time: ~80 hours (Note=At 18th passage) (PubMed=8795574).
CC   Discontinued: ECACC; 93090807; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   253F1
AC   CVCL_B513
DR   SKIP; SKIP001172
DR   Wikidata; Q54583567
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   253F2
AC   CVCL_B514
DR   SKIP; SKIP001173
DR   Wikidata; Q54583568
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   253F3
AC   CVCL_B515
DR   SKIP; SKIP001174
DR   Wikidata; Q54583643
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   253F4
AC   CVCL_B516
DR   SKIP; SKIP001175
DR   Wikidata; Q54583644
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   253F5
AC   CVCL_B517
DR   SKIP; SKIP001176
DR   Wikidata; Q54583648
RX   PubMed=18035408;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   253G1
AC   CVCL_B518
SY   253-G1; HiPS253G1; HPS0002
DR   GEO; GSM1040251
DR   GEO; GSM1040321
DR   GEO; GSM1489219
DR   GEO; GSM1489425
DR   RCB; HPS0002
DR   SKIP; SKIP000002
DR   Wikidata; Q54583649
RX   PubMed=18059259;
RX   PubMed=21098095;
RX   PubMed=22056147;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
RX   PubMed=27806289;
RX   PubMed=28453617;
RX   PubMed=40485979;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   253G4
AC   CVCL_T792
SY   253-G4; 253G-4; HPS4291
DR   GEO; GSM1040252
DR   GEO; GSM1040322
DR   GEO; GSM1489220
DR   GEO; GSM1489250
DR   GEO; GSM1489426
DR   RCB; HPS4291
DR   SKIP; SKIP001451
DR   Wikidata; Q54583651
RX   PubMed=18059259;
RX   PubMed=21098095;
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   253J
AC   CVCL_7935
AS   CVCL_7938
SY   253j; 253-J; 253 J; 253J-P; 253J-Parental; 253J P; 253JP
DR   BTO; BTO_0004796
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-108
DR   BioSample; SAMN10987961
DR   cancercelllines; CVCL_7935
DR   Cell_Model_Passport; SIDM01529
DR   Cosmic; 715794
DR   Cosmic; 760476
DR   Cosmic; 845564
DR   Cosmic; 925827
DR   Cosmic; 928820
DR   Cosmic; 1016884
DR   Cosmic; 1046680
DR   Cosmic; 1082644
DR   Cosmic; 1285102
DR   Cosmic; 1285997
DR   Cosmic; 1927305
DR   Cosmic; 1938694
DR   Cosmic; 2050426
DR   Cosmic; 2057433
DR   Cosmic; 2444255
DR   Cosmic; 2685929
DR   Cosmic; 2700994
DR   DepMap; ACH-000011
DR   GEO; GSM136240
DR   GEO; GSM1574546
DR   GEO; GSM1574574
DR   IARC_TP53; 21034
DR   KCLB; 80001
DR   LiGeA; CCLE_259
DR   PharmacoDB; 253J_14_2019
DR   Wikidata; Q54583653
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RX   PubMed=66978;
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=748774;
RX   PubMed=944089;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=4431054;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=7658585;
RX   PubMed=8873383;
RX   PubMed=11207054;
RX   PubMed=11416159;
RX   PubMed=11921286;
RX   PubMed=12127398;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26589293;
RX   PubMed=26621286;
RX   PubMed=27270441;
RX   PubMed=29732388;
RX   PubMed=31068700;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 36 hours (PubMed=66978; PubMed=748774); 46 +- 3 hours (PubMed=7658585); 28 hours (PubMed=3708594).
CC   HLA typing: A*01:01,03:01; B*08:01,51:01; C*07:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; HTB-108; true.
CC   Derived from site: Metastatic; Retroperitoneal lymph node; UBERON=UBERON_0035371.
ST   Source(s): KCLB=80001; PubMed=11416159; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 11,13
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 11
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   253J laval
AC   CVCL_7936
SY   253J-Laval; 253JLAVAL
DR   BTO; BTO_0004893
DR   Wikidata; Q54583654
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Retroperitoneal lymph node; UBERON=UBERON_0035371.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7935 ! 253J
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   253J-BV
AC   CVCL_7937
SY   253JB-V; 253J B-V; 253JBV; 253J-Bladder-V
DR   BTO; BTO_0004894
DR   EFO; EFO_0022648
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987963
DR   cancercelllines; CVCL_7937
DR   Cell_Model_Passport; SIDM01624
DR   Cosmic; 846282
DR   Cosmic; 1082645
DR   Cosmic; 1938695
DR   DepMap; ACH-000026
DR   GEO; GSM136239
DR   IARC_TP53; 30015
DR   KCLB; 80002
DR   LiGeA; CCLE_144
DR   PharmacoDB; 253JBV_15_2019
DR   Wikidata; Q54583655
RX   PubMed=7658585;
RX   PubMed=26589293;
RX   PubMed=29732388;
RX   PubMed=31068700;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Metastatic phenotype. Obtained after 5 serial passages of the parent cell line in the bladder of nude mice.
CC   Doubling time: 49 +- 5 hours (PubMed=7658585).
CC   HLA typing: A*01:01,03:01; B*08:01,51:01; C*07:06,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Retroperitoneal lymph node; UBERON=UBERON_0035371.
ST   Source(s): KCLB=80002
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7935 ! 253J
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   253J-Lung-IV
AC   CVCL_6G34
SY   253J-lung-IV; 253J-Lung
DR   Wikidata; Q54583657
RX   PubMed=7658585;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Doubling time: 41 +- 4 hours (PubMed=7658585).
CC   Derived from site: Metastatic; Retroperitoneal lymph node; UBERON=UBERON_0035371.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7935 ! 253J
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   254
AC   CVCL_F1E8
RX   PubMed=3594482;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Dog lymphoma cell lines (Note=Immunized against 17-71 (Cellosaurus=CVCL_0B18) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   254H9
AC   CVCL_B0DB
DR   Wikidata; Q108819487
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10792.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10063.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human breast cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   256 BLCL
AC   CVCL_E398
DR   ECACC; 94031687
DR   Wikidata; Q54583660
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   2563
AC   CVCL_M629
DR   BioSample; SAMN03151658
DR   Wikidata; Q54583662
RX   CelloPub=CLPUB00262;
RX   PubMed=66321;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from a male patient with a lung adenocarcinoma. The 2563 cell line is said to be derived from the MAC-21 cell line (Cellosaurus=CVCL_M627) which is also HeLa contaminated but which has never been tested for such a contamination.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00032.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   257 BLCL
AC   CVCL_E399
DR   ECACC; 94031689
DR   Wikidata; Q54583663
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   HLA typing: A*03:29; B*:08,44; C*07; DQB1*02,03; DRB1*03,04 (ECACC=94031689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   257-2
AC   CVCL_F0AF
RX   PubMed=2014246;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   257-D
AC   CVCL_F0AS
SY   257-2D
RX   PubMed=2014246;
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
HI   CVCL_F0AF ! 257-2
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   258C4.4
AC   CVCL_C4U8
DR   Wikidata; Q116047966
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   258C4-5
AC   CVCL_C4U9
DR   Wikidata; Q116047967
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   259 BLCL
AC   CVCL_E400
DR   ECACC; 94031691
DR   Wikidata; Q54583665
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   2599T
AC   CVCL_ZT01
DR   Wikidata; Q98125364
RX   PubMed=3136916;
RX   PubMed=6409440;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8498; Hereditary melanoma
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   25A11
AC   CVCL_E8NV
DR   ABCD; ABCD_BF014
RX   Patent=WO2024196162A1;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UXX9; Human RSPO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   25A4
AC   CVCL_B0LU
DR   Wikidata; Q108819488
RX   PubMed=16714576;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 36-302 = A chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   25B
AC   CVCL_S154
DR   Wikidata; Q54583666
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Arlee 12; VBO=VBO_0017491.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   25C2
AC   CVCL_F1F1
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   25C9
AC   CVCL_E7SC
SY   25C9.3C
RX   PubMed=1379786;
RX   PubMed=2845894;
WW   Provider; OSU CFAES; T2003-125; https://dev.innovatehosted.com/available_technologies/37407/Mouse-hybridoma-25C93C-Secreting-Monoclonal-Antibodies-to-Porcine-Coronavirus
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   25E12
AC   CVCL_E8NW
RX   Patent=WO2024196162A1;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UXX9; Human RSPO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   25E4
AC   CVCL_E7SD
RX   PubMed=1379786;
RX   PubMed=2845894;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   25H4
AC   CVCL_E7SE
RX   PubMed=2845894;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   25H7
AC   CVCL_E7SB
RX   PubMed=2845894;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q0PL25; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   25MA
AC   CVCL_ZU27
SY   25 MAnchester
DR   Wikidata; Q98125365
RX   PubMed=9649131;
CC   Senescence: Senesces at 7 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   26-7-11S
AC   CVCL_G586
DR   CLO; CLO_0001217
DR   ATCC; HB-15
DR   Wikidata; Q54583668
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   26-8-16S
AC   CVCL_G587
DR   CLO; CLO_0001218
DR   ATCC; HB-42
DR   Wikidata; Q54583669
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   26.4.1
AC   CVCL_D3V2
DR   ABCD; ABCD_AE243
DR   Wikidata; Q127378690
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   26.5
AC   CVCL_A0AS
DR   BEI_Resources; ARP-12789
DR   Wikidata; Q108819489
RX   PubMed=15802267;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q95460; Human MR1 (Note=Also reacts with bovine, mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   26/27
AC   CVCL_E439
SY   02627
DR   dbMHC; 48457
DR   ECACC; 94022517
DR   IHW; IHW09251
DR   IPD-IMGT/HLA; 10114
DR   Wikidata; Q54583672
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native Central American; Pima.
CC   HLA typing: A*02:01,24:02; B*51:02:01,48:01:01; C*08:01:01; DPB1*02:01:02,04:02; DQB1*03; DRB1*14; DRB3*01 (IPD-IMGT/HLA=10114).
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*48:01:01,51:02:01; C*08:01:01; DPA1*01:03:01:01,01:03:01:05; DPB1*02:01:02(416:01),04:02:01:02(105:01); DQA1*05:03; DQB1*03:01:01:01; DRB1*14:02:01; DRB3*01:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   260-302-2
AC   CVCL_XY69
DR   Wikidata; Q93302700
WW   Provider; Creative Diagnostics; CSC-H1714; https://www.creative-diagnostics.com/Anti-Dictyostelium-discoideum-actin-binding-protein-34-ABP34-Hybridoma-137332-197.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24005; Dictyostelium discoideum abpB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 4
//
ID   260-33C4
AC   CVCL_J623
DR   CLO; CLO_0001215
DR   ATCC; CRL-2667
DR   Wikidata; Q54583673
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   260F9
AC   CVCL_J908
DR   ATCC; HB-8488
DR   Wikidata; Q54583674
RX   DOI=10.3390/antib1010039;
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8488.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was conjugated to a ricin chain A to produce 260F9-rRTA which was evaluated in two phase 1 clinical trials which were not pursued due to severe toxicity of the conjugate (DOI=10.3390/antib1010039).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer 55 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   260F9-1C9
AC   CVCL_J909
DR   ATCC; HB-8662
DR   Wikidata; Q54583675
RX   Patent=US4753894;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8662.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J908 ! 260F9
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   261-1F3
AC   CVCL_0F04
DR   ATCC; CRL-2666
DR   Wikidata; Q54583677
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00532; Murine sarcoma virus 3611 v-Raf.
CC   Discontinued: ATCC; CRL-2666; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 4
//
ID   26258M
AC   CVCL_WM49
DR   Cosmic; 852223
DR   Wikidata; Q93302720
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   262C
AC   CVCL_J807
DR   Wikidata; Q54583678
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   26396M
AC   CVCL_WM44
DR   cancercelllines; CVCL_WM44
DR   Cosmic; 852218
DR   Wikidata; Q93302728
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-2A>G (IVS2-2A>G); ClinVar=VCV000487034; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   263A17
AC   CVCL_B0VD
DR   Wikidata; Q108819490
RX   Patent=US7579187;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   263K 3F4
AC   CVCL_KR59
SY   263K3F4; 3F4
DR   ATCC; HB-9222
DR   Wikidata; Q54583680
RX   Patent=US4806627;
RX   PubMed=2446004;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9222.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04273; Mesocricetus auratus PRNP/CD230.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   264040
AC   CVCL_V365
DR   IPD-IMGT/HLA; 14451
DR   Wikidata; Q54583681
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*08:30N,56:01; DQB1*03:02,05:02; DRB1*04:01,16:01 (IPD-IMGT/HLA=14451).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   26414M
AC   CVCL_WM53
DR   cancercelllines; CVCL_WM53
DR   Cosmic; 852227
DR   Wikidata; Q93302740
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   2645-94
AC   CVCL_S816
SY   MLS 2645-94
DR   EFO; EFO_0022654
DR   PRIDE; PXD012680
DR   Wikidata; Q54583682
RX   PubMed=10449603;
RX   PubMed=16651630;
RX   PubMed=20515481;
RX   PubMed=25393000;
RX   PubMed=30962207;
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=16651630).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   264E
AC   CVCL_J808
DR   Wikidata; Q54583683
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   26586
AC   CVCL_JD14
SY   TER306; TER-306; Ter-306; Ter 306; TER531; TER-531; Ter-531; Ter 531; Extract 181; Extract 287; Extract 461
DR   IPD-IMGT/HLA; 12247
DR   Wikidata; Q54583686
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/344cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX395Report.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,24:23; B*51:01,15:01; C*03:03,03:04; DPB1*02:01,03:01; DQA1*01:03,03:01; DQB1*06:03,03:02; DRB1*04:07,13:01; DRB3*02:02; DRB4*01:03:01 (IPD-IMGT/HLA=12247).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   265A
AC   CVCL_J809
DR   Wikidata; Q54583690
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02712; Tetronarce californica chrnb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   266-6
AC   CVCL_3481
DR   CLO; CLO_0001216
DR   ATCC; CRL-2151
DR   Ubigene; YC-C014
DR   Wikidata; Q54583691
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
ST   Source(s): Ubigene=YC-C014
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 12-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 18-3: 16
ST   Mouse STR X-1: 28
DI   NCIt; C34036; Mouse pancreatic acinar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   266-6-Luc
AC   CVCL_C8US
DR   Ubigene; YC-C014-Luc-P
DR   Wikidata; Q123030243
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
DI   NCIt; C34036; Mouse pancreatic acinar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   266A4.5
AC   CVCL_C4UA
DR   Wikidata; Q116047968
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   266B2
AC   CVCL_J912
DR   ATCC; HB-8486
DR   Wikidata; Q54583692
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8486.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   266BR
AC   CVCL_ZT31
SY   266 BRighton
DR   Wikidata; Q98125366
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   267.A4.A1
AC   CVCL_C4U5
DR   Wikidata; Q116047969
RX   DOI=10.1016/B978-0-12-249920-3.50017-X;
RX   PubMed=6454757;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   267.C4.C4
AC   CVCL_C4U6
DR   Wikidata; Q116047970
RX   DOI=10.1016/B978-0-12-249920-3.50017-X;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2674T
AC   CVCL_ZT95
SY   2674
DR   Wikidata; Q98125367
RX   PubMed=2259385;
RX   PubMed=7779715;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Heterozygous (PubMed=2259385; PubMed=7779715).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   2675T
AC   CVCL_ZT96
SY   2675
DR   Wikidata; Q98125368
RX   PubMed=2259385;
RX   PubMed=7779715;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Heterozygous (PubMed=2259385; PubMed=7779715).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   2677.1
AC   CVCL_C5X6
DR   Wikidata; Q116047972
RX   PubMed=1602134;
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   267B1
AC   CVCL_4827
SY   267-B1; 267 B1; FNC267B1
DR   EFO; EFO_0001080
DR   FCS-free; 15-2-16-3-6-4
DR   Wikidata; Q54583693
RX   PubMed=2541897;
RX   PubMed=8378190;
RX   PubMed=8548774;
RX   PubMed=9772298;
RX   PubMed=12085227;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200507/http://capcelllines.ca:80/details.asp?id=131
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K058 ! 272E1
OI   CVCL_K059 ! 272E4
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 18
//
ID   267B1/Ki-ras
AC   CVCL_9871
SY   267B1/Ki-Ras; 267B1 Ki-ras; 267B1/v-Ki-ras; 267B1/K-Ras; 267B1/Kras; Ki-ras/267B1
DR   EFO; EFO_0001081
DR   Wikidata; Q54583696
RX   PubMed=8378190;
RX   PubMed=9772298;
RX   PubMed=12085227;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4827 ! 267B1
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 14
//
ID   267B1/X
AC   CVCL_F0TR
SY   X/267B1
RX   PubMed=9772298;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4827 ! 267B1
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   267BR
AC   CVCL_ZT32
SY   267 BRighton
DR   Wikidata; Q98125370
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   267T2
AC   CVCL_8101
DR   BTO; BTO_0002973
DR   Wikidata; Q54583699
RX   PubMed=9427718;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C57BL/Ka.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   268-11
AC   CVCL_F0AE
RX   PubMed=2014246;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   268-D
AC   CVCL_F0AW
SY   268-11D
DR   ABCD; ABCD_BF030
RX   PubMed=2014246;
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
HI   CVCL_F0AE ! 268-11
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2681943
AC   CVCL_V366
DR   IPD-IMGT/HLA; 14459
DR   Wikidata; Q54583701
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,03:01; B*18:01,44:03; C*04:01,07:40; DQB1*02:02,03:02; DRB1*04:05,07:01 (IPD-IMGT/HLA=14459).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   26931
AC   CVCL_E440
DR   dbMHC; 48458
DR   ECACC; 94071422
DR   IHW; IHW09276
DR   IPD-IMGT/HLA; 10116
DR   Wikidata; Q54583702
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*68; B*15:03; C*02 (IPD-IMGT/HLA=10116).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 16
//
ID   2699c4
AC   CVCL_YM17
DR   GEO; GSM2974146
DR   GEO; GSM2974147
DR   GEO; GSM2974148
DR   GEO; GSM2974149
DR   GEO; GSM2974205
DR   GEO; GSM2974904
DR   GEO; GSM2974905
DR   GEO; GSM2974906
DR   GEO; GSM2974907
DR   Kerafast; EUP001-FP
DR   Wikidata; Q93302782
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   26B
AC   CVCL_S155
DR   Wikidata; Q54583704
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Doubling time: 1.4 days (DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Arlee 12; VBO=VBO_0017491.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   26B9
AC   CVCL_B6W6
DR   Wikidata; Q111732658
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   26CB-1
AC   CVCL_4087
SY   26 CB1
DR   CLO; CLO_0001214
DR   CLO; CLO_0001219
DR   CLDB; cl42
DR   ArrayExpress; E-MTAB-1511
DR   ATCC; CRL-1495
DR   ECACC; 89072101
DR   Wikidata; Q54583706
RX   PubMed=186420;
RX   PubMed=24380390;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
OI   CVCL_9Q48 ! 8CB-1
OI   CVCL_9Q47 ! 13CB-1
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   26F4
AC   CVCL_E7SF
RX   PubMed=1379786;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   26ic
AC   CVCL_J624
DR   CLO; CLO_0001220
DR   ATCC; HB-246
DR   NCBI_Iran; H160
DR   Wikidata; Q54583707
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   26v-006
AC   CVCL_6D18
DR   RCB; AES1232
DR   Wikidata; Q54583708
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   26v-009
AC   CVCL_6D19
DR   RCB; AES1233
DR   SKIP; SKIP002937
DR   Wikidata; Q54583710
CC   Knockout cell: Method=Gene trap; MGI; MGI:99204; Zfp57.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   26v-023
AC   CVCL_6D20
DR   RCB; AES1240
DR   SKIP; SKIP002938
DR   Wikidata; Q54583742
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860486; Tdp2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   27-1
AC   CVCL_B6X4
DR   CCRID; 4201PAT-CCTCC00716
DR   Wikidata; Q111732659
RX   Patent=CN105132383A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201592.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   27.10.2
AC   CVCL_D3V3
DR   ABCD; ABCD_AE246
DR   Wikidata; Q127378691
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   27.4b.2
AC   CVCL_D3V4
DR   ABCD; ABCD_AE245
DR   Wikidata; Q127378692
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   27.7.2
AC   CVCL_D3V5
DR   ABCD; ABCD_AE247
DR   Wikidata; Q127378693
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   270-01-3
AC   CVCL_XY70
DR   Wikidata; Q93302789
WW   Provider; Creative Diagnostics; CSC-H1722; https://www.creative-diagnostics.com/Anti-Dictyostelium-discoideum-actin-binding-protein-34-ABP34-Hybridoma-137340-197.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24005; Dictyostelium discoideum abpB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 4
//
ID   2708
AC   CVCL_E441
SY   DURO
DR   dbMHC; 48459
DR   ECACC; 94071406
DR   IHW; IHW09341
DR   IPD-IMGT/HLA; 10119
DR   Wikidata; Q54583745
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DQA1*02:01,01:05; DQB1*02:01; DRB1*13:03:01; DRB3*01:01 (IPD-IMGT/HLA=10119).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   271-14D9.F8
AC   CVCL_JY60
SY   271.14D9/F8; 14D9.F8
DR   Wikidata; Q54583747
RX   Patent=US5985278;
RX   PubMed=7593323;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   271-14E2
AC   CVCL_JY61
SY   14E2
DR   Wikidata; Q54583748
RX   Patent=US5985278;
RX   PubMed=7593323;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human 200 kDa melanomas surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   271-20A9
AC   CVCL_JY62
SY   271.20A9; 20A9
DR   Wikidata; Q54583750
RX   Patent=US5985278;
RX   PubMed=7593323;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   271-21H6
AC   CVCL_JY63
SY   21H6
DR   Wikidata; Q54583752
RX   Patent=US5985278;
RX   PubMed=7593323;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human 200 kDa melanomas surface protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   271-23G5
AC   CVCL_JY64
SY   23G5
DR   Wikidata; Q54583754
RX   Patent=US5985278;
RX   PubMed=7593323;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   2710 mel
AC   CVCL_C7W9
DR   Wikidata; Q123030244
RX   PubMed=22207316;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   272-17E6
AC   CVCL_JY65
SY   17E6; EMD 73034; EMD73034
DR   Wikidata; Q54583755
RX   Patent=US5985278;
RX   PubMed=7593323;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2160.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   272E1
AC   CVCL_K058
DR   Wikidata; Q54583756
RX   PubMed=2541897;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4827 ! 267B1
OI   CVCL_K059 ! 272E4
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   272E4
AC   CVCL_K059
DR   Wikidata; Q54583758
RX   PubMed=2541897;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4827 ! 267B1
OI   CVCL_K058 ! 272E1
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   273
AC   CVCL_A9NL
DR   BEI_Resources; ARP-1279
DR   Wikidata; Q108819491
RX   PubMed=6787798;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp70.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   273T
AC   CVCL_X482
DR   cancercelllines; CVCL_X482
DR   Cosmic; 910551
DR   GEO; GSM784285
DR   GEO; GSM827491
DR   Progenetix; CVCL_X482
DR   Wikidata; Q54583760
RX   PubMed=10545285;
RX   PubMed=15735034;
RX   PubMed=20215515;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Tyr727Cys (c.2180A>G); ClinVar= VCV001026153; Zygosity=Unspecified (PubMed=15735034).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Age of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 15
//
ID   274D
AC   CVCL_J810
DR   Wikidata; Q54583761
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02714; Tetronarce californica chrng.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   275-3-2
AC   CVCL_XG53
DR   Wikidata; Q93302854
RX   PubMed=10901364;
RX   PubMed=17786932;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: v-Ha-Ras.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: (129 x C57BL/6) F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-15FD
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 6
//
ID   277 34B3 20170123
AC   CVCL_A0NW
SY   34B3
DR   Wikidata; Q108819492
RX   Patent=US20210079110;
RX   PubMed=30275220;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02527.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q5H943; Human CT83.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   277-LCL
AC   CVCL_8073
DR   CLO; CLO_0051016
DR   BioSample; SAMN03471953
DR   RCB; RCB2283
DR   TKG; TKG 0609
DR   Wikidata; Q54583762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2283; TKG=TKG 0609
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   2780AD
AC   CVCL_C9BP
DR   Wikidata; Q123030245
RX   PubMed=6372095;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   278A9
AC   CVCL_F1VC
RX   Patent=WO1992012252A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3198.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Selected for resistance to: ChEBI; CHEBI_83970; Cardiac glycoside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   27a
AC   CVCL_C5HZ
DR   Wikidata; Q116047973
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   27b
AC   CVCL_8997
SY   iPS-27b; hiPS-27b; hiPS 27b; 27b-ALS; SOD1-27b; HVRDi008-B; HVRDi012-A
DR   EFO; EFO_0007109
DR   ENCODE; ENCBS466JVT
DR   GEO; GSM637788
DR   GEO; GSM670070
DR   hPSCreg; HVRDi008-B
DR   Wikidata; Q54583763
RX   PubMed=21293464;
RX   PubMed=21295703;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Gly86Ser (c.256G>A) (G85S); ClinVar=VCV000932081; Zygosity=Unspecified (PubMed=21293464).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8998 ! 27e
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   27C10
AC   CVCL_B6W7
DR   Wikidata; Q111732661
RX   DOI=10.15414/jmbfs.2019/20.9.3.573-577;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   27e
AC   CVCL_8998
SY   iPS-27e; hiPS 27e; hiPS-27e; 27e-ALS; SOD1-27e; HVRDi008-A
DR   EFO; EFO_0007110
DR   BioSamples; SAMEA13190959
DR   ENCODE; ENCBS626IJF
DR   GEO; GSM637789
DR   GEO; GSM670064
DR   hPSCreg; HVRDi008-A
DR   SKIP; SKIP004432
DR   Wikidata; Q54583764
RX   PubMed=21293464;
RX   PubMed=21295703;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Gly86Ser (c.256G>A) (G85S); ClinVar=VCV000932081; Zygosity=Unspecified (PubMed=21293464).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8997 ! 27b
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   27X1
AC   CVCL_0B44
DR   Cosmic; 2163757
DR   Wikidata; Q54583765
RX   PubMed=24812411;
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   28-11-5S
AC   CVCL_G588
DR   CLO; CLO_0001221
DR   ATCC; HB-19
DR   IZSLER; BS Hy 60
DR   Wikidata; Q54583767
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: IZSLER; BS Hy 60; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   28-12
AC   CVCL_B3RH
DR   Wikidata; Q110429742
RX   PubMed=6247624;
RX   PubMed=6252419;
RX   PubMed=6283321;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   28-12 (Ara)
AC   CVCL_B3RI
DR   Wikidata; Q110429743
RX   PubMed=6252419;
RX   PubMed=6283321;
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B3RH ! 28-12
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   28-13-3S
AC   CVCL_G589
DR   CLO; CLO_0001222
DR   ATCC; HB-41
DR   Wikidata; Q54583768
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   28-14-8S
AC   CVCL_G590
DR   CLO; CLO_0001223
DR   ATCC; HB-27
DR   Wikidata; Q54583769
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   28-16-8S
AC   CVCL_G591
DR   CLO; CLO_0001224
DR   ATCC; HB-35
DR   Wikidata; Q54583770
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   28-2-3
AC   CVCL_A0IF
SY   #28-2-3
DR   Wikidata; Q108819493
RX   Patent=US8178100;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00144.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02778; Human CXCL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   28-2-7
AC   CVCL_0E28
DR   ATCC; CRL-2487
DR   Wikidata; Q54583774
RX   PubMed=9455702;
CC   Monoclonal antibody isotype: IgG2a, kappa (PubMed=9455702); IgG1, kappa (ATCC=CRL-2487).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   28-4-3
AC   CVCL_0E29
DR   Wikidata; Q54583776
RX   PubMed=9455702;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   28-5-15
AC   CVCL_0E30
DR   ATCC; CRL-2490
DR   Wikidata; Q54583777
RX   PubMed=9455702;
CC   Monoclonal antibody isotype: IgG2a, lambda.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   28-6-20
AC   CVCL_0E31
DR   ATCC; CRL-2489
DR   Wikidata; Q54583780
RX   PubMed=9455702;
CC   Monoclonal antibody isotype: IgG1, kappa (PubMed=9455702); IgG1+IgG2a (ATCC=CRL-2489).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   28-8-6S
AC   CVCL_G592
DR   CLO; CLO_0001226
DR   ATCC; HB-51
DR   KCLB; 80051
DR   Wikidata; Q54583781
RX   PubMed=6935293;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   28.4.10A
AC   CVCL_D3V6
DR   ABCD; ABCD_AE274
DR   Wikidata; Q127378694
RX   PubMed=2464028;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with BSA coupled isomaltohexose (BSA-IM6)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   2800T
AC   CVCL_ZT97
DR   Wikidata; Q98125371
RX   PubMed=7779715;
RX   PubMed=9649131;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Heterozygous (PubMed=7779715).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   280599
AC   CVCL_E442
DR   dbMHC; 48460
DR   IHW; IHW09368
DR   IPD-IMGT/HLA; 25979
DR   Wikidata; Q54583782
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24:02:01:01,26:04; B*38:02:01,39:01:03; C*07:02:01:01; DPA1*01:03:01:01,02:02:02; DPB1*02:01:02,05:01:01; DQA1*01:02:01:01,03:02; DQB1*03:03:02:02,06:02:01; DRB1*09:01:02,15:01:01:02; DRB4*01:03:02; DRB5*01:01 (IPD-IMGT/HLA=25979).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   280A
AC   CVCL_J811
DR   Wikidata; Q54583784
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02712; Tetronarce californica chrnb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   280B
AC   CVCL_J812
DR   Wikidata; Q54583786
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   280D11
AC   CVCL_J911
DR   ATCC; HB-8487
DR   Wikidata; Q54583789
RX   Patent=US4753894;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8487.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   2838c3
AC   CVCL_YM18
DR   GEO; GSM2974150
DR   GEO; GSM2974151
DR   GEO; GSM2974152
DR   GEO; GSM2974153
DR   GEO; GSM2974206
DR   GEO; GSM2974908
DR   GEO; GSM2974909
DR   GEO; GSM2974910
DR   Kerafast; EUP013-FP
DR   Wikidata; Q93303016
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   283TAg
AC   CVCL_6554
DR   CLO; CLO_0001225
DR   ATCC; CRL-2822
DR   Kerafast; ENH120-FP
DR   Wikidata; Q54583790
RX   PubMed=12882965;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97073; Mpg.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   286-1
AC   CVCL_J869
DR   Wikidata; Q54583791
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   287-3
AC   CVCL_J870
DR   Wikidata; Q54583793
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   287BR
AC   CVCL_ZT30
SY   287 BRighton
DR   Wikidata; Q98125373
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   288-3
AC   CVCL_J871
DR   Wikidata; Q54583794
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   28A7
AC   CVCL_E8HJ
RX   PubMed=30362929;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   28B3
AC   CVCL_C3XJ
DR   Wikidata; Q116047974
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   28B4.2
AC   CVCL_F1E2
SY   28B4
DR   ABCD; ABCD_BF049
RX   DOI=10.1021/ja00084a076;
CC   Characteristics: Produces a catalytic monoclonal antibody that catalyzes the periodate-dependent oxidation of sulfide to the corresponding sulfoxide (DOI=10.1021/ja00084a076).
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_40413; 5-[(4-nitrobenzyl)(phosphonomethyl)amino]valeric acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   28cNF
AC   CVCL_B9V9
DR   Wikidata; Q112926917
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   28F11
AC   CVCL_B0HZ
SY   BM2 28F11
DR   Wikidata; Q108819494
RX   Patent=US5236825;
RX   PubMed=2922606;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9971.
CC   Characteristics: Produces a catalytic monoclonal antibody capable of cleaving a Gly-Phe bond when in presence of a metal ion cofactor (PubMed=2922606).
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   28F12
AC   CVCL_E8WC
DR   DSHB; 28F12
RX   PubMed=18300366;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JIE6; Mouse Tslp.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   28G12-2
AC   CVCL_B0U3
DR   Wikidata; Q108819495
RX   Patent=EP0479454A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10543.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   28G2dc1
AC   CVCL_A7XW
DR   Wikidata; Q107113185
RX   PubMed=7838184;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp / Malaysia) apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   28G7
AC   CVCL_C5RE
DR   Wikidata; Q116047975
RX   Patent=CN115073492B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.45161.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_7735; Olanzapine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   28S.3
AC   CVCL_5486
SY   28S.1
DR   CLO; CLO_0001227
DR   ATCC; CRL-2758
DR   Wikidata; Q54583798
RX   PubMed=9809582;
RX   PubMed=18572245;
CC   Group: Fish cell line.
CC   Caution: It is not clear if 28S.1 and 28S.3 are distinct entities: PubMed=9809582 refers to this cell line as 28S.1 while ATCC refers to it as 28S.3.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   28SC-ES
AC   CVCL_EP74
SY   28SC-Endotoxin Sensitive
DR   cancercelllines; CVCL_EP74
DR   JCRB; JCRB1647
DR   Wikidata; Q54583799
RX   PubMed=12944673;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of the STR profile the parent cell line (SC) seems to be a U-937 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00526.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1647
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6444 ! SC [Human contaminated U-937]
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 19
//
ID   29-55-4
AC   CVCL_YA98
SY   21-55-4
DR   ABCD; ABCD_AK424
DR   DSHB; 21-55-4
DR   Wikidata; Q93303093
RX   PubMed=2945827;
RX   PubMed=16453592;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08799; Dictyostelium discoideum mhcA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   29.0.C.27
AC   CVCL_V061
DR   CLO; CLO_0001228
DR   CLDB; cl43
DR   IHW; 11w 8131
DR   Wikidata; Q54583800
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   29/24 B11
AC   CVCL_B0LX
DR   Wikidata; Q108819496
RX   Patent=DD230876A1;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14174; Human MIF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   290-4E10
AC   CVCL_J547
DR   CLO; CLO_0001229
DR   ATCC; CRL-2662
DR   Wikidata; Q54583802
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9133.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00545; Feline sarcoma virus (strain McDonough) v-Fms.
CC   Discontinued: ATCC; CRL-2662; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 9
//
ID   290.5C10
AC   CVCL_KR95
DR   Wikidata; Q54583805
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   29037
AC   CVCL_JC70
SY   TER456; TER-456; Ter 456; Extract 189; Extract 298
DR   IPD-IMGT/HLA; 12190
DR   Wikidata; Q54583880
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/358cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,24:02; B*44:02,49:03; C*05:01,07:01; DQA1*01,03; DQB1*03:01,06:04; DRB1*04:01,13; DRB3*03:01; DRB4*01 (IPD-IMGT/HLA=12190).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   29182
AC   CVCL_JD09
SY   TER389; TER-389; Ter 389; TER504; TER-504; Ter-504; Ter 504; Extract 392; Extract 462
DR   IPD-IMGT/HLA; 10122
DR   Wikidata; Q54583882
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/325cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/326cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/344cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/381cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02,68:02; B*47:03,52:01; C*07:AG,12:02; DPA1*02:01,03:01; DPB1*04:AGGH,09:01; DQA1*01:03; DQB1*06:01,06:08; DRB1*13:01,15:02 (IPD-IMGT/HLA=10122).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   291B2
AC   CVCL_B6VC
DR   Wikidata; Q111732662
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   291C10
AC   CVCL_B6VD
DR   Wikidata; Q111732663
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   291F8
AC   CVCL_B6VE
DR   Wikidata; Q111732664
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   292.118.6.4
AC   CVCL_XE10
DR   Wikidata; Q93303136
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6830.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   292.12.3.1
AC   CVCL_XE11
DR   Wikidata; Q93303141
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6815.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 5
//
ID   292.63.5.3
AC   CVCL_XE12
DR   Wikidata; Q93303145
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6829.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 5
//
ID   292.72.3.1
AC   CVCL_XE13
DR   Wikidata; Q93303148
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6816.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 5
//
ID   292.84.1.6
AC   CVCL_XE14
DR   Wikidata; Q93303151
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6871.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 5
//
ID   292W
AC   CVCL_6G30
DR   Wikidata; Q54583883
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RX   PubMed=748774;
RX   PubMed=944089;
RX   PubMed=6244232;
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   293 ALL
AC   CVCL_E3KY
WW   Provider; Icosagen; -; https://www.icosagen.com/science/qmcf-technology-licensing/
CC   Biotechnology: Used in an expression system called QMCF Technology which allows transient mammalian expression system for recombinant protein production with high yields of up to 1g/L (Icosagen).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06790; Human papillomavirus type 18 regulatory protein E2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Information on name, transfected genes and parent cell line from personal communication of Mannik, Andres.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6642 ! HEK293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   293 c18/DRD4
AC   CVCL_H365
SY   293EC18/D4; 293/D4
DR   GenScript; M00477
DR   Wikidata; Q54583884
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3025; DRD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00477; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 19
//
ID   293 c18/EP4
AC   CVCL_H367
SY   293/EP4
DR   GenScript; M00485
DR   Wikidata; Q54583887
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9596; PTGER4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00485; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   293 EcR Shh
AC   CVCL_6351
DR   CLO; CLO_0001232
DR   ATCC; CRL-2782
DR   ATCC; JHU-64
DR   Wikidata; Q54583889
CC   Characteristics: Transfected with a construct that allows the expression of Shh under ecdysone-inducible control.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98297; Shh.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-2782; true.
CC   Discontinued: ATCC; JHU-64; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2782
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   293 GTP-AC-free
AC   CVCL_2285
DR   ECACC; 05011003
DR   Wikidata; Q54583891
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=05011003
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   293 N3S
AC   CVCL_2286
SY   293N3S
DR   CLO; CLO_0001233
DR   CLDB; cl48
DR   ATCC; CRL-2125
DR   ECACC; 92052131
DR   Wikidata; Q54583892
RX   PubMed=3819703;
CC   Doubling time: ~30 hours (PubMed=3819703); 30 hours (ECACC=92052131).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-2125; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=92052131
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   293 TRE/Cont
AC   CVCL_4W25
DR   JCRB; JCRB1533
DR   Wikidata; Q54583894
CC   Characteristics: Control cell line for 293 TRE/FLAG-POLK (Cellosaurus=CVCL_4W26).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1533
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   293 TRE/FLAG-POLK
AC   CVCL_4W26
DR   JCRB; JCRB1532
DR   Wikidata; Q54583896
CC   Characteristics: Expresses POLK induced by doxycyclin.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9183; POLK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: JCRB; JCRB1532; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1532
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   293-CD40
AC   CVCL_9832
SY   293.CD40
DR   BTO; BTO_0003466
DR   Wikidata; Q54583897
RX   PubMed=10920205;
CC   From: Schwandner, Ralf Thomas; Tularik, Inc.; South San Francisco; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11919; CD40 (Note=With a FLAG tag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   293-CD40L
AC   CVCL_4V25
DR   Wikidata; Q54583900
RX   PubMed=16040385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   293-CD40L-sCD40L
AC   CVCL_4V26
DR   Wikidata; Q54583901
RX   PubMed=16040385;
CC   Characteristics: Transduced with a pMX-sCD40L-IRES-EGFP construct (PubMed=16040385).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11935; CD40LG (Note=Extracellular domain = sCD40L).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V25 ! 293-CD40L
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   293-Db
AC   CVCL_8468
SY   293Db; 293DB; 293 Db
DR   Wikidata; Q54583902
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   293-Dual hSTING-A162
AC   CVCL_A8BL
DR   InvivoGen; 293d-a162
DR   Wikidata; Q107113187
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-a162).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Ser162Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8BK ! 293-Dual Null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   293-Dual hSTING-H232
AC   CVCL_A8BM
DR   InvivoGen; 293d-h232
DR   Wikidata; Q107113188
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-h232).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:5434; IFNB1.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Arg232His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8BK ! 293-Dual Null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   293-Dual hSTING-R232
AC   CVCL_A8BN
DR   InvivoGen; 293d-r232
DR   Wikidata; Q107113190
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-r232).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8BK ! 293-Dual Null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   293-Dual mSTING
AC   CVCL_A8BP
DR   InvivoGen; 293d-mstg
DR   Wikidata; Q107113191
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-mstg).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8BK ! 293-Dual Null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   293-Dual Null
AC   CVCL_A8BK
SY   293-ISG-SEAP/KI-[IFN-beta]Lucia
DR   InvivoGen; 293d-null
DR   Wikidata; Q107113194
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-null).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   293-ESM
AC   CVCL_XI05
SY   HEK-ESM
DR   Wikidata; Q93303252
RX   Patent=WO1999045028A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1971.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3466; ESM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293-Hektor
AC   CVCL_2283
DR   ECACC; 05030204
DR   Wikidata; Q54583903
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in the chemically defined protein- and peptide-free Hektor media from Cell Culture Technologies.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   293-hMyD88
AC   CVCL_A8CD
DR   InvivoGen; 293-hmyd
DR   Wikidata; Q107113196
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Designed to study SARS-CoV-2-host cell fusion. Upon transient transfection, with a spike expression plasmid, these cells become a SARS-CoV-2 mimic, which can then fuse with permissive reporter cells (InvivoGen=293-hmyd).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7562; MYD88 (Note=With p.Leu252Pro (c.755T>C)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   293-hNET
AC   CVCL_E7VM
SY   293-hNET-#3
RX   PubMed=7500004;
WW   Provider; VCCTC; MKT05103; https://vanderbilt.technologypublisher.com/technology/1662
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11048; SLC6A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   293-dSERT
AC   CVCL_E7VN
WW   Provider; VCCTC; MKT9714; https://vanderbilt.technologypublisher.com/technology/12191
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0010414; SerT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   293-hSERT
AC   CVCL_E7V1
RX   PubMed=8987735;
WW   Provider; VCCTC; MKT14139; https://vanderbilt.technologypublisher.com/technology/15809
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11050; SLC6A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   293-IL-1RI
AC   CVCL_9831
SY   293.IL-1RI; 293/IL-1RI; 293 IL-1RI; HEK293R1; HEK293RI; HEK293-IL-1RI
DR   BTO; BTO_0003465
DR   Wikidata; Q54583904
RX   PubMed=8599092;
RX   PubMed=8837778;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5993; IL1R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 17
//
ID   293-IL-8RA
AC   CVCL_F1WH
SY   293-71
RX   Patent=US5440021;
RX   Patent=US20070065441;
RX   PubMed=9356984;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6026; CXCR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   293-IL-8RB
AC   CVCL_F1WI
SY   293-27
RX   Patent=US5440021;
RX   Patent=US20070065441;
RX   PubMed=9356984;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6027; CXCR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   293-Kb
AC   CVCL_8469
SY   293Kb; 293KB; 293 Kb
DR   CCRID; 1101HUM-PUMC000154
DR   Wikidata; Q54583906
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95904; H2-K1 (Note=Allele H2-K1*02 (H2-Kb)).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000154
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D18S51: 18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   293-LA
AC   CVCL_A783
SY   293 clone LA
DR   Wikidata; Q54583908
RX   PubMed=7537736;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   293-M7
AC   CVCL_VN85
DR   JCRB; JCRB1758
DR   Wikidata; Q93303283
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6694; LRP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: JCRB; JCRB1758; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1758
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   293-PERV-PK-CIRCE
AC   CVCL_2284
DR   ECACC; 97051411
DR   Wikidata; Q54583909
RX   PubMed=9055854;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   293-SARS2-S
AC   CVCL_A7YI
DR   InvivoGen; 293-cov2-s
DR   Wikidata; Q107113197
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Stable expression of the SARS-CoV-2 spike protein. For optimal expression, the C-terminal ER-retention signal has been removed. Has a functional furin cleavage site. Recommended for cell-cell fusion assays with ACE2-expressing cells (InvivoGen=293-cov2-s).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   293-SARS2-S-dfur
AC   CVCL_A7YJ
DR   InvivoGen; 293-cov2-sdf
DR   Wikidata; Q107113199
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Stable expression of the SARS-CoV-2 spike protein with an inactive furin (dfur) cleavage site facilitating improved surface expression and detection for flow cytometry. For optimal expression, the C-terminal ER-retention signal has been removed (InvivoGen=293-cov2-sdf).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   293-SCARB2
AC   CVCL_A5HZ
SY   293S
DR   Wikidata; Q107113200
RX   PubMed=23919614;
CC   Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1665; SCARB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   293-SR-B1
AC   CVCL_E8TP
RX   PubMed=12913001;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1664; SCARB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293-VnR
AC   CVCL_M907
SY   HEK-293VnR; HEK293VnR; 293VnR; 293-15D
DR   BTO; BTO_0005839
DR   Wikidata; Q54583911
RX   Patent=US5578704;
RX   Patent=US5652110;
RX   PubMed=7683273;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6156; ITGB3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   293.STAT1 BAX KO
AC   CVCL_B0NB
DR   ATCC; CRL-1573-VHG
DR   Wikidata; Q108819497
RX   CelloPub=CLPUB00659;
CC   Characteristics: Exhibits significantly increased adeno-associated virus (AAV) production capacity for gene therapy applications (ATCC=CRL-1573-VHG).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   293_hEcad
AC   CVCL_RY64
DR   JCRB; JCRB1733
DR   Wikidata; Q54583912
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1748; CDH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1733
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   293_hEcad/hSyn2
AC   CVCL_RY62
DR   JCRB; JCRB1731
DR   Wikidata; Q54583914
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1748; CDH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10659; SDC2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: JCRB; JCRB1731; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1731
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 12
//
ID   293_hSyn1
AC   CVCL_RY72
DR   JCRB; JCRB1736
DR   Wikidata; Q54583915
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10658; SDC1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1736
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   293_hSyn2
AC   CVCL_RY63
DR   JCRB; JCRB1732
DR   Wikidata; Q54583918
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10659; SDC2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: JCRB; JCRB1732; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1732
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 11
//
ID   293_hSyn4
AC   CVCL_RY68
DR   JCRB; JCRB1735
DR   Wikidata; Q54583920
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10661; SDC4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1735
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   293/5-HT7/CRE-Luc
AC   CVCL_H361
DR   GenScript; M00423
DR   Wikidata; Q54583922
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5302; HTR7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00423; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H364 ! 293/CRE-Luc
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   293/ACE2
AC   CVCL_DR94
DR   PRIDE; PXD001330
DR   Wikidata; Q54583924
RX   PubMed=16912115;
RX   PubMed=25764339;
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 17
//
ID   293/ADORA1/Galpha15
AC   CVCL_H362
DR   GenScript; M00255
DR   Wikidata; Q54583925
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:262; ADORA1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   293/ADRB3/CRE-Luc
AC   CVCL_H363
DR   GenScript; M00335
DR   Wikidata; Q54583927
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:288; ADRB3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H364 ! 293/CRE-Luc
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   293/AP1-luc
AC   CVCL_KS32
DR   Wikidata; Q54583929
RX   PubMed=16834536;
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the AP-1 response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0006.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   293/CFP
AC   CVCL_JZ01
DR   Cell_Biolabs; AKR-270
DR   Wikidata; Q54583930
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Cell_Biolabs; AKR-270; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   293/CHE-Fc
AC   CVCL_6352
DR   CLO; CLO_0001234
DR   ATCC; CRL-2368
DR   Wikidata; Q54583932
RX   PubMed=8052660;
CC   Characteristics: Transfected with CHE-Fc, a recombinant soluble chimeric protein fusion of influenza C hemagglutinin-esterase with human IgG1 Fc. It is useful as a probe to detect 9-O-acetylated sialic acids (PubMed=8052660).
CC   Doubling time: ~24 hours (ATCC=CRL-2368).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03465; Influenza C virus (strain C/California/1978) hemagglutinin-esterase-fusion glycoprotein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2368
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   293/CRE-Luc
AC   CVCL_H364
SY   293/CRE-Luciferase; HEK293/CRE-Luc
DR   GenScript; M00188
DR   Wikidata; Q54583933
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (GenScript=M00188).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00188; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   293/CREB-luc
AC   CVCL_KS33
SY   HEK293-Cre-Luc; HEK 293 CRE-luc
DR   Wikidata; Q54583934
RX   PubMed=16834536;
CC   Characteristics: The luciferase reporter gene is under the control of the CREB response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0007.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   293/CrmA
AC   CVCL_J499
SY   293-CrmA
DR   CLO; CLO_0050892
DR   BioSample; SAMN03472112
DR   RCB; RCB1668
DR   Wikidata; Q54583936
RX   PubMed=9874266;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P07385; Cowpox virus crmA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB1668
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 13
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   293/EP1
AC   CVCL_H366
DR   GenScript; M00228
DR   Wikidata; Q54583937
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9593; PTGER1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   293/FP/Galpha15
AC   CVCL_H368
DR   GenScript; M00155
DR   Wikidata; Q54583939
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9600; PTGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   293/GFP
AC   CVCL_JY88
DR   Cell_Biolabs; AKR-200
DR   Wikidata; Q54583940
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   293/GHRH/Galpha15
AC   CVCL_H369
DR   GenScript; M00314
DR   Wikidata; Q54583942
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4266; GHRHR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   293/GNRHR/Galpha15
AC   CVCL_KA76
DR   GenScript; M00210
DR   Wikidata; Q54583943
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4421; GNRHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00210; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   293/GR-luc
AC   CVCL_E3F7
CC   Characteristics: The luciferase reporter gene is under the control of the glucocorticoid receptor (GR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0018.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   293/H1
AC   CVCL_H370
DR   GenScript; M00131
DR   Wikidata; Q54584013
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5182; HRH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   293/hMD2-CD14
AC   CVCL_Y384
SY   293-hMD2-CD14
DR   InvivoGen; 293-hmd2cd14
DR   Wikidata; Q54584014
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 15
//
ID   293/hNOD1
AC   CVCL_A7YV
SY   293-hNOD1
DR   InvivoGen; 293-hnod1
DR   Wikidata; Q107113202
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16390; NOD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   293/hNOD2
AC   CVCL_A7YX
SY   293-hNOD2
DR   InvivoGen; 293-hnod2
DR   Wikidata; Q107113203
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5331; NOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   293/hTLR1-HA
AC   CVCL_Y385
SY   293-hTLR1-HA
DR   InvivoGen; 293-htlr1ha
DR   Wikidata; Q54584015
WW   Provider; InvivoGen; 293-htlr1ha; https://web.archive.org/web/20081119081508/www.invivogen.com/PDF/293-hTLR1-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11847; TLR1 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr1ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR1-TLR2
AC   CVCL_Y417
SY   293-hTLR1/TLR2; 293-hTLR1/2
DR   InvivoGen; 293-htlr12
DR   Wikidata; Q54584017
WW   Provider; InvivoGen; 293-htlr12; https://web.archive.org/web/20081119135340/www.invivogen.com/PDF/293-hTLR1-2_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11847; TLR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr12; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR10-HA
AC   CVCL_Y386
SY   293-hTLR10-HA
DR   InvivoGen; 293-htlr10ha
DR   Wikidata; Q54584016
WW   Provider; InvivoGen; 293-htlr10ha; https://web.archive.org/web/20120627165418/http://www.invivogen.com/PDF/293hTLR10-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15634; TLR10 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr10ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR2
AC   CVCL_Y387
SY   293-hTLR2
DR   InvivoGen; 293-htlr2
DR   Wikidata; Q54584018
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR2-CD14
AC   CVCL_Y388
SY   293-hTLR2-CD14; HEK293-TLR2-CD14
DR   InvivoGen; 293-htlr2cd14
DR   NCBI_Iran; C632
DR   Wikidata; Q54584020
WW   Provider; InvivoGen; 293-htlr2cd14; https://web.archive.org/web/20120627113755/http://www.invivogen.com/PDF/293-hTLR2-CD14_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr2cd14; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 15
//
ID   293/hTLR2-HA
AC   CVCL_Y389
SY   293-hTLR2-HA
DR   InvivoGen; 293-htlr2ha
DR   Wikidata; Q54584021
WW   Provider; InvivoGen; 293-htlr2ha; https://web.archive.org/web/20120627140818/http://www.invivogen.com/PDF/293-hTLR2-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr2ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR2-TLR6
AC   CVCL_Y390
SY   293-hTLR2/6; HEK293-hTLR2/6
DR   InvivoGen; 293-htlr2/6
DR   NCBI_Iran; C630
DR   Wikidata; Q54584024
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16711; TLR6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR3
AC   CVCL_Y391
SY   293-hTLR3
DR   InvivoGen; 293-htlr3
DR   Wikidata; Q54584027
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR3-HA
AC   CVCL_Y392
SY   293-hTLR3-HA
DR   InvivoGen; 293-htlr3ha
DR   Wikidata; Q54584028
WW   Provider; InvivoGen; 293-htlr3ha; https://web.archive.org/web/20120627163725/http://www.invivogen.com/PDF/293-hTLR3-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11849; TLR3 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr3ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR4-HA
AC   CVCL_Y394
SY   293-hTLR4-HA
DR   InvivoGen; 293-htlr4ha
DR   Wikidata; Q54584031
WW   Provider; InvivoGen; 293-htlr4ha; https://web.archive.org/web/20140809014533/http://www.invivogen.com/293-tlr4-ha
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11850; TLR4 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr4ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR4A
AC   CVCL_Y393
SY   293-hTLR4A; 293/hTLR4
DR   InvivoGen; 293-htlr4a
DR   Wikidata; Q54584029
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11850; TLR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR4A-MD2-CD14
AC   CVCL_Y395
SY   293-hTLR4-MD2-CD14
DR   InvivoGen; 293-htlr4md2cd14
DR   Wikidata; Q54584032
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11850; TLR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 15
//
ID   293/hTLR5
AC   CVCL_Y396
SY   293-hTLR5; HEK293-hTLR5; HEK293-hTLR-5
DR   InvivoGen; 293-htlr5
DR   Wikidata; Q54584033
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11851; TLR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR5-CD14
AC   CVCL_Y397
SY   293-hTLR5-CD14
DR   InvivoGen; 293-htlr5cd14
DR   Wikidata; Q54584034
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11851; TLR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 15
//
ID   293/hTLR5-HA
AC   CVCL_Y398
SY   293-hTLR5-HA
DR   InvivoGen; 293-htlr5ha
DR   Wikidata; Q54584035
WW   Provider; InvivoGen; 293-htlr5ha; https://web.archive.org/web/20120626231642/http://www.invivogen.com/PDF/293-hTLR5-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11851; TLR5 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr5ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/hTLR6-HA
AC   CVCL_Y399
SY   293-hTLR6-HA
DR   InvivoGen; 293-htlr6ha
DR   Wikidata; Q54584036
WW   Provider; InvivoGen; 293-htlr6ha; https://web.archive.org/web/20120626073346/http://www.invivogen.com/PDF/293hTLR6-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16711; TLR6 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293-htlr6ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/KDR
AC   CVCL_9V14
SY   HEK29-KDR
DR   NCBI_Iran; C589
DR   Wikidata; Q54584037
RX   PubMed=11570839;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6307; KDR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   293/LacZ
AC   CVCL_Y101
SY   293-LacZ; 293 / LacZ
DR   InvivoGen; 293-lacz
DR   Wikidata; Q54584038
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293/Luc
AC   CVCL_JY95
DR   Cell_Biolabs; AKR-230
DR   Wikidata; Q54584041
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Cell_Biolabs; AKR-230; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   293/MC3/CRE-Luc
AC   CVCL_H371
DR   GenScript; M00337
DR   Wikidata; Q54584042
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6931; MC3R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00337; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H364 ! 293/CRE-Luc
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   293/MCH1
AC   CVCL_H372
DR   GenScript; M00211
DR   Wikidata; Q54584043
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4479; MCHR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   293/mNOD1
AC   CVCL_A7YW
SY   293-mNOD1
DR   InvivoGen; 293-mnod1
DR   Wikidata; Q107113204
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341839; Nod1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   293/mNOD2
AC   CVCL_A7YY
SY   293-mNOD2
DR   InvivoGen; 293-mnod2
DR   Wikidata; Q107113205
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2429397; Nod2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   293/mTLR1
AC   CVCL_Y400
SY   293-mTLR1
DR   InvivoGen; 293-mtlr1
DR   Wikidata; Q54584044
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341295; Tlr1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR1-TLR2
AC   CVCL_Y401
SY   293-mTLR1/2
DR   InvivoGen; 293-mtlr1/2
DR   Wikidata; Q54584045
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341295; Tlr1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346060; Tlr2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR2
AC   CVCL_Y402
SY   293-mTLR2
DR   InvivoGen; 293-mtlr2
DR   Wikidata; Q54584047
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346060; Tlr2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR2-TLR6
AC   CVCL_Y403
SY   293-mTLR2/6
DR   InvivoGen; 293-mtlr2/6
DR   Wikidata; Q54584049
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346060; Tlr2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341296; Tlr6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR3
AC   CVCL_Y404
SY   293-mTLR3
DR   InvivoGen; 293-mtlr3
DR   Wikidata; Q54584050
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2156367; Tlr3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR4
AC   CVCL_Y405
SY   293-mTLR4
DR   InvivoGen; 293-mtlr4
DR   Wikidata; Q54584052
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR4-MD2-CD14
AC   CVCL_Y406
SY   293-mTLR4-MD2-CD14
DR   InvivoGen; 293-mtlr4md2cd14
DR   Wikidata; Q54584054
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88318; Cd14.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341909; Ly96.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 14
//
ID   293/mTLR5
AC   CVCL_Y407
SY   293-mTLR5; HEK293-mTLR-5
DR   InvivoGen; 293-mtlr5
DR   Wikidata; Q54584057
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1858171; Tlr5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR6
AC   CVCL_Y408
SY   293-mTLR6
DR   InvivoGen; 293-mtlr6
DR   Wikidata; Q54584059
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341296; Tlr6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/mTLR9
AC   CVCL_Y409
SY   293-mTLR9
DR   InvivoGen; 293-mtlr9
DR   Wikidata; Q54584060
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1932389; Tlr9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   293/NFkB-luc
AC   CVCL_KS34
SY   HEK293/NF-kappaB-luc
DR   Wikidata; Q54584062
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0014.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   293/NPY1
AC   CVCL_H373
DR   GenScript; M00430
DR   Wikidata; Q54584065
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7956; NPY1R.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00430; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   293/Null
AC   CVCL_A7YU
SY   293-null
DR   InvivoGen; 293-null
DR   Wikidata; Q107113206
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   293/pmiR-155
AC   CVCL_IM63
DR   GEO; GSM235038
DR   GEO; GSM235039
DR   GEO; GSM235040
DR   GEO; GSM235041
DR   Wikidata; Q54584066
RX   PubMed=17881434;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:31542; MIR155.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   293/pmiR-K12-11
AC   CVCL_IM64
DR   GEO; GSM235042
DR   GEO; GSM235043
DR   GEO; GSM235044
DR   GEO; GSM235045
DR   Wikidata; Q54584068
RX   PubMed=17881434;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=Human herpesvirus 8 (HHV-8/KSHV) miR-K12-11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   293/PTH2/CRE-Luc
AC   CVCL_H374
DR   GenScript; M00270
DR   Wikidata; Q54584072
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9609; PTH2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00270; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H364 ! 293/CRE-Luc
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   293/SF
AC   CVCL_UR29
DR   ATCC; CRL-1573.1
DR   Wikidata; Q93303620
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-1573.1; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1573.1
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   293/TP
AC   CVCL_H375
DR   GenScript; M00309
DR   Wikidata; Q54584073
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11608; TBXA2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   293/YFP
AC   CVCL_JY96
DR   Cell_Biolabs; AKR-280
DR   Wikidata; Q54584076
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Cell_Biolabs; AKR-280; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   2934M
AC   CVCL_WM32
DR   cancercelllines; CVCL_WM32
DR   Cosmic; 852207
DR   Wikidata; Q93303630
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   2938
AC   CVCL_C3QB
DR   Wikidata; Q116047976
RX   PubMed=7067035;
RX   PubMed=7374661;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   293AAV
AC   CVCL_KA64
DR   Cell_Biolabs; AAV-100
DR   Wikidata; Q54584111
CC   Characteristics: Compared to parent HEK293 cell line has improved adeno-associated virus production capabilities.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Caution: Not the same cell line as AAV-293 from Stratagene (Cellosaurus=CVCL_6871).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   293AD
AC   CVCL_KA63
DR   Cell_Biolabs; AD-100
DR   Wikidata; Q54584112
CC   Characteristics: Selected for flattened morphology and firm attachment to culture plates. Larger surface area for superior transfection and greater adenoviral yields.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Caution: Not the same cell line as AD-293 from Stratagene (Cellosaurus=CVCL_9804).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   293B9
AC   CVCL_L026
DR   Wikidata; Q54584115
RX   PubMed=2425031;
RX   PubMed=9834055;
CC   Group: Bird cell line.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   293C18P
AC   CVCL_A0DF
SY   293 C18P
DR   CCRID; 4201PAT-CCTCC01329
DR   Wikidata; Q108819498
RX   Patent=CN110438066B;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201913.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   293C8
AC   CVCL_B6VF
DR   Wikidata; Q111732665
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   293D2
AC   CVCL_B6VG
DR   Wikidata; Q111732666
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   293EBNA-B55
AC   CVCL_E3D5
RX   PubMed=15289353;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*55:02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   293EL
AC   CVCL_C0I7
DR   Wikidata; Q112926919
RX   PubMed=36245040;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (PubMed=36245040).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3185; EEA1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0I5 ! HEK293::TMEM192-3xHA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   293EL-APP-/-
AC   CVCL_C0I8
DR   Wikidata; Q112926923
RX   PubMed=36245040;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3185; EEA1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0I7 ! 293EL
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   293EL-APP*
AC   CVCL_C0I9
DR   Wikidata; Q112926925
RX   PubMed=36245040;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:620; APP (Note=With p.Lys670Asn, p.Met671Leu, p.Thr719Asn = APPSw/T700N).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3185; EEA1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0I8 ! 293EL-APP-/-
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   293F4
AC   CVCL_B6VH
DR   Wikidata; Q111732667
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   293Flp-In T-REx MAPPIT
AC   CVCL_6E37
SY   293FTM
DR   BioSamples; SAMEA2018186
DR   Wikidata; Q54584118
RX   PubMed=25182477;
WW   Info; -; -; http://hek293genome.org/v2/
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   293GP
AC   CVCL_E072
SY   293-GP; 293gp; GP-293; GP293
DR   CLO; CLO_0050902
DR   NCBI_Iran; C560
DR   RCB; RCB2354
DR   Wikidata; Q54584119
RX   PubMed=7937806;
RX   PubMed=8396259;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB2354
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   293GP/bsr
AC   CVCL_5F70
SY   293gp/bsr; 293 gp/bsr
DR   Wikidata; Q54584121
RX   PubMed=10535980;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E072 ! 293GP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   293GP/LZRNL
AC   CVCL_5F71
SY   293GP-LZRNL
DR   Wikidata; Q54584122
RX   PubMed=7937806;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E072 ! 293GP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   293LAP10
AC   CVCL_DD14
SY   293Lap10
DR   Wikidata; Q54584124
RX   Patent=WO2000006751A2;
RX   PubMed=10073694;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12586.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03023; Escherichia coli lacI (Note=Modified version LAP348 with at the N-terminal a nuclear localization signal from SV40 T antigen and at the C-terminal the transactivator domain from HSV-1 VP16/Vmw65).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   293LAP13
AC   CVCL_DD15
SY   293Lap13
DR   Wikidata; Q54584127
RX   Patent=WO2000006751A2;
RX   PubMed=10073694;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12587.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03023; Escherichia coli lacI (Note=Modified version LAP348 with at the N-terminal a nuclear localization signal from SV40 T antigen and at the C-terminal the transactivator domain from HSV-1 VP16/Vmw65).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   293LTV
AC   CVCL_JZ09
DR   Cell_Biolabs; LTV-100
DR   IBRC; C10143
DR   Wikidata; Q54584129
CC   Group: Retrovirus packaging cell line.
CC   Characteristics: Specifically selected for high level of lentiviral production.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   293RC21
AC   CVCL_W338
DR   Wikidata; Q54584130
RX   PubMed=10953917;
CC   Group: Adeno-associated virus packaging cell line.
CC   Characteristics: Transfected with a recombinant adeno-associated virus type 2 (rAAV) (PubMed=10953917).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   293RTV
AC   CVCL_JZ10
DR   Cell_Biolabs; RV-100
DR   Wikidata; Q54584131
CC   Characteristics: Specifically selected for high level of retroviral production.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   293sars181A
AC   CVCL_V648
DR   Wikidata; Q54584135
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000170). It was the sole source of information for this entry.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D18S51: 18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   293SGlycoDelete
AC   CVCL_6E38
SY   293SGGD; HEK293SGGD
DR   BioSamples; SAMEA2018187
DR   Wikidata; Q54584136
RX   DOI=10.13005/bpj/1414;
RX   PubMed=24752077;
RX   PubMed=25182477;
WW   Info; -; -; http://hek293genome.org/v2/
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; C4RA89; Hypocrea jecorina endoT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A785 ! HEK293S GnTI-
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   293T cyno ACVR2B 1
AC   CVCL_E8JL
SY   293T-cyno-ACVR2B
DR   KYinno; KC-3897
CC   Doubling time: ~30 hours (KYinno=KC-3897).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WUB7; Macaca fascicularis ACVR2B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno ACVR2B 2
AC   CVCL_E8JM
SY   293T-cyno-ACVR2B
DR   KYinno; KC-4154
CC   Doubling time: ~30 hours (KYinno=KC-4154).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WUB7; Macaca fascicularis ACVR2B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno ADAM9
AC   CVCL_E8JN
SY   293T-cyno-ADAM9
DR   KYinno; KC-3337
CC   Doubling time: ~30 hours (KYinno=KC-3337).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X4X8; Macaca fascicularis ADAM9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno B2M-FCGRT
AC   CVCL_E8JP
SY   293T-cyno-B2M-FCGRT
DR   KYinno; KC-1800
CC   Doubling time: ~30 hours (KYinno=KC-1800).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8SPW0; Macaca fascicularis B2M.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8SPV9; Macaca fascicularis FCGRT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno B7H4
AC   CVCL_E8JQ
SY   293T-cyno-B7H4
DR   KYinno; KC-0257
CC   Doubling time: ~30 hours (KYinno=KC-0257).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5U6S5; Macaca fascicularis VTCN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno BCMA
AC   CVCL_UE53
SY   293T-cyno-BCMA
DR   KYinno; KC-0979
DR   Wikidata; Q93303665
CC   Doubling time: ~30 hours (KYinno=KC-0979).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7Q0I4; Macaca fascicularis TNFRSF17.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T cyno BTLA
AC   CVCL_E8JR
SY   293T-cyno-BTLA
DR   KYinno; KC-2807
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5W7M7; Macaca fascicularis BTLA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CAIX
AC   CVCL_E8JS
SY   293T-cyno-CAIX
DR   KYinno; KC-3230
CC   Doubling time: ~30 hours (KYinno=KC-3230).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VQG9; Macaca fascicularis CA9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CCR5-High
AC   CVCL_E8JT
SY   293T-cyno-CCR5-High
DR   KYinno; KC-3414
CC   Doubling time: ~30 hours (KYinno=KC-3414).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P61814; Macaca fascicularis CCR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CCR5-Low
AC   CVCL_E8JU
SY   293T-cyno-CCR5-Low
DR   KYinno; KC-3415
CC   Doubling time: ~30 hours (KYinno=KC-3415).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P61814; Macaca fascicularis CCR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CCR6
AC   CVCL_UE54
SY   293T-cyno-CCR6; 293T monkey CCR6
DR   KYinno; KC-0358
DR   Wikidata; Q93303666
CC   Doubling time: ~30 hours (KYinno=KC-0358).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WY45; Macaca fascicularis CCR6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T cyno CCR8
AC   CVCL_E8JV
SY   293T-cyno-CCR8
DR   KYinno; KC-1821
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7NYJ2; Macaca fascicularis CCR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD122
AC   CVCL_E8JW
SY   293T-cyno-CD122
DR   KYinno; KC-1008
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q38J85; Macaca fascicularis IL2RB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD123
AC   CVCL_UE55
SY   293T-cyno-CD123; 293T cynomolgous CD123
DR   KYinno; KC-0316
DR   Wikidata; Q93303668
CC   Doubling time: ~30 hours (KYinno=KC-0316).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G8F3K3; Macaca fascicularis IL3RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T cyno CD137
AC   CVCL_UE56
SY   293T-cyno-CD137
DR   KYinno; KC-0255
DR   Wikidata; Q93303669
CC   Doubling time: ~30 hours (KYinno=KC-0255).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A9YYE7; Macaca fascicularis TNFRSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T cyno CD19-High
AC   CVCL_E8JX
SY   293T-cyno-CD19-High
DR   KYinno; KC-3335
CC   Doubling time: ~30 hours (KYinno=KC-3335).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7Q0T7; Macaca fascicularis CD19.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD19-Low
AC   CVCL_E8JY
SY   293T-cyno-CD19-Low
DR   KYinno; KC-3336
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7Q0T7; Macaca fascicularis CD19.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD2
AC   CVCL_E8JZ
SY   293T-cyno-CD2
DR   KYinno; KC-4112
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q6SZ61; Macaca fascicularis CD2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD20
AC   CVCL_E8K0
SY   293T-cyno-CD20
DR   KYinno; KC-3434
CC   Doubling time: ~30 hours (KYinno=KC-3434).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; M4ZHZ6; Macaca fascicularis MS4A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD200R1
AC   CVCL_E8K1
SY   293T-cyno-CD200R1
DR   KYinno; KC-3124
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7NZT0; Macaca fascicularis CD200R1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD22
AC   CVCL_E8K2
SY   293T-cyno-CD22
DR   KYinno; KC-3975
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WCZ6; Macaca fascicularis CD22.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD24
AC   CVCL_E8K3
SY   293T-cyno-CD24
DR   KYinno; KC-1714
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9D3B9; Macaca fascicularis CD24.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD27
AC   CVCL_E8K4
SY   293T-cyno-CD27
DR   KYinno; KC-0254
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Macaca fascicularis CD27.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD36
AC   CVCL_E8K5
SY   293T-cyno-CD36
DR   KYinno; KC-2355
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VL74; Macaca fascicularis CD36.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD38
AC   CVCL_E8MR
SY   293T-cyno-CD38
DR   KYinno; KC-3573
CC   Doubling time: ~30 hours (KYinno=KC-3573).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q5VAN0; Macaca fascicularis CD38.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD39 1
AC   CVCL_E8K6
SY   293T-cyno-CD39
DR   KYinno; KC-3561
CC   Doubling time: ~30 hours (KYinno=KC-3561).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9DGH8; Macaca fascicularis ENTPD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD39 2
AC   CVCL_E8K7
SY   293T-cyno-CD39
DR   KYinno; KC-3977
CC   Doubling time: ~30 hours (KYinno=KC-3977).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9DGH8; Macaca fascicularis ENTPD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD3E
AC   CVCL_E8K8
SY   293T-cyno-CD3E
DR   KYinno; KC-2269
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI5; Macaca fascicularis CD3E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD3ED
AC   CVCL_E8K9
SY   293T-cyno-CD3ED
DR   KYinno; KC-2266
CC   Doubling time: ~30 hours (KYinno=KC-2266).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI8; Macaca fascicularis CD3D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI5; Macaca fascicularis CD3E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD3EDG
AC   CVCL_E8KA
SY   293T-cyno-CD3EDG
DR   KYinno; KC-2483
CC   Doubling time: ~30 hours (KYinno=KC-2483).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI8; Macaca fascicularis CD3D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI5; Macaca fascicularis CD3E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI7; Macaca fascicularis CD3G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD3EG
AC   CVCL_E8KB
SY   293T-cyno-CD3EG
DR   KYinno; KC-2267
CC   Doubling time: ~30 hours (KYinno=KC-2267).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI5; Macaca fascicularis CD3E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95LI7; Macaca fascicularis CD3G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD4
AC   CVCL_E8KC
SY   293T-cyno-CD4
DR   KYinno; KC-4454
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P79185; Macaca fascicularis CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD40
AC   CVCL_XY80
SY   293T-cyno-CD40
DR   KYinno; KC-0913
DR   Wikidata; Q93303671
CC   Doubling time: ~30 hours (KYinno=KC-0913).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PG38; Macaca fascicularis CD40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T cyno CD40L
AC   CVCL_E8KD
SY   293T-cyno-CD40L
DR   KYinno; KC-1098
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7Q1T4; Macaca fascicularis CD40LG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD58
AC   CVCL_E8KE
SY   293T-cyno-CD58
DR   KYinno; KC-4006
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9D5I3; Macaca fascicularis CD58.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD7
AC   CVCL_E8KF
SY   293T-cyno-CD7
DR   KYinno; KC-2365
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VA18; Macaca fascicularis CD7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD70
AC   CVCL_E8KG
SY   293T-cyno-CD70
DR   KYinno; KC-4500
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PYU6; Macaca fascicularis CD70.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD74
AC   CVCL_E8KH
SY   293T-cyno-CD74
DR   KYinno; KC-3182
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5U6J1; Macaca fascicularis CD74.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD79a
AC   CVCL_E8KI
SY   293T-cyno-CD79a
DR   KYinno; KC-3063
CC   Doubling time: ~30 hours (KYinno=KC-3063).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5U9J5; Macaca fascicularis CD79a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD79a-T2A-CD79b
AC   CVCL_E8KJ
SY   293T-cyno-CD79a-T2A-CD79b
DR   KYinno; KC-3191
CC   Doubling time: ~30 hours (KYinno=KC-3191).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5U9J5; Macaca fascicularis CD79a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WTG9; Macaca fascicularis CD79b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD8a
AC   CVCL_E8KK
SY   293T-cyno-CD8a
DR   KYinno; KC-4866
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5ULI8; Macaca fascicularis CD8a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD93
AC   CVCL_E8KL
SY   293T-cyno-CD93
DR   KYinno; KC-2274
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VH53; Macaca fascicularis CD93.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CD94-NKG2A
AC   CVCL_E8KM
SY   293T-cyno-CD94-NKG2A
DR   KYinno; KC-1989
CC   Doubling time: ~30 hours (KYinno=KC-1989).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PJT5; Macaca fascicularis CD94.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q68VD2; Macaca fascicularis NKG2A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CDH17
AC   CVCL_E8KN
SY   293T-cyno-CDH17
DR   KYinno; KC-3095
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X8I8; Macaca fascicularis CDH17 (Note=With p.Met1_Pro57del and p.Ala796_Ser840del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CDH3
AC   CVCL_E8KP
SY   293T-cyno-CDH3
DR   KYinno; KC-3747
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WPN9; Macaca fascicularis CDH3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CDH6
AC   CVCL_E8KQ
SY   293T-cyno-CDH6
DR   KYinno; KC-3176
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TW62; Macaca fascicularis CDH6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CEACAM1
AC   CVCL_E8KR
SY   293T-cyno-CEACAM1
DR   KYinno; KC-4048
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WTW2; Macaca fascicularis CEACAM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CLDN1
AC   CVCL_E8KS
SY   293T-cyno-CLDN1
DR   KYinno; KC-3564
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q4R4Z3; Macaca fascicularis CLDN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CLDN18.2
AC   CVCL_E8KT
SY   293T-cyno-CLDN18.2
DR   KYinno; KC-2554
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VV62; Macaca fascicularis CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CLDN6
AC   CVCL_E8KU
SY   293T-cyno-CLDN6
DR   KYinno; KC-3017
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7Q0B0; Macaca fascicularis CLDN6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CLEC12A
AC   CVCL_E8KV
SY   293T-cyno-CLEC12A
DR   KYinno; KC-1552
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WXQ4; Macaca fascicularis CLEC12A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CLEC4C-FCER1G
AC   CVCL_E8KW
SY   293T-cyno-CLEC4C-FCER1G
DR   KYinno; KC-3339
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UWP4; Macaca fascicularis CLEC4C.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8SPW1; Macaca fascicularis FCER1G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CRLF2
AC   CVCL_E8KX
SY   293T-cyno-CRLF2
DR   KYinno; KC-3957
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Macaca fascicularis CRLF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CSF1R
AC   CVCL_XY81
SY   293T-cyno-CSF1R
DR   KYinno; KC-1221
DR   Wikidata; Q93303674
CC   Doubling time: ~30 hours (KYinno=KC-1221).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WG91; Macaca fascicularis CSF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T cyno CTLA4
AC   CVCL_E8KY
SY   293T-cyno-CTLA4
DR   KYinno; KC-1407
CC   Doubling time: ~30 hours (KYinno=KC-1407).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PL88; Macaca fascicularis CTLA4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CTLA4-delta23
AC   CVCL_E8KZ
SY   293T-cyno-CTLA4-delta23
DR   KYinno; KC-2550
CC   Doubling time: ~30 hours (KYinno=KC-2550).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PL88; Macaca fascicularis CTLA4 (Note=Isoform delta23).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno CXCR5
AC   CVCL_E8L0
SY   293T-cyno-CXCR5
DR   KYinno; KC-2389
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G8F5K4; Macaca fascicularis CXCR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno DDR1
AC   CVCL_E8L1
SY   293T-cyno-DDR1
DR   KYinno; KC-3420
CC   Doubling time: ~30 hours (KYinno=KC-3420).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5V7A3; Macaca fascicularis DDR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno DDR2
AC   CVCL_E8L2
SY   293T-cyno-DDR2
DR   KYinno; KC-3424
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TSW1; Macaca fascicularis DDR2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno Dectin1-A
AC   CVCL_E8L3
SY   293T-cyno-dectin1a
DR   KYinno; KC-3301
CC   Doubling time: ~30 hours (KYinno=KC-3301).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UXY6; Macaca fascicularis CLEC7A (Note=Isoform A).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno Dectin1-B
AC   CVCL_E8L4
SY   293T-cyno-dectin1b
DR   KYinno; KC-3720
CC   Doubling time: ~30 hours (KYinno=KC-3720).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UXY6; Macaca fascicularis CLEC7A (Note=Isoform B).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno DLL3
AC   CVCL_UE58
SY   293T-cyno-DLL3
DR   KYinno; KC-0294
DR   Wikidata; Q93303676
CC   Doubling time: ~30 hours (KYinno=KC-0294).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WSR4; Macaca fascicularis DLL3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T cyno ENPP3
AC   CVCL_E8L5
SY   293T-cyno-ENPP3
DR   KYinno; KC-2742
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TKP4; Macaca fascicularis ENPP3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno ERBB3
AC   CVCL_E8L6
SY   293T-cyno-ERBB3
DR   KYinno; KC-1640
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PIG5; Macaca fascicularis ERBB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno F3
AC   CVCL_E8MG
SY   293T-cyno-TF
DR   KYinno; KC-2411
CC   Doubling time: ~30 hours (KYinno=KC-2411).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VX02; Macaca fascicularis F3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno FCAR
AC   CVCL_E8L7
SY   293T-cyno-FCAR
DR   KYinno; KC-3278
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VQ24; Macaca fascicularis FCAR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno FLT3
AC   CVCL_E8L8
SY   293T-cyno-FLT3
DR   KYinno; KC-1497
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PVX3; Macaca fascicularis FLT3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GARP-LTGFBeta
AC   CVCL_E8L9
SY   293T-cyno-GARP-LTGFB
DR   KYinno; KC-4405
CC   Doubling time: ~30 hours (KYinno=KC-4405).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X2X9; Macaca fascicularis LRRC32.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TJB2; Macaca fascicularis TGFB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GFRAL
AC   CVCL_E8LA
SY   293T-cyno-GFRAL
DR   KYinno; KC-2421
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7P2W4; Macaca fascicularis GFRAL.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GHR-Low
AC   CVCL_E8LB
SY   293T-cyno-GHR-Low
DR   KYinno; KC-3974
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9CU23; Macaca fascicularis GHR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GHR-Middle
AC   CVCL_E8LC
SY   293T-cyno-GHR-Middle
DR   KYinno; KC-3973
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9CU23; Macaca fascicularis GHR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GIPR
AC   CVCL_E8LD
SY   293T-cyno-GIPR
DR   KYinno; KC-3443
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G8F4B4; Macaca fascicularis GIPR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GITR
AC   CVCL_XY82
SY   293T-cyno-GITR
DR   KYinno; KC-0256
DR   Wikidata; Q93303677
CC   Doubling time: ~30 hours (KYinno=KC-0256).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WP38; Macaca fascicularis TNFRSF18.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T cyno GLP1R
AC   CVCL_E8LE
SY   293T-cyno-GLP1R
DR   KYinno; KC-3516
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F8V479; Macaca fascicularis GLP1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GPR84
AC   CVCL_E8LF
SY   293T-cyno-GPR84
DR   KYinno; KC-3769
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G8F5B7; Macaca fascicularis GPR84.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GPRC5D-HA
AC   CVCL_E8LG
SY   293T-cyno-GPRC5D-HA
DR   KYinno; KC-1586
CC   Doubling time: ~30 hours (KYinno=KC-1586).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5W6I7; Macaca fascicularis GPRC5D (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno GUCY2C
AC   CVCL_E8LH
SY   293T-cyno-GUCY2C
DR   KYinno; KC-2502
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PJX5; Macaca fascicularis GUCY2C.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IGF1R-High
AC   CVCL_E8LI
SY   293T-cyno-IGF1R-High
DR   KYinno; KC-3060
CC   Doubling time: ~30 hours (KYinno=KC-3060).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7P9I7; Macaca fascicularis IGF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IGF1R-Low
AC   CVCL_E8LJ
SY   293T-cyno-IGF1R-Low
DR   KYinno; KC-3061
CC   Doubling time: ~30 hours (KYinno=KC-3061).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7P9I7; Macaca fascicularis IGF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IL11RA
AC   CVCL_E8LK
SY   293T-cyno-IL11RA
DR   KYinno; KC-1799
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VLM5; Macaca fascicularis IL11RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IL1RL1
AC   CVCL_E8LL
SY   293T-cyno-IL1RL1
DR   KYinno; KC-3958
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UDB8; Macaca fascicularis IL1RL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IL22RA1
AC   CVCL_E8LM
SY   293T-cyno-IL22RA1
DR   KYinno; KC-2743
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TKX9; Macaca fascicularis IL22RA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IL2RB-IL2RG
AC   CVCL_E8LN
SY   293T-cyno-IL2RB&G
DR   KYinno; KC-1650
CC   Doubling time: ~30 hours (KYinno=KC-1650).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q38J85; Macaca fascicularis IL2RB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VGJ6; Macaca fascicularis IL2RG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IL2RG
AC   CVCL_E8LP
SY   293T-cyno-IL2RG
DR   KYinno; KC-3867
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VGJ6; Macaca fascicularis IL2RG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno IL4R
AC   CVCL_E8LQ
SY   293T-cyno-IL4R
DR   KYinno; KC-1381
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5V580; Macaca fascicularis IL4R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno ITGAE
AC   CVCL_E8LR
SY   293T-cyno-ITGAE
DR   KYinno; KC-3928
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VBE9; Macaca fascicularis ITGAE.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno KLRB1
AC   CVCL_E8LS
SY   293T-cyno-KLRB1
DR   KYinno; KC-2986
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9D796; Macaca fascicularis KLRB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno KLRG1
AC   CVCL_E8LT
SY   293T-cyno-KLRG1
DR   KYinno; KC-3272
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PJR4; Macaca fascicularis KLRG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno LAG3
AC   CVCL_UE57
SY   293T-cyno-LAG3
DR   KYinno; KC-0208
DR   Wikidata; Q93303679
CC   Doubling time: ~30 hours (KYinno=KC-0208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5V5Q3; Macaca fascicularis LAG3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T cyno LGR4
AC   CVCL_E8LU
SY   293T-cyno-LGR4
DR   KYinno; KC-3770
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WFT5; Macaca fascicularis LGR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno LILRB2
AC   CVCL_E8LV
SY   293T-cyno-LILRB2
DR   KYinno; KC-1461
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VBK2; Macaca fascicularis LILRB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno LRRC15
AC   CVCL_E8LW
SY   293T-cyno-LRRC15
DR   KYinno; KC-2646
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7NYR2; Macaca fascicularis LRRC15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno LY6G6D
AC   CVCL_E8LX
SY   293T-cyno-LY6G6D
DR   KYinno; KC-2767
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G8F3X5; Macaca fascicularis LY6G6D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno MUC1
AC   CVCL_E8LY
SY   293T-cyno-Muc1
DR   KYinno; KC-2244
CC   Doubling time: ~30 hours (KYinno=KC-2244).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UMQ1; Macaca fascicularis MUC1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno OX40
AC   CVCL_UE59
SY   293T-cyno-OX40
DR   KYinno; KC-0289
DR   Wikidata; Q93303681
CC   Doubling time: ~30 hours (KYinno=KC-0289).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TJH8; Macaca fascicularis TNFRSF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T cyno OX40L
AC   CVCL_E8LZ
SY   293T-cyno-OX40L
DR   KYinno; KC-1114
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TJH8; Macaca fascicularis TNFRSF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno PD1
AC   CVCL_E8M0
SY   293T-cyno-PD1
DR   KYinno; KC-2422
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; B0LAJ3; Macaca fascicularis PDCD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno PDL1
AC   CVCL_XY83
SY   293T cyno PD-L1
DR   KYinno; KC-1001
DR   Wikidata; Q93303683
CC   Doubling time: ~30 hours (KYinno=KC-1001).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PSE7; Macaca fascicularis CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: KYinno; KC-1001; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T cyno PTGER4 1
AC   CVCL_E8M1
SY   293T-cyno-PTGER4
DR   KYinno; KC-1058
CC   Doubling time: ~30 hours (KYinno=KC-1058).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95J39; Macaca fascicularis PTGER4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno PTGER4 2
AC   CVCL_E8M2
SY   293T-cyno-EP4
DR   KYinno; KC-2131
CC   Doubling time: ~30 hours (KYinno=KC-2131).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q95J39; Macaca fascicularis PTGER4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno PTH1R-High
AC   CVCL_E8M3
SY   293T-cyno-PTH1R-High
DR   KYinno; KC-3338
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5V724; Macaca fascicularis PTH1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno PTH1R-Middle
AC   CVCL_E8M4
SY   293T-cyno-PTH1R-Middle
DR   KYinno; KC-3346
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5V724; Macaca fascicularis PTH1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno PVRIG
AC   CVCL_E8M5
SY   293T-cyno-PVRIG
DR   KYinno; KC-1982
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G8F4G7; Macaca fascicularis PVRIG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno PVRL4
AC   CVCL_E8M6
SY   293T-cyno-PVRL4
DR   KYinno; KC-2186
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; L0N6D9; Macaca fascicularis NECTIN4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno ROR1
AC   CVCL_E8M7
SY   293T-cyno-ROR1
DR   KYinno; KC-2533
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WTX7; Macaca fascicularis ROR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno SEZ6
AC   CVCL_E8M8
SY   293T-cyno-SEZ6
DR   KYinno; KC-3172
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WPJ4; Macaca fascicularis SEZ6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno SIGLEC15
AC   CVCL_E8M9
SY   293T-cyno-SIGLEC15
DR   KYinno; KC-1372
CC   Doubling time: ~30 hours (KYinno=KC-1372).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UY47; Macaca fascicularis SIGLEC15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno SIGLEC15.2
AC   CVCL_E8MA
SY   293T-cyno-siglec15.2
DR   KYinno; KC-1562
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UY47; Macaca fascicularis SIGLEC15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno SIGLEC6
AC   CVCL_E8MB
SY   293T-cyno-SIGLEC6
DR   KYinno; KC-4232
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5W726; Macaca fascicularis SIGLEC6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno SLC34A2
AC   CVCL_E8MC
SY   293T-cyno-SLC34A2
DR   KYinno; KC-3082
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UHY1; Macaca fascicularis SLC34A2 (Note=With p.Leu574_Leu690del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno SLC39A6
AC   CVCL_E8MD
SY   293T-cyno-SLC39A6
DR   KYinno; KC-1841
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WH46; Macaca fascicularis SLC39A6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno STEAP1
AC   CVCL_E8ME
SY   293T-cyno-STEAP1
DR   KYinno; KC-4765
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7P1V0; Macaca fascicularis STEAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TEK
AC   CVCL_E8MF
SY   293T-cyno-TEK
DR   KYinno; KC-2314
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VRE1; Macaca fascicularis TEK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TFRC-High
AC   CVCL_E8MH
SY   293T-cyno-TFRC-High
DR   KYinno; KC-3261
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X958; Macaca fascicularis TFRC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TFRC-Low
AC   CVCL_E8MI
SY   293T-cyno-TFRC-Low
DR   KYinno; KC-3238
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X958; Macaca fascicularis TFRC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TIGIT
AC   CVCL_E8MJ
SY   293T-cyno-TIGIT
DR   KYinno; KC-1981
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7NXM4; Macaca fascicularis TIGIT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TM4SF1
AC   CVCL_E8MK
SY   293T-cyno-TM4SF1
DR   KYinno; KC-3547
CC   Doubling time: ~30 hours (KYinno=KC-3547).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VKY2; Macaca fascicularis TM4SF1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TMEFF2
AC   CVCL_E8ML
SY   293T-cyno-TMEFF2
DR   KYinno; KC-3293
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PL27; Macaca fascicularis TMEFF2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TNFSF14 1
AC   CVCL_E8MM
SY   293T-cyno-TNFSF14
DR   KYinno; KC-1218
CC   Doubling time: ~30 hours (KYinno=KC-1218).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; E9NVF7; Macaca fascicularis TNFSF14.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TNFSF14 2
AC   CVCL_E8MN
SY   293T-cyno-TNFSF14
DR   KYinno; KC-2027
CC   Doubling time: ~30 hours (KYinno=KC-2027).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; E9NVF7; Macaca fascicularis TNFSF14.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TNFSF15
AC   CVCL_E8MP
SY   293T-cyno-TNFSF15
DR   KYinno; KC-3544
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PRK8; Macaca fascicularis TNFSF15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T cyno TREM2-DAP12
AC   CVCL_E8MQ
SY   293T-cyno-TREM2-DAP12
DR   KYinno; KC-2058
CC   Doubling time: ~30 hours (KYinno=KC-2058).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UY39; Macaca fascicularis TREM2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WY34; Macaca fascicularis TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T dog CCR8-HA
AC   CVCL_E8MS
SY   293T-Dog-CCR8-HA
DR   KYinno; KC-2593
CC   Doubling time: ~30 hours (KYinno=KC-2593).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:38916; Dog CCR8 (Note=With a HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T dog CLDN18.2
AC   CVCL_E8MT
SY   293T-Dog-CLDN18.2
DR   KYinno; KC-2553
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:39314; Dog CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T dog CSF1R-Flag
AC   CVCL_XY84
SY   293T-Dog-CSF1R-Flag; 293T-Dog-CSF1R
DR   KYinno; KC-1252
DR   Wikidata; Q93303685
CC   Doubling time: ~30 hours (KYinno=KC-1252).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:39653; Dog CSF1R (Note=With a FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   293T dog GITR
AC   CVCL_XY85
SY   293T-Dog-GITR
DR   KYinno; KC-1225
DR   Wikidata; Q93303687
CC   Doubling time: ~30 hours (KYinno=KC-1225).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:47660; Dog TNFRSF18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   293T dog GPRC5D
AC   CVCL_E8MU
SY   293T-Dog-GPRC5D
DR   KYinno; KC-3436
CC   Doubling time: ~30 hours (KYinno=KC-3436).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:41451; Dog GPRC5D.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T dog IL2RB-IL2RG
AC   CVCL_E8MV
SY   293T-Dog-IL2RB&G
DR   KYinno; KC-1819
CC   Doubling time: ~30 hours (KYinno=KC-1819).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:41978; Dog IL2RB.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:41979; Dog IL2RG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T ERR reporter
AC   CVCL_ZD87
SY   ERRalpha Expressing HEK-293T/17 Cell Line; ERR reporter
DR   Kerafast; ENH070-FP
DR   Wikidata; Q98125374
RX   PubMed=28346099;
CC   Characteristics: Expresses a construct with a pleiotropic nuclear receptor enhancer MHRE that controls the expression of GFP and luciferase (AAB-GFP-Luc).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   293T FOXP3
AC   CVCL_C3GZ
DR   Wikidata; Q114310436
RX   PubMed=27189164;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6106; FOXP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   293T FOXP3Delta3
AC   CVCL_C3H0
DR   Wikidata; Q114310437
RX   PubMed=27189164;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6106; FOXP3 (Note=Isoform Delta3).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   293T GNE
AC   CVCL_0V13
DR   BioSample; SAMN03471905
DR   Wikidata; Q54584137
RX   PubMed=25877200;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 17,19
ST   D21S11: 28,30.2
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 11,12,14,15
ST   FGA: 20,23
ST   Penta D: 9,10
ST   Penta E: 7,14,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   293T human B7H4
AC   CVCL_UE34
SY   293T-B7H4
DR   KYinno; KC-0240
DR   Wikidata; Q93303694
CC   Doubling time: ~30 hours (KYinno=KC-0240).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:28873; VTCN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human BCMA
AC   CVCL_UE35
DR   KYinno; KC-0233
DR   Wikidata; Q93303697
CC   Doubling time: ~30 hours (KYinno=KC-0233).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11913; TNFRSF17.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: KYinno; KC-0233; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CCR6
AC   CVCL_UE36
SY   293T-CCR6
DR   KYinno; KC-0352
DR   Wikidata; Q93303699
CC   Doubling time: ~30 hours (KYinno=KC-0352).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1607; CCR6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD123
AC   CVCL_UC03
SY   293T-CD123
DR   KYinno; KC-0315
DR   Wikidata; Q93303701
CC   Doubling time: ~30 hours (KYinno=KC-0315).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6012; IL3RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD133
AC   CVCL_UE19
SY   293T-CD133
DR   KYinno; KC-0993
DR   Wikidata; Q93303704
CC   Doubling time: ~30 hours (KYinno=KC-0993).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9454; PROM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD137
AC   CVCL_UE20
SY   293T-CD137
DR   KYinno; KC-0207
DR   Wikidata; Q93303706
CC   Doubling time: ~30 hours (KYinno=KC-0207).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD137L
AC   CVCL_XY87
SY   293T-CD137L
DR   KYinno; KC-0241
DR   Wikidata; Q93303708
CC   Doubling time: ~30 hours (KYinno=KC-0241).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11939; TNFSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   293T human CD138
AC   CVCL_UE21
SY   293T-CD138
DR   KYinno; KC-0998
DR   Wikidata; Q93303710
CC   Doubling time: ~30 hours (KYinno=KC-0998).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10658; SDC1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD154(CD40L)
AC   CVCL_UE22
SY   293T-CD154 (CD40L)
DR   KYinno; KC-0229
DR   Wikidata; Q93303713
CC   Doubling time: ~30 hours (KYinno=KC-0229).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD22
AC   CVCL_UE23
SY   293T-CD22
DR   KYinno; KC-0997
DR   Wikidata; Q93303716
CC   Doubling time: ~30 hours (KYinno=KC-0997).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1643; CD22.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD25
AC   CVCL_XY88
SY   293T-CD25; 293T CD25
DR   KYinno; KC-1229
DR   Wikidata; Q93303718
CC   Doubling time: ~30 hours (KYinno=KC-1229).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6008; IL2RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   293T human CD33
AC   CVCL_UE24
SY   293T-CD33
DR   KYinno; KC-0992
DR   Wikidata; Q93303721
CC   Doubling time: ~30 hours (KYinno=KC-0992).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1659; CD33.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD40
AC   CVCL_UE25
SY   293T-CD40
DR   KYinno; KC-0222
DR   Wikidata; Q93303724
CC   Doubling time: ~30 hours (KYinno=KC-0222).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11919; CD40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CD47
AC   CVCL_XY89
SY   293T-CD47
DR   KYinno; KC-0249
DR   Wikidata; Q93303727
CC   Doubling time: ~30 hours (KYinno=KC-0249).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   293T human CLDN18.1
AC   CVCL_UC04
SY   293T-CLDN18.1
DR   KYinno; KC-0990
DR   Wikidata; Q93303731
CC   Doubling time: ~30 hours (KYinno=KC-0990).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CLDN18.1-Flag
AC   CVCL_XY90
SY   293T-CLDN18.1-Flag
DR   KYinno; KC-1257
DR   Wikidata; Q93303734
CC   Doubling time: ~30 hours (KYinno=KC-1257).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A1; with a C-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   293T human CLDN18.2
AC   CVCL_UE18
SY   293T-CLDN18.2
DR   KYinno; KC-0986
DR   Wikidata; Q93303737
CC   Doubling time: ~30 hours (KYinno=KC-0986).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human CLDN18.2-M4
AC   CVCL_XY91
SY   293T-CLDN18.2-M4(A42S-N45Q-Q47E-E56Q)
DR   KYinno; KC-1328
DR   Wikidata; Q93303741
CC   Doubling time: ~30 hours (KYinno=KC-1328).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2; with p.Ala42Ser, p.Asn45Gln, p.Gln47Glu and p.Gln56Glu).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   293T human CSF1R
AC   CVCL_XY86
SY   293T-CSF1R; 293T hCSF1R
DR   KYinno; KC-1220
DR   Wikidata; Q93303743
CC   Doubling time: ~30 hours (KYinno=KC-1220).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2433; CSF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   293T human CTLA4
AC   CVCL_UE37
DR   KYinno; KC-0209
DR   Wikidata; Q93303746
CC   Doubling time: ~30 hours (KYinno=KC-0209).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: KYinno; KC-0209; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human DLL3
AC   CVCL_UE38
SY   293T-DLL3
DR   KYinno; KC-0292
DR   Wikidata; Q93303750
CC   Doubling time: ~30 hours (KYinno=KC-0292).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2909; DLL3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human EGFR vIII
AC   CVCL_UE93
SY   293T human EGFRvIII; 293T-EGFRVIII
DR   KYinno; KC-0996
DR   Wikidata; Q93303753
CC   Doubling time: ~30 hours (KYinno=KC-0996).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human Epcam
AC   CVCL_UE39
SY   293T-Epcam
DR   KYinno; KC-0994
DR   Wikidata; Q93303756
CC   Doubling time: ~30 hours (KYinno=KC-0994).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11529; EPCAM.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human FOLH1
AC   CVCL_UE40
SY   293T-PSMA
DR   KYinno; KC-1005
DR   Wikidata; Q93303759
CC   Doubling time: ~30 hours (KYinno=KC-1005).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3788; FOLH1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human GPC3
AC   CVCL_UE41
SY   293T-GPC3
DR   KYinno; KC-1003
DR   Wikidata; Q93303763
CC   Doubling time: ~30 hours (KYinno=KC-1003).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4451; GPC3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human LAG3
AC   CVCL_UE42
SY   293T-LAG3
DR   KYinno; KC-0214
DR   Wikidata; Q93303766
CC   Doubling time: ~30 hours (KYinno=KC-0214).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6476; LAG3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human NRP1
AC   CVCL_UE43
DR   KYinno; KC-1004
DR   Wikidata; Q93303770
CC   Doubling time: ~30 hours (KYinno=KC-1004).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8004; NRP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: KYinno; KC-1004; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human OX40
AC   CVCL_UE44
SY   293T-OX40
DR   KYinno; KC-0282
DR   Wikidata; Q93303773
CC   Doubling time: ~30 hours (KYinno=KC-0282).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11918; TNFRSF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human OX40L
AC   CVCL_UE45
SY   293T-OX40L
DR   KYinno; KC-0295
DR   Wikidata; Q93303775
CC   Doubling time: ~30 hours (KYinno=KC-0295).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11934; TNFSF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human PD-1
AC   CVCL_UE46
SY   293T-PD1
DR   KYinno; KC-0204
DR   Wikidata; Q93303777
CC   Doubling time: ~30 hours (KYinno=KC-0204).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human PDL1
AC   CVCL_UE47
SY   293T human PD-L1; 293T-PDL1
DR   KYinno; KC-0205
DR   Wikidata; Q93303782
CC   Doubling time: ~30 hours (KYinno=KC-0205).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human PDL2
AC   CVCL_UE48
SY   293T human PD-L2; 293T-PDL2
DR   KYinno; KC-0219
DR   Wikidata; Q93303784
CC   Doubling time: ~30 hours (KYinno=KC-0219).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18731; PDCD1LG2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human PVR
AC   CVCL_XY92
SY   293T human PVR (CD155); 293T-CD155(PVR)
DR   KYinno; KC-1009
DR   Wikidata; Q93303786
CC   Doubling time: ~30 hours (KYinno=KC-1009).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9705; PVR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   293T human ROR1
AC   CVCL_UE49
SY   293T-ROR1
DR   KYinno; KC-1018
DR   Wikidata; Q93303790
CC   Doubling time: ~30 hours (KYinno=KC-1018).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10256; ROR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human TIGIT
AC   CVCL_UE50
SY   293T-TIGIT
DR   KYinno; KC-0246
DR   Wikidata; Q93303793
CC   Doubling time: ~30 hours (KYinno=KC-0246).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:26838; TIGIT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human TIM3
AC   CVCL_UE51
SY   293T-TIM3
DR   KYinno; KC-0215
DR   Wikidata; Q93303795
CC   Doubling time: ~30 hours (KYinno=KC-0215).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18437; HAVCR2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T human TROP2
AC   CVCL_UE52
SY   293T-TROP2
DR   KYinno; KC-0995
DR   Wikidata; Q93303797
CC   Doubling time: ~30 hours (KYinno=KC-0995).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11530; TACSTD2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   293T mouse B7H3-High
AC   CVCL_E8Q8
SY   293T-mouse-B7H3-High
DR   KYinno; KC-2424
CC   Doubling time: ~30 hours (KYinno=KC-2424).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2183926; Cd276.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse B7H3-Middle
AC   CVCL_E8Q9
SY   293T-mouse-B7H3-Middle
DR   KYinno; KC-2425
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2183926; Cd276.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse B7H4
AC   CVCL_E8QA
SY   293T-mouse-B7H4
DR   KYinno; KC-0258
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:3039619; Vtcn1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse BAFFR
AC   CVCL_E8QB
SY   293T-mouse-BAFFR
DR   KYinno; KC-4738
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919299; Tnfrsf13c.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CAIX
AC   CVCL_E8QC
SY   293T-mouse-CAIX
DR   KYinno; KC-3280
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2447188; Car9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CCR5
AC   CVCL_E8QD
SY   293T-mouse-CCR5
DR   KYinno; KC-3919
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:107182; Ccr5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CCR6
AC   CVCL_UE60
SY   293T-mouse-CCR6
DR   KYinno; KC-0355
DR   Wikidata; Q93303800
CC   Doubling time: ~30 hours (KYinno=KC-0355).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1333797; Ccr6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T mouse CCR8
AC   CVCL_E8QE
SY   293T-mouse-CCR8
DR   KYinno; KC-2171
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1201402; Ccr8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD103
AC   CVCL_E8QF
SY   293T-mouse-CD103
DR   KYinno; KC-3927
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1298377; Itgae.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD137
AC   CVCL_E8QG
SY   293T-mouse-CD137
DR   KYinno; KC-1557
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1101059; Tnfrsf9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD2
AC   CVCL_E8QH
SY   293T-mouse-CD2
DR   KYinno; KC-4058
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88320; Cd2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD20
AC   CVCL_E8QI
SY   293T-mouse-CD20
DR   KYinno; KC-3515
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88321; Ms4a1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD22
AC   CVCL_E8QJ
SY   293T-mouse-CD22
DR   KYinno; KC-3960
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88322; Cd22.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD228
AC   CVCL_E8QK
SY   293T-mouse-CD228
DR   KYinno; KC-3622
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1353421; Meltf.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD24
AC   CVCL_E8QL
SY   293T-mouse-CD24
DR   KYinno; KC-1664
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88323; Cd24a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD25-High
AC   CVCL_E8QM
SY   293T-mouse-CD25-High
DR   KYinno; KC-2432
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96549; Il2ra.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD25-Low
AC   CVCL_E8QN
SY   293T-mouse-CD25-Low
DR   KYinno; KC-2433
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96549; Il2ra.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD28
AC   CVCL_E8QP
SY   293T-mouse-CD28
DR   KYinno; KC-2725
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88327; Cd28.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD36
AC   CVCL_E8QQ
SY   293T-mouse-CD36
DR   KYinno; KC-2475
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:107899; Cd36.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD4
AC   CVCL_E8QR
SY   293T-mouse-CD4
DR   KYinno; KC-4467
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88335; Cd4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD40L-High
AC   CVCL_E8QS
SY   293T-mouse-CD40L-High
DR   KYinno; KC-2451
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88337; Cd40lg.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD40L-Middle
AC   CVCL_E8QT
SY   293T-mouse-CD40L-Middle
DR   KYinno; KC-2452
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88337; Cd40lg.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD7
AC   CVCL_E8QU
SY   293T-mouse-CD7
DR   KYinno; KC-2366
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88344; Cd7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD70
AC   CVCL_E8QV
SY   293T-mouse-CD70
DR   KYinno; KC-2549
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1195273; Cd70.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CD74
AC   CVCL_E8QW
SY   293T-mouse-CD74
DR   KYinno; KC-3921
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96534; Cd74.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CDH17
AC   CVCL_E8QX
SY   293T-mouse-CDH17
DR   KYinno; KC-3081
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1095414; Cdh17.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CDH6
AC   CVCL_E8QY
SY   293T-mouse-CDH6
DR   KYinno; KC-3685
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:107435; Cdh6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CLDN18.2
AC   CVCL_UE61
SY   293T-mouse-CLDN18.2
DR   KYinno; KC-1014
DR   Wikidata; Q93303802
CC   Doubling time: ~30 hours (KYinno=KC-1014).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1929209; Cldn18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   293T mouse CLDN6
AC   CVCL_E8QZ
SY   293T-mouse-CLDN6
DR   KYinno; KC-3012
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1859284; Cldn6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CLEC5A
AC   CVCL_E8R0
SY   293T-mouse-CLEC5A
DR   KYinno; KC-3879
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1345151; Clec5a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CRTAM
AC   CVCL_E8R1
SY   293T-mouse-CRTAM
DR   KYinno; KC-3510
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1859822; Crtam.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CSF1R
AC   CVCL_XY93
SY   293T-mouse-CSF1R
DR   KYinno; KC-1055
DR   Wikidata; Q93303804
CC   Doubling time: ~30 hours (KYinno=KC-1055).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1339758; Csf1r.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T mouse CTLA4
AC   CVCL_E8R2
SY   293T-mouse-CTLA4
DR   KYinno; KC-1401
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88556; Ctla4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CTLA4-delta23
AC   CVCL_E8R3
SY   293T-mouse-CTLA4-delta23
DR   KYinno; KC-3000
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88556; Ctla4 (Note=Isoform delta23).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse CXCR5
AC   CVCL_E8R4
SY   293T-mouse-CXCR5
DR   KYinno; KC-2143
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103567; Cxcr5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse Dectin1-A
AC   CVCL_E8R5
SY   293T-mouse-dectin1a
DR   KYinno; KC-3088
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1861431; Clec7a (Note=Isoform A).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse Dectin1-B
AC   CVCL_E8R6
SY   293T-mouse-dectin1b
DR   KYinno; KC-3105
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1861431; Clec7a (Note=Isoform B).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse EPCAM
AC   CVCL_E8R7
SY   293T-mouse-Epcam
DR   KYinno; KC-4458
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:106653; Epcam.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse EPHA2
AC   CVCL_E8R8
SY   293T-mouse-EPHA2
DR   KYinno; KC-3634
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:95278; Epha2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse F3
AC   CVCL_E8R9
SY   293T-mouse-TF
DR   KYinno; KC-2501
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88381; F3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse FGFR3-IIIc
AC   CVCL_E8RA
SY   293T-mouse-FGFR3IIIc
DR   KYinno; KC-4113
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:95524; Fgfr3 (Note=Isoform IIIc).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GCGR
AC   CVCL_E8RB
SY   293T-mouse-GCGR
DR   KYinno; KC-3874
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99572; Gcgr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GFRAL
AC   CVCL_E8RC
SY   293T-mouse-GFRAL
DR   KYinno; KC-3880
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:3607786; Gfral.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GIPR
AC   CVCL_E8RD
SY   293T-mouse-GIPR
DR   KYinno; KC-3577
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1352753; Gipr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GITR
AC   CVCL_XY94
SY   293T-mouse-GITR
DR   KYinno; KC-1269
DR   Wikidata; Q93303807
CC   Doubling time: ~30 hours (KYinno=KC-1269).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:894675; Tnfrsf18.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T mouse GLP1R
AC   CVCL_E8RE
SY   293T-mouse-GLP1R
DR   KYinno; KC-4809
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99571; Glp1r.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GPC3
AC   CVCL_E8RF
SY   293T-mouse-GPC3
DR   KYinno; KC-3631
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104903; Gpc3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GPR75
AC   CVCL_E8RG
SY   293T-mouse-GPR75
DR   KYinno; KC-4446
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2441843; Gpr75.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GPR84
AC   CVCL_E8RH
SY   293T-mouse-GPR84
DR   KYinno; KC-3883
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1934129; Gpr84.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse GPRC5D-HA
AC   CVCL_E8RI
SY   293T-mouse-GPRC5D-HA
DR   KYinno; KC-1585
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1935037; Gprc5d (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse ICAM1
AC   CVCL_E8RJ
SY   293T-mouse-ICAM1
DR   KYinno; KC-3588
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96392; Icam1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse IL11RA
AC   CVCL_E8RK
SY   293T-mouse-IL11RA
DR   KYinno; KC-1775
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:107426; Il11ra1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse IL22RA1
AC   CVCL_E8RL
SY   293T-mouse-IL22RA1
DR   KYinno; KC-3881
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2663588; Il22ra1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse ITGAV
AC   CVCL_E8RM
SY   293T-mouse-ITGAV
DR   KYinno; KC-4462
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96608; Itgav.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse LGR4
AC   CVCL_E8RN
SY   293T-mouse-LGR4
DR   KYinno; KC-3779
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1891468; Lgr4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse MMP7
AC   CVCL_E8RP
SY   293T-mouse-MMP7
DR   KYinno; KC-2245
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103189; Mmp7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse MST1R
AC   CVCL_E8RQ
SY   293T-mouse-MST1R
DR   KYinno; KC-3961
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99614; Mst1r.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse MUC1
AC   CVCL_E8RR
SY   293T-mouse-Muc1
DR   KYinno; KC-3367
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97231; Muc1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse PD1
AC   CVCL_E8RS
SY   293T-mouse-PD1
DR   KYinno; KC-2078
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104879; Pdcd1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse PDL1
AC   CVCL_E8RT
SY   293T-mouse-PDL1
DR   KYinno; KC-1394
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1926446; Cd274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse PTH1R
AC   CVCL_E8RU
SY   293T-mouse-PTH1R
DR   KYinno; KC-3286
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97801; Pth1r.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse PVRIG
AC   CVCL_E8RV
SY   293T-mouse-PVRIG
DR   KYinno; KC-2403
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:5596028; Pvrig.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse PVRL4
AC   CVCL_E8RW
SY   293T-mouse-PVRL4
DR   KYinno; KC-2221
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1918990; Nectin4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse ROR1
AC   CVCL_E8RX
SY   293T-mouse-ROR1
DR   KYinno; KC-2500
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1347520; Ror1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse ROR2
AC   CVCL_E8RY
SY   293T-mouse-ROR2
DR   KYinno; KC-3093
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1347521; Ror2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse SEZ6
AC   CVCL_E8RZ
SY   293T-mouse-SEZ6
DR   KYinno; KC-3201
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104745; Sez6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse SIGLEC15
AC   CVCL_E8S0
SY   293T-mouse-Siglec15
DR   KYinno; KC-1570
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:3646642; Siglec15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse SLC34A2
AC   CVCL_E8S1
SY   293T-mouse-SLC34A2
DR   KYinno; KC-3136
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1342284; Slc34a2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse STEAP1
AC   CVCL_E8S2
SY   293T-mouse-STEAP1
DR   KYinno; KC-4215
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1917608; Steap1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse TEK
AC   CVCL_E8S3
SY   293T-mouse-TEK
DR   KYinno; KC-3924
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98664; Tek.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse TFRC
AC   CVCL_E8S4
SY   293T-mouse-TFRC
DR   KYinno; KC-3258
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98822; Tfrc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse TM4SF1
AC   CVCL_E8S5
SY   293T-mouse-TM4SF1
DR   KYinno; KC-3548
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104678; Tm4sf1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse TMEFF2
AC   CVCL_E8S6
SY   293T-mouse-TMEFF2
DR   KYinno; KC-3890
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1861735; Tmeff2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse TNFSF15
AC   CVCL_E8S7
SY   293T-mouse-TNFSF15
DR   KYinno; KC-4005
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2180140; Tnfsf15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse TPBG
AC   CVCL_E8S8
SY   293T-mouse-TPBG
DR   KYinno; KC-2642
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1341264; Tpbg.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse TREM2-DAP12
AC   CVCL_E8S9
SY   293T-mouse-TREM2-DAP12
DR   KYinno; KC-1991
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1913150; Trem2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1277211; Tyrobp.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse VISTA
AC   CVCL_E8SA
SY   293T-mouse-VISTA
DR   KYinno; KC-3255
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1921298; Vsir.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T mouse XCR1
AC   CVCL_E8SB
SY   293T-mouse-XCR1
DR   KYinno; KC-2529
CC   Doubling time: ~30 hours (KYinno=KC-2529).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1346338; Xcr1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T NF-kb-Luc2 reporter
AC   CVCL_XY95
SY   293T NF-kb luciferase reporter
DR   KYinno; KC-0148
DR   Wikidata; Q93303809
CC   Characteristics: The luciferase reporter gene is under the control of the NF-kappaB response element (KYinno=KC-0148).
CC   Doubling time: ~30 hours (KYinno=KC-0148).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   293T OS8
AC   CVCL_UE94
SY   293T-OS8
DR   KYinno; KC-1113
DR   Wikidata; Q93303812
CC   Characteristics: Transfected with the ScFV sequence of anti-human CD3 mAb OKT3 and a C-terminal domain of mouse CD8a which consists of the transmembrane and cytoplasmic domains (KYinno=KC-1113).
CC   Doubling time: ~30 hours (KYinno=KC-1113).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88346; Cd8a (Note=With p.Met1_Tyr196del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 13
//
ID   293T OS8-hB7H4
AC   CVCL_UE95
SY   293T-OS8-B7H4
DR   KYinno; KC-1111
DR   Wikidata; Q93303815
CC   Characteristics: Transfected with the ScFV sequence of anti-human CD3 mAb OKT3 and a C-terminal domain of mouse CD8a which consists of the transmembrane and cytoplasmic domains (from parent cell line).
CC   Doubling time: ~30 hours (KYinno=KC-1111).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:28873; VTCN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88346; Cd8a (Note=With p.Met1_Tyr196del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 14
//
ID   293T OS8-hPDL1
AC   CVCL_UE96
SY   293T OS8-hPD-L1; 293T-OS8-hPDL1
DR   KYinno; KC-1148
DR   Wikidata; Q93303818
CC   Characteristics: Transfected with the ScFV sequence of anti-human CD3 mAb OKT3 and a C-terminal domain of mouse CD8a which consists of the transmembrane and cytoplasmic domains (from parent cell line).
CC   Doubling time: ~30 hours (KYinno=KC-1148).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88346; Cd8a (Note=With p.Met1_Tyr196del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 14
//
ID   293T PCC/ERR reporter
AC   CVCL_ZD88
SY   ERRalpha/PGC-1alpha Expressing HEK-293T/17 Cell Line; PGC/ERR reporter
DR   Kerafast; ENH071-FP
DR   Wikidata; Q98125375
RX   PubMed=28346099;
CC   Characteristics: Expresses a construct with a pleiotropic nuclear receptor enhancer MHRE that controls the expression of GFP and luciferase (AAB-GFP-Luc).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3471; ESRRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   293T R-Spondin1 expressing
AC   CVCL_RU09
SY   R-Spondin1 expressing 293T
DR   Millipore; SCC111
DR   Wikidata; Q54584138
RX   PubMed=19398967;
CC   Characteristics: Expresses mouse Fc-Rspo1 which consist of the fusion of mouse IgG2a Fc region to the N-terminal of Rspo1 with a N-terminal HA epitope tag (Millipore=SCC111).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2183426; Rspo1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Caution: Could be identical to HA-R-Spondin1-Fc 293T (Cellosaurus=CVCL_RU08) distributed by AMSBIO. Both cell line product pages cite PubMed=19398967 but the Millipore page states "Cell line is not the published cell line from the Kuo lab, but rather a related cell line developed in the same lab using the reference protocol".
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): Millipore=SCC111
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,14
ST   D18S51: 17,18,19
ST   D21S11: 28,29,30,30.2
ST   D3S1358: 16,17
ST   D5S818: 7,8,9
ST   D7S820: 11
ST   D8S1179: 11,12,13,14
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   293T rabbit CCR8-HA
AC   CVCL_E8MW
SY   293T-Rabbit-CCR8-HA
DR   KYinno; KC-2596
CC   Doubling time: ~30 hours (KYinno=KC-2596).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G1T2B2; Rabbit CCR8 (Note=With a HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rabbit CDH6
AC   CVCL_E8MX
SY   293T-Rabbit-CDH6
DR   KYinno; KC-3686
CC   Doubling time: ~30 hours (KYinno=KC-3686).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G1SD52; Rabbit CDH6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rabbit CSF1R-Flag
AC   CVCL_XY96
SY   293T-Rabbit-CSF1R-Flag; 293T-Rabbit-CSF1R
DR   KYinno; KC-1287
DR   Wikidata; Q93303828
CC   Doubling time: ~30 hours (KYinno=KC-1287).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G1TTE0; Rabbit CSF1R (Note=With a FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T rabbit GCGR
AC   CVCL_E8MY
SY   293T-Rabbit-GCGR
DR   KYinno; KC-4162
CC   Doubling time: ~30 hours (KYinno=KC-4162).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Rabbit GCGR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rabbit IL2RB-IL2RG
AC   CVCL_E8MZ
SY   293T-Rabbit-IL2RB&G
DR   KYinno; KC-1646
CC   Doubling time: ~30 hours (KYinno=KC-1646).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Rabbit IL2RB.
CC   Genetic integration: Method=Transduction; Gene=Rabbit IL2RG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CCR8
AC   CVCL_E8N3
SY   293T-Rat-CCR8
DR   KYinno; KC-2298
CC   Genetic integration: Method=Transduction; Gene=RGD; 1304893; Ccr8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CD70
AC   CVCL_E8N4
SY   293T-Rat-CD70
DR   KYinno; KC-4443
CC   Genetic integration: Method=Transduction; Gene=RGD; 1588573; Cd70.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CDH17
AC   CVCL_E8N5
SY   293T-Rat-CDH17
DR   KYinno; KC-3440
CC   Genetic integration: Method=Transduction; Gene=RGD; 619748; Cdh17.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CDH6
AC   CVCL_E8N6
SY   293T-Rat-CDH6
DR   KYinno; KC-3687
CC   Genetic integration: Method=Transduction; Gene=RGD; 2322; Cdh6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CLDN18.1
AC   CVCL_E8N7
SY   293T-Rat-CLDN18.1
DR   KYinno; KC-1823
CC   Genetic integration: Method=Transduction; Gene=RGD; 1359696; Cldn18 (Note=Isoform A1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CLDN18.2
AC   CVCL_E8N8
SY   293T-Rat-CLDN18.2
DR   KYinno; KC-1824
CC   Genetic integration: Method=Transduction; Gene=RGD; 1359696; Cldn18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CLDN6
AC   CVCL_E8N9
SY   293T-Rat-CLDN6
DR   KYinno; KC-4075
CC   Genetic integration: Method=Transduction; Gene=RGD; 1308837; Cldn6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat CSF1R
AC   CVCL_XY97
SY   293T-Rat-CSF1R
DR   KYinno; KC-1309
DR   Wikidata; Q93303831
CC   Doubling time: ~30 hours (KYinno=KC-1309).
CC   Genetic integration: Method=Transduction; Gene=RGD; 2425; Csf1r.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T rat CTLA4
AC   CVCL_E8NA
SY   293T-Rat-CTLA4
DR   KYinno; KC-1395
CC   Genetic integration: Method=Transduction; Gene=RGD; 61975; Ctla4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat FCAR
AC   CVCL_E8NB
SY   293T-Rat-FCAR
DR   KYinno; KC-3392
CC   Genetic integration: Method=Transduction; Gene=RGD; 1303082; Fcar.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat GITR
AC   CVCL_XY98
SY   293T-Rat-GITR
DR   KYinno; KC-1226
DR   Wikidata; Q93303834
CC   Doubling time: ~30 hours (KYinno=KC-1226).
CC   Genetic integration: Method=Transduction; Gene=RGD; 1565872; Tnfrsf18.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   293T rat GPRC5D
AC   CVCL_E8NC
SY   293T-Rat-GPRC5D
DR   KYinno; KC-3891
CC   Genetic integration: Method=Transduction; Gene=RGD; 1563887; Gprc5d.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat IL2RB-IL2RG
AC   CVCL_E8ND
SY   293T-Rat-IL2RB&G
DR   KYinno; KC-1647
CC   Doubling time: ~30 hours (KYinno=KC-1647).
CC   Genetic integration: Method=Transduction; Gene=RGD; 2896; Il2rb.
CC   Genetic integration: Method=Transduction; Gene=RGD; 621466; Il2rg.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat ITGAV
AC   CVCL_E8NE
SY   293T-Rat-ITGAV
DR   KYinno; KC-4461
CC   Genetic integration: Method=Transduction; Gene=RGD; 1310613; Itgav.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat ITGB6-ITGAV
AC   CVCL_E8NF
SY   293T-Rat-ITGB6-ITGAV
DR   KYinno; KC-4830
CC   Doubling time: ~30 hours (KYinno=KC-4830).
CC   Genetic integration: Method=Transduction; Gene=RGD; 1310613; Itgav.
CC   Genetic integration: Method=Transduction; Gene=RGD; 1303119; Itgb6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat LY6G6D
AC   CVCL_E8NG
SY   293T-Rat-LY6G6D
DR   KYinno; KC-2957
CC   Genetic integration: Method=Transduction; Gene=RGD; 1303064; Ly6g6d.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat NKp46
AC   CVCL_E8NH
SY   293T-Rat-NKp46
DR   KYinno; KC-4444
CC   Genetic integration: Method=Transduction; Gene=RGD; 621288; Ncr1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat PD1-Flag
AC   CVCL_E8NI
SY   293T-Rat-PD1-Flag
DR   KYinno; KC-1393
CC   Doubling time: ~30 hours (KYinno=KC-1393).
CC   Genetic integration: Method=Transduction; Gene=RGD; 1311658; Pdcd1 (Note=With a C-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat PDL1
AC   CVCL_E8NJ
SY   293T-Rat-PDL1
DR   KYinno; KC-4622
CC   Genetic integration: Method=Transduction; Gene=RGD; 1566211; Cd274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat PTH1R
AC   CVCL_E8NK
SY   293T-Rat-PTH1R
DR   KYinno; KC-3290
CC   Genetic integration: Method=Transduction; Gene=RGD; 3442; Pth1r.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rat SEZ6
AC   CVCL_E8NL
SY   293T-Rat-SEZ6
DR   KYinno; KC-3221
CC   Genetic integration: Method=Transduction; Gene=RGD; 619780; Sez6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rhesus IL2RB-IL2RG
AC   CVCL_E8N0
SY   293T-Rhesus-IL2RB&G
DR   KYinno; KC-1648
CC   Doubling time: ~30 hours (KYinno=KC-1648).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; H9Z8K1; Macaca mulatta IL2RB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q38JL2; Macaca mulatta IL2RG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rhesus LILRB1
AC   CVCL_E8N1
SY   293T-Rhesus-LILRB1
DR   KYinno; KC-2299
CC   Doubling time: ~30 hours (KYinno=KC-2299).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F7H3G7; Macaca mulatta LILRB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T rhesus MUC1
AC   CVCL_E8N2
SY   293T-Rhesus-Muc1
DR   KYinno; KC-3391
CC   Doubling time: ~30 hours (KYinno=KC-3391).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F6ZVA9; Macaca mulatta MUC1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   293T-CEP4SIVtat
AC   CVCL_1H20
SY   293T-CEP4 Simian Immunodeficiency Virus tat
DR   BEI_Resources; ARP-8123
DR   Wikidata; Q54584141
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q04194; Simian immunodeficiency virus (isolate SIVmne) tat.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   293T-EGFP
AC   CVCL_A9CN
DR   CCRID; 1101HUM-PUMC000621
DR   Wikidata; Q108819499
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000621
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D12S391: 19,20,21
ST   D13S317: 12
ST   D16S539: 9,10,13
ST   D18S51: 17,18
ST   D19S433: 17,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 14,15,16
ST   D5S818: 8,9
ST   D6S1043: 10,11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   293T-FIX
AC   CVCL_AU00
DR   Wikidata; Q54584142
RX   PubMed=26802680;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3551; F9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 13
//
ID   293T-Luc
AC   CVCL_C9C8
DR   Ubigene; YC-A007-Luc-P
DR   Wikidata; Q123030246
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   293T-Luc2-tdT
AC   CVCL_A9CP
DR   CCRID; 1101HUM-PUMC000622
DR   Wikidata; Q108819500
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000622
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D12S391: 19,20,21
ST   D13S317: 12
ST   D16S539: 9,10,13
ST   D18S51: 17,18
ST   D19S433: 17,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 8,9
ST   D6S1043: 10,11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   293T-mCherry
AC   CVCL_A9CM
DR   CCRID; 1101HUM-PUMC000620
DR   Wikidata; Q108819501
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000620
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D12S391: 19,20,21
ST   D13S317: 12
ST   D16S539: 9,10,13
ST   D18S51: 17,18
ST   D19S433: 17,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 8,9
ST   D6S1043: 10,11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   293T-PGC
AC   CVCL_ZD86
DR   Kerafast; ENH069-FP
DR   Wikidata; Q98125377
RX   PubMed=24457025;
CC   Characteristics: Expresses a construct with a pleiotropic nuclear receptor enhancer MHRE that controls the expression of luciferase (AAB-Luc).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   293T-S
AC   CVCL_LC70
DR   Wikidata; Q54584144
WW   Provider; GenHunter; Q401-S; https://www.genhunter.com/products/293t-s-cells-for-serum-free.html
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   293T-tdT
AC   CVCL_A9CL
DR   CCRID; 1101HUM-PUMC000619
DR   Wikidata; Q108819502
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000619
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D12S391: 19,20,21
ST   D13S317: 12
ST   D16S539: 9,10,13
ST   D18S51: 17,18
ST   D19S433: 17,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 8,9
ST   D6S1043: 10,11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   293T/ACE2 [Japan 2021]
AC   CVCL_B0XR
DR   Wikidata; Q108819503
RX   PubMed=33686154;
CC   Group: SARS-CoV-2 research cell line.
CC   Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33686154).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   293T/ACE2 [USA 2003]
AC   CVCL_YZ65
DR   Wikidata; Q98125378
RX   PubMed=14647384;
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   293T/APOBEC3G
AC   CVCL_W645
SY   293-APOBEC3G-HA
DR   BEI_Resources; ARP-10203
DR   Wikidata; Q54584145
RX   PubMed=14564014;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17357; APOBEC3G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   293T/AT1
AC   CVCL_H376
DR   GenScript; M00448
DR   Wikidata; Q54584146
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:336; AGTR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   293T/GFP-Puro
AC   CVCL_JZ02
DR   Cell_Biolabs; AKR-202
DR   Wikidata; Q54584147
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Cell_Biolabs; AKR-202; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   293T/NFkB-luc
AC   CVCL_KS35
DR   Wikidata; Q54584148
RX   PubMed=16834536;
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NF-kappaB response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0001.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 15
//
ID   293T/NMU2
AC   CVCL_H377
DR   GenScript; M00244
DR   Wikidata; Q54584151
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16454; NMUR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   293T/pAPtag-4
AC   CVCL_LC69
DR   Wikidata; Q54584154
WW   Provider; GenHunter; Q402; https://www.genhunter.com/products/293t-paptag-4-stable-cell-line.html
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:439; ALPP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   293Ta
AC   CVCL_BT05
SY   HEK293-TA; Lenti-Pac 293Ta
DR   GeneCopoeia; CLv-PK-01
DR   KCB; KCB 2013068YJ
DR   Wikidata; Q54584155
WW   Provider; GeneCopoeia; CLv-PK-01; https://www.genecopoeia.com/wp-content/uploads/oldpdfs/product/lentiviral/pdf/293ta_packaging_cell_line.pdf
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: GeneCopoeia; CLv-PK-01; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   293TGPRT+R1
AC   CVCL_AR71
DR   ECACC; 04072121
DR   Wikidata; Q54584157
RX   PubMed=12679787;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   293TGPRT+R1-A
AC   CVCL_AR72
DR   ECACC; 04072120
DR   Wikidata; Q54584159
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR71 ! 293TGPRT+R1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   293TsiLL
AC   CVCL_9705
SY   293T-siLL
DR   EFO; EFO_0001083
DR   Wikidata; Q54584161
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   293TT
AC   CVCL_1D85
SY   HEK293TT; NCI-293TT
DR   ATCC; CRL-3467
DR   NCI-DTP; NCI-293TT
DR   Wikidata; Q54584162
RX   PubMed=14694107;
RX   PubMed=23843634;
WW   Provider; NIH OTT; E-120-2008/0-162; https://web.archive.org/web/20150923173827/http://www.ott.nih.gov/erma/nci-293tt-cell-line
CC   Characteristics: Engineered to overexpress the SV40 large T antigen. Was transfected with a constitutive T-antigen expression plasmid (PubMed=14694107).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3467
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D13S317: 11,12,14
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 18
//
ID   293VgRXR
AC   CVCL_E3D4
RX   PubMed=15141036;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (PubMed=15141036).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   293XL/hTLR7
AC   CVCL_Y413
SY   293XL-hTLR7
DR   InvivoGen; 293xl-htlr7
DR   Wikidata; Q54584164
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15631; TLR7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y381 ! 293XL/null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293XL/hTLR7-HA
AC   CVCL_Y410
SY   293XL-hTLR7-HA
DR   InvivoGen; 293xl-htlr7ha
DR   Wikidata; Q54584166
WW   Provider; InvivoGen; 293xl-htlr7ha; https://web.archive.org/web/20120621111118/http://www.invivogen.com/PDF/293XL-hTLR7-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15631; TLR7 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293xl-htlr7ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y381 ! 293XL/null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293XL/hTLR8
AC   CVCL_Y414
SY   293XL-hTLR8A
DR   InvivoGen; 293xl-htlr8
DR   Wikidata; Q54584168
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15632; TLR8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y381 ! 293XL/null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293XL/hTLR8-HA
AC   CVCL_Y411
SY   293XL-hTLR8-HA
DR   InvivoGen; 293xl-htlr8ha
DR   Wikidata; Q54584170
WW   Provider; InvivoGen; 293xl-htlr8ha; https://web.archive.org/web/20120621141410/http://www.invivogen.com/PDF/293XL-hTLR8-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15632; TLR8 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293xl-htlr8ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y381 ! 293XL/null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293XL/hTLR9
AC   CVCL_Y415
SY   293XL/hTLR9A; 293XL-hTLR9A; 293XL-hTLR 9
DR   InvivoGen; 293xl-htlr9
DR   Wikidata; Q54584172
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y381 ! 293XL/null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293XL/hTLR9-HA
AC   CVCL_Y412
SY   293XL-hTLR9-HA
DR   InvivoGen; 293xl-htlr9ha
DR   Wikidata; Q54584174
WW   Provider; InvivoGen; 293xl-htlr9ha; https://web.archive.org/web/20120621111211/http://www.invivogen.com/PDF/293XL-hTLR9-HA_TDS.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15633; TLR9 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; 293xl-htlr9ha; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y381 ! 293XL/null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293XL/mTLR7
AC   CVCL_Y416
SY   293XL-mTLR7; HEK293XL-mTLR7
DR   InvivoGen; 293xl-mtlr7
DR   Wikidata; Q54584176
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2176882; Tlr7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y381 ! 293XL/null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   293XL/null
AC   CVCL_Y381
SY   293XL-null; 293XL / null; 293XL; HEK293XL; HEK-293XL; HEK293-xl
DR   InvivoGen; 293xl-null
DR   Wikidata; Q54584177
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   294.144.3.5
AC   CVCL_XE15
DR   Wikidata; Q93303931
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6873.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   294.154.5.6
AC   CVCL_XE16
DR   Wikidata; Q93303932
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6875.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 5
//
ID   294.163.2.1
AC   CVCL_XE17
DR   ATCC; PTA-6831
DR   Wikidata; Q93303933
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6831.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
CC   Misspelling: 294163.2.1; ATCC=PTA-6831.
CC   Discontinued: ATCC; PTA-6831; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 5
//
ID   294.35.2.6.3
AC   CVCL_XE18
DR   Wikidata; Q93303935
RX   Patent=US7531637;
RX   Patent=US8017122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6872.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6EBC2; Human IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 5
//
ID   294F5
AC   CVCL_B6VI
DR   Wikidata; Q111732668
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   294F7
AC   CVCL_B6VJ
DR   Wikidata; Q111732670
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   294G2
AC   CVCL_B6VK
DR   Wikidata; Q111732671
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   2957/90
AC   CVCL_9557
SY   St 2957; St2957; ST2957
DR   BioSample; SAMN03151784
DR   cancercelllines; CVCL_9557
DR   Cosmic; 887218
DR   Wikidata; Q54584180
RX   PubMed=8100658;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 51 year old male patient with a gastric carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00108.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   295A5
AC   CVCL_B6VL
DR   Wikidata; Q111732672
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   295D2
AC   CVCL_B6VM
DR   Wikidata; Q111732673
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   296
AC   CVCL_J924
SY   Anti PDGF hybridoma #296
DR   ATCC; HB-9370
DR   Wikidata; Q54584183
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9370.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   296A10
AC   CVCL_B6VN
DR   Wikidata; Q111732674
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   296B11
AC   CVCL_B6VP
DR   Wikidata; Q111732675
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   296G2
AC   CVCL_B6VQ
DR   Wikidata; Q111732676
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   296H8
AC   CVCL_B6VR
DR   Wikidata; Q111732677
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   296H9
AC   CVCL_B6VS
DR   Wikidata; Q111732678
RX   DOI=10.15407/ubj91.03.090;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   297-17
AC   CVCL_A7YH
DR   BEI_Resources; MRA-455
DR   Wikidata; Q107113207
RX   PubMed=10816526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Plasmodium sp. thrombospondin-related anonymous protein (TRAP) (Note=Immunized with a synthetic peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T277 ! MOPC-21
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   2974
AC   CVCL_C3QC
DR   Wikidata; Q116047977
RX   PubMed=7374661;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   297A1
AC   CVCL_DP73
AS   CVCL_UP43
SY   1503-4f1; HPS0057
DR   GEO; GSM1040266
DR   GEO; GSM1040336
DR   RCB; HPS0057
DR   Wikidata; Q93303940
RX   PubMed=19956543;
RX   PubMed=22056147;
RX   PubMed=24259714;
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3XV ! HDF1503
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   297F1
AC   CVCL_DP71
SY   1392-4f2; HPS0058
DR   GEO; GSM1040264
DR   GEO; GSM1040334
DR   RCB; HPS0058
DR   Wikidata; Q54581764
RX   PubMed=19956543;
RX   PubMed=22056147;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3XW ! HDF1392
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   297L1
AC   CVCL_A3XU
SY   NHDF-iPS
DR   Wikidata; Q105505897
RX   PubMed=19956543;
RX   PubMed=22056147;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   29a
AC   CVCL_8999
AS   CVCL_B520
SY   29A; A29a; 29a-ALS; iPS29A
DR   SKIP; SKIP004437
DR   Wikidata; Q54584269
RX   PubMed=18669821;
RX   PubMed=21293464;
RX   PubMed=21368825;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (PubMed=21293464).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9000 ! 29b
OI   CVCL_B522 ! 29c
OI   CVCL_9001 ! 29d
OI   CVCL_9002 ! 29e
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   29A9
AC   CVCL_A0UN
DR   CCRID; 4201PAT-CCTCC01292
DR   Wikidata; Q108819504
RX   Patent=CN109652382A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018181.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   29b
AC   CVCL_9000
AS   CVCL_B521
SY   29B; A29b; 29b-ALS
DR   SKIP; SKIP004436
DR   Wikidata; Q54584271
RX   PubMed=18669821;
RX   PubMed=21293464;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (PubMed=21293464).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8999 ! 29a
OI   CVCL_B522 ! 29c
OI   CVCL_9001 ! 29d
OI   CVCL_9002 ! 29e
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   29c
AC   CVCL_B522
SY   A29c; 29c-ALS
DR   SKIP; SKIP004435
DR   Wikidata; Q54584272
RX   PubMed=18669821;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (PubMed=18669821).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8999 ! 29a
OI   CVCL_9000 ! 29b
OI   CVCL_9001 ! 29d
OI   CVCL_9002 ! 29e
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   29d
AC   CVCL_9001
SY   29d-ALS; HVRDi009-B; HVRDi013-A
DR   hPSCreg; HVRDi009-B
DR   SKIP; SKIP004434
DR   Wikidata; Q54584275
RX   PubMed=21293464;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (PubMed=21293464).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8999 ! 29a
OI   CVCL_9000 ! 29b
OI   CVCL_B522 ! 29c
OI   CVCL_9002 ! 29e
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   29e
AC   CVCL_9002
SY   29e-ALS; iPS29e; 29e SOD1 L144F; HVRDi009-A
DR   BioSamples; SAMEA13190950
DR   hPSCreg; HVRDi009-A
DR   SKIP; SKIP004433
DR   Wikidata; Q54584277
RX   PubMed=21293464;
RX   PubMed=21368825;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (PubMed=21293464).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8999 ! 29a
OI   CVCL_9000 ! 29b
OI   CVCL_B522 ! 29c
OI   CVCL_9001 ! 29d
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   29E1
AC   CVCL_A0JG
DR   Wikidata; Q108819505
RX   PubMed=1283092;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2A
AC   CVCL_6353
DR   CLO; CLO_0001236
DR   ATCC; CRL-12013
DR   BioSample; SAMN03471344
DR   Wikidata; Q54584279
RX   Patent=US5591624;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12013.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-12013; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-12013
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   2A1 [Mouse hybridoma against chicken retinal antigen]
AC   CVCL_1930
DR   CLO; CLO_0001237
DR   DSMZ; ACC-281
DR   DSMZCellDive; ACC-281
DR   Wikidata; Q54584281
RX   PubMed=2401203;
CC   Doubling time: ~25 hours (DSMZ=ACC-281).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chicken retinal membrane-associated cytoskeletal 2A1 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   2A1 [Mouse hybridoma against T.kirilowii trichosanthin]
AC   CVCL_C6K2
DR   ABCD; ABCD_AF114
DR   Wikidata; Q116047978
RX   PubMed=8958042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09989; Trichosanthes kirilowii ribosome-inactivating protein alpha-trichosanthin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2A1-H7
AC   CVCL_LI40
DR   Wikidata; Q54584283
RX   PubMed=2161859;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human laminin-binding protein complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   2A10 [Mouse hybridoma against P.falciparum csp]
AC   CVCL_A7VJ
DR   BEI_Resources; MRA-183
DR   Wikidata; Q107113208
RX   PubMed=6189951;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   2A10 [Mouse hybridoma against rotavirus B VP7]
AC   CVCL_D3F8
DR   Wikidata; Q127378695
RX   PubMed=24555935;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; Q80JH1; Human group B rotavirus (strain WH-2) outer capsid glycoprotein VP7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   2A10.1.1
AC   CVCL_U723
SY   anti-FcRH1-2A10
DR   Wikidata; Q54584284
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6333.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96LA6; Human FCRL1/CD307a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   2A11
AC   CVCL_J625
DR   CLO; CLO_0001238
DR   ATCC; CRL-2442
DR   Wikidata; Q54584287
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   2A12
AC   CVCL_F0C7
RX   PubMed=37074339;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2A1H1D1D4
AC   CVCL_WZ81
DR   Wikidata; Q93303999
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   2A2 [Mouse hybridoma against E.coli radA]
AC   CVCL_C5CN
DR   Wikidata; Q116047979
RX   PubMed=22316482;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P24554; Escherichia coli radA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2A2 [Mouse hybridoma against human PSCA]
AC   CVCL_B0TP
DR   Wikidata; Q108819506
RX   Patent=US8524460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12613.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   2A2 [Pig bone marrow]
AC   CVCL_C7HM
SY   2A2 ut; 2A2HLA G1.2
DR   ABM; T0856
DR   Wikidata; Q123030247
RX   PubMed=9317166;
RX   PubMed=11208191;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: Miniature boar (a/a haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   2A2 HLA-A2
AC   CVCL_C7HN
DR   Wikidata; Q123030248
RX   PubMed=9317166;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: Miniature boar (a/a haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C7HM ! 2A2 [Pig bone marrow]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   2A2 HLA-B27
AC   CVCL_C7HP
DR   Wikidata; Q123030249
RX   PubMed=9317166;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*27).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: Miniature boar (a/a haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C7HM ! 2A2 [Pig bone marrow]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   2A2 HLA-Cw3
AC   CVCL_C7HQ
DR   Wikidata; Q123030250
RX   PubMed=9317166;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4933; HLA-C (Note=Allele C*03).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: Miniature boar (a/a haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C7HM ! 2A2 [Pig bone marrow]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   2A2.16.7
AC   CVCL_B0EA
SY   2A2
DR   Wikidata; Q108819507
RX   Patent=US7744881;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3360.
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2A2(PGM1) Clone A6
AC   CVCL_U072
DR   ECACC; 02043024
DR   Wikidata; Q54584290
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36871; Human PGM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   2A2-6E10-1D8
AC   CVCL_J626
SY   1D8
DR   CLO; CLO_0001239
DR   ATCC; HB-12465
DR   Wikidata; Q54584289
RX   Patent=US5861241;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12465.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Norwalk virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   2A3 [Mouse hybridoma against human IL37]
AC   CVCL_B6C0
DR   Wikidata; Q111732679
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   2A3 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ82
DR   Wikidata; Q93304018
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   2A3 [Mouse hybridoma against ZEBOV GP]
AC   CVCL_E8PP
RX   PubMed=32004438;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q05320; Zaire ebolavirus (strain Mayinga-76) GP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2A3A1H
AC   CVCL_J627
SY   2A3
DR   CLO; CLO_0001240
DR   ATCC; HB-8555
DR   Wikidata; Q54584294
RX   Patent=US4845198;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8555.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   2A4 [Mouse hybridoma against human CXCR1]
AC   CVCL_F1WJ
RX   Patent=US5440021;
RX   Patent=US20070065441;
RX   PubMed=9356984;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11377.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25024; Human CXCR1/CD181.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2A4 [Mouse hybridoma against human GYPA]
AC   CVCL_E8P3
RX   PubMed=31486711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   2A5 [Mouse hybridoma against hepatitis C virus NS3]
AC   CVCL_E8I0
RX   PubMed=29267148;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9WMX2; Hepatitis C virus genotype 1b (isolate Con1) (HCV) genome polyprotein (Note=AA=1027-1657 = serine protease/helicase NS3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2A5 [Mouse hybridoma against human GRN]
AC   CVCL_X853
DR   Wikidata; Q54584295
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5589.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   2A5 [Mouse hybridoma against human HFE]
AC   CVCL_D143
AS   CVCL_D144
DR   CLO; CLO_0001241
DR   ATCC; CRL-2444
DR   BCRJ; 0010
DR   Wikidata; Q54584297
RX   PubMed=10022372;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   2A5 [Mouse hybridoma against human IL1RL1]
AC   CVCL_A0GM
DR   Wikidata; Q108819508
RX   Patent=US7087396;
RX   PubMed=10868795;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10189.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2A5 [Mouse hybridoma against human TIMP1]
AC   CVCL_XG94
DR   Wikidata; Q93304036
RX   PubMed=9824606;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01033; Human TIMP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   2A5 [Mouse hybridoma against SVA VP3]
AC   CVCL_B5YS
DR   Wikidata; Q111732680
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 435-673 = Capsid protein VP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   2A6 [Mouse hybridoma against chicken IL7R]
AC   CVCL_C4JS
DR   Wikidata; Q116047980
RX   PubMed=35973349;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A1EA95; Chicken IL7R/CD127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2A6 [Mouse hybridoma against hepatitis C virus NS3]
AC   CVCL_E8I1
RX   PubMed=29267148;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9WMX2; Hepatitis C virus genotype 1b (isolate Con1) (HCV) genome polyprotein (Note=AA=1027-1657 = serine protease/helicase NS3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2A6 [Mouse hybridoma against human RBP4]
AC   CVCL_YA20
DR   CCRID; 4201PAT-CCTCC00210
DR   Wikidata; Q93304038
RX   Patent=CN101294956B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200641.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02753; Human RBP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   2A8 [Mouse hybridoma against phthalate]
AC   CVCL_D5KW
DR   Wikidata; Q127378696
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   2A8 [Mouse hybridoma against saikosaponin A]
AC   CVCL_B6G5
DR   Wikidata; Q111732681
RX   PubMed=14709901;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   2A81G5
AC   CVCL_B0V8
DR   Wikidata; Q108819509
RX   PubMed=8910359;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA (Note=The antibody binds to the chelated Cd++ metal ion).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   2A9 [Mouse hybridoma against human MBL2]
AC   CVCL_B0JX
DR   Wikidata; Q108819510
RX   Patent=WO2000035483A1;
RX   PubMed=10793066;
RX   PubMed=11991814;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12620.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11226; Human MBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   2A9 [Mouse hybridoma against TMUV NS1]
AC   CVCL_E2Z1
RX   PubMed=26871513;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A075M1D2; Tembusu virus (strain SDLC) genome polyprotein (AA 791-1140 = Non-structural protein NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2AC7
AC   CVCL_D1FI
DR   Wikidata; Q127378697
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z067 ! Sp2ab
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   2B11-1F3
AC   CVCL_C3MX
SY   2B11 1F3
DR   Wikidata; Q116047981
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   2B11E6G4
AC   CVCL_XH54
DR   Wikidata; Q93304040
RX   Patent=US9611320;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4375.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01350; Human GAST.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   2B12 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1F6
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2B12 [Mouse hybridoma against deltamethrin]
AC   CVCL_C5NW
DR   Wikidata; Q116047982
RX   PubMed=20593827;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_4388; Deltamethrin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 4
//
ID   2B12-B3
AC   CVCL_E8US
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2B12B6
AC   CVCL_A0UY
DR   Wikidata; Q108819511
RX   Patent=CN107299085B;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2B2 [Mouse hybridoma against human GOLM1]
AC   CVCL_E2ZT
RX   PubMed=27088654;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2B2 [Mouse hybridoma against phOX]
AC   CVCL_C4F3
DR   ABCD; ABCD_AE282
DR   Wikidata; Q116047983
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   2B2-2A7
AC   CVCL_E5NL
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2B2F1E6G3
AC   CVCL_WZ83
DR   Wikidata; Q93304042
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   2B4 [Mouse hybridoma against asiaticoside]
AC   CVCL_B6ME
DR   Wikidata; Q111732682
RX   PubMed=21180694;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_79928; Asiaticoside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   2B4 [Mouse hybridoma against human CD275]
AC   CVCL_E2Z8
RX   PubMed=21851236;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2B4 [Mouse T-cell hybridoma]
AC   CVCL_4Z38
SY   2B4-T; 2B4 T
DR   BTO; BTO_0005682
DR   Wikidata; Q54584299
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 6
//
ID   2B4C8C8
AC   CVCL_XH53
DR   Wikidata; Q93304050
RX   Patent=US9611320;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4374.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01350; Human GAST.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   2B5
AC   CVCL_J448
SY   2B5-G4-F4
DR   CLO; CLO_0001243
DR   ATCC; HB-8963
DR   Wikidata; Q54584301
RX   Patent=US4908431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8963.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01042; Human KNG1 (Note=AA 19-380 = Kininogen heavy chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   2B5.3
AC   CVCL_J450
DR   CLO; CLO_0001244
DR   ATCC; CRL-1960
DR   Wikidata; Q54584304
RX   PubMed=2592009;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Giardia muris trophozoite surface antigens of 31 kDa and 35 kDa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   2B5.F8
AC   CVCL_C4QK
DR   Wikidata; Q116047984
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00004; Horse CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2B6 [Mouse hybridoma against BoHV-1 gD]
AC   CVCL_E8YC
RX   PubMed=29267149;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P0CK29; Bovine herpesvirus 1.1 (strain P8-2) gD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2B6 [Mouse/rat hybridoma against human IL12RB2]
AC   CVCL_DC13
DR   Wikidata; Q54584305
RX   PubMed=10201911;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99665; Human IL12RB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 6
//
ID   2B6H2
AC   CVCL_C6M7
DR   Wikidata; Q116047985
RX   Patent=CN114773456B;
RX   PubMed=36445388;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O64255; Mycobacterium phage D29 Gp63 (Note=AA 45-78 = PK34).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   2B7
AC   CVCL_J451
DR   CLO; CLO_0001245
DR   ATCC; CRL-2443
DR   Wikidata; Q54584308
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   2B7-7
AC   CVCL_C6XL
DR   ABCD; ABCD_AN721
DR   ABCD; ABCD_AN722
DR   ABCD; ABCD_AN723
DR   Wikidata; Q123030251
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   2B8 [Human Burkitt lymphoma]
AC   CVCL_6354
DR   CLO; CLO_0001246
DR   ATCC; CRL-12569
DR   cancercelllines; CVCL_6354
DR   Cell_Model_Passport; SIDM01262
DR   LINCS_LDP; LCL-2015
DR   Wikidata; Q54584309
RX   Patent=US6136599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12569.
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-12569; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W740 ! HH514-16
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 31
//
ID   2B8 [Mouse hybridoma against human GLRX3]
AC   CVCL_E7CV
RX   PubMed=27923109;
RX   PubMed=28029331;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O76003; Human GLRX3 (Note=Also reacts with mouse, rat, Chinese hamster, and zebrafish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2B8 [Mouse hybridoma against human MS4A1]
AC   CVCL_KR60
SY   IDEC-2B8
DR   Wikidata; Q54584310
RX   Patent=US5736137;
RX   PubMed=7506951;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11388.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized rituximab (IDEC-C2B8) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6450 ! Sp2/01-Ag
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 6
//
ID   2B8 [Mouse hybridoma against mouse Bub1]
AC   CVCL_C5MH
DR   Wikidata; Q116047986
RX   PubMed=17600495;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O08901; Mouse Bub1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2B8 [Mouse/rat hybridoma against mouse Kit]
AC   CVCL_E5K6
RX   PubMed=1371359;
WW   Provider; Stanford OTL; S92-096; https://stanford.resoluteinnovation.com/technologies/S92-096_3c1-and-2b8-hybridomas-secreting-a
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P05532; Mouse Kit/Cd117.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2B8-2F10
AC   CVCL_E5NW
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2B9
AC   CVCL_C4AA
DR   Wikidata; Q116047987
RX   PubMed=30763351;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fibrin D-dimer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2BBLC403.4
AC   CVCL_C5X7
DR   Wikidata; Q116047988
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2BBLC803.1
AC   CVCL_C5X8
DR   ABCD; ABCD_AE625
DR   Wikidata; Q116047989
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2BBLC811.2
AC   CVCL_C5X9
DR   Wikidata; Q116047990
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2BBLC817.4
AC   CVCL_C5XA
DR   Wikidata; Q116047991
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2BBLC854.5
AC   CVCL_C5XB
DR   Wikidata; Q116047992
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2BD2
AC   CVCL_B7HN
DR   Wikidata; Q112926932
RX   DOI=10.1080/09712119.2002.9706389;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   2BD4E4 K99
AC   CVCL_4479
SY   2 BD4 E4 K99; 2BD4E4
DR   CLO; CLO_0001173
DR   CLO; CLO_0001247
DR   CLDB; cl5027
DR   ATCC; HB-8178
DR   IZSLER; BS Hy 34
DR   Wikidata; Q54584314
RX   Patent=US4443549;
RX   PubMed=18592539;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8178.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fimbrial protein (fanC).
CC   Misspelling: HB8178; PubMed=18592539; Note=Based on the ATCC catalog number.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   2BG2
AC   CVCL_B7HP
DR   Wikidata; Q112926934
RX   DOI=10.1080/09712119.2002.9706389;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   2BI
AC   CVCL_WX41
SY   2 BIrmingham
DR   Wikidata; Q93304104
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=157803;
RX   PubMed=837385;
RX   PubMed=1196376;
RX   PubMed=1214825;
RX   PubMed=7360141;
RX   PubMed=7471106;
RX   PubMed=11219864;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   2BN
AC   CVCL_8087
DR   BTO; BTO_0004321
DR   Wikidata; Q54584316
RX   PubMed=12604777;
RX   PubMed=19056826;
CC   Sequence variation: Mutation; HGNC; HGNC:25737; NHEJ1; Simple; p.Glu5Glyfs*43 (c.11dupT) (ins11T); ClinVar=VCV000000985; Zygosity=Homozygous (PubMed=19056826).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162695; Severe combined immunodeficiency due to NHEJ1 deficiency
DI   ORDO; Orphanet_169079; Cernunnos-XLF deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   2BNhTERT
AC   CVCL_8089
SY   2BN hTERT; 2BNhT
DR   BTO; BTO_0004323
DR   Wikidata; Q54584319
RX   PubMed=12604777;
RX   PubMed=19056826;
CC   Sequence variation: Mutation; HGNC; HGNC:25737; NHEJ1; Simple; p.Glu5Glyfs*43 (c.11dupT) (ins11T); ClinVar=VCV000000985; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162695; Severe combined immunodeficiency due to NHEJ1 deficiency
DI   ORDO; Orphanet_169079; Cernunnos-XLF deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8087 ! 2BN
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   2BNneo
AC   CVCL_8088
DR   BTO; BTO_0004322
DR   Wikidata; Q54584320
RX   PubMed=12604777;
CC   Senescence: SV40-transformed but with a finite life span.
CC   Sequence variation: Mutation; HGNC; HGNC:25737; NHEJ1; Simple; p.Glu5Glyfs*43 (c.11dupT) (ins11T); ClinVar=VCV000000985; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162695; Severe combined immunodeficiency due to NHEJ1 deficiency
DI   ORDO; Orphanet_169079; Cernunnos-XLF deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8087 ! 2BN
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   2BS
AC   CVCL_BT02
DR   EFO; EFO_0022632
DR   CCRID; 4201HUM-CCTCC00303
DR   CCTCC; GDC0303
DR   KCB; KCB 93016YJ
DR   Wikidata; Q54584312
RX   PubMed=3769747;
RX   PubMed=7564558;
RX   PubMed=8028398;
RX   PubMed=15265694;
RX   PubMed=26116706;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): CCRID=4201HUM-CCTCC00303; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 20,21
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 14,17 (CCRID=4201HUM-CCTCC00303)
ST   D18S51: 15,17 (PubMed=26116706)
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11 (CCRID=4201HUM-CCTCC00303)
ST   D5S818: 12,13 (PubMed=26116706)
ST   D6S1043: 13,14
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 19,22
ST   Penta D: 11,13
ST   Penta E: 7,11 (CCRID=4201HUM-CCTCC00303)
ST   Penta E: 14 (PubMed=26116706)
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 11
//
ID   2C012
AC   CVCL_F332
DR   CLO; CLO_0051076
DR   RCB; HSC0044
DR   Wikidata; Q54584322
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C067
AC   CVCL_F333
DR   CLO; CLO_0051340
DR   RCB; HSC0139
DR   Wikidata; Q54584323
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C076
AC   CVCL_F334
DR   CLO; CLO_0051341
DR   RCB; HSC0141
DR   Wikidata; Q54584326
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C087
AC   CVCL_F335
DR   CLO; CLO_0051170
DR   RCB; HSC0134
DR   Wikidata; Q54584328
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C088
AC   CVCL_F336
DR   CLO; CLO_0051169
DR   RCB; HSC0133
DR   Wikidata; Q54584330
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C089
AC   CVCL_F337
DR   CLO; CLO_0051131
DR   RCB; HSC0041
DR   Wikidata; Q54584331
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C090
AC   CVCL_F338
DR   CLO; CLO_0051123
DR   RCB; HSC0097
DR   Wikidata; Q54584333
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C092
AC   CVCL_F339
DR   CLO; CLO_0051068
DR   RCB; HSC0033
DR   Wikidata; Q54584336
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C1
AC   CVCL_C5NX
DR   Wikidata; Q116047993
RX   PubMed=20593827;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_4388; Deltamethrin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2C10 [Mouse hybridoma against dsDNA]
AC   CVCL_E6K4
DR   ABCD; ABCD_BD779
RX   PubMed=8626460;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C10 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QR
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C100
AC   CVCL_F340
DR   CLO; CLO_0051152
DR   RCB; HSC0046
DR   Wikidata; Q54584337
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American and Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C101
AC   CVCL_F341
DR   CLO; CLO_0051071
DR   RCB; HSC0036
DR   Wikidata; Q54584340
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C11-4
AC   CVCL_C6XM
DR   ABCD; ABCD_AN724
DR   ABCD; ABCD_AN725
DR   Wikidata; Q123030252
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   2C114
AC   CVCL_F342
DR   CLO; CLO_0051069
DR   RCB; HSC0034
DR   Wikidata; Q54584341
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C116
AC   CVCL_F343
DR   CLO; CLO_0051336
DR   RCB; HSC0061
DR   Wikidata; Q54584342
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C118
AC   CVCL_F344
DR   CLO; CLO_0051091
DR   RCB; HSC0062
DR   Wikidata; Q54584417
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C12
AC   CVCL_C5NP
DR   Wikidata; Q116047994
RX   DOI=10.1016/j.foodchem.2010.11.088;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2C122
AC   CVCL_F345
DR   CLO; CLO_0051102
DR   RCB; HSC0075
DR   Wikidata; Q54584418
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C123
AC   CVCL_F346
DR   CLO; CLO_0051100
DR   RCB; HSC0073
DR   Wikidata; Q54584419
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   2C1H7
AC   CVCL_J452
DR   CLO; CLO_0001248
DR   ATCC; CRL-2746
DR   Wikidata; Q54584420
RX   Patent=US6306615;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2686.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human beta-tubulins.
CC   Caution: ATCC indicates PTA-2846 as a synonym, but this is probably a misnomer as it corresponds to another patented hybridoma (ATCC=CRL-2746).
CC   Discontinued: ATCC; CRL-2746; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   2C2 [Mouse hybridoma against JEV NS2B3p]
AC   CVCL_F0HF
RX   PubMed=33625288;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Japanese encephalitis virus (JEV) NS2B3p.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2C2 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MK
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   2C2-2C5
AC   CVCL_E5ND
RX   Patent=US9879087;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C3 [Mouse hybridoma against human MMP9]
AC   CVCL_XG95
DR   Wikidata; Q93304258
RX   PubMed=9771478;
RX   PubMed=9824606;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14780; Human MMP9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   2C3 [Mouse hybridoma against human VEGFA]
AC   CVCL_DE32
DR   ATCC; CRL-13018
DR   Wikidata; Q54584422
RX   Patent=US6524583;
RX   PubMed=9581838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1595.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15692; Human VEGFA.
CC   Discontinued: ATCC; CRL-13018; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 8
//
ID   2C3C5
AC   CVCL_B6MB
DR   Wikidata; Q111732683
RX   PubMed=9581524;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8822; Retrorsine (Note=Also recognizes many other pyrrolizidine alkaloids).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   2C4 [Human fibrosarcoma]
AC   CVCL_1D50
DR   cancercelllines; CVCL_1D50
DR   CancerTools; 154235
DR   Wikidata; Q54584423
DR   Ximbio; 154235
RX   PubMed=7901766;
RX   PubMed=9001223;
CC   Population: Caucasian.
CC   Characteristics: Expression of CD2 is under the control of the IFITM1 promoter inducible by interferon gamma.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1639; CD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 20
//
ID   2C4 [Mouse hybridoma against 2,4-D/2,4-DP]
AC   CVCL_B6GS
DR   ABCD; ABCD_AJ799
DR   Wikidata; Q111732684
RX   Patent=JP2005023015A;
RX   PubMed=19002932;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16738; 2,4-dichlorophenol (2,4-DP).
CC   Monoclonal antibody target: ChEBI; CHEBI_28854; 2,4-dichlorophenoxyacetic acid (2,4-D).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   2C4 [Mouse hybridoma against human ERBB2]
AC   CVCL_B0EI
SY   2c4
DR   ATCC; HB-12697
DR   Wikidata; Q108819512
RX   Patent=US10280228;
RX   PubMed=1689212;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12697.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2C4 [Mouse hybridoma against rabbit RLA-DQ]
AC   CVCL_7236
DR   CLO; CLO_0001249
DR   ATCC; CRL-1760
DR   Wikidata; Q54584424
RX   PubMed=6197360;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Rabbit RLA-DQ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   2C4 gamma1A
AC   CVCL_C0D3
SY   gamma1A
DR   cancercelllines; CVCL_C0D3
DR   Wikidata; Q112926935
RX   PubMed=7901766;
RX   PubMed=9001223;
CC   Population: Caucasian.
CC   Characteristics: Retain a normal IFN-alpha/beta response but is completely defective in the IFN-gamma response (PubMed=9001223).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5440; IFNGR2; Simple; p.Thr299Aspfs*16 (c.897dupT); Zygosity=Homozygous (PubMed=9001223).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1639; CD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D50 ! 2C4 [Human fibrosarcoma]
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   2C4 gamma1A/JAK2
AC   CVCL_1D51
SY   Gamma1A Jak2; Gamma1A/JAK2
DR   cancercelllines; CVCL_1D51
DR   Wikidata; Q54584425
RX   PubMed=7901766;
RX   PubMed=9001223;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5440; IFNGR2; Simple; p.Thr299Aspfs*16 (c.897dupT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1639; CD2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96629; Jak2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0D3 ! 2C4 gamma1A
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   2C4 gamma2A
AC   CVCL_C0D4
SY   gamma2A
DR   EFO; EFO_0022516
DR   cancercelllines; CVCL_C0D4
DR   CancerTools; 154234
DR   Wikidata; Q112926936
DR   Ximbio; 154234
RX   PubMed=9001223;
CC   Population: Caucasian.
CC   Characteristics: Retain a normal IFN-alpha/beta response but is completely defective in the IFN-gamma response (PubMed=9001223).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1639; CD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D50 ! 2C4 [Human fibrosarcoma]
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   2C4 gamma2A/JAK2
AC   CVCL_C0D5
SY   Gamma2A Jak2; Gamma2A/JAK2
DR   cancercelllines; CVCL_C0D5
DR   CancerTools; 151681
DR   Wikidata; Q112926938
DR   Ximbio; 151681
RX   PubMed=9001223;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1639; CD2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96629; Jak2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0D4 ! 2C4 gamma2A
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   2C4C2
AC   CVCL_C4G8
DR   Wikidata; Q116047995
RX   PubMed=7686561;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2C4D1
AC   CVCL_C4G9
DR   Wikidata; Q116047996
RX   PubMed=7686561;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2C5 [Mouse hybridoma against C.perfringens pfo]
AC   CVCL_E4R2
RX   DOI=10.1007/BF01577135;
RX   PubMed=32891180;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   2C5 [Mouse hybridoma against FadV-4 hexon]
AC   CVCL_E9EC
RX   Patent=CN119101660A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.45829.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A142CQY2; Fowl aviadenovirus 4 (FAdV-4) hexon protein (Note=Recognizes p.Arg188 in the epitope 185-GPGRNP-190).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2C5 [Mouse hybridoma against human SPP1]
AC   CVCL_0H92
DR   Wikidata; Q54584427
RX   Patent=US8399207;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11447.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   2C5 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5S9
DR   ABCD; ABCD_AE975
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C5 [Mouse hybridoma against TMUV NS1]
AC   CVCL_E2Z2
RX   PubMed=26871513;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A075M1D2; Tembusu virus (strain SDLC) genome polyprotein (AA 791-1140 = Non-structural protein NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2C5-6
AC   CVCL_J628
DR   CLO; CLO_0001250
DR   ATCC; HB-8995
DR   Wikidata; Q54584429
RX   Patent=US4885256;
RX   PubMed=3162316;
RX   PubMed=10926660;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8995.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_16113; Cholesterol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   2C5D6
AC   CVCL_B0F6
DR   CCRID; 4201PAT-CCTCC01644
DR   Wikidata; Q108819513
RX   Patent=CN113151185B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202091.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O76093; Human FGF18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 4
//
ID   2C6 [Human fetal pancreas]
AC   CVCL_U825
DR   CLO; CLO_0050256
DR   FANTOM5_SSTAR; 10603-108E9
DR   RCB; RCB0794
DR   Wikidata; Q54584431
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
ST   Source(s): RCB=RCB0794
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U822 ! 1B2C6
OI   CVCL_U823 ! 1C3D3
OI   CVCL_U824 ! 1C3IKEI
SX   Sex unspecified
AG   19FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   2C6 [Mouse hybridoma against imazethapyr]
AC   CVCL_B5CV
DR   Wikidata; Q110429745
RX   Patent=EP1043336A2;
RX   PubMed=12033799;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_82022; Imazethapyr (Pursuit) (Note=Also recognizes imazamox and imazapic).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   2C6 [Mouse hybridoma against O.mossambicus IgM]
AC   CVCL_C4B6
DR   Wikidata; Q116047997
RX   Patent=CN106834235B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201644.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Oreochromis mossambicus IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   2C6-2F11
AC   CVCL_E5NK
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C6F3
AC   CVCL_C5D5
DR   ABCD; ABCD_AF651
DR   Wikidata; Q116047998
RX   Patent=US10259884;
RX   PubMed=27270318;
CC   Group: Patented cell line.
CC   Biotechnology: When conjugated to a radioisotope, the monoclonal antibody produced by this hybridoma can be used as a radio-immunoconjugate for the treatment of lung cancer models in mice (PubMed=27270318).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14907; Human TAX1BP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2C7 [Mouse hybridoma against human CA9]
AC   CVCL_C7I0
DR   Wikidata; Q123030253
RX   PubMed=34806527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16790; Human CA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   2C7 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K1
DR   ATCC; HB-12490
DR   Wikidata; Q108819514
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12490.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2C7 [Mouse hybridoma against N.gonorrhoease LOS]
AC   CVCL_B0E6
DR   Wikidata; Q108819515
RX   Patent=US6099839;
RX   PubMed=2428752;
RX   PubMed=10593954;
RX   PubMed=11878767;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11859.
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: Neisseria gonorrhoeae lipo-oligosaccharide (LOS) (Note=Binds to the inner 15253 LOS structure found within WG LOS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   2C7 [Mouse hybridoma against Pasteurellaceae 39-42 kDa OmpA-like]
AC   CVCL_E2SS
RX   PubMed=8454337;
RX   PubMed=9045839;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Pasteurellaceae 39-42 kDa OmpA-like major outer membrane protein (MOMP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2C7 [Mouse hybridoma against phOX]
AC   CVCL_C4F4
DR   Wikidata; Q116047999
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2C8 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5SA
DR   ABCD; ABCD_AE971
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C8 [Mouse hybridoma against SBV N]
AC   CVCL_B6C6
DR   Wikidata; Q111732685
RX   PubMed=23988909;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; H2AM13; Schmallenberg virus (SBV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   2C8G10D6F9
AC   CVCL_WZ84
DR   Wikidata; Q93304326
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   2C8H3
AC   CVCL_C4ZX
DR   Wikidata; Q116048000
RX   PubMed=11304405;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6LEG8; Glycine max calmodulin (SCaM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   2C9 [Mouse hybridoma against aflatoxin M1]
AC   CVCL_A0PF
SY   AFM20092C9
DR   CCRID; 4201PAT-CCTCC00339
DR   Wikidata; Q108819516
RX   DOI=10.1016/j.foodchem.2010.10.006;
RX   Patent=CN102220286B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201018.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_78576; Aflatoxin M1 (AFM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   2C9 [Mouse hybridoma against human FOLH1]
AC   CVCL_D3N5
DR   Wikidata; Q127378698
RX   CelloPub=CLPUB00753;
RX   PubMed=12887366;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   2C9 [Mouse hybridoma against human TFRC]
AC   CVCL_E7DH
RX   PubMed=28234554;
RX   PubMed=28234558;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C9 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MV
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2C9 [Mouse hybridoma against N.fowleri NfCPB]
AC   CVCL_B3MX
DR   Wikidata; Q110429746
RX   PubMed=28919331;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; X5D761; Naegleria fowleri cathepsin B (NfCPB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   2C9B10
AC   CVCL_A9KH
DR   Wikidata; Q108819517
RX   Patent=US9249216;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del; SNAP25(197)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   2CFSMEo-
AC   CVCL_IN60
DR   Wikidata; Q54584432
RX   PubMed=1375758;
WW   Info; Dartmouth; -; https://web.archive.org/web/20190126194809/http://www.dartmouth.edu/~cysfib/cell-lines.html
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln2Ter (c.4C>T); ClinVar=VCV000053980; Zygosity=Heterozygous (from autologous cell lines 6CFSMEo-; CFSMEo-).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from autologous cell lines 6CFSMEo-; CFSMEo-).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, submucosal gland; UBERON=UBERON_8410043.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP33 ! CFSMEo-
OI   CVCL_IN58 ! 3ACFSMEo-
OI   CVCL_IN62 ! 6CFSMEo-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 18
//
ID   2CFSMEo-/6REP-CFTR
AC   CVCL_B4IB
DR   Wikidata; Q110429747
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln2Ter (c.4C>T); ClinVar=VCV000053980; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1884; CFTR.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, submucosal gland; UBERON=UBERON_8410043.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IN60 ! 2CFSMEo-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   2D-7
AC   CVCL_J629
DR   CLO; CLO_0001254
DR   ATCC; HB-9667
DR   Wikidata; Q54584435
RX   Patent=US5196307;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9667.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07199; Human CENPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   2D/11C
AC   CVCL_C4PS
DR   Wikidata; Q116048001
RX   PubMed=16633832;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Schistosoma haematobium soluble egg antigen (SEA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2D1 [Mouse hybridoma against human IL37]
AC   CVCL_B6C1
DR   Wikidata; Q111732686
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   2D1 [Mouse hybridoma against human TcRv beta-8.1]
AC   CVCL_A0ET
DR   Wikidata; Q108819518
RX   Patent=US6171799;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9928.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human T-cell receptor variable beta-8.1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   2D1 [Mouse hybridoma against PEDV spike]
AC   CVCL_D5L6
DR   Wikidata; Q127378699
RX   PubMed=25723278;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; L0H610; Porcine epidemic diarrhea virus (strain CH/ZMDZY/11) spike glycoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   2D10 [Mouse hybridoma against GXM]
AC   CVCL_F1Y2
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2D10 [Mouse hybridoma against methyl-alpha-D-mannopyranoside]
AC   CVCL_C5E7
DR   ABCD; ABCD_AI429
DR   Wikidata; Q116048003
RX   PubMed=15585860;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_43943; Methyl alpha-D-mannoside (Methyl alpha-D-mannopyranoside).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2D10 [Mouse hybridoma against zearalenone]
AC   CVCL_C5NR
DR   Wikidata; Q116048004
RX   PubMed=24465616;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2D10 [Mouse/rat hybridoma against mouse Cd86]
AC   CVCL_9153
DR   CLO; CLO_0001251
DR   ATCC; CRL-2226
DR   Wikidata; Q54584437
RX   PubMed=7510738;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P42082; Mouse Cd86.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   2D11
AC   CVCL_B0KT
DR   CCRID; 4201PAT-CCTCC01328
DR   Wikidata; Q108819519
RX   Patent=CN111434686B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201912.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P40424; Human PBX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   2D12 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FE
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2D12 [Mouse hybridoma against canine distemper virus protein H]
AC   CVCL_A3CH
DR   CCRID; 4201PAT-CCTCC01623
DR   Wikidata; Q105505899
RX   Patent=CN111849923B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202062.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Canine distemper virus (isolate CDV851) hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 7
//
ID   2D12 [Mouse hybridoma against YFV envelope protein]
AC   CVCL_E975
DR   CLO; CLO_0001252
DR   ATCC; CRL-1689
DR   ECACC; 91051509
DR   Wikidata; Q54584439
RX   PubMed=6187129;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03314; Yellow fever virus (strain 17D vaccine) genome polyprotein (Note=Envelope protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   2D12 [Mouse hybridoma against M.rotundus protein]
AC   CVCL_B0UG
DR   Wikidata; Q108819520
RX   DOI=10.1046/j.1365-2761.2002.00372.x;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Myxobolus rotundus 91 kDa spore/trophozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2D1C11
AC   CVCL_XI67
DR   CCRID; 4201PAT-CCTCC00696
DR   Wikidata; Q93304366
RX   Patent=CN105017403B;
RX   Patent=CN105021825B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201564.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96EV8; Human DTNBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   2D3 [Mouse hybridoma against chicken TRIM62]
AC   CVCL_E8HS
RX   PubMed=29813003;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A8V0ZA67; Chicken TRIM62.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2D3 [Mouse hybridoma against human CHI3L2]
AC   CVCL_C5CL
DR   Wikidata; Q116048005
RX   PubMed=22316483;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15782; Human CHI3L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2D3 [Mouse hybridoma against phthalate]
AC   CVCL_D5KZ
DR   Wikidata; Q127378700
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   2D3 [Mouse hybridoma against zearalenone]
AC   CVCL_C5NS
DR   Wikidata; Q116048006
RX   PubMed=24465616;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2D3B5
AC   CVCL_B6MC
DR   Wikidata; Q111732687
RX   PubMed=9581524;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8822; Retrorsine (Note=Also recognizes many other pyrrolizidine alkaloids).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   2D4 [Mouse hybridoma against C.perfringens pfo]
AC   CVCL_E4QY
RX   DOI=10.1007/BF01577135;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   2D4 [Mouse hybridoma against ganglioside GM2]
AC   CVCL_G090
DR   CLO; CLO_0001253
DR   ATCC; TIB-185
DR   Wikidata; Q54584440
RX   PubMed=512581;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27731; Asialo-GM2 ganglioside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   2D4 [Mouse hybridoma against goose parvovirus NS1]
AC   CVCL_C5CF
DR   Wikidata; Q116048007
RX   PubMed=22509917;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; I1VWH1; Goose parvovirus non-structural protein 1 (NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2D4 [Mouse hybridoma against HPV18 E7]
AC   CVCL_B0UL
DR   CCRID; 4201PAT-CCTCC00441
DR   Wikidata; Q108819521
RX   Patent=CN103865883A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201402.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06788; Human papillomavirus type 18 protein E7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2D4 [Mouse hybridoma against human CD86]
AC   CVCL_E5KC
RX   Patent=US7510844;
RX   Patent=US8378082;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7305.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42081; Human CD86.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2D4 [Mouse hybridoma against P.falciparum csp]
AC   CVCL_A7VQ
DR   Wikidata; Q107113210
RX   PubMed=31548526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   2D4 iPS
AC   CVCL_IT48
SY   2D4-iPS
DR   GEO; GSM344763
DR   GEO; GSM344764
DR   PRIDE; PXD000589
DR   Wikidata; Q54584441
RX   PubMed=18371336;
RX   PubMed=25894527;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_IT49 ! 1D4 iPS
SX   Female
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   2D5 [Mouse hybridoma against goose parvovirus VP3]
AC   CVCL_RY65
DR   Wikidata; Q54584442
RX   PubMed=23176172;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; C8CE61; Goose parvovirus (strain Ep22) protein VP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 5
//
ID   2D5 [Mouse hybridoma against human SKI]
AC   CVCL_C5EI
DR   Wikidata; Q116048008
RX   PubMed=21851241;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12755; Human SKI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2D5 [Mouse hybridoma against suid herpesvirus 1 UL42]
AC   CVCL_C6I8
DR   ABCD; ABCD_AV470
DR   Wikidata; Q116048009
RX   PubMed=26377421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F6QNH2; Suid herpesvirus 1 (strain JF) DNA polymerase processivity factor (UL42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2D6
AC   CVCL_B3MY
DR   Wikidata; Q110429748
RX   PubMed=28919331;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; X5D761; Naegleria fowleri cathepsin B (NfCPB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   2D6F9
AC   CVCL_C5D3
DR   ABCD; ABCD_AF650
DR   Wikidata; Q116048011
RX   Patent=US10259884;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11021; Human HSPA5/GRP78.
CC   Misspelling: 2B6F9; Patent=US10259884; Note=Many occurences.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   2D7
AC   CVCL_C7I1
DR   Wikidata; Q123030254
RX   PubMed=34806527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16790; Human CA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   2D7.20
AC   CVCL_A6RF
DR   Wikidata; Q107113211
RX   Patent=US5571714;
RX   PubMed=2537357;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   2D7F10
AC   CVCL_G593
SY   2D7
DR   CLO; CLO_0001255
DR   ATCC; CRL-2025
DR   Wikidata; Q54584444
RX   PubMed=1305402;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Leptospira interrogans serovar Kennewicki.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   2D8 [Mouse hybridoma against human SORT1]
AC   CVCL_E2ZV
RX   PubMed=26683178;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q99523; Human SORT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2D8 [Mouse hybridoma against T.tridentatus TP-1]
AC   CVCL_C5EL
DR   Wikidata; Q116048012
RX   PubMed=21851235;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14213; Tachypleus tridentatus tachyplesin-1 (TP-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   2D8F9H12
AC   CVCL_WZ68
DR   CCRID; 4201PAT-CCTCC00376
DR   Wikidata; Q93304398
RX   Patent=CN102010470B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201057.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02462; Human COL4A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   2D9 [Human glioblastoma]
AC   CVCL_7892
DR   Wikidata; Q54584445
RX   PubMed=8288893;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=2D9
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7259 ! 86HG39
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   2D9 [Mouse hybridoma against H.hepaticus cdtB]
AC   CVCL_B3RJ
DR   CCRID; 4201PAT-CCTCC01899
DR   Wikidata; Q110429749
RX   Patent=CN113462654B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021140.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7VG76; Helicobacter hepaticus cdtB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   2D9 [Mouse hybridoma against HAstV-8 VP25]
AC   CVCL_C5NJ
DR   ABCD; ABCD_AW888
DR   Wikidata; Q116048013
RX   Patent=US20200392578;
RX   PubMed=30355681;
RX   PubMed=31233538;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9IFX1; Human astrovirus-8 (strain Yuc8) (HAstV-8) capsid protein VP90 (Note=AA 424-648 = Capsid protein VP25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   2D9 [Mouse hybridoma against human SAT1]
AC   CVCL_E6JP
RX   PubMed=27228136;
RX   PubMed=27328064;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21673; Human SAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2D9 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA01
DR   Wikidata; Q93304412
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9396.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   2D9 [Mouse hybridoma against RHDV VP1]
AC   CVCL_E8H4
DR   ABCD; ABCD_BF009
RX   PubMed=28247488;
RX   PubMed=28941616;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; I7FLU3; Rabbit hemorrhagic disease virus (RHDV) VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2DD
AC   CVCL_ZS98
DR   Wikidata; Q98125379
RX   PubMed=8505362;
RX   PubMed=15130666;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   2DE12-AE6
AC   CVCL_B0W2
SY   2E6
DR   Wikidata; Q108819522
RX   Patent=KR101782862B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); KCTC 13002BP.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; K0BVN3; Human betacoronavirus 2c (isolate EMC/2012) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   2DE9-BC1
AC   CVCL_B0W3
SY   2C1
DR   Wikidata; Q108819523
RX   Patent=KR101782862B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); KCTC 13003BP.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; K0BVN3; Human betacoronavirus 2c (isolate EMC/2012) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   2DNA1D7
AC   CVCL_XF89
DR   Wikidata; Q93304415
RX   PubMed=17260001;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Differentiates at the restrictive temperature of 37 Celsius.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Podocyte; CL=CL_0000653.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   2E.6
AC   CVCL_9154
DR   CLO; CLO_0001256
DR   ATCC; HB-128
DR   Wikidata; Q54584446
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   2E1 [Mouse hybridoma against human AURKA]
AC   CVCL_A7FA
DR   Wikidata; Q107113212
RX   PubMed=18707550;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14965; Human AURKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   2E1 [Mouse hybridoma against SVA VP1]
AC   CVCL_B5YT
DR   Wikidata; Q111732688
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   2E10-H2
AC   CVCL_1931
DR   CLO; CLO_0001257
DR   CLDB; cl50
DR   ATCC; CRL-1812
DR   DSMZ; ACC-178
DR   DSMZCellDive; ACC-178
DR   Wikidata; Q54584448
RX   PubMed=3281371;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Canine adenovirus serotype 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   2E10.2
AC   CVCL_A7VT
DR   BEI_Resources; MRA-185
DR   Wikidata; Q107113214
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08677; Plasmodium vivax (strain Belem) circumsporozoite protein (CS) (Note=Also reacts with other strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   2E11 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BF
DR   Wikidata; Q116048014
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2E11 [Mouse hybridoma against human SPP1]
AC   CVCL_0H93
DR   Wikidata; Q54584450
RX   Patent=US8399207;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11449.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   2E11 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TG
DR   Wikidata; Q111732689
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   2E11 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HD
SY   2E11-1-1-2
DR   ABCD; ABCD_AU118
DR   Wikidata; Q110429750
RX   Patent=US8846047;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5431.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1 (Note=Also recognizes human HMGB1 and human/rat Hmgb2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   2E12 [Human/mouse hybridoma]
AC   CVCL_A6KL
DR   Wikidata; Q107113215
RX   PubMed=19003328;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6KD ! RF-S1
HI   CVCL_A6KK ! TM-1 [Human leukemia]
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   2E12 [Mouse hybridoma against human VTN]
AC   CVCL_RI31
DR   Wikidata; Q54584453
RX   PubMed=11734303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04004; Human VTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   2E12 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TH
DR   Wikidata; Q111732690
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   2E12 [Mouse hybridoma against phthalate]
AC   CVCL_D5KX
DR   Wikidata; Q127378701
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   2E2A6
AC   CVCL_RA98
DR   Wikidata; Q54584454
RX   Patent=US9249216;
RX   PubMed=23185348;
CC   Group: Patented cell line.
CC   Biotechnology: Used in a bioassay to measure botulinum toxin serotype A (BoNT/A) activity. Together with neuroblastoma cell line SiMa (Cellosaurus=CVCL_1695).
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del = SNAP25(197)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   2E3 [Mouse hybridoma against human KLK6]
AC   CVCL_E2ZN
RX   PubMed=26492623;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92876; Human KLK6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2E3 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TI
DR   Wikidata; Q111732691
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   2E3-1D8
AC   CVCL_C3MY
SY   2E3 1D8
DR   Wikidata; Q116048015
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   2E3-O
AC   CVCL_C6NB
SY   2E3
DR   Wikidata; Q116048016
RX   PubMed=1367911;
RX   PubMed=9050746;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53067; 2,4,6-trinitrophenyl group (TNP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2E4 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QS
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2E4 [Mouse hybridoma against T.annulata macroschizonts]
AC   CVCL_B6PD
DR   Wikidata; Q111732692
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with sporozoites).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   2A5
AC   CVCL_C5G7
DR   Wikidata; Q116048018
RX   PubMed=21707362;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2E5.G10
AC   CVCL_C4QL
DR   ABCD; ABCD_AE779
DR   Wikidata; Q116048019
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00004; Horse CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2E5B7
AC   CVCL_E8HF
RX   PubMed=30132720;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1 (Note=Reacts with 3-nitro-Tyr-166 in a peptide corresponding to AA 153-173).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2E6 [Mouse hybridoma against M.tuberculosis Ag85A]
AC   CVCL_XJ55
DR   Wikidata; Q93304465
RX   PubMed=28713817;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P9WQP3; Mycobacterium tuberculosis diacylglycerol acyltransferase/mycolyltransferase Ag85A (fbpA) (Note=Also recognizes Ag85C/fbpC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   2E6 [Mouse hybridoma against Pseudomonas P.J. 874 hpd]
AC   CVCL_B7CP
DR   Wikidata; Q112926940
RX   Patent=US8153132;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10313.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P80064; Pseudomonas sp. (strain P.J. 874) 4-hydroxyphenylpyruvate dioxygenase (hpd) (Note=With p.Gly335Trp).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   2E6 [Mouse/hamster hybridoma against mouse Itgb2]
AC   CVCL_8939
DR   CLO; CLO_0001258
DR   ATCC; HB-226
DR   Wikidata; Q54584455
RX   PubMed=2185332;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   2E8 [Mouse bone marrow]
AC   CVCL_6555
DR   CLO; CLO_0001259
DR   ATCC; TIB-239
DR   BioSample; SAMN11397661
DR   Wikidata; Q54584457
RX   PubMed=1821694;
RX   PubMed=31220119;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=2E8
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: IL7 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.xid.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 24.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 23.3,24.3
ST   Mouse STR 17-2: 17
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   2E8 [Mouse hybridoma against ITeA]
AC   CVCL_C8LN
DR   Wikidata; Q123030255
RX   DOI=10.1007/s12161-017-1033-9;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_144316; Isotenuazonic acid (ITeA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   2E8 [Mouse hybridoma against MTPS]
AC   CVCL_C4D1
DR   Wikidata; Q116048020
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2E8E9E10F2
AC   CVCL_WZ85
DR   Wikidata; Q93304489
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   2E9 [Mouse hybridoma against human IL37]
AC   CVCL_B6C2
DR   Wikidata; Q111732693
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   2E9 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TJ
DR   Wikidata; Q111732694
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   2EA2
AC   CVCL_B3PA
DR   Wikidata; Q110429751
RX   Patent=CN105154409B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10495.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A1Z0H6; Pseudomonas fluorescens (strain G2) 3-phosphoshikimate 1-carboxyvinyltransferase (aroA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 4
//
ID   2EF
AC   CVCL_LH68
DR   Wikidata; Q54584458
RX   Patent=US8715662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 08021.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   2F-2B
AC   CVCL_6556
DR   CLO; CLO_0001261
DR   ATCC; CRL-2168
DR   Wikidata; Q54584461
RX   PubMed=8496612;
CC   Characteristics: Derived from a SVEC4-10EE2 induced nodular cutaneous tumor (PubMed=8496612).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4394 ! SVEC4-10EE2
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   2F/11F
AC   CVCL_C4PT
DR   Wikidata; Q116048021
RX   PubMed=10669141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Schistosoma haematobium soluble egg antigen (SEA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2F.11.15
AC   CVCL_J630
DR   CLO; CLO_0001260
DR   ATCC; TIB-194
DR   Wikidata; Q54584462
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: ChEBI; CHEBI_53067; 2,4,6-trinitrophenyl group (TNP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   2F1 [Mouse hybridoma against deltamethrin]
AC   CVCL_C5NY
DR   Wikidata; Q116048022
RX   PubMed=20593827;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_4388; Deltamethrin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2F1 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QT
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2F1 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4SX
DR   Wikidata; Q116048023
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   2F1 [Mouse hybridoma against human TPT1]
AC   CVCL_E9DK
RX   PubMed=21466289;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13693; Human TPT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2F1 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ86
DR   Wikidata; Q93304518
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   2F1.E10
AC   CVCL_XC15
DR   Wikidata; Q93304523
RX   PubMed=17161512;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_141524; Ochratoxin B (OTB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   2F10 [Human hybridoma against D.pteronyssinus Der p 2]
AC   CVCL_E8UF
RX   PubMed=32907999;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG40 ! HMMA2.5
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2F10 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QU
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2F10 [Mouse hybridoma against human SPP1]
AC   CVCL_0H94
DR   Wikidata; Q54584463
RX   Patent=US8399207;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11450.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   2F10 [Mouse hybridoma against HPV16 E6]
AC   CVCL_B0UK
DR   CCRID; 4201PAT-CCTCC00440
DR   Wikidata; Q108819524
RX   Patent=CN103865883A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201401.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03126; Human papillomavirus type 16 protein E6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2F11 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA02
DR   Wikidata; Q93304535
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9373.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   2F11 [Mouse hybridoma against S.mansoni]
AC   CVCL_F1DP
RX   PubMed=4058486;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Schistosoma mansoni 28 kDa surface membrane antigen of cercariae and young schistosomula.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2F11 [Mouse hybridoma against tigecycline]
AC   CVCL_C8MY
DR   Wikidata; Q123030256
RX   PubMed=33502396;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_149836; Tigecycline (Tygacil).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   2F11-E10
AC   CVCL_C5BU
DR   Wikidata; Q116048024
RX   PubMed=23098305;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P41159; Human LEP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2F11/A9
AC   CVCL_C3MP
DR   CCRID; 4201PAT-CCTCC00365
DR   Wikidata; Q116048025
RX   Patent=CN101880325A;
RX   PubMed=22034824;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201047.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_5870; Imidacloprid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2F11B5
AC   CVCL_F1DQ
SY   M.1
RX   PubMed=4058486;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Schistosoma mansoni 28 kDa surface membrane antigen of cercariae and young schistosomula.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1DP ! 2F11 [Mouse hybridoma against S.mansoni]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2F12
AC   CVCL_C8N8
DR   Wikidata; Q123030257
RX   PubMed=33765482;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_195425; 4-hydroxybenzohydrazide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   2F12-F5
AC   CVCL_C5WL
DR   Wikidata; Q116048026
RX   PubMed=36229227;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9UJQ4; Human SALL4 (Note=Isoform SALL4A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   2F2 [Mouse hybridoma against A.pleuropneumoniae tonB2]
AC   CVCL_C5BW
DR   Wikidata; Q116048027
RX   PubMed=23098301;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A3MYE8; Actinobacillus pleuropneumoniae tonB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2F2 [Mouse hybridoma against fibrin D-dimer]
AC   CVCL_C4AB
DR   Wikidata; Q116048029
RX   PubMed=30763351;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Fibrin D-dimer (Note=Also reacts strongly with fibrinogen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2F2 [Mouse hybridoma against influenza A HA]
AC   CVCL_A0UM
DR   Wikidata; Q108819525
RX   Patent=CN101220097A;
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200424.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   2F2 [Mouse hybridoma against M.tuberculosis Ag85A]
AC   CVCL_XJ56
DR   Wikidata; Q93304538
RX   PubMed=28713817;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P9WQP3; Mycobacterium tuberculosis diacylglycerol acyltransferase/mycolyltransferase Ag85A (fbpA) (Note=Also recognizes Ag85B/fbpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   2F2 [Mouse hybridoma against mercury]
AC   CVCL_XJ59
DR   CCRID; 4201PAT-CCTCC00644
DR   Wikidata; Q93304541
RX   Patent=CN105137013A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201512.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_16793; Mercury(2+).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   2F2 [Mouse hybridoma against P.vivax csp]
AC   CVCL_A7VR
DR   BEI_Resources; MRA-184
DR   Wikidata; Q107113217
RX   PubMed=6189951;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08677; Plasmodium vivax (strain Belem) circumsporozoite protein (CS) (Note=Also reacts with other strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   2F2F7
AC   CVCL_XG88
DR   CCRID; 4201PAT-CCTCC00260
DR   Wikidata; Q93304544
RX   Patent=CN101519448B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200849.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95925; Human EPPIN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   2F3 [Mouse hybridoma against D.pteronyssinus Der p 21]
AC   CVCL_E5SR
RX   PubMed=38646484;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2L7C5; Dermatophagoides pteronyssinus allergen Der p 21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2F3 [Mouse hybridoma against human GPC3]
AC   CVCL_XX71
DR   Wikidata; Q93304549
RX   PubMed=30896845;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   2F3 [Mouse hybridoma against lutein and other carotenoids]
AC   CVCL_B6IV
DR   Wikidata; Q111732695
RX   Patent=WO2018115885A1;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_40968; Astaxanthin.
CC   Monoclonal antibody target: ChEBI; CHEBI_17579; Beta-carotene.
CC   Monoclonal antibody target: ChEBI; CHEBI_28838; Lutein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   2F3 [Mouse hybridoma against thebaine]
AC   CVCL_B6GB
DR   Wikidata; Q111732696
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   2F3 [Mouse/rat hybridoma against ERBB2]
AC   CVCL_F0C8
RX   PubMed=37074339;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2F4-1E2
AC   CVCL_E5NU
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2F4-1H8
AC   CVCL_E5NV
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2F5 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1EQ
DR   ABCD; ABCD_AH954
RX   PubMed=7520721;
RX   PubMed=7888224;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2F5 [Mouse hybridoma against human IL37]
AC   CVCL_B6C3
DR   Wikidata; Q111732697
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 6
//
ID   2F6 [Mouse hybridoma against human CKB/CKM]
AC   CVCL_B0F1
DR   CCRID; 4201PAT-CCTCC01642
DR   Wikidata; Q108819526
RX   Patent=CN112961834B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202086.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P12277; Human CKB.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   2F6 [Mouse hybridoma against M.synoviae]
AC   CVCL_C5RD
DR   Wikidata; Q116048030
RX   Patent=CN115141810B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.45241.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mycoplasmopsis synoviae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   2F7
AC   CVCL_3482
DR   CLO; CLO_0001262
DR   CCRID; 4201PAT-CCTCC00150
DR   Wikidata; Q54584464
RX   Patent=US5108920;
RX   PubMed=8111047;
RX   PubMed=17324269;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10237.
CC   Characteristics: Secretes IgM lambda (PubMed=8111047).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C8286; AIDS-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   2F8 [Mouse hybridoma against human EGFR]
AC   CVCL_F1XQ
DR   ABCD; ABCD_AH809
RX   Patent=US7247301;
RX   PubMed=15383606;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma is known as zalutumumab and was intended to be used for the treatment of head and neck cancers but was abandonned due to lack of benefits.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=Immunized with both A-431 cells (Cellosaurus=CVCL_0037) and purified EGFR).
CC   Miscellaneous: As the immunized splenic B-cells are from HuMAb mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2F8 [Mouse hybridoma against human OXTR]
AC   CVCL_J704
DR   CLO; CLO_0050391
DR   RCB; RCB2709
DR   Wikidata; Q54584465
RX   PubMed=8593829;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P30559; Human OXTR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   2F8 [Mouse hybridoma against PCV2 Cap]
AC   CVCL_B0KV
DR   CCRID; 4201PAT-CCTCC00529
DR   Wikidata; Q108819527
RX   Patent=CN105542000B;
RX   Patent=CN105675873B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014199.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; V5N005; Porcine circovirus 2 (PCV2) isolate Nanjing caspid protein (Cap).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   2F8.C10
AC   CVCL_C4QM
DR   ABCD; ABCD_AE781
DR   Wikidata; Q116048032
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62898; Rat Cycs.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2F9
AC   CVCL_C7IG
DR   Wikidata; Q123030258
RX   PubMed=9683260;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   2F9-C9
AC   CVCL_C6MQ
DR   Wikidata; Q116048033
RX   PubMed=24285995;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02792; Human FTL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2FLB.Ln
AC   CVCL_3452
SY   2 FLB.Ln
DR   CLO; CLO_0001263
DR   ATCC; CRL-6045
DR   Wikidata; Q54584470
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6045; true.
CC   Derived from site: In situ; Fetal lymph node; UBERON=UBERON_0000029.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   2fTGH
AC   CVCL_0115
SY   2FTGH; 2-fTGH
DR   BTO; BTO_0005765
DR   EFO; EFO_0022432
DR   MCCL; MCC:0000007
DR   cancercelllines; CVCL_0115
DR   CancerTools; 151484
DR   ECACC; 12021508
DR   Wikidata; Q54584472
DR   Ximbio; 151484
RX   PubMed=1837150;
RX   PubMed=1906577;
RX   PubMed=2513475;
CC   Population: Caucasian.
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: ECACC; 12021508; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=12021508
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   2fTGH-U1A
AC   CVCL_A3FC
SY   U1A; 11,1
DR   cancercelllines; CVCL_A3FC
DR   Wikidata; Q105505902
RX   PubMed=2513475;
CC   Population: Caucasian.
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0115 ! 2fTGH
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 10
//
ID   2fTGH-U2A
AC   CVCL_M019
SY   U2A; U2
DR   cancercelllines; CVCL_M019
DR   CancerTools; 151807
DR   ECACC; 12021502
DR   Wikidata; Q54584473
DR   Ximbio; 151807
RX   PubMed=1837150;
RX   PubMed=1906577;
CC   Population: Caucasian.
CC   Characteristics: Unresponsive to alpha and beta interferons. Partially defective in response to interferon-gamma (PubMed=1906577).
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Discontinued: ECACC; 12021502; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=12021502
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0115 ! 2fTGH
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 24
//
ID   2fTGH-U3A
AC   CVCL_9469
SY   U3A
DR   EFO; EFO_0022533
DR   cancercelllines; CVCL_9469
DR   CancerTools; 151810
DR   ECACC; 12021503
DR   Wikidata; Q54584476
DR   Ximbio; 151810
RX   PubMed=1837150;
CC   Population: Caucasian.
CC   Characteristics: Lacks expression of STAT1. Unresponsive to interferon-alpha and interferon-gamma (ECACC=12021503).
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Discontinued: ECACC; 12021503; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=12021503
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0115 ! 2fTGH
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 26
//
ID   2fTGH-U4A
AC   CVCL_9470
SY   U4A
DR   cancercelllines; CVCL_9470
DR   CancerTools; 151809
DR   ECACC; 12021504
DR   Wikidata; Q54584478
DR   Ximbio; 151809
RX   PubMed=1837150;
CC   Population: Caucasian.
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Discontinued: ECACC; 12021504; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=12021504
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0115 ! 2fTGH
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 26
//
ID   2fTGH-U4C
AC   CVCL_D314
SY   U4C
DR   cancercelllines; CVCL_D314
DR   CancerTools; 151806
DR   ECACC; 12021505
DR   Wikidata; Q54584479
DR   Ximbio; 151806
CC   Population: Caucasian.
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Discontinued: ECACC; 12021505; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=12021505
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0115 ! 2fTGH
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   2fTGH-U5A
AC   CVCL_D315
SY   U5A; U-5A
DR   BTO; BTO_0006556
DR   cancercelllines; CVCL_D315
DR   CancerTools; 151808
DR   ECACC; 12021506
DR   Wikidata; Q54584482
DR   Ximbio; 151808
RX   PubMed=7588638;
CC   Population: Caucasian.
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Discontinued: ECACC; 12021506; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=12021506
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0115 ! 2fTGH
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   2fTGH-U6A
AC   CVCL_D316
SY   U6A
DR   EFO; EFO_0022695
DR   cancercelllines; CVCL_D316
DR   CancerTools; 151805
DR   ECACC; 12021507
DR   Wikidata; Q54584567
DR   Ximbio; 151805
CC   Population: Caucasian.
CC   Characteristics: Lacks expression of STAT2. Unresponsive to interferon-alpha. Normal response to IFN-gamma (ECACC=12021507).
CC   Characteristics: 2fTGH was derived from a HPRT negative subline of HT-1080. Expression of gpt is under the control of a IFN-alpha inducible IFI6 (6-16) promoter and is thus only expressed when IFN-alpha is present in the growth medium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Discontinued: ECACC; 12021507; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=12021507
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0115 ! 2fTGH
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   2G1 [Human hybridoma against D.pteronyssinus Der p 2]
AC   CVCL_E8UG
RX   PubMed=32907999;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG40 ! HMMA2.5
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2G1 [Mouse hybridoma against mouse Zbtb33]
AC   CVCL_C4Z8
DR   Wikidata; Q116048034
RX   PubMed=11461664;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8BN78; Mouse Zbtb33 (Note=Also reacts with human, dog, hamster, and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2G1 [Mouse hybridoma against thebaine]
AC   CVCL_B6GC
DR   Wikidata; Q111732698
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   2G1.1.12
AC   CVCL_A6RD
DR   Wikidata; Q107113218
RX   Patent=US5571714;
RX   PubMed=2537357;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   2G10 [Mouse hybridoma against human TACSTD2]
AC   CVCL_LH67
DR   Wikidata; Q54584569
RX   Patent=US8715662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 08020.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   2G10 [Mouse hybridoma against human TYR]
AC   CVCL_C3BT
DR   Wikidata; Q114310438
RX   PubMed=1706743;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14679; Human TYR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2G11 [Mouse hybridoma against C.botulinum botA]
AC   CVCL_B0X7
DR   Wikidata; Q108819528
RX   PubMed=23342681;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_B0WT ! 1C10 [Mouse/sheep heteromyeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   2G11 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MI
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2G11 [Mouse hybridoma against suid herpesvirus 1 UL42]
AC   CVCL_C6IA
DR   ABCD; ABCD_AV466
DR   Wikidata; Q116048035
RX   PubMed=26377421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F6QNH2; Suid herpesvirus 1 (strain JF) DNA polymerase processivity factor (UL42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2G11 [Mouse hybridoma against TMUV prM]
AC   CVCL_E7DF
RX   PubMed=28409665;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0C6DUM8; Tembusu virus (strain TMUV-YY1Du) genome polyprotein (Note=Protein prM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2G12
AC   CVCL_F1FA
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2G12-2B2
AC   CVCL_E5NR
RX   Patent=US9879087;
RX   Patent=US11401330;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2G2
AC   CVCL_B6P7
DR   Wikidata; Q111732699
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   2G2B(AAT) Clone 4D4
AC   CVCL_U073
DR   ECACC; 02043016
DR   Wikidata; Q54584570
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   2G3 [Mouse hybridoma against human 34 kDa antigen]
AC   CVCL_C8DK
DR   Wikidata; Q123030259
RX   PubMed=9862520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 34 kDa cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   2G3 [Mouse hybridoma against human HMW mucin]
AC   CVCL_J902
DR   Wikidata; Q54584573
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8491.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   2G3 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5ML
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2G3 [Mouse hybridoma against rat Fcgrt]
AC   CVCL_J631
DR   CLO; CLO_0001264
DR   ATCC; CRL-2435
DR   Wikidata; Q54584574
RX   PubMed=7889418;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13599; Rat Fcgrt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   2G3-6E3-2E2
AC   CVCL_WU14
DR   ABCD; ABCD_AI202
DR   Wikidata; Q93304671
RX   DOI=10.1021/jf00073a026;
RX   PubMed=8979354;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 4
//
ID   2G4 [Mouse hybridoma against D.pteronyssinus Der p 21]
AC   CVCL_E5SS
RX   PubMed=38646484;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2L7C5; Dermatophagoides pteronyssinus allergen Der p 21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2G4 [Mouse hybridoma against thebaine]
AC   CVCL_B6GD
DR   Wikidata; Q111732700
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   2G5 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5SB
DR   ABCD; ABCD_AE974
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2G5 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HE
SY   3-2G5-4-1-2
DR   Wikidata; Q110429752
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   2G6 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FD
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2G6 [Mouse hybridoma against aflatoxins G]
AC   CVCL_A0PL
SY   AFG20102G6
DR   CCRID; 4201PAT-CCTCC00340
DR   Wikidata; Q108819529
RX   PubMed=26729164;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   2G6 [Mouse hybridoma against SVA VP1]
AC   CVCL_B5YK
DR   Wikidata; Q111732701
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
RX   Patent=CN108329378B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017226.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   2G6/G12
AC   CVCL_C3MQ
DR   Wikidata; Q116048036
RX   PubMed=22034824;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_5870; Imidacloprid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2G7 [Mouse hybridoma against human endothelial cells]
AC   CVCL_J154
DR   Wikidata; Q54584577
RX   Patent=US5011778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10137.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on IL1-activated endothelial cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   2G7 [Mouse hybridoma against human TFGB1/2/3]
AC   CVCL_A6RH
DR   Wikidata; Q107113220
RX   PubMed=2384664;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01137; Human TGFB1.
CC   Monoclonal antibody target: UniProtKB; P61812; Human TGFB2.
CC   Monoclonal antibody target: UniProtKB; P10600; Human TGFB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   2G7 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HF
SY   3-2G7-1-1-1
DR   ABCD; ABCD_AU120
DR   Wikidata; Q110429753
RX   Patent=US8846047;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5432.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   2G7 [Mouse hybridoma against ZEBOV GP]
AC   CVCL_E8PQ
RX   PubMed=32004438;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q05320; Zaire ebolavirus (strain Mayinga-76) GP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2G7-E8
AC   CVCL_C3U0
SY   2G7 E8
DR   Wikidata; Q116048037
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2G8 [Mouse hybridoma against A.pleuropneumoniae tonB2]
AC   CVCL_C5BX
DR   Wikidata; Q116048038
RX   PubMed=23098301;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A3MYE8; Actinobacillus pleuropneumoniae tonB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   2G8 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MW
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2G8.D6
AC   CVCL_G594
DR   CLO; CLO_0001265
DR   ATCC; HB-8190
DR   Wikidata; Q54584581
RX   Patent=US4543439;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8190.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_74956; O(4)-phosphotyrosine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   2G8D10
AC   CVCL_B3QY
DR   CCRID; 4201PAT-CCTCC00610
DR   Wikidata; Q110429754
RX   Patent=CN104046594B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201471.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; M4I2H9; Orf virus major core protein 4a (ORFV086).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   2G9
AC   CVCL_F0H3
RX   Patent=US12252536;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog PDL1/CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2G9B9H6A2
AC   CVCL_WZ87
DR   Wikidata; Q93304692
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   2H-11
AC   CVCL_6762
DR   CLO; CLO_0001266
DR   ATCC; CRL-2163
DR   Wikidata; Q54584583
RX   PubMed=8496612;
CC   Characteristics: Derived from a SVEC4-10EHR1 induced nodular spindle cell tumor (PubMed=8496612).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4395 ! SVEC4-10EHR1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   2H1 [Mouse hybridoma against GXM]
AC   CVCL_F1XX
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   2H1 [Mouse hybridoma against human ACP5]
AC   CVCL_B0XM
DR   Wikidata; Q108819530
RX   PubMed=7586523;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 4
//
ID   2H10
AC   CVCL_E9DL
RX   PubMed=21466289;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13693; Human TPT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2H11
AC   CVCL_E7E0
RX   PubMed=28472594;
RX   PubMed=28636501;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; D2JYB0; Canine distemper virus (strain Snyder Hill) phosphoprotein (P).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2H12 [Mouse hybridoma against human IL37]
AC   CVCL_B6C4
DR   Wikidata; Q111732702
RX   PubMed=28214995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   2H12 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N8
DR   ABCD; ABCD_AE970
RX   PubMed=7705409;
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2H2
AC   CVCL_E5SI
DR   ABCD; ABCD_BD784
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2H3
AC   CVCL_C4SY
DR   Wikidata; Q116048040
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   2H4 [Mouse hybridoma against human CALCA]
AC   CVCL_A0NU
DR   CCRID; 4201PAT-CCTCC00563
DR   Wikidata; Q108819531
RX   Patent=CN104745534B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014232.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2H4 [Mouse hybridoma against human ERBB2]
AC   CVCL_E2SB
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2H4 [Mouse hybridoma against human F2]
AC   CVCL_B0SJ
DR   Wikidata; Q108819532
RX   Patent=US8283162;
RX   Patent=US9120862;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes an abnormal form called PIVKA-II).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   2H4 [Mouse hybridoma against TMUV NS1]
AC   CVCL_E2Z3
RX   PubMed=26871513;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A075M1D2; Tembusu virus (strain SDLC) genome polyprotein (AA 791-1140 = Non-structural protein NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   2H6
AC   CVCL_DB41
DR   Wikidata; Q54584585
RX   Patent=WO1990008185A1;
RX   PubMed=2717936;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9969.
CC   Characteristics: Produces a catalytic monoclonal antibody that acts as a lipase.
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   2H6-C2
AC   CVCL_G091
DR   CLO; CLO_0001267
DR   ATCC; CRL-1853
DR   ECACC; 95022203
DR   Wikidata; Q54584586
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0CK30; Bovine herpesvirus 1.1 gD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   2H7 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ88
DR   Wikidata; Q93304725
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   2H7 [Mouse/rat hybridoma against human KRT18]
AC   CVCL_E9ZZ
RX   PubMed=33064594;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2H8 [C.migratorius hybridoma against mouse Pecam1]
AC   CVCL_D3RL
DR   DSHB; 2H8
DR   Wikidata; Q127378702
RX   PubMed=1415479;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q08481; Mouse Pecam1/Cd31.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   2H8 [Mouse hybridoma against monensin A]
AC   CVCL_XJ61
DR   Wikidata; Q93304728
RX   PubMed=8370924;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27617; Monensin A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   2H8 [Mouse hybridoma against phenylethanolamine A]
AC   CVCL_B6MZ
DR   Wikidata; Q111732703
RX   DOI=10.1039/c4ay00682h;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_144925; 1-(4-methoxyphenyl)-2-{[4-(4-nitrophenyl)butan-2-yl]amino}ethanol (Phenylethylamine A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   2H9 [Mouse hybridoma against CDV hemagglutinin]
AC   CVCL_A3CF
DR   Wikidata; Q105505905
RX   PubMed=25644427;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Canine distemper virus (isolate NJ01) hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   2H9 [Mouse hybridoma against dog CD274]
AC   CVCL_F0H4
RX   Patent=US12252536;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog PDL1/CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2H9 [Mouse hybridoma against human PSCA]
AC   CVCL_B0TQ
DR   Wikidata; Q108819533
RX   Patent=US8524460;
RX   PubMed=10713670;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12614.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2H9 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HL
DR   Wikidata; Q108819534
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   2H9 [Mouse hybridoma against human SPP1]
AC   CVCL_0H95
DR   Wikidata; Q54584587
RX   Patent=US8399207;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11446.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   2H9 [Mouse hybridoma against parathion]
AC   CVCL_C5AA
DR   Wikidata; Q116048041
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2H9 [Mouse hybridoma against trans-resveratrol]
AC   CVCL_B6IQ
DR   Wikidata; Q111732704
RX   Patent=US9547001;
RX   PubMed=23244325;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-121.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_45713; Trans-resveratrol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   2H9 [Mouse hybridoma against ZEBOV GP]
AC   CVCL_E8PR
RX   PubMed=32004438;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q05320; Zaire ebolavirus (strain Mayinga-76) GP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   2HP
AC   CVCL_E3K8
RX   PubMed=8069457;
CC   Characteristics: Produces alpha-amylase (PubMed=8069457).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C4650; Parotid gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   2HP1
AC   CVCL_E3K9
RX   PubMed=8069457;
CC   Characteristics: Tumorigenic. Produces alpha-amylase (PubMed=8069457).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C4650; Parotid gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3K8 ! 2HP
SX   Male
AG   34Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   2Hx-2
AC   CVCL_1932
SY   2HX-2
DR   CLO; CLO_0001268
DR   CLDB; cl51
DR   ATCC; HB-8117
DR   DSMZ; ACC-183
DR   DSMZCellDive; ACC-183
DR   Wikidata; Q54584589
RX   Patent=US4487829;
RX   PubMed=6339552;
RX   PubMed=7222481;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8117.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03277; Human adenovirus C serotype 2 hexon protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   2IN1
AC   CVCL_C6K7
DR   ABCD; ABCD_AF132
DR   Wikidata; Q116048042
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN10
AC   CVCL_C6KG
DR   ABCD; ABCD_AF134
DR   Wikidata; Q116048043
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN11
AC   CVCL_C6KH
DR   ABCD; ABCD_AF133
DR   Wikidata; Q116048044
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN12
AC   CVCL_C6KI
DR   ABCD; ABCD_AF138
DR   Wikidata; Q116048045
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN13
AC   CVCL_C6KJ
DR   ABCD; ABCD_AF135
DR   Wikidata; Q116048046
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN14
AC   CVCL_C6KK
DR   ABCD; ABCD_AF136
DR   Wikidata; Q116048048
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN15
AC   CVCL_C6KL
DR   ABCD; ABCD_AF142
DR   Wikidata; Q116048049
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN16
AC   CVCL_C6KM
DR   ABCD; ABCD_AF141
DR   Wikidata; Q116048050
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN2
AC   CVCL_C6K8
DR   ABCD; ABCD_AF137
DR   Wikidata; Q116048051
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN3
AC   CVCL_C6K9
DR   Wikidata; Q116048052
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN4
AC   CVCL_C6KA
DR   ABCD; ABCD_AF139
DR   Wikidata; Q116048053
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN5
AC   CVCL_C6KB
DR   Wikidata; Q116048054
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN6
AC   CVCL_C6KC
DR   Wikidata; Q116048056
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN7
AC   CVCL_C6KD
DR   ABCD; ABCD_AF143
DR   Wikidata; Q116048057
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN8
AC   CVCL_C6KE
DR   ABCD; ABCD_AF140
DR   Wikidata; Q116048058
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2IN9
AC   CVCL_C6KF
DR   Wikidata; Q116048059
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   2L1
AC   CVCL_QW59
DR   cancercelllines; CVCL_QW59
DR   Wikidata; Q54584593
RX   PubMed=9616138;
RX   PubMed=14671638;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified; Note=Germline (PubMed=9616138).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8252; Therapy-related acute myeloid leukemia
DI   ORDO; Orphanet_86846; Therapy related acute myeloid leukemia and myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   2LBLN
AC   CVCL_3635
DR   CLO; CLO_0001269
DR   ATCC; CRL-6047
DR   Wikidata; Q54584603
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6047; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   2LMF-h-iPS 1
AC   CVCL_E5KQ
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KR ! 2LMF-h-iPS 2
OI   CVCL_E5KS ! 2LMF-h-iPS 3
OI   CVCL_E5KT ! 2LMF-h-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMF-h-iPS 2
AC   CVCL_E5KR
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KQ ! 2LMF-h-iPS 1
OI   CVCL_E5KS ! 2LMF-h-iPS 3
OI   CVCL_E5KT ! 2LMF-h-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMF-h-iPS 3
AC   CVCL_E5KS
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KQ ! 2LMF-h-iPS 1
OI   CVCL_E5KR ! 2LMF-h-iPS 2
OI   CVCL_E5KT ! 2LMF-h-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMF-h-iPS 4
AC   CVCL_E5KT
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KQ ! 2LMF-h-iPS 1
OI   CVCL_E5KR ! 2LMF-h-iPS 2
OI   CVCL_E5KS ! 2LMF-h-iPS 3
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMF-o-iPS 1
AC   CVCL_E5KU
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KV ! 2LMF-o-iPS 2
OI   CVCL_E5KW ! 2LMF-o-iPS 3
OI   CVCL_E5KX ! 2LMF-o-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMF-o-iPS 2
AC   CVCL_E5KV
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KU ! 2LMF-o-iPS 1
OI   CVCL_E5KW ! 2LMF-o-iPS 3
OI   CVCL_E5KX ! 2LMF-o-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMF-o-iPS 3
AC   CVCL_E5KW
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KU ! 2LMF-o-iPS 1
OI   CVCL_E5KV ! 2LMF-o-iPS 2
OI   CVCL_E5KX ! 2LMF-o-iPS 4
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMF-o-iPS 4
AC   CVCL_E5KX
RX   PubMed=23049868;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/cAnNCrl x DBA/2NCrl (CD2F1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E5KU ! 2LMF-o-iPS 1
OI   CVCL_E5KV ! 2LMF-o-iPS 2
OI   CVCL_E5KW ! 2LMF-o-iPS 3
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   2LMP
AC   CVCL_EQ20
SY   2-LMP
DR   cancercelllines; CVCL_EQ20
DR   GEO; GSM1401670
DR   Wikidata; Q54584606
RX   PubMed=9739048;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   2M6
AC   CVCL_1933
DR   CLO; CLO_0001270
DR   CLDB; cl373
DR   DSMZ; ACC-205
DR   DSMZCellDive; ACC-205
DR   Wikidata; Q54584607
RX   PubMed=1879342;
RX   PubMed=1914140;
CC   Doubling time: ~35 hours (DSMZ=ACC-205).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q90634; Chicken TOPAP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   2MAC
AC   CVCL_5979
DR   Wikidata; Q54584609
RX   PubMed=9178646;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=2MAC
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   2nFC
AC   CVCL_UI36
DR   Wikidata; Q93304836
RX   PubMed=30017856;
CC   Group: Fish cell line.
CC   Doubling time: 36.6 hours (PubMed=30017856).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=138676; ! Carassius langsdorfii (Japanese silver crucian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   2O2
AC   CVCL_C0ZA
DR   Wikidata; Q114310439
RX   PubMed=35576682;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A0A8I3MI11; Dog OSMR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   2P10F2
AC   CVCL_C4CA
DR   ABCD; ABCD_AR156
DR   Wikidata; Q116048060
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2P1A6
AC   CVCL_C4C3
DR   Wikidata; Q116048062
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2P1B7
AC   CVCL_C4C4
DR   Wikidata; Q116048064
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2P2D10
AC   CVCL_C4C8
DR   Wikidata; Q116048065
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2P2D6
AC   CVCL_C4C5
DR   Wikidata; Q116048066
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2P2D7
AC   CVCL_C4C7
DR   Wikidata; Q116048067
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2P3G8
AC   CVCL_C4C6
DR   Wikidata; Q116048068
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2P8C12
AC   CVCL_C4C9
DR   Wikidata; Q116048069
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   2PK-3
AC   CVCL_3483
SY   2PK3
DR   CLO; CLO_0001271
DR   ATCC; TIB-203
DR   BCRC; 60309
DR   Lonza; 1142
DR   Wikidata; Q54584611
RX   PubMed=161906;
RX   PubMed=3495708;
RX   PubMed=25277546;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-436.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   2R
AC   CVCL_B6QX
DR   Wikidata; Q111732705
RX   PubMed=2655894;
RX   PubMed=3028610;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   2RS
AC   CVCL_E3KA
RX   PubMed=8069458;
CC   Characteristics: Produces alpha-amylase (PubMed=8069458).
CC   Doubling time: ~25 hours (PubMed=8069458).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   2SOD1-1
AC   CVCL_ZY47
DR   Wikidata; Q102113437
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His47Arg (c.140A>G) (H46R); ClinVar=VCV000014764; Zygosity=Unspecified (PubMed=30127392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY48 ! 2SOD1-4
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   2SOD1-4
AC   CVCL_ZY48
DR   Wikidata; Q102113438
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His47Arg (c.140A>G) (H46R); ClinVar=VCV000014764; Zygosity=Unspecified (PubMed=30127392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY47 ! 2SOD1-1
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   2T3
AC   CVCL_A5DA
DR   BTO; BTO_0004325
DR   Wikidata; Q107113222
RX   PubMed=8536632;
RX   PubMed=16738320;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Bmp2 promoter T-Ag-3 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   2T60
AC   CVCL_XA93
DR   JCRB; IFO50211
DR   Wikidata; Q93304846
RX   Patent=US5496549;
RX   PubMed=21043851;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2623.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
CC   Discontinued: JCRB; IFO50211; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   2T8-3E10
AC   CVCL_J632
DR   CLO; CLO_0001273
DR   ATCC; HB-8213
DR   Wikidata; Q54584613
RX   Patent=US4550086;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8213.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   2T9
AC   CVCL_A5EN
DR   Wikidata; Q107113224
RX   PubMed=10328645;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Bmp2 promoter T-Ag-3 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   2TP-084
AC   CVCL_6D33
DR   RCB; AES1913
DR   SKIP; SKIP002943
DR   Wikidata; Q54584615
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   2TS22C
AC   CVCL_E266
SY   2TS22c
DR   EFO; EFO_0006529
DR   GEO; GSM1385516
DR   RCB; AES0125
DR   RCB; RCB2690
DR   SKIP; SKIP001668
DR   Wikidata; Q54584617
RX   PubMed=17515932;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: RCB; RCB2690; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   2V6.11
AC   CVCL_6355
DR   CLO; CLO_0001274
DR   ATCC; CRL-2784
DR   ATCC; JHU-67
DR   BioSample; SAMN03471789
DR   CCRID; 3101HUMGNHu26
DR   CLS; 305147
DR   Wikidata; Q54584619
RX   PubMed=15141036;
WW   Provider; JHTV; C10340; https://jhu.technologypublisher.com/technology/16640
CC   Characteristics: Adenovirus 5 E4 34kda protein is expressed under the control of an ecdysone-inducible promoter (PubMed=15141036).
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (PubMed=15141036).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q6VGT3; Human adenovirus C serotype 5 E4 34kda protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-2784; true.
CC   Discontinued: ATCC; JHU-67; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2784; CLS=305147
ST   Amelogenin: X
ST   CSF1PO: 7,11,12
ST   D12S391: 19,21
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,19
ST   D19S433: 15,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D6S1043: 11
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3D4 ! 293VgRXR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   2XSB
AC   CVCL_A7NI
DR   ABM; T8335
DR   cancercelllines; CVCL_A7NI
DR   CancerTools; 161801
DR   Wikidata; Q107117558
RX   PubMed=33707600;
CC   Population: Caucasian.
CC   Doubling time: 28.0 +- 3.09 hours (Note=At 6th passage), 27.3 +- 4.06 hours (Note=At 54th passage) (PubMed=33707600).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:19291; CSMD3; Simple; p.Trp3337Ter (c.10010G>A); Zygosity=Heterozygous (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:2976; DNMT1; Simple; c.2586+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:6697; LRP5; Simple; p.Arg428Ter (c.1282C>T); ClinVar=VCV000006269; Zygosity=Heterozygous (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; None_reported; -; Zygosity=- (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:8059; NUMA1; Simple; p.Leu1167Alafs*39 (c.3499_3500delCT); Zygosity=Heterozygous (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro38Ser (c.112C>T); ClinVar=VCV000127688; Zygosity=Homozygous (PubMed=33707600).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His178Asp (c.532C>G); ClinVar=VCV000482223; Zygosity=Homozygous (PubMed=33707600).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: X2SB; Note=In Cellosaurus release 38.
CC   Derived from site: In situ; Right brachial nerve; UBERON=UBERON_0001814.
ST   Source(s): PubMed=33707600
ST   Amelogenin: X
ST   CSF1PO: 15
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14,15.2
ST   D21S11: 30,30.2
ST   D2S1338: 17,26
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 19,23
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 17,18
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   2Y-3t
AC   CVCL_C6GE
DR   Wikidata; Q116048070
RX   PubMed=9824692;
RX   PubMed=12270117;
RX   PubMed=15978002;
CC   Characteristics: Composed of bipotent neural progenitor cells capable of generating both neurons and oligodendrocytes.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
DI   NCIt; C191764; Mouse cerebellar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6GF ! 2Y-6f1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   2Y-6f1
AC   CVCL_C6GF
DR   Wikidata; Q116048072
RX   PubMed=9824692;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
DI   NCIt; C191764; Mouse cerebellar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6GE ! 2Y-3t
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   3-11
AC   CVCL_B3YF
DR   Wikidata; Q110429755
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   3-12
AC   CVCL_C3WB
DR   Wikidata; Q116048073
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-13
AC   CVCL_C3WC
DR   Wikidata; Q116048074
RX   CelloPub=CLPUB00724;
RX   PubMed=2104617;
RX   PubMed=3419436;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa (CelloPub=CLPUB00724; PubMed=6434941); IgM, kappa (PubMed=2104617).
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-14
AC   CVCL_C3WD
DR   Wikidata; Q116048075
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-17
AC   CVCL_C3WE
DR   Wikidata; Q116048076
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-20-1
AC   CVCL_B6X8
DR   Wikidata; Q111732706
RX   Patent=CN102925413B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201202.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   3-22
AC   CVCL_D6TS
RX   PubMed=6432681;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse Ig lambda light chains (Note=Reacts with free and bound lambda chains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3-24
AC   CVCL_C3WF
DR   ABCD; ABCD_AE161
DR   Wikidata; Q116048077
RX   PubMed=2104617;
RX   PubMed=3821741;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-25
AC   CVCL_C3WG
DR   Wikidata; Q116048078
RX   CelloPub=CLPUB00724;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-26-1
AC   CVCL_B6X9
DR   Wikidata; Q111732707
RX   Patent=CN102925413B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201208.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   3-29
AC   CVCL_C3WH
DR   Wikidata; Q116048080
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-2H3
AC   CVCL_J719
DR   CLO; CLO_0050360
DR   RCB; RCB0867
DR   Wikidata; Q54584622
RX   PubMed=3028450;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   3-3
AC   CVCL_C5A1
DR   Wikidata; Q116048081
RX   PubMed=11289226;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CQJ4; Mouse Rnf2 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3-32
AC   CVCL_C3WI
DR   Wikidata; Q116048082
RX   CelloPub=CLPUB00724;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-35
AC   CVCL_C3WJ
DR   Wikidata; Q116048083
RX   CelloPub=CLPUB00724;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-36
AC   CVCL_C3WK
DR   Wikidata; Q116048085
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-43
AC   CVCL_C3WL
DR   Wikidata; Q116048086
RX   CelloPub=CLPUB00724;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-45
AC   CVCL_C3WM
DR   Wikidata; Q116048087
RX   CelloPub=CLPUB00724;
RX   PubMed=3419436;
RX   PubMed=3821741;
RX   PubMed=6434941;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3-5 [Mouse hybridoma against human FCER2]
AC   CVCL_C8U0
DR   Wikidata; Q123030260
RX   Patent=EP0259585B1;
RX   PubMed=2426355;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 87042801.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-583.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06734; Human FCER2/CD23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   3-5 [Mouse hybridoma against human TCN2]
AC   CVCL_B3YG
DR   Wikidata; Q110429756
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 4
//
ID   3-5A6
AC   CVCL_B4HG
SY   5A6
DR   Wikidata; Q110429757
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG2a+IgG2b.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   3-631-436
AC   CVCL_B0CR
DR   Wikidata; Q108819535
RX   Patent=US7731965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6476.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   3-7G
AC   CVCL_C0E3
DR   Wikidata; Q112926941
DR   Ximbio; 160685
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3KPI0; Human CEACAM21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   3-83P
AC   CVCL_J720
DR   CLO; CLO_0001322
DR   ATCC; HB-20
DR   Wikidata; Q54584624
RX   PubMed=7188699;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   3-8D6
AC   CVCL_JY48
DR   Wikidata; Q54584625
RX   Patent=US7285649;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   3-9
AC   CVCL_B3YH
DR   Wikidata; Q110429758
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   3-C4F5
AC   CVCL_C3VT
DR   ABCD; ABCD_AF200
DR   Wikidata; Q116048088
RX   Patent=WO1999012974A1;
RX   PubMed=9680193;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17347; Testosterone (Note=Also recognizes DHEAS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   3-H11
AC   CVCL_XD09
DR   Wikidata; Q93304905
RX   PubMed=23746246;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05413; Human FABP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   3-H5
AC   CVCL_XB15
DR   Wikidata; Q93304908
RX   Patent=CN103045541A;
RX   PubMed=23746246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012140.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05413; Human FABP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   3.1.1
AC   CVCL_ZW81
SY   LN 15845
DR   Wikidata; Q102113440
RX   Patent=US9234041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2791.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   3.15.C3
AC   CVCL_C7H8
DR   Wikidata; Q123030261
RX   PubMed=7309278;
CC   Monoclonal antibody isotype: Not determined.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   3.155
AC   CVCL_9157
DR   CLO; CLO_0001277
DR   ATCC; TIB-211
DR   Wikidata; Q54584627
RX   PubMed=6184304;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   3.19.3
AC   CVCL_C3S6
DR   ABCD; ABCD_AS321
DR   Wikidata; Q116048090
RX   Patent=US10066011;
RX   PubMed=20053776;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7260.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O15123; Human ANGPT2 (Note=Also reacts with mouse).
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   3.2.3E5
AC   CVCL_D3V7
DR   ABCD; ABCD_AE104
DR   Wikidata; Q127378703
RX   PubMed=1698868;
RX   PubMed=2443831;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   3.3.2
AC   CVCL_C3S7
DR   ABCD; ABCD_AS329
DR   Wikidata; Q116048091
RX   Patent=US10066011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7258.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O15123; Human ANGPT2.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   3.334 SC5/8
AC   CVCL_7237
DR   CLO; CLO_0001278
DR   CLDB; cl54
DR   CancerTools; 153249
DR   ECACC; 86082107
DR   Wikidata; Q54584628
DR   Ximbio; 153249
RX   PubMed=6247175;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 (B77)).
CC   Discontinued: ECACC; 86082107; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9116 ! NIH 3T3-TK-
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   3.4.1G6
AC   CVCL_D3V8
DR   Wikidata; Q127378704
RX   PubMed=1698868;
RX   PubMed=2443831;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   3.43
AC   CVCL_A0AM
DR   BEI_Resources; ARP-12791
DR   Wikidata; Q108819536
RX   PubMed=15941912;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95944; Human NCR2/CD336.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   3.C2
AC   CVCL_J716
DR   ECACC; 92092320
DR   Wikidata; Q54584629
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Myelin basic protein from Oreochromine and other types of fish.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   3/121
AC   CVCL_XY72
DR   Wikidata; Q93304934
RX   PubMed=10519007;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Dictyostelium discoideum antigen at distal end of fibrous linkage structure connecting the centrosome to the nucleus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   3'-mRLh-2
AC   CVCL_D104
SY   3'mRLh-2
DR   JCRB; JCRB0431
DR   Wikidata; Q54584633
RX   PubMed=1836893;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   3'-mRLN-30
AC   CVCL_L639
DR   JCRB; JCRB0421
DR   Wikidata; Q54584636
RX   DOI=10.4044/joma1947.90.11-12_1377;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   116D
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   3'-mRLN-31
AC   CVCL_L640
DR   JCRB; JCRB0422
DR   Wikidata; Q54584638
RX   DOI=10.4044/joma1947.90.11-12_1377;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   125D
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   30
AC   CVCL_J925
SY   Anti PDGF hybridoma #30
DR   ATCC; HB-9366
DR   Wikidata; Q54584639
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9366.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   30-2 [Mouse hybridoma against dog SELPLG]
AC   CVCL_D2QF
DR   Wikidata; Q127378705
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   30-2 [Mouse hybridoma against E.coli trpB]
AC   CVCL_C5N9
DR   Wikidata; Q116048092
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   30-5-7S
AC   CVCL_G595
DR   CLO; CLO_0001280
DR   ATCC; HB-31
DR   Wikidata; Q54584641
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   30-C7
AC   CVCL_9155
DR   CLO; CLO_0001282
DR   ATCC; TIB-106
DR   Wikidata; Q54584642
RX   PubMed=398327;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01965; Mouse Ly9/Cd229/Lgp100a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   30-H12
AC   CVCL_9156
DR   CLO; CLO_0001283
DR   ATCC; TIB-107
DR   Wikidata; Q54584676
RX   PubMed=398327;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (Note=Allotype 1.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   30/15
AC   CVCL_J633
DR   CLO; CLO_0001279
DR   ATCC; HB-8152
DR   Wikidata; Q54584677
RX   Patent=US4521510;
RX   Patent=US4524025;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8152.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28177; Theophylline.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   300-19
AC   CVCL_6238
SY   300.19
DR   Lonza; 138
DR   Wikidata; Q54584678
RX   PubMed=3096716;
RX   PubMed=6277505;
RX   PubMed=7689875;
WW   Provider; Tufts TTIC; T000710; https://web.archive.org/web/20150225055738/http://www.tufts.biz/cgi-bin/tech_search.cgi?r=1&case=T000710
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: NIH Swiss.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   300-19 GFP-MS4A4A
AC   CVCL_VD90
SY   300.19-MS4A4A-GFP
DR   Kerafast; EUC013
DR   Wikidata; Q54584680
RX   PubMed=28303902;
CC   Characteristics: Expresses GFP fused to the N-terminus of MS4A4A/CD20L1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13371; MS4A4A.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: NIH Swiss.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6238 ! 300-19
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   300-19 GFP-MS4A8B
AC   CVCL_VD91
SY   300.19-MS4A8B-GFP
DR   Kerafast; EUC015
DR   Wikidata; Q54584682
CC   Characteristics: Expresses GFP fused to the N-terminus of MS4A8.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13380; MS4A8.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: NIH Swiss.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6238 ! 300-19
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   3012T
AC   CVCL_ZT02
DR   Wikidata; Q98125380
RX   PubMed=6409440;
RX   PubMed=6422469;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8498; Hereditary melanoma
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   301B5
AC   CVCL_D3QB
DR   Wikidata; Q127378706
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   302-1
AC   CVCL_J872
DR   Wikidata; Q54584684
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   3051/80
AC   CVCL_9558
SY   St 3051; St3051
DR   BioSample; SAMN03151785
DR   cancercelllines; CVCL_9558
DR   Wikidata; Q54584686
RX   PubMed=8100658;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 66 year old male patient with a gastric carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00109.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   305M
AC   CVCL_6531
SY   305 M
DR   CLO; CLO_0050642
DR   BioSample; SAMN03472339
DR   RCB; RCB0156
DR   Wikidata; Q54584687
RX   PubMed=6525431;
CC   Population: Japanese.
CC   Senescence: Senesces at 47 PDL (RCB=RCB0156).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0156
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   30638
AC   CVCL_JC35
SY   TER319; TER-319; Ter 319; TER360; TER-360; Ter 360; TER446; TER-446; Ter 446; TER515; TER-515; Ter-515; Ter 515
DR   IPD-IMGT/HLA; 12303
DR   Wikidata; Q54584688
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX387_final_rev.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23,32; B*44,41; C*17,04; DPB1*02:01,04:01; DQA1*01:02,02:01; DQB1*02:02,06:09; DRB1*07:01,13:36; DRB3*03:01; DRB4*01:01 (IPD-IMGT/HLA=12303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   306D326.26
AC   CVCL_B0UY
SY   LT1002; Sphingomab
DR   ATCC; SD-5362
DR   Wikidata; Q108819537
RX   Patent=US9163091;
RX   PubMed=19509417;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized sonepcizumab (LT1009; Asonex) therapeutic antibody candidate for treatment of patients with cancer or ocular diseases.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_37550; Sphingosine 1-phosphate (S1P).
CC   Discontinued: ATCC; SD-5362; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   3072T
AC   CVCL_ZT03
DR   Wikidata; Q98125381
RX   PubMed=6409440;
RX   PubMed=6422469;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8498; Hereditary melanoma
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   30733VTIS
AC   CVCL_JD39
SY   Extract 438
DR   IPD-IMGT/HLA; 12315
DR   Wikidata; Q54584690
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/338cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*44:02:01,27:23; C*02:02,05:AB (IPD-IMGT/HLA=12315).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   308/3-3
AC   CVCL_C0E4
DR   Wikidata; Q112926942
DR   Ximbio; 153326
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P40198; Human CEACAM3/CD66d.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   3081
AC   CVCL_E6LW
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3081 corrected
AC   CVCL_E6LX
SY   3081 (isogenic correction)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6LW ! 3081
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3082LN
AC   CVCL_E3YH
RX   PubMed=21764851;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Trp53 fl/fl;Rb1 fl/fl.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E3YI ! 3082T1
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3082T1
AC   CVCL_E3YI
RX   PubMed=21764851;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Trp53 fl/fl;Rb1 fl/fl.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E3YH ! 3082LN
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   308TAg
AC   CVCL_6763
DR   CLO; CLO_0001281
DR   ATCC; CRL-2819
DR   Kerafast; ENH117-FP
DR   Wikidata; Q54584692
RX   PubMed=12882965;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97073; Mpg.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   30966M
AC   CVCL_WM43
DR   cancercelllines; CVCL_WM43
DR   Cosmic; 852233
DR   IARC_TP53; 20615
DR   Wikidata; Q93305043
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys105Valfs*8 (c.313delT); ClinVar=VCV000940879; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   30A-5
AC   CVCL_0117
SY   30A5
DR   MCCL; MCC:0000009
DR   Wikidata; Q54584694
RX   PubMed=2901666;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   30B8
AC   CVCL_D4XH
DR   Wikidata; Q127378707
RX   PubMed=26700326;
CC   Monoclonal antibody target: UniProtKB; Q8IXJ9; Human ASXL1 (Note=Immunized with AA 21-54).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   30F
AC   CVCL_8627
SY   IM-2 cl 30F; Line 30F
DR   Wikidata; Q54584695
RX   PubMed=2466037;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S548 ! IM-2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   30F73.Ln
AC   CVCL_S380
DR   ATCC; CRL-6516
DR   Wikidata; Q54584696
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6516; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
OI   CVCL_S381 ! 30F73.Lu
OI   CVCL_S382 ! 30F73.Mu
OI   CVCL_S383 ! 30F73.Pla
OI   CVCL_S384 ! 30F73.Sk
OI   CVCL_S385 ! 30F73.Ur
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   30F73.Lu
AC   CVCL_S381
DR   ATCC; CRL-6517
DR   Wikidata; Q54584697
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6517; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
OI   CVCL_S380 ! 30F73.Ln
OI   CVCL_S382 ! 30F73.Mu
OI   CVCL_S383 ! 30F73.Pla
OI   CVCL_S384 ! 30F73.Sk
OI   CVCL_S385 ! 30F73.Ur
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   30F73.Mu
AC   CVCL_S382
DR   ATCC; CRL-6518
DR   Wikidata; Q54584700
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6518; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
OI   CVCL_S380 ! 30F73.Ln
OI   CVCL_S381 ! 30F73.Lu
OI   CVCL_S383 ! 30F73.Pla
OI   CVCL_S384 ! 30F73.Sk
OI   CVCL_S385 ! 30F73.Ur
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   30F73.Pla
AC   CVCL_S383
DR   ATCC; CRL-6519
DR   Wikidata; Q54584702
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6519; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
OI   CVCL_S380 ! 30F73.Ln
OI   CVCL_S381 ! 30F73.Lu
OI   CVCL_S382 ! 30F73.Mu
OI   CVCL_S384 ! 30F73.Sk
OI   CVCL_S385 ! 30F73.Ur
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   30F73.Sk
AC   CVCL_S384
DR   ATCC; CRL-6520
DR   Wikidata; Q54584705
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6520; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
OI   CVCL_S380 ! 30F73.Ln
OI   CVCL_S381 ! 30F73.Lu
OI   CVCL_S382 ! 30F73.Mu
OI   CVCL_S383 ! 30F73.Pla
OI   CVCL_S385 ! 30F73.Ur
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   30F73.Ur
AC   CVCL_S385
DR   ATCC; CRL-6521
DR   Wikidata; Q54584706
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6521; true.
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
OI   CVCL_S380 ! 30F73.Ln
OI   CVCL_S381 ! 30F73.Lu
OI   CVCL_S382 ! 30F73.Mu
OI   CVCL_S383 ! 30F73.Pla
OI   CVCL_S384 ! 30F73.Sk
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   30G5C
AC   CVCL_E8HI
RX   PubMed=30362929;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A7U7EX48; Staphylococcus aureus (subsp. aureus ST228) superantigen-like protein 5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   30G8
AC   CVCL_A0QQ
DR   Wikidata; Q108819538
RX   Patent=JP3395817;
RX   PubMed=10816462;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15207.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   30N47-1
AC   CVCL_B4FJ
SY   47-1
DR   Wikidata; Q110429759
RX   Patent=US4948738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-463.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   30Q4H
AC   CVCL_XG66
DR   Wikidata; Q93305117
RX   Patent=US5597725;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11317.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   30Q8A
AC   CVCL_XG65
DR   Wikidata; Q93305120
RX   Patent=US5597725;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11316.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   30S2F
AC   CVCL_XG78
DR   Wikidata; Q93305122
RX   Patent=US5597725;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11319.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   30T.14
AC   CVCL_A0YV
DR   Wikidata; Q108819539
RX   PubMed=8522347;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P24522; Human GADD45A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   30T11G
AC   CVCL_XG79
DR   Wikidata; Q93305127
RX   Patent=US5597725;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11324.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   31-3-4S
AC   CVCL_G596
DR   CLO; CLO_0001287
DR   ATCC; HB-77
DR   Wikidata; Q54584709
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse MHC class I H-2Kd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   31-4
AC   CVCL_C7I7
DR   Wikidata; Q123030262
RX   Patent=JP7061750;
RX   PubMed=31397631;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE P-02579.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NPH9; Human IL26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   31-41
AC   CVCL_F1HU
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   31-42-19
AC   CVCL_J635
DR   CLO; CLO_0001288
DR   Wikidata; Q54584712
RX   Patent=US4983529;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9726.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   31-6-1
AC   CVCL_A0IG
SY   #31-6-1
DR   Wikidata; Q108819540
RX   Patent=US8178100;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00143.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02778; Human CXCL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   31-62
AC   CVCL_F1FR
RX   PubMed=6153633;
RX   PubMed=6341819;
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   31-64
AC   CVCL_F1FS
RX   PubMed=6341819;
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   31-90-25
AC   CVCL_J636
DR   CLO; CLO_0001290
DR   Wikidata; Q54584713
RX   Patent=US4983529;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9725.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   310-29F7
AC   CVCL_J585
DR   CLO; CLO_0001284
DR   ATCC; CRL-2656
DR   Wikidata; Q54584715
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9053.
CC   Monoclonal antibody isotype: IgG1+IgG2b.
CC   Monoclonal antibody target: UniProtKB; P00521; Abelson murine leukemia virus v-Abl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   310-5F5
AC   CVCL_J586
DR   Wikidata; Q54584716
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9002.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00521; Abelson murine leukemia virus v-Abl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   311
AC   CVCL_Z994
DR   CLO; CLO_0001006
DR   CLDB; cl56
DR   ECACC; 90070547
DR   FlyBase_Cell_line; FBtc9000063
DR   KCB; KCB 94027YJ
DR   Wikidata; Q54584718
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   311-11D
AC   CVCL_F0AR
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   311-3D4
AC   CVCL_J634
DR   CLO; CLO_0001285
DR   ATCC; CRL-2657
DR   Wikidata; Q54584720
CC   Monoclonal antibody isotype: IgG1+IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   312-13E8
AC   CVCL_J587
SY   312-13E08
DR   CLO; CLO_0001286
DR   ATCC; CRL-2658
DR   Wikidata; Q54584721
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9208.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00521; Abelson murine leukemia virus v-Abl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   31227ABO
AC   CVCL_E443
SY   31227 ABO; ABUC; ABU; WT9; GM08600
DR   CLO; CLO_0010594
DR   BioSample; SAMN00798098
DR   Coriell; GM08600
DR   dbMHC; 48461
DR   ECACC; 85052103
DR   IHW; IHW09061
DR   IPD-IMGT/HLA; 10131
DR   Wikidata; Q54584723
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*02:01:01:01; B*18:01:01:02; C*07:01:01:01; DPA1*01; DPB1*04:01:01; DQA1*01:04:01; DQB1*05:03:01; DRB1*14:54:01; DRB3*02:02 (IPD-IMGT/HLA=10131).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   3123
AC   CVCL_E6LT
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:28709; TMEM175; Simple; p.Gln65Pro (c.194A>C); ClinVar=VCV001178472; Zygosity=Heterozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3123 corrected
AC   CVCL_E6LU
SY   3123 (isogenic correction)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:28709; TMEM175; Simple_corrected; p.Gln65Pro (c.194A>C); ClinVar=VCV001178472; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6LT ! 3123
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3123 mutated
AC   CVCL_E6LV
SY   3123 (isogenic mutation)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:28709; TMEM175; Simple; p.Gln65Pro (c.194A>C); ClinVar=VCV001178472; Zygosity=Heterozygous (C-BIG).
CC   Sequence variation: Mutation; HGNC; HGNC:28709; TMEM175; Simple_edited; p.Gln65Pro (c.194A>C); ClinVar=VCV001178472; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6LT ! 3123
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3132
AC   CVCL_IZ49
DR   GEO; GSM2282266
DR   Wikidata; Q54584725
RX   PubMed=507490;
RX   PubMed=2617846;
RX   PubMed=27639374;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Caution: Originally classified as originating from a B-cell lymphoma, but is reclassified as a histiocytic sarcoma based on characteristic cytogenomic properties (PubMed=27639374).
CC   Breed/subspecies: Belgian Malinois; VBO=VBO_0200147.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   3134
AC   CVCL_H641
DR   EFO; EFO_0007069
DR   ENCODE; ENCBS023ENC
DR   ENCODE; ENCBS655OXH
DR   GEO; GSM1014196
DR   Wikidata; Q54584727
RX   Patent=US7312032;
RX   PubMed=10497225;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/3134_Stam_protocol.pdf
CC   Group: Patented cell line.
CC   Part of: ENCODE project mouse cell lines.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11998.
CC   Characteristics: Contains 200 copies of the pM18 plasmid. pM18 contains a MMTV LTR promoter (the LTR contains GR-binding sites) driven ha-v-ras and a 69% transforming fragment of bovine papilloma virus type 1 (BPV1) (from parent cell line).
CC   Characteristics: Has undergone a spontaneous integration and amplification of the pM18 episome in the genome (PubMed=10497225).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z933 ! 904.13
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   3151Liv
AC   CVCL_E3YJ
RX   PubMed=21764851;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Trp53 fl/fl;Rb1 fl/fl.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E3YK ! 3151T1
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3151T1
AC   CVCL_E3YK
RX   PubMed=21764851;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Trp53 fl/fl;Rb1 fl/fl.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E3YJ ! 3151Liv
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   315A
AC   CVCL_E3ZE
DR   ABCD; ABCD_AJ807
RX   PubMed=28027008;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61282; Wogonin 7-O-beta-D-glucuronide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   316G1
AC   CVCL_D3QC
DR   Wikidata; Q127378708
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   31708
AC   CVCL_E444
DR   dbMHC; 48462
DR   ECACC; 94071426
DR   IHW; IHW09278
DR   IPD-IMGT/HLA; 10132
DR   Wikidata; Q54584728
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*23:01,68:02; B*15:03,35; C*02:02,04:01 (IPD-IMGT/HLA=10132).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   317G5
AC   CVCL_J637
SY   317G5.C1D3; CTCC 0055
DR   CLO; CLO_0001289
DR   ATCC; HB-8485
DR   ATCC; HB-8691
DR   Wikidata; Q54584729
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8485.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8691.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   31854
AC   CVCL_JC73
SY   TER292; TER-292; Ter 292; TER370; TER-370; Ter 370; TER445; TER-445; Ter 445
DR   IPD-IMGT/HLA; 11976
DR   Wikidata; Q54584732
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/352cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,11; B*15,57; C*04:01,06:02; DPB1*04:01,04:02; DQA1*02:01,05:05; DQB1*03:01,03:03; DRB1*07:01,13:14:02; DRB3*02:02; DRB4*01:03:01:02N (IPD-IMGT/HLA=11976).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   3190T
AC   CVCL_ZT04
DR   Wikidata; Q98125382
RX   PubMed=3136916;
RX   PubMed=6409440;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8498; Hereditary melanoma
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   3191T
AC   CVCL_ZT05
DR   Wikidata; Q98125383
RX   PubMed=3136916;
RX   PubMed=6409440;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8498; Hereditary melanoma
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   3197-3
AC   CVCL_6764
SY   3T3-MSV
DR   CLO; CLO_0001291
DR   ATCC; CRL-1568
DR   IZSLER; BS CL 155
DR   Wikidata; Q54584734
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   31B5
AC   CVCL_C2ER
DR   Wikidata; Q114310440
RX   PubMed=2454657;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Rat lamin B (Note=Uncertain if it recognized both Lmnb1 and Lmnb2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   31BY4-1
AC   CVCL_DD94
DR   Wikidata; Q54584736
RX   PubMed=6840439;
CC   Transformant: NCBI_TaxID; 10529; Adenovirus 31 (Note=BamHI-B fragment).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   31E
AC   CVCL_8628
SY   IM-2 cl 31E; Line 31E
DR   Wikidata; Q54584738
RX   PubMed=2466037;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S548 ! IM-2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   31E9
AC   CVCL_7238
DR   CLO; CLO_0001292
DR   ATCC; HB-11052
DR   CCRID; 4201PAT-CCTCC00112
DR   Wikidata; Q54584739
RX   Patent=US5565338;
RX   Patent=US5723582;
RX   Patent=WO1994026923A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11052.
CC   Characteristics: T-cell hybridoma. Produces MIF.
CC   Monoclonal antibody target: Cryptomeria japonica pollen antigen.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G691 ! BUC
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   31F4L
AC   CVCL_4088
DR   CLO; CLO_0001293
DR   CLDB; cl57
DR   ECACC; 87081901
DR   Wikidata; Q54584741
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   31FSDNC14
AC   CVCL_RH69
SY   DOXTOX1 hiPSC
DR   SKIP; SKIP001181
DR   Wikidata; Q54584742
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   31GY1-2
AC   CVCL_DD95
DR   Wikidata; Q54584744
RX   PubMed=6840439;
CC   Transformant: NCBI_TaxID; 10529; Adenovirus 31 (Note=HindIII-G fragment).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   31GY2-5
AC   CVCL_DD96
DR   Wikidata; Q54584817
RX   PubMed=6840439;
CC   Transformant: NCBI_TaxID; 10529; Adenovirus 31 (Note=HindIII-G fragment).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   31GY3-4
AC   CVCL_DD97
DR   Wikidata; Q54584821
RX   PubMed=6840439;
CC   Transformant: NCBI_TaxID; 10529; Adenovirus 31 (Note=HindIII-G fragment).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   31H12
AC   CVCL_A0JH
DR   Wikidata; Q108819541
RX   PubMed=1283092;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   32-2B
AC   CVCL_J717
DR   ECACC; 91121237
DR   Wikidata; Q54584822
RX   PubMed=3323436;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03763; Bovine DSG1.
CC   Discontinued: ECACC; 91121237; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   32.2
AC   CVCL_J660
SY   M32.2; Hybridoma for mAB 32
DR   CLO; CLO_0001294
DR   ATCC; HB-9469
DR   Wikidata; Q54584823
RX   Patent=US4954617;
RX   Patent=US5833985;
RX   PubMed=2474608;
RX   PubMed=2960735;
RX   PubMed=3017990;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9469.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12314; Human FCGR1A/CD64.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   32.3
AC   CVCL_1J86
DR   Wikidata; Q54584824
RX   Patent=US5698765;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11114.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:88335; Cd4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 7
//
ID   32/32
AC   CVCL_E445
DR   dbMHC; 48463
DR   IHW; IHW09250
DR   IPD-IMGT/HLA; 10134
DR   Wikidata; Q54584826
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*29:02,30:02; B*78:01,57:02; C*16:01,18:01; DPB1*02:01:02,13:01 (IPD-IMGT/HLA=10134).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   32/37
AC   CVCL_E446
DR   dbMHC; 48464
DR   ECACC; 94022519
DR   IHW; IHW09240
DR   IPD-IMGT/HLA; 10135
DR   Wikidata; Q54584827
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*24:02:01:01,30:02; B*27:05:01/27:13,57:02:01; C*02:02,04:01; DPB1*02:01:02,04:02 (IPD-IMGT/HLA=10135).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022519; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   3200P
AC   CVCL_4Y81
DR   Wikidata; Q54584828
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3201
AC   CVCL_X612
SY   3201B
DR   Wikidata; Q54584831
RX   PubMed=212681;
RX   PubMed=8138999;
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 6
//
ID   3201-FIV
AC   CVCL_UG15
SY   3201/FIV
DR   Wikidata; Q93305376
RX   Patent=US6555107;
RX   PubMed=9658135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10909.
CC   Virology: Persistently infected by feline immunodeficiency virus (FIV).
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_X612 ! 3201
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   3201/61E
AC   CVCL_X614
SY   3201/61; FeLV 61E Infected 3201B Cells
DR   BEI_Resources; ARP-198
DR   Wikidata; Q54584834
CC   Virology: Infected with feline leukemia virus (FeLV) isolate 61E.
CC   Doubling time: 15-20 hours (BEI_Resources=ARP-198).
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_X612 ! 3201
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 11
//
ID   3201/EECC
AC   CVCL_X613
SY   3201-EECC; FeLV EECC infected 3201B Cells
DR   BEI_Resources; ARP-197
DR   Wikidata; Q54584833
CC   Virology: Infected with feline leukemia virus (FeLV) isolate EECC.
CC   Doubling time: 15-20 hours (BEI_Resources=ARP-197).
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_X612 ! 3201
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 11
//
ID   320G10
AC   CVCL_B0FW
DR   Wikidata; Q108819542
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4514.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   32367
AC   CVCL_E447
DR   dbMHC; 48465
DR   ECACC; 94050335
DR   IHW; IHW09257
DR   IPD-IMGT/HLA; 10136
DR   Wikidata; Q54584835
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*33:03,74:01; B*56:01,14:01; C*01:02,07:01; DPB1*04:02,16:01 (IPD-IMGT/HLA=10136).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   3248T
AC   CVCL_ZT06
DR   Wikidata; Q98125385
RX   PubMed=3136916;
RX   PubMed=6409440;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8498; Hereditary melanoma
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   325.1
AC   CVCL_0I00
DR   Wikidata; Q54584837
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5120.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   32511
AC   CVCL_E448
SY   TER232; TER-232; Ter 232; TER284; TER-284; Ter 284; TER376; TER-376; Ter 376; TER485; TER-485; Ter 485; Extract 81; Extract 272; Extract 365
DR   dbMHC; 48466
DR   ECACC; 94071436
DR   IHW; IHW09231
DR   IPD-IMGT/HLA; 10137
DR   Wikidata; Q54584839
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/373cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*80:01,02:06; B*18:JV,27:ENN; C*02:02:02; DPB1*01:01:01,05:01; DQA1*01:03,01:04; DQB1*05:03:01,06:03; DRB1*13:01:01,14:54; DRB3*01:01,02:02 (IPD-IMGT/HLA=10137).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   32711
AC   CVCL_JD45
SY   Extract 422
DR   IPD-IMGT/HLA; 12294
DR   Wikidata; Q54584841
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/334cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01:05,11; B*44:02,35; C*05:01,04:01; DQA1*05,01:01; DQB1*05:01,03:01; DRB1*01,11:01; DRB3*02:02 (IPD-IMGT/HLA=12294).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   328/10
AC   CVCL_4480
DR   ECACC; 08062536
DR   Wikidata; Q54584842
RX   PubMed=16829;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   328/11
AC   CVCL_4481
DR   ECACC; 08062538
DR   Wikidata; Q54584843
RX   PubMed=16829;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   328/12
AC   CVCL_4482
DR   ECACC; 08062540
DR   Wikidata; Q54584845
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 4
//
ID   328/14
AC   CVCL_4483
DR   ECACC; 08062541
DR   Wikidata; Q54584846
RX   PubMed=16829;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   328/23
AC   CVCL_UH49
DR   Wikidata; Q93305449
RX   PubMed=16829;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 3
//
ID   328/7
AC   CVCL_4484
DR   ECACC; 08062530
DR   Wikidata; Q54584848
RX   PubMed=16829;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   328/8
AC   CVCL_4485
DR   ECACC; 08062531
DR   Wikidata; Q54584850
RX   PubMed=16829;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   328/9
AC   CVCL_4486
DR   ECACC; 08062533
DR   Wikidata; Q54584851
RX   PubMed=16829;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2135 ! N4TG3
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   32A1
AC   CVCL_B0DC
DR   Wikidata; Q108819543
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10795.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10066.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   32b
AC   CVCL_C5I0
DR   Wikidata; Q116048093
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   32B11
AC   CVCL_J661
DR   CLO; CLO_0001295
DR   ATCC; CRL-2559
DR   Wikidata; Q54584852
RX   DOI=10.1007/BF00012053;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q0H0L1; Rhizophagus irregularis heat shock protein 60 (Glomalin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   32B5C7
AC   CVCL_F0GZ
RX   Patent=US10973915;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279 (Note=Also reacts with M.fascicularis).
CC   Miscellaneous: As the immunized splenic B-cells are from H2L2 transgenic mice the produced mAB is a chimeric Ig having human variable domain and rat constant region.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   32D
AC   CVCL_0118
DR   BTO; BTO_0002882
DR   CLO; CLO_0001296
DR   CLO; CLO_0051044
DR   EFO; EFO_0022796
DR   MCCL; MCC:0000010
DR   DSMZ; ACC-411
DR   DSMZCellDive; ACC-411
DR   Lonza; 673
DR   RCB; RCB1145
DR   Wikidata; Q54584854
RX   PubMed=25277546;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=32D
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/3/cell-lines-detail-139.html
CC   Characteristics: IL3 dependent.
CC   Doubling time: ~15 hours (DSMZ=ACC-411).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   32D Epo1
AC   CVCL_LC54
DR   Wikidata; Q54584856
RX   PubMed=2668305;
CC   Characteristics: IL3 or EPO dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0119 ! 32Dcl3
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   32D G
AC   CVCL_LC55
SY   32D-G; 32D G1
DR   Wikidata; Q54584857
RX   PubMed=2668305;
RX   PubMed=7679009;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=32D-G
CC   Characteristics: CSF3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0119 ! 32Dcl3
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   32D GM
AC   CVCL_LC56
SY   32D-GM; 32D(GM); 32D GM1
DR   Wikidata; Q54584859
RX   PubMed=2668305;
RX   PubMed=7679009;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=32D-GM
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0119 ! 32Dcl3
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   32D KIT isoform 1
AC   CVCL_E6XU
SY   32D c-KIT GNNK+
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 1 = GNNK+).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0118 ! 32D
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   32D KIT isoform 2
AC   CVCL_E6XV
SY   32D c-KIT GNNK-
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 2 = GNNK-).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0118 ! 32D
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   32D-c-fms
AC   CVCL_R769
DR   Wikidata; Q54584860
RX   PubMed=2165597;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2433; CSF1R.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0119 ! 32Dcl3
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   32D-Flt3-ITD
AC   CVCL_WG50
DR   Wikidata; Q93305501
RX   PubMed=19854140;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0119 ! 32Dcl3
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   32D-Flt3-WT
AC   CVCL_WG51
DR   Wikidata; Q93305502
RX   PubMed=19854140;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0119 ! 32Dcl3
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   32D/G-CSF-R
AC   CVCL_A0UA
SY   32D/WT; 32D.WT
DR   Wikidata; Q108819544
RX   PubMed=7542747;
RX   PubMed=8246993;
RX   PubMed=9490675;
RX   PubMed=29553501;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/G-CSF-R p.Gln739Ter
AC   CVCL_A0UD
SY   32D/DA
DR   Wikidata; Q108819545
RX   PubMed=8246993;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Gln739Ter).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/G-CSF-R p.Gln741Ter
AC   CVCL_A0UB
SY   32D.1
DR   Wikidata; Q108819546
RX   PubMed=7542747;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Gln741Ter).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/G-CSF-R p.Gln754Ter
AC   CVCL_A0UC
SY   32D.2
DR   Wikidata; Q108819548
RX   PubMed=7542747;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Gln754Ter).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/G-CSF-R p.Tyr727Phe
AC   CVCL_A0UE
SY   32D/Y704F
DR   Wikidata; Q108819549
RX   PubMed=9490675;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr727Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/G-CSF-R p.Tyr752Phe
AC   CVCL_A0UF
SY   32D/Y729F
DR   Wikidata; Q108819550
RX   PubMed=9490675;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr752Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/G-CSF-R p.Tyr767Phe
AC   CVCL_A0UG
SY   32D/Y744F
DR   Wikidata; Q108819551
RX   PubMed=9490675;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr767Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/G-CSF-R p.Tyr787Phe
AC   CVCL_A0UH
SY   32D/Y764F
DR   Wikidata; Q108819552
RX   PubMed=9490675;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr787Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0TZ ! 32D.C10
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   32D/HNP
AC   CVCL_C6XB
DR   Wikidata; Q123030263
RX   PubMed=8329717;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2761; DEFA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0118 ! 32D
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   32D.C10
AC   CVCL_A0TZ
SY   32D cl-10
DR   Wikidata; Q108819553
RX   PubMed=7542747;
RX   PubMed=8246993;
RX   PubMed=9490675;
CC   Characteristics: IL3 dependent.
CC   Characteristics: Does not express endogenous Csf3r.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0118 ! 32D
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   32Dcl23
AC   CVCL_6G54
SY   32D clone 23; 32Dclone23 32D cl23; 32D cl 23; 32D cl-23; 32Dc23
DR   Wikidata; Q54584861
RX   PubMed=2656885;
RX   PubMed=3089920;
RX   PubMed=6574462;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0118 ! 32D
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   32Dcl3
AC   CVCL_0119
SY   32D clone 3; 32D clone3; 32D cl-3; 32D-Cl3; 32D.cl3; 32D:cl3; 32D/cl3; 32D CL3; 32D Cl3; 32D cl3; 32Dc3; 32D.3
DR   BTO; BTO_0002883
DR   CLO; CLO_0001297
DR   CLO; CLO_0051042
DR   CLO; CLO_0051043
DR   EFO; EFO_0022755
DR   MCCL; MCC:0000011
DR   ATCC; CRL-3594
DR   ATCC; CRL-11346
DR   BCRC; 60456
DR   BCRJ; 0333
DR   BioGRID_ORCS_Cell_line; 1637
DR   CCTCC; GDC0181
DR   RCB; RCB1377
DR   RCB; RCB1538
DR   TOKU-E; 294
DR   Wikidata; Q54584864
RX   Patent=US5521295;
RX   PubMed=2668305;
RX   PubMed=10877550;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=32D
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11346.
CC   Characteristics: Widely used for the in vitro study of hematopoietic cell proliferation, differentiation and apoptosis (PubMed=10877550).
CC   Characteristics: IL3 dependent.
CC   Misspelling: 32Dc13; Note=Occasionally.
CC   Misspelling: 32D c13; Note=Occasionally.
CC   Misspelling: 32D:c13; Note=Occasionally.
CC   Discontinued: ATCC; CRL-11346; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0118 ! 32D
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   32Dcl3/HNP
AC   CVCL_C6XC
SY   32D c13/HNP
DR   Wikidata; Q123030264
RX   PubMed=8329717;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2761; DEFA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0119 ! 32Dcl3
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   32H6
AC   CVCL_E8NX
DR   ABCD; ABCD_BF015
RX   Patent=WO2024196162A1;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UXX9; Human RSPO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   32R1
AC   CVCL_DQ51
SY   HPS3668
DR   PRIDE; PXD000071
DR   RCB; HPS3668
DR   Wikidata; Q54584866
RX   PubMed=20660764;
RX   PubMed=23210603;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   32R2
AC   CVCL_DQ52
SY   HPS0296
DR   RCB; HPS0296
DR   Wikidata; Q54584868
RX   PubMed=20660764;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   32R6
AC   CVCL_DQ53
SY   HPS0326
DR   RCB; HPS0326
DR   Wikidata; Q54584869
RX   PubMed=20660764;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   33-294-17
AC   CVCL_YA99
DR   ABCD; ABCD_AK566
DR   DSHB; 33-294-17
DR   Wikidata; Q93305518
RX   PubMed=2408765;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08796; Dictyostelium discoideum csaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   33-3D
AC   CVCL_J718
DR   ECACC; 91121238
DR   Wikidata; Q54584870
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q03763; Bovine DSG1.
CC   Discontinued: ECACC; 91121238; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   331.12
AC   CVCL_9158
DR   CLO; CLO_0001298
DR   ATCC; TIB-129
DR   BCRJ; 0012
DR   Wikidata; Q54584871
RX   PubMed=6165776;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   33365M
AC   CVCL_WM45
DR   cancercelllines; CVCL_WM45
DR   Cosmic; 852219
DR   Wikidata; Q93305520
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   337-3
AC   CVCL_J873
DR   Wikidata; Q54584873
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   338.11.5
AC   CVCL_C4PY
DR   Wikidata; Q116048094
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8314.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.14.3
AC   CVCL_C4PZ
DR   Wikidata; Q116048095
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8313.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   338.15.5
AC   CVCL_C4Q0
DR   Wikidata; Q116048096
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8315.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.17.3
AC   CVCL_C4Q1
DR   Wikidata; Q116048097
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8316.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.18
AC   CVCL_C5MI
DR   Wikidata; Q116048098
RX   PubMed=17316082;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09237; Human MMP7 (Note=Also reacts with mouse, pig and gerbil).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   338.24.5
AC   CVCL_C4Q2
DR   Wikidata; Q116048099
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8430.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.25.6
AC   CVCL_C4Q3
DR   Wikidata; Q116048100
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8431.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.28.6
AC   CVCL_C4Q4
DR   Wikidata; Q116048101
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8434.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.29.2
AC   CVCL_C4Q5
DR   Wikidata; Q116048103
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8433.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.39.5
AC   CVCL_C4Q6
DR   Wikidata; Q116048104
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8432.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   338.5.4
AC   CVCL_C4Q7
DR   Wikidata; Q116048105
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8317.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   339.15.3.6
AC   CVCL_B0BF
DR   Wikidata; Q108819554
RX   Patent=US10000563;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7987.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16552; Human IL17A.
CC   Monoclonal antibody target: UniProtKB; Q96PD4; Human IL17F.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   339.15.5.3
AC   CVCL_B0BG
DR   Wikidata; Q108819555
RX   Patent=US10000563;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7987.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16552; Human IL17A.
CC   Monoclonal antibody target: UniProtKB; Q96PD4; Human IL17F.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   339.15.6.16
AC   CVCL_B0V1
DR   Wikidata; Q108819556
RX   Patent=US10000563;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7989.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16552; Human IL17A.
CC   Monoclonal antibody target: UniProtKB; Q96PD4; Human IL17F.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   339-1
AC   CVCL_J662
DR   CLO; CLO_0001299
DR   ATCC; HB-186
DR   Wikidata; Q54584874
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   3394
AC   CVCL_C0KW
DR   Wikidata; Q112926944
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   33B
AC   CVCL_3982
DR   BTO; BTO_0002938
DR   CLO; CLO_0001300
DR   CLDB; cl58
DR   ECACC; 85081901
DR   Wikidata; Q54584875
RX   PubMed=1093176;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Spinal cord; UBERON=UBERON_0002240.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C60461; Rat malignant oligodendroglioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4329 ! TR33B
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   33BTE-140
AC   CVCL_C6WS
DR   Wikidata; Q123030265
RX   PubMed=3500416;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW61 ! BW-1100.129
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   33BTE-140.9
AC   CVCL_C6WT
DR   Wikidata; Q123030266
RX   PubMed=3500416;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6WS ! 33BTE-140
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   33D1
AC   CVCL_9159
SY   33 D1
DR   CLO; CLO_0001301
DR   ATCC; TIB-227
DR   BCRJ; 0011
DR   NCBI_Iran; H135
DR   Wikidata; Q54584876
RX   PubMed=6948298;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse dendritic cell inhibitory receptor 2 (DCIR2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   33F11
AC   CVCL_F0VF
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   33F8
AC   CVCL_J913
SY   33F8.C3D12
DR   ATCC; HB-8697
DR   Wikidata; Q54584879
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8697.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   33G2
AC   CVCL_B0LV
DR   Wikidata; Q108819557
RX   PubMed=16714576;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 315-576 = B chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   33G7
AC   CVCL_E7CZ
RX   PubMed=27923109;
RX   PubMed=28029331;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O76003; Human GLRX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   33v1-051
AC   CVCL_6D21
DR   RCB; AES1384
DR   SKIP; SKIP002939
DR   Wikidata; Q54584950
CC   Knockout cell: Method=Gene trap; MGI; MGI:106354; Vps25.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   34
AC   CVCL_J663
DR   CLO; CLO_0001302
DR   ATCC; CRL-1889
DR   Wikidata; Q54584951
RX   PubMed=6305011;
RX   PubMed=6787798;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein p15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   34-1-2S
AC   CVCL_G597
DR   CLO; CLO_0001303
DR   ATCC; HB-79
DR   Wikidata; Q54584952
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse MHC class I H-2Kd/H-2Dd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   34-1-4S
AC   CVCL_Y309
DR   ATCC; HB-74
DR   Wikidata; Q54584954
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse MHC class II I-Ed.
CC   Discontinued: ATCC; HB-74; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   34-2-12S
AC   CVCL_G598
DR   CLO; CLO_0001304
DR   ATCC; HB-87
DR   Wikidata; Q54584956
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse MHC class I H-2Dd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   34-4-20S
AC   CVCL_G599
DR   CLO; CLO_0001305
DR   ATCC; HB-75
DR   IZSLER; BS Hy 61
DR   Wikidata; Q54584958
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse MHC class I H-2Dd.
CC   Discontinued: IZSLER; BS Hy 61; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   34-4-21S
AC   CVCL_G600
DR   CLO; CLO_0001306
DR   ATCC; HB-76
DR   Wikidata; Q54584959
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse MHC class I H-2Dd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   34-5-3S
AC   CVCL_4487
DR   CLO; CLO_0001307
DR   ATCC; HB-85
DR   Wikidata; Q54584961
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse MHC class II I-Ad.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   34-5-8S
AC   CVCL_4488
DR   CLO; CLO_0001308
DR   CLDB; cl5138
DR   ATCC; HB-102
DR   IZSLER; BS Hy 40
DR   Wikidata; Q54584962
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse MHC class I H-2Dd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   34-7-23S
AC   CVCL_4489
DR   CLO; CLO_0001309
DR   ATCC; HB-101
DR   Wikidata; Q54584963
RX   PubMed=7135466;
CC   Monoclonal antibody isotype: IgG2a, kappa (PubMed=7135466); IgM (ATCC=HB-101).
CC   Monoclonal antibody target: Mouse MHC class I H-2Kd/H-2Dd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   34.1
AC   CVCL_A0BV
DR   Wikidata; Q108819558
RX   PubMed=24872420;
RX   PubMed=30502324;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q05059; Human herpesvirus 1 (strain F) glycoprotein D (gD) (Note=Recognizes the p.Lys26_Gln52 N-terminal region used as a purification tag).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   340-RPE-11tv
AC   CVCL_W078
DR   ATCC; CRL-4002
DR   Wikidata; Q54584967
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ATCC; CRL-4002; true.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
ST   Source(s): ATCC=CRL-4002
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B365 ! RPE-340
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   3402P
AC   CVCL_4Y82
DR   Wikidata; Q54584969
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   340529
AC   CVCL_0C67
DR   Wikidata; Q54584971
RX   PubMed=19147538;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   342B1-11
AC   CVCL_C4UB
DR   Wikidata; Q116048106
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   343.11D1
AC   CVCL_LC57
DR   Wikidata; Q54584973
CC   From: Calbiochem-Behring Corp.; La Jolla; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18084; Human ITGB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   3439
AC   CVCL_E6LL
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3439 corrected
AC   CVCL_E6LM
SY   3439 (isogenic correction)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6LL ! 3439
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   343T
AC   CVCL_A2AK
DR   cancercelllines; CVCL_A2AK
DR   Wikidata; Q105505909
RX   PubMed=10545285;
RX   PubMed=14978140;
RX   PubMed=18645002;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=18645002).
CC   Miscellaneous: Age/sex of donor and lung cancer type from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   3445P
AC   CVCL_4Y83
DR   Wikidata; Q54584975
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3446P
AC   CVCL_4Y84
DR   Wikidata; Q54584977
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3448
AC   CVCL_C0KP
DR   Wikidata; Q112926945
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   3450
AC   CVCL_C0KQ
DR   Wikidata; Q112926947
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   346D1
AC   CVCL_DQ33
DR   GEO; GSM2152671
DR   Wikidata; Q54584979
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   346E1
AC   CVCL_DQ34
DR   GEO; GSM2152672
DR   Wikidata; Q54584982
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   346E2
AC   CVCL_DQ35
DR   GEO; GSM2152673
DR   Wikidata; Q54584984
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   346F1
AC   CVCL_DQ36
DR   GEO; GSM2152674
DR   Wikidata; Q54584986
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   347BR
AC   CVCL_WY30
SY   347 BRighton
DR   Wikidata; Q93305604
RX   PubMed=10987302;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   347C2
AC   CVCL_M027
DR   ECACC; 93071515
DR   Wikidata; Q54584987
RX   PubMed=2888227;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fimbrial protein (fanC).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J051 ! 94A1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   347C2b/D4
AC   CVCL_M028
DR   ECACC; 93071503
DR   Wikidata; Q54584990
RX   PubMed=2888227;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fimbrial protein (fanC).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J051 ! 94A1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   348617
AC   CVCL_0C68
DR   Wikidata; Q54584992
RX   PubMed=19147538;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   34893 2L
AC   CVCL_B0KY
SY   348932L; 2L
DR   Wikidata; Q108819559
RX   CelloPub=CLPUB00648;
RX   Patent=US5770447;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12108.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1402; CACNB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13806; Rabbit CACNA2D1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   348C6
AC   CVCL_K116
DR   ECACC; 85062511
DR   Wikidata; Q54584994
RX   PubMed=2888227;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fimbrial protein (fanC).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J051 ! 94A1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   3492
AC   CVCL_E6LY
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Heterozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3498P
AC   CVCL_4Y85
DR   Wikidata; Q54584995
RX   PubMed=1689712;
RX   PubMed=7539412;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from head and neck squamous cell carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   34B2
AC   CVCL_C5DB
DR   Wikidata; Q116048107
RX   PubMed=11991817;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02548; Bovine NEFL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   34B6
AC   CVCL_C2ES
DR   Wikidata; Q114310441
RX   PubMed=2454657;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P48679; Rat Lmna.
CC   Monoclonal antibody target: Rat lamin B (Note=Uncertain if it recognized both Lmnb1 and Lmnb2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   34C9
AC   CVCL_IQ40
DR   Wikidata; Q54584998
RX   Patent=US7259246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2296.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with human, mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   34D03
AC   CVCL_C5A5
DR   ABCD; ABCD_AN899
DR   Wikidata; Q116048108
RX   Patent=US10421807;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; C7G0W1; Dog IL31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   34H1
AC   CVCL_A0QR
DR   Wikidata; Q108819560
RX   PubMed=10816462;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   34T
AC   CVCL_0071
DR   Wikidata; Q54584999
RX   PubMed=21518866;
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 7
//
ID   35
AC   CVCL_4630
DR   CLDB; cl59
DR   Wikidata; Q54585001
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   35 E 10
AC   CVCL_D661
SY   35E10
DR   BCRJ; 0013
DR   Wikidata; Q54585002
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01587; Mouse Csf2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   35.1
AC   CVCL_7239
DR   CLO; CLO_0001310
DR   ATCC; HB-222
DR   CLS; 305002
DR   Wikidata; Q54585003
RX   PubMed=6190907;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
CC   Discontinued: CLS; 305002; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   35.32
AC   CVCL_DD40
DR   Wikidata; Q54585004
RX   Patent=US6218187;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11972.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   35.8.2H
AC   CVCL_D3V9
DR   ABCD; ABCD_AE271
DR   Wikidata; Q127378709
RX   PubMed=2464028;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with BSA coupled isomaltotriose (BSA-IM3)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   35020
AC   CVCL_E449
DR   dbMHC; 48467
DR   ECACC; 94050321
DR   IHW; IHW09232
DR   IPD-IMGT/HLA; 10145
DR   Wikidata; Q54585008
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*80:01,30:01; B*57:02; C*04; DPB1*01:01:01 (IPD-IMGT/HLA=10145).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   3512P
AC   CVCL_4Y86
DR   Wikidata; Q54585010
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3513P
AC   CVCL_4Y87
DR   Wikidata; Q54585012
RX   PubMed=1561323;
RX   PubMed=1689712;
RX   PubMed=7539412;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3518
AC   CVCL_C0KX
DR   Wikidata; Q112926951
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   3519P
AC   CVCL_4Y88
DR   Wikidata; Q54585013
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   351D2/D7
AC   CVCL_J664
DR   ECACC; 93071501
DR   Wikidata; Q54585014
RX   PubMed=2888227;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18103; Escherichia coli K99 fimbrial protein (fanC).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J051 ! 94A1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   3526LN
AC   CVCL_E3YL
RX   PubMed=21764851;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Trp53 fl/fl;Rb1 fl/fl.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   35285
AC   CVCL_JD44
SY   13672711; Extract 425
DR   IPD-IMGT/HLA; 13977
DR   Wikidata; Q54585016
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/335cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,02; B*40:52,37; C*03:04,06:BG; DQA1*01:DF,03; DQB1*05:03,03:JV; DRB1*04:APPJ,14:JCJ; DRB3*02; DRB4*01 (IPD-IMGT/HLA=13977).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   3528P
AC   CVCL_4Y89
DR   Wikidata; Q54585018
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3529P
AC   CVCL_4Y90
DR   Wikidata; Q54585020
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3530P
AC   CVCL_4Y91
DR   Wikidata; Q54585097
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3535P
AC   CVCL_4Y92
DR   Wikidata; Q54585098
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3543P
AC   CVCL_4Y93
DR   Wikidata; Q54585099
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3548P
AC   CVCL_4Y94
DR   Wikidata; Q54585101
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   356-1
AC   CVCL_J665
DR   CLO; CLO_0001312
DR   ATCC; HB-181
DR   IZSLER; BS Hy 37
DR   Wikidata; Q54585103
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   3566P
AC   CVCL_4Y95
DR   Wikidata; Q54585105
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3567
AC   CVCL_E6LN
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Met1646Thr (c.4937T>C); ClinVar=VCV000039200; Zygosity=Heterozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3567 corrected
AC   CVCL_E6LP
SY   3567 (isogenic correction)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Met1646Thr (c.4937T>C); ClinVar=VCV000039200; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6LN ! 3567
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   357-101-4
AC   CVCL_J666
DR   ECACC; 92030603
DR   NCBI_Iran; H117
DR   Wikidata; Q54585106
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   357-167-24
AC   CVCL_J667
DR   ECACC; 92030604
DR   Wikidata; Q54585109
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   3570P
AC   CVCL_4Y96
DR   Wikidata; Q54585110
RX   PubMed=1689712;
RX   PubMed=7539412;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from head and neck squamous cell carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   3573P
AC   CVCL_4Y97
DR   Wikidata; Q54585112
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   3575
AC   CVCL_E6LQ
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3575 corrected
AC   CVCL_E6LR
SY   3575 (isogenic correction)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6LQ ! 3575
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3581
AC   CVCL_E6LZ
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:12649; VAPB; Simple; p.Ala2Val (c.5G>A); Zygosity=Unspecified (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168751; Amyotrophic lateral sclerosis 8
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   35841
AC   CVCL_E450
DR   dbMHC; 48468
DR   ECACC; 94050322
DR   IHW; IHW09235
DR   IPD-IMGT/HLA; 10146
DR   Wikidata; Q54585114
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*80:01,68:01; B*58:02,18; C*02,06:02; DPB1*01:01:01,02:01:02 (IPD-IMGT/HLA=10146).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94050322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   3585P
AC   CVCL_4Y98
DR   Wikidata; Q54585116
RX   PubMed=1689712;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   359-238-8
AC   CVCL_J668
DR   ECACC; 92030605
DR   Wikidata; Q54585119
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01374; Human LTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   359-81-11
AC   CVCL_J669
DR   ECACC; 92030606
DR   NCBI_Iran; H130
DR   Wikidata; Q54585120
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01374; Human LTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   3590P
AC   CVCL_4Y99
DR   Wikidata; Q54585122
RX   PubMed=1561323;
RX   PubMed=1689712;
RX   PubMed=7539412;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from head and neck squamous cell carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   35919
AC   CVCL_JD20
SY   11378859; TER335; TER-335; Ter 335; TER437; TER-437; Ter 437
DR   IPD-IMGT/HLA; 12583
DR   Wikidata; Q54585125
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/349cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,31; B*08,40:01; C*03:04,07; DPB1*04:01,06:01; DQA1*03:01,05:01; DQB1*02:01,03:02; DRB1*03:04,04:04; DRB3*01:01; DRB4*01:03 (IPD-IMGT/HLA=12583).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   35980
AC   CVCL_JD40
SY   1092048; TER289; TER-289; Ter 289; Extract 433
DR   IPD-IMGT/HLA; 12603
DR   Wikidata; Q54585126
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/337cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,68:01; B*40:01,57:08; C*03:04,06:02; DPA1*01:CG; DPB1*03:AMYJ,05:BAJU; DQA1*01,02:01; DQB1*02:02,06:04; DRB1*07:01,13:02; DRB3*03:01; DRB4*01:MZ (IPD-IMGT/HLA=12603).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   359C1-12
AC   CVCL_C4UC
DR   Wikidata; Q116048109
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   35A6
AC   CVCL_A0QS
DR   Wikidata; Q108819561
RX   Patent=JP3395817;
RX   PubMed=10816462;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5244.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; F8WJY4; Mycoplasmoides gallisepticum (strain R) MGC3 (crMA) (Note=Also reacts with other strains, but not avirulent strain F).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   35B5
AC   CVCL_F0VG
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG2a+IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   35C1
AC   CVCL_A7EY
DR   Wikidata; Q107113226
RX   PubMed=12619897;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14965; Human AURKA (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   35C2
AC   CVCL_F0VH
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   35C8
AC   CVCL_XV43
DR   Wikidata; Q93305827
RX   DOI=10.13523/j.cb.20180408;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; X2G6F6; Tupaia belangeri CD3E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   35E10
AC   CVCL_B0DD
DR   Wikidata; Q108819562
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10796.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10067.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human breast cancer 80 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   35H5
AC   CVCL_A0QT
DR   Wikidata; Q108819563
RX   Patent=JP3395817;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15206.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   35H6
AC   CVCL_B0LW
DR   Wikidata; Q108819564
RX   PubMed=16714576;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 315-576 = B chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   36
AC   CVCL_9087
SY   #36
DR   CLO; CLO_0001313
DR   ATCC; CRL-8193
DR   Wikidata; Q54585128
RX   Patent=US4574116;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8193.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
HI   CVCL_J236 ! FU-266 clone E1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   36 BLCL
AC   CVCL_E401
DR   ECACC; 94031601
DR   Wikidata; Q54585129
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   36-54
AC   CVCL_F1HV
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   36-60
AC   CVCL_F1FT
RX   PubMed=6341819;
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   36-65
AC   CVCL_F1H3
DR   ABCD; ABCD_AH020
RX   PubMed=6767242;
RX   PubMed=6843553;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   36-65-1
AC   CVCL_F1FU
RX   PubMed=6341819;
RX   PubMed=6767242;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1H3 ! 36-65
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   36-71
AC   CVCL_F1H4
DR   ABCD; ABCD_AH021
RX   PubMed=6153633;
RX   PubMed=6767242;
RX   PubMed=6843553;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   36.1.2D
AC   CVCL_D3VA
DR   ABCD; ABCD_AE273
DR   Wikidata; Q127378710
RX   PubMed=2464028;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with BSA coupled isomaltotriose (BSA-IM3)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   36.5
AC   CVCL_9090
SY   36.5 (CD8+)
DR   CLO; CLO_0001314
DR   ATCC; CRL-11116
DR   Wikidata; Q54585131
RX   Patent=US5530178;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11116.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:88346; Cd8a.
CC   Discontinued: ATCC; CRL-11116; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 11
//
ID   360-27E06
AC   CVCL_J588
DR   Wikidata; Q54585133
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9280.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00529; UR2 avian sarcoma virus v-Ros.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   3600
AC   CVCL_E6LS
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   361-31C05
AC   CVCL_J589
DR   Wikidata; Q54585134
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9227.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00529; UR2 avian sarcoma virus v-Ros.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   3614
AC   CVCL_ZD44
DR   Wikidata; Q98125386
RX   PubMed=8105609;
CC   Population: Peruvian.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   362.597.3.15
AC   CVCL_C4Q8
DR   Wikidata; Q116048111
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8786.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   362.75.1.1
AC   CVCL_C4Q9
DR   Wikidata; Q116048112
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8791.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   362.78.1.44
AC   CVCL_C4QA
DR   Wikidata; Q116048113
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8790.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   3620
AC   CVCL_C0KY
DR   Wikidata; Q112926953
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   3630
AC   CVCL_C0KZ
DR   Wikidata; Q112926956
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   363G1
AC   CVCL_DQ37
DR   GEO; GSM2152675
DR   Wikidata; Q54585136
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   3640P
AC   CVCL_4Z00
DR   Wikidata; Q54585137
RX   PubMed=1689712;
RX   PubMed=7539412;
RX   PubMed=7685988;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from head and neck squamous cell carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   365A1-1
AC   CVCL_C4UD
DR   Wikidata; Q116048114
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   365A2-4
AC   CVCL_C4UE
DR   Wikidata; Q116048115
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   366.328.10.63
AC   CVCL_C4QB
DR   Wikidata; Q116048116
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8789.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   366.345.6.11
AC   CVCL_C4QC
DR   Wikidata; Q116048117
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8788.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   366.552.11.31
AC   CVCL_C4QD
DR   Wikidata; Q116048118
RX   Patent=US8361470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8787.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9HBE4; Human IL21.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   3660.5
AC   CVCL_C5XC
DR   Wikidata; Q116048119
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3669
AC   CVCL_ZD45
DR   Wikidata; Q98125388
RX   PubMed=8105609;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   366D3-2
AC   CVCL_C4UF
DR   Wikidata; Q116048120
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3675
AC   CVCL_C0L0
DR   Wikidata; Q112926958
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   36777
AC   CVCL_JD61
SY   13964593; NEQ_ED03/03; ED03/03; Extract 389
DR   IPD-IMGT/HLA; 13205
DR   Wikidata; Q54585141
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/326cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01:01,11:15; B*27:05:02,35:01:01; C*02:02:02,04:01:01; DQA1*01:DF,03; DQB1*03:02,05:03; DRB1*04:04,14:01:01; DRB3*02:02:01; DRB4*01:03 (IPD-IMGT/HLA=13205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   367A5-2
AC   CVCL_C4UG
DR   Wikidata; Q116048122
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   368-11
AC   CVCL_C4DX
DR   Wikidata; Q116048123
RX   PubMed=2040800;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   368-13
AC   CVCL_C4DY
DR   Wikidata; Q116048124
RX   PubMed=2040800;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   368-21
AC   CVCL_C4DZ
DR   ABCD; ABCD_AE802
DR   Wikidata; Q116048125
RX   PubMed=2040800;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   368.1
AC   CVCL_0I01
DR   Wikidata; Q54585142
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4568.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   368B1-5
AC   CVCL_C4UH
DR   Wikidata; Q116048126
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   368BR
AC   CVCL_B4FR
SY   368 BRighton
DR   Wikidata; Q110429760
RX   PubMed=10022907;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   369F10
AC   CVCL_J907
SY   369F10.C3A8
DR   ATCC; HB-8682
DR   Wikidata; Q54585145
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8682.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   36B10
AC   CVCL_D602
SY   36B-10; 36 B-10
DR   BTO; BTO_0005252
DR   Wikidata; Q54585147
RX   PubMed=9635836;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 7
//
ID   36C2
AC   CVCL_C2ET
DR   Wikidata; Q114310442
RX   PubMed=2454657;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P48679; Rat Lmna.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   36F-18C
AC   CVCL_G190
SY   36F
DR   CLO; CLO_0001316
DR   ATCC; HB-285
DR   ECACC; 91060547
DR   Wikidata; Q54585148
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; W5QG93; Sheep CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   36v-38
AC   CVCL_6D22
DR   RCB; AES1397
DR   SKIP; SKIP002940
DR   Wikidata; Q54585151
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147677; Lpxn.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   37 BLCL
AC   CVCL_E402
DR   ECACC; 94031602
DR   Wikidata; Q54585152
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   37.04.12
AC   CVCL_J670
SY   PM 37.04.12
DR   CLO; CLO_0001318
DR   ATCC; HB-9312
DR   Wikidata; Q54585153
RX   Patent=US4818685;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9312.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P13051; Human UNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   37.1.1
AC   CVCL_D3VB
DR   Wikidata; Q127378711
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   37.1E5.2
AC   CVCL_D3VC
DR   Wikidata; Q127378712
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   37057
AC   CVCL_JD53
SY   12106291; Extract 402
DR   IPD-IMGT/HLA; 13396
DR   Wikidata; Q54585156
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/329cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:21,31; B*07,49:01; C*07:01; DQA1*01:01,02:01; DQB1*02:02,05:01; DRB1*01:01,07:01; DRB4*01:MZ (IPD-IMGT/HLA=13396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   37165 mel
AC   CVCL_C7UD
DR   Wikidata; Q123030267
RX   PubMed=22207316;
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   371M
AC   CVCL_W438
DR   Wikidata; Q54585157
RX   PubMed=12703547;
CC   Population: Japanese.
CC   Doubling time: 84 hours (Note=At 10th passage), 37 hours (Note=At 34th passage) (PubMed=12703547).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   372
AC   CVCL_J538
DR   CLO; CLO_0001319
DR   ATCC; CRL-1893
DR   Wikidata; Q54585158
RX   PubMed=6305011;
RX   PubMed=6787798;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein p15E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   372B3.5
AC   CVCL_C4UI
DR   Wikidata; Q116048128
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   372D6.5
AC   CVCL_C4UJ
DR   Wikidata; Q116048130
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   373C9C3A1
AC   CVCL_D3SD
DR   DSHB; 373C9C3A1
DR   Wikidata; Q127378713
RX   PubMed=1696825;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0A7V3; Escherichia coli rpsC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   3750
AC   CVCL_C0L1
DR   Wikidata; Q112926961
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   37935
AC   CVCL_JC37
SY   11962305; TER520; TER-520; Ter-520; Ter 520; Extract 445; Extract 574
DR   IPD-IMGT/HLA; 15956
DR   Wikidata; Q54585159
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX389F.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01:38L,02:01; B*57:01,15:17; C*06:02,07:02; DPA1*01:ACDV; DPB1*04:01; DQA1*01:01,02:01; DQB1*03:03,05:01; DRB1*01:01,07:01; DRB4*01:03:01:02N (IPD-IMGT/HLA=15956).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   37A11
AC   CVCL_C3XK
DR   Wikidata; Q116048131
RX   PubMed=3125254;
RX   PubMed=3701062;
RX   PubMed=6747296;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   37A4
AC   CVCL_C3XL
DR   ABCD; ABCD_AE863
DR   Wikidata; Q116048132
RX   PubMed=3125254;
RX   PubMed=3701062;
RX   PubMed=6747296;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   37B11
AC   CVCL_F0VI
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   37G12
AC   CVCL_F1FK
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03366; HIV-1 isolate BH10 env (Note=AA 133-363 = p24).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   37S2.8
AC   CVCL_DD41
DR   Wikidata; Q54585162
RX   Patent=US6218187;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11971.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   37v-42
AC   CVCL_6D23
DR   RCB; AES1421
DR   SKIP; SKIP002941
DR   Wikidata; Q54585165
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   38-1
AC   CVCL_J877
DR   CLO; CLO_0001321
DR   ATCC; HB-182
DR   Wikidata; Q54585166
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   38.1
AC   CVCL_J860
DR   CLO; CLO_0001320
DR   ATCC; HB-231
DR   Wikidata; Q54585240
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   38.13
AC   CVCL_ZJ34
SY   38-13; 38:13
DR   Wikidata; Q98125389
RX   PubMed=2410009;
RX   PubMed=4065950;
RX   PubMed=6286514;
RX   PubMed=7031655;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_18313; Alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide (Globotriaosylceramide; Ceramide trihexoside; CD77).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   38.4
AC   CVCL_C5XD
DR   Wikidata; Q116048133
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   380
AC   CVCL_1047
DR   CLO; CLO_0001007
DR   CLDB; cl63
DR   CLDB; cl4977
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03473573
DR   cancercelllines; CVCL_1047
DR   Cosmic; 924101
DR   Cosmic; 1012056
DR   Cosmic; 1130253
DR   Cosmic; 1524787
DR   Cosmic; 2804869
DR   DSMZ; ACC-39
DR   DSMZCellDive; ACC-39
DR   GEO; GSM119536
DR   GEO; GSM236776
DR   GEO; GSM236812
DR   GEO; GSM1035325
DR   GEO; GSM5137703
DR   IARC_TP53; 27549
DR   ICLC; HTL99019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_1047
DR   Wikidata; Q54585241
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6334305;
RX   PubMed=8108117;
RX   PubMed=16408098;
RX   PubMed=16809887;
RX   PubMed=20164919;
RX   PubMed=26727417;
RX   PubMed=35354797;
CC   Doubling time: 3 days (PubMed=6334305); ~80 hours (DSMZ=ACC-39).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-39
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 15,16
ST   D21S11: 28,29
ST   D2S1338: 16,17
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 19,20
ST   Penta D: 10,13
ST   Penta E: 9,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   3808-1
AC   CVCL_UW46
DR   Wikidata; Q93305927
RX   PubMed=2559742;
RX   PubMed=8744932;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JE12 ! GM03808
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 12
//
ID   38290-TTT
AC   CVCL_WN36
SY   38290 TTT
DR   NCI-DTP; 38290-TTT
DR   Wikidata; Q93305929
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   382D8G1B4
AC   CVCL_D3SE
DR   Wikidata; Q127378714
RX   PubMed=1696825;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0A7V3; Escherichia coli rpsC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   386-D
AC   CVCL_F0AL
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   387H9
AC   CVCL_B0DE
DR   Wikidata; Q108819565
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10802.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10073.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast cancer 40 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   388D4
AC   CVCL_B0DF
SY   388D4-5E
DR   Wikidata; Q108819566
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10794.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10065.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   388F1
AC   CVCL_WL10
SY   HB 388F1
DR   CCRID; 4201PAT-CCTCC00111
DR   Wikidata; Q93305931
RX   Patent=US5565338;
RX   Patent=WO1994026923A1;
RX   PubMed=1730869;
RX   PubMed=7511819;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10472.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14174; Human MIF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 6
//
ID   389C6G7B9
AC   CVCL_D3SF
SY   389C6G7
DR   DSHB; 389C6G7B9
DR   Wikidata; Q127378715
RX   PubMed=2483051;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0A7S9; Escherichia coli rpsM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   38B7
AC   CVCL_A0QU
DR   Wikidata; Q108819567
RX   Patent=JP3395817;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15205.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   38B8
AC   CVCL_LH46
DR   Wikidata; Q54585307
RX   Patent=US20100086997;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8766.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16620; Human NTRK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   38C13
AC   CVCL_0J29
SY   38C-13
DR   Wikidata; Q54585243
RX   PubMed=408154;
RX   PubMed=22400032;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: C3H/eB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 6
//
ID   38E6E7HFK
AC   CVCL_0B34
SY   38E6/E7 HFK; 38E6E7 HFK
DR   BTO; BTO_0005482
DR   Wikidata; Q54585245
RX   PubMed=17898088;
RX   PubMed=21482671;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q80907; Human papillomavirus type 38 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q80908; Human papillomavirus type 38 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 37959; Human papillomavirus type 38 (HPV38).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   38M
AC   CVCL_C6IF
DR   Wikidata; Q116048134
RX   PubMed=30058195;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8BHC0; Mouse Lyve1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   38SB13
AC   CVCL_B0EN
DR   Wikidata; Q108819568
RX   Patent=US8153765;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7667.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   38SB18
AC   CVCL_B0EP
DR   Wikidata; Q108819569
RX   Patent=US8153765;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7669.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   38SB19
AC   CVCL_B0EQ
DR   Wikidata; Q108819570
RX   Patent=US8153765;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7670.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   38SB30
AC   CVCL_B0ER
DR   Wikidata; Q108819571
RX   Patent=US8153765;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7666.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   38SB31
AC   CVCL_B0ES
DR   Wikidata; Q108819572
RX   Patent=US8153765;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7668.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   38SB39
AC   CVCL_B0ET
DR   Wikidata; Q108819573
RX   Patent=US8153765;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7671.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   38v-29
AC   CVCL_6D24
DR   RCB; AES1519
DR   SKIP; SKIP002942
DR   Wikidata; Q54585249
CC   Knockout cell: Method=Gene trap; MGI; MGI:107194; Shroom2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   39 BLCL
AC   CVCL_E403
DR   ECACC; 94031604
DR   Wikidata; Q54585250
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   39-10
AC   CVCL_C6NF
SY   5F2 TK10P2; 5F2
DR   Wikidata; Q116048135
RX   Patent=US9139655;
RX   Patent=US9540447;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-08628.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ULW2; Human FZD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   39-2
AC   CVCL_C6NE
DR   Wikidata; Q116048136
RX   Patent=US9139655;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ULW2; Human FZD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   39-S
AC   CVCL_J600
SY   39S
DR   CLO; CLO_0001323
DR   ATCC; HB-8180
DR   Wikidata; Q54585252
RX   Patent=US4572896;
RX   PubMed=6277788;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8180.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04296; Human herpesvirus 1 (HHV-1) major DNA-binding protein (DBP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   39/3C2.2
AC   CVCL_VS74
DR   ATCC; HB-9
DR   Wikidata; Q93305957
RX   PubMed=567552;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P13379; Mouse Cd5.
CC   Discontinued: ATCC; HB-9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   39.4D5
AC   CVCL_C3HF
DR   DSHB; 39-4D5
DR   Wikidata; Q114310443
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P61374; Rat Isl1 (Note=Also reacts with many other species).
CC   Monoclonal antibody target: UniProtKB; P50480; Rat Isl2 (Note=Also reacts with many other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   390T
AC   CVCL_A2AJ
SY   3-90T
DR   Wikidata; Q105505911
RX   PubMed=14978140;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   391/95-D
AC   CVCL_F0AT
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   391B9E4E1
AC   CVCL_D3SG
DR   DSHB; 391B9E4E1
DR   Wikidata; Q127378716
RX   PubMed=1696825;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0A7V3; Escherichia coli rpsC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   392F10G8
AC   CVCL_D3SH
DR   Wikidata; Q127378717
RX   PubMed=1696825;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0A7V3; Escherichia coli rpsC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   393S
AC   CVCL_C7S2
DR   Wikidata; Q123030268
RX   PubMed=1066320;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7S3 ! 393T
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   393T
AC   CVCL_C7S3
DR   Wikidata; Q123030269
RX   PubMed=77569;
RX   PubMed=1066320;
CC   HLA typing: A*01,08/10; B*w35,w40 (PubMed=77569).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7S2 ! 393S
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 4
//
ID   395A4-4
AC   CVCL_C4UK
DR   Wikidata; Q116048137
RX   DOI=10.1016/B978-0-12-249920-3.50016-8;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   395A5
AC   CVCL_C5C2
SY   BP180
DR   Wikidata; Q116048138
RX   PubMed=22509915;
RX   PubMed=22509921;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; Q9UMD9; Human COL17A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   395D2
AC   CVCL_C5C3
DR   Wikidata; Q116048139
RX   PubMed=22509915;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; Q9UMD9; Human COL17A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3962M
AC   CVCL_WM52
DR   Cosmic; 852226
DR   Wikidata; Q93305959
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   397-mel
AC   CVCL_8050
SY   397-MEL; 397-Mel; 397 mel; 397mel; 397
DR   cancercelllines; CVCL_8050
DR   CGH-DB; 9295-4
DR   Cosmic; 876699
DR   Cosmic; 897736
DR   Cosmic; 905209
DR   Cosmic; 1295344
DR   Wikidata; Q54585254
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=8537970;
RX   PubMed=9670966;
RX   PubMed=9759882;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=11121133;
RX   PubMed=15467732;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,25 (PubMed=9670966).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   397-mel/A31
AC   CVCL_A1DW
SY   397mel/A31
DR   cancercelllines; CVCL_A1DW
DR   Wikidata; Q102113441
RX   PubMed=9759882;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*31).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8050 ! 397-mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   3988M
AC   CVCL_WM51
DR   cancercelllines; CVCL_WM51
DR   Cosmic; 852225
DR   Wikidata; Q93305966
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   399T
AC   CVCL_A2AL
DR   Wikidata; Q105505915
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   39As8
AC   CVCL_C7UP
DR   JCRB; JCRB1886
DR   Wikidata; Q123030270
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Characteristics: Peritoneal disseminated metastatic cell line.
CC   Characteristics: Parent cell line was injected subcutaneously into BALB/c nude mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 12 times.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1886
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 13,14
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A385 ! HSC-39
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 02-05-24; Version: 3
//
ID   39As8Luc
AC   CVCL_C7US
SY   39As8mLuc
DR   JCRB; NIHS1326
DR   Wikidata; Q123030271
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Characteristics: Grand-parent cell line was injected subcutaneously into BALB/c nude mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 12 times.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS1326; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7UP ! 39As8
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   39b
AC   CVCL_X725
SY   39b-ALS
DR   Wikidata; Q54585255
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (PubMed=24704492).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   39D1
AC   CVCL_F0VJ
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   39D5
AC   CVCL_B0N5
DR   Wikidata; Q108819574
RX   Patent=US9052316;
RX   PubMed=19066333;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2930.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13591; Human NCAM1/CD56.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   39E1
AC   CVCL_C3XM
DR   Wikidata; Q116048140
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   39E8
AC   CVCL_A0QV
DR   Wikidata; Q108819575
RX   Patent=JP3395817;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15208.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   39ER22
AC   CVCL_0H89
SY   ER 22; ER22
DR   ChEMBL-Cells; CHEMBL3308448
DR   PubChem_Cell_line; CVCL_0H89
DR   Wikidata; Q54585258
RX   PubMed=2699431;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2886 ! Dede
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   3A sub E
AC   CVCL_2287
SY   3A-sub E; 3A-Sub-E; 3A-sub-E; 3A-subE; 3ASubE
DR   CLO; CLO_0001324
DR   CLO; CLO_0001328
DR   CLDB; cl64
DR   ATCC; CRL-1584
DR   BCRC; 60302
DR   ECACC; 90110508
DR   Wikidata; Q54585259
RX   PubMed=28454693;
RX   PubMed=33043158;
CC   Characteristics: Established from 3A(tPA-30-1) cells that had begun to senesce. By passage 20 the cells had recovered and appeared capable of unlimited proliferation (ATCC=CRL-1584).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ts30).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
ST   Source(s): ATCC=CRL-1584; ECACC=90110508; PubMed=28454693
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 12,20
ST   D19S433: 14,16.2
ST   D21S11: 28,29
ST   D2S1338: 20,22
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 8,9
ST   Penta E: 7,14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2820 ! 3A(tPA-30-1)
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   3A(tPA-30-1)
AC   CVCL_2820
SY   TPA30-1; TPA 30-1; tPA30-1
DR   CLO; CLO_0001325
DR   EFO; EFO_0022454
DR   ATCC; CRL-1583
DR   BioSample; SAMN03471399
DR   ECACC; 96020926
DR   Wikidata; Q54585261
RX   PubMed=206898;
RX   PubMed=3493529;
RX   PubMed=33043158;
CC   Characteristics: Expresses the transformed phenotype at the permissive temperature (33 Celsius) and the non-transformed phenotype at the restrictive temperature (40 Celsius).
CC   Senescence: Has a limited life expectancy of 15 to 18 passages before entering the crisis stage (ATCC=CRL-1583).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ts30).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
ST   Source(s): ATCC=CRL-1583
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 12,20
ST   D19S433: 14,16.2
ST   D21S11: 28,29
ST   D2S1338: 20,22
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 8,9
ST   Penta E: 7,14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H646 ! TPA30-6
OI   CVCL_H645 ! TPWT-2
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   3A1 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IG
DR   Wikidata; Q107113228
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3A1 [Mouse/rat hybridoma against human SDF2]
AC   CVCL_E8NM
RX   PubMed=31916900;
RX   PubMed=32069134;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q99470; Human SDF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3A1-1D6
AC   CVCL_YN92
DR   Wikidata; Q93305986
RX   PubMed=31916900;
RX   PubMed=32069134;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q99470; Human SDF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8NM ! 3A1 [Mouse/rat hybridoma against human SDF2]
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 4
//
ID   3A1-1H10
AC   CVCL_YN93
DR   Wikidata; Q93305988
RX   PubMed=31916900;
RX   PubMed=32069134;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q99470; Human SDF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8NM ! 3A1 [Mouse/rat hybridoma against human SDF2]
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 4
//
ID   3A10 [Mouse hybridoma against E.coli radA]
AC   CVCL_C5CP
DR   Wikidata; Q116048142
RX   PubMed=22316482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24554; Escherichia coli radA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3A10 [Mouse hybridoma against RHDV VP1]
AC   CVCL_E8H5
RX   PubMed=28247488;
RX   PubMed=28941616;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; I7FLU3; Rabbit hemorrhagic disease virus (RHDV) VP1 (Note=Also reacts with RHDVb strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3A10 [Rat hybridoma against mouse TcR gamma-delta]
AC   CVCL_D662
DR   BCRJ; 0014
DR   Wikidata; Q54585264
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) gamma-delta.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 5
//
ID   3A11 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1F5
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3A11 [Mouse hybridoma against thebaine]
AC   CVCL_B6GE
DR   Wikidata; Q111732708
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
ID   3A2 [Mouse hybridoma against human IL1-activated endothelial cells]
AC   CVCL_J155
DR   Wikidata; Q54585266
RX   Patent=US5011778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10138.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on IL1-activated endothelial cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   3A2 [Mouse hybridoma against imazaquin]
AC   CVCL_B5CW
SY   3A2.2
DR   Wikidata; Q110429761
RX   Patent=EP1043336A2;
RX   PubMed=12033799;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_5869; Imazaquin (Scepter) (Note=Also recognizes imazethapyr, imazamox and imazapic).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   3A2 [Mouse hybridoma against phthalate]
AC   CVCL_D5KY
DR   Wikidata; Q127378718
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   3A2 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IH
DR   Wikidata; Q107113231
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3A2-2
AC   CVCL_F1FV
RX   PubMed=6341819;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3A21
AC   CVCL_J721
DR   CLO; CLO_0050301
DR   ABCD; ABCD_AR306
DR   RCB; RCB1285
DR   Wikidata; Q54585268
RX   DOI=10.1016/0922-338X(96)88826-X;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P61823; Bovine RNASE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   3A2D3
AC   CVCL_B0H7
DR   ABCD; ABCD_AI190
DR   Wikidata; Q108819576
RX   Patent=US6291652;
RX   PubMed=22037470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2849.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 5
//
ID   3A3 [Mouse hybridoma against human NEK2]
AC   CVCL_B7I0
DR   Wikidata; Q112926964
RX   PubMed=34706700;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51955; Human NEK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   3A3 [Mouse hybridoma against paclitaxel]
AC   CVCL_E3ZC
DR   ABCD; ABCD_AJ801
RX   PubMed=23007175;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3A3 [Mouse hybridoma against plumbagin]
AC   CVCL_B6IZ
DR   Wikidata; Q111732709
RX   PubMed=18155415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_8273; Plumbagin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   3A3.C2
AC   CVCL_C4QN
DR   Wikidata; Q116048143
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00004; Horse CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3A4
AC   CVCL_XG96
DR   Wikidata; Q93306002
RX   PubMed=9824606;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16035; Human TIMP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   3A415
AC   CVCL_C5D6
DR   Wikidata; Q116048144
RX   Patent=US10259884;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14907; Human TAX1BP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3A4Bla
AC   CVCL_6C47
SY   3A4BLA; 3A4-BLA; CYP3A4-hBLA hES
DR   Wikidata; Q54585270
WW   Provider; VistaGen; -; https://web.archive.org/web/20150918202735/http://www.vistagen.com/pdf_files/SOT-poster-2013.pdf
CC   From: VistaGen Therapeutics, Inc.; South San Francisco; USA.
CC   Characteristics: The humanized beta-lactamase reporter gene is inserted in frame in the 3'-UTR region of the CYP3A4 gene.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=Humanized).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C945 ! K117 [Human ESC]
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   3A5 [Mouse hybridoma against HIV-2 gp120]
AC   CVCL_F1YR
RX   PubMed=8120399;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12449; HIV-2 isolate SBLISY env (Note=AA 22-503 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3A5 [Mouse hybridoma against human HFE]
AC   CVCL_J881
DR   CLO; CLO_0001326
DR   ATCC; CRL-2440
DR   Wikidata; Q54585272
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   3A5 [Mouse hybridoma against RVFV N]
AC   CVCL_F0HC
RX   PubMed=33900823;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9QKA6; Rift valley fever virus (RVFV) N protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3A5 [Mouse hybridoma against imazamethabenz-methyl]
AC   CVCL_B5CX
SY   3A5.1
DR   Wikidata; Q110429762
RX   Patent=EP1043336A2;
RX   PubMed=12033799;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_2894; Imazamethabenz-methyl (Assert) (Note=Also recognizes imazethapyr, imazamethabenz-methyl and imazapic).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   3A6 [Human/mouse hybridoma against HIV-1 p24]
AC   CVCL_F1FL
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03366; HIV-1 isolate BH10 env (Note=AA 133-363 = p24).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3A6 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5SH
DR   ABCD; ABCD_BD783
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3A6 [Mouse hybridoma against RVFV N]
AC   CVCL_F0HD
RX   PubMed=33900823;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9QKA6; Rift valley fever virus (RVFV) N protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3A6 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8II
DR   Wikidata; Q107113232
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   3A6-A12
AC   CVCL_C3U1
SY   3A6 A12
DR   Wikidata; Q116048145
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3A6-E4
AC   CVCL_E2S4
RX   PubMed=26090597;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A125YR49; Toxoplasma gondii (strain ATCC 50611 / Me49) H(+)-exporting diphosphatase (TgVP1) (Note=Also reacts with Plasmodium berghei).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3A7 [Mouse hybridoma against RVFV N]
AC   CVCL_F0HE
RX   PubMed=33900823;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9QKA6; Rift valley fever virus (RVFV) N protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3A7 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IJ
DR   Wikidata; Q107113233
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3A8 [Human/mouse hybridoma against HIV-1 p24]
AC   CVCL_F1FP
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03366; HIV-1 isolate BH10 env (Note=AA 133-363 = p24).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3A8 [Mouse hybridoma against human CD40]
AC   CVCL_J880
DR   CLO; CLO_0001327
DR   ATCC; HB-12024
DR   Wikidata; Q54585274
RX   Patent=US5677165;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12024.
CC   Registration: Chiron Master Culture Collection; CMCC 11066 (CMCC #11066).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   3A8 [Mouse hybridoma against human TNC]
AC   CVCL_D6U8
RX   PubMed=20199146;
RX   PubMed=20199166;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24821; Human TNC (Note=Immunized with domain FN3 D).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3A8 [Mouse hybridoma against human TRAC]
AC   CVCL_A0EQ
SY   alphaF1
DR   Wikidata; Q108819578
RX   Patent=US6171799;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9900.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01848; Human TRAC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3A8 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5SC
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3A9
AC   CVCL_6239
SY   3 A 9
DR   ATCC; CRL-3293
DR   Lonza; 702
DR   Wikidata; Q54585276
RX   PubMed=6607276;
CC   Characteristics: T-cell hybridoma.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   3A9/48
AC   CVCL_VI49
DR   BEI_Resources; MRA-877
DR   Wikidata; Q54585280
RX   PubMed=1542308;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) rhoptry-associated protein 2 (RAP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   3AB-OS
AC   CVCL_LM95
DR   cancercelllines; CVCL_LM95
DR   Millipore; SCC141
DR   Wikidata; Q54585282
RX   DOI=10.14800/ccm.134;
RX   DOI=10.4236/scd.2013.33024;
RX   PubMed=19160414;
RX   PubMed=23129384;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RD derivative (personal communication of Millipore). Originally thought to be a MG-63 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00545.
CC   Population: Caucasian.
CC   Characteristics: Was thought to have cancer stem cell-like characteristics as it was thought to be produced by long term treatment of MG-63 with 3-aminobenzamide (3AB), an inhibitor of poly(ADP-ribose) polymerase.
CC   Doubling time: ~22 hours (PubMed=19160414).
CC   Selected for resistance to: ChEBI; CHEBI_64042; 3-aminobenzamide (3AB).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Millipore; SCC141; true.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
ST   Source(s): Millipore=SCC141
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D21S11: 28,29
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 11,14,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 17
//
ID   3AC3
AC   CVCL_B7HE
DR   Wikidata; Q112926965
RX   DOI=10.1080/09712119.1998.9706217;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No. 216).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   3ACFSMEo-
AC   CVCL_IN58
DR   Wikidata; Q54585284
RX   PubMed=1375758;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln2Ter (c.4C>T); ClinVar=VCV000053980; Zygosity=Heterozygous (from autologous cell lines 6CFSMEo-; CFSMEo-).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from autologous cell lines 6CFSMEo-; CFSMEo-).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP33 ! CFSMEo-
OI   CVCL_IN60 ! 2CFSMEo-
OI   CVCL_IN62 ! 6CFSMEo-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   3AKRP
AC   CVCL_B7S9
DR   Wikidata; Q112926966
RX   PubMed=5000910;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   3AM
AC   CVCL_RB23
DR   Wikidata; Q54585286
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 10
AC   CVCL_RB24
SY   3M10(E)
DR   Wikidata; Q54585288
RX   PubMed=2293913;
RX   PubMed=6100805;
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 11
AC   CVCL_RB25
DR   Wikidata; Q54585289
RX   PubMed=6100805;
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 21
AC   CVCL_RB26
DR   Wikidata; Q54585290
RX   PubMed=6100805;
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 23
AC   CVCL_RB27
DR   Wikidata; Q54585291
RX   PubMed=6100805;
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 25
AC   CVCL_RB28
DR   Wikidata; Q54585294
RX   PubMed=6100805;
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 27
AC   CVCL_RB29
SY   3M27
DR   Wikidata; Q54585296
RX   PubMed=2293913;
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 34
AC   CVCL_RB30
DR   Wikidata; Q54585297
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3AM clone 9
AC   CVCL_RB31
DR   Wikidata; Q54585300
RX   PubMed=6100805;
RX   PubMed=6174210;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RB23 ! 3AM
SX   Male
AG   5W
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   3Ao
AC   CVCL_C6VI
SY   3AO; 3A0
DR   Wikidata; Q123030272
RX   CelloPub=CLPUB00731;
RX   PubMed=11372415;
RX   PubMed=20549538;
CC   Doubling time: 24.9 +- 0.1 hours (CelloPub=CLPUB00731).
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 3
//
ID   3Ao/cDDP
AC   CVCL_C6VJ
SY   3AO/cDDP
DR   Wikidata; Q123030273
RX   CelloPub=CLPUB00731;
RX   PubMed=11372415;
CC   Doubling time: 23.8 +- 0.3 hours (CelloPub=CLPUB00731).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VI ! 3Ao
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   3B-11
AC   CVCL_5487
DR   CLO; CLO_0001330
DR   ATCC; CRL-2160
DR   Wikidata; Q54585301
RX   PubMed=8496612;
CC   Characteristics: Derived from a SVEC4-10EHR1 induced ascite tumor (PubMed=8496612).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4395 ! SVEC4-10EHR1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   3B1
AC   CVCL_A8IK
DR   Wikidata; Q107113234
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3B10 [Mouse hybridoma against GXM]
AC   CVCL_F1XY
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM) (Note=Immunized with C.neoformans serotype A (ATCC 24064)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3B10 [Mouse hybridoma against human TNF]
AC   CVCL_F1V6
RX   PubMed=3805735;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3B10 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ89
DR   Wikidata; Q93306102
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 7
//
ID   3B10/64
AC   CVCL_VI50
DR   BEI_Resources; MRA-873
DR   Wikidata; Q54585303
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) rhoptry-associated protein 1 (RAP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   3B11
AC   CVCL_5488
DR   CLO; CLO_0001329
DR   ATCC; CRL-2757
DR   Wikidata; Q54585304
RX   PubMed=11687262;
RX   PubMed=18572245;
RX   PubMed=18824023;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   3B12 [Mouse hybridoma against lycopene]
AC   CVCL_B6IR
DR   Wikidata; Q111732710
RX   Patent=WO2018115885A1;
RX   PubMed=28402743;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   3B12 [Mouse/rat hybridoma against mouse Dzip3]
AC   CVCL_E8HG
RX   PubMed=29812999;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7TPV2; Mouse Dzip3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3B12-H6
AC   CVCL_E8HL
RX   PubMed=29812999;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7TPV2; Mouse Dzip3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8HG ! 3B12 [Mouse/rat hybridoma against mouse Dzip3]
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3B12F7
AC   CVCL_C0MZ
DR   Wikidata; Q112926967
WW   Provider; OSU; T2015-225; https://dev.innovatehosted.com/available_technologies/15144/Monoclonal-Antibody-for-Cereblon
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96SW2; Human CRBN (Note=Also reacts with other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   3B18
AC   CVCL_J882
DR   CLO; CLO_0001331
DR   ATCC; HB-8654
DR   Wikidata; Q54585305
RX   Patent=US4628032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8654.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   3B3 [Mouse hybridoma against fibrin D-dimer]
AC   CVCL_C4AC
DR   Wikidata; Q116048147
RX   PubMed=30763351;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fibrin D-dimer (Note=Also reacts strongly with fibrinogen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3B3 [Mouse hybridoma against human BSG]
AC   CVCL_XC83
DR   Wikidata; Q93306123
RX   PubMed=16704305;
RX   PubMed=17444954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   3B3 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IL
DR   Wikidata; Q107113235
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3B4 [Mouse hybridoma against HAstV-1 VP25]
AC   CVCL_C5NK
DR   Wikidata; Q116048148
RX   Patent=US20200392578;
RX   PubMed=30355681;
RX   PubMed=31233538;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q82452; Human astrovirus-1 (strain Oxford) (HAstV-1) capsid protein VP90 (Note=AA 424-648 = Capsid protein VP25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   3B4 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IM
DR   Wikidata; Q107113236
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   3B4 [Mouse/rat hybridoma against human VWF]
AC   CVCL_E8NZ
RX   PubMed=31192778;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04275; Human VWF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3B5 [Mouse hybridoma against dog mesothelioma]
AC   CVCL_C1GC
DR   Wikidata; Q114310444
RX   PubMed=7863582;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Dog antigen on mesothelioma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   3B5 [Mouse hybridoma against rabbit Ig kappa b5]
AC   CVCL_D6TU
RX   PubMed=6432680;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rabbit Ig kappa light chain b5 allotype.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3B5 [Mouse hybridoma against FAdV-4 fiber 1]
AC   CVCL_XV44
DR   Wikidata; Q93306128
RX   PubMed=31286975;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A1B1SLD1; Fowl aviadenovirus 4 (FAdV-4) fiber-1 protein (Note=Also reacts with FAdV-10).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   3B5H10
AC   CVCL_B0HA
DR   Wikidata; Q108819579
RX   Patent=US6291652;
RX   PubMed=22037470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2848.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   3B6 [Mouse hybridoma against dog CD274]
AC   CVCL_F0H5
RX   Patent=US12252536;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog PDL1/CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3B6 [Mouse hybridoma against human MMP1]
AC   CVCL_XG97
DR   Wikidata; Q93306131
RX   PubMed=9771478;
RX   PubMed=9824606;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03956; Human MMP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   3B6 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA03
DR   Wikidata; Q93306133
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9399.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 5
//
ID   3B6 [Mouse hybridoma against phOX]
AC   CVCL_C4F5
DR   ABCD; ABCD_AE294
DR   Wikidata; Q116048149
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3B6 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IN
DR   Wikidata; Q107113237
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3B7 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1F7
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3B7 [Mouse hybridoma against DHAV VP3]
AC   CVCL_C4B2
DR   Wikidata; Q116048150
RX   PubMed=28883462;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A4KYM2; Duck hepatitis A virus (strain HP-1) (DHAV) genome polyprotein (Note=AA 257-493 = Capsid protein VP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   3B7 [Mouse hybridoma against FIV p24]
AC   CVCL_B0WK
DR   Wikidata; Q108819580
RX   PubMed=1848596;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16087; Feline immunodeficiency virus (isolate Petaluma) (FIV) gag (Note=AA 136-357 = p24).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   3B7 [Mouse hybridoma against human IFNAR2]
AC   CVCL_F1WQ
RX   Patent=US20030018174;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12427.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48551; Human IFNAR2.
CC   Caution: Patent wrongly indicate the registration number as HP 12427.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3B7 [Mouse hybridoma against human KLK6]
AC   CVCL_E2ZP
RX   PubMed=26492623;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92876; Human KLK6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3B7 [Mouse hybridoma against M.honghuensis shell valve protein]
AC   CVCL_B0UE
DR   CCRID; 4201PAT-CCTCC00435
DR   Wikidata; Q108819581
RX   Patent=CN103755806B;
RX   PubMed=26758653;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013189.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Myxobolus honghuensis shell valve protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3B7-D9
AC   CVCL_D2QX
DR   Wikidata; Q127378719
RX   PubMed=29571514;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A024FCJ9; Dog PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   3B7B5
AC   CVCL_A6NV
DR   DSHB; 3B7B5
DR   Wikidata; Q107113238
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9W266; Drosophila melanogaster wdp.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   3B8 [Mouse hybridoma against chicken IL7R]
AC   CVCL_C4JT
DR   Wikidata; Q116048151
RX   PubMed=35973349;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A1EA95; Chicken IL7R/CD127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3B8 [Mouse hybridoma against M.tuberculosis Ag85A]
AC   CVCL_XJ57
DR   Wikidata; Q93306135
RX   PubMed=28713817;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P9WQP3; Mycobacterium tuberculosis diacylglycerol acyltransferase/mycolyltransferase Ag85A (fbpA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   3B8 [Mouse hybridoma against T.tridentatus TP-1]
AC   CVCL_C5EM
DR   Wikidata; Q116048152
RX   PubMed=21851235;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14213; Tachypleus tridentatus tachyplesin-1 (TP-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3B8.10D9
AC   CVCL_B6ZI
DR   Wikidata; Q111732712
RX   PubMed=21118018;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_34692; Dicofol (Kelthane).
CC   Monoclonal antibody target: ChEBI; CHEBI_190399; 4,4'-dichlorobenzhydrol (DCBH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   3B9 [Mouse hybridoma against CDV hemagglutinin]
AC   CVCL_A3CC
DR   Wikidata; Q105505919
RX   PubMed=25644427;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Canine distemper virus (isolate NJ01) hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   3B9 [Mouse hybridoma against morphine]
AC   CVCL_C6MW
DR   Wikidata; Q116048154
RX   PubMed=2555519;
RX   PubMed=6361525;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3B9-10
AC   CVCL_C6XN
DR   ABCD; ABCD_AN717
DR   Wikidata; Q123030274
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   3BD-26
AC   CVCL_LC07
SY   3BD26
DR   Wikidata; Q54585308
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2695.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   3BD-27
AC   CVCL_LC08
SY   3BD27
DR   Wikidata; Q54585311
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2698.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   3BD-8
AC   CVCL_LC09
SY   3BD8
DR   Wikidata; Q54585313
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2696.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   3BD10
AC   CVCL_E3EQ
RX   PubMed=10022441;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR (Note=Immunized AA 1-289 = TSHR-289).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3BE12
AC   CVCL_E3ER
RX   PubMed=10022441;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR (Note=Immunized AA 1-289 = TSHR-289).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3C1 [Mouse hybridoma against P.falciparum csp]
AC   CVCL_A7VK
DR   Wikidata; Q107113239
RX   PubMed=31548526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   3C1 [Mouse/rat hybridoma against mouse Kit]
AC   CVCL_E5K7
RX   PubMed=1371359;
WW   Provider; Stanford OTL; S92-096; https://stanford.resoluteinnovation.com/technologies/S92-096_3c1-and-2b8-hybridomas-secreting-a
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P05532; Mouse Kit/Cd117.
CC   Misspelling: 3C11; PubMed=1371359; Note=Twice in the text.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3C10 [Mouse hybridoma against human CD14]
AC   CVCL_J000
DR   CLO; CLO_0001332
DR   ATCC; TIB-228
DR   Wikidata; Q54585316
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   3C10 [Mouse hybridoma against human F2]
AC   CVCL_B0SL
SY   PIVKA-II 3C1D-129 p16
DR   Wikidata; Q108819582
RX   Patent=US8283162;
RX   Patent=US9120862;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9638.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes an abnormal form called PIVKA-II).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   3C11
AC   CVCL_G601
DR   CLO; CLO_0001333
DR   ATCC; HB-8511
DR   Wikidata; Q54585398
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8511.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   3C1A5
AC   CVCL_RA99
DR   Wikidata; Q54585399
RX   Patent=US9249216;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del = SNAP25(197)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 4
//
ID   3C2 [Mouse hybridoma against abrin-A]
AC   CVCL_E4C0
RX   PubMed=21870856;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11140; Abrus precatorius abrin-A (Note=AA 262-528 = B chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3C2 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K2
DR   Wikidata; Q108819583
RX   Patent=US6150508;
RX   PubMed=9817391;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3C2 [Mouse hybridoma against human MX1]
AC   CVCL_D6UA
RX   PubMed=20199149;
RX   PubMed=20199159;
CC   Monoclonal antibody isotype: IgG1, kappa (PubMed=20199149); IgG1, lambda (PubMed=20199159).
CC   Monoclonal antibody target: UniProtKB; P20591; Human MX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3C2 [Mouse hybridoma against P.falciparum csp]
AC   CVCL_A7VL
DR   Wikidata; Q107113241
RX   PubMed=31548526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   3C2 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IP
DR   Wikidata; Q107113243
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3C3 [Mouse hybridoma against Chikungunya virus E2]
AC   CVCL_XH67
DR   Wikidata; Q93306173
RX   Patent=US8449887;
RX   PubMed=17949772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3822.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q1W367; Chikungunya virus (strain 06-049) spike glycoprotein E2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   3C3 [Mouse hybridoma against human TSHR]
AC   CVCL_E3EV
RX   PubMed=16088319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3C3 [Mouse hybridoma against zearalenone]
AC   CVCL_C5NT
DR   Wikidata; Q116048155
RX   PubMed=24465616;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3C3E2
AC   CVCL_A9KI
DR   Wikidata; Q108819584
RX   Patent=US9249216;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del = SNAP25(197)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   3C4 [Mouse hybridoma against HIV-2 gp120]
AC   CVCL_F1YS
RX   PubMed=8120399;
RX   PubMed=18706111;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P12449; HIV-2 isolate SBLISY env (Note=AA 22-503 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3C4 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K3
DR   ATCC; HB-12494
DR   Wikidata; Q108819585
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12494.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3C4 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MX
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3C4 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IQ
DR   Wikidata; Q107113244
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3C4A6
AC   CVCL_B0H9
DR   Wikidata; Q108819586
RX   Patent=US6291652;
RX   PubMed=22037470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2850.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   3C5 [Mouse hybridoma against A.australis AaH2]
AC   CVCL_KB11
DR   Wikidata; Q54585400
RX   PubMed=2454259;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01484; Androctonus australis neurotoxin AaH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   3C5 [Mouse hybridoma against human PSCA]
AC   CVCL_B0TR
DR   Wikidata; Q108819587
RX   Patent=US8524460;
RX   PubMed=10713670;
RX   PubMed=11226295;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12616.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3C5 [Mouse hybridoma against phOX]
AC   CVCL_C4FM
DR   ABCD; ABCD_AE299
DR   Wikidata; Q116048156
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3C5 [Mouse hybridoma against TMUV NS1]
AC   CVCL_E2Z4
RX   PubMed=26871513;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A075M1D2; Tembusu virus (strain SDLC) genome polyprotein (AA 791-1140 = Non-structural protein NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3C5.1
AC   CVCL_J722
DR   CLO; CLO_0001334
DR   ATCC; CRL-2284
DR   Wikidata; Q54585401
RX   PubMed=7536191;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q07864; Human POLE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   3C6 [Mouse hybridoma against human CD40]
AC   CVCL_J879
DR   ATCC; HB-11340
DR   Wikidata; Q54585404
RX   Patent=US5677165;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11340.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   3C6 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K4
DR   Wikidata; Q108819588
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12491.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3C6 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IR
DR   Wikidata; Q107113245
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3C6.4.2
AC   CVCL_B6N0
DR   Wikidata; Q111732713
RX   Patent=US20060073146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1347.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   3C7
AC   CVCL_E8HV
RX   PubMed=29630477;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3C7.14
AC   CVCL_A6RE
DR   Wikidata; Q107113246
RX   Patent=US5571714;
RX   PubMed=2537357;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   3C7.2
AC   CVCL_J723
DR   CLO; CLO_0001335
DR   ATCC; CRL-1959
DR   Wikidata; Q54585405
RX   PubMed=2592009;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Giardia muris trophozoite surface antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   3C8 [Mouse hybridoma against human RB1]
AC   CVCL_A0RV
DR   Wikidata; Q108819589
RX   Patent=US5710255;
RX   PubMed=7510760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12313.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1 (Note=Binds to the C-terminal end).
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3C8 [Mouse hybridoma against influenza A HA]
AC   CVCL_XC00
DR   CCRID; 4201PAT-CCTCC00179
DR   Wikidata; Q93306204
RX   Patent=CN101220097A;
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200605.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   3C9 [Mouse hybridoma against human CXCL13]
AC   CVCL_C8CU
DR   Wikidata; Q123030275
RX   Patent=US20160002325;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43927; Human CXCL13 (Note=Also reacts with mouse and Macaca).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   3C9 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K5
DR   ATCC; HB-12484
DR   Wikidata; Q108819590
RX   Patent=US6150508;
RX   PubMed=9817391;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12484.
CC   Monoclonal antibody isotype: IgG1 (Patent=US6150508); IgG2b (PubMed=9817391).
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   3C9-D11-H11
AC   CVCL_4490
SY   3 C9-D11-H11
DR   CLO; CLO_0001275
DR   CLO; CLO_0001336
DR   CLDB; cl5095
DR   ATCC; CRL-1745
DR   ECACC; 92022115
DR   IZSLER; BS Hy 36
DR   Wikidata; Q54585408
RX   PubMed=3009510;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Porcine parvovirus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   3D1 [Mouse hybridoma against monkeypox vCCI]
AC   CVCL_A7VD
SY   #3D1
DR   BEI_Resources; NR-10509
DR   Wikidata; Q107113247
RX   PubMed=18639466;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6YLY9; Monkeypox virus (strain MPXV_ZAI1979_005) CC-type chemokine-binding protein (vCCI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 4
//
ID   3D1 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IS
DR   Wikidata; Q107113249
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3D10
AC   CVCL_C5R0
DR   Wikidata; Q116048157
RX   PubMed=2580015;
RX   PubMed=3079807;
CC   Characteristics: IL2 dependent.
CC   Characteristics: Produces IL3 and IFNG (PubMed=2580015).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   3D11 [Mouse hybridoma against ciguatoxin CTX3C]
AC   CVCL_C4DG
DR   Wikidata; Q116048158
RX   PubMed=12812503;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_61277; Ciguatoxin CTX3C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3D11 [Mouse hybridoma against human HLA-F]
AC   CVCL_C0BU
DR   Wikidata; Q112926968
RX   PubMed=12874228;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30511; Human HLA-F.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   3D11 [Mouse hybridoma against P.berghei csp]
AC   CVCL_A7VE
DR   BEI_Resources; MRA-100
DR   Wikidata; Q107113250
RX   PubMed=6985745;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06915; Plasmodium berghei circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 6
//
ID   3D12 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FB
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3D12 [Mouse hybridoma against human WRN]
AC   CVCL_A7FR
DR   Wikidata; Q107113252
RX   PubMed=9885239;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14191; Human WRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 4
//
ID   3D12 [Mouse hybridoma against phthalate]
AC   CVCL_D5L3
DR   Wikidata; Q127378720
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   3D2 [Mouse hybridoma against A.pleuropneumoniae tonB2]
AC   CVCL_C5BY
DR   Wikidata; Q116048159
RX   PubMed=23098301;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A3MYE8; Actinobacillus pleuropneumoniae tonB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3D2 [Mouse hybridoma against human CXCL13]
AC   CVCL_C8CV
DR   Wikidata; Q123030276
RX   Patent=US20160002325;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43927; Human CXCL13 (Note=Also reacts with mouse and Macaca).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   3D2 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ90
DR   Wikidata; Q93306217
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   3D2 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IT
DR   Wikidata; Q107113254
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3D3 [Mouse hybridoma against chicken IL7]
AC   CVCL_C4JK
DR   Wikidata; Q116048160
RX   PubMed=33652529;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3C0R7; Chicken IL7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3D3 [Mouse hybridoma against MTPS]
AC   CVCL_C4D2
DR   Wikidata; Q116048161
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3D3 [Mouse hybridoma against P.falciparum csp]
AC   CVCL_A7VM
DR   Wikidata; Q107113255
RX   PubMed=31548526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   3D3 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IU
DR   Wikidata; Q107113256
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3D4 [Mouse hybridoma against deltamethrin]
AC   CVCL_C5NZ
DR   Wikidata; Q116048162
RX   PubMed=20593827;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_4388; Deltamethrin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3D4 [Mouse hybridoma against human CHID1]
AC   CVCL_E8NS
RX   PubMed=30657411;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BWS9; Human CHID1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3D4 [Mouse hybridoma against influenza A NA]
AC   CVCL_XA04
DR   Wikidata; Q93306220
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9395.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 neuraminidase (NA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 5
//
ID   3D4 [Mouse hybridoma against HBV HBsAg]
AC   CVCL_B0SZ
DR   Wikidata; Q108819591
RX   Patent=US4870026;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8170.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   3D5 [Human B-cell]
AC   CVCL_7939
DR   BTO; BTO_0004405
DR   Wikidata; Q54585417
RX   PubMed=2243835;
CC   Characteristics: IL4 dependent.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   3D5 [Human melanoma]
AC   CVCL_Y457
DR   Cosmic; 1058336
DR   Wikidata; Q54585418
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   3D5 [Mouse hybridoma against human AFP]
AC   CVCL_XI02
DR   Wikidata; Q93306257
RX   Patent=CN102321167B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.5193.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02771; Human AFP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   3D5 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IV
DR   Wikidata; Q107113257
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3D5-2
AC   CVCL_F1FW
RX   PubMed=6153633;
RX   PubMed=6341819;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3D5.1.10
AC   CVCL_B0EM
SY   3D5
DR   Wikidata; Q108819592
RX   Patent=US7592439;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12536.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262 (Note=Also recognizes TNFRSF10A/CD261).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   3D6 [Mouse hybridoma against human TRAC]
AC   CVCL_A0ER
SY   alphaF2
DR   Wikidata; Q108819593
RX   Patent=US6171799;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9901.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01848; Human TRAC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   3D6 [Mouse hybridoma against S.aureus entB]
AC   CVCL_E8PL
RX   PubMed=31603743;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01552; Staphylococcus aureus entB (Note=Also reacts with entC1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3D7
AC   CVCL_A8IW
DR   Wikidata; Q107113258
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3D7-1.1
AC   CVCL_B0K6
DR   ATCC; HB-12309
DR   Wikidata; Q108819594
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12309.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3D8
AC   CVCL_U276
DR   Wikidata; Q54585419
RX   Patent=US4904581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9101.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: HIV-1 antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   3D9 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1EY
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3D9 [Mouse hybridoma against goose parvovirus NS1]
AC   CVCL_C5CG
DR   Wikidata; Q116048163
RX   PubMed=22509917;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; I1VWH1; Goose parvovirus non-structural protein 1 (NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3D9 [Mouse hybridoma against human GYPA]
AC   CVCL_E8P4
RX   PubMed=31486711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3D9 [Mouse hybridoma against M.tuberculosis Ag85A]
AC   CVCL_XJ58
DR   Wikidata; Q93306263
RX   PubMed=28713817;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P9WQP3; Mycobacterium tuberculosis diacylglycerol acyltransferase/mycolyltransferase Ag85A (fbpA) (Note=Also recognizes Ag85B/fbpB and Ag85C/fbpC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 6
//
ID   3D9 [Mouse hybridoma against NNK]
AC   CVCL_F0SM
RX   PubMed=23518474;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_32692; 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one (NNK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3DD
AC   CVCL_ZS99
DR   Wikidata; Q98125391
RX   PubMed=8505362;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   3e
AC   CVCL_C5I1
DR   Wikidata; Q116048164
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3E1 [Mouse hybridoma against HSV-2 p40]
AC   CVCL_4491
SY   3 E 1
DR   CLO; CLO_0001276
DR   CLO; CLO_0001337
DR   CLDB; cl5098
DR   ATCC; HB-8067
DR   IZSLER; BS Hy 8
DR   Wikidata; Q54585420
RX   Patent=US4430437;
RX   PubMed=91687;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8067.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P89449; Human herpesvirus 2 (HHV-2) capsid scaffolding protein (p40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   3E1 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IX
DR   Wikidata; Q107113259
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3E10 [Human/mouse hybridoma]
AC   CVCL_A6KM
DR   Wikidata; Q107113260
RX   PubMed=19003328;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6KD ! RF-S1
HI   CVCL_A6KK ! TM-1 [Human leukemia]
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   3E10 [Mouse hybridoma against human HMGB1]
AC   CVCL_B4HH
SY   3E10-5-4-1-1
DR   Wikidata; Q110429763
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   3E10 [Mouse hybridoma against human LCN6]
AC   CVCL_E7QV
RX   PubMed=28806153;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62502; Human LCN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3E10-3
AC   CVCL_C0E5
DR   Wikidata; Q112926969
DR   Ximbio; 153322
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   3E10.2
AC   CVCL_B4NS
DR   Wikidata; Q110429764
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   3E10/18
AC   CVCL_VI51
DR   BEI_Resources; MRA-883
DR   Wikidata; Q54585423
RX   PubMed=3045543;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate K1 / Thailand) rhoptry protein 3 (RhopH3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 6
//
ID   3E11 [Mouse hybridoma against human BAD]
AC   CVCL_C3TA
DR   Wikidata; Q116048165
RX   PubMed=9790073;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92934; Human BAD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3E11 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K7
DR   ATCC; HB-12488
DR   Wikidata; Q108819595
RX   Patent=US6150508;
RX   PubMed=9817391;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12488.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   3E11 [Mouse hybridoma against human GLRX3]
AC   CVCL_E7CW
RX   PubMed=27923109;
RX   PubMed=28029331;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O76003; Human GLRX3 (Note=Also reacts with mouse, rat, Chinese hamster, and zebrafish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3E11 [Mouse hybridoma against phthalate]
AC   CVCL_D5L2
DR   Wikidata; Q127378721
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   3E11 1-G9
AC   CVCL_IZ76
SY   3E1
DR   Wikidata; Q54585424
RX   Patent=US7262277;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4017.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 6
//
ID   3E11.5
AC   CVCL_B4NT
DR   Wikidata; Q110429765
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   3E11F1D8F9
AC   CVCL_WZ91
DR   Wikidata; Q93306281
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   3E12-E10
AC   CVCL_C5WM
DR   Wikidata; Q116048166
RX   PubMed=36229227;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9UJQ4; Human SALL4 (Note=Isoform SALL4A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   3E12/B6
AC   CVCL_XK33
DR   Wikidata; Q93306283
RX   DOI=10.1016/j.foodchem.2009.03.097;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_34632; Chlorpyrifos-methyl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   3E13
AC   CVCL_E7CX
RX   PubMed=27923109;
RX   PubMed=28029331;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O76003; Human GLRX3 (Note=Also reacts with mouse, rat, Chinese hamster, and zebrafish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3E14.5
AC   CVCL_B4NU
DR   Wikidata; Q110429767
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   3E17
AC   CVCL_B5Z3
DR   Wikidata; Q111732714
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1421-1984 = Non-structural protein 3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   3E19.8
AC   CVCL_B4NV
DR   Wikidata; Q110429769
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   3E2
AC   CVCL_B5YU
DR   Wikidata; Q111732715
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   3E2-E10
AC   CVCL_C3U2
DR   Wikidata; Q116048167
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3E2-H12
AC   CVCL_C3U3
DR   Wikidata; Q116048168
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3E22.1
AC   CVCL_B4NW
DR   Wikidata; Q110429770
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   3E3
AC   CVCL_C4F6
DR   ABCD; ABCD_AE288
DR   Wikidata; Q116048169
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3E4 [Mouse hybridoma against Chikungunya virus E2]
AC   CVCL_XH68
DR   Wikidata; Q93306286
RX   Patent=US8449887;
RX   PubMed=17949772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3824.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q1W367; Chikungunya virus (strain 06-049) spike glycoprotein E2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   3E4 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IY
DR   Wikidata; Q107113261
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3E4F7
AC   CVCL_B0F7
DR   CCRID; 4201PAT-CCTCC01645
DR   Wikidata; Q108819596
RX   Patent=CN113151185B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202092.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O76093; Human FGF18 (Note=Also recognizes FGF8 and FGF17).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 5
//
ID   3E5 [Mouse hybridoma against GXM]
AC   CVCL_F1XU
DR   ABCD; ABCD_BG424
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3E5 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N7
DR   ABCD; ABCD_AE969
RX   PubMed=7705409;
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3E5 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8IZ
DR   Wikidata; Q107113262
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   3E5G7
AC   CVCL_A0UZ
DR   CCRID; 4201PAT-CCTCC01049
DR   Wikidata; Q108819597
RX   Patent=CN107299085B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201759.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3E6 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K8
DR   Wikidata; Q108819598
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12486.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3E6 [Mouse hybridoma against human PSCA]
AC   CVCL_B0TS
DR   Wikidata; Q108819599
RX   Patent=US8524460;
RX   PubMed=10713670;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3E6 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HM
DR   Wikidata; Q108819600
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3E6 [Mouse hybridoma against human SAT1]
AC   CVCL_E6JQ
RX   PubMed=27228136;
RX   PubMed=27328064;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21673; Human SAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3E6 [Mouse hybridoma against MTPS]
AC   CVCL_C4D3
DR   Wikidata; Q116048170
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3E6/64
AC   CVCL_VI52
DR   BEI_Resources; MRA-875
DR   Wikidata; Q54585427
RX   PubMed=1542308;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Plasmodium falciparum rhoptry-associated protein 2 (RAP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 4
//
ID   3E7 [Human hybridoma against D.farinae allergen]
AC   CVCL_E8UD
RX   PubMed=10648853;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: Dermatophagoides farinae undefined allergen.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8UA ! ICLU-B
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3E7 [Mouse hybridoma against human GRN]
AC   CVCL_C5G8
DR   Wikidata; Q116048171
RX   PubMed=21707362;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   3E7 [Mouse/rat hybridoma against human VWF]
AC   CVCL_E8P0
RX   PubMed=31192778;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04275; Human VWF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3E7.9.20
AC   CVCL_LH37
DR   Wikidata; Q54585428
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6026.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   3E8 [Mouse hybridoma against EBV BHRF1]
AC   CVCL_A9X7
DR   BCRC; 60611
DR   Wikidata; Q102113442
RX   PubMed=15000846;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03182; Epstein-Barr virus (strain B95-8) apoptosis regulator BHRF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 5
//
ID   3E8 [Mouse hybridoma against HAstV-8 VP25]
AC   CVCL_C5NL
DR   ABCD; ABCD_AW887
DR   Wikidata; Q116048172
RX   Patent=US20200392578;
RX   PubMed=30355681;
RX   PubMed=31233538;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9IFX1; Human astrovirus-8 (strain Yuc8) (HAstV-8) capsid protein VP90 (Note=AA 424-648 = Capsid protein VP25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   3E8 [Mouse hybridoma against human MPO]
AC   CVCL_E2Z0
RX   PubMed=26978734;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3E8 [Mouse hybridoma against mouse Vtcn1]
AC   CVCL_A0VI
DR   Wikidata; Q108819601
RX   PubMed=21813370;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7TSP5; Mouse Vtcn1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3E9 [Human/mouse hybridoma against leukemia cell surface antigen]
AC   CVCL_A6KN
DR   Wikidata; Q107113263
RX   PubMed=19003328;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human leukemia cell surface antigen.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6KD ! RF-S1
HI   CVCL_A6KK ! TM-1 [Human leukemia]
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   3E9 [Mouse hybridoma against cell wall peptidoglycans]
AC   CVCL_J022
DR   ATCC; HB-8514
DR   Wikidata; Q54585431
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8514.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   3E9 [Mouse hybridoma against DHAV VP3]
AC   CVCL_C4B3
DR   Wikidata; Q116048174
RX   PubMed=28883462;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; A4KYM2; Duck hepatitis A virus (strain HP-1) (DHAV) genome polyprotein (Note=AA 257-493 = Capsid protein VP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   3E9 [Mouse hybridoma against marinobufagenin]
AC   CVCL_B0LA
SY   MBG3E9
DR   ATCC; PTA-6724
DR   Wikidata; Q108819602
RX   Patent=US8038997;
RX   PubMed=19008721;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6724.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_146151; Marinobufagenin (MBG).
CC   Misspelling: MGB3E9; ATCC=PTA-6724.
CC   Discontinued: ATCC; PTA-6724; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   3E9 [Mouse hybridoma against P.vivax RBP2b]
AC   CVCL_C5VQ
DR   ABCD; ABCD_AJ074
DR   Wikidata; Q116048175
RX   PubMed=29302006;
RX   PubMed=29950717;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A5K736; Plasmodium vivax (strain Salvador I) reticulocyte binding protein 2b (RBP2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   3F1
AC   CVCL_A8JA
DR   Wikidata; Q107113264
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3F10
AC   CVCL_E5MY
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3F10.11.2
AC   CVCL_LH38
DR   Wikidata; Q54585432
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6027.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   3F11
AC   CVCL_E4R0
RX   DOI=10.1007/BF01577135;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3F11.3
AC   CVCL_N023
DR   Wikidata; Q54585436
RX   Patent=US9555107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7312.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9GZX6; Human IL22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 9
//
ID   3F11.39.7
AC   CVCL_B0EJ
DR   Wikidata; Q108819603
RX   Patent=US8092799;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12456.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3F12 [Mouse hybridoma against goose parvovirus NS1]
AC   CVCL_C5CH
DR   Wikidata; Q116048176
RX   PubMed=22509917;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I1VWH1; Goose parvovirus non-structural protein 1 (NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3F12 [Mouse hybridoma against H.ducreyi ompA]
AC   CVCL_E2ST
RX   PubMed=9045839;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P96773; Haemophilus ducreyi ompA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3F12 [Mouse hybridoma against I.punctatus Ig light chains]
AC   CVCL_B7GA
SY   3F12-1
DR   Wikidata; Q112926971
RX   PubMed=6421929;
RX   PubMed=6813154;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Ictalurus punctatus Ig light chains G-type.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 4
//
ID   3F16A4
AC   CVCL_XB79
DR   CCRID; 4201PAT-CCTCC00224
DR   Wikidata; Q93306312
RX   Patent=CN101550188B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200738.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; Q9Q0U6; Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 6
//
ID   3F2 [Mouse hybridoma against human MS4A4A]
AC   CVCL_VD97
DR   Wikidata; Q54585438
RX   PubMed=28303902;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96JQ5; Human MS4A4A/CD20L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   3F2 [Mouse hybridoma against phOX]
AC   CVCL_C4F7
DR   ABCD; ABCD_AE285
DR   Wikidata; Q116048177
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3F2 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JB
DR   Wikidata; Q107113265
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3F2 [Mouse hybridoma against SVA VP2]
AC   CVCL_B5YV
DR   Wikidata; Q111732716
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   3F2 [Rat hybridoma against mouse Kpna7]
AC   CVCL_C5EX
DR   Wikidata; Q116048178
RX   PubMed=21707367;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; C0LLJ0; Mouse Kpna7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3F3.5F
AC   CVCL_ZZ67
DR   Wikidata; Q102113444
RX   PubMed=3747866;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on activated macrophages.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   3F4 [Mouse hybridoma against chicken TSC22D3]
AC   CVCL_E7QX
RX   PubMed=28806151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q06AW4; Chicken TSC22D3/GILZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3F4 [Mouse hybridoma against human GRN]
AC   CVCL_X854
DR   Wikidata; Q54585439
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5590.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   3F4 [Mouse hybridoma against mouse Itga7]
AC   CVCL_E3ZL
RX   PubMed=9004048;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q61738; Mouse Itga7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3F4 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JC
DR   Wikidata; Q107113266
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3f5
AC   CVCL_F0VR
RX   PubMed=1690175;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54939; Chicken TLN1 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3F5 [Mouse hybridoma against human GRN]
AC   CVCL_X855
DR   Wikidata; Q54585441
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5259.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   3F5 [Mouse hybridoma against O.viverrini Ov-TSP-2]
AC   CVCL_A0HE
DR   Wikidata; Q108819604
RX   PubMed=34358156;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; M1G6I5; Opisthorchis viverrini tetraspanin 2A (Ov-TSP-2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   3F5 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JD
DR   Wikidata; Q107113268
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3F5.4G6
AC   CVCL_DN55
DR   ATCC; HB-12060
DR   Wikidata; Q54585442
RX   Patent=US6150508;
RX   PubMed=8602402;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12060.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   3F6 [Mouse hybridoma against cell wall peptidoglycans]
AC   CVCL_G602
DR   CLO; CLO_0001338
DR   ATCC; HB-8512
DR   Wikidata; Q54585445
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8512.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   3F6 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JE
DR   Wikidata; Q107113269
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3F7 [Mouse hybridoma against HIV-1 antigens]
AC   CVCL_KR67
DR   Wikidata; Q54585448
RX   Patent=US4904581;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   3F7 [Mouse hybridoma against human SKI]
AC   CVCL_C5EJ
DR   Wikidata; Q116048179
RX   PubMed=21851241;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P12755; Human SKI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3F8 [Mouse hybridoma against human GRN]
AC   CVCL_X856
DR   Wikidata; Q54585449
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5591.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 6
//
ID   3F8 [Mouse hybridoma against human MBL2]
AC   CVCL_B0JV
DR   Wikidata; Q108819605
RX   Patent=WO2000035483A1;
RX   PubMed=10793066;
RX   PubMed=11991814;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12621.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11226; Human MBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3F8 [Rat hybridoma against human KPNA6]
AC   CVCL_C5ER
DR   Wikidata; Q116048180
RX   PubMed=21707368;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O60684; Human KPNA6 (Note=Also reacts with other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3F9 [Mouse hybridoma against human HSPA5]
AC   CVCL_C5D2
DR   Wikidata; Q116048181
RX   PubMed=22149283;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11021; Human HSPA5/GRP78.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   3F9 [Mouse hybridoma against Lake Victoria marburgvirus VP35]
AC   CVCL_B6LF
DR   Wikidata; Q111732717
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   Patent=RU2393220;
RX   PubMed=10488532;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03039; Lake Victoria marburgvirus (strain Popp-67) polymerase cofactor VP35.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   3G-11
AC   CVCL_C3SW
DR   Wikidata; Q116048182
RX   PubMed=6302177;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10228; Human herpesvirus 1 (HHV-1) glycoprotein C (gC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3G1 [Mouse hybridoma against aflatoxin B1]
AC   CVCL_V646
DR   Wikidata; Q54585450
RX   Patent=WO2013155883A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201014.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   3G1 [Mouse hybridoma against G.vaginalis vaginolysin]
AC   CVCL_C5AT
DR   Wikidata; Q116048183
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3G1 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JF
DR   Wikidata; Q107113270
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3G1-2B4
AC   CVCL_C3MZ
SY   3G1 2B4
DR   Wikidata; Q116048185
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   3G10
AC   CVCL_B6G6
DR   Wikidata; Q111732718
RX   PubMed=14709901;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A.
CC   Monoclonal antibody target: ChEBI; CHEBI_183954; Saikosaponin B2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   3G10G5
AC   CVCL_WN00
SY   3 G10G5
DR   Wikidata; Q93306354
RX   PubMed=1417586;
RX   PubMed=9024803;
CC   Group: Space-flown cell line (cellonaut).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13891; Budgerigar fledgling disease virus VP1.
CC   Anecdotal: Have been flown in space on shuttle flight STS-77 to study antibody production in microgravity (PubMed=9024803).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   3G12 [Mouse hybridoma against B.germanica unknown allergen]
AC   CVCL_C3WZ
DR   Wikidata; Q116048186
RX   PubMed=1993811;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Blattella germanica unknown allergen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3G12 [Mouse hybridoma against HIV-1 antigens]
AC   CVCL_U277
DR   Wikidata; Q54585451
RX   Patent=US4904581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9102.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   3G12 [Mouse hybridoma against PCV2 Cap]
AC   CVCL_B0KW
DR   CCRID; 4201PAT-CCTCC00528
DR   Wikidata; Q108819606
RX   Patent=CN105542000B;
RX   Patent=CN105675873B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014198.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; V5N005; Porcine circovirus 2 (PCV2) isolate Nanjing caspid protein (Cap).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   3G12.7
AC   CVCL_B0KU
DR   CCRID; 4201PAT-CCTCC01632
DR   Wikidata; Q108819607
RX   Patent=CN111944765B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202069.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_6887; Methylphenidate (Ritalin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   3G2 [Mouse hybridoma against human GRN]
AC   CVCL_X857
DR   Wikidata; Q54585453
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5592.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   3G2 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MJ
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3G2 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JG
DR   Wikidata; Q107113272
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3G2 [Mouse hybridoma against TMUV NS1]
AC   CVCL_E2Z5
RX   PubMed=26871513;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A075M1D2; Tembusu virus (strain SDLC) genome polyprotein (AA 791-1140 = Non-structural protein NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3G3 [Mouse hybridoma against cell wall peptidoglycans]
AC   CVCL_G603
DR   CLO; CLO_0001339
DR   ATCC; HB-8516
DR   Wikidata; Q54585456
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8516.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   3G3 [Mouse hybridoma against chicken IFNK]
AC   CVCL_E1H3
RX   PubMed=34271063;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; H8XX39; Chicken IFNK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3G3 [Mouse hybridoma against human PSCA]
AC   CVCL_B0TT
DR   Wikidata; Q108819608
RX   Patent=US8524460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12615.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3G3 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TK
DR   Wikidata; Q111732719
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   3G4 [Mouse hybridoma against human HAVCR2]
AC   CVCL_F1WZ
RX   Patent=US12312403;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3G4 [Mouse hybridoma against influenza HA]
AC   CVCL_A0UL
DR   CCRID; 4201PAT-CCTCC00178
DR   Wikidata; Q108819609
RX   Patent=CN101220097A;
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200604.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 5
//
ID   3G5 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HN
DR   Wikidata; Q108819610
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3G5 [Mouse hybridoma against O-acetylated gangliosides]
AC   CVCL_D291
DR   CLO; CLO_0001340
DR   ATCC; CRL-1814
DR   BCRJ; 0015
DR   Wikidata; Q54585457
RX   PubMed=6368201;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: O-acetylated gangliosides.
CC   Discontinued: BCRJ; 0015; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   3G5-A2
AC   CVCL_E8UT
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3G5-H11
AC   CVCL_E8UU
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   3G5G2
AC   CVCL_A3BZ
DR   Wikidata; Q105505922
RX   Patent=CN111925992B;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00755; Human WNT7A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   3G6 [Mouse hybridoma against CDV hemagglutinin]
AC   CVCL_A3CE
DR   Wikidata; Q105505923
RX   PubMed=25644427;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Canine distemper virus (isolate NJ01) hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   3G6 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0K9
DR   Wikidata; Q108819611
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12485.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3G6 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JH
DR   Wikidata; Q107113273
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3G6 [Mouse hybridoma against vaccinia A14L]
AC   CVCL_E5Q7
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3G6-F9
AC   CVCL_E2S5
RX   PubMed=26090597;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A125YR49; Toxoplasma gondii (strain ATCC 50611 / Me49) H(+)-exporting diphosphatase (TgVP1) (Note=Also reacts with Plasmodium berghei).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3G7
AC   CVCL_A8JI
DR   Wikidata; Q107113274
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3G8 [Mouse hybridoma against ciguatoxin CTX1B]
AC   CVCL_C5GJ
DR   Wikidata; Q116048187
RX   PubMed=22575284;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_36467; Ciguatoxin CTX1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   3G8 [Mouse hybridoma against HIV-1 antigens]
AC   CVCL_U327
DR   Wikidata; Q54585459
RX   Patent=US4904581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9114.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: HIV-1 antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   3G8 [Mouse hybridoma against human FCGR3A]
AC   CVCL_J227
DR   ABCD; ABCD_AD828
DR   TKG; TKG 0178
DR   Wikidata; Q54585460
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08637; Human FCGR3A/CD16a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   3G8 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HI
SY   3G8-7-2-1-5
DR   Wikidata; Q110429771
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   3G9
AC   CVCL_B0E7
DR   Wikidata; Q108819612
RX   PubMed=2428752;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Neisseria gonorrhoeae lipo-oligosaccharide (LOS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3G9F3
AC   CVCL_G604
DR   CLO; CLO_0001341
DR   ATCC; CRL-1843
DR   Wikidata; Q54585461
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   3GC-C2
AC   CVCL_C4PF
DR   Wikidata; Q116048188
RX   PubMed=204013;
RX   PubMed=2580779;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   3H1.18.10
AC   CVCL_B0EK
SY   3H1
DR   Wikidata; Q108819613
RX   Patent=US7592439;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12535.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3H1.4.8
AC   CVCL_LH39
DR   Wikidata; Q54585462
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6028.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 5
//
ID   3H10-2F4
AC   CVCL_B6MA
DR   Wikidata; Q111732720
RX   PubMed=25197955;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_77148; Ginsenoside Re.
CC   Monoclonal antibody target: ChEBI; CHEBI_67987; Ginsenoside Rg1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   3H10-33
AC   CVCL_E6JY
RX   PubMed=11477279;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05386; Human RPLP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   3H11 [Mouse hybridoma against CDV hemagglutinin]
AC   CVCL_A3CB
DR   Wikidata; Q105505928
RX   PubMed=25644427;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Canine distemper virus (isolate NJ01) hemagglutinin glycoprotein (H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   3H11 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA05
DR   Wikidata; Q93306387
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9374.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   3H11 [Mouse hybridoma against PCV2 Cap]
AC   CVCL_B0KX
DR   Wikidata; Q108819614
RX   Patent=CN105542000B;
RX   PubMed=27500643;
RX   PubMed=27556914;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; V5N005; Porcine circovirus 2 (PCV2) isolate Nanjing caspid protein (Cap).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   3H11G12C8D6
AC   CVCL_WZ92
DR   Wikidata; Q93306389
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   3H12
AC   CVCL_F1F4
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   3H2 [Mouse hybridoma against human ERBB2]
AC   CVCL_E2SC
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3H2 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JJ
DR   Wikidata; Q107113275
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   3H3.14.5
AC   CVCL_B0EL
SY   3H3
DR   Wikidata; Q108819615
RX   Patent=US7592439;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12534.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   3H4 [Mouse hybridoma against HAstV-1 VP25]
AC   CVCL_C5NM
DR   Wikidata; Q116048189
RX   Patent=US20200392578;
RX   PubMed=30355681;
RX   PubMed=31233538;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; Q82452; Human astrovirus-1 (strain Oxford) (HAstV-1) capsid protein VP90 (Note=AA 424-648 = Capsid protein VP25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   3H4 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JK
DR   Wikidata; Q107113276
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   3H5 [Mouse hybridoma against HNK-1]
AC   CVCL_C2X5
DR   DSHB; 3H5
DR   Wikidata; Q114310445
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   3H5 [Mouse hybridoma against human TNFRSF6B]
AC   CVCL_XG91
DR   CCRID; 4201PAT-CCTCC00153
DR   Wikidata; Q93306391
RX   Patent=US6843990;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200112.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95407; Human TNFRSF6B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   3H5-1
AC   CVCL_D292
DR   CLO; CLO_0001342
DR   ATCC; HB-46
DR   BCRJ; 0016
DR   Wikidata; Q54585465
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   3H6
AC   CVCL_A8JL
DR   Wikidata; Q107113277
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   3H7
AC   CVCL_D6U4
RX   PubMed=25897610;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B6SE84; Bluetongue virus 25 VP7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   3H7-6
AC   CVCL_C6XP
DR   ABCD; ABCD_AN726
DR   ABCD; ABCD_AN727
DR   Wikidata; Q123030277
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   3H7/64
AC   CVCL_VI53
DR   BEI_Resources; MRA-876
DR   Wikidata; Q54585467
RX   PubMed=1542308;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) rhoptry-associated protein 2 (RAP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   3H8
AC   CVCL_C5CI
DR   Wikidata; Q116048190
RX   PubMed=22509917;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; I1VWH1; Goose parvovirus non-structural protein 1 (NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3H8-G8
AC   CVCL_C3U4
SY   3H8 G8
DR   Wikidata; Q116048191
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3H8H6B1D1
AC   CVCL_WZ93
DR   Wikidata; Q93306401
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   3H9 [Mouse hybridoma against human HBZ]
AC   CVCL_C3TF
DR   Wikidata; Q116048192
RX   PubMed=16305964;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02008; Human HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   3H9 [Mouse hybridoma against human VNN2]
AC   CVCL_J228
DR   TKG; TKG 0621
DR   Wikidata; Q54585536
RX   PubMed=9087970;
RX   PubMed=10201959;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95498; Human VNN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   3HTEo-
AC   CVCL_U403
SY   3/HTEo-; HTE-3o-
DR   Wikidata; Q54585537
RX   PubMed=1375758;
RX   PubMed=2457904;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U404 ! 8HTEo-
OI   CVCL_U405 ! 9HTEo-
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   3J1
AC   CVCL_M056
DR   KCLB; 60053
DR   Wikidata; Q54585539
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   3J24.2
AC   CVCL_E3ZZ
RX   PubMed=14675102;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   3L1
AC   CVCL_RX94
DR   Wikidata; Q54585540
RX   PubMed=27594586;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   3L6
AC   CVCL_RX92
DR   SKIP; SKIP001230
DR   Wikidata; Q54585542
RX   PubMed=27594586;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Unspecified (PubMed=27594586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RX93 ! 3L9
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   3L9
AC   CVCL_RX93
DR   SKIP; SKIP001231
DR   Wikidata; Q54585543
RX   PubMed=27594586;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Unspecified (PubMed=27594586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RX92 ! 3L6
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   3LBLN
AC   CVCL_3636
DR   CLO; CLO_0001343
DR   ATCC; CRL-6048
DR   Wikidata; Q54585544
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6048; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   3LL
AC   CVCL_5653
SY   3-LL; 3 LL; LLC
DR   BTO; BTO_0004004
DR   ChEMBL-Cells; CHEMBL3307811
DR   ChEMBL-Targets; CHEMBL612910
DR   JCRB; JCRB1348
DR   PubChem_Cell_line; CVCL_5653
DR   Wikidata; Q54585548
CC   Doubling time: ~2 days (Note=Lot 07112016), ~33 hours (Note=Lot 08232018) (JCRB=JCRB1348).
CC   Caution: Could be identical to LL/2 (LLC1) (Cellosaurus=CVCL_4358).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   3M
AC   CVCL_4J66
DR   Wikidata; Q54585550
RX   Patent=US9624299;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10481.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   3NA12
AC   CVCL_M959
DR   Wikidata; Q54585551
RX   Patent=US20020048812;
RX   PubMed=10804211;
RX   PubMed=22863662;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Nose, nasal cavity, olfactory epithelium; UBERON=UBERON_0001997.
CC   Cell type: Olfactory sensory neuron; CL=CL_0000207.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1-3D
CA   Conditionally immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   3NB12.13
AC   CVCL_2H34
DR   ATCC; CRL-2354
DR   Wikidata; Q54585553
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharyngeal cells.
CC   Discontinued: ATCC; CRL-2354; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 5
//
ID   3nFC
AC   CVCL_UI37
DR   Wikidata; Q93306440
RX   PubMed=30017856;
CC   Group: Fish cell line.
CC   Doubling time: 38.9 hours (PubMed=30017856).
CC   Karyotypic information: Triploid karyotype.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: (Carassius auratus langsdorfii x Cyprinus carpio) x Carassius auratus langsdorfii.
OX   NCBI_TaxID=138676; ! Carassius langsdorfii (Japanese silver crucian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   3PC
AC   CVCL_JW71
DR   Wikidata; Q54585556
RX   PubMed=2463079;
RX   PubMed=19575421;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: SENCAR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   3PNF_FiPSsv_PM_2
AC   CVCL_UN11
DR   Wikidata; Q93306446
RX   PubMed=30713041;
RX   PubMed=30840859;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_3PNF_FiPSsv_PM_2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO_3PNF_FiPSsv_PM_2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Germans Trias i Pujol (IGTP); Barcelona; Spain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=30713041).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln1315Ter (c.3943C>T); ClinVar=VCV000938573; Zygosity=Heterozygous; Note=Germline (PubMed=30713041).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC; PubMed=30713041
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 21,24
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN12 ! 3PNF_SiPSsv_MM_11
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   3PNF_SiPSsv_MM_11
AC   CVCL_UN12
DR   Wikidata; Q93306448
RX   PubMed=30713041;
RX   PubMed=30840859;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_3PNF_SiPSsv_MM_11-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO_3PNF_SiPSsv_MM_11-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Germans Trias i Pujol (IGTP); Barcelona; Spain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=30713041).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln1315Ter (c.3943C>T); ClinVar=VCV000938573; Zygosity=Heterozygous; Note=Germline (PubMed=30713041).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): BNLC; PubMed=30713041
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 21,24
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN11 ! 3PNF_FiPSsv_PM_2
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   3Pt12B8
AC   CVCL_J724
SY   3 PT12B8
DR   CLO; CLO_0001344
DR   ATCC; HB-8136
DR   Wikidata; Q54585558
RX   Patent=US4443427;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8136.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   3S9
AC   CVCL_C0BS
DR   Wikidata; Q112926972
RX   Patent=US20030095965;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: UniProtKB; P26715; Human KLRC1/CD159a.
CC   Monoclonal antibody target: UniProtKB; P26717; Human KLRC2/CD159c.
CC   Monoclonal antibody target: UniProtKB; Q07444; Human KLRC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   3SB
AC   CVCL_E146
DR   RCB; RCB0681
DR   Wikidata; Q54585560
RX   PubMed=9726009;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: RCB; RCB0681; true.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   3SOD1-1
AC   CVCL_ZY49
DR   Wikidata; Q102113445
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His44Arg (c.131A>G) (H43R); ClinVar=VCV000014756; Zygosity=Unspecified (PubMed=30127392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY50 ! 3SOD1-4
OI   CVCL_ZY51 ! 3SOD1-7
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   3SOD1-4
AC   CVCL_ZY50
DR   Wikidata; Q102113446
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His44Arg (c.131A>G) (H43R); ClinVar=VCV000014756; Zygosity=Unspecified (PubMed=30127392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY49 ! 3SOD1-1
OI   CVCL_ZY51 ! 3SOD1-7
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   3SOD1-7
AC   CVCL_ZY51
DR   Wikidata; Q102113448
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His44Arg (c.131A>G) (H43R); ClinVar=VCV000014756; Zygosity=Unspecified (PubMed=30127392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY49 ! 3SOD1-1
OI   CVCL_ZY50 ! 3SOD1-4
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   3T
AC   CVCL_B7FU
SY   LSTC-3T
DR   Wikidata; Q112926973
RX   PubMed=67703;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   3T3 MEFs KO
AC   CVCL_9091
DR   CLO; CLO_0001347
DR   ATCC; CRL-2753
DR   Wikidata; Q54585561
RX   PubMed=11457855;
CC   Knockout cell: Method=KO mouse; MGI; MGI:102709; Cav1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   3T3 MEFs WT
AC   CVCL_9092
DR   CLO; CLO_0001348
DR   ATCC; CRL-2752
DR   Wikidata; Q54585562
RX   PubMed=11457855;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   3T3 rho-0#8
AC   CVCL_YY06
DR   Kerafast; ESA101
DR   Wikidata; Q98125394
RX   PubMed=27136098;
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Produced by transient transfection with plasmid pMA4008 encoding HSV-1 UL12.5M185 protein, which damages mtDNA by an unknown mechanism.
CC   Discontinued: Kerafast; ESA101; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   3T3(+3)
AC   CVCL_8827
SY   3T3 (+3)
DR   CLO; CLO_0001350
DR   CLDB; cl69
DR   ATCC; CRL-6474
DR   ECACC; 89022402
DR   Wikidata; Q54602678
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6474; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 9
//
ID   3T3-C2
AC   CVCL_0121
SY   3T3C2
DR   MCCL; MCC:0000013
DR   Wikidata; Q54585565
RX   PubMed=6698114;
CC   Caution: Could be identical to 3T3-M2 (Cellosaurus=CVCL_4U11).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   3T3-J2
AC   CVCL_W667
SY   3T3 J2; 3T3J2
DR   AddexBio; P0011008/4994
DR   IZSLER; BS CL 153
DR   Kerafast; EF3003
DR   Wikidata; Q54585567
RX   PubMed=1052771;
CC   Doubling time: ~18 hours (Kerafast=EF3003).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   3T3-L1
AC   CVCL_0123
SY   3T3 L1; 3T3L1; 3T3-L1 ad; NIH-3T3-L1; NIH3T3-L1
DR   BTO; BTO_0000011
DR   CLO; CLO_0001352
DR   EFO; EFO_0001084
DR   MCCL; MCC:0000015
DR   CLDB; cl71
DR   CLDB; cl72
DR   CLDB; cl73
DR   AddexBio; P0011002/407
DR   ATCC; CCL-92.1
DR   ATCC; CL-173
DR   BCRC; 60159
DR   BCRJ; 0019
DR   CCRID; 1101MOU-PUMC000155
DR   CCRID; 3101MOUGNM25
DR   CCRID; 3101MOUSCSP5038
DR   CCRID; 4201MOU-CCTCC00180
DR   CCRID; 5301MOU-KCB92010YJ
DR   CCTCC; GDC0180
DR   ChEMBL-Cells; CHEMBL3307630
DR   ChEMBL-Targets; CHEMBL614510
DR   CLS; 400107
DR   ECACC; 86052701
DR   ENCODE; ENCBS366WMO
DR   ENCODE; ENCBS666CGP
DR   IBRC; C10152
DR   IZSLER; BS CL 100
DR   JCRB; IFO50416
DR   JCRB; JCRB9014
DR   KCB; KCB 92010YJ
DR   KCLB; 10092.1
DR   Kerafast; EF3001
DR   Lonza; 677
DR   Lonza; 1083
DR   MeSH; D041721
DR   PRIDE; PXD001063
DR   PRIDE; PXD001529
DR   PRIDE; PXD003696
DR   PubChem_Cell_line; CVCL_0123
DR   TOKU-E; 331
DR   Wikidata; Q4636414
RX   DOI=10.1016/0092-8674(74)90126-3;
RX   Patent=US4003789;
RX   PubMed=165899;
RX   PubMed=4426090;
RX   PubMed=6698114;
RX   PubMed=28176856;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=3T3-L1%20cells
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-103.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-334.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-72.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/3T3-L1
WW   Provider; BRICS; BRICS0073; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3888
WW   Provider; ZenBio; -; https://www.zen-bio.com/products/cells/3T3L1.php
CC   Doubling time: ~2.2 days (Note=Lot 12142004), 31 hours (Note=Lot 07032008), ~28 hours (Note=Lot 07232012), ~54 hours (Note=Lot 02202015), ~39 hours (Note=Lot 08012016), ~28 hours (Note=Lot 02212018) (JCRB=IFO50416); ~43 hours (Note=Lot 11272012), ~41 hours (Note=Lot 02132012), ~28 hours (Note=Lot 08222011), ~23 hours (Note=Lot 02152011), ~26 hours (Note=Lot 01142010), ~31 hours (Note=Lots 01282009 and 08222016), ~1 day (Note=Lot 01252008), ~1.5 days (Note=Lot 02092007), ~33 hours (Note=Lots 06122006 and 05252015), ~40 hours (Note=Lot 12162004), 60-70 hours (Note=Lot 06082004), ~3 days (Note=Lot 10302002), ~37 hours (Note=Lot 032499), ~30 hours (Note=Lot 06012015), 20-64 hours (Note=Lot 04212017), ~27 hours (Note=Lot 10082020) (JCRB=JCRB9014).
CC   Miscellaneous: STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
CC   Discontinued: ATCC; CCL-92.1; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 10,15
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 13,15
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12,15
ST   Mouse STR 7-1: 25.2,29
ST   Mouse STR 8-1: 15,16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 19
ST   Mouse STR 13-1: 15
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 12,15
ST   Mouse STR 18-3: 17,21
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   3T3-L1 CAR SNRK KO
AC   CVCL_D4DA
SY   3T3-L1SNRK-/-
DR   ATCC; CRL-3477
DR   Wikidata; Q127378722
RX   PubMed=31420304;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108104; Snrk.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 6
//
ID   3T3-L1 EGFP-ATA2
AC   CVCL_QZ17
SY   EGFP-ATA2 3T3-L1
DR   Wikidata; Q54602648
RX   PubMed=17050538;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1915010; Slc38a2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   3T3-L1 MBX
AC   CVCL_0A20
DR   ATCC; CRL-3242
DR   Wikidata; Q54602650
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Has_anyone_used_3T3-L1_MBX_cell_line_from_ATCC_before
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   3T3-L1-GLUT4myc
AC   CVCL_E6YT
RX   PubMed=7686158;
CC   Characteristics: Stably expresses Slc2a4/Glut4 containing a 14 amino-acid epitope of human MYC within its first exofacial loop (PubMed=7686158).
CC   Genetic integration: Method=Transduction; Gene=RGD; 2711; Slc2a4 (Note=With a Myc tag in the 1st ectodomain).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   3T3-L2
AC   CVCL_UJ37
DR   Wikidata; Q93306488
RX   DOI=10.1016/0092-8674(74)90126-3;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   3T3-M2
AC   CVCL_4U11
DR   Wikidata; Q54602652
RX   PubMed=165899;
RX   PubMed=4426090;
CC   Caution: Could be identical to 3T3-C2 (Cellosaurus=CVCL_0121).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   3T3-mB7-H4
AC   CVCL_A0VH
DR   Wikidata; Q108819616
RX   PubMed=21190056;
RX   PubMed=21813370;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:3039619; Vtcn1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   3T3-msCD40L
AC   CVCL_1H10
SY   3T3-CD40L
DR   BEI_Resources; ARP-12535
DR   Wikidata; Q54602655
RX   PubMed=11691813;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88337; Cd40lg.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   3T3-MSV
AC   CVCL_4578
DR   CLO; CLO_0001353
DR   CLDB; cl74
DR   ECACC; 90092701
DR   Wikidata; Q54602657
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   3T3-Swiss albino
AC   CVCL_0120
SY   3T3 Swiss Albino; 3T3; Swiss-3T3; Swiss 3T3; Swiss3T3
DR   CLO; CLO_0001345
DR   CLO; CLO_0001355
DR   MCCL; MCC:0000012
DR   CLDB; cl65
DR   CLDB; cl66
DR   CLDB; cl76
DR   CLDB; cl77
DR   CLDB; cl78
DR   CLDB; cl79
DR   CLDB; cl80
DR   CLDB; cl81
DR   CLDB; cl82
DR   CLDB; cl83
DR   ATCC; CCL-92
DR   BCRC; 60071
DR   BCRJ; 0017
DR   BioSample; SAMN11397627
DR   CCRID; 1101MOU-PUMC000001
DR   CCRID; 1102MOU-NIFDC00039
DR   CCRID; 3101MOUSCSP5012
DR   CLS; 400103
DR   DSMZ; ACC-173
DR   DSMZCellDive; ACC-173
DR   ECACC; 85022108
DR   ICLC; ATL95002
DR   IZSLER; BS CL 82
DR   JCRB; IFO50417
DR   JCRB; JCRB9019
DR   KCB; KCB 2021042YJ
DR   Lonza; 902
DR   MeSH; D041701
DR   RCB; RCB1642
DR   Wikidata; Q54602659
RX   DOI=10.1007/BF02618370;
RX   PubMed=13985244;
RX   PubMed=25277546;
RX   PubMed=31220119;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/3t3/3t3cells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-ccl-92-vs-atcc-crl-1658
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
CC   Doubling time: ~40 hours (DSMZ=ACC-173); ~2 days (Note=Lot 03222011) (JCRB=IFO50417); 36 hours (Note=Lot 090991), ~2 days (Note=Lots 04052005, 04232010 and 08282012) (JCRB=JCRB9019).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: CLS; 400103; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 10,15
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 13,15
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12,15
ST   Mouse STR 7-1: 25.2,29
ST   Mouse STR 8-1: 15,16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 19
ST   Mouse STR 13-1: 15
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 12,15
ST   Mouse STR 18-3: 17,21
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26,27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 32
//
ID   3T3/40L
AC   CVCL_A6ZR
SY   40L
DR   Wikidata; Q107113278
RX   PubMed=21897376;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88337; Cd40lg.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   3T3.T4
AC   CVCL_1E11
SY   NIH-3T3 CD4+
DR   BEI_Resources; ARP-3945
DR   Wikidata; Q54602662
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   3T3.T4.BOB
AC   CVCL_1E12
SY   NIH-3T3 CD4+BoB+
DR   BEI_Resources; ARP-3949
DR   Wikidata; Q54602665
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4469; GPR15.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1E11 ! 3T3.T4
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   3T3.T4.Bonzo
AC   CVCL_1E13
SY   NIH-3T3 CD4+Bonzo+
DR   BEI_Resources; ARP-3950
DR   Wikidata; Q54602667
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16647; CXCR6.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1E11 ! 3T3.T4
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   3T3.T4.CCR3
AC   CVCL_1E14
SY   NIH-3T3 CD4+CCR3+
DR   BEI_Resources; ARP-3946
DR   Wikidata; Q54602670
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1E11 ! 3T3.T4
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   3T3.T4.CCR5
AC   CVCL_1E15
SY   NIH-3T3 CD4+CCR5+
DR   BEI_Resources; ARP-3947
DR   Wikidata; Q54602673
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1E11 ! 3T3.T4
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   3T3.T4.CXCR4
AC   CVCL_1E16
SY   CXCR4-3T3.T4; NIH-3T3 CD4+CXCR4+
DR   BEI_Resources; ARP-3948
DR   Wikidata; Q54602675
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1E11 ! 3T3.T4
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   3T3F442A
AC   CVCL_0122
SY   3T3-F442A; 3T3-442A; F442A; F442-A
DR   BTO; BTO_0001169
DR   EFO; EFO_0002811
DR   MCCL; MCC:0000014
DR   ECACC; 00070654
DR   Kerafast; EF3002
DR   Lonza; 841
DR   Wikidata; Q54602679
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=3T3-F442A
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/3/cell-lines-detail-360.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-344.html
CC   Doubling time: 18 hours (Kerafast=EF3002).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   3T3J2NHP
AC   CVCL_C0R6
DR   Wikidata; Q112926974
RX   PubMed=10648628;
CC   Characteristics: Used a feeder cells to support transduced keratinocyte populations during selection with one of G418, hygromycin or puromycin.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W667 ! 3T3-J2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   3T6-Swiss albino
AC   CVCL_0601
SY   3T6 Swiss Albino; Swiss 3T6; NIH 3T6; 3T6; GM05862
DR   BTO; BTO_0000454
DR   CLO; CLO_0001356
DR   CLO; CLO_0024702
DR   CLO; CLO_0050525
DR   EFO; EFO_0022784
DR   CLDB; cl86
DR   CLDB; cl88
DR   CLDB; cl89
DR   CLDB; cl90
DR   ATCC; CCL-96
DR   BCRC; 60070
DR   BCRJ; 0020
DR   CCRID; 1101MOU-PUMC000121
DR   CCRID; 1102MOU-NIFDC00040
DR   CCRID; 3101MOUGNM1
DR   CLS; 400104
DR   Coriell; GM05862
DR   DSMZ; ACC-202
DR   DSMZCellDive; ACC-202
DR   ECACC; 86120801
DR   IZSLER; BS CL 83
DR   JCRB; JCRB9059
DR   RCB; RCB0248
DR   Wikidata; Q54602683
RX   CelloPub=CLPUB00447;
RX   DOI=10.3917/bhesv.191.0045;
RX   PubMed=13985244;
RX   PubMed=34737324;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-228.html
CC   Doubling time: ~15 hours (DSMZ=ACC-202).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   3XIII
AC   CVCL_WM11
DR   Wikidata; Q93306543
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=821777;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   3Y1-B cl 1-6-K5-4-2
AC   CVCL_J498
DR   RCB; RCB0289
DR   Wikidata; Q54602685
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   3Y1-B clone 1
AC   CVCL_4563
SY   3Y1B clone 1; 3Y1
DR   BTO; BTO_0002368
DR   ChEMBL-Cells; CHEMBL3308639
DR   ChEMBL-Targets; CHEMBL614741
DR   PubChem_Cell_line; CVCL_4563
DR   RCB; RCB0290
DR   TOKU-E; 4132
DR   Wikidata; Q54602686
RX   PubMed=166944;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/3/cell-lines-detail-585.html
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   3Y1-B clone 1-6
AC   CVCL_E147
DR   JCRB; JCRB0734
DR   RCB; RCB0287
DR   RCB; RCB0488
DR   Wikidata; Q54602688
RX   PubMed=166944;
CC   Doubling time: ~1 day (Note=Lot 03172017) (JCRB=JCRB0734).
CC   Discontinued: RCB; RCB0287; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   3Y1-B clone 1-6-2
AC   CVCL_H230
DR   RCB; RCB0288
DR   Wikidata; Q54602690
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   3Y1-SB-15
AC   CVCL_K105
DR   RCB; RCB0323
DR   Wikidata; Q54602692
RX   PubMed=4030625;
CC   Transformant: ChEBI; CHEBI_64103; Sodium butyrate.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1-SB-16
AC   CVCL_K106
DR   RCB; RCB0324
DR   Wikidata; Q54602694
RX   PubMed=4030625;
CC   Transformant: ChEBI; CHEBI_64103; Sodium butyrate.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1BU^(r-1)
AC   CVCL_U201
DR   RCB; RCB0325
DR   Wikidata; Q54602695
RX   CelloPub=CLPUB00012;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   3Y1BU^(r-2)
AC   CVCL_U202
DR   RCB; RCB0326
DR   Wikidata; Q54602697
RX   CelloPub=CLPUB00012;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   3Y1BU^(r-3)
AC   CVCL_U203
DR   RCB; RCB0327
DR   Wikidata; Q54602698
RX   CelloPub=CLPUB00012;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   3Y1ts-101
AC   CVCL_L712
SY   3Y1 ts-101
DR   RCB; RCB0291
DR   Wikidata; Q54602700
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-103
AC   CVCL_L713
SY   3Y1 ts-103
DR   RCB; RCB0293
DR   Wikidata; Q54602701
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-104
AC   CVCL_L714
SY   3Y1 ts-104
DR   RCB; RCB0294
DR   Wikidata; Q54602704
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-105
AC   CVCL_L715
SY   3Y1 ts-105
DR   RCB; RCB0295
DR   Wikidata; Q54602705
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-108
AC   CVCL_L716
SY   3Y1 ts-108
DR   RCB; RCB0298
DR   Wikidata; Q54602707
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-109
AC   CVCL_L717
SY   3Y1 ts-109
DR   RCB; RCB0299
DR   Wikidata; Q54602708
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-111
AC   CVCL_L718
SY   3Y1 ts-111
DR   RCB; RCB0301
DR   Wikidata; Q54602709
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-114
AC   CVCL_L719
SY   3Y1 ts-114
DR   RCB; RCB0304
DR   Wikidata; Q54602712
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-115
AC   CVCL_L720
SY   3Y1 ts-115
DR   RCB; RCB0305
DR   Wikidata; Q54602713
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-117
AC   CVCL_L721
SY   3Y1 ts-117
DR   RCB; RCB0307
DR   Wikidata; Q54602715
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-118
AC   CVCL_L722
SY   3Y1 ts-118
DR   RCB; RCB0308
DR   Wikidata; Q54602716
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-120
AC   CVCL_L723
SY   3Y1 ts-120
DR   RCB; RCB0310
DR   Wikidata; Q54602718
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-122
AC   CVCL_L724
SY   3Y1 ts-122
DR   RCB; RCB0312
DR   Wikidata; Q54602720
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-201
AC   CVCL_L725
SY   3Y1 ts-201
DR   RCB; RCB0317
DR   Wikidata; Q54602721
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1ts-202
AC   CVCL_L726
SY   3Y1 ts-202
DR   RCB; RCB0318
DR   Wikidata; Q54602722
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsA106
AC   CVCL_L727
SY   3Y1 tsA106
DR   RCB; RCB0296
DR   Wikidata; Q54602724
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsB107
AC   CVCL_L728
SY   3Y1 tsB107
DR   RCB; RCB0297
DR   Wikidata; Q54602807
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsC102
AC   CVCL_L729
SY   3Y1 tsC102
DR   RCB; RCB0292
DR   Wikidata; Q54602808
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsC112
AC   CVCL_L730
SY   3Y1 tsC112
DR   RCB; RCB0302
DR   Wikidata; Q54602810
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsC113
AC   CVCL_L731
SY   3Y1 tsC113
DR   RCB; RCB0303
DR   Wikidata; Q54602813
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsC116
AC   CVCL_L732
SY   3Y1 tsC116
DR   RCB; RCB0306
DR   Wikidata; Q54602815
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsC119
AC   CVCL_L733
SY   3Y1 tsC119
DR   RCB; RCB0309
DR   Wikidata; Q54602817
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsC205
AC   CVCL_L734
SY   3Y1 tsC205
DR   RCB; RCB0321
DR   Wikidata; Q54602819
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsD123
AC   CVCL_L735
SY   3Y1 tsD123
DR   RCB; RCB0313
DR   Wikidata; Q54602822
RX   PubMed=2553277;
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsD124
AC   CVCL_L736
SY   3Y1 tsD124
DR   RCB; RCB0314
DR   Wikidata; Q54602824
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsD206
AC   CVCL_L737
SY   3Y1 tsD206
DR   RCB; RCB0322
DR   Wikidata; Q54602825
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsE204
AC   CVCL_L738
SY   3Y1 tsE204
DR   RCB; RCB0320
DR   Wikidata; Q54602827
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsF121
AC   CVCL_L739
SY   3Y1 tsF121
DR   RCB; RCB0311
DR   Wikidata; Q54602829
RX   PubMed=2553277;
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsF126
AC   CVCL_L740
SY   3Y1 tsF126
DR   RCB; RCB0316
DR   Wikidata; Q54602831
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsG125
AC   CVCL_L741
SY   3Y1 tsG125
DR   RCB; RCB0315
DR   Wikidata; Q54602833
RX   PubMed=2553277;
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   3Y1tsH203
AC   CVCL_L742
SY   3Y1 tsH203
DR   RCB; RCB0319
DR   Wikidata; Q54602836
RX   PubMed=2553277;
RX   PubMed=6583851;
CC   Characteristics: Temperature sensitive for proliferation. Defective at 38.5 Celsius (selection temperature) in undergoing the transition from quiescent to proliferating state.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   4-1.10
AC   CVCL_6546
SY   4-1.10''
DR   cancercelllines; CVCL_6546
DR   Wikidata; Q54602838
RX   PubMed=8274294;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=4-1.10
CC   Population: Caucasian.
CC   Characteristics: Selected to be resistant to the anti proliferative effects of oncostatin.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   4-11
AC   CVCL_2821
DR   ECACC; 11033103
DR   Wikidata; Q54602840
RX   Patent=US7537904;
CC   Group: Patented cell line.
CC   Population: African American.
CC   Characteristics: Stably expresses firefly luciferase under the control of the MMTV promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=11033103
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   4-1st
AC   CVCL_L498
SY   4-1ST
DR   Wikidata; Q54602842
RX   PubMed=1295442;
RX   PubMed=14662023;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 10
//
ID   4-2
AC   CVCL_B6X5
DR   CCRID; 4201PAT-CCTCC00714
DR   Wikidata; Q111732721
RX   Patent=CN105132384B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201590.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12277; Human CKB.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   4-2C11
AC   CVCL_J725
DR   CLO; CLO_0050361
DR   RCB; RCB0868
DR   Wikidata; Q54602844
RX   PubMed=3028450;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   4-2D
AC   CVCL_J273
DR   JCRB; JCRB0084
DR   Wikidata; Q54602846
RX   PubMed=2415123;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Chicken DNA primase-DNA polymerase alpha complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   4-4-20
AC   CVCL_C3WN
SY   4-4
DR   ABCD; ABCD_AE166
DR   Wikidata; Q116048193
RX   PubMed=2104617;
RX   PubMed=3821741;
RX   PubMed=3930950;
RX   PubMed=6348779;
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4-6-10
AC   CVCL_C3WP
DR   Wikidata; Q116048194
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG1+IgG2, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4-7
AC   CVCL_B3YI
DR   Wikidata; Q110429772
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   4-8H
AC   CVCL_J272
DR   JCRB; JCRB0083
DR   Wikidata; Q54602849
RX   PubMed=2415123;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; F1NR19; Chicken POLA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   4-9-12-7-7
AC   CVCL_D5K4
SY   277
DR   Wikidata; Q127378723
RX   PubMed=6787586;
CC   Characteristics: Produced from the fusion of the myeloma cell line with mouse fetal liver cell, thus exhibiting several phenotypic characteristics of immature B lymphocytes. This hybridoma produces, but does not secrete IgM chain. No light chain is produced (PubMed=6787586).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   4-HS-MYC
AC   CVCL_5A28
SY   4 HS MYC
DR   Wikidata; Q54602850
RX   Patent=EP0232845A2;
RX   PubMed=3526329;
CC   Characteristics: Expression of mouse Myc is under the control of a Drosophila hsp70 promoter. Contains ~900 copies of the Myc gene (PubMed=3526329).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   4.1.3.C4
AC   CVCL_D3VD
DR   ABCD; ABCD_AE102
DR   Wikidata; Q127378724
RX   PubMed=1698868;
RX   PubMed=2443831;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   4.10.1
AC   CVCL_D2Q4
DR   Wikidata; Q127378725
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   4.14.3
AC   CVCL_D2Q5
DR   Wikidata; Q127378726
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   4.17.3
AC   CVCL_ZW82
DR   Wikidata; Q102113449
RX   Patent=US9234041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2793.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   4.2-05
AC   CVCL_A4VX
DR   Wikidata; Q107113279
RX   PubMed=27252991;
CC   Characteristics: Zfp57+/- (M+Z+) genotype.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   4.2.6.D12
AC   CVCL_D3VE
DR   Wikidata; Q127378727
RX   PubMed=2443831;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   4.23
AC   CVCL_D7DG
RX   PubMed=12354868;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q47952; Haemophilus ducreyi (strain 35000HP / ATCC 700724) hgbA (Note=Also reacts with all other strains of H. ducreyi).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4.3-01
AC   CVCL_A4VY
DR   Wikidata; Q107113280
RX   PubMed=27252991;
CC   Characteristics: Zfp57-/- z (M+Z-) genotype.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   4.3-04
AC   CVCL_A4VZ
DR   Wikidata; Q107113281
RX   PubMed=27252991;
CC   Characteristics: Zfp57-/- z (M+Z-) genotype.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   4.3.6.F8
AC   CVCL_D3VF
DR   Wikidata; Q127378728
RX   PubMed=2443831;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   4.3F1
AC   CVCL_D3VG
DR   ABCD; ABCD_AE100
DR   Wikidata; Q127378730
RX   PubMed=1698868;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   4.6
AC   CVCL_E8HY
RX   PubMed=29708866;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q8K558; Mouse Treml1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4.6.5a114K
AC   CVCL_J886
SY   4.6.5A 114K
DR   ECACC; 93062218
DR   Wikidata; Q54602852
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Dog 144 kdA protein on MDCK cell line apical and basolateral surface.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   4.65
AC   CVCL_D7DH
RX   PubMed=12354868;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q47952; Haemophilus ducreyi (strain 35000HP / ATCC 700724) hgbA (Note=Also reacts with all other strains of H. ducreyi).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4.79
AC   CVCL_E2SM
RX   PubMed=15784585;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; G1UBB6; Haemophilus ducreyi (strain 35000HP / ATCC 700724) dsrA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4.8
AC   CVCL_E8HZ
RX   PubMed=29708866;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q8K558; Mouse Treml1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4.8.1
AC   CVCL_D2Q3
DR   ABCD; ABCD_AE103
DR   Wikidata; Q127378731
RX   PubMed=1698868;
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   4.9.2
AC   CVCL_ZW83
SY   LN 15843
DR   Wikidata; Q102113450
RX   Patent=US9234041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2789.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   4/148
AC   CVCL_XY73
DR   Wikidata; Q93306740
RX   PubMed=10519007;
RX   PubMed=10769206;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q1ZXQ8; Dictyostelium discoideum mtaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   4/21
AC   CVCL_VS26
SY   Line 4/21
DR   Wikidata; Q93306742
RX   PubMed=196977;
RX   PubMed=4344188;
CC   Doubling time: 20.0 +- 0.3 hours (PubMed=196977).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   4/30PRR
AC   CVCL_8480
SY   MPC 4/30PRR
DR   Wikidata; Q54602855
RX   PubMed=15860353;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97306; Nf1.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
CC   Breed/subspecies: C57BL/6 x 129S2/SvPas.
DI   NCIt; C134960; Mouse adrenal gland pheochromocytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   4/4 R.M.-4
AC   CVCL_4089
SY   4/4 RM-4; 4/4 RM4; 44R.M.-4; RM 4; RM4
DR   CLO; CLO_0001357
DR   CLDB; cl91
DR   ATCC; CCL-216
DR   ECACC; 90112711
DR   Wikidata; Q54602856
RX   PubMed=7065527;
RX   PubMed=7216240;
RX   PubMed=7627973;
CC   Derived from site: In situ; Lung, visceral pleura; UBERON=UBERON_0002401.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   2-3M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   4/95
AC   CVCL_XY74
DR   Wikidata; Q93306753
RX   PubMed=10519007;
RX   PubMed=10769206;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q1ZXQ8; Dictyostelium discoideum mtaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   40
AC   CVCL_IW90
DR   Wikidata; Q54602858
RX   PubMed=9437800;
RX   PubMed=28159921;
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1-2M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 6
//
ID   40 BLCL
AC   CVCL_E404
DR   ECACC; 94031605
DR   Wikidata; Q54602859
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   40-1a
AC   CVCL_C2K0
SY   40-1A
DR   DSHB; 40-1a
DR   Wikidata; Q114310446
CC   From: Sanes, Joshua Richard; Department of Molecular and Cellular Biology, Harvard University; Cambridge; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   40.10.09
AC   CVCL_J671
SY   PM 40.10.09
DR   CLO; CLO_0001358
DR   ATCC; HB-9311
DR   Wikidata; Q54602860
RX   Patent=US4818685;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9311.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P13051; Human UNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   40.2D6
AC   CVCL_C3HE
DR   DSHB; 40-2D6
DR   Wikidata; Q114310447
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61374; Rat Isl1 (Note=Also reacts with many other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   40.d7
AC   CVCL_C5I2
SY   40.D7
DR   Wikidata; Q116048195
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   402-10
AC   CVCL_C4E0
DR   Wikidata; Q116048196
RX   PubMed=2040800;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   402-91
AC   CVCL_S813
SY   402/91; MLS 402-91; MLS402
DR   EFO; EFO_0022655
DR   Cosmic; 1105011
DR   Cosmic; 1672267
DR   Cosmic; 2307719
DR   Cosmic; 2800529
DR   Wikidata; Q54602862
RX   PubMed=1283316;
RX   PubMed=16651630;
RX   PubMed=20515481;
RX   PubMed=24726063;
RX   PubMed=25393000;
RX   PubMed=26643872;
RX   PubMed=27270875;
RX   PubMed=30962207;
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=27270875).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=27270875).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   402-91/ET
AC   CVCL_S814
DR   Wikidata; Q54602863
RX   PubMed=21805478;
CC   Selected for resistance to: ChEBI; CHEBI_84050; Trabectedin (Ecteinascidin-743; ET-743).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S813 ! 402-91
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   4022 mel
AC   CVCL_C7UE
DR   Wikidata; Q123030279
RX   PubMed=22207316;
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   4023M
AC   CVCL_WM33
DR   cancercelllines; CVCL_WM33
DR   Cosmic; 852208
DR   Wikidata; Q93306778
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   404C2
AC   CVCL_DP92
SY   404C-2
DR   GEO; GSM1040274
DR   GEO; GSM1040344
DR   GEO; GSM1489194
DR   GEO; GSM1489223
DR   GEO; GSM1489252
DR   GEO; GSM1489427
DR   SKIP; SKIP000821
DR   Wikidata; Q54602865
RX   PubMed=21460823;
RX   PubMed=24259714;
RX   PubMed=27476965;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   HLA typing: A*02:01; B*27:05,50:01; C*01:02;04:01; DQA1*01:01,05:01; DQB1*03:01,05:01; DRB1*01:01,13:03 (PubMed=30853558).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   405VI
AC   CVCL_ZS97
SY   405 VIllejuif
DR   Wikidata; Q98125397
RX   PubMed=14688028;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   4063-21-1
AC   CVCL_WU15
DR   ABCD; ABCD_AJ834
DR   Wikidata; Q93306786
RX   DOI=10.1021/jf00090a018;
RX   DOI=10.1080/09540109609354900;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_15930; Atrazine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 4
//
ID   4087P
AC   CVCL_C2V0
DR   Wikidata; Q114310448
RX   PubMed=7685988;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   409B2
AC   CVCL_K092
SY   409-B2; 409B-2; HPS0076; BRCi023-A; CIRAi007-A
DR   BioSamples; SAMEA114468321
DR   BioSamples; SAMEA114604042
DR   GEO; GSM1040275
DR   GEO; GSM1040345
DR   GEO; GSM1489195
DR   GEO; GSM1489224
DR   GEO; GSM1489251
DR   GEO; GSM1489428
DR   hPSCreg; CIRAi007-A
DR   RCB; HPS0076
DR   SKIP; SKIP000218
DR   Wikidata; Q54602867
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=23434393;
RX   PubMed=24259714;
RX   PubMed=25231866;
RX   PubMed=25665923;
RX   PubMed=26997647;
RX   PubMed=27476965;
RX   PubMed=30127392;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 7,19
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   409B2 HCN4-EGFP/SHOX2-mCherry
AC   CVCL_C3LU
DR   Wikidata; Q116048197
RX   PubMed=36092505;
CC   Population: Caucasian.
CC   Characteristics: Dual reporter cell line. Using homologous recombination EGFP was inserted at the N-terminus of HCN4 and using CRISPR/Cas9 mCherry was inserted at the N-terminus of SHOX2 (PubMed=36092505).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K092 ! 409B2
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   40B11
AC   CVCL_C3XN
DR   Wikidata; Q116048198
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   40B8
AC   CVCL_B0LN
DR   Wikidata; Q108819617
RX   Patent=DE19632755C1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2279.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6YHK3; Human CD109.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   40FSDNC15
AC   CVCL_RH70
SY   DOXTOX2 hiPSC
DR   SKIP; SKIP001182
DR   Wikidata; Q54602868
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   40H6
AC   CVCL_C5NI
DR   Wikidata; Q116048199
RX   PubMed=36084594;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_17833; Gentamicin (Gentamycin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   40L
AC   CVCL_ZJ45
SY   40 L
DR   Wikidata; Q98125401
RX   PubMed=18375821;
RX   PubMed=21505561;
CC   Characteristics: Established from lung micro-metastases in a C57BL/6 mouse subcutaneous injected with the parent cell line (PubMed=21505561).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IW90 ! 40
SX   Male
AG   1-2M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 5
//
ID   40LB
AC   CVCL_A6ZS
SY   3T3/40L/BAFF
DR   RCB; RCB5304
DR   Wikidata; Q107113282
RX   PubMed=21897376;
CC   Characteristics: Can be used as feeder cells for B cell culture. Support efficient proliferation and survival of B cells (PubMed=21897376).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88337; Cd40lg.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1344376; Tnfsf13b.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6ZR ! 3T3/40L
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   41-2
AC   CVCL_G693
SY   mAb 41-2
DR   CLO; CLO_0001360
DR   ATCC; CRL-2695
DR   Wikidata; Q54602869
RX   Patent=US6498014;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-226.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H5V8; Human CDCDP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 9
//
ID   41-71-21
AC   CVCL_A9G9
DR   ABCD; ABCD_AN709
DR   Wikidata; Q102113451
RX   PubMed=2408765;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08796; Dictyostelium discoideum csaA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   41-3.48
AC   CVCL_J727
DR   CLO; CLO_0001361
DR   ATCC; HB-130
DR   Wikidata; Q54602871
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   410.4
AC   CVCL_W343
DR   Wikidata; Q54602872
RX   PubMed=2790822;
RX   PubMed=3940214;
RX   PubMed=6677618;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0I84 ! 168
OI   CVCL_9722 ! 66 [Mouse mammary tumor]
OI   CVCL_0I87 ! 67 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   410.4-B7
AC   CVCL_E3A6
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W344 ! 410.4H
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   410.4H
AC   CVCL_W344
SY   410.4-H
DR   Wikidata; Q54602878
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W343 ! 410.4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 8
//
ID   410.4H.neo
AC   CVCL_E3A5
SY   410.4-H.neo
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W344 ! 410.4H
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   411-14E10
AC   CVCL_J726
DR   CLO; CLO_0001359
DR   ATCC; CRL-2663
DR   Wikidata; Q54602880
CC   Monoclonal antibody isotype: IgG2b, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   411BR
AC   CVCL_A1TX
SY   411 BRighton
DR   Wikidata; Q105505930
RX   PubMed=11779494;
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Ala3Val (c.8C>T); ClinVar=VCV000007676; Zygosity=Homozygous (PubMed=11779494).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Thr9Ile (c.26C>T); ClinVar=VCV000007677; Zygosity=Homozygous (PubMed=11779494).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg278His (c.833G>A); ClinVar=VCV000007675; Zygosity=Homozygous (PubMed=11779494).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   411BRneo
AC   CVCL_A1TY
DR   Wikidata; Q105505933
RX   PubMed=11779494;
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Ala3Val (c.8C>T); ClinVar=VCV000007676; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Thr9Ile (c.26C>T); ClinVar=VCV000007677; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg278His (c.833G>A); ClinVar=VCV000007675; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1TX ! 411BR
SX   Sex unspecified
AG   9Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   412-D
AC   CVCL_F0AU
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   413-15D12
AC   CVCL_J618
DR   CLO; CLO_0001362
DR   ATCC; CRL-2653
DR   Wikidata; Q54602881
CC   Monoclonal antibody isotype: IgG1+IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   41405
AC   CVCL_JD71
SY   Extract 337
DR   IPD-IMGT/HLA; 13256
DR   Wikidata; Q54602882
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,03:01; B*07:02,35:41; C*04:01,07:02; DQA1*05,01:01; DQB1*02:01,05:01; DRB1*01:03,03:AXS; DRB3*01 (IPD-IMGT/HLA=13256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   4143
AC   CVCL_IV49
DR   Wikidata; Q54602982
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6935474;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   414C2
AC   CVCL_DP60
SY   414C-2; HPS4292
DR   GEO; GSM1040276
DR   GEO; GSM1040346
DR   GEO; GSM1899767
DR   RCB; HPS4292
DR   SKIP; SKIP000822
DR   Wikidata; Q54602985
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=26997647;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 7,19
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   416-20E10
AC   CVCL_0F03
DR   ATCC; CRL-2664
DR   Wikidata; Q54602987
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS.
CC   Discontinued: ATCC; CRL-2664; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 4
//
ID   416B
AC   CVCL_3983
DR   BTO; BTO_0002884
DR   CLO; CLO_0001363
DR   EFO; EFO_0005482
DR   CLDB; cl92
DR   ECACC; 85061103
DR   ENCODE; ENCBS024ENC
DR   ENCODE; ENCBS107JSU
DR   GEO; GSE69776
DR   GEO; GSM1014163
DR   GEO; GSM1499158
DR   GEO; GSM1499159
DR   Wikidata; Q54602989
RX   PubMed=763330;
RX   PubMed=6821513;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/416B_Stam_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 85061103; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   4177
AC   CVCL_B6NE
DR   Wikidata; Q111732722
RX   Patent=US10550181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   418-D
AC   CVCL_F0AQ
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   418C1
AC   CVCL_DP93
SY   418C-1
DR   GEO; GSM1489289
DR   SKIP; SKIP000823
DR   Wikidata; Q54602993
RX   PubMed=21460823;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3199 ! TIG-114
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   419-D
AC   CVCL_F0AM
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   41B4
AC   CVCL_B0DG
DR   Wikidata; Q108819618
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10786.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10057.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast cancer 240 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   41D3
AC   CVCL_C3VK
DR   Wikidata; Q116048200
RX   PubMed=9557752;
RX   PubMed=9782268;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A7LCJ3; Pig SIGLEC1/CD169.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   41D5
AC   CVCL_C3VL
DR   Wikidata; Q116048201
RX   PubMed=9557752;
RX   PubMed=9782268;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A7LCJ3; Pig SIGLEC1/CD169.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   41M
AC   CVCL_4993
SY   41-M; OAW41M; 041M; 41 M
DR   BTO; BTO_0003998
DR   BioSample; SAMN03151866
DR   cancercelllines; CVCL_4993
DR   ChEMBL-Cells; CHEMBL3307631
DR   ChEMBL-Targets; CHEMBL614511
DR   ECACC; 93061002
DR   GEO; GSM313659
DR   GEO; GSM851922
DR   Progenetix; CVCL_4993
DR   PubChem_Cell_line; CVCL_4993
DR   Wikidata; Q54602996
RX   PubMed=1423261;
RX   PubMed=1617660;
RX   PubMed=1892748;
RX   PubMed=2653399;
RX   PubMed=8795574;
RX   PubMed=15677628;
RX   PubMed=20143388;
RX   PubMed=22710073;
RX   PubMed=23415752;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OAW28 derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00110.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=2653399).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: M41; GEO=GSM851922.
CC   Discontinued: ECACC; 93061002; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12,14
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,15
ST   FGA: 21,24
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1614 ! OAW28
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   41M-cisR
AC   CVCL_N788
SY   41M/cisR; 41McisR
DR   cancercelllines; CVCL_N788
DR   ChEMBL-Cells; CHEMBL3989321
DR   Cosmic; 1609533
DR   GEO; GSM851923
DR   PubChem_Cell_line; CVCL_N788
DR   Wikidata; Q54602997
RX   PubMed=1617660;
RX   PubMed=22710073;
CC   Problematic cell line: Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: M41CisR; GEO=GSM851923.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12,14
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,15
ST   FGA: 21,24
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4993 ! 41M
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   41M:RD1694
AC   CVCL_Y427
DR   cancercelllines; CVCL_Y427
DR   Wikidata; Q54602998
RX   PubMed=7537518;
CC   Problematic cell line: Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_5847; ICI D1694 (Tomudex; ZD1694).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4993 ! 41M
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   41M47
AC   CVCL_Y037
SY   41m/47
DR   cancercelllines; CVCL_Y037
DR   Cosmic; 688088
DR   Cosmic; 1609530
DR   Wikidata; Q54603001
RX   PubMed=12068308;
CC   Problematic cell line: Contaminated. Parent cell line (41M) has been shown to be a OAW28 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4993 ! 41M
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   42-MG-BA
AC   CVCL_1798
SY   42MGBA
DR   CLO; CLO_0001367
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 440
DR   BioSample; SAMN03473596
DR   BioSample; SAMN10988275
DR   cancercelllines; CVCL_1798
DR   Cell_Model_Passport; SIDM00982
DR   Cosmic; 687561
DR   Cosmic; 1746946
DR   Cosmic; 1995325
DR   Cosmic; 2060804
DR   Cosmic; 2302328
DR   Cosmic; 2732518
DR   Cosmic-CLP; 687561
DR   DepMap; ACH-000323
DR   DSMZ; ACC-431
DR   DSMZCellDive; ACC-431
DR   EGA; EGAS00001000978
DR   GDSC; 687561
DR   GEO; GSM326214
DR   GEO; GSM886839
DR   GEO; GSM887902
DR   GEO; GSM1669567
DR   IARC_TP53; 28274
DR   LiGeA; CCLE_146
DR   LINCS_LDP; LCL-1347
DR   PharmacoDB; 42MGBA_16_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1798
DR   Wikidata; Q54603004
RX   PubMed=9604998;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28464039;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 48-54 hours (PubMed=9604998); ~40 hours (DSMZ=ACC-431).
CC   HLA typing: A*33:03,33:03; B*39:01,39:01; C*12:03,12:03; DRB1*11:11,11:11 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.164+1_164+2insG; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=28464039; Cosmic-CLP=687561).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr211Ile (c.632C>T); ClinVar=VCV001503185; Zygosity=Heterozygous (Cosmic-CLP=687561; DepMap=ACH-000323).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Gln (c.845G>A); ClinVar=VCV000237956; Zygosity=Heterozygous (Cosmic-CLP=687561; DepMap=ACH-000323).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.01%; Native American=0%; East Asian, North=4.88%; East Asian, South=0%; South Asian=0%; European, North=63.22%; European, South=31.9% (PubMed=30894373).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): Cosmic-CLP=687561; DSMZ=ACC-431
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 10
ST   D18S51: 22
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 12,14
ST   Penta E: 7,17
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   42.08.07
AC   CVCL_J672
SY   PM 42.08.07
DR   CLO; CLO_0001364
DR   ATCC; HB-9313
DR   Wikidata; Q54603005
RX   Patent=US4818685;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9313.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P13051; Human UNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   42.2A7.2
AC   CVCL_D3VH
DR   Wikidata; Q127378732
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42.4B12.2
AC   CVCL_D3VI
SY   42.4B.12.2
DR   ABCD; ABCD_AE267
DR   Wikidata; Q127378733
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42.5D4.2
AC   CVCL_D3VJ
DR   Wikidata; Q127378734
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42.7B3.2
AC   CVCL_D3VK
DR   Wikidata; Q127378735
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42.7C11.2
AC   CVCL_D3VL
DR   Wikidata; Q127378736
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42.8E9.2
AC   CVCL_D3VM
DR   Wikidata; Q127378737
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42.8G4.2
AC   CVCL_D3VN
DR   Wikidata; Q127378738
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42.9E5.2
AC   CVCL_D3VP
DR   Wikidata; Q127378739
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   42/04-42D2-66-4-1
AC   CVCL_B0GH
SY   42/04-42D2; 42D2
DR   Wikidata; Q108819619
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121102.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   42/04-42D2-66-4-1-Clone 4
AC   CVCL_B0GI
DR   Wikidata; Q108819620
RX   Patent=US9988431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08041902.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B0GH ! 42/04-42D2-66-4-1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   42/6
AC   CVCL_XC73
DR   ATCC; HB-8094
DR   Wikidata; Q93306877
RX   Patent=US5667781;
RX   PubMed=6280171;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8094.
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   421C1
AC   CVCL_DP94
SY   421C-1
DR   GEO; GSM1899765
DR   SKIP; SKIP000824
DR   Wikidata; Q54603007
RX   PubMed=21460823;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3192 ! TIG-107
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   421E8
AC   CVCL_B0DH
SY   421E8-4B4
DR   Wikidata; Q108819621
RX   Patent=US4938948;
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10793.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10064.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   424GC
AC   CVCL_X064
DR   Wikidata; Q54603008
RX   PubMed=16536871;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: C57BL/6-Tg(CEACAM5-Tag)L5496Wzm transgenic.
DI   NCIt; C24227; Mouse gastric adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   13W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   425
AC   CVCL_LB64
SY   MAb425; mAb 425; mAb425; EMD55900; EMD 55900
DR   ATCC; HB-9629
DR   Wikidata; Q54603012
RX   Patent=US5470571;
RX   PubMed=2434025;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9629.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized matuzumab (EMD 72000) therapeutic antibody. It was developed by Merck Serono for the treatment of a number of cancer types. It failed phase II clinical trials.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   425/2B
AC   CVCL_B6UD
DR   Wikidata; Q111732723
RX   PubMed=2443838;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24. Recognizes M blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   426C2
AC   CVCL_DP95
SY   426C-2
DR   Wikidata; Q54603013
RX   PubMed=21460823;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP67 ! HDF1554
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   427.1
AC   CVCL_L904
DR   Wikidata; Q54603014
RX   PubMed=8500519;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   427.1.86
AC   CVCL_L905
DR   Wikidata; Q54603016
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L904 ! 427.1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   427B7
AC   CVCL_B0FX
DR   Wikidata; Q108819622
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4518.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   427D4
AC   CVCL_DP96
SY   427D-4
DR   SKIP; SKIP005487
DR   Wikidata; Q54603018
RX   PubMed=21460823;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP66 ! HDF1437
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   427F1
AC   CVCL_DQ31
DR   GEO; GSM1489196
DR   GEO; GSM1489225
DR   GEO; GSM1489431
DR   Wikidata; Q54603020
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP66 ! HDF1437
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   428C2
AC   CVCL_DP97
SY   428C-2
DR   GEO; GSM1899766
DR   SKIP; SKIP005486
DR   Wikidata; Q54603022
RX   PubMed=21460823;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3202 ! TIG-120
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   42989
AC   CVCL_JD48
SY   11366532; Extract 409
DR   IPD-IMGT/HLA; 13965
DR   Wikidata; Q54603025
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/331cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:16N,02:BAJC; B*08,44:02; C*05:01,07:VS; DPA1*01:CG; DPB1*03:AMYJ,04:AGGH; DQA1*01:02,05; DQB1*06:02,03:01; DRB1*11:04,15:01; DRB3*02; DRB5*01 (IPD-IMGT/HLA=13965).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   42A11
AC   CVCL_E8NY
RX   Patent=WO2024196162A1;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UXX9; Human RSPO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   42GPA9
AC   CVCL_U464
DR   Wikidata; Q54603027
RX   PubMed=9475418;
RX   PubMed=15541572;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Tg(PyLT).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   42TA
AC   CVCL_5489
DR   CLO; CLO_0001368
DR   ATCC; CRL-2759
DR   Wikidata; Q54603031
RX   PubMed=8988857;
RX   PubMed=18572245;
RX   PubMed=18824023;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   43-9F
AC   CVCL_UF07
DR   Wikidata; Q93306930
RX   Patent=EP0184906A1;
RX   PubMed=2433033;
RX   PubMed=2445477;
RX   PubMed=3422461;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85061402.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Beta-Gal(1->3)-[alpha-Fuc(1->4)]-beta-GlcNAc(1->3)-beta-Gal(1->4)[alpha-Fuc(1->3)]beta-GlcNAc(1->3)-R.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   430F
AC   CVCL_J229
DR   TKG; TKG 0179
DR   Wikidata; Q54603032
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   4330 mel
AC   CVCL_C7UF
DR   Wikidata; Q123030280
RX   PubMed=22207316;
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   435.eB
AC   CVCL_0124
DR   MCCL; MCC:0000016
DR   cancercelllines; CVCL_0124
DR   Wikidata; Q54603035
RX   PubMed=9067293;
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 27
//
ID   435.neo
AC   CVCL_F0XM
RX   PubMed=9067293;
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Characteristics: Control cell line for 435.eB (Cellosaurus=CVCL_0124) (PubMed=9067293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   43623
AC   CVCL_JD52
SY   12162345; Extract 401
DR   IPD-IMGT/HLA; 13546
DR   Wikidata; Q54603037
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/329cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,24:48N; B*08; C*07:01; DPA1*01:CG; DPB1*02:01,03:AMYJ; DQA1*03,05; DQB1*02:01,03:04; DRB1*04:APPB,03:01/03:13/03:23; DRB3*01; DRB4*01 (IPD-IMGT/HLA=13546).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   439-9
AC   CVCL_F0U1
RX   PubMed=2448027;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   439-9B
AC   CVCL_F0U2
SY   439-9b
RX   PubMed=2365382;
RX   PubMed=2448027;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F0U1 ! 439-9
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   43C2
AC   CVCL_C5DC
DR   Wikidata; Q116048203
RX   PubMed=11991817;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F7ED68; Macaca mulatta NEFL (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   43L
AC   CVCL_3356
DR   CLO; CLO_0050280
DR   RCB; RCB2843
DR   TKG; TKG 0381
DR   Wikidata; Q54603038
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   44-2
AC   CVCL_A597
SY   rMTC 44-2
DR   Wikidata; Q54603040
RX   PubMed=6353060;
RX   PubMed=6832044;
RX   PubMed=7736432;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Parafollicular cell; CL=CL_0000570.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C60369; Rat C-cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   44-22-1
AC   CVCL_D663
SY   44.22.1
DR   BCRJ; 0021
DR   Wikidata; Q54603042
RX   PubMed=2459713;
RX   PubMed=2578398;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   44-3
AC   CVCL_4U24
SY   rMTC 44-3
DR   Wikidata; Q54603044
RX   PubMed=6353060;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Parafollicular cell; CL=CL_0000570.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C60369; Rat C-cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A597 ! 44-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   44-3A6
AC   CVCL_ZW10
SY   MCA 44-3A6
DR   ATCC; HB-8986
DR   Wikidata; Q102113452
RX   Patent=US4816402;
RX   PubMed=2413999;
RX   PubMed=31807015;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8986.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human labyrinthin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   44-3C1
AC   CVCL_A598
SY   rMTC 44-3C1; 44-3 clone 1
DR   Wikidata; Q54603047
RX   PubMed=6353060;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Parafollicular cell; CL=CL_0000570.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C60369; Rat C-cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U24 ! 44-3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   44-6-1
AC   CVCL_0E32
DR   ATCC; CRL-2491
DR   Wikidata; Q54603049
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 1D2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   44-6-2
AC   CVCL_0E33
DR   ATCC; CRL-2492
DR   Wikidata; Q54603050
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 1D2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   4405P
AC   CVCL_WM23
DR   cancercelllines; CVCL_WM23
DR   Cosmic; 852199
DR   Wikidata; Q93306974
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Head, skin; UBERON=UBERON_0001084.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   442.5C4
AC   CVCL_LC53
DR   Wikidata; Q54603053
CC   From: Calbiochem-Behring Corp.; La Jolla; USA.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   443-15D3-2F12
AC   CVCL_F772
SY   15D3
DR   CLO; CLO_0001369
DR   ATCC; HB-11342
DR   Wikidata; Q54603055
RX   Patent=US6143873;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11342.
CC   Registration: Chiron Master Culture Collection; CMCC 10748 (CMCC #10748).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   443-17F9-1C6
AC   CVCL_J963
SY   17F9
DR   ATCC; CRL-2694
DR   Wikidata; Q54603058
RX   Patent=US6143873;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-354.
CC   Registration: Chiron Master Culture Collection; CMCC 10747 (CMCC #10747).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
CC   Discontinued: ATCC; CRL-2694; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   4434
AC   CVCL_E9CI
RX   PubMed=25873177;
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=25873177).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Breed/subspecies: C57BL/6 BRAF+/LSL-BRAFV600E;Tyr::CreERT2+/o transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4434-EKAREV-NLS
AC   CVCL_E9CL
RX   PubMed=25873177;
CC   Characteristics: Carries the FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from Cdc25, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=25873177).
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=25873177).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Breed/subspecies: C57BL/6 BRAF+/LSL-BRAFV600E;Tyr::CreERT2+/o transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E9CI ! 4434
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   446.1
AC   CVCL_0I02
DR   Wikidata; Q54603060
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5549.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   447-52-D
AC   CVCL_F0AI
DR   ABCD; ABCD_AH319
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolates ARV2/SF2 and HXB2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4470
AC   CVCL_9669
DR   EFO; EFO_0002807
DR   Wikidata; Q54603061
RX   PubMed=18329371;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: dcrfl/fl, R26R-yfp transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   4473M
AC   CVCL_WM41
DR   cancercelllines; CVCL_WM41
DR   Cosmic; 852216
DR   Wikidata; Q93306996
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   4475
AC   CVCL_9670
DR   EFO; EFO_0002808
DR   Wikidata; Q54603063
RX   PubMed=18329371;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: dcrfl/fl, R26R-yfp transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   448-D100,10,1
AC   CVCL_8940
SY   448-D 100, 10, 1; 448-D
DR   CLO; CLO_0001370
DR   ATCC; HB-10895
DR   Wikidata; Q54603065
RX   Patent=US6241986;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10895.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: HIV-1 protein gp120.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   4483
AC   CVCL_9671
DR   EFO; EFO_0002809
DR   Wikidata; Q54603165
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   44A11
AC   CVCL_E8NP
SY   MAb 44A11
RX   PubMed=32069135;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_234123; Sodium nifurstyrenate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   44aacb
AC   CVCL_J601
DR   CLO; CLO_0001371
DR   ATCC; HB-249
DR   Wikidata; Q54603166
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   44As3
AC   CVCL_XG62
DR   JCRB; JCRB1888
DR   Wikidata; Q93307015
RX   PubMed=15958054;
RX   PubMed=19010905;
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic. Strong capability of inducing the formation of ascites.
CC   Characteristics: Parent cell line was injected subcutaneously into BALB/c nude mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 12 times.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1888
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 13
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A388 ! HSC-44PE
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 6
//
ID   44As3Luc
AC   CVCL_C7UQ
DR   JCRB; JCRB1893
DR   JCRB; NIHS1328
DR   Wikidata; Q123030281
RX   PubMed=19010905;
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic. Strong capability of inducing the formation of ascites.
CC   Characteristics: Grand-parent cell line was injected subcutaneously into BALB/c nude mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 12 times.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS1328; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1893
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 13
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG62 ! 44As3
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   44B2
AC   CVCL_B0DI
DR   Wikidata; Q108819623
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10797.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10068.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   44C11
AC   CVCL_E7SJ
RX   PubMed=1379786;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   44F4
AC   CVCL_B0DJ
DR   Wikidata; Q108819624
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10787.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10058.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human breast/ovarian cancer antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   44FT0
AC   CVCL_0I83
DR   Wikidata; Q54603168
RX   PubMed=3426919;
RX   PubMed=3940214;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W343 ! 410.4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   45
AC   CVCL_C5DD
DR   Wikidata; Q116048204
RX   PubMed=11991817;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F7ED68; Macaca mulatta NEFL (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   45 M
AC   CVCL_WK72
DR   Wikidata; Q93307020
RX   CelloPub=CLPUB00494;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 5
//
ID   45.21.1
AC   CVCL_D3VQ
DR   ABCD; ABCD_AE242
DR   Wikidata; Q127378740
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   45.6
AC   CVCL_1D02
SY   MPC-11 45.6
DR   Wikidata; Q54603169
RX   PubMed=805428;
RX   PubMed=4139712;
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3857 ! MPC-11
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 6
//
ID   45.6.2.4
AC   CVCL_1D03
SY   MPC-11.45.6.2.4
DR   Wikidata; Q54603170
RX   PubMed=805428;
RX   PubMed=4139712;
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1D02 ! 45.6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 6
//
ID   45.6.3.1
AC   CVCL_1D04
SY   MPC-11.45.6.3.1
DR   Wikidata; Q54603172
RX   PubMed=805428;
RX   PubMed=4139712;
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1D02 ! 45.6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 7
//
ID   45.6.TG1.7
AC   CVCL_4090
SY   45,6TG1.7; 45.6TG1.7; MPC11-45.6TG1.7; MPC11-45.6 TG1.7; MPC 11 45.6 TG 1.7; MPC11 TG1.7; GM03572
DR   CLO; CLO_0001372
DR   CLO; CLO_0017235
DR   CLDB; cl96
DR   ATCC; CRL-1608
DR   Coriell; GM03572
DR   ECACC; 90110506
DR   Wikidata; Q54603174
RX   CelloPub=CLPUB00447;
RX   PubMed=605383;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1D02 ! 45.6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   45.6.TG1.7.5
AC   CVCL_D3US
SY   45.6.TG.1.7.5
DR   Wikidata; Q127378741
RX   PubMed=6175897;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4090 ! 45.6.TG1.7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   450-10D
AC   CVCL_F0U3
SY   10D
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-11A1
AC   CVCL_F0U4
SY   11A1
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-28A
AC   CVCL_F0U5
SY   28A
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-28D
AC   CVCL_F0U6
SY   28D
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-30A1
AC   CVCL_F0U7
SY   30A1
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-33D
AC   CVCL_F0U8
SY   33D
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-36B
AC   CVCL_F0U9
SY   36B
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-46A
AC   CVCL_F0UA
SY   46A
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-46D
AC   CVCL_F0UB
SY   46D
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-59B
AC   CVCL_F0UC
SY   59B
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-69B
AC   CVCL_F0UD
SY   69B
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-7A
AC   CVCL_F0UE
SY   7A
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-72B
AC   CVCL_F0UF
SY   72B
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-75B
AC   CVCL_F0UG
SY   75B
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-79B
AC   CVCL_F0UH
SY   79B
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-80C
AC   CVCL_F0UI
SY   80C
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-90C
AC   CVCL_F0UJ
SY   90C
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-92C
AC   CVCL_F0UK
SY   92C
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-95A
AC   CVCL_F0UL
SY   95A1
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   450-9D
AC   CVCL_F0UM
SY   9D
RX   PubMed=2365382;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   451B7
AC   CVCL_B0DK
DR   Wikidata; Q108819625
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   451C3
AC   CVCL_B0DL
DR   Wikidata; Q108819626
RX   Patent=US4938948;
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10810.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10081.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   451F3
AC   CVCL_DP98
SY   451F-3
DR   GEO; GSM1040277
DR   GEO; GSM1040347
DR   GEO; GSM1489197
DR   GEO; GSM1489241
DR   GEO; GSM1489432
DR   SKIP; SKIP005492
DR   Wikidata; Q54603176
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
RX   PubMed=28445466;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   451Lu
AC   CVCL_6357
SY   451LU; 451-LU; WM 451-Lu; WM-451Lu; WM-451LU; WM451Lu; WM451; WC00059; LU451; Lu451; EST81
DR   BTO; BTO_0003710
DR   CLO; CLO_0001373
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2813
DR   BioSample; SAMN03471798
DR   cancercelllines; CVCL_6357
DR   Cell_Model_Passport; SIDM01240
DR   ChEMBL-Cells; CHEMBL4802054
DR   Coriell; WC00059
DR   Cosmic; 686411
DR   Cosmic; 1047656
DR   Cosmic; 1155281
DR   Cosmic; 1155568
DR   Cosmic; 1187587
DR   Cosmic; 1303027
DR   Cosmic; 2163808
DR   Cosmic; 2230114
DR   Cosmic-CLP; 1287706
DR   DepMap; ACH-001002
DR   EGA; EGAS00001000978
DR   ESTDAB; ESTDAB-081
DR   GDSC; 1287706
DR   GEO; GSM156019
DR   GEO; GSM188238
DR   GEO; GSM188268
DR   GEO; GSM188327
DR   GEO; GSM555137
DR   GEO; GSM555187
DR   GEO; GSM952579
DR   GEO; GSM1199178
DR   GEO; GSM1669568
DR   IARC_TP53; 26083
DR   PharmacoDB; 451Lu_17_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_6357
DR   PubChem_Cell_line; CVCL_6357
DR   Rockland; 451Lu-01-0001
DR   Wikidata; Q54603178
RX   PubMed=2068080;
RX   PubMed=2156614;
RX   PubMed=2253310;
RX   PubMed=2918552;
RX   PubMed=8342600;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=18632627;
RX   PubMed=18790768;
RX   PubMed=19340423;
RX   PubMed=21156289;
RX   PubMed=21343389;
RX   PubMed=23285177;
RX   PubMed=23851445;
RX   PubMed=24055054;
RX   PubMed=25056119;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Established from the lung of a nude mouse after 4 sequential passages of the parent cell line (PubMed=2156614).
CC   Doubling time: 72 hours (PubMed=2253310).
CC   HLA typing: A*24:02,24:02; B*07:02,07:02; DPB1*06:01,06:01; DQB1*06:04,06:04; DRB1*13:01,13:01 (PubMed=15592718).
CC   Microsatellite instability: Stable (MSS) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17260012; PubMed=18632627; PubMed=21156289; PubMed=23851445; Cosmic-CLP=1287706; DepMap=ACH-001002; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61fs*59 (c.179dupC) (p.Gly75fs, c.222dupC); Zygosity=Heterozygous (PubMed=23851445; Cosmic-CLP=1287706; DepMap=ACH-001002).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=17260012; PubMed=21156289; PubMed=23851445; Cosmic-CLP=1287706; DepMap=ACH-001002).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.32%; East Asian, North=0.06%; East Asian, South=0.98%; South Asian=0.7%; European, North=67.32%; European, South=29.61% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: CSF1PO: 11,12->12, D18S51: 10->10,13, D5S818: 11,12->12, D7S820: 9,10->10 and FGA: 21->21,25.
CC   Discontinued: ATCC; CRL-2813; true.
CC   Discontinued: Coriell; WC00059; probable.
CC   Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427.
ST   Source(s): ATCC=CRL-2813; Cosmic-CLP=1287706; ESTDAB=ESTDAB-081; PubMed=25056119; Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 10,13
ST   D19S433: 13
ST   D21S11: 28,31.2
ST   D2S1338: 18,19
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9,10 (ATCC=CRL-2813; ESTDAB=ESTDAB-081)
ST   D7S820: 10 (Cosmic-CLP=1287706; Wistar)
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,15
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7928 ! WM164
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   451Lu-BR
AC   CVCL_AP83
SY   451Lu BR; 451LU BR; 451LuBR; 451Lu-R; 451Lu R
DR   cancercelllines; CVCL_AP83
DR   Rockland; 451Lu-BR-01-0001
DR   Wikidata; Q54603181
RX   PubMed=21156289;
RX   PubMed=23285177;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_131882; SB-590885.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=21156289; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61fs*59 (c.179dupC) (p.Gly75fs, c.222dupC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=21156289).
CC   Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6357 ! 451Lu
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 19
//
ID   451Lu-MR
AC   CVCL_DG54
DR   cancercelllines; CVCL_DG54
DR   GEO; GSM1199179
DR   Progenetix; CVCL_DG54
DR   Wikidata; Q54603182
RX   PubMed=24055054;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61fs*59 (c.179dupC) (p.Gly75fs, c.222dupC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6357 ! 451Lu
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   452E12
AC   CVCL_B0DM
DR   Wikidata; Q108819627
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10803.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10074.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast cancer 240 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   452F2
AC   CVCL_N287
SY   452F2-1B2
DR   ATCC; HB-10811
DR   Wikidata; Q54603184
RX   Patent=US4938948;
RX   Patent=US5169774;
RX   PubMed=2470501;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10811.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10082.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   453-D
AC   CVCL_F0AN
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   45305
AC   CVCL_JD29
SY   Extract 470
DR   IPD-IMGT/HLA; 13894
DR   Wikidata; Q54603187
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/346cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BAJC,68; B*51,40:38; C*03:04,14:02; DPA1*01:CG; DPB1*02:01,03:AMYJ; DQA1*01:02,01:03; DQB1*06:03,06:04; DRB1*13:AGTW,13:AUW; DRB3*01,03:01 (IPD-IMGT/HLA=13894).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   453A0
AC   CVCL_UM75
SY   453A; 453 A
DR   Wikidata; Q93307045
RX   PubMed=3402430;
RX   PubMed=10070891;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM87 ! 453B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   453B
AC   CVCL_UM87
SY   453 B
DR   Wikidata; Q93307047
RX   PubMed=3402430;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM75 ! 453A0
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   453C2
AC   CVCL_DR12
DR   GEO; GSM1899762
DR   Wikidata; Q54603190
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ50 ! DP094
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   453F2
AC   CVCL_DP99
SY   453F-2
DR   GEO; GSM1899759
DR   SKIP; SKIP005489
DR   Wikidata; Q54603191
RX   PubMed=21460823;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ50 ! DP094
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   4545
AC   CVCL_B6NF
DR   Wikidata; Q111732724
RX   Patent=US10550181;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   454A12
AC   CVCL_B0DN
DR   Wikidata; Q108819628
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   PubMed=1715033;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10804.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10075.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   454B1
AC   CVCL_DQ01
SY   454B-1
DR   GEO; GSM1899760
DR   SKIP; SKIP005490
DR   Wikidata; Q54603192
RX   PubMed=21460823;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   454C11
AC   CVCL_G605
SY   454 C11
DR   CLO; CLO_0001374
DR   ATCC; HB-8484
DR   Wikidata; Q54603195
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5169774;
RX   Patent=US5629197;
RX   PubMed=1715033;
RX   PubMed=2470501;
WW   Info; -; -; https://www.law.uh.edu/faculty/gvetter3/fcplc/CaseFiles/2004/PDF/Chiron%20Corp.%20v.%20Genentech,%20Inc.,%2003-1158%20(Fed.%20Cir.%20Mar.%2030,%202004).pdf
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8484.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10085.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   454C2
AC   CVCL_DQ02
SY   454C-2
DR   SKIP; SKIP005491
DR   Wikidata; Q54603196
RX   PubMed=21460823;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   454D1
AC   CVCL_DQ03
SY   454D-1
DR   GEO; GSM1899761
DR   SKIP; SKIP005493
DR   Wikidata; Q54603199
RX   PubMed=21460823;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   454E2
AC   CVCL_T791
SY   454-E2; 454 E2; 454E-2; HPS0077
DR   GEO; GSM1040278
DR   GEO; GSM1040348
DR   GEO; GSM1489198
DR   GEO; GSM1489242
DR   GEO; GSM1489433
DR   RCB; HPS0077
DR   SKIP; SKIP000219
DR   SKIP; SKIP005488
DR   Wikidata; Q54603203
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 10,14
ST   D16S539: 9,10
ST   D18S51: 13,19
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   454F1
AC   CVCL_DQ04
SY   454F-1
DR   Wikidata; Q54603205
RX   PubMed=21460823;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   455
AC   CVCL_G191
DR   CLO; CLO_0001375
DR   ATCC; HB-8507
DR   ECACC; 92090408
DR   Wikidata; Q54603207
RX   Patent=US4943533;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8507.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J593 ! NS-1-503
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   455-2A4
AC   CVCL_D3TZ
DR   DSHB; 455-2A4
DR   Wikidata; Q127378742
RX   PubMed=26700680;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q10655; Caenorhabditis elegans elt-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   457C1
AC   CVCL_DQ05
SY   457C-1
DR   GEO; GSM1489199
DR   GEO; GSM1489243
DR   GEO; GSM1489255
DR   GEO; GSM1489434
DR   SKIP; SKIP005494
DR   Wikidata; Q54603208
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 10,14
ST   D16S539: 9,10
ST   D18S51: 13,19
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   457D7
AC   CVCL_B0DP
DR   Wikidata; Q108819629
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10805.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10076.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast cancer 240 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   45A5G
AC   CVCL_XG80
DR   Wikidata; Q93307075
RX   Patent=US5597725;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11318.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   45A8
AC   CVCL_E7SK
RX   PubMed=1379786;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   45C6A
AC   CVCL_XG81
DR   Wikidata; Q93307078
RX   Patent=US5597725;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11320.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   45E10
AC   CVCL_A6NW
DR   DSHB; 45E10
DR   Wikidata; Q107113283
RX   PubMed=1657402;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35992; Drosophila melanogaster Ptp10D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   45F6
AC   CVCL_A0JI
DR   Wikidata; Q108819630
RX   PubMed=1283092;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   46-2
AC   CVCL_G606
DR   CLO; CLO_0001377
DR   ATCC; CRL-2186
DR   Wikidata; Q54603210
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp120.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   46-3
AC   CVCL_0E85
DR   ATCC; CRL-2191
DR   Wikidata; Q54603214
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp120.
CC   Discontinued: ATCC; CRL-2191; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   46-4
AC   CVCL_G608
DR   CLO; CLO_0001378
DR   ATCC; CRL-2178
DR   Wikidata; Q54603216
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp120.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   46-5
AC   CVCL_G609
DR   CLO; CLO_0001379
DR   ATCC; CRL-2184
DR   Wikidata; Q54603217
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp120.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   46-6B5
AC   CVCL_HA21
DR   Wikidata; Q54603219
RX   PubMed=2459713;
RX   PubMed=2578398;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   46-9
AC   CVCL_C5NA
DR   Wikidata; Q116048205
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   46/4
AC   CVCL_G607
DR   CLO; CLO_0001376
DR   ATCC; HB-67
DR   IZSLER; BS Hy 51
DR   Wikidata; Q54603221
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   46117
AC   CVCL_JD30
SY   14905442; Extract 471
DR   IPD-IMGT/HLA; 14043
DR   Wikidata; Q54603224
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/346cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03,68; B*47:01,40; C*03:19,06:02; DPA1*01:CG,02:01; DPB1*04:01,13:01; DQA1*03; DQB1*03:02; DRB1*04:05,04:APPB; DRB4*01 (IPD-IMGT/HLA=14043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   4647
AC   CVCL_4075
SY   Continuous kidney cell line No. 4647
DR   CLO; CLO_0001013
DR   CLDB; cl97
DR   CLDB; cl98
DR   ECACC; 90091902
DR   IZSLER; BS CL 223
DR   Wikidata; Q54603226
RX   PubMed=2175469;
RX   PubMed=3445593;
RX   PubMed=6495709;
RX   PubMed=17500238;
RX   PubMed=28046048;
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Virology: Susceptible to infection by poliovirus type 1, type 2 and type 3 (PubMed=28046048).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   465.12S
AC   CVCL_B5AC
SY   465.12
DR   Wikidata; Q110429773
RX   PubMed=6173115;
RX   PubMed=7033148;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q08380; Human LGALS3BP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   4686M
AC   CVCL_WM34
DR   cancercelllines; CVCL_WM34
DR   Cosmic; 852209
DR   IARC_TP53; 20611
DR   Wikidata; Q93307098
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Arg (c.65A>G); Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro38Ser (c.112C>T); ClinVar=VCV000127688; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380_381CC>TT); Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   46A9BO
AC   CVCL_A8VD
DR   Wikidata; Q108819631
RX   Patent=US10808026;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NRN5; Human OLFML3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   46BR
AC   CVCL_L943
AS   CVCL_7644
SY   46 BRighton; GM16096
DR   BTO; BTO_0004313
DR   CLO; CLO_0018865
DR   Coriell; GM16096
DR   Wikidata; Q54603228
RX   PubMed=2973075;
RX   PubMed=3180052;
RX   PubMed=3856882;
RX   PubMed=6408472;
RX   PubMed=6600729;
RX   PubMed=7067035;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Glu566Lys (c.1696G>A); ClinVar=VCV000016775; Zygosity=Heterozygous (Coriell=GM16096).
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Arg771Trp (c.2311C>T); ClinVar=VCV000016776; Zygosity=Heterozygous (Coriell=GM16096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122658; DNA ligase I deficiency
DI   NCIt; C26931; Hypogammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   46BR.1G1
AC   CVCL_2288
SY   46Br.1G1; 46BR 1G1; 46BR-1G1
DR   BTO; BTO_0005012
DR   CLO; CLO_0001380
DR   CLDB; cl100
DR   ECACC; 92091814
DR   Wikidata; Q54603230
RX   PubMed=2903889;
RX   PubMed=3002824;
RX   PubMed=3180052;
RX   PubMed=7683758;
RX   PubMed=22222975;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Glu566Lys (c.1696G>A); ClinVar=VCV000016775; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Arg771Trp (c.2311C>T); ClinVar=VCV000016776; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122658; DNA ligase I deficiency
DI   NCIt; C26931; Hypogammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L943 ! 46BR
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   46BR.1N
AC   CVCL_2289
AS   CVCL_F225
SY   46BR-1N; 46BR.NEO; 46BRneo; GM16097
DR   CLO; CLO_0001381
DR   CLO; CLO_0018863
DR   CLDB; cl101
DR   Coriell; GM16097
DR   ECACC; 92100623
DR   Wikidata; Q54603234
RX   PubMed=2903889;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Glu566Lys (c.1696G>A); ClinVar=VCV000016775; Zygosity=Heterozygous (Coriell=GM16097).
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Arg771Trp (c.2311C>T); ClinVar=VCV000016776; Zygosity=Heterozygous (Coriell=GM16097).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122658; DNA ligase I deficiency
DI   NCIt; C26931; Hypogammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L943 ! 46BR
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   46BRLigI
AC   CVCL_L950
DR   BTO; BTO_0005013
DR   Wikidata; Q54603236
RX   PubMed=19628465;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Glu566Lys (c.1696G>A); ClinVar=VCV000016775; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6598; LIG1; Simple; p.Arg771Trp (c.2311C>T); ClinVar=VCV000016776; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122658; DNA ligase I deficiency
DI   NCIt; C26931; Hypogammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2288 ! 46BR.1G1
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 20
//
ID   46C
AC   CVCL_Y482
SY   ES-46C; ES46C; 46C ES
DR   EFO; EFO_0005484
DR   ENCODE; ENCBS122ENC
DR   GEO; GSM450272
DR   GEO; GSM450283
DR   Wikidata; Q54603238
RX   PubMed=12524553;
RX   PubMed=14696356;
RX   PubMed=21454627;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/animal-stem-cells-catalogue-isenet.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct. Expresses eGFP under the control of the Sox-1 promoter (PubMed=12524553).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 16
//
ID   46C-Dip2a KO
AC   CVCL_ZE88
SY   IBMSe001-A-1
DR   SKIP; SKIP005729
DR   Wikidata; Q98125404
RX   PubMed=32361465;
CC   Characteristics: Using CRISPR/Cas9 exon 8 of Dip2a was replaced by a PGKp-PuroR-P2A-mCherry construct (PubMed=32361465).
CC   Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct. Expresses eGFP under the control of the Sox-1 promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2385920; Dip2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y482 ! 46C
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   46C-Dip2c KO
AC   CVCL_A7IR
SY   IBMSe001-B-1
DR   Wikidata; Q107113284
RX   PubMed=33813174;
CC   Characteristics: Using CRISPR/Cas9 exon 8 of Dip2c was replaced by a PGKp-PuroR-P2A-mCherry construct (PubMed=33813174).
CC   Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct. Expresses eGFP under the control of the Sox-1 promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1920179; Dip2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y482 ! 46C
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   46C-Rybp KO
AC   CVCL_YJ62
SY   46C-RYBP KO; GIBHe001-A-1
DR   SKIP; SKIP005593
DR   Wikidata; Q93307125
RX   PubMed=31794887;
CC   Characteristics: Using CRISPR/Cas9 the last two exons of Rybp gene were replaced with a PGKp-PuroR construct (PubMed=31794887).
CC   Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct. Expresses eGFP under the control of the Sox-1 promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1929059; Rybp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: Named GIBHe001-A-1 which according to ESC nomenclature rules would imply being a derivative of the GIBHe001-A human ESC cell line, but this is not the case.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y482 ! 46C
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   47 BLCL
AC   CVCL_E405
DR   ECACC; 94031606
DR   Wikidata; Q54603239
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   47.10
AC   CVCL_6820
DR   Wikidata; Q54603240
RX   PubMed=9923447;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=47.10
CC   Characteristics: CSF1 or CSF2 or IL3 dependent.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:2433; CSF1R.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   47:3
AC   CVCL_C5DE
DR   Wikidata; Q116048206
RX   PubMed=11991817;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02548; Bovine NEFL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   471L
AC   CVCL_A2CQ
DR   Cosmic; 2758143
DR   Wikidata; Q105505938
RX   PubMed=29335443;
CC   Characteristics: Established from a second generation nude mouse xenograft.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   477-D
AC   CVCL_F0AV
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   47BR
AC   CVCL_4T38
SY   47 BRighton
DR   Wikidata; Q54603242
RX   PubMed=2973075;
RX   PubMed=6600729;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   47N3-6
AC   CVCL_B4FK
SY   3-6
DR   Wikidata; Q110429774
RX   Patent=US4948738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-466.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   47N30A32
AC   CVCL_B4FQ
SY   32
DR   Wikidata; Q110429775
RX   Patent=US4948738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-464.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   47N30A35
AC   CVCL_B4FL
SY   35
DR   Wikidata; Q110429776
RX   Patent=US4948738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-465.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   47N38B27
AC   CVCL_B4FM
SY   27
DR   Wikidata; Q110429777
RX   Patent=US4948738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-468.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   47N48B22
AC   CVCL_B4FN
SY   22
DR   Wikidata; Q110429778
RX   Patent=US4948738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-469.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   47N9-11
AC   CVCL_B4FP
SY   9-11
DR   Wikidata; Q110429779
RX   Patent=US4948738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-467.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   48
AC   CVCL_J728
DR   CLO; CLO_0001382
DR   ATCC; CRL-1913
DR   Wikidata; Q54603243
RX   PubMed=6305011;
RX   PubMed=6787798;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp70.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   48 BLCL
AC   CVCL_E406
DR   ECACC; 94031607
DR   Wikidata; Q54603303
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   48-1
AC   CVCL_B0T6
DR   Wikidata; Q108819632
RX   PubMed=2984683;
RX   PubMed=3098665;
CC   Group: Non-human primate cell line.
CC   Monoclonal antibody isotype: IgM.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   48-4
AC   CVCL_0C66
SY   Clone 48-4
DR   Wikidata; Q54603304
RX   PubMed=19147538;
RX   PubMed=19754807;
CC   Doubling time: 52 hours (PubMed=19754807).
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   480CT5.4.3
AC   CVCL_C4LQ
DR   ABCD; ABCD_AV132
DR   Wikidata; Q116048207
RX   Patent=CN104059151A;
RX   PubMed=26954291;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18827; Human SDC1/CD138.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   48409 mel
AC   CVCL_C7UG
DR   Wikidata; Q123030282
RX   PubMed=22207316;
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   485 colo can
AC   CVCL_B7UY
DR   Wikidata; Q112926975
RX   Patent=RU2650757;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 740D.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   486P
AC   CVCL_7940
SY   486-P
DR   ATCC; HTB-7
DR   IARC_TP53; 21035
DR   Wikidata; Q54603306
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RX   PubMed=66978;
RX   PubMed=571047;
RX   PubMed=748774;
RX   PubMed=944089;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=66978; PubMed=748774).
CC   Discontinued: ATCC; HTB-7; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   487
AC   CVCL_B0V2
DR   IARC_TP53; 11552
DR   Wikidata; Q108819633
RX   PubMed=10446856;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn235Ile (c.704A>T); Zygosity=Unspecified (PubMed=10446856).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Val (c.751A>G); ClinVar=VCV001759315; Zygosity=Unspecified (PubMed=10446856).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Gly (c.773A>G); ClinVar=VCV000406590; Zygosity=Unspecified (PubMed=10446856).
CC   Misspelling: FK99-487; IARC_TP53=11552; Note=Not really a misspelling but an assignment of a name based on first author of publication.
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   488
AC   CVCL_B0V3
DR   IARC_TP53; 11553
DR   Wikidata; Q108819634
RX   PubMed=10446856;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=10446856).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Arg (c.833C>G); ClinVar=VCV000376644; Zygosity=Unspecified (PubMed=10446856).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu289Leu (c.867C>T); ClinVar=VCV000233110; Zygosity=Unspecified (PubMed=10446856).
CC   Misspelling: FK99-488; IARC_TP53=11553; Note=Not really a misspelling but an assignment of a name based on first author of publication.
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   48BR
AC   CVCL_4T39
SY   48 BRighton
DR   EFO; EFO_0022569
DR   Wikidata; Q54603308
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=2458832;
RX   PubMed=2903889;
RX   PubMed=2973075;
RX   PubMed=3347209;
RX   PubMed=6408472;
RX   PubMed=6459055;
RX   PubMed=6600729;
RX   PubMed=15574327;
RX   PubMed=16874298;
RX   PubMed=19179371;
RX   PubMed=22466610;
CC   Doubling time: 45.5 hours (PubMed=6459055).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   48BRhTERT
AC   CVCL_WX37
SY   48BR hTERT; 48BRhT
DR   Wikidata; Q93307164
RX   PubMed=18757420;
RX   PubMed=19056826;
RX   PubMed=25868131;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T39 ! 48BR
SX   Female
AG   48Y
CA   Telomerase immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   49 BLCL
AC   CVCL_E407
DR   ECACC; 94031608
DR   Wikidata; Q54603315
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   49-15
AC   CVCL_DC77
DR   Wikidata; Q54603319
RX   Patent=EP0008092B1;
RX   PubMed=6153172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8011.
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   49-2
AC   CVCL_B6WV
DR   CCRID; 4201PAT-CCTCC00724
DR   Wikidata; Q111732725
RX   Patent=CN105132379A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015101.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02144; Human MB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   4906
AC   CVCL_LB78
DR   Wikidata; Q54603320
RX   PubMed=23479617;
RX   PubMed=27936237;
CC   Group: Marsupial cell line.
DI   NCIt; C176223; Devil facial tumor disease 1
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_LB75 ! 1/2Pea
OI   CVCL_LB76 ! 1426
OI   CVCL_LB77 ! 2112
OI   CVCL_LB79 ! C5065
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   491
AC   CVCL_B0V4
DR   IARC_TP53; 11554
DR   Wikidata; Q108819635
RX   PubMed=10446856;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp207Asp (c.621T>C); Zygosity=Unspecified (PubMed=10446856).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe212Tyr (c.635T>A); Zygosity=Unspecified (PubMed=10446856).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg290Cys (c.868C>T); ClinVar=VCV000216472; Zygosity=Unspecified (PubMed=10446856).
CC   Misspelling: FK99-491; IARC_TP53=11554; Note=Not really a misspelling but an assignment of a name based on first author of publication.
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   492-1G10E4E2
AC   CVCL_B0W4
DR   Wikidata; Q108819636
RX   PubMed=30355437;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A0A0G3U597; Middle East respiratory syndrome-related coronavirus (isolate KOR/KNIH/002_05_2015) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   49318 mel
AC   CVCL_C7WB
DR   Wikidata; Q123030283
RX   PubMed=22207316;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   49B2
AC   CVCL_S156
DR   Wikidata; Q54603324
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: OSU 142; VBO=VBO_0017494.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   49F2-30
AC   CVCL_B4JY
DR   Wikidata; Q110429780
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11362.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   49K16
AC   CVCL_B5Z4
DR   Wikidata; Q111732726
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   49Z
AC   CVCL_0Q74
SY   49-Z; Z49
DR   Wikidata; Q54603328
RX   PubMed=11696444;
RX   PubMed=18001719;
CC   Doubling time: 34 hours (PubMed=11696444).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   4a-2
AC   CVCL_Z620
SY   4A-2; 4a2
DR   BEI_Resources; MRA-917
DR   Wikidata; Q54603330
RX   PubMed=10681436;
RX   PubMed=23382679;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: 4a r/r.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   4a-2s4
AC   CVCL_Z621
DR   BTO; BTO_0002633
DR   Wikidata; Q54603332
RX   PubMed=12626708;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Breed/subspecies: 4a r/r.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
HI   CVCL_Z620 ! 4a-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   4a-3A
AC   CVCL_Z622
SY   4A-3A; 4a3A
DR   BEI_Resources; MRA-918
DR   Wikidata; Q54603336
RX   PubMed=10206988;
RX   PubMed=22375833;
RX   PubMed=23382679;
RX   PubMed=36514125;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: BEI_Resources; MRA-918; probable.
CC   Breed/subspecies: 4a r/r.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
OI   CVCL_Z623 ! 4a-3B
SX   Female
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   4a-3B
AC   CVCL_Z623
SY   4A-3B; 4a3B; 4a3b
DR   BEI_Resources; MRA-919
DR   Wikidata; Q54603337
RX   PubMed=10206988;
RX   PubMed=23382679;
RX   PubMed=36514125;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Characteristics: Expresses constitutively six prophenoloxidase (PPO) genes (PubMed=10206988).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
CC   Breed/subspecies: 4a r/r.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
OI   CVCL_Z622 ! 4a-3A
SX   Female
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   4A1
AC   CVCL_E5MZ
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4A1-1
AC   CVCL_F1FX
RX   PubMed=6341819;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4A10 [Mouse hybridoma against Dabie bandavirus N]
AC   CVCL_C1M3
DR   Wikidata; Q114310449
RX   PubMed=35835158;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; V5XK21; Dabie bandavirus nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 4
//
ID   4A10 [Mouse hybridoma against human HMGB1]
AC   CVCL_B4HJ
SY   4A10-1-3-1-1
DR   Wikidata; Q110429782
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   4A10 [Mouse hybridoma against human PSCA]
AC   CVCL_B0TU
DR   Wikidata; Q108819637
RX   Patent=US8524460;
RX   PubMed=10713670;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12617.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4A11
AC   CVCL_A6RI
DR   Wikidata; Q107113286
RX   PubMed=2384664;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01137; Human TGFB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   4A2 [Mouse hybridoma against ZEBOV VP40]
AC   CVCL_B6LG
DR   Wikidata; Q111732727
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   Patent=RU2395577;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q05128; Zaire ebolavirus (strain Mayinga-76) matrix protein VP40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   4A2 [Mouse hybridoma against human CA9]
AC   CVCL_C7I2
DR   Wikidata; Q123030284
RX   PubMed=34806527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16790; Human CA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   4A2 [Mouse hybridoma against human CD7]
AC   CVCL_B0H3
SY   4A; X-D
DR   Wikidata; Q108819638
RX   DOI=10.1007/BF01030751;
RX   Patent=US4677056;
RX   PubMed=6980917;
RX   PubMed=10099192;
RX   PubMed=18600799;
RX   PubMed=18612979;
RX   PubMed=18618747;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8350.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   4A2 [Mouse hybridoma against phthalate]
AC   CVCL_D5KU
DR   Wikidata; Q127378743
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   4A2-2
AC   CVCL_B0WU
DR   Wikidata; Q108819639
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-971.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   4A2-4
AC   CVCL_B0WV
DR   Wikidata; Q108819640
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4A3
AC   CVCL_B6IS
DR   Wikidata; Q111732728
RX   Patent=WO2018115885A1;
RX   PubMed=28402743;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-171.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   4A3-B1-E1
AC   CVCL_C3LL
SY   2INS-1
DR   Wikidata; Q116048208
RX   Patent=CN111996173B;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Guangdong Province Microorganism Culture Collection Center; GDMCC 61043.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4A4 [Mouse hybridoma against parathion]
AC   CVCL_C5AB
DR   Wikidata; Q116048209
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4A4 [Mouse hybridoma against T.annulata macroschizonts]
AC   CVCL_B6P8
DR   Wikidata; Q111732730
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   4A4B11
AC   CVCL_G610
DR   CLO; CLO_0001383
DR   ATCC; HB-8327
DR   Wikidata; Q54603338
RX   Patent=US4595654;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8327.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02745; Human C1QA.
CC   Monoclonal antibody target: UniProtKB; P02746; Human C1QB.
CC   Monoclonal antibody target: UniProtKB; P02747; Human C1QC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   4A6 [Mouse hybridoma against C.griseus Nsf]
AC   CVCL_J639
DR   CLO; CLO_0001384
DR   ATCC; CRL-1928
DR   Wikidata; Q54603339
RX   PubMed=3186695;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P18708; Cricetulus griseus Nsf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   4A6 [Mouse hybridoma against chicken ATH]
AC   CVCL_C4ZH
DR   Wikidata; Q116048210
RX   PubMed=1804771;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19753; Chicken ATH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4A6 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N0
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4A7
AC   CVCL_C7XD
DR   Wikidata; Q123030285
RX   PubMed=3356969;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P21250; Onchocerca volvulus Ov33-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   4A7H6
AC   CVCL_C0N0
DR   Wikidata; Q112926977
WW   Provider; OSU; T2015-225; https://dev.innovatehosted.com/available_technologies/15144/Monoclonal-Antibody-for-Cereblon
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96SW2; Human CRBN (Note=Also reacts with other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   4A8 [Mouse hybridoma against chicken ACHE]
AC   CVCL_E8C5
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36196; Chicken ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4A8 [Mouse hybridoma against chicken IL10]
AC   CVCL_E1H8
RX   PubMed=30596381;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6A2H4; Chicken IL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4A8 [Mouse hybridoma against goose parvovirus VP3]
AC   CVCL_RY66
DR   Wikidata; Q54603341
RX   PubMed=23176172;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; C8CE61; Goose parvovirus (strain Ep22) protein VP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 5
//
ID   4A8 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BG
DR   Wikidata; Q116048211
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4A9.12.12
AC   CVCL_LH40
DR   Wikidata; Q54603343
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6029.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   4A9.D6
AC   CVCL_C4QP
DR   ABCD; ABCD_AE778
DR   Wikidata; Q116048212
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00004; Horse CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4B1 [Human/mouse hybridoma against HIV-1 gp120]
AC   CVCL_F1FF
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4B1 [Mouse hybridoma against FLV gp70]
AC   CVCL_B0VN
DR   Wikidata; Q108819641
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   4B10
AC   CVCL_C4SZ
DR   Wikidata; Q116048213
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   4B12 [Mouse bone]
AC   CVCL_C6WU
DR   Wikidata; Q123030286
RX   PubMed=19492422;
CC   Characteristics: Selected by FACS to be Mac-1+cFms+-RANK1+. Depend on Csf1 for both proliferation and osteoclast differentiation (PubMed=19492422).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoclast; CL=CL_0000092.
CC   Breed/subspecies: ddY.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 4
//
ID   4B12 [Mouse hybridoma against 4-hydroxybenzohydrazide]
AC   CVCL_C8N9
DR   Wikidata; Q123030287
RX   PubMed=33765482;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_195425; 4-hydroxybenzohydrazide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   4B2 [Macaca B-cell transformed]
AC   CVCL_A0AH
DR   BEI_Resources; ARP-12196
DR   Wikidata; Q108819642
RX   PubMed=22072749;
CC   Group: Non-human primate cell line.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; E7CWP5; Simian immunodeficiency virus (isolate SIVmac239) (SIV-mac) env (gp41).
CC   Transformant: NCBI_TaxID; 45455; Rhesus lymphocryptovirus (Macacine herpesvirus 4).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A0AI ! 6E6 [Macaca B-cell transformed]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   4B2 [Mouse hybridoma against chicken TRIM62]
AC   CVCL_E8HT
RX   PubMed=29813003;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A8V0ZA67; Chicken TRIM62.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4B2 [Mouse hybridoma against human PTPRC]
AC   CVCL_J048
DR   CLO; CLO_0001385
DR   ATCC; HB-196
DR   Wikidata; Q54603344
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   4B2 [Mouse hybridoma against MTPS]
AC   CVCL_C4D4
DR   Wikidata; Q116048214
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4B2 [Mouse/rat hybridoma against mouse Clec7a]
AC   CVCL_A0GA
DR   Wikidata; Q108819643
RX   Patent=US7915041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10151.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4B2-6C3-1C9
AC   CVCL_J638
SY   1C9
DR   CLO; CLO_0001386
DR   ATCC; HB-12466
DR   Wikidata; Q54603346
RX   Patent=US5861241;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12466.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Norwalk virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   4B2-E2-E7-C3
AC   CVCL_C3LM
SY   INS-12
DR   Wikidata; Q116048215
RX   Patent=CN111996173B;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Guangdong Province Microorganism Culture Collection Center; GDMCC 61044.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4B3 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1F0
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4B3 [Mouse hybridoma against chicken IL10]
AC   CVCL_E1H9
RX   PubMed=30596381;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6A2H4; Chicken IL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   4B3A4
AC   CVCL_C5NV
DR   Wikidata; Q116048216
RX   Patent=CN110054691B;
RX   PubMed=31930453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201927.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99572; Human P2RX7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4B4-1-1
AC   CVCL_JZ91
SY   4B4-1
DR   Wikidata; Q54603348
RX   Patent=US5928893;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 0157BP.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q07011; Human TNFRSF9/CD137.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   4B5 [Mouse hybridoma against rabbit Ig kappa b5]
AC   CVCL_D6TV
RX   PubMed=6432680;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rabbit Ig kappa light chain b5 allotype.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4B5 [Mouse/rat hybridoma against mouse Ncl]
AC   CVCL_C4MX
DR   Wikidata; Q116048217
RX   PubMed=36269321;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09405; Mouse Ncl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   4B6 [Mouse fibroblast]
AC   CVCL_ZC41
DR   Kerafast; ESA102
DR   Wikidata; Q98125405
RX   PubMed=23884459;
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J x Lig3LoxP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZB94 ! Cre4
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   4B6 [Mouse hybridoma against HAstV-2 VP25]
AC   CVCL_C5NN
DR   Wikidata; Q116048218
RX   Patent=US20200392578;
RX   PubMed=30355681;
RX   PubMed=31233538;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A3G6VE25; Human astrovirus-2 (strain Oxford) (HAstV-2) capsid protein VP90 (Note=AA 423-651 = Capsid protein VP25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   4B6 [Mouse hybridoma against human TNF]
AC   CVCL_F1V9
RX   PubMed=3805735;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4B6/3598/3442#2
AC   CVCL_ZC42
DR   Kerafast; ESA103
DR   Wikidata; Q98125409
RX   PubMed=23884459;
CC   Characteristics: Inefficient mitochondrial import of ligA in the absence of Lig3 makes DNA ligase activity limiting for the mtDNA replication and leads to a reduced (10-100 fold) mtDNA copy number (Kerafast=ESA103).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109152; Lig3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P15042; Escherichia coli ligA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J x Lig3LoxP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZC41 ! 4B6 [Mouse fibroblast]
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   4B6/3598/3442#2/4011/4014C1-2
AC   CVCL_ZC44
DR   Kerafast; ESA105
DR   Wikidata; Q98125415
RX   PubMed=23884459;
CC   Characteristics: To generate this cell line the parental cells were transiently transfected with a plasmid pMA4014, which encodes mCherry and FLPo and flow sorted for transfected cells. As a result of FLPo-mediated excision of the MTS in front of the bacterial ligA gene, mitochondrial import of ligA in this cell line is inefficient and mtDNA is maintained at a reduced copy number (Kerafast=ESA105).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109152; Lig3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P15042; Escherichia coli ligA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J x Lig3LoxP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZC43 ! 4B6/3598/3442#2/4011C1
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   4B6/3598/3442#2/4011C1
AC   CVCL_ZC43
DR   Kerafast; ESA104
DR   Wikidata; Q98125419
RX   PubMed=23884459;
CC   Characteristics: Unlike the parental cell line, this cell line maintains mtDNA at normal levels. This was achieved by introducing into the parental cell line a ligA gene fused to an excisable (FRT/FLPo) mitochondrial targeting sequence (MTS) from human ornithine transcarbamylase. The resulting cell line expresses two ligA variants: one without- and another with MTS. The latter is efficiently imported into mitochondria and therefore normal mtDNA copy number is restored in the transduced cells (Kerafast=ESA104).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109152; Lig3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P15042; Escherichia coli ligA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J x Lig3LoxP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZC42 ! 4B6/3598/3442#2
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   4B7 [Mouse hybridoma against P.falciparum pfs25]
AC   CVCL_VI47
DR   BEI_Resources; MRA-315
DR   Wikidata; Q54603351
RX   PubMed=1940798;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q7KQL2; Plasmodium falciparum (isolate 3D7) 25 kDa ookinete surface antigen (pfs25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 7
//
ID   4B7 [Mouse hybridoma against ractopamine]
AC   CVCL_C5QD
DR   Wikidata; Q116048219
RX   PubMed=10995307;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_82644; Ractopamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   4B7-4D5
AC   CVCL_C3N0
SY   4B7 4D5
DR   Wikidata; Q116048220
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   4B8 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BH
DR   Wikidata; Q116048221
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4B8 [Mouse hybridoma against SVA VP2]
AC   CVCL_B5YW
DR   Wikidata; Q111732731
RX   DOI=10.16431/j.cnki.1671-7236.2022.01.033;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   4B8 [Mouse hybridoma against spring viremia of carp G]
AC   CVCL_D6U7
RX   DOI=10.1089/mab.2014.0059;
RX   PubMed=25358003;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q91DS0; Spring viremia of carp virus G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   4B9 [Human LCL mAb producing]
AC   CVCL_JA37
SY   HLCL 4B9
DR   CCRID; 4201PAT-CCTCC00009
DR   Wikidata; Q54603353
RX   Patent=US4970070;
RX   Patent=US5837541;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9008.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Group B streptococci.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 12
//
ID   4B9 [Mouse hybridoma against human PDCD1]
AC   CVCL_YN75
DR   Wikidata; Q93307241
RX   PubMed=20443708;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   4B9 [Mouse hybridoma against saikosaponins A/C]
AC   CVCL_B6G7
DR   Wikidata; Q111732732
RX   PubMed=14709901;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A.
CC   Monoclonal antibody target: ChEBI; CHEBI_189704; Saikosaponin C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   4BA7
AC   CVCL_D1FJ
DR   Wikidata; Q127378744
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z067 ! Sp2ab
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   4BG
AC   CVCL_M614
DR   Wikidata; Q54603355
RX   PubMed=8689637;
RX   PubMed=12354749;
DI   NCIt; C121871; Chondrosarcoma, grade 3
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   4BJ1
AC   CVCL_VG15
DR   SKIP; SKIP000895
DR   Wikidata; Q54603356
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   4BL
AC   CVCL_B6S0
DR   Wikidata; Q111732733
RX   CelloPub=CLPUB00686;
RX   DOI=10.7124/bc.00083D;
RX   DOI=10.7124/visnyk.utgis.14.1.541;
RX   PubMed=24236325;
RX   PubMed=30480421;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   4C
AC   CVCL_J640
SY   SKI 300 4C; mAb 4C; moAb 4C
DR   CLO; CLO_0001387
DR   ATCC; HB-8311
DR   Wikidata; Q54603357
RX   Patent=US4710457;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8311.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   4C1 [Mouse hybridoma against A.australis AaH2]
AC   CVCL_KB12
DR   Wikidata; Q54603358
RX   PubMed=2454259;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01484; Androctonus australis neurotoxin AaH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 6
//
ID   4C1 [Mouse hybridoma against P.falciparum csp]
AC   CVCL_A7VN
DR   Wikidata; Q107113287
RX   PubMed=31548526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   4C1-B8
AC   CVCL_C3U5
SY   4C1 B8; 4C1 B8 3F8; 4C1
DR   ABCD; ABCD_AD583
DR   Wikidata; Q116048222
RX   PubMed=2428875;
RX   PubMed=2442247;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1) (Note=Also reacts with D.pteronyssinus Der p 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   4C1-C6
AC   CVCL_C3U6
DR   Wikidata; Q116048223
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1) (Note=Also reacts with D.pteronyssinus Der p 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   4C10
AC   CVCL_F0V5
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4C11 [Mouse hybridoma against human FcRn]
AC   CVCL_0E08
DR   ATCC; CRL-2436
DR   Wikidata; Q54603361
RX   PubMed=7889418;
CC   Monoclonal antibody isotype: IgG1.
CC   Discontinued: ATCC; CRL-2436; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 6
//
ID   4C11 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HP
DR   Wikidata; Q108819644
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4C11 [Rat hybridoma against mouse Tnfsf14]
AC   CVCL_C5AH
DR   Wikidata; Q116048224
RX   PubMed=16332198;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9QYH9; Mouse Tnfsf14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4C12
AC   CVCL_F0WC
DR   ABCD; ABCD_BF033
RX   PubMed=38479361;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03205; Epstein-Barr virus (strain B95-8) glycoprotein 42 (gp42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4C2
AC   CVCL_XH07
DR   Wikidata; Q93307266
RX   Patent=CN105524888A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201608.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Duck IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   4C2.4A7.5H11
AC   CVCL_J641
SY   4C2
DR   CLO; CLO_0001388
DR   ATCC; CRL-2744
DR   ATCC; JHU-28
DR   Wikidata; Q54603363
WW   Provider; JHTV; C03422; https://jhu.technologypublisher.com/technology/16143
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse MHC class I Qa-1b.
CC   Discontinued: ATCC; CRL-2744; true.
CC   Discontinued: ATCC; JHU-28; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   4C3 [Mouse hybridoma against B.germanica Bla g 2]
AC   CVCL_C3WV
SY   4C3 H5 F6 F7
DR   ABCD; ABCD_AA510
DR   Wikidata; Q116048225
RX   PubMed=21123808;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54958; Blattella germanica aspartic protease Bla g 2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4C3 [Mouse hybridoma against human MSMB]
AC   CVCL_A0JK
DR   Wikidata; Q108819645
RX   Patent=US4863851;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9121.
CC   Registration: Upjohn Culture Collection; UC HB-17.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08118; Human MSMB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   4C4 [Mouse hybridoma against rat Cycs]
AC   CVCL_E5N1
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4C4 [Mouse/rat hybridoma against mouse Cd1d1]
AC   CVCL_9160
DR   CLO; CLO_0001389
DR   ATCC; HB-327
DR   NCBI_Iran; H110
DR   Wikidata; Q54603365
RX   PubMed=9531266;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11609; Mouse Cd1d1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 8
//
ID   4C4.1
AC   CVCL_C5G0
DR   Wikidata; Q116048226
RX   PubMed=2343467;
RX   PubMed=3718975;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23631; Latrodectus tredecimguttatus alpha-latrotoxin-Lt1a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4C5 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N2
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4C5 [Mouse hybridoma against vaccinia A14L]
AC   CVCL_E5Q8
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4C5A3
AC   CVCL_C4MZ
SY   FerAb
DR   Wikidata; Q116048228
RX   PubMed=33189725;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Mouse antigen on ferroptotic cells (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   4C5G
AC   CVCL_J642
DR   CLO; CLO_0001390
DR   ATCC; CRL-2538
DR   Wikidata; Q54603366
RX   PubMed=1846531;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A6QLN5; Bovine PI4K2A (Note=Also reacts with human and other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   4C6 [Mouse hybridoma against goose parvovirus NS1]
AC   CVCL_C5CJ
DR   Wikidata; Q116048229
RX   PubMed=22509917;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; I1VWH1; Goose parvovirus non-structural protein 1 (NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4C6 [Mouse hybridoma against P.falciparum csp]
AC   CVCL_A7VP
DR   Wikidata; Q107113288
RX   PubMed=31548526;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   4C7 [Mouse hybridoma against phthalate]
AC   CVCL_D5L4
DR   Wikidata; Q127378745
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   4C7 [Mouse hybridoma against thebaine]
AC   CVCL_B6GF
DR   Wikidata; Q111732734
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   4C7.2.1
AC   CVCL_J987
DR   Wikidata; Q54603369
RX   Patent=US20080171036;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4999.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   4C71B7
AC   CVCL_A6NX
DR   DSHB; 4C71B7
DR   Wikidata; Q107113290
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35832; Drosophila melanogaster Ptp99A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   4C8 [Mouse hybridoma against human CXCR1]
AC   CVCL_F1WK
RX   Patent=US5440021;
RX   Patent=US20070065441;
RX   PubMed=9356984;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25024; Human CXCR1/CD181.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4C8 [Mouse hybridoma against influenza A HA]
AC   CVCL_C3N1
DR   Wikidata; Q116048230
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   4C8 [Mouse hybridoma against L.donovani gp63]
AC   CVCL_CW40
DR   NCBI_Iran; H146
DR   Wikidata; Q54603373
RX   CelloPub=CLPUB00331;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23223; Leishmania donovani gp63 (Note=Also reacts with other Leishmania species gp63).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   4C8B9
AC   CVCL_B0KA
DR   ATCC; HB-12492
DR   Wikidata; Q108819646
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12492.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4c9
AC   CVCL_E3Z8
SY   4C9
RX   PubMed=11604110;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02794; Human FTH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   4C9 [Mouse hybridoma against human SKI]
AC   CVCL_C5EK
DR   Wikidata; Q116048231
RX   PubMed=21851241;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12755; Human SKI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4C9 [Mouse hybridoma against rat B2m]
AC   CVCL_D150
DR   CLO; CLO_0001391
DR   ATCC; CRL-2437
DR   Wikidata; Q54603374
RX   PubMed=7889418;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07151; Rat B2m.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   4C9 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HK
DR   Wikidata; Q110429783
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   4C9 [Mouse hybridoma against S.aureus entB]
AC   CVCL_E8PM
RX   PubMed=31603743;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01552; Staphylococcus aureus entB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4D1 [Mouse hybridoma against human GRN]
AC   CVCL_X858
DR   Wikidata; Q54603376
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5593.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 6
//
ID   4D1 [Mouse hybridoma against influenza A HA]
AC   CVCL_A0UK
DR   CCRID; 4201PAT-CCTCC00180
DR   Wikidata; Q108819647
RX   Patent=CN101220097A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200606.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   4D1 [Mouse hybridoma against SYNV P]
AC   CVCL_B6X7
DR   Wikidata; Q111732735
RX   Patent=CN105132385B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.9326.
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: UniProtKB; P21299; Sonchus yellow net virus (SYNV) phosphoprotein (P).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   4D1.4
AC   CVCL_C9FS
DR   ABCD; ABCD_BA625
DR   Wikidata; Q123030288
RX   Patent=US8231877;
RX   PubMed=9631008;
CC   Doubling time: 15 hours (PubMed=9631008).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   4D1.5.7
AC   CVCL_J001
SY   4D1
DR   CLO; CLO_0001392
DR   ATCC; HB-11495
DR   Wikidata; Q54603378
RX   Patent=US5440021;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11495.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P25025; Human CXCR2/IL8RB/CD182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   4D11 [Mouse hybridoma against 4-hydroxybenzohydrazide]
AC   CVCL_C8NA
DR   Wikidata; Q123030289
RX   PubMed=33765482;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_195425; 4-hydroxybenzohydrazide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   4D11 [Mouse hybridoma against human CD275]
AC   CVCL_E2Z9
RX   PubMed=21851236;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4D11 [Mouse hybridoma against human HBZ]
AC   CVCL_C3TG
DR   Wikidata; Q116048232
RX   PubMed=16305964;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02008; Human HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4D11 [Rat hybridoma against mouse Klra7]
AC   CVCL_9161
DR   CLO; CLO_0001393
DR   ATCC; HB-240
DR   NCBI_Iran; H134
DR   Wikidata; Q54603379
RX   PubMed=2453582;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q60654; Mouse Klra7 (Note=Isoform Ly-49G.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   4D12 [Mouse hybridoma against dog CD274]
AC   CVCL_F0H6
RX   Patent=US12252536;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog PDL1/CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4D12 [Mouse hybridoma against human B2M/HLA-B]
AC   CVCL_J813
DR   CLO; CLO_0001394
DR   ATCC; HB-178
DR   Wikidata; Q54603381
RX   PubMed=6181035;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*05).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   4D12 [Mouse hybridoma against human HLA-E]
AC   CVCL_C0BV
DR   Wikidata; Q112926979
RX   PubMed=12874228;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   4D12 [Mouse/rat hybridoma against mouse Klra3/Klra5]
AC   CVCL_C0BT
DR   Wikidata; Q112926981
RX   Patent=US20030095965;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q64329; Mouse Klra3/Ly49C.
CC   Monoclonal antibody target: UniProtKB; Q60652; Mouse Klra5/Ly49E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   4D1C2
AC   CVCL_A0VA
DR   Wikidata; Q108819648
RX   Patent=CN107299085B;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4D2 [Mouse hybridoma against human CHI3L2]
AC   CVCL_C5CM
DR   Wikidata; Q116048233
RX   PubMed=22316483;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15782; Human CHI3L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4D2 [Mouse hybridoma against human TNF]
AC   CVCL_F1VA
RX   PubMed=3805735;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4D2 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ94
DR   Wikidata; Q93307310
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   4D20.8
AC   CVCL_RU14
SY   4-D20-8; PureStem 4D20.8, NCr-fac progenitor; ACTC84
DR   Millipore; SCC120
DR   Millipore; SCR220
DR   Wikidata; Q54603382
RX   Patent=US8685386;
RX   PubMed=18462054;
RX   PubMed=22519755;
WW   Provider; ESI BIO; ES-84; https://web.archive.org/web/20141202091553/http://www.esibio.com/purestemr-4d20-8-ncr-fac-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10231.
CC   Characteristics: Has chondrogenic potential.
CC   Senescence: Can undergo 15 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Discontinued: Millipore; SCC120; true.
CC   Discontinued: Millipore; SCR220; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   4D3 [Mouse hybridoma against cell wall peptidoglycans]
AC   CVCL_J023
DR   ATCC; HB-8517
DR   Wikidata; Q54603385
RX   Patent=US4596769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8517.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Cell wall peptidoglycans from a variety of Gram- and Gram+ bacteria.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   4D3 [Mouse hybridoma against human MMP2]
AC   CVCL_XG98
DR   Wikidata; Q93307322
RX   PubMed=9771478;
RX   PubMed=9824606;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08253; Human MMP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   4D3 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ95
DR   Wikidata; Q93307324
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   4D4 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1EX
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4D4 [Mouse hybridoma against D.pteronyssinus Der p 21]
AC   CVCL_E5ST
RX   PubMed=38646484;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2L7C5; Dermatophagoides pteronyssinus allergen Der p 21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4D4 [Mouse hybridoma against GXM]
AC   CVCL_F1Y1
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM) (Note=Immunized with C.neoformans serotype A (ATCC 24064)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4D4 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0KB
DR   ATCC; HB-12493
DR   Wikidata; Q108819649
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12493.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4D4 [Mouse hybridoma against human VNN2]
AC   CVCL_J230
DR   TKG; TKG 0619
DR   Wikidata; Q54603387
RX   PubMed=17543284;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95498; Human VNN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   4D7D12
AC   CVCL_E4JS
RX   PubMed=24237073;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9HBJ0; Human PLAC1 (Note=Immunized with AA 166-177).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   4D8 [Mouse hybridoma against C.perfringens pfo]
AC   CVCL_E4R4
RX   DOI=10.1007/BF01577135;
RX   PubMed=32891180;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
CC   Miscellaneous: While produced in the experiments described in DOI=10.1007/BF01577135 this hybridoma is not mentioned in that publication.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   4D8 [Mouse hybridoma against chicken HMGB1]
AC   CVCL_E7Q2
RX   PubMed=28570826;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9YH06; Chicken HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4D8 [Mouse hybridoma against human FOLH1]
AC   CVCL_B0KC
DR   ATCC; HB-12487
DR   Wikidata; Q108819650
RX   Patent=US6150508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12487.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   4D8G7
AC   CVCL_B0F8
DR   Wikidata; Q108819651
RX   Patent=CN113151185B;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O76093; Human FGF18 (Note=Also recognizes FGF8 and FGF17).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 5
//
ID   4D9
AC   CVCL_A7FS
DR   Wikidata; Q107113291
RX   PubMed=9885239;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14191; Human WRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   4D9-2C11
AC   CVCL_E5NY
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4D9-2D4
AC   CVCL_E5NG
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4D9D4
AC   CVCL_J729
SY   4D9
DR   CLO; CLO_0001395
DR   ATCC; CRL-1818
DR   DSHB; 4D9-anti-engrailed-invected
DR   Wikidata; Q54603478
RX   PubMed=2570637;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02836; Drosophila melanogaster en.
CC   Monoclonal antibody target: UniProtKB; P05527; Drosophila melanogaster inv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   4DE4
AC   CVCL_U623
DR   Wikidata; Q54603480
RX   PubMed=9207005;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/4/cell-lines-detail-440.html
CC   From: Staudt, Louis Michael; National Cancer Institute; Bethesda; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   4DE4-CCR8
AC   CVCL_C8V8
SY   CCR8-4DE4
DR   Wikidata; Q123030290
RX   PubMed=9207005;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U623 ! 4DE4
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   4E1
AC   CVCL_WZ96
DR   Wikidata; Q93307339
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   4E1-7
AC   CVCL_A9PB
DR   Wikidata; Q102113454
RX   PubMed=32651429;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q3C2E2; Dog MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   4E10
AC   CVCL_F1F3
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4E10-1.14
AC   CVCL_B0KD
DR   ATCC; HB-12310
DR   Wikidata; Q108819652
RX   Patent=US6150508;
RX   PubMed=9817391;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12310.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4E11 [Mouse hybridoma against FLAG peptide]
AC   CVCL_J730
DR   CLO; CLO_0001396
DR   ATCC; CRL-3623
DR   ATCC; HB-9259
DR   Wikidata; Q54603483
RX   Patent=US4851341;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9259.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_189550; FLAG peptide (DYKDDDDK).
CC   Discontinued: ATCC; HB-9259; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   4E11 [Mouse hybridoma against parathion]
AC   CVCL_C5AC
DR   Wikidata; Q116048234
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4E11E2
AC   CVCL_C0N1
DR   Wikidata; Q112926984
WW   Provider; OSU; T2015-225; https://dev.innovatehosted.com/available_technologies/15144/Monoclonal-Antibody-for-Cereblon
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96SW2; Human CRBN (Note=Also reacts with other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   4E12 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BI
DR   Wikidata; Q116048235
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4E12 [Mouse hybridoma against human IL2]
AC   CVCL_RW64
DR   ATCC; HB-8093
DR   Wikidata; Q54603485
RX   Patent=USRE33252;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8093.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60568; Human IL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   4E12B2
AC   CVCL_RW65
DR   ATCC; HB-8092
DR   Wikidata; Q54603486
RX   Patent=USRE33252;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8092.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60568; Human IL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW64 ! 4E12 [Mouse hybridoma against human IL2]
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   4E12B2D10
AC   CVCL_RW66
DR   ATCC; HB-8091
DR   Wikidata; Q54603487
RX   Patent=USRE33252;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8091.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60568; Human IL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW65 ! 4E12B2
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   4e2
AC   CVCL_E3Z9
SY   4E2
RX   PubMed=11604110;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02794; Human FTH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   4E2 [Mouse hybridoma against C.neoformans non-capsular antigen]
AC   CVCL_B0L0
DR   Wikidata; Q108819653
RX   PubMed=2068741;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Cryptococcus neoformans var. neoformans non-capsular antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4E2 [Mouse hybridoma against goose parvovirus VP3]
AC   CVCL_RY67
DR   Wikidata; Q54603489
RX   PubMed=23176172;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; C8CE61; Goose parvovirus (strain Ep22) protein VP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 6
//
ID   4E2 [Mouse hybridoma against human TNC]
AC   CVCL_D6U9
RX   PubMed=20199146;
RX   PubMed=20199166;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P24821; Human TNC (Note=Immunized with domain FN3 D).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4E2 [Mouse hybridoma against suid herpesvirus 1 UL42]
AC   CVCL_C6I9
DR   ABCD; ABCD_AV471
DR   Wikidata; Q116048236
RX   PubMed=26377421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F6QNH2; Suid herpesvirus 1 (strain JF) DNA polymerase processivity factor (UL42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4E3-2F7
AC   CVCL_E7DL
RX   PubMed=28186437;
RX   PubMed=28234555;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6P253; Mouse Dmkn (Note=Isoforms Dermokine-beta (1) and Dermokine-alpha (3)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4E6
AC   CVCL_B0XN
DR   Wikidata; Q108819654
RX   PubMed=7586523;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4E7
AC   CVCL_0I03
DR   Wikidata; Q54603491
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5109.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   4E7.24.3
AC   CVCL_B0EC
SY   4E7
DR   Wikidata; Q108819655
RX   Patent=US20110002933;
RX   Patent=WO1999037684A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11454.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4E8C12
AC   CVCL_G611
DR   CLO; CLO_0001397
DR   ATCC; HB-10452
DR   Wikidata; Q54603493
RX   Patent=US5354661;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10452.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Escherichia coli O157:H7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 6
//
ID   4E9 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4T0
DR   Wikidata; Q116048237
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 4
//
ID   4E9 [Mouse hybridoma against S.pneumoniae psaA]
AC   CVCL_F1V3
RX   PubMed=9521144;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A4G2; Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) pneumococcal surface adhesin A (psaA) (Note: Immunized with serotype 22F psaA but recognizes 23 capsular serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4EAB10.4
AC   CVCL_B4NX
DR   Wikidata; Q110429784
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   4EAB3.7
AC   CVCL_B4NY
DR   Wikidata; Q110429785
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   4EAB8.2
AC   CVCL_B4NZ
DR   Wikidata; Q110429787
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   4F1
AC   CVCL_C4CV
DR   ABCD; ABCD_AQ015
DR   Wikidata; Q116048238
RX   Patent=US20100111851;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TBJ4; Human PLPPR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4f1-1
AC   CVCL_VA26
DR   Wikidata; Q54603496
RX   PubMed=28508054;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73109; ! Tokudaia osimensis (Ryukyu spiny rat)
OI   CVCL_VA27 ! 5f1-1
OI   CVCL_VA28 ! 5f2-7
OI   CVCL_VA29 ! 5f2-11
OI   CVCL_VA30 ! 5f2-14
OI   CVCL_VA31 ! 5f2-18
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   4F10 [Human EBV-transformed]
AC   CVCL_JA38
SY   HLCL 4F10
DR   CCRID; 4201PAT-CCTCC00008
DR   Wikidata; Q54603499
RX   Patent=US5837541;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9007.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Accessible carbohydrate determinant of outer membrane lipopolysaccharide of Serratia marcescens.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   4F10 [Mouse hybridoma against human GRN from China]
AC   CVCL_C5G9
DR   Wikidata; Q116048239
RX   PubMed=21707362;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   4F10 [Mouse hybridoma against human GRN from USA]
AC   CVCL_X859
DR   Wikidata; Q54603502
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8763.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 9
//
ID   4F10 [Mouse hybridoma against lycopene]
AC   CVCL_B6IT
DR   Wikidata; Q111732736
RX   Patent=WO2018115885A1;
RX   PubMed=28402743;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   4F10 [Mouse hybridoma against PGE2]
AC   CVCL_E8V6
SY   4F10.3B9
RX   Patent=US8624002;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_15551; Prostaglandin E2 (PGE2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4F10F4
AC   CVCL_WN01
SY   4 F10F4
DR   Wikidata; Q93307382
RX   PubMed=1417586;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13891; Budgerigar fledgling disease virus VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   4F11
AC   CVCL_C4CW
DR   Wikidata; Q116048240
RX   Patent=US20100111851;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TBJ4; Human PLPPR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4F12 [Human/mouse hybridoma against HIV-1 p24]
AC   CVCL_F1FN
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03366; HIV-1 isolate BH10 env (Note=AA 133-363 = p24).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4F12 [Mouse hybridoma against aflatoxin]
AC   CVCL_A0PG
SY   AFB20084F12
DR   CCRID; 4201PAT-CCTCC00335
DR   Wikidata; Q108819656
RX   PubMed=19231357;
RX   PubMed=22548609;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   4F12 [Mouse hybridoma against chicken IL7]
AC   CVCL_C4JL
DR   Wikidata; Q116048241
RX   PubMed=33652529;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3C0R7; Chicken IL7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4F12 [Mouse hybridoma against human PLPPR1]
AC   CVCL_C4CX
DR   ABCD; ABCD_AQ017
DR   Wikidata; Q116048242
RX   Patent=US20100111851;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TBJ4; Human PLPPR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4F12-E6
AC   CVCL_D2QY
DR   Wikidata; Q127378746
RX   PubMed=29571514;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A024FCJ9; Dog PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   4F1B5
AC   CVCL_B0H8
DR   ABCD; ABCD_AI191
DR   Wikidata; Q108819657
RX   Patent=US6291652;
RX   PubMed=22037470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2851.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 5
//
ID   4F2 [Mouse hybridoma against fenitrothion]
AC   CVCL_ZI25
DR   CCRID; 4201PAT-CCTCC00646
DR   Wikidata; Q98125421
RX   Patent=CN104974257A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201511.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34757; Fenitrothion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   4F2 [Mouse hybridoma against T.annulata macroschizonts]
AC   CVCL_B6PB
DR   Wikidata; Q111732737
RX   PubMed=2421227;
RX   PubMed=3088817;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with Theileria parva).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   4F2C13
AC   CVCL_G092
DR   CLO; CLO_0001398
DR   ATCC; HB-22
DR   Wikidata; Q54603503
RX   PubMed=6153676;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   4F3 [Mouse hybridoma against aflatoxins]
AC   CVCL_A0PH
SY   AFB20084F3
DR   CCRID; 4201PAT-CCTCC00336
DR   Wikidata; Q108819658
RX   PubMed=19231357;
RX   PubMed=22548609;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   4F3 [Mouse hybridoma against parathion]
AC   CVCL_C5AD
DR   Wikidata; Q116048243
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4F4
AC   CVCL_C4B0
DR   CCRID; 4201PAT-CCTCC01001
DR   Wikidata; Q116048245
RX   DOI=10.1007/s00217-021-03905-9;
RX   Patent=CN106591240B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201702.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_9440; Tenuazonic acid (TeA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   4F6 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HQ
DR   Wikidata; Q108819659
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4F6 [Mouse hybridoma against human TACSTD2]
AC   CVCL_LH66
DR   Wikidata; Q54603504
RX   Patent=US8715662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 08019.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   4F7 [Mouse hybridoma against P.vivax RBP2b]
AC   CVCL_C5VN
DR   ABCD; ABCD_AJ075
DR   Wikidata; Q116048246
RX   PubMed=29950717;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A5K736; Plasmodium vivax (strain Salvador I) reticulocyte binding protein 2b (RBP2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   4F7 [Mouse/sheep hybridoma against C.botulinum botA]
AC   CVCL_B0X8
DR   Wikidata; Q108819660
RX   PubMed=23342681;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_B0WT ! 1C10 [Mouse/sheep heteromyeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   4F8 [Mouse hybridoma against DHAV VP3]
AC   CVCL_C4B4
DR   Wikidata; Q116048247
RX   PubMed=28883462;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; A4KYM2; Duck hepatitis A virus (strain HP-1) (DHAV) genome polyprotein (Note=AA 257-493 = Capsid protein VP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   4F8 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA06
DR   Wikidata; Q93307393
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9397.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   4F8 [Mouse hybridoma against human PLPPR1]
AC   CVCL_C4CY
DR   ABCD; ABCD_AQ016
DR   Wikidata; Q116048248
RX   Patent=US20100111851;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TBJ4; Human PLPPR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4F8 [Mouse hybridoma against human WRN]
AC   CVCL_A7FT
DR   Wikidata; Q107113292
RX   PubMed=9885239;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14191; Human WRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   4F9 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4T1
DR   Wikidata; Q116048249
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   4F9 [Mouse hybridoma against human PTPRC]
AC   CVCL_WW82
DR   Wikidata; Q93307395
RX   DOI=10.15114/tr.27.37;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   4G1
AC   CVCL_E4C1
RX   PubMed=21870856;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11140; Abrus precatorius abrin-A (Note=AA 1-251 = A chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   4G1-D2
AC   CVCL_B6JH
DR   Wikidata; Q111732738
RX   Patent=RU2652885;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-174.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTW1; Human GAGE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   4G10 [Mouse hybridoma against ginsenoside Re]
AC   CVCL_B6G2
SY   MAb-4G10
DR   Wikidata; Q111732739
RX   Patent=JP2006076896A;
RX   PubMed=16310421;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM AP-20188.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_77148; Ginsenoside Re.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   4G10 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ97
DR   Wikidata; Q93307397
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   4G10 [Mouse hybridoma against O.mossambicus IgM]
AC   CVCL_C4B7
DR   Wikidata; Q116048250
RX   Patent=CN106834235B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201645.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Oreochromis mossambicus IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   4G11 [Mouse hybridoma against human IGF1R]
AC   CVCL_JA55
DR   NCI-DTP; 4G11
DR   Wikidata; Q54603505
RX   PubMed=14710368;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   4G11 [Mouse hybridoma against human unknown protein]
AC   CVCL_WZ98
DR   Wikidata; Q93307399
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   4G11 1.C12
AC   CVCL_IZ77
SY   4G11
DR   Wikidata; Q54603506
RX   Patent=US7262277;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4018.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 6
//
ID   4G12 [Mouse hybridoma against ASFV CD2v]
AC   CVCL_A0IJ
DR   Wikidata; Q108819661
RX   Patent=CN111793128B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19947.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0A7W5A6; African swine fever virus (isolate DB/LN/2018) CD2 homolog (CD2v).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   4G12 [Mouse hybridoma against forskolin]
AC   CVCL_B6FW
DR   ABCD; ABCD_AJ804
DR   Wikidata; Q111732740
RX   PubMed=7765788;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   4G12 [Mouse hybridoma against human 65 kDa glycoprotein]
AC   CVCL_C560
DR   JCRB; IFO50090
DR   Wikidata; Q54603507
RX   PubMed=2455061;
CC   Doubling time: 1.2 days (Note=Lot 06232004) (JCRB=IFO50090).
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human 65 kDa glycoprotein on cancer cells surface.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   4G12 [Mouse hybridoma against parathion]
AC   CVCL_C5AE
DR   Wikidata; Q116048251
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4G12-13
AC   CVCL_XC77
SY   HB 4G12-13
DR   CCRID; 4201PAT-CCTCC00077
DR   Wikidata; Q93307423
RX   Patent=US6207417;
RX   Patent=US20080305074;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10561.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21583; Human KITLG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   4G2 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1EZ
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4G2 [Mouse hybridoma against human RB1]
AC   CVCL_A0RZ
DR   Wikidata; Q108819662
RX   Patent=US5710255;
RX   PubMed=7510760;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 4
//
ID   4G3
AC   CVCL_C8MZ
DR   Wikidata; Q123030291
RX   PubMed=33502396;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_149836; Tigecycline (Tygacil).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   4G4 [Mouse hybridoma against human GYPA]
AC   CVCL_E8P5
RX   PubMed=31486711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4G4 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TL
DR   Wikidata; Q111732741
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   4G4 [Mouse hybridoma against marinobufagenin]
AC   CVCL_B0LB
SY   MBG4G4
DR   ATCC; PTA-6725
DR   Wikidata; Q108819663
RX   Patent=US8038997;
RX   PubMed=19008721;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6725.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_146151; Marinobufagenin (MBG).
CC   Misspelling: MGB4G4; ATCC=PTA-6725.
CC   Discontinued: ATCC; PTA-6725; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   4G5
AC   CVCL_E5MA
RX   PubMed=26889021;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11258; Vaccinia virus protein OPG154 (A27L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4G5(PGM1) Clone B7
AC   CVCL_U074
DR   ECACC; 02043023
DR   Wikidata; Q54603510
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36871; Human PGM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   4G6
AC   CVCL_B6GN
DR   Wikidata; Q111732742
RX   PubMed=11791545;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A).
CC   Monoclonal antibody target: ChEBI; CHEBI_189708; Glycyrrhetic acid 3-O-glucuronide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   4G6F3
AC   CVCL_A3CA
DR   CCRID; 4201PAT-CCTCC01650
DR   Wikidata; Q105505941
RX   Patent=CN111925992B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202096.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00755; Human WNT7A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   4G7 [Mouse hybridoma against human ADRB3]
AC   CVCL_B0SV
DR   CCRID; 4201PAT-CCTCC00752
DR   Wikidata; Q108819664
RX   Patent=US11524073;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015147.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13945; Human ADRB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   4G7 [Mouse hybridoma against human CD19]
AC   CVCL_E5KE
RX   PubMed=6441771;
WW   Provider; Stanford OTL; S83-007; https://stanford.resoluteinnovation.com/technologies/S83-007_anti-leu-12-cd19-monoclonal
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15391; Human CD19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4G7-F1
AC   CVCL_E8UV
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4G7-F2
AC   CVCL_E8UW
RX   PubMed=7521892;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2) (Note=Also reacts with D.fpteronyssinus Der f 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4G7.18.8
AC   CVCL_B0ED
SY   4G7
DR   Wikidata; Q108819665
RX   Patent=US20110002933;
RX   PubMed=11290766;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-99.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4G8 [Mouse hybridoma against fibrin D-dimer]
AC   CVCL_C4AD
DR   Wikidata; Q116048252
RX   PubMed=30763351;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fibrin D-dimer (Note=Also reacts weakly with fibrinogen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4G8 [Mouse hybridoma against human DPP4]
AC   CVCL_C7IH
DR   Wikidata; Q123030294
RX   PubMed=9683260;
RX   PubMed=24502396;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   4G8-1E3
AC   CVCL_E5NC
RX   Patent=US9879087;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4G9-12B
AC   CVCL_C4CT
DR   Wikidata; Q116048253
RX   PubMed=1279746;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_28857; (Z)-hex-3-en-1-ol (Cis-3-Hexen-1-ol).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4CP ! Sp2/0-Ag14-K13
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   4H1-A7
AC   CVCL_1934
DR   CLO; CLO_0001399
DR   CLDB; cl102
DR   ATCC; CRL-1813
DR   DSMZ; ACC-28
DR   DSMZCellDive; ACC-28
DR   Wikidata; Q54603511
RX   PubMed=3281371;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Canine adenovirus serotype 2.
ST   Source(s): DSMZ=ACC-28
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 16,17,18
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 16
ST   Mouse STR 15-3: 22.3,24.3
ST   Mouse STR 18-3: 18
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   4H11 [Mouse hybridoma against human ERBB2]
AC   CVCL_E2SD
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4H11 [Mouse hybridoma against phthalate]
AC   CVCL_D5KV
DR   Wikidata; Q127378747
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   4H11 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HL
DR   Wikidata; Q110429788
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   4H12 [Mouse hybridoma against human MYH9]
AC   CVCL_B0JC
DR   Wikidata; Q108819666
RX   PubMed=34425650;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35579; Human MYH9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4H12 [Mouse hybridoma against human WRN]
AC   CVCL_A7FU
DR   Wikidata; Q107113293
RX   PubMed=9885239;
RX   PubMed=10543396;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14191; Human WRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   4H2 [Mouse hybridoma against human MS4A4A]
AC   CVCL_VD98
DR   Wikidata; Q54603512
RX   PubMed=28303902;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96JQ5; Human MS4A4A/CD20L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   4H2 [Mouse hybridoma against marinobufagenin]
AC   CVCL_B0LC
SY   MBG4H2
DR   Wikidata; Q108819667
RX   Patent=US8038997;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6788.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_146151; Marinobufagenin (MBG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   4H2 [Mouse hybridoma against NNK]
AC   CVCL_F0SN
RX   PubMed=23518474;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_32692; 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one (NNK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4H3
AC   CVCL_F1YA
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   4H3H4H2
AC   CVCL_E7DM
RX   PubMed=22646803;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q6E0U4; Human DMKN (Note=Isoforms beta and gamma. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4H4 [Mouse hybridoma against codeine]
AC   CVCL_B6G8
DR   Wikidata; Q111732744
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16714; Codeine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   4H4 [Mouse hybridoma against TMUV NS1]
AC   CVCL_E2Z6
RX   PubMed=26871513;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A075M1D2; Tembusu virus (strain SDLC) genome polyprotein (AA 791-1140 = Non-structural protein NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   4H5 [Mouse hybridoma against chicken SELENOW]
AC   CVCL_C5D1
DR   Wikidata; Q116048254
RX   PubMed=22149284;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; D0EYG3; Chicken SELENOW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   4H5 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5SD
DR   ABCD; ABCD_AE972
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4H6 [Mouse hybridoma against human RB1]
AC   CVCL_A0SA
DR   Wikidata; Q108819668
RX   PubMed=7510760;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. While this hybridoma is not described by the patent, 6 other hybridomas are described in both sources thus this one was probably produced in an identical manner.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   4H6 [Mouse hybridoma against human SAT1]
AC   CVCL_E6JR
RX   PubMed=27228136;
RX   PubMed=27328064;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21673; Human SAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4H6-20
AC   CVCL_C0E6
DR   Wikidata; Q112926987
DR   Ximbio; 153321
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
CC   Monoclonal antibody target: UniProtKB; P40199; Human CEACAM6/CD66c.
CC   Monoclonal antibody target: UniProtKB; P31997; Human CEACAM8/CD66b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   4H6.17.8
AC   CVCL_B0EE
SY   4H6
DR   ATCC; HB-12455
DR   Wikidata; Q108819669
RX   Patent=US7744881;
RX   Patent=US20110002933;
RX   Patent=WO1999037684A1;
RX   PubMed=11290766;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12455.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4H7 [Mouse hybridoma against BPV12 VP7]
AC   CVCL_C5AW
SY   BTV-4H7
DR   Wikidata; Q116048255
RX   Patent=CN102776152B;
RX   PubMed=25038929;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.5715.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; R4J9J2; Bluetongue virus 12 VP7 (Note=Also reacts with all other BPV serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   4H7 [Mouse hybridoma against human CD276]
AC   CVCL_C5EW
DR   Wikidata; Q116048256
RX   PubMed=16029427;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276 (Note=Isoform 2IgB7-H3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   4H7 [Mouse/rat hybridoma against human NPM1]
AC   CVCL_E7DN
RX   PubMed=39976521;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P06748; Human NPM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4H7H7
AC   CVCL_B0H6
DR   Wikidata; Q108819670
RX   Patent=US6291652;
RX   PubMed=22037470;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2847.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   4H8
AC   CVCL_A0VJ
DR   Wikidata; Q108819671
RX   PubMed=21190056;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7TSP5; Mouse Vtcn1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4H8(GC) Clone 4D4
AC   CVCL_U075
DR   ECACC; 02043019
DR   Wikidata; Q54603513
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02774; Human GC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   4H84
AC   CVCL_XY40
DR   Wikidata; Q93307443
RX   PubMed=9637505;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   4H9
AC   CVCL_E5K5
RX   PubMed=6603882;
WW   Provider; Stanford OTL; S82-068; https://stanford.resoluteinnovation.com/technologies/S82-068_hybridomas-3b12-an-anti-human
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   4I16
AC   CVCL_B5Z5
DR   Wikidata; Q111732745
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   4LP-B4
AC   CVCL_C4PG
DR   Wikidata; Q116048257
RX   PubMed=204013;
RX   PubMed=2580779;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   4MBr-5
AC   CVCL_4492
SY   4MBR-5
DR   CLO; CLO_0001400
DR   ATCC; CCL-208
DR   IZSLER; BS CL 222
DR   Wikidata; Q54603515
RX   CelloPub=CLPUB00288;
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=7065527;
RX   PubMed=28046048;
CC   Group: Non-human primate cell line.
CC   Characteristics: EGF dependent.
CC   Senescence: Senesces at 40 PDL (PubMed=7065527).
CC   Virology: Susceptible to infection by poliovirus type 1, type 2 and type 3 (PubMed=28046048).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   2-3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
ID   4nFC
AC   CVCL_UI38
DR   Wikidata; Q93307449
RX   PubMed=30017856;
CC   Group: Fish cell line.
CC   Doubling time: 41.3 hours (PubMed=30017856).
CC   Karyotypic information: Tetraploid karyotype.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: Carassius auratus langsdorfii x Cyprinus carpio.
OX   NCBI_TaxID=138676; ! Carassius langsdorfii (Japanese silver crucian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   4NfinP9
AC   CVCL_DF54
SY   SACCCL; Stable Autotetraploid Crucian Carp Cell Line
DR   Wikidata; Q54952053
RX   Patent=CN104109652B;
RX   PubMed=26898354;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.9155.
CC   Karyotypic information: Tetraploid karyotype. Polyploidy induced by the JNK inhibitor SP600125 (PubMed=26898354).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=138676; ! Carassius langsdorfii (Japanese silver crucian carp)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 14
//
ID   4nH1
AC   CVCL_N544
DR   Wikidata; Q54603516
RX   PubMed=17531078;
CC   Karyotypic information: Tetraploid karyotype.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N541 ! H-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   4SB3
AC   CVCL_J887
SY   4S.B3
DR   ECACC; 92030610
DR   NCBI_Iran; H113
DR   Wikidata; Q54603519
RX   PubMed=6438252;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   4SKEL20
AC   CVCL_RU17
SY   4-SKEL-20; ACTC127
DR   Millipore; SCC121
DR   Millipore; SCR221
DR   Wikidata; Q54603520
RX   PubMed=18462054;
CC   Discontinued: Millipore; SCC121; true.
CC   Discontinued: Millipore; SCR221; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   4T07
AC   CVCL_B383
SY   4TO7
DR   BTO; BTO_0004026
DR   Wikidata; Q54603521
RX   PubMed=1540948;
RX   PubMed=1993557;
RX   PubMed=3426919;
CC   Characteristics: Non-metastatic.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0I83 ! 44FT0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   4T1
AC   CVCL_0125
SY   4T1-A; 4T1.0; 4T1/WT
DR   BTO; BTO_0004311
DR   CLO; CLO_0001401
DR   EFO; EFO_0002037
DR   MCCL; MCC:0000017
DR   AddexBio; C0006004/13
DR   ATCC; CRL-2539
DR   BCRJ; 0022
DR   BioGRID_ORCS_Cell_line; 1260
DR   BioSample; SAMN11397647
DR   CCRID; 3101MOUSCSP5056
DR   CCRID; 3101MOUTCM32
DR   CCRID; 4201MOU-CCTCC00294
DR   CCRID; 6101MOU-CERC000107
DR   CCTCC; GDC0294
DR   ChEMBL-Cells; CHEMBL3307995
DR   ChEMBL-Targets; CHEMBL612589
DR   CLS; 300300
DR   GEO; GSM1529765
DR   GEO; GSM1529766
DR   GEO; GSM1529767
DR   GEO; GSM1847461
DR   GEO; GSM1847462
DR   KCB; KCB 200967YJ
DR   Lonza; 481
DR   NCBI_Iran; C604
DR   PRIDE; PXD013948
DR   PRIDE; PXD016112
DR   PRIDE; PXD021413
DR   PRIDE; PXD024762
DR   PRIDE; PXD027822
DR   PubChem_Cell_line; CVCL_0125
DR   Ubigene; YC-B004
DR   Wikidata; Q42802273
RX   PubMed=10411109;
RX   PubMed=26857856;
RX   PubMed=27177471;
RX   PubMed=31220119;
RX   PubMed=37712227;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/4/cell-lines-detail-66.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/4T1
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/4t1-xenograft-model/
CC   Characteristics: Metastatic.
CC   Characteristics: Widely used model in cancer research due to its high similarity to human breast cancer. The tumor growth and metastatic spread of 4T1 cells closely mimic the behavior of human breast cancer. The 4T1 cell line is considered an animal model for stage IV human breast cancer, as it is able to spontaneously metastasize in both post-operative and non-surgical models (CLS=300300).
CC   Doubling time: 12.6 hours (ATCC=CRL-2539).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
ST   Source(s): PubMed=31220119; PubMed=37712227; Ubigene=YC-B004
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 18,19,20
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W343 ! 410.4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   4T1-Dura3
AC   CVCL_XB01
DR   Wikidata; Q93307480
RX   PubMed=27203741;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Characteristics: Brain leptomeningeal space metastatic derivative of parental cell line. Established after 3 passages in BALC/cAn mice from internal carotid artery injection (PubMed=27203741).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XG69 ! 4T1/GFP/FlucII
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   4T1-eGFP-Puro
AC   CVCL_QZ56
DR   Imanis; CL021
DR   Wikidata; Q54603525
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-PuroR vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL021).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   4T1-Fluc-Neo
AC   CVCL_QZ57
DR   Imanis; CL020
DR   Wikidata; Q54603527
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Neo vector encoding for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL020).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Imanis; CL020; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   4T1-Fluc-Neo (monoclonal)
AC   CVCL_D5LJ
DR   Imanis; CL126
DR   Wikidata; Q127378748
RX   PubMed=30674994;
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Neo vector encoding for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter (from parent cell line).
CC   Characteristics: A monoclonal population was isolated using three rounds of selection in a methylcellulose-based semi-solid medium (Imanis=CL126).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_QZ57 ! 4T1-Fluc-Neo
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   4T1-Fluc-Neo/eGFP-Puro
AC   CVCL_QZ58
DR   Imanis; CL023
DR   Wikidata; Q54603528
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-PuroR vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-PuroR encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL023).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   4T1-Fluc-Neo/iRFP-Puro
AC   CVCL_QZ59
DR   Imanis; CL078
DR   Wikidata; Q54603530
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-iRFP-P2A-PuroR vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-PuroR encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL078).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   4T1-iRFP-Puro
AC   CVCL_QZ60
DR   Imanis; CL094
DR   Wikidata; Q54603534
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-PuroR vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL094).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   4T1-Luc [JCRB]
AC   CVCL_J239
DR   JCRB; JCRB1447
DR   JCRB; NIHS0696
DR   Wikidata; Q54603537
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0696; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   4T1-Luc [Ubigene]
AC   CVCL_C8UY
DR   Ubigene; YC-B004-Luc-P
DR   Wikidata; Q123030295
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   4T1-Luc2 [ATCC]
AC   CVCL_A4BM
DR   ATCC; CRL-2539-LUC2
DR   Wikidata; Q105505946
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-2539-LUC2).
CC   Doubling time: ~12.3 hours (ATCC=CRL-2539-LUC2).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   4T1-luc2 [Caliper]
AC   CVCL_L899
DR   Revvity/PerkinElmer; 124087
DR   Wikidata; Q54603538
RX   PubMed=19404236;
RX   PubMed=22510147;
WW   Provider; Revvity/PerkinElmer; 124087; https://web.archive.org/web/20150520035101/http://www.perkinelmer.com/catalog/product/id/124087
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124087; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 19
//
ID   4T1-luc2-GFP
AC   CVCL_5J28
SY   4T1-luc2/GFP
DR   Revvity/PerkinElmer; 129090
DR   Wikidata; Q54603540
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 129090; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   4T1-luc2-tdTomato
AC   CVCL_5J46
DR   Revvity/PerkinElmer; 125669
DR   Wikidata; Q54603541
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 125669; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   4T1-mCherry
AC   CVCL_C8UZ
DR   Ubigene; YC-B004-mCherry-P
DR   Wikidata; Q123030296
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   4T1-mNIS (monoclonal)
AC   CVCL_QZ61
DR   Imanis; CL117
DR   Wikidata; Q54603544
RX   PubMed=30674994;
CC   Characteristics: Transduced with the LV-mNIS vector encoding mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL117).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   4T1-mNIS-Neo/eGFP-Puro
AC   CVCL_QZ62
DR   Imanis; CL025
DR   Wikidata; Q54603546
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-eGFP-PGKp-PuroR vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-PuroR encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL025).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   4T1-mNIS-Neo/iRFP-Puro
AC   CVCL_QZ63
DR   Imanis; CL108
DR   Wikidata; Q54603547
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-iRFP-P2A-PuroR vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-PuroR encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL108).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   4T1-mNIS-Puro
AC   CVCL_QZ64
DR   Imanis; CL065
DR   Wikidata; Q54603549
CC   Characteristics: Reporter cell line, transduced with the LV-mNIS-PGKp-PuroR vector encoding for mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL065).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   4T1-mNIS-Puro/Fluc-Neo
AC   CVCL_QZ65
SY   4T1-Fluc-Neo/mNIS-Puro
DR   Imanis; CL066
DR   Wikidata; Q54603553
RX   PubMed=30674994;
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-PGKp-PuroR and LV-Fluc-P2A-Neo vectors. LV-mNIS-PGKp-PuroR encodes for mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL066).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   4T1-Par3
AC   CVCL_XB02
DR   Wikidata; Q93307547
RX   PubMed=27203741;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Characteristics: Brain parenchymal space metastatic derivative of parental cell line. Established after 3 passages in BALC/cAn mice from internal carotid artery injection (PubMed=27203741).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XG69 ! 4T1/GFP/FlucII
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   4T1-Red-FLuc
AC   CVCL_5I84
SY   Bioware Brite 4T1-Red-FLuc; IVISbrite 4T1 Red F-luc
DR   Revvity/PerkinElmer; BW124087
DR   Wikidata; Q54603649
CC   Doubling time: 14 hours (Revvity/PerkinElmer=BW124087).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   4T1-Red-FLuc-GFP
AC   CVCL_5I85
SY   Bioware Brite 4T1-Red-FLuc-GFP; IVISbrite 4T1 Red F-luc-GFP
DR   Revvity/PerkinElmer; BW128090
DR   Wikidata; Q54603650
CC   Doubling time: 14 hours (Revvity/PerkinElmer=BW128090).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   4T1-S
AC   CVCL_HE47
SY   4T1-Sapporo
DR   GEO; GSM1847463
DR   GEO; GSM1847464
DR   Wikidata; Q54603652
RX   PubMed=26857856;
CC   Characteristics: Compared to the parent cell line, it is much more immunogenic. When it is subcutaneously injected, striking enlargement of draining lymph nodes and increase of activated T cells are observed.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   4T1-SIINFEKL/H-2Kb
AC   CVCL_E7FZ
RX   PubMed=30347189;
CC   Characteristics: Enables the large-scale and continuous batch production of soluble, fully folded and epitope-defined MHC class I molecules. Engineered to secrete peptide/MHC complexes that can be selectively purified in bulk using affinity chromatography, biotinylated, multimerized (via streptavidin) and the resulting reagent incorporated into immunologically relevant assays for detection of antigen-specific T-cells (PubMed=30347189).
CC   Characteristics: Using a sleeping beauty transposon system a SIINFEKL-linker-B2m-linker-H2K(b)-AviTag construct was integrated in the parent cell line (PubMed=30347189).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:88127; B2m.
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   4T1-tdTomato
AC   CVCL_5J45
DR   Revvity/PerkinElmer; 125668
DR   Wikidata; Q54603654
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Discontinued: Revvity/PerkinElmer; 125668; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   4T1.13
AC   CVCL_GR31
DR   ATCC; CRL-3407
DR   Wikidata; Q54603657
RX   PubMed=15671244;
CC   Characteristics: High propensity to metastasize spontaneously to bone, causing fractures and/or hindlimb paralysis (ATCC=CRL-3407).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   4T1.2
AC   CVCL_GR32
SY   4 T1.2
DR   ATCC; CRL-3406
DR   ChEMBL-Cells; CHEMBL4483001
DR   ChEMBL-Targets; CHEMBL4483221
DR   PubChem_Cell_line; CVCL_GR32
DR   Wikidata; Q54603658
RX   PubMed=10411109;
RX   PubMed=15671244;
RX   PubMed=22510147;
CC   Characteristics: High propensity to metastasize spontaneously to bone, causing fractures and/or hindlimb paralysis (ATCC=CRL-3406).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   4T1.2 luc1
AC   CVCL_E8TB
SY   4T1.2 Luc1
RX   PubMed=22510147;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR32 ! 4T1.2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4T1.2 luc2
AC   CVCL_E8TC
SY   4T1.2 Luc2
RX   PubMed=22510147;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR32 ! 4T1.2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4T1.2 luc3
AC   CVCL_E8TD
SY   4T1.2 Luc3
RX   PubMed=22510147;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR32 ! 4T1.2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4T1.2 luc4
AC   CVCL_E8TE
SY   4T1.2 Luc4
RX   PubMed=22510147;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR32 ! 4T1.2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4T1.2 luc5
AC   CVCL_E8TF
SY   4T1.2 Luc5
RX   PubMed=22510147;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR32 ! 4T1.2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   4T1.3
AC   CVCL_B3QZ
DR   Wikidata; Q110429789
RX   PubMed=27177471;
RX   PubMed=34632664;
CC   Characteristics: Metastasizes with high frequency to bone upon orthotopic injection into the mammary fat pad of immunocompetent female BALB/c mice (PubMed=27177471).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   4T1/Cas9-hyg
AC   CVCL_C9FJ
SY   4T1-Cas9-hyg
DR   GeneCopoeia; SL581
DR   Wikidata; Q123030297
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL581).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   4T1/CMV-Luc #6
AC   CVCL_JG34
SY   4T1 CMV-Luc #6
DR   JCRB; JCRB1686
DR   JCRB; NIHS1044
DR   Wikidata; Q54603656
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1686).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1044; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   4T1/EPB
AC   CVCL_C0U6
DR   PRIDE; PXD027822
DR   Wikidata; Q112926990
RX   PubMed=34589084;
CC   Selected for resistance to: ChEBI; CHEBI_47898; 4'-epidoxorubicin (Epirubicin).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   4T1/GFP/FlucII
AC   CVCL_XG69
DR   Wikidata; Q93307585
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Miscellaneous: Cell line information from personal communication of Lorger, Mihaela.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   4TCYA1
AC   CVCL_A0YW
DR   Wikidata; Q108819672
RX   PubMed=8522347;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24522; Human GADD45A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   4TG-11
AC   CVCL_XG05
DR   Wikidata; Q93307582
RX   PubMed=1688246;
CC   Characteristics: Deficient in HPRT.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   4Z-B-1
AC   CVCL_B7D6
DR   CCRID; 4201PAT-CCTCC01847
DR   Wikidata; Q112926992
RX   PubMed=34141711;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202123.
CC   Population: Chinese.
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive (PubMed=34141711).
CC   Doubling time: 40 hours (PubMed=34141711).
CC   Karyotypic information: Nearly triploid (PubMed=34141711).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=34141711
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 10
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   5-12
AC   CVCL_C5A2
DR   Wikidata; Q116048258
RX   PubMed=11289226;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CQJ4; Mouse Rnf2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5-14
AC   CVCL_C3WQ
DR   ABCD; ABCD_AE160
DR   Wikidata; Q116048259
RX   PubMed=2104617;
RX   PubMed=3821741;
RX   PubMed=3930950;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   5-18
AC   CVCL_B3YJ
DR   Wikidata; Q110429790
RX   PubMed=8630061;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20062; Human TCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   5-2
AC   CVCL_W172
SY   GMI-M5-2
DR   Wikidata; Q54603662
RX   Patent=US6673605;
RX   PubMed=11054807;
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6J(H-2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1W
CA   Factor-dependent cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   5-21-3
AC   CVCL_C1G4
DR   Wikidata; Q114310450
RX   Patent=EP0335134B1;
RX   Patent=US20030118985;
RX   PubMed=1694451;
RX   PubMed=1694452;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9628.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   5-27
AC   CVCL_C3WR
DR   ABCD; ABCD_AE164
DR   Wikidata; Q116048260
RX   PubMed=2104617;
RX   PubMed=3821741;
RX   PubMed=3930950;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   5-5-6
AC   CVCL_B0VW
DR   Wikidata; Q108819673
RX   Patent=US9676843;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2923.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   5-8F
AC   CVCL_C528
SY   58F; SUNE-1-5-8F
DR   BTO; BTO_0006010
DR   EFO; EFO_0022677
DR   cancercelllines; CVCL_C528
DR   Cosmic; 1322951
DR   Cosmic; 1459415
DR   GEO; GSM375842
DR   Progenetix; CVCL_C528
DR   Wikidata; Q54603663
RX   CelloPub=CLPUB00484;
RX   PubMed=12485491;
RX   PubMed=21122407;
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of the STR profile (PubMed=26116706) it seems to be a hybrid of HeLa and of cell line of unknown origin. Originally thought to originate from SUNE1 which has also been shown to be contaminated.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00596.
CC   Doubling time: 26.63 hours (PubMed=21122407).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1490; CAPZA2 + HGNC; HGNC:7029; MET; Name(s)=CAPZA2-MET (CelloPub=CLPUB00484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 12,13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 11,14,18
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 8,9,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6946 ! SUNE1
CA   Hybrid cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 21
//
ID   5-8F/Erbitux
AC   CVCL_S665
SY   5-8F-Erbitux
DR   Cosmic; 1459416
DR   Wikidata; Q54603664
RX   PubMed=21122407;
CC   Problematic cell line: Contaminated. Parent cell line (5-8F) has been shown to be an hybrid of HeLa and a cell line of unknown origin.
CC   Doubling time: 142.30 hours (PubMed=21122407).
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1490; CAPZA2 + HGNC; HGNC:7029; MET; Name(s)=CAPZA2-MET (from parent cell line).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C528 ! 5-8F
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 16
//
ID   5/9 m a3-18
AC   CVCL_6358
SY   5/9 M alpha 3-18; 5/9 ma3-18 (0.2); CHO 5/9 M alpha3-18; CHO-3ACSF-69
DR   CLO; CLO_0001403
DR   ATCC; CRL-10154
DR   BCRC; 60185
DR   Wikidata; Q54603667
RX   Patent=US4868119;
RX   Patent=US5573763;
RX   PubMed=3493529;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10154.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2432; CSF1.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   5.2
AC   CVCL_E3YZ
DR   ABCD; ABCD_AF727
RX   PubMed=3514459;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04933; Plasmodium falciparum (isolate Wellcome) MSP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   5.54.4.24.1
AC   CVCL_D2Q6
SY   5.54.4
DR   Wikidata; Q127378749
RX   PubMed=1698868;
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   5.88.3
AC   CVCL_C3S8
DR   ABCD; ABCD_AS413
DR   Wikidata; Q116048261
RX   Patent=US10066011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7259.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O15123; Human ANGPT2.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   50 AZA SEL
AC   CVCL_J884
DR   ECACC; 85062505
DR   Wikidata; Q54603668
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_J883 ! GA4
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   50-11-10
AC   CVCL_J888
SY   50.11.10
DR   ECACC; 94020814
DR   Wikidata; Q54603670
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   50-6
AC   CVCL_G694
SY   mAb 50-6
DR   CLO; CLO_0001404
DR   ATCC; CRL-2696
DR   Wikidata; Q54603672
RX   Patent=US6498014;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-227.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 9
//
ID   50-69
AC   CVCL_9V04
DR   Wikidata; Q54603674
RX   Patent=US5731189;
RX   PubMed=2922401;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: HIV-1 protein gp41.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   500
AC   CVCL_A9NJ
DR   BEI_Resources; ARP-1277
DR   Wikidata; Q108819674
RX   PubMed=6305011;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp80.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   501-EBV
AC   CVCL_A1DM
DR   Wikidata; Q102113455
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=9670966;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02:01,24 (PubMed=9670966).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4633 ! 501-mel
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   501-mel
AC   CVCL_4633
AS   CVCL_C608
SY   501-MEL; 501 mel; 501 Mel; 501Mel; 501mel; 501MEL; 501; Mel 501; Mel501; MEL501; Me 501; Me-501; Me501
DR   BTO; BTO_0002956
DR   cancercelllines; CVCL_4633
DR   CGH-DB; 9296-4
DR   Cosmic; 686481
DR   Cosmic; 876680
DR   Cosmic; 905210
DR   Cosmic; 1197392
DR   Cosmic; 1238106
DR   Cosmic; 1458962
DR   Cosmic; 1559440
DR   Cosmic; 2159451
DR   Cosmic; 2163827
DR   Cosmic; 2440478
DR   ESTDAB; ESTDAB-120
DR   GEO; GSM188239
DR   GEO; GSM188269
DR   GEO; GSM188328
DR   GEO; GSM433918
DR   GEO; GSM555120
DR   GEO; GSM555174
DR   IGRhCellID; 501Mel
DR   Progenetix; CVCL_4633
DR   Wikidata; Q54603677
RX   PubMed=8027550;
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=15467732;
RX   PubMed=15592718;
RX   PubMed=20149136;
RX   PubMed=21343389;
RX   PubMed=23671654;
RX   PubMed=23851445;
RX   PubMed=25950383;
RX   PubMed=25960936;
RX   PubMed=30674989;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02; DPB1*04:01,02:01:02; DQB1*06:03,05:01; DRB1*11:01:01,04:01:01 (PubMed=15592718).
CC   HLA typing: A*02:01,24:02; B*18:01,35:08; C*04:04,07:01 (PubMed=25960936).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Arg (c.1405G>A); ClinVar=VCV000177775; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-120
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DM ! 501-EBV
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   501.1
AC   CVCL_0I04
DR   Wikidata; Q54603679
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4569.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   501T
AC   CVCL_F0T6
RX   PubMed=1255758;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   504-D
AC   CVCL_F0AP
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   505-05-01
AC   CVCL_E059
DR   CLO; CLO_0050202
DR   RCB; RCB0761
DR   Wikidata; Q54603682
RX   PubMed=7050499;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/Ka x C3H/He.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   506-2G10G5
AC   CVCL_B0W5
DR   Wikidata; Q108819675
RX   PubMed=30355437;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A0G3U597; Middle East respiratory syndrome-related coronavirus (isolate KOR/KNIH/002_05_2015) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   50B11
AC   CVCL_M745
DR   GEO; GSE147186
DR   Wikidata; Q54603686
RX   PubMed=17565537;
RX   PubMed=24269872;
RX   PubMed=32636736;
RX   PubMed=33307981;
RX   PubMed=35782611;
CC   Characteristics: Differentiation into neurons with nociceptive properties can be accomplished by using forskolin (PubMed=17565537).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   50B11 clone D4W
AC   CVCL_C1LC
DR   Wikidata; Q114310451
RX   PubMed=35782611;
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1589721; Gla.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M745 ! 50B11
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   50B11 clone E4
AC   CVCL_C1LD
DR   Wikidata; Q114310452
RX   PubMed=35782611;
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1589721; Gla.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M745 ! 50B11
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   50D10
AC   CVCL_ZU63
DR   Wikidata; Q98125423
RX   PubMed=32519673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_2955; Azithromycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 4
//
ID   51 BLCL
AC   CVCL_E408
DR   ECACC; 94031609
DR   Wikidata; Q54603688
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   HLA typing: A*02,25; B*13,18; C*06; DQB1*01,02; DRB1*02,07 (ECACC=94031609).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   51.1
AC   CVCL_7240
DR   CLO; CLO_0001405
DR   ATCC; HB-230
DR   Wikidata; Q54603689
RX   PubMed=6197474;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human CD8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   512
AC   CVCL_B6NC
DR   Wikidata; Q111732746
RX   Patent=US10550181;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   513D
AC   CVCL_UM76
SY   513 D
DR   Wikidata; Q93307650
RX   PubMed=3402430;
RX   PubMed=10070891;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM86 ! 513E
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   513E
AC   CVCL_UM86
SY   513 E
DR   Wikidata; Q93307652
RX   PubMed=3402430;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM76 ! 513D
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   514
AC   CVCL_J926
DR   CLO; CLO_0001406
DR   ATCC; CRL-1914
DR   Wikidata; Q54603690
RX   PubMed=6305011;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp70.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   5175
AC   CVCL_EQ44
DR   GEO; GSM666034
DR   GEO; GSM666035
DR   Wikidata; Q54603691
RX   PubMed=22033105;
CC   Sequence variation: Mutation; HGNC; HGNC:7714; NDUFS7; Simple; p.Val122Met (c.364G>A); ClinVar=VCV000007681; Zygosity=Homozygous (PubMed=22033105).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   517F1
AC   CVCL_B0FY
DR   Wikidata; Q108819676
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4502.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   518A1
AC   CVCL_UM89
SY   518 A1
DR   Wikidata; Q93307663
RX   PubMed=3402430;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM77 ! 518A2
OI   CVCL_UM90 ! 518B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   518A2
AC   CVCL_UM77
SY   518.A2
DR   cancercelllines; CVCL_UM77
DR   ChEMBL-Cells; CHEMBL4483167
DR   ChEMBL-Targets; CHEMBL4483222
DR   Cosmic; 1418466
DR   GEO; GSM1507935
DR   IARC_TP53; 10952
DR   PubChem_Cell_line; CVCL_UM77
DR   Wikidata; Q93307666
RX   PubMed=10070891;
RX   PubMed=25502142;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Unspecified (PubMed=10070891).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM89 ! 518A1
OI   CVCL_UM90 ! 518B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   518B
AC   CVCL_UM90
SY   518 B
DR   Wikidata; Q93307668
RX   PubMed=3402430;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM89 ! 518A1
OI   CVCL_UM77 ! 518A2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   51B
AC   CVCL_D232
DR   Wikidata; Q54603694
RX   PubMed=3028609;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   51B LiM-1
AC   CVCL_D233
DR   Wikidata; Q54603697
RX   PubMed=3028609;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D232 ! 51B
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   51B LiM-2
AC   CVCL_D234
DR   Wikidata; Q54603699
RX   PubMed=3028609;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D233 ! 51B LiM-1
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   51B LiM-3
AC   CVCL_D235
DR   Wikidata; Q54603701
RX   PubMed=3028609;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D234 ! 51B LiM-2
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   51B LiM-4
AC   CVCL_D236
DR   Wikidata; Q54603703
RX   PubMed=3028609;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D235 ! 51B LiM-3
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   51B LiM-5
AC   CVCL_D237
SY   51B LiM 5; 51BLiM5
DR   Wikidata; Q54603707
RX   PubMed=3028609;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D236 ! 51B LiM-4
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   51B LiM-6
AC   CVCL_D238
SY   51B LiM 6; 51BLiM6
DR   Wikidata; Q54603708
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D237 ! 51B LiM-5
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   51A8
AC   CVCL_E4SB
RX   PubMed=27419852;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_62485; Blood group A antigen type 1 (Alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc) (Note=Also reacts with Blood group A antigen type 2 and 3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   51B8
AC   CVCL_B5Z6
DR   Wikidata; Q111732747
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   51FSDNC18
AC   CVCL_RH71
SY   DOXTOX3 hiPSC
DR   SKIP; SKIP001183
DR   Wikidata; Q54603710
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   52
AC   CVCL_J927
SY   Anti PDGF hybridoma #52
DR   CLO; CLO_0001407
DR   ATCC; HB-9361
DR   Wikidata; Q54603711
RX   Patent=US5175255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9361.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01127; Human PDGFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   52.3
AC   CVCL_C4TP
SY   Clone 52.3
DR   Wikidata; Q116048263
RX   PubMed=6233013;
CC   Characteristics: Recognizes the terpolymer Glu60-Ala30-Tyr10, known as GAT.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4TL ! BDF1/52
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   52-1H4
AC   CVCL_F0A2
DR   ABCD; ABCD_AW196
RX   PubMed=33290148;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9QX05; Rat Tlr4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   52-3D
AC   CVCL_K117
DR   ECACC; 91121235
DR   Wikidata; Q54603713
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   52-581-SC258
AC   CVCL_F1Z8
SY   SC258
RX   PubMed=7690418;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with BH10, MN and RF isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   52-684-238
AC   CVCL_F1Z9
SY   684-238
RX   PubMed=7690418;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   52-S
AC   CVCL_J597
SY   52S
DR   CLO; CLO_0001410
DR   ATCC; HB-8181
DR   IZSLER; BS Hy 50
DR   Wikidata; Q54603714
RX   Patent=US4572896;
RX   PubMed=6277788;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8181.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06477; Human herpesvirus 1 (HHV-1) glycoprotein H (gH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   520C9
AC   CVCL_G612
SY   520C9.C3B10T; 520 C9
DR   CLO; CLO_0001408
DR   ATCC; HB-8696
DR   Wikidata; Q54603715
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US5169774;
RX   PubMed=1715033;
RX   PubMed=2470501;
WW   Info; -; -; https://www.law.uh.edu/faculty/gvetter3/fcplc/CaseFiles/2004/PDF/Chiron%20Corp.%20v.%20Genentech,%20Inc.,%2003-1158%20(Fed.%20Cir.%20Mar.%2030,%202004).pdf
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8696.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   5210-87-13
AC   CVCL_A0GZ
DR   Wikidata; Q108819677
RX   PubMed=31544853;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9UH17; Human APOBEC3B (Note=Also partially reacts with APOBEC3A and APOBEC3G).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z068 ! 240E-W
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   522-2666
AC   CVCL_RL74
DR   Wikidata; Q54603717
RX   PubMed=29274549;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~200] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=29274549).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   525A5
AC   CVCL_C2W4
DR   Wikidata; Q114310454
RX   PubMed=6270685;
RX   PubMed=6830241;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 5
//
ID   526-mel
AC   CVCL_8051
SY   526-MEL; 526 mel; 526mel; 526MEL; 526; MEL-526; Mel526; MEL526
DR   cancercelllines; CVCL_8051
DR   CGH-DB; 9297-4
DR   Cosmic; 905211
DR   Cosmic; 1303043
DR   GEO; GSM206440
DR   GEO; GSM218052
DR   Progenetix; CVCL_8051
DR   Wikidata; Q54603719
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=8537970;
RX   PubMed=9598804;
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=15467732;
RX   PubMed=18172304;
RX   PubMed=21857157;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02:01,03; B*50,62; C*03 (PubMed=9670966).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Unspecified (PubMed=9598804).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Misspelling: 527MEL; GEO=GSM206440.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 15
ST   D12S391: 17,20
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 14
ST   D1S1656: 17.3,18.3
ST   D21S11: 29,31.2
ST   D22S1045: 11,16
ST   D2S1338: 19,24
ST   D2S441: 11,14
ST   D3S1358: 15,19
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 16,18
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   528 [Human melanoma]
AC   CVCL_UM85
DR   Wikidata; Q93307733
RX   PubMed=3402430;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   528 [Mouse hybridoma against human EGFR]
AC   CVCL_J596
DR   CLO; CLO_0001409
DR   ATCC; HB-8509
DR   Wikidata; Q54603720
RX   Patent=US4943533;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8509.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   529SU
AC   CVCL_IZ07
DR   FlyBase_Cell_line; FBtc9000010
DR   Wikidata; Q54603722
RX   PubMed=11756545;
CC   Group: Insect cell line.
CC   Characteristics: Stably transfected with expression vectors for FLAG-tagged Smt3 and HA-tagged Ubc9 (lwr), both under the control of the Cu2+ inducible metallothionein promoter.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0010602; lwr.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0264922; Smt3.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   52M51
AC   CVCL_C3X1
DR   ABCD; ABCD_AF832
DR   Wikidata; Q116048264
RX   Patent=US8435513;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9405.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized brontictuzumab (OMP-52M51; 52M51H4L3) therapeutic antibody which was used in clinical trials for the treatment of lymphoid malignancies.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P46531; Human NOTCH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   52R43
AC   CVCL_C3X2
DR   Wikidata; Q116048265
RX   Patent=US8435513;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9548.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P46531; Human NOTCH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   53-1
AC   CVCL_D2QG
DR   Wikidata; Q127378750
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   53-569
AC   CVCL_DC78
DR   Wikidata; Q54603723
RX   Patent=EP0008092B1;
RX   PubMed=6153172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8010.
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   53-6.72
AC   CVCL_9162
SY   53-6.7
DR   CLO; CLO_0001411
DR   ATCC; TIB-105
DR   BCRC; 60319
DR   BCRJ; 0023
DR   Wikidata; Q54603820
RX   PubMed=398327;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   53-7.313
AC   CVCL_9163
SY   53-7.3
DR   CLO; CLO_0001412
DR   ATCC; TIB-104
DR   BCRJ; 0025
DR   Wikidata; Q54603823
RX   PubMed=398327;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13379; Mouse Cd5.
CC   Discontinued: BCRJ; 0025; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 12
//
ID   53-S
AC   CVCL_J598
SY   53S
DR   CLO; CLO_0001413
DR   ATCC; HB-8182
DR   Wikidata; Q54603826
RX   Patent=US4572896;
RX   PubMed=6277788;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8182.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06477; Human herpesvirus 1 (HHV-1) glycoprotein H (gH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   530
AC   CVCL_W282
DR   Wikidata; Q54603828
RX   PubMed=1918136;
RX   PubMed=2060184;
RX   PubMed=3402430;
RX   PubMed=10070891;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   530C8
AC   CVCL_B0FZ
DR   Wikidata; Q108819678
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4728.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   533 OOS
AC   CVCL_B7UZ
DR   Wikidata; Q112926993
RX   Patent=RU2650759;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 742D.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   534F8
AC   CVCL_C2W5
DR   Wikidata; Q114310455
RX   PubMed=6270685;
RX   PubMed=6830241;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 5
//
ID   534G9
AC   CVCL_B0G0
DR   Wikidata; Q108819679
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4729.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   535F7
AC   CVCL_B0G1
DR   Wikidata; Q108819681
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4510.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   537-B1-1
AC   CVCL_K118
DR   ECACC; 93102701
DR   Wikidata; Q54603829
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Sheep antigen on lymphocytes/endothelium.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   537-D
AC   CVCL_F0AK
SY   537-10D
DR   ABCD; ABCD_BF029
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   537-EBV
AC   CVCL_WL47
DR   Wikidata; Q93307767
RX   PubMed=8027550;
RX   PubMed=8081556;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8052 ! 537-mel
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   537-mel
AC   CVCL_8052
SY   537-MEL; 537 mel; 537 MEL; 537mel; 537MEL; 537; Mel537
DR   EFO; EFO_0006357
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471452
DR   CGH-DB; 9298-4
DR   Cosmic; 876685
DR   Cosmic; 905212
DR   Cosmic; 1507618
DR   Cosmic; 2233664
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM274694
DR   PharmacoDB; 537MEL_19_2019
DR   Wikidata; Q54603831
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=15467732;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=36139163;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,26 (PubMed=9670966).
CC   HLA typing: A*01:01,26:01; B*15:32,44:02; C*01:02,05:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:8598; PANK1; Zygosity=Homozygous (PubMed=36139163).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 11,15
ST   D21S11: 29,31.2
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 7,17
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL47 ! 537-EBV
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   538-MG-BA
AC   CVCL_LM82
DR   DSMZ; ACC-805
DR   DSMZCellDive; ACC-805
DR   Wikidata; Q54603833
RX   PubMed=30509096;
CC   Doubling time: 28 hours (PubMed=30509096); ~30-35 hours (DSMZ=ACC-805).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): DSMZ=ACC-805
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 17,18
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 12,21
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   538F12
AC   CVCL_C2W6
DR   Wikidata; Q114310456
RX   PubMed=6270685;
RX   PubMed=6830241;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 5
//
ID   53B3
AC   CVCL_J061
DR   ECACC; 85062501
DR   Wikidata; Q54603835
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   53Bp1-/- MEF
AC   CVCL_UJ19
SY   53Bp1-/-
DR   ATCC; CRL-3257
DR   Wikidata; Q93307782
RX   PubMed=20362325;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1351320; Trp53bp1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   53D11
AC   CVCL_C6JD
DR   Wikidata; Q116048266
RX   PubMed=19293534;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00592; Human PODXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   53FC3
AC   CVCL_E8VV
RX   PubMed=2246269;
RX   PubMed=6323023;
RX   PubMed=7188254;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P28494; Rat Man2a1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   54-11-10
AC   CVCL_KR94
DR   DSHB; 54-11-10
DR   Wikidata; Q54603837
RX   PubMed=2914932;
WW   Provider; DSHB; -; https://web.archive.org/web/20170703150116/http://dshb.biology.uiowa.edu/Hisactophilin-Dd-gelation-factor
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13231; Dictyostelium discoideum hatA.
CC   Discontinued: DSHB; 54-11-10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   54-12
AC   CVCL_F1J8
SY   Clone 12
RX   PubMed=22871573;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (PubMed=22871573).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived bears the contraction (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-2
AC   CVCL_F1J3
SY   Clone 2
RX   PubMed=22871573;
RX   PubMed=29533181;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (PubMed=22871573).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived bears the contraction (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-3
AC   CVCL_F1JC
SY   Clone 3
RX   PubMed=22871573;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived were normal (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-6
AC   CVCL_F1JD
SY   Clone 6
RX   PubMed=22871573;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived were normal (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-A1
AC   CVCL_F1JE
SY   Clone A1
RX   PubMed=22871573;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived were normal (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-A10
AC   CVCL_F1JG
SY   Clone A10
RX   PubMed=22871573;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived were normal (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-A11
AC   CVCL_F1JB
SY   Clone A11
RX   PubMed=22871573;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (PubMed=22871573).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived bears the contraction (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-A2
AC   CVCL_F1J9
SY   Clone A2
RX   PubMed=22871573;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (PubMed=22871573).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived bears the contraction (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-A4
AC   CVCL_F1JF
SY   Clone A4
RX   PubMed=22871573;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived were normal (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JA ! 54-A5
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   54-A5
AC   CVCL_F1JA
SY   Clone A5
RX   PubMed=22871573;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (PubMed=22871573).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The cells from which this cell line was derived bears the contraction (PubMed=22871573).
CC   Derived from site: In situ; Muscle, biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1J3 ! 54-2
OI   CVCL_F1JC ! 54-3
OI   CVCL_F1JD ! 54-6
OI   CVCL_F1J8 ! 54-12
OI   CVCL_F1JE ! 54-A1
OI   CVCL_F1J9 ! 54-A2
OI   CVCL_F1JF ! 54-A4
OI   CVCL_F1JG ! 54-A10
OI   CVCL_F1JB ! 54-A11
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   547A1
AC   CVCL_B0G2
DR   Wikidata; Q108819682
RX   Patent=US10161930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4506.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   548
AC   CVCL_K119
DR   CLO; CLO_0001414
DR   ATCC; CRL-1890
DR   Wikidata; Q54603838
RX   PubMed=6305011;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein p12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   54B3
AC   CVCL_J062
DR   ECACC; 93071512
DR   Wikidata; Q54603839
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   54BR
AC   CVCL_WY85
SY   54 BRighton
DR   Wikidata; Q93307797
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=2903889;
RX   PubMed=6307543;
RX   PubMed=6459055;
RX   PubMed=7067035;
RX   PubMed=11219864;
CC   Doubling time: 45.9 hours (PubMed=6459055).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   54N
AC   CVCL_C7S4
DR   Wikidata; Q123030298
RX   PubMed=1066320;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7S5 ! 54T [Human osteosarcoma]
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   54SCC2
AC   CVCL_4091
DR   ECACC; 08062560
DR   Wikidata; Q54603840
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1970 ! C6-BU-1
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   54SCC3
AC   CVCL_4092
DR   ECACC; 08062561
DR   Wikidata; Q54603842
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1970 ! C6-BU-1
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   54SCC7
AC   CVCL_4093
DR   ECACC; 08062518
DR   Wikidata; Q54603843
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1970 ! C6-BU-1
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   54T [Human lung carcinoma]
AC   CVCL_A2AM
DR   Wikidata; Q105505949
RX   PubMed=11929836;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   54T [Human osteosarcoma]
AC   CVCL_C7S5
DR   Wikidata; Q123030299
RX   PubMed=1066320;
CC   Derived from site: Metastatic; Popliteal fossa; UBERON=UBERON_0013069.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7S4 ! 54N
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   55-100
AC   CVCL_0E86
DR   ATCC; CRL-2157
DR   Wikidata; Q54603845
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp120.
CC   Discontinued: ATCC; CRL-2157; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   55-2
AC   CVCL_G613
DR   CLO; CLO_0001415
DR   ATCC; CRL-2155
DR   Wikidata; Q54603846
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp120.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   55-2F12
AC   CVCL_A9NI
SY   55-2F
DR   BEI_Resources; ARP-1547
DR   Wikidata; Q108819683
RX   PubMed=1383547;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05894; Simian immunodeficiency virus (isolate Mm142-83) (SIV-mac) gag (Note=AA 136-364 = p24).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   55-36
AC   CVCL_G614
DR   CLO; CLO_0001416
DR   ATCC; CRL-2153
DR   Wikidata; Q54603847
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 protein gp120.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   55-6
AC   CVCL_G615
DR   CLO; CLO_0001417
DR   ATCC; CRL-2156
DR   ECACC; 97040308
DR   Wikidata; Q54603848
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: HIV-1 protein gp120.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   55-83
AC   CVCL_G616
DR   CLO; CLO_0001418
DR   ATCC; CRL-2185
DR   Wikidata; Q54603850
RX   PubMed=7590785;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: HIV-1 protein gp120.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   551-iPS8
AC   CVCL_C248
SY   551-IPS8
DR   Wikidata; Q54603853
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2434 ! Detroit 551
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   553-mel
AC   CVCL_8053
SY   553-MEL; 553 mel; 553mel; 553
DR   Wikidata; Q54603854
RX   PubMed=8027550;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,23 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   553B-mel
AC   CVCL_W285
SY   553B mel; 553Bmel
DR   EFO; EFO_0022443
DR   cancercelllines; CVCL_W285
DR   CGH-DB; 9299-4
DR   Cosmic; 905213
DR   Wikidata; Q54603857
RX   PubMed=10048982;
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   5555
AC   CVCL_E9CJ
RX   DOI=10.4161/intv.24790;
RX   PubMed=25873177;
RX   PubMed=26414886;
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=25873177).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Breed/subspecies: C57BL/6 BRAF+/LSL-BRAFV600E;Tyr::CreERT2+/o transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5555-EKAREV-NLS
AC   CVCL_E9CK
RX   PubMed=25873177;
RX   PubMed=26414886;
CC   Characteristics: Carries the FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from Cdc25, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=25873177).
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=25873177).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Breed/subspecies: C57BL/6 BRAF+/LSL-BRAFV600E;Tyr::CreERT2+/o transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E9CJ ! 5555
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   558-D100,10,1
AC   CVCL_8941
SY   558-D 100, 10, 1; 558-D
DR   CLO; CLO_0001419
DR   ATCC; HB-10894
DR   Wikidata; Q54603858
RX   Patent=US6241986;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10894.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: HIV-1 protein gp120.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: 588D; Patent=US6241986.
CC   Misspelling: 588-D100,10,1; Patent=US6241986.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 8
//
ID   559/64-D100,10,1
AC   CVCL_8942
SY   559/64-D 100, 10, 1; 559/64-D
DR   CLO; CLO_0001420
DR   ATCC; HB-10893
DR   Wikidata; Q54603860
RX   Patent=US6241986;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10893.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: HIV-1 protein gp120.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 8
//
ID   55B3
AC   CVCL_C2EU
DR   Wikidata; Q114310458
RX   PubMed=2454657;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P48679; Rat Lmna.
CC   Monoclonal antibody target: Rat lamin B (Note=Uncertain if it recognized both Lmnb1 and Lmnb2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   55E7-79
AC   CVCL_B4JZ
DR   Wikidata; Q110429791
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11363.
CC   Monoclonal antibody isotype: IgG1+IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   56-396-5
AC   CVCL_YB00
DR   DSHB; 56-396-5
DR   Wikidata; Q93307826
RX   PubMed=2945827;
RX   PubMed=16453592;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08799; Dictyostelium discoideum mhcA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   56/10 A1
AC   CVCL_F758
DR   Wikidata; Q54603861
RX   PubMed=1662315;
CC   Doubling time: 30 hours (PubMed=1662315).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, glomerular visceral epithelium; UBERON=UBERON_0005751.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   56.4H7
AC   CVCL_D3TY
SY   4H7
DR   DSHB; 56.4H7
DR   Wikidata; Q127378751
RX   PubMed=9811589;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O93468; Chicken RHOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   5637
AC   CVCL_0126
DR   BTO; BTO_0003137
DR   CLO; CLO_0001421
DR   CLO; CLO_0050845
DR   EFO; EFO_0002096
DR   MCCL; MCC:0000018
DR   CLDB; cl1
DR   CLDB; cl105
DR   CLDB; cl7118
DR   AddexBio; C0002001/8
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-9
DR   BCRC; 60061
DR   BCRJ; 0026
DR   BioGRID_ORCS_Cell_line; 316
DR   BioSample; SAMN01821610
DR   BioSample; SAMN03472760
DR   BioSample; SAMN03473359
DR   BioSample; SAMN10987658
DR   cancercelllines; CVCL_0126
DR   CCRID; 1101HUM-PUMC000242
DR   CCRID; 3101HUMTCHu01
DR   CCRID; 3101HUMTCHu1
DR   Cell_Model_Passport; SIDM00807
DR   ChEMBL-Cells; CHEMBL3308352
DR   ChEMBL-Targets; CHEMBL612565
DR   CLS; 300105
DR   Cosmic; 687452
DR   Cosmic; 715695
DR   Cosmic; 760484
DR   Cosmic; 845565
DR   Cosmic; 846281
DR   Cosmic; 928819
DR   Cosmic; 943732
DR   Cosmic; 1016892
DR   Cosmic; 1046675
DR   Cosmic; 1093983
DR   Cosmic; 1285103
DR   Cosmic; 1285998
DR   Cosmic; 1927307
DR   Cosmic; 2050427
DR   Cosmic; 2057434
DR   Cosmic; 2301520
DR   Cosmic; 2444227
DR   Cosmic; 2685930
DR   Cosmic; 2700995
DR   Cosmic-CLP; 687452
DR   DepMap; ACH-000905
DR   DSMZ; ACC-35
DR   DSMZCellDive; ACC-35
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10418-106C4
DR   GDSC; 687452
DR   GEO; GSM136228
DR   GEO; GSM142303
DR   GEO; GSM142309
DR   GEO; GSM886840
DR   GEO; GSM887903
DR   GEO; GSM1374370
DR   GEO; GSM1574578
DR   GEO; GSM1669563
DR   IARC_TP53; 3717
DR   ICLC; HTL01017
DR   IGRhCellID; 5637
DR   KCLB; 30009
DR   LiGeA; CCLE_867
DR   LINCS_HMS; 50001
DR   LINCS_LDP; LCL-1702
DR   NCBI_Iran; C450
DR   PharmacoDB; 5637_20_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0126
DR   PubChem_Cell_line; CVCL_0126
DR   RCB; RCB1191
DR   RCB; RCB3676
DR   SKY/M-FISH/CGH; 17
DR   TKG; TKG 0605
DR   Ubigene; YC-C102
DR   Wikidata; Q54603866
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=7459858;
RX   PubMed=7787250;
RX   PubMed=8873383;
RX   PubMed=9850064;
RX   PubMed=11416159;
RX   PubMed=11921286;
RX   PubMed=12127398;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=17254797;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=24459064;
RX   PubMed=25997541;
RX   PubMed=26055179;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=5637
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/5/cell-lines-detail-354.html
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Doubling time: 23 hours (PubMed=26055179); ~24 hours (DSMZ=ACC-35).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (ATCC=HTB-9; Cosmic-CLP=687452; DepMap=ACH-000905).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (PubMed=27270441; Cosmic-CLP=687452; DepMap=ACH-000905).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (PubMed=7787250; PubMed=9850064; Cosmic-CLP=687452; DepMap=ACH-000905).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=30.56%; Native American=0.45%; East Asian, North=11.48%; East Asian, South=40.31%; South Asian=0.35%; European, North=4.97%; European, South=11.89% (PubMed=30894373).
CC   Misspelling: HTB9; Note=Based on the ATCC catalog number.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=HTB-9; CCRID; CLS=300105; Cosmic-CLP=687452; DSMZ=ACC-35; KCLB=30009; PubMed=11416159; PubMed=17254797; PubMed=27270441; RCB=RCB1191; TKG=TKG 0605
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 20
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16,18
ST   D19S433: 13,15
ST   D1S1656: 15
ST   D21S11: 36
ST   D2S1338: 25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 16,20
ST   D7S820: 10,11
ST   D8S1179: 10,16
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 10,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18 (ATCC=HTB-9; Cosmic-CLP=687452; PubMed=27270441; TKG=TKG 0605)
ST   vWA: 18 (CCRID; CLS=300105; DSMZ=ACC-35; KCLB=30009; PubMed=11416159; PubMed=17254797; RCB=RCB1191)
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   5637 subclone 1A6
AC   CVCL_6344
SY   5637 (subclone 1A6); 1A6
DR   CLO; CLO_0001149
DR   ATCC; CRL-2742
DR   cancercelllines; CVCL_6344
DR   Cosmic; 2037945
DR   GEO; GSM136246
DR   GEO; GSM827286
DR   GEO; GSM1374374
DR   LINCS_LDP; LCL-1703
DR   Progenetix; CVCL_6344
DR   Wikidata; Q54582656
RX   Patent=US6114166;
RX   PubMed=20215515;
RX   PubMed=24018021;
RX   PubMed=29732388;
CC   Group: Patented cell line.
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-556.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-2742; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-2742
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   5637rCDDP1000
AC   CVCL_RR13
DR   cancercelllines; CVCL_RR13
DR   Wikidata; Q54603868
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Doubling time: 29.5 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   5637rGEMCI20
AC   CVCL_RR14
DR   cancercelllines; CVCL_RR14
DR   Wikidata; Q54603871
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Doubling time: 41.8 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   56B3
AC   CVCL_6765
SY   56b3
DR   CLO; CLO_0001422
DR   ATCC; CRL-2542
DR   Wikidata; Q54603873
RX   Patent=US5625122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11117.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96756; Lck.
CC   Discontinued: ATCC; CRL-2542; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   56FHTE8o-
AC   CVCL_IN61
SY   56FHTE8o(-); 56FHTEo-; 56FHTE-8o-; 56 FHTE
DR   Millipore; SCC154
DR   Wikidata; Q54603874
RX   PubMed=1375758;
RX   PubMed=10498856;
RX   PubMed=15463957;
WW   Info; Dartmouth; -; https://web.archive.org/web/20190126194809/http://www.dartmouth.edu/~cysfib/cell-lines.html
CC   Characteristics: Useful model for the study of epithelial ion transport, secretion and biochemistry (Millipore=SCC154).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Fetal trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
ST   Source(s): Millipore=SCC154
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D18S51: 17
ST   D21S11: 30,34.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 9,11
ST   Penta E: 7
ST   TH01: 6,9
ST   TPOX: 10,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   575A
AC   CVCL_7941
DR   ATCC; HTB-8
DR   Cosmic; 1016885
DR   GEO; GSM136251
DR   GEO; GSM1574575
DR   Wikidata; Q54603875
RX   PubMed=66978;
RX   PubMed=571047;
RX   PubMed=748774;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6935474;
RX   PubMed=16885334;
RX   PubMed=25997541;
RX   PubMed=26621286;
RX   PubMed=27270441;
RX   PubMed=29732388;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 50 hours (PubMed=66978; PubMed=748774).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; HTB-8; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   577MF
AC   CVCL_2290
DR   ECACC; 06011802
DR   Wikidata; Q54603878
RX   PubMed=6169654;
RX   PubMed=7471097;
CC   Derived from site: Metastatic; Forehead; UBERON=UBERON_0008200.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C509 ! 577ML
OI   CVCL_C510 ! 577MR
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   577ML
AC   CVCL_C509
DR   Wikidata; Q54603881
RX   PubMed=7471097;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2290 ! 577MF
OI   CVCL_C510 ! 577MR
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   577MR
AC   CVCL_C510
DR   Wikidata; Q54603882
RX   PubMed=7471097;
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2290 ! 577MF
OI   CVCL_C509 ! 577ML
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   579
AC   CVCL_J595
DR   CLO; CLO_0001423
DR   ATCC; HB-8506
DR   Wikidata; Q54603883
RX   Patent=US4943533;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8506.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   57L9
AC   CVCL_D5HS
DR   Wikidata; Q127378753
RX   PubMed=24483192;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic (PubMed=24483192).
CC   Characteristics: Parent cell line was injected in the portal vein of SCID mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 9 times (PubMed=24483192).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A613 ! HSC-57
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   57L9Luc
AC   CVCL_D5HT
DR   JCRB; JCRB1932
DR   JCRB; NIHS1331
DR   Wikidata; Q127378754
RX   PubMed=24483192;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic (PubMed=24483192).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1331; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1932
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D5S818: 10,14
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5HS ! 57L9
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   58-S
AC   CVCL_J599
SY   58S
DR   CLO; CLO_0001426
DR   ATCC; HB-8183
DR   Wikidata; Q54603886
RX   Patent=US4572896;
RX   PubMed=6277788;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8183.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   58.2C10.3
AC   CVCL_D3VR
SY   58.2C.10.3
DR   ABCD; ABCD_AE265
DR   Wikidata; Q127378756
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltopentaose (ST-IM5)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   5810P
AC   CVCL_WM20
DR   cancercelllines; CVCL_WM20
DR   Cosmic; 852196
DR   Wikidata; Q93307873
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   5821c3
AC   CVCL_YM19
DR   Wikidata; Q93307874
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   583
AC   CVCL_E3Z1
SY   5A3
DR   ABCD; ABCD_AF604
RX   Patent=US10239941;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P81172; Human HAMP (Note=AA 60-84 = Hepcidin-25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   585A1
AC   CVCL_DQ06
SY   HPS0354
DR   GEO; GSM1040279
DR   GEO; GSM1040349
DR   GEO; GSM1489230
DR   GEO; GSM1489447
DR   GEO; GSM2152683
DR   GEO; GSM2152684
DR   GEO; GSM2152685
DR   GEO; GSM2152686
DR   GEO; GSM2152687
DR   GEO; GSM2152688
DR   GEO; GSM2152689
DR   GEO; GSM2152690
DR   GEO; GSM2592208
DR   GEO; GSM2592209
DR   PRIDE; PXD000071
DR   RCB; HPS0354
DR   SKIP; SKIP000858
DR   Wikidata; Q54603888
RX   Patent=US20200407693;
RX   PubMed=22802639;
RX   PubMed=23193063;
RX   PubMed=23210603;
RX   PubMed=24259714;
RX   PubMed=25665923;
RX   PubMed=26189426;
RX   PubMed=27476965;
RX   PubMed=28453617;
RX   PubMed=30735882;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02,52:01; C*07:02,12:02; DRB1*01:01,15:01 (PubMed=30853558).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ07 ! 585B1
OI   CVCL_DQ20 ! 692D2
OI   CVCL_LJ36 ! 692E1
OI   CVCL_DQ21 ! 703A1
OI   CVCL_DQ22 ! 703B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   585A1-B2M-KO
AC   CVCL_C1FM
DR   Wikidata; Q114310459
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ06 ! 585A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   585A1-C7 #3-1
AC   CVCL_C1FZ
SY   585A1-C7-retained #3-1; C7 #3-1
DR   Wikidata; Q114310460
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4933; HLA-C (Note=1 of 2 alleles: C*12:02, leaving C*07:01 intact).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ06 ! 585A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   585A1-C7 #3-3
AC   CVCL_C1G0
SY   585A1-C7-retained #3-3; C7 #3-3
DR   Wikidata; Q114310461
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4933; HLA-C (Note=1 of 2 alleles: C*12:02, leaving C*07:01 intact).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ06 ! 585A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   585B1
AC   CVCL_DQ07
DR   GEO; GSM1040280
DR   GEO; GSM1040350
DR   GEO; GSM1489231
DR   GEO; GSM1489448
DR   SKIP; SKIP000859
DR   Wikidata; Q54603890
RX   PubMed=22802639;
RX   PubMed=23193063;
RX   PubMed=24259714;
RX   PubMed=26189426;
RX   PubMed=27418197;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ06 ! 585A1
OI   CVCL_DQ20 ! 692D2
OI   CVCL_LJ36 ! 692E1
OI   CVCL_DQ21 ! 703A1
OI   CVCL_DQ22 ! 703B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   585B1-868
AC   CVCL_UP50
SY   BTAG 585B1-868; 585B1 BTAG (XY)
DR   GEO; GSM2592205
DR   GEO; GSM2592206
DR   Wikidata; Q93307890
RX   PubMed=26189426;
RX   PubMed=28453617;
RX   PubMed=30237246;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Characteristics: Using TALEN a 2A-tdTomato construct was inserted at the C-terminal end of PRDM1 (BLIMP1) as well as 2A-EGFP construct at the C-terminal end of TFAP2C.
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ07 ! 585B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   586-EBV
AC   CVCL_GR76
SY   586EBV
DR   Wikidata; Q54603892
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=9759882;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z021 ! 586-mel
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   586-mel
AC   CVCL_Z021
SY   586-MEL; 586 MEL; 586 Mel; 586 mel; 586mel; 586
DR   Cosmic; 876700
DR   Wikidata; Q54603893
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=9670966;
RX   PubMed=9759882;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*29,31; B*44,68 (PubMed=8027550).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR76 ! 586-EBV
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   587CT7.3.6.5
AC   CVCL_C4LR
DR   ABCD; ABCD_AV131
DR   Wikidata; Q116048267
RX   Patent=CN104059151A;
RX   PubMed=26954291;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P18827; Human SDC1/CD138.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   587X
AC   CVCL_VK11
DR   cancercelllines; CVCL_VK11
DR   Cosmic; 2727474
DR   Wikidata; Q93307910
RX   PubMed=7704014;
CC   Sequence variation: Mutation; HGNC; HGNC:9175; POLD1; Simple; p.Asp502Asn (c.1504G>A); ClinVar=VCV000414774; Zygosity=Heterozygous; Note=Not somatic (PubMed=7704014).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   >70Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   58967 NRK
AC   CVCL_7241
SY   NRK cell line No. 58967; TR-NRK-P
DR   CLO; CLO_0001424
DR   CLDB; cl107
DR   Wikidata; Q54603988
RX   PubMed=170369;
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   58As1
AC   CVCL_XG63
DR   Wikidata; Q93307924
RX   PubMed=15958054;
RX   PubMed=19010905;
RX   PubMed=22844455;
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic. Strong capability of inducing the formation of ascites.
CC   Characteristics: Parent cell line was injected subcutaneously into BALB/c nude mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 12 times.
CC   Doubling time: 27 hours (PubMed=22844455).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A391 ! HSC-58
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 6
//
ID   58As1mLuc
AC   CVCL_A9K1
SY   58As1Luc
DR   JCRB; NIHS1333
DR   Wikidata; Q102113456
RX   PubMed=19010905;
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1333; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG63 ! 58As1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   58As9
AC   CVCL_XG64
DR   Wikidata; Q93307927
RX   PubMed=15958054;
RX   PubMed=22844455;
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic. Strong capability of inducing the formation of ascites.
CC   Characteristics: Parent cell line was injected subcutaneously into BALB/c nude mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 12 times.
CC   Doubling time: 23 hours (PubMed=22844455).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A391 ! HSC-58
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 6
//
ID   58As9Luc
AC   CVCL_C7UR
DR   Wikidata; Q123030300
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic. Strong capability of inducing the formation of ascites.
CC   Characteristics: Grand-parent cell line was injected subcutaneously into BALB/c nude mice. Cells from metastatic ascitic tumor cells were harvested and re-injected into mice. This process was carried out 12 times.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG64 ! 58As9
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 4
//
ID   58B2C
AC   CVCL_S157
DR   Wikidata; Q54603990
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Doubling time: 3.4 days (DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: OSU 142; VBO=VBO_0017494.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   58CrPM
AC   CVCL_E0Z5
DR   BTO; BTO_0005395
RX   DOI=10.1016/S0168-9452(01)00554-4;
CC   Group: Plant cell line.
OX   NCBI_TaxID=4058; ! Catharanthus roseus (Madagascar periwinkle)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   58D3C9
AC   CVCL_V062
DR   CLO; CLO_0001425
DR   CLDB; cl108
DR   IHW; 11w 8007
DR   Wikidata; Q54603993
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   58F8dc1
AC   CVCL_A7XX
SY   58F8
DR   BEI_Resources; MRA-896
DR   Wikidata; Q107113294
RX   PubMed=7838184;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp / Malaysia) apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   59-3
AC   CVCL_J874
DR   Wikidata; Q54603994
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   59.1G2.2
AC   CVCL_D3VS
SY   59.1.G.2.2
DR   ABCD; ABCD_AE099
DR   Wikidata; Q127378757
RX   PubMed=1698868;
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltopentaose (ST-IM5)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   591 [Human B-cell 12IHW]
AC   CVCL_E451
DR   dbMHC; 48469
DR   ECACC; 94050343
DR   IHW; IHW09230
DR   IPD-IMGT/HLA; 10166
DR   Wikidata; Q54603996
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*11:01,31:01; B*39:01:03,67:01:01; C*07:02; DPB1*05:01 (IPD-IMGT/HLA=10166).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   591 [Human iPSC]
AC   CVCL_B3UX
DR   Wikidata; Q110429792
RX   PubMed=30567931;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   594S
AC   CVCL_E151
SY   594-S; S594
DR   Wikidata; Q54603997
RX   PubMed=194867;
RX   PubMed=12707056;
WW   Provider; NHPRR; 126; https://web.archive.org/web/20240412201913/https://www.nhpreagents.org/Store/ProductID/126
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Misspelling: S594S; Note=In Cellosaurus releases 4 to 25.
CC   Discontinued: NHPRR; Catalog number 126.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Female
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 11
//
ID   594S-1X1055
AC   CVCL_IZ84
DR   Wikidata; Q54603998
RX   PubMed=2303734;
CC   Group: Non-human primate cell line.
CC   Characteristics: Produced by infecting peripheral blood lymphocytes of baboon 1X1055 with the supernatant of cell line 594S (Cellosaurus=CVCL_E151).
CC   Virology: Produces large amounts of Papiine herpesvirus 1.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Misspelling: S394; Note=Occasionally.
CC   Misspelling: S394-1X1055; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   595
AC   CVCL_B3UY
DR   Wikidata; Q110429793
RX   PubMed=30567931;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   597
AC   CVCL_B3UZ
DR   Wikidata; Q110429794
RX   PubMed=30567931;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   598RCC
AC   CVCL_B384
SY   598-RCC
DR   BTO; BTO_0003734
DR   Wikidata; Q54604000
RX   PubMed=17284252;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   59B5
AC   CVCL_N779
DR   ATCC; CRL-11115
DR   Wikidata; Q54604001
RX   Patent=US5625122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11115.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96756; Lck.
CC   Misspelling: 5gb5; Patent=US5625122.
CC   Discontinued: ATCC; CRL-11115; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   59FSDNC3
AC   CVCL_RH65
SY   DOX1 hiPSC
DR   SKIP; SKIP001177
DR   Wikidata; Q54604002
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin but did not experience cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   59M
AC   CVCL_2291
SY   OAW59M; OAW 59M; 59 M
DR   CLO; CLO_0001428
DR   EFO; EFO_0006358
DR   CLDB; cl110
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 498
DR   BioSample; SAMN03472466
DR   BioSample; SAMN10988041
DR   cancercelllines; CVCL_2291
DR   Cell_Model_Passport; SIDM01528
DR   DepMap; ACH-000520
DR   ECACC; 89081802
DR   EGA; EGAS00001000610
DR   GEO; GSM313717
DR   GEO; GSM887904
DR   GEO; GSM1291125
DR   GEO; GSM1374376
DR   IARC_TP53; 28342
DR   LiGeA; CCLE_458
DR   PharmacoDB; 59M_21_2019
DR   PRIDE; PXD003668
DR   Progenetix; CVCL_2291
DR   Wikidata; Q54604004
RX   PubMed=2653399;
RX   PubMed=8795574;
RX   PubMed=15677628;
RX   PubMed=22460905;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (Note=At 6th passage) (PubMed=2653399; PubMed=8795574); 66.24 hours (JWGray panel).
CC   HLA typing: A*03:01,11:01; B*35:01,44:02; C*04:01,05:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Lysfs*49 (c.577_592delCATCTTATCCGAGTGG); Zygosity=Heterozygous (DepMap=ACH-000520).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.2%; Native American=0%; East Asian, North=4.18%; East Asian, South=0%; South Asian=0%; European, North=58.71%; European, South=33.91% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 14,16
ST   D21S11: 31
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 22.2
ST   Penta D: 8
ST   Penta E: 15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   59M13
AC   CVCL_6E55
SY   59m/13
DR   Cosmic; 1609532
DR   Wikidata; Q54604006
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Lysfs*49 (c.577_592delCATCTTATCCGAGTGG); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2291 ! 59M
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   59SCV3
AC   CVCL_QX16
DR   Wikidata; Q54604007
RX   Patent=US10519422;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Gly188Arg (c.562G>A); ClinVar=VCV000143081; Zygosity=Unspecified (from autologous cell lines 59SV3; 59SV4; 59SV9).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX17 ! 59SV3
OI   CVCL_QX18 ! 59SV4
OI   CVCL_QX19 ! 59SV9
OI   CVCL_T837 ! P59M8
OI   CVCL_QX67 ! P59M9
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   59SV3
AC   CVCL_QX17
DR   GEO; GSM1227443
DR   Wikidata; Q54604009
RX   PubMed=24527394;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Gly188Arg (c.562G>A); ClinVar=VCV000143081; Zygosity=Unspecified (PubMed=24527394).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX16 ! 59SCV3
OI   CVCL_QX18 ! 59SV4
OI   CVCL_QX19 ! 59SV9
OI   CVCL_T837 ! P59M8
OI   CVCL_QX67 ! P59M9
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   59SV4
AC   CVCL_QX18
DR   GEO; GSM1227444
DR   Wikidata; Q54604011
RX   Patent=US10519422;
RX   PubMed=24527394;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Gly188Arg (c.562G>A); ClinVar=VCV000143081; Zygosity=Unspecified (PubMed=24527394).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX16 ! 59SCV3
OI   CVCL_QX17 ! 59SV3
OI   CVCL_QX19 ! 59SV9
OI   CVCL_T837 ! P59M8
OI   CVCL_QX67 ! P59M9
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   59SV9
AC   CVCL_QX19
DR   GEO; GSM1227445
DR   GEO; GSM1227446
DR   Wikidata; Q54604012
RX   Patent=US10519422;
RX   PubMed=24527394;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Gly188Arg (c.562G>A); ClinVar=VCV000143081; Zygosity=Unspecified (PubMed=24527394).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX16 ! 59SCV3
OI   CVCL_QX17 ! 59SV3
OI   CVCL_QX18 ! 59SV4
OI   CVCL_T837 ! P59M8
OI   CVCL_QX67 ! P59M9
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   5A
AC   CVCL_C4SQ
DR   Wikidata; Q116048268
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   5A-HS-MYC
AC   CVCL_4586
SY   5A HS MYC
DR   CLO; CLO_0002845
DR   ATCC; CRL-9010
DR   Wikidata; Q54604013
RX   Patent=EP0232845A2;
RX   PubMed=3526329;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9010.
CC   Characteristics: Expression of mouse Myc is under the control of a Drosophila hsp70 promoter. Contains ~2700 copies of the Myc gene (PubMed=3526329).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Caution: ATCC CRL-9010 use DUKX B1 as the name of the cell line which is a misspelling of the parent cell line from Patent=EP0232845A2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   5A1 [Mouse hybridoma against human GLRX3]
AC   CVCL_E7CY
RX   PubMed=27923109;
RX   PubMed=28029331;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O76003; Human GLRX3 (Note=Also reacts with mouse, rat, Chinese hamster, and zebrafish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5A1 [Mouse hybridoma against SARS-CoV-2 spike]
AC   CVCL_A8JM
DR   Wikidata; Q107113295
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   5A1 [Mouse hybridoma against spring viremia of carp M]
AC   CVCL_D6U5
SY   MAb 5A1
RX   PubMed=25897611;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04888; Spring viremia of carp virus M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   5A1 [Rat hybridoma against mouse Csf1]
AC   CVCL_8943
DR   CLO; CLO_0001429
DR   ATCC; CRL-2702
DR   Wikidata; Q54604014
RX   PubMed=2454994;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07141; Mouse Csf1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   5A12 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MM
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5A12 [Mouse hybridoma against ouabain]
AC   CVCL_B0PY
DR   Wikidata; Q108819684
RX   Patent=US7348412;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-813.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   5A2
AC   CVCL_E7D9
RX   PubMed=27705080;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09084; Mouse Pax1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5A2-2-4
AC   CVCL_C5QW
SY   5A2
DR   Wikidata; Q116048269
RX   PubMed=2449607;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5A3 [Mouse hybridoma against C.livia CYC]
AC   CVCL_E6JU
RX   PubMed=8618905;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00021; Columba livia CYC (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5A3 [Mouse hybridoma against chicken IFNK]
AC   CVCL_E1H4
RX   PubMed=34271063;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; H8XX39; Chicken IFNK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   5A3 [Mouse hybridoma against EV71 P2A]
AC   CVCL_E8PT
RX   PubMed=31603742;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B9VUU3; Human enterovirus 71 (EV71) genome polyprotein (Note=AA 863-1012 = Protease 2A. Also reacts with Coxsackievirus A16, Coxsackievirus B3 and Coxsackievirus B6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5A4
AC   CVCL_C8LK
DR   Wikidata; Q123030301
RX   PubMed=36934705;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38639; Spirodiclofen (Envidor).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   5A5 [Mouse hybridoma against glycyrrhizin]
AC   CVCL_B6GP
DR   Wikidata; Q111732748
RX   PubMed=11791545;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A).
CC   Monoclonal antibody target: ChEBI; CHEBI_189708; Glycyrrhetic acid 3-O-glucuronide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   5A5 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA07
DR   Wikidata; Q93308069
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8528.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   5A5 [Mouse/rat hybridoma against human CD14]
AC   CVCL_A8ES
SY   5A5.1
DR   TKG; TKG 0760
DR   Wikidata; Q107113296
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 4
//
ID   5A5 [Rat hybridoma against human CLDN3/CLDN4]
AC   CVCL_C3UJ
DR   Wikidata; Q116048270
RX   PubMed=25118216;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 3
//
ID   5A5-WASP
AC   CVCL_B990
DR   CLO; CLO_0050380
DR   RCB; RCB2740
DR   TKG; TKG 0631
DR   Wikidata; Q54604018
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P42768; Human WAS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   5A6
AC   CVCL_E5K8
RX   PubMed=1695320;
RX   PubMed=2398277;
WW   Provider; Stanford OTL; S97-184; https://stanford.resoluteinnovation.com/technologies/S97-184_monoclonal-antibody-to-human-cd81
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P60033; Human CD81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5A6.E9
AC   CVCL_A0EM
SY   5.A6.E9; Anti-TCRdelta1
DR   Wikidata; Q108819685
RX   Patent=US5024940;
RX   Patent=US6171799;
RX   PubMed=3672118;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9772.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04234; Human CD3D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   5A8 [Mouse hybridoma against glycyrrhizin]
AC   CVCL_B6GQ
DR   Wikidata; Q111732749
RX   PubMed=11791545;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   5A8 [Mouse hybridoma against human GRN]
AC   CVCL_VU21
DR   Wikidata; Q93308080
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5594.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 6
//
ID   5A8.11.6
AC   CVCL_LH41
DR   Wikidata; Q54604021
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6030.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   5A9 [Mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1ZD
RX   PubMed=21076400;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   5A9 [Mouse hybridoma against PEDV nsp13]
AC   CVCL_F0AA
RX   PubMed=33351713;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Porcine epidemic diarrhea virus (strain CH/JX/01/P30) replicase polyprotein 1ab (Note=Recognizes non-structural protein nsp13. Nucleotide entry is KX058033).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   5A9B8
AC   CVCL_XW99
DR   CCRID; 4201PAT-CCTCC01045
DR   Wikidata; Q93308092
RX   Patent=CN106967689B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201751.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07307; Human ASGR2 (Note=Isoform sH2a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 7
//
ID   5B-HS-MYC
AC   CVCL_5A29
DR   Wikidata; Q54604024
RX   Patent=EP0232845A2;
RX   PubMed=3526329;
CC   Characteristics: Expression of mouse Myc is under the control of a Drosophila hsp70 promoter. Contains ~90 copies of the Myc gene (PubMed=3526329).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   5B1
AC   CVCL_VG16
DR   SKIP; SKIP000897
DR   Wikidata; Q54604027
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   5B1-C12
AC   CVCL_C3U7
SY   5B1 C12
DR   Wikidata; Q116048271
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5B11
AC   CVCL_D3F9
DR   CCRID; 4201PAT-CCTCC01909
DR   Wikidata; Q127378758
RX   Patent=CN113817054B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021191.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; G8FRJ7; Porcine rotavirus VP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   5B12
AC   CVCL_E8I2
RX   PubMed=29267148;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9WMX2; Hepatitis C virus genotype 1b (isolate Con1) (HCV) genome polyprotein (Note=AA=1027-1657 = serine protease/helicase NS3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5B14
AC   CVCL_C0BW
DR   Wikidata; Q112926994
RX   PubMed=15314238;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   5B4 [Mouse hybridoma against glycyrrhizin]
AC   CVCL_B6GR
DR   Wikidata; Q111732750
RX   PubMed=11791545;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A).
CC   Monoclonal antibody target: ChEBI; CHEBI_189708; Glycyrrhetic acid 3-O-glucuronide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   5B4 [Mouse hybridoma against human GOLM1]
AC   CVCL_E2ZU
RX   PubMed=27088654;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5B4 [Mouse hybridoma against human GRN]
AC   CVCL_X860
DR   Wikidata; Q54604031
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5260.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   5B5-E6
AC   CVCL_C3U8
DR   Wikidata; Q116048272
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5B6
AC   CVCL_B6GG
DR   Wikidata; Q111732751
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   5B6.3.10
AC   CVCL_J988
DR   Wikidata; Q54604034
RX   Patent=US20080171036;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4298.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   5B7
AC   CVCL_C5GA
DR   Wikidata; Q116048273
RX   PubMed=21707362;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5B7F5
AC   CVCL_YN78
DR   Wikidata; Q93308130
RX   PubMed=23727927;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   5B8
AC   CVCL_B0SW
DR   CCRID; 4201PAT-CCTCC00980
DR   Wikidata; Q108819686
RX   Patent=US11524073;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016202.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13945; Human ADRB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   5B9
AC   CVCL_C5GK
DR   Wikidata; Q116048274
RX   PubMed=24055552;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; E7BLC7; Androctonus crassicauda toxin Acra3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5C
AC   CVCL_C4SR
DR   Wikidata; Q116048275
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   5C1
AC   CVCL_B0XP
DR   Wikidata; Q108819687
RX   PubMed=7586523;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   5C10
AC   CVCL_C4T2
DR   Wikidata; Q116048276
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   5C10/66
AC   CVCL_E3L0
RX   PubMed=2471191;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q25684; Plasmodium chabaudi adami major merozoite surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   5C11 [Mouse hybridoma against aflatoxin B1]
AC   CVCL_C8JY
DR   Wikidata; Q123030303
RX   PubMed=30978883;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   5C11 [Mouse hybridoma against HBsAg]
AC   CVCL_B0T1
DR   Wikidata; Q108819688
RX   Patent=US4870026;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8171.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   5C11 [Mouse hybridoma against phthalate]
AC   CVCL_D5L1
DR   Wikidata; Q127378759
RX   PubMed=6765319;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_26092; Phthalate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   5C12 [Mouse hybridoma against human HMGB1]
AC   CVCL_B4HM
SY   5C12-1-1-1-1
DR   Wikidata; Q110429796
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   5C12 [Mouse hybridoma against human MS4A4A]
AC   CVCL_VD99
DR   Wikidata; Q54604035
RX   PubMed=28303902;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96JQ5; Human MS4A4A/CD20L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   5C12 [Mouse hybridoma against human TYR]
AC   CVCL_C3BU
DR   Wikidata; Q114310464
RX   PubMed=3127479;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14679; Human TYR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   5C2
AC   CVCL_S158
DR   Wikidata; Q54604036
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Doubling time: 5.6 days (DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Hot Creek 71; VBO=VBO_0017492.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   5C2-4
AC   CVCL_E3ZU
RX   PubMed=10438974;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
CC   Monoclonal antibody target: ChEBI; CHEBI_28544; Digitoxin.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   5c3
AC   CVCL_E3ZA
SY   5C3
RX   PubMed=11604110;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02794; Human FTH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   5C3 [Mouse hybridoma against human TPT1]
AC   CVCL_E9DM
RX   PubMed=21466289;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13693; Human TPT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5C3 [Mouse hybridoma against phOX]
AC   CVCL_C4F8
DR   Wikidata; Q116048277
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   5C4-D4
AC   CVCL_E9E9
RX   PubMed=27721406;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P07900; Human HSP90AA1 (Note=Immunized with AA 236-350).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5C5 [Mouse hybridoma against influenza A HA]
AC   CVCL_XA08
DR   Wikidata; Q93308151
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8529.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 5
//
ID   5C5 [Mouse hybridoma against L.donovani gp63]
AC   CVCL_CW39
DR   NCBI_Iran; H145
DR   Wikidata; Q54604037
RX   CelloPub=CLPUB00331;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P23223; Leishmania donovani gp63 (Note=Also reacts with other Leishmania species gp63).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
ID   5C6
AC   CVCL_B6GK
DR   Wikidata; Q111732752
RX   PubMed=11534608;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_34975; Sennoside B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   5C6 Clone 1
AC   CVCL_8828
DR   CLO; CLO_0001430
DR   ATCC; CRL-1969
DR   Wikidata; Q54604039
RX   PubMed=2445894;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   5C6.10.4
AC   CVCL_J929
DR   ATCC; HB-9572
DR   Wikidata; Q54604042
RX   Patent=US5194593;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9572.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   5C6D5
AC   CVCL_YN79
DR   Wikidata; Q93308178
RX   PubMed=23727927;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   5C7 [Mouse hybridoma against PEDV nsp13]
AC   CVCL_F0AB
RX   PubMed=33351713;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Porcine epidemic diarrhea virus (strain CH/JX/01/P30) replicase polyprotein 1ab (Note=Recognizes non-structural protein nsp13. Nucleotide entry is KX058033).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5C7 [Mouse hybridoma against sennoside B]
AC   CVCL_B6GL
DR   Wikidata; Q111732753
RX   PubMed=11534608;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_34975; Sennoside B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   5C7 [Rat hybridoma against rat Chrna4]
AC   CVCL_B6RZ
DR   Wikidata; Q111732754
RX   PubMed=10501468;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P09483; Rat Chrna4 (Note=Recognizes AA 216-227).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   5c8
AC   CVCL_J906
DR   CLO; CLO_0001431
DR   ABCD; ABCD_AA379
DR   ATCC; HB-10916
DR   Wikidata; Q54604044
RX   Patent=US5474771;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10916.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P29965; Human CD40LG/CD154.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   5C8C4
AC   CVCL_C0E7
DR   Wikidata; Q112926995
DR   Ximbio; 153325
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   5C8H5
AC   CVCL_A9KK
DR   CCRID; 4201PAT-CCTCC00504
DR   Wikidata; Q108819689
RX   Patent=CN104327185B;
RX   PubMed=25817256;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014173.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 first 15 residues).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   5C9 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5SE
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5C9 [Mouse hybridoma against pig IgM]
AC   CVCL_4493
SY   5 C 9
DR   CLO; CLO_0001402
DR   CLO; CLO_0001432
DR   CLDB; cl5099
DR   ATCC; HB-8371
DR   IZSLER; BS Hy 38
DR   Wikidata; Q54604046
RX   Patent=US4468346;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8371.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; K7ZJP7; Pig immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   5C9D6E11E6
AC   CVCL_C8KA
DR   Wikidata; Q123030304
RX   PubMed=14969520;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28584; Gossypol.
CC   Monoclonal antibody target: ChEBI; CHEBI_5654; Hemigossypol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   5C9H2
AC   CVCL_E7D0
RX   PubMed=28409695;
RX   PubMed=28430078;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q92847; Human GHSR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5D1 [Mouse hybridoma against chicken TRIM62]
AC   CVCL_E8HU
RX   PubMed=29813003;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A8V0ZA67; Chicken TRIM62.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5D1 [Mouse hybridoma against human ADRB3]
AC   CVCL_B0SX
DR   CCRID; 4201PAT-CCTCC00751
DR   Wikidata; Q108819690
RX   Patent=US11524073;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015146.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13945; Human ADRB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   5D10
AC   CVCL_E8UH
RX   PubMed=32907999;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus mite group 2 allergen Der p 2 (DERP2).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG40 ! HMMA2.5
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5D11 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4T3
DR   Wikidata; Q116048278
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   5D11 [Mouse hybridoma against MTPS]
AC   CVCL_C4D5
DR   ABCD; ABCD_AQ819
DR   Wikidata; Q116048279
RX   PubMed=31243995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   5D11/49
AC   CVCL_VI54
DR   BEI_Resources; MRA-884
DR   Wikidata; Q54604047
RX   PubMed=3045543;
CC   Group: Malaria research cell line.
CC   From: Saul, Allan James; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) rhoptry protein 1 (RhopH1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 6
//
ID   5D12 [Mouse hybridoma against human CD40]
AC   CVCL_J878
DR   ABCD; ABCD_AA961
DR   ATCC; HB-11339
DR   Wikidata; Q54604048
RX   Patent=US5677165;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11339.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   5D12 [Mouse hybridoma against parathion]
AC   CVCL_C5AF
DR   Wikidata; Q116048280
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   5D12 [Rat hybridoma against human CLDN4]
AC   CVCL_C3UK
DR   Wikidata; Q116048281
RX   PubMed=27713828;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5D2M
AC   CVCL_C5R1
DR   Wikidata; Q116048282
RX   PubMed=3079807;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   5D3 [Mouse hybridoma against HBV HBsAg]
AC   CVCL_B0T0
DR   Wikidata; Q108819691
RX   Patent=US4271145;
RX   Patent=US4870026;
RX   PubMed=6940137;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9801.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   5D3 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4T4
DR   Wikidata; Q116048283
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   5D3-1B5
AC   CVCL_C3N2
SY   5D3 1B5
DR   Wikidata; Q116048284
RX   Patent=CN111825763B;
RX   PubMed=33819520;
RX   PubMed=35142127;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   5D4
AC   CVCL_B6TM
DR   Wikidata; Q111732755
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   5D4-11
AC   CVCL_J928
SY   5D4
DR   CLO; CLO_0001433
DR   ATCC; HB-49
DR   Wikidata; Q54604051
RX   PubMed=6285749;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27915; Dengue virus type 3 genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 6
//
ID   5D5.11.6
AC   CVCL_J002
SY   5D5
DR   CLO; CLO_0001434
DR   ABCD; ABCD_AA627
DR   ATCC; HB-11895
DR   Wikidata; Q54604053
RX   Patent=US5646036;
RX   Patent=US5686292;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11895.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   5D5/47
AC   CVCL_VI55
DR   BEI_Resources; MRA-880
DR   Wikidata; Q54604055
RX   PubMed=1574088;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) merozoite surface protein 1 (MSP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   5D6 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BJ
DR   Wikidata; Q116048286
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5D6 [Mouse hybridoma against influenza D HE]
AC   CVCL_B6TN
DR   Wikidata; Q111732756
RX   PubMed=30179314;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   5D6 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5F5
DR   Wikidata; Q116048288
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5D7-D8-F9
AC   CVCL_E2ZF
SY   5D7
RX   PubMed=26492621;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01034; Human CST3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5D9 [Mouse hybridoma against C.livia CYC]
AC   CVCL_E6JV
DR   ABCD; ABCD_AE976
RX   PubMed=8618905;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00021; Columba livia CYC (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5D9 [Mouse hybridoma against C.neoformans non-capsular antigen]
AC   CVCL_B0L1
DR   Wikidata; Q108819692
RX   PubMed=2068741;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Cryptococcus neoformans var. neoformans non-capsular antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   5D9 [Mouse hybridoma against human ADRB3]
AC   CVCL_B0SY
DR   CCRID; 4201PAT-CCTCC00981
DR   Wikidata; Q108819693
RX   Patent=US11524073;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016203.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13945; Human ADRB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   5E08
AC   CVCL_XV60
DR   Wikidata; Q93308239
RX   Patent=CN109750002B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.14723.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O00478; Human BTN3A3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   5E10 [Mouse hybridoma against human 110 kDa glycoprotein]
AC   CVCL_U333
DR   ATCC; CRL-2698
DR   Wikidata; Q54604058
RX   Patent=US6512096;
RX   PubMed=9851244;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-865.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human 110 kDa glycoprotein on prostate cell lines surface.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 8
//
ID   5E10 [Mouse hybridoma against human THY1]
AC   CVCL_KR32
DR   Wikidata; Q54604061
RX   PubMed=7683034;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04216; Human THY1/CD90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   5E10 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5F6
DR   Wikidata; Q116048289
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5E11
AC   CVCL_C3TB
DR   Wikidata; Q116048290
RX   PubMed=9790073;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92934; Human BAD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5E11.1.2
AC   CVCL_B6N1
DR   Wikidata; Q111732757
RX   Patent=US20060073146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1346.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   5E11.E11
AC   CVCL_B7CM
DR   Wikidata; Q112926997
RX   Patent=US7807791;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8903.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   5E12.5
AC   CVCL_B0CQ
SY   5E12.5-A; 5E12
DR   Wikidata; Q108819694
RX   Patent=US7153686;
RX   PubMed=11121071;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-994.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human 125 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   5E2
AC   CVCL_B0X9
DR   Wikidata; Q108819695
RX   PubMed=23342681;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_B0WT ! 1C10 [Mouse/sheep heteromyeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   5E4
AC   CVCL_G617
DR   CLO; CLO_0001435
DR   ATCC; CRL-2635
DR   Wikidata; Q54604063
RX   PubMed=11401970;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   5E6
AC   CVCL_C3TC
DR   Wikidata; Q116048292
RX   PubMed=9790073;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92934; Human BAD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5E6-2E7
AC   CVCL_E5NE
RX   Patent=US9879087;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5E7 [Mouse hybridoma against HIV-2 gp120]
AC   CVCL_F1YT
RX   PubMed=8120399;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12449; HIV-2 isolate SBLISY env (Note=AA 22-503 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   5E7 [Mouse hybridoma against parathion]
AC   CVCL_C5AG
DR   Wikidata; Q116048293
RX   PubMed=16332196;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27928; Parathion.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 4
//
ID   5E8
AC   CVCL_B3R6
DR   Wikidata; Q110429797
RX   Patent=CN105017419B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10586.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q14980; Human NUMA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   5E8.7.4
AC   CVCL_B6N2
DR   Wikidata; Q111732758
RX   Patent=US20060073146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1344.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   5E9 [Mouse hybridoma against GXM]
AC   CVCL_F1XV
RX   PubMed=1583327;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53457; Cryptococcus neoformans glucuronoxylomannan (GXM) (Note=Immunized with C.neoformans serotype A (ATCC 24064)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   5E9 [Mouse hybridoma against human TPT1]
AC   CVCL_E9DN
RX   PubMed=21466289;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13693; Human TPT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5E9 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5F7
DR   Wikidata; Q116048294
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   5E9 TLK-2
AC   CVCL_Y108
DR   BCRC; 60524
DR   Wikidata; Q54604066
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86UE8; Human TLK2.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   5F1
AC   CVCL_B6LH
DR   Wikidata; Q111732759
RX   PubMed=10488532;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P35263; Lake Victoria marburgvirus (strain Popp-67) nucleoprotein (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   5f1-1
AC   CVCL_VA27
DR   Wikidata; Q54604159
RX   PubMed=28508054;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73109; ! Tokudaia osimensis (Ryukyu spiny rat)
OI   CVCL_VA26 ! 4f1-1
OI   CVCL_VA28 ! 5f2-7
OI   CVCL_VA29 ! 5f2-11
OI   CVCL_VA30 ! 5f2-14
OI   CVCL_VA31 ! 5f2-18
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   5F10
AC   CVCL_B6LI
DR   Wikidata; Q111732760
RX   Patent=RU2393219;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06725; Human cytomegalovirus (strain AD169) 65 kDa phosphoprotein (pp65).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   5F11
AC   CVCL_WT46
DR   ABCD; ABCD_AD047
DR   Wikidata; Q93308285
RX   PubMed=12881320;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was developed by Medarex into a therapeutic mAB known as Iratumumab (MDX-060) to be used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28908; Human TNFRSF8/CD30.
CC   Miscellaneous: As the immunized splenic B-cells are from HuMAb mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 5
//
ID   5F11G11
AC   CVCL_E7QK
RX   PubMed=28704165;
RX   PubMed=28806155;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Human BCR/ABL1 out-of-frame fusion protein (Bcr/Abl-OOF).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5F12
AC   CVCL_C0ZB
DR   Wikidata; Q114310465
RX   PubMed=35746813;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F1SPC2; Pig CD69.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   5F12 AD3
AC   CVCL_C552
SY   5 F12 AD 3
DR   CLO; CLO_0001437
DR   ATCC; HB-8209
DR   CCRID; 4201PAT-CCTCC00094
DR   Wikidata; Q54604160
RX   Patent=US4558006;
RX   Patent=US5106760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8209.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01588; Human EPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   5f2-11
AC   CVCL_VA29
DR   Wikidata; Q54604162
RX   PubMed=28508054;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73109; ! Tokudaia osimensis (Ryukyu spiny rat)
OI   CVCL_VA26 ! 4f1-1
OI   CVCL_VA27 ! 5f1-1
OI   CVCL_VA28 ! 5f2-7
OI   CVCL_VA30 ! 5f2-14
OI   CVCL_VA31 ! 5f2-18
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   5f2-14
AC   CVCL_VA30
DR   Wikidata; Q54604163
RX   PubMed=28508054;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73109; ! Tokudaia osimensis (Ryukyu spiny rat)
OI   CVCL_VA26 ! 4f1-1
OI   CVCL_VA27 ! 5f1-1
OI   CVCL_VA28 ! 5f2-7
OI   CVCL_VA29 ! 5f2-11
OI   CVCL_VA31 ! 5f2-18
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   5f2-18
AC   CVCL_VA31
DR   Wikidata; Q54604164
RX   PubMed=28508054;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73109; ! Tokudaia osimensis (Ryukyu spiny rat)
OI   CVCL_VA26 ! 4f1-1
OI   CVCL_VA27 ! 5f1-1
OI   CVCL_VA28 ! 5f2-7
OI   CVCL_VA29 ! 5f2-11
OI   CVCL_VA30 ! 5f2-14
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   5f2-7
AC   CVCL_VA28
DR   Wikidata; Q54604166
RX   PubMed=28508054;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73109; ! Tokudaia osimensis (Ryukyu spiny rat)
OI   CVCL_VA26 ! 4f1-1
OI   CVCL_VA27 ! 5f1-1
OI   CVCL_VA29 ! 5f2-11
OI   CVCL_VA30 ! 5f2-14
OI   CVCL_VA31 ! 5f2-18
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   5F2.6.14
AC   CVCL_LH42
DR   Wikidata; Q54604168
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6031.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   5F2B1
AC   CVCL_B6MD
DR   Wikidata; Q111732761
RX   PubMed=9581524;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8822; Retrorsine (Note=Also recognizes many other pyrrolizidine alkaloids).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   5F2D8
AC   CVCL_E2YW
RX   PubMed=26301926;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q6TVN4; Orf virus (strain Goat/Texas/SA00/2000) core protein 4a (ORFV086).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5F3 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1F8
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   5F3 [Mouse hybridoma against DSGb5]
AC   CVCL_D4C8
DR   Wikidata; Q127378760
RX   PubMed=12084983;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_140624; Disialosyl globopentaosylceramide (DSGb5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   5F3 [Mouse hybridoma against human GALNT2]
AC   CVCL_C5DF
DR   Wikidata; Q116048295
RX   PubMed=22149281;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q10471; Human GALNT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   5F7 [Mouse hybridoma against influenza A HA]
AC   CVCL_C3N3
DR   Wikidata; Q116048296
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   5F7 [Mouse hybridoma against thebaine]
AC   CVCL_B6GH
DR   Wikidata; Q111732762
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   5F7 [Mouse hybridoma against zearalenone]
AC   CVCL_C5NU
DR   Wikidata; Q116048297
RX   PubMed=24465616;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   5F7 [Mouse/sheep hybridoma against C.botulinum botA]
AC   CVCL_B0XA
DR   Wikidata; Q108819696
RX   PubMed=23342681;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_B0WT ! 1C10 [Mouse/sheep heteromyeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   5F8 [Mouse hybridoma against human PTHLH]
AC   CVCL_C4T5
DR   Wikidata; Q116048298
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   5F8 [Mouse hybridoma against S.typhimurium spiC]
AC   CVCL_XJ60
DR   Wikidata; Q93308341
RX   Patent=CN104928257A;
RX   PubMed=26683183;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201563.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0CZ04; Salmonella typhimurium spiC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   5F8 [Mouse hybridoma against suid herpesvirus 1 UL42]
AC   CVCL_C6IB
DR   ABCD; ABCD_AV469
DR   Wikidata; Q116048299
RX   PubMed=26377421;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F6QNH2; Suid herpesvirus 1 (strain JF) DNA polymerase processivity factor (UL42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5F8.B7
AC   CVCL_C4QQ
DR   Wikidata; Q116048300
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00004; Horse CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5F9 [Mouse hybridoma against phOX]
AC   CVCL_C4FN
DR   Wikidata; Q116048301
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 4
//
ID   5F9 [Mouse hybridoma against pig EDN1]
AC   CVCL_F0V6
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   5G1
AC   CVCL_C5F8
DR   Wikidata; Q116048302
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5G10
AC   CVCL_C5QE
DR   Wikidata; Q116048303
RX   PubMed=10995307;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_82644; Ractopamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   5G11 [Mouse hybridoma against phOX]
AC   CVCL_C4F9
DR   ABCD; ABCD_AE296
DR   Wikidata; Q116048304
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   5G11 [Rat hybridoma against human THBS1]
AC   CVCL_C4R2
DR   Wikidata; Q116048305
RX   PubMed=2461742;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07996; Human THBS1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5G11.17.1
AC   CVCL_B0EF
SY   5G11
DR   Wikidata; Q108819697
RX   Patent=US20110002933;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12694.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   5G12
AC   CVCL_C1M4
DR   Wikidata; Q114310467
RX   PubMed=35835158;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; V5XK21; Dabie bandavirus nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 4
//
ID   5G2
AC   CVCL_L105
DR   Wikidata; Q54604170
RX   Patent=US4834975;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8797.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 6.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   5G2-1B3
AC   CVCL_E5NM
RX   Patent=US9879087;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5G3 [Mouse hybridoma against clenbuterol]
AC   CVCL_4494
SY   5g3
DR   CLO; CLO_0001438
DR   CLDB; cl5108
DR   IZSLER; BS Hy 47
DR   Wikidata; Q54604173
RX   DOI=10.1080/09540109609354898;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_174690; Clenbuterol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   5G3 [Mouse hybridoma against human L1CAM]
AC   CVCL_WZ39
DR   Wikidata; Q93308360
RX   PubMed=3136168;
RX   PubMed=3525541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P32004; Human L1CAM/CD171.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   5G5 [Mouse hybridoma against dog CD274]
AC   CVCL_F0H7
RX   Patent=US12252536;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog PDL1/CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5G5 [Mouse hybridoma against H.pylori vacA]
AC   CVCL_G618
DR   CLO; CLO_0001439
DR   ATCC; CRL-2633
DR   Wikidata; Q54604175
RX   PubMed=11401970;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   5G5 [Mouse hybridoma against human TLR9]
AC   CVCL_E5MF
RX   PubMed=12115616;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q9NR96; Human TLR9 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5G5-A4
AC   CVCL_C3U9
DR   Wikidata; Q116048306
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5G6
AC   CVCL_X861
DR   Wikidata; Q54604177
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5595.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 6
//
ID   5G7 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1F9
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   5G7 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BK
DR   Wikidata; Q116048307
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5G7 [Mouse hybridoma against P.olivaceus IgD]
AC   CVCL_XK20
DR   Wikidata; Q93308380
RX   PubMed=28359942;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Paralichthys olivaceus IgD heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   5G7 [Mouse hybridoma against PEDV nsp13]
AC   CVCL_F0AC
RX   PubMed=33351713;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Porcine epidemic diarrhea virus (strain CH/JX/01/P30) replicase polyprotein 1ab (Note=Recognizes non-structural protein nsp13. Nucleotide entry is KX058033).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   5G8
AC   CVCL_E2ZQ
RX   PubMed=26492623;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92876; Human KLK6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5G8.2.2
AC   CVCL_B6N3
DR   Wikidata; Q111732763
RX   Patent=US20060073146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1345.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   5G9A10E3
AC   CVCL_C4BG
DR   ABCD; ABCD_AX029
DR   CCRID; 4201PAT-CCTCC00377
DR   Wikidata; Q116048308
RX   Patent=CN102030825B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201059.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5H1
AC   CVCL_C4T6
DR   Wikidata; Q116048309
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   5H10
AC   CVCL_E2SH
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5H10-2D1
AC   CVCL_C3N4
SY   5H10 2D1
DR   Wikidata; Q116048310
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   5H11 [Mouse hybridoma against C.livia CYC]
AC   CVCL_E6JW
DR   ABCD; ABCD_AE978
RX   PubMed=8618905;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00021; Columba livia CYC (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   5H11 [Mouse hybridoma against human ERBB2]
AC   CVCL_E2SK
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   5H11.H6
AC   CVCL_XX99
SY   5H11.H6(4)
DR   Wikidata; Q93308384
RX   Patent=US7820797;
RX   PubMed=20305658;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_28009; N-acetyl-beta-D-glucosamine (Note=In beta-O-glycosidic linkage to serine and threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   5H12
AC   CVCL_E2ZR
RX   PubMed=26492623;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92876; Human KLK6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5H2
AC   CVCL_C5EN
DR   Wikidata; Q116048311
RX   PubMed=21851235;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14213; Tachypleus tridentatus tachyplesin-1 (TP-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5H2-17
AC   CVCL_C6XQ
DR   ABCD; ABCD_AN728
DR   ABCD; ABCD_AN729
DR   ABCD; ABCD_AN730
DR   Wikidata; Q123030305
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   5H5
AC   CVCL_E2SJ
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5H6 [Mouse bone marrow]
AC   CVCL_K226
DR   Wikidata; Q54604178
RX   PubMed=9495512;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 8
//
ID   5H6 [Mouse hybridoma against human ERBB2]
AC   CVCL_E2SE
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5H7
AC   CVCL_0P39
DR   Kerafast; EP0006
DR   Wikidata; Q54604179
RX   PubMed=20410930;
CC   Characteristics: Is diphtheria toxin (DT) resistant due to transfection with a DT-resistant elongation factor-2 (EEF2) gene.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3214; EEF2 (Note=With p.Gly717Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Kerafast; EP0006; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 17
//
ID   5H8 [Mouse hybridoma against human ERBB2]
AC   CVCL_E2SF
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5H8 [Mouse hybridoma against human POSTN]
AC   CVCL_G619
DR   CLO; CLO_0001440
DR   ATCC; CRL-2646
DR   Wikidata; Q54604181
RX   Patent=US7087727;
RX   PubMed=11550156;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4589.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15063; Human POSTN.
CC   Discontinued: ATCC; CRL-2646; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 5
//
ID   5H8-C12
AC   CVCL_C3UA
SY   5H8 C12; 5H8 C12 D9
DR   Wikidata; Q116048312
RX   PubMed=2442247;
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5H8-D8
AC   CVCL_C3UB
SY   5H8 D8; 5H8 D8 B4
DR   Wikidata; Q116048313
RX   PubMed=2442247;
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   5H9
AC   CVCL_E2SG
RX   PubMed=26090600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   5H9-2F1
AC   CVCL_C3N5
SY   5H9 2F1
DR   Wikidata; Q116048314
RX   PubMed=33819520;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A2K8GIH5; Influenza A virus (strain A/Chicken/Guangdong/GD15/2016 H7N9) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   5HL2
AC   CVCL_Y459
DR   Wikidata; Q54604183
RX   PubMed=2591959;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4599 ! UV5
CA   Hybrid cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 7
//
ID   5HL2-B
AC   CVCL_Y461
SY   5HL2 B; GM10792
DR   CLO; CLO_0023670
DR   Coriell; GM10792
DR   Wikidata; Q54604184
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y459 ! 5HL2
CA   Hybrid cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 9
//
ID   5HL9
AC   CVCL_Y460
DR   Wikidata; Q54604186
RX   PubMed=1967982;
RX   PubMed=2591959;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 19 mapping. Contains a complete copy of chromosome 19.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4599 ! UV5
CA   Hybrid cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 8
//
ID   5HL9-4
AC   CVCL_Y462
SY   GM10449
DR   CLO; CLO_0028515
DR   Coriell; GM10449
DR   Wikidata; Q54604189
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=2591959;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 19 mapping. Contains a complete copy of chromosome 19.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y460 ! 5HL9
CA   Hybrid cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 10
//
ID   5L
AC   CVCL_F951
SY   5-L
DR   Wikidata; Q54604191
RX   PubMed=7085765;
RX   PubMed=16548065;
RX   PubMed=23639626;
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 13
//
ID   5LAC-20
AC   CVCL_LC10
SY   5LAC20
DR   Wikidata; Q54604193
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2694.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   5LAC-23
AC   CVCL_LB93
SY   5LAC23
DR   Wikidata; Q54604194
RX   Patent=US7419792;
RX   Patent=US7420039;
RX   Patent=US7442776;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5690.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   5LBLN
AC   CVCL_3637
DR   CLO; CLO_0001441
DR   ATCC; CRL-6049
DR   Wikidata; Q54604196
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6049; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   5PNF_TDiPSsv_MM_4
AC   CVCL_UN13
DR   Wikidata; Q93308485
RX   PubMed=30713041;
RX   PubMed=30840859;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_5PNF_TDiPSsv_MM_4-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO_5PNF_DiPSsv_MM_4-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Germans Trias i Pujol (IGTP); Barcelona; Spain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=30713041).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Ex16-57del; Zygosity=Heterozygous; Note=Germline (PubMed=30713041).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): BNLC; PubMed=30713041
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   D8S1179: 8,13
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN14 ! 5PNF_TDiPSsv_PM_6
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   5PNF_TDiPSsv_PM_6
AC   CVCL_UN14
DR   Wikidata; Q93308488
RX   PubMed=30713041;
RX   PubMed=30840859;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_5PNF_TDiPSsv_PM_6-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO_5PNF_DiPSsv_PM_6-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Germans Trias i Pujol (IGTP); Barcelona; Spain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=30713041).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Ex16-57del; Zygosity=Heterozygous; Note=Germline (PubMed=30713041).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): BNLC; PubMed=30713041
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   D8S1179: 8,13
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN13 ! 5PNF_TDiPSsv_MM_4
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   5R
AC   CVCL_B6QV
DR   Wikidata; Q111732764
RX   PubMed=2655894;
RX   PubMed=3028610;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   5RP7
AC   CVCL_5490
DR   JCRB; IFO50277
DR   Wikidata; Q54604198
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B6QV ! 5R
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   5S
AC   CVCL_E3Z7
DR   ABCD; ABCD_AH928
RX   PubMed=14597165;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   5T33MMvt
AC   CVCL_G080
SY   5T33MM; 5T33 cell line
DR   EFO; EFO_0006530
DR   Wikidata; Q54604200
RX   PubMed=1457349;
CC   Characteristics: Produces IgG2b kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/KaLwRij.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VI66 ! 5TGM1
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   5TGM1
AC   CVCL_VI66
SY   5T33 cell line
DR   BTO; BTO_0006375
DR   ChEMBL-Cells; CHEMBL4482254
DR   PubChem_Cell_line; CVCL_VI66
DR   Wikidata; Q93308507
RX   PubMed=9177864;
CC   Characteristics: Produces IgG2b kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/KaLwRij.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_G080 ! 5T33MMvt
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   5UD5
AC   CVCL_A6IN
DR   Wikidata; Q107113297
RX   Patent=IT1252598B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10849.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   6-1 [Mouse hybridoma against dog SELPLG]
AC   CVCL_D2QH
DR   Wikidata; Q127378761
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   6-1 [Mouse brain]
AC   CVCL_W173
SY   GMI-M6-1
DR   Wikidata; Q54604202
RX   Patent=US6673605;
RX   PubMed=11054807;
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6J(H-2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1W
CA   Factor-dependent cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 8
//
ID   6-1-3
AC   CVCL_C8JQ
DR   Wikidata; Q123030306
RX   PubMed=6090455;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P10443; Escherichia coli polC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   6-1-6
AC   CVCL_B0VX
DR   Wikidata; Q108819698
RX   Patent=US9676843;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2924.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6-10-6
AC   CVCL_C3WS
DR   Wikidata; Q116048315
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6-10B
AC   CVCL_C529
DR   BTO; BTO_0006011
DR   cancercelllines; CVCL_C529
DR   Cosmic; 2366878
DR   GEO; GSM375843
DR   Progenetix; CVCL_C529
DR   Wikidata; Q54604204
RX   PubMed=12485491;
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of the STR profile (PubMed=26116706) it seems to be a hybrid of HeLa and of cell line of unknown origin. Originally thought to originate from SUNE1 which has also been shown to be contaminated.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00597.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 11,14,18
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 8,9,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6946 ! SUNE1
CA   Hybrid cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   6-19-1
AC   CVCL_C3WT
DR   Wikidata; Q116048317
RX   PubMed=7335083;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6-23
AC   CVCL_A599
SY   rMTC-6-23; rMTC 6-23
DR   Wikidata; Q54604206
RX   PubMed=6248326;
RX   PubMed=6353060;
RX   PubMed=6932046;
RX   PubMed=7389665;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Parafollicular cell; CL=CL_0000570.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C60369; Rat C-cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   6-23C6
AC   CVCL_4495
SY   rMTC 6-23C6; 6-23 clone 6; 6-23 (Clone 6); 6-23 (clone 6)
DR   CLO; CLO_0001446
DR   CLO; CLO_0001447
DR   CLDB; cl111
DR   CLDB; cl5109
DR   ATCC; CRL-1607
DR   ECACC; 87042206
DR   IZSLER; BS TCL 130
DR   JCRB; IFO50270
DR   Wikidata; Q54604208
RX   PubMed=6353060;
RX   PubMed=7736432;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Parafollicular cell; CL=CL_0000570.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C60369; Rat C-cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A599 ! 6-23
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   6-296-534
AC   CVCL_A9RF
SY   HCV 6-296-534
DR   ATCC; HB-10607
DR   Wikidata; Q102113457
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10607.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1191-1457 = Serine protease NS3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   6-3
AC   CVCL_W174
SY   GMI-M6-3
DR   Wikidata; Q54604210
RX   Patent=US6673605;
RX   PubMed=11054807;
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6J(H-2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1W
CA   Factor-dependent cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   6-4-11
AC   CVCL_XI00
DR   Wikidata; Q93308555
RX   Patent=US5811098;
RX   PubMed=7535774;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11715.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15303; Human ERBB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   6-914-518
AC   CVCL_A9RG
SY   HCV 6-914-518
DR   ATCC; HB-10600
DR   Wikidata; Q102113458
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10600.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1191-1457 = Serine protease NS3).
CC   Misspelling: HCA 6-914-518; ATCC=HB-10600.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   6.1.1
AC   CVCL_L906
DR   Wikidata; Q54604211
RX   PubMed=8500519;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_L908 ! 6.1.7
OI   CVCL_L907 ! 6.1.11
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   6.1.11
AC   CVCL_L907
DR   Wikidata; Q54604213
RX   PubMed=8500519;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_L906 ! 6.1.1
OI   CVCL_L908 ! 6.1.7
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   6.1.6
AC   CVCL_B7M7
DR   Wikidata; Q112926998
RX   PubMed=75508;
RX   PubMed=1852002;
RX   PubMed=2511169;
RX   PubMed=6967232;
RX   PubMed=9118943;
CC   Characteristics: Good model for bare lymphocyte syndorme 2 as it does not express MHC class II determinants due to mutations in the RFXAP gene.
CC   HLA typing: A*01,02; B*08,27; C*01 (PubMed=6967232).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Gly102Argfs*5 (c.302dupG) (1-BP INS, 413G); ClinVar=VCV000007649; Zygosity=Heterozygous (PubMed=9118943).
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser132Glnfs*43 (c.392dupG) (1-BP INS, 505G); ClinVar=VCV000007650; Zygosity=Heterozygous (PubMed=9118943).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   NCIt; C34726; Infectious mononucleosis
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E839 ! T5-1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   6.1.7
AC   CVCL_L908
DR   Wikidata; Q54604215
RX   PubMed=8500519;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: (C57BL/6J x SJL/J) F2 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_L906 ! 6.1.1
OI   CVCL_L907 ! 6.1.11
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   6.12
AC   CVCL_6766
DR   CLO; CLO_0001442
DR   ATCC; CRL-13006
DR   Wikidata; Q54604217
RX   Patent=US6365157;
RX   Patent=US6448077;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3344.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 8
//
ID   6.18
AC   CVCL_D7DI
RX   PubMed=12354868;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q47952; Haemophilus ducreyi (strain 35000HP / ATCC 700724) hgbA (Note=Also reacts with all other strains of H. ducreyi).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   6.1A8
AC   CVCL_A0MN
SY   BI#3 Clone #2
DR   Wikidata; Q108819699
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3647.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6.23.58K
AC   CVCL_K134
DR   ECACC; 93062219
DR   Wikidata; Q54604219
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Dog 58 kdA protein on MDCK cell line basolateral surface.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   6.2A1
AC   CVCL_A0MP
SY   6.2A1-1 (#7)
DR   Wikidata; Q108819700
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3896.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6.2B1
AC   CVCL_A0MQ
SY   BI#3 Clone #85
DR   Wikidata; Q108819701
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3646.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6.2B10
AC   CVCL_A0MR
SY   BI#3 Clone #10
DR   Wikidata; Q108819702
RX   Patent=US9745376;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3648.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6.2E5
AC   CVCL_A0MS
SY   6.2E5-1 (#13)
DR   Wikidata; Q108819703
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3897.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6.3G9
AC   CVCL_A0MT
SY   BI#3 Clone #25
DR   Wikidata; Q108819704
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3649.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6.4B4
AC   CVCL_A0MU
DR   Wikidata; Q108819705
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6.6B5
AC   CVCL_A0MV
DR   Wikidata; Q108819706
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6.8B4
AC   CVCL_A0MW
DR   Wikidata; Q108819707
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6.8G6
AC   CVCL_A0MX
SY   BI#3 Clone #56
DR   Wikidata; Q108819708
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3645.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18564; Human ITGB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6.95
AC   CVCL_E2SN
RX   PubMed=25897604;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; G1UBB6; Haemophilus ducreyi (strain 35000HP / ATCC 700724) dsrA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   6/11
AC   CVCL_A9ES
DR   Wikidata; Q108819709
RX   Patent=US4680258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9072.
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6/1G
AC   CVCL_D5GK
DR   Wikidata; Q127378762
RX   PubMed=9935209;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P21439; Human ABCB4 (Note=Immunized with AA 13-24).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   6/22-10-30-13
AC   CVCL_XI16
DR   Wikidata; Q93308600
RX   Patent=US7611894;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2625.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody SC-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   6/40c
AC   CVCL_C0E8
DR   Wikidata; Q112926999
DR   Ximbio; 153323
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31997; Human CEACAM8/CD66b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   6/9CII
AC   CVCL_VT76
DR   Wikidata; Q93308603
RX   PubMed=7500016;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95499; Fcgr2b (Note=With p.Lys204_Ile330del).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   60
AC   CVCL_C917
DR   Wikidata; Q54604221
RX   PubMed=19252478;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 8
//
ID   6005
AC   CVCL_6G42
DR   Wikidata; Q54604223
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=7459858;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 5
//
ID   600A6
AC   CVCL_C2W7
DR   Wikidata; Q114310469
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   600D11
AC   CVCL_C2W8
DR   Wikidata; Q114310471
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   600MPE
AC   CVCL_9875
AS   CVCL_8287
SY   600 MPE; 600-MPE; MPE-600; MPE 600; MPE600; 600PE; 600-PEI
DR   CLO; CLO_0009908
DR   EFO; EFO_0001085
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   cancercelllines; CVCL_9875
DR   Cosmic; 997932
DR   Cosmic; 1000128
DR   Cosmic; 1046948
DR   Cosmic; 1091346
DR   Cosmic; 1136351
DR   Cosmic; 1176628
DR   Cosmic; 1287907
DR   Cosmic; 1289403
DR   Cosmic; 2301521
DR   DepMap; ACH-002320
DR   GEO; GSM814
DR   GEO; GSM320174
DR   GEO; GSM421881
DR   GEO; GSM1053688
DR   GEO; GSM1172850
DR   GEO; GSM1172938
DR   GEO; GSM1661985
DR   IARC_TP53; 24335
DR   LINCS_HMS; 51092
DR   LINCS_LDP; LCL-2073
DR   PharmacoDB; 600MPE_22_2019
DR   Progenetix; CVCL_9875
DR   Wikidata; Q54604225
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=3470538;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11343771;
RX   PubMed=11687795;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19593635;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Doubling time: 85.17 hours (JWGray panel).
CC   HLA typing: A*29:02,29:02; B*44:02,44:02; C*16:02,16:02 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; c.1138-21_1138del22; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; c.219-1G>C; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=19593635).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: MPE699; Cosmic=1287907.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 35
//
ID   601
AC   CVCL_U662
SY   Line 601
DR   cancercelllines; CVCL_U662
DR   Wikidata; Q54604229
RX   PubMed=10590124;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U656 ! AE1-2a
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   602G2
AC   CVCL_C2W9
DR   Wikidata; Q114310473
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   603
AC   CVCL_UM78
DR   Wikidata; Q93308644
RX   PubMed=3402430;
RX   PubMed=10070891;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   603A11
AC   CVCL_C2WA
DR   Wikidata; Q114310474
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   603A6
AC   CVCL_C2WB
DR   Wikidata; Q114310475
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   603B
AC   CVCL_B7GF
DR   Wikidata; Q112927000
RX   PubMed=9840621;
RX   PubMed=12640721;
RX   PubMed=14977638;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   603B-iNOS antisense
AC   CVCL_B7GG
DR   Wikidata; Q112927001
RX   PubMed=14977638;
CC   Characteristics: Transduced with an antisense human INOS gene fragment (PubMed=14977638).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7873; NOS2 (Note=In antisense orientation).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7GF ! 603B
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   603F5
AC   CVCL_C2WC
DR   Wikidata; Q114310476
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   604A1
AC   CVCL_DQ08
DR   GEO; GSM1040281
DR   GEO; GSM1040351
DR   GEO; GSM1489290
DR   Wikidata; Q54604230
RX   PubMed=22802639;
RX   PubMed=23193063;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ10 ! 604B1
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ30 ! 648A1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   604A3
AC   CVCL_DQ09
DR   GEO; GSM1040282
DR   GEO; GSM1040352
DR   Wikidata; Q54604232
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ10 ! 604B1
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ30 ! 648A1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   604A9
AC   CVCL_C2WD
DR   Wikidata; Q114310477
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   604B1
AC   CVCL_DQ10
DR   GEO; GSM1040283
DR   GEO; GSM1040353
DR   Wikidata; Q54604318
RX   Patent=US20200407693;
RX   PubMed=22802639;
RX   PubMed=23193063;
RX   PubMed=24259714;
RX   PubMed=25665923;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*01:01,24:02; B*07:02,37:01; C*06:02,07:02; DQA1*01:01,03:03; DQB1*03:03,05:01; DRB1*01:01 (PubMed=30853558).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ30 ! 648A1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   604B1-B2M-KO
AC   CVCL_C1FN
SY   604B1-B2M-KO #1; 604B1-B2M-#1
DR   Wikidata; Q114310478
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ10 ! 604B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   604B4
AC   CVCL_C2WE
DR   Wikidata; Q114310479
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   606A1
AC   CVCL_DQ11
SY   HPS0328
DR   GEO; GSM1040284
DR   GEO; GSM1040354
DR   GEO; GSM1489239
DR   GEO; GSM1489442
DR   PRIDE; PXD000071
DR   RCB; HPS0328
DR   SKIP; SKIP001143
DR   SKIP; SKIP001229
DR   Wikidata; Q54604320
RX   PubMed=22802639;
RX   PubMed=23210603;
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ12 ! 606B1
OI   CVCL_DQ23 ! 711A1
OI   CVCL_DR11 ! 711A5
OI   CVCL_DQ24 ! 711A6
OI   CVCL_DQ25 ! 711C1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   606B1
AC   CVCL_DQ12
DR   GEO; GSM1040285
DR   GEO; GSM1040355
DR   SKIP; SKIP001104
DR   Wikidata; Q54604322
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ11 ! 606A1
OI   CVCL_DQ23 ! 711A1
OI   CVCL_DR11 ! 711A5
OI   CVCL_DQ24 ! 711A6
OI   CVCL_DQ25 ! 711C1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   607B
AC   CVCL_UM79
DR   cancercelllines; CVCL_UM79
DR   Cosmic; 1418453
DR   IARC_TP53; 10954
DR   Wikidata; Q93308696
RX   PubMed=10070891;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Unspecified (PubMed=10070891).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   60905OM
AC   CVCL_4065
SY   609050M
DR   GEO; GSM2474970
DR   Wikidata; Q54604324
RX   PubMed=22585861;
RX   PubMed=28273451;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=22585861
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 24
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   60As6Luc
AC   CVCL_A9J4
DR   JCRB; NIHS1336
DR   Wikidata; Q102113459
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS1336; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A616 ! HSC-60
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   60bca
AC   CVCL_J905
DR   CLO; CLO_0001443
DR   ATCC; HB-247
DR   Wikidata; Q54604326
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   60FSDNC1
AC   CVCL_RH66
SY   DOX2 hiPSC
DR   SKIP; SKIP001178
DR   Wikidata; Q54604329
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin but did not experience cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   60H9(9)D10.E6
AC   CVCL_2822
SY   D10.E6
DR   CLO; CLO_0001444
DR   CLDB; cl112
DR   BEI_Resources; ARP-8132
DR   ECACC; 94111519
DR   NCBI_Iran; C157
DR   Wikidata; Q54604330
RX   PubMed=1717573;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1658-1711 = Non-structural protein 4A).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: BEI_Resources; ARP-8132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   61
AC   CVCL_C918
DR   Wikidata; Q54604332
RX   PubMed=19252478;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 8
//
ID   61/7
AC   CVCL_J643
DR   CLO; CLO_0001445
DR   ATCC; HB-8154
DR   Wikidata; Q54604333
RX   Patent=US4521510;
RX   Patent=US4524025;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8154.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28177; Theophylline.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   610
AC   CVCL_UM80
DR   Wikidata; Q93308742
RX   PubMed=10070891;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   610A2
AC   CVCL_DQ13
DR   GEO; GSM1040286
DR   GEO; GSM1040356
DR   Wikidata; Q54604337
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ14 ! 610B1
OI   CVCL_DQ18 ! 665A1
OI   CVCL_DQ19 ! 665A7
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   610A8
AC   CVCL_C2WF
DR   Wikidata; Q114310480
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   610B1
AC   CVCL_DQ14
SY   HPS0331
DR   GEO; GSM1040287
DR   GEO; GSM1040357
DR   GEO; GSM1489240
DR   GEO; GSM1489258
DR   GEO; GSM1489443
DR   GEO; GSM1942571
DR   RCB; HPS0331
DR   SKIP; SKIP001144
DR   Wikidata; Q54604339
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ13 ! 610A2
OI   CVCL_DQ18 ! 665A1
OI   CVCL_DQ19 ! 665A7
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   612D5
AC   CVCL_C2WG
DR   Wikidata; Q114310481
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   6132A
AC   CVCL_E3SU
RX   PubMed=2787379;
RX   PubMed=16491399;
RX   PubMed=32439494;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-5M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   6132A-Cerulean
AC   CVCL_E3SV
RX   PubMed=32439494;
CC   Genetic integration: Method=Transduction; Gene=FPbase; CVUYM; Cerulean (Note=Bright cyan fluorescent protein derived from GFP).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3SU ! 6132A
SX   Female
AG   4-5M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   6139B
AC   CVCL_E3SW
RX   PubMed=2787379;
RX   PubMed=16491399;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-5M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   61H9
AC   CVCL_D5YG
DR   Wikidata; Q127378763
RX   PubMed=38495763;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y624; Human F11R/CD321.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   62-3G1
AC   CVCL_E9E3
DR   DSHB; 62-3G1
RX   PubMed=1377081;
RX   PubMed=3038574;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/62-3G1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2W5; Bovine GABRB2 (Note=Also reacts with human, mouse, rat and chicken).
CC   Monoclonal antibody target: UniProtKB; A5D7U6; Bovine GABRB3 (Note=Also reacts with human, mouse, rat and chicken).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   62.1E6
AC   CVCL_J619
DR   BCRJ; 0027
DR   DSHB; 62-1E6
DR   Wikidata; Q54604340
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; E1C375; Chicken SNAI2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 7
//
ID   62.3A6.2
AC   CVCL_D3VT
DR   Wikidata; Q127378764
RX   PubMed=2415810;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltohexaose (ST-IM6)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   621-101
AC   CVCL_S879
DR   CLO; CLO_0009973
DR   cancercelllines; CVCL_S879
DR   LINCS_LDP; LCL-2004
DR   Wikidata; Q54604343
RX   PubMed=12922981;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg611Gln (c.1832G>A); ClinVar=VCV000012397; Zygosity=Unspecified (PubMed=12922981).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C38153; Lung lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   621.1
AC   CVCL_0I05
DR   Wikidata; Q54604345
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5121.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   621NST
AC   CVCL_S880
DR   cancercelllines; CVCL_S880
DR   Wikidata; Q54604347
RX   DOI=10.1158/1055-9965.DISP-11-A64;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg611Gln (c.1832G>A); ClinVar=VCV000012397; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C38153; Lung lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S879 ! 621-101
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   622C1
AC   CVCL_DQ32
DR   GEO; GSM2152676
DR   Wikidata; Q54604348
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ10 ! 604B1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ30 ! 648A1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   622E1
AC   CVCL_DQ15
DR   GEO; GSM1040288
DR   GEO; GSM1040358
DR   GEO; GSM2152677
DR   Wikidata; Q54604351
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ10 ! 604B1
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ30 ! 648A1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   622G1
AC   CVCL_DQ16
DR   GEO; GSM1040289
DR   GEO; GSM1040359
DR   Wikidata; Q54604353
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ10 ! 604B1
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ30 ! 648A1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   624-mel
AC   CVCL_8054
SY   624-MEL; 624 MEL; 624 Mel; 624 mel; 624mel; 624MEL; 624; Mel-624; Mel624; MEL624
DR   BTO; BTO_0002951
DR   EFO; EFO_0006359
DR   ArrayExpress; E-MTAB-2706
DR   BioGRID_ORCS_Cell_line; 754
DR   BioSample; SAMN03471309
DR   cancercelllines; CVCL_8054
DR   CGH-DB; 9301-4
DR   ChEMBL-Cells; CHEMBL3885941
DR   Cosmic; 876683
DR   Cosmic; 905214
DR   Cosmic; 1303044
DR   Cosmic; 1559441
DR   Cosmic; 2163793
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   ESTDAB; ESTDAB-049
DR   GEO; GSM206438
DR   GEO; GSM274692
DR   PharmacoDB; 624mel_23_2019
DR   PubChem_Cell_line; CVCL_8054
DR   Wikidata; Q54604356
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=8537970;
RX   PubMed=9759882;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=15467732;
RX   PubMed=15592718;
RX   PubMed=19340423;
RX   PubMed=23851445;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27600516;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02:01,03:01; B*07:02,14:01; C*07:02,08:02; DPB1*15:01,20:01; DQB1*03:01:01,02:01; DRB1*04:01,07:01 (PubMed=15592718).
CC   HLA typing: A*02:01,03:01; B*07:02,14:02; C*07:02,08:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Trp (c.825T>G); ClinVar=VCV000485044; Zygosity=Unspecified (PubMed=23851445; PubMed=25485619).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-049; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 14
ST   D18S51: 16
ST   D21S11: 29
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12 (PubMed=25877200)
ST   D8S1179: 12,15 (Technion Genomics Center)
ST   FGA: 23,24 (Technion Genomics Center)
ST   FGA: 24 (ESTDAB=ESTDAB-049; PubMed=25877200)
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   624-mel/A31
AC   CVCL_A1DV
SY   624mel/A31
DR   Wikidata; Q102113460
RX   PubMed=9759882;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*31).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8054 ! 624-mel
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   624.28 Mel
AC   CVCL_C586
SY   624.28-MEL; Mel-624.28; Me 624.28; 624.28; 624-28
DR   cancercelllines; CVCL_C586
DR   ESTDAB; ESTDAB-121
DR   GEO; GSM218053
DR   GEO; GSM1092560
DR   Progenetix; CVCL_C586
DR   Wikidata; Q54604359
RX   PubMed=9670966;
RX   PubMed=10754339;
RX   PubMed=11924911;
RX   PubMed=15592718;
RX   PubMed=18172304;
CC   HLA typing: A*11:01,03:01; B*07:02,14:02; C*08:02; DPB1*20:01,15:01; DQB1*03:01:01,02:01; DRB1*04:01:01,07:01 (PubMed=15592718).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-121
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8054 ! 624-mel
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   624.38 Mel
AC   CVCL_C588
SY   624.38-MEL; Mel-624.38; Me624.38; Mel624.38; 624.38; 624-38
DR   cancercelllines; CVCL_C588
DR   ESTDAB; ESTDAB-113
DR   GEO; GSM218056
DR   Progenetix; CVCL_C588
DR   Wikidata; Q54604361
RX   PubMed=9670966;
RX   PubMed=10754339;
RX   PubMed=11924911;
RX   PubMed=15592718;
RX   PubMed=18172304;
CC   HLA typing: A*03:01,03:02; B*14:01,07:02; DPB1*20:01,15:01; DQB1*03:01:01,02:01; DRB1*04:01,07:01 (PubMed=15592718).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-113
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8054 ! 624-mel
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   624A12
AC   CVCL_C2WH
DR   Wikidata; Q114310482
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   624A3
AC   CVCL_C2WI
DR   Wikidata; Q114310483
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   624A6
AC   CVCL_C2WJ
DR   Wikidata; Q114310484
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   624E8
AC   CVCL_C2WK
DR   Wikidata; Q114310485
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   624H12
AC   CVCL_C2WL
DR   Wikidata; Q114310486
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   624H7
AC   CVCL_C2WM
DR   Wikidata; Q114310487
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   625B4
AC   CVCL_C2WN
DR   Wikidata; Q114310488
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   625E3
AC   CVCL_C2WP
DR   Wikidata; Q114310489
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   625E5
AC   CVCL_C2WQ
DR   Wikidata; Q114310490
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   625G10
AC   CVCL_C2WR
DR   Wikidata; Q114310491
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   625G12
AC   CVCL_C2WS
DR   Wikidata; Q114310492
RX   PubMed=6713399;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   6278
AC   CVCL_LK65
DR   Wikidata; Q54604362
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   63 BLCL
AC   CVCL_E409
DR   ECACC; 94031610
DR   Wikidata; Q54604364
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   632A1.1
AC   CVCL_C4UL
DR   Wikidata; Q116048318
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   633
AC   CVCL_E066
SY   Line 633
DR   CLO; CLO_0050068
DR   BioSample; SAMN03471969
DR   cancercelllines; CVCL_E066
DR   RCB; RCB2352
DR   Wikidata; Q54604367
RX   PubMed=10590124;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2352
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U656 ! AE1-2a
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   633.1
AC   CVCL_0I06
DR   Wikidata; Q54604369
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5122.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   633A1.4
AC   CVCL_C4UM
DR   Wikidata; Q116048319
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   634
AC   CVCL_UM81
DR   Wikidata; Q93308826
RX   PubMed=10070891;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   638-F1
AC   CVCL_C9BY
DR   Wikidata; Q123030307
RX   PubMed=10974411;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0102 ! SNU-638
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   638-F2
AC   CVCL_C9BZ
DR   Wikidata; Q123030308
RX   PubMed=10974411;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0102 ! SNU-638
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   639V
AC   CVCL_1048
SY   639v; 639-V; 639 V
DR   CLO; CLO_0001448
DR   EFO; EFO_0002097
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-109
DR   BioGRID_ORCS_Cell_line; 499
DR   BioSample; SAMN03473587
DR   BioSample; SAMN10989559
DR   cancercelllines; CVCL_1048
DR   Cell_Model_Passport; SIDM00999
DR   ChEMBL-Cells; CHEMBL3308703
DR   ChEMBL-Targets; CHEMBL1075383
DR   Cosmic; 906798
DR   Cosmic; 923375
DR   Cosmic; 928821
DR   Cosmic; 1285104
DR   Cosmic; 1927315
DR   Cosmic; 2050428
DR   Cosmic; 2685931
DR   Cosmic-CLP; 906798
DR   DepMap; ACH-000973
DR   DSMZ; ACC-413
DR   DSMZCellDive; ACC-413
DR   EGA; EGAS00001000978
DR   GDSC; 906798
DR   GEO; GSM827155
DR   GEO; GSM886841
DR   GEO; GSM887905
DR   GEO; GSM1567846
DR   GEO; GSM1574552
DR   GEO; GSM1574584
DR   GEO; GSM1669569
DR   IARC_TP53; 6601
DR   IGRhCellID; 639V
DR   LiGeA; CCLE_355
DR   LINCS_LDP; LCL-1943
DR   PharmacoDB; 639V_24_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1048
DR   PubChem_Cell_line; CVCL_1048
DR   Wikidata; Q52155313
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RX   PubMed=66978;
RX   PubMed=571047;
RX   PubMed=748774;
RX   PubMed=944089;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=8873383;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26589293;
RX   PubMed=26621286;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=66978; PubMed=748774); ~30 hours (DSMZ=ACC-413).
CC   HLA typing: A*01:01,02:01; B*44:02,57:01; C*05:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Heterozygous (Cosmic-CLP=906798; DepMap=ACH-000973).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=906798; DepMap=ACH-000973).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gln (c.389G>A); ClinVar=VCV000007829; Zygosity=Heterozygous (Cosmic-CLP=906798; DepMap=ACH-000973).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Heterozygous (Cosmic-CLP=906798; DepMap=ACH-000973).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=906798; DepMap=ACH-000973).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0.6%; South Asian=0%; European, North=74.77%; European, South=24.62% (PubMed=30894373).
CC   Misspelling: 639L; Note=In PhosphoSite, due to an error in a patent.
CC   Discontinued: ATCC; HTB-109; true.
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
ST   Source(s): Cosmic-CLP=906798; DSMZ=ACC-413
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D18S51: 15,16,17
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 16,19
DI   NCIt; C4830; Ureter urothelial carcinoma
DI   ORDO; Orphanet_598216; Upper tract urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   63B6
AC   CVCL_E4SC
RX   PubMed=27419852;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Blood group B antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   63D3
AC   CVCL_G620
DR   CLO; CLO_0001449
DR   ATCC; HB-44
DR   Wikidata; Q54604379
RX   PubMed=2441245;
RX   PubMed=6935683;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 5
//
ID   64-1
AC   CVCL_D2QI
DR   Wikidata; Q127378765
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   64-683
AC   CVCL_JJ89
DR   Wikidata; Q54604382
RX   Patent=US5646041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12304.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: HSV-1 and HSV-2 glycoprotein gD.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JJ88 ! SPAZ-4
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   6419c1
AC   CVCL_YM20
DR   GEO; GSM2974154
DR   GEO; GSM2974155
DR   GEO; GSM2974207
DR   GEO; GSM2974911
DR   GEO; GSM2974912
DR   Kerafast; EUP002-FP
DR   Wikidata; Q93308851
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM21 ! 6419c5
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6419c5
AC   CVCL_YM21
DR   GEO; GSM2974157
DR   GEO; GSM2974158
DR   GEO; GSM2974208
DR   GEO; GSM2974913
DR   GEO; GSM2974914
DR   Kerafast; EUP005-FP
DR   Wikidata; Q93308853
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM20 ! 6419c1
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6421c2
AC   CVCL_YM22
DR   GEO; GSM2974159
DR   GEO; GSM2974160
DR   GEO; GSM2974209
DR   GEO; GSM2974915
DR   GEO; GSM2974916
DR   Kerafast; EUP014-FP
DR   Wikidata; Q93308856
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6422c1
AC   CVCL_YM23
DR   GEO; GSM2974161
DR   GEO; GSM2974210
DR   GEO; GSM2974917
DR   Kerafast; EUP004-FP
DR   Wikidata; Q93308860
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM24 ! 6422c5
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6422c5
AC   CVCL_YM24
DR   GEO; GSM2974162
DR   GEO; GSM2974163
DR   GEO; GSM2974211
DR   GEO; GSM2974918
DR   GEO; GSM2974919
DR   Kerafast; EUP009-FP
DR   Wikidata; Q93308863
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM23 ! 6422c1
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   644
AC   CVCL_B6ND
DR   Wikidata; Q111732765
RX   Patent=US10550181;
CC   Monoclonal antibody isotype: IgG4.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   647V
AC   CVCL_1049
SY   647-V; 647 V
DR   CLO; CLO_0001450
DR   EFO; EFO_0002098
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-110
DR   BioGRID_ORCS_Cell_line; 500
DR   BioSample; SAMN03473588
DR   BioSample; SAMN10989565
DR   cancercelllines; CVCL_1049
DR   Cell_Model_Passport; SIDM00983
DR   ChEMBL-Cells; CHEMBL3308704
DR   ChEMBL-Targets; CHEMBL1075384
DR   Cosmic; 906797
DR   Cosmic; 928822
DR   Cosmic; 1046676
DR   Cosmic; 1285105
DR   Cosmic; 1286005
DR   Cosmic; 1927309
DR   Cosmic; 2050429
DR   Cosmic; 2057435
DR   Cosmic; 2444239
DR   Cosmic; 2685932
DR   Cosmic-CLP; 906797
DR   DepMap; ACH-000896
DR   DSMZ; ACC-414
DR   DSMZCellDive; ACC-414
DR   EGA; EGAS00001000978
DR   GDSC; 906797
DR   GEO; GSM827156
DR   GEO; GSM886842
DR   GEO; GSM887906
DR   GEO; GSM1374377
DR   GEO; GSM1669570
DR   IARC_TP53; 21152
DR   IGRhCellID; 647V
DR   LiGeA; CCLE_044
DR   LINCS_HMS; 50002
DR   LINCS_LDP; LCL-1708
DR   PharmacoDB; 647V_25_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1049
DR   PubChem_Cell_line; CVCL_1049
DR   Wikidata; Q51951823
RX   DOI=10.1016/B978-0-12-043050-5.50049-4;
RX   PubMed=66978;
RX   PubMed=571047;
RX   PubMed=748774;
RX   PubMed=944089;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=7459858;
RX   PubMed=8873383;
RX   PubMed=15846775;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 32 hours (PubMed=66978; PubMed=748774); ~30 hours (DSMZ=ACC-414).
CC   HLA typing: A*02:01; B*27:05,40:01; C*02:02,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Gln993Ter (c.2977C>T); Zygosity=Homozygous (Cosmic-CLP=906797; DepMap=ACH-000896).
CC   Sequence variation: Mutation; HGNC; HGNC:6974; MDM4; Simple; p.Ser161Ter (c.482C>G); Zygosity=Heterozygous (Cosmic-CLP=906797; DepMap=ACH-000896).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile162Asn (c.485T>A); ClinVar=VCV001408611; Zygosity=Heterozygous (Cosmic-CLP=906797; DepMap=ACH-000896).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Heterozygous (Cosmic-CLP=906797; DepMap=ACH-000896).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.52%; Native American=0%; East Asian, North=1.95%; East Asian, South=0%; South Asian=0%; European, North=64.01%; European, South=32.52% (PubMed=30894373).
CC   Misspelling: 647B; PubMed=748774.
CC   Discontinued: ATCC; HTB-110; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Cosmic-CLP=906797; DSMZ=ACC-414
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 12
ST   D21S11: 28,30
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 10,11
ST   Penta E: 13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18,21
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   648A1
AC   CVCL_DQ30
SY   HPS0360
DR   GEO; GSM1489207
DR   GEO; GSM1489233
DR   GEO; GSM1489257
DR   GEO; GSM1489445
DR   RCB; HPS0360
DR   SKIP; SKIP000860
DR   SKIP; SKIP001145
DR   Wikidata; Q54604387
RX   PubMed=23193063;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ10 ! 604B1
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   648B1
AC   CVCL_DQ17
DR   GEO; GSM1489208
DR   GEO; GSM1489234
DR   GEO; GSM1489446
DR   SKIP; SKIP000861
DR   Wikidata; Q54604388
RX   PubMed=23193063;
RX   PubMed=25665923;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ10 ! 604B1
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ30 ! 648A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   6499c3
AC   CVCL_YM25
DR   GEO; GSM2974126
DR   GEO; GSM2974164
DR   GEO; GSM2974212
DR   GEO; GSM2974920
DR   GEO; GSM2974921
DR   Kerafast; EUP007-FP
DR   Wikidata; Q93308896
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM26 ! 6499c4
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6499c4
AC   CVCL_YM26
DR   GEO; GSM2974127
DR   GEO; GSM2974128
DR   GEO; GSM2974213
DR   GEO; GSM2974922
DR   GEO; GSM2974923
DR   Kerafast; EUP015-FP
DR   Wikidata; Q93308900
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM25 ! 6499c3
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   64BA
AC   CVCL_C2SS
DR   ICLDB; 64ba
DR   Wikidata; Q114310493
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   64Bc
AC   CVCL_C2ST
DR   ICLDB; 64bc
DR   Wikidata; Q114310494
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   64CP
AC   CVCL_1B36
SY   833K(64CP)
DR   Wikidata; Q54604390
RX   CelloPub=CLPUB00240;
RX   PubMed=9772905;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2292 ! 833K-E
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   64FSDNC1
AC   CVCL_RH67
SY   DOX3 hiPSC
DR   SKIP; SKIP001179
DR   Wikidata; Q54604394
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin but did not experience cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   64G11F
AC   CVCL_XG82
DR   Wikidata; Q93308921
RX   Patent=US5597725;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11527.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   64M2
AC   CVCL_B6MY
DR   Wikidata; Q111732766
RX   PubMed=1499835;
RX   PubMed=8799617;
CC   Group: Fish cell line.
CC   Miscellaneous: It is probable that what is termed '64M2' in PubMed=8799617 is termed 'cell culture 2' in PubMed=1499835.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   64R
AC   CVCL_C6IG
DR   Wikidata; Q116048320
RX   PubMed=30058195;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8BHC0; Mouse Lyve1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   650E2
AC   CVCL_J903
SY   650E2-2B12
DR   CLO; CLO_0001451
DR   ATCC; HB-10812
DR   Wikidata; Q54604397
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10812.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10083.
CC   Registration: Chiron Master Culture Collection; CMCC 10121 (CMCC #10121).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast/ovarian cancer 42 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   652-15
AC   CVCL_C2SU
DR   ICLDB; 652-15
DR   Wikidata; Q114310495
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   654.1
AC   CVCL_0I07
DR   Wikidata; Q54604399
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5247.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   654RM
AC   CVCL_XX64
DR   Wikidata; Q93308942
RX   PubMed=21112256;
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; c.7287+5G>A (IVS23+5G>A); Zygosity=Homozygous (PubMed=21112256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   6555c3
AC   CVCL_YM27
DR   GEO; GSM2974129
DR   GEO; GSM2974130
DR   GEO; GSM2974214
DR   GEO; GSM2974924
DR   GEO; GSM2974925
DR   Kerafast; EUP011-FP
DR   Wikidata; Q93308945
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6556c3
AC   CVCL_YM28
DR   GEO; GSM2974131
DR   GEO; GSM2974132
DR   GEO; GSM2974215
DR   GEO; GSM2974926
DR   GEO; GSM2974927
DR   Kerafast; EUP003-FP
DR   Wikidata; Q93308948
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM29 ! 6556c4
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6556c4
AC   CVCL_YM29
DR   GEO; GSM2974133
DR   GEO; GSM2974134
DR   GEO; GSM2974928
DR   GEO; GSM2974929
DR   Kerafast; EUP010-FP
DR   Wikidata; Q93308952
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM28 ! 6556c3
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   655RM
AC   CVCL_XX65
DR   Wikidata; Q93308955
RX   PubMed=21112256;
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; c.7287+5G>A (IVS23+5G>A); Zygosity=Homozygous (PubMed=21112256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   65FSDNC2
AC   CVCL_RH68
SY   DOX4 hiPSC
DR   SKIP; SKIP001180
DR   Wikidata; Q54604401
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin but did not experience cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   65LO
AC   CVCL_C3QD
SY   65 LOndon; C1
DR   Wikidata; Q116048321
RX   PubMed=140146;
RX   PubMed=6459055;
CC   Doubling time: 75.9 hours (PubMed=6459055).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   65RQ
AC   CVCL_C2SV
DR   ICLDB; 65rq
DR   Wikidata; Q114310496
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   65x/-22
AC   CVCL_C2SW
DR   ICLDB; 65x-22
DR   Wikidata; Q114310497
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   66 [Human iPSC]
AC   CVCL_C919
DR   Wikidata; Q54604404
RX   PubMed=19252478;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   66 [Mouse mammary tumor]
AC   CVCL_9722
AS   CVCL_B393
SY   Line 66; Clone 66; Cl-66; Cl66
DR   BTO; BTO_0004309
DR   Wikidata; Q54604406
RX   PubMed=210930;
RX   PubMed=2413152;
RX   PubMed=2790822;
RX   PubMed=3940214;
RX   PubMed=6677618;
RX   PubMed=6871851;
RX   PubMed=10651311;
CC   Doubling time: 30.8 +- 4.2 hours (PubMed=10651311).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0I84 ! 168
OI   CVCL_W343 ! 410.4
OI   CVCL_0I87 ! 67 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   6606PDA
AC   CVCL_HX26
DR   Wikidata; Q54604407
RX   PubMed=21276229;
RX   PubMed=21720167;
RX   PubMed=26322225;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6 Mist1KrasG12D transgenic.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
ID   6613
AC   CVCL_EQ45
SY   6603
DR   GEO; GSM666036
DR   GEO; GSM666037
DR   Wikidata; Q54604408
RX   PubMed=22033105;
CC   Sequence variation: Mutation; HGNC; HGNC:7715; NDUFS8; Simple; p.Arg94Cys; Zygosity=Homozygous (PubMed=22033105).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   661W
AC   CVCL_6240
SY   661w; 661 W
DR   BTO; BTO_0001554
DR   ChEMBL-Cells; CHEMBL4483169
DR   ChEMBL-Targets; CHEMBL4483223
DR   GEO; GSE119190
DR   Lonza; 336
DR   PubChem_Cell_line; CVCL_6240
DR   Wikidata; Q54604409
RX   PubMed=11243878;
RX   PubMed=12407171;
RX   PubMed=14985288;
RX   PubMed=18188958;
RX   PubMed=23975727;
RX   PubMed=26854824;
RX   PubMed=29203899;
RX   PubMed=31024622;
RX   PubMed=31819341;
RX   PubMed=34208617;
RX   PubMed=40170180;
CC   Doubling time: ~24 hours (PubMed=12407171).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the IRBP promoter).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Retinal cone cell; CL=CL_0000573.
CC   Breed/subspecies: C57BL/6N transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   661W-A11
AC   CVCL_E9DQ
RX   PubMed=34208617;
CC   Characteristics: Shows a significant increase in expression of rod-specific genes but not of cone-specific genes, compared with the parent cell line (PubMed=34208617).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:102567; Nrl.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the IRBP promoter).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Retinal cone cell; CL=CL_0000573.
CC   Breed/subspecies: C57BL/6N transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6240 ! 661W
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   6620c1
AC   CVCL_YM30
DR   GEO; GSM2974135
DR   GEO; GSM2974136
DR   GEO; GSM2974216
DR   GEO; GSM2974930
DR   GEO; GSM2974931
DR   Kerafast; EUP016-FP
DR   Wikidata; Q93309013
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   6647
AC   CVCL_H722
SY   #6647
DR   cancercelllines; CVCL_H722
DR   Cosmic; 1078384
DR   Cosmic; 1082508
DR   Cosmic; 1718435
DR   Cosmic; 2228212
DR   Wikidata; Q53996682
RX   PubMed=327080;
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=8040301;
RX   PubMed=8617485;
RX   PubMed=11891184;
RX   PubMed=18160777;
RX   PubMed=22142829;
RX   PubMed=25010205;
RX   PubMed=26428435;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=8040301; PubMed=11891184; PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 13,19
ST   D19S433: 14,14.2
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 27
//
ID   665A1
AC   CVCL_DQ18
DR   GEO; GSM1040292
DR   GEO; GSM1040362
DR   Wikidata; Q54604417
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ13 ! 610A2
OI   CVCL_DQ14 ! 610B1
OI   CVCL_DQ19 ! 665A7
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   665A7
AC   CVCL_DQ19
DR   GEO; GSM1040293
DR   GEO; GSM1040363
DR   GEO; GSM1489238
DR   GEO; GSM1489444
DR   Wikidata; Q54604468
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ13 ! 610A2
OI   CVCL_DQ14 ! 610B1
OI   CVCL_DQ18 ! 665A1
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   6661 hIPSC
AC   CVCL_A4FW
DR   SKIP; SKIP003150
DR   Wikidata; Q105505952
RX   PubMed=29474672;
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   6679 hIPSC
AC   CVCL_A4FX
DR   SKIP; SKIP003151
DR   Wikidata; Q105505955
RX   PubMed=29474672;
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   6686 hIPSC
AC   CVCL_A4FY
DR   SKIP; SKIP003152
DR   Wikidata; Q105505957
RX   PubMed=29474672;
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   6688 hIPSC
AC   CVCL_A4FZ
DR   SKIP; SKIP003153
DR   Wikidata; Q105505960
RX   PubMed=29474672;
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   6694c2
AC   CVCL_YM31
DR   GEO; GSM2974137
DR   GEO; GSM2974138
DR   GEO; GSM2974217
DR   GEO; GSM2974932
DR   GEO; GSM2974933
DR   Kerafast; EUP006-FP
DR   Wikidata; Q93309036
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   66c14 luc1
AC   CVCL_E8TG
SY   66c14 Luc1
RX   PubMed=22510147;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9721 ! 66cl-4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   66c14 luc2
AC   CVCL_E8TH
SY   66c14 Luc2
RX   PubMed=22510147;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9721 ! 66cl-4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   66c14 luc3
AC   CVCL_E8TI
SY   66c14 Luc3
RX   PubMed=22510147;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9721 ! 66cl-4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   66c14 luc4
AC   CVCL_E8TJ
SY   66c14 Luc4
RX   PubMed=22510147;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9721 ! 66cl-4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   66c14 luc5
AC   CVCL_E8TK
SY   66c14 Luc5
RX   PubMed=22510147;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9721 ! 66cl-4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   66cl-4
AC   CVCL_9721
SY   66cl4; 66c14; Line 66 clone 4
DR   EFO; EFO_0002038
DR   Wikidata; Q54604470
RX   PubMed=1993557;
RX   PubMed=3940214;
RX   PubMed=6871851;
RX   PubMed=10411109;
RX   PubMed=15671244;
RX   PubMed=15687706;
RX   PubMed=22510147;
CC   Characteristics: Metastatic (PubMed=1993557).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9722 ! 66 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 14
//
ID   66LO
AC   CVCL_C3QE
SY   66 LOndon; C2
DR   Wikidata; Q116048322
RX   PubMed=140146;
RX   PubMed=6459055;
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   66MA
AC   CVCL_ZU28
SY   66 MAnchester
DR   Wikidata; Q98125424
RX   PubMed=9649131;
CC   Senescence: Senesces at 28 PDL (PubMed=9649131).
CC   Donor information: Established from an unaffected member of a Li-Fraumeni syndrome family.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   67 [Human iPSC]
AC   CVCL_C920
DR   Wikidata; Q54604472
RX   PubMed=19252478;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 8
//
ID   67 [Mouse mammary tumor]
AC   CVCL_0I87
SY   Line 67
DR   Wikidata; Q54604473
RX   PubMed=210930;
RX   PubMed=1540948;
RX   PubMed=2413152;
RX   PubMed=6677618;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0I84 ! 168
OI   CVCL_W343 ! 410.4
OI   CVCL_9722 ! 66 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   67-1
AC   CVCL_8165
SY   67-I
DR   Wikidata; Q54604474
RX   PubMed=8525373;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   67-2
AC   CVCL_C7I4
DR   Wikidata; Q123030309
RX   PubMed=26431358;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized pepinemab (VX15/2503) therapeutic antibody which is used in clinical trials for the treatment of a number of neuroinflammatory/neurodegenerative diseases.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92854; Human SEMA4D/CD100 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   672-1
AC   CVCL_XK21
DR   Wikidata; Q93309069
RX   Patent=US8137984;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_27732; Caffeine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   672-2
AC   CVCL_XK22
DR   Wikidata; Q93309072
RX   Patent=US8137984;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_27732; Caffeine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   672-3
AC   CVCL_XK23
DR   Wikidata; Q93309075
RX   Patent=US8137984;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9544.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_27732; Caffeine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   672-4
AC   CVCL_XK24
DR   Wikidata; Q93309080
RX   Patent=US8137984;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_27732; Caffeine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   677-mel
AC   CVCL_8055
SY   677-MEL; 677 mel; 677
DR   Wikidata; Q54604475
RX   PubMed=8027550;
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,11 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   67BR
AC   CVCL_HF27
SY   67 BRighton
DR   Wikidata; Q54604477
RX   PubMed=2973075;
RX   PubMed=6600729;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   67I
AC   CVCL_8166
DR   Wikidata; Q54604478
RX   PubMed=1845822;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   67j25A
AC   CVCL_WY64
SY   67j25 A
DR   Wikidata; Q93309107
RX   CelloPub=CLPUB00185;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon R-C; FlyBase_Strain=FBsn0000277.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
OI   CVCL_Z425 ! 67j25D
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 5
//
ID   67j25D
AC   CVCL_Z425
SY   67J25D; 67j 25D; 67j25 D; DM; 25j67D
DR   CLO; CLO_0001454
DR   CLDB; cl116
DR   DGRC; 173
DR   FlyBase_Cell_line; FBtc0000173
DR   Wikidata; Q54006381
RX   CelloPub=CLPUB00185;
RX   DOI=10.1016/0020-1790(83)90040-9;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: 48.3 hours (DGRC=173).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon R-C; FlyBase_Strain=FBsn0000277.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
OI   CVCL_WY64 ! 67j25A
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   67j25D-G
AC   CVCL_Z426
DR   FlyBase_Cell_line; FBtc9000021
DR   Wikidata; Q54604484
RX   CelloPub=CLPUB00496;
RX   DOI=10.1099/0022-1317-54-1-23;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon R-C; FlyBase_Strain=FBsn0000277.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z425 ! 67j25D
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   67j25D-P
AC   CVCL_Z427
DR   FlyBase_Cell_line; FBtc9000022
DR   Wikidata; Q54604485
RX   DOI=10.1099/0022-1317-54-1-23;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon R-C; FlyBase_Strain=FBsn0000277.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z425 ! 67j25D
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   67NR
AC   CVCL_9723
DR   EFO; EFO_0002039
DR   Wikidata; Q54604487
RX   PubMed=1540948;
RX   PubMed=10411109;
RX   PubMed=15671244;
CC   Characteristics: Non-metastatic.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0I87 ! 67 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   67T
AC   CVCL_8167
DR   Wikidata; Q54604489
RX   PubMed=1845822;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8166 ! 67I
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   68-1
AC   CVCL_C5NB
DR   Wikidata; Q116048323
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   68-1-2
AC   CVCL_3273
DR   CLO; CLO_0001455
DR   ATCC; CRL-1712
DR   Wikidata; Q54604490
RX   PubMed=6090455;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P10443; Escherichia coli polC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 7
//
ID   68-41
AC   CVCL_C8Z9
DR   Wikidata; Q123030310
RX   PubMed=8155595;
RX   PubMed=28768188;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   68-41-Cas9
AC   CVCL_C8ZA
DR   BioGRID_ORCS_Cell_line; 1207
DR   Wikidata; Q123030311
RX   PubMed=28768188;
CC   Characteristics: T-cell hybridoma.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8Z9 ! 68-41
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   682B
AC   CVCL_WG96
DR   Wikidata; Q93309162
RX   PubMed=748774;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   6854M
AC   CVCL_WM56
DR   cancercelllines; CVCL_WM56
DR   Cosmic; 852230
DR   Wikidata; Q93309166
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   686LN-M3e
AC   CVCL_D099
SY   M3e
DR   Wikidata; Q54604491
RX   PubMed=17028921;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6984 ! MDA-686Ln
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   686LN-M4e
AC   CVCL_D097
SY   M4e
DR   Wikidata; Q54604492
RX   PubMed=17028921;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6984 ! MDA-686Ln
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   686LN-R30
AC   CVCL_D098
SY   R30
DR   Wikidata; Q54604495
RX   PubMed=18473353;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6984 ! MDA-686Ln
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   68LO
AC   CVCL_C3QF
SY   68 LOndon
DR   Wikidata; Q116048325
RX   PubMed=6459055;
CC   Doubling time: 106.5 hours (PubMed=6459055).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   69-10
AC   CVCL_C7I8
DR   Wikidata; Q123030312
RX   Patent=JP7061750;
RX   PubMed=31397631;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE P-02577.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NPH9; Human IL26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   69-4
AC   CVCL_C5NC
DR   Wikidata; Q116048326
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   69.3.4
AC   CVCL_F1KC
SY   69
RX   PubMed=2464646;
RX   PubMed=3081578;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   691-13
AC   CVCL_B6Q9
DR   Wikidata; Q111732767
RX   PubMed=80012;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-13-17
AC   CVCL_B6QA
SY   13-17
DR   Wikidata; Q111732769
RX   PubMed=80012;
RX   PubMed=6159966;
WW   Provider; Wistar; -; https://web.archive.org/web/20221204232513/https://wistar.org/sites/default/files/2017-11/Herlyn%20Lab%20-%20Monoclonal%20Antibodies%20-%202017.pdf
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01911; Human HLA-DRB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6Q9 ! 691-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   691-19
AC   CVCL_B6QB
DR   Wikidata; Q111732770
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-19-19
AC   CVCL_B6QC
DR   Wikidata; Q111732771
RX   PubMed=80012;
RX   PubMed=6159966;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QB ! 691-19
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-2
AC   CVCL_B6QD
DR   Wikidata; Q111732773
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-2-4
AC   CVCL_B6QE
DR   Wikidata; Q111732774
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QD ! 691-2
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-4
AC   CVCL_B6QF
DR   Wikidata; Q111732775
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-4-144
AC   CVCL_B6QG
DR   Wikidata; Q111732776
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QF ! 691-4
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-4-155
AC   CVCL_B6QH
DR   Wikidata; Q111732777
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QF ! 691-4
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-4-27
AC   CVCL_B6QI
DR   Wikidata; Q111732778
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QF ! 691-4
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-6
AC   CVCL_B6QJ
DR   Wikidata; Q111732780
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-6-11
AC   CVCL_B6QP
DR   Wikidata; Q111732781
RX   PubMed=6159966;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QJ ! 691-6
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-6-37
AC   CVCL_B6QQ
DR   Wikidata; Q111732782
RX   PubMed=6159966;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QJ ! 691-6
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-6-5
AC   CVCL_B6QK
DR   Wikidata; Q111732783
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6QJ ! 691-6
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-I-5Nu 4
AC   CVCL_B6Q7
DR   Wikidata; Q111732784
RX   PubMed=80012;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-I-5Nu-4-42
AC   CVCL_B6Q8
DR   Wikidata; Q111732785
RX   PubMed=80012;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6Q7 ! 691-I-5Nu 4
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   691-I-5Nu4B
AC   CVCL_B6QR
SY   691-I5-Nu4B; Nu4B
DR   Wikidata; Q111732786
RX   PubMed=6159966;
WW   Provider; Wistar; -; https://web.archive.org/web/20221204232513/https://wistar.org/sites/default/files/2017-11/Herlyn%20Lab%20-%20Monoclonal%20Antibodies%20-%202017.pdf
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6Q7 ! 691-I-5Nu 4
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   692D2
AC   CVCL_DQ20
DR   GEO; GSM1489209
DR   GEO; GSM1489232
DR   GEO; GSM1489256
DR   GEO; GSM1489449
DR   GEO; GSM1942573
DR   SKIP; SKIP000862
DR   Wikidata; Q54604497
RX   PubMed=23193063;
RX   PubMed=25665923;
RX   PubMed=27476965;
RX   PubMed=30735882;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ06 ! 585A1
OI   CVCL_DQ07 ! 585B1
OI   CVCL_LJ36 ! 692E1
OI   CVCL_DQ21 ! 703A1
OI   CVCL_DQ22 ! 703B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   692E1
AC   CVCL_LJ36
DR   SKIP; SKIP000863
DR   Wikidata; Q54604498
RX   PubMed=23193063;
RX   PubMed=28453617;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ06 ! 585A1
OI   CVCL_DQ07 ! 585B1
OI   CVCL_DQ20 ! 692D2
OI   CVCL_DQ21 ! 703A1
OI   CVCL_DQ22 ! 703B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   6938-1
AC   CVCL_UW47
DR   Wikidata; Q93309217
RX   PubMed=2559742;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5N52 ! GM06938
SX   Male
AG   3W
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 11
//
ID   694/98-D
AC   CVCL_F0AJ
RX   PubMed=7678279;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=Selected with the peptide 306-YNKRKRIHIGPGRAFYTTKNIIG-328 from gp120 V3 region. Also reacts with isolate ARV2/SF2 and HXB2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   697
AC   CVCL_0079
AS   CVCL_8861
SY   Line 697; EU-3; Emory University-3
DR   BTO; BTO_0001969
DR   CLO; CLO_0001008
DR   EFO; EFO_0022690
DR   CLDB; cl117
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 1757
DR   BioSample; SAMN03473591
DR   BioSample; SAMN10988566
DR   cancercelllines; CVCL_0079
DR   Cell_Model_Passport; SIDM01076
DR   ChEMBL-Cells; CHEMBL3308147
DR   ChEMBL-Targets; CHEMBL2366253
DR   Cosmic; 906800
DR   Cosmic; 1037742
DR   Cosmic; 1130252
DR   Cosmic; 1191693
DR   Cosmic; 1524788
DR   Cosmic; 2396142
DR   Cosmic; 2427693
DR   Cosmic; 2649230
DR   Cosmic-CLP; 906800
DR   DepMap; ACH-000070
DR   DSMZ; ACC-42
DR   DSMZCellDive; ACC-42
DR   EGA; EGAS00001000978
DR   GDSC; 906800
DR   GEO; GSM236777
DR   GEO; GSM236813
DR   GEO; GSM886843
DR   GEO; GSM887907
DR   GEO; GSM1669562
DR   GEO; GSM5137704
DR   GEO; GSM5137749
DR   IARC_TP53; 21153
DR   IZSLER; BS TCL 241
DR   LiGeA; CCLE_726
DR   LINCS_LDP; LCL-1042
DR   Lonza; 235
DR   PharmacoDB; 697_26_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0079
DR   PubChem_Cell_line; CVCL_0079
DR   Wikidata; Q54604500
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6982733;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=10490826;
RX   PubMed=11021758;
RX   PubMed=11843816;
RX   PubMed=15843827;
RX   PubMed=20164919;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=21538216;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29786757;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31305009;
RX   PubMed=31978347;
RX   PubMed=35124168;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~60-70 hours (PubMed=6982733); 40 hours (PubMed=25984343); ~30-40 hours (DSMZ=ACC-42).
CC   HLA typing: A*02:01:01,25:01:01; B*07:02:01,15:01:01; C*03:03:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,02:01:02; DQA1*01:01:01,01:01:01; DQB1*05:01:01,05:01:01; DRA*01:01:01,01:01:01; DRB1*01:01:01,01:01:01 (DSMZCellDive=ACC-42).
CC   HLA typing: A*02:01,25:01; B*07:02,15:01; C*03:03,07:02; DQA1*01:01,01:01; DQB1*05:01,05:01; DRB1*01:01,11:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=11843816; PubMed=15843827; PubMed=35354797; DepMap=ACH-000070).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.56%; Native American=0.55%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=65.87%; European, South=33.02% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=906800; DSMZ=ACC-42
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 28,32.2
ST   D2S1338: 20,21
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 10,13
ST   Penta E: 7,10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   697-D
AC   CVCL_F1ZB
SY   697D; 697
DR   ABCD; ABCD_BF058
RX   PubMed=7525987;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 (isolate BH10) env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   697-EBV
AC   CVCL_A1DP
DR   Wikidata; Q102113461
RX   PubMed=8027550;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8056 ! 697-mel
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   697-mel
AC   CVCL_8056
SY   697-MEL; 697 Mel; 697 mel; 697mel; 697
DR   cancercelllines; CVCL_8056
DR   CGH-DB; 9302-4
DR   Cosmic; 905215
DR   Wikidata; Q54604501
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,11 (PubMed=10048982).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=15467732).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DP ! 697-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   697-R
AC   CVCL_D3Z6
SY   697R
DR   Wikidata; Q127378766
RX   PubMed=21538216;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_66484; Silvestrol.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0079 ! 697
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   697B3
AC   CVCL_B0DQ
DR   Wikidata; Q108819710
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10806.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10077.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6A-6
AC   CVCL_C3SX
DR   Wikidata; Q116048327
RX   PubMed=6302177;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human herpesvirus 2 (HHV-2) 140 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6A-HS-MYC
AC   CVCL_5A27
DR   Wikidata; Q54604505
RX   Patent=EP0232845A2;
RX   PubMed=3526329;
CC   Characteristics: Expression of mouse Myc is under the control of a Drosophila hsp70 promoter. Contains ~1500 copies of the Myc gene (PubMed=3526329).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   6A1
AC   CVCL_B6M7
DR   Wikidata; Q111732787
RX   PubMed=29490384;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   6A10
AC   CVCL_E7DP
RX   PubMed=38836825;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P22234; Human PAICS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6A11 [Mouse hybridoma against human BAD]
AC   CVCL_C3TD
DR   Wikidata; Q116048328
RX   PubMed=9790073;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92934; Human BAD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   6A11 [Mouse hybridoma against human TPT1]
AC   CVCL_E9DP
RX   PubMed=21466289;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13693; Human TPT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   6A4
AC   CVCL_F1BQ
RX   DOI=10.1577/1548-8667(1999)011<0017:POMAMA>2.0.CO;2;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: White spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   6A5
AC   CVCL_E6JX
DR   ABCD; ABCD_AE979
RX   PubMed=8618905;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00021; Columba livia CYC (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6A7
AC   CVCL_E5SF
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6A7.E5
AC   CVCL_C4QR
DR   ABCD; ABCD_AE782
DR   Wikidata; Q116048329
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62898; Rat Cycs.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6A7M
AC   CVCL_G621
SY   6A7
DR   CLO; CLO_0001456
DR   ABCD; ABCD_AF002
DR   ATCC; HB-8159
DR   Wikidata; Q54604506
RX   Patent=US4767710;
RX   PubMed=6197636;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8159.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24. Recognizes M blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   6A8-B10
AC   CVCL_C3UC
SY   6A8 B10; 6A8 B10 D12; 6A8
DR   Wikidata; Q116048330
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6A8-E8
AC   CVCL_C3UD
DR   Wikidata; Q116048331
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6A8.6F10.1A6
AC   CVCL_J914
SY   6F10
DR   CLO; CLO_0001457
DR   ATCC; CRL-2743
DR   ATCC; JHU-27
DR   Wikidata; Q54604507
WW   Provider; JHTV; C03422; https://jhu.technologypublisher.com/technology/16143
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mouse MHC class I Qa-1b.
CC   Discontinued: ATCC; CRL-2743; true.
CC   Discontinued: ATCC; JHU-27; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   6A9-D7
AC   CVCL_C3UE
DR   Wikidata; Q116048332
RX   PubMed=2428875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16311; Dermatophagoides farinae peptidase 1 (allergen Der f 1) (DERF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6B [Mouse embryonal carcinoma]
AC   CVCL_1N72
SY   6BTG; AG13178
DR   CLO; CLO_0022097
DR   Coriell; AG13178
DR   Wikidata; Q54604508
RX   CelloPub=CLPUB00597;
RX   PubMed=2791350;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: CBA.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N70 ! H6
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 6
//
ID   6B [Oncorhynchus]
AC   CVCL_S159
DR   Wikidata; Q54604511
RX   DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2;
CC   Group: Fish cell line.
CC   Doubling time: 3.5 days (DOI=10.1577/1548-8667(1998)010<0075:DOLTCL>2.0.CO;2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Hot Creek 71; VBO=VBO_0017492.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   6B(NG)C25
AC   CVCL_1N74
SY   AG13179
DR   CLO; CLO_0022098
DR   Coriell; AG13179
DR   Wikidata; Q54604512
RX   CelloPub=CLPUB00597;
RX   PubMed=2321096;
RX   PubMed=2791350;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Breed/subspecies: CBA.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N72 ! 6B [Mouse embryonal carcinoma]
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 6
//
ID   6B10
AC   CVCL_C4FP
DR   Wikidata; Q116048334
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6B11
AC   CVCL_C5AU
DR   Wikidata; Q116048335
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6B11-2E3
AC   CVCL_E5NP
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6B12
AC   CVCL_C5EP
DR   Wikidata; Q116048336
RX   PubMed=21851235;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14213; Tachypleus tridentatus tachyplesin-1 (TP-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6B2 [Mouse hybridoma against FeLV p15E]
AC   CVCL_B0VP
DR   Wikidata; Q108819711
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 446-625 = p15E/TM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   6B2 [Mouse hybridoma against human GRN]
AC   CVCL_X862
DR   Wikidata; Q54604513
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5261.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 6
//
ID   6B2 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5F9
DR   Wikidata; Q116048338
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6B2-2
AC   CVCL_B0WW
DR   Wikidata; Q108819712
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-969.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6B3 [Mouse hybridoma against human GRN]
AC   CVCL_X863
DR   Wikidata; Q54604514
RX   Patent=US7091047;
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5262.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   6B3 [Mouse hybridoma against human LGALS3BP]
AC   CVCL_WZ40
DR   Wikidata; Q93309301
RX   CelloPub=CLPUB00527;
RX   PubMed=7508905;
RX   PubMed=8407567;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08380; Human LGALS3BP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   6B4
AC   CVCL_JZ92
DR   Wikidata; Q54604519
RX   Patent=US7332162;
RX   PubMed=10807753;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 5108CB.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07359; Human GP1BA/CD42b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   6B4/3D2
AC   CVCL_C4YQ
DR   Wikidata; Q116048340
RX   PubMed=11604114;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P11436; Pseudomonas aeruginosa alpha-amidase (amiE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6B5
AC   CVCL_C4KQ
DR   ABCD; ABCD_AF204
DR   Wikidata; Q116048341
RX   PubMed=8371148;
RX   PubMed=9786848;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_8058; Phencyclidine (PCP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6B6
AC   CVCL_E8C6
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A8V0X807; Chicken COLQ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6B6-6
AC   CVCL_F1FY
RX   PubMed=6153633;
RX   PubMed=6341819;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   6B8D11H12
AC   CVCL_C4AF
DR   ABCD; ABCD_AD567
DR   CCRID; 4201PAT-CCTCC00378
DR   Wikidata; Q116048342
RX   Patent=CN102010472B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201060.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Fibrin D-dimer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6B9 [Mouse hybridoma against codeine]
AC   CVCL_B6G9
DR   Wikidata; Q111732790
RX   PubMed=22358905;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16714; Codeine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   6B9 [Mouse hybridoma against fibrin D-dimer]
AC   CVCL_C4AE
DR   Wikidata; Q116048344
RX   PubMed=30763351;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fibrin D-dimer (Note=Also reacts strongly with fibrinogen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6B9 [Mouse hybridoma against lycopene]
AC   CVCL_B6IU
DR   ABCD; ABCD_BE643
DR   Wikidata; Q111732791
RX   Patent=WO2018115885A1;
RX   PubMed=28402743;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-172.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   6B9-4
AC   CVCL_C6XR
DR   ABCD; ABCD_AN731
DR   ABCD; ABCD_AN732
DR   ABCD; ABCD_AN733
DR   Wikidata; Q123030313
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   6BD-25
AC   CVCL_LB94
DR   Wikidata; Q54604521
RX   Patent=US7420039;
RX   Patent=US7442776;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5691.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   6BF10
AC   CVCL_D1FS
DR   Wikidata; Q127378767
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z067 ! Sp2ab
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   6C
AC   CVCL_C4SS
DR   Wikidata; Q116048345
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   6C1
AC   CVCL_C5GB
DR   Wikidata; Q116048346
RX   PubMed=21707362;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6C12 [Mouse hybridoma against human GRN]
AC   CVCL_X864
DR   Wikidata; Q54604522
RX   Patent=US7368428;
RX   Patent=US7674460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5597.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   6C12 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5FA
DR   Wikidata; Q116048347
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6C1.10
AC   CVCL_C9FT
DR   Wikidata; Q123030314
RX   Patent=US8231877;
RX   PubMed=9631008;
CC   Doubling time: 17 hours (PubMed=9631008).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   6C2
AC   CVCL_XE22
DR   Wikidata; Q93309316
RX   PubMed=15490328;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_37659; Oleanolic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   6C2-4
AC   CVCL_B0WX
DR   Wikidata; Q108819713
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-970.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   6C3 [Mouse hybridoma against lutein]
AC   CVCL_B6IW
DR   Wikidata; Q111732792
RX   Patent=WO2018115885A1;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_28838; Lutein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   6C3 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N3
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6C3HED-OG
AC   CVCL_F966
SY   6C3HED/OG
DR   TKG; TKG 0146
DR   Wikidata; Q54604524
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   6C4
AC   CVCL_E8HA
RX   PubMed=30130141;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CUB6; Mouse Otud1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   6C6 [Mouse hybridoma against influenza A NA]
AC   CVCL_XA09
DR   Wikidata; Q93309328
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8526.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 neuraminidase (NA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   6C6 [Mouse hybridoma against MTPS]
AC   CVCL_C4D6
DR   ABCD; ABCD_AH089
DR   Wikidata; Q116048348
RX   PubMed=25756188;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6C7
AC   CVCL_F1YU
RX   PubMed=8120399;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12449; HIV-2 isolate SBLISY env (Note=AA 22-503 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   6C8
AC   CVCL_C4D7
DR   ABCD; ABCD_AH087
DR   Wikidata; Q116048349
RX   PubMed=25756188;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6C9(A)-D6
AC   CVCL_B5A7
SY   6C9a
DR   Wikidata; Q110429798
RX   Patent=WO1997024141A1;
RX   PubMed=9988333;
CC   Group: Malaria research cell line.
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
ID   6C9(B)-G7
AC   CVCL_B5A8
SY   6C9b
DR   Wikidata; Q110429799
RX   Patent=WO1997024141A1;
RX   PubMed=9988333;
CC   Group: Malaria research cell line.
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
ID   6C9A
AC   CVCL_XC78
DR   Wikidata; Q93309331
RX   Patent=US6207417;
RX   Patent=US20080305074;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21583; Human KITLG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   6CFSMEo-
AC   CVCL_IN62
SY   6CFSMEO
DR   Millipore; SCC157
DR   Wikidata; Q54604526
RX   PubMed=1375758;
RX   PubMed=15463957;
RX   PubMed=16037690;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln2Ter (c.4C>T); ClinVar=VCV000053980; Zygosity=Heterozygous (PubMed=15463957; PubMed=16037690).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=15463957; PubMed=16037690).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, submucosal gland; UBERON=UBERON_8410043.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC157
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 14
ST   D18S51: 16,20
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 8,13
ST   FGA: 19
ST   Penta D: 9,10
ST   Penta E: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP33 ! CFSMEo-
OI   CVCL_IN60 ! 2CFSMEo-
OI   CVCL_IN58 ! 3ACFSMEo-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   6D/6F
AC   CVCL_C4PU
DR   Wikidata; Q116048351
RX   DOI=10.1016/j.cegh.2019.09.014;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni soluble egg antigen (SEA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6D10
AC   CVCL_YC94
DR   Wikidata; Q93309344
RX   Patent=US7566764;
RX   PubMed=11156388;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9QZH2; Rat Bard1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   6D11.3.1
AC   CVCL_J989
DR   Wikidata; Q54604529
RX   Patent=US20080171036;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4299.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   6D12 [Mouse hybridoma against A.aegypti salivary glands lobes]
AC   CVCL_VI37
DR   BEI_Resources; MRA-249
DR   Wikidata; Q54604531
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female and male salivary glands distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 4
//
ID   6D12 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MS
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6D2.6
AC   CVCL_A0CG
DR   BEI_Resources; ARP-2739
DR   Wikidata; Q108819714
RX   PubMed=8438567;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20881; HIV-2 isolate ST vpx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   6D3.4.4
AC   CVCL_J930
DR   ATCC; HB-9573
DR   Wikidata; Q54604533
RX   Patent=US5194593;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9573.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   6D4
AC   CVCL_B0VQ
DR   Wikidata; Q108819715
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   6D6
AC   CVCL_4T76
DR   Wikidata; Q54604535
RX   Patent=US5662905;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9171.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 2.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 11
//
ID   6D7
AC   CVCL_E2ZC
RX   PubMed=26788906;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   6D8
AC   CVCL_C5FB
DR   Wikidata; Q116048352
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6D8MB4
AC   CVCL_G094
SY   6D8 MB4
DR   CLO; CLO_0001458
DR   ATCC; CRL-1842
DR   ECACC; 95022201
DR   Wikidata; Q54604536
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   6DT1
AC   CVCL_C8PZ
DR   BTO; BTO_0006530
DR   Wikidata; Q123030315
RX   PubMed=15180438;
RX   PubMed=25368990;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   6DT1-shTpx2#1
AC   CVCL_C8Q0
DR   Wikidata; Q123030316
RX   PubMed=25368990;
CC   Knockout cell: Method=shRNA knockdown; MGI; MGI:1919369; Tpx2.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8PZ ! 6DT1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   6DT1-shTpx2#2
AC   CVCL_C8Q1
DR   Wikidata; Q123030317
RX   PubMed=25368990;
CC   Knockout cell: Method=shRNA knockdown; MGI; MGI:1919369; Tpx2.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8PZ ! 6DT1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   6D9
AC   CVCL_E7E1
RX   PubMed=28472594;
RX   PubMed=28636501;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; D2JYA9; Canine distemper virus (strain Snyder Hill) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6D9F4
AC   CVCL_WN02
SY   6 D9F4
DR   Wikidata; Q93309392
RX   PubMed=1417586;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13891; Budgerigar fledgling disease virus VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   6E-12
AC   CVCL_C3SY
DR   Wikidata; Q116048353
RX   PubMed=6302177;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human herpesvirus 2 (HHV-2) 50-55 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6E10-10
AC   CVCL_B0WY
DR   Wikidata; Q108819716
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6E10-4
AC   CVCL_B0WZ
DR   Wikidata; Q108819718
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6E10-5
AC   CVCL_B0X0
DR   Wikidata; Q108819719
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6E10-8
AC   CVCL_B0X1
DR   Wikidata; Q108819720
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6E11 [Mouse hybridoma against CDV F]
AC   CVCL_E7E2
RX   PubMed=28472594;
RX   PubMed=28636501;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; D2JYB4; Canine distemper virus (strain Snyder Hill) fusion glycoprotein (F).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6E11 [Mouse hybridoma against chicken CCL5]
AC   CVCL_C4JN
DR   Wikidata; Q116048354
RX   PubMed=33497732;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8QG57; Chicken CCL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6E11 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5FC
DR   Wikidata; Q116048355
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6E2 [Mouse hybridoma against human GRN]
AC   CVCL_C5GC
DR   Wikidata; Q116048356
RX   PubMed=21707362;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6E2 [Mouse hybridoma against SSEA-4]
AC   CVCL_KA97
DR   RCB; RCB2931
DR   Wikidata; Q54604539
RX   PubMed=7713330;
RX   PubMed=18273440;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_189546; NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) (Stage-specific embryonic antigen-4; SSEA-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   6E2B6
AC   CVCL_C6M9
DR   ABCD; ABCD_AX640
DR   Wikidata; Q116048357
RX   Patent=CN114773456B;
RX   PubMed=36445388;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202226.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O64255; Mycobacterium phage D29 Gp63 (Note=AA 45-78 = PK34).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   6E2F11
AC   CVCL_C6M8
DR   Wikidata; Q116048358
RX   Patent=CN114773456B;
RX   PubMed=36445388;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O64255; Mycobacterium phage D29 Gp63 (Note=AA 45-78 = PK34).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   6E4
AC   CVCL_B6ZF
DR   CCRID; 4201PAT-CCTCC01884
DR   Wikidata; Q111732793
RX   Patent=CN114107218B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202181.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Enzootic nasal tumour virus of goats (ENTV-2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   6E6 [Macaca B-cell transformed]
AC   CVCL_A0AI
DR   BEI_Resources; ARP-12197
DR   Wikidata; Q108819721
RX   PubMed=22072749;
CC   Group: Non-human primate cell line.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; E7CWP5; Simian immunodeficiency virus (isolate SIVmac239) (SIV-mac) env (gp41).
CC   Transformant: NCBI_TaxID; 45455; Rhesus lymphocryptovirus (Macacine herpesvirus 4).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A0AH ! 4B2 [Macaca B-cell transformed]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   6E6 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HN
SY   6E6-7-1-1
DR   ABCD; ABCD_AU117
DR   Wikidata; Q110429800
RX   Patent=US8846047;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5433.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   6E9 [Mouse hybridoma against A.aegypti]
AC   CVCL_VI38
DR   BEI_Resources; MRA-250
DR   Wikidata; Q54604588
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female salivary glands and midgut tissue.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 4
//
ID   6E9 [Mouse hybridoma against human CXCR1]
AC   CVCL_F1WL
RX   Patent=US5440021;
RX   Patent=US20070065441;
RX   PubMed=9356984;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25024; Human CXCR1/CD181.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   6E9-1
AC   CVCL_B0X2
DR   Wikidata; Q108819722
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6E9-3
AC   CVCL_B0X3
DR   Wikidata; Q108819723
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6E9-4
AC   CVCL_B0X4
DR   Wikidata; Q108819724
RX   Patent=US7879330;
RX   PubMed=11119555;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6F10
AC   CVCL_C5BZ
DR   Wikidata; Q116048359
RX   PubMed=23098301;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A3MYE8; Actinobacillus pleuropneumoniae tonB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6F11 [Human LCL against P.aeruginosa LPS]
AC   CVCL_L106
DR   Wikidata; Q54604589
RX   Patent=US4834975;
RX   Patent=US5662905;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8562.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 2.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   6F11 [Mouse hybridoma against vaccinia A27L]
AC   CVCL_E5M8
RX   PubMed=26889021;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11258; Vaccinia virus protein OPG154 (A27L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6F12
AC   CVCL_KS78
SY   K140
DR   Wikidata; Q54604590
RX   PubMed=1517226;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13751; Human LAMB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   6F2.1.1
AC   CVCL_U724
SY   anti-FcRH3-6F2
DR   Wikidata; Q54604591
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6337.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96P31; Human FCRL3/CD307c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   6F20
AC   CVCL_XV45
DR   CCRID; 4201PAT-CCTCC00991
DR   Wikidata; Q93309446
RX   Patent=CN107177557B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016219.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05413; Human FABP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   6F3H
AC   CVCL_B6ZE
DR   CCRID; 4201PAT-CCTCC01917
DR   Wikidata; Q111732794
RX   Patent=CN114057867B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021286.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O11424; Duck adenovirus 1 fiber protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   6F4/53
AC   CVCL_VI56
DR   BEI_Resources; MRA-885
DR   Wikidata; Q54604593
RX   PubMed=3045543;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) high-molecular-mass rhoptry protein complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   6F4C5
AC   CVCL_J150
DR   CLO; CLO_0001460
DR   ATCC; CRL-1869
DR   Wikidata; Q54604596
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   6F5
AC   CVCL_C5CQ
DR   Wikidata; Q116048360
RX   PubMed=22316482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24554; Escherichia coli radA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6F6
AC   CVCL_F1V4
RX   PubMed=9521144;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A4G2; Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) pneumococcal surface adhesin A (psaA) (Note: Immunized with serotype 22F psaA but recognizes 23 capsular serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   6F6-1
AC   CVCL_C6XS
DR   ABCD; ABCD_AN734
DR   ABCD; ABCD_AN735
DR   ABCD; ABCD_AN736
DR   Wikidata; Q123030318
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   6F7 [Mouse hybridoma against ZEBOV VP35]
AC   CVCL_B6LK
DR   Wikidata; Q111732795
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   PubMed=12800775;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q05127; Zaire ebolavirus (strain Mayinga-76) polymerase cofactor VP35.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   6F7 [Mouse hybridoma against phOX]
AC   CVCL_C4FQ
DR   Wikidata; Q116048361
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6F8 [Human LCL]
AC   CVCL_F1ET
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a HIV-1 infected patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   6F8 [Human/mouse hybridoma against HIV-1 gp41]
AC   CVCL_F1EU
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 512-856 = gp41).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1ET ! 6F8 [Human LCL]
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   6F8 [Mouse hybridoma against mouse Zbtb33]
AC   CVCL_C4Z9
DR   Wikidata; Q116048362
RX   PubMed=11461664;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8BN78; Mouse Zbtb33 (Note=Also reacts with human, dog, hamster, monkey, rat and chicken).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 3
//
ID   6F9
AC   CVCL_A6LM
DR   Wikidata; Q107113298
RX   Patent=WO1992017608A1;
RX   PubMed=2007622;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-1006.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   6F9D5
AC   CVCL_A0VB
DR   Wikidata; Q108819725
RX   Patent=CN107299085B;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   6FA9A6
AC   CVCL_E7DT
RX   PubMed=37589992;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P19338; Human NCL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6G10-46-63
AC   CVCL_YK86
DR   Wikidata; Q93309467
RX   Patent=US8546093;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00202.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07944; Staphylococcus aureus beta-lactam-inducible penicillin-binding protein (PBP2a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   6G11 [Mouse hybridoma against human ATP5F1B]
AC   CVCL_C5BV
DR   Wikidata; Q116048363
RX   PubMed=23098302;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06576; Human ATP5F1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6G11 [Mouse hybridoma against phOX]
AC   CVCL_C4FA
DR   Wikidata; Q116048364
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   6G11 [Mouse hybridoma against T.annularis PA2 inhibitor gamma A2]
AC   CVCL_C5FD
DR   Wikidata; Q116048365
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6G2
AC   CVCL_KR70
DR   Wikidata; Q54604597
RX   PubMed=9114041;
WW   Info; -; -; http://www.its.caltech.edu/~bjorker/mAbs.html
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25311; Human AZGP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   6G3
AC   CVCL_B0VR
DR   Wikidata; Q108819726
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   6G4.2.5
AC   CVCL_J003
DR   CLO; CLO_0001461
DR   ATCC; HB-11722
DR   Wikidata; Q54604599
RX   Patent=US5677426;
RX   Patent=US6025158;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11722.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P19874; Rabbit IL8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   6G5.1
AC   CVCL_C9FU
DR   Wikidata; Q123030319
RX   Patent=US8231877;
RX   PubMed=9631008;
CC   Doubling time: 22 hours (PubMed=9631008).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   6G5(AAT) Clone 1C9
AC   CVCL_U076
DR   ECACC; 02043017
DR   Wikidata; Q54604601
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   6G6
AC   CVCL_E9ZX
RX   PubMed=33001741;
RX   PubMed=33085940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6YQN3; Foot-and-mouth disease virus serotype O (Strain O/CHN/Mya98/33-P) genome polyprotein (Note=AA 286-502 = VP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   6H
AC   CVCL_J418
DR   Wikidata; Q54604602
RX   PubMed=11437454;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084.
CC   Breed/subspecies: FVB/N Nkx2.5-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   6H-11
AC   CVCL_C3SZ
DR   Wikidata; Q116048366
RX   PubMed=6302177;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human herpesvirus 2 (HHV-2) 38 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6H1 [Mouse hybridoma against chicken CCL5]
AC   CVCL_C4K1
DR   Wikidata; Q116048367
RX   PubMed=33497732;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QG57; Chicken CCL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6H1 [Mouse hybridoma against P.vivax RBP2b]
AC   CVCL_C5VP
DR   ABCD; ABCD_AJ077
DR   Wikidata; Q116048369
RX   PubMed=29302006;
RX   PubMed=29950717;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A5K736; Plasmodium vivax (strain Salvador I) reticulocyte binding protein 2b (RBP2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   6H11
AC   CVCL_B7CQ
DR   Wikidata; Q112927002
RX   Patent=US8153132;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10314.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P80064; Pseudomonas sp. (strain P.J. 874) 4-hydroxyphenylpyruvate dioxygenase (hpd) (Note=With p.Gly335Trp).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   6H2.B4
AC   CVCL_C4QS
DR   ABCD; ABCD_AE783
DR   Wikidata; Q116048370
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62898; Rat Cycs.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6H4
AC   CVCL_IQ39
DR   Wikidata; Q54604604
RX   Patent=US7259246;
RX   PubMed=9363892;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2295.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with hamster, human, mouse, pig and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   6H6 [Mouse hybridoma against 4-hydroxybenzohydrazide]
AC   CVCL_C8NB
DR   Wikidata; Q123030320
RX   PubMed=33765482;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_195425; 4-hydroxybenzohydrazide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   6H6 [Mouse hybridoma against human F2]
AC   CVCL_B0SK
DR   Wikidata; Q108819727
RX   Patent=US9120862;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10541.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes an abnormal form called PIVKA-II).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   6H6 [Mouse hybridoma against human IL3RA]
AC   CVCL_C3X3
DR   Wikidata; Q116048371
RX   PubMed=8547680;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26951; Human IL3RA/CD123.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   6H7 [Mouse hybridoma against A.farreri 155 kDa protein]
AC   CVCL_XX88
DR   CCRID; 4201PAT-CCTCC00360
DR   Wikidata; Q93309507
RX   Patent=WO2011150690A1;
RX   PubMed=21419852;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201042.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Azumapecten farreri granulocytes 155 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   6H7 [Mouse hybridoma against human 128 kDa antigen]
AC   CVCL_E5M4
RX   PubMed=2466761;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 128 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   6H7(PGM1) Clone D10
AC   CVCL_U077
DR   ECACC; 02043022
DR   Wikidata; Q54604606
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P36871; Human PGM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   6H8
AC   CVCL_B6IX
DR   Wikidata; Q111732796
RX   Patent=WO2018115885A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-176.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_28838; Lutein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   6H9 [Mouse hybridoma against fowl aviadenovirus 4 fiber-1 protein]
AC   CVCL_XV46
DR   Wikidata; Q93309511
RX   PubMed=31286975;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A1B1SLD1; Fowl aviadenovirus 4 (FAdV-4) fiber-1 protein (Note=Also reacts with FAdV-10).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   6H9 [Mouse hybridoma against human AMACR]
AC   CVCL_B6JI
DR   Wikidata; Q111732797
RX   PubMed=29345292;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9UHK6; Human AMACR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   6H9 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HP
SY   6H9-1-1-2
DR   Wikidata; Q110429801
RX   Patent=US8846047;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5434.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1 (Note=Also recognizes human HMGB1 and human/rat Hmgb2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   6LBLN
AC   CVCL_3638
DR   CLO; CLO_0001462
DR   ATCC; CRL-6050
DR   Wikidata; Q54604608
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6050; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   6N5-2-1
AC   CVCL_XH70
DR   Wikidata; Q93309512
RX   Patent=US4973556;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-279.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01563; Human IFNA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   6PNF_SiPSrv_PM_2
AC   CVCL_UN15
SY   6PNF SiPSrv_PM_2
DR   Wikidata; Q93309513
RX   PubMed=30713041;
RX   PubMed=30840859;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520de%2520deposito-6PNF_SiPSrv_PM_2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-%25206PNF_SiPSrv_PM_2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Germans Trias i Pujol (IGTP); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu983Ter (c.2946delT); Zygosity=Heterozygous; Note=Germline (PubMed=30713041).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): BNLC; PubMed=30713041
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 9,13
ST   D18S51: 11,13
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 17,23
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 21,27
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   6R081Cl1
AC   CVCL_6A83
DR   Wikidata; Q54604610
RX   PubMed=286129;
CC   Derived from site: In situ; Upper jaw, hypodermis; UBERON=UBERON_0001709+UBERON_0002072.
DI   NCIt; C134772; Gerbil fibrosarcoma
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   6T-CEM
AC   CVCL_6869
SY   6-T CEM
DR   ATCC; CRL-8296
DR   BioSample; SAMN03471201
DR   cancercelllines; CVCL_6869
DR   CCRID; 3101HUMTCHu2
DR   CLS; 305132
DR   Wikidata; Q54604612
RX   Patent=US4705687;
RX   Patent=US4728614;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8296.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-8296; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8296; CCRID=3101HUMTCHu2; CLS=305132
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 17,18,20,21
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 31,33.2
ST   D2S1338: 24
ST   D3S1358: 14,15 (CCRID=3101HUMTCHu2)
ST   D3S1358: 15 (CLS=305132)
ST   D5S818: 11,12,13 (ATCC=CRL-8296)
ST   D5S818: 11,13 (CCRID=3101HUMTCHu2; CLS=305132)
ST   D6S1043: 11,14
ST   D7S820: 9,14
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   6T-CEM20
AC   CVCL_U293
SY   6T-CEM-20; 6-T CEM-20; 6TCEM20
DR   cancercelllines; CVCL_U293
DR   Wikidata; Q54604614
RX   Patent=US4705687;
RX   Patent=US4728614;
RX   PubMed=6234996;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8295.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6869 ! 6T-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   7 mel
AC   CVCL_C7WC
DR   Wikidata; Q123030321
RX   PubMed=22207316;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   7-1 [Mouse hybridoma against human CKB/CKM]
AC   CVCL_B6X6
DR   CCRID; 4201PAT-CCTCC00715
DR   Wikidata; Q111732798
RX   Patent=CN105132384B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201591.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12277; Human CKB.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   7-1 [Mouse hybridoma against ouabain]
AC   CVCL_B0PZ
DR   Wikidata; Q108819728
RX   Patent=US7348412;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-814.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   7-142
AC   CVCL_XI01
DR   Wikidata; Q93309518
RX   Patent=US5811098;
RX   PubMed=7535774;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11716.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15303; Human ERBB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   7-17
AC   CVCL_6241
DR   Lonza; 1468
DR   Wikidata; Q54604615
RX   PubMed=2885757;
RX   PubMed=8759735;
CC   Characteristics: IL2 or IL7 dependent.
CC   Caution: Erroneously indicated as originating from human in Lonza=1468.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Dendritic epidermal T-cell; CL=CL_0000916.
CC   Breed/subspecies: AKR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   7-34-1
AC   CVCL_G622
DR   CLO; CLO_0001472
DR   ATCC; CRL-1945
DR   Wikidata; Q54604616
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   7-90T
AC   CVCL_A2AN
DR   Wikidata; Q105505963
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   7-TD-1
AC   CVCL_1935
SY   7 TD 1; 7.TD1; 7TD1; 7TDI
DR   CLO; CLO_0001502
DR   CLO; CLO_0001503
DR   CLO; CLO_0050386
DR   CLDB; cl118
DR   ATCC; CRL-1851
DR   ChEMBL-Cells; CHEMBL3307673
DR   ChEMBL-Targets; CHEMBL614646
DR   DSMZ; ACC-23
DR   DSMZCellDive; ACC-23
DR   ICLC; HYL96001
DR   IZSLER; BS Hy 54
DR   PubChem_Cell_line; CVCL_1935
DR   RCB; RCB1190
DR   Wikidata; Q54604618
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=2948184;
RX   PubMed=8747713;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/7td1-atcc-crl-1851
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=7TD1
CC   Doubling time: ~24-25 hours (DSMZ=ACC-23).
CC   Caution: Was reported to be IL6 dependent, but is not according to ATCC.
CC   Discontinued: ATCC; CRL-1851; true.
CC   Discontinued: ICLC; HYL96001; true.
ST   Source(s): DSMZ=ACC-23
ST   Mouse STR 4-2: 18.3,21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 16,17,18
ST   Mouse STR 6-7: 12,13
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 15-3: 20.3,22.3
ST   Mouse STR 18-3: 18,19,20
ST   Mouse STR X-1: 25,26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   7.107 pRSV-T
AC   CVCL_L074
SY   7.107
DR   Wikidata; Q54604621
RX   Patent=US5672498;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11136.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 14
//
ID   7.10D7
AC   CVCL_A0NL
DR   Wikidata; Q108819729
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.10H2
AC   CVCL_A0NM
DR   Wikidata; Q108819730
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.159.2
AC   CVCL_B0L4
SY   50-002-7.159.2 HSFM; MEDI-573
DR   ABCD; ABCD_AA677
DR   Wikidata; Q108819731
RX   Patent=US9796779;
RX   PubMed=21245093;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7424.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma is tested as a potential therapeutic antibody with antineoplastic activity under the name dusigitumab.
CC   Monoclonal antibody isotype: IgG2, lambda.
CC   Monoclonal antibody target: UniProtKB; P05019; Human IGF1.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 6
//
ID   7.16.4
AC   CVCL_X742
DR   ATCC; HB-10493
DR   Wikidata; Q54604622
RX   Patent=US5824311;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10493.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   7.160.2
AC   CVCL_B0L5
DR   Wikidata; Q108819732
RX   Patent=US9796779;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1).
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   7.1C5
AC   CVCL_A0MY
SY   7.1C5-1(#2)
DR   Wikidata; Q108819733
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3900.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   7.1G10
AC   CVCL_A0MZ
SY   7.1G10-2-1(#5)
DR   Wikidata; Q108819734
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3898.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   7.2
AC   CVCL_XH61
DR   Wikidata; Q93309563
RX   Patent=US10716838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4402.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00481; Human BTN3A1/CD277.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   7.2-02
AC   CVCL_A4WA
DR   Wikidata; Q107113299
RX   PubMed=27252991;
CC   Characteristics: Zfp57-/- mz (M-Z-) genotype.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   7.234.2
AC   CVCL_B0L6
DR   Wikidata; Q108819735
RX   Patent=US9796779;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1).
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   7.251.3
AC   CVCL_B0L7
DR   Wikidata; Q108819736
RX   Patent=US9796779;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7422.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1).
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 5
//
ID   7.2A1
AC   CVCL_A0NA
DR   Wikidata; Q108819737
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.2F5
AC   CVCL_A0NB
DR   Wikidata; Q108819738
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.2H2
AC   CVCL_A0NC
DR   Wikidata; Q108819739
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.34.1
AC   CVCL_B0L8
DR   Wikidata; Q108819740
RX   Patent=US9796779;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7423.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1).
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 5
//
ID   7.4
AC   CVCL_XY42
SY   7F12
DR   Wikidata; Q93309567
RX   Patent=US7192582;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24071; Human FCAR/CD89.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   7.4.C4
AC   CVCL_M029
DR   ECACC; 92092321
DR   Wikidata; Q54604624
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Cell surface components expressed on leukocytes, red blood cells and vascular endothelial cells of fish.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   7.4A3
AC   CVCL_A0ND
DR   Wikidata; Q108819741
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.7G5
AC   CVCL_A0NE
SY   7.7G5-1-1(#32)
DR   Wikidata; Q108819742
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3899.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   7.8B3
AC   CVCL_A0NF
DR   Wikidata; Q108819743
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.8C9
AC   CVCL_A0NG
DR   Wikidata; Q108819744
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.8H12
AC   CVCL_A0NH
DR   Wikidata; Q108819745
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.9D4
AC   CVCL_A0NI
DR   Wikidata; Q108819746
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.9G8
AC   CVCL_A0NJ
DR   Wikidata; Q108819747
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7.9H5
AC   CVCL_A0NK
DR   Wikidata; Q108819748
RX   Patent=US9745376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   70-100-1
AC   CVCL_YA07
DR   ABCD; ABCD_AK421
DR   DSHB; 70-100-1
DR   Wikidata; Q93309578
RX   DOI=10.24450/journals/abrep.2019.e56;
RX   DOI=10.24450/journals/abrep.2019.e57;
RX   PubMed=1328220;
RX   PubMed=9704504;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01501; Dictyostelium discoideum porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   701-LCL
AC   CVCL_8072
DR   CLO; CLO_0051015
DR   BioSample; SAMN03471952
DR   RCB; RCB2282
DR   TKG; TKG 0610
DR   Wikidata; Q54604626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2282; TKG=TKG 0610
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 7,11 (TKG=TKG 0610)
ST   TPOX: 11 (RCB=RCB2282)
ST   vWA: 16,17,18 (RCB=RCB2282)
ST   vWA: 16,18 (TKG=TKG 0610)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   703.2
AC   CVCL_C5XE
DR   Wikidata; Q116048372
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   703A1
AC   CVCL_DQ21
DR   GEO; GSM1040290
DR   GEO; GSM1040360
DR   Wikidata; Q54604628
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ06 ! 585A1
OI   CVCL_DQ07 ! 585B1
OI   CVCL_DQ20 ! 692D2
OI   CVCL_LJ36 ! 692E1
OI   CVCL_DQ22 ! 703B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   703B1
AC   CVCL_DQ22
DR   GEO; GSM1040291
DR   GEO; GSM1040361
DR   Wikidata; Q54604629
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ06 ! 585A1
OI   CVCL_DQ07 ! 585B1
OI   CVCL_DQ20 ! 692D2
OI   CVCL_LJ36 ! 692E1
OI   CVCL_DQ21 ! 703A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   703D4
AC   CVCL_J151
DR   CLO; CLO_0001465
DR   ATCC; HB-8301
DR   TKG; TKG 0180
DR   Wikidata; Q54604631
RX   Patent=US4569788;
RX   PubMed=6306102;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8301.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P22626; Human HNRNPA2B1.
CC   Discontinued: TKG; TKG 0180; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   704A1
AC   CVCL_QZ03
DR   Wikidata; Q54604632
RX   Patent=US4569788;
RX   PubMed=6306102;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8302.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P22626; Human HNRNPA2B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   707.fl
AC   CVCL_H711
DR   CLO; CLO_0050779
DR   ECACC; 99072807
DR   RCB; RCB0569
DR   Wikidata; Q54604634
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 8
//
ID   707B1011C3
AC   CVCL_4094
DR   CLO; CLO_0001467
DR   CLDB; cl122
DR   ECACC; 87120401
DR   Wikidata; Q54604636
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   70BR
AC   CVCL_ZT29
SY   70 BRighton
DR   Wikidata; Q98125425
RX   PubMed=2903889;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   70E5
AC   CVCL_D5YH
DR   Wikidata; Q127378768
RX   PubMed=38495763;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y624; Human F11R/CD321.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   70Z/3
AC   CVCL_0127
SY   70 Z/3; 70 z/3; 70Z3; 70Z/3.12; 7OZ/3
DR   BTO; BTO_0000788
DR   CLO; CLO_0001468
DR   EFO; EFO_0022769
DR   MCCL; MCC:0000019
DR   CLDB; cl123
DR   ATCC; TIB-158
DR   ECACC; 91092002
DR   TOKU-E; 406
DR   Wikidata; Q54604640
RX   PubMed=308074;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Misspelling: 702/3; Note=Occasionally.
CC   Breed/subspecies: C57BL/6 x DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   71 BLCL
AC   CVCL_E410
DR   ECACC; 94031611
DR   Wikidata; Q54604641
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   71-31
AC   CVCL_9V05
DR   Wikidata; Q54604643
RX   Patent=US5731189;
RX   PubMed=2922401;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: HIV-1 capsid protein p24.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   71-5.2F9
AC   CVCL_A6HZ
SY   2F9
DR   Wikidata; Q107113300
RX   PubMed=2474525;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human gastric carcinoma cell surface carbohydrate epitope.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V73 ! HM-5 [Human/mouse heteromyeloma]
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   711A1
AC   CVCL_DQ23
DR   GEO; GSM1040294
DR   GEO; GSM1040364
DR   Wikidata; Q54604645
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ11 ! 606A1
OI   CVCL_DQ12 ! 606B1
OI   CVCL_DR11 ! 711A5
OI   CVCL_DQ24 ! 711A6
OI   CVCL_DQ25 ! 711C1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   711A5
AC   CVCL_DR11
DR   GEO; GSM2152678
DR   Wikidata; Q54604647
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ11 ! 606A1
OI   CVCL_DQ12 ! 606B1
OI   CVCL_DQ23 ! 711A1
OI   CVCL_DQ24 ! 711A6
OI   CVCL_DQ25 ! 711C1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   711A6
AC   CVCL_DQ24
DR   GEO; GSM1040295
DR   GEO; GSM1040365
DR   Wikidata; Q54604649
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ11 ! 606A1
OI   CVCL_DQ12 ! 606B1
OI   CVCL_DQ23 ! 711A1
OI   CVCL_DR11 ! 711A5
OI   CVCL_DQ25 ! 711C1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   711C1
AC   CVCL_DQ25
DR   GEO; GSM1040296
DR   GEO; GSM1040366
DR   Wikidata; Q54604650
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ11 ! 606A1
OI   CVCL_DQ12 ! 606B1
OI   CVCL_DQ23 ! 711A1
OI   CVCL_DR11 ! 711A5
OI   CVCL_DQ24 ! 711A6
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   715
AC   CVCL_A9NK
DR   BEI_Resources; ARP-1278
DR   Wikidata; Q108819749
RX   PubMed=2983494;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp70.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   716 SS MNV
AC   CVCL_B7V0
SY   716
DR   Wikidata; Q112927004
RX   Patent=RU2740800;
RX   PubMed=33290900;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 790D.
CC   Derived from site: Metastatic; Colon; UBERON=UBERON_0001155.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   7160c2
AC   CVCL_YM32
DR   GEO; GSM2974142
DR   GEO; GSM2974143
DR   GEO; GSM2974218
DR   GEO; GSM2974937
DR   GEO; GSM2974938
DR   Kerafast; EUP012-FP
DR   Wikidata; Q93309652
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM33 ! 7160c5
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   7160c5
AC   CVCL_YM33
DR   GEO; GSM2974144
DR   GEO; GSM2974145
DR   GEO; GSM2974219
DR   GEO; GSM2974939
DR   GEO; GSM2974940
DR   Kerafast; EUP008-FP
DR   Wikidata; Q93309654
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_YM32 ! 7160c2
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   71A7
AC   CVCL_J049
DR   CLO; CLO_0001469
DR   ATCC; TIB-147
DR   Wikidata; Q54604653
RX   PubMed=6161967;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   71A8
AC   CVCL_D5YI
DR   Wikidata; Q127378769
RX   PubMed=38495763;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y624; Human F11R/CD321.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   71BR
AC   CVCL_ZT28
SY   71 BRighton
DR   Wikidata; Q98125426
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   71L2
AC   CVCL_B5Z7
DR   Wikidata; Q111732799
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1-561 = mRNA-capping enzyme nsP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   720
AC   CVCL_6242
DR   Lonza; 1033
DR   Wikidata; Q54604654
CC   Knockout cell: Method=KO mouse; MGI; MGI:102688; H2ax.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   725.1
AC   CVCL_0I08
DR   Wikidata; Q54604655
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5124.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   7265PDA
AC   CVCL_HX27
DR   Wikidata; Q54604658
RX   PubMed=26322225;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 4
//
ID   729-mel
AC   CVCL_S561
SY   729-MEL; 729mel
DR   cancercelllines; CVCL_S561
DR   CGH-DB; 9303-4
DR   Cosmic; 905216
DR   Wikidata; Q54604753
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   72A1
AC   CVCL_1936
SY   72 A1
DR   CLO; CLO_0001470
DR   CLDB; cl124
DR   CLDB; cl5143
DR   ABCD; ABCD_AI642
DR   ATCC; HB-168
DR   DSMZ; ACC-89
DR   DSMZCellDive; ACC-89
DR   IZSLER; BS Hy 35
DR   Wikidata; Q54604755
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=6182100;
RX   PubMed=6248876;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03200; Epstein-Barr virus (strain B95-8) envelope glycoprotein GP350 (BLLF1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   73/1
AC   CVCL_G623
DR   CLO; CLO_0001471
DR   ATCC; HB-66
DR   IZSLER; BS Hy 56
DR   Wikidata; Q54604756
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03441; Influenza A virus (strain A/Bangkok/1/1979 H3N2) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   731-mel
AC   CVCL_S562
SY   731-MEL; 731mel
DR   cancercelllines; CVCL_S562
DR   CGH-DB; 9304-4
DR   Cosmic; 905217
DR   Wikidata; Q54604758
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   7316A
AC   CVCL_3944
SY   Morris hepatoma 7316A; Morris hepatoma-7316A
DR   BTO; BTO_0001941
DR   Wikidata; Q54604761
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   7349-3
AC   CVCL_E4K1
RX   PubMed=36202854;
CC   Sequence variation: Gene deletion; HGNC; HGNC:14294; SHANK3; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Sequence variation, sampling site and cell type from personal communication of Ullah, H.M. Arif.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   736G9
AC   CVCL_B0DR
DR   Wikidata; Q108819750
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   73B
AC   CVCL_M030
DR   ECACC; 91060554
DR   Wikidata; Q54604763
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; W5Q2E5; Sheep PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   74 BLCL
AC   CVCL_E411
DR   ECACC; 94031612
DR   Wikidata; Q54604766
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   74-11-10
AC   CVCL_4467
DR   CLO; CLO_0001473
DR   CLDB; cl5150
DR   ATCC; HB-139
DR   IZSLER; BS Hy 19
DR   Wikidata; Q54604768
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgG2b, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   74-12-4
AC   CVCL_4468
DR   CLO; CLO_0001474
DR   CLDB; cl5152
DR   ATCC; HB-147
DR   IZSLER; BS Hy 20
DR   Wikidata; Q54604769
RX   PubMed=2114680;
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6R3N4; Pig CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   74-22-15
AC   CVCL_4469
DR   CLO; CLO_0001475
DR   CLDB; cl5153
DR   ATCC; HB-142
DR   IZSLER; BS Hy 21
DR   Wikidata; Q54604771
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   74-22-15A
AC   CVCL_4470
DR   CLO; CLO_0001476
DR   ATCC; HB-142.1
DR   Wikidata; Q54604774
CC   Characteristics: Isotype switched derivative of 74-22-15.
CC   Monoclonal antibody isotype: IgG2b, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4469 ! 74-22-15
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   74-9-3
AC   CVCL_4471
DR   CLO; CLO_0001478
DR   CLDB; cl5144
DR   ATCC; HB-156
DR   IZSLER; BS Hy 15
DR   Wikidata; Q54604776
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; K7GMW0; Pig PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   741F8
AC   CVCL_N286
SY   741F8-2B9
DR   ATCC; HB-10807
DR   Wikidata; Q54604777
RX   Patent=US4938948;
RX   Patent=US5169774;
RX   PubMed=2470501;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10807.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10078.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   743E
AC   CVCL_7944
DR   Wikidata; Q54604778
RX   PubMed=66978;
RX   PubMed=748774;
RX   PubMed=6244232;
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=66978; PubMed=748774).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   744
AC   CVCL_VG60
DR   Wikidata; Q54604780
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg959Trp (c.2875C>T) (p.Arg977Trp, c.2929C>T); ClinVar=VCV000284254; Zygosity=Heterozygous (Jain Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Trp1869Ter (c.5606G>A) (p.Trp1908Ter, c.5724G>A); ClinVar=VCV000571837; Zygosity=Heterozygous (Jain Foundation).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, triceps brachii; UBERON=UBERON_0001509.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   744A2
AC   CVCL_DQ26
DR   GEO; GSM936066
DR   GEO; GSM1489210
DR   GEO; GSM1489236
DR   GEO; GSM1489450
DR   GEO; GSM1942572
DR   GEO; GSM1942588
DR   GEO; GSM1942589
DR   Wikidata; Q54604781
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ27 ! 744B9
OI   CVCL_DQ28 ! 751A3
OI   CVCL_DQ29 ! 751B4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   744B9
AC   CVCL_DQ27
DR   GEO; GSM936067
DR   GEO; GSM1489211
DR   GEO; GSM1489235
DR   GEO; GSM1489451
DR   SKIP; SKIP001464
DR   Wikidata; Q54604784
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ26 ! 744A2
OI   CVCL_DQ28 ! 751A3
OI   CVCL_DQ29 ! 751B4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   745C2
AC   CVCL_4095
DR   CLO; CLO_0001477
DR   CLDB; cl125
DR   ECACC; 87030901
DR   Wikidata; Q54604785
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   748.4
AC   CVCL_C5XF
DR   Wikidata; Q116048373
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   749.1
AC   CVCL_C5XG
DR   Wikidata; Q116048374
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   74C3
AC   CVCL_RB01
DR   Wikidata; Q54604786
RX   PubMed=1116142;
RX   PubMed=1260765;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Sex unspecified
AG   48D
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   74H3
AC   CVCL_D5YJ
DR   Wikidata; Q127378770
RX   PubMed=38495763;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y624; Human F11R/CD321.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   7501
AC   CVCL_B991
SY   A7501
DR   CLO; CLO_0050403
DR   RCB; RCB0116
DR   Wikidata; Q54604789
RX   PubMed=2828049;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0CS90; Saccharomyces cerevisiae SSC1/ENS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   751-NA-15
AC   CVCL_M361
SY   751-NA; 751
DR   CCRID; 4201PAT-CCTCC00103
DR   Wikidata; Q54604797
RX   Patent=US5981708;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10992.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12160.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   751A3
AC   CVCL_DQ28
DR   GEO; GSM936064
DR   GEO; GSM1489212
DR   GEO; GSM1489228
DR   GEO; GSM1489452
DR   Wikidata; Q54604791
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ26 ! 744A2
OI   CVCL_DQ27 ! 744B9
OI   CVCL_DQ29 ! 751B4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   751B4
AC   CVCL_DQ29
DR   GEO; GSM936065
DR   GEO; GSM1489213
DR   GEO; GSM1489229
DR   GEO; GSM1489453
DR   GEO; GSM1493701
DR   GEO; GSM1942577
DR   GEO; GSM1942578
DR   GEO; GSM1942579
DR   Wikidata; Q54604792
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ26 ! 744A2
OI   CVCL_DQ27 ! 744B9
OI   CVCL_DQ28 ! 751A3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   751G
AC   CVCL_7945
DR   Wikidata; Q54604794
RX   PubMed=66978;
RX   PubMed=748774;
RX   PubMed=6244232;
CC   Population: Caucasian.
CC   Doubling time: 56 hours (PubMed=66978; PubMed=748774).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   758G5
AC   CVCL_B0DS
DR   Wikidata; Q108819751
RX   PubMed=1715033;
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   759E3
AC   CVCL_B0DT
DR   Wikidata; Q108819752
RX   Patent=US4938948;
RX   PubMed=2470501;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10808.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10079.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   759G12
AC   CVCL_B0DU
DR   Wikidata; Q108819753
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   75B10
AC   CVCL_E7SI
RX   PubMed=1379786;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   75e7vg1
AC   CVCL_Z927
SY   75e 7vg1; 75 e 7 vg1
DR   FlyBase_Cell_line; FBtc9000023
DR   Wikidata; Q54604798
RX   CelloPub=CLPUB00208;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/0020-1790(83)90040-9;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   75e7vg2
AC   CVCL_Z917
SY   75e 7vg2; 75 e 7 vg2
DR   CLO; CLO_0001479
DR   CLDB; cl126
DR   FlyBase_Cell_line; FBtc9000024
DR   Wikidata; Q54604801
RX   CelloPub=CLPUB00208;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   75e7vg3
AC   CVCL_Z928
SY   75e 7vg3; 75 e 7 vg3
DR   FlyBase_Cell_line; FBtc9000025
DR   Wikidata; Q54604802
RX   CelloPub=CLPUB00208;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   75e7vg4
AC   CVCL_Z929
SY   75e 7vg4; 75 e 7 vg4
DR   FlyBase_Cell_line; FBtc9000026
DR   Wikidata; Q54604805
RX   CelloPub=CLPUB00208;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   75e7vg5
AC   CVCL_Z918
SY   75e 7vg5; 75 e 7 vg5
DR   FlyBase_Cell_line; FBtc9000027
DR   Wikidata; Q54604806
RX   CelloPub=CLPUB00208;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   75e7vg6
AC   CVCL_Z930
SY   75e 7vg6; 75 e 7 vg6
DR   FlyBase_Cell_line; FBtc9000028
DR   Wikidata; Q54604809
RX   CelloPub=CLPUB00208;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   75e7vg7
AC   CVCL_Z919
SY   75e 7vg7; 75 e 7 vg7
DR   FlyBase_Cell_line; FBtc9000029
DR   Wikidata; Q54604811
RX   CelloPub=CLPUB00208;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   75II
AC   CVCL_XV47
DR   Wikidata; Q93309808
RX   DOI=10.13523/j.cb.20180408;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; X2G6F6; Tupaia belangeri CD3E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   75j23pe34
AC   CVCL_Z926
SY   75j23PE
DR   CLO; CLO_0001480
DR   CLDB; cl127
DR   Wikidata; Q54604814
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/0020-1790(83)90040-9;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   76 BLCL
AC   CVCL_E412
DR   ECACC; 94031613
DR   Wikidata; Q54604817
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   76-1
AC   CVCL_E7YG
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 6 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   76-2
AC   CVCL_Z022
DR   Wikidata; Q54604818
RX   PubMed=7817386;
RX   PubMed=9163851;
CC   Population: Japanese.
CC   Doubling time: 0.9 day (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   76-2-11
AC   CVCL_4472
DR   CLO; CLO_0001481
DR   ATCC; HB-143
DR   Wikidata; Q54604819
RX   PubMed=2114680;
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F1SVD3; Pig CD8A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   76-3
AC   CVCL_E7YH
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 1.7 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   76-5-28
AC   CVCL_4473
DR   CLO; CLO_0001482
DR   ATCC; HB-153
DR   Wikidata; Q54604822
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   76-6-7
AC   CVCL_4474
DR   CLO; CLO_0001483
DR   ATCC; HB-141
DR   Wikidata; Q54604824
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   76-7-4
AC   CVCL_4475
DR   CLO; CLO_0001484
DR   CLDB; cl5154
DR   ATCC; HB-140
DR   IZSLER; BS Hy 22
DR   Wikidata; Q54604826
RX   PubMed=6609988;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   7603830
AC   CVCL_E931
DR   Wikidata; Q54604827
RX   PubMed=11528123;
WW   Info; KCCMR; -; https://web.archive.org/web/20110829112150/http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Bolivian/Peruvian hybrid.
OX   NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis (Bolivian squirrel monkey)
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   760C5
AC   CVCL_B0DV
DR   Wikidata; Q108819754
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   761B10
AC   CVCL_B0DW
DR   Wikidata; Q108819755
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   762B3.1
AC   CVCL_C4UN
DR   Wikidata; Q116048375
RX   PubMed=2944952;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   769-P
AC   CVCL_1050
SY   769P; 769-p
DR   BTO; BTO_0006376
DR   CLO; CLO_0001485
DR   EFO; EFO_0002099
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1933
DR   BioGRID_ORCS_Cell_line; 501
DR   BioSample; SAMN03473275
DR   BioSample; SAMN10988198
DR   cancercelllines; CVCL_1050
DR   CCRID; 1101HUM-PUMC000333
DR   CCRID; 3101HUMSCSP5060
DR   CCRID; 3101HUMTCHu215
DR   CCRID; 4201HUM-CCTCC00103
DR   CCTCC; GDC0103
DR   Cell_Model_Passport; SIDM00803
DR   ChEMBL-Cells; CHEMBL3308705
DR   ChEMBL-Targets; CHEMBL1075385
DR   CLS; 300106
DR   Cosmic; 687935
DR   Cosmic; 801355
DR   Cosmic; 910922
DR   Cosmic; 982280
DR   Cosmic; 1779197
DR   Cosmic; 2520640
DR   Cosmic-CLP; 910922
DR   DepMap; ACH-000411
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910922
DR   GEO; GSM374479
DR   GEO; GSM827256
DR   GEO; GSM886844
DR   GEO; GSM887908
DR   GEO; GSM1669571
DR   IARC_TP53; 21154
DR   IGRhCellID; 769P
DR   IZSLER; BS TCL 123
DR   KCB; KCB 2013031YJ
DR   LiGeA; CCLE_445
DR   LINCS_LDP; LCL-1772
DR   PharmacoDB; 769P_27_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1050
DR   PubChem_Cell_line; CVCL_1050
DR   Wikidata; Q54604830
RX   PubMed=721102;
RX   PubMed=1010528;
RX   PubMed=6244232;
RX   PubMed=17178751;
RX   PubMed=20215515;
RX   PubMed=22185343;
RX   PubMed=22460905;
RX   PubMed=22949125;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27993170;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=721102).
CC   HLA typing: A*03:01,24:02; B*07:02,07:02; C*07:02,07:02; DQB1*06:07,06:07; DRB1*15:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.32%; Native American=0%; East Asian, North=3.45%; East Asian, South=0%; South Asian=0%; European, North=68.23%; European, South=27% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1933; CCRID; CLS=300106; Cosmic-CLP=910922; IZSLER=BS TCL 123; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,14
ST   D16S539: 9,13
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,16
ST   FGA: 20,22
ST   Penta D: 12,16
ST   Penta E: 7,18
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   769E11
AC   CVCL_B0DX
DR   Wikidata; Q108819756
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   76G5B3
AC   CVCL_F0H0
RX   Patent=US10973915;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279 (Note=Also reacts with M.fascicularis).
CC   Miscellaneous: As the immunized splenic B-cells are from H2L2 transgenic mice the produced mAB is a chimeric Ig having human variable domain and rat constant region.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   76N
AC   CVCL_A5AG
DR   EFO; EFO_0022346
DR   GEO; GSM324070
DR   GEO; GSM324071
DR   GEO; GSM324072
DR   Wikidata; Q107113301
RX   PubMed=7537374;
RX   PubMed=10438818;
RX   PubMed=19147561;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   76N RhoA.G14V
AC   CVCL_C2V2
DR   GEO; GSM324076
DR   GEO; GSM324077
DR   GEO; GSM324078
DR   Wikidata; Q114310499
RX   PubMed=19147561;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:667; RHOA (Note=With p.Gly14Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: RHOA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AG ! 76N
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   76N RhoA.T19N
AC   CVCL_C2V3
DR   Wikidata; Q114310500
RX   PubMed=19147561;
CC   Senescence: Senesces at ~20 PDL (PubMed=19147561).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:667; RHOA (Note=With p.Thr19Asn).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AG ! 76N
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   76N RhoA.T37A
AC   CVCL_C2V4
DR   GEO; GSM324079
DR   GEO; GSM324080
DR   GEO; GSM324081
DR   Wikidata; Q114310501
RX   PubMed=19147561;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:667; RHOA (Note=With p.Thr37Ala).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: RHOA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AG ! 76N
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   76N RhoA.WT
AC   CVCL_C2V1
DR   GEO; GSM324073
DR   GEO; GSM324074
DR   GEO; GSM324075
DR   Wikidata; Q114310502
RX   PubMed=19147561;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:667; RHOA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: RHOA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AG ! 76N
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   76N-F2V
AC   CVCL_A5AH
SY   76NF2V
DR   BTO; BTO_0006202
DR   GEO; GSM2258686
DR   GEO; GSM2258687
DR   GEO; GSM2258688
DR   GEO; GSM2258689
DR   GEO; GSM2258690
DR   GEO; GSM2258691
DR   GEO; GSM2258692
DR   GEO; GSM2258693
DR   GEO; GSM2258694
DR   GEO; GSM2258695
DR   GEO; GSM2258696
DR   GEO; GSM2258697
DR   GEO; GSM2258698
DR   GEO; GSM2258699
DR   GEO; GSM2258700
DR   GEO; GSM2258701
DR   GEO; GSM2258702
DR   GEO; GSM2258703
DR   GEO; GSM2258920
DR   GEO; GSM2258921
DR   GEO; GSM2258922
DR   Wikidata; Q107113302
RX   PubMed=10438818;
RX   PubMed=23722650;
RX   PubMed=29273624;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With p.Phe9Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AG ! 76N
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   76NE6
AC   CVCL_S909
SY   76E6
DR   Wikidata; Q54604927
RX   PubMed=1658367;
RX   PubMed=7537374;
RX   PubMed=23722650;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AG ! 76N
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   76NE7
AC   CVCL_S910
SY   76E7
DR   Wikidata; Q54604928
RX   PubMed=1658367;
RX   PubMed=7537374;
RX   PubMed=23722650;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AG ! 76N
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   76T
AC   CVCL_A2AP
DR   Wikidata; Q105505965
RX   PubMed=10545285;
RX   PubMed=14978140;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   77-1
AC   CVCL_A5MS
DR   Wikidata; Q107113304
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.4 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   77-2
AC   CVCL_E7YI
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 28 days (PubMed=7817386).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   77-3
AC   CVCL_RA79
DR   Wikidata; Q54604930
RX   PubMed=1306323;
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 6 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   77-4
AC   CVCL_Z023
DR   Wikidata; Q54604932
RX   PubMed=7817386;
RX   PubMed=9163851;
CC   Population: Japanese.
CC   Doubling time: 1.9 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   770G4
AC   CVCL_B0DY
DR   Wikidata; Q108819757
RX   PubMed=2470501;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   776.1
AC   CVCL_0I09
DR   Wikidata; Q54604934
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4570.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   7777-14b-aza
AC   CVCL_0F78
SY   7777-14b-AZA
DR   Wikidata; Q54604935
RX   PubMed=3859464;
RX   PubMed=6604949;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0444 ! McA-RH7777
OI   CVCL_2113 ! MH-7777A
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   77LO
AC   CVCL_C3QG
SY   77 LOndon
DR   Wikidata; Q116048376
RX   PubMed=6459055;
CC   Doubling time: 54.1 hours (PubMed=6459055).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   77N1
AC   CVCL_6810
DR   JCRB; IFO50280
DR   Wikidata; Q54604939
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 (B77)).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   77RD218
AC   CVCL_B5MF
DR   Wikidata; Q111732800
RX   PubMed=3337113;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   77RD224
AC   CVCL_B5MG
DR   Wikidata; Q111732801
RX   PubMed=3337113;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   77RD40
AC   CVCL_B5MH
SY   77 RD 40
DR   Wikidata; Q111732804
RX   PubMed=6303650;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   77RD6
AC   CVCL_B5MI
SY   77 RD 6
DR   Wikidata; Q111732805
RX   PubMed=6303650;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   78 BLCL
AC   CVCL_E413
DR   ECACC; 94031614
DR   Wikidata; Q54604940
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   78-1
AC   CVCL_E7YB
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 5.0 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   78-2
AC   CVCL_E7Y6
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.8 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   78-299-4
AC   CVCL_C4E1
DR   ABCD; ABCD_AE816
DR   Wikidata; Q116048377
RX   PubMed=2122240;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   78-5
AC   CVCL_1Q52
DR   Wikidata; Q54604942
RX   PubMed=2595451;
RX   PubMed=4332008;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U406 ! CHO-glyA
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   78-5j1
AC   CVCL_1Q53
SY   J1; J1(glyA)
DR   Wikidata; Q54604945
RX   PubMed=2595451;
RX   PubMed=4332008;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q52 ! 78-5
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   7800C1
AC   CVCL_3870
SY   7800 C1; Morris hepatoma 7800C1
DR   BTO; BTO_0002535
DR   ChEMBL-Cells; CHEMBL3308566
DR   ChEMBL-Targets; CHEMBL614742
DR   PubChem_Cell_line; CVCL_3870
DR   Wikidata; Q54604947
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   783E2
AC   CVCL_B7DI
DR   Wikidata; Q112927006
RX   PubMed=28233934;
RX   PubMed=28858313;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7DF ! 1274A8
OI   CVCL_B7DE ! 1274A15
OI   CVCL_B7DK ! PD12-1
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   784T
AC   CVCL_A2AQ
DR   Wikidata; Q105505968
RX   PubMed=10545285;
RX   PubMed=11929836;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   786-M1A
AC   CVCL_VR30
DR   cancercelllines; CVCL_VR30
DR   GEO; GSM800328
DR   Wikidata; Q93309878
RX   PubMed=23223005;
CC   Population: Caucasian.
CC   Characteristics: Established from lung metastatis in NOD/SCID mice which were intravenous inoculated with the parental cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   786-M1B
AC   CVCL_VR31
DR   cancercelllines; CVCL_VR31
DR   GEO; GSM800329
DR   Wikidata; Q93309879
RX   PubMed=23223005;
CC   Population: Caucasian.
CC   Characteristics: Established from lung metastatis in NOD/SCID mice which were intravenous inoculated with the parental cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   786-M2A
AC   CVCL_VR32
DR   cancercelllines; CVCL_VR32
DR   GEO; GSM800330
DR   Wikidata; Q93309880
RX   PubMed=23223005;
CC   Population: Caucasian.
CC   Characteristics: Established from lung metastatis in NOD/SCID mice which were intravenous inoculated with the parental cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR30 ! 786-M1A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   786-M2B
AC   CVCL_VR33
DR   cancercelllines; CVCL_VR33
DR   GEO; GSM800331
DR   Wikidata; Q93309881
RX   PubMed=23223005;
CC   Population: Caucasian.
CC   Characteristics: Established from lung metastatis in NOD/SCID mice which were intravenous inoculated with the parental cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR30 ! 786-M1A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   786-O
AC   CVCL_1051
SY   786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT
DR   BTO; BTO_0003781
DR   CLO; CLO_0001486
DR   EFO; EFO_0005707
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1932
DR   BCRC; 60243
DR   BioGRID_ORCS_Cell_line; 502
DR   BioSample; SAMN03471906
DR   BioSample; SAMN10988199
DR   cancercelllines; CVCL_1051
DR   CCRID; 1101HUM-PUMC000243
DR   CCRID; 3101HUMSCSP5059
DR   CCRID; 3101HUMTCHu186
DR   CCRID; 4201HUM-CCTCC00159
DR   CCRID; 5301HUM-KCB09014YJ
DR   CCTCC; GDC0159
DR   Cell_Model_Passport; SIDM00125
DR   ChEMBL-Cells; CHEMBL3308018
DR   ChEMBL-Targets; CHEMBL613102
DR   CLS; 300107
DR   Cosmic; 687936
DR   Cosmic; 875874
DR   Cosmic; 897461
DR   Cosmic; 905947
DR   Cosmic; 972929
DR   Cosmic; 974305
DR   Cosmic; 982276
DR   Cosmic; 1044259
DR   Cosmic; 1092589
DR   Cosmic; 1175848
DR   Cosmic; 1305372
DR   Cosmic; 1312360
DR   Cosmic; 1481416
DR   Cosmic; 1998431
DR   Cosmic; 2036676
DR   Cosmic; 2520637
DR   Cosmic; 2663796
DR   Cosmic-CLP; 905947
DR   DepMap; ACH-000649
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS261AAA
DR   ENCODE; ENCBS413VCR
DR   ENCODE; ENCBS807WMR
DR   GDSC; 905947
DR   GEO; GSM2128
DR   GEO; GSM50226
DR   GEO; GSM50290
DR   GEO; GSM482711
DR   GEO; GSM743488
DR   GEO; GSM750838
DR   GEO; GSM799371
DR   GEO; GSM799377
DR   GEO; GSM799434
DR   GEO; GSM843437
DR   GEO; GSM846283
DR   GEO; GSM886845
DR   GEO; GSM887909
DR   GEO; GSM1153444
DR   GEO; GSM1177874
DR   GEO; GSM1177875
DR   GEO; GSM1177876
DR   GEO; GSM1181296
DR   GEO; GSM1181322
DR   GEO; GSM1669572
DR   GEO; GSM2124635
DR   IARC_TP53; 18076
DR   IARC_TP53; 28222
DR   IZSLER; BS TCL 124
DR   KCB; KCB 200941YJ
DR   LiGeA; CCLE_806
DR   LINCS_LDP; LCL-1773
DR   Lonza; 1087
DR   MetaboLights; MTBLS737
DR   NCI-DTP; 786-0
DR   PharmacoDB; 7860_28_2019
DR   PRIDE; PXD000335
DR   PRIDE; PXD000589
DR   PRIDE; PXD001493
DR   PRIDE; PXD003105
DR   PRIDE; PXD003539
DR   PRIDE; PXD005453
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1051
DR   PubChem_Cell_line; CVCL_1051
DR   SKY/M-FISH/CGH; 2782
DR   Ubigene; YC-C113
DR   Wikidata; Q54604950
RX   PubMed=721102;
RX   PubMed=1010528;
RX   PubMed=2041050;
RX   PubMed=6244232;
RX   PubMed=7915601;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15585611;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22185343;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22949125;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=27993170;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30260228;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31267758;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/RCC7860_Crawford_protocol.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=40
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/786o-xenograft-model/
WW   Provider; BRICS; BRICS0120; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3924
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 45 hours (PubMed=721102); 24 hours (PubMed=25984343); ~24 hours (CLS=300107); 22.4 hours (NCI-DTP=786-0).
CC   HLA typing: A*03; B*07,44 (PubMed=15585611).
CC   HLA typing: A*03:01:01; B*07,44; C*05,07:02:01; DPB1*04:02; DQB1*06,06; DRB1*13,15 (PubMed=15748285).
CC   HLA typing: A*03:01,03:01; B*07:02,44:02; C*05:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (PubMed=17088437; Cosmic-CLP=905947; DepMap=ACH-000649).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=905947; DepMap=ACH-000649).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (PubMed=9331090; Cosmic-CLP=905947; DepMap=ACH-000649).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (PubMed=7915601; PubMed=17088437; Cosmic-CLP=905947; DepMap=ACH-000649).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.77%; Native American=0%; East Asian, North=4.36%; East Asian, South=0%; South Asian=0%; European, North=65.75%; European, South=29.12% (PubMed=30894373).
CC   Misspelling: 768-0; Note=Occasionally.
CC   Misspelling: 796-0; Note=Occasionally.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1932; CCRID; CLS=300107; Cosmic-CLP=905947; IZSLER=BS TCL 124; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24 (ATCC=CRL-1932; CCRID; PubMed=19372543; PubMed=25877200)
ST   FGA: 24,25 (CLS=300107)
ST   Penta D: 9,12
ST   Penta E: 7,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   786-O PBRM1 KO 1
AC   CVCL_E3VJ
SY   786O PBRM1 KO1; 786-O PBRM1 KO clone 1; 786-O PBRM1 KO clone 35
DR   CancerTools; 161884
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   786-O PBRM1 KO 2
AC   CVCL_E3VK
SY   786O PBRM1 KO2; 786-O PBRM1 KO clone 2; 786-O PBRM1 KO clone 2.7
DR   CancerTools; 161885
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   786-O PBRM1 KO 3
AC   CVCL_E3VL
SY   786O PBRM1 KO3; 786-O PBRM1 KO clone 3; 786-O PBRM1 KO clone 2.8
DR   CancerTools; 161886
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   786-O PBRM1 KO 4
AC   CVCL_E3VM
SY   786O PBRM1 KO 4; 786-O PBRM1 KO clone 4; 786-O PBRM1 KO clone 2.40
DR   CancerTools; 161887
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   786-O SAV1 clone 1
AC   CVCL_D6UU
SY   786-O SAV1-1
RX   PubMed=22185343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17795; SAV1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   786-O SAV1 clone 2
AC   CVCL_D6UV
SY   786-O SAV1-2
RX   PubMed=22185343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17795; SAV1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   786-O-Luc [JCRB]
AC   CVCL_J240
SY   786-0-Luc
DR   cancercelllines; CVCL_J240
DR   JCRB; JCRB1397
DR   JCRB; NIHS0651
DR   Wikidata; Q54604951
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0651; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   786-O-Luc [Ubigene]
AC   CVCL_C8WU
SY   786-0-Luc
DR   Ubigene; YC-C113-Luc-P
DR   Wikidata; Q123030322
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   786-O/Cas9-hyg
AC   CVCL_C9F5
DR   GeneCopoeia; SL577
DR   Wikidata; Q123030323
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL577).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   786-O/GFP
AC   CVCL_E6XL
SY   786-O / GFP
WW   Provider; GenTarget; SC069-G; https://www.gentarget.com/product/human-786-o-gfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-eGFP-Rsv-PuroR construct (GenTarget=SC069-G).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   786-O/Luc
AC   CVCL_AS74
SY   786-0/Luciferase
DR   cancercelllines; CVCL_AS74
DR   Wikidata; Q54604953
RX   PubMed=20443133;
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 19
//
ID   786-O/Luciferase-2A-GFP
AC   CVCL_E6XK
SY   786-O / Luciferase & GFP
WW   Provider; GenTarget; SC069-LG; https://www.gentarget.com/product/human-786-o-luciferase-gfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-2A-eGFP-Rsv-PuroR construct (GenTarget=SC069-LG).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   786-OR
AC   CVCL_WV95
DR   cancercelllines; CVCL_WV95
DR   Wikidata; Q93309883
RX   PubMed=31267758;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68478; Everolimus (RAD001).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   786-TGL
AC   CVCL_VR34
SY   786-HSV1-TK/GFP/Fluc
DR   cancercelllines; CVCL_VR34
DR   Wikidata; Q93309884
CC   Population: Caucasian.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 14
//
ID   7889SA APP(Swe/Swe)
AC   CVCL_E7G7
RX   PubMed=27120160;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Lys670_Met671delinsAsnLeu (c.2010_2011inv) (c.2010_2011delGAinsTC); ClinVar=VCV000018093; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=27120160).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AD15 ! NYSCF-AD-1019-AG07889-Skin-RV-IPSC1
SX   Male
AG   17Y8M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7889SA APP(WT/Swe)
AC   CVCL_E7G8
RX   PubMed=27120160;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Lys670_Met671delinsAsnLeu (c.2010_2011inv) (c.2010_2011delGAinsTC); ClinVar=VCV000018093; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=27120160).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AD15 ! NYSCF-AD-1019-AG07889-Skin-RV-IPSC1
SX   Male
AG   17Y8M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7889SA PSEN1(M146V/M146V)
AC   CVCL_E7G9
RX   PubMed=27120160;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Met146Val (c.436A>G); ClinVar=VCV000018129; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=27120160).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AD15 ! NYSCF-AD-1019-AG07889-Skin-RV-IPSC1
SX   Male
AG   17Y8M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7889SA PSEN1(M146V/M146V)-iCas9
AC   CVCL_E7GC
SY   7889SA-iCas9-PSENM146V/M146V
RX   PubMed=38917806;
CC   Population: Caucasian; Italian.
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9 and an edited homozygous PSEN1(M146V) mutation (PubMed=38917806).
CC   Characteristics: Using TALEN two constructs SA-2A-HygR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele (PubMed=38917806).
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Met146Val (c.436A>G); ClinVar=VCV000018129; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38917806).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7G9 ! 7889SA PSEN1(M146V/M146V)
SX   Male
AG   17Y8M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   7889SA PSEN1(WT/M146V)
AC   CVCL_E7GA
RX   PubMed=27120160;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Met146Val (c.436A>G); ClinVar=VCV000018129; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=27120160).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AD15 ! NYSCF-AD-1019-AG07889-Skin-RV-IPSC1
SX   Male
AG   17Y8M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7889SA-iCas9
AC   CVCL_E7GB
RX   PubMed=38917806;
CC   Population: Caucasian; Italian.
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9 (PubMed=38917806).
CC   Characteristics: Using TALEN two constructs SA-2A-HygR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele (PubMed=38917806).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AD15 ! NYSCF-AD-1019-AG07889-Skin-RV-IPSC1
SX   Male
AG   17Y8M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   788G6
AC   CVCL_B0DZ
DR   Wikidata; Q108819758
RX   Patent=US4938948;
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8692.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10080.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7898
AC   CVCL_EQ46
SY   5260
DR   GEO; GSM666038
DR   GEO; GSM666039
DR   Wikidata; Q54604954
RX   PubMed=22033105;
CC   Sequence variation: Mutation; HGNC; HGNC:7711; NDUFS4; Simple; p.Arg106Ter (c.316C>T); ClinVar=VCV000006889; Zygosity=Homozygous (PubMed=22033105).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6-7M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   78I
AC   CVCL_XV48
DR   Wikidata; Q93309885
RX   DOI=10.13523/j.cb.20180408;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; X2G6F6; Tupaia belangeri CD3E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   78K5
AC   CVCL_B5Z8
DR   Wikidata; Q111732806
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 861-1322 = Spike glycoprotein E1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   78LO
AC   CVCL_B4IG
SY   78 LOndon
DR   Wikidata; Q110429802
RX   PubMed=6459055;
RX   PubMed=18079351;
CC   Doubling time: 36.0 hours (PubMed=6459055).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   79-1
AC   CVCL_RA80
DR   Wikidata; Q54604956
RX   PubMed=1306323;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 0.7 day (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3756; Mixed embryonal carcinoma and teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   791T/36
AC   CVCL_B4II
SY   791T/36 Clone 3
DR   Wikidata; Q110429804
RX   PubMed=6359372;
RX   PubMed=6941806;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08174; Human CD55.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   791T/48
AC   CVCL_B4IJ
SY   791T/48 Clone 15
DR   Wikidata; Q110429805
RX   PubMed=6359372;
RX   PubMed=6941806;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   7926
AC   CVCL_1937
DR   DSMZ; ACC-587
DR   DSMZCellDive; ACC-587
DR   Wikidata; Q54604961
RX   PubMed=9885975;
RX   PubMed=11747540;
RX   PubMed=20638124;
CC   From: Yoshida, Kazuko; National Institute of Radiological Sciences; Chiba-shi; Japan.
CC   Doubling time: ~50-80 hours (DSMZ=ACC-587).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   793 OsSar RVV
AC   CVCL_A2SU
SY   793
DR   Wikidata; Q105505971
RX   Patent=RU2722867;
RX   PubMed=33290900;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 789D.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 7
//
ID   794CSF
AC   CVCL_EJ06
DR   cancercelllines; CVCL_EJ06
DR   Cosmic; 1751978
DR   Wikidata; Q54604963
RX   PubMed=22082607;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22082607).
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   798-mel
AC   CVCL_S563
SY   798-MEL; 798mel
DR   cancercelllines; CVCL_S563
DR   CGH-DB; 9305-4
DR   Cosmic; 905218
DR   Wikidata; Q54604964
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   798A3
AC   CVCL_DQ38
DR   GEO; GSM2152679
DR   Wikidata; Q54604965
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ50 ! DP094
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   798B2
AC   CVCL_DQ39
DR   GEO; GSM2152680
DR   Wikidata; Q54604967
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ50 ! DP094
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   79f7Dv3g
AC   CVCL_Z280
SY   79 f7 Dv 3g
DR   CLO; CLO_0001487
DR   CLDB; cl130
DR   Wikidata; Q54604969
RX   DOI=10.1007/BF02623449;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7244; ! Drosophila virilis (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   79FSDNC1
AC   CVCL_RH72
SY   DOXTOX4 hiPSC
DR   SKIP; SKIP001184
DR   Wikidata; Q54604971
RX   PubMed=27089514;
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   79MA
AC   CVCL_ZU29
SY   79 MAnchester
DR   Wikidata; Q98125427
RX   PubMed=9649131;
RX   PubMed=9681890;
CC   Senescence: Senesces at 38 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 7
//
ID   79RD200
AC   CVCL_B5MJ
SY   79 RD 200
DR   Wikidata; Q111732807
RX   PubMed=6303650;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   79RD220
AC   CVCL_B5MK
SY   79 RD 220
DR   Wikidata; Q111732808
RX   PubMed=6303650;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   79RD27
AC   CVCL_A0EU
DR   Wikidata; Q108819759
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   PubMed=3248383;
RX   PubMed=3337113;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   79RD257
AC   CVCL_B5ML
SY   79 RD 257
DR   Wikidata; Q111732809
RX   PubMed=6303650;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   7A-NKAD3
AC   CVCL_D4B3
DR   Wikidata; Q127378771
RX   PubMed=37087860;
CC   Group: Fish cell line.
CC   Doubling time: 40 +- 9 hours (PubMed=37087860).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: MZCS-0430.
OX   NCBI_TaxID=1051664; ! Nothobranchius kadleci (African annual killifish)
SX   Sex unspecified
AG   Diapause III embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   7A/8F
AC   CVCL_C4PV
SY   7A 8F
DR   Wikidata; Q116048378
RX   PubMed=36179853;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Schistosoma mansoni soluble egg antigen (SEA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7A1
AC   CVCL_C8SJ
DR   Wikidata; Q123030324
RX   PubMed=15051893;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O88324; Mouse Cd83.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   7A10
AC   CVCL_C5FE
DR   Wikidata; Q116048380
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7A11 [Mouse hybridoma against E.coli radA]
AC   CVCL_C5CR
DR   Wikidata; Q116048382
RX   PubMed=22316482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24554; Escherichia coli radA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7A11 [Mouse hybridoma against human MUC16]
AC   CVCL_0I10
DR   Wikidata; Q54604974
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5110.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   7A12 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MN
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   7A12 [Mouse/rat hybridoma against human VWF]
AC   CVCL_E8P1
RX   PubMed=31192778;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04275; Human VWF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7A2.4.1
AC   CVCL_U725
SY   anti-FcRH1,2,3-7A2
DR   Wikidata; Q54604975
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6335.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96LA6; Human FCRL1/CD307a.
CC   Monoclonal antibody target: UniProtKB; Q96LA5; Human FCRL2/CD307b.
CC   Monoclonal antibody target: UniProtKB; Q96P31; Human FCRL3/CD307c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   7A5
AC   CVCL_A0HR
DR   Wikidata; Q108819760
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7A5-2G12
AC   CVCL_E5NN
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7A5F9
AC   CVCL_A0JL
DR   Wikidata; Q108819761
RX   Patent=US4863851;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9224.
CC   Registration: Upjohn Culture Collection; UC HB-18.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08118; Human MSMB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7A6
AC   CVCL_XE23
DR   Wikidata; Q93309915
RX   PubMed=15490328;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_37659; Oleanolic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   7A6-2A2
AC   CVCL_E5SK
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7A8
AC   CVCL_VH04
DR   Wikidata; Q54604978
RX   PubMed=28922396;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O88855; Mouse Ltb4r.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   7A8-B8-B5
AC   CVCL_E2ZG
SY   7A8
RX   PubMed=26492621;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01034; Human CST3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   7a9
AC   CVCL_E3ZB
SY   7A9
RX   PubMed=11604110;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02794; Human FTH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   7A9 [Mouse hybridoma against human IL1-activated endothelial cells]
AC   CVCL_J152
DR   CLO; CLO_0001488
DR   ATCC; HB-10135
DR   Wikidata; Q54604981
RX   Patent=US5011778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10135.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on IL1-activated endothelial cells.
CC   Discontinued: ATCC; HB-10135; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   7A9 [Mouse/rat hybridoma against mouse Dzip3]
AC   CVCL_E8HH
RX   PubMed=29812999;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7TPV2; Mouse Dzip3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7A9-F6
AC   CVCL_E8HM
RX   PubMed=29812999;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7TPV2; Mouse Dzip3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8HH ! 7A9 [Mouse/rat hybridoma against mouse Dzip3]
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7B1
AC   CVCL_VG17
DR   SKIP; SKIP000899
DR   Wikidata; Q54604982
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   7B10
AC   CVCL_C4FB
DR   Wikidata; Q116048383
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   7B11 [Mouse hybridoma against human AFP]
AC   CVCL_XI03
DR   Wikidata; Q93309930
RX   Patent=CN102321167B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.5194.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02771; Human AFP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   7B11 [Rat hybridoma against ZEBOV NP]
AC   CVCL_B6LL
DR   Wikidata; Q111732810
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   Patent=RU2395576;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P18272; Zaire ebolavirus (strain Mayinga-76) nucleoprotein (NP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   7B13
AC   CVCL_F1Y6
RX   PubMed=1676047;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Cryptococcus neoformans (D serotype) capsular polysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   7B17.7
AC   CVCL_B4P0
DR   Wikidata; Q110429806
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   7B24.4
AC   CVCL_B4P1
DR   Wikidata; Q110429807
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cell line BEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   7B3
AC   CVCL_B0VS
DR   Wikidata; Q108819762
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   7B3.5
AC   CVCL_B4P2
DR   Wikidata; Q110429808
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   7B5
AC   CVCL_A7FB
DR   Wikidata; Q107113305
RX   PubMed=18707550;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14965; Human AURKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   7B5.4
AC   CVCL_B4P3
DR   Wikidata; Q110429810
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   7B6
AC   CVCL_VG18
DR   SKIP; SKIP000898
DR   Wikidata; Q54604985
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   7B6.15.11
AC   CVCL_J990
DR   Wikidata; Q54604986
RX   Patent=US20080171036;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5000.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14836; Human TNFRSF13B/TACI/CD267.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   7B9 [Mouse hybridoma against human ICOSLG]
AC   CVCL_E2ZD
RX   PubMed=26788906;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   7B9 [Mouse/rat hybridoma against mouse Otud1]
AC   CVCL_E8H9
RX   PubMed=30130141;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CUB6; Mouse Otud1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7BC9.1
AC   CVCL_B4P4
DR   Wikidata; Q110429811
RX   PubMed=7171457;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on lung cancer cell line BEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   7BD-14
AC   CVCL_LC12
SY   7BD14
DR   Wikidata; Q54604988
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2697.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   7BD-33-11A
AC   CVCL_LC13
DR   Wikidata; Q54604990
RX   Patent=US7175846;
RX   Patent=US7431923;
RX   Patent=US7488475;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4890.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   7BDI-60
AC   CVCL_LC14
DR   Wikidata; Q54604992
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4623.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   7c
AC   CVCL_C5I3
DR   Wikidata; Q116048384
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7C10
AC   CVCL_E8UM
RX   PubMed=1958138;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00855; Dermatophagoides farinae mite group 2 allergen Der f 2 (DERF2) (Note=Also reacts with D.pteronyssinus Der p 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7C11 [Mouse hybridoma against B.germanica Bla g 2]
AC   CVCL_C3WW
SY   7C11 C2 A6
DR   ABCD; ABCD_AA509
DR   Wikidata; Q116048385
RX   PubMed=18519566;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54958; Blattella germanica aspartic protease Bla g 2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7C11 [Mouse hybridoma against suid herpesvirus 1 UL42]
AC   CVCL_C6IC
DR   ABCD; ABCD_AV467
DR   Wikidata; Q116048386
RX   PubMed=26377421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F6QNH2; Suid herpesvirus 1 (strain JF) DNA polymerase processivity factor (UL42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7C2 [Mouse hybridoma against human ERBB2]
AC   CVCL_B0EG
SY   #741; 7C2.B9; NB10151-65
DR   ATCC; HB-12215
DR   Wikidata; Q108819763
RX   Patent=US10280228;
RX   PubMed=1689212;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12215.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7C2 [Mouse hybridoma against sheep CD8A]
AC   CVCL_M052
DR   ECACC; 91060550
DR   Wikidata; Q54604993
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; W5QHT2; Sheep CD8A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   7C2C5C12
AC   CVCL_4496
SY   7C2C5; 7C2 C5
DR   CLO; CLO_0001490
DR   CLDB; cl5111
DR   ATCC; HB-8678
DR   IZSLER; BS Hy 48
DR   Wikidata; Q54604994
RX   Patent=US4670384;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8678.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Trichinella spiralis antigens Ts.45, Ts.49 and Ts.53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   7C3
AC   CVCL_C5BS
DR   Wikidata; Q116048387
RX   PubMed=23098307;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14211; Mouse Calr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7C4
AC   CVCL_B6LM
DR   Wikidata; Q111732811
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   PubMed=10488532;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   7C6
AC   CVCL_0I11
DR   Wikidata; Q54604996
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5111.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   7C6.5.4
AC   CVCL_J931
DR   CLO; CLO_0001491
DR   ATCC; HB-9574
DR   Wikidata; Q54604997
RX   Patent=US5194593;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9574.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   7C7
AC   CVCL_B0L2
DR   Wikidata; Q108819764
RX   PubMed=2068741;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Cryptococcus neoformans var. neoformans non-capsular antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7C72F7
AC   CVCL_XE82
DR   Wikidata; Q93309974
RX   PubMed=30576715;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q52UN8; Cyprinid herpesvirus 3 major capsid protein (ORF92).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   7C8 [Mouse hybridoma against HIV-2 gp120]
AC   CVCL_F1YW
DR   ABCD; ABCD_BF055
RX   PubMed=8120399;
RX   PubMed=18706111;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12449; HIV-2 isolate SBLISY env (Note=AA 22-503 = gp120).
CC   Miscellaneous: While produced in the experiments described in PubMed=8120399 this hybridoma is not mentioned in that publication.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   7C8 [Mouse hybridoma against rat Cav1]
AC   CVCL_A6UG
DR   Wikidata; Q107113306
RX   PubMed=12637562;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P41350; Rat Cav1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   7C8 [Mouse hybridoma against synthetic peptide]
AC   CVCL_J156
DR   CLO; CLO_0001492
DR   ATCC; HB-8465
DR   Wikidata; Q54604998
RX   Patent=US4703004;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8465.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Synthetic polypeptide DYKDDDDKGPKKG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   7C9
AC   CVCL_F0H8
RX   Patent=US12252536;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog PDL1/CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7D-2/12
AC   CVCL_C0ED
DR   Wikidata; Q112927009
DR   Ximbio; 160693
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A1D5QNP0; Macaca mulatta CEACAM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   7D1
AC   CVCL_E5MT
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7D10 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BL
DR   Wikidata; Q116048388
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7D10 [Mouse hybridoma against mouse Mif]
AC   CVCL_IQ48
DR   Wikidata; Q54605001
RX   Patent=EP0162812B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-418.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P34884; Mouse Mif.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 8
//
ID   7D11 [Mouse hybridoma against chicken BCHE]
AC   CVCL_E8C7
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q90ZK8; Chicken BCHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7D11 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BM
DR   Wikidata; Q116048389
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   7D11-1
AC   CVCL_A0TN
DR   Wikidata; Q108819765
RX   Patent=WO2020103691A1;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03971; Human AMH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7D11.1.1
AC   CVCL_U726
SY   anti-FcRH5c-7D11
DR   Wikidata; Q54605087
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6340.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   7D12
AC   CVCL_C5QF
DR   Wikidata; Q116048390
RX   PubMed=10995307;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_82644; Ractopamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   7D2
AC   CVCL_E9ZY
RX   PubMed=33001741;
RX   PubMed=33085940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6YQN3; Foot-and-mouth disease virus serotype O (Strain O/CHN/Mya98/33-P) genome polyprotein (Note=AA 724-934 = VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7D2-1.4.1.5
AC   CVCL_8829
DR   CLO; CLO_0001493
DR   ATCC; HB-92
DR   Wikidata; Q54605088
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Mouse IgG2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   7D3-2C10
AC   CVCL_E5NJ
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7D3A.2
AC   CVCL_J932
DR   CLO; CLO_0001494
DR   ATCC; CRL-1886
DR   Wikidata; Q54605090
RX   PubMed=6186076;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P18609; Bluetongue virus 17 VP7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   7D4
AC   CVCL_4497
SY   7 D4
DR   CLO; CLO_0001463
DR   CLO; CLO_0001495
DR   CLDB; cl5110
DR   ATCC; CRL-1698
DR   BCRJ; 0028
DR   ECACC; 88111402
DR   IZSLER; BS Hy 24
DR   JCRB; JCRB9092
DR   Wikidata; Q54605094
RX   PubMed=6412230;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   7D4-1H12-2B3
AC   CVCL_E5P0
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7D4-2A2-2F2
AC   CVCL_E5NZ
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7D4.H4
AC   CVCL_C4QT
DR   Wikidata; Q116048391
RX   PubMed=1703527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62894; Bovine CYCS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7D5 [Mouse hybridoma against MTPS]
AC   CVCL_C4D8
DR   Wikidata; Q116048393
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   7D5 [Mouse/rat hybridoma against mouse Nr5a1]
AC   CVCL_E7DR
RX   PubMed=19382844;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P33242; Mouse Nr5a1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7D7 [Human LCL]
AC   CVCL_JA39
SY   HLCL 7D7
DR   CCRID; 4201PAT-CCTCC00010
DR   Wikidata; Q54605095
RX   Patent=US5837541;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9009.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Accessible carbohydrate determinant of outer membrane lipopolysaccharide of Escherichia coli and Serratia marcescens.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   7D7 [Mouse hybridoma against chicken COLQ]
AC   CVCL_E8C8
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A0A8V0X807; Chicken COLQ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7D7 [Mouse hybridoma against human KLK2]
AC   CVCL_E4A5
RX   PubMed=15247158;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P20151; Human KLK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   7D7F10
AC   CVCL_D3XN
SY   Navbeta4(209-228)7D7F10
DR   RCB; RCB5510
DR   Wikidata; Q127378772
RX   PubMed=25413837;
CC   Monoclonal antibody target: UniProtKB; Q8IWT1; Human SCN4B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   7D8
AC   CVCL_B6LN
DR   Wikidata; Q111732812
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   Patent=RU2395575;
RX   PubMed=10488532;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   7E1-13
AC   CVCL_C6XT
DR   ABCD; ABCD_AN754
DR   ABCD; ABCD_AN755
DR   Wikidata; Q123030325
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   7E10-F6
AC   CVCL_C3UF
SY   7E10 F6
DR   Wikidata; Q116048394
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7E10(GC) Clone A
AC   CVCL_U078
DR   ECACC; 02043021
DR   Wikidata; Q54605097
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02774; Human GC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   7E11 [Mouse hybridoma against alprenolol]
AC   CVCL_C3XP
DR   Wikidata; Q116048395
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   7E11 [Rat hybridoma against human IQGAP1]
AC   CVCL_C4MY
DR   Wikidata; Q116048396
RX   PubMed=34076498;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P46940; Human IQGAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7E11A1
AC   CVCL_XC12
DR   Wikidata; Q93310014
RX   Patent=CN101149377B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200730.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Aspergillus fumigatus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   7E11C5
AC   CVCL_J934
SY   7E11-C5; 7E11-C5.3; 7E11.C5; 7E11; CYT-356
DR   CLO; CLO_0001496
DR   ATCC; HB-10494
DR   Wikidata; Q54605099
RX   Patent=US5763202;
RX   PubMed=2449118;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10494.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 9
//
ID   7E12H12
AC   CVCL_G696
SY   Das-1; DAS-1
DR   CLO; CLO_0001497
DR   ATCC; HB-9397
DR   Wikidata; Q54605102
RX   Patent=US5869048;
RX   PubMed=3295053;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9397.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human colonic epithelial protein (CEP).
CC   Misspelling: 7312H12; ATCC=HB-9397.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   7E2
AC   CVCL_9V27
DR   Wikidata; Q54605105
RX   PubMed=2264287;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of bovine lymphocytes with P3X63Ag8.653 (PubMed=2264287).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 7
//
ID   7E3
AC   CVCL_J935
DR   CLO; CLO_0001498
DR   ATCC; HB-8832
DR   Wikidata; Q54605106
RX   Patent=US5976532;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8832.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the chimeric abciximab (ReoPro) therapeutic antibody which is used as a platelet aggregation inhibitor.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 11
//
ID   7E3-E8
AC   CVCL_C3UG
SY   7E3 E8
DR   Wikidata; Q116048398
RX   PubMed=6207232;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08176; Dermatophagoides pteronyssinus peptidase 1 (allergen Der p 1) (DERP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7E3-N
AC   CVCL_WN48
DR   Wikidata; Q93310032
RX   PubMed=8118409;
CC   Group: Space-flown cell line (cellonaut).
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; Q53QV2; Human LBP.
CC   Anecdotal: Have been flown in space on shuttle flight STS-42 (Spacelab IML-1) to study growth in microgravity (PubMed=8118409).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   7E4.1.1
AC   CVCL_U727
SY   anti-FcRH1,2,3,5-7E4
DR   Wikidata; Q54605107
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6338.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96LA6; Human FCRL1/CD307a.
CC   Monoclonal antibody target: UniProtKB; Q96LA5; Human FCRL2/CD307b.
CC   Monoclonal antibody target: UniProtKB; Q96P31; Human FCRL3/CD307c.
CC   Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   7E6
AC   CVCL_F1YV
RX   PubMed=8120399;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12449; HIV-2 isolate SBLISY env (Note=AA 22-503 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   7E7/A4
AC   CVCL_C3Q3
SY   A4
DR   Wikidata; Q116048399
RX   PubMed=12470474;
RX   PubMed=20689762;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q91Y06; Mouse Pcdhb13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7E7/A4M
AC   CVCL_C3QS
SY   A4M
DR   Wikidata; Q116048400
RX   PubMed=20689762;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q91Y06; Mouse Pcdhb13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C3Q3 ! 7E7/A4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7E7/B11
AC   CVCL_C3Q2
SY   B11
DR   Wikidata; Q116048402
RX   PubMed=12470474;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse antigen on melanoma cell line B16 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   7E9
AC   CVCL_N024
DR   Wikidata; Q54605108
RX   Patent=US9555107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7313.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8N6P7; Human IL22RA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 7
//
ID   7F
AC   CVCL_F0SP
DR   ABCD; ABCD_AO871
RX   PubMed=23518474;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_32692; 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one (NNK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F0SN ! 4H2 [Mouse hybridoma against NNK]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   7F1/6B
AC   CVCL_C4PW
DR   Wikidata; Q116048403
RX   PubMed=7665943;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni soluble egg antigen (SEA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7F10
AC   CVCL_0I12
DR   Wikidata; Q54605111
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5112.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   7F11
AC   CVCL_E8HB
RX   PubMed=30130141;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CUB6; Mouse Otud1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7F12
AC   CVCL_A0SB
DR   Wikidata; Q108819766
RX   Patent=US5710255;
RX   PubMed=7510760;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7F2
AC   CVCL_6558
DR   CLO; CLO_0001499
DR   ATCC; CRL-12557
DR   BCRC; 60453
DR   Wikidata; Q54605114
RX   Patent=US5830682;
RX   PubMed=9495512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12557.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Discontinued: ATCC; CRL-12557; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   7F2-31
AC   CVCL_E3ZV
RX   PubMed=10438974;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
CC   Monoclonal antibody target: ChEBI; CHEBI_28544; Digitoxin.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   7F2-6D4-8E7
AC   CVCL_G624
SY   8E7
DR   CLO; CLO_0001500
DR   ATCC; HB-11945
DR   Wikidata; Q54605115
RX   Patent=US5556746;
RX   PubMed=3134491;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11945.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human astrovirus 2 (Note=Also reacts with other serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   7F3
AC   CVCL_B0EH
SY   #456; NB7865/5
DR   ATCC; HB-12216
DR   Wikidata; Q108819767
RX   Patent=US10280228;
RX   PubMed=1689212;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12216.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   7F5F3
AC   CVCL_YN80
DR   Wikidata; Q93310047
RX   PubMed=23727927;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   7F8
AC   CVCL_VI39
DR   BEI_Resources; MRA-251
DR   Wikidata; Q54605116
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female salivary glands median and distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   7F8.C7
AC   CVCL_IV64
SY   7F8
DR   Wikidata; Q54605118
RX   Patent=US8022175;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8335.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Newcastle disease virus HN protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   7F9 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5N4
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7F9 [Mouse hybridoma against rat Cpm]
AC   CVCL_U638
DR   CLO; CLO_0050404
DR   RCB; RCB2811
DR   Wikidata; Q54605119
RX   PubMed=17207026;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; D4A9Q5; Rat Cpm.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   7G10
AC   CVCL_0I13
DR   Wikidata; Q54605122
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5245.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   7G11
AC   CVCL_C4B1
DR   CCRID; 4201PAT-CCTCC01002
DR   Wikidata; Q116048404
RX   Patent=CN106701688B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201703.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_64983; Alternariol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   7G12 [Mouse hybridoma against human PPIA]
AC   CVCL_C4K0
DR   Wikidata; Q116048405
RX   PubMed=30384873;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P62937; Human PPIA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 3
//
ID   7G12 [Mouse hybridoma against NNK]
AC   CVCL_F0WF
RX   PubMed=23518474;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_32692; 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one (NNK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   7G2.2
AC   CVCL_C9FV
DR   Wikidata; Q123030326
RX   Patent=US8231877;
RX   PubMed=9631008;
CC   Doubling time: 13 hours (PubMed=9631008).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Miscellaneous: As the immunized splenic B-cells are from humanized transgenic HC2/KCo5/JHD/JCkappaD mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   7G2.2.11
AC   CVCL_E3ZT
SY   7G2
RX   PubMed=2137649;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P21589; Human NT5E/CD73.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   7G3
AC   CVCL_C3X5
DR   Wikidata; Q116048406
RX   PubMed=8547680;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized talacotuzumab (CSL362) therapeutic antibody which was used in clinical trials for the treatment of acute myeloid leukemia.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P26951; Human IL3RA/CD123.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7G4
AC   CVCL_E8H8
RX   PubMed=30130141;
RX   PubMed=30161019;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CUB6; Mouse Otud1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7G4-A6
AC   CVCL_E8HC
RX   PubMed=30130141;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CUB6; Mouse Otud1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8H8 ! 7G4
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7G4-A8
AC   CVCL_E8HD
RX   PubMed=30130141;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CUB6; Mouse Otud1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8H8 ! 7G4
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7G4-B12
AC   CVCL_E8HE
RX   PubMed=30130141;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9CUB6; Mouse Otud1 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8H8 ! 7G4
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   7G5.3B6
AC   CVCL_IQ65
SY   <CSF-1R>7G5.3B6
DR   Wikidata; Q54605125
RX   Patent=US9624302;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2921.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07333; Human CSF1R/CD115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   7G7.7.8
AC   CVCL_U728
SY   anti-FcRH2-7G7
DR   Wikidata; Q54605127
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6336.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96LA5; Human FCRL2/CD307b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   7G7B6
AC   CVCL_J731
SY   7G7/B6
DR   CLO; CLO_0001501
DR   ABCD; ABCD_AJ519
DR   ATCC; HB-8784
DR   NCBI_Iran; H161
DR   Wikidata; Q54605128
RX   Patent=US4707443;
RX   PubMed=2408992;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8784.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   7G8 [Mouse hybridoma against chicken ACHE]
AC   CVCL_E8C9
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P36196; Chicken ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7G8 [Mouse hybridoma against human HMGB]
AC   CVCL_B4HQ
DR   Wikidata; Q110429812
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   7G9-G1
AC   CVCL_B5A5
SY   7G9
DR   Wikidata; Q110429813
RX   Patent=WO1997024141A1;
RX   PubMed=9988333;
CC   Group: Malaria research cell line.
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   7H1
AC   CVCL_0I14
DR   Wikidata; Q54605135
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5114.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   7H10 [Human iPSC]
AC   CVCL_VG20
DR   SKIP; SKIP000894
DR   Wikidata; Q54605136
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   7H10 [Mouse hybridoma against Marburg virus VP40]
AC   CVCL_B6LP
DR   Wikidata; Q111732813
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   Patent=RU2395575;
RX   PubMed=10488532;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   7H12
AC   CVCL_B6GM
DR   Wikidata; Q111732814
RX   PubMed=11534608;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_34975; Sennoside B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   7H2
AC   CVCL_VG22
DR   SKIP; SKIP000891
DR   Wikidata; Q54605140
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   7H3
AC   CVCL_B4HR
DR   Wikidata; Q110429814
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1+IgG3.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   7H5
AC   CVCL_VG21
DR   SKIP; SKIP000890
DR   Wikidata; Q54605143
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   7H7
AC   CVCL_C5BN
DR   Wikidata; Q116048407
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   7H8 [Human skin fibroblast]
AC   CVCL_VG23
DR   SKIP; SKIP000892
DR   Wikidata; Q54605145
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   7H8 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MP
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   7H8/50
AC   CVCL_VI57
DR   BEI_Resources; MRA-833
DR   Wikidata; Q54605147
RX   PubMed=1542308;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) rhoptry-associated protein 1 (RAP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   7H9
AC   CVCL_VG24
DR   SKIP; SKIP000893
DR   Wikidata; Q54605149
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   7IJY1
AC   CVCL_WW79
SY   7IJY-1
DR   Wikidata; Q93310122
RX   DOI=10.15114/tr.20.43;
RX   PubMed=676073;
CC   Transformant: NCBI_TaxID; 10519; Adenovirus 7.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   7IJY1-1
AC   CVCL_WW81
DR   Wikidata; Q93310124
RX   DOI=10.15114/tr.20.43;
CC   Transformant: NCBI_TaxID; 10519; Adenovirus 7.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WW79 ! 7IJY1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   7KE2
AC   CVCL_DR15
DR   GEO; GSM1489216
DR   GEO; GSM1489456
DR   Wikidata; Q54605152
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   7LBLN
AC   CVCL_S345
DR   ATCC; CRL-6051
DR   Wikidata; Q54605154
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6051; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 7
//
ID   7N2-4
AC   CVCL_XH71
DR   Wikidata; Q93310134
RX   Patent=US4973556;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-278.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01563; Human IFNA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   7N4-1
AC   CVCL_XH72
DR   Wikidata; Q93310136
RX   Patent=US4973556;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-277.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01563; Human IFNA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   7PEND24
AC   CVCL_RU15
SY   7-PEND-24; PureStem 7PEND24, NCr-fac progenitor; ACTC283
DR   Millipore; SCC122
DR   Millipore; SCR222
DR   Wikidata; Q54605156
RX   Patent=US8685386;
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-283; https://web.archive.org/web/20141202115757/http://www.esibio.com/purestemr-7pend24-ncr-fac-meso-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11149.
CC   Characteristics: Used to study chondrogenesis in a neural crest progenitor with low levels of hypertrophic marker COL10A1.
CC   Senescence: Can undergo 10 PDL (ESI BIO).
CC   Doubling time: ~40 hours (ESI BIO).
CC   Discontinued: Millipore; SCC122; true.
CC   Discontinued: Millipore; SCR222; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   7PNF_SiPSrv_PM_12
AC   CVCL_UN16
DR   Wikidata; Q93310143
RX   PubMed=30713041;
RX   PubMed=30840859;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520de%2520deposito%2520-%25207PNF_SiPSrv_PM_12.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-7PNF_SiPSrv_PM_12.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Germans Trias i Pujol (IGTP); Barcelona; Spain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=30713041).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Ile679Aspfs*20 (c.2034_2035insC) (c.2034_2035dupC); ClinVar=VCV001048682; Zygosity=Heterozygous; Note=Germline (PubMed=30713041).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): BNLC; PubMed=30713041
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 15,20
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   7R2/A4
AC   CVCL_J052
DR   ECACC; 92030601
DR   NCBI_Iran; H116
DR   Wikidata; Q54605158
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   7SA
AC   CVCL_HA77
DR   Wikidata; Q54605160
RX   PubMed=1737362;
RX   PubMed=1973007;
RX   PubMed=2496488;
RX   PubMed=2505924;
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   7SMOO32
AC   CVCL_RU16
SY   7-SMOO-32; 7SM0032; PureStem 7SMOO32, NCr-fac progenitor; ACTC278
DR   Millipore; SCC123
DR   Millipore; SCR223
DR   Wikidata; Q54605165
RX   Patent=US8685386;
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-278; https://web.archive.org/web/20141202115746/http://www.esibio.com/purestemr-7smoo32-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10233.
CC   Senescence: Can undergo 15 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Discontinued: Millipore; SCC123; true.
CC   Discontinued: Millipore; SCR223; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   7SuR
AC   CVCL_XI63
DR   cancercelllines; CVCL_XI63
DR   CCRID; 4201PAT-CCTCC00547
DR   Wikidata; Q93310157
RX   Patent=CN104988122B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014217.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_38940; Sunitinib.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   7T1
AC   CVCL_4E63
DR   RCB; RCB0171
DR   Wikidata; Q54605167
RX   DOI=10.1247/csf.4.267;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   7WY1
AC   CVCL_WW80
SY   7WY-1
DR   Wikidata; Q93310164
RX   PubMed=676073;
CC   Transformant: NCBI_TaxID; 10519; Adenovirus 7.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   8-1
AC   CVCL_B6WH
DR   CCRID; 4201PAT-CCTCC00719
DR   Wikidata; Q111732815
RX   Patent=CN105132378B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201595.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   8-18C5
AC   CVCL_KS90
SY   8.18C5
DR   Wikidata; Q54605168
RX   PubMed=6207204;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63345; Rat Mog.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   8-1A
AC   CVCL_E3XF
RX   PubMed=16338478;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
CC   Miscellaneous: As the immunized splenic B-cells are from KM mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   8-30
AC   CVCL_C8U1
DR   Wikidata; Q123030328
RX   Patent=EP0259585B1;
RX   PubMed=2426355;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 87042802.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-584.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P06734; Human FCER2/CD23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   8-SVHCE
AC   CVCL_B7GP
SY   8-month baby SV40-transformed Human Ciliary Epithelium
DR   Wikidata; Q112927012
RX   PubMed=2119313;
RX   PubMed=3022303;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778.
CC   Cell type: Non-pigmented ciliary epithelial cell; CL=CL_0002304.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   8M
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   8-MG-BA
AC   CVCL_1052
SY   8MGBA
DR   CLO; CLO_0001523
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 503
DR   BioSample; SAMN03473597
DR   BioSample; SAMN10988303
DR   cancercelllines; CVCL_1052
DR   Cell_Model_Passport; SIDM00998
DR   ChEMBL-Cells; CHEMBL3308251
DR   ChEMBL-Targets; CHEMBL2366115
DR   Cosmic; 687562
DR   Cosmic; 1746945
DR   Cosmic; 2302327
DR   Cosmic; 2367505
DR   Cosmic-CLP; 687562
DR   DepMap; ACH-000137
DR   DSMZ; ACC-432
DR   DSMZCellDive; ACC-432
DR   EGA; EGAS00001000978
DR   GDSC; 687562
DR   GEO; GSM326211
DR   GEO; GSM886848
DR   GEO; GSM887912
DR   GEO; GSM1669575
DR   IARC_TP53; 21155
DR   LiGeA; CCLE_823
DR   LINCS_LDP; LCL-1365
DR   PharmacoDB; 8MGBA_29_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1052
DR   PubChem_Cell_line; CVCL_1052
DR   Wikidata; Q54605281
RX   PubMed=9604998;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 20-24 hours (PubMed=9604998); ~100 hours (DSMZ=ACC-432).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (Cosmic-CLP=687562; DepMap=ACH-000137).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.1%; East Asian, North=2.53%; East Asian, South=0%; South Asian=2.29%; European, North=61.9%; European, South=33.19% (PubMed=30894373).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): Cosmic-CLP=687562; DSMZ=ACC-432
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 12,14
ST   D21S11: 28,29
ST   D2S1338: 16,17
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 12,14
ST   Penta E: 12,16
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   8.03.4
AC   CVCL_J170
SY   8.03
DR   ATCC; HB-8388
DR   Wikidata; Q54605283
RX   Patent=US4650676;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8388.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella merozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   8.1
AC   CVCL_B0CU
DR   Wikidata; Q108819768
RX   Patent=US6162902;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12050.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   8.1.1
AC   CVCL_D3RC
DR   DSHB; 8-1-1
DR   Wikidata; Q127378773
RX   PubMed=1374092;
RX   PubMed=1402691;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q62011; Mouse Pdpn.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   8.2 [Mouse hybridoma against human CD89]
AC   CVCL_XY43
SY   8D2
DR   Wikidata; Q93310179
RX   Patent=US7192582;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24071; Human FCAR/CD89.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   8.2 [Mouse T-cell]
AC   CVCL_K252
DR   Wikidata; Q54605285
RX   PubMed=8566067;
CC   Characteristics: IL4 dependent.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K251 ! LD8
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   80 V 5B4
AC   CVCL_J732
DR   CLO; CLO_0001504
DR   ATCC; TIB-132
DR   Wikidata; Q54605288
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   80-1
AC   CVCL_N033
DR   ATCC; HB-11871
DR   Wikidata; Q54605291
RX   Patent=US5675063;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11871.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_J972 ! 240E1-1-2
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   80-52-13
AC   CVCL_YB04
DR   ABCD; ABCD_AN710
DR   DSHB; 80-52-13
DR   Wikidata; Q93310196
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dictyostelium discoideum discoidin 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   8016
AC   CVCL_HF00
DR   Wikidata; Q54605293
RX   PubMed=9885975;
RX   PubMed=20638124;
CC   From: Yoshida, Kazuko; National Institute of Radiological Sciences; Chiba-shi; Japan.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 5
//
ID   8029 DDP4
AC   CVCL_7001
SY   8029 DDP
DR   Wikidata; Q54605294
RX   PubMed=8679156;
RX   PubMed=20947470;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7000 ! 8029 NA
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   8029 NA
AC   CVCL_7000
DR   Wikidata; Q54605295
RX   PubMed=8679156;
RX   PubMed=20947470;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6648 ! HLaC-79
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   802C11
AC   CVCL_C475
DR   CLO; CLO_0050278
DR   RCB; RCB2308
DR   Wikidata; Q54605296
RX   PubMed=9758151;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q61490; Mouse Alcam/Cd166.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 7
//
ID   803-15.6
AC   CVCL_J936
DR   CLO; CLO_0001505
DR   ATCC; CRL-2395
DR   Wikidata; Q54605299
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   803YT
AC   CVCL_TZ87
DR   Wikidata; Q54605300
RX   PubMed=17511773;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   804 G
AC   CVCL_J122
SY   804G
DR   Wikidata; Q54605302
RX   PubMed=7448785;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_91112; N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C64146; Squamous cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   >2Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   804G.003A
AC   CVCL_C1IY
DR   ATCC; CRL-11555
DR   Wikidata; Q114310503
RX   Patent=US5541106;
RX   PubMed=1986003;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11555.
CC   Transformant: ChEBI; CHEBI_91112; N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C64146; Squamous cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_J122 ! 804 G
SX   Male
AG   >2Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   807-09
AC   CVCL_D3AS
DR   Wikidata; Q127378774
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-12
AC   CVCL_D3AT
DR   Wikidata; Q127378775
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-13
AC   CVCL_D3B5
DR   Wikidata; Q127378776
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q8JPR0; Bunyavirus La Crosse nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-15
AC   CVCL_J937
SY   807.15
DR   CLO; CLO_0001506
DR   ATCC; CRL-2287
DR   Wikidata; Q54605305
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   807-18
AC   CVCL_D3AU
DR   Wikidata; Q127378777
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-21
AC   CVCL_D3AV
DR   Wikidata; Q127378778
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-22
AC   CVCL_D3AW
DR   Wikidata; Q127378779
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-25
AC   CVCL_D3AX
DR   Wikidata; Q127378780
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-26
AC   CVCL_D3AY
DR   Wikidata; Q127378781
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-28
AC   CVCL_D3B6
DR   Wikidata; Q127378782
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8JPR0; Bunyavirus La Crosse nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-31
AC   CVCL_J938
SY   807.31
DR   CLO; CLO_0001507
DR   ATCC; CRL-2282
DR   Wikidata; Q54605306
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   807-32
AC   CVCL_D3B7
DR   Wikidata; Q127378783
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q8JPR0; Bunyavirus La Crosse nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   807-33
AC   CVCL_J939
SY   807.33
DR   CLO; CLO_0001508
DR   ATCC; CRL-2290
DR   Wikidata; Q54605309
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   807-35
AC   CVCL_D3AZ
DR   Wikidata; Q127378784
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8JPR1; Bunyavirus La Crosse envelopment polyprotein GP (Note=AA 474-1441 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   80MA
AC   CVCL_ZU30
SY   80 MAnchester
DR   Wikidata; Q98125428
RX   PubMed=9649131;
CC   Senescence: Senesces at 39 PDL (PubMed=9649131).
CC   Donor information: Established from an unaffected member of a Li-Fraumeni syndrome family.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   80RD143
AC   CVCL_B5MM
SY   80 RD 143
DR   Wikidata; Q111732816
RX   PubMed=6303650;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   80T
AC   CVCL_6359
DR   CLO; CLO_0001509
DR   ATCC; CRL-7901
DR   Wikidata; Q54605311
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7901; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   81-1
AC   CVCL_E7YJ
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 4.4 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   81-86T
AC   CVCL_A2AR
DR   Wikidata; Q105505975
RX   PubMed=14978140;
RX   PubMed=17592641;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   66Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   81.3
AC   CVCL_0602
DR   CLO; CLO_0001001
DR   CLDB; cl131
DR   ArrayExpress; E-MTAB-1511
DR   ECACC; 85100105
DR   Wikidata; Q54605312
RX   PubMed=24380390;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   813-13
AC   CVCL_D3B0
DR   Wikidata; Q127378785
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E5EZ30; Bunyavirus Tahyna (isolate 92 Bardos) envelopment polyprotein GP (Note=AA 474-1440 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   813-48
AC   CVCL_D3B1
DR   Wikidata; Q127378786
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E5EZ30; Bunyavirus Tahyna (isolate 92 Bardos) envelopment polyprotein GP (Note=AA 474-1440 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   813-77
AC   CVCL_D3B2
DR   Wikidata; Q127378787
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E5EZ30; Bunyavirus Tahyna (isolate 92 Bardos) envelopment polyprotein GP (Note=AA 474-1440 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   814-02
AC   CVCL_D3B8
DR   Wikidata; Q127378788
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q98750; Bunyavirus Tahyna (isolate 92 Bardos) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   814-08
AC   CVCL_D3B9
DR   Wikidata; Q127378789
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; Q98750; Bunyavirus Tahyna (isolate 92 Bardos) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   814-44
AC   CVCL_D3B3
DR   Wikidata; Q127378790
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E5EZ30; Bunyavirus Tahyna (isolate 92 Bardos) envelopment polyprotein GP (Note=AA 474-1440 = Glycoprotein GC/G1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   814-47
AC   CVCL_D3BA
DR   Wikidata; Q127378791
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q98750; Bunyavirus Tahyna (isolate 92 Bardos) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   814-87
AC   CVCL_D3BB
DR   Wikidata; Q127378792
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q98750; Bunyavirus Tahyna (isolate 92 Bardos) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   81MA
AC   CVCL_ZU31
SY   81 MAnchester
DR   Wikidata; Q98125429
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 55 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   81RD5
AC   CVCL_B5MN
SY   81 RD 5
DR   Wikidata; Q111732817
RX   PubMed=6303650;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   82-132
AC   CVCL_5U99
SY   Clara M
DR   Wikidata; Q54605313
RX   PubMed=6850563;
RX   PubMed=9347924;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   82-6
AC   CVCL_U636
DR   Wikidata; Q54605316
RX   PubMed=12034742;
RX   PubMed=17870066;
RX   PubMed=23847654;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/8/cell-lines-detail-533.html
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   82-6pBlox
AC   CVCL_U637
SY   82-6pBloxTSH; 82-6 hTERT
DR   Wikidata; Q54605317
RX   PubMed=12034742;
RX   PubMed=17870066;
RX   PubMed=23847654;
CC   Characteristics: Transduced with a lentiviral vector containing a LTR-loxP-hTERT-SV40p-hisD-PuroR-LTR construct. When transfected with Cre recombinase the cells loose telomerase activity and histidinol sensitivity due to the excision of the hTERT and hisD genes. Simultaneously, the cells acquire puromycin resistance because the excision brings the PuroR gene under the control of the retroviral promoter (LTR).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U636 ! 82-6
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   82.3
AC   CVCL_A7NJ
DR   Wikidata; Q107113307
RX   PubMed=33922695;
CC   Population: Caucasian; Italian.
CC   Characteristics: Shows cross-resistance to gemcitabine, 5-fluorouracil, carboplatin and oxaliplatin (PubMed=33922695).
CC   Characteristics: Established from a 4th generation xenograft maintained in NOD/SCID mice (PubMed=33922695).
CC   Doubling time: 48-53 hours (PubMed=33922695).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): PubMed=33922695
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 13,16
ST   D21S11: 30
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 10,16
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   820-374
AC   CVCL_D3B4
DR   Wikidata; Q127378793
RX   PubMed=7101727;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q8JPR0; Bunyavirus La Crosse nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   8213
AC   CVCL_B6NG
DR   Wikidata; Q111732818
RX   Patent=US10550181;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   821A1
AC   CVCL_DQ40
DR   GEO; GSM2152681
DR   Wikidata; Q54605318
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   821B1
AC   CVCL_DQ41
DR   GEO; GSM2152682
DR   Wikidata; Q54605322
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP68 ! DP074
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   83-1
AC   CVCL_E7YK
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 2.2 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   83-12-5
AC   CVCL_K120
DR   CLO; CLO_0001511
DR   ATCC; CRL-1971
DR   Wikidata; Q54605324
RX   PubMed=3097135;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   83-2
AC   CVCL_E7YL
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 10 days (PubMed=7817386).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   83-3
AC   CVCL_E7YM
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 6 days (PubMed=7817386).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   83.5
AC   CVCL_C5XH
DR   Wikidata; Q116048408
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   830-c
AC   CVCL_VS18
SY   830c; NHM 830-c
DR   Wikidata; Q93310283
RX   PubMed=12006619;
RX   PubMed=16880792;
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Arg160Trp (c.478C>T); ClinVar=VCV000014310; Zygosity=Heterozygous (PubMed=12006619).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Asp294His (c.880G>C); ClinVar=VCV000014307; Zygosity=Heterozygous (PubMed=12006619).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   8305C
AC   CVCL_1053
SY   8305c; 8305-C; 8305C_1
DR   BTO; BTO_0000919
DR   CLO; CLO_0001510
DR   CLO; CLO_0050949
DR   EFO; EFO_0022717
DR   CLDB; cl132
DR   CLDB; cl133
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 318
DR   BioSample; SAMN01821670
DR   BioSample; SAMN03470959
DR   BioSample; SAMN03473414
DR   BioSample; SAMN10988447
DR   cancercelllines; CVCL_1053
DR   CCRID; 3101HUMSCSP540
DR   Cell_Model_Passport; SIDM00997
DR   CGH-DB; 53-1
DR   ChEMBL-Cells; CHEMBL3308706
DR   ChEMBL-Targets; CHEMBL1075386
DR   CLS; 305101
DR   Cosmic; 906795
DR   Cosmic; 922364
DR   Cosmic; 2009523
DR   Cosmic; 2054104
DR   Cosmic; 2613247
DR   Cosmic; 2786687
DR   Cosmic-CLP; 906795
DR   DepMap; ACH-001306
DR   DSMZ; ACC-133
DR   DSMZCellDive; ACC-133
DR   ECACC; 94090183
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10428-106D5
DR   GDSC; 906795
DR   GEO; GSM886846
DR   GEO; GSM887910
DR   GEO; GSM1669573
DR   IARC_TP53; 21156
DR   ICLC; HTL96026
DR   JCRB; JCRB0824
DR   LiGeA; CCLE_684
DR   LINCS_LDP; LCL-1685
DR   NCBI_Iran; C597
DR   PharmacoDB; 8305C_30_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1053
DR   PubChem_Cell_line; CVCL_1053
DR   RCB; RCB1909
DR   TKG; TKG 0446
DR   Wikidata; Q54605326
RX   PubMed=9177455;
RX   PubMed=9290701;
RX   PubMed=14522906;
RX   PubMed=15613457;
RX   PubMed=16924234;
RX   PubMed=20164919;
RX   PubMed=21566963;
RX   PubMed=22460905;
RX   PubMed=23833040;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 43 hours (PubMed=21566963); ~54 hours (DSMZ=ACC-133); ~50 hours (Note=Lot 07252003) (JCRB=JCRB0824).
CC   HLA typing: A*11:01,11:01; B*15:01,54:01; C*01:02,04:01; DQB1*04:02,04:02; DRB1*11:14,11:14 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800Ter (c.8398C>T); ClinVar=VCV001171818; Zygosity=Heterozygous (PubMed=30737244; Cosmic-CLP=906795; DepMap=ACH-001306).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244; Cosmic-CLP=906795; DepMap=ACH-001306).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Phe90Leufs*14 (c.270delT); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=14522906; PubMed=21566963; PubMed=30737244; Cosmic-CLP=906795; DepMap=ACH-001306).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.04%; East Asian, North=74.78%; East Asian, South=24.09%; South Asian=0%; European, North=0%; European, South=0.09% (PubMed=30894373).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=906795; DSMZ=ACC-133; ECACC=94090183; JCRB=JCRB0824; PubMed=25877200; PubMed=30737244; RCB=RCB1909; TKG=TKG 0446
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9
ST   D16S539: 10,11
ST   D18S51: 13,24
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 8 (DSMZ=ACC-133)
ST   D7S820: 8,10 (Cosmic-CLP=906795; ECACC=94090183; JCRB=JCRB0824; PubMed=25877200; PubMed=30737244; RCB=RCB1909; TKG=TKG 0446)
ST   D8S1179: 11,14
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 15,17
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   8328
AC   CVCL_EQ47
DR   GEO; GSM666040
DR   GEO; GSM666041
DR   Wikidata; Q54605328
RX   PubMed=20382551;
RX   PubMed=22033105;
CC   Sequence variation: Mutation; HGNC; HGNC:7707; NDUFS1; Simple; p.Glu211del (c.631_633delGAA) (211delE); ClinVar=VCV002430648; Zygosity=Heterozygous (PubMed=20382551; PubMed=22033105).
CC   Sequence variation: Mutation; HGNC; HGNC:7707; NDUFS1; Simple; p.Val228Ala (c.683T>C); ClinVar=VCV000429933; Zygosity=Heterozygous (PubMed=20382551; PubMed=22033105).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   8330-iPS-8
AC   CVCL_VK56
DR   Wikidata; Q93310294
RX   PubMed=24271013;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N044 ! GM08330
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   833K-E
AC   CVCL_2292
SY   833KE; 833-KE; 833K; HT-E
DR   ChEMBL-Cells; CHEMBL3307813
DR   ChEMBL-Targets; CHEMBL613103
DR   Cosmic; 821812
DR   Cosmic; 2077187
DR   ECACC; 06072611
DR   PubChem_Cell_line; CVCL_2292
DR   Wikidata; Q54605331
RX   PubMed=3518877;
RX   PubMed=6169654;
RX   PubMed=6244232;
RX   PubMed=7388807;
RX   PubMed=7471097;
RX   PubMed=9772905;
RX   PubMed=11416159;
RX   PubMed=14762065;
CC   Omics: Variations; CNV analysis.
CC   Misspelling: 833K-2; PubMed=3518877.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 12,16
ST   D21S11: 28,31
ST   D8S1179: 13
ST   FGA: 22
ST   TH01: 6,9
ST   vWA: 15,18,19
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C508 ! 833K-LC
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   833K-LC
AC   CVCL_C508
SY   833-K-LC; 833KLC; 833K/LC
DR   Wikidata; Q54605332
RX   PubMed=6169654;
RX   PubMed=7388807;
RX   PubMed=14762065;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2292 ! 833K-E
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   836-mel
AC   CVCL_8057
SY   836-MEL; 836 mel; 836
DR   Wikidata; Q54605333
RX   PubMed=10048982;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02,11 (PubMed=10048982).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   836B3
AC   CVCL_RI44
DR   SKIP; SKIP001338
DR   Wikidata; Q54605335
RX   PubMed=24672756;
RX   PubMed=28233934;
RX   PubMed=28858313;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Caucasian.
CC   Misspelling: 863B3; Note=Occasionally.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   83CT2
AC   CVCL_C8Q3
SY   Myc83C tumor 2
DR   Wikidata; Q123030329
RX   PubMed=15180438;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   83MA
AC   CVCL_ZU32
SY   83 MAnchester
DR   Wikidata; Q98125432
RX   PubMed=9649131;
CC   Senescence: Senesces at 36 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   84 BLCL
AC   CVCL_E414
DR   ECACC; 94031615
DR   Wikidata; Q54605337
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   84-1
AC   CVCL_E7YN
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 0.8 day (PubMed=10328163).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   84-2
AC   CVCL_E7Y7
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.3 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   84-3
AC   CVCL_E7YP
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 9 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   84-4
AC   CVCL_E7YF
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 7.8 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   84-5
AC   CVCL_E7Y8
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 0.9 day (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Mediastinal lymph node; UBERON=UBERON_0002524.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   84BR
AC   CVCL_2293
SY   84 BRighton
DR   CLO; CLO_0001512
DR   CLDB; cl134
DR   ECACC; 90011805
DR   Wikidata; Q54605339
RX   PubMed=8609460;
RX   PubMed=23093295;
CC   Doubling time: 48 hours (PubMed=8609460).
CC   Donor information: Established from the non-affected skin biopsy of a radiosensitive breast cancer patient.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ECACC=90011805
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   84MA
AC   CVCL_ZU33
SY   84 MAnchester
DR   Wikidata; Q98125433
RX   PubMed=9649131;
CC   Senescence: Senesces at 26 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   84T
AC   CVCL_A2AS
DR   Wikidata; Q105505978
RX   PubMed=10545285;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor and lung cancer type (incorrect in PubMed=10545285) from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   85-1 [Human lung carcinoma]
AC   CVCL_E7XS
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 0.9 day (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   85-1 [Mouse hybridoma against dog CD162]
AC   CVCL_D2QJ
DR   Wikidata; Q127378794
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   85-3
AC   CVCL_E7XR
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 2.9 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   85-4
AC   CVCL_E7YQ
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 6 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   85-5
AC   CVCL_E7XW
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 2.1 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   85-6
AC   CVCL_E7YR
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 5 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8505C
AC   CVCL_1054
SY   8505c
DR   BTO; BTO_0005550
DR   CLO; CLO_0001513
DR   CLO; CLO_0050951
DR   EFO; EFO_0022669
DR   CLDB; cl135
DR   CLDB; cl136
DR   AddexBio; C0025002/19
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0398
DR   BioSample; SAMN01821611
DR   BioSample; SAMN03470935
DR   BioSample; SAMN03472518
DR   BioSample; SAMN03473379
DR   BioSample; SAMN10988556
DR   cancercelllines; CVCL_1054
DR   Cell_Model_Passport; SIDM00996
DR   CGH-DB; 54-1
DR   ChEMBL-Cells; CHEMBL3308353
DR   ChEMBL-Targets; CHEMBL1075387
DR   Cosmic; 889489
DR   Cosmic; 891256
DR   Cosmic; 922365
DR   Cosmic; 924102
DR   Cosmic; 1084283
DR   Cosmic; 1132598
DR   Cosmic; 1152114
DR   Cosmic; 1162837
DR   Cosmic; 1239959
DR   Cosmic; 2036694
DR   Cosmic; 2054105
DR   Cosmic; 2613248
DR   Cosmic-CLP; 924102
DR   DepMap; ACH-001307
DR   DSMZ; ACC-219
DR   DSMZCellDive; ACC-219
DR   ECACC; 94090184
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10437-106E5
DR   GDSC; 924102
DR   GEO; GSM886847
DR   GEO; GSM887911
DR   GEO; GSM1669574
DR   IARC_TP53; 1305
DR   JCRB; JCRB0826
DR   LiGeA; CCLE_065
DR   LINCS_LDP; LCL-1686
DR   PharmacoDB; 8505C_31_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1054
DR   PubChem_Cell_line; CVCL_1054
DR   RCB; RCB2103
DR   TKG; TKG 0439
DR   Wikidata; Q54605341
RX   PubMed=1516062;
RX   PubMed=9247707;
RX   PubMed=9290701;
RX   PubMed=14522906;
RX   PubMed=15613457;
RX   PubMed=16924234;
RX   PubMed=17725429;
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=19087340;
RX   PubMed=20164919;
RX   PubMed=21566963;
RX   PubMed=21868764;
RX   PubMed=22460905;
RX   PubMed=23162534;
RX   PubMed=23833040;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/8505c-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=21566963); ~30-40 hours (DSMZ=ACC-219); ~1.5 days (Note=Lot 11252003) (JCRB=JCRB0826).
CC   HLA typing: A*02:01,26:01; B*39:01,51:01; C*07:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=23833040; PubMed=30737244; Cosmic-CLP=924102; DepMap=ACH-001307).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Glu129Ter (c.385G>T); Zygosity=Homozygous (PubMed=30737244; Cosmic-CLP=924102; DepMap=ACH-001307).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gly (c.742C>G); ClinVar=VCV000376652; Zygosity=Hemizygous (PubMed=1516062; PubMed=14522906; PubMed=21566963; PubMed=23162534; PubMed=30737244; Cosmic-CLP=924102; DepMap=ACH-001307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.58%; Native American=0%; East Asian, North=84.79%; East Asian, South=11.83%; South Asian=0%; European, North=0%; European, South=2.8% (PubMed=30894373).
CC   Misspelling: 8509C; Cosmic=1132598.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=924102; DSMZ=ACC-219; ECACC=94090184; JCRB=JCRB0826; PubMed=18713817; PubMed=21868764; PubMed=25877200; PubMed=30737244; RCB=RCB2103; TKG=TKG 0439
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 17,24
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 12,15
ST   TH01: 6 (PubMed=25877200)
ST   TH01: 6,9 (Cosmic-CLP=924102; DSMZ=ACC-219; ECACC=94090184; JCRB=JCRB0826; PubMed=21868764; PubMed=30737244; RCB=RCB2103; TKG=TKG 0439)
ST   TPOX: 10,11 (Cosmic-CLP=924102; DSMZ=ACC-219; PubMed=30737244; RCB=RCB2103; TKG=TKG 0439)
ST   TPOX: 11 (ECACC=94090184; JCRB=JCRB0826; PubMed=21868764; PubMed=25877200)
ST   vWA: 17,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   851129W
AC   CVCL_WY27
SY   1129W
DR   Wikidata; Q93310329
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   PubMed=3248383;
RX   PubMed=10987302;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (PubMed=10987302).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   8540
AC   CVCL_WY91
DR   cancercelllines; CVCL_WY91
DR   Wikidata; Q93310331
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 18,19
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D1S1656: 13,17.3
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D6S1043: 11,19
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 7
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   8587
AC   CVCL_JY33
DR   cancercelllines; CVCL_JY33
DR   Wikidata; Q54605344
RX   PubMed=25862976;
RX   PubMed=31150822;
CC   Doubling time: 6-9 days (PubMed=25862976).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=25862976; PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 20,22
ST   D13S317: 11,13
ST   D16S539: 10,14
ST   D18S51: 15,17
ST   D19S433: 13
ST   D1S1656: 16,16.3
ST   D21S11: 28,30
ST   D2S1338: 20,26
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   859H5
AC   CVCL_C477
DR   CLO; CLO_0050523
DR   RCB; RCB2312
DR   Wikidata; Q54605346
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   85As2
AC   CVCL_D5HV
DR   GEO; GSM3097054
DR   GEO; GSM3097055
DR   GEO; GSM3097056
DR   JCRB; JCRB1950
DR   Wikidata; Q127378795
RX   PubMed=23659450;
RX   PubMed=30410674;
CC   Population: Japanese.
CC   Characteristics: Metastatic and cachexia-inducing (PubMed=23659450).
CC   Characteristics: The parent cell line was orthotopically grafted into mice, and peritoneal cavity cells were collected from specimens exhibiting peritoneal metastasis. These cells were then cultured and xenografted. This process was carried out 11 times (PubMed=23659450).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1950
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5HU ! MKN45cl85
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   85As2mLuc
AC   CVCL_D5HW
DR   JCRB; JCRB1953
DR   JCRB; NIHS1340
DR   Wikidata; Q127378796
RX   PubMed=23659450;
CC   Population: Japanese.
CC   Characteristics: Metastatic and cachexia-inducing (PubMed=23659450).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS1340; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1953
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5HV ! 85As2
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   85HG-3
AC   CVCL_B7R4
DR   Wikidata; Q112927014
RX   PubMed=3316507;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   85HG-59
AC   CVCL_B7R5
DR   Wikidata; Q112927016
RX   PubMed=1373627;
RX   PubMed=2747842;
RX   PubMed=3316507;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 6
//
ID   85HG-63
AC   CVCL_B7R6
DR   Wikidata; Q112927019
RX   PubMed=1373627;
RX   PubMed=3316507;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 6
//
ID   85HG-64
AC   CVCL_B7R7
DR   Wikidata; Q112927020
RX   PubMed=1373627;
RX   PubMed=3316507;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 6
//
ID   85HG-65
AC   CVCL_B7R8
DR   Wikidata; Q112927022
RX   PubMed=3316507;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   85HG-66
AC   CVCL_B7R9
SY   85HG66
DR   Wikidata; Q112927023
RX   Patent=DE3940527C2;
RX   Patent=WO1990015150A1;
RX   PubMed=1373627;
RX   PubMed=2747842;
RX   PubMed=3316507;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   85MA
AC   CVCL_ZU34
SY   85 MAnchester
DR   Wikidata; Q98125434
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
RX   PubMed=9681890;
RX   PubMed=18079351;
CC   Senescence: Senesces at 36 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 7
//
ID   86 BLCL
AC   CVCL_E415
DR   ECACC; 94031616
DR   Wikidata; Q54605347
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   86-1
AC   CVCL_E7YX
RX   CelloPub=CLPUB00161;
CC   Population: Japanese.
CC   Doubling time: 7.1 days (CelloPub=CLPUB00161).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   86-10
AC   CVCL_E7YZ
RX   CelloPub=CLPUB00161;
CC   Population: Japanese.
CC   Doubling time: 7.9 days (CelloPub=CLPUB00161).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   86-11
AC   CVCL_UJ62
DR   Wikidata; Q93310346
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.0 day (CelloPub=CLPUB00161; PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   86-12
AC   CVCL_E7Z0
RX   CelloPub=CLPUB00161;
CC   Population: Japanese.
CC   Doubling time: 11.4 days (CelloPub=CLPUB00161).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   86-13
AC   CVCL_E7Z1
RX   CelloPub=CLPUB00161;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   86-14
AC   CVCL_UJ63
DR   Wikidata; Q93310348
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 5 days (CelloPub=CLPUB00161; PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   86-2
AC   CVCL_6757
DR   CLO; CLO_0050053
DR   BioSample; SAMN03472011
DR   CGH-DB; 9185-4
DR   Cosmic; 946066
DR   Cosmic; 1048223
DR   Cosmic; 1066157
DR   Cosmic; 1656908
DR   RCB; RCB2134
DR   TKG; TKG 0181
DR   Wikidata; Q54605348
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=9023415;
RX   PubMed=9538136;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=22313637;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Doubling time: 1.5 days (CelloPub=CLPUB00161; PubMed=7817386).
CC   HLA typing: A*11:01; B*51:01; C*04:01,15:02 (PubMed=9023415).
CC   Misspelling: 31444; BioSample=SAMN03472011.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2134; TKG=TKG 0181
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   86-3 [Human lung carcinoma]
AC   CVCL_E7YW
RX   CelloPub=CLPUB00161;
CC   Population: Japanese.
CC   Doubling time: 9.0 days (CelloPub=CLPUB00161).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   86-3 [Mouse hybridoma against coxsackievirus B4]
AC   CVCL_J875
DR   Wikidata; Q54605352
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   86-4
AC   CVCL_UJ57
DR   Wikidata; Q93310360
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 7.0 days (CelloPub=CLPUB00161; PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   86-5
AC   CVCL_UJ58
DR   Wikidata; Q93310362
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 10 days (CelloPub=CLPUB00161; PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   86-6
AC   CVCL_UJ59
DR   Wikidata; Q93310364
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 17.7 days (CelloPub=CLPUB00161; PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   86-7
AC   CVCL_UJ60
DR   Wikidata; Q93310367
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 6.7 days (CelloPub=CLPUB00161; PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   86-8
AC   CVCL_UJ61
DR   Wikidata; Q93310369
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 5.8 days (CelloPub=CLPUB00161; PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   86-9
AC   CVCL_E7YY
RX   CelloPub=CLPUB00161;
CC   Population: Japanese.
CC   Doubling time: 5.9 days (CelloPub=CLPUB00161).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   862L
AC   CVCL_8477
AS   CVCL_5F72
SY   MPC 862L; MPC line 862; MPC862L
DR   BTO; BTO_0004580
DR   Wikidata; Q54605355
RX   PubMed=11151443;
RX   PubMed=12438155;
RX   PubMed=15860353;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97306; Nf1.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
CC   Breed/subspecies: C57BL/6 x 129S2/SvPas.
DI   NCIt; C134960; Mouse adrenal gland pheochromocytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   863.D4
AC   CVCL_C7EY
DR   Wikidata; Q123030330
RX   PubMed=6205980;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01133; Human EGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   8645
AC   CVCL_D1GZ
DR   Wikidata; Q127378797
RX   PubMed=21447744;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=21447744; PubMed=29348827).
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   865-mel
AC   CVCL_S564
SY   865-MEL; 865mel
DR   cancercelllines; CVCL_S564
DR   CGH-DB; 9306-4
DR   Cosmic; 905219
DR   Wikidata; Q54605356
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   866MT
AC   CVCL_8090
SY   866 MT
DR   cancercelllines; CVCL_8090
DR   Cosmic; 929964
DR   Cosmic; 932917
DR   Cosmic; 934540
DR   Cosmic; 2668259
DR   IARC_TP53; 118
DR   Wikidata; Q54605357
RX   PubMed=1855224;
RX   PubMed=7972006;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.131_150+13del; Zygosity=Unspecified (PubMed=7972006).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=1855224).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Glu49Lys (c.145G>A); Zygosity=Unspecified (PubMed=1855224).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Ter (c.687T>A); Zygosity=Unspecified (PubMed=1855224).
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   8684
AC   CVCL_WY98
DR   Wikidata; Q93310380
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp184Glufs*24 (c.552_553del2); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 16,17
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15,16
ST   D19S433: 13,16
ST   D1S1656: 12,15
ST   D21S11: 29,32.2
ST   D2S1338: 26
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 26
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   86D
AC   CVCL_G095
SY   127.5-9
DR   CLO; CLO_0001514
DR   ATCC; HB-286
DR   ECACC; 91060557
DR   Wikidata; Q54605436
RX   PubMed=2528463;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Sheep T-cell receptor gamma/delta.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   86HG39
AC   CVCL_7259
SY   86HG-39; 86-HG-39
DR   Wikidata; Q54605438
RX   PubMed=1460090;
RX   PubMed=1708926;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   86MA
AC   CVCL_ZU35
SY   86 MAnchester
DR   Wikidata; Q98125435
RX   PubMed=9649131;
CC   Senescence: Senesces at 17 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   87-1
AC   CVCL_UJ53
DR   Wikidata; Q93310386
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 12.1 days (CelloPub=CLPUB00161; PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   87-12
AC   CVCL_E7XY
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 2.0 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   87-13
AC   CVCL_RA81
DR   Wikidata; Q54605440
RX   PubMed=1306323;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 11.7 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   87-16
AC   CVCL_E7Y9
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 2.1 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   87-17
AC   CVCL_E7XZ
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 3.7 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   87-2
AC   CVCL_UJ54
DR   Wikidata; Q93310393
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 5.4 days (CelloPub=CLPUB00161; PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   87-3
AC   CVCL_UJ55
DR   Wikidata; Q93310395
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 14.0 days (CelloPub=CLPUB00161; PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   87-4
AC   CVCL_UJ56
DR   Wikidata; Q93310397
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 9.2 days (CelloPub=CLPUB00161; PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   87-5
AC   CVCL_6750
DR   CLO; CLO_0050040
DR   BioSample; SAMN03472058
DR   CGH-DB; 9048-4
DR   CGH-DB; 96-1
DR   RCB; RCB2092
DR   TKG; TKG 0503
DR   Wikidata; Q54605443
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=10328163;
RX   PubMed=12107105;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   Doubling time: 1.8 days (CelloPub=CLPUB00161; PubMed=7817386; PubMed=10328163).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): RCB=RCB2092; TKG=TKG 0503
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 13,14
ST   D5S818: 13
ST   D7S820: 10,11,12 (RCB=RCB2092)
ST   D7S820: 11,12 (TKG=TKG 0503)
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17,18 (RCB=RCB2092)
ST   vWA: 16,18 (TKG=TKG 0503)
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   87-6
AC   CVCL_UJ52
DR   Wikidata; Q93310404
RX   CelloPub=CLPUB00161;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 6.7 days (CelloPub=CLPUB00161; PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   8701-BC
AC   CVCL_H610
SY   8701 BC; 8701BC
DR   ChEMBL-Cells; CHEMBL3307701
DR   ChEMBL-Targets; CHEMBL614777
DR   PubChem_Cell_line; CVCL_H610
DR   Wikidata; Q54605445
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.1186/bcr31;
RX   DOI=10.25904/1912/1434;
RX   PubMed=1665496;
RX   PubMed=2548558;
RX   PubMed=7556886;
CC   Doubling time: ~29 hours (PubMed=2548558).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   8709
AC   CVCL_1938
DR   DSMZ; ACC-588
DR   DSMZCellDive; ACC-588
DR   Wikidata; Q54605447
RX   PubMed=9885975;
RX   PubMed=11747540;
RX   PubMed=20638124;
CC   From: Yoshida, Kazuko; National Institute of Radiological Sciences; Chiba-shi; Japan.
CC   Doubling time: ~60-80 hours (DSMZ=ACC-588).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   8713
AC   CVCL_WZ04
DR   cancercelllines; CVCL_WZ04
DR   Wikidata; Q93310416
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Gln1138Leu (c.3413A>T); ClinVar=VCV000051458; Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20,22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 19
ST   D19S433: 13,15
ST   D1S1656: 11,12
ST   D21S11: 30
ST   D2S1338: 18,25
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D6S1043: 11
ST   D7S820: 8,9
ST   D8S1179: 15,16
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 11
//
ID   8714
AC   CVCL_WZ05
DR   cancercelllines; CVCL_WZ05
DR   Wikidata; Q93310418
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D19S433: 14
ST   D1S1656: 10,17.3
ST   D21S11: 33.2
ST   D2S1338: 18,24
ST   D3S1358: 17,20
ST   D5S818: 12,13
ST   D6S1043: 18,19
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21.2
ST   Penta D: 9,10
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ06 ! 17457
OI   CVCL_WZ07 ! EK_R1
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   8715
AC   CVCL_WZ09
DR   cancercelllines; CVCL_WZ09
DR   Wikidata; Q93310420
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys3326Ter (c.9976A>T) (10204A>T); ClinVar=VCV000038266; Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 17,23
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D1S1656: 13,15.3
ST   D21S11: 28
ST   D2S1338: 16,17
ST   D3S1358: 14
ST   D5S818: 11
ST   D6S1043: 11,17
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ08 ! 17480
OI   CVCL_WZ10 ! 8716
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   8716
AC   CVCL_WZ10
DR   cancercelllines; CVCL_WZ10
DR   Wikidata; Q93310423
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys3326Ter (c.9976A>T) (10204A>T); ClinVar=VCV000038266; Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 17,23
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D1S1656: 13,15.3
ST   D21S11: 28
ST   D2S1338: 16,17
ST   D3S1358: 14
ST   D5S818: 11
ST   D6S1043: 11,17
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ08 ! 17480
OI   CVCL_WZ09 ! 8715
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   871E3
AC   CVCL_B0E0
DR   Wikidata; Q108819769
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10813.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10084.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   8724
AC   CVCL_WZ11
DR   cancercelllines; CVCL_WZ11
DR   Wikidata; Q93310425
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3013Ile (c.9038C>T); ClinVar=VCV000038205; Zygosity=Unspecified (PubMed=31150822).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 16,22
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D1S1656: 14,16.3
ST   D21S11: 27,31.2
ST   D2S1338: 18,21
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D6S1043: 13
ST   D7S820: 9,10
ST   D8S1179: 11,15
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,19
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 11
//
ID   8732
AC   CVCL_WZ12
DR   Wikidata; Q93310427
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr253del (c.757_759delACC); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 24
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 15
ST   D1S1656: 15.3,16
ST   D21S11: 29
ST   D2S1338: 18,26
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 10
ST   Penta E: 12,15
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   879M
AC   CVCL_WM40
DR   Cosmic; 852215
DR   Wikidata; Q93310429
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   87H7
AC   CVCL_B0E1
DR   Wikidata; Q108819770
RX   Patent=US4938948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10788.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10059.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human breast cancer 230 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   87HG28
AC   CVCL_V026
SY   87HG-28
DR   Wikidata; Q54605449
RX   PubMed=1460090;
RX   PubMed=1708926;
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   87HG31
AC   CVCL_V027
SY   87HG-31
DR   Wikidata; Q54605451
RX   PubMed=1460090;
RX   PubMed=1708926;
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   87I
AC   CVCL_XV49
DR   Wikidata; Q93310440
RX   DOI=10.13523/j.cb.20180408;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; X2G6F6; Tupaia belangeri CD3E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   87RD102
AC   CVCL_WY28
DR   Wikidata; Q93310442
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   PubMed=3248383;
RX   PubMed=10987302;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (PubMed=10987302).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   87T1a
AC   CVCL_C8Q4
DR   Wikidata; Q123030331
RX   PubMed=15180438;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C8Q5 ! 87T1b
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   87T1b
AC   CVCL_C8Q5
DR   Wikidata; Q123030332
RX   PubMed=15180438;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C8Q4 ! 87T1a
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   88 BLCL
AC   CVCL_E416
DR   ECACC; 94031617
DR   Wikidata; Q54605454
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   88-1 [Human lung carcinoma]
AC   CVCL_E7YU
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 4.2 hours (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-1 [Human skin fibroblast]
AC   CVCL_A9G3
DR   Wikidata; Q102113462
RX   PubMed=7822435;
RX   PubMed=23847654;
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 6
//
ID   88-1 [Mouse hybridoma against dog SELPLG]
AC   CVCL_D2QK
DR   Wikidata; Q127378798
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   88-1 hTERT
AC   CVCL_A9G4
DR   Wikidata; Q102113463
RX   PubMed=23847654;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector containing a LTR-loxP-hTERT-SV40p-hisD-PuroR-LTR construct.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9G3 ! 88-1 [Human skin fibroblast]
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   88-10
AC   CVCL_E7Y0
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 7.0 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-12
AC   CVCL_E7Y1
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 13.5 days (PubMed=10328163).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-13
AC   CVCL_E7Y2
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 2.0 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-14
AC   CVCL_E7XV
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 4.1 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-2
AC   CVCL_RA75
DR   Wikidata; Q54605455
RX   PubMed=1306323;
RX   PubMed=7817386;
RX   PubMed=12111518;
CC   Population: Japanese.
CC   Doubling time: 1.5 days (PubMed=7817386); 36.0 +- 2.1 hours (PubMed=12111518).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RA76 ! 88-2F
OI   CVCL_RA77 ! 88-2FA
OI   CVCL_RA78 ! 88-2T
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   88-29
AC   CVCL_E7Y3
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 9.0 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-2F
AC   CVCL_RA76
DR   Wikidata; Q54605456
RX   PubMed=1306323;
RX   PubMed=12111518;
CC   Population: Japanese.
CC   Doubling time: 26.4 +- 1.8 hours (PubMed=12111518).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RA75 ! 88-2
OI   CVCL_RA77 ! 88-2FA
OI   CVCL_RA78 ! 88-2T
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   88-2FA
AC   CVCL_RA77
DR   Wikidata; Q54605458
RX   PubMed=1306323;
RX   PubMed=12111518;
CC   Population: Japanese.
CC   Doubling time: 99.2 +- 2.9 hours (PubMed=12111518).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RA75 ! 88-2
OI   CVCL_RA76 ! 88-2F
OI   CVCL_RA78 ! 88-2T
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   88-2T
AC   CVCL_RA78
DR   Wikidata; Q54605459
RX   PubMed=1306323;
RX   PubMed=12111518;
CC   Population: Japanese.
CC   Doubling time: 91.2 +- 2.6 hours (PubMed=12111518).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RA75 ! 88-2
OI   CVCL_RA76 ! 88-2F
OI   CVCL_RA77 ! 88-2FA
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   88-3
AC   CVCL_RA82
DR   Wikidata; Q54605460
RX   PubMed=1306323;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.7 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   88-4
AC   CVCL_E7XT
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.7 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-5
AC   CVCL_E7XU
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 2.0 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-6 [Human lung carcinoma]
AC   CVCL_E7YV
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 6 days (PubMed=7817386).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-6 [Human skin fibroblast]
AC   CVCL_A9G5
DR   Wikidata; Q102113464
RX   PubMed=7822435;
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   88-7
AC   CVCL_E7YT
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 7 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-8
AC   CVCL_E7YS
RX   PubMed=7817386;
CC   Population: Japanese.
CC   Doubling time: 3.2 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88-9
AC   CVCL_E7YA
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 2.4 days (PubMed=10328163).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   88.6
AC   CVCL_B5NX
DR   Wikidata; Q111732819
RX   PubMed=11059771;
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   88.6/D200-A
AC   CVCL_B5NY
SY   D200-A
DR   Wikidata; Q111732820
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5NX ! 88.6
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   88.6/D200-B
AC   CVCL_B5NZ
SY   D200-B
DR   Wikidata; Q111732821
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5NX ! 88.6
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   88.6/D800-A
AC   CVCL_B5P0
SY   D800-A
DR   Wikidata; Q111732822
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Met (c.1445G>T); Zygosity=Homozygous (PubMed=11956086).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5NX ! 88.6
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   88.6/D800-B
AC   CVCL_B5P1
SY   D800-B
DR   Wikidata; Q111732824
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Ser (c.1446G>T); Zygosity=Homozygous (PubMed=11956086).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5NX ! 88.6
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   8807
AC   CVCL_EQ48
SY   7276
DR   GEO; GSM666042
DR   GEO; GSM666043
DR   Wikidata; Q54605463
RX   PubMed=22033105;
CC   Sequence variation: Mutation; HGNC; HGNC:7708; NDUFS2; Simple; p.Asp446Asn (c.1336G>A); Zygosity=Homozygous (PubMed=22033105).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   8823
AC   CVCL_UM82
DR   cancercelllines; CVCL_UM82
DR   Cosmic; 1418454
DR   IARC_TP53; 10956
DR   Wikidata; Q93310478
RX   PubMed=10070891;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn247Thr (c.740A>C); Zygosity=Unspecified (PubMed=10070891).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=10070891).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   883-mel
AC   CVCL_S565
SY   883-MEL; 883mel; 883
DR   cancercelllines; CVCL_S565
DR   CGH-DB; 9307-4
DR   Cosmic; 905220
DR   Wikidata; Q54605464
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,03; B*07,08; C*07 (PubMed=9670966).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   883L
AC   CVCL_6A87
SY   883-L; 883 L
DR   Wikidata; Q54605467
RX   PubMed=216485;
RX   PubMed=4333982;
RX   PubMed=4345944;
RX   PubMed=4346033;
RX   PubMed=4357683;
RX   PubMed=6294325;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   884F11
AC   CVCL_C476
DR   CLO; CLO_0050279
DR   RCB; RCB2313
DR   Wikidata; Q54605469
RX   PubMed=10616916;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08226; Mouse Apoe.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 7
//
ID   8858-1
AC   CVCL_E4CH
RX   PubMed=28817799;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4CI ! 8858-3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   8858-3
AC   CVCL_E4CI
RX   PubMed=28817799;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4CH ! 8858-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   888-EBV
AC   CVCL_A1DN
DR   Wikidata; Q102113465
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=9670966;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   HLA typing: A*01,24; B*52,55; C*01:02,12:01 (PubMed=9670966).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7943 ! 1290-mel
OI   CVCL_DI11 ! 1858-mel a
OI   CVCL_DI12 ! 1858-mel b
OI   CVCL_DI13 ! 1858-mel c
OI   CVCL_DI14 ! 1936-mel
OI   CVCL_DI15 ! 1962-mel
OI   CVCL_4632 ! 888-mel
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   888-mel
AC   CVCL_4632
SY   888-MEL; 888 mel; 888mel; 888MEL; 888; Mel888; mel888; MG-888
DR   BTO; BTO_0002950
DR   EFO; EFO_0006531
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_4632
DR   CGH-DB; 9308-4
DR   Cosmic; 876679
DR   Cosmic; 877281
DR   Cosmic; 905221
DR   Cosmic; 1042621
DR   Cosmic; 1238108
DR   Cosmic; 1303045
DR   EGA; EGAS00001000610
DR   GEO; GSM206439
DR   GEO; GSM218046
DR   GEO; GSM274691
DR   GEO; GSM1092556
DR   GEO; GSM1507930
DR   PharmacoDB; 888mel_32_2019
DR   Progenetix; CVCL_4632
DR   Wikidata; Q54605471
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=8537970;
RX   PubMed=9598804;
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=15467732;
RX   PubMed=16470173;
RX   PubMed=18172304;
RX   PubMed=25485619;
RX   PubMed=25502142;
RX   PubMed=25538140;
WW   Provider; NIH OTT; E-070-2010/0-8; https://web.archive.org/web/20150923174650/http://www.ott.nih.gov/erma/metastatic-melanoma-cancer-cell-line-888-mel
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   HLA typing: A*01,24; B*52,55; C*01:02,12:01 (PubMed=9670966).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Oral cavity, soft palate, hypodermis; UBERON=UBERON_0001733+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7943 ! 1290-mel
OI   CVCL_DI11 ! 1858-mel a
OI   CVCL_DI12 ! 1858-mel b
OI   CVCL_DI13 ! 1858-mel c
OI   CVCL_DI14 ! 1936-mel
OI   CVCL_DI15 ! 1962-mel
OI   CVCL_A1DN ! 888-EBV
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   888A2 mel
AC   CVCL_C612
SY   888 A2 Mel
DR   Wikidata; Q54605474
RX   PubMed=11924911;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Oral cavity, soft palate, hypodermis; UBERON=UBERON_0001733+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4632 ! 888-mel
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   88B
AC   CVCL_J733
DR   CLO; CLO_0001515
DR   ATCC; CRL-1967
DR   Wikidata; Q54605475
RX   PubMed=6189834;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02718; Tetronarce californica chrnd.
CC   Monoclonal antibody target: UniProtKB; P02714; Tetronarce californica chrng.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   88CT1
AC   CVCL_C8Q6
SY   Myc88C tumor 1
DR   Wikidata; Q123030333
RX   PubMed=15180438;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C8Q7 ! 88CT3
OI   CVCL_C8Q8 ! 88CT5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   88CT3
AC   CVCL_C8Q7
SY   Myc88C tumor 3
DR   Wikidata; Q123030334
RX   PubMed=15180438;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C8Q6 ! 88CT1
OI   CVCL_C8Q8 ! 88CT5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   88CT5
AC   CVCL_C8Q8
SY   Myc88C tumor 5
DR   Wikidata; Q123030335
RX   PubMed=15180438;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C8Q6 ! 88CT1
OI   CVCL_C8Q7 ! 88CT3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   88TAg
AC   CVCL_6768
DR   CLO; CLO_0001516
DR   ATCC; CRL-2820
DR   Kerafast; ENH116-FP
DR   Wikidata; Q54605477
RX   PubMed=12882965;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   894-mel
AC   CVCL_S566
SY   894-MEL; 894mel
DR   CGH-DB; 9309-4
DR   Cosmic; 905222
DR   Wikidata; Q54605478
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   8959M
AC   CVCL_WM35
DR   cancercelllines; CVCL_WM35
DR   Cosmic; 852210
DR   Wikidata; Q93310517
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   89MA
AC   CVCL_ZU36
SY   89 MAnchester
DR   Wikidata; Q98125436
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 24 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   89MS30
AC   CVCL_G625
SY   GLXA-Ab1
DR   CLO; CLO_0001517
DR   ATCC; HB-11300
DR   Wikidata; Q54605479
RX   Patent=US5656271;
RX   PubMed=8837610;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11300.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Chlamydia trachomatis exoglycolipid antigen (GLXA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   8a
AC   CVCL_C5I4
DR   Wikidata; Q116048409
RX   PubMed=8985752;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01575; Paracoccidioides brasiliensis 43 kDa secreted glycoprotein (Gp43).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8A1
AC   CVCL_0I15
DR   Wikidata; Q54605481
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5115.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   8A12 [Mouse hybridoma against chicken CSF1]
AC   CVCL_C4JZ
DR   Wikidata; Q116048410
RX   PubMed=35688031;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; D8UWD9; Chicken CSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8A12 [Mouse hybridoma against guinea pig MBP1]
AC   CVCL_L532
DR   ECACC; 94091319
DR   Wikidata; Q54605484
RX   PubMed=8334540;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22032; Cavia porcellus MBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   8A12 [Mouse hybridoma against human IL22RA1]
AC   CVCL_N025
DR   Wikidata; Q54605486
RX   Patent=US9555107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7318.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8N6P7; Human IL22RA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 9
//
ID   8A16
AC   CVCL_B5Z9
DR   Wikidata; Q111732825
RX   PubMed=16227235;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1-561 = mRNA-capping enzyme nsP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   8A2N
AC   CVCL_G626
SY   8A2
DR   CLO; CLO_0001518
DR   ATCC; HB-8161
DR   Wikidata; Q54605487
RX   Patent=US4767710;
RX   PubMed=6197636;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8161.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   8A3A10
AC   CVCL_E3A0
RX   PubMed=26771404;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0N9P2C3; Porcine epidemic diarrhea virus (strain HN1303) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   8A3B.6
AC   CVCL_J734
DR   CLO; CLO_0001519
DR   ATCC; CRL-1875
DR   Wikidata; Q54605489
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=6186076;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18609; Bluetongue virus 17 VP7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   8A4
AC   CVCL_XH69
DR   Wikidata; Q93310546
RX   Patent=US8449887;
RX   PubMed=17949772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3823.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q1W367; Chikungunya virus (strain 06-049) spike glycoprotein E2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   8A7
AC   CVCL_E2SR
RX   PubMed=6200440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Haemophilus ducreyi (strain 35000HP / ATCC 700724) antigen (Note=Also reacts with many other Haemophilus ducreyi strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   8A7B4
AC   CVCL_YN81
DR   Wikidata; Q93310548
RX   PubMed=23727927;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   8B1-2
AC   CVCL_F1FZ
RX   PubMed=6341819;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8B10
AC   CVCL_C4D9
DR   ABCD; ABCD_AH088
DR   Wikidata; Q116048411
RX   PubMed=25756188;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   8B1B.1
AC   CVCL_J735
DR   CLO; CLO_0001520
DR   ATCC; CRL-1877
DR   Wikidata; Q54605492
RX   PubMed=6186076;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P18609; Bluetongue virus 17 VP7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   8B2
AC   CVCL_C5BP
DR   Wikidata; Q116048412
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8B3G11
AC   CVCL_XH05
DR   CCRID; 4201PAT-CCTCC01058
DR   Wikidata; Q93310555
RX   Patent=CN107271667B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201770.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; R4J9I3; Bluetongue virus 8 outer capsid protein VP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   8B4
AC   CVCL_C5EU
DR   Wikidata; Q116048413
RX   PubMed=21707366;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01151; Human CD83.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8B5
AC   CVCL_0I16
DR   Wikidata; Q54605493
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5116.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   8B5D4
AC   CVCL_XH06
DR   CCRID; 4201PAT-CCTCC01057
DR   Wikidata; Q93310561
RX   Patent=CN107271667B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201769.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; R4J9I3; Bluetongue virus 8 outer capsid protein VP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   8B8
AC   CVCL_JY49
SY   3-8B8
DR   ATCC; HB-12070
DR   Wikidata; Q54605494
RX   Patent=US7285649;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12070.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   8B9
AC   CVCL_F1X0
RX   Patent=US12312403;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8BB10
AC   CVCL_D1FR
DR   Wikidata; Q127378799
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z067 ! Sp2ab
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   8C10
AC   CVCL_XA97
DR   Wikidata; Q93310562
RX   PubMed=23750481;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5T2D2; Human TREML2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   8C11 [Mouse hybridoma against chicken HMGB1]
AC   CVCL_E7Q1
RX   PubMed=28570826;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9YH06; Chicken HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8C11 [Mouse hybridoma against hepatitis E virus ORF2]
AC   CVCL_WZ62
DR   Wikidata; Q93310563
RX   Patent=US9428554;
RX   PubMed=15780737;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200116.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q81871; Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) secreted protein ORF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   8C12
AC   CVCL_E3AV
RX   PubMed=2437192;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11411; Leuconostoc mesenteroides glucose-6-phosphate 1-dehydrogenase (zwf).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   8C2-2D6
AC   CVCL_E5NI
RX   Patent=US9879087;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8C3 [Mouse hybridoma against D.pteronyssinus Der p 21]
AC   CVCL_E5SU
RX   PubMed=38646484;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2L7C5; Dermatophagoides pteronyssinus allergen Der p 21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8C3 [Mouse hybridoma against human MUC18]
AC   CVCL_0I17
DR   Wikidata; Q54605495
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5246.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   8C4
AC   CVCL_F1X1
RX   Patent=US12312403;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8C6
AC   CVCL_E5QC
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8C7
AC   CVCL_C5FF
DR   Wikidata; Q116048414
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8C9
AC   CVCL_J736
DR   CLO; CLO_0050288
DR   ECACC; 99072805
DR   RCB; RCB0844
DR   Wikidata; Q54605498
RX   PubMed=1281958;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P16671; Human CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   8C9E8
AC   CVCL_YP09
DR   Wikidata; Q93310569
RX   PubMed=23727927;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   8CB-1
AC   CVCL_9Q48
DR   Wikidata; Q54605501
RX   PubMed=186420;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
OI   CVCL_9Q47 ! 13CB-1
OI   CVCL_4087 ! 26CB-1
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   8D12
AC   CVCL_G200
DR   ECACC; 94091320
DR   Wikidata; Q54605502
RX   PubMed=8334540;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22032; Cavia porcellus MBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   8D12-G5
AC   CVCL_E2ZH
SY   8D12
RX   PubMed=26492621;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01034; Human CST3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   8D12/49
AC   CVCL_VI58
DR   BEI_Resources; MRA-874
DR   Wikidata; Q54605504
RX   PubMed=3045543;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) rhoptry protein 3 (RhopH3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   8d4
AC   CVCL_F0VS
RX   PubMed=1690175;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54939; Chicken TLN1 (Note=Also reacts with human, rat and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8D8
AC   CVCL_E5MU
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8E11
AC   CVCL_A0PI
DR   Wikidata; Q108819771
RX   PubMed=19231357;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   8E11.9
AC   CVCL_N026
DR   Wikidata; Q54605505
RX   Patent=US9555107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7319.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9GZX6; Human IL22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 9
//
ID   8E12
AC   CVCL_C5FG
DR   Wikidata; Q116048415
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8E3 [Mouse hybridoma against human MUC16]
AC   CVCL_0I18
DR   Wikidata; Q54605507
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5118.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   8E3 [Mouse hybridoma against vaccinia A27L]
AC   CVCL_E5MB
RX   PubMed=26889021;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11258; Vaccinia virus protein OPG154 (A27L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8E4 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HS
DR   Wikidata; Q108819772
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   8E4 [Mouse hybridoma against ouabain]
AC   CVCL_B0Q0
DR   Wikidata; Q108819773
RX   Patent=US7348412;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-815.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   8E5
AC   CVCL_C5FH
DR   Wikidata; Q116252589
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8E5(CEM)
AC   CVCL_3484
SY   8E5/LAV; 8E5
DR   CLO; CLO_0001521
DR   ATCC; CRL-3617
DR   ATCC; CRL-8993
DR   BEI_Resources; ARP-95
DR   BioSample; SAMN03471213
DR   cancercelllines; CVCL_3484
DR   Wikidata; Q54605508
RX   Patent=US4752565;
RX   PubMed=3014036;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8993.
CC   Population: Caucasian.
CC   Virology: HIV-1 producing cell line.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-8993; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-3617
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 12
ST   D7S820: 9,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6244 ! CEM A3.01
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   8e6
AC   CVCL_F0VT
RX   PubMed=1690175;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54939; Chicken TLN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8E7 [Human B-cell P.aeruginosa LPS mAB producing]
AC   CVCL_6360
DR   CLO; CLO_0001522
DR   ATCC; CRL-8795
DR   BioSample; SAMN03472814
DR   Wikidata; Q54605601
RX   Patent=US4834975;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8795.
CC   Doubling time: ~24-36 hours (ATCC=CRL-8795).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 7.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8795
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   8E7 [Mouse hybridoma against HIV-1 rev]
AC   CVCL_A0CC
DR   Wikidata; Q108819774
RX   PubMed=8107211;
RX   PubMed=9305730;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   8E8
AC   CVCL_B6RX
DR   Wikidata; Q111732826
RX   CelloPub=CLPUB00685;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00254; Human F2RL2 (Note=Immunized with AA 31-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   8F10
AC   CVCL_C5BQ
DR   Wikidata; Q116048418
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8F12
AC   CVCL_E5N5
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8F3
AC   CVCL_B0VT
DR   Wikidata; Q108819775
RX   PubMed=6331649;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   8F4 [Mouse hybridoma against B.germanica Bla g 2]
AC   CVCL_C3X0
DR   Wikidata; Q116048419
RX   PubMed=1993811;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54958; Blattella germanica aspartic protease Bla g 2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   8F4 [Rat hybridoma against mouse Ccr8]
AC   CVCL_E6IZ
RX   PubMed=11123295;
RX   PubMed=14573924;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P56484; Mouse Ccr8/Cd198.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8F5 [Mouse hybridoma against human PDCD1]
AC   CVCL_YN76
DR   Wikidata; Q93310600
RX   PubMed=20443708;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   8F5 [Mouse hybridoma against T.tridentatus TP-1]
AC   CVCL_C5EQ
DR   Wikidata; Q116048420
RX   PubMed=21851235;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14213; Tachypleus tridentatus tachyplesin-1 (TP-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8F6
AC   CVCL_A0PJ
DR   Wikidata; Q108819776
RX   PubMed=19231357;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2).
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1).
CC   Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   8F8
AC   CVCL_KB82
DR   Wikidata; Q54605602
RX   PubMed=2447167;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04823; Rat Il3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   8F9
AC   CVCL_C6ID
DR   ABCD; ABCD_AV468
DR   Wikidata; Q116048422
RX   PubMed=26377421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F6QNH2; Suid herpesvirus 1 (strain JF) DNA polymerase processivity factor (UL42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8FR23
AC   CVCL_WY63
SY   8 days Foie de Rat at 23th passage
DR   Wikidata; Q93310607
RX   PubMed=4467909;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8D
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   8G1
AC   CVCL_C5FI
DR   Wikidata; Q116048423
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8G1.7
AC   CVCL_B0CP
SY   8G1.7-A; 8G1
DR   Wikidata; Q108819777
RX   Patent=US7153686;
RX   PubMed=11121071;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-993.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P25063; Human CD24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   8G10 [Mouse hybridoma against human LRRK2]
AC   CVCL_E9E4
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/8G10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5S007; Human LRRK2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   8G10 [Mouse hybridoma against NNK]
AC   CVCL_F0WG
RX   PubMed=23518474;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_32692; 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one (NNK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8G10/48
AC   CVCL_VI59
DR   BEI_Resources; MRA-834
DR   Wikidata; Q54605605
RX   PubMed=3045543;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) merozoite surface protein 2 (MSP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   8G11
AC   CVCL_E7SG
RX   PubMed=1379786;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P33470; Porcine transmissible gastroenteritis coronavirus (strain Miller) (TGEV) spike glycoprotein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8G12 [Mouse hybridoma against L.mesenteroides zwf]
AC   CVCL_E3AW
RX   PubMed=2437192;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11411; Leuconostoc mesenteroides glucose-6-phosphate 1-dehydrogenase (zwf).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   8G12 [Mouse hybridoma against S.pneumoniae psaA]
AC   CVCL_F1V5
RX   PubMed=9521144;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A4G2; Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) pneumococcal surface adhesin A (psaA) (Note: Immunized with serotype 22F psaA but recognizes 23 capsular serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8G2 [Mouse hybridoma against T.annularis PA2]
AC   CVCL_C5FJ
DR   Wikidata; Q116048424
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   8G2 [Mouse/rat hybridoma against mouse Nr5a1]
AC   CVCL_E7DS
RX   PubMed=19382844;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P33242; Mouse Nr5a1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8G3
AC   CVCL_B6M3
DR   Wikidata; Q111732828
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   PubMed=10488532;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q03039; Lake Victoria marburgvirus (strain Popp-67) polymerase cofactor VP35.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   8G3-A8
AC   CVCL_E2ZI
SY   8G3
RX   PubMed=26492621;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01034; Human CST3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   8G6 [Mouse hybridoma against human GPC3]
AC   CVCL_C5BR
DR   Wikidata; Q116048425
RX   PubMed=23244326;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8G6 [Mouse hybridoma against phOX]
AC   CVCL_C4FR
DR   Wikidata; Q116048426
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   8G6 [Mouse hybridoma against progesterone]
AC   CVCL_E2QU
RX   PubMed=26301932;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   8G6-5
AC   CVCL_C6XU
DR   ABCD; ABCD_AN737
DR   ABCD; ABCD_AN738
DR   ABCD; ABCD_AN739
DR   Wikidata; Q123030336
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   8G7
AC   CVCL_C5VM
DR   Wikidata; Q116048427
RX   PubMed=29302006;
RX   PubMed=29950717;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A5K736; Plasmodium vivax (strain Salvador I) reticulocyte binding protein 2b (RBP2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   8G9 [Mouse hybridoma against human MUC16]
AC   CVCL_0I19
DR   Wikidata; Q54605606
RX   Patent=US9676866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5119.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   8G9 [Mouse hybridoma against influenza A HA]
AC   CVCL_XC01
DR   CCRID; 4201PAT-CCTCC00208
DR   Wikidata; Q93310617
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200639.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   8H10 [Mouse hybridoma against pig EDN1]
AC   CVCL_F0V7
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   8H10 [Mouse hybridoma against vaccinia A27L]
AC   CVCL_E5M7
RX   PubMed=26889021;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11258; Vaccinia virus protein OPG154 (A27L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   8H11 [Mouse hybridoma against chicken ACHE]
AC   CVCL_E8CA
RX   PubMed=3288716;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36196; Chicken ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   8H11 [Mouse hybridoma against chicken CCL5]
AC   CVCL_C4K2
DR   Wikidata; Q116048428
RX   PubMed=33497732;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8QG57; Chicken CCL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8H11 [Mouse hybridoma against human IL22RA1]
AC   CVCL_N027
DR   Wikidata; Q54605607
RX   Patent=US9555107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7317.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8N6P7; Human IL22RA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   8H11 [Mouse hybridoma against human POSTN]
AC   CVCL_E2SA
RX   Patent=US7087727;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4590.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15063; Human POSTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   8H12
AC   CVCL_XA10
DR   Wikidata; Q93310623
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9394.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 neuraminidase (NA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   8H3 [Mouse hybridoma against hepatitis E virus]
AC   CVCL_WZ63
DR   Wikidata; Q93310625
RX   Patent=US9428554;
RX   PubMed=15780737;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200117.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q81871; Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) secreted protein ORF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 6
//
ID   8H3 [Mouse hybridoma against human WRN]
AC   CVCL_A7FV
DR   Wikidata; Q107113308
RX   PubMed=9885239;
RX   PubMed=10543396;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14191; Human WRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   8H3C4
AC   CVCL_A0VC
DR   CCRID; 4201PAT-CCTCC01050
DR   Wikidata; Q108819778
RX   Patent=CN107299085B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201760.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   8H4 [Mouse hybridoma against ciguatoxin]
AC   CVCL_C5GI
DR   Wikidata; Q116048429
RX   PubMed=16890263;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_36467; Ciguatoxin CTX1B.
CC   Monoclonal antibody target: ChEBI; CHEBI_61279; 51-hydroxy ciguatoxin CTX3C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   8H4 [Mouse hybridoma against H.ducreyi]
AC   CVCL_E2SQ
RX   PubMed=6200440;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Haemophilus ducreyi (strain 35000HP / ATCC 700724) antigen (Note=Also reacts with all other Haemophilus ducreyi strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   8H4C7
AC   CVCL_A0JM
DR   Wikidata; Q108819779
RX   Patent=US4863851;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9225.
CC   Registration: Upjohn Culture Collection; UC HB-19.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08118; Human MSMB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   8H5 [Mouse hybridoma against influenza A HA]
AC   CVCL_A0UI
DR   CCRID; 4201PAT-CCTCC00181
DR   Wikidata; Q108819780
RX   Patent=CN101220097A;
RX   Patent=US8603467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200607.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   8H5 [Mouse/rat hybridoma against human GABARAP]
AC   CVCL_B5L9
DR   Wikidata; Q111732829
RX   PubMed=30679523;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O95166; Human GABARAP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   8H7 [Human hybridoma against P.aeruginosa LPS]
AC   CVCL_4T77
DR   Wikidata; Q54605608
RX   Patent=US5662905;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9258.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 12
//
ID   8H7 [Mouse hybridoma against A.lucorum EcR-A]
AC   CVCL_B0U8
DR   CCRID; 4201PAT-CCTCC00982
DR   Wikidata; Q108819781
RX   Patent=CN106589125B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016206.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A0K0N8J0; Apolygus lucorum 20-hydroxy-ecdysone receptor (EcR-A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   8H7A
AC   CVCL_XC79
SY   HB 8H7A
DR   CCRID; 4201PAT-CCTCC00078
DR   Wikidata; Q93310631
RX   Patent=US6207417;
RX   Patent=US20080305074;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10560.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21583; Human KITLG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   8H9 [Mouse hybridoma against human CD276]
AC   CVCL_B0L9
DR   ABCD; ABCD_AH797
DR   Wikidata; Q108819782
RX   Patent=US9938351;
RX   PubMed=11358824;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10926.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized omburtamab potential therapeutic antibody against neuroblastoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 6
//
ID   8H9 [Mouse hybridoma against human GRN]
AC   CVCL_C5GD
DR   Wikidata; Q116048430
RX   PubMed=21707362;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28799; Human GRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   8H9 [Mouse hybridoma against MTPS]
AC   CVCL_C4DA
DR   Wikidata; Q116048431
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   8HTEo-
AC   CVCL_U404
SY   8/HTEo-; HTE-8o-
DR   Wikidata; Q54605611
RX   PubMed=2457904;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U403 ! 3HTEo-
OI   CVCL_U405 ! 9HTEo-
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   8M14.3
AC   CVCL_E4A0
RX   PubMed=14675102;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   9-1
AC   CVCL_B6WY
DR   CCRID; 4201PAT-CCTCC00726
DR   Wikidata; Q111732830
RX   Patent=CN105132380B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015103.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P09104; Human ENO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   9-15c
AC   CVCL_6532
SY   9-15C
DR   CLO; CLO_0051036
DR   JCRB; JCRB1181
DR   RCB; RCB2323
DR   Wikidata; Q54605612
RX   PubMed=21155951;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   9-1A11
AC   CVCL_J737
DR   CLO; CLO_0050362
DR   RCB; RCB0869
DR   Wikidata; Q54605614
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   9-2
AC   CVCL_B6WW
DR   CCRID; 4201PAT-CCTCC00725
DR   Wikidata; Q111732831
RX   Patent=CN105132379A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015102.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02144; Human MB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   9-2-4
AC   CVCL_G560
DR   ATCC; CRL-2485
DR   Wikidata; Q54605616
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody TC31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   9-4
AC   CVCL_J876
DR   Wikidata; Q54605618
RX   PubMed=6183593;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Coxsackievirus B4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   9-4-3
AC   CVCL_4476
SY   9-4'3
DR   CLO; CLO_0001533
DR   CLDB; cl5121
DR   ATCC; HB-8935
DR   IZSLER; BS Hy 39
DR   Wikidata; Q54605619
RX   Patent=US4790987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8935.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06828; Human parainfluenza 3 virus (strain Wash/47885/57) fusion glycoprotein (F).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   9-40
AC   CVCL_C3WU
DR   Wikidata; Q116048432
RX   PubMed=2104617;
RX   PubMed=3821741;
RX   PubMed=3930950;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_172923; Fluorescein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   9-A5
AC   CVCL_J738
DR   CLO; CLO_0001534
DR   ATCC; CRL-1844
DR   BCRC; 60144
DR   Wikidata; Q54605621
RX   PubMed=6310568;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   9-B1
AC   CVCL_J047
DR   CLO; CLO_0001536
DR   ATCC; CRL-1845
DR   Wikidata; Q54605623
RX   PubMed=6310568;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   9.0.4.C43
AC   CVCL_7242
DR   CLO; CLO_0001525
DR   CLDB; cl138
DR   IHW; 11w 8117
DR   Wikidata; Q54605624
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   9.14.7
AC   CVCL_D3VU
DR   Wikidata; Q127378800
RX   PubMed=1698868;
RX   PubMed=6175897;
RX   PubMed=6178962;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3US ! 45.6.TG1.7.5
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   9.2.27
AC   CVCL_ZZ66
DR   Wikidata; Q102113466
RX   PubMed=1366594;
RX   PubMed=6208119;
RX   PubMed=6386801;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   9.3
AC   CVCL_A9KL
DR   Wikidata; Q108819783
RX   Patent=US6010902;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10271.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10747; Human CD28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   9.3F10
AC   CVCL_J739
DR   CLO; CLO_0001526
DR   ATCC; HB-180
DR   Wikidata; Q54605625
RX   PubMed=6190974;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   9.4
AC   CVCL_C553
SY   HB 9.4
DR   CLO; CLO_0001527
DR   ATCC; HB-10508
DR   CCRID; 4201PAT-CCTCC00041
DR   Wikidata; Q54605626
RX   Patent=US5273738;
RX   Patent=US6010902;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10270.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10508.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   9.4.5
AC   CVCL_D2Q7
DR   ABCD; ABCD_AE105
DR   Wikidata; Q127378802
RX   PubMed=1698868;
RX   PubMed=2409142;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with dextran B512).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   9.6
AC   CVCL_A9EB
SY   HB 9.6
DR   CCRID; 4201PAT-CCTCC00044
DR   Wikidata; Q108819784
RX   Patent=US6010902;
RX   PubMed=6190907;
RX   PubMed=6969782;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10267.
CC   Monoclonal antibody isotype: IgG2a (Patent=US6010902); IgG2b (PubMed=6969782).
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   9.76
AC   CVCL_D7DJ
RX   PubMed=12354868;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q47952; Haemophilus ducreyi (strain 35000HP / ATCC 700724) hgbA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   9/3L
AC   CVCL_8479
SY   MPC 9/3L
DR   Wikidata; Q54605628
RX   PubMed=15860353;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97306; Nf1.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
CC   Breed/subspecies: C57BL/6 x 129S2/SvPas.
DI   NCIt; C134960; Mouse adrenal gland pheochromocytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   90 BLCL
AC   CVCL_E417
DR   ECACC; 94031618
DR   Wikidata; Q54605630
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   90-1
AC   CVCL_D2QL
DR   Wikidata; Q127378804
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   90-5
AC   CVCL_E7Y4
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 3.7 days (PubMed=10328163).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   90.74
AC   CVCL_6361
DR   CLO; CLO_0001528
DR   ATCC; CRL-11654
DR   Wikidata; Q54605633
RX   Patent=US5858740;
RX   Patent=US6218187;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11654.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-11654; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   900-2K-34
AC   CVCL_6E68
DR   Wikidata; Q54605637
RX   PubMed=195084;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA900).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6E66 ! C3H2K-C4
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   900-3Y-11
AC   CVCL_6E70
DR   Wikidata; Q54605638
RX   PubMed=195084;
RX   PubMed=6262522;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA900).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   9007
AC   CVCL_UM83
DR   Wikidata; Q93310688
RX   PubMed=10070891;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   9009B
AC   CVCL_1K12
DR   Wikidata; Q54605642
RX   Patent=US5587164;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11302.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_3845 ! MA-104
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   90196B
AC   CVCL_6362
DR   CLO; CLO_0001529
DR   ATCC; CRL-9853
DR   BioSample; SAMN03471078
DR   GEO; GSE27071
DR   Wikidata; Q54605643
RX   Patent=US5447861;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9853.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-9853; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-9853
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   902
AC   CVCL_A0CM
SY   Clone 902
DR   BEI_Resources; ARP-521
DR   Wikidata; Q108819785
RX   PubMed=3047430;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   904.13
AC   CVCL_Z933
DR   Wikidata; Q54605648
RX   PubMed=2822386;
RX   PubMed=10497225;
CC   Characteristics: Contains 200 copies of the pM18 plasmid. pM18 contains a MMTV LTR promoter (the LTR contains GR-binding sites) driven ha-v-ras and a 69% transforming fragment of bovine papilloma virus type 1 (BPV1) (PubMed=2822386).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   907.2
AC   CVCL_F0QA
RX   PubMed=6318079;
CC   Characteristics: Contains 200 copies of the pM18 plasmid. pM18 contains a MMTV LTR promoter (the LTR contains GR-binding sites) driven ha-v-ras and a 69% transforming fragment of bovine papilloma virus type 1 (BPV1) (PubMed=6318079).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   90P
AC   CVCL_K050
DR   Wikidata; Q54605649
RX   PubMed=10739701;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu23Valfs*17 (c.68_69delAG) (c.66_67AG[1]) (185delAG); ClinVar=VCV000017662; Zygosity=Heterozygous (PubMed=10739701).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   90P-hTERT
AC   CVCL_K051
DR   Wikidata; Q54605651
RX   PubMed=17395154;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu23Valfs*17 (c.68_69delAG) (c.66_67AG[1]) (185delAG); ClinVar=VCV000017662; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K050 ! 90P
SX   Female
AG   35Y
CA   Telomerase immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   90PE6E7
AC   CVCL_K052
DR   Wikidata; Q54605653
RX   PubMed=10739701;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu23Valfs*17 (c.68_69delAG) (c.66_67AG[1]) (185delAG); ClinVar=VCV000017662; Zygosity=Heterozygous (PubMed=10739701).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K050 ! 90P
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   91-1
AC   CVCL_2H63
SY   91-1 (Hsa21)
DR   Wikidata; Q54605655
RX   PubMed=16179473;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/017529P27productspec.pdf
CC   Characteristics: Contains 90% of human chromosome 21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2H62 ! MPI-VI
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   91-4
AC   CVCL_E7XX
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 3.4 days (PubMed=10328163).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   91-5
AC   CVCL_9V03
DR   Wikidata; Q54605657
RX   Patent=US5731189;
RX   PubMed=2922401;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10038.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: HIV-1 capsid protein p24.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   91-6
AC   CVCL_A2WX
DR   Wikidata; Q105505981
RX   Patent=US5731189;
RX   PubMed=2922401;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: HIV-1 capsid protein p24.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   91.1.F1
AC   CVCL_6559
DR   Wikidata; Q54605658
RX   PubMed=22083648;
CC   Group: Amphibian cell line.
CC   Doubling time: ~90 hours (PubMed=22083648).
CC   Derived from site: In situ; Hindlimb; UBERON=UBERON_0002103.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8364; ! Xenopus tropicalis (Western clawed frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   911
AC   CVCL_1K15
SY   HER;911; HER911; Human Embryonic Retinoblasts 911
DR   EFO; EFO_0022646
DR   Wikidata; Q54605659
RX   Patent=US6602706;
RX   PubMed=8788172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 95062101.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
CC   Cell type: Retinoblast; CL=CL_4023129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G704 ! PER.C6
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 17
//
ID   91MS441
AC   CVCL_G627
SY   GLXA-Ab2
DR   CLO; CLO_0001530
DR   ATCC; HB-11301
DR   Wikidata; Q54605661
RX   Patent=US5656271;
RX   PubMed=8837610;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11301.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody GLXA-Ab1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   91T
AC   CVCL_A2AT
DR   cancercelllines; CVCL_A2AT
DR   Wikidata; Q105505987
RX   PubMed=10545285;
RX   PubMed=11929836;
RX   PubMed=18645002;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=18645002).
CC   Miscellaneous: Age of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   92-1 [Human bladder carcinoma]
AC   CVCL_W909
SY   TCC 92-1
DR   Cosmic; 1046694
DR   Cosmic; 1285106
DR   Cosmic; 2037941
DR   Cosmic; 2050430
DR   Cosmic; 2212690
DR   GEO; GSM1567847
DR   GEO; GSM1574585
DR   GEO; GSM1574588
DR   Wikidata; Q54605662
RX   PubMed=9436977;
RX   PubMed=10919661;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   92-1 [Human thymoma]
AC   CVCL_E7YC
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.4 days (PubMed=10328163).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C3411; Thymoma
DI   ORDO; Orphanet_99867; Thymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   92-1 [Human uveal melanoma]
AC   CVCL_8607
SY   92_1; 92.1; 921
DR   EFO; EFO_0022503
DR   CLDB; cl7221
DR   cancercelllines; CVCL_8607
DR   Cosmic; 848328
DR   Cosmic; 899893
DR   Cosmic; 916137
DR   Cosmic; 986619
DR   Cosmic; 1320371
DR   Cosmic; 1628394
DR   Cosmic; 1669117
DR   Cosmic; 2036703
DR   Cosmic; 2163829
DR   DepMap; ACH-001441
DR   ECACC; 13012458
DR   ESTDAB; ESTDAB-127
DR   GEO; GSM276761
DR   ICLC; HTL12001
DR   PRIDE; PXD032215
DR   PRIDE; PXD051055
DR   Wikidata; Q54605663
RX   PubMed=7622289;
RX   PubMed=15714118;
RX   PubMed=16772116;
RX   PubMed=17487557;
RX   PubMed=19340423;
RX   PubMed=22236444;
RX   PubMed=22383533;
RX   PubMed=23849826;
RX   PubMed=23851445;
RX   PubMed=24994677;
RX   PubMed=28018010;
RX   PubMed=32430489;
RX   PubMed=36164296;
RX   PubMed=38601020;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Exhibits a mesenchymal phenotype (PubMed=38601020).
CC   Doubling time: 58 hours (PubMed=7622289); 38 hours (PubMed=24994677).
CC   HLA typing: A*02:01,03:01; B*44:02,51:01; C*05:01,14:02 (PubMed=28018010).
CC   Sequence variation: Mutation; HGNC; HGNC:3250; EIF1AX; Simple; p.Gly6Asp (c.17G>A); Zygosity=Unspecified (PubMed=39042403).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Heterozygous (PubMed=22236444; PubMed=22383533; PubMed=23851445; PubMed=24994677; PubMed=28018010).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): DepMap=ACH-001441; ECACC=13012458; ESTDAB=ESTDAB-127; PubMed=22236444; PubMed=24994677; PubMed=28018010
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11 (ESTDAB=ESTDAB-127; PubMed=24994677)
ST   D13S317: 11,12 (DepMap=ACH-001441; ECACC=13012458; PubMed=22236444)
ST   D16S539: 11,12 (PubMed=22236444; PubMed=24994677)
ST   D16S539: 12 (DepMap=ACH-001441; ECACC=13012458)
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 14,15
ST   D5S818: 9,11 (DepMap=ACH-001441; ECACC=13012458; PubMed=22236444; PubMed=24994677)
ST   D5S818: 12,13 (ESTDAB=ESTDAB-127)
ST   D7S820: 10,11 (DepMap=ACH-001441; ECACC=13012458; PubMed=22236444; PubMed=24994677)
ST   D7S820: 11 (ESTDAB=ESTDAB-127)
ST   D8S1179: 15
ST   FGA: 21,23
ST   Penta D: 9,11
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C300 ! 92-2 [Human uveal melanoma]
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   92-13
AC   CVCL_C6NG
DR   Wikidata; Q116048433
RX   Patent=US9139655;
RX   PubMed=18271942;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10628.
CC   Biotechnology: When radiolabeled with Yttrium-90 the monoclonal antibody produced by this hybridoma can be used for the treatment of synovial sarcomas.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ULW2; Human FZD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   92-2 [Human lung carcinoma]
AC   CVCL_E7YD
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.1 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   92-2 [Human uveal melanoma]
AC   CVCL_C300
SY   92_2; 92.2
DR   cancercelllines; CVCL_C300
DR   Cosmic; 916138
DR   Wikidata; Q54605665
RX   PubMed=7622289;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8607 ! 92-1 [Human uveal melanoma]
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   92-3
AC   CVCL_E7YE
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 1.9 days (PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   92.1-A
AC   CVCL_C4PP
DR   PRIDE; PXD032215
DR   Wikidata; Q116048434
RX   PubMed=36164296;
CC   Characteristics: Established after transplantation of the parent cell line in the back of the eyeball of inbred line nude mice.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8607 ! 92-1 [Human uveal melanoma]
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   92.1-B
AC   CVCL_C4PQ
DR   PRIDE; PXD032215
DR   Wikidata; Q116048435
RX   PubMed=36164296;
CC   Characteristics: Established after transplantation of the parent cell line in the brain of inbred line nude mice.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8607 ! 92-1 [Human uveal melanoma]
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   92.30
AC   CVCL_D5ZQ
DR   Wikidata; Q127378805
RX   PubMed=17575147;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9UHE8; Human STEAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   927
AC   CVCL_B5N6
DR   Wikidata; Q111732832
RX   PubMed=16920966;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8R2Q8; Mouse Bst2/Cd317.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   929.1
AC   CVCL_F0QB
RX   PubMed=6318079;
CC   Characteristics: Contains 200 copies of the pM19 plasmid. pM19 contains a MMTV LTR driven ha-v-ras and a 69% transforming fragment of bovine papilloma virus type 1 (BPV1) (PubMed=6318079).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   92BR
AC   CVCL_4096
SY   92 BRighton
DR   CLO; CLO_0001531
DR   CLDB; cl140
DR   ECACC; 90011874
DR   Wikidata; Q54605670
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9793; ! Equus asinus (Donkey)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   92D1
AC   CVCL_XV50
DR   Wikidata; Q93310694
RX   DOI=10.13523/j.cb.20180408;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; X2G6F6; Tupaia belangeri CD3E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   92TAg
AC   CVCL_6363
DR   CLO; CLO_0001532
DR   ATCC; CRL-2816
DR   Kerafast; ENH115-FP
DR   Wikidata; Q54605672
RX   PubMed=12882965;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   93 BLCL
AC   CVCL_E418
DR   ECACC; 94031619
DR   Wikidata; Q54605674
RX   PubMed=8588125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   93-22
AC   CVCL_C6NI
DR   ABCD; ABCD_AP908
DR   Wikidata; Q116048436
RX   Patent=US9139655;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10620.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ULW2; Human FZD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   93-6
AC   CVCL_C5ND
DR   ABCD; ABCD_AE448
DR   Wikidata; Q116048437
RX   PubMed=6419774;
RX   PubMed=7759486;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9304
AC   CVCL_UM84
DR   Wikidata; Q93310696
RX   PubMed=10070891;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   935.1-11
AC   CVCL_F0Q9
SY   935.1
RX   PubMed=2822386;
RX   PubMed=6318079;
CC   Characteristics: Contains 200 copies of the pM19 plasmid. pM19 contains a MMTV LTR driven ha-v-ras and a 69% transforming fragment of bovine papilloma virus type 1 (BPV1) (PubMed=6318079).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   936T
AC   CVCL_A2AU
DR   Wikidata; Q105505990
RX   PubMed=14978140;
RX   PubMed=17592641;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   938-mel
AC   CVCL_8058
SY   938-MEL; 938 mel; 938
DR   BTO; BTO_0002949
DR   cancercelllines; CVCL_8058
DR   Cosmic; 876686
DR   GEO; GSM218055
DR   GEO; GSM1092561
DR   Progenetix; CVCL_8058
DR   Wikidata; Q54605772
RX   PubMed=8027550;
RX   PubMed=8081556;
RX   PubMed=9670966;
RX   PubMed=10048982;
RX   PubMed=10754339;
RX   PubMed=18172304;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*01,24 (PubMed=9670966).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   93MA
AC   CVCL_ZU37
SY   93 MAnchester
DR   Wikidata; Q98125437
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 64 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   93RS2
AC   CVCL_6D59
DR   Wikidata; Q54605776
RX   PubMed=9283952;
CC   Characteristics: At the permissive temperature (32 Celsius) proliferates and has enhanced expression of a differentiated Sertoli cell phenotype at the restrictive temperature (40-41 Celsius).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   16D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   93T449
AC   CVCL_U614
DR   ArrayExpress; E-MTAB-5625
DR   ATCC; CRL-3043
DR   cancercelllines; CVCL_U614
DR   Cell_Model_Passport; SIDM01898
DR   DepMap; ACH-001794
DR   Wikidata; Q54605788
RX   PubMed=18823700;
RX   PubMed=29279323;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: 94T779; Note=In Cellosaurus releases 9 to 30.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): ATCC=CRL-3043; DepMap=ACH-001794
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 12,17
ST   D21S11: 29,31
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 19,27
ST   Penta D: 12,13,14
ST   Penta E: 7,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U613 ! 94T778
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   94-10
AC   CVCL_8608
SY   TCC 94-10
DR   Cosmic; 2050431
DR   Cosmic; 2057436
DR   Cosmic; 2212691
DR   Cosmic; 2444254
DR   Wikidata; Q54605778
RX   PubMed=9436977;
RX   PubMed=10919661;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   94-H4
AC   CVCL_J818
DR   BTO; BTO_0004029
DR   Wikidata; Q54605783
RX   PubMed=11751457;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J816 ! S91 6neo
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   94-H48
AC   CVCL_J819
DR   BTO; BTO_0004027
DR   Wikidata; Q54605784
RX   PubMed=11751457;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J816 ! S91 6neo
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   9460M
AC   CVCL_WM28
DR   cancercelllines; CVCL_WM28
DR   Cosmic; 852203
DR   Wikidata; Q93310723
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   94A1
AC   CVCL_J051
DR   ECACC; 85062503
DR   Wikidata; Q54605786
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   94P0496
AC   CVCL_B7IJ
DR   Wikidata; Q112927025
RX   PubMed=29445421;
CC   Population: Caucasian; Polish.
CC   Karyotypic information: Mosaic; 46,XY; 45,XY,der(6)(6pter->6q11.1::13q11->13q21.33::20q11.22->20qter),-13 (PubMed=29445421).
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (PubMed=29445421).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   94T
AC   CVCL_A2AV
DR   Wikidata; Q105505993
RX   PubMed=14978140;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   94T778
AC   CVCL_U613
DR   ArrayExpress; E-MTAB-5625
DR   ATCC; CRL-3044
DR   cancercelllines; CVCL_U613
DR   Cell_Model_Passport; SIDM01897
DR   DepMap; ACH-001795
DR   Wikidata; Q54605787
RX   PubMed=18823700;
RX   PubMed=29279323;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): ATCC=CRL-3044; DepMap=ACH-001795
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 12,13
ST   D18S51: 12,17
ST   D21S11: 29,31
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 19,27
ST   Penta D: 12,13
ST   Penta E: 7,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U614 ! 93T449
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   95-H1
AC   CVCL_J820
DR   BTO; BTO_0004028
DR   Wikidata; Q54605789
RX   PubMed=11751457;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J816 ! S91 6neo
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   95-H12
AC   CVCL_J821
DR   BTO; BTO_0004031
DR   Wikidata; Q54605791
RX   PubMed=11751457;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J816 ! S91 6neo
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   95-H3
AC   CVCL_J822
DR   BTO; BTO_0004030
DR   Wikidata; Q54605792
RX   PubMed=11751457;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J816 ! S91 6neo
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   950-5-BIK
AC   CVCL_A1UH
SY   9505BIK
DR   cancercelllines; CVCL_A1UH
DR   Cell_Model_Passport; SIDM01972
DR   DepMap; ACH-001999
DR   Wikidata; Q105505996
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (DepMap=ACH-001999).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (DepMap=ACH-001999).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): DepMap=ACH-001999
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D18S51: 15
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 23,26
ST   Penta D: 10,13
ST   Penta E: 11,16
ST   TH01: 5,7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   952-mel
AC   CVCL_S567
SY   952-MEL; 952mel
DR   cancercelllines; CVCL_S567
DR   CGH-DB; 9311-4
DR   Cosmic; 905224
DR   Wikidata; Q54605793
RX   PubMed=15467732;
CC   From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   957E/hTERT
AC   CVCL_X476
DR   Wikidata; Q54605796
RX   PubMed=11507036;
RX   PubMed=16413016;
CC   Population: Caucasian.
CC   Doubling time: 32 hours (PubMed=16413016).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 10
//
ID   95RD28
AC   CVCL_ZP50
DR   Wikidata; Q98125438
RX   PubMed=9579555;
RX   PubMed=20221251;
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg799Trp (c.2395C>T) (R788W); ClinVar=VCV000016580; Zygosity=Heterozygous (PubMed=9579555).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   95T1000
AC   CVCL_WU67
DR   ArrayExpress; E-MTAB-5625
DR   cancercelllines; CVCL_WU67
DR   Cell_Model_Passport; SIDM01896
DR   DepMap; ACH-001796
DR   Wikidata; Q93310755
RX   PubMed=22678079;
RX   PubMed=29279323;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
ST   Source(s): DepMap=ACH-001796
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 14,15
ST   D21S11: 29
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   D8S1179: 15
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 9,13
ST   TH01: 9,10
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   96-1
AC   CVCL_8609
SY   TCC 96-1
DR   Cosmic; 1046700
DR   Cosmic; 1285107
DR   Cosmic; 2037942
DR   Cosmic; 2050432
DR   Cosmic; 2057437
DR   Cosmic; 2444232
DR   Cosmic; 2685933
DR   GEO; GSM1567848
DR   GEO; GSM1574576
DR   Wikidata; Q54605797
RX   PubMed=9436977;
RX   PubMed=10919661;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   96-11
AC   CVCL_8610
SY   TCC 96-11
DR   Wikidata; Q54605798
RX   PubMed=9436977;
CC   Senescence: Does not grow continuously, undergoes crisis and senescence (PubMed=9436977).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   96-12
AC   CVCL_8611
SY   TCC 96-12
DR   Wikidata; Q54605801
RX   PubMed=9436977;
CC   Senescence: Does not grow continuously, undergoes crisis and senescence (PubMed=9436977).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   96-13
AC   CVCL_8612
SY   TCC 96-13
DR   Wikidata; Q54605802
RX   PubMed=9436977;
CC   Senescence: Does not grow continuously, undergoes crisis and senescence (PubMed=9436977).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   96-16
AC   CVCL_8613
SY   TCC 96-16
DR   Wikidata; Q54605804
RX   PubMed=9436977;
CC   Senescence: Does not grow continuously, undergoes crisis and senescence (PubMed=9436977).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   96-2
AC   CVCL_8614
SY   TCC 96-2
DR   Wikidata; Q54605806
RX   PubMed=9436977;
RX   PubMed=10919661;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   96.9H9
AC   CVCL_C8H3
DR   Wikidata; Q123030337
RX   PubMed=12193278;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   964 Lung
AC   CVCL_A9C3
DR   Wikidata; Q102113467
RX   PubMed=6538202;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9C4 ! 964 Skin
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   964 Skin
AC   CVCL_A9C4
SY   964 S; 964-S; 964S
DR   Wikidata; Q102113469
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
RX   PubMed=6538202;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9C3 ! 964 Lung
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   96-9
AC   CVCL_8615
SY   TCC 96-9
DR   Wikidata; Q54605807
RX   PubMed=9436977;
CC   Senescence: Does not grow continuously, undergoes crisis and senescence (PubMed=9436977).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   97-1 [Human bladder carcinoma]
AC   CVCL_8616
SY   TCC 97-1
DR   cancercelllines; CVCL_8616
DR   Cosmic; 1046701
DR   Cosmic; 1285108
DR   Cosmic; 1927314
DR   Cosmic; 2050433
DR   Cosmic; 2057438
DR   Cosmic; 2444253
DR   Cosmic; 2685934
DR   GEO; GSM1567849
DR   GEO; GSM1574542
DR   Wikidata; Q54605808
RX   PubMed=9436977;
RX   PubMed=10919661;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Arg692Ter (c.2074C>T); ClinVar=VCV000048885; Zygosity=Homozygous (PubMed=23401075).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   97-1 [Mouse hybridoma against dog SELPLG]
AC   CVCL_D2QM
DR   Wikidata; Q127378806
RX   PubMed=21600666;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F7J212; Dog SELPLG/CD162.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   97-10
AC   CVCL_8617
SY   TCC 97-10
DR   Wikidata; Q54605810
RX   PubMed=9436977;
CC   Senescence: Does not grow continuously, undergoes crisis and senescence (PubMed=9436977).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   97-15
AC   CVCL_8618
SY   TCC 97-15
DR   Wikidata; Q54605812
RX   PubMed=10919661;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   97-18-I
AC   CVCL_8619
SY   TCC 97-18-I; TCC 97-18; 97-18
DR   Cosmic; 1046697
DR   Cosmic; 2037943
DR   Cosmic; 2050434
DR   Cosmic; 2057440
DR   Cosmic; 2444256
DR   Cosmic; 2685935
DR   GEO; GSM1567850
DR   GEO; GSM1574577
DR   Wikidata; Q54605814
RX   PubMed=10919661;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8620 ! 97-21-M
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   97-21-M
AC   CVCL_8620
SY   TCC 97-21-M; TCC 97-21; 97-21
DR   Cosmic; 1046698
DR   Cosmic; 1285109
DR   Wikidata; Q54605815
RX   PubMed=10919661;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8619 ! 97-18-I
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   97-24
AC   CVCL_8621
SY   TCC 97-24
DR   Cosmic; 1046699
DR   Cosmic; 1285110
DR   Cosmic; 2037944
DR   Cosmic; 2050435
DR   Cosmic; 2057441
DR   Cosmic; 2444247
DR   Cosmic; 2685936
DR   GEO; GSM1567851
DR   GEO; GSM1574582
DR   GEO; GSM1574589
DR   Wikidata; Q54605817
RX   PubMed=10919661;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   97-29
AC   CVCL_8622
SY   TCC 97-29
DR   Cosmic; 1046695
DR   Wikidata; Q54605819
RX   PubMed=10919661;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   97-5
AC   CVCL_8623
SY   TCC 97-5
DR   Wikidata; Q54605822
RX   PubMed=9436977;
CC   Senescence: Does not grow continuously, undergoes crisis and senescence (PubMed=9436977).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   97-6
AC   CVCL_8624
SY   TCC 97-6
DR   Wikidata; Q54605824
RX   PubMed=9436977;
RX   PubMed=10919661;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   97-7
AC   CVCL_8625
SY   TCC 97-7
DR   Cosmic; 1046696
DR   Cosmic; 1285111
DR   Cosmic; 2050436
DR   Cosmic; 2057439
DR   Cosmic; 2444241
DR   Cosmic; 2685937
DR   GEO; GSM1567852
DR   GEO; GSM1574551
DR   Wikidata; Q54605829
RX   PubMed=10919661;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   97A6
AC   CVCL_IQ43
DR   Wikidata; Q54605831
RX   Patent=US6323321;
RX   PubMed=11342463;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2297.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14638; Human ENPP3/CD203c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   98-4.3
AC   CVCL_F0AH
RX   PubMed=2072448;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: HIV-1 capsid protein p24.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   98-4.9
AC   CVCL_A2WV
DR   Wikidata; Q105506000
RX   Patent=US5731189;
RX   PubMed=2922401;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: HIV-1 capsid protein p24.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   98-43
AC   CVCL_9V06
DR   Wikidata; Q54605833
RX   Patent=US5731189;
RX   PubMed=2922401;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: HIV-1 protein gp41.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   98-6
AC   CVCL_9V07
DR   Wikidata; Q54605835
RX   Patent=US5731189;
RX   PubMed=2922401;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: HIV-1 protein gp41.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   98.3
AC   CVCL_C5XI
DR   Wikidata; Q116048438
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   984LN
AC   CVCL_E3YM
SY   984-LN
RX   PubMed=21764851;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Trp53 fl/fl;Rb1 fl/fl.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E3YN ! 984T6
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   984T6
AC   CVCL_E3YN
RX   PubMed=21764851;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Trp53 fl/fl;Rb1 fl/fl.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E3YM ! 984LN
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   987A12
AC   CVCL_RY23
DR   Wikidata; Q54605837
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY24 ! 987A3
OI   CVCL_RY25 ! 987A7
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   987A3
AC   CVCL_RY24
DR   Wikidata; Q54605839
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Doubling time: 26.00 hours (PubMed=24399248).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY25 ! 987A7
OI   CVCL_RY23 ! 987A12
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   987A7
AC   CVCL_RY25
DR   Wikidata; Q54605840
RX   PubMed=24399248;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Doubling time: 28.09 hours (PubMed=24399248).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY24 ! 987A3
OI   CVCL_RY23 ! 987A12
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   989RM
AC   CVCL_XX66
DR   Wikidata; Q93310858
RX   PubMed=21112256;
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; c.6106+3393c.7101-22del20648bp/ins25 (Ex16-23del); Zygosity=Heterozygous (PubMed=21112256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   98T
AC   CVCL_A2AW
DR   Wikidata; Q105506002
RX   PubMed=14978140;
CC   From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA.
CC   Miscellaneous: Age/sex of donor from personal communication of Siegfried, Jill M.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   99-12-1
AC   CVCL_B0NP
DR   Wikidata; Q108819786
RX   Patent=US5728814;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11863.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q07021; Human C1QBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   990RM
AC   CVCL_XX67
DR   Wikidata; Q93310861
RX   PubMed=21112256;
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; c.6106+3393c.7101-22del20648bp/ins25 (Ex16-23del); Zygosity=Homozygous (PubMed=21112256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   9923M
AC   CVCL_WM27
DR   cancercelllines; CVCL_WM27
DR   Cosmic; 852202
DR   Wikidata; Q93310863
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000177778; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM24 ! 9923P
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   9927 AlS SIO
AC   CVCL_D2PV
DR   Wikidata; Q127378807
RX   Patent=RU2796356;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 807D.
CC   HLA typing: A*01,02; B*07,35; C*06,07 (Patent=RU2796356).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Patent=RU2796356
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D10S1248: 12,16
ST   D12S391: 18,20
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D1S1656: 16,17
ST   D21S11: 30.2,32.2
ST   D22S1045: 11,14
ST   D2S441: 11,14
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   SE33: 28.2,29.2
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C3750; Alveolar soft part sarcoma
DI   ORDO; Orphanet_163699; Alveolar soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   9923P
AC   CVCL_WM24
DR   cancercelllines; CVCL_WM24
DR   Cosmic; 852200
DR   Wikidata; Q93310865
RX   PubMed=15195137;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000177778; Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: In situ; Foot, skin; UBERON=UBERON_0001513.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM27 ! 9923M
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   99S6
AC   CVCL_J969
DR   Wikidata; Q54605841
RX   Patent=US8173375;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6015.
CC   Registration: Chiron Master Culture Collection; CMCC 12337 (CMCC #12337).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Hepatitis B virus surface antigens.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_J972 ! 240E1-1-2
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 8
//
ID   99S9
AC   CVCL_J970
DR   Wikidata; Q54605842
RX   Patent=US8173375;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6014.
CC   Registration: Chiron Master Culture Collection; CMCC 12336 (CMCC #12336).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_J972 ! 240E1-1-2
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   9A10
AC   CVCL_C5FK
DR   Wikidata; Q116048439
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9A10C3
AC   CVCL_XG92
DR   Wikidata; Q93310875
RX   Patent=US6843990;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200113.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95407; Human TNFRSF6B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   9A3-2G8
AC   CVCL_A5DB
DR   Wikidata; Q107113309
RX   Patent=US6358737;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12395.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse osteocyte antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 4
//
ID   9A3M
AC   CVCL_Y310
SY   9A3
DR   ATCC; HB-8160
DR   Wikidata; Q54605844
RX   Patent=US4767710;
RX   PubMed=6197636;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8160.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24. Recognizes M blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 9
//
ID   9A4
AC   CVCL_E6K0
RX   PubMed=10712664;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9A8
AC   CVCL_C4JU
DR   Wikidata; Q116048440
RX   PubMed=35973349;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A1EA95; Chicken IL7R/CD127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9AD4
AC   CVCL_D1FQ
DR   Wikidata; Q127378808
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z067 ! Sp2ab
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   9AE10
AC   CVCL_J740
DR   CLO; CLO_0001535
DR   ATCC; CRL-1761
DR   Wikidata; Q54605847
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   9AE3
AC   CVCL_B7HF
DR   Wikidata; Q112927026
RX   DOI=10.1080/09712119.1998.9706217;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No. 216).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   9AG3
AC   CVCL_B7HG
DR   Wikidata; Q112927027
RX   DOI=10.1080/09712119.1998.9706217;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No. 216).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   9B10
AC   CVCL_JA40
SY   HLCL 9B10
DR   CCRID; 4201PAT-CCTCC00007
DR   Wikidata; Q54605893
RX   Patent=US4970070;
RX   Patent=US5837541;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9006.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Accessible carbohydrate determinant of outer membrane lipopolysaccharide of Escherichia coli K1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   9B2.1
AC   CVCL_E8BK
DR   DSHB; 9B2-1-anti-glass
RX   PubMed=8187644;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13360; Drosophila melanogaster glass.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9B2C6C9
AC   CVCL_F0H1
RX   Patent=US10973915;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279 (Note=Also reacts with M.fascicularis).
CC   Miscellaneous: As the immunized splenic B-cells are from H2L2 transgenic mice the produced mAB is a chimeric Ig having human variable domain and rat constant region.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   9B4
AC   CVCL_C5AV
DR   Wikidata; Q116048441
RX   PubMed=20298711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B2ZUI2; Gardnerella vaginalis vaginolysin (vly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9B6
AC   CVCL_C7I3
DR   Wikidata; Q123030338
RX   PubMed=34806527;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16790; Human CA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   9B6-4
AC   CVCL_E6JZ
RX   PubMed=11477279;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05386; Human RPLP1.
CC   Monoclonal antibody target: UniProtKB; P05387; Human RPLP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9B7
AC   CVCL_F0V8
RX   PubMed=2179120;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P09558; Pig EDN1 (Note=AA 53-73 = Endothelin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   9B8
AC   CVCL_C5FL
DR   Wikidata; Q116048442
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9BC6
AC   CVCL_B7HH
DR   Wikidata; Q112927028
RX   DOI=10.1080/09712119.1998.9706217;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No. 216).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   9BG5
AC   CVCL_4498
SY   9 BG 5
DR   CLO; CLO_0001524
DR   CLO; CLO_0001537
DR   CLDB; cl5129
DR   ATCC; HB-167
DR   IZSLER; BS Hy 5
DR   Wikidata; Q54605894
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   9C1
AC   CVCL_XA11
DR   Wikidata; Q93310894
RX   Patent=US8574581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9372.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   9C11 [Mouse hybridoma against human DPP4]
AC   CVCL_C7II
DR   Wikidata; Q123030339
RX   PubMed=9683260;
RX   PubMed=24502396;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   9C11 [Rat hybridoma against mouse Pdpn]
AC   CVCL_A5DC
DR   Wikidata; Q107113310
RX   Patent=US6358737;
RX   PubMed=16738320;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q62011; Mouse Pdpn.
CC   Miscellaneous: This hybridoma was lost (Patent=US6358737).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 4
//
ID   9C11-14
AC   CVCL_C6XV
DR   ABCD; ABCD_AN718
DR   ABCD; ABCD_AN719
DR   ABCD; ABCD_AN720
DR   Wikidata; Q123030340
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   9C2
AC   CVCL_KB13
DR   Wikidata; Q54605895
RX   PubMed=10570931;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01479; Androctonus australis neurotoxin AaH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   9C2C1A9
AC   CVCL_B0NR
SY   9C2
DR   ATCC; HB-11862
DR   Wikidata; Q108819787
RX   Patent=US6441143;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11862.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   9C3 [Human lymphoblastoid]
AC   CVCL_JA41
SY   HLCL 9C3
DR   CCRID; 4201PAT-CCTCC00011
DR   Wikidata; Q54605897
RX   Patent=US5837541;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9239.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Accessible carbohydrate determinant of outer membrane lipopolysaccharide of Pseudomonas aeruginosa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   9C3 [Mouse hybridoma against human WFDC2]
AC   CVCL_QW77
DR   Wikidata; Q54605906
RX   PubMed=28928083;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q14508; Human WFDC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   9C3 [Mouse hybridoma against vaccinia A14L]
AC   CVCL_E5QB
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9C3-8
AC   CVCL_C6XW
DR   ABCD; ABCD_AN740
DR   Wikidata; Q123030341
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   9C6
AC   CVCL_B0E2
DR   Wikidata; Q108819788
RX   Patent=US4938948;
RX   Patent=US4956453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10785.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10056.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human breast/ovarian cancer 70 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   9C6-52-40
AC   CVCL_YK87
DR   Wikidata; Q93310909
RX   Patent=US8546093;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00203.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07944; Staphylococcus aureus beta-lactam-inducible penicillin-binding protein (PBP2a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   9C7
AC   CVCL_B6M2
DR   Wikidata; Q111732833
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   PubMed=10488532;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P35263; Lake Victoria marburgvirus (strain Popp-67) nucleoprotein (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   9C9H9
AC   CVCL_XC17
DR   Wikidata; Q93310911
RX   Patent=US8003766;
RX   PubMed=18698802;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_7719; Ochratoxin A (OTA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 5
//
ID   9CE5
AC   CVCL_B7HI
DR   Wikidata; Q112927029
RX   DOI=10.1080/09712119.1998.9706217;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No. 216).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   9Cr58 A12A2
AC   CVCL_E2WA
SY   A12A2
RX   DOI=10.1016/S0168-9452(01)00554-4;
CC   Group: Plant cell line.
CC   Characteristics: Alkaloid accumulating (DOI=10.1016/S0168-9452(01)00554-4).
OX   NCBI_TaxID=4058; ! Catharanthus roseus (Madagascar periwinkle)
HI   CVCL_E0Z5 ! 58CrPM
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   9D
AC   CVCL_C4ST
DR   Wikidata; Q116048443
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   9D1.E4
AC   CVCL_XX63
SY   9D1.E4(10)
DR   Wikidata; Q93310913
RX   Patent=US7820797;
RX   PubMed=20305658;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9340.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_28009; N-acetyl-beta-D-glucosamine (Note=In beta-O-glycosidic linkage to serine and threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   9D10
AC   CVCL_6364
DR   CLO; CLO_0001538
DR   ATCC; CRL-8752
DR   BioSample; SAMN03471208
DR   Wikidata; Q54605909
RX   Patent=US4834975;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8752.
CC   Doubling time: ~24-36 hours (ATCC=CRL-8752).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 4.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-8752
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D18S51: 12,15
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 7,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   9D11.2E8
AC   CVCL_B0W1
SY   <CSF-1R>9D11.2E8
DR   Wikidata; Q108819789
RX   Patent=US10336830;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2920.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07333; Human CSF1R/CD115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   9D12 [Mouse hybridoma against forskolin]
AC   CVCL_B6FX
DR   Wikidata; Q111732834
RX   PubMed=7765788;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   9D12 [Mouse hybridoma against H.ducreyi ompA/ompA2]
AC   CVCL_E2SP
RX   PubMed=6200440;
RX   PubMed=8454337;
RX   PubMed=9045839;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P96773; Haemophilus ducreyi ompA (Note=Also reacts with other Haemophilus ducreyi strains).
CC   Monoclonal antibody target: UniProtKB; P96774; Haemophilus ducreyi ompA2 (Note=Also reacts with other Haemophilus ducreyi strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   9D4-7
AC   CVCL_C6XX
DR   ABCD; ABCD_AN741
DR   ABCD; ABCD_AN742
DR   Wikidata; Q123030342
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   9D4.9.1
AC   CVCL_M908
DR   ATCC; HB-11031
DR   Wikidata; Q54605911
RX   Patent=US5578704;
RX   Patent=US5652110;
RX   PubMed=7683273;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11031.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   9D47A1
AC   CVCL_XC13
DR   CCRID; 4201PAT-CCTCC00219
DR   Wikidata; Q93310924
RX   Patent=CN101149377B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200731.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Aspergillus fumigatus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   9D5
AC   CVCL_C4DB
DR   Wikidata; Q116048444
RX   PubMed=22685303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_85377; 8-methoxypyrene-1,3,6-trisulfonic acid (MTPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   9D6
AC   CVCL_B6GJ
DR   Wikidata; Q111732835
RX   PubMed=18804644;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_2981; Baicalin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   9D6.11.15
AC   CVCL_LH43
DR   Wikidata; Q54605913
RX   Patent=US7410772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6032.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8NFU4; Human FDCSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   9D7
AC   CVCL_E6K1
DR   ABCD; ABCD_BD778
RX   PubMed=10712664;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9D8 [Mouse hybridoma against human RPSA]
AC   CVCL_A0HU
DR   Wikidata; Q108819790
RX   PubMed=15455689;
RX   PubMed=19961413;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08865; Human RPSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   9D8 [Mouse hybridoma against Marburg virus VP35]
AC   CVCL_B6M4
DR   Wikidata; Q111732836
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   PubMed=10488532;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q03039; Lake Victoria marburgvirus (strain Popp-67) polymerase cofactor VP35.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   9D82B3
AC   CVCL_A6NY
SY   9D8
DR   DSHB; 9D82B3
DR   Wikidata; Q107113311
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16621; Drosophila melanogaster Lar.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   9D9-2F5
AC   CVCL_A5DD
DR   Wikidata; Q107113312
RX   Patent=US6358737;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12396.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse osteocyte antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 4
//
ID   9E12
AC   CVCL_B6FY
DR   Wikidata; Q111732837
RX   PubMed=7765788;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   9E4-20
AC   CVCL_C6XY
DR   ABCD; ABCD_AN743
DR   ABCD; ABCD_AN744
DR   Wikidata; Q123030343
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   9E5-1A8
AC   CVCL_E5NS
RX   Patent=US9879087;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9E6
AC   CVCL_B0L3
DR   Wikidata; Q108819791
RX   PubMed=2068741;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Cryptococcus neoformans var. neoformans non-capsular antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   9E8
AC   CVCL_E5MQ
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9EG7
AC   CVCL_RQ13
DR   Wikidata; Q54605917
RX   PubMed=7692444;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09055; Mouse Itgb1/Cd29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   9F [Mouse hybridoma against ginkgolic acids]
AC   CVCL_B6LS
DR   Wikidata; Q111732838
RX   PubMed=15154283;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_5354; Ginkgolic acids (Ginkgoic acid).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   9F [Mouse hybridoma against human PTHLH]
AC   CVCL_C4SU
DR   Wikidata; Q116048445
RX   PubMed=1690780;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH (Note=AA 37-70 = PTHrP[1-34]).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   9F11-1F7
AC   CVCL_E5NF
RX   Patent=US9879087;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9F12
AC   CVCL_8944
DR   CLO; CLO_0001540
DR   ABCD; ABCD_AE461
DR   ATCC; HB-8177
DR   Wikidata; Q54605918
RX   Patent=US4689299;
RX   PubMed=6607295;
RX   PubMed=7174795;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8177.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   9F2
AC   CVCL_A8JN
DR   Wikidata; Q107113313
RX   PubMed=33958613;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   9F3.18.5
AC   CVCL_F1WG
SY   9F3
DR   ABCD; ABCD_BG479
RX   Patent=US8557967;
RX   PubMed=11594789;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2917.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized rontalizumab (9F3v13) therapeutic antibody which was designed to target and block the effects of interferon-alphain patients with autoimmune diseases like systemic lupus erythematosus (SLE).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   9F5
AC   CVCL_C3X4
DR   Wikidata; Q116048446
RX   PubMed=8547680;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26951; Human IL3RA/CD123.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9F6
AC   CVCL_F1X2
RX   Patent=US12312403;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   9F7-F11
AC   CVCL_D5JN
DR   Wikidata; Q127378809
RX   Patent=US9127065;
RX   PubMed=23479511;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   9F8BO
AC   CVCL_A8VE
DR   Wikidata; Q108819792
RX   Patent=US10808026;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NRN5; Human OLFML3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   9F9
AC   CVCL_E5SG
RX   PubMed=7705409;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9G1
AC   CVCL_B4HS
DR   Wikidata; Q110429815
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   9G2 [Mouse hybridoma against HIV-1 rev]
AC   CVCL_A0CD
DR   Wikidata; Q108819793
RX   PubMed=8107211;
RX   PubMed=9305730;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   9G2 [Mouse hybridoma against rat Hmgb1]
AC   CVCL_B4HT
SY   9G2-7-1-1-1
DR   Wikidata; Q110429816
RX   Patent=US8846047;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   9G2.1.3
AC   CVCL_M909
DR   ATCC; HB-11030
DR   Wikidata; Q54605922
RX   Patent=US5578704;
RX   Patent=US5652110;
RX   PubMed=7683273;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11030.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   9G3
AC   CVCL_E5MC
SY   9G3.23
DR   ABCD; ABCD_AW949
RX   PubMed=9315664;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14777; Human NDC80.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9G6 [Mouse hybridoma against Lake Victoria marburgvirus VP40]
AC   CVCL_B6M5
DR   Wikidata; Q111732839
RX   DOI=10.15789/1563-0625-2010-3-177-190;
RX   PubMed=10488532;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   9G6 [Mouse hybridoma against phOX]
AC   CVCL_C4FC
DR   ABCD; ABCD_AE290
DR   Wikidata; Q116048447
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   9G7 [Mouse hybridoma against ginsenoside Rb1]
AC   CVCL_B6G1
DR   Wikidata; Q111732840
RX   Patent=JPH11290071A;
RX   PubMed=22359060;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_67989; Ginsenoside Rb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   9G7 [Mouse hybridoma against mouse Cycs]
AC   CVCL_E5MR
RX   PubMed=8955180;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62897; Mouse Cycs (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   9G9
AC   CVCL_VI40
DR   BEI_Resources; MRA-252
DR   Wikidata; Q54605130
RX   PubMed=10406090;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anophele aegypti female salivary glands median and distal lateral lobes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   9H1 [Mouse hybridoma against human CXCR1]
AC   CVCL_F1WM
RX   Patent=US5440021;
RX   Patent=US20070065441;
RX   PubMed=9356984;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11377.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25024; Human CXCR1/CD181.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   9H1 [Mouse hybridoma against human PDCD1]
AC   CVCL_YN77
DR   Wikidata; Q93310950
RX   PubMed=20443708;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 4
//
ID   9H10-A4
AC   CVCL_J933
DR   Wikidata; Q54605924
RX   Patent=US5763202;
RX   PubMed=2449118;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11430.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   9H11/53
AC   CVCL_VI60
DR   BEI_Resources; MRA-816
DR   Wikidata; Q54605925
RX   PubMed=1574088;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Plasmodium falciparum (isolate FCQ27/PNG) merozoite surface protein 1 (MSP1) (19 kDa fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   9H3
AC   CVCL_C5FY
DR   Wikidata; Q116048448
RX   PubMed=9839680;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P81694; Cupiennius salei toxin CSTX-1/CSTX-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9H4
AC   CVCL_C5FM
DR   Wikidata; Q116048451
RX   PubMed=28785278;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DQX3; Trimerodytes annularis phospholipase A2 inhibitor gamma A2 (Note=Also reacts with many other snake PA2 inhibitors).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   9H4-12
AC   CVCL_C6WV
DR   ABCD; ABCD_AN745
DR   ABCD; ABCD_AN746
DR   ABCD; ABCD_AN747
DR   Wikidata; Q123030344
RX   Patent=US8329181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Miscellaneous: As the immunized splenic B-cells are from VelocImmune mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   9H5-4
AC   CVCL_B4JS
DR   Wikidata; Q110429818
RX   Patent=US9803026;
RX   Patent=US10730955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11356.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   9H7
AC   CVCL_CW38
DR   NCBI_Iran; H144
DR   Wikidata; Q54605927
RX   CelloPub=CLPUB00330;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   9HTEo-
AC   CVCL_U405
SY   9/HTEo-; 9/HTEo(-); 9/HTEo; HTE-9o-; 9HTE
DR   Millipore; SCC153
DR   Wikidata; Q54605931
RX   PubMed=1282304;
RX   PubMed=1375758;
RX   PubMed=2457904;
RX   PubMed=8843701;
RX   PubMed=10498856;
RX   PubMed=15463957;
WW   Info; Dartmouth; -; https://web.archive.org/web/20190126194809/http://www.dartmouth.edu/~cysfib/cell-lines.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/9/cell-lines-detail-469.html
CC   Characteristics: Useful model for the study of epithelial ion transport, secretion and biochemistry and frequently used as a wild-type control for cystic fibrosis tracheobronchial epithelial cells (Millipore=SCC153).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
ST   Source(s): Millipore=SCC153
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 14
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   D8S1179: 15
ST   FGA: 25,26
ST   Penta D: 13
ST   Penta E: 10,11
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U403 ! 3HTEo-
OI   CVCL_U404 ! 8HTEo-
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   9HTEo-/Dx
AC   CVCL_HJ44
DR   Wikidata; Q54605935
RX   PubMed=7904600;
RX   PubMed=8843701;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U405 ! 9HTEo-
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   9HTEo-/S
AC   CVCL_HJ45
DR   Wikidata; Q54605936
RX   PubMed=1282304;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U405 ! 9HTEo-
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 7
//
ID   9L
AC   CVCL_1928
AS   CVCL_3373
SY   GS-9L; GS9L; T9
DR   CLO; CLO_0003574
DR   CLDB; cl1522
DR   CLDB; cl1523
DR   ChEMBL-Cells; CHEMBL3308019
DR   ChEMBL-Targets; CHEMBL613105
DR   ECACC; 94110705
DR   ICLC; ATL96001
DR   MetaboLights; MTBLS6212
DR   PubChem_Cell_line; CVCL_1928
DR   Wikidata; Q54605940
RX   PubMed=5547317;
RX   PubMed=7435138;
RX   PubMed=7760095;
RX   PubMed=9525831;
RX   PubMed=19381449;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=GS-9L
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   9L-2
AC   CVCL_U696
DR   Wikidata; Q54605943
RX   PubMed=3860285;
CC   Selected for resistance to: ChEBI; CHEBI_3423; Carmustine (BCNU).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   9L-27-9
AC   CVCL_B6CT
DR   Wikidata; Q111732841
RX   DOI=10.1080/00021369.1986.10867734;
CC   Characteristics: Seems to secrete two different mAbs.
CC   Monoclonal antibody isotype: IgA+IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   9L-7
AC   CVCL_U697
DR   Wikidata; Q54605945
RX   PubMed=3860285;
CC   Selected for resistance to: ChEBI; CHEBI_3423; Carmustine (BCNU).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   9L-8
AC   CVCL_U698
DR   Wikidata; Q54605948
RX   PubMed=3860285;
CC   Selected for resistance to: ChEBI; CHEBI_3423; Carmustine (BCNU).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   9L/ACNU
AC   CVCL_4V34
DR   Wikidata; Q54605950
RX   PubMed=3479534;
CC   Selected for resistance to: ChEBI; CHEBI_75270; Nimustine (ACNU).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   9L/BH-1
AC   CVCL_E9DC
RX   PubMed=9080121;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   9L/HSV-TK clone I
AC   CVCL_E9C7
RX   PubMed=21541545;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   9L/HSV-TK clone II
AC   CVCL_E9C8
RX   PubMed=21541545;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   9L/HSV-TK clone III
AC   CVCL_E9C9
RX   PubMed=21541545;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   9L/lacZ
AC   CVCL_5656
SY   9L/LacZ
DR   CLO; CLO_0001541
DR   ATCC; CRL-2200
DR   BCRC; 60247
DR   BCRJ; 0029
DR   CCRID; 3101RATTCR13
DR   CLS; 305208
DR   Wikidata; Q54605952
RX   PubMed=1737331;
RX   PubMed=8416743;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1928 ! 9L
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   9O12.2l
AC   CVCL_E3ZY
DR   ABCD; ABCD_AP861
RX   PubMed=14675102;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   9P-13-4
AC   CVCL_B6CU
DR   Wikidata; Q111732842
RX   DOI=10.1080/00021369.1986.10867734;
CC   Characteristics: Seems to secrete two different mAbs.
CC   Monoclonal antibody isotype: IgA+IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   9TR#1
AC   CVCL_6560
DR   CLO; CLO_0001542
DR   ATCC; CRL-11379
DR   Wikidata; Q54605953
RX   Patent=US5684222;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11379.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1314884; Tnfrsf1a.
CC   Discontinued: ATCC; CRL-11379; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   A 123
AC   CVCL_J176
SY   A123; M-26
DR   CLO; CLO_0001555
DR   Wikidata; Q54605955
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8451.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   A 124
AC   CVCL_J177
SY   A124; M-27
DR   CLO; CLO_0001556
DR   Wikidata; Q54605957
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8452.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-27.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   a intermediate filament
AC   CVCL_K121
SY   alpha intermediate filament
DR   CLO; CLO_0009729
DR   ATCC; TIB-131
DR   Wikidata; Q54605960
RX   PubMed=6086105;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   A-1-18
AC   CVCL_B5AF
DR   Wikidata; Q110429820
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   A-1-19
AC   CVCL_B5AG
DR   Wikidata; Q110429821
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   A-1-27
AC   CVCL_B5AH
DR   Wikidata; Q110429822
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   A-1-43
AC   CVCL_B5AI
DR   Wikidata; Q110429824
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   A-1-6
AC   CVCL_B5AJ
DR   Wikidata; Q110429826
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   A-10
AC   CVCL_0130
SY   A10
DR   BTO; BTO_0002196
DR   CLO; CLO_0001550
DR   MCCL; MCC:0000022
DR   CLDB; cl184
DR   ATCC; CRL-1476
DR   BCRC; 60127
DR   ChEMBL-Cells; CHEMBL3307383
DR   ChEMBL-Targets; CHEMBL614513
DR   DSMZ; ACC-132
DR   DSMZCellDive; ACC-132
DR   JCRB; IFO50275
DR   Lonza; 763
DR   NCBI_Iran; C600
DR   PubChem_Cell_line; CVCL_0130
DR   TOKU-E; 452
DR   Wikidata; Q54605962
RX   PubMed=943301;
RX   PubMed=9415280;
RX   PubMed=24628920;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/a10/a10cells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/cellsincultureindex
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-79.html
CC   Doubling time: ~29 hours (ATCC=CRL-1476); ~70-100 hours (DSMZ=ACC-132).
CC   Discontinued: JCRB; IFO50275; true.
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   A-10-33-1
AC   CVCL_B5AK
DR   Wikidata; Q110429828
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   A-10-365
AC   CVCL_B5AL
DR   Wikidata; Q110429830
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   A-1095
AC   CVCL_ZZ70
SY   A1095
DR   Wikidata; Q102113470
RX   PubMed=6954533;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-11-124
AC   CVCL_B5AM
DR   Wikidata; Q110429833
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   A-11-352
AC   CVCL_B5AN
DR   Wikidata; Q110429836
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   A-1165
AC   CVCL_D135
SY   A1165
DR   cancercelllines; CVCL_D135
DR   Cosmic; 735608
DR   Wikidata; Q54606256
RX   PubMed=375235;
RX   PubMed=3945555;
RX   PubMed=6500159;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=3945555).
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   A-1186
AC   CVCL_F0T4
SY   A1186
RX   PubMed=1255758;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A-1207
AC   CVCL_8481
SY   A1207; A 1207
DR   BTO; BTO_0002213
DR   BioSample; SAMN10988410
DR   cancercelllines; CVCL_8481
DR   Cell_Model_Passport; SIDM01527
DR   Cosmic; 2516011
DR   DepMap; ACH-000283
DR   PharmacoDB; A1207_35_2019
DR   Wikidata; Q54605964
RX   PubMed=1255758;
RX   PubMed=1385192;
RX   PubMed=6173755;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000283).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.38%; Native American=0%; East Asian, North=3.29%; East Asian, South=0%; South Asian=0%; European, North=63.52%; European, South=32.81% (PubMed=30894373).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 23
//
ID   A-1235
AC   CVCL_7002
SY   A1235
DR   BTO; BTO_0002214
DR   Cosmic; 1014070
DR   Wikidata; Q54605966
RX   PubMed=1385192;
RX   PubMed=6173755;
RX   PubMed=6256643;
RX   PubMed=6825208;
RX   PubMed=6954533;
RX   PubMed=7523863;
RX   PubMed=10698499;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; c.(2062_3114)ins?; Zygosity=Unspecified (PubMed=10698499).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   A-1306
AC   CVCL_ZZ48
SY   A1306
DR   Wikidata; Q102113471
RX   PubMed=6173755;
RX   PubMed=6954533;
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 5
//
ID   A-1336
AC   CVCL_ZZ49
SY   A1336
DR   Wikidata; Q102113472
RX   PubMed=6256643;
RX   PubMed=6825208;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-1383
AC   CVCL_ZZ50
SY   A1383
DR   Wikidata; Q102113473
RX   PubMed=1385192;
RX   PubMed=6173755;
RX   PubMed=6954533;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 5
//
ID   A-1498
AC   CVCL_ZZ51
SY   A1498
DR   Wikidata; Q102113475
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C6605; Soft tissue fibrosarcoma
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-1589
AC   CVCL_D136
SY   A1589
DR   Wikidata; Q54606392
RX   PubMed=375235;
DI   NCIt; C2929; Squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   A-1604
AC   CVCL_V398
SY   A1604
DR   Wikidata; Q54606397
RX   PubMed=6954533;
RX   PubMed=7144906;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   A-1617
AC   CVCL_ZZ52
SY   A1617
DR   Wikidata; Q102113476
RX   PubMed=6173755;
RX   PubMed=6256643;
RX   PubMed=6954533;
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 5
//
ID   A-1632
AC   CVCL_ZZ53
SY   A1632
DR   Wikidata; Q102113477
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-1663
AC   CVCL_D137
SY   A1663
DR   cancercelllines; CVCL_D137
DR   Cosmic; 735610
DR   Wikidata; Q54606400
RX   PubMed=375235;
RX   PubMed=3945555;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=3945555).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   A-1673
AC   CVCL_ZZ54
SY   A1673
DR   Wikidata; Q102113478
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-1684
AC   CVCL_UW32
SY   A 1684; A1684
DR   Wikidata; Q93311024
RX   PubMed=212188;
RX   PubMed=2986151;
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   A-1690
AC   CVCL_ZZ55
SY   A1690
DR   Wikidata; Q102113479
RX   PubMed=1385192;
RX   PubMed=6173755;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 5
//
ID   A-1698
AC   CVCL_V399
SY   A1698
DR   Cosmic; 760487
DR   Wikidata; Q54606402
RX   PubMed=3413074;
RX   PubMed=7144906;
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   A-172
AC   CVCL_0131
SY   A172; A 172; A-172 MG; A-172MG
DR   BTO; BTO_0000016
DR   CLO; CLO_0001543
DR   CLO; CLO_0001559
DR   CLO; CLO_0001560
DR   CLO; CLO_0050637
DR   EFO; EFO_0002101
DR   MCCL; MCC:0000023
DR   CLDB; cl142
DR   CLDB; cl143
DR   CLDB; cl144
DR   CLDB; cl146
DR   AddexBio; C0005009/5018
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1620
DR   ATCC; CRL-7899
DR   BioGRID_ORCS_Cell_line; 823
DR   BioSample; SAMN03471115
DR   BioSample; SAMN03471212
DR   BioSample; SAMN03471659
DR   BioSample; SAMN03471918
DR   BioSample; SAMN10988258
DR   cancercelllines; CVCL_0131
DR   CCRID; 3101HUMTCHu171
DR   Cell_Model_Passport; SIDM00799
DR   CGH-DB; 138-1
DR   ChEMBL-Cells; CHEMBL3308491
DR   ChEMBL-Targets; CHEMBL614512
DR   CLS; 300108
DR   Cosmic; 687563
DR   Cosmic; 849883
DR   Cosmic; 897446
DR   Cosmic; 1014068
DR   Cosmic; 1036334
DR   Cosmic; 1066233
DR   Cosmic; 1171223
DR   Cosmic; 1236360
DR   Cosmic; 1610751
DR   Cosmic; 1746956
DR   Cosmic; 1995327
DR   Cosmic; 2302321
DR   Cosmic; 2367506
DR   Cosmic; 2516012
DR   Cosmic-CLP; 687563
DR   DepMap; ACH-000558
DR   ECACC; 88062428
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS225AJI
DR   ENCODE; ENCBS874LTK
DR   FANTOM5_SSTAR; 10444-106F3
DR   GDSC; 687563
DR   GEO; GSM101609
DR   GEO; GSM101610
DR   GEO; GSM326244
DR   GEO; GSM886850
DR   GEO; GSM887914
DR   GEO; GSM1374378
DR   GEO; GSM1669577
DR   IARC_TP53; 21157
DR   ICLC; HTL97013
DR   IGRhCellID; A172
DR   IZSLER; BS TCL 2
DR   JCRB; JCRB0228
DR   KCB; KCB 200966YJ
DR   KCLB; 21620
DR   LiGeA; CCLE_757
DR   LINCS_LDP; LCL-1348
DR   Lonza; 178
DR   NCBI_Iran; C211
DR   PharmacoDB; A172_36_2019
DR   PRIDE; PXD001110
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0131
DR   PubChem_Cell_line; CVCL_0131
DR   RCB; RCB2530
DR   TKG; TKG 0183
DR   Wikidata; Q54605968
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=77569;
RX   PubMed=212188;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=1255758;
RX   PubMed=1385192;
RX   PubMed=3518877;
RX   PubMed=3675803;
RX   PubMed=3759084;
RX   PubMed=4357758;
RX   PubMed=6173755;
RX   PubMed=6220172;
RX   PubMed=6256643;
RX   PubMed=6260907;
RX   PubMed=6652614;
RX   PubMed=6825208;
RX   PubMed=6954533;
RX   PubMed=7523863;
RX   PubMed=9090379;
RX   PubMed=9220028;
RX   PubMed=9290701;
RX   PubMed=9842975;
RX   PubMed=10402232;
RX   PubMed=10416987;
RX   PubMed=10698499;
RX   PubMed=11351043;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=15900046;
RX   PubMed=16232199;
RX   PubMed=16697959;
RX   PubMed=17254797;
RX   PubMed=17595512;
RX   PubMed=19365568;
RX   PubMed=19435942;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21406405;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=23637631;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30188626;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34036375;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-280.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Population: Caucasian.
CC   Doubling time: 44 hours (PubMed=9842975); 40 hours (PubMed=25984343); 33-48 hours (PubMed=30188626); ~45 hours (Note=Lot 021999), ~30 hours (Note=Lot 06092006), ~42 hours (Note=Lot 06262015), ~26 hours (Note=Lot 12192018) (JCRB=JCRB0228).
CC   HLA typing: A*01,02; B*07,08 (PubMed=77569).
CC   HLA typing: A*01:01,03:01; B*07:02,08:01; C*07:01,07:01; DQB1*06:07,06:07; DRB1*11:26,13:09 (PubMed=26589293).
CC   HLA typing: A*01:01:01,03:01:01; B*07:02:01,08:01:01; C*07:01:01,07:02:01; DPB1*02:01:02G,04:02:01G; DQA1*05:01,05:05; DQB1*02:01,03:01; DRB1*03:01,11:01 (CLS=300108).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=9090379).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=14614447; PubMed=15900046).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.05%; East Asian, South=0%; South Asian=1.21%; European, North=68.98%; European, South=27.77% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7899; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): AddexBio=C0005009/5018; ATCC=CRL-1620; CLS=300108; Cosmic-CLP=687563; ECACC=88062428; IZSLER=BS TCL 2; JCRB=JCRB0228; KCLB=21620; PubMed=17254797; PubMed=22570425; PubMed=25877200; RCB=RCB2530; Technion Genomics Center; TKG=TKG 0183
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11 (PubMed=17254797)
ST   CSF1PO: 9,12 (AddexBio=C0005009/5018; ATCC=CRL-1620; CLS=300108; Cosmic-CLP=687563; ECACC=88062428; IZSLER=BS TCL 2; JCRB=JCRB0228; KCLB=21620; PubMed=22570425; PubMed=25877200; RCB=RCB2530; Technion Genomics Center; TKG=TKG 0183)
ST   D10S1248: 15
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11 (PubMed=17254797)
ST   D16S539: 12 (AddexBio=C0005009/5018; ATCC=CRL-1620; CLS=300108; Cosmic-CLP=687563; ECACC=88062428; IZSLER=BS TCL 2; JCRB=JCRB0228; KCLB=21620; PubMed=22570425; PubMed=25877200; RCB=RCB2530; Technion Genomics Center; TKG=TKG 0183)
ST   D18S51: 12,13
ST   D19S433: 12,15.2
ST   D1S1656: 12,14
ST   D21S11: 27,32 (PubMed=17254797)
ST   D21S11: 28,32.2 (ATCC=CRL-1620; CLS=300108; IZSLER=BS TCL 2; PubMed=22570425; PubMed=25877200; Technion Genomics Center)
ST   D22S1045: 16
ST   D2S1338: 20,21
ST   D2S441: 10,11
ST   D3S1358: 14,18 (ATCC=CRL-1620; CLS=300108; PubMed=22570425; PubMed=25877200; Technion Genomics Center)
ST   D3S1358: 15,18 (PubMed=17254797)
ST   D5S818: 11,12
ST   D6S1043: 13,18
ST   D7S820: 11
ST   D8S1179: 13,14
ST   DYS391: 11
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 5,10
ST   TH01: 6,9.3 (AddexBio=C0005009/5018; ATCC=CRL-1620; CLS=300108; Cosmic-CLP=687563; ECACC=88062428; IZSLER=BS TCL 2; KCLB=21620; PubMed=22570425; PubMed=25877200; RCB=RCB2530; Technion Genomics Center; TKG=TKG 0183)
ST   TH01: 6,10 (JCRB=JCRB0228; PubMed=17254797)
ST   TPOX: 8,11
ST   vWA: 17,20 (RCB=RCB2530)
ST   vWA: 20 (AddexBio=C0005009/5018; ATCC=CRL-1620; CLS=300108; Cosmic-CLP=687563; ECACC=88062428; IZSLER=BS TCL 2; JCRB=JCRB0228; KCLB=21620; PubMed=17254797; PubMed=22570425; PubMed=25877200; Technion Genomics Center; TKG=TKG 0183)
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   A-172 EMC10 isoform HSS1
AC   CVCL_F1JP
SY   A172 pcDNA3.1-hHSS1
RX   PubMed=20680400;
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=20680400).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27609; EMC10 (Note=Isoform HSS1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0131 ! A-172
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A-172 neo
AC   CVCL_F1JQ
SY   A172 pcDNA3.1
RX   PubMed=20680400;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for A-172 EMC10 isoform HSS1 (Cellosaurus=CVCL_F1JP) (PubMed=20680400).
CC   Doubling time: 30.5 hours (PubMed=20680400).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0131 ! A-172
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A-1723
AC   CVCL_UW33
SY   A1723
DR   Wikidata; Q93311026
RX   PubMed=212188;
RX   PubMed=7789980;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   A-1A5
AC   CVCL_C8GF
SY   A1A5
DR   Wikidata; Q123030345
RX   PubMed=6408178;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   A-2
AC   CVCL_1939
SY   A2
DR   CLO; CLO_0001563
DR   DSMZ; ACC-276
DR   DSMZCellDive; ACC-276
DR   Wikidata; Q54605972
RX   PubMed=528010;
CC   Group: Fish cell line.
CC   Doubling time: ~2-3 days (DSMZ=ACC-276).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: YF1.
OX   NCBI_TaxID=8086; ! Xiphophorus xiphidium (Spiketail platyfish)
SX   Sex unspecified
AG   Late embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   A-2-5
AC   CVCL_F0WV
RX   PubMed=6177865;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Epstein-Barr virus (strain B95-8) 212/236 kDa membrane antigen complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A-20
AC   CVCL_B3QH
DR   Wikidata; Q110429838
RX   CelloPub=CLPUB00656;
RX   PubMed=6220106;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/anti-cd45-1-mouse-monoclonal-antibody-clone-20
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2003-077.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45 (Note=Isoform Ly5.1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   A-204
AC   CVCL_1058
SY   A204
DR   BTO; BTO_0003767
DR   CLO; CLO_0001565
DR   EFO; EFO_0002102
DR   CLDB; cl147
DR   CLDB; cl148
DR   CLDB; cl149
DR   CLDB; cl150
DR   CLDB; cl4895
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7900
DR   ATCC; HTB-82
DR   BioSample; SAMN01821534
DR   BioSample; SAMN01821612
DR   BioSample; SAMN03471116
DR   BioSample; SAMN10987802
DR   cancercelllines; CVCL_1058
DR   CCRID; 1101HUM-PUMC000031
DR   CCRID; 1102HUM-NIFDC00105
DR   CCRID; 4201HUM-CCTCC00310
DR   CCTCC; GDC0310
DR   Cell_Model_Passport; SIDM00798
DR   ChEMBL-Cells; CHEMBL3308354
DR   ChEMBL-Targets; CHEMBL614514
DR   CLS; 300109
DR   Cosmic; 687946
DR   Cosmic; 802041
DR   Cosmic; 910784
DR   Cosmic; 1097754
DR   Cosmic; 1202066
DR   Cosmic; 1995328
DR   Cosmic-CLP; 910784
DR   DepMap; ACH-000201
DR   DSMZ; ACC-250
DR   DSMZCellDive; ACC-250
DR   EGA; EGAS00001000978
DR   GDSC; 910784
DR   GEO; GSM184386
DR   GEO; GSM184387
DR   GEO; GSM886851
DR   GEO; GSM887915
DR   GEO; GSM1669578
DR   GEO; GSM1676295
DR   GEO; GSM1676338
DR   GEO; GSM1701622
DR   GEO; GSM1701670
DR   GEO; GSM1701697
DR   IARC_TP53; 21158
DR   ICLC; HTL99002
DR   IGRhCellID; A204
DR   LiGeA; CCLE_652
DR   LINCS_LDP; LCL-1409
DR   Lonza; 1655
DR   PharmacoDB; A204_37_2019
DR   PRIDE; PXD005536
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1058
DR   PubChem_Cell_line; CVCL_1058
DR   TOKU-E; 460
DR   Wikidata; Q54605978
RX   CelloPub=CLPUB00569;
RX   PubMed=77569;
RX   PubMed=212188;
RX   PubMed=327080;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=1255758;
RX   PubMed=1385192;
RX   PubMed=2302710;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=4357758;
RX   PubMed=8275086;
RX   PubMed=9823299;
RX   PubMed=10602515;
RX   PubMed=11668190;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23882450;
RX   PubMed=25984343;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28842319;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-541.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=25984343); 26-36 hours (CLS=300109); ~36 hours (DSMZ=ACC-250).
CC   HLA typing: A*01,02; B*08,14; C*w03 (PubMed=77569).
CC   HLA typing: A*01:01,02:01; B*35:20,35:20; C*03:04,07:01; DQA1*03:02,03:02; DQB1*04:01,04:01; DRB1*15:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Gln182Alafs*28 (c.543_544delTC); Zygosity=Heterozygous (PubMed=10602515; Cosmic-CLP=910784; DepMap=ACH-000201).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.2%; East Asian, North=0.35%; East Asian, South=0%; South Asian=0.83%; European, North=70.8%; European, South=27.82% (PubMed=30894373).
CC   Misspelling: HTB82; Note=Based on the ATCC catalog number.
CC   Discontinued: ATCC; CRL-7900; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
ST   Source(s): ATCC=HTB-82; CCRID; CLS=300109; Cosmic-CLP=910784; DepMap=ACH-000201; DSMZ=ACC-250
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 17,18
ST   D19S433: 12,13
ST   D21S11: 28,30
ST   D2S1338: 17,22
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 45
//
ID   A-204/DasR
AC   CVCL_QY40
SY   DasR/A204
DR   PRIDE; PXD005536
DR   Wikidata; Q54605979
RX   PubMed=28842319;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Gln182Alafs*28 (c.543_544delTC); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1058 ! A-204
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   A-204/PazR
AC   CVCL_QY41
SY   PazR/A204
DR   PRIDE; PXD005536
DR   Wikidata; Q54605983
RX   PubMed=28842319;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_71219; Pazopanib (Votrient).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Gln182Alafs*28 (c.543_544delTC); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1058 ! A-204
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   A-2095
AC   CVCL_ZZ57
SY   A2095
DR   Wikidata; Q102113480
RX   PubMed=1385192;
RX   PubMed=6173755;
RX   PubMed=6256643;
RX   PubMed=6825208;
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C6605; Soft tissue fibrosarcoma
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 5
//
ID   A-2182
AC   CVCL_8091
SY   A2182
DR   cancercelllines; CVCL_8091
DR   Cosmic; 929963
DR   Cosmic; 932916
DR   Cosmic; 2668260
DR   Wikidata; Q54606447
RX   PubMed=1855224;
RX   PubMed=3413074;
RX   PubMed=6825208;
RX   PubMed=7144906;
RX   PubMed=15848055;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=1855224).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   A-2233
AC   CVCL_V400
SY   A2233
DR   Wikidata; Q54606449
RX   PubMed=7144906;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   A-2394
AC   CVCL_ZZ69
SY   A2394
DR   Wikidata; Q102113481
RX   PubMed=6173755;
RX   PubMed=6954533;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 6
//
ID   A-253
AC   CVCL_1060
SY   A 253; A253
DR   BTO; BTO_0003206
DR   CLO; CLO_0001569
DR   CLO; CLO_0001570
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7902
DR   ATCC; HTB-41
DR   BCRC; 60367
DR   BCRJ; 0322
DR   BioGRID_ORCS_Cell_line; 824
DR   BioSample; SAMN03471117
DR   BioSample; SAMN10988034
DR   cancercelllines; CVCL_1060
DR   Cell_Model_Passport; SIDM00796
DR   ChEMBL-Cells; CHEMBL3307893
DR   ChEMBL-Targets; CHEMBL614255
DR   Cosmic; 688036
DR   Cosmic; 906794
DR   Cosmic; 921831
DR   Cosmic; 1006471
DR   Cosmic; 1017790
DR   Cosmic; 1041671
DR   Cosmic; 1995330
DR   Cosmic; 2646649
DR   Cosmic-CLP; 906794
DR   DepMap; ACH-000740
DR   EGA; EGAS00001000978
DR   GDSC; 906794
DR   GEO; GSM422867
DR   GEO; GSM423670
DR   GEO; GSM886852
DR   GEO; GSM887917
DR   GEO; GSM1669580
DR   IARC_TP53; 21160
DR   IZSLER; BS TCL 199
DR   KCLB; 30041
DR   LiGeA; CCLE_437
DR   LINCS_LDP; LCL-2034
DR   PharmacoDB; A253_39_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1060
DR   PubChem_Cell_line; CVCL_1060
DR   TOKU-E; 462
DR   Wikidata; Q54605985
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3138611;
RX   PubMed=3518877;
RX   PubMed=4357758;
RX   PubMed=6256643;
RX   PubMed=20014447;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29923277;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*32:01,32:01; B*44:02,44:02; C*03:04,05:01; DQB1*06:08,06:08; DRB1*13:10,13:10 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala17fs*5 (c.49_61delGCCACGGCCGCGG); Zygosity=Heterozygous (ATCC=HTB-41; Cosmic-CLP=906794; DepMap=ACH-000740).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gly3092Ter (c.9274G>T); Zygosity=Heterozygous (Cosmic-CLP=906794; DepMap=ACH-000740).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu152Pro (c.455T>C); ClinVar=VCV000536551; Zygosity=Homozygous (Cosmic-CLP=906794; DepMap=ACH-000740).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180fs*67 (c.539delA); Zygosity=Homozygous (ATCC=HTB-41; Cosmic-CLP=906794; DepMap=ACH-000740).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.97%; Native American=0%; East Asian, North=1.81%; East Asian, South=0%; South Asian=0%; European, North=61.82%; European, South=35.39% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7902; true.
CC   Discontinued: KCLB; 30041; probable.
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
ST   Source(s): ATCC=HTB-41; Cosmic-CLP=906794; IZSLER=BS TCL 199; PubMed=29923277
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 25,26
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 7
ST   TH01: 6,8
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   A-253 clone B2
AC   CVCL_A2EP
SY   B2
DR   cancercelllines; CVCL_A2EP
DR   Wikidata; Q105506004
RX   PubMed=32842479;
CC   Population: Caucasian.
CC   Characteristics: Clone of ductal origin. Particularly suitable for transport studies in biomarker research (PubMed=32842479).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala17fs*5 (c.49_61delGCCACGGCCGCGG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gly3092Ter (c.9274G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu152Pro (c.455T>C); ClinVar=VCV000536551; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180fs*67 (c.539delA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1060 ! A-253
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   A-253 clone B4
AC   CVCL_A2EQ
SY   B4
DR   cancercelllines; CVCL_A2EQ
DR   Wikidata; Q105506007
RX   PubMed=32842479;
CC   Population: Caucasian.
CC   Characteristics: Clone is presumably a mixture of acinar and ductal origin (PubMed=32842479).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala17fs*5 (c.49_61delGCCACGGCCGCGG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gly3092Ter (c.9274G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu152Pro (c.455T>C); ClinVar=VCV000536551; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180fs*67 (c.539delA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1060 ! A-253
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   A-253 clone B9
AC   CVCL_A2ER
SY   B9
DR   cancercelllines; CVCL_A2ER
DR   Wikidata; Q105506011
RX   PubMed=32842479;
CC   Population: Caucasian.
CC   Characteristics: Clone of acinar origin (PubMed=32842479).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala17fs*5 (c.49_61delGCCACGGCCGCGG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gly3092Ter (c.9274G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu152Pro (c.455T>C); ClinVar=VCV000536551; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180fs*67 (c.539delA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Salivary gland acinar cell; CL=CL_0002623.
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1060 ! A-253
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   A-253 clone D3
AC   CVCL_A2ES
SY   D3
DR   cancercelllines; CVCL_A2ES
DR   Wikidata; Q105506014
RX   PubMed=32842479;
CC   Population: Caucasian.
CC   Characteristics: Clone of acinar origin (PubMed=32842479).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala17fs*5 (c.49_61delGCCACGGCCGCGG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gly3092Ter (c.9274G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu152Pro (c.455T>C); ClinVar=VCV000536551; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180fs*67 (c.539delA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Salivary gland acinar cell; CL=CL_0002623.
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1060 ! A-253
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   A-253 clone F11
AC   CVCL_A2ET
SY   F11
DR   cancercelllines; CVCL_A2ET
DR   Wikidata; Q105506020
RX   PubMed=32842479;
CC   Population: Caucasian.
CC   Characteristics: Clone of myoepithelial origin (PubMed=32842479).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala17fs*5 (c.49_61delGCCACGGCCGCGG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gly3092Ter (c.9274G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu152Pro (c.455T>C); ClinVar=VCV000536551; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180fs*67 (c.539delA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1060 ! A-253
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   A-2781
AC   CVCL_F0T5
SY   A2781
RX   PubMed=6173755;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A-2984
AC   CVCL_ZZ58
SY   A2984
DR   Wikidata; Q102113483
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-3008
AC   CVCL_ZZ59
SY   A3008
DR   Wikidata; Q102113485
RX   PubMed=8188761;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-3243
AC   CVCL_ZZ56
SY   A3243
DR   Wikidata; Q102113487
RX   PubMed=1385192;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
DI   NCIt; C6605; Soft tissue fibrosarcoma
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   A-375
AC   CVCL_0132
SY   A 375; A375; A375-MEL; A375-mel; A375mel; 375
DR   BTO; BTO_0002806
DR   CLO; CLO_0001544
DR   CLO; CLO_0001581
DR   CLO; CLO_0001582
DR   EFO; EFO_0002103
DR   MCCL; MCC:0000024
DR   CLDB; cl198
DR   CLDB; cl199
DR   Abcam; ab275461
DR   AddexBio; C0020004/4992
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1619
DR   ATCC; CRL-7904
DR   BCRC; 60039
DR   BCRJ; 0278
DR   BioGRID_ORCS_Cell_line; 44
DR   BioSample; SAMN03472142
DR   BioSample; SAMN05292441
DR   BioSample; SAMN07709998
DR   BioSample; SAMN07709999
DR   BioSample; SAMN07710000
DR   BioSample; SAMN07710001
DR   BioSample; SAMN07710002
DR   BioSample; SAMN07710003
DR   BioSample; SAMN07710004
DR   BioSample; SAMN10988347
DR   cancercelllines; CVCL_0132
DR   CCRID; 1101HUM-PUMC000126
DR   CCRID; 1101HUM-PUMC000327
DR   CCRID; 3101HUMSCSP533
DR   CCRID; 3101HUMTCHu155
DR   CCRID; 4201HUM-CCTCC00285
DR   CCTCC; GDC0285
DR   CCTCC; GDC0314
DR   Cell_Model_Passport; SIDM00795
DR   CGH-DB; 9313-4
DR   ChEMBL-Cells; CHEMBL3308077
DR   ChEMBL-Targets; CHEMBL613859
DR   CLS; 300110
DR   Cosmic; 686480
DR   Cosmic; 687431
DR   Cosmic; 706114
DR   Cosmic; 876698
DR   Cosmic; 888861
DR   Cosmic; 897482
DR   Cosmic; 897735
DR   Cosmic; 905226
DR   Cosmic; 906793
DR   Cosmic; 928688
DR   Cosmic; 933003
DR   Cosmic; 1006556
DR   Cosmic; 1022280
DR   Cosmic; 1054855
DR   Cosmic; 1132587
DR   Cosmic; 1155278
DR   Cosmic; 1211162
DR   Cosmic; 1303032
DR   Cosmic; 1458961
DR   Cosmic; 1459655
DR   Cosmic; 1477406
DR   Cosmic; 1481413
DR   Cosmic; 1507620
DR   Cosmic; 1537486
DR   Cosmic; 1555009
DR   Cosmic; 1669118
DR   Cosmic; 1812178
DR   Cosmic; 1888914
DR   Cosmic; 1890486
DR   Cosmic; 1989294
DR   Cosmic; 1995332
DR   Cosmic; 2036699
DR   Cosmic; 2230112
DR   Cosmic; 2233660
DR   Cosmic; 2479252
DR   Cosmic; 2791113
DR   Cosmic-CLP; 906793
DR   DepMap; ACH-000219
DR   ECACC; 88113005
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS606AAA
DR   ENCODE; ENCBS607AAA
DR   GDSC; 906793
DR   GEO; GSM206443
DR   GEO; GSM218051
DR   GEO; GSM274681
DR   GEO; GSM276771
DR   GEO; GSM555121
DR   GEO; GSM555173
DR   GEO; GSM827158
DR   GEO; GSM886854
DR   GEO; GSM887919
DR   GEO; GSM952580
DR   GEO; GSM1092559
DR   GEO; GSM1138787
DR   GEO; GSM1177892
DR   GEO; GSM1177893
DR   GEO; GSM1374382
DR   GEO; GSM1669582
DR   GEO; GSM1671962
DR   GEO; GSM1671967
DR   GEO; GSM1671977
DR   GEO; GSM1671981
DR   GEO; GSM1671982
DR   GEO; GSM1671987
DR   GEO; GSM1671990
DR   GEO; GSM1672001
DR   GEO; GSM1672004
DR   GEO; GSM1672007
DR   GEO; GSM1672011
DR   GEO; GSM1672017
DR   GEO; GSM1672024
DR   GEO; GSM1672027
DR   GEO; GSM1672030
DR   GEO; GSM1672039
DR   GEO; GSM1672051
DR   GEO; GSM1672062
DR   GEO; GSM1672067
DR   GEO; GSM1672078
DR   GEO; GSM1672097
DR   GEO; GSM1672102
DR   GEO; GSM1672119
DR   GEO; GSM1672135
DR   GEO; GSM3039510
DR   GEO; GSM3039516
DR   GEO; GSM3039517
DR   GEO; GSM3039518
DR   IARC_TP53; 21163
DR   IBRC; C10141
DR   IGRhCellID; A375
DR   IZSLER; BS TCL 88
DR   KCB; KCB 99003YJ
DR   LiGeA; CCLE_226
DR   LINCS_HMS; 50060
DR   LINCS_LDP; LCL-1235
DR   Lonza; 970
DR   NCBI_Iran; C136
DR   PharmacoDB; A375_42_2019
DR   PRIDE; PXD001485
DR   PRIDE; PXD004343
DR   PRIDE; PXD005912
DR   PRIDE; PXD007265
DR   PRIDE; PXD021877
DR   PRIDE; PXD022992
DR   PRIDE; PXD025255
DR   PRIDE; PXD025881
DR   PRIDE; PXD026952
DR   PRIDE; PXD027886
DR   PRIDE; PXD028863
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0132
DR   PubChem_Cell_line; CVCL_0132
DR   Ubigene; YC-C036
DR   Wikidata; Q54605986
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=77569;
RX   PubMed=265522;
RX   PubMed=327080;
RX   PubMed=375235;
RX   PubMed=833871;
RX   PubMed=1255758;
RX   PubMed=1832891;
RX   PubMed=3518877;
RX   PubMed=4357758;
RX   PubMed=6173755;
RX   PubMed=6220172;
RX   PubMed=6500159;
RX   PubMed=6584666;
RX   PubMed=6954533;
RX   PubMed=9670966;
RX   PubMed=9973934;
RX   PubMed=10497214;
RX   PubMed=12068308;
RX   PubMed=14871852;
RX   PubMed=15009714;
RX   PubMed=15467732;
RX   PubMed=17308088;
RX   PubMed=18172304;
RX   PubMed=19727395;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21343389;
RX   PubMed=21424129;
RX   PubMed=21673604;
RX   PubMed=21857157;
RX   PubMed=22178978;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=23039341;
RX   PubMed=24581590;
RX   PubMed=25056119;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26405815;
RX   PubMed=26589293;
RX   PubMed=26673621;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29275043;
RX   PubMed=29492214;
RX   PubMed=29605720;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35128241;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A375
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544560
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/a375-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 26.9 +- 6.9 hours (PubMed=29275043); ~32 hours (PBCF).
CC   HLA typing: A*01,02; B*12,13 (PubMed=77569).
CC   HLA typing: A*01:01,02:01; B*44:03,57:01; C*06:02,16:02; DQA1*03:02,02:01; DQB1*03:03,03:03; DRB1*04:05,07:01 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*44:03,57:01; C*06:02,16:01; DQA1*03:02,02:01; DQB1*03:02,03:02; DRB1*04:05,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=26405815; PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (PubMed=29492214; ATCC=CRL-1619; Cosmic-CLP=906793; DepMap=ACH-000219).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.84%; Native American=0.49%; East Asian, North=1.69%; East Asian, South=0%; South Asian=0%; European, North=67.22%; European, South=29.75% (PubMed=30894373).
CC   Misspelling: A-735; Note=Occasionally.
CC   Discontinued: ATCC; CRL-7904; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): AddexBio=C0020004/4992; ATCC=CRL-1619; CCRID; CLS=300110; Cosmic-CLP=906793; ECACC=88113005; IZSLER=BS TCL 88; PubMed=25056119; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 16
ST   D12S391: 18,21
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 12,17
ST   D19S433: 13,14.2
ST   D1S1656: 16,17.3
ST   D21S11: 29,30
ST   D22S1045: 16
ST   D2S1338: 16,24
ST   D2S441: 11
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 9,15
ST   Penta E: 10,12
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   A-375 Human CD228
AC   CVCL_E8SQ
SY   A375-CD228
DR   KYinno; KC-2110
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+118-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7037; MELTF.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A-375 Human CLDN18.2
AC   CVCL_E8SR
SY   A375-CLDN18.2
DR   KYinno; KC-3320
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+118-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A-375 Human EGFR vIII
AC   CVCL_XZ66
SY   A375-EGFRVIII; U87MG Human EGFR vIII
DR   cancercelllines; CVCL_XZ66
DR   KYinno; KC-1308
DR   Wikidata; Q98133791
CC   Problematic cell line: Misidentified. Was originally thought to originate from the U87MG cell line. STR profiling carried out at KYinno has shown it was derived from A-375. Be aware of this issue if you obtained this cell line before it was indicated as being derived from K-562.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-1308).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+118-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   A-375 KRAS p.G13D
AC   CVCL_UD29
SY   A-375 KRASG13D; KRAS mutant-A375 Isogenic Cell Line
DR   ATCC; CRL-1619IG-1
DR   cancercelllines; CVCL_UD29
DR   Wikidata; Q93311029
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/isogenic-cell-line-with-ras-mutation
CC   Population: Caucasian.
CC   Characteristics: Exhibits significant resistance to the BRAF inhibitors Dabrafineb and Vemurafenib when compared to its parental cell line. Can be a useful model to study the RAS-RAF-MEK-ERK-MAP kinase signaling pathway and to screen potential BRAF inhibitors and anti-cancer compounds for drug discovery and development (ATCC=CRL-1619IG-1).
CC   Doubling time: ~21 hours (ATCC=CRL-1619IG-1).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (ATCC=CRL-1619IG-1).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1619IG-1
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 15
//
ID   A-375 KRAS p.G13D-Luc2
AC   CVCL_UR34
SY   KRAS mutant-A375 Isogenic-Luc2
DR   ATCC; CRL-1619IG-1-LUC2
DR   cancercelllines; CVCL_UR34
DR   Wikidata; Q93311030
CC   Population: Caucasian.
CC   Characteristics: Exhibits significant resistance to the BRAF inhibitors Dabrafineb and Vemurafenib when compared to its parental cell line. Can be a useful model to study the RAS-RAF-MEK-ERK-MAP kinase signaling pathway and to screen potential BRAF inhibitors and anti-cancer compounds for drug discovery and development (ATCC=CRL-1619IG-1-LUC2).
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (ATCC=CRL-1619IG-1-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1619IG-1-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD29 ! A-375 KRAS p.G13D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 15
//
ID   A-375 MEK1 p.Q56P
AC   CVCL_UD28
SY   A-375 MEK1Q56P; MEK1 Mutant-A375 Isogenic Cell Line
DR   ATCC; CRL-1619IG-3
DR   cancercelllines; CVCL_UD28
DR   Wikidata; Q93311031
CC   Population: Caucasian.
CC   Characteristics: Exhibits significant resistance to the BRAF inhibitors Dabrafineb and Vemurafenib, as well as the MAP2K1 inhibitor trametinib when compared to its parental cell line. Displays increased sensitivity to combination MAP2K1/BRAF inhibitor treatments, making this line an ideal model system for the development of novel combination therapies targeting multiple points in the RAS-RAF-MEK-ERK-MAPK signaling pathway, as well as for the screening of new potential BRAF and MAP2K1 inhibitors (ATCC=CRL-1619IG-3).
CC   Doubling time: ~19 hours (ATCC=CRL-1619IG-3).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple_edited; p.Gln56Pro (c.167A>C); ClinVar=VCV000375978; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (ATCC=CRL-1619IG-3).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1619IG-3
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 13
//
ID   A-375 NRAS p.Q61K
AC   CVCL_JF22
SY   A-375 NRASQ61K; NRAS mutant-A375 Isogenic Cell Line
DR   ATCC; CRL-1619IG-2
DR   cancercelllines; CVCL_JF22
DR   Wikidata; Q54605989
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/isogenic-cell-line-with-ras-mutation
CC   Population: Caucasian.
CC   Characteristics: Shows significant resistance to the BRAF inhibitors Dabrafineb and Vemurafenib when compared to its parental cell line in 2D and 3D culture systems. Can be a useful model to study the RAS-RAF-MEK-ERK-MAP kinase signaling pathway and to screen potential BRAF inhibitors and anti-cancer compounds for drug discovery and development (ATCC=CRL-1619IG-2).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Homozygous; Note=By CRISPR/Cas9 (ATCC=CRL-1619IG-2).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1619IG-2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 19
//
ID   A-375 NRAS p.Q61K-Luc2
AC   CVCL_VR65
SY   NRAS-mutant-A375 Isogenic-Luc2
DR   ATCC; CRL-1619IG-2-LUC2
DR   cancercelllines; CVCL_VR65
DR   Wikidata; Q93311033
CC   Population: Caucasian.
CC   Characteristics: Shows significant resistance to the BRAF inhibitors Dabrafineb and Vemurafenib when compared to its parental cell line in 2D and 3D culture systems. Can be a useful model to study the RAS-RAF-MEK-ERK-MAP kinase signaling pathway and to screen potential BRAF inhibitors and anti-cancer compounds for drug discovery and development (ATCC=CRL-1619IG-2-LUC2).
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Homozygous; Note=By CRISPR/Cas9 (ATCC=CRL-1619IG-2-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1619IG-2-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JF22 ! A-375 NRAS p.Q61K
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 15
//
ID   A-375-Luc
AC   CVCL_C8WV
DR   Ubigene; YC-C036-Luc-P
DR   Wikidata; Q123030346
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   A-382
AC   CVCL_S186
SY   A382
DR   ATCC; CRL-7903
DR   Wikidata; Q54605991
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=77569;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4357758;
RX   PubMed=6935474;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   HLA typing: A*02,10; B*08,14 (PubMed=77569).
CC   Miscellaneous: STR profile from personal communication of Aaronson, Stuart A. & Korch, Christopher T.
CC   Discontinued: ATCC; CRL-7903; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 15
ST   D21S11: 32.2
ST   D2S1338: 20,23
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   A-388
AC   CVCL_1063
SY   A388
DR   CLO; CLO_0001584
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7905
DR   BioSample; SAMN03471118
DR   cancercelllines; CVCL_1063
DR   Cell_Model_Passport; SIDM00794
DR   ChEMBL-Cells; CHEMBL3308159
DR   ChEMBL-Targets; CHEMBL2366355
DR   Cosmic; 688037
DR   Cosmic; 910697
DR   Cosmic; 1995333
DR   Cosmic-CLP; 910697
DR   DepMap; ACH-001442
DR   EGA; EGAS00001000978
DR   GDSC; 910697
DR   GEO; GSM1669583
DR   IARC_TP53; 21164
DR   LINCS_LDP; LCL-1342
DR   PharmacoDB; A388_43_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1063
DR   Wikidata; Q54606033
RX   PubMed=327080;
RX   PubMed=375235;
RX   PubMed=833871;
RX   PubMed=1255758;
RX   PubMed=1358434;
RX   PubMed=3518877;
RX   PubMed=4357758;
RX   PubMed=6173755;
RX   PubMed=6256643;
RX   PubMed=6954533;
RX   PubMed=20164919;
RX   PubMed=22282976;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-and-growth-of-a388-crl-7905
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg832Cys (c.2494C>T); ClinVar=VCV000936373; Zygosity=Heterozygous (ATCC=CRL-7905; DepMap=ACH-001442).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (ATCC=CRL-7905; DepMap=ACH-001442).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (ATCC=CRL-7905; Cosmic-CLP=910697; DepMap=ACH-001442).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.06%; Native American=0.32%; East Asian, North=3.84%; East Asian, South=0%; South Asian=0%; European, North=50.76%; European, South=41.03% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-7905; Cosmic-CLP=910697; DepMap=ACH-001442
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 12,15
ST   D21S11: 28,30
ST   D2S1338: 18,25
ST   D3S1358: 13
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 7,10
ST   Penta E: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 40
//
ID   A-427
AC   CVCL_1055
SY   A427; A427N
DR   BTO; BTO_0003770
DR   CLO; CLO_0001590
DR   EFO; EFO_0002104
DR   CLDB; cl152
DR   CLDB; cl153
DR   CLDB; cl5024
DR   AddexBio; C0016004/21
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7906
DR   ATCC; HTB-53
DR   BioSample; SAMN01821535
DR   BioSample; SAMN01821613
DR   BioSample; SAMN03471087
DR   BioSample; SAMN10989597
DR   cancercelllines; CVCL_1055
DR   Cell_Model_Passport; SIDM00810
DR   ChEMBL-Cells; CHEMBL3307775
DR   ChEMBL-Targets; CHEMBL614515
DR   CLS; 300111
DR   Cosmic; 724857
DR   Cosmic; 735606
DR   Cosmic; 801570
DR   Cosmic; 844825
DR   Cosmic; 876134
DR   Cosmic; 910851
DR   Cosmic; 917971
DR   Cosmic; 929961
DR   Cosmic; 932914
DR   Cosmic; 933581
DR   Cosmic; 961832
DR   Cosmic; 1006531
DR   Cosmic; 1146870
DR   Cosmic; 1218868
DR   Cosmic; 1239866
DR   Cosmic; 2042862
DR   Cosmic; 2125175
DR   Cosmic; 2668263
DR   Cosmic; 2668303
DR   Cosmic-CLP; 910851
DR   DepMap; ACH-000757
DR   DSMZ; ACC-234
DR   DSMZCellDive; ACC-234
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910851
DR   GEO; GSM206444
DR   GEO; GSM274755
DR   GEO; GSM274756
DR   GEO; GSM353235
DR   GEO; GSM434323
DR   GEO; GSM784204
DR   GEO; GSM827284
DR   GEO; GSM1374383
DR   GEO; GSM1526628
DR   GEO; GSM1526629
DR   GEO; GSM1669585
DR   IARC_TP53; 21166
DR   IGRhCellID; A427
DR   IZSLER; BS TCL 120
DR   KCLB; 30053
DR   LINCS_LDP; LCL-1600
DR   PharmacoDB; A427_45_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1055
DR   PubChem_Cell_line; CVCL_1055
DR   Wikidata; Q54606034
RX   DOI=10.2307/1308677;
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1855224;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=3940644;
RX   PubMed=3945555;
RX   PubMed=4357758;
RX   PubMed=6256643;
RX   PubMed=6401685;
RX   PubMed=6500159;
RX   PubMed=6825208;
RX   PubMed=6935474;
RX   PubMed=7144906;
RX   PubMed=7459858;
RX   PubMed=10536175;
RX   PubMed=10908148;
RX   PubMed=11005564;
RX   PubMed=19153074;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22282976;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 28 hours (Note=In RPMI 1640 + 10% FBS), 38 hours (Note=In ACL-3), 42 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 36.6 hours (PubMed=29681454); ~60-70 hours (DSMZ=ACC-234).
CC   HLA typing: A*03,10; B*w35; C*w04 (PubMed=77569).
CC   HLA typing: A*03:01,03:01; B*35:03,35:03; C*12:03,12:03; DQA1*01:02,01:02; DQB1*06:08,06:08; DRB1*11:02,11:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (ATCC=HTB-53; DepMap=ACH-000757).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=1855224; PubMed=3945555; ATCC=HTB-53; Cosmic-CLP=910851; DepMap=ACH-000757).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.4%; East Asian, North=1.31%; East Asian, South=0.28%; South Asian=1.59%; European, North=71.98%; European, South=24.43% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7906; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016004/21; ATCC=HTB-53; CLS=300111; Cosmic-CLP=910851; DSMZ=ACC-234; IZSLER=BS TCL 120; KCLB=30053; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,15
ST   D12S391: 18,20
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12
ST   D19S433: 13,14
ST   D1S1656: 13,15
ST   D21S11: 31.2
ST   D22S1045: 16,17
ST   D2S1338: 17
ST   D2S441: 10
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   DYS391: 11
ST   FGA: 18
ST   Penta D: 13
ST   Penta E: 15,17
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX72 ! A-427F
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   A-427F
AC   CVCL_ZX72
SY   A427F
DR   Wikidata; Q102113490
RX   DOI=10.2307/1308677;
RX   PubMed=6256643;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1055 ! A-427
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   A-431
AC   CVCL_0037
SY   A431; A431/P
DR   BTO; BTO_0000017
DR   CLO; CLO_0001591
DR   CLO; CLO_0001592
DR   CLO; CLO_0050011
DR   CLO; CLO_0050012
DR   EFO; EFO_0006268
DR   MCCL; MCC:0000025
DR   CLDB; cl155
DR   CLDB; cl156
DR   CLDB; cl157
DR   CLDB; cl159
DR   CLDB; cl160
DR   CLDB; cl161
DR   Abcam; ab263975
DR   Abcam; ab275462
DR   AddexBio; C0012001/22
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1555
DR   ATCC; CRL-7907
DR   BCRC; 60161
DR   BCRJ; 0032
DR   BioGRID_ORCS_Cell_line; 1572
DR   BioSample; SAMN01821614
DR   BioSample; SAMN01821671
DR   BioSample; SAMN01821724
DR   BioSample; SAMN03472220
DR   cancercelllines; CVCL_0037
DR   CCRID; 1101HUM-PUMC000092
DR   CCRID; 3101HUMSCSP5042
DR   CCRID; 3101HUMTCHu188
DR   CCRID; 4201HUM-CCTCC00084
DR   CCTCC; GDC0084
DR   Cell_Model_Passport; SIDM00995
DR   ChEMBL-Cells; CHEMBL3307523
DR   ChEMBL-Targets; CHEMBL614069
DR   CLS; 300112
DR   Cosmic; 688038
DR   Cosmic; 735609
DR   Cosmic; 755305
DR   Cosmic; 876559
DR   Cosmic; 897743
DR   Cosmic; 910564
DR   Cosmic; 910925
DR   Cosmic; 974317
DR   Cosmic; 1071898
DR   Cosmic; 1176624
DR   Cosmic; 1351516
DR   Cosmic; 1477434
DR   Cosmic; 1945879
DR   Cosmic; 1995334
DR   Cosmic; 2131571
DR   Cosmic; 2301592
DR   Cosmic; 2646654
DR   Cosmic-CLP; 910925
DR   DepMap; ACH-001328
DR   DSMZ; ACC-91
DR   DSMZCellDive; ACC-91
DR   ECACC; 85090402
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10426-106D3
DR   GDSC; 910925
DR   GEO; GSM183432
DR   GEO; GSM183433
DR   GEO; GSM270524
DR   GEO; GSM270525
DR   GEO; GSM270526
DR   GEO; GSM827302
DR   GEO; GSM1374384
DR   GEO; GSM1669586
DR   GEO; GSM2112551
DR   GEO; GSM2112555
DR   GEO; GSM7701410
DR   GEO; GSM7701411
DR   IARC_TP53; 21167
DR   IARC_TP53; 23618
DR   IZSLER; BS TCL 161
DR   JCRB; IFO50411
DR   JCRB; JCRB0004
DR   JCRB; JCRB9009
DR   KCB; KCB 200651YJ
DR   KCLB; 21555
DR   KCLB; 80005
DR   LINCS_LDP; LCL-1404
DR   Lonza; 814
DR   NCBI_Iran; C204
DR   PharmacoDB; A431_46_2019
DR   PRIDE; PXD000065
DR   PRIDE; PXD000589
DR   PRIDE; PXD000681
DR   PRIDE; PXD001582
DR   PRIDE; PXD003937
DR   PRIDE; PXD005301
DR   PRIDE; PXD006291
DR   PRIDE; PXD007206
DR   PRIDE; PXD008996
DR   PRIDE; PXD017536
DR   PRIDE; PXD030304
DR   PRIDE; PXD030984
DR   PRIDE; PXD033685
DR   Progenetix; CVCL_0037
DR   PubChem_Cell_line; CVCL_0037
DR   RCB; RCB0202
DR   RCB; RCB1872
DR   TKG; TKG 0182
DR   TOKU-E; 476
DR   Ubigene; YC-D016
DR   Wikidata; Q4649310
RX   PubMed=212188;
RX   PubMed=1394225;
RX   PubMed=2228902;
RX   PubMed=2758419;
RX   PubMed=2990217;
RX   PubMed=4357758;
RX   PubMed=6092175;
RX   PubMed=6173755;
RX   PubMed=6254071;
RX   PubMed=6500159;
RX   PubMed=6954533;
RX   PubMed=6983291;
RX   PubMed=9290701;
RX   PubMed=9887230;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=16957166;
RX   PubMed=17124637;
RX   PubMed=17178626;
RX   PubMed=18568074;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22108792;
RX   PubMed=22282976;
RX   PubMed=23637631;
RX   PubMed=24804581;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26989177;
RX   PubMed=27397505;
RX   PubMed=28176443;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/a431/a431cells.html
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A431
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-78.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/A431_cells
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/a431-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: ~80-100 hours (DSMZ=ACC-91).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02; DRB1*11:04,12:01 (PubMed=26589293).
CC   Karyotypic information: Hypertriploid karyotype (ATCC=CRL-1555).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=1394225).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.82%; Native American=0%; East Asian, North=7.84%; East Asian, South=0%; South Asian=6.03%; European, North=17.15%; European, South=65.16% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7907; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
ST   Source(s): AddexBio=C0012001/22; ATCC=CRL-1555; CCRID; CLS=300112; Cosmic-CLP=910925; DepMap=ACH-001328; DSMZ=ACC-91; IZSLER=BS TCL 161; JCRB=IFO50411; JCRB=JCRB0004; KCLB=21555; KCLB=80005; PubMed=11416159; PubMed=25877200; RCB=RCB0202; RCB=RCB1872; Technion Genomics Center; TKG=TKG 0182
ST   Amelogenin: X (ATCC=CRL-1555; CCRID; CLS=300112; Cosmic-CLP=910925; DepMap=ACH-001328; DSMZ=ACC-91; IZSLER=BS TCL 161; JCRB=IFO50411; JCRB=JCRB0004; KCLB=21555; PubMed=11416159; PubMed=25877200; RCB=RCB0202; RCB=RCB1872; Technion Genomics Center; TKG=TKG 0182)
ST   Amelogenin: X,Y (AddexBio=C0012001/22)
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 18,23
ST   D13S317: 9,13
ST   D16S539: 12,14
ST   D18S51: 13,17
ST   D19S433: 15,15.2 (ATCC=CRL-1555; CCRID; Technion Genomics Center)
ST   D19S433: 15,16 (DSMZ=ACC-91)
ST   D1S1656: 16,17
ST   D21S11: 28 (ATCC=CRL-1555; CCRID; DepMap=ACH-001328; IZSLER=BS TCL 161; PubMed=25877200; Technion Genomics Center)
ST   D21S11: 28,30 (CLS=300112; DSMZ=ACC-91; PubMed=11416159)
ST   D22S1045: 15,16
ST   D2S1338: 17,20
ST   D2S441: 11.3,15
ST   D3S1358: 14 (ATCC=CRL-1555; CLS=300112; DepMap=ACH-001328; DSMZ=ACC-91; KCLB=21555; KCLB=80005; PubMed=25877200; Technion Genomics Center)
ST   D3S1358: 14,20 (CCRID)
ST   D5S818: 11,13 (AddexBio=C0012001/22)
ST   D5S818: 12,13 (ATCC=CRL-1555; CCRID; CLS=300112; Cosmic-CLP=910925; DepMap=ACH-001328; DSMZ=ACC-91; IZSLER=BS TCL 161; JCRB=IFO50411; JCRB=JCRB0004; KCLB=21555; KCLB=80005; PubMed=25877200; RCB=RCB0202; RCB=RCB1872; Technion Genomics Center; TKG=TKG 0182)
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 9,11 (CLS=300112; DSMZ=ACC-91)
ST   Penta D: 11 (ATCC=CRL-1555; DepMap=ACH-001328; PubMed=25877200; Technion Genomics Center)
ST   Penta E: 12,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 53
//
ID   A-431-Luc
AC   CVCL_C8WW
DR   Ubigene; YC-D016-Luc-P
DR   Wikidata; Q123030347
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   A-431-Luc2
AC   CVCL_A4BS
DR   ATCC; CRL-1555-LUC2
DR   cancercelllines; CVCL_A4BS
DR   Wikidata; Q105506024
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1555-LUC2).
CC   Doubling time: ~22 hours (ATCC=CRL-1555-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
ST   Source(s): ATCC=CRL-1555-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 12,14
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   A-431-SF
AC   CVCL_C8Z1
DR   Wikidata; Q123030348
RX   PubMed=6983291;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   A-498
AC   CVCL_1056
SY   A498
DR   BTO; BTO_0003769
DR   CLO; CLO_0001596
DR   CLO; CLO_0009974
DR   EFO; EFO_0002105
DR   CLDB; cl163
DR   CLDB; cl164
DR   CLDB; cl5025
DR   CLDB; cl7160
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7908
DR   ATCC; HTB-44
DR   BCRC; 60241
DR   BioSample; SAMN03471119
DR   BioSample; SAMN03472919
DR   BioSample; SAMN03473534
DR   BioSample; SAMN10987879
DR   cancercelllines; CVCL_1056
DR   CCRID; 1101HUM-PUMC000171
DR   Cell_Model_Passport; SIDM00124
DR   ChEMBL-Cells; CHEMBL3308425
DR   ChEMBL-Targets; CHEMBL614516
DR   CLS; 300113
DR   Cosmic; 687937
DR   Cosmic; 735612
DR   Cosmic; 845930
DR   Cosmic; 849378
DR   Cosmic; 874610
DR   Cosmic; 877453
DR   Cosmic; 905948
DR   Cosmic; 972874
DR   Cosmic; 972928
DR   Cosmic; 974301
DR   Cosmic; 982277
DR   Cosmic; 1092590
DR   Cosmic; 1152531
DR   Cosmic; 1175849
DR   Cosmic; 1305373
DR   Cosmic; 1312361
DR   Cosmic; 1995335
DR   Cosmic; 1998432
DR   Cosmic; 2520636
DR   Cosmic; 2653897
DR   Cosmic; 2663797
DR   Cosmic-CLP; 905948
DR   DepMap; ACH-000555
DR   DSMZ; ACC-55
DR   DSMZCellDive; ACC-55
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905948
DR   GEO; GSM2132
DR   GEO; GSM50227
DR   GEO; GSM50291
DR   GEO; GSM743481
DR   GEO; GSM750836
DR   GEO; GSM799372
DR   GEO; GSM799435
DR   GEO; GSM843438
DR   GEO; GSM846284
DR   GEO; GSM886856
DR   GEO; GSM887921
DR   GEO; GSM1153445
DR   GEO; GSM1181297
DR   GEO; GSM1181323
DR   GEO; GSM1669587
DR   GEO; GSM2124636
DR   IARC_TP53; 21036
DR   ICLC; HTL04005
DR   IGRhCellID; A498
DR   IZSLER; BS TCL 111
DR   KCLB; 30044
DR   LiGeA; CCLE_161
DR   LINCS_LDP; LCL-1761
DR   Lonza; 1198
DR   NCI-DTP; A498
DR   PharmacoDB; A498_47_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1056
DR   PubChem_Cell_line; CVCL_1056
DR   SKY/M-FISH/CGH; 2783
DR   TOKU-E; 478
DR   Wikidata; Q54606041
RX   PubMed=327080;
RX   PubMed=375235;
RX   PubMed=450131;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=4357758;
RX   PubMed=6173755;
RX   PubMed=6244232;
RX   PubMed=6401685;
RX   PubMed=6825208;
RX   PubMed=6935474;
RX   PubMed=6954533;
RX   PubMed=7459858;
RX   PubMed=7915601;
RX   PubMed=8493574;
RX   PubMed=9331090;
RX   PubMed=9488600;
RX   PubMed=10700174;
RX   PubMed=10723130;
RX   PubMed=10929426;
RX   PubMed=11146448;
RX   PubMed=15585611;
RX   PubMed=15604581;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17409424;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22282976;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22949125;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26759240;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=27993170;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=37
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-361.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/a498-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 33 hours (PubMed=9488600); 58.4 hours (PubMed=22628656); ~62 hours (CLS=300113); ~60 hours (DSMZ=ACC-55); 66.8 hours (NCI-DTP=A498).
CC   HLA typing: A*02; B*08; C*07 (PubMed=15585611).
CC   HLA typing: A*02:01:01; B*08:01; C*07; DPB1*01:01:01; DQB1*02:01; DRB1*03:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,02:01; B*08:01,08:01; C*07:01,07:01; DQB1*02:02,06:07 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Asp1067Val (c.3200A>T); Zygosity=Heterozygous (PubMed=26759240; Cosmic-CLP=905948; DepMap=ACH-000555).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Val142fs*30 (c.425_429delTTGAC); Zygosity=Unspecified (PubMed=8493574).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly144Serfs*14 (c.426_429delTGAC); Zygosity=Homozygous (PubMed=17088437).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=2.1%; East Asian, South=0%; South Asian=0%; European, North=63.47%; European, South=34.06% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7908; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=HTB-44; CCRID=1101HUM-PUMC000171; CLS=300113; Cosmic-CLP=905948; DSMZ=ACC-55; KCLB=30044; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 12
ST   D21S11: 28,32
ST   D2S1338: 26
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,11 (ATCC=HTB-44; CCRID=1101HUM-PUMC000171; Cosmic-CLP=905948; DSMZ=ACC-55; KCLB=30044; PubMed=19372543; PubMed=25877200)
ST   D7S820: 11,12 (CLS=300113)
ST   D8S1179: 13,15
ST   FGA: 18,20
ST   Penta D: 9,14
ST   Penta E: 10,14
ST   TH01: 6,9.3
ST   TPOX: 8 (PubMed=25877200)
ST   TPOX: 8,11 (ATCC=HTB-44; CCRID=1101HUM-PUMC000171; CLS=300113; Cosmic-CLP=905948; DSMZ=ACC-55; KCLB=30044; PubMed=19372543)
ST   vWA: 16,18 (DSMZ=ACC-55)
ST   vWA: 18 (ATCC=HTB-44; CCRID=1101HUM-PUMC000171; CLS=300113; Cosmic-CLP=905948; KCLB=30044; PubMed=19372543; PubMed=25877200)
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   A-498-Luc
AC   CVCL_J241
SY   A498-Luc
DR   JCRB; JCRB1388
DR   JCRB; NIHS0652
DR   Wikidata; Q54606042
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Asp1067Val (c.3200A>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly144Serfs*14 (c.426_429delTGAC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0652; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1388
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1056 ! A-498
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   A-4A7
AC   CVCL_B6KX
DR   Wikidata; Q111732843
RX   Patent=RU2360966;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 722D.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09466; Human PAEP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   A-549
AC   CVCL_0023
AS   CVCL_H249
SY   A 549; A549; NCI-A549; A549/ATCC; A549 ATCC; A549ATCC; hA549
DR   BTO; BTO_0000018
DR   CLO; CLO_0001601
DR   CLO; CLO_0050025
DR   EFO; EFO_0001086
DR   CLDB; cl202
DR   CLDB; cl203
DR   CLDB; cl204
DR   CLDB; cl205
DR   CLDB; cl206
DR   CLDB; cl207
DR   CLDB; cl5100
DR   CLDB; cl7131
DR   4DN; 4DNSRFLY6T15
DR   Abcam; ab255450
DR   Abcam; ab259777
DR   Abcam; ab275463
DR   Abcam; ab288558
DR   AddexBio; C0016002/23
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-185
DR   ATCC; CRL-7909
DR   ATCC; CRM-CCL-185
DR   BCRC; 60074
DR   BCRJ; 0033
DR   BEI_Resources; NR-52268
DR   BioGRID_ORCS_Cell_line; 328
DR   BioSample; SAMN01821615
DR   BioSample; SAMN03472926
DR   BioSample; SAMN10988257
DR   cancercelllines; CVCL_0023
DR   CCLV; CCLV-RIE 1035
DR   CCRID; 1101HUM-PUMC000002
DR   CCRID; 1102HUM-NIFDC00008
DR   CCRID; 3101HUMSCSP503
DR   CCRID; 3101HUMTCHu150
DR   CCRID; 4201HUM-CCTCC00063
DR   CCRID; 5301HUM-KCB04034YJ
DR   CCTCC; GDC0063
DR   Cell_Model_Passport; SIDM00903
DR   CGH-DB; 202-1
DR   CGH-DB; 9164-4
DR   ChEMBL-Cells; CHEMBL3307651
DR   ChEMBL-Targets; CHEMBL392
DR   CLS; 300114
DR   Cosmic; 713864
DR   Cosmic; 716170
DR   Cosmic; 719675
DR   Cosmic; 735605
DR   Cosmic; 755468
DR   Cosmic; 801571
DR   Cosmic; 844592
DR   Cosmic; 844826
DR   Cosmic; 875854
DR   Cosmic; 876152
DR   Cosmic; 877443
DR   Cosmic; 889090
DR   Cosmic; 905949
DR   Cosmic; 910552
DR   Cosmic; 910560
DR   Cosmic; 914947
DR   Cosmic; 917386
DR   Cosmic; 917972
DR   Cosmic; 929148
DR   Cosmic; 929962
DR   Cosmic; 932915
DR   Cosmic; 961833
DR   Cosmic; 974287
DR   Cosmic; 1004698
DR   Cosmic; 1017830
DR   Cosmic; 1028950
DR   Cosmic; 1047097
DR   Cosmic; 1089216
DR   Cosmic; 1092591
DR   Cosmic; 1146871
DR   Cosmic; 1152518
DR   Cosmic; 1154597
DR   Cosmic; 1188587
DR   Cosmic; 1219057
DR   Cosmic; 1239867
DR   Cosmic; 1305342
DR   Cosmic; 1312328
DR   Cosmic; 1352406
DR   Cosmic; 1434961
DR   Cosmic; 1436014
DR   Cosmic; 1466799
DR   Cosmic; 1571729
DR   Cosmic; 1600605
DR   Cosmic; 1608839
DR   Cosmic; 1656896
DR   Cosmic; 1802312
DR   Cosmic; 1870260
DR   Cosmic; 1945870
DR   Cosmic; 1995337
DR   Cosmic; 1998433
DR   Cosmic; 2036687
DR   Cosmic; 2042861
DR   Cosmic; 2058649
DR   Cosmic; 2125176
DR   Cosmic; 2301571
DR   Cosmic; 2433750
DR   Cosmic; 2560224
DR   Cosmic; 2630410
DR   Cosmic; 2647635
DR   Cosmic; 2664115
DR   Cosmic; 2668269
DR   Cosmic; 2668304
DR   Cosmic; 2749159
DR   Cosmic; 2756374
DR   Cosmic; 2772163
DR   Cosmic-CLP; 905949
DR   DepMap; ACH-000681
DR   DSMZ; ACC-107
DR   DSMZCellDive; ACC-107
DR   ECACC; 86012804
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS000CWG
DR   ENCODE; ENCBS002UWD
DR   ENCODE; ENCBS003GAH
DR   ENCODE; ENCBS004IAZ
DR   ENCODE; ENCBS004LAJ
DR   ENCODE; ENCBS004PAW
DR   ENCODE; ENCBS004RKE
DR   ENCODE; ENCBS004XDE
DR   ENCODE; ENCBS005TRZ
DR   ENCODE; ENCBS006JGY
DR   ENCODE; ENCBS006KFZ
DR   ENCODE; ENCBS006TYD
DR   ENCODE; ENCBS007LES
DR   ENCODE; ENCBS009FYJ
DR   ENCODE; ENCBS009OIC
DR   ENCODE; ENCBS009OYK
DR   ENCODE; ENCBS010CCH
DR   ENCODE; ENCBS011GKY
DR   ENCODE; ENCBS012BFT
DR   ENCODE; ENCBS012TTG
DR   ENCODE; ENCBS013GXJ
DR   ENCODE; ENCBS013HGJ
DR   ENCODE; ENCBS013HOT
DR   ENCODE; ENCBS015HRP
DR   ENCODE; ENCBS016CUF
DR   ENCODE; ENCBS016ESU
DR   ENCODE; ENCBS016VTZ
DR   ENCODE; ENCBS017CJM
DR   ENCODE; ENCBS018TOF
DR   ENCODE; ENCBS021JVU
DR   ENCODE; ENCBS022OPA
DR   ENCODE; ENCBS023FRY
DR   ENCODE; ENCBS024QOG
DR   ENCODE; ENCBS025UWS
DR   ENCODE; ENCBS026DZZ
DR   ENCODE; ENCBS027OSU
DR   ENCODE; ENCBS029TTL
DR   ENCODE; ENCBS032DUJ
DR   ENCODE; ENCBS032EMA
DR   ENCODE; ENCBS032WTC
DR   ENCODE; ENCBS033HGM
DR   ENCODE; ENCBS034OEE
DR   ENCODE; ENCBS036LKM
DR   ENCODE; ENCBS041KVF
DR   ENCODE; ENCBS043VXT
DR   ENCODE; ENCBS044GJG
DR   ENCODE; ENCBS044YWQ
DR   ENCODE; ENCBS047ROF
DR   ENCODE; ENCBS049TTA
DR   ENCODE; ENCBS051YPR
DR   ENCODE; ENCBS054AGF
DR   ENCODE; ENCBS056ESU
DR   ENCODE; ENCBS057UPO
DR   ENCODE; ENCBS058HUF
DR   ENCODE; ENCBS058QGC
DR   ENCODE; ENCBS059GTH
DR   ENCODE; ENCBS059RHT
DR   ENCODE; ENCBS060XOR
DR   ENCODE; ENCBS061GHE
DR   ENCODE; ENCBS061UZO
DR   ENCODE; ENCBS062PME
DR   ENCODE; ENCBS063ZVJ
DR   ENCODE; ENCBS066ACG
DR   ENCODE; ENCBS069CLB
DR   ENCODE; ENCBS070TPK
DR   ENCODE; ENCBS071SOD
DR   ENCODE; ENCBS072GEK
DR   ENCODE; ENCBS075ZKJ
DR   ENCODE; ENCBS076MNA
DR   ENCODE; ENCBS076NFI
DR   ENCODE; ENCBS077ELW
DR   ENCODE; ENCBS079SJM
DR   ENCODE; ENCBS081GHS
DR   ENCODE; ENCBS083RUN
DR   ENCODE; ENCBS083TEY
DR   ENCODE; ENCBS083ZIM
DR   ENCODE; ENCBS086UGG
DR   ENCODE; ENCBS087LLT
DR   ENCODE; ENCBS087YWG
DR   ENCODE; ENCBS089RUP
DR   ENCODE; ENCBS090AZM
DR   ENCODE; ENCBS090WQR
DR   ENCODE; ENCBS091RAT
DR   ENCODE; ENCBS091SYA
DR   ENCODE; ENCBS092WKJ
DR   ENCODE; ENCBS093FKM
DR   ENCODE; ENCBS094BQG
DR   ENCODE; ENCBS094XGP
DR   ENCODE; ENCBS095SEF
DR   ENCODE; ENCBS096ODB
DR   ENCODE; ENCBS097WCE
DR   ENCODE; ENCBS097ZMG
DR   ENCODE; ENCBS098XEU
DR   ENCODE; ENCBS099QUK
DR   ENCODE; ENCBS100LYC
DR   ENCODE; ENCBS101CXZ
DR   ENCODE; ENCBS101WRY
DR   ENCODE; ENCBS102GDA
DR   ENCODE; ENCBS102TQY
DR   ENCODE; ENCBS106FRF
DR   ENCODE; ENCBS106VMV
DR   ENCODE; ENCBS107TAZ
DR   ENCODE; ENCBS107VVO
DR   ENCODE; ENCBS108SIA
DR   ENCODE; ENCBS108SYG
DR   ENCODE; ENCBS108VDW
DR   ENCODE; ENCBS109SYJ
DR   ENCODE; ENCBS114PSH
DR   ENCODE; ENCBS116MCD
DR   ENCODE; ENCBS116THZ
DR   ENCODE; ENCBS117OOH
DR   ENCODE; ENCBS117POP
DR   ENCODE; ENCBS121DKS
DR   ENCODE; ENCBS121YTQ
DR   ENCODE; ENCBS126WEL
DR   ENCODE; ENCBS127GWZ
DR   ENCODE; ENCBS128BGV
DR   ENCODE; ENCBS128VHT
DR   ENCODE; ENCBS130SLA
DR   ENCODE; ENCBS131VWP
DR   ENCODE; ENCBS132RXT
DR   ENCODE; ENCBS133BUS
DR   ENCODE; ENCBS133IJF
DR   ENCODE; ENCBS133KFY
DR   ENCODE; ENCBS133PHP
DR   ENCODE; ENCBS134FJI
DR   ENCODE; ENCBS136ZVQ
DR   ENCODE; ENCBS137IAE
DR   ENCODE; ENCBS139BXF
DR   ENCODE; ENCBS139WGU
DR   ENCODE; ENCBS141FQJ
DR   ENCODE; ENCBS141HBH
DR   ENCODE; ENCBS142GEF
DR   ENCODE; ENCBS143KAK
DR   ENCODE; ENCBS144NAE
DR   ENCODE; ENCBS144OZN
DR   ENCODE; ENCBS145FXO
DR   ENCODE; ENCBS146CRN
DR   ENCODE; ENCBS146HUP
DR   ENCODE; ENCBS148NZA
DR   ENCODE; ENCBS148XSC
DR   ENCODE; ENCBS149FQX
DR   ENCODE; ENCBS149KNM
DR   ENCODE; ENCBS150LLO
DR   ENCODE; ENCBS151QJK
DR   ENCODE; ENCBS152DKS
DR   ENCODE; ENCBS153BPN
DR   ENCODE; ENCBS153NPL
DR   ENCODE; ENCBS154OIS
DR   ENCODE; ENCBS157WWD
DR   ENCODE; ENCBS157YZR
DR   ENCODE; ENCBS158PRQ
DR   ENCODE; ENCBS159AAA
DR   ENCODE; ENCBS159MAK
DR   ENCODE; ENCBS160AAA
DR   ENCODE; ENCBS160CCZ
DR   ENCODE; ENCBS161AAA
DR   ENCODE; ENCBS161JYI
DR   ENCODE; ENCBS162AAA
DR   ENCODE; ENCBS162TUK
DR   ENCODE; ENCBS163AAA
DR   ENCODE; ENCBS163NSQ
DR   ENCODE; ENCBS164AAA
DR   ENCODE; ENCBS165AAA
DR   ENCODE; ENCBS165TOL
DR   ENCODE; ENCBS166AAA
DR   ENCODE; ENCBS167AAA
DR   ENCODE; ENCBS167GTR
DR   ENCODE; ENCBS168AAA
DR   ENCODE; ENCBS168IFT
DR   ENCODE; ENCBS169AAA
DR   ENCODE; ENCBS170AAA
DR   ENCODE; ENCBS173DBY
DR   ENCODE; ENCBS173GFE
DR   ENCODE; ENCBS174YVF
DR   ENCODE; ENCBS176HWE
DR   ENCODE; ENCBS177BTE
DR   ENCODE; ENCBS177ULF
DR   ENCODE; ENCBS178CIW
DR   ENCODE; ENCBS179DJA
DR   ENCODE; ENCBS179WSX
DR   ENCODE; ENCBS180FQJ
DR   ENCODE; ENCBS180JPF
DR   ENCODE; ENCBS181LQF
DR   ENCODE; ENCBS181LVW
DR   ENCODE; ENCBS182KPQ
DR   ENCODE; ENCBS183GJP
DR   ENCODE; ENCBS185EJU
DR   ENCODE; ENCBS189KLL
DR   ENCODE; ENCBS190JXX
DR   ENCODE; ENCBS191VYO
DR   ENCODE; ENCBS192IRK
DR   ENCODE; ENCBS194BUG
DR   ENCODE; ENCBS194DFG
DR   ENCODE; ENCBS194QRX
DR   ENCODE; ENCBS196MXU
DR   ENCODE; ENCBS198BBA
DR   ENCODE; ENCBS198WYR
DR   ENCODE; ENCBS198XRT
DR   ENCODE; ENCBS202SSL
DR   ENCODE; ENCBS202TJN
DR   ENCODE; ENCBS203TZH
DR   ENCODE; ENCBS204ZVO
DR   ENCODE; ENCBS206NTN
DR   ENCODE; ENCBS207IUA
DR   ENCODE; ENCBS211HEU
DR   ENCODE; ENCBS212WQT
DR   ENCODE; ENCBS213TPT
DR   ENCODE; ENCBS213WGX
DR   ENCODE; ENCBS214HMB
DR   ENCODE; ENCBS216FNP
DR   ENCODE; ENCBS217ZWD
DR   ENCODE; ENCBS218EVW
DR   ENCODE; ENCBS218RFX
DR   ENCODE; ENCBS219THB
DR   ENCODE; ENCBS221ZIM
DR   ENCODE; ENCBS222WNL
DR   ENCODE; ENCBS224IPU
DR   ENCODE; ENCBS229QHJ
DR   ENCODE; ENCBS230KLP
DR   ENCODE; ENCBS231UGF
DR   ENCODE; ENCBS232SYQ
DR   ENCODE; ENCBS235ANB
DR   ENCODE; ENCBS236JDF
DR   ENCODE; ENCBS237FNI
DR   ENCODE; ENCBS237PGF
DR   ENCODE; ENCBS238JNS
DR   ENCODE; ENCBS238VUA
DR   ENCODE; ENCBS238ZNP
DR   ENCODE; ENCBS239RRE
DR   ENCODE; ENCBS241DOQ
DR   ENCODE; ENCBS242RJZ
DR   ENCODE; ENCBS242SAZ
DR   ENCODE; ENCBS245EST
DR   ENCODE; ENCBS246FMQ
DR   ENCODE; ENCBS246IJP
DR   ENCODE; ENCBS253PKE
DR   ENCODE; ENCBS255OGK
DR   ENCODE; ENCBS255WLF
DR   ENCODE; ENCBS257YHA
DR   ENCODE; ENCBS257YLQ
DR   ENCODE; ENCBS258YUU
DR   ENCODE; ENCBS260HPC
DR   ENCODE; ENCBS260OBW
DR   ENCODE; ENCBS261PDK
DR   ENCODE; ENCBS262AII
DR   ENCODE; ENCBS262GBB
DR   ENCODE; ENCBS262OWH
DR   ENCODE; ENCBS263BGQ
DR   ENCODE; ENCBS266TGV
DR   ENCODE; ENCBS266ZMP
DR   ENCODE; ENCBS267EOV
DR   ENCODE; ENCBS267YAE
DR   ENCODE; ENCBS270JQP
DR   ENCODE; ENCBS270TGZ
DR   ENCODE; ENCBS272AFG
DR   ENCODE; ENCBS272CXK
DR   ENCODE; ENCBS273XQH
DR   ENCODE; ENCBS274ZVG
DR   ENCODE; ENCBS276FMI
DR   ENCODE; ENCBS277AMO
DR   ENCODE; ENCBS277NZL
DR   ENCODE; ENCBS278VLL
DR   ENCODE; ENCBS279PFT
DR   ENCODE; ENCBS281AZP
DR   ENCODE; ENCBS282BWY
DR   ENCODE; ENCBS284JUE
DR   ENCODE; ENCBS287FJW
DR   ENCODE; ENCBS287PYF
DR   ENCODE; ENCBS287TJZ
DR   ENCODE; ENCBS290TVV
DR   ENCODE; ENCBS291IYO
DR   ENCODE; ENCBS291TVJ
DR   ENCODE; ENCBS292ELQ
DR   ENCODE; ENCBS293DPI
DR   ENCODE; ENCBS293HYY
DR   ENCODE; ENCBS293IUY
DR   ENCODE; ENCBS296DQU
DR   ENCODE; ENCBS297CID
DR   ENCODE; ENCBS297OJC
DR   ENCODE; ENCBS299XUO
DR   ENCODE; ENCBS301FPL
DR   ENCODE; ENCBS301SWX
DR   ENCODE; ENCBS302GLU
DR   ENCODE; ENCBS302MZJ
DR   ENCODE; ENCBS302TDW
DR   ENCODE; ENCBS303AZP
DR   ENCODE; ENCBS304EKC
DR   ENCODE; ENCBS306KID
DR   ENCODE; ENCBS307KAV
DR   ENCODE; ENCBS307SRO
DR   ENCODE; ENCBS308VXK
DR   ENCODE; ENCBS309HYH
DR   ENCODE; ENCBS311CCO
DR   ENCODE; ENCBS311ILN
DR   ENCODE; ENCBS311LQB
DR   ENCODE; ENCBS311NZY
DR   ENCODE; ENCBS312TVA
DR   ENCODE; ENCBS313YTO
DR   ENCODE; ENCBS314UJS
DR   ENCODE; ENCBS316RGG
DR   ENCODE; ENCBS317OMN
DR   ENCODE; ENCBS317RWG
DR   ENCODE; ENCBS317YUF
DR   ENCODE; ENCBS318NXZ
DR   ENCODE; ENCBS321WEQ
DR   ENCODE; ENCBS321YPJ
DR   ENCODE; ENCBS322EKP
DR   ENCODE; ENCBS323CFG
DR   ENCODE; ENCBS326TJA
DR   ENCODE; ENCBS327IUO
DR   ENCODE; ENCBS328YSW
DR   ENCODE; ENCBS329VDX
DR   ENCODE; ENCBS330OQB
DR   ENCODE; ENCBS331QMP
DR   ENCODE; ENCBS331TBM
DR   ENCODE; ENCBS334AKK
DR   ENCODE; ENCBS334UWV
DR   ENCODE; ENCBS335AHR
DR   ENCODE; ENCBS335EZX
DR   ENCODE; ENCBS335SZC
DR   ENCODE; ENCBS336AKR
DR   ENCODE; ENCBS336FCB
DR   ENCODE; ENCBS339MWA
DR   ENCODE; ENCBS340DMX
DR   ENCODE; ENCBS340RXI
DR   ENCODE; ENCBS342HZL
DR   ENCODE; ENCBS343SXZ
DR   ENCODE; ENCBS343YHO
DR   ENCODE; ENCBS349MXJ
DR   ENCODE; ENCBS349YRA
DR   ENCODE; ENCBS353WHL
DR   ENCODE; ENCBS353ZPN
DR   ENCODE; ENCBS355ZGM
DR   ENCODE; ENCBS358PMO
DR   ENCODE; ENCBS359PKV
DR   ENCODE; ENCBS360YMB
DR   ENCODE; ENCBS361ETR
DR   ENCODE; ENCBS362CIG
DR   ENCODE; ENCBS362JCG
DR   ENCODE; ENCBS363RMQ
DR   ENCODE; ENCBS363TVX
DR   ENCODE; ENCBS364GKY
DR   ENCODE; ENCBS366BMB
DR   ENCODE; ENCBS366JKZ
DR   ENCODE; ENCBS366SBH
DR   ENCODE; ENCBS369ESF
DR   ENCODE; ENCBS370PMJ
DR   ENCODE; ENCBS372GEL
DR   ENCODE; ENCBS373POM
DR   ENCODE; ENCBS374ABX
DR   ENCODE; ENCBS374UXY
DR   ENCODE; ENCBS377KRQ
DR   ENCODE; ENCBS379YBF
DR   ENCODE; ENCBS380CAL
DR   ENCODE; ENCBS380JKY
DR   ENCODE; ENCBS381CYW
DR   ENCODE; ENCBS383LCQ
DR   ENCODE; ENCBS384DUN
DR   ENCODE; ENCBS385PXA
DR   ENCODE; ENCBS386HKI
DR   ENCODE; ENCBS388ADX
DR   ENCODE; ENCBS389XCA
DR   ENCODE; ENCBS392TVW
DR   ENCODE; ENCBS393EBF
DR   ENCODE; ENCBS393PAL
DR   ENCODE; ENCBS395TGI
DR   ENCODE; ENCBS396JKU
DR   ENCODE; ENCBS397CMU
DR   ENCODE; ENCBS398XGZ
DR   ENCODE; ENCBS399VKP
DR   ENCODE; ENCBS401GHI
DR   ENCODE; ENCBS401RHC
DR   ENCODE; ENCBS402NSI
DR   ENCODE; ENCBS404OUV
DR   ENCODE; ENCBS404RGH
DR   ENCODE; ENCBS405EQX
DR   ENCODE; ENCBS405WSN
DR   ENCODE; ENCBS405XWH
DR   ENCODE; ENCBS407BKP
DR   ENCODE; ENCBS407XHO
DR   ENCODE; ENCBS410NHM
DR   ENCODE; ENCBS412ZNQ
DR   ENCODE; ENCBS417GDL
DR   ENCODE; ENCBS417IIV
DR   ENCODE; ENCBS418DNO
DR   ENCODE; ENCBS419HCP
DR   ENCODE; ENCBS419LEN
DR   ENCODE; ENCBS419TTO
DR   ENCODE; ENCBS420GJD
DR   ENCODE; ENCBS420ZHM
DR   ENCODE; ENCBS422ZAB
DR   ENCODE; ENCBS423AHV
DR   ENCODE; ENCBS423ENC
DR   ENCODE; ENCBS423SRU
DR   ENCODE; ENCBS424FNE
DR   ENCODE; ENCBS424IHJ
DR   ENCODE; ENCBS426JGZ
DR   ENCODE; ENCBS427FJS
DR   ENCODE; ENCBS430EPP
DR   ENCODE; ENCBS431BEM
DR   ENCODE; ENCBS431FWG
DR   ENCODE; ENCBS431KOR
DR   ENCODE; ENCBS432NMW
DR   ENCODE; ENCBS434SIS
DR   ENCODE; ENCBS434XNK
DR   ENCODE; ENCBS435CFB
DR   ENCODE; ENCBS435PZT
DR   ENCODE; ENCBS438XGI
DR   ENCODE; ENCBS439IVX
DR   ENCODE; ENCBS440AKK
DR   ENCODE; ENCBS441YHT
DR   ENCODE; ENCBS442FTF
DR   ENCODE; ENCBS443EUC
DR   ENCODE; ENCBS443PXM
DR   ENCODE; ENCBS444ENC
DR   ENCODE; ENCBS444MVA
DR   ENCODE; ENCBS445ENC
DR   ENCODE; ENCBS445QON
DR   ENCODE; ENCBS446ENC
DR   ENCODE; ENCBS447ENC
DR   ENCODE; ENCBS447LYH
DR   ENCODE; ENCBS448ENC
DR   ENCODE; ENCBS449ENC
DR   ENCODE; ENCBS450ENC
DR   ENCODE; ENCBS451ENC
DR   ENCODE; ENCBS452TOO
DR   ENCODE; ENCBS452UTE
DR   ENCODE; ENCBS453DQV
DR   ENCODE; ENCBS455PIS
DR   ENCODE; ENCBS460QXP
DR   ENCODE; ENCBS461AUZ
DR   ENCODE; ENCBS461GBL
DR   ENCODE; ENCBS461IGF
DR   ENCODE; ENCBS461XLE
DR   ENCODE; ENCBS462FXS
DR   ENCODE; ENCBS462SQL
DR   ENCODE; ENCBS465DXD
DR   ENCODE; ENCBS465PUD
DR   ENCODE; ENCBS466BWX
DR   ENCODE; ENCBS467NGP
DR   ENCODE; ENCBS468TPT
DR   ENCODE; ENCBS468UQT
DR   ENCODE; ENCBS471LLC
DR   ENCODE; ENCBS471WAI
DR   ENCODE; ENCBS472FTV
DR   ENCODE; ENCBS472MKE
DR   ENCODE; ENCBS473OMG
DR   ENCODE; ENCBS473QAB
DR   ENCODE; ENCBS475OAC
DR   ENCODE; ENCBS475UJY
DR   ENCODE; ENCBS477BQZ
DR   ENCODE; ENCBS477GCU
DR   ENCODE; ENCBS478CQR
DR   ENCODE; ENCBS478IHD
DR   ENCODE; ENCBS478XMC
DR   ENCODE; ENCBS479HSK
DR   ENCODE; ENCBS479IGH
DR   ENCODE; ENCBS484NJJ
DR   ENCODE; ENCBS485DRF
DR   ENCODE; ENCBS485UNU
DR   ENCODE; ENCBS487FRL
DR   ENCODE; ENCBS488EBW
DR   ENCODE; ENCBS488JXY
DR   ENCODE; ENCBS488ZDO
DR   ENCODE; ENCBS490HND
DR   ENCODE; ENCBS490YBT
DR   ENCODE; ENCBS491KZL
DR   ENCODE; ENCBS492GFZ
DR   ENCODE; ENCBS492NSR
DR   ENCODE; ENCBS493WOG
DR   ENCODE; ENCBS496OVY
DR   ENCODE; ENCBS497NSM
DR   ENCODE; ENCBS498NRD
DR   ENCODE; ENCBS502YOK
DR   ENCODE; ENCBS503NHT
DR   ENCODE; ENCBS503WAV
DR   ENCODE; ENCBS504CVA
DR   ENCODE; ENCBS505GEX
DR   ENCODE; ENCBS505STB
DR   ENCODE; ENCBS506AEB
DR   ENCODE; ENCBS506NAT
DR   ENCODE; ENCBS507ILZ
DR   ENCODE; ENCBS507SWE
DR   ENCODE; ENCBS508IUN
DR   ENCODE; ENCBS508LJT
DR   ENCODE; ENCBS509FZP
DR   ENCODE; ENCBS509STK
DR   ENCODE; ENCBS509SVT
DR   ENCODE; ENCBS509USH
DR   ENCODE; ENCBS509YOS
DR   ENCODE; ENCBS513CFP
DR   ENCODE; ENCBS514LZY
DR   ENCODE; ENCBS514NHD
DR   ENCODE; ENCBS514OCX
DR   ENCODE; ENCBS515PAZ
DR   ENCODE; ENCBS515ZMK
DR   ENCODE; ENCBS516WZJ
DR   ENCODE; ENCBS518HSM
DR   ENCODE; ENCBS518WHI
DR   ENCODE; ENCBS520AXC
DR   ENCODE; ENCBS521RDU
DR   ENCODE; ENCBS522XYT
DR   ENCODE; ENCBS522ZOC
DR   ENCODE; ENCBS525GZL
DR   ENCODE; ENCBS527MAH
DR   ENCODE; ENCBS528HKR
DR   ENCODE; ENCBS531GNJ
DR   ENCODE; ENCBS533VQN
DR   ENCODE; ENCBS533ZLP
DR   ENCODE; ENCBS535ZFG
DR   ENCODE; ENCBS536GDK
DR   ENCODE; ENCBS537JEP
DR   ENCODE; ENCBS537WCE
DR   ENCODE; ENCBS538GZG
DR   ENCODE; ENCBS539ECE
DR   ENCODE; ENCBS540LZG
DR   ENCODE; ENCBS542BDV
DR   ENCODE; ENCBS543NSF
DR   ENCODE; ENCBS545DBX
DR   ENCODE; ENCBS547ACC
DR   ENCODE; ENCBS547VCK
DR   ENCODE; ENCBS547WFZ
DR   ENCODE; ENCBS548JCP
DR   ENCODE; ENCBS549TVN
DR   ENCODE; ENCBS551POM
DR   ENCODE; ENCBS552KSE
DR   ENCODE; ENCBS553BBK
DR   ENCODE; ENCBS555HHK
DR   ENCODE; ENCBS555SMT
DR   ENCODE; ENCBS561DRV
DR   ENCODE; ENCBS561RRL
DR   ENCODE; ENCBS562TBY
DR   ENCODE; ENCBS563TDU
DR   ENCODE; ENCBS565NTN
DR   ENCODE; ENCBS565TIR
DR   ENCODE; ENCBS566UAZ
DR   ENCODE; ENCBS568YMR
DR   ENCODE; ENCBS570ODA
DR   ENCODE; ENCBS570PSF
DR   ENCODE; ENCBS570WAL
DR   ENCODE; ENCBS573ZZW
DR   ENCODE; ENCBS574IVR
DR   ENCODE; ENCBS574SHM
DR   ENCODE; ENCBS578DPH
DR   ENCODE; ENCBS579YWF
DR   ENCODE; ENCBS581KGX
DR   ENCODE; ENCBS581PSW
DR   ENCODE; ENCBS582BMI
DR   ENCODE; ENCBS582CLM
DR   ENCODE; ENCBS582VVW
DR   ENCODE; ENCBS583GBH
DR   ENCODE; ENCBS584DBQ
DR   ENCODE; ENCBS585LTD
DR   ENCODE; ENCBS586UFT
DR   ENCODE; ENCBS587DMY
DR   ENCODE; ENCBS588OSJ
DR   ENCODE; ENCBS591HRC
DR   ENCODE; ENCBS593PHP
DR   ENCODE; ENCBS594NFK
DR   ENCODE; ENCBS597DCL
DR   ENCODE; ENCBS597WFL
DR   ENCODE; ENCBS598CCT
DR   ENCODE; ENCBS598OWL
DR   ENCODE; ENCBS599ALV
DR   ENCODE; ENCBS600GFD
DR   ENCODE; ENCBS600VQI
DR   ENCODE; ENCBS600ZKV
DR   ENCODE; ENCBS601MYW
DR   ENCODE; ENCBS601TIS
DR   ENCODE; ENCBS601YNV
DR   ENCODE; ENCBS605JHD
DR   ENCODE; ENCBS606CKR
DR   ENCODE; ENCBS606KBB
DR   ENCODE; ENCBS606UTY
DR   ENCODE; ENCBS608SQG
DR   ENCODE; ENCBS608WXT
DR   ENCODE; ENCBS609BAO
DR   ENCODE; ENCBS610CLZ
DR   ENCODE; ENCBS611BGI
DR   ENCODE; ENCBS611JSC
DR   ENCODE; ENCBS613VBS
DR   ENCODE; ENCBS613WNR
DR   ENCODE; ENCBS615RCL
DR   ENCODE; ENCBS616EUG
DR   ENCODE; ENCBS617TCT
DR   ENCODE; ENCBS620RNZ
DR   ENCODE; ENCBS620RRT
DR   ENCODE; ENCBS620TKD
DR   ENCODE; ENCBS620YUM
DR   ENCODE; ENCBS622VVI
DR   ENCODE; ENCBS624HVD
DR   ENCODE; ENCBS624XBK
DR   ENCODE; ENCBS625OVV
DR   ENCODE; ENCBS626ALW
DR   ENCODE; ENCBS628PAB
DR   ENCODE; ENCBS629ILN
DR   ENCODE; ENCBS630KEQ
DR   ENCODE; ENCBS631PPT
DR   ENCODE; ENCBS633FJA
DR   ENCODE; ENCBS633IMH
DR   ENCODE; ENCBS633XBY
DR   ENCODE; ENCBS634TKN
DR   ENCODE; ENCBS636XOH
DR   ENCODE; ENCBS637CSP
DR   ENCODE; ENCBS637FHG
DR   ENCODE; ENCBS637RXS
DR   ENCODE; ENCBS638FWD
DR   ENCODE; ENCBS638OUQ
DR   ENCODE; ENCBS639YSC
DR   ENCODE; ENCBS640AFN
DR   ENCODE; ENCBS640FKD
DR   ENCODE; ENCBS643KEB
DR   ENCODE; ENCBS643TDG
DR   ENCODE; ENCBS643ZJW
DR   ENCODE; ENCBS644IJZ
DR   ENCODE; ENCBS644OKR
DR   ENCODE; ENCBS645JZI
DR   ENCODE; ENCBS646DYP
DR   ENCODE; ENCBS646TBQ
DR   ENCODE; ENCBS651RKS
DR   ENCODE; ENCBS652AAX
DR   ENCODE; ENCBS652QEI
DR   ENCODE; ENCBS653LWC
DR   ENCODE; ENCBS654LYN
DR   ENCODE; ENCBS656MMP
DR   ENCODE; ENCBS657XCY
DR   ENCODE; ENCBS658RMM
DR   ENCODE; ENCBS659JPG
DR   ENCODE; ENCBS663MZB
DR   ENCODE; ENCBS664ATC
DR   ENCODE; ENCBS664XGI
DR   ENCODE; ENCBS665QBD
DR   ENCODE; ENCBS665VWV
DR   ENCODE; ENCBS670OTD
DR   ENCODE; ENCBS672OLU
DR   ENCODE; ENCBS674TBV
DR   ENCODE; ENCBS675GRD
DR   ENCODE; ENCBS675TOV
DR   ENCODE; ENCBS676DUD
DR   ENCODE; ENCBS678LVM
DR   ENCODE; ENCBS681IDY
DR   ENCODE; ENCBS681JBN
DR   ENCODE; ENCBS681LUH
DR   ENCODE; ENCBS681NJX
DR   ENCODE; ENCBS682PYF
DR   ENCODE; ENCBS684TZE
DR   ENCODE; ENCBS685EHX
DR   ENCODE; ENCBS685FEM
DR   ENCODE; ENCBS685PHX
DR   ENCODE; ENCBS685QBT
DR   ENCODE; ENCBS686TDM
DR   ENCODE; ENCBS686YFS
DR   ENCODE; ENCBS686ZWW
DR   ENCODE; ENCBS687HVT
DR   ENCODE; ENCBS689EJO
DR   ENCODE; ENCBS689NRV
DR   ENCODE; ENCBS691ANI
DR   ENCODE; ENCBS691UVA
DR   ENCODE; ENCBS695NLF
DR   ENCODE; ENCBS700HNY
DR   ENCODE; ENCBS701ZPZ
DR   ENCODE; ENCBS705AWL
DR   ENCODE; ENCBS705DFQ
DR   ENCODE; ENCBS706OMV
DR   ENCODE; ENCBS708WVC
DR   ENCODE; ENCBS710NDE
DR   ENCODE; ENCBS711SCS
DR   ENCODE; ENCBS712HYP
DR   ENCODE; ENCBS712NKI
DR   ENCODE; ENCBS713DBQ
DR   ENCODE; ENCBS714CHO
DR   ENCODE; ENCBS714GDR
DR   ENCODE; ENCBS714IGN
DR   ENCODE; ENCBS715QQC
DR   ENCODE; ENCBS718OED
DR   ENCODE; ENCBS719BFR
DR   ENCODE; ENCBS719FNK
DR   ENCODE; ENCBS720VDH
DR   ENCODE; ENCBS721HGM
DR   ENCODE; ENCBS721JKR
DR   ENCODE; ENCBS722DJI
DR   ENCODE; ENCBS722NAW
DR   ENCODE; ENCBS724CGL
DR   ENCODE; ENCBS724JIH
DR   ENCODE; ENCBS725ZWM
DR   ENCODE; ENCBS726LXJ
DR   ENCODE; ENCBS728DQK
DR   ENCODE; ENCBS729ATM
DR   ENCODE; ENCBS731CWS
DR   ENCODE; ENCBS731OAC
DR   ENCODE; ENCBS734NQI
DR   ENCODE; ENCBS735SFW
DR   ENCODE; ENCBS736RMD
DR   ENCODE; ENCBS736RNG
DR   ENCODE; ENCBS737LUY
DR   ENCODE; ENCBS737MBE
DR   ENCODE; ENCBS739PTK
DR   ENCODE; ENCBS741LOB
DR   ENCODE; ENCBS742QNT
DR   ENCODE; ENCBS743GRW
DR   ENCODE; ENCBS744CZP
DR   ENCODE; ENCBS745PHH
DR   ENCODE; ENCBS745XRX
DR   ENCODE; ENCBS746SZI
DR   ENCODE; ENCBS747KQQ
DR   ENCODE; ENCBS749QGQ
DR   ENCODE; ENCBS751ANS
DR   ENCODE; ENCBS754LRU
DR   ENCODE; ENCBS756PNA
DR   ENCODE; ENCBS756YTM
DR   ENCODE; ENCBS758URS
DR   ENCODE; ENCBS765UHA
DR   ENCODE; ENCBS766MZP
DR   ENCODE; ENCBS766TTZ
DR   ENCODE; ENCBS771LUP
DR   ENCODE; ENCBS772RGZ
DR   ENCODE; ENCBS774BEL
DR   ENCODE; ENCBS774FRJ
DR   ENCODE; ENCBS775XSE
DR   ENCODE; ENCBS776AGG
DR   ENCODE; ENCBS776MHF
DR   ENCODE; ENCBS776TKS
DR   ENCODE; ENCBS777YGA
DR   ENCODE; ENCBS777ZVL
DR   ENCODE; ENCBS778YOH
DR   ENCODE; ENCBS779CAS
DR   ENCODE; ENCBS780PIR
DR   ENCODE; ENCBS780YEC
DR   ENCODE; ENCBS781DZW
DR   ENCODE; ENCBS783DNA
DR   ENCODE; ENCBS784EFT
DR   ENCODE; ENCBS784LUH
DR   ENCODE; ENCBS785DSY
DR   ENCODE; ENCBS787TLC
DR   ENCODE; ENCBS787WXX
DR   ENCODE; ENCBS788QQI
DR   ENCODE; ENCBS788RGJ
DR   ENCODE; ENCBS790ILW
DR   ENCODE; ENCBS790LFN
DR   ENCODE; ENCBS792ASV
DR   ENCODE; ENCBS792THF
DR   ENCODE; ENCBS793IHC
DR   ENCODE; ENCBS793JQQ
DR   ENCODE; ENCBS794GVB
DR   ENCODE; ENCBS794TLJ
DR   ENCODE; ENCBS795HVL
DR   ENCODE; ENCBS797SEZ
DR   ENCODE; ENCBS798DNC
DR   ENCODE; ENCBS802OFY
DR   ENCODE; ENCBS804CVK
DR   ENCODE; ENCBS805BJW
DR   ENCODE; ENCBS806ZLH
DR   ENCODE; ENCBS807JBI
DR   ENCODE; ENCBS807RCH
DR   ENCODE; ENCBS808EGR
DR   ENCODE; ENCBS809MNA
DR   ENCODE; ENCBS810BRT
DR   ENCODE; ENCBS810LXW
DR   ENCODE; ENCBS814SSA
DR   ENCODE; ENCBS815HMT
DR   ENCODE; ENCBS818CJE
DR   ENCODE; ENCBS818RAI
DR   ENCODE; ENCBS819DMA
DR   ENCODE; ENCBS820MUM
DR   ENCODE; ENCBS820ONJ
DR   ENCODE; ENCBS820SVQ
DR   ENCODE; ENCBS821RUT
DR   ENCODE; ENCBS821YWV
DR   ENCODE; ENCBS823HFB
DR   ENCODE; ENCBS823UOD
DR   ENCODE; ENCBS826RWQ
DR   ENCODE; ENCBS828JTD
DR   ENCODE; ENCBS831YRP
DR   ENCODE; ENCBS833LTI
DR   ENCODE; ENCBS833VOT
DR   ENCODE; ENCBS834ANM
DR   ENCODE; ENCBS837CSI
DR   ENCODE; ENCBS841KAV
DR   ENCODE; ENCBS844DON
DR   ENCODE; ENCBS844JPS
DR   ENCODE; ENCBS844UJU
DR   ENCODE; ENCBS844USI
DR   ENCODE; ENCBS847XVV
DR   ENCODE; ENCBS848GZD
DR   ENCODE; ENCBS848SUF
DR   ENCODE; ENCBS848UWA
DR   ENCODE; ENCBS848YCU
DR   ENCODE; ENCBS851NMG
DR   ENCODE; ENCBS854ROL
DR   ENCODE; ENCBS856DBT
DR   ENCODE; ENCBS858LUL
DR   ENCODE; ENCBS859WOF
DR   ENCODE; ENCBS861FXN
DR   ENCODE; ENCBS861MJO
DR   ENCODE; ENCBS864LYS
DR   ENCODE; ENCBS865TFY
DR   ENCODE; ENCBS867ZRE
DR   ENCODE; ENCBS868JZZ
DR   ENCODE; ENCBS868SZM
DR   ENCODE; ENCBS875AZA
DR   ENCODE; ENCBS875EJK
DR   ENCODE; ENCBS875EKF
DR   ENCODE; ENCBS875FUH
DR   ENCODE; ENCBS875WSM
DR   ENCODE; ENCBS876BXS
DR   ENCODE; ENCBS876CAE
DR   ENCODE; ENCBS876WBK
DR   ENCODE; ENCBS879LDL
DR   ENCODE; ENCBS880AKY
DR   ENCODE; ENCBS880JFJ
DR   ENCODE; ENCBS883MPQ
DR   ENCODE; ENCBS884PLU
DR   ENCODE; ENCBS886DPW
DR   ENCODE; ENCBS887WBA
DR   ENCODE; ENCBS887WFS
DR   ENCODE; ENCBS888YJZ
DR   ENCODE; ENCBS889EQG
DR   ENCODE; ENCBS889KBF
DR   ENCODE; ENCBS889QXH
DR   ENCODE; ENCBS890NQU
DR   ENCODE; ENCBS892LLD
DR   ENCODE; ENCBS894DBY
DR   ENCODE; ENCBS895JFB
DR   ENCODE; ENCBS895TOZ
DR   ENCODE; ENCBS896DFQ
DR   ENCODE; ENCBS896RCE
DR   ENCODE; ENCBS897QKO
DR   ENCODE; ENCBS898BLW
DR   ENCODE; ENCBS898FLP
DR   ENCODE; ENCBS901OWZ
DR   ENCODE; ENCBS901YZG
DR   ENCODE; ENCBS902DWK
DR   ENCODE; ENCBS904ZPH
DR   ENCODE; ENCBS905SVC
DR   ENCODE; ENCBS907YTU
DR   ENCODE; ENCBS909XAR
DR   ENCODE; ENCBS910NQY
DR   ENCODE; ENCBS911UKO
DR   ENCODE; ENCBS911XCD
DR   ENCODE; ENCBS914AZQ
DR   ENCODE; ENCBS914SLE
DR   ENCODE; ENCBS915DYB
DR   ENCODE; ENCBS915ELT
DR   ENCODE; ENCBS916GRQ
DR   ENCODE; ENCBS918QQA
DR   ENCODE; ENCBS919DDI
DR   ENCODE; ENCBS919WJV
DR   ENCODE; ENCBS920QFZ
DR   ENCODE; ENCBS922MBD
DR   ENCODE; ENCBS923XGQ
DR   ENCODE; ENCBS924DBS
DR   ENCODE; ENCBS924SSS
DR   ENCODE; ENCBS928VYM
DR   ENCODE; ENCBS928ZCB
DR   ENCODE; ENCBS929VTV
DR   ENCODE; ENCBS930DNO
DR   ENCODE; ENCBS930EPD
DR   ENCODE; ENCBS933OVE
DR   ENCODE; ENCBS933PFW
DR   ENCODE; ENCBS934GIO
DR   ENCODE; ENCBS935QKL
DR   ENCODE; ENCBS937BMQ
DR   ENCODE; ENCBS938EZW
DR   ENCODE; ENCBS938LTP
DR   ENCODE; ENCBS942FEE
DR   ENCODE; ENCBS944BMM
DR   ENCODE; ENCBS944DJS
DR   ENCODE; ENCBS944KBZ
DR   ENCODE; ENCBS945ASE
DR   ENCODE; ENCBS947WTB
DR   ENCODE; ENCBS949VOR
DR   ENCODE; ENCBS950YDL
DR   ENCODE; ENCBS951GWL
DR   ENCODE; ENCBS951SRH
DR   ENCODE; ENCBS952KGJ
DR   ENCODE; ENCBS952TPH
DR   ENCODE; ENCBS953AYB
DR   ENCODE; ENCBS953UYS
DR   ENCODE; ENCBS954JBG
DR   ENCODE; ENCBS957SRX
DR   ENCODE; ENCBS960LFK
DR   ENCODE; ENCBS961BTU
DR   ENCODE; ENCBS962DEK
DR   ENCODE; ENCBS962WOF
DR   ENCODE; ENCBS964CQT
DR   ENCODE; ENCBS966VII
DR   ENCODE; ENCBS969VAO
DR   ENCODE; ENCBS971BDW
DR   ENCODE; ENCBS971NYL
DR   ENCODE; ENCBS972JHA
DR   ENCODE; ENCBS972YKN
DR   ENCODE; ENCBS973LNL
DR   ENCODE; ENCBS974GKC
DR   ENCODE; ENCBS974OAE
DR   ENCODE; ENCBS974WHQ
DR   ENCODE; ENCBS975BCL
DR   ENCODE; ENCBS976HVM
DR   ENCODE; ENCBS976TIO
DR   ENCODE; ENCBS977SDW
DR   ENCODE; ENCBS978CEM
DR   ENCODE; ENCBS979STP
DR   ENCODE; ENCBS981XNC
DR   ENCODE; ENCBS982NSX
DR   ENCODE; ENCBS983ZXV
DR   ENCODE; ENCBS985AGQ
DR   ENCODE; ENCBS989MQH
DR   ENCODE; ENCBS991JCM
DR   ENCODE; ENCBS993AJE
DR   ENCODE; ENCBS996IAL
DR   ENCODE; ENCBS996NTP
DR   ENCODE; ENCBS996ZFV
DR   ENCODE; ENCBS997NQT
DR   ENCODE; ENCBS998DSH
DR   ENCODE; ENCBS998IQV
DR   ENCODE; ENCBS998NWZ
DR   ENCODE; ENCBS998UBJ
DR   ENCODE; ENCBS998XMJ
DR   FANTOM5_SSTAR; 10499-107C4
DR   FCS-free; 237-2-485-2-16-12
DR   GDSC; 905949
DR   GEO; GSM2114
DR   GEO; GSM50209
DR   GEO; GSM50272
DR   GEO; GSM108799
DR   GEO; GSM108800
DR   GEO; GSM139640
DR   GEO; GSM139641
DR   GEO; GSM139642
DR   GEO; GSM139643
DR   GEO; GSM139644
DR   GEO; GSM139645
DR   GEO; GSM139646
DR   GEO; GSM139647
DR   GEO; GSM139648
DR   GEO; GSM139649
DR   GEO; GSM139652
DR   GEO; GSM139653
DR   GEO; GSM185869
DR   GEO; GSM206445
DR   GEO; GSM253306
DR   GEO; GSM274739
DR   GEO; GSM274740
DR   GEO; GSM353234
DR   GEO; GSM434265
DR   GEO; GSM513947
DR   GEO; GSM514317
DR   GEO; GSM651560
DR   GEO; GSM651561
DR   GEO; GSM729842
DR   GEO; GSM729843
DR   GEO; GSM729844
DR   GEO; GSM729845
DR   GEO; GSM729846
DR   GEO; GSM729847
DR   GEO; GSM729848
DR   GEO; GSM729849
DR   GEO; GSM743448
DR   GEO; GSM750779
DR   GEO; GSM750780
DR   GEO; GSM750788
DR   GEO; GSM750789
DR   GEO; GSM750791
DR   GEO; GSM784244
DR   GEO; GSM794260
DR   GEO; GSM799336
DR   GEO; GSM799399
DR   GEO; GSM816649
DR   GEO; GSM817062
DR   GEO; GSM827464
DR   GEO; GSM843439
DR   GEO; GSM846285
DR   GEO; GSM886858
DR   GEO; GSM887923
DR   GEO; GSM923418
DR   GEO; GSM923420
DR   GEO; GSM923425
DR   GEO; GSM923432
DR   GEO; GSM923433
DR   GEO; GSM923435
DR   GEO; GSM945243
DR   GEO; GSM945244
DR   GEO; GSM1022639
DR   GEO; GSM1022640
DR   GEO; GSM1022674
DR   GEO; GSM1086289
DR   GEO; GSM1086290
DR   GEO; GSM1153406
DR   GEO; GSM1177909
DR   GEO; GSM1177910
DR   GEO; GSM1177911
DR   GEO; GSM1181254
DR   GEO; GSM1181311
DR   GEO; GSM1181344
DR   GEO; GSM1181353
DR   GEO; GSM1181354
DR   GEO; GSM1181355
DR   GEO; GSM1181356
DR   GEO; GSM1181364
DR   GEO; GSM1374385
DR   GEO; GSM1374386
DR   GEO; GSM1374387
DR   GEO; GSM1557133
DR   GEO; GSM1669589
DR   GEO; GSM1887937
DR   GEO; GSM2124637
DR   GEO; GSM2141954
DR   GEO; GSM2141955
DR   GEO; GSM2141960
DR   GEO; GSM2141961
DR   GEO; GSM2141964
DR   GEO; GSM2141967
DR   GEO; GSM2141973
DR   GEO; GSM2141976
DR   GEO; GSM2141984
DR   GEO; GSM2141985
DR   GEO; GSM2141990
DR   GEO; GSM2141992
DR   GEO; GSM2141996
DR   GEO; GSM2141997
DR   GEO; GSM2142001
DR   GEO; GSM2142003
DR   GEO; GSM2142010
DR   GEO; GSM2142017
DR   GEO; GSM2142033
DR   GEO; GSM2142034
DR   GEO; GSM2142038
DR   GEO; GSM2142042
DR   GEO; GSM2142043
DR   GEO; GSM2142044
DR   GEO; GSM2142045
DR   GEO; GSM2142050
DR   GEO; GSM2142054
DR   GEO; GSM2142056
DR   GEO; GSM2142058
DR   GEO; GSM2142061
DR   GEO; GSM2635915
DR   GEO; GSM2635917
DR   GEO; GSM2635920
DR   GEO; GSM7701357
DR   GEO; GSM7701358
DR   IARC_TP53; 21037
DR   IBRC; C10080
DR   IBRC; C10681
DR   ICLC; HTL03001
DR   IGRhCellID; A549GEO
DR   IZSLER; BS TCL 101
DR   JCRB; IFO50153
DR   JCRB; JCRB0076
DR   KCB; KCB 200434YJ
DR   KCLB; 10185
DR   Kerafast; ESA114
DR   LiGeA; CCLE_515
DR   LINCS_HMS; 50084
DR   LINCS_LDP; LCL-1601
DR   Lonza; 675
DR   MeSH; D000072283
DR   MetaboLights; MTBLS102
DR   MetaboLights; MTBLS873
DR   NCBI_Iran; C137
DR   NCI-DTP; A549
DR   PharmacoDB; A549_48_2019
DR   PRIDE; PXD000418
DR   PRIDE; PXD000661
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   PRIDE; PXD002395
DR   PRIDE; PXD002453
DR   PRIDE; PXD003539
DR   PRIDE; PXD003627
DR   PRIDE; PXD004452
DR   PRIDE; PXD005291
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD007223
DR   PRIDE; PXD015270
DR   PRIDE; PXD023286
DR   PRIDE; PXD027362
DR   PRIDE; PXD030097
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0023
DR   PubChem_Cell_line; CVCL_0023
DR   RCB; RCB0098
DR   RCB; RCB3677
DR   SKY/M-FISH/CGH; 2809
DR   TKG; TKG 0184
DR   TOKU-E; 3615
DR   Ubigene; YC-C016
DR   Wikidata; Q4649475
RX   DOI=10.5897/IJBMBR2013.0154;
RX   PubMed=77569;
RX   PubMed=175022;
RX   PubMed=327080;
RX   PubMed=375235;
RX   PubMed=833871;
RX   PubMed=842942;
RX   PubMed=924690;
RX   PubMed=1255758;
RX   PubMed=1855224;
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=3129183;
RX   PubMed=3335022;
RX   PubMed=3413074;
RX   PubMed=3518877;
RX   PubMed=3940644;
RX   PubMed=3945555;
RX   PubMed=4357758;
RX   PubMed=6148444;
RX   PubMed=6173755;
RX   PubMed=6256643;
RX   PubMed=6272398;
RX   PubMed=6500159;
RX   PubMed=6825208;
RX   PubMed=6935474;
RX   PubMed=6954533;
RX   PubMed=7065527;
RX   PubMed=7459858;
RX   PubMed=7736387;
RX   PubMed=8132585;
RX   PubMed=8263009;
RX   PubMed=8286010;
RX   PubMed=8626706;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=9331090;
RX   PubMed=9538136;
RX   PubMed=9636188;
RX   PubMed=9649128;
RX   PubMed=9673367;
RX   PubMed=9743595;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=10700174;
RX   PubMed=11005564;
RX   PubMed=11369051;
RX   PubMed=11958134;
RX   PubMed=12661003;
RX   PubMed=12794755;
RX   PubMed=14581340;
RX   PubMed=15746151;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=15999539;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=17331233;
RX   PubMed=17332333;
RX   PubMed=17511773;
RX   PubMed=18083107;
RX   PubMed=19153074;
RX   PubMed=19372543;
RX   PubMed=19472407;
RX   PubMed=19608861;
RX   PubMed=19657000;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20545000;
RX   PubMed=20557307;
RX   PubMed=21060948;
RX   PubMed=22068913;
RX   PubMed=22278370;
RX   PubMed=22282976;
RX   PubMed=22313637;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22481983;
RX   PubMed=22576795;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23325432;
RX   PubMed=23404217;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24135919;
RX   PubMed=24279929;
RX   PubMed=24618588;
RX   PubMed=24670534;
RX   PubMed=25120651;
RX   PubMed=25475639;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26202522;
RX   PubMed=26554430;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28114404;
RX   PubMed=28196595;
RX   PubMed=28408844;
RX   PubMed=28601559;
RX   PubMed=28746345;
RX   PubMed=28766886;
RX   PubMed=29444439;
RX   PubMed=29457907;
RX   PubMed=29468137;
RX   PubMed=29681454;
RX   PubMed=29718670;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32351780;
RX   PubMed=34320349;
RX   PubMed=34737324;
RX   PubMed=35117401;
RX   PubMed=35839778;
RX   PubMed=35976051;
RX   PubMed=38861359;
WW   Info; -; -; https://a549.com/
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/a549/a549cells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-ccl-185
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CCL-185
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/a549/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/A549_protocol.pdf
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/fluorescence/pages/a549cellmitosislarge
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; MicroscopyU; -; https://www.microscopyu.com/gallery-images/male-human-lung-carcinoma-epithelial-cells-a-549-line
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=8
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-58.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/A549_cell
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/a549-xenograft-model/
WW   Provider; BRICS; BRICS0129; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3932
WW   Provider; NCI TTC; TAB-3903/E-129-2009-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-3903
WW   Provider; Vircell; -; https://www.vircell.com/en/products/a-549-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 2.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: NCI-7 clinical proteomics reference material cell line panel.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2000.
CC   Population: Caucasian.
CC   Characteristics: Expresses HPRT1 at the surface of the cell membrane (PubMed=28408844).
CC   Virology: Highly susceptible to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   Doubling time: 18 hours (Note=In RPMI 1640 + 10% FBS), 37 hours (Note=In ACL-3), 36 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 27.0 hours (PubMed=8286010); 22 hours (PubMed=25984343); 23.9 hours (PubMed=29681454); 27 hours (Note=From cell counting), 27 hours (Note=From absorbance) (DOI=10.5897/IJBMBR2013.0154); 26.08 hours (PubMed=35976051); ~28 hours (CLS=300114); ~40 hours (DSMZ=ACC-107); 22.9 hours (NCI-DTP=A549).
CC   HLA typing: A*10,w19; B*08,12 (PubMed=77569).
CC   HLA typing: A*25:01,30:01; B*18,44:03:01; C*12:03:01,16:01; DQB1*02:02,03:01:01; DRB1*07:01,11:04:01 (PubMed=15748285).
CC   HLA typing: A*25:01,30:01; B*18:01,44:03; C*12:03,16:01; DQB1*02:02,02:02 (PubMed=25960936).
CC   HLA typing: A*26:03,30:01; B*18:01,44:03:01; C*12:03,16:01 (PubMed=9023415).
CC   HLA typing: A*25:01,30:01; B*07:02,44:03; C*12:03,12:03 (PubMed=26589293).
CC   HLA typing: A*25:01:01,30:01:01; B*18:01:01,20:03:01; C*12:03:01,16:01:01; DPB1*03:01,06:01; DQA1*02:01:01,05:05:01; DQB1*02:02:01,03:01:01; DRB1*07:01:01,11:04:01 (CLS=300114).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (PubMed=1855224; PubMed=8263009; PubMed=12794755; PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=15900046; PubMed=20557307).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Acetylation.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.72%; East Asian, South=0%; South Asian=0%; European, North=66.12%; European, South=33.16% (PubMed=30894373).
CC   Misspelling: A59; PubMed=16354588.
CC   Misspelling: A594; Note=In abstract of PubMed 18227028.
CC   Discontinued: ATCC; CRL-7909; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016002/23; ATCC=CCL-185; CCRID; CLS=300114; Cosmic-CLP=905949; DSMZ=ACC-107; ECACC=86012804; IZSLER=BS TCL 101; JCRB=IFO50153; JCRB=JCRB0076; KCLB=10185; PubMed=19372543; PubMed=25877200; RCB=RCB0098; Technion Genomics Center; TKG=TKG 0184
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,16
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D1S1656: 17,18.3
ST   D21S11: 29
ST   D22S1045: 15
ST   D2S1338: 24
ST   D2S441: 10,13
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 53
//
ID   A-6
AC   CVCL_N545
DR   CLO; CLO_0050200
DR   RCB; RCB1517
DR   Wikidata; Q54606053
RX   PubMed=10445502;
CC   Characteristics: FGF2, FLT3LG, or KITLG dependent (PubMed=10445502).
CC   Doubling time: 40 hours (Note=Grown with FGF2 in medium) (PubMed=10445502).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N541 ! H-1
SX   Male
AG   Blastocyst stage
CA   Factor-dependent cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   A-6/FL
AC   CVCL_E8DZ
RX   PubMed=10445502;
CC   Characteristics: FLT3LG dependent (PubMed=10445502).
CC   Doubling time: 54 hours (PubMed=10445502).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N545 ! A-6
SX   Male
AG   Blastocyst stage
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   A-6/SCF
AC   CVCL_E8E0
RX   PubMed=10445502;
CC   Characteristics: KITLG dependent (PubMed=10445502).
CC   Doubling time: 52 hours (PubMed=10445502).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N545 ! A-6
SX   Male
AG   Blastocyst stage
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   A-673
AC   CVCL_0080
SY   A673; RMS 1598; RMS1598
DR   BTO; BTO_0003768
DR   CLO; CLO_0001605
DR   CLO; CLO_0001606
DR   EFO; EFO_0002106
DR   CLDB; cl166
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1598
DR   ATCC; CRL-7910
DR   BioGRID_ORCS_Cell_line; 160
DR   BioSample; SAMN03473282
DR   BioSample; SAMN10987881
DR   cancercelllines; CVCL_0080
DR   CCRID; 3101HUMTCHu223
DR   Cell_Model_Passport; SIDM00848
DR   ChEMBL-Cells; CHEMBL3307384
DR   ChEMBL-Targets; CHEMBL614517
DR   CLS; 300454
DR   Cosmic; 684052
DR   Cosmic; 1091064
DR   Cosmic; 1097757
DR   Cosmic; 1388901
DR   Cosmic; 1718108
DR   Cosmic; 1995338
DR   Cosmic; 2228213
DR   Cosmic; 2250469
DR   Cosmic; 2294580
DR   Cosmic-CLP; 684052
DR   DepMap; ACH-000052
DR   ECACC; 85111504
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS304EKV
DR   ENCODE; ENCBS385OLC
DR   ENCODE; ENCBS615MBV
DR   ENCODE; ENCBS790NPQ
DR   GDSC; 684052
DR   GEO; GSM510002
DR   GEO; GSM827304
DR   GEO; GSM886859
DR   GEO; GSM887924
DR   GEO; GSM1669590
DR   GEO; GSM1676306
DR   GEO; GSM1701623
DR   GEO; GSM1899422
DR   GEO; GSM5359628
DR   GEO; GSM5359629
DR   GEO; GSM5359630
DR   GEO; GSM5359631
DR   GEO; GSM5359632
DR   GEO; GSM5359633
DR   GEO; GSM5362876
DR   GEO; GSM5362877
DR   GEO; GSM5362878
DR   GEO; GSM5362879
DR   GEO; GSM5362880
DR   GEO; GSM5362881
DR   GEO; GSM5363936
DR   GEO; GSM5363937
DR   GEO; GSM5363938
DR   GEO; GSM5363939
DR   GEO; GSM5363940
DR   IARC_TP53; 705
DR   IARC_TP53; 21168
DR   IGRhCellID; A673
DR   KCLB; 21598
DR   LiGeA; CCLE_182
DR   LINCS_LDP; LCL-1410
DR   Lonza; 1455
DR   PharmacoDB; A673_49_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0080
DR   PubChem_Cell_line; CVCL_0080
DR   Wikidata; Q54606055
RX   DOI=10.5282/edoc.27750;
RX   PubMed=212188;
RX   PubMed=327080;
RX   PubMed=375235;
RX   PubMed=3335022;
RX   PubMed=4357758;
RX   PubMed=6173755;
RX   PubMed=6256643;
RX   PubMed=6825208;
RX   PubMed=6954533;
RX   PubMed=8275086;
RX   PubMed=8378080;
RX   PubMed=10379870;
RX   PubMed=11423975;
RX   PubMed=12068308;
RX   PubMed=12606131;
RX   PubMed=14697648;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21822310;
RX   PubMed=22142829;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=23882450;
RX   PubMed=24312454;
RX   PubMed=24758355;
RX   PubMed=25010205;
RX   PubMed=25223734;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26351324;
RX   PubMed=26428435;
RX   PubMed=26589293;
RX   PubMed=26979953;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34413129;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Misclassified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=10379870; PubMed=12606131; PubMed=14697648).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=16888811); 25 hours (PubMed=24312454); 28 hours (PubMed=25984343).
CC   HLA typing: A*01:01,02:01; B*07:02,07:02; C*07:02,07:02; DQB1*03:02,03:02; DRB1*15:01,14:76 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792; PubMed=25010205; PubMed=25223734; ATCC=CRL-1598).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=11423975; PubMed=25010205; PubMed=25485619; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=22142829; PubMed=25010205; ATCC=CRL-1598; Cosmic-CLP=684052; DepMap=ACH-000052).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala119Glnfs*5 (c.353_354dupCA) (c.354_355insCA); Zygosity=Homozygous (PubMed=8378080; PubMed=19787792; PubMed=25010205; PubMed=25223734; ATCC=CRL-1598; Cosmic-CLP=684052; DepMap=ACH-000052).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.54%; Native American=0%; East Asian, North=1.77%; East Asian, South=0%; South Asian=0%; European, North=69.11%; European, South=28.57% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7910; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
ST   Source(s): ATCC=CRL-1598; CCRID=3101HUMTCHu223; CLS=300454; Cosmic-CLP=684052; ECACC=85111504; KCLB=21598; PubMed=19787792; PubMed=24312454; PubMed=25010205; PubMed=25877200; PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 16,21
ST   D3S1358: 14
ST   D5S818: 11,12 (ATCC=CRL-1598; CCRID=3101HUMTCHu223; CLS=300454; Cosmic-CLP=684052; ECACC=85111504; KCLB=21598; PubMed=24312454; PubMed=25010205; PubMed=25877200; PubMed=30879952)
ST   D5S818: 12 (PubMed=19787792)
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 19,20
ST   Penta D: 12,13
ST   Penta E: 10,13
ST   SE33: 30.2,32.2
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   A-673 clone Asp114
AC   CVCL_JM58
SY   A673 clone Asp114; ASP114; Asp114; A673/TR/shEF
DR   cancercelllines; CVCL_JM58
DR   GEO; GSE27524
DR   PRIDE; PXD002765
DR   Wikidata; Q54606058
RX   PubMed=17438102;
RX   PubMed=23940108;
RX   PubMed=28062706;
CC   Problematic cell line: Misclassified. Parent cell line (A-673) was originally thought to be a rhabdomyosarcoma cell line but is an Ewing sarcoma cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct harboring a doxycycline-inducible shRNA against the EWSR1-FLI1 fusion protein.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:3508; EWSR1 (Note=EWSR1-FLI1 fusion).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:3749; FLI1 (Note=EWSR1-FLI1 fusion).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala119Glnfs*5 (c.353_354dupCA) (c.354_355insCA); Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0080 ! A-673
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 19
//
ID   A-673 EHD1 KO
AC   CVCL_D6TY
SY   EHD1-KO A673
RX   PubMed=37474760;
CC   Problematic cell line: Misclassified. Parent cell line (A-673) was originally thought to be a rhabdomyosarcoma cell line but is an Ewing sarcoma cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3242; EHD1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala119Glnfs*5 (c.353_354dupCA) (c.354_355insCA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0080 ! A-673
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   A-704
AC   CVCL_1065
SY   A.704; A704
DR   BTO; BTO_0004583
DR   CLO; CLO_0001546
DR   CLO; CLO_0001609
DR   CLO; CLO_0001610
DR   CLDB; cl167
DR   CLDB; cl168
DR   CLDB; cl170
DR   CLDB; cl5026
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7911
DR   ATCC; HTB-45
DR   BioSample; SAMN03471120
DR   BioSample; SAMN03472920
DR   BioSample; SAMN10987988
DR   cancercelllines; CVCL_1065
DR   Cell_Model_Passport; SIDM00849
DR   ChEMBL-Cells; CHEMBL3307650
DR   ChEMBL-Targets; CHEMBL614567
DR   CLS; 300217
DR   Cosmic; 687938
DR   Cosmic; 910920
DR   Cosmic; 979707
DR   Cosmic; 982279
DR   Cosmic; 1995339
DR   Cosmic; 2520641
DR   Cosmic-CLP; 910920
DR   DepMap; ACH-000429
DR   ECACC; 93020513
DR   EGA; EGAS00001000978
DR   GDSC; 910920
DR   GEO; GSM374459
DR   GEO; GSM886860
DR   GEO; GSM887925
DR   GEO; GSM1669591
DR   IARC_TP53; 21169
DR   IARC_TP53; 27550
DR   ICLC; HTL95007
DR   IZSLER; BS TCL 117
DR   KCLB; 30045
DR   LiGeA; CCLE_470
DR   LINCS_LDP; LCL-1762
DR   NCI-DTP; A704
DR   PharmacoDB; A704_50_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1065
DR   PubChem_Cell_line; CVCL_1065
DR   Wikidata; Q54606061
RX   PubMed=77569;
RX   PubMed=450131;
RX   PubMed=571047;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=4357758;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=6256643;
RX   PubMed=6500159;
RX   PubMed=6825208;
RX   PubMed=7591954;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22949125;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   HLA typing: A*01,03; B*08,12 (PubMed=77569).
CC   HLA typing: A*34:02,74:01; B*35:01,44:03; C*04:01,04:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*11:02,15:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Asp (c.376T>G); ClinVar=VCV000265333; Zygosity=Heterozygous (Cosmic-CLP=910920).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Arg (c.403T>C); ClinVar=VCV000376560; Zygosity=Heterozygous (Cosmic-CLP=910920).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Ter (c.772G>T); ClinVar=VCV000486557; Zygosity=Heterozygous (Cosmic-CLP=910920).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=71.07%; Native American=0%; East Asian, North=6.26%; East Asian, South=0%; South Asian=0%; European, North=2.53%; European, South=20.13% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7911; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): ATCC=HTB-45; CLS=300217; Cosmic-CLP=910920; ECACC=93020513; IZSLER=BS TCL 117; KCLB=30045; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 7,8
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D19S433: 13
ST   D21S11: 28,32
ST   D2S1338: 16,21
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 2.2,11
ST   Penta E: 8,17
ST   TH01: 7 (PubMed=25877200)
ST   TH01: 7,9 (ATCC=HTB-45; CLS=300217; Cosmic-CLP=910920; ECACC=93020513; IZSLER=BS TCL 117; KCLB=30045)
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   A-72
AC   CVCL_3453
SY   A 72; A72
DR   CLO; CLO_0001545
DR   CLO; CLO_0001612
DR   CLDB; cl171
DR   CLDB; cl172
DR   AddexBio; C0034001/4943
DR   ATCC; CRL-1542
DR   BCRC; 60480
DR   BCRJ; 0368
DR   CLS; 602398
DR   ECACC; 89050908
DR   IZSLER; BS TCL 1
DR   Wikidata; Q54606062
RX   PubMed=6254399;
RX   PubMed=21801068;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-558.html
CC   Doubling time: ~27 hours (Note=At 123th passage) (PubMed=6254399); ~24 hours (CLS=602398).
CC   Derived from site: In situ; Left thigh; UBERON=UBERON_0000376.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   A-8-125
AC   CVCL_B5AP
DR   Wikidata; Q110429840
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   A-8-17
AC   CVCL_B5AQ
DR   Wikidata; Q110429842
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   A-875
AC   CVCL_4733
SY   A875; 875
DR   BTO; BTO_0000525
DR   CCRID; 1101HUM-PUMC000094
DR   CCRID; 4201HUM-CCTCC00312
DR   CCTCC; GDC0312
DR   CLS; 305099
DR   GEO; GSM1507933
DR   KCB; KCB 2012028YJ
DR   Wikidata; Q54606065
RX   PubMed=265522;
RX   PubMed=375235;
RX   PubMed=1255758;
RX   PubMed=4357758;
RX   PubMed=6256643;
RX   PubMed=6988327;
RX   PubMed=25502142;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-568.html
CC   Doubling time: ~4 days (PubMed=265522).
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Incorrectly indicated in table 2 of PubMed=265522 to originate from a 78 year old male.
CC   Derived from site: Metastatic; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): CCRID; CLS=305099
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 13.2,14
ST   D21S11: 28,30.2
ST   D2S1338: 20,24
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11
ST   FGA: 22
ST   Penta D: 10,12
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 23
//
ID   A-9
AC   CVCL_3984
SY   A9; A9 (Hamprecht); A9(Hamprecht); AG 9; GM00346; GM-346; GM346; GM00346B
DR   BTO; BTO_0002887
DR   CLO; CLO_0001618
DR   CLO; CLO_0001620
DR   CLO; CLO_0025566
DR   CLDB; cl219
DR   CLDB; cl220
DR   AddexBio; P0011007/4965
DR   ATCC; CCL-1.4
DR   ATCC; CRL-6319
DR   BCRC; 60138
DR   BioSample; SAMN11397623
DR   CCRID; 3101MOUGNM12
DR   CCTCC; GDC0259
DR   ChEMBL-Cells; CHEMBL3307632
DR   ChEMBL-Targets; CHEMBL614518
DR   CLS; 305166
DR   Coriell; GM00346
DR   ECACC; 08062526
DR   ECACC; 85011426
DR   IZSLER; BS CL 209
DR   JCRB; JCRB0211
DR   PubChem_Cell_line; CVCL_3984
DR   TOKU-E; 493
DR   Wikidata; Q54606068
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=174085;
RX   PubMed=1260760;
RX   PubMed=8710496;
RX   PubMed=14067106;
RX   PubMed=14213660;
RX   PubMed=31220119;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: ~1 day (Note=Lot 07122006) (JCRB=JCRB0211).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Miscellaneous: ECACC has two catalogue entries for A-9 which differ in that they were deposited by different groups: A9 (ECACC=85011426) and A9 (Hamprecht) (ECACC=08062526).
CC   Discontinued: ATCC; CRL-6319; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26,27
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15,16,17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 25.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26,27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   A-A946F
AC   CVCL_LM91
SY   A-A94; TNGB-65649; 65649
DR   CLO; CLO_0001632
DR   CLDB; cl173
DR   TNGB; 65649
DR   Wikidata; Q54606069
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18-22FW
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   A-HER2
AC   CVCL_J973
SY   4D5; NB9644P28
DR   CLO; CLO_0001687
DR   Wikidata; Q54606072
RX   Patent=US5677171;
RX   Patent=US10280228;
RX   PubMed=1689212;
RX   PubMed=2566907;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10463.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized trastuzumab (herceptin) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   A-iPSC-16
AC   CVCL_LI30
SY   Aged-iPSC-16
DR   GEO; GSM2452098
DR   Wikidata; Q54606073
RX   PubMed=28846095;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 6
//
ID   A-iPSC-19
AC   CVCL_LI31
SY   Aged-iPSC-19
DR   GEO; GSM2452099
DR   Wikidata; Q54606074
RX   PubMed=28846095;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 6
//
ID   A-iPSC-ZSCAN10-3
AC   CVCL_LI32
SY   Aged-iPSC-ZSCAN10-3
DR   GEO; GSM2452096
DR   Wikidata; Q54606076
RX   PubMed=28846095;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12997; ZSCAN10.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   A-iPSC-ZSCAN10-7
AC   CVCL_LI33
SY   Aged-iPSC-ZSCAN10-7
DR   GEO; GSM2452097
DR   Wikidata; Q54606077
RX   PubMed=28846095;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12997; ZSCAN10.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   A-mel-3
AC   CVCL_IS48
SY   A-mel 3; A.Mel. 3
DR   Wikidata; Q54606080
RX   PubMed=8567124;
RX   PubMed=11027436;
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   A-PTC
AC   CVCL_W335
DR   Wikidata; Q54606083
RX   PubMed=24567186;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   A-S-30D
AC   CVCL_1949
AS   CVCL_5684
SY   AS-30D; AS30D
DR   BTO; BTO_0002013
DR   CLO; CLO_0001752
DR   CLDB; cl179
DR   CLS; 500116
DR   DSMZ; ACC-208
DR   DSMZCellDive; ACC-208
DR   Wikidata; Q54606084
RX   PubMed=3370139;
CC   Doubling time: ~26 hours (CLS=500116); ~29 hours (DSMZ=ACC-208).
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   A-THP-1
AC   CVCL_5115
SY   Activated-THP-1
DR   CLO; CLO_0050998
DR   cancercelllines; CVCL_5115
DR   RCB; RCB2128
DR   TKG; TKG 0296
DR   Wikidata; Q54606088
RX   PubMed=10223614;
CC   Population: Japanese.
CC   Characteristics: Enriched with adherent cells. Maintains an activated state without exogenous stimulation (PubMed=10223614).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2128; TKG=TKG 0296
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   A.P.
AC   CVCL_6365
SY   A. P. Mongoose; APM
DR   CLO; CLO_0001547
DR   ATCC; CRL-6295
DR   Wikidata; Q54606091
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/apm/apmcells.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=210642; ! Atilax paludinosus (Marsh mongoose)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   A.t. GRIP-1
AC   CVCL_Z265
DR   Wikidata; Q54606092
RX   PubMed=8551501;
CC   Group: Insect cell line.
CC   Doubling time: 30 hours (PubMed=8551501).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7162; ! Ochlerotatus triseriatus (Eastern treehole mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   A.t. GRIP-2
AC   CVCL_Z266
DR   Wikidata; Q54606094
RX   PubMed=8551501;
CC   Group: Insect cell line.
CC   Doubling time: 60 hours (PubMed=8551501).
OX   NCBI_TaxID=7162; ! Ochlerotatus triseriatus (Eastern treehole mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   A.t. GRIP-3
AC   CVCL_Z267
DR   Wikidata; Q54606097
RX   PubMed=8551501;
CC   Group: Insect cell line.
CC   Doubling time: 60 hours (PubMed=8551501).
OX   NCBI_TaxID=7162; ! Ochlerotatus triseriatus (Eastern treehole mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   A'dam 1
AC   CVCL_E7Q3
RX   PubMed=3152545;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype 1.7 porA (Note=Mouse was immunized with proteins from three different strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   A0001
AC   CVCL_T364
DR   RCB; GMC0037
DR   Wikidata; Q54606185
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T365 ! B0001
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0010
AC   CVCL_T352
DR   CLO; CLO_0050478
DR   RCB; GMC0027
DR   Wikidata; Q54606188
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T353 ! B0010
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0022
AC   CVCL_T345
DR   CLO; CLO_0050718
DR   RCB; GMC0021
DR   Wikidata; Q54606189
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T344 ! B0022
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0026
AC   CVCL_T362
DR   CLO; CLO_0050711
DR   RCB; GMC0036
DR   Wikidata; Q54606192
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T363 ! B0026
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0031
AC   CVCL_T338
DR   CLO; CLO_0050704
DR   RCB; GMC0012
DR   Wikidata; Q54606193
RX   PubMed=25390333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=25390333).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25390333).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T339 ! B0031
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   A0031 iPS#23
AC   CVCL_IN37
SY   A0031 #23; A0031-derived iPSC clone 23
DR   Wikidata; Q54606194
RX   PubMed=25390333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=25390333).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25390333).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T338 ! A0031
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   A0031 iPS#34
AC   CVCL_IN38
SY   A0031 #34; A0031-derived iPSC clone 34; WS iPSC #34
DR   GEO; GSM1519866
DR   Wikidata; Q54606195
RX   PubMed=25390333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=25390333).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25390333).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T338 ! A0031
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   A0031 iPS#64
AC   CVCL_IN39
SY   A0031 #64; A0031-derived iPSC clone 64
DR   Wikidata; Q54606200
RX   PubMed=25390333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=25390333).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25390333).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T338 ! A0031
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   A0042
AC   CVCL_T343
DR   CLO; CLO_0050705
DR   RCB; GMC0014
DR   Wikidata; Q54606201
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T342 ! B0042
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0050
AC   CVCL_T354
DR   CLO; CLO_0050710
DR   RCB; GMC0031
DR   Wikidata; Q54606202
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T355 ! B0050
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0055
AC   CVCL_T346
DR   CLO; CLO_0050706
DR   RCB; GMC0022
DR   Wikidata; Q54606205
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T347 ! B0055
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0058
AC   CVCL_T357
DR   CLO; CLO_0050709
DR   RCB; GMC0028
DR   Wikidata; Q54606207
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T358 ! B0058
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0065
AC   CVCL_T337
DR   CLO; CLO_0050712
DR   RCB; GMC0004
DR   Wikidata; Q54606208
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0072
AC   CVCL_T350
DR   CLO; CLO_0050708
DR   RCB; GMC0024
DR   Wikidata; Q54606210
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T351 ! B0072
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A0082
AC   CVCL_T335
DR   CLO; CLO_0050701
DR   RCB; GMC0002
DR   Wikidata; Q54606213
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T334 ! B0082
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A02-JLO
AC   CVCL_W875
AS   CVCL_S858
SY   A02; A02M1; JLO
DR   cancercelllines; CVCL_W875
DR   Cosmic; 888981
DR   Cosmic; 928739
DR   Cosmic; 1996407
DR   GEO; GSM170595
DR   GEO; GSM215715
DR   GEO; GSM4178049
DR   Progenetix; CVCL_W875
DR   Wikidata; Q54606215
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   A03
AC   CVCL_C6NK
DR   Wikidata; Q123030349
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   A04-GEH
AC   CVCL_S856
SY   A04; A04M
DR   cancercelllines; CVCL_S856
DR   Cosmic; 928718
DR   Cosmic; 1211160
DR   GEO; GSM170992
DR   GEO; GSM215716
DR   GEO; GSM4178050
DR   Progenetix; CVCL_S856
DR   Wikidata; Q54606216
RX   PubMed=9354451;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   A05
AC   CVCL_W876
DR   cancercelllines; CVCL_W876
DR   Cosmic; 888982
DR   Cosmic; 1211161
DR   Wikidata; Q54606217
RX   PubMed=15048078;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   A06-MLC
AC   CVCL_S857
SY   A06; A06M; MLC
DR   cancercelllines; CVCL_S857
DR   Cosmic; 928719
DR   Cosmic; 1996408
DR   GEO; GSM170844
DR   GEO; GSM215717
DR   GEO; GSM4178051
DR   Progenetix; CVCL_S857
DR   Wikidata; Q54606222
RX   PubMed=9354451;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   A07-RM
AC   CVCL_W879
AS   CVCL_LJ86
SY   A07; A07RM; A07.RM; RM
DR   cancercelllines; CVCL_W879
DR   Cosmic; 888983
DR   Cosmic; 928733
DR   GEO; GSM78832
DR   GEO; GSM78833
DR   GEO; GSM78835
DR   GEO; GSM228380
DR   Progenetix; CVCL_W879
DR   Wikidata; Q54606224
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu2Lys (c.4G>A); Zygosity=Unspecified (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000177778; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   A08
AC   CVCL_C6NJ
DR   Wikidata; Q123030350
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   A1 [Human leukemia]
AC   CVCL_6G43
SY   A-1
DR   Wikidata; Q54606227
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1531243;
RX   PubMed=2595371;
CC   Doubling time: 48 hours (PubMed=1531243).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   A1 [Human ovarian carcinoma]
AC   CVCL_A8KH
SY   A-1; A 1
DR   Wikidata; Q108819794
RX   PubMed=2910777;
CC   Doubling time: 67 hours (PubMed=2910777).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   A1 [Mouse brain]
AC   CVCL_U223
DR   JCRB; IFO50519
DR   Wikidata; Q54606228
CC   Doubling time: ~18 hours (Note=Lot 11132008), ~23 hours (Note=Lot 06142017) (JCRB=IFO50519).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   A1 [Newt ankle]
AC   CVCL_B7RL
DR   Wikidata; Q112927031
RX   PubMed=1454825;
RX   PubMed=25740486;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Hindlimb, ankle, hypodermis; UBERON=UBERON_0001488+UBERON_0002072.
OX   NCBI_TaxID=8316; ! Notophthalmus viridescens (Eastern newt)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   A1-201
AC   CVCL_LN00
DR   Wikidata; Q54606230
RX   PubMed=2448252;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 4
//
ID   A1-245
AC   CVCL_LN01
DR   Wikidata; Q54606232
RX   PubMed=2448252;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 4
//
ID   A1-267
AC   CVCL_LN02
DR   Wikidata; Q54606234
RX   PubMed=2121721;
RX   PubMed=2448252;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 5
//
ID   A1-287
AC   CVCL_LN03
DR   Wikidata; Q54606236
RX   PubMed=2448252;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 4
//
ID   A1-410
AC   CVCL_LN04
DR   Wikidata; Q54606237
RX   PubMed=2448252;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 4
//
ID   A1-425
AC   CVCL_LN05
DR   Wikidata; Q54606238
RX   PubMed=2121721;
RX   PubMed=2448252;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 5
//
ID   A1.1
AC   CVCL_B0WP
DR   Wikidata; Q108819795
RX   PubMed=6822659;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   A10-2-4
AC   CVCL_DD07
DR   Wikidata; Q54606240
RX   PubMed=6270122;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DD06 ! N211-1-8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   A10-85
AC   CVCL_4097
DR   CLO; CLO_0001552
DR   CLDB; cl185
DR   ECACC; 93040117
DR   Wikidata; Q54606241
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0130 ! A-10
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   A10.7
AC   CVCL_E301
AS   CVCL_D552
SY   LZ10.7; E3LZ10.7; Pa03C
DR   AddexBio; C0018005/168
DR   AddexBio; C0018006/288
DR   ChEMBL-Cells; CHEMBL4483156
DR   ChEMBL-Targets; CHEMBL4483263
DR   Cosmic; 1473117
DR   Cosmic; 1509850
DR   PubChem_Cell_line; CVCL_E301
DR   Wikidata; Q54606243
RX   PubMed=17332349;
RX   PubMed=17912029;
RX   PubMed=20037478;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   A101D
AC   CVCL_1057
SY   A-101D
DR   CLO; CLO_0001551
DR   EFO; EFO_0002100
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7898
DR   BioSample; SAMN03471114
DR   BioSample; SAMN10988170
DR   cancercelllines; CVCL_1057
DR   Cell_Model_Passport; SIDM00801
DR   ChEMBL-Cells; CHEMBL3308182
DR   ChEMBL-Targets; CHEMBL2366306
DR   Cosmic; 687429
DR   Cosmic; 910921
DR   Cosmic; 1155279
DR   Cosmic; 1995326
DR   Cosmic-CLP; 910921
DR   DepMap; ACH-000008
DR   EGA; EGAS00001000978
DR   GDSC; 910921
DR   GEO; GSM886849
DR   GEO; GSM887913
DR   GEO; GSM1669576
DR   IARC_TP53; 21132
DR   IGRhCellID; A101D
DR   LiGeA; CCLE_455
DR   LINCS_LDP; LCL-1267
DR   PharmacoDB; A101D_34_2019
DR   Progenetix; CVCL_1057
DR   PubChem_Cell_line; CVCL_1057
DR   Wikidata; Q54606245
RX   PubMed=833871;
RX   PubMed=6173755;
RX   PubMed=6825208;
RX   PubMed=6954533;
RX   PubMed=6988327;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,25:01; B*07:02,08:01; C*07:02,07:02; DQA1*01:02,01:02; DQB1*02:01,06:02; DRB1*03:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; ATCC=CRL-7898; Cosmic-CLP=910921; DepMap=ACH-000008).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.99%; East Asian, South=0%; South Asian=0.52%; European, North=71.28%; European, South=27.21% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-7898; Cosmic-CLP=910921
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,17
ST   D19S433: 14,14.2
ST   D21S11: 30
ST   D2S1338: 17,24
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 23,24
ST   Penta D: 13
ST   Penta E: 7,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0331 ! Hs 294T
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 42
//
ID   A10B2.18
AC   CVCL_B0NU
SY   CR-2
DR   Wikidata; Q108819796
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3311.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A11 [Human melanoma]
AC   CVCL_W877
SY   A11-IC; A11M
DR   Cosmic; 888984
DR   Cosmic; 1303028
DR   GEO; GSM162928
DR   GEO; GSM4178052
DR   Wikidata; Q54606246
RX   PubMed=15048078;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; None_reported; -; Zygosity=- (PubMed=15048078).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   A11 [Mouse hybridoma against human TERT]
AC   CVCL_C4YR
DR   Wikidata; Q116048452
RX   PubMed=11604111;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   A11 [Mouse IHW]
AC   CVCL_V063
DR   CLO; CLO_0001553
DR   CLDB; cl186
DR   IHW; 11w 8006
DR   Wikidata; Q54606250
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   A11.1 M
AC   CVCL_J175
DR   CLO; CLO_0001554
DR   ATCC; HB-164
DR   Wikidata; Q54606251
RX   PubMed=1377666;
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J171 ! Sp2/08A2
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   A110L
AC   CVCL_U093
DR   CLO; CLO_0050065
DR   RCB; RCB2816
DR   Wikidata; Q54606253
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=19799608;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; C*12:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   A110L-B35
AC   CVCL_YD59
DR   Wikidata; Q93311325
RX   PubMed=11369790;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U093 ! A110L
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   A11B3
AC   CVCL_C4AW
DR   ABCD; ABCD_AF675
DR   Wikidata; Q116048453
RX   Patent=CN106957367B;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132His).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   A12
AC   CVCL_DH60
DR   cancercelllines; CVCL_DH60
DR   GEO; GSM228381
DR   Progenetix; CVCL_DH60
DR   Wikidata; Q54606375
RX   PubMed=17363583;
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   A12/18
AC   CVCL_E9E7
SY   A12/18.1
DR   ABCD; ABCD_AX013
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/A12_18.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P97685; Rat Nfasc (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A121(A)
AC   CVCL_A8KL
SY   A121(Ascites)
DR   Wikidata; Q108819797
RX   PubMed=2910777;
RX   PubMed=7959296;
CC   Doubling time: 25 hours (PubMed=2910777).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G294 ! A121(P)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   A121(P)
AC   CVCL_G294
SY   A121; A121(Primary)
DR   ChEMBL-Cells; CHEMBL3308020
DR   ChEMBL-Targets; CHEMBL613106
DR   PubChem_Cell_line; CVCL_G294
DR   Wikidata; Q54606378
RX   PubMed=2910777;
RX   PubMed=7959296;
CC   Doubling time: 22 hours (PubMed=2910777).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8KL ! A121(A)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   A126-1B2
AC   CVCL_0133
SY   A126.1B2; A1261B2
DR   MCCL; MCC:0000026
DR   Wikidata; Q54606379
RX   PubMed=1645738;
RX   PubMed=3018542;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   A129L
AC   CVCL_U094
DR   RCB; RCB3532
DR   Wikidata; Q54606382
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=38639832;
CC   Population: Japanese and Lao.
CC   HLA typing: A*02:06; B*07:02; C*07:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   A13
AC   CVCL_DH61
DR   cancercelllines; CVCL_DH61
DR   GEO; GSM170833
DR   GEO; GSM215718
DR   Progenetix; CVCL_DH61
DR   Wikidata; Q54606384
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   A13/BACii
AC   CVCL_B6GX
DR   Wikidata; Q111732845
RX   PubMed=22398355;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Joint articular cartilage; UBERON=UBERON_0010996.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   18-21M
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   A14 [Human melanoma]
AC   CVCL_C6NL
DR   Wikidata; Q123030352
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   A14 [Thyroid adenoma]
AC   CVCL_6309
DR   Wikidata; Q54606385
RX   PubMed=9054892;
CC   Doubling time: 26 hours (PubMed=9054892).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4161; Thyroid gland macrofollicular adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 10
//
ID   A15 [Human melanoma]
AC   CVCL_W878
SY   A15-BEP; A15M2
DR   cancercelllines; CVCL_W878
DR   Cosmic; 888985
DR   Cosmic; 1303029
DR   GEO; GSM170862
DR   GEO; GSM215719
DR   GEO; GSM4178053
DR   Progenetix; CVCL_W878
DR   Wikidata; Q54606388
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   A15 [Rat glioma]
AC   CVCL_4098
DR   CLO; CLO_0001557
DR   CLDB; cl187
DR   ECACC; 93040110
DR   Wikidata; Q54606389
RX   PubMed=221002;
CC   Characteristics: Tumorigenic in BDIX rats (ECACC=93040110).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y001 ! 1A2 [Rat glioma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   A1502
AC   CVCL_E2VI
RX   PubMed=265522;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A15A10
AC   CVCL_Y002
DR   Wikidata; Q54606393
RX   PubMed=221002;
RX   PubMed=638021;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4098 ! A15 [Rat glioma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 11
//
ID   A15A5
AC   CVCL_8780
DR   Wikidata; Q54606395
RX   PubMed=221002;
RX   PubMed=638021;
RX   PubMed=3081277;
RX   PubMed=7190976;
RX   PubMed=7459259;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4098 ! A15 [Rat glioma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A17.2#1
AC   CVCL_XK76
DR   Wikidata; Q93311365
RX   Patent=US4172124;
RX   PubMed=79181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   A172/TMZ
AC   CVCL_D5ZN
DR   Wikidata; Q127378810
RX   PubMed=34036375;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72564; Temozolomide (TMZ).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0131 ! A-172
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   A175
AC   CVCL_A8KI
SY   A-175; A 175
DR   Wikidata; Q108819798
RX   PubMed=2910777;
CC   Doubling time: 59 hours (PubMed=2910777).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   A17G12.1
AC   CVCL_B0NV
SY   CR-5
DR   Wikidata; Q108819799
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3314.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A1847
AC   CVCL_9724
SY   A-1847
DR   BTO; BTO_0002562
DR   cancercelllines; CVCL_9724
DR   Cosmic; 1102822
DR   Cosmic; 1175879
DR   GEO; GSM184380
DR   GEO; GSM184381
DR   GEO; GSM184382
DR   GEO; GSM184383
DR   GEO; GSM711694
DR   Progenetix; CVCL_9724
DR   Wikidata; Q54605971
RX   PubMed=1348364;
RX   PubMed=6173755;
RX   PubMed=6372095;
RX   PubMed=9041185;
RX   PubMed=23415752;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 14
//
ID   A1847/CP6
AC   CVCL_B7S3
DR   Wikidata; Q112927033
RX   PubMed=1348364;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9724 ! A1847
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   A18B3.11
AC   CVCL_B0NW
SY   CR-3
DR   Wikidata; Q108819800
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3312.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A18GH
AC   CVCL_YJ32
DR   Wikidata; Q93311367
RX   PubMed=31759029;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; E3ULB7; Avian leukosis virus subgroup A (isolate SDAU09C1) protein gp85 (env).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   A1923
AC   CVCL_N281
SY   NR-M1-02
DR   ATCC; HB-9352
DR   Wikidata; Q54606403
RX   Patent=US4879225;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9352.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   A1993
AC   CVCL_N282
SY   NR-M1-04
DR   ATCC; HB-9351
DR   Wikidata; Q54606406
RX   Patent=US4879225;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9351.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   A1ATD patient 1 line 1
AC   CVCL_WV63
SY   A1ATD-iPSC patient 1; BOB
DR   Wikidata; Q93311378
RX   PubMed=20739751;
RX   PubMed=30784590;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20739751).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV64 ! A1ATD patient 1 line 2
OI   CVCL_WV65 ! A1ATD patient 1 line 3
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   A1ATD patient 1 line 2
AC   CVCL_WV64
DR   Wikidata; Q93311380
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20739751).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV63 ! A1ATD patient 1 line 1
OI   CVCL_WV65 ! A1ATD patient 1 line 3
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   A1ATD patient 1 line 3
AC   CVCL_WV65
DR   Wikidata; Q93311382
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20739751).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV63 ! A1ATD patient 1 line 1
OI   CVCL_WV64 ! A1ATD patient 1 line 2
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   A1ATD patient 2 line 1
AC   CVCL_WV66
DR   Wikidata; Q93311384
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20739751).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV67 ! A1ATD patient 2 line 2
OI   CVCL_WV68 ! A1ATD patient 2 line 3
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   A1ATD patient 2 line 2
AC   CVCL_WV67
DR   Wikidata; Q93311386
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20739751).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV66 ! A1ATD patient 2 line 1
OI   CVCL_WV68 ! A1ATD patient 2 line 3
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   A1ATD patient 2 line 3
AC   CVCL_WV68
DR   Wikidata; Q93311388
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20739751).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV66 ! A1ATD patient 2 line 1
OI   CVCL_WV67 ! A1ATD patient 2 line 2
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   A1ATD patient 3 line 1
AC   CVCL_WV69
DR   Wikidata; Q93311390
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20739751).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   A1ATH
AC   CVCL_Y379
SY   A1 ATH
DR   CLO; CLO_0001549
DR   Wikidata; Q54606408
RX   PubMed=6971250;
CC   Characteristics: Leukemia cells were transferred by intraperitoneal passage in syngeneic recipients. The cell line was obtained from tumour cells successfully grown in ascites for a few passages (PubMed=6971250).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: A.TH.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-5M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 5
//
ID   A1E1
AC   CVCL_C3XQ
DR   Wikidata; Q116048454
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   A1G3
AC   CVCL_J974
DR   CLO; CLO_0001561
DR   ATCC; HB-177
DR   Wikidata; Q54606411
RX   PubMed=2646376;
RX   PubMed=6224850;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   A1G8F7
AC   CVCL_E2TP
RX   PubMed=16424596;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19111; Bovine ALPI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A1G9G3
AC   CVCL_E2TQ
RX   PubMed=16424596;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19111; Bovine ALPI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A1H4
AC   CVCL_L533
DR   ECACC; 93062220
DR   Wikidata; Q54606412
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F1PAA9; Dog CDH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   A1HTT
AC   CVCL_C8QY
DR   Wikidata; Q123030353
RX   PubMed=315438;
CC   Characteristics: Leukemia cells were transferred by intraperitoneal passage in syngeneic recipients. The cell line was obtained from tumour cells successfully grown in ascites for a few passages (PubMed=315438).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: B10.HTT.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-5M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   A2 [Carp]
AC   CVCL_A8VI
DR   Wikidata; Q108819801
RX   PubMed=22514610;
CC   Group: Fish cell line.
CC   Virology: Not susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: INRA Sy derived homozygous clone A2.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   A2 [Hamster]
AC   CVCL_4099
DR   CLO; CLO_0001562
DR   CLDB; cl189
DR   ECACC; 89030316
DR   Wikidata; Q54606413
RX   PubMed=3924915;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H340 ! CHO-A7
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 10
//
ID   A2.1
AC   CVCL_E303
SY   GS2.1; Pa01C
DR   Cosmic; 1473030
DR   Cosmic; 1509848
DR   Wikidata; Q54606419
RX   PubMed=17912029;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   A2.A2
AC   CVCL_6243
DR   Lonza; 179
DR   Wikidata; Q54606422
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   A2/82
AC   CVCL_E2Y7
DR   Cosmic; 713866
DR   Cosmic; 929147
RX   PubMed=8263009;
RX   PubMed=9673367;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9673367).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=8263009).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   A20
AC   CVCL_1940
SY   A-20
DR   BTO; BTO_0001930
DR   CLO; CLO_0001564
DR   CLO; CLO_0050194
DR   EFO; EFO_0005285
DR   ATCC; TIB-208
DR   BCRC; 60556
DR   BCRJ; 0030
DR   BioSample; SAMN11397658
DR   ChEMBL-Cells; CHEMBL3307765
DR   ChEMBL-Targets; CHEMBL613850
DR   CLS; 305263
DR   ENCODE; ENCBS119ENC
DR   ENCODE; ENCBS431JNZ
DR   GEO; GSM1014167
DR   Lonza; 743
DR   PubChem_Cell_line; CVCL_1940
DR   RCB; RCB2745
DR   TKG; TKG 0571
DR   TOKU-E; 459
DR   Ubigene; YC-C061
DR   Wikidata; Q54606424
RX   PubMed=310843;
RX   PubMed=22400032;
RX   PubMed=28902524;
RX   PubMed=31220119;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/A20_Stam_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-448.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/A20_cells
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/a20-xenograft-model/
CC   Part of: ENCODE project mouse cell lines.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 18 hours (PubMed=310843).
CC   Omics: Variations; Array-based CGH.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
ST   Source(s): PubMed=31220119; Ubigene=YC-C061
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 11,12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 12,13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 15,16,18
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 25
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   A20 NF-kappaB
AC   CVCL_YU22
SY   A20_NF-kappaB
DR   Wikidata; Q93311424
RX   PubMed=32094407;
CC   Characteristics: Reporter cell line for the measurement of the biological activity of a wide variety of cytokines (PubMed=32094407).
CC   Characteristics: Activated by NF-kappaB through a NF-kappaB response element fused to a secNanoLuc-T2A-mCherry construct (PubMed=32094407).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   A20-eGFP-Neo/Fluc-Puro
AC   CVCL_D5KA
DR   Imanis; CL152
DR   Wikidata; Q127378812
CC   Characteristics: Reporter cell line, transduced with both the LV-eGFP-P2A-Neo and LV-Fluc-P2A-PuroR vectors. LV-eGFP-P2A-Neo encodes for eGFP linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter and LV-Fluc-P2A-PuroR encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL152).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   A20-Fluc-Puro
AC   CVCL_QZ66
DR   Imanis; CL147
DR   Wikidata; Q54606426
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL147).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   A20-Nluc-copGFP
AC   CVCL_C0MY
DR   Kerafast; EF4008
DR   Wikidata; Q112927035
CC   From: Sehgal, Lalit; Ohio State University; Columbus; USA.
CC   Characteristics: Transduced with a CMV-Nluc-P2A-copGFP-T2A-PuroR construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   A20.IIA
AC   CVCL_0J27
SY   IIA1.6; IIA-1
DR   Wikidata; Q54606430
RX   PubMed=2415625;
RX   PubMed=21949734;
RX   PubMed=22400032;
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D138 ! A20/2J
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 6
//
ID   A20.IIA-GFP
AC   CVCL_0J28
DR   Wikidata; Q54606432
RX   PubMed=21949734;
RX   PubMed=22400032;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J27 ! A20.IIA
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
ID   A20/2J
AC   CVCL_D138
SY   A20-2J; A20.2J
DR   Wikidata; Q54606428
RX   PubMed=2415625;
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 8
//
ID   A2018
AC   CVCL_E2VJ
RX   PubMed=265522;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A204.1
AC   CVCL_L305
DR   EFO; EFO_0005702
DR   ENCODE; ENCBS256AAA
DR   Wikidata; Q54606433
RX   PubMed=16897758;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/MRTA204.1_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Gln182Alafs*28 (c.543_544delTC); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1058 ! A-204
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   A2058
AC   CVCL_1059
SY   A 2058; A-2058
DR   BTO; BTO_0002975
DR   CLO; CLO_0001566
DR   EFO; EFO_0006361
DR   CLDB; cl190
DR   CLDB; cl7207
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3601
DR   ATCC; CRL-11147
DR   BCRC; 60240
DR   BioGRID_ORCS_Cell_line; 326
DR   BioSample; SAMN01821723
DR   BioSample; SAMN03470825
DR   BioSample; SAMN10988063
DR   cancercelllines; CVCL_1059
DR   Cell_Model_Passport; SIDM00797
DR   CGH-DB; 9291-4
DR   ChEMBL-Cells; CHEMBL3308030
DR   ChEMBL-Targets; CHEMBL613503
DR   CLS; 305046
DR   Cosmic; 687430
DR   Cosmic; 888986
DR   Cosmic; 890885
DR   Cosmic; 905205
DR   Cosmic; 906792
DR   Cosmic; 928750
DR   Cosmic; 1022284
DR   Cosmic; 1028799
DR   Cosmic; 1054857
DR   Cosmic; 1155286
DR   Cosmic; 1303031
DR   Cosmic; 1477415
DR   Cosmic; 1481414
DR   Cosmic; 1507608
DR   Cosmic; 1669119
DR   Cosmic; 1995329
DR   Cosmic; 2159438
DR   Cosmic; 2233659
DR   Cosmic; 2651881
DR   Cosmic-CLP; 906792
DR   DepMap; ACH-000788
DR   ECACC; 91100402
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906792
DR   GEO; GSM162906
DR   GEO; GSM206442
DR   GEO; GSM274680
DR   GEO; GSM276736
DR   GEO; GSM827157
DR   GEO; GSM887916
DR   GEO; GSM1138786
DR   GEO; GSM1374379
DR   GEO; GSM1669579
DR   IARC_TP53; 21159
DR   ICLC; HTL08002
DR   JCRB; IFO50276
DR   LiGeA; CCLE_398
DR   LINCS_LDP; LCL-1237
DR   Lonza; 999
DR   PharmacoDB; A2058_38_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1059
DR   PubChem_Cell_line; CVCL_1059
DR   Wikidata; Q54606435
RX   DOI=10.1080/00087114.2001.10589242;
RX   PubMed=265522;
RX   PubMed=2203689;
RX   PubMed=6254071;
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9354451;
RX   PubMed=9466661;
RX   PubMed=11448059;
RX   PubMed=12068308;
RX   PubMed=14692828;
RX   PubMed=15048078;
RX   PubMed=15467732;
RX   PubMed=17308088;
RX   PubMed=17516929;
RX   PubMed=19147755;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22383533;
RX   PubMed=22460905;
RX   PubMed=23285177;
RX   PubMed=24576830;
RX   PubMed=24581590;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A2058
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/a2058-xenograft-model/
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11147.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=25984343).
CC   HLA typing: A*03:01,25:01; B*07:02,35:08; C*07:02,07:02; DQA1*01:02,02:01; DQB1*06:02,06:02; DRB1*15:01,14:10 (PubMed=25960936).
CC   HLA typing: A*03:01,25:01; B*07:02,18:01; C*07:02,12:03; DQA1*01:02,03:02; DQB1*06:02,06:02; DRB1*04:08,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=15048078; PubMed=15467732; PubMed=22383533; PubMed=24576830; ATCC=CRL-3601; Cosmic-CLP=906792; DepMap=ACH-000788).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Homozygous (Cosmic-CLP=906792; DepMap=ACH-000788).
CC   Sequence variation: Mutation; HGNC; HGNC:15979; TP63; Simple; p.Arg379Cys (c.1135C>T); Zygosity=Heterozygous (Cosmic-CLP=906792; DepMap=ACH-000788).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.45%; East Asian, North=0.51%; East Asian, South=0%; South Asian=0.49%; European, North=71.7%; European, South=26.84% (PubMed=30894373).
CC   Misspelling: A2658; CGH-DB=9291-4.
CC   Discontinued: ATCC; CRL-11147; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3601; Cosmic-CLP=906792; JCRB=IFO50276; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 14,15
ST   D12S391: 22,23
ST   D13S317: 13,14
ST   D16S539: 9,13
ST   D18S51: 13,15
ST   D19S433: 14
ST   D1S1656: 15,18.3
ST   D21S11: 29,30.2
ST   D22S1045: 16,17,18
ST   D2S1338: 17,18
ST   D2S441: 11.3,14
ST   D3S1358: 14,15
ST   D5S818: 9,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   DYS391: 11
ST   FGA: 21,24
ST   Penta D: 9,12
ST   Penta E: 10,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   A2058-RFP/H2B-GFP
AC   CVCL_XH73
SY   A2058(RFP/H2B-GFP)
DR   cancercelllines; CVCL_XH73
DR   Wikidata; Q93311453
RX   PubMed=27521448;
CC   Population: Caucasian.
CC   Characteristics: The H2B-eGFP fusion construct is under the control of the pPGK promoter and localizes to the nucleus.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11 (Note=With p.Gly26Asp and p.Ile119Val and fused in frame with eGFP).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1059 ! A2058
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   A2058-RFP/H2B-GFP BrM
AC   CVCL_XH74
SY   A2058(RFP/H2B-GFP) BrM
DR   cancercelllines; CVCL_XH74
DR   Wikidata; Q93311456
RX   PubMed=27521448;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Population: Caucasian.
CC   Characteristics: Brain parenchymal space metastatic derivative of parental cell line. Established after 3 passages in NMRI-nu/nu mice 4 weeks after intra-cardiac injection.
CC   Characteristics: The H2B-eGFP fusion construct is under the control of the pPGK promoter and localizes to the nucleus.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11 (Note=With p.Gly26Asp and p.Ile119Val and fused in frame with eGFP).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XH73 ! A2058-RFP/H2B-GFP
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   A206
AC   CVCL_B4IH
DR   Wikidata; Q110429844
RX   PubMed=10475274;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12-16FW
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   A208-4
AC   CVCL_X983
DR   Wikidata; Q54606438
RX   PubMed=3018542;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 10
//
ID   A208-7
AC   CVCL_X984
DR   Wikidata; Q54606440
RX   PubMed=3018542;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 10
//
ID   A2095
AC   CVCL_Y038
DR   Cosmic; 687564
DR   Wikidata; Q54606441
RX   PubMed=12068308;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   A2106
AC   CVCL_N283
SY   NR-M1-05
DR   ATCC; HB-9350
DR   Wikidata; Q54606445
RX   Patent=US4879225;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9350.
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   A212
AC   CVCL_ZD46
DR   Wikidata; Q98125439
RX   PubMed=8105609;
RX   PubMed=12920029;
CC   Population: Egyptian.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   A22
AC   CVCL_A8VJ
DR   Wikidata; Q108819802
RX   PubMed=22514610;
RX   PubMed=29921219;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: INRA Sy derived homozygous clone A22.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   A2215
AC   CVCL_N284
SY   NR-M1-03
DR   ATCC; HB-9349
DR   Wikidata; Q54606448
RX   Patent=US4879225;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9349.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   A224
AC   CVCL_D277
SY   A-224
DR   BTO; BTO_0004034
DR   Wikidata; Q54606453
RX   PubMed=9554442;
RX   PubMed=12080474;
CC   From: De Greve, Jacques; Oncologisch Centrum; Brussels; Belgium.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   A2243
AC   CVCL_F682
SY   A-2243; HA2243; HA 2243
DR   ABM; T8324
DR   Cosmic; 1217473
DR   Wikidata; Q54606455
RX   PubMed=7539744;
WW   Provider; NCI TTC; TAB-4070/E-160-2005-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4070
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Characteristics: Tumorigenic in nude mice (NCI TTC=TAB-4070/E-160-2005-0).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (PubMed=7539744).
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   A22D2
AC   CVCL_D7E3
RX   Patent=US8685399;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02548; Human PAX5 (Note=Recognizes AA 370-375).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A23-16
AC   CVCL_WZ43
DR   Wikidata; Q93311494
RX   PubMed=2826463;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human sulfated glycoprotein preferentially expressed by small cell lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   A23-A/D3
AC   CVCL_B0PW
DR   Wikidata; Q108819803
RX   Patent=DD242423B1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0004.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02769; Bovine ALB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A23-iPSC
AC   CVCL_DD64
DR   Wikidata; Q54606456
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=27191603).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   A238
AC   CVCL_K264
SY   A-238
DR   CLO; CLO_0001567
DR   CLDB; cl191
DR   Wikidata; Q54606554
RX   PubMed=2988162;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_K265 ! Don/a23
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   A24
AC   CVCL_V064
DR   CLO; CLO_0001568
DR   CLDB; cl192
DR   IHW; 11w 8009
DR   Wikidata; Q54606557
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   A25.1#1B3
AC   CVCL_XK77
SY   PAb1
DR   Wikidata; Q93311508
RX   Patent=US4172124;
RX   PubMed=79181;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   A27.15
AC   CVCL_XC74
DR   Wikidata; Q93311511
RX   Patent=US5667781;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10395.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 5
//
ID   A2774
AC   CVCL_U376
SY   A-2774
DR   Wikidata; Q54606558
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-63.html
CC   From: Benard, Jean; Institut Gustave Roussy; Villejuif; France.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   A2780
AC   CVCL_0134
SY   A-2780; 2780; A2780S; A2780par
DR   BTO; BTO_0002549
DR   CLO; CLO_0001571
DR   EFO; EFO_0006362
DR   MCCL; MCC:0000027
DR   CLDB; cl193
DR   CLDB; cl194
DR   CLDB; cl4894
DR   ABM; T8089
DR   AddexBio; C0017002/20
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0031
DR   BioGRID_ORCS_Cell_line; 329
DR   BioSample; SAMN03472806
DR   BioSample; SAMN10988216
DR   cancercelllines; CVCL_0134
DR   CancerTools; 152706
DR   Cell_Model_Passport; SIDM00210
DR   ChEMBL-Cells; CHEMBL3308421
DR   ChEMBL-Targets; CHEMBL614004
DR   CLS; 300491
DR   Cosmic; 688090
DR   Cosmic; 755844
DR   Cosmic; 849607
DR   Cosmic; 906804
DR   Cosmic; 923108
DR   Cosmic; 948284
DR   Cosmic; 987394
DR   Cosmic; 1093558
DR   Cosmic; 1102819
DR   Cosmic; 1139223
DR   Cosmic; 1198265
DR   Cosmic; 1305309
DR   Cosmic; 1609529
DR   Cosmic; 1707564
DR   Cosmic; 1708387
DR   Cosmic; 1709251
DR   Cosmic; 1945872
DR   Cosmic; 1995331
DR   Cosmic; 2582805
DR   Cosmic; 2674698
DR   Cosmic-CLP; 906804
DR   DepMap; ACH-000657
DR   ECACC; 93112519
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906804
DR   GEO; GSM184388
DR   GEO; GSM184389
DR   GEO; GSM383925
DR   GEO; GSM503257
DR   GEO; GSM659370
DR   GEO; GSM711722
DR   GEO; GSM827312
DR   GEO; GSM851909
DR   GEO; GSM886853
DR   GEO; GSM887918
DR   GEO; GSM1001419
DR   GEO; GSM1001420
DR   GEO; GSM1001488
DR   GEO; GSM1291126
DR   GEO; GSM1291129
DR   GEO; GSM1340577
DR   GEO; GSM1374380
DR   GEO; GSM1374381
DR   GEO; GSM1669581
DR   GEO; GSM2474971
DR   GEO; GSM4845007
DR   GEO; GSM4845008
DR   GEO; GSM6065211
DR   GEO; GSM6065212
DR   GEO; GSM6065213
DR   IARC_TP53; 21161
DR   ICLC; HTL98008
DR   LiGeA; CCLE_809
DR   LINCS_LDP; LCL-1518
DR   Lonza; 207
DR   MetaboLights; MTBLS156
DR   MetaboLights; MTBLS1014
DR   NCI-DTP; A2780
DR   PharmacoDB; A2780_40_2019
DR   PRIDE; PXD001176
DR   PRIDE; PXD003105
DR   PRIDE; PXD003252
DR   PRIDE; PXD003668
DR   PRIDE; PXD013811
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0134
DR   PubChem_Cell_line; CVCL_0134
DR   Wikidata; Q54606559
DR   Ximbio; 152706
RX   PubMed=1348364;
RX   PubMed=1999494;
RX   PubMed=2429947;
RX   PubMed=2751261;
RX   PubMed=3335022;
RX   PubMed=3539322;
RX   PubMed=3986765;
RX   PubMed=6173755;
RX   PubMed=6372095;
RX   PubMed=6954533;
RX   PubMed=7927910;
RX   PubMed=8012063;
RX   PubMed=8557231;
RX   PubMed=9041185;
RX   PubMed=11103784;
RX   PubMed=11416159;
RX   PubMed=12080474;
RX   PubMed=15677628;
RX   PubMed=18273836;
RX   PubMed=19714814;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=22328975;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22705003;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25846456;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27235858;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=28546799;
RX   PubMed=30485824;
RX   PubMed=30894224;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=33287223;
RX   PubMed=34071702;
RX   PubMed=35839778;
RX   PubMed=36476833;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/a2780/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-64.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: African American.
CC   Doubling time: 25.3 +- 1 hours (PubMed=3539322); 16 hours (PubMed=25984343); 18.41 hours (JWGray panel).
CC   HLA typing: A*26:03,26:03; B*37:04,49:01; C*02:02,07:01; DQB1*06:07,06:07; DRB1*01:01,01:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15677628; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (PubMed=25846456).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (DepMap=ACH-000657).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (PubMed=25230021; DepMap=ACH-000657).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (DepMap=ACH-000657).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Glycomics; N-glycan profiling; Lectin array.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=93.08%; Native American=0%; East Asian, North=2.76%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=4.17% (PubMed=30894373).
CC   Discontinued: ECACC; 93112519; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): AddexBio=C0017002/20; Cosmic-CLP=906804; ECACC=93112519; ICLC=HTL98008; PubMed=11416159; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12,13 (ICLC=HTL98008)
ST   D16S539: 11,13 (AddexBio=C0017002/20; Cosmic-CLP=906804; ECACC=93112519; PubMed=25230021; PubMed=25877200; PubMed=30485824)
ST   D18S51: 16,18
ST   D19S433: 12
ST   D21S11: 28 (PubMed=25230021; PubMed=25877200)
ST   D21S11: 28,29 (PubMed=30485824)
ST   D2S1338: 21,22
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15,17
ST   FGA: 19,24
ST   Penta D: 8,9
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   A2780 LIN28B KO
AC   CVCL_C3NF
DR   ABM; T9506
DR   Wikidata; Q116048455
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   A2780 PTX(128)
AC   CVCL_C0DB
SY   A2780 PTX (128); A/128 PTX-37d; A/128PTX-37d
DR   cancercelllines; CVCL_C0DB
DR   CancerTools; 160734
DR   GEO; GSM4845019
DR   GEO; GSM4845020
DR   Wikidata; Q112927036
DR   Ximbio; 160734
RX   Patent=PL420318A1;
RX   PubMed=33287223;
WW   Provider; IBCH PAS; -; https://portal.ichb.pl/commercialization-of-model-for-drug-resistant-cancer-cells/
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0DA ! A2780 PTX(64)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780 PTX(16)
AC   CVCL_C0D8
SY   A2780 PTX (16); A/16 PTX-56d; A/16PTX-56d
DR   cancercelllines; CVCL_C0D8
DR   CancerTools; 160731
DR   GEO; GSM4845013
DR   GEO; GSM4845014
DR   Wikidata; Q112927037
DR   Ximbio; 160731
RX   Patent=PL420318A1;
RX   PubMed=33287223;
WW   Provider; IBCH PAS; -; https://portal.ichb.pl/commercialization-of-model-for-drug-resistant-cancer-cells/
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0D7 ! A2780 PTX(8)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780 PTX(32)
AC   CVCL_C0D9
SY   A2780 PTX (32); A/32 PTX-48d; A/32PTX-48d
DR   cancercelllines; CVCL_C0D9
DR   CancerTools; 160732
DR   GEO; GSM4845015
DR   GEO; GSM4845016
DR   Wikidata; Q112927039
DR   Ximbio; 160732
RX   Patent=PL420318A1;
RX   PubMed=33287223;
WW   Provider; IBCH PAS; -; https://portal.ichb.pl/commercialization-of-model-for-drug-resistant-cancer-cells/
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0D8 ! A2780 PTX(16)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780 PTX(4)
AC   CVCL_C0D6
SY   A2780 PTX (4); A/4 PTX-63d; A/4PTX-63d
DR   cancercelllines; CVCL_C0D6
DR   CancerTools; 160729
DR   GEO; GSM4845009
DR   GEO; GSM4845010
DR   Wikidata; Q112927041
DR   Ximbio; 160729
RX   Patent=PL420318A1;
RX   PubMed=33287223;
WW   Provider; IBCH PAS; -; https://portal.ichb.pl/commercialization-of-model-for-drug-resistant-cancer-cells/
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780 PTX(64)
AC   CVCL_C0DA
SY   A2780 PTX (64); A/64 PTX-30d; A/64PTX-30d
DR   cancercelllines; CVCL_C0DA
DR   CancerTools; 160733
DR   GEO; GSM4845017
DR   GEO; GSM4845018
DR   Wikidata; Q112927043
DR   Ximbio; 160733
RX   Patent=PL420318A1;
RX   PubMed=33287223;
WW   Provider; IBCH PAS; -; https://portal.ichb.pl/commercialization-of-model-for-drug-resistant-cancer-cells/
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0D9 ! A2780 PTX(32)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780 PTX(8)
AC   CVCL_C0D7
SY   A2780 PTX (8); A/8 PTX-33d; A/8PTX-33d
DR   cancercelllines; CVCL_C0D7
DR   CancerTools; 160730
DR   GEO; GSM4845011
DR   GEO; GSM4845012
DR   Wikidata; Q112927044
DR   Ximbio; 160730
RX   Patent=PL420318A1;
RX   PubMed=33287223;
WW   Provider; IBCH PAS; -; https://portal.ichb.pl/commercialization-of-model-for-drug-resistant-cancer-cells/
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0D6 ! A2780 PTX(4)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780 RRAS2 KO#20
AC   CVCL_E5L2
DR   GEO; GSM6065214
DR   GEO; GSM6065215
DR   GEO; GSM6065216
RX   PubMed=36476833;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   A2780 RRAS2 KO#3
AC   CVCL_E5L1
RX   PubMed=36476833;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   A2780-1A9
AC   CVCL_H619
SY   A2780/1A9; A2780(1A9); 1A9
DR   cancercelllines; CVCL_H619
DR   ChEMBL-Cells; CHEMBL3307529
DR   ChEMBL-Targets; CHEMBL614075
DR   GEO; GSM95437
DR   Progenetix; CVCL_H619
DR   PubChem_Cell_line; CVCL_H619
DR   Wikidata; Q54582664
RX   PubMed=1348364;
RX   PubMed=16382445;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: IA9; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 24
//
ID   A2780-CBDCA-R
AC   CVCL_ZE22
SY   CBDCA-R-A2780
DR   cancercelllines; CVCL_ZE22
DR   Wikidata; Q98125441
RX   PubMed=30894224;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   A2780-cisR
AC   CVCL_H745
SY   A2780-CISR; A2780/cisR; A2780cisR; A2780(cisR)
DR   cancercelllines; CVCL_H745
DR   ChEMBL-Cells; CHEMBL3307508
DR   ChEMBL-Targets; CHEMBL614023
DR   Cosmic; 688091
DR   MetaboLights; MTBLS156
DR   MetaboLights; MTBLS1014
DR   PubChem_Cell_line; CVCL_H745
DR   Wikidata; Q54606563
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 23
//
ID   A2780-DR
AC   CVCL_EG64
DR   cancercelllines; CVCL_EG64
DR   PRIDE; PXD001176
DR   PRIDE; PXD003252
DR   Wikidata; Q54606564
RX   PubMed=25096996;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   A2780-DX1
AC   CVCL_4T95
DR   cancercelllines; CVCL_4T95
DR   Wikidata; Q54606565
RX   PubMed=2243668;
RX   PubMed=2598402;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   A2780-DX2
AC   CVCL_4T96
DR   cancercelllines; CVCL_4T96
DR   Wikidata; Q54606567
RX   PubMed=2598402;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T95 ! A2780-DX1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   A2780-DX3
AC   CVCL_7225
SY   A2780/DX3; A2780 DX3; DX3
DR   BTO; BTO_0002642
DR   cancercelllines; CVCL_7225
DR   Wikidata; Q54606570
RX   PubMed=2598402;
RX   PubMed=2751261;
RX   PubMed=7713987;
RX   PubMed=8012063;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T96 ! A2780-DX2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   A2780-DX4
AC   CVCL_4T97
DR   cancercelllines; CVCL_4T97
DR   Wikidata; Q54606571
RX   PubMed=2598402;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7225 ! A2780-DX3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   A2780-DX5
AC   CVCL_4T98
SY   A2780 DX5; A2780/Dx5
DR   cancercelllines; CVCL_4T98
DR   Wikidata; Q54606574
RX   PubMed=2598402;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T97 ! A2780-DX4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   A2780-DX6
AC   CVCL_4T99
DR   cancercelllines; CVCL_4T99
DR   Wikidata; Q54606575
RX   PubMed=2598402;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T98 ! A2780-DX5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   A2780-E(80)
AC   CVCL_S476
SY   A2780 E(80)
DR   cancercelllines; CVCL_S476
DR   Wikidata; Q54606577
RX   PubMed=10772682;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H619 ! A2780-1A9
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   A2780-M
AC   CVCL_TZ68
DR   cancercelllines; CVCL_TZ68
DR   Wikidata; Q93311561
RX   PubMed=30046596;
CC   Population: African American.
CC   Characteristics: Compared to the parent cell line, has high invasiveness and motility.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=30046596
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 18,19,20
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 16,18,19
ST   D19S433: 12
ST   D21S11: 28
ST   D2S1338: 21,22
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D6S1043: 11,19
ST   D7S820: 10
ST   D8S1179: 15,17
ST   FGA: 19,24
ST   Penta D: 9,10
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   A2780-NiraR
AC   CVCL_E5I4
DR   CCRID; 4201PAT-CCTCC02086
RX   Patent=US20240263142;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202299.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_176844; Niraparib.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   A2780-SCA
AC   CVCL_DI16
DR   cancercelllines; CVCL_DI16
DR   GEO; GSM459649
DR   GEO; GSM459730
DR   Progenetix; CVCL_DI16
DR   Wikidata; Q54606579
RX   PubMed=12509269;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   A2780-TC1
AC   CVCL_1F93
SY   A2780 TC1; A2780TC1; TC1
DR   cancercelllines; CVCL_1F93
DR   Wikidata; Q54606582
RX   PubMed=12815160;
RX   PubMed=19714814;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   A2780/100
AC   CVCL_7224
SY   A2780(100)
DR   BTO; BTO_0003207
DR   cancercelllines; CVCL_7224
DR   Wikidata; Q54606583
RX   PubMed=10413308;
RX   PubMed=10644989;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28830; Chlorambucil (CBL; Leukeran).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   A2780/ACR6
AC   CVCL_D156
SY   ACR6
DR   cancercelllines; CVCL_D156
DR   Wikidata; Q54606586
RX   PubMed=12726863;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   A2780/ACRP
AC   CVCL_D157
SY   ACRP
DR   BCRJ; 0036
DR   cancercelllines; CVCL_D157
DR   Wikidata; Q54606587
RX   PubMed=12726863;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): BCRJ=0036
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 16,18
ST   D19S433: 12
ST   D21S11: 28
ST   D2S1338: 21,22
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15,17
ST   FGA: 19,23
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   A2780/AD10
AC   CVCL_B037
SY   A2780-AD10; A2780-AD-10; AD10; AD-10
DR   BTO; BTO_0004037
DR   cancercelllines; CVCL_B037
DR   Wikidata; Q54606588
RX   PubMed=8557231;
RX   PubMed=9554442;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   A2780/ADDP
AC   CVCL_D537
SY   A2780 ADDP; ADDP
DR   cancercelllines; CVCL_D537
DR   ChEMBL-Cells; CHEMBL3307898
DR   ChEMBL-Targets; CHEMBL614264
DR   PubChem_Cell_line; CVCL_D537
DR   Wikidata; Q54606592
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   A2780/C100
AC   CVCL_B7S7
SY   C100
DR   cancercelllines; CVCL_B7S7
DR   Wikidata; Q112927045
RX   PubMed=1348364;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780/C200
AC   CVCL_F638
SY   C200
DR   cancercelllines; CVCL_F638
DR   GEO; GSM184394
DR   GEO; GSM184395
DR   Progenetix; CVCL_F638
DR   Wikidata; Q54606593
RX   PubMed=1348364;
RX   PubMed=7954422;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   A2780/C30
AC   CVCL_F639
SY   C30
DR   cancercelllines; CVCL_F639
DR   GEO; GSM184396
DR   GEO; GSM184397
DR   Progenetix; CVCL_F639
DR   Wikidata; Q54606596
RX   PubMed=1348364;
RX   PubMed=7954422;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   A2780/C300
AC   CVCL_B7S6
SY   C300
DR   cancercelllines; CVCL_B7S6
DR   Wikidata; Q112927048
RX   PubMed=1348364;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780/C50
AC   CVCL_B7S8
SY   C50
DR   cancercelllines; CVCL_B7S8
DR   Wikidata; Q112927050
RX   PubMed=1348364;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780/C80
AC   CVCL_B7S5
SY   C80
DR   cancercelllines; CVCL_B7S5
DR   Wikidata; Q112927053
RX   PubMed=1348364;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   A2780/CBP
AC   CVCL_D620
SY   A-car
DR   cancercelllines; CVCL_D620
DR   Wikidata; Q54606598
RX   PubMed=15254775;
RX   PubMed=17269733;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   A2780/cDDP
AC   CVCL_Y180
DR   cancercelllines; CVCL_Y180
DR   CGH-DB; 9110-4
DR   Wikidata; Q54606601
RX   PubMed=14973057;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   A2780/CDDP
AC   CVCL_D619
DR   BTO; BTO_0005152
DR   cancercelllines; CVCL_D619
DR   Wikidata; Q54606602
RX   PubMed=15254775;
RX   PubMed=17269733;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   A2780/cmv
AC   CVCL_A5AB
DR   cancercelllines; CVCL_A5AB
DR   Wikidata; Q107113314
RX   PubMed=9924699;
RX   PubMed=12093475;
CC   Population: African American.
CC   Characteristics: Control cell line for A2780/m175 (Cellosaurus=CVCL_A5AC), A2780/m248 (Cellosaurus=CVCL_A5AD) and A2780/m273 (Cellosaurus=CVCL_A5AE) (PubMed=9924699).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   A2780/CP20
AC   CVCL_A5PS
SY   A2780(CP20); A2780-CP-20; A2780CP20
DR   cancercelllines; CVCL_A5PS
DR   IARC_TP53; 5551
DR   Wikidata; Q107113315
RX   PubMed=3539322;
RX   PubMed=8557231;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Phe (c.517G>T); Zygosity=Unspecified (PubMed=8557231).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   A2780/CP70
AC   CVCL_0135
SY   A2780/cp70; A2780 CP70; A2780(CP70); A2780CP70; A2780/CP; A2780-CP; A2780-cp; A 2780 CP; A2780CP; 2780CP; CP70; CP-70
DR   BTO; BTO_0003845
DR   MCCL; MCC:0000028
DR   cancercelllines; CVCL_0135
DR   GEO; GSM184400
DR   GEO; GSM184401
DR   GEO; GSM743511
DR   GEO; GSM851908
DR   GEO; GSM1178064
DR   GEO; GSM1178065
DR   NCBI_Iran; C454
DR   PRIDE; PXD003668
DR   Progenetix; CVCL_0135
DR   Wikidata; Q54606604
RX   PubMed=1348364;
RX   PubMed=1999494;
RX   PubMed=2429947;
RX   PubMed=3335022;
RX   PubMed=3539322;
RX   PubMed=7954422;
RX   PubMed=9554442;
RX   PubMed=12080474;
RX   PubMed=17254797;
RX   PubMed=19926575;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=28546799;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Glycomics; N-glycan profiling; Lectin array.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 16,18
ST   D21S11: 27,28
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 15,17
ST   FGA: 19,24
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   A2780/CP8
AC   CVCL_A5PT
SY   A2780(CP8); A2780CP8
DR   cancercelllines; CVCL_A5PT
DR   Wikidata; Q107113316
RX   PubMed=1348364;
RX   PubMed=3539322;
CC   Population: African American.
CC   Doubling time: 22.1 +- 0.7 hours (PubMed=3539322).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   A2780/m175
AC   CVCL_A5AC
DR   cancercelllines; CVCL_A5AC
DR   Wikidata; Q107113318
RX   PubMed=9924699;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg175His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   A2780/m248
AC   CVCL_A5AD
DR   cancercelllines; CVCL_A5AD
DR   Wikidata; Q107113319
RX   PubMed=9924699;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg248Trp).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   A2780/m273
AC   CVCL_A5AE
SY   A2780/mt273
DR   cancercelllines; CVCL_A5AE
DR   Wikidata; Q107113320
RX   PubMed=9924699;
RX   PubMed=12093475;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   A2780/R
AC   CVCL_4862
DR   BTO; BTO_0005130
DR   cancercelllines; CVCL_4862
DR   Wikidata; Q54606605
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_48120; Anthracycline.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   A2780/S
AC   CVCL_4863
SY   A 2780 S
DR   BTO; BTO_0005129
DR   cancercelllines; CVCL_4863
DR   ChEMBL-Cells; CHEMBL4295440
DR   ChEMBL-Targets; CHEMBL4296398
DR   NCBI_Iran; C461
DR   PubChem_Cell_line; CVCL_4863
DR   Wikidata; Q54606607
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   A2780/Taxol
AC   CVCL_IJ13
SY   A2780/T
DR   cancercelllines; CVCL_IJ13
DR   ChEMBL-Cells; CHEMBL4483130
DR   ChEMBL-Targets; CHEMBL4483224
DR   Wikidata; Q54606608
RX   PubMed=24175763;
CC   Population: African American.
CC   Doubling time: 24.22 +- 0.22 hours (PubMed=24175763).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   A2780/TPT
AC   CVCL_4V45
DR   cancercelllines; CVCL_4V45
DR   Wikidata; Q54606611
RX   DOI=10.3969/j.issn.1004-7379.2004.03.003;
RX   PubMed=14693055;
RX   PubMed=15196431;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   A2780AD
AC   CVCL_UJ39
SY   A2780/AD
DR   BTO; BTO_0006326
DR   cancercelllines; CVCL_UJ39
DR   Wikidata; Q93311635
RX   PubMed=2429947;
RX   PubMed=7927910;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   A2780ADR
AC   CVCL_1941
SY   A2780-ADR; A2780 ADR
DR   CLO; CLO_0001572
DR   BioGRID_ORCS_Cell_line; 826
DR   cancercelllines; CVCL_1941
DR   CancerTools; 152707
DR   Cell_Model_Passport; SIDM01211
DR   ChEMBL-Cells; CHEMBL3988401
DR   Cosmic; 1139224
DR   ECACC; 93112520
DR   GEO; GSM827329
DR   GEO; GSM1291127
DR   LINCS_LDP; LCL-1694
DR   Progenetix; CVCL_1941
DR   PubChem_Cell_line; CVCL_1941
DR   Wikidata; Q54606613
DR   Ximbio; 152707
RX   PubMed=11416159;
RX   PubMed=20215515;
RX   PubMed=25230021;
RX   PubMed=30971826;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 93112520; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ECACC=93112520; PubMed=11416159; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,14
ST   D18S51: 15
ST   D19S433: 12
ST   D21S11: 28
ST   D2S1338: 21,22
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 14,15,16,17 (PubMed=25230021)
ST   D8S1179: 15,16,17 (PubMed=11416159)
ST   FGA: 19,25
ST   Penta D: 8,9
ST   Penta E: 10,13
ST   TH01: 6 (ECACC=93112520; PubMed=25230021)
ST   TH01: 6,9.3 (PubMed=11416159)
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   A2780cis
AC   CVCL_1942
SY   A2780Cis; A2780CIS; A2780_CIS; A2780 CIS
DR   CLO; CLO_0001573
DR   CLDB; cl195
DR   AddexBio; C0017003/4911
DR   BioGRID_ORCS_Cell_line; 827
DR   cancercelllines; CVCL_1942
DR   CancerTools; 152708
DR   Cell_Model_Passport; SIDM01212
DR   ChEMBL-Cells; CHEMBL4295428
DR   ECACC; 93112517
DR   GEO; GSM827456
DR   GEO; GSM1291128
DR   GEO; GSM2474972
DR   LINCS_LDP; LCL-1696
DR   Progenetix; CVCL_1942
DR   PubChem_Cell_line; CVCL_1942
DR   Wikidata; Q54606614
DR   Ximbio; 152708
RX   PubMed=11416159;
RX   PubMed=18273836;
RX   PubMed=20215515;
RX   PubMed=22585861;
RX   PubMed=25230021;
RX   PubMed=28273451;
RX   PubMed=30971826;
RX   PubMed=34071702;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 93112517; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): AddexBio=C0017003/4911; ECACC=93112517; PubMed=11416159; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D19S433: 12
ST   D21S11: 28
ST   D2S1338: 21,23
ST   D3S1358: 13,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 15,18
ST   FGA: 19,24
ST   Penta D: 8,9
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   A2780ME
AC   CVCL_UJ38
DR   cancercelllines; CVCL_UJ38
DR   Wikidata; Q93311647
RX   PubMed=2429947;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   A2780veliR
AC   CVCL_C1NE
DR   cancercelllines; CVCL_C1NE
DR   Wikidata; Q114310504
RX   PubMed=34445211;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_62880; Veliparib (ABT-888).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0134 ! A2780
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   A27F6.1
AC   CVCL_B0NX
SY   CR-1; CR1
DR   Wikidata; Q108819804
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3310.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A28-4-1
AC   CVCL_E9W6
RX   PubMed=7730618;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2299; Cd28.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D138 ! A20/2J
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A2B5 clone 105
AC   CVCL_7946
SY   A2B5
DR   CLO; CLO_0001574
DR   ATCC; CRL-1520
DR   ATCC; HB-29
DR   ECACC; 90070501
DR   JCRB; IFO50284
DR   Wikidata; Q54606616
RX   PubMed=388422;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_28892; Ganglioside.
CC   Discontinued: ATCC; HB-29; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   A2BR
AC   CVCL_C8QZ
DR   Wikidata; Q123030354
RX   PubMed=315438;
CC   Characteristics: Leukemia cells were transferred by intraperitoneal passage in syngeneic recipients. The cell line was obtained from tumour cells successfully grown in ascites for a few passages (PubMed=315438).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: B10.BR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-5M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   A2C7
AC   CVCL_J024
DR   Wikidata; Q54606618
RX   Patent=US4670382;
RX   Patent=US4806465;
RX   PubMed=6365778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8397.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30575; Candida albicans enolase 1 (ENO1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   A2E11
AC   CVCL_D151
DR   CLO; CLO_0001575
DR   ATCC; CRL-1846
DR   Wikidata; Q54606621
RX   PubMed=3453564;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_27584; Aldosterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 6
//
ID   A2E8
AC   CVCL_C4AX
DR   ABCD; ABCD_AF674
DR   Wikidata; Q116048456
RX   Patent=CN106957367B;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132His).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   A2EN
AC   CVCL_0P36
SY   DT-21
DR   ABM; T0595
DR   CancerTools; 157949
DR   Kerafast; ELU101
DR   Millipore; SCC131
DR   Wikidata; Q54606622
RX   PubMed=18201283;
RX   PubMed=21943934;
CC   Characteristics: Established as a model for sexually transmitted pathogens infection, pathogenesis and innate immune response studies (Kerafast=ELU101).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): Millipore=SCC131
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 12,16
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 20
//
ID   A2F10
AC   CVCL_KA98
DR   RCB; RCB4485
DR   Wikidata; Q54606623
RX   PubMed=9620281;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q00342; Mouse Flt3/Cd135.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   A2H
AC   CVCL_4100
DR   CLO; CLO_0001576
DR   CLDB; cl196
DR   ECACC; 85011441
DR   Wikidata; Q54606628
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 8
//
ID   A2L
AC   CVCL_X201
DR   Wikidata; Q54606625
RX   PubMed=6088881;
RX   PubMed=6310010;
RX   PubMed=6324641;
CC   Doubling time: 26 hours (Note=At 65th passage) (PubMed=6088881).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   A2L/AH
AC   CVCL_X202
DR   Wikidata; Q54606627
RX   PubMed=3008992;
RX   PubMed=6088881;
RX   PubMed=6324641;
CC   Doubling time: 30 hours (PubMed=6088881).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X201 ! A2L
HI   CVCL_X200 ! Ad-AH
CA   Hybrid cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 6
//
ID   A2SW
AC   CVCL_C8R0
DR   Wikidata; Q123030355
RX   PubMed=315438;
CC   Characteristics: Leukemia cells were transferred by intraperitoneal passage in syngeneic recipients. The cell line was obtained from tumour cells successfully grown in ascites for a few passages (PubMed=315438).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: A.SW.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-5M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   A2TH
AC   CVCL_C8R1
DR   Wikidata; Q123030356
RX   PubMed=315438;
CC   Characteristics: Leukemia cells were transferred by intraperitoneal passage in syngeneic recipients. The cell line was obtained from tumour cells successfully grown in ascites for a few passages (PubMed=315438).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: A.TH.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-5M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   A3 [Mouse Sertoli]
AC   CVCL_E3B1
RX   PubMed=23509371;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A3 [Oncorhynchus]
AC   CVCL_A8VK
DR   Wikidata; Q109346709
RX   PubMed=22514610;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: INRA Sy derived homozygous clone A3.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   A3-1
AC   CVCL_GS33
DR   Wikidata; Q54606733
RX   DOI=10.1262/jrd1977.37.37;
RX   PubMed=8648758;
RX   PubMed=9353641;
RX   PubMed=9373942;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   A3.13.1
AC   CVCL_D3F3
DR   Wikidata; Q127378813
RX   PubMed=1380254;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15692; Human VEGFA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   A3.4H2
AC   CVCL_G628
DR   CLO; CLO_0001579
DR   ATCC; HB-12319
DR   Wikidata; Q54606729
RX   Patent=US6207156;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12319.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   A3.6B10
AC   CVCL_G629
DR   CLO; CLO_0001580
DR   ATCC; HB-12318
DR   Wikidata; Q54606731
RX   Patent=US6207156;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12318.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   A3/Kawakami
AC   CVCL_1062
SY   A3/KAW; A3-KAW; A3KAW; A3/Kawa
DR   CLO; CLO_0037046
DR   EFO; EFO_0006532
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470896
DR   BioSample; SAMN10987848
DR   cancercelllines; CVCL_1062
DR   Cell_Model_Passport; SIDM00495
DR   ChEMBL-Cells; CHEMBL3308225
DR   ChEMBL-Targets; CHEMBL2366273
DR   Cosmic; 910935
DR   Cosmic; 919153
DR   Cosmic-CLP; 910935
DR   DepMap; ACH-000697
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910935
DR   GEO; GSM886855
DR   GEO; GSM887920
DR   GEO; GSM1669584
DR   IARC_TP53; 183
DR   IARC_TP53; 21162
DR   JCRB; JCRB0101
DR   LiGeA; CCLE_380
DR   LINCS_LDP; LCL-1149
DR   PharmacoDB; A3KAW_41_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1062
DR   PubChem_Cell_line; CVCL_1062
DR   Wikidata; Q54606737
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2144611;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6601597;
RX   PubMed=9290701;
RX   PubMed=9510473;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 20-22 hours (PubMed=6601597); 38 hours (Note=Lot 01142009), ~39 hours (Note=Lot 03142016) (JCRB=JCRB0101).
CC   HLA typing: A*02:03,02:03; B*39:01,39:01; C*07:02,07:02; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*11:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (PubMed=2144611).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (PubMed=2144611).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=79.02%; East Asian, South=20.54%; South Asian=0%; European, North=0.43%; European, South=0% (PubMed=30894373).
CC   Misspelling: A3/KAWASAKI; PubMed=10739008; PubMed=11226526.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=910935; JCRB=JCRB0101; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10
ST   D18S51: 17
ST   D19S433: 12,14
ST   D21S11: 32.2,33.2
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 20,23
ST   Penta D: 10,14
ST   Penta E: 15,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   A3/MHV
AC   CVCL_GS34
DR   Wikidata; Q54606735
RX   PubMed=8648758;
CC   Virology: Persistently infected by mouse hepatitis virus type-2 (MHV-2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS33 ! A3-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   A3026
AC   CVCL_N285
SY   NR-M1-06
DR   ATCC; HB-9348
DR   Wikidata; Q54606740
RX   Patent=US4879225;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9348.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   A31-714
AC   CVCL_VI61
DR   Wikidata; Q93311690
RX   PubMed=4792350;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   A31-714 C4
AC   CVCL_L989
DR   JCRB; IFO50021
DR   Wikidata; Q54606746
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VI61 ! A31-714
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   A31-IS11 EGF-2
AC   CVCL_A9DY
SY   A31-IS11EGF-2
DR   Wikidata; Q108819806
RX   Patent=US4935352;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50093.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3229; EGF.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   A31B1
AC   CVCL_E3B2
RX   PubMed=23509371;
CC   Doubling time: 18 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B1 ! A3 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A31B4
AC   CVCL_E3B3
RX   PubMed=23509371;
CC   Doubling time: 26 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B1 ! A3 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A31C1
AC   CVCL_E3B4
RX   PubMed=23509371;
CC   Doubling time: 23 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B1 ! A3 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A31C4
AC   CVCL_E3B5
RX   PubMed=23509371;
CC   Doubling time: 18 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B1 ! A3 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A32-1
AC   CVCL_E275
SY   Pa07c
DR   Cosmic; 1473089
DR   Cosmic; 1509853
DR   Wikidata; Q54606750
RX   PubMed=18772397;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   A32B4
AC   CVCL_E3B6
RX   PubMed=23509371;
CC   Doubling time: 23 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B1 ! A3 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A33
AC   CVCL_J975
SY   AS 33; AS33
DR   CLO; CLO_0001751
DR   ATCC; HB-8779
DR   Wikidata; Q54750581
RX   Patent=US5160723;
RX   PubMed=2230877;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8779.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99795; Human GPA33.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   A33A4
AC   CVCL_E3B7
RX   PubMed=23509371;
CC   Doubling time: 18 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B1 ! A3 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A36
AC   CVCL_A8VL
DR   Wikidata; Q108819807
RX   PubMed=22514610;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: INRA Sy derived homozygous clone A36.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   A364
AC   CVCL_6561
SY   A-364
DR   BTO; BTO_0004246
DR   Wikidata; Q54606751
RX   PubMed=12080474;
CC   From: De Greve, Jacques; Oncologisch Centrum; Brussels; Belgium.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   A375 NRAS (Q61K/+/+)
AC   CVCL_LC86
SY   NRAS (Q61K/+/+) A375
DR   cancercelllines; CVCL_LC86
DR   Horizon_Discovery; HD+118-001
DR   Wikidata; Q54606773
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+118-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   A375 NY-ESO-1 High
AC   CVCL_C3DA
DR   cancercelllines; CVCL_C3DA
DR   Sigma-Aldrich; ATG004
DR   Wikidata; Q114310505
CC   Population: Caucasian.
CC   Characteristics: Expresses CTAG1B at high level (Sigma-Aldrich=ATG004).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:2491; CTAG1B.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2491; CTAG1B.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3D8 ! A375 NY-ESO-1 Knockout
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   A375 NY-ESO-1 Knockout
AC   CVCL_C3D8
SY   A375 NY-ESO-1-/-
DR   cancercelllines; CVCL_C3D8
DR   Sigma-Aldrich; ATG004
DR   Wikidata; Q114310506
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:2491; CTAG1B.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): Sigma-Aldrich=ATG004
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 9,15
ST   Penta E: 10,12
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   A375 NY-ESO-1 Low
AC   CVCL_C3D9
DR   cancercelllines; CVCL_C3D9
DR   Sigma-Aldrich; ATG004
DR   Wikidata; Q114310507
CC   Population: Caucasian.
CC   Characteristics: Expresses CTAG1B at low level (Sigma-Aldrich=ATG004).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:2491; CTAG1B.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2491; CTAG1B.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3D8 ! A375 NY-ESO-1 Knockout
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   A375 PLX/AZD-resistant
AC   CVCL_C0Q6
DR   cancercelllines; CVCL_C0Q6
DR   PRIDE; PXD026952
DR   Wikidata; Q112927056
RX   PubMed=35128241;
CC   Population: Caucasian.
CC   Characteristics: Established by growing the parent cell line in an increasing concentration PLX4032 and AZD6244 up to a concentration of 1 microMolar (PubMed=35128241).
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   A375 RL
AC   CVCL_E8FX
SY   A375-RL
DR   ABM; T3350
RX   PubMed=31877948;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A375 Safe Harbor Landing Pad
AC   CVCL_C3EX
DR   cancercelllines; CVCL_C3EX
DR   Sigma-Aldrich; CLL1219
DR   Wikidata; Q114310508
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a fluorescent mKATE2 tag flanked by Cre-lox sites (LoxN-EF1a-Lox2272-mKATE2-LoxP) was introduced in the AAVS1 safe harbor locus. The mKATE2 tag can be exchanged for a payload of the user's choice using Cre recombinase and a targeting vector with appropriate lox sites (Sigma-Aldrich=CLL1219).
CC   Doubling time: ~22 hours (Sigma-Aldrich=CLL1219).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): Sigma-Aldrich=CLL1219
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A375 XPA-mutated clone A3
AC   CVCL_C4RR
DR   Wikidata; Q116048457
RX   PubMed=36232946;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple_edited; p.Ile69_Asp70delinsAsn (c.206_208delTTG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36232946).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple_edited; p.Asp70Hisfs*31 (c.208_209delGA); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36232946).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   A375 XPA-mutated clone A9
AC   CVCL_C4RS
DR   Wikidata; Q116048458
RX   PubMed=36232946;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple_edited; p.Ala7Leufs*8 (c.19delG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36232946).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple_edited; p.Ala7Glyfs*55 (c.19_20insG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36232946).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   A375 XPA-mutated clone B1
AC   CVCL_C4RT
DR   Wikidata; Q116048459
RX   PubMed=36232946;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple_edited; p.Ala7Leufs*8 (c.19delG); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36232946).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   A375-12R5-1
AC   CVCL_R746
SY   12R5-1
DR   cancercelllines; CVCL_R746
DR   Cosmic; 1890494
DR   Wikidata; Q54606754
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   A375-12R5-3
AC   CVCL_R747
SY   12R5-3
DR   cancercelllines; CVCL_R747
DR   Cosmic; 1890487
DR   Wikidata; Q54606755
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   A375-12R5-5
AC   CVCL_R748
SY   12R5-5
DR   cancercelllines; CVCL_R748
DR   Cosmic; 1890495
DR   Wikidata; Q54606756
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   A375-12R8-1
AC   CVCL_R749
SY   12R8-1
DR   cancercelllines; CVCL_R749
DR   Cosmic; 1890488
DR   Wikidata; Q54606759
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   A375-12R8-3
AC   CVCL_R750
SY   12R8-3
DR   cancercelllines; CVCL_R750
DR   Cosmic; 1890489
DR   Wikidata; Q54606761
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   A375-16R5-2
AC   CVCL_R751
SY   16R5-2
DR   cancercelllines; CVCL_R751
DR   Wikidata; Q54606762
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   A375-16R5-5
AC   CVCL_R752
SY   16R5-5
DR   cancercelllines; CVCL_R752
DR   Cosmic; 1890491
DR   Wikidata; Q54606766
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   A375-16R6-2
AC   CVCL_R753
SY   16R6-2
DR   cancercelllines; CVCL_R753
DR   Cosmic; 1890492
DR   Wikidata; Q54606767
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   A375-16R6-3
AC   CVCL_R754
SY   16R6-3
DR   cancercelllines; CVCL_R754
DR   Cosmic; 1890490
DR   Wikidata; Q54606769
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   A375-16R6-4
AC   CVCL_R755
SY   16R6-4
DR   cancercelllines; CVCL_R755
DR   Cosmic; 1890493
DR   Wikidata; Q54606771
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R745 ! A375PF11
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   A375-C5
AC   CVCL_2294
SY   A375Cl-5
DR   cancercelllines; CVCL_2294
DR   Cosmic; 932715
DR   ECACC; 97011320
DR   Wikidata; Q54606776
RX   PubMed=2584706;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A375-C5
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   A375-C6
AC   CVCL_2295
DR   CLO; CLO_0037118
DR   cancercelllines; CVCL_2295
DR   ECACC; 97011321
DR   GEO; GSM827328
DR   LINCS_LDP; LCL-1284
DR   Progenetix; CVCL_2295
DR   Wikidata; Q54606779
RX   PubMed=2584706;
RX   PubMed=20215515;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A375-C6
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: A373-C6; CLO=CLO_0037118; Note=Also in Sigma-Aldrich catalog.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ECACC=97011321
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   A375-eGFP-Puro
AC   CVCL_QZ67
DR   cancercelllines; CVCL_QZ67
DR   Imanis; CL056
DR   Wikidata; Q54606780
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL056).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   A375-ER-2
AC   CVCL_C8YB
SY   A375 SKIN CJ2; A375-CJ2
DR   Cell_Model_Passport; SIDM01937
DR   DepMap; ACH-002002
DR   Wikidata; Q123030357
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Johannessen, Cory M.; Broad Institute of MIT and Harvard; Harvard; USA.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_167670; SCH772984.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   A375-Fluc-Neo/eGFP-Puro
AC   CVCL_QZ68
DR   cancercelllines; CVCL_QZ68
DR   Imanis; CL085
DR   Wikidata; Q54606782
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL085).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   A375-Fluc-Neo/hNIS-Puro
AC   CVCL_QZ69
DR   cancercelllines; CVCL_QZ69
DR   Imanis; CL087
DR   Wikidata; Q54606785
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-hNIS-P2A-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-hNIS-P2A-Puro encodes for human SLC5A5 linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL087).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   A375-Fluc-Puro
AC   CVCL_QZ70
DR   cancercelllines; CVCL_QZ70
DR   Imanis; CL055
DR   Wikidata; Q54606788
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL055).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   A375-hNIS-Neo/eGFP-Puro
AC   CVCL_QZ71
DR   cancercelllines; CVCL_QZ71
DR   Imanis; CL086
DR   Wikidata; Q54606791
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-eGFP-PGKp-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL086).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   A375-hNIS-Puro
AC   CVCL_QZ72
DR   cancercelllines; CVCL_QZ72
DR   Imanis; CL058
DR   Wikidata; Q54606792
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-hNIS-P2A-Puro vector encoding for human SLC5A5 linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL058).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   A375-iRFP-Neo
AC   CVCL_QZ73
DR   cancercelllines; CVCL_QZ73
DR   Imanis; CL088
DR   Wikidata; Q54606794
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Neo which encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL088).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   A375-iRFP-Neo/Fluc-Puro
AC   CVCL_QZ74
DR   cancercelllines; CVCL_QZ74
DR   Imanis; CL089
DR   Wikidata; Q54606795
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-iRFP-P2A-Neo and LV-Fluc-P2A-Puro vectors. LV-iRFP-P2A-Neo encodes for iRFP linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL089).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 17
//
ID   A375-iRFP-Neo/hNIS-Puro
AC   CVCL_QZ75
DR   cancercelllines; CVCL_QZ75
DR   Imanis; CL090
DR   Wikidata; Q54606797
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-iRFP-P2A-Neo and LV-hNIS-P2A-Puro vectors. LV-iRFP-P2A-Neo encodes for iRFP linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-hNIS-P2A-Puro encodes for human SLC5A5 linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL090).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 17
//
ID   A375-Luc-RFP
AC   CVCL_B7NR
SY   Luciferase/tdTomato Dual-Reporter A375 Cell Line
DR   cancercelllines; CVCL_B7NR
DR   Wikidata; Q112927058
WW   Provider; ALSTEM; LRL02; https://www.alstembio.com/web/product_details.php?id=35
CC   Population: Caucasian.
CC   Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   A375-Luc2
AC   CVCL_UR32
DR   ATCC; CRL-1619-LUC2
DR   cancercelllines; CVCL_UR32
DR   Wikidata; Q93311724
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1619-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1619-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 15
//
ID   A375-M
AC   CVCL_B222
SY   A375M; A375m
DR   cancercelllines; CVCL_B222
DR   Wikidata; Q54606798
RX   PubMed=1671030;
RX   PubMed=2731157;
RX   PubMed=6744277;
RX   PubMed=7648437;
RX   PubMed=7780963;
RX   PubMed=22323893;
RX   PubMed=25950383;
CC   Population: Caucasian.
CC   Characteristics: Metastatic variant of A-375. Established from a tumor obtained in nude mice injected with the parent cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   A375-MA1
AC   CVCL_X494
SY   A375-M1; MA-1
DR   ATCC; CRL-3222
DR   cancercelllines; CVCL_X494
DR   Wikidata; Q54606801
RX   PubMed=18505921;
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Derived by intravenous injection of parental cells into nude mice and harvesting of the mung metastases.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-3222
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 19
//
ID   A375-MA2
AC   CVCL_X495
SY   A375-M2; MA-2
DR   ATCC; CRL-3223
DR   cancercelllines; CVCL_X495
DR   Wikidata; Q54606804
RX   PubMed=18505921;
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Derived by intravenous injection of parental cells into nude mice and harvesting of the mung metastases.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-3223
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X494 ! A375-MA1
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 19
//
ID   A375-NTP-R
AC   CVCL_C7GI
DR   Wikidata; Q123030358
RX   PubMed=36630862;
CC   Population: Caucasian.
CC   Selected for resistance to: NCIt; C192869; Non-thermal plasma.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   A375-P
AC   CVCL_6233
SY   A-375P; A375P; A375p
DR   BTO; BTO_0003984
DR   EFO; EFO_0022514
DR   ATCC; CRL-3224
DR   cancercelllines; CVCL_6233
DR   ChEMBL-Cells; CHEMBL4879545
DR   Cosmic; 932714
DR   Cosmic; 1045406
DR   Cosmic; 1067223
DR   Cosmic; 1238110
DR   KCLB; 80003
DR   PRIDE; PXD005277
DR   Wikidata; Q54606807
RX   PubMed=1671030;
RX   PubMed=2731157;
RX   PubMed=10952316;
RX   PubMed=22323893;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-3224
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 27
//
ID   A375-R
AC   CVCL_6234
DR   cancercelllines; CVCL_6234
DR   Wikidata; Q54606861
RX   PubMed=3260254;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A375-R
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   A375-R1
AC   CVCL_A2CR
DR   cancercelllines; CVCL_A2CR
DR   Cosmic; 2755761
DR   Wikidata; Q105506027
RX   PubMed=29605720;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:25657; BCORL1; Simple; p.Gln1076His (c.3228G>T); Zygosity=Heterozygous; Note=Acquired during resistance selection process (PubMed=29605720).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val47_Asp380del (c.139_1140del1002); Zygosity=Heterozygous; Note=Acquired during resistance selection process (PubMed=29605720).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=29605720).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   A375-RMR
AC   CVCL_A1VP
SY   A375 RMR; A375 SKIN CJ1; A375-CJ1
DR   cancercelllines; CVCL_A1VP
DR   Cell_Model_Passport; SIDM01935
DR   DepMap; ACH-002001
DR   Wikidata; Q105506031
RX   PubMed=31882401;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002001).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): DepMap=ACH-002001
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,14
ST   FGA: 22,23
ST   Penta D: 9,15
ST   Penta E: 10,12
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 10
//
ID   A375-RMR SCH 0.25
AC   CVCL_B3PJ
SY   A375 SKIN CJ3; A375-CJ3
DR   cancercelllines; CVCL_B3PJ
DR   Cell_Model_Passport; SIDM01936
DR   DepMap; ACH-002003
DR   Wikidata; Q110429848
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Johannessen, Cory M.; Broad Institute of MIT and Harvard; Harvard; USA.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002003).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): DepMap=ACH-002003
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,14
ST   FGA: 22,23
ST   Penta D: 9,15
ST   Penta E: 10,12
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1VP ! A375-RMR
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 10
//
ID   A375-SM
AC   CVCL_5649
SY   A-375SM; A375SM
DR   BTO; BTO_0003985
DR   cancercelllines; CVCL_5649
DR   ChEMBL-Cells; CHEMBL4513103
DR   ChEMBL-Targets; CHEMBL4513121
DR   Cosmic; 932716
DR   Cosmic; 1238111
DR   Cosmic; 1303033
DR   KCLB; 80004
DR   PubChem_Cell_line; CVCL_5649
DR   Wikidata; Q54606863
RX   PubMed=1826230;
RX   PubMed=2297053;
RX   PubMed=7648437;
RX   PubMed=22323893;
CC   Population: Caucasian.
CC   Characteristics: Highly metastatic. Established from a tumor obtained in nude mice injected with the parent cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): KCLB=80004
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   FGA: 20,23
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   A375-VR [2014]
AC   CVCL_AP96
DR   cancercelllines; CVCL_AP96
DR   Wikidata; Q54606865
RX   PubMed=24398428;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   A375-VR [2015]
AC   CVCL_AQ00
DR   cancercelllines; CVCL_AQ00
DR   Wikidata; Q54606866
RX   PubMed=26497853;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   A375.S2
AC   CVCL_0136
SY   A-375.S2; A375-S2; A375S2; A375s2
DR   BTO; BTO_0005815
DR   CLO; CLO_0001583
DR   MCCL; MCC:0000029
DR   ATCC; CRL-1872
DR   BCRC; 60263
DR   cancercelllines; CVCL_0136
DR   GEO; GSM827493
DR   LINCS_HMS; 50003
DR   LINCS_LDP; LCL-1231
DR   Progenetix; CVCL_0136
DR   Wikidata; Q54606870
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Not sure what is the relationship between A375.S2 and A375S1.
CC   Discontinued: ATCC; CRL-1872; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1872
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   A375/R
AC   CVCL_IW10
DR   cancercelllines; CVCL_IW10
DR   ChEMBL-Cells; CHEMBL4296205
DR   ChEMBL-Targets; CHEMBL4296383
DR   PubChem_Cell_line; CVCL_IW10
DR   Wikidata; Q54606867
RX   PubMed=26365896;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90295; PLX-4720 (PLX4720).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 17
//
ID   A375M1
AC   CVCL_C0RN
DR   cancercelllines; CVCL_C0RN
DR   Wikidata; Q112927060
RX   PubMed=10952316;
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Established from pulmonary metastases obtained afer intravenous injection of the parent cell line into the tail veins of nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6233 ! A375-P
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   A375M2
AC   CVCL_C0RP
DR   cancercelllines; CVCL_C0RP
DR   PRIDE; PXD005277
DR   Wikidata; Q112927061
RX   PubMed=10952316;
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Established from pulmonary metastases obtained afer intravenous injection of the parent cell line into the tail veins of nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RN ! A375M1
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   A375P-5
AC   CVCL_RN37
DR   cancercelllines; CVCL_RN37
DR   Wikidata; Q54606871
RX   PubMed=2731157;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6233 ! A375-P
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   A375P-beta6/puro
AC   CVCL_5F66
SY   A375Pbeta6puro
DR   cancercelllines; CVCL_5F66
DR   CancerTools; 151626
DR   Wikidata; Q54606874
DR   Ximbio; 151626
RX   PubMed=17244604;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6161; ITGB6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6233 ! A375-P
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   A375P-puro
AC   CVCL_E3GF
SY   A375Ppuro
RX   PubMed=17244604;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for A375P-beta6/puro (Cellosaurus=CVCL_5F66) (PubMed=17244604).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6233 ! A375-P
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   A375PF11
AC   CVCL_R745
SY   A375 PF11
DR   cancercelllines; CVCL_R745
DR   Wikidata; Q54606876
RX   Patent=US9402846;
RX   PubMed=22389471;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   A375S1
AC   CVCL_Y439
DR   cancercelllines; CVCL_Y439
DR   Wikidata; Q54606878
RX   PubMed=3261584;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Miscellaneous: Not sure what is the relationship between A375.S2 and A375S1.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 17
//
ID   A375sci
AC   CVCL_XE59
DR   cancercelllines; CVCL_XE59
DR   CCRID; 4201PAT-CCTCC00306
DR   Wikidata; Q93311762
RX   Patent=CN102067828B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200954.
CC   Population: Caucasian.
CC   Characteristics: Highly metastatic.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   A38-5
AC   CVCL_E276
SY   Pa08c
DR   Cosmic; 1473125
DR   Cosmic; 1509854
DR   Wikidata; Q54606883
RX   PubMed=18772397;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   A387
AC   CVCL_KS96
DR   Wikidata; Q54606887
RX   Patent=WO2004018997A2;
RX   PubMed=17288597;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   A388.6TG.c2
AC   CVCL_ZF53
SY   A3886TGc2
DR   cancercelllines; CVCL_ZF53
DR   Wikidata; Q98125444
RX   PubMed=1358434;
RX   PubMed=10942591;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg832Cys (c.2494C>T); ClinVar=VCV000936373; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1063 ! A-388
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   A388.6TG.c2.neoc1
AC   CVCL_ZF54
SY   A3886TGc2 Neo c1
DR   cancercelllines; CVCL_ZF54
DR   Wikidata; Q98125449
RX   PubMed=1358434;
RX   PubMed=10942591;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg832Cys (c.2494C>T); ClinVar=VCV000936373; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZF53 ! A388.6TG.c2
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   A3A7
AC   CVCL_C3XR
SY   A3A7A5
DR   Wikidata; Q116048461
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   A3C
AC   CVCL_YM09
DR   CCRID; 4201PAT-CCTCC00286
DR   Wikidata; Q93311766
RX   Patent=CN101519447A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200921.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P27410; Rabbit hemorrhagic disease virus genome polyprotein (Note=AA 1768-2344 = Capsid protein VP60).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 7
//
ID   A3D8
AC   CVCL_A7QK
DR   Wikidata; Q107113321
RX   PubMed=2646376;
RX   PubMed=6466869;
RX   PubMed=6863545;
CC   Monoclonal antibody isotype: IgG1 (PubMed=2646376); IgM (PubMed=6466869; PubMed=6863545).
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   A3R5.7
AC   CVCL_S540
SY   A3.01/R5.7; A3R5
DR   BEI_Resources; ARP-12386
DR   cancercelllines; CVCL_S540
DR   Wikidata; Q54606881
RX   PubMed=24312168;
RX   PubMed=24607608;
CC   Population: Caucasian.
CC   Characteristics: Expresses CCR5 under the control of a CMV promoter (PubMed=24312168).
CC   Characteristics: Useful for the detection of weak neutralizing antibody responses against tier 2 strains of HIV-1 (PubMed=24607608).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6244 ! CEM A3.01
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   A4 [Mouse]
AC   CVCL_F962
DR   RCB; RCB2637
DR   TKG; TKG 0298
DR   Wikidata; Q54606890
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Val659Glu).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   A4 [Pig peripheral blood]
AC   CVCL_6G31
DR   Wikidata; Q54606893
RX   PubMed=3261912;
RX   PubMed=7951345;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Duroc; VBO=VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   4M
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   A4-15
AC   CVCL_LK59
DR   Wikidata; Q54606895
RX   PubMed=2565325;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Val659Glu).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F962 ! A4 [Mouse]
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 8
//
ID   A4-1B1
AC   CVCL_A0UP
SY   1B1
DR   CCRID; 4201PAT-CCTCC01113
DR   Wikidata; Q108819808
RX   Patent=CN108998421A;
RX   Patent=CN109055318A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017144.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   A4-6A2
AC   CVCL_A0UQ
SY   6A2
DR   CCRID; 4201PAT-CCTCC01111
DR   Wikidata; Q108819809
RX   Patent=CN108998421A;
RX   Patent=CN109055318A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017143.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   A4.1025
AC   CVCL_1943
AS   CVCL_0E77
SY   A4-1025
DR   CLO; CLO_0001588
DR   ATCC; CRL-2044
DR   DSMZ; ACC-296
DR   DSMZCellDive; ACC-296
DR   Wikidata; Q54606897
RX   PubMed=7531198;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-296).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human myosin heavy chains (Note=Also reacts with other species).
CC   Discontinued: ATCC; CRL-2044; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   A4.1077
AC   CVCL_1944
SY   A4-1077; 4A.1077
DR   CLO; CLO_0001589
DR   DSMZ; ACC-297
DR   DSMZCellDive; ACC-297
DR   Wikidata; Q54606899
RX   PubMed=7531198;
CC   Doubling time: ~20-40 hours (DSMZ=ACC-297).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human myosin heavy chains (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   A4.1519
AC   CVCL_0E78
SY   4A.1519
DR   ATCC; CRL-2045
DR   Wikidata; Q54606901
RX   PubMed=7531198;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human myosin heavy chains (Note=Also reacts with other species).
CC   Discontinued: ATCC; CRL-2045; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   A4.6.1
AC   CVCL_D3F4
SY   A.4.6.1
DR   ABCD; ABCD_AE653
DR   Wikidata; Q127378814
RX   PubMed=1380254;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized bevacizumab (Avastin) therapeutic antibody used for the treatment of a number of cancers and of age-related macular degeneration.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15692; Human VEGFA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   A4.74
AC   CVCL_J940
SY   4A.74
DR   CLO; CLO_0001585
DR   ATCC; CRL-2041
DR   Wikidata; Q54606903
RX   PubMed=7531198;
RX   PubMed=7687223;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human myosin heavy chains (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   A4.840
AC   CVCL_1945
AS   CVCL_0E79
SY   A4-840; 4A.840
DR   CLO; CLO_0001586
DR   CLO; CLO_0001594
DR   CLDB; cl49
DR   ATCC; CRL-2043
DR   DSMZ; ACC-213
DR   DSMZCellDive; ACC-213
DR   Wikidata; Q54606905
RX   PubMed=7531198;
RX   PubMed=7687223;
CC   Doubling time: ~25 hours (DSMZ=ACC-213).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human myosin heavy chains (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   A4.85
AC   CVCL_D7D7
RX   PubMed=8423153;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55126; Neisseria meningitidis serogroup C frpA (Note=Also reacts with RTX toxins from other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A4.951
AC   CVCL_1946
AS   CVCL_0E80
SY   A4-951; 4A.951
DR   CLO; CLO_0001587
DR   CLO; CLO_0001595
DR   ATCC; CRL-2046
DR   DSMZ; ACC-214
DR   DSMZCellDive; ACC-214
DR   Wikidata; Q54606908
RX   PubMed=7687223;
CC   Doubling time: ~24 hours (DSMZ=ACC-214).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human myosin heavy chains (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   A4/Fukuda
AC   CVCL_1064
SY   A4/Fuk; A4/FUK; A4-Fuk; A4-FUK; A4:FUK; A4FUK; A4Fuk
DR   CLO; CLO_0037119
DR   EFO; EFO_0006533
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470900
DR   BioSample; SAMN10987839
DR   cancercelllines; CVCL_1064
DR   Cell_Model_Passport; SIDM00502
DR   ChEMBL-Cells; CHEMBL3308226
DR   ChEMBL-Targets; CHEMBL2366356
DR   Cosmic; 910934
DR   Cosmic; 998704
DR   Cosmic; 1037706
DR   Cosmic; 1995336
DR   Cosmic-CLP; 910934
DR   DepMap; ACH-000157
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910934
DR   GEO; GSM886857
DR   GEO; GSM887922
DR   GEO; GSM1669588
DR   IARC_TP53; 21165
DR   JCRB; JCRB0097
DR   LiGeA; CCLE_495
DR   LINCS_LDP; LCL-1268
DR   PharmacoDB; A4Fuk_44_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1064
DR   PubChem_Cell_line; CVCL_1064
DR   Wikidata; Q54606910
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6601597;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31510952;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Produces IgM kappa.
CC   Doubling time: 20-22 hours (PubMed=6601597); 38-43 hours (Note=Lot 02162007) (JCRB=JCRB0097).
CC   HLA typing: A*24:02,24:02; B*52:01,59:01; C*01:02,01:02; DQA1*01:02,03:02; DRB1*15:02,13:07 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Homozygous (Cosmic-CLP=910934).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.76%; East Asian, South=24.23%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=910934; JCRB=JCRB0097; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 14,17
ST   D19S433: 14,15.2
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 19
ST   Penta D: 13
ST   Penta E: 5
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18,19,20
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   A40G12.8
AC   CVCL_B0NY
SY   CR-7
DR   Wikidata; Q108819810
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3316.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A431 GR
AC   CVCL_E4DP
SY   A431-GR; A431_GR
DR   GEO; GSM270527
DR   GEO; GSM270528
DR   GEO; GSM270529
RX   PubMed=18568074;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   A431 siYAP
AC   CVCL_QX11
SY   siYAP_A431
DR   cancercelllines; CVCL_QX11
DR   GEO; GSM2112552
DR   GEO; GSM2112553
DR   GEO; GSM2112554
DR   Wikidata; Q54606911
RX   PubMed=26989177;
CC   Population: Caucasian.
CC   Knockout cell: Method=siRNA knockdown; HGNC; HGNC:16262; YAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 14
//
ID   A431 YAP-5SA
AC   CVCL_QX12
SY   YAP_5SA_A431
DR   cancercelllines; CVCL_QX12
DR   GEO; GSM2112556
DR   GEO; GSM2112557
DR   GEO; GSM2112558
DR   Wikidata; Q54606913
RX   PubMed=26989177;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser61Ala, p.Ser109Ala, p.Ser127Ala, p.Ser164Ala and p.Ser381Ala = YAP-5SA).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 16
//
ID   A431-AC3
AC   CVCL_B5YD
DR   cancercelllines; CVCL_B5YD
DR   Wikidata; Q111732846
RX   PubMed=10764804;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4056; G6PC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   A431-PR
AC   CVCL_EQ67
SY   A431 PR
DR   cancercelllines; CVCL_EQ67
DR   GEO; GSM183434
DR   GEO; GSM183435
DR   Wikidata; Q54606915
RX   PubMed=17560336;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   A431/CDDP1
AC   CVCL_GY97
DR   cancercelllines; CVCL_GY97
DR   Wikidata; Q54606917
RX   PubMed=9755302;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   A431/CDDP2
AC   CVCL_GY98
DR   cancercelllines; CVCL_GY98
DR   Wikidata; Q54606918
RX   PubMed=9755302;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   A431/TPT
AC   CVCL_4V41
DR   cancercelllines; CVCL_4V41
DR   Wikidata; Q54606919
RX   PubMed=19765546;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   A431NS
AC   CVCL_3485
SY   A431-NS
DR   CLO; CLO_0001593
DR   ATCC; CRL-2592
DR   cancercelllines; CVCL_3485
DR   TOKU-E; 477
DR   Wikidata; Q54606922
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
ST   Source(s): ATCC=CRL-2592
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 12,14
ST   D18S51: 12,17
ST   D19S433: 15,15.2
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 12,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   A431PF
AC   CVCL_WS72
SY   A431 Protein Free
DR   cancercelllines; CVCL_WS72
DR   Wikidata; Q93311853
RX   PubMed=2228902;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   A4573
AC   CVCL_6245
SY   A-4573; ES-A4573
DR   cancercelllines; CVCL_6245
DR   Cosmic; 1718428
DR   Cosmic; 2060798
DR   GEO; GSM510001
DR   Progenetix; CVCL_6245
DR   Wikidata; Q54606924
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2620246;
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=6750238;
RX   PubMed=21822310;
RX   PubMed=22142829;
RX   PubMed=28196595;
RX   PubMed=29464090;
RX   PubMed=30879952;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,10
ST   D16S539: 12
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   FGA: 24
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   A4H12
AC   CVCL_A6KJ
DR   cancercelllines; CVCL_A6KJ
DR   Wikidata; Q107113322
RX   DOI=10.1007/978-94-011-2044-9_87;
RX   PubMed=1368811;
RX   PubMed=1576323;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   A4xC
AC   CVCL_9258
DR   Wikidata; Q54606927
RX   CelloPub=CLPUB00606;
CC   Characteristics: Hybrid of pig embryonic kidney cells with pig splenocytes (CelloPub=CLPUB00606).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   A4xL
AC   CVCL_9257
DR   CLO; CLO_0001597
DR   CLDB; cl200
DR   Wikidata; Q54606928
CC   Characteristics: Hybrid of pig embryonic kidney cells with equine lymphocytes.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   A4xS
AC   CVCL_A5XT
SY   A4C2/9K; A4C2/9k
DR   Wikidata; Q107113323
RX   DOI=10.3103/S1068367415020056;
RX   Patent=RU2545720;
RX   PubMed=26182658;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 87.
CC   Characteristics: Hybrid of pig embryonic kidney cells with pig splenocytes (Patent=RU2545720).
CC   Virology: Susceptible to infection by African swine fever virus (AFSV) (PubMed=26182658).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   A5
AC   CVCL_B6ZG
DR   CCRID; 4201PAT-CCTCC01925
DR   Wikidata; Q111732848
RX   Patent=CN114045266A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021127.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_169037; Armillaric acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   A5-BAG
AC   CVCL_9Y71
DR   Wikidata; Q54606930
RX   PubMed=8845386;
RX   PubMed=9548567;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Salivary gland, submandibular gland, epithelium; UBERON=UBERON_0003359.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9Y70 ! RSMT-A5
SX   Male
AG   30D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   A5-DAP
AC   CVCL_9Y72
DR   Wikidata; Q54606933
RX   PubMed=9358855;
RX   PubMed=9548567;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Salivary gland, submandibular gland, epithelium; UBERON=UBERON_0003359.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9Y70 ! RSMT-A5
SX   Male
AG   30D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   A5.12.14
AC   CVCL_J004
SY   5.12.14
DR   CLO; CLO_0001598
DR   ATCC; HB-11553
DR   Wikidata; Q54606935
RX   Patent=US5677426;
RX   Patent=US6025158;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11553.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10145; Human IL8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   A5.4
AC   CVCL_G630
SY   1506 A5.4
DR   CLO; CLO_0001599
DR   ATCC; CRL-2275
DR   Wikidata; Q54606938
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   A5.B12.1
AC   CVCL_D3VV
DR   ABCD; ABCD_AE106
DR   Wikidata; Q127378815
RX   PubMed=1698868;
RX   PubMed=2443831;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran (Note=Immunized with stearyl-isomaltotetraose (ST-IM4)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   A5201A
AC   CVCL_A7DN
DR   Wikidata; Q107113324
RX   PubMed=21725355;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q92542; Human NCSTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   A5226A
AC   CVCL_A7DP
DR   Wikidata; Q107113325
RX   PubMed=21725355;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q92542; Human NCSTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   A529L
AC   CVCL_8655
DR   CLO; CLO_0050056
DR   BioSample; SAMN03471928
DR   RCB; RCB2817
DR   Wikidata; Q54606939
RX   PubMed=11267941;
RX   PubMed=11518743;
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; C*12:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2817
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   A529L-CD80
AC   CVCL_A5AQ
DR   Wikidata; Q107113326
RX   PubMed=11267941;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8655 ! A529L
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   A53T
AC   CVCL_E3C7
RX   PubMed=35688132;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=35688132).
CC   Donor information: Established from a Contursi kindred patient.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   A53T-1A
AC   CVCL_E3C8
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian; Italian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=35688132).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a Contursi kindred patient.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3C7 ! A53T
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   A53T-1A CORR28
AC   CVCL_E3CE
SY   CORR28 (A53T-1A)
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian; Italian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35688132).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a Contursi kindred patient.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3C8 ! A53T-1A
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   A53T-1A CORR63
AC   CVCL_E3CF
SY   CORR63 (A53T-1A)
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian; Italian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35688132).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a Contursi kindred patient.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3C8 ! A53T-1A
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   A53T-1C
AC   CVCL_E3C9
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian; Italian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=35688132).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a Contursi kindred patient.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3C7 ! A53T
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   A53T-1D
AC   CVCL_E3CA
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian; Italian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=35688132).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a Contursi kindred patient.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3C7 ! A53T
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   A547
AC   CVCL_6562
SY   A-547
DR   BTO; BTO_0004247
DR   Wikidata; Q54606942
RX   PubMed=12080474;
CC   From: De Greve, Jacques; Oncologisch Centrum; Brussels; Belgium.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   A549 ATGL-KO
AC   CVCL_UJ32
DR   cancercelllines; CVCL_UJ32
DR   PRIDE; PXD007223
DR   Wikidata; Q93311893
RX   PubMed=29457907;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30802; PNPLA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   A549 B2M KO
AC   CVCL_C3CC
DR   cancercelllines; CVCL_C3CC
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310509
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Sigma-Aldrich=HLA003
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 BLTP3A KO clone C2
AC   CVCL_E9W1
SY   A549 BLTP3A KO-C2
RX   DOI=10.1101/2024.09.28.615015;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21216; BLTP3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A549 BLTP3A KO clone D9
AC   CVCL_E9W2
SY   A549 BLTP3A KO-D9
RX   DOI=10.1101/2024.09.28.615015;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21216; BLTP3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A549 BLTP3A-V5 clone B6
AC   CVCL_E9W3
RX   DOI=10.1101/2024.09.28.615015;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a V5 tag was introduced just after p.Val904 of both alleles of BLTP3A (DOI=10.1101/2024.09.28.615015).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A549 BLTP3A-V5 clone C5
AC   CVCL_E9W4
RX   DOI=10.1101/2024.09.28.615015;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a V5 tag was introduced just after p.Val904 of both alleles of BLTP3A (DOI=10.1101/2024.09.28.615015).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A549 Cas9
AC   CVCL_DX70
DR   Horizon_Discovery; HD+Cas9-001
DR   Wikidata; Q127378816
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-001).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   A549 dCas9-KRAB
AC   CVCL_VR73
DR   ATCC; CCL-185dCas9-KRAB
DR   cancercelllines; CVCL_VR73
DR   Wikidata; Q93311895
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a construct containing KRAB-dCas9-2A-Pac-2A-RFP-PA was introduced in the AAVS1 safe harbor locus.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CCL-185dCas9-KRAB
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12,13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   A549 dCas9-VPR
AC   CVCL_DX71
DR   Horizon_Discovery; HD+dCas9-VPR-001
DR   Wikidata; Q127378818
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-dCas9-VPR-WPRE, where VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA (Horizon_Discovery=HD+dCas9-VPR-001).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   A549 DHODH-/-
AC   CVCL_YZ46
SY   DHODH-/- A549
DR   cancercelllines; CVCL_YZ46
DR   Wikidata; Q98125454
RX   PubMed=32754890;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2867; DHODH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   A549 EGFR High
AC   CVCL_C3DD
DR   cancercelllines; CVCL_C3DD
DR   Sigma-Aldrich; ATG002
DR   Wikidata; Q114310510
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR at high level (Sigma-Aldrich=ATG002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3DB ! A549 EGFR Knockout
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 EGFR Knockout
AC   CVCL_C3DB
SY   A549 EGFR-/-
DR   cancercelllines; CVCL_C3DB
DR   Sigma-Aldrich; ATG002
DR   Sigma-Aldrich; ATG005
DR   Wikidata; Q114310511
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Sigma-Aldrich=ATG002
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 EGFR Low
AC   CVCL_C3DC
DR   cancercelllines; CVCL_C3DC
DR   Sigma-Aldrich; ATG002
DR   Wikidata; Q114310512
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR at high level (Sigma-Aldrich=ATG002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3DB ! A549 EGFR Knockout
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 EGFR Biosensor
AC   CVCL_C3ET
SY   A549 EGFR SH2 Biosensor
DR   cancercelllines; CVCL_C3ET
DR   Sigma-Aldrich; CLL1097
DR   Wikidata; Q114310513
CC   Population: Caucasian.
CC   Characteristics: Within minutes after stimulation of the cell line with EGF, the biosensor shows robust redistribution towards the cell membrane and subsequent internalization through endocytosis (Sigma-Aldrich=CLL1097).
CC   Characteristics: Transduced with a TagGFP2-SH2-SH2 construct (Sigma-Aldrich=CLL1097).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 EGFRvIII High
AC   CVCL_C3EU
DR   cancercelllines; CVCL_C3EU
DR   Sigma-Aldrich; ATG005
DR   Wikidata; Q114310514
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR isoform vIII (EGFRvIII) at high level (Sigma-Aldrich=ATG005).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3DB ! A549 EGFR Knockout
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 EML4-ALK
AC   CVCL_JK07
SY   EML4-ALK Fusion-A549 Isogenic Cell Line
DR   ATCC; CCL-185IG
DR   cancercelllines; CVCL_JK07
DR   Wikidata; Q54606944
RX   CelloPub=CLPUB00395;
CC   Population: Caucasian.
CC   Characteristics: An EML4-ALK4 fusion was generated by CRISPR/Cas9.
CC   Characteristics: More sensitive to the ALK inhibitor crizotinib when compared to the parental cell line. Can be a useful model to study tyrosine kinase signaling pathway and to screen ALK inhibitors.
CC   Doubling time: ~25 hours (ATCC=CCL-185IG).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CCL-185IG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   A549 EML4-ALK-Luc2
AC   CVCL_VR66
SY   EML4-ALK Fusion-A549 Isogenic-Luc2
DR   ATCC; CCL-185IG-LUC2
DR   cancercelllines; CVCL_VR66
DR   Wikidata; Q93311901
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter.
CC   Doubling time: ~23 hours (ATCC=CCL-185IG-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CCL-185IG-LUC2
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JK07 ! A549 EML4-ALK
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   A549 fat-1
AC   CVCL_E6ZC
SY   f-A549
DR   ABM; T6262
RX   DOI=10.1158/1538-7445.AM2016-4651;
CC   Population: Caucasian.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6262).
CC   Doubling time: 18-26 hours (ABM=T6262).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   A549 GFP-CTNNB1 RFP-LMNB1
AC   CVCL_C3C7
DR   Sigma-Aldrich; CLL1149
DR   Wikidata; Q114310515
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the CTNNB1 locus to insert a 3xFLAG-TagGFP2 construct at the N-terminus of the gene and at the LMNB1 locus to insert a TagRFP construct at the N-terminus of the gene (Sigma-Aldrich=CLL1149).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   A549 GFP-EGFR
AC   CVCL_RT13
DR   cancercelllines; CVCL_RT13
DR   Sigma-Aldrich; CLL1141
DR   Wikidata; Q54606995
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the C-terminus of the EGFR gene (Sigma-Aldrich=CLL1141).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   A549 GFP-SMAD4
AC   CVCL_C3C6
DR   cancercelllines; CVCL_C3C6
DR   Sigma-Aldrich; CLL1167
DR   Wikidata; Q114310516
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the C-terminus of the SMAD4 gene (Sigma-Aldrich=CLL1167).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   A549 GFP-STAT1
AC   CVCL_RQ89
DR   cancercelllines; CVCL_RQ89
DR   Sigma-Aldrich; CLL1158
DR   Wikidata; Q54606998
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the C-terminus of the STAT1 gene (Sigma-Aldrich=CLL1158).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   A549 HIF1A -/-/-
AC   CVCL_C3C5
SY   A549 HIF1a -/-/-
DR   cancercelllines; CVCL_C3C5
DR   Sigma-Aldrich; CLLS1014
DR   Wikidata; Q114310517
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:4910; HIF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-A*01:01
AC   CVCL_C3CF
DR   cancercelllines; CVCL_C3CF
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310518
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*01:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-A*02:01
AC   CVCL_C3CG
DR   cancercelllines; CVCL_C3CG
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310519
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-A*03:01
AC   CVCL_C3CH
DR   cancercelllines; CVCL_C3CH
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310520
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*03:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-A*11:01
AC   CVCL_C3CI
DR   cancercelllines; CVCL_C3CI
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310521
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*11:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-A*24:02
AC   CVCL_C3CJ
DR   cancercelllines; CVCL_C3CJ
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310522
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*24:02).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-B*07:02
AC   CVCL_C3CK
DR   cancercelllines; CVCL_C3CK
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310523
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07:02).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-B*08:01
AC   CVCL_C3CL
DR   cancercelllines; CVCL_C3CL
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310524
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*08:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-B*15:10
AC   CVCL_C3CM
DR   cancercelllines; CVCL_C3CM
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310525
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*15:10).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-B*35:01
AC   CVCL_C3CN
DR   cancercelllines; CVCL_C3CN
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310526
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 HLA-B*40:01
AC   CVCL_C3CP
DR   cancercelllines; CVCL_C3CP
DR   Sigma-Aldrich; HLA003
DR   Wikidata; Q114310527
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA003).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*40:01).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CC ! A549 B2M KO
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 IFITM2/3-KO
AC   CVCL_B0A6
SY   C1-3
DR   cancercelllines; CVCL_B0A6
DR   Wikidata; Q108819811
RX   PubMed=30643282;
CC   Population: Caucasian.
CC   Characteristics: Has also reduced expression of IFITM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   A549 MIR1343 KO
AC   CVCL_C3IT
SY   miR-1343Delta A549
DR   cancercelllines; CVCL_C3IT
DR   GEO; GSM2635908
DR   GEO; GSM2635910
DR   GEO; GSM2635913
DR   Wikidata; Q114310528
RX   PubMed=29022142;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:41902; MIR1343.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   A549 MMP7 KO
AC   CVCL_F0RJ
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7174; MMP7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Biddle, Michael S.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A549 MX10
AC   CVCL_LB65
DR   cancercelllines; CVCL_LB65
DR   Wikidata; Q54607002
RX   PubMed=11406094;
RX   PubMed=11559526;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 10 nM of mitoxantrone (PubMed=11559526).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   A549 NR3C1 KO
AC   CVCL_F0RK
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Biddle, Michael S.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A549 NucLight Green
AC   CVCL_DF39
DR   cancercelllines; CVCL_DF39
DR   Wikidata; Q54607005
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4492.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 18
//
ID   A549 NucLight Red
AC   CVCL_DF40
DR   cancercelllines; CVCL_DF40
DR   Wikidata; Q54607008
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4491.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 18
//
ID   A549 OS8
AC   CVCL_XY99
SY   A549-OS8
DR   cancercelllines; CVCL_XY99
DR   KYinno; KC-1047
DR   Wikidata; Q93311932
CC   Population: Caucasian.
CC   Characteristics: Transfected with the ScFV sequence of anti-human CD3 mAb OKT3 and a C-terminal domain of mouse CD8a which consists of the transmembrane and cytoplasmic domains.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88346; Cd8a (Note=With p.Met1_Tyr196del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   A549 PIP4P1 KO
AC   CVCL_D3VW
SY   A549 TMEM55B KO
DR   Wikidata; Q127378819
RX   DOI=10.1101/2023.06.07.544051;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19299; PIP4P1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   A549 PPM1H-BromoTag
AC   CVCL_C8YV
SY   A549 PPM1H-BromoTag CRISPR/Cas9 knock-in
DR   Wikidata; Q123030359
RX   DOI=10.1101/2023.07.25.550405;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 PPM1H was tagged on both alleles at the C-terminus with a BromoTag thus enabling the rapid and selective degradation of PPM1H (DOI=10.1101/2023.07.25.550405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13575; BRD4 (Note=With p.Met1_Lys332del, p.Pro461_Phe1362del and p.Leu387Ala = BromoTag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   A549 RFP-STAT3
AC   CVCL_C3C8
DR   cancercelllines; CVCL_C3C8
DR   Sigma-Aldrich; CLL1140
DR   Wikidata; Q114310529
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the STAT3 locus to insert a TagRFP construct at the N-terminus of the gene (Sigma-Aldrich=CLL1140).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 rho-0#1a
AC   CVCL_C0DV
SY   A549rho0#1a; A549p0#1a; A549p0#1
DR   cancercelllines; CVCL_C0DV
DR   CancerTools; 160508
DR   Kerafast; ESA113
DR   Wikidata; Q112927062
DR   Ximbio; 160508
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Obtained by growth of parental cell line with ethidium bromide.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   A549 Safe Harbor Landing Pad
AC   CVCL_C3EV
DR   cancercelllines; CVCL_C3EV
DR   Sigma-Aldrich; CLL1220
DR   Wikidata; Q114310530
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a fluorescent mKATE2 tag flanked by Cre-lox sites (LoxN-EF1a-Lox2272-mKATE2-LoxP) was introduced in the AAVS1 safe harbor locus. The mKATE2 tag can be exchanged for a payload of the user's choice using Cre recombinase and a targeting vector with appropriate lox sites (Sigma-Aldrich=CLL1220).
CC   Doubling time: ~22 hours (Sigma-Aldrich=CLL1220).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   A549 SMAD4 -/-
AC   CVCL_C3C4
DR   cancercelllines; CVCL_C3C4
DR   Sigma-Aldrich; CLLS1013
DR   Wikidata; Q114310531
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549 VIM RFP
AC   CVCL_LI35
SY   A549 Vim RFP; A-549 VIM RFP
DR   ATCC; CCL-185EMT
DR   cancercelllines; CVCL_LI35
DR   Wikidata; Q54607012
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a red fluorescent protein (RFP) tag was added to the C-terminal of the VIM gene. Allows to monitor the epithelial-to-mesenchymal transition (EMT) status of cells in vitro by monitoring RFP expression.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CCL-185EMT
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   A549 VPS13C KO
AC   CVCL_E6IP
SY   A549-VPS13C knockout
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Wang, Xin-Bo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   A549(Cas9)
AC   CVCL_E7IZ
WW   Provider; BRICS; ECC3001; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3935
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   A549(VM)28
AC   CVCL_4V06
DR   cancercelllines; CVCL_4V06
DR   Wikidata; Q54607058
RX   PubMed=1717144;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   A549(VP)28
AC   CVCL_4V07
DR   cancercelllines; CVCL_4V07
DR   Wikidata; Q54607060
RX   PubMed=1717144;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   A549-1
AC   CVCL_A1ZW
DR   cancercelllines; CVCL_A1ZW
DR   Wikidata; Q105506036
RX   PubMed=3032416;
RX   PubMed=3165706;
CC   Population: Caucasian.
CC   Characteristics: Selected to grow at low density.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   A549-5Fu
AC   CVCL_XE67
DR   cancercelllines; CVCL_XE67
DR   CCRID; 1101HUM-PUMC000394
DR   Wikidata; Q93311933
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000394
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   A549-A2-ESO
AC   CVCL_A0WA
SY   A549-NY-ESO-1-A2-CBG
DR   cancercelllines; CVCL_A0WA
DR   Wikidata; Q108819812
RX   PubMed=33537176;
CC   Population: Caucasian.
CC   Characteristics: Transduced with both a CBG-T2A-GFP construct and a NY-ESO-1-T2A-HLA-A2 construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24198; CTAG1A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Genetic integration: Method=Transduction; Gene=Click beetle green luciferase (CBG).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0VZ ! A549-CBG
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   A549-AC
AC   CVCL_D1JI
DR   Wikidata; Q127378820
RX   PubMed=36032971;
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Characteristics: Expresses ACE2 under the control of the EF1a promoter (from parent cell line).
CC   Characteristics: Transduced with a EF1a-Cas9-2A-eGFP vector (PubMed=36032971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7UV ! A549-hACE2 [BEI resources]
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   A549-ACE2
AC   CVCL_C0Q5
SY   A549-Ace2
DR   cancercelllines; CVCL_C0Q5
DR   GEO; GSM5224710
DR   GEO; GSM5224711
DR   GEO; GSM5224712
DR   PRIDE; PXD019645
DR   PRIDE; PXD023418
DR   Wikidata; Q112927063
RX   PubMed=33208793;
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   A549-Cas9-538
AC   CVCL_XE68
DR   cancercelllines; CVCL_XE68
DR   CCRID; 1101HUM-PUMC000538
DR   Wikidata; Q93311934
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000538
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   A549-Cas9-860
AC   CVCL_A9MB
DR   cancercelllines; CVCL_A9MB
DR   CCRID; 1101HUM-PUMC000860
DR   Wikidata; Q108819813
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000860
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   A549-Cas9-861
AC   CVCL_A9MC
DR   cancercelllines; CVCL_A9MC
DR   CCRID; 1101HUM-PUMC000861
DR   Wikidata; Q108819814
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000861
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   A549-Cas9-862
AC   CVCL_A9MD
DR   cancercelllines; CVCL_A9MD
DR   CCRID; 1101HUM-PUMC000862
DR   Wikidata; Q108819815
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000862
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   A549-Cas9-863
AC   CVCL_A9ME
DR   cancercelllines; CVCL_A9ME
DR   CCRID; 1101HUM-PUMC000863
DR   Wikidata; Q108819816
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000863
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   A549-CBG
AC   CVCL_A0VZ
DR   cancercelllines; CVCL_A0VZ
DR   Wikidata; Q108819817
RX   PubMed=33537176;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a CBG-T2A-GFP construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=Click beetle green luciferase (CBG).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   A549-CEACAM1-4L
AC   CVCL_C0DZ
DR   cancercelllines; CVCL_C0DZ
DR   Wikidata; Q112927064
RX   PubMed=24743304;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1814; CEACAM1 (Note=Isoform 4L).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   A549-CR
AC   CVCL_IP03
DR   BTO; BTO_0005816
DR   cancercelllines; CVCL_IP03
DR   Wikidata; Q54607013
RX   PubMed=26692948;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   A549-deltaSTAT1
AC   CVCL_C9AT
SY   A549 STAT1-/-
DR   Wikidata; Q123030360
RX   PubMed=29321309;
RX   PubMed=35421191;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   A549-deltaSTAT1-SunTag
AC   CVCL_C9AU
DR   BioGRID_ORCS_Cell_line; 1595
DR   Wikidata; Q123030361
RX   PubMed=35421191;
CC   Population: Caucasian.
CC   Characteristics: Doxycycline induces the expression of pCW-TRE-scFv-SunTag. SunTag consists of 24 copies of a short peptide epitope from yeast GCN4 and is used to recruite multiple protein copies to a polypeptide scaffold.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9AT ! A549-deltaSTAT1
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   A549-deltaSTAT1-SunTag ACE2
AC   CVCL_C9AV
DR   Wikidata; Q123030362
RX   PubMed=35421191;
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Characteristics: Doxycycline induces the expression of pCW-TRE-scFv-SunTag. SunTag consists of 24 copies of a short peptide epitope from yeast GCN4 and is used to recruite multiple protein copies to a polypeptide scaffold.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9AU ! A549-deltaSTAT1-SunTag
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   A549-Dual
AC   CVCL_5I73
DR   cancercelllines; CVCL_5I73
DR   InvivoGen; a549d-nfis
DR   Wikidata; Q54607014
CC   Population: Caucasian.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-nfis).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   A549-Dual hACE2-TMPRSS2
AC   CVCL_A7ZQ
DR   cancercelllines; CVCL_A7ZQ
DR   InvivoGen; a549d-cov2r
DR   Wikidata; Q107113327
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies. These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen=a549d-cov2r).
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-cov2r).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I73 ! A549-Dual
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 12
//
ID   A549-Dual KO-MAVS
AC   CVCL_A7ZM
DR   cancercelllines; CVCL_A7ZM
DR   InvivoGen; a549d-komavs
DR   Wikidata; Q107113328
CC   Population: Caucasian.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-komavs).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I73 ! A549-Dual
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   A549-Dual KO-MDA5
AC   CVCL_A7ZP
DR   cancercelllines; CVCL_A7ZP
DR   InvivoGen; a549d-komda5
DR   Wikidata; Q107113329
CC   Population: Caucasian.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-komda5).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I73 ! A549-Dual
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   A549-Dual KO-MDA5 hACE2-TMPRSS2
AC   CVCL_A7ZR
DR   cancercelllines; CVCL_A7ZR
DR   InvivoGen; a549d-komda5-cov2r
DR   Wikidata; Q107113330
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies. These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen=a549d-komda5-cov2r).
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-komda5-cov2r).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ZP ! A549-Dual KO-MDA5
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 12
//
ID   A549-Dual KO-RIG-I
AC   CVCL_A7ZN
DR   cancercelllines; CVCL_A7ZN
DR   InvivoGen; a549d-korigi
DR   Wikidata; Q107113331
CC   Population: Caucasian.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-korigi).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I73 ! A549-Dual
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   A549-Dual KO-RIG-I hACE2-TMPRSS2
AC   CVCL_A7ZS
DR   cancercelllines; CVCL_A7ZS
DR   InvivoGen; a549d-korigi-cov2r
DR   Wikidata; Q107113333
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies. These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen=a549d-korigi-cov2r).
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-korigi-cov2r).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ZN ! A549-Dual KO-RIG-I
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 12
//
ID   A549-EGFP
AC   CVCL_XB31
DR   cancercelllines; CVCL_XB31
DR   Ubigene; YC-C016-EGFP-P
DR   Wikidata; Q93311936
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   A549-eGFP-Puro
AC   CVCL_QZ76
DR   cancercelllines; CVCL_QZ76
DR   Imanis; CL079
DR   Wikidata; Q54607016
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL079).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   A549-ESM
AC   CVCL_XI06
SY   A549-MSB
DR   cancercelllines; CVCL_XI06
DR   Wikidata; Q93311939
RX   Patent=WO1999045028A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1972.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3466; ESM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   A549-Fluc-Neo/eGFP-Puro
AC   CVCL_QZ77
DR   cancercelllines; CVCL_QZ77
DR   Imanis; CL097
DR   Wikidata; Q54607020
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL097).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   A549-Fluc-Neo/iRFP-Puro
AC   CVCL_QZ78
DR   cancercelllines; CVCL_QZ78
DR   Imanis; CL098
DR   Wikidata; Q54607022
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-iRFP-P2A-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL098).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   A549-Fluc-Puro
AC   CVCL_QZ79
DR   cancercelllines; CVCL_QZ79
DR   Imanis; CL080
DR   Wikidata; Q54607024
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL080).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   A549-hACE2 [BEI resources]
AC   CVCL_A7UV
DR   BEI_Resources; NR-53821
DR   cancercelllines; CVCL_A7UV
DR   Wikidata; Q107113334
CC   Group: SARS-CoV-2 research cell line.
CC   From: Baric, Ralph Steven; Department of Epidemiology, University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Population: Caucasian.
CC   Characteristics: Expresses ACE2 under the control of the EF1a promoter (BEI_Resources=NR-53821).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   A549-hACE2 [Invivogen]
AC   CVCL_A5KA
DR   cancercelllines; CVCL_A5KA
DR   InvivoGen; a549-hace2
DR   Wikidata; Q107113335
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Characteristics: Permissive to infection by SARS-CoV-2 and/or spike-pseudotyped lentiviral particles (InvivoGen=a549-hace2).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   A549-hACE2 (HA-FLAG)
AC   CVCL_A7UW
DR   BEI_Resources; NR-53522
DR   cancercelllines; CVCL_A7UW
DR   Wikidata; Q107113336
CC   Group: SARS-CoV-2 research cell line.
CC   From: Garcia-Sastre, Adolfo; Icahn School of Medicine at Mount Sinai Medical School; New York; USA.
CC   Population: Caucasian.
CC   Characteristics: Expresses ACE2 with C-terminal HA and FLAG tags under the control the CMV promoter (BEI_Resources=NR-53522).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   A549-hACE2-TMPRSS2
AC   CVCL_A5KB
DR   cancercelllines; CVCL_A5KB
DR   InvivoGen; a549-hace2tpsa
DR   Wikidata; Q107113337
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) and/or spike-pseudotyped lentiviral particles (InvivoGen=a549-hace2tpsa).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5KA ! A549-hACE2 [Invivogen]
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   A549-hNIS-Neo
AC   CVCL_QZ80
DR   cancercelllines; CVCL_QZ80
DR   Imanis; CL004
DR   Wikidata; Q54607025
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-hNIS-IRES-Neo vector encoding for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL004).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   A549-hNIS-Neo/eGFP-Puro
AC   CVCL_QZ81
DR   cancercelllines; CVCL_QZ81
DR   Imanis; CL026
DR   Wikidata; Q54607026
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-eGFP-PGKp-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL026).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   A549-hNIS-Neo/Fluc-Puro
AC   CVCL_QZ82
DR   cancercelllines; CVCL_QZ82
DR   Imanis; CL083
DR   Wikidata; Q54607028
RX   PubMed=30674994;
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-Fluc-P2A-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL083).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   A549-hNIS-Neo/iRFP-Puro
AC   CVCL_QZ83
DR   cancercelllines; CVCL_QZ83
DR   Imanis; CL084
DR   Wikidata; Q54607029
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-iRFP-P2A-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL084).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   A549-hrGFP
AC   CVCL_E9DR
SY   A549-GFP
RX   PubMed=32591581;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a CAG-hrGFP-PuroR construct was introduced in the AAVS1 safe harbor locus (PubMed=32591581).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 84CGO; rrGFP (Note=hrGFP; luorescent protein published in 2007, green fluorescent protein derived from R.reniformis).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A549-IR3
AC   CVCL_C7GS
DR   Wikidata; Q123030363
RX   PubMed=35976051;
CC   Population: Caucasian.
CC   Characteristics: Irradiated 3 times with 4 Gy and with at least a three-week interval between each two consecutive irradiations (PubMed=35976051).
CC   Doubling time: 23.07 hours (PubMed=35976051).
CC   Selected for resistance to: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   A549-IR6
AC   CVCL_C7GT
DR   Wikidata; Q123030364
RX   PubMed=35976051;
CC   Population: Caucasian.
CC   Characteristics: Irradiated 6 times with 4 Gy and with at least a three-week interval between each two consecutive irradiations (PubMed=35976051).
CC   Doubling time: 28.23 hours (PubMed=35976051).
CC   Selected for resistance to: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   A549-iRFP-Neo
AC   CVCL_QZ84
DR   cancercelllines; CVCL_QZ84
DR   Imanis; CL081
DR   Wikidata; Q54607033
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Neo which encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL081).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   A549-iRFP-Puro
AC   CVCL_QZ85
DR   cancercelllines; CVCL_QZ85
DR   Imanis; CL082
DR   Wikidata; Q54607035
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Puro vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL082).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   A549-Luc [JCRB]
AC   CVCL_J242
DR   cancercelllines; CVCL_J242
DR   JCRB; JCRB1414
DR   JCRB; NIHS0659
DR   Wikidata; Q54607036
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0659; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1414
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   A549-Luc [Ubigene]
AC   CVCL_C8WF
DR   Ubigene; YC-C016-Luc-P
DR   Wikidata; Q123030365
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   A549-luc-C8
AC   CVCL_5J13
DR   cancercelllines; CVCL_5J13
DR   Revvity/PerkinElmer; 119266
DR   Wikidata; Q54607038
RX   PubMed=14713107;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119266; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 15
//
ID   A549-Luc2
AC   CVCL_UR31
DR   ATCC; CCL-185-LUC2
DR   cancercelllines; CVCL_UR31
DR   Wikidata; Q93311981
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-185-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CCL-185-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   A549-Luc2-tdT-2
AC   CVCL_XE69
DR   cancercelllines; CVCL_XE69
DR   CCRID; 1101HUM-PUMC000632
DR   Wikidata; Q93311984
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000632
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   A549-mCherry
AC   CVCL_XB30
DR   cancercelllines; CVCL_XB30
DR   CCRID; 1101HUM-PUMC000630
DR   Wikidata; Q93311986
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000630
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   A549-Mx2/EGFP L2A6
AC   CVCL_RX08
SY   A549 L2A6; A549L2A6; L2A6
DR   cancercelllines; CVCL_RX08
DR   Wikidata; Q54607000
RX   PubMed=22373148;
CC   Population: Caucasian.
CC   Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency.
CC   Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   A549-Mx2/EGFP L2G9
AC   CVCL_RX09
SY   A549L2G9; A549 L2G9; L2G9
DR   cancercelllines; CVCL_RX09
DR   Wikidata; Q54607001
RX   PubMed=22373148;
RX   PubMed=27346232;
CC   Population: Caucasian.
CC   Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency (PubMed=27346232).
CC   Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter (PubMed=27346232).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   A549-R0
AC   CVCL_A1ZX
DR   cancercelllines; CVCL_A1ZX
DR   Wikidata; Q105506038
RX   PubMed=8132585;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Doubling time: 8-10 days (PubMed=8132585).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   A549-Red-FLuc
AC   CVCL_5I86
SY   A549 Red-FLuc; Bioware Brite A549 Red-FLuc; IVISbrite A549 Red F-luc
DR   cancercelllines; CVCL_5I86
DR   Revvity/PerkinElmer; BW119266
DR   Wikidata; Q54607040
CC   Population: Caucasian.
CC   Doubling time: 22 hours (Revvity/PerkinElmer=BW119266).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   A549-RepTor
AC   CVCL_E8FG
DR   InvivoGen; a549-rtor
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR (Note=Optimized).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   A549-SunTag
AC   CVCL_C9AW
DR   BioGRID_ORCS_Cell_line; 1594
DR   Wikidata; Q123030366
RX   PubMed=35421191;
CC   Population: Caucasian.
CC   Characteristics: Doxycycline induces the expression of pCW-TRE-scFv-SunTag. SunTag consists of 24 copies of a short peptide epitope from yeast GCN4 and is used to recruite multiple protein copies to a polypeptide scaffold.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   A549-SunTag ACE2
AC   CVCL_C9AX
DR   BioGRID_ORCS_Cell_line; 1599
DR   Wikidata; Q123030368
RX   PubMed=35421191;
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Characteristics: Doxycycline induces the expression of pCW-TRE-scFv-SunTag. SunTag consists of 24 copies of a short peptide epitope from yeast GCN4 and is used to recruite multiple protein copies to a polypeptide scaffold.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9AW ! A549-SunTag
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   A549-Taxol
AC   CVCL_W218
SY   A549/Taxol
DR   cancercelllines; CVCL_W218
DR   Wikidata; Q54607041
RX   PubMed=20499251;
RX   PubMed=22460125;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   A549-tdT
AC   CVCL_XB27
DR   cancercelllines; CVCL_XB27
DR   CCRID; 1101HUM-PUMC000629
DR   Wikidata; Q93311997
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000629
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   A549.EpoB40
AC   CVCL_4Z15
SY   EpoB40
DR   cancercelllines; CVCL_4Z15
DR   Wikidata; Q54607056
RX   PubMed=12467233;
RX   PubMed=15956256;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31550; Epothilone B (EpoB).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   A549/8
AC   CVCL_IY87
DR   cancercelllines; CVCL_IY87
DR   Wikidata; Q54607043
RX   PubMed=94594;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   A549/Asc-1
AC   CVCL_YA87
SY   A549/ASC-1
DR   cancercelllines; CVCL_YA87
DR   GEO; GSM1177927
DR   GEO; GSM1177928
DR   Wikidata; Q93312009
RX   PubMed=3129183;
RX   PubMed=3335022;
CC   Population: Caucasian.
CC   Characteristics: Established following in vivo propagation of parent cell line as an ascites tumor (PubMed=3129183).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   A549/Cas9 AAVS1
AC   CVCL_C9BK
DR   GeneCopoeia; SL504
DR   Wikidata; Q123030369
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-PuroR-SV40pa construct from the AAVS1 safe harbor locus (GeneCopoeia=SL504).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   A549/CDDP
AC   CVCL_C5RT
SY   A549/cDDP
DR   ChEMBL-Cells; CHEMBL4483129
DR   ChEMBL-Targets; CHEMBL4483225
DR   Wikidata; Q116048462
RX   PubMed=20716419;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   A549/cis
AC   CVCL_E9XL
SY   A549/Cis
DR   CCRID; 1101HUM-PUMC000519
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000519
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A549/CisR
AC   CVCL_C5RZ
DR   Wikidata; Q116048463
RX   PubMed=26498137;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   A549/CPT
AC   CVCL_H268
DR   cancercelllines; CVCL_H268
DR   CGH-DB; 9107-4
DR   Wikidata; Q54607045
RX   PubMed=2170010;
RX   PubMed=2174738;
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   A549/DDP
AC   CVCL_C0W4
DR   cancercelllines; CVCL_C0W4
DR   CLS; 305047
DR   Wikidata; Q114310532
RX   PubMed=28114404;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=305047
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   A549/GFP
AC   CVCL_JY87
DR   cancercelllines; CVCL_JY87
DR   Cell_Biolabs; AKR-209
DR   Wikidata; Q54607048
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   A549/NFkB-luc
AC   CVCL_KS36
DR   cancercelllines; CVCL_KS36
DR   Wikidata; Q54607050
RX   PubMed=16834536;
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NF-kappaB response element (PubMed=16834536).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0002.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   A549/SF
AC   CVCL_UJ49
DR   ATCC; CCL-185.1
DR   cancercelllines; CVCL_UJ49
DR   Wikidata; Q93312024
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CCL-185.1; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   A549/TR
AC   CVCL_C5S0
DR   ChEMBL-Cells; CHEMBL4483127
DR   ChEMBL-Targets; CHEMBL4483226
DR   Wikidata; Q116048464
RX   PubMed=26498137;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   A549/TS1
AC   CVCL_B7N5
DR   cancercelllines; CVCL_B7N5
DR   Wikidata; Q112927065
RX   PubMed=21487406;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   A549/TS2
AC   CVCL_B7N6
DR   cancercelllines; CVCL_B7N6
DR   Wikidata; Q112927066
RX   PubMed=21487406;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   A549/TXL10
AC   CVCL_W190
DR   cancercelllines; CVCL_W190
DR   Wikidata; Q54607052
RX   CelloPub=CLPUB00006;
CC   Population: Caucasian.
CC   Doubling time: 75.5 hours (CelloPub=CLPUB00006).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   A549/TXL20
AC   CVCL_W191
DR   cancercelllines; CVCL_W191
DR   Wikidata; Q54607053
RX   CelloPub=CLPUB00006;
CC   Population: Caucasian.
CC   Doubling time: 77.3 hours (CelloPub=CLPUB00006).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   A549/TXL5
AC   CVCL_W192
DR   cancercelllines; CVCL_W192
DR   Wikidata; Q54607054
RX   CelloPub=CLPUB00006;
CC   Population: Caucasian.
CC   Doubling time: 74.7 hours (CelloPub=CLPUB00006).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   A549L0
AC   CVCL_ZX73
DR   cancercelllines; CVCL_ZX73
DR   Wikidata; Q102113491
RX   Patent=CN103756968B;
RX   PubMed=26090868;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   A549L6
AC   CVCL_ZX74
DR   cancercelllines; CVCL_ZX74
DR   Wikidata; Q102113493
RX   Patent=CN103756968B;
RX   PubMed=26090868;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201346.
CC   Population: Caucasian.
CC   Characteristics: Highly metastatic to spine. Established after 3 rounds of intracardial injection of the parent cell line in nude mice and extraction of the metastatic cells from spine tumors.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX73 ! A549L0
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   A549rCDDP2000
AC   CVCL_RQ47
DR   cancercelllines; CVCL_RQ47
DR   Wikidata; Q54607064
RX   PubMed=28746345;
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   A57H
AC   CVCL_D6SU
RX   PubMed=9191417;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human IgG (Note=Recognizes the CH3 domain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   A590
AC   CVCL_6A73
SY   A 590
DR   Cosmic; 933523
DR   Wikidata; Q54607066
RX   PubMed=1906154;
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 3
//
ID   A5B9
AC   CVCL_C3XS
SY   A5B9A8
DR   Wikidata; Q116048465
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   A5GR1
AC   CVCL_5V00
DR   Wikidata; Q54607068
RX   PubMed=8695360;
RX   PubMed=9347924;
CC   Genetic integration: Method=Transduction; Gene=RGD; 2741; Nr3c1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U93 ! NAL1A clone C1SA5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   A6
AC   CVCL_4101
SY   A-6
DR   BTO; BTO_0004248
DR   CLO; CLO_0001603
DR   CLO; CLO_0050248
DR   CLDB; cl209
DR   ATCC; CCL-102
DR   ECACC; 89072613
DR   Kerafast; EMU037
DR   RCB; RCB0772
DR   Wikidata; Q54607073
RX   DOI=10.1007/978-3-642-85791-1_5;
RX   DOI=10.1007/BF02618370;
RX   PubMed=1556737;
RX   PubMed=1811155;
RX   PubMed=8320717;
RX   PubMed=11249203;
RX   PubMed=12058078;
RX   PubMed=12892530;
RX   PubMed=20732225;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-366.html
CC   Group: Amphibian cell line.
CC   Doubling time: ~36 hours (Note=At 25 Celsius) (PubMed=11249203).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Male
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   A6-2F3
AC   CVCL_F714
SY   A6 2F3; 2F3
DR   Wikidata; Q54607076
RX   PubMed=1556737;
RX   PubMed=3032984;
RX   PubMed=8320717;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_4101 ! A6
SX   Male
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 14
//
ID   A6-iPSC
AC   CVCL_DD59
DR   Wikidata; Q54607167
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=27191603).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   A6-KR
AC   CVCL_VQ55
SY   KR
DR   Wikidata; Q93312063
RX   PubMed=1811155;
RX   PubMed=2416614;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_4101 ! A6
SX   Male
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 8
//
ID   A6/C1
AC   CVCL_B7ED
SY   A6-C1; A6C1
DR   Wikidata; Q112927067
RX   PubMed=3032984;
RX   PubMed=8189433;
RX   PubMed=8392584;
CC   Group: Amphibian cell line.
CC   Characteristics: Selected for its high transepithelial resistance and for its responsiveness to aldosterone and antidiuretic hormone (PubMed=8392584).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_F714 ! A6-2F3
SX   Male
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   A61-5
AC   CVCL_E281
SY   Pa101C
DR   Cosmic; 1477307
DR   Cosmic; 1509878
DR   Wikidata; Q54607169
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   A61130087P
AC   CVCL_WS44
DR   FCS-free; 149-17-267-3-4-6
DR   Wikidata; Q93312070
RX   PubMed=17123500;
CC   Doubling time: 28.4 +- 1.8 hours (Note=In FBS-containing medium), 26.0 +- 3.9 hours (Note=In serum/protein free medium) (PubMed=17123500).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   A61140087P
AC   CVCL_WS45
DR   FCS-free; 149-17-267-3-4-6
DR   Wikidata; Q93312072
RX   PubMed=17123500;
CC   Doubling time: 36.9 +- 3.2 hours (Note=In FBS-containing medium), 30.9 +- 6.0 hours (Note=In serum/protein free medium) (PubMed=17123500).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   A64-CLS
AC   CVCL_5968
SY   A-64CLS
DR   CLS; 300199
DR   Wikidata; Q54607171
CC   Population: Caucasian.
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
ST   Source(s): CLS=300199
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D21S11: 30,31
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 11
ST   FGA: 21.2
ST   Penta D: 9,10
ST   Penta E: 10,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C5977; Submandibular gland carcinoma ex pleomorphic adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   A640-3Y1-1
AC   CVCL_H731
SY   A640-3Y1
DR   RCB; RCB0344
DR   Wikidata; Q54607172
RX   PubMed=3533570;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   A640-BB-1
AC   CVCL_B3R8
DR   Wikidata; Q110429850
RX   PubMed=2995424;
RX   PubMed=6086676;
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   A640-BB-2
AC   CVCL_JJ75
DR   Wikidata; Q54607173
RX   CelloPub=CLPUB00657;
RX   PubMed=1369104;
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   A640-BB-3
AC   CVCL_B3R9
DR   Wikidata; Q110429853
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   A640-BB-4
AC   CVCL_B3RA
DR   Wikidata; Q110429855
RX   PubMed=6086676;
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   A640-BB-5
AC   CVCL_B3RB
DR   Wikidata; Q110429858
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   A640-IS
AC   CVCL_H640
DR   BTO; BTO_0003530
DR   Wikidata; Q54607176
RX   PubMed=9252141;
RX   PubMed=17760834;
CC   Characteristics: Grows actively at the permissive temperature (33 Celsius). At the repressive temperature (39 Celsius) the cells do not grow and differentiate into Ito cells.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   A673-SLFN11-KO
AC   CVCL_C6N5
DR   Wikidata; Q116048466
RX   PubMed=34413129;
CC   Problematic cell line: Misclassified. Parent cell line (A-673) was originally thought to be a rhabdomyosarcoma cell line but is an Ewing sarcoma cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala119Glnfs*5 (c.353_354dupCA) (c.354_355insCA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0080 ! A-673
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   A68177
AC   CVCL_6366
SY   A68-177
DR   CLO; CLO_0001607
DR   ATCC; CRL-7714
DR   Wikidata; Q54607177
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/origins-of-crl-7761-and-crl-7762
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7714; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   A69
AC   CVCL_A8KJ
SY   A-69; A 69
DR   Wikidata; Q108819818
RX   PubMed=2910777;
CC   Doubling time: 62 hours (PubMed=2910777).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   A6ATL
AC   CVCL_Y380
SY   A6 ATL; A6.ATL
DR   CLO; CLO_0001604
DR   Wikidata; Q54607178
RX   PubMed=6971250;
CC   Characteristics: Leukemia cells were transferred by intraperitoneal passage in syngeneic recipients. The cell line was obtained from tumour cells successfully grown in ascites for a few passages (PubMed=6971250).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: AT.L.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-5M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 5
//
ID   A6F8.6
AC   CVCL_B0NZ
SY   CR-9
DR   Wikidata; Q108819819
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3318.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A6L
AC   CVCL_E302
AS   CVCL_D553
SY   A6; GM6L; Pa02C
DR   Cosmic; 1473116
DR   Cosmic; 1509849
DR   Wikidata; Q54607180
RX   PubMed=17912029;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   A7 [Mouse stellate]
AC   CVCL_M113
DR   BTO; BTO_0003532
DR   Wikidata; Q54607181
RX   PubMed=17760834;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   A7 [Rat brain astrocyte]
AC   CVCL_E150
DR   Wikidata; Q54607184
RX   PubMed=22358592;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-5D
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   A7 [Rat optic nerve astrocyte]
AC   CVCL_E148
DR   Wikidata; Q54607185
RX   PubMed=3053737;
RX   PubMed=7583324;
RX   PubMed=8076662;
RX   PubMed=10516297;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Central nervous system, optic nerve; UBERON=UBERON_0000941.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   A716
AC   CVCL_D595
SY   A-716
DR   BTO; BTO_0005308
DR   Wikidata; Q54607187
CC   From: Lerman, Michael I.; Center for Cancer Research, National Cancer Institute; Frederick; USA.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   A717
AC   CVCL_G631
DR   CLO; CLO_0001611
DR   ATCC; HB-9596
DR   Wikidata; Q54607188
RX   Patent=US5518720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9596.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02768; Human ALB (Note=Glycated).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   A72E
AC   CVCL_IZ50
SY   A72E-epithelioid
DR   Wikidata; Q54607193
RX   PubMed=2617846;
CC   Derived from site: In situ; Left thigh; UBERON=UBERON_0000376.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_3453 ! A-72
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   A72F
AC   CVCL_IZ51
SY   A72-fibroblastic
DR   Wikidata; Q54607196
RX   PubMed=2617846;
CC   Derived from site: In situ; Left thigh; UBERON=UBERON_0000376.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_3453 ! A-72
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   A735
AC   CVCL_X371
DR   Wikidata; Q54607200
RX   PubMed=10475274;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=p375.6).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12-16FW
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 11
//
ID   A7573
AC   CVCL_9501
SY   A 7573
DR   CLO; CLO_0001613
DR   CLDB; cl213
DR   Wikidata; Q54607202
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   A7573/HL-23V
AC   CVCL_L209
SY   A7573-HL23V; A7573(HL-23V)
DR   Wikidata; Q54607204
RX   PubMed=52117;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_9501 ! A7573
SX   Female
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 11
//
ID   A79V-GC-hiPSC
AC   CVCL_A4MY
DR   Wikidata; Q105506041
RX   PubMed=27345973;
RX   PubMed=27879212;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_corrected; p.Ala79Val (c.236C>T); ClinVar=VCV000018157; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=27879212).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ85 ! A79V-hiPSC
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   A79V-hiPSC
AC   CVCL_DQ85
DR   Wikidata; Q54607206
RX   PubMed=27345973;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala79Val (c.236C>T); ClinVar=VCV000018157; Zygosity=Heterozygous (PubMed=27345973).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   A7d
AC   CVCL_6870
DR   Wikidata; Q54607209
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6342; KIT.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000093). It was the sole source of information for this entry.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   A7R34
AC   CVCL_KB00
DR   RCB; RCB4481
DR   Wikidata; Q54607211
RX   PubMed=8415665;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16872; Mouse Il7r/Cd127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   A7r5
AC   CVCL_0137
SY   A7R5
DR   BTO; BTO_0000019
DR   CLO; CLO_0001614
DR   MCCL; MCC:0000030
DR   CLDB; cl214
DR   CLDB; cl215
DR   ATCC; CRL-1444
DR   BCRC; 60082
DR   BCRJ; 0034
DR   CCRID; 3101RATGNR7
DR   ChEMBL-Cells; CHEMBL3833741
DR   CLS; 305198
DR   ECACC; 86050803
DR   IZSLER; BS CL 162
DR   KCB; KCB 2010186YJ
DR   Lonza; 997
DR   NCBI_Iran; C607
DR   PubChem_Cell_line; CVCL_0137
DR   Wikidata; Q54607214
RX   PubMed=943301;
RX   PubMed=24628920;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   A7r5 hSSAO/VAP-1
AC   CVCL_E8GQ
DR   ABM; T3155
RX   PubMed=17393062;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:550; AOC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0137 ! A7r5
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   A8 [Mouse hybridoma against human PRSS1]
AC   CVCL_F0UY
RX   PubMed=2347596;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07477; Human PRSS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   A8 [Xenopus]
AC   CVCL_4564
SY   A-8
DR   CLO; CLO_0050154
DR   RCB; RCB0773
DR   Wikidata; Q54607217
RX   DOI=10.1007/978-3-642-85791-1_5;
RX   PubMed=307557;
RX   PubMed=12892530;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   A8 2k
AC   CVCL_C0YN
DR   Wikidata; Q114310533
RX   PubMed=307557;
CC   Group: Amphibian cell line.
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_4564 ! A8 [Xenopus]
SX   Female
AG   Adult stage
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   A8/D1
AC   CVCL_3272
SY   A8/DI
DR   CLO; CLO_0001615
DR   CLDB; cl218
DR   CLDB; cl4896
DR   ECACC; 94031011
DR   ICLC; ATL98012
DR   Wikidata; Q54607219
RX   PubMed=1401954;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: ECACC; 94031011; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   A818
AC   CVCL_3890
DR   Wikidata; Q54607222
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10415853;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   A818-1
AC   CVCL_3891
AS   CVCL_8604
SY   A-818-1; A 818-1; A818.1; A818 1; 818-1; 818_1; 818.1
DR   cancercelllines; CVCL_3891
DR   Cosmic; 736266
DR   Cosmic; 808169
DR   Cosmic; 933524
DR   Wikidata; Q54607224
RX   PubMed=1764370;
RX   PubMed=1906154;
RX   PubMed=8426738;
RX   PubMed=8430098;
RX   PubMed=10415853;
RX   PubMed=11169959;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/A818.html
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11169959).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=8426738; PubMed=11169959).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3890 ! A818
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   A818-4
AC   CVCL_3892
AS   CVCL_0128
SY   A-818-4; A 818-4; A818.4; A818 4; A8184; 818-4; 818_4; 818.4; 8184
DR   MCCL; MCC:0000020
DR   cancercelllines; CVCL_3892
DR   Cosmic; 710850
DR   Cosmic; 736267
DR   Cosmic; 808168
DR   Cosmic; 933525
DR   Cosmic; 1108342
DR   Cosmic; 1320466
DR   Wikidata; Q54607225
RX   PubMed=1764370;
RX   PubMed=1906154;
RX   PubMed=8426738;
RX   PubMed=8430098;
RX   PubMed=9472115;
RX   PubMed=10415853;
RX   PubMed=11787853;
RX   PubMed=12692724;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=8426738; PubMed=11787853).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3890 ! A818
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   A818-6
AC   CVCL_3893
SY   A818.6; A818 6
DR   Wikidata; Q54607227
RX   PubMed=11238448;
CC   Doubling time: 69 hours (PubMed=11238448).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3890 ! A818
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   A818-7
AC   CVCL_8777
AS   CVCL_8605
SY   A-818-7; A 818-7; 818-7
DR   cancercelllines; CVCL_8777
DR   Cosmic; 736268
DR   Cosmic; 933526
DR   Wikidata; Q54607229
RX   PubMed=1906154;
RX   PubMed=8105469;
RX   PubMed=8426738;
RX   PubMed=8430098;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=8426738).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3890 ! A818
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   A8G3.5
AC   CVCL_B0P0
SY   CR-8
DR   Wikidata; Q108819820
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3317.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A8H3.1
AC   CVCL_B0P1
SY   CR-6
DR   Wikidata; Q108819821
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3315.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   A9 [Mouse hybridoma against Ev71]
AC   CVCL_XD59
DR   Wikidata; Q93312189
RX   Patent=CN102409028B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.5330.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q66479; Human enterovirus 71 (EV71) genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 6
//
ID   A9 [Mouse hybridoma against hamster Hmgcr]
AC   CVCL_9094
DR   CLO; CLO_0001619
DR   ATCC; CRL-1811
DR   Wikidata; Q54607230
RX   PubMed=6688077;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00347; Cricetulus griseus Hmgcr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   A9 [Mouse Lewis lung carcinoma]
AC   CVCL_S007
SY   3LL-A9; 3LL clone A9
DR   Wikidata; Q54607231
RX   PubMed=3855489;
RX   PubMed=6490207;
RX   PubMed=8425771;
CC   Characteristics: Low metastatic potential.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   A9 L hD2 S.C. 18
AC   CVCL_9095
SY   A9 L cell line hD2 subclone #18; A9 D2 Subclone 18
DR   CLO; CLO_0001621
DR   ATCC; CRL-10225
DR   Wikidata; Q54607232
RX   Patent=US6214615;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10225.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3023; DRD2.
CC   Discontinued: ATCC; CRL-10225; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   A9-PM
AC   CVCL_A2ZV
DR   Wikidata; Q105506045
RX   PubMed=33296661;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome X with the 80-85 CGG repeats in the FMR1 gene.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_AX90 ! GM06892
CA   Hybrid cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   A9(An4)-2
AC   CVCL_2830
DR   JCRB; JCRB0727
DR   Wikidata; Q54607337
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   A9(Bsr10)
AC   CVCL_2831
DR   JCRB; JCRB2210
DR   Wikidata; Q54607339
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 10.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   A9(BsrX)
AC   CVCL_2832
DR   JCRB; JCRB2223
DR   Wikidata; Q54607342
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome X.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   A9(GM0097)-1
AC   CVCL_1P02
DR   Wikidata; Q54607345
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V747 ! GM00097
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM0194)-3
AC   CVCL_1P03
DR   Wikidata; Q54607347
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_H961 ! GM00194
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM0439)-1
AC   CVCL_2825
SY   A9(0439)-1
DR   JCRB; JCRB0732
DR   Wikidata; Q54607349
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V771 ! GM00439
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   A9(GM1533)-1
AC   CVCL_1P04
DR   Wikidata; Q54607352
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V806 ! GM01533
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM1695)-3
AC   CVCL_1P05
DR   Wikidata; Q54607354
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V811 ! GM01695
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM1695)-4
AC   CVCL_1P06
DR   Wikidata; Q54607356
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V811 ! GM01695
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM1695)-5
AC   CVCL_1P07
DR   Wikidata; Q54607357
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V811 ! GM01695
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM2621)-4
AC   CVCL_2826
SY   A9(2621)-4
DR   JCRB; JCRB0730
DR   Wikidata; Q54607361
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1P01 ! GM02621
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   A9(GM2859)-3
AC   CVCL_1P08
DR   Wikidata; Q54607363
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_M932 ! GM02859
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM2859)-4
AC   CVCL_1P09
DR   Wikidata; Q54607364
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_M932 ! GM02859
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM3322)-1
AC   CVCL_1P10
DR   Wikidata; Q54607366
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_Y091 ! GM03322
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM3322)-2
AC   CVCL_1P11
DR   Wikidata; Q54607368
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_Y091 ! GM03322
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM3552)-2
AC   CVCL_2827
SY   A9(3552)-2
DR   JCRB; JCRB0731
DR   Wikidata; Q54607370
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_N009 ! GM03552
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   A9(GM3884)-1
AC   CVCL_2828
SY   A9(3884)-1
DR   JCRB; JCRB0729
DR   Wikidata; Q54607371
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N62 ! GM03884
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   A9(GM3884)-2
AC   CVCL_1P12
DR   Wikidata; Q54607373
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N62 ! GM03884
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM4618)-10
AC   CVCL_1P13
DR   Wikidata; Q54607376
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_N128 ! GM04618
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM4618)-2
AC   CVCL_1P14
DR   Wikidata; Q54607378
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_N128 ! GM04618
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   A9(GM7151)-3
AC   CVCL_2829
SY   A9(7151)-3
DR   JCRB; JCRB0728
DR   Wikidata; Q54607382
RX   PubMed=2498246;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_X048 ! GM07151
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   A9(Hygro13)
AC   CVCL_2833
DR   JCRB; JCRB2213
DR   Wikidata; Q54607385
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 13.
CC   Doubling time: ~30 hours (Note=Lot 05202016) (JCRB=JCRB2213).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   A9(Hygro14)
AC   CVCL_2834
DR   JCRB; JCRB2214
DR   Wikidata; Q54607386
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 14.
CC   Doubling time: ~21 hours (Note=Lot 12142017) (JCRB=JCRB2214).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   A9(Hygro21)
AC   CVCL_2835
DR   JCRB; JCRB2221
DR   Wikidata; Q54607388
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 21.
CC   Doubling time: ~1 day (Note=Lot 04242006) (JCRB=JCRB2221).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   A9(Hygro22)
AC   CVCL_2836
DR   JCRB; JCRB2222
DR   Wikidata; Q54607391
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 22.
CC   Doubling time: ~1 day (Note=Lot 04102006) (JCRB=JCRB2222).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   A9(Neo1)
AC   CVCL_2837
SY   A9(neo-1); A9(Neo-1)-4; A9-1neo; GM13139
DR   CLO; CLO_0013668
DR   Coriell; GM13139
DR   JCRB; JCRB2201
DR   Wikidata; Q54607392
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 1.
CC   Doubling time: ~27 hours (Note=Lot 11192018) (JCRB=JCRB2201).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0440 ! MRC-5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A9(Neo11)
AC   CVCL_2838
SY   A9(neo11); A9(Neo-11)-1; A9 (Neo-11)-1
DR   JCRB; JCRB2211
DR   Wikidata; Q54607393
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0440 ! MRC-5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   A9(Neo12)
AC   CVCL_2839
SY   A9(neo-12); A9(Neo-12)-4
DR   JCRB; JCRB2212
DR   Wikidata; Q54607395
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 12.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_3080 ! NTI-4
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A9(Neo15)
AC   CVCL_2840
SY   A9(Neo-15)-2
DR   JCRB; JCRB2215
DR   Wikidata; Q54607399
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   A9(Neo16)
AC   CVCL_2841
DR   JCRB; JCRB2216
DR   Wikidata; Q54607401
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   A9(Neo17)
AC   CVCL_2842
DR   JCRB; JCRB2217
DR   Wikidata; Q54607402
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 17.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   A9(Neo18)
AC   CVCL_2843
SY   A9(Neo-18)-5
DR   JCRB; JCRB2218
DR   Wikidata; Q54607404
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   A9(Neo19)
AC   CVCL_2844
SY   A9(Neo-19)-1
DR   JCRB; JCRB2219
DR   Wikidata; Q54607406
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 19.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0440 ! MRC-5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A9(Neo2)
AC   CVCL_2845
SY   A9(Neo-2)-1
DR   JCRB; JCRB2202
DR   Wikidata; Q54607408
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 2.
CC   Doubling time: ~1 day (Note=Lot 09192017) (JCRB=JCRB2202).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   A9(Neo20)
AC   CVCL_2846
SY   A9(Neo-20)-3; A9-20neo; GM13140
DR   CLO; CLO_0013667
DR   Coriell; GM13140
DR   JCRB; JCRB2220
DR   Wikidata; Q54607410
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 20.
CC   Doubling time: ~21 hours (Note=Lot 12032018) (JCRB=JCRB2220).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0440 ! MRC-5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A9(Neo3)
AC   CVCL_2847
DR   JCRB; JCRB2203
DR   Wikidata; Q54607412
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_3080 ! NTI-4
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A9(Neo4)
AC   CVCL_2848
DR   JCRB; JCRB2204
DR   Wikidata; Q54607413
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0440 ! MRC-5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A9(Neo5)
AC   CVCL_2849
SY   A9(Neo-5)-4
DR   JCRB; JCRB2205
DR   Wikidata; Q54607416
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   A9(Neo6)
AC   CVCL_2850
SY   A9(Neo-6)-3
DR   JCRB; JCRB2206
DR   Wikidata; Q54607419
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 6.
CC   Doubling time: ~24 hours (Note=Lot 03052019) (JCRB=JCRB2206).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   A9(Neo7)
AC   CVCL_2851
SY   A9(Neo-7)-2
DR   JCRB; JCRB2207
DR   Wikidata; Q54607421
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: It is possible that A9(Neo7) and A9(NTI8)-2 (Cellosaurus=CVCL_2853) are the same cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_3080 ! NTI-4
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   A9(Neo8)
AC   CVCL_2852
SY   A9(Neo-8)-1
DR   JCRB; JCRB2208
DR   Wikidata; Q54607538
RX   PubMed=2502516;
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 8.
CC   Doubling time: 31-34 hours (Note=Lot 02012016) (JCRB=JCRB2208).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   A9(NTI8)-2
AC   CVCL_2853
SY   NTI8
DR   JCRB; JCRB0726
DR   Wikidata; Q54607539
RX   PubMed=8905237;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: It is possible that A9(NTI8)-2 and A9(Neo7) (Cellosaurus=CVCL_2851) are the same cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   A9+12
AC   CVCL_1P15
SY   GM13259
DR   CLO; CLO_0013121
DR   Coriell; GM13259
DR   Wikidata; Q54607233
RX   PubMed=8325652;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   A9+15
AC   CVCL_1P16
SY   GM11715
DR   CLO; CLO_0021263
DR   Coriell; GM11715
DR   Wikidata; Q54607234
RX   CelloPub=CLPUB00447;
RX   PubMed=1582264;
RX   PubMed=8325652;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   A9+2
AC   CVCL_1P17
SY   GM11712
DR   CLO; CLO_0021273
DR   Coriell; GM11712
DR   Wikidata; Q54607237
RX   CelloPub=CLPUB00447;
RX   PubMed=1582264;
RX   PubMed=8325652;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   A9+20
AC   CVCL_1P18
SY   GM13260
DR   CLO; CLO_0013119
DR   Coriell; GM13260
DR   Wikidata; Q54607238
RX   PubMed=8325652;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   A9+22
AC   CVCL_1P19
SY   GM13258
DR   CLO; CLO_0013066
DR   Coriell; GM13258
DR   Wikidata; Q54607239
RX   PubMed=8325652;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   A9+3
AC   CVCL_1P20
SY   GM11713
DR   CLO; CLO_0021275
DR   Coriell; GM11713
DR   Wikidata; Q54607240
RX   CelloPub=CLPUB00447;
RX   PubMed=1582264;
RX   PubMed=8325652;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   A9+5
AC   CVCL_1P21
SY   GM11714
DR   CLO; CLO_0021262
DR   Coriell; GM11714
DR   Wikidata; Q54607241
RX   CelloPub=CLPUB00447;
RX   PubMed=1582264;
RX   PubMed=8325652;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   A9.12
AC   CVCL_VU13
DR   Wikidata; Q93312386
RX   CelloPub=CLPUB00480;
RX   PubMed=9744750;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=A9.12
CC   Characteristics: IL2 dependent.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: SJL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VV42 ! A9.2
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   A9.2
AC   CVCL_VV42
DR   Wikidata; Q93312389
RX   CelloPub=CLPUB00480;
CC   Characteristics: IL2 dependent.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: SJL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VU13 ! A9.12
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   A90
AC   CVCL_A8KK
SY   A-90; A 90
DR   Wikidata; Q108819822
RX   PubMed=2910777;
RX   PubMed=7959296;
CC   Doubling time: 71 hours (PubMed=2910777).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   A904-EBV-B
AC   CVCL_A5AL
DR   Wikidata; Q107113338
RX   PubMed=15994973;
RX   PubMed=17131342;
CC   Population: Chinese; Han and Korean.
CC   HLA typing: A*24:02,26:03; B*07:02,39:01; C*07:02 (PubMed=15994973).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U095 ! A904L
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   A904L
AC   CVCL_U095
DR   RCB; RCB3531
DR   TOKU-E; 3583
DR   Wikidata; Q54607542
RX   PubMed=11267941;
RX   PubMed=12114371;
RX   PubMed=15994973;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=19799608;
RX   PubMed=38639832;
CC   Population: Chinese; Han and Korean.
CC   HLA typing: A*24:02; B*07:02; C*07:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5AL ! A904-EBV-B
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 13
//
ID   A904L-A26
AC   CVCL_A5AN
DR   Wikidata; Q107113339
RX   PubMed=15994973;
CC   Population: Chinese; Han and Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*26:03).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AM ! A904L-CD80
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   A904L-B39
AC   CVCL_A5AP
DR   Wikidata; Q107113340
RX   PubMed=15994973;
CC   Population: Chinese; Han and Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*39:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5AM ! A904L-CD80
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   A904L-CD80
AC   CVCL_A5AM
DR   Wikidata; Q107113341
RX   PubMed=11267941;
RX   PubMed=15994973;
CC   Population: Chinese; Han and Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U095 ! A904L
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   A924
AC   CVCL_N715
DR   Wikidata; Q54607544
RX   PubMed=16820947;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   A925L
AC   CVCL_U096
DR   Wikidata; Q54607546
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=25581823;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*46:01,59:01; C*01:02,01:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   A925LPE3
AC   CVCL_TZ85
DR   Wikidata; Q54607549
RX   PubMed=25581823;
CC   Population: Japanese.
CC   Characteristics: Established from parent cell line after 3 passages in the thoracic cavity of SCID mice.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U096 ! A925L
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   A9423
AC   CVCL_W143
SY   9423
DR   Wikidata; Q54607550
RX   PubMed=3004699;
RX   PubMed=6750238;
CC   From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 12
//
ID   A964
AC   CVCL_N716
DR   Wikidata; Q54607554
RX   PubMed=16820947;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   A99
AC   CVCL_D699
SY   a 99
DR   cancercelllines; CVCL_D699
DR   Cosmic; 1767220
DR   Wikidata; Q54607556
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=21768923;
RX   PubMed=29765522;
CC   Characteristics: Established from a nude mice xenograft. Tumorigenic (PubMed=21768923).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Leu (c.34_35GG>CT) (c.34_35delinsCT); Zygosity=Homozygous (PubMed=21768923).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Thr (c.379T>A); ClinVar=VCV000824232; Zygosity=Homozygous (PubMed=21768923).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C95583; Pancreatic small cell carcinoma
DI   ORDO; Orphanet_97253; Neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   A9G TG100
AC   CVCL_LB85
DR   Wikidata; Q54607560
RX   PubMed=1064870;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_LB84 ! A9G TG40
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   A9G TG40
AC   CVCL_LB84
DR   Wikidata; Q54607558
RX   PubMed=1064870;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   A9HT
AC   CVCL_4387
SY   A9 high take
DR   CLO; CLO_0001626
DR   CLDB; cl225
DR   ECACC; 88042804
DR   Wikidata; Q54607561
RX   PubMed=4506195;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   AA-103A
AC   CVCL_YZ42
SY   103A
DR   Wikidata; Q98125455
RX   PubMed=31576543;
CC   Population: African American.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=31576543
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 8,9
ST   D18S51: 15,17
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 7,8
ST   Penta E: 5,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ43 ! AA-103B
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AA-103B
AC   CVCL_YZ43
SY   103B
DR   Wikidata; Q98125456
RX   PubMed=31576543;
CC   Population: African American.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=31576543
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 8,9
ST   D18S51: 15,17
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 7,8
ST   Penta E: 5,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ42 ! AA-103A
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AA-2
AC   CVCL_8168
SY   AA2
DR   BEI_Resources; ARP-135
DR   Wikidata; Q54607564
RX   PubMed=3261775;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   AA1
AC   CVCL_C7IU
DR   Wikidata; Q123030370
RX   Patent=GB2103654A;
RX   PubMed=7057905;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
CC   Monoclonal antibody target: ChEBI; CHEBI_16076; 11alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   AA101
AC   CVCL_B5X0
SY   AA 101
DR   Wikidata; Q111732850
RX   PubMed=8187845;
RX   PubMed=9009094;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_182040; Aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   AA224
AC   CVCL_J178
DR   CLO; CLO_0001628
DR   ATCC; HB-10183
DR   Wikidata; Q54607568
RX   Patent=US5238824;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10183.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Edwardsiella ictaluri antigens of about 14, 39, 48, 60, 66, 83 and 93 Kda.
CC   Discontinued: ATCC; HB-10183; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   Aa23
AC   CVCL_Z817
DR   Wikidata; Q54607569
RX   PubMed=9013253;
RX   PubMed=18401667;
RX   PubMed=22375833;
RX   PubMed=33389257;
CC   Group: Insect cell line.
CC   Characteristics: Infected by the intracellular symbiont Wolbachia pipientis.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   Aa23-T
AC   CVCL_RP53
SY   Aa23.T; Aa23T
DR   MetaboLights; MTBLS210
DR   Wikidata; Q54607571
RX   PubMed=18836024;
RX   PubMed=19951376;
RX   PubMed=22375833;
RX   PubMed=26287231;
RX   PubMed=26994075;
CC   Group: Insect cell line.
CC   Characteristics: Cured of Wolbachia pipientis strain wAlbB infection by tetracycline.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z817 ! Aa23
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   Aa23-T.wMel
AC   CVCL_RP54
SY   Aa23.wMel
DR   MetaboLights; MTBLS210
DR   Wikidata; Q54607574
RX   PubMed=26287231;
RX   PubMed=26994075;
CC   Group: Insect cell line.
CC   Characteristics: Infected by Wolbachia pipientis strain wMel.
CC   Characteristics: Cured of Wolbachia pipientis strain wAlbB infection by tetracycline.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_RP53 ! Aa23-T
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   Aa23-T.wMelPop
AC   CVCL_RP55
SY   Aa23.wMelPop
DR   MetaboLights; MTBLS210
DR   Wikidata; Q54607575
RX   PubMed=26287231;
RX   PubMed=26994075;
CC   Group: Insect cell line.
CC   Characteristics: Infected by Wolbachia pipientis strain wMelPop.
CC   Characteristics: Cured of Wolbachia pipientis strain wAlbB infection by tetracycline.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_RP53 ! Aa23-T
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   Aa23E
AC   CVCL_RP51
DR   Wikidata; Q54607578
RX   PubMed=18401667;
CC   Group: Insect cell line.
CC   Characteristics: Adapted to growth in Eagle's minimal medium.
CC   Characteristics: Infected by the intracellular symbiont Wolbachia pipientis strain wAlbB.
CC   Doubling time: 4-5 days (PubMed=18401667).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z817 ! Aa23
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   Aa23E(T)
AC   CVCL_RP52
DR   Wikidata; Q54607581
RX   PubMed=18401667;
CC   Group: Insect cell line.
CC   Characteristics: Adapted to growth in Eagle's minimal medium.
CC   Characteristics: Cured of Wolbachia pipientis strain wAlbB infection by tetracycline.
CC   Doubling time: 4-5 days (PubMed=18401667).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_RP51 ! Aa23E
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   Aa4
AC   CVCL_WM03
DR   Wikidata; Q93312473
RX   DOI=10.1111/j.1439-0418.1981.tb04507.x;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z223 ! ATC-15
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AA4.1
AC   CVCL_D664
SY   AA 4.1
DR   BCRJ; 0035
DR   Wikidata; Q54607563
RX   PubMed=6606670;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O89103; Mouse Cd93.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   AA5
AC   CVCL_J053
DR   CLO; CLO_0001629
DR   ATCC; CRL-2637
DR   Wikidata; Q54607583
RX   PubMed=9922460;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P30944; Xenopus laevis cad1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AA859
AC   CVCL_F546
SY   TER47; TER156; Extract 264
DR   IPD-IMGT/HLA; 10216
DR   Wikidata; Q54607586
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:01,68:03:01; B*07:02,39:05; C*07:02 (IPD-IMGT/HLA=10216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   AA9 [Mouse hybridoma against puerarin]
AC   CVCL_B6LU
DR   Wikidata; Q111732851
RX   PubMed=24583873;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_8633; Puerarin.
CC   Monoclonal antibody target: ChEBI; CHEBI_2979; Baicalein (Note=58% reactivity compared to puerarin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   AA9 [Mouse sarcoma]
AC   CVCL_0P26
DR   Kerafast; EWU001
DR   Wikidata; Q54607587
RX   DOI=10.1016/j.vetimm.2008.10.066;
RX   Patent=US8563313;
CC   Group: Patented cell line.
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (Patent=US8563313).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:108736; Pig SIGLEC1.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0358 ! J774A1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 16
//
ID   AAE12
AC   CVCL_Z188
DR   Wikidata; Q54607591
RX   PubMed=17662657;
RX   PubMed=19242658;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6943; ! Amblyomma americanum (Lone star tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   AAE2
AC   CVCL_Z189
DR   Wikidata; Q54607592
RX   PubMed=16922866;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6943; ! Amblyomma americanum (Lone star tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Aag-2
AC   CVCL_Z617
SY   Aag2; Peleg's line 59; 59; AA-P
DR   BTO; BTO_0006292
DR   PRIDE; PXD010191
DR   PRIDE; PXD033231
DR   Wikidata; Q54607594
RX   CelloPub=CLPUB00492;
RX   DOI=10.1303/aez.13.170;
RX   PubMed=627872;
RX   PubMed=2267971;
RX   PubMed=4869110;
RX   PubMed=5142332;
RX   PubMed=22827926;
RX   PubMed=28497119;
RX   PubMed=32807211;
RX   PubMed=34878970;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_72b2b87ee3
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_dba68c637d
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_f6bb097de7
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Doubling time: ~24 hours (PubMed=627872).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 19
//
ID   Aag2 (C)
AC   CVCL_C3S1
SY   A. aegypti (c)
DR   Wikidata; Q116048467
RX   PubMed=627872;
CC   Group: Insect cell line.
CC   Characteristics: Adapted to growth at 15 Celsius (PubMed=627872).
CC   Virology: Supports replication of Sindbis virus (PubMed=627872).
CC   Doubling time: ~10 days (PubMed=627872).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z617 ! Aag-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Aag2 eGFP-Ago3
AC   CVCL_C0RB
DR   PRIDE; PXD021382
DR   Wikidata; Q112927068
RX   PubMed=33951430;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a PUb-GFP-V5-3F-Ago3-2A-PuroR construct.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q170R5; Aedes aegypti Ago3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z617 ! Aag-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   Aag2 eGFP-Piwi4
AC   CVCL_C0RC
DR   PRIDE; PXD021382
DR   Wikidata; Q112927069
RX   PubMed=33951430;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a PUb-GFP-V5-3F-Piwi4-2A-PuroR construct.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q171B3; Aedes aegypti Piwi4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z617 ! Aag-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   Aag2 eGFP-Piwi5
AC   CVCL_C0RD
DR   PRIDE; PXD021382
DR   Wikidata; Q112927070
RX   PubMed=33951430;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a PUb-GFP-V5-3F-Piwi5-2A-PuroR construct.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q16JS2; Aedes aegypti Piwi5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z617 ! Aag-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   Aag2 eGFP-Piwi6
AC   CVCL_C0RE
DR   PRIDE; PXD021382
DR   Wikidata; Q112927071
RX   PubMed=33951430;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a PUb-GFP-V5-3F-Piwi6-2A-PuroR construct.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q16JS1; Aedes aegypti Piwi6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z617 ! Aag-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   Aag2-AF319
AC   CVCL_A8M6
SY   AF319
DR   ECACC; 19022602
DR   Wikidata; Q102113494
RX   PubMed=28497119;
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q49LL4; Dcr2.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_A8M5 ! Aag2-AF5
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   Aag2-AF5
AC   CVCL_A8M5
SY   AF5
DR   ECACC; 19022601
DR   Wikidata; Q102113496
RX   PubMed=28497119;
CC   Group: Insect cell line.
CC   Characteristics: Immunocompetent for RNAi (siRNA and piRNA pathways) and NF-kappaB signalling.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z617 ! Aag-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   Aag2INF
AC   CVCL_B6Y7
SY   Aag2(INF)
DR   Wikidata; Q111732852
RX   PubMed=34878970;
CC   Group: Insect cell line.
CC   Virology: Persistently infected by Chikungunya virus and Mayaro virus (PubMed=34878970).
CC   Virology: The Chikungunya virus in this cell line has accumulated non-synonymous mutations and encodes a shorter nsP3 gene and has lost the capacity to infect mammalian cells (PubMed=34878970).
CC   Anecdotal: Was accidentally created by a student that was working with Aag-2 and also manipulating samples containing arboviruses.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z617 ! Aag-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 6
//
ID   AAKIPSi001-A
AC   CVCL_A5PJ
DR   BioSamples; SAMEA8307195
DR   hPSCreg; AAKIPSi001-A
DR   Wikidata; Q107113342
CC   From: INSERM; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   AAKIPSi002-A
AC   CVCL_A5PK
DR   BioSamples; SAMEA8307196
DR   hPSCreg; AAKIPSi002-A
DR   Wikidata; Q107113343
CC   From: INSERM; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   AAKIPSi003-A
AC   CVCL_A5PL
DR   BioSamples; SAMEA8307198
DR   hPSCreg; AAKIPSi003-A
DR   Wikidata; Q107113344
CC   From: INSERM; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   Aalb-105
AC   CVCL_Z535
SY   Aalb105
DR   Wikidata; Q54607596
RX   DOI=10.3969/j.issn.1673-5234.2000.04.020;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   AALEB
AC   CVCL_ZC94
DR   Wikidata; Q98125458
RX   PubMed=12085236;
RX   PubMed=15804356;
RX   PubMed=18978040;
WW   Provider; UNC OTC; 19-0116; https://web.archive.org/web/20200120011157/http://technologies.unc.edu/technologies/19-0116_cell-line-aaleb
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, tracheobronchial epithelium; UBERON=UBERON_0008397.
CC   Cell type: Epithelial cell of tracheobronchial tree; CL=CL_0002202.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   AAP1
AC   CVCL_D6DP
DR   Wikidata; Q127378821
RX   PubMed=7314066;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09923; Human ALPI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AAV-293
AC   CVCL_6871
SY   AAV293
DR   CCRID; 1101HUM-PUMC000669
DR   CCRID; 3101HUMGNHu13
DR   CLS; 305127
DR   NCBI_Iran; C548
DR   Wikidata; Q54607598
WW   Provider; Agilent; 240073; http://2010.igem.org/wiki/images/e/e0/Freiburg10_AAv293_cell_line.pdf
WW   Provider; BRICS; BRICS0071; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3886
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Caution: Not the same cell line as 293AAV from Cell Biolabs (Cellosaurus=CVCL_KA64).
CC   Discontinued: Agilent/Stratagene; Catalog number 240073.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000669
ST   Amelogenin: X
ST   CSF1PO: 7,11,12
ST   D12S391: 19,21
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D6S1043: 11
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   AAVpro 293T
AC   CVCL_B0XW
DR   Wikidata; Q110429861
WW   Provider; Takara Bio; 632273; https://www.takarabio.com/products/gene-function/viral-transduction/adeno-associated-virus-(aav)/packaging-systems-and-cells/293t-cell-line
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Ab 187-272
AC   CVCL_C8JR
DR   Wikidata; Q123030371
RX   PubMed=2429950;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P60422; Escherichia coli rplB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Ab 21.1
AC   CVCL_J054
SY   Ab21.1
DR   CLO; CLO_0001634
DR   ATCC; HB-11601
DR   Wikidata; Q54607599
RX   Patent=US5587458;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11601.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   Ab 23.1
AC   CVCL_J055
SY   Ab23.1
DR   CLO; CLO_0001635
DR   ATCC; HB-11602
DR   Wikidata; Q54607603
RX   Patent=US5587458;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11602.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   Ab 5-186
AC   CVCL_C8JS
DR   Wikidata; Q123030372
RX   PubMed=2429950;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P60422; Escherichia coli rplB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   AB-170
AC   CVCL_WD20
DR   IBRC; C10238
DR   Wikidata; Q93312520
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-231
AC   CVCL_WD21
DR   IBRC; C10495
DR   Wikidata; Q93312522
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-232
AC   CVCL_WD22
DR   IBRC; C10496
DR   Wikidata; Q93312524
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-233
AC   CVCL_WD23
DR   IBRC; C10497
DR   Wikidata; Q93312526
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-234
AC   CVCL_WD24
DR   IBRC; C10498
DR   Wikidata; Q93312528
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-235
AC   CVCL_WD25
DR   IBRC; C10499
DR   Wikidata; Q93312530
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-237
AC   CVCL_WD26
DR   IBRC; C10501
DR   Wikidata; Q93312532
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-239
AC   CVCL_WD27
DR   IBRC; C10503
DR   Wikidata; Q93312534
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-241
AC   CVCL_WD28
DR   IBRC; C10505
DR   Wikidata; Q93312536
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-243
AC   CVCL_WD29
DR   IBRC; C10512
DR   Wikidata; Q93312538
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-244
AC   CVCL_WD30
DR   IBRC; C10513
DR   Wikidata; Q93312540
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-245
AC   CVCL_WD31
DR   IBRC; C10514
DR   Wikidata; Q93312543
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-247
AC   CVCL_WD32
DR   IBRC; C10516
DR   Wikidata; Q93312545
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-248
AC   CVCL_WD33
DR   IBRC; C10517
DR   Wikidata; Q93312547
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-250
AC   CVCL_WD34
DR   IBRC; C10519
DR   Wikidata; Q93312549
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-251
AC   CVCL_WD35
DR   IBRC; C10520
DR   Wikidata; Q93312552
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-255
AC   CVCL_WD36
DR   IBRC; C10547
DR   Wikidata; Q93312554
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-257
AC   CVCL_WD37
DR   IBRC; C10534
DR   Wikidata; Q93312557
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-260
AC   CVCL_WD38
DR   IBRC; C10525
DR   Wikidata; Q93312559
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-261
AC   CVCL_WD39
DR   IBRC; C10552
DR   Wikidata; Q93312561
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-262
AC   CVCL_WD40
DR   IBRC; C10526
DR   Wikidata; Q93312563
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-263
AC   CVCL_WD41
DR   IBRC; C10527
DR   Wikidata; Q93312565
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-264
AC   CVCL_WD42
DR   IBRC; C10549
DR   Wikidata; Q93312567
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-265
AC   CVCL_WD43
DR   IBRC; C10537
DR   Wikidata; Q93312569
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-266
AC   CVCL_WD44
DR   IBRC; C10548
DR   Wikidata; Q93312571
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-267
AC   CVCL_WD45
DR   IBRC; C10540
DR   Wikidata; Q93312574
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-269
AC   CVCL_WD46
DR   IBRC; C10529
DR   Wikidata; Q93312576
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-270
AC   CVCL_WD47
DR   IBRC; C10530
DR   Wikidata; Q93312579
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-271
AC   CVCL_WD48
DR   IBRC; C10531
DR   Wikidata; Q93312581
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-276
AC   CVCL_WD49
DR   IBRC; C10553
DR   Wikidata; Q93312584
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-278
AC   CVCL_WD50
DR   IBRC; C10528
DR   Wikidata; Q93312586
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-279
AC   CVCL_WD51
DR   IBRC; C10536
DR   Wikidata; Q93312588
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-280
AC   CVCL_WD52
DR   IBRC; C10543
DR   Wikidata; Q93312590
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-282
AC   CVCL_WD53
DR   IBRC; C10541
DR   Wikidata; Q93312592
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   AB-284
AC   CVCL_WD54
DR   IBRC; C10539
DR   Wikidata; Q93312594
RX   PubMed=32358742;
CC   Population: Iranian; Arab.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   Ab-CTF
AC   CVCL_C8JT
DR   Wikidata; Q123030373
RX   PubMed=2581957;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P0A7K2; Escherichia coli rplL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Ab-NTF
AC   CVCL_C8JU
DR   Wikidata; Q123030374
RX   PubMed=2581957;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P0A7K2; Escherichia coli rplL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   AB.11
AC   CVCL_X985
SY   AB-11
DR   Wikidata; Q54607605
RX   PubMed=1651325;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 10
//
ID   AB.9
AC   CVCL_6311
SY   AB-9; AB9
DR   CLO; CLO_0001636
DR   ATCC; CRL-2298
DR   BCRC; 60478
DR   Wikidata; Q4650009
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.14800/mr.992;
RX   PubMed=9891354;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/AB9
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: AB; VBO=VBO_0017495.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   AB0001
AC   CVCL_8B35
DR   ECACC; 89092221
DR   Wikidata; Q54607610
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89092221; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   AB0023
AC   CVCL_C6IJ
DR   Wikidata; Q116048468
RX   Patent=US8680246;
RX   Patent=US10494443;
RX   PubMed=20439985;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized simtuzumab (GS 6624) therapeutic antibody that was investigated in a failed phase 2 clinical study for the treatment of idiopathic pulmonary fibrosis.
CC   Characteristics: The monoclonal produced by this hybridoma allosterically inhibits the activity of LOXL2 (PubMed=20439985).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AB0048
AC   CVCL_E3YG
RX   PubMed=14754601;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Was probably part of the ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AB1 [Mouse ESC]
AC   CVCL_N791
SY   AB-1
DR   ATCC; SCRC-1022
DR   Wikidata; Q54607614
RX   PubMed=2205396;
RX   PubMed=9353641;
RX   PubMed=9853825;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-83.html
CC   Discontinued: ATCC; SCRC-1022; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S7/SvEvBrd-Hprt<+>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   AB1 [Mouse hybridoma against ganglioside GD1b]
AC   CVCL_U858
DR   CLO; CLO_0050384
DR   RCB; RCB2316
DR   Wikidata; Q54607616
RX   PubMed=9106500;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_28175; Ganglioside GD1b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 7
//
ID   AB1 [Mouse hybridoma against human B cell antigen]
AC   CVCL_F1KD
RX   PubMed=6334716;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human B cell activation antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AB1 [Mouse hybridoma against human TSHR]
AC   CVCL_F0HN
RX   PubMed=9570567;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AB1 [Mouse mesothelioma]
AC   CVCL_4403
SY   AB-1
DR   CBA; CBA-0144
DR   ECACC; 10092305
DR   Wikidata; Q54607618
RX   PubMed=1459729;
RX   PubMed=22581112;
RX   PubMed=28577549;
RX   PubMed=32944078;
CC   Doubling time: 30 hours (PubMed=1459729).
CC   Karyotypic information: Hypo-tetraploid (PubMed=32944078).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Ab1
AC   CVCL_E4RM
DR   ABCD; ABCD_AH515
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AB1 HA
AC   CVCL_G361
SY   AB-1 HA
DR   CBA; CBA-1374
DR   ECACC; 12070506
DR   Wikidata; Q54607620
RX   PubMed=10070965;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4403 ! AB1 [Mouse mesothelioma]
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   AB1-2
AC   CVCL_4404
DR   CLO; CLO_0001637
DR   ATCC; HB-33
DR   Wikidata; Q54607621
RX   PubMed=7035186;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   Ab10 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T9
DR   Wikidata; Q111732853
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5NID3; Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) rplL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   AB10 [Mouse hybridoma against vaccinia D13L]
AC   CVCL_E5RR
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68440; Vaccinia virus scaffold protein OPG125 (D13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ab10 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RW
DR   ABCD; ABCD_AH524
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AB1079
AC   CVCL_E9XR
RX   PubMed=38832025;
WW   Provider; Institut de Myologie; -; https://www.institut-myologie.org/wp-content/uploads/2024/08/2024-Cells-Myoline-1.pdf
CC   Part of: MyoLine cell line collection.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, left biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ab11 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6TA
DR   Wikidata; Q111732854
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5NE75; Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) membrane protein FTT_1778c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Ab11 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RX
DR   ABCD; ABCD_AH525
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AB12 [Mouse hybridoma against vaccinia D8L]
AC   CVCL_E5QD
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AB12 [Mouse mesothelioma]
AC   CVCL_4405
DR   CBA; CBA-0146
DR   ECACC; 10092306
DR   Wikidata; Q54607623
RX   PubMed=1459729;
RX   PubMed=22581112;
RX   PubMed=28577549;
CC   Doubling time: 24 hours (PubMed=1459729).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   Ab12 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6TB
DR   Wikidata; Q111732855
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5NEE1; Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) groEL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab12 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RY
DR   ABCD; ABCD_AH526
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AB13
AC   CVCL_LJ78
DR   Wikidata; Q54607624
RX   PubMed=1459729;
RX   PubMed=28577549;
CC   Doubling time: 16 hours (PubMed=1459729).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   Ab13 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6TC
DR   Wikidata; Q111732856
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5NFG7; Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) dnaK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab13 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RZ
DR   ABCD; ABCD_AH527
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab14
AC   CVCL_E4S0
DR   ABCD; ABCD_AH528
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab15
AC   CVCL_E4S1
DR   ABCD; ABCD_AH529
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab17
AC   CVCL_B6TD
DR   Wikidata; Q111732858
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5NI56; Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) yidC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   AB2 [Mouse hybridoma against nisin]
AC   CVCL_C5P0
DR   Wikidata; Q116048469
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13068; Lactococcus lactis subsp. lactis nisin-A (nisA).
CC   Monoclonal antibody target: UniProtKB; P29559; Lactococcus lactis subsp. lactis nisin-Z (nisZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AB2 [Mouse mesothelioma]
AC   CVCL_LJ79
DR   Wikidata; Q54607676
RX   PubMed=1459729;
CC   Doubling time: 16 hours (PubMed=1459729).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Ab2 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T1
DR   Wikidata; Q111732859
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab2 [Mouse hybridoma against human SCL3A2]
AC   CVCL_E4RN
DR   ABCD; ABCD_AH516
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AB2.1
AC   CVCL_Y609
DR   Wikidata; Q54607678
RX   PubMed=1997203;
RX   PubMed=9853825;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S7/SvEvBrd-Hprt<b-m2>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   AB2.2
AC   CVCL_C261
DR   EFO; EFO_0002812
DR   ATCC; SCRC-1023
DR   CCRID; 3101MOUSCSP217
DR   TOKU-E; 4119
DR   Wikidata; Q54607681
RX   PubMed=9853825;
RX   PubMed=23320952;
RX   PubMed=25277546;
CC   Karyotypic information: Mosaic; 42,XY,+Y,+8; 41,XY,+Y; 40,XY (PubMed=23320952).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S7/SvEvBrd-Hprt<b-m2>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   AB22
AC   CVCL_4406
DR   CBA; CBA-0148
DR   ECACC; 10092307
DR   Wikidata; Q54607684
RX   PubMed=1459729;
RX   PubMed=28577549;
RX   PubMed=32944078;
CC   Doubling time: 27 hours (PubMed=1459729).
CC   Karyotypic information: Near-tetraploid (PubMed=32944078).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   AB253
AC   CVCL_RA46
SY   BPM09
DR   Wikidata; Q54607687
RX   Patent=US8067550;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 06080101.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99572; Human P2RX7 (Note=Recognizes non-functional receptor).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   Ab3 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T2
DR   Wikidata; Q111732860
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab3 [Mouse hybridoma against human SCL3A2]
AC   CVCL_E4RP
DR   ABCD; ABCD_AH517
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AB3.B8
AC   CVCL_F0W4
SY   AB3
RX   PubMed=2312130;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: Mouse B cell surface complex of 67 kDa associated with MHC class II.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Ab31
AC   CVCL_B6TE
DR   Wikidata; Q111732861
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5NFG7; Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) dnaK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   AB320LGMD2B29Q
AC   CVCL_VG61
DR   Wikidata; Q54607689
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.342-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (Jain Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Phe1172_Ser1173insTer (c.3516_3517delTT) (p.Ser1173Terfs) (p.Phe1190_Ser1191insTer, c.3570_3571del); ClinVar=VCV000217226; Zygosity=Heterozygous (Jain Foundation).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   Ab4 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T3
DR   Wikidata; Q111732862
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab4 [Mouse hybridoma against human SCL3A2]
AC   CVCL_E4RQ
DR   ABCD; ABCD_AH518
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab5 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T4
DR   Wikidata; Q111732863
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab5 [Mouse hybridoma against human SCL3A2]
AC   CVCL_E4RR
DR   ABCD; ABCD_AH519
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab6 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T5
DR   Wikidata; Q111732864
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Ab6 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RS
DR   ABCD; ABCD_AH520
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab6 [Rat hybridoma against mouse Cd38]
AC   CVCL_D3RI
DR   Wikidata; Q127378822
RX   PubMed=9013949;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56528; Mouse Cd38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   AB678
AC   CVCL_E9XQ
RX   PubMed=38832025;
WW   Provider; Institut de Myologie; -; https://www.institut-myologie.org/wp-content/uploads/2024/08/2024-Cells-Myoline-1.pdf
CC   Part of: MyoLine cell line collection.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ab7 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T6
DR   Wikidata; Q111732865
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab7 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RT
DR   ABCD; ABCD_AH521
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab8 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T7
DR   Wikidata; Q111732866
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab8 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RU
DR   ABCD; ABCD_AH522
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab9 [Mouse hybridoma against F.tularensis O-antigen]
AC   CVCL_B6T8
DR   Wikidata; Q111732867
RX   PubMed=17764754;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Ab9 [Rat hybridoma against human SCL3A2]
AC   CVCL_E4RV
DR   ABCD; ABCD_AH523
RX   Patent=US20230135723;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08195; Human SLC3A2/CD98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ab90
AC   CVCL_D3RJ
SY   Ab.90
DR   DSHB; Ab.90
DR   Wikidata; Q127378823
RX   PubMed=9013949;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56528; Mouse Cd38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Ab92
AC   CVCL_D3RK
DR   Wikidata; Q127378824
RX   PubMed=9013949;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P56528; Mouse Cd38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ABA 1
AC   CVCL_E2WS
RX   PubMed=16665552;
CC   Group: Plant cell line.
CC   Characteristics: Abscisic acid (ABA) insensitive. Capable of developing into plantlets in the presence of ABA (PubMed=16665552).
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Juwarot.
OX   NCBI_TaxID=79200; ! Daucus carota subsp. sativus (Carrot)
HI   CVCL_E2WQ ! HA
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ABA 15
AC   CVCL_E2WT
RX   PubMed=16593974;
RX   PubMed=16665552;
CC   Group: Plant cell line.
CC   Characteristics: Abscisic acid (ABA) insensitive. Capable of developing into plantlets in the presence of ABA (PubMed=16665552).
CC   Caution: Wrongly indicated to derive from W001C (Cellosaurus=CVCL_E2WR) (PubMed=16593974).
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Juwarot.
OX   NCBI_TaxID=79200; ! Daucus carota subsp. sativus (Carrot)
HI   CVCL_E2WQ ! HA
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ABA 17
AC   CVCL_E2WU
RX   PubMed=16665552;
CC   Group: Plant cell line.
CC   Characteristics: Abscisic acid (ABA) insensitive. Capable of developing into plantlets in the presence of ABA (PubMed=16665552).
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Juwarot.
OX   NCBI_TaxID=79200; ! Daucus carota subsp. sativus (Carrot)
HI   CVCL_E2WQ ! HA
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ABAD-CuVa-1087-1
AC   CVCL_Z968
SY   CuVa-1
DR   Wikidata; Q54607691
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Doubling time: 24 hours (Note=At 15th passage) (PubMed=2553822).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABAD-CuVa-1087-2
AC   CVCL_Z969
SY   CuVa-2
DR   Wikidata; Q54607693
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABAD-CuVa-1087-3
AC   CVCL_Z970
SY   CuVa-3
DR   Wikidata; Q54607696
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABAD-CuVa-1087-4
AC   CVCL_Z971
SY   CuVa-4
DR   Wikidata; Q54607699
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Doubling time: 72 hours (Note=At 20th passage) (PubMed=2553822).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABAD-CuVa-1087-5
AC   CVCL_Z972
SY   CuVa-5
DR   Wikidata; Q54607700
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABAD-CuVa-1087-6
AC   CVCL_Z973
SY   CuVa-6
DR   Wikidata; Q54607705
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABAD-CuVa-1087-7
AC   CVCL_Z974
SY   CuVa-7
DR   Wikidata; Q54607707
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABAD-CuVa-1087-8
AC   CVCL_Z975
SY   CuVa-8
DR   Wikidata; Q54607708
RX   PubMed=2553822;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AA laboratory colony.
OX   NCBI_TaxID=46212; ! Culicoides variipennis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ABADRL-Cs-W3
AC   CVCL_ZU85
SY   W3
DR   Wikidata; Q98125460
RX   PubMed=12943114;
CC   Group: Insect cell line.
CC   Doubling time: ~14 hours (PubMed=12943114).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=179676; ! Culicoides sonorensis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   ABADRL-Cs-W8A
AC   CVCL_ZU86
SY   W8
DR   Wikidata; Q98125461
RX   PubMed=12943114;
CC   Group: Insect cell line.
CC   Doubling time: ~14 hours (PubMed=12943114).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=179676; ! Culicoides sonorensis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   ABADRL-Cv-KC
AC   CVCL_RW99
SY   KC
DR   CCLV; CCLV-RIE 1062
DR   Wikidata; Q54899592
RX   PubMed=2022869;
RX   PubMed=12943114;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_3a8f35b31c
CC   Group: Insect cell line.
CC   Doubling time: ~14 hours (PubMed=12943114).
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: This cell line was derived from what was at the time known as the AK laboratory colony of Culicoides variipennis but which has been reclassified as being from Culicoides sonorensis (PubMed=12943114).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AK laboratory colony.
OX   NCBI_TaxID=179676; ! Culicoides sonorensis (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   ABAE
AC   CVCL_C7WJ
SY   Adult Bovine Aortic Endothelial cells
DR   Wikidata; Q123030375
RX   PubMed=301144;
RX   PubMed=688381;
RX   PubMed=1069301;
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   ABAE-CA1
AC   CVCL_C7WK
DR   Wikidata; Q123030376
RX   PubMed=688381;
CC   Transformant: ChEBI; CHEBI_27871; Chloroacetaldehyde.
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_C7WJ ! ABAE
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   Abana
AC   CVCL_N701
SY   ABANA
DR   cancercelllines; CVCL_N701
DR   Cosmic; 2808219
DR   Wikidata; Q54607710
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=8344493;
RX   PubMed=8515068;
CC   Population: African; Ghanaian.
CC   Virology: Almost completely (>99%) EBV-negative (PubMed=6243721).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8344493).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   ABC-1
AC   CVCL_1066
SY   ABC1
DR   CLO; CLO_0001641
DR   EFO; EFO_0002813
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 504
DR   BioSample; SAMN03471587
DR   BioSample; SAMN10988302
DR   cancercelllines; CVCL_1066
DR   Cell_Model_Passport; SIDM00494
DR   CGH-DB; 203-1
DR   CGH-DB; 9165-4
DR   ChEMBL-Cells; CHEMBL3308707
DR   ChEMBL-Targets; CHEMBL1075391
DR   Cosmic; 801582
DR   Cosmic; 876153
DR   Cosmic; 906791
DR   Cosmic; 917991
DR   Cosmic; 946050
DR   Cosmic; 1066158
DR   Cosmic; 1154598
DR   Cosmic; 1239868
DR   Cosmic; 1571728
DR   Cosmic; 2125217
DR   Cosmic; 2668323
DR   Cosmic-CLP; 906791
DR   DepMap; ACH-000528
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906791
DR   GEO; GSM274670
DR   GEO; GSM784267
DR   GEO; GSM827573
DR   GEO; GSM886861
DR   GEO; GSM887926
DR   GEO; GSM1669592
DR   IARC_TP53; 11875
DR   JCRB; JCRB0815
DR   LiGeA; CCLE_411
DR   LINCS_LDP; LCL-1634
DR   PharmacoDB; ABC1_51_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1066
DR   PubChem_Cell_line; CVCL_1066
DR   Wikidata; Q54607712
RX   DOI=10.2482/haigan.22.53;
RX   DOI=10.4044/joma1947.97.7-8_691;
RX   DOI=10.4044/joma1947.97.7-8_701;
RX   PubMed=8286010;
RX   PubMed=9290701;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=15999539;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 72 hours (DOI=10.4044/joma1947.97.7-8_691); 23.8 hours (PubMed=8286010).
CC   HLA typing: A*24:02,24:02; B*37:04,58:05; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=In 10% of cells (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Homozygous (PubMed=10536175; PubMed=20557307; Cosmic-CLP=906791; DepMap=ACH-000528).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.72%; Native American=0.92%; East Asian, North=78.6%; East Asian, South=18.68%; South Asian=0%; European, North=0%; European, South=1.09% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906791; JCRB=JCRB0815; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 18
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 8,11
ST   Penta E: 5,16
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   ABC-1#IL-6
AC   CVCL_Y023
DR   cancercelllines; CVCL_Y023
DR   Wikidata; Q54607715
RX   PubMed=15185009;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6018; IL6.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1066 ! ABC-1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   ABC-11
AC   CVCL_Y477
DR   Wikidata; Q54607718
RX   PubMed=25170107;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (PubMed=25170107).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   ABC-14
AC   CVCL_A1EF
DR   Cosmic; 2843080
DR   Wikidata; Q102113498
RX   PubMed=31374369;
CC   Population: Japanese.
CC   Characteristics: Sensitive to crizotinib and resistant to alectinib.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (PubMed=31374369).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1EG ! ABC-17
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   ABC-17
AC   CVCL_A1EG
DR   cancercelllines; CVCL_A1EG
DR   Cosmic; 2843084
DR   Wikidata; Q102113499
RX   PubMed=31374369;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft produced by subcutaneous injection of tumor cells into NOG (NOD/Shi-scid, IL-2RgammaKO Jic) mice.
CC   Characteristics: Resistant to alectinib and crizotinib.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (PubMed=31374369).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Gly1202Arg (c.3604G>A); ClinVar=VCV000376134; Zygosity=Unspecified (PubMed=31374369).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1EF ! ABC-14
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   ABC-3
AC   CVCL_UW51
DR   Wikidata; Q93312720
RX   PubMed=8286010;
RX   PubMed=10358721;
RX   PubMed=15999539;
CC   Population: Japanese.
CC   Doubling time: 46.8 hours (PubMed=8286010).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   ABC-31
AC   CVCL_A6ZT
DR   cancercelllines; CVCL_A6ZT
DR   Wikidata; Q107113346
RX   PubMed=33829270;
CC   Population: Japanese.
CC   Characteristics: Resistant to the tyrosine kinase inhibitor osimertinib. Has activated IGF1R (PubMed=33829270).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (PubMed=33829270).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   ABC-5
AC   CVCL_UW52
DR   Wikidata; Q93312722
RX   PubMed=8286010;
RX   PubMed=10358721;
RX   PubMed=15999539;
CC   Population: Japanese.
CC   Doubling time: 37.9 hours (PubMed=8286010).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   ABC01
AC   CVCL_C8N0
DR   Wikidata; Q123030378
RX   Patent=WO2022116782A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19178.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_169105; Ethyl maltol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC02
AC   CVCL_C8N1
DR   Wikidata; Q123030380
RX   Patent=CN112375744A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19177.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_50075; Dihydropyridine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC03
AC   CVCL_C8MW
SY   2G7
DR   Wikidata; Q123030381
RX   Patent=CN112375745B;
RX   PubMed=33502396;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19176.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_149836; Tigecycline (Tygacil).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC04
AC   CVCL_C8N2
DR   Wikidata; Q123030382
RX   Patent=CN112266901B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19175.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC05
AC   CVCL_C8N3
DR   Wikidata; Q123030383
RX   Patent=CN112280745B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19174.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38626; Pyridaben (Sanmite).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC06
AC   CVCL_C8N4
DR   Wikidata; Q123030384
RX   Patent=CN112574957B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19181.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_3751; Clomazone (Dimethazone).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC07
AC   CVCL_C8N5
DR   Wikidata; Q123030385
RX   Patent=CN112574956B;
RX   PubMed=34788953;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19180.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_82033; Propamocarb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC08
AC   CVCL_C8LQ
DR   Wikidata; Q123030386
RX   Patent=CN112501128B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19179.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC09
AC   CVCL_C8LM
DR   Wikidata; Q123030387
RX   Patent=CN111454912B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19162.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_92386; Xylazine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC10
AC   CVCL_C8N6
DR   Wikidata; Q123030388
RX   Patent=CN111748528B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19168.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_5063; Fipronil.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ABC11
AC   CVCL_C8N7
DR   Wikidata; Q123030389
RX   Patent=CN111778215B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19167.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_195437; Gamithromycin (Zactran).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AbC1
AC   CVCL_ZB62
SY   AbC-1
DR   Kerafast; EAB001
DR   Wikidata; Q98125463
RX   PubMed=2557357;
RX   PubMed=6189530;
RX   PubMed=21573540;
CC   Characteristics: Produces melanin pigment when L-tyrosine or L-DOPA are added to the culture media - along with new organelle formation - melanosomes and increased expression of MSH receptors (Kerafast=EAB001).
CC   Characteristics: Established from the transplantable Bomirski hamster amelanotic melanoma.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   Abcam A-375 IL13RA2 KO
AC   CVCL_B0ZF
SY   Human IL13RA2 knockout A375
DR   Abcam; ab273381
DR   cancercelllines; CVCL_B0ZF
DR   Wikidata; Q110429863
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5975; IL13RA2.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   Abcam A-375 NT5E KO
AC   CVCL_B7V4
SY   Human NT5E knockout A375
DR   Abcam; ab281591
DR   cancercelllines; CVCL_B7V4
DR   Wikidata; Q112927072
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8021; NT5E.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-431 ACSL4 KO
AC   CVCL_D7FT
SY   Human ACSL4 (FACL4) knockout A-431
DR   Abcam; ab269613
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-431 ADRB2 KO
AC   CVCL_B1BR
SY   Human ADRB2 knockout A-431
DR   Abcam; ab261888
DR   cancercelllines; CVCL_B1BR
DR   Wikidata; Q110429866
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 B2M KO
AC   CVCL_B1BS
SY   Human B2M (beta 2 Microglobulin) knockout A-431
DR   Abcam; ab261893
DR   cancercelllines; CVCL_B1BS
DR   Wikidata; Q110429868
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 BCAM KO
AC   CVCL_E1FF
SY   Human BCAM knockout A-431
DR   Abcam; ab269619
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6722; BCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-431 BST2 KO
AC   CVCL_B1BT
SY   Human BST2 (Tetherin) knockout A-431
DR   Abcam; ab261907
DR   cancercelllines; CVCL_B1BT
DR   Wikidata; Q110429871
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1119; BST2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 CAV1 KO
AC   CVCL_B1BU
SY   Human CAV1 (Caveolin-1) knockout A-431
DR   Abcam; ab269583
DR   cancercelllines; CVCL_B1BU
DR   Wikidata; Q110429873
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 CBFB KO
AC   CVCL_B1BV
SY   Human CBFB knockout A-431
DR   Abcam; ab270472
DR   cancercelllines; CVCL_B1BV
DR   Wikidata; Q110429874
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1539; CBFB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 CENPB KO
AC   CVCL_B1BW
SY   Human CENPB knockout A-431
DR   Abcam; ab274919
DR   cancercelllines; CVCL_B1BW
DR   Wikidata; Q110429875
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1852; CENPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 CLDN1 KO
AC   CVCL_B1BX
SY   Human CLDN1 knockout A-431
DR   Abcam; ab261889
DR   cancercelllines; CVCL_B1BX
DR   Wikidata; Q110429876
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2032; CLDN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 CTNNB1 KO
AC   CVCL_B1BY
SY   Human CTNNB1 (beta Catenin) knockout A-431
DR   Abcam; ab280822
DR   cancercelllines; CVCL_B1BY
DR   Wikidata; Q110429877
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 CTSD KO
AC   CVCL_B1BZ
SY   Human CTSD knockout A-431
DR   Abcam; ab261891
DR   cancercelllines; CVCL_B1BZ
DR   Wikidata; Q110429878
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2529; CTSD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 DDAH1 KO
AC   CVCL_B1C0
SY   Human DDAH1 knockout A-431
DR   Abcam; ab261909
DR   cancercelllines; CVCL_B1C0
DR   Wikidata; Q110429879
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2715; DDAH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 DHCR24 KO
AC   CVCL_B1C1
SY   Human DHCR24 knockout A-431
DR   Abcam; ab262480
DR   cancercelllines; CVCL_B1C1
DR   Wikidata; Q110429881
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2859; DHCR24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 DPF2 KO
AC   CVCL_B1C2
SY   Human DPF2 knockout A-431
DR   Abcam; ab270473
DR   cancercelllines; CVCL_B1C2
DR   Wikidata; Q110429882
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9964; DPF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 DUSP6 KO
AC   CVCL_B1C3
SY   Human DUSP6 knockout A-431
DR   Abcam; ab261885
DR   cancercelllines; CVCL_B1C3
DR   Wikidata; Q110429883
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3072; DUSP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 EPCAM KO
AC   CVCL_B1C4
SY   Human EPCAM knockout A-431
DR   Abcam; ab261902
DR   cancercelllines; CVCL_B1C4
DR   Wikidata; Q110429884
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11529; EPCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 G3BP1 KO
AC   CVCL_B1C5
SY   Human G3BP1 knockout A-431
DR   Abcam; ab261886
DR   cancercelllines; CVCL_B1C5
DR   Wikidata; Q110429885
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30292; G3BP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 GPD2 KO
AC   CVCL_E1FG
SY   Human GPD2 knockout A-431
DR   Abcam; ab269618
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4456; GPD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-431 GRB2 KO
AC   CVCL_B1C6
SY   Human GRB2 knockout A-431
DR   Abcam; ab276085
DR   cancercelllines; CVCL_B1C6
DR   Wikidata; Q110429886
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4566; GRB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 H1-0 KO
AC   CVCL_B1C7
SY   Human H1F0 knockout A-431
DR   Abcam; ab262478
DR   cancercelllines; CVCL_B1C7
DR   Wikidata; Q110429887
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 HLA-A KO
AC   CVCL_B1C8
SY   Human HLA-A knockout A-431
DR   Abcam; ab261894
DR   cancercelllines; CVCL_B1C8
DR   Wikidata; Q110429888
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 HSP90AB1 KO
AC   CVCL_B1C9
SY   Human HSP90AB1 (Hsp90 beta) knockout A-431
DR   Abcam; ab269491
DR   cancercelllines; CVCL_B1C9
DR   Wikidata; Q110429889
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5258; HSP90AB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 IL1RN KO 1
AC   CVCL_B1CA
SY   Human IL1RN (IL1 Receptor Antagonist) knockout A-431
DR   Abcam; ab273379
DR   cancercelllines; CVCL_B1CA
DR   Wikidata; Q110429890
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6000; IL1RN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-431 IL1RN KO 2
AC   CVCL_E1FH
SY   Human IL1RN knockout A-431
DR   Abcam; ab274918
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6000; IL1RN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-431 KRT13 KO
AC   CVCL_B1CB
SY   Human KRT13 knockout A-431
DR   Abcam; ab269483
DR   cancercelllines; CVCL_B1CB
DR   Wikidata; Q110429892
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6415; KRT13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 KRT14 KO
AC   CVCL_B1CC
SY   Human KRT14 (Cytokeratin 14) knockout A-431
DR   Abcam; ab261897
DR   cancercelllines; CVCL_B1CC
DR   Wikidata; Q110429894
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6416; KRT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 KRT15 KO
AC   CVCL_B1CD
SY   Human KRT15 knockout A-431
DR   Abcam; ab262484
DR   cancercelllines; CVCL_B1CD
DR   Wikidata; Q110429895
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6421; KRT15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 MAGEA4 KO
AC   CVCL_E1FI
SY   Human MAGEA4 knockout A-431
DR   Abcam; ab273857
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6802; MAGEA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-431 MMP14 KO
AC   CVCL_B1CE
SY   Human MMP14 knockout A-431
DR   Abcam; ab261890
DR   cancercelllines; CVCL_B1CE
DR   Wikidata; Q110429896
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7160; MMP14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 MYL9 KO
AC   CVCL_B1CF
SY   Human MYL9 knockout A-431
DR   Abcam; ab261903
DR   cancercelllines; CVCL_B1CF
DR   Wikidata; Q110429897
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15754; MYL9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 NBN KO
AC   CVCL_B1CG
SY   Human NBN (p95/NBS1) knockout A-431
DR   Abcam; ab269506
DR   cancercelllines; CVCL_B1CG
DR   Wikidata; Q110429898
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 NDRG1 KO
AC   CVCL_B1CS
SY   Human NDRG1 knockout A-431
DR   Abcam; ab277849
DR   cancercelllines; CVCL_B1CS
DR   Wikidata; Q110429899
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7679; NDRG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Abcam; ab277849; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 NEK9 KO
AC   CVCL_B1CH
SY   Human NEK9 knockout A-431
DR   Abcam; ab270474
DR   cancercelllines; CVCL_B1CH
DR   Wikidata; Q110429900
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18591; NEK9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 NT5E KO
AC   CVCL_B1CI
SY   Human NT5E knockout A-431
DR   Abcam; ab261895
DR   cancercelllines; CVCL_B1CI
DR   Wikidata; Q110429901
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8021; NT5E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 P4HB KO
AC   CVCL_B1CJ
SY   Human P4HB knockout A-431
DR   Abcam; ab261887
DR   cancercelllines; CVCL_B1CJ
DR   Wikidata; Q110429902
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8548; P4HB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 PERP KO
AC   CVCL_B1CK
SY   Human PERP knockout A-431
DR   Abcam; ab270475
DR   cancercelllines; CVCL_B1CK
DR   Wikidata; Q110429903
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17637; PERP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 PPP2R5C KO
AC   CVCL_E1FJ
SY   Human PPP2R5C knockout A-431
DR   Abcam; ab269620
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9311; PPP2R5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-431 PPP2R5D KO
AC   CVCL_B1CL
SY   Human PPP2R5D knockout A-431
DR   Abcam; ab270476
DR   cancercelllines; CVCL_B1CL
DR   Wikidata; Q110429906
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9312; PPP2R5D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 PTGS1 KO
AC   CVCL_E1FK
SY   Human PTGS1 knockout A-431
DR   Abcam; ab270477
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9604; PTGS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-431 PXN KO
AC   CVCL_B1CM
SY   Human PXN (Paxillin) knockout A-431
DR   Abcam; ab261892
DR   cancercelllines; CVCL_B1CM
DR   Wikidata; Q110429907
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9718; PXN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 SOS1 KO
AC   CVCL_B1CN
SY   Human SOS1 knockout A-431
DR   Abcam; ab276087
DR   cancercelllines; CVCL_B1CN
DR   Wikidata; Q110429908
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 STK24 KO
AC   CVCL_B1CP
SY   Human STK24 knockout A-431
DR   Abcam; ab269479
DR   cancercelllines; CVCL_B1CP
DR   Wikidata; Q110429910
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11403; STK24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 VAMP8 KO
AC   CVCL_B1CQ
SY   Human VAMP8 (EDB) knockout A-431
DR   Abcam; ab269584
DR   cancercelllines; CVCL_B1CQ
DR   Wikidata; Q110429912
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12647; VAMP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-431 VCL KO
AC   CVCL_B1CR
SY   Human VCL (Vinculin) knockout A-431
DR   Abcam; ab261898
DR   cancercelllines; CVCL_B1CR
DR   Wikidata; Q110429914
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12665; VCL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ABCA1 KO
AC   CVCL_D1V0
SY   Human ABCA1 knockout A549
DR   Abcam; ab300813
DR   Wikidata; Q127378825
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29; ABCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ABCC1 KO
AC   CVCL_B1EG
SY   Human ABCC1 (MRP1) knockout A549
DR   Abcam; ab261871
DR   cancercelllines; CVCL_B1EG
DR   Wikidata; Q110429917
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ABCC2 KO
AC   CVCL_B2M0
SY   Human ABCC2 knockout A549
DR   Abcam; ab261855
DR   cancercelllines; CVCL_B2M0
DR   Wikidata; Q110429921
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:53; ABCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ABCC4 KO
AC   CVCL_D1V1
SY   Human ABCC4 knockout A549
DR   Abcam; ab300815
DR   Wikidata; Q127378826
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:55; ABCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ABCG2 KO
AC   CVCL_B1EH
SY   Human ABCG2 knockout A549
DR   Abcam; ab259773
DR   cancercelllines; CVCL_B1EH
DR   Wikidata; Q110429925
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:74; ABCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ABL2 KO
AC   CVCL_B9CT
SY   Human ABL2 knockout A549
DR   Abcam; ab286695
DR   cancercelllines; CVCL_B9CT
DR   Wikidata; Q112927073
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ACACA KO
AC   CVCL_D1V2
SY   Human ACACA knockout A549
DR   Abcam; ab300818
DR   Wikidata; Q127378827
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:84; ACACA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ACKR3 KO
AC   CVCL_B9CU
SY   Human ACKR3 knockout A549
DR   Abcam; ab287187
DR   cancercelllines; CVCL_B9CU
DR   Wikidata; Q112927074
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23692; ACKR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ACLY KO
AC   CVCL_D1V3
SY   Human ACLY knockout A549
DR   Abcam; ab300821
DR   Wikidata; Q127378828
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:115; ACLY.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ACTA2 KO
AC   CVCL_B9CV
SY   Human ACTA2 knockout A549
DR   Abcam; ab287190
DR   cancercelllines; CVCL_B9CV
DR   Wikidata; Q112927075
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:130; ACTA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ACVR1 KO
AC   CVCL_D1V4
SY   Human ACVR1 knockout A549
DR   Abcam; ab300824
DR   Wikidata; Q127378829
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:171; ACVR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ACVR1B KO
AC   CVCL_B9CW
SY   Human ACVR1B knockout A549
DR   Abcam; ab287194
DR   cancercelllines; CVCL_B9CW
DR   Wikidata; Q112927076
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:172; ACVR1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ADA KO
AC   CVCL_B9CX
SY   Human ADA knockout A549
DR   Abcam; ab288866
DR   cancercelllines; CVCL_B9CX
DR   Wikidata; Q112927077
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:186; ADA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ADAM10 KO
AC   CVCL_B9CY
SY   Human ADAM10 knockout A549
DR   Abcam; ab287199
DR   cancercelllines; CVCL_B9CY
DR   Wikidata; Q112927078
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ADAR KO
AC   CVCL_B9CZ
SY   Human ADAR knockout A549
DR   Abcam; ab288826
DR   cancercelllines; CVCL_B9CZ
DR   Wikidata; Q112927080
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ADK KO
AC   CVCL_B9D0
SY   Human ADK knockout A549
DR   Abcam; ab288937
DR   cancercelllines; CVCL_B9D0
DR   Wikidata; Q112927082
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:257; ADK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ADORA2A KO
AC   CVCL_B9D1
SY   Human ADORA2A knockout A549
DR   Abcam; ab288861
DR   cancercelllines; CVCL_B9D1
DR   Wikidata; Q112927085
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ADRA2B KO
AC   CVCL_B9D2
SY   Human ADRA2B knockout A549
DR   Abcam; ab288947
DR   cancercelllines; CVCL_B9D2
DR   Wikidata; Q112927087
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:282; ADRA2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ADRB2 KO
AC   CVCL_B9D3
SY   Human ADRB2 knockout A549
DR   Abcam; ab287201
DR   cancercelllines; CVCL_B9D3
DR   Wikidata; Q112927090
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AFP KO
AC   CVCL_B9D4
SY   Human AFP knockout A549
DR   Abcam; ab288907
DR   cancercelllines; CVCL_B9D4
DR   Wikidata; Q112927092
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:317; AFP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AGER KO
AC   CVCL_D1V5
SY   Human AGER knockout A549
DR   Abcam; ab300827
DR   Wikidata; Q127378830
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:320; AGER.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 AGO2 KO
AC   CVCL_B9D5
SY   Human AGO2 knockout A549
DR   Abcam; ab287204
DR   cancercelllines; CVCL_B9D5
DR   Wikidata; Q112927094
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3263; AGO2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AGO4 KO
AC   CVCL_B9D6
SY   Human AGO4 knockout A549
DR   Abcam; ab288944
DR   cancercelllines; CVCL_B9D6
DR   Wikidata; Q112927095
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18424; AGO4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AGTR2 KO
AC   CVCL_D1V6
SY   Human AGTR2 knockout A549
DR   Abcam; ab300829
DR   Wikidata; Q127378831
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:338; AGTR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 AKR1B1 KO
AC   CVCL_D1V7
SY   Human AKR1B1 knockout A549
DR   Abcam; ab300832
DR   Wikidata; Q127378832
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 AKT1 KO
AC   CVCL_B9D7
SY   Human AKT1 knockout A549
DR   Abcam; ab286751
DR   cancercelllines; CVCL_B9D7
DR   Wikidata; Q112927096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AKT2 KO
AC   CVCL_B9D8
SY   Human AKT2 knockout A549
DR   Abcam; ab286450
DR   cancercelllines; CVCL_B9D8
DR   Wikidata; Q112927097
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AKT3 KO
AC   CVCL_B9D9
SY   Human AKT3 knockout A549
DR   Abcam; ab286451
DR   cancercelllines; CVCL_B9D9
DR   Wikidata; Q112927098
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ALDH1A1 KO
AC   CVCL_B2M1
SY   Human ALDH1A1 knockout A549
DR   Abcam; ab261864
DR   cancercelllines; CVCL_B2M1
DR   Wikidata; Q110429928
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:402; ALDH1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ALK KO
AC   CVCL_B9DA
SY   Human ALK knockout A549
DR   Abcam; ab286367
DR   cancercelllines; CVCL_B9DA
DR   Wikidata; Q112927099
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:427; ALK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ANGPT1 KO
AC   CVCL_B9DB
SY   Human ANGPT1 knockout A549
DR   Abcam; ab287207
DR   cancercelllines; CVCL_B9DB
DR   Wikidata; Q112927100
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:484; ANGPT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ANGPT2 KO
AC   CVCL_B9DC
SY   Human ANGPT2 knockout A549
DR   Abcam; ab287211
DR   cancercelllines; CVCL_B9DC
DR   Wikidata; Q112927101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:485; ANGPT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ANGPTL6 KO
AC   CVCL_B1EI
SY   Human ANGPTL6 knockout A549
DR   Abcam; ab267141
DR   cancercelllines; CVCL_B1EI
DR   Wikidata; Q110429929
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23140; ANGPTL6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ANO1 KO
AC   CVCL_D1V8
SY   Human ANO1 knockout A549
DR   Abcam; ab300834
DR   Wikidata; Q127378833
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ANXA1 KO
AC   CVCL_B9DD
SY   Human ANXA1 knockout A549
DR   Abcam; ab287214
DR   cancercelllines; CVCL_B9DD
DR   Wikidata; Q112927102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:533; ANXA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ANXA2 KO
AC   CVCL_D1V9
SY   Human ANXA2 knockout A549
DR   Abcam; ab300837
DR   Wikidata; Q127378834
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:537; ANXA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ANXA5 KO
AC   CVCL_D1VA
SY   Human ANXA5 knockout A549
DR   Abcam; ab300840
DR   Wikidata; Q127378835
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:543; ANXA5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 APAF1 KO
AC   CVCL_C7D4
SY   Human APAF1 knockout A549
DR   Abcam; ab300843
DR   Wikidata; Q123030390
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:576; APAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 APEX1 KO
AC   CVCL_B9DE
SY   Human APEX1 (APE1) knockout A549
DR   Abcam; ab276101
DR   cancercelllines; CVCL_B9DE
DR   Wikidata; Q112927103
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 APOL2 KO 1
AC   CVCL_B2M2
SY   Human APOL2 knockout A549
DR   Abcam; ab267066
DR   cancercelllines; CVCL_B2M2
DR   Wikidata; Q110429931
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:619; APOL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 APOL2 KO 2
AC   CVCL_B1EJ
SY   Human APOL2 knockout A549
DR   Abcam; ab267067
DR   cancercelllines; CVCL_B1EJ
DR   Wikidata; Q110429933
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:619; APOL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 APOL6 KO 1
AC   CVCL_B2M3
SY   Human APOL6 knockout A549
DR   Abcam; ab266958
DR   cancercelllines; CVCL_B2M3
DR   Wikidata; Q110429934
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14870; APOL6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 APOL6 KO 2
AC   CVCL_B1EK
SY   Human APOL6 knockout A549
DR   Abcam; ab266959
DR   cancercelllines; CVCL_B1EK
DR   Wikidata; Q110429935
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14870; APOL6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AQP1 KO
AC   CVCL_D1VB
SY   Human AQP1 knockout A549
DR   Abcam; ab300845
DR   Wikidata; Q127378836
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:633; AQP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 AQP2 KO
AC   CVCL_D1VC
SY   Human AQP2 knockout A549
DR   Abcam; ab300848
DR   Wikidata; Q127378837
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:634; AQP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 AQP4 KO
AC   CVCL_B9DF
SY   Human AQP4 knockout A549
DR   Abcam; ab286489
DR   cancercelllines; CVCL_B9DF
DR   Wikidata; Q112927104
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:637; AQP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AR KO
AC   CVCL_B9DG
SY   Human AR knockout A549
DR   Abcam; ab286710
DR   cancercelllines; CVCL_B9DG
DR   Wikidata; Q112927105
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ARAF KO
AC   CVCL_B9DH
SY   Human ARAF knockout A549
DR   Abcam; ab286379
DR   cancercelllines; CVCL_B9DH
DR   Wikidata; Q112927106
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AREG KO
AC   CVCL_B9DI
SY   Human AREG knockout A549
DR   Abcam; ab288948
DR   cancercelllines; CVCL_B9DI
DR   Wikidata; Q112927107
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:651; AREG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ARF6 KO
AC   CVCL_D1VD
SY   Human ARF6 knockout A549
DR   Abcam; ab300850
DR   Wikidata; Q127378838
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:659; ARF6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ARID1A KO
AC   CVCL_B7Q1
SY   Human ARID1A knockout A549
DR   Abcam; ab287217
DR   cancercelllines; CVCL_B7Q1
DR   Wikidata; Q112927108
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ARID1B KO
AC   CVCL_B9DJ
SY   Human ARID1B knockout A549
DR   Abcam; ab287220
DR   cancercelllines; CVCL_B9DJ
DR   Wikidata; Q112927109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ARNT KO
AC   CVCL_B9DK
SY   Human ARNT knockout A549
DR   Abcam; ab287223
DR   cancercelllines; CVCL_B9DK
DR   Wikidata; Q112927110
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:700; ARNT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ARNTL KO
AC   CVCL_B9DL
SY   Human ARNTL knockout A549
DR   Abcam; ab288835
DR   cancercelllines; CVCL_B9DL
DR   Wikidata; Q112927111
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:701; BMAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 ARRB1 KO
AC   CVCL_B9DM
SY   Human ARRB1 knockout A549
DR   Abcam; ab277839
DR   cancercelllines; CVCL_B9DM
DR   Wikidata; Q112927113
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:711; ARRB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ARRB2 KO
AC   CVCL_B9DN
SY   Human ARRB2 (Beta Arrestin 2) knockout A549
DR   Abcam; ab277840
DR   cancercelllines; CVCL_B9DN
DR   Wikidata; Q112927116
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ARRDC3 KO
AC   CVCL_B2M4
SY   Human ARRDC3 knockout A549
DR   Abcam; ab266979
DR   cancercelllines; CVCL_B2M4
DR   Wikidata; Q110429936
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29263; ARRDC3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ASH2L KO
AC   CVCL_B9DP
SY   Human ASH2L knockout A549
DR   Abcam; ab287226
DR   cancercelllines; CVCL_B9DP
DR   Wikidata; Q112927118
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:744; ASH2L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ASNS KO
AC   CVCL_D1VE
SY   Human ASNS knockout A549
DR   Abcam; ab300853
DR   Wikidata; Q127378839
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:753; ASNS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ATF2 KO
AC   CVCL_B9DQ
SY   Human ATF2 knockout A549
DR   Abcam; ab287229
DR   cancercelllines; CVCL_B9DQ
DR   Wikidata; Q112927121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ATF3 KO
AC   CVCL_B1EL
SY   Human ATF3 knockout A549
DR   Abcam; ab266955
DR   cancercelllines; CVCL_B1EL
DR   Wikidata; Q110429937
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ATF6 KO
AC   CVCL_B9DR
SY   Human ATF6 knockout A549
DR   Abcam; ab288910
DR   cancercelllines; CVCL_B9DR
DR   Wikidata; Q112927123
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ATM KO
AC   CVCL_B2M5
SY   Human ATM knockout A549
DR   Abcam; ab276095
DR   cancercelllines; CVCL_B2M5
DR   Wikidata; Q110429938
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ATP10A KO
AC   CVCL_B1EM
SY   Human ATP10A knockout A549
DR   Abcam; ab267040
DR   cancercelllines; CVCL_B1EM
DR   Wikidata; Q110429939
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13542; ATP10A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ATP1B3 KO
AC   CVCL_D1VF
SY   Human ATP1B3 knockout A549
DR   Abcam; ab300855
DR   Wikidata; Q127378840
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:806; ATP1B3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ATR KO
AC   CVCL_B2M6
SY   Human ATR knockout (hetero) A549
DR   Abcam; ab276104
DR   cancercelllines; CVCL_B2M6
DR   Wikidata; Q110429940
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:882; ATR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ATRX KO
AC   CVCL_B9DS
SY   Human ATRX knockout A549
DR   Abcam; ab287232
DR   cancercelllines; CVCL_B9DS
DR   Wikidata; Q112927126
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 AXIN1 KO
AC   CVCL_B9DT
SY   Human AXIN1 (Axin 1) knockout A549
DR   Abcam; ab277901
DR   cancercelllines; CVCL_B9DT
DR   Wikidata; Q112927127
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 B2M KO
AC   CVCL_B9DU
SY   Human B2M knockout A549
DR   Abcam; ab286573
DR   cancercelllines; CVCL_B9DU
DR   Wikidata; Q112927128
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BAD KO
AC   CVCL_B9DV
SY   Human BAD knockout A549
DR   Abcam; ab288879
DR   cancercelllines; CVCL_B9DV
DR   Wikidata; Q112927129
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BATF2 KO 1
AC   CVCL_B1EN
SY   Human BATF2 (SARI) knockout A549
DR   Abcam; ab267050
DR   cancercelllines; CVCL_B1EN
DR   Wikidata; Q110429941
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25163; BATF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BATF2 KO 2
AC   CVCL_B2M7
SY   Human BATF2 (SARI) knockout A549
DR   Abcam; ab267051
DR   cancercelllines; CVCL_B2M7
DR   Wikidata; Q110429942
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25163; BATF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BAX KO
AC   CVCL_B9DW
SY   Human BAX knockout A549
DR   Abcam; ab286754
DR   cancercelllines; CVCL_B9DW
DR   Wikidata; Q112927130
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BCAR1 KO
AC   CVCL_B9DX
SY   Human BCAR1 knockout A549
DR   Abcam; ab288951
DR   cancercelllines; CVCL_B9DX
DR   Wikidata; Q112927131
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:971; BCAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BCL10 KO
AC   CVCL_B9DY
SY   Human BCL10 knockout A549
DR   Abcam; ab286755
DR   cancercelllines; CVCL_B9DY
DR   Wikidata; Q112927132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BCL11A KO
AC   CVCL_B9DZ
SY   Human BCL11A knockout A549
DR   Abcam; ab286732
DR   cancercelllines; CVCL_B9DZ
DR   Wikidata; Q112927133
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13221; BCL11A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BCL11B KO
AC   CVCL_B9E0
SY   Human BCL11B knockout A549
DR   Abcam; ab286726
DR   cancercelllines; CVCL_B9E0
DR   Wikidata; Q112927134
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13222; BCL11B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BCL2 KO
AC   CVCL_B9E1
SY   Human BCL2 knockout A549
DR   Abcam; ab286741
DR   cancercelllines; CVCL_B9E1
DR   Wikidata; Q112927135
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BCL3 KO
AC   CVCL_B9E2
SY   Human BCL3 knockout A549
DR   Abcam; ab286737
DR   cancercelllines; CVCL_B9E2
DR   Wikidata; Q112927136
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:998; BCL3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BCL6 KO
AC   CVCL_B9E3
SY   Human BCL6 knockout A549
DR   Abcam; ab287235
DR   cancercelllines; CVCL_B9E3
DR   Wikidata; Q112927137
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BDNF KO
AC   CVCL_B9E4
SY   Human BDNF knockout A549
DR   Abcam; ab280828
DR   cancercelllines; CVCL_B9E4
DR   Wikidata; Q112927138
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1033; BDNF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BHLHE40 KO
AC   CVCL_B9E5
SY   Human BHLHE40 knockout A549
DR   Abcam; ab288952
DR   cancercelllines; CVCL_B9E5
DR   Wikidata; Q112927139
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1046; BHLHE40.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BLM KO
AC   CVCL_B9E6
SY   Human BLM knockout A549
DR   Abcam; ab287238
DR   cancercelllines; CVCL_B9E6
DR   Wikidata; Q112927142
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1058; BLM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BMP4 KO
AC   CVCL_B9E7
SY   Human BMP4 knockout A549
DR   Abcam; ab277884
DR   cancercelllines; CVCL_B9E7
DR   Wikidata; Q112927143
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1071; BMP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BMPR1A KO
AC   CVCL_B9E8
SY   Human BMPR1A knockout A549
DR   Abcam; ab286743
DR   cancercelllines; CVCL_B9E8
DR   Wikidata; Q112927144
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BRAF KO
AC   CVCL_B9E9
SY   Human BRAF knockout A549
DR   Abcam; ab276079
DR   cancercelllines; CVCL_B9E9
DR   Wikidata; Q112927145
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BRCA1 KO
AC   CVCL_B1EP
SY   Human BRCA1 knockout A549
DR   Abcam; ab276099
DR   cancercelllines; CVCL_B1EP
DR   Wikidata; Q110429944
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1100; BRCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab276099; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 BRD3 KO
AC   CVCL_B9EA
SY   Human BRD3 knockout A549
DR   Abcam; ab287241
DR   cancercelllines; CVCL_B9EA
DR   Wikidata; Q112927146
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BRD4 KO
AC   CVCL_B9EB
SY   Human BRD4 knockout A549
DR   Abcam; ab286640
DR   cancercelllines; CVCL_B9EB
DR   Wikidata; Q112927147
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BRD7 KO
AC   CVCL_B9EC
SY   Human BRD7 knockout A549
DR   Abcam; ab287243
DR   cancercelllines; CVCL_B9EC
DR   Wikidata; Q112927149
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14310; BRD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BRIP1 KO
AC   CVCL_B9ED
SY   Human BRIP1 knockout A549
DR   Abcam; ab286641
DR   cancercelllines; CVCL_B9ED
DR   Wikidata; Q112927151
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20473; BRIP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 BSG KO
AC   CVCL_B2M8
SY   Human BSG (CD147) knockout A549
DR   Abcam; ab273748
DR   cancercelllines; CVCL_B2M8
DR   Wikidata; Q110429945
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 C1QBP KO
AC   CVCL_D1VG
SY   Human C1QBP knockout A549
DR   Abcam; ab300857
DR   Wikidata; Q127378841
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1243; C1QBP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 C3AR1 KO
AC   CVCL_B9EE
SY   Human C3AR1 knockout A549
DR   Abcam; ab289022
DR   cancercelllines; CVCL_B9EE
DR   Wikidata; Q112927154
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1319; C3AR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 C5AR1 KO
AC   CVCL_B9EF
SY   Human C5AR1 knockout A549
DR   Abcam; ab289028
DR   cancercelllines; CVCL_B9EF
DR   Wikidata; Q112927156
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1338; C5AR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CA12 KO
AC   CVCL_B1EQ
SY   Human CA12 knockout A549
DR   Abcam; ab273738
DR   cancercelllines; CVCL_B1EQ
DR   Wikidata; Q110429946
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1371; CA12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CA9 KO
AC   CVCL_B9EG
SY   Human CA9 knockout A549
DR   Abcam; ab287250
DR   cancercelllines; CVCL_B9EG
DR   Wikidata; Q112927158
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1383; CA9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CACNA1D KO
AC   CVCL_B9EH
SY   Human CACNA1D knockout A549
DR   Abcam; ab289529
DR   cancercelllines; CVCL_B9EH
DR   Wikidata; Q112927159
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1391; CACNA1D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CALR KO
AC   CVCL_B9EI
SY   Human CALR knockout A549
DR   Abcam; ab286714
DR   cancercelllines; CVCL_B9EI
DR   Wikidata; Q112927160
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1455; CALR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CAPN1 KO
AC   CVCL_D1VH
SY   Human CAPN1 knockout A549
DR   Abcam; ab300860
DR   Wikidata; Q127378842
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1476; CAPN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CARD11 KO
AC   CVCL_B9EJ
SY   Human CARD11 knockout A549
DR   Abcam; ab286696
DR   cancercelllines; CVCL_B9EJ
DR   Wikidata; Q112927161
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16393; CARD11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CARD9 KO
AC   CVCL_B9EK
SY   Human CARD9 knockout A549
DR   Abcam; ab288997
DR   cancercelllines; CVCL_B9EK
DR   Wikidata; Q112927162
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16391; CARD9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CARM1 KO
AC   CVCL_B9EL
SY   Human CARM1 knockout A549
DR   Abcam; ab287252
DR   cancercelllines; CVCL_B9EL
DR   Wikidata; Q112927163
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CASP4 KO
AC   CVCL_C7D5
SY   Human CASP4 knockout A549
DR   Abcam; ab300863
DR   Wikidata; Q123030391
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1505; CASP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 CASP6 KO
AC   CVCL_D1VI
SY   Human CASP6 knockout A549
DR   Abcam; ab300865
DR   Wikidata; Q127378843
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1507; CASP6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CASP8 KO
AC   CVCL_B9EM
SY   Human CASP8 knockout A549
DR   Abcam; ab286757
DR   cancercelllines; CVCL_B9EM
DR   Wikidata; Q112927164
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CAST KO
AC   CVCL_D1VJ
SY   Human CAST knockout A549
DR   Abcam; ab300867
DR   Wikidata; Q127378844
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1515; CAST.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CBL KO
AC   CVCL_B9EN
SY   Human CBL knockout A549
DR   Abcam; ab287256
DR   cancercelllines; CVCL_B9EN
DR   Wikidata; Q112927165
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CBLB KO
AC   CVCL_B9EP
SY   Human CBLB knockout A549
DR   Abcam; ab286758
DR   cancercelllines; CVCL_B9EP
DR   Wikidata; Q112927166
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1542; CBLB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CBR1 KO
AC   CVCL_B2M9
SY   Human CBR1 knockout A549
DR   Abcam; ab266954
DR   cancercelllines; CVCL_B2M9
DR   Wikidata; Q110429947
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1548; CBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CBX5 KO
AC   CVCL_D1VK
SY   Human CBX5 knockout A549
DR   Abcam; ab300869
DR   Wikidata; Q127378845
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CCL2 KO
AC   CVCL_E1FL
SY   Human CCL2 (MCP1) knockout A549
DR   Abcam; ab270478
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10618; CCL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam A-549 CCL3 KO
AC   CVCL_B9EQ
SY   Human CCL3 knockout A549
DR   Abcam; ab288998
DR   cancercelllines; CVCL_B9EQ
DR   Wikidata; Q112927167
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10627; CCL3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCNB1 KO
AC   CVCL_B9ER
SY   Human CCNB1 knockout A549
DR   Abcam; ab286544
DR   cancercelllines; CVCL_B9ER
DR   Wikidata; Q112927168
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1579; CCNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCND1 KO
AC   CVCL_B9ES
SY   Human CCND1 knockout A549
DR   Abcam; ab286759
DR   cancercelllines; CVCL_B9ES
DR   Wikidata; Q112927169
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCND2 KO
AC   CVCL_B9ET
SY   Human CCND2 knockout A549
DR   Abcam; ab287259
DR   cancercelllines; CVCL_B9ET
DR   Wikidata; Q112927170
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCNE1 KO
AC   CVCL_B9EU
SY   Human CCNE1 knockout A549
DR   Abcam; ab286681
DR   cancercelllines; CVCL_B9EU
DR   Wikidata; Q112927171
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1589; CCNE1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCR1 KO
AC   CVCL_D1VL
SY   Human CCR1 knockout A549
DR   Abcam; ab300875
DR   Wikidata; Q127378846
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1602; CCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CCR3 KO
AC   CVCL_B9EV
SY   Human CCR3 knockout A549
DR   Abcam; ab288935
DR   cancercelllines; CVCL_B9EV
DR   Wikidata; Q112927172
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1604; CCR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCR4 KO
AC   CVCL_B9EW
SY   Human CCR4 knockout A549
DR   Abcam; ab287262
DR   cancercelllines; CVCL_B9EW
DR   Wikidata; Q112927173
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1605; CCR4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCR5 KO
AC   CVCL_B9EX
SY   Human CCR5 knockout A549
DR   Abcam; ab288993
DR   cancercelllines; CVCL_B9EX
DR   Wikidata; Q112927174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1606; CCR5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCR6 KO
AC   CVCL_B9EY
SY   Human CCR6 knockout A549
DR   Abcam; ab287263
DR   cancercelllines; CVCL_B9EY
DR   Wikidata; Q112927175
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1607; CCR6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCR7 KO
AC   CVCL_B9EZ
SY   Human CCR7 knockout A549
DR   Abcam; ab287268
DR   cancercelllines; CVCL_B9EZ
DR   Wikidata; Q112927176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1608; CCR7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CCR9 KO
AC   CVCL_B9F0
SY   Human CCR9 knockout A549
DR   Abcam; ab288963
DR   cancercelllines; CVCL_B9F0
DR   Wikidata; Q112927177
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1610; CCR9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD14 KO
AC   CVCL_B9F1
SY   Human CD14 knockout A549
DR   Abcam; ab287269
DR   cancercelllines; CVCL_B9F1
DR   Wikidata; Q112927179
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1628; CD14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD163 KO
AC   CVCL_B9F2
SY   Human CD163 knockout A549
DR   Abcam; ab288887
DR   cancercelllines; CVCL_B9F2
DR   Wikidata; Q112927180
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1631; CD163.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD19 KO
AC   CVCL_B9F3
SY   Human CD19 knockout A549
DR   Abcam; ab287273
DR   cancercelllines; CVCL_B9F3
DR   Wikidata; Q112927181
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD209 KO
AC   CVCL_B9F4
SY   Human CD209 knockout A549
DR   Abcam; ab287277
DR   cancercelllines; CVCL_B9F4
DR   Wikidata; Q112927182
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1641; CD209.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD226 KO
AC   CVCL_B9F5
SY   Human CD226 knockout A549
DR   Abcam; ab289034
DR   cancercelllines; CVCL_B9F5
DR   Wikidata; Q112927183
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16961; CD226.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD274 KO 1
AC   CVCL_B1ER
SY   Human CD274 (PD-L1) knockout A549
DR   Abcam; ab267054
DR   cancercelllines; CVCL_B1ER
DR   Wikidata; Q110429948
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD274 KO 2
AC   CVCL_B2MA
SY   Human CD274 (PD-L1) knockout A549
DR   Abcam; ab267055
DR   cancercelllines; CVCL_B2MA
DR   Wikidata; Q110429949
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD28 KO
AC   CVCL_B9F6
SY   Human CD28 knockout A549
DR   Abcam; ab287279
DR   cancercelllines; CVCL_B9F6
DR   Wikidata; Q112927184
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD34 KO
AC   CVCL_B9F7
SY   Human CD34 knockout A549
DR   Abcam; ab288968
DR   cancercelllines; CVCL_B9F7
DR   Wikidata; Q112927185
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1662; CD34.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD38 KO
AC   CVCL_B9F8
SY   Human CD38 knockout A549
DR   Abcam; ab289025
DR   cancercelllines; CVCL_B9F8
DR   Wikidata; Q112927186
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1667; CD38.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD3E KO
AC   CVCL_B9UM
SY   Human CD3E knockout A549
DR   Abcam; ab287283
DR   cancercelllines; CVCL_B9UM
DR   Wikidata; Q112927187
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD4 KO
AC   CVCL_B9F9
SY   Human CD4 knockout A549
DR   Abcam; ab287285
DR   cancercelllines; CVCL_B9F9
DR   Wikidata; Q112927188
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1678; CD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD40LG KO
AC   CVCL_B9FA
SY   Human CD40LG knockout A549
DR   Abcam; ab288981
DR   cancercelllines; CVCL_B9FA
DR   Wikidata; Q112927189
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11935; CD40LG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD46 KO
AC   CVCL_D1VM
SY   Human CD46 knockout A549
DR   Abcam; ab300878
DR   Wikidata; Q127378847
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CD5 KO
AC   CVCL_B9FB
SY   Human CD5 knockout A549
DR   Abcam; ab288942
DR   cancercelllines; CVCL_B9FB
DR   Wikidata; Q112927190
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1685; CD5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD69 KO
AC   CVCL_B9FC
SY   Human CD69 knockout A549
DR   Abcam; ab288920
DR   cancercelllines; CVCL_B9FC
DR   Wikidata; Q112927191
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1694; CD69.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD7 KO
AC   CVCL_B9FD
SY   Human CD7 knockout A549
DR   Abcam; ab288857
DR   cancercelllines; CVCL_B9FD
DR   Wikidata; Q112927192
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1695; CD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD74 KO
AC   CVCL_B9FE
SY   Human CD74 knockout A549
DR   Abcam; ab287290
DR   cancercelllines; CVCL_B9FE
DR   Wikidata; Q112927193
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD79A KO
AC   CVCL_B9FF
SY   Human CD79A knockout A549
DR   Abcam; ab287295
DR   cancercelllines; CVCL_B9FF
DR   Wikidata; Q112927194
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1698; CD79A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD80 KO
AC   CVCL_B9FG
SY   Human CD80 knockout A549
DR   Abcam; ab287297
DR   cancercelllines; CVCL_B9FG
DR   Wikidata; Q112927195
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1700; CD80.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD86 KO
AC   CVCL_B9FH
SY   Human CD86 knockout A549
DR   Abcam; ab287300
DR   cancercelllines; CVCL_B9FH
DR   Wikidata; Q112927196
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1705; CD86.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD8A KO
AC   CVCL_B9FI
SY   Human CD8A knockout A549
DR   Abcam; ab288973
DR   cancercelllines; CVCL_B9FI
DR   Wikidata; Q112927197
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1706; CD8A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CD9 KO
AC   CVCL_B1ES
SY   Human CD9 knockout A549
DR   Abcam; ab261878
DR   cancercelllines; CVCL_B1ES
DR   Wikidata; Q110429950
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDA KO
AC   CVCL_D1VN
SY   Human CDA knockout A549
DR   Abcam; ab300883
DR   Wikidata; Q127378848
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1712; CDA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CDH11 KO
AC   CVCL_B9FJ
SY   Human CDH11 knockout A549
DR   Abcam; ab286642
DR   cancercelllines; CVCL_B9FJ
DR   Wikidata; Q112927198
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1750; CDH11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDH5 KO
AC   CVCL_D1VP
SY   Human CDH5 knockout A549
DR   Abcam; ab300885
DR   Wikidata; Q127378849
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1764; CDH5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CDK4 KO
AC   CVCL_B9FK
SY   Human CDK4 knockout A549
DR   Abcam; ab286579
DR   cancercelllines; CVCL_B9FK
DR   Wikidata; Q112927199
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1773; CDK4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDK5 KO
AC   CVCL_B9FL
SY   Human CDK5 knockout A549
DR   Abcam; ab287304
DR   cancercelllines; CVCL_B9FL
DR   Wikidata; Q112927200
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDK6 KO
AC   CVCL_B9FM
SY   Human CDK6 knockout A549
DR   Abcam; ab287307
DR   cancercelllines; CVCL_B9FM
DR   Wikidata; Q112927201
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDK8 KO
AC   CVCL_B9FN
SY   Human CDK8 knockout A549
DR   Abcam; ab287310
DR   cancercelllines; CVCL_B9FN
DR   Wikidata; Q112927202
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1779; CDK8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDKN1A KO
AC   CVCL_B9FP
SY   Human CDKN1A knockout A549
DR   Abcam; ab288213
DR   cancercelllines; CVCL_B9FP
DR   Wikidata; Q112927203
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDKN1B KO
AC   CVCL_B9FQ
SY   Human CDKN1B knockout A549
DR   Abcam; ab286761
DR   cancercelllines; CVCL_B9FQ
DR   Wikidata; Q112927204
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDKN1C KO
AC   CVCL_B9FR
SY   Human CDKN1C knockout A549
DR   Abcam; ab289036
DR   cancercelllines; CVCL_B9FR
DR   Wikidata; Q112927205
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1786; CDKN1C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CDX2 KO
AC   CVCL_B9FS
SY   Human CDX2 knockout A549
DR   Abcam; ab287316
DR   cancercelllines; CVCL_B9FS
DR   Wikidata; Q112927206
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1806; CDX2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CEACAM1 KO 1
AC   CVCL_B2MB
SY   Human CEACAM1 knockout A549
DR   Abcam; ab267046
DR   cancercelllines; CVCL_B2MB
DR   Wikidata; Q110429951
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1814; CEACAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CEACAM1 KO 2
AC   CVCL_B1ET
SY   Human CEACAM1 knockout A549
DR   Abcam; ab267047
DR   cancercelllines; CVCL_B1ET
DR   Wikidata; Q110429952
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1814; CEACAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CEACAM5 KO
AC   CVCL_B9FT
SY   Human CEACAM5 knockout A549
DR   Abcam; ab287319
DR   cancercelllines; CVCL_B9FT
DR   Wikidata; Q112927207
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1817; CEACAM5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CEBPA KO
AC   CVCL_B9FU
SY   Human CEBPA knockout A549
DR   Abcam; ab286718
DR   cancercelllines; CVCL_B9FU
DR   Wikidata; Q112927208
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CEBPD KO
AC   CVCL_D1VQ
SY   Human CEBPD knockout A549
DR   Abcam; ab300887
DR   Wikidata; Q127378850
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1835; CEBPD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CES1 KO
AC   CVCL_D1VR
SY   Human CES1 knockout A549
DR   Abcam; ab300889
DR   Wikidata; Q127378851
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1863; CES1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CFD KO
AC   CVCL_D1VS
SY   Human CFD knockout A549
DR   Abcam; ab300891
DR   Wikidata; Q127378852
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2771; CFD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CFH KO
AC   CVCL_B2MC
SY   Human CFH (Factor H) knockout A549
DR   Abcam; ab267031
DR   cancercelllines; CVCL_B2MC
DR   Wikidata; Q110429953
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4883; CFH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CFHR3 KO 1
AC   CVCL_B1EU
SY   Human CFHR3 (Complement factor H-related protein 3) knockout A549
DR   Abcam; ab267092
DR   cancercelllines; CVCL_B1EU
DR   Wikidata; Q110429954
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16980; CFHR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CFHR3 KO 2
AC   CVCL_B2MD
SY   Human CFHR3 (Complement factor H-related protein 3) knockout A549
DR   Abcam; ab267093
DR   cancercelllines; CVCL_B2MD
DR   Wikidata; Q110429955
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16980; CFHR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHAT KO
AC   CVCL_D1VT
SY   Human CHAT knockout A549
DR   Abcam; ab300894
DR   Wikidata; Q127378853
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1912; CHAT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CHD5 KO
AC   CVCL_B9FV
SY   Human CHD5 knockout A549
DR   Abcam; ab288214
DR   cancercelllines; CVCL_B9FV
DR   Wikidata; Q112927209
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16816; CHD5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHD7 KO
AC   CVCL_B9FW
SY   Human CHD7 knockout A549
DR   Abcam; ab288885
DR   cancercelllines; CVCL_B9FW
DR   Wikidata; Q112927210
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20626; CHD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHD8 KO
AC   CVCL_B9FX
SY   Human CHD8 knockout A549
DR   Abcam; ab288828
DR   cancercelllines; CVCL_B9FX
DR   Wikidata; Q112927211
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHD9 KO
AC   CVCL_B9FY
SY   Human CHD9 knockout A549
DR   Abcam; ab288215
DR   cancercelllines; CVCL_B9FY
DR   Wikidata; Q112927212
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25701; CHD9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHEK1 KO
AC   CVCL_B1EV
SY   Human CHEK1 knockout A549
DR   Abcam; ab276102
DR   cancercelllines; CVCL_B1EV
DR   Wikidata; Q110429956
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1925; CHEK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHEK2 KO
AC   CVCL_B2ME
SY   Human CHEK2 (Chk2) knockout A549
DR   Abcam; ab276098
DR   cancercelllines; CVCL_B2ME
DR   Wikidata; Q110429957
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHMP2B KO
AC   CVCL_B1EW
SY   Human CHMP2B knockout A549
DR   Abcam; ab261874
DR   cancercelllines; CVCL_B1EW
DR   Wikidata; Q110429958
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CHUK KO
AC   CVCL_B9FZ
SY   Human CHUK knockout A549
DR   Abcam; ab287321
DR   cancercelllines; CVCL_B9FZ
DR   Wikidata; Q112927213
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CIRBP KO
AC   CVCL_B9G0
SY   Human CIRBP knockout A549
DR   Abcam; ab288915
DR   cancercelllines; CVCL_B9G0
DR   Wikidata; Q112927214
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1982; CIRBP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CISH KO
AC   CVCL_B9G1
SY   Human CISH knockout A549
DR   Abcam; ab288990
DR   cancercelllines; CVCL_B9G1
DR   Wikidata; Q112927215
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1984; CISH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CKAP4 KO
AC   CVCL_D1VU
SY   Human CKAP4 knockout A549
DR   Abcam; ab300896
DR   Wikidata; Q127378854
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16991; CKAP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CLDN18 KO
AC   CVCL_B9G2
SY   Human CLDN18 knockout A549
DR   Abcam; ab288862
DR   cancercelllines; CVCL_B9G2
DR   Wikidata; Q112927216
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2039; CLDN18.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CLDN3 KO
AC   CVCL_D1VV
SY   Human CLDN3 knockout A549
DR   Abcam; ab300898
DR   Wikidata; Q127378855
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2045; CLDN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CLOCK KO
AC   CVCL_B9G3
SY   Human CLOCK knockout A549
DR   Abcam; ab287326
DR   cancercelllines; CVCL_B9G3
DR   Wikidata; Q112927217
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CMPK2 KO 1
AC   CVCL_B2MF
SY   Human CMPK2 knockout A549
DR   Abcam; ab266935
DR   cancercelllines; CVCL_B2MF
DR   Wikidata; Q110429959
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27015; CMPK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CMPK2 KO 2
AC   CVCL_B1EX
SY   Human CMPK2 knockout A549
DR   Abcam; ab266936
DR   cancercelllines; CVCL_B1EX
DR   Wikidata; Q110429960
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27015; CMPK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CNOT6 KO
AC   CVCL_B9G4
SY   Human CNOT6 knockout A549
DR   Abcam; ab288914
DR   cancercelllines; CVCL_B9G4
DR   Wikidata; Q112927218
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14099; CNOT6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CNTNAP2 KO
AC   CVCL_B9G5
SY   Human CNTNAP2 knockout A549
DR   Abcam; ab286740
DR   cancercelllines; CVCL_B9G5
DR   Wikidata; Q112927219
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13830; CNTNAP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 COL1A1 KO
AC   CVCL_B9G6
SY   Human COL1A1 knockout A549
DR   Abcam; ab287329
DR   cancercelllines; CVCL_B9G6
DR   Wikidata; Q112927220
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CR2 KO
AC   CVCL_B9G7
SY   Human CR2 knockout A549
DR   Abcam; ab288886
DR   cancercelllines; CVCL_B9G7
DR   Wikidata; Q112927221
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2336; CR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CRBN KO
AC   CVCL_B9G8
SY   Human CRBN knockout A549
DR   Abcam; ab288959
DR   cancercelllines; CVCL_B9G8
DR   Wikidata; Q112927222
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CREB1 KO
AC   CVCL_B9G9
SY   Human CREB1 knockout A549
DR   Abcam; ab286720
DR   cancercelllines; CVCL_B9G9
DR   Wikidata; Q112927223
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CREBBP KO
AC   CVCL_B9GA
SY   Human CREBBP knockout A549
DR   Abcam; ab277885
DR   cancercelllines; CVCL_B9GA
DR   Wikidata; Q112927224
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CRLF2 KO
AC   CVCL_B9GB
SY   Human CRLF2 knockout A549
DR   Abcam; ab287332
DR   cancercelllines; CVCL_B9GB
DR   Wikidata; Q112927225
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14281; CRLF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CRTC1 KO
AC   CVCL_D1VW
SY   Human CRTC1 knockout A549
DR   Abcam; ab300900
DR   Wikidata; Q127378856
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16062; CRTC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CSF1 KO
AC   CVCL_B9GC
SY   Human CSF1 knockout A549
DR   Abcam; ab288845
DR   cancercelllines; CVCL_B9GC
DR   Wikidata; Q112927226
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CSF1R KO
AC   CVCL_B9GD
SY   Human CSF1R knockout A549
DR   Abcam; ab287336
DR   cancercelllines; CVCL_B9GD
DR   Wikidata; Q112927227
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CSF3R KO
AC   CVCL_B9GE
SY   Human CSF3R knockout A549
DR   Abcam; ab287339
DR   cancercelllines; CVCL_B9GE
DR   Wikidata; Q112927228
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2439; CSF3R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CSK KO
AC   CVCL_D1VX
SY   Human CSK knockout A549
DR   Abcam; ab300902
DR   Wikidata; Q127378857
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2444; CSK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CSPG4 KO
AC   CVCL_B9GF
SY   Human CSPG4 knockout A549
DR   Abcam; ab288983
DR   cancercelllines; CVCL_B9GF
DR   Wikidata; Q112927229
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2466; CSPG4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CTH KO
AC   CVCL_D1VY
SY   Human CTH knockout A549
DR   Abcam; ab300903
DR   Wikidata; Q127378858
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2501; CTH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CTLA4 KO
AC   CVCL_B9GG
SY   Human CTLA4 knockout A549
DR   Abcam; ab287340
DR   cancercelllines; CVCL_B9GG
DR   Wikidata; Q112927230
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2505; CTLA4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CTNNB1 KO
AC   CVCL_B9GH
SY   Human CTNNB1 knockout A549
DR   Abcam; ab286583
DR   cancercelllines; CVCL_B9GH
DR   Wikidata; Q112927231
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CTSG KO
AC   CVCL_D1VZ
SY   Human CTSG knockout A549
DR   Abcam; ab300905
DR   Wikidata; Q127378859
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2532; CTSG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CUL4A KO
AC   CVCL_D1W0
SY   Human CUL4A knockout A549
DR   Abcam; ab300908
DR   Wikidata; Q127378860
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2554; CUL4A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 CX3CL1 KO
AC   CVCL_B9GI
SY   Human CX3CL1 knockout A549
DR   Abcam; ab289010
DR   cancercelllines; CVCL_B9GI
DR   Wikidata; Q112927232
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10647; CX3CL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCL10 KO 1
AC   CVCL_B2MG
SY   Human CXCL10 (IP10) knockout A549
DR   Abcam; ab266969
DR   cancercelllines; CVCL_B2MG
DR   Wikidata; Q110429961
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCL10 KO 2
AC   CVCL_B1EY
SY   Human CXCL10 (IP10) knockout A549
DR   Abcam; ab266970
DR   cancercelllines; CVCL_B1EY
DR   Wikidata; Q110429962
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCL10 KO 3
AC   CVCL_B2MH
SY   Human CXCL10 (IP10) knockout A549
DR   Abcam; ab266971
DR   cancercelllines; CVCL_B2MH
DR   Wikidata; Q110429963
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCL11 KO
AC   CVCL_C0BH
SY   Human CXCL11 knockout A549
DR   Abcam; ab288837
DR   cancercelllines; CVCL_C0BH
DR   Wikidata; Q112927233
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10638; CXCL11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCL13 KO
AC   CVCL_B9GJ
SY   Human CXCL13 knockout A549
DR   Abcam; ab289006
DR   cancercelllines; CVCL_B9GJ
DR   Wikidata; Q112927234
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10639; CXCL13.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCR1 KO
AC   CVCL_B9GK
SY   Human CXCR1 knockout A549
DR   Abcam; ab287345
DR   cancercelllines; CVCL_B9GK
DR   Wikidata; Q112927235
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6026; CXCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCR3 KO
AC   CVCL_B9GL
SY   Human CXCR3 knockout A549
DR   Abcam; ab289038
DR   cancercelllines; CVCL_B9GL
DR   Wikidata; Q112927236
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4540; CXCR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCR4 KO
AC   CVCL_B9GM
SY   Human CXCR4 knockout A549
DR   Abcam; ab287349
DR   cancercelllines; CVCL_B9GM
DR   Wikidata; Q112927237
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CXCR6 KO
AC   CVCL_B9GN
SY   Human CXCR6 knockout A549
DR   Abcam; ab289035
DR   cancercelllines; CVCL_B9GN
DR   Wikidata; Q112927239
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16647; CXCR6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CYBB KO
AC   CVCL_B9GP
SY   Human CYBB knockout A549
DR   Abcam; ab287352
DR   cancercelllines; CVCL_B9GP
DR   Wikidata; Q112927240
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2578; CYBB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CYLD KO
AC   CVCL_B9GQ
SY   Human CYLD knockout A549
DR   Abcam; ab286643
DR   cancercelllines; CVCL_B9GQ
DR   Wikidata; Q112927241
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CYP1B1 KO 1
AC   CVCL_B1EZ
SY   Human CYP1B1 knockout A549
DR   Abcam; ab267095
DR   cancercelllines; CVCL_B1EZ
DR   Wikidata; Q110429964
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2597; CYP1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 CYP1B1 KO 2
AC   CVCL_B9CP
SY   Human CYP1B1 knockout A549
DR   Abcam; ab269476
DR   cancercelllines; CVCL_B9CP
DR   Wikidata; Q112927243
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2597; CYP1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 CYP24A1 KO
AC   CVCL_B2MI
SY   Human CYP24A1 knockout A549
DR   Abcam; ab273735
DR   cancercelllines; CVCL_B2MI
DR   Wikidata; Q110429965
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2602; CYP24A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DAXX KO
AC   CVCL_B9GR
SY   Human DAXX knockout A549
DR   Abcam; ab287356
DR   cancercelllines; CVCL_B9GR
DR   Wikidata; Q112927244
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DCC KO
AC   CVCL_B9GS
SY   Human DCC knockout A549
DR   Abcam; ab286719
DR   cancercelllines; CVCL_B9GS
DR   Wikidata; Q112927245
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2701; DCC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DCK KO
AC   CVCL_D1W1
SY   Human DCK knockout A549
DR   Abcam; ab300911
DR   Wikidata; Q127378861
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2704; DCK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 DDB2 KO
AC   CVCL_B9GT
SY   Human DDB2 knockout A549
DR   Abcam; ab287359
DR   cancercelllines; CVCL_B9GT
DR   Wikidata; Q112927246
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2718; DDB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DDIT4 KO
AC   CVCL_D1W2
SY   Human DDIT4 knockout A549
DR   Abcam; ab300913
DR   Wikidata; Q127378862
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24944; DDIT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 DDR2 KO
AC   CVCL_B9GU
SY   Human DDR2 knockout A549
DR   Abcam; ab286744
DR   cancercelllines; CVCL_B9GU
DR   Wikidata; Q112927247
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DDX3X KO
AC   CVCL_B9GV
SY   Human DDX3X knockout A549
DR   Abcam; ab287362
DR   cancercelllines; CVCL_B9GV
DR   Wikidata; Q112927248
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2745; DDX3X.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DDX4 KO
AC   CVCL_B9GW
SY   Human DDX4 knockout A549
DR   Abcam; ab288898
DR   cancercelllines; CVCL_B9GW
DR   Wikidata; Q112927249
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18700; DDX4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DDX58 KO 1
AC   CVCL_B1F0
SY   Human DDX58 (RIG-I) knockout A549
DR   Abcam; ab267116
DR   cancercelllines; CVCL_B1F0
DR   Wikidata; Q110429966
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 DDX58 KO 2
AC   CVCL_B2MJ
SY   Human DDX58 (RIG-I) knockout A549
DR   Abcam; ab267117
DR   cancercelllines; CVCL_B2MJ
DR   Wikidata; Q110429967
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 DDX60 KO
AC   CVCL_B1F1
SY   Human DDX60 knockout A549
DR   Abcam; ab267165
DR   cancercelllines; CVCL_B1F1
DR   Wikidata; Q110429968
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25942; DDX60.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DDX60L KO
AC   CVCL_B2MK
SY   Human DDX60L knockout A549
DR   Abcam; ab266944
DR   cancercelllines; CVCL_B2MK
DR   Wikidata; Q110429969
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26429; DDX60L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DEPDC5 KO
AC   CVCL_B1F2
SY   Human DEPDC5 knockout A549
DR   Abcam; ab266906
DR   cancercelllines; CVCL_B1F2
DR   Wikidata; Q110429970
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18423; DEPDC5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DGCR8 KO
AC   CVCL_B9GX
SY   Human DGCR8 knockout A549
DR   Abcam; ab287368
DR   cancercelllines; CVCL_B9GX
DR   Wikidata; Q112927250
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2847; DGCR8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DHX58 KO
AC   CVCL_B2ML
SY   Human DHX58 (RLR) knockout A549
DR   Abcam; ab266937
DR   cancercelllines; CVCL_B2ML
DR   Wikidata; Q110429972
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29517; DHX58.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DLAT KO
AC   CVCL_D1W3
SY   Human DLAT knockout A549
DR   Abcam; ab300919
DR   Wikidata; Q127378863
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2896; DLAT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 DLL3 KO
AC   CVCL_B9GY
SY   Human DLL3 knockout A549
DR   Abcam; ab288918
DR   cancercelllines; CVCL_B9GY
DR   Wikidata; Q112927251
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DMC1 KO
AC   CVCL_B9GZ
SY   Human DMC1 knockout A549
DR   Abcam; ab288216
DR   cancercelllines; CVCL_B9GZ
DR   Wikidata; Q112927252
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2927; DMC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DNAH5 KO
AC   CVCL_B1F3
SY   Human DNAH5 knockout A549
DR   Abcam; ab267118
DR   cancercelllines; CVCL_B1F3
DR   Wikidata; Q110429973
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2950; DNAH5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DNAJB1 KO
AC   CVCL_B9H0
SY   Human DNAJB1 knockout A549
DR   Abcam; ab286763
DR   cancercelllines; CVCL_B9H0
DR   Wikidata; Q112927253
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5270; DNAJB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DNMT3B KO
AC   CVCL_B9H1
SY   Human DNMT3B knockout A549
DR   Abcam; ab287371
DR   cancercelllines; CVCL_B9H1
DR   Wikidata; Q112927254
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DOT1L KO
AC   CVCL_B9H2
SY   Human DOT1L knockout A549
DR   Abcam; ab287374
DR   cancercelllines; CVCL_B9H2
DR   Wikidata; Q112927255
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24948; DOT1L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DPP4 KO
AC   CVCL_B9H3
SY   Human DPP4 knockout A549
DR   Abcam; ab288832
DR   cancercelllines; CVCL_B9H3
DR   Wikidata; Q112927256
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3009; DPP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DPYSL2 KO
AC   CVCL_D1W4
SY   Human DPYSL2 knockout A549
DR   Abcam; ab300921
DR   Wikidata; Q127378864
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3014; DPYSL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 DROSHA KO
AC   CVCL_B9H4
SY   Human DROSHA knockout A549
DR   Abcam; ab287377
DR   cancercelllines; CVCL_B9H4
DR   Wikidata; Q112927257
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17904; DROSHA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DSG2 KO 1
AC   CVCL_B2MM
SY   Human DSG2 (Desmoglein 2) knockout A549
DR   Abcam; ab267085
DR   cancercelllines; CVCL_B2MM
DR   Wikidata; Q110429974
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DSG2 KO 2
AC   CVCL_B1F4
SY   Human Desmoglein 2 knockout A549
DR   Abcam; ab267086
DR   cancercelllines; CVCL_B1F4
DR   Wikidata; Q110429975
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DTX3L KO 1
AC   CVCL_B2MN
SY   Human DTX3L knockout A549
DR   Abcam; ab266963
DR   cancercelllines; CVCL_B2MN
DR   Wikidata; Q110429976
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DTX3L KO 2
AC   CVCL_B1F5
SY   Human DTX3L knockout A549
DR   Abcam; ab266964
DR   cancercelllines; CVCL_B1F5
DR   Wikidata; Q110429977
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DUSP1 KO
AC   CVCL_D1W5
SY   Human DUSP1 knockout A549
DR   Abcam; ab300924
DR   Wikidata; Q127378865
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3064; DUSP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 DUSP4 KO
AC   CVCL_B2MP
SY   Human DUSP4 knockout A549
DR   Abcam; ab273859
DR   cancercelllines; CVCL_B2MP
DR   Wikidata; Q110429978
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 DVL2 KO
AC   CVCL_B9H5
SY   Human DVL2 knockout A549
DR   Abcam; ab277903
DR   cancercelllines; CVCL_B9H5
DR   Wikidata; Q112927258
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3086; DVL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 E2F1 KO
AC   CVCL_B9H6
SY   Human E2F1 knockout A549
DR   Abcam; ab287379
DR   cancercelllines; CVCL_B9H6
DR   Wikidata; Q112927259
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 E2F2 KO
AC   CVCL_B9H7
SY   Human E2F2 knockout A549
DR   Abcam; ab288999
DR   cancercelllines; CVCL_B9H7
DR   Wikidata; Q112927260
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3114; E2F2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EBF1 KO
AC   CVCL_B9H8
SY   Human EBF1 knockout A549
DR   Abcam; ab286728
DR   cancercelllines; CVCL_B9H8
DR   Wikidata; Q112927261
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3126; EBF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EBI3 KO
AC   CVCL_B9H9
SY   Human EBI3 knockout A549
DR   Abcam; ab287381
DR   cancercelllines; CVCL_B9H9
DR   Wikidata; Q112927262
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3129; EBI3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EDNRA KO
AC   CVCL_D1W6
SY   Human EDNRA knockout A549
DR   Abcam; ab300926
DR   Wikidata; Q127378866
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3179; EDNRA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 EGF KO
AC   CVCL_B9HA
SY   Human EGF knockout A549
DR   Abcam; ab287385
DR   cancercelllines; CVCL_B9HA
DR   Wikidata; Q112927263
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3229; EGF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EGFR KO
AC   CVCL_B9HB
SY   Human EGFR knockout A549
DR   Abcam; ab286394
DR   cancercelllines; CVCL_B9HB
DR   Wikidata; Q112927264
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EGLN3 KO
AC   CVCL_B9HC
SY   Human EGLN3 knockout A549
DR   Abcam; ab288964
DR   cancercelllines; CVCL_B9HC
DR   Wikidata; Q112927265
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14661; EGLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EGR1 KO
AC   CVCL_B9HD
SY   Human EGR1 knockout A549
DR   Abcam; ab288911
DR   cancercelllines; CVCL_B9HD
DR   Wikidata; Q112927266
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3238; EGR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EHMT1 KO
AC   CVCL_B9HE
SY   Human EHMT1 knockout A549
DR   Abcam; ab287389
DR   cancercelllines; CVCL_B9HE
DR   Wikidata; Q112927267
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EIF2AK2 KO 1
AC   CVCL_B1F6
SY   Human EIF2AK2 (PKR) knockout A549
DR   Abcam; ab266999
DR   cancercelllines; CVCL_B1F6
DR   Wikidata; Q110429979
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EIF2AK2 KO 2
AC   CVCL_B2MQ
SY   Human EIF2AK2 (PKR) knockout A549
DR   Abcam; ab267000
DR   cancercelllines; CVCL_B2MQ
DR   Wikidata; Q110429981
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EIF2AK3 KO
AC   CVCL_B9HF
SY   Human EIF2AK3 knockout A549
DR   Abcam; ab288905
DR   cancercelllines; CVCL_B9HF
DR   Wikidata; Q112927268
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ELK1 KO
AC   CVCL_B9HG
SY   Human ELK1 knockout A549
DR   Abcam; ab288922
DR   cancercelllines; CVCL_B9HG
DR   Wikidata; Q112927269
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ENTPD1 KO
AC   CVCL_B9HH
SY   Human ENTPD1 knockout A549
DR   Abcam; ab288884
DR   cancercelllines; CVCL_B9HH
DR   Wikidata; Q112927270
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3363; ENTPD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EOMES KO
AC   CVCL_B9HI
SY   Human EOMES knockout A549
DR   Abcam; ab288877
DR   cancercelllines; CVCL_B9HI
DR   Wikidata; Q112927272
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3372; EOMES.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EP300 KO
AC   CVCL_B9HJ
SY   Human EP300 knockout A549
DR   Abcam; ab286764
DR   cancercelllines; CVCL_B9HJ
DR   Wikidata; Q112927273
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EPAS1 KO
AC   CVCL_B1F7
SY   Human EPAS1 (HIF-2-alpha) knockout A549
DR   Abcam; ab259774
DR   cancercelllines; CVCL_B1F7
DR   Wikidata; Q110429984
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3374; EPAS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EPC1 KO
AC   CVCL_B9HK
SY   Human EPC1 knockout A549
DR   Abcam; ab288217
DR   cancercelllines; CVCL_B9HK
DR   Wikidata; Q112927274
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19876; EPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EPHA3 KO
AC   CVCL_B9HL
SY   Human EPHA3 knockout A549
DR   Abcam; ab287392
DR   cancercelllines; CVCL_B9HL
DR   Wikidata; Q112927275
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3387; EPHA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EPHB2 KO
AC   CVCL_B9HM
SY   Human EPHB2 knockout A549
DR   Abcam; ab287394
DR   cancercelllines; CVCL_B9HM
DR   Wikidata; Q112927276
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3393; EPHB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EPSTI1 KO 1
AC   CVCL_B2MR
SY   Human EPSTI1 knockout A549
DR   Abcam; ab267182
DR   cancercelllines; CVCL_B2MR
DR   Wikidata; Q110429986
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16465; EPSTI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EPSTI1 KO 2
AC   CVCL_B1F8
SY   Human EPSTI1 knockout A549
DR   Abcam; ab267183
DR   cancercelllines; CVCL_B1F8
DR   Wikidata; Q110429991
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16465; EPSTI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ERBB2 KO
AC   CVCL_B9HN
SY   Human ERBB2 knockout A549
DR   Abcam; ab286455
DR   cancercelllines; CVCL_B9HN
DR   Wikidata; Q112927277
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ERBB3 KO
AC   CVCL_B9HP
SY   Human ERBB3 knockout A549
DR   Abcam; ab286697
DR   cancercelllines; CVCL_B9HP
DR   Wikidata; Q112927278
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ERBB4 KO
AC   CVCL_B9HQ
SY   Human ERBB4 knockout A549
DR   Abcam; ab287397
DR   cancercelllines; CVCL_B9HQ
DR   Wikidata; Q112927279
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3432; ERBB4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ERCC1 KO
AC   CVCL_B2MS
SY   Human ERCC1 knockout A549
DR   Abcam; ab276106
DR   cancercelllines; CVCL_B2MS
DR   Wikidata; Q110429993
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3433; ERCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab276106; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 ERCC4 KO
AC   CVCL_B9HR
SY   Human ERCC4 knockout A549
DR   Abcam; ab287401
DR   cancercelllines; CVCL_B9HR
DR   Wikidata; Q112927280
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3436; ERCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ERCC5 KO
AC   CVCL_B9HS
SY   Human ERCC5 knockout A549
DR   Abcam; ab286645
DR   cancercelllines; CVCL_B9HS
DR   Wikidata; Q112927281
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3437; ERCC5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EREG KO
AC   CVCL_D1W7
SY   Human EREG knockout A549
DR   Abcam; ab300928
DR   Wikidata; Q127378867
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3443; EREG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ERRFI1 KO
AC   CVCL_D1W8
SY   Human ERRFI1 knockout A549
DR   Abcam; ab300930
DR   Wikidata; Q127378868
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18185; ERRFI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ESR1 KO
AC   CVCL_B9HT
SY   Human ESR1 knockout A549
DR   Abcam; ab286700
DR   cancercelllines; CVCL_B9HT
DR   Wikidata; Q112927282
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3467; ESR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ESRRA KO
AC   CVCL_B9HU
SY   Human ESRRA knockout A549
DR   Abcam; ab288834
DR   cancercelllines; CVCL_B9HU
DR   Wikidata; Q112927283
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3471; ESRRA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ETS1 KO
AC   CVCL_B9HV
SY   Human ETS1 knockout A549
DR   Abcam; ab287407
DR   cancercelllines; CVCL_B9HV
DR   Wikidata; Q112927284
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ETV6 KO 1
AC   CVCL_B1F9
SY   Human ETV6 (Tel) knockout A549
DR   Abcam; ab267099
DR   cancercelllines; CVCL_B1F9
DR   Wikidata; Q110429995
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ETV6 KO 2
AC   CVCL_B2MT
SY   Human ETV6 (Tel) knockout A549
DR   Abcam; ab267100
DR   cancercelllines; CVCL_B2MT
DR   Wikidata; Q110429998
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ETV6 KO 3
AC   CVCL_B9UK
SY   Human ETV6 knockout A549
DR   Abcam; ab286765
DR   cancercelllines; CVCL_B9UK
DR   Wikidata; Q112927285
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ETV7 KO 1
AC   CVCL_B1FA
SY   Human ETV7 knockout A549
DR   Abcam; ab267074
DR   cancercelllines; CVCL_B1FA
DR   Wikidata; Q110430000
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18160; ETV7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ETV7 KO 2
AC   CVCL_B2MU
SY   Human ETV7 knockout A549
DR   Abcam; ab267075
DR   cancercelllines; CVCL_B2MU
DR   Wikidata; Q110430002
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18160; ETV7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EZH1 KO
AC   CVCL_B9HW
SY   Human EZH1 knockout A549
DR   Abcam; ab288218
DR   cancercelllines; CVCL_B9HW
DR   Wikidata; Q112927286
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3526; EZH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 EZR KO
AC   CVCL_D1W9
SY   Human EZR knockout A549
DR   Abcam; ab300934
DR   Wikidata; Q127378869
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12691; EZR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 F2R KO
AC   CVCL_D1WA
SY   Human F2R knockout A549
DR   Abcam; ab300936
DR   Wikidata; Q127378870
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 FANCA KO
AC   CVCL_B9HX
SY   Human FANCA knockout A549
DR   Abcam; ab287410
DR   cancercelllines; CVCL_B9HX
DR   Wikidata; Q112927287
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FANCD2 KO
AC   CVCL_B9HY
SY   Human FANCD2 knockout A549
DR   Abcam; ab276107
DR   cancercelllines; CVCL_B9HY
DR   Wikidata; Q112927288
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FAP KO
AC   CVCL_B9HZ
SY   Human FAP knockout A549
DR   Abcam; ab288843
DR   cancercelllines; CVCL_B9HZ
DR   Wikidata; Q112927289
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3590; FAP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FAS KO
AC   CVCL_B9I0
SY   Human FAS knockout A549
DR   Abcam; ab286766
DR   cancercelllines; CVCL_B9I0
DR   Wikidata; Q112927290
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FASN KO
AC   CVCL_D1WB
SY   Human FASN knockout A549
DR   Abcam; ab300941
DR   Wikidata; Q127378871
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3594; FASN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 FBXO38 KO
AC   CVCL_B9I1
SY   Human FBXO38 knockout A549
DR   Abcam; ab286796
DR   cancercelllines; CVCL_B9I1
DR   Wikidata; Q112927291
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28844; FBXO38.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FCER2 KO
AC   CVCL_B9I2
SY   Human FCER2 knockout A549
DR   Abcam; ab287413
DR   cancercelllines; CVCL_B9I2
DR   Wikidata; Q112927292
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3612; FCER2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FCGR2A KO
AC   CVCL_B9I3
SY   Human FCGR2A knockout A549
DR   Abcam; ab287416
DR   cancercelllines; CVCL_B9I3
DR   Wikidata; Q112927293
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3616; FCGR2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FCGR2B KO
AC   CVCL_B9I4
SY   Human FCGR2B knockout A549
DR   Abcam; ab287419
DR   cancercelllines; CVCL_B9I4
DR   Wikidata; Q112927294
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3618; FCGR2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FCGR3A KO
AC   CVCL_B9I5
SY   Human FCGR3A knockout A549
DR   Abcam; ab287422
DR   cancercelllines; CVCL_B9I5
DR   Wikidata; Q112927295
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3619; FCGR3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FDFT1 KO
AC   CVCL_D1WC
SY   Human FDFT1 knockout A549
DR   Abcam; ab300944
DR   Wikidata; Q127378872
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3629; FDFT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 FEN1 KO
AC   CVCL_B9I6
SY   Human FEN1 knockout A549
DR   Abcam; ab286797
DR   cancercelllines; CVCL_B9I6
DR   Wikidata; Q112927296
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3650; FEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FGF2 KO
AC   CVCL_B9I7
SY   Human FGF2 knockout A549
DR   Abcam; ab288995
DR   cancercelllines; CVCL_B9I7
DR   Wikidata; Q112927297
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3676; FGF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FGFR2 KO
AC   CVCL_B9I8
SY   Human FGFR2 knockout A549
DR   Abcam; ab286646
DR   cancercelllines; CVCL_B9I8
DR   Wikidata; Q112927298
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3689; FGFR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FGFR4 KO
AC   CVCL_B9I9
SY   Human FGFR4 knockout A549
DR   Abcam; ab286767
DR   cancercelllines; CVCL_B9I9
DR   Wikidata; Q112927299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FKBP4 KO
AC   CVCL_D1WD
SY   Human FKBP4 knockout A549
DR   Abcam; ab300947
DR   Wikidata; Q127378873
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3720; FKBP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 FLI1 KO
AC   CVCL_B9IA
SY   Human FLI1 knockout A549
DR   Abcam; ab287425
DR   cancercelllines; CVCL_B9IA
DR   Wikidata; Q112927300
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3749; FLI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FLT1 KO
AC   CVCL_B9IB
SY   Human FLT1 knockout A549
DR   Abcam; ab286677
DR   cancercelllines; CVCL_B9IB
DR   Wikidata; Q112927301
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FLT3LG KO
AC   CVCL_B9IC
SY   Human Flt3lg knockout A549
DR   Abcam; ab288878
DR   cancercelllines; CVCL_B9IC
DR   Wikidata; Q112927303
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FLT4 KO
AC   CVCL_B9ID
SY   Human FLT4 knockout A549
DR   Abcam; ab280064
DR   cancercelllines; CVCL_B9ID
DR   Wikidata; Q112927304
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3767; FLT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FMR1 KO
AC   CVCL_B9IE
SY   Human FMR1 knockout A549
DR   Abcam; ab288956
DR   cancercelllines; CVCL_B9IE
DR   Wikidata; Q112927305
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FN1 KO
AC   CVCL_B9IF
SY   Human FN1 knockout A549
DR   Abcam; ab286514
DR   cancercelllines; CVCL_B9IF
DR   Wikidata; Q112927306
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOLH1 KO
AC   CVCL_B9IG
SY   Human FOLH1 knockout A549
DR   Abcam; ab288870
DR   cancercelllines; CVCL_B9IG
DR   Wikidata; Q112927307
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3788; FOLH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOLR1 KO
AC   CVCL_B9IH
SY   Human FOLR1 knockout A549
DR   Abcam; ab288897
DR   cancercelllines; CVCL_B9IH
DR   Wikidata; Q112927308
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOS KO
AC   CVCL_B9II
SY   Human FOS knockout A549
DR   Abcam; ab287426
DR   cancercelllines; CVCL_B9II
DR   Wikidata; Q112927309
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOSL1 KO
AC   CVCL_B9IJ
SY   Human FOSL1 knockout A549
DR   Abcam; ab287431
DR   cancercelllines; CVCL_B9IJ
DR   Wikidata; Q112927310
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXA1 KO
AC   CVCL_B9IK
SY   Human FOXA1 knockout A549
DR   Abcam; ab287433
DR   cancercelllines; CVCL_B9IK
DR   Wikidata; Q112927311
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXA2 KO
AC   CVCL_B9IL
SY   Human FOXA2 knockout A549
DR   Abcam; ab288848
DR   cancercelllines; CVCL_B9IL
DR   Wikidata; Q112927312
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXC1 KO
AC   CVCL_B9IM
SY   Human FOXC1 knockout A549
DR   Abcam; ab288976
DR   cancercelllines; CVCL_B9IM
DR   Wikidata; Q112927313
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3800; FOXC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXC2 KO
AC   CVCL_B9IN
SY   Human FOXC2 knockout A549
DR   Abcam; ab288940
DR   cancercelllines; CVCL_B9IN
DR   Wikidata; Q112927314
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3801; FOXC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXG1 KO
AC   CVCL_B9IP
SY   Human FOXG1 knockout A549
DR   Abcam; ab289005
DR   cancercelllines; CVCL_B9IP
DR   Wikidata; Q112927316
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3811; FOXG1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXM1 KO
AC   CVCL_B9IQ
SY   Human FOXM1 knockout A549
DR   Abcam; ab287437
DR   cancercelllines; CVCL_B9IQ
DR   Wikidata; Q112927317
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXO4 KO
AC   CVCL_B9IR
SY   Human FOXO4 knockout A549
DR   Abcam; ab287440
DR   cancercelllines; CVCL_B9IR
DR   Wikidata; Q112927318
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7139; FOXO4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXP1 KO
AC   CVCL_B9IS
SY   Human FOXP1 knockout A549
DR   Abcam; ab286647
DR   cancercelllines; CVCL_B9IS
DR   Wikidata; Q112927319
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3823; FOXP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 FOXP3 KO
AC   CVCL_B9IT
SY   Human FOXP3 knockout A549
DR   Abcam; ab288994
DR   cancercelllines; CVCL_B9IT
DR   Wikidata; Q112927320
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6106; FOXP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 G6PD KO
AC   CVCL_D1WE
SY   Human G6PD knockout A549
DR   Abcam; ab300951
DR   Wikidata; Q127378874
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4057; G6PD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GABRA1 KO
AC   CVCL_B9IU
SY   Human GABRA1 knockout A549
DR   Abcam; ab286557
DR   cancercelllines; CVCL_B9IU
DR   Wikidata; Q112927321
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4075; GABRA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GABRG2 KO
AC   CVCL_B9IV
SY   Human GABRG2 knockout A549
DR   Abcam; ab286506
DR   cancercelllines; CVCL_B9IV
DR   Wikidata; Q112927322
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4087; GABRG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GAD1 KO
AC   CVCL_D1WF
SY   Human GAD1 knockout A549
DR   Abcam; ab300953
DR   Wikidata; Q127378875
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4092; GAD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GADD45B KO
AC   CVCL_B9IW
SY   Human GADD45B knockout A549
DR   Abcam; ab288977
DR   cancercelllines; CVCL_B9IW
DR   Wikidata; Q112927323
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GATA1 KO
AC   CVCL_B9IX
SY   Human GATA1 knockout A549
DR   Abcam; ab286685
DR   cancercelllines; CVCL_B9IX
DR   Wikidata; Q112927324
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4170; GATA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GATA2 KO
AC   CVCL_B9IY
SY   Human GATA2 knockout A549
DR   Abcam; ab287443
DR   cancercelllines; CVCL_B9IY
DR   Wikidata; Q112927325
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GATA3 KO
AC   CVCL_B9IZ
SY   Human GATA3 knockout A549
DR   Abcam; ab286669
DR   cancercelllines; CVCL_B9IZ
DR   Wikidata; Q112927326
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4172; GATA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GATA4 KO
AC   CVCL_B9J0
SY   Human GATA4 knockout A549
DR   Abcam; ab288895
DR   cancercelllines; CVCL_B9J0
DR   Wikidata; Q112927327
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4173; GATA4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GATA6 KO
AC   CVCL_B9J1
SY   Human GATA6 knockout A549
DR   Abcam; ab288946
DR   cancercelllines; CVCL_B9J1
DR   Wikidata; Q112927328
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4174; GATA6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GBP1 KO
AC   CVCL_B1FB
SY   Human GBP1 knockout A549
DR   Abcam; ab267202
DR   cancercelllines; CVCL_B1FB
DR   Wikidata; Q110430005
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4182; GBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GBP2 KO 1
AC   CVCL_B2MV
SY   Human GBP2 knockout A549
DR   Abcam; ab267218
DR   cancercelllines; CVCL_B2MV
DR   Wikidata; Q110430007
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4183; GBP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GBP2 KO 2
AC   CVCL_B1FC
SY   Human GBP2 knockout A549
DR   Abcam; ab267219
DR   cancercelllines; CVCL_B1FC
DR   Wikidata; Q110430008
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4183; GBP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GBP3 KO
AC   CVCL_B2MW
SY   Human GBP3 knockout A549
DR   Abcam; ab267190
DR   cancercelllines; CVCL_B2MW
DR   Wikidata; Q110430009
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4184; GBP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GBP4 KO 1
AC   CVCL_B1FD
SY   Human GBP4 knockout A549
DR   Abcam; ab267044
DR   cancercelllines; CVCL_B1FD
DR   Wikidata; Q110430010
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20480; GBP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GBP4 KO 2
AC   CVCL_B2MX
SY   Human GBP4 knockout A549
DR   Abcam; ab267045
DR   cancercelllines; CVCL_B2MX
DR   Wikidata; Q110430012
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20480; GBP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GCH1 KO 1
AC   CVCL_B1FE
SY   Human GCH1 knockout A549
DR   Abcam; ab267052
DR   cancercelllines; CVCL_B1FE
DR   Wikidata; Q110430013
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4193; GCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GCH1 KO 2
AC   CVCL_B2MY
SY   Human GCH1 knockout A549
DR   Abcam; ab267053
DR   cancercelllines; CVCL_B2MY
DR   Wikidata; Q110430014
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4193; GCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GCLC KO
AC   CVCL_C7D6
SY   Human GLCL knockout A549
DR   Abcam; ab300956
DR   Wikidata; Q123030393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4311; GCLC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 GCLM KO
AC   CVCL_D1WG
SY   Human GCLM knockout A549
DR   Abcam; ab300959
DR   Wikidata; Q127378876
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4312; GCLM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GGT1 KO
AC   CVCL_D1WH
SY   Human GGT1 knockout A549
DR   Abcam; ab300962
DR   Wikidata; Q127378877
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4250; GGT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GHR KO
AC   CVCL_D1WI
SY   Human GHR knockout A549
DR   Abcam; ab300965
DR   Wikidata; Q127378879
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4263; GHR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GHSR KO
AC   CVCL_D1WJ
SY   Human GHSR knockout A549
DR   Abcam; ab300968
DR   Wikidata; Q127378880
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4267; GHSR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GJB2 KO
AC   CVCL_D1WK
SY   Human GJB2 knockout A549
DR   Abcam; ab300970
DR   Wikidata; Q127378881
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4284; GJB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GLDC KO
AC   CVCL_D1WL
SY   Human GLDC knockout A549
DR   Abcam; ab300972
DR   Wikidata; Q127378882
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4313; GLDC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GLI1 KO
AC   CVCL_B9J2
SY   Human GLI1 knockout A549
DR   Abcam; ab277815
DR   cancercelllines; CVCL_B9J2
DR   Wikidata; Q112927329
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4317; GLI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GLI2 KO
AC   CVCL_B9J3
SY   Human GLI2 knockout A549
DR   Abcam; ab277816
DR   cancercelllines; CVCL_B9J3
DR   Wikidata; Q112927330
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4318; GLI2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GLI3 KO
AC   CVCL_B9J4
SY   Human GLI3 knockout A549
DR   Abcam; ab289524
DR   cancercelllines; CVCL_B9J4
DR   Wikidata; Q112927331
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4319; GLI3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GLS KO
AC   CVCL_B9J5
SY   Human GLS knockout A549
DR   Abcam; ab287446
DR   cancercelllines; CVCL_B9J5
DR   Wikidata; Q112927332
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4331; GLS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GMPR KO 1
AC   CVCL_B1FF
SY   Human GMPR (GMPR1) knockout A549
DR   Abcam; ab267103
DR   cancercelllines; CVCL_B1FF
DR   Wikidata; Q110430015
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4376; GMPR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GMPR KO 2
AC   CVCL_B2MZ
SY   Human GMPR (GMPR1) knockout A549
DR   Abcam; ab267104
DR   cancercelllines; CVCL_B2MZ
DR   Wikidata; Q110430016
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4376; GMPR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GOT1 KO
AC   CVCL_D1WM
SY   Human GOT1 knockout A549
DR   Abcam; ab300974
DR   Wikidata; Q127378883
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4432; GOT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GP1BA KO
AC   CVCL_B9J6
SY   Human GP1BA knockout A549
DR   Abcam; ab287448
DR   cancercelllines; CVCL_B9J6
DR   Wikidata; Q112927333
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4439; GP1BA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GPC1 KO
AC   CVCL_B9J7
SY   Human GPC1 knockout A549
DR   Abcam; ab287450
DR   cancercelllines; CVCL_B9J7
DR   Wikidata; Q112927334
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4449; GPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GPER1 KO
AC   CVCL_B9J8
SY   Human GPER1 knockout A549
DR   Abcam; ab288967
DR   cancercelllines; CVCL_B9J8
DR   Wikidata; Q112927335
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4485; GPER1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GPNMB KO
AC   CVCL_B9J9
SY   Human GPNMB knockout A549
DR   Abcam; ab287453
DR   cancercelllines; CVCL_B9J9
DR   Wikidata; Q112927336
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GRIN2B KO
AC   CVCL_D1WN
SY   Human GRIN2B knockout A549
DR   Abcam; ab300976
DR   Wikidata; Q127378884
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GSK3B KO
AC   CVCL_B9JA
SY   Human GSK3B (GSK3 beta) knockout A549
DR   Abcam; ab277904
DR   cancercelllines; CVCL_B9JA
DR   Wikidata; Q112927337
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GSR KO
AC   CVCL_B9JB
SY   Human GSR knockout A549
DR   Abcam; ab287458
DR   cancercelllines; CVCL_B9JB
DR   Wikidata; Q112927338
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4623; GSR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 GSTP1 KO
AC   CVCL_D1WP
SY   Human GSTP1 knockout A549
DR   Abcam; ab300979
DR   Wikidata; Q127378885
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4638; GSTP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 GZMB KO
AC   CVCL_B9JC
SY   Human GZMB knockout A549
DR   Abcam; ab289016
DR   cancercelllines; CVCL_B9JC
DR   Wikidata; Q112927339
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4709; GZMB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 H1-2 KO
AC   CVCL_B1FK
SY   Human HIST1H1C (Histone H1.2) knockout A549
DR   Abcam; ab261873
DR   cancercelllines; CVCL_B1FK
DR   Wikidata; Q110430017
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 H2BC21 KO
AC   CVCL_B9JD
SY   Human HIST2H2BE knockout A549
DR   Abcam; ab289047
DR   cancercelllines; CVCL_B9JD
DR   Wikidata; Q112927340
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4760; H2BC21.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HAPLN3 KO 1
AC   CVCL_B1FG
SY   Human HAPLN3 knockout A549
DR   Abcam; ab267058
DR   cancercelllines; CVCL_B1FG
DR   Wikidata; Q110430018
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21446; HAPLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HAPLN3 KO 2
AC   CVCL_B2N0
SY   Human HAPLN3 knockout A549
DR   Abcam; ab267059
DR   cancercelllines; CVCL_B2N0
DR   Wikidata; Q110430019
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21446; HAPLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HAT1 KO
AC   CVCL_B9JE
SY   Human HAT1 knockout A549
DR   Abcam; ab287461
DR   cancercelllines; CVCL_B9JE
DR   Wikidata; Q112927341
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4821; HAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HAVCR2 KO
AC   CVCL_B9JF
SY   Human HAVCR2 knockout A549
DR   Abcam; ab288930
DR   cancercelllines; CVCL_B9JF
DR   Wikidata; Q112927342
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18437; HAVCR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HDAC1 KO
AC   CVCL_B9JG
SY   Human HDAC1 knockout A549
DR   Abcam; ab286486
DR   cancercelllines; CVCL_B9JG
DR   Wikidata; Q112927343
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HDAC2 KO
AC   CVCL_B9JH
SY   Human HDAC2 knockout A549
DR   Abcam; ab287463
DR   cancercelllines; CVCL_B9JH
DR   Wikidata; Q112927344
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HDAC4 KO
AC   CVCL_B9JI
SY   Human HDAC4 knockout A549
DR   Abcam; ab286674
DR   cancercelllines; CVCL_B9JI
DR   Wikidata; Q112927345
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14063; HDAC4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HDAC5 KO
AC   CVCL_B9JJ
SY   Human HDAC5 knockout A549
DR   Abcam; ab286684
DR   cancercelllines; CVCL_B9JJ
DR   Wikidata; Q112927346
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14068; HDAC5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HDAC6 KO
AC   CVCL_B9JK
SY   Human HDAC6 knockout A549
DR   Abcam; ab287467
DR   cancercelllines; CVCL_B9JK
DR   Wikidata; Q112927347
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HELQ KO
AC   CVCL_B9JL
SY   Human HELQ knockout A549
DR   Abcam; ab288219
DR   cancercelllines; CVCL_B9JL
DR   Wikidata; Q112927348
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18536; HELQ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HELZ2 KO 1
AC   CVCL_B1FH
SY   Human HELZ2 knockout A549
DR   Abcam; ab267036
DR   cancercelllines; CVCL_B1FH
DR   Wikidata; Q110430020
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30021; HELZ2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HELZ2 KO 2
AC   CVCL_B2N1
SY   Human HELZ2 knockout A549
DR   Abcam; ab267037
DR   cancercelllines; CVCL_B2N1
DR   Wikidata; Q110430021
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30021; HELZ2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HERC5 KO 1
AC   CVCL_B1FI
SY   Human HERC5 knockout A549
DR   Abcam; ab267200
DR   cancercelllines; CVCL_B1FI
DR   Wikidata; Q110430023
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24368; HERC5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HERC5 KO 2
AC   CVCL_B2N2
SY   Human HERC5 knockout A549
DR   Abcam; ab267201
DR   cancercelllines; CVCL_B2N2
DR   Wikidata; Q110430025
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24368; HERC5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HERC6 KO
AC   CVCL_B1FJ
SY   Human HERC6 knockout A549
DR   Abcam; ab267001
DR   cancercelllines; CVCL_B1FJ
DR   Wikidata; Q110430026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26072; HERC6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HES4 KO
AC   CVCL_B2N3
SY   Human HES4 knockout A549
DR   Abcam; ab267134
DR   cancercelllines; CVCL_B2N3
DR   Wikidata; Q110430027
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24149; HES4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HEY1 KO
AC   CVCL_B9JM
SY   Human HEY1 knockout A549
DR   Abcam; ab286504
DR   cancercelllines; CVCL_B9JM
DR   Wikidata; Q112927349
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HGF KO
AC   CVCL_B9JN
SY   Human HGF knockout A549
DR   Abcam; ab287469
DR   cancercelllines; CVCL_B9JN
DR   Wikidata; Q112927350
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4893; HGF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HGS KO
AC   CVCL_D1WQ
SY   Human HGS knockout A549
DR   Abcam; ab300982
DR   Wikidata; Q127378886
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4897; HGS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 HIF1A KO
AC   CVCL_B9JP
SY   Human HIF1A (HIF-1 alpha) knockout A549
DR   Abcam; ab280798
DR   cancercelllines; CVCL_B9JP
DR   Wikidata; Q112927351
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HLA-A KO
AC   CVCL_B9JQ
SY   Human HLA-A knockout A549
DR   Abcam; ab287473
DR   cancercelllines; CVCL_B9JQ
DR   Wikidata; Q112927352
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HLA-DRA KO
AC   CVCL_B9JR
SY   Human HLA-DRA knockout A549
DR   Abcam; ab287476
DR   cancercelllines; CVCL_B9JR
DR   Wikidata; Q112927353
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4947; HLA-DRA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HLA-E KO 1
AC   CVCL_B2N4
SY   Human HLA-E (HLA E) knockout A549
DR   Abcam; ab267080
DR   cancercelllines; CVCL_B2N4
DR   Wikidata; Q110430028
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HLA-E KO 2
AC   CVCL_B1FL
SY   Human HLA-E (HLA E) knockout A549
DR   Abcam; ab267081
DR   cancercelllines; CVCL_B1FL
DR   Wikidata; Q110430029
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HLA-G KO
AC   CVCL_B9JS
SY   Human HLA-G knockout A549
DR   Abcam; ab288985
DR   cancercelllines; CVCL_B9JS
DR   Wikidata; Q112927354
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4964; HLA-G.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HMGA2 KO
AC   CVCL_B9JT
SY   Human HMGA2 knockout A549
DR   Abcam; ab287479
DR   cancercelllines; CVCL_B9JT
DR   Wikidata; Q112927355
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5009; HMGA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HMGB3 KO
AC   CVCL_D1WR
SY   Human HMGB3 knockout A549
DR   Abcam; ab300984
DR   Wikidata; Q127378887
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5004; HMGB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 HMMR KO
AC   CVCL_D1WS
SY   Human HMMR knockout A549
DR   Abcam; ab300986
DR   Wikidata; Q127378888
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5012; HMMR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 HMOX1 KO
AC   CVCL_B2N5
SY   Human HMOX1 (Heme Oxygenase 1) knockout A549
DR   Abcam; ab269503
DR   cancercelllines; CVCL_B2N5
DR   Wikidata; Q110430031
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5013; HMOX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HNF1A KO
AC   CVCL_B9JU
SY   Human HNF1A knockout A549
DR   Abcam; ab286713
DR   cancercelllines; CVCL_B9JU
DR   Wikidata; Q112927356
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11621; HNF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HNF4A KO
AC   CVCL_B9JV
SY   Human HNF4A knockout A549
DR   Abcam; ab288931
DR   cancercelllines; CVCL_B9JV
DR   Wikidata; Q112927357
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5024; HNF4A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HOXA9 KO
AC   CVCL_B9JW
SY   Human HOXA9 knockout A549
DR   Abcam; ab287487
DR   cancercelllines; CVCL_B9JW
DR   Wikidata; Q112927358
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HPRT1 KO
AC   CVCL_D1WT
SY   Human HPRT1 knockout A549
DR   Abcam; ab300990
DR   Wikidata; Q127378889
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5157; HPRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 HPSE KO
AC   CVCL_B9JX
SY   Human HPSE knockout A549
DR   Abcam; ab289013
DR   cancercelllines; CVCL_B9JX
DR   Wikidata; Q112927359
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5164; HPSE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HRAS KO
AC   CVCL_B9JY
SY   Human HRAS knockout A549
DR   Abcam; ab286592
DR   cancercelllines; CVCL_B9JY
DR   Wikidata; Q112927360
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HTR3D KO 1
AC   CVCL_B1FM
SY   Human HTR3D (5HT3D Receptor) knockout A549
DR   Abcam; ab266992
DR   cancercelllines; CVCL_B1FM
DR   Wikidata; Q110430033
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24004; HTR3D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 HTR3D KO 2
AC   CVCL_B2N6
SY   Human HTR3D (5HT3D Receptor) knockout A549
DR   Abcam; ab266993
DR   cancercelllines; CVCL_B2N6
DR   Wikidata; Q110430036
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24004; HTR3D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ICAM1 KO
AC   CVCL_B9JZ
SY   Human ICAM1 knockout A549
DR   Abcam; ab289009
DR   cancercelllines; CVCL_B9JZ
DR   Wikidata; Q112927361
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ICOS KO
AC   CVCL_B9K0
SY   Human ICOS knockout A549
DR   Abcam; ab287490
DR   cancercelllines; CVCL_B9K0
DR   Wikidata; Q112927362
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5351; ICOS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ICOSLG KO
AC   CVCL_B9K1
SY   Human ICOSLG knockout A549
DR   Abcam; ab289055
DR   cancercelllines; CVCL_B9K1
DR   Wikidata; Q112927363
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17087; ICOSLG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IDH1 KO
AC   CVCL_B9K2
SY   Human IDH1 knockout A549
DR   Abcam; ab287493
DR   cancercelllines; CVCL_B9K2
DR   Wikidata; Q112927364
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IDH2 KO
AC   CVCL_B9K3
SY   Human IDH2 knockout A549
DR   Abcam; ab287497
DR   cancercelllines; CVCL_B9K3
DR   Wikidata; Q112927365
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IDO1 KO 1
AC   CVCL_B1FN
SY   Human IDO1 (Indoleamine 2,3-dioxygenase) knockout A549
DR   Abcam; ab266949
DR   cancercelllines; CVCL_B1FN
DR   Wikidata; Q110430037
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6059; IDO1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 IDO1 KO 2
AC   CVCL_B2N7
SY   Human IDO1 (Indoleamine 2,3-dioxygenase) knockout A549
DR   Abcam; ab266950
DR   cancercelllines; CVCL_B2N7
DR   Wikidata; Q110430038
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6059; IDO1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab266950; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   Abcam A-549 IFI16 KO 1
AC   CVCL_B1FP
SY   Human IFI16 knockout A549
DR   Abcam; ab267142
DR   cancercelllines; CVCL_B1FP
DR   Wikidata; Q110430039
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5395; IFI16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI16 KO 2
AC   CVCL_B2N8
SY   Human IFI16 knockout A549
DR   Abcam; ab267143
DR   cancercelllines; CVCL_B2N8
DR   Wikidata; Q110430040
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5395; IFI16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI27 KO
AC   CVCL_B1FQ
SY   Human IFI27 knockout A549
DR   Abcam; ab267089
DR   cancercelllines; CVCL_B1FQ
DR   Wikidata; Q110430041
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5397; IFI27.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI35 KO
AC   CVCL_B2N9
SY   Human IFI35 knockout A549
DR   Abcam; ab267172
DR   cancercelllines; CVCL_B2N9
DR   Wikidata; Q110430043
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5399; IFI35.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI44 KO 1
AC   CVCL_B1FR
SY   Human IFI44 knockout A549
DR   Abcam; ab267029
DR   cancercelllines; CVCL_B1FR
DR   Wikidata; Q110430044
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16938; IFI44.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI44 KO 2
AC   CVCL_B2NA
SY   Human IFI44 knockout A549
DR   Abcam; ab267030
DR   cancercelllines; CVCL_B2NA
DR   Wikidata; Q110430045
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16938; IFI44.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI44L KO 1
AC   CVCL_B1FS
SY   Human IFI44L knockout A549
DR   Abcam; ab267163
DR   cancercelllines; CVCL_B1FS
DR   Wikidata; Q110430046
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17817; IFI44L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI44L KO 2
AC   CVCL_B2NB
SY   Human IFI44L knockout A549
DR   Abcam; ab267164
DR   cancercelllines; CVCL_B2NB
DR   Wikidata; Q110430047
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17817; IFI44L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI6 KO 1
AC   CVCL_B1FT
SY   Human IFI6 knockout A549
DR   Abcam; ab267076
DR   cancercelllines; CVCL_B1FT
DR   Wikidata; Q110430048
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4054; IFI6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFI6 KO 2
AC   CVCL_B2NC
SY   Human IFI6 knockout A549
DR   Abcam; ab267077
DR   cancercelllines; CVCL_B2NC
DR   Wikidata; Q110430049
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4054; IFI6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFIH1 KO 1
AC   CVCL_B1FU
SY   Human IFIH1 (MDA5) knockout A549
DR   Abcam; ab266997
DR   cancercelllines; CVCL_B1FU
DR   Wikidata; Q110430050
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFIH1 KO 2
AC   CVCL_B2ND
SY   Human IFIH1 (MDA5) knockout A549
DR   Abcam; ab266998
DR   cancercelllines; CVCL_B2ND
DR   Wikidata; Q110430051
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFIT2 KO 1
AC   CVCL_B1FV
SY   Human IFIT2 knockout A549
DR   Abcam; ab267137
DR   cancercelllines; CVCL_B1FV
DR   Wikidata; Q110430052
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5409; IFIT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFIT2 KO 2
AC   CVCL_B2NE
SY   Human IFIT2 knockout A549
DR   Abcam; ab267138
DR   cancercelllines; CVCL_B2NE
DR   Wikidata; Q110430053
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5409; IFIT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFIT3 KO
AC   CVCL_B1FW
SY   Human IFIT3 (P60) knockout A549
DR   Abcam; ab267009
DR   cancercelllines; CVCL_B1FW
DR   Wikidata; Q110430054
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5411; IFIT3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFIT5 KO 1
AC   CVCL_B2NF
SY   Human IFIT5 knockout A549
DR   Abcam; ab267022
DR   cancercelllines; CVCL_B2NF
DR   Wikidata; Q110430055
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13328; IFIT5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFIT5 KO 2
AC   CVCL_B1FX
SY   Human IFIT5 knockout A549
DR   Abcam; ab267023
DR   cancercelllines; CVCL_B1FX
DR   Wikidata; Q110430056
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13328; IFIT5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFITM1 KO
AC   CVCL_B9K4
SY   Human IFITM1 knockout A549
DR   Abcam; ab289048
DR   cancercelllines; CVCL_B9K4
DR   Wikidata; Q112927366
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFNAR1 KO
AC   CVCL_B9K5
SY   Human IFNAR1 knockout A549
DR   Abcam; ab288934
DR   cancercelllines; CVCL_B9K5
DR   Wikidata; Q112927367
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFNB1 KO
AC   CVCL_B9K6
SY   Human IFNB1 knockout A549
DR   Abcam; ab287499
DR   cancercelllines; CVCL_B9K6
DR   Wikidata; Q112927368
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5434; IFNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFNGR1 KO
AC   CVCL_B9K7
SY   Human IFNGR1 knockout A549
DR   Abcam; ab287503
DR   cancercelllines; CVCL_B9K7
DR   Wikidata; Q112927369
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFNGR2 KO
AC   CVCL_B9K8
SY   Human IFNGR2 knockout A549
DR   Abcam; ab287506
DR   cancercelllines; CVCL_B9K8
DR   Wikidata; Q112927370
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IFNL3 KO
AC   CVCL_B2NG
SY   Human IFNL3 knockout A549
DR   Abcam; ab266972
DR   cancercelllines; CVCL_B2NG
DR   Wikidata; Q110430057
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18365; IFNL3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IGF1 KO
AC   CVCL_B9K9
SY   Human IGF1 knockout A549
DR   Abcam; ab286480
DR   cancercelllines; CVCL_B9K9
DR   Wikidata; Q112927371
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5464; IGF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IGF2BP1 KO
AC   CVCL_B9KA
SY   Human IGF2BP1 knockout A549
DR   Abcam; ab288943
DR   cancercelllines; CVCL_B9KA
DR   Wikidata; Q112927372
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28866; IGF2BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IGF2BP2 KO
AC   CVCL_B9KB
SY   Human IGF2BP2 knockout A549
DR   Abcam; ab287512
DR   cancercelllines; CVCL_B9KB
DR   Wikidata; Q112927373
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IGF2BP3 KO
AC   CVCL_B9KC
SY   Human IGF2BP3 knockout A549
DR   Abcam; ab289020
DR   cancercelllines; CVCL_B9KC
DR   Wikidata; Q112927374
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IGF2R KO
AC   CVCL_D1WU
SY   Human IGF2R knockout A549
DR   Abcam; ab300995
DR   Wikidata; Q127378890
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5467; IGF2R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 IHH KO
AC   CVCL_B9KD
SY   Human IHH knockout A549
DR   Abcam; ab289528
DR   cancercelllines; CVCL_B9KD
DR   Wikidata; Q112927375
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5956; IHH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IKBKE KO
AC   CVCL_B9KE
SY   Human IKBKE knockout A549
DR   Abcam; ab289023
DR   cancercelllines; CVCL_B9KE
DR   Wikidata; Q112927376
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL12A KO
AC   CVCL_B9KF
SY   Human IL12A knockout A549
DR   Abcam; ab287516
DR   cancercelllines; CVCL_B9KF
DR   Wikidata; Q112927377
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL15 KO
AC   CVCL_B9KG
SY   Human IL15 knockout A549
DR   Abcam; ab289014
DR   cancercelllines; CVCL_B9KG
DR   Wikidata; Q112927378
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5977; IL15.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL15RA KO 1
AC   CVCL_B1FY
SY   Human IL15RA knockout A549
DR   Abcam; ab266982
DR   cancercelllines; CVCL_B1FY
DR   Wikidata; Q110430058
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL15RA KO 2
AC   CVCL_B2NH
SY   Human IL15RA knockout A549
DR   Abcam; ab266983
DR   cancercelllines; CVCL_B2NH
DR   Wikidata; Q110430059
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL17A KO
AC   CVCL_B9KH
SY   Human IL17A knockout A549
DR   Abcam; ab288950
DR   cancercelllines; CVCL_B9KH
DR   Wikidata; Q112927379
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5981; IL17A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL17RA KO
AC   CVCL_D1WV
SY   Human IL17RA knockout A549
DR   Abcam; ab300997
DR   Wikidata; Q127378891
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5985; IL17RA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 IL18 KO
AC   CVCL_B9KI
SY   Human IL18 knockout A549
DR   Abcam; ab287521
DR   cancercelllines; CVCL_B9KI
DR   Wikidata; Q112927380
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5986; IL18.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL1A KO
AC   CVCL_B9KJ
SY   Human IL1A knockout A549
DR   Abcam; ab287524
DR   cancercelllines; CVCL_B9KJ
DR   Wikidata; Q112927381
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5991; IL1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL1B KO
AC   CVCL_B9KK
SY   Human IL1B knockout A549
DR   Abcam; ab287527
DR   cancercelllines; CVCL_B9KK
DR   Wikidata; Q112927382
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL1RL1 KO
AC   CVCL_D1WW
SY   Human IL1RL1 knockout A549
DR   Abcam; ab300999
DR   Wikidata; Q127378892
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5998; IL1RL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 IL23A KO
AC   CVCL_B9KL
SY   Human IL23A knockout A549
DR   Abcam; ab288838
DR   cancercelllines; CVCL_B9KL
DR   Wikidata; Q112927383
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15488; IL23A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL23R KO
AC   CVCL_B9KM
SY   Human IL23R knockout A549
DR   Abcam; ab288975
DR   cancercelllines; CVCL_B9KM
DR   Wikidata; Q112927384
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19100; IL23R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL27 KO
AC   CVCL_B9KN
SY   Human IL27 knockout A549
DR   Abcam; ab287531
DR   cancercelllines; CVCL_B9KN
DR   Wikidata; Q112927385
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19157; IL27.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL2RB KO
AC   CVCL_B9KP
SY   Human IL2RB knockout A549
DR   Abcam; ab287539
DR   cancercelllines; CVCL_B9KP
DR   Wikidata; Q112927386
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6009; IL2RB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL3RA KO
AC   CVCL_B9KQ
SY   Human IL3RA knockout A549
DR   Abcam; ab287545
DR   cancercelllines; CVCL_B9KQ
DR   Wikidata; Q112927387
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6012; IL3RA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL6 KO
AC   CVCL_B1FZ
SY   Human IL-6 knockout A549
DR   Abcam; ab273751
DR   cancercelllines; CVCL_B1FZ
DR   Wikidata; Q110430060
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6018; IL6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL6R KO
AC   CVCL_B9KR
SY   Human IL6R knockout A549
DR   Abcam; ab287549
DR   cancercelllines; CVCL_B9KR
DR   Wikidata; Q112927389
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL6ST KO
AC   CVCL_B2NI
SY   Human IL6ST (CD130/gp130) knockout A549
DR   Abcam; ab266938
DR   cancercelllines; CVCL_B2NI
DR   Wikidata; Q110430061
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL7R KO
AC   CVCL_B9KS
SY   Human IL7R knockout A549
DR   Abcam; ab286679
DR   cancercelllines; CVCL_B9KS
DR   Wikidata; Q112927390
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6024; IL7R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IL9 KO
AC   CVCL_B9KT
SY   Human IL9 knockout A549
DR   Abcam; ab288979
DR   cancercelllines; CVCL_B9KT
DR   Wikidata; Q112927391
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6029; IL9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 INHBA KO
AC   CVCL_B9KU
SY   Human INHBA knockout A549
DR   Abcam; ab277899
DR   cancercelllines; CVCL_B9KU
DR   Wikidata; Q112927392
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6066; INHBA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 INPP5D KO
AC   CVCL_B9KV
SY   Human INPP5D knockout A549
DR   Abcam; ab287554
DR   cancercelllines; CVCL_B9KV
DR   Wikidata; Q112927393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6079; INPP5D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 INPPL1 KO
AC   CVCL_D1WX
SY   Human INPPL1 knockout A549
DR   Abcam; ab301003
DR   Wikidata; Q127378893
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6080; INPPL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 IQGAP1 KO
AC   CVCL_B9KW
SY   Human IQGAP1 knockout A549
DR   Abcam; ab288840
DR   cancercelllines; CVCL_B9KW
DR   Wikidata; Q112927394
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6110; IQGAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRAK1 KO
AC   CVCL_B9KX
SY   Human IRAK1 knockout A549
DR   Abcam; ab288974
DR   cancercelllines; CVCL_B9KX
DR   Wikidata; Q112927395
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRAK4 KO
AC   CVCL_B9KY
SY   Human IRAK4 knockout A549
DR   Abcam; ab287555
DR   cancercelllines; CVCL_B9KY
DR   Wikidata; Q112927396
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF1 KO
AC   CVCL_B1G0
SY   Human IRF1 knockout A549
DR   Abcam; ab267042
DR   cancercelllines; CVCL_B1G0
DR   Wikidata; Q110430062
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF2 KO 1
AC   CVCL_B2NJ
SY   Human IRF2 knockout A549
DR   Abcam; ab267015
DR   cancercelllines; CVCL_B2NJ
DR   Wikidata; Q110430063
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF2 KO 2
AC   CVCL_B1G1
SY   Human IRF2 knockout A549
DR   Abcam; ab267016
DR   cancercelllines; CVCL_B1G1
DR   Wikidata; Q110430064
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF3 KO 1
AC   CVCL_B2NK
SY   Human IRF3 knockout A549
DR   Abcam; ab267097
DR   cancercelllines; CVCL_B2NK
DR   Wikidata; Q110430065
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF3 KO 2
AC   CVCL_B1G2
SY   Human IRF3 knockout A549
DR   Abcam; ab267098
DR   cancercelllines; CVCL_B1G2
DR   Wikidata; Q110430066
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF4 KO
AC   CVCL_B9KZ
SY   Human IRF4 knockout A549
DR   Abcam; ab287560
DR   cancercelllines; CVCL_B9KZ
DR   Wikidata; Q112927397
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6119; IRF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF5 KO
AC   CVCL_D1WY
SY   Human IRF5 knockout A549
DR   Abcam; ab301006
DR   Wikidata; Q127378894
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6120; IRF5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 IRF7 KO 1
AC   CVCL_B2NL
SY   Human IRF7 knockout A549
DR   Abcam; ab267210
DR   cancercelllines; CVCL_B2NL
DR   Wikidata; Q110430067
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF7 KO 2
AC   CVCL_B1G3
SY   Human IRF7 knockout A549
DR   Abcam; ab267211
DR   cancercelllines; CVCL_B1G3
DR   Wikidata; Q110430068
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRF9 KO
AC   CVCL_B2NM
SY   Human IRF9 (Interferon regulatory factor 9) knockout A549
DR   Abcam; ab267119
DR   cancercelllines; CVCL_B2NM
DR   Wikidata; Q110430069
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6131; IRF9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 IRS1 KO
AC   CVCL_D1WZ
SY   Human IRS1 knockout A549
DR   Abcam; ab301008
DR   Wikidata; Q127378895
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6125; IRS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ISM1 KO 1
AC   CVCL_B1G4
SY   Human ISM1 knockout A549
DR   Abcam; ab267122
DR   cancercelllines; CVCL_B1G4
DR   Wikidata; Q110430070
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16213; ISM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ISM1 KO 2
AC   CVCL_B2NN
SY   Human ISM1 knockout A549
DR   Abcam; ab267123
DR   cancercelllines; CVCL_B2NN
DR   Wikidata; Q110430071
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16213; ISM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGA2 KO
AC   CVCL_B9L0
SY   Human ITGA2 knockout A549
DR   Abcam; ab287562
DR   cancercelllines; CVCL_B9L0
DR   Wikidata; Q112927398
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGA3 KO
AC   CVCL_D1X0
SY   Human ITGA3 knockout A549
DR   Abcam; ab301010
DR   Wikidata; Q127378896
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6139; ITGA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ITGA5 KO
AC   CVCL_D1X1
SY   Human ITGA5 knockout A549
DR   Abcam; ab301013
DR   Wikidata; Q127378897
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ITGAE KO
AC   CVCL_B9L1
SY   Human ITGAE knockout A549
DR   Abcam; ab287566
DR   cancercelllines; CVCL_B9L1
DR   Wikidata; Q112927399
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGAL KO
AC   CVCL_B9L2
SY   Human ITGAL knockout A549
DR   Abcam; ab287569
DR   cancercelllines; CVCL_B9L2
DR   Wikidata; Q112927400
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6148; ITGAL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGAM KO
AC   CVCL_B9L3
SY   Human ITGAM knockout A549
DR   Abcam; ab287572
DR   cancercelllines; CVCL_B9L3
DR   Wikidata; Q112927401
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGAV KO
AC   CVCL_B9L4
SY   Human ITGAV knockout A549
DR   Abcam; ab286515
DR   cancercelllines; CVCL_B9L4
DR   Wikidata; Q112927402
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6150; ITGAV.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGAX KO
AC   CVCL_B9L5
SY   Human ITGAX knockout A549
DR   Abcam; ab287575
DR   cancercelllines; CVCL_B9L5
DR   Wikidata; Q112927403
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6152; ITGAX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGB1 KO
AC   CVCL_B9L6
SY   Human ITGB1 knockout A549
DR   Abcam; ab286593
DR   cancercelllines; CVCL_B9L6
DR   Wikidata; Q112927404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITGB2 KO
AC   CVCL_D1X2
SY   Human ITGB2 knockout A549
DR   Abcam; ab301015
DR   Wikidata; Q127378898
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6155; ITGB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ITGB3 KO
AC   CVCL_D1X3
SY   Human ITGB3 knockout A549
DR   Abcam; ab301017
DR   Wikidata; Q127378899
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6156; ITGB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ITGB4 KO
AC   CVCL_D1X4
SY   Human ITGB4 knockout A549
DR   Abcam; ab301019
DR   Wikidata; Q127378900
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6158; ITGB4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 ITK KO
AC   CVCL_B9L7
SY   Human ITK knockout A549
DR   Abcam; ab286731
DR   cancercelllines; CVCL_B9L7
DR   Wikidata; Q112927405
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6171; ITK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ITPR1 KO
AC   CVCL_B9L8
SY   Human ITPR1 knockout A549
DR   Abcam; ab286552
DR   cancercelllines; CVCL_B9L8
DR   Wikidata; Q112927406
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 JAK1 KO
AC   CVCL_B9L9
SY   Human JAK1 knockout A549
DR   Abcam; ab286648
DR   cancercelllines; CVCL_B9L9
DR   Wikidata; Q112927407
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 JAK2 KO
AC   CVCL_B1G5
SY   Human JAK2 knockout A549
DR   Abcam; ab267113
DR   cancercelllines; CVCL_B1G5
DR   Wikidata; Q110430072
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 JAK3 KO
AC   CVCL_B9LA
SY   Human JAK3 knockout A549
DR   Abcam; ab286649
DR   cancercelllines; CVCL_B9LA
DR   Wikidata; Q112927408
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6193; JAK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 JARID2 KO
AC   CVCL_B9LB
SY   Human JARID2 knockout A549
DR   Abcam; ab288852
DR   cancercelllines; CVCL_B9LB
DR   Wikidata; Q112927409
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6196; JARID2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 JUNB KO
AC   CVCL_D1X5
SY   Human JUNB knockout A549
DR   Abcam; ab301023
DR   Wikidata; Q127378901
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6205; JUNB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 JUND KO
AC   CVCL_D1X6
SY   Human JUND knockout A549
DR   Abcam; ab301025
DR   Wikidata; Q127378902
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6206; JUND.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 KAT2A KO
AC   CVCL_B9LC
SY   Human KAT2A knockout A549
DR   Abcam; ab287576
DR   cancercelllines; CVCL_B9LC
DR   Wikidata; Q112927410
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4201; KAT2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KAT2B KO
AC   CVCL_B9LD
SY   Human KAT2B knockout A549
DR   Abcam; ab287580
DR   cancercelllines; CVCL_B9LD
DR   Wikidata; Q112927411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KCNQ1 KO
AC   CVCL_D1X7
SY   Human KCNQ1 knockout A549
DR   Abcam; ab301028
DR   Wikidata; Q127378903
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 KDM1A KO
AC   CVCL_B9LE
SY   Human KDM1A knockout A549
DR   Abcam; ab287584
DR   cancercelllines; CVCL_B9LE
DR   Wikidata; Q112927412
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KDM3A KO
AC   CVCL_B9LF
SY   Human KDM3A knockout A549
DR   Abcam; ab287587
DR   cancercelllines; CVCL_B9LF
DR   Wikidata; Q112927413
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20815; KDM3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KDM5A KO
AC   CVCL_B9LG
SY   Human KDM5A knockout A549
DR   Abcam; ab287590
DR   cancercelllines; CVCL_B9LG
DR   Wikidata; Q112927414
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KDM5B KO
AC   CVCL_B9LH
SY   Human KDM5B knockout A549
DR   Abcam; ab287593
DR   cancercelllines; CVCL_B9LH
DR   Wikidata; Q112927415
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KDM6A KO
AC   CVCL_B9LI
SY   Human KDM6A knockout A549
DR   Abcam; ab287596
DR   cancercelllines; CVCL_B9LI
DR   Wikidata; Q112927416
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KDM7A KO 1
AC   CVCL_B2NP
SY   Human KDM7A (JHDM1D) knockout A549
DR   Abcam; ab267032
DR   cancercelllines; CVCL_B2NP
DR   Wikidata; Q110430074
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22224; KDM7A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KDM7A KO 2
AC   CVCL_B1G6
SY   Human KDM7A (JHDM1D) knockout A549
DR   Abcam; ab267033
DR   cancercelllines; CVCL_B1G6
DR   Wikidata; Q110430076
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22224; KDM7A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KEAP1 KO
AC   CVCL_B9LJ
SY   Human KEAP1 knockout A549
DR   Abcam; ab286671
DR   cancercelllines; CVCL_B9LJ
DR   Wikidata; Q112927417
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KIT KO
AC   CVCL_B9LK
SY   Human KIT knockout A549
DR   Abcam; ab286745
DR   cancercelllines; CVCL_B9LK
DR   Wikidata; Q112927418
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KITLG KO
AC   CVCL_B9LL
SY   Human KITLG knockout A549
DR   Abcam; ab288896
DR   cancercelllines; CVCL_B9LL
DR   Wikidata; Q112927419
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6343; KITLG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KLF4 KO
AC   CVCL_B9LM
SY   Human KLF4 knockout A549
DR   Abcam; ab286712
DR   cancercelllines; CVCL_B9LM
DR   Wikidata; Q112927420
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6348; KLF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KLF5 KO
AC   CVCL_D1X8
SY   Human KLF5 knockout A549
DR   Abcam; ab301031
DR   Wikidata; Q127378904
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6349; KLF5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 KLRB1 KO
AC   CVCL_B9LN
SY   Human KLRB1 knockout A549
DR   Abcam; ab289001
DR   cancercelllines; CVCL_B9LN
DR   Wikidata; Q112927421
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6373; KLRB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KLRC1 KO
AC   CVCL_B9LP
SY   Human KLRC1 knockout A549
DR   Abcam; ab288932
DR   cancercelllines; CVCL_B9LP
DR   Wikidata; Q112927422
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6374; KLRC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KMT2A KO
AC   CVCL_B9LQ
SY   Human KMT2A knockout A549
DR   Abcam; ab286675
DR   cancercelllines; CVCL_B9LQ
DR   Wikidata; Q112927423
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7132; KMT2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KMT2D KO
AC   CVCL_B9LR
SY   Human KMT2D knockout A549
DR   Abcam; ab286692
DR   cancercelllines; CVCL_B9LR
DR   Wikidata; Q112927424
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KRT1 KO
AC   CVCL_B9LS
SY   Human KRT1 knockout A549
DR   Abcam; ab288856
DR   cancercelllines; CVCL_B9LS
DR   Wikidata; Q112927425
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6412; KRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 KRT19 KO
AC   CVCL_D1X9
SY   Human KRT19 knockout A549
DR   Abcam; ab301033
DR   Wikidata; Q127378905
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6436; KRT19.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 KRT7 KO
AC   CVCL_B2NQ
SY   Human KRT7 knockout A549
DR   Abcam; ab261867
DR   cancercelllines; CVCL_B2NQ
DR   Wikidata; Q110430078
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6445; KRT7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LAMP1 KO
AC   CVCL_B9LT
SY   Human LAMP1 knockout A549
DR   Abcam; ab288919
DR   cancercelllines; CVCL_B9LT
DR   Wikidata; Q112927426
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LAMP3 KO 1
AC   CVCL_B1G7
SY   Human LAMP3 knockout A549
DR   Abcam; ab267082
DR   cancercelllines; CVCL_B1G7
DR   Wikidata; Q110430079
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14582; LAMP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LAMP3 KO 2
AC   CVCL_B2NR
SY   Human LAMP3 knockout A549
DR   Abcam; ab267083
DR   cancercelllines; CVCL_B2NR
DR   Wikidata; Q110430080
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14582; LAMP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LAP3 KO
AC   CVCL_B1G8
SY   Human LAP3 knockout A549
DR   Abcam; ab266986
DR   cancercelllines; CVCL_B1G8
DR   Wikidata; Q110430081
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18449; LAP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LATS1 KO
AC   CVCL_B9LU
SY   Human LATS1 knockout A549
DR   Abcam; ab286769
DR   cancercelllines; CVCL_B9LU
DR   Wikidata; Q112927427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LATS2 KO
AC   CVCL_B9LV
SY   Human LATS2 knockout A549
DR   Abcam; ab286746
DR   cancercelllines; CVCL_B9LV
DR   Wikidata; Q112927428
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LCK KO
AC   CVCL_B9LW
SY   Human LCK knockout A549
DR   Abcam; ab287602
DR   cancercelllines; CVCL_B9LW
DR   Wikidata; Q112927429
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6524; LCK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LEP KO
AC   CVCL_D1XA
SY   Human LEP knockout A549
DR   Abcam; ab301035
DR   Wikidata; Q127378906
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6553; LEP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 LGALS1 KO
AC   CVCL_B9LX
SY   Human LGALS1 knockout A549
DR   Abcam; ab289015
DR   cancercelllines; CVCL_B9LX
DR   Wikidata; Q112927430
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LGALS3 KO
AC   CVCL_B9LY
SY   Human LGALS3 knockout A549
DR   Abcam; ab288970
DR   cancercelllines; CVCL_B9LY
DR   Wikidata; Q112927431
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LGALS9 KO
AC   CVCL_B2NS
SY   Human Lgals9 (galectin 9/Gal-9) knockout A549
DR   Abcam; ab266923
DR   cancercelllines; CVCL_B2NS
DR   Wikidata; Q110430082
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6570; LGALS9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LGALS9C KO
AC   CVCL_B1G9
SY   Human LGALS9C knockout A549
DR   Abcam; ab267189
DR   cancercelllines; CVCL_B1G9
DR   Wikidata; Q110430083
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33874; LGALS9C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LGR5 KO
AC   CVCL_B9LZ
SY   Human LGR5 knockout A549
DR   Abcam; ab288960
DR   cancercelllines; CVCL_B9LZ
DR   Wikidata; Q112927432
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4504; LGR5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LILRB1 KO
AC   CVCL_B9M0
SY   Human LILRB1 knockout A549
DR   Abcam; ab288874
DR   cancercelllines; CVCL_B9M0
DR   Wikidata; Q112927433
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6605; LILRB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LILRB4 KO
AC   CVCL_B2NT
SY   Human LILRB4 (ILT-3) knockout A549
DR   Abcam; ab266985
DR   cancercelllines; CVCL_B2NT
DR   Wikidata; Q110430084
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6608; LILRB4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LIMK1 KO
AC   CVCL_D1XB
SY   Human LIMK1 knockout A549
DR   Abcam; ab301040
DR   Wikidata; Q127378907
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6613; LIMK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 LIN28A KO
AC   CVCL_B9M1
SY   Human LIN28A knockout A549
DR   Abcam; ab288831
DR   cancercelllines; CVCL_B9M1
DR   Wikidata; Q112927434
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15986; LIN28A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LIN28B KO
AC   CVCL_B9M2
SY   Human LIN28B knockout A549
DR   Abcam; ab288867
DR   cancercelllines; CVCL_B9M2
DR   Wikidata; Q112927435
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LMNA KO
AC   CVCL_B9M3
SY   Human LMNA knockout A549
DR   Abcam; ab287605
DR   cancercelllines; CVCL_B9M3
DR   Wikidata; Q112927437
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LMO2 KO
AC   CVCL_B1GA
SY   Human LMO2 knockout A549
DR   Abcam; ab267167
DR   cancercelllines; CVCL_B1GA
DR   Wikidata; Q110430086
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6642; LMO2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267167; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 LOX KO
AC   CVCL_D1XC
SY   Human LOX knockout A549
DR   Abcam; ab301043
DR   Wikidata; Q127378908
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6664; LOX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 LPAR1 KO
AC   CVCL_D1XD
SY   Human LPAR1 knockout A549
DR   Abcam; ab301046
DR   Wikidata; Q127378909
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3166; LPAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 LPIN1 KO
AC   CVCL_D1XE
SY   Human LPIN1 knockout A549
DR   Abcam; ab301047
DR   Wikidata; Q127378910
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13345; LPIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 LRG1 KO
AC   CVCL_D1XF
SY   Human LRG1 knockout A549
DR   Abcam; ab301049
DR   Wikidata; Q127378911
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29480; LRG1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 LRRK2 KO
AC   CVCL_B2NU
SY   Human LRRK2 knockout A549
DR   Abcam; ab277993
DR   cancercelllines; CVCL_B2NU
DR   Wikidata; Q110430087
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab277993; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 LRP5 KO
AC   CVCL_B9M4
SY   Human LRP5 knockout A549
DR   Abcam; ab286596
DR   cancercelllines; CVCL_B9M4
DR   Wikidata; Q112927438
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 LTBR KO
AC   CVCL_D1XG
SY   Human LTBR knockout A549
DR   Abcam; ab301052
DR   Wikidata; Q127378912
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6718; LTBR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 LYN KO
AC   CVCL_B9M5
SY   Human LYN knockout A549
DR   Abcam; ab286463
DR   cancercelllines; CVCL_B9M5
DR   Wikidata; Q112927439
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAD1L1 KO
AC   CVCL_C7D7
SY   Human MAD1L1 knockout A549
DR   Abcam; ab301055
DR   Wikidata; Q123030394
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6762; MAD1L1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 MAF KO
AC   CVCL_B9M6
SY   Human MAF knockout A549
DR   Abcam; ab287608
DR   cancercelllines; CVCL_B9M6
DR   Wikidata; Q112927440
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6776; MAF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MALT1 KO
AC   CVCL_B9M7
SY   Human MALT1 knockout A549
DR   Abcam; ab286771
DR   cancercelllines; CVCL_B9M7
DR   Wikidata; Q112927441
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP2K1 KO
AC   CVCL_B9M8
SY   Human MAP2K1 knockout A549
DR   Abcam; ab286598
DR   cancercelllines; CVCL_B9M8
DR   Wikidata; Q112927442
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP2K2 KO
AC   CVCL_B9M9
SY   Human MAP2K2 knockout A549
DR   Abcam; ab286773
DR   cancercelllines; CVCL_B9M9
DR   Wikidata; Q112927443
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP2K4 KO
AC   CVCL_B9MA
SY   Human MAP2K4 knockout A549
DR   Abcam; ab286747
DR   cancercelllines; CVCL_B9MA
DR   Wikidata; Q112927445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP2K7 KO 1
AC   CVCL_B1GB
SY   Human MAP2K7 (MKK7) knockout A549
DR   Abcam; ab266913
DR   cancercelllines; CVCL_B1GB
DR   Wikidata; Q110430088
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP2K7 KO 2
AC   CVCL_B2NV
SY   Human MAP2K7 (MKK7) knockout A549
DR   Abcam; ab266914
DR   cancercelllines; CVCL_B2NV
DR   Wikidata; Q110430089
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K11 KO 1
AC   CVCL_B1GC
SY   Human MAP3K11 (MLK3) knockout A549
DR   Abcam; ab267168
DR   cancercelllines; CVCL_B1GC
DR   Wikidata; Q110430090
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K11 KO 2
AC   CVCL_B2NW
SY   Human MAP3K11 (MLK3) knockout A549
DR   Abcam; ab267169
DR   cancercelllines; CVCL_B2NW
DR   Wikidata; Q110430091
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K11 KO 3
AC   CVCL_B9CQ
SY   Human MAP3K11 knockout A549
DR   Abcam; ab286600
DR   cancercelllines; CVCL_B9CQ
DR   Wikidata; Q112927446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K14 KO
AC   CVCL_B1GD
SY   Human MAP3K14 (NFkB Inducing Kinase NIK) knockout A549
DR   Abcam; ab267221
DR   cancercelllines; CVCL_B1GD
DR   Wikidata; Q110430092
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6853; MAP3K14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K15 KO 1
AC   CVCL_B2NX
SY   Human MAP3K15 (ASK3) knockout A549
DR   Abcam; ab267196
DR   cancercelllines; CVCL_B2NX
DR   Wikidata; Q110430093
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31689; MAP3K15.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K15 KO 2
AC   CVCL_B1GE
SY   Human MAP3K15 (ASK3) knockout A549
DR   Abcam; ab267197
DR   cancercelllines; CVCL_B1GE
DR   Wikidata; Q110430094
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31689; MAP3K15.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K2 KO 1
AC   CVCL_B2NY
SY   Human MAP3K2 (MEKK2) knockout A549
DR   Abcam; ab267152
DR   cancercelllines; CVCL_B2NY
DR   Wikidata; Q110430095
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K2 KO 2
AC   CVCL_B1GF
SY   Human MAP3K2 (MEKK2) knockout A549
DR   Abcam; ab267153
DR   cancercelllines; CVCL_B1GF
DR   Wikidata; Q110430096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAP3K5 KO
AC   CVCL_D1XH
SY   Human MAP3K5 knockout A549
DR   Abcam; ab301060
DR   Wikidata; Q127378913
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6857; MAP3K5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 MAP3K7 KO
AC   CVCL_B9MB
SY   Human MAP3K7 knockout A549
DR   Abcam; ab287610
DR   cancercelllines; CVCL_B9MB
DR   Wikidata; Q112927447
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAPK1 KO
AC   CVCL_B9MC
SY   Human MAPK1 knockout A549
DR   Abcam; ab286775
DR   cancercelllines; CVCL_B9MC
DR   Wikidata; Q112927448
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAPK14 KO
AC   CVCL_B9MD
SY   Human MAPK14 knockout A549
DR   Abcam; ab286602
DR   cancercelllines; CVCL_B9MD
DR   Wikidata; Q112927449
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAPK3 KO
AC   CVCL_B9ME
SY   Human MAPK3 knockout A549
DR   Abcam; ab286777
DR   cancercelllines; CVCL_B9ME
DR   Wikidata; Q112927450
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6877; MAPK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MAPKAPK2 KO
AC   CVCL_D1XI
SY   Human MAPKAPK2 knockout A549
DR   Abcam; ab301062
DR   Wikidata; Q127378914
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6887; MAPKAPK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 MARK2 KO
AC   CVCL_D1XJ
SY   Human MARK2 knockout A549
DR   Abcam; ab301066
DR   Wikidata; Q127378915
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3332; MARK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 MAVS KO
AC   CVCL_B9MF
SY   Human MAVS knockout A549
DR   Abcam; ab282354
DR   cancercelllines; CVCL_B9MF
DR   Wikidata; Q112927451
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MBNL1 KO
AC   CVCL_D1XK
SY   Human MBNL1 knockout A549
DR   Abcam; ab301069
DR   Wikidata; Q127378916
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6923; MBNL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 MDC1 KO
AC   CVCL_B9MG
SY   Human MDC1 knockout A549
DR   Abcam; ab287613
DR   cancercelllines; CVCL_B9MG
DR   Wikidata; Q112927452
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21163; MDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ME1 KO
AC   CVCL_C7D8
SY   Human ME1 knockout A549
DR   Abcam; ab301071
DR   Wikidata; Q123030395
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6983; ME1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 MECOM KO
AC   CVCL_B9MH
SY   Human MECOM knockout A549
DR   Abcam; ab286694
DR   cancercelllines; CVCL_B9MH
DR   Wikidata; Q112927453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3498; MECOM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MECP2 KO
AC   CVCL_B9MI
SY   Human MECP2 knockout A549
DR   Abcam; ab288966
DR   cancercelllines; CVCL_B9MI
DR   Wikidata; Q112927454
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6990; MECP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MED12 KO
AC   CVCL_B9MJ
SY   Human MED12 knockout A549
DR   Abcam; ab286652
DR   cancercelllines; CVCL_B9MJ
DR   Wikidata; Q112927455
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11957; MED12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MEF2A KO
AC   CVCL_B9MK
SY   Human MEF2A knockout A549
DR   Abcam; ab288929
DR   cancercelllines; CVCL_B9MK
DR   Wikidata; Q112927456
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6993; MEF2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MEF2C KO
AC   CVCL_B9ML
SY   Human MEF2C knockout A549
DR   Abcam; ab288986
DR   cancercelllines; CVCL_B9ML
DR   Wikidata; Q112927457
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6996; MEF2C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MEN1 KO
AC   CVCL_B9MM
SY   Human MEN1 knockout A549
DR   Abcam; ab287617
DR   cancercelllines; CVCL_B9MM
DR   Wikidata; Q112927458
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MERTK KO
AC   CVCL_D1XL
SY   Human MERTK knockout A549
DR   Abcam; ab301074
DR   Wikidata; Q127378917
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 MET KO
AC   CVCL_B9MN
SY   Human MET knockout A549
DR   Abcam; ab286606
DR   cancercelllines; CVCL_B9MN
DR   Wikidata; Q112927459
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MGMT KO
AC   CVCL_B9MP
SY   Human MGMT knockout A549
DR   Abcam; ab286724
DR   cancercelllines; CVCL_B9MP
DR   Wikidata; Q112927460
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MIB1 KO
AC   CVCL_D1XM
SY   Human MIB1 knockout A549
DR   Abcam; ab301076
DR   Wikidata; Q127378918
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21086; MIB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 MICA KO
AC   CVCL_B9MQ
SY   Human MICA knockout A549
DR   Abcam; ab288893
DR   cancercelllines; CVCL_B9MQ
DR   Wikidata; Q112927461
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7090; MICA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MICB KO
AC   CVCL_B9MR
SY   Human MICB knockout A549
DR   Abcam; ab288864
DR   cancercelllines; CVCL_B9MR
DR   Wikidata; Q112927462
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7091; MICB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MITF KO
AC   CVCL_B9MS
SY   Human MITF knockout A549
DR   Abcam; ab286678
DR   cancercelllines; CVCL_B9MS
DR   Wikidata; Q112927463
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7105; MITF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MKI67 KO
AC   CVCL_B9MT
SY   Human MKI67 knockout A549
DR   Abcam; ab288859
DR   cancercelllines; CVCL_B9MT
DR   Wikidata; Q112927464
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MLH1 KO
AC   CVCL_B2NZ
SY   Human MLH1 knockout A549
DR   Abcam; ab276105
DR   cancercelllines; CVCL_B2NZ
DR   Wikidata; Q110430097
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MMP1 KO
AC   CVCL_B9MU
SY   Human MMP1 knockout A549
DR   Abcam; ab286533
DR   cancercelllines; CVCL_B9MU
DR   Wikidata; Q112927466
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7155; MMP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MMP12 KO
AC   CVCL_B9MV
SY   Human MMP12 knockout A549
DR   Abcam; ab287620
DR   cancercelllines; CVCL_B9MV
DR   Wikidata; Q112927467
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7158; MMP12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MMP2 KO
AC   CVCL_B9MW
SY   Human MMP2 knockout A549
DR   Abcam; ab286481
DR   cancercelllines; CVCL_B9MW
DR   Wikidata; Q112927468
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7166; MMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MMP3 KO
AC   CVCL_C7D9
SY   Human MMP3 knockout A549
DR   Abcam; ab301082
DR   Wikidata; Q123030396
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7173; MMP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 MMP9 KO
AC   CVCL_B9MX
SY   Human MMP9 knockout A549
DR   Abcam; ab286527
DR   cancercelllines; CVCL_B9MX
DR   Wikidata; Q112927469
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7176; MMP9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MPO KO
AC   CVCL_B9MY
SY   Human MPO knockout A549
DR   Abcam; ab288909
DR   cancercelllines; CVCL_B9MY
DR   Wikidata; Q112927471
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7218; MPO.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MRC1 KO
AC   CVCL_B9MZ
SY   Human MRC1 knockout A549
DR   Abcam; ab289018
DR   cancercelllines; CVCL_B9MZ
DR   Wikidata; Q112927472
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7228; MRC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MSH2 KO
AC   CVCL_B9N0
SY   Human MSH2 knockout A549
DR   Abcam; ab286653
DR   cancercelllines; CVCL_B9N0
DR   Wikidata; Q112927473
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MSH3 KO
AC   CVCL_B9N1
SY   Human MSH3 knockout A549
DR   Abcam; ab288875
DR   cancercelllines; CVCL_B9N1
DR   Wikidata; Q112927474
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MSH6 KO
AC   CVCL_B9N2
SY   Human MSH6 knockout A549
DR   Abcam; ab276109
DR   cancercelllines; CVCL_B9N2
DR   Wikidata; Q112927475
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MSI1 KO
AC   CVCL_D1XN
SY   Human MSI1 knockout A549
DR   Abcam; ab301084
DR   Wikidata; Q127378919
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7330; MSI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 MSLN KO
AC   CVCL_B9N3
SY   Human MSLN knockout A549
DR   Abcam; ab289030
DR   cancercelllines; CVCL_B9N3
DR   Wikidata; Q112927476
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7371; MSLN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MSR1 KO
AC   CVCL_B9N4
SY   Human MSR1 knockout A549
DR   Abcam; ab287621
DR   cancercelllines; CVCL_B9N4
DR   Wikidata; Q112927477
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7376; MSR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MST1R KO
AC   CVCL_C7DA
SY   Human MST1R knockout A549
DR   Abcam; ab301087
DR   Wikidata; Q123030397
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7381; MST1R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 MSX1 KO 1
AC   CVCL_B1GG
SY   Human MSX1 knockout A549
DR   Abcam; ab267156
DR   cancercelllines; CVCL_B1GG
DR   Wikidata; Q110430099
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7391; MSX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MSX1 KO 2
AC   CVCL_B2P0
SY   Human MSX1 knockout A549
DR   Abcam; ab267157
DR   cancercelllines; CVCL_B2P0
DR   Wikidata; Q110430100
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7391; MSX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MTA2 KO
AC   CVCL_B9N5
SY   Human MTA2 knockout A549
DR   Abcam; ab287626
DR   cancercelllines; CVCL_B9N5
DR   Wikidata; Q112927478
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7411; MTA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MUC1 KO
AC   CVCL_B9N6
SY   Human MUC1 knockout A549
DR   Abcam; ab287628
DR   cancercelllines; CVCL_B9N6
DR   Wikidata; Q112927479
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MUC16 KO
AC   CVCL_B9N7
SY   Human MUC16 knockout A549
DR   Abcam; ab287631
DR   cancercelllines; CVCL_B9N7
DR   Wikidata; Q112927481
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15582; MUC16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MX1 KO
AC   CVCL_B1GH
SY   Human MX1 knockout A549
DR   Abcam; ab267035
DR   cancercelllines; CVCL_B1GH
DR   Wikidata; Q110430101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7532; MX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267035; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 MX2 KO 1
AC   CVCL_B2P1
SY   Human MX2 knockout A549
DR   Abcam; ab267146
DR   cancercelllines; CVCL_B2P1
DR   Wikidata; Q110430102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7533; MX2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MX2 KO 2
AC   CVCL_B1GI
SY   Human MX2 knockout A549
DR   Abcam; ab267147
DR   cancercelllines; CVCL_B1GI
DR   Wikidata; Q110430103
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7533; MX2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MYB KO
AC   CVCL_B9N8
SY   Human MYB knockout A549
DR   Abcam; ab287635
DR   cancercelllines; CVCL_B9N8
DR   Wikidata; Q112927482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MYD88 KO
AC   CVCL_B9N9
SY   Human MYD88 knockout A549
DR   Abcam; ab286715
DR   cancercelllines; CVCL_B9N9
DR   Wikidata; Q112927483
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 MYH2 KO 1
AC   CVCL_B2P2
SY   Human MYH2 knockout A549
DR   Abcam; ab267027
DR   cancercelllines; CVCL_B2P2
DR   Wikidata; Q110430104
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7572; MYH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267027; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 MYH2 KO 2
AC   CVCL_B1GJ
SY   Human MYH2 knockout A549
DR   Abcam; ab267028
DR   cancercelllines; CVCL_B1GJ
DR   Wikidata; Q110430105
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7572; MYH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267028; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 MYOD1 KO
AC   CVCL_B9NA
SY   Human MYOD1 knockout A549
DR   Abcam; ab286736
DR   cancercelllines; CVCL_B9NA
DR   Wikidata; Q112927484
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7611; MYOD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NAMPT KO
AC   CVCL_D1XP
SY   Human NAMPT knockout A549
DR   Abcam; ab301090
DR   Wikidata; Q127378920
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30092; NAMPT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NANOG KO
AC   CVCL_B9NB
SY   Human NANOG knockout A549
DR   Abcam; ab288865
DR   cancercelllines; CVCL_B9NB
DR   Wikidata; Q112927485
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20857; NANOG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NBN KO
AC   CVCL_B2P3
SY   Human NBN (p95/NBS1) knockout A549
DR   Abcam; ab276103
DR   cancercelllines; CVCL_B2P3
DR   Wikidata; Q110430106
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab276103; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 NCAM1 KO
AC   CVCL_B9NC
SY   Human NCAM1 knockout A549
DR   Abcam; ab287637
DR   cancercelllines; CVCL_B9NC
DR   Wikidata; Q112927486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NCAM2 KO
AC   CVCL_B9ND
SY   Human NCAM2 knockout A549
DR   Abcam; ab289000
DR   cancercelllines; CVCL_B9ND
DR   Wikidata; Q112927487
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7657; NCAM2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NCF4 KO
AC   CVCL_B9NE
SY   Human NCF4 knockout A549
DR   Abcam; ab288991
DR   cancercelllines; CVCL_B9NE
DR   Wikidata; Q112927488
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7662; NCF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NCOA1 KO
AC   CVCL_B9NF
SY   Human NCOA1 knockout A549
DR   Abcam; ab287641
DR   cancercelllines; CVCL_B9NF
DR   Wikidata; Q112927489
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7668; NCOA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NCOA7 KO 1
AC   CVCL_B1GK
SY   Human NCOA7 knockout A549
DR   Abcam; ab267144
DR   cancercelllines; CVCL_B1GK
DR   Wikidata; Q110430108
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21081; NCOA7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NCOA7 KO 2
AC   CVCL_B2P4
SY   Human NCOA7 knockout A549
DR   Abcam; ab267145
DR   cancercelllines; CVCL_B2P4
DR   Wikidata; Q110430111
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21081; NCOA7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NCR1 KO
AC   CVCL_B9NG
SY   Human NCR1 knockout A549
DR   Abcam; ab288953
DR   cancercelllines; CVCL_B9NG
DR   Wikidata; Q112927490
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6731; NCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NECTIN2 KO
AC   CVCL_B9NH
SY   Human NECTIN2 knockout A549
DR   Abcam; ab288906
DR   cancercelllines; CVCL_B9NH
DR   Wikidata; Q112927491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9707; NECTIN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NECTIN3 KO
AC   CVCL_B9NI
SY   Human NECTIN3 knockout A549
DR   Abcam; ab289027
DR   cancercelllines; CVCL_B9NI
DR   Wikidata; Q112927492
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17664; NECTIN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NEDD4L KO
AC   CVCL_C7DB
SY   Human NEDD4L knockout A549
DR   Abcam; ab301093
DR   Wikidata; Q123030398
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7728; NEDD4L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 NEU1 KO
AC   CVCL_D1XQ
SY   Human NEU1 knockout A549
DR   Abcam; ab301095
DR   Wikidata; Q127378921
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NF1 KO
AC   CVCL_B9NJ
SY   Human NF1 knockout A549
DR   Abcam; ab286780
DR   cancercelllines; CVCL_B9NJ
DR   Wikidata; Q112927493
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NF2 KO
AC   CVCL_B9NK
SY   Human NF2 knockout A549
DR   Abcam; ab286781
DR   cancercelllines; CVCL_B9NK
DR   Wikidata; Q112927494
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NFATC1 KO
AC   CVCL_B9NL
SY   Human NFATC1 knockout A549
DR   Abcam; ab289039
DR   cancercelllines; CVCL_B9NL
DR   Wikidata; Q112927495
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NFATC2 KO
AC   CVCL_B9NM
SY   Human NFATC2 knockout A549
DR   Abcam; ab287644
DR   cancercelllines; CVCL_B9NM
DR   Wikidata; Q112927496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7776; NFATC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NFIB KO
AC   CVCL_D1XR
SY   Human NFIB knockout A549
DR   Abcam; ab301097
DR   Wikidata; Q127378923
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7785; NFIB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NLRC5 KO
AC   CVCL_B1GL
SY   Human NLRC5 knockout A549
DR   Abcam; ab266987
DR   cancercelllines; CVCL_B1GL
DR   Wikidata; Q110430113
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29933; NLRC5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NMI KO
AC   CVCL_B2P5
SY   Human NMI (N myc interactor/NMI) knockout A549
DR   Abcam; ab267013
DR   cancercelllines; CVCL_B2P5
DR   Wikidata; Q110430116
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7854; NMI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NOD1 KO
AC   CVCL_C7DC
SY   Human NOD1 knockout A549
DR   Abcam; ab301100
DR   Wikidata; Q123030399
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16390; NOD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 NOS1 KO
AC   CVCL_D1XS
SY   Human NOS1 knockout A549
DR   Abcam; ab301103
DR   Wikidata; Q127378924
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7872; NOS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NOS2 KO
AC   CVCL_B9NN
SY   Human NOS2 knockout A549
DR   Abcam; ab287650
DR   cancercelllines; CVCL_B9NN
DR   Wikidata; Q112927497
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NOTCH1 KO
AC   CVCL_B9NP
SY   Human NOTCH1 knockout A549
DR   Abcam; ab287653
DR   cancercelllines; CVCL_B9NP
DR   Wikidata; Q112927498
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NOTCH2 KO
AC   CVCL_B9NQ
SY   Human NOTCH2 knockout A549
DR   Abcam; ab286654
DR   cancercelllines; CVCL_B9NQ
DR   Wikidata; Q112927499
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NPC1 KO
AC   CVCL_D1XT
SY   Human NPC1 knockout A549
DR   Abcam; ab301105
DR   Wikidata; Q127378925
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NR1D1 KO
AC   CVCL_D1XU
SY   Human NR1D1 knockout A549
DR   Abcam; ab301108
DR   Wikidata; Q127378926
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7962; NR1D1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NR1H2 KO
AC   CVCL_B1GM
SY   Human NR1H2 knockout A549
DR   Abcam; ab273756
DR   cancercelllines; CVCL_B1GM
DR   Wikidata; Q110430119
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7965; NR1H2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NR1H3 KO
AC   CVCL_B9NR
SY   Human NR1H3 knockout A549
DR   Abcam; ab289017
DR   cancercelllines; CVCL_B9NR
DR   Wikidata; Q112927500
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NR3C1 KO
AC   CVCL_B2P6
SY   Human NR3C1 (Glucocorticoid Receptor) knockout A549
DR   Abcam; ab261862
DR   cancercelllines; CVCL_B2P6
DR   Wikidata; Q110430121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NR4A1 KO
AC   CVCL_B9NS
SY   Human NR4A1 knockout A549
DR   Abcam; ab287655
DR   cancercelllines; CVCL_B9NS
DR   Wikidata; Q112927501
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NR4A3 KO
AC   CVCL_B9NT
SY   Human NR4A3 knockout A549
DR   Abcam; ab286730
DR   cancercelllines; CVCL_B9NT
DR   Wikidata; Q112927502
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7982; NR4A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NR5A2 KO
AC   CVCL_D1XV
SY   Human NR5A2 knockout A549
DR   Abcam; ab301110
DR   Wikidata; Q127378927
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7984; NR5A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NRAS KO
AC   CVCL_B9NU
SY   Human NRAS knockout A549
DR   Abcam; ab286611
DR   cancercelllines; CVCL_B9NU
DR   Wikidata; Q112927503
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NRP1 KO
AC   CVCL_B1GN
SY   Human NRP1 knockout A549
DR   Abcam; ab269507
DR   cancercelllines; CVCL_B1GN
DR   Wikidata; Q110430125
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8004; NRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NRP2 KO
AC   CVCL_D1XW
SY   Human NRP2 knockout A549
DR   Abcam; ab301113
DR   Wikidata; Q127378928
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7751; NELL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 NSD2 KO
AC   CVCL_B9NV
SY   Human NSD2 knockout A549
DR   Abcam; ab287659
DR   cancercelllines; CVCL_B9NV
DR   Wikidata; Q112927504
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NT5C3A KO 1
AC   CVCL_B2P7
SY   Human NT5C3A (PN-I) knockout A549
DR   Abcam; ab267208
DR   cancercelllines; CVCL_B2P7
DR   Wikidata; Q110430127
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NT5C3A KO 2
AC   CVCL_B1GP
SY   Human NT5C3A (PN-I) knockout A549
DR   Abcam; ab267209
DR   cancercelllines; CVCL_B1GP
DR   Wikidata; Q110430130
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NTRK2 KO
AC   CVCL_B9NW
SY   Human NTRK2 knockout A549
DR   Abcam; ab288965
DR   cancercelllines; CVCL_B9NW
DR   Wikidata; Q112927505
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8032; NTRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 NTRK3 KO
AC   CVCL_B9NX
SY   Human NTRK3 knockout A549
DR   Abcam; ab286721
DR   cancercelllines; CVCL_B9NX
DR   Wikidata; Q112927506
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8033; NTRK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OAS1 KO 1
AC   CVCL_B9CR
SY   Human OAS1 knockout A549
DR   Abcam; ab267107
DR   cancercelllines; CVCL_B9CR
DR   Wikidata; Q112927507
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8086; OAS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OAS1 KO 2
AC   CVCL_B2P8
SY   Human OAS1 knockout A549
DR   Abcam; ab267108
DR   cancercelllines; CVCL_B2P8
DR   Wikidata; Q110430132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8086; OAS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 OAS2 KO 1
AC   CVCL_B1GQ
SY   Human OAS2 knockout A549
DR   Abcam; ab267179
DR   cancercelllines; CVCL_B1GQ
DR   Wikidata; Q110430134
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8087; OAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OAS2 KO 2
AC   CVCL_B2P9
SY   Human OAS2 knockout A549
DR   Abcam; ab267180
DR   cancercelllines; CVCL_B2P9
DR   Wikidata; Q110430137
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8087; OAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OAS2 KO 3
AC   CVCL_B1GR
SY   Human OAS2 knockout A549
DR   Abcam; ab267181
DR   cancercelllines; CVCL_B1GR
DR   Wikidata; Q110430140
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8087; OAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OAS3 KO
AC   CVCL_B2PA
SY   Human OAS3 knockout A549
DR   Abcam; ab267212
DR   cancercelllines; CVCL_B2PA
DR   Wikidata; Q110430142
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8088; OAS3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OASL KO 1
AC   CVCL_B1GS
SY   Human OASL knockout A549
DR   Abcam; ab267193
DR   cancercelllines; CVCL_B1GS
DR   Wikidata; Q110430145
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8090; OASL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OASL KO 2
AC   CVCL_B2PB
SY   Human OASL knockout A549
DR   Abcam; ab267194
DR   cancercelllines; CVCL_B2PB
DR   Wikidata; Q110430147
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8090; OASL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ODC1 KO
AC   CVCL_D1XX
SY   Human ODC1 knockout A549
DR   Abcam; ab301116
DR   Wikidata; Q127378929
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8109; ODC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 OGG1 KO
AC   CVCL_D1XY
SY   Human OGG1 knockout A549
DR   Abcam; ab301118
DR   Wikidata; Q127378930
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8125; OGG1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 OGT KO
AC   CVCL_B9NY
SY   Human OGT knockout A549
DR   Abcam; ab287662
DR   cancercelllines; CVCL_B9NY
DR   Wikidata; Q112927508
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8127; OGT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OLIG2 KO
AC   CVCL_B9NZ
SY   Human OLIG2 knockout A549
DR   Abcam; ab286729
DR   cancercelllines; CVCL_B9NZ
DR   Wikidata; Q112927509
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9398; OLIG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OPRM1 KO
AC   CVCL_B9P0
SY   Human OPRM1 knockout A549
DR   Abcam; ab286683
DR   cancercelllines; CVCL_B9P0
DR   Wikidata; Q112927510
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8156; OPRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ORAI1 KO
AC   CVCL_D1XZ
SY   Human ORAI1 knockout A549
DR   Abcam; ab301121
DR   Wikidata; Q127378931
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25896; ORAI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 OTOP3 KO 1
AC   CVCL_B1GT
SY   Human OTOP3 knockout A549
DR   Abcam; ab266928
DR   cancercelllines; CVCL_B1GT
DR   Wikidata; Q110430150
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19658; OTOP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 OTOP3 KO 2
AC   CVCL_B2PC
SY   Human OTOP3 knockout A549
DR   Abcam; ab266929
DR   cancercelllines; CVCL_B2PC
DR   Wikidata; Q110430153
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19658; OTOP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 P2RX7 KO
AC   CVCL_D1Y0
SY   Human P2RX7 knockout A549
DR   Abcam; ab301124
DR   Wikidata; Q127378932
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8537; P2RX7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 P2RY12 KO
AC   CVCL_D1Y1
SY   Human P2RY12 knockout A549
DR   Abcam; ab301126
DR   Wikidata; Q127378933
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18124; P2RY12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PABPC1 KO
AC   CVCL_D1Y2
SY   Human PABPC1 knockout A549
DR   Abcam; ab301128
DR   Wikidata; Q127378934
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8554; PABPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PADI4 KO
AC   CVCL_B9P1
SY   Human PADI4 knockout A549
DR   Abcam; ab287664
DR   cancercelllines; CVCL_B9P1
DR   Wikidata; Q112927511
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18368; PADI4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PAK1 KO
AC   CVCL_B9P2
SY   Human PAK1 knockout A549
DR   Abcam; ab286612
DR   cancercelllines; CVCL_B9P2
DR   Wikidata; Q112927512
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PAK2 KO
AC   CVCL_B9P3
SY   Human PAK2 knockout A549
DR   Abcam; ab287667
DR   cancercelllines; CVCL_B9P3
DR   Wikidata; Q112927513
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PAK4 KO
AC   CVCL_B9P4
SY   Human PAK4 knockout A549
DR   Abcam; ab288873
DR   cancercelllines; CVCL_B9P4
DR   Wikidata; Q112927514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PALB2 KO
AC   CVCL_B9P5
SY   Human PALB2 knockout A549
DR   Abcam; ab286798
DR   cancercelllines; CVCL_B9P5
DR   Wikidata; Q112927516
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26144; PALB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PANX1 KO
AC   CVCL_D1Y3
SY   Human PANX1 knockout A549
DR   Abcam; ab301131
DR   Wikidata; Q127378935
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8599; PANX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PARG KO
AC   CVCL_D1Y4
SY   Human PARG knockout A549
DR   Abcam; ab301133
DR   Wikidata; Q127378936
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PARP1 KO
AC   CVCL_B9P6
SY   Human PARP1 knockout A549
DR   Abcam; ab276094
DR   cancercelllines; CVCL_B9P6
DR   Wikidata; Q112927517
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP10 KO 1
AC   CVCL_B1GU
SY   Human PARP10 (ARTD10) knockout A549
DR   Abcam; ab267161
DR   cancercelllines; CVCL_B1GU
DR   Wikidata; Q110430155
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25895; PARP10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP10 KO 2
AC   CVCL_B2PD
SY   Human PARP10 (ARTD10) knockout A549
DR   Abcam; ab267162
DR   cancercelllines; CVCL_B2PD
DR   Wikidata; Q110430157
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25895; PARP10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP12 KO
AC   CVCL_B1GV
SY   Human PARP12 knockout A549
DR   Abcam; ab267220
DR   cancercelllines; CVCL_B1GV
DR   Wikidata; Q110430159
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21919; PARP12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP14 KO 1
AC   CVCL_B2PE
SY   Human PARP14 knockout A549
DR   Abcam; ab267070
DR   cancercelllines; CVCL_B2PE
DR   Wikidata; Q110430162
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29232; PARP14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP14 KO 2
AC   CVCL_B1GW
SY   Human PARP14 knockout A549
DR   Abcam; ab267071
DR   cancercelllines; CVCL_B1GW
DR   Wikidata; Q110430164
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29232; PARP14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP3 KO
AC   CVCL_B9P7
SY   Human PARP3 knockout A549
DR   Abcam; ab288220
DR   cancercelllines; CVCL_B9P7
DR   Wikidata; Q112927518
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP9 KO 1
AC   CVCL_B2PF
SY   Human PARP9 knockout A549
DR   Abcam; ab267128
DR   cancercelllines; CVCL_B2PF
DR   Wikidata; Q110430166
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24118; PARP9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PARP9 KO 2
AC   CVCL_B1GX
SY   Human PARP9 knockout A549
DR   Abcam; ab267129
DR   cancercelllines; CVCL_B1GX
DR   Wikidata; Q110430169
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24118; PARP9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PAX5 KO
AC   CVCL_B9P8
SY   Human PAX5 knockout A549
DR   Abcam; ab287670
DR   cancercelllines; CVCL_B9P8
DR   Wikidata; Q112927519
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8619; PAX5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PAX6 KO
AC   CVCL_B9P9
SY   Human PAX6 knockout A549
DR   Abcam; ab288955
DR   cancercelllines; CVCL_B9P9
DR   Wikidata; Q112927520
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PAX7 KO
AC   CVCL_B9PA
SY   Human PAX7 knockout A549
DR   Abcam; ab287673
DR   cancercelllines; CVCL_B9PA
DR   Wikidata; Q112927521
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8621; PAX7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PAX8 KO
AC   CVCL_B9PB
SY   Human PAX8 knockout A549
DR   Abcam; ab287676
DR   cancercelllines; CVCL_B9PB
DR   Wikidata; Q112927522
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8622; PAX8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PBK KO
AC   CVCL_B9PC
SY   Human PBK knockout A549
DR   Abcam; ab289024
DR   cancercelllines; CVCL_B9PC
DR   Wikidata; Q112927523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PBRM1 KO
AC   CVCL_B9PD
SY   Human PBRM1 knockout A549
DR   Abcam; ab286686
DR   cancercelllines; CVCL_B9PD
DR   Wikidata; Q112927524
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PCK1 KO
AC   CVCL_D1Y5
SY   Human PCK1 knockout A549
DR   Abcam; ab301135
DR   Wikidata; Q127378937
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8724; PCK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PCSK9 KO
AC   CVCL_C7DD
SY   Human PCSK9 knockout A549
DR   Abcam; ab301138
DR   Wikidata; Q123030400
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20001; PCSK9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 PDCD1 KO
AC   CVCL_B9PE
SY   Human PDCD1 knockout A549
DR   Abcam; ab287678
DR   cancercelllines; CVCL_B9PE
DR   Wikidata; Q112927525
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PDCD1LG2 KO
AC   CVCL_B2PG
SY   Human PDCD1LG2 (PD-L2) knockout A549
DR   Abcam; ab267019
DR   cancercelllines; CVCL_B2PG
DR   Wikidata; Q110430171
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267019; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 PDE5A KO
AC   CVCL_C7DE
SY   Human PDE5A knockout A549
DR   Abcam; ab301140
DR   Wikidata; Q123030401
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8784; PDE5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 PDGFB KO
AC   CVCL_B9PF
SY   Human PDGFB knockout A549
DR   Abcam; ab287682
DR   cancercelllines; CVCL_B9PF
DR   Wikidata; Q112927526
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8800; PDGFB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PDGFRA KO
AC   CVCL_B9PG
SY   Human PDGFRA knockout A549
DR   Abcam; ab287685
DR   cancercelllines; CVCL_B9PG
DR   Wikidata; Q112927527
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PDGFRB KO
AC   CVCL_B9PH
SY   Human PDGFRB knockout A549
DR   Abcam; ab286784
DR   cancercelllines; CVCL_B9PH
DR   Wikidata; Q112927528
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8804; PDGFRB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PDIA3 KO
AC   CVCL_D1Y6
SY   Human PDIA3 knockout A549
DR   Abcam; ab301143
DR   Wikidata; Q127378938
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4606; PDIA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PDPN KO
AC   CVCL_B9PI
SY   Human PDPN knockout A549
DR   Abcam; ab289033
DR   cancercelllines; CVCL_B9PI
DR   Wikidata; Q112927529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PDX1 KO
AC   CVCL_D1Y7
SY   Human PDX1 knockout A549
DR   Abcam; ab301145
DR   Wikidata; Q127378939
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6107; PDX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PEBP1 KO
AC   CVCL_B9PJ
SY   Human PEBP1 knockout A549
DR   Abcam; ab288933
DR   cancercelllines; CVCL_B9PJ
DR   Wikidata; Q112927530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8630; PEBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PECAM1 KO
AC   CVCL_B9PK
SY   Human PECAM1 knockout A549
DR   Abcam; ab289049
DR   cancercelllines; CVCL_B9PK
DR   Wikidata; Q112927531
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8823; PECAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PER1 KO
AC   CVCL_B9PL
SY   Human PER1 knockout A549
DR   Abcam; ab288221
DR   cancercelllines; CVCL_B9PL
DR   Wikidata; Q112927532
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8845; PER1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PER2 KO
AC   CVCL_D1Y8
SY   Human PER2 knockout A549
DR   Abcam; ab301148
DR   Wikidata; Q127378940
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8846; PER2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PFKFB3 KO
AC   CVCL_D1Y9
SY   Human PFKFB3 knockout A549
DR   Abcam; ab301151
DR   Wikidata; Q127378941
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PGF KO
AC   CVCL_B9PM
SY   Human PGF knockout A549
DR   Abcam; ab287693
DR   cancercelllines; CVCL_B9PM
DR   Wikidata; Q112927533
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8893; PGF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PGR KO
AC   CVCL_B9PN
SY   Human PGR knockout A549
DR   Abcam; ab287696
DR   cancercelllines; CVCL_B9PN
DR   Wikidata; Q112927534
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8910; PGR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PGK1 KO
AC   CVCL_D1YA
SY   Human PGK1 knockout A549
DR   Abcam; ab301154
DR   Wikidata; Q127378942
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8896; PGK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PHF1 KO
AC   CVCL_B9PP
SY   Human PHF1 knockout A549
DR   Abcam; ab288222
DR   cancercelllines; CVCL_B9PP
DR   Wikidata; Q112927535
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8919; PHF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PHGDH KO
AC   CVCL_D1YB
SY   Human PHGDH knockout A549
DR   Abcam; ab301156
DR   Wikidata; Q127378943
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8923; PHGDH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PHLPP1 KO
AC   CVCL_B9PQ
SY   Human PHLPP1 knockout A549
DR   Abcam; ab287700
DR   cancercelllines; CVCL_B9PQ
DR   Wikidata; Q112927536
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20610; PHLPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PIK3C3 KO
AC   CVCL_D1YC
SY   Human PIK3C3 knockout A549
DR   Abcam; ab301159
DR   Wikidata; Q127378944
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8974; PIK3C3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PIK3CA KO
AC   CVCL_B9PR
SY   Human PIK3CA knockout A549
DR   Abcam; ab286447
DR   cancercelllines; CVCL_B9PR
DR   Wikidata; Q112927537
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PIK3R1 KO
AC   CVCL_B9PS
SY   Human PIK3R1 knockout A549
DR   Abcam; ab286785
DR   cancercelllines; CVCL_B9PS
DR   Wikidata; Q112927538
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PIK3R2 KO
AC   CVCL_B9PT
SY   Human PIK3R2 knockout A549
DR   Abcam; ab286615
DR   cancercelllines; CVCL_B9PT
DR   Wikidata; Q112927539
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PINK1 KO
AC   CVCL_B9PU
SY   Human PINK1 knockout A549
DR   Abcam; ab280768
DR   cancercelllines; CVCL_B9PU
DR   Wikidata; Q112927540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PIWIL4 KO
AC   CVCL_B9PV
SY   Human PIWIL4 knockout A549
DR   Abcam; ab288921
DR   cancercelllines; CVCL_B9PV
DR   Wikidata; Q112927541
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18444; PIWIL4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PKD2 KO
AC   CVCL_D1YD
SY   Human PKD2 knockout A549
DR   Abcam; ab301161
DR   Wikidata; Q127378945
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PLAAT4 KO 1
AC   CVCL_B1GY
SY   Human RARRES3 (TIG3) knockout A549
DR   Abcam; ab266967
DR   cancercelllines; CVCL_B1GY
DR   Wikidata; Q110430174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9869; PLAAT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PLAAT4 KO 2
AC   CVCL_B2PH
SY   Human RARRES3 (TIG3) knockout A549
DR   Abcam; ab266968
DR   cancercelllines; CVCL_B2PH
DR   Wikidata; Q110430176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9869; PLAAT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PLAUR KO
AC   CVCL_D1YE
SY   Human PLAUR knockout A549
DR   Abcam; ab301164
DR   Wikidata; Q127378946
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9053; PLAUR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PLCG2 KO
AC   CVCL_D1YF
SY   Human PLCG2 knockout A549
DR   Abcam; ab301167
DR   Wikidata; Q127378947
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PLD1 KO
AC   CVCL_D1YG
SY   Human PLD1 knockout A549
DR   Abcam; ab301170
DR   Wikidata; Q127378948
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9067; PLD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PLEKHA4 KO 1
AC   CVCL_B1GZ
SY   Human PLEKHA4 knockout A549
DR   Abcam; ab266977
DR   cancercelllines; CVCL_B1GZ
DR   Wikidata; Q110430178
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14339; PLEKHA4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PLEKHA4 KO 2
AC   CVCL_B2PI
SY   Human PLEKHA4 knockout A549
DR   Abcam; ab266978
DR   cancercelllines; CVCL_B2PI
DR   Wikidata; Q110430180
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14339; PLEKHA4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PLSCR1 KO 1
AC   CVCL_B1H0
SY   Human PLSCR1 (Scramblase 1) knockout A549
DR   Abcam; ab266988
DR   cancercelllines; CVCL_B1H0
DR   Wikidata; Q110430183
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9092; PLSCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PLSCR1 KO 2
AC   CVCL_B2PJ
SY   Human PLSCR1 (Scramblase 1) knockout A549
DR   Abcam; ab266989
DR   cancercelllines; CVCL_B2PJ
DR   Wikidata; Q110430185
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9092; PLSCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PMAIP1 KO 1
AC   CVCL_B1H1
SY   Human PMAIP1 (Noxa) knockout A549
DR   Abcam; ab267135
DR   cancercelllines; CVCL_B1H1
DR   Wikidata; Q110430187
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9108; PMAIP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PMAIP1 KO 2
AC   CVCL_B2PK
SY   Human PMAIP1 (Noxa) knockout A549
DR   Abcam; ab267136
DR   cancercelllines; CVCL_B2PK
DR   Wikidata; Q110430189
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9108; PMAIP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PMEL KO
AC   CVCL_B9PW
SY   Human PMEL knockout A549
DR   Abcam; ab288949
DR   cancercelllines; CVCL_B9PW
DR   Wikidata; Q112927542
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10880; PMEL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PML KO 1
AC   CVCL_B9PX
SY   Human PML (PML Protein) knockout A549
DR   Abcam; ab266980
DR   cancercelllines; CVCL_B9PX
DR   Wikidata; Q112927543
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PML KO 2
AC   CVCL_B9PY
SY   Human PML (PML Protein) knockout A549
DR   Abcam; ab276096
DR   cancercelllines; CVCL_B9PY
DR   Wikidata; Q112927544
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PMS2 KO
AC   CVCL_B9PZ
SY   Human PMS2 knockout A549
DR   Abcam; ab276110
DR   cancercelllines; CVCL_B9PZ
DR   Wikidata; Q112927545
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9122; PMS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 POLQ KO
AC   CVCL_B9Q0
SY   Human POLQ knockout A549
DR   Abcam; ab286655
DR   cancercelllines; CVCL_B9Q0
DR   Wikidata; Q112927546
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9186; POLQ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 POLR2A KO
AC   CVCL_B9Q1
SY   Human POLR2A knockout A549
DR   Abcam; ab287702
DR   cancercelllines; CVCL_B9Q1
DR   Wikidata; Q112927547
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9187; POLR2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 POU2F1 KO
AC   CVCL_D1YH
SY   Human POU2F1 knockout A549
DR   Abcam; ab301172
DR   Wikidata; Q127378949
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9212; POU2F1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 POU2F2 KO
AC   CVCL_B9Q2
SY   Human POU2F2 knockout A549
DR   Abcam; ab289040
DR   cancercelllines; CVCL_B9Q2
DR   Wikidata; Q112927548
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9213; POU2F2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 POU5F1 KO
AC   CVCL_B9Q3
SY   Human POU5F1 knockout A549
DR   Abcam; ab286722
DR   cancercelllines; CVCL_B9Q3
DR   Wikidata; Q112927549
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9221; POU5F1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PPARA KO
AC   CVCL_B9Q4
SY   Human PPARA knockout A549
DR   Abcam; ab288958
DR   cancercelllines; CVCL_B9Q4
DR   Wikidata; Q112927550
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PPARD KO
AC   CVCL_B9Q5
SY   Human PPARD knockout A549
DR   Abcam; ab288989
DR   cancercelllines; CVCL_B9Q5
DR   Wikidata; Q112927551
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9235; PPARD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PPARG KO
AC   CVCL_B9Q6
SY   Human PPARG knockout A549
DR   Abcam; ab287706
DR   cancercelllines; CVCL_B9Q6
DR   Wikidata; Q112927552
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PPM1D KO
AC   CVCL_D1YI
SY   Human PPM1D knockout A549
DR   Abcam; ab301175
DR   Wikidata; Q127378952
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9277; PPM1D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PRDM1 KO
AC   CVCL_B9Q7
SY   Human PRDM1 knockout A549
DR   Abcam; ab287709
DR   cancercelllines; CVCL_B9Q7
DR   Wikidata; Q112927553
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9346; PRDM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRDM16 KO
AC   CVCL_B9Q8
SY   Human PRDM16 knockout A549
DR   Abcam; ab286687
DR   cancercelllines; CVCL_B9Q8
DR   Wikidata; Q112927554
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14000; PRDM16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRDX6 KO
AC   CVCL_C7DF
SY   Human PRDX6 knockout A549
DR   Abcam; ab301178
DR   Wikidata; Q123030402
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16753; PRDX6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 PRF1 KO
AC   CVCL_B9Q9
SY   Human PRF1 knockout A549
DR   Abcam; ab287712
DR   cancercelllines; CVCL_B9Q9
DR   Wikidata; Q112927555
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9360; PRF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRKAA1 KO
AC   CVCL_B9QA
SY   Human PRKAA1 knockout A549
DR   Abcam; ab287714
DR   cancercelllines; CVCL_B9QA
DR   Wikidata; Q112927556
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRKAA2 KO
AC   CVCL_B9QB
SY   Human PRKAA2 knockout A549
DR   Abcam; ab286748
DR   cancercelllines; CVCL_B9QB
DR   Wikidata; Q112927557
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRKAR1A KO
AC   CVCL_B9QC
SY   Human PRKAR1A knockout A549
DR   Abcam; ab288833
DR   cancercelllines; CVCL_B9QC
DR   Wikidata; Q112927558
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9388; PRKAR1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRKCA KO
AC   CVCL_B9QD
SY   Human PRKCA knockout A549
DR   Abcam; ab286733
DR   cancercelllines; CVCL_B9QD
DR   Wikidata; Q112927559
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRKCB KO
AC   CVCL_B9QE
SY   Human PRKCB knockout A549
DR   Abcam; ab287718
DR   cancercelllines; CVCL_B9QE
DR   Wikidata; Q112927561
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9395; PRKCB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PRKD2 KO
AC   CVCL_D1YK
SY   Human PRKD2 knockout A549
DR   Abcam; ab301181
DR   Wikidata; Q127378954
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PRKDC KO
AC   CVCL_B9QF
SY   Human PRKDC knockout A549
DR   Abcam; ab276100
DR   cancercelllines; CVCL_B9QF
DR   Wikidata; Q112927562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9413; PRKDC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PROCR KO
AC   CVCL_B9QG
SY   Human PROCR knockout A549
DR   Abcam; ab287720
DR   cancercelllines; CVCL_B9QG
DR   Wikidata; Q112927563
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9452; PROCR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PROM1 KO
AC   CVCL_B9QH
SY   Human PROM1 knockout A549
DR   Abcam; ab288992
DR   cancercelllines; CVCL_B9QH
DR   Wikidata; Q112927564
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9454; PROM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PROX1 KO
AC   CVCL_B9QI
SY   Human PROX1 knockout A549
DR   Abcam; ab287724
DR   cancercelllines; CVCL_B9QI
DR   Wikidata; Q112927565
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9459; PROX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PSMB8 KO 1
AC   CVCL_B1H2
SY   Human PSMB8 (Proteasome 20S LMP7) knockout A549
DR   Abcam; ab267148
DR   cancercelllines; CVCL_B1H2
DR   Wikidata; Q110430192
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9545; PSMB8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PSMB8 KO 2
AC   CVCL_B2PL
SY   Human PSMB8 (Proteasome 20S LMP7) knockout A549
DR   Abcam; ab267149
DR   cancercelllines; CVCL_B2PL
DR   Wikidata; Q110430194
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9545; PSMB8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PSMB9 KO
AC   CVCL_C7DG
SY   Human PSMB9 knockout A549
DR   Abcam; ab301184
DR   Wikidata; Q123030403
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9546; PSMB9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 PTCH1 KO
AC   CVCL_B9QJ
SY   Human PTCH1 knockout A549
DR   Abcam; ab289526
DR   cancercelllines; CVCL_B9QJ
DR   Wikidata; Q112927566
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTCH2 KO
AC   CVCL_B9QK
SY   Human PTCH2 knockout A549
DR   Abcam; ab289527
DR   cancercelllines; CVCL_B9QK
DR   Wikidata; Q112927567
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9586; PTCH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTEN KO
AC   CVCL_B9QL
SY   Human PTEN knockout A549
DR   Abcam; ab286704
DR   cancercelllines; CVCL_B9QL
DR   Wikidata; Q112927568
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTGES KO
AC   CVCL_D1YL
SY   Human PTGES knockout A549
DR   Abcam; ab301186
DR   Wikidata; Q127378955
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9599; PTGES.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PTGS1 KO
AC   CVCL_B9QM
SY   Human PTGS1 knockout A549
DR   Abcam; ab287727
DR   cancercelllines; CVCL_B9QM
DR   Wikidata; Q112927569
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9604; PTGS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTGS2 KO
AC   CVCL_B1H3
SY   Human PTGS2 (COX2 / Cyclooxygenase 2) knockout A549
DR   Abcam; ab280802
DR   cancercelllines; CVCL_B1H3
DR   Wikidata; Q110430196
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9605; PTGS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTHLH KO
AC   CVCL_C7DH
SY   Human PTHLH knockout A549
DR   Abcam; ab301188
DR   Wikidata; Q123030404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9607; PTHLH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 PTK2B KO
AC   CVCL_D1YM
SY   Human PTK2B knockout A549
DR   Abcam; ab301191
DR   Wikidata; Q127378956
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PTK6 KO
AC   CVCL_B9QN
SY   Human PTK6 knockout A549
DR   Abcam; ab288972
DR   cancercelllines; CVCL_B9QN
DR   Wikidata; Q112927570
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9617; PTK6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTN KO
AC   CVCL_B9QP
SY   Human PTN knockout A549
DR   Abcam; ab288980
DR   cancercelllines; CVCL_B9QP
DR   Wikidata; Q112927571
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9630; PTN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTPN1 KO
AC   CVCL_B9QQ
SY   Human PTPN1 knockout A549
DR   Abcam; ab288844
DR   cancercelllines; CVCL_B9QQ
DR   Wikidata; Q112927572
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTPN11 KO
AC   CVCL_B9QR
SY   Human PTPN11 knockout A549
DR   Abcam; ab286787
DR   cancercelllines; CVCL_B9QR
DR   Wikidata; Q112927573
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTPN2 KO
AC   CVCL_B9QS
SY   Human PTPN2 knockout A549
DR   Abcam; ab287730
DR   cancercelllines; CVCL_B9QS
DR   Wikidata; Q112927574
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTPN6 KO
AC   CVCL_B9QT
SY   Human PTPN6 knockout A549
DR   Abcam; ab287733
DR   cancercelllines; CVCL_B9QT
DR   Wikidata; Q112927575
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTPRK KO 1
AC   CVCL_B2PM
SY   Human PTPRK knockout A549
DR   Abcam; ab266990
DR   cancercelllines; CVCL_B2PM
DR   Wikidata; Q110430199
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PTPRK KO 2
AC   CVCL_B1H4
SY   Human PTPRK knockout A549
DR   Abcam; ab266991
DR   cancercelllines; CVCL_B1H4
DR   Wikidata; Q110430201
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PVR KO
AC   CVCL_B2PN
SY   Human PVR (Poliovirus Receptor) knockout A549
DR   Abcam; ab261877
DR   cancercelllines; CVCL_B2PN
DR   Wikidata; Q110430204
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PYGB KO
AC   CVCL_D1YN
SY   Human PYGB knockout A549
DR   Abcam; ab301194
DR   Wikidata; Q127378957
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9723; PYGB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 PYHIN1 KO 1
AC   CVCL_B1H5
SY   Human PYHIN1 knockout A549
DR   Abcam; ab267007
DR   cancercelllines; CVCL_B1H5
DR   Wikidata; Q110430206
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28894; PYHIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 PYHIN1 KO 2
AC   CVCL_B2PP
SY   Human PYHIN1 knockout A549
DR   Abcam; ab267008
DR   cancercelllines; CVCL_B2PP
DR   Wikidata; Q110430207
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28894; PYHIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAB10 KO
AC   CVCL_B1H6
SY   Human RAB10 knockout A549
DR   Abcam; ab261868
DR   cancercelllines; CVCL_B1H6
DR   Wikidata; Q110430208
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAB27A KO
AC   CVCL_B2PQ
SY   Human RAB27A knockout A549
DR   Abcam; ab266921
DR   cancercelllines; CVCL_B2PQ
DR   Wikidata; Q110430209
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAB29 KO
AC   CVCL_B1H7
SY   Human RAB29 knockout A549
DR   Abcam; ab280040
DR   cancercelllines; CVCL_B1H7
DR   Wikidata; Q110430210
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9789; RAB29.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAB5A KO
AC   CVCL_D1YP
SY   Human RAB5A knockout A549
DR   Abcam; ab301197
DR   Wikidata; Q127378959
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9783; RAB5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 RAB8 KO
AC   CVCL_B9QU
SY   Human RAB8 knockout A549
DR   Abcam; ab280769
DR   cancercelllines; CVCL_B9QU
DR   Wikidata; Q112927576
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAD50 KO
AC   CVCL_B9QV
SY   Human RAD50 knockout A549
DR   Abcam; ab286636
DR   cancercelllines; CVCL_B9QV
DR   Wikidata; Q112927578
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9816; RAD50.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAD51D KO
AC   CVCL_B9QW
SY   Human RAD51D knockout A549
DR   Abcam; ab286665
DR   cancercelllines; CVCL_B9QW
DR   Wikidata; Q112927579
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAET1E KO
AC   CVCL_B9QX
SY   Human RAET1E knockout A549
DR   Abcam; ab289029
DR   cancercelllines; CVCL_B9QX
DR   Wikidata; Q112927580
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16793; RAET1E.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RAF1 KO
AC   CVCL_B9QY
SY   Human RAF1 knockout A549
DR   Abcam; ab286788
DR   cancercelllines; CVCL_B9QY
DR   Wikidata; Q112927581
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RARB KO
AC   CVCL_B9QZ
SY   Human RARB knockout A549
DR   Abcam; ab287739
DR   cancercelllines; CVCL_B9QZ
DR   Wikidata; Q112927582
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9865; RARB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RASGRP3 KO 1
AC   CVCL_B2PR
SY   Human RASGRP3 knockout A549
DR   Abcam; ab267198
DR   cancercelllines; CVCL_B2PR
DR   Wikidata; Q110430211
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14545; RASGRP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267198; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 RASGRP3 KO 2
AC   CVCL_B1H8
SY   Human RASGRP3 knockout A549
DR   Abcam; ab267199
DR   cancercelllines; CVCL_B1H8
DR   Wikidata; Q110430212
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14545; RASGRP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267199; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 RB1 KO
AC   CVCL_B9R0
SY   Human RB1 knockout A549
DR   Abcam; ab286470
DR   cancercelllines; CVCL_B9R0
DR   Wikidata; Q112927583
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RB1CC1 KO
AC   CVCL_B9R1
SY   Human RB1CC1 (FIP200) knockout A549
DR   Abcam; ab277823
DR   cancercelllines; CVCL_B9R1
DR   Wikidata; Q112927584
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15574; RB1CC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RBL2 KO
AC   CVCL_C7DI
SY   Human RBL2 knockout A549
DR   Abcam; ab301200
DR   Wikidata; Q123030406
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9894; RBL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 RBP4 KO
AC   CVCL_D1YQ
SY   Human RBP4 knockout A549
DR   Abcam; ab301201
DR   Wikidata; Q127378961
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9922; RBP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 REC8 KO
AC   CVCL_B2PS
SY   Human REC8 knockout A549
DR   Abcam; ab266975
DR   cancercelllines; CVCL_B2PS
DR   Wikidata; Q110430213
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16879; REC8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 REL KO
AC   CVCL_B9R2
SY   Human REL knockout A549
DR   Abcam; ab286658
DR   cancercelllines; CVCL_B9R2
DR   Wikidata; Q112927585
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9954; REL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RELA KO
AC   CVCL_B9R3
SY   Human RELA knockout A549
DR   Abcam; ab287741
DR   cancercelllines; CVCL_B9R3
DR   Wikidata; Q112927586
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 REST KO
AC   CVCL_B9R4
SY   Human REST knockout A549
DR   Abcam; ab287745
DR   cancercelllines; CVCL_B9R4
DR   Wikidata; Q112927587
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9966; REST.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RET KO
AC   CVCL_B9R5
SY   Human RET knockout A549
DR   Abcam; ab286659
DR   cancercelllines; CVCL_B9R5
DR   Wikidata; Q112927588
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RETN KO
AC   CVCL_D1YR
SY   Human RETN knockout A549
DR   Abcam; ab301205
DR   Wikidata; Q127378962
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20389; RETN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 RHOB KO
AC   CVCL_D1YS
SY   Human RHOB knockout A549
DR   Abcam; ab301207
DR   Wikidata; Q127378965
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:668; RHOB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 RICTOR KO
AC   CVCL_B1H9
SY   Human RICTOR knockout A549
DR   Abcam; ab277866
DR   cancercelllines; CVCL_B1H9
DR   Wikidata; Q110430214
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RNF19B KO 1
AC   CVCL_B2PT
SY   Human RNF19B knockout A549
DR   Abcam; ab266911
DR   cancercelllines; CVCL_B2PT
DR   Wikidata; Q110430215
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26886; RNF19B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RNF19B KO 2
AC   CVCL_B1HA
SY   Human RNF19B knockout A549
DR   Abcam; ab266912
DR   cancercelllines; CVCL_B1HA
DR   Wikidata; Q110430216
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26886; RNF19B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RNF2 KO
AC   CVCL_B9R6
SY   Human RNF2 knockout A549
DR   Abcam; ab287748
DR   cancercelllines; CVCL_B9R6
DR   Wikidata; Q112927589
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ROCK1 KO
AC   CVCL_C7DJ
SY   Human ROCK1 knockout A549
DR   Abcam; ab301210
DR   Wikidata; Q123030407
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 ROR1 KO
AC   CVCL_B9R7
SY   Human ROR1 knockout A549
DR   Abcam; ab277905
DR   cancercelllines; CVCL_B9R7
DR   Wikidata; Q112927590
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10256; ROR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RORC KO
AC   CVCL_B9R8
SY   Human RORC knockout A549
DR   Abcam; ab288830
DR   cancercelllines; CVCL_B9R8
DR   Wikidata; Q112927591
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10260; RORC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ROS1 KO
AC   CVCL_B9R9
SY   Human ROS1 knockout A549
DR   Abcam; ab286749
DR   cancercelllines; CVCL_B9R9
DR   Wikidata; Q112927592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10261; ROS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RPS6KA1 KO
AC   CVCL_B9RA
SY   Human RPS6KA1 knockout A549
DR   Abcam; ab288853
DR   cancercelllines; CVCL_B9RA
DR   Wikidata; Q112927593
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10430; RPS6KA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RPS6KA3 KO
AC   CVCL_B9RB
SY   Human RPS6KA3 knockout A549
DR   Abcam; ab287751
DR   cancercelllines; CVCL_B9RB
DR   Wikidata; Q112927594
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10432; RPS6KA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RPS6KB2 KO
AC   CVCL_D1YT
SY   Human RPS6KB2 knockout A549
DR   Abcam; ab301212
DR   Wikidata; Q127378967
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10437; RPS6KB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 RSAD2 KO
AC   CVCL_B2PU
SY   Human RSAD2 (Viperin) knockout A549
DR   Abcam; ab267130
DR   cancercelllines; CVCL_B2PU
DR   Wikidata; Q110430217
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30908; RSAD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267130; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 RSF1 KO
AC   CVCL_B9RC
SY   Human RSF1 knockout A549
DR   Abcam; ab288223
DR   cancercelllines; CVCL_B9RC
DR   Wikidata; Q112927595
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18118; RSF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RSPO2 KO
AC   CVCL_B9RD
SY   Human RSPO2 knockout A549
DR   Abcam; ab286660
DR   cancercelllines; CVCL_B9RD
DR   Wikidata; Q112927597
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28583; RSPO2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RTP4 KO 1
AC   CVCL_B1HB
SY   Human RTP4 knockout A549
DR   Abcam; ab267114
DR   cancercelllines; CVCL_B1HB
DR   Wikidata; Q110430220
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23992; RTP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RTP4 KO 2
AC   CVCL_B2PV
SY   Human RTP4 knockout A549
DR   Abcam; ab267115
DR   cancercelllines; CVCL_B2PV
DR   Wikidata; Q110430222
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23992; RTP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RUNX1 KO
AC   CVCL_B9RE
SY   Human RUNX1 knockout A549
DR   Abcam; ab287754
DR   cancercelllines; CVCL_B9RE
DR   Wikidata; Q112927598
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RUNX3 KO
AC   CVCL_B9RF
SY   Human RUNX3 knockout A549
DR   Abcam; ab288880
DR   cancercelllines; CVCL_B9RF
DR   Wikidata; Q112927599
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10473; RUNX3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 RYR1 KO
AC   CVCL_D1YU
SY   Human RYR1 knockout A549
DR   Abcam; ab301215
DR   Wikidata; Q127378968
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10483; RYR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 S100A10 KO
AC   CVCL_D1YV
SY   Human S100A10 knockout A549
DR   Abcam; ab301217
DR   Wikidata; Q127378969
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10487; S100A10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 S100A4 KO
AC   CVCL_B1HC
SY   Human S100A4 knockout A549
DR   Abcam; ab261865
DR   cancercelllines; CVCL_B1HC
DR   Wikidata; Q110430224
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10494; S100A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 S100A8 KO
AC   CVCL_B9RG
SY   Human S100A8 knockout A549
DR   Abcam; ab288904
DR   cancercelllines; CVCL_B9RG
DR   Wikidata; Q112927600
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10498; S100A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SAA1 KO 1
AC   CVCL_B2PW
SY   Human SAA1 knockout A549
DR   Abcam; ab266994
DR   cancercelllines; CVCL_B2PW
DR   Wikidata; Q110430226
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10513; SAA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab266994; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 SAA1 KO 2
AC   CVCL_B1HD
SY   Human SAA1 knockout A549
DR   Abcam; ab266995
DR   cancercelllines; CVCL_B1HD
DR   Wikidata; Q110430228
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10513; SAA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SALL4 KO
AC   CVCL_B9RH
SY   Human SALL4 knockout A549
DR   Abcam; ab286725
DR   cancercelllines; CVCL_B9RH
DR   Wikidata; Q112927602
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15924; SALL4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SAMD9 KO 1
AC   CVCL_B2PX
SY   Human SAMD9 knockout A549
DR   Abcam; ab267038
DR   cancercelllines; CVCL_B2PX
DR   Wikidata; Q110430230
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1348; SAMD9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SAMD9 KO 2
AC   CVCL_B1HE
SY   Human SAMD9 knockout A549
DR   Abcam; ab267039
DR   cancercelllines; CVCL_B1HE
DR   Wikidata; Q110430232
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1348; SAMD9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SAMD9L KO 1
AC   CVCL_B2PY
SY   Human SAMD9L knockout A549
DR   Abcam; ab266965
DR   cancercelllines; CVCL_B2PY
DR   Wikidata; Q110430235
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1349; SAMD9L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SAMD9L KO 2
AC   CVCL_B1HF
SY   Human SAMD9L knockout A549
DR   Abcam; ab266966
DR   cancercelllines; CVCL_B1HF
DR   Wikidata; Q110430237
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1349; SAMD9L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SATB1 KO
AC   CVCL_D1YW
SY   Human SATB1 knockout A549
DR   Abcam; ab301219
DR   Wikidata; Q127378970
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10541; SATB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SAV1 KO
AC   CVCL_B9RI
SY   Human SAV1 knockout A549
DR   Abcam; ab277850
DR   cancercelllines; CVCL_B9RI
DR   Wikidata; Q112927604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17795; SAV1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SECTM1 KO 1
AC   CVCL_B2PZ
SY   Human SECTM1 knockout A549
DR   Abcam; ab267020
DR   cancercelllines; CVCL_B2PZ
DR   Wikidata; Q110430239
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10707; SECTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SECTM1 KO 2
AC   CVCL_B1HG
SY   Human SECTM1 knockout A549
DR   Abcam; ab267021
DR   cancercelllines; CVCL_B1HG
DR   Wikidata; Q110430241
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10707; SECTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SEMA4D KO
AC   CVCL_B9RJ
SY   Human SEMA4D knockout A549
DR   Abcam; ab288912
DR   cancercelllines; CVCL_B9RJ
DR   Wikidata; Q112927605
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10732; SEMA4D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SEMA7A KO
AC   CVCL_B9RK
SY   Human SEMA7A knockout A549
DR   Abcam; ab289026
DR   cancercelllines; CVCL_B9RK
DR   Wikidata; Q112927606
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10741; SEMA7A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SENP1 KO
AC   CVCL_B9RL
SY   Human SENP1 knockout A549
DR   Abcam; ab288917
DR   cancercelllines; CVCL_B9RL
DR   Wikidata; Q112927607
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17927; SENP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SERPINE1 KO
AC   CVCL_B9RM
SY   Human SERPINE1 knockout A549
DR   Abcam; ab289007
DR   cancercelllines; CVCL_B9RM
DR   Wikidata; Q112927608
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8583; SERPINE1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SERPING1 KO 1
AC   CVCL_B2Q0
SY   Human SERPING1 knockout A549
DR   Abcam; ab266940
DR   cancercelllines; CVCL_B2Q0
DR   Wikidata; Q110430244
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1228; SERPING1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab266940; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 SERPING1 KO 2
AC   CVCL_B1HH
SY   Human SERPING1 knockout A549
DR   Abcam; ab266941
DR   cancercelllines; CVCL_B1HH
DR   Wikidata; Q110430247
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1228; SERPING1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab266941; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 SERPINH1 KO
AC   CVCL_D1YX
SY   Human SERPINH1 knockout A549
DR   Abcam; ab301221
DR   Wikidata; Q127378971
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1546; SERPINH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SETD7 KO
AC   CVCL_B9RN
SY   Human SETD7 knockout A549
DR   Abcam; ab287757
DR   cancercelllines; CVCL_B9RN
DR   Wikidata; Q112927609
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30412; SETD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SFRP1 KO
AC   CVCL_B2Q1
SY   Human SFRP1 knockout A549
DR   Abcam; ab277906
DR   cancercelllines; CVCL_B2Q1
DR   Wikidata; Q110430249
RX   PubMed=39319244;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10776; SFRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam A-549 SHFL KO 1
AC   CVCL_B1HI
SY   Human C19orf66 knockout A549
DR   Abcam; ab267111
DR   cancercelllines; CVCL_B1HI
DR   Wikidata; Q110430252
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25649; SHFL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SHFL KO 2
AC   CVCL_B2Q2
SY   Human C19orf66 knockout A549
DR   Abcam; ab267112
DR   cancercelllines; CVCL_B2Q2
DR   Wikidata; Q110430254
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25649; SHFL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SHMT2 KO
AC   CVCL_D1YY
SY   Human SHMT2 knockout A549
DR   Abcam; ab301223
DR   Wikidata; Q127378972
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10852; SHMT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SIDT1 KO 1
AC   CVCL_B1HJ
SY   Human SIDT1 knockout A549
DR   Abcam; ab267078
DR   cancercelllines; CVCL_B1HJ
DR   Wikidata; Q110430256
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25967; SIDT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIDT1 KO 2
AC   CVCL_B2Q3
SY   Human SIDT1 knockout A549
DR   Abcam; ab267079
DR   cancercelllines; CVCL_B2Q3
DR   Wikidata; Q110430258
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25967; SIDT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRPA KO
AC   CVCL_B9RP
SY   Human SIRPA knockout A549
DR   Abcam; ab287760
DR   cancercelllines; CVCL_B9RP
DR   Wikidata; Q112927610
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9662; SIRPA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRT1 KO
AC   CVCL_B9RQ
SY   Human SIRT1 knockout A549
DR   Abcam; ab287763
DR   cancercelllines; CVCL_B9RQ
DR   Wikidata; Q112927611
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRT2 KO
AC   CVCL_B9RR
SY   Human SIRT2 knockout A549
DR   Abcam; ab288850
DR   cancercelllines; CVCL_B9RR
DR   Wikidata; Q112927612
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRT3 KO
AC   CVCL_B9RS
SY   Human SIRT3 knockout A549
DR   Abcam; ab288987
DR   cancercelllines; CVCL_B9RS
DR   Wikidata; Q112927613
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRT4 KO
AC   CVCL_B9RT
SY   Human SIRT4 knockout A549
DR   Abcam; ab288854
DR   cancercelllines; CVCL_B9RT
DR   Wikidata; Q112927614
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14932; SIRT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRT5 KO
AC   CVCL_B9RU
SY   Human SIRT5 knockout A549
DR   Abcam; ab282634
DR   cancercelllines; CVCL_B9RU
DR   Wikidata; Q112927615
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14933; SIRT5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRT6 KO
AC   CVCL_B9RV
SY   Human SIRT6 knockout A549
DR   Abcam; ab288900
DR   cancercelllines; CVCL_B9RV
DR   Wikidata; Q112927616
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SIRT7 KO
AC   CVCL_B9RW
SY   Human SIRT7 knockout A549
DR   Abcam; ab288872
DR   cancercelllines; CVCL_B9RW
DR   Wikidata; Q112927617
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14935; SIRT7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SLAMF1 KO
AC   CVCL_B9RX
SY   Human SLAMF1 knockout A549
DR   Abcam; ab288892
DR   cancercelllines; CVCL_B9RX
DR   Wikidata; Q112927618
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10903; SLAMF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SLC12A5 KO
AC   CVCL_D1YZ
SY   Human SLC12A5 knockout A549
DR   Abcam; ab301229
DR   Wikidata; Q127378973
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13818; SLC12A5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SLC15A3 KO
AC   CVCL_B1HK
SY   Human SLC15A3 knockout A549
DR   Abcam; ab266960
DR   cancercelllines; CVCL_B1HK
DR   Wikidata; Q110430260
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18068; SLC15A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SLC16A1 KO
AC   CVCL_D1Z0
SY   Human SLC16A1 knockout A549
DR   Abcam; ab301232
DR   Wikidata; Q127378974
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10922; SLC16A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SLC16A3 KO
AC   CVCL_D1Z1
SY   Human SLC16A3 knockout A549
DR   Abcam; ab301234
DR   Wikidata; Q127378975
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10924; SLC16A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SLC25A28 KO 1
AC   CVCL_B2Q4
SY   Human SLC25A28 knockout A549
DR   Abcam; ab267132
DR   cancercelllines; CVCL_B2Q4
DR   Wikidata; Q110430262
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SLC25A28 KO 2
AC   CVCL_B1HL
SY   Human SLC25A28 knockout A549
DR   Abcam; ab267133
DR   cancercelllines; CVCL_B1HL
DR   Wikidata; Q110430265
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SLC25A4 KO
AC   CVCL_C7DK
SY   Human SLC25A4 knockout A549
DR   Abcam; ab301236
DR   Wikidata; Q123030408
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 SLC2A1 KO
AC   CVCL_B2Q5
SY   Human SLC2A1 (Glucose Transporter GLUT1) knockout A549
DR   Abcam; ab261869
DR   cancercelllines; CVCL_B2Q5
DR   Wikidata; Q110430267
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SLC2A3 KO
AC   CVCL_C7DL
SY   Human SLC2A3 knockout A549
DR   Abcam; ab301240
DR   Wikidata; Q123030409
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11007; SLC2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 SLC8A1 KO
AC   CVCL_D1Z2
SY   Human SLC8A1 knockout A549
DR   Abcam; ab301242
DR   Wikidata; Q127378976
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11068; SLC8A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SLC9A1 KO
AC   CVCL_D1Z3
SY   Human SLC9A1 knockout A549
DR   Abcam; ab301245
DR   Wikidata; Q127378977
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SKP2 KO
AC   CVCL_C7DM
SY   Human SKP2 knockout A549
DR   Abcam; ab301226
DR   Wikidata; Q123030410
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 SMAD1 KO
AC   CVCL_B9RY
SY   Human SMAD1 knockout A549
DR   Abcam; ab277886
DR   cancercelllines; CVCL_B9RY
DR   Wikidata; Q112927619
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6767; SMAD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMAD2 KO
AC   CVCL_B9RZ
SY   Human SMAD2 knockout A549
DR   Abcam; ab277887
DR   cancercelllines; CVCL_B9RZ
DR   Wikidata; Q112927620
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMAD3 KO 1
AC   CVCL_B1HM
SY   Human SMAD3 knockout A549
DR   Abcam; ab263915
DR   cancercelllines; CVCL_B1HM
DR   Wikidata; Q110430269
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMAD3 KO 2
AC   CVCL_B2Q6
SY   Human SMAD3 knockout A549
DR   Abcam; ab277888
DR   cancercelllines; CVCL_B2Q6
DR   Wikidata; Q110430271
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMAD4 KO
AC   CVCL_B9S0
SY   Human SMAD4 knockout A549
DR   Abcam; ab277889
DR   cancercelllines; CVCL_B9S0
DR   Wikidata; Q112927621
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMAD5 KO
AC   CVCL_B9S1
SY   Human SMAD5 knockout A549
DR   Abcam; ab277890
DR   cancercelllines; CVCL_B9S1
DR   Wikidata; Q112927622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6771; SMAD5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMAD6 KO
AC   CVCL_B1HN
SY   Human SMAD6 knockout A549
DR   Abcam; ab277891
DR   cancercelllines; CVCL_B1HN
DR   Wikidata; Q110430273
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6772; SMAD6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMAD7 KO
AC   CVCL_B9S2
SY   Human SMAD7 (MADH7) knockout A549
DR   Abcam; ab277892
DR   cancercelllines; CVCL_B9S2
DR   Wikidata; Q112927623
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMARCA1 KO
AC   CVCL_B9S3
SY   Human SMARCA1 knockout A549
DR   Abcam; ab288224
DR   cancercelllines; CVCL_B9S3
DR   Wikidata; Q112927624
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11097; SMARCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMARCA2 KO
AC   CVCL_B9S4
SY   Human SMARCA2 (BRM) knockout A549
DR   Abcam; ab282636
DR   cancercelllines; CVCL_B9S4
DR   Wikidata; Q112927625
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11098; SMARCA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMARCA4 KO
AC   CVCL_B9S5
SY   Human SMARCA4 knockout A549
DR   Abcam; ab286625
DR   cancercelllines; CVCL_B9S5
DR   Wikidata; Q112927626
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMARCC1 KO
AC   CVCL_B9S6
SY   Human SMARCC1 knockout A549
DR   Abcam; ab287766
DR   cancercelllines; CVCL_B9S6
DR   Wikidata; Q112927627
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMARCD3 KO
AC   CVCL_B9S7
SY   Human SMARCD3 knockout A549
DR   Abcam; ab288225
DR   cancercelllines; CVCL_B9S7
DR   Wikidata; Q112927628
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11108; SMARCD3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMN1 KO
AC   CVCL_D1Z4
SY   Human SMN1 knockout A549
DR   Abcam; ab301247
DR   Wikidata; Q127378978
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11117; SMN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SMO KO
AC   CVCL_B9S8
SY   Human SMO knockout A549
DR   Abcam; ab289525
DR   cancercelllines; CVCL_B9S8
DR   Wikidata; Q112927629
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SMPD1 KO
AC   CVCL_C7DN
SY   Human SMPD1 knockout A549
DR   Abcam; ab301249
DR   Wikidata; Q123030411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 SNAI1 KO
AC   CVCL_B9S9
SY   Human SNAI1 knockout A549
DR   Abcam; ab289012
DR   cancercelllines; CVCL_B9S9
DR   Wikidata; Q112927630
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11128; SNAI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SNAI2 KO
AC   CVCL_B9SA
SY   Human SNAI2 knockout A549
DR   Abcam; ab288941
DR   cancercelllines; CVCL_B9SA
DR   Wikidata; Q112927631
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11094; SNAI2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SOCS1 KO
AC   CVCL_B2Q7
SY   Human SOCS1 knockout A549
DR   Abcam; ab266924
DR   cancercelllines; CVCL_B2Q7
DR   Wikidata; Q110430275
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19383; SOCS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SOS1 KO
AC   CVCL_B9SB
SY   Human SOS1 knockout A549
DR   Abcam; ab286377
DR   cancercelllines; CVCL_B9SB
DR   Wikidata; Q112927632
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SOX10 KO
AC   CVCL_B9SC
SY   Human SOX10 knockout A549
DR   Abcam; ab288894
DR   cancercelllines; CVCL_B9SC
DR   Wikidata; Q112927633
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11190; SOX10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SOX11 KO
AC   CVCL_B9SD
SY   Human SOX11 knockout A549
DR   Abcam; ab288869
DR   cancercelllines; CVCL_B9SD
DR   Wikidata; Q112927634
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11191; SOX11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SOX17 KO
AC   CVCL_B9SE
SY   Human SOX17 knockout A549
DR   Abcam; ab288928
DR   cancercelllines; CVCL_B9SE
DR   Wikidata; Q112927635
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18122; SOX17.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SOX2 KO
AC   CVCL_B9SF
SY   Human SOX2 knockout A549
DR   Abcam; ab287769
DR   cancercelllines; CVCL_B9SF
DR   Wikidata; Q112927636
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11195; SOX2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SOX6 KO
AC   CVCL_B9SG
SY   Human SOX6 knockout A549
DR   Abcam; ab289002
DR   cancercelllines; CVCL_B9SG
DR   Wikidata; Q112927637
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16421; SOX6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SP1 KO
AC   CVCL_B9SH
SY   Human SP1 knockout A549
DR   Abcam; ab287772
DR   cancercelllines; CVCL_B9SH
DR   Wikidata; Q112927638
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SP100 KO
AC   CVCL_B1HP
SY   Human SP100 knockout A549
DR   Abcam; ab266932
DR   cancercelllines; CVCL_B1HP
DR   Wikidata; Q110430279
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11206; SP100.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SP110 KO
AC   CVCL_B2Q8
SY   Human SP110 knockout A549
DR   Abcam; ab266953
DR   cancercelllines; CVCL_B2Q8
DR   Wikidata; Q110430282
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5401; SP110.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SP140 KO 1
AC   CVCL_B1HQ
SY   Human SP140 knockout A549
DR   Abcam; ab267087
DR   cancercelllines; CVCL_B1HQ
DR   Wikidata; Q110430284
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17133; SP140.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SP140 KO 2
AC   CVCL_B2Q9
SY   Human SP140 knockout A549
DR   Abcam; ab267088
DR   cancercelllines; CVCL_B2Q9
DR   Wikidata; Q110430286
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17133; SP140.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SPARC KO
AC   CVCL_C7DP
SY   Human SPARC knockout A549
DR   Abcam; ab301251
DR   Wikidata; Q123030412
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11219; SPARC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 SPHK1 KO
AC   CVCL_D1Z5
SY   Human SPHK1 knockout A549
DR   Abcam; ab301254
DR   Wikidata; Q127378979
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 SPI1 KO
AC   CVCL_B9SI
SY   Human SPI1 knockout A549
DR   Abcam; ab288881
DR   cancercelllines; CVCL_B9SI
DR   Wikidata; Q112927639
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11241; SPI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SPINK1 KO 1
AC   CVCL_B1HR
SY   Human SPINK1 (P12) knockout A549
DR   Abcam; ab267204
DR   cancercelllines; CVCL_B1HR
DR   Wikidata; Q110430288
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11244; SPINK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267204; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 SPINK1 KO 2
AC   CVCL_B2QA
SY   Human SPINK1 (P12) knockout A549
DR   Abcam; ab267205
DR   cancercelllines; CVCL_B2QA
DR   Wikidata; Q110430290
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11244; SPINK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267205; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 SPINK1 KO 3
AC   CVCL_B1HS
SY   Human SPINK1 (P12) knockout A549
DR   Abcam; ab267206
DR   cancercelllines; CVCL_B1HS
DR   Wikidata; Q110430292
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11244; SPINK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab267206; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 SPN KO
AC   CVCL_B9SJ
SY   Human SPN knockout A549
DR   Abcam; ab287775
DR   cancercelllines; CVCL_B9SJ
DR   Wikidata; Q112927640
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11249; SPN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SPP1 KO
AC   CVCL_B9SK
SY   Human SPP1 knockout A549
DR   Abcam; ab287778
DR   cancercelllines; CVCL_B9SK
DR   Wikidata; Q112927641
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SRC KO
AC   CVCL_B9SL
SY   Human SRC knockout A549
DR   Abcam; ab286707
DR   cancercelllines; CVCL_B9SL
DR   Wikidata; Q112927642
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SREBF1 KO
AC   CVCL_B9SM
SY   Human SREBF1 knockout A549
DR   Abcam; ab288882
DR   cancercelllines; CVCL_B9SM
DR   Wikidata; Q112927643
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11289; SREBF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SREBF2 KO
AC   CVCL_B9SN
SY   Human SREBF2 knockout A549
DR   Abcam; ab289003
DR   cancercelllines; CVCL_B9SN
DR   Wikidata; Q112927644
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SS18 KO
AC   CVCL_B9SP
SY   Human SS18 knockout A549
DR   Abcam; ab287781
DR   cancercelllines; CVCL_B9SP
DR   Wikidata; Q112927645
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STAG2 KO
AC   CVCL_B9SQ
SY   Human STAG2 knockout A549
DR   Abcam; ab287784
DR   cancercelllines; CVCL_B9SQ
DR   Wikidata; Q112927647
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STAT2 KO 1
AC   CVCL_B2QB
SY   Human STAT2 knockout A549
DR   Abcam; ab267004
DR   cancercelllines; CVCL_B2QB
DR   Wikidata; Q110430294
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STAT2 KO 2
AC   CVCL_B1HT
SY   Human STAT2 knockout A549
DR   Abcam; ab267005
DR   cancercelllines; CVCL_B1HT
DR   Wikidata; Q110430297
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STAT2 KO 3
AC   CVCL_B2QC
SY   Human STAT2 knockout A549
DR   Abcam; ab267006
DR   cancercelllines; CVCL_B2QC
DR   Wikidata; Q110430299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STAT3 KO
AC   CVCL_B9SR
SY   Human STAT3 knockout A549
DR   Abcam; ab287787
DR   cancercelllines; CVCL_B9SR
DR   Wikidata; Q112927648
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STAT5B KO
AC   CVCL_B9SS
SY   Human STAT5B knockout A549
DR   Abcam; ab288860
DR   cancercelllines; CVCL_B9SS
DR   Wikidata; Q112927649
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STAT6 KO
AC   CVCL_B9ST
SY   Human STAT6 knockout A549
DR   Abcam; ab286716
DR   cancercelllines; CVCL_B9ST
DR   Wikidata; Q112927650
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 STC2 KO
AC   CVCL_D1Z6
SY   Human STC2 knockout A549
DR   Abcam; ab301256
DR   Wikidata; Q127378980
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11374; STC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 STIM2 KO
AC   CVCL_D1Z7
SY   Human STIM2 knockout A549
DR   Abcam; ab301259
DR   Wikidata; Q127378981
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19205; STIM2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 STIP1 KO
AC   CVCL_D1Z8
SY   Human STIP1 knockout A549
DR   Abcam; ab301262
DR   Wikidata; Q127378982
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11387; STIP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 STK11 KO
AC   CVCL_B9SU
SY   Human STK11 knockout A549
DR   Abcam; ab286790
DR   cancercelllines; CVCL_B9SU
DR   Wikidata; Q112927651
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SUFU KO
AC   CVCL_B9SV
SY   Human SUFU knockout A549
DR   Abcam; ab277842
DR   cancercelllines; CVCL_B9SV
DR   Wikidata; Q112927652
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SYK KO
AC   CVCL_B9SW
SY   Human SYK knockout A549
DR   Abcam; ab288938
DR   cancercelllines; CVCL_B9SW
DR   Wikidata; Q112927653
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 SYN1 KO
AC   CVCL_B1HU
SY   Human SYN1 (Synapsin I) knockout A549
DR   Abcam; ab266917
DR   cancercelllines; CVCL_B1HU
DR   Wikidata; Q110430301
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11494; SYN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Abcam; ab266917; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 TAB2 KO
AC   CVCL_D1Z9
SY   Human TAB2 knockout A549
DR   Abcam; ab301263
DR   Wikidata; Q127378983
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TACSTD2 KO
AC   CVCL_B9SX
SY   Human TACSTD2 knockout A549
DR   Abcam; ab286708
DR   cancercelllines; CVCL_B9SX
DR   Wikidata; Q112927654
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TAFAZZIN KO
AC   CVCL_B9SY
SY   Human TAZ knockout A549
DR   Abcam; ab277852
DR   cancercelllines; CVCL_B9SY
DR   Wikidata; Q112927655
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TAP2 KO
AC   CVCL_B2QD
SY   Human TAP2 knockout A549
DR   Abcam; ab267195
DR   cancercelllines; CVCL_B2QD
DR   Wikidata; Q110430303
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18655; SEC14L3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TBX21 KO
AC   CVCL_B9SZ
SY   Human TBX21 knockout A549
DR   Abcam; ab288978
DR   cancercelllines; CVCL_B9SZ
DR   Wikidata; Q112927656
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11599; TBX21.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TBX3 KO
AC   CVCL_D1ZA
SY   Human TBX3 knockout A549
DR   Abcam; ab301265
DR   Wikidata; Q127378984
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11602; TBX3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TDO2 KO
AC   CVCL_B9T0
SY   Human TDO2 knockout A549
DR   Abcam; ab288855
DR   cancercelllines; CVCL_B9T0
DR   Wikidata; Q112927657
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11708; TDO2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TDRD7 KO 1
AC   CVCL_B1HV
SY   Human TDRD7 knockout A549
DR   Abcam; ab267048
DR   cancercelllines; CVCL_B1HV
DR   Wikidata; Q110430305
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30831; TDRD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TDRD7 KO 2
AC   CVCL_B2QE
SY   Human TDRD7 knockout A549
DR   Abcam; ab267049
DR   cancercelllines; CVCL_B2QE
DR   Wikidata; Q110430307
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30831; TDRD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TEAD1 KO
AC   CVCL_B1HW
SY   Human TEAD1 knockout A549
DR   Abcam; ab261901
DR   cancercelllines; CVCL_B1HW
DR   Wikidata; Q110430310
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11714; TEAD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TEAD2 KO
AC   CVCL_B2QF
SY   Human TEAD2 knockout A549
DR   Abcam; ab277854
DR   cancercelllines; CVCL_B2QF
DR   Wikidata; Q110430312
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11715; TEAD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TEAD4 KO
AC   CVCL_B1HX
SY   Human TEAD4 knockout A549
DR   Abcam; ab277855
DR   cancercelllines; CVCL_B1HX
DR   Wikidata; Q110430314
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11717; TEAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TEK KO
AC   CVCL_B9T1
SY   Human TEK knockout A549
DR   Abcam; ab288945
DR   cancercelllines; CVCL_B9T1
DR   Wikidata; Q112927658
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11724; TEK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TENT5A KO 1
AC   CVCL_B2QG
SY   Human FAM46A knockout A549
DR   Abcam; ab266933
DR   cancercelllines; CVCL_B2QG
DR   Wikidata; Q110430316
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18345; TENT5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TENT5A KO 2
AC   CVCL_B1HY
SY   Human FAM46A knockout A549
DR   Abcam; ab266934
DR   cancercelllines; CVCL_B1HY
DR   Wikidata; Q110430318
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18345; TENT5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TERT KO
AC   CVCL_B9T2
SY   Human TERT knockout A549
DR   Abcam; ab289032
DR   cancercelllines; CVCL_B9T2
DR   Wikidata; Q112927659
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TET1 KO
AC   CVCL_B9T3
SY   Human TET1 knockout A549
DR   Abcam; ab288846
DR   cancercelllines; CVCL_B9T3
DR   Wikidata; Q112927660
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TET2 KO
AC   CVCL_B9T4
SY   Human TET2 knockout A549
DR   Abcam; ab286689
DR   cancercelllines; CVCL_B9T4
DR   Wikidata; Q112927661
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TET3 KO
AC   CVCL_B9T5
SY   Human TET3 knockout A549
DR   Abcam; ab288889
DR   cancercelllines; CVCL_B9T5
DR   Wikidata; Q112927662
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28313; TET3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TFAP2A KO
AC   CVCL_B9T6
SY   Human TFAP2A knockout A549
DR   Abcam; ab288868
DR   cancercelllines; CVCL_B9T6
DR   Wikidata; Q112927663
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11742; TFAP2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TGFB1 KO
AC   CVCL_B2QH
SY   Human TGFB1 (TGF beta 1) knockout A549
DR   Abcam; ab269509
DR   cancercelllines; CVCL_B2QH
DR   Wikidata; Q110430321
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TGFB2 KO
AC   CVCL_D1ZB
SY   Human TGFB2 knockout A549
DR   Abcam; ab301268
DR   Wikidata; Q127378985
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11768; TGFB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TGFBR1 KO
AC   CVCL_B1HZ
SY   Human TGFBR1 knockout A549
DR   Abcam; ab277894
DR   cancercelllines; CVCL_B1HZ
DR   Wikidata; Q110430323
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TGFBR2 KO 1
AC   CVCL_B2QI
SY   Human TGFBR2 (TGF beta Receptor II) knockout A549
DR   Abcam; ab261863
DR   cancercelllines; CVCL_B2QI
DR   Wikidata; Q110430325
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam A-549 TGFBR2 KO 2
AC   CVCL_B9CS
SY   Human TGFBR2 (TGF beta Receptor II) knockout A549
DR   Abcam; ab277895
DR   cancercelllines; CVCL_B9CS
DR   Wikidata; Q112927664
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TGFBR3 KO
AC   CVCL_B9T7
SY   Human TGFBR3 knockout A549
DR   Abcam; ab277896
DR   cancercelllines; CVCL_B9T7
DR   Wikidata; Q112927665
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11774; TGFBR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TGM2 KO 1
AC   CVCL_B1I0
SY   Human TGM2 (Transglutaminase 2) knockout A549
DR   Abcam; ab261876
DR   cancercelllines; CVCL_B1I0
DR   Wikidata; Q110430327
RX   PubMed=39220380;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11778; TGM2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam A-549 TGM2 KO 2
AC   CVCL_B2QJ
SY   Human TGM2 (Transglutaminase 2) knockout A549
DR   Abcam; ab267110
DR   cancercelllines; CVCL_B2QJ
DR   Wikidata; Q110430330
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11778; TGM2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TGOLN2 KO
AC   CVCL_B1I1
SY   Human TGOLN2 (TGN46) knockout A549
DR   Abcam; ab269510
DR   cancercelllines; CVCL_B1I1
DR   Wikidata; Q110430333
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15450; TGOLN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 THBD KO
AC   CVCL_B9T8
SY   Human THBD knockout A549
DR   Abcam; ab288961
DR   cancercelllines; CVCL_B9T8
DR   Wikidata; Q112927666
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11784; THBD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 THEMIS2 KO 1
AC   CVCL_B2QK
SY   Human THEMIS2 (ICB1) knockout A549
DR   Abcam; ab266909
DR   cancercelllines; CVCL_B2QK
DR   Wikidata; Q110430336
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16839; THEMIS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 THEMIS2 KO 2
AC   CVCL_B1I2
SY   Human THEMIS2 (ICB1) knockout A549
DR   Abcam; ab266910
DR   cancercelllines; CVCL_B1I2
DR   Wikidata; Q110430340
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16839; THEMIS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TIA1 KO
AC   CVCL_B9T9
SY   Human TIA1 knockout A549
DR   Abcam; ab288916
DR   cancercelllines; CVCL_B9T9
DR   Wikidata; Q112927667
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TIMP2 KO
AC   CVCL_C7DQ
SY   Human TIMP2 knockout A549
DR   Abcam; ab301271
DR   Wikidata; Q123030413
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11821; TIMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 TKT KO
AC   CVCL_D1ZC
SY   Human TKT knockout A549
DR   Abcam; ab301273
DR   Wikidata; Q127378986
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11834; TKT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TLDC2 KO 1
AC   CVCL_B2QL
SY   Human TLDC2 (C20orf118) knockout A549
DR   Abcam; ab267101
DR   cancercelllines; CVCL_B2QL
DR   Wikidata; Q110430345
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16112; TLDC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TLDC2 KO 2
AC   CVCL_B1I3
SY   Human TLDC2 (C20orf118) knockout A549
DR   Abcam; ab267102
DR   cancercelllines; CVCL_B1I3
DR   Wikidata; Q110430347
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16112; TLDC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TLR1 KO
AC   CVCL_B9TA
SY   Human TLR1 knockout A549
DR   Abcam; ab289019
DR   cancercelllines; CVCL_B9TA
DR   Wikidata; Q112927668
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11847; TLR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TLR2 KO
AC   CVCL_B9TB
SY   Human TLR2 knockout A549
DR   Abcam; ab288876
DR   cancercelllines; CVCL_B9TB
DR   Wikidata; Q112927669
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TLR3 KO
AC   CVCL_B9TC
SY   Human TLR3 knockout A549
DR   Abcam; ab288996
DR   cancercelllines; CVCL_B9TC
DR   Wikidata; Q112927670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11849; TLR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TLR4 KO
AC   CVCL_B9TD
SY   Human TLR4 knockout A549
DR   Abcam; ab288888
DR   cancercelllines; CVCL_B9TD
DR   Wikidata; Q112927671
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TLR6 KO
AC   CVCL_B9TE
SY   Human TLR6 knockout A549
DR   Abcam; ab288913
DR   cancercelllines; CVCL_B9TE
DR   Wikidata; Q112927672
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16711; TLR6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TLR7 KO
AC   CVCL_B9TF
SY   Human TLR7 knockout A549
DR   Abcam; ab288863
DR   cancercelllines; CVCL_B9TF
DR   Wikidata; Q112927673
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15631; TLR7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TMEM106B KO
AC   CVCL_B2QM
SY   Human TMEM106B knockout A549
DR   Abcam; ab273711
DR   cancercelllines; CVCL_B2QM
DR   Wikidata; Q110430350
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22407; TMEM106B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TMEM140 KO 1
AC   CVCL_B1I4
SY   Human TMEM140 knockout A549
DR   Abcam; ab266942
DR   cancercelllines; CVCL_B1I4
DR   Wikidata; Q110430352
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21870; TMEM140.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TMEM140 KO 2
AC   CVCL_B2QN
SY   Human TMEM140 knockout A549
DR   Abcam; ab266943
DR   cancercelllines; CVCL_B2QN
DR   Wikidata; Q110430354
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21870; TMEM140.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TMEM173 KO
AC   CVCL_B9TG
SY   Human TMEM173 knockout A549
DR   Abcam; ab286792
DR   cancercelllines; CVCL_B9TG
DR   Wikidata; Q112927674
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TMEM64 KO 1
AC   CVCL_B1I5
SY   Human TMEM64 (TMM64) knockout A549
DR   Abcam; ab266915
DR   cancercelllines; CVCL_B1I5
DR   Wikidata; Q110430356
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25441; TMEM64.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TMEM64 KO 2
AC   CVCL_B2QP
SY   Human TMEM64 (TMM64) knockout A549
DR   Abcam; ab266916
DR   cancercelllines; CVCL_B2QP
DR   Wikidata; Q110430358
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25441; TMEM64.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFAIP3 KO 1
AC   CVCL_B1I6
SY   Human TNFAIP3 knockout A549
DR   Abcam; ab266945
DR   cancercelllines; CVCL_B1I6
DR   Wikidata; Q110430360
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFAIP3 KO 2
AC   CVCL_B2QQ
SY   Human TNFAIP3 knockout A549
DR   Abcam; ab266946
DR   cancercelllines; CVCL_B2QQ
DR   Wikidata; Q110430363
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFRSF17 KO
AC   CVCL_B9TH
SY   Human TNFRSF17 knockout A549
DR   Abcam; ab288891
DR   cancercelllines; CVCL_B9TH
DR   Wikidata; Q112927676
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11913; TNFRSF17.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFRSF18 KO
AC   CVCL_B9TI
SY   Human TNFRSF18 knockout A549
DR   Abcam; ab289037
DR   cancercelllines; CVCL_B9TI
DR   Wikidata; Q112927677
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11914; TNFRSF18.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFRSF4 KO
AC   CVCL_B9TJ
SY   Human TNFRSF4 knockout A549
DR   Abcam; ab288971
DR   cancercelllines; CVCL_B9TJ
DR   Wikidata; Q112927678
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11918; TNFRSF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFRSF8 KO
AC   CVCL_B9TK
SY   Human TNFRSF8 knockout A549
DR   Abcam; ab288829
DR   cancercelllines; CVCL_B9TK
DR   Wikidata; Q112927679
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11923; TNFRSF8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFSF10 KO
AC   CVCL_B1I7
SY   Human TNFSF10 (TRAIL) knockout A549
DR   Abcam; ab267160
DR   cancercelllines; CVCL_B1I7
DR   Wikidata; Q110430365
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11925; TNFSF10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFRSF9 KO
AC   CVCL_B9TL
SY   Human TNFRSF9 knockout A549
DR   Abcam; ab288908
DR   cancercelllines; CVCL_B9TL
DR   Wikidata; Q112927680
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11924; TNFRSF9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNFSF11 KO
AC   CVCL_B9TM
SY   Human TNFSF11 knockout A549
DR   Abcam; ab286479
DR   cancercelllines; CVCL_B9TM
DR   Wikidata; Q112927681
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11926; TNFSF11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TNK2 KO
AC   CVCL_D1ZD
SY   Human TNK2 knockout A549
DR   Abcam; ab301275
DR   Wikidata; Q127378988
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19297; TNK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TP53 KO
AC   CVCL_B2QR
SY   Human TP53 (p53) knockout A549
DR   Abcam; ab276092
DR   cancercelllines; CVCL_B2QR
DR   Wikidata; Q110430366
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TP53BP1 KO
AC   CVCL_B9TN
SY   Human TP53BP1 knockout A549
DR   Abcam; ab288957
DR   cancercelllines; CVCL_B9TN
DR   Wikidata; Q112927682
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TP63 KO
AC   CVCL_B9TP
SY   Human TP63 knockout A549
DR   Abcam; ab286709
DR   cancercelllines; CVCL_B9TP
DR   Wikidata; Q112927683
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15979; TP63.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TPM1 KO
AC   CVCL_D1ZE
SY   Human TPM1 knockout A549
DR   Abcam; ab301278
DR   Wikidata; Q127378989
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12010; TPM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TRAF1 KO
AC   CVCL_B9TQ
SY   Human TRAF1 knockout A549
DR   Abcam; ab288962
DR   cancercelllines; CVCL_B9TQ
DR   Wikidata; Q112927684
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12031; TRAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRANK1 KO 1
AC   CVCL_B1I8
SY   Human TRANK1 knockout A549
DR   Abcam; ab267186
DR   cancercelllines; CVCL_B1I8
DR   Wikidata; Q110430367
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29011; TRANK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRANK1 KO 2
AC   CVCL_B2QS
SY   Human TRANK1 knockout A549
DR   Abcam; ab267187
DR   cancercelllines; CVCL_B2QS
DR   Wikidata; Q110430368
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29011; TRANK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRAP1 KO
AC   CVCL_C7DR
SY   Human TRAP1 knockout A549
DR   Abcam; ab301281
DR   Wikidata; Q123030414
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16264; TRAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 TREM1 KO
AC   CVCL_D1ZF
SY   Human TREM1 knockout A549
DR   Abcam; ab301283
DR   Wikidata; Q127378990
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17760; TREM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TREX1 KO
AC   CVCL_B1I9
SY   Human TREX1 knockout A549
DR   Abcam; ab266927
DR   cancercelllines; CVCL_B1I9
DR   Wikidata; Q110430369
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM14 KO 1
AC   CVCL_B2QT
SY   Human TRIM14 knockout A549
DR   Abcam; ab267175
DR   cancercelllines; CVCL_B2QT
DR   Wikidata; Q110430370
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16283; TRIM14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM14 KO 2
AC   CVCL_B1IA
SY   Human TRIM14 knockout A549
DR   Abcam; ab267176
DR   cancercelllines; CVCL_B1IA
DR   Wikidata; Q110430371
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16283; TRIM14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM21 KO 1
AC   CVCL_B2QU
SY   Human TRIM21 (SS-A) knockout A549
DR   Abcam; ab267024
DR   cancercelllines; CVCL_B2QU
DR   Wikidata; Q110430372
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM21 KO 2
AC   CVCL_B1IB
SY   Human TRIM21 (SS-A) knockout A549
DR   Abcam; ab267025
DR   cancercelllines; CVCL_B1IB
DR   Wikidata; Q110430373
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM22 KO
AC   CVCL_B2QV
SY   Human TRIM22 knockout A549
DR   Abcam; ab266996
DR   cancercelllines; CVCL_B2QV
DR   Wikidata; Q110430374
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16379; TRIM22.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM24 KO
AC   CVCL_B9TR
SY   Human TRIM24 knockout A549
DR   Abcam; ab289021
DR   cancercelllines; CVCL_B9TR
DR   Wikidata; Q112927685
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11812; TRIM24.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM28 KO
AC   CVCL_B9TS
SY   Human TRIM28 knockout A549
DR   Abcam; ab288842
DR   cancercelllines; CVCL_B9TS
DR   Wikidata; Q112927686
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16384; TRIM28.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM33 KO
AC   CVCL_B9TT
SY   Human TRIM33 knockout A549
DR   Abcam; ab288836
DR   cancercelllines; CVCL_B9TT
DR   Wikidata; Q112927687
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16290; TRIM33.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM34 KO 1
AC   CVCL_B1IC
SY   Human TRIM34 (RNF21/IFP1) knockout A549
DR   Abcam; ab267011
DR   cancercelllines; CVCL_B1IC
DR   Wikidata; Q110430375
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10063; TRIM34.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM34 KO 2
AC   CVCL_B2QW
SY   Human TRIM34 (RNF21/IFP1) knockout A549
DR   Abcam; ab267012
DR   cancercelllines; CVCL_B2QW
DR   Wikidata; Q110430376
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10063; TRIM34.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM38 KO 1
AC   CVCL_B1ID
SY   Human TRIM38 knockout A549
DR   Abcam; ab267154
DR   cancercelllines; CVCL_B1ID
DR   Wikidata; Q110430377
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10059; TRIM38.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM38 KO 2
AC   CVCL_B2QX
SY   Human TRIM38 knockout A549
DR   Abcam; ab267155
DR   cancercelllines; CVCL_B2QX
DR   Wikidata; Q110430378
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10059; TRIM38.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM56 KO 1
AC   CVCL_B1IE
SY   Human TRIM56 knockout A549
DR   Abcam; ab267062
DR   cancercelllines; CVCL_B1IE
DR   Wikidata; Q110430379
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19028; TRIM56.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRIM56 KO 2
AC   CVCL_B2QY
SY   Human TRIM56 knockout A549
DR   Abcam; ab267063
DR   cancercelllines; CVCL_B2QY
DR   Wikidata; Q110430380
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19028; TRIM56.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TRPC1 KO
AC   CVCL_D1ZG
SY   Human TRPC1 knockout A549
DR   Abcam; ab301285
DR   Wikidata; Q127378992
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12333; TRPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TRPM8 KO
AC   CVCL_D1ZH
SY   Human TRPM8 knockout A549
DR   Abcam; ab301287
DR   Wikidata; Q127378993
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17961; TRPM8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TSC1 KO
AC   CVCL_B9TU
SY   Human TSC1 knockout A549
DR   Abcam; ab280823
DR   cancercelllines; CVCL_B9TU
DR   Wikidata; Q112927688
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TSC2 KO
AC   CVCL_B9TV
SY   Human TSC2 (Tuberin) knockout A549
DR   Abcam; ab277867
DR   cancercelllines; CVCL_B9TV
DR   Wikidata; Q112927689
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 TUBA4A KO
AC   CVCL_D1ZI
SY   Human TUBA4A knockout A549
DR   Abcam; ab301290
DR   Wikidata; Q127378994
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12407; TUBA4A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 TXNRD1 KO
AC   CVCL_C7DS
SY   Human TXNRD1 knockout A549
DR   Abcam; ab301296
DR   Wikidata; Q123030415
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12437; TXNRD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 TXNIP KO
AC   CVCL_C7DT
SY   Human TXNIP knockout A549
DR   Abcam; ab301293
DR   Wikidata; Q123030416
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16952; TXNIP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam A-549 UBB KO
AC   CVCL_B9TW
SY   Human UBB knockout A549
DR   Abcam; ab289041
DR   cancercelllines; CVCL_B9TW
DR   Wikidata; Q112927690
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12463; UBB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 UCP2 KO
AC   CVCL_D1ZJ
SY   Human UCP2 knockout A549
DR   Abcam; ab301302
DR   Wikidata; Q127378995
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 UHRF1 KO
AC   CVCL_B9TX
SY   Human UHRF1 knockout A549
DR   Abcam; ab289050
DR   cancercelllines; CVCL_B9TX
DR   Wikidata; Q112927691
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12556; UHRF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ULK1 KO
AC   CVCL_B9TY
SY   Human ULK1 knockout A549
DR   Abcam; ab277825
DR   cancercelllines; CVCL_B9TY
DR   Wikidata; Q112927692
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 USP18 KO 1
AC   CVCL_B1IF
SY   Human USP18 (UBP43) knockout A549
DR   Abcam; ab267177
DR   cancercelllines; CVCL_B1IF
DR   Wikidata; Q110430381
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 USP18 KO 2
AC   CVCL_B2QZ
SY   Human USP18 (UBP43) knockout A549
DR   Abcam; ab267178
DR   cancercelllines; CVCL_B2QZ
DR   Wikidata; Q110430383
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 USP22 KO
AC   CVCL_B9TZ
SY   Human USP22 knockout A549
DR   Abcam; ab289031
DR   cancercelllines; CVCL_B9TZ
DR   Wikidata; Q112927693
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 USP8 KO
AC   CVCL_B9U0
SY   Human USP8 knockout A549
DR   Abcam; ab286793
DR   cancercelllines; CVCL_B9U0
DR   Wikidata; Q112927694
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 VCAM1 KO
AC   CVCL_B1IG
SY   Human VCAM1 knockout A549
DR   Abcam; ab273758
DR   cancercelllines; CVCL_B1IG
DR   Wikidata; Q110430384
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12663; VCAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 VDR KO
AC   CVCL_B9U1
SY   Human VDR knockout A549
DR   Abcam; ab288954
DR   cancercelllines; CVCL_B9U1
DR   Wikidata; Q112927695
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 VEGFA KO
AC   CVCL_B9U2
SY   Human VEGFA knockout A549
DR   Abcam; ab289054
DR   cancercelllines; CVCL_B9U2
DR   Wikidata; Q112927696
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 VEGFC KO
AC   CVCL_B9U3
SY   Human VEGFC knockout A549
DR   Abcam; ab288969
DR   cancercelllines; CVCL_B9U3
DR   Wikidata; Q112927697
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12682; VEGFC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 VIM KO
AC   CVCL_B9U4
SY   Human VIM knockout A549
DR   Abcam; ab288984
DR   cancercelllines; CVCL_B9U4
DR   Wikidata; Q112927698
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 VSIR KO
AC   CVCL_B9U5
SY   Human VSIR knockout A549
DR   Abcam; ab289051
DR   cancercelllines; CVCL_B9U5
DR   Wikidata; Q112927699
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30085; VSIR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 VTCN1 KO
AC   CVCL_B9U6
SY   Human VTCN1 knockout A549
DR   Abcam; ab289052
DR   cancercelllines; CVCL_B9U6
DR   Wikidata; Q112927700
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28873; VTCN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 WIF1 KO
AC   CVCL_B9U7
SY   Human WIF1 knockout A549
DR   Abcam; ab277907
DR   cancercelllines; CVCL_B9U7
DR   Wikidata; Q112927701
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18081; WIF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 WNK1 KO
AC   CVCL_D1ZK
SY   Human WNK1 knockout A549
DR   Abcam; ab301304
DR   Wikidata; Q127378996
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14540; WNK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 WNT3A KO
AC   CVCL_B9U8
SY   Human Wnt3a knockout A549
DR   Abcam; ab289042
DR   cancercelllines; CVCL_B9U8
DR   Wikidata; Q112927702
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15983; WNT3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 WNT5A KO
AC   CVCL_B9U9
SY   Human WNT5A knockout A549
DR   Abcam; ab277822
DR   cancercelllines; CVCL_B9U9
DR   Wikidata; Q112927703
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12784; WNT5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 WRN KO
AC   CVCL_B9UA
SY   Human WRN knockout A549
DR   Abcam; ab286690
DR   cancercelllines; CVCL_B9UA
DR   Wikidata; Q112927704
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12791; WRN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 WT1 KO
AC   CVCL_B9UB
SY   Human WT1 knockout A549
DR   Abcam; ab289056
DR   cancercelllines; CVCL_B9UB
DR   Wikidata; Q112927705
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 WWTR1 KO
AC   CVCL_B9UC
SY   Human WWTR1 knockout A549
DR   Abcam; ab286794
DR   cancercelllines; CVCL_B9UC
DR   Wikidata; Q112927706
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 XBP1 KO
AC   CVCL_D1ZL
SY   Human XBP1 knockout A549
DR   Abcam; ab301307
DR   Wikidata; Q127378997
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12801; XBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 XDH KO
AC   CVCL_D1ZM
SY   Human XDH knockout A549
DR   Abcam; ab301310
DR   Wikidata; Q127378998
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12805; XDH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam A-549 XIAP KO
AC   CVCL_B9UD
SY   Human XIAP knockout A549
DR   Abcam; ab289043
DR   cancercelllines; CVCL_B9UD
DR   Wikidata; Q112927707
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 XPC KO
AC   CVCL_B9UE
SY   Human XPC knockout A549
DR   Abcam; ab286663
DR   cancercelllines; CVCL_B9UE
DR   Wikidata; Q112927708
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12816; XPC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 XPO1 KO
AC   CVCL_B7VL
SY   Human xpo1 knockout A549
DR   Abcam; ab289044
DR   cancercelllines; CVCL_B7VL
DR   Wikidata; Q112927709
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12825; XPO1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 YTHDF2 KO
AC   CVCL_B9UF
SY   Human YTHDF2 knockout A549
DR   Abcam; ab289053
DR   cancercelllines; CVCL_B9UF
DR   Wikidata; Q112927710
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31675; YTHDF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 YWHAB KO
AC   CVCL_B9UG
SY   Human YWHAB knockout A549
DR   Abcam; ab289045
DR   cancercelllines; CVCL_B9UG
DR   Wikidata; Q112927711
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12849; YWHAB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 YWHAQ KO
AC   CVCL_B9UH
SY   Human YWHAQ knockout A549
DR   Abcam; ab277856
DR   cancercelllines; CVCL_B9UH
DR   Wikidata; Q112927712
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12854; YWHAQ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ZBTB16 KO
AC   CVCL_B9UI
SY   Human ZBTB16 knockout A549
DR   Abcam; ab286682
DR   cancercelllines; CVCL_B9UI
DR   Wikidata; Q112927713
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12930; ZBTB16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ZC3HAV1 KO 1
AC   CVCL_B2R0
SY   Human ZC3HAV1 (Zinc finger antiviral protein) knockout A549
DR   Abcam; ab266951
DR   cancercelllines; CVCL_B2R0
DR   Wikidata; Q110430385
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23721; ZC3HAV1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ZC3HAV1 KO 2
AC   CVCL_B1IH
SY   Human ZC3HAV1 (Zinc finger antiviral protein) knockout A549
DR   Abcam; ab266952
DR   cancercelllines; CVCL_B1IH
DR   Wikidata; Q110430386
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23721; ZC3HAV1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ZCCHC2 KO 1
AC   CVCL_B2R1
SY   Human ZCCHC2 knockout A549
DR   Abcam; ab267173
DR   cancercelllines; CVCL_B2R1
DR   Wikidata; Q110430387
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22916; ZCCHC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ZCCHC2 KO 2
AC   CVCL_B1II
SY   Human ZCCHC2 knockout A549
DR   Abcam; ab267174
DR   cancercelllines; CVCL_B1II
DR   Wikidata; Q110430388
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22916; ZCCHC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam A-549 ZEB1 KO
AC   CVCL_B9UJ
SY   Human ZEB1 knockout A549
DR   Abcam; ab286670
DR   cancercelllines; CVCL_B9UJ
DR   Wikidata; Q112927714
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Caco-2 ACE2 KO
AC   CVCL_B0YL
SY   Human ACE2 knockout Caco-2
DR   Abcam; ab273731
DR   cancercelllines; CVCL_B0YL
DR   Wikidata; Q110430389
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13557; ACE2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Caco-2 BMP2 KO
AC   CVCL_C0BL
SY   Human BMP2 knockout Caco-2
DR   Abcam; ab280046
DR   cancercelllines; CVCL_C0BL
DR   Wikidata; Q112927715
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1069; BMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Caco-2 TMPRSS2 KO
AC   CVCL_C0BM
SY   Human TMPRSS2 knockout Caco-2
DR   Abcam; ab273737
DR   cancercelllines; CVCL_C0BM
DR   Wikidata; Q112927716
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11876; TMPRSS2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Calu-3 TMPRSS2 KO
AC   CVCL_B0ZC
SY   Human TMPRSS2 knockout Calu-3
DR   Abcam; ab273734
DR   cancercelllines; CVCL_B0ZC
DR   Wikidata; Q110430391
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11876; TMPRSS2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0609 ! Calu-3
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HCT 116 ABCA1 KO
AC   CVCL_D1ZN
SY   Human ABCA1 knockout HCT116
DR   Abcam; ab300812
DR   Wikidata; Q127378999
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29; ABCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ABCC1 KO
AC   CVCL_B8AQ
SY   Human ABCC1 knockout HCT116
DR   Abcam; ab286569
DR   cancercelllines; CVCL_B8AQ
DR   Wikidata; Q112927717
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ABCC4 KO
AC   CVCL_D1ZP
SY   Human ABCC4 knockout HCT116
DR   Abcam; ab300814
DR   Wikidata; Q127379001
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:55; ABCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ABL2 KO
AC   CVCL_B8AR
SY   Human ABL2 knockout HCT116
DR   Abcam; ab286508
DR   cancercelllines; CVCL_B8AR
DR   Wikidata; Q112927718
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ACACA KO
AC   CVCL_D1ZQ
SY   Human ACACA knockout HCT116
DR   Abcam; ab300817
DR   Wikidata; Q127379002
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:84; ACACA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ACKR3 KO
AC   CVCL_B8AS
SY   Human ACKR3 knockout HCT116
DR   Abcam; ab287185
DR   cancercelllines; CVCL_B8AS
DR   Wikidata; Q112927719
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23692; ACKR3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ACLY KO
AC   CVCL_D1ZR
SY   Human ACLY knockout HCT116
DR   Abcam; ab300820
DR   Wikidata; Q127379003
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:115; ACLY.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ACTA2 KO
AC   CVCL_B8AT
SY   Human ACTA2 knockout HCT116
DR   Abcam; ab287189
DR   cancercelllines; CVCL_B8AT
DR   Wikidata; Q112927720
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:130; ACTA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ACVR1 KO
AC   CVCL_D1ZS
SY   Human ACVR1 knockout HCT116
DR   Abcam; ab300823
DR   Wikidata; Q127379005
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:171; ACVR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ACVR1B KO
AC   CVCL_B8AU
SY   Human ACVR1B knockout HCT116
DR   Abcam; ab287196
DR   cancercelllines; CVCL_B8AU
DR   Wikidata; Q112927721
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:172; ACVR1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ADA KO
AC   CVCL_B8AV
SY   Human ADA knockout HCT116
DR   Abcam; ab289097
DR   cancercelllines; CVCL_B8AV
DR   Wikidata; Q112927722
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:186; ADA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ADAM10 KO
AC   CVCL_B8AW
SY   Human ADAM10 knockout HCT116
DR   Abcam; ab287198
DR   cancercelllines; CVCL_B8AW
DR   Wikidata; Q112927723
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ADAM17 KO
AC   CVCL_B1D7
SY   Human ADAM17 knockout HCT116
DR   Abcam; ab266873
DR   cancercelllines; CVCL_B1D7
DR   Wikidata; Q110430392
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 ADAR KO
AC   CVCL_B8AX
SY   Human ADAR knockout HCT116
DR   Abcam; ab289057
DR   cancercelllines; CVCL_B8AX
DR   Wikidata; Q112927724
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ADK KO
AC   CVCL_B8AY
SY   Human ADK knockout HCT116
DR   Abcam; ab289164
DR   cancercelllines; CVCL_B8AY
DR   Wikidata; Q112927725
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:257; ADK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ADORA2A KO
AC   CVCL_B8AZ
SY   Human ADORA2A knockout HCT116
DR   Abcam; ab289092
DR   cancercelllines; CVCL_B8AZ
DR   Wikidata; Q112927726
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ADRA2B KO
AC   CVCL_B8B0
SY   Human ADRA2B knockout HCT116
DR   Abcam; ab289174
DR   cancercelllines; CVCL_B8B0
DR   Wikidata; Q112927727
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:282; ADRA2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ADRB2 KO
AC   CVCL_B8B1
SY   Human ADRB2 knockout HCT116
DR   Abcam; ab287202
DR   cancercelllines; CVCL_B8B1
DR   Wikidata; Q112927728
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AFP KO
AC   CVCL_B8B2
SY   Human AFP knockout HCT116
DR   Abcam; ab289139
DR   cancercelllines; CVCL_B8B2
DR   Wikidata; Q112927729
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:317; AFP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AGER KO
AC   CVCL_D1ZT
SY   Human AGER knockout HCT116
DR   Abcam; ab300826
DR   Wikidata; Q127379006
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:320; AGER.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 AGO2 KO
AC   CVCL_B8B3
SY   Human AGO2 knockout HCT116
DR   Abcam; ab287205
DR   cancercelllines; CVCL_B8B3
DR   Wikidata; Q112927730
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3263; AGO2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AGO4 KO
AC   CVCL_B8B4
SY   Human AGO4 knockout HCT116
DR   Abcam; ab289171
DR   cancercelllines; CVCL_B8B4
DR   Wikidata; Q112927731
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18424; AGO4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AKR1B1 KO
AC   CVCL_D1ZU
SY   Human AKR1B1 knockout HCT116
DR   Abcam; ab300831
DR   Wikidata; Q127379007
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 AKT1 KO
AC   CVCL_B8B5
SY   Human AKT1 knockout HCT116
DR   Abcam; ab286570
DR   cancercelllines; CVCL_B8B5
DR   Wikidata; Q112927732
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AKT2 KO
AC   CVCL_B8B6
SY   Human AKT2 knockout HCT116
DR   Abcam; ab286638
DR   cancercelllines; CVCL_B8B6
DR   Wikidata; Q112927733
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AKT3 KO
AC   CVCL_B8B7
SY   Human AKT3 knockout HCT116
DR   Abcam; ab286639
DR   cancercelllines; CVCL_B8B7
DR   Wikidata; Q112927734
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ANGPT1 KO
AC   CVCL_B8B8
SY   Human ANGPT1 knockout HCT116
DR   Abcam; ab287208
DR   cancercelllines; CVCL_B8B8
DR   Wikidata; Q112927736
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:484; ANGPT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ANGPT2 KO
AC   CVCL_B8B9
SY   Human ANGPT2 knockout HCT116
DR   Abcam; ab287210
DR   cancercelllines; CVCL_B8B9
DR   Wikidata; Q112927737
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:485; ANGPT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ANO1 KO
AC   CVCL_D1ZV
SY   Human ANO1 knockout HCT116
DR   Abcam; ab300833
DR   Wikidata; Q127379008
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ANXA1 KO
AC   CVCL_B8BA
SY   Human ANXA1 knockout HCT116
DR   Abcam; ab287213
DR   cancercelllines; CVCL_B8BA
DR   Wikidata; Q112927738
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:533; ANXA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ANXA2 KO
AC   CVCL_D1ZW
SY   Human ANXA2 knockout HCT116
DR   Abcam; ab300836
DR   Wikidata; Q127379009
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:537; ANXA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ANXA5 KO
AC   CVCL_D1ZX
SY   Human ANXA5 knockout HCT116
DR   Abcam; ab300839
DR   Wikidata; Q127379010
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:543; ANXA5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 APAF1 KO
AC   CVCL_C7DU
SY   Human APAF1 knockout HCT116
DR   Abcam; ab300842
DR   Wikidata; Q123030417
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:576; APAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 APC KO
AC   CVCL_B8BB
SY   Human APC knockout HCT116
DR   Abcam; ab277914
DR   cancercelllines; CVCL_B8BB
DR   Wikidata; Q112927739
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AQP1 KO
AC   CVCL_D1ZY
SY   Human AQP1 knockout HCT116
DR   Abcam; ab300844
DR   Wikidata; Q127379012
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:633; AQP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 AQP2 KO
AC   CVCL_D1ZZ
SY   Human AQP2 knockout HCT116
DR   Abcam; ab300847
DR   Wikidata; Q127379013
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:634; AQP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 AQP4 KO
AC   CVCL_B8BC
SY   Human AQP4 knockout HCT116
DR   Abcam; ab286676
DR   cancercelllines; CVCL_B8BC
DR   Wikidata; Q112927740
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:637; AQP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AR KO
AC   CVCL_B8BD
SY   Human AR knockout HCT116
DR   Abcam; ab286526
DR   cancercelllines; CVCL_B8BD
DR   Wikidata; Q112927741
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ARAF KO
AC   CVCL_B8BE
SY   Human A-Raf knockout HCT116
DR   Abcam; ab286752
DR   cancercelllines; CVCL_B8BE
DR   Wikidata; Q112927742
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 AREG KO
AC   CVCL_B8BF
SY   Human AREG knockout HCT116
DR   Abcam; ab289175
DR   cancercelllines; CVCL_B8BF
DR   Wikidata; Q112927743
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:651; AREG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ARID1A KO
AC   CVCL_B7PS
SY   Human ARID1A knockout HCT116
DR   Abcam; ab287216
DR   cancercelllines; CVCL_B7PS
DR   Wikidata; Q112927744
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ARID1B KO
AC   CVCL_B8BG
SY   Human ARID1B knockout HCT116
DR   Abcam; ab287219
DR   cancercelllines; CVCL_B8BG
DR   Wikidata; Q112927745
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ARNT KO
AC   CVCL_B8BH
SY   Human ARNT knockout HCT116
DR   Abcam; ab287222
DR   cancercelllines; CVCL_B8BH
DR   Wikidata; Q112927746
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:700; ARNT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ARNTL KO
AC   CVCL_B8BI
SY   Human ARNTL knockout HCT116
DR   Abcam; ab289066
DR   cancercelllines; CVCL_B8BI
DR   Wikidata; Q112927747
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:701; BMAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 ASH2L KO
AC   CVCL_B8BJ
SY   Human ASH2L knockout HCT116
DR   Abcam; ab287225
DR   cancercelllines; CVCL_B8BJ
DR   Wikidata; Q112927748
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:744; ASH2L.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ASNS KO
AC   CVCL_D2A0
SY   Human ASNS knockout HCT116
DR   Abcam; ab300852
DR   Wikidata; Q127379014
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:753; ASNS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ATF2 KO
AC   CVCL_B8BK
SY   Human ATF2 knockout HCT116
DR   Abcam; ab287228
DR   cancercelllines; CVCL_B8BK
DR   Wikidata; Q112927749
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ATF3 KO
AC   CVCL_B1D8
SY   Human ATF3 knockout HCT116
DR   Abcam; ab266872
DR   cancercelllines; CVCL_B1D8
DR   Wikidata; Q110430393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 ATF6 KO
AC   CVCL_B8BL
SY   Human ATF6 knockout HCT116
DR   Abcam; ab289142
DR   cancercelllines; CVCL_B8BL
DR   Wikidata; Q112927750
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ATG14 KO
AC   CVCL_B8BM
SY   Human ATG14 (ATG14L) knockout HCT116
DR   Abcam; ab277832
DR   cancercelllines; CVCL_B8BM
DR   Wikidata; Q112927751
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ATP1B3 KO
AC   CVCL_D2A1
SY   Human ATP1B3 knockout HCT116
DR   Abcam; ab300854
DR   Wikidata; Q127379015
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:806; ATP1B3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ATRX KO
AC   CVCL_B8BN
SY   Human ATRX knockout HCT116
DR   Abcam; ab287231
DR   cancercelllines; CVCL_B8BN
DR   Wikidata; Q112927752
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 AXIN1 KO
AC   CVCL_B8BP
SY   Human AXIN1 knockout HCT116
DR   Abcam; ab286572
DR   cancercelllines; CVCL_B8BP
DR   Wikidata; Q112927753
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 B2M KO
AC   CVCL_B8BQ
SY   Human B2M knockout HCT116
DR   Abcam; ab286381
DR   cancercelllines; CVCL_B8BQ
DR   Wikidata; Q112927754
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BAD KO
AC   CVCL_B8BR
SY   Human BAD knockout HCT116
DR   Abcam; ab289110
DR   cancercelllines; CVCL_B8BR
DR   Wikidata; Q112927755
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BAX KO
AC   CVCL_B8BS
SY   Human BAX knockout HCT116
DR   Abcam; ab286382
DR   cancercelllines; CVCL_B8BS
DR   Wikidata; Q112927756
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BCAR1 KO
AC   CVCL_B8BT
SY   Human BCAR1 knockout HCT116
DR   Abcam; ab289178
DR   cancercelllines; CVCL_B8BT
DR   Wikidata; Q112927757
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:971; BCAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BCL10 KO
AC   CVCL_B8BU
SY   Human BCL10 knockout HCT116
DR   Abcam; ab286383
DR   cancercelllines; CVCL_B8BU
DR   Wikidata; Q112927758
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BCL11A KO
AC   CVCL_B8BV
SY   Human BCL11A knockout HCT116
DR   Abcam; ab286550
DR   cancercelllines; CVCL_B8BV
DR   Wikidata; Q112927759
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13221; BCL11A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BCL11B KO
AC   CVCL_B8BW
SY   Human BCL11B knockout HCT116
DR   Abcam; ab286543
DR   cancercelllines; CVCL_B8BW
DR   Wikidata; Q112927760
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13222; BCL11B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BCL2 KO
AC   CVCL_B8BX
SY   Human BCL2 knockout HCT116
DR   Abcam; ab286559
DR   cancercelllines; CVCL_B8BX
DR   Wikidata; Q112927761
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BCL3 KO
AC   CVCL_B8BY
SY   Human BCL3 knockout HCT116
DR   Abcam; ab286363
DR   cancercelllines; CVCL_B8BY
DR   Wikidata; Q112927762
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:998; BCL3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BCL6 KO
AC   CVCL_B8BZ
SY   Human BCL6 knockout HCT116
DR   Abcam; ab287234
DR   cancercelllines; CVCL_B8BZ
DR   Wikidata; Q112927763
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BHLHE40 KO
AC   CVCL_B8C0
SY   Human BHLHE40 knockout HCT116
DR   Abcam; ab289179
DR   cancercelllines; CVCL_B8C0
DR   Wikidata; Q112927764
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1046; BHLHE40.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BLM KO
AC   CVCL_B8C1
SY   Human BLM knockout HCT116
DR   Abcam; ab287237
DR   cancercelllines; CVCL_B8C1
DR   Wikidata; Q112927765
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1058; BLM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BMPR1A KO
AC   CVCL_B8C2
SY   Human BMPR1A knockout HCT116
DR   Abcam; ab286370
DR   cancercelllines; CVCL_B8C2
DR   Wikidata; Q112927766
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BRAF KO
AC   CVCL_B8C3
SY   Human BRAF knockout HCT116
DR   Abcam; ab286384
DR   cancercelllines; CVCL_B8C3
DR   Wikidata; Q112927767
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BRD3 KO
AC   CVCL_B8C4
SY   Human BRD3 knockout HCT116
DR   Abcam; ab287239
DR   cancercelllines; CVCL_B8C4
DR   Wikidata; Q112927768
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BRD4 KO
AC   CVCL_B8C5
SY   Human BRD4 knockout HCT116
DR   Abcam; ab286256
DR   cancercelllines; CVCL_B8C5
DR   Wikidata; Q112927769
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BRD7 KO
AC   CVCL_B8C6
SY   Human BRD7 knockout HCT116
DR   Abcam; ab287244
DR   cancercelllines; CVCL_B8C6
DR   Wikidata; Q112927770
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14310; BRD7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 BRIP1 KO
AC   CVCL_B8C7
SY   Human BRIP1 knockout HCT116
DR   Abcam; ab286452
DR   cancercelllines; CVCL_B8C7
DR   Wikidata; Q112927771
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20473; BRIP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 C1QBP KO
AC   CVCL_D2A2
SY   Human C1QBP knockout HCT116
DR   Abcam; ab300856
DR   Wikidata; Q127379016
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1243; C1QBP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 C3AR1 KO
AC   CVCL_B8C8
SY   Human C3AR1 knockout HCT116
DR   Abcam; ab289249
DR   cancercelllines; CVCL_B8C8
DR   Wikidata; Q112927772
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1319; C3AR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 C5AR1 KO
AC   CVCL_B8C9
SY   Human C5AR1 knockout HCT116
DR   Abcam; ab289255
DR   cancercelllines; CVCL_B8C9
DR   Wikidata; Q112927773
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1338; C5AR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CA9 KO
AC   CVCL_B8CA
SY   Human CA9 knockout HCT116
DR   Abcam; ab287249
DR   cancercelllines; CVCL_B8CA
DR   Wikidata; Q112927774
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1383; CA9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CACNA1D KO
AC   CVCL_B8CB
SY   Human CACNA1D knockout HCT116
DR   Abcam; ab289541
DR   cancercelllines; CVCL_B8CB
DR   Wikidata; Q112927775
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1391; CACNA1D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CALR KO
AC   CVCL_B8CC
SY   Human CALR knockout HCT116
DR   Abcam; ab286338
DR   cancercelllines; CVCL_B8CC
DR   Wikidata; Q112927776
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1455; CALR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CAPN1 KO
AC   CVCL_D2A3
SY   Human CAPN1 knockout HCT116
DR   Abcam; ab300859
DR   Wikidata; Q127379017
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1476; CAPN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CARD11 KO
AC   CVCL_B8CD
SY   Human CARD11 knockout HCT116
DR   Abcam; ab286509
DR   cancercelllines; CVCL_B8CD
DR   Wikidata; Q112927777
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16393; CARD11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CARD9 KO
AC   CVCL_B8CE
SY   Human CARD9 knockout HCT116
DR   Abcam; ab289224
DR   cancercelllines; CVCL_B8CE
DR   Wikidata; Q112927778
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16391; CARD9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CARM1 KO
AC   CVCL_B8CF
SY   Human CARM1 knockout HCT116
DR   Abcam; ab287253
DR   cancercelllines; CVCL_B8CF
DR   Wikidata; Q112927779
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CASP4 KO
AC   CVCL_C7DV
SY   Human CASP4 knockout HCT116
DR   Abcam; ab300862
DR   Wikidata; Q123030418
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1505; CASP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 CASP6 KO
AC   CVCL_D2A4
SY   Human CASP6 knockout HCT116
DR   Abcam; ab300864
DR   Wikidata; Q127379018
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1507; CASP6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CASP8 KO
AC   CVCL_B8CG
SY   Human CASP8 knockout HCT116
DR   Abcam; ab286576
DR   cancercelllines; CVCL_B8CG
DR   Wikidata; Q112927780
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CBL KO
AC   CVCL_B8CH
SY   Human CBL knockout HCT116
DR   Abcam; ab287255
DR   cancercelllines; CVCL_B8CH
DR   Wikidata; Q112927781
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CBLB KO
AC   CVCL_B8CI
SY   Human CBLB knockout HCT116
DR   Abcam; ab286577
DR   cancercelllines; CVCL_B8CI
DR   Wikidata; Q112927782
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1542; CBLB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CBX5 KO
AC   CVCL_D2A5
SY   Human CBX5 knockout HCT116
DR   Abcam; ab300868
DR   Wikidata; Q127379019
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CCL3 KO
AC   CVCL_B8CJ
SY   Human CCL3 knockout HCT116
DR   Abcam; ab289225
DR   cancercelllines; CVCL_B8CJ
DR   Wikidata; Q112927783
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10627; CCL3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCND2 KO
AC   CVCL_B8CK
SY   Human CCND2 knockout HCT116
DR   Abcam; ab287258
DR   cancercelllines; CVCL_B8CK
DR   Wikidata; Q112927784
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCNE1 KO
AC   CVCL_B8CL
SY   Human CCNE1 knockout HCT116
DR   Abcam; ab286494
DR   cancercelllines; CVCL_B8CL
DR   Wikidata; Q112927785
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1589; CCNE1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCR1 KO
AC   CVCL_D2A6
SY   Human CCR1 knockout HCT116
DR   Abcam; ab300874
DR   Wikidata; Q127379020
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1602; CCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CCR3 KO
AC   CVCL_B8CM
SY   Human CCR3 knockout HCT116
DR   Abcam; ab289162
DR   cancercelllines; CVCL_B8CM
DR   Wikidata; Q112927786
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1604; CCR3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCR4 KO
AC   CVCL_B8CN
SY   Human CCR4 knockout HCT116
DR   Abcam; ab287261
DR   cancercelllines; CVCL_B8CN
DR   Wikidata; Q112927787
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1605; CCR4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCR5 KO
AC   CVCL_B8CP
SY   Human CCR5 knockout HCT116
DR   Abcam; ab289220
DR   cancercelllines; CVCL_B8CP
DR   Wikidata; Q112927788
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1606; CCR5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCR6 KO
AC   CVCL_B8CQ
SY   Human CCR6 knockout HCT116
DR   Abcam; ab287264
DR   cancercelllines; CVCL_B8CQ
DR   Wikidata; Q112927789
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1607; CCR6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCR7 KO
AC   CVCL_B8CR
SY   Human CCR7 knockout HCT116
DR   Abcam; ab287267
DR   cancercelllines; CVCL_B8CR
DR   Wikidata; Q112927790
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1608; CCR7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CCR9 KO
AC   CVCL_B8CS
SY   Human CCR9 knockout HCT116
DR   Abcam; ab289190
DR   cancercelllines; CVCL_B8CS
DR   Wikidata; Q112927791
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1610; CCR9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD14 KO
AC   CVCL_B8CT
SY   Human CD14 knockout HCT116
DR   Abcam; ab287271
DR   cancercelllines; CVCL_B8CT
DR   Wikidata; Q112927792
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1628; CD14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD163 KO
AC   CVCL_B8CU
SY   Human CD163 knockout HCT116
DR   Abcam; ab289118
DR   cancercelllines; CVCL_B8CU
DR   Wikidata; Q112927793
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1631; CD163.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD19 KO
AC   CVCL_B8CV
SY   Human CD19 knockout HCT116
DR   Abcam; ab287274
DR   cancercelllines; CVCL_B8CV
DR   Wikidata; Q112927794
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD209 KO
AC   CVCL_B8CW
SY   Human CD209 knockout HCT116
DR   Abcam; ab287275
DR   cancercelllines; CVCL_B8CW
DR   Wikidata; Q112927795
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1641; CD209.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD226 KO
AC   CVCL_B8CX
SY   Human CD226 knockout HCT116
DR   Abcam; ab289261
DR   cancercelllines; CVCL_B8CX
DR   Wikidata; Q112927796
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16961; CD226.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD28 KO
AC   CVCL_B8CY
SY   Human CD28 knockout HCT116
DR   Abcam; ab287280
DR   cancercelllines; CVCL_B8CY
DR   Wikidata; Q112927797
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD2BP2 KO
AC   CVCL_B1D9
SY   Human CD2BP2 knockout HCT116
DR   Abcam; ab266885
DR   cancercelllines; CVCL_B1D9
DR   Wikidata; Q110430394
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1656; CD2BP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 CD34 KO
AC   CVCL_B8CZ
SY   Human CD34 knockout HCT116
DR   Abcam; ab289195
DR   cancercelllines; CVCL_B8CZ
DR   Wikidata; Q112927798
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1662; CD34.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD38 KO
AC   CVCL_B8D0
SY   Human CD38 knockout HCT116
DR   Abcam; ab289252
DR   cancercelllines; CVCL_B8D0
DR   Wikidata; Q112927800
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1667; CD38.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD3E KO
AC   CVCL_B8D1
SY   Human CD3E knockout HCT116
DR   Abcam; ab287282
DR   cancercelllines; CVCL_B8D1
DR   Wikidata; Q112927801
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD4 KO
AC   CVCL_B8D2
SY   Human CD4 knockout HCT116
DR   Abcam; ab287286
DR   cancercelllines; CVCL_B8D2
DR   Wikidata; Q112927802
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1678; CD4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD40LG KO
AC   CVCL_B8D3
SY   Human CD40LG knockout HCT116
DR   Abcam; ab289208
DR   cancercelllines; CVCL_B8D3
DR   Wikidata; Q112927803
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11935; CD40LG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD46 KO
AC   CVCL_D2A7
SY   Human CD46 knockout HCT116
DR   Abcam; ab300877
DR   Wikidata; Q127379021
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CD5 KO
AC   CVCL_B8D4
SY   Human CD5 knockout HCT116
DR   Abcam; ab289169
DR   cancercelllines; CVCL_B8D4
DR   Wikidata; Q112927804
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1685; CD5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD69 KO
AC   CVCL_B8D5
SY   Human CD69 knockout HCT116
DR   Abcam; ab289152
DR   cancercelllines; CVCL_B8D5
DR   Wikidata; Q112927805
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1694; CD69.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD7 KO
AC   CVCL_B8D6
SY   Human CD7 knockout HCT116
DR   Abcam; ab289088
DR   cancercelllines; CVCL_B8D6
DR   Wikidata; Q112927806
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1695; CD7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD74 KO
AC   CVCL_B8D7
SY   Human CD74 knockout HCT116
DR   Abcam; ab287292
DR   cancercelllines; CVCL_B8D7
DR   Wikidata; Q112927807
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD79A KO
AC   CVCL_B8D8
SY   Human CD79A knockout HCT116
DR   Abcam; ab287293
DR   cancercelllines; CVCL_B8D8
DR   Wikidata; Q112927808
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1698; CD79A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD80 KO
AC   CVCL_B8D9
SY   Human CD80 knockout HCT116
DR   Abcam; ab287298
DR   cancercelllines; CVCL_B8D9
DR   Wikidata; Q112927809
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1700; CD80.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD86 KO
AC   CVCL_B8DA
SY   Human CD86 knockout HCT116
DR   Abcam; ab287301
DR   cancercelllines; CVCL_B8DA
DR   Wikidata; Q112927810
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1705; CD86.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CD8A KO
AC   CVCL_B8DB
SY   Human CD8A knockout HCT116
DR   Abcam; ab289200
DR   cancercelllines; CVCL_B8DB
DR   Wikidata; Q112927811
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1706; CD8A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDA KO
AC   CVCL_D2A8
SY   Human CDA knockout HCT116
DR   Abcam; ab300882
DR   Wikidata; Q127379022
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1712; CDA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CDH11 KO
AC   CVCL_B8DC
SY   Human CDH11 knockout HCT116
DR   Abcam; ab286453
DR   cancercelllines; CVCL_B8DC
DR   Wikidata; Q112927812
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1750; CDH11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDH5 KO
AC   CVCL_D2A9
SY   Human CDH5 knockout HCT116
DR   Abcam; ab300884
DR   Wikidata; Q127379023
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1764; CDH5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CDK4 KO
AC   CVCL_B8DD
SY   Human CDK4 knockout HCT116
DR   Abcam; ab286760
DR   cancercelllines; CVCL_B8DD
DR   Wikidata; Q112927813
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1773; CDK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDK5 KO
AC   CVCL_B8DE
SY   Human CDK5 knockout HCT116
DR   Abcam; ab287303
DR   cancercelllines; CVCL_B8DE
DR   Wikidata; Q112927814
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDK6 KO
AC   CVCL_B8DF
SY   Human CDK6 knockout HCT116
DR   Abcam; ab287306
DR   cancercelllines; CVCL_B8DF
DR   Wikidata; Q112927815
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDK8 KO
AC   CVCL_B8DG
SY   Human CDK8 knockout HCT116
DR   Abcam; ab287309
DR   cancercelllines; CVCL_B8DG
DR   Wikidata; Q112927816
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1779; CDK8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDKN1A KO 1
AC   CVCL_B1DA
SY   Human CDKN1A knockout HCT116
DR   Abcam; ab266860
DR   cancercelllines; CVCL_B1DA
DR   Wikidata; Q110430395
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 CDKN1A KO 2
AC   CVCL_B8AN
SY   Human CDKN1A knockout HCT116
DR   Abcam; ab288187
DR   cancercelllines; CVCL_B8AN
DR   Wikidata; Q112927817
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDKN1B KO
AC   CVCL_B8DH
SY   Human CDKN1B knockout HCT116
DR   Abcam; ab286580
DR   cancercelllines; CVCL_B8DH
DR   Wikidata; Q112927818
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDKN1C KO
AC   CVCL_B8DI
SY   Human CDKN1C knockout HCT116
DR   Abcam; ab289263
DR   cancercelllines; CVCL_B8DI
DR   Wikidata; Q112927819
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1786; CDKN1C.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CDX2 KO
AC   CVCL_B8DJ
SY   Human CDX2 knockout HCT116
DR   Abcam; ab287314
DR   cancercelllines; CVCL_B8DJ
DR   Wikidata; Q112927820
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1806; CDX2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CEACAM5 KO
AC   CVCL_B8DK
SY   Human CEACAM5 knockout HCT116
DR   Abcam; ab287318
DR   cancercelllines; CVCL_B8DK
DR   Wikidata; Q112927821
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1817; CEACAM5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CEBPA KO
AC   CVCL_B8DL
SY   Human CEBPA knockout HCT116
DR   Abcam; ab286534
DR   cancercelllines; CVCL_B8DL
DR   Wikidata; Q112927822
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CHAT KO
AC   CVCL_D2AA
SY   Human CHAT knockout HCT116
DR   Abcam; ab300893
DR   Wikidata; Q127379024
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1912; CHAT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CHD5 KO
AC   CVCL_B8DM
SY   Human CHD5 knockout HCT116
DR   Abcam; ab288188
DR   cancercelllines; CVCL_B8DM
DR   Wikidata; Q112927823
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16816; CHD5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CHD7 KO
AC   CVCL_B8DN
SY   Human CHD7 knockout HCT116
DR   Abcam; ab289116
DR   cancercelllines; CVCL_B8DN
DR   Wikidata; Q112927824
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20626; CHD7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CHD8 KO
AC   CVCL_B8DP
SY   Human CHD8 knockout HCT116
DR   Abcam; ab289059
DR   cancercelllines; CVCL_B8DP
DR   Wikidata; Q112927825
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CHD9 KO
AC   CVCL_B8DQ
SY   Human CHD9 knockout HCT116
DR   Abcam; ab288189
DR   cancercelllines; CVCL_B8DQ
DR   Wikidata; Q112927826
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25701; CHD9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CHUK KO
AC   CVCL_B8DR
SY   Human CHUK knockout HCT116
DR   Abcam; ab287322
DR   cancercelllines; CVCL_B8DR
DR   Wikidata; Q112927827
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CIRBP KO
AC   CVCL_B8DS
SY   Human CIRBP knockout HCT116
DR   Abcam; ab289147
DR   cancercelllines; CVCL_B8DS
DR   Wikidata; Q112927828
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1982; CIRBP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CISH KO
AC   CVCL_B8DT
SY   Human CISH knockout HCT116
DR   Abcam; ab289217
DR   cancercelllines; CVCL_B8DT
DR   Wikidata; Q112927829
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1984; CISH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CKAP4 KO
AC   CVCL_D2AB
SY   Human CKAP4 knockout HCT116
DR   Abcam; ab300895
DR   Wikidata; Q127379025
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16991; CKAP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CLDN18 KO
AC   CVCL_B8DU
SY   Human CLDN18 knockout HCT116
DR   Abcam; ab289093
DR   cancercelllines; CVCL_B8DU
DR   Wikidata; Q112927830
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2039; CLDN18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CLDN3 KO
AC   CVCL_D2AC
SY   Human CLDN3 knockout HCT116
DR   Abcam; ab300897
DR   Wikidata; Q127379026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2045; CLDN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CLOCK KO
AC   CVCL_B8DV
SY   Human CLOCK knockout HCT116
DR   Abcam; ab287325
DR   cancercelllines; CVCL_B8DV
DR   Wikidata; Q112927831
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CNOT6 KO
AC   CVCL_B8DW
SY   Human CNOT6 knockout HCT116
DR   Abcam; ab289146
DR   cancercelllines; CVCL_B8DW
DR   Wikidata; Q112927832
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14099; CNOT6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CNTNAP2 KO
AC   CVCL_B8DX
SY   Human CNTNAP2 knockout HCT116
DR   Abcam; ab286558
DR   cancercelllines; CVCL_B8DX
DR   Wikidata; Q112927833
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13830; CNTNAP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 COL1A1 KO
AC   CVCL_B8DY
SY   Human COL1A1 knockout HCT116
DR   Abcam; ab287328
DR   cancercelllines; CVCL_B8DY
DR   Wikidata; Q112927834
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CR2 KO
AC   CVCL_B8DZ
SY   Human CR2 knockout HCT116
DR   Abcam; ab289117
DR   cancercelllines; CVCL_B8DZ
DR   Wikidata; Q112927835
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2336; CR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CRBN KO
AC   CVCL_B8E0
SY   Human CRBN knockout HCT116
DR   Abcam; ab289186
DR   cancercelllines; CVCL_B8E0
DR   Wikidata; Q112927836
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CREB1 KO
AC   CVCL_B8E1
SY   Human CREB1 knockout HCT116
DR   Abcam; ab286536
DR   cancercelllines; CVCL_B8E1
DR   Wikidata; Q112927837
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CREBBP KO
AC   CVCL_B8E2
SY   Human CREBBP knockout HCT116
DR   Abcam; ab286582
DR   cancercelllines; CVCL_B8E2
DR   Wikidata; Q112927838
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CRLF2 KO
AC   CVCL_B8E3
SY   Human CRLF2 knockout HCT116
DR   Abcam; ab287330
DR   cancercelllines; CVCL_B8E3
DR   Wikidata; Q112927839
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14281; CRLF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CRTC1 KO
AC   CVCL_D2AD
SY   Human CRTC1 knockout HCT116
DR   Abcam; ab300899
DR   Wikidata; Q127379027
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16062; CRTC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CSF1 KO
AC   CVCL_B8E4
SY   Human CSF1 knockout HCT116
DR   Abcam; ab289076
DR   cancercelllines; CVCL_B8E4
DR   Wikidata; Q112927840
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CSF1R KO
AC   CVCL_B8E5
SY   Human CSF1R knockout HCT116
DR   Abcam; ab287334
DR   cancercelllines; CVCL_B8E5
DR   Wikidata; Q112927841
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CSF3R KO
AC   CVCL_B8E6
SY   Human CSF3R knockout HCT116
DR   Abcam; ab287338
DR   cancercelllines; CVCL_B8E6
DR   Wikidata; Q112927842
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2439; CSF3R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CSK KO
AC   CVCL_D2AE
SY   Human CSK knockout HCT116
DR   Abcam; ab300901
DR   Wikidata; Q127379028
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2444; CSK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CSNK2A1 KO
AC   CVCL_B1DB
SY   Human CSNK2A1 knockout HCT116
DR   Abcam; ab266864
DR   cancercelllines; CVCL_B1DB
DR   Wikidata; Q110430397
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2457; CSNK2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 CSPG4 KO
AC   CVCL_B8E7
SY   Human CSPG4 knockout HCT116
DR   Abcam; ab289210
DR   cancercelllines; CVCL_B8E7
DR   Wikidata; Q112927843
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2466; CSPG4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CTLA4 KO
AC   CVCL_B8E8
SY   Human CTLA4 knockout HCT116
DR   Abcam; ab287342
DR   cancercelllines; CVCL_B8E8
DR   Wikidata; Q112927844
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2505; CTLA4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CTNNB1 KO
AC   CVCL_B1DC
SY   Human CTNNB1 (beta Catenin II) knockout HCT116
DR   Abcam; ab273712
DR   cancercelllines; CVCL_B1DC
DR   Wikidata; Q110430398
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 CUL4A KO
AC   CVCL_D2AF
SY   Human CUL4A knockout HCT116
DR   Abcam; ab300907
DR   Wikidata; Q127379029
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2554; CUL4A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 CX3CL1 KO
AC   CVCL_B8E9
SY   Human CX3CL1 knockout HCT116
DR   Abcam; ab289237
DR   cancercelllines; CVCL_B8E9
DR   Wikidata; Q112927845
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10647; CX3CL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CXCL11 KO
AC   CVCL_B8EA
SY   Human CXCL11 knockout HCT116
DR   Abcam; ab289068
DR   cancercelllines; CVCL_B8EA
DR   Wikidata; Q112927846
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10638; CXCL11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CXCL13 KO
AC   CVCL_B8EB
SY   Human CXCL13 knockout HCT116
DR   Abcam; ab289233
DR   cancercelllines; CVCL_B8EB
DR   Wikidata; Q112927847
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10639; CXCL13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CXCR1 KO
AC   CVCL_B8EC
SY   Human CXCR1 knockout HCT116
DR   Abcam; ab287344
DR   cancercelllines; CVCL_B8EC
DR   Wikidata; Q112927848
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6026; CXCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CXCR3 KO
AC   CVCL_B8ED
SY   Human CXCR3 knockout HCT116
DR   Abcam; ab289265
DR   cancercelllines; CVCL_B8ED
DR   Wikidata; Q112927849
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4540; CXCR3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CXCR4 KO
AC   CVCL_B8EE
SY   Human CXCR4 knockout HCT116
DR   Abcam; ab287346
DR   cancercelllines; CVCL_B8EE
DR   Wikidata; Q112927850
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CXCR6 KO
AC   CVCL_B8EF
SY   Human CXCR6 knockout HCT116
DR   Abcam; ab289262
DR   cancercelllines; CVCL_B8EF
DR   Wikidata; Q112927851
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16647; CXCR6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CYBB KO
AC   CVCL_B8EG
SY   Human CYBB knockout HCT116
DR   Abcam; ab287351
DR   cancercelllines; CVCL_B8EG
DR   Wikidata; Q112927852
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2578; CYBB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 CYLD KO
AC   CVCL_B8EH
SY   Human CYLD knockout HCT116
DR   Abcam; ab286454
DR   cancercelllines; CVCL_B8EH
DR   Wikidata; Q112927853
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DAXX KO
AC   CVCL_B8EI
SY   Human DAXX knockout HCT116
DR   Abcam; ab287355
DR   cancercelllines; CVCL_B8EI
DR   Wikidata; Q112927854
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DCC KO
AC   CVCL_B8EJ
SY   Human DCC knockout HCT116
DR   Abcam; ab286343
DR   cancercelllines; CVCL_B8EJ
DR   Wikidata; Q112927855
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2701; DCC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DCK KO
AC   CVCL_D2AG
SY   Human DCK knockout HCT116
DR   Abcam; ab300910
DR   Wikidata; Q127379030
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2704; DCK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 DDB2 KO
AC   CVCL_B8EK
SY   Human DDB2 knockout HCT116
DR   Abcam; ab287358
DR   cancercelllines; CVCL_B8EK
DR   Wikidata; Q112927856
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2718; DDB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DDR2 KO
AC   CVCL_B8EL
SY   Human DDR2 knockout HCT116
DR   Abcam; ab286562
DR   cancercelllines; CVCL_B8EL
DR   Wikidata; Q112927857
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DDIT4 KO
AC   CVCL_D2AH
SY   Human DDIT4 knockout HCT116
DR   Abcam; ab300912
DR   Wikidata; Q127379031
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24944; DDIT4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 DDX4 KO
AC   CVCL_B8EM
SY   Human DDX4 knockout HCT116
DR   Abcam; ab289130
DR   cancercelllines; CVCL_B8EM
DR   Wikidata; Q112927858
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18700; DDX4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DGCR8 KO
AC   CVCL_B8EN
SY   Human DGCR8 knockout HCT116
DR   Abcam; ab287366
DR   cancercelllines; CVCL_B8EN
DR   Wikidata; Q112927859
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2847; DGCR8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DIAPH1 KO
AC   CVCL_B1DD
SY   Human DIAPH1 knockout HCT116
DR   Abcam; ab273727
DR   cancercelllines; CVCL_B1DD
DR   Wikidata; Q110430399
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2876; DIAPH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 DLL3 KO
AC   CVCL_B8EP
SY   Human DLL3 knockout HCT116
DR   Abcam; ab289150
DR   cancercelllines; CVCL_B8EP
DR   Wikidata; Q112927860
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DMC1 KO
AC   CVCL_B8EQ
SY   Human DMC1 knockout HCT116
DR   Abcam; ab288190
DR   cancercelllines; CVCL_B8EQ
DR   Wikidata; Q112927861
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2927; DMC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DMPK KO
AC   CVCL_B1DE
SY   Human DMPK (Dystrophia myotonica protein kinase) knockout HCT116
DR   Abcam; ab266870
DR   cancercelllines; CVCL_B1DE
DR   Wikidata; Q110430400
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2933; DMPK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 DNAJB1 KO
AC   CVCL_B8ER
SY   Human DNAJB1 knockout HCT116
DR   Abcam; ab286584
DR   cancercelllines; CVCL_B8ER
DR   Wikidata; Q112927862
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5270; DNAJB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DNMT1 KO
AC   CVCL_B8ES
SY   Human DNMT1 knockout HCT116
DR   Abcam; ab286485
DR   cancercelllines; CVCL_B8ES
DR   Wikidata; Q112927863
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2976; DNMT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DNMT3B KO
AC   CVCL_B8ET
SY   Human DNMT3B knockout HCT116
DR   Abcam; ab287370
DR   cancercelllines; CVCL_B8ET
DR   Wikidata; Q112927864
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DOT1L KO
AC   CVCL_B8EU
SY   Human DOT1L knockout HCT116
DR   Abcam; ab287373
DR   cancercelllines; CVCL_B8EU
DR   Wikidata; Q112927865
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24948; DOT1L.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DPP4 KO
AC   CVCL_B8EV
SY   Human DPP4 knockout HCT116
DR   Abcam; ab289063
DR   cancercelllines; CVCL_B8EV
DR   Wikidata; Q112927866
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3009; DPP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DROSHA KO
AC   CVCL_B8EW
SY   Human DROSHA knockout HCT116
DR   Abcam; ab287376
DR   cancercelllines; CVCL_B8EW
DR   Wikidata; Q112927867
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17904; DROSHA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 DUSP1 KO
AC   CVCL_D2AI
SY   Human DUSP1 knockout HCT116
DR   Abcam; ab300923
DR   Wikidata; Q127379032
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3064; DUSP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 DUSP4 KO
AC   CVCL_B8EX
SY   Human DUSP4 knockout HCT116
DR   Abcam; ab286585
DR   cancercelllines; CVCL_B8EX
DR   Wikidata; Q112927868
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 E2F1 KO
AC   CVCL_B8EY
SY   Human E2F1 knockout HCT116
DR   Abcam; ab287380
DR   cancercelllines; CVCL_B8EY
DR   Wikidata; Q112927869
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 E2F2 KO
AC   CVCL_B8EZ
SY   Human E2F2 knockout HCT116
DR   Abcam; ab289226
DR   cancercelllines; CVCL_B8EZ
DR   Wikidata; Q112927871
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3114; E2F2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EBF1 KO
AC   CVCL_B8F0
SY   Human EBF1 knockout HCT116
DR   Abcam; ab286545
DR   cancercelllines; CVCL_B8F0
DR   Wikidata; Q112927872
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3126; EBF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EBI3 KO
AC   CVCL_B8F1
SY   Human EBI3 knockout HCT116
DR   Abcam; ab287383
DR   cancercelllines; CVCL_B8F1
DR   Wikidata; Q112927873
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3129; EBI3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EDNRA KO
AC   CVCL_D2AJ
SY   Human EDNRA knockout HCT116
DR   Abcam; ab300925
DR   Wikidata; Q127379033
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3179; EDNRA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 EGF KO
AC   CVCL_B8F2
SY   Human EGF knockout HCT116
DR   Abcam; ab287386
DR   cancercelllines; CVCL_B8F2
DR   Wikidata; Q112927874
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3229; EGF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EGFR KO
AC   CVCL_B8F3
SY   Human EGFR knockout HCT116
DR   Abcam; ab281597
DR   cancercelllines; CVCL_B8F3
DR   Wikidata; Q112927875
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EGLN3 KO
AC   CVCL_B8F4
SY   Human EGLN3 knockout HCT116
DR   Abcam; ab289191
DR   cancercelllines; CVCL_B8F4
DR   Wikidata; Q112927877
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14661; EGLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EGR1 KO
AC   CVCL_B8F5
SY   Human EGR1 knockout HCT116
DR   Abcam; ab289143
DR   cancercelllines; CVCL_B8F5
DR   Wikidata; Q112927878
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3238; EGR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EHMT1 KO
AC   CVCL_B8F6
SY   Human EHMT1 knockout HCT116
DR   Abcam; ab287388
DR   cancercelllines; CVCL_B8F6
DR   Wikidata; Q112927879
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EIF1 KO
AC   CVCL_B1DF
SY   Human EIF1 knockout HCT116
DR   Abcam; ab266858
DR   cancercelllines; CVCL_B1DF
DR   Wikidata; Q110430401
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3249; EIF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 EIF2AK3 KO
AC   CVCL_B8F7
SY   Human EIF2AK3 knockout HCT116
DR   Abcam; ab289137
DR   cancercelllines; CVCL_B8F7
DR   Wikidata; Q112927880
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ELK1 KO
AC   CVCL_B8F8
SY   Human ELK1 knockout HCT116
DR   Abcam; ab289154
DR   cancercelllines; CVCL_B8F8
DR   Wikidata; Q112927881
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ENTPD1 KO
AC   CVCL_B8F9
SY   Human ENTPD1 knockout HCT116
DR   Abcam; ab289115
DR   cancercelllines; CVCL_B8F9
DR   Wikidata; Q112927882
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3363; ENTPD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EOMES KO
AC   CVCL_B8FA
SY   Human EOMES knockout HCT116
DR   Abcam; ab289108
DR   cancercelllines; CVCL_B8FA
DR   Wikidata; Q112927883
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3372; EOMES.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EP300 KO
AC   CVCL_B8FB
SY   Human EP300 knockout HCT116
DR   Abcam; ab286395
DR   cancercelllines; CVCL_B8FB
DR   Wikidata; Q112927884
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EPC1 KO
AC   CVCL_B8FC
SY   Human EPC1 knockout HCT116
DR   Abcam; ab288191
DR   cancercelllines; CVCL_B8FC
DR   Wikidata; Q112927885
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19876; EPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EPHA2 KO
AC   CVCL_B1DG
SY   Human EPHA2 (Eph receptor A2) knockout HCT116
DR   Abcam; ab266856
DR   cancercelllines; CVCL_B1DG
DR   Wikidata; Q110430402
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 EPHA3 KO
AC   CVCL_B8FD
SY   Human EPHA3 knockout HCT116
DR   Abcam; ab287391
DR   cancercelllines; CVCL_B8FD
DR   Wikidata; Q112927886
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3387; EPHA3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EPHB2 KO
AC   CVCL_B8FE
SY   Human EPHB2 knockout HCT116
DR   Abcam; ab287395
DR   cancercelllines; CVCL_B8FE
DR   Wikidata; Q112927887
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3393; EPHB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ERBB2 KO
AC   CVCL_B8FF
SY   Human ERBB2 knockout HCT116
DR   Abcam; ab286644
DR   cancercelllines; CVCL_B8FF
DR   Wikidata; Q112927888
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ERBB3 KO
AC   CVCL_B8FG
SY   Human ERBB3 knockout HCT116
DR   Abcam; ab286510
DR   cancercelllines; CVCL_B8FG
DR   Wikidata; Q112927889
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ERBB4 KO
AC   CVCL_B8FH
SY   Human ERBB4 knockout HCT116
DR   Abcam; ab287398
DR   cancercelllines; CVCL_B8FH
DR   Wikidata; Q112927890
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3432; ERBB4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ERCC4 KO
AC   CVCL_B8FI
SY   Human ERCC4 knockout HCT116
DR   Abcam; ab287399
DR   cancercelllines; CVCL_B8FI
DR   Wikidata; Q112927892
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3436; ERCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ERCC5 KO
AC   CVCL_B8FJ
SY   Human ERCC5 knockout HCT116
DR   Abcam; ab286261
DR   cancercelllines; CVCL_B8FJ
DR   Wikidata; Q112927893
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3437; ERCC5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EREG KO
AC   CVCL_D2AK
SY   Human EREG knockout HCT116
DR   Abcam; ab300927
DR   Wikidata; Q127379034
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3443; EREG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ERRFI1 KO
AC   CVCL_D2AL
SY   Human ERRFI1 knockout HCT116
DR   Abcam; ab300929
DR   Wikidata; Q127379035
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18185; ERRFI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ESR1 KO
AC   CVCL_B8FK
SY   Human ESR1 knockout HCT116
DR   Abcam; ab286513
DR   cancercelllines; CVCL_B8FK
DR   Wikidata; Q112927894
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3467; ESR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ESRRA KO
AC   CVCL_B8FL
SY   Human ESRRA knockout HCT116
DR   Abcam; ab289065
DR   cancercelllines; CVCL_B8FL
DR   Wikidata; Q112927895
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3471; ESRRA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ETS1 KO
AC   CVCL_B8FM
SY   Human ETS1 knockout HCT116
DR   Abcam; ab287406
DR   cancercelllines; CVCL_B8FM
DR   Wikidata; Q112927896
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ETV6 KO
AC   CVCL_B8FN
SY   Human ETV6 knockout HCT116
DR   Abcam; ab286587
DR   cancercelllines; CVCL_B8FN
DR   Wikidata; Q112927897
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EZH1 KO
AC   CVCL_B8FP
SY   Human EZH1 knockout HCT116
DR   Abcam; ab288192
DR   cancercelllines; CVCL_B8FP
DR   Wikidata; Q112927899
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3526; EZH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 EZR KO
AC   CVCL_D2AM
SY   Human EZR knockout HCT116
DR   Abcam; ab300933
DR   Wikidata; Q127379036
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12691; EZR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 F2R KO
AC   CVCL_D2AN
SY   Human F2R knockout HCT116
DR   Abcam; ab300935
DR   Wikidata; Q127379037
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 F2RL1 KO
AC   CVCL_D2AP
SY   Human F2RL1 knockout HCT116
DR   Abcam; ab300938
DR   Wikidata; Q127379038
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3538; F2RL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 FANCA KO
AC   CVCL_B8FQ
SY   Human FANCA knockout HCT116
DR   Abcam; ab287408
DR   cancercelllines; CVCL_B8FQ
DR   Wikidata; Q112927900
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FANCD2 KO
AC   CVCL_B8FR
SY   Human FANCD2 knockout HCT116
DR   Abcam; ab286588
DR   cancercelllines; CVCL_B8FR
DR   Wikidata; Q112927901
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FAP KO
AC   CVCL_B8FS
SY   Human FAP knockout HCT116
DR   Abcam; ab289074
DR   cancercelllines; CVCL_B8FS
DR   Wikidata; Q112927902
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3590; FAP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FAS KO
AC   CVCL_B8FT
SY   Human FAS knockout HCT116
DR   Abcam; ab286589
DR   cancercelllines; CVCL_B8FT
DR   Wikidata; Q112927903
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FASN KO
AC   CVCL_D2AQ
SY   Human FASN knockout HCT116
DR   Abcam; ab300940
DR   Wikidata; Q127379039
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3594; FASN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 FBXO38 KO
AC   CVCL_B8FU
SY   Human FBXO38 knockout HCT116
DR   Abcam; ab286633
DR   cancercelllines; CVCL_B8FU
DR   Wikidata; Q112927904
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28844; FBXO38.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FCER2 KO
AC   CVCL_B8FV
SY   Human FCER2 knockout HCT116
DR   Abcam; ab287412
DR   cancercelllines; CVCL_B8FV
DR   Wikidata; Q112927905
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3612; FCER2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FCGR2A KO
AC   CVCL_B8FW
SY   Human FCGR2A knockout HCT116
DR   Abcam; ab287415
DR   cancercelllines; CVCL_B8FW
DR   Wikidata; Q112927906
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3616; FCGR2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FCGR2B KO
AC   CVCL_B8FX
SY   Human FCGR2B knockout HCT116
DR   Abcam; ab287418
DR   cancercelllines; CVCL_B8FX
DR   Wikidata; Q112927907
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3618; FCGR2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FCGR3A KO
AC   CVCL_B8FY
SY   Human FCGR3A knockout HCT116
DR   Abcam; ab287421
DR   cancercelllines; CVCL_B8FY
DR   Wikidata; Q112927908
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3619; FCGR3A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FDFT1 KO
AC   CVCL_D2AR
SY   Human FDFT1 knockout HCT116
DR   Abcam; ab300943
DR   Wikidata; Q127379040
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3629; FDFT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 FEN1 KO
AC   CVCL_B8FZ
SY   Human FEN1 knockout HCT116
DR   Abcam; ab286634
DR   cancercelllines; CVCL_B8FZ
DR   Wikidata; Q112927909
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3650; FEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FGF2 KO
AC   CVCL_B8G0
SY   Human FGF2 knockout HCT116
DR   Abcam; ab289222
DR   cancercelllines; CVCL_B8G0
DR   Wikidata; Q112927911
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3676; FGF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FGFR2 KO
AC   CVCL_B8G1
SY   Human FGFR2 knockout HCT116
DR   Abcam; ab286457
DR   cancercelllines; CVCL_B8G1
DR   Wikidata; Q112927912
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3689; FGFR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FGFR4 KO 1
AC   CVCL_B1DH
SY   Human FGFR4 knockout HCT116
DR   Abcam; ab266875
DR   cancercelllines; CVCL_B1DH
DR   Wikidata; Q110430403
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 FGFR4 KO 2
AC   CVCL_B8AP
SY   Human FGFR4 knockout HCT116
DR   Abcam; ab286590
DR   cancercelllines; CVCL_B8AP
DR   Wikidata; Q112927914
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FKBP4 KO
AC   CVCL_D2AS
SY   Human FKBP4 knockout HCT116
DR   Abcam; ab300946
DR   Wikidata; Q127379041
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3720; FKBP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 FLI1 KO
AC   CVCL_B8G2
SY   Human FLI1 knockout HCT116
DR   Abcam; ab287424
DR   cancercelllines; CVCL_B8G2
DR   Wikidata; Q112927915
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3749; FLI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FLT1 KO
AC   CVCL_B8G3
SY   Human FLT1 knockout HCT116
DR   Abcam; ab286299
DR   cancercelllines; CVCL_B8G3
DR   Wikidata; Q112927916
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FLT3LG KO
AC   CVCL_B8GK
SY   Human Flt3lg knockout HCT116
DR   Abcam; ab289109
DR   cancercelllines; CVCL_B8GK
DR   Wikidata; Q112927917
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FLT4 KO
AC   CVCL_B8G4
SY   Human FLT4 knockout HCT116
DR   Abcam; ab286591
DR   cancercelllines; CVCL_B8G4
DR   Wikidata; Q112927919
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3767; FLT4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FMR1 KO
AC   CVCL_B8G5
SY   Human FMR1 knockout HCT116
DR   Abcam; ab289183
DR   cancercelllines; CVCL_B8G5
DR   Wikidata; Q112927920
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FN1 KO
AC   CVCL_B8G6
SY   Human FN1 knockout HCT116
DR   Abcam; ab286701
DR   cancercelllines; CVCL_B8G6
DR   Wikidata; Q112927921
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOLH1 KO
AC   CVCL_B8G7
SY   Human FOLH1 knockout HCT116
DR   Abcam; ab289101
DR   cancercelllines; CVCL_B8G7
DR   Wikidata; Q112927922
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3788; FOLH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOLR1 KO
AC   CVCL_B8G8
SY   Human FOLR1 knockout HCT116
DR   Abcam; ab289129
DR   cancercelllines; CVCL_B8G8
DR   Wikidata; Q112927923
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOS KO
AC   CVCL_B8G9
SY   Human FOS knockout HCT116
DR   Abcam; ab287428
DR   cancercelllines; CVCL_B8G9
DR   Wikidata; Q112927924
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOSL1 KO
AC   CVCL_B8GA
SY   Human FOSL1 knockout HCT116
DR   Abcam; ab287429
DR   cancercelllines; CVCL_B8GA
DR   Wikidata; Q112927925
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXA1 KO
AC   CVCL_B8GB
SY   Human FOXA1 knockout HCT116
DR   Abcam; ab287434
DR   cancercelllines; CVCL_B8GB
DR   Wikidata; Q112927927
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXA2 KO
AC   CVCL_B8GC
SY   Human FOXA2 knockout HCT116
DR   Abcam; ab289079
DR   cancercelllines; CVCL_B8GC
DR   Wikidata; Q112927928
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXC1 KO
AC   CVCL_B8GD
SY   Human FOXC1 knockout HCT116
DR   Abcam; ab289203
DR   cancercelllines; CVCL_B8GD
DR   Wikidata; Q112927929
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3800; FOXC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXC2 KO
AC   CVCL_B8GE
SY   Human FOXC2 knockout HCT116
DR   Abcam; ab289167
DR   cancercelllines; CVCL_B8GE
DR   Wikidata; Q112927930
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3801; FOXC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXG1 KO
AC   CVCL_B8GF
SY   Human FOXG1 knockout HCT116
DR   Abcam; ab289232
DR   cancercelllines; CVCL_B8GF
DR   Wikidata; Q112927931
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3811; FOXG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXM1 KO
AC   CVCL_B8GG
SY   Human FOXM1 knockout HCT116
DR   Abcam; ab287436
DR   cancercelllines; CVCL_B8GG
DR   Wikidata; Q112927932
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXO4 KO
AC   CVCL_B8GH
SY   Human FOXO4 knockout HCT116
DR   Abcam; ab287439
DR   cancercelllines; CVCL_B8GH
DR   Wikidata; Q112927934
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7139; FOXO4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXP1 KO
AC   CVCL_B8GI
SY   Human FOXP1 knockout HCT116
DR   Abcam; ab286458
DR   cancercelllines; CVCL_B8GI
DR   Wikidata; Q112927935
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3823; FOXP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FOXP3 KO
AC   CVCL_B8GJ
SY   Human FOXP3 knockout HCT116
DR   Abcam; ab289221
DR   cancercelllines; CVCL_B8GJ
DR   Wikidata; Q112927936
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6106; FOXP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 FSCN1 KO
AC   CVCL_B1DI
SY   Human FSCN1 (Fascin) knockout HCT116
DR   Abcam; ab266895
DR   cancercelllines; CVCL_B1DI
DR   Wikidata; Q110430404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11148; FSCN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 G6PD KO
AC   CVCL_D2AT
SY   Human G6PD knockout HCT116
DR   Abcam; ab300950
DR   Wikidata; Q127379042
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4057; G6PD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GABRA1 KO
AC   CVCL_B8GL
SY   Human GABRA1 knockout HCT116
DR   Abcam; ab286739
DR   cancercelllines; CVCL_B8GL
DR   Wikidata; Q112927937
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4075; GABRA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GABRG2 KO
AC   CVCL_B8GM
SY   Human GABRG2 knockout HCT116
DR   Abcam; ab286693
DR   cancercelllines; CVCL_B8GM
DR   Wikidata; Q112927938
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4087; GABRG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GAD1 KO
AC   CVCL_D2AU
SY   Human GAD1 knockout HCT116
DR   Abcam; ab300952
DR   Wikidata; Q127379043
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4092; GAD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GADD45B KO
AC   CVCL_B8GN
SY   Human GADD45B knockout HCT116
DR   Abcam; ab289204
DR   cancercelllines; CVCL_B8GN
DR   Wikidata; Q112927939
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GATA1 KO
AC   CVCL_B8GP
SY   Human GATA1 knockout HCT116
DR   Abcam; ab286498
DR   cancercelllines; CVCL_B8GP
DR   Wikidata; Q112927941
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4170; GATA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GATA2 KO
AC   CVCL_B8GQ
SY   Human GATA2 knockout HCT116
DR   Abcam; ab287442
DR   cancercelllines; CVCL_B8GQ
DR   Wikidata; Q112927942
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GATA3 KO
AC   CVCL_B8GR
SY   Human GATA3 knockout HCT116
DR   Abcam; ab286482
DR   cancercelllines; CVCL_B8GR
DR   Wikidata; Q112927943
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4172; GATA3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GATA4 KO
AC   CVCL_B8GS
SY   Human GATA4 knockout HCT116
DR   Abcam; ab289127
DR   cancercelllines; CVCL_B8GS
DR   Wikidata; Q112927944
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4173; GATA4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GATA6 KO
AC   CVCL_B8GT
SY   Human GATA6 knockout HCT116
DR   Abcam; ab289173
DR   cancercelllines; CVCL_B8GT
DR   Wikidata; Q112927945
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4174; GATA6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GCLC KO
AC   CVCL_C7DW
SY   Human GCLC knockout HCT116
DR   Abcam; ab300955
DR   Wikidata; Q123030419
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4311; GCLC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 GCLM KO
AC   CVCL_D2AV
SY   Human GCLM knockout HCT116
DR   Abcam; ab300958
DR   Wikidata; Q127379044
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4312; GCLM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GGT1 KO
AC   CVCL_D2AW
SY   Human GGT1 knockout HCT116
DR   Abcam; ab300961
DR   Wikidata; Q127379046
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4250; GGT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GHR KO
AC   CVCL_D2AX
SY   Human GHR knockout HCT116
DR   Abcam; ab300964
DR   Wikidata; Q127379048
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4263; GHR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GHSR KO
AC   CVCL_D2AY
SY   Human GHSR knockout HCT116
DR   Abcam; ab300967
DR   Wikidata; Q127379049
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4267; GHSR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GLDC KO
AC   CVCL_D2AZ
SY   Human GLDC knockout HCT116
DR   Abcam; ab300971
DR   Wikidata; Q127379050
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4313; GLDC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GLI2 KO
AC   CVCL_B8GU
SY   Human GLI2 knockout HCT116
DR   Abcam; ab286459
DR   cancercelllines; CVCL_B8GU
DR   Wikidata; Q112927946
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4318; GLI2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GLI3 KO
AC   CVCL_B8GV
SY   Human GLI3 knockout HCT116
DR   Abcam; ab289536
DR   cancercelllines; CVCL_B8GV
DR   Wikidata; Q112927947
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4319; GLI3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GLI4 KO
AC   CVCL_B1DJ
SY   Human GLI4 knockout HCT116
DR   Abcam; ab266857
DR   cancercelllines; CVCL_B1DJ
DR   Wikidata; Q110430405
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4320; GLI4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 GLS KO
AC   CVCL_B8GW
SY   Human GLS knockout HCT116
DR   Abcam; ab287445
DR   cancercelllines; CVCL_B8GW
DR   Wikidata; Q112927948
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4331; GLS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GNA13 KO
AC   CVCL_B1DK
SY   Human GNA13 knockout HCT116
DR   Abcam; ab266862
DR   cancercelllines; CVCL_B1DK
DR   Wikidata; Q110430406
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4381; GNA13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 GNB1 KO
AC   CVCL_B1DL
SY   Human GNB1 knockout HCT116
DR   Abcam; ab266890
DR   cancercelllines; CVCL_B1DL
DR   Wikidata; Q110430408
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4396; GNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 GOT1 KO
AC   CVCL_D2B0
SY   Human GOT1 knockout HCT116
DR   Abcam; ab300973
DR   Wikidata; Q127379051
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4432; GOT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GP1BA KO
AC   CVCL_B8GX
SY   Human GP1BA knockout HCT116
DR   Abcam; ab287449
DR   cancercelllines; CVCL_B8GX
DR   Wikidata; Q112927949
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4439; GP1BA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GPC1 KO
AC   CVCL_B8GY
SY   Human GPC1 knockout HCT116
DR   Abcam; ab287451
DR   cancercelllines; CVCL_B8GY
DR   Wikidata; Q112927950
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4449; GPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GPER1 KO
AC   CVCL_B8GZ
SY   Human GPER1 knockout HCT116
DR   Abcam; ab289194
DR   cancercelllines; CVCL_B8GZ
DR   Wikidata; Q112927951
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4485; GPER1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GPNMB KO
AC   CVCL_B8H0
SY   Human GPNMB knockout HCT116
DR   Abcam; ab287455
DR   cancercelllines; CVCL_B8H0
DR   Wikidata; Q112927952
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GRB2 KO
AC   CVCL_B1DM
SY   Human GRB2 knockout HCT116
DR   Abcam; ab273715
DR   cancercelllines; CVCL_B1DM
DR   Wikidata; Q110430409
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4566; GRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 GRIN2B KO
AC   CVCL_D2B1
SY   Human GRIN2B knockout HCT116
DR   Abcam; ab300975
DR   Wikidata; Q127379052
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GSR KO
AC   CVCL_B8H1
SY   Human GSR knockout HCT116
DR   Abcam; ab287457
DR   cancercelllines; CVCL_B8H1
DR   Wikidata; Q112927953
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4623; GSR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 GSTP1 KO
AC   CVCL_D2B2
SY   Human GSTP1 knockout HCT116
DR   Abcam; ab300978
DR   Wikidata; Q127379053
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4638; GSTP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 GZMB KO
AC   CVCL_B8H2
SY   Human GZMB knockout HCT116
DR   Abcam; ab289243
DR   cancercelllines; CVCL_B8H2
DR   Wikidata; Q112927954
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4709; GZMB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 H2BC21 KO
AC   CVCL_B8H3
SY   Human HIST2H2BE knockout HCT116
DR   Abcam; ab289274
DR   cancercelllines; CVCL_B8H3
DR   Wikidata; Q112927955
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4760; H2BC21.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HAT1 KO
AC   CVCL_B8H4
SY   Human HAT1 knockout HCT116
DR   Abcam; ab287460
DR   cancercelllines; CVCL_B8H4
DR   Wikidata; Q112927956
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4821; HAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HAVCR2 KO
AC   CVCL_B8H5
SY   Human HAVCR2 knockout HCT116
DR   Abcam; ab289157
DR   cancercelllines; CVCL_B8H5
DR   Wikidata; Q112927957
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18437; HAVCR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HDAC1 KO
AC   CVCL_B8H6
SY   Human HDAC1 knockout HCT116
DR   Abcam; ab286673
DR   cancercelllines; CVCL_B8H6
DR   Wikidata; Q112927958
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HDAC2 KO
AC   CVCL_B8H7
SY   Human HDAC2 knockout HCT116
DR   Abcam; ab287464
DR   cancercelllines; CVCL_B8H7
DR   Wikidata; Q112927959
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HDAC4 KO
AC   CVCL_B8H8
SY   Human HDAC4 knockout HCT116
DR   Abcam; ab286487
DR   cancercelllines; CVCL_B8H8
DR   Wikidata; Q112927960
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14063; HDAC4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HDAC5 KO
AC   CVCL_B8H9
SY   Human HDAC5 knockout HCT116
DR   Abcam; ab286497
DR   cancercelllines; CVCL_B8H9
DR   Wikidata; Q112927961
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14068; HDAC5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HDAC6 KO
AC   CVCL_B8HA
SY   Human HDAC6 knockout HCT116
DR   Abcam; ab287466
DR   cancercelllines; CVCL_B8HA
DR   Wikidata; Q112927962
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HDAC7 KO
AC   CVCL_B8HB
SY   Human HDAC7 knockout HCT116
DR   Abcam; ab286549
DR   cancercelllines; CVCL_B8HB
DR   Wikidata; Q112927963
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14067; HDAC7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HELLS KO
AC   CVCL_B1DN
SY   Human HELLS (SMARCA6) knockout HCT116
DR   Abcam; ab266892
DR   cancercelllines; CVCL_B1DN
DR   Wikidata; Q110430411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4861; HELLS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 HELQ KO
AC   CVCL_B8HC
SY   Human HELQ knockout HCT116
DR   Abcam; ab288193
DR   cancercelllines; CVCL_B8HC
DR   Wikidata; Q112927964
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18536; HELQ.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HEY1 KO
AC   CVCL_B8HD
SY   Human HEY1 knockout HCT116
DR   Abcam; ab286691
DR   cancercelllines; CVCL_B8HD
DR   Wikidata; Q112927965
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HGF KO
AC   CVCL_B8HE
SY   Human HGF knockout HCT116
DR   Abcam; ab287470
DR   cancercelllines; CVCL_B8HE
DR   Wikidata; Q112927966
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4893; HGF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HGS KO
AC   CVCL_D2B3
SY   Human HGS knockout HCT116
DR   Abcam; ab300981
DR   Wikidata; Q127379054
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4897; HGS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 HIF1A KO
AC   CVCL_B1DP
SY   Human HIF1A (HIF-1 alpha) knockout HCT116
DR   Abcam; ab255394
DR   cancercelllines; CVCL_B1DP
DR   Wikidata; Q110430412
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 HK2 KO
AC   CVCL_B1DQ
SY   Human HK2 (Hexokinase II) knockout HCT116
DR   Abcam; ab273721
DR   cancercelllines; CVCL_B1DQ
DR   Wikidata; Q110430413
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4923; HK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 HLA-A KO
AC   CVCL_B8HF
SY   Human HLA-A knockout HCT116
DR   Abcam; ab287471
DR   cancercelllines; CVCL_B8HF
DR   Wikidata; Q112927967
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HLA-DRA KO
AC   CVCL_B8HG
SY   Human HLA-DRA knockout HCT116
DR   Abcam; ab287475
DR   cancercelllines; CVCL_B8HG
DR   Wikidata; Q112927968
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4947; HLA-DRA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HLA-G KO
AC   CVCL_B8HH
SY   Human HLA-G knockout HCT116
DR   Abcam; ab289212
DR   cancercelllines; CVCL_B8HH
DR   Wikidata; Q112927969
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4964; HLA-G.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HMGA2 KO
AC   CVCL_B8HI
SY   Human HMGA2 knockout HCT116
DR   Abcam; ab287478
DR   cancercelllines; CVCL_B8HI
DR   Wikidata; Q112927970
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5009; HMGA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HMGB3 KO
AC   CVCL_D2B4
SY   Human HMGB3 knockout HCT116
DR   Abcam; ab300983
DR   Wikidata; Q127379055
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5004; HMGB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 HNF1A KO
AC   CVCL_B8HJ
SY   Human HNF1A knockout HCT116
DR   Abcam; ab286337
DR   cancercelllines; CVCL_B8HJ
DR   Wikidata; Q112927971
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11621; HNF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HNF4A KO
AC   CVCL_B8HK
SY   Human HNF4A knockout HCT116
DR   Abcam; ab289158
DR   cancercelllines; CVCL_B8HK
DR   Wikidata; Q112927973
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5024; HNF4A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HOXA9 KO
AC   CVCL_B8HL
SY   Human HOXA9 knockout HCT116
DR   Abcam; ab287488
DR   cancercelllines; CVCL_B8HL
DR   Wikidata; Q112927974
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HPRT1 KO
AC   CVCL_D2B5
SY   Human HPRT1 knockout HCT116
DR   Abcam; ab300989
DR   Wikidata; Q127379056
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5157; HPRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 HPSE KO
AC   CVCL_B8HM
SY   Human HPSE knockout HCT116
DR   Abcam; ab289240
DR   cancercelllines; CVCL_B8HM
DR   Wikidata; Q112927975
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5164; HPSE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 HRAS KO
AC   CVCL_B8HN
SY   Human HRAS knockout HCT116
DR   Abcam; ab286768
DR   cancercelllines; CVCL_B8HN
DR   Wikidata; Q112927976
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ICAM1 KO
AC   CVCL_B8HP
SY   Human ICAM1 knockout HCT116
DR   Abcam; ab289236
DR   cancercelllines; CVCL_B8HP
DR   Wikidata; Q112927977
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ICOS KO
AC   CVCL_B8HQ
SY   Human ICOS knockout HCT116
DR   Abcam; ab287491
DR   cancercelllines; CVCL_B8HQ
DR   Wikidata; Q112927978
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5351; ICOS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ICOSLG KO
AC   CVCL_B8HR
SY   Human ICOSLG knockout HCT116
DR   Abcam; ab289282
DR   cancercelllines; CVCL_B8HR
DR   Wikidata; Q112927979
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17087; ICOSLG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IDH1 KO
AC   CVCL_B8HS
SY   Human IDH1 knockout HCT116
DR   Abcam; ab287494
DR   cancercelllines; CVCL_B8HS
DR   Wikidata; Q112927980
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IDH2 KO
AC   CVCL_B8HT
SY   Human IDH2 knockout HCT116
DR   Abcam; ab287496
DR   cancercelllines; CVCL_B8HT
DR   Wikidata; Q112927981
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IFITM1 KO
AC   CVCL_B8HU
SY   Human IFITM1 knockout HCT116
DR   Abcam; ab289275
DR   cancercelllines; CVCL_B8HU
DR   Wikidata; Q112927982
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IFNAR1 KO
AC   CVCL_B8HV
SY   Human IFNAR1 knockout HCT116
DR   Abcam; ab289161
DR   cancercelllines; CVCL_B8HV
DR   Wikidata; Q112927983
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IFNB1 KO
AC   CVCL_B8HW
SY   Human IFNB1 knockout HCT116
DR   Abcam; ab287500
DR   cancercelllines; CVCL_B8HW
DR   Wikidata; Q112927984
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5434; IFNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IFNGR1 KO
AC   CVCL_B8HX
SY   Human IFNGR1 knockout HCT116
DR   Abcam; ab287502
DR   cancercelllines; CVCL_B8HX
DR   Wikidata; Q112927985
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IFNGR2 KO
AC   CVCL_B8HY
SY   Human IFNGR2 knockout HCT116
DR   Abcam; ab287505
DR   cancercelllines; CVCL_B8HY
DR   Wikidata; Q112927986
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IGF1 KO
AC   CVCL_B8HZ
SY   Human IGF1 knockout HCT116
DR   Abcam; ab286667
DR   cancercelllines; CVCL_B8HZ
DR   Wikidata; Q112927987
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5464; IGF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IGF1R KO
AC   CVCL_B8I0
SY   Human IGF1R knockout HCT116
DR   Abcam; ab287509
DR   cancercelllines; CVCL_B8I0
DR   Wikidata; Q112927988
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IGF2BP1 KO
AC   CVCL_B8I1
SY   Human IGF2BP1 knockout HCT116
DR   Abcam; ab289170
DR   cancercelllines; CVCL_B8I1
DR   Wikidata; Q112927989
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28866; IGF2BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IGF2BP2 KO
AC   CVCL_B8I2
SY   Human IGF2BP2 knockout HCT116
DR   Abcam; ab287511
DR   cancercelllines; CVCL_B8I2
DR   Wikidata; Q112927990
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IGF2BP3 KO
AC   CVCL_B8I3
SY   Human IGF2BP3 knockout HCT116
DR   Abcam; ab289247
DR   cancercelllines; CVCL_B8I3
DR   Wikidata; Q112927991
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IGF2R KO
AC   CVCL_D2B6
SY   Human IGF2R knockout HCT116
DR   Abcam; ab300994
DR   Wikidata; Q127379057
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5467; IGF2R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 IHH KO
AC   CVCL_B8I4
SY   Human IHH knockout HCT116
DR   Abcam; ab289540
DR   cancercelllines; CVCL_B8I4
DR   Wikidata; Q112927992
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5956; IHH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IKBKE KO
AC   CVCL_B8I5
SY   Human IKBKE knockout HCT116
DR   Abcam; ab289250
DR   cancercelllines; CVCL_B8I5
DR   Wikidata; Q112927993
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL12A KO
AC   CVCL_B8I6
SY   Human IL12A knockout HCT116
DR   Abcam; ab287518
DR   cancercelllines; CVCL_B8I6
DR   Wikidata; Q112927994
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL15 KO
AC   CVCL_B8I7
SY   Human IL15 knockout HCT116
DR   Abcam; ab289241
DR   cancercelllines; CVCL_B8I7
DR   Wikidata; Q112927995
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5977; IL15.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL17A KO
AC   CVCL_B8I8
SY   Human IL17A knockout HCT116
DR   Abcam; ab289177
DR   cancercelllines; CVCL_B8I8
DR   Wikidata; Q112927996
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5981; IL17A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL18 KO
AC   CVCL_B8I9
SY   Human IL18 knockout HCT116
DR   Abcam; ab287520
DR   cancercelllines; CVCL_B8I9
DR   Wikidata; Q112927997
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5986; IL18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL1A KO
AC   CVCL_B8IA
SY   Human IL1A knockout HCT116
DR   Abcam; ab287522
DR   cancercelllines; CVCL_B8IA
DR   Wikidata; Q112927998
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5991; IL1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL1B KO
AC   CVCL_B8IB
SY   Human IL1B knockout HCT116
DR   Abcam; ab287526
DR   cancercelllines; CVCL_B8IB
DR   Wikidata; Q112927999
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL1RL1 KO
AC   CVCL_D2B7
SY   Human IL1RL1 knockout HCT116
DR   Abcam; ab300998
DR   Wikidata; Q127379058
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5998; IL1RL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 IL23A KO
AC   CVCL_B8IC
SY   Human IL23A knockout HCT116
DR   Abcam; ab289069
DR   cancercelllines; CVCL_B8IC
DR   Wikidata; Q112928000
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15488; IL23A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL23R KO
AC   CVCL_B8ID
SY   Human IL23R knockout HCT116
DR   Abcam; ab289202
DR   cancercelllines; CVCL_B8ID
DR   Wikidata; Q112928001
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19100; IL23R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL27 KO
AC   CVCL_B8IE
SY   Human IL27 knockout HCT116
DR   Abcam; ab287533
DR   cancercelllines; CVCL_B8IE
DR   Wikidata; Q112928002
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19157; IL27.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL2RB KO
AC   CVCL_B8IF
SY   Human IL2RB knockout HCT116
DR   Abcam; ab287538
DR   cancercelllines; CVCL_B8IF
DR   Wikidata; Q112928003
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6009; IL2RB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL3RA KO
AC   CVCL_B8IG
SY   Human IL3RA knockout HCT116
DR   Abcam; ab287544
DR   cancercelllines; CVCL_B8IG
DR   Wikidata; Q112928004
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6012; IL3RA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL6R KO
AC   CVCL_B8IH
SY   Human IL6R knockout HCT116
DR   Abcam; ab287551
DR   cancercelllines; CVCL_B8IH
DR   Wikidata; Q112928005
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL7R KO
AC   CVCL_B8II
SY   Human IL7R knockout HCT116
DR   Abcam; ab286492
DR   cancercelllines; CVCL_B8II
DR   Wikidata; Q112928006
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6024; IL7R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IL9 KO
AC   CVCL_B8IJ
SY   Human IL9 knockout HCT116
DR   Abcam; ab289206
DR   cancercelllines; CVCL_B8IJ
DR   Wikidata; Q112928007
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6029; IL9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 INPP5D KO
AC   CVCL_B8IK
SY   Human INPP5D knockout HCT116
DR   Abcam; ab287553
DR   cancercelllines; CVCL_B8IK
DR   Wikidata; Q112928009
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6079; INPP5D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 INPPL1 KO
AC   CVCL_D2B8
SY   Human INPPL1 knockout HCT116
DR   Abcam; ab301002
DR   Wikidata; Q127379059
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6080; INPPL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 IQGAP1 KO
AC   CVCL_B8IL
SY   Human IQGAP1 knockout HCT116
DR   Abcam; ab289071
DR   cancercelllines; CVCL_B8IL
DR   Wikidata; Q112928010
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6110; IQGAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IRAK1 KO
AC   CVCL_B8IM
SY   Human IRAK1 knockout HCT116
DR   Abcam; ab289201
DR   cancercelllines; CVCL_B8IM
DR   Wikidata; Q112928011
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IRAK4 KO
AC   CVCL_B8IN
SY   Human IRAK4 knockout HCT116
DR   Abcam; ab287557
DR   cancercelllines; CVCL_B8IN
DR   Wikidata; Q112928012
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IRF4 KO
AC   CVCL_B8IP
SY   Human IRF4 knockout HCT116
DR   Abcam; ab287559
DR   cancercelllines; CVCL_B8IP
DR   Wikidata; Q112928013
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6119; IRF4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 IRF5 KO
AC   CVCL_D2B9
SY   Human IRF5 knockout HCT116
DR   Abcam; ab301005
DR   Wikidata; Q127379061
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6120; IRF5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 IRS1 KO
AC   CVCL_D2BA
SY   Human IRS1 knockout HCT116
DR   Abcam; ab301007
DR   Wikidata; Q127379062
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6125; IRS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ITGA2 KO
AC   CVCL_B8IQ
SY   Human ITGA2 knockout HCT116
DR   Abcam; ab287563
DR   cancercelllines; CVCL_B8IQ
DR   Wikidata; Q112928014
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ITGA3 KO
AC   CVCL_D2BB
SY   Human ITGA3 knockout HCT116
DR   Abcam; ab301009
DR   Wikidata; Q127379063
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6139; ITGA3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ITGA5 KO
AC   CVCL_D2BC
SY   Human ITGA5 knockout HCT116
DR   Abcam; ab301012
DR   Wikidata; Q127379064
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ITGAE KO
AC   CVCL_B8IR
SY   Human ITGAE knockout HCT116
DR   Abcam; ab287565
DR   cancercelllines; CVCL_B8IR
DR   Wikidata; Q112928015
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ITGAL KO
AC   CVCL_B8IS
SY   Human ITGAL knockout HCT116
DR   Abcam; ab287568
DR   cancercelllines; CVCL_B8IS
DR   Wikidata; Q112928016
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6148; ITGAL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ITGAM KO
AC   CVCL_B8IT
SY   Human ITGAM knockout HCT116
DR   Abcam; ab287571
DR   cancercelllines; CVCL_B8IT
DR   Wikidata; Q112928017
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ITGAV KO
AC   CVCL_B8IU
SY   Human ITGAV knockout HCT116
DR   Abcam; ab286702
DR   cancercelllines; CVCL_B8IU
DR   Wikidata; Q112928018
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6150; ITGAV.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ITGAX KO
AC   CVCL_B8IV
SY   Human ITGAX knockout HCT116
DR   Abcam; ab287574
DR   cancercelllines; CVCL_B8IV
DR   Wikidata; Q112928019
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6152; ITGAX.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ITGB1 KO
AC   CVCL_B1DR
SY   Human ITGB1 (CD29) knockout HCT116
DR   Abcam; ab273724
DR   cancercelllines; CVCL_B1DR
DR   Wikidata; Q110430416
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 ITGB4 KO
AC   CVCL_D2BD
SY   Human ITGB4 knockout HCT116
DR   Abcam; ab301018
DR   Wikidata; Q127379065
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6158; ITGB4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 ITK KO
AC   CVCL_B8IW
SY   Human ITK knockout HCT116
DR   Abcam; ab286548
DR   cancercelllines; CVCL_B8IW
DR   Wikidata; Q112928020
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6171; ITK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ITPR1 KO
AC   CVCL_B8IX
SY   Human ITPR1 knockout HCT116
DR   Abcam; ab286734
DR   cancercelllines; CVCL_B8IX
DR   Wikidata; Q112928021
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 JAK1 KO
AC   CVCL_B8IY
SY   Human JAK1 knockout HCT116
DR   Abcam; ab286460
DR   cancercelllines; CVCL_B8IY
DR   Wikidata; Q112928022
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 JAK3 KO
AC   CVCL_B8IZ
SY   Human JAK3 knockout HCT116
DR   Abcam; ab286461
DR   cancercelllines; CVCL_B8IZ
DR   Wikidata; Q112928023
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6193; JAK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 JARID2 KO
AC   CVCL_B8J0
SY   Human JARID2 knockout HCT116
DR   Abcam; ab289083
DR   cancercelllines; CVCL_B8J0
DR   Wikidata; Q112928024
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6196; JARID2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 JUNB KO
AC   CVCL_D2BE
SY   Human JUNB knockout HCT116
DR   Abcam; ab301022
DR   Wikidata; Q127379066
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6205; JUNB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 JUND KO
AC   CVCL_D2BF
SY   Human JUND knockout HCT116
DR   Abcam; ab301024
DR   Wikidata; Q127379067
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6206; JUND.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 KAT2A KO
AC   CVCL_B8J1
SY   Human KAT2A knockout HCT116
DR   Abcam; ab287577
DR   cancercelllines; CVCL_B8J1
DR   Wikidata; Q112928025
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4201; KAT2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KAT2B KO
AC   CVCL_B8J2
SY   Human KAT2B knockout HCT116
DR   Abcam; ab287581
DR   cancercelllines; CVCL_B8J2
DR   Wikidata; Q112928026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KCNQ1 KO
AC   CVCL_D2BG
SY   Human KCNQ1 knockout HCT116
DR   Abcam; ab301027
DR   Wikidata; Q127379068
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 KDM1A KO
AC   CVCL_B8J3
SY   Human KDM1A knockout HCT116
DR   Abcam; ab287583
DR   cancercelllines; CVCL_B8J3
DR   Wikidata; Q112928027
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KDM3A KO
AC   CVCL_B8J4
SY   Human KDM3A knockout HCT116
DR   Abcam; ab287586
DR   cancercelllines; CVCL_B8J4
DR   Wikidata; Q112928028
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20815; KDM3A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KDM5A KO
AC   CVCL_B8J5
SY   Human KDM5A knockout HCT116
DR   Abcam; ab287588
DR   cancercelllines; CVCL_B8J5
DR   Wikidata; Q112928029
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KDM5B KO
AC   CVCL_B8J6
SY   Human KDM5B knockout HCT116
DR   Abcam; ab287592
DR   cancercelllines; CVCL_B8J6
DR   Wikidata; Q112928030
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KDM6A KO
AC   CVCL_B8J7
SY   Human KDM6A knockout HCT116
DR   Abcam; ab287595
DR   cancercelllines; CVCL_B8J7
DR   Wikidata; Q112928031
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KDR KO
AC   CVCL_B8J8
SY   Human KDR knockout HCT116
DR   Abcam; ab286462
DR   cancercelllines; CVCL_B8J8
DR   Wikidata; Q112928032
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6307; KDR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KEAP1 KO
AC   CVCL_B8J9
SY   Human KEAP1 knockout HCT116
DR   Abcam; ab286484
DR   cancercelllines; CVCL_B8J9
DR   Wikidata; Q112928033
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KIT KO
AC   CVCL_B8JA
SY   Human KIT knockout HCT116
DR   Abcam; ab286563
DR   cancercelllines; CVCL_B8JA
DR   Wikidata; Q112928034
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KITLG KO
AC   CVCL_B8JB
SY   Human KITLG knockout HCT116
DR   Abcam; ab289128
DR   cancercelllines; CVCL_B8JB
DR   Wikidata; Q112928035
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6343; KITLG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KLF4 KO
AC   CVCL_B8JC
SY   Human KLF4 knockout HCT116
DR   Abcam; ab286528
DR   cancercelllines; CVCL_B8JC
DR   Wikidata; Q112928036
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6348; KLF4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KLF5 KO
AC   CVCL_D2BH
SY   Human KLF5 knockout HCT116
DR   Abcam; ab301030
DR   Wikidata; Q127379069
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6349; KLF5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 KLRB1 KO
AC   CVCL_B8JD
SY   Human KLRB1 knockout HCT116
DR   Abcam; ab289228
DR   cancercelllines; CVCL_B8JD
DR   Wikidata; Q112928037
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6373; KLRB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KLRC1 KO
AC   CVCL_B8JE
SY   Human KLRC1 knockout HCT116
DR   Abcam; ab289159
DR   cancercelllines; CVCL_B8JE
DR   Wikidata; Q112928038
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6374; KLRC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KMT2A KO
AC   CVCL_B8JF
SY   Human KMT2A knockout HCT116
DR   Abcam; ab286488
DR   cancercelllines; CVCL_B8JF
DR   Wikidata; Q112928039
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7132; KMT2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KMT2D KO
AC   CVCL_B8JG
SY   Human KMT2D knockout HCT116
DR   Abcam; ab286314
DR   cancercelllines; CVCL_B8JG
DR   Wikidata; Q112928040
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KMT5A KO
AC   CVCL_B8JH
SY   Human KMT5A knockout HCT116
DR   Abcam; ab287598
DR   cancercelllines; CVCL_B8JH
DR   Wikidata; Q112928041
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29489; KMT5A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KRAS KO
AC   CVCL_B1DS
SY   Human KRAS knockout HCT116
DR   Abcam; ab276083
DR   cancercelllines; CVCL_B1DS
DR   Wikidata; Q110430419
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 KRT1 KO
AC   CVCL_B8JI
SY   Human KRT1 knockout HCT116
DR   Abcam; ab289087
DR   cancercelllines; CVCL_B8JI
DR   Wikidata; Q112928042
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6412; KRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 KRT19 KO
AC   CVCL_D2BI
SY   Human KRT19 knockout HCT116
DR   Abcam; ab301032
DR   Wikidata; Q127379070
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6436; KRT19.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LAMP1 KO
AC   CVCL_B8JJ
SY   Human LAMP1 knockout HCT116
DR   Abcam; ab289151
DR   cancercelllines; CVCL_B8JJ
DR   Wikidata; Q112928043
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LATS1 KO
AC   CVCL_B8JK
SY   Human LATS1 knockout HCT116
DR   Abcam; ab286595
DR   cancercelllines; CVCL_B8JK
DR   Wikidata; Q112928044
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LATS2 KO
AC   CVCL_B8JL
SY   Human LATS2 knockout HCT116
DR   Abcam; ab286564
DR   cancercelllines; CVCL_B8JL
DR   Wikidata; Q112928045
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LCK KO
AC   CVCL_B8JM
SY   Human LCK knockout HCT116
DR   Abcam; ab287601
DR   cancercelllines; CVCL_B8JM
DR   Wikidata; Q112928046
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6524; LCK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LEP KO
AC   CVCL_D2BJ
SY   Human LEP knockout HCT116
DR   Abcam; ab301034
DR   Wikidata; Q127379072
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6553; LEP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LGALS1 KO
AC   CVCL_B8JN
SY   Human LGALS1 knockout HCT116
DR   Abcam; ab289242
DR   cancercelllines; CVCL_B8JN
DR   Wikidata; Q112928047
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LGALS3 KO
AC   CVCL_B8JP
SY   Human LGALS3 knockout HCT116
DR   Abcam; ab289197
DR   cancercelllines; CVCL_B8JP
DR   Wikidata; Q112928048
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LGMN KO
AC   CVCL_D2BK
SY   Human LGMN knockout HCT116
DR   Abcam; ab301037
DR   Wikidata; Q127379073
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9472; LGMN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LGR5 KO
AC   CVCL_B8JQ
SY   Human LGR5 knockout HCT116
DR   Abcam; ab289187
DR   cancercelllines; CVCL_B8JQ
DR   Wikidata; Q112928049
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4504; LGR5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LILRB1 KO
AC   CVCL_B8JR
SY   Human LILRB1 knockout HCT116
DR   Abcam; ab289105
DR   cancercelllines; CVCL_B8JR
DR   Wikidata; Q112928050
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6605; LILRB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LIMK1 KO
AC   CVCL_D2BL
SY   Human LIMK1 knockout HCT116
DR   Abcam; ab301039
DR   Wikidata; Q127379074
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6613; LIMK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LIN28A KO
AC   CVCL_B8JS
SY   Human LIN28A knockout HCT116
DR   Abcam; ab289062
DR   cancercelllines; CVCL_B8JS
DR   Wikidata; Q112928051
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15986; LIN28A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LIN28B KO
AC   CVCL_B8JT
SY   Human LIN28B knockout HCT116
DR   Abcam; ab289098
DR   cancercelllines; CVCL_B8JT
DR   Wikidata; Q112928052
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LMNA KO
AC   CVCL_B8JU
SY   Human LMNA knockout HCT116
DR   Abcam; ab287604
DR   cancercelllines; CVCL_B8JU
DR   Wikidata; Q112928053
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LOX KO
AC   CVCL_D2BM
SY   Human LOX knockout HCT116
DR   Abcam; ab301042
DR   Wikidata; Q127379075
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6664; LOX.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LPAR1 KO
AC   CVCL_D2BN
SY   Human LPAR1 knockout HCT116
DR   Abcam; ab301045
DR   Wikidata; Q127379076
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3166; LPAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LRG1 KO
AC   CVCL_D2BP
SY   Human LRG1 knockout HCT116
DR   Abcam; ab301048
DR   Wikidata; Q127379077
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29480; LRG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LRP5 KO
AC   CVCL_B8JV
SY   Human LRP5 knockout HCT116
DR   Abcam; ab286770
DR   cancercelllines; CVCL_B8JV
DR   Wikidata; Q112928054
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 LTBR KO
AC   CVCL_D2BQ
SY   Human LTBR knockout HCT116
DR   Abcam; ab301051
DR   Wikidata; Q127379078
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6718; LTBR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 LYN KO
AC   CVCL_B8JW
SY   Human LYN knockout HCT116
DR   Abcam; ab286650
DR   cancercelllines; CVCL_B8JW
DR   Wikidata; Q112928055
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAD1L1 KO
AC   CVCL_C7DX
SY   Human MAD1L1 knockout HCT116
DR   Abcam; ab301054
DR   Wikidata; Q123030420
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6762; MAD1L1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 MAF KO
AC   CVCL_B8JX
SY   Human MAF knockout HCT116
DR   Abcam; ab287606
DR   cancercelllines; CVCL_B8JX
DR   Wikidata; Q112928056
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6776; MAF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MALT1 KO
AC   CVCL_B8JY
SY   Human MALT1 knockout HCT116
DR   Abcam; ab286597
DR   cancercelllines; CVCL_B8JY
DR   Wikidata; Q112928057
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAP2K1 KO
AC   CVCL_B8JZ
SY   Human MAP2K1 knockout HCT116
DR   Abcam; ab286406
DR   cancercelllines; CVCL_B8JZ
DR   Wikidata; Q112928058
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAP2K2 KO
AC   CVCL_B8K0
SY   Human MAP2K2 knockout HCT116
DR   Abcam; ab286599
DR   cancercelllines; CVCL_B8K0
DR   Wikidata; Q112928059
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAP2K4 KO
AC   CVCL_B8K1
SY   Human MAP2K4 knockout HCT116
DR   Abcam; ab286565
DR   cancercelllines; CVCL_B8K1
DR   Wikidata; Q112928060
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAP3K11 KO
AC   CVCL_B8K2
SY   Human MAP3K11 knockout HCT116
DR   Abcam; ab286774
DR   cancercelllines; CVCL_B8K2
DR   Wikidata; Q112928061
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAP3K5 KO
AC   CVCL_D2BR
SY   Human MAP3K5 knockout HCT116
DR   Abcam; ab301059
DR   Wikidata; Q127379079
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6857; MAP3K5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MAP3K7 KO
AC   CVCL_B8K3
SY   Human MAP3K7 knockout HCT116
DR   Abcam; ab287611
DR   cancercelllines; CVCL_B8K3
DR   Wikidata; Q112928062
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAPK1 KO
AC   CVCL_B8K4
SY   Human MAPK1 knockout HCT116
DR   Abcam; ab286601
DR   cancercelllines; CVCL_B8K4
DR   Wikidata; Q112928063
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAPK14 KO
AC   CVCL_B8K5
SY   Human MAPK14 knockout HCT116
DR   Abcam; ab286776
DR   cancercelllines; CVCL_B8K5
DR   Wikidata; Q112928064
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAPK3 KO
AC   CVCL_B8K6
SY   Human MAPK3 knockout HCT116
DR   Abcam; ab286603
DR   cancercelllines; CVCL_B8K6
DR   Wikidata; Q112928065
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6877; MAPK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MAPKAPK2 KO
AC   CVCL_D2BS
SY   Human MAPKAPK2 knockout HCT116
DR   Abcam; ab301061
DR   Wikidata; Q127379080
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6887; MAPKAPK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MARCKS KO
AC   CVCL_D2BT
SY   Human MARCKS knockout HCT116
DR   Abcam; ab301064
DR   Wikidata; Q127379081
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6759; MARCKS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MARK2 KO
AC   CVCL_D2BU
SY   Human MARK2 knockout HCT116
DR   Abcam; ab301065
DR   Wikidata; Q127379082
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3332; MARK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MBNL1 KO
AC   CVCL_D2BV
SY   Human MBNL1 knockout HCT116
DR   Abcam; ab301068
DR   Wikidata; Q127379083
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6923; MBNL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MDC1 KO
AC   CVCL_B8K7
SY   Human MDC1 knockout HCT116
DR   Abcam; ab287614
DR   cancercelllines; CVCL_B8K7
DR   Wikidata; Q112928066
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21163; MDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ME1 KO
AC   CVCL_C7DY
SY   Human ME1 knockout HCT116
DR   Abcam; ab301070
DR   Wikidata; Q123030421
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6983; ME1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 MECOM KO
AC   CVCL_B8K8
SY   Human MECOM knockout HCT116
DR   Abcam; ab286507
DR   cancercelllines; CVCL_B8K8
DR   Wikidata; Q112928067
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3498; MECOM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MECP2 KO
AC   CVCL_B8K9
SY   Human MECP2 knockout HCT116
DR   Abcam; ab289193
DR   cancercelllines; CVCL_B8K9
DR   Wikidata; Q112928068
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6990; MECP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MED12 KO
AC   CVCL_B8KA
SY   Human MED12 knockout HCT116
DR   Abcam; ab286465
DR   cancercelllines; CVCL_B8KA
DR   Wikidata; Q112928069
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11957; MED12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MEF2A KO
AC   CVCL_B8KB
SY   Human MEF2A knockout HCT116
DR   Abcam; ab289156
DR   cancercelllines; CVCL_B8KB
DR   Wikidata; Q112928070
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6993; MEF2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MEF2C KO
AC   CVCL_B8KC
SY   Human MEF2C knockout HCT116
DR   Abcam; ab289213
DR   cancercelllines; CVCL_B8KC
DR   Wikidata; Q112928071
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6996; MEF2C.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MELK KO
AC   CVCL_B1DT
SY   Human MELK knockout HCT116
DR   Abcam; ab266896
DR   cancercelllines; CVCL_B1DT
DR   Wikidata; Q110430422
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16870; MELK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 MEN1 KO
AC   CVCL_B8KD
SY   Human MEN1 knockout HCT116
DR   Abcam; ab287616
DR   cancercelllines; CVCL_B8KD
DR   Wikidata; Q112928072
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MERTK KO
AC   CVCL_D2BW
SY   Human MERTK knockout HCT116
DR   Abcam; ab301073
DR   Wikidata; Q127379084
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MET KO
AC   CVCL_B8KE
SY   Human MET knockout HCT116
DR   Abcam; ab286779
DR   cancercelllines; CVCL_B8KE
DR   Wikidata; Q112928073
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MGMT KO
AC   CVCL_B8KF
SY   Human MGMT knockout HCT116
DR   Abcam; ab286541
DR   cancercelllines; CVCL_B8KF
DR   Wikidata; Q112928074
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MIB1 KO
AC   CVCL_D2BX
SY   Human MIB1 knockout HCT116
DR   Abcam; ab301075
DR   Wikidata; Q127379085
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21086; MIB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MICA KO
AC   CVCL_B8KG
SY   Human MICA knockout HCT116
DR   Abcam; ab289124
DR   cancercelllines; CVCL_B8KG
DR   Wikidata; Q112928075
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7090; MICA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MICB KO
AC   CVCL_B8KH
SY   Human MICB knockout HCT116
DR   Abcam; ab289095
DR   cancercelllines; CVCL_B8KH
DR   Wikidata; Q112928076
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7091; MICB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MIF KO
AC   CVCL_D2BY
SY   Human MIF knockout HCT116
DR   Abcam; ab301078
DR   Wikidata; Q127379086
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7097; MIF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MITF KO
AC   CVCL_B8KI
SY   Human MITF knockout HCT116
DR   Abcam; ab286491
DR   cancercelllines; CVCL_B8KI
DR   Wikidata; Q112928077
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7105; MITF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MKI67 KO
AC   CVCL_B8KJ
SY   Human MKI67 knockout HCT116
DR   Abcam; ab289090
DR   cancercelllines; CVCL_B8KJ
DR   Wikidata; Q112928078
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MLH1 KO
AC   CVCL_B8KK
SY   Human MLH1 knockout HCT116
DR   Abcam; ab286414
DR   cancercelllines; CVCL_B8KK
DR   Wikidata; Q112928079
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MLST8 KO
AC   CVCL_B1DU
SY   Human MLST8 (G protein beta subunit like/GBL) knockout HCT116
DR   Abcam; ab266868
DR   cancercelllines; CVCL_B1DU
DR   Wikidata; Q110430425
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24825; MLST8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 MMP1 KO
AC   CVCL_B8KL
SY   Human MMP1 knockout HCT116
DR   Abcam; ab286717
DR   cancercelllines; CVCL_B8KL
DR   Wikidata; Q112928080
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7155; MMP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MMP12 KO
AC   CVCL_B8KM
SY   Human MMP12 knockout HCT116
DR   Abcam; ab287619
DR   cancercelllines; CVCL_B8KM
DR   Wikidata; Q112928081
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7158; MMP12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MMP2 KO
AC   CVCL_B8KN
SY   Human MMP2 knockout HCT116
DR   Abcam; ab286668
DR   cancercelllines; CVCL_B8KN
DR   Wikidata; Q112928082
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7166; MMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MMP3 KO
AC   CVCL_C7DZ
SY   Human MMP3 knockout HCT116
DR   Abcam; ab301081
DR   Wikidata; Q123030422
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7173; MMP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 MMP9 KO
AC   CVCL_B8KP
SY   Human MMP9 knockout HCT116
DR   Abcam; ab286711
DR   cancercelllines; CVCL_B8KP
DR   Wikidata; Q112928083
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7176; MMP9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MORF4L2 KO
AC   CVCL_B1DV
SY   Human MORF4L2 (MRGX) knockout HCT116
DR   Abcam; ab266861
DR   cancercelllines; CVCL_B1DV
DR   Wikidata; Q110430427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16849; MORF4L2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 MPO KO
AC   CVCL_B8KQ
SY   Human MPO knockout HCT116
DR   Abcam; ab289141
DR   cancercelllines; CVCL_B8KQ
DR   Wikidata; Q112928084
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7218; MPO.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MRC1 KO
AC   CVCL_B8KR
SY   Human MRC1 knockout HCT116
DR   Abcam; ab289245
DR   cancercelllines; CVCL_B8KR
DR   Wikidata; Q112928085
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7228; MRC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MRE11 KO
AC   CVCL_B8KS
SY   Human MRE11 knockout HCT116
DR   Abcam; ab286539
DR   cancercelllines; CVCL_B8KS
DR   Wikidata; Q112928086
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7230; MRE11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MSH2 KO
AC   CVCL_B8KT
SY   Human MSH2 knockout HCT116
DR   Abcam; ab286273
DR   cancercelllines; CVCL_B8KT
DR   Wikidata; Q112928087
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MSH3 KO
AC   CVCL_B8KU
SY   Human MSH3 knockout HCT116
DR   Abcam; ab289106
DR   cancercelllines; CVCL_B8KU
DR   Wikidata; Q112928088
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MSH6 KO
AC   CVCL_B8KV
SY   Human MSH6 knockout HCT116
DR   Abcam; ab282629
DR   cancercelllines; CVCL_B8KV
DR   Wikidata; Q112928089
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MSI1 KO
AC   CVCL_D2BZ
SY   Human MSI1 knockout HCT116
DR   Abcam; ab301083
DR   Wikidata; Q127379087
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7330; MSI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 MSLN KO
AC   CVCL_B8KW
SY   Human MSLN knockout HCT116
DR   Abcam; ab289257
DR   cancercelllines; CVCL_B8KW
DR   Wikidata; Q112928090
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7371; MSLN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MSR1 KO
AC   CVCL_B8KX
SY   Human MSR1 knockout HCT116
DR   Abcam; ab287623
DR   cancercelllines; CVCL_B8KX
DR   Wikidata; Q112928091
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7376; MSR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MST1R KO
AC   CVCL_C7E0
SY   Human MST1R knockout HCT116
DR   Abcam; ab301086
DR   Wikidata; Q123030423
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7381; MST1R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 MTA2 KO
AC   CVCL_B8KY
SY   Human MTA2 knockout HCT116
DR   Abcam; ab287625
DR   cancercelllines; CVCL_B8KY
DR   Wikidata; Q112928093
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7411; MTA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MUC1 KO
AC   CVCL_B8KZ
SY   Human MUC1 knockout HCT116
DR   Abcam; ab287629
DR   cancercelllines; CVCL_B8KZ
DR   Wikidata; Q112928095
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MUC16 KO
AC   CVCL_B8L0
SY   Human MUC16 knockout HCT116
DR   Abcam; ab287632
DR   cancercelllines; CVCL_B8L0
DR   Wikidata; Q112928096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15582; MUC16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MYB KO
AC   CVCL_B8L1
SY   Human MYB knockout HCT116
DR   Abcam; ab287634
DR   cancercelllines; CVCL_B8L1
DR   Wikidata; Q112928097
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MYD88 KO
AC   CVCL_B8L2
SY   Human MYD88 knockout HCT116
DR   Abcam; ab286531
DR   cancercelllines; CVCL_B8L2
DR   Wikidata; Q112928098
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 MYOD1 KO
AC   CVCL_B8L3
SY   Human MYOD1 knockout HCT116
DR   Abcam; ab286362
DR   cancercelllines; CVCL_B8L3
DR   Wikidata; Q112928099
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7611; MYOD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NAMPT KO
AC   CVCL_D2C0
SY   Human NAMPT knockout HCT116
DR   Abcam; ab301089
DR   Wikidata; Q127379088
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30092; NAMPT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 NANOG KO
AC   CVCL_B8L4
SY   Human NANOG knockout HCT116
DR   Abcam; ab289096
DR   cancercelllines; CVCL_B8L4
DR   Wikidata; Q112928100
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20857; NANOG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NBN KO
AC   CVCL_B8L5
SY   Human NBN knockout HCT116
DR   Abcam; ab286608
DR   cancercelllines; CVCL_B8L5
DR   Wikidata; Q112928101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NCAM1 KO
AC   CVCL_B8L6
SY   Human NCAM1 knockout HCT116
DR   Abcam; ab287638
DR   cancercelllines; CVCL_B8L6
DR   Wikidata; Q112928102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NCAM2 KO
AC   CVCL_B8L7
SY   Human NCAM2 knockout HCT116
DR   Abcam; ab289227
DR   cancercelllines; CVCL_B8L7
DR   Wikidata; Q112928103
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7657; NCAM2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NCF4 KO
AC   CVCL_B8L8
SY   Human NCF4 knockout HCT116
DR   Abcam; ab289218
DR   cancercelllines; CVCL_B8L8
DR   Wikidata; Q112928104
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7662; NCF4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NCOA1 KO
AC   CVCL_B8L9
SY   Human NCOA1 knockout HCT116
DR   Abcam; ab287640
DR   cancercelllines; CVCL_B8L9
DR   Wikidata; Q112928105
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7668; NCOA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NCR1 KO
AC   CVCL_B8LA
SY   Human NCR1 knockout HCT116
DR   Abcam; ab289180
DR   cancercelllines; CVCL_B8LA
DR   Wikidata; Q112928106
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6731; NCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NECTIN2 KO
AC   CVCL_B8LB
SY   Human NECTIN2 knockout HCT116
DR   Abcam; ab289138
DR   cancercelllines; CVCL_B8LB
DR   Wikidata; Q112928107
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9707; NECTIN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NECTIN3 KO
AC   CVCL_B8LC
SY   Human NECTIN3 knockout HCT116
DR   Abcam; ab289254
DR   cancercelllines; CVCL_B8LC
DR   Wikidata; Q112928108
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17664; NECTIN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NEDD4L KO
AC   CVCL_C7E1
SY   Human NEDD4L knockout HCT116
DR   Abcam; ab301092
DR   Wikidata; Q123030424
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7728; NEDD4L.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 NF1 KO
AC   CVCL_B8LD
SY   Human NF1 knockout HCT116
DR   Abcam; ab286609
DR   cancercelllines; CVCL_B8LD
DR   Wikidata; Q112928109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NF2 KO
AC   CVCL_B8LE
SY   Human NF2 knockout HCT116
DR   Abcam; ab286610
DR   cancercelllines; CVCL_B8LE
DR   Wikidata; Q112928110
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NFATC1 KO
AC   CVCL_B8LF
SY   Human NFATC1 knockout HCT116
DR   Abcam; ab289266
DR   cancercelllines; CVCL_B8LF
DR   Wikidata; Q112928111
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NFATC2 KO
AC   CVCL_B8LG
SY   Human NFATC2 knockout HCT116
DR   Abcam; ab287643
DR   cancercelllines; CVCL_B8LG
DR   Wikidata; Q112928112
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7776; NFATC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NFE2L2 KO
AC   CVCL_B8LH
SY   Human NFE2L2 knockout HCT116
DR   Abcam; ab287647
DR   cancercelllines; CVCL_B8LH
DR   Wikidata; Q112928113
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NFIB KO
AC   CVCL_D2C1
SY   Human NFIB knockout HCT116
DR   Abcam; ab301096
DR   Wikidata; Q127379089
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7785; NFIB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 NFKB2 KO
AC   CVCL_B1DW
SY   Human NFKB2 (NFkB p100/NFKB2) knockout HCT116
DR   Abcam; ab266883
DR   cancercelllines; CVCL_B1DW
DR   Wikidata; Q110430428
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 NOD1 KO
AC   CVCL_C7E2
SY   Human NOD1 knockout HCT116
DR   Abcam; ab301099
DR   Wikidata; Q123030425
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16390; NOD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 NOS1 KO
AC   CVCL_D2C2
SY   Human NOS1 knockout HCT116
DR   Abcam; ab301102
DR   Wikidata; Q127379090
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7872; NOS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 NOS2 KO
AC   CVCL_B8LI
SY   Human NOS2 knockout HCT116
DR   Abcam; ab287649
DR   cancercelllines; CVCL_B8LI
DR   Wikidata; Q112928114
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NOTCH1 KO
AC   CVCL_B8LJ
SY   Human NOTCH1 knockout HCT116
DR   Abcam; ab287652
DR   cancercelllines; CVCL_B8LJ
DR   Wikidata; Q112928115
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NOTCH2 KO
AC   CVCL_B8LK
SY   Human NOTCH2 knockout HCT116
DR   Abcam; ab286467
DR   cancercelllines; CVCL_B8LK
DR   Wikidata; Q112928116
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NR1D1 KO
AC   CVCL_D2C3
SY   Human NR1D1 knockout HCT116
DR   Abcam; ab301107
DR   Wikidata; Q127379091
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7962; NR1D1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 NR1H3 KO
AC   CVCL_B8LL
SY   Human NR1H3 knockout HCT116
DR   Abcam; ab289244
DR   cancercelllines; CVCL_B8LL
DR   Wikidata; Q112928118
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NR2F2 KO
AC   CVCL_B1DX
SY   Human NR2F2 knockout HCT116
DR   Abcam; ab266888
DR   cancercelllines; CVCL_B1DX
DR   Wikidata; Q110430429
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7976; NR2F2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 NR4A1 KO
AC   CVCL_B8LM
SY   Human NR4A1 knockout HCT116
DR   Abcam; ab287656
DR   cancercelllines; CVCL_B8LM
DR   Wikidata; Q112928119
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NR4A3 KO
AC   CVCL_B8LN
SY   Human NR4A3 knockout HCT116
DR   Abcam; ab286355
DR   cancercelllines; CVCL_B8LN
DR   Wikidata; Q112928120
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7982; NR4A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NR5A2 KO
AC   CVCL_D2C4
SY   Human NR5A2 knockout HCT116
DR   Abcam; ab301109
DR   Wikidata; Q127379093
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7984; NR5A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 NRAS KO
AC   CVCL_B8LP
SY   Human NRAS knockout HCT116
DR   Abcam; ab286418
DR   cancercelllines; CVCL_B8LP
DR   Wikidata; Q112928121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NRP2 KO
AC   CVCL_D2C5
SY   Human NRP2 knockout HCT116
DR   Abcam; ab301112
DR   Wikidata; Q127379094
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7751; NELL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 NSD2 KO
AC   CVCL_B8LQ
SY   Human NSD2 knockout HCT116
DR   Abcam; ab287658
DR   cancercelllines; CVCL_B8LQ
DR   Wikidata; Q112928123
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NTRK2 KO
AC   CVCL_B8LR
SY   Human NTRK2 knockout HCT116
DR   Abcam; ab289192
DR   cancercelllines; CVCL_B8LR
DR   Wikidata; Q112928124
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8032; NTRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 NTRK3 KO
AC   CVCL_B8LS
SY   Human NTRK3 knockout HCT116
DR   Abcam; ab286537
DR   cancercelllines; CVCL_B8LS
DR   Wikidata; Q112928125
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8033; NTRK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ODC1 KO
AC   CVCL_D2C6
SY   Human ODC1 knockout HCT116
DR   Abcam; ab301115
DR   Wikidata; Q127379095
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8109; ODC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 OGG1 KO
AC   CVCL_D2C7
SY   Human OGG1 knockout HCT116
DR   Abcam; ab301117
DR   Wikidata; Q127379096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8125; OGG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 OLIG2 KO
AC   CVCL_B8LT
SY   Human OLIG2 knockout HCT116
DR   Abcam; ab286354
DR   cancercelllines; CVCL_B8LT
DR   Wikidata; Q112928126
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9398; OLIG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 OPRM1 KO
AC   CVCL_B8LU
SY   Human OPRM1 knockout HCT116
DR   Abcam; ab286496
DR   cancercelllines; CVCL_B8LU
DR   Wikidata; Q112928127
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8156; OPRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ORAI1 KO
AC   CVCL_D2C8
SY   Human ORAI1 knockout HCT116
DR   Abcam; ab301120
DR   Wikidata; Q127379097
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25896; ORAI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 P2RX7 KO
AC   CVCL_D2C9
SY   Human P2RX7 knockout HCT116
DR   Abcam; ab301123
DR   Wikidata; Q127379098
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8537; P2RX7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PABPC1 KO
AC   CVCL_D2CA
SY   Human PABPC1 knockout HCT116
DR   Abcam; ab301127
DR   Wikidata; Q127379099
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8554; PABPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PADI4 KO
AC   CVCL_B8LV
SY   Human PADI4 knockout HCT116
DR   Abcam; ab287663
DR   cancercelllines; CVCL_B8LV
DR   Wikidata; Q112928128
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18368; PADI4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PAK1 KO
AC   CVCL_B8LW
SY   Human PAK1 knockout HCT116
DR   Abcam; ab286783
DR   cancercelllines; CVCL_B8LW
DR   Wikidata; Q112928129
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PAK2 KO
AC   CVCL_B8LX
SY   Human PAK2 knockout HCT116
DR   Abcam; ab287666
DR   cancercelllines; CVCL_B8LX
DR   Wikidata; Q112928130
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PAK4 KO
AC   CVCL_B8LY
SY   Human PAK4 knockout HCT116
DR   Abcam; ab289104
DR   cancercelllines; CVCL_B8LY
DR   Wikidata; Q112928131
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PALB2 KO
AC   CVCL_B8LZ
SY   Human PALB2 knockout HCT116
DR   Abcam; ab286635
DR   cancercelllines; CVCL_B8LZ
DR   Wikidata; Q112928132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26144; PALB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PANX1 KO
AC   CVCL_D2CB
SY   Human PANX1 knockout HCT116
DR   Abcam; ab301130
DR   Wikidata; Q127379100
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8599; PANX1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PARG KO
AC   CVCL_D2CC
SY   Human PARG knockout HCT116
DR   Abcam; ab301132
DR   Wikidata; Q127379101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PARP3 KO
AC   CVCL_B8M0
SY   Human PARP3 knockout HCT116
DR   Abcam; ab288194
DR   cancercelllines; CVCL_B8M0
DR   Wikidata; Q112928133
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PAX5 KO
AC   CVCL_B8M1
SY   Human PAX5 knockout HCT116
DR   Abcam; ab287669
DR   cancercelllines; CVCL_B8M1
DR   Wikidata; Q112928134
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8619; PAX5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PAX6 KO
AC   CVCL_B8M2
SY   Human PAX6 knockout HCT116
DR   Abcam; ab289182
DR   cancercelllines; CVCL_B8M2
DR   Wikidata; Q112928135
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PAX7 KO
AC   CVCL_B8M3
SY   Human PAX7 knockout HCT116
DR   Abcam; ab287671
DR   cancercelllines; CVCL_B8M3
DR   Wikidata; Q112928136
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8621; PAX7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PAX8 KO
AC   CVCL_B8M4
SY   Human PAX8 knockout HCT116
DR   Abcam; ab287675
DR   cancercelllines; CVCL_B8M4
DR   Wikidata; Q112928137
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8622; PAX8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PBK KO
AC   CVCL_B8M5
SY   Human PBK knockout HCT116
DR   Abcam; ab289251
DR   cancercelllines; CVCL_B8M5
DR   Wikidata; Q112928138
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PBRM1 KO
AC   CVCL_B8M6
SY   Human PBRM1 knockout HCT116
DR   Abcam; ab286499
DR   cancercelllines; CVCL_B8M6
DR   Wikidata; Q112928139
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PCK1 KO
AC   CVCL_D2CD
SY   Human PCK1 knockout HCT116
DR   Abcam; ab301134
DR   Wikidata; Q127379102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8724; PCK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PCSK9 KO
AC   CVCL_C7E3
SY   Human PCSK9 knockout HCT116
DR   Abcam; ab301137
DR   Wikidata; Q123030427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20001; PCSK9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 PDCD1 KO
AC   CVCL_B8M7
SY   Human PDCD1 knockout HCT116
DR   Abcam; ab287679
DR   cancercelllines; CVCL_B8M7
DR   Wikidata; Q112928140
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PDE5A KO
AC   CVCL_C7E4
SY   Human PDE5A knockout HCT116
DR   Abcam; ab301139
DR   Wikidata; Q123030428
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8784; PDE5A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 PDGFB KO
AC   CVCL_B8M8
SY   Human PDGFB knockout HCT116
DR   Abcam; ab287681
DR   cancercelllines; CVCL_B8M8
DR   Wikidata; Q112928141
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8800; PDGFB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PDGFRA KO
AC   CVCL_B8M9
SY   Human PDGFRA knockout HCT116
DR   Abcam; ab287684
DR   cancercelllines; CVCL_B8M9
DR   Wikidata; Q112928144
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PDGFRB KO
AC   CVCL_B8MA
SY   Human PDGFRB knockout HCT116
DR   Abcam; ab286613
DR   cancercelllines; CVCL_B8MA
DR   Wikidata; Q112928146
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8804; PDGFRB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PDIA3 KO
AC   CVCL_D2CE
SY   Human PDIA3 knockout HCT116
DR   Abcam; ab301142
DR   Wikidata; Q127379104
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4606; PDIA3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PDPK1 KO
AC   CVCL_B8MB
SY   Human PDPK1 knockout HCT116
DR   Abcam; ab287687
DR   cancercelllines; CVCL_B8MB
DR   Wikidata; Q112928147
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8816; PDPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PDPN KO
AC   CVCL_B8MC
SY   Human PDPN knockout HCT116
DR   Abcam; ab289260
DR   cancercelllines; CVCL_B8MC
DR   Wikidata; Q112928148
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PEBP1 KO
AC   CVCL_B8MD
SY   Human PEBP1 knockout HCT116
DR   Abcam; ab289160
DR   cancercelllines; CVCL_B8MD
DR   Wikidata; Q112928149
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8630; PEBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PECAM1 KO
AC   CVCL_B8ME
SY   Human PECAM1 knockout HCT116
DR   Abcam; ab289276
DR   cancercelllines; CVCL_B8ME
DR   Wikidata; Q112928150
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8823; PECAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PER1 KO
AC   CVCL_B8MF
SY   Human PER1 knockout HCT116
DR   Abcam; ab288195
DR   cancercelllines; CVCL_B8MF
DR   Wikidata; Q112928151
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8845; PER1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PER2 KO
AC   CVCL_D2CF
SY   Human PER2 knockout HCT116
DR   Abcam; ab301147
DR   Wikidata; Q127379105
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8846; PER2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PFKFB3 KO
AC   CVCL_D2CG
SY   Human PFKFB3 knockout HCT116
DR   Abcam; ab301150
DR   Wikidata; Q127379106
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PGF KO
AC   CVCL_B8MG
SY   Human PGF knockout HCT116
DR   Abcam; ab287692
DR   cancercelllines; CVCL_B8MG
DR   Wikidata; Q112928152
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8893; PGF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PGK1 KO
AC   CVCL_D2CH
SY   Human PGK1 knockout HCT116
DR   Abcam; ab301153
DR   Wikidata; Q127379107
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8896; PGK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PGR KO
AC   CVCL_B8MH
SY   Human PGR knockout HCT116
DR   Abcam; ab287697
DR   cancercelllines; CVCL_B8MH
DR   Wikidata; Q112928153
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8910; PGR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PHF1 KO
AC   CVCL_B8MI
SY   Human PHF1 knockout HCT116
DR   Abcam; ab288196
DR   cancercelllines; CVCL_B8MI
DR   Wikidata; Q112928154
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8919; PHF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PHLPP1 KO
AC   CVCL_B8MJ
SY   Human PHLPP1 knockout HCT116
DR   Abcam; ab287699
DR   cancercelllines; CVCL_B8MJ
DR   Wikidata; Q112928155
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20610; PHLPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PIK3C3 KO
AC   CVCL_D2CI
SY   Human PIK3C3 knockout HCT116
DR   Abcam; ab301158
DR   Wikidata; Q127379108
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8974; PIK3C3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PIK3R1 KO
AC   CVCL_B8MK
SY   Human PIK3R1 knockout HCT116
DR   Abcam; ab286614
DR   cancercelllines; CVCL_B8MK
DR   Wikidata; Q112928156
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PIK3R2 KO
AC   CVCL_B8ML
SY   Human PIK3R2 knockout HCT116
DR   Abcam; ab286786
DR   cancercelllines; CVCL_B8ML
DR   Wikidata; Q112928157
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PIWIL4 KO
AC   CVCL_B8MM
SY   Human PIWIL4 knockout HCT116
DR   Abcam; ab289153
DR   cancercelllines; CVCL_B8MM
DR   Wikidata; Q112928158
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18444; PIWIL4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PKD2 KO
AC   CVCL_D2CJ
SY   Human PKD2 knockout HCT116
DR   Abcam; ab301160
DR   Wikidata; Q127379109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PKN2 KO
AC   CVCL_B1DY
SY   Human PKN2 knockout HCT116
DR   Abcam; ab266894
DR   cancercelllines; CVCL_B1DY
DR   Wikidata; Q110430430
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 PLAUR KO
AC   CVCL_D2CK
SY   Human PLAUR knockout HCT116
DR   Abcam; ab301163
DR   Wikidata; Q127379110
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9053; PLAUR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PLCG2 KO
AC   CVCL_D2CL
SY   Human PLCG2 knockout HCT116
DR   Abcam; ab301166
DR   Wikidata; Q127379111
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PLD1 KO
AC   CVCL_D2CM
SY   Human PLD1 knockout HCT116
DR   Abcam; ab301169
DR   Wikidata; Q127379112
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9067; PLD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PLK2 KO
AC   CVCL_B1DZ
SY   Human PLK2 knockout HCT116
DR   Abcam; ab266859
DR   cancercelllines; CVCL_B1DZ
DR   Wikidata; Q110430432
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 PMEL KO
AC   CVCL_B8MN
SY   Human PMEL knockout HCT116
DR   Abcam; ab289176
DR   cancercelllines; CVCL_B8MN
DR   Wikidata; Q112928159
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10880; PMEL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PML KO
AC   CVCL_B8MP
SY   Human PML knockout HCT116
DR   Abcam; ab286616
DR   cancercelllines; CVCL_B8MP
DR   Wikidata; Q112928160
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PMS2 KO
AC   CVCL_B8MQ
SY   Human PMS2 knockout HCT116
DR   Abcam; ab286425
DR   cancercelllines; CVCL_B8MQ
DR   Wikidata; Q112928161
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9122; PMS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PODXL KO
AC   CVCL_B1E0
SY   Human PODXL knockout HCT116
DR   Abcam; ab266887
DR   cancercelllines; CVCL_B1E0
DR   Wikidata; Q110430433
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 POLQ KO
AC   CVCL_B8MR
SY   Human POLQ knockout HCT116
DR   Abcam; ab286468
DR   cancercelllines; CVCL_B8MR
DR   Wikidata; Q112928162
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9186; POLQ.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 POLR2A KO
AC   CVCL_B8MS
SY   Human POLR2A knockout HCT116
DR   Abcam; ab287703
DR   cancercelllines; CVCL_B8MS
DR   Wikidata; Q112928163
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9187; POLR2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 POR KO
AC   CVCL_B1E1
SY   Human POR (Cytochrome P450 Reductase) knockout HCT116
DR   Abcam; ab266889
DR   cancercelllines; CVCL_B1E1
DR   Wikidata; Q110430434
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 POU2F2 KO
AC   CVCL_B8MT
SY   Human POU2F2 knockout HCT116
DR   Abcam; ab289267
DR   cancercelllines; CVCL_B8MT
DR   Wikidata; Q112928164
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9213; POU2F2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 POU5F1 KO
AC   CVCL_B8MU
SY   Human POU5F1 knockout HCT116
DR   Abcam; ab286538
DR   cancercelllines; CVCL_B8MU
DR   Wikidata; Q112928165
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9221; POU5F1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PPARA KO
AC   CVCL_B8MV
SY   Human PPARA knockout HCT116
DR   Abcam; ab289185
DR   cancercelllines; CVCL_B8MV
DR   Wikidata; Q112928166
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PPARD KO
AC   CVCL_B8MW
SY   Human PPARD knockout HCT116
DR   Abcam; ab289216
DR   cancercelllines; CVCL_B8MW
DR   Wikidata; Q112928167
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9235; PPARD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PPARG KO
AC   CVCL_B8MX
SY   Human PPARG knockout HCT116
DR   Abcam; ab287704
DR   cancercelllines; CVCL_B8MX
DR   Wikidata; Q112928168
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PPM1D KO
AC   CVCL_D2CN
SY   Human PPM1D knockout HCT116
DR   Abcam; ab301174
DR   Wikidata; Q127379113
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9277; PPM1D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PRDM1 KO
AC   CVCL_B8MY
SY   Human PRDM1 knockout HCT116
DR   Abcam; ab287707
DR   cancercelllines; CVCL_B8MY
DR   Wikidata; Q112928169
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9346; PRDM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRDM16 KO
AC   CVCL_B8MZ
SY   Human PRDM16 knockout HCT116
DR   Abcam; ab286500
DR   cancercelllines; CVCL_B8MZ
DR   Wikidata; Q112928170
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14000; PRDM16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRDX6 KO
AC   CVCL_C7E5
SY   Human PRDX6 knockout HCT116
DR   Abcam; ab301177
DR   Wikidata; Q123030430
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16753; PRDX6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 PRF1 KO
AC   CVCL_B8N0
SY   Human PRF1 knockout HCT116
DR   Abcam; ab287710
DR   cancercelllines; CVCL_B8N0
DR   Wikidata; Q112928171
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9360; PRF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRKAA1 KO
AC   CVCL_B8N1
SY   Human PRKAA1 knockout HCT116
DR   Abcam; ab287715
DR   cancercelllines; CVCL_B8N1
DR   Wikidata; Q112928172
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRKAA2 KO
AC   CVCL_B8N2
SY   Human PRKAA2 knockout HCT116
DR   Abcam; ab286566
DR   cancercelllines; CVCL_B8N2
DR   Wikidata; Q112928173
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRKAR1A KO
AC   CVCL_B8N3
SY   Human PRKAR1A knockout HCT116
DR   Abcam; ab289064
DR   cancercelllines; CVCL_B8N3
DR   Wikidata; Q112928174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9388; PRKAR1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRKCA KO
AC   CVCL_B8N4
SY   Human PRKCA knockout HCT116
DR   Abcam; ab286551
DR   cancercelllines; CVCL_B8N4
DR   Wikidata; Q112928175
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRKCB KO
AC   CVCL_B8N5
SY   Human PRKCB knockout HCT116
DR   Abcam; ab287717
DR   cancercelllines; CVCL_B8N5
DR   Wikidata; Q112928176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9395; PRKCB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PRKD2 KO
AC   CVCL_D2CP
SY   Human PRKD2 knockout HCT116
DR   Abcam; ab301180
DR   Wikidata; Q127379114
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PROCR KO
AC   CVCL_B8N6
SY   Human PROCR knockout HCT116
DR   Abcam; ab287721
DR   cancercelllines; CVCL_B8N6
DR   Wikidata; Q112928177
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9452; PROCR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PROM1 KO
AC   CVCL_B8N7
SY   Human PROM1 knockout HCT116
DR   Abcam; ab289219
DR   cancercelllines; CVCL_B8N7
DR   Wikidata; Q112928178
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9454; PROM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PROX1 KO
AC   CVCL_B8N8
SY   Human PROX1 knockout HCT116
DR   Abcam; ab287723
DR   cancercelllines; CVCL_B8N8
DR   Wikidata; Q112928179
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9459; PROX1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PSMB9 KO
AC   CVCL_C7E6
SY   Human PSMB9 knockout HCT116
DR   Abcam; ab301183
DR   Wikidata; Q123030431
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9546; PSMB9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 PTCH1 KO
AC   CVCL_B8N9
SY   Human PTCH1 knockout HCT116
DR   Abcam; ab289538
DR   cancercelllines; CVCL_B8N9
DR   Wikidata; Q112928180
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTCH2 KO
AC   CVCL_B8NA
SY   Human PTCH2 knockout HCT116
DR   Abcam; ab289539
DR   cancercelllines; CVCL_B8NA
DR   Wikidata; Q112928181
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9586; PTCH2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTEN KO
AC   CVCL_B8NB
SY   Human PTEN knockout HCT116
DR   Abcam; ab286518
DR   cancercelllines; CVCL_B8NB
DR   Wikidata; Q112928182
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTGES KO
AC   CVCL_D2CQ
SY   Human PTGES knockout HCT116
DR   Abcam; ab301185
DR   Wikidata; Q127379115
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9599; PTGES.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PTGS1 KO
AC   CVCL_B8NC
SY   Human PTGS1 knockout HCT116
DR   Abcam; ab287725
DR   cancercelllines; CVCL_B8NC
DR   Wikidata; Q112928183
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9604; PTGS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTHLH KO
AC   CVCL_C7E7
SY   Human PTHLH knockout HCT116
DR   Abcam; ab301187
DR   Wikidata; Q123030432
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9607; PTHLH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 PTK2B KO
AC   CVCL_D2CR
SY   Human PTK2B knockout HCT116
DR   Abcam; ab301190
DR   Wikidata; Q127379116
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 PTK6 KO
AC   CVCL_B8ND
SY   Human PTK6 knockout HCT116
DR   Abcam; ab289199
DR   cancercelllines; CVCL_B8ND
DR   Wikidata; Q112928184
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9617; PTK6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTN KO
AC   CVCL_B8NE
SY   Human PTN knockout HCT116
DR   Abcam; ab289207
DR   cancercelllines; CVCL_B8NE
DR   Wikidata; Q112928185
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9630; PTN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTPN1 KO
AC   CVCL_B8NF
SY   Human PTPN1 knockout HCT116
DR   Abcam; ab289075
DR   cancercelllines; CVCL_B8NF
DR   Wikidata; Q112928186
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTPN11 KO
AC   CVCL_B8NG
SY   Human PTPN11 knockout HCT116
DR   Abcam; ab286618
DR   cancercelllines; CVCL_B8NG
DR   Wikidata; Q112928187
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTPN2 KO
AC   CVCL_B8NH
SY   Human PTPN2 knockout HCT116
DR   Abcam; ab287729
DR   cancercelllines; CVCL_B8NH
DR   Wikidata; Q112928188
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PTPN6 KO
AC   CVCL_B8NI
SY   Human PTPN6 knockout HCT116
DR   Abcam; ab287731
DR   cancercelllines; CVCL_B8NI
DR   Wikidata; Q112928189
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 PYGB KO
AC   CVCL_D2CS
SY   Human PYGB knockout HCT116
DR   Abcam; ab301193
DR   Wikidata; Q127379117
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9723; PYGB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 RAB5A KO
AC   CVCL_D2CT
SY   Human RAB5A knockout HCT116
DR   Abcam; ab301196
DR   Wikidata; Q127379118
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9783; RAB5A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 RAD50 KO
AC   CVCL_B8NJ
SY   Human RAD50 knockout HCT116
DR   Abcam; ab286799
DR   cancercelllines; CVCL_B8NJ
DR   Wikidata; Q112928190
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9816; RAD50.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RAD51D KO
AC   CVCL_B8NK
SY   Human RAD51D knockout HCT116
DR   Abcam; ab286478
DR   cancercelllines; CVCL_B8NK
DR   Wikidata; Q112928191
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RAET1E KO
AC   CVCL_B8NL
SY   Human RAET1E knockout HCT116
DR   Abcam; ab289256
DR   cancercelllines; CVCL_B8NL
DR   Wikidata; Q112928193
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16793; RAET1E.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RAF1 KO
AC   CVCL_B8NM
SY   Human RAF1 knockout HCT116
DR   Abcam; ab286619
DR   cancercelllines; CVCL_B8NM
DR   Wikidata; Q112928194
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RARB KO
AC   CVCL_B8NN
SY   Human RARB knockout HCT116
DR   Abcam; ab287738
DR   cancercelllines; CVCL_B8NN
DR   Wikidata; Q112928195
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9865; RARB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RB1 KO
AC   CVCL_B8NP
SY   Human RB1 knockout HCT116
DR   Abcam; ab286657
DR   cancercelllines; CVCL_B8NP
DR   Wikidata; Q112928196
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RBBP7 KO
AC   CVCL_B1E2
SY   Human RBBP7 (RbAp46) knockout HCT116
DR   Abcam; ab266877
DR   cancercelllines; CVCL_B1E2
DR   Wikidata; Q110430435
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9890; RBBP7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 RBL2 KO
AC   CVCL_C7E8
SY   Human RBL2 knockout HCT116
DR   Abcam; ab301199
DR   Wikidata; Q123030433
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9894; RBL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 REL KO
AC   CVCL_B8NQ
SY   Human REL knockout HCT116
DR   Abcam; ab286471
DR   cancercelllines; CVCL_B8NQ
DR   Wikidata; Q112928197
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9954; REL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RELA KO
AC   CVCL_B8NR
SY   Human RELA knockout HCT116
DR   Abcam; ab287742
DR   cancercelllines; CVCL_B8NR
DR   Wikidata; Q112928198
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 REST KO
AC   CVCL_B8NS
SY   Human REST knockout HCT116
DR   Abcam; ab287744
DR   cancercelllines; CVCL_B8NS
DR   Wikidata; Q112928199
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9966; REST.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RET KO
AC   CVCL_B8NT
SY   Human RET knockout HCT116
DR   Abcam; ab286472
DR   cancercelllines; CVCL_B8NT
DR   Wikidata; Q112928200
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RHOB KO
AC   CVCL_D2CU
SY   Human RHOB knockout HCT116
DR   Abcam; ab301206
DR   Wikidata; Q127379119
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:668; RHOB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 RICTOR KO
AC   CVCL_B8NU
SY   Human RICTOR knockout HCT116
DR   Abcam; ab286621
DR   cancercelllines; CVCL_B8NU
DR   Wikidata; Q112928201
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RNF2 KO
AC   CVCL_B8NV
SY   Human RNF2 knockout HCT116
DR   Abcam; ab287747
DR   cancercelllines; CVCL_B8NV
DR   Wikidata; Q112928202
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ROCK1 KO
AC   CVCL_C7E9
SY   Human ROCK1 knockout HCT116
DR   Abcam; ab301209
DR   Wikidata; Q123030434
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 RORC KO
AC   CVCL_B8NW
SY   Human RORC knockout HCT116
DR   Abcam; ab289061
DR   cancercelllines; CVCL_B8NW
DR   Wikidata; Q112928204
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10260; RORC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ROS1 KO
AC   CVCL_B8NX
SY   Human ROS1 knockout HCT116
DR   Abcam; ab286567
DR   cancercelllines; CVCL_B8NX
DR   Wikidata; Q112928205
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10261; ROS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RPS6KA1 KO
AC   CVCL_B8NY
SY   Human RPS6KA1 knockout HCT116
DR   Abcam; ab289084
DR   cancercelllines; CVCL_B8NY
DR   Wikidata; Q112928206
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10430; RPS6KA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RPS6KA3 KO
AC   CVCL_B8NZ
SY   Human RPS6KA3 knockout HCT116
DR   Abcam; ab287750
DR   cancercelllines; CVCL_B8NZ
DR   Wikidata; Q112928207
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10432; RPS6KA3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RPS6KB2 KO
AC   CVCL_D2CV
SY   Human RPS6KB2 knockout HCT116
DR   Abcam; ab301211
DR   Wikidata; Q127379120
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10437; RPS6KB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 RRM2B KO
AC   CVCL_B1E3
SY   Human RRM2B (p53R2) knockout HCT116
DR   Abcam; ab266897
DR   cancercelllines; CVCL_B1E3
DR   Wikidata; Q110430436
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17296; RRM2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 RSF1 KO
AC   CVCL_B8P0
SY   Human RSF1 knockout HCT116
DR   Abcam; ab288197
DR   cancercelllines; CVCL_B8P0
DR   Wikidata; Q112928208
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18118; RSF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RSPO2 KO
AC   CVCL_B8P1
SY   Human RSPO2 knockout HCT116
DR   Abcam; ab286473
DR   cancercelllines; CVCL_B8P1
DR   Wikidata; Q112928209
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28583; RSPO2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RUNX1 KO
AC   CVCL_B8P2
SY   Human RUNX1 knockout HCT116
DR   Abcam; ab287753
DR   cancercelllines; CVCL_B8P2
DR   Wikidata; Q112928210
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RUNX3 KO
AC   CVCL_B8P3
SY   Human RUNX3 knockout HCT116
DR   Abcam; ab289111
DR   cancercelllines; CVCL_B8P3
DR   Wikidata; Q112928211
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10473; RUNX3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 RXRA KO
AC   CVCL_B1E4
SY   Human RXRA knockout HCT116
DR   Abcam; ab273708
DR   cancercelllines; CVCL_B1E4
DR   Wikidata; Q110430437
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 RYR1 KO
AC   CVCL_D2CW
SY   Human RYR1 knockout HCT116
DR   Abcam; ab301214
DR   Wikidata; Q127379121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10483; RYR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 S100A10 KO
AC   CVCL_D2CX
SY   Human S100A10 knockout HCT116
DR   Abcam; ab301216
DR   Wikidata; Q127379122
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10487; S100A10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 S100A8 KO
AC   CVCL_B8P4
SY   Human S100A8 knockout HCT116
DR   Abcam; ab289136
DR   cancercelllines; CVCL_B8P4
DR   Wikidata; Q112928212
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10498; S100A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SALL4 KO
AC   CVCL_B8P5
SY   Human SALL4 knockout HCT116
DR   Abcam; ab286350
DR   cancercelllines; CVCL_B8P5
DR   Wikidata; Q112928213
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15924; SALL4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SEMA4D KO
AC   CVCL_B8P6
SY   Human SEMA4D knockout HCT116
DR   Abcam; ab289144
DR   cancercelllines; CVCL_B8P6
DR   Wikidata; Q112928214
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10732; SEMA4D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SEMA7A KO
AC   CVCL_B8P7
SY   Human SEMA7A knockout HCT116
DR   Abcam; ab289253
DR   cancercelllines; CVCL_B8P7
DR   Wikidata; Q112928215
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10741; SEMA7A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SENP1 KO
AC   CVCL_B8P8
SY   Human SENP1 knockout HCT116
DR   Abcam; ab289149
DR   cancercelllines; CVCL_B8P8
DR   Wikidata; Q112928216
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17927; SENP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SERPINE1 KO
AC   CVCL_B8P9
SY   Human SERPINE1 knockout HCT116
DR   Abcam; ab289234
DR   cancercelllines; CVCL_B8P9
DR   Wikidata; Q112928217
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8583; SERPINE1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SERPINH1 KO
AC   CVCL_D2CY
SY   Human SERPINH1 knockout HCT116
DR   Abcam; ab301220
DR   Wikidata; Q127379123
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1546; SERPINH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SETD7 KO
AC   CVCL_B8PA
SY   Human SETD7 knockout HCT116
DR   Abcam; ab287756
DR   cancercelllines; CVCL_B8PA
DR   Wikidata; Q112928218
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30412; SETD7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SHMT2 KO
AC   CVCL_D2CZ
SY   Human SHMT2 knockout HCT116
DR   Abcam; ab301222
DR   Wikidata; Q127379124
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10852; SHMT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SIRPA KO
AC   CVCL_B8PB
SY   Human SIRPA knockout HCT116
DR   Abcam; ab287759
DR   cancercelllines; CVCL_B8PB
DR   Wikidata; Q112928219
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9662; SIRPA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SIRT1 KO
AC   CVCL_B8PC
SY   Human SIRT1 knockout HCT116
DR   Abcam; ab287762
DR   cancercelllines; CVCL_B8PC
DR   Wikidata; Q112928220
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SIRT2 KO
AC   CVCL_B8PD
SY   Human SIRT2 knockout HCT116
DR   Abcam; ab289081
DR   cancercelllines; CVCL_B8PD
DR   Wikidata; Q112928221
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SIRT3 KO
AC   CVCL_B8PE
SY   Human SIRT3 knockout HCT116
DR   Abcam; ab289214
DR   cancercelllines; CVCL_B8PE
DR   Wikidata; Q112928222
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SIRT4 KO
AC   CVCL_B8PF
SY   Human SIRT4 knockout HCT116
DR   Abcam; ab289085
DR   cancercelllines; CVCL_B8PF
DR   Wikidata; Q112928223
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14932; SIRT4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SIRT6 KO
AC   CVCL_B8PG
SY   Human SIRT6 knockout HCT116
DR   Abcam; ab289132
DR   cancercelllines; CVCL_B8PG
DR   Wikidata; Q112928224
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SIRT7 KO
AC   CVCL_B8PH
SY   Human SIRT7 knockout HCT116
DR   Abcam; ab289103
DR   cancercelllines; CVCL_B8PH
DR   Wikidata; Q112928225
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14935; SIRT7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SKP2 KO
AC   CVCL_C7EA
SY   Human SKP2 knockout HCT116
DR   Abcam; ab301225
DR   Wikidata; Q123030435
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 SLAMF1 KO
AC   CVCL_B8PI
SY   Human SLAMF1 knockout HCT116
DR   Abcam; ab289123
DR   cancercelllines; CVCL_B8PI
DR   Wikidata; Q112928226
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10903; SLAMF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SLC12A5 KO
AC   CVCL_D2D0
SY   Human SLC12A5 knockout HCT116
DR   Abcam; ab301228
DR   Wikidata; Q127379126
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13818; SLC12A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SLC16A1 KO
AC   CVCL_D2D1
SY   Human SLC16A1 knockout HCT116
DR   Abcam; ab301231
DR   Wikidata; Q127379127
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10922; SLC16A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SLC16A3 KO
AC   CVCL_D2D2
SY   Human SLC16A3 knockout HCT116
DR   Abcam; ab301233
DR   Wikidata; Q127379128
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10924; SLC16A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SLC25A4 KO
AC   CVCL_C7EB
SY   Human SLC25A4 knockout HCT116
DR   Abcam; ab301235
DR   Wikidata; Q123030436
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 SLC29A1 KO
AC   CVCL_D2D3
SY   Human SLC29A1 knockout HCT116
DR   Abcam; ab301238
DR   Wikidata; Q127379129
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SLC2A3 KO
AC   CVCL_C7EC
SY   Human SLC2A3 knockout HCT116
DR   Abcam; ab301239
DR   Wikidata; Q123030437
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11007; SLC2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 SLC8A1 KO
AC   CVCL_D2D4
SY   Human SLC8A1 knockout HCT116
DR   Abcam; ab301241
DR   Wikidata; Q127379130
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11068; SLC8A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SLC9A1 KO
AC   CVCL_D2D5
SY   Human SLC9A1 knockout HCT116
DR   Abcam; ab301244
DR   Wikidata; Q127379131
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SLC9A3R1 KO
AC   CVCL_B1E5
SY   Human SLC9A3R1 (EBP50/NHERF-1) knockout HCT116
DR   Abcam; ab266876
DR   cancercelllines; CVCL_B1E5
DR   Wikidata; Q110430438
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11075; NHERF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   Abcam HCT 116 SMAD2 KO
AC   CVCL_B8PJ
SY   Human SMAD2 knockout HCT116
DR   Abcam; ab286430
DR   cancercelllines; CVCL_B8PJ
DR   Wikidata; Q112928227
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMAD3 KO
AC   CVCL_B8PK
SY   Human SMAD3 knockout HCT116
DR   Abcam; ab286431
DR   cancercelllines; CVCL_B8PK
DR   Wikidata; Q112928228
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMAD4 KO
AC   CVCL_B8PL
SY   Human SMAD4 knockout HCT116
DR   Abcam; ab286432
DR   cancercelllines; CVCL_B8PL
DR   Wikidata; Q112928229
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMAD7 KO
AC   CVCL_B8PM
SY   Human SMAD7 knockout HCT116
DR   Abcam; ab286433
DR   cancercelllines; CVCL_B8PM
DR   Wikidata; Q112928230
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMARCA1 KO
AC   CVCL_B8PN
SY   Human SMARCA1 knockout HCT116
DR   Abcam; ab288198
DR   cancercelllines; CVCL_B8PN
DR   Wikidata; Q112928232
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11097; SMARCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMARCA4 KO
AC   CVCL_B8PP
SY   Human SMARCA4 knockout HCT116
DR   Abcam; ab286434
DR   cancercelllines; CVCL_B8PP
DR   Wikidata; Q112928233
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMARCC1 KO
AC   CVCL_B8PQ
SY   Human SMARCC1 knockout HCT116
DR   Abcam; ab287765
DR   cancercelllines; CVCL_B8PQ
DR   Wikidata; Q112928234
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMARCD3 KO
AC   CVCL_B8PR
SY   Human SMARCD3 knockout HCT116
DR   Abcam; ab288199
DR   cancercelllines; CVCL_B8PR
DR   Wikidata; Q112928235
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11108; SMARCD3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SMN1 KO
AC   CVCL_D2D6
SY   Human SMN1 knockout HCT116
DR   Abcam; ab301246
DR   Wikidata; Q127379132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11117; SMN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SMO KO
AC   CVCL_B8PS
SY   Human SMO knockout HCT116
DR   Abcam; ab289537
DR   cancercelllines; CVCL_B8PS
DR   Wikidata; Q112928236
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SNAI1 KO
AC   CVCL_B8PT
SY   Human SNAI1 knockout HCT116
DR   Abcam; ab289239
DR   cancercelllines; CVCL_B8PT
DR   Wikidata; Q112928237
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11128; SNAI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SNAI2 KO
AC   CVCL_B8PU
SY   Human SNAI2 knockout HCT116
DR   Abcam; ab289168
DR   cancercelllines; CVCL_B8PU
DR   Wikidata; Q112928238
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11094; SNAI2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SOS1 KO
AC   CVCL_B8PV
SY   Human SOS1 knockout HCT116
DR   Abcam; ab286750
DR   cancercelllines; CVCL_B8PV
DR   Wikidata; Q112928239
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SOX10 KO
AC   CVCL_B8PW
SY   Human SOX10 knockout HCT116
DR   Abcam; ab289126
DR   cancercelllines; CVCL_B8PW
DR   Wikidata; Q112928240
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11190; SOX10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SOX11 KO
AC   CVCL_B8PX
SY   Human SOX11 knockout HCT116
DR   Abcam; ab289100
DR   cancercelllines; CVCL_B8PX
DR   Wikidata; Q112928241
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11191; SOX11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SOX17 KO
AC   CVCL_B8PY
SY   Human SOX17 knockout HCT116
DR   Abcam; ab289155
DR   cancercelllines; CVCL_B8PY
DR   Wikidata; Q112928242
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18122; SOX17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SOX2 KO
AC   CVCL_B8PZ
SY   Human SOX2 knockout HCT116
DR   Abcam; ab287767
DR   cancercelllines; CVCL_B8PZ
DR   Wikidata; Q112928243
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11195; SOX2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SOX6 KO
AC   CVCL_B8Q0
SY   Human SOX6 knockout HCT116
DR   Abcam; ab289229
DR   cancercelllines; CVCL_B8Q0
DR   Wikidata; Q112928244
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16421; SOX6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SP1 KO
AC   CVCL_B8Q1
SY   Human SP1 knockout HCT116
DR   Abcam; ab287771
DR   cancercelllines; CVCL_B8Q1
DR   Wikidata; Q112928245
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SP3 KO
AC   CVCL_B1E6
SY   Human SP3 knockout HCT116
DR   Abcam; ab266879
DR   cancercelllines; CVCL_B1E6
DR   Wikidata; Q110430439
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11208; SP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 SPARC KO
AC   CVCL_C7ED
SY   Human SPARC knockout HCT116
DR   Abcam; ab301250
DR   Wikidata; Q123030438
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11219; SPARC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 SPHK1 KO
AC   CVCL_D2D7
SY   Human SPHK1 knockout HCT116
DR   Abcam; ab301253
DR   Wikidata; Q127379133
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 SPI1 KO
AC   CVCL_B8Q2
SY   Human SPI1 knockout HCT116
DR   Abcam; ab289112
DR   cancercelllines; CVCL_B8Q2
DR   Wikidata; Q112928246
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11241; SPI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SPN KO
AC   CVCL_B8Q3
SY   Human SPN knockout HCT116
DR   Abcam; ab287774
DR   cancercelllines; CVCL_B8Q3
DR   Wikidata; Q112928247
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11249; SPN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SPP1 KO
AC   CVCL_B8Q4
SY   Human SPP1 knockout HCT116
DR   Abcam; ab287777
DR   cancercelllines; CVCL_B8Q4
DR   Wikidata; Q112928248
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SQSTM1 KO
AC   CVCL_B1E7
SY   Human SQSTM1 (p62) knockout HCT116
DR   Abcam; ab266871
DR   cancercelllines; CVCL_B1E7
DR   Wikidata; Q110430440
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 SRC KO
AC   CVCL_B8Q5
SY   Human SRC knockout HCT116
DR   Abcam; ab286329
DR   cancercelllines; CVCL_B8Q5
DR   Wikidata; Q112928249
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SREBF1 KO
AC   CVCL_B8Q6
SY   Human SREBF1 knockout HCT116
DR   Abcam; ab289113
DR   cancercelllines; CVCL_B8Q6
DR   Wikidata; Q112928250
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11289; SREBF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SREBF2 KO
AC   CVCL_B8Q7
SY   Human SREBF2 knockout HCT116
DR   Abcam; ab289230
DR   cancercelllines; CVCL_B8Q7
DR   Wikidata; Q112928251
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SS18 KO
AC   CVCL_B8Q8
SY   Human SS18 knockout HCT116
DR   Abcam; ab287780
DR   cancercelllines; CVCL_B8Q8
DR   Wikidata; Q112928252
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 STAG2 KO
AC   CVCL_B8Q9
SY   Human STAG2 knockout HCT116
DR   Abcam; ab287783
DR   cancercelllines; CVCL_B8Q9
DR   Wikidata; Q112928253
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 STAT3 KO
AC   CVCL_B8QA
SY   Human STAT3 knockout HCT116
DR   Abcam; ab287785
DR   cancercelllines; CVCL_B8QA
DR   Wikidata; Q112928255
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 STAT5B KO
AC   CVCL_B8QB
SY   Human STAT5B knockout HCT116
DR   Abcam; ab289091
DR   cancercelllines; CVCL_B8QB
DR   Wikidata; Q112928256
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 STAT6 KO
AC   CVCL_B8QC
SY   Human STAT6 knockout HCT116
DR   Abcam; ab286532
DR   cancercelllines; CVCL_B8QC
DR   Wikidata; Q112928257
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 STC2 KO
AC   CVCL_D2D8
SY   Human STC2 knockout HCT116
DR   Abcam; ab301255
DR   Wikidata; Q127379134
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11374; STC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 STIM2 KO
AC   CVCL_D2D9
SY   Human STIM2 knockout HCT116
DR   Abcam; ab301258
DR   Wikidata; Q127379135
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19205; STIM2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 STIP1 KO
AC   CVCL_D2DA
SY   Human STIP1 knockout HCT116
DR   Abcam; ab301261
DR   Wikidata; Q127379136
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11387; STIP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 STK11 KO
AC   CVCL_B8QD
SY   Human STK11 knockout HCT116
DR   Abcam; ab286626
DR   cancercelllines; CVCL_B8QD
DR   Wikidata; Q112928258
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SUFU KO
AC   CVCL_B8QE
SY   Human sufU knockout HCT116
DR   Abcam; ab286627
DR   cancercelllines; CVCL_B8QE
DR   Wikidata; Q112928259
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 SYK KO
AC   CVCL_B8QF
SY   Human SYK knockout HCT116
DR   Abcam; ab289165
DR   cancercelllines; CVCL_B8QF
DR   Wikidata; Q112928260
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TACSTD2 KO
AC   CVCL_B8QG
SY   Human TACSTD2 knockout HCT116
DR   Abcam; ab286522
DR   cancercelllines; CVCL_B8QG
DR   Wikidata; Q112928261
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TAFFAZIN KO
AC   CVCL_B8QH
SY   Human TAZ knockout HCT116
DR   Abcam; ab286637
DR   cancercelllines; CVCL_B8QH
DR   Wikidata; Q112928262
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TBX21 KO
AC   CVCL_B8QI
SY   Human TBX21 knockout HCT116
DR   Abcam; ab289205
DR   cancercelllines; CVCL_B8QI
DR   Wikidata; Q112928263
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11599; TBX21.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TBX3 KO
AC   CVCL_D2DB
SY   Human TBX3 knockout HCT116
DR   Abcam; ab301264
DR   Wikidata; Q127379137
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11602; TBX3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TDO2 KO
AC   CVCL_B8QJ
SY   Human TDO2 knockout HCT116
DR   Abcam; ab289086
DR   cancercelllines; CVCL_B8QJ
DR   Wikidata; Q112928264
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11708; TDO2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TEK KO
AC   CVCL_B8QK
SY   Human TEK knockout HCT116
DR   Abcam; ab289172
DR   cancercelllines; CVCL_B8QK
DR   Wikidata; Q112928265
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11724; TEK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TERT KO
AC   CVCL_B8QL
SY   Human TERT knockout HCT116
DR   Abcam; ab289259
DR   cancercelllines; CVCL_B8QL
DR   Wikidata; Q112928266
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TET1 KO
AC   CVCL_B8QM
SY   Human TET1 knockout HCT116
DR   Abcam; ab289077
DR   cancercelllines; CVCL_B8QM
DR   Wikidata; Q112928267
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TET2 KO
AC   CVCL_B8QN
SY   Human TET2 knockout HCT116
DR   Abcam; ab286502
DR   cancercelllines; CVCL_B8QN
DR   Wikidata; Q112928268
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TET3 KO
AC   CVCL_B8QP
SY   Human TET3 knockout HCT116
DR   Abcam; ab289120
DR   cancercelllines; CVCL_B8QP
DR   Wikidata; Q112928269
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28313; TET3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TFAP2A KO
AC   CVCL_B8QQ
SY   Human TFAP2A knockout HCT116
DR   Abcam; ab289099
DR   cancercelllines; CVCL_B8QQ
DR   Wikidata; Q112928270
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11742; TFAP2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TGFB1 KO
AC   CVCL_B8QR
SY   Human TGFB1 knockout HCT116
DR   Abcam; ab286791
DR   cancercelllines; CVCL_B8QR
DR   Wikidata; Q112928271
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TGFB2 KO
AC   CVCL_D2DC
SY   Human TGFB2 knockout HCT116
DR   Abcam; ab301267
DR   Wikidata; Q127379138
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11768; TGFB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TGFBR1 KO
AC   CVCL_B8QS
SY   Human TGFBR1 knockout HCT116
DR   Abcam; ab289125
DR   cancercelllines; CVCL_B8QS
DR   Wikidata; Q112928272
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TGFBR2 KO
AC   CVCL_B8QT
SY   Human TGFBR2 knockout HCT116
DR   Abcam; ab286438
DR   cancercelllines; CVCL_B8QT
DR   Wikidata; Q112928273
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 THBD KO
AC   CVCL_B8QU
SY   Human THBD knockout HCT116
DR   Abcam; ab289188
DR   cancercelllines; CVCL_B8QU
DR   Wikidata; Q112928274
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11784; THBD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TIA1 KO
AC   CVCL_B8QV
SY   Human TIA1 knockout HCT116
DR   Abcam; ab289148
DR   cancercelllines; CVCL_B8QV
DR   Wikidata; Q112928275
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TIMP2 KO
AC   CVCL_C7EE
SY   Human TIMP2 knockout HCT116
DR   Abcam; ab301270
DR   Wikidata; Q123030439
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11821; TIMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 TKT KO
AC   CVCL_D2DD
SY   Human TKT knockout HCT116
DR   Abcam; ab301272
DR   Wikidata; Q127379139
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11834; TKT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TLE5 KO
AC   CVCL_B1E8
SY   Human AES (Amino-terminal enhancer of split) knockout HCT116
DR   Abcam; ab266886
DR   cancercelllines; CVCL_B1E8
DR   Wikidata; Q110430441
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:307; TLE5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 TLR1 KO
AC   CVCL_B8QW
SY   Human TLR1 knockout HCT116
DR   Abcam; ab289246
DR   cancercelllines; CVCL_B8QW
DR   Wikidata; Q112928276
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11847; TLR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TLR2 KO
AC   CVCL_B8QX
SY   Human TLR2 knockout HCT116
DR   Abcam; ab289107
DR   cancercelllines; CVCL_B8QX
DR   Wikidata; Q112928277
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TLR3 KO
AC   CVCL_B8QY
SY   Human TLR3 knockout HCT116
DR   Abcam; ab289223
DR   cancercelllines; CVCL_B8QY
DR   Wikidata; Q112928278
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11849; TLR3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TLR4 KO
AC   CVCL_B8QZ
SY   Human TLR4 knockout HCT116
DR   Abcam; ab289119
DR   cancercelllines; CVCL_B8QZ
DR   Wikidata; Q112928279
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TLR6 KO
AC   CVCL_B8R0
SY   Human TLR6 knockout HCT116
DR   Abcam; ab289145
DR   cancercelllines; CVCL_B8R0
DR   Wikidata; Q112928280
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16711; TLR6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TLR7 KO
AC   CVCL_B8R1
SY   Human TLR7 knockout HCT116
DR   Abcam; ab289094
DR   cancercelllines; CVCL_B8R1
DR   Wikidata; Q112928281
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15631; TLR7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TMEM173 KO
AC   CVCL_B8R2
SY   Human TMEM173 knockout HCT116
DR   Abcam; ab286629
DR   cancercelllines; CVCL_B8R2
DR   Wikidata; Q112928282
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TMSB10 KO
AC   CVCL_B1E9
SY   Human TMSB10 (Thymosin beta 10) knockout HCT116
DR   Abcam; ab266891
DR   cancercelllines; CVCL_B1E9
DR   Wikidata; Q110430443
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11879; TMSB10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 TNFRSF17 KO
AC   CVCL_B8R3
SY   Human TNFRSF17 knockout HCT116
DR   Abcam; ab289122
DR   cancercelllines; CVCL_B8R3
DR   Wikidata; Q112928283
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11913; TNFRSF17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TNFRSF18 KO
AC   CVCL_B8R4
SY   Human TNFRSF18 knockout HCT116
DR   Abcam; ab289264
DR   cancercelllines; CVCL_B8R4
DR   Wikidata; Q112928284
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11914; TNFRSF18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TNFRSF4 KO
AC   CVCL_B8R5
SY   Human TNFRSF4 knockout HCT116
DR   Abcam; ab289198
DR   cancercelllines; CVCL_B8R5
DR   Wikidata; Q112928285
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11918; TNFRSF4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TNFRSF8 KO
AC   CVCL_B8R6
SY   Human TNFRSF8 knockout HCT116
DR   Abcam; ab289060
DR   cancercelllines; CVCL_B8R6
DR   Wikidata; Q112928286
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11923; TNFRSF8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TNFRSF9 KO
AC   CVCL_B8R7
SY   Human TNFRSF9 knockout HCT116
DR   Abcam; ab289140
DR   cancercelllines; CVCL_B8R7
DR   Wikidata; Q112928287
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11924; TNFRSF9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TNFSF11 KO
AC   CVCL_B8R8
SY   Human TNFSF11 knockout HCT116
DR   Abcam; ab286666
DR   cancercelllines; CVCL_B8R8
DR   Wikidata; Q112928288
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11926; TNFSF11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TNK2 KO
AC   CVCL_D2DE
SY   Human TNK2 knockout HCT116
DR   Abcam; ab301274
DR   Wikidata; Q127379140
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19297; TNK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TP53BP1 KO
AC   CVCL_B8R9
SY   Human TP53BP1 knockout HCT116
DR   Abcam; ab289184
DR   cancercelllines; CVCL_B8R9
DR   Wikidata; Q112928289
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TP63 KO
AC   CVCL_B8RA
SY   Human TP63 knockout HCT116
DR   Abcam; ab286523
DR   cancercelllines; CVCL_B8RA
DR   Wikidata; Q112928290
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15979; TP63.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TPM1 KO
AC   CVCL_D2DF
SY   Human TPM1 knockout HCT116
DR   Abcam; ab301277
DR   Wikidata; Q127379141
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12010; TPM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TRAF1 KO
AC   CVCL_B8RB
SY   Human TRAF1 knockout HCT116
DR   Abcam; ab289189
DR   cancercelllines; CVCL_B8RB
DR   Wikidata; Q112928291
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12031; TRAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TRAP1 KO
AC   CVCL_C7EF
SY   Human TRAP1 knockout HCT116
DR   Abcam; ab301280
DR   Wikidata; Q123030440
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16264; TRAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 TRIB3 KO
AC   CVCL_B1EA
SY   Human TRIB3 knockout HCT116
DR   Abcam; ab273718
DR   cancercelllines; CVCL_B1EA
DR   Wikidata; Q110430444
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 TRIM24 KO
AC   CVCL_B8RC
SY   Human TRIM24 knockout HCT116
DR   Abcam; ab289248
DR   cancercelllines; CVCL_B8RC
DR   Wikidata; Q112928292
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11812; TRIM24.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TRIM28 KO
AC   CVCL_B8RD
SY   Human TRIM28 knockout HCT116
DR   Abcam; ab289073
DR   cancercelllines; CVCL_B8RD
DR   Wikidata; Q112928293
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16384; TRIM28.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TRIM33 KO
AC   CVCL_B8RE
SY   Human TRIM33 knockout HCT116
DR   Abcam; ab289067
DR   cancercelllines; CVCL_B8RE
DR   Wikidata; Q112928294
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16290; TRIM33.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TRPC1 KO
AC   CVCL_D2DG
SY   Human TRPC1 knockout HCT116
DR   Abcam; ab301284
DR   Wikidata; Q127379142
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12333; TRPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TRPM8 KO
AC   CVCL_D2DH
SY   Human TRPM8 knockout HCT116
DR   Abcam; ab301286
DR   Wikidata; Q127379143
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17961; TRPM8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TSC1 KO
AC   CVCL_B8RF
SY   Human TSC1 knockout HCT116
DR   Abcam; ab286524
DR   cancercelllines; CVCL_B8RF
DR   Wikidata; Q112928295
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TSC2 KO
AC   CVCL_B8RG
SY   Human TSC2 knockout HCT116
DR   Abcam; ab286333
DR   cancercelllines; CVCL_B8RG
DR   Wikidata; Q112928296
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 TSPO KO
AC   CVCL_B1EB
SY   Human TSPO (PBR) knockout HCT116
DR   Abcam; ab266878
DR   cancercelllines; CVCL_B1EB
DR   Wikidata; Q110430445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 TUBA4A KO
AC   CVCL_D2DI
SY   Human TUBA4A knockout HCT116
DR   Abcam; ab301289
DR   Wikidata; Q127379144
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12407; TUBA4A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 TUBB3 KO
AC   CVCL_B1EC
SY   Human TUBB3 (beta III Tubulin) knockout HCT116
DR   Abcam; ab266900
DR   cancercelllines; CVCL_B1EC
DR   Wikidata; Q110430446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20772; TUBB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 TXNRD1 KO
AC   CVCL_C7EG
SY   Human TXNRD1 knockout HCT116
DR   Abcam; ab301295
DR   Wikidata; Q123030441
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12437; TXNRD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 TXNIP KO
AC   CVCL_C7EH
SY   Human TXNIP knockout HCT116
DR   Abcam; ab301292
DR   Wikidata; Q123030442
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16952; TXNIP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   Abcam HCT 116 TYMS KO
AC   CVCL_D2DJ
SY   Human TYMS knockout HCT116
DR   Abcam; ab301298
DR   Wikidata; Q127379145
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12441; TYMS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 UBB KO
AC   CVCL_B8RH
SY   Human UBB knockout HCT116
DR   Abcam; ab289268
DR   cancercelllines; CVCL_B8RH
DR   Wikidata; Q112928297
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12463; UBB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 UBE2H KO
AC   CVCL_B1ED
SY   Human UBE2H knockout HCT116
DR   Abcam; ab266869
DR   cancercelllines; CVCL_B1ED
DR   Wikidata; Q110430447
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12484; UBE2H.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 UBE2K KO
AC   CVCL_B1EE
SY   Human UBE2K (HIP2/LIG) knockout HCT116
DR   Abcam; ab266899
DR   cancercelllines; CVCL_B1EE
DR   Wikidata; Q110430448
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4914; UBE2K.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HCT 116 UCP2 KO
AC   CVCL_D2DK
SY   Human UCP2 knockout HCT116
DR   Abcam; ab301301
DR   Wikidata; Q127379146
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 UHRF1 KO
AC   CVCL_B8RI
SY   Human UHRF1 knockout HCT116
DR   Abcam; ab289277
DR   cancercelllines; CVCL_B8RI
DR   Wikidata; Q112928298
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12556; UHRF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 USP22 KO
AC   CVCL_B8RJ
SY   Human USP22 knockout HCT116
DR   Abcam; ab289258
DR   cancercelllines; CVCL_B8RJ
DR   Wikidata; Q112928299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 USP8 KO
AC   CVCL_B8RK
SY   Human USP8 knockout HCT116
DR   Abcam; ab286630
DR   cancercelllines; CVCL_B8RK
DR   Wikidata; Q112928300
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 VDR KO
AC   CVCL_B8RL
SY   Human VDR knockout HCT116
DR   Abcam; ab289181
DR   cancercelllines; CVCL_B8RL
DR   Wikidata; Q112928301
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 VEGFA KO
AC   CVCL_B8RM
SY   Human VEGFA knockout HCT116
DR   Abcam; ab289281
DR   cancercelllines; CVCL_B8RM
DR   Wikidata; Q112928302
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 VEGFC KO
AC   CVCL_B8RN
SY   Human VEGFC knockout HCT116
DR   Abcam; ab289196
DR   cancercelllines; CVCL_B8RN
DR   Wikidata; Q112928303
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12682; VEGFC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 VIM KO
AC   CVCL_B8RP
SY   Human VIM knockout HCT116
DR   Abcam; ab289211
DR   cancercelllines; CVCL_B8RP
DR   Wikidata; Q112928304
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 VSIR KO
AC   CVCL_B8RQ
SY   Human VSIR knockout HCT116
DR   Abcam; ab289278
DR   cancercelllines; CVCL_B8RQ
DR   Wikidata; Q112928305
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30085; VSIR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 VTCN1 KO
AC   CVCL_B8RR
SY   Human VTCN1 knockout HCT116
DR   Abcam; ab289279
DR   cancercelllines; CVCL_B8RR
DR   Wikidata; Q112928306
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28873; VTCN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 WNK1 KO
AC   CVCL_D2DL
SY   Human WNK1 knockout HCT116
DR   Abcam; ab301303
DR   Wikidata; Q127379147
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14540; WNK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 WT1 KO
AC   CVCL_B8RS
SY   Human WT1 knockout HCT116
DR   Abcam; ab289283
DR   cancercelllines; CVCL_B8RS
DR   Wikidata; Q112928307
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 WWTR1 KO
AC   CVCL_B8RT
SY   Human WWTR1 knockout HCT116
DR   Abcam; ab286631
DR   cancercelllines; CVCL_B8RT
DR   Wikidata; Q112928308
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 WNT3A KO
AC   CVCL_B8RU
SY   Human Wnt3a knockout HCT116
DR   Abcam; ab289269
DR   cancercelllines; CVCL_B8RU
DR   Wikidata; Q112928309
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15983; WNT3A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 XBP1 KO
AC   CVCL_D2DM
SY   Human XBP1 knockout HCT116
DR   Abcam; ab301306
DR   Wikidata; Q127379148
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12801; XBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 XDH KO
AC   CVCL_D2DN
SY   Human XDH knockout HCT116
DR   Abcam; ab301309
DR   Wikidata; Q127379149
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12805; XDH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam HCT 116 XIAP KO
AC   CVCL_B8RV
SY   Human XIAP knockout HCT116
DR   Abcam; ab289270
DR   cancercelllines; CVCL_B8RV
DR   Wikidata; Q112928310
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 XPC KO
AC   CVCL_B8RW
SY   Human XPC knockout HCT116
DR   Abcam; ab286476
DR   cancercelllines; CVCL_B8RW
DR   Wikidata; Q112928311
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12816; XPC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 XPO1 KO
AC   CVCL_B7VM
SY   Human xpo1 knockout HCT116
DR   Abcam; ab289271
DR   cancercelllines; CVCL_B7VM
DR   Wikidata; Q112928312
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12825; XPO1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 YTHDF2 KO
AC   CVCL_B8RX
SY   Human YTHDF2 knockout HCT116
DR   Abcam; ab289280
DR   cancercelllines; CVCL_B8RX
DR   Wikidata; Q112928313
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31675; YTHDF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 YWHAB KO
AC   CVCL_B8RY
SY   Human YWHAB knockout HCT116
DR   Abcam; ab289272
DR   cancercelllines; CVCL_B8RY
DR   Wikidata; Q112928314
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12849; YWHAB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ZBTB16 KO
AC   CVCL_B8RZ
SY   Human ZBTB16 knockout HCT116
DR   Abcam; ab286495
DR   cancercelllines; CVCL_B8RZ
DR   Wikidata; Q112928315
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12930; ZBTB16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ZEB1 KO
AC   CVCL_B8S0
SY   Human ZEB1 knockout HCT116
DR   Abcam; ab286483
DR   cancercelllines; CVCL_B8S0
DR   Wikidata; Q112928316
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam HCT 116 ZFYVE16 KO
AC   CVCL_B1EF
SY   Human ZFYVE16 (Endofin) knockout HCT116
DR   Abcam; ab266855
DR   cancercelllines; CVCL_B1EF
DR   Wikidata; Q110430449
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam HEK293 ACP1 KO
AC   CVCL_B1AN
SY   Human ACP1 (Acid phosphatase) knockout HEK-293
DR   Abcam; ab261859
DR   Wikidata; Q110430450
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:122; ACP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 AGO2 KO
AC   CVCL_E1FM
SY   Human AGO2 knockout HEK-293
DR   Abcam; ab277162
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3263; AGO2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 ATP13A2 KO
AC   CVCL_B1AP
SY   Human ATP13A2 knockout HEK-293
DR   Abcam; ab274925
DR   Wikidata; Q110430451
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30213; ATP13A2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 CBX4 KO
AC   CVCL_B9VU
SY   Human CBX4 knockout HEK-293
DR   Abcam; ab261723
DR   Wikidata; Q112928317
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1554; CBX4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 CHD8 KO
AC   CVCL_E1FN
SY   Human CHD8 knockout HEK-293
DR   Abcam; ab275836
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 DCP1A KO
AC   CVCL_B1AQ
SY   Human DCP1A knockout HEK-293
DR   Abcam; ab261857
DR   Wikidata; Q110430452
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18714; DCP1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 DDX17 KO
AC   CVCL_B1AR
SY   Human DDX17 knockout HEK-293
DR   Abcam; ab261721
DR   Wikidata; Q110430453
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2740; DDX17.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 DIAPH1 KO
AC   CVCL_E1FP
SY   Human DIAPH1 knockout HEK-293
DR   Abcam; ab273865
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2876; DIAPH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 E2F1 KO
AC   CVCL_B1AS
SY   Human E2F1 knockout HEK-293
DR   Abcam; ab269502
DR   Wikidata; Q110430454
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 FANCI KO
AC   CVCL_E1FQ
SY   Human FANCI knockout HEK-293
DR   Abcam; ab273707
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25568; FANCI.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 FGFR3 KO
AC   CVCL_B1AT
SY   Human FGFR3 knockout HEK-293
DR   Abcam; ab259775
DR   Wikidata; Q110430455
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3690; FGFR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 FOXC1 KO
AC   CVCL_B1AU
SY   Human FOXC1 knockout HEK-293
DR   Abcam; ab269474
DR   Wikidata; Q110430456
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3800; FOXC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Abcam; ab269474; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   Abcam HEK293 FOXO3 KO
AC   CVCL_B1AV
SY   Human FOXO3 (FOXO3A) knockout HEK-293
DR   Abcam; ab260857
DR   Wikidata; Q110430457
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 FYN KO
AC   CVCL_B9VY
SY   Human FYN knockout HEK-293
DR   Abcam; ab269630
DR   Wikidata; Q112928318
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 GAS6 KO
AC   CVCL_B9VZ
SY   Human GAS6 knockout HEK-293
DR   Abcam; ab275837
DR   Wikidata; Q112928319
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4168; GAS6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 GATA2 KO
AC   CVCL_B1AW
SY   Human GATA2 knockout HEK-293
DR   Abcam; ab261720
DR   Wikidata; Q110430458
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 GJA1 KO
AC   CVCL_B1AX
SY   Human GJA1 knockout HEK-293
DR   Abcam; ab261719
DR   Wikidata; Q110430459
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4274; GJA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 GYS1 KO
AC   CVCL_B1AY
SY   Human GYS1 (Glycogen synthase 1) knockout HEK-293
DR   Abcam; ab262475
DR   Wikidata; Q110430461
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4706; GYS1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 HK1 KO
AC   CVCL_E1FR
SY   Human HK1 (Hexokinase 1) knockout HEK-293
DR   Abcam; ab262477
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4922; HK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 HK2 KO
AC   CVCL_B1AZ
SY   Human HK2 (Hexokinase II) knockout HEK-293
DR   Abcam; ab269485
DR   Wikidata; Q110430462
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4923; HK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 HOXA9 KO 1
AC   CVCL_B1B0
SY   Human HOXA9 knockout HEK-293
DR   Abcam; ab273706
DR   Wikidata; Q110430463
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 HOXA9 KO 2
AC   CVCL_B1B1
SY   Human HOXA9 knockout HEK-293
DR   Abcam; ab280053
DR   Wikidata; Q110430464
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 HRAS KO
AC   CVCL_B1B2
SY   Human HRAS knockout HEK-293
DR   Abcam; ab260858
DR   Wikidata; Q110430465
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 IFNGR1 KO
AC   CVCL_B1B3
SY   Human IFNGR1 knockout HEK-293
DR   Abcam; ab269471
DR   Wikidata; Q110430466
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 IRS2 KO
AC   CVCL_B1B4
SY   Human IRS2 knockout HEK-293
DR   Abcam; ab264013
DR   Wikidata; Q110430467
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6126; IRS2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 JUN KO
AC   CVCL_B0YG
SY   Human JUN knockout HEK-293
DR   Abcam; ab260862
DR   Wikidata; Q110430468
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 KMT5A KO
AC   CVCL_B1B5
SY   Human KMT5A knockout HEK-293
DR   Abcam; ab261858
DR   Wikidata; Q110430469
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29489; KMT5A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 LAMP2 KO
AC   CVCL_B1B6
SY   Human LAMP2 knockout HEK-293
DR   Abcam; ab260863
DR   Wikidata; Q110430470
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 MFN2 KO
AC   CVCL_B1B7
SY   Human MFN2 (Mitofusin 2) knockout HEK-293
DR   Abcam; ab260861
DR   Wikidata; Q110430471
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16877; MFN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 NDRG1 KO
AC   CVCL_B1B8
SY   Human NDRG1 knockout HEK-293
DR   Abcam; ab261856
DR   Wikidata; Q110430473
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7679; NDRG1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 NKX2-5 KO
AC   CVCL_B1B9
SY   Human NKX2-5 knockout HEK-293
DR   Abcam; ab261899
DR   Wikidata; Q110430474
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2488; NKX2-5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 PDCD6IP KO
AC   CVCL_B1BA
SY   Human PDCD6IP knockout HEK-293
DR   Abcam; ab260864
DR   Wikidata; Q110430475
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8766; PDCD6IP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 PHF10 KO
AC   CVCL_B1BB
SY   Human PHF10 knockout HEK-293
DR   Abcam; ab274904
DR   Wikidata; Q110430476
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18250; PHF10.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 PHF23 KO
AC   CVCL_E1FS
SY   Human PHF23 knockout HEK-293
DR   Abcam; ab273753
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28428; PHF23.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 PHF6 KO
AC   CVCL_B1BC
SY   Human PHF6 (PHD finger protein 6) knockout HEK-293
DR   Abcam; ab261722
DR   Wikidata; Q110430477
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 PLXNB2 KO
AC   CVCL_B1BD
SY   Human PLXNB2 (Plexin B2/MM1) knockout HEK-293
DR   Abcam; ab269468
DR   Wikidata; Q110430478
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9104; PLXNB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 PRMT6 KO
AC   CVCL_B1BE
SY   Human PRMT6 knockout HEK-293
DR   Abcam; ab269473
DR   Wikidata; Q110430479
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18241; PRMT6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 PSENEN KO
AC   CVCL_B9W0
SY   Human PSENEN (PEN2) knockout HEK-293
DR   Abcam; ab273720
DR   Wikidata; Q112928320
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30100; PSENEN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 SDHA KO
AC   CVCL_B1BF
SY   Human SDHA knockout HEK-293
DR   Abcam; ab261853
DR   Wikidata; Q110430480
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10680; SDHA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 SDHB KO
AC   CVCL_B0YF
SY   Human SDHB knockout HEK-293
DR   Abcam; ab260860
DR   Wikidata; Q110430481
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10681; SDHB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 SESN2 KO
AC   CVCL_B1BG
SY   Human SESN2 (Sestrin-2) knockout HEK-293
DR   Abcam; ab269486
DR   Wikidata; Q110430482
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20746; SESN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 SIRT1 KO
AC   CVCL_B1BH
SY   Human SIRT1 knockout HEK-293
DR   Abcam; ab269508
DR   Wikidata; Q110430483
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 SLIT2 KO
AC   CVCL_E1FT
SY   Human SLIT2 knockout HEK-293
DR   Abcam; ab273723
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11086; SLIT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 SMAD5 KO
AC   CVCL_B1BI
SY   Human SMAD5 knockout HEK-293
DR   Abcam; ab269470
DR   Wikidata; Q110430485
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6771; SMAD5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 SMARCC1 KO
AC   CVCL_B1BJ
SY   Human SMARCC1 (BAF155) knockout HEK-293
DR   Abcam; ab261854
DR   Wikidata; Q110430486
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   Abcam HEK293 SPOP KO
AC   CVCL_E1FU
SY   Human SPOP knockout HEK-293
DR   Abcam; ab273864
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11254; SPOP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 TUBB2B KO
AC   CVCL_E1FV
SY   Human TUBB2B knockout HEK-293
DR   Abcam; ab277165
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30829; TUBB2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293 UCHL5 KO
AC   CVCL_E1FW
SY   Human UCHL5 knockout HEK-293
DR   Abcam; ab275842
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19678; UCHL5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abcam HEK293T AADAT KO
AC   CVCL_B2R2
SY   Human AADAT (KAT2) knockout HEK-293T
DR   Abcam; ab266107
DR   Wikidata; Q110430487
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17929; AADAT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ABCF2 KO
AC   CVCL_B2R3
SY   Human ABCF2 knockout HEK-293T
DR   Abcam; ab266516
DR   Wikidata; Q110430488
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:71; ABCF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ACADVL KO
AC   CVCL_B2R4
SY   Human ACADVL (VLCAD) knockout HEK-293T
DR   Abcam; ab266484
DR   Wikidata; Q110430489
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:92; ACADVL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ADAR KO
AC   CVCL_B2R5
SY   Human ADAR (ADAR1) knockout HEK-293T
DR   Abcam; ab266846
DR   Wikidata; Q110430490
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ADARB1 KO
AC   CVCL_B2R6
SY   Human ADARB1 (RED1) knockout HEK-293T
DR   Abcam; ab267278
DR   Wikidata; Q110430491
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:226; ADARB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ADPGK KO
AC   CVCL_B2R7
SY   Human ADPGK knockout HEK-293T
DR   Abcam; ab267277
DR   Wikidata; Q110430492
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25250; ADPGK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ADRM1 KO
AC   CVCL_B2R8
SY   Human ADRM1 (ARM-1) knockout HEK-293T
DR   Abcam; ab266765
DR   Wikidata; Q110430493
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15759; ADRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AGA KO
AC   CVCL_B2R9
SY   Human AGA knockout HEK-293T
DR   Abcam; ab266561
DR   Wikidata; Q110430494
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:318; AGA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AIFM1 KO
AC   CVCL_B2RA
SY   Human AIFM1 (AIF) knockout HEK-293T
DR   Abcam; ab266347
DR   Wikidata; Q110430495
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8768; AIFM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AK2 KO
AC   CVCL_B2RB
SY   Human AK2 knockout HEK-293T
DR   Abcam; ab266539
DR   Wikidata; Q110430497
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:362; AK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AK3 KO
AC   CVCL_B2RC
SY   Human AK3 knockout HEK-293T
DR   Abcam; ab267307
DR   Wikidata; Q110430499
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17376; AK3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AKAP1 KO
AC   CVCL_B2RD
SY   Human AKAP1 knockout HEK-293T
DR   Abcam; ab266182
DR   Wikidata; Q110430500
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:367; AKAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AKR1A1 KO
AC   CVCL_B2RE
SY   Human AKR1A1 knockout HEK-293T
DR   Abcam; ab266212
DR   Wikidata; Q110430501
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:380; AKR1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ALAS1 KO
AC   CVCL_B2RF
SY   Human ALAS1 knockout HEK-293T
DR   Abcam; ab266473
DR   Wikidata; Q110430503
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:396; ALAS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ALDH18A1 KO
AC   CVCL_B2RG
SY   Human ALDH18A1 (P5CS) knockout HEK-293T
DR   Abcam; ab266378
DR   Wikidata; Q110430504
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9722; ALDH18A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ALDH9A1 KO
AC   CVCL_B2RH
SY   Human ALDH9A1 knockout HEK-293T
DR   Abcam; ab266777
DR   Wikidata; Q110430505
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:412; ALDH9A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ALKBH2 KO
AC   CVCL_B2RI
SY   Human ALKBH2 knockout HEK-293T
DR   Abcam; ab266790
DR   Wikidata; Q110430506
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32487; ALKBH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ALKBH5 KO
AC   CVCL_B2RJ
SY   Human ALKBH5 knockout HEK-293T
DR   Abcam; ab266762
DR   Wikidata; Q110430507
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AMPD2 KO
AC   CVCL_B2RK
SY   Human AMPD2 knockout HEK-293T
DR   Abcam; ab266673
DR   Wikidata; Q110430508
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:469; AMPD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ANAPC15 KO
AC   CVCL_B2RL
SY   Human ANAPC15 (APC15) knockout HEK-293T
DR   Abcam; ab266720
DR   Wikidata; Q110430509
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24531; ANAPC15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ANKRD52 KO
AC   CVCL_B2RM
SY   Human ANKRD52 (ANR52) knockout HEK-293T
DR   Abcam; ab266442
DR   Wikidata; Q110430510
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26614; ANKRD52.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ANP32A KO
AC   CVCL_B2RN
SY   Human ANP32A (PHAP1) knockout HEK-293T
DR   Abcam; ab266148
DR   Wikidata; Q110430511
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13233; ANP32A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ANP32B KO
AC   CVCL_B2RP
SY   Human ANP32B (PHAPI2/APRIL) knockout HEK-293T
DR   Abcam; ab266818
DR   Wikidata; Q110430513
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16677; ANP32B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ANXA11 KO
AC   CVCL_B2RQ
SY   Human ANXA11 (Annexin-11) knockout HEK-293T
DR   Abcam; ab266670
DR   Wikidata; Q110430514
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:535; ANXA11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T AP1B1 KO
AC   CVCL_B2RR
SY   Human AP1B1 knockout HEK-293T
DR   Abcam; ab266200
DR   Wikidata; Q110430515
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:554; AP1B1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T APBB1 KO
AC   CVCL_B2RS
SY   Human APBB1 (FE65) knockout HEK-293T
DR   Abcam; ab267294
DR   Wikidata; Q110430516
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:581; APBB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T APEH KO
AC   CVCL_B2RT
SY   Human APEH (APH) knockout HEK-293T
DR   Abcam; ab266515
DR   Wikidata; Q110430517
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:586; APEH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T APEX2 KO
AC   CVCL_B2RU
SY   Human APEX2 knockout HEK-293T
DR   Abcam; ab266558
DR   Wikidata; Q110430518
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17889; APEX2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T APP KO
AC   CVCL_B2RV
SY   Human APP (Amyloid Precursor Protein) knockout HEK-293T
DR   Abcam; ab255362
DR   Wikidata; Q110430519
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T APRT KO
AC   CVCL_B2RW
SY   Human APRT knockout HEK-293T
DR   Abcam; ab266281
DR   Wikidata; Q110430520
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:626; APRT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARAF KO
AC   CVCL_B2RX
SY   Human A-Raf knockout HEK-293T
DR   Abcam; ab266351
DR   Wikidata; Q110430521
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T ARF3 KO
AC   CVCL_B2RY
SY   Human ARF3 knockout HEK-293T
DR   Abcam; ab266155
DR   Wikidata; Q110430522
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:654; ARF3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARF5 KO
AC   CVCL_B2RZ
SY   Human ARF5 knockout HEK-293T
DR   Abcam; ab266614
DR   Wikidata; Q110430523
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:658; ARF5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARFIP1 KO
AC   CVCL_B2S0
SY   Human ARFIP1 (Arfaptin-1) knockout HEK-293T
DR   Abcam; ab267258
DR   Wikidata; Q110430525
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21496; ARFIP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARHGDIA KO 1
AC   CVCL_B2S1
SY   Human ARHGDIA (RhoGDI) knockout HEK-293T
DR   Abcam; ab266446
DR   Wikidata; Q110430526
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:678; ARHGDIA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARHGDIA KO 2
AC   CVCL_B2S2
SY   Human ARHGDIA (RhoGDI) knockout HEK-293T
DR   Abcam; ab266447
DR   Wikidata; Q110430527
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:678; ARHGDIA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARHGEF1 KO
AC   CVCL_B2S3
SY   Human Arhgef1 (p115-RhoGEF) knockout HEK-293T
DR   Abcam; ab266667
DR   Wikidata; Q110430528
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:681; ARHGEF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARID1A KO
AC   CVCL_B2S4
SY   Human ARID1A knockout HEK-293T
DR   Abcam; ab266189
DR   Wikidata; Q110430529
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARL6IP1 KO
AC   CVCL_B2S5
SY   Human ARL6IP1 knockout HEK-293T
DR   Abcam; ab266301
DR   Wikidata; Q110430530
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:697; ARL6IP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARL6IP4 KO
AC   CVCL_B2S6
SY   Human ARL6IP4 (SR-25) knockout HEK-293T
DR   Abcam; ab266784
DR   Wikidata; Q110430531
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18076; ARL6IP4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARPC5L KO
AC   CVCL_B2S7
SY   Human ARPC5L knockout HEK-293T
DR   Abcam; ab266399
DR   Wikidata; Q110430532
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23366; ARPC5L.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARPP19 KO
AC   CVCL_B2S8
SY   Human ARPP19 knockout HEK-293T
DR   Abcam; ab266093
DR   Wikidata; Q110430533
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16967; ARPP19.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ARRB2 KO
AC   CVCL_B2S9
SY   Human ARRB2 (Beta Arrestin 2) knockout HEK-293T
DR   Abcam; ab266116
DR   Wikidata; Q110430534
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATG3 KO
AC   CVCL_B2SA
SY   Human ATG3 knockout HEK-293T
DR   Abcam; ab266707
DR   Wikidata; Q110430535
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATG4C KO
AC   CVCL_B2SB
SY   Human ATG4C knockout HEK-293T
DR   Abcam; ab267324
DR   Wikidata; Q110430536
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16040; ATG4C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATOX1 KO
AC   CVCL_B2SC
SY   Human ATOX1 knockout HEK-293T
DR   Abcam; ab266651
DR   Wikidata; Q110430537
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:798; ATOX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATP2C1 KO
AC   CVCL_B2SD
SY   Human ATP2C1 knockout HEK-293T
DR   Abcam; ab266253
DR   Wikidata; Q110430538
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13211; ATP2C1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATP5IF1 KO
AC   CVCL_B2SE
SY   Human ATPIF1 (ATPase Inhibitory Factor 1/IF1) knockout HEK-293T
DR   Abcam; ab266433
DR   Wikidata; Q110430539
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:871; ATP5IF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATP5MC2 KO
AC   CVCL_B2SF
SY   Human ATP5G2 knockout HEK-293T
DR   Abcam; ab266394
DR   Wikidata; Q110430540
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:842; ATP5MC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATP5MC3 KO
AC   CVCL_B2SG
SY   Human ATP5G3 knockout HEK-293T
DR   Abcam; ab266145
DR   Wikidata; Q110430541
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:843; ATP5MC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATP5MF KO
AC   CVCL_B2SH
SY   Human ATP5J2 knockout HEK-293T
DR   Abcam; ab266582
DR   Wikidata; Q110430542
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:848; ATP5MF.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATRAID KO
AC   CVCL_B2SI
SY   Human ATRAID (C2orf28) knockout HEK-293T
DR   Abcam; ab266386
DR   Wikidata; Q110430543
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24090; ATRAID.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ATXN2L KO
AC   CVCL_B2SJ
SY   Human ATXN2L knockout HEK-293T
DR   Abcam; ab266075
DR   Wikidata; Q110430544
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31326; ATXN2L.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T B2M KO
AC   CVCL_B2SK
SY   Human B2M (beta 2 Microglobulin) knockout HEK-293T
DR   Abcam; ab266828
DR   Wikidata; Q110430545
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T B4GALT2 KO
AC   CVCL_B2SL
SY   Human B4GALT2 knockout HEK-293T
DR   Abcam; ab266764
DR   Wikidata; Q110430546
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:925; B4GALT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BAMBI KO
AC   CVCL_B2SM
SY   Human BAMBI (NMA) knockout HEK-293T
DR   Abcam; ab265061
DR   Wikidata; Q110430547
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30251; BAMBI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BCAP31 KO
AC   CVCL_B2SN
SY   Human BCAP31 (BAP31) knockout HEK-293T
DR   Abcam; ab266634
DR   Wikidata; Q110430548
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16695; BCAP31.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BCKDHA KO
AC   CVCL_B2SP
SY   Human BCKDHA knockout HEK-293T
DR   Abcam; ab266439
DR   Wikidata; Q110430551
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:986; BCKDHA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BCL2L2-PABPN1 KO
AC   CVCL_B2SQ
SY   Human BCL2L2-PABPN1 knockout HEK-293T
DR   Abcam; ab266179
DR   Wikidata; Q110430554
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:42959; BCL2L2-PABPN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BCR KO
AC   CVCL_B2SR
SY   Human BCR knockout HEK-293T
DR   Abcam; ab266714
DR   Wikidata; Q110430556
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1014; BCR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BEX3 KO
AC   CVCL_B2SS
SY   Human NGFRAP1 (BEX3) knockout HEK-293T
DR   Abcam; ab266236
DR   Wikidata; Q110430559
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13388; BEX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BLVRA KO
AC   CVCL_B2ST
SY   Human BLVRA (BVR) knockout HEK-293T
DR   Abcam; ab266444
DR   Wikidata; Q110430562
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1062; BLVRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BLVRB KO
AC   CVCL_B2SU
SY   Human BLVRB (FLR) knockout HEK-293T
DR   Abcam; ab266220
DR   Wikidata; Q110430564
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1063; BLVRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BMI1 KO
AC   CVCL_B2SV
SY   Human BMI1 knockout HEK-293T
DR   Abcam; ab266514
DR   Wikidata; Q110430566
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BRAP KO
AC   CVCL_B2SW
SY   Human BRAP knockout HEK-293T
DR   Abcam; ab267236
DR   Wikidata; Q110430567
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1099; BRAP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BRCA2 KO 1
AC   CVCL_B2SX
SY   Human BRCA2 knockout HEK-293T
DR   Abcam; ab267304
DR   Wikidata; Q110430568
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BRCA2 KO 2
AC   CVCL_B2SY
SY   Human BRCA2 knockout HEK-293T
DR   Abcam; ab267305
DR   Wikidata; Q110430569
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BRD2 KO
AC   CVCL_B2SZ
SY   Human BRD2 knockout HEK-293T
DR   Abcam; ab267265
DR   Wikidata; Q110430570
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BRD3 KO
AC   CVCL_B2T0
SY   Human BRD3 knockout HEK-293T
DR   Abcam; ab266793
DR   Wikidata; Q110430571
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BRD9 KO
AC   CVCL_B2T1
SY   Human BRD9 knockout HEK-293T
DR   Abcam; ab266763
DR   Wikidata; Q110430572
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BRPF1 KO
AC   CVCL_B2T2
SY   Human BRPF1 (Peregrin) knockout HEK-293T
DR   Abcam; ab266549
DR   Wikidata; Q110430573
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14255; BRPF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BSG KO
AC   CVCL_B2T3
SY   Human BSG (CD147) knockout HEK-293T
DR   Abcam; ab266331
DR   Wikidata; Q110430574
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BTBD1 KO
AC   CVCL_B2T4
SY   Human BTBD1 knockout HEK-293T
DR   Abcam; ab266078
DR   Wikidata; Q110430576
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1120; BTBD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BTRC KO
AC   CVCL_B2T5
SY   Human BTRC (Beta TRCP/HOS) knockout HEK-293T
DR   Abcam; ab266201
DR   Wikidata; Q110430578
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T BZW1 KO
AC   CVCL_B2T6
SY   Human BZW1 (Protein Orf) knockout HEK-293T
DR   Abcam; ab266562
DR   Wikidata; Q110430579
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18380; BZW1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T C12orf57 KO
AC   CVCL_B2T7
SY   Human C12orf57 (GRCC10) knockout HEK-293T
DR   Abcam; ab266109
DR   Wikidata; Q110430581
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29521; C12orf57.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T C19orf48 KO
AC   CVCL_B2T8
SY   Human C19orf48 knockout HEK-293T
DR   Abcam; ab266071
DR   Wikidata; Q110430582
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29667; C19orf48P.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T C1orf43 KO
AC   CVCL_B2T9
SY   Human C1orf43 (NICE3) knockout HEK-293T
DR   Abcam; ab266811
DR   Wikidata; Q110430583
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29876; C1orf43.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T C20orf27 KO
AC   CVCL_B2TA
SY   Human C20orf27 knockout HEK-293T
DR   Abcam; ab266626
DR   Wikidata; Q110430584
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15873; ADISSP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T CA2 KO
AC   CVCL_B2TB
SY   Human CA2 (Carbonic anhydrase 2) knockout HEK-293T
DR   Abcam; ab265072
DR   Wikidata; Q110430585
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1373; CA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CALM3 KO
AC   CVCL_B2TC
SY   Human CALM3 knockout HEK-293T
DR   Abcam; ab266801
DR   Wikidata; Q110430586
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1449; CALM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CAMK2D KO
AC   CVCL_B2TD
SY   Human CAMK2D (CaMKII delta) knockout HEK-293T
DR   Abcam; ab267322
DR   Wikidata; Q110430587
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1462; CAMK2D.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CAMKK2 KO
AC   CVCL_B2TE
SY   Human CAMKK2 knockout HEK-293T
DR   Abcam; ab266300
DR   Wikidata; Q110430588
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1470; CAMKK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CANX KO
AC   CVCL_B2TF
SY   Human CANX (Calnexin) knockout HEK-293T
DR   Abcam; ab255368
DR   Wikidata; Q110430590
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1473; CANX.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CAPN2 KO
AC   CVCL_B2TG
SY   Human CAPN2 (Calpain 2) knockout HEK-293T
DR   Abcam; ab266628
DR   Wikidata; Q110430591
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1479; CAPN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CARM1 KO
AC   CVCL_B2TH
SY   Human CARM1 knockout HEK-293T
DR   Abcam; ab266557
DR   Wikidata; Q110430592
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CASP1 KO
AC   CVCL_B2TI
SY   Human CASP1 (Caspase-1) knockout HEK-293T
DR   Abcam; ab266226
DR   Wikidata; Q110430593
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1499; CASP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266226; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T CBL KO
AC   CVCL_B2TJ
SY   Human CBL knockout HEK-293T
DR   Abcam; ab267245
DR   Wikidata; Q110430594
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CBX1 KO
AC   CVCL_B2TK
SY   Human CBX1 (HP1 beta) knockout HEK-293T
DR   Abcam; ab266356
DR   Wikidata; Q110430595
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1551; CBX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CCND2 KO
AC   CVCL_B2TL
SY   Human CCND2 (Cyclin D2) knockout HEK-293T
DR   Abcam; ab267318
DR   Wikidata; Q110430596
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CCND3 KO
AC   CVCL_B2TM
SY   Human CCND3 (Cyclin D3) knockout HEK-293T
DR   Abcam; ab266518
DR   Wikidata; Q110430597
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1585; CCND3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266518; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T CCNI KO
AC   CVCL_B2TN
SY   Human CCNI (Cyclin) knockout HEK-293T
DR   Abcam; ab266219
DR   Wikidata; Q110430598
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1595; CCNI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CCNL2 KO
AC   CVCL_B2TP
SY   Human CCNL2 knockout HEK-293T
DR   Abcam; ab266455
DR   Wikidata; Q110430599
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20570; CCNL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CCP110 KO
AC   CVCL_B2TQ
SY   Human CCP110 (CP110) knockout HEK-293T
DR   Abcam; ab266629
DR   Wikidata; Q110430601
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24342; CCP110.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CD164 KO
AC   CVCL_B2TR
SY   Human CD164 knockout HEK-293T
DR   Abcam; ab266616
DR   Wikidata; Q110430602
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1632; CD164.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CD276 KO
AC   CVCL_B2TS
SY   Human CD276 knockout HEK-293T
DR   Abcam; ab266658
DR   Wikidata; Q110430603
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19137; CD276.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CD2BP2 KO
AC   CVCL_B2TT
SY   Human CD2BP2 knockout HEK-293T
DR   Abcam; ab266641
DR   Wikidata; Q110430605
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1656; CD2BP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CD47 KO
AC   CVCL_B2TU
SY   Human CD47 knockout HEK-293T
DR   Abcam; ab266324
DR   Wikidata; Q110430606
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CDC14B KO
AC   CVCL_B2TV
SY   Human CDC14B knockout HEK-293T
DR   Abcam; ab266580
DR   Wikidata; Q110430607
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1719; CDC14B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CDC16 KO
AC   CVCL_B2TW
SY   Human CDC16 (Apc6) knockout HEK-293T
DR   Abcam; ab267254
DR   Wikidata; Q110430608
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1720; CDC16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab267254; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T CDC42 KO
AC   CVCL_B2TX
SY   Human CDC42 knockout HEK-293T
DR   Abcam; ab266522
DR   Wikidata; Q110430609
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1736; CDC42.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CDH2 KO
AC   CVCL_B2TY
SY   Human CDH2 (N Cadherin) knockout HEK-293T
DR   Abcam; ab255377
DR   Wikidata; Q110430610
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1759; CDH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CDK10 KO
AC   CVCL_B2TZ
SY   Human CDK10 knockout HEK-293T
DR   Abcam; ab266785
DR   Wikidata; Q110430611
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1770; CDK10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CDK11A KO
AC   CVCL_B2U0
SY   Human CDK11A (CDC2L2) knockout HEK-293T
DR   Abcam; ab267306
DR   Wikidata; Q110430612
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1730; CDK11A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CDK5 KO
AC   CVCL_B2U1
SY   Human CDK5 knockout HEK-293T
DR   Abcam; ab266089
DR   Wikidata; Q110430613
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CDV3 KO
AC   CVCL_B2U2
SY   Human CDV3 knockout HEK-293T
DR   Abcam; ab266466
DR   Wikidata; Q110430614
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26928; CDV3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CELF1 KO
AC   CVCL_B2U3
SY   Human CELF1 (CUG-BP1) knockout HEK-293T
DR   Abcam; ab266086
DR   Wikidata; Q110430615
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2549; CELF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CERK KO
AC   CVCL_B2U4
SY   Human CERK knockout HEK-293T
DR   Abcam; ab267331
DR   Wikidata; Q110430616
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19256; CERK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CERS2 KO
AC   CVCL_B2U5
SY   Human CERS2 knockout HEK-293T
DR   Abcam; ab266198
DR   Wikidata; Q110430617
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14076; CERS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266198; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T CERS6 KO
AC   CVCL_B2U6
SY   Human CERS6 (LASS6) knockout HEK-293T
DR   Abcam; ab265074
DR   Wikidata; Q110430618
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23826; CERS6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CERT1 KO
AC   CVCL_B2U7
SY   Human COL4A3BP (CERT) knockout HEK-293T
DR   Abcam; ab267249
DR   Wikidata; Q110430619
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2205; CERT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CHCHD2 KO
AC   CVCL_B2U8
SY   Human CHCHD2 knockout HEK-293T
DR   Abcam; ab266665
DR   Wikidata; Q110430620
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21645; CHCHD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CHCHD3 KO
AC   CVCL_B2U9
SY   Human CHCHD3 (MIC19) knockout HEK-293T
DR   Abcam; ab266471
DR   Wikidata; Q110430621
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21906; CHCHD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CHCHD6 KO
AC   CVCL_B2UA
SY   Human CHCHD6 knockout HEK-293T
DR   Abcam; ab266550
DR   Wikidata; Q110430622
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28184; CHCHD6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CHD1 KO
AC   CVCL_B2UB
SY   Human CHD1 knockout HEK-293T
DR   Abcam; ab266512
DR   Wikidata; Q110430623
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1915; CHD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CIB1 KO
AC   CVCL_B2UC
SY   Human CIB1 (KIP) knockout HEK-293T
DR   Abcam; ab266081
DR   Wikidata; Q110430624
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16920; CIB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CIB2 KO
AC   CVCL_B2UD
SY   Human CIB2 knockout HEK-293T
DR   Abcam; ab267335
DR   Wikidata; Q110430625
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24579; CIB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CIRBP KO
AC   CVCL_B2UE
SY   Human CIRBP (CIRP) knockout HEK-293T
DR   Abcam; ab266187
DR   Wikidata; Q110430626
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1982; CIRBP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CIT KO
AC   CVCL_B2UF
SY   Human CIT knockout HEK-293T
DR   Abcam; ab267255
DR   Wikidata; Q110430627
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1985; CIT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CKMT1A KO
AC   CVCL_B2UG
SY   Human CKMT1A (Creatine kinase MT) knockout HEK-293T
DR   Abcam; ab267289
DR   Wikidata; Q110430628
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31736; CKMT1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CLTA KO
AC   CVCL_B2UH
SY   Human CLTA (Clathrin light chain A) knockout HEK-293T
DR   Abcam; ab267334
DR   Wikidata; Q110430629
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2090; CLTA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CLUH KO
AC   CVCL_B2UI
SY   Human CLUH knockout HEK-293T
DR   Abcam; ab266407
DR   Wikidata; Q110430630
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29094; CLUH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CMC2 KO 1
AC   CVCL_B2UJ
SY   Human CMC2 (C16orf61) knockout HEK-293T
DR   Abcam; ab266424
DR   Wikidata; Q110430631
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24447; CMC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CMC2 KO 2
AC   CVCL_B2UK
SY   Human CMC2 (C16orf61) knockout HEK-293T
DR   Abcam; ab266425
DR   Wikidata; Q110430632
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24447; CMC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CNIH4 KO
AC   CVCL_B2UL
SY   Human CNIH4 knockout HEK-293T
DR   Abcam; ab266560
DR   Wikidata; Q110430633
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25013; CNIH4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CNKSR3 KO
AC   CVCL_B2UM
SY   Human CNKSR3 knockout HEK-293T
DR   Abcam; ab267240
DR   Wikidata; Q110430635
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23034; CNKSR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CNOT1 KO
AC   CVCL_B2UN
SY   Human CNOT1 knockout HEK-293T
DR   Abcam; ab266478
DR   Wikidata; Q110430636
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7877; CNOT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CNPY2 KO
AC   CVCL_B2UP
SY   Human CNPY2 (MSAP) knockout HEK-293T
DR   Abcam; ab266617
DR   Wikidata; Q110430637
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13529; CNPY2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COA1 KO
AC   CVCL_B2UQ
SY   Human COA1 (C7orf44) knockout HEK-293T
DR   Abcam; ab266074
DR   Wikidata; Q110430638
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21868; COA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COA3 KO
AC   CVCL_B2UR
SY   Human COA3 (CCDC56) knockout HEK-293T
DR   Abcam; ab266833
DR   Wikidata; Q110430639
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24990; COA3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COA4 KO
AC   CVCL_B2US
SY   Human COA4 (CHCHD8) knockout HEK-293T
DR   Abcam; ab266069
DR   Wikidata; Q110430641
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24604; COA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COL6A1 KO
AC   CVCL_B2UT
SY   Human COL6A1 knockout HEK-293T
DR   Abcam; ab265060
DR   Wikidata; Q110430642
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2211; COL6A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COL6A2 KO
AC   CVCL_B2UU
SY   Human COL6A2 (Collagen VI alpha 2) knockout HEK-293T
DR   Abcam; ab266482
DR   Wikidata; Q110430643
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2212; COL6A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266482; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T COLGALT1 KO
AC   CVCL_B2UV
SY   Human COLGALT1 (GLT25D1) knockout HEK-293T
DR   Abcam; ab266750
DR   Wikidata; Q110430644
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26182; COLGALT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COMT KO
AC   CVCL_B2UW
SY   Human COMT knockout HEK-293T
DR   Abcam; ab266537
DR   Wikidata; Q110430646
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2228; COMT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COPS7A KO
AC   CVCL_B2UX
SY   Human COPS7A (CSN7A) knockout HEK-293T
DR   Abcam; ab266380
DR   Wikidata; Q110430647
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16758; COPS7A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COPS7B KO
AC   CVCL_B2UY
SY   Human COPS7B (CSN7b) knockout HEK-293T
DR   Abcam; ab266646
DR   Wikidata; Q110430648
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16760; COPS7B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COQ8A KO
AC   CVCL_B2UZ
SY   Human ADCK3 knockout HEK-293T
DR   Abcam; ab267295
DR   Wikidata; Q110430650
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16812; COQ8A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COQ9 KO
AC   CVCL_B2V0
SY   Human COQ9 knockout HEK-293T
DR   Abcam; ab266761
DR   Wikidata; Q110430651
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25302; COQ9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CORO1C KO
AC   CVCL_B2V1
SY   Human CORO1C (Coronin-1C) knockout HEK-293T
DR   Abcam; ab266381
DR   Wikidata; Q110430652
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2254; CORO1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COX7A2 KO
AC   CVCL_B2V2
SY   Human COX7A2 knockout HEK-293T
DR   Abcam; ab266710
DR   Wikidata; Q110430653
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2288; COX7A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T COX8A KO
AC   CVCL_B2V3
SY   Human COX8A knockout HEK-293T
DR   Abcam; ab266594
DR   Wikidata; Q110430654
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2294; COX8A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CPNE1 KO
AC   CVCL_B2V4
SY   Human CPNE1 knockout HEK-293T
DR   Abcam; ab266064
DR   Wikidata; Q110430655
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2314; CPNE1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CPSF7 KO
AC   CVCL_B2V5
SY   Human CPSF7 knockout HEK-293T
DR   Abcam; ab266275
DR   Wikidata; Q110430656
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30098; CPSF7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CPT1A KO
AC   CVCL_B2V6
SY   Human CPT1A knockout HEK-293T
DR   Abcam; ab266319
DR   Wikidata; Q110430657
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2328; CPT1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CRAT KO
AC   CVCL_B2V7
SY   Human CRAT knockout HEK-293T
DR   Abcam; ab266361
DR   Wikidata; Q110430658
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2342; CRAT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CREBBP KO
AC   CVCL_B2V8
SY   Human CREBBP knockout HEK-293T
DR   Abcam; ab266099
DR   Wikidata; Q110430660
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CRIM1 KO
AC   CVCL_B2V9
SY   Human CRIM1 knockout HEK-293T
DR   Abcam; ab267286
DR   Wikidata; Q110430661
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2359; CRIM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CSF2 KO
AC   CVCL_B2VA
SY   Human GMCSF knockout HEK-293T
DR   Abcam; ab267274
DR   Wikidata; Q110430662
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CSTB KO
AC   CVCL_B2VB
SY   Human CSTB (Cystatin-B) knockout HEK-293T
DR   Abcam; ab266321
DR   Wikidata; Q110430663
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2482; CSTB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CTDNEP1 KO
AC   CVCL_B2VC
SY   Human CTDNEP1 (DULLARD) knockout HEK-293T
DR   Abcam; ab266284
DR   Wikidata; Q110430664
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19085; CTDNEP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CTDSP1 KO
AC   CVCL_B2VD
SY   Human CTDSP1 knockout HEK-293T
DR   Abcam; ab266523
DR   Wikidata; Q110430665
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21614; CTDSP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CTSH KO
AC   CVCL_B2VE
SY   Human CTSH (Cathepsin H) knockout HEK-293T
DR   Abcam; ab266245
DR   Wikidata; Q110430666
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2535; CTSH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CTSL KO
AC   CVCL_B2VF
SY   Human CTSL (Cathepsin L/MEP) knockout HEK-293T
DR   Abcam; ab266521
DR   Wikidata; Q110430667
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2537; CTSL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CTTN KO
AC   CVCL_B2VG
SY   Human CTTN (Cortactin) knockout HEK-293T
DR   Abcam; ab266819
DR   Wikidata; Q110430668
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3338; CTTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CYBA KO
AC   CVCL_B2VH
SY   Human CYBA (Cytochrome b245 Light Chain/p22-phox) knockout HEK-293T
DR   Abcam; ab266721
DR   Wikidata; Q110430669
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2577; CYBA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T CYSTM1 KO
AC   CVCL_B2VI
SY   Human CYSTM1 (ORF1 FL49) knockout HEK-293T
DR   Abcam; ab266448
DR   Wikidata; Q110430670
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30239; CYSTM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DAG1 KO
AC   CVCL_B2VJ
SY   Human DAG1 knockout HEK-293T
DR   Abcam; ab266263
DR   Wikidata; Q110430672
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2666; DAG1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DAPK1 KO
AC   CVCL_B2VK
SY   Human DAPK1 (DAP Kinase 1) knockout HEK-293T
DR   Abcam; ab266224
DR   Wikidata; Q110430673
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2674; DAPK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DAPK3 KO
AC   CVCL_B2VL
SY   Human DAPK3 (ZIP Kinase) knockout HEK-293T
DR   Abcam; ab266755
DR   Wikidata; Q110430674
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2676; DAPK3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DAZAP1 KO 1
AC   CVCL_B2VM
SY   Human DAZAP1 knockout HEK-293T
DR   Abcam; ab266469
DR   Wikidata; Q110430675
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2683; DAZAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DAZAP1 KO 2
AC   CVCL_B2VN
SY   Human DAZAP1 knockout HEK-293T
DR   Abcam; ab266470
DR   Wikidata; Q110430676
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2683; DAZAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DAZAP2 KO
AC   CVCL_B2VP
SY   Human DAZAP2 knockout HEK-293T
DR   Abcam; ab266412
DR   Wikidata; Q110430677
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2684; DAZAP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DBI KO
AC   CVCL_B2VQ
SY   Human DBI knockout HEK-293T
DR   Abcam; ab266722
DR   Wikidata; Q110430678
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2690; DBI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DCTPP1 KO
AC   CVCL_B2VR
SY   Human DCTPP1 (XTP3TPA) knockout HEK-293T
DR   Abcam; ab266726
DR   Wikidata; Q110430679
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28777; DCTPP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DCXR KO
AC   CVCL_B2VS
SY   Human DCXR knockout HEK-293T
DR   Abcam; ab266369
DR   Wikidata; Q110430680
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18985; DCXR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DEGS1 KO
AC   CVCL_B2VT
SY   Human DEGS1 (MLD) knockout HEK-293T
DR   Abcam; ab266481
DR   Wikidata; Q110430681
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13709; DEGS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DESI1 KO
AC   CVCL_B2VU
SY   Human DESI1 knockout HEK-293T
DR   Abcam; ab266317
DR   Wikidata; Q110430682
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24577; DESI1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DGUOK KO
AC   CVCL_B2VV
SY   Human DGUOK (dGK) knockout HEK-293T
DR   Abcam; ab266160
DR   Wikidata; Q110430683
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DIAPH1 KO
AC   CVCL_B2VW
SY   Human DIAPH1 knockout HEK-293T
DR   Abcam; ab266120
DR   Wikidata; Q110430686
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2876; DIAPH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DMPK KO
AC   CVCL_B2VX
SY   Human DMPK (Dystrophia myotonica protein kinase) knockout HEK-293T
DR   Abcam; ab266366
DR   Wikidata; Q110430687
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2933; DMPK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DNAJA1 KO
AC   CVCL_B2VY
SY   Human DNAJA1 knockout HEK-293T
DR   Abcam; ab266437
DR   Wikidata; Q110430688
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5229; DNAJA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DNAJB1 KO
AC   CVCL_B2VZ
SY   Human DNAJB1 (Hsp40) knockout HEK-293T
DR   Abcam; ab266344
DR   Wikidata; Q110430689
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5270; DNAJB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DNAJC2 KO
AC   CVCL_B2W0
SY   Human DNAJC2 (ZRF1) knockout HEK-293T
DR   Abcam; ab266662
DR   Wikidata; Q110430690
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13192; DNAJC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DNAJC9 KO
AC   CVCL_B9W2
SY   Human DNAJC9 knockout HEK-293T
DR   Abcam; ab266364
DR   Wikidata; Q112928321
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19123; DNAJC9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DR1 KO
AC   CVCL_B2W1
SY   Human DR1 knockout HEK-293T
DR   Abcam; ab266510
DR   Wikidata; Q110430692
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3017; DR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DRG1 KO
AC   CVCL_B2W2
SY   Human DRG1 knockout HEK-293T
DR   Abcam; ab266362
DR   Wikidata; Q110430693
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3029; DRG1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DROSHA KO
AC   CVCL_B2W3
SY   Human DROSHA knockout HEK-293T
DR   Abcam; ab266217
DR   Wikidata; Q110430694
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17904; DROSHA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DYNC2I2 KO
AC   CVCL_B2W4
SY   Human WDR34 knockout HEK-293T
DR   Abcam; ab266593
DR   Wikidata; Q110430695
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28296; DYNC2I2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T DYRK1A KO
AC   CVCL_B2W5
SY   Human DYRK1A knockout HEK-293T
DR   Abcam; ab267336
DR   Wikidata; Q110430696
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3091; DYRK1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T E2F4 KO
AC   CVCL_B2W6
SY   Human E2F4 knockout HEK-293T
DR   Abcam; ab266119
DR   Wikidata; Q110430697
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3118; E2F4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ECH1 KO
AC   CVCL_B2W7
SY   Human ECH1 knockout HEK-293T
DR   Abcam; ab266748
DR   Wikidata; Q110430698
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3149; ECH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ECI2 KO
AC   CVCL_B2W8
SY   Human ECI2 (PECI) knockout HEK-293T
DR   Abcam; ab266396
DR   Wikidata; Q110430699
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14601; ECI2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EEF1B2 KO
AC   CVCL_B2W9
SY   Human EEF1B2 knockout HEK-293T
DR   Abcam; ab266769
DR   Wikidata; Q110430700
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3208; EEF1B2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EEF1E1 KO
AC   CVCL_B2WA
SY   Human EEF1E1 (AIMP3/p18) knockout HEK-293T
DR   Abcam; ab266678
DR   Wikidata; Q110430701
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3212; EEF1E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EIF1 KO
AC   CVCL_B2WB
SY   Human EIF1 knockout HEK-293T
DR   Abcam; ab266166
DR   Wikidata; Q110430702
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3249; EIF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EIF2AK4 KO 1
AC   CVCL_B2WC
SY   Human EIF2AK4 (GCN2) knockout HEK-293T
DR   Abcam; ab267246
DR   Wikidata; Q110430703
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EIF2AK4 KO 2
AC   CVCL_B2WD
SY   Human EIF2AK4 (GCN2) knockout HEK-293T
DR   Abcam; ab267247
DR   Wikidata; Q110430704
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EIF2D KO
AC   CVCL_B2WE
SY   Human EIF2D knockout HEK-293T
DR   Abcam; ab266113
DR   Wikidata; Q110430705
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6583; EIF2D.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EIF3K KO
AC   CVCL_B2WF
SY   Human EIF3K knockout HEK-293T
DR   Abcam; ab266841
DR   Wikidata; Q110430706
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24656; EIF3K.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EIF4G2 KO
AC   CVCL_B2WG
SY   Human EIF4G2 (P97/DAP5) knockout HEK-293T
DR   Abcam; ab266209
DR   Wikidata; Q110430707
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3297; EIF4G2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EIF4H KO
AC   CVCL_B2WH
SY   Human EIF4H knockout HEK-293T
DR   Abcam; ab266430
DR   Wikidata; Q110430708
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12741; EIF4H.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ELOF1 KO
AC   CVCL_B2WI
SY   Human ELOF1 knockout HEK-293T
DR   Abcam; ab266208
DR   Wikidata; Q110430709
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28691; ELOF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EMD KO
AC   CVCL_B2WJ
SY   Human EMD (Emerin) knockout HEK-293T
DR   Abcam; ab266336
DR   Wikidata; Q110430710
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3331; EMD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EPHB4 KO 1
AC   CVCL_B2WK
SY   Human EPHB4 (Eph receptor B4/HTK) knockout HEK-293T
DR   Abcam; ab266732
DR   Wikidata; Q110430711
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T EPHB4 KO 2
AC   CVCL_B2WL
SY   Human EPHB4 (Eph receptor B4/HTK) knockout HEK-293T
DR   Abcam; ab266733
DR   Wikidata; Q110430712
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ERF KO
AC   CVCL_B2WM
SY   Human ERF knockout HEK-293T
DR   Abcam; ab266716
DR   Wikidata; Q110430713
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3444; ERF.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ERGIC3 KO
AC   CVCL_B2WN
SY   Human ERGIC3 knockout HEK-293T
DR   Abcam; ab266489
DR   Wikidata; Q110430714
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15927; ERGIC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ERP29 KO
AC   CVCL_B2WP
SY   Human ERP29 knockout HEK-293T
DR   Abcam; ab266543
DR   Wikidata; Q110430715
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13799; ERP29.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ESD KO
AC   CVCL_B2WQ
SY   Human ESD knockout HEK-293T
DR   Abcam; ab266360
DR   Wikidata; Q110430716
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3465; ESD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ETFA KO
AC   CVCL_B2WR
SY   Human ETFA knockout HEK-293T
DR   Abcam; ab266513
DR   Wikidata; Q110430717
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3481; ETFA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T F2R KO
AC   CVCL_B2WS
SY   Human F2R (PAR1/Thrombin Receptor) knockout HEK-293T
DR   Abcam; ab266398
DR   Wikidata; Q110430718
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266398; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T FAM120A KO
AC   CVCL_B2WT
SY   Human FAM120A (OSSA) knockout HEK-293T
DR   Abcam; ab266524
DR   Wikidata; Q110430719
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13247; FAM120A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FAM136A KO
AC   CVCL_B2WU
SY   Human FAM136A knockout HEK-293T
DR   Abcam; ab266445
DR   Wikidata; Q110430720
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25911; FAM136A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FAM162A KO
AC   CVCL_B2WV
SY   Human FAM162A knockout HEK-293T
DR   Abcam; ab266174
DR   Wikidata; Q110430721
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17865; FAM162A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FAM174C KO
AC   CVCL_B2WW
SY   Human C19orf24 knockout HEK-293T
DR   Abcam; ab266218
DR   Wikidata; Q110430722
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26073; FAM174C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FAM83D KO
AC   CVCL_B2WX
SY   Human FAM83D knockout HEK-293T
DR   Abcam; ab266371
DR   Wikidata; Q110430723
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16122; FAM83D.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FANCG KO
AC   CVCL_B2WY
SY   Human FANCG knockout HEK-293T
DR   Abcam; ab266776
DR   Wikidata; Q110430724
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3588; FANCG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FANCI KO
AC   CVCL_B2WZ
SY   Human FANCI knockout HEK-293T
DR   Abcam; ab266278
DR   Wikidata; Q110430725
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25568; FANCI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FCGRT KO
AC   CVCL_B2X0
SY   Human FCGRT (FCRN) knockout HEK-293T
DR   Abcam; ab265075
DR   Wikidata; Q110430726
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3621; FCGRT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FCSK KO
AC   CVCL_B2X1
SY   Human FUK knockout HEK-293T
DR   Abcam; ab267312
DR   Wikidata; Q110430727
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29500; FCSK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FGF13 KO
AC   CVCL_B2X2
SY   Human FGF13 knockout HEK-293T
DR   Abcam; ab267284
DR   Wikidata; Q110430729
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3670; FGF13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FGFR1 KO
AC   CVCL_B2X3
SY   Human FGFR1 knockout HEK-293T
DR   Abcam; ab266743
DR   Wikidata; Q110430731
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FKBP10 KO
AC   CVCL_B2X4
SY   Human FKBP10 knockout HEK-293T
DR   Abcam; ab266249
DR   Wikidata; Q110430733
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18169; FKBP10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FKBP2 KO
AC   CVCL_B2X5
SY   Human FKBP2 knockout HEK-293T
DR   Abcam; ab266527
DR   Wikidata; Q110430735
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3718; FKBP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FLAD1 KO
AC   CVCL_B2X6
SY   Human FLAD1 knockout HEK-293T
DR   Abcam; ab266699
DR   Wikidata; Q110430738
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24671; FLAD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FLOT1 KO
AC   CVCL_B2X7
SY   Human FLOT1 (Flotillin 1) knockout HEK-293T
DR   Abcam; ab267276
DR   Wikidata; Q110430740
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3757; FLOT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FLOT2 KO
AC   CVCL_B2X8
SY   Human FLOT2 (Flotillin 2/ESA) knockout HEK-293T
DR   Abcam; ab266847
DR   Wikidata; Q110430742
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3758; FLOT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FOXO3 KO
AC   CVCL_B2X9
SY   Human FOXO3 (FOXO3A) knockout HEK-293T
DR   Abcam; ab265069
DR   Wikidata; Q110430744
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FTH1 KO
AC   CVCL_B2XA
SY   Human FTH1 knockout HEK-293T
DR   Abcam; ab266581
DR   Wikidata; Q110430746
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3976; FTH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FTSJ1 KO
AC   CVCL_B2XB
SY   Human FTSJ1 knockout HEK-293T
DR   Abcam; ab266506
DR   Wikidata; Q110430748
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13254; FTSJ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FUCA2 KO
AC   CVCL_B2XC
SY   Human FUCA2 knockout HEK-293T
DR   Abcam; ab266754
DR   Wikidata; Q110430750
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4008; FUCA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FUS KO
AC   CVCL_B2XD
SY   Human FUS (TLS) knockout HEK-293T
DR   Abcam; ab266587
DR   Wikidata; Q110430752
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FXYD5 KO
AC   CVCL_B2XE
SY   Human FXYD5 (Dysadherin) knockout HEK-293T
DR   Abcam; ab266233
DR   Wikidata; Q110430753
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4029; FXYD5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FYN KO
AC   CVCL_B2XF
SY   Human FYN knockout HEK-293T
DR   Abcam; ab266133
DR   Wikidata; Q110430754
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T FZR1 KO
AC   CVCL_B2XG
SY   Human FZR1 knockout HEK-293T
DR   Abcam; ab267263
DR   Wikidata; Q110430755
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24824; FZR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T G6PC3 KO
AC   CVCL_B2XH
SY   Human G6PC3 knockout HEK-293T
DR   Abcam; ab266349
DR   Wikidata; Q110430756
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24861; G6PC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GAA KO
AC   CVCL_B2XI
SY   Human GAA knockout HEK-293T
DR   Abcam; ab266259
DR   Wikidata; Q110430757
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GAK KO
AC   CVCL_B2XJ
SY   Human GAK knockout HEK-293T
DR   Abcam; ab266417
DR   Wikidata; Q110430758
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4113; GAK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GCN1 KO
AC   CVCL_B2XK
SY   Human GCN1L1 knockout HEK-293T
DR   Abcam; ab266780
DR   Wikidata; Q110430759
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4199; GCN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GDI2 KO
AC   CVCL_B2XL
SY   Human GDI2 knockout HEK-293T
DR   Abcam; ab266289
DR   Wikidata; Q110430760
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4227; GDI2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GHITM KO 1
AC   CVCL_B2XM
SY   Human GHITM (MICS1) knockout HEK-293T
DR   Abcam; ab266479
DR   Wikidata; Q110430761
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17281; GHITM.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GHITM KO 2
AC   CVCL_B2XN
SY   Human GHITM (MICS1) knockout HEK-293T
DR   Abcam; ab266480
DR   Wikidata; Q110430762
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17281; GHITM.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GIPC1 KO
AC   CVCL_B2XP
SY   Human GIPC1 knockout HEK-293T
DR   Abcam; ab266406
DR   Wikidata; Q110430763
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1226; GIPC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GK KO
AC   CVCL_B2XQ
SY   Human GK (Glycerol kinase) knockout HEK-293T
DR   Abcam; ab267328
DR   Wikidata; Q110430764
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4289; GK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GLI4 KO
AC   CVCL_B2XR
SY   Human GLI4 knockout HEK-293T
DR   Abcam; ab265057
DR   Wikidata; Q110430765
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4320; GLI4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GLYR1 KO
AC   CVCL_B2XS
SY   Human GLYR1 knockout HEK-293T
DR   Abcam; ab266610
DR   Wikidata; Q110430766
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24434; GLYR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GNAI1 KO
AC   CVCL_B2XT
SY   Human GNAI1 knockout HEK-293T
DR   Abcam; ab266611
DR   Wikidata; Q110430767
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4384; GNAI1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GNB2 KO
AC   CVCL_B2XU
SY   Human GNB2 knockout HEK-293T
DR   Abcam; ab266528
DR   Wikidata; Q110430768
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4398; GNB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GNG4 KO
AC   CVCL_B2XV
SY   Human GNG4 knockout HEK-293T
DR   Abcam; ab266067
DR   Wikidata; Q110430769
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4407; GNG4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GNG5 KO
AC   CVCL_B2XW
SY   Human GNG5 knockout HEK-293T
DR   Abcam; ab266291
DR   Wikidata; Q110430770
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4408; GNG5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GNG8 KO
AC   CVCL_B2XX
SY   Human GNG8 (Gamma-9) knockout HEK-293T
DR   Abcam; ab266108
DR   Wikidata; Q110430771
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19664; GNG8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GNPDA1 KO
AC   CVCL_B2XY
SY   Human GNPDA1 knockout HEK-293T
DR   Abcam; ab266376
DR   Wikidata; Q110430772
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4417; GNPDA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GOLGA5 KO
AC   CVCL_B2XZ
SY   Human GOLGA5 (Golgin-84) knockout HEK-293T
DR   Abcam; ab267252
DR   Wikidata; Q110430773
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4428; GOLGA5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GOLIM4 KO
AC   CVCL_B2Y0
SY   Human GOLIM4 (GOLPH4/GPP130) knockout HEK-293T
DR   Abcam; ab266123
DR   Wikidata; Q110430774
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15448; GOLIM4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GOLM1 KO
AC   CVCL_B2Y1
SY   Human GOLM1 (GOLPH2) knockout HEK-293T
DR   Abcam; ab266505
DR   Wikidata; Q110430775
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15451; GOLM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GPAA1 KO
AC   CVCL_B2Y2
SY   Human GPAA1 (GAA1) knockout HEK-293T
DR   Abcam; ab266092
DR   Wikidata; Q110430776
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4446; GPAA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GPATCH4 KO
AC   CVCL_B2Y3
SY   Human GPATCH4 knockout HEK-293T
DR   Abcam; ab266701
DR   Wikidata; Q110430777
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25982; GPATCH4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GPC4 KO
AC   CVCL_B2Y4
SY   Human GPC4 (Glypican 4) knockout HEK-293T
DR   Abcam; ab266213
DR   Wikidata; Q110430778
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4452; GPC4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GPI KO
AC   CVCL_B2Y5
SY   Human GPI (AMF) knockout HEK-293T
DR   Abcam; ab266834
DR   Wikidata; Q110430779
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4458; GPI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GPX1 KO
AC   CVCL_B2Y6
SY   Human GPX1 (Glutathione Peroxidase 1) knockout HEK-293T
DR   Abcam; ab266650
DR   Wikidata; Q110430781
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4553; GPX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GRHPR KO
AC   CVCL_B2Y7
SY   Human GRHPR knockout HEK-293T
DR   Abcam; ab266129
DR   Wikidata; Q110430782
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4570; GRHPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GRK2 KO
AC   CVCL_B2Y8
SY   Human ADRBK1 (GRK2) knockout HEK-293T
DR   Abcam; ab266352
DR   Wikidata; Q110430783
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:289; GRK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GRN KO
AC   CVCL_B2Y9
SY   Human GRN (Granulin) knockout HEK-293T
DR   Abcam; ab266738
DR   Wikidata; Q110430784
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GSK3A KO
AC   CVCL_B2YA
SY   Human GSK3A (GSK3 alpha) knockout HEK-293T
DR   Abcam; ab266742
DR   Wikidata; Q110430785
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4616; GSK3A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GSS KO
AC   CVCL_B2YB
SY   Human GSS (Glutathione Synthetase) knockout HEK-293T
DR   Abcam; ab266342
DR   Wikidata; Q110430786
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4624; GSS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GSTK1 KO
AC   CVCL_B2YC
SY   Human GSTK1 knockout HEK-293T
DR   Abcam; ab266112
DR   Wikidata; Q110430787
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16906; GSTK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GSTO1 KO
AC   CVCL_B2YD
SY   Human GSTO1 (glutathione S transferase Omega 1/p28) knockout HEK-293T
DR   Abcam; ab266277
DR   Wikidata; Q110430788
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13312; GSTO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GTF2F1 KO
AC   CVCL_B2YE
SY   Human GTF2F1 knockout HEK-293T
DR   Abcam; ab266655
DR   Wikidata; Q110430789
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4652; GTF2F1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T GTF3C6 KO
AC   CVCL_B2YF
SY   Human GTF3C6 knockout HEK-293T
DR   Abcam; ab266494
DR   Wikidata; Q110430790
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20872; GTF3C6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T H3-3B KO
AC   CVCL_B2YG
SY   Human H3F3B knockout HEK-293T
DR   Abcam; ab266410
DR   Wikidata; Q110430791
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4765; H3-3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HADHA KO
AC   CVCL_B2YH
SY   Human HADHA knockout HEK-293T
DR   Abcam; ab266274
DR   Wikidata; Q110430793
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4801; HADHA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HCFC1R1 KO
AC   CVCL_B2YI
SY   Human HCFC1R1 (Host cell factor C1 regulator 1) knockout HEK-293T
DR   Abcam; ab266341
DR   Wikidata; Q110430794
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21198; HCFC1R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HDAC2 KO 1
AC   CVCL_B2YJ
SY   Human HDAC2 knockout HEK-293T
DR   Abcam; ab266588
DR   Wikidata; Q110430795
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HDAC2 KO 2
AC   CVCL_B2YK
SY   Human HDAC2 knockout HEK-293T
DR   Abcam; ab266589
DR   Wikidata; Q110430796
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HDAC2 KO 3
AC   CVCL_B2YL
SY   Human HDAC2 knockout HEK-293T
DR   Abcam; ab266590
DR   Wikidata; Q110430797
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HDHD5 KO
AC   CVCL_B2YM
SY   Human CECR5 knockout HEK-293T
DR   Abcam; ab266708
DR   Wikidata; Q110430798
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1843; HDHD5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HEY1 KO
AC   CVCL_B2YN
SY   Human HEY1 knockout HEK-293T
DR   Abcam; ab267338
DR   Wikidata; Q110430799
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab267338; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T HINT2 KO
AC   CVCL_B2YP
SY   Human HINT2 knockout HEK-293T
DR   Abcam; ab266498
DR   Wikidata; Q110430800
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18344; HINT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HK1 KO
AC   CVCL_B2YQ
SY   Human HK1 (Hexokinase 1) knockout HEK-293T
DR   Abcam; ab267279
DR   Wikidata; Q110430801
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4922; HK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HLA-E KO
AC   CVCL_B2YR
SY   Human HLA-E (HLA E) knockout HEK-293T
DR   Abcam; ab267231
DR   Wikidata; Q110430802
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HM13 KO
AC   CVCL_B2YS
SY   Human HM13 (SPP) knockout HEK-293T
DR   Abcam; ab266584
DR   Wikidata; Q110430803
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16435; HM13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HMGB2 KO
AC   CVCL_B2YT
SY   Human HMGB2 knockout HEK-293T
DR   Abcam; ab266358
DR   Wikidata; Q110430805
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5000; HMGB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HMGN2 KO
AC   CVCL_B2YU
SY   Human HMGN2 knockout HEK-293T
DR   Abcam; ab266700
DR   Wikidata; Q110430806
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4986; HMGN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HMGN3 KO
AC   CVCL_B2YV
SY   Human HMGN3 knockout HEK-293T
DR   Abcam; ab266390
DR   Wikidata; Q110430807
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12312; HMGN3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPA0 KO
AC   CVCL_B2YW
SY   Human HNRNPA0 knockout HEK-293T
DR   Abcam; ab266314
DR   Wikidata; Q110430809
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5030; HNRNPA0.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPA1 KO
AC   CVCL_B2YX
SY   Human HNRNPA1 knockout HEK-293T
DR   Abcam; ab266193
DR   Wikidata; Q110430810
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5031; HNRNPA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPA1L2 KO
AC   CVCL_B2YY
SY   Human HNRNPA1L2 (Heterogeneous Nuclear Ribonucleoprotein A1-like) knockout HEK-293T
DR   Abcam; ab266657
DR   Wikidata; Q110430811
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27067; HNRNPA1L2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPA2B1 KO
AC   CVCL_B2YZ
SY   Human HNRNPA2B1 knockout HEK-293T
DR   Abcam; ab266404
DR   Wikidata; Q110430812
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5033; HNRNPA2B1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPA3 KO
AC   CVCL_B2Z0
SY   Human HNRNPA3 knockout HEK-293T
DR   Abcam; ab266302
DR   Wikidata; Q110430813
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24941; HNRNPA3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPAB KO
AC   CVCL_B2Z1
SY   Human HNRNPAB knockout HEK-293T
DR   Abcam; ab266459
DR   Wikidata; Q110430814
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5034; HNRNPAB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPR KO
AC   CVCL_B2Z2
SY   Human HNRNPR knockout HEK-293T
DR   Abcam; ab266723
DR   Wikidata; Q110430815
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5047; HNRNPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HNRNPUL1 KO
AC   CVCL_B2Z3
SY   Human HNRNPUL1 (E1B-AP5) knockout HEK-293T
DR   Abcam; ab266142
DR   Wikidata; Q110430817
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17011; HNRNPUL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HP1BP3 KO
AC   CVCL_B2Z4
SY   Human HP1BP3 knockout HEK-293T
DR   Abcam; ab266438
DR   Wikidata; Q110430818
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24973; HP1BP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HSP90AA1 KO
AC   CVCL_B2Z5
SY   Human HSP90AA1 (Hsp90 alpha) knockout HEK-293T
DR   Abcam; ab266591
DR   Wikidata; Q110430819
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HSP90AB1 KO
AC   CVCL_B2Z6
SY   Human HSP90AB1 (Hsp90 beta) knockout HEK-293T
DR   Abcam; ab266117
DR   Wikidata; Q110430820
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5258; HSP90AB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T HSP90B1 KO
AC   CVCL_B2Z7
SY   Human HSP90B1 (GRP94) knockout HEK-293T
DR   Abcam; ab266313
DR   Wikidata; Q110430821
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12028; HSP90B1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T IDH3G KO
AC   CVCL_B2Z8
SY   Human IDH3G knockout HEK-293T
DR   Abcam; ab266640
DR   Wikidata; Q110430822
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5386; IDH3G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T IKBKG KO
AC   CVCL_B2Z9
SY   Human IKBKG (IKK gamma/NEMO) knockout HEK-293T
DR   Abcam; ab266674
DR   Wikidata; Q110430823
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T IL4R KO
AC   CVCL_B2ZA
SY   Human IL4R (IL-4R) knockout HEK-293T
DR   Abcam; ab266429
DR   Wikidata; Q110430824
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ILKAP KO
AC   CVCL_B2ZB
SY   Human ILKAP knockout HEK-293T
DR   Abcam; ab266475
DR   Wikidata; Q110430826
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15566; ILKAP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T INVS KO
AC   CVCL_B2ZC
SY   Human INVS (Inversin) knockout HEK-293T
DR   Abcam; ab266312
DR   Wikidata; Q110430827
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17870; INVS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T IPO4 KO
AC   CVCL_B2ZD
SY   Human IPO4 (Importin4/Imp4) knockout HEK-293T
DR   Abcam; ab266175
DR   Wikidata; Q110430828
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19426; IPO4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T IPPK KO
AC   CVCL_B2ZE
SY   Human IPPK (IPK1) knockout HEK-293T
DR   Abcam; ab267287
DR   Wikidata; Q110430829
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14645; IPPK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T IRS1 KO
AC   CVCL_B2ZF
SY   Human IRS1 knockout HEK-293T
DR   Abcam; ab267320
DR   Wikidata; Q110430830
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6125; IRS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab267320; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T ITPA KO
AC   CVCL_B2ZG
SY   Human ITPA knockout HEK-293T
DR   Abcam; ab266679
DR   Wikidata; Q110430832
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6176; ITPA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T JMJD6 KO
AC   CVCL_B2ZH
SY   Human JMJD6 knockout HEK-293T
DR   Abcam; ab266402
DR   Wikidata; Q110430833
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T JOSD1 KO
AC   CVCL_B2ZI
SY   Human JOSD1 knockout HEK-293T
DR   Abcam; ab267332
DR   Wikidata; Q110430834
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28953; JOSD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T JUP KO
AC   CVCL_B2ZJ
SY   Human JUP (gamma Catenin) knockout HEK-293T
DR   Abcam; ab266272
DR   Wikidata; Q110430835
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6207; JUP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KDELR1 KO
AC   CVCL_B2ZK
SY   Human KDELR1 (KDEL Receptor) knockout HEK-293T
DR   Abcam; ab266105
DR   Wikidata; Q110430836
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6304; KDELR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KDELR2 KO
AC   CVCL_B2ZL
SY   Human KDELR2 (ELP-1) knockout HEK-293T
DR   Abcam; ab266511
DR   Wikidata; Q110430837
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6305; KDELR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KDM5C KO 1
AC   CVCL_B2ZM
SY   Human KDM5C (Jarid1C / SMCX) knockout HEK-293T
DR   Abcam; ab266251
DR   Wikidata; Q110430838
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11114; KDM5C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KDM5C KO 2
AC   CVCL_B2ZN
SY   Human KDM5C (Jarid1C / SMCX) knockout HEK-293T
DR   Abcam; ab266252
DR   Wikidata; Q110430839
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11114; KDM5C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KDM6B KO
AC   CVCL_B2ZP
SY   Human KDM6B (JMJD3) knockout HEK-293T
DR   Abcam; ab266294
DR   Wikidata; Q110430840
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KHK KO
AC   CVCL_B2ZQ
SY   Human KHK (ketohexokinase) knockout HEK-293T
DR   Abcam; ab267292
DR   Wikidata; Q110430841
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6315; KHK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KIAA0100 KO
AC   CVCL_B2ZR
SY   Human KIAA0100 knockout HEK-293T
DR   Abcam; ab266526
DR   Wikidata; Q110430843
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28960; BLTP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T KIF1C KO
AC   CVCL_B2ZS
SY   Human KIF1C knockout HEK-293T
DR   Abcam; ab266544
DR   Wikidata; Q110430844
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6317; KIF1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KIF20A KO
AC   CVCL_B2ZT
SY   Human KIF20A knockout HEK-293T
DR   Abcam; ab266648
DR   Wikidata; Q110430845
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9787; KIF20A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KIF22 KO
AC   CVCL_B2ZU
SY   Human KIF22 knockout HEK-293T
DR   Abcam; ab266817
DR   Wikidata; Q110430846
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6391; KIF22.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KLHDC3 KO
AC   CVCL_B2ZV
SY   Human KLHDC3 knockout HEK-293T
DR   Abcam; ab266106
DR   Wikidata; Q110430847
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20704; KLHDC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KNSTRN KO
AC   CVCL_B2ZW
SY   Human KNSTRN (SKAP) knockout HEK-293T
DR   Abcam; ab266082
DR   Wikidata; Q110430848
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30767; KNSTRN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KRTCAP2 KO
AC   CVCL_B2ZX
SY   Human KRTCAP2 (KCP-2) knockout HEK-293T
DR   Abcam; ab266719
DR   Wikidata; Q110430849
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28942; KRTCAP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T KXD1 KO
AC   CVCL_B2ZY
SY   Human KXD1 (C19orf50) knockout HEK-293T
DR   Abcam; ab266559
DR   Wikidata; Q110430850
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28420; KXD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T L3MBTL3 KO
AC   CVCL_B2ZZ
SY   Human L3MBTL3 knockout HEK-293T
DR   Abcam; ab266172
DR   Wikidata; Q110430851
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23035; L3MBTL3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LAMTOR4 KO
AC   CVCL_B3A0
SY   Human LAMTOR4 knockout HEK-293T
DR   Abcam; ab266225
DR   Wikidata; Q110430852
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33772; LAMTOR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LAPTM4A KO
AC   CVCL_B3A1
SY   Human LAPTM4A knockout HEK-293T
DR   Abcam; ab266686
DR   Wikidata; Q110430877
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6924; LAPTM4A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LARP1 KO
AC   CVCL_B3A2
SY   Human LARP1 knockout HEK-293T
DR   Abcam; ab266295
DR   Wikidata; Q110430878
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29531; LARP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266295; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T LBR KO
AC   CVCL_B3A3
SY   Human LBR (Lamin B Receptor) knockout HEK-293T
DR   Abcam; ab266308
DR   Wikidata; Q110430879
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6518; LBR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LDHB KO
AC   CVCL_B3A4
SY   Human LDHB (Lactate Dehydrogenase B) knockout HEK-293T
DR   Abcam; ab255403
DR   Wikidata; Q110430880
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6541; LDHB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LGALS1 KO
AC   CVCL_B3A5
SY   Human LGALS1 (Galectin 1) knockout HEK-293T
DR   Abcam; ab266850
DR   Wikidata; Q110430881
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LIN28B KO
AC   CVCL_B3A6
SY   Human LIN28B knockout HEK-293T
DR   Abcam; ab265066
DR   Wikidata; Q110430882
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LMAN1 KO
AC   CVCL_B3A7
SY   Human LMAN1 knockout HEK-293T
DR   Abcam; ab266248
DR   Wikidata; Q110430883
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6631; LMAN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LMAN2 KO
AC   CVCL_B3A8
SY   Human LMAN2 (VIP36) knockout HEK-293T
DR   Abcam; ab266370
DR   Wikidata; Q110430884
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16986; LMAN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LPAR3 KO
AC   CVCL_B3A9
SY   Human LPAR3 (LPA-3) knockout HEK-293T
DR   Abcam; ab266718
DR   Wikidata; Q110430885
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14298; LPAR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LRP5 KO
AC   CVCL_B3AA
SY   Human LRP5 knockout HEK-293T
DR   Abcam; ab266618
DR   Wikidata; Q110430886
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LRRC59 KO
AC   CVCL_B3AB
SY   Human LRRC59 knockout HEK-293T
DR   Abcam; ab266307
DR   Wikidata; Q110430888
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28817; LRRC59.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LTA4H KO
AC   CVCL_B3AC
SY   Human LTA4H (Leukotriene A4 hydrolase) knockout HEK-293T
DR   Abcam; ab266467
DR   Wikidata; Q110430889
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6710; LTA4H.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LUC7L2 KO
AC   CVCL_B3AD
SY   Human LUC7L2 knockout HEK-293T
DR   Abcam; ab266577
DR   Wikidata; Q110430890
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21608; LUC7L2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LYPLA1 KO
AC   CVCL_B3AE
SY   Human LYPLA1 (Lysophospholipase 1/LPL-I) knockout HEK-293T
DR   Abcam; ab266195
DR   Wikidata; Q110430891
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6737; LYPLA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T LYPLA2 KO
AC   CVCL_B3AF
SY   Human LYPLA2 (APT-2) knockout HEK-293T
DR   Abcam; ab266696
DR   Wikidata; Q110430892
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6738; LYPLA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T M6PR KO
AC   CVCL_B3AG
SY   Human M6PR knockout HEK-293T
DR   Abcam; ab266668
DR   Wikidata; Q110430893
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6752; M6PR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266668; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T MACROH2A1 KO
AC   CVCL_B3AH
SY   Human H2AFY (mH2A1) knockout HEK-293T
DR   Abcam; ab266241
DR   Wikidata; Q110430894
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4740; MACROH2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAF1 KO
AC   CVCL_B3AI
SY   Human MAF1 knockout HEK-293T
DR   Abcam; ab266508
DR   Wikidata; Q110430895
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24966; MAF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAP2K2 KO
AC   CVCL_B3AJ
SY   Human MAP2K2 (MEK2) knockout HEK-293T
DR   Abcam; ab266315
DR   Wikidata; Q110430896
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAP3K10 KO
AC   CVCL_B3AK
SY   Human MAP3K10 (MLK2) knockout HEK-293T
DR   Abcam; ab267288
DR   Wikidata; Q110430897
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6849; MAP3K10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAP3K7 KO
AC   CVCL_B3AL
SY   Human MAP3K7 (TAK1) knockout HEK-293T
DR   Abcam; ab266555
DR   Wikidata; Q110430899
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAP7D1 KO
AC   CVCL_B3AM
SY   Human MAP7D1 knockout HEK-293T
DR   Abcam; ab266232
DR   Wikidata; Q110430900
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25514; MAP7D1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAPK12 KO
AC   CVCL_B3AN
SY   Human MAPK12 knockout HEK-293T
DR   Abcam; ab266280
DR   Wikidata; Q110430901
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6874; MAPK12.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAPK14 KO
AC   CVCL_B3AP
SY   Human MAPK14 (p38) knockout HEK-293T
DR   Abcam; ab255406
DR   Wikidata; Q110430902
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAPK3 KO
AC   CVCL_B3AQ
SY   Human MAPK3 (ERK1) knockout HEK-293T
DR   Abcam; ab266519
DR   Wikidata; Q110430903
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6877; MAPK3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAPK8IP1 KO
AC   CVCL_B3AR
SY   Human MAPK8IP1 (IB-1) knockout HEK-293T
DR   Abcam; ab267340
DR   Wikidata; Q110430904
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6882; MAPK8IP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAPK9 KO
AC   CVCL_B3AS
SY   Human MAPK9 (JNK2) knockout HEK-293T
DR   Abcam; ab266355
DR   Wikidata; Q110430905
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6886; MAPK9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAPKAPK5 KO
AC   CVCL_B3AT
SY   Human MAPKAPK5 (PRAK/MK5) knockout HEK-293T
DR   Abcam; ab266118
DR   Wikidata; Q110430906
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MAT2B KO
AC   CVCL_B3AU
SY   Human MAT2B (TGR) knockout HEK-293T
DR   Abcam; ab266712
DR   Wikidata; Q110430907
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6905; MAT2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MATK KO
AC   CVCL_B3AV
SY   Human MATK knockout HEK-293T
DR   Abcam; ab266171
DR   Wikidata; Q110430908
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6906; MATK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266171; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T MCL1 KO
AC   CVCL_B3AW
SY   Human MCL1 knockout HEK-293T
DR   Abcam; ab266838
DR   Wikidata; Q110430909
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6943; MCL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MDH2 KO
AC   CVCL_B3AX
SY   Human MDH2 knockout HEK-293T
DR   Abcam; ab266449
DR   Wikidata; Q110430910
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6971; MDH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MEA1 KO
AC   CVCL_B3AY
SY   Human MEA1 knockout HEK-293T
DR   Abcam; ab266808
DR   Wikidata; Q110430911
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6986; MEA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MEX3B KO
AC   CVCL_B3AZ
SY   Human MEX3B knockout HEK-293T
DR   Abcam; ab267234
DR   Wikidata; Q110430912
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25297; MEX3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MIX23 KO
AC   CVCL_B3B0
SY   Human CCDC58 knockout HEK-293T
DR   Abcam; ab266144
DR   Wikidata; Q110430913
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31136; MIX23.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MKNK2 KO
AC   CVCL_B3B1
SY   Human MKNK2 (MNK2) knockout HEK-293T
DR   Abcam; ab266097
DR   Wikidata; Q110430914
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MKRN1 KO
AC   CVCL_B3B2
SY   Human MKRN1 knockout HEK-293T
DR   Abcam; ab266443
DR   Wikidata; Q110430915
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7112; MKRN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MMADHC KO
AC   CVCL_B3B3
SY   Human MMADHC knockout HEK-293T
DR   Abcam; ab266140
DR   Wikidata; Q110430916
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25221; MMADHC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MPDU1 KO
AC   CVCL_B3B4
SY   Human MPDU1 (SL15) knockout HEK-293T
DR   Abcam; ab266694
DR   Wikidata; Q110430917
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7207; MPDU1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MPI KO
AC   CVCL_B9W3
SY   Human MPI (Mannose Phosphate Isomerase) knockout HEK-293T
DR   Abcam; ab266298
DR   Wikidata; Q112928322
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7216; MPI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MPP1 KO
AC   CVCL_B3B5
SY   Human MPP1 knockout HEK-293T
DR   Abcam; ab267248
DR   Wikidata; Q110430918
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7219; MPP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MPP2 KO
AC   CVCL_B3B6
SY   Human MPP2 knockout HEK-293T
DR   Abcam; ab267333
DR   Wikidata; Q110430919
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7220; MPP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MPST KO
AC   CVCL_B3B7
SY   Human MPST (MST) knockout HEK-293T
DR   Abcam; ab266789
DR   Wikidata; Q110430920
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7223; MPST.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MRFAP1 KO
AC   CVCL_B3B8
SY   Human MRFAP1 knockout HEK-293T
DR   Abcam; ab266620
DR   Wikidata; Q110430921
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24549; MRFAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MRPL2 KO
AC   CVCL_B3B9
SY   Human MRPL2 knockout HEK-293T
DR   Abcam; ab266698
DR   Wikidata; Q110430922
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14056; MRPL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MRPL50 KO
AC   CVCL_B3BA
SY   Human MRPL50 knockout HEK-293T
DR   Abcam; ab266832
DR   Wikidata; Q110430923
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16654; MRPL50.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MRPS28 KO
AC   CVCL_B3BB
SY   Human MRPS28 knockout HEK-293T
DR   Abcam; ab266282
DR   Wikidata; Q110430924
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14513; MRPS28.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MT2A KO
AC   CVCL_B3BC
SY   Human MT2A knockout HEK-293T
DR   Abcam; ab266538
DR   Wikidata; Q110430925
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7406; MT2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266538; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T MTCH2 KO
AC   CVCL_B3BD
SY   Human MTCH2 knockout HEK-293T
DR   Abcam; ab266083
DR   Wikidata; Q110430927
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17587; MTCH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTHFD1L KO
AC   CVCL_B3BE
SY   Human MTHFD1L knockout HEK-293T
DR   Abcam; ab266135
DR   Wikidata; Q110430928
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21055; MTHFD1L.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTHFD2 KO
AC   CVCL_B3BF
SY   Human MTHFD2 knockout HEK-293T
DR   Abcam; ab266383
DR   Wikidata; Q110430929
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7434; MTHFD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTMR4 KO
AC   CVCL_B3BG
SY   Human MTMR4 knockout HEK-293T
DR   Abcam; ab266411
DR   Wikidata; Q110430930
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7452; MTMR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTOR KO
AC   CVCL_B3BH
SY   Human MTOR knockout HEK-293T
DR   Abcam; ab255411
DR   Wikidata; Q110430932
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3942; MTOR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTR KO
AC   CVCL_B3BI
SY   Human MTR knockout HEK-293T
DR   Abcam; ab266810
DR   Wikidata; Q110430933
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7468; MTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTRNR2L1 KO
AC   CVCL_B3BJ
SY   Human MTRNR2L1 (Humanin-like protein 1) knockout HEK-293T
DR   Abcam; ab266441
DR   Wikidata; Q110430934
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37155; MTRNR2L1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTRNR2L8 KO
AC   CVCL_B3BK
SY   Human MTRNR2L8 knockout HEK-293T
DR   Abcam; ab266534
DR   Wikidata; Q110430935
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37165; MTRNR2L8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MTX1 KO
AC   CVCL_B3BL
SY   Human MTX1 (MTX) knockout HEK-293T
DR   Abcam; ab266796
DR   Wikidata; Q110430936
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7504; MTX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MYC KO
AC   CVCL_B3BM
SY   Human MYC (c-Myc) knockout HEK-293T
DR   Abcam; ab256500
DR   Wikidata; Q110430937
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MYL6B KO
AC   CVCL_B3BN
SY   Human MYL6B (MLC1SA) knockout HEK-293T
DR   Abcam; ab266839
DR   Wikidata; Q110430939
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29823; MYL6B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MYSM1 KO
AC   CVCL_B3BP
SY   Human MYSM1 knockout HEK-293T
DR   Abcam; ab267297
DR   Wikidata; Q110430940
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29401; MYSM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T MZT2B KO
AC   CVCL_B3BQ
SY   Human MZT2B knockout HEK-293T
DR   Abcam; ab266243
DR   Wikidata; Q110430941
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25886; MZT2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NABP2 KO
AC   CVCL_B3BR
SY   Human NABP2 (hSSB1) knockout HEK-293T
DR   Abcam; ab266497
DR   Wikidata; Q110430942
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28412; NABP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NACA KO
AC   CVCL_B3BS
SY   Human NACA (NACA1) knockout HEK-293T
DR   Abcam; ab266836
DR   Wikidata; Q110430943
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7629; NACA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NADK KO
AC   CVCL_B3BT
SY   Human NADK knockout HEK-293T
DR   Abcam; ab267326
DR   Wikidata; Q110430944
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29831; NADK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NANS KO
AC   CVCL_B3BU
SY   Human NANS knockout HEK-293T
DR   Abcam; ab266134
DR   Wikidata; Q110430945
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19237; NANS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NASP KO
AC   CVCL_B3BV
SY   Human NASP knockout HEK-293T
DR   Abcam; ab266303
DR   Wikidata; Q110430946
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7644; NASP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NCAPG2 KO
AC   CVCL_B3BW
SY   Human NCAPG2 knockout HEK-293T
DR   Abcam; ab266636
DR   Wikidata; Q110430947
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21904; NCAPG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NCOA2 KO
AC   CVCL_B3BX
SY   Human NCOA2 (KAT13C) knockout HEK-293T
DR   Abcam; ab265068
DR   Wikidata; Q110430948
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7669; NCOA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NCSTN KO
AC   CVCL_B3BY
SY   Human NCSTN (Nicastrin) knockout HEK-293T
DR   Abcam; ab266602
DR   Wikidata; Q110430949
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17091; NCSTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDRG1 KO
AC   CVCL_B3BZ
SY   Human NDRG1 knockout HEK-293T
DR   Abcam; ab267301
DR   Wikidata; Q110430950
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7679; NDRG1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFA11 KO
AC   CVCL_B3C0
SY   Human NDUFA11 (NDUAB) knockout HEK-293T
DR   Abcam; ab266180
DR   Wikidata; Q110430952
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20371; NDUFA11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFA4 KO
AC   CVCL_B3C1
SY   Human NDUFA4 knockout HEK-293T
DR   Abcam; ab266757
DR   Wikidata; Q110430953
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7687; NDUFA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFA7 KO
AC   CVCL_B3C2
SY   Human NDUFA7 knockout HEK-293T
DR   Abcam; ab266597
DR   Wikidata; Q110430954
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7691; NDUFA7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFAF8 KO
AC   CVCL_B3C3
SY   Human C17orf89 knockout HEK-293T
DR   Abcam; ab266760
DR   Wikidata; Q110430956
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33551; NDUFAF8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFB1 KO
AC   CVCL_B3C4
SY   Human NDUFB1 knockout HEK-293T
DR   Abcam; ab266332
DR   Wikidata; Q110430957
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7695; NDUFB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFC1 KO
AC   CVCL_B3C5
SY   Human NDUFC1 knockout HEK-293T
DR   Abcam; ab266285
DR   Wikidata; Q110430958
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7705; NDUFC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFS3 KO
AC   CVCL_B3C6
SY   Human NDUFS3 knockout HEK-293T
DR   Abcam; ab266419
DR   Wikidata; Q110430959
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NDUFV1 KO
AC   CVCL_B3C7
SY   Human NDUFV1 knockout HEK-293T
DR   Abcam; ab266553
DR   Wikidata; Q110430960
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7716; NDUFV1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NEFM KO
AC   CVCL_B3C8
SY   Human NEFM (160 kD Neurofilament Medium) knockout HEK-293T
DR   Abcam; ab266741
DR   Wikidata; Q110430961
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7734; NEFM.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NEIL1 KO 1
AC   CVCL_B3C9
SY   Human NEIL1 knockout HEK-293T
DR   Abcam; ab266167
DR   Wikidata; Q110430962
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NEIL1 KO 2
AC   CVCL_B3CA
SY   Human NEIL1 knockout HEK-293T
DR   Abcam; ab266168
DR   Wikidata; Q110430963
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NFATC3 KO
AC   CVCL_B3CB
SY   Human NFATC3 (NFAT4) knockout HEK-293T
DR   Abcam; ab267300
DR   Wikidata; Q110430964
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7777; NFATC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NFE2L1 KO
AC   CVCL_B3CC
SY   Human NFE2L1 knockout HEK-293T
DR   Abcam; ab266125
DR   Wikidata; Q110430966
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7781; NFE2L1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NIBAN2 KO
AC   CVCL_B3CD
SY   Human FAM129B knockout HEK-293T
DR   Abcam; ab266826
DR   Wikidata; Q110430967
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25282; NIBAN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NIT2 KO
AC   CVCL_B3CE
SY   Human NIT2 knockout HEK-293T
DR   Abcam; ab266605
DR   Wikidata; Q110430968
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29878; NIT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NME1 KO
AC   CVCL_B3CF
SY   Human NME1 (NM23A) knockout HEK-293T
DR   Abcam; ab266215
DR   Wikidata; Q110430969
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7849; NME1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NME4 KO 1
AC   CVCL_B3CG
SY   Human NME4 knockout HEK-293T
DR   Abcam; ab267280
DR   Wikidata; Q110430970
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NME4 KO 2
AC   CVCL_B3CH
SY   Human NME4 knockout HEK-293T
DR   Abcam; ab267281
DR   Wikidata; Q110430971
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NME6 KO
AC   CVCL_B3CI
SY   Human NME6 knockout HEK-293T
DR   Abcam; ab267283
DR   Wikidata; Q110430972
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20567; NME6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NOL7 KO
AC   CVCL_B3CJ
SY   Human NOL7 knockout HEK-293T
DR   Abcam; ab266638
DR   Wikidata; Q110430973
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21040; NOL7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NONO KO
AC   CVCL_B3CK
SY   Human NONO (nmt55 / p54nrb) knockout HEK-293T
DR   Abcam; ab266244
DR   Wikidata; Q110430974
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7871; NONO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NOSIP KO
AC   CVCL_B3CL
SY   Human NOSIP knockout HEK-293T
DR   Abcam; ab266607
DR   Wikidata; Q110430975
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17946; NOSIP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NPC2 KO
AC   CVCL_B3CM
SY   Human NPC2 (Niemann Pick C2) knockout HEK-293T
DR   Abcam; ab266749
DR   Wikidata; Q110430976
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14537; NPC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NPM3 KO
AC   CVCL_B3CN
SY   Human NPM3 knockout HEK-293T
DR   Abcam; ab266751
DR   Wikidata; Q110430978
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7931; NPM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NPTN KO
AC   CVCL_B3CP
SY   Human NPTN knockout HEK-293T
DR   Abcam; ab266803
DR   Wikidata; Q110430979
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17867; NPTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NR2C2 KO
AC   CVCL_B3CQ
SY   Human NR2C2 (TR4) knockout HEK-293T
DR   Abcam; ab266228
DR   Wikidata; Q110430980
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7972; NR2C2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NRAS KO
AC   CVCL_B3CR
SY   Human NRAS knockout HEK-293T
DR   Abcam; ab266684
DR   Wikidata; Q110430981
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NRDC KO
AC   CVCL_B3CS
SY   Human NRD1 (Nardilysin) knockout HEK-293T
DR   Abcam; ab266385
DR   Wikidata; Q110430982
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7995; NRDC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NSD1 KO
AC   CVCL_B3CT
SY   Human NSD1 (KMT3B) knockout HEK-293T
DR   Abcam; ab266306
DR   Wikidata; Q110430983
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14234; NSD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NSDHL KO
AC   CVCL_B3CU
SY   Human NSDHL knockout HEK-293T
DR   Abcam; ab266682
DR   Wikidata; Q110430984
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13398; NSDHL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NSUN2 KO
AC   CVCL_B3CV
SY   Human NSUN2 (SAKI) knockout HEK-293T
DR   Abcam; ab266273
DR   Wikidata; Q110430985
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25994; NSUN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NT5C KO
AC   CVCL_B3CW
SY   Human NT5C knockout HEK-293T
DR   Abcam; ab266740
DR   Wikidata; Q110430986
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17144; NT5C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NTPCR KO
AC   CVCL_B3CX
SY   Human NTPCR (Nucleoside triphosphate phosphohydrolase) knockout HEK-293T
DR   Abcam; ab266397
DR   Wikidata; Q110430987
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28204; NTPCR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NUCKS1 KO
AC   CVCL_B3CY
SY   Human NUCKS1 knockout HEK-293T
DR   Abcam; ab266265
DR   Wikidata; Q110430988
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29923; NUCKS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NUDT1 KO
AC   CVCL_B3CZ
SY   Human NUDT1 (MTH1) knockout HEK-293T
DR   Abcam; ab266400
DR   Wikidata; Q110430989
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8048; NUDT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NUDT5 KO
AC   CVCL_B3D0
SY   Human NUDT5 knockout HEK-293T
DR   Abcam; ab266242
DR   Wikidata; Q110430990
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8052; NUDT5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T NUP210 KO
AC   CVCL_B3D1
SY   Human NUP210 (GP210) knockout HEK-293T
DR   Abcam; ab266492
DR   Wikidata; Q110430991
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30052; NUP210.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T OAZ1 KO
AC   CVCL_B3D2
SY   Human OAZ1 knockout HEK-293T
DR   Abcam; ab266377
DR   Wikidata; Q110430992
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8095; OAZ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T OCIAD1 KO
AC   CVCL_B3D3
SY   Human OCIAD1 knockout HEK-293T
DR   Abcam; ab266062
DR   Wikidata; Q110430993
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16074; OCIAD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T OSTC KO
AC   CVCL_B3D4
SY   Human OSTC knockout HEK-293T
DR   Abcam; ab266596
DR   Wikidata; Q110430994
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24448; OSTC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T OTUB1 KO
AC   CVCL_B3D5
SY   Human OTUB1 knockout HEK-293T
DR   Abcam; ab266551
DR   Wikidata; Q110430995
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23077; OTUB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T OXA1L KO
AC   CVCL_B3D6
SY   Human OXA1L knockout HEK-293T
DR   Abcam; ab266823
DR   Wikidata; Q110430996
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8526; OXA1L.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PACSIN3 KO
AC   CVCL_B3D7
SY   Human PACSIN3 knockout HEK-293T
DR   Abcam; ab266831
DR   Wikidata; Q110430997
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8572; PACSIN3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PAFAH1B3 KO
AC   CVCL_B3D8
SY   Human PAFAH1B3 knockout HEK-293T
DR   Abcam; ab266669
DR   Wikidata; Q110430998
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8576; PAFAH1B3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PAIP2 KO
AC   CVCL_B3D9
SY   Human PAIP2 knockout HEK-293T
DR   Abcam; ab266169
DR   Wikidata; Q110430999
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17970; PAIP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PAK4 KO
AC   CVCL_B3DA
SY   Human PAK4 knockout HEK-293T
DR   Abcam; ab266807
DR   Wikidata; Q110431001
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PANK4 KO
AC   CVCL_B3DB
SY   Human PANK4 (Pantothenate kinase 4) knockout HEK-293T
DR   Abcam; ab267311
DR   Wikidata; Q110431003
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19366; PANK4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PAPOLA KO
AC   CVCL_B3DC
SY   Human PAPOLA knockout HEK-293T
DR   Abcam; ab266621
DR   Wikidata; Q110431004
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14981; PAPOLA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PARK7 KO
AC   CVCL_B3DD
SY   Human PARK7 (DJ1) knockout HEK-293T
DR   Abcam; ab266338
DR   Wikidata; Q110431005
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PARL KO
AC   CVCL_B3DE
SY   Human PARL knockout HEK-293T
DR   Abcam; ab266608
DR   Wikidata; Q110431006
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18253; PARL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PARP1 KO
AC   CVCL_B3DF
SY   Human PARP1 knockout HEK-293T
DR   Abcam; ab266598
DR   Wikidata; Q110431007
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PARP2 KO
AC   CVCL_B3DG
SY   Human PARP2 knockout HEK-293T
DR   Abcam; ab266414
DR   Wikidata; Q110431008
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PBK KO
AC   CVCL_B3DH
SY   Human PBK (SPK) knockout HEK-293T
DR   Abcam; ab266827
DR   Wikidata; Q110431009
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PCBD1 KO
AC   CVCL_B3DI
SY   Human PCBD1 knockout HEK-293T
DR   Abcam; ab266261
DR   Wikidata; Q110431010
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8646; PCBD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PCCB KO
AC   CVCL_B3DJ
SY   Human PCCB knockout HEK-293T
DR   Abcam; ab266318
DR   Wikidata; Q110431011
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8654; PCCB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PCNP KO
AC   CVCL_B3DK
SY   Human PCNP knockout HEK-293T
DR   Abcam; ab266247
DR   Wikidata; Q110431012
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30023; PCNP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PCNT KO
AC   CVCL_B3DL
SY   Human PCNT (Pericentrin) knockout HEK-293T
DR   Abcam; ab266121
DR   Wikidata; Q110431013
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16068; PCNT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PDAP1 KO
AC   CVCL_B3DM
SY   Human PDAP1 knockout HEK-293T
DR   Abcam; ab266415
DR   Wikidata; Q110431014
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14634; PDAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PDCD6 KO
AC   CVCL_B3DN
SY   Human PDCD6 (ALG-2) knockout HEK-293T
DR   Abcam; ab266323
DR   Wikidata; Q110431015
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8765; PDCD6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PDXK KO
AC   CVCL_B3DP
SY   Human PDXK (PDXK.1) knockout HEK-293T
DR   Abcam; ab266440
DR   Wikidata; Q110431016
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8819; PDXK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PEA15 KO
AC   CVCL_B3DQ
SY   Human PEA15 knockout HEK-293T
DR   Abcam; ab266695
DR   Wikidata; Q110431017
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8822; PEA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PEX5 KO
AC   CVCL_B3DR
SY   Human PEX5 (PER3) knockout HEK-293T
DR   Abcam; ab266150
DR   Wikidata; Q110431019
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9719; PEX5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PHF23 KO
AC   CVCL_B3DS
SY   Human PHF23 knockout HEK-293T
DR   Abcam; ab266624
DR   Wikidata; Q110431020
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28428; PHF23.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PHKA1 KO
AC   CVCL_B3DT
SY   Human PHKA1 knockout HEK-293T
DR   Abcam; ab267337
DR   Wikidata; Q110431021
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8925; PHKA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PIGT KO
AC   CVCL_B3DU
SY   Human PIGT knockout HEK-293T
DR   Abcam; ab266183
DR   Wikidata; Q110431022
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14938; PIGT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PIK3R2 KO
AC   CVCL_B3DV
SY   Human PIK3R2 (PI 3 Kinase p85 beta) knockout HEK-293T
DR   Abcam; ab266799
DR   Wikidata; Q110431023
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PINK1 KO
AC   CVCL_B3DW
SY   Human PINK1 knockout HEK-293T
DR   Abcam; ab266393
DR   Wikidata; Q110431024
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PIP5K1A KO
AC   CVCL_B3DX
SY   Human PIP5K1A knockout HEK-293T
DR   Abcam; ab266426
DR   Wikidata; Q110431025
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PKN1 KO
AC   CVCL_B3DY
SY   Human PKN1 knockout HEK-293T
DR   Abcam; ab266599
DR   Wikidata; Q110431026
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PLCG1 KO
AC   CVCL_B3DZ
SY   Human PLCG1 (Phospholipase C gamma 1/PLC-gamma-1) knockout HEK-293T
DR   Abcam; ab266530
DR   Wikidata; Q110431027
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PLD3 KO
AC   CVCL_B3E0
SY   Human PLD3 knockout HEK-293T
DR   Abcam; ab266563
DR   Wikidata; Q110431028
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PLD6 KO
AC   CVCL_B3E1
SY   Human PLD6 knockout HEK-293T
DR   Abcam; ab266787
DR   Wikidata; Q110431030
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30447; PLD6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PLEKHJ1 KO
AC   CVCL_B3E2
SY   Human PLEKHJ1 (GNRPX) knockout HEK-293T
DR   Abcam; ab266645
DR   Wikidata; Q110431031
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18211; PLEKHJ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PLOD2 KO
AC   CVCL_B3E3
SY   Human PLOD2 (PLOD2/LH2) knockout HEK-293T
DR   Abcam; ab266279
DR   Wikidata; Q110431032
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9082; PLOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PLOD3 KO
AC   CVCL_B3E4
SY   Human PLOD3 knockout HEK-293T
DR   Abcam; ab266781
DR   Wikidata; Q110431033
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9083; PLOD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PLS3 KO
AC   CVCL_B3E5
SY   Human PLS3 (T Plastin/PLS3) knockout HEK-293T
DR   Abcam; ab266821
DR   Wikidata; Q110431034
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9091; PLS3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PNP KO
AC   CVCL_B3E6
SY   Human PNP (Nucleoside phosphorylase) knockout HEK-293T
DR   Abcam; ab266158
DR   Wikidata; Q110431035
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7892; PNP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T POLE3 KO
AC   CVCL_B3E7
SY   Human POLE3 (CHRAC-17) knockout HEK-293T
DR   Abcam; ab266096
DR   Wikidata; Q110431036
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13546; POLE3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T POMGNT1 KO
AC   CVCL_B3E8
SY   Human POMGNT1 knockout HEK-293T
DR   Abcam; ab266788
DR   Wikidata; Q110431037
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19139; POMGNT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T POMK KO
AC   CVCL_B3E9
SY   Human POMK knockout HEK-293T
DR   Abcam; ab267313
DR   Wikidata; Q110431038
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26267; POMK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T POP5 KO
AC   CVCL_B3EA
SY   Human POP5 knockout HEK-293T
DR   Abcam; ab266849
DR   Wikidata; Q110431039
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17689; POP5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T POU4F2 KO
AC   CVCL_B3EB
SY   Human POU4F2 (BRN3B) knockout HEK-293T
DR   Abcam; ab266542
DR   Wikidata; Q110431040
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9219; POU4F2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPHLN1 KO
AC   CVCL_B3EC
SY   Human PPHLN1 (Periphilin-1) knockout HEK-293T
DR   Abcam; ab266374
DR   Wikidata; Q110431041
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19369; PPHLN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPIF KO
AC   CVCL_B3ED
SY   Human PPIF (Cyclophilin F) knockout HEK-293T
DR   Abcam; ab266077
DR   Wikidata; Q110431043
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9259; PPIF.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPIH KO
AC   CVCL_B3EE
SY   Human PPIH knockout HEK-293T
DR   Abcam; ab266288
DR   Wikidata; Q110431044
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14651; PPIH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPM1B KO
AC   CVCL_B3EF
SY   Human PPM1B knockout HEK-293T
DR   Abcam; ab266310
DR   Wikidata; Q110431045
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9276; PPM1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPM1F KO
AC   CVCL_B3EG
SY   Human PPM1F (POPX2) knockout HEK-293T
DR   Abcam; ab266176
DR   Wikidata; Q110431046
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19388; PPM1F.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPM1G KO
AC   CVCL_B3EH
SY   Human PPM1G knockout HEK-293T
DR   Abcam; ab266162
DR   Wikidata; Q110431047
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9278; PPM1G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPP1R16A KO
AC   CVCL_B3EI
SY   Human PPP1R16A knockout HEK-293T
DR   Abcam; ab266203
DR   Wikidata; Q110431048
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14941; PPP1R16A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPP2R1B KO
AC   CVCL_B3EJ
SY   Human PPP2R1B knockout HEK-293T
DR   Abcam; ab266729
DR   Wikidata; Q110431049
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9303; PPP2R1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPP2R5C KO
AC   CVCL_B3EK
SY   Human PPP2R5C knockout HEK-293T
DR   Abcam; ab266204
DR   Wikidata; Q110431050
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9311; PPP2R5C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPP4R2 KO
AC   CVCL_B3EL
SY   Human PPP4R2 knockout HEK-293T
DR   Abcam; ab266206
DR   Wikidata; Q110431051
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18296; PPP4R2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPP5C KO
AC   CVCL_B3EM
SY   Human PPP5C (PP-T) knockout HEK-293T
DR   Abcam; ab266507
DR   Wikidata; Q110431052
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9322; PPP5C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PPP6R1 KO
AC   CVCL_B3EN
SY   Human PPP6R1 (SAPS1) knockout HEK-293T
DR   Abcam; ab266297
DR   Wikidata; Q110431054
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29195; PPP6R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PQBP1 KO
AC   CVCL_B3EP
SY   Human PQBP1 knockout HEK-293T
DR   Abcam; ab266767
DR   Wikidata; Q110431057
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9330; PQBP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRCC KO
AC   CVCL_B3EQ
SY   Human PRCC (Papillary renal cell carcinoma) knockout HEK-293T
DR   Abcam; ab266268
DR   Wikidata; Q110431058
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9343; PRCC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRDX1 KO
AC   CVCL_B3ER
SY   Human PRDX1 (Peroxiredoxin 1/PAG) knockout HEK-293T
DR   Abcam; ab266842
DR   Wikidata; Q110431060
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRDX2 KO
AC   CVCL_B3ES
SY   Human PRDX2 (Peroxiredoxin 2/PRP) knockout HEK-293T
DR   Abcam; ab266392
DR   Wikidata; Q110431061
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9353; PRDX2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRDX4 KO
AC   CVCL_B3ET
SY   Human PRDX4 (Peroxiredoxin 4) knockout HEK-293T
DR   Abcam; ab266727
DR   Wikidata; Q110431063
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17169; PRDX4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PREP KO
AC   CVCL_B3EU
SY   Human PREP (Prolyl Endopeptidase) knockout HEK-293T
DR   Abcam; ab266286
DR   Wikidata; Q110431064
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9358; PREP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRKCD KO
AC   CVCL_B3EV
SY   Human PRKCD (PKC delta) knockout HEK-293T
DR   Abcam; ab266143
DR   Wikidata; Q110431065
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9399; PRKCD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRKCSH KO
AC   CVCL_B3EW
SY   Human PRKCSH (Glucosidase 2 subunit beta) knockout HEK-293T
DR   Abcam; ab266770
DR   Wikidata; Q110431066
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9411; PRKCSH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRKCZ KO 1
AC   CVCL_B3EX
SY   Human PRKCZ (PKC zeta) knockout HEK-293T
DR   Abcam; ab265073
DR   Wikidata; Q110431067
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab265073; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T PRKCZ KO 2
AC   CVCL_B3EY
SY   Human PRKCZ (PKC zeta) knockout HEK-293T
DR   Abcam; ab266681
DR   Wikidata; Q110431069
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266681; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T PRKRA KO
AC   CVCL_B3EZ
SY   Human PRKRA (PACT) knockout HEK-293T
DR   Abcam; ab266806
DR   Wikidata; Q110431070
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9438; PRKRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRPF4B KO
AC   CVCL_B3F0
SY   Human PRPF4B knockout HEK-293T
DR   Abcam; ab267310
DR   Wikidata; Q110431072
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17346; PRPF4B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRPS1 KO
AC   CVCL_B3F1
SY   Human PRPS1 knockout HEK-293T
DR   Abcam; ab266418
DR   Wikidata; Q110431075
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9462; PRPS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PRRC2B KO
AC   CVCL_B3F2
SY   Human PRRC2B knockout HEK-293T
DR   Abcam; ab266837
DR   Wikidata; Q110431076
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28121; PRRC2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PSAT1 KO
AC   CVCL_B3F3
SY   Human PSAT1 (Phosphoserine Aminotransferase) knockout HEK-293T
DR   Abcam; ab266632
DR   Wikidata; Q110431078
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19129; PSAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PSIP1 KO
AC   CVCL_B3F4
SY   Human PSIP1 (LEDGF) knockout HEK-293T
DR   Abcam; ab266464
DR   Wikidata; Q110431079
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9527; PSIP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PSMD8 KO
AC   CVCL_B3F5
SY   Human PSMD8 knockout HEK-293T
DR   Abcam; ab266329
DR   Wikidata; Q110431080
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9566; PSMD8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PSME1 KO
AC   CVCL_B3F6
SY   Human PSME1 knockout HEK-293T
DR   Abcam; ab266192
DR   Wikidata; Q110431081
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9568; PSME1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PSME3 KO
AC   CVCL_B3F7
SY   Human PSME3 knockout HEK-293T
DR   Abcam; ab266379
DR   Wikidata; Q110431083
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9570; PSME3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PTDSS1 KO
AC   CVCL_B3F8
SY   Human PTDSS1 knockout HEK-293T
DR   Abcam; ab266068
DR   Wikidata; Q110431085
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9587; PTDSS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PTGES3 KO
AC   CVCL_B3F9
SY   Human PTGES3 (p23) knockout HEK-293T
DR   Abcam; ab266791
DR   Wikidata; Q110431086
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16049; PTGES3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PTK2 KO
AC   CVCL_B3FA
SY   Human PTK2 (FAK) knockout HEK-293T
DR   Abcam; ab255421
DR   Wikidata; Q110431087
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PTPN11 KO
AC   CVCL_B3FB
SY   Human PTPN11 (SHP2) knockout HEK-293T
DR   Abcam; ab266450
DR   Wikidata; Q110431088
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PTPRF KO
AC   CVCL_B3FC
SY   Human PTPRF (LAR) knockout HEK-293T
DR   Abcam; ab266585
DR   Wikidata; Q110431090
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9670; PTPRF.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PTRH2 KO
AC   CVCL_B3FD
SY   Human PTRH2 (BIT1) knockout HEK-293T
DR   Abcam; ab266715
DR   Wikidata; Q110431091
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24265; PTRH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266715; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T PTTG1 KO
AC   CVCL_B9W4
SY   Human PTTG1 (Securin) knockout HEK-293T
DR   Abcam; ab266231
DR   Wikidata; Q112928323
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9690; PTTG1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PUS1 KO
AC   CVCL_B3FE
SY   Human PUS1 knockout HEK-293T
DR   Abcam; ab266091
DR   Wikidata; Q110431092
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15508; PUS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PVR KO
AC   CVCL_B3FF
SY   Human PVR (Poliovirus Receptor) knockout HEK-293T
DR   Abcam; ab266102
DR   Wikidata; Q110431093
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PXK KO
AC   CVCL_B3FG
SY   Human PXK knockout HEK-293T
DR   Abcam; ab267241
DR   Wikidata; Q110431094
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23326; PXK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T PYM1 KO
AC   CVCL_B3FH
SY   Human WIBG (PYM) knockout HEK-293T
DR   Abcam; ab266709
DR   Wikidata; Q110431097
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30258; PYM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAB13 KO
AC   CVCL_B3FI
SY   Human RAB13 knockout HEK-293T
DR   Abcam; ab266843
DR   Wikidata; Q110431099
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9762; RAB13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAB14 KO
AC   CVCL_B3FJ
SY   Human RAB14 knockout HEK-293T
DR   Abcam; ab266583
DR   Wikidata; Q110431101
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16524; RAB14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAB1A KO
AC   CVCL_B3FK
SY   Human RAB1A knockout HEK-293T
DR   Abcam; ab266472
DR   Wikidata; Q110431102
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9758; RAB1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAB1B KO
AC   CVCL_B3FL
SY   Human RAB1B knockout HEK-293T
DR   Abcam; ab266502
DR   Wikidata; Q110431103
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18370; RAB1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAB2A KO
AC   CVCL_B3FM
SY   Human RAB2A (Rab2) knockout HEK-293T
DR   Abcam; ab266564
DR   Wikidata; Q110431104
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9763; RAB2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAB5IF KO
AC   CVCL_B3FN
SY   Human C20orf24 knockout HEK-293T
DR   Abcam; ab266292
DR   Wikidata; Q110431105
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15870; RAB5IF.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAB6A KO
AC   CVCL_B3FP
SY   Human RAB6A (Rab-6) knockout HEK-293T
DR   Abcam; ab266725
DR   Wikidata; Q110431106
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9786; RAB6A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RAD23A KO
AC   CVCL_B3FQ
SY   Human RAD23A (hHR23A) knockout HEK-293T
DR   Abcam; ab266343
DR   Wikidata; Q110431108
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9812; RAD23A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RANBP1 KO
AC   CVCL_B3FR
SY   Human RANBP1 knockout HEK-293T
DR   Abcam; ab266202
DR   Wikidata; Q110431109
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9847; RANBP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RBM3 KO
AC   CVCL_B3FS
SY   Human RBM3 knockout HEK-293T
DR   Abcam; ab266663
DR   Wikidata; Q110431110
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9900; RBM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RBM4 KO
AC   CVCL_B3FT
SY   Human RBM4 knockout HEK-293T
DR   Abcam; ab266639
DR   Wikidata; Q110431111
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9901; RBM4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RBM42 KO
AC   CVCL_B3FU
SY   Human RBM42 knockout HEK-293T
DR   Abcam; ab266800
DR   Wikidata; Q110431112
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28117; RBM42.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RCN1 KO
AC   CVCL_B3FV
SY   Human RCN1 (RCN) knockout HEK-293T
DR   Abcam; ab266098
DR   Wikidata; Q110431113
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9934; RCN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RCN2 KO
AC   CVCL_B3FW
SY   Human RCN2 knockout HEK-293T
DR   Abcam; ab266531
DR   Wikidata; Q110431114
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9935; RCN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T REPIN1 KO
AC   CVCL_B3FX
SY   Human REPIN1 (AP4) knockout HEK-293T
DR   Abcam; ab266363
DR   Wikidata; Q110431115
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17922; REPIN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T REXO2 KO
AC   CVCL_B3FY
SY   Human REXO2 knockout HEK-293T
DR   Abcam; ab266063
DR   Wikidata; Q110431116
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17851; REXO2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RFX5 KO
AC   CVCL_B3FZ
SY   Human RFX5 knockout HEK-293T
DR   Abcam; ab266211
DR   Wikidata; Q110431117
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9986; RFX5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RHOA KO
AC   CVCL_B3G0
SY   Human RHOA knockout HEK-293T
DR   Abcam; ab266592
DR   Wikidata; Q110431118
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:667; RHOA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RHOG KO
AC   CVCL_B3G1
SY   Human RHOG knockout HEK-293T
DR   Abcam; ab266753
DR   Wikidata; Q110431121
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:672; RHOG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RNASEH2A KO
AC   CVCL_B3G2
SY   Human RNASEH2A (Ribonuclease H2, subunit A) knockout HEK-293T
DR   Abcam; ab266702
DR   Wikidata; Q110431122
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18518; RNASEH2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RNF10 KO
AC   CVCL_B3G3
SY   Human RNF10 knockout HEK-293T
DR   Abcam; ab266802
DR   Wikidata; Q110431123
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10055; RNF10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RNF167 KO
AC   CVCL_B3G4
SY   Human RNF167 knockout HEK-293T
DR   Abcam; ab266335
DR   Wikidata; Q110431125
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24544; RNF167.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RNF181 KO
AC   CVCL_B3G5
SY   Human RNF181 (LOC51255) knockout HEK-293T
DR   Abcam; ab266357
DR   Wikidata; Q110431126
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28037; RNF181.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RPE KO
AC   CVCL_B3G6
SY   Human RPE knockout HEK-293T
DR   Abcam; ab266325
DR   Wikidata; Q110431128
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10293; RPE.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RPF1 KO
AC   CVCL_B3G7
SY   Human RPF1 knockout HEK-293T
DR   Abcam; ab266631
DR   Wikidata; Q110431129
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30350; RPF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RPL22 KO
AC   CVCL_B3G8
SY   Human RPL22 knockout HEK-293T
DR   Abcam; ab266612
DR   Wikidata; Q110431130
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10315; RPL22.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RPL36AL KO
AC   CVCL_B3G9
SY   Human RPL36AL knockout HEK-293T
DR   Abcam; ab266664
DR   Wikidata; Q110431131
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10346; RPL36AL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T RRAGA KO
AC   CVCL_B3GA
SY   Human RRAGA (Rag A) knockout HEK-293T
DR   Abcam; ab267321
DR   Wikidata; Q110431132
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16963; RRAGA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RRAGD KO
AC   CVCL_B3GB
SY   Human RRAGD (Rag D) knockout HEK-293T
DR   Abcam; ab266287
DR   Wikidata; Q110431133
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19903; RRAGD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RRAS2 KO
AC   CVCL_B3GC
SY   Human RRAS2 (TC21) knockout HEK-293T
DR   Abcam; ab266728
DR   Wikidata; Q110431135
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RTL8C KO
AC   CVCL_B3GD
SY   Human FAM127A (CXX1) knockout HEK-293T
DR   Abcam; ab266656
DR   Wikidata; Q110431137
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2569; RTL8C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T RTN3 KO
AC   CVCL_B3GE
SY   Human RTN3 (RTN3/HAP) knockout HEK-293T
DR   Abcam; ab266517
DR   Wikidata; Q110431138
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10469; RTN3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T S100A13 KO
AC   CVCL_B3GF
SY   Human S100A13 (S100 Calcium Binding Protein A13) knockout HEK-293T
DR   Abcam; ab266065
DR   Wikidata; Q110431139
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10490; S100A13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SARNP KO
AC   CVCL_B3GG
SY   Human SARNP (CIP29) knockout HEK-293T
DR   Abcam; ab266465
DR   Wikidata; Q110431140
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24432; SARNP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SCARB1 KO
AC   CVCL_B9W5
SY   Human SCARB1 knockout HEK-293T
DR   Abcam; ab282646
DR   Wikidata; Q112928324
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1664; SCARB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SCO1 KO
AC   CVCL_B3GH
SY   Human SCO1 knockout HEK-293T
DR   Abcam; ab266104
DR   Wikidata; Q110431142
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10603; SCO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SCYL1 KO
AC   CVCL_B3GI
SY   Human SCYL1 knockout HEK-293T
DR   Abcam; ab266768
DR   Wikidata; Q110431143
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14372; SCYL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SDF2L1 KO
AC   CVCL_B3GJ
SY   Human SDF2L1 knockout HEK-293T
DR   Abcam; ab266270
DR   Wikidata; Q110431144
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10676; SDF2L1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SDF4 KO
AC   CVCL_B3GK
SY   Human SDF4 knockout HEK-293T
DR   Abcam; ab266671
DR   Wikidata; Q110431145
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24188; SDF4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SDHD KO
AC   CVCL_B3GL
SY   Human SDHD knockout HEK-293T
DR   Abcam; ab266491
DR   Wikidata; Q110431146
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10683; SDHD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SEC11A KO
AC   CVCL_B3GM
SY   Human SEC11A (SPC18) knockout HEK-293T
DR   Abcam; ab266575
DR   Wikidata; Q110431148
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17718; SEC11A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SEC13 KO
AC   CVCL_B3GN
SY   Human SEC13 (SEC13L1) knockout HEK-293T
DR   Abcam; ab267319
DR   Wikidata; Q110431149
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10697; SEC13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SEC61B KO
AC   CVCL_B3GP
SY   Human SEC61B knockout HEK-293T
DR   Abcam; ab266816
DR   Wikidata; Q110431151
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16993; SEC61B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SEC61G KO
AC   CVCL_B3GQ
SY   Human SEC61G knockout HEK-293T
DR   Abcam; ab266181
DR   Wikidata; Q110431152
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18277; SEC61G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SELENOH KO
AC   CVCL_B3GR
SY   Human C11orf31 knockout HEK-293T
DR   Abcam; ab266070
DR   Wikidata; Q110431154
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18251; SELENOH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SEPHS1 KO
AC   CVCL_B3GS
SY   Human SEPHS1 (Selenophosphate synthetase 1) knockout HEK-293T
DR   Abcam; ab266115
DR   Wikidata; Q110431155
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19685; SEPHS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SERBP1 KO
AC   CVCL_B3GT
SY   Human SERBP1 knockout HEK-293T
DR   Abcam; ab266290
DR   Wikidata; Q110431157
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17860; SERBP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SERP1 KO
AC   CVCL_B3GU
SY   Human SERP1 knockout HEK-293T
DR   Abcam; ab266556
DR   Wikidata; Q110431158
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10759; SERP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SETD2 KO
AC   CVCL_B3GV
SY   Human SETD2 (KMT3A / HYPB / HIF-1) knockout HEK-293T
DR   Abcam; ab266690
DR   Wikidata; Q110431160
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SGTA KO
AC   CVCL_B3GW
SY   Human SGTA knockout HEK-293T
DR   Abcam; ab266809
DR   Wikidata; Q110431162
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10819; SGTA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SH2B2 KO
AC   CVCL_B3GX
SY   Human SH2B2 (APS) knockout HEK-293T
DR   Abcam; ab266136
DR   Wikidata; Q110431163
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17381; SH2B2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SH3BGRL3 KO
AC   CVCL_B3GY
SY   Human SH3BGRL3 knockout HEK-293T
DR   Abcam; ab266822
DR   Wikidata; Q110431164
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15568; SH3BGRL3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SH3GL1 KO
AC   CVCL_B3GZ
SY   Human SH3GL1 (EEN) knockout HEK-293T
DR   Abcam; ab266260
DR   Wikidata; Q110431165
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10830; SH3GL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SHPK KO
AC   CVCL_B3H0
SY   Human SHPK (SHK) knockout HEK-293T
DR   Abcam; ab267257
DR   Wikidata; Q110431166
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1492; SHPK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SIGMAR1 KO
AC   CVCL_B0XT
SY   Human SIGMAR1 (Sigma1-receptor) knockout HEK-293T
DR   Abcam; ab266619
DR   Wikidata; Q110431167
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SIVA1 KO
AC   CVCL_B3H1
SY   Human SIVA1 (SIVA) knockout HEK-293T
DR   Abcam; ab266675
DR   Wikidata; Q110431168
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17712; SIVA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC19A1 KO
AC   CVCL_B3H2
SY   Human SLC19A1 (RFC) knockout HEK-293T
DR   Abcam; ab266453
DR   Wikidata; Q110431169
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10937; SLC19A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A10 KO
AC   CVCL_B3H3
SY   Human SLC25A10 (Mitochondrial dicarboxylate carrier) knockout HEK-293T
DR   Abcam; ab266122
DR   Wikidata; Q110431170
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10980; SLC25A10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A15 KO
AC   CVCL_B3H4
SY   Human SLC25A15 knockout HEK-293T
DR   Abcam; ab266773
DR   Wikidata; Q110431171
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10985; SLC25A15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A22 KO
AC   CVCL_B3H5
SY   Human SLC25A22 (GC-1) knockout HEK-293T
DR   Abcam; ab266327
DR   Wikidata; Q110431173
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19954; SLC25A22.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A23 KO
AC   CVCL_B3H6
SY   Human SLC25A23 knockout HEK-293T
DR   Abcam; ab266196
DR   Wikidata; Q110431174
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19375; SLC25A23.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A32 KO
AC   CVCL_B3H7
SY   Human SLC25A32 knockout HEK-293T
DR   Abcam; ab266330
DR   Wikidata; Q110431175
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29683; SLC25A32.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A38 KO
AC   CVCL_B3H8
SY   Human SLC25A38 knockout HEK-293T
DR   Abcam; ab266194
DR   Wikidata; Q110431176
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26054; SLC25A38.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A39 KO
AC   CVCL_B3H9
SY   Human SLC25A39 knockout HEK-293T
DR   Abcam; ab266221
DR   Wikidata; Q110431177
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24279; SLC25A39.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A40 KO
AC   CVCL_B3HA
SY   Human SLC25A40 knockout HEK-293T
DR   Abcam; ab267327
DR   Wikidata; Q110431178
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC25A46 KO
AC   CVCL_B3HB
SY   Human SLC25A46 (TB1) knockout HEK-293T
DR   Abcam; ab266408
DR   Wikidata; Q110431179
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25198; SLC25A46.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC27A4 KO
AC   CVCL_B3HC
SY   Human SLC27A4 (FATP4) knockout HEK-293T
DR   Abcam; ab266114
DR   Wikidata; Q110431181
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10998; SLC27A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC30A5 KO
AC   CVCL_B3HD
SY   Human SLC30A5 knockout HEK-293T
DR   Abcam; ab266840
DR   Wikidata; Q110431182
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19089; SLC30A5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC35A4 KO
AC   CVCL_B3HE
SY   Human SLC35A4 knockout HEK-293T
DR   Abcam; ab266541
DR   Wikidata; Q110431183
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20753; SLC35A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC35F2 KO
AC   CVCL_B3HF
SY   Human SLC35F2 knockout HEK-293T
DR   Abcam; ab266190
DR   Wikidata; Q110431184
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23615; SLC35F2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC38A10 KO
AC   CVCL_B3HG
SY   Human SLC38A10 knockout HEK-293T
DR   Abcam; ab266269
DR   Wikidata; Q110431185
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28237; SLC38A10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC39A14 KO
AC   CVCL_B3HH
SY   Human SLC39A14 (ZIP-14) knockout HEK-293T
DR   Abcam; ab266126
DR   Wikidata; Q110431186
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20858; SLC39A14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC41A3 KO
AC   CVCL_B3HI
SY   Human SLC41A3 knockout HEK-293T
DR   Abcam; ab267256
DR   Wikidata; Q110431187
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31046; SLC41A3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC5A6 KO
AC   CVCL_B3HJ
SY   Human SLC5A6 knockout HEK-293T
DR   Abcam; ab266804
DR   Wikidata; Q110431188
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11041; SLC5A6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC7A1 KO
AC   CVCL_B3HK
SY   Human SLC7A1 (CAT1) knockout HEK-293T
DR   Abcam; ab266234
DR   Wikidata; Q110431190
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11057; SLC7A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SLC9A3R2 KO
AC   CVCL_B3HL
SY   Human SLC9A3R2 (NHERF-2/SIP-1) knockout HEK-293T
DR   Abcam; ab266778
DR   Wikidata; Q110431191
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11076; NHERF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T SLX9 KO
AC   CVCL_B3HM
SY   Human FAM207A (C21orf70) knockout HEK-293T
DR   Abcam; ab266462
DR   Wikidata; Q110431193
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15811; SLX9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SMAD9 KO
AC   CVCL_B3HN
SY   Human SMAD9 knockout HEK-293T
DR   Abcam; ab266326
DR   Wikidata; Q110431195
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6774; SMAD9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SMARCA4 KO
AC   CVCL_B3HP
SY   Human SMARCA4 (BRG1) knockout HEK-293T
DR   Abcam; ab255432
DR   Wikidata; Q110431196
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SMARCB1 KO
AC   CVCL_B3HQ
SY   Human SMARCB1 (SNF5) knockout HEK-293T
DR   Abcam; ab267269
DR   Wikidata; Q110431197
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11103; SMARCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SMARCD1 KO
AC   CVCL_B3HR
SY   Human SMARCD1 knockout HEK-293T
DR   Abcam; ab266458
DR   Wikidata; Q110431199
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11106; SMARCD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SMO KO
AC   CVCL_B3HS
SY   Human SMO (Smoothened) knockout HEK-293T
DR   Abcam; ab266423
DR   Wikidata; Q110431200
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SNCA KO
AC   CVCL_B3HT
SY   Human SNCA (Alpha-synuclein) knockout HEK-293T
DR   Abcam; ab255433
DR   Wikidata; Q110431201
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SNRNP40 KO
AC   CVCL_B3HU
SY   Human SNRNP40 knockout HEK-293T
DR   Abcam; ab266207
DR   Wikidata; Q110431202
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30857; SNRNP40.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SNX3 KO
AC   CVCL_B3HV
SY   Human SNX3 knockout HEK-293T
DR   Abcam; ab266164
DR   Wikidata; Q110431203
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11174; SNX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266164; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T SOD2 KO
AC   CVCL_B3HW
SY   Human SOD2 (MnSOD) knockout HEK-293T
DR   Abcam; ab255434
DR   Wikidata; Q110431204
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11180; SOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SORBS3 KO
AC   CVCL_B3HX
SY   Human SORBS3 (Vinexin) knockout HEK-293T
DR   Abcam; ab266454
DR   Wikidata; Q110431206
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30907; SORBS3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SPAG5 KO
AC   CVCL_B3HY
SY   Human SPAG5 (Astrin/Deepest) knockout HEK-293T
DR   Abcam; ab266536
DR   Wikidata; Q110431208
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13452; SPAG5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SPAG7 KO
AC   CVCL_B3HZ
SY   Human SPAG7 knockout HEK-293T
DR   Abcam; ab266775
DR   Wikidata; Q110431209
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11216; SPAG7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SPAST KO
AC   CVCL_B3I0
SY   Human SPAST (Spastin) knockout HEK-293T
DR   Abcam; ab267238
DR   Wikidata; Q110431211
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SPCS1 KO
AC   CVCL_B3I1
SY   Human SPCS1 knockout HEK-293T
DR   Abcam; ab266405
DR   Wikidata; Q110431212
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23401; SPCS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SPHK2 KO
AC   CVCL_B3I2
SY   Human SPHK2 knockout HEK-293T
DR   Abcam; ab267293
DR   Wikidata; Q110431213
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SQSTM1 KO
AC   CVCL_B3I3
SY   Human SQSTM1 (p62) knockout HEK-293T
DR   Abcam; ab255343
DR   Wikidata; Q110431214
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SRP14 KO
AC   CVCL_B3I4
SY   Human SRP14 knockout HEK-293T
DR   Abcam; ab266431
DR   Wikidata; Q110431216
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11299; SRP14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SRP68 KO
AC   CVCL_B3I5
SY   Human SRP68 knockout HEK-293T
DR   Abcam; ab266745
DR   Wikidata; Q110431217
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11302; SRP68.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SRP9 KO
AC   CVCL_B3I6
SY   Human SRP9 knockout HEK-293T
DR   Abcam; ab266613
DR   Wikidata; Q110431218
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11304; SRP9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SRSF10 KO
AC   CVCL_B3I7
SY   Human SRSF10 knockout HEK-293T
DR   Abcam; ab266756
DR   Wikidata; Q110431219
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16713; SRSF10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SRSF5 KO
AC   CVCL_B3I8
SY   Human SRSF5 knockout HEK-293T
DR   Abcam; ab266246
DR   Wikidata; Q110431220
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10787; SRSF5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SRSF6 KO
AC   CVCL_B3I9
SY   Human SRSF6 (SR protein repeat) knockout HEK-293T
DR   Abcam; ab266529
DR   Wikidata; Q110431221
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10788; SRSF6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SSBP4 KO
AC   CVCL_B3IA
SY   Human SSBP4 knockout HEK-293T
DR   Abcam; ab266079
DR   Wikidata; Q110431222
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15676; SSBP4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SSNA1 KO
AC   CVCL_B3IB
SY   Human SSNA1 knockout HEK-293T
DR   Abcam; ab266409
DR   Wikidata; Q110431223
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11321; SSNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SSR4 KO
AC   CVCL_B3IC
SY   Human SSR4 knockout HEK-293T
DR   Abcam; ab266736
DR   Wikidata; Q110431225
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11326; SSR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STAM KO
AC   CVCL_B3ID
SY   Human STAM (STAM1) knockout HEK-293T
DR   Abcam; ab267325
DR   Wikidata; Q110431226
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11357; STAM.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STK11 KO
AC   CVCL_B3IE
SY   Human STK11 (LKB1) knockout HEK-293T
DR   Abcam; ab266647
DR   Wikidata; Q110431228
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STK16 KO
AC   CVCL_B3IF
SY   Human STK16 knockout HEK-293T
DR   Abcam; ab267339
DR   Wikidata; Q110431229
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11394; STK16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STK35 KO
AC   CVCL_B3IG
SY   Human STK35 knockout HEK-293T
DR   Abcam; ab267285
DR   Wikidata; Q110431231
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16254; STK35.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STRADB KO
AC   CVCL_B3IH
SY   Human STRADB (ALS2CR2) knockout HEK-293T
DR   Abcam; ab266138
DR   Wikidata; Q110431233
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13205; STRADB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STRAP KO
AC   CVCL_B3II
SY   Human STRAP (Unrip) knockout HEK-293T
DR   Abcam; ab266578
DR   Wikidata; Q110431234
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30796; STRAP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STT3A KO
AC   CVCL_B3IJ
SY   Human STT3A knockout HEK-293T
DR   Abcam; ab266320
DR   Wikidata; Q110431236
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6172; STT3A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STT3B KO
AC   CVCL_B3IK
SY   Human STT3B knockout HEK-293T
DR   Abcam; ab266461
DR   Wikidata; Q110431237
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30611; STT3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T STX10 KO
AC   CVCL_B3IL
SY   Human STX10 knockout HEK-293T
DR   Abcam; ab266829
DR   Wikidata; Q110431239
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11428; STX10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SUCLG1 KO
AC   CVCL_B3IM
SY   Human SUCLG1 knockout HEK-293T
DR   Abcam; ab266797
DR   Wikidata; Q110431240
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11449; SUCLG1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SUCLG2 KO
AC   CVCL_B3IN
SY   Human SUCLG2 knockout HEK-293T
DR   Abcam; ab266677
DR   Wikidata; Q110431241
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11450; SUCLG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SUFU KO
AC   CVCL_B3IP
SY   Human SUFU knockout HEK-293T
DR   Abcam; ab267282
DR   Wikidata; Q110431242
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SUPT20H KO
AC   CVCL_B3IQ
SY   Human SUPT20H (p38IP) knockout HEK-293T
DR   Abcam; ab266094
DR   Wikidata; Q110431243
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20596; SUPT20H.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SURF4 KO
AC   CVCL_B3IR
SY   Human SURF4 knockout HEK-293T
DR   Abcam; ab266463
DR   Wikidata; Q110431244
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11476; SURF4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SYAP1 KO
AC   CVCL_B3IS
SY   Human SYAP1 knockout HEK-293T
DR   Abcam; ab266159
DR   Wikidata; Q110431246
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16273; SYAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SYK KO
AC   CVCL_B9W6
SY   Human SYK knockout HEK-293T
DR   Abcam; ab282649
DR   Wikidata; Q112928325
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SYNGR2 KO
AC   CVCL_B3IT
SY   Human SYNGR2 (Synaptogyrin 2) knockout HEK-293T
DR   Abcam; ab266072
DR   Wikidata; Q110431247
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11499; SYNGR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SYP KO 1
AC   CVCL_B3IU
SY   Human SYP (Synaptophysin) knockout HEK-293T
DR   Abcam; ab255356
DR   Wikidata; Q110431248
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11506; SYP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T SYP KO 2
AC   CVCL_B3IV
SY   Human SYP (Synaptophysin) knockout HEK-293T
DR   Abcam; ab267272
DR   Wikidata; Q110431249
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11506; SYP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TAB1 KO
AC   CVCL_B3IW
SY   Human TAB1 knockout HEK-293T
DR   Abcam; ab266845
DR   Wikidata; Q110431251
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TACC1 KO
AC   CVCL_B3IX
SY   Human TACC1 knockout HEK-293T
DR   Abcam; ab266266
DR   Wikidata; Q110431252
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11522; TACC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TACC3 KO
AC   CVCL_B3IY
SY   Human TACC3 knockout HEK-293T
DR   Abcam; ab266316
DR   Wikidata; Q110431254
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11524; TACC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TAGLN2 KO
AC   CVCL_B3IZ
SY   Human TAGLN2 knockout HEK-293T
DR   Abcam; ab266615
DR   Wikidata; Q110431255
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11554; TAGLN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TALDO1 KO
AC   CVCL_B3J0
SY   Human TALDO1 (Transaldolase 1) knockout HEK-293T
DR   Abcam; ab266100
DR   Wikidata; Q110431257
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11559; TALDO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TAOK2 KO
AC   CVCL_B3J1
SY   Human TAOK2 knockout HEK-293T
DR   Abcam; ab266382
DR   Wikidata; Q110431259
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16835; TAOK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TAX1BP1 KO
AC   CVCL_B3J2
SY   Human TAX1BP1 (TRAF6BP) knockout HEK-293T
DR   Abcam; ab266124
DR   Wikidata; Q110431260
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TBRG4 KO
AC   CVCL_B3J3
SY   Human TBRG4 knockout HEK-293T
DR   Abcam; ab266644
DR   Wikidata; Q110431262
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17443; TBRG4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TCEAL9 KO
AC   CVCL_B3J4
SY   Human WBP5 knockout HEK-293T
DR   Abcam; ab266711
DR   Wikidata; Q110431264
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30084; TCEAL9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TEAD4 KO
AC   CVCL_B3J5
SY   Human TEAD4 knockout HEK-293T
DR   Abcam; ab266185
DR   Wikidata; Q110431266
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11717; TEAD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TECR KO
AC   CVCL_B3J6
SY   Human TECR (GPSN2) knockout HEK-293T
DR   Abcam; ab266276
DR   Wikidata; Q110431267
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4551; TECR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TFDP2 KO
AC   CVCL_B3J7
SY   Human TFDP2 (DP2) knockout HEK-293T
DR   Abcam; ab267291
DR   Wikidata; Q110431269
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11751; TFDP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TIMM17A KO
AC   CVCL_B3J8
SY   Human TIMM17A (TIM17) knockout HEK-293T
DR   Abcam; ab266305
DR   Wikidata; Q110431270
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17315; TIMM17A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TIMM17B KO
AC   CVCL_B3J9
SY   Human TIMM17B knockout HEK-293T
DR   Abcam; ab266566
DR   Wikidata; Q110431272
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17310; TIMM17B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TIPRL KO
AC   CVCL_B3JA
SY   Human TIPRL knockout HEK-293T
DR   Abcam; ab266752
DR   Wikidata; Q110431273
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30231; TIPRL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TK1 KO
AC   CVCL_B3JB
SY   Human TK1 (Thymidine Kinase 1) knockout HEK-293T
DR   Abcam; ab266230
DR   Wikidata; Q110431274
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11830; TK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TLE1 KO
AC   CVCL_B3JC
SY   Human TLE1 knockout HEK-293T
DR   Abcam; ab265059
DR   Wikidata; Q110431275
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMED10 KO
AC   CVCL_B3JD
SY   Human TMED10 (TMP21) knockout HEK-293T
DR   Abcam; ab266227
DR   Wikidata; Q110431276
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16998; TMED10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMED4 KO
AC   CVCL_B3JE
SY   Human TMED4 knockout HEK-293T
DR   Abcam; ab266576
DR   Wikidata; Q110431278
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22301; TMED4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMED9 KO
AC   CVCL_B3JF
SY   Human TMED9 knockout HEK-293T
DR   Abcam; ab266080
DR   Wikidata; Q110431279
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24878; TMED9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM106C KO
AC   CVCL_B3JG
SY   Human TMEM106C knockout HEK-293T
DR   Abcam; ab266488
DR   Wikidata; Q110431280
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28775; TMEM106C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM126B KO
AC   CVCL_B3JH
SY   Human TMEM126B knockout HEK-293T
DR   Abcam; ab266199
DR   Wikidata; Q110431281
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30883; TMEM126B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM147 KO
AC   CVCL_B3JI
SY   Human TMEM147 knockout HEK-293T
DR   Abcam; ab266258
DR   Wikidata; Q110431282
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30414; TMEM147.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM14B KO
AC   CVCL_B3JJ
SY   Human TMEM14B knockout HEK-293T
DR   Abcam; ab266283
DR   Wikidata; Q110431283
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21384; TMEM14B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM160 KO
AC   CVCL_B3JK
SY   Human TMEM160 knockout HEK-293T
DR   Abcam; ab266090
DR   Wikidata; Q110431284
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26042; TMEM160.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM165 KO
AC   CVCL_B3JL
SY   Human TMEM165 knockout HEK-293T
DR   Abcam; ab266572
DR   Wikidata; Q110431286
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30760; TMEM165.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM208 KO
AC   CVCL_B3JM
SY   Human TMEM208 knockout HEK-293T
DR   Abcam; ab266633
DR   Wikidata; Q110431288
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25015; TMEM208.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM259 KO
AC   CVCL_B3JN
SY   Human TMEM259 (Membralin) knockout HEK-293T
DR   Abcam; ab266813
DR   Wikidata; Q110431290
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17039; TMEM259.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM59 KO
AC   CVCL_B3JP
SY   Human TMEM59 knockout HEK-293T
DR   Abcam; ab266468
DR   Wikidata; Q110431291
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1239; TMEM59.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMEM97 KO
AC   CVCL_B3JQ
SY   Human TMEM97 knockout HEK-293T
DR   Abcam; ab266499
DR   Wikidata; Q110431293
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28106; TMEM97.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMSB10 KO
AC   CVCL_B3JR
SY   Human TMSB10 (Thymosin beta 10) knockout HEK-293T
DR   Abcam; ab266706
DR   Wikidata; Q110431294
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11879; TMSB10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TMSB4X KO
AC   CVCL_B3JS
SY   Human TMSB4X (Thymosin beta 4) knockout HEK-293T
DR   Abcam; ab266490
DR   Wikidata; Q110431295
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11881; TMSB4X.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TOMM6 KO
AC   CVCL_B3JT
SY   Human TOMM6 (TOM6) knockout HEK-293T
DR   Abcam; ab266110
DR   Wikidata; Q110431296
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34528; TOMM6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TOMM7 KO
AC   CVCL_B3JU
SY   Human TOMM7 (TOM7) knockout HEK-293T
DR   Abcam; ab266073
DR   Wikidata; Q110431297
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21648; TOMM7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TOP1MT KO
AC   CVCL_B3JV
SY   Human TOP1MT knockout HEK-293T
DR   Abcam; ab266525
DR   Wikidata; Q110431298
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29787; TOP1MT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TOP2B KO
AC   CVCL_B3JW
SY   Human TOP2B (Topoisomerase II beta) knockout HEK-293T
DR   Abcam; ab266340
DR   Wikidata; Q110431299
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11990; TOP2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TP53INP2 KO
AC   CVCL_B3JX
SY   Human TP53INP2 knockout HEK-293T
DR   Abcam; ab266474
DR   Wikidata; Q110431301
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16104; TP53INP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TPM3 KO
AC   CVCL_B3JY
SY   Human TPM3 (Tropomyosin 3) knockout HEK-293T
DR   Abcam; ab266422
DR   Wikidata; Q110431302
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12012; TPM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TPM4 KO
AC   CVCL_B3JZ
SY   Human TPM4 knockout HEK-293T
DR   Abcam; ab266606
DR   Wikidata; Q110431304
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12013; TPM4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRABD KO
AC   CVCL_B3K0
SY   Human TRABD (TraB domain containing) knockout HEK-293T
DR   Abcam; ab266476
DR   Wikidata; Q110431305
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28805; TRABD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRAF2 KO
AC   CVCL_B3K1
SY   Human TRAF2 knockout HEK-293T
DR   Abcam; ab266060
DR   Wikidata; Q110431306
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRAPPC2L KO
AC   CVCL_B3K2
SY   Human TRAPPC2L knockout HEK-293T
DR   Abcam; ab266365
DR   Wikidata; Q110431307
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30887; TRAPPC2L.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRIO KO
AC   CVCL_B3K3
SY   Human TRIO knockout HEK-293T
DR   Abcam; ab267298
DR   Wikidata; Q110431308
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12303; TRIO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRIP10 KO
AC   CVCL_B3K4
SY   Human TRIP10 (Cip4) knockout HEK-293T
DR   Abcam; ab266428
DR   Wikidata; Q110431309
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12304; TRIP10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRIP13 KO 1
AC   CVCL_B3K5
SY   Human TRIP13 (PCH2) knockout HEK-293T
DR   Abcam; ab266495
DR   Wikidata; Q110431310
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12307; TRIP13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRIP13 KO 2
AC   CVCL_B3K6
SY   Human TRIP13 (PCH2) knockout HEK-293T
DR   Abcam; ab266496
DR   Wikidata; Q110431311
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12307; TRIP13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TRMT1 KO
AC   CVCL_B3K7
SY   Human TRMT1 (TRM1) knockout HEK-293T
DR   Abcam; ab266705
DR   Wikidata; Q110431312
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25980; TRMT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TROAP KO
AC   CVCL_B3K8
SY   Human TROAP knockout HEK-293T
DR   Abcam; ab266779
DR   Wikidata; Q110431313
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12327; TROAP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TTLL12 KO
AC   CVCL_B3K9
SY   Human TTLL12 knockout HEK-293T
DR   Abcam; ab266737
DR   Wikidata; Q110431314
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28974; TTLL12.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TUBB2A KO
AC   CVCL_B3KA
SY   Human TUBB2A knockout HEK-293T
DR   Abcam; ab266692
DR   Wikidata; Q110431316
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12412; TUBB2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TUBB4B KO
AC   CVCL_B3KB
SY   Human TUBB4B knockout HEK-293T
DR   Abcam; ab266087
DR   Wikidata; Q110431317
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20771; TUBB4B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TWF2 KO
AC   CVCL_B3KC
SY   Human TWF2 knockout HEK-293T
DR   Abcam; ab266334
DR   Wikidata; Q110431318
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9621; TWF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TXNDC5 KO
AC   CVCL_B3KD
SY   Human TXNDC5 knockout HEK-293T
DR   Abcam; ab266609
DR   Wikidata; Q110431319
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21073; TXNDC5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TXNL1 KO
AC   CVCL_B3KE
SY   Human TXNL1 knockout HEK-293T
DR   Abcam; ab266413
DR   Wikidata; Q110431320
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12436; TXNL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TXNRD2 KO
AC   CVCL_B3KF
SY   Human TXNRD2 knockout HEK-293T
DR   Abcam; ab267267
DR   Wikidata; Q110431321
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18155; TXNRD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TXNRD3 KO
AC   CVCL_B3KG
SY   Human TXNRD3 knockout HEK-293T
DR   Abcam; ab267273
DR   Wikidata; Q110431323
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20667; TXNRD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T TYK2 KO
AC   CVCL_B3KH
SY   Human TYK2 knockout HEK-293T
DR   Abcam; ab266730
DR   Wikidata; Q110431324
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UBE2A KO
AC   CVCL_B3KI
SY   Human UBE2A knockout HEK-293T
DR   Abcam; ab266322
DR   Wikidata; Q110431326
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12472; UBE2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UBE2E1 KO
AC   CVCL_B3KJ
SY   Human UBE2E1 (UBCH6) knockout HEK-293T
DR   Abcam; ab266346
DR   Wikidata; Q110431328
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12477; UBE2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UBE2G1 KO
AC   CVCL_B3KK
SY   Human UBE2G1 knockout HEK-293T
DR   Abcam; ab267232
DR   Wikidata; Q110431329
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12482; UBE2G1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UBE2J2 KO
AC   CVCL_B3KL
SY   Human UBE2J2 knockout HEK-293T
DR   Abcam; ab266264
DR   Wikidata; Q110431331
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19268; UBE2J2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UBE2S KO
AC   CVCL_B3KM
SY   Human UBE2S knockout HEK-293T
DR   Abcam; ab266375
DR   Wikidata; Q110431332
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17895; UBE2S.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UBXN1 KO
AC   CVCL_B3KN
SY   Human UBXN1 knockout HEK-293T
DR   Abcam; ab266197
DR   Wikidata; Q110431334
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18402; UBXN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UBXN6 KO
AC   CVCL_B3KP
SY   Human UBXN6 (UBXD1) knockout HEK-293T
DR   Abcam; ab266689
DR   Wikidata; Q110431335
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14928; UBXN6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UCHL1 KO
AC   CVCL_B3KQ
SY   Human UCHL1 (PGP9.5) knockout HEK-293T
DR   Abcam; ab255443
DR   Wikidata; Q110431336
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12513; UCHL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UCK1 KO
AC   CVCL_B3KR
SY   Human UCK1 (UCK) knockout HEK-293T
DR   Abcam; ab267262
DR   Wikidata; Q110431339
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14859; UCK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UFC1 KO
AC   CVCL_B3KS
SY   Human UFC1 knockout HEK-293T
DR   Abcam; ab266814
DR   Wikidata; Q110431341
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26941; UFC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UFL1 KO
AC   CVCL_B3KT
SY   Human UFL1 knockout HEK-293T
DR   Abcam; ab266500
DR   Wikidata; Q110431343
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23039; UFL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UFM1 KO
AC   CVCL_B3KU
SY   Human UFM1 knockout HEK-293T
DR   Abcam; ab266782
DR   Wikidata; Q110431344
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20597; UFM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UFSP2 KO
AC   CVCL_B3KV
SY   Human UFSP2 knockout HEK-293T
DR   Abcam; ab266368
DR   Wikidata; Q110431345
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25640; UFSP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ULK3 KO
AC   CVCL_B3KW
SY   Human ULK3 knockout HEK-293T
DR   Abcam; ab266152
DR   Wikidata; Q110431346
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19703; ULK3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UQCC2 KO
AC   CVCL_B3KX
SY   Human UQCC2 (MNF1) knockout HEK-293T
DR   Abcam; ab266685
DR   Wikidata; Q110431347
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21237; UQCC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UQCRQ KO
AC   CVCL_B3KY
SY   Human UQCRQ knockout HEK-293T
DR   Abcam; ab267244
DR   Wikidata; Q110431348
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29594; UQCRQ.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T USP16 KO
AC   CVCL_B3KZ
SY   Human USP16 knockout HEK-293T
DR   Abcam; ab266214
DR   Wikidata; Q110431349
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T USP24 KO
AC   CVCL_B3L0
SY   Human USP24 knockout HEK-293T
DR   Abcam; ab266643
DR   Wikidata; Q110431351
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12623; USP24.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Abcam; ab266643; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HEK293T USP33 KO
AC   CVCL_B3L1
SY   Human USP33 knockout HEK-293T
DR   Abcam; ab266103
DR   Wikidata; Q110431353
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20059; USP33.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T USP7 KO
AC   CVCL_B3L2
SY   Human USP7 (HAUSP) knockout HEK-293T
DR   Abcam; ab266535
DR   Wikidata; Q110431354
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12630; USP7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T UTP11 KO
AC   CVCL_B3L3
SY   Human UTP11L knockout HEK-293T
DR   Abcam; ab266717
DR   Wikidata; Q110431355
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24329; UTP11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T VAMP8 KO
AC   CVCL_B3L4
SY   Human VAMP8 (EDB) knockout HEK-293T
DR   Abcam; ab266293
DR   Wikidata; Q110431356
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12647; VAMP8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T VAT1 KO
AC   CVCL_B3L5
SY   Human VAT1 knockout HEK-293T
DR   Abcam; ab266311
DR   Wikidata; Q110431357
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16919; VAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T VDAC1 KO
AC   CVCL_B3L6
SY   Human VDAC1 (Porin) knockout HEK-293T
DR   Abcam; ab255444
DR   Wikidata; Q110431358
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12669; VDAC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T VDAC3 KO
AC   CVCL_B3L7
SY   Human VDAC3 knockout HEK-293T
DR   Abcam; ab266066
DR   Wikidata; Q110431359
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T VKORC1 KO
AC   CVCL_B3L8
SY   Human VKORC1 knockout HEK-293T
DR   Abcam; ab266095
DR   Wikidata; Q110431360
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23663; VKORC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T VRK1 KO
AC   CVCL_B3L9
SY   Human VRK1 knockout HEK-293T
DR   Abcam; ab266257
DR   Wikidata; Q110431361
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12718; VRK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T WASF3 KO 1
AC   CVCL_B3LA
SY   Human WASF3 knockout HEK-293T
DR   Abcam; ab266567
DR   Wikidata; Q110431362
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12734; WASF3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T WASF3 KO 2
AC   CVCL_B3LB
SY   Human WASF3 knockout HEK-293T
DR   Abcam; ab266568
DR   Wikidata; Q110431363
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12734; WASF3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T WDR83OS KO
AC   CVCL_B3LC
SY   Human WDR83OS (C19orf56) knockout HEK-293T
DR   Abcam; ab266660
DR   Wikidata; Q110431364
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30203; WDR83OS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T WNK2 KO 1
AC   CVCL_B3LD
SY   Human WNK2 knockout HEK-293T
DR   Abcam; ab267329
DR   Wikidata; Q110431365
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14542; WNK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T WNK2 KO 2
AC   CVCL_B3LE
SY   Human WNK2 knockout HEK-293T
DR   Abcam; ab267330
DR   Wikidata; Q110431366
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14542; WNK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T YBX3 KO
AC   CVCL_B3LF
SY   Human YBX3 (DBPA) knockout HEK-293T
DR   Abcam; ab266216
DR   Wikidata; Q110431367
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2428; YBX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T YDJC KO
AC   CVCL_B3LG
SY   Human YDJC knockout HEK-293T
DR   Abcam; ab266256
DR   Wikidata; Q110431369
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27158; YDJC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T YIF1A KO
AC   CVCL_B3LH
SY   Human YIF1A knockout HEK-293T
DR   Abcam; ab266545
DR   Wikidata; Q110431370
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16688; YIF1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T YIPF3 KO
AC   CVCL_B3LI
SY   Human YIPF3 knockout HEK-293T
DR   Abcam; ab266746
DR   Wikidata; Q110431371
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21023; YIPF3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T YWHAG KO
AC   CVCL_B3LJ
SY   Human YWHAG (14-3-3 gamma) knockout HEK-293T
DR   Abcam; ab266734
DR   Wikidata; Q110431372
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12852; YWHAG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ZC3H15 KO
AC   CVCL_B3LK
SY   Human ZC3H15 knockout HEK-293T
DR   Abcam; ab266652
DR   Wikidata; Q110431373
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29528; ZC3H15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ZFR KO
AC   CVCL_B3LL
SY   Human ZFR knockout HEK-293T
DR   Abcam; ab266501
DR   Wikidata; Q110431374
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17277; ZFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ZNF593 KO
AC   CVCL_B3LM
SY   Human ZNF593 knockout HEK-293T
DR   Abcam; ab266205
DR   Wikidata; Q110431375
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30943; ZNF593.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ZNHIT1 KO
AC   CVCL_B3LN
SY   Human ZNHIT1 knockout HEK-293T
DR   Abcam; ab266552
DR   Wikidata; Q110431376
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21688; ZNHIT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ZNRD2 KO
AC   CVCL_B3LP
SY   Human SSSCA1 knockout HEK-293T
DR   Abcam; ab266088
DR   Wikidata; Q110431377
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11328; ZNRD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ZYX KO 1
AC   CVCL_B9W1
SY   Human ZYX (Zyxin) knockout HEK-293T
DR   Abcam; ab266503
DR   Wikidata; Q112928326
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13200; ZYX.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   Abcam HEK293T ZYX KO 2
AC   CVCL_B3LQ
SY   Human ZYX (Zyxin) knockout HEK-293T
DR   Abcam; ab266504
DR   Wikidata; Q110431378
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13200; ZYX.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Abcam HeLa AAK1 KO
AC   CVCL_B1IJ
SY   Human AAK1 knockout HeLa
DR   Abcam; ab265047
DR   Wikidata; Q110431379
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19679; AAK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ABCC1 KO
AC   CVCL_B1IK
SY   Human ABCC1 (MRP1) knockout HeLa
DR   Abcam; ab265256
DR   Wikidata; Q110431382
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ABCC3 KO
AC   CVCL_B1IL
SY   Human ABCC3 (MRP3) knockout HeLa
DR   Abcam; ab264665
DR   Wikidata; Q110431383
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:54; ABCC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ABCF3 KO
AC   CVCL_B1IM
SY   Human ABCF3 knockout HeLa
DR   Abcam; ab265920
DR   Wikidata; Q110431384
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:72; ABCF3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ABHD17A KO
AC   CVCL_B1IN
SY   Human ABHD17A (FAM108A1) knockout HeLa
DR   Abcam; ab265695
DR   Wikidata; Q110431385
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28756; ABHD17A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ABHD6 KO
AC   CVCL_B1IP
SY   Human ABHD6 knockout HeLa
DR   Abcam; ab264730
DR   Wikidata; Q110431386
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21398; ABHD6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ABL1 KO 1
AC   CVCL_B1IQ
SY   Human ABL1 knockout HeLa
DR   Abcam; ab265612
DR   Wikidata; Q110431387
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ABL1 KO 2
AC   CVCL_E1FX
SY   Human ABL1 knockout HeLa
DR   Abcam; ab277152
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Abcam HeLa ACAD9 KO
AC   CVCL_B1IR
SY   Human ACAD9 knockout HeLa
DR   Abcam; ab265168
DR   Wikidata; Q110431388
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21497; ACAD9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ACHE KO
AC   CVCL_B1IS
SY   Human ACHE (Acetylcholinesterase) knockout HeLa
DR   Abcam; ab261818
DR   Wikidata; Q110431389
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:108; ACHE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ACOT9 KO
AC   CVCL_B1IT
SY   Human ACOT9 (Acyl-CoA Thioesterase 9) knockout HeLa
DR   Abcam; ab265673
DR   Wikidata; Q110431390
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17152; ACOT9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ACOX3 KO
AC   CVCL_B1IU
SY   Human ACOX3 knockout HeLa
DR   Abcam; ab265712
DR   Wikidata; Q110431391
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:121; ACOX3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ACSL1 KO
AC   CVCL_B1IV
SY   Human ACSL1 knockout HeLa
DR   Abcam; ab265555
DR   Wikidata; Q110431392
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3569; ACSL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ACSL3 KO
AC   CVCL_B1IW
SY   Human ACSL3 knockout HeLa
DR   Abcam; ab265102
DR   Wikidata; Q110431393
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3570; ACSL3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ACTA2 KO
AC   CVCL_B1IX
SY   Human ACTA2 knockout HeLa
DR   Abcam; ab264014
DR   Wikidata; Q110431395
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:130; ACTA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ACTN1 KO
AC   CVCL_B1IY
SY   Human ACTN1 (alpha Actinin) knockout HeLa
DR   Abcam; ab265610
DR   Wikidata; Q110431396
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:163; ACTN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADAM17 KO
AC   CVCL_B1IZ
SY   Human ADAM17 knockout HeLa
DR   Abcam; ab264911
DR   Wikidata; Q110431397
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADAM9 KO
AC   CVCL_B1J0
SY   Human ADAM9 knockout HeLa
DR   Abcam; ab265484
DR   Wikidata; Q110431398
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADARB1 KO
AC   CVCL_B1J1
SY   Human ADARB1 (RED1) knockout HeLa
DR   Abcam; ab265817
DR   Wikidata; Q110431399
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:226; ADARB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADCK2 KO
AC   CVCL_B1J2
SY   Human ADCK2 knockout HeLa
DR   Abcam; ab266025
DR   Wikidata; Q110431400
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19039; ADCK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADCY3 KO
AC   CVCL_B1J3
SY   Human ADCY3 (AC3) knockout HeLa
DR   Abcam; ab264709
DR   Wikidata; Q110431401
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:234; ADCY3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADCY7 KO
AC   CVCL_B1J4
SY   Human ADCY7 knockout HeLa
DR   Abcam; ab265081
DR   Wikidata; Q110431403
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:238; ADCY7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADGRE1 KO
AC   CVCL_B1R8
SY   Human EMR1 (F4/80) knockout HeLa
DR   Abcam; ab265670
DR   Wikidata; Q110431404
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3336; ADGRE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADK KO
AC   CVCL_B1J5
SY   Human ADK knockout HeLa
DR   Abcam; ab265646
DR   Wikidata; Q110431405
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:257; ADK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADORA2A KO
AC   CVCL_B9VD
SY   Human ADORA2A knockout HeLa
DR   Abcam; ab275414
DR   Wikidata; Q112928327
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ADRB1 KO
AC   CVCL_B1J6
SY   Human ADRB1 (beta 1 Adrenergic Receptor) knockout HeLa
DR   Abcam; ab261831
DR   Wikidata; Q110431406
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:285; ADRB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab261831; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa AGO1 KO
AC   CVCL_B1J7
SY   Human AGO1 knockout HeLa
DR   Abcam; ab265481
DR   Wikidata; Q110431408
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3262; AGO1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AGO3 KO
AC   CVCL_B1J8
SY   Human AGO3 knockout HeLa
DR   Abcam; ab265320
DR   Wikidata; Q110431409
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18421; AGO3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AIP KO
AC   CVCL_B1J9
SY   Human AIP knockout HeLa
DR   Abcam; ab265502
DR   Wikidata; Q110431410
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:358; AIP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AK1 KO
AC   CVCL_B1JA
SY   Human AK1 knockout HeLa
DR   Abcam; ab265132
DR   Wikidata; Q110431411
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:361; AK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AK4 KO
AC   CVCL_B1JB
SY   Human AK4 (AK3L1) knockout HeLa
DR   Abcam; ab265331
DR   Wikidata; Q110431412
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:363; AK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AKAP11 KO
AC   CVCL_B1JC
SY   Human AKAP11 (AKAP 220) knockout HeLa
DR   Abcam; ab265423
DR   Wikidata; Q110431413
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:369; AKAP11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AKT1 KO
AC   CVCL_B1JD
SY   Human AKT1 knockout HeLa
DR   Abcam; ab264852
DR   Wikidata; Q110431414
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AKT3 KO
AC   CVCL_B1JE
SY   Human AKT3 knockout HeLa
DR   Abcam; ab265687
DR   Wikidata; Q110431415
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265687; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ALDH3A2 KO
AC   CVCL_B1JF
SY   Human ALDH3A2 (Aldehyde dehydrogenase 10) knockout HeLa
DR   Abcam; ab265427
DR   Wikidata; Q110431416
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:403; ALDH3A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ALK KO
AC   CVCL_B1JG
SY   Human ALK knockout HeLa
DR   Abcam; ab266003
DR   Wikidata; Q110431417
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:427; ALK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab266003; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ALPP KO
AC   CVCL_B1JH
SY   Human ALPP (PLAP) knockout HeLa
DR   Abcam; ab261763
DR   Wikidata; Q110431418
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:439; ALPP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab261763; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ANKRD13A KO
AC   CVCL_B1JI
SY   Human ANKRD13A knockout HeLa
DR   Abcam; ab265254
DR   Wikidata; Q110431420
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21268; ANKRD13A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ANKRD17 KO
AC   CVCL_B1JJ
SY   Human ANKRD17 knockout HeLa
DR   Abcam; ab265465
DR   Wikidata; Q110431421
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23575; ANKRD17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ANTXR1 KO
AC   CVCL_B1JK
SY   Human ANTXR1 (TEM8/ATR) knockout HeLa
DR   Abcam; ab265077
DR   Wikidata; Q110431422
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21014; ANTXR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ANXA3 KO
AC   CVCL_B1JL
SY   Human ANXA3 (Annexin A3) knockout HeLa
DR   Abcam; ab264700
DR   Wikidata; Q110431423
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:541; ANXA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ANXA6 KO
AC   CVCL_B1JM
SY   Human ANXA6 (Annexin-6) knockout HeLa
DR   Abcam; ab265677
DR   Wikidata; Q110431424
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:544; ANXA6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AP1M1 KO
AC   CVCL_B1JN
SY   Human AP1M1 knockout HeLa
DR   Abcam; ab265506
DR   Wikidata; Q110431425
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13667; AP1M1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AP1M2 KO
AC   CVCL_B1JP
SY   Human AP1M2 knockout HeLa
DR   Abcam; ab265095
DR   Wikidata; Q110431426
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:558; AP1M2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa APH1A KO
AC   CVCL_B1JQ
SY   Human APH1A knockout HeLa
DR   Abcam; ab266016
DR   Wikidata; Q110431427
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29509; APH1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa APLNR KO
AC   CVCL_B1JR
SY   Human APLNR (APJ Receptor) knockout HeLa
DR   Abcam; ab264732
DR   Wikidata; Q110431428
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:339; APLNR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa APPL1 KO
AC   CVCL_B1JS
SY   Human APPL1 (APPL) knockout HeLa
DR   Abcam; ab265187
DR   Wikidata; Q110431429
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24035; APPL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa APTX KO
AC   CVCL_B1JT
SY   Human APTX (Aprataxin) knockout HeLa
DR   Abcam; ab265118
DR   Wikidata; Q110431430
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15984; APTX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARAP3 KO
AC   CVCL_B1JU
SY   Human ARAP3 knockout HeLa
DR   Abcam; ab265165
DR   Wikidata; Q110431431
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24097; ARAP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARF1 KO
AC   CVCL_B1JV
SY   Human ARF1 knockout HeLa
DR   Abcam; ab264939
DR   Wikidata; Q110431432
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:652; ARF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARFIP2 KO
AC   CVCL_B1JW
SY   Human ARFIP2 (POR1) knockout HeLa
DR   Abcam; ab265813
DR   Wikidata; Q110431434
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17160; ARFIP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265813; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ARHGEF2 KO
AC   CVCL_B1JX
SY   Human ARHGEF2 (GEF H1) knockout HeLa
DR   Abcam; ab265797
DR   Wikidata; Q110431435
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:682; ARHGEF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARID2 KO
AC   CVCL_B1JY
SY   Human ARID2 knockout HeLa
DR   Abcam; ab265137
DR   Wikidata; Q110431436
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARL13B KO
AC   CVCL_B1JZ
SY   Human ARL13B knockout HeLa
DR   Abcam; ab261802
DR   Wikidata; Q110431437
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25419; ARL13B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARL2BP KO
AC   CVCL_B1K0
SY   Human ARL2BP knockout HeLa
DR   Abcam; ab265269
DR   Wikidata; Q110431438
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17146; ARL2BP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARL8B KO
AC   CVCL_B1K1
SY   Human ARL8B knockout HeLa
DR   Abcam; ab265325
DR   Wikidata; Q110431439
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25564; ARL8B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ARNTL KO
AC   CVCL_B1K2
SY   Human ARNTL (BMAL1) knockout HeLa
DR   Abcam; ab264701
DR   Wikidata; Q110431440
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:701; BMAL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ASAP1 KO
AC   CVCL_B1K3
SY   Human ASAP1 (DDEF1) knockout HeLa
DR   Abcam; ab265796
DR   Wikidata; Q110431441
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2720; ASAP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ASCC2 KO
AC   CVCL_B1K4
SY   Human ASCC2 knockout HeLa
DR   Abcam; ab265781
DR   Wikidata; Q110431442
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24103; ASCC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265781; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ASH1L KO
AC   CVCL_B1K5
SY   Human ASH1L knockout HeLa
DR   Abcam; ab264959
DR   Wikidata; Q110431443
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19088; ASH1L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ASS1 KO
AC   CVCL_B1K6
SY   Human ASS1 knockout HeLa
DR   Abcam; ab264989
DR   Wikidata; Q110431444
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:758; ASS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ASXL1 KO
AC   CVCL_B1K7
SY   Human ASXL1 knockout HeLa
DR   Abcam; ab265789
DR   Wikidata; Q110431445
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18318; ASXL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATAD2 KO
AC   CVCL_B1K8
SY   Human ATAD2 knockout HeLa
DR   Abcam; ab264957
DR   Wikidata; Q110431446
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30123; ATAD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATF3 KO
AC   CVCL_B1K9
SY   Human ATF3 knockout HeLa
DR   Abcam; ab264908
DR   Wikidata; Q110431447
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATF6 KO
AC   CVCL_B1KA
SY   Human ATF6 knockout HeLa
DR   Abcam; ab261800
DR   Wikidata; Q110431448
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG10 KO
AC   CVCL_B1KB
SY   Human ATG10 knockout HeLa
DR   Abcam; ab265682
DR   Wikidata; Q110431449
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20315; ATG10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG101 KO
AC   CVCL_B1KC
SY   Human C12orf44 knockout HeLa
DR   Abcam; ab265815
DR   Wikidata; Q110431450
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25679; ATG101.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG14 KO
AC   CVCL_B1KD
SY   Human ATG14 (ATG14L) knockout HeLa
DR   Abcam; ab264684
DR   Wikidata; Q110431451
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG16L1 KO 1
AC   CVCL_B1KE
SY   Human ATG16L1 knockout HeLa
DR   Abcam; ab261772
DR   Wikidata; Q110431452
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG16L1 KO 2
AC   CVCL_B1KF
SY   Human ATG16L1 knockout HeLa
DR   Abcam; ab261773
DR   Wikidata; Q110431454
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG16L1 KO 3
AC   CVCL_B1KG
SY   Human ATG16L1 knockout HeLa
DR   Abcam; ab265263
DR   Wikidata; Q110431455
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG16L2 KO
AC   CVCL_B1KH
SY   Human ATG16L2 knockout HeLa
DR   Abcam; ab265867
DR   Wikidata; Q110431456
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25464; ATG16L2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG2A KO
AC   CVCL_B1KI
SY   Human ATG2A knockout HeLa
DR   Abcam; ab265726
DR   Wikidata; Q110431458
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG2B KO
AC   CVCL_B1KJ
SY   Human ATG2B knockout HeLa
DR   Abcam; ab266010
DR   Wikidata; Q110431459
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG3 KO
AC   CVCL_E1FY
SY   Human ATG3 knockout HeLa
DR   Abcam; ab274921
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Abcam HeLa ATG4A KO
AC   CVCL_B1KK
SY   Human ATG4A knockout HeLa
DR   Abcam; ab265738
DR   Wikidata; Q110431460
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16489; ATG4A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG4B KO
AC   CVCL_B1KL
SY   Human ATG4B knockout HeLa
DR   Abcam; ab265814
DR   Wikidata; Q110431461
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20790; ATG4B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG4D KO
AC   CVCL_B1KM
SY   Human ATG4D knockout HeLa
DR   Abcam; ab265980
DR   Wikidata; Q110431462
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20789; ATG4D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATG7 KO
AC   CVCL_B9VE
SY   Human ATG7 knockout HeLa
DR   Abcam; ab283307
DR   Wikidata; Q112928328
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATP13A3 KO
AC   CVCL_B1KN
SY   Human ATP13A3 knockout HeLa
DR   Abcam; ab266024
DR   Wikidata; Q110431463
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24113; ATP13A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATP2B1 KO
AC   CVCL_B1KP
SY   Human ATP2B1 (PMCA1) knockout HeLa
DR   Abcam; ab265561
DR   Wikidata; Q110431464
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:814; ATP2B1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATP2B4 KO
AC   CVCL_B1KQ
SY   Human ATP2B4 (Calcium Pump PMCA4 ATPase) knockout HeLa
DR   Abcam; ab264720
DR   Wikidata; Q110431466
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:817; ATP2B4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ATP5F1E KO
AC   CVCL_B1KR
SY   Human ATP5E knockout HeLa
DR   Abcam; ab265717
DR   Wikidata; Q110431467
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:838; ATP5F1E.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AXL KO 1
AC   CVCL_B1KS
SY   Human AXL knockout HeLa
DR   Abcam; ab261810
DR   Wikidata; Q110431468
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:905; AXL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AXL KO 2
AC   CVCL_B1KT
SY   Human AXL knockout HeLa
DR   Abcam; ab265392
DR   Wikidata; Q110431469
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:905; AXL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AZI2 KO
AC   CVCL_B1KU
SY   Human AZI2 knockout HeLa
DR   Abcam; ab265686
DR   Wikidata; Q110431470
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa AZIN1 KO
AC   CVCL_B1KV
SY   Human AZIN1 (Antizyme inhibitor 1) knockout HeLa
DR   Abcam; ab265296
DR   Wikidata; Q110431471
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16432; AZIN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa B4GALT1 KO
AC   CVCL_B1KW
SY   Human B4GALT1 knockout HeLa
DR   Abcam; ab265869
DR   Wikidata; Q110431472
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:924; B4GALT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BAG2 KO
AC   CVCL_B1KX
SY   Human BAG2 knockout HeLa
DR   Abcam; ab265907
DR   Wikidata; Q110431473
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:938; BAG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BAK1 KO
AC   CVCL_B1KY
SY   Human BAK1 (Bak) knockout HeLa
DR   Abcam; ab265277
DR   Wikidata; Q110431474
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BAX KO
AC   CVCL_B1KZ
SY   Human BAX knockout HeLa
DR   Abcam; ab255363
DR   Wikidata; Q110431475
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BAZ1A KO
AC   CVCL_B1L0
SY   Human BAZ1A (ACF1) knockout HeLa
DR   Abcam; ab264925
DR   Wikidata; Q110431477
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:960; BAZ1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BAZ1B KO
AC   CVCL_B1L1
SY   Human BAZ1B (WSTF) knockout HeLa
DR   Abcam; ab264907
DR   Wikidata; Q110431479
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:961; BAZ1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BBC3 KO
AC   CVCL_B1L2
SY   Human BBC3 (PUMA) knockout HeLa
DR   Abcam; ab261832
DR   Wikidata; Q110431480
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17868; BBC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BCAR3 KO
AC   CVCL_B1L3
SY   Human BCAR3 (NSP2) knockout HeLa
DR   Abcam; ab265399
DR   Wikidata; Q110431481
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:973; BCAR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BCL10 KO
AC   CVCL_B1L4
SY   Human BCL10 knockout HeLa
DR   Abcam; ab261797
DR   Wikidata; Q110431482
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BCL2L2 KO
AC   CVCL_B1L5
SY   Human BCL2L2 knockout HeLa
DR   Abcam; ab265368
DR   Wikidata; Q110431483
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:995; BCL2L2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BCL6 KO
AC   CVCL_B1L6
SY   Human BCL6 knockout HeLa
DR   Abcam; ab265410
DR   Wikidata; Q110431484
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BCOR KO
AC   CVCL_B1L7
SY   Human BCOR knockout HeLa
DR   Abcam; ab265125
DR   Wikidata; Q110431485
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20893; BCOR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BECN1 KO
AC   CVCL_B1L8
SY   Human BECN1 (Beclin 1) knockout HeLa
DR   Abcam; ab262511
DR   Wikidata; Q110431486
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1034; BECN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BIRC2 KO
AC   CVCL_B1L9
SY   Human BIRC2 (cIAP1) knockout HeLa
DR   Abcam; ab265896
DR   Wikidata; Q110431487
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:590; BIRC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BLMH KO
AC   CVCL_B1LA
SY   Human BLMH knockout HeLa
DR   Abcam; ab265361
DR   Wikidata; Q110431488
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1059; BLMH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BLOC1S1 KO
AC   CVCL_B1LB
SY   Human BLOC1S1 knockout HeLa
DR   Abcam; ab265830
DR   Wikidata; Q110431489
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4200; BLOC1S1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BMP2 KO
AC   CVCL_B1LC
SY   Human BMP2 knockout HeLa
DR   Abcam; ab261767
DR   Wikidata; Q110431491
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1069; BMP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BMP2K KO
AC   CVCL_B1LD
SY   Human BMP2K knockout HeLa
DR   Abcam; ab264666
DR   Wikidata; Q110431493
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18041; BMP2K.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BMPR1A KO
AC   CVCL_B1LE
SY   Human BMPR1A knockout HeLa
DR   Abcam; ab264776
DR   Wikidata; Q110431494
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BOD1 KO
AC   CVCL_B1LF
SY   Human BOD1 knockout HeLa
DR   Abcam; ab265086
DR   Wikidata; Q110431495
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25114; BOD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BRAF KO
AC   CVCL_B1LG
SY   Human BRAF knockout HeLa
DR   Abcam; ab265373
DR   Wikidata; Q110431496
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BRE KO
AC   CVCL_B1LH
SY   Human BRE (BRCC45) knockout HeLa
DR   Abcam; ab264928
DR   Wikidata; Q110431497
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1106; BABAM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BRK1 KO
AC   CVCL_B1LI
SY   Human BRK1 (C3orf10) knockout HeLa
DR   Abcam; ab265685
DR   Wikidata; Q110431498
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23057; BRK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BRSK1 KO
AC   CVCL_B1LJ
SY   Human BRSK1 knockout HeLa
DR   Abcam; ab264705
DR   Wikidata; Q110431499
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18994; BRSK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BRSK2 KO
AC   CVCL_B1LK
SY   Human BRSK2 knockout HeLa
DR   Abcam; ab265718
DR   Wikidata; Q110431500
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11405; BRSK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BRWD1 KO
AC   CVCL_B1LL
SY   Human BRWD1 (WDR9) knockout HeLa
DR   Abcam; ab264995
DR   Wikidata; Q110431501
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12760; BRWD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BTN3A2 KO
AC   CVCL_B1LM
SY   Human BTN3A2 knockout HeLa
DR   Abcam; ab265300
DR   Wikidata; Q110431502
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1139; BTN3A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa BUB1 KO
AC   CVCL_B1LN
SY   Human BUB1 knockout HeLa
DR   Abcam; ab265145
DR   Wikidata; Q110431503
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1148; BUB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa C11orf58 KO
AC   CVCL_B1LP
SY   Human C11orf58 knockout HeLa
DR   Abcam; ab265739
DR   Wikidata; Q110431505
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16990; C11orf58.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa C19orf33 KO
AC   CVCL_B1LQ
SY   Human C19orf33 knockout HeLa
DR   Abcam; ab265737
DR   Wikidata; Q110431506
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16668; C19orf33.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa C1D KO
AC   CVCL_B1LR
SY   Human C1D knockout HeLa
DR   Abcam; ab266023
DR   Wikidata; Q110431507
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29911; C1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab266023; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa C1orf131 KO
AC   CVCL_B1LS
SY   Human C1orf131 knockout HeLa
DR   Abcam; ab265970
DR   Wikidata; Q110431508
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25332; C1orf131.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa C5orf51 KO
AC   CVCL_B1LT
SY   Human C5orf51 knockout HeLa
DR   Abcam; ab265321
DR   Wikidata; Q110431509
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27750; RIMOC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa C6orf62 KO
AC   CVCL_B1LU
SY   Human C6orf62 knockout HeLa
DR   Abcam; ab265397
DR   Wikidata; Q110431510
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20998; C6orf62.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa C9orf69 KO
AC   CVCL_B1LV
SY   Human C9orf69 knockout HeLa
DR   Abcam; ab265501
DR   Wikidata; Q110431511
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31009; TMEM250.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa C9orf78 KO
AC   CVCL_B1LW
SY   Human C9orf78 knockout HeLa
DR   Abcam; ab265157
DR   Wikidata; Q110431512
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24932; C9orf78.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CACNA2D1 KO
AC   CVCL_B1LX
SY   Human CACNA2D1 (Calcium channel L type DHPR alpha 2 subunit) knockout HeLa
DR   Abcam; ab265080
DR   Wikidata; Q110431513
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1399; CACNA2D1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CACNB3 KO
AC   CVCL_B1LY
SY   Human CACNB3 (CAB3) knockout HeLa
DR   Abcam; ab265180
DR   Wikidata; Q110431514
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1403; CACNB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CALD1 KO
AC   CVCL_B1LZ
SY   Human CALD1 (Caldesmon/CDM) knockout HeLa
DR   Abcam; ab265026
DR   Wikidata; Q110431515
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1441; CALD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CALM2 KO
AC   CVCL_B1M0
SY   Human CALM2 knockout HeLa
DR   Abcam; ab265467
DR   Wikidata; Q110431517
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1445; CALM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CAMK2G KO
AC   CVCL_B1M1
SY   Human CAMK2G (CamKII gamma) knockout HeLa
DR   Abcam; ab264712
DR   Wikidata; Q110431518
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1463; CAMK2G.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CAMKK1 KO
AC   CVCL_B1M2
SY   Human CAMKK1 (CaMKK) knockout HeLa
DR   Abcam; ab265635
DR   Wikidata; Q110431519
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1469; CAMKK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CAPG KO
AC   CVCL_B1M3
SY   Human CAPG (MCP) knockout HeLa
DR   Abcam; ab265766
DR   Wikidata; Q110431520
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1474; CAPG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CASP3 KO
AC   CVCL_B1M4
SY   Human CASP3 (Caspase-3) knockout HeLa
DR   Abcam; ab255370
DR   Wikidata; Q110431521
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CASP7 KO
AC   CVCL_B1M5
SY   Human CASP7 (Caspase-7) knockout HeLa
DR   Abcam; ab265777
DR   Wikidata; Q110431522
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1508; CASP7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CASP8 KO
AC   CVCL_B1M6
SY   Human CASP8 (Caspase-8) knockout HeLa
DR   Abcam; ab264958
DR   Wikidata; Q110431523
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CAT KO 1
AC   CVCL_B1M7
SY   Human CAT (Catalase) knockout HeLa
DR   Abcam; ab261816
DR   Wikidata; Q110431524
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1516; CAT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CAT KO 2
AC   CVCL_B1M8
SY   Human CAT (Catalase) knockout HeLa
DR   Abcam; ab265250
DR   Wikidata; Q110431525
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1516; CAT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CAV1 KO
AC   CVCL_B1M9
SY   Human CAV1 (Caveolin-1) knockout HeLa
DR   Abcam; ab255371
DR   Wikidata; Q110431526
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CAVIN1 KO
AC   CVCL_B1MA
SY   Human PTRF knockout HeLa
DR   Abcam; ab265435
DR   Wikidata; Q110431527
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9688; CAVIN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CBLB KO
AC   CVCL_B1MB
SY   Human CBLB knockout HeLa
DR   Abcam; ab264711
DR   Wikidata; Q110431528
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1542; CBLB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CBLL1 KO
AC   CVCL_B1MC
SY   Human CBLL1 knockout HeLa
DR   Abcam; ab265855
DR   Wikidata; Q110431529
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21225; CBLL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CBS KO
AC   CVCL_B1MD
SY   Human CBS knockout HeLa
DR   Abcam; ab264950
DR   Wikidata; Q110431530
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1550; CBS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CBX3 KO
AC   CVCL_B1ME
SY   Human CBX3 (HP1 gamma) knockout HeLa
DR   Abcam; ab261744
DR   Wikidata; Q110431531
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1553; CBX3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCDC137 KO
AC   CVCL_B1MF
SY   Human CCDC137 (CC137) knockout HeLa
DR   Abcam; ab265439
DR   Wikidata; Q110431532
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33451; CCDC137.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCDC6 KO
AC   CVCL_B1MG
SY   Human CCDC6 knockout HeLa
DR   Abcam; ab265425
DR   Wikidata; Q110431533
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18782; CCDC6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCL2 KO
AC   CVCL_B1MH
SY   Human CCL2 (MCP1) knockout HeLa
DR   Abcam; ab255372
DR   Wikidata; Q110431534
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10618; CCL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCL20 KO
AC   CVCL_B1MI
SY   Human CCL20 (Macrophage Inflammatory Protein 3 alpha) knockout HeLa
DR   Abcam; ab265379
DR   Wikidata; Q110431535
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10619; CCL20.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCN1 KO
AC   CVCL_B1PR
SY   Human CYR61 (CCN1) knockout HeLa
DR   Abcam; ab265288
DR   Wikidata; Q110431536
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2654; CCN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCN2 KO
AC   CVCL_B1MJ
SY   Human CTGF knockout HeLa
DR   Abcam; ab255382
DR   Wikidata; Q110431537
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2500; CCN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCND1 KO 1
AC   CVCL_B1MK
SY   Human CCND1 (Cyclin D1) knockout HeLa
DR   Abcam; ab255348
DR   Wikidata; Q110431539
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CCND1 KO 2
AC   CVCL_B1ML
SY   Human CCND1 (Cyclin D1) knockout HeLa
DR   Abcam; ab261760
DR   Wikidata; Q110431540
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CD160 KO
AC   CVCL_B1MM
SY   Human CD160 knockout HeLa
DR   Abcam; ab265834
DR   Wikidata; Q110431541
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17013; CD160.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265834; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa CD276 KO
AC   CVCL_B1MN
SY   Human CD276 knockout HeLa
DR   Abcam; ab261756
DR   Wikidata; Q110431542
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19137; CD276.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CD28 KO
AC   CVCL_B1MP
SY   Human CD28 knockout HeLa
DR   Abcam; ab261739
DR   Wikidata; Q110431543
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab261739; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa CD38 KO
AC   CVCL_B1MQ
SY   Human CD38 knockout HeLa
DR   Abcam; ab265951
DR   Wikidata; Q110431544
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1667; CD38.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265951; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa CD44 KO
AC   CVCL_B1MR
SY   Human CD44 knockout HeLa
DR   Abcam; ab262515
DR   Wikidata; Q110431545
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CD58 KO
AC   CVCL_B1MS
SY   Human CD58 knockout HeLa
DR   Abcam; ab265947
DR   Wikidata; Q110431546
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1688; CD58.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CD70 KO
AC   CVCL_B1MT
SY   Human CD70 knockout HeLa
DR   Abcam; ab265750
DR   Wikidata; Q110431547
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11937; CD70.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CD9 KO
AC   CVCL_B1MU
SY   Human CD9 knockout HeLa
DR   Abcam; ab255375
DR   Wikidata; Q110431548
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDC25C KO
AC   CVCL_B1MV
SY   Human CDC25C knockout HeLa
DR   Abcam; ab265189
DR   Wikidata; Q110431549
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1727; CDC25C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDC42BPA KO
AC   CVCL_B1MW
SY   Human CDC42BPA (CDC42 binding protein kinase alpha) knockout HeLa
DR   Abcam; ab265622
DR   Wikidata; Q110431550
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1737; CDC42BPA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDC42EP4 KO
AC   CVCL_B1MX
SY   Human CDC42EP4 knockout HeLa
DR   Abcam; ab265954
DR   Wikidata; Q110431551
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17147; CDC42EP4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDC42SE1 KO
AC   CVCL_B1MY
SY   Human CDC42SE1 knockout HeLa
DR   Abcam; ab265759
DR   Wikidata; Q110431552
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17719; CDC42SE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDK12 KO
AC   CVCL_B1MZ
SY   Human CDK12 knockout HeLa
DR   Abcam; ab265209
DR   Wikidata; Q110431553
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24224; CDK12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265209; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa CDK17 KO
AC   CVCL_B1N0
SY   Human CDK17 (PCTAIRE2) knockout HeLa
DR   Abcam; ab264985
DR   Wikidata; Q110431554
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8750; CDK17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDK19 KO
AC   CVCL_B1N1
SY   Human CDK19 (CDC2L6) knockout HeLa
DR   Abcam; ab264668
DR   Wikidata; Q110431555
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19338; CDK19.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDK3 KO
AC   CVCL_B1N2
SY   Human CDK3 knockout HeLa
DR   Abcam; ab265431
DR   Wikidata; Q110431557
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1772; CDK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDK4 KO
AC   CVCL_B1N3
SY   Human CDK4 knockout HeLa
DR   Abcam; ab255378
DR   Wikidata; Q110431558
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1773; CDK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDK6 KO
AC   CVCL_B1N4
SY   Human CDK6 knockout HeLa
DR   Abcam; ab266059
DR   Wikidata; Q110431559
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDK8 KO
AC   CVCL_B1N5
SY   Human CDK8 knockout HeLa
DR   Abcam; ab265087
DR   Wikidata; Q110431560
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1779; CDK8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDKL1 KO
AC   CVCL_B1N6
SY   Human CDKL1 knockout HeLa
DR   Abcam; ab265652
DR   Wikidata; Q110431561
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1781; CDKL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDKN1A KO
AC   CVCL_B1N7
SY   Human CDKN1A knockout HeLa
DR   Abcam; ab255349
DR   Wikidata; Q110431562
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDKN1C KO
AC   CVCL_B9VF
SY   Human CDKN1C (p57 Kip2) knockout HeLa
DR   Abcam; ab280061
DR   Wikidata; Q112928329
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1786; CDKN1C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CDKN2B KO
AC   CVCL_B1N8
SY   Human CDKN2B (p15 INK4b) knockout HeLa
DR   Abcam; ab261761
DR   Wikidata; Q110431563
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1788; CDKN2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CEBPB KO
AC   CVCL_B1N9
SY   Human CEBPB (CEBP Beta) knockout HeLa
DR   Abcam; ab261771
DR   Wikidata; Q110431564
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1834; CEBPB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CEP57 KO
AC   CVCL_B1NA
SY   Human CEP57 knockout HeLa
DR   Abcam; ab266056
DR   Wikidata; Q110431565
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30794; CEP57.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CHAT KO
AC   CVCL_B1NB
SY   Human CHAT (Choline Acetyltransferase) knockout HeLa
DR   Abcam; ab266018
DR   Wikidata; Q110431566
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1912; CHAT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab266018; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa CHEK2 KO
AC   CVCL_B1NC
SY   Human CHEK2 (Chk2) knockout HeLa
DR   Abcam; ab264815
DR   Wikidata; Q110431567
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CHMP4A KO
AC   CVCL_B1ND
SY   Human CHMP4A knockout HeLa
DR   Abcam; ab265570
DR   Wikidata; Q110431569
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20274; CHMP4A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CIC KO
AC   CVCL_B1NE
SY   Human CIC (Capicua) knockout HeLa
DR   Abcam; ab264678
DR   Wikidata; Q110431570
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14214; CIC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CISD1 KO
AC   CVCL_B1NF
SY   Human CISD1 (MitoNEET) knockout HeLa
DR   Abcam; ab265276
DR   Wikidata; Q110431571
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30880; CISD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLCN7 KO
AC   CVCL_B1NG
SY   Human CLCN7 (CLC7) knockout HeLa
DR   Abcam; ab265973
DR   Wikidata; Q110431572
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2025; CLCN7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLK1 KO
AC   CVCL_B1NH
SY   Human CLK1 knockout HeLa
DR   Abcam; ab265448
DR   Wikidata; Q110431573
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2068; CLK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLK3 KO
AC   CVCL_B1NI
SY   Human CLK3 knockout HeLa
DR   Abcam; ab264693
DR   Wikidata; Q110431574
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2071; CLK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLK4 KO
AC   CVCL_B1NJ
SY   Human CLK4 knockout HeLa
DR   Abcam; ab265885
DR   Wikidata; Q110431575
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13659; CLK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLOCK KO 1
AC   CVCL_B1NK
SY   Human CLOCK (KAT13D) knockout HeLa
DR   Abcam; ab265301
DR   Wikidata; Q110431576
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLOCK KO 2
AC   CVCL_B1NL
SY   Human CLOCK (KAT13D) knockout HeLa
DR   Abcam; ab266054
DR   Wikidata; Q110431578
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLPX KO
AC   CVCL_B1NM
SY   Human CLPX knockout HeLa
DR   Abcam; ab265655
DR   Wikidata; Q110431579
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2088; CLPX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CLTCL1 KO
AC   CVCL_B1NN
SY   Human CLTCL1 knockout HeLa
DR   Abcam; ab264969
DR   Wikidata; Q110431580
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2093; CLTCL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CNN1 KO
AC   CVCL_B1NP
SY   Human CNN1 (Calponin 1) knockout HeLa
DR   Abcam; ab265620
DR   Wikidata; Q110431582
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2155; CNN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265620; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa CNOT7 KO
AC   CVCL_B1NQ
SY   Human CNOT7 knockout HeLa
DR   Abcam; ab265811
DR   Wikidata; Q110431584
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14101; CNOT7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CNOT9 KO
AC   CVCL_B1NR
SY   Human RQCD1 knockout HeLa
DR   Abcam; ab265307
DR   Wikidata; Q110431585
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10445; CNOT9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CNP KO
AC   CVCL_B1NS
SY   Human CNP (CNPase) knockout HeLa
DR   Abcam; ab264949
DR   Wikidata; Q110431586
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2158; CNP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COIL KO
AC   CVCL_B1NT
SY   Human COIL (Coilin) knockout HeLa
DR   Abcam; ab261757
DR   Wikidata; Q110431587
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2184; COIL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL4A1 KO
AC   CVCL_B1NU
SY   Human COL4A1 (Collagen IV alpha 1) knockout HeLa
DR   Abcam; ab255379
DR   Wikidata; Q110431588
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2202; COL4A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL4A2 KO
AC   CVCL_B1NV
SY   Human COL4A2 knockout HeLa
DR   Abcam; ab264788
DR   Wikidata; Q110431589
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2203; COL4A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL4A3 KO
AC   CVCL_B1NW
SY   Human COL4A3 knockout HeLa
DR   Abcam; ab265875
DR   Wikidata; Q110431590
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2204; COL4A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL4A4 KO
AC   CVCL_B1NX
SY   Human COL4A4 (Collagen alpha-4(IV) chain) knockout HeLa
DR   Abcam; ab265614
DR   Wikidata; Q110431591
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2206; COL4A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL4A5 KO
AC   CVCL_B1NY
SY   Human COL4A5 knockout HeLa
DR   Abcam; ab265913
DR   Wikidata; Q110431592
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL4A6 KO
AC   CVCL_B1NZ
SY   Human COL4A6 (Collagen IV alpha 6) knockout HeLa
DR   Abcam; ab265914
DR   Wikidata; Q110431593
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2208; COL4A6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL5A1 KO
AC   CVCL_B1P0
SY   Human COL5A1 knockout HeLa
DR   Abcam; ab264708
DR   Wikidata; Q110431594
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2209; COL5A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COL9A3 KO
AC   CVCL_B1P1
SY   Human COL9A3 knockout HeLa
DR   Abcam; ab264707
DR   Wikidata; Q110431595
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2219; COL9A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa COP1 KO
AC   CVCL_B1P2
SY   Human RFWD2 (COP1) knockout HeLa
DR   Abcam; ab266013
DR   Wikidata; Q110431596
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17440; COP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab266013; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa COQ8B KO
AC   CVCL_B1P3
SY   Human ADCK4 knockout HeLa
DR   Abcam; ab264970
DR   Wikidata; Q110431597
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19041; COQ8B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CPA4 KO
AC   CVCL_B1P4
SY   Human CPA4 knockout HeLa
DR   Abcam; ab265831
DR   Wikidata; Q110431598
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15740; CPA4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CPS1 KO
AC   CVCL_B1P5
SY   Human CPS1 knockout HeLa
DR   Abcam; ab261809
DR   Wikidata; Q110431599
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2323; CPS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CPT2 KO
AC   CVCL_B1P6
SY   Human CPT2 knockout HeLa
DR   Abcam; ab265931
DR   Wikidata; Q110431600
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2330; CPT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CREB3L2 KO
AC   CVCL_B1P7
SY   Human CREB3L2 (BBF2H7) knockout HeLa
DR   Abcam; ab265884
DR   Wikidata; Q110431601
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23720; CREB3L2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CREB5 KO
AC   CVCL_B1P8
SY   Human CREB5 knockout HeLa
DR   Abcam; ab264752
DR   Wikidata; Q110431602
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16844; CREB5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CRK KO
AC   CVCL_B1P9
SY   Human CRK (Crk p38) knockout HeLa
DR   Abcam; ab265097
DR   Wikidata; Q110431603
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2362; CRK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CRKL KO
AC   CVCL_B1PA
SY   Human CRKL knockout HeLa
DR   Abcam; ab265993
DR   Wikidata; Q110431604
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2363; CRKL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CRY1 KO
AC   CVCL_B1PB
SY   Human CRY1 (Cryptochrome I) knockout HeLa
DR   Abcam; ab265791
DR   Wikidata; Q110431605
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2384; CRY1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CSAD KO
AC   CVCL_B1PC
SY   Human CSAD (CSD) knockout HeLa
DR   Abcam; ab265786
DR   Wikidata; Q110431606
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18966; CSAD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CSF1R KO
AC   CVCL_B1PD
SY   Human CSF1R (CSF-1-R) knockout HeLa
DR   Abcam; ab267226
DR   Wikidata; Q110431607
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CSNK1D KO
AC   CVCL_B1PE
SY   Human CSNK1D (Casein Kinase 1 delta) knockout HeLa
DR   Abcam; ab264667
DR   Wikidata; Q110431608
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CSNK1E KO
AC   CVCL_B1PF
SY   Human CSNK1E (CK1 epsilon) knockout HeLa
DR   Abcam; ab264674
DR   Wikidata; Q110431609
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2453; CSNK1E.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CSNK1G1 KO
AC   CVCL_B1PG
SY   Human CSNK1G1 knockout HeLa
DR   Abcam; ab265013
DR   Wikidata; Q110431610
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CSRP1 KO
AC   CVCL_B1PH
SY   Human CSRP1 knockout HeLa
DR   Abcam; ab265235
DR   Wikidata; Q110431611
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2469; CSRP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CSTF2 KO
AC   CVCL_B1PI
SY   Human CSTF2 (CstF-64) knockout HeLa
DR   Abcam; ab265207
DR   Wikidata; Q110431612
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2484; CSTF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CTDSPL KO
AC   CVCL_B1PJ
SY   Human CTDSPL knockout HeLa
DR   Abcam; ab265366
DR   Wikidata; Q110431613
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16890; CTDSPL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CTNNB1 KO
AC   CVCL_B1PK
SY   Human CTNNB1 (beta Catenin) knockout HeLa
DR   Abcam; ab255352
DR   Wikidata; Q110431614
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CTSC KO
AC   CVCL_B1PL
SY   Human CTSC (Cathepsin C) knockout HeLa
DR   Abcam; ab265822
DR   Wikidata; Q110431615
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2528; CTSC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CUTC KO
AC   CVCL_B1PM
SY   Human CUTC knockout HeLa
DR   Abcam; ab265860
DR   Wikidata; Q110431616
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24271; CUTC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CXCL1 KO
AC   CVCL_B1PN
SY   Human CXCL1 (GRO alpha) knockout HeLa
DR   Abcam; ab261774
DR   Wikidata; Q110431617
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4602; CXCL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CXCR4 KO
AC   CVCL_B1PP
SY   Human CXCR4 knockout HeLa
DR   Abcam; ab255383
DR   Wikidata; Q110431618
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa CYRIB KO
AC   CVCL_B1PQ
SY   Human FAM49B knockout HeLa
DR   Abcam; ab265906
DR   Wikidata; Q110431619
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25216; CYRIB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DAB2 KO
AC   CVCL_B1PS
SY   Human DAB2 knockout HeLa
DR   Abcam; ab265731
DR   Wikidata; Q110431620
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2662; DAB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DAXX KO
AC   CVCL_B1PT
SY   Human DAXX knockout HeLa
DR   Abcam; ab265233
DR   Wikidata; Q110431621
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DCAF12 KO
AC   CVCL_B1PU
SY   Human DCAF12 knockout HeLa
DR   Abcam; ab265422
DR   Wikidata; Q110431622
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19911; DCAF12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DDB2 KO
AC   CVCL_B1PV
SY   Human DDB2 knockout HeLa
DR   Abcam; ab265115
DR   Wikidata; Q110431623
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2718; DDB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DDIT3 KO
AC   CVCL_B1PW
SY   Human DDIT3 knockout HeLa
DR   Abcam; ab265760
DR   Wikidata; Q110431624
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2726; DDIT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DDR1 KO
AC   CVCL_B1PX
SY   Human DDR1 (MCK10/NEP) knockout HeLa
DR   Abcam; ab265915
DR   Wikidata; Q110431625
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2730; DDR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DDR2 KO
AC   CVCL_B1PY
SY   Human DDR2 knockout HeLa
DR   Abcam; ab264864
DR   Wikidata; Q110431626
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264864; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa DENND4B KO
AC   CVCL_B1PZ
SY   Human DENND4B knockout HeLa
DR   Abcam; ab265967
DR   Wikidata; Q110431627
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29044; DENND4B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DENND5A KO
AC   CVCL_B1Q0
SY   Human DENND5A knockout HeLa
DR   Abcam; ab265772
DR   Wikidata; Q110431628
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19344; DENND5A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DENR KO
AC   CVCL_B1Q1
SY   Human DENR (Density Regulated Protein) knockout HeLa
DR   Abcam; ab265473
DR   Wikidata; Q110431629
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2769; DENR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DGKD KO
AC   CVCL_B1Q2
SY   Human DGKD knockout HeLa
DR   Abcam; ab265991
DR   Wikidata; Q110431630
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2851; DGKD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DHCR7 KO
AC   CVCL_B1Q3
SY   Human DHCR7 knockout HeLa
DR   Abcam; ab265281
DR   Wikidata; Q110431632
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2860; DHCR7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DHRS13 KO
AC   CVCL_B1Q4
SY   Human DHRS13 knockout HeLa
DR   Abcam; ab265257
DR   Wikidata; Q110431633
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28326; DHRS13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DLD KO
AC   CVCL_B1Q5
SY   Human DLD (Lipoamide Dehydrogenase) knockout HeLa
DR   Abcam; ab265535
DR   Wikidata; Q110431635
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2898; DLD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DMAC2 KO
AC   CVCL_B1Q6
SY   Human ATP5SL knockout HeLa
DR   Abcam; ab265953
DR   Wikidata; Q110431636
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25496; DMAC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DNAJB4 KO
AC   CVCL_B1Q7
SY   Human DNAJB4 knockout HeLa
DR   Abcam; ab265319
DR   Wikidata; Q110431637
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14886; DNAJB4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DNAJC10 KO
AC   CVCL_B1Q8
SY   Human DNAJC10 knockout HeLa
DR   Abcam; ab266015
DR   Wikidata; Q110431638
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24637; DNAJC10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DNAJC13 KO
AC   CVCL_B1Q9
SY   Human DNAJC13 (RME-8) knockout HeLa
DR   Abcam; ab265328
DR   Wikidata; Q110431639
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30343; DNAJC13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DNAJC14 KO
AC   CVCL_B1QA
SY   Human DNAJC14 knockout HeLa
DR   Abcam; ab265150
DR   Wikidata; Q110431640
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24581; DNAJC14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DNMT3A KO
AC   CVCL_B1QB
SY   Human DNMT3A knockout HeLa
DR   Abcam; ab261793
DR   Wikidata; Q110431641
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2978; DNMT3A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DPH2 KO
AC   CVCL_B1QC
SY   Human DPH2 knockout HeLa
DR   Abcam; ab265657
DR   Wikidata; Q110431642
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3004; DPH2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DPM2 KO
AC   CVCL_B1QD
SY   Human DPM2 knockout HeLa
DR   Abcam; ab265514
DR   Wikidata; Q110431643
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3006; DPM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DSG2 KO
AC   CVCL_B1QE
SY   Human DSG2 (Desmoglein 2) knockout HeLa
DR   Abcam; ab261826
DR   Wikidata; Q110431644
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DSTYK KO
AC   CVCL_B1QF
SY   Human DSTYK (RIPK5) knockout HeLa
DR   Abcam; ab265003
DR   Wikidata; Q110431646
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29043; DSTYK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DTX3 KO
AC   CVCL_B1QG
SY   Human DTX3 knockout HeLa
DR   Abcam; ab265078
DR   Wikidata; Q110431647
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24457; DTX3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DYNLL1 KO
AC   CVCL_B1QH
SY   Human DYNLL1 (PIN) knockout HeLa
DR   Abcam; ab265265
DR   Wikidata; Q110431648
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15476; DYNLL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DYNLT3 KO
AC   CVCL_B1QI
SY   Human DYNLT3 knockout HeLa
DR   Abcam; ab265556
DR   Wikidata; Q110431649
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11694; DYNLT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DYRK3 KO
AC   CVCL_B1QJ
SY   Human DYRK3 knockout HeLa
DR   Abcam; ab265198
DR   Wikidata; Q110431650
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3094; DYRK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DYRK4 KO
AC   CVCL_B1QK
SY   Human DYRK4 knockout HeLa
DR   Abcam; ab265729
DR   Wikidata; Q110431651
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3095; DYRK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa DYSF KO
AC   CVCL_B1QL
SY   Human DYSF (Dysferlin) knockout HeLa
DR   Abcam; ab264764
DR   Wikidata; Q110431652
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3097; DYSF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264764; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa E2F3 KO
AC   CVCL_B1QM
SY   Human E2F3 knockout HeLa
DR   Abcam; ab265362
DR   Wikidata; Q110431653
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3115; E2F3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ECE2 KO
AC   CVCL_B1QN
SY   Human ECE2 knockout HeLa
DR   Abcam; ab264738
DR   Wikidata; Q110431655
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13275; ECE2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ECHDC1 KO
AC   CVCL_B1QP
SY   Human ECHDC1 knockout HeLa
DR   Abcam; ab266053
DR   Wikidata; Q110431656
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21489; ECHDC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EEA1 KO
AC   CVCL_B1QQ
SY   Human EEA1 knockout HeLa
DR   Abcam; ab261822
DR   Wikidata; Q110431658
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3185; EEA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EFNA1 KO
AC   CVCL_B1QR
SY   Human EFNA1 (Ephrin A1) knockout HeLa
DR   Abcam; ab265232
DR   Wikidata; Q110431659
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3221; EFNA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265232; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa EGF KO
AC   CVCL_B1QS
SY   Human EGF knockout HeLa
DR   Abcam; ab261830
DR   Wikidata; Q110431660
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3229; EGF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EGFR KO
AC   CVCL_B1QT
SY   Human EGFR knockout HeLa
DR   Abcam; ab255385
DR   Wikidata; Q110431661
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EGR1 KO
AC   CVCL_E1FZ
SY   Human EGR1 knockout HeLa
DR   Abcam; ab274929
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3238; EGR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Abcam HeLa EHMT2 KO
AC   CVCL_B9VG
SY   Human EHMT2 (G9A) knockout HeLa
DR   Abcam; ab265149
DR   Wikidata; Q112928330
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EI24 KO
AC   CVCL_B1QU
SY   Human EI24 knockout HeLa
DR   Abcam; ab265103
DR   Wikidata; Q110431662
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13276; EI24.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EIF2AK2 KO
AC   CVCL_B1QV
SY   Human EIF2AK2 (PKR) knockout HeLa
DR   Abcam; ab261824
DR   Wikidata; Q110431663
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EIF3H KO
AC   CVCL_B1QW
SY   Human EIF3H knockout HeLa
DR   Abcam; ab265292
DR   Wikidata; Q110431664
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3273; EIF3H.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EIF4EBP1 KO
AC   CVCL_B1QX
SY   Human EIF4EBP1 knockout HeLa
DR   Abcam; ab264784
DR   Wikidata; Q110431665
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3288; EIF4EBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EIPR1 KO
AC   CVCL_B1QY
SY   Human TSSC1 knockout HeLa
DR   Abcam; ab265955
DR   Wikidata; Q110431666
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12383; EIPR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ELK1 KO
AC   CVCL_B1QZ
SY   Human ELK1 knockout HeLa
DR   Abcam; ab261764
DR   Wikidata; Q110431667
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ELL2 KO
AC   CVCL_B1R0
SY   Human ELL2 knockout HeLa
DR   Abcam; ab265499
DR   Wikidata; Q110431668
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17064; ELL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ELOVL5 KO
AC   CVCL_B1R1
SY   Human ELOVL5 knockout HeLa
DR   Abcam; ab265942
DR   Wikidata; Q110431670
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21308; ELOVL5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265942; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa EMC10 KO
AC   CVCL_B1R2
SY   Human EMC10 (C19orf63) knockout HeLa
DR   Abcam; ab265783
DR   Wikidata; Q110431671
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27609; EMC10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EMC2 KO
AC   CVCL_B1R3
SY   Human EMC2 (TTC35) knockout HeLa
DR   Abcam; ab265234
DR   Wikidata; Q110431672
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28963; EMC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EMC6 KO
AC   CVCL_B1R4
SY   Human EMC6 (Transmembrane protein 93) knockout HeLa
DR   Abcam; ab265710
DR   Wikidata; Q110431673
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28430; EMC6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EMC8 KO
AC   CVCL_B1R5
SY   Human EMC8 (COX4NB) knockout HeLa
DR   Abcam; ab265851
DR   Wikidata; Q110431674
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7864; EMC8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EML4 KO
AC   CVCL_B1R6
SY   Human EML4 knockout HeLa
DR   Abcam; ab265098
DR   Wikidata; Q110431675
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1316; EML4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EMP1 KO
AC   CVCL_B1R7
SY   Human EMP1 knockout HeLa
DR   Abcam; ab265806
DR   Wikidata; Q110431676
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3333; EMP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ENG KO
AC   CVCL_B1R9
SY   Human ENG (CD105) knockout HeLa
DR   Abcam; ab265178
DR   Wikidata; Q110431677
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3349; ENG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ENPP2 KO
AC   CVCL_B1RA
SY   Human ENPP2 (ATX) knockout HeLa
DR   Abcam; ab265377
DR   Wikidata; Q110431678
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3357; ENPP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EPHA1 KO
AC   CVCL_B1RB
SY   Human EPHA1 (Eph receptor A1) knockout HeLa
DR   Abcam; ab265452
DR   Wikidata; Q110431679
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3385; EPHA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EPHA2 KO
AC   CVCL_B1RC
SY   Human EPHA2 (Eph receptor A2) knockout HeLa
DR   Abcam; ab264795
DR   Wikidata; Q110431680
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EPHA4 KO
AC   CVCL_B1RD
SY   Human EPHA4 (Eph receptor A4/SEK) knockout HeLa
DR   Abcam; ab264760
DR   Wikidata; Q110431681
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3388; EPHA4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EPHB3 KO
AC   CVCL_B1RE
SY   Human EPHB3 (Eph receptor B3) knockout HeLa
DR   Abcam; ab265529
DR   Wikidata; Q110431683
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3394; EPHB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265529; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa EPS8L2 KO
AC   CVCL_B1RF
SY   Human EPS8L2 knockout HeLa
DR   Abcam; ab265785
DR   Wikidata; Q110431684
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21296; EPS8L2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ERCC4 KO
AC   CVCL_B9VH
SY   Human ERCC4 knockout HeLa
DR   Abcam; ab280068
DR   Wikidata; Q112928331
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3436; ERCC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ERGIC2 KO
AC   CVCL_B1RG
SY   Human ERGIC2 (PTX1) knockout HeLa
DR   Abcam; ab265745
DR   Wikidata; Q110431685
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30208; ERGIC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ERI3 KO
AC   CVCL_B1RH
SY   Human ERI3 knockout HeLa
DR   Abcam; ab265999
DR   Wikidata; Q110431686
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17276; ERI3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ERMP1 KO
AC   CVCL_B1RI
SY   Human ERMP1 knockout HeLa
DR   Abcam; ab265824
DR   Wikidata; Q110431687
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23703; ERMP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ERN1 KO
AC   CVCL_B1RJ
SY   Human ERN1 (IRE1) knockout HeLa
DR   Abcam; ab255389
DR   Wikidata; Q110431688
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ESRP2 KO
AC   CVCL_B1RK
SY   Human ESRP2 knockout HeLa
DR   Abcam; ab265107
DR   Wikidata; Q110431689
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26152; ESRP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ETNK1 KO
AC   CVCL_B1RL
SY   Human ETNK1 (ethanolamine kinase) knockout HeLa
DR   Abcam; ab265219
DR   Wikidata; Q110431690
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24649; ETNK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ETV5 KO
AC   CVCL_B1RM
SY   Human ETV5 (ERM) knockout HeLa
DR   Abcam; ab264714
DR   Wikidata; Q110431691
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3494; ETV5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EXOC2 KO
AC   CVCL_B1RN
SY   Human EXOC2 knockout HeLa
DR   Abcam; ab265839
DR   Wikidata; Q110431692
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24968; EXOC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EXOC7 KO
AC   CVCL_B1RP
SY   Human EXOC7 knockout HeLa
DR   Abcam; ab265415
DR   Wikidata; Q110431693
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23214; EXOC7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa EXOSC1 KO
AC   CVCL_B1RQ
SY   Human EXOSC1 (CSL4) knockout HeLa
DR   Abcam; ab265194
DR   Wikidata; Q110431694
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17286; EXOSC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265194; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa EZR KO
AC   CVCL_B1RR
SY   Human EZR (Ezrin) knockout HeLa
DR   Abcam; ab264912
DR   Wikidata; Q110431695
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12691; EZR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264912; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa FABP5 KO
AC   CVCL_B1RS
SY   Human FABP5 knockout HeLa
DR   Abcam; ab265905
DR   Wikidata; Q110431696
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3560; FABP5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FADD KO
AC   CVCL_B1RT
SY   Human FADD knockout HeLa
DR   Abcam; ab261817
DR   Wikidata; Q110431697
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3573; FADD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FAM20B KO
AC   CVCL_B1RU
SY   Human FAM20B knockout HeLa
DR   Abcam; ab266038
DR   Wikidata; Q110431698
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23017; FAM20B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FAM3C KO
AC   CVCL_B1RV
SY   Human FAM3C (ILEI) knockout HeLa
DR   Abcam; ab264723
DR   Wikidata; Q110431699
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18664; FAM3C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FAM98A KO
AC   CVCL_B1RW
SY   Human FAM98A knockout HeLa
DR   Abcam; ab265648
DR   Wikidata; Q110431700
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24520; FAM98A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FANCD2 KO
AC   CVCL_B1RX
SY   Human FANCD2 knockout HeLa
DR   Abcam; ab261743
DR   Wikidata; Q110431701
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FAS KO
AC   CVCL_B1RY
SY   Human FAS knockout HeLa
DR   Abcam; ab265260
DR   Wikidata; Q110431702
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FASTK KO
AC   CVCL_B1RZ
SY   Human FASTK knockout HeLa
DR   Abcam; ab265046
DR   Wikidata; Q110431703
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24676; FASTK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FBXO11 KO
AC   CVCL_B1S0
SY   Human FBXO11 knockout HeLa
DR   Abcam; ab265763
DR   Wikidata; Q110431704
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13590; FBXO11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FCER2 KO
AC   CVCL_B1S1
SY   Human FCER2 (CD23) knockout HeLa
DR   Abcam; ab266040
DR   Wikidata; Q110431705
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3612; FCER2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab266040; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa FER KO
AC   CVCL_B1S2
SY   Human FER knockout HeLa
DR   Abcam; ab265226
DR   Wikidata; Q110431706
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3655; FER.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FERMT2 KO
AC   CVCL_B1S3
SY   Human FERMT2 (Kindlin 2) knockout HeLa
DR   Abcam; ab265247
DR   Wikidata; Q110431708
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15767; FERMT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FGF21 KO
AC   CVCL_B9VI
SY   Human FGF21 knockout HeLa
DR   Abcam; ab265974
DR   Wikidata; Q112928332
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3678; FGF21.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FHL1 KO
AC   CVCL_B1S4
SY   Human FHL1 knockout HeLa
DR   Abcam; ab266011
DR   Wikidata; Q110431709
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3702; FHL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FHL2 KO
AC   CVCL_B1S5
SY   Human FHL2 knockout HeLa
DR   Abcam; ab265475
DR   Wikidata; Q110431710
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3703; FHL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FIBP KO
AC   CVCL_B1S6
SY   Human FIBP knockout HeLa
DR   Abcam; ab265716
DR   Wikidata; Q110431711
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3705; FIBP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FLCN KO
AC   CVCL_B9VJ
SY   Human FLCN knockout HeLa
DR   Abcam; ab265268
DR   Wikidata; Q112928333
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27310; FLCN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FLII KO
AC   CVCL_B1S7
SY   Human FLII (Flightless I) knockout HeLa
DR   Abcam; ab265890
DR   Wikidata; Q110431712
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3750; FLII.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FLYWCH1 KO
AC   CVCL_B1S8
SY   Human FLYWCH1 knockout HeLa
DR   Abcam; ab266004
DR   Wikidata; Q110431713
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25404; FLYWCH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FOCAD KO
AC   CVCL_B1S9
SY   Human FOCAD (Focadhesin) knockout HeLa
DR   Abcam; ab265627
DR   Wikidata; Q110431714
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23377; FOCAD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FOLR1 KO
AC   CVCL_B1SA
SY   Human FOLR1 (Folate Binding Protein/FBP) knockout HeLa
DR   Abcam; ab264921
DR   Wikidata; Q110431715
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FOXA1 KO
AC   CVCL_B1SB
SY   Human FOXA1 knockout HeLa
DR   Abcam; ab261823
DR   Wikidata; Q110431716
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FOXA2 KO
AC   CVCL_B1SC
SY   Human FOXA2 knockout HeLa
DR   Abcam; ab265862
DR   Wikidata; Q110431717
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265862; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa FTL KO 1
AC   CVCL_B1SD
SY   Human FTL knockout HeLa
DR   Abcam; ab265533
DR   Wikidata; Q110431718
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FTL KO 2
AC   CVCL_B1SE
SY   Human FTL knockout HeLa
DR   Abcam; ab265534
DR   Wikidata; Q110431719
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FXR1 KO
AC   CVCL_B1SF
SY   Human FXR1 knockout HeLa
DR   Abcam; ab264017
DR   Wikidata; Q110431720
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4023; FXR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FZD1 KO
AC   CVCL_B1SG
SY   Human FZD1 (Frizzled homolog 1) knockout HeLa
DR   Abcam; ab265463
DR   Wikidata; Q110431722
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4038; FZD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FZD2 KO
AC   CVCL_B1SH
SY   Human FZD2 (Frizzled 2) knockout HeLa
DR   Abcam; ab264727
DR   Wikidata; Q110431723
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4040; FZD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa FZD6 KO
AC   CVCL_B1SI
SY   Human FZD6 (Frizzled 6) knockout HeLa
DR   Abcam; ab265280
DR   Wikidata; Q110431724
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4044; FZD6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GABRE KO
AC   CVCL_B1SJ
SY   Human GABRE knockout HeLa
DR   Abcam; ab265643
DR   Wikidata; Q110431725
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4085; GABRE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GADD45B KO
AC   CVCL_B1SK
SY   Human GADD45B knockout HeLa
DR   Abcam; ab264974
DR   Wikidata; Q110431726
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GAGE12J KO
AC   CVCL_B1SL
SY   Human GAGE12J knockout HeLa
DR   Abcam; ab265428
DR   Wikidata; Q110431727
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17778; GAGE12J.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GAL KO
AC   CVCL_B1SM
SY   Human GAL (Galanin) knockout HeLa
DR   Abcam; ab264992
DR   Wikidata; Q110431728
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4114; GAL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GALK1 KO
AC   CVCL_B1SN
SY   Human GALK1 knockout HeLa
DR   Abcam; ab265644
DR   Wikidata; Q110431729
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4118; GALK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GANC KO
AC   CVCL_B1SP
SY   Human GANC knockout HeLa
DR   Abcam; ab265096
DR   Wikidata; Q110431730
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4139; GANC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GBA KO
AC   CVCL_B1SQ
SY   Human GBA knockout HeLa
DR   Abcam; ab265038
DR   Wikidata; Q110431731
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa GDA KO
AC   CVCL_B1SR
SY   Human GDA knockout HeLa
DR   Abcam; ab264695
DR   Wikidata; Q110431732
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4212; GDA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GDE1 KO
AC   CVCL_B1SS
SY   Human GDE1 (MIR16) knockout HeLa
DR   Abcam; ab265866
DR   Wikidata; Q110431734
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29644; GDE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GEMIN6 KO
AC   CVCL_B1ST
SY   Human GEMIN6 (SIP2) knockout HeLa
DR   Abcam; ab265305
DR   Wikidata; Q110431735
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20044; GEMIN6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GGCX KO
AC   CVCL_B1SU
SY   Human GGCX knockout HeLa
DR   Abcam; ab265204
DR   Wikidata; Q110431736
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4247; GGCX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GIT1 KO
AC   CVCL_B1SV
SY   Human GIT1 knockout HeLa
DR   Abcam; ab265230
DR   Wikidata; Q110431737
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4272; GIT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GLA KO
AC   CVCL_B1SW
SY   Human GLA (Galactosidase alpha) knockout HeLa
DR   Abcam; ab265563
DR   Wikidata; Q110431738
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GLOD4 KO
AC   CVCL_B1SX
SY   Human GLOD4 knockout HeLa
DR   Abcam; ab265560
DR   Wikidata; Q110431739
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14111; GLOD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GLRX2 KO
AC   CVCL_B1SY
SY   Human GLRX2 (GRX2) knockout HeLa
DR   Abcam; ab265732
DR   Wikidata; Q110431740
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16065; GLRX2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GMNN KO
AC   CVCL_B1SZ
SY   Human GMNN (Geminin) knockout HeLa
DR   Abcam; ab264972
DR   Wikidata; Q110431741
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17493; GMNN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GNA13 KO
AC   CVCL_B1T0
SY   Human GNA13 knockout HeLa
DR   Abcam; ab264846
DR   Wikidata; Q110431742
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4381; GNA13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GNB1 KO
AC   CVCL_B1T1
SY   Human GNB1 knockout HeLa
DR   Abcam; ab264689
DR   Wikidata; Q110431743
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4396; GNB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GNB4 KO
AC   CVCL_B1T2
SY   Human GNB4 knockout HeLa
DR   Abcam; ab264891
DR   Wikidata; Q110431744
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20731; GNB4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GNG11 KO
AC   CVCL_B1T3
SY   Human GNG11 knockout HeLa
DR   Abcam; ab264799
DR   Wikidata; Q110431746
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4403; GNG11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GNPAT KO
AC   CVCL_B1T4
SY   Human GNPAT (DAPAT) knockout HeLa
DR   Abcam; ab265611
DR   Wikidata; Q110431748
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4416; GNPAT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GNS KO
AC   CVCL_B1T5
SY   Human GNS knockout HeLa
DR   Abcam; ab265495
DR   Wikidata; Q110431749
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4422; GNS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GOLM2 KO
AC   CVCL_B1T6
SY   Human CASC4 knockout HeLa
DR   Abcam; ab265832
DR   Wikidata; Q110431750
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24892; GOLM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GPSM2 KO
AC   CVCL_B1T7
SY   Human GPSM2 (LGN) knockout HeLa
DR   Abcam; ab264715
DR   Wikidata; Q110431751
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29501; GPSM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GPX4 KO
AC   CVCL_B1T8
SY   Human GPX4 knockout HeLa
DR   Abcam; ab262509
DR   Wikidata; Q110431752
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4556; GPX4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GRK4 KO
AC   CVCL_B1T9
SY   Human GRK4 knockout HeLa
DR   Abcam; ab265139
DR   Wikidata; Q110431754
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4543; GRK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GSN KO
AC   CVCL_B9VK
SY   Human GSN (Gelsolin) knockout HeLa
DR   Abcam; ab265201
DR   Wikidata; Q112928334
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4620; GSN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GSTM4 KO
AC   CVCL_B1TA
SY   Human GSTM4 knockout HeLa
DR   Abcam; ab265995
DR   Wikidata; Q110431755
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4636; GSTM4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GSTT2B KO
AC   CVCL_B1TB
SY   Human GSTT2B (GSTT2) knockout HeLa
DR   Abcam; ab264703
DR   Wikidata; Q110431756
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33437; GSTT2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GTPBP2 KO
AC   CVCL_B1TC
SY   Human GTPBP2 knockout HeLa
DR   Abcam; ab266045
DR   Wikidata; Q110431757
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4670; GTPBP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa GYS1 KO
AC   CVCL_B1TD
SY   Human GYS1 (Glycogen synthase 1) knockout HeLa
DR   Abcam; ab265388
DR   Wikidata; Q110431758
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4706; GYS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa H1-2 KO
AC   CVCL_B1TE
SY   Human HIST1H1C (Histone H1.2) knockout HeLa
DR   Abcam; ab261794
DR   Wikidata; Q110431759
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HAGH KO
AC   CVCL_B1TF
SY   Human HAGH (GLO2) knockout HeLa
DR   Abcam; ab265912
DR   Wikidata; Q110431760
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4805; HAGH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HAO1 KO
AC   CVCL_B1TG
SY   Human HAO1 (GOX) knockout HeLa
DR   Abcam; ab264716
DR   Wikidata; Q110431761
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4809; HAO1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HELLS KO
AC   CVCL_B1TH
SY   Human HELLS (SMARCA6) knockout HeLa
DR   Abcam; ab265006
DR   Wikidata; Q110431762
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4861; HELLS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HENMT1 KO
AC   CVCL_B1TI
SY   Human HENMT1 knockout HeLa
DR   Abcam; ab265405
DR   Wikidata; Q110431763
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26400; HENMT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HERC4 KO
AC   CVCL_B1TJ
SY   Human HERC4 knockout HeLa
DR   Abcam; ab265937
DR   Wikidata; Q110431765
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24521; HERC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HES1 KO
AC   CVCL_B1TK
SY   Human HES1 knockout HeLa
DR   Abcam; ab265638
DR   Wikidata; Q110431766
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HGF KO
AC   CVCL_B1TL
SY   Human HGF knockout HeLa
DR   Abcam; ab265221
DR   Wikidata; Q110431767
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4893; HGF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265221; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa HIBADH KO
AC   CVCL_B1TM
SY   Human HIBADH knockout HeLa
DR   Abcam; ab265888
DR   Wikidata; Q110431768
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4907; HIBADH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HINT1 KO
AC   CVCL_B1TN
SY   Human HINT1 knockout HeLa
DR   Abcam; ab265776
DR   Wikidata; Q110431769
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4912; HINT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HIPK3 KO
AC   CVCL_B1TP
SY   Human HIPK3 (FIST) knockout HeLa
DR   Abcam; ab264840
DR   Wikidata; Q110431770
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4915; HIPK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HMGB1 KO
AC   CVCL_B1TQ
SY   Human HMGB1 knockout HeLa
DR   Abcam; ab255395
DR   Wikidata; Q110431771
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4983; HMGB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HMGN4 KO
AC   CVCL_B1TR
SY   Human HMGN4 knockout HeLa
DR   Abcam; ab265746
DR   Wikidata; Q110431772
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4989; HMGN4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HNRNPDL KO
AC   CVCL_B1TS
SY   Human HNRNPDL knockout HeLa
DR   Abcam; ab265117
DR   Wikidata; Q110431773
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5037; HNRNPDL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HPCAL1 KO
AC   CVCL_B1TT
SY   Human HPCAL1 (VILIP3) knockout HeLa
DR   Abcam; ab265779
DR   Wikidata; Q110431774
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5145; HPCAL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HPDL KO
AC   CVCL_B1TU
SY   Human HPDL knockout HeLa
DR   Abcam; ab265868
DR   Wikidata; Q110431775
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28242; HPDL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HPS5 KO
AC   CVCL_B1TV
SY   Human HPS5 knockout HeLa
DR   Abcam; ab265119
DR   Wikidata; Q110431776
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17022; HPS5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HPSE KO
AC   CVCL_B1TW
SY   Human HPSE (Heparanase 1) knockout HeLa
DR   Abcam; ab265413
DR   Wikidata; Q110431777
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5164; HPSE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HR KO
AC   CVCL_B1TX
SY   Human HR (Hairless) knockout HeLa
DR   Abcam; ab265009
DR   Wikidata; Q110431778
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5172; HR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HSD3B7 KO
AC   CVCL_B1TY
SY   Human HSD3B7 knockout HeLa
DR   Abcam; ab265239
DR   Wikidata; Q110431779
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18324; HSD3B7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HSPA8 KO
AC   CVCL_B1TZ
SY   Human HSPA8 (Hsc70) knockout HeLa
DR   Abcam; ab265664
DR   Wikidata; Q110431781
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5241; HSPA8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HSPB1 KO
AC   CVCL_B1U0
SY   Human HSPB1 (Hsp27) knockout HeLa
DR   Abcam; ab261738
DR   Wikidata; Q110431782
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HSPB8 KO
AC   CVCL_B1U1
SY   Human HSPB8 (Hsp22) knockout HeLa
DR   Abcam; ab265112
DR   Wikidata; Q110431784
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30171; HSPB8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa HTT KO
AC   CVCL_B1U2
SY   Human HTT (Huntingtin) knockout HeLa
DR   Abcam; ab265976
DR   Wikidata; Q110431785
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ICAM1 KO
AC   CVCL_B1U3
SY   Human ICAM1 knockout HeLa
DR   Abcam; ab261742
DR   Wikidata; Q110431786
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IDE KO
AC   CVCL_B1U4
SY   Human IDE (Insulin degrading enzyme) knockout HeLa
DR   Abcam; ab261755
DR   Wikidata; Q110431787
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5381; IDE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IDH1 KO
AC   CVCL_B1U5
SY   Human IDH1 knockout HeLa
DR   Abcam; ab264916
DR   Wikidata; Q110431788
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IDS KO
AC   CVCL_B1U6
SY   Human IDS (Iduronate 2 sulfatase/SIDS) knockout HeLa
DR   Abcam; ab264747
DR   Wikidata; Q110431789
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5389; IDS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IER2 KO
AC   CVCL_B1U7
SY   Human IER2 knockout HeLa
DR   Abcam; ab265148
DR   Wikidata; Q110431790
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28871; IER2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IFITM3 KO
AC   CVCL_B1U8
SY   Human IFITM3 (Fragilis) knockout HeLa
DR   Abcam; ab265698
DR   Wikidata; Q110431792
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IFNAR1 KO
AC   CVCL_B9VL
SY   Human IFNAR1 (Interferon alpha/beta receptor 1) knockout HeLa
DR   Abcam; ab261782
DR   Wikidata; Q112928335
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IFNE KO
AC   CVCL_B1U9
SY   Human IFNE (IFNE1) knockout HeLa
DR   Abcam; ab265774
DR   Wikidata; Q110431794
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18163; IFNE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IFNGR1 KO
AC   CVCL_B1UA
SY   Human IFNGR1 knockout HeLa
DR   Abcam; ab265111
DR   Wikidata; Q110431795
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IGF1R KO
AC   CVCL_B1UB
SY   Human IGF1R (IGF1 Receptor) knockout HeLa
DR   Abcam; ab264801
DR   Wikidata; Q110431796
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IKBKB KO
AC   CVCL_B1UC
SY   Human IKBKB (IKK beta) knockout HeLa
DR   Abcam; ab264847
DR   Wikidata; Q110431797
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IL13RA1 KO
AC   CVCL_B1UD
SY   Human IL13RA1 knockout HeLa
DR   Abcam; ab265998
DR   Wikidata; Q110431798
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265998; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa IL18 KO
AC   CVCL_B1UE
SY   Human IL18 knockout HeLa
DR   Abcam; ab265274
DR   Wikidata; Q110431799
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5986; IL18.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IL1RAP KO
AC   CVCL_B1UF
SY   Human IL1RAP knockout HeLa
DR   Abcam; ab273375
DR   Wikidata; Q110431800
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5995; IL1RAP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IL20 KO
AC   CVCL_B1UG
SY   Human IL20 knockout HeLa
DR   Abcam; ab265382
DR   Wikidata; Q110431801
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6002; IL20.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IL6ST KO
AC   CVCL_B1UH
SY   Human IL6ST (CD130/gp130) knockout HeLa
DR   Abcam; ab265767
DR   Wikidata; Q110431802
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa INA KO
AC   CVCL_B1UI
SY   Human INA (alpha Internexin) knockout HeLa
DR   Abcam; ab265264
DR   Wikidata; Q110431803
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6057; INA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa INF2 KO
AC   CVCL_B1UJ
SY   Human INF2 knockout HeLa
DR   Abcam; ab265926
DR   Wikidata; Q110431805
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23791; INF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa INPP5K KO
AC   CVCL_B1UK
SY   Human INPP5K (SKIP) knockout HeLa
DR   Abcam; ab265311
DR   Wikidata; Q110431806
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33882; INPP5K.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IP6K2 KO
AC   CVCL_B1UL
SY   Human IP6K2 knockout HeLa
DR   Abcam; ab265192
DR   Wikidata; Q110431807
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17313; IP6K2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IPO9 KO
AC   CVCL_B1UM
SY   Human IPO9 (Importin 9/RANBP9) knockout HeLa
DR   Abcam; ab265352
DR   Wikidata; Q110431808
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19425; IPO9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IRF1 KO
AC   CVCL_B1UN
SY   Human IRF1 knockout HeLa
DR   Abcam; ab264919
DR   Wikidata; Q110431809
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IRF3 KO
AC   CVCL_B1UP
SY   Human IRF3 knockout HeLa
DR   Abcam; ab255345
DR   Wikidata; Q110431810
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IRF7 KO
AC   CVCL_B1UQ
SY   Human IRF7 knockout HeLa
DR   Abcam; ab265554
DR   Wikidata; Q110431811
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IRF9 KO
AC   CVCL_B1UR
SY   Human IRF9 (Interferon regulatory factor 9) knockout HeLa
DR   Abcam; ab266051
DR   Wikidata; Q110431813
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6131; IRF9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ITCH KO
AC   CVCL_B1US
SY   Human ITCH (AIP4) knockout HeLa
DR   Abcam; ab265338
DR   Wikidata; Q110431814
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13890; ITCH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ITFG1 KO
AC   CVCL_B1UT
SY   Human ITFG1 (CDA08) knockout HeLa
DR   Abcam; ab265562
DR   Wikidata; Q110431815
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30697; ITFG1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ITGA11 KO
AC   CVCL_B1UU
SY   Human ITGA11 knockout HeLa
DR   Abcam; ab265494
DR   Wikidata; Q110431816
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6136; ITGA11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ITGA2 KO
AC   CVCL_B1UV
SY   Human ITGA2 (CD49b) knockout HeLa
DR   Abcam; ab264819
DR   Wikidata; Q110431819
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ITGA6 KO
AC   CVCL_B1UW
SY   Human ITGA6 (Integrin alpha 6) knockout HeLa
DR   Abcam; ab265838
DR   Wikidata; Q110431821
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6142; ITGA6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IVNS1ABP KO
AC   CVCL_B1UX
SY   Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa
DR   Abcam; ab265837
DR   Wikidata; Q110431824
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16951; IVNS1ABP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa IWS1 KO
AC   CVCL_B1UY
SY   Human IWS1 knockout HeLa
DR   Abcam; ab265784
DR   Wikidata; Q110431825
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25467; IWS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa JAG2 KO
AC   CVCL_B1UZ
SY   Human JAG2 (Jagged 2) knockout HeLa
DR   Abcam; ab265966
DR   Wikidata; Q110431826
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6189; JAG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa JKAMP KO
AC   CVCL_B1V0
SY   Human JKAMP knockout HeLa
DR   Abcam; ab265992
DR   Wikidata; Q110431827
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20184; JKAMP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KCNJ11 KO
AC   CVCL_B1V1
SY   Human KCNJ11 (Kir6.2/BIR) knockout HeLa
DR   Abcam; ab264735
DR   Wikidata; Q110431828
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6257; KCNJ11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KCNN4 KO
AC   CVCL_B1V2
SY   Human KCNN4 knockout HeLa
DR   Abcam; ab265835
DR   Wikidata; Q110431829
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6293; KCNN4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KDM1A KO
AC   CVCL_B1V3
SY   Human KDM1A (LSD1) knockout HeLa
DR   Abcam; ab265790
DR   Wikidata; Q110431830
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KDM1B KO
AC   CVCL_B1V4
SY   Human KDM1B (LSD2 / AOF1) knockout HeLa
DR   Abcam; ab265969
DR   Wikidata; Q110431831
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KDM6A KO
AC   CVCL_B1V5
SY   Human KDM6A (UTX) knockout HeLa
DR   Abcam; ab265110
DR   Wikidata; Q110431832
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KHDC4 KO
AC   CVCL_B1V6
SY   Human KIAA0907 knockout HeLa
DR   Abcam; ab265642
DR   Wikidata; Q110431834
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29145; KHDC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KIAA1191 KO
AC   CVCL_B1V7
SY   Human KIAA1191 knockout HeLa
DR   Abcam; ab265356
DR   Wikidata; Q110431835
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29209; KIAA1191.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KIF7 KO
AC   CVCL_B1V8
SY   Human KIF7 knockout HeLa
DR   Abcam; ab264742
DR   Wikidata; Q110431836
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30497; KIF7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KIFC3 KO
AC   CVCL_B1V9
SY   Human KIFC3 knockout HeLa
DR   Abcam; ab265485
DR   Wikidata; Q110431837
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6326; KIFC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KIT KO
AC   CVCL_B1VA
SY   Human KIT (c-Kit) knockout HeLa
DR   Abcam; ab264768
DR   Wikidata; Q110431838
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264768; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa KLC1 KO
AC   CVCL_B1VB
SY   Human KLC1 knockout HeLa
DR   Abcam; ab265284
DR   Wikidata; Q110431839
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6387; KLC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KMT2C KO
AC   CVCL_B1VC
SY   Human KMT2C (MLL3) knockout HeLa
DR   Abcam; ab265223
DR   Wikidata; Q110431840
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13726; KMT2C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa KRT8 KO
AC   CVCL_B1VD
SY   Human KRT8 (Cytokeratin 8) knockout HeLa
DR   Abcam; ab255400
DR   Wikidata; Q110431841
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6446; KRT8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa L1CAM KO 1
AC   CVCL_B1VE
SY   Human L1CAM knockout HeLa
DR   Abcam; ab255401
DR   Wikidata; Q110431842
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6470; L1CAM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa L1CAM KO 2
AC   CVCL_B1VF
SY   Human L1CAM knockout HeLa
DR   Abcam; ab273836
DR   Wikidata; Q110431843
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6470; L1CAM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa L3MBTL2 KO
AC   CVCL_B1VG
SY   Human L3MBTL2 knockout HeLa
DR   Abcam; ab264904
DR   Wikidata; Q110431844
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18594; L3MBTL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LAMA3 KO
AC   CVCL_B1VH
SY   Human LAMA3 knockout HeLa
DR   Abcam; ab265663
DR   Wikidata; Q110431845
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6483; LAMA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LAMB1 KO
AC   CVCL_B1VI
SY   Human LAMB1 (Laminin beta 1) knockout HeLa
DR   Abcam; ab265414
DR   Wikidata; Q110431846
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6486; LAMB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LAMP2 KO
AC   CVCL_B1VJ
SY   Human LAMP2 knockout HeLa
DR   Abcam; ab255402
DR   Wikidata; Q110431847
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LAMP3 KO
AC   CVCL_B1VK
SY   Human LAMP3 knockout HeLa
DR   Abcam; ab264719
DR   Wikidata; Q110431848
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14582; LAMP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LAMTOR1 KO
AC   CVCL_B1VL
SY   Human LAMTOR1 knockout HeLa
DR   Abcam; ab265351
DR   Wikidata; Q110431849
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26068; LAMTOR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LAMTOR2 KO
AC   CVCL_B1VM
SY   Human LAMTOR2 knockout HeLa
DR   Abcam; ab265828
DR   Wikidata; Q110431850
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29796; LAMTOR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LAMTOR3 KO
AC   CVCL_B1VN
SY   Human LAMTOR3 (MAP2K1IP1) knockout HeLa
DR   Abcam; ab265624
DR   Wikidata; Q110431851
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15606; LAMTOR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LANCL1 KO
AC   CVCL_B1VP
SY   Human LANCL1 knockout HeLa
DR   Abcam; ab265928
DR   Wikidata; Q110431852
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6508; LANCL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LARP4B KO
AC   CVCL_B1VQ
SY   Human LARP4B knockout HeLa
DR   Abcam; ab265369
DR   Wikidata; Q110431853
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28987; LARP4B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LDB1 KO
AC   CVCL_B1VR
SY   Human LDB1 knockout HeLa
DR   Abcam; ab265727
DR   Wikidata; Q110431854
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6532; LDB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LDLR KO
AC   CVCL_E1G0
SY   Human LDLR (LDL Receptor) knockout HeLa
DR   Abcam; ab273838
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Abcam HeLa LIF KO
AC   CVCL_B1VS
SY   Human LIF knockout HeLa
DR   Abcam; ab264737
DR   Wikidata; Q110431855
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6596; LIF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LIMCH1 KO
AC   CVCL_B1VT
SY   Human LIMCH1 knockout HeLa
DR   Abcam; ab266044
DR   Wikidata; Q110431856
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29191; LIMCH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LIN7C KO
AC   CVCL_B1VU
SY   Human LIN7C knockout HeLa
DR   Abcam; ab265441
DR   Wikidata; Q110431857
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17789; LIN7C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LITAF KO
AC   CVCL_B1VV
SY   Human LITAF knockout HeLa
DR   Abcam; ab265387
DR   Wikidata; Q110431858
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16841; LITAF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LIX1L KO
AC   CVCL_B1VW
SY   Human LIX1L knockout HeLa
DR   Abcam; ab265950
DR   Wikidata; Q110431859
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28715; LIX1L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LMF2 KO
AC   CVCL_B1VX
SY   Human LMF2 knockout HeLa
DR   Abcam; ab265647
DR   Wikidata; Q110431860
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25096; LMF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LMNA KO
AC   CVCL_B1VY
SY   Human LMNA (Lamin A) knockout HeLa
DR   Abcam; ab261787
DR   Wikidata; Q110431861
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LMNB1 KO
AC   CVCL_B1VZ
SY   Human LMNB1 (Lamin B1) knockout HeLa
DR   Abcam; ab255404
DR   Wikidata; Q110431862
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LOX KO
AC   CVCL_B1W0
SY   Human LOX knockout HeLa
DR   Abcam; ab261801
DR   Wikidata; Q110431863
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6664; LOX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LOXL2 KO
AC   CVCL_B1W1
SY   Human LOXL2 knockout HeLa
DR   Abcam; ab261804
DR   Wikidata; Q110431864
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6666; LOXL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LPGAT1 KO
AC   CVCL_B1W2
SY   Human LPGAT1 knockout HeLa
DR   Abcam; ab265523
DR   Wikidata; Q110431865
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28985; LPGAT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LPL KO
AC   CVCL_B1W3
SY   Human LPL (Lipoprotein lipase) knockout HeLa
DR   Abcam; ab264016
DR   Wikidata; Q110431866
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6677; LPL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LRRC41 KO
AC   CVCL_B1W4
SY   Human LRRC41 knockout HeLa
DR   Abcam; ab265104
DR   Wikidata; Q110431867
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16917; LRRC41.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LRRC58 KO
AC   CVCL_B1W5
SY   Human LRRC58 knockout HeLa
DR   Abcam; ab265432
DR   Wikidata; Q110431868
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26968; LRRC58.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LRRK1 KO
AC   CVCL_B1W6
SY   Human LRRK1 knockout HeLa
DR   Abcam; ab264726
DR   Wikidata; Q110431869
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18608; LRRK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LRWD1 KO
AC   CVCL_B1W7
SY   Human LRWD1 knockout HeLa
DR   Abcam; ab265266
DR   Wikidata; Q110431870
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21769; LRWD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LTB4R2 KO
AC   CVCL_B1W8
SY   Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa
DR   Abcam; ab265153
DR   Wikidata; Q110431871
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19260; LTB4R2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LXN KO
AC   CVCL_B1W9
SY   Human LXN (TCI) knockout HeLa
DR   Abcam; ab265921
DR   Wikidata; Q110431872
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13347; LXN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LY6K KO
AC   CVCL_B1WA
SY   Human LY6K (Ly-6K) knockout HeLa
DR   Abcam; ab265874
DR   Wikidata; Q110431873
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24225; LY6K.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa LYPLA2 KO
AC   CVCL_B1WB
SY   Human LYPLA2 (APT-2) knockout HeLa
DR   Abcam; ab265900
DR   Wikidata; Q110431874
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6738; LYPLA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAD2L1BP KO
AC   CVCL_B9VM
SY   Human MAD2L1BP (CMT2) knockout HeLa
DR   Abcam; ab265854
DR   Wikidata; Q112928336
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21059; MAD2L1BP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAGEA6 KO
AC   CVCL_B1WC
SY   Human MAGEA6 knockout HeLa
DR   Abcam; ab265297
DR   Wikidata; Q110431875
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6804; MAGEA6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAGT1 KO
AC   CVCL_B1WD
SY   Human MAGT1 knockout HeLa
DR   Abcam; ab265214
DR   Wikidata; Q110431876
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28880; MAGT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MALT1 KO
AC   CVCL_B1WE
SY   Human MALT1 (MLT) knockout HeLa
DR   Abcam; ab264930
DR   Wikidata; Q110431877
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAN1C1 KO
AC   CVCL_B1WF
SY   Human MAN1C1 (HMIC) knockout HeLa
DR   Abcam; ab265977
DR   Wikidata; Q110431878
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19080; MAN1C1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP3K1 KO
AC   CVCL_B1WG
SY   Human MAP3K1 knockout HeLa
DR   Abcam; ab265505
DR   Wikidata; Q110431879
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP3K11 KO
AC   CVCL_B1WH
SY   Human MAP3K11 (MLK3) knockout HeLa
DR   Abcam; ab264857
DR   Wikidata; Q110431880
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP3K12 KO
AC   CVCL_B1WI
SY   Human MAP3K12 knockout HeLa
DR   Abcam; ab264743
DR   Wikidata; Q110431881
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6851; MAP3K12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP3K2 KO
AC   CVCL_B1WJ
SY   Human MAP3K2 (MEKK2) knockout HeLa
DR   Abcam; ab264944
DR   Wikidata; Q110431882
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP3K20 KO
AC   CVCL_B1WK
SY   Human ZAK knockout HeLa
DR   Abcam; ab265237
DR   Wikidata; Q110431883
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17797; MAP3K20.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP3K8 KO
AC   CVCL_B1WL
SY   Human MAP3K8 (COT) knockout HeLa
DR   Abcam; ab265152
DR   Wikidata; Q110431884
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6860; MAP3K8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP4 KO
AC   CVCL_B1WM
SY   Human MAP4 knockout HeLa
DR   Abcam; ab264838
DR   Wikidata; Q110431885
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6862; MAP4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAP4K3 KO
AC   CVCL_B1WN
SY   Human MAP4K3 (GLK) knockout HeLa
DR   Abcam; ab264796
DR   Wikidata; Q110431886
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6865; MAP4K3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAPK1 KO
AC   CVCL_B1WP
SY   Human MAPK1 (ERK2) knockout HeLa
DR   Abcam; ab265052
DR   Wikidata; Q110431887
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAPK6 KO
AC   CVCL_B1WQ
SY   Human MAPK6 (ERK3) knockout HeLa
DR   Abcam; ab264910
DR   Wikidata; Q110431888
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6879; MAPK6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAPK7 KO
AC   CVCL_B1WR
SY   Human MAPK7 (ERK5) knockout HeLa
DR   Abcam; ab265508
DR   Wikidata; Q110431889
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MAST2 KO
AC   CVCL_B1WS
SY   Human MAST2 (MAST205) knockout HeLa
DR   Abcam; ab265758
DR   Wikidata; Q110431890
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19035; MAST2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MBD1 KO
AC   CVCL_B1WT
SY   Human MBD1 knockout HeLa
DR   Abcam; ab265029
DR   Wikidata; Q110431891
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MBD4 KO
AC   CVCL_B1WU
SY   Human MBD4 (MED1) knockout HeLa
DR   Abcam; ab264937
DR   Wikidata; Q110431893
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6919; MBD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MC2R KO
AC   CVCL_B1WV
SY   Human MC2R knockout HeLa
DR   Abcam; ab264722
DR   Wikidata; Q110431894
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6930; MC2R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MCAM KO
AC   CVCL_B1WW
SY   Human MCAM (CD146) knockout HeLa
DR   Abcam; ab261790
DR   Wikidata; Q110431895
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6934; MCAM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MCFD2 KO
AC   CVCL_B1WX
SY   Human MCFD2 knockout HeLa
DR   Abcam; ab265164
DR   Wikidata; Q110431896
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18451; MCFD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MEOX1 KO
AC   CVCL_B1WY
SY   Human MEOX1 (MOX1) knockout HeLa
DR   Abcam; ab265364
DR   Wikidata; Q110431897
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7013; MEOX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MERTK KO
AC   CVCL_B1WZ
SY   Human MERTK knockout HeLa
DR   Abcam; ab264765
DR   Wikidata; Q110431898
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264765; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa MET KO
AC   CVCL_B1X0
SY   Human MET (Met (c-Met)) knockout HeLa
DR   Abcam; ab265961
DR   Wikidata; Q110431899
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa METTL5 KO
AC   CVCL_B1X1
SY   Human METTL5 (Methyltransferase like 5) knockout HeLa
DR   Abcam; ab265372
DR   Wikidata; Q110431901
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25006; METTL5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MFSD1 KO
AC   CVCL_B1X2
SY   Human MFSD1 knockout HeLa
DR   Abcam; ab265330
DR   Wikidata; Q110431902
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25874; MFSD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MIOS KO
AC   CVCL_B1X3
SY   Human MIOS knockout HeLa
DR   Abcam; ab265880
DR   Wikidata; Q110431903
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21905; MIOS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MISP KO
AC   CVCL_B1X4
SY   Human MISP (C19orf21) knockout HeLa
DR   Abcam; ab265302
DR   Wikidata; Q110431904
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27000; MISP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MKI67 KO
AC   CVCL_B1X5
SY   Human MKI67 (Ki67) knockout HeLa
DR   Abcam; ab255407
DR   Wikidata; Q110431905
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MKNK1 KO
AC   CVCL_B1X6
SY   Human MKNK1 (MNK1) knockout HeLa
DR   Abcam; ab264758
DR   Wikidata; Q110431906
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MLEC KO
AC   CVCL_B1X7
SY   Human MLEC (Malectin) knockout HeLa
DR   Abcam; ab265662
DR   Wikidata; Q110431907
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28973; MLEC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MLH1 KO
AC   CVCL_B1X8
SY   Human MLH1 knockout HeLa
DR   Abcam; ab267223
DR   Wikidata; Q110431908
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MLKL KO
AC   CVCL_B1X9
SY   Human MLKL knockout HeLa
DR   Abcam; ab255408
DR   Wikidata; Q110431909
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26617; MLKL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MME KO
AC   CVCL_B1XA
SY   Human MME (CD10) knockout HeLa
DR   Abcam; ab264794
DR   Wikidata; Q110431910
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7154; MME.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264794; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa MMP24 KO
AC   CVCL_B1XB
SY   Human MMP24 knockout HeLa
DR   Abcam; ab265211
DR   Wikidata; Q110431911
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7172; MMP24.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MMRN1 KO
AC   CVCL_B1XC
SY   Human MMRN1 (ECM) knockout HeLa
DR   Abcam; ab265238
DR   Wikidata; Q110431912
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7178; MMRN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MOK KO
AC   CVCL_B1XD
SY   Human MOK knockout HeLa
DR   Abcam; ab264704
DR   Wikidata; Q110431913
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9833; MOK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MPLKIP KO
AC   CVCL_B1XE
SY   Human MPLKIP (TTDN1) knockout HeLa
DR   Abcam; ab264878
DR   Wikidata; Q110431914
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16002; MPLKIP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MPND KO
AC   CVCL_B1XF
SY   Human MPND knockout HeLa
DR   Abcam; ab265769
DR   Wikidata; Q110431915
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25934; MPND.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MPRIP KO
AC   CVCL_B1XG
SY   Human MPRIP knockout HeLa
DR   Abcam; ab265805
DR   Wikidata; Q110431916
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30321; MPRIP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MPV17 KO
AC   CVCL_B1XH
SY   Human MPV17 knockout HeLa
DR   Abcam; ab265083
DR   Wikidata; Q110431917
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7224; MPV17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MPZL1 KO
AC   CVCL_B1XI
SY   Human MPZL1 (MPZL) knockout HeLa
DR   Abcam; ab265332
DR   Wikidata; Q110431918
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7226; MPZL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MRAS KO
AC   CVCL_B1XJ
SY   Human MRAS knockout HeLa
DR   Abcam; ab265510
DR   Wikidata; Q110431919
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7227; MRAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MRPL40 KO
AC   CVCL_B1XK
SY   Human MRPL40 knockout HeLa
DR   Abcam; ab265240
DR   Wikidata; Q110431920
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14491; MRPL40.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MRPS7 KO
AC   CVCL_B1XL
SY   Human MRPS7 knockout HeLa
DR   Abcam; ab265179
DR   Wikidata; Q110431921
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14499; MRPS7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MSH5 KO
AC   CVCL_B1XM
SY   Human MSH5 knockout HeLa
DR   Abcam; ab265170
DR   Wikidata; Q110431922
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7328; MSH5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MSH6 KO
AC   CVCL_B1XN
SY   Human MSH6 knockout HeLa
DR   Abcam; ab255410
DR   Wikidata; Q110431923
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MSL1 KO
AC   CVCL_B1XP
SY   Human MSL1 knockout HeLa
DR   Abcam; ab265730
DR   Wikidata; Q110431925
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27905; MSL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MSN KO
AC   CVCL_B9VN
SY   Human MSN (Moesin) knockout HeLa
DR   Abcam; ab265020
DR   Wikidata; Q112928337
RX   PubMed=38106655;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7373; MSN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa MT1X KO
AC   CVCL_B1XQ
SY   Human MT1X knockout HeLa
DR   Abcam; ab265309
DR   Wikidata; Q110431926
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7405; MT1X.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MTAP KO
AC   CVCL_B1XR
SY   Human MTAP knockout HeLa
DR   Abcam; ab265272
DR   Wikidata; Q110431929
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MTCH1 KO
AC   CVCL_B1XS
SY   Human MTCH1 knockout HeLa
DR   Abcam; ab265091
DR   Wikidata; Q110431930
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17586; MTCH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MTFP1 KO
AC   CVCL_B1XT
SY   Human MTFP1 (MTP18) knockout HeLa
DR   Abcam; ab265161
DR   Wikidata; Q110431931
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26945; MTFP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MTMR14 KO
AC   CVCL_B1XU
SY   Human MTMR14 knockout HeLa
DR   Abcam; ab265689
DR   Wikidata; Q110431932
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26190; MTMR14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MTMR2 KO
AC   CVCL_B1XV
SY   Human MTMR2 knockout HeLa
DR   Abcam; ab265751
DR   Wikidata; Q110431933
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7450; MTMR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MTMR3 KO
AC   CVCL_B1XW
SY   Human MTMR3 knockout HeLa
DR   Abcam; ab265902
DR   Wikidata; Q110431934
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7451; MTMR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MUC1 KO
AC   CVCL_B1XX
SY   Human MUC1 knockout HeLa
DR   Abcam; ab255412
DR   Wikidata; Q110431935
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MVB12A KO
AC   CVCL_B1XY
SY   Human MVB12A (FAM125A) knockout HeLa
DR   Abcam; ab265886
DR   Wikidata; Q110431936
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25153; MVB12A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MVP KO
AC   CVCL_B1XZ
SY   Human MVP knockout HeLa
DR   Abcam; ab264817
DR   Wikidata; Q110431937
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7531; MVP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MYG1 KO
AC   CVCL_B1Y0
SY   Human C12orf10 knockout HeLa
DR   Abcam; ab266035
DR   Wikidata; Q110431938
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17590; MYG1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MYL9 KO
AC   CVCL_B1Y1
SY   Human MYL9 knockout HeLa
DR   Abcam; ab266036
DR   Wikidata; Q110431939
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15754; MYL9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MYOF KO
AC   CVCL_B1Y2
SY   Human MYOF (Myoferlin) knockout HeLa
DR   Abcam; ab265782
DR   Wikidata; Q110431940
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3656; MYOF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MYPN KO
AC   CVCL_B1Y3
SY   Human MYPN knockout HeLa
DR   Abcam; ab266058
DR   Wikidata; Q110431942
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23246; MYPN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa MZT1 KO
AC   CVCL_B1Y4
SY   Human MZT1 knockout HeLa
DR   Abcam; ab265808
DR   Wikidata; Q110431943
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33830; MZT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NAA60 KO
AC   CVCL_B1Y5
SY   Human NAA60 (FLJ14154) knockout HeLa
DR   Abcam; ab265472
DR   Wikidata; Q110431944
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25875; NAA60.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NARF KO
AC   CVCL_B1Y6
SY   Human NARF (IOP2) knockout HeLa
DR   Abcam; ab265489
DR   Wikidata; Q110431945
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29916; NARF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NBN KO
AC   CVCL_B9VP
SY   Human NBN (p95/NBS1) knockout HeLa
DR   Abcam; ab261834
DR   Wikidata; Q112928338
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NCAM1 KO
AC   CVCL_B1Y7
SY   Human NCAM1 knockout HeLa
DR   Abcam; ab265275
DR   Wikidata; Q110431946
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265275; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa NCAPD3 KO
AC   CVCL_B1Y8
SY   Human NCAPD3 (hCAP-D3) knockout HeLa
DR   Abcam; ab266021
DR   Wikidata; Q110431947
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28952; NCAPD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NCK1 KO
AC   CVCL_B1Y9
SY   Human NCK1 (Nck) knockout HeLa
DR   Abcam; ab265323
DR   Wikidata; Q110431948
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7664; NCK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NCL KO
AC   CVCL_B1YA
SY   Human NCL (Nucleolin) knockout HeLa
DR   Abcam; ab264885
DR   Wikidata; Q110431949
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7667; NCL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NDC1 KO
AC   CVCL_B1YB
SY   Human NDC1 knockout HeLa
DR   Abcam; ab265705
DR   Wikidata; Q110431950
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25525; NDC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NDUFA13 KO
AC   CVCL_B1YC
SY   Human NDUFA13 (GRIM19) knockout HeLa
DR   Abcam; ab265863
DR   Wikidata; Q110431951
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17194; NDUFA13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NDUFA2 KO
AC   CVCL_B1YD
SY   Human NDUFA2 knockout HeLa
DR   Abcam; ab265503
DR   Wikidata; Q110431952
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7685; NDUFA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NDUFA6 KO
AC   CVCL_B1YE
SY   Human NDUFA6 knockout HeLa
DR   Abcam; ab265844
DR   Wikidata; Q110431953
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7690; NDUFA6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NDUFB5 KO
AC   CVCL_B1YF
SY   Human NDUFB5 knockout HeLa
DR   Abcam; ab265466
DR   Wikidata; Q110431955
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7700; NDUFB5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NDUFB9 KO
AC   CVCL_B1YG
SY   Human NDUFB9 knockout HeLa
DR   Abcam; ab265946
DR   Wikidata; Q110431957
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7704; NDUFB9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NEFH KO
AC   CVCL_B1YH
SY   Human NEFH (Neurofilament heavy polypeptide) knockout HeLa
DR   Abcam; ab255413
DR   Wikidata; Q110431958
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7737; NEFH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab255413; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa NEK2 KO
AC   CVCL_B9VQ
SY   Human NEK2 knockout HeLa
DR   Abcam; ab273850
DR   Wikidata; Q112928339
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7745; NEK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NEK6 KO
AC   CVCL_B1YI
SY   Human NEK6 knockout HeLa
DR   Abcam; ab265910
DR   Wikidata; Q110431959
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7749; NEK6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NF1 KO
AC   CVCL_B1YJ
SY   Human NF1 (Neurofibromin) knockout HeLa
DR   Abcam; ab264725
DR   Wikidata; Q110431960
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NF2 KO
AC   CVCL_B1YK
SY   Human NF2 (Merlin) knockout HeLa
DR   Abcam; ab261796
DR   Wikidata; Q110431961
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NFATC1 KO
AC   CVCL_B1YL
SY   Human NFATC1 (NFAT2) knockout HeLa
DR   Abcam; ab265199
DR   Wikidata; Q110431962
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265199; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa NFE2L2 KO
AC   CVCL_B9VR
SY   Human NFE2L2 (Nrf2) knockout HeLa
DR   Abcam; ab262507
DR   Wikidata; Q112928340
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NLGN4X KO
AC   CVCL_B1YM
SY   Human NLGN4X knockout HeLa
DR   Abcam; ab264783
DR   Wikidata; Q110431963
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14287; NLGN4X.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NLK KO
AC   CVCL_B1YN
SY   Human NLK knockout HeLa
DR   Abcam; ab265001
DR   Wikidata; Q110431964
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29858; NLK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NLRX1 KO
AC   CVCL_B1YP
SY   Human NLRX1 knockout HeLa
DR   Abcam; ab265964
DR   Wikidata; Q110431965
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29890; NLRX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NNMT KO
AC   CVCL_B1YQ
SY   Human NNMT knockout HeLa
DR   Abcam; ab265700
DR   Wikidata; Q110431966
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7861; NNMT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NOMO2 KO
AC   CVCL_B1YR
SY   Human NOMO2 knockout HeLa
DR   Abcam; ab265218
DR   Wikidata; Q110431967
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22652; NOMO2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NOS2 KO
AC   CVCL_B1YS
SY   Human NOS2 (iNOS) knockout HeLa
DR   Abcam; ab255416
DR   Wikidata; Q110431968
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NOTCH1 KO
AC   CVCL_B1YT
SY   Human NOTCH1 knockout HeLa
DR   Abcam; ab261762
DR   Wikidata; Q110431970
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NPHS1 KO
AC   CVCL_B1YU
SY   Human Nphs1 (Nephrin) knockout HeLa
DR   Abcam; ab265099
DR   Wikidata; Q110431971
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7908; NPHS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265099; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa NPPB KO
AC   CVCL_B1YV
SY   Human BNP knockout HeLa
DR   Abcam; ab277072
DR   Wikidata; Q110431972
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7940; NPPB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NPR1 KO
AC   CVCL_B1YW
SY   Human NPR1 (Natriuretic Peptide Receptor A/GC-A) knockout HeLa
DR   Abcam; ab265930
DR   Wikidata; Q110431973
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7943; NPR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NPTX1 KO
AC   CVCL_B1YX
SY   Human NPTX1 (NP-I) knockout HeLa
DR   Abcam; ab265186
DR   Wikidata; Q110431975
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7952; NPTX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NPY4R KO
AC   CVCL_B1YY
SY   Human NPY4R knockout HeLa
DR   Abcam; ab265185
DR   Wikidata; Q110431976
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9329; NPY4R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NR2F2 KO
AC   CVCL_B1YZ
SY   Human NR2F2 knockout HeLa
DR   Abcam; ab261829
DR   Wikidata; Q110431977
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7976; NR2F2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab261829; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa NR3C1 KO
AC   CVCL_B1Z0
SY   Human NR3C1 (Glucocorticoid Receptor) knockout HeLa
DR   Abcam; ab261766
DR   Wikidata; Q110431978
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NR3C2 KO
AC   CVCL_B1Z1
SY   Human NR3C2 (Mineralocorticoid Receptor) knockout HeLa
DR   Abcam; ab265540
DR   Wikidata; Q110431979
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NR4A1 KO
AC   CVCL_B9VS
SY   Human NR4A1 (NUR77) knockout HeLa
DR   Abcam; ab264021
DR   Wikidata; Q112928341
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NRAS KO 1
AC   CVCL_B1Z2
SY   Human NRAS knockout HeLa
DR   Abcam; ab264999
DR   Wikidata; Q110431980
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NRAS KO 2
AC   CVCL_B1Z3
SY   Human NRAS knockout HeLa
DR   Abcam; ab267224
DR   Wikidata; Q110431981
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NRAS KO 3
AC   CVCL_B1Z4
SY   Human NRAS knockout HeLa
DR   Abcam; ab267225
DR   Wikidata; Q110431982
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab267225; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa NRBF2 KO
AC   CVCL_B1Z5
SY   Human NRBF2 knockout HeLa
DR   Abcam; ab265986
DR   Wikidata; Q110431983
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19692; NRBF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NRBP2 KO
AC   CVCL_B1Z6
SY   Human NRBP2 knockout HeLa
DR   Abcam; ab265956
DR   Wikidata; Q110431984
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19339; NRBP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NRG2 KO
AC   CVCL_B1Z7
SY   Human NRG2 knockout HeLa
DR   Abcam; ab265747
DR   Wikidata; Q110431985
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7998; NRG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NRG4 KO
AC   CVCL_B1Z8
SY   Human NRG4 knockout HeLa
DR   Abcam; ab264734
DR   Wikidata; Q110431986
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29862; NRG4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NSD2 KO
AC   CVCL_B1Z9
SY   Human WHSC1 (NSD2) knockout HeLa
DR   Abcam; ab264936
DR   Wikidata; Q110431987
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NTRK2 KO
AC   CVCL_B1ZA
SY   Human NTRK2 (TrkB) knockout HeLa
DR   Abcam; ab261808
DR   Wikidata; Q110431988
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8032; NTRK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab261808; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa NUDT2 KO
AC   CVCL_B1ZB
SY   Human NUDT2 knockout HeLa
DR   Abcam; ab265752
DR   Wikidata; Q110431989
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8049; NUDT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NUDT3 KO
AC   CVCL_B1ZC
SY   Human NUDT3 (DIPP) knockout HeLa
DR   Abcam; ab265451
DR   Wikidata; Q110431990
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8050; NUDT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NUP153 KO
AC   CVCL_B1ZD
SY   Human NUP153 knockout HeLa
DR   Abcam; ab265421
DR   Wikidata; Q110431991
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8062; NUP153.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa NUPR1 KO
AC   CVCL_B1ZE
SY   Human NUPR1 (p8) knockout HeLa
DR   Abcam; ab264759
DR   Wikidata; Q110431992
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29990; NUPR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OAS1 KO
AC   CVCL_B1ZF
SY   Human OAS1 knockout HeLa
DR   Abcam; ab265578
DR   Wikidata; Q110431993
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8086; OAS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OBSCN KO
AC   CVCL_B1ZG
SY   Human OBSCN knockout HeLa
DR   Abcam; ab265496
DR   Wikidata; Q110431994
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15719; OBSCN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OGA KO
AC   CVCL_B1ZH
SY   Human MGEA5 (OGA) knockout HeLa
DR   Abcam; ab265821
DR   Wikidata; Q110431995
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7056; OGA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OGFR KO
AC   CVCL_B1ZI
SY   Human OGFR knockout HeLa
DR   Abcam; ab266037
DR   Wikidata; Q110431996
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15768; OGFR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OSBPL5 KO
AC   CVCL_B1ZJ
SY   Human OSBPL5 (ORP5) knockout HeLa
DR   Abcam; ab265771
DR   Wikidata; Q110431997
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16392; OSBPL5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OSMR KO
AC   CVCL_B1ZK
SY   Human OSMR knockout HeLa
DR   Abcam; ab264713
DR   Wikidata; Q110431998
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8507; OSMR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OTUD4 KO
AC   CVCL_B1ZL
SY   Human OTUD4 (HIN-1) knockout HeLa
DR   Abcam; ab265979
DR   Wikidata; Q110431999
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24949; OTUD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OTUD7B KO
AC   CVCL_B1ZM
SY   Human OTUD7B (Cezanne) knockout HeLa
DR   Abcam; ab265997
DR   Wikidata; Q110432000
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16683; OTUD7B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa OTX2 KO
AC   CVCL_B1ZN
SY   Human OTX2 knockout HeLa
DR   Abcam; ab265267
DR   Wikidata; Q110432001
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8522; OTX2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265267; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa OXCT1 KO
AC   CVCL_B1ZP
SY   Human OXCT1 (SCOT) knockout HeLa
DR   Abcam; ab265358
DR   Wikidata; Q110432002
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8527; OXCT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa P2RX5 KO
AC   CVCL_B1ZQ
SY   Human P2RX5 (P2X5) knockout HeLa
DR   Abcam; ab265865
DR   Wikidata; Q110432003
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8536; P2RX5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PACSIN2 KO
AC   CVCL_B1ZR
SY   Human PACSIN2 knockout HeLa
DR   Abcam; ab265298
DR   Wikidata; Q110432004
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8571; PACSIN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PAK1 KO
AC   CVCL_B1ZS
SY   Human PAK1 knockout HeLa
DR   Abcam; ab264889
DR   Wikidata; Q110432005
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PAK2 KO
AC   CVCL_B1ZT
SY   Human PAK2 knockout HeLa
DR   Abcam; ab264814
DR   Wikidata; Q110432006
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PALM KO
AC   CVCL_B1ZU
SY   Human PALM (Paralemmin-1) knockout HeLa
DR   Abcam; ab264954
DR   Wikidata; Q110432007
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8594; PALM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PALS1 KO
AC   CVCL_B1ZV
SY   Human MPP5 (Pals1) knockout HeLa
DR   Abcam; ab265715
DR   Wikidata; Q110432008
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18669; PALS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PAPSS2 KO
AC   CVCL_B1ZW
SY   Human PAPSS2 knockout HeLa
DR   Abcam; ab265516
DR   Wikidata; Q110432010
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8604; PAPSS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PAQR4 KO
AC   CVCL_B1ZX
SY   Human PAQR4 knockout HeLa
DR   Abcam; ab265181
DR   Wikidata; Q110432011
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26386; PAQR4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PAQR5 KO
AC   CVCL_B1ZY
SY   Human PAQR5 knockout HeLa
DR   Abcam; ab265542
DR   Wikidata; Q110432012
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29645; PAQR5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PARD6A KO
AC   CVCL_B1ZZ
SY   Human PARD6A (PAR6) knockout HeLa
DR   Abcam; ab265171
DR   Wikidata; Q110432013
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15943; PARD6A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PARP3 KO
AC   CVCL_B2A0
SY   Human PARP3 (IRT1) knockout HeLa
DR   Abcam; ab265173
DR   Wikidata; Q110432014
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PATL1 KO
AC   CVCL_B2A1
SY   Human PATL1 (Pat1b) knockout HeLa
DR   Abcam; ab265243
DR   Wikidata; Q110432015
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26721; PATL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PCNT KO
AC   CVCL_B2A2
SY   Human PCNT (Pericentrin) knockout HeLa
DR   Abcam; ab264973
DR   Wikidata; Q110432016
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16068; PCNT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PCOLCE2 KO
AC   CVCL_B2A3
SY   Human PCOLCE2 (PCPE-2) knockout HeLa
DR   Abcam; ab265453
DR   Wikidata; Q110432017
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8739; PCOLCE2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDCD1 KO
AC   CVCL_B2A4
SY   Human PDCD1 (PD1) knockout HeLa
DR   Abcam; ab255417
DR   Wikidata; Q110432018
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDCD10 KO
AC   CVCL_B2A5
SY   Human PDCD10 (CCM3) knockout HeLa
DR   Abcam; ab265755
DR   Wikidata; Q110432019
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8761; PDCD10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDCD4 KO
AC   CVCL_B2A6
SY   Human PDCD4 knockout HeLa
DR   Abcam; ab261833
DR   Wikidata; Q110432020
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8763; PDCD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDE3B KO
AC   CVCL_B2A7
SY   Human PDE3B knockout HeLa
DR   Abcam; ab264718
DR   Wikidata; Q110432021
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8779; PDE3B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDE4B KO
AC   CVCL_B2A8
SY   Human PDE4B knockout HeLa
DR   Abcam; ab265259
DR   Wikidata; Q110432023
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8781; PDE4B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDGFC KO
AC   CVCL_B2A9
SY   Human PDGFC knockout HeLa
DR   Abcam; ab264740
DR   Wikidata; Q110432024
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8801; PDGFC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDGFD KO
AC   CVCL_B2AA
SY   Human PDGFD (SCDGFB) knockout HeLa
DR   Abcam; ab265304
DR   Wikidata; Q110432026
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30620; PDGFD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265304; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa PDGFRA KO
AC   CVCL_B2AB
SY   Human PDGFRA knockout HeLa
DR   Abcam; ab261827
DR   Wikidata; Q110432027
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab261827; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa PDHA1 KO
AC   CVCL_B2AC
SY   Human PDHA1 knockout HeLa
DR   Abcam; ab261866
DR   Wikidata; Q110432028
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8806; PDHA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDIA5 KO
AC   CVCL_B2AD
SY   Human PDIA5 knockout HeLa
DR   Abcam; ab265829
DR   Wikidata; Q110432029
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24811; PDIA5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PDK4 KO
AC   CVCL_B2AE
SY   Human PDK4 knockout HeLa
DR   Abcam; ab261805
DR   Wikidata; Q110432030
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8812; PDK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PEG10 KO
AC   CVCL_B2AF
SY   Human PEG10 (EDR) knockout HeLa
DR   Abcam; ab265925
DR   Wikidata; Q110432031
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14005; PEG10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PERP KO
AC   CVCL_B2AG
SY   Human PERP knockout HeLa
DR   Abcam; ab265335
DR   Wikidata; Q110432032
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17637; PERP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PFN2 KO
AC   CVCL_C0BK
SY   Human PFN2 (Profilin 2) knockout HeLa
DR   Abcam; ab265833
DR   Wikidata; Q112928342
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8882; PFN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PFKP KO
AC   CVCL_B2AH
SY   Human PFKP knockout HeLa
DR   Abcam; ab265136
DR   Wikidata; Q110432033
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8878; PFKP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PGAM5 KO
AC   CVCL_B2AI
SY   Human PGAM5 knockout HeLa
DR   Abcam; ab265141
DR   Wikidata; Q110432035
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28763; PGAM5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PGR KO
AC   CVCL_B2AJ
SY   Human PGR (Progesterone Receptor) knockout HeLa
DR   Abcam; ab261785
DR   Wikidata; Q110432037
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8910; PGR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PHF6 KO
AC   CVCL_B2AK
SY   Human PHF6 (PHD finger protein 6) knockout HeLa
DR   Abcam; ab264902
DR   Wikidata; Q110432038
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PHIP KO
AC   CVCL_B2AL
SY   Human PHIP knockout HeLa
DR   Abcam; ab265403
DR   Wikidata; Q110432039
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15673; PHIP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PHLDA3 KO
AC   CVCL_B2AM
SY   Human PHLDA3 knockout HeLa
DR   Abcam; ab265197
DR   Wikidata; Q110432040
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8934; PHLDA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PI4K2A KO
AC   CVCL_B2AN
SY   Human PI4K2A knockout HeLa
DR   Abcam; ab265820
DR   Wikidata; Q110432041
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PI4K2B KO
AC   CVCL_B2AP
SY   Human PI4K2B knockout HeLa
DR   Abcam; ab264683
DR   Wikidata; Q110432042
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PICALM KO
AC   CVCL_B2AQ
SY   Human PICALM knockout HeLa
DR   Abcam; ab265653
DR   Wikidata; Q110432043
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15514; PICALM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PIK3C2A KO
AC   CVCL_B2AR
SY   Human PIK3C2A (PI 3 Kinase Class 2A/Cpk) knockout HeLa
DR   Abcam; ab264943
DR   Wikidata; Q110432044
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PIK3R1 KO
AC   CVCL_B2AS
SY   Human PIK3R1 (PI 3 Kinase p85 alpha) knockout HeLa
DR   Abcam; ab265116
DR   Wikidata; Q110432045
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PIP4K2A KO
AC   CVCL_B2AT
SY   Human PIP4K2A knockout HeLa
DR   Abcam; ab265200
DR   Wikidata; Q110432046
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PIP4K2C KO
AC   CVCL_B2AU
SY   Human PIP4K2C (PIP5K2 gamma) knockout HeLa
DR   Abcam; ab265390
DR   Wikidata; Q110432047
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23786; PIP4K2C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PIP5K1C KO
AC   CVCL_B2AV
SY   Human PIP5K1C knockout HeLa
DR   Abcam; ab265545
DR   Wikidata; Q110432048
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PITPNB KO
AC   CVCL_B2AW
SY   Human PITPNB knockout HeLa
DR   Abcam; ab264940
DR   Wikidata; Q110432050
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9002; PITPNB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PKDCC KO
AC   CVCL_B2AX
SY   Human PKDCC (VLK) knockout HeLa
DR   Abcam; ab265084
DR   Wikidata; Q110432052
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25123; PKDCC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PKN2 KO
AC   CVCL_B2AY
SY   Human PKN2 knockout HeLa
DR   Abcam; ab264691
DR   Wikidata; Q110432053
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PKP3 KO
AC   CVCL_B2AZ
SY   Human PKP3 (Plakophilin 3) knockout HeLa
DR   Abcam; ab265539
DR   Wikidata; Q110432054
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9025; PKP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLA2G12A KO
AC   CVCL_B2B0
SY   Human PLA2G12A (Phospholipase A2 XII) knockout HeLa
DR   Abcam; ab265089
DR   Wikidata; Q110432055
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18554; PLA2G12A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLA2G15 KO
AC   CVCL_B2B1
SY   Human PLA2G15 (LPLA2) knockout HeLa
DR   Abcam; ab265293
DR   Wikidata; Q110432056
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17163; PLA2G15.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLA2G4A KO
AC   CVCL_B2B2
SY   Human PLA2G4A (Cytosolic Phospholipase A2) knockout HeLa
DR   Abcam; ab265490
DR   Wikidata; Q110432057
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLAA KO
AC   CVCL_B2B3
SY   Human PLAA knockout HeLa
DR   Abcam; ab265255
DR   Wikidata; Q110432058
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9043; PLAA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLCB1 KO
AC   CVCL_B2B4
SY   Human Plcb1 (Phospholipase C beta 1) knockout HeLa
DR   Abcam; ab266033
DR   Wikidata; Q110432059
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15917; PLCB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLCB3 KO
AC   CVCL_B2B5
SY   Human PLCB3 (Phospholipase C beta 3) knockout HeLa
DR   Abcam; ab266034
DR   Wikidata; Q110432060
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLD2 KO
AC   CVCL_B2B6
SY   Human PLD2 knockout HeLa
DR   Abcam; ab265183
DR   Wikidata; Q110432061
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9068; PLD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PLK2 KO
AC   CVCL_B2B7
SY   Human PLK2 knockout HeLa
DR   Abcam; ab264810
DR   Wikidata; Q110432063
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PML KO
AC   CVCL_B2B8
SY   Human PML (PML Protein) knockout HeLa
DR   Abcam; ab261811
DR   Wikidata; Q110432064
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PMS2 KO
AC   CVCL_B2B9
SY   Human PMS2 knockout HeLa
DR   Abcam; ab261776
DR   Wikidata; Q110432065
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9122; PMS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PNKD KO
AC   CVCL_B2BA
SY   Human PNKD knockout HeLa
DR   Abcam; ab265134
DR   Wikidata; Q110432066
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9153; PNKD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PODXL KO
AC   CVCL_B2BB
SY   Human PODXL knockout HeLa
DR   Abcam; ab264984
DR   Wikidata; Q110432067
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POGK KO
AC   CVCL_B2BC
SY   Human POGK knockout HeLa
DR   Abcam; ab265917
DR   Wikidata; Q110432068
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18800; POGK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POLB KO
AC   CVCL_B2BD
SY   Human POLB (DNA Polymerase beta) knockout HeLa
DR   Abcam; ab261748
DR   Wikidata; Q110432069
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab261748; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa POLDIP3 KO
AC   CVCL_B2BE
SY   Human POLDIP3 (p46) knockout HeLa
DR   Abcam; ab265843
DR   Wikidata; Q110432070
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23782; POLDIP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POLE4 KO
AC   CVCL_B2BF
SY   Human POLE4 knockout HeLa
DR   Abcam; ab264947
DR   Wikidata; Q110432071
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18755; POLE4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POLL KO
AC   CVCL_B2BG
SY   Human POLL (DNA Polymerase lambda/Polk) knockout HeLa
DR   Abcam; ab264754
DR   Wikidata; Q110432072
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9184; POLL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POLM KO
AC   CVCL_B2BH
SY   Human POLM (DNA polymerase mu) knockout HeLa
DR   Abcam; ab265557
DR   Wikidata; Q110432073
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9185; POLM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POLR1D KO
AC   CVCL_B2BI
SY   Human POLR1D knockout HeLa
DR   Abcam; ab265470
DR   Wikidata; Q110432074
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20422; POLR1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PON2 KO
AC   CVCL_B2BJ
SY   Human PON2 knockout HeLa
DR   Abcam; ab265927
DR   Wikidata; Q110432075
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9205; PON2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POR KO
AC   CVCL_B2BK
SY   Human POR (Cytochrome P450 Reductase) knockout HeLa
DR   Abcam; ab264996
DR   Wikidata; Q110432076
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PORCN KO
AC   CVCL_B2BL
SY   Human PORCN (PPN) knockout HeLa
DR   Abcam; ab265129
DR   Wikidata; Q110432078
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17652; PORCN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa POSTN KO
AC   CVCL_B2BM
SY   Human POSTN (Periostin) knockout HeLa
DR   Abcam; ab261806
DR   Wikidata; Q110432080
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16953; POSTN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPIB KO
AC   CVCL_B2BN
SY   Human PPIB (Cyclophilin B) knockout HeLa
DR   Abcam; ab261746
DR   Wikidata; Q110432081
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9255; PPIB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPID KO
AC   CVCL_B2BP
SY   Human PPID (Cyclophilin 40) knockout HeLa
DR   Abcam; ab265788
DR   Wikidata; Q110432082
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9257; PPID.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPM1A KO
AC   CVCL_B2BQ
SY   Human PPM1A knockout HeLa
DR   Abcam; ab265348
DR   Wikidata; Q110432083
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9275; PPM1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPM1H KO
AC   CVCL_B2BR
SY   Human PPM1H knockout HeLa
DR   Abcam; ab265564
DR   Wikidata; Q110432084
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18583; PPM1H.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP1CC KO
AC   CVCL_B2BS
SY   Human PPP1CC (PP1C gamma) knockout HeLa
DR   Abcam; ab264875
DR   Wikidata; Q110432085
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9283; PPP1CC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP1R13L KO
AC   CVCL_B2BT
SY   Human PPP1R13L (iASPP) knockout HeLa
DR   Abcam; ab265802
DR   Wikidata; Q110432086
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18838; PPP1R13L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP1R15B KO
AC   CVCL_B2BU
SY   Human PPP1R15B knockout HeLa
DR   Abcam; ab265959
DR   Wikidata; Q110432087
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14951; PPP1R15B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP1R2 KO
AC   CVCL_B2BV
SY   Human PPP1R2 (Protein phosphatase 1 inhibitor subunit 2) knockout HeLa
DR   Abcam; ab265684
DR   Wikidata; Q110432088
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9288; PPP1R2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP1R26 KO
AC   CVCL_B2BW
SY   Human PPP1R26 (KIAA0649) knockout HeLa
DR   Abcam; ab265333
DR   Wikidata; Q110432089
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29089; PPP1R26.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP1R3C KO
AC   CVCL_B2BX
SY   Human PPP1R3C knockout HeLa
DR   Abcam; ab265106
DR   Wikidata; Q110432090
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9293; PPP1R3C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP2R5E KO
AC   CVCL_B2BY
SY   Human PPP2R5E knockout HeLa
DR   Abcam; ab265637
DR   Wikidata; Q110432091
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9313; PPP2R5E.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP3CA KO
AC   CVCL_B2BZ
SY   Human PPP3CA (Calcineurin A) knockout HeLa
DR   Abcam; ab265130
DR   Wikidata; Q110432093
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9314; PPP3CA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PPP4R3B KO
AC   CVCL_B2C0
SY   Human SMEK2 knockout HeLa
DR   Abcam; ab265691
DR   Wikidata; Q110432094
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29267; PPP4R3B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRAP1 KO
AC   CVCL_B2C1
SY   Human PRAP1 knockout HeLa
DR   Abcam; ab265474
DR   Wikidata; Q110432095
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23304; PRAP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRKAA1 KO
AC   CVCL_E1G1
SY   Human PRKAA1 knockout HeLa
DR   Abcam; ab277149
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Abcam HeLa PRKACB KO
AC   CVCL_B2C2
SY   Human PRKACB (PKA beta catalytic subunit) knockout HeLa
DR   Abcam; ab264673
DR   Wikidata; Q110432097
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRKAR1B KO
AC   CVCL_B2C3
SY   Human PRKAR1B knockout HeLa
DR   Abcam; ab265193
DR   Wikidata; Q110432098
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9390; PRKAR1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRKAR2A KO
AC   CVCL_B2C4
SY   Human PRKAR2A (PKA R2/PKR2) knockout HeLa
DR   Abcam; ab265748
DR   Wikidata; Q110432099
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9391; PRKAR2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRKCD KO
AC   CVCL_B2C5
SY   Human PRKCD (PKC delta) knockout HeLa
DR   Abcam; ab265721
DR   Wikidata; Q110432100
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9399; PRKCD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRKCI KO
AC   CVCL_B2C6
SY   Human PRKCI (PKC iota) knockout HeLa
DR   Abcam; ab264670
DR   Wikidata; Q110432101
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRKD3 KO
AC   CVCL_B2C7
SY   Human PRKD3 (PKC nu/PRKD3) knockout HeLa
DR   Abcam; ab265050
DR   Wikidata; Q110432102
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9408; PRKD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRRT2 KO
AC   CVCL_B2C8
SY   Human PRRT2 knockout HeLa
DR   Abcam; ab265360
DR   Wikidata; Q110432103
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30500; PRRT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRSS21 KO
AC   CVCL_B2C9
SY   Human PRSS21 (ESP1) knockout HeLa
DR   Abcam; ab265809
DR   Wikidata; Q110432105
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9485; PRSS21.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PRSS23 KO
AC   CVCL_B2CA
SY   Human PRSS23 knockout HeLa
DR   Abcam; ab265210
DR   Wikidata; Q110432106
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14370; PRSS23.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSAP KO
AC   CVCL_B2CB
SY   Human PSAP knockout HeLa
DR   Abcam; ab265989
DR   Wikidata; Q110432108
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9498; PSAP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSCA KO
AC   CVCL_B2CC
SY   Human PSCA knockout HeLa
DR   Abcam; ab264676
DR   Wikidata; Q110432109
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9500; PSCA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSENEN KO
AC   CVCL_B2CD
SY   Human PSENEN (PEN2) knockout HeLa
DR   Abcam; ab265826
DR   Wikidata; Q110432110
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30100; PSENEN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265826; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa PSKH1 KO
AC   CVCL_B2CE
SY   Human PSKH1 knockout HeLa
DR   Abcam; ab265146
DR   Wikidata; Q110432111
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9529; PSKH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSMB10 KO
AC   CVCL_B2CF
SY   Human PSMB10 (MECL1) knockout HeLa
DR   Abcam; ab264923
DR   Wikidata; Q110432112
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9538; PSMB10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSMD10 KO
AC   CVCL_B2CG
SY   Human PSMD10 (Gankyrin) knockout HeLa
DR   Abcam; ab265680
DR   Wikidata; Q110432113
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9555; PSMD10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSMD5 KO
AC   CVCL_B2CH
SY   Human PSMD5 knockout HeLa
DR   Abcam; ab265558
DR   Wikidata; Q110432114
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9563; PSMD5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSME4 KO
AC   CVCL_B2CI
SY   Human PSME4 (Proteasome Activator Subunit 4) knockout HeLa
DR   Abcam; ab265661
DR   Wikidata; Q110432115
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20635; PSME4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PSRC1 KO
AC   CVCL_B2CJ
SY   Human PSRC1 (DDA3) knockout HeLa
DR   Abcam; ab265242
DR   Wikidata; Q110432116
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24472; PSRC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTBP1 KO
AC   CVCL_B2CK
SY   Human PTBP1 knockout HeLa
DR   Abcam; ab265155
DR   Wikidata; Q110432117
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9583; PTBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTEN KO
AC   CVCL_B2CL
SY   Human PTEN knockout HeLa
DR   Abcam; ab255419
DR   Wikidata; Q110432118
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTGER3 KO
AC   CVCL_B2CM
SY   Human PTGER3 knockout HeLa
DR   Abcam; ab265517
DR   Wikidata; Q110432119
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9595; PTGER3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTGFRN KO
AC   CVCL_B2CN
SY   Human PTGFRN knockout HeLa
DR   Abcam; ab265538
DR   Wikidata; Q110432121
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9601; PTGFRN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTGR1 KO
AC   CVCL_B2CP
SY   Human PTGR1 knockout HeLa
DR   Abcam; ab265169
DR   Wikidata; Q110432122
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18429; PTGR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTGS2 KO
AC   CVCL_B2CQ
SY   Human PTGS2 (COX2 / Cyclooxygenase 2) knockout HeLa
DR   Abcam; ab255420
DR   Wikidata; Q110432123
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9605; PTGS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTPN1 KO
AC   CVCL_B2CR
SY   Human PTPN1 (PTP1B) knockout HeLa
DR   Abcam; ab265014
DR   Wikidata; Q110432124
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTPN13 KO
AC   CVCL_B2CS
SY   Human PTPN13 (FAP-1) knockout HeLa
DR   Abcam; ab265724
DR   Wikidata; Q110432125
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9646; PTPN13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTPRS KO
AC   CVCL_B2CT
SY   Human PTPRS knockout HeLa
DR   Abcam; ab265156
DR   Wikidata; Q110432126
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9681; PTPRS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PTS KO
AC   CVCL_B2CU
SY   Human PTS (PTPS) knockout HeLa
DR   Abcam; ab264913
DR   Wikidata; Q110432127
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9689; PTS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PUM1 KO
AC   CVCL_B2CV
SY   Human PUM1 (Pumilio 1) knockout HeLa
DR   Abcam; ab265285
DR   Wikidata; Q110432128
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14957; PUM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PUS7 KO
AC   CVCL_B2CW
SY   Human PUS7 knockout HeLa
DR   Abcam; ab265407
DR   Wikidata; Q110432129
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26033; PUS7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa PXN KO
AC   CVCL_B2CX
SY   Human PXN (Paxillin) knockout HeLa
DR   Abcam; ab264767
DR   Wikidata; Q110432130
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9718; PXN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa QRICH1 KO
AC   CVCL_B2CY
SY   Human QRICH1 (Glutamine-rich protein 1) knockout HeLa
DR   Abcam; ab266043
DR   Wikidata; Q110432131
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24713; QRICH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa QTRT1 KO
AC   CVCL_B2CZ
SY   Human QTRT1 knockout HeLa
DR   Abcam; ab265454
DR   Wikidata; Q110432133
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23797; QTRT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAB20 KO
AC   CVCL_B2D0
SY   Human RAB20 knockout HeLa
DR   Abcam; ab265924
DR   Wikidata; Q110432134
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18260; RAB20.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAB27A KO
AC   CVCL_B2D1
SY   Human RAB27A knockout HeLa
DR   Abcam; ab265123
DR   Wikidata; Q110432135
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAB31 KO
AC   CVCL_B2D2
SY   Human RAB31 knockout HeLa
DR   Abcam; ab265371
DR   Wikidata; Q110432136
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9771; RAB31.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAB35 KO
AC   CVCL_B2D3
SY   Human RAB35 knockout HeLa
DR   Abcam; ab265984
DR   Wikidata; Q110432137
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9774; RAB35.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAB7A KO
AC   CVCL_B2D4
SY   Human RAB7A (RAB7) knockout HeLa
DR   Abcam; ab255423
DR   Wikidata; Q110432138
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAB8A KO
AC   CVCL_B2D5
SY   Human RAB8A knockout HeLa
DR   Abcam; ab264993
DR   Wikidata; Q110432139
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAB9A KO
AC   CVCL_B2D6
SY   Human RAB9A (Rab9) knockout HeLa
DR   Abcam; ab265693
DR   Wikidata; Q110432140
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9792; RAB9A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RABAC1 KO
AC   CVCL_B2D7
SY   Human RABAC1 (PRA1) knockout HeLa
DR   Abcam; ab265702
DR   Wikidata; Q110432141
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9794; RABAC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAD1 KO
AC   CVCL_B2D8
SY   Human RAD1 knockout HeLa
DR   Abcam; ab265749
DR   Wikidata; Q110432142
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9806; RAD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAF1 KO
AC   CVCL_B2D9
SY   Human RAF1 knockout HeLa
DR   Abcam; ab264978
DR   Wikidata; Q110432143
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RALA KO
AC   CVCL_B2DA
SY   Human RALA knockout HeLa
DR   Abcam; ab265092
DR   Wikidata; Q110432146
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9839; RALA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RALBP1 KO
AC   CVCL_B2DB
SY   Human RALBP1 knockout HeLa
DR   Abcam; ab265404
DR   Wikidata; Q110432147
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9841; RALBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RANBP10 KO
AC   CVCL_B2DC
SY   Human RANBP10 knockout HeLa
DR   Abcam; ab277990
DR   Wikidata; Q110432148
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29285; RANBP10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RANBP2 KO
AC   CVCL_B2DD
SY   Human RANBP2 knockout HeLa
DR   Abcam; ab265618
DR   Wikidata; Q110432149
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9848; RANBP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAP1GDS1 KO
AC   CVCL_B2DE
SY   Human RAP1GDS1 knockout HeLa
DR   Abcam; ab265203
DR   Wikidata; Q110432150
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9859; RAP1GDS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RARA KO
AC   CVCL_B2DF
SY   Human RARA (Retinoic Acid Receptor alpha) knockout HeLa
DR   Abcam; ab265176
DR   Wikidata; Q110432151
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9864; RARA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RAVER1 KO
AC   CVCL_B2DG
SY   Human RAVER1 knockout HeLa
DR   Abcam; ab265341
DR   Wikidata; Q110432152
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30296; RAVER1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RBBP7 KO
AC   CVCL_B2DH
SY   Human RBBP7 (RbAp46) knockout HeLa
DR   Abcam; ab264677
DR   Wikidata; Q110432153
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9890; RBBP7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RBL1 KO
AC   CVCL_B2DI
SY   Human RBL1 (p107) knockout HeLa
DR   Abcam; ab264706
DR   Wikidata; Q110432154
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9893; RBL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RBPMS KO
AC   CVCL_B2DJ
SY   Human RBPMS knockout HeLa
DR   Abcam; ab264697
DR   Wikidata; Q110432155
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19097; RBPMS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RCHY1 KO
AC   CVCL_B2DK
SY   Human RCHY1 (Pirh2) knockout HeLa
DR   Abcam; ab265478
DR   Wikidata; Q110432156
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17479; RCHY1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RELA KO
AC   CVCL_B2DL
SY   Human RELA (NF-kB p65) knockout HeLa
DR   Abcam; ab255425
DR   Wikidata; Q110432157
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RELB KO
AC   CVCL_B2DM
SY   Human RELB (Rel B) knockout HeLa
DR   Abcam; ab265948
DR   Wikidata; Q110432158
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9956; RELB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa REST KO
AC   CVCL_B9VT
SY   Human REST (NRSF) knockout HeLa
DR   Abcam; ab265017
DR   Wikidata; Q112928343
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9966; REST.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa REXO4 KO
AC   CVCL_B2DN
SY   Human REXO4 knockout HeLa
DR   Abcam; ab265222
DR   Wikidata; Q110432159
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12820; REXO4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RFWD3 KO
AC   CVCL_B2DP
SY   Human RFWD3 knockout HeLa
DR   Abcam; ab265128
DR   Wikidata; Q110432160
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25539; RFWD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RHOT1 KO
AC   CVCL_B2DQ
SY   Human RHOT1 (MIRO1) knockout HeLa
DR   Abcam; ab265792
DR   Wikidata; Q110432161
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21168; RHOT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RHOT2 KO
AC   CVCL_B2DR
SY   Human RHOT2 (MIRO2) knockout HeLa
DR   Abcam; ab265801
DR   Wikidata; Q110432162
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21169; RHOT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RIN1 KO
AC   CVCL_B2DS
SY   Human RIN1 knockout HeLa
DR   Abcam; ab265507
DR   Wikidata; Q110432163
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18749; RIN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RIOK3 KO
AC   CVCL_B2DT
SY   Human RIOK3 knockout HeLa
DR   Abcam; ab264774
DR   Wikidata; Q110432164
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11451; RIOK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RIPK2 KO
AC   CVCL_B2DU
SY   Human RIPK2 (RIP2) knockout HeLa
DR   Abcam; ab264688
DR   Wikidata; Q110432165
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10020; RIPK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RIPOR1 KO
AC   CVCL_B2DV
SY   Human FAM65A knockout HeLa
DR   Abcam; ab265944
DR   Wikidata; Q110432166
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25836; RIPOR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RMDN3 KO
AC   CVCL_B2DW
SY   Human RMDN3 (PTPIP51) knockout HeLa
DR   Abcam; ab265688
DR   Wikidata; Q110432167
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25550; RMDN3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RNF149 KO
AC   CVCL_B2DX
SY   Human RNF149 knockout HeLa
DR   Abcam; ab265671
DR   Wikidata; Q110432168
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23137; RNF149.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RNF2 KO
AC   CVCL_B2DY
SY   Human RNF2 (RING2 / RING1B) knockout HeLa
DR   Abcam; ab264845
DR   Wikidata; Q110432169
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RNF4 KO
AC   CVCL_B2DZ
SY   Human RNF4 knockout HeLa
DR   Abcam; ab265299
DR   Wikidata; Q110432170
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10067; RNF4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RNF41 KO
AC   CVCL_B2E0
SY   Human RNF41 (NRDP1) knockout HeLa
DR   Abcam; ab265213
DR   Wikidata; Q110432172
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18401; RNF41.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ROBO1 KO
AC   CVCL_E1G2
SY   Human ROBO1 knockout HeLa
DR   Abcam; ab275835
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10249; ROBO1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Abcam HeLa ROCK2 KO
AC   CVCL_B2E1
SY   Human ROCK2 knockout HeLa
DR   Abcam; ab265679
DR   Wikidata; Q110432174
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RORC KO
AC   CVCL_B2E2
SY   Human RORC (ROR gamma) knockout HeLa
DR   Abcam; ab265090
DR   Wikidata; Q110432175
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10260; RORC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RPL36A KO
AC   CVCL_B2E3
SY   Human RPL36A knockout HeLa
DR   Abcam; ab265182
DR   Wikidata; Q110432176
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10359; RPL36A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RPRM KO
AC   CVCL_B2E4
SY   Human RPRM (Protein reprimo) knockout HeLa
DR   Abcam; ab265810
DR   Wikidata; Q110432177
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24201; RPRM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RPS27L KO
AC   CVCL_B2E5
SY   Human RPS27L knockout HeLa
DR   Abcam; ab265918
DR   Wikidata; Q110432178
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18476; RPS27L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RRAGB KO
AC   CVCL_B2E6
SY   Human RRAGB knockout HeLa
DR   Abcam; ab264761
DR   Wikidata; Q110432179
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19901; RRAGB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RRAGC KO
AC   CVCL_B2E7
SY   Human RRAGC knockout HeLa
DR   Abcam; ab264753
DR   Wikidata; Q110432180
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19902; RRAGC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RRAS KO
AC   CVCL_B2E8
SY   Human RRAS knockout HeLa
DR   Abcam; ab265306
DR   Wikidata; Q110432181
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10447; RRAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265306; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa RRBP1 KO
AC   CVCL_B2E9
SY   Human RRBP1 knockout HeLa
DR   Abcam; ab265246
DR   Wikidata; Q110432182
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10448; RRBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RRM2B KO
AC   CVCL_B2EA
SY   Human RRM2B (p53R2) knockout HeLa
DR   Abcam; ab261769
DR   Wikidata; Q110432183
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17296; RRM2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RRP36 KO
AC   CVCL_B2EB
SY   Human RRP36 knockout HeLa
DR   Abcam; ab266019
DR   Wikidata; Q110432184
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21374; RRP36.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RTN4RL2 KO
AC   CVCL_B2EC
SY   Human RTN4RL2 (NgR2) knockout HeLa
DR   Abcam; ab265229
DR   Wikidata; Q110432185
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23053; RTN4RL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RUNX1 KO
AC   CVCL_B2ED
SY   Human RUNX1 (AML1) knockout HeLa
DR   Abcam; ab265486
DR   Wikidata; Q110432187
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa RYK KO
AC   CVCL_B2EE
SY   Human RYK knockout HeLa
DR   Abcam; ab265518
DR   Wikidata; Q110432188
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10481; RYK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa S100A11 KO
AC   CVCL_B2EF
SY   Human S100A11 knockout HeLa
DR   Abcam; ab265085
DR   Wikidata; Q110432189
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10488; S100A11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa S100A16 KO
AC   CVCL_B2EG
SY   Human S100A16 knockout HeLa
DR   Abcam; ab265316
DR   Wikidata; Q110432190
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20441; S100A16.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa S100A4 KO
AC   CVCL_B2EH
SY   Human S100A4 knockout HeLa
DR   Abcam; ab265709
DR   Wikidata; Q110432191
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10494; S100A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa S100A8 KO
AC   CVCL_B2EI
SY   Human S100A8 (MRP8) knockout HeLa
DR   Abcam; ab265632
DR   Wikidata; Q110432192
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10498; S100A8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265632; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa S100P KO
AC   CVCL_B2EJ
SY   Human S100P knockout HeLa
DR   Abcam; ab266026
DR   Wikidata; Q110432193
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10504; S100P.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa S1PR1 KO
AC   CVCL_B2EK
SY   Human S1PR1 (S1P1/EDG1) knockout HeLa
DR   Abcam; ab265936
DR   Wikidata; Q110432194
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCAF11 KO
AC   CVCL_B2EL
SY   Human SCAF11 (SFRS2IP) knockout HeLa
DR   Abcam; ab265343
DR   Wikidata; Q110432195
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10784; SCAF11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCAMP1 KO
AC   CVCL_B2EM
SY   Human SCAMP1 knockout HeLa
DR   Abcam; ab265567
DR   Wikidata; Q110432197
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10563; SCAMP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCAND1 KO
AC   CVCL_B2EN
SY   Human SCAND1 knockout HeLa
DR   Abcam; ab265291
DR   Wikidata; Q110432198
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10566; SCAND1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCD KO
AC   CVCL_B2EP
SY   Human SCD (SCD1) knockout HeLa
DR   Abcam; ab265220
DR   Wikidata; Q110432200
RX   DOI=10.12688/f1000research.160217.1;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10571; SCD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCD5 KO
AC   CVCL_B2EQ
SY   Human SCD5 knockout HeLa
DR   Abcam; ab265898
DR   Wikidata; Q110432201
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21088; SCD5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCFD2 KO
AC   CVCL_B2ER
SY   Human SCFD2 knockout HeLa
DR   Abcam; ab264851
DR   Wikidata; Q110432202
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30676; SCFD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCN1B KO
AC   CVCL_B2ES
SY   Human SCN1B knockout HeLa
DR   Abcam; ab264733
DR   Wikidata; Q110432203
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10586; SCN1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCNN1D KO
AC   CVCL_B2ET
SY   Human SCNN1D knockout HeLa
DR   Abcam; ab265346
DR   Wikidata; Q110432204
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10601; SCNN1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCRIB KO
AC   CVCL_B2EU
SY   Human SCRIB (SCRIBBLE) knockout HeLa
DR   Abcam; ab265190
DR   Wikidata; Q110432205
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30377; SCRIB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SCYL2 KO
AC   CVCL_B2EV
SY   Human SCYL2 knockout HeLa
DR   Abcam; ab264926
DR   Wikidata; Q110432206
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19286; SCYL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SDHAF2 KO
AC   CVCL_B2EW
SY   Human SDHAF2 (C11orf79) knockout HeLa
DR   Abcam; ab265764
DR   Wikidata; Q110432207
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26034; SDHAF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SEC16A KO
AC   CVCL_B2EX
SY   Human SEC16A (SEC16) knockout HeLa
DR   Abcam; ab265978
DR   Wikidata; Q110432208
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29006; SEC16A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SELENBP1 KO
AC   CVCL_B2EY
SY   Human SELENBP1 (Selenium Binding Protein 1/SBP) knockout HeLa
DR   Abcam; ab265279
DR   Wikidata; Q110432209
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10719; SELENBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SELENOS KO
AC   CVCL_B2EZ
SY   Human VIMP (SELS) knockout HeLa
DR   Abcam; ab265440
DR   Wikidata; Q110432210
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30396; SELENOS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SENP5 KO
AC   CVCL_B2F0
SY   Human SENP5 knockout HeLa
DR   Abcam; ab265971
DR   Wikidata; Q110432212
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28407; SENP5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SERPINB5 KO
AC   CVCL_B2F1
SY   Human SERPINB5 (MASPIN) knockout HeLa
DR   Abcam; ab264750
DR   Wikidata; Q110432213
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8949; SERPINB5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SERTAD3 KO
AC   CVCL_B2F2
SY   Human SERTAD3 knockout HeLa
DR   Abcam; ab265649
DR   Wikidata; Q110432215
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17931; SERTAD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SESN2 KO
AC   CVCL_B2F3
SY   Human SESN2 (Sestrin-2) knockout HeLa
DR   Abcam; ab265669
DR   Wikidata; Q110432216
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20746; SESN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SETD2 KO
AC   CVCL_B9VV
SY   Human SETD2 (KMT3A / HYPB / HIF-1) knockout HeLa
DR   Abcam; ab261792
DR   Wikidata; Q112928344
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SETD7 KO
AC   CVCL_B2F4
SY   Human SETD7 (SET7) knockout HeLa
DR   Abcam; ab265770
DR   Wikidata; Q110432217
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30412; SETD7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SFN KO
AC   CVCL_B2F5
SY   Human SFN (14-3-3 sigma) knockout HeLa
DR   Abcam; ab261779
DR   Wikidata; Q110432218
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10773; SFN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SH2D4A KO
AC   CVCL_B2F6
SY   Human SH2D4A knockout HeLa
DR   Abcam; ab265701
DR   Wikidata; Q110432219
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26102; SH2D4A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SHC2 KO
AC   CVCL_B2F7
SY   Human SHC2 knockout HeLa
DR   Abcam; ab265433
DR   Wikidata; Q110432220
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29869; SHC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SHC3 KO
AC   CVCL_B2F8
SY   Human SHC3 (SHCC) knockout HeLa
DR   Abcam; ab266029
DR   Wikidata; Q110432221
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18181; SHC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SHC4 KO
AC   CVCL_B2F9
SY   Human SHC4 (SHCD) knockout HeLa
DR   Abcam; ab265660
DR   Wikidata; Q110432223
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16743; SHC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SHKBP1 KO
AC   CVCL_B2FA
SY   Human SHKBP1 knockout HeLa
DR   Abcam; ab265544
DR   Wikidata; Q110432224
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19214; SHKBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SIAH1 KO
AC   CVCL_B2FB
SY   Human SIAH1 knockout HeLa
DR   Abcam; ab264746
DR   Wikidata; Q110432225
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10857; SIAH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SIK1 KO
AC   CVCL_B2FC
SY   Human SIK1 knockout HeLa
DR   Abcam; ab265681
DR   Wikidata; Q110432227
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11142; SIK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SIKE1 KO
AC   CVCL_B2FD
SY   Human SIKE1 knockout HeLa
DR   Abcam; ab265933
DR   Wikidata; Q110432228
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26119; SIKE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SIPA1 KO
AC   CVCL_B2FE
SY   Human SIPA1 (Spa-1) knockout HeLa
DR   Abcam; ab265434
DR   Wikidata; Q110432229
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10885; SIPA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SIRT5 KO
AC   CVCL_B2FF
SY   Human SIRT5 knockout HeLa
DR   Abcam; ab265617
DR   Wikidata; Q110432230
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14933; SIRT5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265617; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa SIRT6 KO
AC   CVCL_B2FG
SY   Human SIRT6 knockout HeLa
DR   Abcam; ab265054
DR   Wikidata; Q110432231
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC11A2 KO
AC   CVCL_B2FH
SY   Human SLC11A2 knockout HeLa
DR   Abcam; ab265650
DR   Wikidata; Q110432232
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10908; SLC11A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC12A9 KO
AC   CVCL_B2FI
SY   Human SLC12A9 knockout HeLa
DR   Abcam; ab266055
DR   Wikidata; Q110432233
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17435; SLC12A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC17A5 KO
AC   CVCL_B2FJ
SY   Human SLC17A5 knockout HeLa
DR   Abcam; ab265175
DR   Wikidata; Q110432234
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC1A4 KO
AC   CVCL_B2FK
SY   Human SLC1A4 (ASCT-1) knockout HeLa
DR   Abcam; ab265754
DR   Wikidata; Q110432235
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10942; SLC1A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC20A2 KO
AC   CVCL_B2FL
SY   Human SLC20A2 (PIT2) knockout HeLa
DR   Abcam; ab265574
DR   Wikidata; Q110432236
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC22A5 KO
AC   CVCL_B2FM
SY   Human SLC22A5 (Solute carrier family 22 member 5) knockout HeLa
DR   Abcam; ab265487
DR   Wikidata; Q110432237
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10969; SLC22A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC25A13 KO
AC   CVCL_B2FN
SY   Human SLC25A13 (Citrin) knockout HeLa
DR   Abcam; ab265668
DR   Wikidata; Q110432238
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10983; SLC25A13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC25A20 KO
AC   CVCL_B2FP
SY   Human SLC25A20 knockout HeLa
DR   Abcam; ab265159
DR   Wikidata; Q110432239
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1421; SLC25A20.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC25A29 KO
AC   CVCL_B2FQ
SY   Human SLC25A29 knockout HeLa
DR   Abcam; ab265094
DR   Wikidata; Q110432240
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20116; SLC25A29.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC25A40 KO
AC   CVCL_B2FR
SY   Human SLC25A40 knockout HeLa
DR   Abcam; ab265188
DR   Wikidata; Q110432241
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC25A5 KO
AC   CVCL_B2FS
SY   Human SLC25A5 (Adenine Nucleotide Translocator 2/ANT 2) knockout HeLa
DR   Abcam; ab265314
DR   Wikidata; Q110432242
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC2A4 KO
AC   CVCL_B2FT
SY   Human SLC2A4 (Glucose Transporter GLUT4) knockout HeLa
DR   Abcam; ab265262
DR   Wikidata; Q110432243
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11009; SLC2A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC2A8 KO
AC   CVCL_B2FU
SY   Human SLC2A8 (Glucose Transporter 8) knockout HeLa
DR   Abcam; ab265674
DR   Wikidata; Q110432244
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13812; SLC2A8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC30A1 KO
AC   CVCL_B2FV
SY   Human SLC30A1 (ZnT1) knockout HeLa
DR   Abcam; ab264664
DR   Wikidata; Q110432245
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11012; SLC30A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC30A7 KO
AC   CVCL_B2FW
SY   Human SLC30A7 (ZnT-7) knockout HeLa
DR   Abcam; ab265733
DR   Wikidata; Q110432246
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19306; SLC30A7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC35A1 KO
AC   CVCL_B2FX
SY   Human SLC35A1 knockout HeLa
DR   Abcam; ab265941
DR   Wikidata; Q110432247
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC35A2 KO
AC   CVCL_B2FY
SY   Human SLC35A2 knockout HeLa
DR   Abcam; ab265312
DR   Wikidata; Q110432248
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11022; SLC35A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC35A5 KO
AC   CVCL_B2FZ
SY   Human SLC35A5 knockout HeLa
DR   Abcam; ab265996
DR   Wikidata; Q110432249
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20792; SLC35A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC35B2 KO
AC   CVCL_B2G0
SY   Human SLC35B2 knockout HeLa
DR   Abcam; ab264762
DR   Wikidata; Q110432250
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16872; SLC35B2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC35C1 KO
AC   CVCL_B2G1
SY   Human SLC35C1 knockout HeLa
DR   Abcam; ab265537
DR   Wikidata; Q110432251
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC35E2B KO
AC   CVCL_B2G2
SY   Human SLC35E2B knockout HeLa
DR   Abcam; ab265740
DR   Wikidata; Q110432252
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33941; SLC35E2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC38A5 KO
AC   CVCL_B2G3
SY   Human SLC38A5 (SNAT5) knockout HeLa
DR   Abcam; ab265819
DR   Wikidata; Q110432253
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18070; SLC38A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC38A9 KO
AC   CVCL_B2G4
SY   Human SLC38A9 knockout HeLa
DR   Abcam; ab265823
DR   Wikidata; Q110432255
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC39A1 KO
AC   CVCL_B2G5
SY   Human SLC39A1 knockout HeLa
DR   Abcam; ab265035
DR   Wikidata; Q110432256
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12876; SLC39A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC39A8 KO
AC   CVCL_B2G6
SY   Human SLC39A8 (BIGM103/ZIP8) knockout HeLa
DR   Abcam; ab264686
DR   Wikidata; Q110432257
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC39A9 KO
AC   CVCL_B2G7
SY   Human SLC39A9 (ZIP-9) knockout HeLa
DR   Abcam; ab265711
DR   Wikidata; Q110432258
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20182; SLC39A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC3A2 KO
AC   CVCL_B2G8
SY   Human SLC3A2 (CD98) knockout HeLa
DR   Abcam; ab265708
DR   Wikidata; Q110432259
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11026; SLC3A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC43A3 KO
AC   CVCL_B2G9
SY   Human SLC43A3 knockout HeLa
DR   Abcam; ab264924
DR   Wikidata; Q110432260
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17466; SLC43A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC44A1 KO
AC   CVCL_B2GA
SY   Human SLC44A1 (CTL1) knockout HeLa
DR   Abcam; ab265357
DR   Wikidata; Q110432261
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18798; SLC44A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC50A1 KO
AC   CVCL_B2GB
SY   Human SLC50A1 (RAG1AP1) knockout HeLa
DR   Abcam; ab265573
DR   Wikidata; Q110432262
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30657; SLC50A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC52A2 KO
AC   CVCL_B2GC
SY   Human SLC52A2 (GPR172A/PAR1) knockout HeLa
DR   Abcam; ab265411
DR   Wikidata; Q110432263
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30224; SLC52A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC7A6 KO
AC   CVCL_B2GD
SY   Human SLC7A6 knockout HeLa
DR   Abcam; ab265037
DR   Wikidata; Q110432264
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11064; SLC7A6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLC9A3R1 KO
AC   CVCL_B2GE
SY   Human SLC9A3R1 (EBP50/NHERF-1) knockout HeLa
DR   Abcam; ab264914
DR   Wikidata; Q110432266
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11075; NHERF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa SLCO4A1 KO
AC   CVCL_B2GF
SY   Human SLCO4A1 knockout HeLa
DR   Abcam; ab265807
DR   Wikidata; Q110432267
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10953; SLCO4A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SLPI KO
AC   CVCL_B2GG
SY   Human SLPI knockout HeLa
DR   Abcam; ab265215
DR   Wikidata; Q110432268
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11092; SLPI.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMAD1 KO
AC   CVCL_B2GH
SY   Human SMAD1 knockout HeLa
DR   Abcam; ab265400
DR   Wikidata; Q110432269
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6767; SMAD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMAD2 KO
AC   CVCL_B2GI
SY   Human SMAD2 knockout HeLa
DR   Abcam; ab255430
DR   Wikidata; Q110432270
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMAD3 KO
AC   CVCL_B2GJ
SY   Human SMAD3 knockout HeLa
DR   Abcam; ab255431
DR   Wikidata; Q110432271
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMAD7 KO
AC   CVCL_B2GK
SY   Human SMAD7 (MADH7) knockout HeLa
DR   Abcam; ab264745
DR   Wikidata; Q110432272
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMARCA2 KO
AC   CVCL_B2GL
SY   Human SMARCA2 (BRM) knockout HeLa
DR   Abcam; ab265416
DR   Wikidata; Q110432273
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11098; SMARCA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMARCC1 KO
AC   CVCL_B2GM
SY   Human SMARCC1 (BAF155) knockout HeLa
DR   Abcam; ab264859
DR   Wikidata; Q110432274
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMC1B KO
AC   CVCL_B2GN
SY   Human SMC1B (SMC1L2) knockout HeLa
DR   Abcam; ab265287
DR   Wikidata; Q110432275
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11112; SMC1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SMIM4 KO
AC   CVCL_B2GP
SY   Human SMIM4 (C3orf78) knockout HeLa
DR   Abcam; ab265444
DR   Wikidata; Q110432276
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37257; UQCC5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa SMURF2 KO
AC   CVCL_B2GQ
SY   Human SMURF2 knockout HeLa
DR   Abcam; ab265231
DR   Wikidata; Q110432277
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16809; SMURF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNAI1 KO
AC   CVCL_B2GR
SY   Human SNAI1 (SNAIL) knockout HeLa
DR   Abcam; ab265963
DR   Wikidata; Q110432278
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11128; SNAI1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNAP29 KO
AC   CVCL_B2GS
SY   Human SNAP29 knockout HeLa
DR   Abcam; ab265289
DR   Wikidata; Q110432280
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11133; SNAP29.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNAPIN KO
AC   CVCL_B2GT
SY   Human SNAPIN knockout HeLa
DR   Abcam; ab265393
DR   Wikidata; Q110432281
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17145; SNAPIN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNCG KO
AC   CVCL_B2GU
SY   Human SNCG (gamma Synuclein) knockout HeLa
DR   Abcam; ab265623
DR   Wikidata; Q110432282
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11141; SNCG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNRK KO
AC   CVCL_B2GV
SY   Human SNRK knockout HeLa
DR   Abcam; ab265904
DR   Wikidata; Q110432283
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30598; SNRK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNRPB2 KO
AC   CVCL_B2GW
SY   Human SNRPB2 knockout HeLa
DR   Abcam; ab265100
DR   Wikidata; Q110432284
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11155; SNRPB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNX12 KO
AC   CVCL_B2GX
SY   Human SNX12 knockout HeLa
DR   Abcam; ab265728
DR   Wikidata; Q110432285
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14976; SNX12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNX17 KO
AC   CVCL_B2GY
SY   Human SNX17 knockout HeLa
DR   Abcam; ab265940
DR   Wikidata; Q110432286
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14979; SNX17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SNX2 KO
AC   CVCL_B2GZ
SY   Human SNX2 knockout HeLa
DR   Abcam; ab265908
DR   Wikidata; Q110432287
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11173; SNX2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SOAT1 KO
AC   CVCL_B2H0
SY   Human SOAT1 (ACAT1) knockout HeLa
DR   Abcam; ab264862
DR   Wikidata; Q110432288
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11177; SOAT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SOCS4 KO
AC   CVCL_B2H1
SY   Human SOCS4 knockout HeLa
DR   Abcam; ab265162
DR   Wikidata; Q110432289
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19392; SOCS4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SORT1 KO
AC   CVCL_B0XV
SY   Human SORT1 (Sortilin/NT3) knockout HeLa
DR   Abcam; ab264772
DR   Wikidata; Q110432290
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11186; SORT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SOX17 KO
AC   CVCL_B2H2
SY   Human SOX17 knockout HeLa
DR   Abcam; ab265744
DR   Wikidata; Q110432292
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18122; SOX17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SP1 KO
AC   CVCL_B2H3
SY   Human SP1 knockout HeLa
DR   Abcam; ab265519
DR   Wikidata; Q110432293
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SP100 KO
AC   CVCL_B2H4
SY   Human SP100 knockout HeLa
DR   Abcam; ab264757
DR   Wikidata; Q110432294
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11206; SP100.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SPCS3 KO
AC   CVCL_B2H5
SY   Human SPCS3 knockout HeLa
DR   Abcam; ab265707
DR   Wikidata; Q110432295
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26212; SPCS3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SPG11 KO
AC   CVCL_B2H6
SY   Human SPG11 knockout HeLa
DR   Abcam; ab265402
DR   Wikidata; Q110432296
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11226; SPG11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SPOP KO
AC   CVCL_B2H7
SY   Human SPOP knockout HeLa
DR   Abcam; ab265634
DR   Wikidata; Q110432297
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11254; SPOP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SPP1 KO
AC   CVCL_B2H8
SY   Human SPP1 (Osteopontin) knockout HeLa
DR   Abcam; ab255435
DR   Wikidata; Q110432298
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab255435; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa SPR KO
AC   CVCL_B2H9
SY   Human SPR knockout HeLa
DR   Abcam; ab264681
DR   Wikidata; Q110432299
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11257; SPR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SQLE KO
AC   CVCL_B2HA
SY   Human SQLE (Squalene Epoxidase) knockout HeLa
DR   Abcam; ab265787
DR   Wikidata; Q110432300
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11279; SQLE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SRD5A1 KO
AC   CVCL_B2HB
SY   Human SRD5A1 knockout HeLa
DR   Abcam; ab264932
DR   Wikidata; Q110432301
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11284; SRD5A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SREBF1 KO
AC   CVCL_E1G3
SY   Human SREBF1 (SREBP1) knockout HeLa
DR   Abcam; ab277151
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11289; SREBF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Abcam HeLa SRGN KO
AC   CVCL_B2HC
SY   Human SRGN (Serglycin) knockout HeLa
DR   Abcam; ab265911
DR   Wikidata; Q110432302
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9361; SRGN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SS18 KO
AC   CVCL_B2HD
SY   Human SS18 knockout HeLa
DR   Abcam; ab265493
DR   Wikidata; Q110432303
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SSBP3 KO
AC   CVCL_B2HE
SY   Human SSBP3 knockout HeLa
DR   Abcam; ab265479
DR   Wikidata; Q110432304
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15674; SSBP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STAG2 KO
AC   CVCL_B2HF
SY   Human STAG2 (SA2) knockout HeLa
DR   Abcam; ab265461
DR   Wikidata; Q110432306
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STAMBP KO
AC   CVCL_B2HG
SY   Human STAMBP (AMSH) knockout HeLa
DR   Abcam; ab265249
DR   Wikidata; Q110432307
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16950; STAMBP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STAR KO
AC   CVCL_B2HH
SY   Human STAR knockout HeLa
DR   Abcam; ab265303
DR   Wikidata; Q110432308
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11359; STAR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STAT1 KO
AC   CVCL_B2HI
SY   Human STAT1 knockout HeLa
DR   Abcam; ab255346
DR   Wikidata; Q110432309
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STAT2 KO
AC   CVCL_B2HJ
SY   Human STAT2 knockout HeLa
DR   Abcam; ab261819
DR   Wikidata; Q110432310
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STAT3 KO
AC   CVCL_B2HK
SY   Human STAT3 knockout HeLa
DR   Abcam; ab255436
DR   Wikidata; Q110432311
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STAT5B KO
AC   CVCL_B2HL
SY   Human STAT5B knockout HeLa
DR   Abcam; ab266006
DR   Wikidata; Q110432312
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STK10 KO
AC   CVCL_B2HM
SY   Human STK10 (LOK) knockout HeLa
DR   Abcam; ab264900
DR   Wikidata; Q110432313
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11388; STK10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STK17A KO
AC   CVCL_B2HN
SY   Human STK17A knockout HeLa
DR   Abcam; ab265317
DR   Wikidata; Q110432314
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11395; STK17A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STK3 KO
AC   CVCL_B2HP
SY   Human STK3 (MST-2) knockout HeLa
DR   Abcam; ab265082
DR   Wikidata; Q110432315
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11406; STK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STK38L KO
AC   CVCL_B2HQ
SY   Human STK38L (Ndr2) knockout HeLa
DR   Abcam; ab265381
DR   Wikidata; Q110432316
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17848; STK38L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STK4 KO
AC   CVCL_B2HR
SY   Human STK4 (Serine/threonine-protein kinase 4/MST-1) knockout HeLa
DR   Abcam; ab265442
DR   Wikidata; Q110432317
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STK40 KO
AC   CVCL_B2HS
SY   Human STK40 knockout HeLa
DR   Abcam; ab264871
DR   Wikidata; Q110432318
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21373; STK40.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STS KO
AC   CVCL_B2HT
SY   Human STS (Steroid sulfatase) knockout HeLa
DR   Abcam; ab265965
DR   Wikidata; Q110432320
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11425; STS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa STX17 KO
AC   CVCL_B2HU
SY   Human STX17 knockout HeLa
DR   Abcam; ab265909
DR   Wikidata; Q110432321
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11432; STX17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SUGP2 KO
AC   CVCL_B2HV
SY   Human SUGP2 (SFRS14) knockout HeLa
DR   Abcam; ab265135
DR   Wikidata; Q110432322
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18641; SUGP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SUGT1 KO
AC   CVCL_B2HW
SY   Human SUGT1 knockout HeLa
DR   Abcam; ab265960
DR   Wikidata; Q110432323
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16987; SUGT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SURF6 KO
AC   CVCL_B2HX
SY   Human SURF6 knockout HeLa
DR   Abcam; ab265690
DR   Wikidata; Q110432324
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11478; SURF6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SUZ12 KO
AC   CVCL_B2HY
SY   Human SUZ12 knockout HeLa
DR   Abcam; ab264983
DR   Wikidata; Q110432325
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SYNJ1 KO
AC   CVCL_B2HZ
SY   Human SYNJ1 (Synaptojanin) knockout HeLa
DR   Abcam; ab266005
DR   Wikidata; Q110432326
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11503; SYNJ1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa SYNJ2 KO
AC   CVCL_B2I0
SY   Human SYNJ2 (Synaptojanin 2) knockout HeLa
DR   Abcam; ab265359
DR   Wikidata; Q110432327
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11504; SYNJ2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TACC2 KO
AC   CVCL_B2I1
SY   Human TACC2 knockout HeLa
DR   Abcam; ab264869
DR   Wikidata; Q110432328
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11523; TACC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TAF11 KO
AC   CVCL_B2I2
SY   Human TAF11 knockout HeLa
DR   Abcam; ab265504
DR   Wikidata; Q110432329
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11544; TAF11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TAF12 KO
AC   CVCL_B2I3
SY   Human TAF12 knockout HeLa
DR   Abcam; ab265818
DR   Wikidata; Q110432330
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11545; TAF12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TANK KO
AC   CVCL_B2I4
SY   Human TANK (TRAF2) knockout HeLa
DR   Abcam; ab264887
DR   Wikidata; Q110432331
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TAOK3 KO
AC   CVCL_B2I5
SY   Human TAOK3 (KDS) knockout HeLa
DR   Abcam; ab265108
DR   Wikidata; Q110432332
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18133; TAOK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TAP2 KO
AC   CVCL_B2I6
SY   Human TAP2 knockout HeLa
DR   Abcam; ab265426
DR   Wikidata; Q110432333
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:44; TAP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TBC1D7 KO
AC   CVCL_B2I7
SY   Human TBC1D7 knockout HeLa
DR   Abcam; ab265559
DR   Wikidata; Q110432334
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21066; TBC1D7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TBKBP1 KO
AC   CVCL_B2I8
SY   Human TBKBP1 knockout HeLa
DR   Abcam; ab265883
DR   Wikidata; Q110432335
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TBL1X KO
AC   CVCL_B2I9
SY   Human TBL1X (TBL1) knockout HeLa
DR   Abcam; ab264717
DR   Wikidata; Q110432336
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11585; TBL1X.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264717; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa TCF7 KO
AC   CVCL_B2IA
SY   Human TCF7 knockout HeLa
DR   Abcam; ab265127
DR   Wikidata; Q110432337
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11639; TCF7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TDP2 KO
AC   CVCL_B2IB
SY   Human TDP2 knockout HeLa
DR   Abcam; ab265536
DR   Wikidata; Q110432338
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17768; TDP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TFAP2A KO
AC   CVCL_B2IC
SY   Human TFAP2A (Transcription factor AP-2-alpha) knockout HeLa
DR   Abcam; ab265122
DR   Wikidata; Q110432339
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11742; TFAP2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TFAP4 KO
AC   CVCL_B2ID
SY   Human TFAP4 knockout HeLa
DR   Abcam; ab265658
DR   Wikidata; Q110432340
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11745; TFAP4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TFG KO
AC   CVCL_B2IE
SY   Human TFG (TRK fused gene) knockout HeLa
DR   Abcam; ab265841
DR   Wikidata; Q110432342
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11758; TFG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TGFB1 KO
AC   CVCL_B2IF
SY   Human TGFB1 (TGF beta 1) knockout HeLa
DR   Abcam; ab255439
DR   Wikidata; Q110432343
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TGM2 KO
AC   CVCL_B2IG
SY   Human TGM2 (Transglutaminase 2) knockout HeLa
DR   Abcam; ab265245
DR   Wikidata; Q110432345
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11778; TGM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa THAP7 KO
AC   CVCL_B2IH
SY   Human THAP7 knockout HeLa
DR   Abcam; ab265827
DR   Wikidata; Q110432346
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa THOC3 KO
AC   CVCL_B2II
SY   Human THOC3 knockout HeLa
DR   Abcam; ab265581
DR   Wikidata; Q110432347
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19072; THOC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa THY1 KO
AC   CVCL_B2IJ
SY   Human THY1 (CD90) knockout HeLa
DR   Abcam; ab255440
DR   Wikidata; Q110432348
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11801; THY1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TIAL1 KO
AC   CVCL_B2IK
SY   Human TIAL1 knockout HeLa
DR   Abcam; ab265793
DR   Wikidata; Q110432349
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11804; TIAL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TJP1 KO
AC   CVCL_B2IL
SY   Human TJP1 (ZO1 tight junction protein) knockout HeLa
DR   Abcam; ab264897
DR   Wikidata; Q110432350
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11827; TJP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TLE1 KO
AC   CVCL_B2IM
SY   Human TLE1 knockout HeLa
DR   Abcam; ab264901
DR   Wikidata; Q110432351
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TLK1 KO
AC   CVCL_B2IN
SY   Human TLK1 knockout HeLa
DR   Abcam; ab264898
DR   Wikidata; Q110432352
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11841; TLK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TM4SF1 KO
AC   CVCL_B2IP
SY   Human TM4SF1 (Transmembrane 4 L6 family member 1) knockout HeLa
DR   Abcam; ab265743
DR   Wikidata; Q110432353
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11853; TM4SF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TM9SF4 KO
AC   CVCL_B2IQ
SY   Human TM9SF4 knockout HeLa
DR   Abcam; ab265870
DR   Wikidata; Q110432354
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30797; TM9SF4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMEM126A KO
AC   CVCL_B2IR
SY   Human TMEM126A knockout HeLa
DR   Abcam; ab265577
DR   Wikidata; Q110432355
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25382; TMEM126A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMEM175 KO
AC   CVCL_B2IS
SY   Human TMEM175 knockout HeLa
DR   Abcam; ab265571
DR   Wikidata; Q110432357
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMEM30A KO
AC   CVCL_B2IT
SY   Human TMEM30A (Transmembrane protein 30A) knockout HeLa
DR   Abcam; ab265565
DR   Wikidata; Q110432358
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16667; TMEM30A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMEM69 KO
AC   CVCL_B2IU
SY   Human TMEM69 knockout HeLa
DR   Abcam; ab265639
DR   Wikidata; Q110432359
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28035; TMEM69.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMOD3 KO
AC   CVCL_B2IV
SY   Human TMOD3 (Tropomodulin 3) knockout HeLa
DR   Abcam; ab265543
DR   Wikidata; Q110432360
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11873; TMOD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMPRSS6 KO
AC   CVCL_B2IW
SY   Human TMPRSS6 (Matriptase 2) knockout HeLa
DR   Abcam; ab264744
DR   Wikidata; Q110432361
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16517; TMPRSS6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMUB1 KO
AC   CVCL_B2IX
SY   Human TMUB1 knockout HeLa
DR   Abcam; ab278130
DR   Wikidata; Q110432363
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21709; TMUB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TMUB1 partial KO
AC   CVCL_B2IY
SY   Human TMUB1 partial knockout HeLa
DR   Abcam; ab265852
DR   Wikidata; Q110432364
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21709; TMUB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNC KO
AC   CVCL_B2IZ
SY   Human TNC (Tenascin C) knockout HeLa
DR   Abcam; ab265511
DR   Wikidata; Q110432365
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5318; TNC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNFAIP3 KO
AC   CVCL_B2J0
SY   Human TNFAIP3 knockout HeLa
DR   Abcam; ab265983
DR   Wikidata; Q110432366
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNFRSF10A KO
AC   CVCL_B2J1
SY   Human TNFRSF10A (DR4) knockout HeLa
DR   Abcam; ab264687
DR   Wikidata; Q110432367
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11904; TNFRSF10A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNFRSF10B KO
AC   CVCL_B2J2
SY   Human TNFRSF10B (DR5) knockout HeLa
DR   Abcam; ab264922
DR   Wikidata; Q110432368
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNFRSF1A KO
AC   CVCL_B2J3
SY   Human TNFRSF1A (TNF Receptor I) knockout HeLa
DR   Abcam; ab265972
DR   Wikidata; Q110432369
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNFRSF8 KO
AC   CVCL_B2J4
SY   Human TNFRSF8 (CD30) knockout HeLa
DR   Abcam; ab265460
DR   Wikidata; Q110432370
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11923; TNFRSF8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265460; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa TNFSF10 KO
AC   CVCL_B2J5
SY   Human TNFSF10 (TRAIL) knockout HeLa
DR   Abcam; ab261825
DR   Wikidata; Q110432372
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11925; TNFSF10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNIP1 KO
AC   CVCL_B2J6
SY   Human TNIP1 knockout HeLa
DR   Abcam; ab265678
DR   Wikidata; Q110432373
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16903; TNIP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNK1 KO
AC   CVCL_B2J7
SY   Human TNK1 knockout HeLa
DR   Abcam; ab264870
DR   Wikidata; Q110432374
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11940; TNK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TNKS1BP1 KO
AC   CVCL_B2J8
SY   Human TNKS1BP1 (Tankyrase binding protein 1) knockout HeLa
DR   Abcam; ab265812
DR   Wikidata; Q110432375
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19081; TNKS1BP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TOB1 KO
AC   CVCL_B2J9
SY   Human TOB1 (TOB) knockout HeLa
DR   Abcam; ab264748
DR   Wikidata; Q110432376
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11979; TOB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TOMM34 KO
AC   CVCL_B2JA
SY   Human TOMM34 knockout HeLa
DR   Abcam; ab265546
DR   Wikidata; Q110432377
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15746; TOMM34.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TOMM70A KO
AC   CVCL_B2JB
SY   Human TOMM70A (TOM70) knockout HeLa
DR   Abcam; ab265396
DR   Wikidata; Q110432378
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11985; TOMM70.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TOR3A KO
AC   CVCL_B2JC
SY   Human TOR3A knockout HeLa
DR   Abcam; ab265113
DR   Wikidata; Q110432379
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11997; TOR3A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TP53I3 KO
AC   CVCL_B2JD
SY   Human TP53I3 (PIG3) knockout HeLa
DR   Abcam; ab265703
DR   Wikidata; Q110432380
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19373; TP53I3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TPD52L1 KO
AC   CVCL_B2JE
SY   Human TPD52L1 knockout HeLa
DR   Abcam; ab265244
DR   Wikidata; Q110432381
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12006; TPD52L1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TPGS2 KO
AC   CVCL_B2JF
SY   Human TPGS2 (L17) knockout HeLa
DR   Abcam; ab265398
DR   Wikidata; Q110432382
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24561; TPGS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRAF3 KO
AC   CVCL_B2JG
SY   Human TRAF3 knockout HeLa
DR   Abcam; ab265101
DR   Wikidata; Q110432384
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265101; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa TRAF5 KO
AC   CVCL_B2JH
SY   Human TRAF5 knockout HeLa
DR   Abcam; ab265408
DR   Wikidata; Q110432385
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12035; TRAF5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRAF6 KO
AC   CVCL_B2JI
SY   Human TRAF6 knockout HeLa
DR   Abcam; ab266009
DR   Wikidata; Q110432386
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRAF7 KO
AC   CVCL_B2JJ
SY   Human TRAF7 knockout HeLa
DR   Abcam; ab264998
DR   Wikidata; Q110432387
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20456; TRAF7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab264998; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa TREX1 KO
AC   CVCL_B2JK
SY   Human TREX1 knockout HeLa
DR   Abcam; ab265313
DR   Wikidata; Q110432388
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRIB3 KO
AC   CVCL_B2JL
SY   Human TRIB3 knockout HeLa
DR   Abcam; ab264792
DR   Wikidata; Q110432389
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRIM16 KO
AC   CVCL_B2JM
SY   Human TRIM16 knockout HeLa
DR   Abcam; ab265258
DR   Wikidata; Q110432390
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17241; TRIM16.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRIM24 KO
AC   CVCL_B2JN
SY   Human TRIM24 knockout HeLa
DR   Abcam; ab264963
DR   Wikidata; Q110432391
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11812; TRIM24.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRIM29 KO
AC   CVCL_B2JP
SY   Human TRIM29 knockout HeLa
DR   Abcam; ab265878
DR   Wikidata; Q110432393
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17274; TRIM29.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRIM7 KO
AC   CVCL_B2JQ
SY   Human TRIM7 (RNF90/GNIP) knockout HeLa
DR   Abcam; ab265184
DR   Wikidata; Q110432394
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16278; TRIM7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRMT2A KO
AC   CVCL_B2JR
SY   Human TRMT2A (HTF9C) knockout HeLa
DR   Abcam; ab265160
DR   Wikidata; Q110432395
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TRPM7 KO
AC   CVCL_B2JS
SY   Human TRPM7 knockout HeLa
DR   Abcam; ab265480
DR   Wikidata; Q110432396
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17994; TRPM7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TSC22D4 KO
AC   CVCL_B2JT
SY   Human TSC22D4 (TSC22 domain family, member 4) knockout HeLa
DR   Abcam; ab264698
DR   Wikidata; Q110432397
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21696; TSC22D4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TSPO KO
AC   CVCL_B2JU
SY   Human TSPO (PBR) knockout HeLa
DR   Abcam; ab264942
DR   Wikidata; Q110432398
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TSSK3 KO
AC   CVCL_B2JV
SY   Human TSSK3 (TSSK-3) knockout HeLa
DR   Abcam; ab265568
DR   Wikidata; Q110432399
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15473; TSSK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TSSK4 KO
AC   CVCL_B2JW
SY   Human TSSK4 knockout HeLa
DR   Abcam; ab266012
DR   Wikidata; Q110432400
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19825; TSSK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TTC3 KO
AC   CVCL_B2JX
SY   Human TTC3 knockout HeLa
DR   Abcam; ab266049
DR   Wikidata; Q110432401
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12393; TTC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TUBB3 KO
AC   CVCL_B2JY
SY   Human TUBB3 (beta III Tubulin) knockout HeLa
DR   Abcam; ab255358
DR   Wikidata; Q110432402
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20772; TUBB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TWF1 KO
AC   CVCL_B2JZ
SY   Human TWF1 (Twinfilin-1) knockout HeLa
DR   Abcam; ab265697
DR   Wikidata; Q110432403
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9620; TWF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TXLNA KO
AC   CVCL_B2K0
SY   Human TXLNA (Alpha Taxilin) knockout HeLa
DR   Abcam; ab265167
DR   Wikidata; Q110432404
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30685; TXLNA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TXNDC9 KO
AC   CVCL_B2K1
SY   Human TXNDC9 knockout HeLa
DR   Abcam; ab265420
DR   Wikidata; Q110432405
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24110; TXNDC9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa TYMP KO
AC   CVCL_B2K2
SY   Human TYMP (Thymidine Phosphorylase) knockout HeLa
DR   Abcam; ab265138
DR   Wikidata; Q110432406
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3148; TYMP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE2C KO
AC   CVCL_B9VW
SY   Human UBE2C knockout HeLa
DR   Abcam; ab265032
DR   Wikidata; Q112928345
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15937; UBE2C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE2D4 KO
AC   CVCL_B2K3
SY   Human UBE2D4 knockout HeLa
DR   Abcam; ab265326
DR   Wikidata; Q110432407
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21647; UBE2D4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE2F KO
AC   CVCL_B2K4
SY   Human UBE2F (NCE2) knockout HeLa
DR   Abcam; ab265339
DR   Wikidata; Q110432408
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12480; UBE2F.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE2H KO
AC   CVCL_B2K5
SY   Human UBE2H knockout HeLa
DR   Abcam; ab265455
DR   Wikidata; Q110432409
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12484; UBE2H.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE2J1 KO
AC   CVCL_B2K6
SY   Human UBE2J1 (UBC6e) knockout HeLa
DR   Abcam; ab265491
DR   Wikidata; Q110432410
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17598; UBE2J1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE2K KO
AC   CVCL_B2K7
SY   Human UBE2K (HIP2/LIG) knockout HeLa
DR   Abcam; ab266031
DR   Wikidata; Q110432411
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4914; UBE2K.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE2O KO
AC   CVCL_B2K8
SY   Human UBE2O knockout HeLa
DR   Abcam; ab264948
DR   Wikidata; Q110432412
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29554; UBE2O.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE3B KO 1
AC   CVCL_B2K9
SY   Human UBE3B knockout HeLa
DR   Abcam; ab265140
DR   Wikidata; Q110432414
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13478; UBE3B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBE3B KO 2
AC   CVCL_B2KA
SY   Human UBE3B knockout HeLa
DR   Abcam; ab266030
DR   Wikidata; Q110432415
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13478; UBE3B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBQLN1 KO
AC   CVCL_B2KB
SY   Human UBQLN1 (Ubiquilin) knockout HeLa
DR   Abcam; ab266047
DR   Wikidata; Q110432416
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UBXN4 KO
AC   CVCL_B2KC
SY   Human UBXN4 (Erasin) knockout HeLa
DR   Abcam; ab265897
DR   Wikidata; Q110432418
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14860; UBXN4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UGCG KO
AC   CVCL_B2KD
SY   Human UGCG (Ceramide glucosyltransferase) knockout HeLa
DR   Abcam; ab265916
DR   Wikidata; Q110432419
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12524; UGCG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265916; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa UHMK1 KO
AC   CVCL_B2KE
SY   Human UHMK1 (KIST/KIS) knockout HeLa
DR   Abcam; ab264692
DR   Wikidata; Q110432420
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19683; UHMK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa UNG KO
AC   CVCL_B2KF
SY   Human UNG knockout HeLa
DR   Abcam; ab265725
DR   Wikidata; Q110432421
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12572; UNG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USB1 KO
AC   CVCL_B2KG
SY   Human USB1 (C16orf57) knockout HeLa
DR   Abcam; ab265114
DR   Wikidata; Q110432422
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25792; USB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP1 KO
AC   CVCL_B2KH
SY   Human USP1 knockout HeLa
DR   Abcam; ab265336
DR   Wikidata; Q110432423
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12607; USP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP14 KO
AC   CVCL_B2KI
SY   Human USP14 (TGT) knockout HeLa
DR   Abcam; ab266854
DR   Wikidata; Q110432425
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12612; USP14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP18 KO
AC   CVCL_B2KJ
SY   Human USP18 (UBP43) knockout HeLa
DR   Abcam; ab265458
DR   Wikidata; Q110432426
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265458; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa USP22 KO
AC   CVCL_B2KK
SY   Human USP22 knockout HeLa
DR   Abcam; ab264888
DR   Wikidata; Q110432427
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP34 KO
AC   CVCL_B2KL
SY   Human USP34 knockout HeLa
DR   Abcam; ab265845
DR   Wikidata; Q110432428
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20066; USP34.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP40 KO 1
AC   CVCL_B2KM
SY   Human USP40 knockout HeLa
DR   Abcam; ab264893
DR   Wikidata; Q110432429
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20069; USP40.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP40 KO 2
AC   CVCL_B2KN
SY   Human USP40 knockout HeLa
DR   Abcam; ab265531
DR   Wikidata; Q110432430
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20069; USP40.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP42 KO
AC   CVCL_B2KP
SY   Human USP42 knockout HeLa
DR   Abcam; ab264981
DR   Wikidata; Q110432431
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20068; USP42.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP54 KO
AC   CVCL_B2KQ
SY   Human USP54 knockout HeLa
DR   Abcam; ab265768
DR   Wikidata; Q110432432
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23513; USP54.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP8 KO
AC   CVCL_B2KR
SY   Human USP8 (UBPY) knockout HeLa
DR   Abcam; ab265228
DR   Wikidata; Q110432434
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa USP9X KO
AC   CVCL_B2KS
SY   Human USP9X knockout HeLa
DR   Abcam; ab265665
DR   Wikidata; Q110432435
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12632; USP9X.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VAC14 KO
AC   CVCL_B2KT
SY   Human VAC14 knockout HeLa
DR   Abcam; ab265295
DR   Wikidata; Q110432436
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25507; VAC14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VASP KO
AC   CVCL_B2KU
SY   Human VASP knockout HeLa
DR   Abcam; ab265892
DR   Wikidata; Q110432438
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12652; VASP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VAV1 KO
AC   CVCL_B2KV
SY   Human VAV1 knockout HeLa
DR   Abcam; ab265196
DR   Wikidata; Q110432439
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12657; VAV1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265196; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa VAV2 KO
AC   CVCL_B2KW
SY   Human VAV2 knockout HeLa
DR   Abcam; ab265318
DR   Wikidata; Q110432440
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12658; VAV2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VAV3 KO
AC   CVCL_B2KX
SY   Human VAV3 knockout HeLa
DR   Abcam; ab265419
DR   Wikidata; Q110432441
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12659; VAV3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VCL KO
AC   CVCL_B2KY
SY   Human VCL (Vinculin) knockout HeLa
DR   Abcam; ab265580
DR   Wikidata; Q110432442
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12665; VCL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VCPIP1 KO
AC   CVCL_B2KZ
SY   Human VCPIP1 (VCIP 135) knockout HeLa
DR   Abcam; ab264680
DR   Wikidata; Q110432443
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30897; VCPIP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VDR KO
AC   CVCL_B2L0
SY   Human VDR (Vitamin D Receptor) knockout HeLa
DR   Abcam; ab265430
DR   Wikidata; Q110432444
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VEGFA KO
AC   CVCL_B2L1
SY   Human VEGFA knockout HeLa
DR   Abcam; ab255445
DR   Wikidata; Q110432445
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab255445; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa VIM KO
AC   CVCL_B2L2
SY   Human VIM (Vimentin) knockout HeLa
DR   Abcam; ab255446
DR   Wikidata; Q110432446
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VKORC1 KO
AC   CVCL_B2L3
SY   Human VKORC1 knockout HeLa
DR   Abcam; ab264785
DR   Wikidata; Q110432447
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23663; VKORC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VOPP1 KO
AC   CVCL_B2L4
SY   Human VOPP1 knockout HeLa
DR   Abcam; ab265641
DR   Wikidata; Q110432448
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34518; VOPP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VRK2 KO
AC   CVCL_B2L5
SY   Human VRK2 knockout HeLa
DR   Abcam; ab265881
DR   Wikidata; Q110432450
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12719; VRK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VRK3 KO
AC   CVCL_B2L6
SY   Human VRK3 knockout HeLa
DR   Abcam; ab264721
DR   Wikidata; Q110432451
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18996; VRK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa VTI1B KO
AC   CVCL_B2L7
SY   Human VTI1B knockout HeLa
DR   Abcam; ab265483
DR   Wikidata; Q110432452
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17793; VTI1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WASF2 KO
AC   CVCL_B2L8
SY   Human WASF2 (WAVE2) knockout HeLa
DR   Abcam; ab265762
DR   Wikidata; Q110432453
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12733; WASF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WBP2 KO
AC   CVCL_B2L9
SY   Human WBP2 knockout HeLa
DR   Abcam; ab265735
DR   Wikidata; Q110432454
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12738; WBP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WDR13 KO
AC   CVCL_B2LA
SY   Human WDR13 knockout HeLa
DR   Abcam; ab265513
DR   Wikidata; Q110432455
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14352; WDR13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WDR4 KO
AC   CVCL_B2LB
SY   Human WDR4 knockout HeLa
DR   Abcam; ab265109
DR   Wikidata; Q110432456
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12756; WDR4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WDR41 KO
AC   CVCL_B2LC
SY   Human WDR41 knockout HeLa
DR   Abcam; ab265975
DR   Wikidata; Q110432457
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25601; WDR41.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WDR45 KO
AC   CVCL_B2LD
SY   Human WDR45 knockout HeLa
DR   Abcam; ab265981
DR   Wikidata; Q110432458
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28912; WDR45.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WDR59 KO
AC   CVCL_B2LE
SY   Human WDR59 knockout HeLa
DR   Abcam; ab265994
DR   Wikidata; Q110432459
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25706; WDR59.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WDR6 KO
AC   CVCL_B2LF
SY   Human WDR6 knockout HeLa
DR   Abcam; ab265378
DR   Wikidata; Q110432460
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12758; WDR6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WNT5A KO
AC   CVCL_B2LG
SY   Human WNT5A knockout HeLa
DR   Abcam; ab264019
DR   Wikidata; Q110432462
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12784; WNT5A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WRNIP1 KO
AC   CVCL_B2LH
SY   Human WRNIP1 (WHIP) knockout HeLa
DR   Abcam; ab265500
DR   Wikidata; Q110432463
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20876; WRNIP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WSB2 KO
AC   CVCL_B2LI
SY   Human WSB2 knockout HeLa
DR   Abcam; ab265985
DR   Wikidata; Q110432464
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19222; WSB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WWC2 KO
AC   CVCL_B2LJ
SY   Human WWC2 knockout HeLa
DR   Abcam; ab265550
DR   Wikidata; Q110432465
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24148; WWC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa WWTR1 KO
AC   CVCL_B9VX
SY   Human WWTR1 knockout HeLa
DR   Abcam; ab281598
DR   Wikidata; Q112928346
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa YES1 KO
AC   CVCL_B2LK
SY   Human YES1 knockout HeLa
DR   Abcam; ab265202
DR   Wikidata; Q110432466
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12841; YES1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa YY1AP1 KO
AC   CVCL_B2LL
SY   Human YY1AP1 knockout HeLa
DR   Abcam; ab265512
DR   Wikidata; Q110432467
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30935; YY1AP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZAP70 KO
AC   CVCL_B2LM
SY   Human ZAP70 knockout HeLa
DR   Abcam; ab265522
DR   Wikidata; Q110432468
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12858; ZAP70.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Abcam; ab265522; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Abcam HeLa ZCCHC17 KO
AC   CVCL_B2LN
SY   Human ZCCHC17 (pNO40) knockout HeLa
DR   Abcam; ab265206
DR   Wikidata; Q110432469
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30246; ZCCHC17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZDHHC6 KO
AC   CVCL_B2LP
SY   Human ZDHHC6 (DHHC-6) knockout HeLa
DR   Abcam; ab265144
DR   Wikidata; Q110432470
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19160; ZDHHC6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZDHHC7 KO
AC   CVCL_B2LQ
SY   Human ZDHHC7 knockout HeLa
DR   Abcam; ab265468
DR   Wikidata; Q110432471
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18459; ZDHHC7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZMAT3 KO
AC   CVCL_B2LR
SY   Human ZMAT3 (PAG608) knockout HeLa
DR   Abcam; ab265093
DR   Wikidata; Q110432472
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29983; ZMAT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZMPSTE24 KO
AC   CVCL_B2LS
SY   Human ZMPSTE24 knockout HeLa
DR   Abcam; ab264736
DR   Wikidata; Q110432474
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12877; ZMPSTE24.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZMYM3 KO
AC   CVCL_B2LT
SY   Human ZMYM3 knockout HeLa
DR   Abcam; ab264671
DR   Wikidata; Q110432475
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13054; ZMYM3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZNF326 KO
AC   CVCL_B2LU
SY   Human ZNF326 knockout HeLa
DR   Abcam; ab265765
DR   Wikidata; Q110432476
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14104; ZNF326.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZNF609 KO
AC   CVCL_B2LV
SY   Human ZNF609 knockout HeLa
DR   Abcam; ab265076
DR   Wikidata; Q110432477
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29003; ZNF609.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZNF622 KO
AC   CVCL_B2LW
SY   Human ZNF622 (ZPR9) knockout HeLa
DR   Abcam; ab264694
DR   Wikidata; Q110432478
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30958; ZNF622.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZNF692 KO
AC   CVCL_B2LX
SY   Human ZNF692 knockout HeLa
DR   Abcam; ab265324
DR   Wikidata; Q110432479
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26049; ZNF692.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZNHIT6 KO
AC   CVCL_B2LY
SY   Human ZNHIT6 (C1orf181) knockout HeLa
DR   Abcam; ab265532
DR   Wikidata; Q110432480
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26089; ZNHIT6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam HeLa ZRANB1 KO
AC   CVCL_B2LZ
SY   Human ZRANB1 knockout HeLa
DR   Abcam; ab265848
DR   Wikidata; Q110432481
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18224; ZRANB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam Hep-G2 ACE2 KO
AC   CVCL_B0ZH
SY   Human ACE2 knockout Hep G2
DR   Abcam; ab273733
DR   cancercelllines; CVCL_B0ZH
DR   Wikidata; Q110432482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13557; ACE2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 APOE KO
AC   CVCL_B7V5
SY   Human APOE knockout Hep G2
DR   Abcam; ab280875
DR   cancercelllines; CVCL_B7V5
DR   Wikidata; Q112928347
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 ARRB2 KO
AC   CVCL_B0ZI
SY   Human ARRB2 (Beta Arrestin 2) knockout Hep G2
DR   Abcam; ab262320
DR   cancercelllines; CVCL_B0ZI
DR   Wikidata; Q110432483
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 ARG1 KO
AC   CVCL_B7V6
SY   Human ARG1 knockout Hep G2
DR   Abcam; ab281603
DR   cancercelllines; CVCL_B7V6
DR   Wikidata; Q112928348
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:663; ARG1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 B2M KO
AC   CVCL_B0ZJ
SY   Human B2M (beta 2 Microglobulin) knockout Hep G2
DR   Abcam; ab262325
DR   cancercelllines; CVCL_B0ZJ
DR   Wikidata; Q110432484
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 CD63 KO
AC   CVCL_B0ZK
SY   Human CD63 knockout Hep G2
DR   Abcam; ab280796
DR   cancercelllines; CVCL_B0ZK
DR   Wikidata; Q110432485
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1692; CD63.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 CTNNB1 KO
AC   CVCL_B0ZL
SY   Human CTNNB1 (beta Catenin) knockout Hep G2
DR   Abcam; ab277911
DR   cancercelllines; CVCL_B0ZL
DR   Wikidata; Q110432486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 LRP6 KO
AC   CVCL_B0ZM
SY   Human LRP6 knockout Hep G2
DR   Abcam; ab277909
DR   cancercelllines; CVCL_B0ZM
DR   Wikidata; Q110432487
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6698; LRP6.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 MTOR KO
AC   CVCL_B0ZN
SY   Human MTOR knockout Hep G2
DR   Abcam; ab277829
DR   cancercelllines; CVCL_B0ZN
DR   Wikidata; Q110432488
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3942; MTOR.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Abcam; ab277829; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Hep-G2 NF2 KO
AC   CVCL_B0ZP
SY   Human NF2 (Merlin) knockout Hep G2
DR   Abcam; ab277859
DR   cancercelllines; CVCL_B0ZP
DR   Wikidata; Q110432489
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 NFKB2 KO
AC   CVCL_B0ZQ
SY   Human NFKB2 (NFkB p100/NFKB2) knockout Hep G2
DR   Abcam; ab262323
DR   cancercelllines; CVCL_B0ZQ
DR   Wikidata; Q110432490
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 SLC2A1 KO
AC   CVCL_B0ZR
SY   Human SLC2A1 (Glucose Transporter GLUT1) knockout Hep G2
DR   Abcam; ab280797
DR   cancercelllines; CVCL_B0ZR
DR   Wikidata; Q110432491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 SLC7A11 KO
AC   CVCL_B7V7
SY   Human SLC7A11 (xCT) knockout Hep G2
DR   Abcam; ab275411
DR   cancercelllines; CVCL_B7V7
DR   Wikidata; Q112928349
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11059; SLC7A11.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Hep-G2 TFEB KO
AC   CVCL_B0ZS
SY   Human TFEB knockout Hep G2
DR   Abcam; ab277871
DR   cancercelllines; CVCL_B0ZS
DR   Wikidata; Q110432492
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11753; TFEB.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat ABI1 KO
AC   CVCL_UQ00
SY   Human ABI1 knockout Jurkat
DR   Abcam; ab301825
DR   Wikidata; Q127379150
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11320; ABI1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Abcam; ab301825; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Abcam Jurkat ACAA1 KO
AC   CVCL_UQ01
SY   Human ACAA1 knockout Jurkat
DR   Abcam; ab301828
DR   Wikidata; Q127379151
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:82; ACAA1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Abcam; ab301828; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Abcam Jurkat ACAT2 KO
AC   CVCL_UQ02
SY   Human ACAT2 knockout Jurkat
DR   Abcam; ab301831
DR   Wikidata; Q127379152
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:94; ACAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ACOT13 KO
AC   CVCL_UQ03
SY   Human ACOT13 knockout Jurkat
DR   Abcam; ab301833
DR   Wikidata; Q127379153
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20999; ACOT13.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Abcam; ab301833; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Abcam Jurkat ACTR3 KO
AC   CVCL_UQ04
SY   Human ACTR3 knockout Jurkat
DR   Abcam; ab301836
DR   Wikidata; Q127379155
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:170; ACTR3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ACVR2B KO
AC   CVCL_UQ05
SY   Human ACVR2B knockout Jurkat
DR   Abcam; ab301839
DR   Wikidata; Q127379156
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ACVRL1 KO
AC   CVCL_UQ06
SY   Human ACVRL1 knockout Jurkat
DR   Abcam; ab301842
DR   Wikidata; Q127379157
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:175; ACVRL1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ACY1 KO
AC   CVCL_UQ07
SY   Human ACY1 knockout Jurkat
DR   Abcam; ab301845
DR   Wikidata; Q127379158
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:177; ACY1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ADD1 KO
AC   CVCL_UQ08
SY   Human ADD1 knockout Jurkat
DR   Abcam; ab301848
DR   Wikidata; Q127379159
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:243; ADD1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat AHCY KO
AC   CVCL_UQ09
SY   Human AHCY knockout Jurkat
DR   Abcam; ab301851
DR   Wikidata; Q127379160
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:343; AHCY.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat AKR7A2 KO
AC   CVCL_UQ10
SY   Human AKR7A2 knockout Jurkat
DR   Abcam; ab301854
DR   Wikidata; Q127379161
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:389; AKR7A2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ALAD KO
AC   CVCL_UQ11
SY   Human ALAD knockout Jurkat
DR   Abcam; ab301857
DR   Wikidata; Q127379162
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:395; ALAD.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ALDH1A2 KO
AC   CVCL_UQ12
SY   Human ALDH1A2 knockout Jurkat
DR   Abcam; ab301860
DR   Wikidata; Q127379163
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15472; ALDH1A2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ALDH4A1 KO
AC   CVCL_UQ13
SY   Human ALDH4A1 knockout Jurkat
DR   Abcam; ab301863
DR   Wikidata; Q127379164
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:406; ALDH4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ALDOB KO
AC   CVCL_UQ14
SY   Human ALDOB knockout Jurkat
DR   Abcam; ab301866
DR   Wikidata; Q127379165
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:417; ALDOB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ALOX5AP KO
AC   CVCL_UQ15
SY   Human ALOX5AP knockout Jurkat
DR   Abcam; ab301869
DR   Wikidata; Q127379166
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:436; ALOX5AP.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ARSA KO
AC   CVCL_UQ16
SY   Human ARSA knockout Jurkat
DR   Abcam; ab301878
DR   Wikidata; Q127379167
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:713; ARSA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ASL KO
AC   CVCL_UQ17
SY   Human ASL knockout Jurkat
DR   Abcam; ab301881
DR   Wikidata; Q127379168
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:746; ASL.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ATXN2 KO
AC   CVCL_UQ18
SY   Human ATXN2 knockout Jurkat
DR   Abcam; ab301884
DR   Wikidata; Q127379169
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10555; ATXN2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat BAZ2A KO
AC   CVCL_UQ19
SY   Human BAZ2A knockout Jurkat
DR   Abcam; ab301887
DR   Wikidata; Q127379170
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:962; BAZ2A.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat BCAT1 KO
AC   CVCL_UQ20
SY   Human BCAT1 knockout Jurkat
DR   Abcam; ab301890
DR   Wikidata; Q127379171
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat BCAT2 KO
AC   CVCL_UQ21
SY   Human BCAT2 knockout Jurkat
DR   Abcam; ab301893
DR   Wikidata; Q127379172
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:977; BCAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat BRMS1 KO
AC   CVCL_UQ22
SY   Human BRMS1 knockout Jurkat
DR   Abcam; ab301899
DR   Wikidata; Q127379173
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17262; BRMS1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat BTLA KO
AC   CVCL_UQ23
SY   Human BTLA knockout Jurkat
DR   Abcam; ab301902
DR   Wikidata; Q127379174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21087; BTLA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CA8 KO
AC   CVCL_UQ24
SY   Human CA8 knockout Jurkat
DR   Abcam; ab301905
DR   Wikidata; Q127379175
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1382; CA8.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CALU KO
AC   CVCL_UQ25
SY   Human CALU knockout Jurkat
DR   Abcam; ab301908
DR   Wikidata; Q127379176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1458; CALU.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CAMK4 KO
AC   CVCL_UQ26
SY   Human CAMK4 knockout Jurkat
DR   Abcam; ab301911
DR   Wikidata; Q127379177
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1464; CAMK4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CASP10 KO
AC   CVCL_UQ27
SY   Human CASP10 knockout Jurkat
DR   Abcam; ab301917
DR   Wikidata; Q127379178
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1500; CASP10.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CASP2 KO
AC   CVCL_UQ28
SY   Human CASP2 knockout Jurkat
DR   Abcam; ab301919
DR   Wikidata; Q127379179
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1503; CASP2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CBLC KO
AC   CVCL_UQ29
SY   Human CBLC knockout Jurkat
DR   Abcam; ab301922
DR   Wikidata; Q127379180
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15961; CBLC.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CCS KO
AC   CVCL_UQ30
SY   Human CCS knockout Jurkat
DR   Abcam; ab301925
DR   Wikidata; Q127379182
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1613; CCS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CD1A KO
AC   CVCL_B7V8
SY   Human CD1A knockout Jurkat
DR   Abcam; ab274926
DR   cancercelllines; CVCL_B7V8
DR   Wikidata; Q112928350
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1634; CD1A.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat CD1C KO
AC   CVCL_B0Z5
SY   Human CD1C knockout Jurkat
DR   Abcam; ab273867
DR   cancercelllines; CVCL_B0Z5
DR   Wikidata; Q110432493
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1636; CD1C.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Jurkat CD247 KO
AC   CVCL_B7V9
SY   Human CD247 knockout Jurkat
DR   Abcam; ab273856
DR   cancercelllines; CVCL_B7V9
DR   Wikidata; Q112928351
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1677; CD247.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat CD3E KO
AC   CVCL_E1G4
SY   Human CD3E knockout Jurkat
DR   Abcam; ab277186
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Jurkat CD3G KO
AC   CVCL_E1G5
SY   Human CD3G knockout Jurkat
DR   Abcam; ab273872
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1675; CD3G.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Jurkat CHP1 KO
AC   CVCL_UQ31
SY   Human CHP1 knockout Jurkat
DR   Abcam; ab301931
DR   Wikidata; Q127379183
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17433; CHP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CLASP1 KO
AC   CVCL_UQ32
SY   Human CLASP1 knockout Jurkat
DR   Abcam; ab301934
DR   Wikidata; Q127379184
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17088; CLASP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CLPP KO
AC   CVCL_UQ33
SY   Human CLPP knockout Jurkat
DR   Abcam; ab301937
DR   Wikidata; Q127379185
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2084; CLPP.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CMAS KO
AC   CVCL_UQ34
SY   Human CMAS knockout Jurkat
DR   Abcam; ab301940
DR   Wikidata; Q127379186
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18290; CMAS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CNDP2 KO
AC   CVCL_UQ35
SY   Human CNDP2 knockout Jurkat
DR   Abcam; ab301943
DR   Wikidata; Q127379187
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24437; CNDP2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CRYZ KO
AC   CVCL_UQ36
SY   Human CRYZ knockout Jurkat
DR   Abcam; ab301946
DR   Wikidata; Q127379188
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2419; CRYZ.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CYB5A KO
AC   CVCL_UQ37
SY   Human CYB5A knockout Jurkat
DR   Abcam; ab301949
DR   Wikidata; Q127379191
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2570; CYB5A.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat CYB5R3 KO
AC   CVCL_UQ38
SY   Human CYB5R3 knockout Jurkat
DR   Abcam; ab301952
DR   Wikidata; Q127379192
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2873; CYB5R3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat DFFB KO
AC   CVCL_UQ39
SY   Human DFFB knockout Jurkat
DR   Abcam; ab301958
DR   Wikidata; Q127379193
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2773; DFFB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat DGAT1 KO
AC   CVCL_UQ40
SY   Human DGAT1 knockout Jurkat
DR   Abcam; ab301961
DR   Wikidata; Q127379194
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2843; DGAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat DGKA KO
AC   CVCL_UQ41
SY   Human DGKA knockout Jurkat
DR   Abcam; ab301964
DR   Wikidata; Q127379195
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2849; DGKA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat DNPEP KO
AC   CVCL_UQ42
SY   Human DNPEP knockout Jurkat
DR   Abcam; ab301967
DR   Wikidata; Q127379196
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2981; DNPEP.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat DNTT KO
AC   CVCL_UQ43
SY   Human DNTT knockout Jurkat
DR   Abcam; ab301970
DR   Wikidata; Q127379197
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2983; DNTT.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat DPP8 KO
AC   CVCL_UQ44
SY   Human DPP8 knockout Jurkat
DR   Abcam; ab301973
DR   Wikidata; Q127379198
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16490; DPP8.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ENO2 KO
AC   CVCL_E1G6
SY   Human ENO2 knockout Jurkat
DR   Abcam; ab275829
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3353; ENO2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Jurkat EPHX1 KO
AC   CVCL_UQ45
SY   Human EPHX1 knockout Jurkat
DR   Abcam; ab301982
DR   Wikidata; Q127379199
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3401; EPHX1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat EPHX2 KO
AC   CVCL_UQ46
SY   Human EPHX2 knockout Jurkat
DR   Abcam; ab301985
DR   Wikidata; Q127379200
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3402; EPHX2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat EPN1 KO
AC   CVCL_UQ47
SY   Human EPN1 knockout Jurkat
DR   Abcam; ab301988
DR   Wikidata; Q127379201
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21604; EPN1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ETV4 KO
AC   CVCL_UQ48
SY   Human ETV4 knockout Jurkat
DR   Abcam; ab301991
DR   Wikidata; Q127379202
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3493; ETV4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat FDX1 KO
AC   CVCL_UQ49
SY   Human FDX1 knockout Jurkat
DR   Abcam; ab301994
DR   Wikidata; Q127379203
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3638; FDX1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat FECH KO
AC   CVCL_UQ50
SY   Human FECH knockout Jurkat
DR   Abcam; ab301997
DR   Wikidata; Q127379205
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3647; FECH.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat FOLR2 KO
AC   CVCL_UQ51
SY   Human FOLR2 knockout Jurkat
DR   Abcam; ab302000
DR   Wikidata; Q127379206
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3793; FOLR2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat FOSB KO
AC   CVCL_UQ52
SY   Human FOSB knockout Jurkat
DR   Abcam; ab302003
DR   Wikidata; Q127379207
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3797; FOSB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat FPGS KO
AC   CVCL_UQ53
SY   Human FPGS knockout Jurkat
DR   Abcam; ab302006
DR   Wikidata; Q127379208
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3824; FPGS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat FRK KO
AC   CVCL_UQ54
SY   Human FRK knockout Jurkat
DR   Abcam; ab302009
DR   Wikidata; Q127379209
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3955; FRK.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat FUBP1 KO
AC   CVCL_UQ55
SY   Human FUBP1 knockout Jurkat
DR   Abcam; ab302012
DR   Wikidata; Q127379210
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4004; FUBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GAMT KO
AC   CVCL_UQ56
SY   Human GAMT knockout Jurkat
DR   Abcam; ab302015
DR   Wikidata; Q127379212
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4136; GAMT.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GANAB KO
AC   CVCL_UQ57
SY   Human GANAB knockout Jurkat
DR   Abcam; ab302018
DR   Wikidata; Q127379213
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4138; GANAB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GART KO
AC   CVCL_UQ58
SY   Human GART knockout Jurkat
DR   Abcam; ab302021
DR   Wikidata; Q127379214
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4163; GART.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GCDH KO
AC   CVCL_UQ59
SY   Human GCDH knockout Jurkat
DR   Abcam; ab302024
DR   Wikidata; Q127379215
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4189; GCDH.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GGH KO
AC   CVCL_UQ60
SY   Human GGH knockout Jurkat
DR   Abcam; ab302027
DR   Wikidata; Q127379216
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4248; GGH.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GLG1 KO
AC   CVCL_UQ61
SY   Human GLG1 knockout Jurkat
DR   Abcam; ab302030
DR   Wikidata; Q127379217
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4316; GLG1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GLUL KO
AC   CVCL_UQ62
SY   Human GLUL knockout Jurkat
DR   Abcam; ab302033
DR   Wikidata; Q127379218
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GNE KO
AC   CVCL_UQ63
SY   Human GNE knockout Jurkat
DR   Abcam; ab302036
DR   Wikidata; Q127379219
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23657; GNE.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GRK3 KO
AC   CVCL_UQ64
SY   Human GRK3 knockout Jurkat
DR   Abcam; ab302039
DR   Wikidata; Q127379220
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GRK6 KO
AC   CVCL_UQ65
SY   Human GRK6 knockout Jurkat
DR   Abcam; ab302042
DR   Wikidata; Q127379221
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4545; GRK6.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat GUSB KO
AC   CVCL_UQ66
SY   Human GUSB knockout Jurkat
DR   Abcam; ab302045
DR   Wikidata; Q127379222
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4696; GUSB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HDAC10 KO
AC   CVCL_UQ67
SY   Human HDAC10 knockout Jurkat
DR   Abcam; ab302048
DR   Wikidata; Q127379223
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18128; HDAC10.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HDGF KO
AC   CVCL_UQ68
SY   Human HDGF knockout Jurkat
DR   Abcam; ab302051
DR   Wikidata; Q127379224
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4856; HDGF.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HEXA KO
AC   CVCL_UQ69
SY   Human HEXA knockout Jurkat
DR   Abcam; ab302054
DR   Wikidata; Q127379225
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4878; HEXA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HIF1AN KO
AC   CVCL_UQ70
SY   Human HIF1AN knockout Jurkat
DR   Abcam; ab302057
DR   Wikidata; Q127379226
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17113; HIF1AN.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HMBS KO
AC   CVCL_D1LF
SY   Human HMBS knockout Jurkat
DR   Abcam; ab302060
DR   Wikidata; Q127379227
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4982; HMBS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HMGCS2 KO
AC   CVCL_UQ71
SY   Human HMGCS2 knockout Jurkat
DR   Abcam; ab302063
DR   Wikidata; Q127379228
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5008; HMGCS2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HMOX2 KO
AC   CVCL_UQ72
SY   Human HMOX2 knockout Jurkat
DR   Abcam; ab302066
DR   Wikidata; Q127379229
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5014; HMOX2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HSD17B10 KO
AC   CVCL_UQ73
SY   Human HSD17B10 knockout Jurkat
DR   Abcam; ab302072
DR   Wikidata; Q127379230
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4800; HSD17B10.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HSD17B4 KO
AC   CVCL_UQ74
SY   Human HSD17B4 knockout Jurkat
DR   Abcam; ab302075
DR   Wikidata; Q127379231
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5213; HSD17B4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HSPA13 KO
AC   CVCL_UQ75
SY   Human HSPA13 knockout Jurkat
DR   Abcam; ab302078
DR   Wikidata; Q127379232
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11375; HSPA13.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HSPA1L KO
AC   CVCL_UQ76
SY   Human HSPA1L knockout Jurkat
DR   Abcam; ab302081
DR   Wikidata; Q127379233
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5234; HSPA1L.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HSPA2 KO
AC   CVCL_UQ77
SY   Human HSPA2 knockout Jurkat
DR   Abcam; ab302084
DR   Wikidata; Q127379234
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5235; HSPA2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HSPA4 KO
AC   CVCL_UQ78
SY   Human HSPA4 knockout Jurkat
DR   Abcam; ab302087
DR   Wikidata; Q127379235
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5237; HSPA4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat HSPH1 KO
AC   CVCL_UQ79
SY   Human HSPH1 knockout Jurkat
DR   Abcam; ab302090
DR   Wikidata; Q127379236
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16969; HSPH1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat IDH2 KO
AC   CVCL_B7VD
SY   Human IDH2 knockout Jurkat
DR   Abcam; ab282331
DR   cancercelllines; CVCL_B7VD
DR   Wikidata; Q112928352
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat IFI16 KO
AC   CVCL_E1G7
SY   Human IFI16 knockout Jurkat
DR   Abcam; ab273854
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5395; IFI16.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Jurkat IFNG KO
AC   CVCL_B0Z6
SY   Human IFNG knockout Jurkat
DR   Abcam; ab273746
DR   cancercelllines; CVCL_B0Z6
DR   Wikidata; Q110432494
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5438; IFNG.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Jurkat IKZF1 KO
AC   CVCL_B0Z7
SY   Human IKZF1 knockout Jurkat
DR   Abcam; ab274920
DR   cancercelllines; CVCL_B0Z7
DR   Wikidata; Q110432495
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13176; IKZF1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Jurkat IKZF3 KO
AC   CVCL_UQ80
SY   Human IKZF3 knockout Jurkat
DR   Abcam; ab302093
DR   Wikidata; Q127379237
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13178; IKZF3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat IL13RA1 KO
AC   CVCL_UQ81
SY   Human IL13RA1 knockout Jurkat
DR   Abcam; ab302096
DR   Wikidata; Q127379238
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat IL2RG KO
AC   CVCL_UQ82
SY   Human IL2RG knockout Jurkat
DR   Abcam; ab302099
DR   Wikidata; Q127379239
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6010; IL2RG.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat IMPDH1 KO
AC   CVCL_UQ83
SY   Human IMPDH1 knockout Jurkat
DR   Abcam; ab302105
DR   Wikidata; Q127379240
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6052; IMPDH1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ITGA4 KO
AC   CVCL_UQ84
SY   Human ITGA4 knockout Jurkat
DR   Abcam; ab302108
DR   Wikidata; Q127379241
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6140; ITGA4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat LCK KO
AC   CVCL_B7VA
SY   Human LCK knockout Jurkat
DR   Abcam; ab273855
DR   cancercelllines; CVCL_B7VA
DR   Wikidata; Q112928353
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6524; LCK.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat LEF1 KO
AC   CVCL_B7VB
SY   Human LEF1 knockout Jurkat
DR   Abcam; ab274898
DR   cancercelllines; CVCL_B7VB
DR   Wikidata; Q112928354
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6551; LEF1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat LGALS8 KO
AC   CVCL_UQ85
SY   Human LGALS8 knockout Jurkat
DR   Abcam; ab302111
DR   Wikidata; Q127379242
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6569; LGALS8.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat LIAS KO
AC   CVCL_UQ86
SY   Human LIAS knockout Jurkat
DR   Abcam; ab302114
DR   Wikidata; Q127379243
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16429; LIAS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat LPXN KO
AC   CVCL_UQ87
SY   Human LPXN knockout Jurkat
DR   Abcam; ab302117
DR   Wikidata; Q127379244
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14061; LPXN.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MAEA KO
AC   CVCL_UQ88
SY   Human MAEA knockout Jurkat
DR   Abcam; ab302119
DR   Wikidata; Q127379245
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13731; MAEA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MAP3K4 KO
AC   CVCL_UQ89
SY   Human MAP3K4 knockout Jurkat
DR   Abcam; ab302122
DR   Wikidata; Q127379246
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MAP4K1 KO
AC   CVCL_UQ90
SY   Human MAP4K1 knockout Jurkat
DR   Abcam; ab302125
DR   Wikidata; Q127379247
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6863; MAP4K1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MAP4K4 KO
AC   CVCL_UQ91
SY   Human MAP4K4 knockout Jurkat
DR   Abcam; ab302128
DR   Wikidata; Q127379248
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6866; MAP4K4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MARK3 KO
AC   CVCL_UQ92
SY   Human MARK3 knockout Jurkat
DR   Abcam; ab302131
DR   Wikidata; Q127379250
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6897; MARK3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MAT1A KO
AC   CVCL_UQ93
SY   Human MAT1A knockout Jurkat
DR   Abcam; ab302134
DR   Wikidata; Q127379251
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6903; MAT1A.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ME2 KO
AC   CVCL_UQ94
SY   Human ME2 knockout Jurkat
DR   Abcam; ab302137
DR   Wikidata; Q127379252
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6984; ME2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MMACHC KO
AC   CVCL_UQ95
SY   Human MMACHC knockout Jurkat
DR   Abcam; ab302140
DR   Wikidata; Q127379253
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24525; MMACHC.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MPG KO
AC   CVCL_UQ96
SY   Human MPG knockout Jurkat
DR   Abcam; ab302143
DR   Wikidata; Q127379254
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7211; MPG.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat MTHFR KO
AC   CVCL_UQ97
SY   Human MTHFR knockout Jurkat
DR   Abcam; ab302146
DR   Wikidata; Q127379256
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7436; MTHFR.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NAGK KO
AC   CVCL_UQ98
SY   Human NAGK knockout Jurkat
DR   Abcam; ab302149
DR   Wikidata; Q127379257
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17174; NAGK.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NAPRT KO
AC   CVCL_UQ99
SY   Human NAPRT knockout Jurkat
DR   Abcam; ab302151
DR   Wikidata; Q127379258
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30450; NAPRT.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NAT1 KO
AC   CVCL_WQ00
SY   Human NAT1 knockout Jurkat
DR   Abcam; ab302154
DR   Wikidata; Q127379259
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NCOA5 KO
AC   CVCL_WQ01
SY   Human NCOA5 knockout Jurkat
DR   Abcam; ab302157
DR   Wikidata; Q127379260
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15909; NCOA5.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NDUFA12 KO
AC   CVCL_WQ02
SY   Human NDUFA12 knockout Jurkat
DR   Abcam; ab302160
DR   Wikidata; Q127379261
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23987; NDUFA12.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NDUFAF2 KO
AC   CVCL_WQ03
SY   Human NDUFAF2 knockout Jurkat
DR   Abcam; ab302163
DR   Wikidata; Q127379263
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28086; NDUFAF2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NDUFB6 KO
AC   CVCL_WQ04
SY   Human NDUFB6 knockout Jurkat
DR   Abcam; ab302166
DR   Wikidata; Q127379264
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7701; NDUFB6.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NDUFB8 KO
AC   CVCL_WQ05
SY   Human NDUFB8 knockout Jurkat
DR   Abcam; ab302169
DR   Wikidata; Q127379266
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7703; NDUFB8.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NDUFS1 KO
AC   CVCL_WQ06
SY   Human NDUFS1 knockout Jurkat
DR   Abcam; ab302172
DR   Wikidata; Q127379267
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7707; NDUFS1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NDUFS2 KO
AC   CVCL_WQ07
SY   Human NDUFS2 knockout Jurkat
DR   Abcam; ab302175
DR   Wikidata; Q127379268
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7708; NDUFS2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NFKBIA KO
AC   CVCL_WQ08
SY   Human NFKBIA knockout Jurkat
DR   Abcam; ab302178
DR   Wikidata; Q127379269
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NFKBIB KO
AC   CVCL_WQ09
SY   Human NFKBIB knockout Jurkat
DR   Abcam; ab302181
DR   Wikidata; Q127379270
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7798; NFKBIB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NMNAT1 KO
AC   CVCL_WQ10
SY   Human NMNAT1 knockout Jurkat
DR   Abcam; ab302184
DR   Wikidata; Q127379271
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17877; NMNAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NMT1 KO
AC   CVCL_WQ11
SY   Human NMT1 knockout Jurkat
DR   Abcam; ab302187
DR   Wikidata; Q127379272
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NMT2 KO
AC   CVCL_WQ12
SY   Human NMT2 knockout Jurkat
DR   Abcam; ab302190
DR   Wikidata; Q127379273
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7858; NMT2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NOD2 KO
AC   CVCL_WQ13
SY   Human NOD2 knockout Jurkat
DR   Abcam; ab302193
DR   Wikidata; Q127379274
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5331; NOD2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NOX5 KO
AC   CVCL_WQ14
SY   Human NOX5 knockout Jurkat
DR   Abcam; ab302196
DR   Wikidata; Q127379275
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14874; NOX5.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NPEPPS KO
AC   CVCL_WQ15
SY   Human NPEPPS knockout Jurkat
DR   Abcam; ab302199
DR   Wikidata; Q127379277
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7900; NPEPPS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NQO2 KO
AC   CVCL_WQ16
SY   Human NQO2 knockout Jurkat
DR   Abcam; ab302202
DR   Wikidata; Q127379278
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7856; NQO2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat NUCB2 KO
AC   CVCL_WQ17
SY   Human NUCB2 knockout Jurkat
DR   Abcam; ab302205
DR   Wikidata; Q127379279
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8044; NUCB2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat OAT KO
AC   CVCL_WQ18
SY   Human OAT knockout Jurkat
DR   Abcam; ab302208
DR   Wikidata; Q127379281
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8091; OAT.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat OXSR1 KO
AC   CVCL_WQ19
SY   Human OXSR1 knockout Jurkat
DR   Abcam; ab302211
DR   Wikidata; Q127379282
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8508; OXSR1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat P3H1 KO
AC   CVCL_D1LE
SY   Human P3H1 knockout Jurkat
DR   Abcam; ab302214
DR   Wikidata; Q127379283
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19316; P3H1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PADI2 KO
AC   CVCL_D1LB
SY   Human PADI2 knockout Jurkat
DR   Abcam; ab302217
DR   Wikidata; Q127379284
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18341; PADI2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PAICS KO
AC   CVCL_WQ20
SY   Human PAICS knockout Jurkat
DR   Abcam; ab302220
DR   Wikidata; Q127379286
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8587; PAICS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PCMT1 KO
AC   CVCL_WQ21
SY   Human PCMT1 knockout Jurkat
DR   Abcam; ab302223
DR   Wikidata; Q127379287
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8728; PCMT1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PCYT2 KO
AC   CVCL_WQ22
SY   Human PCYT2 knockout Jurkat
DR   Abcam; ab302226
DR   Wikidata; Q127379288
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8756; PCYT2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PDHB KO
AC   CVCL_WQ23
SY   Human PDHB knockout Jurkat
DR   Abcam; ab302232
DR   Wikidata; Q127379289
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8808; PDHB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PDHX KO
AC   CVCL_WQ24
SY   Human PDHX knockout Jurkat
DR   Abcam; ab302235
DR   Wikidata; Q127379290
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21350; PDHX.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PEF1 KO
AC   CVCL_WQ25
SY   Human PEF1 knockout Jurkat
DR   Abcam; ab302241
DR   Wikidata; Q127379291
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30009; PEF1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PGAM1 KO
AC   CVCL_WQ26
SY   Human PGAM1 knockout Jurkat
DR   Abcam; ab302244
DR   Wikidata; Q127379292
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8888; PGAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PGRMC1 KO
AC   CVCL_WQ27
SY   Human PGRMC1 knockout Jurkat
DR   Abcam; ab302247
DR   Wikidata; Q127379294
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16090; PGRMC1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PI4KB KO
AC   CVCL_WQ28
SY   Human PI4KB knockout Jurkat
DR   Abcam; ab302250
DR   Wikidata; Q127379295
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PIM2 KO
AC   CVCL_WQ29
SY   Human PIM2 knockout Jurkat
DR   Abcam; ab302253
DR   Wikidata; Q127379296
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8987; PIM2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PKLR KO
AC   CVCL_WQ30
SY   Human PKLR knockout Jurkat
DR   Abcam; ab302256
DR   Wikidata; Q127379297
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9020; PKLR.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PLIN3 KO
AC   CVCL_WQ31
SY   Human PLIN3 knockout Jurkat
DR   Abcam; ab302259
DR   Wikidata; Q127379298
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16893; PLIN3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PMVK KO
AC   CVCL_WQ32
SY   Human PMVK knockout Jurkat
DR   Abcam; ab302261
DR   Wikidata; Q127379299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9141; PMVK.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PNMT KO
AC   CVCL_WQ33
SY   Human PNMT knockout Jurkat
DR   Abcam; ab302264
DR   Wikidata; Q127379300
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9160; PNMT.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat POLH KO
AC   CVCL_WQ34
SY   Human POLH knockout Jurkat
DR   Abcam; ab302267
DR   Wikidata; Q127379302
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9181; POLH.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PPOX KO
AC   CVCL_WQ35
SY   Human PPOX knockout Jurkat
DR   Abcam; ab302270
DR   Wikidata; Q127379303
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9280; PPOX.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PPP2CB KO
AC   CVCL_WQ36
SY   Human PPP2CB knockout Jurkat
DR   Abcam; ab302273
DR   Wikidata; Q127379304
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9300; PPP2CB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRDX5 KO
AC   CVCL_WQ37
SY   Human PRDX5 knockout Jurkat
DR   Abcam; ab302276
DR   Wikidata; Q127379305
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9355; PRDX5.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRG2 KO
AC   CVCL_D1LG
SY   Human PRG2 knockout Jurkat
DR   Abcam; ab302279
DR   Wikidata; Q127379306
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9362; PRG2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRKAB1 KO
AC   CVCL_WQ38
SY   Human PRKAB1 knockout Jurkat
DR   Abcam; ab302282
DR   Wikidata; Q127379307
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRKACA KO
AC   CVCL_WQ39
SY   Human PRKACA knockout Jurkat
DR   Abcam; ab302285
DR   Wikidata; Q127379308
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9380; PRKACA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRKAG1 KO
AC   CVCL_WQ40
SY   Human PRKAG1 knockout Jurkat
DR   Abcam; ab302288
DR   Wikidata; Q127379309
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRKCG KO
AC   CVCL_WQ41
SY   Human PRKCG knockout Jurkat
DR   Abcam; ab302291
DR   Wikidata; Q127379310
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRKD1 KO
AC   CVCL_WQ42
SY   Human PRKD1 knockout Jurkat
DR   Abcam; ab302445
DR   Wikidata; Q127379311
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9407; PRKD1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PRSS8 KO
AC   CVCL_D1LI
SY   Human PRSS8 knockout Jurkat
DR   Abcam; ab302296
DR   Wikidata; Q127379312
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9491; PRSS8.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PSMF1 KO
AC   CVCL_D1LH
SY   Human PSMF1 knockout Jurkat
DR   Abcam; ab302299
DR   Wikidata; Q127379313
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9571; PSMF1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PTPA KO
AC   CVCL_WQ43
SY   Human PTPA knockout Jurkat
DR   Abcam; ab302302
DR   Wikidata; Q127379314
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9308; PTPA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat PTPN2 KO
AC   CVCL_B0Z8
SY   Human PTPN2 knockout Jurkat
DR   Abcam; ab274899
DR   cancercelllines; CVCL_B0Z8
DR   Wikidata; Q110432496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Jurkat PVRIG KO
AC   CVCL_B7VF
SY   Human PVRIG knockout Jurkat
DR   Abcam; ab274900
DR   cancercelllines; CVCL_B7VF
DR   Wikidata; Q112928355
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32190; PVRIG.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat PYCR1 KO
AC   CVCL_WQ44
SY   Human PYCR1 knockout Jurkat
DR   Abcam; ab302305
DR   Wikidata; Q127379315
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9721; PYCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat QDPR KO
AC   CVCL_WQ45
SY   Human QDPR knockout Jurkat
DR   Abcam; ab302308
DR   Wikidata; Q127379316
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9752; QDPR.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat RECQL KO
AC   CVCL_WQ46
SY   Human RECQL knockout Jurkat
DR   Abcam; ab302317
DR   Wikidata; Q127379318
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9948; RECQL.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat REEP5 KO
AC   CVCL_WQ47
SY   Human REEP5 knockout Jurkat
DR   Abcam; ab302320
DR   Wikidata; Q127379319
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30077; REEP5.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat RPIA KO
AC   CVCL_WQ48
SY   Human RPIA knockout Jurkat
DR   Abcam; ab302323
DR   Wikidata; Q127379320
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10297; RPIA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat RXRB KO
AC   CVCL_WQ49
SY   Human RXRB knockout Jurkat
DR   Abcam; ab302326
DR   Wikidata; Q127379321
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10478; RXRB.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SELENOP KO
AC   CVCL_WQ50
SY   Human SELENOP knockout Jurkat
DR   Abcam; ab302329
DR   Wikidata; Q127379322
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10751; SELENOP.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SELPLG KO
AC   CVCL_E1G8
SY   Human SELPLG knockout Jurkat
DR   Abcam; ab273870
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10722; SELPLG.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Jurkat SERPINB9 KO
AC   CVCL_WQ51
SY   Human SERPINB9 knockout Jurkat
DR   Abcam; ab302332
DR   Wikidata; Q127379325
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8955; SERPINB9.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SH2D1A KO
AC   CVCL_WQ52
SY   Human SH2D1A knockout Jurkat
DR   Abcam; ab302335
DR   Wikidata; Q127379326
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10820; SH2D1A.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SLAMF6 KO
AC   CVCL_WQ53
SY   Human SLAMF6 knockout Jurkat
DR   Abcam; ab302337
DR   Wikidata; Q127379328
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21392; SLAMF6.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SLC25A12 KO
AC   CVCL_WQ54
SY   Human SLC25A12 knockout Jurkat
DR   Abcam; ab302339
DR   Wikidata; Q127379330
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10982; SLC25A12.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SLC5A1 KO
AC   CVCL_WQ55
SY   Human SLC5A1 knockout Jurkat
DR   Abcam; ab302342
DR   Wikidata; Q127379331
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11036; SLC5A1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SLK KO
AC   CVCL_WQ56
SY   Human SLK knockout Jurkat
DR   Abcam; ab302345
DR   Wikidata; Q127379332
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11088; SLK.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SMS KO
AC   CVCL_D1LD
SY   Human SMS knockout Jurkat
DR   Abcam; ab302348
DR   Wikidata; Q127379333
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11123; SMS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SORD KO
AC   CVCL_WQ57
SY   Human SORD knockout Jurkat
DR   Abcam; ab302351
DR   Wikidata; Q127379334
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11184; SORD.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SPAG9 KO
AC   CVCL_WQ58
SY   Human SPAG9 knockout Jurkat
DR   Abcam; ab302354
DR   Wikidata; Q127379335
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14524; SPAG9.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SPTLC2 KO
AC   CVCL_WQ59
SY   Human SPTLC2 knockout Jurkat
DR   Abcam; ab302357
DR   Wikidata; Q127379336
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11278; SPTLC2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SRSF4 KO
AC   CVCL_WQ60
SY   Human SRSF4 knockout Jurkat
DR   Abcam; ab302360
DR   Wikidata; Q127379337
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10786; SRSF4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat SSTR2 KO
AC   CVCL_WQ61
SY   Human SSTR2 knockout Jurkat
DR   Abcam; ab302363
DR   Wikidata; Q127379338
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11331; SSTR2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat STK17B KO
AC   CVCL_WQ62
SY   Human STK17B knockout Jurkat
DR   Abcam; ab302369
DR   Wikidata; Q127379339
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11396; STK17B.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TACR1 KO
AC   CVCL_WQ63
SY   Human TACR1 knockout Jurkat
DR   Abcam; ab302372
DR   Wikidata; Q127379340
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11526; TACR1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TAL1 KO
AC   CVCL_B0Z9
SY   Human TAL1 knockout Jurkat
DR   Abcam; ab273862
DR   cancercelllines; CVCL_B0Z9
DR   Wikidata; Q110432497
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11556; TAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Jurkat TBL1XR1 KO
AC   CVCL_WQ64
SY   Human TBL1XR1 knockout Jurkat
DR   Abcam; ab302375
DR   Wikidata; Q127379341
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29529; TBL1XR1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TDP1 KO
AC   CVCL_WQ65
SY   Human TDP1 knockout Jurkat
DR   Abcam; ab302378
DR   Wikidata; Q127379342
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18884; TDP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TEC KO
AC   CVCL_WQ66
SY   Human TEC knockout Jurkat
DR   Abcam; ab302381
DR   Wikidata; Q127379343
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11719; TEC.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat THOP1 KO
AC   CVCL_WQ67
SY   Human THOP1 knockout Jurkat
DR   Abcam; ab302384
DR   Wikidata; Q127379344
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11793; THOP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TLE3 KO
AC   CVCL_WQ68
SY   Human TLE3 knockout Jurkat
DR   Abcam; ab302387
DR   Wikidata; Q127379345
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TNFSF9 KO
AC   CVCL_WQ69
SY   Human TNFSF9 knockout Jurkat
DR   Abcam; ab302390
DR   Wikidata; Q127379346
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11939; TNFSF9.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TP53 KO
AC   CVCL_B7VE
SY   Human TP53 (p53) knockout Jurkat
DR   Abcam; ab276112
DR   cancercelllines; CVCL_B7VE
DR   Wikidata; Q112928357
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Jurkat TPD52 KO
AC   CVCL_WQ70
SY   Human TPD52 knockout Jurkat
DR   Abcam; ab302396
DR   Wikidata; Q127379347
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12005; TPD52.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TPMT KO
AC   CVCL_WQ71
SY   Human TPMT knockout Jurkat
DR   Abcam; ab302398
DR   Wikidata; Q127379348
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12014; TPMT.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TPP1 KO
AC   CVCL_WQ72
SY   Human TPP1 knockout Jurkat
DR   Abcam; ab302401
DR   Wikidata; Q127379349
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TPP2 KO
AC   CVCL_WQ73
SY   Human TPP2 knockout Jurkat
DR   Abcam; ab302404
DR   Wikidata; Q127379350
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12016; TPP2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TRPC3 KO
AC   CVCL_WQ74
SY   Human TRPC3 knockout Jurkat
DR   Abcam; ab302407
DR   Wikidata; Q127379351
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12335; TRPC3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat TRPM2 KO
AC   CVCL_D1LC
SY   Human TRPM2 knockout Jurkat
DR   Abcam; ab302410
DR   Wikidata; Q127379352
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12339; TRPM2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat UAP1 KO
AC   CVCL_WQ75
SY   Human UAP1 knockout Jurkat
DR   Abcam; ab302413
DR   Wikidata; Q127379353
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12457; UAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat UBE2T KO
AC   CVCL_WQ76
SY   Human UBE2T knockout Jurkat
DR   Abcam; ab302416
DR   Wikidata; Q127379354
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25009; UBE2T.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat UBR1 KO
AC   CVCL_WQ77
SY   Human UBR1 knockout Jurkat
DR   Abcam; ab302419
DR   Wikidata; Q127379355
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16808; UBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat UNC119 KO
AC   CVCL_WQ78
SY   Human UNC119 knockout Jurkat
DR   Abcam; ab302425
DR   Wikidata; Q127379356
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12565; UNC119.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat UPP1 KO
AC   CVCL_WQ79
SY   Human UPP1 knockout Jurkat
DR   Abcam; ab302428
DR   Wikidata; Q127379357
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12576; UPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat VDAC2 KO
AC   CVCL_WQ80
SY   Human VDAC2 knockout Jurkat
DR   Abcam; ab302431
DR   Wikidata; Q127379358
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12672; VDAC2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat VPS37A KO
AC   CVCL_WQ81
SY   Human VPS37A knockout Jurkat
DR   Abcam; ab302434
DR   Wikidata; Q127379359
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24928; VPS37A.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat WAS KO
AC   CVCL_WQ82
SY   Human WAS knockout Jurkat
DR   Abcam; ab302437
DR   Wikidata; Q127379360
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12731; WAS.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat XPNPEP1 KO
AC   CVCL_WQ83
SY   Human XPNPEP1 knockout Jurkat
DR   Abcam; ab302442
DR   Wikidata; Q127379361
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12822; XPNPEP1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam Jurkat ZAP70 KO
AC   CVCL_B7VC
SY   Human ZAP70 knockout Jurkat
DR   Abcam; ab273841
DR   cancercelllines; CVCL_B7VC
DR   Wikidata; Q112928358
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12858; ZAP70.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam K-562 ABI1 KO
AC   CVCL_WQ84
SY   Human ABI1 knockout K562
DR   Abcam; ab301826
DR   Wikidata; Q127379362
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11320; ABI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ACAA1 KO
AC   CVCL_WQ85
SY   Human ACAA1 knockout K562
DR   Abcam; ab301829
DR   Wikidata; Q127379363
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:82; ACAA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ACAT2 KO
AC   CVCL_WQ86
SY   Human ACAT2 knockout K562
DR   Abcam; ab301832
DR   Wikidata; Q127379364
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:94; ACAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ACOT13 KO
AC   CVCL_WQ87
SY   Human ACOT13 knockout K562
DR   Abcam; ab301834
DR   Wikidata; Q127379365
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20999; ACOT13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ACTR3 KO
AC   CVCL_WQ88
SY   Human ACTR3 knockout K562
DR   Abcam; ab301837
DR   Wikidata; Q127379366
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:170; ACTR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ACVR2B KO
AC   CVCL_WQ89
SY   Human ACVR2B knockout K562
DR   Abcam; ab301840
DR   Wikidata; Q127379368
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ACVRL1 KO
AC   CVCL_WQ90
SY   Human ACVRL1 knockout K562
DR   Abcam; ab301843
DR   Wikidata; Q127379369
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:175; ACVRL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ACY1 KO
AC   CVCL_WQ91
SY   Human ACY1 knockout K562
DR   Abcam; ab301846
DR   Wikidata; Q127379370
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:177; ACY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ADAM17 KO
AC   CVCL_B0ZA
SY   Human ADAM17 knockout K562
DR   Abcam; ab280045
DR   Wikidata; Q110432498
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   Abcam K-562 ADD1 KO
AC   CVCL_WQ92
SY   Human ADD1 knockout K562
DR   Abcam; ab301849
DR   Wikidata; Q127379371
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:243; ADD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 AHCY KO
AC   CVCL_WQ93
SY   Human AHCY knockout K562
DR   Abcam; ab301852
DR   Wikidata; Q127379372
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:343; AHCY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 AKR7A2 KO
AC   CVCL_WQ94
SY   Human AKR7A2 knockout K562
DR   Abcam; ab301855
DR   Wikidata; Q127379373
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:389; AKR7A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ALAD KO
AC   CVCL_WQ95
SY   Human ALAD knockout K562
DR   Abcam; ab301858
DR   Wikidata; Q127379374
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:395; ALAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ALDH1A2 KO
AC   CVCL_WQ96
SY   Human ALDH1A2 knockout K562
DR   Abcam; ab301861
DR   Wikidata; Q127379375
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15472; ALDH1A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ALDH4A1 KO
AC   CVCL_WQ97
SY   Human ALDH4A1 knockout K562
DR   Abcam; ab301864
DR   Wikidata; Q127379376
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:406; ALDH4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ALDOB KO
AC   CVCL_WQ98
SY   Human ALDOB knockout K562
DR   Abcam; ab301867
DR   Wikidata; Q127379377
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:417; ALDOB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ALOX5AP KO
AC   CVCL_WQ99
SY   Human ALOX5AP knockout K562
DR   Abcam; ab301870
DR   Wikidata; Q127379378
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:436; ALOX5AP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ARSA KO
AC   CVCL_D1LJ
SY   Human ARSA knockout K562
DR   Abcam; ab301879
DR   Wikidata; Q127379379
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:713; ARSA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ASL KO
AC   CVCL_D1LK
SY   Human ASL knockout K562
DR   Abcam; ab301882
DR   Wikidata; Q127379380
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:746; ASL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ATXN2 KO
AC   CVCL_D1LL
SY   Human ATXN2 knockout K562
DR   Abcam; ab301885
DR   Wikidata; Q127379381
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10555; ATXN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 BAZ2A KO
AC   CVCL_D1LM
SY   Human BAZ2A knockout K562
DR   Abcam; ab301888
DR   Wikidata; Q127379382
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:962; BAZ2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 BCAT1 KO
AC   CVCL_D1LN
SY   Human BCAT1 knockout K562
DR   Abcam; ab301891
DR   Wikidata; Q127379383
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 BCAT2 KO
AC   CVCL_D1LP
SY   Human BCAT2 knockout K562
DR   Abcam; ab301894
DR   Wikidata; Q127379384
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:977; BCAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 BRMS1 KO
AC   CVCL_D1LQ
SY   Human BRMS1 knockout K562
DR   Abcam; ab301900
DR   Wikidata; Q127379385
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17262; BRMS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 BTLA KO
AC   CVCL_D1LR
SY   Human BTLA knockout K562
DR   Abcam; ab301903
DR   Wikidata; Q127379386
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21087; BTLA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CA8 KO
AC   CVCL_D1LS
SY   Human CA8 knockout K562
DR   Abcam; ab301906
DR   Wikidata; Q127379387
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1382; CA8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CALU KO
AC   CVCL_D1LT
SY   Human CALU knockout K562
DR   Abcam; ab301909
DR   Wikidata; Q127379388
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1458; CALU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CAMK4 KO
AC   CVCL_D1LU
SY   Human CAMK4 knockout K562
DR   Abcam; ab301912
DR   Wikidata; Q127379389
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1464; CAMK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CASP10 KO
AC   CVCL_D1LV
SY   Human CASP10 knockout K562
DR   Abcam; ab301918
DR   Wikidata; Q127379390
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1500; CASP10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CASP2 KO
AC   CVCL_D1LW
SY   Human CASP2 knockout K562
DR   Abcam; ab301920
DR   Wikidata; Q127379391
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1503; CASP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CBLC KO
AC   CVCL_D1LX
SY   Human CBLC knockout K562
DR   Abcam; ab301923
DR   Wikidata; Q127379392
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15961; CBLC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CCS KO
AC   CVCL_D1LY
SY   Human CCS knockout K562
DR   Abcam; ab301926
DR   Wikidata; Q127379393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1613; CCS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CHP1 KO
AC   CVCL_D1LZ
SY   Human CHP1 knockout K562
DR   Abcam; ab301932
DR   Wikidata; Q127379394
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17433; CHP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CLASP1 KO
AC   CVCL_D1M0
SY   Human CLASP1 knockout K562
DR   Abcam; ab301935
DR   Wikidata; Q127379395
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17088; CLASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CLPP KO
AC   CVCL_D1M1
SY   Human CLPP knockout K562
DR   Abcam; ab301938
DR   Wikidata; Q127379396
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2084; CLPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CMAS KO
AC   CVCL_D1M2
SY   Human CMAS knockout K562
DR   Abcam; ab301941
DR   Wikidata; Q127379397
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18290; CMAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CNDP2 KO
AC   CVCL_D1M3
SY   Human CNDP2 knockout K562
DR   Abcam; ab301944
DR   Wikidata; Q127379399
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24437; CNDP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CRYZ KO
AC   CVCL_D1M4
SY   Human CRYZ knockout K562
DR   Abcam; ab301947
DR   Wikidata; Q127379400
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2419; CRYZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CSF3 KO
AC   CVCL_B0ZB
SY   Human CSF3 knockout K562
DR   Abcam; ab273740
DR   Wikidata; Q110432499
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2438; CSF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   Abcam K-562 CYB5A KO
AC   CVCL_D1M5
SY   Human CYB5A knockout K562
DR   Abcam; ab301950
DR   Wikidata; Q127379402
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2570; CYB5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 CYB5R3 KO
AC   CVCL_D1M6
SY   Human CYB5R3 knockout K562
DR   Abcam; ab301953
DR   Wikidata; Q127379403
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2873; CYB5R3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 DFFB KO
AC   CVCL_D1M7
SY   Human DFFB knockout K562
DR   Abcam; ab301959
DR   Wikidata; Q127379404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2773; DFFB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 DGAT1 KO
AC   CVCL_D1M8
SY   Human DGAT1 knockout K562
DR   Abcam; ab301962
DR   Wikidata; Q127379405
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2843; DGAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 DGKA KO
AC   CVCL_D1M9
SY   Human DGKA knockout K562
DR   Abcam; ab301965
DR   Wikidata; Q127379406
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2849; DGKA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 DNPEP KO
AC   CVCL_D1MA
SY   Human DNPEP knockout K562
DR   Abcam; ab301968
DR   Wikidata; Q127379407
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2981; DNPEP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 DNTT KO
AC   CVCL_D1MB
SY   Human DNTT knockout K562
DR   Abcam; ab301971
DR   Wikidata; Q127379408
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2983; DNTT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 DPP8 KO
AC   CVCL_D1MC
SY   Human DPP8 knockout K562
DR   Abcam; ab301974
DR   Wikidata; Q127379410
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16490; DPP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 EP300 KO
AC   CVCL_B7VR
SY   Human EP300 knockout K562
DR   Abcam; ab277897
DR   Wikidata; Q112928359
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam K-562 EPHX1 KO
AC   CVCL_D1MD
SY   Human EPHX1 knockout K562
DR   Abcam; ab301983
DR   Wikidata; Q127379411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3401; EPHX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 EPHX2 KO
AC   CVCL_D1ME
SY   Human EPHX2 knockout K562
DR   Abcam; ab301986
DR   Wikidata; Q127379412
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3402; EPHX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 EPN1 KO
AC   CVCL_D1MF
SY   Human EPN1 knockout K562
DR   Abcam; ab301989
DR   Wikidata; Q127379413
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21604; EPN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ETV4 KO
AC   CVCL_D1MG
SY   Human ETV4 knockout K562
DR   Abcam; ab301992
DR   Wikidata; Q127379414
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3493; ETV4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 FDX1 KO
AC   CVCL_D1MH
SY   Human FDX1 knockout K562
DR   Abcam; ab301995
DR   Wikidata; Q127379415
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3638; FDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 FECH KO
AC   CVCL_D1MI
SY   Human FECH knockout K562
DR   Abcam; ab301998
DR   Wikidata; Q127379416
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3647; FECH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 FOLR2 KO
AC   CVCL_D1MJ
SY   Human FOLR2 knockout K562
DR   Abcam; ab302001
DR   Wikidata; Q127379417
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3793; FOLR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 FOSB KO
AC   CVCL_D1MK
SY   Human FOSB knockout K562
DR   Abcam; ab302004
DR   Wikidata; Q127379418
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3797; FOSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 FPGS KO
AC   CVCL_D1ML
SY   Human FPGS knockout K562
DR   Abcam; ab302007
DR   Wikidata; Q127379419
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3824; FPGS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 FRK KO
AC   CVCL_D1MM
SY   Human FRK knockout K562
DR   Abcam; ab302010
DR   Wikidata; Q127379420
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3955; FRK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 FUBP1 KO
AC   CVCL_D1MN
SY   Human FUBP1 knockout K562
DR   Abcam; ab302013
DR   Wikidata; Q127379421
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4004; FUBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GAMT KO
AC   CVCL_D1MP
SY   Human GAMT knockout K562
DR   Abcam; ab302016
DR   Wikidata; Q127379422
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4136; GAMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GANAB KO
AC   CVCL_D1MQ
SY   Human GANAB knockout K562
DR   Abcam; ab302019
DR   Wikidata; Q127379423
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4138; GANAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GART KO
AC   CVCL_D1MR
SY   Human GART knockout K562
DR   Abcam; ab302022
DR   Wikidata; Q127379424
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4163; GART.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GCDH KO
AC   CVCL_D1MS
SY   Human GCDH knockout K562
DR   Abcam; ab302025
DR   Wikidata; Q127379425
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4189; GCDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GGH KO
AC   CVCL_D1MT
SY   Human GGH knockout K562
DR   Abcam; ab302028
DR   Wikidata; Q127379426
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4248; GGH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GLG1 KO
AC   CVCL_D1MU
SY   Human GLG1 knockout K562
DR   Abcam; ab302031
DR   Wikidata; Q127379427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4316; GLG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GLUL KO
AC   CVCL_D1MV
SY   Human GLUL knockout K562
DR   Abcam; ab302034
DR   Wikidata; Q127379428
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GNE KO
AC   CVCL_D1MW
SY   Human GNE knockout K562
DR   Abcam; ab302037
DR   Wikidata; Q127379429
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23657; GNE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GRK3 KO
AC   CVCL_D1MX
SY   Human GRK3 knockout K562
DR   Abcam; ab302040
DR   Wikidata; Q127379430
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GRK6 KO
AC   CVCL_D1MY
SY   Human GRK6 knockout K562
DR   Abcam; ab302043
DR   Wikidata; Q127379431
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4545; GRK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 GUSB KO
AC   CVCL_D1MZ
SY   Human GUSB knockout K562
DR   Abcam; ab302046
DR   Wikidata; Q127379432
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4696; GUSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HDAC10 KO
AC   CVCL_D1N0
SY   Human HDAC10 knockout K562
DR   Abcam; ab302049
DR   Wikidata; Q127379434
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18128; HDAC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HDGF KO
AC   CVCL_D1N1
SY   Human HDGF knockout K562
DR   Abcam; ab302052
DR   Wikidata; Q127379436
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4856; HDGF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HEXA KO
AC   CVCL_D1N2
SY   Human HEXA knockout K562
DR   Abcam; ab302055
DR   Wikidata; Q127379437
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4878; HEXA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HIF1AN KO
AC   CVCL_D1N3
SY   Human HIF1AN knockout K562
DR   Abcam; ab302058
DR   Wikidata; Q127379438
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17113; HIF1AN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HMBS KO
AC   CVCL_D1N4
SY   Human HMBS knockout K562
DR   Abcam; ab302061
DR   Wikidata; Q127379439
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4982; HMBS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HMGCS2 KO
AC   CVCL_D1N5
SY   Human HMGCS2 knockout K562
DR   Abcam; ab302064
DR   Wikidata; Q127379440
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5008; HMGCS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HMOX2 KO
AC   CVCL_D1N6
SY   Human HMOX2 knockout K562
DR   Abcam; ab302067
DR   Wikidata; Q127379441
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5014; HMOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HSD17B10 KO
AC   CVCL_D1N7
SY   Human HSD17B10 knockout K562
DR   Abcam; ab302073
DR   Wikidata; Q127379443
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4800; HSD17B10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HSD17B4 KO
AC   CVCL_D1N8
SY   Human HSD17B4 knockout K562
DR   Abcam; ab302076
DR   Wikidata; Q127379444
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5213; HSD17B4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HSPA13 KO
AC   CVCL_D1N9
SY   Human HSPA13 knockout K562
DR   Abcam; ab302079
DR   Wikidata; Q127379446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11375; HSPA13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HSPA1L KO
AC   CVCL_D1NA
SY   Human HSPA1L knockout K562
DR   Abcam; ab302082
DR   Wikidata; Q127379447
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5234; HSPA1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HSPA2 KO
AC   CVCL_D1NB
SY   Human HSPA2 knockout K562
DR   Abcam; ab302085
DR   Wikidata; Q127379448
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5235; HSPA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HSPA4 KO
AC   CVCL_D1NC
SY   Human HSPA4 knockout K562
DR   Abcam; ab302088
DR   Wikidata; Q127379449
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5237; HSPA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 HSPH1 KO
AC   CVCL_D1ND
SY   Human HSPH1 knockout K562
DR   Abcam; ab302091
DR   Wikidata; Q127379450
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16969; HSPH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 IKZF3 KO
AC   CVCL_D1NE
SY   Human IKZF3 knockout K562
DR   Abcam; ab302094
DR   Wikidata; Q127379451
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13178; IKZF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 IL13RA1 KO
AC   CVCL_D1NF
SY   Human IL13RA1 knockout K562
DR   Abcam; ab302097
DR   Wikidata; Q127379452
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 IL2RG KO
AC   CVCL_D1NG
SY   Human IL2RG knockout K562
DR   Abcam; ab302100
DR   Wikidata; Q127379453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6010; IL2RG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 IMPDH1 KO
AC   CVCL_D1NH
SY   Human IMPDH1 knockout K562
DR   Abcam; ab302106
DR   Wikidata; Q127379454
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6052; IMPDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ITGA4 KO
AC   CVCL_D1NI
SY   Human ITGA4 knockout K562
DR   Abcam; ab302109
DR   Wikidata; Q127379455
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6140; ITGA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 LGALS8 KO
AC   CVCL_D1NJ
SY   Human LGALS8 knockout K562
DR   Abcam; ab302112
DR   Wikidata; Q127379456
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6569; LGALS8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 LIAS KO
AC   CVCL_D1NK
SY   Human LIAS knockout K562
DR   Abcam; ab302115
DR   Wikidata; Q127379457
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16429; LIAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MAEA KO
AC   CVCL_D1NL
SY   Human MAEA knockout K562
DR   Abcam; ab302120
DR   Wikidata; Q127379458
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13731; MAEA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MAP3K4 KO
AC   CVCL_D1NM
SY   Human MAP3K4 knockout K562
DR   Abcam; ab302123
DR   Wikidata; Q127379459
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MAP4K1 KO
AC   CVCL_D1NN
SY   Human MAP4K1 knockout K562
DR   Abcam; ab302126
DR   Wikidata; Q127379460
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6863; MAP4K1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MAP4K4 KO
AC   CVCL_D1NP
SY   Human MAP4K4 knockout K562
DR   Abcam; ab302129
DR   Wikidata; Q127379461
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6866; MAP4K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MARK3 KO
AC   CVCL_D1NQ
SY   Human MARK3 knockout K562
DR   Abcam; ab302132
DR   Wikidata; Q127379462
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6897; MARK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MAT1A KO
AC   CVCL_D1NR
SY   Human MAT1A knockout K562
DR   Abcam; ab302135
DR   Wikidata; Q127379463
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6903; MAT1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 ME2 KO
AC   CVCL_D1NS
SY   Human ME2 knockout K562
DR   Abcam; ab302138
DR   Wikidata; Q127379464
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6984; ME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MMACHC KO
AC   CVCL_D1NT
SY   Human MMACHC knockout K562
DR   Abcam; ab302141
DR   Wikidata; Q127379465
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24525; MMACHC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MPG KO
AC   CVCL_D1NU
SY   Human MPG knockout K562
DR   Abcam; ab302144
DR   Wikidata; Q127379466
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7211; MPG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 MTHFR KO
AC   CVCL_D1NV
SY   Human MTHFR knockout K562
DR   Abcam; ab302147
DR   Wikidata; Q127379467
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7436; MTHFR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NAGK KO
AC   CVCL_D1NW
SY   Human NAGK knockout K562
DR   Abcam; ab302150
DR   Wikidata; Q127379468
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17174; NAGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NAPRT KO
AC   CVCL_D1NX
SY   Human NAPRT knockout K562
DR   Abcam; ab302152
DR   Wikidata; Q127379469
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30450; NAPRT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NAT1 KO
AC   CVCL_D1NY
SY   Human NAT1 knockout K562
DR   Abcam; ab302155
DR   Wikidata; Q127379470
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NCOA5 KO
AC   CVCL_D1NZ
SY   Human NCOA5 knockout K562
DR   Abcam; ab302158
DR   Wikidata; Q127379471
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15909; NCOA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NDUFA12 KO
AC   CVCL_D1P0
SY   Human NDUFA12 knockout K562
DR   Abcam; ab302161
DR   Wikidata; Q127379472
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23987; NDUFA12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NDUFAF2 KO
AC   CVCL_D1P1
SY   Human NDUFAF2 knockout K562
DR   Abcam; ab302164
DR   Wikidata; Q127379473
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28086; NDUFAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NDUFB6 KO
AC   CVCL_D1P2
SY   Human NDUFB6 knockout K562
DR   Abcam; ab302167
DR   Wikidata; Q127379474
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7701; NDUFB6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NDUFB8 KO
AC   CVCL_D1P3
SY   Human NDUFB8 knockout K562
DR   Abcam; ab302170
DR   Wikidata; Q127379475
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7703; NDUFB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NDUFS1 KO
AC   CVCL_D1P4
SY   Human NDUFS1 knockout K562
DR   Abcam; ab302173
DR   Wikidata; Q127379476
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7707; NDUFS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NDUFS2 KO
AC   CVCL_D1P5
SY   Human NDUFS2 knockout K562
DR   Abcam; ab302176
DR   Wikidata; Q127379477
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7708; NDUFS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NFKBIB KO
AC   CVCL_D1P6
SY   Human NFKBIB knockout K562
DR   Abcam; ab302182
DR   Wikidata; Q127379478
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7798; NFKBIB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NMNAT1 KO
AC   CVCL_D1P7
SY   Human NMNAT1 knockout K562
DR   Abcam; ab302185
DR   Wikidata; Q127379479
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17877; NMNAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NMT1 KO
AC   CVCL_D1P8
SY   Human NMT1 knockout K562
DR   Abcam; ab302188
DR   Wikidata; Q127379480
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NMT2 KO
AC   CVCL_D1P9
SY   Human NMT2 knockout K562
DR   Abcam; ab302191
DR   Wikidata; Q127379481
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7858; NMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NOD2 KO
AC   CVCL_D1PA
SY   Human NOD2 knockout K562
DR   Abcam; ab302194
DR   Wikidata; Q127379482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5331; NOD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NOX5 KO
AC   CVCL_D1PB
SY   Human NOX5 knockout K562
DR   Abcam; ab302197
DR   Wikidata; Q127379483
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14874; NOX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NPEPPS KO
AC   CVCL_D1PC
SY   Human NPEPPS knockout K562
DR   Abcam; ab302200
DR   Wikidata; Q127379484
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7900; NPEPPS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NQO2 KO
AC   CVCL_D1PD
SY   Human NQO2 knockout K562
DR   Abcam; ab302203
DR   Wikidata; Q127379485
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7856; NQO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 NUCB2 KO
AC   CVCL_D1PE
SY   Human NUCB2 knockout K562
DR   Abcam; ab302206
DR   Wikidata; Q127379486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8044; NUCB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 OAT KO
AC   CVCL_D1PF
SY   Human OAT knockout K562
DR   Abcam; ab302209
DR   Wikidata; Q127379487
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8091; OAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 OXSR1 KO
AC   CVCL_D1PG
SY   Human OXSR1 knockout K562
DR   Abcam; ab302212
DR   Wikidata; Q127379488
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8508; OXSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 P3H1 KO
AC   CVCL_D1PH
SY   Human P3H1 knockout K562
DR   Abcam; ab302215
DR   Wikidata; Q127379489
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19316; P3H1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PADI2 KO
AC   CVCL_D1PI
SY   Human PADI2 knockout K562
DR   Abcam; ab302218
DR   Wikidata; Q127379490
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18341; PADI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PAICS KO
AC   CVCL_D1PJ
SY   Human PAICS knockout K562
DR   Abcam; ab302221
DR   Wikidata; Q127379491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8587; PAICS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PCMT1 KO
AC   CVCL_D1PK
SY   Human PCMT1 knockout K562
DR   Abcam; ab302224
DR   Wikidata; Q127379492
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8728; PCMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PCYT2 KO
AC   CVCL_D1PL
SY   Human PCYT2 knockout K562
DR   Abcam; ab302227
DR   Wikidata; Q127379493
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8756; PCYT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PDHB KO
AC   CVCL_D1PM
SY   Human PDHB knockout K562
DR   Abcam; ab302233
DR   Wikidata; Q127379494
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8808; PDHB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PDHX KO
AC   CVCL_D1PN
SY   Human PDHX knockout K562
DR   Abcam; ab302236
DR   Wikidata; Q127379495
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21350; PDHX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PEF1 KO
AC   CVCL_D1PP
SY   Human PEF1 knockout K562
DR   Abcam; ab302242
DR   Wikidata; Q127379496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30009; PEF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PGAM1 KO
AC   CVCL_D1PQ
SY   Human PGAM1 knockout K562
DR   Abcam; ab302245
DR   Wikidata; Q127379497
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8888; PGAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PGRMC1 KO
AC   CVCL_D1PR
SY   Human PGRMC1 knockout K562
DR   Abcam; ab302248
DR   Wikidata; Q127379498
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16090; PGRMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PI4KB KO
AC   CVCL_D1PS
SY   Human PI4KB knockout K562
DR   Abcam; ab302251
DR   Wikidata; Q127379499
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PIM2 KO
AC   CVCL_D1PT
SY   Human PIM2 knockout K562
DR   Abcam; ab302254
DR   Wikidata; Q127379500
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8987; PIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PKLR KO
AC   CVCL_D1PU
SY   Human PKLR knockout K562
DR   Abcam; ab302257
DR   Wikidata; Q127379501
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9020; PKLR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PMVK KO
AC   CVCL_D1PV
SY   Human PMVK knockout K562
DR   Abcam; ab302262
DR   Wikidata; Q127379502
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9141; PMVK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PNMT KO
AC   CVCL_D1PW
SY   Human PNMT knockout K562
DR   Abcam; ab302265
DR   Wikidata; Q127379503
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9160; PNMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 POLH KO
AC   CVCL_D1PX
SY   Human POLH knockout K562
DR   Abcam; ab302268
DR   Wikidata; Q127379504
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9181; POLH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PPOX KO
AC   CVCL_D1PY
SY   Human PPOX knockout K562
DR   Abcam; ab302271
DR   Wikidata; Q127379505
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9280; PPOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PPP2CB KO
AC   CVCL_D1PZ
SY   Human PPP2CB knockout K562
DR   Abcam; ab302274
DR   Wikidata; Q127379507
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9300; PPP2CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRDX5 KO
AC   CVCL_D1Q0
SY   Human PRDX5 knockout K562
DR   Abcam; ab302277
DR   Wikidata; Q127379508
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9355; PRDX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRG2 KO
AC   CVCL_D1Q1
SY   Human PRG2 knockout K562
DR   Abcam; ab302280
DR   Wikidata; Q127379509
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9362; PRG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRKAB1 KO
AC   CVCL_D1Q2
SY   Human PRKAB1 knockout K562
DR   Abcam; ab302283
DR   Wikidata; Q127379511
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRKACA KO
AC   CVCL_D1Q3
SY   Human PRKACA knockout K562
DR   Abcam; ab302286
DR   Wikidata; Q127379512
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9380; PRKACA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRKAG1 KO
AC   CVCL_D1Q4
SY   Human PRKAG1 knockout K562
DR   Abcam; ab302289
DR   Wikidata; Q127379513
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRKCG KO
AC   CVCL_D1Q5
SY   Human PRKCG knockout K562
DR   Abcam; ab302292
DR   Wikidata; Q127379514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRKD1 KO
AC   CVCL_D1Q6
SY   Human PRKD1 knockout K562
DR   Abcam; ab302294
DR   Wikidata; Q127379515
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9407; PRKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PRSS8 KO
AC   CVCL_D1Q7
SY   Human PRSS8 knockout K562
DR   Abcam; ab302297
DR   Wikidata; Q127379516
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9491; PRSS8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PSMF1 KO
AC   CVCL_D1Q8
SY   Human PSMF1 knockout K562
DR   Abcam; ab302300
DR   Wikidata; Q127379517
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9571; PSMF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PTPA KO
AC   CVCL_D1Q9
SY   Human PTPA knockout K562
DR   Abcam; ab302303
DR   Wikidata; Q127379518
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9308; PTPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 PYCR1 KO
AC   CVCL_D1QA
SY   Human PYCR1 knockout K562
DR   Abcam; ab302306
DR   Wikidata; Q127379520
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9721; PYCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 QDPR KO
AC   CVCL_D1QB
SY   Human QDPR knockout K562
DR   Abcam; ab302309
DR   Wikidata; Q127379521
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9752; QDPR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 RECQL KO
AC   CVCL_D1QC
SY   Human RECQL knockout K562
DR   Abcam; ab302318
DR   Wikidata; Q127379522
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9948; RECQL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 REEP5 KO
AC   CVCL_D1QD
SY   Human REEP5 knockout K562
DR   Abcam; ab302321
DR   Wikidata; Q127379523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30077; REEP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 RPIA KO
AC   CVCL_D1QE
SY   Human RPIA knockout K562
DR   Abcam; ab302324
DR   Wikidata; Q127379524
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10297; RPIA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 RXRB KO
AC   CVCL_D1QF
SY   Human RXRB knockout K562
DR   Abcam; ab302327
DR   Wikidata; Q127379525
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10478; RXRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SELENOP KO
AC   CVCL_D1QG
SY   Human SELENOP knockout K562
DR   Abcam; ab302330
DR   Wikidata; Q127379526
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10751; SELENOP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SERPINB9 KO
AC   CVCL_D1QH
SY   Human SERPINB9 knockout K562
DR   Abcam; ab302333
DR   Wikidata; Q127379527
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8955; SERPINB9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SH2D1A KO
AC   CVCL_D1QI
SY   Human SH2D1A knockout K562
DR   Abcam; ab302336
DR   Wikidata; Q127379528
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10820; SH2D1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SLC25A12 KO
AC   CVCL_D1QJ
SY   Human SLC25A12 knockout K562
DR   Abcam; ab302340
DR   Wikidata; Q127379529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10982; SLC25A12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SLC5A1 KO
AC   CVCL_D1QK
SY   Human SLC5A1 knockout K562
DR   Abcam; ab302343
DR   Wikidata; Q127379530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11036; SLC5A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SLK KO
AC   CVCL_D1QL
SY   Human SLK knockout K562
DR   Abcam; ab302346
DR   Wikidata; Q127379531
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11088; SLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SMS KO
AC   CVCL_D1QM
SY   Human SMS knockout K562
DR   Abcam; ab302349
DR   Wikidata; Q127379532
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11123; SMS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SORD KO
AC   CVCL_D1QN
SY   Human SORD knockout K562
DR   Abcam; ab302352
DR   Wikidata; Q127379533
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11184; SORD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SPAG9 KO
AC   CVCL_D1QP
SY   Human SPAG9 knockout K562
DR   Abcam; ab302355
DR   Wikidata; Q127379534
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14524; SPAG9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SPTLC2 KO
AC   CVCL_D1QQ
SY   Human SPTLC2 knockout K562
DR   Abcam; ab302358
DR   Wikidata; Q127379535
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11278; SPTLC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SRSF4 KO
AC   CVCL_D1QR
SY   Human SRSF4 knockout K562
DR   Abcam; ab302361
DR   Wikidata; Q127379537
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10786; SRSF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 SSTR2 KO
AC   CVCL_D1QS
SY   Human SSTR2 knockout K562
DR   Abcam; ab302364
DR   Wikidata; Q127379538
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11331; SSTR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 STK17B KO
AC   CVCL_D1QT
SY   Human STK17B knockout K562
DR   Abcam; ab302370
DR   Wikidata; Q127379539
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11396; STK17B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TACR1 KO
AC   CVCL_D1QU
SY   Human TACR1 knockout K562
DR   Abcam; ab302373
DR   Wikidata; Q127379540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11526; TACR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TBL1XR1 KO
AC   CVCL_D1QV
SY   Human TBL1XR1 knockout K562
DR   Abcam; ab302376
DR   Wikidata; Q127379541
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29529; TBL1XR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TDP1 KO
AC   CVCL_D1QW
SY   Human TDP1 knockout K562
DR   Abcam; ab302379
DR   Wikidata; Q127379542
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18884; TDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TEC KO
AC   CVCL_D1QX
SY   Human TEC knockout K562
DR   Abcam; ab302382
DR   Wikidata; Q127379543
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11719; TEC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 THOP1 KO
AC   CVCL_D1QY
SY   Human THOP1 knockout K562
DR   Abcam; ab302385
DR   Wikidata; Q127379544
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11793; THOP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TLE3 KO
AC   CVCL_D1QZ
SY   Human TLE3 knockout K562
DR   Abcam; ab302388
DR   Wikidata; Q127379545
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TNFSF9 KO
AC   CVCL_D1R0
SY   Human TNFSF9 knockout K562
DR   Abcam; ab302391
DR   Wikidata; Q127379546
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11939; TNFSF9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TPMT KO
AC   CVCL_D1R1
SY   Human TPMT knockout K562
DR   Abcam; ab302399
DR   Wikidata; Q127379547
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12014; TPMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TPP1 KO
AC   CVCL_D1R2
SY   Human TPP1 knockout K562
DR   Abcam; ab302402
DR   Wikidata; Q127379548
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TPP2 KO
AC   CVCL_D1R3
SY   Human TPP2 knockout K562
DR   Abcam; ab302405
DR   Wikidata; Q127379549
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12016; TPP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TRPC3 KO
AC   CVCL_D1R4
SY   Human TRPC3 knockout K562
DR   Abcam; ab302408
DR   Wikidata; Q127379550
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12335; TRPC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 TRPM2 KO
AC   CVCL_D1R5
SY   Human TRPM2 knockout K562
DR   Abcam; ab302411
DR   Wikidata; Q127379551
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12339; TRPM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 UAP1 KO
AC   CVCL_D1R6
SY   Human UAP1 knockout K562
DR   Abcam; ab302414
DR   Wikidata; Q127379552
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12457; UAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 UBE2T KO
AC   CVCL_D1R7
SY   Human UBE2T knockout K562
DR   Abcam; ab302417
DR   Wikidata; Q127379553
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25009; UBE2T.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 UBR1 KO
AC   CVCL_D1R8
SY   Human UBR1 knockout K562
DR   Abcam; ab302420
DR   Wikidata; Q127379554
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16808; UBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 UNC119 KO
AC   CVCL_D1R9
SY   Human UNC119 knockout K562
DR   Abcam; ab302426
DR   Wikidata; Q127379555
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12565; UNC119.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 UPP1 KO
AC   CVCL_D1RA
SY   Human UPP1 knockout K562
DR   Abcam; ab302429
DR   Wikidata; Q127379556
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12576; UPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 VDAC2 KO
AC   CVCL_D1RB
SY   Human VDAC2 knockout K562
DR   Abcam; ab302432
DR   Wikidata; Q127379557
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12672; VDAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 VPS37A KO
AC   CVCL_D1RC
SY   Human VPS37A knockout K562
DR   Abcam; ab302435
DR   Wikidata; Q127379558
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24928; VPS37A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 WAS KO
AC   CVCL_D1RD
SY   Human WAS knockout K562
DR   Abcam; ab302438
DR   Wikidata; Q127379559
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12731; WAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam K-562 XPNPEP1 KO
AC   CVCL_D1RE
SY   Human XPNPEP1 knockout K562
DR   Abcam; ab302443
DR   Wikidata; Q127379560
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12822; XPNPEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam LNCaP clone FGC TMPRSS2 KO
AC   CVCL_C0BI
SY   Human TMPRSS2 knockout LNCaP
DR   Abcam; ab273745
DR   cancercelllines; CVCL_C0BI
DR   Wikidata; Q112928360
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11876; TMPRSS2.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam MCF-7 ABCC1 KO
AC   CVCL_B8S1
SY   Human ABCC1 knockout MCF7
DR   Abcam; ab286378
DR   cancercelllines; CVCL_B8S1
DR   Wikidata; Q112928361
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ABL2 KO
AC   CVCL_B8S2
SY   Human ABL2 knockout MCF7
DR   Abcam; ab286318
DR   cancercelllines; CVCL_B8S2
DR   Wikidata; Q112928362
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ACKR3 KO
AC   CVCL_B8S3
SY   Human ACKR3 knockout MCF7
DR   Abcam; ab287186
DR   cancercelllines; CVCL_B8S3
DR   Wikidata; Q112928363
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23692; ACKR3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ACTA2 KO
AC   CVCL_B8S4
SY   Human ACTA2 knockout MCF7
DR   Abcam; ab287188
DR   cancercelllines; CVCL_B8S4
DR   Wikidata; Q112928364
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:130; ACTA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ACVR1B KO
AC   CVCL_B8S5
SY   Human ACVR1B knockout MCF7
DR   Abcam; ab287195
DR   cancercelllines; CVCL_B8S5
DR   Wikidata; Q112928365
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:172; ACVR1B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ADA KO
AC   CVCL_D2DP
SY   Human ADA knockout MCF7
DR   Abcam; ab289325
DR   Wikidata; Q127379561
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:186; ADA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ADAM10 KO
AC   CVCL_B8S6
SY   Human ADAM10 knockout MCF7
DR   Abcam; ab287197
DR   cancercelllines; CVCL_B8S6
DR   Wikidata; Q112928366
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ADAR KO
AC   CVCL_D2DQ
SY   Human ADAR knockout MCF7
DR   Abcam; ab289284
DR   Wikidata; Q127379562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ADK KO
AC   CVCL_D2DR
SY   Human ADK knockout MCF7
DR   Abcam; ab289404
DR   Wikidata; Q127379563
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:257; ADK.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ADORA2A KO
AC   CVCL_D2DS
SY   Human ADORA2A knockout MCF7
DR   Abcam; ab289319
DR   Wikidata; Q127379564
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ADRA2B KO
AC   CVCL_D2DT
SY   Human ADRA2B knockout MCF7
DR   Abcam; ab289414
DR   Wikidata; Q127379566
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:282; ADRA2B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ADRB2 KO
AC   CVCL_B8S7
SY   Human ADRB2 knockout MCF7
DR   Abcam; ab287200
DR   cancercelllines; CVCL_B8S7
DR   Wikidata; Q112928367
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 AFP KO
AC   CVCL_D2DU
SY   Human AFP knockout MCF7
DR   Abcam; ab289379
DR   Wikidata; Q127379567
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:317; AFP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 AGO2 KO
AC   CVCL_B8S8
SY   Human AGO2 knockout MCF7
DR   Abcam; ab287203
DR   cancercelllines; CVCL_B8S8
DR   Wikidata; Q112928368
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3263; AGO2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 AGO4 KO
AC   CVCL_D2DV
SY   Human AGO4 knockout MCF7
DR   Abcam; ab289411
DR   Wikidata; Q127379569
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18424; AGO4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 AKT1 KO
AC   CVCL_B8S9
SY   Human AKT1 knockout MCF7
DR   Abcam; ab280821
DR   cancercelllines; CVCL_B8S9
DR   Wikidata; Q112928369
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 AKT2 KO
AC   CVCL_B8SA
SY   Human AKT2 knockout MCF7
DR   Abcam; ab286253
DR   cancercelllines; CVCL_B8SA
DR   Wikidata; Q112928371
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 AKT3 KO
AC   CVCL_B8SB
SY   Human AKT3 knockout MCF7
DR   Abcam; ab286254
DR   cancercelllines; CVCL_B8SB
DR   Wikidata; Q112928372
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ALKBH5 KO
AC   CVCL_B8SC
SY   Human ALKBH5 knockout MCF7
DR   Abcam; ab282675
DR   cancercelllines; CVCL_B8SC
DR   Wikidata; Q112928373
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ANGPT1 KO
AC   CVCL_B8SD
SY   Human ANGPT1 knockout MCF7
DR   Abcam; ab287206
DR   cancercelllines; CVCL_B8SD
DR   Wikidata; Q112928374
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:484; ANGPT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ANGPT2 KO
AC   CVCL_B8SE
SY   Human ANGPT2 knockout MCF7
DR   Abcam; ab287209
DR   cancercelllines; CVCL_B8SE
DR   Wikidata; Q112928375
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:485; ANGPT2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ANXA1 KO
AC   CVCL_B8SF
SY   Human ANXA1 knockout MCF7
DR   Abcam; ab287212
DR   cancercelllines; CVCL_B8SF
DR   Wikidata; Q112928376
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:533; ANXA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 AQP4 KO
AC   CVCL_B8SG
SY   Human AQP4 knockout MCF7
DR   Abcam; ab286298
DR   cancercelllines; CVCL_B8SG
DR   Wikidata; Q112928377
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:637; AQP4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 AR KO
AC   CVCL_B8SH
SY   Human AR knockout MCF7
DR   Abcam; ab286334
DR   cancercelllines; CVCL_B8SH
DR   Wikidata; Q112928378
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ARAF KO
AC   CVCL_B8SI
SY   Human A-Raf knockout MCF7
DR   Abcam; ab286571
DR   cancercelllines; CVCL_B8SI
DR   Wikidata; Q112928380
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam MCF-7 AREG KO
AC   CVCL_D2DW
SY   Human AREG knockout MCF7
DR   Abcam; ab289415
DR   Wikidata; Q127379570
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:651; AREG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ARID1A KO
AC   CVCL_B8SJ
SY   Human ARID1A knockout MCF7
DR   Abcam; ab287215
DR   cancercelllines; CVCL_B8SJ
DR   Wikidata; Q112928381
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ARID1B KO
AC   CVCL_B8SK
SY   Human ARID1B knockout MCF7
DR   Abcam; ab287218
DR   cancercelllines; CVCL_B8SK
DR   Wikidata; Q112928382
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ARNT KO
AC   CVCL_B8SL
SY   Human ARNT knockout MCF7
DR   Abcam; ab287221
DR   cancercelllines; CVCL_B8SL
DR   Wikidata; Q112928383
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:700; ARNT.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ARNTL KO
AC   CVCL_D1UZ
SY   Human ARNTL knockout MCF7
DR   Abcam; ab289293
DR   Wikidata; Q127379571
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:701; BMAL1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ATAD2 KO
AC   CVCL_B0ZT
SY   Human ATAD2 knockout MCF7
DR   Abcam; ab262329
DR   cancercelllines; CVCL_B0ZT
DR   Wikidata; Q110432501
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30123; ATAD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ATF2 KO
AC   CVCL_B8SM
SY   Human ATF2 knockout MCF7
DR   Abcam; ab287227
DR   cancercelllines; CVCL_B8SM
DR   Wikidata; Q112928384
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ATF6 KO
AC   CVCL_D2DX
SY   Human ATF6 knockout MCF7
DR   Abcam; ab289382
DR   Wikidata; Q127379572
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ATM KO
AC   CVCL_B0ZU
SY   Human ATM knockout MCF7
DR   Abcam; ab282630
DR   cancercelllines; CVCL_B0ZU
DR   Wikidata; Q110432502
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ATRX KO
AC   CVCL_B8SN
SY   Human ATRX knockout MCF7
DR   Abcam; ab287230
DR   cancercelllines; CVCL_B8SN
DR   Wikidata; Q112928385
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 AXIN1 KO
AC   CVCL_B8SP
SY   Human AXIN1 knockout MCF7
DR   Abcam; ab286380
DR   cancercelllines; CVCL_B8SP
DR   Wikidata; Q112928386
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 B2M KO
AC   CVCL_B8SQ
SY   Human B2M knockout MCF7
DR   Abcam; ab286753
DR   cancercelllines; CVCL_B8SQ
DR   Wikidata; Q112928387
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BAD KO
AC   CVCL_D2DY
SY   Human BAD knockout MCF7
DR   Abcam; ab289338
DR   Wikidata; Q127379573
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 BARD1 KO
AC   CVCL_B8SR
SY   Human BARD1 knockout MCF7
DR   Abcam; ab286255
DR   cancercelllines; CVCL_B8SR
DR   Wikidata; Q112928388
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:952; BARD1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BAX KO
AC   CVCL_B8SS
SY   Human BAX knockout MCF7
DR   Abcam; ab286574
DR   cancercelllines; CVCL_B8SS
DR   Wikidata; Q112928389
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BCAR1 KO
AC   CVCL_D2DZ
SY   Human BCAR1 knockout MCF7
DR   Abcam; ab289418
DR   Wikidata; Q127379574
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:971; BCAR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 BCL10 KO
AC   CVCL_B8ST
SY   Human BCL10 knockout MCF7
DR   Abcam; ab286575
DR   cancercelllines; CVCL_B8ST
DR   Wikidata; Q112928390
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BCL11A KO
AC   CVCL_B8SU
SY   Human BCL11A knockout MCF7
DR   Abcam; ab286358
DR   cancercelllines; CVCL_B8SU
DR   Wikidata; Q112928391
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13221; BCL11A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BCL11B KO
AC   CVCL_B8SV
SY   Human BCL11B knockout MCF7
DR   Abcam; ab286351
DR   cancercelllines; CVCL_B8SV
DR   Wikidata; Q112928392
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13222; BCL11B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BCL2 KO
AC   CVCL_B8SW
SY   Human BCL2 knockout MCF7
DR   Abcam; ab286368
DR   cancercelllines; CVCL_B8SW
DR   Wikidata; Q112928393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BCL3 KO
AC   CVCL_B8SX
SY   Human BCL3 knockout MCF7
DR   Abcam; ab286555
DR   cancercelllines; CVCL_B8SX
DR   Wikidata; Q112928394
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:998; BCL3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BCL6 KO
AC   CVCL_B8SY
SY   Human BCL6 knockout MCF7
DR   Abcam; ab287233
DR   cancercelllines; CVCL_B8SY
DR   Wikidata; Q112928395
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BHLHE40 KO
AC   CVCL_D2E0
SY   Human BHLHE40 knockout MCF7
DR   Abcam; ab289419
DR   Wikidata; Q127379575
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1046; BHLHE40.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 BLM KO
AC   CVCL_B8SZ
SY   Human BLM knockout MCF7
DR   Abcam; ab287236
DR   cancercelllines; CVCL_B8SZ
DR   Wikidata; Q112928396
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1058; BLM.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BMI1 KO
AC   CVCL_B0ZV
SY   Human BMI1 knockout MCF7
DR   Abcam; ab262319
DR   cancercelllines; CVCL_B0ZV
DR   Wikidata; Q110432503
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1066; BMI1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BMPR1A KO
AC   CVCL_B8T0
SY   Human BMPR1A knockout MCF7
DR   Abcam; ab286561
DR   cancercelllines; CVCL_B8T0
DR   Wikidata; Q112928397
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BRAF KO
AC   CVCL_B8T1
SY   Human BRAF knockout MCF7
DR   Abcam; ab286756
DR   cancercelllines; CVCL_B8T1
DR   Wikidata; Q112928398
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BRCA1 KO
AC   CVCL_B8T2
SY   Human BRCA1 knockout MCF7
DR   Abcam; ab286284
DR   cancercelllines; CVCL_B8T2
DR   Wikidata; Q112928399
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1100; BRCA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BRCA2 KO
AC   CVCL_B8T3
SY   Human BRCA2 knockout MCF7
DR   Abcam; ab286285
DR   cancercelllines; CVCL_B8T3
DR   Wikidata; Q112928400
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BRD3 KO
AC   CVCL_B8T4
SY   Human BRD3 knockout MCF7
DR   Abcam; ab287240
DR   cancercelllines; CVCL_B8T4
DR   Wikidata; Q112928401
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BRD4 KO
AC   CVCL_B0ZW
SY   Human BRD4 knockout MCF7
DR   Abcam; ab282674
DR   cancercelllines; CVCL_B0ZW
DR   Wikidata; Q110432504
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Abcam; ab282674; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam MCF-7 BRD7 KO
AC   CVCL_B8T5
SY   Human BRD7 knockout MCF7
DR   Abcam; ab287242
DR   cancercelllines; CVCL_B8T5
DR   Wikidata; Q112928402
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14310; BRD7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 BRIP1 KO
AC   CVCL_B8T6
SY   Human BRIP1 knockout MCF7
DR   Abcam; ab286257
DR   cancercelllines; CVCL_B8T6
DR   Wikidata; Q112928403
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20473; BRIP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 C3AR1 KO
AC   CVCL_D2E1
SY   Human C3AR1 knockout MCF7
DR   Abcam; ab289489
DR   Wikidata; Q127379576
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1319; C3AR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 C5AR1 KO
AC   CVCL_D2E2
SY   Human C5AR1 knockout MCF7
DR   Abcam; ab289495
DR   Wikidata; Q127379577
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1338; C5AR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CA9 KO
AC   CVCL_B8T7
SY   Human CA9 knockout MCF7
DR   Abcam; ab287248
DR   cancercelllines; CVCL_B8T7
DR   Wikidata; Q112928404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1383; CA9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CALR KO
AC   CVCL_B8T8
SY   Human CALR knockout MCF7
DR   Abcam; ab286530
DR   cancercelllines; CVCL_B8T8
DR   Wikidata; Q112928405
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1455; CALR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CARD11 KO
AC   CVCL_B8T9
SY   Human CARD11 knockout MCF7
DR   Abcam; ab286319
DR   cancercelllines; CVCL_B8T9
DR   Wikidata; Q112928406
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16393; CARD11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CARD9 KO
AC   CVCL_D2E3
SY   Human CARD9 knockout MCF7
DR   Abcam; ab289464
DR   Wikidata; Q127379578
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16391; CARD9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CARM1 KO
AC   CVCL_B8TA
SY   Human CARM1 knockout MCF7
DR   Abcam; ab287251
DR   cancercelllines; CVCL_B8TA
DR   Wikidata; Q112928407
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CASP8 KO
AC   CVCL_B8TB
SY   Human CASP8 knockout MCF7
DR   Abcam; ab286385
DR   cancercelllines; CVCL_B8TB
DR   Wikidata; Q112928408
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CBL KO
AC   CVCL_B8TC
SY   Human CBL knockout MCF7
DR   Abcam; ab287254
DR   cancercelllines; CVCL_B8TC
DR   Wikidata; Q112928409
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CBLB KO
AC   CVCL_B8TD
SY   Human CBLB knockout MCF7
DR   Abcam; ab286386
DR   cancercelllines; CVCL_B8TD
DR   Wikidata; Q112928410
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1542; CBLB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CCND2 KO
AC   CVCL_B8TE
SY   Human CCND2 knockout MCF7
DR   Abcam; ab287257
DR   cancercelllines; CVCL_B8TE
DR   Wikidata; Q112928412
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CCNE1 KO
AC   CVCL_B8TF
SY   Human CCNE1 knockout MCF7
DR   Abcam; ab286303
DR   cancercelllines; CVCL_B8TF
DR   Wikidata; Q112928413
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1589; CCNE1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CCR3 KO
AC   CVCL_D2E4
SY   Human CCR3 knockout MCF7
DR   Abcam; ab289402
DR   Wikidata; Q127379579
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1604; CCR3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CCR4 KO
AC   CVCL_B8TG
SY   Human CCR4 knockout MCF7
DR   Abcam; ab287260
DR   cancercelllines; CVCL_B8TG
DR   Wikidata; Q112928414
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1605; CCR4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CCR5 KO
AC   CVCL_D2E5
SY   Human CCR5 knockout MCF7
DR   Abcam; ab289460
DR   Wikidata; Q127379580
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1606; CCR5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CCR6 KO
AC   CVCL_B8TH
SY   Human CCR6 knockout MCF7
DR   Abcam; ab287265
DR   cancercelllines; CVCL_B8TH
DR   Wikidata; Q112928415
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1607; CCR6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CCR7 KO
AC   CVCL_B8TI
SY   Human CCR7 knockout MCF7
DR   Abcam; ab287266
DR   cancercelllines; CVCL_B8TI
DR   Wikidata; Q112928416
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1608; CCR7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CCR9 KO
AC   CVCL_D2E6
SY   Human CCR9 knockout MCF7
DR   Abcam; ab289430
DR   Wikidata; Q127379581
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1610; CCR9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CD14 KO
AC   CVCL_B8TJ
SY   Human CD14 knockout MCF7
DR   Abcam; ab287270
DR   cancercelllines; CVCL_B8TJ
DR   Wikidata; Q112928417
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1628; CD14.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD19 KO
AC   CVCL_B8TK
SY   Human CD19 knockout MCF7
DR   Abcam; ab287272
DR   cancercelllines; CVCL_B8TK
DR   Wikidata; Q112928418
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD209 KO
AC   CVCL_B8TL
SY   Human CD209 knockout MCF7
DR   Abcam; ab287276
DR   cancercelllines; CVCL_B8TL
DR   Wikidata; Q112928419
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1641; CD209.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD226 KO
AC   CVCL_D2E7
SY   Human CD226 knockout MCF7
DR   Abcam; ab289501
DR   Wikidata; Q127379582
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16961; CD226.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CD28 KO
AC   CVCL_B8TM
SY   Human CD28 knockout MCF7
DR   Abcam; ab287278
DR   cancercelllines; CVCL_B8TM
DR   Wikidata; Q112928420
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD34 KO
AC   CVCL_D2E8
SY   Human CD34 knockout MCF7
DR   Abcam; ab289435
DR   Wikidata; Q127379584
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1662; CD34.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CD3E KO
AC   CVCL_B8TN
SY   Human CD3E knockout MCF7
DR   Abcam; ab287281
DR   cancercelllines; CVCL_B8TN
DR   Wikidata; Q112928422
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD4 KO
AC   CVCL_B8TP
SY   Human CD4 knockout MCF7
DR   Abcam; ab287284
DR   cancercelllines; CVCL_B8TP
DR   Wikidata; Q112928423
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1678; CD4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD47 KO
AC   CVCL_E1G9
SY   Human CD47 knockout MCF7
DR   Abcam; ab269496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam MCF-7 CD5 KO
AC   CVCL_D2E9
SY   Human CD5 knockout MCF7
DR   Abcam; ab289409
DR   Wikidata; Q127379585
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1685; CD5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CD55 KO
AC   CVCL_E1GA
SY   Human CD55 knockout MCF7
DR   Abcam; ab269494
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2665; CD55.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam MCF-7 CD69 KO
AC   CVCL_D2EA
SY   Human CD69 knockout MCF7
DR   Abcam; ab289392
DR   Wikidata; Q127379586
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1694; CD69.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CD7 KO
AC   CVCL_D2EB
SY   Human CD7 knockout MCF7
DR   Abcam; ab289315
DR   Wikidata; Q127379587
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1695; CD7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CD74 KO
AC   CVCL_B8TQ
SY   Human CD74 knockout MCF7
DR   Abcam; ab287291
DR   cancercelllines; CVCL_B8TQ
DR   Wikidata; Q112928424
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD79A KO
AC   CVCL_B8TR
SY   Human CD79A knockout MCF7
DR   Abcam; ab287294
DR   cancercelllines; CVCL_B8TR
DR   Wikidata; Q112928425
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1698; CD79A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD80 KO
AC   CVCL_B8TS
SY   Human CD80 knockout MCF7
DR   Abcam; ab287296
DR   cancercelllines; CVCL_B8TS
DR   Wikidata; Q112928426
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1700; CD80.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CD86 KO
AC   CVCL_B8TT
SY   Human CD86 knockout MCF7
DR   Abcam; ab287299
DR   cancercelllines; CVCL_B8TT
DR   Wikidata; Q112928427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1705; CD86.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDH11 KO
AC   CVCL_B8TU
SY   Human CDH11 knockout MCF7
DR   Abcam; ab286258
DR   cancercelllines; CVCL_B8TU
DR   Wikidata; Q112928428
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1750; CDH11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDK2 KO
AC   CVCL_B8TV
SY   Human CDK2 knockout MCF7
DR   Abcam; ab282628
DR   cancercelllines; CVCL_B8TV
DR   Wikidata; Q112928429
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1771; CDK2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDK5 KO
AC   CVCL_B8TW
SY   Human CDK5 knockout MCF7
DR   Abcam; ab287302
DR   cancercelllines; CVCL_B8TW
DR   Wikidata; Q112928430
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDK6 KO
AC   CVCL_B8TX
SY   Human CDK6 knockout MCF7
DR   Abcam; ab287305
DR   cancercelllines; CVCL_B8TX
DR   Wikidata; Q112928431
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDK8 KO
AC   CVCL_B8TY
SY   Human CDK8 knockout MCF7
DR   Abcam; ab287308
DR   cancercelllines; CVCL_B8TY
DR   Wikidata; Q112928432
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1779; CDK8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDKN1A KO
AC   CVCL_B8TZ
SY   Human CDKN1A knockout MCF7
DR   Abcam; ab288200
DR   cancercelllines; CVCL_B8TZ
DR   Wikidata; Q112928433
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDKN1B KO
AC   CVCL_B8U0
SY   Human CDKN1B knockout MCF7
DR   Abcam; ab286389
DR   cancercelllines; CVCL_B8U0
DR   Wikidata; Q112928434
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CDKN1C KO
AC   CVCL_D2EC
SY   Human CDKN1C knockout MCF7
DR   Abcam; ab289503
DR   Wikidata; Q127379588
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1786; CDKN1C.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CDX2 KO
AC   CVCL_B8U1
SY   Human CDX2 knockout MCF7
DR   Abcam; ab287315
DR   cancercelllines; CVCL_B8U1
DR   Wikidata; Q112928435
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1806; CDX2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CEACAM5 KO
AC   CVCL_B8U2
SY   Human CEACAM5 knockout MCF7
DR   Abcam; ab287317
DR   cancercelllines; CVCL_B8U2
DR   Wikidata; Q112928436
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1817; CEACAM5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CEBPA KO
AC   CVCL_B8U3
SY   Human CEBPA knockout MCF7
DR   Abcam; ab286342
DR   cancercelllines; CVCL_B8U3
DR   Wikidata; Q112928437
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CHD5 KO
AC   CVCL_B8U4
SY   Human CHD5 knockout MCF7
DR   Abcam; ab288201
DR   cancercelllines; CVCL_B8U4
DR   Wikidata; Q112928438
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16816; CHD5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CHD7 KO
AC   CVCL_D2ED
SY   Human CHD7 knockout MCF7
DR   Abcam; ab289344
DR   Wikidata; Q127379590
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20626; CHD7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CHD8 KO
AC   CVCL_D2EE
SY   Human CHD8 knockout MCF7
DR   Abcam; ab289286
DR   Wikidata; Q127379591
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CHD9 KO
AC   CVCL_B8U5
SY   Human CHD9 knockout MCF7
DR   Abcam; ab288202
DR   cancercelllines; CVCL_B8U5
DR   Wikidata; Q112928439
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25701; CHD9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CHUK KO
AC   CVCL_B8U6
SY   Human CHUK knockout MCF7
DR   Abcam; ab287320
DR   cancercelllines; CVCL_B8U6
DR   Wikidata; Q112928440
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CIRBP KO
AC   CVCL_D2EF
SY   Human CIRBP knockout MCF7
DR   Abcam; ab289387
DR   Wikidata; Q127379592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1982; CIRBP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CISH KO
AC   CVCL_D2EG
SY   Human CISH knockout MCF7
DR   Abcam; ab289457
DR   Wikidata; Q127379593
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1984; CISH.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CLDN18 KO
AC   CVCL_D2EH
SY   Human CLDN18 knockout MCF7
DR   Abcam; ab289320
DR   Wikidata; Q127379594
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2039; CLDN18.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CLOCK KO
AC   CVCL_B8U7
SY   Human CLOCK knockout MCF7
DR   Abcam; ab287323
DR   cancercelllines; CVCL_B8U7
DR   Wikidata; Q112928441
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CNOT6 KO
AC   CVCL_D2EI
SY   Human CNOT6 knockout MCF7
DR   Abcam; ab289386
DR   Wikidata; Q127379595
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14099; CNOT6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CNTNAP2 KO
AC   CVCL_B8U8
SY   Human CNTNAP2 knockout MCF7
DR   Abcam; ab286366
DR   cancercelllines; CVCL_B8U8
DR   Wikidata; Q112928442
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13830; CNTNAP2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 COL1A1 KO
AC   CVCL_B8U9
SY   Human COL1A1 knockout MCF7
DR   Abcam; ab287327
DR   cancercelllines; CVCL_B8U9
DR   Wikidata; Q112928443
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CR2 KO
AC   CVCL_D2EJ
SY   Human CR2 knockout MCF7
DR   Abcam; ab289345
DR   Wikidata; Q127379596
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2336; CR2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CRBN KO
AC   CVCL_D2EK
SY   Human CRBN knockout MCF7
DR   Abcam; ab289426
DR   Wikidata; Q127379597
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CREB1 KO
AC   CVCL_B8UA
SY   Human CREB1 knockout MCF7
DR   Abcam; ab286344
DR   cancercelllines; CVCL_B8UA
DR   Wikidata; Q112928444
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CREBBP KO
AC   CVCL_B8UB
SY   Human CREBBP knockout MCF7
DR   Abcam; ab286391
DR   cancercelllines; CVCL_B8UB
DR   Wikidata; Q112928445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CRLF2 KO
AC   CVCL_B8UC
SY   Human CRLF2 knockout MCF7
DR   Abcam; ab287331
DR   cancercelllines; CVCL_B8UC
DR   Wikidata; Q112928446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14281; CRLF2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CSF1 KO
AC   CVCL_D2EL
SY   Human CSF1 knockout MCF7
DR   Abcam; ab289303
DR   Wikidata; Q127379598
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CSF1R KO
AC   CVCL_B8UD
SY   Human CSF1R knockout MCF7
DR   Abcam; ab287333
DR   cancercelllines; CVCL_B8UD
DR   Wikidata; Q112928447
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CSF3R KO
AC   CVCL_B8UE
SY   Human CSF3R knockout MCF7
DR   Abcam; ab287337
DR   cancercelllines; CVCL_B8UE
DR   Wikidata; Q112928448
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2439; CSF3R.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CSPG4 KO
AC   CVCL_D2EM
SY   Human CSPG4 knockout MCF7
DR   Abcam; ab289450
DR   Wikidata; Q127379599
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2466; CSPG4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CTLA4 KO
AC   CVCL_B8UF
SY   Human CTLA4 knockout MCF7
DR   Abcam; ab287341
DR   cancercelllines; CVCL_B8UF
DR   Wikidata; Q112928449
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2505; CTLA4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CTNNB1 KO
AC   CVCL_B8UG
SY   Human CTNNB1 knockout MCF7
DR   Abcam; ab286762
DR   cancercelllines; CVCL_B8UG
DR   Wikidata; Q112928450
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CX3CL1 KO
AC   CVCL_D2EN
SY   Human CX3CL1 knockout MCF7
DR   Abcam; ab289477
DR   Wikidata; Q127379600
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10647; CX3CL1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CXCL11 KO
AC   CVCL_D2EP
SY   Human CXCL11 knockout MCF7
DR   Abcam; ab289295
DR   Wikidata; Q127379601
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10638; CXCL11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CXCL13 KO
AC   CVCL_D2EQ
SY   Human CXCL13 knockout MCF7
DR   Abcam; ab289473
DR   Wikidata; Q127379602
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10639; CXCL13.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CXCR1 KO
AC   CVCL_B8UH
SY   Human CXCR1 knockout MCF7
DR   Abcam; ab287343
DR   cancercelllines; CVCL_B8UH
DR   Wikidata; Q112928451
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6026; CXCR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CXCR3 KO
AC   CVCL_D2ER
SY   Human CXCR3 knockout MCF7
DR   Abcam; ab289505
DR   Wikidata; Q127379603
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4540; CXCR3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CXCR4 KO
AC   CVCL_B8UI
SY   Human CXCR4 knockout MCF7
DR   Abcam; ab287347
DR   cancercelllines; CVCL_B8UI
DR   Wikidata; Q112928452
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CXCR6 KO
AC   CVCL_D2ES
SY   Human CXCR6 knockout MCF7
DR   Abcam; ab289502
DR   Wikidata; Q127379604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16647; CXCR6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 CYBB KO
AC   CVCL_B8UJ
SY   Human CYBB knockout MCF7
DR   Abcam; ab287350
DR   cancercelllines; CVCL_B8UJ
DR   Wikidata; Q112928453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2578; CYBB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 CYLD KO
AC   CVCL_B8UK
SY   Human CYLD knockout MCF7
DR   Abcam; ab286259
DR   cancercelllines; CVCL_B8UK
DR   Wikidata; Q112928454
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DAXX KO
AC   CVCL_B8UL
SY   Human DAXX knockout MCF7
DR   Abcam; ab287354
DR   cancercelllines; CVCL_B8UL
DR   Wikidata; Q112928455
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DCC KO
AC   CVCL_B8UM
SY   Human DCC knockout MCF7
DR   Abcam; ab286535
DR   cancercelllines; CVCL_B8UM
DR   Wikidata; Q112928456
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2701; DCC.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DDB2 KO
AC   CVCL_B8UN
SY   Human DDB2 knockout MCF7
DR   Abcam; ab287357
DR   cancercelllines; CVCL_B8UN
DR   Wikidata; Q112928457
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2718; DDB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DDR1 KO
AC   CVCL_B8UP
SY   Human DDR1 (MCK10/NEP) knockout MCF7
DR   Abcam; ab280048
DR   cancercelllines; CVCL_B8UP
DR   Wikidata; Q112928459
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2730; DDR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DDR2 KO
AC   CVCL_B8UQ
SY   Human DDR2 knockout MCF7
DR   Abcam; ab286371
DR   cancercelllines; CVCL_B8UQ
DR   Wikidata; Q112928460
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DDX4 KO
AC   CVCL_D2ET
SY   Human DDX4 knockout MCF7
DR   Abcam; ab289358
DR   Wikidata; Q127379605
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18700; DDX4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 DDX5 KO
AC   CVCL_B8UR
SY   Human DDX5 knockout MCF7
DR   Abcam; ab287364
DR   cancercelllines; CVCL_B8UR
DR   Wikidata; Q112928461
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2746; DDX5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DEPTOR KO
AC   CVCL_B8US
SY   Human DEPTOR knockout MCF7
DR   Abcam; ab277830
DR   cancercelllines; CVCL_B8US
DR   Wikidata; Q112928462
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22953; DEPTOR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DGCR8 KO
AC   CVCL_B8UT
SY   Human DGCR8 knockout MCF7
DR   Abcam; ab287367
DR   cancercelllines; CVCL_B8UT
DR   Wikidata; Q112928463
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2847; DGCR8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DLL3 KO
AC   CVCL_D2EU
SY   Human DLL3 knockout MCF7
DR   Abcam; ab289390
DR   Wikidata; Q127379607
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 DMC1 KO
AC   CVCL_B8UU
SY   Human DMC1 knockout MCF7
DR   Abcam; ab288203
DR   cancercelllines; CVCL_B8UU
DR   Wikidata; Q112928464
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2927; DMC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DNAJB1 KO
AC   CVCL_B8UV
SY   Human DNAJB1 knockout MCF7
DR   Abcam; ab286392
DR   cancercelllines; CVCL_B8UV
DR   Wikidata; Q112928465
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5270; DNAJB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DNMT1 KO
AC   CVCL_B8UW
SY   Human DNMT1 knockout MCF7
DR   Abcam; ab286294
DR   cancercelllines; CVCL_B8UW
DR   Wikidata; Q112928466
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2976; DNMT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DNMT3B KO
AC   CVCL_B8UX
SY   Human DNMT3B knockout MCF7
DR   Abcam; ab287369
DR   cancercelllines; CVCL_B8UX
DR   Wikidata; Q112928467
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DOT1L KO
AC   CVCL_B8UY
SY   Human DOT1L knockout MCF7
DR   Abcam; ab287372
DR   cancercelllines; CVCL_B8UY
DR   Wikidata; Q112928468
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24948; DOT1L.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DPP4 KO
AC   CVCL_D2EV
SY   Human DPP4 knockout MCF7
DR   Abcam; ab289290
DR   Wikidata; Q127379608
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3009; DPP4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 DROSHA KO
AC   CVCL_B8UZ
SY   Human DROSHA knockout MCF7
DR   Abcam; ab287375
DR   cancercelllines; CVCL_B8UZ
DR   Wikidata; Q112928469
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17904; DROSHA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 DUSP4 KO
AC   CVCL_B8V0
SY   Human DUSP4 knockout MCF7
DR   Abcam; ab286393
DR   cancercelllines; CVCL_B8V0
DR   Wikidata; Q112928470
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 E2F1 KO
AC   CVCL_B8V1
SY   Human E2F1 knockout MCF7
DR   Abcam; ab287378
DR   cancercelllines; CVCL_B8V1
DR   Wikidata; Q112928471
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 E2F2 KO
AC   CVCL_D2EW
SY   Human E2F2 knockout MCF7
DR   Abcam; ab289466
DR   Wikidata; Q127379609
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3114; E2F2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 EBF1 KO
AC   CVCL_B8V2
SY   Human EBF1 knockout MCF7
DR   Abcam; ab286353
DR   cancercelllines; CVCL_B8V2
DR   Wikidata; Q112928472
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3126; EBF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EBI3 KO
AC   CVCL_B8V3
SY   Human EBI3 knockout MCF7
DR   Abcam; ab287382
DR   cancercelllines; CVCL_B8V3
DR   Wikidata; Q112928473
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3129; EBI3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EGF KO
AC   CVCL_B8V4
SY   Human EGF knockout MCF7
DR   Abcam; ab287384
DR   cancercelllines; CVCL_B8V4
DR   Wikidata; Q112928474
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3229; EGF.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EGFR KO
AC   CVCL_B8V5
SY   Human EGFR knockout MCF7
DR   Abcam; ab286586
DR   cancercelllines; CVCL_B8V5
DR   Wikidata; Q112928475
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EGLN3 KO
AC   CVCL_D2EX
SY   Human EGLN3 knockout MCF7
DR   Abcam; ab289431
DR   Wikidata; Q127379610
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14661; EGLN3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 EGR1 KO
AC   CVCL_D2EY
SY   Human EGR1 knockout MCF7
DR   Abcam; ab289383
DR   Wikidata; Q127379611
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3238; EGR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 EHMT1 KO
AC   CVCL_B8V6
SY   Human EHMT1 knockout MCF7
DR   Abcam; ab287387
DR   cancercelllines; CVCL_B8V6
DR   Wikidata; Q112928476
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EIF2AK3 KO
AC   CVCL_D2EZ
SY   Human EIF2AK3 knockout MCF7
DR   Abcam; ab289377
DR   Wikidata; Q127379612
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ELK1 KO
AC   CVCL_D2F0
SY   Human ELK1 knockout MCF7
DR   Abcam; ab289394
DR   Wikidata; Q127379613
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ENTPD1 KO
AC   CVCL_D2F1
SY   Human ENTPD1 knockout MCF7
DR   Abcam; ab289343
DR   Wikidata; Q127379614
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3363; ENTPD1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 EOMES KO
AC   CVCL_D2F2
SY   Human EOMES knockout MCF7
DR   Abcam; ab289336
DR   Wikidata; Q127379615
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3372; EOMES.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 EP300 KO
AC   CVCL_B8V7
SY   Human EP300 knockout MCF7
DR   Abcam; ab282633
DR   cancercelllines; CVCL_B8V7
DR   Wikidata; Q112928477
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EPC1 KO
AC   CVCL_B8V8
SY   Human EPC1 knockout MCF7
DR   Abcam; ab288204
DR   cancercelllines; CVCL_B8V8
DR   Wikidata; Q112928478
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19876; EPC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EPHA3 KO
AC   CVCL_B8V9
SY   Human EPHA3 knockout MCF7
DR   Abcam; ab287390
DR   cancercelllines; CVCL_B8V9
DR   Wikidata; Q112928479
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3387; EPHA3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EPHB2 KO
AC   CVCL_B8VA
SY   Human EPHB2 knockout MCF7
DR   Abcam; ab287393
DR   cancercelllines; CVCL_B8VA
DR   Wikidata; Q112928480
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3393; EPHB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ERBB2 KO
AC   CVCL_B8VB
SY   Human ERBB2 knockout MCF7
DR   Abcam; ab286260
DR   cancercelllines; CVCL_B8VB
DR   Wikidata; Q112928481
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ERBB3 KO
AC   CVCL_B8VC
SY   Human ERBB3 knockout MCF7
DR   Abcam; ab286320
DR   cancercelllines; CVCL_B8VC
DR   Wikidata; Q112928482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ERBB4 KO
AC   CVCL_B8VD
SY   Human ERBB4 knockout MCF7
DR   Abcam; ab287396
DR   cancercelllines; CVCL_B8VD
DR   Wikidata; Q112928483
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3432; ERBB4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ERCC4 KO
AC   CVCL_B8VE
SY   Human ERCC4 knockout MCF7
DR   Abcam; ab287400
DR   cancercelllines; CVCL_B8VE
DR   Wikidata; Q112928484
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3436; ERCC4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ERCC5 KO
AC   CVCL_B8VF
SY   Human ERCC5 knockout MCF7
DR   Abcam; ab286456
DR   cancercelllines; CVCL_B8VF
DR   Wikidata; Q112928485
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3437; ERCC5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ESR1 KO
AC   CVCL_B8VG
SY   Human ESR1 knockout MCF7
DR   Abcam; ab286323
DR   cancercelllines; CVCL_B8VG
DR   Wikidata; Q112928486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3467; ESR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ESRRA KO
AC   CVCL_D2F3
SY   Human ESRRA knockout MCF7
DR   Abcam; ab289292
DR   Wikidata; Q127379616
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3471; ESRRA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ETS1 KO
AC   CVCL_B8VH
SY   Human ETS1 knockout MCF7
DR   Abcam; ab287405
DR   cancercelllines; CVCL_B8VH
DR   Wikidata; Q112928487
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ETV6 KO
AC   CVCL_B8VI
SY   Human ETV6 knockout MCF7
DR   Abcam; ab286396
DR   cancercelllines; CVCL_B8VI
DR   Wikidata; Q112928488
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 EZH1 KO
AC   CVCL_B8VJ
SY   Human EZH1 knockout MCF7
DR   Abcam; ab288205
DR   cancercelllines; CVCL_B8VJ
DR   Wikidata; Q112928489
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3526; EZH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FANCA KO
AC   CVCL_B8VK
SY   Human FANCA knockout MCF7
DR   Abcam; ab287409
DR   cancercelllines; CVCL_B8VK
DR   Wikidata; Q112928490
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FANCD2 KO
AC   CVCL_B8VL
SY   Human FANCD2 knockout MCF7
DR   Abcam; ab286397
DR   cancercelllines; CVCL_B8VL
DR   Wikidata; Q112928491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FAP KO
AC   CVCL_D2F4
SY   Human FAP knockout MCF7
DR   Abcam; ab289301
DR   Wikidata; Q127379617
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3590; FAP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FAS KO
AC   CVCL_B8VM
SY   Human FAS knockout MCF7
DR   Abcam; ab286398
DR   cancercelllines; CVCL_B8VM
DR   Wikidata; Q112928492
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FBXO38 KO
AC   CVCL_B8VN
SY   Human FBXO38 knockout MCF7
DR   Abcam; ab286444
DR   cancercelllines; CVCL_B8VN
DR   Wikidata; Q112928493
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28844; FBXO38.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FCER2 KO
AC   CVCL_B8VP
SY   Human FCER2 knockout MCF7
DR   Abcam; ab287411
DR   cancercelllines; CVCL_B8VP
DR   Wikidata; Q112928494
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3612; FCER2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FCGR2A KO
AC   CVCL_B8VQ
SY   Human FCGR2A knockout MCF7
DR   Abcam; ab287414
DR   cancercelllines; CVCL_B8VQ
DR   Wikidata; Q112928495
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3616; FCGR2A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FCGR2B KO
AC   CVCL_B8VR
SY   Human FCGR2B knockout MCF7
DR   Abcam; ab287417
DR   cancercelllines; CVCL_B8VR
DR   Wikidata; Q112928496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3618; FCGR2B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FCGR3A KO
AC   CVCL_B8VS
SY   Human FCGR3A knockout MCF7
DR   Abcam; ab287420
DR   cancercelllines; CVCL_B8VS
DR   Wikidata; Q112928497
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3619; FCGR3A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FEN1 KO
AC   CVCL_B8VT
SY   Human FEN1 knockout MCF7
DR   Abcam; ab286445
DR   cancercelllines; CVCL_B8VT
DR   Wikidata; Q112928498
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3650; FEN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FGFR2 KO
AC   CVCL_B8VU
SY   Human FGFR2 knockout MCF7
DR   Abcam; ab286262
DR   cancercelllines; CVCL_B8VU
DR   Wikidata; Q112928499
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3689; FGFR2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FGFR4 KO
AC   CVCL_B8VV
SY   Human FGFR4 knockout MCF7
DR   Abcam; ab286399
DR   cancercelllines; CVCL_B8VV
DR   Wikidata; Q112928500
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FLI1 KO
AC   CVCL_B8VW
SY   Human FLI1 knockout MCF7
DR   Abcam; ab287423
DR   cancercelllines; CVCL_B8VW
DR   Wikidata; Q112928501
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3749; FLI1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FLT1 KO
AC   CVCL_B8VX
SY   Human FLT1 knockout MCF7
DR   Abcam; ab286490
DR   cancercelllines; CVCL_B8VX
DR   Wikidata; Q112928502
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FLT3LG KO
AC   CVCL_D2FB
SY   Human Flt3lg knockout MCF7
DR   Abcam; ab289337
DR   Wikidata; Q127379618
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FLT4 KO
AC   CVCL_B8VY
SY   Human FLT4 knockout MCF7
DR   Abcam; ab286400
DR   cancercelllines; CVCL_B8VY
DR   Wikidata; Q112928503
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3767; FLT4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FN1 KO
AC   CVCL_B8VZ
SY   Human FN1 knockout MCF7
DR   Abcam; ab286324
DR   cancercelllines; CVCL_B8VZ
DR   Wikidata; Q112928504
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FOLR1 KO
AC   CVCL_D2F5
SY   Human FOLR1 knockout MCF7
DR   Abcam; ab289357
DR   Wikidata; Q127379619
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FOS KO
AC   CVCL_B8W0
SY   Human FOS knockout MCF7
DR   Abcam; ab287427
DR   cancercelllines; CVCL_B8W0
DR   Wikidata; Q112928505
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FOSL1 KO
AC   CVCL_B8W1
SY   Human FOSL1 knockout MCF7
DR   Abcam; ab287430
DR   cancercelllines; CVCL_B8W1
DR   Wikidata; Q112928506
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FOXA2 KO
AC   CVCL_D2F6
SY   Human FOXA2 knockout MCF7
DR   Abcam; ab289306
DR   Wikidata; Q127379620
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FOXC1 KO
AC   CVCL_D2F7
SY   Human FOXC1 knockout MCF7
DR   Abcam; ab289443
DR   Wikidata; Q127379622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3800; FOXC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FOXC2 KO
AC   CVCL_D2F8
SY   Human FOXC2 knockout MCF7
DR   Abcam; ab289407
DR   Wikidata; Q127379623
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3801; FOXC2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FOXG1 KO
AC   CVCL_D2F9
SY   Human FOXG1 knockout MCF7
DR   Abcam; ab289472
DR   Wikidata; Q127379624
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3811; FOXG1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FOXM1 KO
AC   CVCL_B8W2
SY   Human FOXM1 knockout MCF7
DR   Abcam; ab287435
DR   cancercelllines; CVCL_B8W2
DR   Wikidata; Q112928507
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FOXO4 KO
AC   CVCL_B8W3
SY   Human FOXO4 knockout MCF7
DR   Abcam; ab287438
DR   cancercelllines; CVCL_B8W3
DR   Wikidata; Q112928508
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7139; FOXO4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FOXP1 KO
AC   CVCL_B8W4
SY   Human FOXP1 knockout MCF7
DR   Abcam; ab286263
DR   cancercelllines; CVCL_B8W4
DR   Wikidata; Q112928509
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3823; FOXP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 FOXP3 KO
AC   CVCL_D2FA
SY   Human FOXP3 knockout MCF7
DR   Abcam; ab289461
DR   Wikidata; Q127379625
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6106; FOXP3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 FTO KO
AC   CVCL_B8W5
SY   Human FTO knockout MCF7
DR   Abcam; ab282631
DR   cancercelllines; CVCL_B8W5
DR   Wikidata; Q112928510
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GABRA1 KO
AC   CVCL_B8W6
SY   Human GABRA1 knockout MCF7
DR   Abcam; ab286365
DR   cancercelllines; CVCL_B8W6
DR   Wikidata; Q112928511
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4075; GABRA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GABRG2 KO
AC   CVCL_B8W7
SY   Human GABRG2 knockout MCF7
DR   Abcam; ab286316
DR   cancercelllines; CVCL_B8W7
DR   Wikidata; Q112928512
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4087; GABRG2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GADD45B KO
AC   CVCL_D2FC
SY   Human GADD45B knockout MCF7
DR   Abcam; ab289444
DR   Wikidata; Q127379626
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 GATA1 KO
AC   CVCL_B8W8
SY   Human GATA1 knockout MCF7
DR   Abcam; ab286307
DR   cancercelllines; CVCL_B8W8
DR   Wikidata; Q112928513
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4170; GATA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GATA2 KO
AC   CVCL_B8W9
SY   Human GATA2 knockout MCF7
DR   Abcam; ab287441
DR   cancercelllines; CVCL_B8W9
DR   Wikidata; Q112928514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GATA4 KO
AC   CVCL_D2FD
SY   Human GATA4 knockout MCF7
DR   Abcam; ab289355
DR   Wikidata; Q127379627
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4173; GATA4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 GATA6 KO
AC   CVCL_D2FE
SY   Human GATA6 knockout MCF7
DR   Abcam; ab289413
DR   Wikidata; Q127379628
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4174; GATA6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 GLI1 KO
AC   CVCL_B8WA
SY   Human GLI1 knockout MCF7
DR   Abcam; ab286264
DR   cancercelllines; CVCL_B8WA
DR   Wikidata; Q112928515
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4317; GLI1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GLI2 KO
AC   CVCL_B8WB
SY   Human GLI2 knockout MCF7
DR   Abcam; ab286265
DR   cancercelllines; CVCL_B8WB
DR   Wikidata; Q112928516
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4318; GLI2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GLS KO
AC   CVCL_B8WC
SY   Human GLS knockout MCF7
DR   Abcam; ab287444
DR   cancercelllines; CVCL_B8WC
DR   Wikidata; Q112928517
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4331; GLS.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GP1BA KO
AC   CVCL_B8WD
SY   Human GP1BA knockout MCF7
DR   Abcam; ab287447
DR   cancercelllines; CVCL_B8WD
DR   Wikidata; Q112928518
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4439; GP1BA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GPER1 KO
AC   CVCL_D2FF
SY   Human GPER1 knockout MCF7
DR   Abcam; ab289434
DR   Wikidata; Q127379629
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4485; GPER1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 GPNMB KO
AC   CVCL_B8WE
SY   Human GPNMB knockout MCF7
DR   Abcam; ab287454
DR   cancercelllines; CVCL_B8WE
DR   Wikidata; Q112928519
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GSK3B KO
AC   CVCL_B8WF
SY   Human GSK3B knockout MCF7
DR   Abcam; ab286266
DR   cancercelllines; CVCL_B8WF
DR   Wikidata; Q112928520
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GSR KO
AC   CVCL_B8WG
SY   Human GSR knockout MCF7
DR   Abcam; ab287456
DR   cancercelllines; CVCL_B8WG
DR   Wikidata; Q112928521
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4623; GSR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 GZMB KO
AC   CVCL_D2FG
SY   Human GZMB knockout MCF7
DR   Abcam; ab289483
DR   Wikidata; Q127379630
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4709; GZMB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 HAT1 KO
AC   CVCL_B8WH
SY   Human HAT1 knockout MCF7
DR   Abcam; ab287459
DR   cancercelllines; CVCL_B8WH
DR   Wikidata; Q112928522
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4821; HAT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HAVCR2 KO
AC   CVCL_D2FH
SY   Human HAVCR2 knockout MCF7
DR   Abcam; ab289397
DR   Wikidata; Q127379631
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18437; HAVCR2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 HCN1 KO
AC   CVCL_B8WI
SY   Human HCN1 knockout MCF7
DR   Abcam; ab286315
DR   cancercelllines; CVCL_B8WI
DR   Wikidata; Q112928523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4845; HCN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HDAC1 KO
AC   CVCL_B8WJ
SY   Human HDAC1 knockout MCF7
DR   Abcam; ab286295
DR   cancercelllines; CVCL_B8WJ
DR   Wikidata; Q112928524
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HDAC2 KO
AC   CVCL_B8WK
SY   Human HDAC2 knockout MCF7
DR   Abcam; ab287462
DR   cancercelllines; CVCL_B8WK
DR   Wikidata; Q112928525
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HDAC4 KO
AC   CVCL_B8WL
SY   Human HDAC4 knockout MCF7
DR   Abcam; ab286296
DR   cancercelllines; CVCL_B8WL
DR   Wikidata; Q112928526
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14063; HDAC4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HDAC5 KO
AC   CVCL_B8WM
SY   Human HDAC5 knockout MCF7
DR   Abcam; ab286306
DR   cancercelllines; CVCL_B8WM
DR   Wikidata; Q112928527
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14068; HDAC5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HDAC6 KO
AC   CVCL_B8WN
SY   Human HDAC6 knockout MCF7
DR   Abcam; ab287465
DR   cancercelllines; CVCL_B8WN
DR   Wikidata; Q112928528
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HDAC7 KO
AC   CVCL_B8WP
SY   Human HDAC7 knockout MCF7
DR   Abcam; ab286357
DR   cancercelllines; CVCL_B8WP
DR   Wikidata; Q112928529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14067; HDAC7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HELQ KO
AC   CVCL_B8WQ
SY   Human HELQ knockout MCF7
DR   Abcam; ab288206
DR   cancercelllines; CVCL_B8WQ
DR   Wikidata; Q112928530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18536; HELQ.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HES1 KO
AC   CVCL_B0ZX
SY   Human HES1 knockout MCF7
DR   Abcam; ab269495
DR   cancercelllines; CVCL_B0ZX
DR   Wikidata; Q110432505
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HEY1 KO
AC   CVCL_B8WR
SY   Human HEY1 knockout MCF7
DR   Abcam; ab286313
DR   cancercelllines; CVCL_B8WR
DR   Wikidata; Q112928531
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HGF KO
AC   CVCL_B8WS
SY   Human HGF knockout MCF7
DR   Abcam; ab287468
DR   cancercelllines; CVCL_B8WS
DR   Wikidata; Q112928532
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4893; HGF.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HIST2H2BE KO
AC   CVCL_D2FI
SY   Human HIST2H2BE knockout MCF7
DR   Abcam; ab289514
DR   Wikidata; Q127379632
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4760; H2BC21.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 HLA-A KO
AC   CVCL_B8WT
SY   Human HLA-A knockout MCF7
DR   Abcam; ab287472
DR   cancercelllines; CVCL_B8WT
DR   Wikidata; Q112928533
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HLA-DRA KO
AC   CVCL_B8WU
SY   Human HLA-DRA knockout MCF7
DR   Abcam; ab287474
DR   cancercelllines; CVCL_B8WU
DR   Wikidata; Q112928534
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4947; HLA-DRA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HLA-G KO
AC   CVCL_D2FJ
SY   Human HLA-G knockout MCF7
DR   Abcam; ab289452
DR   Wikidata; Q127379634
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4964; HLA-G.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 HMGA2 KO
AC   CVCL_B8WV
SY   Human HMGA2 knockout MCF7
DR   Abcam; ab287477
DR   cancercelllines; CVCL_B8WV
DR   Wikidata; Q112928535
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5009; HMGA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HNF1A KO
AC   CVCL_B8WW
SY   Human HNF1A knockout MCF7
DR   Abcam; ab286529
DR   cancercelllines; CVCL_B8WW
DR   Wikidata; Q112928536
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11621; HNF1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HNF4A KO
AC   CVCL_D2FK
SY   Human HNF4A knockout MCF7
DR   Abcam; ab289398
DR   Wikidata; Q127379635
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5024; HNF4A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 HOXA9 KO
AC   CVCL_B8WX
SY   Human HOXA9 knockout MCF7
DR   Abcam; ab287486
DR   cancercelllines; CVCL_B8WX
DR   Wikidata; Q112928537
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 HPSE KO
AC   CVCL_D2FL
SY   Human HPSE knockout MCF7
DR   Abcam; ab289480
DR   Wikidata; Q127379636
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5164; HPSE.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 HRAS KO
AC   CVCL_B8WY
SY   Human HRAS knockout MCF7
DR   Abcam; ab286401
DR   cancercelllines; CVCL_B8WY
DR   Wikidata; Q112928538
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ICAM1 KO
AC   CVCL_D2FM
SY   Human ICAM1 knockout MCF7
DR   Abcam; ab289476
DR   Wikidata; Q127379637
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 ICOS KO
AC   CVCL_B8WZ
SY   Human ICOS knockout MCF7
DR   Abcam; ab287489
DR   cancercelllines; CVCL_B8WZ
DR   Wikidata; Q112928539
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5351; ICOS.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ICOSLG KO
AC   CVCL_D2FN
SY   Human ICOSLG knockout MCF7
DR   Abcam; ab289522
DR   Wikidata; Q127379638
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17087; ICOSLG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IDH1 KO
AC   CVCL_B8X0
SY   Human IDH1 knockout MCF7
DR   Abcam; ab287492
DR   cancercelllines; CVCL_B8X0
DR   Wikidata; Q112928540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IDH2 KO
AC   CVCL_B8X1
SY   Human IDH2 knockout MCF7
DR   Abcam; ab287495
DR   cancercelllines; CVCL_B8X1
DR   Wikidata; Q112928541
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IFITM1 KO
AC   CVCL_D2FP
SY   Human IFITM1 knockout MCF7
DR   Abcam; ab289515
DR   Wikidata; Q127379639
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IFNAR1 KO
AC   CVCL_D2FQ
SY   Human IFNAR1 knockout MCF7
DR   Abcam; ab289401
DR   Wikidata; Q127379640
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IFNB1 KO
AC   CVCL_B8X2
SY   Human IFNB1 knockout MCF7
DR   Abcam; ab287498
DR   cancercelllines; CVCL_B8X2
DR   Wikidata; Q112928542
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5434; IFNB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IFNGR1 KO
AC   CVCL_B8X3
SY   Human IFNGR1 knockout MCF7
DR   Abcam; ab287501
DR   cancercelllines; CVCL_B8X3
DR   Wikidata; Q112928543
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IFNGR2 KO
AC   CVCL_B8X4
SY   Human IFNGR2 knockout MCF7
DR   Abcam; ab287504
DR   cancercelllines; CVCL_B8X4
DR   Wikidata; Q112928544
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IGF1 KO
AC   CVCL_B8X5
SY   Human IGF1 knockout MCF7
DR   Abcam; ab286289
DR   cancercelllines; CVCL_B8X5
DR   Wikidata; Q112928545
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5464; IGF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IGF1R KO
AC   CVCL_B8X6
SY   Human IGF1R knockout MCF7
DR   Abcam; ab287507
DR   cancercelllines; CVCL_B8X6
DR   Wikidata; Q112928546
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IGF2BP1 KO
AC   CVCL_D2FR
SY   Human IGF2BP1 knockout MCF7
DR   Abcam; ab289410
DR   Wikidata; Q127379641
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28866; IGF2BP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IGF2BP2 KO
AC   CVCL_B8X7
SY   Human IGF2BP2 knockout MCF7
DR   Abcam; ab287510
DR   cancercelllines; CVCL_B8X7
DR   Wikidata; Q112928547
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IGF2BP3 KO
AC   CVCL_D2FS
SY   Human IGF2BP3 knockout MCF7
DR   Abcam; ab289487
DR   Wikidata; Q127379642
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IKBKE KO
AC   CVCL_D2FT
SY   Human IKBKE knockout MCF7
DR   Abcam; ab289490
DR   Wikidata; Q127379643
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IL12A KO
AC   CVCL_B8X8
SY   Human IL12A knockout MCF7
DR   Abcam; ab287517
DR   cancercelllines; CVCL_B8X8
DR   Wikidata; Q112928548
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL18 KO
AC   CVCL_B8X9
SY   Human IL18 knockout MCF7
DR   Abcam; ab287519
DR   cancercelllines; CVCL_B8X9
DR   Wikidata; Q112928549
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5986; IL18.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL1A KO
AC   CVCL_B8XA
SY   Human IL1A knockout MCF7
DR   Abcam; ab287523
DR   cancercelllines; CVCL_B8XA
DR   Wikidata; Q112928550
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5991; IL1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL1B KO
AC   CVCL_B8XB
SY   Human IL1B knockout MCF7
DR   Abcam; ab287525
DR   cancercelllines; CVCL_B8XB
DR   Wikidata; Q112928551
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL23R KO
AC   CVCL_D2FU
SY   Human IL23R knockout MCF7
DR   Abcam; ab289442
DR   Wikidata; Q127379644
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19100; IL23R.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IL27 KO
AC   CVCL_B8XC
SY   Human IL27 knockout MCF7
DR   Abcam; ab287532
DR   cancercelllines; CVCL_B8XC
DR   Wikidata; Q112928552
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19157; IL27.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL2RB KO
AC   CVCL_B8XD
SY   Human IL2RB knockout MCF7
DR   Abcam; ab287537
DR   cancercelllines; CVCL_B8XD
DR   Wikidata; Q112928553
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6009; IL2RB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL3RA KO
AC   CVCL_B8XE
SY   Human IL3RA knockout MCF7
DR   Abcam; ab287543
DR   cancercelllines; CVCL_B8XE
DR   Wikidata; Q112928554
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6012; IL3RA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL6R KO
AC   CVCL_B8XF
SY   Human IL6R knockout MCF7
DR   Abcam; ab287550
DR   cancercelllines; CVCL_B8XF
DR   Wikidata; Q112928555
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL7R KO
AC   CVCL_B8XG
SY   Human IL7R knockout MCF7
DR   Abcam; ab286301
DR   cancercelllines; CVCL_B8XG
DR   Wikidata; Q112928556
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6024; IL7R.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IL9 KO
AC   CVCL_D2FV
SY   Human IL9 knockout MCF7
DR   Abcam; ab289446
DR   Wikidata; Q127379645
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6029; IL9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 INPP5D KO
AC   CVCL_B8XH
SY   Human INPP5D knockout MCF7
DR   Abcam; ab287552
DR   cancercelllines; CVCL_B8XH
DR   Wikidata; Q112928557
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6079; INPP5D.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IQGAP1 KO
AC   CVCL_D2FW
SY   Human IQGAP1 knockout MCF7
DR   Abcam; ab289298
DR   Wikidata; Q127379646
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6110; IQGAP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IRAK1 KO
AC   CVCL_D2FX
SY   Human IRAK1 knockout MCF7
DR   Abcam; ab289441
DR   Wikidata; Q127379647
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 IRAK4 KO
AC   CVCL_B8XI
SY   Human IRAK4 knockout MCF7
DR   Abcam; ab287556
DR   cancercelllines; CVCL_B8XI
DR   Wikidata; Q112928558
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 IRF4 KO
AC   CVCL_B8XJ
SY   Human IRF4 knockout MCF7
DR   Abcam; ab287558
DR   cancercelllines; CVCL_B8XJ
DR   Wikidata; Q112928559
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6119; IRF4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITGA2 KO
AC   CVCL_B8XK
SY   Human ITGA2 knockout MCF7
DR   Abcam; ab287561
DR   cancercelllines; CVCL_B8XK
DR   Wikidata; Q112928560
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITGAE KO
AC   CVCL_B8XL
SY   Human ITGAE knockout MCF7
DR   Abcam; ab287564
DR   cancercelllines; CVCL_B8XL
DR   Wikidata; Q112928561
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITGAL KO
AC   CVCL_B8XM
SY   Human ITGAL knockout MCF7
DR   Abcam; ab287567
DR   cancercelllines; CVCL_B8XM
DR   Wikidata; Q112928562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6148; ITGAL.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITGAM KO
AC   CVCL_B8XN
SY   Human ITGAM knockout MCF7
DR   Abcam; ab287570
DR   cancercelllines; CVCL_B8XN
DR   Wikidata; Q112928563
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITGAV KO
AC   CVCL_B8XP
SY   Human ITGAV knockout MCF7
DR   Abcam; ab286325
DR   cancercelllines; CVCL_B8XP
DR   Wikidata; Q112928564
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6150; ITGAV.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITGAX KO
AC   CVCL_B8XQ
SY   Human ITGAX knockout MCF7
DR   Abcam; ab287573
DR   cancercelllines; CVCL_B8XQ
DR   Wikidata; Q112928565
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6152; ITGAX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITGB1 KO
AC   CVCL_B8XR
SY   Human ITGB1 knockout MCF7
DR   Abcam; ab286402
DR   cancercelllines; CVCL_B8XR
DR   Wikidata; Q112928566
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITK KO
AC   CVCL_B8XS
SY   Human ITK knockout MCF7
DR   Abcam; ab286356
DR   cancercelllines; CVCL_B8XS
DR   Wikidata; Q112928567
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6171; ITK.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ITPR1 KO
AC   CVCL_B8XT
SY   Human ITPR1 knockout MCF7
DR   Abcam; ab286360
DR   cancercelllines; CVCL_B8XT
DR   Wikidata; Q112928568
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 JAK1 KO
AC   CVCL_B8XU
SY   Human JAK1 knockout MCF7
DR   Abcam; ab286267
DR   cancercelllines; CVCL_B8XU
DR   Wikidata; Q112928569
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 JAK3 KO
AC   CVCL_B8XV
SY   Human JAK3 knockout MCF7
DR   Abcam; ab286268
DR   cancercelllines; CVCL_B8XV
DR   Wikidata; Q112928570
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6193; JAK3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 JARID2 KO
AC   CVCL_D2FY
SY   Human JARID2 knockout MCF7
DR   Abcam; ab289310
DR   Wikidata; Q127379648
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6196; JARID2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 KAT2B KO
AC   CVCL_B8XW
SY   Human KAT2B knockout MCF7
DR   Abcam; ab287579
DR   cancercelllines; CVCL_B8XW
DR   Wikidata; Q112928571
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KDM1A KO
AC   CVCL_B8XX
SY   Human KDM1A knockout MCF7
DR   Abcam; ab287582
DR   cancercelllines; CVCL_B8XX
DR   Wikidata; Q112928572
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KDM3A KO
AC   CVCL_B8XY
SY   Human KDM3A knockout MCF7
DR   Abcam; ab287585
DR   cancercelllines; CVCL_B8XY
DR   Wikidata; Q112928573
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20815; KDM3A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KDM5A KO
AC   CVCL_B8XZ
SY   Human KDM5A knockout MCF7
DR   Abcam; ab287589
DR   cancercelllines; CVCL_B8XZ
DR   Wikidata; Q112928574
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KDM5B KO
AC   CVCL_B8Y0
SY   Human KDM5B knockout MCF7
DR   Abcam; ab287591
DR   cancercelllines; CVCL_B8Y0
DR   Wikidata; Q112928575
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KDM6A KO
AC   CVCL_B8Y1
SY   Human KDM6A knockout MCF7
DR   Abcam; ab287594
DR   cancercelllines; CVCL_B8Y1
DR   Wikidata; Q112928576
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KDR KO
AC   CVCL_B8Y2
SY   Human KDR knockout MCF7
DR   Abcam; ab286269
DR   cancercelllines; CVCL_B8Y2
DR   Wikidata; Q112928577
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6307; KDR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KEAP1 KO
AC   CVCL_B8Y3
SY   Human KEAP1 knockout MCF7
DR   Abcam; ab286293
DR   cancercelllines; CVCL_B8Y3
DR   Wikidata; Q112928578
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KIT KO
AC   CVCL_B8Y4
SY   Human KIT knockout MCF7
DR   Abcam; ab286372
DR   cancercelllines; CVCL_B8Y4
DR   Wikidata; Q112928579
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KITLG KO
AC   CVCL_D2FZ
SY   Human KITLG knockout MCF7
DR   Abcam; ab289356
DR   Wikidata; Q127379649
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6343; KITLG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 KLF4 KO
AC   CVCL_B8Y5
SY   Human KLF4 knockout MCF7
DR   Abcam; ab286336
DR   cancercelllines; CVCL_B8Y5
DR   Wikidata; Q112928580
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6348; KLF4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KLRB1 KO
AC   CVCL_D2G0
SY   Human KLRB1 knockout MCF7
DR   Abcam; ab289468
DR   Wikidata; Q127379650
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6373; KLRB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 KLRC1 KO
AC   CVCL_D2G1
SY   Human KLRC1 knockout MCF7
DR   Abcam; ab289399
DR   Wikidata; Q127379651
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6374; KLRC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 KMT2A KO
AC   CVCL_B8Y6
SY   Human KMT2A knockout MCF7
DR   Abcam; ab286297
DR   cancercelllines; CVCL_B8Y6
DR   Wikidata; Q112928581
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7132; KMT2A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KMT2D KO
AC   CVCL_B8Y7
SY   Human KMT2D knockout MCF7
DR   Abcam; ab286505
DR   cancercelllines; CVCL_B8Y7
DR   Wikidata; Q112928582
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 KRT1 KO
AC   CVCL_D2G2
SY   Human KRT1 knockout MCF7
DR   Abcam; ab289314
DR   Wikidata; Q127379652
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6412; KRT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LAMP1 KO
AC   CVCL_D2G3
SY   Human LAMP1 knockout MCF7
DR   Abcam; ab289391
DR   Wikidata; Q127379653
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LATS1 KO
AC   CVCL_B8Y8
SY   Human LATS1 knockout MCF7
DR   Abcam; ab286403
DR   cancercelllines; CVCL_B8Y8
DR   Wikidata; Q112928583
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 LATS2 KO
AC   CVCL_B8Y9
SY   Human LATS2 knockout MCF7
DR   Abcam; ab286373
DR   cancercelllines; CVCL_B8Y9
DR   Wikidata; Q112928584
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 LCK KO
AC   CVCL_B8YA
SY   Human LCK knockout MCF7
DR   Abcam; ab287600
DR   cancercelllines; CVCL_B8YA
DR   Wikidata; Q112928585
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6524; LCK.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 LGALS1 KO
AC   CVCL_D2G4
SY   Human LGALS1 knockout MCF7
DR   Abcam; ab289482
DR   Wikidata; Q127379654
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LGALS3 KO
AC   CVCL_D2G5
SY   Human LGALS3 knockout MCF7
DR   Abcam; ab289437
DR   Wikidata; Q127379655
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LGR5 KO
AC   CVCL_D2G6
SY   Human LGR5 knockout MCF7
DR   Abcam; ab289427
DR   Wikidata; Q127379656
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4504; LGR5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LILRB1 KO
AC   CVCL_D2G7
SY   Human LILRB1 knockout MCF7
DR   Abcam; ab289333
DR   Wikidata; Q127379657
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6605; LILRB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LIN28A KO
AC   CVCL_D2G8
SY   Human LIN28A knockout MCF7
DR   Abcam; ab289289
DR   Wikidata; Q127379658
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15986; LIN28A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LIN28B KO
AC   CVCL_D2G9
SY   Human LIN28B knockout MCF7
DR   Abcam; ab289326
DR   Wikidata; Q127379659
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 LMNA KO
AC   CVCL_B8YB
SY   Human LMNA knockout MCF7
DR   Abcam; ab287603
DR   cancercelllines; CVCL_B8YB
DR   Wikidata; Q112928586
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 LRP5 KO
AC   CVCL_B8YC
SY   Human LRP5 knockout MCF7
DR   Abcam; ab286404
DR   cancercelllines; CVCL_B8YC
DR   Wikidata; Q112928587
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 LYN KO
AC   CVCL_B8YD
SY   Human LYN knockout MCF7
DR   Abcam; ab286270
DR   cancercelllines; CVCL_B8YD
DR   Wikidata; Q112928588
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAF KO
AC   CVCL_B8YE
SY   Human MAF knockout MCF7
DR   Abcam; ab287607
DR   cancercelllines; CVCL_B8YE
DR   Wikidata; Q112928589
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6776; MAF.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MALT1 KO
AC   CVCL_B8YF
SY   Human MALT1 knockout MCF7
DR   Abcam; ab286405
DR   cancercelllines; CVCL_B8YF
DR   Wikidata; Q112928590
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAP2K1 KO
AC   CVCL_B8YG
SY   Human MAP2K1 knockout MCF7
DR   Abcam; ab286772
DR   cancercelllines; CVCL_B8YG
DR   Wikidata; Q112928591
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAP2K2 KO
AC   CVCL_B8YH
SY   Human MAP2K2 knockout MCF7
DR   Abcam; ab286407
DR   cancercelllines; CVCL_B8YH
DR   Wikidata; Q112928592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAP2K4 KO
AC   CVCL_B8YI
SY   Human MAP2K4 knockout MCF7
DR   Abcam; ab286374
DR   cancercelllines; CVCL_B8YI
DR   Wikidata; Q112928593
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAP3K11 KO
AC   CVCL_B8YJ
SY   Human MAP3K11 knockout MCF7
DR   Abcam; ab286408
DR   cancercelllines; CVCL_B8YJ
DR   Wikidata; Q112928594
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAP3K7 KO
AC   CVCL_B8YK
SY   Human MAP3K7 knockout MCF7
DR   Abcam; ab287609
DR   cancercelllines; CVCL_B8YK
DR   Wikidata; Q112928595
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAPK1 KO
AC   CVCL_B8YL
SY   Human MAPK1 knockout MCF7
DR   Abcam; ab286409
DR   cancercelllines; CVCL_B8YL
DR   Wikidata; Q112928596
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAPK14 KO
AC   CVCL_B8YM
SY   Human MAPK14 knockout MCF7
DR   Abcam; ab286410
DR   cancercelllines; CVCL_B8YM
DR   Wikidata; Q112928597
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MAPK3 KO
AC   CVCL_B8YN
SY   Human MAPK3 knockout MCF7
DR   Abcam; ab286411
DR   cancercelllines; CVCL_B8YN
DR   Wikidata; Q112928598
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6877; MAPK3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MDC1 KO
AC   CVCL_B8YP
SY   Human MDC1 knockout MCF7
DR   Abcam; ab287612
DR   cancercelllines; CVCL_B8YP
DR   Wikidata; Q112928599
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21163; MDC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MECOM KO
AC   CVCL_B8YQ
SY   Human MECOM knockout MCF7
DR   Abcam; ab286317
DR   cancercelllines; CVCL_B8YQ
DR   Wikidata; Q112928600
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3498; MECOM.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MECP2 KO
AC   CVCL_D2GA
SY   Human MECP2 knockout MCF7
DR   Abcam; ab289433
DR   Wikidata; Q127379660
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6990; MECP2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MED12 KO
AC   CVCL_B8YR
SY   Human MED12 knockout MCF7
DR   Abcam; ab286272
DR   cancercelllines; CVCL_B8YR
DR   Wikidata; Q112928601
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11957; MED12.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MEN1 KO
AC   CVCL_B8YS
SY   Human MEN1 knockout MCF7
DR   Abcam; ab287615
DR   cancercelllines; CVCL_B8YS
DR   Wikidata; Q112928602
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MEF2A KO
AC   CVCL_D2GB
SY   Human MEF2A knockout MCF7
DR   Abcam; ab289396
DR   Wikidata; Q127379662
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6993; MEF2A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MEF2C KO
AC   CVCL_D2GC
SY   Human MEF2C knockout MCF7
DR   Abcam; ab289453
DR   Wikidata; Q127379663
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6996; MEF2C.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MET KO
AC   CVCL_B8YT
SY   Human MET knockout MCF7
DR   Abcam; ab286413
DR   cancercelllines; CVCL_B8YT
DR   Wikidata; Q112928603
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MGMT KO
AC   CVCL_B8YU
SY   Human MGMT knockout MCF7
DR   Abcam; ab286349
DR   cancercelllines; CVCL_B8YU
DR   Wikidata; Q112928604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MICA KO
AC   CVCL_D2GD
SY   Human MICA knockout MCF7
DR   Abcam; ab289352
DR   Wikidata; Q127379665
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7090; MICA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MICB KO
AC   CVCL_D2GE
SY   Human MICB knockout MCF7
DR   Abcam; ab289322
DR   Wikidata; Q127379666
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7091; MICB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MITF KO
AC   CVCL_B8YV
SY   Human MITF knockout MCF7
DR   Abcam; ab286300
DR   cancercelllines; CVCL_B8YV
DR   Wikidata; Q112928605
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7105; MITF.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MKI67 KO
AC   CVCL_D2GF
SY   Human MKI67 knockout MCF7
DR   Abcam; ab289317
DR   Wikidata; Q127379667
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MLH1 KO
AC   CVCL_B8YW
SY   Human MLH1 knockout MCF7
DR   Abcam; ab286607
DR   cancercelllines; CVCL_B8YW
DR   Wikidata; Q112928606
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MMP1 KO
AC   CVCL_B8YX
SY   Human MMP1 knockout MCF7
DR   Abcam; ab286341
DR   cancercelllines; CVCL_B8YX
DR   Wikidata; Q112928607
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7155; MMP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MMP12 KO
AC   CVCL_B8YY
SY   Human MMP12 knockout MCF7
DR   Abcam; ab287618
DR   cancercelllines; CVCL_B8YY
DR   Wikidata; Q112928608
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7158; MMP12.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MMP2 KO
AC   CVCL_B8YZ
SY   Human MMP2 knockout MCF7
DR   Abcam; ab286290
DR   cancercelllines; CVCL_B8YZ
DR   Wikidata; Q112928609
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7166; MMP2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MMP9 KO
AC   CVCL_B8Z0
SY   Human MMP9 knockout MCF7
DR   Abcam; ab286335
DR   cancercelllines; CVCL_B8Z0
DR   Wikidata; Q112928610
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7176; MMP9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MRE11 KO
AC   CVCL_B8Z1
SY   Human MRE11 knockout MCF7
DR   Abcam; ab286347
DR   cancercelllines; CVCL_B8Z1
DR   Wikidata; Q112928611
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7230; MRE11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MSH2 KO
AC   CVCL_B8Z2
SY   Human MSH2 knockout MCF7
DR   Abcam; ab286466
DR   cancercelllines; CVCL_B8Z2
DR   Wikidata; Q112928612
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MSH3 KO
AC   CVCL_D2GG
SY   Human MSH3 knockout MCF7
DR   Abcam; ab289334
DR   Wikidata; Q127379668
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MSH6 KO
AC   CVCL_B8Z3
SY   Human MSH6 knockout MCF7
DR   Abcam; ab286516
DR   cancercelllines; CVCL_B8Z3
DR   Wikidata; Q112928613
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MSLN KO
AC   CVCL_D2GH
SY   Human MSLN knockout MCF7
DR   Abcam; ab289497
DR   Wikidata; Q127379669
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7371; MSLN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 MSR1 KO
AC   CVCL_B8Z4
SY   Human MSR1 knockout MCF7
DR   Abcam; ab287622
DR   cancercelllines; CVCL_B8Z4
DR   Wikidata; Q112928614
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7376; MSR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MTA2 KO
AC   CVCL_B8Z5
SY   Human MTA2 knockout MCF7
DR   Abcam; ab287624
DR   cancercelllines; CVCL_B8Z5
DR   Wikidata; Q112928615
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7411; MTA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MUC1 KO
AC   CVCL_B8Z6
SY   Human MUC1 knockout MCF7
DR   Abcam; ab287627
DR   cancercelllines; CVCL_B8Z6
DR   Wikidata; Q112928616
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MUC16 KO
AC   CVCL_B8Z7
SY   Human MUC16 knockout MCF7
DR   Abcam; ab287630
DR   cancercelllines; CVCL_B8Z7
DR   Wikidata; Q112928618
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15582; MUC16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MYB KO
AC   CVCL_B8Z8
SY   Human MYB knockout MCF7
DR   Abcam; ab287633
DR   cancercelllines; CVCL_B8Z8
DR   Wikidata; Q112928619
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MYD88 KO
AC   CVCL_B8Z9
SY   Human MYD88 knockout MCF7
DR   Abcam; ab286339
DR   cancercelllines; CVCL_B8Z9
DR   Wikidata; Q112928620
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 MYOD1 KO
AC   CVCL_B8ZA
SY   Human MYOD1 knockout MCF7
DR   Abcam; ab286554
DR   cancercelllines; CVCL_B8ZA
DR   Wikidata; Q112928621
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7611; MYOD1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NANOG KO
AC   CVCL_D2GI
SY   Human NANOG knockout MCF7
DR   Abcam; ab289323
DR   Wikidata; Q127379671
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20857; NANOG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NBN KO
AC   CVCL_B8ZB
SY   Human NBN knockout MCF7
DR   Abcam; ab286415
DR   cancercelllines; CVCL_B8ZB
DR   Wikidata; Q112928622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NCAM1 KO
AC   CVCL_B8ZC
SY   Human NCAM1 knockout MCF7
DR   Abcam; ab287636
DR   cancercelllines; CVCL_B8ZC
DR   Wikidata; Q112928623
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NCAM2 KO
AC   CVCL_D2GJ
SY   Human NCAM2 knockout MCF7
DR   Abcam; ab289467
DR   Wikidata; Q127379672
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7657; NCAM2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NCF4 KO
AC   CVCL_D2GK
SY   Human NCF4 knockout MCF7
DR   Abcam; ab289458
DR   Wikidata; Q127379673
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7662; NCF4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NCOA1 KO
AC   CVCL_B8ZD
SY   Human NCOA1 knockout MCF7
DR   Abcam; ab287639
DR   cancercelllines; CVCL_B8ZD
DR   Wikidata; Q112928624
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7668; NCOA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NCR1 KO
AC   CVCL_D2GL
SY   Human NCR1 knockout MCF7
DR   Abcam; ab289420
DR   Wikidata; Q127379674
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6731; NCR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NECTIN2 KO
AC   CVCL_D2GM
SY   Human NECTIN2 knockout MCF7
DR   Abcam; ab289378
DR   Wikidata; Q127379675
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9707; NECTIN2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NECTIN3 KO
AC   CVCL_D2GN
SY   Human NECTIN3 knockout MCF7
DR   Abcam; ab289494
DR   Wikidata; Q127379676
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17664; NECTIN3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NF1 KO
AC   CVCL_B8ZE
SY   Human NF1 knockout MCF7
DR   Abcam; ab286416
DR   cancercelllines; CVCL_B8ZE
DR   Wikidata; Q112928625
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NF2 KO
AC   CVCL_B8ZF
SY   Human NF2 knockout MCF7
DR   Abcam; ab286417
DR   cancercelllines; CVCL_B8ZF
DR   Wikidata; Q112928626
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NFATC1 KO
AC   CVCL_D2GP
SY   Human NFATC1 knockout MCF7
DR   Abcam; ab289506
DR   Wikidata; Q127379677
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NFATC2 KO
AC   CVCL_B8ZG
SY   Human NFATC2 knockout MCF7
DR   Abcam; ab287642
DR   cancercelllines; CVCL_B8ZG
DR   Wikidata; Q112928627
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7776; NFATC2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NFE2L2 KO
AC   CVCL_B8ZH
SY   Human NFE2L2 knockout MCF7
DR   Abcam; ab287646
DR   cancercelllines; CVCL_B8ZH
DR   Wikidata; Q112928628
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NOS2 KO
AC   CVCL_B8ZI
SY   Human NOS2 knockout MCF7
DR   Abcam; ab287648
DR   cancercelllines; CVCL_B8ZI
DR   Wikidata; Q112928629
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NOTCH1 KO
AC   CVCL_B8ZJ
SY   Human NOTCH1 knockout MCF7
DR   Abcam; ab287651
DR   cancercelllines; CVCL_B8ZJ
DR   Wikidata; Q112928630
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NOTCH2 KO
AC   CVCL_B8ZK
SY   Human NOTCH2 knockout MCF7
DR   Abcam; ab286274
DR   cancercelllines; CVCL_B8ZK
DR   Wikidata; Q112928631
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NR1H3 KO
AC   CVCL_D2GQ
SY   Human NR1H3 knockout MCF7
DR   Abcam; ab289484
DR   Wikidata; Q127379678
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NR4A1 KO
AC   CVCL_B8ZL
SY   Human NR4A1 knockout MCF7
DR   Abcam; ab287654
DR   cancercelllines; CVCL_B8ZL
DR   Wikidata; Q112928632
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NR4A3 KO
AC   CVCL_B8ZM
SY   Human NR4A3 knockout MCF7
DR   Abcam; ab286547
DR   cancercelllines; CVCL_B8ZM
DR   Wikidata; Q112928633
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7982; NR4A3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NRAS KO
AC   CVCL_B8ZN
SY   Human NRAS knockout MCF7
DR   Abcam; ab286782
DR   cancercelllines; CVCL_B8ZN
DR   Wikidata; Q112928634
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NSD2 KO
AC   CVCL_B8ZP
SY   Human NSD2 knockout MCF7
DR   Abcam; ab287657
DR   cancercelllines; CVCL_B8ZP
DR   Wikidata; Q112928635
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 NTN1 KO
AC   CVCL_E8G1
SY   Human NTN1 knockout MCF7
DR   Abcam; ab323856
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8029; NTN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Abcam MCF-7 NTRK2 KO
AC   CVCL_D2GR
SY   Human NTRK2 knockout MCF7
DR   Abcam; ab289432
DR   Wikidata; Q127379679
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8032; NTRK2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 NTRK3 KO
AC   CVCL_B8ZQ
SY   Human NTRK3 knockout MCF7
DR   Abcam; ab286345
DR   cancercelllines; CVCL_B8ZQ
DR   Wikidata; Q112928636
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8033; NTRK3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 OLIG2 KO
AC   CVCL_B8ZR
SY   Human OLIG2 knockout MCF7
DR   Abcam; ab286546
DR   cancercelllines; CVCL_B8ZR
DR   Wikidata; Q112928637
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9398; OLIG2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 OPRM1 KO
AC   CVCL_B8ZS
SY   Human OPRM1 knockout MCF7
DR   Abcam; ab286305
DR   cancercelllines; CVCL_B8ZS
DR   Wikidata; Q112928638
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8156; OPRM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PAK1 KO
AC   CVCL_B8ZT
SY   Human PAK1 knockout MCF7
DR   Abcam; ab286419
DR   cancercelllines; CVCL_B8ZT
DR   Wikidata; Q112928639
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PAK2 KO
AC   CVCL_B8ZU
SY   Human PAK2 knockout MCF7
DR   Abcam; ab287665
DR   cancercelllines; CVCL_B8ZU
DR   Wikidata; Q112928640
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PAK4 KO
AC   CVCL_D2GS
SY   Human PAK4 knockout MCF7
DR   Abcam; ab289332
DR   Wikidata; Q127379680
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PALB2 KO
AC   CVCL_B8ZV
SY   Human PALB2 knockout MCF7
DR   Abcam; ab286446
DR   cancercelllines; CVCL_B8ZV
DR   Wikidata; Q112928641
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26144; PALB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PARP1 KO
AC   CVCL_B8ZW
SY   Human PARP1 knockout MCF7
DR   Abcam; ab286420
DR   cancercelllines; CVCL_B8ZW
DR   Wikidata; Q112928643
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PARP3 KO
AC   CVCL_B8ZX
SY   Human PARP3 knockout MCF7
DR   Abcam; ab288207
DR   cancercelllines; CVCL_B8ZX
DR   Wikidata; Q112928644
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PAX5 KO
AC   CVCL_B8ZY
SY   Human PAX5 knockout MCF7
DR   Abcam; ab287668
DR   cancercelllines; CVCL_B8ZY
DR   Wikidata; Q112928645
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8619; PAX5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PAX6 KO
AC   CVCL_D2GT
SY   Human PAX6 knockout MCF7
DR   Abcam; ab289422
DR   Wikidata; Q127379681
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PAX7 KO
AC   CVCL_B8ZZ
SY   Human PAX7 knockout MCF7
DR   Abcam; ab287672
DR   cancercelllines; CVCL_B8ZZ
DR   Wikidata; Q112928646
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8621; PAX7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PAX8 KO
AC   CVCL_B9A0
SY   Human PAX8 knockout MCF7
DR   Abcam; ab287674
DR   cancercelllines; CVCL_B9A0
DR   Wikidata; Q112928647
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8622; PAX8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PBRM1 KO
AC   CVCL_B9A1
SY   Human PBRM1 knockout MCF7
DR   Abcam; ab286308
DR   cancercelllines; CVCL_B9A1
DR   Wikidata; Q112928648
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PCK2 KO
AC   CVCL_E1GB
SY   Human PCK2 knockout MCF7
DR   Abcam; ab273845
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8725; PCK2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam MCF-7 PDCD1 KO
AC   CVCL_B9A2
SY   Human PDCD1 knockout MCF7
DR   Abcam; ab287677
DR   cancercelllines; CVCL_B9A2
DR   Wikidata; Q112928649
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PDE3B KO
AC   CVCL_B0ZY
SY   Human PDE3B knockout MCF7
DR   Abcam; ab262333
DR   cancercelllines; CVCL_B0ZY
DR   Wikidata; Q110432506
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8779; PDE3B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PDGFB KO
AC   CVCL_B9A3
SY   Human PDGFB knockout MCF7
DR   Abcam; ab287680
DR   cancercelllines; CVCL_B9A3
DR   Wikidata; Q112928650
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8800; PDGFB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PDGFRA KO
AC   CVCL_B9A4
SY   Human PDGFRA knockout MCF7
DR   Abcam; ab287683
DR   cancercelllines; CVCL_B9A4
DR   Wikidata; Q112928651
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PDGFRB KO
AC   CVCL_B9A5
SY   Human PDGFRB knockout MCF7
DR   Abcam; ab286421
DR   cancercelllines; CVCL_B9A5
DR   Wikidata; Q112928652
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8804; PDGFRB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PDPN KO
AC   CVCL_D2GU
SY   Human PDPN knockout MCF7
DR   Abcam; ab289500
DR   Wikidata; Q127379682
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PEBP1 KO
AC   CVCL_D2GV
SY   Human PEBP1 knockout MCF7
DR   Abcam; ab289400
DR   Wikidata; Q127379683
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8630; PEBP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PECAM1 KO
AC   CVCL_D2GW
SY   Human PECAM1 knockout MCF7
DR   Abcam; ab289516
DR   Wikidata; Q127379684
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8823; PECAM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PER1 KO
AC   CVCL_B9A6
SY   Human PER1 knockout MCF7
DR   Abcam; ab288208
DR   cancercelllines; CVCL_B9A6
DR   Wikidata; Q112928653
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8845; PER1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PGF KO
AC   CVCL_B9A7
SY   Human PGF knockout MCF7
DR   Abcam; ab287694
DR   cancercelllines; CVCL_B9A7
DR   Wikidata; Q112928654
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8893; PGF.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PGR KO
AC   CVCL_B9A8
SY   Human PGR knockout MCF7
DR   Abcam; ab287695
DR   cancercelllines; CVCL_B9A8
DR   Wikidata; Q112928655
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8910; PGR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PHF1 KO
AC   CVCL_B9A9
SY   Human PHF1 knockout MCF7
DR   Abcam; ab288209
DR   cancercelllines; CVCL_B9A9
DR   Wikidata; Q112928656
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8919; PHF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PHLPP1 KO
AC   CVCL_B9AA
SY   Human PHLPP1 knockout MCF7
DR   Abcam; ab287698
DR   cancercelllines; CVCL_B9AA
DR   Wikidata; Q112928657
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20610; PHLPP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PIK3R1 KO
AC   CVCL_B9AB
SY   Human PIK3R1 knockout MCF7
DR   Abcam; ab286422
DR   cancercelllines; CVCL_B9AB
DR   Wikidata; Q112928658
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PIK3R2 KO
AC   CVCL_B9AC
SY   Human PIK3R2 knockout MCF7
DR   Abcam; ab286423
DR   cancercelllines; CVCL_B9AC
DR   Wikidata; Q112928659
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PIWIL4 KO
AC   CVCL_D2GX
SY   Human PIWIL4 knockout MCF7
DR   Abcam; ab289393
DR   Wikidata; Q127379685
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18444; PIWIL4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PMEL KO
AC   CVCL_D2GY
SY   Human PMEL knockout MCF7
DR   Abcam; ab289416
DR   Wikidata; Q127379686
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10880; PMEL.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PML KO
AC   CVCL_B9AD
SY   Human PML knockout MCF7
DR   Abcam; ab286424
DR   cancercelllines; CVCL_B9AD
DR   Wikidata; Q112928660
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PMS2 KO
AC   CVCL_B9AE
SY   Human PMS2 knockout MCF7
DR   Abcam; ab286617
DR   cancercelllines; CVCL_B9AE
DR   Wikidata; Q112928661
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9122; PMS2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 POLQ KO
AC   CVCL_B9AF
SY   Human POLQ knockout MCF7
DR   Abcam; ab286275
DR   cancercelllines; CVCL_B9AF
DR   Wikidata; Q112928662
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9186; POLQ.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 POLR2A KO
AC   CVCL_B9AG
SY   Human POLR2A knockout MCF7
DR   Abcam; ab287701
DR   cancercelllines; CVCL_B9AG
DR   Wikidata; Q112928663
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9187; POLR2A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 POU2F2 KO
AC   CVCL_D2GZ
SY   Human POU2F2 knockout MCF7
DR   Abcam; ab289507
DR   Wikidata; Q127379687
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9213; POU2F2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 POU5F1 KO
AC   CVCL_B9AH
SY   Human POU5F1 knockout MCF7
DR   Abcam; ab286346
DR   cancercelllines; CVCL_B9AH
DR   Wikidata; Q112928664
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9221; POU5F1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PPARA KO
AC   CVCL_D2H0
SY   Human PPARA knockout MCF7
DR   Abcam; ab289425
DR   Wikidata; Q127379688
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PPARD KO
AC   CVCL_D2H1
SY   Human PPARD knockout MCF7
DR   Abcam; ab289456
DR   Wikidata; Q127379689
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9235; PPARD.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PPARG KO
AC   CVCL_B9AI
SY   Human PPARG knockout MCF7
DR   Abcam; ab287705
DR   cancercelllines; CVCL_B9AI
DR   Wikidata; Q112928665
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PRDM1 KO
AC   CVCL_B9AJ
SY   Human PRDM1 knockout MCF7
DR   Abcam; ab287708
DR   cancercelllines; CVCL_B9AJ
DR   Wikidata; Q112928666
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9346; PRDM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PRDM16 KO
AC   CVCL_B9AK
SY   Human PRDM16 knockout MCF7
DR   Abcam; ab286309
DR   cancercelllines; CVCL_B9AK
DR   Wikidata; Q112928668
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14000; PRDM16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PRF1 KO
AC   CVCL_B9AL
SY   Human PRF1 knockout MCF7
DR   Abcam; ab287711
DR   cancercelllines; CVCL_B9AL
DR   Wikidata; Q112928669
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9360; PRF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PRKAA1 KO
AC   CVCL_B9AM
SY   Human PRKAA1 knockout MCF7
DR   Abcam; ab287713
DR   cancercelllines; CVCL_B9AM
DR   Wikidata; Q112928670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PRKAA2 KO
AC   CVCL_B9AN
SY   Human PRKAA2 knockout MCF7
DR   Abcam; ab286375
DR   cancercelllines; CVCL_B9AN
DR   Wikidata; Q112928671
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PRKAR1A KO
AC   CVCL_D2H2
SY   Human PRKAR1A knockout MCF7
DR   Abcam; ab289291
DR   Wikidata; Q127379690
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9388; PRKAR1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PRKCA KO
AC   CVCL_B9AP
SY   Human PRKCA knockout MCF7
DR   Abcam; ab286359
DR   cancercelllines; CVCL_B9AP
DR   Wikidata; Q112928672
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PRKCB KO
AC   CVCL_B9AQ
SY   Human PRKCB knockout MCF7
DR   Abcam; ab287716
DR   cancercelllines; CVCL_B9AQ
DR   Wikidata; Q112928673
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9395; PRKCB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PROCR KO
AC   CVCL_B9AR
SY   Human PROCR knockout MCF7
DR   Abcam; ab287719
DR   cancercelllines; CVCL_B9AR
DR   Wikidata; Q112928674
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9452; PROCR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PROX1 KO
AC   CVCL_B9AS
SY   Human PROX1 knockout MCF7
DR   Abcam; ab287722
DR   cancercelllines; CVCL_B9AS
DR   Wikidata; Q112928675
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9459; PROX1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PTEN KO
AC   CVCL_B9AT
SY   Human PTEN knockout MCF7
DR   Abcam; ab280820
DR   cancercelllines; CVCL_B9AT
DR   Wikidata; Q112928676
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PTGS1 KO
AC   CVCL_B9AU
SY   Human PTGS1 knockout MCF7
DR   Abcam; ab287726
DR   cancercelllines; CVCL_B9AU
DR   Wikidata; Q112928677
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9604; PTGS1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PTN KO
AC   CVCL_D2H3
SY   Human PTN knockout MCF7
DR   Abcam; ab289447
DR   Wikidata; Q127379691
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9630; PTN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PTPN1 KO
AC   CVCL_D2H4
SY   Human PTPN1 knockout MCF7
DR   Abcam; ab289302
DR   Wikidata; Q127379692
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 PTPN2 KO
AC   CVCL_B9AV
SY   Human PTPN2 knockout MCF7
DR   Abcam; ab287728
DR   cancercelllines; CVCL_B9AV
DR   Wikidata; Q112928678
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 PTPN6 KO
AC   CVCL_B9AW
SY   Human PTPN6 knockout MCF7
DR   Abcam; ab287732
DR   cancercelllines; CVCL_B9AW
DR   Wikidata; Q112928679
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RAD50 KO
AC   CVCL_B9AX
SY   Human RAD50 knockout MCF7
DR   Abcam; ab286448
DR   cancercelllines; CVCL_B9AX
DR   Wikidata; Q112928680
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9816; RAD50.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RAD51D KO
AC   CVCL_B9AY
SY   Human RAD51D knockout MCF7
DR   Abcam; ab286287
DR   cancercelllines; CVCL_B9AY
DR   Wikidata; Q112928681
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RAET1E KO
AC   CVCL_D2H5
SY   Human RAET1E knockout MCF7
DR   Abcam; ab289496
DR   Wikidata; Q127379693
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16793; RAET1E.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 RAF1 KO
AC   CVCL_B9AZ
SY   Human RAF1 knockout MCF7
DR   Abcam; ab286427
DR   cancercelllines; CVCL_B9AZ
DR   Wikidata; Q112928682
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RARB KO
AC   CVCL_B9B0
SY   Human RARB knockout MCF7
DR   Abcam; ab287737
DR   cancercelllines; CVCL_B9B0
DR   Wikidata; Q112928683
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9865; RARB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RB1 KO
AC   CVCL_B9B1
SY   Human RB1 knockout MCF7
DR   Abcam; ab286277
DR   cancercelllines; CVCL_B9B1
DR   Wikidata; Q112928684
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 REL KO
AC   CVCL_B9B2
SY   Human REL knockout MCF7
DR   Abcam; ab286278
DR   cancercelllines; CVCL_B9B2
DR   Wikidata; Q112928685
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9954; REL.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RELA KO
AC   CVCL_B9B3
SY   Human RELA knockout MCF7
DR   Abcam; ab287740
DR   cancercelllines; CVCL_B9B3
DR   Wikidata; Q112928686
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 REST KO
AC   CVCL_B9B4
SY   Human REST knockout MCF7
DR   Abcam; ab287743
DR   cancercelllines; CVCL_B9B4
DR   Wikidata; Q112928688
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9966; REST.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RET KO
AC   CVCL_B9B5
SY   Human RET knockout MCF7
DR   Abcam; ab286279
DR   cancercelllines; CVCL_B9B5
DR   Wikidata; Q112928691
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RICTOR KO
AC   CVCL_B9B6
SY   Human RICTOR knockout MCF7
DR   Abcam; ab286429
DR   cancercelllines; CVCL_B9B6
DR   Wikidata; Q112928692
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RNF2 KO
AC   CVCL_B9B7
SY   Human RNF2 knockout MCF7
DR   Abcam; ab287746
DR   cancercelllines; CVCL_B9B7
DR   Wikidata; Q112928693
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ROS1 KO
AC   CVCL_B9B8
SY   Human ROS1 knockout MCF7
DR   Abcam; ab286376
DR   cancercelllines; CVCL_B9B8
DR   Wikidata; Q112928694
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10261; ROS1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RPS6KA1 KO
AC   CVCL_D2H6
SY   Human RPS6KA1 knockout MCF7
DR   Abcam; ab289311
DR   Wikidata; Q127379694
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10430; RPS6KA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 RPS6KA3 KO
AC   CVCL_B9B9
SY   Human RPS6KA3 knockout MCF7
DR   Abcam; ab287749
DR   cancercelllines; CVCL_B9B9
DR   Wikidata; Q112928695
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10432; RPS6KA3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RSF1 KO
AC   CVCL_B9BA
SY   Human RSF1 knockout MCF7
DR   Abcam; ab288210
DR   cancercelllines; CVCL_B9BA
DR   Wikidata; Q112928696
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18118; RSF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RSPO2 KO
AC   CVCL_B9BB
SY   Human RSPO2 knockout MCF7
DR   Abcam; ab286280
DR   cancercelllines; CVCL_B9BB
DR   Wikidata; Q112928697
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28583; RSPO2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RUNX1 KO
AC   CVCL_B9BC
SY   Human RUNX1 knockout MCF7
DR   Abcam; ab287752
DR   cancercelllines; CVCL_B9BC
DR   Wikidata; Q112928698
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 RUNX3 KO
AC   CVCL_D2H7
SY   Human RUNX3 knockout MCF7
DR   Abcam; ab289339
DR   Wikidata; Q127379695
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10473; RUNX3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 S100A8 KO
AC   CVCL_D2H8
SY   Human S100A8 knockout MCF7
DR   Abcam; ab289376
DR   Wikidata; Q127379696
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10498; S100A8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 SALL4 KO
AC   CVCL_B9BD
SY   Human SALL4 knockout MCF7
DR   Abcam; ab286542
DR   cancercelllines; CVCL_B9BD
DR   Wikidata; Q112928699
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15924; SALL4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SCARB2 KO
AC   CVCL_B9BE
SY   Human SCARB2 knockout MCF7
DR   Abcam; ab274952
DR   cancercelllines; CVCL_B9BE
DR   Wikidata; Q112928700
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1665; SCARB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SETD7 KO
AC   CVCL_B9BF
SY   Human SETD7 knockout MCF7
DR   Abcam; ab287755
DR   cancercelllines; CVCL_B9BF
DR   Wikidata; Q112928701
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30412; SETD7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SIRPA KO
AC   CVCL_B9BG
SY   Human SIRPA knockout MCF7
DR   Abcam; ab287758
DR   cancercelllines; CVCL_B9BG
DR   Wikidata; Q112928702
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9662; SIRPA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SIRT1 KO
AC   CVCL_B9BH
SY   Human SIRT1 knockout MCF7
DR   Abcam; ab287761
DR   cancercelllines; CVCL_B9BH
DR   Wikidata; Q112928703
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SIRT2 KO
AC   CVCL_D2H9
SY   Human SIRT2 knockout MCF7
DR   Abcam; ab289308
DR   Wikidata; Q127379697
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 SIRT6 KO
AC   CVCL_D2HA
SY   Human SIRT6 knockout MCF7
DR   Abcam; ab289360
DR   Wikidata; Q127379698
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 SMAD2 KO
AC   CVCL_B9BI
SY   Human smad2 knockout MCF7
DR   Abcam; ab286622
DR   cancercelllines; CVCL_B9BI
DR   Wikidata; Q112928704
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SMAD3 KO
AC   CVCL_B9BJ
SY   Human SMAD3 knockout MCF7
DR   Abcam; ab286623
DR   cancercelllines; CVCL_B9BJ
DR   Wikidata; Q112928705
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SMAD4 KO
AC   CVCL_B9BK
SY   Human SMAD4 knockout MCF7
DR   Abcam; ab286624
DR   cancercelllines; CVCL_B9BK
DR   Wikidata; Q112928706
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SMARCA1 KO
AC   CVCL_B9BL
SY   Human SMARCA1 knockout MCF7
DR   Abcam; ab288211
DR   cancercelllines; CVCL_B9BL
DR   Wikidata; Q112928707
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11097; SMARCA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SMARCA4 KO
AC   CVCL_B9BM
SY   Human SMARCA4 (BRG1) knockout MCF7
DR   Abcam; ab282647
DR   cancercelllines; CVCL_B9BM
DR   Wikidata; Q112928708
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SMARCC1 KO
AC   CVCL_B9BN
SY   Human SMARCC1 knockout MCF7
DR   Abcam; ab287764
DR   cancercelllines; CVCL_B9BN
DR   Wikidata; Q112928709
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SMARCD3 KO
AC   CVCL_B9BP
SY   Human SMARCD3 knockout MCF7
DR   Abcam; ab288212
DR   cancercelllines; CVCL_B9BP
DR   Wikidata; Q112928710
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11108; SMARCD3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SOS1 KO
AC   CVCL_B9BQ
SY   Human SOS1 knockout MCF7
DR   Abcam; ab286568
DR   cancercelllines; CVCL_B9BQ
DR   Wikidata; Q112928711
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SOX2 KO
AC   CVCL_B9BR
SY   Human SOX2 knockout MCF7
DR   Abcam; ab287768
DR   cancercelllines; CVCL_B9BR
DR   Wikidata; Q112928712
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11195; SOX2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SP1 KO
AC   CVCL_B9BS
SY   Human SP1 knockout MCF7
DR   Abcam; ab287770
DR   cancercelllines; CVCL_B9BS
DR   Wikidata; Q112928713
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SPI1 KO
AC   CVCL_D2HB
SY   Human SPI1 knockout MCF7
DR   Abcam; ab289340
DR   Wikidata; Q127379699
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11241; SPI1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 SPN KO
AC   CVCL_B9BT
SY   Human SPN knockout MCF7
DR   Abcam; ab287773
DR   cancercelllines; CVCL_B9BT
DR   Wikidata; Q112928714
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11249; SPN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SPP1 KO
AC   CVCL_B9BU
SY   Human SPP1 knockout MCF7
DR   Abcam; ab287776
DR   cancercelllines; CVCL_B9BU
DR   Wikidata; Q112928715
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SRC KO
AC   CVCL_B9BV
SY   Human SRC knockout MCF7
DR   Abcam; ab286521
DR   cancercelllines; CVCL_B9BV
DR   Wikidata; Q112928716
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SS18 KO
AC   CVCL_B9BW
SY   Human SS18 knockout MCF7
DR   Abcam; ab287779
DR   cancercelllines; CVCL_B9BW
DR   Wikidata; Q112928717
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 STAG2 KO
AC   CVCL_B9BX
SY   Human STAG2 knockout MCF7
DR   Abcam; ab287782
DR   cancercelllines; CVCL_B9BX
DR   Wikidata; Q112928718
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 STAT1 KO
AC   CVCL_B9BY
SY   Human STAT1 knockout MCF7
DR   Abcam; ab277900
DR   cancercelllines; CVCL_B9BY
DR   Wikidata; Q112928719
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 STAT3 KO
AC   CVCL_B9BZ
SY   Human STAT3 knockout MCF7
DR   Abcam; ab287786
DR   cancercelllines; CVCL_B9BZ
DR   Wikidata; Q112928720
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 STAT5B KO
AC   CVCL_D2HC
SY   Human STAT5B knockout MCF7
DR   Abcam; ab289318
DR   Wikidata; Q127379700
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 STAT6 KO
AC   CVCL_B9C0
SY   Human STAT6 knockout MCF7
DR   Abcam; ab286340
DR   cancercelllines; CVCL_B9C0
DR   Wikidata; Q112928721
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 STING1 KO
AC   CVCL_B9C1
SY   Human TMEM173 knockout MCF7
DR   Abcam; ab286439
DR   cancercelllines; CVCL_B9C1
DR   Wikidata; Q112928722
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 STK11 KO
AC   CVCL_B9C2
SY   Human STK11 knockout MCF7
DR   Abcam; ab286435
DR   cancercelllines; CVCL_B9C2
DR   Wikidata; Q112928723
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 SUFU KO
AC   CVCL_B9C3
SY   Human sufU knockout MCF7
DR   Abcam; ab286436
DR   cancercelllines; CVCL_B9C3
DR   Wikidata; Q112928724
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TACSTD2 KO
AC   CVCL_B9C4
SY   Human TACSTD2 knockout MCF7
DR   Abcam; ab286330
DR   cancercelllines; CVCL_B9C4
DR   Wikidata; Q112928725
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TAFFAZIN KO
AC   CVCL_B9C5
SY   Human TAZ knockout MCF7
DR   Abcam; ab286449
DR   cancercelllines; CVCL_B9C5
DR   Wikidata; Q112928726
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TDO2 KO
AC   CVCL_D2HD
SY   Human TDO2 knockout MCF7
DR   Abcam; ab289313
DR   Wikidata; Q127379701
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11708; TDO2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TET2 KO
AC   CVCL_B9C6
SY   Human TET2 knockout MCF7
DR   Abcam; ab286311
DR   cancercelllines; CVCL_B9C6
DR   Wikidata; Q112928727
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TFF3 KO
AC   CVCL_B9C7
SY   Human TFF3 knockout MCF7
DR   Abcam; ab274936
DR   cancercelllines; CVCL_B9C7
DR   Wikidata; Q112928728
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11757; TFF3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TGFB1 KO
AC   CVCL_B9C8
SY   Human TGFB1 knockout MCF7
DR   Abcam; ab286437
DR   cancercelllines; CVCL_B9C8
DR   Wikidata; Q112928730
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TGFBR2 KO
AC   CVCL_B9C9
SY   Human TGFBR2 knockout MCF7
DR   Abcam; ab286628
DR   cancercelllines; CVCL_B9C9
DR   Wikidata; Q112928731
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TIA1 KO
AC   CVCL_D2HE
SY   Human TIA1 knockout MCF7
DR   Abcam; ab289388
DR   Wikidata; Q127379702
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TLE1 KO
AC   CVCL_B0ZZ
SY   Human TLE1 knockout MCF7
DR   Abcam; ab269498
DR   cancercelllines; CVCL_B0ZZ
DR   Wikidata; Q110432507
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TNFRSF17 KO
AC   CVCL_D2HF
SY   Human TNFRSF17 knockout MCF7
DR   Abcam; ab289350
DR   Wikidata; Q127379703
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11913; TNFRSF17.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TNFRSF18 KO
AC   CVCL_D2HG
SY   Human TNFRSF18 knockout MCF7
DR   Abcam; ab289504
DR   Wikidata; Q127379704
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11914; TNFRSF18.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TNFRSF4 KO
AC   CVCL_D2HH
SY   Human TNFRSF4 knockout MCF7
DR   Abcam; ab289438
DR   Wikidata; Q127379705
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11918; TNFRSF4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TNFRSF8 KO
AC   CVCL_D2HI
SY   Human TNFRSF8 knockout MCF7
DR   Abcam; ab289287
DR   Wikidata; Q127379706
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11923; TNFRSF8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TNFRSF9 KO
AC   CVCL_D2HJ
SY   Human TNFRSF9 knockout MCF7
DR   Abcam; ab289380
DR   Wikidata; Q127379707
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11924; TNFRSF9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TNFSF11 KO
AC   CVCL_B9CA
SY   Human TNFSF11 knockout MCF7
DR   Abcam; ab286288
DR   cancercelllines; CVCL_B9CA
DR   Wikidata; Q112928732
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11926; TNFSF11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TP53 KO
AC   CVCL_B9CB
SY   Human TP53 knockout MCF7
DR   Abcam; ab286440
DR   cancercelllines; CVCL_B9CB
DR   Wikidata; Q112928733
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TP63 KO
AC   CVCL_B9CC
SY   Human TP63 knockout MCF7
DR   Abcam; ab286331
DR   cancercelllines; CVCL_B9CC
DR   Wikidata; Q112928734
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15979; TP63.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TPBG KO
AC   CVCL_B1A0
SY   Human TPBG knockout MCF7
DR   Abcam; ab269499
DR   cancercelllines; CVCL_B1A0
DR   Wikidata; Q110432508
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12004; TPBG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TRAF1 KO
AC   CVCL_D2HK
SY   Human TRAF1 knockout MCF7
DR   Abcam; ab289429
DR   Wikidata; Q127379709
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12031; TRAF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 TSC1 KO
AC   CVCL_B9CD
SY   Human TSC1 knockout MCF7
DR   Abcam; ab286332
DR   cancercelllines; CVCL_B9CD
DR   Wikidata; Q112928735
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 TSC2 KO
AC   CVCL_B9CE
SY   Human TSC2 knockout MCF7
DR   Abcam; ab286525
DR   cancercelllines; CVCL_B9CE
DR   Wikidata; Q112928736
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 UBB KO
AC   CVCL_D2HL
SY   Human UBB knockout MCF7
DR   Abcam; ab289508
DR   Wikidata; Q127379710
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12463; UBB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 USP8 KO
AC   CVCL_B9CF
SY   Human USP8 knockout MCF7
DR   Abcam; ab286441
DR   cancercelllines; CVCL_B9CF
DR   Wikidata; Q112928737
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 VDR KO
AC   CVCL_D2HM
SY   Human VDR knockout MCF7
DR   Abcam; ab289421
DR   Wikidata; Q127379711
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 VEGFA KO
AC   CVCL_D2HN
SY   Human VEGFA knockout MCF7
DR   Abcam; ab289521
DR   Wikidata; Q127379712
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 WRN KO
AC   CVCL_B9CG
SY   Human WRN knockout MCF7
DR   Abcam; ab286503
DR   cancercelllines; CVCL_B9CG
DR   Wikidata; Q112928738
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12791; WRN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 WT1 KO
AC   CVCL_D2HP
SY   Human WT1 knockout MCF7
DR   Abcam; ab289523
DR   Wikidata; Q127379714
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 WWTR1 KO
AC   CVCL_B9CH
SY   Human WWTR1 knockout MCF7
DR   Abcam; ab286442
DR   cancercelllines; CVCL_B9CH
DR   Wikidata; Q112928739
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 XPC KO
AC   CVCL_B9CI
SY   Human XPC knockout MCF7
DR   Abcam; ab286283
DR   cancercelllines; CVCL_B9CI
DR   Wikidata; Q112928740
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12816; XPC.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 XPO1 KO
AC   CVCL_D1UY
SY   Human xpo1 knockout MCF7
DR   Abcam; ab289511
DR   Wikidata; Q127379715
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12825; XPO1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam MCF-7 YAP1 KO
AC   CVCL_B9CJ
SY   Human YAP1 knockout MCF7
DR   Abcam; ab277861
DR   cancercelllines; CVCL_B9CJ
DR   Wikidata; Q112928741
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ZBTB16 KO
AC   CVCL_B9CK
SY   Human ZBTB16 knockout MCF7
DR   Abcam; ab286304
DR   cancercelllines; CVCL_B9CK
DR   Wikidata; Q112928742
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12930; ZBTB16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam MCF-7 ZEB1 KO
AC   CVCL_B9CL
SY   Human ZEB1 knockout MCF7
DR   Abcam; ab286292
DR   cancercelllines; CVCL_B9CL
DR   Wikidata; Q112928743
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam Neuro-2a Arc KO
AC   CVCL_B7VJ
SY   Mouse ARC knockout Neuro-2a
DR   Abcam; ab280071
DR   Wikidata; Q112928744
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88067; Arc.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 5
//
ID   Abcam PC-3 AATF KO
AC   CVCL_C6Y9
SY   Human AATF knockout PC-3
DR   Abcam; ab290578
DR   Wikidata; Q123030443
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19235; AATF.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ABCB1 KO
AC   CVCL_C6YA
SY   Human ABCB1 knockout PC-3
DR   Abcam; ab290607
DR   Wikidata; Q123030444
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ABL1 KO
AC   CVCL_C6YB
SY   Human ABL1 knockout PC-3
DR   Abcam; ab290494
DR   Wikidata; Q123030445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ADGRG1 KO
AC   CVCL_C6YC
SY   Human ADGRG1 knockout PC-3
DR   Abcam; ab290589
DR   Wikidata; Q123030446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4512; ADGRG1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 AGTR1 KO
AC   CVCL_C6YD
SY   Human AGTR1 knockout PC-3
DR   Abcam; ab290616
DR   Wikidata; Q123030447
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:336; AGTR1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 AHR KO
AC   CVCL_C6YE
SY   Human AHR knockout PC-3
DR   Abcam; ab290608
DR   Wikidata; Q123030448
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 AIM2 KO
AC   CVCL_C6YF
SY   Human AIM2 knockout PC-3
DR   Abcam; ab290617
DR   Wikidata; Q123030449
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:357; AIM2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ALCAM KO
AC   CVCL_C6YG
SY   Human ALCAM knockout PC-3
DR   Abcam; ab290485
DR   Wikidata; Q123030450
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:400; ALCAM.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ALKBH1 KO
AC   CVCL_C6YH
SY   Human ALKBH1 knockout PC-3
DR   Abcam; ab290603
DR   Wikidata; Q123030452
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17911; ALKBH1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ALYREF KO
AC   CVCL_C6YI
SY   Human ALYREF knockout PC-3
DR   Abcam; ab290570
DR   Wikidata; Q123030453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19071; ALYREF.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 APOBEC3B KO
AC   CVCL_C6YJ
SY   Human APOBEC3B knockout PC-3
DR   Abcam; ab290565
DR   Wikidata; Q123030454
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17352; APOBEC3B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ASAH1 KO
AC   CVCL_C6YK
SY   Human ASAH1 knockout PC-3
DR   Abcam; ab290554
DR   Wikidata; Q123030455
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:735; ASAH1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ATF5 KO
AC   CVCL_C6YL
SY   Human ATF5 knockout PC-3
DR   Abcam; ab290592
DR   Wikidata; Q123030457
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ATG3 KO
AC   CVCL_C6YM
SY   Human ATG3 knockout PC-3
DR   Abcam; ab290566
DR   Wikidata; Q123030458
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ATG9A KO
AC   CVCL_C6YN
SY   Human ATG9A knockout PC-3
DR   Abcam; ab290489
DR   Wikidata; Q123030459
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BAK1 KO
AC   CVCL_C6YP
SY   Human BAK1 knockout PC-3
DR   Abcam; ab290528
DR   Wikidata; Q123030460
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BMPR2 KO
AC   CVCL_C6YQ
SY   Human BMPR2 knockout PC-3
DR   Abcam; ab290618
DR   Wikidata; Q123030461
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BRD1 KO
AC   CVCL_C6YR
SY   Human BRD1 knockout PC-3
DR   Abcam; ab290600
DR   Wikidata; Q123030462
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BRD2 KO
AC   CVCL_C6YS
SY   Human BRD2 knockout PC-3
DR   Abcam; ab290548
DR   Wikidata; Q123030463
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BRD9 KO
AC   CVCL_C6YT
SY   Human BRD9 knockout PC-3
DR   Abcam; ab290572
DR   Wikidata; Q123030464
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BTG1 KO
AC   CVCL_C6YU
SY   Human BTG1 knockout PC-3
DR   Abcam; ab290581
DR   Wikidata; Q123030465
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1130; BTG1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BTK KO
AC   CVCL_C6YV
SY   Human BTK knockout PC-3
DR   Abcam; ab290466
DR   Wikidata; Q123030466
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1133; BTK.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 BTRC KO
AC   CVCL_C6YW
SY   Human BTRC knockout PC-3
DR   Abcam; ab290557
DR   Wikidata; Q123030467
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 C3 KO
AC   CVCL_C6YX
SY   Human C3 knockout PC-3
DR   Abcam; ab290619
DR   Wikidata; Q123030468
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1318; C3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CASP3 KO
AC   CVCL_C6YY
SY   Human CASP3 knockout PC-3
DR   Abcam; ab290463
DR   Wikidata; Q123030469
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CCRL2 KO
AC   CVCL_C6YZ
SY   Human CCRL2 knockout PC-3
DR   Abcam; ab290509
DR   Wikidata; Q123030470
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1612; CCRL2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CD36 KO
AC   CVCL_C6Z0
SY   Human CD36 knockout PC-3
DR   Abcam; ab290609
DR   Wikidata; Q123030471
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1663; CD36.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CD58 KO
AC   CVCL_C6Z1
SY   Human CD58 knockout PC-3
DR   Abcam; ab290588
DR   Wikidata; Q123030472
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1688; CD58.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CD59 KO
AC   CVCL_C6Z2
SY   Human CD59 knockout PC-3
DR   Abcam; ab290620
DR   Wikidata; Q123030473
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1689; CD59.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CD81 KO
AC   CVCL_C6Z3
SY   Human CD81 knockout PC-3
DR   Abcam; ab290621
DR   Wikidata; Q123030474
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CITED2 KO
AC   CVCL_C6Z4
SY   Human CITED2 knockout PC-3
DR   Abcam; ab290521
DR   Wikidata; Q123030475
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1987; CITED2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CLU KO
AC   CVCL_C6Z5
SY   Human CLU knockout PC-3
DR   Abcam; ab290610
DR   Wikidata; Q123030476
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2095; CLU.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CMKLR1 KO
AC   CVCL_C6Z6
SY   Human CMKLR1 knockout PC-3
DR   Abcam; ab290504
DR   Wikidata; Q123030477
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2121; CMKLR1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CMTM6 KO
AC   CVCL_C6Z7
SY   Human CMTM6 knockout PC-3
DR   Abcam; ab290597
DR   Wikidata; Q123030478
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CNR2 KO
AC   CVCL_C6Z8
SY   Human CNR2 knockout PC-3
DR   Abcam; ab290622
DR   Wikidata; Q123030480
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2160; CNR2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CST3 KO
AC   CVCL_C6Z9
SY   Human CST3 knockout PC-3
DR   Abcam; ab290623
DR   Wikidata; Q123030482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2475; CST3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CTSB KO
AC   CVCL_C6ZA
SY   Human CTSB knockout PC-3
DR   Abcam; ab290624
DR   Wikidata; Q123030483
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CUL2 KO
AC   CVCL_C6ZB
SY   Human CUL2 knockout PC-3
DR   Abcam; ab290562
DR   Wikidata; Q123030484
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2552; CUL2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CUL3 KO
AC   CVCL_C6ZC
SY   Human CUL3 knockout PC-3
DR   Abcam; ab290502
DR   Wikidata; Q123030485
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2553; CUL3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CUL4B KO
AC   CVCL_C6ZD
SY   Human CUL4B knockout PC-3
DR   Abcam; ab290514
DR   Wikidata; Q123030486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2555; CUL4B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 CXCL8 KO
AC   CVCL_B0ZD
SY   Human CXCL8 knockout PC-3
DR   Abcam; ab273743
DR   cancercelllines; CVCL_B0ZD
DR   Wikidata; Q110432509
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6025; CXCL8.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam PC-3 CXXC1 KO
AC   CVCL_C6ZE
SY   Human CXXC1 knockout PC-3
DR   Abcam; ab290577
DR   Wikidata; Q123030487
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24343; CXXC1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 DCP2 KO
AC   CVCL_C6ZF
SY   Human DCP2 knockout PC-3
DR   Abcam; ab290599
DR   Wikidata; Q123030488
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24452; DCP2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 DLL1 KO
AC   CVCL_C6ZG
SY   Human DLL1 knockout PC-3
DR   Abcam; ab290474
DR   Wikidata; Q123030489
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2908; DLL1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 DVL3 KO
AC   CVCL_C6ZH
SY   Human DVL3 knockout PC-3
DR   Abcam; ab290517
DR   Wikidata; Q123030490
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3087; DVL3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 EGLN1 KO
AC   CVCL_C6ZI
SY   Human EGLN1 knockout PC-3
DR   Abcam; ab290481
DR   Wikidata; Q123030491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1232; EGLN1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 EHMT2 KO
AC   CVCL_C6ZJ
SY   Human EHMT2 knockout PC-3
DR   Abcam; ab290526
DR   Wikidata; Q123030492
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 EIF2AK4 KO
AC   CVCL_C6ZK
SY   Human EIF2AK4 knockout PC-3
DR   Abcam; ab290551
DR   Wikidata; Q123030493
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ENG KO
AC   CVCL_C6ZL
SY   Human ENG knockout PC-3
DR   Abcam; ab290553
DR   Wikidata; Q123030494
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3349; ENG.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 EPHB4 KO
AC   CVCL_C6ZM
SY   Human EPHB4 knockout PC-3
DR   Abcam; ab290560
DR   Wikidata; Q123030496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ERAP1 KO
AC   CVCL_C6ZN
SY   Human ERAP1 knockout PC-3
DR   Abcam; ab290593
DR   Wikidata; Q123030497
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ETS2 KO
AC   CVCL_C6ZP
SY   Human ETS2 knockout PC-3
DR   Abcam; ab290576
DR   Wikidata; Q123030498
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3489; ETS2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 EXO1 KO
AC   CVCL_C6ZQ
SY   Human EXO1 knockout PC-3
DR   Abcam; ab290500
DR   Wikidata; Q123030499
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3511; EXO1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FABP4 KO
AC   CVCL_C6ZR
SY   Human FABP4 knockout PC-3
DR   Abcam; ab290611
DR   Wikidata; Q123030500
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3559; FABP4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FGF23 KO
AC   CVCL_C6ZS
SY   Human FGF23 knockout PC-3
DR   Abcam; ab290475
DR   Wikidata; Q123030501
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3680; FGF23.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FKBP5 KO
AC   CVCL_C6ZT
SY   Human FKBP5 knockout PC-3
DR   Abcam; ab290625
DR   Wikidata; Q123030502
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3721; FKBP5.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FOXO1 KO
AC   CVCL_C6ZU
SY   Human FOXO1 knockout PC-3
DR   Abcam; ab290461
DR   Wikidata; Q123030503
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3819; FOXO1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FOXO3 KO
AC   CVCL_C6ZV
SY   Human FOXO3 knockout PC-3
DR   Abcam; ab290534
DR   Wikidata; Q123030504
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FST KO
AC   CVCL_C6ZW
SY   Human FST knockout PC-3
DR   Abcam; ab290486
DR   Wikidata; Q123030505
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3971; FST.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FTL KO
AC   CVCL_C6ZX
SY   Human FTL knockout PC-3
DR   Abcam; ab290535
DR   Wikidata; Q123030506
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 FZD7 KO
AC   CVCL_C6ZY
SY   Human FZD7 knockout PC-3
DR   Abcam; ab290516
DR   Wikidata; Q123030507
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 GAB1 KO
AC   CVCL_C6ZZ
SY   Human GAB1 knockout PC-3
DR   Abcam; ab290550
DR   Wikidata; Q123030508
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4066; GAB1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 GLB1 KO
AC   CVCL_C7A0
SY   Human GLB1 knockout PC-3
DR   Abcam; ab290493
DR   Wikidata; Q123030509
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 GPR132 KO
AC   CVCL_C7A1
SY   Human GPR132 knockout PC-3
DR   Abcam; ab290519
DR   Wikidata; Q123030511
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17482; GPR132.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 GZMA KO
AC   CVCL_C7A2
SY   Human GZMA knockout PC-3
DR   Abcam; ab290511
DR   Wikidata; Q123030512
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4708; GZMA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 HNF1B KO
AC   CVCL_C7A3
SY   Human HNF1B knockout PC-3
DR   Abcam; ab290503
DR   Wikidata; Q123030513
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11630; HNF1B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 HSPG2 KO
AC   CVCL_C7A4
SY   Human HSPG2 knockout PC-3
DR   Abcam; ab290612
DR   Wikidata; Q123030514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ID2 KO
AC   CVCL_C7A5
SY   Human ID2 knockout PC-3
DR   Abcam; ab290476
DR   Wikidata; Q123030515
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5361; ID2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 IL17RB KO
AC   CVCL_C7A6
SY   Human IL17RB knockout PC-3
DR   Abcam; ab290492
DR   Wikidata; Q123030516
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18015; IL17RB.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ITPR3 KO
AC   CVCL_C7A7
SY   Human ITPR3 knockout PC-3
DR   Abcam; ab290490
DR   Wikidata; Q123030517
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 JAG1 KO
AC   CVCL_C7A8
SY   Human JAG1 knockout PC-3
DR   Abcam; ab290477
DR   Wikidata; Q123030520
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 JMJD6 KO
AC   CVCL_C7A9
SY   Human JMJD6 knockout PC-3
DR   Abcam; ab290559
DR   Wikidata; Q123030521
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 KAT7 KO
AC   CVCL_C7AA
SY   Human KAT7 knockout PC-3
DR   Abcam; ab290586
DR   Wikidata; Q123030522
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 KDM1B KO
AC   CVCL_C7AB
SY   Human KDM1B knockout PC-3
DR   Abcam; ab290595
DR   Wikidata; Q123030523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 KDM6B KO
AC   CVCL_C7AC
SY   Human KDM6B knockout PC-3
DR   Abcam; ab290505
DR   Wikidata; Q123030524
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 KPNA2 KO
AC   CVCL_C7AD
SY   Human KPNA2 knockout PC-3
DR   Abcam; ab290518
DR   Wikidata; Q123030525
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6395; KPNA2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 LAIR1 KO
AC   CVCL_C7AE
SY   Human LAIR1 knockout PC-3
DR   Abcam; ab290515
DR   Wikidata; Q123030526
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6477; LAIR1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 LAMP2 KO
AC   CVCL_C7AF
SY   Human LAMP2 knockout PC-3
DR   Abcam; ab290536
DR   Wikidata; Q123030527
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 LDHA KO
AC   CVCL_C7AG
SY   Human LDHA knockout PC-3
DR   Abcam; ab290473
DR   Wikidata; Q123030528
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 LGR6 KO
AC   CVCL_C7AH
SY   Human LGR6 knockout PC-3
DR   Abcam; ab290552
DR   Wikidata; Q123030529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19719; LGR6.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 LMNB1 KO
AC   CVCL_C7AI
SY   Human LMNB1 knockout PC-3
DR   Abcam; ab290530
DR   Wikidata; Q123030530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MAGEA3 KO
AC   CVCL_C7AJ
SY   Human MAGEA3 knockout PC-3
DR   Abcam; ab290598
DR   Wikidata; Q123030531
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6801; MAGEA3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MAP2K3 KO
AC   CVCL_C7AK
SY   Human MAP2K3 knockout PC-3
DR   Abcam; ab290561
DR   Wikidata; Q123030532
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MAP3K3 KO
AC   CVCL_C7AL
SY   Human MAP3K3 knockout PC-3
DR   Abcam; ab290539
DR   Wikidata; Q123030533
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6855; MAP3K3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MAPK7 KO
AC   CVCL_C7AM
SY   Human MAPK7 knockout PC-3
DR   Abcam; ab290527
DR   Wikidata; Q123030535
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MBD1 KO
AC   CVCL_C7AN
SY   Human MBD1 knockout PC-3
DR   Abcam; ab290590
DR   Wikidata; Q123030537
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MBD3 KO
AC   CVCL_C7AP
SY   Human MBD3 knockout PC-3
DR   Abcam; ab290582
DR   Wikidata; Q123030538
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6918; MBD3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MMP13 KO
AC   CVCL_C7AQ
SY   Human MMP13 knockout PC-3
DR   Abcam; ab290626
DR   Wikidata; Q123030539
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7159; MMP13.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MMP8 KO
AC   CVCL_C7AR
SY   Human MMP8 knockout PC-3
DR   Abcam; ab290520
DR   Wikidata; Q123030540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7175; MMP8.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 MTA3 KO
AC   CVCL_C7AS
SY   Human MTA3 knockout PC-3
DR   Abcam; ab290579
DR   Wikidata; Q123030541
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23784; MTA3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NBR1 KO
AC   CVCL_C7AT
SY   Human NBR1 knockout PC-3
DR   Abcam; ab290491
DR   Wikidata; Q123030542
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NCR3LG1 KO
AC   CVCL_C7AU
SY   Human NCR3LG1 knockout PC-3
DR   Abcam; ab290580
DR   Wikidata; Q123030543
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:42400; NCR3LG1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NFKB1 KO
AC   CVCL_C7AV
SY   Human NFKB1 knockout PC-3
DR   Abcam; ab290483
DR   Wikidata; Q123030544
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NLRC4 KO
AC   CVCL_C7AW
SY   Human NLRC4 knockout PC-3
DR   Abcam; ab290627
DR   Wikidata; Q123030545
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16412; NLRC4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NOTCH3 KO
AC   CVCL_C7AX
SY   Human NOTCH3 knockout PC-3
DR   Abcam; ab290482
DR   Wikidata; Q123030546
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NOTCH4 KO
AC   CVCL_C7AY
SY   Human NOTCH4 knockout PC-3
DR   Abcam; ab290510
DR   Wikidata; Q123030547
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7884; NOTCH4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NQO1 KO
AC   CVCL_C7AZ
SY   Human NQO1 knockout PC-3
DR   Abcam; ab290613
DR   Wikidata; Q123030548
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2874; NQO1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NR1H4 KO
AC   CVCL_C7B0
SY   Human NR1H4 knockout PC-3
DR   Abcam; ab290628
DR   Wikidata; Q123030549
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7967; NR1H4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 NR3C2 KO
AC   CVCL_C7B1
SY   Human NR3C2 knockout PC-3
DR   Abcam; ab290470
DR   Wikidata; Q123030550
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PDCD1LG2 KO
AC   CVCL_C7B2
SY   Human PDCD1LG2 knockout PC-3
DR   Abcam; ab290465
DR   Wikidata; Q123030551
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PHF8 KO
AC   CVCL_C7B3
SY   Human PHF8 knockout PC-3
DR   Abcam; ab290584
DR   Wikidata; Q123030552
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20672; PHF8.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PIK3CA KO
AC   CVCL_C7B4
SY   Human PIK3CA knockout PC-3
DR   Abcam; ab290472
DR   Wikidata; Q123030553
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PIK3CD KO
AC   CVCL_C7B5
SY   Human PIK3CD knockout PC-3
DR   Abcam; ab290525
DR   Wikidata; Q123030554
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PIK3R4 KO
AC   CVCL_C7B6
SY   Human PIK3R4 knockout PC-3
DR   Abcam; ab290542
DR   Wikidata; Q123030555
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8982; PIK3R4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PLA2G4A KO
AC   CVCL_C7B7
SY   Human PLA2G4A knockout PC-3
DR   Abcam; ab290538
DR   Wikidata; Q123030556
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PLAU KO
AC   CVCL_C7B8
SY   Human PLAU knockout PC-3
DR   Abcam; ab290629
DR   Wikidata; Q123030557
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9052; PLAU.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PLCB3 KO
AC   CVCL_C7B9
SY   Human PLCB3 knockout PC-3
DR   Abcam; ab290585
DR   Wikidata; Q123030558
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PLCG1 KO
AC   CVCL_C7BA
SY   Human PLCG1 knockout PC-3
DR   Abcam; ab290556
DR   Wikidata; Q123030560
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PRMT7 KO
AC   CVCL_C7BB
SY   Human PRMT7 knockout PC-3
DR   Abcam; ab290602
DR   Wikidata; Q123030561
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25557; PRMT7.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PSEN1 KO
AC   CVCL_C7BC
SY   Human PSEN1 knockout PC-3
DR   Abcam; ab290614
DR   Wikidata; Q123030563
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PTGER4 KO
AC   CVCL_C7BD
SY   Human PTGER4 knockout PC-3
DR   Abcam; ab290543
DR   Wikidata; Q123030564
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9596; PTGER4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PTGES2 KO
AC   CVCL_C7BE
SY   Human PTGES2 knockout PC-3
DR   Abcam; ab290513
DR   Wikidata; Q123030565
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17822; PTGES2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PTK2 KO
AC   CVCL_C7BF
SY   Human PTK2 knockout PC-3
DR   Abcam; ab290531
DR   Wikidata; Q123030566
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PTP4A3 KO
AC   CVCL_C7BG
SY   Human PTP4A3 knockout PC-3
DR   Abcam; ab290497
DR   Wikidata; Q123030567
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9636; PTP4A3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PTPN12 KO
AC   CVCL_C7BH
SY   Human PTPN12 knockout PC-3
DR   Abcam; ab290506
DR   Wikidata; Q123030568
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9645; PTPN12.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 PUS1 KO
AC   CVCL_C7BI
SY   Human PUS1 knockout PC-3
DR   Abcam; ab290604
DR   Wikidata; Q123030569
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15508; PUS1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 RAC2 KO
AC   CVCL_C7BJ
SY   Human RAC2 knockout PC-3
DR   Abcam; ab290480
DR   Wikidata; Q123030570
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9802; RAC2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 RING1 KO
AC   CVCL_C7BK
SY   Human RING1 knockout PC-3
DR   Abcam; ab290573
DR   Wikidata; Q123030571
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ROCK2 KO
AC   CVCL_C7BL
SY   Human ROCK2 knockout PC-3
DR   Abcam; ab290524
DR   Wikidata; Q123030572
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ROR2 KO
AC   CVCL_C7BM
SY   Human ROR2 knockout PC-3
DR   Abcam; ab290533
DR   Wikidata; Q123030573
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 RUNX2 KO
AC   CVCL_C7BN
SY   Human RUNX2 knockout PC-3
DR   Abcam; ab290469
DR   Wikidata; Q123030575
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10472; RUNX2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 RYBP KO
AC   CVCL_C7BP
SY   Human RYBP knockout PC-3
DR   Abcam; ab290583
DR   Wikidata; Q123030576
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10480; RYBP.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SCARB1 KO
AC   CVCL_C7BQ
SY   Human SCARB1 knockout PC-3
DR   Abcam; ab290537
DR   Wikidata; Q123030577
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1664; SCARB1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SDC4 KO
AC   CVCL_C7BR
SY   Human SDC4 knockout PC-3
DR   Abcam; ab290478
DR   Wikidata; Q123030579
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10661; SDC4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SETD2 KO
AC   CVCL_C7BS
SY   Human SETD2 knockout PC-3
DR   Abcam; ab290541
DR   Wikidata; Q123030580
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SLFN11 KO
AC   CVCL_C7BT
SY   Human SLFN11 knockout PC-3
DR   Abcam; ab290591
DR   Wikidata; Q123030581
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SMARCAL1 KO
AC   CVCL_C7BU
SY   Human SMARCAL1 knockout PC-3
DR   Abcam; ab290555
DR   Wikidata; Q123030582
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SMARCC2 KO
AC   CVCL_C7BV
SY   Human SMARCC2 knockout PC-3
DR   Abcam; ab290549
DR   Wikidata; Q123030584
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11105; SMARCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SMARCE1 KO
AC   CVCL_C7BW
SY   Human SMARCE1 knockout PC-3
DR   Abcam; ab290574
DR   Wikidata; Q123030585
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11109; SMARCE1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SMURF1 KO
AC   CVCL_C7BX
SY   Human SMURF1 knockout PC-3
DR   Abcam; ab290507
DR   Wikidata; Q123030586
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SMYD2 KO
AC   CVCL_C7BY
SY   Human SMYD2 knockout PC-3
DR   Abcam; ab290547
DR   Wikidata; Q123030587
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20982; SMYD2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SMYD3 KO
AC   CVCL_C7BZ
SY   Human SMYD3 knockout PC-3
DR   Abcam; ab290569
DR   Wikidata; Q123030588
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15513; SMYD3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SOCS3 KO
AC   CVCL_C7C0
SY   Human SOCS3 knockout PC-3
DR   Abcam; ab290630
DR   Wikidata; Q123030589
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SRF KO
AC   CVCL_C7C1
SY   Human SRF knockout PC-3
DR   Abcam; ab290501
DR   Wikidata; Q123030590
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11291; SRF.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SRPK1 KO
AC   CVCL_C7C2
SY   Human SRPK1 knockout PC-3
DR   Abcam; ab290568
DR   Wikidata; Q123030591
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 STAT4 KO
AC   CVCL_C7C3
SY   Human STAT4 knockout PC-3
DR   Abcam; ab290484
DR   Wikidata; Q123030592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11365; STAT4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 STAT5A KO
AC   CVCL_C7C4
SY   Human STAT5A knockout PC-3
DR   Abcam; ab290464
DR   Wikidata; Q123030593
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11366; STAT5A.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 STK4 KO
AC   CVCL_C7C5
SY   Human STK4 knockout PC-3
DR   Abcam; ab290540
DR   Wikidata; Q123030594
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SUV39H1 KO
AC   CVCL_C7C6
SY   Human SUV39H1 knockout PC-3
DR   Abcam; ab290512
DR   Wikidata; Q123030595
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 SUZ12 KO
AC   CVCL_C7C7
SY   Human SUZ12 knockout PC-3
DR   Abcam; ab290488
DR   Wikidata; Q123030596
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TAPBP KO
AC   CVCL_C7C8
SY   Human TAPBP knockout PC-3
DR   Abcam; ab290563
DR   Wikidata; Q123030597
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11566; TAPBP.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TBK1 KO
AC   CVCL_C7C9
SY   Human TBK1 knockout PC-3
DR   Abcam; ab290467
DR   Wikidata; Q123030598
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TBP KO
AC   CVCL_C7CA
SY   Human TBP knockout PC-3
DR   Abcam; ab290532
DR   Wikidata; Q123030599
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11588; TBP.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TCF7L2 KO
AC   CVCL_C7CB
SY   Human TCF7L2 knockout PC-3
DR   Abcam; ab290508
DR   Wikidata; Q123030600
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11641; TCF7L2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TFDP1 KO
AC   CVCL_C7CC
SY   Human TFDP1 knockout PC-3
DR   Abcam; ab290601
DR   Wikidata; Q123030601
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11749; TFDP1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 THBS1 KO
AC   CVCL_C7CD
SY   Human THBS1 knockout PC-3
DR   Abcam; ab290615
DR   Wikidata; Q123030602
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11785; THBS1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TIMP3 KO
AC   CVCL_C7CE
SY   Human TIMP3 knockout PC-3
DR   Abcam; ab290479
DR   Wikidata; Q123030603
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11822; TIMP3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TLN1 KO
AC   CVCL_C7CF
SY   Human TLN1 knockout PC-3
DR   Abcam; ab290495
DR   Wikidata; Q123030604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11845; TLN1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TNFRSF10B KO
AC   CVCL_C7CG
SY   Human TNFRSF10B knockout PC-3
DR   Abcam; ab290529
DR   Wikidata; Q123030606
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TNFRSF1B KO
AC   CVCL_C7CH
SY   Human TNFRSF1B knockout PC-3
DR   Abcam; ab290471
DR   Wikidata; Q123030607
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11917; TNFRSF1B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TP73 KO
AC   CVCL_C7CI
SY   Human TP73 knockout PC-3
DR   Abcam; ab290558
DR   Wikidata; Q123030608
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12003; TP73.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TRADD KO
AC   CVCL_C7CJ
SY   Human TRADD knockout PC-3
DR   Abcam; ab290496
DR   Wikidata; Q123030609
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12030; TRADD.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TRAF2 KO
AC   CVCL_C7CK
SY   Human TRAF2 knockout PC-3
DR   Abcam; ab290544
DR   Wikidata; Q123030610
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TRMT2A KO
AC   CVCL_C7CL
SY   Human TRMT2A knockout PC-3
DR   Abcam; ab290606
DR   Wikidata; Q123030611
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TWIST1 KO
AC   CVCL_C7CM
SY   Human TWIST1 knockout PC-3
DR   Abcam; ab290462
DR   Wikidata; Q123030612
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12428; TWIST1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 TWIST2 KO
AC   CVCL_C7CN
SY   Human TWIST2 knockout PC-3
DR   Abcam; ab290567
DR   Wikidata; Q123030613
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20670; TWIST2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 U2AF1 KO
AC   CVCL_C7CP
SY   Human U2AF1 knockout PC-3
DR   Abcam; ab290522
DR   Wikidata; Q123030614
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12453; U2AF1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 UBA1 KO
AC   CVCL_C7CQ
SY   Human UBA1 knockout PC-3
DR   Abcam; ab290546
DR   Wikidata; Q123030615
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12469; UBA1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 UBE2D2 KO
AC   CVCL_C7CR
SY   Human UBE2D2 knockout PC-3
DR   Abcam; ab290605
DR   Wikidata; Q123030616
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12475; UBE2D2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 UCHL5 KO
AC   CVCL_C7CS
SY   Human UCHL5 knockout PC-3
DR   Abcam; ab290575
DR   Wikidata; Q123030617
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19678; UCHL5.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ULBP2 KO
AC   CVCL_C7CT
SY   Human ULBP2 knockout PC-3
DR   Abcam; ab290545
DR   Wikidata; Q123030618
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14894; ULBP2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ULBP3 KO
AC   CVCL_C7CU
SY   Human ULBP3 knockout PC-3
DR   Abcam; ab290594
DR   Wikidata; Q123030619
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14895; ULBP3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 UVRAG KO
AC   CVCL_C7CV
SY   Human UVRAG knockout PC-3
DR   Abcam; ab290487
DR   Wikidata; Q123030620
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12640; UVRAG.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 VCAN KO
AC   CVCL_C7CW
SY   Human VCAN knockout PC-3
DR   Abcam; ab290499
DR   Wikidata; Q123030622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2464; VCAN.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 WDR77 KO
AC   CVCL_C7CX
SY   Human WDR77 knockout PC-3
DR   Abcam; ab290571
DR   Wikidata; Q123030623
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29652; WDR77.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 WNT11 KO
AC   CVCL_C7CY
SY   Human Wnt11 knockout PC-3
DR   Abcam; ab290523
DR   Wikidata; Q123030624
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12776; WNT11.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 YTHDC2 KO
AC   CVCL_C7CZ
SY   Human YTHDC2 knockout PC-3
DR   Abcam; ab290596
DR   Wikidata; Q123030625
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24721; YTHDC2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 YTHDF1 KO
AC   CVCL_C7D0
SY   Human YTHDF1 knockout PC-3
DR   Abcam; ab290564
DR   Wikidata; Q123030626
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 YTHDF3 KO
AC   CVCL_C7D1
SY   Human YTHDF3 knockout PC-3
DR   Abcam; ab290587
DR   Wikidata; Q123030627
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26465; YTHDF3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 YY1 KO
AC   CVCL_C7D2
SY   Human YY1 knockout PC-3
DR   Abcam; ab290498
DR   Wikidata; Q123030628
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12856; YY1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam PC-3 ZEB2 KO
AC   CVCL_C7D3
SY   Human ZEB2 knockout PC-3
DR   Abcam; ab290468
DR   Wikidata; Q123030629
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji AATF KO
AC   CVCL_B7VS
SY   Human AATF knockout Raji
DR   Abcam; ab290412
DR   cancercelllines; CVCL_B7VS
DR   Wikidata; Q112928745
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19235; AATF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ABCB1 KO
AC   CVCL_B7VT
SY   Human ABCB1 knockout Raji
DR   Abcam; ab290440
DR   cancercelllines; CVCL_B7VT
DR   Wikidata; Q112928746
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ABI1 KO
AC   CVCL_D2HQ
SY   Human ABI1 knockout Raji
DR   Abcam; ab301827
DR   Wikidata; Q127379716
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11320; ABI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ACAA1 KO
AC   CVCL_D2HR
SY   Human ACAA1 knockout Raji
DR   Abcam; ab301830
DR   Wikidata; Q127379717
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:82; ACAA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ACOT13 KO
AC   CVCL_D2HS
SY   Human ACOT13 knockout Raji
DR   Abcam; ab301835
DR   Wikidata; Q127379718
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20999; ACOT13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ACTR3 KO
AC   CVCL_D2HT
SY   Human ACTR3 knockout Raji
DR   Abcam; ab301838
DR   Wikidata; Q127379719
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:170; ACTR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ACVR2B KO
AC   CVCL_D2HU
SY   Human ACVR2B knockout Raji
DR   Abcam; ab301841
DR   Wikidata; Q127379720
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ACVRL1 KO
AC   CVCL_D2HV
SY   Human ACVRL1 knockout Raji
DR   Abcam; ab301844
DR   Wikidata; Q127379721
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:175; ACVRL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ACY1 KO
AC   CVCL_D2HW
SY   Human ACY1 knockout Raji
DR   Abcam; ab301847
DR   Wikidata; Q127379722
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:177; ACY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ADD1 KO
AC   CVCL_D2HX
SY   Human ADD1 knockout Raji
DR   Abcam; ab301850
DR   Wikidata; Q127379724
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:243; ADD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji AGTR1 KO
AC   CVCL_B7VU
SY   Human AGTR1 knockout Raji
DR   Abcam; ab290447
DR   cancercelllines; CVCL_B7VU
DR   Wikidata; Q112928748
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:336; AGTR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji AHCY KO
AC   CVCL_D2HY
SY   Human AHCY knockout Raji
DR   Abcam; ab301853
DR   Wikidata; Q127379725
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:343; AHCY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji AHR KO
AC   CVCL_B7VV
SY   Human AHR knockout Raji
DR   Abcam; ab290441
DR   cancercelllines; CVCL_B7VV
DR   Wikidata; Q112928749
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji AIM2 KO
AC   CVCL_B7VW
SY   Human AIM2 knockout Raji
DR   Abcam; ab290448
DR   cancercelllines; CVCL_B7VW
DR   Wikidata; Q112928750
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:357; AIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji AKR7A2 KO
AC   CVCL_D2HZ
SY   Human AKR7A2 knockout Raji
DR   Abcam; ab301856
DR   Wikidata; Q127379726
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:389; AKR7A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ALAD KO
AC   CVCL_D2I0
SY   Human ALAD knockout Raji
DR   Abcam; ab301859
DR   Wikidata; Q127379727
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:395; ALAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ALCAM KO
AC   CVCL_B7VX
SY   Human ALCAM knockout Raji
DR   Abcam; ab290319
DR   cancercelllines; CVCL_B7VX
DR   Wikidata; Q112928751
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:400; ALCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ALDH1A2 KO
AC   CVCL_D2I1
SY   Human ALDH1A2 knockout Raji
DR   Abcam; ab301862
DR   Wikidata; Q127379728
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15472; ALDH1A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ALDH4A1 KO
AC   CVCL_D2I2
SY   Human ALDH4A1 knockout Raji
DR   Abcam; ab301865
DR   Wikidata; Q127379729
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:406; ALDH4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ALDOB KO
AC   CVCL_D2I3
SY   Human ALDOB knockout Raji
DR   Abcam; ab301868
DR   Wikidata; Q127379730
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:417; ALDOB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ALKBH1 KO
AC   CVCL_B7VY
SY   Human ALKBH1 knockout Raji
DR   Abcam; ab290436
DR   cancercelllines; CVCL_B7VY
DR   Wikidata; Q112928752
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17911; ALKBH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ALOX5AP KO
AC   CVCL_D2I4
SY   Human ALOX5AP knockout Raji
DR   Abcam; ab301871
DR   Wikidata; Q127379731
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:436; ALOX5AP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ALYREF KO
AC   CVCL_B7VZ
SY   Human ALYREF knockout Raji
DR   Abcam; ab290404
DR   cancercelllines; CVCL_B7VZ
DR   Wikidata; Q112928753
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19071; ALYREF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji APOBEC3B KO
AC   CVCL_B7W0
SY   Human APOBEC3B knockout Raji
DR   Abcam; ab290399
DR   cancercelllines; CVCL_B7W0
DR   Wikidata; Q112928754
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17352; APOBEC3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ARSA KO
AC   CVCL_D2I5
SY   Human ARSA knockout Raji
DR   Abcam; ab301880
DR   Wikidata; Q127379732
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:713; ARSA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ASAH1 KO
AC   CVCL_B7W1
SY   Human ASAH1 knockout Raji
DR   Abcam; ab290387
DR   cancercelllines; CVCL_B7W1
DR   Wikidata; Q112928755
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:735; ASAH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ASL KO
AC   CVCL_D2I6
SY   Human ASL knockout Raji
DR   Abcam; ab301883
DR   Wikidata; Q127379733
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:746; ASL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ATF5 KO
AC   CVCL_B7W2
SY   Human ATF5 knockout Raji
DR   Abcam; ab290425
DR   cancercelllines; CVCL_B7W2
DR   Wikidata; Q112928756
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ATG3 KO
AC   CVCL_B7W3
SY   Human ATG3 knockout Raji
DR   Abcam; ab290400
DR   cancercelllines; CVCL_B7W3
DR   Wikidata; Q112928757
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ATG9A KO
AC   CVCL_B7W4
SY   Human ATG9A knockout Raji
DR   Abcam; ab290323
DR   cancercelllines; CVCL_B7W4
DR   Wikidata; Q112928758
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ATXN2 KO
AC   CVCL_D2I7
SY   Human ATXN2 knockout Raji
DR   Abcam; ab301886
DR   Wikidata; Q127379734
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10555; ATXN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji BAK1 KO
AC   CVCL_B7W5
SY   Human BAK1 knockout Raji
DR   Abcam; ab290363
DR   cancercelllines; CVCL_B7W5
DR   Wikidata; Q112928759
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji BAZ2A KO
AC   CVCL_D2I8
SY   Human BAZ2A knockout Raji
DR   Abcam; ab301889
DR   Wikidata; Q127379735
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:962; BAZ2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji BCAT1 KO
AC   CVCL_D2I9
SY   Human BCAT1 knockout Raji
DR   Abcam; ab301892
DR   Wikidata; Q127379736
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji BCAT2 KO
AC   CVCL_D2IA
SY   Human BCAT2 knockout Raji
DR   Abcam; ab301895
DR   Wikidata; Q127379737
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:977; BCAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji BMPR2 KO
AC   CVCL_B7W6
SY   Human BMPR2 knockout Raji
DR   Abcam; ab290449
DR   cancercelllines; CVCL_B7W6
DR   Wikidata; Q112928760
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji BRD1 KO
AC   CVCL_B7W7
SY   Human BRD1 knockout Raji
DR   Abcam; ab290433
DR   cancercelllines; CVCL_B7W7
DR   Wikidata; Q112928761
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji BRD2 KO
AC   CVCL_B7W8
SY   Human BRD2 knockout Raji
DR   Abcam; ab290382
DR   cancercelllines; CVCL_B7W8
DR   Wikidata; Q112928762
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji BRD9 KO
AC   CVCL_B7W9
SY   Human BRD9 knockout Raji
DR   Abcam; ab290406
DR   cancercelllines; CVCL_B7W9
DR   Wikidata; Q112928763
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji BRMS1 KO
AC   CVCL_D2IB
SY   Human BRMS1 knockout Raji
DR   Abcam; ab301901
DR   Wikidata; Q127379738
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17262; BRMS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji BTG1 KO
AC   CVCL_B7WA
SY   Human BTG1 knockout Raji
DR   Abcam; ab290415
DR   cancercelllines; CVCL_B7WA
DR   Wikidata; Q112928764
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1130; BTG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji BTK KO
AC   CVCL_B7WB
SY   Human BTK knockout Raji
DR   Abcam; ab290300
DR   cancercelllines; CVCL_B7WB
DR   Wikidata; Q112928765
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1133; BTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji BTLA KO
AC   CVCL_D2IC
SY   Human BTLA knockout Raji
DR   Abcam; ab301904
DR   Wikidata; Q127379739
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21087; BTLA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji BTRC KO
AC   CVCL_B7WC
SY   Human BTRC knockout Raji
DR   Abcam; ab290390
DR   cancercelllines; CVCL_B7WC
DR   Wikidata; Q112928766
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji C3 KO
AC   CVCL_B7WD
SY   Human C3 knockout Raji
DR   Abcam; ab290450
DR   cancercelllines; CVCL_B7WD
DR   Wikidata; Q112928767
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1318; C3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CA8 KO
AC   CVCL_D2ID
SY   Human CA8 knockout Raji
DR   Abcam; ab301907
DR   Wikidata; Q127379740
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1382; CA8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CALU KO
AC   CVCL_D2IE
SY   Human CALU knockout Raji
DR   Abcam; ab301910
DR   Wikidata; Q127379741
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1458; CALU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CAMK4 KO
AC   CVCL_D2IF
SY   Human CAMK4 knockout Raji
DR   Abcam; ab301913
DR   Wikidata; Q127379742
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1464; CAMK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CASP2 KO
AC   CVCL_D2IG
SY   Human CASP2 knockout Raji
DR   Abcam; ab301921
DR   Wikidata; Q127379743
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1503; CASP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CASP3 KO
AC   CVCL_B7WE
SY   Human CASP3 knockout Raji
DR   Abcam; ab290297
DR   cancercelllines; CVCL_B7WE
DR   Wikidata; Q112928768
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CBLC KO
AC   CVCL_D2IH
SY   Human CBLC knockout Raji
DR   Abcam; ab301924
DR   Wikidata; Q127379744
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15961; CBLC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CCL22 KO
AC   CVCL_B7WG
SY   Human CCl22 knockout Raji
DR   Abcam; ab290312
DR   cancercelllines; CVCL_B7WG
DR   Wikidata; Q112928770
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10621; CCL22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CCRL2 KO
AC   CVCL_B7WF
SY   Human CCRL2 knockout Raji
DR   Abcam; ab290342
DR   cancercelllines; CVCL_B7WF
DR   Wikidata; Q112928769
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1612; CCRL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CCS KO
AC   CVCL_D2II
SY   Human CCS knockout Raji
DR   Abcam; ab301927
DR   Wikidata; Q127379745
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1613; CCS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CD19 KO
AC   CVCL_E1GC
SY   Human CD19 knockout Raji
DR   Abcam; ab274913
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Raji CD22 KO
AC   CVCL_E1GD
SY   Human CD22 knockout Raji
DR   Abcam; ab277160
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1643; CD22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Raji CD27 KO
AC   CVCL_B1BK
SY   Human CD27A knockout Raji
DR   Abcam; ab274910
DR   cancercelllines; CVCL_B1BK
DR   Wikidata; Q110432511
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11922; CD27.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD36 KO
AC   CVCL_B7WH
SY   Human CD36 knockout Raji
DR   Abcam; ab290442
DR   cancercelllines; CVCL_B7WH
DR   Wikidata; Q112928771
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1663; CD36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD48 KO
AC   CVCL_B7WI
SY   Human CD48 knockout Raji
DR   Abcam; ab290355
DR   cancercelllines; CVCL_B7WI
DR   Wikidata; Q112928772
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1683; CD48.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD58 KO
AC   CVCL_B7WJ
SY   Human CD58 knockout Raji
DR   Abcam; ab290422
DR   cancercelllines; CVCL_B7WJ
DR   Wikidata; Q112928773
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1688; CD58.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD59 KO
AC   CVCL_B7WK
SY   Human CD59 knockout Raji
DR   Abcam; ab290451
DR   cancercelllines; CVCL_B7WK
DR   Wikidata; Q112928774
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1689; CD59.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD74 KO 1
AC   CVCL_B1BL
SY   Human CD74 knockout Raji
DR   Abcam; ab273378
DR   cancercelllines; CVCL_B1BL
DR   Wikidata; Q110432512
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD74 KO 2
AC   CVCL_B1BM
SY   Human CD74 knockout Raji
DR   Abcam; ab273876
DR   cancercelllines; CVCL_B1BM
DR   Wikidata; Q110432513
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD79A KO
AC   CVCL_B8AM
SY   Human CD791 knockout Raji
DR   Abcam; ab274911
DR   cancercelllines; CVCL_B8AM
DR   Wikidata; Q112928775
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1698; CD79A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD80 KO
AC   CVCL_B1BN
SY   Human CD80 knockout Raji
DR   Abcam; ab273873
DR   cancercelllines; CVCL_B1BN
DR   Wikidata; Q110432515
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1700; CD80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD81 KO
AC   CVCL_B7WL
SY   Human CD81 knockout Raji
DR   Abcam; ab290452
DR   cancercelllines; CVCL_B7WL
DR   Wikidata; Q112928776
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD83 KO
AC   CVCL_B7WM
SY   Human CD83 knockout Raji
DR   Abcam; ab277183
DR   cancercelllines; CVCL_B7WM
DR   Wikidata; Q112928777
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1703; CD83.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CD86 KO
AC   CVCL_B1BP
SY   Human CD86 knockout Raji
DR   Abcam; ab273858
DR   cancercelllines; CVCL_B1BP
DR   Wikidata; Q110432517
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1705; CD86.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CHP1 KO
AC   CVCL_D2IJ
SY   Human CHP1 knockout Raji
DR   Abcam; ab301933
DR   Wikidata; Q127379746
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17433; CHP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CITED2 KO
AC   CVCL_B7WN
SY   Human CITED2 knockout Raji
DR   Abcam; ab290356
DR   cancercelllines; CVCL_B7WN
DR   Wikidata; Q112928778
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1987; CITED2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CLASP1 KO
AC   CVCL_D2IK
SY   Human CLASP1 knockout Raji
DR   Abcam; ab301936
DR   Wikidata; Q127379747
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17088; CLASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CLPP KO
AC   CVCL_D2IL
SY   Human CLPP knockout Raji
DR   Abcam; ab301939
DR   Wikidata; Q127379748
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2084; CLPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CLU KO
AC   CVCL_B7WP
SY   Human CLU knockout Raji
DR   Abcam; ab290443
DR   cancercelllines; CVCL_B7WP
DR   Wikidata; Q112928779
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2095; CLU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CMAS KO
AC   CVCL_D2IM
SY   Human CMAS knockout Raji
DR   Abcam; ab301942
DR   Wikidata; Q127379749
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18290; CMAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CMKLR1 KO
AC   CVCL_B7WQ
SY   Human CMKLR1 knockout Raji
DR   Abcam; ab290337
DR   cancercelllines; CVCL_B7WQ
DR   Wikidata; Q112928780
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2121; CMKLR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CMTM6 KO
AC   CVCL_B7WR
SY   Human CMTM6 knockout Raji
DR   Abcam; ab290430
DR   cancercelllines; CVCL_B7WR
DR   Wikidata; Q112928781
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CNDP2 KO
AC   CVCL_D2IN
SY   Human CNDP2 knockout Raji
DR   Abcam; ab301945
DR   Wikidata; Q127379750
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24437; CNDP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CNR2 KO
AC   CVCL_B7WS
SY   Human CNR2 knockout Raji
DR   Abcam; ab290453
DR   cancercelllines; CVCL_B7WS
DR   Wikidata; Q112928782
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2160; CNR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CRYZ KO
AC   CVCL_D2IP
SY   Human CRYZ knockout Raji
DR   Abcam; ab301948
DR   Wikidata; Q127379751
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2419; CRYZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CST3 KO
AC   CVCL_B7WT
SY   Human CST3 knockout Raji
DR   Abcam; ab290454
DR   cancercelllines; CVCL_B7WT
DR   Wikidata; Q112928783
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2475; CST3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CTSB KO
AC   CVCL_B7WU
SY   Human CTSB knockout Raji
DR   Abcam; ab290455
DR   cancercelllines; CVCL_B7WU
DR   Wikidata; Q112928784
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CUL2 KO
AC   CVCL_B7WV
SY   Human CUL2 knockout Raji
DR   Abcam; ab290395
DR   cancercelllines; CVCL_B7WV
DR   Wikidata; Q112928785
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2552; CUL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CUL3 KO
AC   CVCL_B7WW
SY   Human CUL3 knockout Raji
DR   Abcam; ab290335
DR   cancercelllines; CVCL_B7WW
DR   Wikidata; Q112928786
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2553; CUL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CUL4B KO
AC   CVCL_B7WX
SY   Human CUL4B knockout Raji
DR   Abcam; ab290348
DR   cancercelllines; CVCL_B7WX
DR   Wikidata; Q112928787
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2555; CUL4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CXCR5 KO
AC   CVCL_B1BQ
SY   Human CXCR5 knockout Raji
DR   Abcam; ab273380
DR   cancercelllines; CVCL_B1BQ
DR   Wikidata; Q110432518
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1060; CXCR5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CXXC1 KO
AC   CVCL_B7WY
SY   Human CXXC1 knockout Raji
DR   Abcam; ab290411
DR   cancercelllines; CVCL_B7WY
DR   Wikidata; Q112928788
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24343; CXXC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji CYB5A KO
AC   CVCL_D2IQ
SY   Human CYB5A knockout Raji
DR   Abcam; ab301951
DR   Wikidata; Q127379752
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2570; CYB5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji CYB5R3 KO
AC   CVCL_D2IR
SY   Human CYB5R3 knockout Raji
DR   Abcam; ab301954
DR   Wikidata; Q127379753
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2873; CYB5R3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji DCP2 KO
AC   CVCL_B7WZ
SY   Human DCP2 knockout Raji
DR   Abcam; ab290432
DR   cancercelllines; CVCL_B7WZ
DR   Wikidata; Q112928789
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24452; DCP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji DFFB KO
AC   CVCL_D2IS
SY   Human DFFB knockout Raji
DR   Abcam; ab301960
DR   Wikidata; Q127379754
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2773; DFFB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji DGAT1 KO
AC   CVCL_D2IT
SY   Human DGAT1 knockout Raji
DR   Abcam; ab301963
DR   Wikidata; Q127379755
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2843; DGAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji DGKA KO
AC   CVCL_D2IU
SY   Human DGKA knockout Raji
DR   Abcam; ab301966
DR   Wikidata; Q127379756
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2849; DGKA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji DLL1 KO
AC   CVCL_B7X0
SY   Human DLL1 knockout Raji
DR   Abcam; ab290307
DR   cancercelllines; CVCL_B7X0
DR   Wikidata; Q112928790
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2908; DLL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji DNPEP KO
AC   CVCL_D2IV
SY   Human DNPEP knockout Raji
DR   Abcam; ab301969
DR   Wikidata; Q127379757
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2981; DNPEP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji DNTT KO
AC   CVCL_D2IW
SY   Human DNTT knockout Raji
DR   Abcam; ab301972
DR   Wikidata; Q127379758
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2983; DNTT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji DPP8 KO
AC   CVCL_D2IX
SY   Human DPP8 knockout Raji
DR   Abcam; ab301975
DR   Wikidata; Q127379759
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16490; DPP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji DVL3 KO
AC   CVCL_B7X1
SY   Human DVL3 knockout Raji
DR   Abcam; ab290351
DR   cancercelllines; CVCL_B7X1
DR   Wikidata; Q112928791
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3087; DVL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji EGLN1 KO
AC   CVCL_B7X2
SY   Human EGLN1 knockout Raji
DR   Abcam; ab290315
DR   cancercelllines; CVCL_B7X2
DR   Wikidata; Q112928792
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1232; EGLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji EHMT2 KO
AC   CVCL_B7X3
SY   Human EHMT2 knockout Raji
DR   Abcam; ab290361
DR   cancercelllines; CVCL_B7X3
DR   Wikidata; Q112928793
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji EIF2AK4 KO
AC   CVCL_B7X4
SY   Human EIF2AK4 knockout Raji
DR   Abcam; ab290385
DR   cancercelllines; CVCL_B7X4
DR   Wikidata; Q112928794
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji EPHB4 KO
AC   CVCL_B7X5
SY   Human EPHB4 knockout Raji
DR   Abcam; ab290393
DR   cancercelllines; CVCL_B7X5
DR   Wikidata; Q112928795
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji EPHX1 KO
AC   CVCL_D2IY
SY   Human EPHX1 knockout Raji
DR   Abcam; ab301984
DR   Wikidata; Q127379760
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3401; EPHX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji EPHX2 KO
AC   CVCL_D2IZ
SY   Human EPHX2 knockout Raji
DR   Abcam; ab301987
DR   Wikidata; Q127379761
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3402; EPHX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji EPN1 KO
AC   CVCL_D2J0
SY   Human EPN1 knockout Raji
DR   Abcam; ab301990
DR   Wikidata; Q127379763
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21604; EPN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ERAP1 KO
AC   CVCL_B7X6
SY   Human ERAP1 knockout Raji
DR   Abcam; ab290426
DR   cancercelllines; CVCL_B7X6
DR   Wikidata; Q112928796
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ETS2 KO
AC   CVCL_B7X7
SY   Human ETS2 knockout Raji
DR   Abcam; ab290410
DR   cancercelllines; CVCL_B7X7
DR   Wikidata; Q112928797
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3489; ETS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ETV4 KO
AC   CVCL_D2J1
SY   Human ETV4 knockout Raji
DR   Abcam; ab301993
DR   Wikidata; Q127379764
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3493; ETV4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji EXO1 KO
AC   CVCL_B7X8
SY   Human EXO1 knockout Raji
DR   Abcam; ab290333
DR   cancercelllines; CVCL_B7X8
DR   Wikidata; Q112928798
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3511; EXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji FABP4 KO
AC   CVCL_B7X9
SY   Human FABP4 knockout Raji
DR   Abcam; ab290444
DR   cancercelllines; CVCL_B7X9
DR   Wikidata; Q112928799
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3559; FABP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji FDX1 KO
AC   CVCL_D2J2
SY   Human FDX1 knockout Raji
DR   Abcam; ab301996
DR   Wikidata; Q127379765
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3638; FDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji FECH KO
AC   CVCL_D2J3
SY   Human FECH knockout Raji
DR   Abcam; ab301999
DR   Wikidata; Q127379766
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3647; FECH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji FKBP5 KO
AC   CVCL_B7XA
SY   Human FKBP5 knockout Raji
DR   Abcam; ab290456
DR   cancercelllines; CVCL_B7XA
DR   Wikidata; Q112928800
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3721; FKBP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji FOLR2 KO
AC   CVCL_D2J4
SY   Human FOLR2 knockout Raji
DR   Abcam; ab302002
DR   Wikidata; Q127379767
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3793; FOLR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji FOSB KO
AC   CVCL_D2J5
SY   Human FOSB knockout Raji
DR   Abcam; ab302005
DR   Wikidata; Q127379768
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3797; FOSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji FOXO1 KO
AC   CVCL_B7XB
SY   Human FOXO1 knockout Raji
DR   Abcam; ab290294
DR   cancercelllines; CVCL_B7XB
DR   Wikidata; Q112928801
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3819; FOXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji FOXO3 KO
AC   CVCL_B7XC
SY   Human FOXO3 knockout Raji
DR   Abcam; ab290369
DR   cancercelllines; CVCL_B7XC
DR   Wikidata; Q112928802
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji FPGS KO
AC   CVCL_D2J6
SY   Human FPGS knockout Raji
DR   Abcam; ab302008
DR   Wikidata; Q127379769
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3824; FPGS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji FRK KO
AC   CVCL_D2J7
SY   Human FRK knockout Raji
DR   Abcam; ab302011
DR   Wikidata; Q127379770
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3955; FRK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji FST KO
AC   CVCL_B7XD
SY   Human FST knockout Raji
DR   Abcam; ab290320
DR   cancercelllines; CVCL_B7XD
DR   Wikidata; Q112928803
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3971; FST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji FTL KO
AC   CVCL_B7XE
SY   Human FTL knockout Raji
DR   Abcam; ab290370
DR   cancercelllines; CVCL_B7XE
DR   Wikidata; Q112928804
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji FUBP1 KO
AC   CVCL_D2J8
SY   Human FUBP1 knockout Raji
DR   Abcam; ab302014
DR   Wikidata; Q127379771
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4004; FUBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji FZD7 KO
AC   CVCL_B7XF
SY   Human FZD7 knockout Raji
DR   Abcam; ab290350
DR   cancercelllines; CVCL_B7XF
DR   Wikidata; Q112928805
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji GAB1 KO
AC   CVCL_B7XG
SY   Human GAB1 knockout Raji
DR   Abcam; ab290384
DR   cancercelllines; CVCL_B7XG
DR   Wikidata; Q112928806
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4066; GAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji GAMT KO
AC   CVCL_D2J9
SY   Human GAMT knockout Raji
DR   Abcam; ab302017
DR   Wikidata; Q127379772
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4136; GAMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GANAB KO
AC   CVCL_D2JA
SY   Human GANAB knockout Raji
DR   Abcam; ab302020
DR   Wikidata; Q127379773
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4138; GANAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GART KO
AC   CVCL_D2JB
SY   Human GART knockout Raji
DR   Abcam; ab302023
DR   Wikidata; Q127379774
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4163; GART.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GCDH KO
AC   CVCL_D2JC
SY   Human GCDH knockout Raji
DR   Abcam; ab302026
DR   Wikidata; Q127379775
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4189; GCDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GGH KO
AC   CVCL_D2JD
SY   Human GGH knockout Raji
DR   Abcam; ab302029
DR   Wikidata; Q127379776
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4248; GGH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GLB1 KO
AC   CVCL_B7XH
SY   Human GLB1 knockout Raji
DR   Abcam; ab290327
DR   cancercelllines; CVCL_B7XH
DR   Wikidata; Q112928807
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji GLG1 KO
AC   CVCL_D2JE
SY   Human GLG1 knockout Raji
DR   Abcam; ab302032
DR   Wikidata; Q127379778
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4316; GLG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GLUL KO
AC   CVCL_D2JF
SY   Human GLUL knockout Raji
DR   Abcam; ab302035
DR   Wikidata; Q127379779
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GNE KO
AC   CVCL_D2JG
SY   Human GNE knockout Raji
DR   Abcam; ab302038
DR   Wikidata; Q127379780
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23657; GNE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GPR132 KO
AC   CVCL_B7XI
SY   Human GPR132 knockout Raji
DR   Abcam; ab290353
DR   cancercelllines; CVCL_B7XI
DR   Wikidata; Q112928808
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17482; GPR132.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji GRK3 KO
AC   CVCL_D2JH
SY   Human GRK3 knockout Raji
DR   Abcam; ab302041
DR   Wikidata; Q127379781
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GRK6 KO
AC   CVCL_D2JI
SY   Human GRK6 knockout Raji
DR   Abcam; ab302044
DR   Wikidata; Q127379782
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4545; GRK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GUSB KO
AC   CVCL_D2JJ
SY   Human GUSB knockout Raji
DR   Abcam; ab302047
DR   Wikidata; Q127379783
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4696; GUSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji GZMA KO
AC   CVCL_B7XJ
SY   Human GZMA knockout Raji
DR   Abcam; ab290345
DR   cancercelllines; CVCL_B7XJ
DR   Wikidata; Q112928809
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4708; GZMA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji HDAC10 KO
AC   CVCL_D2JK
SY   Human HDAC10 knockout Raji
DR   Abcam; ab302050
DR   Wikidata; Q127379784
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18128; HDAC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HDGF KO
AC   CVCL_D2JL
SY   Human HDGF knockout Raji
DR   Abcam; ab302053
DR   Wikidata; Q127379785
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4856; HDGF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HEXA KO
AC   CVCL_D2JM
SY   Human HEXA knockout Raji
DR   Abcam; ab302056
DR   Wikidata; Q127379786
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4878; HEXA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HIF1AN KO
AC   CVCL_D2JN
SY   Human HIF1AN knockout Raji
DR   Abcam; ab302059
DR   Wikidata; Q127379787
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17113; HIF1AN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HLA-B KO
AC   CVCL_B7XK
SY   Human HLA-B knockout Raji
DR   Abcam; ab290396
DR   cancercelllines; CVCL_B7XK
DR   Wikidata; Q112928810
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji HMBS KO
AC   CVCL_D2JP
SY   Human HMBS knockout Raji
DR   Abcam; ab302062
DR   Wikidata; Q127379788
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4982; HMBS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HMGCS2 KO
AC   CVCL_D2JQ
SY   Human HMGCS2 knockout Raji
DR   Abcam; ab302065
DR   Wikidata; Q127379789
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5008; HMGCS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HMOX2 KO
AC   CVCL_D2JR
SY   Human HMOX2 knockout Raji
DR   Abcam; ab302068
DR   Wikidata; Q127379790
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5014; HMOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HNF1B KO
AC   CVCL_B7XL
SY   Human HNF1B knockout Raji
DR   Abcam; ab290336
DR   cancercelllines; CVCL_B7XL
DR   Wikidata; Q112928811
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11630; HNF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji HSD17B10 KO
AC   CVCL_D2JS
SY   Human HSD17B10 knockout Raji
DR   Abcam; ab302074
DR   Wikidata; Q127379791
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4800; HSD17B10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HSD17B4 KO
AC   CVCL_D2JT
SY   Human HSD17B4 knockout Raji
DR   Abcam; ab302077
DR   Wikidata; Q127379792
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5213; HSD17B4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HSPA13 KO
AC   CVCL_D2JU
SY   Human HSPA13 knockout Raji
DR   Abcam; ab302080
DR   Wikidata; Q127379793
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11375; HSPA13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HSPA1L KO
AC   CVCL_D2JV
SY   Human HSPA1L knockout Raji
DR   Abcam; ab302083
DR   Wikidata; Q127379794
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5234; HSPA1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HSPA2 KO
AC   CVCL_D2JW
SY   Human HSPA2 knockout Raji
DR   Abcam; ab302086
DR   Wikidata; Q127379795
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5235; HSPA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HSPA4 KO
AC   CVCL_D2JX
SY   Human HSPA4 knockout Raji
DR   Abcam; ab302089
DR   Wikidata; Q127379796
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5237; HSPA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji HSPG2 KO
AC   CVCL_B7XM
SY   Human HSPG2 knockout Raji
DR   Abcam; ab290445
DR   cancercelllines; CVCL_B7XM
DR   Wikidata; Q112928812
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji HSPH1 KO
AC   CVCL_D2JY
SY   Human HSPH1 knockout Raji
DR   Abcam; ab302092
DR   Wikidata; Q127379797
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16969; HSPH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ID2 KO
AC   CVCL_B7XN
SY   Human ID2 knockout Raji
DR   Abcam; ab290309
DR   cancercelllines; CVCL_B7XN
DR   Wikidata; Q112928813
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5361; ID2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji IKZF3 KO
AC   CVCL_D2JZ
SY   Human IKZF3 knockout Raji
DR   Abcam; ab302095
DR   Wikidata; Q127379798
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13178; IKZF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji IL13RA1 KO
AC   CVCL_D2K0
SY   Human IL13RA1 knockout Raji
DR   Abcam; ab302098
DR   Wikidata; Q127379799
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji IL17RB KO
AC   CVCL_B7XP
SY   Human IL17RB knockout Raji
DR   Abcam; ab290326
DR   cancercelllines; CVCL_B7XP
DR   Wikidata; Q112928814
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18015; IL17RB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji IL21R KO
AC   CVCL_E1GE
SY   Human IL21R knockout Raji
DR   Abcam; ab275824
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6006; IL21R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Raji IL2RG KO
AC   CVCL_D2K1
SY   Human IL2RG knockout Raji
DR   Abcam; ab302101
DR   Wikidata; Q127379800
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6010; IL2RG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji IMPDH1 KO
AC   CVCL_D2K2
SY   Human IMPDH1 knockout Raji
DR   Abcam; ab302107
DR   Wikidata; Q127379805
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6052; IMPDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ITGA4 KO
AC   CVCL_D2K3
SY   Human ITGA4 knockout Raji
DR   Abcam; ab302110
DR   Wikidata; Q127379806
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6140; ITGA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji ITPR3 KO
AC   CVCL_B7XQ
SY   Human ITPR3 knockout Raji
DR   Abcam; ab290324
DR   cancercelllines; CVCL_B7XQ
DR   Wikidata; Q112928815
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji JAG1 KO
AC   CVCL_B7XR
SY   Human JAG1 knockout Raji
DR   Abcam; ab290310
DR   cancercelllines; CVCL_B7XR
DR   Wikidata; Q112928816
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji JMJD6 KO
AC   CVCL_B7XS
SY   Human JMJD6 knockout Raji
DR   Abcam; ab290392
DR   cancercelllines; CVCL_B7XS
DR   Wikidata; Q112928817
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji KAT7 KO
AC   CVCL_B7XT
SY   Human KAT7 knockout Raji
DR   Abcam; ab290420
DR   cancercelllines; CVCL_B7XT
DR   Wikidata; Q112928818
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji KDM1B KO
AC   CVCL_B7XU
SY   Human KDM1B knockout Raji
DR   Abcam; ab290428
DR   cancercelllines; CVCL_B7XU
DR   Wikidata; Q112928819
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji KDM6B KO
AC   CVCL_B7XV
SY   Human KDM6B knockout Raji
DR   Abcam; ab290338
DR   cancercelllines; CVCL_B7XV
DR   Wikidata; Q112928820
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji KPNA2 KO
AC   CVCL_B7XW
SY   Human KPNA2 knockout Raji
DR   Abcam; ab290352
DR   cancercelllines; CVCL_B7XW
DR   Wikidata; Q112928821
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6395; KPNA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji LAIR1 KO
AC   CVCL_B7XX
SY   Human LAIR1 knockout Raji
DR   Abcam; ab290349
DR   cancercelllines; CVCL_B7XX
DR   Wikidata; Q112928822
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6477; LAIR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji LAMP2 KO
AC   CVCL_B7XY
SY   Human LAMP2 knockout Raji
DR   Abcam; ab290371
DR   cancercelllines; CVCL_B7XY
DR   Wikidata; Q112928823
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji LDHA KO
AC   CVCL_B7XZ
SY   Human LDHA knockout Raji
DR   Abcam; ab290306
DR   cancercelllines; CVCL_B7XZ
DR   Wikidata; Q112928824
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji LGALS8 KO
AC   CVCL_D2K4
SY   Human LGALS8 knockout Raji
DR   Abcam; ab302113
DR   Wikidata; Q127379807
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6569; LGALS8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji LGR6 KO
AC   CVCL_B7Y0
SY   Human LGR6 knockout Raji
DR   Abcam; ab290386
DR   cancercelllines; CVCL_B7Y0
DR   Wikidata; Q112928825
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19719; LGR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji LIAS KO
AC   CVCL_D2K5
SY   Human LIAS knockout Raji
DR   Abcam; ab302116
DR   Wikidata; Q127379808
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16429; LIAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji LMNB1 KO
AC   CVCL_B7Y1
SY   Human LMNB1 knockout Raji
DR   Abcam; ab290365
DR   cancercelllines; CVCL_B7Y1
DR   Wikidata; Q112928826
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji LPXN KO
AC   CVCL_D2K6
SY   Human LPXN knockout Raji
DR   Abcam; ab302118
DR   Wikidata; Q127379810
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14061; LPXN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MACROH2A1 KO
AC   CVCL_B7Y2
SY   Human H2AFY knockout Raji
DR   Abcam; ab290296
DR   cancercelllines; CVCL_B7Y2
DR   Wikidata; Q112928827
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4740; MACROH2A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MAEA KO
AC   CVCL_D2K7
SY   Human MAEA knockout Raji
DR   Abcam; ab302121
DR   Wikidata; Q127379811
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13731; MAEA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MAGEA3 KO
AC   CVCL_B7Y3
SY   Human MAGEA3 knockout Raji
DR   Abcam; ab290431
DR   cancercelllines; CVCL_B7Y3
DR   Wikidata; Q112928828
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6801; MAGEA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MAP2K3 KO
AC   CVCL_B7Y4
SY   Human MAP2K3 knockout Raji
DR   Abcam; ab290394
DR   cancercelllines; CVCL_B7Y4
DR   Wikidata; Q112928829
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MAP3K3 KO
AC   CVCL_B7Y5
SY   Human MAP3K3 knockout Raji
DR   Abcam; ab290374
DR   cancercelllines; CVCL_B7Y5
DR   Wikidata; Q112928830
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6855; MAP3K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MAP3K4 KO
AC   CVCL_D2K8
SY   Human MAP3K4 knockout Raji
DR   Abcam; ab302124
DR   Wikidata; Q127379813
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MAP4K1 KO
AC   CVCL_D2K9
SY   Human MAP4K1 knockout Raji
DR   Abcam; ab302127
DR   Wikidata; Q127379814
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6863; MAP4K1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MAP4K4 KO
AC   CVCL_D2KA
SY   Human MAP4K4 knockout Raji
DR   Abcam; ab302130
DR   Wikidata; Q127379815
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6866; MAP4K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MAPK7 KO
AC   CVCL_B7Y6
SY   Human MAPK7 knockout Raji
DR   Abcam; ab290362
DR   cancercelllines; CVCL_B7Y6
DR   Wikidata; Q112928832
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MARK3 KO
AC   CVCL_D2KB
SY   Human MARK3 knockout Raji
DR   Abcam; ab302133
DR   Wikidata; Q127379816
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6897; MARK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MAT1A KO
AC   CVCL_D2KC
SY   Human MAT1A knockout Raji
DR   Abcam; ab302136
DR   Wikidata; Q127379817
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6903; MAT1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MBD1 KO
AC   CVCL_B7Y7
SY   Human MBD1 knockout Raji
DR   Abcam; ab290423
DR   cancercelllines; CVCL_B7Y7
DR   Wikidata; Q112928833
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MBD3 KO
AC   CVCL_B7Y8
SY   Human MBD3 knockout Raji
DR   Abcam; ab290416
DR   cancercelllines; CVCL_B7Y8
DR   Wikidata; Q112928834
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6918; MBD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ME2 KO
AC   CVCL_D2KD
SY   Human ME2 knockout Raji
DR   Abcam; ab302139
DR   Wikidata; Q127379818
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6984; ME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MMACHC KO
AC   CVCL_D2KE
SY   Human MMACHC knockout Raji
DR   Abcam; ab302142
DR   Wikidata; Q127379819
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24525; MMACHC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MME KO
AC   CVCL_B7Y9
SY   Human MME knockout Raji
DR   Abcam; ab290308
DR   cancercelllines; CVCL_B7Y9
DR   Wikidata; Q112928835
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7154; MME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MMP13 KO
AC   CVCL_B7YA
SY   Human MMP13 knockout Raji
DR   Abcam; ab290457
DR   cancercelllines; CVCL_B7YA
DR   Wikidata; Q112928836
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7159; MMP13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MMP8 KO
AC   CVCL_B7YB
SY   Human MMP8 knockout Raji
DR   Abcam; ab290354
DR   cancercelllines; CVCL_B7YB
DR   Wikidata; Q112928837
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7175; MMP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MPG KO
AC   CVCL_D2KF
SY   Human MPG knockout Raji
DR   Abcam; ab302145
DR   Wikidata; Q127379820
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7211; MPG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji MS4A1 KO
AC   CVCL_B7YC
SY   Human MS4A1 (CD20) knockout Raji
DR   Abcam; ab273871
DR   cancercelllines; CVCL_B7YC
DR   Wikidata; Q112928838
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7315; MS4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MTA3 KO
AC   CVCL_B7YD
SY   Human MTA3 knockout Raji
DR   Abcam; ab290413
DR   cancercelllines; CVCL_B7YD
DR   Wikidata; Q112928839
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23784; MTA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji MTHFR KO
AC   CVCL_D2KG
SY   Human MTHFR knockout Raji
DR   Abcam; ab302148
DR   Wikidata; Q127379821
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7436; MTHFR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NAPRT KO
AC   CVCL_D2KH
SY   Human NAPRT knockout Raji
DR   Abcam; ab302153
DR   Wikidata; Q127379822
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30450; NAPRT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NAT1 KO
AC   CVCL_D2KI
SY   Human NAT1 knockout Raji
DR   Abcam; ab302156
DR   Wikidata; Q127379824
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NBR1 KO
AC   CVCL_B7YE
SY   Human NBR1 knockout Raji
DR   Abcam; ab290325
DR   cancercelllines; CVCL_B7YE
DR   Wikidata; Q112928840
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NCOA5 KO
AC   CVCL_D2KJ
SY   Human NCOA5 knockout Raji
DR   Abcam; ab302159
DR   Wikidata; Q127379825
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15909; NCOA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NCR3LG1 KO
AC   CVCL_B7YF
SY   Human NCR3LG1 knockout Raji
DR   Abcam; ab290414
DR   cancercelllines; CVCL_B7YF
DR   Wikidata; Q112928841
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:42400; NCR3LG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NDUFA12 KO
AC   CVCL_D2KK
SY   Human NDUFA12 knockout Raji
DR   Abcam; ab302162
DR   Wikidata; Q127379826
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23987; NDUFA12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NDUFAF2 KO
AC   CVCL_D2KL
SY   Human NDUFAF2 knockout Raji
DR   Abcam; ab302165
DR   Wikidata; Q127379827
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28086; NDUFAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NDUFB6 KO
AC   CVCL_D2KM
SY   Human NDUFB6 knockout Raji
DR   Abcam; ab302168
DR   Wikidata; Q127379828
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7701; NDUFB6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NDUFB8 KO
AC   CVCL_D2KN
SY   Human NDUFB8 knockout Raji
DR   Abcam; ab302171
DR   Wikidata; Q127379829
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7703; NDUFB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NDUFS1 KO
AC   CVCL_D2KP
SY   Human NDUFS1 knockout Raji
DR   Abcam; ab302174
DR   Wikidata; Q127379830
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7707; NDUFS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NDUFS2 KO
AC   CVCL_D2KQ
SY   Human NDUFS2 knockout Raji
DR   Abcam; ab302177
DR   Wikidata; Q127379832
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7708; NDUFS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NFATC2 KO
AC   CVCL_B7YG
SY   Human NFATC2 knockout Raji
DR   Abcam; ab280906
DR   cancercelllines; CVCL_B7YG
DR   Wikidata; Q112928842
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7776; NFATC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NFKB1 KO
AC   CVCL_B7YH
SY   Human NFKB1 knockout Raji
DR   Abcam; ab290317
DR   cancercelllines; CVCL_B7YH
DR   Wikidata; Q112928843
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NFKBIA KO
AC   CVCL_D2KR
SY   Human NFKBIA knockout Raji
DR   Abcam; ab302180
DR   Wikidata; Q127379833
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NFKBIB KO
AC   CVCL_D2KS
SY   Human NFKBIB knockout Raji
DR   Abcam; ab302183
DR   Wikidata; Q127379834
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7798; NFKBIB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NLRC4 KO
AC   CVCL_B7YI
SY   Human NLRC4 knockout Raji
DR   Abcam; ab290458
DR   cancercelllines; CVCL_B7YI
DR   Wikidata; Q112928844
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16412; NLRC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NMNAT1 KO
AC   CVCL_D2KT
SY   Human NMNAT1 knockout Raji
DR   Abcam; ab302186
DR   Wikidata; Q127379835
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17877; NMNAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NMT1 KO
AC   CVCL_D2KU
SY   Human NMT1 knockout Raji
DR   Abcam; ab302189
DR   Wikidata; Q127379836
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NMT2 KO
AC   CVCL_D2KV
SY   Human NMT2 knockout Raji
DR   Abcam; ab302192
DR   Wikidata; Q127379837
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7858; NMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NOD2 KO
AC   CVCL_D2KW
SY   Human NOD2 knockout Raji
DR   Abcam; ab302195
DR   Wikidata; Q127379838
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5331; NOD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NOTCH3 KO
AC   CVCL_B7YJ
SY   Human NOTCH3 knockout Raji
DR   Abcam; ab290316
DR   cancercelllines; CVCL_B7YJ
DR   Wikidata; Q112928845
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NOTCH4 KO
AC   CVCL_B7YK
SY   Human NOTCH4 knockout Raji
DR   Abcam; ab290343
DR   cancercelllines; CVCL_B7YK
DR   Wikidata; Q112928846
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7884; NOTCH4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NOX5 KO
AC   CVCL_D2KX
SY   Human NOX5 knockout Raji
DR   Abcam; ab302198
DR   Wikidata; Q127379839
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14874; NOX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NPEPPS KO
AC   CVCL_D2KY
SY   Human NPEPPS knockout Raji
DR   Abcam; ab302201
DR   Wikidata; Q127379840
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7900; NPEPPS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NQO2 KO
AC   CVCL_D2KZ
SY   Human NQO2 knockout Raji
DR   Abcam; ab302204
DR   Wikidata; Q127379841
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7856; NQO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji NR1H4 KO
AC   CVCL_B7YL
SY   Human NR1H4 knockout Raji
DR   Abcam; ab290459
DR   cancercelllines; CVCL_B7YL
DR   Wikidata; Q112928847
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7967; NR1H4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NR3C2 KO
AC   CVCL_B7YM
SY   Human NR3C2 knockout Raji
DR   Abcam; ab290303
DR   cancercelllines; CVCL_B7YM
DR   Wikidata; Q112928848
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji NUCB2 KO
AC   CVCL_D2L0
SY   Human NUCB2 knockout Raji
DR   Abcam; ab302207
DR   Wikidata; Q127379842
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8044; NUCB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji OAT KO
AC   CVCL_D2L1
SY   Human OAT knockout Raji
DR   Abcam; ab302210
DR   Wikidata; Q127379843
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8091; OAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji OXSR1 KO
AC   CVCL_D2L2
SY   Human OXSR1 knockout Raji
DR   Abcam; ab302213
DR   Wikidata; Q127379844
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8508; OXSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji P3H1 KO
AC   CVCL_D2L3
SY   Human P3H1 knockout Raji
DR   Abcam; ab302216
DR   Wikidata; Q127379845
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19316; P3H1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PADI2 KO
AC   CVCL_D2L4
SY   Human PADI2 knockout Raji
DR   Abcam; ab302219
DR   Wikidata; Q127379846
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18341; PADI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PAICS KO
AC   CVCL_D2L5
SY   Human PAICS knockout Raji
DR   Abcam; ab302222
DR   Wikidata; Q127379847
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8587; PAICS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PCMT1 KO
AC   CVCL_D2L6
SY   Human PCMT1 knockout Raji
DR   Abcam; ab302225
DR   Wikidata; Q127379848
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8728; PCMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PCYT2 KO
AC   CVCL_D2L7
SY   Human PCYT2 knockout Raji
DR   Abcam; ab302228
DR   Wikidata; Q127379849
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8756; PCYT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PDCD1LG2 KO
AC   CVCL_B7YN
SY   Human PDCD1LG2 knockout Raji
DR   Abcam; ab290299
DR   cancercelllines; CVCL_B7YN
DR   Wikidata; Q112928849
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PDHB KO
AC   CVCL_D2L8
SY   Human PDHB knockout Raji
DR   Abcam; ab302234
DR   Wikidata; Q127379850
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8808; PDHB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PDHX KO
AC   CVCL_D2L9
SY   Human PDHX knockout Raji
DR   Abcam; ab302237
DR   Wikidata; Q127379851
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21350; PDHX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PEF1 KO
AC   CVCL_D2LA
SY   Human PEF1 knockout Raji
DR   Abcam; ab302243
DR   Wikidata; Q127379853
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30009; PEF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PGAM1 KO
AC   CVCL_D2LB
SY   Human PGAM1 knockout Raji
DR   Abcam; ab302246
DR   Wikidata; Q127379854
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8888; PGAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PGRMC1 KO
AC   CVCL_D2LC
SY   Human PGRMC1 knockout Raji
DR   Abcam; ab302249
DR   Wikidata; Q127379855
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16090; PGRMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PHF8 KO
AC   CVCL_B7YP
SY   Human PHF8 knockout Raji
DR   Abcam; ab290418
DR   cancercelllines; CVCL_B7YP
DR   Wikidata; Q112928850
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20672; PHF8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PI4KB KO
AC   CVCL_D2LD
SY   Human PI4KB knockout Raji
DR   Abcam; ab302252
DR   Wikidata; Q127379856
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PIK3CA KO
AC   CVCL_B7YQ
SY   Human PIK3CA knockout Raji
DR   Abcam; ab290305
DR   cancercelllines; CVCL_B7YQ
DR   Wikidata; Q112928851
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PIK3CD KO
AC   CVCL_B7YR
SY   Human PIK3CD knockout Raji
DR   Abcam; ab290360
DR   cancercelllines; CVCL_B7YR
DR   Wikidata; Q112928852
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PIK3R4 KO
AC   CVCL_B7YS
SY   Human PIK3R4 knockout Raji
DR   Abcam; ab290377
DR   cancercelllines; CVCL_B7YS
DR   Wikidata; Q112928853
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8982; PIK3R4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PIM2 KO
AC   CVCL_D2LE
SY   Human PIM2 knockout Raji
DR   Abcam; ab302255
DR   Wikidata; Q127379857
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8987; PIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PKLR KO
AC   CVCL_D2LF
SY   Human PKLR knockout Raji
DR   Abcam; ab302258
DR   Wikidata; Q127379858
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9020; PKLR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PLA2G4A KO
AC   CVCL_B7YT
SY   Human PLA2G4A knockout Raji
DR   Abcam; ab290373
DR   cancercelllines; CVCL_B7YT
DR   Wikidata; Q112928854
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PLCB3 KO
AC   CVCL_B7YU
SY   Human PLCB3 knockout Raji
DR   Abcam; ab290419
DR   cancercelllines; CVCL_B7YU
DR   Wikidata; Q112928855
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PLCG1 KO
AC   CVCL_B7YV
SY   Human PLCG1 knockout Raji
DR   Abcam; ab290389
DR   cancercelllines; CVCL_B7YV
DR   Wikidata; Q112928856
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PLIN3 KO
AC   CVCL_D2LG
SY   Human PLIN3 knockout Raji
DR   Abcam; ab302260
DR   Wikidata; Q127379859
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16893; PLIN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PMVK KO
AC   CVCL_D2LH
SY   Human PMVK knockout Raji
DR   Abcam; ab302263
DR   Wikidata; Q127379860
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9141; PMVK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PNMT KO
AC   CVCL_D2LI
SY   Human PNMT knockout Raji
DR   Abcam; ab302266
DR   Wikidata; Q127379861
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9160; PNMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji POLH KO
AC   CVCL_D2LJ
SY   Human POLH knockout Raji
DR   Abcam; ab302269
DR   Wikidata; Q127379863
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9181; POLH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PPOX KO
AC   CVCL_D2LK
SY   Human PPOX knockout Raji
DR   Abcam; ab302272
DR   Wikidata; Q127379864
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9280; PPOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PPP2CB KO
AC   CVCL_D2LL
SY   Human PPP2CB knockout Raji
DR   Abcam; ab302275
DR   Wikidata; Q127379865
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9300; PPP2CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PRG2 KO
AC   CVCL_D2LM
SY   Human PRG2 knockout Raji
DR   Abcam; ab302281
DR   Wikidata; Q127379866
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9362; PRG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PRKAB1 KO
AC   CVCL_D2LN
SY   Human PRKAB1 knockout Raji
DR   Abcam; ab302284
DR   Wikidata; Q127379867
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PRKACA KO
AC   CVCL_D2LP
SY   Human PRKACA knockout Raji
DR   Abcam; ab302287
DR   Wikidata; Q127379868
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9380; PRKACA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PRKAG1 KO
AC   CVCL_D2LQ
SY   Human PRKAG1 knockout Raji
DR   Abcam; ab302290
DR   Wikidata; Q127379869
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PRKCG KO
AC   CVCL_D2LR
SY   Human PRKCG knockout Raji
DR   Abcam; ab302293
DR   Wikidata; Q127379870
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PRKD1 KO
AC   CVCL_D2LS
SY   Human PRKD1 knockout Raji
DR   Abcam; ab302295
DR   Wikidata; Q127379871
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9407; PRKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PRMT7 KO
AC   CVCL_B7YW
SY   Human PRMT7 knockout Raji
DR   Abcam; ab290435
DR   cancercelllines; CVCL_B7YW
DR   Wikidata; Q112928857
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25557; PRMT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PRSS8 KO
AC   CVCL_D2LT
SY   Human PRSS8 knockout Raji
DR   Abcam; ab302298
DR   Wikidata; Q127379872
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9491; PRSS8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PSEN1 KO
AC   CVCL_B7YX
SY   Human PSEN1 knockout Raji
DR   Abcam; ab290446
DR   cancercelllines; CVCL_B7YX
DR   Wikidata; Q112928858
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PSMF1 KO
AC   CVCL_D2LU
SY   Human PSMF1 knockout Raji
DR   Abcam; ab302301
DR   Wikidata; Q127379873
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9571; PSMF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PTGER4 KO
AC   CVCL_B7YY
SY   Human PTGER4 knockout Raji
DR   Abcam; ab290378
DR   cancercelllines; CVCL_B7YY
DR   Wikidata; Q112928859
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9596; PTGER4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PTGES2 KO
AC   CVCL_B7YZ
SY   Human PTGES2 knockout Raji
DR   Abcam; ab290347
DR   cancercelllines; CVCL_B7YZ
DR   Wikidata; Q112928860
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17822; PTGES2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PTK2 KO
AC   CVCL_B7Z0
SY   Human PTK2 knockout Raji
DR   Abcam; ab290366
DR   cancercelllines; CVCL_B7Z0
DR   Wikidata; Q112928861
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PTP4A3 KO
AC   CVCL_B7Z1
SY   Human PTP4A3 knockout Raji
DR   Abcam; ab290330
DR   cancercelllines; CVCL_B7Z1
DR   Wikidata; Q112928862
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9636; PTP4A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PTPA KO
AC   CVCL_D2LV
SY   Human PTPA knockout Raji
DR   Abcam; ab302304
DR   Wikidata; Q127379875
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9308; PTPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji PTPN12 KO
AC   CVCL_B7Z2
SY   Human PTPN12 knockout Raji
DR   Abcam; ab290339
DR   cancercelllines; CVCL_B7Z2
DR   Wikidata; Q112928863
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9645; PTPN12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PUS1 KO
AC   CVCL_B7Z3
SY   Human PUS1 knockout Raji
DR   Abcam; ab290437
DR   cancercelllines; CVCL_B7Z3
DR   Wikidata; Q112928864
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15508; PUS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji PYCR1 KO
AC   CVCL_D2LW
SY   Human PYCR1 knockout Raji
DR   Abcam; ab302307
DR   Wikidata; Q127379876
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9721; PYCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji QDPR KO
AC   CVCL_D2LX
SY   Human QDPR knockout Raji
DR   Abcam; ab302310
DR   Wikidata; Q127379877
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9752; QDPR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji RAC2 KO
AC   CVCL_B7Z4
SY   Human RAC2 knockout Raji
DR   Abcam; ab290314
DR   cancercelllines; CVCL_B7Z4
DR   Wikidata; Q112928865
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9802; RAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji RECQL KO
AC   CVCL_D2LY
SY   Human RECQL knockout Raji
DR   Abcam; ab302319
DR   Wikidata; Q127379878
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9948; RECQL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji REEP5 KO
AC   CVCL_D2LZ
SY   Human REEP5 knockout Raji
DR   Abcam; ab302322
DR   Wikidata; Q127379879
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30077; REEP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji RING1 KO
AC   CVCL_B7Z5
SY   Human RING1 knockout Raji
DR   Abcam; ab290407
DR   cancercelllines; CVCL_B7Z5
DR   Wikidata; Q112928866
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ROCK2 KO
AC   CVCL_B7Z6
SY   Human ROCK2 knockout Raji
DR   Abcam; ab290359
DR   cancercelllines; CVCL_B7Z6
DR   Wikidata; Q112928867
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ROR2 KO
AC   CVCL_B7Z7
SY   Human ROR2 knockout Raji
DR   Abcam; ab290368
DR   cancercelllines; CVCL_B7Z7
DR   Wikidata; Q112928868
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji RPIA KO
AC   CVCL_D2M0
SY   Human RPIA knockout Raji
DR   Abcam; ab302325
DR   Wikidata; Q127379880
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10297; RPIA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji RXRB KO
AC   CVCL_D2M1
SY   Human RXRB knockout Raji
DR   Abcam; ab302328
DR   Wikidata; Q127379881
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10478; RXRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji RYBP KO
AC   CVCL_B7Z8
SY   Human RYBP knockout Raji
DR   Abcam; ab290417
DR   cancercelllines; CVCL_B7Z8
DR   Wikidata; Q112928869
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10480; RYBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SCARB1 KO
AC   CVCL_B7Z9
SY   Human SCARB1 knockout Raji
DR   Abcam; ab290372
DR   cancercelllines; CVCL_B7Z9
DR   Wikidata; Q112928870
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1664; SCARB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SDC4 KO
AC   CVCL_B7ZA
SY   Human SDC4 knockout Raji
DR   Abcam; ab290311
DR   cancercelllines; CVCL_B7ZA
DR   Wikidata; Q112928871
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10661; SDC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SELENOP KO
AC   CVCL_D2M2
SY   Human SELENOP knockout Raji
DR   Abcam; ab302331
DR   Wikidata; Q127379882
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10751; SELENOP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SERPINB9 KO
AC   CVCL_D2M3
SY   Human SERPINB9 knockout Raji
DR   Abcam; ab302334
DR   Wikidata; Q127379883
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8955; SERPINB9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SETD2 KO
AC   CVCL_B7ZB
SY   Human SETD2 knockout Raji
DR   Abcam; ab290376
DR   cancercelllines; CVCL_B7ZB
DR   Wikidata; Q112928872
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SLAMF6 KO
AC   CVCL_D2M4
SY   Human SLAMF6 knockout Raji
DR   Abcam; ab302338
DR   Wikidata; Q127379884
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21392; SLAMF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SLC25A12 KO
AC   CVCL_D2M5
SY   Human SLC25A12 knockout Raji
DR   Abcam; ab302341
DR   Wikidata; Q127379885
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10982; SLC25A12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SLC5A1 KO
AC   CVCL_D2M6
SY   Human SLC5A1 knockout Raji
DR   Abcam; ab302344
DR   Wikidata; Q127379886
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11036; SLC5A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SLFN11 KO
AC   CVCL_B7ZC
SY   Human SLFN11 knockout Raji
DR   Abcam; ab290424
DR   cancercelllines; CVCL_B7ZC
DR   Wikidata; Q112928873
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SLK KO
AC   CVCL_D2M7
SY   Human SLK knockout Raji
DR   Abcam; ab302347
DR   Wikidata; Q127379887
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11088; SLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SMARCAL1 KO
AC   CVCL_B7ZD
SY   Human SMARCAL1 knockout Raji
DR   Abcam; ab290388
DR   cancercelllines; CVCL_B7ZD
DR   Wikidata; Q112928874
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SMARCC2 KO
AC   CVCL_B7ZE
SY   Human SMARCC2 knockout Raji
DR   Abcam; ab290383
DR   cancercelllines; CVCL_B7ZE
DR   Wikidata; Q112928875
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11105; SMARCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SMARCE1 KO
AC   CVCL_B7ZF
SY   Human SMARCE1 knockout Raji
DR   Abcam; ab290408
DR   cancercelllines; CVCL_B7ZF
DR   Wikidata; Q112928876
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11109; SMARCE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SMS KO
AC   CVCL_D2M8
SY   Human SMS knockout Raji
DR   Abcam; ab302350
DR   Wikidata; Q127379888
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11123; SMS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SMURF1 KO
AC   CVCL_B7ZG
SY   Human SMURF1 knockout Raji
DR   Abcam; ab290340
DR   cancercelllines; CVCL_B7ZG
DR   Wikidata; Q112928877
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SMYD2 KO
AC   CVCL_B7ZH
SY   Human SMYD2 knockout Raji
DR   Abcam; ab290381
DR   cancercelllines; CVCL_B7ZH
DR   Wikidata; Q112928878
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20982; SMYD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SMYD3 KO
AC   CVCL_B7ZI
SY   Human SMYD3 knockout Raji
DR   Abcam; ab290403
DR   cancercelllines; CVCL_B7ZI
DR   Wikidata; Q112928879
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15513; SMYD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SOCS3 KO
AC   CVCL_B7ZJ
SY   Human SOCS3 knockout Raji
DR   Abcam; ab290460
DR   cancercelllines; CVCL_B7ZJ
DR   Wikidata; Q112928880
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SORD KO
AC   CVCL_D2M9
SY   Human SORD knockout Raji
DR   Abcam; ab302353
DR   Wikidata; Q127379889
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11184; SORD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SPAG9 KO
AC   CVCL_D2MA
SY   Human SPAG9 knockout Raji
DR   Abcam; ab302356
DR   Wikidata; Q127379890
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14524; SPAG9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SPTLC2 KO
AC   CVCL_D2MB
SY   Human SPTLC2 knockout Raji
DR   Abcam; ab302359
DR   Wikidata; Q127379891
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11278; SPTLC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SRF KO
AC   CVCL_B7ZK
SY   Human SRF knockout Raji
DR   Abcam; ab290334
DR   cancercelllines; CVCL_B7ZK
DR   Wikidata; Q112928881
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11291; SRF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SRPK1 KO
AC   CVCL_B7ZL
SY   Human SRPK1 knockout Raji
DR   Abcam; ab290402
DR   cancercelllines; CVCL_B7ZL
DR   Wikidata; Q112928882
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SRSF4 KO
AC   CVCL_D2MC
SY   Human SRSF4 knockout Raji
DR   Abcam; ab302362
DR   Wikidata; Q127379892
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10786; SRSF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji SSTR2 KO
AC   CVCL_D2MD
SY   Human SSTR2 knockout Raji
DR   Abcam; ab302365
DR   Wikidata; Q127379894
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11331; SSTR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji STAT4 KO
AC   CVCL_B7ZM
SY   Human STAT4 knockout Raji
DR   Abcam; ab290318
DR   cancercelllines; CVCL_B7ZM
DR   Wikidata; Q112928884
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11365; STAT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji STAT5A KO
AC   CVCL_B7ZN
SY   Human STAT5A knockout Raji
DR   Abcam; ab290298
DR   cancercelllines; CVCL_B7ZN
DR   Wikidata; Q112928885
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11366; STAT5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji STK17B KO
AC   CVCL_D2ME
SY   Human STK17B knockout Raji
DR   Abcam; ab302371
DR   Wikidata; Q127379895
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11396; STK17B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji STK4 KO
AC   CVCL_B7ZP
SY   Human STK4 knockout Raji
DR   Abcam; ab290375
DR   cancercelllines; CVCL_B7ZP
DR   Wikidata; Q112928886
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SUV39H1 KO
AC   CVCL_B7ZQ
SY   Human SUV39H1 knockout Raji
DR   Abcam; ab290346
DR   cancercelllines; CVCL_B7ZQ
DR   Wikidata; Q112928887
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji SUZ12 KO
AC   CVCL_B7ZR
SY   Human SUZ12 knockout Raji
DR   Abcam; ab290322
DR   cancercelllines; CVCL_B7ZR
DR   Wikidata; Q112928888
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TACR1 KO
AC   CVCL_D2MF
SY   Human TACR1 knockout Raji
DR   Abcam; ab302374
DR   Wikidata; Q127379896
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11526; TACR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TAPBP KO
AC   CVCL_B7ZS
SY   Human TAPBP knockout Raji
DR   Abcam; ab290397
DR   cancercelllines; CVCL_B7ZS
DR   Wikidata; Q112928889
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11566; TAPBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TBK1 KO
AC   CVCL_B7ZT
SY   Human TBK1 knockout Raji
DR   Abcam; ab290301
DR   cancercelllines; CVCL_B7ZT
DR   Wikidata; Q112928890
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TBL1XR1 KO
AC   CVCL_D2MG
SY   Human TBL1XR1 knockout Raji
DR   Abcam; ab302377
DR   Wikidata; Q127379897
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29529; TBL1XR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TBP KO
AC   CVCL_B7ZU
SY   Human TBP knockout Raji
DR   Abcam; ab290367
DR   cancercelllines; CVCL_B7ZU
DR   Wikidata; Q112928891
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11588; TBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TCF7L2 KO
AC   CVCL_B7ZV
SY   Human TCF7L2 knockout Raji
DR   Abcam; ab290341
DR   cancercelllines; CVCL_B7ZV
DR   Wikidata; Q112928892
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11641; TCF7L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TDP1 KO
AC   CVCL_D2MH
SY   Human TDP1 knockout Raji
DR   Abcam; ab302380
DR   Wikidata; Q127379898
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18884; TDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TEC KO
AC   CVCL_D2MI
SY   Human TEC knockout Raji
DR   Abcam; ab302383
DR   Wikidata; Q127379899
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11719; TEC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TFDP1 KO
AC   CVCL_B7ZW
SY   Human TFDP1 knockout Raji
DR   Abcam; ab290434
DR   cancercelllines; CVCL_B7ZW
DR   Wikidata; Q112928893
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11749; TFDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TFEB KO
AC   CVCL_E1GF
SY   Human TFEB knockout Raji
DR   Abcam; ab275832
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11753; TFEB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam Raji THOP1 KO
AC   CVCL_D2MJ
SY   Human THOP1 knockout Raji
DR   Abcam; ab302386
DR   Wikidata; Q127379900
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11793; THOP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TIMP3 KO
AC   CVCL_B7ZX
SY   Human TIMP3 knockout Raji
DR   Abcam; ab290313
DR   cancercelllines; CVCL_B7ZX
DR   Wikidata; Q112928894
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11822; TIMP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TLE3 KO
AC   CVCL_D2MK
SY   Human TLE3 knockout Raji
DR   Abcam; ab302389
DR   Wikidata; Q127379901
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TLN1 KO
AC   CVCL_B7ZY
SY   Human TLN1 knockout Raji
DR   Abcam; ab290328
DR   cancercelllines; CVCL_B7ZY
DR   Wikidata; Q112928895
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11845; TLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TNFRSF10B KO
AC   CVCL_B7ZZ
SY   Human TNFRSF10B knockout Raji
DR   Abcam; ab290364
DR   cancercelllines; CVCL_B7ZZ
DR   Wikidata; Q112928896
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TNFRSF1B KO
AC   CVCL_B8A0
SY   Human TNFRSF1B knockout Raji
DR   Abcam; ab290304
DR   cancercelllines; CVCL_B8A0
DR   Wikidata; Q112928897
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11917; TNFRSF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TNFSF9 KO
AC   CVCL_D2ML
SY   Human TNFSF9 knockout Raji
DR   Abcam; ab302392
DR   Wikidata; Q127379902
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11939; TNFSF9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TP73 KO
AC   CVCL_B8A1
SY   Human TP73 knockout Raji
DR   Abcam; ab290391
DR   cancercelllines; CVCL_B8A1
DR   Wikidata; Q112928899
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12003; TP73.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TPD52 KO
AC   CVCL_D2MM
SY   Human TPD52 knockout Raji
DR   Abcam; ab302397
DR   Wikidata; Q127379903
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12005; TPD52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TPMT KO
AC   CVCL_D2MN
SY   Human TPMT knockout Raji
DR   Abcam; ab302400
DR   Wikidata; Q127379904
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12014; TPMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TPP1 KO
AC   CVCL_D2MP
SY   Human TPP1 knockout Raji
DR   Abcam; ab302403
DR   Wikidata; Q127379906
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TPP2 KO
AC   CVCL_D2MQ
SY   Human TPP2 knockout Raji
DR   Abcam; ab302406
DR   Wikidata; Q127379907
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12016; TPP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TRADD KO
AC   CVCL_B8A2
SY   Human TRADD knockout Raji
DR   Abcam; ab290329
DR   cancercelllines; CVCL_B8A2
DR   Wikidata; Q112928900
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12030; TRADD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TRAF2 KO
AC   CVCL_B8A3
SY   Human TRAF2 knockout Raji
DR   Abcam; ab290379
DR   cancercelllines; CVCL_B8A3
DR   Wikidata; Q112928901
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TRMT2A KO
AC   CVCL_B8A4
SY   Human TRMT2A knockout Raji
DR   Abcam; ab290439
DR   cancercelllines; CVCL_B8A4
DR   Wikidata; Q112928902
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TRPC3 KO
AC   CVCL_D2MR
SY   Human TRPC3 knockout Raji
DR   Abcam; ab302409
DR   Wikidata; Q127379908
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12335; TRPC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TRPM2 KO
AC   CVCL_D2MS
SY   Human TRPM2 knockout Raji
DR   Abcam; ab302412
DR   Wikidata; Q127379909
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12339; TRPM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji TWIST1 KO
AC   CVCL_B8A5
SY   Human TWIST1 knockout Raji
DR   Abcam; ab290295
DR   cancercelllines; CVCL_B8A5
DR   Wikidata; Q112928903
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12428; TWIST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji TWIST2 KO
AC   CVCL_B8A6
SY   Human TWIST2 knockout Raji
DR   Abcam; ab290401
DR   cancercelllines; CVCL_B8A6
DR   Wikidata; Q112928905
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20670; TWIST2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji U2AF1 KO
AC   CVCL_B8A7
SY   Human U2AF1 knockout Raji
DR   Abcam; ab290357
DR   cancercelllines; CVCL_B8A7
DR   Wikidata; Q112928906
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12453; U2AF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji UAP1 KO
AC   CVCL_D2MT
SY   Human UAP1 knockout Raji
DR   Abcam; ab302415
DR   Wikidata; Q127379910
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12457; UAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji UBA1 KO
AC   CVCL_B8A8
SY   Human UBA1 knockout Raji
DR   Abcam; ab290380
DR   cancercelllines; CVCL_B8A8
DR   Wikidata; Q112928907
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12469; UBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji UBE2D2 KO
AC   CVCL_B8A9
SY   Human UBE2D2 knockout Raji
DR   Abcam; ab290438
DR   cancercelllines; CVCL_B8A9
DR   Wikidata; Q112928908
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12475; UBE2D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji UBE2T KO
AC   CVCL_D2MU
SY   Human UBE2T knockout Raji
DR   Abcam; ab302418
DR   Wikidata; Q127379911
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25009; UBE2T.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji UBR1 KO
AC   CVCL_D2MV
SY   Human UBR1 knockout Raji
DR   Abcam; ab302421
DR   Wikidata; Q127379913
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16808; UBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji UCHL5 KO
AC   CVCL_B8AA
SY   Human UCHL5 knockout Raji
DR   Abcam; ab290409
DR   cancercelllines; CVCL_B8AA
DR   Wikidata; Q112928909
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19678; UCHL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ULBP3 KO
AC   CVCL_B8AB
SY   Human ULBP3 knockout Raji
DR   Abcam; ab290427
DR   cancercelllines; CVCL_B8AB
DR   Wikidata; Q112928910
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14895; ULBP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji UNC119 KO
AC   CVCL_D2MW
SY   Human UNC119 knockout Raji
DR   Abcam; ab302427
DR   Wikidata; Q127379914
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12565; UNC119.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji UPP1 KO
AC   CVCL_D2MX
SY   Human UPP1 knockout Raji
DR   Abcam; ab302430
DR   Wikidata; Q127379915
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12576; UPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji UVRAG KO
AC   CVCL_B8AC
SY   Human UVRAG knockout Raji
DR   Abcam; ab290321
DR   cancercelllines; CVCL_B8AC
DR   Wikidata; Q112928911
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12640; UVRAG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji VAV1 KO
AC   CVCL_B8AD
SY   Human VAV1 knockout Raji
DR   Abcam; ab290344
DR   cancercelllines; CVCL_B8AD
DR   Wikidata; Q112928912
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12657; VAV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji VCAN KO
AC   CVCL_B8AE
SY   Human VCAN knockout Raji
DR   Abcam; ab290332
DR   cancercelllines; CVCL_B8AE
DR   Wikidata; Q112928913
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2464; VCAN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji VDAC2 KO
AC   CVCL_D2MY
SY   Human VDAC2 knockout Raji
DR   Abcam; ab302433
DR   Wikidata; Q127379916
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12672; VDAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji VPS37A KO
AC   CVCL_D2MZ
SY   Human VPS37A knockout Raji
DR   Abcam; ab302436
DR   Wikidata; Q127379917
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24928; VPS37A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji WAS KO
AC   CVCL_D2N0
SY   Human WAS knockout Raji
DR   Abcam; ab302439
DR   Wikidata; Q127379918
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12731; WAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji WDR77 KO
AC   CVCL_B8AF
SY   Human WDR77 knockout Raji
DR   Abcam; ab290405
DR   cancercelllines; CVCL_B8AF
DR   Wikidata; Q112928914
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29652; WDR77.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji WNT11 KO
AC   CVCL_B8AG
SY   Human Wnt11 knockout Raji
DR   Abcam; ab290358
DR   cancercelllines; CVCL_B8AG
DR   Wikidata; Q112928915
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12776; WNT11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji XPNPEP1 KO
AC   CVCL_D2N1
SY   Human XPNPEP1 knockout Raji
DR   Abcam; ab302444
DR   Wikidata; Q127379919
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12822; XPNPEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   Abcam Raji YTHDC2 KO
AC   CVCL_B8AH
SY   Human YTHDC2 knockout Raji
DR   Abcam; ab290429
DR   cancercelllines; CVCL_B8AH
DR   Wikidata; Q112928916
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24721; YTHDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji YTHDF1 KO
AC   CVCL_B8AI
SY   Human YTHDF1 knockout Raji
DR   Abcam; ab290398
DR   cancercelllines; CVCL_B8AI
DR   Wikidata; Q112928917
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji YTHDF3 KO
AC   CVCL_B8AJ
SY   Human YTHDF3 knockout Raji
DR   Abcam; ab290421
DR   cancercelllines; CVCL_B8AJ
DR   Wikidata; Q112928918
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26465; YTHDF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji YY1 KO
AC   CVCL_B8AK
SY   Human YY1 knockout Raji
DR   Abcam; ab290331
DR   cancercelllines; CVCL_B8AK
DR   Wikidata; Q112928919
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12856; YY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam Raji ZEB2 KO
AC   CVCL_B8AL
SY   Human ZEB2 knockout Raji
DR   Abcam; ab290302
DR   cancercelllines; CVCL_B8AL
DR   Wikidata; Q112928920
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Abcam RAW 264.7 Ccl7 KO
AC   CVCL_B0YM
SY   Mouse CCL7 knockout RAW 264.7
DR   Abcam; ab273755
DR   Wikidata; Q110432519
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99512; Ccl7.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   Abcam RAW 264.7 Ccr2 KO
AC   CVCL_B7VG
SY   Mouse CCR2 knockout RAW 264.7
DR   Abcam; ab281620
DR   Wikidata; Q112928921
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:106185; Ccr2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Abcam RAW 264.7 Cd68 KO
AC   CVCL_B0YN
SY   Mouse CD68 knockout RAW 264.7
DR   Abcam; ab280047
DR   Wikidata; Q110432520
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88342; Cd68.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   Abcam RAW 264.7 Cdkn1b KO
AC   CVCL_B7VK
SY   Mouse CDKN1B (p27 KIP 1) knockout RAW 264.7
DR   Abcam; ab281619
DR   Wikidata; Q112928922
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104565; Cdkn1b.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Abcam RAW 264.7 Cx3cr1 KO
AC   CVCL_B7VH
SY   Mouse CX3CR1 knockout RAW 264.7
DR   Abcam; ab273752
DR   Wikidata; Q112928923
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1333815; Cx3cr1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Abcam RAW 264.7 Prkaa1 KO
AC   CVCL_B0YP
SY   Mouse PRKAA1 knockout RAW 264.7
DR   Abcam; ab280055
DR   Wikidata; Q110432521
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2145955; Prkaa1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   Abcam RAW 264.7 Sirpa KO
AC   CVCL_B7VI
SY   Mouse SIRPA knockout RAW 264.7
DR   Abcam; ab281618
DR   Wikidata; Q112928924
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108563; Sirpa.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Abcam SH-SY5Y DLG4 KO
AC   CVCL_B0YJ
SY   Human PSD95 knockout SH-SY5Y
DR   Abcam; ab280043
DR   cancercelllines; CVCL_B0YJ
DR   Wikidata; Q110432522
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2903; DLG4.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam SH-SY5Y EFNB2 KO
AC   CVCL_B7VN
SY   Human EFNB2 knockout SH-SY5Y
DR   Abcam; ab275409
DR   cancercelllines; CVCL_B7VN
DR   Wikidata; Q112928925
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3227; EFNB2.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam SH-SY5Y LMOD1 KO
AC   CVCL_B7VQ
SY   Human LMOD1 knockout SH-SY5Y
DR   Abcam; ab282566
DR   cancercelllines; CVCL_B7VQ
DR   Wikidata; Q112928926
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6647; LMOD1.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam SH-SY5Y PDGFRA KO
AC   CVCL_B0YH
SY   Human PDGFRA knockout SH-SY5Y
DR   Abcam; ab275335
DR   cancercelllines; CVCL_B0YH
DR   Wikidata; Q110432523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam SH-SY5Y PDGFRB KO
AC   CVCL_B0YI
SY   Human PDGFRB knockout SH-SY5Y
DR   Abcam; ab273749
DR   cancercelllines; CVCL_B0YI
DR   Wikidata; Q110432524
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8804; PDGFRB.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam SH-SY5Y PINK1 KO
AC   CVCL_B0YK
SY   Human PINK1 knockout SH-SY5Y
DR   Abcam; ab280876
DR   cancercelllines; CVCL_B0YK
DR   Wikidata; Q110432525
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam SH-SY5Y PRKN KO
AC   CVCL_B0N9
SY   Human PARK2 (Parkin) knockout SH-SY5Y
DR   Abcam; ab280042
DR   cancercelllines; CVCL_B0N9
DR   Wikidata; Q108821298
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam SH-SY5Y SNAP25 KO
AC   CVCL_B7VP
SY   Human SNAP25 knockout SH-SY5Y
DR   Abcam; ab280041
DR   cancercelllines; CVCL_B7VP
DR   Wikidata; Q112928927
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11132; SNAP25.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam SK-HEP-1 S1PR1 KO
AC   CVCL_E7C3
RX   DOI=10.12688/f1000research.153244.3;
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Custom made by Abcam for the experiments described in DOI=10.12688/f1000research.153244.3.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Abcam SK-N-BE(2) GRM5 KO
AC   CVCL_B0ZE
SY   Human GRM5 knockout SK-N-BE(2)
DR   Abcam; ab273376
DR   cancercelllines; CVCL_B0ZE
DR   Wikidata; Q110432526
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4597; GRM5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Abcam; ab273376; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0528 ! SK-N-BE(2)
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   Abcam SK-N-FI RAB3A KO
AC   CVCL_D7FQ
SY   Human RAB3A knockout SK-N-FI
DR   Abcam; ab288708
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9777; RAB3A.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Partial deletion; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Arg (c.737T>G); ClinVar=VCV000127822; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1702 ! SK-N-FI
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam SW480 ACAT1 KO
AC   CVCL_B0YQ
SY   Human ACAT1 knockout SW480
DR   Abcam; ab269621
DR   cancercelllines; CVCL_B0YQ
DR   Wikidata; Q110432528
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:93; ACAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam SW480 ALDH2 KO
AC   CVCL_B0YR
SY   Human ALDH2 knockout SW480
DR   Abcam; ab270483
DR   cancercelllines; CVCL_B0YR
DR   Wikidata; Q110432529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:404; ALDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam SW480 BACE2 KO
AC   CVCL_E1GG
SY   Human BACE2 knockout SW480
DR   Abcam; ab269622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:934; BACE2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam SW480 BID KO
AC   CVCL_E1GH
SY   Human BID knockout SW480
DR   Abcam; ab274917
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1050; BID.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam SW480 DDIT3 KO
AC   CVCL_B0YS
SY   Human DDIT3 knockout SW480
DR   Abcam; ab269585
DR   cancercelllines; CVCL_B0YS
DR   Wikidata; Q110432530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2726; DDIT3.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam SW480 ELAVL1 KO
AC   CVCL_B0YT
SY   Human ELAVL1 knockout SW480
DR   Abcam; ab270485
DR   cancercelllines; CVCL_B0YT
DR   Wikidata; Q110432531
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3312; ELAVL1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam SW480 ITGA6 KO
AC   CVCL_B0YU
SY   Human ITGA6 (Integrin alpha 6) knockout SW480
DR   Abcam; ab273699
DR   cancercelllines; CVCL_B0YU
DR   Wikidata; Q110432532
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6142; ITGA6.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam SW480 LCN2 KO
AC   CVCL_B0YV
SY   Human LCN2 knockout SW480
DR   Abcam; ab270486
DR   cancercelllines; CVCL_B0YV
DR   Wikidata; Q110432533
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6526; LCN2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam SW480 SERPINA1 KO
AC   CVCL_B0YW
SY   Human SERPINA1 knockout SW480
DR   Abcam; ab270488
DR   cancercelllines; CVCL_B0YW
DR   Wikidata; Q110432534
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8941; SERPINA1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam SW480 STXBP1 KO
AC   CVCL_E1GI
SY   Human STXBP1 knockout SW480
DR   Abcam; ab277169
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11444; STXBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam THP-1 AATF KO
AC   CVCL_B9W7
SY   Human AATF knockout THP-1
DR   Abcam; ab290241
DR   cancercelllines; CVCL_B9W7
DR   Wikidata; Q112928928
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19235; AATF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ABCB1 KO
AC   CVCL_B9W8
SY   Human ABCB1 knockout THP-1
DR   Abcam; ab290270
DR   cancercelllines; CVCL_B9W8
DR   Wikidata; Q112928929
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ABL1 KO
AC   CVCL_B9W9
SY   Human ABL1 knockout THP-1
DR   Abcam; ab290154
DR   cancercelllines; CVCL_B9W9
DR   Wikidata; Q112928930
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ACVR1B KO
AC   CVCL_B9WA
SY   Human ACVR1B (Activin A Receptor Type IB/ALK-4) knockout THP-1
DR   Abcam; ab280057
DR   cancercelllines; CVCL_B9WA
DR   Wikidata; Q112928931
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:172; ACVR1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ADGRG1 KO
AC   CVCL_B9WB
SY   Human ADGRG1 knockout THP-1
DR   Abcam; ab290252
DR   cancercelllines; CVCL_B9WB
DR   Wikidata; Q112928932
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4512; ADGRG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 AGER KO
AC   CVCL_D2N2
SY   Human AGER knockout THP-1
DR   Abcam; ab300825
DR   Wikidata; Q127379920
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:320; AGER.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 AGTR1 KO
AC   CVCL_B9WC
SY   Human AGTR1 knockout THP-1
DR   Abcam; ab290279
DR   cancercelllines; CVCL_B9WC
DR   Wikidata; Q112928934
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:336; AGTR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 AHR KO
AC   CVCL_B9WD
SY   Human AHR knockout THP-1
DR   Abcam; ab290271
DR   cancercelllines; CVCL_B9WD
DR   Wikidata; Q112928935
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 AIM2 KO
AC   CVCL_B9WE
SY   Human AIM2 knockout THP-1
DR   Abcam; ab290280
DR   cancercelllines; CVCL_B9WE
DR   Wikidata; Q112928936
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:357; AIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 AKR1B1 KO
AC   CVCL_D2N3
SY   Human AKR1B1 knockout THP-1
DR   Abcam; ab300830
DR   Wikidata; Q127379921
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 ALCAM KO
AC   CVCL_B9WF
SY   Human ALCAM knockout THP-1
DR   Abcam; ab290145
DR   cancercelllines; CVCL_B9WF
DR   Wikidata; Q112928937
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:400; ALCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ALKBH1 KO
AC   CVCL_B9WG
SY   Human ALKBH1 knockout THP-1
DR   Abcam; ab290266
DR   cancercelllines; CVCL_B9WG
DR   Wikidata; Q112928938
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17911; ALKBH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ALYREF KO
AC   CVCL_B9WH
SY   Human ALYREF knockout THP-1
DR   Abcam; ab290233
DR   cancercelllines; CVCL_B9WH
DR   Wikidata; Q112928939
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19071; ALYREF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ANPEP KO
AC   CVCL_B1A1
SY   Human ANPEP (CD13) knockout THP-1
DR   Abcam; ab273759
DR   cancercelllines; CVCL_B1A1
DR   Wikidata; Q110432535
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:500; ANPEP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ANXA2 KO
AC   CVCL_D2N4
SY   Human ANXA2 knockout THP-1
DR   Abcam; ab300835
DR   Wikidata; Q127379922
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:537; ANXA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 ANXA5 KO
AC   CVCL_D2N5
SY   Human ANXA5 knockout THP-1
DR   Abcam; ab300838
DR   Wikidata; Q127379923
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:543; ANXA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 APAF1 KO
AC   CVCL_C7EI
SY   Human APAF1 knockout THP-1
DR   Abcam; ab300841
DR   Wikidata; Q123030630
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:576; APAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 APOBEC3B KO
AC   CVCL_B9WI
SY   Human APOBEC3B knockout THP-1
DR   Abcam; ab290228
DR   cancercelllines; CVCL_B9WI
DR   Wikidata; Q112928940
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17352; APOBEC3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ASAH1 KO
AC   CVCL_B9WJ
SY   Human ASAH1 knockout THP-1
DR   Abcam; ab290216
DR   cancercelllines; CVCL_B9WJ
DR   Wikidata; Q112928941
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:735; ASAH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ATF5 KO
AC   CVCL_B9WK
SY   Human ATF5 knockout THP-1
DR   Abcam; ab290255
DR   cancercelllines; CVCL_B9WK
DR   Wikidata; Q112928942
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ATG12 KO
AC   CVCL_B1A2
SY   Human ATG12 knockout THP-1
DR   Abcam; ab277831
DR   cancercelllines; CVCL_B1A2
DR   Wikidata; Q110432536
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:588; ATG12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ATG14 KO
AC   CVCL_B1A3
SY   Human ATG14 (ATG14L) knockout THP-1
DR   Abcam; ab277833
DR   cancercelllines; CVCL_B1A3
DR   Wikidata; Q110432537
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ATG16L1 KO
AC   CVCL_B1A4
SY   Human ATG16L1 knockout THP-1
DR   Abcam; ab277834
DR   cancercelllines; CVCL_B1A4
DR   Wikidata; Q110432538
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ATG3 KO
AC   CVCL_B9WL
SY   Human ATG3 knockout THP-1
DR   Abcam; ab290229
DR   cancercelllines; CVCL_B9WL
DR   Wikidata; Q112928943
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ATG5 KO
AC   CVCL_B1A5
SY   Human ATG5 knockout THP-1
DR   Abcam; ab277835
DR   cancercelllines; CVCL_B1A5
DR   Wikidata; Q110432540
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ATG7 KO
AC   CVCL_B1A6
SY   Human ATG7 knockout THP-1
DR   Abcam; ab277836
DR   cancercelllines; CVCL_B1A6
DR   Wikidata; Q110432541
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ATG9A KO
AC   CVCL_B9WM
SY   Human ATG9A knockout THP-1
DR   Abcam; ab290149
DR   cancercelllines; CVCL_B9WM
DR   Wikidata; Q112928944
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 BAK1 KO
AC   CVCL_B9WN
SY   Human BAK1 knockout THP-1
DR   Abcam; ab290190
DR   cancercelllines; CVCL_B9WN
DR   Wikidata; Q112928945
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 BCL2 KO
AC   CVCL_B1A7
SY   Human BCL2 knockout THP-1
DR   Abcam; ab276113
DR   cancercelllines; CVCL_B1A7
DR   Wikidata; Q110432542
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Abcam; ab276113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   Abcam THP-1 BMPR2 KO
AC   CVCL_B9WP
SY   Human BMPR2 knockout THP-1
DR   Abcam; ab290281
DR   cancercelllines; CVCL_B9WP
DR   Wikidata; Q112928946
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 BRD1 KO
AC   CVCL_B9WQ
SY   Human BRD1 knockout THP-1
DR   Abcam; ab290263
DR   cancercelllines; CVCL_B9WQ
DR   Wikidata; Q112928947
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 BRD2 KO
AC   CVCL_B9WR
SY   Human BRD2 knockout THP-1
DR   Abcam; ab290210
DR   cancercelllines; CVCL_B9WR
DR   Wikidata; Q112928948
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 BRD9 KO
AC   CVCL_B9WS
SY   Human BRD9 knockout THP-1
DR   Abcam; ab290235
DR   cancercelllines; CVCL_B9WS
DR   Wikidata; Q112928949
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 BTG1 KO
AC   CVCL_B9WT
SY   Human BTG1 knockout THP-1
DR   Abcam; ab290244
DR   cancercelllines; CVCL_B9WT
DR   Wikidata; Q112928950
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1130; BTG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 BTK KO
AC   CVCL_B9WU
SY   Human BTK knockout THP-1
DR   Abcam; ab290124
DR   cancercelllines; CVCL_B9WU
DR   Wikidata; Q112928951
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1133; BTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 BTRC KO
AC   CVCL_B9WV
SY   Human BTRC knockout THP-1
DR   Abcam; ab290219
DR   cancercelllines; CVCL_B9WV
DR   Wikidata; Q112928952
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 C3 KO
AC   CVCL_B9WW
SY   Human C3 knockout THP-1
DR   Abcam; ab290282
DR   cancercelllines; CVCL_B9WW
DR   Wikidata; Q112928953
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1318; C3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CASP1 KO
AC   CVCL_B1A8
SY   Human CASP1 (Caspase-1) knockout THP-1
DR   Abcam; ab276116
DR   cancercelllines; CVCL_B1A8
DR   Wikidata; Q110432543
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1499; CASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CASP3 KO
AC   CVCL_B9WX
SY   Human CASP3 knockout THP-1
DR   Abcam; ab290121
DR   cancercelllines; CVCL_B9WX
DR   Wikidata; Q112928954
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CASP4 KO
AC   CVCL_C7EJ
SY   Human CASP4 knockout THP-1
DR   Abcam; ab300861
DR   Wikidata; Q123030631
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1505; CASP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 CASP9 KO
AC   CVCL_B1A9
SY   Human CASP9 knockout THP-1
DR   Abcam; ab276122
DR   cancercelllines; CVCL_B1A9
DR   Wikidata; Q110432544
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1511; CASP9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CAST KO
AC   CVCL_D2N6
SY   Human CAST knockout THP-1
DR   Abcam; ab300866
DR   Wikidata; Q127379924
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1515; CAST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 CCL3 KO
AC   CVCL_B1AA
SY   Human CCL3 (Macrophage Inflammatory Protein 1) knockout THP-1
DR   Abcam; ab273760
DR   cancercelllines; CVCL_B1AA
DR   Wikidata; Q110432545
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10627; CCL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CCL4 KO
AC   CVCL_B9WY
SY   Human CCL4 knockout THP-1
DR   Abcam; ab273719
DR   cancercelllines; CVCL_B9WY
DR   Wikidata; Q112928955
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10630; CCL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CCR2 KO
AC   CVCL_B9WZ
SY   Human CCR2 knockout THP-1
DR   Abcam; ab273716
DR   cancercelllines; CVCL_B9WZ
DR   Wikidata; Q112928956
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1603; CCR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CCRL2 KO
AC   CVCL_B9X0
SY   Human CCRL2 knockout THP-1
DR   Abcam; ab290169
DR   cancercelllines; CVCL_B9X0
DR   Wikidata; Q112928957
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1612; CCRL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CCL22 KO
AC   CVCL_B9X1
SY   Human CCl22 knockout THP-1
DR   Abcam; ab290138
DR   cancercelllines; CVCL_B9X1
DR   Wikidata; Q112928958
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10621; CCL22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CD36 KO
AC   CVCL_B9X2
SY   Human CD36 knockout THP-1
DR   Abcam; ab290272
DR   cancercelllines; CVCL_B9X2
DR   Wikidata; Q112928959
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1663; CD36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CD46 KO
AC   CVCL_D2N7
SY   Human CD46 knockout THP-1
DR   Abcam; ab300876
DR   Wikidata; Q127379925
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 CD48 KO
AC   CVCL_B9X3
SY   Human CD48 knockout THP-1
DR   Abcam; ab290182
DR   cancercelllines; CVCL_B9X3
DR   Wikidata; Q112928960
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1683; CD48.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CD58 KO
AC   CVCL_B9X4
SY   Human CD58 knockout THP-1
DR   Abcam; ab290251
DR   cancercelllines; CVCL_B9X4
DR   Wikidata; Q112928961
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1688; CD58.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CD59 KO
AC   CVCL_B9X5
SY   Human CD59 knockout THP-1
DR   Abcam; ab290283
DR   cancercelllines; CVCL_B9X5
DR   Wikidata; Q112928962
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1689; CD59.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CD81 KO
AC   CVCL_B9X6
SY   Human CD81 knockout THP-1
DR   Abcam; ab290284
DR   cancercelllines; CVCL_B9X6
DR   Wikidata; Q112928963
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CES1 KO
AC   CVCL_D2N8
SY   Human CES1 knockout THP-1
DR   Abcam; ab300888
DR   Wikidata; Q127379926
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1863; CES1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 CHI3L1 KO
AC   CVCL_B1AB
SY   Human CHI3L1 knockout THP-1
DR   Abcam; ab280038
DR   cancercelllines; CVCL_B1AB
DR   Wikidata; Q110432546
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1932; CHI3L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CITED2 KO
AC   CVCL_B9X7
SY   Human CITED2 knockout THP-1
DR   Abcam; ab290183
DR   cancercelllines; CVCL_B9X7
DR   Wikidata; Q112928964
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1987; CITED2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CLU KO
AC   CVCL_B9X8
SY   Human CLU knockout THP-1
DR   Abcam; ab290273
DR   cancercelllines; CVCL_B9X8
DR   Wikidata; Q112928965
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2095; CLU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CMKLR1 KO
AC   CVCL_B9X9
SY   Human CMKLR1 knockout THP-1
DR   Abcam; ab290164
DR   cancercelllines; CVCL_B9X9
DR   Wikidata; Q112928966
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2121; CMKLR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CMTM6 KO
AC   CVCL_B9XA
SY   Human CMTM6 knockout THP-1
DR   Abcam; ab290260
DR   cancercelllines; CVCL_B9XA
DR   Wikidata; Q112928967
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CNR2 KO
AC   CVCL_B9XB
SY   Human CNR2 knockout THP-1
DR   Abcam; ab290285
DR   cancercelllines; CVCL_B9XB
DR   Wikidata; Q112928968
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2160; CNR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CST3 KO
AC   CVCL_B9XC
SY   Human CST3 knockout THP-1
DR   Abcam; ab290286
DR   cancercelllines; CVCL_B9XC
DR   Wikidata; Q112928969
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2475; CST3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CTSB KO
AC   CVCL_B9XD
SY   Human CTSB knockout THP-1
DR   Abcam; ab290287
DR   cancercelllines; CVCL_B9XD
DR   Wikidata; Q112928970
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CTSG KO
AC   CVCL_D2N9
SY   Human CTSG knockout THP-1
DR   Abcam; ab300904
DR   Wikidata; Q127379927
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2532; CTSG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 CTSS KO
AC   CVCL_B9XE
SY   Human CTSS knockout THP-1
DR   Abcam; ab275846
DR   cancercelllines; CVCL_B9XE
DR   Wikidata; Q112928971
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2545; CTSS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CUL2 KO
AC   CVCL_B9XF
SY   Human CUL2 knockout THP-1
DR   Abcam; ab290224
DR   cancercelllines; CVCL_B9XF
DR   Wikidata; Q112928972
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2552; CUL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 CUL3 KO
AC   CVCL_B9XG
SY   Human CUL3 knockout THP-1
DR   Abcam; ab290162
DR   cancercelllines; CVCL_B9XG
DR   Wikidata; Q112928973
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2553; CUL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CUL4A KO
AC   CVCL_D2NA
SY   Human CUL4A knockout THP-1
DR   Abcam; ab300906
DR   Wikidata; Q127379928
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2554; CUL4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 CUL4B KO
AC   CVCL_B9XH
SY   Human CUL4B knockout THP-1
DR   Abcam; ab290175
DR   cancercelllines; CVCL_B9XH
DR   Wikidata; Q112928974
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2555; CUL4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CX3CR1 KO
AC   CVCL_B9XI
SY   Human CX3CR1 knockout THP-1
DR   Abcam; ab273713
DR   cancercelllines; CVCL_B9XI
DR   Wikidata; Q112928975
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2558; CX3CR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CXCL10 KO
AC   CVCL_B1AC
SY   Human CXCL10 (IP10) knockout THP-1
DR   Abcam; ab277860
DR   cancercelllines; CVCL_B1AC
DR   Wikidata; Q110432547
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CXCR2 KO
AC   CVCL_B1AD
SY   Human CXCR2 knockout THP-1
DR   Abcam; ab273725
DR   cancercelllines; CVCL_B1AD
DR   Wikidata; Q110432549
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6027; CXCR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 CXXC1 KO
AC   CVCL_B9XJ
SY   Human CXXC1 knockout THP-1
DR   Abcam; ab290240
DR   cancercelllines; CVCL_B9XJ
DR   Wikidata; Q112928976
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24343; CXXC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 DCK KO
AC   CVCL_D2NB
SY   Human DCK knockout THP-1
DR   Abcam; ab300909
DR   Wikidata; Q127379929
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2704; DCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 DCP2 KO
AC   CVCL_B9XK
SY   Human DCP2 knockout THP-1
DR   Abcam; ab290262
DR   cancercelllines; CVCL_B9XK
DR   Wikidata; Q112928977
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24452; DCP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 DLL1 KO
AC   CVCL_B9XL
SY   Human DLL1 knockout THP-1
DR   Abcam; ab290132
DR   cancercelllines; CVCL_B9XL
DR   Wikidata; Q112928978
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2908; DLL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 DVL3 KO
AC   CVCL_B9XM
SY   Human DVL3 knockout THP-1
DR   Abcam; ab290178
DR   cancercelllines; CVCL_B9XM
DR   Wikidata; Q112928979
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3087; DVL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 EGLN1 KO
AC   CVCL_B9XN
SY   Human EGLN1 knockout THP-1
DR   Abcam; ab290141
DR   cancercelllines; CVCL_B9XN
DR   Wikidata; Q112928980
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1232; EGLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 EHMT2 KO
AC   CVCL_B9XP
SY   Human EHMT2 knockout THP-1
DR   Abcam; ab290188
DR   cancercelllines; CVCL_B9XP
DR   Wikidata; Q112928982
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 EIF2AK4 KO
AC   CVCL_B9XQ
SY   Human EIF2AK4 knockout THP-1
DR   Abcam; ab290213
DR   cancercelllines; CVCL_B9XQ
DR   Wikidata; Q112928983
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ENG KO
AC   CVCL_B9XR
SY   Human ENG knockout THP-1
DR   Abcam; ab290215
DR   cancercelllines; CVCL_B9XR
DR   Wikidata; Q112928984
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3349; ENG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 EPHB4 KO
AC   CVCL_B9XS
SY   Human EPHB4 knockout THP-1
DR   Abcam; ab290222
DR   cancercelllines; CVCL_B9XS
DR   Wikidata; Q112928985
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ERAP1 KO
AC   CVCL_B9XT
SY   Human ERAP1 knockout THP-1
DR   Abcam; ab290256
DR   cancercelllines; CVCL_B9XT
DR   Wikidata; Q112928986
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ETS2 KO
AC   CVCL_B9XU
SY   Human ETS2 knockout THP-1
DR   Abcam; ab290239
DR   cancercelllines; CVCL_B9XU
DR   Wikidata; Q112928987
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3489; ETS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 EXO1 KO
AC   CVCL_B9XV
SY   Human EXO1 knockout THP-1
DR   Abcam; ab290160
DR   cancercelllines; CVCL_B9XV
DR   Wikidata; Q112928988
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3511; EXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 EZH2 KO
AC   CVCL_D2NC
SY   Human EZH2 knockout THP-1
DR   Abcam; ab300931
DR   Wikidata; Q127379930
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 FABP4 KO
AC   CVCL_B9XW
SY   Human FABP4 knockout THP-1
DR   Abcam; ab290274
DR   cancercelllines; CVCL_B9XW
DR   Wikidata; Q112928990
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3559; FABP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 FCER1G KO
AC   CVCL_D5HB
SY   Human FCER1G knockout THP-1
DR   Abcam; ab288699
DR   Wikidata; Q127379932
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3611; FCER1G.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 FCGR1A KO
AC   CVCL_B9XX
SY   Human FCGR1A knockout THP-1
DR   Abcam; ab275843
DR   cancercelllines; CVCL_B9XX
DR   Wikidata; Q112928991
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3613; FCGR1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 FDFT1 KO
AC   CVCL_D2ND
SY   Human FDFT1 knockout THP-1
DR   Abcam; ab300942
DR   Wikidata; Q127379934
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3629; FDFT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 FGF23 KO
AC   CVCL_B9XY
SY   Human FGF23 knockout THP-1
DR   Abcam; ab290134
DR   cancercelllines; CVCL_B9XY
DR   Wikidata; Q112928992
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3680; FGF23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 FKBP5 KO
AC   CVCL_B9XZ
SY   Human FKBP5 knockout THP-1
DR   Abcam; ab290288
DR   cancercelllines; CVCL_B9XZ
DR   Wikidata; Q112928993
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3721; FKBP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 FOXO1 KO
AC   CVCL_B9Y0
SY   Human FOXO1 knockout THP-1
DR   Abcam; ab290118
DR   cancercelllines; CVCL_B9Y0
DR   Wikidata; Q112928994
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3819; FOXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 FOXO3 KO
AC   CVCL_B9Y1
SY   Human FOXO3 knockout THP-1
DR   Abcam; ab290196
DR   cancercelllines; CVCL_B9Y1
DR   Wikidata; Q112928995
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 FST KO
AC   CVCL_B9Y2
SY   Human FST knockout THP-1
DR   Abcam; ab290146
DR   cancercelllines; CVCL_B9Y2
DR   Wikidata; Q112928996
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3971; FST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 FTL KO
AC   CVCL_B9Y3
SY   Human FTL knockout THP-1
DR   Abcam; ab290197
DR   cancercelllines; CVCL_B9Y3
DR   Wikidata; Q112928997
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 FZD7 KO
AC   CVCL_B9Y4
SY   Human FZD7 knockout THP-1
DR   Abcam; ab290177
DR   cancercelllines; CVCL_B9Y4
DR   Wikidata; Q112928998
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 GAB1 KO
AC   CVCL_B9Y5
SY   Human GAB1 knockout THP-1
DR   Abcam; ab290212
DR   cancercelllines; CVCL_B9Y5
DR   Wikidata; Q112928999
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4066; GAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 GCLM KO
AC   CVCL_D2NE
SY   Human GCLM knockout THP-1
DR   Abcam; ab300957
DR   Wikidata; Q127379935
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4312; GCLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 GGT1 KO
AC   CVCL_D2NF
SY   Human GGT1 knockout THP-1
DR   Abcam; ab300960
DR   Wikidata; Q127379936
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4250; GGT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 GHR KO
AC   CVCL_D2NG
SY   Human GHR knockout THP-1
DR   Abcam; ab300963
DR   Wikidata; Q127379938
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4263; GHR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 GLB1 KO
AC   CVCL_B9Y6
SY   Human GLB1 knockout THP-1
DR   Abcam; ab290153
DR   cancercelllines; CVCL_B9Y6
DR   Wikidata; Q112929000
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 GPR132 KO
AC   CVCL_B9Y7
SY   Human GPR132 knockout THP-1
DR   Abcam; ab290180
DR   cancercelllines; CVCL_B9Y7
DR   Wikidata; Q112929001
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17482; GPR132.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 GSTP1 KO
AC   CVCL_D2NH
SY   Human GSTP1 knockout THP-1
DR   Abcam; ab300977
DR   Wikidata; Q127379939
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4638; GSTP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 GZMA KO
AC   CVCL_B9Y8
SY   Human GZMA knockout THP-1
DR   Abcam; ab290172
DR   cancercelllines; CVCL_B9Y8
DR   Wikidata; Q112929002
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4708; GZMA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 HLA-B KO
AC   CVCL_B9Y9
SY   Human HLA-B knockout THP-1
DR   Abcam; ab290225
DR   cancercelllines; CVCL_B9Y9
DR   Wikidata; Q112929003
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 HMMR KO
AC   CVCL_D2NI
SY   Human HMMR knockout THP-1
DR   Abcam; ab300985
DR   Wikidata; Q127379941
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5012; HMMR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 HNF1B KO
AC   CVCL_B9YA
SY   Human HNF1B knockout THP-1
DR   Abcam; ab290163
DR   cancercelllines; CVCL_B9YA
DR   Wikidata; Q112929004
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11630; HNF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 HSPG2 KO
AC   CVCL_B9YB
SY   Human HSPG2 knockout THP-1
DR   Abcam; ab290275
DR   cancercelllines; CVCL_B9YB
DR   Wikidata; Q112929005
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ID2 KO
AC   CVCL_B9YC
SY   Human ID2 knockout THP-1
DR   Abcam; ab290135
DR   cancercelllines; CVCL_B9YC
DR   Wikidata; Q112929006
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5361; ID2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 IL17RB KO
AC   CVCL_B9YD
SY   Human IL17RB knockout THP-1
DR   Abcam; ab290152
DR   cancercelllines; CVCL_B9YD
DR   Wikidata; Q112929007
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18015; IL17RB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 IL1B KO
AC   CVCL_B1AE
SY   Human IL1B knockout THP-1
DR   Abcam; ab273762
DR   cancercelllines; CVCL_B1AE
DR   Wikidata; Q110432550
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 IRAK3 KO
AC   CVCL_B9YE
SY   Human IRAK3 knockout THP-1
DR   Abcam; ab281629
DR   cancercelllines; CVCL_B9YE
DR   Wikidata; Q112929008
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17020; IRAK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ITGA5 KO
AC   CVCL_D2NJ
SY   Human ITGA5 knockout THP-1
DR   Abcam; ab301011
DR   Wikidata; Q127379942
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 ITPR3 KO
AC   CVCL_B9YF
SY   Human ITPR3 knockout THP-1
DR   Abcam; ab290150
DR   cancercelllines; CVCL_B9YF
DR   Wikidata; Q112929009
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 JAG1 KO
AC   CVCL_B9YG
SY   Human JAG1 knockout THP-1
DR   Abcam; ab290136
DR   cancercelllines; CVCL_B9YG
DR   Wikidata; Q112929010
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 JAK2 KO
AC   CVCL_D2NK
SY   Human JAK2 knockout THP-1
DR   Abcam; ab301021
DR   Wikidata; Q127379943
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 JMJD6 KO
AC   CVCL_B9YH
SY   Human JMJD6 knockout THP-1
DR   Abcam; ab290221
DR   cancercelllines; CVCL_B9YH
DR   Wikidata; Q112929011
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 KAT7 KO
AC   CVCL_B9YI
SY   Human KAT7 knockout THP-1
DR   Abcam; ab290249
DR   cancercelllines; CVCL_B9YI
DR   Wikidata; Q112929012
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 KDM1B KO
AC   CVCL_B9YJ
SY   Human KDM1B knockout THP-1
DR   Abcam; ab290258
DR   cancercelllines; CVCL_B9YJ
DR   Wikidata; Q112929013
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 KDM6B KO
AC   CVCL_B9YK
SY   Human KDM6B knockout THP-1
DR   Abcam; ab290165
DR   cancercelllines; CVCL_B9YK
DR   Wikidata; Q112929014
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 KPNA2 KO
AC   CVCL_B9YL
SY   Human KPNA2 knockout THP-1
DR   Abcam; ab290179
DR   cancercelllines; CVCL_B9YL
DR   Wikidata; Q112929015
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6395; KPNA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 LAIR1 KO
AC   CVCL_B9YM
SY   Human LAIR1 knockout THP-1
DR   Abcam; ab290176
DR   cancercelllines; CVCL_B9YM
DR   Wikidata; Q112929016
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6477; LAIR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 LAMP2 KO
AC   CVCL_B9YN
SY   Human LAMP2 knockout THP-1
DR   Abcam; ab290198
DR   cancercelllines; CVCL_B9YN
DR   Wikidata; Q112929017
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 LATS1 KO
AC   CVCL_B1AF
SY   Human LATS1 (WARTS) knockout THP-1
DR   Abcam; ab277862
DR   cancercelllines; CVCL_B1AF
DR   Wikidata; Q110432551
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 LDHA KO
AC   CVCL_B9YP
SY   Human LDHA knockout THP-1
DR   Abcam; ab290131
DR   cancercelllines; CVCL_B9YP
DR   Wikidata; Q112929018
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 LGALS9 KO
AC   CVCL_B1AG
SY   Human Lgals9 (galectin 9/Gal-9) knockout THP-1
DR   Abcam; ab269505
DR   cancercelllines; CVCL_B1AG
DR   Wikidata; Q110432552
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6570; LGALS9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 LGMN KO
AC   CVCL_D2NL
SY   Human LGMN knockout THP-1
DR   Abcam; ab301036
DR   Wikidata; Q127379945
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9472; LGMN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 LGR6 KO
AC   CVCL_B9YQ
SY   Human LGR6 knockout THP-1
DR   Abcam; ab290214
DR   cancercelllines; CVCL_B9YQ
DR   Wikidata; Q112929019
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19719; LGR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 LMNB1 KO
AC   CVCL_B9YR
SY   Human LMNB1 knockout THP-1
DR   Abcam; ab290192
DR   cancercelllines; CVCL_B9YR
DR   Wikidata; Q112929020
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 LOX KO
AC   CVCL_D2NM
SY   Human LOX knockout THP-1
DR   Abcam; ab301041
DR   Wikidata; Q127379946
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6664; LOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 LYZ KO
AC   CVCL_B1AH
SY   Human LYZ (Lysozyme) knockout THP-1
DR   Abcam; ab269595
DR   cancercelllines; CVCL_B1AH
DR   Wikidata; Q110432553
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6740; LYZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 MACROH2A1 KO
AC   CVCL_B9YS
SY   Human H2AFY knockout THP-1
DR   Abcam; ab290120
DR   cancercelllines; CVCL_B9YS
DR   Wikidata; Q112929021
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4740; MACROH2A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 MAD1L1 KO
AC   CVCL_C7EK
SY   Human MAD1L1 knockout THP-1
DR   Abcam; ab301053
DR   Wikidata; Q123030632
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6762; MAD1L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 MAGEA3 KO
AC   CVCL_B9YT
SY   Human MAGEA3 knockout THP-1
DR   Abcam; ab290261
DR   cancercelllines; CVCL_B9YT
DR   Wikidata; Q112929022
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6801; MAGEA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MAP2K3 KO
AC   CVCL_B9YU
SY   Human MAP2K3 knockout THP-1
DR   Abcam; ab290223
DR   cancercelllines; CVCL_B9YU
DR   Wikidata; Q112929023
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MAP3K3 KO
AC   CVCL_B9YV
SY   Human MAP3K3 knockout THP-1
DR   Abcam; ab290201
DR   cancercelllines; CVCL_B9YV
DR   Wikidata; Q112929024
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6855; MAP3K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MAPK7 KO
AC   CVCL_B9YW
SY   Human MAPK7 knockout THP-1
DR   Abcam; ab290189
DR   cancercelllines; CVCL_B9YW
DR   Wikidata; Q112929025
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MARCKS KO
AC   CVCL_D2NN
SY   Human MARCKS knockout THP-1
DR   Abcam; ab301063
DR   Wikidata; Q127379948
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6759; MARCKS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 MBD1 KO
AC   CVCL_B9YX
SY   Human MBD1 knockout THP-1
DR   Abcam; ab290253
DR   cancercelllines; CVCL_B9YX
DR   Wikidata; Q112929026
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MBD3 KO
AC   CVCL_B9YY
SY   Human MBD3 knockout THP-1
DR   Abcam; ab290245
DR   cancercelllines; CVCL_B9YY
DR   Wikidata; Q112929027
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6918; MBD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MBNL1 KO
AC   CVCL_D2NP
SY   Human MBNL1 knockout THP-1
DR   Abcam; ab301067
DR   Wikidata; Q127379950
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6923; MBNL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 MME KO
AC   CVCL_B9YZ
SY   Human MME knockout THP-1
DR   Abcam; ab290133
DR   cancercelllines; CVCL_B9YZ
DR   Wikidata; Q112929028
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7154; MME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 MMP13 KO
AC   CVCL_B9Z0
SY   Human MMP13 knockout THP-1
DR   Abcam; ab290289
DR   cancercelllines; CVCL_B9Z0
DR   Wikidata; Q112929029
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7159; MMP13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MMP3 KO
AC   CVCL_C7EL
SY   Human MMP3 knockout THP-1
DR   Abcam; ab301080
DR   Wikidata; Q123030633
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7173; MMP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 MMP8 KO
AC   CVCL_B9Z1
SY   Human MMP8 knockout THP-1
DR   Abcam; ab290181
DR   cancercelllines; CVCL_B9Z1
DR   Wikidata; Q112929030
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7175; MMP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 MTA3 KO
AC   CVCL_B9Z2
SY   Human MTA3 knockout THP-1
DR   Abcam; ab290242
DR   cancercelllines; CVCL_B9Z2
DR   Wikidata; Q112929031
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23784; MTA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 NAMPT KO
AC   CVCL_D2NQ
SY   Human NAMPT knockout THP-1
DR   Abcam; ab301088
DR   Wikidata; Q127379951
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30092; NAMPT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 NBR1 KO
AC   CVCL_B9Z3
SY   Human NBR1 knockout THP-1
DR   Abcam; ab290151
DR   cancercelllines; CVCL_B9Z3
DR   Wikidata; Q112929032
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 NCR3LG1 KO
AC   CVCL_B9Z4
SY   Human NCR3LG1 knockout THP-1
DR   Abcam; ab290243
DR   cancercelllines; CVCL_B9Z4
DR   Wikidata; Q112929033
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:42400; NCR3LG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 NFKB1 KO
AC   CVCL_B9Z5
SY   Human NFKB1 knockout THP-1
DR   Abcam; ab290143
DR   cancercelllines; CVCL_B9Z5
DR   Wikidata; Q112929034
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 NLRC4 KO
AC   CVCL_B9Z6
SY   Human NLRC4 knockout THP-1
DR   Abcam; ab290290
DR   cancercelllines; CVCL_B9Z6
DR   Wikidata; Q112929035
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16412; NLRC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 NLRP3 KO
AC   CVCL_B9Z7
SY   Human NLRP3 knockout THP-1
DR   Abcam; ab280063
DR   cancercelllines; CVCL_B9Z7
DR   Wikidata; Q112929036
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16400; NLRP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 NOTCH3 KO
AC   CVCL_B9Z8
SY   Human NOTCH3 knockout THP-1
DR   Abcam; ab290142
DR   cancercelllines; CVCL_B9Z8
DR   Wikidata; Q112929037
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 NOTCH4 KO
AC   CVCL_B9Z9
SY   Human NOTCH4 knockout THP-1
DR   Abcam; ab290170
DR   cancercelllines; CVCL_B9Z9
DR   Wikidata; Q112929038
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7884; NOTCH4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 NQO1 KO
AC   CVCL_B9ZA
SY   Human NQO1 knockout THP-1
DR   Abcam; ab290276
DR   cancercelllines; CVCL_B9ZA
DR   Wikidata; Q112929039
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2874; NQO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 NR1H4 KO
AC   CVCL_B9ZB
SY   Human NR1H4 knockout THP-1
DR   Abcam; ab290291
DR   cancercelllines; CVCL_B9ZB
DR   Wikidata; Q112929040
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7967; NR1H4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 NR3C2 KO
AC   CVCL_B9ZC
SY   Human NR3C2 knockout THP-1
DR   Abcam; ab290128
DR   cancercelllines; CVCL_B9ZC
DR   Wikidata; Q112929041
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ODC1 KO
AC   CVCL_D2NR
SY   Human ODC1 knockout THP-1
DR   Abcam; ab301114
DR   Wikidata; Q127379954
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8109; ODC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 P2RX7 KO
AC   CVCL_D2NS
SY   Human P2RX7 knockout THP-1
DR   Abcam; ab301122
DR   Wikidata; Q127379956
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8537; P2RX7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 P2RY12 KO
AC   CVCL_D2NT
SY   Human P2RY12 knockout THP-1
DR   Abcam; ab301125
DR   Wikidata; Q127379959
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18124; P2RY12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PDCD1LG2 KO
AC   CVCL_B9ZD
SY   Human PDCD1LG2 knockout THP-1
DR   Abcam; ab290123
DR   cancercelllines; CVCL_B9ZD
DR   Wikidata; Q112929042
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 PDIA3 KO
AC   CVCL_D2NU
SY   Human PDIA3 knockout THP-1
DR   Abcam; ab301141
DR   Wikidata; Q127379962
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4606; PDIA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PGK1 KO
AC   CVCL_D2NV
SY   Human PGK1 knockout THP-1
DR   Abcam; ab301152
DR   Wikidata; Q127379963
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8896; PGK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PHF8 KO
AC   CVCL_B9ZE
SY   Human PHF8 knockout THP-1
DR   Abcam; ab290247
DR   cancercelllines; CVCL_B9ZE
DR   Wikidata; Q112929043
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20672; PHF8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PHGDH KO
AC   CVCL_D2NW
SY   Human PHGDH knockout THP-1
DR   Abcam; ab301155
DR   Wikidata; Q127379964
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8923; PHGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PIK3CA KO
AC   CVCL_B9ZF
SY   Human PIK3CA knockout THP-1
DR   Abcam; ab290130
DR   cancercelllines; CVCL_B9ZF
DR   Wikidata; Q112929044
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 PIK3CD KO
AC   CVCL_B9ZG
SY   Human PIK3CD knockout THP-1
DR   Abcam; ab290187
DR   cancercelllines; CVCL_B9ZG
DR   Wikidata; Q112929045
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PIK3R4 KO
AC   CVCL_B9ZH
SY   Human PIK3R4 knockout THP-1
DR   Abcam; ab290204
DR   cancercelllines; CVCL_B9ZH
DR   Wikidata; Q112929046
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8982; PIK3R4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PLA2G4A KO
AC   CVCL_B9ZI
SY   Human PLA2G4A knockout THP-1
DR   Abcam; ab290200
DR   cancercelllines; CVCL_B9ZI
DR   Wikidata; Q112929047
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PLAU KO
AC   CVCL_B9ZJ
SY   Human PLAU knockout THP-1
DR   Abcam; ab290292
DR   cancercelllines; CVCL_B9ZJ
DR   Wikidata; Q112929048
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9052; PLAU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PLAUR KO
AC   CVCL_D2NX
SY   Human PLAUR knockout THP-1
DR   Abcam; ab301162
DR   Wikidata; Q127379965
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9053; PLAUR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PLCB3 KO
AC   CVCL_B9ZK
SY   Human PLCB3 knockout THP-1
DR   Abcam; ab290248
DR   cancercelllines; CVCL_B9ZK
DR   Wikidata; Q112929049
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PLCG1 KO
AC   CVCL_B9ZL
SY   Human PLCG1 knockout THP-1
DR   Abcam; ab290218
DR   cancercelllines; CVCL_B9ZL
DR   Wikidata; Q112929050
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PLCG2 KO
AC   CVCL_E7C2
SY   Human PLCG2 knockout THP-1
DR   Abcam; ab308482
RX   PubMed=39429638;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Abcam THP-1 POU2F1 KO
AC   CVCL_D2NY
SY   Human POU2F1 knockout THP-1
DR   Abcam; ab301171
DR   Wikidata; Q127379967
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9212; POU2F1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PRDX6 KO
AC   CVCL_D1YJ
SY   Human PRDX6 knockout THP-1
DR   Abcam; ab301176
DR   Wikidata; Q127379968
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16753; PRDX6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PRMT7 KO
AC   CVCL_B9ZM
SY   Human PRMT7 knockout THP-1
DR   Abcam; ab290265
DR   cancercelllines; CVCL_B9ZM
DR   Wikidata; Q112929051
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25557; PRMT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PSEN1 KO
AC   CVCL_B9ZN
SY   Human PSEN1 knockout THP-1
DR   Abcam; ab290277
DR   cancercelllines; CVCL_B9ZN
DR   Wikidata; Q112929052
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PSMB9 KO
AC   CVCL_C7EM
SY   Human PSMB9 knockout THP-1
DR   Abcam; ab301182
DR   Wikidata; Q123030636
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9546; PSMB9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 PTGER4 KO
AC   CVCL_B9ZP
SY   Human PTGER4 knockout THP-1
DR   Abcam; ab290205
DR   cancercelllines; CVCL_B9ZP
DR   Wikidata; Q112929053
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9596; PTGER4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PTGES2 KO
AC   CVCL_B9ZQ
SY   Human PTGES2 knockout THP-1
DR   Abcam; ab290174
DR   cancercelllines; CVCL_B9ZQ
DR   Wikidata; Q112929054
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17822; PTGES2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 PTK2 KO
AC   CVCL_B9ZR
SY   Human PTK2 knockout THP-1
DR   Abcam; ab290193
DR   cancercelllines; CVCL_B9ZR
DR   Wikidata; Q112929055
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 PTK2B KO
AC   CVCL_D2NZ
SY   Human PTK2B knockout THP-1
DR   Abcam; ab301189
DR   Wikidata; Q127379970
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 PTP4A3 KO
AC   CVCL_B9ZS
SY   Human PTP4A3 knockout THP-1
DR   Abcam; ab290157
DR   cancercelllines; CVCL_B9ZS
DR   Wikidata; Q112929056
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9636; PTP4A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 PTPN12 KO
AC   CVCL_B9ZT
SY   Human PTPN12 knockout THP-1
DR   Abcam; ab290166
DR   cancercelllines; CVCL_B9ZT
DR   Wikidata; Q112929057
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9645; PTPN12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 PTPN6 KO
AC   CVCL_B1AI
SY   Human PTPN6 knockout THP-1
DR   Abcam; ab273717
DR   cancercelllines; CVCL_B1AI
DR   Wikidata; Q110432554
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 PUS1 KO
AC   CVCL_B9ZU
SY   Human PUS1 knockout THP-1
DR   Abcam; ab290267
DR   cancercelllines; CVCL_B9ZU
DR   Wikidata; Q112929058
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15508; PUS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 RAB5A KO
AC   CVCL_D2P0
SY   Human RAB5A knockout THP-1
DR   Abcam; ab301195
DR   Wikidata; Q127379972
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9783; RAB5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 RAC2 KO
AC   CVCL_B9ZV
SY   Human RAC2 knockout THP-1
DR   Abcam; ab290140
DR   cancercelllines; CVCL_B9ZV
DR   Wikidata; Q112929059
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9802; RAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 RBL2 KO
AC   CVCL_C7EN
SY   Human RBL2 knockout THP-1
DR   Abcam; ab301198
DR   Wikidata; Q123030637
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9894; RBL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 RETN KO
AC   CVCL_D2P1
SY   Human RETN knockout THP-1
DR   Abcam; ab301204
DR   Wikidata; Q127379976
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20389; RETN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 RING1 KO
AC   CVCL_B9ZW
SY   Human RING1 knockout THP-1
DR   Abcam; ab290236
DR   cancercelllines; CVCL_B9ZW
DR   Wikidata; Q112929060
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 RIPK1 KO
AC   CVCL_B1AJ
SY   Human RIPK1 knockout THP-1
DR   Abcam; ab276121
DR   cancercelllines; CVCL_B1AJ
DR   Wikidata; Q110432555
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ROCK1 KO
AC   CVCL_C7EP
SY   Human ROCK1 knockout THP-1
DR   Abcam; ab301208
DR   Wikidata; Q123030638
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 ROCK2 KO
AC   CVCL_B9ZX
SY   Human ROCK2 knockout THP-1
DR   Abcam; ab290186
DR   cancercelllines; CVCL_B9ZX
DR   Wikidata; Q112929061
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ROR2 KO
AC   CVCL_B9ZY
SY   Human ROR2 knockout THP-1
DR   Abcam; ab290195
DR   cancercelllines; CVCL_B9ZY
DR   Wikidata; Q112929062
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 RUNX2 KO
AC   CVCL_B9ZZ
SY   Human RUNX2 knockout THP-1
DR   Abcam; ab290127
DR   cancercelllines; CVCL_B9ZZ
DR   Wikidata; Q112929063
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10472; RUNX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 RYBP KO
AC   CVCL_C0A0
SY   Human RYBP knockout THP-1
DR   Abcam; ab290246
DR   cancercelllines; CVCL_C0A0
DR   Wikidata; Q112929064
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10480; RYBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 RYR1 KO
AC   CVCL_D2P2
SY   Human RYR1 knockout THP-1
DR   Abcam; ab301213
DR   Wikidata; Q127379978
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10483; RYR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 S100A8 KO
AC   CVCL_C0A1
SY   Human S100A8 (MRP8) knockout THP-1
DR   Abcam; ab269487
DR   cancercelllines; CVCL_C0A1
DR   Wikidata; Q112929065
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10498; S100A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 SATB1 KO
AC   CVCL_D2P3
SY   Human SATB1 knockout THP-1
DR   Abcam; ab301218
DR   Wikidata; Q127379980
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10541; SATB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 SCARB1 KO
AC   CVCL_C0A2
SY   Human SCARB1 knockout THP-1
DR   Abcam; ab290199
DR   cancercelllines; CVCL_C0A2
DR   Wikidata; Q112929066
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1664; SCARB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SDC4 KO
AC   CVCL_C0A3
SY   Human SDC4 knockout THP-1
DR   Abcam; ab290137
DR   cancercelllines; CVCL_C0A3
DR   Wikidata; Q112929067
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10661; SDC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 SETD2 KO
AC   CVCL_C0A4
SY   Human SETD2 knockout THP-1
DR   Abcam; ab290203
DR   cancercelllines; CVCL_C0A4
DR   Wikidata; Q112929068
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SKP2 KO
AC   CVCL_C7EQ
SY   Human SKP2 knockout THP-1
DR   Abcam; ab301224
DR   Wikidata; Q123030639
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 SLC12A5 KO
AC   CVCL_D2P4
SY   Human SLC12A5 knockout THP-1
DR   Abcam; ab301227
DR   Wikidata; Q127379981
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13818; SLC12A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 SLC16A1 KO
AC   CVCL_D2P5
SY   Human SLC16A1 knockout THP-1
DR   Abcam; ab301230
DR   Wikidata; Q127379982
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10922; SLC16A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 SLC29A1 KO
AC   CVCL_D2P6
SY   Human SLC29A1 knockout THP-1
DR   Abcam; ab301237
DR   Wikidata; Q127379984
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 SLC9A1 KO
AC   CVCL_D2P7
SY   Human SLC9A1 knockout THP-1
DR   Abcam; ab301243
DR   Wikidata; Q127379985
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 SLFN11 KO
AC   CVCL_C0A5
SY   Human SLFN11 knockout THP-1
DR   Abcam; ab290254
DR   cancercelllines; CVCL_C0A5
DR   Wikidata; Q112929069
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SMARCAL1 KO
AC   CVCL_C0A6
SY   Human SMARCAL1 knockout THP-1
DR   Abcam; ab290217
DR   cancercelllines; CVCL_C0A6
DR   Wikidata; Q112929070
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SMARCC2 KO
AC   CVCL_C0A7
SY   Human SMARCC2 knockout THP-1
DR   Abcam; ab290211
DR   cancercelllines; CVCL_C0A7
DR   Wikidata; Q112929071
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11105; SMARCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SMARCE1 KO
AC   CVCL_C0A8
SY   Human SMARCE1 knockout THP-1
DR   Abcam; ab290237
DR   cancercelllines; CVCL_C0A8
DR   Wikidata; Q112929072
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11109; SMARCE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SMPD1 KO
AC   CVCL_C7ER
SY   Human SMPD1 knockout THP-1
DR   Abcam; ab301248
DR   Wikidata; Q123030640
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 SMURF1 KO
AC   CVCL_C0A9
SY   Human SMURF1 knockout THP-1
DR   Abcam; ab290167
DR   cancercelllines; CVCL_C0A9
DR   Wikidata; Q112929073
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 SMYD2 KO
AC   CVCL_C0AA
SY   Human SMYD2 knockout THP-1
DR   Abcam; ab290209
DR   cancercelllines; CVCL_C0AA
DR   Wikidata; Q112929074
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20982; SMYD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SMYD3 KO
AC   CVCL_C0AB
SY   Human SMYD3 knockout THP-1
DR   Abcam; ab290232
DR   cancercelllines; CVCL_C0AB
DR   Wikidata; Q112929075
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15513; SMYD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SOCS3 KO
AC   CVCL_C0AC
SY   Human SOCS3 knockout THP-1
DR   Abcam; ab290293
DR   cancercelllines; CVCL_C0AC
DR   Wikidata; Q112929076
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 SPHK1 KO
AC   CVCL_D2P8
SY   Human SPHK1 knockout THP-1
DR   Abcam; ab301252
DR   Wikidata; Q127379986
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 SRF KO
AC   CVCL_C0AD
SY   Human SRF knockout THP-1
DR   Abcam; ab290161
DR   cancercelllines; CVCL_C0AD
DR   Wikidata; Q112929077
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11291; SRF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 SRPK1 KO
AC   CVCL_C0AE
SY   Human SRPK1 knockout THP-1
DR   Abcam; ab290231
DR   cancercelllines; CVCL_C0AE
DR   Wikidata; Q112929078
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 STAT4 KO
AC   CVCL_C0AF
SY   Human STAT4 knockout THP-1
DR   Abcam; ab290144
DR   cancercelllines; CVCL_C0AF
DR   Wikidata; Q112929079
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11365; STAT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 STAT5A KO
AC   CVCL_C0AG
SY   Human STAT5A knockout THP-1
DR   Abcam; ab290122
DR   cancercelllines; CVCL_C0AG
DR   Wikidata; Q112929080
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11366; STAT5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 STIM2 KO
AC   CVCL_D2P9
SY   Human STIM2 knockout THP-1
DR   Abcam; ab301257
DR   Wikidata; Q127379987
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19205; STIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 STING1 KO
AC   CVCL_B1AK
SY   Human TMEM173 knockout THP-1
DR   Abcam; ab270493
DR   cancercelllines; CVCL_B1AK
DR   Wikidata; Q110432556
RX   DOI=10.12688/f1000research.155929.2;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 STIP1 KO
AC   CVCL_D2PA
SY   Human STIP1 knockout THP-1
DR   Abcam; ab301260
DR   Wikidata; Q127379991
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11387; STIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 STK4 KO
AC   CVCL_C0AH
SY   Human STK4 knockout THP-1
DR   Abcam; ab290202
DR   cancercelllines; CVCL_C0AH
DR   Wikidata; Q112929081
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 SUV39H1 KO
AC   CVCL_C0AI
SY   Human SUV39H1 knockout THP-1
DR   Abcam; ab290173
DR   cancercelllines; CVCL_C0AI
DR   Wikidata; Q112929082
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 SUZ12 KO
AC   CVCL_C0AJ
SY   Human SUZ12 knockout THP-1
DR   Abcam; ab290148
DR   cancercelllines; CVCL_C0AJ
DR   Wikidata; Q112929083
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 SYK KO
AC   CVCL_E7C4
SY   Human SYK knockout THP-1
DR   Abcam; ab288700
RX   PubMed=38948505;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Abcam THP-1 TAPBP KO
AC   CVCL_C0AK
SY   Human TAPBP knockout THP-1
DR   Abcam; ab290226
DR   cancercelllines; CVCL_C0AK
DR   Wikidata; Q112929084
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11566; TAPBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TBK1 KO
AC   CVCL_C0AL
SY   Human TBK1 knockout THP-1
DR   Abcam; ab290125
DR   cancercelllines; CVCL_C0AL
DR   Wikidata; Q112929085
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TBP KO
AC   CVCL_C0AM
SY   Human TBP knockout THP-1
DR   Abcam; ab290194
DR   cancercelllines; CVCL_C0AM
DR   Wikidata; Q112929086
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11588; TBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TCF7L2 KO
AC   CVCL_C0AN
SY   Human TCF7L2 knockout THP-1
DR   Abcam; ab290168
DR   cancercelllines; CVCL_C0AN
DR   Wikidata; Q112929087
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11641; TCF7L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TFDP1 KO
AC   CVCL_C0AP
SY   Human TFDP1 knockout THP-1
DR   Abcam; ab290264
DR   cancercelllines; CVCL_C0AP
DR   Wikidata; Q112929088
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11749; TFDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 THBS1 KO
AC   CVCL_C0AQ
SY   Human THBS1 knockout THP-1
DR   Abcam; ab290278
DR   cancercelllines; CVCL_C0AQ
DR   Wikidata; Q112929089
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11785; THBS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TIMP2 KO
AC   CVCL_C7ES
SY   Human TIMP2 knockout THP-1
DR   Abcam; ab301269
DR   Wikidata; Q123030641
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11821; TIMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 TIMP3 KO
AC   CVCL_C0AR
SY   Human TIMP3 knockout THP-1
DR   Abcam; ab290139
DR   cancercelllines; CVCL_C0AR
DR   Wikidata; Q112929090
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11822; TIMP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TLN1 KO
AC   CVCL_C0AS
SY   Human TLN1 knockout THP-1
DR   Abcam; ab290155
DR   cancercelllines; CVCL_C0AS
DR   Wikidata; Q112929091
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11845; TLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TNF KO
AC   CVCL_B1AL
SY   Human TNF knockout THP-1
DR   Abcam; ab273761
DR   cancercelllines; CVCL_B1AL
DR   Wikidata; Q110432557
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11892; TNF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TNFRSF10B KO
AC   CVCL_C0AT
SY   Human TNFRSF10B knockout THP-1
DR   Abcam; ab290191
DR   cancercelllines; CVCL_C0AT
DR   Wikidata; Q112929092
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TNFRSF1B KO
AC   CVCL_C0AU
SY   Human TNFRSF1B knockout THP-1
DR   Abcam; ab290129
DR   cancercelllines; CVCL_C0AU
DR   Wikidata; Q112929093
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11917; TNFRSF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TP73 KO
AC   CVCL_C0AV
SY   Human TP73 knockout THP-1
DR   Abcam; ab290220
DR   cancercelllines; CVCL_C0AV
DR   Wikidata; Q112929094
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12003; TP73.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TPM1 KO
AC   CVCL_D2PB
SY   Human TPM1 knockout THP-1
DR   Abcam; ab301276
DR   Wikidata; Q127379993
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12010; TPM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 TRADD KO
AC   CVCL_C0AW
SY   Human TRADD knockout THP-1
DR   Abcam; ab290156
DR   cancercelllines; CVCL_C0AW
DR   Wikidata; Q112929095
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12030; TRADD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TRAF2 KO
AC   CVCL_C0AX
SY   Human TRAF2 knockout THP-1
DR   Abcam; ab290206
DR   cancercelllines; CVCL_C0AX
DR   Wikidata; Q112929096
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TRAP1 KO
AC   CVCL_C7ET
SY   Human TRAP1 knockout THP-1
DR   Abcam; ab301279
DR   Wikidata; Q123030642
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16264; TRAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 TREM2 KO
AC   CVCL_B1AM
SY   Human TREM2 knockout THP-1
DR   Abcam; ab269489
DR   cancercelllines; CVCL_B1AM
DR   Wikidata; Q110432558
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TRMT2A KO
AC   CVCL_C0AY
SY   Human TRMT2A knockout THP-1
DR   Abcam; ab290269
DR   cancercelllines; CVCL_C0AY
DR   Wikidata; Q112929097
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TUBA4A KO
AC   CVCL_D2PC
SY   Human TUBA4A knockout THP-1
DR   Abcam; ab301288
DR   Wikidata; Q127379994
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12407; TUBA4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 TWIST1 KO
AC   CVCL_C0AZ
SY   Human TWIST1 knockout THP-1
DR   Abcam; ab290119
DR   cancercelllines; CVCL_C0AZ
DR   Wikidata; Q112929098
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12428; TWIST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 TWIST2 KO
AC   CVCL_C0B0
SY   Human TWIST2 knockout THP-1
DR   Abcam; ab290230
DR   cancercelllines; CVCL_C0B0
DR   Wikidata; Q112929099
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20670; TWIST2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 TXNRD1 KO
AC   CVCL_C7EU
SY   Human TXNRD1 knockout THP-1
DR   Abcam; ab301294
DR   Wikidata; Q123030643
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12437; TXNRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 TXNIP KO
AC   CVCL_C7EV
SY   Human TXNIP knockout THP-1
DR   Abcam; ab301291
DR   Wikidata; Q123030645
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16952; TXNIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Abcam THP-1 TYMS KO
AC   CVCL_D2PD
SY   Human TYMS knockout THP-1
DR   Abcam; ab301297
DR   Wikidata; Q127379996
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12441; TYMS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 TYROBP KO
AC   CVCL_B7TG
SY   Human TYROBP (DAP12) knockout THP-1
DR   Abcam; ab273726
DR   cancercelllines; CVCL_B7TG
DR   Wikidata; Q112929100
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12449; TYROBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 U2AF1 KO
AC   CVCL_C0B1
SY   Human U2AF1 knockout THP-1
DR   Abcam; ab290184
DR   cancercelllines; CVCL_C0B1
DR   Wikidata; Q112929101
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12453; U2AF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 UBA1 KO
AC   CVCL_C0B2
SY   Human UBA1 knockout THP-1
DR   Abcam; ab290208
DR   cancercelllines; CVCL_C0B2
DR   Wikidata; Q112929102
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12469; UBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 UBE2D2 KO
AC   CVCL_C0B3
SY   Human UBE2D2 knockout THP-1
DR   Abcam; ab290268
DR   cancercelllines; CVCL_C0B3
DR   Wikidata; Q112929103
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12475; UBE2D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 UCHL5 KO
AC   CVCL_C0B4
SY   Human UCHL5 knockout THP-1
DR   Abcam; ab290238
DR   cancercelllines; CVCL_C0B4
DR   Wikidata; Q112929105
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19678; UCHL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 UCP2 KO
AC   CVCL_D2PE
SY   Human UCP2 knockout THP-1
DR   Abcam; ab301300
DR   Wikidata; Q127379998
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 ULBP2 KO
AC   CVCL_C0B5
SY   Human ULBP2 knockout THP-1
DR   Abcam; ab290207
DR   cancercelllines; CVCL_C0B5
DR   Wikidata; Q112929106
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14894; ULBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 ULBP3 KO
AC   CVCL_C0B6
SY   Human ULBP3 knockout THP-1
DR   Abcam; ab290257
DR   cancercelllines; CVCL_C0B6
DR   Wikidata; Q112929107
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14895; ULBP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 UVRAG KO
AC   CVCL_C0B7
SY   Human UVRAG knockout THP-1
DR   Abcam; ab290147
DR   cancercelllines; CVCL_C0B7
DR   Wikidata; Q112929108
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12640; UVRAG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 VAV1 KO
AC   CVCL_C0B8
SY   Human VAV1 knockout THP-1
DR   Abcam; ab290171
DR   cancercelllines; CVCL_C0B8
DR   Wikidata; Q112929109
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12657; VAV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 VCAN KO
AC   CVCL_C0B9
SY   Human VCAN knockout THP-1
DR   Abcam; ab290159
DR   cancercelllines; CVCL_C0B9
DR   Wikidata; Q112929110
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2464; VCAN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 WDR77 KO
AC   CVCL_C0BA
SY   Human WDR77 knockout THP-1
DR   Abcam; ab290234
DR   cancercelllines; CVCL_C0BA
DR   Wikidata; Q112929111
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29652; WDR77.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 WNT11 KO
AC   CVCL_C0BB
SY   Human Wnt11 knockout THP-1
DR   Abcam; ab290185
DR   cancercelllines; CVCL_C0BB
DR   Wikidata; Q112929112
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12776; WNT11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 XBP1 KO
AC   CVCL_D2PF
SY   Human XBP1 knockout THP-1
DR   Abcam; ab301305
DR   Wikidata; Q127379999
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12801; XBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 XDH KO
AC   CVCL_D2PG
SY   Human XDH knockout THP-1
DR   Abcam; ab301308
DR   Wikidata; Q127380000
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12805; XDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam THP-1 YTHDC2 KO
AC   CVCL_C0BC
SY   Human YTHDC2 knockout THP-1
DR   Abcam; ab290259
DR   cancercelllines; CVCL_C0BC
DR   Wikidata; Q112929113
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24721; YTHDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 YTHDF1 KO
AC   CVCL_C0BD
SY   Human YTHDF1 knockout THP-1
DR   Abcam; ab290227
DR   cancercelllines; CVCL_C0BD
DR   Wikidata; Q112929114
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 YTHDF3 KO
AC   CVCL_C0BE
SY   Human YTHDF3 knockout THP-1
DR   Abcam; ab290250
DR   cancercelllines; CVCL_C0BE
DR   Wikidata; Q112929115
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26465; YTHDF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Abcam THP-1 YY1 KO
AC   CVCL_C0BF
SY   Human YY1 knockout THP-1
DR   Abcam; ab290158
DR   cancercelllines; CVCL_C0BF
DR   Wikidata; Q112929116
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12856; YY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam THP-1 ZEB2 KO
AC   CVCL_C0BG
SY   Human ZEB2 knockout THP-1
DR   Abcam; ab290126
DR   cancercelllines; CVCL_C0BG
DR   Wikidata; Q112929117
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam U-87MG ABCA1 KO
AC   CVCL_D1RF
SY   Human ABCA1 knockout U-87 MG
DR   Abcam; ab306610
DR   Wikidata; Q127380003
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29; ABCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ABL1 KO
AC   CVCL_D1RG
SY   Human ABL1 knockout U-87 MG
DR   Abcam; ab306611
DR   Wikidata; Q127380005
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ADAM10 KO
AC   CVCL_D1RH
SY   Human ADAM10 knockout U-87 MG
DR   Abcam; ab306612
DR   Wikidata; Q127380006
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ADRB3 KO
AC   CVCL_D1RI
SY   Human ADRB3 knockout U-87 MG
DR   Abcam; ab306613
DR   Wikidata; Q127380007
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:288; ADRB3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG AKR1C1 KO
AC   CVCL_D1RJ
SY   Human AKR1C1 knockout U-87 MG
DR   Abcam; ab306828
DR   Wikidata; Q127380008
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:384; AKR1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ALDH1A1 KO
AC   CVCL_D1RK
SY   Human ALDH1A1 knockout U-87 MG
DR   Abcam; ab306615
DR   Wikidata; Q127380009
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:402; ALDH1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG APP KO
AC   CVCL_D1RL
SY   Human APP knockout U-87 MG
DR   Abcam; ab306617
DR   Wikidata; Q127380011
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ASNS KO
AC   CVCL_D1RM
SY   Human ASNS knockout U-87 MG
DR   Abcam; ab306859
DR   Wikidata; Q127380012
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:753; ASNS.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ASS1 KO
AC   CVCL_D1RN
SY   Human ASS1 knockout U-87 MG
DR   Abcam; ab306830
DR   Wikidata; Q127380014
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:758; ASS1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ATP1A3 KO
AC   CVCL_D1RP
SY   Human ATP1A3 knockout U-87 MG
DR   Abcam; ab306622
DR   Wikidata; Q127380015
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:801; ATP1A3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG BACE2 KO
AC   CVCL_D1RQ
SY   Human BACE2 knockout U-87 MG
DR   Abcam; ab306624
DR   Wikidata; Q127380016
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:934; BACE2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG BEST1 KO
AC   CVCL_D1RR
SY   Human BEST1 knockout U-87 MG
DR   Abcam; ab306626
DR   Wikidata; Q127380018
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12703; BEST1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG BIN1 KO
AC   CVCL_D1RS
SY   Human BIN1 knockout U-87 MG
DR   Abcam; ab306627
DR   Wikidata; Q127380019
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1052; BIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CACNA2D1 KO
AC   CVCL_D1RT
SY   Human CACNA2D1 knockout U-87 MG
DR   Abcam; ab306832
DR   Wikidata; Q127380020
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1399; CACNA2D1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CAV1 KO
AC   CVCL_D1RU
SY   Human CAV1 knockout U-87 MG
DR   Abcam; ab306811
DR   Wikidata; Q127380021
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CD82 KO
AC   CVCL_D1RV
SY   Human CD82 knockout U-87 MG
DR   Abcam; ab306834
DR   Wikidata; Q127380022
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6210; CD82.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CHI3L1 KO
AC   CVCL_D1RW
SY   Human CHI3L1 knockout U-87 MG
DR   Abcam; ab306635
DR   Wikidata; Q127380024
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1932; CHI3L1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CHRM3 KO
AC   CVCL_D1RX
SY   Human CHRM3 knockout U-87 MG
DR   Abcam; ab306637
DR   Wikidata; Q127380025
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1952; CHRM3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CHRNA5 KO
AC   CVCL_D1RY
SY   Human CHRNA5 knockout U-87 MG
DR   Abcam; ab306639
DR   Wikidata; Q127380026
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1959; CHRNA5.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CNTNAP1 KO
AC   CVCL_D1RZ
SY   Human CNTNAP1 knockout U-87 MG
DR   Abcam; ab306642
DR   Wikidata; Q127380027
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8011; CNTNAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CSF1 KO
AC   CVCL_D1S0
SY   Human CSF1 knockout U-87 MG
DR   Abcam; ab288711
DR   Wikidata; Q127380029
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CST3 KO
AC   CVCL_D1S1
SY   Human CST3 knockout U-87 MG
DR   Abcam; ab306645
DR   Wikidata; Q127380031
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2475; CST3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CTSD KO
AC   CVCL_D1S2
SY   Human CTSD knockout U-87 MG
DR   Abcam; ab306647
DR   Wikidata; Q127380032
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2529; CTSD.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG CYP1B1 KO
AC   CVCL_D1S3
SY   Human CYP1B1 knockout U-87 MG
DR   Abcam; ab306650
DR   Wikidata; Q127380033
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2597; CYP1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG DCX KO
AC   CVCL_D1S4
SY   Human DCX knockout U-87 MG
DR   Abcam; ab306651
DR   Wikidata; Q127380034
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2714; DCX.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG DLG4 KO
AC   CVCL_D1S5
SY   Human DLG4 knockout U-87 MG
DR   Abcam; ab306652
DR   Wikidata; Q127380038
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2903; DLG4.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG DRD1 KO
AC   CVCL_D1S6
SY   Human DRD1 knockout U-87 MG
DR   Abcam; ab306654
DR   Wikidata; Q127380039
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3020; DRD1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG DYRK1A KO
AC   CVCL_D1S7
SY   Human DYRK1A knockout U-87 MG
DR   Abcam; ab306655
DR   Wikidata; Q127380041
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3091; DYRK1A.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ECE1 KO
AC   CVCL_D1S8
SY   Human ECE1 knockout U-87 MG
DR   Abcam; ab288712
DR   Wikidata; Q127380042
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3146; ECE1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG EGFR KO
AC   CVCL_D1S9
SY   Human EGFR knockout U-87 MG
DR   Abcam; ab306812
DR   Wikidata; Q127380046
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ELAVL3 KO
AC   CVCL_D1SA
SY   Human ELAVL3 knockout U-87 MG
DR   Abcam; ab306657
DR   Wikidata; Q127380047
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3314; ELAVL3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ELAVL4 KO
AC   CVCL_D1SB
SY   Human ELAVL4 knockout U-87 MG
DR   Abcam; ab306658
DR   Wikidata; Q127380048
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3315; ELAVL4.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ENPP2 KO
AC   CVCL_D1SC
SY   Human ENPP2 knockout U-87 MG
DR   Abcam; ab306822
DR   Wikidata; Q127380049
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3357; ENPP2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ERN1 KO
AC   CVCL_D1SD
SY   Human ERN1 knockout U-87 MG
DR   Abcam; ab306817
DR   Wikidata; Q127380051
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG FGFR1 KO
AC   CVCL_D1SE
SY   Human FGFR1 knockout U-87 MG
DR   Abcam; ab306662
DR   Wikidata; Q127380052
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG FLT1 KO
AC   CVCL_D1SF
SY   Human FLT1 knockout U-87 MG
DR   Abcam; ab306663
DR   Wikidata; Q127380053
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG FMR1 KO
AC   CVCL_D1SG
SY   Human FMR1 knockout U-87 MG
DR   Abcam; ab306664
DR   Wikidata; Q127380056
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG FN1 KO
AC   CVCL_D1SH
SY   Human FN1 knockout U-87 MG
DR   Abcam; ab306837
DR   Wikidata; Q127380058
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG FOS KO
AC   CVCL_D1SI
SY   Human FOS knockout U-87 MG
DR   Abcam; ab306665
DR   Wikidata; Q127380059
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG FOXA2 KO
AC   CVCL_D1SJ
SY   Human FOXA2 knockout U-87 MG
DR   Abcam; ab306666
DR   Wikidata; Q127380060
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG FOXC2 KO
AC   CVCL_D1SK
SY   Human FOXC2 knockout U-87 MG
DR   Abcam; ab306838
DR   Wikidata; Q127380061
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3801; FOXC2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG G3BP1 KO
AC   CVCL_D1SL
SY   Human G3BP1 knockout U-87 MG
DR   Abcam; ab306667
DR   Wikidata; Q127380065
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30292; G3BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GABBR1 KO
AC   CVCL_D1SM
SY   Human GABBR1 knockout U-87 MG
DR   Abcam; ab306668
DR   Wikidata; Q127380066
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4070; GABBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GABRA1 KO
AC   CVCL_D1SN
SY   Human GABRA1 knockout U-87 MG
DR   Abcam; ab306669
DR   Wikidata; Q127380067
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4075; GABRA1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GAD1 KO
AC   CVCL_D1SP
SY   Human GAD1 knockout U-87 MG
DR   Abcam; ab306670
DR   Wikidata; Q127380068
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4092; GAD1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GBA KO
AC   CVCL_D1SQ
SY   Human GBA knockout U-87 MG
DR   Abcam; ab306673
DR   Wikidata; Q127380069
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GFAP KO
AC   CVCL_D1SR
SY   Human GFAP knockout U-87 MG
DR   Abcam; ab306675
DR   Wikidata; Q127380071
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4235; GFAP.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GJA1 KO
AC   CVCL_D1SS
SY   Human GJA1 knockout U-87 MG
DR   Abcam; ab306676
DR   Wikidata; Q127380073
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4274; GJA1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GLUL KO
AC   CVCL_D1ST
SY   Human GLUL knockout U-87 MG
DR   Abcam; ab306679
DR   Wikidata; Q127380074
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRIA1 KO
AC   CVCL_D1SU
SY   Human GRIA1 knockout U-87 MG
DR   Abcam; ab306682
DR   Wikidata; Q127380075
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4571; GRIA1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRIA2 KO
AC   CVCL_D1SV
SY   Human GRIA2 knockout U-87 MG
DR   Abcam; ab306683
DR   Wikidata; Q127380077
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4572; GRIA2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRIA4 KO
AC   CVCL_D1SW
SY   Human GRIA4 knockout U-87 MG
DR   Abcam; ab306685
DR   Wikidata; Q127380078
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4574; GRIA4.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRIN2A KO
AC   CVCL_D1SX
SY   Human GRIN2A knockout U-87 MG
DR   Abcam; ab306687
DR   Wikidata; Q127380079
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4585; GRIN2A.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRIN2B KO
AC   CVCL_D1SY
SY   Human GRIN2B knockout U-87 MG
DR   Abcam; ab306688
DR   Wikidata; Q127380080
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRM1 KO
AC   CVCL_D1SZ
SY   Human GRM1 knockout U-87 MG
DR   Abcam; ab306689
DR   Wikidata; Q127380082
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4593; GRM1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRM3 KO
AC   CVCL_D1T0
SY   Human GRM3 knockout U-87 MG
DR   Abcam; ab306690
DR   Wikidata; Q127380083
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4595; GRM3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRM5 KO
AC   CVCL_D1T1
SY   Human GRM5 knockout U-87 MG
DR   Abcam; ab306691
DR   Wikidata; Q127380084
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4597; GRM5.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GRM7 KO
AC   CVCL_D1T2
SY   Human GRM7 knockout U-87 MG
DR   Abcam; ab306692
DR   Wikidata; Q127380085
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4599; GRM7.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GSK3A KO
AC   CVCL_D1T3
SY   Human GSK3A knockout U-87 MG
DR   Abcam; ab306694
DR   Wikidata; Q127380088
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4616; GSK3A.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG GSN KO
AC   CVCL_D1T4
SY   Human GSN knockout U-87 MG
DR   Abcam; ab306696
DR   Wikidata; Q127380089
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4620; GSN.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG HTR7 KO
AC   CVCL_D1T5
SY   Human HTR7 knockout U-87 MG
DR   Abcam; ab306705
DR   Wikidata; Q127380090
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5302; HTR7.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG HTT KO
AC   CVCL_D1T6
SY   Human HTT knockout U-87 MG
DR   Abcam; ab306706
DR   Wikidata; Q127380092
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG IDH1 KO
AC   CVCL_D1T7
SY   Human IDH1 knockout U-87 MG
DR   Abcam; ab306820
DR   Wikidata; Q127380093
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG IL13RA2 KO
AC   CVCL_D1T8
SY   Human IL13RA2 knockout U-87 MG
DR   Abcam; ab306839
DR   Wikidata; Q127380095
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5975; IL13RA2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ITPR1 KO
AC   CVCL_D1T9
SY   Human ITPR1 knockout U-87 MG
DR   Abcam; ab306712
DR   Wikidata; Q127380096
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG KCND2 KO
AC   CVCL_D1TA
SY   Human KCND2 knockout U-87 MG
DR   Abcam; ab306714
DR   Wikidata; Q127380097
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6238; KCND2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG KCNJ6 KO
AC   CVCL_D1TB
SY   Human KCNJ6 knockout U-87 MG
DR   Abcam; ab306715
DR   Wikidata; Q127380098
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6267; KCNJ6.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG KEAP1 KO
AC   CVCL_D1TC
SY   Human KEAP1 knockout U-87 MG
DR   Abcam; ab306716
DR   Wikidata; Q127380100
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG L1CAM KO
AC   CVCL_D1TD
SY   Human L1CAM knockout U-87 MG
DR   Abcam; ab306718
DR   Wikidata; Q127380101
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6470; L1CAM.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG LAMP1 KO
AC   CVCL_D1TE
SY   Human LAMP1 knockout U-87 MG
DR   Abcam; ab306719
DR   Wikidata; Q127380102
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG LAMP2 KO
AC   CVCL_D1TF
SY   Human LAMP2 knockout U-87 MG
DR   Abcam; ab306720
DR   Wikidata; Q127380103
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG LGI1 KO
AC   CVCL_D1TG
SY   Human LGI1 knockout U-87 MG
DR   Abcam; ab306721
DR   Wikidata; Q127380105
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6572; LGI1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG LOXL1 KO
AC   CVCL_D1TH
SY   Human LOXL1 knockout U-87 MG
DR   Abcam; ab306843
DR   Wikidata; Q127380106
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6665; LOXL1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG MAP2 KO
AC   CVCL_D1TI
SY   Human MAP2 knockout U-87 MG
DR   Abcam; ab306723
DR   Wikidata; Q127380107
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6839; MAP2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG MAPT KO
AC   CVCL_B0ZG
SY   Human MAPT knockout U-87 MG
DR   Abcam; ab269490
DR   cancercelllines; CVCL_B0ZG
DR   Wikidata; Q110432559
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Abcam; ab269490; true.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U-87MG MGLL KO
AC   CVCL_D1TJ
SY   Human MGLL knockout U-87 MG
DR   Abcam; ab306845
DR   Wikidata; Q127380108
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17038; MGLL.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG MMP3 KO
AC   CVCL_D1TK
SY   Human MMP3 knockout U-87 MG
DR   Abcam; ab306727
DR   Wikidata; Q127380110
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7173; MMP3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG MMP9 KO
AC   CVCL_D1TL
SY   Human MMP9 knockout U-87 MG
DR   Abcam; ab306728
DR   Wikidata; Q127380111
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7176; MMP9.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NCAM1 KO
AC   CVCL_D1TM
SY   Human NCAM1 knockout U-87 MG
DR   Abcam; ab306729
DR   Wikidata; Q127380112
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NCSTN KO
AC   CVCL_D1TN
SY   Human NCSTN knockout U-87 MG
DR   Abcam; ab306730
DR   Wikidata; Q127380113
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17091; NCSTN.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NEO1 KO
AC   CVCL_D1TP
SY   Human NEO1 knockout U-87 MG
DR   Abcam; ab306732
DR   Wikidata; Q127380115
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7754; NEO1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NFE2L2 KO
AC   CVCL_D1TQ
SY   Human NFE2L2 knockout U-87 MG
DR   Abcam; ab306733
DR   Wikidata; Q127380117
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NPTX1 KO
AC   CVCL_D1TR
SY   Human NPTX1 knockout U-87 MG
DR   Abcam; ab306738
DR   Wikidata; Q127380118
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7952; NPTX1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NRP2 KO
AC   CVCL_D1TS
SY   Human NRP2 knockout U-87 MG
DR   Abcam; ab306847
DR   Wikidata; Q127380119
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7751; NELL2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NTRK2 KO
AC   CVCL_D1TT
SY   Human NTRK2 knockout U-87 MG
DR   Abcam; ab306743
DR   Wikidata; Q127380121
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8032; NTRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG NTRK3 KO
AC   CVCL_D1TU
SY   Human NTRK3 knockout U-87 MG
DR   Abcam; ab306744
DR   Wikidata; Q127380122
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8033; NTRK3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PARK7 KO
AC   CVCL_D1TV
SY   Human PARK7 knockout U-87 MG
DR   Abcam; ab306748
DR   Wikidata; Q127380123
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PDE5A KO
AC   CVCL_D1TW
SY   Human PDE5A knockout U-87 MG
DR   Abcam; ab306749
DR   Wikidata; Q127380124
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8784; PDE5A.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PEA15 KO
AC   CVCL_D1TX
SY   Human PEA15 knockout U-87 MG
DR   Abcam; ab306860
DR   Wikidata; Q127380125
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8822; PEA15.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PLA2G6 KO
AC   CVCL_D1TY
SY   Human PLA2G6 knockout U-87 MG
DR   Abcam; ab306752
DR   Wikidata; Q127380127
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9039; PLA2G6.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PLAUR KO
AC   CVCL_D1TZ
SY   Human PLAUR knockout U-87 MG
DR   Abcam; ab306821
DR   Wikidata; Q127380128
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9053; PLAUR.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PLXNB2 KO
AC   CVCL_D1U0
SY   Human PLXNB2 knockout U-87 MG
DR   Abcam; ab306753
DR   Wikidata; Q127380129
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9104; PLXNB2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PML KO
AC   CVCL_D1U1
SY   Human PML knockout U-87 MG
DR   Abcam; ab306823
DR   Wikidata; Q127380131
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PRKCA KO
AC   CVCL_D1U2
SY   Human PRKCA knockout U-87 MG
DR   Abcam; ab306755
DR   Wikidata; Q127380132
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PRKCD KO
AC   CVCL_D1U3
SY   Human PRKCD knockout U-87 MG
DR   Abcam; ab306756
DR   Wikidata; Q127380133
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9399; PRKCD.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG PRKCG KO
AC   CVCL_D1U4
SY   Human PRKCG knockout U-87 MG
DR   Abcam; ab306757
DR   Wikidata; Q127380134
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG RAB39B KO
AC   CVCL_D1U5
SY   Human RAB39B knockout U-87 MG
DR   Abcam; ab306767
DR   Wikidata; Q127380136
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16499; RAB39B.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG RAB8A KO
AC   CVCL_D1U6
SY   Human RAB8A knockout U-87 MG
DR   Abcam; ab306769
DR   Wikidata; Q127380137
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG ROBO1 KO
AC   CVCL_D1U7
SY   Human ROBO1 knockout U-87 MG
DR   Abcam; ab306771
DR   Wikidata; Q127380138
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10249; ROBO1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG RUNx1 KO
AC   CVCL_D1U8
SY   Human RUNx1 knockout U-87 MG
DR   Abcam; ab306773
DR   Wikidata; Q127380139
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SCARB2 KO
AC   CVCL_D1U9
SY   Human SCARB2 knockout U-87 MG
DR   Abcam; ab306774
DR   Wikidata; Q127380142
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1665; SCARB2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SCG2 KO
AC   CVCL_D1UA
SY   Human SCG2 knockout U-87 MG
DR   Abcam; ab306865
DR   Wikidata; Q127380143
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10575; SCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SDHB KO
AC   CVCL_D1UB
SY   Human SDHB knockout U-87 MG
DR   Abcam; ab306825
DR   Wikidata; Q127380144
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10681; SDHB.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SERPINB2 KO
AC   CVCL_D1UC
SY   Human SERPINB2 knockout U-87 MG
DR   Abcam; ab306850
DR   Wikidata; Q127380145
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8584; SERPINB2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SERPINE1 KO
AC   CVCL_D1UD
SY   Human SERPINE1 knockout U-87 MG
DR   Abcam; ab306851
DR   Wikidata; Q127380147
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8583; SERPINE1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SFRP1 KO
AC   CVCL_D1UE
SY   Human SFRP1 knockout U-87 MG
DR   Abcam; ab306775
DR   Wikidata; Q127380148
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10776; SFRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SLC2A3 KO
AC   CVCL_D1UF
SY   Human SLC2A3 knockout U-87 MG
DR   Abcam; ab306815
DR   Wikidata; Q127380149
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11007; SLC2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SLC6A4 KO
AC   CVCL_D1UG
SY   Human SLC6A4 knockout U-87 MG
DR   Abcam; ab306778
DR   Wikidata; Q127380150
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11050; SLC6A4.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SLIT2 KO
AC   CVCL_D1UH
SY   Human SLIT2 knockout U-87 MG
DR   Abcam; ab306779
DR   Wikidata; Q127380152
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11086; SLIT2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG SNCA KO
AC   CVCL_C0BJ
SY   Human SNCA (Alpha-synuclein) knockout U-87 MG
DR   Abcam; ab282333
DR   cancercelllines; CVCL_C0BJ
DR   Wikidata; Q112929118
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Abcam U-87MG SQSTM1 KO
AC   CVCL_D1UI
SY   Human SQSTM1 knockout U-87 MG
DR   Abcam; ab306783
DR   Wikidata; Q127380153
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG STMN1 KO
AC   CVCL_D1UJ
SY   Human STMN1 knockout U-87 MG
DR   Abcam; ab306785
DR   Wikidata; Q127380154
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6510; STMN1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG STXBP1 KO
AC   CVCL_E4AP
SY   Human STXBP1 knockout U-87 MG
DR   Abcam; ab322392
RX   DOI=10.12688/f1000research.160174.1;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11444; STXBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Abcam U-87MG TBX2 KO
AC   CVCL_D1UK
SY   Human TBX2 knockout U-87 MG
DR   Abcam; ab306853
DR   Wikidata; Q127380155
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11597; TBX2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG TH KO
AC   CVCL_D1UL
SY   Human TH knockout U-87 MG
DR   Abcam; ab306790
DR   Wikidata; Q127380157
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11782; TH.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG TICAM1 KO
AC   CVCL_E9DI
SY   Human TICAM1 knockout U-87 MG
DR   Abcam; ab305279
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18348; TICAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Abcam U-87MG TLR4 KO
AC   CVCL_D1UM
SY   Human TLR4 knockout U-87 MG
DR   Abcam; ab306791
DR   Wikidata; Q127380158
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG TNC KO
AC   CVCL_D1UN
SY   Human TNC knockout U-87 MG
DR   Abcam; ab306856
DR   Wikidata; Q127380159
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5318; TNC.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG TNFAIP3 KO
AC   CVCL_D1UP
SY   Human TNFAIP3 knockout U-87 MG
DR   Abcam; ab306792
DR   Wikidata; Q127380160
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG TRPM8 KO
AC   CVCL_D1UQ
SY   Human TRPM8 knockout U-87 MG
DR   Abcam; ab306794
DR   Wikidata; Q127380161
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17961; TRPM8.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG TSPO KO
AC   CVCL_D1UR
SY   Human TSPO knockout U-87 MG
DR   Abcam; ab306795
DR   Wikidata; Q127380164
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG TUBB3 KO
AC   CVCL_D1US
SY   Human TUBB3 knockout U-87 MG
DR   Abcam; ab306796
DR   Wikidata; Q127380165
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20772; TUBB3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG UBE3A KO
AC   CVCL_D1UT
SY   Human UBE3A knockout U-87 MG
DR   Abcam; ab306798
DR   Wikidata; Q127380166
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12496; UBE3A.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG UCHL1 KO
AC   CVCL_D1UU
SY   Human UCHL1 knockout U-87 MG
DR   Abcam; ab306800
DR   Wikidata; Q127380167
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12513; UCHL1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG VCAN KO
AC   CVCL_D1UV
SY   Human VCAN knockout U-87 MG
DR   Abcam; ab306857
DR   Wikidata; Q127380169
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2464; VCAN.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG VIM KO
AC   CVCL_D1UW
SY   Human VIM knockout U-87 MG
DR   Abcam; ab306806
DR   Wikidata; Q127380170
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U-87MG VLDLR KO
AC   CVCL_D1UX
SY   Human VLDLR knockout U-87 MG
DR   Abcam; ab306807
DR   Wikidata; Q127380171
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12698; VLDLR.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Abcam U2OS ACO1 KO
AC   CVCL_B0YX
SY   Human ACO1 knockout U-2 OS
DR   Abcam; ab261884
DR   Wikidata; Q110432560
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:117; ACO1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS ATF1 KO
AC   CVCL_E1GJ
DR   Abcam; ab277176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:783; ATF1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam U2OS CD40 KO
AC   CVCL_B0YY
SY   Human CD40 knockout U-2 OS
DR   Abcam; ab262486
DR   Wikidata; Q110432561
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11919; CD40.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS COL1A1 KO
AC   CVCL_C0BN
SY   Human COL1A1 (PICP) knockout U-2 OS
DR   Abcam; ab273846
DR   Wikidata; Q112929119
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS DDX1 KO
AC   CVCL_E7RY
SY   Human DDX1 knockout U-2 OS
DR   Abcam; ab323670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2734; DDX1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Abcam U2OS EZHIP KO
AC   CVCL_C0BP
SY   Human EZHIP knockout U-2 OS
DR   Abcam; ab281631
DR   Wikidata; Q112929120
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33738; EZHIP.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS FHL2 KO
AC   CVCL_B0YZ
SY   Human FHL2 knockout U-2 OS
DR   Abcam; ab262496
DR   Wikidata; Q110432562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3703; FHL2.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS GPR137 KO
AC   CVCL_E1GK
SY   Human GPR137 knockout U-2 OS
DR   Abcam; ab277179
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24300; GPR137.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam U2OS HNRNPD KO
AC   CVCL_B0Z0
SY   Human HNRNPD knockout U-2 OS
DR   Abcam; ab273860
DR   Wikidata; Q110432563
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5036; HNRNPD.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS KDM4C KO
AC   CVCL_C0BQ
SY   Human KDM4C knockout U-2 OS
DR   Abcam; ab280074
DR   Wikidata; Q112929121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17071; KDM4C.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS MAGEA1 KO
AC   CVCL_E1GL
SY   Human MAGEA1 knockout U-2 OS
DR   Abcam; ab275826
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6796; MAGEA1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam U2OS PARP2 KO
AC   CVCL_C0BR
SY   Human PARP2 knockout U-2 OS
DR   Abcam; ab261883
DR   Wikidata; Q112929122
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS PICALM KO
AC   CVCL_B0Z1
SY   Human PICALM knockout U-2 OS
DR   Abcam; ab262500
DR   Wikidata; Q110432564
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15514; PICALM.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS PRAME KO
AC   CVCL_E1GM
SY   Human PRAME knockout U-2 OS
DR   Abcam; ab275834
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9336; PRAME.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam U2OS QKI KO
AC   CVCL_E1GN
SY   Human QKI knockout U-2 OS
DR   Abcam; ab275828
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21100; QKI.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Abcam U2OS SUV39H2 KO
AC   CVCL_B0Z2
SY   Human SUV39H2 knockout U-2 OS
DR   Abcam; ab261882
DR   Wikidata; Q110432565
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17287; SUV39H2.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS THY1 KO
AC   CVCL_B0Z3
SY   Human THY1 (CD90) knockout U-2 OS
DR   Abcam; ab262490
DR   Wikidata; Q110432566
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11801; THY1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcam U2OS TNC KO
AC   CVCL_B0Z4
SY   Human TNC (Tenascin C) knockout U-2 OS
DR   Abcam; ab262488
DR   Wikidata; Q110432567
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5318; TNC.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Abcc8-A2
AC   CVCL_A4GW
DR   Wikidata; Q105506049
RX   PubMed=27934605;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:59; ABCC8 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C122923; Persistent hyperinsulinemic hypoglycemia of infancy
DI   ORDO; Orphanet_276575; Autosomal dominant hyperinsulinism due to SUR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   Abcc8-A4
AC   CVCL_A4GR
DR   Wikidata; Q105506051
RX   PubMed=27934599;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:59; ABCC8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C122923; Persistent hyperinsulinemic hypoglycemia of infancy
DI   ORDO; Orphanet_276575; Autosomal dominant hyperinsulinism due to SUR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ABCRIi001-A
AC   CVCL_E3QR
SY   hiPSC_ALFAS037_C9
DR   BioSamples; SAMEA115809895
DR   hPSCreg; ABCRIi001-A
RX   PubMed=39437566;
CC   From: Algarve Biomedical Center Research Institute (ABC-Ri), Universidade do Algarve; Faro; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ABE-8.1/2
AC   CVCL_3487
SY   Abelson 8.1
DR   CLO; CLO_0001642
DR   ATCC; TIB-205
DR   ChEMBL-Cells; CHEMBL3307803
DR   ChEMBL-Targets; CHEMBL612562
DR   PubChem_Cell_line; CVCL_3487
DR   Wikidata; Q54607719
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   Abeomics Ba/F3 GFP
AC   CVCL_D7B9
SY   GFP/Ba/F3
DR   Abeomics; 14-906ACL
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Abeomics CHO-K1 A2AR
AC   CVCL_D7BA
SY   CHO-K1/A2AR
DR   Abeomics; 14-522ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:263; ADORA2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 ACE2
AC   CVCL_D7BB
SY   ACE2/CHO-K1
DR   Abeomics; 14-523ACL
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 B7-H3
AC   CVCL_D7BC
SY   CHO-K1/B7-H3
DR   Abeomics; 14-521ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19137; CD276.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 CD28
AC   CVCL_D7BD
SY   CHO-K1/CD28
DR   Abeomics; 14-529ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1653; CD28.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 CD80
AC   CVCL_D7BE
SY   CHO-K1/CD80
DR   Abeomics; 14-505ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 CTLA4
AC   CVCL_D7BF
SY   CHO-K1/CTLA4
DR   Abeomics; 14-506ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 GFP
AC   CVCL_D7BG
SY   GFP/CHO-K1
DR   Abeomics; 14-901ACL
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Abeomics CHO-K1 GPC3
AC   CVCL_D7BH
SY   CHO-K1/GPC3
DR   Abeomics; 14-518ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4451; GPC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 hB7-H4
AC   CVCL_D7BI
SY   CHO-K1/hB7-H4
DR   Abeomics; 14-507ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28873; VTCN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 ICOS
AC   CVCL_D7BJ
SY   CHO-K1/ICOS
DR   Abeomics; 14-503ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5351; ICOS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 ICOSL
AC   CVCL_D7BK
SY   CHO-K1/ICOSL
DR   Abeomics; 14-504ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17087; ICOSLG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 Langerin
AC   CVCL_D7BL
SY   CHO-K1/Langerin
DR   Abeomics; 14-509ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17935; CD207.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 mB7-H4
AC   CVCL_D7BM
SY   CHO-K1/mB7-H4
DR   Abeomics; 14-508ACL
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:3039619; Vtcn1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Abeomics CHO-K1 mCD73
AC   CVCL_D7BN
SY   CHO-K1/mCD73
DR   Abeomics; 14-517ACL
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99782; Nt5e.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Abeomics CHO-K1 NKp30
AC   CVCL_D7BP
SY   CHO-K1/NKp30
DR   Abeomics; 14-511ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19077; NCR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 NKp46
AC   CVCL_D7BQ
SY   CHO-K1/NKp46
DR   Abeomics; 14-512ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6731; NCR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 PD-1
AC   CVCL_D7BR
SY   CHO-K1/PD-1
DR   Abeomics; 14-500ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 PD-L1
AC   CVCL_D7BS
SY   CHO-K1/PD-L1
DR   Abeomics; 14-501ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 PD-L2
AC   CVCL_D7BT
SY   CHO-K1/PD-L2
DR   Abeomics; 14-502ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18731; PDCD1LG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 SIGLEC5
AC   CVCL_D7BU
SY   CHO-K1/SIGLEC5
DR   Abeomics; 14-526ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10874; SIGLEC5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 SIGLEC9
AC   CVCL_D7BV
SY   CHO-K1/SIGLEC9
DR   Abeomics; 14-527ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10878; SIGLEC9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 TIM-3
AC   CVCL_D7BW
SY   CHO-K1/TIM-3
DR   Abeomics; 14-520ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18437; HAVCR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics CHO-K1 VISTA
AC   CVCL_D7BX
SY   CHO-K1/VISTA
DR   Abeomics; 14-516ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30085; VSIR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics HEK293 ACE2
AC   CVCL_D7BY
SY   ACE2/HEK293
DR   Abeomics; 14-524ACL
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics HEK293 Cas9
AC   CVCL_D7BZ
SY   HEK293/Cas9
DR   Abeomics; 14-510ACL
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics HEK293 GFP
AC   CVCL_D7C0
SY   GFP/HEK293
DR   Abeomics; 14-900ACL
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Abeomics HEK293 GPC3
AC   CVCL_D7C1
SY   HEK293/GPC3
DR   Abeomics; 14-514ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4451; GPC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics HEK293 mCD73
AC   CVCL_D7C2
SY   HEK293/mCD73
DR   Abeomics; 14-513ACL
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99782; Nt5e.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Abeomics HEK293 VEGFR2
AC   CVCL_D7C3
SY   HEK293/VEGFR2
DR   Abeomics; 14-515ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6307; KDR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics HEK293 VISTA
AC   CVCL_D7C4
SY   HEK293/VISTA
DR   Abeomics; 14-519ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30085; VSIR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics HeLa GFP
AC   CVCL_D7C5
SY   GFP/HeLa
DR   Abeomics; 14-904ACL
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics Jurkat GFP
AC   CVCL_D7C6
SY   GFP/Jurkat
DR   Abeomics; 14-905ACL
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics NIH 3T3 C3aR1
AC   CVCL_D7C7
SY   C3aR1/NIH 3T3
DR   Abeomics; 14-528ACL
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1319; C3AR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics RAW264.7 GFP
AC   CVCL_D7C8
SY   GFP/RAW264.7
DR   Abeomics; 14-907ACL
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Abeomics U87MG GFP
AC   CVCL_D7C9
SY   GFP/U87MG
DR   Abeomics; 14-903ACL
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics Vero ACE2
AC   CVCL_D7CA
SY   ACE2/VERO
DR   Abeomics; 14-525ACL
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Abeomics Vero GFP
AC   CVCL_D7CB
SY   GFP/VERO
DR   Abeomics; 14-902ACL
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   ABFTL-1
AC   CVCL_S485
DR   Wikidata; Q54607720
RX   PubMed=2988783;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   ABFTL-2
AC   CVCL_S486
DR   Wikidata; Q54607722
RX   PubMed=2988783;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   ABFTL-3
AC   CVCL_S487
DR   Wikidata; Q54607725
RX   PubMed=2988783;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   ABFTL-6
AC   CVCL_8830
DR   BTO; BTO_0002172
DR   Wikidata; Q54607728
RX   PubMed=1376147;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   ABG1
AC   CVCL_YD76
SY   Acipenser Baerii Gonad 1
DR   Wikidata; Q93312744
RX   DOI=10.1186/s41240-016-0015-y;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   ABG3
AC   CVCL_YD77
SY   Acipenser Baerii Gonad 3
DR   Wikidata; Q93312745
RX   DOI=10.1186/s41240-016-0015-y;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   ABG5
AC   CVCL_YD78
SY   Acipenser Baerii Gonad 5
DR   Wikidata; Q93312746
RX   DOI=10.1186/s41240-016-0015-y;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   ABG6
AC   CVCL_YD79
SY   Acipenser Baerii Gonad 6
DR   Wikidata; Q93312747
RX   DOI=10.1186/s41240-016-0015-y;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   ABG7
AC   CVCL_YD80
SY   Acipenser Baerii Gonad 7
DR   Wikidata; Q93312748
RX   DOI=10.1186/s41240-016-0015-y;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   Abgenix 4.153.1
AC   CVCL_D3NH
SY   4.153.1
DR   Wikidata; Q127380173
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4388.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.16.1
AC   CVCL_D3NI
SY   4.16.1
DR   Wikidata; Q127380175
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4357.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.177.3
AC   CVCL_D3NJ
SY   4.177.3
DR   Wikidata; Q127380176
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4557.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.209.3
AC   CVCL_D3NK
SY   4.209.3
DR   Wikidata; Q127380177
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4365.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.219.3
AC   CVCL_D3NL
SY   4.219.3
DR   Wikidata; Q127380178
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4366.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.22.3
AC   CVCL_D3NM
SY   4.22.3
DR   Wikidata; Q127380179
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4358.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.232.3
AC   CVCL_D3NN
SY   4.232.3
DR   Wikidata; Q127380181
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4389.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.248.2
AC   CVCL_D3NP
SY   4.248.2
DR   Wikidata; Q127380182
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4427.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.28.3
AC   CVCL_D3NQ
SY   4.28.3
DR   Wikidata; Q127380183
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4359.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.288.1
AC   CVCL_D3NR
SY   4.288.1
DR   Wikidata; Q127380184
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4367.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.292.3
AC   CVCL_D3NS
SY   4.292.3
DR   Wikidata; Q127380186
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4390.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.304.1
AC   CVCL_D3NT
SY   4.304.1
DR   Wikidata; Q127380187
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4391.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.333.1
AC   CVCL_D3NU
SY   4.333.1
DR   Wikidata; Q127380188
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4368.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.360.3
AC   CVCL_D3NV
SY   4.360.3
DR   Wikidata; Q127380189
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4428.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.4.1
AC   CVCL_D3NW
SY   4.4.1
DR   Wikidata; Q127380191
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4556.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.40.2
AC   CVCL_D3NX
SY   4.40.2
DR   Wikidata; Q127380192
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4360.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.48.3
AC   CVCL_D3NY
SY   4.48.3
DR   Wikidata; Q127380193
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4361.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.49.1
AC   CVCL_D3NZ
SY   4.49.1
DR   Wikidata; Q127380195
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4362.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.54.1
AC   CVCL_D3P0
SY   4.54.1
DR   Wikidata; Q127380196
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4363.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Abgenix 4.7.1
AC   CVCL_D3P1
SY   4.7.1
DR   Wikidata; Q127380198
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4429.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ABI
AC   CVCL_B7LJ
SY   ABI-T1.5
DR   Wikidata; Q112929123
RX   PubMed=7721350;
RX   PubMed=9287230;
RX   PubMed=9536093;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Gln55Ter (c.163C>T); ClinVar=VCV000007652; Zygosity=Homozygous (PubMed=9287230).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ABi001-A
AC   CVCL_C6TI
SY   SMN
DR   BioSamples; SAMEA112165269
DR   hPSCreg; ABi001-A
DR   Wikidata; Q123030646
RX   PubMed=37121194;
CC   From: Moscow Institute of Physics and Technology, National Research University; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19698; KCNV2; Simple; p.Ala259Thr (c.775G>A); Zygosity=Heterozygous (PubMed=37121194).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   ABi002-A
AC   CVCL_C6TJ
SY   KCNV2-/-
DR   BioSamples; SAMEA112165270
DR   hPSCreg; ABi002-A
DR   Wikidata; Q123030647
RX   PubMed=37121194;
CC   From: Moscow Institute of Physics and Technology, National Research University; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19698; KCNV2; Simple; p.Lys252Ter (c.754A>T); Zygosity=Heterozygous (PubMed=37121194).
CC   Sequence variation: Mutation; HGNC; HGNC:19698; KCNV2; Simple; p.Ala259Thr (c.775G>A); Zygosity=Heterozygous (PubMed=37121194).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192089; Retinal cone dystrophy 3B
DI   ORDO; Orphanet_209932; Cone dystrophy with supernormal rod response
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   ABi004-A
AC   CVCL_E3QS
SY   KAA
DR   BioSamples; SAMEA115102216
DR   hPSCreg; ABi004-A
RX   PubMed=39083856;
CC   From: Moscow Institute of Physics and Technology, National Research University; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19698; KCNV2; Simple; p.Gln287Ter (c.859C>T); Zygosity=Heterozygous (PubMed=39083856).
CC   Sequence variation: Mutation; HGNC; HGNC:19698; KCNV2; Simple; p.Lys371Ter (c.1109dup); Zygosity=Heterozygous (PubMed=39083856).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192089; Retinal cone dystrophy 3B
DI   ORDO; Orphanet_209932; Cone dystrophy with supernormal rod response
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   aBJ-2
AC   CVCL_0J13
DR   RCB; AES0147
DR   SKIP; SKIP002999
DR   Wikidata; Q54607729
RX   PubMed=19241381;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Cr x JF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   aBJ-3
AC   CVCL_0J14
DR   RCB; AES0148
DR   SKIP; SKIP002998
DR   Wikidata; Q54607730
RX   PubMed=19241381;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Cr x JF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   aBJ-4
AC   CVCL_0J15
DR   RCB; AES0149
DR   SKIP; SKIP002997
DR   Wikidata; Q54607734
RX   PubMed=19241381;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Cr x JF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   ABL-2
AC   CVCL_D321
DR   CGH-DB; 9188-4
DR   Wikidata; Q54607735
RX   PubMed=3934897;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 32 hours (PubMed=3934897).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 13
//
ID   aBL5C2.870005
AC   CVCL_8945
SY   alpha BL5C2.870005; 870005
DR   Wikidata; Q54607737
RX   Patent=US5087693;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9907.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine herpesvirus 1.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 8
//
ID   aBL5C2.870009
AC   CVCL_8946
SY   alpha BL5C2.870009; 870009
DR   Wikidata; Q54607740
RX   Patent=US5087693;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9908.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine herpesvirus 1.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 8
//
ID   aBL5C2.870016
AC   CVCL_8947
SY   alpha BL5C2.870016; 870016
DR   Wikidata; Q54607743
RX   Patent=US5087693;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9909.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine herpesvirus 1.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 8
//
ID   ABLS-1
AC   CVCL_RP68
DR   Wikidata; Q54607745
RX   PubMed=171081;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   ABLS-5
AC   CVCL_RP69
DR   Wikidata; Q54607747
RX   PubMed=171081;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   ABLS-8
AC   CVCL_RP70
SY   ABLS8
DR   Wikidata; Q54607749
RX   PubMed=171081;
RX   PubMed=25277546;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 4
//
ID   ABPC 20
AC   CVCL_RP74
SY   ABPC20; Abelson-plus-Pristane-induced PlasmaCytoma 20
DR   Wikidata; Q54607751
RX   PubMed=6202819;
RX   PubMed=17764563;
RX   PubMed=25277546;
CC   Characteristics: Produces IgG2b kappa.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: BALB/cAnPt.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   ABPC 22
AC   CVCL_RP75
SY   ABPC22; Abelson-plus-Pristane-induced PlasmaCytoma 22
DR   Wikidata; Q54607753
RX   PubMed=6202819;
RX   PubMed=17764563;
CC   Characteristics: Produces IgM kappa.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Breed/subspecies: BALB/cAnPt.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   ABPC 4
AC   CVCL_RP73
SY   ABPC4; Abelson-plus-Pristane-induced PlasmaCytoma 4
DR   Wikidata; Q54607755
RX   PubMed=6202819;
CC   Characteristics: Produces IgA kappa.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Breed/subspecies: BALB/cAnPt.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   Abrams
AC   CVCL_L309
SY   OSA-Abrams
DR   BTO; BTO_0005353
DR   GEO; GSM1974775
DR   Wikidata; Q54607756
RX   PubMed=21552385;
RX   PubMed=21908323;
RX   PubMed=22849686;
RX   PubMed=22916246;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
RX   PubMed=31640712;
RX   PubMed=36099278;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 27.2 hours (PubMed=22916246); 19 hours (PubMed=27257868); 18.72 hours (PubMed=31640712).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Cys267Phe (c.800G>T); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 227,235
ST   Dog FHC2054: 160,176
ST   Dog FHC2079: 287,291
ST   Dog PEZ1: 107,119
ST   Dog PEZ3: 121
ST   Dog PEZ5: 103
ST   Dog PEZ6: 179,187
ST   Dog PEZ8: 228,236
ST   Dog PEZ12: 274,301
ST   Dog PEZ20: 176
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 21
//
ID   ABS-9
AC   CVCL_E133
DR   RCB; RCB1427
DR   Wikidata; Q54607757
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin. Originally thought to originate from an acute myelocytic leukemia (RCB=RCB1427).
CC   Discontinued: RCB; RCB1427; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 11
//
ID   ABSa15
AC   CVCL_6E03
SY   Arches Branchial Sparus aurata 15
DR   ECACC; 13112201
DR   Wikidata; Q54607758
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
RX   PubMed=15820747;
RX   PubMed=19002990;
RX   PubMed=24361749;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone, branchial arch; UBERON=UBERON_0002539.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   AC
AC   CVCL_HA69
DR   CLDB; cl7228
DR   ICLC; HTL14005
DR   Wikidata; Q54607761
CC   HLA typing: A*02; B*08,35; C*02,07 (ICLC=HTL14005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   AC-10
AC   CVCL_C4MC
DR   Wikidata; Q116048470
RX   PubMed=9426306;
CC   Doubling time: ~24 hours (Note=In the presence of 20 ng/ml FGF2), ~48 hours (Note=Without FGF2) (PubMed=9426306).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = Truncated).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, mesencephalon; UBERON=UBERON_0009616.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   AC-1M32
AC   CVCL_1799
SY   AC1M-32; AC1-M32
DR   CLO; CLO_0001644
DR   BioSample; SAMN03473546
DR   DSMZ; ACC-442
DR   DSMZCellDive; ACC-442
DR   Wikidata; Q54607855
RX   PubMed=33810901;
CC   Characteristics: Fusion of the AC1-1 choriocarcinoma cell line with normal human trophoblast cells (from parent cell line).
CC   Doubling time: ~20-30 hours (DSMZ=ACC-442).
ST   Source(s): DSMZ=ACC-442; PubMed=33810901
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D10S1248: 13,14,15
ST   D12S391: 17,19,21,24
ST   D13S317: 9,11
ST   D16S539: 12,13 (DSMZ=ACC-442)
ST   D16S539: 12,13,14 (PubMed=33810901)
ST   D18S51: 13,14,15
ST   D19S433: 13,15
ST   D1S1656: 14,16
ST   D21S11: 30,31
ST   D22S1045: 15,16
ST   D2S1338: 20,22,24
ST   D2S441: 10,12,14
ST   D3S1358: 15,16,18
ST   D5S818: 10,11
ST   D7S820: 10,12,13
ST   D8S1179: 12
ST   FGA: 21,22,23
ST   Penta D: 8,9,12,14
ST   Penta E: 5,8,12
ST   SE33: 15,36
ST   TH01: 9,9.3
ST   TPOX: 8,11,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1804 ! ACH-1P
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   AC-1M46
AC   CVCL_1800
DR   CLO; CLO_0001645
DR   CLDB; cl7074
DR   DSMZ; ACC-454
DR   DSMZCellDive; ACC-454
DR   Wikidata; Q54607858
CC   Characteristics: Fusion of the AC1-1 choriocarcinoma cell line with normal human trophoblast cells (from parent cell line).
CC   Doubling time: ~40-50 hours (DSMZ=ACC-454).
ST   Source(s): DSMZ=ACC-454
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 9,11
ST   D16S539: 12,13,14
ST   D18S51: 13,14,15
ST   D19S433: 13,14,15
ST   D21S11: 30,31
ST   D2S1338: 20,22,23,24
ST   D3S1358: 15,16,18
ST   D5S818: 10,11
ST   D7S820: 10,12,13
ST   D8S1179: 12
ST   FGA: 21,22,23
ST   Penta D: 8,9,12,14
ST   Penta E: 5,8,12
ST   TH01: 9,9.3
ST   TPOX: 8,11,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1804 ! ACH-1P
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   AC-1M59
AC   CVCL_1801
SY   AC1-M59
DR   CLO; CLO_0001646
DR   CLDB; cl7075
DR   BioSample; SAMN03473552
DR   DSMZ; ACC-455
DR   DSMZCellDive; ACC-455
DR   Wikidata; Q54607859
RX   PubMed=33096371;
RX   PubMed=33810901;
CC   Characteristics: Fusion of the AC1-1 choriocarcinoma cell line with normal human trophoblast cells (from parent cell line).
CC   Doubling time: ~50 hours (DSMZ=ACC-455).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=33096371).
ST   Source(s): DSMZ=ACC-455; PubMed=33810901
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D10S1248: 13,14,15
ST   D12S391: 17,19,21,24
ST   D13S317: 9,11
ST   D16S539: 12,13,14
ST   D18S51: 13,14,15
ST   D19S433: 13,14,15
ST   D1S1656: 14,16
ST   D21S11: 30,31
ST   D22S1045: 15,16
ST   D2S1338: 20,22,23,24 (DSMZ=ACC-455)
ST   D2S1338: 20,22,24 (PubMed=33810901)
ST   D2S441: 10,12,14
ST   D3S1358: 15,16,18
ST   D5S818: 10,11 (PubMed=33810901)
ST   D5S818: 11 (DSMZ=ACC-455)
ST   D7S820: 10,12,13
ST   D8S1179: 12
ST   FGA: 21,22,23
ST   Penta D: 8,9,12,14
ST   Penta E: 5,8,12
ST   SE33: 15,36
ST   TH01: 9,9.3
ST   TPOX: 8,11,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1804 ! ACH-1P
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   AC-1M81
AC   CVCL_1802
DR   CLO; CLO_0001647
DR   CLDB; cl7076
DR   BioSample; SAMN03473553
DR   DSMZ; ACC-456
DR   DSMZCellDive; ACC-456
DR   Wikidata; Q54607862
CC   Doubling time: ~24 hours (DSMZ=ACC-456).
ST   Source(s): DSMZ=ACC-456
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 9,11
ST   D16S539: 12,13,14
ST   D18S51: 13,14,15
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 20,22,23,24
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 10,12,13
ST   D8S1179: 12
ST   FGA: 21,22,23
ST   Penta D: 8,9,12,14
ST   Penta E: 5,8,12
ST   TH01: 9,9.3
ST   TPOX: 8,11,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1804 ! ACH-1P
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   AC-1M88
AC   CVCL_1803
SY   AC1M-88
DR   CLO; CLO_0001648
DR   CLDB; cl7077
DR   BioSample; SAMN03473554
DR   DSMZ; ACC-457
DR   DSMZCellDive; ACC-457
DR   Wikidata; Q54607865
CC   Doubling time: ~30-50 hours (DSMZ=ACC-457).
ST   Source(s): DSMZ=ACC-457
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 9,11
ST   D16S539: 12,13,14
ST   D18S51: 13,14,15
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 20,22,23,24
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 10,12,13
ST   D8S1179: 12
ST   FGA: 21,22,23
ST   Penta D: 8,9,14
ST   Penta E: 5,8,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1804 ! ACH-1P
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   AC-258
AC   CVCL_RW21
DR   Wikidata; Q54607868
RX   PubMed=7060993;
RX   PubMed=7448794;
CC   Doubling time: 22 hours (PubMed=7060993).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   AC-33
AC   CVCL_Z046
DR   JCRB; IFO50155
DR   Wikidata; Q54607870
RX   Patent=US5126259;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2143.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; IFO50155; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   AC-6.21
AC   CVCL_5980
SY   AC 6.21; AC6.21
DR   Wikidata; Q54607872
RX   PubMed=3493849;
RX   PubMed=21374134;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AC6.21
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5M
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   AC0001
AC   CVCL_8B36
DR   ECACC; 89092229
DR   Wikidata; Q54607873
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AC0002
AC   CVCL_8B37
DR   ECACC; 90092405
DR   Wikidata; Q54607875
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AC0004
AC   CVCL_8B38
DR   ECACC; 89121302
DR   Wikidata; Q54607877
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AC0006
AC   CVCL_8B39
DR   ECACC; 90041201
DR   Wikidata; Q54607879
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AC0094
AC   CVCL_8B40
DR   ECACC; 91042507
DR   Wikidata; Q54607882
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AC0291
AC   CVCL_8B41
DR   ECACC; 92110606
DR   Wikidata; Q54607884
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(21) (ECACC=92110606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C186278; Ring chromosome 21 syndrome
DI   ORDO; Orphanet_1445; Ring chromosome 21 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AC0302
AC   CVCL_8B42
DR   ECACC; 92120901
DR   Wikidata; Q54607889
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,?dup(21)(p22.1->qter) (ECACC=92120901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AC0350
AC   CVCL_8B43
DR   ECACC; 93032603
DR   Wikidata; Q54607890
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,dup21(qter->p13::q22.1->qter) (ECACC=93032603).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AC0360
AC   CVCL_8B44
DR   ECACC; 93051436
DR   Wikidata; Q54607895
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(21;21) (ECACC=93051436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AC0451
AC   CVCL_8B45
DR   ECACC; 94092014
DR   Wikidata; Q54607897
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian and Caucasian.
CC   Karyotypic information: 46,XX,t(11;22)(q23.3;q13.1) (ECACC=94092014).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94092014; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   AC0452
AC   CVCL_8B46
DR   ECACC; 94092015
DR   Wikidata; Q54607900
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Karyotypic information: 46,XX,t(11;22)(q23.3;q13.1) (ECACC=94092015).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94092015; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   AC1 [Human gestational choriocarcinoma]
AC   CVCL_9559
DR   Wikidata; Q54607904
RX   DOI=10.1016/S0143-4004(97)80089-6;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   AC1 [Human hybrid cardiomyocyte]
AC   CVCL_4U15
DR   Wikidata; Q54607901
RX   PubMed=15913645;
CC   Characteristics: Hybrid of adult ventricular cardiomiocytes with a SV40 transformed, uridine auxotroph human fibroblast cell line devoid of mitochondrial DNA (PubMed=15913645).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U14 ! DWFb1-rho0
CA   Hybrid cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 7
//
ID   AC1 [Mouse hybridoma against ganglioside GD1c]
AC   CVCL_U859
DR   CLO; CLO_0050355
DR   RCB; RCB2317
DR   Wikidata; Q54607905
RX   PubMed=9106500;
RX   PubMed=9644263;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_87990; Ganglioside GD1c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 7
//
ID   AC1-1
AC   CVCL_9560
DR   Wikidata; Q54607907
RX   DOI=10.1016/S0143-4004(97)80089-6;
RX   PubMed=10616526;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9559 ! AC1 [Human gestational choriocarcinoma]
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   AC1-5
AC   CVCL_9561
DR   Wikidata; Q54607910
RX   DOI=10.1016/S0143-4004(97)80089-6;
RX   PubMed=10616526;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9559 ! AC1 [Human gestational choriocarcinoma]
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   AC1-9
AC   CVCL_9562
DR   Wikidata; Q54607912
RX   DOI=10.1016/S0143-4004(97)80089-6;
RX   PubMed=10616526;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9559 ! AC1 [Human gestational choriocarcinoma]
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   AC10
AC   CVCL_4U16
DR   ATCC; CRL-3569
DR   Wikidata; Q54607914
RX   Patent=US7223599;
RX   PubMed=15913645;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1501.
CC   Characteristics: Hybrid of adult ventricular cardiomiocytes with a SV40 transformed, uridine auxotroph human fibroblast cell line devoid of mitochondrial DNA (PubMed=15913645).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U14 ! DWFb1-rho0
CA   Hybrid cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 10
//
ID   Ac106
AC   CVCL_C4BL
DR   Wikidata; Q116048471
RX   PubMed=398773;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B1-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AC12
AC   CVCL_4U17
DR   Wikidata; Q54607915
RX   PubMed=15913645;
CC   Characteristics: Hybrid of adult ventricular cardiomiocytes with a SV40 transformed, uridine auxotroph human fibroblast cell line devoid of mitochondrial DNA (PubMed=15913645).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U14 ! DWFb1-rho0
CA   Hybrid cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 7
//
ID   AC133.1
AC   CVCL_G632
SY   AC133
DR   CLO; CLO_0001643
DR   ATCC; HB-12346
DR   Wikidata; Q54607919
RX   Patent=US5843633;
RX   PubMed=9389720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12346.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43490; Human PROM1/CD133.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AC14
AC   CVCL_LJ80
DR   Wikidata; Q54607920
RX   PubMed=1459729;
CC   Doubling time: 22 hours (PubMed=1459729).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 5
//
ID   Ac146
AC   CVCL_C4BJ
DR   Wikidata; Q116048472
RX   PubMed=398773;
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B1-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AC16 [Human hybrid cardiomyocyte]
AC   CVCL_4U18
DR   EFO; EFO_0022630
DR   ATCC; CRL-3568
DR   CLS; 305215
DR   Millipore; SCC109
DR   Wikidata; Q54607923
RX   Patent=US7223599;
RX   PubMed=15913645;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1500.
CC   Characteristics: Hybrid of adult ventricular cardiomiocytes with a SV40 transformed, uridine auxotroph human fibroblast cell line devoid of mitochondrial DNA (PubMed=15913645).
CC   Characteristics: Can differentiate when cultured in mitogen-free medium. The cells may be used to study developmental regulation of cardiomyocytes (Millipore=SCC109).
CC   Doubling time: 24.49 hours (PubMed=15913645).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
ST   Source(s): Millipore=SCC109
ST   Amelogenin: X
ST   CSF1PO: 9,11,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 32.2,33.2
ST   D3S1358: 17,18
ST   D5S818: 9,11
ST   D7S820: 10,11,12
ST   D8S1179: 12,14
ST   FGA: 21,25
ST   Penta D: 2.2,9
ST   Penta E: 7,8,16
ST   TH01: 7,8,9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U14 ! DWFb1-rho0
CA   Hybrid cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   AC16 [Mouse mesothelioma]
AC   CVCL_LJ81
DR   Wikidata; Q54607925
RX   PubMed=1459729;
RX   PubMed=28577549;
CC   Doubling time: 14 hours (PubMed=1459729).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   Ac17
AC   CVCL_C4BH
DR   Wikidata; Q116048473
RX   PubMed=398773;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B1-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AC173
AC   CVCL_2H64
SY   AC173/GrsrJ; DBA/2J AC173/GrsrJ
DR   Wikidata; Q54607926
RX   PubMed=23209647;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000671P11productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC175
AC   CVCL_2H93
DR   Wikidata; Q54607929
RX   PubMed=23209647;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   AC2
AC   CVCL_4102
AS   CVCL_HE68
SY   S-480-3; S480-3
DR   CLO; CLO_0001649
DR   CLDB; cl233
DR   ECACC; 86061902
DR   Wikidata; Q54607931
RX   PubMed=3089920;
RX   PubMed=3491256;
RX   PubMed=6422470;
CC   Characteristics: IL3 dependent.
CC   Doubling time: 23 hours (PubMed=6422470).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   AC20
AC   CVCL_Z577
SY   AC-20; ACAN-20; AC2
DR   ICLDB; acan-20-bcirl
DR   Wikidata; Q54607933
RX   CelloPub=CLPUB00492;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=1017845;
RX   PubMed=4633071;
RX   PubMed=6053431;
RX   PubMed=8799737;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Doubling time: ~45 hours (Note=In TC199-MK) (PubMed=4633071); 72 hours (DOI=10.1016/B978-0-12-709902-6.50017-0).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1585285; ! Agallia constricta (Constricted leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   AC203
AC   CVCL_2H65
SY   AC203/GrsrJ; DBA/2J AC203/GrsrJ
DR   Wikidata; Q54607934
RX   PubMed=23209647;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000671P12productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC216
AC   CVCL_2H94
DR   Wikidata; Q54607937
RX   PubMed=23209647;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   Ac22
AC   CVCL_C4BI
DR   Wikidata; Q116048474
RX   PubMed=398773;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B1-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AC24
AC   CVCL_RP18
DR   Wikidata; Q54607939
RX   PubMed=1459729;
RX   PubMed=28577549;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   AC28
AC   CVCL_LJ82
DR   Wikidata; Q54607942
RX   PubMed=1459729;
RX   PubMed=28577549;
CC   Doubling time: 23 hours (PubMed=1459729).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   AC29
AC   CVCL_4407
DR   CBA; CBA-0152
DR   CBA; CBA-1664
DR   ECACC; 10092308
DR   ECACC; 21102109
DR   Wikidata; Q54607945
RX   PubMed=1459729;
RX   PubMed=22581112;
RX   PubMed=28577549;
RX   PubMed=32944078;
CC   Problematic cell line: Partially contaminated. The stock formerly distributed by CBA under the catalog number CBA-0152 was a mixture of at least two different cell lines from different mouse strains.
CC   Doubling time: 27 hours (PubMed=1459729).
CC   Karyotypic information: Hyper-triploid (PubMed=32944078).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: CBA; CBA-0152; true.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   Ac2F
AC   CVCL_D262
SY   AC2F; JTC-37; Japanese Tissue Culture-37
DR   JCRB; JCRB0408
DR   Wikidata; Q54608052
RX   PubMed=90011;
CC   Doubling time: 68.5 hours (PubMed=90011).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UY84 ! RAL-5
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   Ac2F(DT)
AC   CVCL_G286
SY   Ac2F (DT); Ac2F(Dimethylaminoazobenzene Transformed)
DR   JCRB; JCRB0416
DR   Wikidata; Q54608059
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D262 ! Ac2F
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   Ac2F(ST)
AC   CVCL_G287
SY   Ac2F (ST); Ac2F(Spontaneously Transformed)
DR   JCRB; JCRB0417
DR   Wikidata; Q54608061
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D262 ! Ac2F
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   Ac2F-CR10
AC   CVCL_9W03
DR   Wikidata; Q54608055
RX   PubMed=10353263;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D262 ! Ac2F
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   Ac2F-CR4
AC   CVCL_9W04
DR   Wikidata; Q54608057
RX   PubMed=10353263;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D262 ! Ac2F
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   AC2M2
AC   CVCL_AZ67
DR   BTO; BTO_0005748
DR   Wikidata; Q54608063
RX   PubMed=15987432;
CC   Caution: Could be identical to SP1-3M (Cellosaurus=CVCL_AZ66).
CC   Breed/subspecies: CBA/J.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AZ65 ! SP1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 5
//
ID   AC31
AC   CVCL_LJ83
DR   Wikidata; Q54608065
RX   PubMed=1459729;
RX   PubMed=28577549;
CC   Doubling time: 22 hours (PubMed=1459729).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   AC32
AC   CVCL_LJ84
DR   Wikidata; Q54608069
RX   PubMed=1459729;
CC   Doubling time: 26 hours (PubMed=1459729).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 5
//
ID   AC34
AC   CVCL_Y610
DR   Wikidata; Q54608070
RX   PubMed=1459729;
RX   PubMed=22581112;
CC   Doubling time: 19 hours (PubMed=1459729).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: CBA.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 6
//
ID   Ac38
AC   CVCL_C4BK
DR   Wikidata; Q116048475
RX   PubMed=398773;
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B1-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AC383
AC   CVCL_2H66
SY   AC383/GrsrJ; BALB/cByJ AC383/GrsrJ; JR#001026
DR   Wikidata; Q54608074
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001026P10productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/cByJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC386
AC   CVCL_2H67
SY   AC386/GrsrJ; C3H/HeJ AC386/GrsrJ; JR#000659
DR   Wikidata; Q54608076
RX   PubMed=24504480;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000659P11productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC401
AC   CVCL_2H68
SY   AC401/GrsrJ; PWD/PhJ AC401/GrsrJ; JR#004660
DR   Wikidata; Q54608079
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004660P7productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: PWD/PhJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC429
AC   CVCL_2H69
SY   AC429/GrsrJ; C57BL/6J-Chr 9A/J/NaJ AC429/GrsrJ
DR   Wikidata; Q54608082
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004387productspec.pdf
CC   Misspelling: AC429/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 9A/J/NaJ AC429/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 9A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC446
AC   CVCL_2H70
SY   AC446/GrsrJ; C57BL/6J-Chr 10A/J/NaJ AC446/GrsrJ
DR   Wikidata; Q54608083
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004388productspec.pdf
CC   Misspelling: AC446/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 10A/J/NaJ AC446/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 10A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC453
AC   CVCL_2H71
SY   AC453/GrsrJ; C57BL/6J-Chr 11A/J/NaJ AC453/GrsrJ
DR   Wikidata; Q54608085
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004389productspec.pdf
CC   Misspelling: AC453/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 11A/J/NaJ AC453/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 6A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC464
AC   CVCL_ZL16
SY   AC464/GrsrJ C57BL/6J-Chr 12A/J/NaJ AC464/GrsrJ
DR   Wikidata; Q98125464
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004390P8productspec.pdf
CC   Misspelling: AC464/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 12A/J/NaJ AC464/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 12A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   AC5
AC   CVCL_WK47
DR   ATCC; HB-10473
DR   CCRID; 4201PAT-CCTCC00113
DR   Wikidata; Q93312956
RX   Patent=US5565338;
RX   Patent=US5723582;
RX   Patent=WO1994026923A1;
RX   PubMed=1573271;
RX   PubMed=1730869;
RX   PubMed=7511819;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10473.
CC   Characteristics: T-cell hybridoma. Produces MIF.
CC   Monoclonal antibody target: UniProtKB; P00630; Apis mellifera phospholipase A2.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G691 ! BUC
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   AC576
AC   CVCL_2H72
SY   AC576/GrsJ; NOD/ShiLtJ AC576/GrsJ; JR#001976
DR   Wikidata; Q54608089
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001976P5productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NOD/ShiLtJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   AC6C3
AC   CVCL_B0J5
SY   AC6C3(IH8)
DR   Wikidata; Q108819823
RX   Patent=US5434076;
RX   PubMed=2032733;
RX   PubMed=7493338;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10305.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 32 kDa protein on the surface of many cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JJ88 ! SPAZ-4
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   AC6C3-2B12
AC   CVCL_B0J6
DR   Wikidata; Q108819824
RX   PubMed=7493338;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 32 kDa protein on the surface of many cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B0J5 ! AC6C3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Ac76
AC   CVCL_C4BM
DR   Wikidata; Q116048476
RX   PubMed=398773;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B1-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Ac7E
AC   CVCL_UY86
DR   Wikidata; Q93312964
RX   PubMed=90011;
RX   PubMed=7319197;
CC   Doubling time: 40.5 hours (PubMed=90011); 45.1 hours (PubMed=7319197).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UY84 ! RAL-5
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   Ac7E/LI
AC   CVCL_UY87
DR   Wikidata; Q93312966
RX   PubMed=7319197;
CC   Doubling time: 12.6 hours (Note=At 60th passage), 34.6 hours (Note=At 36th passage) (PubMed=7319197).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UY86 ! Ac7E
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   Ac7E/SI
AC   CVCL_UY88
DR   Wikidata; Q93312968
RX   PubMed=7319197;
CC   Doubling time: 14.9 hours (Note=At 126th generation), 36.9 hours (Note=At 45th generation) (PubMed=7319197).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UY86 ! Ac7E
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   AcA101
AC   CVCL_5F75
SY   AcA 101
DR   Wikidata; Q54608091
RX   PubMed=11784300;
CC   Doubling time: 24-30 hours (Note=At 33 Celsius) (PubMed=11784300).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   AcA201
AC   CVCL_5F76
SY   AcA 201
DR   Wikidata; Q54608092
RX   PubMed=11784300;
CC   Doubling time: 24-30 hours (Note=At 33 Celsius) (PubMed=11784300).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   ACB-1
AC   CVCL_E8CB
RX   PubMed=3830186;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P36196; Chicken ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ACB-1085
AC   CVCL_M488
SY   ACB1085
DR   Wikidata; Q54608094
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1980237;
RX   PubMed=3472643;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M487 ! ACB-885
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   ACB-2
AC   CVCL_E8CC
RX   PubMed=3830186;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36196; Chicken ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ACB-885
AC   CVCL_M487
SY   ACB885
DR   Wikidata; Q54608097
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1980237;
RX   PubMed=3472643;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~30-35 hours (PubMed=3472643).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M488 ! ACB-1085
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   ACB-985
AC   CVCL_A5YM
SY   ACB985
DR   Wikidata; Q107113347
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1980237;
CC   Characteristics: Produces IgG kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   ACBA
AC   CVCL_YB40
SY   Artic Char Bulbus Arteriosus
DR   Wikidata; Q93312980
RX   PubMed=28261806;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 1 to 20 Celsius, the optimal temperature is 18-20 Celsius.
CC   Doubling time: 21 days (Note=At 4 Celsius), 84 days (Note=At 1 Celsius) (PubMed=28261806).
CC   Derived from site: In situ; Heart, bulbus arteriosus; UBERON=UBERON_0004152.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8036; ! Salvelinus alpinus (Arctic char)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 6
//
ID   ACC-2
AC   CVCL_6872
SY   Acc-2; ACC2
DR   BioSample; SAMN03151659
DR   CCTCC; GDC0048
DR   Cosmic; 932295
DR   Wikidata; Q54608098
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=15495191;
RX   PubMed=19557180;
RX   PubMed=20143388;
RX   PubMed=21868764;
RX   PubMed=26116706;
WW   Info; ACCRF; -; https://web.archive.org/web/20110617125837/http://www.accrf.org/pdf/accrf_update_march2009.pdf
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706). Originally thought to originate from a 28 year old female patient with a salivary gland adenoid cystic carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00357.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Formerly the CCRID database had 3 entries describing this cell line (3111C0001CCC000272, 3131C0001000700062, 3142C0001000000048). They were one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=21868764; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18 (PubMed=21868764; PubMed=26116706)
ST   vWA: 17,18 (CCRID)
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   ACC-3
AC   CVCL_6873
SY   Acc-3; ACC3
DR   BioSample; SAMN03151660
DR   Wikidata; Q54608099
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=10359046;
RX   PubMed=19557180;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   Info; ACCRF; -; https://web.archive.org/web/20110617125837/http://www.accrf.org/pdf/accrf_update_march2009.pdf
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764). Originally thought to originate from a 49 year old male patient with a salivary gland adenoid cystic carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00358.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   ACC-LC-170
AC   CVCL_7003
SY   SA; SCLC-SA; Aichi Cancer Center-Lung Cancer-170
DR   CGH-DB; 84-1
DR   CGH-DB; 9054-4
DR   Cosmic; 934437
DR   Wikidata; Q54608100
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=12107105;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   ACC-LC-171
AC   CVCL_7004
SY   SM; SCLC-SM; Aichi Cancer Center-Lung Cancer-171
DR   Cosmic; 934438
DR   Wikidata; Q54608102
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ACC-LC-172
AC   CVCL_7005
AS   CVCL_Y201
SY   ACC-LC172; SK3; SCLC-SK3; Aichi Cancer Center-Lung Cancer-172
DR   cancercelllines; CVCL_7005
DR   CGH-DB; 85-1
DR   CGH-DB; 9055-4
DR   Cosmic; 934472
DR   Cosmic; 1089237
DR   IARC_TP53; 18798
DR   Wikidata; Q54608104
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=2547517;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=12107105;
RX   PubMed=12794755;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (PubMed=12794755).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7020 ! ACC-LC-5
OI   CVCL_7016 ! ACC-LC-35
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   ACC-LC-172/CDDP
AC   CVCL_Y202
SY   SK3/CDDP
DR   cancercelllines; CVCL_Y202
DR   Wikidata; Q54608105
RX   PubMed=2547517;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7005 ! ACC-LC-172
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   ACC-LC-173
AC   CVCL_7006
SY   NT2; SCLC-NT2; Aichi Cancer Center-Lung Cancer-173
DR   CGH-DB; 86-1
DR   CGH-DB; 9056-4
DR   Cosmic; 934433
DR   Wikidata; Q54608106
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
RX   PubMed=12107105;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7029 ! ACC-LC-87
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   ACC-LC-174
AC   CVCL_7007
SY   TS2; Aichi Cancer Center-Lung Cancer-174
DR   Cosmic; 934454
DR   Wikidata; Q54608109
RX   PubMed=7834619;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7032 ! ACC-LC-94
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   ACC-LC-175
AC   CVCL_Z026
SY   TG; SCLC-TG; Aichi Cancer Center-Lung Cancer-175
DR   Wikidata; Q54608110
RX   PubMed=1710138;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ACC-LC-176
AC   CVCL_7008
SY   KS; Aichi Cancer Center-Lung Cancer-176
DR   Cosmic; 934456
DR   Cosmic; 1089226
DR   IARC_TP53; 21038
DR   Wikidata; Q54608113
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=11583962;
RX   PubMed=12794755;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   ACC-LC-177
AC   CVCL_7009
SY   SL1; SCLC-SL1; Aichi Cancer Center-Lung Cancer-177
DR   Cosmic; 934440
DR   Wikidata; Q54608115
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7010 ! ACC-LC-178
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ACC-LC-178
AC   CVCL_7010
SY   SL2; SCLC-SL2; Aichi Cancer Center-Lung Cancer-178
DR   Cosmic; 934441
DR   Wikidata; Q54608117
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=7834619;
RX   PubMed=8384671;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7009 ! ACC-LC-177
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   ACC-LC-180
AC   CVCL_JY53
SY   Aichi Cancer Center-Lung Cancer-180
DR   Wikidata; Q54608118
RX   PubMed=8385084;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   ACC-LC-314
AC   CVCL_7011
SY   Aichi Cancer Center-Lung Cancer-314
DR   Cosmic; 934458
DR   Wikidata; Q54608119
RX   PubMed=7834619;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7012 ! ACC-LC-319
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   ACC-LC-319
AC   CVCL_7012
SY   ACC-LC319; Aichi Cancer Center-Lung Cancer-319
DR   BTO; BTO_0004887
DR   cancercelllines; CVCL_7012
DR   Cosmic; 934459
DR   Cosmic; 1089222
DR   Cosmic; 2647636
DR   IARC_TP53; 18790
DR   Wikidata; Q54608121
RX   PubMed=7834619;
RX   PubMed=11583962;
RX   PubMed=12794755;
RX   PubMed=19806789;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (PubMed=12794755).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro71fs (c.211delC); Zygosity=Unspecified (PubMed=12794755).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7011 ! ACC-LC-314
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   ACC-LC-319/bone2
AC   CVCL_A1GQ
DR   cancercelllines; CVCL_A1GQ
DR   Wikidata; Q102113500
RX   PubMed=19806789;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic to bone. Obtained after 2 cycles of intravenous injection of parental cells into NK cell-depleted SCID mice and harvesting of the bone metastases.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro71fs (c.211delC); Zygosity=Unspecified (from parent cell line).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7012 ! ACC-LC-319
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   ACC-LC-321
AC   CVCL_7013
SY   Aichi Cancer Center-Lung Cancer-321
DR   Cosmic; 934443
DR   Wikidata; Q54608122
RX   PubMed=7834619;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   ACC-LC-323
AC   CVCL_7014
SY   Aichi Cancer Center-Lung Cancer-323
DR   Cosmic; 934461
DR   Wikidata; Q54608125
RX   PubMed=7834619;
CC   Population: Japanese.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   ACC-LC-33
AC   CVCL_7015
SY   YI; Aichi Cancer Center-Lung Cancer-33
DR   CGH-DB; 196-1
DR   CGH-DB; 9182-4
DR   Cosmic; 934444
DR   Wikidata; Q54608128
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=15746151;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   ACC-LC-35
AC   CVCL_7016
AS   CVCL_Y200
SY   SK2; SCLC-SK2; Aichi Cancer Center-Lung Cancer-35
DR   Cosmic; 934413
DR   Wikidata; Q54608129
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=2547517;
RX   PubMed=7834619;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7020 ! ACC-LC-5
OI   CVCL_7005 ! ACC-LC-172
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ACC-LC-35D
AC   CVCL_Z024
SY   SK2D; Aichi Cancer Center-Lung Cancer-35D
DR   Wikidata; Q54608130
RX   PubMed=2547517;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7016 ! ACC-LC-35
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ACC-LC-36
AC   CVCL_7017
AS   CVCL_Y207
SY   TM1; SCLC-TM1; Aichi Cancer Center-Lung Cancer-36
DR   Cosmic; 934415
DR   Wikidata; Q54608192
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=2547517;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y208 ! ACC-LC-51
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ACC-LC-48
AC   CVCL_7018
SY   OT1; SCLC-OT1; Aichi Cancer Center-Lung Cancer-48
DR   cancercelllines; CVCL_7018
DR   Cosmic; 934417
DR   Cosmic; 1089234
DR   IARC_TP53; 18795
DR   Wikidata; Q54608193
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
RX   PubMed=12794755;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=12794755).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7021 ! ACC-LC-52
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   ACC-LC-49
AC   CVCL_7019
SY   MO; SCLC-MO; Aichi Cancer Center-Lung Cancer-49
DR   cancercelllines; CVCL_7019
DR   Cosmic; 934420
DR   Cosmic; 1089235
DR   IARC_TP53; 18796
DR   Wikidata; Q54608196
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=12794755;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Valfs*13 (c.328delC); ClinVar=VCV000127807; Zygosity=Unspecified (PubMed=12794755).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   ACC-LC-5
AC   CVCL_7020
AS   CVCL_Y199
SY   SK1; SCLC-SK1; Aichi Cancer Center-Lung Cancer-5
DR   CGH-DB; 87-1
DR   CGH-DB; 9052-4
DR   Cosmic; 934412
DR   Wikidata; Q54608198
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=2547517;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
RX   PubMed=12107105;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7016 ! ACC-LC-35
OI   CVCL_7005 ! ACC-LC-172
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   ACC-LC-51
AC   CVCL_Y208
SY   ACC LC 51; TM2; SCLC-TM2; Aichi Cancer Center-Lung Cancer-51
DR   Wikidata; Q54608200
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=2547517;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Mesentery; UBERON=UBERON_0002095.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7017 ! ACC-LC-36
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   ACC-LC-52
AC   CVCL_7021
SY   OT2; SCLC-OT2; Aichi Cancer Center-Lung Cancer-52
DR   Cosmic; 934418
DR   Wikidata; Q54608201
RX   PubMed=1710138;
RX   PubMed=2540905;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7018 ! ACC-LC-48
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   ACC-LC-60
AC   CVCL_7022
SY   ZM; SCLC-ZM; Aichi Cancer Center-Lung Cancer-60
DR   Cosmic; 934422
DR   Wikidata; Q54608203
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   ACC-LC-61
AC   CVCL_7023
SY   KA; SCLC-KA; Aichi Cancer Center-Lung Cancer-61
DR   Cosmic; 934424
DR   Wikidata; Q54608205
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   ACC-LC-66
AC   CVCL_Z028
SY   MY; SCLC-MY; Aichi Cancer Center-Lung Cancer-66
DR   Wikidata; Q54608207
RX   PubMed=1710138;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ACC-LC-67
AC   CVCL_7024
SY   YN; SCLC-YN; Aichi Cancer Center-Lung Cancer-67
DR   Cosmic; 934426
DR   Wikidata; Q54608209
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   ACC-LC-71
AC   CVCL_7025
SY   ST; Aichi Cancer Center-Lung Cancer-71
DR   Cosmic; 934446
DR   Wikidata; Q54608210
RX   PubMed=7834619;
RX   PubMed=8384671;
CC   Population: Japanese.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   ACC-LC-73
AC   CVCL_7026
SY   TH; Aichi Cancer Center-Lung Cancer-73
DR   CGH-DB; 9179-4
DR   Cosmic; 934447
DR   Wikidata; Q54608214
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
RX   PubMed=14581340;
RX   PubMed=15746151;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   ACC-LC-76
AC   CVCL_7027
SY   SS; SCLC-SS; Aichi Cancer Center-Lung Cancer-76
DR   Cosmic; 934428
DR   Wikidata; Q54608215
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ACC-LC-78
AC   CVCL_Z027
SY   MA; SCLC-MA; Aichi Cancer Center-Lung Cancer-78
DR   Wikidata; Q54608217
RX   PubMed=1710138;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   ACC-LC-80
AC   CVCL_7028
SY   ACC-LC80; SY; SCLC-SY; Aichi Cancer Center-Lung Cancer-80
DR   cancercelllines; CVCL_7028
DR   CGH-DB; 104-1
DR   CGH-DB; 9053-4
DR   Cosmic; 934430
DR   Cosmic; 1089236
DR   IARC_TP53; 18797
DR   Wikidata; Q54608221
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
RX   PubMed=12107105;
RX   PubMed=12794755;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Unspecified (PubMed=12794755).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   ACC-LC-87
AC   CVCL_7029
SY   NT1; SCLC-NT1; Aichi Cancer Center-Lung Cancer-87
DR   Cosmic; 934432
DR   Wikidata; Q54608224
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7006 ! ACC-LC-173
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ACC-LC-91
AC   CVCL_7030
SY   YS; Aichi Cancer Center-Lung Cancer-91
DR   Cosmic; 934449
DR   Cosmic; 2647638
DR   Wikidata; Q54608227
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   ACC-LC-93
AC   CVCL_7031
SY   YO; Aichi Cancer Center-Lung Cancer-93
DR   Cosmic; 934451
DR   Wikidata; Q54608230
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   ACC-LC-94
AC   CVCL_7032
SY   ACC-LC94; TS1; Aichi Cancer Center-Lung Cancer-94
DR   cancercelllines; CVCL_7032
DR   Cosmic; 934453
DR   Cosmic; 1089221
DR   IARC_TP53; 18789
DR   Wikidata; Q54608233
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
RX   PubMed=11583962;
RX   PubMed=12794755;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=12794755).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Gly (c.842A>G); ClinVar=VCV000141141; Zygosity=Unspecified (PubMed=12794755).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7007 ! ACC-LC-174
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   ACC-LC-96
AC   CVCL_7033
SY   HS; SCLC-HS; Aichi Cancer Center-Lung Cancer-96
DR   Cosmic; 934435
DR   Wikidata; Q54608237
RX   PubMed=1710138;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ACC-LC-97
AC   CVCL_Z025
SY   TU; SCLC-TU; Aichi Cancer Center-Lung Cancer-97
DR   Wikidata; Q54608239
RX   PubMed=1710138;
RX   PubMed=8384671;
RX   PubMed=8385084;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   ACC-M
AC   CVCL_6874
SY   Acc-M; ACCM
DR   BioSample; SAMN03151661
DR   Wikidata; Q54608240
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=9151166;
RX   PubMed=19557180;
RX   PubMed=20143388;
RX   PubMed=21868764;
RX   PubMed=26116706;
WW   Info; ACCRF; -; https://web.archive.org/web/20110617125837/http://www.accrf.org/pdf/accrf_update_march2009.pdf
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (ACC-2) has been shown to be a HeLa derivative (PubMed=19557180; PubMed=20143388; PubMed=21868764; PubMed=26116706).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00359.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=21868764; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18 (PubMed=26116706)
ST   vWA: 17,18 (PubMed=21868764)
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6872 ! ACC-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   ACC-MESO-1
AC   CVCL_5113
SY   ACC-Meso-1; ACCMESO1; MESO-1
DR   CLO; CLO_0050082
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03471958
DR   BioSample; SAMN10987705
DR   cancercelllines; CVCL_5113
DR   Cell_Model_Passport; SIDM01526
DR   Cosmic; 877273
DR   Cosmic; 1481540
DR   Cosmic; 2759002
DR   Cosmic; 2759214
DR   DepMap; ACH-000086
DR   FANTOM5_SSTAR; 10493-107B7
DR   GEO; GSM551967
DR   GEO; GSM850296
DR   GEO; GSM886862
DR   GEO; GSM887927
DR   IARC_TP53; 24548
DR   IARC_TP53; 30221
DR   LiGeA; CCLE_096
DR   PharmacoDB; ACCMESO1_52_2019
DR   Progenetix; CVCL_5113
DR   RCB; RCB2292
DR   Wikidata; Q54608242
RX   PubMed=16630136;
RX   PubMed=17270034;
RX   PubMed=21245096;
RX   PubMed=22460905;
RX   PubMed=25902174;
RX   PubMed=26011428;
RX   PubMed=26589293;
RX   PubMed=28553954;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*31:01,31:01; B*15:01,46:01; C*15:02,15:02 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Gln389Ter (c.1165C>T); Zygosity=Homozygous (PubMed=16630136; DepMap=ACH-000086).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.98%; Native American=0.64%; East Asian, North=84.83%; East Asian, South=11.7%; South Asian=0%; European, North=0%; European, South=0.85% (PubMed=30894373).
CC   Donor information: No history of asbestos exposure (PubMed=16630136).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): RCB=RCB2292
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   ACC-MESO-4
AC   CVCL_5114
SY   ACC-Meso-4; MESO-4
DR   CLO; CLO_0050083
DR   BioSample; SAMN03471959
DR   cancercelllines; CVCL_5114
DR   Cosmic; 877274
DR   Cosmic; 1481541
DR   Cosmic; 2759003
DR   Cosmic; 2759232
DR   FANTOM5_SSTAR; 10494-107B8
DR   GEO; GSM551968
DR   GEO; GSM850297
DR   IARC_TP53; 24549
DR   Progenetix; CVCL_5114
DR   RCB; RCB2293
DR   Wikidata; Q54608246
RX   PubMed=16630136;
RX   PubMed=17270034;
RX   PubMed=21245096;
RX   PubMed=25902174;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Tyr724Ter (c.2172delC); Zygosity=Unspecified (PubMed=26011428).
CC   Sequence variation: Mutation; HGNC; HGNC:20796; RASSF6; Simple; p.Arg155fs (c.464_465insA); Zygosity=Unspecified (PubMed=25902174).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): RCB=RCB2293
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 9,11
ST   D7S820: 12,14
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   ACC-OV43
AC   CVCL_DG87
DR   Wikidata; Q54608248
RX   PubMed=16759149;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ACC-OV551
AC   CVCL_DG88
SY   OV55-1
DR   cancercelllines; CVCL_DG88
DR   GEO; GSM185121
DR   GEO; GSM185122
DR   Progenetix; CVCL_DG88
DR   Wikidata; Q54608254
RX   PubMed=16759149;
CC   Doubling time: 36.7 +- 0.2 hours (PubMed=16759149).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG89 ! ACC-OV552
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 9
//
ID   ACC-OV552
AC   CVCL_DG89
SY   OV55-2
DR   cancercelllines; CVCL_DG89
DR   GEO; GSM185123
DR   GEO; GSM185124
DR   Progenetix; CVCL_DG89
DR   Wikidata; Q54608255
RX   PubMed=16759149;
CC   Doubling time: 78.5 +- 2.6 hours (PubMed=16759149).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG88 ! ACC-OV551
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   ACC-OV60
AC   CVCL_DG90
DR   Wikidata; Q54608256
RX   PubMed=16759149;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   ACC-OV614
AC   CVCL_DG91
DR   Wikidata; Q54608260
RX   PubMed=16759149;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG92 ! ACC-OV616
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   ACC-OV616
AC   CVCL_DG92
DR   Wikidata; Q54608261
RX   PubMed=16759149;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG91 ! ACC-OV614
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   ACC-OV62
AC   CVCL_DG93
DR   Wikidata; Q54608262
RX   PubMed=16759149;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   ACC-OV682
AC   CVCL_DG94
DR   Wikidata; Q54608266
RX   PubMed=16759149;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG95 ! ACC-OV684
OI   CVCL_DG96 ! ACC-OV68A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   ACC-OV684
AC   CVCL_DG95
SY   OV684
DR   cancercelllines; CVCL_DG95
DR   GEO; GSM185127
DR   GEO; GSM185128
DR   Progenetix; CVCL_DG95
DR   Wikidata; Q54608268
RX   PubMed=16759149;
CC   Doubling time: 26.9 +- 2.7 hours (PubMed=16759149).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG94 ! ACC-OV682
OI   CVCL_DG96 ! ACC-OV68A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   ACC-OV68A
AC   CVCL_DG96
SY   OV68 ASC; OV68ASC
DR   cancercelllines; CVCL_DG96
DR   GEO; GSM185125
DR   GEO; GSM185126
DR   Progenetix; CVCL_DG96
DR   Wikidata; Q54608269
RX   PubMed=16759149;
CC   Doubling time: 44.7 +- 5.7 hours (PubMed=16759149).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG94 ! ACC-OV682
OI   CVCL_DG95 ! ACC-OV684
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   ACC-OV7
AC   CVCL_DG86
SY   OV7
DR   cancercelllines; CVCL_DG86
DR   GEO; GSM185129
DR   GEO; GSM185130
DR   Progenetix; CVCL_DG86
DR   Wikidata; Q54608273
RX   PubMed=16759149;
CC   Doubling time: 24.5 +- 4.9 hours (PubMed=16759149).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   ACC-OV77
AC   CVCL_DG97
DR   Wikidata; Q54608276
RX   PubMed=16759149;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   ACC-OV79
AC   CVCL_DG98
DR   Wikidata; Q54608277
RX   PubMed=16759149;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   ACC-OV84
AC   CVCL_DG99
DR   Wikidata; Q54608280
RX   PubMed=16759149;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   ACC212102
AC   CVCL_D074
DR   Wikidata; Q54608282
RX   PubMed=21971914;
CC   Population: Chinese.
CC   Doubling time: 25 hours (PubMed=21971914).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   ACCAY
AC   CVCL_UD36
DR   Wikidata; Q93313178
RX   DOI=10.1007/0-306-46872-7_9;
RX   Patent=JP2823567;
RX   PubMed=2570487;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2034.
CC   Population: Japanese.
CC   Doubling time: 48-50 hours (PubMed=2570487).
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 5
//
ID   ACCNS
AC   CVCL_6875
SY   ACC-NS
DR   BioSample; SAMN03152000
DR   Wikidata; Q54608284
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=17203170;
RX   PubMed=19557180;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (PubMed=19557180; PubMed=20143388). Originally thought to originate from a male patient with a salivary gland adenoid cystic carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00360.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   ACCS
AC   CVCL_6876
SY   ACC-S
DR   BioSample; SAMN03151936
DR   BioSample; SAMN10989595
DR   cancercelllines; CVCL_6876
DR   Cell_Model_Passport; SIDM01166
DR   DepMap; ACH-001011
DR   IARC_TP53; 28390
DR   PharmacoDB; ACCS_53_2019
DR   Wikidata; Q54608335
RX   DOI=10.1007/0-306-46872-7_9;
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=2162254;
RX   PubMed=19557180;
RX   PubMed=20143388;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=19557180; PubMed=20143388). Originally thought to originate from a 56 year old female patient with a salivary gland adenoid cystic carcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00361.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (DepMap=ACH-001011).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: DepMap; ACH-001011; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   ACCY
AC   CVCL_6877
DR   Wikidata; Q54608337
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=2162254;
CC   Population: Japanese.
CC   Doubling time: 130 hours (PubMed=2162254).
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   ACD1
AC   CVCL_KB01
DR   RCB; RCB4487
DR   Wikidata; Q54608340
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30285; Mouse Cdk4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   Ace-1
AC   CVCL_L310
SY   ACE-1
DR   ABM; T8280
DR   Wikidata; Q54608341
RX   PubMed=16683269;
RX   PubMed=21801068;
RX   PubMed=23335024;
RX   PubMed=26940014;
CC   Characteristics: Orthotopic injection of Ace-1 in dogs results in prostatic tumors with metastases to lungs and lymph nodes (PubMed=23335024).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   Ace-1-Luc
AC   CVCL_E8GS
DR   ABM; T8281
RX   PubMed=16683269;
CC   Doubling time: 28-38 hours (ABM=T8281).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L310 ! Ace-1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ace-1(CMV)
AC   CVCL_DA11
SY   Ace-1CMV
DR   Wikidata; Q54608343
RX   PubMed=26940014;
CC   Characteristics: Control cell line for Ace-1(huGRPr) (Cellosaurus=CVCL_DA12) (PubMed=26940014).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L310 ! Ace-1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   Ace-1(huGRPr)
AC   CVCL_DA12
SY   Ace-1huGRPr
DR   Wikidata; Q54608344
RX   PubMed=26940014;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4609; GRPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L310 ! Ace-1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   ACE2plusC3
AC   CVCL_D4Z5
SY   ACE2plusC3-A549/ACE2/TMPRSS2
DR   ATCC; CRL-3560
DR   Wikidata; Q127380199
RX   PubMed=35891350;
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=35891350).
CC   Doubling time: ~24-36 hours (ATCC=CRL-3560).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-3560
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   AcE60
AC   CVCL_5F77
SY   Ace 60
DR   Wikidata; Q54608347
RX   PubMed=11784300;
CC   Doubling time: 24-30 hours (Note=At 33 Celsius) (PubMed=11784300).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   ACGII-1-#1
AC   CVCL_RJ12
DR   SKIP; SKIP000797
DR   Wikidata; Q54608348
RX   PubMed=25187577;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Unexplicit; Exon 41 acceptor site T>C substitution; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GR12 ! GM07892
SX   Female
AG   32FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ACGII-1-#2
AC   CVCL_RJ13
DR   SKIP; SKIP000798
DR   Wikidata; Q54608349
RX   PubMed=25187577;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Unexplicit; Exon 41 acceptor site T>C substitution; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GR12 ! GM07892
SX   Female
AG   32FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ACGII-1-#3
AC   CVCL_RJ14
DR   SKIP; SKIP000799
DR   Wikidata; Q54608353
RX   PubMed=25187577;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Unexplicit; Exon 41 acceptor site T>C substitution; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GR12 ! GM07892
SX   Female
AG   32FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ACGII-2-#21
AC   CVCL_RJ15
DR   SKIP; SKIP000800
DR   Wikidata; Q54608354
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly1182Ala; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ16 ! ACGII-2-#22
OI   CVCL_RJ17 ! ACGII-2-#23
OI   CVCL_RJ18 ! ACGII-2-iChon
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ACGII-2-#22
AC   CVCL_RJ16
DR   SKIP; SKIP000801
DR   Wikidata; Q54608356
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly1182Ala; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ15 ! ACGII-2-#21
OI   CVCL_RJ17 ! ACGII-2-#23
OI   CVCL_RJ18 ! ACGII-2-iChon
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ACGII-2-#23
AC   CVCL_RJ17
DR   SKIP; SKIP000802
DR   Wikidata; Q54608359
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly1182Ala; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ15 ! ACGII-2-#21
OI   CVCL_RJ16 ! ACGII-2-#22
OI   CVCL_RJ18 ! ACGII-2-iChon
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ACGII-2-iChon
AC   CVCL_RJ18
DR   SKIP; SKIP001225
DR   Wikidata; Q54608361
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly1182Ala; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ15 ! ACGII-2-#21
OI   CVCL_RJ16 ! ACGII-2-#22
OI   CVCL_RJ17 ! ACGII-2-#23
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ACH-1P
AC   CVCL_1804
SY   ACH1P
DR   CLO; CLO_0001653
DR   CLDB; cl7078
DR   BioSample; SAMN03473561
DR   DSMZ; ACC-481
DR   DSMZCellDive; ACC-481
DR   Wikidata; Q54608366
RX   PubMed=10616526;
CC   Characteristics: Fusion of the AC1-1 choriocarcinoma cell line with normal human trophoblast cells (PubMed=10616526).
CC   Doubling time: ~40-50 hours (DSMZ=ACC-481).
ST   Source(s): DSMZ=ACC-481
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 9,11
ST   D16S539: 12,13,14
ST   D18S51: 13,14,15
ST   D19S433: 13,14,15
ST   D21S11: 30,31
ST   D2S1338: 20,22,23,24
ST   D3S1358: 15,16,18
ST   D5S818: 10,11
ST   D7S820: 10,12,13
ST   D8S1179: 12,17
ST   FGA: 21,22,23
ST   Penta D: 8,9,12,14
ST   Penta E: 5,8,12
ST   TH01: 9,9.3
ST   TPOX: 8,11,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9560 ! AC1-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   ACH-2
AC   CVCL_0138
SY   ACH2
DR   BTO; BTO_0002551
DR   MCCL; MCC:0000031
DR   BEI_Resources; ARP-349
DR   cancercelllines; CVCL_0138
DR   ChEMBL-Cells; CHEMBL3307897
DR   ChEMBL-Targets; CHEMBL614263
DR   PubChem_Cell_line; CVCL_0138
DR   Wikidata; Q54608362
RX   PubMed=2463307;
RX   PubMed=26912621;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1 isolate LAI. The main site of integration of the HIV-1 genome is located in the NT5C3A gene. Additional integration sites are found in the SLC25A25-AS, EPT1 and NPLOC4 genes (PubMed=26912621; PubMed=28086908).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6244 ! CEM A3.01
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   ACH-3P
AC   CVCL_4829
SY   ACH 3P
DR   BTO; BTO_0003421
DR   EFO; EFO_0006269
DR   Wikidata; Q54608363
RX   PubMed=18093301;
RX   PubMed=28724925;
RX   PubMed=33096371;
RX   PubMed=33810901;
CC   Characteristics: Fusion of the AC1-1 choriocarcinoma cell line with primary first trimester trophoblasts (week 12 of gestation) (PubMed=18093301).
CC   Doubling time: 2.74 +- 0.35 days (PubMed=28724925).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=33096371).
ST   Source(s): PubMed=33810901
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D10S1248: 13,14,15
ST   D12S391: 17,19,21,24
ST   D13S317: 9,11
ST   D16S539: 12,13,14
ST   D18S51: 13,14,15
ST   D19S433: 13,15
ST   D1S1656: 14,16
ST   D21S11: 30,31
ST   D22S1045: 15,16
ST   D2S1338: 20,22,24
ST   D2S441: 10,12,14
ST   D3S1358: 15,16,18
ST   D5S818: 10,11
ST   D7S820: 10,12,13
ST   D8S1179: 12
ST   FGA: 21,22,23
ST   Penta D: 8,9,12,14
ST   Penta E: 5,8,12
ST   SE33: 15,36
ST   TH01: 9,9.3
ST   TPOX: 8,11,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9560 ! AC1-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   ACH-8857-1
AC   CVCL_RJ24
DR   SKIP; SKIP000815
DR   Wikidata; Q54608364
RX   PubMed=25231866;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Heterozygous (PubMed=25231866).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U879 ! GM08857
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ACH-8858-6
AC   CVCL_RJ25
DR   SKIP; SKIP000816
DR   Wikidata; Q54608365
RX   PubMed=25231866;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Heterozygous (PubMed=25231866).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U880 ! GM08858
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ACHhomo-8859-3
AC   CVCL_RJ26
DR   SKIP; SKIP000817
DR   Wikidata; Q54608368
RX   PubMed=25231866;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Homozygous (PubMed=25231866).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U881 ! GM08859
SX   Female
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ACHN
AC   CVCL_1067
DR   BTO; BTO_0003846
DR   CLO; CLO_0001654
DR   EFO; EFO_0002108
DR   CLDB; cl236
DR   CLDB; cl237
DR   CLDB; cl4951
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1611
DR   BioSample; SAMN01821536
DR   BioSample; SAMN03473205
DR   BioSample; SAMN10988309
DR   cancercelllines; CVCL_1067
DR   CCRID; 1101HUM-PUMC000334
DR   CCRID; 3101HUMSCSP5063
DR   CCRID; 3101HUMTCHu199
DR   CCRID; 4201HUM-CCTCC00102
DR   CCTCC; GDC0102
DR   Cell_Model_Passport; SIDM00123
DR   ChEMBL-Cells; CHEMBL3307633
DR   ChEMBL-Targets; CHEMBL614519
DR   CLS; 300117
DR   Cosmic; 687939
DR   Cosmic; 849382
DR   Cosmic; 875873
DR   Cosmic; 877456
DR   Cosmic; 897462
DR   Cosmic; 905950
DR   Cosmic; 974302
DR   Cosmic; 979708
DR   Cosmic; 982275
DR   Cosmic; 1044260
DR   Cosmic; 1092592
DR   Cosmic; 1152534
DR   Cosmic; 1175850
DR   Cosmic; 1305374
DR   Cosmic; 1312362
DR   Cosmic; 1436045
DR   Cosmic; 1998434
DR   Cosmic; 2520631
DR   Cosmic-CLP; 905950
DR   DepMap; ACH-000046
DR   ECACC; 88100508
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS569UYK
DR   ENCODE; ENCBS897ZFQ
DR   ENCODE; ENCBS972GIY
DR   GDSC; 905950
DR   GEO; GSM2093
DR   GEO; GSM50228
DR   GEO; GSM50292
DR   GEO; GSM743482
DR   GEO; GSM750837
DR   GEO; GSM799373
DR   GEO; GSM799436
DR   GEO; GSM846286
DR   GEO; GSM886863
DR   GEO; GSM887928
DR   GEO; GSM1153446
DR   GEO; GSM1181298
DR   GEO; GSM1181324
DR   GEO; GSM1669593
DR   GEO; GSM2124661
DR   IARC_TP53; 21039
DR   IBRC; C10105
DR   ICLC; HTL99007
DR   IGRhCellID; ACHN
DR   IZSLER; BS TCL 68
DR   KCB; KCB 200611YJ
DR   KCLB; 21611
DR   LiGeA; CCLE_085
DR   LINCS_LDP; LCL-1756
DR   Lonza; 1467
DR   NCBI_Iran; C206
DR   NCI-DTP; ACHN
DR   PharmacoDB; ACHN_54_2019
DR   PRIDE; PXD001962
DR   PRIDE; PXD003105
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1067
DR   PubChem_Cell_line; CVCL_1067
DR   RCB; RCB1962
DR   SKY/M-FISH/CGH; 2789
DR   TKG; TKG 0578
DR   Ubigene; YC-C087
DR   Wikidata; Q54608371
RX   PubMed=2041050;
RX   PubMed=7591954;
RX   PubMed=8620516;
RX   PubMed=9331090;
RX   PubMed=10074909;
RX   PubMed=10700174;
RX   PubMed=10929426;
RX   PubMed=11146448;
RX   PubMed=11414198;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17409424;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22949125;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24477694;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=27993170;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=41
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-614.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 32 hours (PubMed=25984343); ~30 hours (CLS=300117); 27.5 hours (NCI-DTP=ACHN).
CC   HLA typing: A*26:01; B*49:01; C*07; DPB1*02:01:02; DQB1*05:02:01; DRB1*16:01:01 (PubMed=15748285).
CC   HLA typing: A*26:01,26:01; B*49:01,49:01; C*07:01,07:01; DQB1*05:02,05:02 (PubMed=26589293).
CC   HLA typing: A*26:01:01; B*49:01:01; C*07:01:01; DPB1*02:01:02; DQA1*01:02:02; DQB1*05:02:01; DRB1*16:01:01 (CLS=300117).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (Cosmic-CLP=905950; DepMap=ACH-000046).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.83%; East Asian, South=1.52%; South Asian=1.78%; European, North=70.53%; European, South=25.34% (PubMed=30894373).
CC   Misspelling: ACHN-1; Note=Occasionally.
CC   Misspelling: ACHN1; Note=Occasionally.
CC   Discontinued: RCB; RCB1962; true.
CC   Discontinued: TKG; TKG 0578; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-1611; CCRID; CLS=300117; Cosmic-CLP=905950; ECACC=88100508; IZSLER=BS TCL 68; KCLB=21611; PubMed=19372543; PubMed=25877200; RCB=RCB1962
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 14 (PubMed=19372543)
ST   D19S433: 14,15 (ATCC=CRL-1611; CCRID)
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 16
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   ACHN-IL2
AC   CVCL_W666
DR   cancercelllines; CVCL_W666
DR   IZSLER; BS TCL 116
DR   Wikidata; Q54608373
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): IZSLER=BS TCL 116
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1067 ! ACHN
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   ACHN-luc2
AC   CVCL_5J27
DR   cancercelllines; CVCL_5J27
DR   Revvity/PerkinElmer; 125056
DR   Wikidata; Q54608374
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 125056; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1067 ! ACHN
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   ACI-1
AC   CVCL_IU11
DR   Wikidata; Q54608376
RX   PubMed=19888321;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 4
//
ID   ACI-126
AC   CVCL_N827
SY   ACI_126
DR   Cosmic; 1622889
DR   GEO; GSM3161706
DR   GEO; GSM3161707
DR   Wikidata; Q54608378
RX   PubMed=21882256;
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   ACI-158
AC   CVCL_D716
SY   ACI_158
DR   cancercelllines; CVCL_D716
DR   Cosmic; 1622905
DR   GEO; GSM3161708
DR   GEO; GSM3161709
DR   Wikidata; Q54608381
RX   PubMed=21882256;
CC   Sequence variation: Mutation; HGNC; HGNC:9302; PPP2R1A; Simple; p.Pro179Arg (c.536C>G); ClinVar=VCV000376504; Zygosity=Unspecified (PubMed=21882256).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=21882256).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   ACI-17
AC   CVCL_IU12
DR   Wikidata; Q54608382
RX   PubMed=19888321;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 4
//
ID   ACI-181
AC   CVCL_N828
DR   Cosmic; 1622891
DR   Wikidata; Q54608385
RX   PubMed=21882256;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   ACI-23
AC   CVCL_N830
DR   Wikidata; Q54608388
RX   PubMed=19888321;
RX   PubMed=27235858;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 6
//
ID   ACI-27
AC   CVCL_N831
DR   Wikidata; Q54608390
RX   PubMed=19888321;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 6
//
ID   ACI-35
AC   CVCL_IU13
DR   Wikidata; Q54608392
RX   PubMed=19888321;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 4
//
ID   ACI-45
AC   CVCL_N833
DR   BTO; BTO_0006269
DR   Cosmic; 1622882
DR   Wikidata; Q54608393
RX   PubMed=21882256;
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 9
//
ID   ACI-52
AC   CVCL_N834
DR   Cosmic; 1622883
DR   Wikidata; Q54608395
RX   PubMed=21882256;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   ACI-54
AC   CVCL_N832
DR   Wikidata; Q54608397
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 6
//
ID   ACI-61
AC   CVCL_N835
DR   Cosmic; 1622884
DR   Wikidata; Q54608400
RX   PubMed=21882256;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   ACI-68
AC   CVCL_N836
DR   Cosmic; 1622885
DR   Wikidata; Q54608402
RX   PubMed=21882256;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   ACI-70
AC   CVCL_N837
DR   Cosmic; 1622886
DR   Wikidata; Q54608403
RX   PubMed=21882256;
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   ACI-8
AC   CVCL_N829
DR   Wikidata; Q54608406
RX   PubMed=19888321;
RX   PubMed=27235858;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 6
//
ID   ACI-80
AC   CVCL_N838
DR   Cosmic; 1622887
DR   Wikidata; Q54608409
RX   PubMed=21882256;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   ACI-89
AC   CVCL_D717
SY   ACI-89-2
DR   cancercelllines; CVCL_D717
DR   Cosmic; 1622907
DR   Wikidata; Q54608411
RX   PubMed=19888321;
RX   PubMed=21882256;
CC   Sequence variation: Mutation; HGNC; HGNC:9302; PPP2R1A; Simple; p.Arg183Trp (c.547C>T); ClinVar=VCV000376505; Zygosity=Unspecified (PubMed=21882256).
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   ACI-98
AC   CVCL_N839
DR   Cosmic; 1622888
DR   Wikidata; Q54608515
RX   PubMed=21882256;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   ACI-RCC
AC   CVCL_4W27
SY   ACI-RCC clone 4
DR   JCRB; JCRB1585
DR   Wikidata; Q54608517
RX   PubMed=20303523;
CC   Transformant: ChEBI; CHEBI_132238; Iron(III) nitrilotriacetate.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   ACI-RCC-cbLuc
AC   CVCL_JG45
DR   JCRB; JCRB1596
DR   Wikidata; Q54608518
RX   PubMed=20303523;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=Click beetle green luciferase (CBG).
CC   Transformant: ChEBI; CHEBI_132238; Iron(III) nitrilotriacetate.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4W27 ! ACI-RCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   ACI-RCC-ffLuc
AC   CVCL_JG46
DR   JCRB; JCRB1588
DR   Wikidata; Q54608522
RX   PubMed=20303523;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_132238; Iron(III) nitrilotriacetate.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4W27 ! ACI-RCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   Aciba-Dsfin
AC   CVCL_E4CA
RX   DOI=10.1080/00087114.1997.10797388;
CC   Group: Fish cell line.
CC   Doubling time: 24-48 hours (DOI=10.1080/00087114.1997.10797388).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Acitr-Dsfin
AC   CVCL_E4CB
RX   DOI=10.1080/00087114.1997.10797388;
CC   Group: Fish cell line.
CC   Doubling time: 48 hours (DOI=10.1080/00087114.1997.10797388).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   ACK2
AC   CVCL_KB02
DR   RCB; RCB4477
DR   Wikidata; Q54608524
RX   PubMed=1711568;
RX   PubMed=1712289;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05532; Mouse Kit/Cd117.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   ACK30
AC   CVCL_KB03
DR   RCB; RCB4479
DR   Wikidata; Q54608525
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05532; Mouse Kit/Cd117.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   ACK4
AC   CVCL_KB04
DR   RCB; RCB4478
DR   Wikidata; Q54608527
RX   PubMed=1711568;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05532; Mouse Kit/Cd117.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   ACK45
AC   CVCL_KB05
DR   RCB; RCB4480
DR   Wikidata; Q54608528
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05532; Mouse Kit/Cd117.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   ACL
AC   CVCL_DE03
SY   Atlantic Cod Larvae
DR   Wikidata; Q54608533
RX   PubMed=23108254;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
OX   NCBI_TaxID=8049; ! Gadus morhua (Atlantic cod)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ACL-15
AC   CVCL_5491
DR   CLO; CLO_0051586
DR   RCB; RCB0510
DR   Wikidata; Q54608537
RX   CelloPub=CLPUB00016;
CC   Doubling time: 24 hours (CelloPub=CLPUB00016).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   ACN
AC   CVCL_1068
DR   CLO; CLO_0001655
DR   CLDB; cl239
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1068
DR   Cell_Model_Passport; SIDM00057
DR   ChEMBL-Cells; CHEMBL3308148
DR   ChEMBL-Targets; CHEMBL2366195
DR   Cosmic; 906803
DR   Cosmic-CLP; 906803
DR   DepMap; ACH-002389
DR   EGA; EGAS00001000978
DR   GDSC; 906803
DR   GEO; GSM1669594
DR   IARC_TP53; 21170
DR   ICLC; HTL96020
DR   LINCS_LDP; LCL-1982
DR   PharmacoDB; ACN_55_2019
DR   PubChem_Cell_line; CVCL_1068
DR   Wikidata; Q54608539
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=1354203;
RX   PubMed=2467885;
RX   PubMed=8509230;
RX   PubMed=15150552;
RX   PubMed=20164919;
RX   PubMed=30894373;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Probably contaminated. The STR profile of ACN and LN-464 are identical. SNP analysis (DepMap) also shows identity of both cell lines. We believe this is a melanoma cell line based on the presence of the BRAF V600E mutation as well as the RNASeq expression profile of LN-464 (DepMap) which clusters with that of melanoma patient samples. Originally thought to originate from the bone marrow of a 36-month old boy with a metastatic adrenal stage-IV neuroblastoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00623.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=906803; DepMap=ACH-002389).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn184fs*6 (c.545_546insA); Zygosity=Heterozygous (Cosmic-CLP=906803; DepMap=ACH-002389).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Homozygous (Cosmic-CLP=906803; DepMap=ACH-002389).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.3%; Native American=0.69%; East Asian, North=0%; East Asian, South=0.16%; South Asian=1.02%; European, North=70.67%; European, South=27.16% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=906803; ICLC=HTL96020
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 10,14
ST   TH01: 9
ST   TPOX: 9,12
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3962 ! LN-464
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   ACN/IFN-gamma
AC   CVCL_B7TC
DR   cancercelllines; CVCL_B7TC
DR   Wikidata; Q112929124
RX   PubMed=15150552;
CC   Problematic cell line: Probably contaminated. Parent cell line (ACN) has been shown to probably be a melanoma cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn184fs*6 (c.545_546insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1068 ! ACN
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   ACN/neo
AC   CVCL_B7TD
DR   cancercelllines; CVCL_B7TD
DR   Wikidata; Q112929125
RX   PubMed=15150552;
CC   Problematic cell line: Probably contaminated. Parent cell line (ACN) has been shown to probably be a melanoma cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn184fs*6 (c.545_546insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1068 ! ACN
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   ACOSC16
AC   CVCL_VV84
DR   Wikidata; Q93313423
RX   PubMed=30816493;
CC   Population: Indian.
CC   Characteristics: Tumorigenic in nude mice.
CC   Doubling time: 34.0 hours (PubMed=30816493).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=30816493
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   ACOSC3
AC   CVCL_VV85
DR   Wikidata; Q93313426
RX   PubMed=30816493;
CC   Population: Indian.
CC   Characteristics: Tumorigenic in nude mice.
CC   Doubling time: 45.42 hours (PubMed=30816493).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=30816493
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   ACOSC4
AC   CVCL_VV86
DR   Wikidata; Q93313428
RX   PubMed=30816493;
CC   Population: Indian.
CC   Characteristics: Tumorigenic in nude mice.
CC   Doubling time: 33.78 hours (PubMed=30816493).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=30816493
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 16,19
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   AcoSI-1
AC   CVCL_E6Z7
SY   Acomys Spontaneously Immortalized-1
DR   ABM; T0220
RX   PubMed=37418364;
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10068; ! Acomys cahirinus (Cairo spiny mouse)
SX   Male
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AcoSV40
AC   CVCL_E6Z8
SY   Acomys SV40 transformed
DR   ABM; T0221
RX   PubMed=37418364;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10068; ! Acomys cahirinus (Cairo spiny mouse)
SX   Female
AG   3D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ACP01
AC   CVCL_9490
DR   Wikidata; Q54608541
RX   PubMed=15558189;
CC   Population: African and Caucasian.
CC   Doubling time: ~40 hours (PubMed=15558189).
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   ACP02
AC   CVCL_IK51
DR   Wikidata; Q54608543
RX   PubMed=19837275;
RX   PubMed=27920471;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, cardia; UBERON=UBERON_0001162.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   ACP03
AC   CVCL_IK52
DR   Wikidata; Q54608545
RX   PubMed=19837275;
RX   PubMed=27920471;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   ACR-P
AC   CVCL_D5JE
DR   Wikidata; Q127380200
RX   DOI=10.1016/S0074-7696(08)62455-9;
RX   PubMed=16666458;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (PubMed=16666458).
CC   Doubling time: ~14 days (PubMed=16666458).
CC   Miscellaneous: This cell line was lost (DOI=10.1016/S0074-7696(08)62455-9).
CC   Derived from site: In situ; Cotyledon; PO=PO_0020030.
CC   Derived from site: In situ; Hypocotyl; PO=PO_0020100.
OX   NCBI_TaxID=117272; ! Amaranthus cruentus (Purple amaranth)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   ACr41
AC   CVCL_U185
DR   Wikidata; Q54608546
RX   PubMed=3163531;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_75270; Nimustine (ACNU).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U181 ! MR10-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   ACr42
AC   CVCL_U186
DR   Wikidata; Q54608547
RX   PubMed=3163531;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_75270; Nimustine (ACNU).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U181 ! MR10-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   ACRJ-BC24
AC   CVCL_F0QY
SY   Anti Cancer Research Jamaica-Breast Cancer 24
RX   DOI=10.1158/1538-7445.AM2024-3381;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caribbean; Jamaican.
CC   Doubling time: 70 hours (DOI=10.1158/1538-7445.AM2024-3381).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ACRJ-BC24alpha
AC   CVCL_F0QZ
SY   Anti Cancer Research Jamaica-Breast Cancer 24alpha
RX   DOI=10.1158/1538-7445.AM2024-3381;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caribbean; Jamaican.
CC   Doubling time: 133 hours (DOI=10.1158/1538-7445.AM2024-3381).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0QY ! ACRJ-BC24
SX   Female
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ACRJ-BC24beta
AC   CVCL_F0R0
SY   Anti Cancer Research Jamaica-Breast Cancer 24beta
RX   DOI=10.1158/1538-7445.AM2024-3381;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caribbean; Jamaican.
CC   Doubling time: 70 hours (DOI=10.1158/1538-7445.AM2024-3381).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0QY ! ACRJ-BC24
SX   Female
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ACRJ-PC28
AC   CVCL_B6XF
SY   Anti Cancer Research Jamaica-Prostate Cancer 28
DR   ABM; T0398
DR   Wikidata; Q111732869
RX   DOI=10.1158/1538-7755.DISP21-PO-138;
RX   PubMed=36643868;
WW   Info; -; -; https://www.cancer.gov/about-nci/organization/cgh/blog/2021/grantee-spotlight-badal
CC   Population: Caribbean; Jamaican.
CC   Characteristics: Lack of expression of AR (DOI=10.1158/1538-7755.DISP21-PO-138; PubMed=36643868).
CC   Doubling time: 45 hours (DOI=10.1158/1538-7755.DISP21-PO-138; PubMed=36643868).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 8
//
ID   ACSuR
AC   CVCL_XI64
DR   cancercelllines; CVCL_XI64
DR   CCRID; 4201PAT-CCTCC00548
DR   CCRID; 4201PAT-CCTCC00565
DR   Wikidata; Q93313455
RX   Patent=CN104988122B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014238.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_38940; Sunitinib.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: ACSu; CCRID=4201PAT-CCTCC00548.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1067 ! ACHN
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   ACT I
AC   CVCL_4499
SY   Act I; ACT 1
DR   CLO; CLO_0001656
DR   CLO; CLO_0001657
DR   CLDB; cl5131
DR   ABCD; ABCD_AF295
DR   ATCC; HB-80
DR   IZSLER; BS Hy 1
DR   Wikidata; Q54608550
RX   PubMed=6203918;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dictyostelium discoideum actins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   ACT II
AC   CVCL_KB14
SY   Act II
DR   Wikidata; Q54608553
RX   PubMed=6203918;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dictyostelium discoideum actins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   ACT IV
AC   CVCL_C410
SY   Act IV
DR   CLO; CLO_0001658
DR   ATCC; HB-81
DR   Wikidata; Q54608555
RX   PubMed=6203918;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dictyostelium discoideum actins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   ACT-1 [Human adrenocortical carcinoma]
AC   CVCL_6290
DR   Wikidata; Q54608557
RX   PubMed=11168692;
RX   PubMed=21924324;
CC   Population: Japanese.
CC   Doubling time: 24 hours (Note=At 26th passage) (PubMed=11168692).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   ACT-1 [Human thyroid carcinoma]
AC   CVCL_6291
SY   ACT1
DR   BTO; BTO_0004858
DR   cancercelllines; CVCL_6291
DR   CCRID; 3101HUMSCSP541
DR   Cosmic; 1152115
DR   Cosmic; 1239968
DR   Cosmic; 2054109
DR   Wikidata; Q54608560
RX   PubMed=12495476;
RX   PubMed=18713817;
RX   PubMed=23833040;
RX   PubMed=26137260;
RX   PubMed=26680454;
RX   PubMed=30737244;
CC   From: Ohata, Seiji; Tokushima University; Tokushima; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Ser (c.725G>C); ClinVar=VCV000647334; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 23,24
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   ACT-14
AC   CVCL_B523
AS   CVCL_C336
SY   MA14; MA 14; ACTe003-A
DR   hPSCreg; ACTe003-A
DR   SKIP; SKIP002050
DR   Wikidata; Q54608561
RX   PubMed=15885296;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Anecdotal: First human embryonic stem cell line derived in feeder-free conditions.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   Act5C-GS>Ras attP-LB-Clone6
AC   CVCL_C7GC
SY   ActGSB-6
DR   DGRC; 329
DR   FlyBase_Cell_line; FBtc0000329
DR   Wikidata; Q123030648
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: Expresses Act5C-GeneSwitch-Gal4; UAS-GFP; attP, UAS-RasV12.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 7
//
ID   Act5C-GS>Ras attP-GFP-LI-CloneI2
AC   CVCL_C7GD
SY   ActGSI-2
DR   DGRC; 330
DR   FlyBase_Cell_line; FBtc0000330
DR   Wikidata; Q123030649
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: Expresses Act5C-GeneSwitch-Gal4; UAS-GFP; attP, UAS-RasV12.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 7
//
ID   Act5C-GS>Ras attP-GFP-LI-Clone3
AC   CVCL_C7GE
SY   ActGSI-3
DR   DGRC; 331
DR   FlyBase_Cell_line; FBtc0000331
DR   Wikidata; Q123030651
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: Expresses Act5C-GeneSwitch-Gal4; UAS-GFP; attP, UAS-RasV12.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 7
//
ID   ACTH2
AC   CVCL_WA36
DR   IBRC; C11135
DR   Wikidata; Q93313485
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WA37 ! EPTH2
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   ActiCre-B1
AC   CVCL_A4SE
DR   Wikidata; Q107113348
RX   PubMed=33453576;
CC   Group: Non-human primate cell line.
CC   Characteristics: Ubiquitously expresses the tamoxifen-inducible Cre-driver ERT2iCreERT2. Using CRISPR/Cas9 a IRES-ERT2iCreERT2-IRES-Hyg construct was introduced into the 3'UTR of ACTB (PubMed=33453576).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_B946 ! CMES40
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   ACTK1
AC   CVCL_BS99
SY   African Clawed Toad Kidney 1
DR   KCB; KCB 82004YJ
DR   Wikidata; Q54608563
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   ACTOne ADCYAP1R1
AC   CVCL_C0RZ
DR   Wikidata; Q112929126
WW   Provider; Dexorgen; CB-80300-234; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne ADORA1
AC   CVCL_C0S0
DR   Wikidata; Q112929127
WW   Provider; Dexorgen; CB-80300-212; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:262; ADORA1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne ADORA2A
AC   CVCL_C0S1
DR   Wikidata; Q112929128
WW   Provider; Dexorgen; CB-80200-261; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:263; ADORA2A.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne ADORA2B
AC   CVCL_C0S2
DR   Wikidata; Q112929129
WW   Provider; Dexorgen; CB-80200-260; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:264; ADORA2B.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne ADORA3
AC   CVCL_C0S3
DR   Wikidata; Q112929130
WW   Provider; Dexorgen; CB-80300-232; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:268; ADORA3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne ADRB1
AC   CVCL_C0S4
DR   Wikidata; Q112929131
WW   Provider; Dexorgen; CB-80200-272; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:285; ADRB1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne ADRB2
AC   CVCL_C0S5
DR   Wikidata; Q112929132
WW   Provider; Dexorgen; CB-80200-253; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne AGTRL1
AC   CVCL_C0S6
DR   Wikidata; Q112929133
WW   Provider; Dexorgen; CB-80300-267; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne AMY3
AC   CVCL_C0S7
DR   Wikidata; Q112929134
WW   Provider; Dexorgen; CB-80200-271; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9845; RAMP3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0S9 ! ACTOne CALCR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne AVPR2
AC   CVCL_C0S8
DR   Wikidata; Q112929135
WW   Provider; Dexorgen; CB-80200-246; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:897; AVPR2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne CALCR
AC   CVCL_C0S9
DR   Wikidata; Q112929136
WW   Provider; Dexorgen; CB-80200-258; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne CALCRL
AC   CVCL_C0SA
DR   Wikidata; Q112929137
WW   Provider; Dexorgen; CB-80200-251; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne cAMP-PDE10A
AC   CVCL_C0TF
SY   ACTOne PDE10A
DR   Wikidata; Q112929181
WW   Provider; Dexorgen; CB-81200-102; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8772; PDE10A.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RW ! HEK293-CNG-Gs
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne cAMP-PDE1B
AC   CVCL_C0TG
SY   ACTOne PDE1B
DR   Wikidata; Q112929182
WW   Provider; Dexorgen; CB-81200-103; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8775; PDE1B.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RW ! HEK293-CNG-Gs
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne cAMP-PDE1C
AC   CVCL_C0TH
SY   ACTOne PDE1C
DR   Wikidata; Q112929183
WW   Provider; Dexorgen; CB-81200-104; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8776; PDE1C.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RW ! HEK293-CNG-Gs
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne cAMP-PDE2A
AC   CVCL_C0TI
SY   ACTOne PDE2A
DR   Wikidata; Q112929184
WW   Provider; Dexorgen; CB-81200-101; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8777; PDE2A.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RW ! HEK293-CNG-Gs
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne cAMP-PDE4A
AC   CVCL_C0U2
SY   ACTOne PDE4A; PDE4A ACTOne; CHO-K1-CNG-PDE4A
DR   Wikidata; Q112929138
WW   Provider; Dexorgen; CB-81200-105; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8780; PDE4A.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C0RV ! CHO-K1-CNG-Gs
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne cAMP-PDE4B
AC   CVCL_C0U3
SY   ACTOne PDE4B; PDE4B ACTOne; CHO-K1-CNG-PDE4B
DR   Wikidata; Q112929139
WW   Provider; Dexorgen; CB-81200-106; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8781; PDE4B.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C0RV ! CHO-K1-CNG-Gs
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne cAMP-PDE4C
AC   CVCL_C0U4
SY   ACTOne PDE4C; PDE4C ACTOne; CHO-K1-CNG-PDE4C
DR   Wikidata; Q112929140
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8782; PDE4C.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Dexorgen; Catalog number CL-02-PDE4C.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C0RV ! CHO-K1-CNG-Gs
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne cAMP-PDE4D
AC   CVCL_C0U5
SY   ACTOne PDE4D; PDE4D ACTOne; CHO-K1-CNG-PDE4D
DR   Wikidata; Q112929141
WW   Provider; Dexorgen; CB-81200-107; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8783; PDE4D.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C0RV ! CHO-K1-CNG-Gs
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   ACTOne CB1
AC   CVCL_C0SB
SY   ACTOne HEK-CNG+CB1; HEK-CNG + CB1
DR   Wikidata; Q112929142
RX   PubMed=26772161;
RX   PubMed=27115025;
WW   Provider; Dexorgen; CB-80300-205; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne CB2
AC   CVCL_C0SD
SY   ACTOne-CB2
DR   Wikidata; Q112929143
WW   Provider; Dexorgen; CB-80300-225; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2160; CNR2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne CCR5
AC   CVCL_C0SE
DR   Wikidata; Q112929144
WW   Provider; Dexorgen; CB-80300-213; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne CRHR1
AC   CVCL_C0SF
DR   Wikidata; Q112929145
WW   Provider; Dexorgen; CB-80200-249; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2357; CRHR1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne CRHR2
AC   CVCL_C0SG
DR   Wikidata; Q112929146
WW   Provider; Dexorgen; CB-80200-233; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2358; CRHR2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne CXCR4
AC   CVCL_C0SH
DR   Wikidata; Q112929147
WW   Provider; Dexorgen; CB-80300-265; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne DRD1
AC   CVCL_C0SI
DR   Wikidata; Q112929148
WW   Provider; Dexorgen; CB-80200-218; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3020; DRD1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne DRD2
AC   CVCL_C0SJ
DR   Wikidata; Q112929149
WW   Provider; Dexorgen; CB-80300-206; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3023; DRD2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne DRD5
AC   CVCL_C0SK
DR   Wikidata; Q112929150
WW   Provider; Dexorgen; CB-80200-222; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3026; DRD5.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne EDG1
AC   CVCL_C0SL
DR   Wikidata; Q112929151
WW   Provider; Dexorgen; CB-80300-254; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3165; S1PR1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne FSHR
AC   CVCL_C0SM
DR   Wikidata; Q112929152
WW   Provider; Dexorgen; CB-80200-236; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3969; FSHR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GCGR
AC   CVCL_C0SN
DR   Wikidata; Q112929153
WW   Provider; Dexorgen; CB-80200-217; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4192; GCGR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GIPR
AC   CVCL_C0SP
DR   Wikidata; Q112929154
WW   Provider; Dexorgen; CB-80200-221; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4271; GIPR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GLP1R
AC   CVCL_C0SQ
DR   Wikidata; Q112929155
WW   Provider; Dexorgen; CB-80200-248; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GLP2R
AC   CVCL_C0SR
DR   Wikidata; Q112929156
WW   Provider; Dexorgen; CB-80200-241; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4325; GLP2R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GPR119
AC   CVCL_C0SS
DR   Wikidata; Q112929157
WW   Provider; Dexorgen; CB-80200-274; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19060; GPR119.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GRM2
AC   CVCL_C0ST
DR   Wikidata; Q112929158
WW   Provider; Dexorgen; CB-80300-262; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4594; GRM2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10941; SLC1A3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RX ! HEK293-CNG-Slc1a3
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GRM4
AC   CVCL_C0SU
DR   Wikidata; Q112929159
WW   Provider; Dexorgen; CB-80300-269; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4596; GRM4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10941; SLC1A3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RX ! HEK293-CNG-Slc1a3
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GRM7
AC   CVCL_C0SV
DR   Wikidata; Q112929160
WW   Provider; Dexorgen; CB-80300-259; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4599; GRM7.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10941; SLC1A3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RX ! HEK293-CNG-Slc1a3
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne GRM8
AC   CVCL_C0SW
DR   Wikidata; Q112929162
WW   Provider; Dexorgen; CB-80300-239; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4600; GRM8.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10941; SLC1A3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RX ! HEK293-CNG-Slc1a3
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne HTR1A
AC   CVCL_C0SX
DR   Wikidata; Q112929163
WW   Provider; Dexorgen; CB-80200-277; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5286; HTR1A.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne HTR1F
AC   CVCL_C0SY
DR   Wikidata; Q112929164
WW   Provider; Dexorgen; CB-80200-276; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5292; HTR1F.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne HTR4
AC   CVCL_C0SZ
DR   Wikidata; Q112929165
WW   Provider; Dexorgen; CB-80200-231; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5299; HTR4.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne HTR6
AC   CVCL_C0T0
DR   Wikidata; Q112929166
WW   Provider; Dexorgen; CB-80200-237; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5301; HTR6.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne HTR7B
AC   CVCL_C0T1
DR   Wikidata; Q112929167
WW   Provider; Dexorgen; CB-80200-240; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5302; HTR7 (Note=Isoform B).
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne LHCGR
AC   CVCL_C0T2
DR   Wikidata; Q112929168
WW   Provider; Dexorgen; CB-80200-282; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6585; LHCGR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne MC1R
AC   CVCL_C0T3
DR   Wikidata; Q112929169
WW   Provider; Dexorgen; CB-80200-257; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6929; MC1R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne MC3R
AC   CVCL_C0T4
DR   Wikidata; Q112929170
WW   Provider; Dexorgen; CB-80200-243; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6931; MC3R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne MC4R
AC   CVCL_C0T5
DR   Wikidata; Q112929171
WW   Provider; Dexorgen; CB-80200-211; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6932; MC4R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne MC5R
AC   CVCL_C0T6
DR   Wikidata; Q112929172
WW   Provider; Dexorgen; CB-80200-215; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6933; MC5R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne MCHR1
AC   CVCL_C0T7
DR   Wikidata; Q112929173
WW   Provider; Dexorgen; CB-80300-214; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4479; MCHR1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne NPY1R
AC   CVCL_C0T8
DR   Wikidata; Q112929174
WW   Provider; Dexorgen; CB-80300-244; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7956; NPY1R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne NPY2R
AC   CVCL_C0T9
DR   Wikidata; Q112929175
WW   Provider; Dexorgen; CB-80300-245; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7957; NPY2R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne NPY5R
AC   CVCL_C0TA
DR   Wikidata; Q112929176
WW   Provider; Dexorgen; CB-80300-280; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7958; NPY5R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne OPRD1
AC   CVCL_C0TC
DR   Wikidata; Q112929178
WW   Provider; Dexorgen; CB-80300-279; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8153; OPRD1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne OPRK1
AC   CVCL_C0TB
DR   Wikidata; Q112929177
WW   Provider; Dexorgen; CB-80300-230; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8154; OPRK1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne OPRL1
AC   CVCL_C0TD
DR   Wikidata; Q112929179
WW   Provider; Dexorgen; CB-80300-266; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8155; OPRL1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne OPRM1
AC   CVCL_C0TE
DR   Wikidata; Q112929180
WW   Provider; Dexorgen; CB-80300-268; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8156; OPRM1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne PPYR1
AC   CVCL_C0TJ
DR   Wikidata; Q112929185
WW   Provider; Dexorgen; CB-80300-270; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9329; NPY4R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne PTGDR2
AC   CVCL_C0TK
DR   Wikidata; Q112929187
WW   Provider; Dexorgen; CB-80200-255; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4502; PTGDR2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne PTGER2
AC   CVCL_C0TL
DR   Wikidata; Q112929188
WW   Provider; Dexorgen; CB-80200-256; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9594; PTGER2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne PTGER4
AC   CVCL_C0TM
DR   Wikidata; Q112929189
WW   Provider; Dexorgen; CB-80200-219; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9596; PTGER4.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne PTGIR
AC   CVCL_C0TN
DR   Wikidata; Q112929190
WW   Provider; Dexorgen; CB-80200-247; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9602; PTGIR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne PTHR1
AC   CVCL_C0TP
SY   ACTOne PTH1R
DR   Wikidata; Q112929191
WW   Provider; Dexorgen; CB-80200-216; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9608; PTH1R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne PTHR2
AC   CVCL_C0TQ
SY   ACTOne PTH2R; HEK293-CNG-PTH2R
DR   Wikidata; Q112929192
RX   PubMed=18087071;
WW   Provider; Dexorgen; CB-80200-228; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9609; PTH2R.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne SCTR
AC   CVCL_C0TR
DR   Wikidata; Q112929193
WW   Provider; Dexorgen; CB-80200-235; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10608; SCTR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne SSTR5
AC   CVCL_C0TS
DR   Wikidata; Q112929194
WW   Provider; Dexorgen; CB-80300-207; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11334; SSTR5.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne TGR5
AC   CVCL_C0TT
DR   Wikidata; Q112929195
WW   Provider; Dexorgen; CB-80200-275; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19680; GPBAR1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne TSHR
AC   CVCL_C0TU
DR   Wikidata; Q112929196
RX   PubMed=18216391;
WW   Provider; Dexorgen; CB-80200-242; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12373; TSHR.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne VIPR1
AC   CVCL_C0TV
DR   Wikidata; Q112929197
WW   Provider; Dexorgen; CB-80200-220; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12694; VIPR1.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ACTOne VIPR2
AC   CVCL_C0TW
DR   Wikidata; Q112929198
WW   Provider; Dexorgen; CB-80200-209; https://www.dexorgen.com/actone-cell-lines/
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12695; VIPR2.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   AD [Human chondrosarcoma]
AC   CVCL_M606
DR   Wikidata; Q54608565
RX   PubMed=16039953;
CC   Doubling time: 24 hours (PubMed=16039953).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   AD [Mouse hybridoma against phenacetin]
AC   CVCL_B6Z3
DR   Wikidata; Q111732870
RX   Patent=CN112877296B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19681.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_8050; Phenacetin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   Ad Hot
AC   CVCL_3639
DR   CLO; CLO_0001659
DR   ATCC; CRL-1227
DR   Wikidata; Q54608567
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   AD-2
AC   CVCL_B5VA
DR   Wikidata; Q111732871
RX   PubMed=10412038;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: SAMR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   Ad-211/SV40
AC   CVCL_V288
SY   Ad 211; Ad211
DR   Wikidata; Q54608568
RX   PubMed=1384660;
RX   PubMed=7923078;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   Ad-220/SV40
AC   CVCL_WT22
SY   Ad 220; Ad220
DR   Wikidata; Q93313491
RX   PubMed=1384660;
RX   PubMed=7923078;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   Ad-248/SV40
AC   CVCL_V289
DR   Wikidata; Q54608571
RX   PubMed=1384660;
RX   PubMed=7850744;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Ad-263/SV40
AC   CVCL_V290
DR   Wikidata; Q54608573
RX   PubMed=1384660;
RX   PubMed=7850744;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AD-293
AC   CVCL_9804
SY   Ad-293; AD293; Adeno-293; Adeno 293; HEK-AD293; HEK (AD293); HEK AD293; HEK-AD 293; AdHek
DR   BTO; BTO_0003263
DR   ChEMBL-Cells; CHEMBL4630767
DR   ChEMBL-Targets; CHEMBL4630775
DR   IBRC; C10451
DR   NCBI_Iran; C559
DR   PubChem_Cell_line; CVCL_9804
DR   Wikidata; Q54608574
WW   Provider; Agilent; 240085; https://www.chem-agilent.com/pdf/strata/240085.pdf
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Caution: Not the same cell line as 293AD from Cell Biolabs (Cellosaurus=CVCL_KA63).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   Ad-295/SV40
AC   CVCL_V291
DR   Wikidata; Q54608575
RX   PubMed=1384660;
RX   PubMed=7850744;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Ad-302/SV40
AC   CVCL_V292
DR   Wikidata; Q54608577
RX   PubMed=1384660;
RX   PubMed=7850744;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Ad-312/SV40
AC   CVCL_V293
DR   Wikidata; Q54608581
RX   PubMed=1384660;
RX   PubMed=7850744;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Ad-366/SV40
AC   CVCL_V294
DR   Wikidata; Q54608582
RX   PubMed=7850744;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AD-A
AC   CVCL_0C05
DR   Cosmic; 2239082
DR   Wikidata; Q54608584
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
RX   PubMed=10100721;
CC   Doubling time: 45 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   Ad-AH
AC   CVCL_X200
SY   AdAH
DR   Wikidata; Q54608585
RX   PubMed=6088881;
RX   PubMed=6318711;
RX   PubMed=6324641;
RX   PubMed=24991015;
CC   Virology: EBV-negative.
CC   Doubling time: 26 hours (Note=At 59th passage) (PubMed=6088881).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY39 ! 2-27-Ad
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   AD-BP001-iPSC
AC   CVCL_JJ77
DR   Wikidata; Q54608588
RX   PubMed=28413002;
CC   From: Jilin University First Hospital; Changchun; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   AD-iPS26B
AC   CVCL_0U10
DR   Wikidata; Q54608591
RX   PubMed=25765079;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9ST ! NFH-46
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 9
//
ID   AD-iPS5
AC   CVCL_0U09
DR   Wikidata; Q54608593
RX   PubMed=25765079;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9ST ! NFH-46
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 9
//
ID   AD-MSC-01
AC   CVCL_WG55
SY   Adipose-Derived Mesenchymal Stem Cells-01
DR   IBRC; C10856
DR   Wikidata; Q93313508
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   AD-MSC-02
AC   CVCL_WG56
SY   Adipose-Derived Mesenchymal Stem Cells-02
DR   IBRC; C10889
DR   Wikidata; Q93313511
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   AD-MSC-03
AC   CVCL_WG57
SY   Adipose-Derived Mesenchymal Stem Cells-03
DR   IBRC; C10891
DR   Wikidata; Q93313513
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   AD-S
AC   CVCL_DE06
DR   Wikidata; Q54608594
RX   PubMed=2543775;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3820; Cyclic neutropenia
DI   ORDO; Orphanet_2686; Cyclic neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   AD1
AC   CVCL_E9VM
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD10 [Mouse hybridoma against human CHKA]
AC   CVCL_E9VW
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD10 [Mouse hybridoma against L.lactis nisin]
AC   CVCL_C5P1
DR   Wikidata; Q116048478
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13068; Lactococcus lactis subsp. lactis nisin-A (nisA).
CC   Monoclonal antibody target: UniProtKB; P29559; Lactococcus lactis subsp. lactis nisin-Z (nisZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   AD10 [Mouse hybridoma against vaccinia A14L]
AC   CVCL_E5R2
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AD11
AC   CVCL_E9VX
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD12
AC   CVCL_E9VY
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ad12-3Y1-W5
AC   CVCL_H233
DR   RCB; RCB0331
DR   Wikidata; Q54608699
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Ad12-3Y1-Z11
AC   CVCL_H234
DR   RCB; RCB0328
DR   Wikidata; Q54608701
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Ad12-3Y1-Z13
AC   CVCL_H235
DR   RCB; RCB0329
DR   Wikidata; Q54608704
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Ad12-3Y1-Z19
AC   CVCL_F283
DR   JCRB; JCRB0737
DR   RCB; RCB0330
DR   Wikidata; Q54608706
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   AD13
AC   CVCL_E9VZ
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD14
AC   CVCL_E9W0
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD2 [Mouse hybridoma against human CHKA]
AC   CVCL_E9VN
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD2 [Mouse hybridoma against human neuroblastoma antigen]
AC   CVCL_E3ZN
RX   PubMed=3943922;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen found on some neuroblastoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ad2-3Y1-1
AC   CVCL_K107
DR   RCB; RCB0338
DR   Wikidata; Q54608709
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   Ad2-3Y1-2
AC   CVCL_K108
DR   RCB; RCB0339
DR   Wikidata; Q54608711
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   Ad2-3Y1-3
AC   CVCL_K109
DR   RCB; RCB0340
DR   Wikidata; Q54608714
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   AD293 EGFRVIII
AC   CVCL_E3DQ
RX   PubMed=27153109;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9804 ! AD-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   AD293 EGFRvIII+WT
AC   CVCL_E3DR
RX   PubMed=27153109;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9804 ! AD-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   AD293 EGFRwt
AC   CVCL_E3DS
RX   PubMed=27153109;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9804 ! AD-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   AD3 [Human myeloma]
AC   CVCL_M504
DR   Wikidata; Q54608719
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1697013;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: 16 hours (PubMed=1697013).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M505 ! FR4
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   AD3 [Mouse hybridoma against human CHKA]
AC   CVCL_E9VP
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD3 [Mouse hybridoma against MDI]
AC   CVCL_C4DH
DR   ABCD; ABCD_AG200
DR   Wikidata; Q116048479
RX   PubMed=23295252;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53218; Diphenylmethane-4,4'-diisocyanate (Methylene diphenyl diisocyanate; MDI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AD3E211
AC   CVCL_RN71
SY   AD3E 211
DR   Wikidata; Q54608723
RX   PubMed=23434393;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD4 [Mouse hybridoma against human CHKA]
AC   CVCL_E9VQ
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD4 [Mouse hybridoma against vaccinia D13L]
AC   CVCL_E5RQ
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P68440; Vaccinia virus scaffold protein OPG125 (D13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   AD5 [Mouse hybridoma against human CHKA]
AC   CVCL_E9VR
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD5 [Mouse hybridoma against vaccinia A14L]
AC   CVCL_E5RA
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   AD501ABR
AC   CVCL_RN76
SY   Alzheimer Disease 501 Australia BRisbane
DR   Wikidata; Q54608725
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD502ABR
AC   CVCL_RN77
SY   Alzheimer Disease 502 Australia BRisbane
DR   Wikidata; Q54608728
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD505ABR
AC   CVCL_RN78
SY   Alzheimer Disease 505 Australia BRisbane
DR   Wikidata; Q54608730
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD506ABR
AC   CVCL_RN79
SY   Alzheimer Disease 506 Australia BRisbane
DR   Wikidata; Q54608734
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD507ABR
AC   CVCL_RN80
SY   Alzheimer Disease 507 Australia BRisbane
DR   Wikidata; Q54608736
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD508ABR
AC   CVCL_RN81
SY   Alzheimer Disease 508 Australia BRisbane
DR   Wikidata; Q54608739
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD509ABR
AC   CVCL_RN82
SY   Alzheimer Disease 509 Australia BRisbane
DR   Wikidata; Q54608741
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD512ABR
AC   CVCL_RN83
SY   Alzheimer Disease 512 Australia BRisbane
DR   Wikidata; Q54608744
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD515ABR
AC   CVCL_RN84
SY   Alzheimer Disease 515 Australia BRisbane
DR   Wikidata; Q54608747
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD517ABR
AC   CVCL_RN85
SY   Alzheimer Disease 517 Australia BRisbane
DR   Wikidata; Q54608748
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD518ABR
AC   CVCL_RN86
SY   Alzheimer Disease 518 Australia BRisbane
DR   Wikidata; Q54608752
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD523ABR
AC   CVCL_RN87
SY   Alzheimer Disease 523 Australia BRisbane
DR   Wikidata; Q54608754
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD528ABR
AC   CVCL_RN88
SY   Alzheimer Disease 528 Australia BRisbane
DR   Wikidata; Q54608755
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD576ABR
AC   CVCL_RN89
SY   Alzheimer Disease 576 Australia BRisbane
DR   Wikidata; Q54608756
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD6
AC   CVCL_E9VS
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD7
AC   CVCL_E9VT
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD8 [Mouse hybridoma against bovine milk ALP]
AC   CVCL_D6DR
DR   Wikidata; Q127380201
RX   PubMed=17466113;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Bovine milk alkaline phosphatase.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AD8 [Mouse hybridoma against human CHKA]
AC   CVCL_E9VU
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD8 [Mouse hybridoma against L.lactis nisA/Z]
AC   CVCL_C5P2
DR   Wikidata; Q116048480
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13068; Lactococcus lactis subsp. lactis nisin-A (nisA).
CC   Monoclonal antibody target: UniProtKB; P29559; Lactococcus lactis subsp. lactis nisin-Z (nisZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   AD8K213
AC   CVCL_RN72
SY   AD8K 213
DR   Wikidata; Q54608758
RX   PubMed=23434393;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AD9
AC   CVCL_E9VV
RX   Patent=WO2007138143A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AD94IL2
AC   CVCL_IM43
DR   CLO; CLO_0001660
DR   CLDB; cl240
DR   Wikidata; Q54608761
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Characteristics: IL2 dependent.
CC   Karyotypic information: 46,XX,t(3;17)(p11.2;p13.2)mat (CLDB=cl240).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M078 ! AD94LEBV
SX   Female
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   AD94LEBV
AC   CVCL_M078
DR   CLO; CLO_0001661
DR   CLDB; cl241
DR   Wikidata; Q54608764
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(3;17)(p11.2;p13.2)mat (CLDB=cl241).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IM43 ! AD94IL2
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   ADA-iPS2
AC   CVCL_C104
SY   ADA-IPS2
DR   Wikidata; Q54608765
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.1050_1054delGAAGA; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8517 ! GM01390
SX   Male
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 24
//
ID   ADA-iPS3
AC   CVCL_C105
SY   ADA-IPS3
DR   Wikidata; Q54608768
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.1050_1054delGAAGA; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8517 ! GM01390
SX   Male
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 24
//
ID   ADBA10260AN
AC   CVCL_QX08
DR   IPD-IMGT/HLA; 14782
DR   Wikidata; Q54608772
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:AF,24; B*08:33,39:01:01; C*07:APUZ; DQB1*05:03,03:AF; DRB1*04:01,14:01; DRB3*02:AM; DRB4*01:DWH (IPD-IMGT/HLA=14782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   ADBSi001-A
AC   CVCL_VN35
SY   D161
DR   hPSCreg; ADBSi001-A
DR   Wikidata; Q93313658
RX   PubMed=29778976;
CC   From: Institute for Stem Cell Biology and Regenerative Medicine; Bangalore; India.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   ADBSi002-A
AC   CVCL_VN36
SY   D149
DR   hPSCreg; ADBSi002-A
DR   Wikidata; Q93313660
RX   PubMed=29778976;
CC   From: Institute for Stem Cell Biology and Regenerative Medicine; Bangalore; India.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   ADEc
AC   CVCL_E8FL
SY   Acipenser Dabryanus Embryonic cell line
RX   DOI=10.1016/j.aquaculture.2023.739807;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Doubling time: 165.6 hours (DOI=10.1016/j.aquaculture.2023.739807).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=62061; ! Acipenser dabryanus (Yangtze sturgeon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ADF
AC   CVCL_4689
DR   BTO; BTO_0004326
DR   CLO; CLO_0001662
DR   Wikidata; Q54608844
RX   PubMed=7519632;
RX   PubMed=10455409;
RX   PubMed=16447258;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   ADG
AC   CVCL_B6FF
SY   Abalone Digestive Gland
DR   Wikidata; Q111732872
RX   PubMed=19002810;
RX   PubMed=22358657;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to originate from an abalone but rather seem to either be from a protist or a fungi living in the digestive gland of the abalone (PubMed=22358657).
OX   NCBI_TaxID=32644; ! Unidentified organism (Unknown organism)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   ADHD-10 iPSC
AC   CVCL_GP68
DR   Wikidata; Q54608847
RX   PubMed=27558611;
CC   From: D'Or Institute for Research and Education; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   ADHD-4 iPSC
AC   CVCL_GP69
DR   Wikidata; Q54608849
RX   PubMed=27558611;
CC   From: D'Or Institute for Research and Education; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   ADHD-5 iPSC
AC   CVCL_GP70
DR   Wikidata; Q54608851
RX   PubMed=27558611;
CC   From: D'Or Institute for Research and Education; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   ADI-1
AC   CVCL_D5AY
DR   Wikidata; Q127380202
RX   PubMed=1531093;
RX   PubMed=8091415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42161; Dog IFNG (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   ADI-23
AC   CVCL_D5AZ
DR   Wikidata; Q127380204
RX   PubMed=8091415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42161; Dog IFNG (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   ADIPO-P2
AC   CVCL_E7BP
RX   PubMed=22564429;
RX   PubMed=26653979;
CC   From: IMBICE Cell Repository, La Plata; Buenos Aires; Argentina.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ADJ/PC6
AC   CVCL_1E22
SY   ADJ/PC 6
DR   ChEMBL-Cells; CHEMBL3307899
DR   ChEMBL-Targets; CHEMBL614265
DR   PubChem_Cell_line; CVCL_1E22
DR   Wikidata; Q54608855
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   ADK-VR2
AC   CVCL_E6J5
RX   PubMed=36519016;
CC   Population: Southeast Asian; Filipino.
CC   Doubling time: 34.88 hours (Direct_author_submission).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:10661; SDC4; Name(s)=SDC4-ROS1; Note=SDC4 exon 2 fused to ROS exon 32 (PubMed=36519016).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from a treatment-naive non-smoker patient (PubMed=36519016).
CC   Miscellaneous: Doubling time and ethnic origin of patient from personal communication of Angelicola, Stefania.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ADK-VR2 AG143
AC   CVCL_E6J6
RX   PubMed=36519016;
CC   Population: Southeast Asian; Filipino.
CC   Characteristics: Grown in 3D culture in the presence of crizotinib. Has a significantly lower sensitivity to crizotinib than the parental cell line in adherent cultures and is not sensitive to lorlatinib, entrectinib and DS-6051b (PubMed=36519016).
CC   Doubling time: 25.77 hours (Direct_author_submission).
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:10661; SDC4; Name(s)=SDC4-ROS1; Note=SDC4 exon 2 fused to ROS exon 32 (PubMed=36519016).
CC   Donor information: Established from a treatment-naive non-smoker patient (PubMed=36519016).
CC   Miscellaneous: Doubling time and ethnic origin of patient from personal communication of Angelicola, Stefania.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6J5 ! ADK-VR2
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ADK6
AC   CVCL_E8BH
RX   PubMed=21917944;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O56137; Adeno-associated virus 6 (AAV-6) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ADK8
AC   CVCL_E8BI
RX   PubMed=21917944;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8JQF8; Adeno-associated virus 8 (AAV-8) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ADK9
AC   CVCL_E8BJ
RX   PubMed=21917944;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6JC40; Adeno-associated virus 9 (AAV-9) capsid protein VP1 (Note=Also recognizes AAV-8).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ADL,HG
AC   CVCL_E452
SY   ADL, HG
DR   dbMHC; 48470
DR   ECACC; 94082244
DR   IHW; IHW09144
DR   IPD-IMGT/HLA; 11687
DR   Wikidata; Q54608857
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,68:01:02; B*08:01,40:01:01; C*03; DPB1*01:01:01,03:01:01; DQA1*05:01,03; DQB1*02:01,03:01:01; DRB1*03:01:01,04:01:01; DRB3*01:01:02:01; DRB4*01:01 (IPD-IMGT/HLA=11687).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   ADLC-5M2
AC   CVCL_8169
SY   ADenocarcinoma Lung Cancer-5M2
DR   BioSample; SAMN03151662
DR   Wikidata; Q54608860
RX   PubMed=2840315;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 67 year old male patient with a lung adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00111.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   ADod-01
AC   CVCL_VW46
DR   IBRC; C11096
DR   Wikidata; Q93313692
CC   Derived from site: In situ; Ovary, adipose tissue; UBERON=UBERON_0018131.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_VW45 ! CTOD1
SX   Female
AG   1Y4M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   aDON-1
AC   CVCL_C8JZ
DR   Wikidata; Q123030653
RX   DOI=10.1021/jf00081a064;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_10022; Deoxynivalenol (DON; vomitoxin) (Note=Also recognizes 3-O-acylated DONs).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ADPKD#10D
AC   CVCL_A4QF
DR   SKIP; SKIP000919
DR   Wikidata; Q105506054
RX   PubMed=22142803;
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Trp3842Ter (c.11525G>A); ClinVar=VCV000805142; Zygosity=Heterozygous (PubMed=22142803).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QG ! ADPKD#50B
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ADPKD#50B
AC   CVCL_A4QG
DR   SKIP; SKIP000918
DR   Wikidata; Q105506057
RX   PubMed=22142803;
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Trp3842Ter (c.11525G>A); ClinVar=VCV000805142; Zygosity=Heterozygous (PubMed=22142803).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QF ! ADPKD#10D
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   AdPX3
AC   CVCL_B6F2
DR   Wikidata; Q111732874
RX   PubMed=3669153;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   AdPX4
AC   CVCL_B6F3
DR   Wikidata; Q111732875
RX   PubMed=3669153;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   ADRI Cf2Th-69/EIAV
AC   CVCL_0E87
SY   ADRI/Cf2Th-EIAV
DR   ATCC; CRL-2251
DR   Wikidata; Q54608861
RX   Patent=US5112756;
CC   Virology: In vitro infected by equine infectious anemia virus (EIAV).
CC   Discontinued: ATCC; CRL-2251; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   ADRI Cf2Th/BMVLV
AC   CVCL_W644
SY   ADRI/Cf2Th/BMVLV; Cf2Th/BMVLV
DR   Wikidata; Q54608864
RX   Patent=US5112756;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10816.
CC   Virology: In vitro infected by bovine immunodeficiency virus.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 14
//
ID   ADRI-PFT-19
AC   CVCL_0F46
SY   19-PFT; 19PFT; PFT; Pig Fallopian Tube
DR   ATCC; CRL-2250
DR   Wikidata; Q54608867
RX   PubMed=3274;
RX   PubMed=1335761;
RX   PubMed=4586534;
RX   PubMed=6928992;
CC   Doubling time: 20-25 hours (PubMed=3274).
CC   Discontinued: ATCC; CRL-2250; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   Adult/T315I
AC   CVCL_5K96
DR   cancercelllines; CVCL_5K96
DR   Wikidata; Q54608870
RX   PubMed=21474579;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=21474579).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Thr315Ile (c.944C>T) (c.1001C>T); ClinVar=VCV000012624; Zygosity=Unspecified (PubMed=21474579).
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   ADx210
AC   CVCL_B0G5
SY   IGH-593; 7G1G3; YT1.10
DR   Wikidata; Q108819825
RX   Patent=US9447179;
RX   PubMed=25540200;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 8347CB.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   ADx211
AC   CVCL_B0G6
SY   IGH-603; 23H5G11
DR   Wikidata; Q108819826
RX   Patent=US9447179;
RX   PubMed=25540200;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 8348CB.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   ADx215
AC   CVCL_B0G7
SY   YT1.15
DR   Wikidata; Q108819827
RX   Patent=US9447179;
RX   PubMed=25540200;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 9679CB.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Ae
AC   CVCL_Z109
SY   A.e.; Grace's Antheraea cells; Grace's Antheraea eucalypti cells; Antheraea cells
DR   CLO; CLO_0051456
DR   CLDB; cl278
DR   ATCC; CCL-80
DR   ECACC; 90111908
DR   ICLDB; ae
DR   RCB; RCB0985
DR   Wikidata; Q54608871
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00537;
RX   DOI=10.11416/kontyushigen1930.35.349;
RX   PubMed=4402510;
RX   PubMed=6020481;
RX   PubMed=7615077;
RX   PubMed=13900940;
CC   Group: Insect cell line.
CC   Anecdotal: First arthropod cell line, established in 1962.
CC   Discontinued: ECACC; 90111908; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=180277; ! Opodiphthera eucalypti (Emperor gum moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 13
//
ID   AE-1
AC   CVCL_4500
SY   AE1
DR   CLO; CLO_0001666
DR   CLDB; cl5132
DR   ATCC; HB-72
DR   CLS; 300635
DR   IZSLER; BS Hy 2
DR   Wikidata; Q54608874
RX   PubMed=6175961;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-582.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   AE-2
AC   CVCL_4501
SY   AE2
DR   CLO; CLO_0001667
DR   CLDB; cl5133
DR   ATCC; HB-73
DR   CLS; 300638
DR   IZSLER; BS Hy 3
DR   Wikidata; Q54608877
RX   PubMed=6175961;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   AE-3
AC   CVCL_1Y16
SY   AE3
DR   Wikidata; Q54608879
RX   PubMed=6175961;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   Ae-Aedae
AC   CVCL_1R48
SY   Aedes aegypti, Suitor's clone
DR   BioSample; SAMN03151994
DR   Wikidata; Q54608881
RX   PubMed=4402510;
RX   PubMed=5337207;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Aedes aegypti origin but found to be a Opodiphthera eucalypti Ae derivative (PubMed=4402510; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00014.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=180277; ! Opodiphthera eucalypti (Emperor gum moth)
HI   CVCL_Z109 ! Ae
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   Ae-Aedve
AC   CVCL_1R46
SY   Aedes vexans culture
DR   BioSample; SAMN03151995
DR   Wikidata; Q54608884
RX   PubMed=4393461;
RX   PubMed=4402510;
RX   PubMed=5142332;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Aedes vexans origin but found to be a Opodiphthera eucalypti Ae derivative (PubMed=4402510; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00015.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=180277; ! Opodiphthera eucalypti (Emperor gum moth)
HI   CVCL_Z109 ! Ae
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   Ae-Culin
AC   CVCL_1R47
SY   Culiseta inornata culture
DR   BioSample; SAMN03151997
DR   Wikidata; Q54608888
RX   PubMed=4393461;
RX   PubMed=4402510;
RX   PubMed=5142332;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Culiseta inornata origin but found to be a Opodiphthera eucalypti Ae derivative (PubMed=4402510; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00018.
CC   Misspelling: Culisita inornata culture; Note=In ICLAC cross-contaminations list from release 6.1 to 8.0.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=180277; ! Opodiphthera eucalypti (Emperor gum moth)
HI   CVCL_Z109 ! Ae
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   AE.C9
AC   CVCL_XH84
DR   Wikidata; Q93313743
RX   Patent=US6770745;
RX   PubMed=9759867;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12106.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   AE.F8
AC   CVCL_XH85
DR   Wikidata; Q93313745
RX   PubMed=9759867;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   AE1
AC   CVCL_L849
SY   AE 1
DR   CLO; CLO_0001663
DR   CLDB; cl244
DR   Wikidata; Q54608890
RX   PubMed=22358579;
CC   Doubling time: 72 hours (PubMed=22358579).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L850 ! AE2
OI   CVCL_L851 ! AE3 [Human SCLC]
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AE1-2a
AC   CVCL_U656
SY   AE1-2A
DR   cancercelllines; CVCL_U656
DR   Wikidata; Q54608893
RX   PubMed=8648763;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   AE11
AC   CVCL_E5RX
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07240; Vaccinia virus eNvelope protein OPG108 (H3L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AE1201
AC   CVCL_8470
SY   AE 1201
DR   cancercelllines; CVCL_8470
DR   CCRID; 4201PAT-CCTCC00143
DR   Wikidata; Q54608897
RX   Patent=CN1061093C;
CC   Group: Adeno-associated virus packaging cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C97001.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   AE16
AC   CVCL_RP15
DR   Wikidata; Q54608899
RX   PubMed=28577549;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   AE17
AC   CVCL_4408
DR   CBA; CBA-0156
DR   ECACC; 10092310
DR   Wikidata; Q54608901
RX   PubMed=14607902;
RX   PubMed=22581112;
RX   PubMed=28577549;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   AE17-sOVA
AC   CVCL_LJ85
SY   AE17-secretory OVA
DR   Wikidata; Q54608903
RX   PubMed=14607902;
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4408 ! AE17
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 7
//
ID   AE19
AC   CVCL_RP16
DR   Wikidata; Q54608906
RX   PubMed=28577549;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   AE2
AC   CVCL_L850
SY   AE 2
DR   CLO; CLO_0001664
DR   CLDB; cl245
DR   Wikidata; Q54608907
RX   PubMed=22358579;
CC   Doubling time: 78 hours (PubMed=22358579).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L849 ! AE1
OI   CVCL_L851 ! AE3 [Human SCLC]
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AE3 [Human SCLC]
AC   CVCL_L851
SY   AE 3
DR   CLO; CLO_0001665
DR   CLDB; cl246
DR   Wikidata; Q54608910
RX   PubMed=22358579;
CC   Doubling time: 78 hours (PubMed=22358579).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L849 ! AE1
OI   CVCL_L850 ! AE2
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AE3 [Mouse mesothelioma]
AC   CVCL_RP17
DR   Wikidata; Q54608912
RX   PubMed=28577549;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   AE4
AC   CVCL_E5PL
RX   Patent=WO1991006668A1;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AE5
AC   CVCL_E5RS
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68440; Vaccinia virus scaffold protein OPG125 (D13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AE9D6
AC   CVCL_G633
DR   CLO; CLO_0001669
DR   ABCD; ABCD_AE999
DR   ATCC; HB-125
DR   Wikidata; Q54608916
RX   PubMed=6193965;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   AeAe-GH98
AC   CVCL_A1LU
DR   Wikidata; Q102113501
RX   PubMed=33000384;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by yellow fever virus (YFV) and Zika virus (ZIKV). Not susceptible to infection by dengue virus types 1 and 2.
CC   Doubling time: ~1.3 days (PubMed=33000384).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Strain GH98.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   AF-1
AC   CVCL_F1BJ
SY   Asp Fin-1
RX   PubMed=40559539;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 25 Celsius (PubMed=40559539).
CC   Virology: Susceptible to infection by European catfish virus (ECV), ictalurid herpesvirus 2 (IcHV-2), pike fry rhabdovirus (PFRV) and spring viraemia of carp virus (SVCV) (PubMed=40559539).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=98928; ! Leuciscus aspius (Asp)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AF-2 clone 9B5
AC   CVCL_2573
SY   AF-2 cl.9B5
DR   CLO; CLO_0001674
DR   CLDB; cl252
DR   CLDB; cl253
DR   ICLC; HYL95001
DR   Wikidata; Q54608920
RX   PubMed=2004654;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human AF-2 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   AF-29
AC   CVCL_WY66
SY   Ayu Fin-29
DR   Wikidata; Q93313762
RX   CelloPub=CLPUB00103;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=61084; ! Plecoglossus altivelis (Ayu)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   AF-6
AC   CVCL_U801
SY   AF6
DR   cancercelllines; CVCL_U801
DR   Cosmic; 928732
DR   GEO; GSM162930
DR   GEO; GSM215720
DR   Progenetix; CVCL_U801
DR   Wikidata; Q54608922
RX   PubMed=9354451;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   AF-TTTS-iPS
AC   CVCL_D5HQ
DR   Wikidata; Q127380206
RX   PubMed=28591652;
CC   Population: Japanese.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): PubMed=28591652
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 18
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C113824; Twin-twin transfusion syndrome
DI   ORDO; Orphanet_95431; Twin to twin transfusion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19-26FW
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AF-TTTS-iPS #17
AC   CVCL_D5HP
DR   JCRB; JCRB1912
DR   Wikidata; Q127380207
RX   PubMed=28591652;
CC   Population: Japanese.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): JCRB=JCRB1912
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C113824; Twin-twin transfusion syndrome
DI   ORDO; Orphanet_95431; Twin to twin transfusion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AF.F4
AC   CVCL_XH86
DR   ATCC; HB-12104
DR   Wikidata; Q93313764
RX   Patent=US6770745;
RX   PubMed=9759867;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12104.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   AF1-113
AC   CVCL_E5PX
RX   Patent=US5437995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AF1-114
AC   CVCL_E5PY
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2608.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50206.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AF1-52
AC   CVCL_E5PV
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2607.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50204.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AF1-81
AC   CVCL_E5PW
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2681.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50205.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AF10 [Human myeloma]
AC   CVCL_C833
SY   AF-10
DR   cancercelllines; CVCL_C833
DR   Cosmic; 1070696
DR   Cosmic; 1071879
DR   Cosmic; 1176601
DR   Wikidata; Q54608927
RX   PubMed=9762409;
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   AF10 [Mouse hybridoma against vaccinia A25]
AC   CVCL_E5RI
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AF11
AC   CVCL_E5PM
RX   Patent=WO1991006668A1;
RX   PubMed=2479375;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AF208
AC   CVCL_C7G1
DR   Wikidata; Q123030654
RX   PubMed=35221159;
CC   From: Alman, Benjamin Aaron; The Hospital for Sick Children; Toronto; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=35221159).
DI   NCIt; C9182; Desmoid fibromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   AF22
AC   CVCL_A5CW
DR   BTO; BTO_0006445
DR   GEO; GSM7701478
DR   GEO; GSM7701479
DR   Wikidata; Q107113349
RX   PubMed=22272239;
RX   PubMed=23884946;
RX   PubMed=28041877;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sex of donor from personal communication of BioKryo (ISENET Biobanking).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   AF23
AC   CVCL_A5CX
DR   Wikidata; Q107113351
RX   PubMed=22272239;
RX   PubMed=23884946;
CC   Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neuroepithelial stem cell; CL=CL_0002259.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A234 ! Edi 2
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   AF24
AC   CVCL_A5CY
DR   Wikidata; Q107113352
RX   PubMed=22272239;
RX   PubMed=23884946;
CC   Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239).
CC   Cell type: Neuroepithelial stem cell; CL=CL_0002259.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   AF3-12.1.3
AC   CVCL_J742
DR   CLO; CLO_0001675
DR   ATCC; HB-160
DR   Wikidata; Q54608928
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AF4-73.3.1
AC   CVCL_J743
DR   CLO; CLO_0001676
DR   ATCC; HB-201
DR   Wikidata; Q54608929
RX   PubMed=6690619;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse IgD (allotype e, Igh-5.5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AF5
AC   CVCL_8831
SY   AF-5
DR   BTO; BTO_0003422
DR   ABM; T0358
DR   Wikidata; Q54608932
RX   PubMed=9426306;
RX   PubMed=12061863;
RX   PubMed=22863662;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, mesencephalon; UBERON=UBERON_0009616.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   14FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   AF6
AC   CVCL_B3MZ
DR   Wikidata; Q110432568
RX   PubMed=34561750;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Acanthamoeba castellanii galactose-binding protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   AF6-120.1.2
AC   CVCL_J744
DR   CLO; CLO_0001677
DR   ATCC; HB-163
DR   Wikidata; Q54608934
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AF6-122.2.5
AC   CVCL_J745
DR   CLO; CLO_0001678
DR   ATCC; HB-199
DR   Wikidata; Q54608937
RX   PubMed=6690619;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AF6-78.25.4
AC   CVCL_J746
SY   AF6-78.25
DR   CLO; CLO_0001679
DR   ATCC; HB-162
DR   Wikidata; Q54608939
RX   PubMed=6690619;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AF6-88.5.3
AC   CVCL_J747
DR   CLO; CLO_0001680
DR   ATCC; HB-158
DR   Wikidata; Q54609002
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AF9
AC   CVCL_E5S3
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P68638; Vaccinia virus complement control protein C3 (C3L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AFB-1
AC   CVCL_HA76
DR   Wikidata; Q54609007
RX   DOI=10.2520/myco.52.1;
RX   PubMed=1327557;
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344/JCI.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 4
//
ID   AFC003
AC   CVCL_9U83
DR   Wikidata; Q54609008
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   AFF
AC   CVCL_IW60
SY   AngelFish Fin
DR   NRFC; NRFC051
DR   Wikidata; Q54609010
RX   CelloPub=CLPUB00463;
RX   PubMed=27458084;
WW   Provider; NRFC; NRFC051; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC051.
CC   Characteristics: Capable of growing from 20 to 37 Celsius, the optimal temperature is 28 Celsius (PubMed=27458084).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74131; ! Pterophyllum scalare (Angelfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 13
//
ID   AHF2:1
AC   CVCL_E9VI
RX   PubMed=2483383;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02671; Human FGA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AHF2:2
AC   CVCL_E9VJ
RX   PubMed=2483383;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human fibrinogen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AHF2:3
AC   CVCL_E9VK
RX   PubMed=2483383;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P02675; Human FGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AHF2:4
AC   CVCL_E9VL
RX   PubMed=2483383;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02675; Human FGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AFiPSC10
AC   CVCL_9T26
SY   AFiPSC line 10
DR   Wikidata; Q54609011
RX   PubMed=26987930;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T27 ! AFiPSC4
OI   CVCL_9T29 ! AFiPSC5
OI   CVCL_9T30 ! AFiPSC6
OI   CVCL_9T28 ! AFiPSC41
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   AFiPSC4
AC   CVCL_9T27
SY   AFiPSC line 4
DR   Wikidata; Q54609012
RX   PubMed=26987930;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T29 ! AFiPSC5
OI   CVCL_9T30 ! AFiPSC6
OI   CVCL_9T26 ! AFiPSC10
OI   CVCL_9T28 ! AFiPSC41
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AFiPSC41
AC   CVCL_9T28
SY   AFiPSC line 41
DR   Wikidata; Q54609015
RX   PubMed=26987930;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T27 ! AFiPSC4
OI   CVCL_9T29 ! AFiPSC5
OI   CVCL_9T30 ! AFiPSC6
OI   CVCL_9T26 ! AFiPSC10
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   AFiPSC5
AC   CVCL_9T29
SY   AFiPSC line 5
DR   Wikidata; Q54609016
RX   PubMed=26987930;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T27 ! AFiPSC4
OI   CVCL_9T30 ! AFiPSC6
OI   CVCL_9T26 ! AFiPSC10
OI   CVCL_9T28 ! AFiPSC41
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   AFiPSC6
AC   CVCL_9T30
SY   AFiPSC line 6
DR   Wikidata; Q54609017
RX   PubMed=26987930;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T27 ! AFiPSC4
OI   CVCL_9T29 ! AFiPSC5
OI   CVCL_9T26 ! AFiPSC10
OI   CVCL_9T28 ! AFiPSC41
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   AFKM-On-H
AC   CVCL_9T82
DR   Wikidata; Q54609018
RX   PubMed=17846857;
CC   Group: Insect cell line.
CC   Doubling time: 40 hours (Note=At 80th passage and 28 Celsius), 29 hours (Note=At 125th passage and 28 Celsius), 35 hours (Note=At 122th passage and 25 Celsius), 34 hours (Note=At 169th passage and 25 Celsius) (PubMed=17846857).
OX   NCBI_TaxID=29057; ! Ostrinia nubilalis (European corn borer)
SX   Sex unspecified
AG   Sixth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AFL4
AC   CVCL_KB06
DR   RCB; RCB4488
DR   Wikidata; Q54609020
RX   PubMed=10887117;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35917; Mouse Flt4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AFLB8
AC   CVCL_C125
DR   Wikidata; Q54609023
RX   PubMed=7514612;
RX   PubMed=10223185;
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   10D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   Aflu2
AC   CVCL_B7AW
DR   Wikidata; Q111732876
RX   PubMed=34584163;
CC   Group: Insect cell line.
CC   Characteristics: Not infected by Wolbachia strain wFlu (PubMed=34584163).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=658031; ! Aedes fluviatilis (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AFP-27
AC   CVCL_B6E9
SY   AFP-27-P
DR   Wikidata; Q111732878
RX   DOI=10.1007/BF00153748;
RX   PubMed=18592539;
RX   PubMed=18600866;
RX   PubMed=22358661;
CC   From: Vessella, Robert Louis; Department of Urologic Surgery at the University of Minnesota; Minneapolis; USA.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02771; Human AFP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   AFP-27-NP
AC   CVCL_B6EA
DR   Wikidata; Q111732879
RX   PubMed=18592539;
RX   PubMed=18597307;
RX   PubMed=18600866;
CC   Characteristics: Non-producing clone.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02771; Human AFP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6E9 ! AFP-27
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   AFRC 17D1
AC   CVCL_L815
SY   EQ17
DR   ECACC; 94120825
DR   Wikidata; Q54609025
RX   PubMed=1632074;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybrid cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 6
//
ID   AFRC 56D2
AC   CVCL_L816
DR   ECACC; 94120826
DR   Wikidata; Q54609028
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC 58D6
AC   CVCL_L817
DR   ECACC; 94120827
DR   Wikidata; Q54609030
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC 78A3
AC   CVCL_L818
DR   ECACC; 94120828
DR   Wikidata; Q54609032
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC 84B4
AC   CVCL_L819
DR   ECACC; 94120829
DR   Wikidata; Q54609033
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC 84C6
AC   CVCL_L820
DR   ECACC; 94120830
DR   Wikidata; Q54609036
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC 85A2
AC   CVCL_L821
DR   ECACC; 94120831
DR   Wikidata; Q54609039
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC 85B5
AC   CVCL_L822
DR   ECACC; 94120832
DR   Wikidata; Q54609041
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC 85D6
AC   CVCL_L823
DR   ECACC; 94120833
DR   Wikidata; Q54609044
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; A0A023PW73; Influenza A virus (strain A/Equine/New Market/1979 H3N8) hemagglutinin (HA).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L815 ! AFRC 17D1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC MAC 1
AC   CVCL_K178
SY   ARC MAC 1
DR   ECACC; 85102263
DR   Wikidata; Q54609046
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 10
AC   CVCL_K179
SY   ARC MAC 10
DR   ECACC; 85102274
DR   Wikidata; Q54609047
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 11
AC   CVCL_K180
SY   ARC MAC 11
DR   ECACC; 85102273
DR   Wikidata; Q54609050
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 12
AC   CVCL_K181
SY   ARC MAC 12
DR   ECACC; 86030301
DR   Wikidata; Q54609053
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 127
AC   CVCL_K182
SY   MAC127
DR   ECACC; 92102334
DR   Wikidata; Q54609056
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 128
AC   CVCL_K183
SY   MAC128
DR   ECACC; 92102335
DR   Wikidata; Q54609059
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 129
AC   CVCL_K184
SY   MAC129
DR   ECACC; 92102340
DR   Wikidata; Q54609061
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 13
AC   CVCL_K185
SY   ARC MAC 13
DR   ECACC; 86030302
DR   Wikidata; Q54609063
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 130
AC   CVCL_K186
SY   MAC130
DR   ECACC; 92102342
DR   Wikidata; Q54609066
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 131
AC   CVCL_K187
SY   MAC131
DR   ECACC; 92102343
DR   Wikidata; Q54609067
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 132
AC   CVCL_K188
SY   MAC132
DR   ECACC; 92102341
DR   Wikidata; Q54609070
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 133
AC   CVCL_K189
SY   MAC133
DR   ECACC; 92102344
DR   Wikidata; Q54609073
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 14
AC   CVCL_K190
SY   ARC MAC 14
DR   ECACC; 86030303
DR   Wikidata; Q54609074
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 15
AC   CVCL_J005
SY   ARC MAC 15
DR   ECACC; 86030304
DR   Wikidata; Q54609076
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 156
AC   CVCL_K191
SY   MAC 156
DR   ECACC; 93090996
DR   Wikidata; Q54609078
RX   DOI=10.1016/S0031-9422(00)83851-0;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_62881; N(6)-(Delta(2)-isopentenyl)adenosine (Riboprine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   AFRC MAC 157
AC   CVCL_K192
SY   MAC 157
DR   ECACC; 93090997
DR   Wikidata; Q54609082
RX   DOI=10.1016/S0031-9422(00)83851-0;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_62881; N(6)-(Delta(2)-isopentenyl)adenosine (Riboprine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   AFRC MAC 158
AC   CVCL_K193
SY   MAC 158
DR   ECACC; 93090998
DR   Wikidata; Q54609085
RX   DOI=10.1016/S0031-9422(00)83851-0;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_62881; N(6)-(Delta(2)-isopentenyl)adenosine (Riboprine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   AFRC MAC 159
AC   CVCL_K194
SY   MAC 159
DR   ECACC; 93090999
DR   Wikidata; Q54609088
RX   DOI=10.1016/S0031-9422(00)83851-0;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_62881; N(6)-(Delta(2)-isopentenyl)adenosine (Riboprine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   AFRC MAC 16
AC   CVCL_CZ00
SY   ARC MAC 16
DR   Wikidata; Q54609091
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 160
AC   CVCL_K195
SY   MAC 160
DR   ECACC; 93091001
DR   Wikidata; Q54609201
RX   DOI=10.1016/S0031-9422(00)83851-0;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_62881; N(6)-(Delta(2)-isopentenyl)adenosine (Riboprine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   AFRC MAC 17
AC   CVCL_K196
SY   ARC MAC 17
DR   ECACC; 86030306
DR   Wikidata; Q54609202
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 18
AC   CVCL_J006
SY   ARC MAC 18
DR   ECACC; 86030307
DR   Wikidata; Q54609203
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 188
AC   CVCL_K197
SY   MAC188
DR   ECACC; 92102372
DR   Wikidata; Q54609206
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20063; Rabbit LDLR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 19
AC   CVCL_J007
SY   ARC MAC 19
DR   ECACC; 86030308
DR   Wikidata; Q54609210
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 2
AC   CVCL_J008
SY   ARC MAC 2
DR   ECACC; 85102264
DR   Wikidata; Q54609211
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 20
AC   CVCL_J009
SY   ARC MAC 20
DR   ECACC; 86030309
DR   Wikidata; Q54609215
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 22
AC   CVCL_K198
SY   MAC22
DR   ECACC; 92102336
DR   Wikidata; Q54609218
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 23
AC   CVCL_K199
SY   MAC23
DR   ECACC; 92102338
DR   Wikidata; Q54609219
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 24
AC   CVCL_K200
SY   MAC24
DR   ECACC; 92102337
DR   Wikidata; Q54609220
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Rabbit low density lipoprotein (LDL).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 25
AC   CVCL_K201
SY   MAC25
DR   ECACC; 92102330
DR   Wikidata; Q54609222
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Rabbit low density lipoprotein (LDL).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 252
AC   CVCL_G702
SY   MAC 252; MAC252
DR   ECACC; 01071008
DR   ECACC; 92012453
DR   Wikidata; Q54609225
RX   PubMed=10938836;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_2365; (+)-abscisic acid.
CC   Discontinued: ECACC; 92012453; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E7X2 ! AFRC MAC 62
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   AFRC MAC 256
AC   CVCL_J010
SY   MAC 256
DR   ECACC; 89120557
DR   Wikidata; Q54609228
RX   PubMed=24220948;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13689; Maize auxin-binding protein 1 (ABP1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 257
AC   CVCL_K202
SY   MAC 257
DR   ECACC; 89120558
DR   Wikidata; Q54609230
RX   PubMed=24220948;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P13689; Maize auxin-binding protein 1 (ABP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   AFRC MAC 258
AC   CVCL_L824
SY   MAC 258
DR   ECACC; 89120559
DR   Wikidata; Q54609231
RX   PubMed=24220948;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P13689; Maize auxin-binding protein 1 (ABP1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 259
AC   CVCL_L825
SY   MAC 259
DR   ECACC; 89120560
DR   Wikidata; Q54609234
RX   PubMed=24220948;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13689; Maize auxin-binding protein 1 (ABP1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 26
AC   CVCL_L826
SY   MAC26
DR   ECACC; 92102345
DR   Wikidata; Q54609235
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2783 ! Y0
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 260
AC   CVCL_L827
SY   MAC 260
DR   ECACC; 89120561
DR   Wikidata; Q54609237
RX   PubMed=24220948;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P13689; Maize auxin-binding protein 1 (ABP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 27
AC   CVCL_H164
SY   MAC27
DR   ECACC; 92102339
DR   Wikidata; Q54609238
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2783 ! Y0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 28
AC   CVCL_H165
SY   MAC28
DR   ECACC; 92102331
DR   Wikidata; Q54609241
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2783 ! Y0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 29
AC   CVCL_H166
SY   MAC29
DR   ECACC; 92102332
DR   Wikidata; Q54609244
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2783 ! Y0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 3
AC   CVCL_H167
SY   ARC MAC 3
DR   ECACC; 85102265
DR   Wikidata; Q54609245
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 31
AC   CVCL_L828
SY   MAC31
DR   ECACC; 92102333
DR   Wikidata; Q54609247
RX   PubMed=2458711;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17165; Rabbit APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2783 ! Y0
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   AFRC MAC 4
AC   CVCL_L829
SY   ARC MAC 4
DR   ECACC; 85102266
DR   Wikidata; Q54609249
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 48
AC   CVCL_L830
SY   ARC MAC 48; MAC 48
DR   ECACC; 85060403
DR   Wikidata; Q54609251
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 30-01-24; Version: 6
//
ID   AFRC MAC 49
AC   CVCL_L831
SY   ARC MAC 49; MAC 49
DR   ECACC; 85060404
DR   Wikidata; Q54609254
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 30-01-24; Version: 6
//
ID   AFRC MAC 5
AC   CVCL_H168
SY   ARC MAC 5
DR   ECACC; 85102267
DR   Wikidata; Q54609257
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 50
AC   CVCL_K145
SY   ARC MAC 50; MAC 50
DR   ECACC; 85102259
DR   Wikidata; Q54609258
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   AFRC MAC 51
AC   CVCL_K146
SY   ARC MAC 51; MAC 51
DR   ECACC; 85060405
DR   Wikidata; Q54609260
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   AFRC MAC 52
AC   CVCL_K147
SY   ARC MAC 52; MAC 52
DR   ECACC; 85060406
DR   Wikidata; Q54609262
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   AFRC MAC 54
AC   CVCL_K148
SY   ARC MAC 54; MAC 54
DR   ECACC; 85060407
DR   Wikidata; Q54609265
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   AFRC MAC 55
AC   CVCL_CZ01
SY   ARC MAC 55; MAC 55
DR   Wikidata; Q54609267
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 5
//
ID   AFRC MAC 56
AC   CVCL_CZ02
SY   ARC MAC 56; MAC 56
DR   Wikidata; Q54609269
RX   PubMed=24258587;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06593; Avena sativa phytochrome A-3 (PHYA3) (Note=Recognizes probably also other PHYA).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 5
//
ID   AFRC MAC 57
AC   CVCL_K149
DR   ECACC; 86030310
DR   Wikidata; Q54609271
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 6
AC   CVCL_H169
SY   ARC MAC 6
DR   ECACC; 85102268
DR   Wikidata; Q54609273
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 60
AC   CVCL_G701
DR   ECACC; 86052303
DR   Wikidata; Q54609275
RX   PubMed=2937340;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_2365; (+)-abscisic acid.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AFRC MAC 61
AC   CVCL_H170
DR   ECACC; 86052301
DR   Wikidata; Q54609276
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: ChEBI; CHEBI_2365; (+)-abscisic acid.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   AFRC MAC 61.6
AC   CVCL_U067
DR   ECACC; 01010804
DR   Wikidata; Q54609277
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: ChEBI; CHEBI_2365; (+)-abscisic acid.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_H170 ! AFRC MAC 61
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 6
//
ID   AFRC MAC 62
AC   CVCL_E7X2
SY   MAC 62; MAC62
RX   PubMed=2937340;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_2365; (+)-abscisic acid.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AFRC MAC 63
AC   CVCL_K150
DR   ECACC; 86030311
DR   Wikidata; Q54609278
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 65
AC   CVCL_K151
DR   ECACC; 86030313
DR   Wikidata; Q54609279
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 7
AC   CVCL_K152
SY   ARC MAC 7
DR   ECACC; 85102269
DR   Wikidata; Q54609381
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
CC   Discontinued: ECACC; 85102269; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   AFRC MAC 74
AC   CVCL_K153
SY   MAC 74
DR   ECACC; 86112690
DR   Wikidata; Q54609382
RX   PubMed=24240965;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P23312; Spinacia oleracea NIA.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 75
AC   CVCL_K154
SY   MAC 75
DR   ECACC; 85102260
DR   Wikidata; Q54609385
RX   PubMed=24240965;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23312; Spinacia oleracea NIA.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 76
AC   CVCL_K155
SY   MAC 76
DR   ECACC; 85102261
DR   Wikidata; Q54609386
RX   PubMed=24240965;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P23312; Spinacia oleracea NIA.
CC   Discontinued: ECACC; 85102261; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 6
//
ID   AFRC MAC 77
AC   CVCL_K156
SY   MAC 77
DR   ECACC; 85102262
DR   Wikidata; Q54609389
RX   PubMed=24240965;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P23312; Spinacia oleracea NIA.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 78
AC   CVCL_K157
SY   MAC 78
DR   ECACC; 85102272
DR   Wikidata; Q54609391
RX   PubMed=24240965;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P23312; Spinacia oleracea NIA.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 79
AC   CVCL_H171
SY   MAC 79
DR   ECACC; 86112691
DR   Wikidata; Q54609399
RX   PubMed=24240965;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P23312; Spinacia oleracea NIA.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AFRC MAC 8
AC   CVCL_K158
SY   ARC MAC 8
DR   ECACC; 85102270
DR   Wikidata; Q54609402
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFRC MAC 9
AC   CVCL_K159
SY   ARC MAC 9
DR   ECACC; 85102271
DR   Wikidata; Q54609404
RX   PubMed=24253722;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chlamydomonas reinhardii cell wall glycoprotein complex 2BII.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AFS98
AC   CVCL_KA99
DR   RCB; RCB4486
DR   Wikidata; Q54609406
RX   PubMed=8545103;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09581; Mouse Csf1r/Cd115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AFT011
AC   CVCL_9U84
DR   Wikidata; Q54609408
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   AFT024
AC   CVCL_5431
DR   CLO; CLO_0001682
DR   ATCC; SCRC-1007
DR   BCRJ; 0038
DR   Wikidata; Q54609411
RX   DOI=10.1089/bioe.2022.0015;
RX   PubMed=9108096;
RX   PubMed=9192756;
RX   PubMed=12244569;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AFT024
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   AG-F
AC   CVCL_D101
SY   AGF
DR   ATCC; CRL-2530
DR   BioSample; SAMN03151617
DR   BioSample; SAMN03471608
DR   cancercelllines; CVCL_D101
DR   Wikidata; Q54609413
RX   Patent=US5480825;
RX   PubMed=8255104;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=29533902;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AG-F
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Originally thought to originates from the bone marrow of a patient suffering from neuroblastoma that evolved into a Hodgkin lymphoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00171.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11391.
CC   Population: Caucasian.
CC   Doubling time: 9 hours (Note=In DMEM), 20 hours (Note=In serum-free medium) (PubMed=8255104); ~8-9 hours (Patent=US5480825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2530; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2530
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 11,12
ST   D16S539: 10,13,14
ST   D5S818: 11,13,14,15
ST   D7S820: 8,14.1
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,17,18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 32
//
ID   AG00716
AC   CVCL_JE32
SY   AG-716; AG 716; AG0716; AG716
DR   Coriell; AG00716
DR   Wikidata; Q54609416
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG00716; probable.
DI   NCIt; C3060; Glomus tumor
DI   ORDO; Orphanet_391651; Glomus tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 7
//
ID   AG00780
AC   CVCL_U282
AS   CVCL_CV49
SY   AG 780; AG780; AG00780F; GM00780; GM-780; GM 780; GM780
DR   CLO; CLO_0036916
DR   Coriell; AG00780
DR   Coriell; GM00780
DR   GEO; GSM1184264
DR   GEO; GSM1184265
DR   GEO; GSM1535458
DR   GEO; GSM1535467
DR   Wikidata; Q54609418
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=6223188;
RX   PubMed=7176709;
RX   PubMed=7253718;
RX   PubMed=24749076;
RX   PubMed=26984941;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (Coriell=GM00780).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Discontinued: Coriell; GM00780; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 20
//
ID   AG00781
AC   CVCL_W842
SY   AG0781B
DR   Coriell; AG00781
DR   Wikidata; Q54609419
CC   Discontinued: Coriell; AG00781; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   AG00990
AC   CVCL_W843
AS   CVCL_U781
SY   AG-990; AG 990; AG0990; AG00990B; GM00990; GM-990; GM00990B; Ke He; K.H.; KH2
DR   CLO; CLO_0036899
DR   ATCC; CRL-1277
DR   Coriell; AG00990
DR   Coriell; GM00990
DR   Wikidata; Q54609421
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4083160;
RX   PubMed=4412878;
RX   PubMed=7253718;
CC   Senescence: Senesces at 27 PDL (PubMed=4083160).
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Thr10Ile (c.29C>T); ClinVar=VCV000066888; Zygosity=Heterozygous (Coriell=GM00990).
CC   Discontinued: ATCC; CRL-1277; true.
CC   Discontinued: Coriell; GM00990; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JB86 ! GM01828
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 18
//
ID   AG00991
AC   CVCL_V551
AS   CVCL_CV50
SY   AG-991; AG 991; AG991; AG0991A; GM00991; GM-991; GM 991; GM991; L.D.
DR   Coriell; AG00991
DR   Coriell; GM00991
DR   Wikidata; Q54609424
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4412878;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Discontinued: Coriell; AG00991; probable.
CC   Discontinued: Coriell; GM00991; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   AG0124
AC   CVCL_8B47
DR   ECACC; 90052207
DR   Wikidata; Q54609426
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90052207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG01231
AC   CVCL_A2KR
SY   AG1231
DR   Coriell; AG01231
DR   Wikidata; Q105506059
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01231; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2PF ! AG01232
SX   Female
AG   1Y10M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG01232
AC   CVCL_A2PF
SY   AG1232
DR   Coriell; AG01232
DR   Wikidata; Q105506063
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01232; probable.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2KR ! AG01231
SX   Female
AG   1Y10M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   AG01262
AC   CVCL_JE41
SY   AG-1262; AG 1262; AG1262
DR   Coriell; AG01262
DR   Wikidata; Q54609427
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01262; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M3W
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG01360
AC   CVCL_JE36
SY   AG-1360; AG 1360; AG1360
DR   Coriell; AG01360
DR   Wikidata; Q54609430
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3860870;
RX   PubMed=7253718;
CC   Population: African American.
CC   Discontinued: Coriell; AG01360; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE37 ! AG01485
OI   CVCL_J110 ! GM01311
OI   CVCL_J111 ! GM01312
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG0138
AC   CVCL_8B48
DR   ECACC; 90070301
DR   Wikidata; Q54609432
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90070301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG0143
AC   CVCL_8B49
DR   ECACC; 90072402
DR   Wikidata; Q54609433
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90072402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG01437
AC   CVCL_U701
SY   AG-1437; AG 1437; AG1437; AG01437B; HG3004
DR   CLO; CLO_0036897
DR   BioSamples; SAME56937
DR   Coriell; AG01437
DR   Wikidata; Q54609436
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01437; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG01439
AC   CVCL_X760
SY   AG-1439; AG 1439; AG1439
DR   CLO; CLO_0036890
DR   Coriell; AG01439
DR   Wikidata; Q54609438
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG01440
AC   CVCL_2Q69
SY   AG-1440; AG 1440; AG1440
DR   CLO; CLO_0036893
DR   Coriell; AG01440
DR   Wikidata; Q54609439
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Population: African American.
CC   Discontinued: Coriell; AG01440; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG01485
AC   CVCL_JE37
SY   AG-1485; AG 1485; AG1485
DR   Coriell; AG01485
DR   Wikidata; Q54609441
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Population: African American.
CC   Discontinued: Coriell; AG01485; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE36 ! AG01360
OI   CVCL_J110 ! GM01311
OI   CVCL_J111 ! GM01312
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG0150
AC   CVCL_8B50
DR   ECACC; 90081516
DR   Wikidata; Q54609443
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90081516; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG0151
AC   CVCL_8B51
DR   ECACC; 90081517
DR   Wikidata; Q54609444
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90081517; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG01517
AC   CVCL_A2KS
SY   AG1517
DR   Coriell; AG01517
DR   Wikidata; Q105506064
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01517; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG01518
AC   CVCL_F696
SY   AG-1518; AG 1518; AG1518; AG01518B; AG01518C
DR   CLO; CLO_0036887
DR   Coriell; AG01518
DR   GEO; GSE14256
DR   GEO; GSM158559
DR   GEO; GSM158560
DR   GEO; GSM158561
DR   Wikidata; Q54609447
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2897722;
RX   PubMed=2973075;
RX   PubMed=6810166;
RX   PubMed=7253718;
RX   PubMed=7329430;
RX   PubMed=7374661;
RX   PubMed=7471105;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   AG01519
AC   CVCL_H764
SY   AG-1519; AG 1519; AG1519; AG01519A
DR   CLO; CLO_0036888
DR   Coriell; AG01519
DR   Wikidata; Q54609450
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   AG0152
AC   CVCL_8B52
DR   ECACC; 90082301
DR   Wikidata; Q54609452
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90082301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG01520
AC   CVCL_H750
SY   AG-1520; AG 1520; AG1520; AG01520A
DR   CLO; CLO_0036903
DR   Coriell; AG01520
DR   Wikidata; Q54609454
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3745952;
RX   PubMed=7253718;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG01521
AC   CVCL_H751
SY   AG-1521; AG 1521; AG1521; AG01521A
DR   CLO; CLO_0036904
DR   Coriell; AG01521
DR   Wikidata; Q54609456
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6810166;
RX   PubMed=7253718;
RX   PubMed=19896956;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG01522
AC   CVCL_H759
SY   AG-1522; AG 1522; AG1522; AG01522B; AGO 1522; AGO1522; AG1522D; 1522
DR   CLO; CLO_0036902
DR   Coriell; AG01522
DR   GEO; GSE93860
DR   GEO; GSM520723
DR   GEO; GSM520724
DR   GEO; GSM520725
DR   GEO; GSM520726
DR   GEO; GSM520727
DR   GEO; GSM520728
DR   GEO; GSM520729
DR   GEO; GSM520730
DR   GEO; GSM520731
DR   GEO; GSM520732
DR   NCBI_Iran; C449
DR   Wikidata; Q54609458
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1574572;
RX   PubMed=1845955;
RX   PubMed=2380097;
RX   PubMed=2559742;
RX   PubMed=2897722;
RX   PubMed=2973075;
RX   PubMed=3182330;
RX   PubMed=6148444;
RX   PubMed=6442144;
RX   PubMed=6810166;
RX   PubMed=6843573;
RX   PubMed=7104995;
RX   PubMed=7253718;
RX   PubMed=7329430;
RX   PubMed=7374661;
RX   PubMed=7471105;
RX   PubMed=19896956;
RX   PubMed=21149446;
RX   PubMed=28248986;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/fibroblast/ag1522/index.html
CC   Group: Space-flown cell line (cellonaut).
CC   Anecdotal: Have been flown in space on the ISS to study growth in microgravity (PubMed=28248986).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): NCBI_Iran=C449
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 10
ST   D18S51: 12
ST   D21S11: 29,30
ST   D5S818: 10
ST   D7S820: 15
ST   D8S1179: 12,14
ST   FGA: 20,25
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 24
//
ID   AG01523
AC   CVCL_F697
SY   AG-1523; AG 1523; AG1523; Ag1523; AG01523B
DR   CLO; CLO_0036879
DR   ChEMBL-Cells; CHEMBL3307578
DR   ChEMBL-Targets; CHEMBL614268
DR   Coriell; AG01523
DR   PubChem_Cell_line; CVCL_F697
DR   Wikidata; Q54609460
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2550144;
RX   PubMed=2848260;
RX   PubMed=2897722;
RX   PubMed=3020539;
RX   PubMed=7253718;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 16
//
ID   AG0158
AC   CVCL_8B53
DR   ECACC; 90091901
DR   Wikidata; Q54609461
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90091901; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG01615
AC   CVCL_V541
SY   AG-1615; AG 1615; AG1615
DR   Coriell; AG01615
DR   Wikidata; Q54609463
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Donor information: Established from the non-irradiated skin of a nephroblastoma patient.
CC   Discontinued: Coriell; AG01615; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE42 ! AG01616
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   AG01616
AC   CVCL_JE42
SY   AG-1616; AG 1616; AG1616
DR   Coriell; AG01616
DR   Wikidata; Q54609464
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from the irradiated skin of a nephroblastoma patient.
CC   Discontinued: Coriell; AG01616; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V541 ! AG01615
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   AG01710
AC   CVCL_JE27
SY   AG-1710; AG 1710; AG1710
DR   Coriell; AG01710
DR   Wikidata; Q54609465
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01710; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   AG01731
AC   CVCL_JE30
SY   AG-1731; AG 1731; AG1731
DR   Coriell; AG01731
DR   Wikidata; Q54609521
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from the irradiated skin of a leukemia patient.
CC   Discontinued: Coriell; AG01731; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE31 ! AG01732
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   AG01732
AC   CVCL_JE31
SY   AG-1732; AG 1732; AG1732
DR   Coriell; AG01732
DR   Wikidata; Q54609524
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from the non-irradiated skin of a leukemia patient.
CC   Discontinued: Coriell; AG01732; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE30 ! AG01731
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   AG01756
AC   CVCL_JE20
SY   AG-1756; AG 1756; AG1756
DR   Coriell; AG01756
DR   Wikidata; Q54609526
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01756; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84940; Oculocerebrorenal syndrome
DI   ORDO; Orphanet_534; Oculocerebrorenal syndrome of Lowe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   AG0179
AC   CVCL_8B54
DR   ECACC; 90101202
DR   Wikidata; Q54609528
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90101202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG01839
AC   CVCL_JE28
SY   AG-1839; AG 1839; AG1839
DR   Coriell; AG01839
DR   Wikidata; Q54609529
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Discontinued: Coriell; AG01839; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M987 ! GM01840
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   AG01894
AC   CVCL_JE45
SY   AG-1894; AG 1894; AG1894
DR   Coriell; AG01894
DR   Wikidata; Q54609530
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from the irradiated skin of a Wilm's tumor patient.
CC   Discontinued: Coriell; AG01894; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE46 ! AG01895
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   AG01895
AC   CVCL_JE46
SY   AG-1895; AG 1895; AG1895
DR   Coriell; AG01895
DR   Wikidata; Q54609533
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from the non-irradiated skin of a Wilm's tumor patient.
CC   Discontinued: Coriell; AG01895; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE45 ! AG01894
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   AG01946
AC   CVCL_V552
SY   AG-1946; AG 1946; AG1946
DR   Coriell; AG01946
DR   Wikidata; Q54609534
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7471105;
CC   Discontinued: Coriell; AG01946; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG01947
AC   CVCL_V553
SY   AG-1947; AG 1947; AG1947
DR   Coriell; AG01947
DR   Wikidata; Q54609537
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Discontinued: Coriell; AG01947; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG01950
AC   CVCL_JE29
SY   AG-1950; AG 1950
DR   Coriell; AG01950
DR   Wikidata; Q54609539
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; AG01950; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG01964
AC   CVCL_JE21
SY   AG-1964; AG 1964; AG1964
DR   Coriell; AG01964
DR   Wikidata; Q54609546
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01964; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3076; Cowden syndrome
DI   ORDO; Orphanet_201; Cowden syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG01965
AC   CVCL_JE22
SY   AG-1965; AG 1965; AG1965
DR   Coriell; AG01965
DR   Wikidata; Q54609548
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01965; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG01966
AC   CVCL_JE23
SY   AG-1966; AG 1966; AG1966
DR   Coriell; AG01966
DR   Wikidata; Q54609551
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01966; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3076; Cowden syndrome
DI   ORDO; Orphanet_201; Cowden syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG01967
AC   CVCL_JE24
SY   AG-1967; AG 1967; AG1967
DR   Coriell; AG01967
DR   Wikidata; Q54609553
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01967; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG01968
AC   CVCL_JE25
SY   AG-1968; AG 1968; AG1968
DR   Coriell; AG01968
DR   Wikidata; Q54609554
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01968; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG01969
AC   CVCL_JE26
SY   AG-1969; AG 1969; AG1969
DR   Coriell; AG01969
DR   Wikidata; Q54609560
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01969; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG01978
AC   CVCL_V544
SY   AG-1978; AG 1978; AG1978
DR   Coriell; AG01978
DR   Wikidata; Q54609562
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2973075;
RX   PubMed=6843573;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01978; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   AG01979
AC   CVCL_V554
SY   AG-1979; AG 1979; AG1979
DR   Coriell; AG01979
DR   Wikidata; Q54609564
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Discontinued: Coriell; AG01979; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG01980
AC   CVCL_JE40
SY   AG-1980; AG 1980; AG1980
DR   Coriell; AG01980
DR   Wikidata; Q54609566
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01980; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG0206
AC   CVCL_8B55
DR   ECACC; 91010404
DR   Wikidata; Q54609567
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91010404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG02086
AC   CVCL_JE38
SY   AG-2086; AG 2086; AG2086
DR   Coriell; AG02086
DR   Wikidata; Q54609569
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from an osteogenic sarcoma patient.
CC   Discontinued: Coriell; AG02086; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG02089
AC   CVCL_JE47
SY   AG-2089; AG 2089; AG2089
DR   Coriell; AG02089
DR   Wikidata; Q54609570
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02089; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG02101
AC   CVCL_W439
SY   AG2101
DR   CLO; CLO_0036875
DR   Coriell; AG02101
DR   Wikidata; Q54609572
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=2436984;
RX   PubMed=7253718;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG02102
AC   CVCL_W440
SY   AG2102
DR   CLO; CLO_0036876
DR   Coriell; AG02102
DR   Wikidata; Q54609574
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=2436984;
RX   PubMed=7253718;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG02120
AC   CVCL_A2KT
SY   AG2120
DR   Coriell; AG02120
DR   Wikidata; Q105506067
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02120; probable.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10042; ! Peromyscus maniculatus (North American deer mouse)
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02122
AC   CVCL_X808
SY   AG-2122; AG 2122; AG2122
DR   CLO; CLO_0036877
DR   Coriell; AG02122
DR   Wikidata; Q54609577
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Sequence variation: Mutation; HGNC; HGNC:7523; TRIM37; Simple; c.493-2A>G (p.Arg166Cysfs*10, r.493_497delGAAAG); ClinVar=VCV000005240; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=AG02122).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84906; Mulibrey nanism
DI   ORDO; Orphanet_2576; Mulibrey nanism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y5M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 16
//
ID   AG02129
AC   CVCL_JE43
SY   AG-2129; AG 2129; AG2129
DR   Coriell; AG02129
DR   Wikidata; Q54609580
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02129; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE44 ! AG02130
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG02130
AC   CVCL_JE44
SY   AG-2130; AG 2130; AG2130
DR   Coriell; AG02130
DR   Wikidata; Q54609581
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG02130; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE43 ! AG02129
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG02202
AC   CVCL_JE33
SY   AG-2202; AG 2202; AG2202
DR   Coriell; AG02202
DR   Wikidata; Q54609583
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3860870;
RX   PubMed=7253718;
CC   Donor information: Established from the non-irradiated skin of a neuroblastoma patient.
CC   Discontinued: Coriell; AG02202; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE34 ! AG02203
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG02203
AC   CVCL_JE34
SY   AG-2203; AG 2203; AG2203
DR   Coriell; AG02203
DR   Wikidata; Q54609585
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from the irradiated skin of a neuroblastoma patient.
CC   Discontinued: Coriell; AG02203; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE33 ! AG02202
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG02220
AC   CVCL_JE48
SY   AG-2220; AG 2220; AG2220
DR   Coriell; AG02220
DR   Wikidata; Q54609587
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02220; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AG02222
AC   CVCL_0D97
SY   AG-2222; AG 2222; AG2222
DR   CLO; CLO_0036878
DR   Coriell; AG02222
DR   Wikidata; Q54609588
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG02257
AC   CVCL_JB58
SY   AG-2257; AG 2257; AG2257
DR   Coriell; AG02257
DR   Wikidata; Q54609591
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02257; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N52 ! AG02258
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AG02258
AC   CVCL_0N52
SY   AG-2258; AG 2258; AG2258; AG02258A
DR   CLO; CLO_0036883
DR   Coriell; AG02258
DR   Wikidata; Q54609593
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JB58 ! AG02257
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG02261
AC   CVCL_0D98
SY   AG 2261; AG2261; AG02261B
DR   CLO; CLO_0036884
DR   Coriell; AG02261
DR   Wikidata; Q54609595
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=6223188;
RX   PubMed=7176709;
RX   PubMed=7253718;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0D99 ! AG02262
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG02262
AC   CVCL_0D99
SY   AG2262; AG02262A
DR   CLO; CLO_0036993
DR   Coriell; AG02262
DR   Wikidata; Q54609598
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0D98 ! AG02261
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG02272
AC   CVCL_JE35
SY   AG-2272; AG 2272; AG2272
DR   Coriell; AG02272
DR   Wikidata; Q54609599
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Donor information: Established from a neuroblastoma patient.
CC   Discontinued: Coriell; AG02272; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   AG02308
AC   CVCL_A2LC
SY   AG2308
DR   Coriell; AG02308
DR   Wikidata; Q105506069
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Donor information: Established from the irradiated skin of an osteogenic sarcoma patient.
CC   Discontinued: Coriell; AG02308; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LD ! AG02309
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG02309
AC   CVCL_A2LD
SY   AG2309
DR   Coriell; AG02309
DR   Wikidata; Q105506073
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Donor information: Established from the non-irradiated skin of an osteogenic sarcoma patient.
CC   Discontinued: Coriell; AG02309; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LC ! AG02308
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG02310
AC   CVCL_A2LE
SY   AG2310
DR   Coriell; AG02310
DR   Wikidata; Q105506076
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Donor information: Established from the irradiated skin of a Wilm's tumor patient.
CC   Discontinued: Coriell; AG02310; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LF ! AG02311
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG02311
AC   CVCL_A2LF
SY   AG2311
DR   Coriell; AG02311
DR   Wikidata; Q105506080
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Donor information: Established from the non-irradiated skin of a Wilm's tumor patient.
CC   Discontinued: Coriell; AG02311; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LE ! AG02310
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG02360
AC   CVCL_A2LG
SY   AG2360
DR   Coriell; AG02360
DR   Wikidata; Q105506083
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02360; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02409
AC   CVCL_A2KI
SY   AG2409
DR   Coriell; AG02409
DR   Wikidata; Q105506086
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02409; probable.
CC   Derived from site: In situ; Smooth muscle; UBERON=UBERON_0001135.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02410
AC   CVCL_A2KJ
SY   AG2410
DR   Coriell; AG02410
DR   Wikidata; Q105506090
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02410; probable.
CC   Derived from site: In situ; Smooth muscle; UBERON=UBERON_0001135.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02411
AC   CVCL_A2KK
SY   AG2411
DR   Coriell; AG02411
DR   Wikidata; Q105506093
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02411; probable.
CC   Derived from site: In situ; Smooth muscle; UBERON=UBERON_0001135.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02493
AC   CVCL_A2EA
SY   AG2493
DR   Coriell; AG02493
DR   Wikidata; Q105506097
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02493; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02494
AC   CVCL_A2EB
SY   AG2494
DR   Coriell; AG02494
DR   Wikidata; Q105506099
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02494; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02496
AC   CVCL_X771
SY   AG2496
DR   CLO; CLO_0037004
DR   Coriell; AG02496
DR   Wikidata; Q54609601
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG02505
AC   CVCL_X809
SY   AG2505
DR   CLO; CLO_0037003
DR   Coriell; AG02505
DR   Wikidata; Q54609602
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:7523; TRIM37; Simple; c.493-2A>G (p.Arg166Cysfs*10, r.493_497delGAAAG); ClinVar=VCV000005240; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=AG02505).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84906; Mulibrey nanism
DI   ORDO; Orphanet_2576; Mulibrey nanism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y10M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 16
//
ID   AG02506
AC   CVCL_X810
SY   AG2506
DR   CLO; CLO_0037006
DR   Coriell; AG02506
DR   Wikidata; Q54609705
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:7523; TRIM37; Simple; c.493-2A>G (p.Arg166Cysfs*10, r.493_497delGAAAG); ClinVar=VCV000005240; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=AG02506).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84906; Mulibrey nanism
DI   ORDO; Orphanet_2576; Mulibrey nanism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 16
//
ID   AG02508
AC   CVCL_A2LI
SY   AG2508
DR   Coriell; AG02508
DR   Wikidata; Q105506102
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02508; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02510
AC   CVCL_A2LJ
SY   AG2510
DR   Coriell; AG02510
DR   Wikidata; Q105506105
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02510; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02511
AC   CVCL_A2LK
SY   AG2511
DR   Coriell; AG02511
DR   Wikidata; Q105506107
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02511; probable.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LL ! AG02512
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02512
AC   CVCL_A2LL
SY   AG2512
DR   Coriell; AG02512
DR   Wikidata; Q105506110
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02512; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LK ! AG02511
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02514
AC   CVCL_A2LH
SY   AG2514
DR   Coriell; AG02514
DR   Wikidata; Q105506113
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02514; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02602
AC   CVCL_0D95
SY   AG 2602; AG2602; AG02602A
DR   CLO; CLO_0037005
DR   Coriell; AG02602
DR   Wikidata; Q54609706
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=6223188;
RX   PubMed=7176709;
RX   PubMed=7253718;
RX   PubMed=10408806;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0D96 ! AG02603
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG02603
AC   CVCL_0D96
SY   AG2603
DR   CLO; CLO_0037008
DR   EFO; EFO_0022570
DR   Coriell; AG02603
DR   Wikidata; Q54609707
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0D95 ! AG02602
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 11
//
ID   AG02611
AC   CVCL_A2LM
SY   AG2611
DR   Coriell; AG02611
DR   Wikidata; Q105506117
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02611; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02646
AC   CVCL_A2LN
SY   AG2646
DR   Coriell; AG02646
DR   Wikidata; Q105506119
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG02646; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LP ! AG02647
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02647
AC   CVCL_A2LP
SY   AG2647
DR   Coriell; AG02647
DR   Wikidata; Q105506123
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02647; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LN ! AG02646
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02648
AC   CVCL_A2LQ
SY   AG2648
DR   Coriell; AG02648
DR   Wikidata; Q105506128
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG02648; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LR ! AG02649
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02649
AC   CVCL_A2LR
SY   AG2649
DR   Coriell; AG02649
DR   Wikidata; Q105506132
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02649; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LQ ! AG02648
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02650
AC   CVCL_A2LS
SY   AG2650
DR   Coriell; AG02650
DR   Wikidata; Q105506136
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG02650; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LT ! AG02651
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02651
AC   CVCL_A2LT
SY   AG2651
DR   Coriell; AG02651
DR   Wikidata; Q105506139
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02651; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LS ! AG02650
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02653
AC   CVCL_A2LU
SY   AG2653
DR   Coriell; AG02653
DR   Wikidata; Q105506142
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02653; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2ME ! AG03607
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG02655
AC   CVCL_A2LV
SY   AG2655; AG 2655
DR   Coriell; AG02655
DR   Wikidata; Q105506145
RX   CelloPub=CLPUB00387;
RX   PubMed=3860870;
RX   PubMed=7253718;
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Discontinued: Coriell; AG02655; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG02791
AC   CVCL_A2KL
SY   AG2791
DR   Coriell; AG02791
DR   Wikidata; Q105506150
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG02791; probable.
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   4W
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG02804
AC   CVCL_M222
SY   AG2804; AG02804A; AG2804A; AG02804B; AG2804B; AG02804C; AG02804D; 90VA-VI
DR   CLO; CLO_0037007
DR   Coriell; AG02804
DR   Wikidata; Q54609711
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=2995426;
RX   PubMed=7253718;
RX   PubMed=11416159;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain Rh911).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16,17
ST   D21S11: 30.2,31
ST   D8S1179: 13,14
ST   FGA: 25,26
ST   TH01: 8,9.3
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M230 ! AG03204
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 18
//
ID   AG02871
AC   CVCL_X780
SY   AG2871
DR   CLO; CLO_0037010
DR   BioSamples; SAME58121
DR   Coriell; AG02871
DR   Wikidata; Q54609712
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Population: Chilean.
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG03000
AC   CVCL_A2LW
SY   AG3000; AG 3000
DR   Coriell; AG03000
DR   Wikidata; Q105506152
RX   CelloPub=CLPUB00387;
RX   PubMed=3860870;
RX   PubMed=7253718;
CC   Donor information: Established from a patient suffering from medulloblastoma.
CC   Discontinued: Coriell; AG03000; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG03001
AC   CVCL_A2LX
SY   AG3001
DR   Coriell; AG03001
DR   Wikidata; Q105506155
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03001; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03002
AC   CVCL_A2LY
SY   AG3002
DR   Coriell; AG03002
DR   Wikidata; Q105506158
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03002; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03057
AC   CVCL_X764
SY   AG 3057; AG3057
DR   CLO; CLO_0037002
DR   Coriell; AG03057
DR   Wikidata; Q54609716
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7104995;
RX   PubMed=7253718;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y8M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG03058
AC   CVCL_X765
SY   AG 3058; AG3058
DR   CLO; CLO_0036981
DR   Coriell; AG03058
DR   Wikidata; Q54609718
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7104995;
RX   PubMed=7253718;
RX   PubMed=12554677;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y2M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG03059
AC   CVCL_X766
SY   AG 3059; AG3059
DR   CLO; CLO_0036982
DR   Coriell; AG03059
DR   Wikidata; Q54609720
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7104995;
RX   PubMed=7253718;
RX   PubMed=12554677;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y8M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG03139
AC   CVCL_HF28
SY   AG3139
DR   Coriell; AG03139
DR   Wikidata; Q54609722
RX   CelloPub=CLPUB00387;
RX   PubMed=2973075;
RX   PubMed=3762576;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03139; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG03141
AC   CVCL_X767
SY   AG 3141; AG3141; AG03141A; AG03141B
DR   CLO; CLO_0036986
DR   Coriell; AG03141
DR   GEO; GSM1184266
DR   GEO; GSM1184267
DR   GEO; GSM1535462
DR   GEO; GSM1535470
DR   Wikidata; Q54609725
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=10615119;
RX   PubMed=10655550;
RX   PubMed=16339323;
RX   PubMed=24749076;
RX   PubMed=26984941;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln748Ter (c.2242C>T) (2476C>T); ClinVar=VCV000835212; Zygosity=Homozygous (Coriell=AG03141).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y11M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 17
//
ID   AG03141.hTERT clone 8
AC   CVCL_B4N4
SY   AG03141B:pBABE-hTERT clone 8
DR   Wikidata; Q110432569
RX   PubMed=10615119;
RX   PubMed=16339323;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln748Ter (c.2242C>T) (2476C>T); ClinVar=VCV000835212; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X767 ! AG03141
SX   Female
AG   29Y11M
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   AG03198
AC   CVCL_L614
SY   AG3198; AG03198A
DR   CLO; CLO_0036985
DR   Coriell; AG03198
DR   Wikidata; Q54609727
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=8246632;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from autologous cell line AG03259).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L616 ! AG03199
OI   CVCL_L617 ! AG03259
SX   Female
AG   10Y8M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   AG03199
AC   CVCL_L616
SY   AG 3199; AG3199
DR   CLO; CLO_0036984
DR   Coriell; AG03199
DR   Wikidata; Q54609728
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7176709;
RX   PubMed=7253718;
RX   PubMed=8246632;
RX   PubMed=15130666;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from autologous cell line AG03259).
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L614 ! AG03198
OI   CVCL_L617 ! AG03259
SX   Female
AG   10Y8M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   AG03204
AC   CVCL_M230
SY   AG3204; AG03204A
DR   CLO; CLO_0036983
DR   Coriell; AG03204
DR   Wikidata; Q54609731
RX   CelloPub=CLPUB00597;
RX   PubMed=2995426;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain Rh911).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   AG03257
AC   CVCL_L621
SY   AG3257
DR   CLO; CLO_0036990
DR   Coriell; AG03257
DR   Wikidata; Q54609732
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=8246632;
RX   PubMed=28855503;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L618 ! AG03260
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   AG03258
AC   CVCL_L622
SY   AG3258
DR   CLO; CLO_0036989
DR   Coriell; AG03258
DR   Wikidata; Q54609735
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=8246632;
RX   PubMed=12714972;
RX   PubMed=28855503;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   AG03259
AC   CVCL_L617
SY   AG03259A; AG3259A
DR   CLO; CLO_0036988
DR   Coriell; AG03259
DR   Wikidata; Q54609739
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
RX   PubMed=12768443;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; PubMed=12768443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L614 ! AG03198
OI   CVCL_L616 ! AG03199
SX   Female
AG   10Y10M
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   AG03260
AC   CVCL_L618
SY   AG03260A; AG3260A
DR   CLO; CLO_0036987
DR   Coriell; AG03260
DR   Wikidata; Q54609741
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L621 ! AG03257
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   AG03262
AC   CVCL_L619
SY   AG03262A; AG3262A
DR   CLO; CLO_0036961
DR   Coriell; AG03262
DR   Wikidata; Q54609744
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG03263
AC   CVCL_L620
SY   AG03263A; AG3263A
DR   CLO; CLO_0036962
DR   Coriell; AG03263
DR   Wikidata; Q54609746
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG03302
AC   CVCL_A2KU
SY   AG3302
DR   Coriell; AG03302
DR   Wikidata; Q105506162
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03302; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03307
AC   CVCL_A2KV
SY   AG3307
DR   Coriell; AG03307
DR   Wikidata; Q105506165
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03307; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C213199; Junctional nevus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   AG03308
AC   CVCL_A2KW
SY   AG3308; AG 3308
DR   Coriell; AG03308
DR   Wikidata; Q105506169
RX   CelloPub=CLPUB00387;
RX   PubMed=3860870;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03308; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG03309
AC   CVCL_A2KX
SY   AG3309
DR   Coriell; AG03309
DR   Wikidata; Q105506173
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03309; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03310
AC   CVCL_A2KY
SY   AG3310
DR   Coriell; AG03310
DR   Wikidata; Q105506176
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03310; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3272; Neurofibroma
DI   ORDO; Orphanet_252183; Neurofibroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03311
AC   CVCL_A2KZ
SY   AG3311
DR   Coriell; AG03311
DR   Wikidata; Q105506179
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03311; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03326
AC   CVCL_HF29
SY   AG3326
DR   Coriell; AG03326
DR   Wikidata; Q54609748
RX   CelloPub=CLPUB00387;
RX   PubMed=2973075;
RX   PubMed=3762576;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03326; probable.
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG03342
AC   CVCL_2A30
SY   AG3342
DR   CLO; CLO_0036963
DR   Coriell; AG03342
DR   Wikidata; Q54609749
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03342; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG03343
AC   CVCL_W838
SY   AG3343
DR   CLO; CLO_0036978
DR   Coriell; AG03343
DR   Wikidata; Q54609751
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   AG03344
AC   CVCL_W839
SY   AG3344
DR   CLO; CLO_0036977
DR   Coriell; AG03344
DR   Wikidata; Q54609754
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
RX   PubMed=12768443;
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; PubMed=12768443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 15
//
ID   AG03345
AC   CVCL_W840
SY   AG3345
DR   CLO; CLO_0036980
DR   Coriell; AG03345
DR   Wikidata; Q54609756
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   AG03346
AC   CVCL_W841
SY   AG3346
DR   CLO; CLO_0036979
DR   Coriell; AG03346
DR   Wikidata; Q54609758
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   AG03354
AC   CVCL_A2EF
SY   AG3354
DR   Coriell; AG03354
DR   Wikidata; Q105506182
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03354; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03364
AC   CVCL_U309
SY   AG03364A; AG3364A
DR   CLO; CLO_0036975
DR   Coriell; AG03364
DR   GEO; GSM1052417
DR   Wikidata; Q54609760
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=23257959;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   AG03376
AC   CVCL_A2LZ
SY   AG3376
DR   Coriell; AG03376
DR   Wikidata; Q105506185
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03376; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2MA ! AG03664
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG03436
AC   CVCL_A2MB
SY   AG3436
DR   Coriell; AG03436
DR   Wikidata; Q105506187
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03436; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG03499
AC   CVCL_ZS47
SY   AG 3499; AG3499
DR   Coriell; AG03499
DR   Wikidata; Q98125466
RX   CelloPub=CLPUB00387;
RX   PubMed=2897722;
RX   PubMed=3860870;
RX   PubMed=7253718;
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG03499; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   AG03504
AC   CVCL_L603
SY   AG3504
DR   CLO; CLO_0036974
DR   Coriell; AG03504
DR   Wikidata; Q54609762
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L604 ! AG03512
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   AG03505
AC   CVCL_L608
SY   AG3505
DR   CLO; CLO_0036976
DR   Coriell; AG03505
DR   Wikidata; Q54609765
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CV35 ! AG03511
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG03506
AC   CVCL_L609
SY   AG3506
DR   CLO; CLO_0036943
DR   Coriell; AG03506
DR   Wikidata; Q54609768
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
RX   PubMed=12768443;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; PubMed=12768443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L610 ! AG03513
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   AG03507
AC   CVCL_L611
SY   AG3507
DR   CLO; CLO_0036944
DR   Coriell; AG03507
DR   Wikidata; Q54609769
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   AG03508
AC   CVCL_L612
SY   AG3508
DR   CLO; CLO_0036941
DR   Coriell; AG03508
DR   Wikidata; Q54609770
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=12714972;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   AG03511
AC   CVCL_CV35
SY   AG 3511; AG3511
DR   Coriell; AG03511
DR   Wikidata; Q54609772
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
RX   PubMed=8246632;
CC   Population: Mexican.
CC   Discontinued: Coriell; AG03511; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L608 ! AG03505
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   AG03512
AC   CVCL_L604
SY   AG3512
DR   CLO; CLO_0036942
DR   Coriell; AG03512
DR   Wikidata; Q54609775
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
RX   PubMed=8246632;
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L603 ! AG03504
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   AG03513
AC   CVCL_L610
SY   AG 3513; AG3513; AG03513D; AG03513d
DR   CLO; CLO_0036960
DR   Coriell; AG03513
DR   Wikidata; Q54609778
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=6223188;
RX   PubMed=7176709;
RX   PubMed=7253718;
RX   PubMed=8246632;
RX   PubMed=16126733;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from autologous cell line AG03506).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L609 ! AG03506
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   AG03515
AC   CVCL_A2LA
SY   AG3515
DR   Coriell; AG03515
DR   Wikidata; Q105506191
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03515; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03516
AC   CVCL_A2LB
SY   AG3516
DR   Coriell; AG03516
DR   Wikidata; Q105506194
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03516; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03532
AC   CVCL_A2ED
SY   AG3532
DR   Coriell; AG03532
DR   Wikidata; Q105506198
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03532; probable.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   14Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03533
AC   CVCL_A2EE
SY   AG3533
DR   Coriell; AG03533
DR   Wikidata; Q105506202
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03533; probable.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   23Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03556
AC   CVCL_A2EH
SY   AG3556
DR   Coriell; AG03556
DR   Wikidata; Q105506205
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03556; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03574
AC   CVCL_A2EG
SY   AG3574
DR   Coriell; AG03574
DR   Wikidata; Q105506208
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03574; probable.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03587
AC   CVCL_X811
SY   AG3587
DR   CLO; CLO_0036959
DR   Coriell; AG03587
DR   Wikidata; Q54609781
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG03593
AC   CVCL_A2MC
SY   AG 3593; AG3593
DR   Coriell; AG03593
DR   Wikidata; Q105506210
RX   CelloPub=CLPUB00387;
RX   PubMed=7176709;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03593; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03594
AC   CVCL_A2MD
SY   AG3594
DR   Coriell; AG03594
DR   Wikidata; Q105506213
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03594; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03607
AC   CVCL_A2ME
SY   AG3607
DR   Coriell; AG03607
DR   Wikidata; Q105506215
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03607; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LU ! AG02653
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03633
AC   CVCL_A2KN
SY   AG3633
DR   Coriell; AG03633
DR   Wikidata; Q105506217
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03633; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   66Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG03634
AC   CVCL_A2KP
SY   AG3634
DR   Coriell; AG03634
DR   Wikidata; Q105506220
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03634; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2KQ ! AG03635
SX   Sex unspecified
AG   59Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03635
AC   CVCL_A2KQ
SY   AG3635
DR   Coriell; AG03635
DR   Wikidata; Q105506223
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03635; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2KP ! AG03634
SX   Sex unspecified
AG   59Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG03664
AC   CVCL_A2MA
SY   AG3664
DR   Coriell; AG03664
DR   Wikidata; Q105506227
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03664; probable.
CC   Derived from site: Metastatic; Spinal cord; UBERON=UBERON_0002240.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2LZ ! AG03376
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG03674
AC   CVCL_A2MF
SY   AG3674
DR   Coriell; AG03674
DR   Wikidata; Q105506229
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03674; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2PE ! AG03675
OI   CVCL_A2MG ! AG03678
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG03675
AC   CVCL_A2PE
SY   AG3675
DR   Coriell; AG03675
DR   Wikidata; Q105506232
RX   CelloPub=CLPUB00387;
CC   Discontinued: Coriell; AG03675; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2MF ! AG03674
OI   CVCL_A2MG ! AG03678
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03678
AC   CVCL_A2MG
SY   AG3678
DR   Coriell; AG03678
DR   Wikidata; Q105506235
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03678; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2MF ! AG03674
OI   CVCL_A2PE ! AG03675
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03690
AC   CVCL_A2MH
SY   AG3690
DR   Coriell; AG03690
DR   Wikidata; Q105506237
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03690; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03692
AC   CVCL_A2KM
SY   AG3692
DR   Coriell; AG03692
DR   Wikidata; Q105506241
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03692; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03730
AC   CVCL_A2MI
SY   AG3730
DR   Coriell; AG03730
DR   Wikidata; Q105506245
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03730; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03738
AC   CVCL_X785
SY   AG03738A
DR   CLO; CLO_0036958
DR   Coriell; AG03738
DR   Wikidata; Q54609783
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y5M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG03739
AC   CVCL_2A31
SY   AG03739A
DR   CLO; CLO_0036957
DR   Coriell; AG03739
DR   Wikidata; Q54609784
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03739; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG03758
AC   CVCL_A2EC
SY   AG3758
DR   Coriell; AG03758
DR   Wikidata; Q105506249
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03758; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03805
AC   CVCL_A2MJ
SY   AG3805
DR   Coriell; AG03805
DR   Wikidata; Q105506251
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03805; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03818
AC   CVCL_A2MK
SY   AG3818
DR   Coriell; AG03818
DR   Wikidata; Q105506255
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03818; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03819
AC   CVCL_A2ML
SY   AG3819
DR   Coriell; AG03819
DR   Wikidata; Q105506261
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03819; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03820
AC   CVCL_A2MQ
SY   AG3820
DR   Coriell; AG03820
DR   Wikidata; Q105506264
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03820; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03829
AC   CVCL_W043
SY   AG3829
DR   CLO; CLO_0036956
DR   Coriell; AG03829
DR   Wikidata; Q54609788
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   AG03848
AC   CVCL_A2MM
SY   AG 3848; AG3848; SMA2FABE
DR   Coriell; AG03848
DR   Wikidata; Q105506266
RX   CelloPub=CLPUB00387;
RX   PubMed=3941662;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03848; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03849
AC   CVCL_A2MN
SY   AG 3849; AG3849; SMAM2FABE
DR   Coriell; AG03849
DR   Wikidata; Q105506270
RX   CelloPub=CLPUB00387;
RX   PubMed=3941662;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03849; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2MP ! AG03927
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG03927
AC   CVCL_A2MP
SY   AG3927
DR   Coriell; AG03927
DR   Wikidata; Q105506275
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03927; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2MN ! AG03849
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG04054
AC   CVCL_2A41
SY   AG 4054; AG04054A; AG04054B; GRC#0173
DR   CLO; CLO_0034761
DR   Coriell; AG04054
DR   GEO; GSM244109
DR   GEO; GSM244110
DR   GEO; GSM476002
DR   GEO; GSM3124568
DR   Wikidata; Q54609902
RX   CelloPub=CLPUB00597;
RX   PubMed=3745952;
RX   PubMed=6223188;
RX   PubMed=7176709;
RX   PubMed=7307581;
RX   PubMed=18631391;
RX   PubMed=19966276;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E07 ! AG11557
OI   CVCL_2G15 ! AG13442
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   AG04055
AC   CVCL_2A42
SY   GRC#0263
DR   CLO; CLO_0034762
DR   Coriell; AG04055
DR   Wikidata; Q54609903
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04056
AC   CVCL_2A43
SY   GRC#0171
DR   CLO; CLO_0034767
DR   Coriell; AG04056
DR   Wikidata; Q54609905
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [92%]; 45,X [4%]; 47,XY,+18 [4%] (Coriell=AG04056).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04057
AC   CVCL_2A44
SY   AG 4057; GRC#0172
DR   CLO; CLO_0034768
DR   Coriell; AG04057
DR   Wikidata; Q54609908
RX   CelloPub=CLPUB00597;
RX   PubMed=6223188;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E33 ! AG11730
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04058
AC   CVCL_0J78
SY   GRC#0176
DR   CLO; CLO_0034765
DR   Coriell; AG04058
DR   Wikidata; Q54609910
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG04059
AC   CVCL_L623
SY   AG-4059; AG 4059; AG04059B; GRC#0179
DR   CLO; CLO_0034766
DR   Coriell; AG04059
DR   GEO; GSM3124624
DR   Wikidata; Q54609911
RX   CelloPub=CLPUB00597;
RX   PubMed=3374507;
RX   PubMed=6223188;
RX   PubMed=6538202;
RX   PubMed=7176709;
RX   PubMed=7307581;
RX   PubMed=10741968;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG04059).
CC   Karyotypic information: 46,XY [94%]; 45,X [6%] (Coriell=AG04059).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   AG0406
AC   CVCL_8B56
DR   ECACC; 91072504
DR   Wikidata; Q54609912
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG04060
AC   CVCL_2A45
SY   GRC#0158
DR   CLO; CLO_0034769
DR   Coriell; AG04060
DR   Wikidata; Q54609913
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [88%]; 46,XY,t(2;13)(2qter->2p13::13q32->13qter;13pter->13q32::2p13->2pter) [12%] (Coriell=AG04060).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04061
AC   CVCL_2A46
SY   GRC#0159
DR   CLO; CLO_0034770
DR   Coriell; AG04061
DR   Wikidata; Q54609915
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=8247227;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 54 PDL (PubMed=7307581); 53 PDL (Coriell=AG04061).
CC   Karyotypic information: 46,XY [80%]; 46,XY,t(8;18)(8pter->8q11::18q11->18qter;18pter->18q11::8q11->8qter) [20%] (Coriell=AG04061).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04062
AC   CVCL_2A47
SY   GRC#0210
DR   CLO; CLO_0034771
DR   Coriell; AG04062
DR   Wikidata; Q54609917
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34-44 PDL (PubMed=9724752); 31 PDL (Coriell=AG04062).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E76 ! AG12660
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04063
AC   CVCL_2A48
SY   GRC#0211
DR   CLO; CLO_0034772
DR   Coriell; AG04063
DR   GEO; GSM3124584
DR   Wikidata; Q54609919
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG04063).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG04064
AC   CVCL_L624
SY   AG04064A; GRC#0189
DR   CLO; CLO_0034773
DR   Coriell; AG04064
DR   GEO; GSM244111
DR   GEO; GSM244112
DR   GEO; GSM3124676
DR   Wikidata; Q54609920
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=9724752;
RX   PubMed=10741968;
RX   PubMed=18631391;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (PubMed=7307581); 32 PDL (PubMed=9724752).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L625 ! AG08433
SX   Male
AG   92Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   AG04065
AC   CVCL_2A49
SY   AG04065C; AG04065D; GRC#0191
DR   CLO; CLO_0034774
DR   Coriell; AG04065
DR   GEO; GSM3124619
DR   Wikidata; Q54609921
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [80%]; 46,XY,der(9)t(1;9)(q23;p24) [4%]; 46,XY,t(1;12;22)(p36;q13;q12),del(3)(q22;q25),der(10)t(10;15)(q26;q14),del(19)(?) [16%] (Coriell=AG04065).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   AG04103
AC   CVCL_U310
DR   CLO; CLO_0034775
DR   Coriell; AG04103
DR   Wikidata; Q54609923
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (Coriell=AG04103).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   AG04110
AC   CVCL_U311
DR   CLO; CLO_0034776
DR   Coriell; AG04110
DR   GEO; GSM1535463
DR   GEO; GSM1535468
DR   Wikidata; Q54609925
RX   CelloPub=CLPUB00597;
RX   PubMed=26984941;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Glu578Val (c.1733A>T); ClinVar=VCV000066863; Zygosity=Heterozygous (Coriell=AG04110).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Caution: Is stated not be from a Werner syndrome patient by PubMed=26984941.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   AG04142
AC   CVCL_2A50
SY   AG 4142; AG04142A; GRC#0174
DR   CLO; CLO_0034777
DR   Coriell; AG04142
DR   Wikidata; Q54609927
RX   CelloPub=CLPUB00597;
RX   PubMed=1590792;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG04142).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04143
AC   CVCL_2A51
DR   CLO; CLO_0034778
DR   Coriell; AG04143
DR   GEO; GSM3124613
DR   Wikidata; Q54609928
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG04143).
CC   Karyotypic information: 46,XY [76%]; 45,X [10%]; 46,XY,t(1;5)(q24;p15) [14%] (Coriell=AG04143).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG04144
AC   CVCL_0J79
SY   GRC#0177
DR   CLO; CLO_0034781
DR   Coriell; AG04144
DR   Wikidata; Q54609930
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J80 ! AG09558
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   AG04145
AC   CVCL_2A52
SY   GRC#0183
DR   CLO; CLO_0034782
DR   Coriell; AG04145
DR   Wikidata; Q54609933
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 56 PDL (PubMed=7307581).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E10 ! AG11643
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04146
AC   CVCL_2A53
SY   GRC#0181
DR   CLO; CLO_0034779
DR   Coriell; AG04146
DR   Wikidata; Q54609934
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,9qh+ (Coriell=AG04146).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C18 ! AG07123
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04147
AC   CVCL_2A54
SY   AG 4147; GRC#0161
DR   CLO; CLO_0034780
DR   Coriell; AG04147
DR   GEO; GSM426260
DR   Wikidata; Q54609935
RX   CelloPub=CLPUB00597;
RX   PubMed=6223188;
RX   PubMed=7307581;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG04147).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   AG04148
AC   CVCL_2A55
SY   AG 4148; AG04148A; AG 4148A; GRC#0167
DR   CLO; CLO_0034787
DR   Coriell; AG04148
DR   Wikidata; Q54609938
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7307581;
RX   PubMed=8643543;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 55 PDL (PubMed=7307581).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04149
AC   CVCL_2A56
SY   GRC#0212
DR   CLO; CLO_0034788
DR   Coriell; AG04149
DR   Wikidata; Q54609939
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F05 ! AG12965
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04150
AC   CVCL_2A57
SY   GRC#0213
DR   CLO; CLO_0034785
DR   Coriell; AG04150
DR   Wikidata; Q54609942
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 54 PDL (PubMed=7307581); 45 PDL (Coriell=AG04150).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G31 ! AG14099
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04151
AC   CVCL_2A58
SY   AG-4151; AG 4151; GRC#0220
DR   CLO; CLO_0034786
DR   Coriell; AG04151
DR   Wikidata; Q54609944
RX   CelloPub=CLPUB00597;
RX   PubMed=3374507;
RX   PubMed=6538202;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [60%]; 46,XY,t(2;18)(2pter->2q33::18q21->18qter;18pter->18q21::2q33->2qter) [40%] (Coriell=AG04151).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G01 ! AG13334
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04152
AC   CVCL_2A59
SY   GRC#0216
DR   CLO; CLO_0034783
DR   Coriell; AG04152
DR   Wikidata; Q54609946
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04153
AC   CVCL_2A60
SY   AG04153A; AG04153B; GRC#0206
DR   CLO; CLO_0034784
DR   Coriell; AG04153
DR   Wikidata; Q54609949
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=10408806;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [43]; 46,XY,der(9)(9qter->9p23::7q11->7qter) [3]; 46,XY,der(13)(13qter->13p13::7q11->7qter) [2]; 46,XY,add(13)(?::p13->qter) [2] (Coriell=AG04153).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04159
AC   CVCL_V150
SY   AG 4159; AG04159A; RB 4159; AD1BE
DR   CLO; CLO_0034793
DR   Coriell; AG04159
DR   Wikidata; Q54609950
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=3941662;
RX   PubMed=8247227;
RX   PubMed=8643543;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V151 ! AG04160
SX   Female
AG   52Y3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   AG04160
AC   CVCL_V151
SY   AG04160B; AG 04160B; AG04160C
DR   CLO; CLO_0034789
DR   Coriell; AG04160
DR   Wikidata; Q54609952
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from autologous cell line AG04159).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V150 ! AG04159
SX   Female
AG   52Y3M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   AG0422
AC   CVCL_8B57
DR   ECACC; 91081203
DR   Wikidata; Q54609953
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91081203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG0423
AC   CVCL_8B58
DR   ECACC; 91081204
DR   Wikidata; Q54609956
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91081204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG0425
AC   CVCL_8B59
DR   ECACC; 91082128
DR   Wikidata; Q54609958
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG04348
AC   CVCL_2A61
DR   CLO; CLO_0034791
DR   Coriell; AG04348
DR   Wikidata; Q54609962
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG04348).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG04349
AC   CVCL_2A62
DR   CLO; CLO_0034792
DR   Coriell; AG04349
DR   Wikidata; Q54609964
RX   PubMed=16081512;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 51 PDL (Coriell=AG04349).
CC   Karyotypic information: 46,XY [70%]; 47,XY,+mar [30%] (Coriell=AG04349).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04350
AC   CVCL_2A63
SY   GRC#0160
DR   CLO; CLO_0034795
DR   Coriell; AG04350
DR   Wikidata; Q54609965
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (PubMed=7307581); 40 PDL (Coriell=AG04350).
CC   Karyotypic information: 46,XY [78%]; 46,XY,1q+ [22%] (Coriell=AG04350).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E06 ! AG11555
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04351
AC   CVCL_2A64
SY   GRC#0163
DR   CLO; CLO_0034796
DR   Coriell; AG04351
DR   GEO; GSM426261
DR   Wikidata; Q54610051
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (Coriell=AG04351).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG04352
AC   CVCL_2A65
SY   GRC#0164
DR   CLO; CLO_0034797
DR   Coriell; AG04352
DR   Wikidata; Q54610053
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG04352).
CC   Karyotypic information: 46,XY [96%]; 46,XY,t(1;8)(p22;q13) [4%] (Coriell=AG04352).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G10 ! AG13367
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04353
AC   CVCL_2A66
SY   AG-4353; AG 4353; GRC#0165
DR   CLO; CLO_0034798
DR   Coriell; AG04353
DR   Wikidata; Q54610054
RX   CelloPub=CLPUB00597;
RX   PubMed=3374507;
RX   PubMed=6538202;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (PubMed=7307581).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B52 ! AG05804
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   AG04354
AC   CVCL_2A67
SY   GRC#0166
DR   CLO; CLO_0034794
DR   Coriell; AG04354
DR   Wikidata; Q54610057
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG04354).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E77 ! AG12733
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04355
AC   CVCL_2A68
DR   CLO; CLO_0034804
DR   Coriell; AG04355
DR   Wikidata; Q54610059
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG04355).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG04356
AC   CVCL_2A69
SY   GRC#0208
DR   CLO; CLO_0034803
DR   Coriell; AG04356
DR   Wikidata; Q54610060
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG04356).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04357
AC   CVCL_2A70
SY   GRC#0182
DR   CLO; CLO_0034808
DR   Coriell; AG04357
DR   Wikidata; Q54610063
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04378
AC   CVCL_2A71
SY   GRC#0225
DR   CLO; CLO_0034807
DR   Coriell; AG04378
DR   Wikidata; Q54610065
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04379
AC   CVCL_2A72
SY   AG04379A; GRC#0226
DR   CLO; CLO_0034806
DR   Coriell; AG04379
DR   Wikidata; Q54610068
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG04379).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG0438
AC   CVCL_8B60
DR   ECACC; 91091602
DR   Wikidata; Q54610071
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG04380
AC   CVCL_2A73
SY   AG04380A; GRC#0227
DR   CLO; CLO_0034805
DR   Coriell; AG04380
DR   Wikidata; Q54610073
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG04380).
CC   Karyotypic information: 46,XY [68%]; 46,XY,12p+ [32%] (Coriell=AG04380).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G04 ! AG13348
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04381
AC   CVCL_2A74
SY   GRC#0228
DR   CLO; CLO_0034802
DR   Coriell; AG04381
DR   Wikidata; Q54610075
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG04381).
CC   Karyotypic information: 46,XY [40%]; 45,X [60%] (Coriell=AG04381).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04382
AC   CVCL_2A75
SY   GRC#0229
DR   CLO; CLO_0034801
DR   Coriell; AG04382
DR   Wikidata; Q54610078
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C70 ! AG08791
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04383
AC   CVCL_2A76
SY   GRC#0230
DR   CLO; CLO_0034800
DR   Coriell; AG04383
DR   Wikidata; Q54610079
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=8247227;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04384
AC   CVCL_2A77
SY   GRC#0231
DR   CLO; CLO_0034799
DR   Coriell; AG04384
DR   Wikidata; Q54610081
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG04384).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04385
AC   CVCL_2A78
SY   GRC#0232
DR   CLO; CLO_0034812
DR   Coriell; AG04385
DR   Wikidata; Q54610082
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG04385).
CC   Karyotypic information: 46,XY [88%]; 46,XY,t(1;21)(p12;p11.2),t(3;14)(q12;q11.2) [12%] (Coriell=AG04385).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04386
AC   CVCL_2A79
SY   GRC#0233
DR   CLO; CLO_0034814
DR   Coriell; AG04386
DR   GEO; GSM3124602
DR   Wikidata; Q54610083
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG04386).
CC   Karyotypic information: 46,XY [70%]; 46,XY,8p-,22q+ [16%]; 46,XY,1p+,3p-,3q-,11p-,21q+ [10%] (Coriell=AG04386).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG04387
AC   CVCL_2A80
SY   GRC#0234
DR   CLO; CLO_0034813
DR   Coriell; AG04387
DR   Wikidata; Q54610086
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04388
AC   CVCL_2I14
DR   CLO; CLO_0034816
DR   Coriell; AG04388
DR   Wikidata; Q54610088
RX   CelloPub=CLPUB00597;
CC   Senescence: Senesces at 45 PDL (Coriell=AG04388).
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG0439
AC   CVCL_8B61
DR   ECACC; 91092529
DR   Wikidata; Q54610089
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092529; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG04392
AC   CVCL_0J95
DR   CLO; CLO_0034815
DR   Coriell; AG04392
DR   Wikidata; Q54610090
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=12297622;
CC   Senescence: Senesces at 55 PDL (PubMed=9724752).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J96 ! AG04393
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG04393
AC   CVCL_0J96
DR   CLO; CLO_0034818
DR   Coriell; AG04393
DR   Wikidata; Q54610092
RX   CelloPub=CLPUB00597;
RX   PubMed=12297622;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J95 ! AG04392
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG0440
AC   CVCL_8B62
DR   ECACC; 91092530
DR   Wikidata; Q54610095
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092530; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG04400
AC   CVCL_H786
SY   AG 4400; AG4400; AG04400A
DR   CLO; CLO_0034817
DR   Coriell; AG04400
DR   Wikidata; Q54610097
RX   CelloPub=CLPUB00597;
RX   PubMed=1590792;
RX   PubMed=7847674;
RX   PubMed=10408806;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   AG04401
AC   CVCL_H787
SY   AG 4401; AG4401; AG04401D
DR   CLO; CLO_0034810
DR   Coriell; AG04401
DR   Wikidata; Q54610098
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7847674;
RX   PubMed=8643543;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG04402
AC   CVCL_H788
SY   AG4402; AG04402A
DR   CLO; CLO_0034809
DR   Coriell; AG04402
DR   Wikidata; Q54610099
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
RX   PubMed=10408806;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG04405
AC   CVCL_X772
SY   AG 04405
DR   CLO; CLO_0034811
DR   Coriell; AG04405
DR   Wikidata; Q54610103
RX   CelloPub=CLPUB00597;
RX   PubMed=12554677;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y5M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG04407
AC   CVCL_X773
DR   Coriell; AG04407
DR   Wikidata; Q54610104
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG04407).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG0441
AC   CVCL_8B63
DR   ECACC; 91092607
DR   Wikidata; Q54610105
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG0442
AC   CVCL_8B64
DR   ECACC; 91092608
DR   Wikidata; Q54610107
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG04431
AC   CVCL_0J97
SY   AG04431A; AG04431B
DR   CLO; CLO_0034828
DR   Coriell; AG04431
DR   Wikidata; Q54610109
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Senescence: Senesces at 54 PDL (PubMed=9724752).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J98 ! AG04432
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG04432
AC   CVCL_0J98
DR   CLO; CLO_0034827
DR   Coriell; AG04432
DR   Wikidata; Q54610110
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J97 ! AG04431
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG04433
AC   CVCL_0J99
DR   CLO; CLO_0034826
DR   Coriell; AG04433
DR   Wikidata; Q54610115
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Senescence: Senesces at 30-36 PDL (PubMed=9724752).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0K00 ! AG04434
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG04434
AC   CVCL_0K00
DR   CLO; CLO_0034825
DR   Coriell; AG04434
DR   Wikidata; Q54610116
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J99 ! AG04433
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG04438
AC   CVCL_2A81
SY   GRC#0257
DR   CLO; CLO_0034824
DR   Coriell; AG04438
DR   Wikidata; Q54610118
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG04438).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04439
AC   CVCL_2A82
SY   GRC#0258
DR   CLO; CLO_0034823
DR   Coriell; AG04439
DR   Wikidata; Q54610119
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG04439).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E74 ! AG12605
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04440
AC   CVCL_L023
SY   AG04440A; GRC#0259
DR   CLO; CLO_0034822
DR   Coriell; AG04440
DR   Wikidata; Q54610123
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG04440).
CC   Karyotypic information: 46,XY,9qh- (Coriell=AG04440).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG04441
AC   CVCL_2A83
SY   AG04441A; AG04441B; GRC#0260
DR   CLO; CLO_0034821
DR   Coriell; AG04441
DR   Wikidata; Q54610124
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37-38 PDL (PubMed=9724752); 47 PDL (Coriell=AG04441).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F63 ! AG13156
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04442
AC   CVCL_2A84
SY   GRC#0261
DR   CLO; CLO_0034820
DR   Coriell; AG04442
DR   Wikidata; Q54610128
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG04442).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04443
AC   CVCL_2A85
SY   GRC#0262
DR   CLO; CLO_0034819
DR   Coriell; AG04443
DR   Wikidata; Q54610129
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG04443).
CC   Doubling time: Slow growth (Coriell=AG04443).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04444
AC   CVCL_2A86
SY   GRC#0264
DR   CLO; CLO_0034829
DR   Coriell; AG04444
DR   Wikidata; Q54610231
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG04444).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04445
AC   CVCL_2A87
SY   AG-4445; AG 4445; A04445A; GRC#0265
DR   CLO; CLO_0034836
DR   Coriell; AG04445
DR   Wikidata; Q54610234
RX   CelloPub=CLPUB00597;
RX   PubMed=3374507;
RX   PubMed=6538202;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 20 PDL (Coriell=AG04445).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04446
AC   CVCL_2A88
SY   AG_04446; GRC#0246
DR   CLO; CLO_0034835
DR   Coriell; AG04446
DR   GEO; GSM6347
DR   GEO; GSM6386
DR   Wikidata; Q54610236
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=9724752;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (PubMed=9724752); 33 PDL (Coriell=AG04446).
CC   Doubling time: 2.2 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E80 ! AG12851
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   AG04447
AC   CVCL_2A89
SY   AG04447A; GRC#0247
DR   CLO; CLO_0034838
DR   Coriell; AG04447
DR   Wikidata; Q54610238
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG04447).
CC   Karyotypic information: 46,XY [90%]; 46,XY,t(4;9)(4pter->4q33::9q12->9qter;9pter->9q12::4q33->4qter) [10%] (Coriell=AG04447).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E73 ! AG12602
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04449
AC   CVCL_F485
DR   CLO; CLO_0034837
DR   Coriell; AG04449
DR   ENCODE; ENCBS003ENC
DR   ENCODE; ENCBS338DRP
DR   ENCODE; ENCBS667XPG
DR   ENCODE; ENCBS747YUA
DR   GEO; GSM510528
DR   GEO; GSM510530
DR   GEO; GSM749678
DR   GEO; GSM749695
DR   GEO; GSM749702
DR   GEO; GSM945176
DR   GEO; GSM945187
DR   Wikidata; Q54610240
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=12297622;
RX   PubMed=23325432;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/AG04449_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Senescence: Senesces at 31 PDL (PubMed=9724752).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F486 ! AG04450
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   AG04450
AC   CVCL_F486
DR   CLO; CLO_0034832
DR   EFO; EFO_0006270
DR   Coriell; AG04450
DR   ENCODE; ENCBS004ENC
DR   ENCODE; ENCBS008ENC
DR   ENCODE; ENCBS485QDY
DR   ENCODE; ENCBS554API
DR   GEO; GSM510532
DR   GEO; GSM510534
DR   GEO; GSM749697
DR   GEO; GSM749769
DR   GEO; GSM945169
DR   GEO; GSM945177
DR   GEO; GSM1010912
DR   GEO; GSM1010913
DR   GEO; GSM1010914
DR   GEO; GSM1022635
DR   GEO; GSM2072418
DR   GEO; GSM2072419
DR   GEO; GSM2072446
DR   GEO; GSM2072447
DR   Wikidata; Q54610242
RX   CelloPub=CLPUB00597;
RX   PubMed=12297622;
RX   PubMed=23325432;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/AG04450_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F485 ! AG04449
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   AG04451
AC   CVCL_0N53
DR   CLO; CLO_0034831
DR   Coriell; AG04451
DR   Wikidata; Q54610243
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Senescence: Senesces at 57 PDL (PubMed=9724752).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N54 ! AG04452
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG04452
AC   CVCL_0N54
DR   CLO; CLO_0034834
DR   Coriell; AG04452
DR   Wikidata; Q54610245
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N53 ! AG04451
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG04453
AC   CVCL_2A90
SY   GRC#0192
DR   CLO; CLO_0034833
DR   Coriell; AG04453
DR   Wikidata; Q54610249
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (PubMed=7307581).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D34 ! AG10047
OI   CVCL_2G30 ! AG14048
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04454
AC   CVCL_2A91
SY   AG04454A; AG04454B; GRC#0193
DR   CLO; CLO_0034830
DR   Coriell; AG04454
DR   Wikidata; Q54610250
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=15450399;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG04454).
CC   Karyotypic information: 46,XY [11]; 46,XY,der(15)(15qter->15p11.2::17q21->17qter) [34]; 45,X [3]; 46,XY,t(2;10)(2qter->p23::10p13->10pter;10qter->10p13::2p23->2pter) [2] (Coriell=AG04454).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F32 ! AG13076
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04455
AC   CVCL_2A92
SY   GRC#0194
DR   CLO; CLO_0034679
DR   Coriell; AG04455
DR   Wikidata; Q54610251
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=30699343;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B47 ! AG05414
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04456
AC   CVCL_2A93
SY   GRC#0195
DR   CLO; CLO_0034677
DR   Coriell; AG04456
DR   GEO; GSM244113
DR   GEO; GSM244114
DR   Wikidata; Q54610252
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=18631391;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [8]; 46,XY,t(1;6)(1pter->1q25::6q13->6qter;6pter->6q13::1q25->1qter) [42] (Coriell=AG04456).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G36 ! AG14251
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG04457
AC   CVCL_2A94
SY   GRC#0196
DR   CLO; CLO_0034659
DR   Coriell; AG04457
DR   GEO; GSM3124604
DR   Wikidata; Q54610255
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [23]; 46,XY,t(7;20)(7pter->7q11::20q11->20qter;20pter->20q11::7q11->7qter) [15]; 45,X [12] (Coriell=AG04457).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B34 ! AG05248
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG04458
AC   CVCL_2A95
SY   AG04458A; GRC#0197
DR   CLO; CLO_0034660
DR   Coriell; AG04458
DR   Wikidata; Q54610257
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG04458).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C89 ! AG09158
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04459
AC   CVCL_2A96
SY   GRC#0198
DR   CLO; CLO_0034661
DR   Coriell; AG04459
DR   Wikidata; Q54610258
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG04459; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E19 ! AG11693
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04460
AC   CVCL_2A97
DR   CLO; CLO_0034662
DR   Coriell; AG04460
DR   Wikidata; Q54610259
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG04460).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG04461
AC   CVCL_2A98
SY   GRC#0201
DR   CLO; CLO_0034664
DR   Coriell; AG04461
DR   GEO; GSM3124595
DR   Wikidata; Q54610263
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [54%]; 46,XY,2p-,5q+,22p+,Xp- [26%]; 46,XY,t(1;2)(q21;q37) [8%)]; 46,XY,16q+ [6%]; 46,XY,11p- [4%]; 46,XY,1p- [2%] (Coriell=AG04461).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G03 ! AG13345
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG04462
AC   CVCL_L626
SY   AG04462A; GRC#0202
DR   CLO; CLO_0034666
DR   Coriell; AG04462
DR   Wikidata; Q54610266
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L627 ! AG11556
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   AG04475
AC   CVCL_X790
DR   CLO; CLO_0034668
DR   Coriell; AG04475
DR   Wikidata; Q54610267
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~4000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=AG04475).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   AG0448
AC   CVCL_8B65
DR   ECACC; 91100410
DR   Wikidata; Q54610268
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91100410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG0449
AC   CVCL_8B66
DR   ECACC; 91100411
DR   Wikidata; Q54610270
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91100411; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG04525
AC   CVCL_X791
SY   AG 4525
DR   CLO; CLO_0034669
DR   Coriell; AG04525
DR   Wikidata; Q54610273
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=12297622;
CC   Senescence: Senesces at 27-36 PDL (PubMed=9724752).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X792 ! AG04526
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG04526
AC   CVCL_X792
DR   CLO; CLO_0034698
DR   Coriell; AG04526
DR   Wikidata; Q54610275
RX   CelloPub=CLPUB00597;
RX   PubMed=12297622;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X791 ! AG04525
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG04551
AC   CVCL_2A99
SY   GRC#0248
DR   CLO; CLO_0034697
DR   Coriell; AG04551
DR   Wikidata; Q54610278
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG04551).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C99 ! AG09270
OI   CVCL_2D60 ! AG11019
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04552
AC   CVCL_2B00
SY   AG04552A; GRC#0249
DR   CLO; CLO_0034694
DR   Coriell; AG04552
DR   Wikidata; Q54610280
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (PubMed=9724752).
CC   Karyotypic information: 46,XY [66%]; 45,XY,t(13;21)(13qter->cen->21qter) [34%] (Coriell=AG04552).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F61 ! AG13152
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG04553
AC   CVCL_2B01
SY   GRC#0250
DR   CLO; CLO_0034682
DR   Coriell; AG04553
DR   Wikidata; Q54610284
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG04553).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04554
AC   CVCL_2B02
SY   GRC#0251
DR   CLO; CLO_0034683
DR   Coriell; AG04554
DR   Wikidata; Q54610286
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG04554).
CC   Karyotypic information: 46,XY [90%]; 46,XY,inv(1)(pter->p32::p11->p32::p11->qter) [8%] (Coriell=AG04554).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04555
AC   CVCL_2B03
SY   GRC#0253
DR   CLO; CLO_0034680
DR   Coriell; AG04555
DR   Wikidata; Q54610287
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04556
AC   CVCL_2B04
SY   GRC#0254
DR   CLO; CLO_0034681
DR   Coriell; AG04556
DR   Wikidata; Q54610289
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,1qh+ [28%]; 46,Y,1qh+,t(X;1)(Xpter->Xq24::1q25->1qter;1pter->1q25::Xq24->Xqter) [72%] (Coriell=AG04556).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F94 ! AG13297
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04557
AC   CVCL_2B05
SY   GRC#0255
DR   CLO; CLO_0034687
DR   Coriell; AG04557
DR   Wikidata; Q54610291
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG04557).
CC   Karyotypic information: 46,XY,inv(1)(q11;q21) [96%]; 46,XY,inv(1)(q11;q21),t(1;13)(1pter->1q25::13q12->13qter;13pter->13q12::1q25->1qter) [4%] (Coriell=AG04557).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04558
AC   CVCL_2B06
SY   GRC#0256
DR   CLO; CLO_0034688
DR   Coriell; AG04558
DR   Wikidata; Q54610295
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG04558).
CC   Karyotypic information: 46,XY,der(11)(11qter->11p15;14q11->14qter) [25]; 46,XY,add(11)(11qter->11p15:?) [11]; 46,XY,der(11)(11qter->11p15::3p14->3pter) [4]; 46,XY,inv(5)(pter->q22::q31->q22::q31->qter) [2]; 46,XY [8] (Coriell=AG04558).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04559
AC   CVCL_2B07
SY   GRC#0184
DR   CLO; CLO_0034685
DR   Coriell; AG04559
DR   Wikidata; Q54610297
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [46]; 45,XY,-9 [2]; 45,XY,der(7)(7qter->7p22::11q13->11qter),-9 [1]; 43,X,der(Y;13)(Yqter->Yq10;13q10->13qter),-3,der(7)(7qter->7p22::11q13->11qter),-11 [1] (Coriell=AG04559).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04560
AC   CVCL_H789
SY   AG4560; AG 4560; AG04560B; GRC#0185
DR   CLO; CLO_0034912
DR   Coriell; AG04560
DR   Wikidata; Q54610299
RX   CelloPub=CLPUB00597;
RX   PubMed=3745952;
RX   PubMed=7307581;
RX   PubMed=7847674;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG04645
AC   CVCL_X786
DR   CLO; CLO_0034914
DR   Coriell; AG04645
DR   Wikidata; Q54610300
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X787 ! AG04646
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG04646
AC   CVCL_X787
DR   CLO; CLO_0034913
DR   Coriell; AG04646
DR   Wikidata; Q54610303
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X786 ! AG04645
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG04654
AC   CVCL_2B08
SY   GRC#0205
DR   CLO; CLO_0034916
DR   Coriell; AG04654
DR   Wikidata; Q54610305
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [49]; 46,XY,t(7;12)(7pter->7q22::12q13->12qter;12pter->12q13::7q22->7qter) [1] (Coriell=AG04654).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C45 ! AG07724
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04655
AC   CVCL_2B09
SY   AG 4655; GRC#0207
DR   CLO; CLO_0034915
DR   Coriell; AG04655
DR   GEO; GSM426262
DR   Wikidata; Q54610306
RX   CelloPub=CLPUB00597;
RX   PubMed=3745952;
RX   PubMed=7307581;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E67 ! AG12588
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG04656
AC   CVCL_2B10
SY   AG 4656; GRC#0221
DR   CLO; CLO_0034919
DR   Coriell; AG04656
DR   Wikidata; Q54610307
RX   CelloPub=CLPUB00597;
RX   PubMed=3745952;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG04656).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F31 ! AG13075
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04657
AC   CVCL_2B11
DR   CLO; CLO_0034917
DR   Coriell; AG04657
DR   Wikidata; Q54610313
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG04657).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG04658
AC   CVCL_2B12
SY   GRC#0237
DR   CLO; CLO_0034922
DR   Coriell; AG04658
DR   Wikidata; Q54610316
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG04658).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04659
AC   CVCL_2B13
SY   AG_04659; AG4659; GRC#0219
DR   CLO; CLO_0034920
DR   Coriell; AG04659
DR   GEO; GSM6348
DR   Wikidata; Q54610375
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=12840040;
RX   PubMed=14662655;
RX   PubMed=16081512;
RX   PubMed=18368133;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG04659).
CC   Doubling time: 1.7 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B43 ! AG05283
OI   CVCL_2D83 ! AG11243
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   AG04660
AC   CVCL_2B14
SY   GRC#0240
DR   CLO; CLO_0034899
DR   Coriell; AG04660
DR   Wikidata; Q54610378
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG04661
AC   CVCL_2B15
SY   GRC#0238
DR   CLO; CLO_0034885
DR   Coriell; AG04661
DR   GEO; GSM3124611
DR   Wikidata; Q54610381
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG04661).
CC   Karyotypic information: 46,XY [16%]; 46,XY,inv(2),15q-,17p+ [84%] (Coriell=AG04661).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG04662
AC   CVCL_2B16
SY   AG04662C; AG04662D; GRC#0235
DR   CLO; CLO_0034884
DR   Coriell; AG04662
DR   GEO; GSM3124672
DR   Wikidata; Q54610382
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [21]; 45,X [22]; 47,XY,+7 [7] (Coriell=AG04662).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG04676
AC   CVCL_2I15
SY   AG-4676; AG 04676
DR   CLO; CLO_0034892
DR   Coriell; AG04676
DR   Wikidata; Q54610384
RX   CelloPub=CLPUB00597;
RX   PubMed=6642663;
RX   PubMed=7269278;
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   5D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG04677
AC   CVCL_2I16
SY   AG-4677; AG 04677A
DR   CLO; CLO_0034891
DR   Coriell; AG04677
DR   Wikidata; Q54610386
RX   CelloPub=CLPUB00597;
RX   PubMed=6642663;
RX   PubMed=7269278;
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG04762
AC   CVCL_2I17
SY   AG04762A
DR   CLO; CLO_0034890
DR   Coriell; AG04762
DR   Wikidata; Q54610387
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2I22 ! BFAE-39
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 13
//
ID   AG04765
AC   CVCL_2I18
DR   CLO; CLO_0034889
DR   Coriell; AG04765
DR   Wikidata; Q28873059
RX   CelloPub=CLPUB00597;
CC   Karyotypic information: 41,X [60%]; 41,X,11q+ [40%] (Coriell=AG04765).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex ambiguous
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   AG0479
AC   CVCL_8B67
DR   ECACC; 91102207
DR   Wikidata; Q54739756
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91102207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG04823
AC   CVCL_X788
DR   CLO; CLO_0034898
DR   Coriell; AG04823
DR   Wikidata; Q54739758
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG04907
AC   CVCL_2I19
DR   CLO; CLO_0034897
DR   Coriell; AG04907
DR   Wikidata; Q54739761
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG05012
AC   CVCL_0J83
SY   AG5012
DR   CLO; CLO_0034895
DR   Coriell; AG05012
DR   Wikidata; Q54739763
RX   CelloPub=CLPUB00597;
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG05013
AC   CVCL_X812
DR   CLO; CLO_0034893
DR   Coriell; AG05013
DR   GEO; GSM476016
DR   Wikidata; Q54739764
RX   CelloPub=CLPUB00597;
RX   PubMed=19966276;
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.2059-1G>T (IVS12AS,G-T,-1); ClinVar=VCV000006065; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG05013).
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.His831Argfs*52 (c.2492_2493delAT) (2-BP DEL,NT2492); ClinVar=VCV000006064; Zygosity=Heterozygous (Coriell=AG05013).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 18
//
ID   AG05024
AC   CVCL_X789
DR   CLO; CLO_0035183
DR   Coriell; AG05024
DR   Wikidata; Q54739765
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG05025
AC   CVCL_F252
SY   AG 5025
DR   CLO; CLO_0001683
DR   CLO; CLO_0035181
DR   CLDB; cl255
DR   Coriell; AG05025
DR   Wikidata; Q54739766
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Karyotypic information: 69,XXY (Coriell=AG05025).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Fetus
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   AG05055
AC   CVCL_2I20
DR   CLO; CLO_0035182
DR   Coriell; AG05055
DR   Wikidata; Q54739767
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG05056
AC   CVCL_2I21
SY   AG 05056
DR   CLO; CLO_0035176
DR   Coriell; AG05056
DR   Wikidata; Q54739768
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG05095
AC   CVCL_2B17
SY   GRC#0244
DR   CLO; CLO_0035177
DR   Coriell; AG05095
DR   Wikidata; Q54739769
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG05095).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05096
AC   CVCL_2B18
SY   AG05096A; GRC#0243
DR   CLO; CLO_0035174
DR   Coriell; AG05096
DR   Wikidata; Q54739771
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (PubMed=9724752); 29 PDL (Coriell=AG05096).
CC   Karyotypic information: 46,XY [96%]; 46,XY,add(14)(q32) [4%] (Coriell=AG05096).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F55 ! AG13129
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG05097
AC   CVCL_2B19
SY   GRC#0242
DR   CLO; CLO_0035175
DR   Coriell; AG05097
DR   Wikidata; Q54739773
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05098
AC   CVCL_2B20
SY   GRC#0241
DR   CLO; CLO_0035179
DR   Coriell; AG05098
DR   Wikidata; Q54739776
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG05098).
CC   Karyotypic information: 46,XY,del(9)(pter>q22),t(19;19)(19pter->19q13.3::19q13.4->19qter;19pter->19q13.4::19q13.3->19qter) (Coriell=AG05098).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05099
AC   CVCL_2B21
SY   GRC#0188
DR   CLO; CLO_0035180
DR   Coriell; AG05099
DR   Wikidata; Q54739777
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG05099).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C98 ! AG09269
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05100
AC   CVCL_2B22
SY   GRC#0239
DR   CLO; CLO_0035178
DR   Coriell; AG05100
DR   Wikidata; Q54739780
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [8]; 46,XY,t(17;19)(17qter->17p11.1::19q13.3->19qter;19pter->19q13.3::17p11.1->17pter) [42] (Coriell=AG05100).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05101
AC   CVCL_2B23
SY   GRC#0187
DR   CLO; CLO_0035190
DR   Coriell; AG05101
DR   Wikidata; Q54739782
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Asian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG05101).
CC   Karyotypic information: 46,XY [52%]; 46,XY,inv(7)(q22;q32),t(9;17)(q34;q21.3) [32%]; 46,XY,t(9;17)(q34;q21.3) [16%] (Coriell=AG05101).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05102
AC   CVCL_2B24
SY   GRC#0209
DR   CLO; CLO_0035191
DR   Coriell; AG05102
DR   Wikidata; Q54739784
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG05102).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05103
AC   CVCL_2B25
SY   GRC#0186
DR   CLO; CLO_0035192
DR   Coriell; AG05103
DR   Wikidata; Q54739786
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,1qh+ [48]; 46,XY,1qh+,t(3;8)(3pter->3q29::8p12->8pter;8qter->8p12::3q29->3qter) [2] (Coriell=AG05103).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E72 ! AG12599
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05120
AC   CVCL_X865
DR   CLO; CLO_0035193
DR   Coriell; AG05120
DR   Wikidata; Q54739788
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X866 ! AG05121
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG05121
AC   CVCL_X866
DR   CLO; CLO_0035184
DR   Coriell; AG05121
DR   Wikidata; Q54739789
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X865 ! AG05120
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG05139
AC   CVCL_X813
DR   CLO; CLO_0035185
DR   Coriell; AG05139
DR   Wikidata; Q54739790
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X814 ! AG05140
SX   Male
AG   10Y3M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG05140
AC   CVCL_X814
SY   AG05140B
DR   CLO; CLO_0035186
DR   Coriell; AG05140
DR   Wikidata; Q54739793
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X813 ! AG05139
SX   Male
AG   10Y3M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG05186
AC   CVCL_2B26
SY   AG5186; AG05186A; GRC#0203
DR   CLO; CLO_0035187
DR   Coriell; AG05186
DR   Wikidata; Q54739795
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
RX   PubMed=16081512;
RX   PubMed=18368133;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG05186).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E08 ! AG11561
OI   CVCL_2G11 ! AG13369
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   AG05187
AC   CVCL_A2CX
SY   AG05187A; GRC#0214
DR   Coriell; AG05187
DR   Wikidata; Q105506277
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG05187; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG05188
AC   CVCL_2B27
SY   GRC#0222
DR   CLO; CLO_0035188
DR   Coriell; AG05188
DR   Wikidata; Q54739797
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B53 ! AG05805
OI   CVCL_2F28 ! AG13065
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05189
AC   CVCL_2B28
SY   GRC#0223
DR   CLO; CLO_0035189
DR   Coriell; AG05189
DR   Wikidata; Q54739799
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG05189).
CC   Karyotypic information: 46,XY [86%]; 46,XY,2q+ [12%] (Coriell=AG05189).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05190
AC   CVCL_2B29
DR   CLO; CLO_0035163
DR   Coriell; AG05190
DR   Wikidata; Q54739801
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG05190).
CC   Karyotypic information: 46,XY [92%]; 45,X [8%] (Coriell=AG05190).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG05191
AC   CVCL_2B30
SY   GRC#0217
DR   CLO; CLO_0035161
DR   Coriell; AG05191
DR   Wikidata; Q54739803
RX   CelloPub=CLPUB00597;
RX   PubMed=7307581;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG05191).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05192
AC   CVCL_X832
SY   AG 5192; AG05192A; GRC#0218
DR   CLO; CLO_0035162
DR   Coriell; AG05192
DR   Wikidata; Q54739805
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7307581;
RX   PubMed=8643543;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 54 PDL (PubMed=7307581).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X833 ! AG09844
OI   CVCL_X834 ! AG12587
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 13
//
ID   AG05229
AC   CVCL_X835
SY   AG05229B
DR   CLO; CLO_0035159
DR   Coriell; AG05229
DR   GEO; GSM476004
DR   GEO; GSM1184268
DR   GEO; GSM1184269
DR   GEO; GSM1535460
DR   GEO; GSM1535472
DR   Wikidata; Q54739808
RX   CelloPub=CLPUB00597;
RX   PubMed=10615119;
RX   PubMed=16339323;
RX   PubMed=19966276;
RX   PubMed=24749076;
RX   PubMed=26984941;
CC   Population: Japanese.
CC   Karyotypic information: 46,XY/46 [37%]; XY,t(12;12)(q13;q24) [13%]; 46,XY,-4,-21,t(5;8)(q15;q22),+2mar [13%] (Coriell=AG05229).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=26984941).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=26984941).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X836 ! AG12799
OI   CVCL_X837 ! AG12800
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 15
//
ID   AG05230
AC   CVCL_A2DZ
DR   Coriell; AG05230
DR   Wikidata; Q105506280
CC   Population: Japanese.
CC   Discontinued: Coriell; AG05230; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2DY ! AG12796
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG05231
AC   CVCL_U312
DR   Coriell; AG05231
DR   Wikidata; Q54739810
CC   Population: Japanese.
CC   Discontinued: Coriell; AG05231; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U316 ! AG12795
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   AG05233
AC   CVCL_X768
SY   AG5233; AG05233A
DR   CLO; CLO_0035160
DR   Coriell; AG05233
DR   Wikidata; Q54739812
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous; Note=Splice acceptor mutation (from autologous cell line AG12797).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X769 ! AG12797
OI   CVCL_X770 ! AG12798
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 11
//
ID   AG05243
AC   CVCL_0J84
SY   AG5243; AG05243A
DR   CLO; CLO_0035157
DR   Coriell; AG05243
DR   Wikidata; Q54739814
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG05244
AC   CVCL_2B31
SY   GRC#0432
DR   CLO; CLO_0035158
DR   Coriell; AG05244
DR   Wikidata; Q54739817
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,22p+ (Coriell=AG05244).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05245
AC   CVCL_2B32
SY   GRC#0435
DR   CLO; CLO_0035155
DR   Coriell; AG05245
DR   Wikidata; Q54739819
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G23 ! AG13968
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05246
AC   CVCL_2B33
SY   GRC#0444
DR   CLO; CLO_0035156
DR   Coriell; AG05246
DR   Wikidata; Q54739820
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [88]; 46,XX,t(3;10)(3pter->3q25::10q22->10qter->10pter->10q22::3q25->3qter),t(11;19)(11pter->11q13::19q13.3->19qter;19pter->19q13.3::11q13->11qter) [12] (Coriell=AG05246).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05247
AC   CVCL_L605
SY   AG05247D; AG05247E; GRC#0445
DR   CLO; CLO_0035154
DR   Coriell; AG05247
DR   GEO; GSM3124615
DR   Wikidata; Q54739823
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=16081512;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (PubMed=9724752).
CC   Karyotypic information: 46,XX [45]; 46,XX,t(2;6)(2pter->2q23::6q21->6qter;6pter->6q21::2q23->2qter) [3]; 46,XX,t(7;18)(7qter->7p22::18q21->18qter;18pter->18q21::7p22->7pter) [2] (Coriell=AG05247).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L607 ! AG09602
SX   Female
AG   87Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   AG05248
AC   CVCL_2B34
SY   AG05248A; GRC#0520
DR   CLO; CLO_0035172
DR   Coriell; AG05248
DR   GEO; GSM3124617
DR   Wikidata; Q54739825
RX   CelloPub=CLPUB00597;
RX   PubMed=15450399;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A94 ! AG04457
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG05251
AC   CVCL_V973
SY   AG05251A; AG05251B
DR   Coriell; AG05251
DR   Wikidata; Q54739826
RX   CelloPub=CLPUB00597;
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG05251; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   AG05252
AC   CVCL_1G38
DR   Coriell; AG05252
DR   GEO; GSM349680
DR   Wikidata; Q54739828
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG05252; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
OI   CVCL_2V04 ! PR00002
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   AG05253
AC   CVCL_1G37
DR   Coriell; AG05253
DR   Wikidata; Q54739829
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG05253; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG05253-iPS
AC   CVCL_2Z84
SY   AG05253 iPSC-2; Bonobo iPS2
DR   GEO; GSM1153525
DR   GEO; GSM1153526
DR   Wikidata; Q54739934
RX   PubMed=24153179;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
HI   CVCL_1G37 ! AG05253
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG05265
AC   CVCL_2B35
SY   GRC#0438
DR   CLO; CLO_0035173
DR   Coriell; AG05265
DR   Wikidata; Q54739936
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,21s+ [60%]; 46,XX,21s+,t(1;8)(p36 or p35;q23) [40%] (Coriell=AG05265).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05266
AC   CVCL_2B36
SY   AG05266B; GRC#0439
DR   CLO; CLO_0035168
DR   Coriell; AG05266
DR   Wikidata; Q54739938
RX   CelloPub=CLPUB00597;
RX   PubMed=8832629;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG05266).
CC   Karyotypic information: 46,XX,15s+ (Coriell=AG05266).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D78 ! AG11161
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05270
AC   CVCL_2B37
SY   GRC#0448
DR   CLO; CLO_0035169
DR   Coriell; AG05270
DR   Wikidata; Q54739941
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E70 ! AG12597
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05271
AC   CVCL_2B38
SY   AG05271A; GRC#0514
DR   CLO; CLO_0035170
DR   Coriell; AG05271
DR   Wikidata; Q54739943
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [48]; 47,XY,+2,dup(11)(pter->q23::q23->q21::q23->qter) [2] (Coriell=AG05271).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C47 ! AG07801
OI   CVCL_2D74 ! AG11157
OI   CVCL_2G05 ! AG13349
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05274
AC   CVCL_2B39
SY   AG05274B; GRC#0540
DR   CLO; CLO_0035171
DR   Coriell; AG05274
DR   GEO; GSM3124609
DR   Wikidata; Q54739947
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (PubMed=9724752); 52 PDL (Coriell=AG05274).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D43 ! AG10884
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG05275
AC   CVCL_2B40
SY   GRC#0446
DR   CLO; CLO_0035164
DR   Coriell; AG05275
DR   Wikidata; Q54739949
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F91 ! AG13246
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05277
AC   CVCL_2B41
DR   CLO; CLO_0035165
DR   Coriell; AG05277
DR   Wikidata; Q54739952
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG05278
AC   CVCL_2B42
DR   CLO; CLO_0035166
DR   Coriell; AG05278
DR   Wikidata; Q54739954
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG05278).
CC   Karyotypic information: 46,XX [10%]; 45,X [90%] (Coriell=AG05278).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG05283
AC   CVCL_2B43
SY   AG_05283; GRC#0556
DR   CLO; CLO_0035167
DR   Coriell; AG05283
DR   GEO; GSM6364
DR   Wikidata; Q54739956
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 49 PDL (Coriell=AG05283).
CC   Doubling time: 1.7 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B13 ! AG04659
OI   CVCL_2D83 ! AG11243
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG05307
AC   CVCL_A2PA
DR   Coriell; AG05307
DR   Wikidata; Q105506283
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG05307; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=88029; ! Semnopithecus entellus (Northern plains gray langur)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG05308
AC   CVCL_2I26
DR   CLO; CLO_0035216
DR   Coriell; AG05308
DR   Wikidata; Q54739960
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=78454; ! Saguinus labiatus (Red-chested mustached tamarin)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG05311
AC   CVCL_2I27
DR   CLO; CLO_0035215
DR   Coriell; AG05311
DR   Wikidata; Q54739961
RX   CelloPub=CLPUB00597;
RX   PubMed=21489251;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9521; ! Saimiri sciureus (Common squirrel monkey)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG05313
AC   CVCL_2I28
DR   CLO; CLO_0035214
DR   Coriell; AG05313
DR   Wikidata; Q54739965
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9487; ! Leontocebus fuscicollis (Brown-mantled tamarin)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG05322
AC   CVCL_0U83
DR   Coriell; AG05322
DR   Wikidata; Q54739967
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   AG05324
AC   CVCL_0U84
DR   Coriell; AG05324
DR   Wikidata; Q54739970
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U85 ! AG05325
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   AG05325
AC   CVCL_0U85
DR   Coriell; AG05325
DR   Wikidata; Q54739971
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG05325; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U84 ! AG05324
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG05326
AC   CVCL_0U86
DR   Coriell; AG05326
DR   Wikidata; Q54739976
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U87 ! AG05327
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   AG05327
AC   CVCL_0U87
DR   Coriell; AG05327
DR   Wikidata; Q54739977
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U86 ! AG05326
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG05352
AC   CVCL_UD19
DR   Coriell; AG05352
DR   Wikidata; Q93315092
RX   CelloPub=CLPUB00597;
RX   PubMed=21489251;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG05352; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9509; ! Ateles geoffroyi (Black-handed spider monkey)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   AG05356
AC   CVCL_2I29
DR   CLO; CLO_0035218
DR   Coriell; AG05356
DR   Wikidata; Q54739979
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9519; ! Lagothrix lagotricha (Brown woolly monkey)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG05357
AC   CVCL_A2NX
DR   Coriell; AG05357
DR   Wikidata; Q105506286
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG05357; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=47178; ! Eulemur fulvus collaris (Collared brown lemur)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG05397
AC   CVCL_L780
SY   AG5397
DR   CLO; CLO_0035217
DR   Coriell; AG05397
DR   Wikidata; Q54739981
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
RX   PubMed=18691744;
RX   PubMed=23716668;
RX   PubMed=24119401;
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 17
//
ID   AG05410
AC   CVCL_2B44
SY   GRC#0304
DR   CLO; CLO_0035223
DR   Coriell; AG05410
DR   Wikidata; Q54739984
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [47]; 46,XY,t(1;3)(1qter->1p32::3p21->3pter;3qter->3p21::1p32->1pter) [3] (Coriell=AG05410).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C44 ! AG07723
OI   CVCL_2F65 ! AG13198
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05411
AC   CVCL_2B45
SY   AG05411A; GRC#0305
DR   CLO; CLO_0035222
DR   Coriell; AG05411
DR   Wikidata; Q54739988
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG05411).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F92 ! AG13285
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05412
AC   CVCL_2F95
SY   AG05412A; GRC#0306
DR   Coriell; AG05412
DR   Wikidata; Q54739989
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG05412; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F96 ! AG13299
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05413
AC   CVCL_2B46
SY   GRC#0294
DR   CLO; CLO_0035221
DR   Coriell; AG05413
DR   GEO; GSM3124603
DR   Wikidata; Q54739990
RX   CelloPub=CLPUB00597;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG05413).
CC   Karyotypic information: 46,XY [94%]; 45,X,t(9;16)(9pter->9q34::16p11.2->16pter;16qter->16p11.2::9q34->9qter) [6%] (Coriell=AG05413).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG05414
AC   CVCL_2B47
SY   AG_05414; GRC#0298
DR   CLO; CLO_0035230
DR   Coriell; AG05414
DR   GEO; GSM6349
DR   GEO; GSM6387
DR   Wikidata; Q54739991
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: 2.3 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A92 ! AG04455
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG05415
AC   CVCL_2B48
SY   AG05415A; GRC#0288
DR   CLO; CLO_0035229
DR   Coriell; AG05415
DR   Wikidata; Q54739996
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG05415; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G06 ! AG13353
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG05416
AC   CVCL_2B49
SY   GRC#0293
DR   CLO; CLO_0035232
DR   Coriell; AG05416
DR   GEO; GSM426257
DR   Wikidata; Q54739997
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D95 ! AG11364
OI   CVCL_2F57 ! AG13145
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG05417
AC   CVCL_2B50
SY   GRC#0279
DR   CLO; CLO_0035231
DR   Coriell; AG05417
DR   Wikidata; Q54740002
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [96%]; 45,XY,-22 [4%] (Coriell=AG05417).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E45 ! AG11746
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05419
AC   CVCL_2B51
SY   GRC#0292
DR   CLO; CLO_0035234
DR   Coriell; AG05419
DR   Wikidata; Q54740003
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG05419).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05749
AC   CVCL_X851
SY   AG05749A
DR   CLO; CLO_0035233
DR   Coriell; AG05749
DR   Wikidata; Q54740004
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG05770
AC   CVCL_0J85
SY   AG05770D
DR   CLO; CLO_0035236
DR   Coriell; AG05770
DR   Wikidata; Q54740008
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Population: Caucasian.
CC   Derived from site: In situ; Calf, skin; UBERON=UBERON_8480050.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG05804
AC   CVCL_2B52
SY   AG05804B; GRC#0621
DR   CLO; CLO_0035235
DR   Coriell; AG05804
DR   Wikidata; Q54740009
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A66 ! AG04353
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05805
AC   CVCL_2B53
SY   AG05805B; GRC#0625
DR   CLO; CLO_0035238
DR   Coriell; AG05805
DR   Wikidata; Q54740014
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG05805).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B27 ! AG05188
OI   CVCL_2F28 ! AG13065
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05806
AC   CVCL_2B54
SY   AG05806B; GRC#0506
DR   CLO; CLO_0035237
DR   Coriell; AG05806
DR   Wikidata; Q54740016
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 51 PDL (Coriell=AG05806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05807
AC   CVCL_2B55
SY   AG05807A; GRC#0630
DR   CLO; CLO_0035194
DR   Coriell; AG05807
DR   Wikidata; Q54740019
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [94%]; 45,X [6%] (Coriell=AG05807).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05809
AC   CVCL_0J86
SY   AG 5809; AG05809A; AG05809B
DR   CLO; CLO_0035202
DR   Coriell; AG05809
DR   Wikidata; Q54740020
RX   CelloPub=CLPUB00597;
RX   PubMed=1590792;
RX   PubMed=7847674;
RX   PubMed=10408806;
CC   Population: Jewish.
CC   Karyotypic information: 46,XX [56%]; 47,XX,+21 [44%] (Coriell=AG05809).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG05810
AC   CVCL_0J87
SY   AG 5810; AG05810C; AG05810D
DR   CLO; CLO_0035201
DR   Coriell; AG05810
DR   Wikidata; Q54740023
RX   CelloPub=CLPUB00597;
RX   PubMed=1590792;
RX   PubMed=10408806;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (Coriell=AG05810).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   AG05811
AC   CVCL_2B56
SY   AG05811B; GRC#0605
DR   CLO; CLO_0035200
DR   Coriell; AG05811
DR   Wikidata; Q54740027
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 53 PDL (Coriell=AG05811).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05813
AC   CVCL_2B57
SY   AG05813B; GRC#0496
DR   CLO; CLO_0035199
DR   Coriell; AG05813
DR   Wikidata; Q54740029
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,9qh+ (Coriell=AG05813).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05836
AC   CVCL_2B58
SY   AG05836B; GRC#0522
DR   CLO; CLO_0035198
DR   Coriell; AG05836
DR   Wikidata; Q54740031
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG05836).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG05837
AC   CVCL_2B59
SY   AG05837B; GRC#0571
DR   CLO; CLO_0035197
DR   Coriell; AG05837
DR   Wikidata; Q54740127
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG05837).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D87 ! AG11248
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05838
AC   CVCL_2B60
SY   AG_05838; AG05838B; GRC#0575
DR   CLO; CLO_0035196
DR   Coriell; AG05838
DR   GEO; GSM6350
DR   Wikidata; Q54740129
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 54 PDL (Coriell=AG05838).
CC   Doubling time: 2.5 days (PubMed=12840040).
CC   Karyotypic information: 46,XX,22p+ (Coriell=AG05838).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E44 ! AG11745
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG05839
AC   CVCL_2B61
SY   AG05839A; GRC#0530
DR   CLO; CLO_0035195
DR   Coriell; AG05839
DR   Wikidata; Q54740130
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG05839).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05840
AC   CVCL_2B62
SY   AG05840A; GRC#0537
DR   CLO; CLO_0035203
DR   Coriell; AG05840
DR   Wikidata; Q54740131
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG05844
AC   CVCL_2B63
SY   AG_05844; AG05844A; GRC#0584
DR   CLO; CLO_0035204
DR   Coriell; AG05844
DR   GEO; GSM6351
DR   Wikidata; Q54740134
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: 2.1 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D93 ! AG11362
OI   CVCL_2F56 ! AG13144
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG06009
AC   CVCL_2B64
SY   AG06009A; GRC#0505
DR   CLO; CLO_0035213
DR   Coriell; AG06009
DR   Wikidata; Q54740136
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG06009).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06010
AC   CVCL_2B65
SY   AG06010C; GRC#0541
DR   CLO; CLO_0035212
DR   Coriell; AG06010
DR   Wikidata; Q54740138
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06040
AC   CVCL_F288
DR   CLO; CLO_0035207
DR   Coriell; AG06040
DR   Wikidata; Q54740140
RX   CelloPub=CLPUB00597;
RX   PubMed=908169;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (Coriell=AG06040).
CC   Donor information: From Bloom Syndrome Registry patient 42(RaFr) (BSR42).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   AG06062
AC   CVCL_2Y85
DR   CLO; CLO_0035206
DR   Coriell; AG06062
DR   Wikidata; Q54740141
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG06063
AC   CVCL_6G83
DR   CLO; CLO_0035209
DR   Coriell; AG06063
DR   Wikidata; Q54740143
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG06064
AC   CVCL_6G84
DR   CLO; CLO_0035208
DR   Coriell; AG06064
DR   Wikidata; Q54740147
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG06083
AC   CVCL_6G85
DR   CLO; CLO_0035287
DR   Coriell; AG06083
DR   GEO; GSM2064580
DR   GEO; GSM2064582
DR   GEO; GSM2064583
DR   GEO; GSM2064584
DR   Wikidata; Q54740148
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   AG06084
AC   CVCL_6G86
SY   AG06084A
DR   CLO; CLO_0035286
DR   Coriell; AG06084
DR   Wikidata; Q54740149
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG06085
AC   CVCL_6G87
DR   CLO; CLO_0035289
DR   Coriell; AG06085
DR   Wikidata; Q54740152
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG06086
AC   CVCL_6G88
DR   CLO; CLO_0035288
DR   Coriell; AG06086
DR   Wikidata; Q54740153
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG06103
AC   CVCL_0J88
SY   AG 6103
DR   CLO; CLO_0035285
DR   Coriell; AG06103
DR   Wikidata; Q54740155
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06105
AC   CVCL_EF56
DR   Coriell; AG06105
DR   GEO; GSM349698
DR   Wikidata; Q54740157
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG06105; probable.
CC   Derived from site: In situ; Thoracolumbar junction, skin; UBERON=UBERON_8480052.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   AG06115
AC   CVCL_2I30
DR   CLO; CLO_0035282
DR   Coriell; AG06115
DR   Wikidata; Q54740159
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9523; ! Plecturocebus moloch (Dusky titi monkey)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06116
AC   CVCL_2I31
DR   CLO; CLO_0035247
DR   Coriell; AG06116
DR   Wikidata; Q54740161
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9538; ! Erythrocebus patas (Red guenon)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG06204
AC   CVCL_0U88
DR   CLO; CLO_0035261
DR   Coriell; AG06204
DR   Wikidata; Q54740162
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U89 ! AG06205
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   AG06205
AC   CVCL_0U89
SY   AG 6205; AG 06205; AG06205C; AG 6205C; AG06205D
DR   CLO; CLO_0035259
DR   Coriell; AG06205
DR   Wikidata; Q54740163
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U88 ! AG06204
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG06209
AC   CVCL_2I39
DR   Coriell; AG06209
DR   Wikidata; Q54740165
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG06209; probable.
CC   Derived from site: In situ; Thoracolumbar junction, skin; UBERON=UBERON_8480052.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   27Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG06211
AC   CVCL_A2PB
DR   Coriell; AG06211
DR   Wikidata; Q105506290
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG06211; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9612; ! Canis lupus (Gray wolf)
SX   Female
AG   11Y7M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG06234
AC   CVCL_2B66
SY   AG 6234; AG06234B; AG06234C; GRC#0440
DR   CLO; CLO_0035258
DR   Coriell; AG06234
DR   Wikidata; Q54740168
RX   CelloPub=CLPUB00597;
RX   PubMed=3745952;
RX   PubMed=9724752;
RX   PubMed=15450399;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22-26 PDL (PubMed=9724752).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F62 ! AG13153
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG06235
AC   CVCL_2B67
SY   AG_06235; GRC#0441
DR   CLO; CLO_0035257
DR   Coriell; AG06235
DR   GEO; GSM6352
DR   GEO; GSM6388
DR   Wikidata; Q54740169
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: 1.7 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F60 ! AG13151
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG06236
AC   CVCL_2B68
SY   GRC#0453
DR   CLO; CLO_0035256
DR   Coriell; AG06236
DR   Wikidata; Q54740172
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG06236).
CC   Karyotypic information: 46,XY [96%]; 46,XY,t(9;9)(9pter->9q13::9q34->9qter;9pter->9q34::9q13->9qter) [4%] (Coriell=AG06236).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D56 ! AG11014
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06237
AC   CVCL_2B69
SY   GRC#0461
DR   CLO; CLO_0035254
DR   Coriell; AG06237
DR   GEO; GSM426263
DR   Wikidata; Q54740173
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG06237).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG06239
AC   CVCL_2B70
SY   GRC#0477
DR   CLO; CLO_0035253
DR   Coriell; AG06239
DR   Wikidata; Q54740176
RX   CelloPub=CLPUB00597;
RX   PubMed=12060391;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG06239).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG06240
AC   CVCL_2B71
SY   AG 6240; GRC#0485
DR   CLO; CLO_0035252
DR   Coriell; AG06240
DR   Wikidata; Q54740180
RX   CelloPub=CLPUB00597;
RX   PubMed=1590792;
RX   PubMed=3745952;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 52 PDL (Coriell=AG06240).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06241
AC   CVCL_H790
SY   AG6241; AG06241A; GRC#0486
DR   CLO; CLO_0035250
DR   Coriell; AG06241
DR   Wikidata; Q54740181
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
RX   PubMed=8832629;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG06242
AC   CVCL_2B72
SY   GRC#0500
DR   CLO; CLO_0035336
DR   Coriell; AG06242
DR   Wikidata; Q54740184
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG06242).
CC   Karyotypic information: 46,XY [94%]; 46,XY,t(2;15)(2pter->2q33::15p11.1->15pter;15qter->15p11.1::2q33->2qter) [6%] (Coriell=AG06242).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E14 ! AG11648
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06243
AC   CVCL_2B73
SY   GRC#0502
DR   CLO; CLO_0035362
DR   Coriell; AG06243
DR   Wikidata; Q54740186
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG06243).
CC   Karyotypic information: 46,XY [38%]; 45,X [6%]; 46,XY,t(2;19)(q23;p13.1) [48%]; 46,XY,t(1;17)(q32;p11.2),t(2;13)(q31;p11.2),9q+,10q-,18q-,18q- [6%] (Coriell=AG06243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06244
AC   CVCL_0J89
DR   CLO; CLO_0035359
DR   Coriell; AG06244
DR   Wikidata; Q54740189
RX   CelloPub=CLPUB00597;
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG06249
AC   CVCL_2I32
DR   CLO; CLO_0035338
DR   Coriell; AG06249
DR   Wikidata; Q54740191
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG06252
AC   CVCL_2I33
DR   CLO; CLO_0035337
DR   Coriell; AG06252
DR   Wikidata; Q54740193
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG06253
AC   CVCL_2I34
DR   CLO; CLO_0035340
DR   Coriell; AG06253
DR   Wikidata; Q54740195
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG06254
AC   CVCL_2I35
DR   CLO; CLO_0035339
DR   Coriell; AG06254
DR   Wikidata; Q54740196
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9538; ! Erythrocebus patas (Red guenon)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG06262
AC   CVCL_X838
SY   AG06262A
DR   CLO; CLO_0035342
DR   Coriell; AG06262
DR   Wikidata; Q54740200
RX   CelloPub=CLPUB00597;
RX   PubMed=8832629;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG06263
AC   CVCL_X839
SY   AG06263A
DR   CLO; CLO_0035341
DR   Coriell; AG06263
DR   Wikidata; Q54740202
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG06264
AC   CVCL_H779
SY   AG6264; AG06264C
DR   CLO; CLO_0035345
DR   Coriell; AG06264
DR   Wikidata; Q54740203
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   AG06265
AC   CVCL_H780
SY   AG6265; AG06265A
DR   CLO; CLO_0035343
DR   Coriell; AG06265
DR   Wikidata; Q54740205
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   AG06266
AC   CVCL_F253
DR   CLO; CLO_0035328
DR   Coriell; AG06266
DR   Wikidata; Q54740248
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Karyotypic information: 69,XXY (Coriell=AG06266).
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   AG06269
AC   CVCL_0J90
DR   CLO; CLO_0035325
DR   Coriell; AG06269
DR   Wikidata; Q54740250
RX   CelloPub=CLPUB00597;
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y9M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG06276
AC   CVCL_2B74
DR   CLO; CLO_0035323
DR   Coriell; AG06276
DR   GEO; GSM3124606
DR   Wikidata; Q54740253
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 13 PDL (Coriell=AG06276).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG06277
AC   CVCL_2B75
SY   GRC#0507
DR   CLO; CLO_0035310
DR   Coriell; AG06277
DR   Wikidata; Q54740255
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG06277).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06278
AC   CVCL_X752
SY   AG 6278; GRC#0508
DR   CLO; CLO_0035309
DR   Coriell; AG06278
DR   Wikidata; Q54740258
RX   CelloPub=CLPUB00597;
RX   PubMed=16126733;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 12
//
ID   AG06279
AC   CVCL_2B76
SY   AG06279A; GRC#0510
DR   CLO; CLO_0035308
DR   Coriell; AG06279
DR   Wikidata; Q54740259
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 52 PDL (Coriell=AG06279).
CC   Karyotypic information: 46,XY [82%]; 45,X [18%] (Coriell=AG06279).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06280
AC   CVCL_2B77
SY   GRC#0513
DR   CLO; CLO_0035307
DR   Coriell; AG06280
DR   Wikidata; Q54740261
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [66%]; 46,XY,t(3;17)(p23;p13),t(12;17)(q?;q?) [34%] (Coriell=AG06280).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06281
AC   CVCL_2B78
DR   CLO; CLO_0035314
DR   Coriell; AG06281
DR   Wikidata; Q54740263
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG06281).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG06282
AC   CVCL_2B79
SY   GRC#0517
DR   CLO; CLO_0035313
DR   Coriell; AG06282
DR   Wikidata; Q54740265
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG06282).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F93 ! AG13292
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06283
AC   CVCL_2B80
SY   AG06283A; GRC#0519
DR   CLO; CLO_0035311
DR   Coriell; AG06283
DR   Wikidata; Q54740267
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG06283).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06284
AC   CVCL_2B81
SY   AG 6284; GRC#0521
DR   CLO; CLO_0035501
DR   Coriell; AG06284
DR   Wikidata; Q54740270
RX   CelloPub=CLPUB00597;
RX   PubMed=3745952;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG06284).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F98 ! AG13308
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06285
AC   CVCL_2B82
SY   AG06285A; GRC#0531
DR   CLO; CLO_0035502
DR   Coriell; AG06285
DR   Wikidata; Q54740271
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26-29 PDL (PubMed=9724752); 51 PDL (Coriell=AG06285).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG06287
AC   CVCL_2B83
SY   GRC#0535
DR   CLO; CLO_0035499
DR   Coriell; AG06287
DR   Wikidata; Q54740275
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F27 ! AG13018
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06288
AC   CVCL_2B84
SY   AG06288A; GRC#0538
DR   CLO; CLO_0035500
DR   Coriell; AG06288
DR   Wikidata; Q54740277
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 48 PDL (Coriell=AG06288).
CC   Karyotypic information: 46,XY [92%]; 45,X [8%] (Coriell=AG06288).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D51 ! AG10944
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06289
AC   CVCL_2B85
SY   GRC#0539
DR   CLO; CLO_0035505
DR   Coriell; AG06289
DR   Wikidata; Q54740279
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06290
AC   CVCL_2B86
SY   AG 6290; GRC#0542
DR   CLO; CLO_0035506
DR   Coriell; AG06290
DR   Wikidata; Q54740280
RX   CelloPub=CLPUB00597;
RX   PubMed=1590792;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 51 PDL (Coriell=AG06290).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06291
AC   CVCL_2B87
SY   AG 6291; AG06291A; AG06291C; GRC#0544
DR   CLO; CLO_0035503
DR   Coriell; AG06291
DR   GEO; GSM3124673
DR   Wikidata; Q54740282
RX   CelloPub=CLPUB00597;
RX   PubMed=3745952;
RX   PubMed=9724752;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 19 PDL (PubMed=9724752).
CC   Karyotypic information: 46,XY [96%]; 46,XY,del(5)(q14) [4%] (Coriell=AG06291).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG06292
AC   CVCL_2B88
SY   GRC#0546
DR   CLO; CLO_0035504
DR   Coriell; AG06292
DR   Wikidata; Q54740284
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (Coriell=AG06292).
CC   Karyotypic information: 46,XY [70%]; 46,XY,t(14;19)(q11.2;q13.3) [18%]; 46,XY,t(5;6;8)(q13;p21;q22),t(10;14)(q22;q22) [10%] (Coriell=AG06292).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06294
AC   CVCL_2B89
SY   GRC#0548
DR   CLO; CLO_0035507
DR   Coriell; AG06294
DR   Wikidata; Q54740287
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 49 PDL (Coriell=AG06294).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D12 ! AG09697
OI   CVCL_2F34 ! AG13084
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06295
AC   CVCL_2B90
SY   GRC#0550
DR   CLO; CLO_0035508
DR   Coriell; AG06295
DR   Wikidata; Q54740288
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [41]; 46,XY,inv(4)(pter->p14::q12->p14::q12->qter) [9] (Coriell=AG06295).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D55 ! AG11013
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06296
AC   CVCL_2B91
SY   GRC#0551
DR   CLO; CLO_0035509
DR   Coriell; AG06296
DR   Wikidata; Q54740293
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [44]; 46,XY,t(2;12)(2pter->2q14::12q23->12qter;12pter->12q23::2q14->2qter) [6] (Coriell=AG06296).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D96 ! AG11365
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06297
AC   CVCL_H765
SY   AG06297A; AG06297B; AG06297C
DR   CLO; CLO_0035510
DR   Coriell; AG06297
DR   Wikidata; Q54740296
RX   CelloPub=CLPUB00597;
RX   PubMed=10741968;
RX   PubMed=12714972;
RX   PubMed=15130666;
RX   PubMed=16126733;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; Coriell=AG06297).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y2M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   AG06298
AC   CVCL_2A29
DR   Coriell; AG06298
DR   Wikidata; Q54740299
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
CC   Discontinued: Coriell; AG06298; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y11M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG06299
AC   CVCL_L606
DR   CLO; CLO_0035511
DR   Coriell; AG06299
DR   Wikidata; Q54740301
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y11M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AG06300
AC   CVCL_0J91
SY   AG06300A
DR   CLO; CLO_0035512
DR   Coriell; AG06300
DR   GEO; GSM1184270
DR   GEO; GSM1184271
DR   GEO; GSM1535459
DR   GEO; GSM1535469
DR   Wikidata; Q54740303
RX   CelloPub=CLPUB00597;
RX   PubMed=24749076;
RX   PubMed=26984941;
CC   Population: Caucasian.
CC   Senescence: Senesces at 35-40 PDL (Coriell=AG06300).
CC   Karyotypic information: 47,XY,t(7;11)(11qter->11q23::7p22->7qter;11pter->11q23::7p22->7pter) [88%]; 46,XY[20].arr(1-22)x2,(X,Y)x1 [12%] (Coriell=AG06300).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Caution: Is stated not be from a Werner syndrome patient by PubMed=26984941.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   AG06302
AC   CVCL_2B92
SY   GRC#0554
DR   CLO; CLO_0035513
DR   Coriell; AG06302
DR   Wikidata; Q54740306
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG06302).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06303
AC   CVCL_A2CY
SY   AG06303B; GRC#0555
DR   Coriell; AG06303
DR   Wikidata; Q105506295
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [18%]; 46,XY,t(8;13) [82%] (Coriell=AG06303).
CC   Discontinued: Coriell; AG06303; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG06304
AC   CVCL_2B93
SY   AG06304A; GRC#0557
DR   CLO; CLO_0035514
DR   Coriell; AG06304
DR   Wikidata; Q54740308
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG06304).
CC   Doubling time: Slow growth (Coriell=AG06304).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06305
AC   CVCL_2B94
SY   GRC#0559
DR   CLO; CLO_0035515
DR   Coriell; AG06305
DR   Wikidata; Q54740312
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG06305).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F90 ! AG13245
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06306
AC   CVCL_2B95
SY   GRC#0560
DR   CLO; CLO_0035516
DR   Coriell; AG06306
DR   Wikidata; Q54740314
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG06306).
CC   Karyotypic information: 46,XY [36%]; 46,XY,t(1;9) [64%] (Coriell=AG06306).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 12
//
ID   AG06307
AC   CVCL_2B96
SY   GRC#0561
DR   CLO; CLO_0035517
DR   Coriell; AG06307
DR   Wikidata; Q54740315
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG06307).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D48 ! AG10941
OI   CVCL_2F30 ! AG13067
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06308
AC   CVCL_2B97
SY   AG06308A; GRC#0564
DR   CLO; CLO_0035518
DR   Coriell; AG06308
DR   GEO; GSM3124674
DR   Wikidata; Q54740316
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG06308).
CC   Karyotypic information: 46,XY [64%]; 46,XY,t(13;15)(q14;q12) [36%] (Coriell=AG06308).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C46 ! AG07725
SX   Male
AG   89Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG06310
AC   CVCL_2B98
SY   AG06310A; GRC#0568
DR   CLO; CLO_0035523
DR   Coriell; AG06310
DR   GEO; GSM476001
DR   Wikidata; Q54740318
RX   CelloPub=CLPUB00597;
RX   PubMed=19966276;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG06310).
CC   Karyotypic information: 46,XY,9qh+ (Coriell=AG06310).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG06311
AC   CVCL_A2DX
DR   Coriell; AG06311
DR   Wikidata; Q105506297
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG06311; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG0650
AC   CVCL_8B68
DR   ECACC; 92032522
DR   Wikidata; Q54740319
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92032522; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101029; Atrioventricular septal defect
DI   ORDO; Orphanet_98722; Atrioventricular canal defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG0654
AC   CVCL_JM24
DR   ECACC; 92050711
DR   Wikidata; Q54740321
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92050711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   AG0655
AC   CVCL_8B69
DR   ECACC; 92050712
DR   Wikidata; Q54740325
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92050712; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG06555
AC   CVCL_0N55
SY   AG06555A
DR   CLO; CLO_0035524
DR   Coriell; AG06555
DR   Wikidata; Q54740326
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Senescence: Senesces at 30-31 PDL (PubMed=9724752).
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N56 ! AG06556
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG06556
AC   CVCL_0N56
DR   CLO; CLO_0035521
DR   Coriell; AG06556
DR   Wikidata; Q54740328
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N55 ! AG06555
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06557
AC   CVCL_0N57
DR   CLO; CLO_0035522
DR   Coriell; AG06557
DR   Wikidata; Q54740330
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N58 ! AG06558
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06558
AC   CVCL_0N58
DR   CLO; CLO_0035519
DR   Coriell; AG06558
DR   Wikidata; Q54740333
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N57 ! AG06557
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06559
AC   CVCL_0N59
DR   CLO; CLO_0035520
DR   Coriell; AG06559
DR   Wikidata; Q54740335
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Population: African American.
CC   Senescence: Senesces at 30-31 PDL (PubMed=9724752).
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N60 ! AG06560
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG0656
AC   CVCL_GR82
SY   AG656
DR   ECACC; 04101820
DR   TOKU-E; 4015
DR   Wikidata; Q54740393
RX   PubMed=14630800;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 04101820; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129027; Fanconi anemia, complementation group J
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   AG06560
AC   CVCL_0N60
DR   CLO; CLO_0035527
DR   Coriell; AG06560
DR   Wikidata; Q54740394
RX   CelloPub=CLPUB00597;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N59 ! AG06559
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06561
AC   CVCL_0N61
DR   CLO; CLO_0035528
DR   Coriell; AG06561
DR   Wikidata; Q54740396
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N62 ! AG06562
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06562
AC   CVCL_0N62
DR   CLO; CLO_0035525
DR   Coriell; AG06562
DR   Wikidata; Q54740398
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N61 ! AG06561
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06692
AC   CVCL_WY36
SY   AG6692
DR   Coriell; AG06692
DR   Wikidata; Q93315464
RX   PubMed=24119401;
CC   Discontinued: Coriell; AG06692; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AG06838
AC   CVCL_H791
SY   AG06838A
DR   CLO; CLO_0035535
DR   Coriell; AG06838
DR   Wikidata; Q54740401
RX   CelloPub=CLPUB00597;
RX   PubMed=8832629;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H792 ! AG06839
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   AG06839
AC   CVCL_H792
DR   CLO; CLO_0035529
DR   Coriell; AG06839
DR   Wikidata; Q54740402
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H791 ! AG06838
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   AG06840
AC   CVCL_H793
SY   AG 6840A; AG06840A; AG06840B
DR   CLO; CLO_0035530
DR   Coriell; AG06840
DR   Wikidata; Q54740403
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7847674;
RX   PubMed=8643543;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=10408806; Coriell=AG06840).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H794 ! AG06841
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   AG06841
AC   CVCL_H794
SY   AG06841A
DR   CLO; CLO_0035531
DR   Coriell; AG06841
DR   Wikidata; Q54740404
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (Coriell=AG06841).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H793 ! AG06840
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   AG06842
AC   CVCL_H777
SY   AG6842; AG06842A
DR   CLO; CLO_0035532
DR   Coriell; AG06842
DR   Wikidata; Q54740408
RX   CelloPub=CLPUB00597;
RX   PubMed=8832629;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H778 ! AG06843
SX   Male
AG   75Y3M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   AG06843
AC   CVCL_H778
DR   CLO; CLO_0035536
DR   Coriell; AG06843
DR   Wikidata; Q54740409
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H777 ! AG06842
SX   Male
AG   75Y3M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   AG06844
AC   CVCL_F257
SY   AG 6844B; AG06844C; AG 6844C; AG06844D
DR   CLO; CLO_0035537
DR   Coriell; AG06844
DR   Wikidata; Q54740411
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7847674;
RX   PubMed=8247227;
RX   PubMed=8643543;
RX   PubMed=8832629;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F258 ! AG07647
SX   Male
AG   59Y1M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   AG06846
AC   CVCL_H799
SY   AG6846; AG06846A
DR   CLO; CLO_0035538
DR   Coriell; AG06846
DR   Wikidata; Q54740412
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H800 ! AG06847
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   AG06847
AC   CVCL_H800
SY   AG06847A
DR   CLO; CLO_0035465
DR   Coriell; AG06847
DR   Wikidata; Q54740414
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H799 ! AG06846
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG06848
AC   CVCL_D534
SY   AG6848; AG06848A; AG 6848A; AG06848B; AG 6848B; AG06848C
DR   CLO; CLO_0035464
DR   ChEMBL-Cells; CHEMBL3308626
DR   ChEMBL-Targets; CHEMBL614700
DR   Coriell; AG06848
DR   PubChem_Cell_line; CVCL_D534
DR   Wikidata; Q54740417
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7847674;
RX   PubMed=8247227;
RX   PubMed=8643543;
RX   PubMed=8832629;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Heterozygous (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F229 ! AG06849
SX   Female
AG   55Y6M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   AG06849
AC   CVCL_F229
SY   AG06849B
DR   CLO; CLO_0035463
DR   Coriell; AG06849
DR   Wikidata; Q54740418
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Heterozygous (from autologous cell line AG06848).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D534 ! AG06848
SX   Female
AG   55Y6M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   AG06858
AC   CVCL_0N63
DR   CLO; CLO_0035462
DR   Coriell; AG06858
DR   Wikidata; Q54740423
RX   CelloPub=CLPUB00597;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG06868
AC   CVCL_0J92
SY   AG06868A
DR   CLO; CLO_0035469
DR   Coriell; AG06868
DR   Wikidata; Q54740424
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line AG06869).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J93 ! AG06869
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   AG06869
AC   CVCL_0J93
SY   AG 6869
DR   CLO; CLO_0035468
DR   Coriell; AG06869
DR   Wikidata; Q54740425
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=30699343).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J92 ! AG06868
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   AG06872
AC   CVCL_X867
DR   CLO; CLO_0035467
DR   Coriell; AG06872
DR   Wikidata; Q54740429
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG06877
AC   CVCL_2B99
SY   GRC#0569
DR   CLO; CLO_0035466
DR   Coriell; AG06877
DR   Wikidata; Q54740430
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG06877).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06878
AC   CVCL_2C00
SY   GRC#0572
DR   CLO; CLO_0035461
DR   Coriell; AG06878
DR   Wikidata; Q54740433
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 53 PDL (Coriell=AG06878).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06879
AC   CVCL_2C01
SY   AG06879A; GRC#0577
DR   CLO; CLO_0035460
DR   Coriell; AG06879
DR   Wikidata; Q54740435
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG06879).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E66 ! AG12443
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06880
AC   CVCL_2C02
SY   GRC#0578
DR   CLO; CLO_0035479
DR   Coriell; AG06880
DR   Wikidata; Q54740437
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG06880).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06881
AC   CVCL_0F99
SY   GRC#0581
DR   CLO; CLO_0035472
DR   Coriell; AG06881
DR   Wikidata; Q54740439
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG06881).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G00 ! AG11247
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   AG06882
AC   CVCL_2C03
SY   GRC#0589
DR   CLO; CLO_0035471
DR   Coriell; AG06882
DR   Wikidata; Q54740441
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG06882).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06883
AC   CVCL_2C04
SY   GRC#0596
DR   CLO; CLO_0035474
DR   Coriell; AG06883
DR   Wikidata; Q54740444
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 51 PDL (Coriell=AG06883).
CC   Karyotypic information: 46,XY [80%]; 46,XY,t(9;21)(q34;q21) [20%] (Coriell=AG06883).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06885
AC   CVCL_2C05
SY   AG06885A; GRC#0598
DR   CLO; CLO_0035473
DR   Coriell; AG06885
DR   Wikidata; Q54740446
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG06885).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06886
AC   CVCL_2C06
SY   GRC#0602
DR   CLO; CLO_0035476
DR   Coriell; AG06886
DR   Wikidata; Q54740448
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG06886).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06917
AC   CVCL_L613
SY   AG 6917; AG06917A
DR   CLO; CLO_0035475
DR   Coriell; AG06917
DR   Wikidata; Q54740451
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; Coriell=AG06917).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   AG06922
AC   CVCL_X793
SY   AG06922A
DR   CLO; CLO_0035478
DR   Coriell; AG06922
DR   Wikidata; Q54740453
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG06939
AC   CVCL_V975
SY   AG06939A
DR   Coriell; AG06939
DR   Wikidata; Q54740457
RX   CelloPub=CLPUB00597;
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG06939; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AG06952
AC   CVCL_2C07
SY   AG_06952; GRC#0606
DR   CLO; CLO_0035470
DR   Coriell; AG06952
DR   GEO; GSM6353
DR   Wikidata; Q54740458
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (PubMed=9724752).
CC   Doubling time: 2.4 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D61 ! AG11020
OI   CVCL_2F33 ! AG13077
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   AG06953
AC   CVCL_2C08
SY   GRC#0607
DR   CLO; CLO_0035669
DR   Coriell; AG06953
DR   Wikidata; Q54740462
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG06953).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06956
AC   CVCL_2C09
SY   GRC#0612
DR   CLO; CLO_0035670
DR   Coriell; AG06956
DR   Wikidata; Q54740464
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 50 PDL (Coriell=AG06956).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06957
AC   CVCL_2C10
SY   GRC#0619
DR   CLO; CLO_0035672
DR   Coriell; AG06957
DR   Wikidata; Q54740466
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 50 PDL (Coriell=AG06957).
CC   Karyotypic information: 46,XY [94%]; 45,X [6%] (Coriell=AG06957).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F58 ! AG13146
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06959
AC   CVCL_2C11
DR   CLO; CLO_0035674
DR   Coriell; AG06959
DR   Wikidata; Q54740467
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG06959).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F99 ! AG13329
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG06961
AC   CVCL_6G89
DR   CLO; CLO_0035676
DR   Coriell; AG06961
DR   Wikidata; Q54740471
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG06962
AC   CVCL_2C12
SY   GRC#0604
DR   CLO; CLO_0035678
DR   Coriell; AG06962
DR   Wikidata; Q54740472
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F89 ! AG13244
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG06971
AC   CVCL_V268
SY   AG6971
DR   CLO; CLO_0035680
DR   Coriell; AG06971
DR   Wikidata; Q54740475
RX   CelloPub=CLPUB00597;
RX   PubMed=9671271;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Leu117Glufs*4 (c.349_353delCTTAT) (349del5); ClinVar=VCV000000994; Zygosity=Heterozygous (PubMed=9671271).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-12A>G; Zygosity=Heterozygous (PubMed=9671271).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   AG07075
AC   CVCL_0N64
DR   CLO; CLO_0035649
DR   Coriell; AG07075
DR   Wikidata; Q54740529
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Heterozygous (Coriell=AG07075).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Ala205Pro (c.613G>C); ClinVar=VCV000001718; Zygosity=Heterozygous (Coriell=AG07075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N65 ! AG07076
SX   Female
AG   10Y10M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   AG07076
AC   CVCL_0N65
DR   CLO; CLO_0035648
DR   Coriell; AG07076
DR   Wikidata; Q54740532
RX   CelloPub=CLPUB00597;
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Heterozygous (from autologous cell line AG07075).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Ala205Pro (c.613G>C); ClinVar=VCV000001718; Zygosity=Heterozygous (from autologous cell line AG07075).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N64 ! AG07075
SX   Female
AG   10Y10M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   AG07091
AC   CVCL_4N48
SY   AG07091A
DR   CLO; CLO_0035651
DR   Coriell; AG07091
DR   Wikidata; Q54740534
RX   CelloPub=CLPUB00597;
RX   PubMed=12768443;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg471Cys (c.1411C>T) (c.1623C>T); ClinVar=VCV000014503; Zygosity=Heterozygous (PubMed=12768443).
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Cys (c.1579C>T) (c.1791C>T); ClinVar=VCV000014487; Zygosity=Heterozygous (PubMed=12768443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123417; Mandibuloacral dysplasia with type A lipodystrophy
DI   ORDO; Orphanet_90153; Mandibuloacral dysplasia with type A lipodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG07095
AC   CVCL_0N66
DR   CLO; CLO_0035652
DR   Coriell; AG07095
DR   Wikidata; Q54740537
RX   CelloPub=CLPUB00597;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG07096
AC   CVCL_X868
DR   CLO; CLO_0035659
DR   Coriell; AG07096
DR   Wikidata; Q54740539
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG07098
AC   CVCL_2I40
SY   AG07098A
DR   CLO; CLO_0035661
DR   Coriell; AG07098
DR   Wikidata; Q54740541
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   8D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07099
AC   CVCL_2I41
SY   AG07099A
DR   CLO; CLO_0035655
DR   BioSamples; SAME57934
DR   Coriell; AG07099
DR   Wikidata; Q54740544
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG07099; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07100
AC   CVCL_2I42
SY   AG07100B
DR   CLO; CLO_0035657
DR   Coriell; AG07100
DR   Wikidata; Q54740546
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG07100; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07101
AC   CVCL_2I43
SY   AG07101A
DR   CLO; CLO_0035613
DR   Coriell; AG07101
DR   Wikidata; Q54740547
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54600; ! Macaca nigra (Celebes black macaque)
SX   Male
AG   19Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07102
AC   CVCL_2I44
SY   AG07102A
DR   CLO; CLO_0035614
DR   Coriell; AG07102
DR   Wikidata; Q54740551
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54600; ! Macaca nigra (Celebes black macaque)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07107
AC   CVCL_2I52
SY   AG07107A
DR   CLO; CLO_0035625
DR   Coriell; AG07107
DR   Wikidata; Q54740552
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07108
AC   CVCL_2I53
SY   AG07108A
DR   CLO; CLO_0035642
DR   Coriell; AG07108
DR   Wikidata; Q54740554
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07109
AC   CVCL_2I45
SY   AG07109A
DR   CLO; CLO_0035641
DR   Coriell; AG07109
DR   Wikidata; Q54740557
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07110
AC   CVCL_2I46
SY   AG07110A
DR   CLO; CLO_0035644
DR   Coriell; AG07110
DR   Wikidata; Q54740562
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07118
AC   CVCL_2C13
SY   GRC#0662
DR   CLO; CLO_0035643
DR   Coriell; AG07118
DR   Wikidata; Q54740564
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G09 ! AG13364
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07119
AC   CVCL_2C14
SY   AG07119A; GRC#0673
DR   CLO; CLO_0035635
DR   Coriell; AG07119
DR   Wikidata; Q54740566
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG07119).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07120
AC   CVCL_2C15
SY   GRC#0676
DR   CLO; CLO_0035634
DR   Coriell; AG07120
DR   Wikidata; Q54740568
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (Coriell=AG07120).
CC   Karyotypic information: 46,XX,1qh-,16qh+ (Coriell=AG07120).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07121
AC   CVCL_2C16
SY   GRC#0686
DR   CLO; CLO_0035639
DR   Coriell; AG07121
DR   Wikidata; Q54740571
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,9qh+ [49]; 46,XX,9qh+,del(10)(qter->p13) [1] (Coriell=AG07121).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07122
AC   CVCL_2C17
SY   GRC#0687
DR   CLO; CLO_0035637
DR   Coriell; AG07122
DR   Wikidata; Q54740573
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [39]; 46,XX,add(14)(?::p13>qter) [11] (Coriell=AG07122).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D70 ! AG11081
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07123
AC   CVCL_2C18
SY   GRC#0693
DR   CLO; CLO_0035582
DR   Coriell; AG07123
DR   Wikidata; Q54740574
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG07123).
CC   Karyotypic information: 46,XY,9qh+,16qh+ (Coriell=AG07123).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A53 ! AG04146
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07124
AC   CVCL_2C19
SY   GRC#0695
DR   CLO; CLO_0035594
DR   Coriell; AG07124
DR   GEO; GSM3124566
DR   Wikidata; Q54740576
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [78%]; 47,XX,+8; [12%]; 48,XX,+8,+20 [10%] (Coriell=AG07124).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG07127
AC   CVCL_2I54
SY   AG07127A
DR   CLO; CLO_0035592
DR   Coriell; AG07127
DR   Wikidata; Q54740578
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07128
AC   CVCL_2I55
SY   AG07128A
DR   CLO; CLO_0035612
DR   Coriell; AG07128
DR   Wikidata; Q54740579
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Indian.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07130
AC   CVCL_A2NY
SY   AG07130A
DR   Coriell; AG07130
DR   Wikidata; Q105506301
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG07130; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG07135
AC   CVCL_L630
SY   GRC#0383
DR   CLO; CLO_0035611
DR   Coriell; AG07135
DR   Wikidata; Q54740580
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,13s+ (Coriell=AG07135).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L631 ! AG07143
OI   CVCL_L629 ! AG11488
OI   CVCL_L632 ! AG12788
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG07136
AC   CVCL_2C20
SY   GRC#0447
DR   CLO; CLO_0035610
DR   Coriell; AG07136
DR   Wikidata; Q54740581
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG07136).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C25 ! AG07144
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07137
AC   CVCL_2C21
SY   GRC#0387
DR   CLO; CLO_0035609
DR   Coriell; AG07137
DR   Wikidata; Q54740585
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG07137).
CC   Karyotypic information: 46,XY [66%]; 46,XY,t(1;17)(p22;q12) [34%] (Coriell=AG07137).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07139
AC   CVCL_2C22
SY   GRC#0665
DR   CLO; CLO_0035608
DR   Coriell; AG07139
DR   GEO; GSM426264
DR   Wikidata; Q54740587
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG07139).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG07140
AC   CVCL_2C23
SY   GRC#0666
DR   CLO; CLO_0035607
DR   Coriell; AG07140
DR   Wikidata; Q54740589
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG07140).
CC   Karyotypic information: 46,XX [88%]; 46,XX,t(4;12)(4pter->4q21::12q13->12qter;12pter->12q13::4q21->4qter) [12%] (Coriell=AG07140).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07141
AC   CVCL_2C24
SY   GRC#0675
DR   CLO; CLO_0035605
DR   Coriell; AG07141
DR   Wikidata; Q54740591
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
RX   PubMed=8832629;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG07141).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07143
AC   CVCL_L631
SY   GRC#0741
DR   Coriell; AG07143
DR   Wikidata; Q54740594
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG07143; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L630 ! AG07135
OI   CVCL_L629 ! AG11488
OI   CVCL_L632 ! AG12788
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG07144
AC   CVCL_2C25
SY   GRC#0732
DR   CLO; CLO_0035604
DR   Coriell; AG07144
DR   Wikidata; Q54740596
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG07144).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C20 ! AG07136
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07167
AC   CVCL_0N67
DR   CLO; CLO_0035571
DR   Coriell; AG07167
DR   Wikidata; Q54740598
RX   CelloPub=CLPUB00597;
CC   Population: African American.
CC   Karyotypic information: 47,XX,+18 (Coriell=AG07167).
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG07180
AC   CVCL_2I56
DR   CLO; CLO_0035573
DR   Coriell; AG07180
DR   Wikidata; Q54740600
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG07180; probable.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lak:LVG(SYR); VBO=VBO_0017488.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   30D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG07184
AC   CVCL_2I57
DR   CLO; CLO_0035572
DR   Coriell; AG07184
DR   Wikidata; Q54740602
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Lak:LVG(SYR); VBO=VBO_0017488.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   30D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG07302
AC   CVCL_2C26
SY   GRC#0683
DR   CLO; CLO_0035574
DR   Coriell; AG07302
DR   Wikidata; Q54740604
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG07302).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07303
AC   CVCL_2C27
SY   GRC#0688
DR   CLO; CLO_0035577
DR   Coriell; AG07303
DR   Wikidata; Q54740605
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [80%]; 46,XX,t(8;15)(q11;q15) [14%]; 46,XX,t(15;19)(q15;p13.3) [6%] (Coriell=AG07303).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07304
AC   CVCL_A2CU
SY   GRC#0689
DR   Coriell; AG07304
DR   Wikidata; Q105506302
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG07304; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG07306
AC   CVCL_2C28
SY   AG07306A; GRC#0698
DR   CLO; CLO_0035576
DR   Coriell; AG07306
DR   Wikidata; Q54740609
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07307
AC   CVCL_X753
SY   GRC#0699
DR   CLO; CLO_0035579
DR   Coriell; AG07307
DR   GEO; GSM426265
DR   Wikidata; Q54740611
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X755 ! AG12493
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 14
//
ID   AG07308
AC   CVCL_X754
SY   AG 7308; GRC#0700
DR   CLO; CLO_0035578
DR   Coriell; AG07308
DR   Wikidata; Q54740614
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X756 ! AG14271
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 12
//
ID   AG07309
AC   CVCL_2C29
SY   GRC#0701
DR   CLO; CLO_0035580
DR   Coriell; AG07309
DR   Wikidata; Q54740616
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [33]; 46,XX,t(2;5)(2pter->2q35::5p11->5pter;5qter->5p11::2q35->2qter) [17] (Coriell=AG07309).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F97 ! AG13300
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07310
AC   CVCL_2C30
SY   GRC#0702
DR   CLO; CLO_0035553
DR   Coriell; AG07310
DR   Wikidata; Q54740677
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG07310).
CC   Karyotypic information: 46,XX,16qh+ (Coriell=AG07310).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G08 ! AG13358
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07311
AC   CVCL_2G53
SY   GRC#0706
DR   CLO; CLO_0035552
DR   Coriell; AG07311
DR   Wikidata; Q54740678
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07374
AC   CVCL_X840
SY   AG07374B
DR   CLO; CLO_0035551
DR   Coriell; AG07374
DR   Wikidata; Q54740680
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG07375
AC   CVCL_X841
SY   AG07375A
DR   CLO; CLO_0035550
DR   Coriell; AG07375
DR   Wikidata; Q54740682
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
RX   PubMed=8832629;
RX   PubMed=10408806;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG07376
AC   CVCL_X842
SY   AG07376B
DR   CLO; CLO_0035557
DR   Coriell; AG07376
DR   Wikidata; Q54740684
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 12
//
ID   AG07377
AC   CVCL_H803
SY   AG7377; AG07377A
DR   CLO; CLO_0035556
DR   Coriell; AG07377
DR   Wikidata; Q54740687
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
RX   PubMed=8832629;
RX   PubMed=10408806;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG07388
AC   CVCL_2I58
DR   CLO; CLO_0035555
DR   Coriell; AG07388
DR   Wikidata; Q54740688
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AG07409
AC   CVCL_X869
DR   CLO; CLO_0035554
DR   Coriell; AG07409
DR   Wikidata; Q54740691
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG07429
AC   CVCL_H975
DR   CLO; CLO_0035559
DR   Coriell; AG07429
DR   Wikidata; Q54740692
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_H976 ! AG07430
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 15
//
ID   AG07430
AC   CVCL_H976
DR   CLO; CLO_0035558
DR   Coriell; AG07430
DR   Wikidata; Q54740693
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_H975 ! AG07429
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   AG07438
AC   CVCL_X870
SY   AG7438; AG07438A
DR   CLO; CLO_0035824
DR   Coriell; AG07438
DR   Wikidata; Q54740695
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
RX   PubMed=24119401;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 13
//
ID   AG07443
AC   CVCL_0N68
DR   CLO; CLO_0035827
DR   Coriell; AG07443
DR   Wikidata; Q54740697
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG07454
AC   CVCL_H977
DR   CLO; CLO_0035828
DR   Coriell; AG07454
DR   Wikidata; Q54740699
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_H978 ! AG07455
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   AG07455
AC   CVCL_H978
DR   CLO; CLO_0035825
DR   Coriell; AG07455
DR   Wikidata; Q54740701
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_H977 ! AG07454
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   AG07471
AC   CVCL_2C31
SY   AG07471A; GRC#0710
DR   CLO; CLO_0035826
DR   Coriell; AG07471
DR   Wikidata; Q54740703
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (PubMed=9724752); 42 PDL (Coriell=AG07471).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E69 ! AG12596
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07472
AC   CVCL_2C32
SY   GRC#0711
DR   CLO; CLO_0035821
DR   Coriell; AG07472
DR   Wikidata; Q54740706
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG07472).
CC   Karyotypic information: 46,XX [48%]; 46,XX,t(6;14)(6pter->6q22.2::14p11.2->14pter;14qter->14p11.2::6q22.2->6qter) [52%] (Coriell=AG07472).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E71 ! AG12598
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07473
AC   CVCL_2C33
SY   GRC#0712
DR   CLO; CLO_0035822
DR   Coriell; AG07473
DR   Wikidata; Q54740708
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG07473).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07475
AC   CVCL_2C34
SY   GRC#0715
DR   CLO; CLO_0035819
DR   Coriell; AG07475
DR   Wikidata; Q54740710
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07476
AC   CVCL_2C35
SY   GRC#0716
DR   CLO; CLO_0035820
DR   Coriell; AG07476
DR   Wikidata; Q54740713
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07477
AC   CVCL_2C36
SY   AG07477A; GRC#0717
DR   CLO; CLO_0035823
DR   Coriell; AG07477
DR   Wikidata; Q54740716
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG07477).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07478
AC   CVCL_2C37
SY   AG07478A; GRC#0718
DR   CLO; CLO_0035833
DR   Coriell; AG07478
DR   GEO; GSM3124569
DR   Wikidata; Q54740718
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG07478).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG07479
AC   CVCL_2C38
SY   GRC#0719
DR   CLO; CLO_0035834
DR   Coriell; AG07479
DR   Wikidata; Q54740720
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,22s+ (Coriell=AG07479).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D59 ! AG11018
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07493
AC   CVCL_0Q89
SY   AG7493; AG07493A
DR   CLO; CLO_0035835
DR   Coriell; AG07493
DR   Wikidata; Q54740722
RX   CelloPub=CLPUB00597;
RX   PubMed=8246632;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q98 ! AG11572
SX   Female
AG   1Y9M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   AG07549
AC   CVCL_0N69
DR   CLO; CLO_0035836
DR   Coriell; AG07549
DR   Wikidata; Q54740724
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG07558
AC   CVCL_4N49
DR   CLO; CLO_0035837
DR   Coriell; AG07558
DR   Wikidata; Q54740727
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N50 ! AG07559
SX   Female
AG   45Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07559
AC   CVCL_4N50
SY   AG07559B
DR   CLO; CLO_0035838
DR   Coriell; AG07559
DR   Wikidata; Q54740728
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N49 ! AG07558
SX   Female
AG   45Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07560
AC   CVCL_4N51
DR   CLO; CLO_0035829
DR   Coriell; AG07560
DR   Wikidata; Q54740729
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N52 ! AG07561
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07561
AC   CVCL_4N52
SY   AG07561A
DR   CLO; CLO_0035830
DR   Coriell; AG07561
DR   Wikidata; Q54740733
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N51 ! AG07560
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07562
AC   CVCL_4N53
DR   CLO; CLO_0035831
DR   Coriell; AG07562
DR   Wikidata; Q54740735
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N54 ! AG07563
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07563
AC   CVCL_4N54
SY   AG07563A
DR   CLO; CLO_0035832
DR   Coriell; AG07563
DR   Wikidata; Q54740739
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N53 ! AG07562
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07564
AC   CVCL_4N55
DR   CLO; CLO_0035808
DR   Coriell; AG07564
DR   Wikidata; Q54740740
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N56 ! AG07565
SX   Male
AG   45Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07565
AC   CVCL_4N56
DR   CLO; CLO_0035806
DR   Coriell; AG07565
DR   Wikidata; Q54740742
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N55 ! AG07564
SX   Male
AG   45Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07566
AC   CVCL_4N57
DR   CLO; CLO_0035807
DR   Coriell; AG07566
DR   Wikidata; Q54740743
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N58 ! AG07567
SX   Male
AG   38Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07567
AC   CVCL_4N58
DR   CLO; CLO_0035804
DR   Coriell; AG07567
DR   Wikidata; Q54740746
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N57 ! AG07566
SX   Male
AG   38Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07568
AC   CVCL_4N59
DR   CLO; CLO_0035805
DR   Coriell; AG07568
DR   Wikidata; Q54740747
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N60 ! AG07569
SX   Male
AG   15Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07569
AC   CVCL_4N60
DR   CLO; CLO_0035802
DR   Coriell; AG07569
DR   Wikidata; Q54740749
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N59 ! AG07568
SX   Male
AG   15Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07570
AC   CVCL_4N61
DR   CLO; CLO_0035803
DR   Coriell; AG07570
DR   Wikidata; Q54740752
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N62 ! AG07571
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07571
AC   CVCL_4N62
DR   CLO; CLO_0035800
DR   Coriell; AG07571
DR   Wikidata; Q54740754
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N61 ! AG07570
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07572
AC   CVCL_4N63
DR   CLO; CLO_0035801
DR   Coriell; AG07572
DR   Wikidata; Q54740757
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N64 ! AG07573
SX   Male
AG   36Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07573
AC   CVCL_4N64
DR   CLO; CLO_0035799
DR   Coriell; AG07573
DR   Wikidata; Q54740760
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N63 ! AG07572
SX   Male
AG   36Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07574
AC   CVCL_4N65
SY   AG07574A
DR   CLO; CLO_0035815
DR   Coriell; AG07574
DR   Wikidata; Q54740807
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N66 ! AG07575
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07575
AC   CVCL_4N66
DR   CLO; CLO_0035816
DR   Coriell; AG07575
DR   Wikidata; Q54740809
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N65 ! AG07574
SX   Female
AG   38Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07576
AC   CVCL_4N67
DR   CLO; CLO_0035817
DR   Coriell; AG07576
DR   Wikidata; Q54740811
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07578
AC   CVCL_4N68
DR   CLO; CLO_0035818
DR   Coriell; AG07578
DR   Wikidata; Q54740813
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N69 ! AG07579
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07579
AC   CVCL_4N69
SY   AG07579A
DR   CLO; CLO_0035811
DR   Coriell; AG07579
DR   Wikidata; Q54740815
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N68 ! AG07578
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07580
AC   CVCL_4N70
DR   CLO; CLO_0035812
DR   Coriell; AG07580
DR   Wikidata; Q54740818
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N71 ! AG07581
SX   Female
AG   56Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07581
AC   CVCL_4N71
SY   AG07581A
DR   CLO; CLO_0035813
DR   Coriell; AG07581
DR   Wikidata; Q54740821
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N70 ! AG07580
SX   Female
AG   56Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07582
AC   CVCL_4N72
SY   AG07582A
DR   CLO; CLO_0035814
DR   Coriell; AG07582
DR   Wikidata; Q54740822
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N73 ! AG07583
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07583
AC   CVCL_4N73
SY   AG07583A
DR   CLO; CLO_0035809
DR   Coriell; AG07583
DR   Wikidata; Q54740824
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N72 ! AG07582
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07584
AC   CVCL_4N74
SY   AG07584A
DR   CLO; CLO_0035810
DR   Coriell; AG07584
DR   Wikidata; Q54740825
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07587
AC   CVCL_YX77
SY   AG07587A
DR   Coriell; AG07587
DR   Wikidata; Q93315883
RX   PubMed=8247227;
CC   Discontinued: Coriell; AG07587; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   AG07588
AC   CVCL_4N75
DR   CLO; CLO_0032866
DR   Coriell; AG07588
DR   Wikidata; Q54740826
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N76 ! AG07589
SX   Female
AG   23Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07589
AC   CVCL_4N76
DR   CLO; CLO_0032865
DR   Coriell; AG07589
DR   Wikidata; Q54740830
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N75 ! AG07588
SX   Female
AG   23Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07590
AC   CVCL_4N77
DR   CLO; CLO_0032864
DR   Coriell; AG07590
DR   Wikidata; Q54740836
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P60 ! AG08176
SX   Female
AG   37Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07592
AC   CVCL_4N78
SY   AG07592A
DR   CLO; CLO_0032863
DR   Coriell; AG07592
DR   Wikidata; Q54740840
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N79 ! AG07593
SX   Male
AG   18Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07593
AC   CVCL_4N79
DR   CLO; CLO_0032862
DR   Coriell; AG07593
DR   Wikidata; Q54740841
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG07593).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N78 ! AG07592
SX   Male
AG   18Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07594
AC   CVCL_4N80
DR   CLO; CLO_0032861
DR   Coriell; AG07594
DR   Wikidata; Q54740842
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07596
AC   CVCL_4N81
DR   CLO; CLO_0032889
DR   Coriell; AG07596
DR   Wikidata; Q54740843
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P59 ! AG08175
SX   Female
AG   32Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07597
AC   CVCL_4N82
DR   CLO; CLO_0032891
DR   Coriell; AG07597
DR   Wikidata; Q54740847
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N83 ! AG07598
SX   Male
AG   37Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07598
AC   CVCL_4N83
DR   CLO; CLO_0032893
DR   Coriell; AG07598
DR   Wikidata; Q54740849
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N82 ! AG07597
SX   Male
AG   37Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07599
AC   CVCL_4N84
DR   CLO; CLO_0032894
DR   Coriell; AG07599
DR   Wikidata; Q54740852
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N85 ! AG07600
SX   Male
AG   28Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07600
AC   CVCL_4N85
DR   CLO; CLO_0032881
DR   Coriell; AG07600
DR   Wikidata; Q54740854
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N84 ! AG07599
SX   Male
AG   28Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07601
AC   CVCL_4N86
DR   CLO; CLO_0032883
DR   Coriell; AG07601
DR   Wikidata; Q54740856
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N87 ! AG07602
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG07602
AC   CVCL_4N87
DR   CLO; CLO_0032882
DR   Coriell; AG07602
DR   Wikidata; Q54740861
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N86 ! AG07601
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07603
AC   CVCL_4N88
SY   AG07603A
DR   CLO; CLO_0032878
DR   Coriell; AG07603
DR   Wikidata; Q54740863
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
RX   PubMed=8247227;
RX   PubMed=8832629;
RX   PubMed=9724752;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24-32 PDL (PubMed=9724752).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N89 ! AG07604
SX   Female
AG   61Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG07604
AC   CVCL_4N89
DR   CLO; CLO_0032877
DR   Coriell; AG07604
DR   Wikidata; Q54740865
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N88 ! AG07603
SX   Female
AG   61Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   AG07607
AC   CVCL_4N90
DR   CLO; CLO_0032880
DR   Coriell; AG07607
DR   Wikidata; Q54740867
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N91 ! AG07608
SX   Female
AG   36Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07608
AC   CVCL_4N91
DR   CLO; CLO_0032879
DR   Coriell; AG07608
DR   Wikidata; Q54740870
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N90 ! AG07607
SX   Female
AG   36Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07609
AC   CVCL_4N92
DR   CLO; CLO_0032831
DR   Coriell; AG07609
DR   Wikidata; Q54740872
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N93 ! AG07610
SX   Male
AG   25Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07610
AC   CVCL_4N93
DR   CLO; CLO_0032833
DR   Coriell; AG07610
DR   Wikidata; Q54740873
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N92 ! AG07609
SX   Male
AG   25Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07613
AC   CVCL_4N94
SY   AG07613A; AG 7613A; AG07613B
DR   CLO; CLO_0032828
DR   Coriell; AG07613
DR   Wikidata; Q54740874
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG07613).
CC   Karyotypic information: 46,XY,inv(Y)(pter->p11.2::q12->p11.2::q12->qter) (Coriell=AG07613).
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N95 ! AG07614
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07614
AC   CVCL_4N95
SY   AG07614A
DR   CLO; CLO_0032823
DR   Coriell; AG07614
DR   Wikidata; Q54740878
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N94 ! AG07613
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07615
AC   CVCL_4N96
SY   AG07615B
DR   CLO; CLO_0032821
DR   Coriell; AG07615
DR   Wikidata; Q54740880
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N97 ! AG07616
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07616
AC   CVCL_4N97
DR   CLO; CLO_0032820
DR   Coriell; AG07616
DR   Wikidata; Q54740881
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N96 ! AG07615
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07617
AC   CVCL_4N98
DR   CLO; CLO_0032819
DR   Coriell; AG07617
DR   Wikidata; Q54740887
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N99 ! AG07618
SX   Female
AG   29Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07618
AC   CVCL_4N99
DR   CLO; CLO_0032827
DR   Coriell; AG07618
DR   Wikidata; Q54740888
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N98 ! AG07617
SX   Female
AG   29Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07619
AC   CVCL_4P00
SY   AG07619A
DR   CLO; CLO_0032826
DR   Coriell; AG07619
DR   Wikidata; Q54740891
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P01 ! AG07620
SX   Male
AG   68Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07620
AC   CVCL_4P01
SY   AG07620B
DR   CLO; CLO_0032825
DR   Coriell; AG07620
DR   Wikidata; Q54740893
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P00 ! AG07619
SX   Male
AG   68Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07621
AC   CVCL_4P02
SY   AG07621B
DR   CLO; CLO_0032824
DR   Coriell; AG07621
DR   Wikidata; Q54740894
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P03 ! AG07622
SX   Male
AG   57Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07622
AC   CVCL_4P03
SY   AG07622A
DR   CLO; CLO_0032852
DR   Coriell; AG07622
DR   Wikidata; Q54740897
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P02 ! AG07621
SX   Male
AG   57Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07623
AC   CVCL_4P04
SY   AG07623A
DR   CLO; CLO_0032853
DR   Coriell; AG07623
DR   Wikidata; Q54740899
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P05 ! AG07624
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07624
AC   CVCL_4P05
SY   AG07624A
DR   CLO; CLO_0032840
DR   Coriell; AG07624
DR   Wikidata; Q54740951
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P04 ! AG07623
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07627
AC   CVCL_4P06
SY   AG07627A; AG07627B
DR   CLO; CLO_0032844
DR   Coriell; AG07627
DR   Wikidata; Q54740953
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG07627; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P07 ! AG07628
SX   Female
AG   48Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07628
AC   CVCL_4P07
SY   AG07628A
DR   CLO; CLO_0032842
DR   Coriell; AG07628
DR   Wikidata; Q54740956
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P06 ! AG07627
SX   Female
AG   48Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07629
AC   CVCL_4P08
SY   AG07629B; AG 7629B
DR   CLO; CLO_0032846
DR   Coriell; AG07629
DR   Wikidata; Q54740958
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P09 ! AG07630
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07630
AC   CVCL_4P09
SY   AG07630A
DR   CLO; CLO_0032845
DR   Coriell; AG07630
DR   Wikidata; Q54740960
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P08 ! AG07629
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07631
AC   CVCL_4P10
DR   CLO; CLO_0032848
DR   Coriell; AG07631
DR   Wikidata; Q54740965
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P11 ! AG07632
SX   Male
AG   35Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG07632
AC   CVCL_4P11
DR   CLO; CLO_0032847
DR   Coriell; AG07632
DR   Wikidata; Q54740967
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P10 ! AG07631
SX   Male
AG   35Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07634
AC   CVCL_4P12
DR   CLO; CLO_0032850
DR   Coriell; AG07634
DR   Wikidata; Q54740970
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07635
AC   CVCL_4P13
DR   CLO; CLO_0032849
DR   Coriell; AG07635
DR   Wikidata; Q54740972
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P14 ! AG07636
SX   Female
AG   18Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07636
AC   CVCL_4P14
SY   AG07636A
DR   CLO; CLO_0032988
DR   Coriell; AG07636
DR   Wikidata; Q54740974
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P13 ! AG07635
SX   Female
AG   18Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07637
AC   CVCL_4P15
SY   AG07637A; AG 7637A
DR   CLO; CLO_0032970
DR   Coriell; AG07637
DR   Wikidata; Q54740977
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7847674;
RX   PubMed=8247227;
RX   PubMed=8643543;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P16 ! AG07638
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07638
AC   CVCL_4P16
SY   AG07638B
DR   CLO; CLO_0032972
DR   Coriell; AG07638
DR   Wikidata; Q54740979
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P15 ! AG07637
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07639
AC   CVCL_4P17
SY   AG07639A; AG7639A
DR   CLO; CLO_0032966
DR   Coriell; AG07639
DR   Wikidata; Q54740983
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P18 ! AG07640
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07640
AC   CVCL_4P18
SY   AG07640B
DR   CLO; CLO_0032968
DR   Coriell; AG07640
DR   Wikidata; Q54740987
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P17 ! AG07639
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07641
AC   CVCL_4P19
DR   CLO; CLO_0032962
DR   Coriell; AG07641
DR   Wikidata; Q54740990
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P20 ! AG07642
SX   Female
AG   28Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07642
AC   CVCL_4P20
DR   CLO; CLO_0032965
DR   Coriell; AG07642
DR   Wikidata; Q54740992
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P19 ! AG07641
SX   Female
AG   28Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07644
AC   CVCL_4P21
DR   CLO; CLO_0032960
DR   Coriell; AG07644
DR   Wikidata; Q54740995
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07645
AC   CVCL_V148
DR   CLO; CLO_0032961
DR   Coriell; AG07645
DR   Wikidata; Q54740997
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from child cell line ESi035-A).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V149 ! AG07646
SX   Female
AG   15Y6M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   AG07646
AC   CVCL_V149
DR   CLO; CLO_0032958
DR   Coriell; AG07646
DR   Wikidata; Q54740999
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from autologous cell line AG07645).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V148 ! AG07645
SX   Female
AG   15Y6M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   AG07647
AC   CVCL_F258
SY   AG07647A
DR   CLO; CLO_0032959
DR   Coriell; AG07647
DR   Wikidata; Q54741001
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from autologous cell line AG06844).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F257 ! AG06844
SX   Male
AG   60Y1M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   AG07648
AC   CVCL_2L78
DR   CLO; CLO_0033003
DR   Coriell; AG07648
DR   Wikidata; Q54741004
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AG07652
AC   CVCL_4P22
DR   CLO; CLO_0033005
DR   Coriell; AG07652
DR   Wikidata; Q54741005
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P23 ! AG07653
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07653
AC   CVCL_4P23
DR   CLO; CLO_0033006
DR   Coriell; AG07653
DR   Wikidata; Q54741009
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P22 ! AG07652
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07654
AC   CVCL_4P24
DR   CLO; CLO_0032994
DR   Coriell; AG07654
DR   Wikidata; Q54741010
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P25 ! AG07655
SX   Female
AG   47Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07655
AC   CVCL_4P25
SY   AG 7655; AG07655B
DR   CLO; CLO_0032996
DR   Coriell; AG07655
DR   Wikidata; Q54741011
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P24 ! AG07654
SX   Female
AG   47Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07656
AC   CVCL_4P26
SY   AG07656A
DR   CLO; CLO_0032998
DR   Coriell; AG07656
DR   Wikidata; Q54741013
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P27 ! AG07657
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07657
AC   CVCL_4P27
SY   AG07657A
DR   CLO; CLO_0032999
DR   Coriell; AG07657
DR   Wikidata; Q54741015
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P26 ! AG07656
SX   Female
AG   88Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07660
AC   CVCL_4P28
SY   AG07660D
DR   CLO; CLO_0032989
DR   Coriell; AG07660
DR   Wikidata; Q54741018
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P29 ! AG07661
SX   Female
AG   61Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07661
AC   CVCL_4P29
SY   AG07661B
DR   CLO; CLO_0032991
DR   Coriell; AG07661
DR   Wikidata; Q54741020
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P28 ! AG07660
SX   Female
AG   61Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07662
AC   CVCL_4P30
DR   CLO; CLO_0032992
DR   Coriell; AG07662
DR   Wikidata; Q54741023
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P31 ! AG07663
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07663
AC   CVCL_4P31
SY   AG07663A; AG 7663A
DR   CLO; CLO_0032914
DR   Coriell; AG07663
DR   Wikidata; Q54741025
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P30 ! AG07662
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07664
AC   CVCL_4P32
DR   CLO; CLO_0032916
DR   Coriell; AG07664
DR   Wikidata; Q54741029
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P33 ! AG07665
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07665
AC   CVCL_4P33
SY   AG07665A
DR   CLO; CLO_0032911
DR   Coriell; AG07665
DR   Wikidata; Q54741030
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG07665).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P32 ! AG07664
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07666
AC   CVCL_4P34
DR   CLO; CLO_0032912
DR   Coriell; AG07666
DR   Wikidata; Q54741032
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P35 ! AG07667
SX   Female
AG   42Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07667
AC   CVCL_4P35
SY   AG07667B
DR   CLO; CLO_0032903
DR   Coriell; AG07667
DR   Wikidata; Q54741035
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG07667).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P34 ! AG07666
SX   Female
AG   42Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07668
AC   CVCL_4P36
DR   CLO; CLO_0032905
DR   Coriell; AG07668
DR   Wikidata; Q54741038
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P37 ! AG07669
SX   Female
AG   39Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07669
AC   CVCL_4P37
DR   CLO; CLO_0032897
DR   Coriell; AG07669
DR   Wikidata; Q54741040
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P36 ! AG07668
SX   Female
AG   39Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07670
AC   CVCL_4P38
DR   CLO; CLO_0032899
DR   Coriell; AG07670
DR   Wikidata; Q54741042
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from autologous cell line AG07671).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P39 ! AG07671
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG07671
AC   CVCL_4P39
SY   AG 7671; AG07671A
DR   CLO; CLO_0032907
DR   Coriell; AG07671
DR   Wikidata; Q54741044
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
RX   PubMed=24416243;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=24416243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P38 ! AG07670
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG07672
AC   CVCL_4P40
DR   CLO; CLO_0032908
DR   Coriell; AG07672
DR   Wikidata; Q54741047
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07673
AC   CVCL_4P41
DR   CLO; CLO_0032940
DR   Coriell; AG07673
DR   Wikidata; Q54741099
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07714
AC   CVCL_L750
SY   GRC#0720
DR   CLO; CLO_0032930
DR   Coriell; AG07714
DR   Wikidata; Q54741112
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [94%]; 46,XX,1p+,3p-,3q-,10q-,13p+,16q+ [6%] (Coriell=AG07714).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L751 ! AG12927
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG07715
AC   CVCL_2C39
SY   GRC#0723
DR   CLO; CLO_0032932
DR   Coriell; AG07715
DR   Wikidata; Q54741114
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07716
AC   CVCL_2C40
SY   GRC#0727
DR   CLO; CLO_0032934
DR   Coriell; AG07716
DR   Wikidata; Q54741115
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07719
AC   CVCL_2C41
SY   AG07719A; GRC#0735
DR   CLO; CLO_0032936
DR   Coriell; AG07719
DR   Wikidata; Q54741117
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34-37 PDL (PubMed=9724752); 36 PDL (Coriell=AG07719).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07720
AC   CVCL_2C42
SY   AG07720A; GRC#0737
DR   CLO; CLO_0032650
DR   Coriell; AG07720
DR   Wikidata; Q54741120
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (PubMed=9724752); 36 PDL (Coriell=AG07720).
CC   Karyotypic information: 46,XX [92%]; 46,XX,add(14)(p12) [8%] (Coriell=AG07720).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07721
AC   CVCL_CV36
SY   AG7721; AG07721C; AG07721D; GRC#0738
DR   Coriell; AG07721
DR   Wikidata; Q54741122
RX   CelloPub=CLPUB00597;
RX   PubMed=8246632;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG07721; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   AG07722
AC   CVCL_2C43
SY   GRC#0745
DR   CLO; CLO_0032649
DR   Coriell; AG07722
DR   Wikidata; Q54741125
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG07722).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07723
AC   CVCL_2C44
SY   GRC#0750
DR   CLO; CLO_0032652
DR   Coriell; AG07723
DR   Wikidata; Q54741126
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B44 ! AG05410
OI   CVCL_2F65 ! AG13198
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07724
AC   CVCL_2C45
SY   GRC#0768
DR   CLO; CLO_0032651
DR   Coriell; AG07724
DR   Wikidata; Q54741131
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 51 PDL (Coriell=AG07724).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B08 ! AG04654
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07725
AC   CVCL_2C46
SY   AG07725A; GRC#0800
DR   CLO; CLO_0032654
DR   Coriell; AG07725
DR   GEO; GSM3124622
DR   Wikidata; Q54741133
RX   CelloPub=CLPUB00597;
RX   PubMed=15450399;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B97 ! AG06308
SX   Male
AG   91Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG07756
AC   CVCL_4P42
DR   CLO; CLO_0032653
DR   Coriell; AG07756
DR   Wikidata; Q54741136
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P43 ! AG07757
SX   Female
AG   61Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07757
AC   CVCL_4P43
DR   CLO; CLO_0032656
DR   Coriell; AG07757
DR   Wikidata; Q54741138
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P42 ! AG07756
SX   Female
AG   61Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07759
AC   CVCL_4P44
DR   CLO; CLO_0032655
DR   Coriell; AG07759
DR   Wikidata; Q54741140
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG07761
AC   CVCL_4P45
DR   CLO; CLO_0032658
DR   Coriell; AG07761
DR   Wikidata; Q54741141
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P46 ! AG07762
SX   Female
AG   58Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07762
AC   CVCL_4P46
DR   CLO; CLO_0032657
DR   Coriell; AG07762
DR   Wikidata; Q54741143
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P45 ! AG07761
SX   Female
AG   58Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07763
AC   CVCL_4P47
DR   CLO; CLO_0032630
DR   Coriell; AG07763
DR   Wikidata; Q54741145
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07765
AC   CVCL_4P48
DR   CLO; CLO_0032629
DR   Coriell; AG07765
DR   Wikidata; Q54741147
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P49 ! AG07766
SX   Male
AG   41Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07766
AC   CVCL_4P49
DR   CLO; CLO_0032628
DR   Coriell; AG07766
DR   Wikidata; Q54741148
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P48 ! AG07765
SX   Male
AG   41Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07767
AC   CVCL_T878
DR   CLO; CLO_0032635
DR   Coriell; AG07767
DR   Wikidata; Q54741150
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from autologous cell line AG07768).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T877 ! AG07768
SX   Female
AG   30Y6M
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   AG07768
AC   CVCL_T877
DR   CLO; CLO_0032633
DR   Coriell; AG07768
DR   Wikidata; Q54741152
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
RX   PubMed=21900357;
RX   PubMed=24416243;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=21900357; PubMed=24416243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T878 ! AG07767
SX   Female
AG   30Y6M
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   AG07769
AC   CVCL_4P50
DR   CLO; CLO_0032632
DR   Coriell; AG07769
DR   Wikidata; Q54741154
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07771
AC   CVCL_4P51
DR   CLO; CLO_0032631
DR   Coriell; AG07771
DR   Wikidata; Q54741156
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07801
AC   CVCL_2C47
SY   AG07801B; GRC#0285
DR   CLO; CLO_0032638
DR   Coriell; AG07801
DR   Wikidata; Q54741159
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [82%]; 47,XY,+2 [6%] (Coriell=AG07801).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B38 ! AG05271
OI   CVCL_2D74 ! AG11157
OI   CVCL_2G05 ! AG13349
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07802
AC   CVCL_2C48
SY   GRC#0724
DR   CLO; CLO_0032637
DR   Coriell; AG07802
DR   Wikidata; Q54741161
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG07802).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07803
AC   CVCL_2C49
SY   GRC#0730
DR   CLO; CLO_0032636
DR   Coriell; AG07803
DR   Wikidata; Q54741163
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07804
AC   CVCL_2C50
SY   AG07804A; GRC#0736
DR   CLO; CLO_0033415
DR   Coriell; AG07804
DR   Wikidata; Q54741165
RX   CelloPub=CLPUB00597;
RX   PubMed=15450399;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [92%]; 45,X [4%]; 45,XY,-17 [4%] (Coriell=AG07804).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG0781
AC   CVCL_8B70
DR   ECACC; 93071608
DR   Wikidata; Q54741166
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93071608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG07864
AC   CVCL_4J81
SY   AG07864A
DR   CLO; CLO_0033416
DR   Coriell; AG07864
DR   Wikidata; Q54741168
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J82 ! AG07865
SX   Female
AG   47Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07865
AC   CVCL_4J82
DR   CLO; CLO_0033418
DR   Coriell; AG07865
DR   Wikidata; Q54741172
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
RX   PubMed=10408806;
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J81 ! AG07864
SX   Female
AG   47Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07866
AC   CVCL_4J83
DR   CLO; CLO_0033420
DR   Coriell; AG07866
DR   Wikidata; Q54741174
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J84 ! AG07867
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07867
AC   CVCL_4J84
DR   CLO; CLO_0033423
DR   Coriell; AG07867
DR   Wikidata; Q54741177
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J83 ! AG07866
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07868
AC   CVCL_4J85
DR   CLO; CLO_0033430
DR   Coriell; AG07868
DR   Wikidata; Q54741178
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J86 ! AG07869
SX   Male
AG   27Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07869
AC   CVCL_4J86
DR   CLO; CLO_0033429
DR   Coriell; AG07869
DR   Wikidata; Q54741182
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J85 ! AG07868
SX   Male
AG   27Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07870
AC   CVCL_4J87
DR   CLO; CLO_0033426
DR   Coriell; AG07870
DR   Wikidata; Q54741184
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J88 ! AG07871
SX   Female
AG   49Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07871
AC   CVCL_4J88
DR   CLO; CLO_0033425
DR   Coriell; AG07871
DR   Wikidata; Q54741236
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J87 ! AG07870
SX   Female
AG   49Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07872
AC   CVCL_4J89
DR   CLO; CLO_0033434
DR   Coriell; AG07872
DR   Wikidata; Q54741240
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J90 ! AG07877
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG07877
AC   CVCL_4J90
SY   AG07877A
DR   CLO; CLO_0033442
DR   Coriell; AG07877
DR   Wikidata; Q54741241
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (from autologous cell line AG07872).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J89 ! AG07872
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG07878
AC   CVCL_4J91
DR   CLO; CLO_0033444
DR   Coriell; AG07878
DR   Wikidata; Q54741243
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07879
AC   CVCL_4J92
DR   CLO; CLO_0033452
DR   Coriell; AG07879
DR   Wikidata; Q54741245
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07880
AC   CVCL_4J93
DR   CLO; CLO_0033454
DR   Coriell; AG07880
DR   Wikidata; Q54741247
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J94 ! AG07881
SX   Male
AG   16Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07881
AC   CVCL_4J94
DR   CLO; CLO_0033448
DR   Coriell; AG07881
DR   Wikidata; Q54741249
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J93 ! AG07880
SX   Male
AG   16Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07882
AC   CVCL_4J95
DR   CLO; CLO_0033450
DR   Coriell; AG07882
DR   Wikidata; Q54741251
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J96 ! AG07883
SX   Male
AG   21Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07883
AC   CVCL_4J96
DR   CLO; CLO_0033474
DR   Coriell; AG07883
DR   Wikidata; Q54741252
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J95 ! AG07882
SX   Male
AG   21Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07884
AC   CVCL_4J97
DR   CLO; CLO_0033475
DR   Coriell; AG07884
DR   Wikidata; Q54741256
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J98 ! AG07885
SX   Female
AG   20Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07885
AC   CVCL_4J98
DR   CLO; CLO_0033472
DR   Coriell; AG07885
DR   Wikidata; Q54741259
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J97 ! AG07884
SX   Female
AG   20Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07886
AC   CVCL_4J99
DR   CLO; CLO_0033473
DR   Coriell; AG07886
DR   Wikidata; Q54741260
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K00 ! AG07887
SX   Female
AG   17Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07887
AC   CVCL_4K00
DR   CLO; CLO_0033466
DR   Coriell; AG07887
DR   Wikidata; Q54741262
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J99 ! AG07886
SX   Female
AG   17Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07888
AC   CVCL_4K01
DR   CLO; CLO_0033464
DR   Coriell; AG07888
DR   Wikidata; Q54741263
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K02 ! AG07889
SX   Male
AG   17Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07889
AC   CVCL_4K02
DR   CLO; CLO_0033463
DR   Coriell; AG07889
DR   Wikidata; Q54741265
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K01 ! AG07888
SX   Male
AG   17Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07896
AC   CVCL_U313
SY   AG07896A
DR   CLO; CLO_0033461
DR   Coriell; AG07896
DR   GEO; GSM1052418
DR   Wikidata; Q54741267
RX   CelloPub=CLPUB00597;
RX   PubMed=23257959;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y5M
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   AG07897
AC   CVCL_U314
DR   CLO; CLO_0033459
DR   Coriell; AG07897
DR   Wikidata; Q54741268
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   AG07898
AC   CVCL_U315
DR   CLO; CLO_0033457
DR   Coriell; AG07898
DR   Wikidata; Q54741270
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   AG07906
AC   CVCL_2L83
DR   CLO; CLO_0033455
DR   Coriell; AG07906
DR   Wikidata; Q54741271
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L84 ! AG07937
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG07915
AC   CVCL_2L85
DR   CLO; CLO_0033494
DR   Coriell; AG07915
DR   Wikidata; Q54741273
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   12Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07921
AC   CVCL_2I47
DR   CLO; CLO_0033495
DR   Coriell; AG07921
DR   Wikidata; Q54741275
RX   CelloPub=CLPUB00597;
RX   PubMed=21489251;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   24Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07923
AC   CVCL_2L86
DR   CLO; CLO_0033496
DR   Coriell; AG07923
DR   Wikidata; Q54741276
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   15Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07925
AC   CVCL_4K03
DR   CLO; CLO_0033486
DR   Coriell; AG07925
DR   Wikidata; Q54741280
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K04 ! AG07926
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07926
AC   CVCL_4K04
SY   AG07926A
DR   CLO; CLO_0033484
DR   Coriell; AG07926
DR   Wikidata; Q54741281
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K03 ! AG07925
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07927
AC   CVCL_4K05
DR   CLO; CLO_0033490
DR   Coriell; AG07927
DR   Wikidata; Q54741285
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K06 ! AG07928
SX   Female
AG   46Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07928
AC   CVCL_4K06
DR   CLO; CLO_0033489
DR   Coriell; AG07928
DR   Wikidata; Q54741286
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K05 ! AG07927
SX   Female
AG   46Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07929
AC   CVCL_4K07
DR   CLO; CLO_0033479
DR   Coriell; AG07929
DR   Wikidata; Q54741287
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K08 ! AG07930
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07930
AC   CVCL_4K08
DR   CLO; CLO_0033477
DR   Coriell; AG07930
DR   Wikidata; Q54741290
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K07 ! AG07929
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07931
AC   CVCL_4K09
DR   CLO; CLO_0033483
DR   Coriell; AG07931
DR   Wikidata; Q54741292
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07933
AC   CVCL_4K10
DR   CLO; CLO_0033480
DR   Coriell; AG07933
DR   Wikidata; Q54741294
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K11 ! AG07934
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07934
AC   CVCL_4K11
DR   CLO; CLO_0033510
DR   Coriell; AG07934
DR   Wikidata; Q54741295
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K10 ! AG07933
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07935
AC   CVCL_4K12
DR   CLO; CLO_0033512
DR   Coriell; AG07935
DR   Wikidata; Q54741299
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K13 ! AG07936
SX   Female
AG   68Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07936
AC   CVCL_4K13
SY   AG07936A; AG07936B
DR   CLO; CLO_0033507
DR   Coriell; AG07936
DR   Wikidata; Q54741301
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K12 ! AG07935
SX   Female
AG   68Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG07937
AC   CVCL_2L84
SY   AG07937A
DR   CLO; CLO_0033501
DR   Coriell; AG07937
DR   Wikidata; Q54741302
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L83 ! AG07906
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG07946
AC   CVCL_0U90
SY   AG7946
DR   CLO; CLO_0033499
DR   Coriell; AG07946
DR   Wikidata; Q54741307
RX   CelloPub=CLPUB00597;
CC   Population: African American.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG07950
AC   CVCL_2I59
DR   CLO; CLO_0033498
DR   Coriell; AG07950
DR   Wikidata; Q54741308
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I60 ! AG07951
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07951
AC   CVCL_2I60
DR   CLO; CLO_0033497
DR   Coriell; AG07951
DR   Wikidata; Q54741311
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I59 ! AG07950
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07952
AC   CVCL_2I61
SY   AG07952A
DR   CLO; CLO_0033506
DR   Coriell; AG07952
DR   Wikidata; Q54741313
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I62 ! AG07953
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07953
AC   CVCL_2I62
DR   CLO; CLO_0033505
DR   Coriell; AG07953
DR   Wikidata; Q54741317
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I61 ! AG07952
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07954
AC   CVCL_2I63
SY   AG07954A
DR   CLO; CLO_0033504
DR   Coriell; AG07954
DR   Wikidata; Q54741319
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I64 ! AG07955
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07955
AC   CVCL_2I64
DR   CLO; CLO_0033503
DR   Coriell; AG07955
DR   Wikidata; Q54741424
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I63 ! AG07954
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07956
AC   CVCL_2I65
DR   CLO; CLO_0033528
DR   Coriell; AG07956
DR   Wikidata; Q54741429
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I66 ! AG07957
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07957
AC   CVCL_2I66
DR   CLO; CLO_0033527
DR   Coriell; AG07957
DR   Wikidata; Q54741430
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I65 ! AG07956
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07958
AC   CVCL_2I67
DR   CLO; CLO_0033526
DR   Coriell; AG07958
DR   Wikidata; Q54741435
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I68 ! AG07959
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07959
AC   CVCL_2I68
DR   CLO; CLO_0033519
DR   Coriell; AG07959
DR   Wikidata; Q54741436
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I67 ! AG07958
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07960
AC   CVCL_2I69
DR   CLO; CLO_0033518
DR   Coriell; AG07960
DR   Wikidata; Q54741437
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I70 ! AG07961
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07961
AC   CVCL_2I70
DR   CLO; CLO_0033521
DR   Coriell; AG07961
DR   Wikidata; Q54741440
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I69 ! AG07960
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07962
AC   CVCL_2I71
DR   CLO; CLO_0033520
DR   Coriell; AG07962
DR   Wikidata; Q54741442
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I72 ! AG07963
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG07963
AC   CVCL_2I72
DR   CLO; CLO_0033523
DR   Coriell; AG07963
DR   Wikidata; Q54741444
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I71 ! AG07962
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG07980
AC   CVCL_2L87
DR   CLO; CLO_0033522
DR   Coriell; AG07980
DR   Wikidata; Q54741447
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L88 ! AG07984
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG07984
AC   CVCL_2L88
DR   CLO; CLO_0033525
DR   Coriell; AG07984
DR   Wikidata; Q54741451
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L87 ! AG07980
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG07988
AC   CVCL_A2NQ
SY   AG07988A
DR   Coriell; AG07988
DR   Wikidata; Q105506305
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG07988; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y11M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG07989
AC   CVCL_4P52
DR   CLO; CLO_0033524
DR   Coriell; AG07989
DR   Wikidata; Q54741454
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG07996
AC   CVCL_2C51
SY   GRC#0749
DR   CLO; CLO_0033534
DR   Coriell; AG07996
DR   Wikidata; Q54741455
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG07996).
CC   Karyotypic information: 46,XY [2%]; 46,XY,inv(8)(p2?;q2?) [98%] (Coriell=AG07996).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07997
AC   CVCL_2C52
SY   GRC#0751
DR   CLO; CLO_0033530
DR   Coriell; AG07997
DR   Wikidata; Q54741458
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F64 ! AG13197
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07998
AC   CVCL_2C53
SY   AG07998A; GRC#0752
DR   CLO; CLO_0033531
DR   Coriell; AG07998
DR   Wikidata; Q54741460
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG07998).
CC   Doubling time: Slow growth (Coriell=AG07998).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG07999
AC   CVCL_2C54
SY   AG_07999; GRC#0753
DR   CLO; CLO_0033545
DR   Coriell; AG07999
DR   GEO; GSM6354
DR   Wikidata; Q54741461
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: 2.5 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F29 ! AG13066
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG08000
AC   CVCL_2C55
SY   GRC#0754
DR   CLO; CLO_0033547
DR   Coriell; AG08000
DR   Wikidata; Q54741462
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG08000).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08006
AC   CVCL_2I73
DR   CLO; CLO_0033542
DR   Coriell; AG08006
DR   Wikidata; Q54741465
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08016
AC   CVCL_0N70
DR   CLO; CLO_0033544
DR   Coriell; AG08016
DR   Wikidata; Q54741467
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG08025
AC   CVCL_4K14
DR   CLO; CLO_0033540
DR   Coriell; AG08025
DR   Wikidata; Q54741472
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K15 ! AG08026
SX   Male
AG   43Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08026
AC   CVCL_4K15
DR   Coriell; AG08026
DR   Wikidata; Q54741473
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Discontinued: Coriell; AG08026; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K14 ! AG08025
SX   Male
AG   43Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG08027
AC   CVCL_4K16
SY   AG08027B
DR   CLO; CLO_0033541
DR   Coriell; AG08027
DR   Wikidata; Q54741474
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08029
AC   CVCL_2L89
DR   CLO; CLO_0033539
DR   Coriell; AG08029
DR   Wikidata; Q54741475
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L90 ! AG08030
OI   CVCL_2L91 ! AG08031
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08030
AC   CVCL_2L90
DR   CLO; CLO_0033559
DR   Coriell; AG08030
DR   Wikidata; Q54741477
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L89 ! AG08029
OI   CVCL_2L91 ! AG08031
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08031
AC   CVCL_2L91
DR   CLO; CLO_0033561
DR   Coriell; AG08031
DR   Wikidata; Q54741480
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L89 ! AG08029
OI   CVCL_2L90 ! AG08030
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08032
AC   CVCL_2L92
DR   CLO; CLO_0033564
DR   Coriell; AG08032
DR   Wikidata; Q54741481
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L93 ! AG08033
OI   CVCL_2L94 ! AG08034
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08033
AC   CVCL_2L93
SY   AG8033A
DR   CLO; CLO_0033566
DR   Coriell; AG08033
DR   Wikidata; Q54741484
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L92 ! AG08032
OI   CVCL_2L94 ! AG08034
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08034
AC   CVCL_2L94
DR   CLO; CLO_0033571
DR   Coriell; AG08034
DR   Wikidata; Q54741487
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2L92 ! AG08032
OI   CVCL_2L93 ! AG08033
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08044
AC   CVCL_H804
SY   AG8044; GRC#0765
DR   CLO; CLO_0033573
DR   Coriell; AG08044
DR   Wikidata; Q54741489
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 36 PDL (Coriell=AG08044).
CC   Karyotypic information: 46,XX,21s+ (Coriell=AG08044).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   AG08045
AC   CVCL_2C56
SY   GRC#0766
DR   CLO; CLO_0033575
DR   Coriell; AG08045
DR   Wikidata; Q54741491
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [86%]; 45,X [4%]; 46,XY,t(5;6)(p15;q23) [10%] (Coriell=AG08045).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08046
AC   CVCL_2C57
SY   GRC#0769
DR   CLO; CLO_0033577
DR   Coriell; AG08046
DR   GEO; GSM426266
DR   Wikidata; Q54741492
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG08046).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG08047
AC   CVCL_2C58
SY   GRC#0770
DR   CLO; CLO_0033569
DR   Coriell; AG08047
DR   Wikidata; Q54741493
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG08047).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08048
AC   CVCL_2C59
SY   GRC#0771
DR   CLO; CLO_0033570
DR   Coriell; AG08048
DR   GEO; GSM426267
DR   Wikidata; Q54741496
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F07 ! AG12988
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG08049
AC   CVCL_2C60
SY   GRC#0773
DR   CLO; CLO_0033590
DR   Coriell; AG08049
DR   Wikidata; Q54741497
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F08 ! AG12989
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08050
AC   CVCL_2C61
SY   GRC#0774
DR   CLO; CLO_0033596
DR   Coriell; AG08050
DR   Wikidata; Q54741498
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG08050).
CC   Karyotypic information: 46,XX [83%]; 46,XX,t(7;20)(7pter->7q22::20p13->20pter;20qter->20p13::7q22->7qter) [17%] (Coriell=AG08050).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08052
AC   CVCL_2L95
DR   CLO; CLO_0033598
DR   Coriell; AG08052
DR   Wikidata; Q54741500
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2L96 ! AG08053
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08053
AC   CVCL_2L96
DR   CLO; CLO_0033591
DR   Coriell; AG08053
DR   Wikidata; Q54741503
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2L95 ! AG08052
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08056
AC   CVCL_2L97
DR   CLO; CLO_0033593
DR   Coriell; AG08056
DR   Wikidata; Q54741505
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2L98 ! AG08057
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08057
AC   CVCL_2L98
DR   CLO; CLO_0033603
DR   Coriell; AG08057
DR   Wikidata; Q54741509
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2L97 ! AG08056
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08063
AC   CVCL_4K17
DR   CLO; CLO_0033606
DR   Coriell; AG08063
DR   Wikidata; Q54741510
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K18 ! AG08064
SX   Male
AG   41Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   AG08064
AC   CVCL_4K18
SY   AG08064A
DR   CLO; CLO_0033599
DR   Coriell; AG08064
DR   Wikidata; Q54741559
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K17 ! AG08063
SX   Male
AG   41Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08075
AC   CVCL_2L99
DR   CLO; CLO_0033602
DR   Coriell; AG08075
DR   Wikidata; Q54741562
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M00 ! AG08076
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08076
AC   CVCL_2M00
DR   CLO; CLO_0033607
DR   Coriell; AG08076
DR   Wikidata; Q54741563
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2L99 ! AG08075
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08080
AC   CVCL_2M01
DR   CLO; CLO_0033609
DR   Coriell; AG08080
DR   Wikidata; Q54741565
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2M02 ! AG08082
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08082
AC   CVCL_2M02
DR   CLO; CLO_0033610
DR   Coriell; AG08082
DR   Wikidata; Q54741567
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2M01 ! AG08080
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08102
AC   CVCL_2M03
DR   CLO; CLO_0033611
DR   Coriell; AG08102
DR   Wikidata; Q54741568
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M04 ! AG08103
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08103
AC   CVCL_2M04
DR   CLO; CLO_0033614
DR   Coriell; AG08103
DR   Wikidata; Q54741569
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M03 ! AG08102
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08109
AC   CVCL_4K19
SY   AG08109B
DR   CLO; CLO_0033615
DR   Coriell; AG08109
DR   Wikidata; Q54741574
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (from autologous cell line AG08110).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K20 ! AG08110
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG08110
AC   CVCL_4K20
DR   CLO; CLO_0033617
DR   Coriell; AG08110
DR   Wikidata; Q54741576
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K19 ! AG08109
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG08111
AC   CVCL_4K21
SY   AG08111A
DR   CLO; CLO_0033619
DR   Coriell; AG08111
DR   Wikidata; Q54741580
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K22 ! AG08112
SX   Female
AG   24Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08112
AC   CVCL_4K22
DR   CLO; CLO_0033622
DR   Coriell; AG08112
DR   Wikidata; Q54741582
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K21 ! AG08111
SX   Female
AG   24Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08113
AC   CVCL_H980
SY   AG 08113
DR   CLO; CLO_0033624
DR   Coriell; AG08113
DR   Wikidata; Q54741584
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Duroc; VBO=VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_H981 ! AG08114
OI   CVCL_H979 ! AG08116
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   AG08114
AC   CVCL_H981
SY   AG 08114
DR   CLO; CLO_0033625
DR   Coriell; AG08114
DR   Wikidata; Q54741586
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Duroc; VBO=VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_H980 ! AG08113
OI   CVCL_H979 ! AG08116
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   AG08116
AC   CVCL_H979
DR   CLO; CLO_0033721
DR   Coriell; AG08116
DR   Wikidata; Q54741589
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Duroc; VBO=VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_H980 ! AG08113
OI   CVCL_H981 ! AG08114
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   AG08117
AC   CVCL_2M05
DR   CLO; CLO_0033722
DR   Coriell; AG08117
DR   Wikidata; Q54741590
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M06 ! AG08118
SX   Female
AG   16D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08118
AC   CVCL_2M06
DR   CLO; CLO_0033723
DR   Coriell; AG08118
DR   Wikidata; Q54741591
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M05 ! AG08117
SX   Female
AG   16D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08124
AC   CVCL_4K23
DR   CLO; CLO_0033724
DR   Coriell; AG08124
DR   Wikidata; Q54741592
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K24 ! AG08125
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08125
AC   CVCL_4K24
SY   AG08125A
DR   CLO; CLO_0033751
DR   Coriell; AG08125
DR   Wikidata; Q54741596
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
RX   PubMed=30699343;
CC   Population: Caucasian; Italian.
CC   Doubling time: Slow growth (Coriell=AG08125).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K23 ! AG08124
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08126
AC   CVCL_4K25
DR   CLO; CLO_0033749
DR   Coriell; AG08126
DR   Wikidata; Q54741598
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K26 ! AG08127
SX   Female
AG   37Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08127
AC   CVCL_4K26
DR   CLO; CLO_0033748
DR   Coriell; AG08127
DR   Wikidata; Q54741599
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K25 ! AG08126
SX   Female
AG   37Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08128
AC   CVCL_4P53
DR   CLO; CLO_0033746
DR   Coriell; AG08128
DR   Wikidata; Q54741602
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P54 ! AG08129
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG08129
AC   CVCL_4P54
SY   AG 8129
DR   CLO; CLO_0033745
DR   Coriell; AG08129
DR   Wikidata; Q54741604
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P53 ! AG08128
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08130
AC   CVCL_H982
DR   CLO; CLO_0033743
DR   Coriell; AG08130
DR   Wikidata; Q54741606
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_H983 ! AG08131
OI   CVCL_H984 ! AG08132
OI   CVCL_H985 ! AG08133
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   AG08131
AC   CVCL_H983
SY   AG08131A
DR   CLO; CLO_0033739
DR   Coriell; AG08131
DR   Wikidata; Q54741609
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_H982 ! AG08130
OI   CVCL_H984 ! AG08132
OI   CVCL_H985 ! AG08133
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   AG08132
AC   CVCL_H984
SY   AG08132A; AG08132B
DR   CLO; CLO_0033737
DR   Coriell; AG08132
DR   Wikidata; Q54741611
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_H982 ! AG08130
OI   CVCL_H983 ! AG08131
OI   CVCL_H985 ! AG08133
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   AG08133
AC   CVCL_H985
SY   AG08133A
DR   CLO; CLO_0033738
DR   Coriell; AG08133
DR   Wikidata; Q54741613
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_H982 ! AG08130
OI   CVCL_H983 ! AG08131
OI   CVCL_H984 ! AG08132
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   AG08136
AC   CVCL_4K27
DR   CLO; CLO_0033735
DR   Coriell; AG08136
DR   Wikidata; Q54741614
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K28 ! AG08137
SX   Male
AG   28Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08137
AC   CVCL_4K28
SY   AG08137A
DR   CLO; CLO_0033736
DR   Coriell; AG08137
DR   Wikidata; Q54741616
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K27 ! AG08136
SX   Male
AG   28Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08138
AC   CVCL_4K29
DR   CLO; CLO_0033691
DR   Coriell; AG08138
DR   Wikidata; Q54741617
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K30 ! AG08139
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08139
AC   CVCL_4K30
DR   CLO; CLO_0033689
DR   Coriell; AG08139
DR   Wikidata; Q54741621
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Doubling time: Slow growth (Coriell=AG08139).
CC   Karyotypic information: 46,XY,t(1;5)(1qter->1p13::5p13->5pter::5qter->5p13::1p13->1pter) [2]; 46,XY [48] (Coriell=AG08139).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K29 ! AG08138
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08140
AC   CVCL_4K31
DR   CLO; CLO_0033694
DR   Coriell; AG08140
DR   Wikidata; Q54741622
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K32 ! AG08141
SX   Male
AG   23Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08141
AC   CVCL_4K32
DR   CLO; CLO_0033693
DR   Coriell; AG08141
DR   Wikidata; Q54741624
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K31 ! AG08140
SX   Male
AG   23Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08142
AC   CVCL_4K33
DR   CLO; CLO_0033697
DR   Coriell; AG08142
DR   Wikidata; Q54741628
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08143
AC   CVCL_4K34
DR   CLO; CLO_0033679
DR   Coriell; AG08143
DR   Wikidata; Q54741629
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08151
AC   CVCL_2M07
DR   CLO; CLO_0033680
DR   Coriell; AG08151
DR   Wikidata; Q54741633
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M08 ! AG08152
OI   CVCL_2M09 ! AG08153
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08152
AC   CVCL_2M08
DR   CLO; CLO_0033681
DR   Coriell; AG08152
DR   Wikidata; Q54741635
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M07 ! AG08151
OI   CVCL_2M09 ! AG08153
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08153
AC   CVCL_2M09
DR   CLO; CLO_0033682
DR   Coriell; AG08153
DR   Wikidata; Q54741637
RX   CelloPub=CLPUB00597;
CC   Doubling time: Slow growth (Coriell=AG08153).
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M07 ! AG08151
OI   CVCL_2M08 ! AG08152
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AG08157
AC   CVCL_2M10
DR   CLO; CLO_0033683
DR   Coriell; AG08157
DR   Wikidata; Q54741640
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M11 ! AG08158
OI   CVCL_2M12 ! AG08160
SX   Male
AG   42D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08158
AC   CVCL_2M11
DR   CLO; CLO_0033684
DR   Coriell; AG08158
DR   Wikidata; Q54741642
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M10 ! AG08157
OI   CVCL_2M12 ! AG08160
SX   Male
AG   42D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08160
AC   CVCL_2M12
DR   CLO; CLO_0033715
DR   Coriell; AG08160
DR   Wikidata; Q54741643
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M10 ! AG08157
OI   CVCL_2M11 ! AG08158
SX   Male
AG   42D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08161
AC   CVCL_X843
DR   CLO; CLO_0033714
DR   Coriell; AG08161
DR   Wikidata; Q54741700
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X844 ! AG08162
SX   Female
AG   49Y4M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 13
//
ID   AG08162
AC   CVCL_X844
DR   CLO; CLO_0033712
DR   Coriell; AG08162
DR   Wikidata; Q54741703
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X843 ! AG08161
SX   Female
AG   49Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG08163
AC   CVCL_X845
DR   CLO; CLO_0033710
DR   Coriell; AG08163
DR   Wikidata; Q54741705
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X846 ! AG08164
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   AG08164
AC   CVCL_X846
DR   CLO; CLO_0033702
DR   Coriell; AG08164
DR   Wikidata; Q54741706
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X845 ! AG08163
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   AG08165
AC   CVCL_X847
DR   CLO; CLO_0033700
DR   Coriell; AG08165
DR   Wikidata; Q54741708
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X848 ! AG08166
SX   Female
AG   27Y4M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   AG08166
AC   CVCL_X848
DR   CLO; CLO_0033701
DR   Coriell; AG08166
DR   Wikidata; Q54741712
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X847 ! AG08165
SX   Female
AG   27Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   AG08167
AC   CVCL_X849
DR   CLO; CLO_0033705
DR   Coriell; AG08167
DR   Wikidata; Q54741713
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X850 ! AG08168
SX   Female
AG   46Y8M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 13
//
ID   AG08168
AC   CVCL_X850
DR   CLO; CLO_0033706
DR   Coriell; AG08168
DR   Wikidata; Q54741716
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X849 ! AG08167
SX   Female
AG   46Y8M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG08169
AC   CVCL_H805
SY   AG08169B
DR   CLO; CLO_0033703
DR   Coriell; AG08169
DR   Wikidata; Q54741719
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from autologous cell line AG08170).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H806 ! AG08170
SX   Male
AG   56Y3M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   AG08170
AC   CVCL_H806
SY   AG8170; AG 8170A; AG08170A; AG08170B
DR   CLO; CLO_0033704
DR   Coriell; AG08170
DR   Wikidata; Q54741721
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=7847674;
RX   PubMed=8247227;
RX   PubMed=8643543;
RX   PubMed=8832629;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H805 ! AG08169
SX   Male
AG   56Y3M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   AG08171
AC   CVCL_4P55
DR   CLO; CLO_0033984
DR   Coriell; AG08171
DR   Wikidata; Q54741725
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P56 ! AG08172
SX   Male
AG   44Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08172
AC   CVCL_4P56
DR   CLO; CLO_0033986
DR   Coriell; AG08172
DR   Wikidata; Q54741726
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG08172).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P55 ! AG08171
SX   Male
AG   44Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08173
AC   CVCL_4P57
DR   CLO; CLO_0033981
DR   Coriell; AG08173
DR   Wikidata; Q54741729
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P58 ! AG08174
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08174
AC   CVCL_4P58
DR   CLO; CLO_0034007
DR   Coriell; AG08174
DR   Wikidata; Q54741733
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P57 ! AG08173
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08175
AC   CVCL_4P59
DR   CLO; CLO_0034005
DR   Coriell; AG08175
DR   Wikidata; Q54741734
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N81 ! AG07596
SX   Female
AG   33Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08176
AC   CVCL_4P60
DR   CLO; CLO_0034002
DR   Coriell; AG08176
DR   Wikidata; Q54741736
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N77 ! AG07590
SX   Female
AG   38Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08178
AC   CVCL_4P61
DR   CLO; CLO_0034000
DR   Coriell; AG08178
DR   Wikidata; Q54741739
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P62 ! AG08179
SX   Male
AG   53Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08179
AC   CVCL_4P62
SY   AG08179A; AG08179B
DR   CLO; CLO_0033997
DR   Coriell; AG08179
DR   Wikidata; Q54741741
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P61 ! AG08178
SX   Male
AG   53Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08180
AC   CVCL_4P63
DR   CLO; CLO_0033996
DR   Coriell; AG08180
DR   Wikidata; Q54741743
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P64 ! AG08181
SX   Male
AG   33Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08181
AC   CVCL_4P64
DR   CLO; CLO_0033994
DR   Coriell; AG08181
DR   Wikidata; Q54741749
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P63 ! AG08180
SX   Male
AG   33Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08182
AC   CVCL_4P65
DR   CLO; CLO_0033993
DR   Coriell; AG08182
DR   Wikidata; Q54741750
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P66 ! AG08183
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08183
AC   CVCL_4P66
DR   CLO; CLO_0034011
DR   Coriell; AG08183
DR   Wikidata; Q54741752
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P65 ! AG08182
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08184
AC   CVCL_4P67
DR   CLO; CLO_0034014
DR   Coriell; AG08184
DR   Wikidata; Q54741756
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P68 ! AG08185
SX   Female
AG   49Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08185
AC   CVCL_4P68
DR   CLO; CLO_0034021
DR   Coriell; AG08185
DR   Wikidata; Q54741759
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P67 ! AG08184
SX   Female
AG   49Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG0819
AC   CVCL_8B71
DR   ECACC; 93112202
DR   Wikidata; Q54741761
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG08242
AC   CVCL_4K35
DR   CLO; CLO_0034033
DR   Coriell; AG08242
DR   Wikidata; Q54741764
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (Coriell=AG08242).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K36 ! AG08243
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG08243
AC   CVCL_4K36
DR   CLO; CLO_0034032
DR   Coriell; AG08243
DR   Wikidata; Q54741767
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
RX   PubMed=10408806;
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K35 ! AG08242
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08244
AC   CVCL_4K37
DR   CLO; CLO_0034038
DR   Coriell; AG08244
DR   Wikidata; Q54741770
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K38 ! AG08245
SX   Male
AG   74Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08245
AC   CVCL_4K38
DR   CLO; CLO_0034035
DR   Coriell; AG08245
DR   Wikidata; Q54741773
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K37 ! AG08244
SX   Male
AG   74Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08248
AC   CVCL_2M13
DR   CLO; CLO_0034027
DR   Coriell; AG08248
DR   Wikidata; Q54741775
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M14 ! AG08249
OI   CVCL_2M15 ! AG08250
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08249
AC   CVCL_2M14
DR   CLO; CLO_0034025
DR   Coriell; AG08249
DR   Wikidata; Q54741776
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M13 ! AG08248
OI   CVCL_2M15 ! AG08250
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08250
AC   CVCL_2M15
DR   CLO; CLO_0034030
DR   Coriell; AG08250
DR   Wikidata; Q54741779
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M13 ! AG08248
OI   CVCL_2M14 ! AG08249
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08252
AC   CVCL_4P69
DR   CLO; CLO_0034029
DR   Coriell; AG08252
DR   Wikidata; Q54741781
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P70 ! AG08253
SX   Male
AG   29Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08253
AC   CVCL_4P70
DR   CLO; CLO_0033915
DR   Coriell; AG08253
DR   Wikidata; Q54741783
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P69 ! AG08252
SX   Male
AG   29Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08257
AC   CVCL_4K39
DR   CLO; CLO_0033925
DR   Coriell; AG08257
DR   Wikidata; Q54741784
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K42 ! AG08260
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08258
AC   CVCL_4K40
DR   CLO; CLO_0033923
DR   Coriell; AG08258
DR   Wikidata; Q54741786
RX   CelloPub=CLPUB00597;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K41 ! AG08259
SX   Male
AG   90Y11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08259
AC   CVCL_4K41
DR   CLO; CLO_0033936
DR   Coriell; AG08259
DR   Wikidata; Q54741788
RX   CelloPub=CLPUB00597;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K40 ! AG08258
SX   Male
AG   90Y11M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08260
AC   CVCL_4K42
DR   CLO; CLO_0033934
DR   Coriell; AG08260
DR   Wikidata; Q54741790
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K39 ! AG08257
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08264
AC   CVCL_4K43
SY   AG08264A
DR   CLO; CLO_0033931
DR   Coriell; AG08264
DR   Wikidata; Q54741792
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K44 ! AG08265
SX   Male
AG   59Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08265
AC   CVCL_4K44
SY   AG08265A
DR   CLO; CLO_0033929
DR   Coriell; AG08265
DR   Wikidata; Q54741793
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K43 ! AG08264
SX   Male
AG   59Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08266
AC   CVCL_4K45
DR   CLO; CLO_0033945
DR   Coriell; AG08266
DR   Wikidata; Q54741852
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08268
AC   CVCL_4K46
DR   CLO; CLO_0033942
DR   Coriell; AG08268
DR   Wikidata; Q54741854
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K47 ! AG08269
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08269
AC   CVCL_4K47
DR   CLO; CLO_0033941
DR   Coriell; AG08269
DR   Wikidata; Q54741857
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K46 ! AG08268
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08305
AC   CVCL_2M16
DR   CLO; CLO_0033939
DR   Coriell; AG08305
DR   Wikidata; Q54741859
RX   CelloPub=CLPUB00597;
RX   PubMed=21489251;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08308
AC   CVCL_2M17
DR   CLO; CLO_0033955
DR   Coriell; AG08308
DR   Wikidata; Q54741861
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08311
AC   CVCL_4K48
DR   CLO; CLO_0033958
DR   Coriell; AG08311
DR   Wikidata; Q54741864
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08312
AC   CVCL_2M18
DR   CLO; CLO_0033956
DR   Coriell; AG08312
DR   Wikidata; Q54741866
RX   CelloPub=CLPUB00597;
RX   PubMed=21489251;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08316
AC   CVCL_H986
DR   CLO; CLO_0033962
DR   Coriell; AG08316
DR   Wikidata; Q54741868
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_H987 ! AG08318
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   AG08318
AC   CVCL_H987
SY   AG08318A
DR   CLO; CLO_0033960
DR   Coriell; AG08318
DR   Wikidata; Q54741870
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_H986 ! AG08316
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   AG08319
AC   CVCL_2M19
DR   CLO; CLO_0033966
DR   Coriell; AG08319
DR   Wikidata; Q54741873
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_2M20 ! AG08320
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08320
AC   CVCL_2M20
DR   CLO; CLO_0033963
DR   Coriell; AG08320
DR   Wikidata; Q54741876
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_2M19 ! AG08319
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08323
AC   CVCL_2M21
SY   AG08323A
DR   CLO; CLO_0033972
DR   Coriell; AG08323
DR   Wikidata; Q54741878
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_2M22 ! AG08324
OI   CVCL_2M23 ! AG08326
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08324
AC   CVCL_2M22
DR   CLO; CLO_0033969
DR   Coriell; AG08324
DR   Wikidata; Q54741880
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_2M21 ! AG08323
OI   CVCL_2M23 ! AG08326
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08326
AC   CVCL_2M23
DR   CLO; CLO_0033975
DR   Coriell; AG08326
DR   Wikidata; Q54741882
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_2M21 ! AG08323
OI   CVCL_2M22 ! AG08324
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08346
AC   CVCL_2M24
DR   CLO; CLO_0033875
DR   Coriell; AG08346
DR   Wikidata; Q54741884
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M25 ! AG08347
OI   CVCL_2M26 ! AG08351
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08347
AC   CVCL_2M25
DR   CLO; CLO_0033877
DR   Coriell; AG08347
DR   Wikidata; Q54741886
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M24 ! AG08346
OI   CVCL_2M26 ! AG08351
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08351
AC   CVCL_2M26
DR   CLO; CLO_0033871
DR   Coriell; AG08351
DR   Wikidata; Q54741888
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M24 ! AG08346
OI   CVCL_2M25 ! AG08347
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08374
AC   CVCL_4K49
SY   AG08374A
DR   CLO; CLO_0033874
DR   Coriell; AG08374
DR   Wikidata; Q54741890
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K50 ! AG08375
SX   Female
AG   13Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08375
AC   CVCL_4K50
DR   CLO; CLO_0033868
DR   Coriell; AG08375
DR   Wikidata; Q54741893
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K49 ! AG08374
SX   Female
AG   13Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08376
AC   CVCL_4K51
DR   CLO; CLO_0033869
DR   Coriell; AG08376
DR   Wikidata; Q54741894
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08378
AC   CVCL_4K52
DR   CLO; CLO_0033865
DR   Coriell; AG08378
DR   Wikidata; Q54741897
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K53 ! AG08379
SX   Female
AG   60Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08379
AC   CVCL_4K53
DR   CLO; CLO_0033866
DR   Coriell; AG08379
DR   Wikidata; Q54741899
RX   PubMed=10408806;
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K52 ! AG08378
SX   Female
AG   60Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08380
AC   CVCL_4K54
DR   CLO; CLO_0033863
DR   Coriell; AG08380
DR   Wikidata; Q54741901
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K55 ! AG08381
SX   Female
AG   40Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08381
AC   CVCL_4K55
DR   CLO; CLO_0033864
DR   Coriell; AG08381
DR   Wikidata; Q54741903
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K54 ! AG08380
SX   Female
AG   40Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08395
AC   CVCL_N795
SY   PF95
DR   CLO; CLO_0033911
DR   Coriell; AG08395
DR   ENCODE; ENCBS040ENC
DR   ENCODE; ENCBS287AAA
DR   GEO; GSM1008575
DR   Wikidata; Q54741905
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/FibroP_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N796 ! AG08396
SX   Female
AG   85Y9M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   AG08396
AC   CVCL_N796
SY   PF96
DR   CLO; CLO_0033902
DR   Coriell; AG08396
DR   ENCODE; ENCBS288AAA
DR   GEO; GSM1008562
DR   Wikidata; Q54741908
RX   CelloPub=CLPUB00597;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/FibroP_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N795 ! AG08395
SX   Female
AG   85Y9M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   AG08419
AC   CVCL_2M27
DR   CLO; CLO_0033903
DR   Coriell; AG08419
DR   Wikidata; Q54741909
RX   CelloPub=CLPUB00597;
RX   PubMed=21518243;
CC   Senescence: Senesces at 55 PDL (PubMed=21518243).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2M28 ! AG08420
OI   CVCL_2M29 ! AG08421
OI   CVCL_2M30 ! AG08422
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08420
AC   CVCL_2M28
DR   CLO; CLO_0033906
DR   Coriell; AG08420
DR   Wikidata; Q54741911
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2M27 ! AG08419
OI   CVCL_2M29 ! AG08421
OI   CVCL_2M30 ! AG08422
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08421
AC   CVCL_2M29
DR   CLO; CLO_0033908
DR   Coriell; AG08421
DR   Wikidata; Q54741913
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2M27 ! AG08419
OI   CVCL_2M28 ! AG08420
OI   CVCL_2M30 ! AG08422
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08422
AC   CVCL_2M30
DR   CLO; CLO_0033895
DR   Coriell; AG08422
DR   Wikidata; Q54741915
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_2M27 ! AG08419
OI   CVCL_2M28 ! AG08420
OI   CVCL_2M29 ! AG08421
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08423
AC   CVCL_2M31
DR   CLO; CLO_0033897
DR   Coriell; AG08423
DR   Wikidata; Q54741917
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M32 ! AG08424
SX   Female
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08424
AC   CVCL_2M32
DR   CLO; CLO_0033898
DR   Coriell; AG08424
DR   Wikidata; Q54741918
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M31 ! AG08423
SX   Female
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08426
AC   CVCL_2M33
DR   CLO; CLO_0033899
DR   Coriell; AG08426
DR   Wikidata; Q54741921
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M34 ! AG08427
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08427
AC   CVCL_2M34
DR   CLO; CLO_0033893
DR   Coriell; AG08427
DR   Wikidata; Q54741923
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M33 ! AG08426
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08430
AC   CVCL_2C62
SY   GRC#0329
DR   CLO; CLO_0034212
DR   Coriell; AG08430
DR   Wikidata; Q54741925
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F04 ! AG12964
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08431
AC   CVCL_2C63
SY   GRC#0316
DR   CLO; CLO_0034214
DR   Coriell; AG08431
DR   Wikidata; Q54741927
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [8%]; 46,XY,t(1;10)(q12;q26),t(13;15)(q22;p13) [92%] (Coriell=AG08431).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G02 ! AG13337
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08432
AC   CVCL_2C64
SY   GRC#0326
DR   CLO; CLO_0034213
DR   Coriell; AG08432
DR   Wikidata; Q54741929
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08433
AC   CVCL_L625
SY   AG08433B; GRC#0336
DR   CLO; CLO_0034238
DR   Coriell; AG08433
DR   GEO; GSM3124670
DR   Wikidata; Q54741932
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=15450399;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (PubMed=9724752).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L624 ! AG04064
SX   Male
AG   94Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   AG08434
AC   CVCL_2C65
SY   AG08434A; GRC#0384
DR   CLO; CLO_0034240
DR   Coriell; AG08434
DR   Wikidata; Q54741933
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 51 PDL (Coriell=AG08434).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08440
AC   CVCL_4K56
DR   CLO; CLO_0034234
DR   Coriell; AG08440
DR   Wikidata; Q54741936
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08442
AC   CVCL_2C66
DR   CLO; CLO_0034237
DR   Coriell; AG08442
DR   Wikidata; Q54741986
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08445
AC   CVCL_4K57
DR   CLO; CLO_0034244
DR   Coriell; AG08445
DR   Wikidata; Q54741990
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (from autologous cell line AG08446).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K58 ! AG08446
SX   Male
AG   38Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG08446
AC   CVCL_4K58
DR   CLO; CLO_0034245
DR   Coriell; AG08446
DR   Wikidata; Q54741991
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
RX   PubMed=24416243;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (PubMed=10408806; PubMed=24416243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K57 ! AG08445
SX   Male
AG   38Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08452
AC   CVCL_2I48
DR   CLO; CLO_0034242
DR   Coriell; AG08452
DR   Wikidata; Q54741992
RX   CelloPub=CLPUB00597;
RX   PubMed=21489251;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2I49 ! AG08453
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08453
AC   CVCL_2I49
DR   CLO; CLO_0034228
DR   Coriell; AG08453
DR   Wikidata; Q54741994
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2I48 ! AG08452
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08454
AC   CVCL_2M35
DR   CLO; CLO_0034227
DR   Coriell; AG08454
DR   Wikidata; Q54741997
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M36 ! AG08455
OI   CVCL_2M37 ! AG08457
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08455
AC   CVCL_2M36
DR   CLO; CLO_0034226
DR   Coriell; AG08455
DR   Wikidata; Q54741999
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M35 ! AG08454
OI   CVCL_2M37 ! AG08457
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08457
AC   CVCL_2M37
DR   CLO; CLO_0034225
DR   Coriell; AG08457
DR   Wikidata; Q54742001
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M35 ! AG08454
OI   CVCL_2M36 ! AG08455
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08458
AC   CVCL_2M38
DR   CLO; CLO_0034146
DR   Coriell; AG08458
DR   Wikidata; Q54742004
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M39 ! AG08459
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08459
AC   CVCL_2M39
DR   CLO; CLO_0034145
DR   Coriell; AG08459
DR   Wikidata; Q54742007
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M38 ! AG08458
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08462
AC   CVCL_2M40
DR   CLO; CLO_0034148
DR   Coriell; AG08462
DR   Wikidata; Q54742010
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M41 ! AG08463
OI   CVCL_2M42 ! AG08465
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08463
AC   CVCL_2M41
DR   CLO; CLO_0034147
DR   Coriell; AG08463
DR   Wikidata; Q54742012
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M40 ! AG08462
OI   CVCL_2M42 ! AG08465
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08465
AC   CVCL_2M42
DR   CLO; CLO_0034144
DR   Coriell; AG08465
DR   Wikidata; Q54742014
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M40 ! AG08462
OI   CVCL_2M41 ! AG08463
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG08466
AC   CVCL_L272
SY   AG8466
DR   CLO; CLO_0034143
DR   Coriell; AG08466
DR   Wikidata; Q54742017
RX   CelloPub=CLPUB00597;
RX   PubMed=8246632;
RX   PubMed=15130666;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L273 ! AG08467
OI   CVCL_L271 ! AG08671
SX   Female
AG   8Y5M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   AG08467
AC   CVCL_L273
DR   CLO; CLO_0034142
DR   Coriell; AG08467
DR   Wikidata; Q54742018
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L272 ! AG08466
OI   CVCL_L271 ! AG08671
SX   Female
AG   8Y5M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   AG08468
AC   CVCL_L274
SY   AG8468
DR   CLO; CLO_0034138
DR   Coriell; AG08468
DR   Wikidata; Q54742022
RX   CelloPub=CLPUB00597;
RX   PubMed=8246632;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L276 ! AG08672
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AG08469
AC   CVCL_L275
SY   AG8469
DR   CLO; CLO_0034139
DR   Coriell; AG08469
DR   Wikidata; Q54742024
RX   CelloPub=CLPUB00597;
RX   PubMed=8246632;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L278 ! AG08916
SX   Male
AG   38Y6M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AG08470
AC   CVCL_L270
SY   AG08470A
DR   CLO; CLO_0034140
DR   Coriell; AG08470
DR   ENCODE; ENCBS284AAA
DR   GEO; GSM1023614
DR   GEO; GSM1023615
DR   Wikidata; Q54742027
RX   CelloPub=CLPUB00597;
RX   PubMed=19958786;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/fibroblast_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L277 ! AG08673
SX   Female
AG   10Y9M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   AG08471
AC   CVCL_1Y50
DR   CLO; CLO_0034141
DR   Coriell; AG08471
DR   Wikidata; Q54742029
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08472
AC   CVCL_2M43
SY   AG08472A
DR   CLO; CLO_0034159
DR   Coriell; AG08472
DR   Wikidata; Q54742030
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2M44 ! AG08473
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08473
AC   CVCL_2M44
SY   AG08473A
DR   CLO; CLO_0034158
DR   Coriell; AG08473
DR   Wikidata; Q54742032
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2M43 ! AG08472
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08475
AC   CVCL_2M45
DR   CLO; CLO_0034157
DR   Coriell; AG08475
DR   Wikidata; Q54742035
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08477
AC   CVCL_2M46
DR   CLO; CLO_0034156
DR   Coriell; AG08477
DR   Wikidata; Q54742036
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08478
AC   CVCL_2M47
DR   CLO; CLO_0034155
DR   Coriell; AG08478
DR   Wikidata; Q54742037
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M48 ! AG08479
OI   CVCL_2M49 ! AG08480
SX   Female
AG   51D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08479
AC   CVCL_2M48
DR   CLO; CLO_0034153
DR   Coriell; AG08479
DR   Wikidata; Q54742039
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M47 ! AG08478
OI   CVCL_2M49 ! AG08480
SX   Female
AG   51D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08480
AC   CVCL_2M49
DR   CLO; CLO_0034154
DR   Coriell; AG08480
DR   Wikidata; Q54742040
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M47 ! AG08478
OI   CVCL_2M48 ! AG08479
SX   Female
AG   51D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08482
AC   CVCL_2M50
DR   CLO; CLO_0034151
DR   Coriell; AG08482
DR   Wikidata; Q54742043
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M51 ! AG08483
SX   Male
AG   7FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08483
AC   CVCL_2M51
DR   CLO; CLO_0034152
DR   Coriell; AG08483
DR   Wikidata; Q54742045
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M50 ! AG08482
SX   Male
AG   7FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08486
AC   CVCL_2M52
DR   CLO; CLO_0034149
DR   Coriell; AG08486
DR   Wikidata; Q54742047
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Doubling time: Slow growth (Coriell=AG08486).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08488
AC   CVCL_2M53
DR   CLO; CLO_0034150
DR   Coriell; AG08488
DR   Wikidata; Q54742050
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08490
AC   CVCL_2M54
DR   CLO; CLO_0034169
DR   Coriell; AG08490
DR   Wikidata; Q54742052
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08491
AC   CVCL_2M55
DR   CLO; CLO_0034168
DR   Coriell; AG08491
DR   Wikidata; Q54742055
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08493
AC   CVCL_2M56
DR   CLO; CLO_0034174
DR   Coriell; AG08493
DR   Wikidata; Q54742058
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08494
AC   CVCL_2M57
DR   CLO; CLO_0034172
DR   Coriell; AG08494
DR   Wikidata; Q54742061
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   9Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08495
AC   CVCL_2M58
DR   CLO; CLO_0034160
DR   Coriell; AG08495
DR   Wikidata; Q54742063
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08498
AC   CVCL_1Y51
DR   CLO; CLO_0034161
DR   Coriell; AG08498
DR   GEO; GSM3124560
DR   Wikidata; Q54742064
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   AG08500
AC   CVCL_2M59
DR   CLO; CLO_0034162
DR   Coriell; AG08500
DR   Wikidata; Q54742065
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08501
AC   CVCL_2M60
DR   CLO; CLO_0034163
DR   Coriell; AG08501
DR   Wikidata; Q54742067
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08503
AC   CVCL_2M61
DR   CLO; CLO_0034164
DR   Coriell; AG08503
DR   Wikidata; Q54742070
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M62 ! AG08504
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08504
AC   CVCL_2M62
SY   AG08504A
DR   CLO; CLO_0034165
DR   Coriell; AG08504
DR   Wikidata; Q54742071
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M61 ! AG08503
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08506
AC   CVCL_4K59
DR   CLO; CLO_0034166
DR   Coriell; AG08506
DR   Wikidata; Q54742126
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K60 ! AG08507
SX   Female
AG   17Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08507
AC   CVCL_4K60
DR   CLO; CLO_0034191
DR   Coriell; AG08507
DR   Wikidata; Q54742127
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K59 ! AG08506
SX   Female
AG   17Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08508
AC   CVCL_A2DW
SY   AG08508B
DR   Coriell; AG08508
DR   Wikidata; Q105506306
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (from autologous cell line AG08509).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG08508; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K61 ! AG08509
SX   Male
AG   72Y10M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   AG08509
AC   CVCL_4K61
DR   CLO; CLO_0034190
DR   Coriell; AG08509
DR   Wikidata; Q54742130
RX   CelloPub=CLPUB00597;
RX   PubMed=30699343;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2DW ! AG08508
SX   Male
AG   72Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   AG08511
AC   CVCL_4K62
DR   CLO; CLO_0034189
DR   Coriell; AG08511
DR   Wikidata; Q54742131
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08512
AC   CVCL_4K63
DR   CLO; CLO_0034183
DR   Coriell; AG08512
DR   Wikidata; Q54742133
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K64 ! AG08513
SX   Male
AG   36Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08513
AC   CVCL_4K64
DR   CLO; CLO_0034184
DR   Coriell; AG08513
DR   Wikidata; Q54742136
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K63 ! AG08512
SX   Male
AG   36Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08514
AC   CVCL_4K65
DR   CLO; CLO_0034181
DR   Coriell; AG08514
DR   Wikidata; Q54742138
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K66 ! AG08515
SX   Male
AG   44Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08515
AC   CVCL_4K66
DR   CLO; CLO_0034182
DR   Coriell; AG08515
DR   Wikidata; Q54742140
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K65 ! AG08514
SX   Male
AG   44Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08516
AC   CVCL_4K67
DR   CLO; CLO_0034187
DR   Coriell; AG08516
DR   Wikidata; Q54742143
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K68 ! AG08517
SX   Female
AG   66Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08517
AC   CVCL_4K68
DR   CLO; CLO_0034188
DR   Coriell; AG08517
DR   Wikidata; Q54742144
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K67 ! AG08516
SX   Female
AG   66Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08518
AC   CVCL_4K69
DR   CLO; CLO_0034185
DR   Coriell; AG08518
DR   Wikidata; Q54742149
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08520
AC   CVCL_4K70
DR   CLO; CLO_0034186
DR   Coriell; AG08520
DR   Wikidata; Q54742150
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08522
AC   CVCL_4K71
SY   AG08522A
DR   CLO; CLO_0034334
DR   Coriell; AG08522
DR   Wikidata; Q54742153
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (from autologous cell line AG08523).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K72 ! AG08523
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG08523
AC   CVCL_4K72
DR   CLO; CLO_0034335
DR   Coriell; AG08523
DR   Wikidata; Q54742156
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K71 ! AG08522
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG08524
AC   CVCL_4K73
DR   CLO; CLO_0034352
DR   Coriell; AG08524
DR   Wikidata; Q54742158
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K74 ! AG08525
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08525
AC   CVCL_4K74
DR   CLO; CLO_0034350
DR   Coriell; AG08525
DR   Wikidata; Q54742160
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K73 ! AG08524
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08526
AC   CVCL_4K75
DR   CLO; CLO_0034349
DR   Coriell; AG08526
DR   Wikidata; Q54742163
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (from autologous cell line AG08527).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K76 ! AG08527
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG08527
AC   CVCL_4K76
SY   AG08527A
DR   CLO; CLO_0034347
DR   Coriell; AG08527
DR   Wikidata; Q54742165
RX   CelloPub=CLPUB00597;
RX   PubMed=8832629;
RX   PubMed=10408806;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K75 ! AG08526
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08528
AC   CVCL_4K77
SY   AG08528A
DR   CLO; CLO_0034342
DR   Coriell; AG08528
DR   Wikidata; Q54742167
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K78 ! AG08529
SX   Female
AG   59Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08529
AC   CVCL_4K78
DR   CLO; CLO_0034341
DR   Coriell; AG08529
DR   Wikidata; Q54742169
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K77 ! AG08528
SX   Female
AG   59Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08530
AC   CVCL_4K79
DR   CLO; CLO_0034340
DR   Coriell; AG08530
DR   Wikidata; Q54742171
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K80 ! AG08531
SX   Male
AG   33Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08531
AC   CVCL_4K80
DR   CLO; CLO_0034338
DR   Coriell; AG08531
DR   Wikidata; Q54742172
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K79 ! AG08530
SX   Male
AG   33Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08532
AC   CVCL_4K81
DR   CLO; CLO_0034337
DR   Coriell; AG08532
DR   Wikidata; Q54742173
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K82 ! AG08533
SX   Male
AG   52Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08533
AC   CVCL_4K82
DR   CLO; CLO_0034364
DR   Coriell; AG08533
DR   Wikidata; Q54742176
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K81 ! AG08532
SX   Male
AG   52Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08534
AC   CVCL_4K83
DR   CLO; CLO_0034388
DR   Coriell; AG08534
DR   Wikidata; Q54742177
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K84 ! AG08535
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08535
AC   CVCL_4K84
DR   CLO; CLO_0034386
DR   Coriell; AG08535
DR   Wikidata; Q54742180
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K83 ! AG08534
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08536
AC   CVCL_4K85
DR   CLO; CLO_0034378
DR   Coriell; AG08536
DR   Wikidata; Q54742182
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K86 ! AG08537
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08537
AC   CVCL_4K86
DR   CLO; CLO_0034376
DR   Coriell; AG08537
DR   Wikidata; Q54742183
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K85 ! AG08536
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08539
AC   CVCL_4K87
DR   CLO; CLO_0034382
DR   Coriell; AG08539
DR   Wikidata; Q54742185
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08541
AC   CVCL_4K88
SY   AG08541A
DR   CLO; CLO_0034380
DR   Coriell; AG08541
DR   Wikidata; Q54742187
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08542
AC   CVCL_4K89
DR   CLO; CLO_0034372
DR   Coriell; AG08542
DR   Wikidata; Q54742191
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K90 ! AG08543
SX   Male
AG   61Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08543
AC   CVCL_4K90
DR   CLO; CLO_0034369
DR   Coriell; AG08543
DR   Wikidata; Q54742192
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K89 ! AG08542
SX   Male
AG   61Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08544
AC   CVCL_4K91
DR   CLO; CLO_0034374
DR   Coriell; AG08544
DR   Wikidata; Q54742197
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K92 ! AG08545
SX   Male
AG   23Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08545
AC   CVCL_4K92
DR   CLO; CLO_0034373
DR   Coriell; AG08545
DR   Wikidata; Q54742198
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Doubling time: Slow growth (Coriell=AG08545).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K91 ! AG08544
SX   Male
AG   23Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08546
AC   CVCL_4K93
DR   CLO; CLO_0034408
DR   Coriell; AG08546
DR   Wikidata; Q54742201
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K94 ! AG08547
SX   Female
AG   46Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08547
AC   CVCL_4K94
DR   CLO; CLO_0034406
DR   Coriell; AG08547
DR   Wikidata; Q54742203
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K93 ! AG08546
SX   Female
AG   46Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08548
AC   CVCL_4K95
DR   CLO; CLO_0034404
DR   Coriell; AG08548
DR   Wikidata; Q54742205
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K96 ! AG08549
SX   Female
AG   40Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08549
AC   CVCL_4K96
DR   CLO; CLO_0034396
DR   Coriell; AG08549
DR   Wikidata; Q54742206
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K95 ! AG08548
SX   Female
AG   40Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08550
AC   CVCL_4K97
DR   CLO; CLO_0034394
DR   Coriell; AG08550
DR   Wikidata; Q54742209
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K98 ! AG08551
SX   Female
AG   29Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08551
AC   CVCL_4K98
DR   CLO; CLO_0034393
DR   Coriell; AG08551
DR   Wikidata; Q54742212
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K97 ! AG08550
SX   Female
AG   29Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08552
AC   CVCL_4K99
DR   CLO; CLO_0034391
DR   Coriell; AG08552
DR   Wikidata; Q54742259
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L00 ! AG08553
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08553
AC   CVCL_4L00
SY   AG08553A
DR   CLO; CLO_0034403
DR   Coriell; AG08553
DR   Wikidata; Q54742260
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4K99 ! AG08552
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08554
AC   CVCL_F259
DR   CLO; CLO_0034400
DR   Coriell; AG08554
DR   Wikidata; Q54742263
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (from autologous cell line AG08555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F260 ! AG08555
SX   Male
AG   49Y2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   AG08555
AC   CVCL_F260
DR   CLO; CLO_0034399
DR   Coriell; AG08555
DR   Wikidata; Q54742265
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F259 ! AG08554
SX   Male
AG   49Y2M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   AG08556
AC   CVCL_4L01
SY   AG08556A
DR   CLO; CLO_0034434
DR   Coriell; AG08556
DR   Wikidata; Q54742267
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L02 ! AG08557
SX   Female
AG   27Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08557
AC   CVCL_4L02
DR   CLO; CLO_0034433
DR   Coriell; AG08557
DR   Wikidata; Q54742268
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L01 ! AG08556
SX   Female
AG   27Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08558
AC   CVCL_4L03
SY   AG08558A
DR   CLO; CLO_0034438
DR   Coriell; AG08558
DR   Wikidata; Q54742272
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L04 ! AG08559
SX   Female
AG   36Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08559
AC   CVCL_4L04
DR   CLO; CLO_0034436
DR   Coriell; AG08559
DR   Wikidata; Q54742274
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L03 ! AG08558
SX   Female
AG   36Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08560
AC   CVCL_4L05
DR   CLO; CLO_0034421
DR   Coriell; AG08560
DR   Wikidata; Q54742275
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L06 ! AG08561
SX   Male
AG   40Y11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08561
AC   CVCL_4L06
DR   CLO; CLO_0034420
DR   Coriell; AG08561
DR   Wikidata; Q54742278
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L05 ! AG08560
SX   Male
AG   40Y11M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08562
AC   CVCL_4L07
SY   AG08562A
DR   CLO; CLO_0034426
DR   Coriell; AG08562
DR   Wikidata; Q54742282
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (from autologous cell line AG08563).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L08 ! AG08563
SX   Female
AG   37Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG08563
AC   CVCL_4L08
SY   AG08563A
DR   CLO; CLO_0034423
DR   Coriell; AG08563
DR   Wikidata; Q54742283
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L07 ! AG08562
SX   Female
AG   37Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08564
AC   CVCL_4L09
DR   CLO; CLO_0034430
DR   Coriell; AG08564
DR   Wikidata; Q54742287
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L10 ! AG08565
SX   Female
AG   28Y11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08565
AC   CVCL_4L10
DR   CLO; CLO_0034428
DR   Coriell; AG08565
DR   Wikidata; Q54742288
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L09 ! AG08564
SX   Female
AG   28Y11M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08566
AC   CVCL_4L11
DR   CLO; CLO_0031363
DR   Coriell; AG08566
DR   Wikidata; Q54742291
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L12 ! AG08567
SX   Female
AG   56Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08567
AC   CVCL_4L12
DR   CLO; CLO_0031364
DR   Coriell; AG08567
DR   Wikidata; Q54742293
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L11 ! AG08566
SX   Female
AG   56Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08573
AC   CVCL_2M63
DR   CLO; CLO_0031359
DR   Coriell; AG08573
DR   Wikidata; Q54742295
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M64 ! AG08574
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08574
AC   CVCL_2M64
DR   CLO; CLO_0031358
DR   Coriell; AG08574
DR   Wikidata; Q54742298
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M63 ! AG08573
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08578
AC   CVCL_4L13
DR   CLO; CLO_0031357
DR   Coriell; AG08578
DR   Wikidata; Q54742300
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08591
AC   CVCL_2M65
SY   AG08591A
DR   CLO; CLO_0031356
DR   Coriell; AG08591
DR   Wikidata; Q54742302
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08592
AC   CVCL_2M66
SY   AG08592A
DR   CLO; CLO_0031355
DR   Coriell; AG08592
DR   Wikidata; Q54742304
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M67 ! AG08593
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08593
AC   CVCL_2M67
SY   AG08593A
DR   CLO; CLO_0031354
DR   Coriell; AG08593
DR   Wikidata; Q54742306
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M66 ! AG08592
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08594
AC   CVCL_2M68
DR   CLO; CLO_0031353
DR   Coriell; AG08594
DR   Wikidata; Q54742309
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M69 ! AG08595
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08595
AC   CVCL_2M69
SY   AG08595A
DR   CLO; CLO_0031352
DR   Coriell; AG08595
DR   Wikidata; Q54742311
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M68 ! AG08594
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08596
AC   CVCL_4L14
DR   CLO; CLO_0031362
DR   Coriell; AG08596
DR   Wikidata; Q54742315
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (from autologous cell line AG08597).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L15 ! AG08597
SX   Male
AG   49Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG08597
AC   CVCL_4L15
DR   CLO; CLO_0031360
DR   Coriell; AG08597
DR   Wikidata; Q54742318
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu286Val (c.856C>G); ClinVar=VCV000018126; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L14 ! AG08596
SX   Male
AG   49Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG08606
AC   CVCL_2I74
DR   CLO; CLO_0031361
DR   Coriell; AG08606
DR   Wikidata; Q54742321
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I75 ! AG08607
SX   Female
AG   5Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08607
AC   CVCL_2I75
DR   CLO; CLO_0031342
DR   Coriell; AG08607
DR   Wikidata; Q54742323
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2I74 ! AG08606
SX   Female
AG   5Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08608
AC   CVCL_2M70
DR   CLO; CLO_0031341
DR   Coriell; AG08608
DR   Wikidata; Q54742325
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M71 ! AG08609
SX   Female
AG   7FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08609
AC   CVCL_2M71
DR   CLO; CLO_0031344
DR   Coriell; AG08609
DR   Wikidata; Q54742327
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M70 ! AG08608
SX   Female
AG   7FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG0861
AC   CVCL_8B72
DR   ECACC; 94080539
DR   Wikidata; Q54742330
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080539; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84643; Coffin-Lowry syndrome
DI   ORDO; Orphanet_192; Coffin-Lowry syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG08610
AC   CVCL_2I50
DR   CLO; CLO_0031343
DR   Coriell; AG08610
DR   Wikidata; Q54742331
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2I51 ! AG08611
SX   Female
AG   24FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08611
AC   CVCL_2I51
DR   CLO; CLO_0031346
DR   Coriell; AG08611
DR   Wikidata; Q54742333
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2I50 ! AG08610
SX   Female
AG   24FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08614
AC   CVCL_2M72
DR   CLO; CLO_0031345
DR   Coriell; AG08614
DR   Wikidata; Q54742337
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M73 ! AG08615
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08615
AC   CVCL_2M73
DR   CLO; CLO_0031347
DR   Coriell; AG08615
DR   Wikidata; Q54742338
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M72 ! AG08614
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08619
AC   CVCL_4L16
DR   CLO; CLO_0031348
DR   Coriell; AG08619
DR   Wikidata; Q54742341
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L17 ! AG08620
SX   Female
AG   64Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG0862
AC   CVCL_8B73
DR   ECACC; 94080540
DR   Wikidata; Q54742343
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080540; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84643; Coffin-Lowry syndrome
DI   ORDO; Orphanet_192; Coffin-Lowry syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   AG08620
AC   CVCL_4L17
DR   CLO; CLO_0031349
DR   Coriell; AG08620
DR   Wikidata; Q54742346
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
RX   PubMed=24379375;
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L16 ! AG08619
SX   Female
AG   64Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08624
AC   CVCL_2M74
DR   CLO; CLO_0031350
DR   Coriell; AG08624
DR   Wikidata; Q54742349
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M75 ! AG08625
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08625
AC   CVCL_2M75
DR   CLO; CLO_0031351
DR   Coriell; AG08625
DR   Wikidata; Q54742351
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_2M74 ! AG08624
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG08653
AC   CVCL_4L18
DR   CLO; CLO_0031333
DR   Coriell; AG08653
DR   Wikidata; Q54742401
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08654
AC   CVCL_4L19
SY   AG08654A
DR   CLO; CLO_0031332
DR   Coriell; AG08654
DR   Wikidata; Q54742404
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08655
AC   CVCL_4L20
DR   CLO; CLO_0031331
DR   Coriell; AG08655
DR   Wikidata; Q54742406
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08656
AC   CVCL_4L21
DR   CLO; CLO_0031330
DR   Coriell; AG08656
DR   Wikidata; Q54742407
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08657
AC   CVCL_4L22
DR   CLO; CLO_0031335
DR   Coriell; AG08657
DR   Wikidata; Q54742412
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08658
AC   CVCL_4L23
DR   CLO; CLO_0031334
DR   Coriell; AG08658
DR   Wikidata; Q54742415
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08659
AC   CVCL_4L24
DR   CLO; CLO_0031336
DR   Coriell; AG08659
DR   Wikidata; Q54742417
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08671
AC   CVCL_L271
DR   CLO; CLO_0031339
DR   Coriell; AG08671
DR   Wikidata; Q54742419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L272 ! AG08466
OI   CVCL_L273 ! AG08467
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   AG08672
AC   CVCL_L276
DR   CLO; CLO_0031340
DR   Coriell; AG08672
DR   Wikidata; Q54742422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L274 ! AG08468
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AG08673
AC   CVCL_L277
DR   CLO; CLO_0031337
DR   Coriell; AG08673
DR   Wikidata; Q54742423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L270 ! AG08470
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AG08692
AC   CVCL_2C67
SY   GRC#1000
DR   CLO; CLO_0031338
DR   Coriell; AG08692
DR   Wikidata; Q54742426
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG08692).
CC   Karyotypic information: 46,XX [80%]; 46,XX,t(4;7)(q31.3;q32),t(5;6)(p15.3;p21.3) [20%] (Coriell=AG08692).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F59 ! AG13150
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08700
AC   CVCL_4P71
DR   CLO; CLO_0031409
DR   Coriell; AG08700
DR   Wikidata; Q54742428
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P72 ! AG08701
SX   Female
AG   62Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08701
AC   CVCL_4P72
DR   CLO; CLO_0031410
DR   Coriell; AG08701
DR   Wikidata; Q54742430
RX   CelloPub=CLPUB00597;
RX   PubMed=8247227;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P71 ! AG08700
SX   Female
AG   62Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08702
AC   CVCL_4P73
DR   CLO; CLO_0031411
DR   Coriell; AG08702
DR   Wikidata; Q54742433
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P74 ! AG08703
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08703
AC   CVCL_4P74
DR   CLO; CLO_0031412
DR   Coriell; AG08703
DR   Wikidata; Q54742435
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P73 ! AG08702
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08704
AC   CVCL_4P75
DR   CLO; CLO_0031408
DR   Coriell; AG08704
DR   Wikidata; Q54742437
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P76 ! AG08705
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08705
AC   CVCL_4P76
DR   CLO; CLO_0031423
DR   Coriell; AG08705
DR   Wikidata; Q54742440
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P75 ! AG08704
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08706
AC   CVCL_4P77
DR   CLO; CLO_0031422
DR   Coriell; AG08706
DR   Wikidata; Q54742442
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P78 ! AG08707
SX   Male
AG   24Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08707
AC   CVCL_4P78
DR   CLO; CLO_0031416
DR   Coriell; AG08707
DR   Wikidata; Q54742444
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P77 ! AG08706
SX   Male
AG   24Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08708
AC   CVCL_4P79
DR   CLO; CLO_0031414
DR   Coriell; AG08708
DR   Wikidata; Q54742446
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P80 ! AG08709
SX   Male
AG   59Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08709
AC   CVCL_4P80
DR   CLO; CLO_0031420
DR   Coriell; AG08709
DR   Wikidata; Q54742450
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P79 ! AG08708
SX   Male
AG   59Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08710
AC   CVCL_4P81
DR   CLO; CLO_0031417
DR   Coriell; AG08710
DR   Wikidata; Q54742452
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (Coriell=AG08710).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P82 ! AG08711
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG08711
AC   CVCL_4P82
DR   CLO; CLO_0031389
DR   Coriell; AG08711
DR   Wikidata; Q54742454
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (Coriell=AG08711).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P81 ! AG08710
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG08712
AC   CVCL_4P83
SY   AG08712A
DR   CLO; CLO_0031390
DR   Coriell; AG08712
DR   Wikidata; Q54742456
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P84 ! AG08713
SX   Female
AG   89Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG08713
AC   CVCL_4P84
DR   CLO; CLO_0031387
DR   Coriell; AG08713
DR   Wikidata; Q54742458
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P83 ! AG08712
SX   Female
AG   89Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08733
AC   CVCL_2M76
DR   CLO; CLO_0031388
DR   Coriell; AG08733
DR   Wikidata; Q54742460
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG08742
AC   CVCL_2M77
DR   CLO; CLO_0031401
DR   Coriell; AG08742
DR   Wikidata; Q54742461
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M78 ! AG08743
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08743
AC   CVCL_2M78
DR   CLO; CLO_0031400
DR   Coriell; AG08743
DR   Wikidata; Q54742463
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M77 ! AG08742
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08744
AC   CVCL_4L25
DR   CLO; CLO_0031399
DR   Coriell; AG08744
DR   Wikidata; Q54742464
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08746
AC   CVCL_4P85
SY   AG08746A
DR   CLO; CLO_0031398
DR   Coriell; AG08746
DR   Wikidata; Q54742466
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG08748
AC   CVCL_2M79
DR   CLO; CLO_0031395
DR   Coriell; AG08748
DR   Wikidata; Q54742469
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   10FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08750
AC   CVCL_2M80
DR   CLO; CLO_0031394
DR   Coriell; AG08750
DR   Wikidata; Q54742471
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M81 ! AG08751
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08751
AC   CVCL_2M81
DR   CLO; CLO_0031391
DR   Coriell; AG08751
DR   Wikidata; Q54742472
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
OI   CVCL_2M80 ! AG08750
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08789
AC   CVCL_2C68
SY   GRC#0307
DR   CLO; CLO_0031376
DR   Coriell; AG08789
DR   Wikidata; Q54742476
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 20 PDL (Coriell=AG08789).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E60 ! AG12361
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08790
AC   CVCL_2C69
SY   GRC#0311
DR   CLO; CLO_0031377
DR   Coriell; AG08790
DR   Wikidata; Q54742477
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G35 ! AG14245
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08791
AC   CVCL_2C70
SY   GRC#0312
DR   CLO; CLO_0031378
DR   Coriell; AG08791
DR   Wikidata; Q54742480
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A75 ! AG04382
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08792
AC   CVCL_2C71
SY   AG08792A; GRC#0313
DR   CLO; CLO_0031380
DR   Coriell; AG08792
DR   Wikidata; Q54742482
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(1)(pter->p34::p31->p34::p31->qter) [47]; 46,XY [3] (Coriell=AG08792).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E59 ! AG12327
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08793
AC   CVCL_2C72
SY   GRC#0314
DR   CLO; CLO_0031379
DR   Coriell; AG08793
DR   Wikidata; Q54742484
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG08793).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG0880
AC   CVCL_8B74
DR   ECACC; 94101407
DR   Wikidata; Q54742487
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94101407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG08804
AC   CVCL_0N71
SY   AG08804A
DR   CLO; CLO_0031384
DR   Coriell; AG08804
DR   Wikidata; Q54742531
RX   CelloPub=CLPUB00597;
RX   PubMed=9447232;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N72 ! AG08805
SX   Female
AG   44Y4M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG08805
AC   CVCL_0N72
SY   AG8805
DR   CLO; CLO_0031383
DR   Coriell; AG08805
DR   Wikidata; Q54742533
RX   CelloPub=CLPUB00597;
RX   PubMed=8823375;
RX   PubMed=9447232;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N71 ! AG08804
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG08806
AC   CVCL_0N73
SY   AG08806A
DR   CLO; CLO_0031386
DR   Coriell; AG08806
DR   Wikidata; Q54742536
RX   CelloPub=CLPUB00597;
RX   PubMed=9447232;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu11Ter (c.31G>T); Zygosity=Heterozygous (PubMed=9447232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N74 ! AG08807
SX   Male
AG   44Y2M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   AG08807
AC   CVCL_0N74
SY   AG8807
DR   CLO; CLO_0031385
DR   Coriell; AG08807
DR   Wikidata; Q54742539
RX   CelloPub=CLPUB00597;
RX   PubMed=8823375;
RX   PubMed=9447232;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu11Ter (c.31G>T); Zygosity=Heterozygous (from autologous cell line AG08806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N73 ! AG08806
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   AG0881
AC   CVCL_8B75
DR   ECACC; 94101408
DR   Wikidata; Q54742542
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94101408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG08815
AC   CVCL_2C73
SY   GRC#0315
DR   CLO; CLO_0031365
DR   Coriell; AG08815
DR   Wikidata; Q54742543
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG08815).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08816
AC   CVCL_2C74
SY   AG08816A; GRC#0317
DR   CLO; CLO_0031366
DR   Coriell; AG08816
DR   Wikidata; Q54742544
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG08816).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 12
//
ID   AG08817
AC   CVCL_X758
SY   AG08817A; GRC#0318
DR   CLO; CLO_0031375
DR   Coriell; AG08817
DR   Wikidata; Q54742545
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26-31 PDL (PubMed=9724752); 39 PDL (Coriell=AG08817).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 13
//
ID   AG08818
AC   CVCL_2C75
SY   GRC#0319
DR   CLO; CLO_0031370
DR   Coriell; AG08818
DR   Wikidata; Q54742546
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG08818).
CC   Karyotypic information: 46,XY [88%]; 46,XY,t(2;7)(p25;q31) [12%] (Coriell=AG08818).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G13 ! AG13414
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08819
AC   CVCL_2C76
SY   GRC#0320
DR   CLO; CLO_0031369
DR   Coriell; AG08819
DR   Wikidata; Q54742548
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG08819).
CC   Karyotypic information: 46,XY,t(6;12;22)(6pter->6q12::12q12->12q13::22q13.1->22qter::12pter->12q12::6q12->6qter;22pter->22q13.1::12q13->12qter) (Coriell=AG08819).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG0882
AC   CVCL_8B76
DR   ECACC; 94101409
DR   Wikidata; Q54742550
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94101409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG0883
AC   CVCL_8B77
DR   ECACC; 94101410
DR   Wikidata; Q54742552
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94101410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG08836
AC   CVCL_4L26
DR   CLO; CLO_0031368
DR   Coriell; AG08836
DR   Wikidata; Q54742554
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08838
AC   CVCL_4L27
SY   AG08838A
DR   CLO; CLO_0031367
DR   Coriell; AG08838
DR   Wikidata; Q54742555
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08839
AC   CVCL_4L28
DR   CLO; CLO_0031374
DR   Coriell; AG08839
DR   Wikidata; Q54742558
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08842
AC   CVCL_4L29
DR   CLO; CLO_0031373
DR   Coriell; AG08842
DR   Wikidata; Q54742560
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08843
AC   CVCL_4L30
SY   AG08843A
DR   CLO; CLO_0031372
DR   Coriell; AG08843
DR   Wikidata; Q54742563
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08844
AC   CVCL_4L31
DR   CLO; CLO_0031371
DR   Coriell; AG08844
DR   Wikidata; Q54742564
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08845
AC   CVCL_4L32
SY   AG08845A
DR   CLO; CLO_0031248
DR   Coriell; AG08845
DR   Wikidata; Q54742565
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08846
AC   CVCL_4L33
SY   AG08846A
DR   CLO; CLO_0031221
DR   Coriell; AG08846
DR   Wikidata; Q54742567
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08847
AC   CVCL_4L34
DR   CLO; CLO_0031224
DR   Coriell; AG08847
DR   Wikidata; Q54742570
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08897
AC   CVCL_4L35
DR   CLO; CLO_0031237
DR   Coriell; AG08897
DR   Wikidata; Q54742571
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08899
AC   CVCL_4L36
DR   CLO; CLO_0031240
DR   Coriell; AG08899
DR   Wikidata; Q54742573
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08900
AC   CVCL_4L37
DR   CLO; CLO_0031233
DR   Coriell; AG08900
DR   Wikidata; Q54742574
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08902
AC   CVCL_2C77
SY   GRC#0281
DR   CLO; CLO_0031235
DR   Coriell; AG08902
DR   Wikidata; Q54742577
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG08902).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08903
AC   CVCL_2C78
SY   GRC#0282
DR   CLO; CLO_0031231
DR   Coriell; AG08903
DR   Wikidata; Q54742580
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG08903).
CC   Karyotypic information: 46,XY [18%]; 45,X [82%] (Coriell=AG08903).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08904
AC   CVCL_2C79
SY   GRC#0328
DR   CLO; CLO_0031232
DR   Coriell; AG08904
DR   GEO; GSM426268
DR   Wikidata; Q54742583
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG08904).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D50 ! AG10943
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG08905
AC   CVCL_2C80
SY   GRC#0331
DR   CLO; CLO_0031229
DR   Coriell; AG08905
DR   Wikidata; Q54742584
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG08905).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08906
AC   CVCL_2C81
SY   GRC#0339
DR   CLO; CLO_0031230
DR   Coriell; AG08906
DR   Wikidata; Q54742586
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG08906).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D49 ! AG10942
OI   CVCL_2E75 ! AG12657
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG08908
AC   CVCL_2C82
DR   CLO; CLO_0031192
DR   Coriell; AG08908
DR   Wikidata; Q54742589
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG08916
AC   CVCL_L278
DR   CLO; CLO_0031195
DR   Coriell; AG08916
DR   Wikidata; Q54742592
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L275 ! AG08469
SX   Male
AG   38Y6M
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   AG08918
AC   CVCL_4L38
DR   CLO; CLO_0031196
DR   Coriell; AG08918
DR   Wikidata; Q54742593
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG08941
AC   CVCL_X871
DR   CLO; CLO_0031204
DR   Coriell; AG08941
DR   Wikidata; Q54742598
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG08942
AC   CVCL_X872
DR   CLO; CLO_0031205
DR   Coriell; AG08942
DR   Wikidata; Q54742600
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
RX   PubMed=17668376;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG09019
AC   CVCL_4L39
DR   CLO; CLO_0031208
DR   Coriell; AG09019
DR   Wikidata; Q54742602
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG09021
AC   CVCL_4L40
DR   CLO; CLO_0031210
DR   Coriell; AG09021
DR   Wikidata; Q54742606
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG09022
AC   CVCL_0N75
DR   CLO; CLO_0031199
DR   Coriell; AG09022
DR   Wikidata; Q54742607
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG09034
AC   CVCL_4P86
DR   CLO; CLO_0031200
DR   Coriell; AG09034
DR   Wikidata; Q54742609
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P87 ! AG09035
SX   Male
AG   35Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG09035
AC   CVCL_4P87
DR   CLO; CLO_0031202
DR   Coriell; AG09035
DR   Wikidata; Q54742612
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4P86 ! AG09034
SX   Male
AG   35Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   AG09095
AC   CVCL_4L41
DR   CLO; CLO_0021794
DR   Coriell; AG09095
DR   Wikidata; Q54742666
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L42 ! AG09096
SX   Female
AG   54Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09096
AC   CVCL_4L42
DR   Coriell; AG09096
DR   Wikidata; Q54742669
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG09096; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L41 ! AG09095
SX   Female
AG   54Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG09097
AC   CVCL_4L43
DR   CLO; CLO_0021793
DR   Coriell; AG09097
DR   Wikidata; Q54742670
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L44 ! AG09098
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09098
AC   CVCL_4L44
DR   CLO; CLO_0021799
DR   Coriell; AG09098
DR   Wikidata; Q54742672
RX   CelloPub=CLPUB00597;
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L43 ! AG09097
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG09103
AC   CVCL_4L45
DR   CLO; CLO_0021796
DR   Coriell; AG09103
DR   Wikidata; Q54742674
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09104
AC   CVCL_4L46
DR   CLO; CLO_0021801
DR   Coriell; AG09104
DR   Wikidata; Q54742676
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09105
AC   CVCL_4L47
DR   CLO; CLO_0021800
DR   Coriell; AG09105
DR   Wikidata; Q54742679
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09106
AC   CVCL_4L48
DR   CLO; CLO_0021803
DR   Coriell; AG09106
DR   Wikidata; Q54742682
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09107
AC   CVCL_4L49
DR   CLO; CLO_0021802
DR   Coriell; AG09107
DR   Wikidata; Q54742685
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09108
AC   CVCL_4L50
DR   CLO; CLO_0021805
DR   Coriell; AG09108
DR   Wikidata; Q54742686
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09109
AC   CVCL_4L51
DR   CLO; CLO_0021804
DR   Coriell; AG09109
DR   Wikidata; Q54742688
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09119
AC   CVCL_4L52
DR   CLO; CLO_0021849
DR   Coriell; AG09119
DR   Wikidata; Q54742690
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09120
AC   CVCL_4L53
DR   CLO; CLO_0021848
DR   Coriell; AG09120
DR   Wikidata; Q54742693
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09121
AC   CVCL_4L54
DR   CLO; CLO_0021847
DR   Coriell; AG09121
DR   Wikidata; Q54742696
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09122
AC   CVCL_4L55
DR   CLO; CLO_0021846
DR   Coriell; AG09122
DR   Wikidata; Q54742698
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09123
AC   CVCL_4L56
SY   AG09123A
DR   CLO; CLO_0021845
DR   Coriell; AG09123
DR   Wikidata; Q54742702
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09124
AC   CVCL_4L57
DR   CLO; CLO_0021854
DR   Coriell; AG09124
DR   Wikidata; Q54742704
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09125
AC   CVCL_4L58
DR   CLO; CLO_0021853
DR   Coriell; AG09125
DR   Wikidata; Q54742706
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09126
AC   CVCL_4L59
DR   CLO; CLO_0021852
DR   Coriell; AG09126
DR   Wikidata; Q54742709
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09127
AC   CVCL_2Q57
DR   CLO; CLO_0021851
DR   Coriell; AG09127
DR   Wikidata; Q54742711
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09128
AC   CVCL_2Q58
DR   CLO; CLO_0021850
DR   Coriell; AG09128
DR   Wikidata; Q54742712
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Discontinued: Coriell; AG09128; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09129
AC   CVCL_2Q59
DR   CLO; CLO_0021834
DR   Coriell; AG09129
DR   Wikidata; Q54742714
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09130
AC   CVCL_2Q60
DR   CLO; CLO_0021832
DR   Coriell; AG09130
DR   Wikidata; Q54742717
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09131
AC   CVCL_2Q61
SY   AG09131A
DR   CLO; CLO_0021827
DR   Coriell; AG09131
DR   Wikidata; Q54742719
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   AG09147
AC   CVCL_2C83
SY   GRC#0322
DR   CLO; CLO_0021825
DR   Coriell; AG09147
DR   Wikidata; Q54742721
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG09147).
CC   Karyotypic information: 46,XY [30%]; 46,XY,t(2;12)(p23;q21) [70%] (Coriell=AG09147).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09148
AC   CVCL_2C84
DR   CLO; CLO_0021831
DR   Coriell; AG09148
DR   Wikidata; Q54742723
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09149
AC   CVCL_2C85
SY   GRC#0325
DR   CLO; CLO_0021828
DR   Coriell; AG09149
DR   Wikidata; Q54742725
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09150
AC   CVCL_2C86
DR   CLO; CLO_0021837
DR   Coriell; AG09150
DR   Wikidata; Q54742727
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09156
AC   CVCL_2C87
SY   GRC#0342
DR   CLO; CLO_0021836
DR   Coriell; AG09156
DR   Wikidata; Q54742728
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG09156).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09157
AC   CVCL_2C88
SY   GRC#0344
DR   CLO; CLO_0021839
DR   Coriell; AG09157
DR   Wikidata; Q54742730
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 53 PDL (Coriell=AG09157).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G00 ! AG13333
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09158
AC   CVCL_2C89
SY   GRC#0415
DR   CLO; CLO_0021838
DR   Coriell; AG09158
DR   Wikidata; Q54742731
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A95 ! AG04458
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09159
AC   CVCL_2C90
SY   GRC#0416
DR   CLO; CLO_0021692
DR   Coriell; AG09159
DR   Wikidata; Q54742733
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09160
AC   CVCL_2C91
SY   GRC#0417
DR   CLO; CLO_0021693
DR   Coriell; AG09160
DR   Wikidata; Q54742736
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG09160).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D91 ! AG11358
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09162
AC   CVCL_2C92
SY   AG09162A; GRC#0929
DR   CLO; CLO_0021694
DR   Coriell; AG09162
DR   Wikidata; Q54742738
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 54 PDL (Coriell=AG09162).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F06 ! AG12985
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09166
AC   CVCL_4L60
DR   CLO; CLO_0021695
DR   Coriell; AG09166
DR   Wikidata; Q54742740
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L61 ! AG09167
SX   Male
AG   34Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09167
AC   CVCL_4L61
DR   CLO; CLO_0021696
DR   Coriell; AG09167
DR   Wikidata; Q54742742
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L60 ! AG09166
SX   Male
AG   34Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09169
AC   CVCL_4L62
SY   AG09169A
DR   CLO; CLO_0021697
DR   Coriell; AG09169
DR   Wikidata; Q54742744
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09170
AC   CVCL_4L63
DR   CLO; CLO_0021699
DR   Coriell; AG09170
DR   Wikidata; Q54742746
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L64 ! AG09171
SX   Male
AG   29Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09171
AC   CVCL_4L64
DR   CLO; CLO_0021689
DR   Coriell; AG09171
DR   Wikidata; Q54742747
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L63 ! AG09170
SX   Male
AG   29Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09172
AC   CVCL_4L65
DR   CLO; CLO_0021690
DR   Coriell; AG09172
DR   Wikidata; Q54742748
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L66 ! AG09173
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09173
AC   CVCL_4L66
DR   CLO; CLO_0021691
DR   Coriell; AG09173
DR   Wikidata; Q54742791
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
RX   PubMed=30699343;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L65 ! AG09172
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09174
AC   CVCL_4L67
SY   AG09174A
DR   CLO; CLO_0021673
DR   Coriell; AG09174
DR   Wikidata; Q54742793
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L68 ! AG09175
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09175
AC   CVCL_4L68
DR   CLO; CLO_0021674
DR   Coriell; AG09175
DR   Wikidata; Q54742794
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L67 ! AG09174
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09176
AC   CVCL_4L69
DR   CLO; CLO_0021671
DR   Coriell; AG09176
DR   Wikidata; Q54742797
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L70 ! AG09177
SX   Female
AG   48Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09177
AC   CVCL_4L70
DR   CLO; CLO_0021672
DR   Coriell; AG09177
DR   Wikidata; Q54742799
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L69 ! AG09176
SX   Female
AG   48Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09178
AC   CVCL_4L71
DR   CLO; CLO_0021677
DR   Coriell; AG09178
DR   Wikidata; Q54742801
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L72 ! AG09179
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09179
AC   CVCL_4L72
DR   Coriell; AG09179
DR   Wikidata; Q54742803
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Discontinued: Coriell; AG09179; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L71 ! AG09178
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG09180
AC   CVCL_4L73
SY   AG09180B
DR   CLO; CLO_0021678
DR   Coriell; AG09180
DR   Wikidata; Q54742807
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L74 ! AG09181
SX   Male
AG   56Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09181
AC   CVCL_4L74
DR   CLO; CLO_0021675
DR   Coriell; AG09181
DR   Wikidata; Q54742809
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L73 ! AG09180
SX   Male
AG   56Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG09182
AC   CVCL_4L75
DR   CLO; CLO_0021676
DR   Coriell; AG09182
DR   Wikidata; Q54742811
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09183
AC   CVCL_4L76
DR   CLO; CLO_0021669
DR   Coriell; AG09183
DR   Wikidata; Q54742813
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09184
AC   CVCL_4L77
DR   CLO; CLO_0021670
DR   Coriell; AG09184
DR   Wikidata; Q54742815
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09185
AC   CVCL_4L78
SY   AG09185A
DR   CLO; CLO_0021724
DR   Coriell; AG09185
DR   Wikidata; Q54742818
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09186
AC   CVCL_4L79
DR   CLO; CLO_0021738
DR   Coriell; AG09186
DR   Wikidata; Q54742820
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09187
AC   CVCL_4L80
DR   CLO; CLO_0021739
DR   Coriell; AG09187
DR   Wikidata; Q54742822
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09188
AC   CVCL_4L81
SY   AG09188A
DR   CLO; CLO_0021740
DR   Coriell; AG09188
DR   Wikidata; Q54742824
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG0920
AC   CVCL_8B78
DR   ECACC; 95030321
DR   Wikidata; Q54742825
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95030321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AG09224
AC   CVCL_2C93
SY   GRC#1036
DR   CLO; CLO_0021741
DR   Coriell; AG09224
DR   Wikidata; Q54742827
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Doubling time: Slow growth (Coriell=AG09224).
CC   Karyotypic information: 46,XX,t(3;14)(3pter->3q23::14q13->14qter;14pter->14q13::3q23->3qter) [5]; 46,XX [45] (Coriell=AG09224).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09225
AC   CVCL_2C94
DR   CLO; CLO_0021731
DR   Coriell; AG09225
DR   Wikidata; Q54742830
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG09225).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09233
AC   CVCL_0N76
DR   CLO; CLO_0021733
DR   Coriell; AG09233
DR   Wikidata; Q54742832
RX   CelloPub=CLPUB00597;
RX   PubMed=12768443;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121565; Neonatal progeroid syndrome
DI   ORDO; Orphanet_3455; Wiedemann-Rautenstrauch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N77 ! AG09279
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG09235
AC   CVCL_4P88
DR   CLO; CLO_0021735
DR   Coriell; AG09235
DR   Wikidata; Q54742834
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG09259
AC   CVCL_4L82
DR   CLO; CLO_0021737
DR   Coriell; AG09259
DR   Wikidata; Q54742837
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L83 ! AG09260
SX   Male
AG   32Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09260
AC   CVCL_4L83
SY   AG09260A
DR   CLO; CLO_0021730
DR   Coriell; AG09260
DR   Wikidata; Q54742839
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4L82 ! AG09259
SX   Male
AG   32Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09266
AC   CVCL_2C95
SY   AG09266A; GRC#0386
DR   CLO; CLO_0021703
DR   Coriell; AG09266
DR   Wikidata; Q54742842
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [84%]; 46,XY,t(1;17)(q21;q21) [2%]; 46,XY,t(1;17)(q21;q21),t(11;16)(q13;q13) [12%] (Coriell=AG09266).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09267
AC   CVCL_2C96
SY   GRC#0389
DR   CLO; CLO_0021701
DR   Coriell; AG09267
DR   Wikidata; Q54742844
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Chinese.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09268
AC   CVCL_2C97
SY   GRC#0390
DR   CLO; CLO_0021719
DR   Coriell; AG09268
DR   Wikidata; Q54742846
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [82%]; 46,XY,t(4;19)(4pter->4q32::19q13->19qter;19pter->19q13::4q32->4qter) [18%] (Coriell=AG09268).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E79 ! AG12850
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09269
AC   CVCL_2C98
SY   GRC#0392
DR   CLO; CLO_0021720
DR   Coriell; AG09269
DR   Wikidata; Q54742850
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG09269).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B21 ! AG05099
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09270
AC   CVCL_2C99
SY   AG09270A; GRC#0393
DR   CLO; CLO_0021717
DR   Coriell; AG09270
DR   Wikidata; Q54742852
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG09270).
CC   Karyotypic information: 46,XY [62%]; 45,X [38%] (Coriell=AG09270).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A99 ! AG04551
OI   CVCL_2D60 ! AG11019
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09271
AC   CVCL_2D00
SY   GRC#0418
DR   CLO; CLO_0021718
DR   Coriell; AG09271
DR   Wikidata; Q54742857
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09272
AC   CVCL_2D01
SY   GRC#0645
DR   CLO; CLO_0021715
DR   Coriell; AG09272
DR   Wikidata; Q54742858
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG09272).
CC   Karyotypic information: 46,XY [22%]; 46,XY,inv(16)(pter->p13.1::q12.1->p13.1::q12.1->qter) [78%] (Coriell=AG09272).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09274
AC   CVCL_2D02
DR   CLO; CLO_0021716
DR   Coriell; AG09274
DR   Wikidata; Q54742861
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG09274).
CC   Karyotypic information: 46,XX [10]; 46,XX,der(15)t(7;15)(15qter->15p13::7q11.2->7qter) [37]; 45,XX,der(15)t(7;15)(p13;q11.2,tf(19;19)(qter->pter::pter->qter) [3] (Coriell=AG09274).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09275
AC   CVCL_4L84
SY   AG09275A
DR   CLO; CLO_0021711
DR   Coriell; AG09275
DR   Wikidata; Q54742863
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09279
AC   CVCL_0N77
DR   CLO; CLO_0021713
DR   Coriell; AG09279
DR   Wikidata; Q54742865
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C121565; Neonatal progeroid syndrome
DI   ORDO; Orphanet_3455; Wiedemann-Rautenstrauch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N76 ! AG09233
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG09309
AC   CVCL_L242
SY   AG 9309
DR   CLO; CLO_0021752
DR   Coriell; AG09309
DR   ENCODE; ENCBS005ENC
DR   ENCODE; ENCBS035TPY
DR   ENCODE; ENCBS112TMK
DR   ENCODE; ENCBS394ULN
DR   GEO; GSM510522
DR   GEO; GSM510525
DR   GEO; GSM749680
DR   GEO; GSM749718
DR   GEO; GSM749750
DR   GEO; GSM945167
DR   GEO; GSM945168
DR   Wikidata; Q54742869
RX   CelloPub=CLPUB00597;
RX   Patent=US5773219;
RX   PubMed=8643543;
RX   PubMed=12297622;
RX   PubMed=22720000;
RX   PubMed=23325432;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/AG09309_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Misspelling: GM 9309; PubMed=8643543.
CC   Derived from site: In situ; Toe, skin; UBERON=UBERON_0003530.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   AG09315
AC   CVCL_4L85
DR   CLO; CLO_0021753
DR   Coriell; AG09315
DR   Wikidata; Q54742870
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09319
AC   CVCL_L243
DR   CLO; CLO_0021754
DR   Coriell; AG09319
DR   ENCODE; ENCBS037NAC
DR   ENCODE; ENCBS443ENC
DR   ENCODE; ENCBS697FJI
DR   ENCODE; ENCBS992UXD
DR   GEO; GSM510536
DR   GEO; GSM510538
DR   GEO; GSM525415
DR   GEO; GSM525416
DR   GEO; GSM525417
DR   GEO; GSM749671
DR   GEO; GSM749723
DR   GEO; GSM749728
DR   GEO; GSM945166
DR   GEO; GSM945173
DR   Wikidata; Q54742872
RX   CelloPub=CLPUB00597;
RX   PubMed=12297622;
RX   PubMed=21074045;
RX   PubMed=21490598;
RX   PubMed=22720000;
RX   PubMed=23325432;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/AG09319_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   AG09369
AC   CVCL_4P89
SY   AG09369A
DR   CLO; CLO_0021756
DR   Coriell; AG09369
DR   Wikidata; Q54742875
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (Coriell=AG09369).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG09370
AC   CVCL_A2DV
SY   AG09370A
DR   Coriell; AG09370
DR   Wikidata; Q105506309
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG09370; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG09371
AC   CVCL_A2DU
DR   Coriell; AG09371
DR   Wikidata; Q105506313
RX   CelloPub=CLPUB00597;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG09371; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG09387
AC   CVCL_0N78
DR   CLO; CLO_0021755
DR   Coriell; AG09387
DR   Wikidata; Q54742876
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG09388
AC   CVCL_GR90
DR   CLO; CLO_0021758
DR   Coriell; AG09388
DR   Wikidata; Q54742879
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   AG09389
AC   CVCL_2I78
DR   CLO; CLO_0021757
DR   Coriell; AG09389
DR   Wikidata; Q54742881
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09390
AC   CVCL_2I79
DR   CLO; CLO_0021760
DR   Coriell; AG09390
DR   Wikidata; Q54742929
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09391
AC   CVCL_2I80
DR   CLO; CLO_0021759
DR   Coriell; AG09391
DR   Wikidata; Q54742930
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09392
AC   CVCL_2I81
DR   CLO; CLO_0021761
DR   Coriell; AG09392
DR   Wikidata; Q54742932
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09393
AC   CVCL_2I82
DR   CLO; CLO_0021744
DR   Coriell; AG09393
DR   Wikidata; Q54742936
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09394
AC   CVCL_V457
DR   CLO; CLO_0021745
DR   Coriell; AG09394
DR   Wikidata; Q54742937
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   AG09396
AC   CVCL_4L86
DR   CLO; CLO_0021742
DR   Coriell; AG09396
DR   Wikidata; Q54742940
RX   CelloPub=CLPUB00597;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09397
AC   CVCL_4L87
DR   CLO; CLO_0021743
DR   Coriell; AG09397
DR   Wikidata; Q54742941
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09429
AC   CVCL_V976
DR   CLO; CLO_0021749
DR   Coriell; AG09429
DR   Wikidata; Q54742943
RX   CelloPub=CLPUB00597;
RX   PubMed=12297622;
RX   PubMed=21490598;
RX   PubMed=22720000;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG09492
AC   CVCL_4L88
DR   CLO; CLO_0021748
DR   Coriell; AG09492
DR   Wikidata; Q54742946
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09493
AC   CVCL_4L89
DR   CLO; CLO_0021747
DR   Coriell; AG09493
DR   Wikidata; Q54742948
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09524
AC   CVCL_4L90
DR   CLO; CLO_0021746
DR   Coriell; AG09524
DR   Wikidata; Q54742950
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09525
AC   CVCL_4L91
DR   CLO; CLO_0021751
DR   Coriell; AG09525
DR   Wikidata; Q54742952
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09526
AC   CVCL_4L92
SY   AG09526A
DR   CLO; CLO_0021750
DR   Coriell; AG09526
DR   Wikidata; Q54742954
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09527
AC   CVCL_4L93
DR   CLO; CLO_0021786
DR   Coriell; AG09527
DR   Wikidata; Q54742956
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09529
AC   CVCL_4L94
SY   AG09529A
DR   CLO; CLO_0021777
DR   Coriell; AG09529
DR   Wikidata; Q54742958
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09530
AC   CVCL_4L95
DR   CLO; CLO_0021778
DR   Coriell; AG09530
DR   Wikidata; Q54742959
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09553
AC   CVCL_H807
SY   AG9553; AG09553B; GRC#0364
DR   CLO; CLO_0021780
DR   Coriell; AG09553
DR   Wikidata; Q54742962
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG09553).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   AG09555
AC   CVCL_2D03
SY   GRC#1088
DR   CLO; CLO_0021782
DR   Coriell; AG09555
DR   Wikidata; Q54742963
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 24 PDL (Coriell=AG09555).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09556
AC   CVCL_2D04
SY   GRC#1092
DR   CLO; CLO_0021789
DR   Coriell; AG09556
DR   Wikidata; Q54742967
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 27 PDL (Coriell=AG09556).
CC   Karyotypic information: 46,XY [90%]; 45,X [10%] (Coriell=AG09556).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09557
AC   CVCL_2D05
SY   GRC#1142
DR   CLO; CLO_0021788
DR   Coriell; AG09557
DR   Wikidata; Q54742969
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (PubMed=9724752).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG09558
AC   CVCL_0J80
SY   AG09558A; GRC#1150
DR   CLO; CLO_0021791
DR   Coriell; AG09558
DR   Wikidata; Q54742972
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0J79 ! AG04144
SX   Male
AG   85Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   AG09559
AC   CVCL_2D06
DR   CLO; CLO_0021790
DR   Coriell; AG09559
DR   GEO; GSM3124567
DR   Wikidata; Q54742973
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG09559).
CC   Karyotypic information: 46,XY [78%]; 46,XY,add(5)(q?) [22%] (Coriell=AG09559).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG09561
AC   CVCL_X757
SY   GRC#1165
DR   CLO; CLO_0021787
DR   Coriell; AG09561
DR   Wikidata; Q54742976
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG09561).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 12
//
ID   AG09599
AC   CVCL_2D07
SY   GRC#1097
DR   CLO; CLO_0021909
DR   Coriell; AG09599
DR   GEO; GSM3124571
DR   Wikidata; Q54742978
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG09600
AC   CVCL_2D08
SY   GRC#1108
DR   CLO; CLO_0021910
DR   Coriell; AG09600
DR   Wikidata; Q54742980
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG09600).
CC   Karyotypic information: 46,XX [64%]; 45,X [2%]; 45,X,inv(17)(q11.2;q23) [6%]; 46,XX,inv(17)(q11.2;q23) [28%] (Coriell=AG09600).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09601
AC   CVCL_2D09
SY   GRC#1116
DR   CLO; CLO_0021911
DR   Coriell; AG09601
DR   Wikidata; Q54742982
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [48]; 47,XX,t(9;15)(9pter->q11::15p11.2->15pter;15qter->15p11.2::9q11->9qter),+20 [2] (Coriell=AG09601).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09602
AC   CVCL_L607
SY   AG09602A; GRC#1134
DR   CLO; CLO_0021915
DR   Coriell; AG09602
DR   GEO; GSM3124623
DR   Wikidata; Q54742983
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42-48 PDL (PubMed=9724752).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L605 ! AG05247
SX   Female
AG   92Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   AG09603
AC   CVCL_2D10
SY   GRC#1143
DR   CLO; CLO_0021916
DR   Coriell; AG09603
DR   Wikidata; Q54742987
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 52 PDL (PubMed=9724752); 18 PDL (Coriell=AG09603).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG09605
AC   CVCL_2D11
SY   GRC#1149
DR   CLO; CLO_0021917
DR   Coriell; AG09605
DR   GEO; GSM3124573
DR   Wikidata; Q54742990
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG09605).
CC   Karyotypic information: 46,XY [18%]; 46,XY,t(15;19)(p11.2;p13.1),t(15;19)(q26.3;q13.1) [68%]; 46,XY,t(4;6)(p12;q13),t(11;20)(q13;p13) [12%] (Coriell=AG09605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG09697
AC   CVCL_2D12
SY   GRC#0786
DR   CLO; CLO_0021918
DR   Coriell; AG09697
DR   Wikidata; Q54742991
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 12 PDL (Coriell=AG09697).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B89 ! AG06294
OI   CVCL_2F34 ! AG13084
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09698
AC   CVCL_2D13
SY   AG09698A; GRC#0789
DR   CLO; CLO_0021912
DR   Coriell; AG09698
DR   Wikidata; Q54742993
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG09698).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E11 ! AG11645
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09699
AC   CVCL_2D14
SY   GRC#1186
DR   CLO; CLO_0021913
DR   Coriell; AG09699
DR   GEO; GSM426269
DR   Wikidata; Q54742996
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 41 PDL (Coriell=AG09699).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG09701
AC   CVCL_2D15
SY   AG09701A; GRC#1193
DR   CLO; CLO_0021914
DR   Coriell; AG09701
DR   Wikidata; Q54742999
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG09701).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09710
AC   CVCL_4L96
DR   CLO; CLO_0021958
DR   Coriell; AG09710
DR   Wikidata; Q54743001
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09714
AC   CVCL_4L97
DR   CLO; CLO_0021957
DR   Coriell; AG09714
DR   Wikidata; Q54743002
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (Coriell=AG09714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG09715
AC   CVCL_4L98
SY   AG09715A
DR   CLO; CLO_0021956
DR   Coriell; AG09715
DR   Wikidata; Q54743005
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09750
AC   CVCL_4P90
SY   AG09750A
DR   CLO; CLO_0021955
DR   Coriell; AG09750
DR   Wikidata; Q54743006
RX   CelloPub=CLPUB00597;
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG09798
AC   CVCL_4L99
DR   CLO; CLO_0021952
DR   Coriell; AG09798
DR   Wikidata; Q54743010
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09802
AC   CVCL_X794
DR   CLO; CLO_0021950
DR   Coriell; AG09802
DR   Wikidata; Q54743012
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG09831
AC   CVCL_4M00
DR   CLO; CLO_0021949
DR   Coriell; AG09831
DR   Wikidata; Q54743013
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09843
AC   CVCL_2D16
SY   AG09843A; GRC#1224
DR   CLO; CLO_0021954
DR   Coriell; AG09843
DR   GEO; GSM3124675
DR   Wikidata; Q54743056
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG09843).
CC   Karyotypic information: 46,XY,-10,+der(10)t(9;10)(q12;q26) [72%]; 46,XY,-10,-10,+mar(10),+mar(10) [28%] (Coriell=AG09843).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG09844
AC   CVCL_X833
SY   GRC#1170
DR   CLO; CLO_0021953
DR   Coriell; AG09844
DR   Wikidata; Q54743058
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [45]; 47,XY,+8 [5] (Coriell=AG09844).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X832 ! AG05192
OI   CVCL_X834 ! AG12587
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 12
//
ID   AG09854
AC   CVCL_2D17
SY   GRC#1204
DR   CLO; CLO_0021944
DR   Coriell; AG09854
DR   Wikidata; Q54743061
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 50 PDL (Coriell=AG09854).
CC   Karyotypic information: 46,XX,t(1;2)(p36.1;p23),t(9;18)(q32;q21.3) (Coriell=AG09854).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G18 ! AG13781
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09857
AC   CVCL_2D18
DR   CLO; CLO_0021946
DR   Coriell; AG09857
DR   Wikidata; Q54743062
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 14 PDL (Coriell=AG09857).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09858
AC   CVCL_2D19
DR   CLO; CLO_0021945
DR   Coriell; AG09858
DR   Wikidata; Q54743064
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG09858).
CC   Karyotypic information: 46,XX [76%]; 46,XX,t(1;5)(q21?;q34?) [24%] (Coriell=AG09858).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09860
AC   CVCL_2D20
DR   CLO; CLO_0021948
DR   Coriell; AG09860
DR   GEO; GSM3124565
DR   Wikidata; Q54743065
RX   PubMed=15450399;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG09861
AC   CVCL_2D21
SY   GRC#1202
DR   CLO; CLO_0021947
DR   Coriell; AG09861
DR   Wikidata; Q54743068
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG09861).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09875
AC   CVCL_2D22
DR   CLO; CLO_0021942
DR   Coriell; AG09875
DR   Wikidata; Q54743070
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG09875).
CC   Karyotypic information: 46,XY [78%]; 45,X [2%]; 45,X,add(5)(q3?) [4%]; 46,XY,t(1;3)(p1?;p2?) [12%]; 46,XY,t(2;5)(q3?;q3?) [4%] (Coriell=AG09875).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09876
AC   CVCL_2D23
DR   CLO; CLO_0021941
DR   Coriell; AG09876
DR   Wikidata; Q54743072
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG09876).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09877
AC   CVCL_2D24
DR   CLO; CLO_0021943
DR   Coriell; AG09877
DR   GEO; GSM426270
DR   Wikidata; Q54743075
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG09877).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG09878
AC   CVCL_H808
SY   AG9878; AG09878A; GRC#1168
DR   CLO; CLO_0021938
DR   Coriell; AG09878
DR   Wikidata; Q54743078
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG09878).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H809 ! AG12589
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG09879
AC   CVCL_2D25
SY   GRC#1169
DR   CLO; CLO_0021937
DR   Coriell; AG09879
DR   Wikidata; Q54743080
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG09879).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E58 ! AG12322
SX   Female
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09896
AC   CVCL_4M01
DR   CLO; CLO_0021936
DR   Coriell; AG09896
DR   Wikidata; Q54743082
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09903
AC   CVCL_4M02
DR   CLO; CLO_0021934
DR   Coriell; AG09903
DR   Wikidata; Q54743084
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09904
AC   CVCL_4M03
DR   CLO; CLO_0021933
DR   Coriell; AG09904
DR   Wikidata; Q54743087
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09905
AC   CVCL_4P91
DR   CLO; CLO_0021932
DR   Coriell; AG09905
DR   Wikidata; Q54743090
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (Coriell=AG09905).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   AG09906
AC   CVCL_4P92
SY   AG09906A
DR   CLO; CLO_0021931
DR   Coriell; AG09906
DR   Wikidata; Q54743093
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09907
AC   CVCL_T871
DR   CLO; CLO_0021930
DR   Coriell; AG09907
DR   Wikidata; Q54743096
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (Coriell=AG09907).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   AG09908
AC   CVCL_T872
SY   AG09908*A
DR   CLO; CLO_0021929
DR   Coriell; AG09908
DR   Wikidata; Q54743097
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
RX   PubMed=21900357;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=10408806; Coriell=AG09908).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   AG09945
AC   CVCL_4M04
DR   CLO; CLO_0021926
DR   Coriell; AG09945
DR   Wikidata; Q54743100
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09949
AC   CVCL_4P93
DR   CLO; CLO_0021928
DR   Coriell; AG09949
DR   Wikidata; Q54743102
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09950
AC   CVCL_0N79
DR   CLO; CLO_0021927
DR   Coriell; AG09950
DR   Wikidata; Q54743104
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Ala117Val (c.350C>T); ClinVar=VCV000013396; Zygosity=Unspecified (Coriell=AG09950).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84727; Gerstmann-Straussler-Scheinker disease
DI   ORDO; Orphanet_356; Gerstmann-Straussler-Scheinker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   AG09951
AC   CVCL_4M05
DR   CLO; CLO_0021923
DR   Coriell; AG09951
DR   Wikidata; Q54743108
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09952
AC   CVCL_4M06
DR   CLO; CLO_0021922
DR   Coriell; AG09952
DR   Wikidata; Q54743110
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (Coriell=AG09952).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M66 ! AG11368
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   AG09953
AC   CVCL_4M07
DR   CLO; CLO_0021925
DR   Coriell; AG09953
DR   Wikidata; Q54743111
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09955
AC   CVCL_4M08
DR   CLO; CLO_0021924
DR   Coriell; AG09955
DR   Wikidata; Q54743115
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09961
AC   CVCL_0J81
DR   CLO; CLO_0021920
DR   Coriell; AG09961
DR   Wikidata; Q54743117
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y2M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG09968
AC   CVCL_2D26
DR   CLO; CLO_0021919
DR   Coriell; AG09968
DR   Wikidata; Q54743119
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 48 PDL (Coriell=AG09968).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09969
AC   CVCL_2D27
DR   CLO; CLO_0021921
DR   Coriell; AG09969
DR   Wikidata; Q54743120
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG09969).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09970
AC   CVCL_2D28
DR   CLO; CLO_0021889
DR   Coriell; AG09970
DR   Wikidata; Q54743122
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09971
AC   CVCL_2D29
SY   AG09971A; GRC#0429
DR   CLO; CLO_0021890
DR   Coriell; AG09971
DR   Wikidata; Q54743125
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG09971).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG09974
AC   CVCL_2D30
DR   CLO; CLO_0021891
DR   Coriell; AG09974
DR   Wikidata; Q54743126
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG09974).
CC   Karyotypic information: 46,XY [92%]; 45,X [8%] (Coriell=AG09974).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09975
AC   CVCL_2D31
DR   CLO; CLO_0021892
DR   Coriell; AG09975
DR   GEO; GSM476003
DR   GEO; GSM3124563
DR   Wikidata; Q54743129
RX   PubMed=15450399;
RX   PubMed=19966276;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [66%]; 46,Y,t(X;3)(p22;q21) [34%] (Coriell=AG09975).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG09977
AC   CVCL_2D32
DR   CLO; CLO_0021893
DR   Coriell; AG09977
DR   Wikidata; Q54743131
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG09977).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG09980
AC   CVCL_0N80
DR   CLO; CLO_0021894
DR   Coriell; AG09980
DR   Wikidata; Q54743133
RX   CelloPub=CLPUB00597;
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y11M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG09983
AC   CVCL_4M09
DR   CLO; CLO_0021895
DR   Coriell; AG09983
DR   Wikidata; Q54743135
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG09997
AC   CVCL_4M10
SY   AG09997A
DR   CLO; CLO_0021896
DR   Coriell; AG09997
DR   Wikidata; Q54743138
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10007
AC   CVCL_4M11
DR   CLO; CLO_0021897
DR   Coriell; AG10007
DR   Wikidata; Q54743140
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10008
AC   CVCL_4M12
DR   CLO; CLO_0021898
DR   Coriell; AG10008
DR   Wikidata; Q54743143
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10009
AC   CVCL_4M13
DR   CLO; CLO_0021879
DR   Coriell; AG10009
DR   Wikidata; Q54743145
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10010
AC   CVCL_4M14
DR   CLO; CLO_0021882
DR   Coriell; AG10010
DR   Wikidata; Q54743190
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10028
AC   CVCL_0J94
SY   AG10028A
DR   CLO; CLO_0021883
DR   Coriell; AG10028
DR   Wikidata; Q54743192
RX   CelloPub=CLPUB00597;
CC   Population: Chilean.
CC   Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y2M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG10037
AC   CVCL_4M15
SY   AG10037A
DR   CLO; CLO_0021884
DR   Coriell; AG10037
DR   Wikidata; Q54743203
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10039
AC   CVCL_4M16
DR   CLO; CLO_0021885
DR   Coriell; AG10039
DR   Wikidata; Q54743206
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (Coriell=AG10039).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG10046
AC   CVCL_2D33
SY   GRC#0278
DR   CLO; CLO_0021888
DR   Coriell; AG10046
DR   Wikidata; Q54743207
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG10046).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10047
AC   CVCL_2D34
SY   GRC#0283
DR   CLO; CLO_0021870
DR   Coriell; AG10047
DR   Wikidata; Q54743209
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG10047).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A90 ! AG04453
OI   CVCL_2G30 ! AG14048
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10048
AC   CVCL_2D35
SY   GRC#0280
DR   CLO; CLO_0021869
DR   Coriell; AG10048
DR   Wikidata; Q54743213
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG10048).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10049
AC   CVCL_2D36
SY   GRC#0323
DR   CLO; CLO_0021875
DR   Coriell; AG10049
DR   GEO; GSM426271
DR   Wikidata; Q54743215
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG10049).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G46 ! AG16030
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG10052
AC   CVCL_2D37
SY   GRC#1199
DR   CLO; CLO_0021876
DR   Coriell; AG10052
DR   Wikidata; Q54743217
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG10052).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10053
AC   CVCL_2D38
DR   CLO; CLO_0021877
DR   Coriell; AG10053
DR   Wikidata; Q54743219
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10054
AC   CVCL_2D39
DR   CLO; CLO_0021878
DR   Coriell; AG10054
DR   Wikidata; Q54743220
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG10054).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10055
AC   CVCL_2D40
SY   GRC#1227
DR   CLO; CLO_0021871
DR   Coriell; AG10055
DR   Wikidata; Q54743222
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=AG10055).
CC   Karyotypic information: 46,XY,der(7)t(1;7)(7pter->7q36::1q21->1qter) [2]; 46,XY [48] (Coriell=AG10055).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10076
AC   CVCL_0U81
SY   5965C-VA1
DR   CLO; CLO_0021872
DR   Coriell; AG10076
DR   Wikidata; Q54743224
RX   CelloPub=CLPUB00597;
CC   Senescence: SV40-transformed but with a finite life span.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H749 ! MRC-5 PDL27
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
ID   AG10097
AC   CVCL_2I83
DR   CLO; CLO_0021873
DR   Coriell; AG10097
DR   Wikidata; Q54743225
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10098
AC   CVCL_X873
DR   CLO; CLO_0021874
DR   Coriell; AG10098
DR   Wikidata; Q54743226
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y3M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG10103
AC   CVCL_2I84
DR   CLO; CLO_0021861
DR   Coriell; AG10103
DR   Wikidata; Q54743228
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10104
AC   CVCL_A2NR
DR   Coriell; AG10104
DR   Wikidata; Q105506317
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG10104; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y3M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG10105
AC   CVCL_2I85
DR   CLO; CLO_0021860
DR   Coriell; AG10105
DR   Wikidata; Q54743231
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10106
AC   CVCL_X874
DR   CLO; CLO_0021859
DR   Coriell; AG10106
DR   Wikidata; Q54743234
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y6M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG10107
AC   CVCL_2I86
DR   CLO; CLO_0021867
DR   Coriell; AG10107
DR   Wikidata; Q54743237
RX   CelloPub=CLPUB00597;
RX   PubMed=9804340;
RX   PubMed=11511294;
RX   PubMed=18368133;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10111
AC   CVCL_2I87
DR   CLO; CLO_0021868
DR   Coriell; AG10111
DR   Wikidata; Q54743238
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10187
AC   CVCL_2I02
SY   LTSMC-3; AG 10187
DR   CLO; CLO_0021865
DR   Coriell; AG10187
DR   Wikidata; Q54743241
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10200
AC   CVCL_2I03
SY   LTSMC-3B
DR   CLO; CLO_0021866
DR   Coriell; AG10200
DR   Wikidata; Q54743243
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10202
AC   CVCL_2I04
SY   LTSMC-3G
DR   CLO; CLO_0021863
DR   Coriell; AG10202
DR   Wikidata; Q54743245
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10203
AC   CVCL_2I05
SY   LTSMC-3L
DR   CLO; CLO_0021864
DR   Coriell; AG10203
DR   Wikidata; Q54743246
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10213
AC   CVCL_0N81
DR   CLO; CLO_0021862
DR   Coriell; AG10213
DR   Wikidata; Q54743247
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y9M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG10215
AC   CVCL_0N82
DR   CLO; CLO_0021899
DR   Coriell; AG10215
DR   Wikidata; Q54743250
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y6M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG10218
AC   CVCL_2I06
SY   LTSMC-3E
DR   CLO; CLO_0021900
DR   Coriell; AG10218
DR   Wikidata; Q54743252
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10220
AC   CVCL_2I07
SY   LTSMC-3Q
DR   CLO; CLO_0021901
DR   Coriell; AG10220
DR   Wikidata; Q54743254
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10240
AC   CVCL_2I08
SY   LTSMC-3F
DR   CLO; CLO_0021902
DR   Coriell; AG10240
DR   Wikidata; Q54743256
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10242
AC   CVCL_2I09
SY   LTSMC-3N
DR   CLO; CLO_0021904
DR   Coriell; AG10242
DR   Wikidata; Q54743257
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10244
AC   CVCL_2I10
SY   LTSMC-3S
DR   CLO; CLO_0021903
DR   Coriell; AG10244
DR   Wikidata; Q54743258
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10265
AC   CVCL_4M17
SY   AG10265A
DR   CLO; CLO_0021906
DR   Coriell; AG10265
DR   Wikidata; Q54743259
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10278
AC   CVCL_4M18
DR   CLO; CLO_0021905
DR   Coriell; AG10278
DR   Wikidata; Q54743262
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10279
AC   CVCL_4M19
DR   CLO; CLO_0021908
DR   Coriell; AG10279
DR   Wikidata; Q54743263
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10285
AC   CVCL_2I11
SY   AG10285A; LTSMC-3U
DR   CLO; CLO_0021907
DR   Coriell; AG10285
DR   Wikidata; Q54743265
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10286
AC   CVCL_2I12
SY   LTSMC-3T
DR   CLO; CLO_0021537
DR   Coriell; AG10286
DR   Wikidata; Q54743266
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10292
AC   CVCL_0N83
DR   CLO; CLO_0021538
DR   Coriell; AG10292
DR   Wikidata; Q54743312
RX   CelloPub=CLPUB00597;
CC   Karyotypic information: 47,XX,+13 (Coriell=AG10292).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG10293
AC   CVCL_4M20
DR   CLO; CLO_0021529
DR   Coriell; AG10293
DR   Wikidata; Q54743314
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10299
AC   CVCL_4M21
SY   AG10299A
DR   CLO; CLO_0021530
DR   Coriell; AG10299
DR   Wikidata; Q54743315
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10307
AC   CVCL_4M22
DR   CLO; CLO_0021531
DR   Coriell; AG10307
DR   Wikidata; Q54743318
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10312
AC   CVCL_4M23
DR   CLO; CLO_0021532
DR   Coriell; AG10312
DR   Wikidata; Q54743320
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10316
AC   CVCL_X875
DR   CLO; CLO_0021533
DR   Coriell; AG10316
DR   Wikidata; Q54743321
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y5M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG10317
AC   CVCL_X876
DR   CLO; CLO_0021534
DR   Coriell; AG10317
DR   Wikidata; Q54743323
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y5M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   AG10326
AC   CVCL_A2NS
DR   Coriell; AG10326
DR   Wikidata; Q105506320
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG10326; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y1M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG10328
AC   CVCL_2I13
SY   LTSMC-3P
DR   CLO; CLO_0021535
DR   Coriell; AG10328
DR   Wikidata; Q54743325
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Smooth muscle, trachealis; UBERON=UBERON_0006680.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2I02 ! AG10187
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10375
AC   CVCL_2M82
DR   CLO; CLO_0021536
DR   Coriell; AG10375
DR   Wikidata; Q54743326
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M83 ! AG10385
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10385
AC   CVCL_2M83
DR   CLO; CLO_0021558
DR   Coriell; AG10385
DR   Wikidata; Q54743330
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M82 ! AG10375
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG10390
AC   CVCL_0N84
DR   CLO; CLO_0021556
DR   Coriell; AG10390
DR   Wikidata; Q54743331
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y2M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG10391
AC   CVCL_0N85
DR   CLO; CLO_0021557
DR   Coriell; AG10391
DR   Wikidata; Q54743333
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y5M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG10400
AC   CVCL_0N86
DR   CLO; CLO_0021554
DR   Coriell; AG10400
DR   Wikidata; Q54743335
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y1M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG10427
AC   CVCL_0E21
DR   CLO; CLO_0021555
DR   Coriell; AG10427
DR   Wikidata; Q54743337
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0E15 ! HIAE-43/7-12
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG10442
AC   CVCL_2M84
DR   CLO; CLO_0021552
DR   Coriell; AG10442
DR   Wikidata; Q54743338
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10447
AC   CVCL_2M85
DR   CLO; CLO_0021553
DR   Coriell; AG10447
DR   Wikidata; Q54743340
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10466
AC   CVCL_2M86
DR   CLO; CLO_0021551
DR   Coriell; AG10466
DR   Wikidata; Q54743342
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M87 ! AG10467
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG10467
AC   CVCL_2M87
DR   CLO; CLO_0021549
DR   Coriell; AG10467
DR   Wikidata; Q54743344
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M86 ! AG10466
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10477
AC   CVCL_2M88
DR   CLO; CLO_0021545
DR   Coriell; AG10477
DR   Wikidata; Q54743345
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10484
AC   CVCL_2M89
DR   CLO; CLO_0021546
DR   Coriell; AG10484
DR   Wikidata; Q54743347
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M90 ! AG10602
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   Ag104A
AC   CVCL_J407
SY   AG104A; AG-104A
DR   Wikidata; Q54743348
RX   PubMed=2787379;
CC   Breed/subspecies: C3H.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   Ag104A-Ld
AC   CVCL_J408
SY   AG104A-Ld; AG104-Ld; Ag104Ld
DR   Wikidata; Q54743350
RX   PubMed=9221752;
CC   Breed/subspecies: C3H.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J407 ! Ag104A
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AG10548
AC   CVCL_L628
SY   C8803
DR   Coriell; AG10548
DR   Wikidata; Q54743352
RX   CelloPub=CLPUB00597;
RX   PubMed=10741968;
RX   PubMed=12714972;
CC   Discontinued: Coriell; AG10548; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y4M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   AG10553
AC   CVCL_2M92
DR   CLO; CLO_0021547
DR   Coriell; AG10553
DR   Wikidata; Q54743353
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M93 ! AG10554
OI   CVCL_2M94 ! AG10604
OI   CVCL_2M95 ! AG10696
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG10554
AC   CVCL_2M93
DR   CLO; CLO_0021548
DR   Coriell; AG10554
DR   Wikidata; Q54743355
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M92 ! AG10553
OI   CVCL_2M94 ! AG10604
OI   CVCL_2M95 ! AG10696
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10555
AC   CVCL_2M96
DR   CLO; CLO_0021541
DR   Coriell; AG10555
DR   Wikidata; Q54743358
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M97 ! AG10605
OI   CVCL_2M98 ! AG10697
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG10578
AC   CVCL_0Q90
DR   CLO; CLO_0021542
DR   Coriell; AG10578
DR   Wikidata; Q54743359
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
RX   PubMed=15130666;
CC   Population: Caucasian; Dutch/South African.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y6M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG10579
AC   CVCL_0Q91
DR   CLO; CLO_0021543
DR   Coriell; AG10579
DR   Wikidata; Q54743363
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
RX   PubMed=12768443;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; PubMed=12768443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   AG10583
AC   CVCL_0Q92
DR   CLO; CLO_0021544
DR   Coriell; AG10583
DR   Wikidata; Q54743365
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG10585
AC   CVCL_0Q93
DR   CLO; CLO_0021539
DR   Coriell; AG10585
DR   Wikidata; Q54743367
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG10587
AC   CVCL_0Q88
DR   CLO; CLO_0021540
DR   Coriell; AG10587
DR   Wikidata; Q54743369
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
RX   PubMed=12768443;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; PubMed=12768443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L615 ! AG10750
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   AG10588
AC   CVCL_0Q94
DR   CLO; CLO_0021499
DR   Coriell; AG10588
DR   Wikidata; Q54743372
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG10589
AC   CVCL_0U82
DR   CLO; CLO_0021503
DR   Coriell; AG10589
DR   Wikidata; Q54743374
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85008; Pick's disease
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG10598
AC   CVCL_4M24
DR   CLO; CLO_0021502
DR   Coriell; AG10598
DR   Wikidata; Q54743377
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10599
AC   CVCL_4M25
DR   CLO; CLO_0021501
DR   Coriell; AG10599
DR   Wikidata; Q54743380
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10600
AC   CVCL_4M26
SY   AG10600A
DR   CLO; CLO_0021500
DR   Coriell; AG10600
DR   Wikidata; Q54743383
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10602
AC   CVCL_2M90
DR   CLO; CLO_0021507
DR   Coriell; AG10602
DR   Wikidata; Q54743384
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M89 ! AG10484
SX   Male
AG   16W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10604
AC   CVCL_2M94
SY   AG10604A
DR   CLO; CLO_0021506
DR   Coriell; AG10604
DR   Wikidata; Q54743386
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M92 ! AG10553
OI   CVCL_2M93 ! AG10554
OI   CVCL_2M95 ! AG10696
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10605
AC   CVCL_2M97
DR   CLO; CLO_0021505
DR   Coriell; AG10605
DR   Wikidata; Q54743388
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M96 ! AG10555
OI   CVCL_2M98 ! AG10697
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG10630
AC   CVCL_2N19
DR   CLO; CLO_0021504
DR   Coriell; AG10630
DR   Wikidata; Q54743392
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2N20 ! AG10631
OI   CVCL_2N21 ! AG10637
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG10631
AC   CVCL_2N20
DR   CLO; CLO_0021508
DR   Coriell; AG10631
DR   Wikidata; Q54743445
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2N19 ! AG10630
OI   CVCL_2N21 ! AG10637
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10632
AC   CVCL_2N17
DR   CLO; CLO_0021490
DR   Coriell; AG10632
DR   Wikidata; Q54743448
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2N18 ! AG10638
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10637
AC   CVCL_2N21
DR   CLO; CLO_0021489
DR   Coriell; AG10637
DR   Wikidata; Q54743450
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2N19 ! AG10630
OI   CVCL_2N20 ! AG10631
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10638
AC   CVCL_2N18
DR   CLO; CLO_0021492
DR   Coriell; AG10638
DR   Wikidata; Q54743451
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2N17 ! AG10632
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG10643
AC   CVCL_4M27
DR   CLO; CLO_0021491
DR   Coriell; AG10643
DR   Wikidata; Q54743453
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10644
AC   CVCL_4M28
SY   AG10644A
DR   CLO; CLO_0021494
DR   Coriell; AG10644
DR   Wikidata; Q54743457
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10645
AC   CVCL_4M29
DR   CLO; CLO_0021493
DR   Coriell; AG10645
DR   Wikidata; Q54743458
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M67 ! AG11369
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10646
AC   CVCL_YX78
DR   Coriell; AG10646
DR   Wikidata; Q93318346
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG10646; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   AG10671
AC   CVCL_2N16
DR   CLO; CLO_0021496
DR   Coriell; AG10671
DR   Wikidata; Q54743459
RX   CelloPub=CLPUB00597;
CC   Doubling time: Slow growth (Coriell=AG10671).
CC   Derived from site: In situ; Carotid artery; UBERON=UBERON_0005396.
CC   Cell type: Carotid artery smooth muscle cell; CL=CL_0002596.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG10673
AC   CVCL_2I88
SY   AG10673A
DR   CLO; CLO_0021495
DR   Coriell; AG10673
DR   Wikidata; Q54743461
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10674
AC   CVCL_2I89
SY   AG10674A
DR   CLO; CLO_0021498
DR   Coriell; AG10674
DR   Wikidata; Q54743463
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10677
AC   CVCL_0Q95
DR   CLO; CLO_0021497
DR   Coriell; AG10677
DR   Wikidata; Q54743464
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
RX   PubMed=15130666;
CC   Population: Caucasian; English/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Glu145Lys (c.433G>A); ClinVar=VCV000014502; Zygosity=Heterozygous (PubMed=12714972).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   AG10696
AC   CVCL_2M95
DR   CLO; CLO_0021525
DR   Coriell; AG10696
DR   Wikidata; Q54743468
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M92 ! AG10553
OI   CVCL_2M93 ! AG10554
OI   CVCL_2M94 ! AG10604
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG10697
AC   CVCL_2M98
DR   CLO; CLO_0021524
DR   Coriell; AG10697
DR   Wikidata; Q54743469
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2M96 ! AG10555
OI   CVCL_2M97 ! AG10605
SX   Male
AG   15W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG10727
AC   CVCL_4M30
DR   CLO; CLO_0021523
DR   Coriell; AG10727
DR   Wikidata; Q54743473
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10750
AC   CVCL_L615
DR   Coriell; AG10750
DR   GEO; GSM87553
DR   GEO; GSM87751
DR   GEO; GSM88282
DR   GEO; GSM88298
DR   GEO; GSM88299
DR   GEO; GSM88300
DR   Wikidata; Q54743475
RX   CelloPub=CLPUB00597;
RX   PubMed=10741968;
RX   PubMed=15130666;
RX   PubMed=15268757;
RX   PubMed=16126733;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG10750).
CC   Discontinued: Coriell; AG10750; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q88 ! AG10587
SX   Male
AG   9Y4M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   AG10757
AC   CVCL_4M31
DR   CLO; CLO_0021522
DR   Coriell; AG10757
DR   Wikidata; Q54743478
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10758
AC   CVCL_4M32
DR   CLO; CLO_0021521
DR   Coriell; AG10758
DR   Wikidata; Q54743479
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10759
AC   CVCL_4M33
DR   CLO; CLO_0021520
DR   Coriell; AG10759
DR   Wikidata; Q54743483
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10760
AC   CVCL_4M34
DR   CLO; CLO_0021519
DR   Coriell; AG10760
DR   Wikidata; Q54743484
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10761
AC   CVCL_4M35
SY   AG10761A
DR   CLO; CLO_0021528
DR   Coriell; AG10761
DR   Wikidata; Q54743485
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10762
AC   CVCL_4M36
DR   CLO; CLO_0021527
DR   Coriell; AG10762
DR   Wikidata; Q54743490
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10788
AC   CVCL_4M37
DR   CLO; CLO_0021509
DR   Coriell; AG10788
DR   Wikidata; Q54743491
RX   CelloPub=CLPUB00597;
RX   PubMed=10408806;
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=30699343).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M51 ! AG10956
SX   Female
AG   87Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG10801
AC   CVCL_0Q96
DR   CLO; CLO_0021512
DR   Coriell; AG10801
DR   Wikidata; Q54743492
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
RX   PubMed=12768443;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Ser (c.1822G>A); ClinVar=VCV000014501; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; PubMed=12768443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y10M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   AG10803
AC   CVCL_L244
DR   CLO; CLO_0021511
DR   Coriell; AG10803
DR   ENCODE; ENCBS065SFO
DR   ENCODE; ENCBS287ITL
DR   ENCODE; ENCBS408ENC
DR   ENCODE; ENCBS793PDT
DR   GEO; GSM244115
DR   GEO; GSM244116
DR   GEO; GSM510520
DR   GEO; GSM510521
DR   GEO; GSM749714
DR   GEO; GSM749734
DR   GEO; GSM749759
DR   GEO; GSM945171
DR   GEO; GSM945172
DR   Wikidata; Q54743495
RX   CelloPub=CLPUB00597;
RX   PubMed=12297622;
RX   PubMed=18631391;
RX   PubMed=22720000;
RX   PubMed=23325432;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/AG10803_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y8M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   AG10819
AC   CVCL_4M38
SY   AG10819A
DR   CLO; CLO_0021518
DR   Coriell; AG10819
DR   Wikidata; Q54743497
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10820
AC   CVCL_4M39
SY   AG10820A
DR   CLO; CLO_0021517
DR   Coriell; AG10820
DR   Wikidata; Q54743498
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10821
AC   CVCL_4M40
DR   CLO; CLO_0021478
DR   Coriell; AG10821
DR   Wikidata; Q54743502
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10822
AC   CVCL_4M41
DR   CLO; CLO_0021470
DR   Coriell; AG10822
DR   Wikidata; Q54743503
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10823
AC   CVCL_4M42
SY   AG10823A
DR   CLO; CLO_0021471
DR   Coriell; AG10823
DR   Wikidata; Q54743505
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10824
AC   CVCL_4M43
DR   CLO; CLO_0021472
DR   Coriell; AG10824
DR   Wikidata; Q54743507
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10825
AC   CVCL_4M44
SY   AG10825B
DR   CLO; CLO_0021473
DR   Coriell; AG10825
DR   Wikidata; Q54743510
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10877
AC   CVCL_4M45
DR   CLO; CLO_0021474
DR   Coriell; AG10877
DR   Wikidata; Q54743512
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10882
AC   CVCL_2D41
SY   GRC#0498
DR   CLO; CLO_0021475
DR   Coriell; AG10882
DR   Wikidata; Q54743514
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG10882).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10883
AC   CVCL_2D42
SY   GRC#0489
DR   CLO; CLO_0021476
DR   Coriell; AG10883
DR   Wikidata; Q54743516
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G52 ! AG16359
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10884
AC   CVCL_2D43
SY   GRC#0925
DR   CLO; CLO_0021477
DR   Coriell; AG10884
DR   GEO; GSM3124616
DR   Wikidata; Q54743518
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=15450399;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (PubMed=9724752).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B39 ! AG05274
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG10891
AC   CVCL_4M46
DR   CLO; CLO_0021469
DR   Coriell; AG10891
DR   Wikidata; Q54743520
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10937
AC   CVCL_2D44
SY   GRC#1288
DR   CLO; CLO_0021468
DR   Coriell; AG10937
DR   Wikidata; Q54743523
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG10937).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10938
AC   CVCL_2D45
SY   GRC#1287
DR   CLO; CLO_0021467
DR   Coriell; AG10938
DR   Wikidata; Q54743524
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10939
AC   CVCL_2D46
SY   GRC#1285
DR   CLO; CLO_0021461
DR   Coriell; AG10939
DR   Wikidata; Q54743528
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG10939).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10940
AC   CVCL_2D47
SY   GRC#1286
DR   CLO; CLO_0021462
DR   Coriell; AG10940
DR   Wikidata; Q54743529
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG10940).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10941
AC   CVCL_2D48
SY   GRC#1280
DR   CLO; CLO_0021459
DR   Coriell; AG10941
DR   GEO; GSM426272
DR   Wikidata; Q54743581
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG10941).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B96 ! AG06307
OI   CVCL_2F30 ! AG13067
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG10942
AC   CVCL_2D49
SY   AG_10942; GRC#1282
DR   CLO; CLO_0021460
DR   Coriell; AG10942
DR   GEO; GSM6355
DR   Wikidata; Q54743584
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG10942).
CC   Doubling time: 2.6 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C81 ! AG08906
OI   CVCL_2E75 ! AG12657
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG10943
AC   CVCL_2D50
SY   GRC#1284
DR   CLO; CLO_0021465
DR   Coriell; AG10943
DR   Wikidata; Q54743587
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 20 PDL (Coriell=AG10943).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C79 ! AG08904
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10944
AC   CVCL_2D51
SY   GRC#1275
DR   CLO; CLO_0021466
DR   Coriell; AG10944
DR   Wikidata; Q54743589
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG10944).
CC   Karyotypic information: 46,XY [76%]; 46,XY,t(2;4)(2pter->2q31::4q35->4qter;4pter->4q35::2q31->2qter) [22%] (Coriell=AG10944).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B84 ! AG06288
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10950
AC   CVCL_4M47
DR   CLO; CLO_0021463
DR   Coriell; AG10950
DR   Wikidata; Q54743591
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10952
AC   CVCL_4M48
SY   AG10952A
DR   CLO; CLO_0021464
DR   Coriell; AG10952
DR   Wikidata; Q54743594
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10953
AC   CVCL_4M49
DR   CLO; CLO_0021486
DR   Coriell; AG10953
DR   Wikidata; Q54743596
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10955
AC   CVCL_4M50
DR   CLO; CLO_0021488
DR   Coriell; AG10955
DR   Wikidata; Q54743598
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10956
AC   CVCL_4M51
SY   AG10956B
DR   CLO; CLO_0021487
DR   Coriell; AG10956
DR   Wikidata; Q54743599
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (Coriell=AG10956).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M37 ! AG10788
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   AG10957
AC   CVCL_4M52
DR   CLO; CLO_0021482
DR   Coriell; AG10957
DR   Wikidata; Q54743603
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10984
AC   CVCL_4M53
SY   AG10984A
DR   CLO; CLO_0021483
DR   Coriell; AG10984
DR   Wikidata; Q54743604
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10986
AC   CVCL_4M54
DR   CLO; CLO_0021484
DR   Coriell; AG10986
DR   Wikidata; Q54743606
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG10987
AC   CVCL_4M55
DR   CLO; CLO_0021485
DR   Coriell; AG10987
DR   Wikidata; Q54743607
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M84 ! AG14149
SX   Sex unspecified
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG10992
AC   CVCL_2D52
SY   GRC#1276
DR   CLO; CLO_0021479
DR   Coriell; AG10992
DR   Wikidata; Q54743609
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG10992).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10993
AC   CVCL_2D53
SY   GRC#1277
DR   CLO; CLO_0021480
DR   Coriell; AG10993
DR   Wikidata; Q54743612
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG10993).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG10998
AC   CVCL_A2PC
DR   Coriell; AG10998
DR   Wikidata; Q105506324
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG10998; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9792; ! Equus grevyi (Grevy's zebra)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG10999
AC   CVCL_A2PD
DR   Coriell; AG10999
DR   Wikidata; Q105506327
RX   CelloPub=CLPUB00597;
RX   PubMed=21518243;
CC   Senescence: Senesces at 52 PDL (PubMed=21518243).
CC   Discontinued: Coriell; AG10999; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9792; ! Equus grevyi (Grevy's zebra)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   AG11000
AC   CVCL_4M56
SY   AG11000A
DR   CLO; CLO_0021481
DR   Coriell; AG11000
DR   Wikidata; Q54743613
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11001
AC   CVCL_4M57
DR   CLO; CLO_0021658
DR   Coriell; AG11001
DR   Wikidata; Q54743616
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11008
AC   CVCL_4M58
DR   CLO; CLO_0021653
DR   Coriell; AG11008
DR   Wikidata; Q54743619
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11009
AC   CVCL_4M59
SY   AG11009D
DR   CLO; CLO_0021652
DR   Coriell; AG11009
DR   Wikidata; Q54743620
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (from autologous cell line AG14244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M86 ! AG14244
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   AG11011
AC   CVCL_2D54
SY   GRC#1274
DR   CLO; CLO_0021651
DR   Coriell; AG11011
DR   Wikidata; Q54743622
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG11011).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11013
AC   CVCL_2D55
SY   GRC#1307
DR   CLO; CLO_0021650
DR   Coriell; AG11013
DR   Wikidata; Q54743625
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG11013).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B90 ! AG06295
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11014
AC   CVCL_2D56
SY   GRC#1306
DR   CLO; CLO_0021657
DR   Coriell; AG11014
DR   Wikidata; Q54743627
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [62%]; 45,X [10%]; 46,XY,t(2;5),t(10;11) [28%] (Coriell=AG11014).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B68 ! AG06236
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11015
AC   CVCL_4M60
DR   CLO; CLO_0021656
DR   Coriell; AG11015
DR   Wikidata; Q54743629
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11016
AC   CVCL_2D57
SY   GRC#1299
DR   CLO; CLO_0021655
DR   Coriell; AG11016
DR   Wikidata; Q54743630
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (PubMed=9724752); 36 PDL (Coriell=AG11016).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG11017
AC   CVCL_2D58
SY   GRC#1302
DR   CLO; CLO_0021654
DR   Coriell; AG11017
DR   GEO; GSM3124618
DR   Wikidata; Q54743633
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 32 PDL (Coriell=AG11017).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11018
AC   CVCL_2D59
SY   AG11018A; GRC#1296
DR   CLO; CLO_0021639
DR   Coriell; AG11018
DR   Wikidata; Q54743635
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C38 ! AG07479
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11019
AC   CVCL_2D60
SY   GRC#1297
DR   CLO; CLO_0021640
DR   Coriell; AG11019
DR   Wikidata; Q54743636
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A99 ! AG04551
OI   CVCL_2C99 ! AG09270
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11020
AC   CVCL_2D61
SY   AG_11020; GRC#1265
DR   CLO; CLO_0021641
DR   Coriell; AG11020
DR   GEO; GSM6356
DR   Wikidata; Q54743640
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 67 PDL (PubMed=9724752).
CC   Doubling time: 2.3 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C07 ! AG06952
OI   CVCL_2F33 ! AG13077
SX   Female
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   AG11070
AC   CVCL_4M61
DR   CLO; CLO_0021644
DR   Coriell; AG11070
DR   Wikidata; Q54743642
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11072
AC   CVCL_2D62
SY   GRC#1291
DR   CLO; CLO_0021645
DR   Coriell; AG11072
DR   Wikidata; Q54743644
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG11072).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11073
AC   CVCL_2D63
SY   GRC#1289
DR   CLO; CLO_0021642
DR   Coriell; AG11073
DR   Wikidata; Q54743648
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 20 PDL (Coriell=AG11073).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G27 ! AG13993
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11074
AC   CVCL_2M91
SY   GRC#1279
DR   CLO; CLO_0021643
DR   Coriell; AG11074
DR   Wikidata; Q54743650
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG11074; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11075
AC   CVCL_2D64
SY   GRC#1294
DR   CLO; CLO_0021648
DR   Coriell; AG11075
DR   Wikidata; Q54743652
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11075).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11076
AC   CVCL_2D65
SY   GRC#1292
DR   CLO; CLO_0021649
DR   Coriell; AG11076
DR   Wikidata; Q54743654
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG11076).
CC   Karyotypic information: 46,XY [96%]; 47,XYY [4%] (Coriell=AG11076).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11077
AC   CVCL_2D66
SY   GRC#1316
DR   CLO; CLO_0021646
DR   Coriell; AG11077
DR   Wikidata; Q54743658
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 20 PDL (Coriell=AG11077).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11078
AC   CVCL_2D67
SY   GRC#1315
DR   CLO; CLO_0021647
DR   Coriell; AG11078
DR   Wikidata; Q54743660
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11078).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11079
AC   CVCL_2D68
SY   GRC#1314
DR   CLO; CLO_0021629
DR   Coriell; AG11079
DR   Wikidata; Q54743661
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 9 PDL (Coriell=AG11079).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11080
AC   CVCL_2D69
SY   GRC#1313
DR   CLO; CLO_0021630
DR   Coriell; AG11080
DR   Wikidata; Q54743664
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG11080).
CC   Karyotypic information: 46,XX [96%]; 45,XX,-3 [4%] (Coriell=AG11080).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11081
AC   CVCL_2D70
SY   AG11081A; GRC#1312
DR   CLO; CLO_0021631
DR   Coriell; AG11081
DR   Wikidata; Q54743666
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (PubMed=9724752); 44 PDL (Coriell=AG11081).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C17 ! AG07122
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG11082
AC   CVCL_0E22
DR   CLO; CLO_0021632
DR   Coriell; AG11082
DR   Wikidata; Q54743668
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0E15 ! HIAE-43/7-12
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG11088
AC   CVCL_4M62
SY   AG11088B
DR   CLO; CLO_0021633
DR   Coriell; AG11088
DR   Wikidata; Q54743752
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11089
AC   CVCL_4M63
DR   CLO; CLO_0021634
DR   Coriell; AG11089
DR   Wikidata; Q54743755
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11131
AC   CVCL_2Q19
SY   40GL/AC209
DR   CLO; CLO_0021635
DR   Coriell; AG11131
DR   Wikidata; Q54743757
RX   CelloPub=CLPUB00597;
RX   DOI=10.1007/BF01797781;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
DI   NCIt; C3073; Gynecomastia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG11132
AC   CVCL_2Q20
SY   48R/AC170
DR   CLO; CLO_0021636
DR   Coriell; AG11132
DR   Wikidata; Q54743758
RX   CelloPub=CLPUB00597;
RX   DOI=10.1007/BF01797781;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG11134
AC   CVCL_2Q21
SY   172R/AA765
DR   CLO; CLO_0021637
DR   Coriell; AG11134
DR   Wikidata; Q54743761
RX   CelloPub=CLPUB00597;
RX   DOI=10.1007/BF01797781;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG11136
AC   CVCL_2Q22
SY   210C/AB470
DR   CLO; CLO_0021638
DR   Coriell; AG11136
DR   Wikidata; Q54743763
RX   CelloPub=CLPUB00597;
RX   DOI=10.1007/BF01797781;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG11137
AC   CVCL_2Q23
SY   AG11137A; 239/AA480
DR   CLO; CLO_0021621
DR   Coriell; AG11137
DR   Wikidata; Q54743765
RX   CelloPub=CLPUB00597;
RX   DOI=10.1007/BF01797781;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG11138
AC   CVCL_2Q24
SY   AG11138A; 192P/AA832
DR   CLO; CLO_0021622
DR   Coriell; AG11138
DR   Wikidata; Q54743768
RX   CelloPub=CLPUB00597;
RX   DOI=10.1007/BF01797781;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AG11153
AC   CVCL_2D71
SY   GRC#1323
DR   CLO; CLO_0021619
DR   Coriell; AG11153
DR   Wikidata; Q54743772
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (Coriell=AG11153).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11154
AC   CVCL_2D72
SY   GRC#1324
DR   CLO; CLO_0021620
DR   Coriell; AG11154
DR   GEO; GSM3124589
DR   Wikidata; Q54743774
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG11154).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11156
AC   CVCL_2D73
SY   GRC#1329
DR   CLO; CLO_0021627
DR   Coriell; AG11156
DR   Wikidata; Q54743776
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG11156).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11157
AC   CVCL_2D74
SY   GRC#1330
DR   CLO; CLO_0021628
DR   Coriell; AG11157
DR   Wikidata; Q54743778
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B38 ! AG05271
OI   CVCL_2C47 ! AG07801
OI   CVCL_2G05 ! AG13349
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11158
AC   CVCL_2D75
SY   GRC#1331
DR   CLO; CLO_0021625
DR   Coriell; AG11158
DR   Wikidata; Q54743779
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG11158).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11159
AC   CVCL_2D76
SY   GRC#1332
DR   CLO; CLO_0021626
DR   Coriell; AG11159
DR   Wikidata; Q54743783
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG11159).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11160
AC   CVCL_2D77
SY   GRC#1336
DR   CLO; CLO_0021623
DR   Coriell; AG11160
DR   Wikidata; Q54743785
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (Coriell=AG11160).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11161
AC   CVCL_2D78
SY   GRC#1338
DR   CLO; CLO_0021624
DR   Coriell; AG11161
DR   Wikidata; Q54743786
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG11161).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B36 ! AG05266
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11162
AC   CVCL_2D79
SY   GRC#1337
DR   CLO; CLO_0021613
DR   Coriell; AG11162
DR   GEO; GSM3124587
DR   Wikidata; Q54743790
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG11162).
CC   Karyotypic information: 46,XY [78%]; 46,XY,t(3;6)(q26;q16) [22%] (Coriell=AG11162).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11240
AC   CVCL_2D80
SY   GRC#1244
DR   CLO; CLO_0021615
DR   Coriell; AG11240
DR   Wikidata; Q54743792
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (PubMed=9724752); 21 PDL (Coriell=AG11240).
CC   Doubling time: Slow growth (Coriell=AG11240).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG11241
AC   CVCL_2D81
SY   GRC#1247
DR   CLO; CLO_0021616
DR   Coriell; AG11241
DR   Wikidata; Q54743794
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG11241).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11242
AC   CVCL_2D82
SY   GRC#1249
DR   CLO; CLO_0021617
DR   Coriell; AG11242
DR   Wikidata; Q54743797
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG11242).
CC   Doubling time: Slow growth (Coriell=AG11242).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11243
AC   CVCL_2D83
SY   GRC#1257
DR   CLO; CLO_0021618
DR   Coriell; AG11243
DR   Wikidata; Q54743798
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG11243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B13 ! AG04659
OI   CVCL_2B43 ! AG05283
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11244
AC   CVCL_2D84
SY   GRC#1258
DR   CLO; CLO_0021614
DR   Coriell; AG11244
DR   Wikidata; Q54743801
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG11244).
CC   Karyotypic information: 46,XY [88%]; 46,XY,t(2;19)(p23;p12) [12%] (Coriell=AG11244).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11245
AC   CVCL_2D85
SY   GRC#1259
DR   CLO; CLO_0021604
DR   Coriell; AG11245
DR   Wikidata; Q54743804
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11246
AC   CVCL_2D86
SY   GRC#1260
DR   CLO; CLO_0021603
DR   Coriell; AG11246
DR   Wikidata; Q54743805
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (PubMed=9724752).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG11247
AC   CVCL_0G00
SY   GRC#1261
DR   CLO; CLO_0021608
DR   Coriell; AG11247
DR   Wikidata; Q54743808
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG11247).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0F99 ! AG06881
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   AG11248
AC   CVCL_2D87
SY   AG11248A; GRC#1262
DR   CLO; CLO_0021607
DR   Coriell; AG11248
DR   Wikidata; Q54743811
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG11248).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B59 ! AG05837
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11249
AC   CVCL_2D88
SY   GRC#1263
DR   CLO; CLO_0021606
DR   Coriell; AG11249
DR   Wikidata; Q54743812
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11249).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11339
AC   CVCL_2I90
SY   AG11339C
DR   CLO; CLO_0021605
DR   Coriell; AG11339
DR   Wikidata; Q54743814
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11340
AC   CVCL_2I91
DR   CLO; CLO_0021602
DR   Coriell; AG11340
DR   Wikidata; Q54743815
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11343
AC   CVCL_2I92
DR   CLO; CLO_0021601
DR   Coriell; AG11343
DR   Wikidata; Q54743817
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11344
AC   CVCL_2I93
SY   AG11344A
DR   CLO; CLO_0021600
DR   Coriell; AG11344
DR   Wikidata; Q54743819
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11354
AC   CVCL_2I94
DR   CLO; CLO_0021599
DR   Coriell; AG11354
DR   Wikidata; Q54743822
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11356
AC   CVCL_2D89
SY   GRC#1308
DR   CLO; CLO_0021592
DR   Coriell; AG11356
DR   Wikidata; Q54743824
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 48 PDL (Coriell=AG11356).
CC   Doubling time: Slow growth (Coriell=AG11356).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11357
AC   CVCL_2D90
SY   GRC#1309
DR   CLO; CLO_0021594
DR   Coriell; AG11357
DR   GEO; GSM3124592
DR   Wikidata; Q54743828
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG11357).
CC   Karyotypic information: 46,XX [76%]; 46,XX,-14,+mar [24%] (Coriell=AG11357).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11358
AC   CVCL_2D91
SY   AG11358A; GRC#1311
DR   CLO; CLO_0021593
DR   Coriell; AG11358
DR   Wikidata; Q54743830
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C91 ! AG09160
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11361
AC   CVCL_2D92
SY   GRC#1269
DR   CLO; CLO_0021596
DR   Coriell; AG11361
DR   Wikidata; Q54743833
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG11361).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11362
AC   CVCL_2D93
SY   AG_11362; GRC#1270
DR   CLO; CLO_0021595
DR   Coriell; AG11362
DR   GEO; GSM6357
DR   Wikidata; Q54743836
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11362).
CC   Doubling time: 2.1 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B63 ! AG05844
OI   CVCL_2F56 ! AG13144
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG11363
AC   CVCL_2D94
SY   GRC#1271
DR   CLO; CLO_0021598
DR   Coriell; AG11363
DR   Wikidata; Q54743839
RX   CelloPub=CLPUB00597;
RX   PubMed=7847674;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11364
AC   CVCL_2D95
SY   GRC#1248
DR   CLO; CLO_0021597
DR   Coriell; AG11364
DR   GEO; GSM426258
DR   Wikidata; Q54743841
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG11364).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B49 ! AG05416
OI   CVCL_2F57 ! AG13145
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG11365
AC   CVCL_2D96
SY   GRC#1252
DR   CLO; CLO_0021590
DR   Coriell; AG11365
DR   Wikidata; Q54743844
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG11365).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B91 ! AG06296
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11366
AC   CVCL_4M64
DR   CLO; CLO_0021589
DR   Coriell; AG11366
DR   Wikidata; Q54743896
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M69 ! AG11415
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11367
AC   CVCL_4M65
DR   CLO; CLO_0021591
DR   Coriell; AG11367
DR   Wikidata; Q54743898
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11368
AC   CVCL_4M66
DR   CLO; CLO_0021588
DR   Coriell; AG11368
DR   Wikidata; Q54743900
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (Coriell=AG11368).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M06 ! AG09952
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG11369
AC   CVCL_4M67
DR   CLO; CLO_0021587
DR   Coriell; AG11369
DR   Wikidata; Q54743903
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M29 ! AG10645
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG11371
AC   CVCL_2I95
SY   AG11371A
DR   CLO; CLO_0021586
DR   Coriell; AG11371
DR   Wikidata; Q54743905
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11372
AC   CVCL_2I96
DR   CLO; CLO_0021585
DR   Coriell; AG11372
DR   Wikidata; Q54743907
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11378
AC   CVCL_2I97
DR   CLO; CLO_0021584
DR   Coriell; AG11378
DR   Wikidata; Q54743909
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11379
AC   CVCL_2I98
DR   CLO; CLO_0021583
DR   Coriell; AG11379
DR   Wikidata; Q54743911
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11395
AC   CVCL_U281
SY   WS780
DR   CLO; CLO_0021582
DR   EFO; EFO_0022407
DR   Coriell; AG11395
DR   GEO; GSM1052419
DR   Wikidata; Q54743912
RX   CelloPub=CLPUB00597;
RX   CelloPub=CLPUB00712;
RX   PubMed=1671011;
RX   PubMed=9230208;
RX   PubMed=10606667;
RX   PubMed=19935656;
RX   PubMed=23257959;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9230208; Coriell=AG11395).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Misspelling: AG11385; GEO=GSM1052419; PubMed=23257959.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U282 ! AG00780
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 23
//
ID   AG11398
AC   CVCL_2I99
DR   CLO; CLO_0021581
DR   Coriell; AG11398
DR   Wikidata; Q54743916
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11399
AC   CVCL_2J00
DR   CLO; CLO_0021580
DR   Coriell; AG11399
DR   Wikidata; Q54743917
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11400
AC   CVCL_2J01
SY   AG11400A
DR   CLO; CLO_0021579
DR   Coriell; AG11400
DR   Wikidata; Q54743918
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11414
AC   CVCL_4M68
DR   CLO; CLO_0021569
DR   Coriell; AG11414
DR   Wikidata; Q54743919
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (Coriell=AG11414).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   AG11415
AC   CVCL_4M69
DR   CLO; CLO_0021576
DR   Coriell; AG11415
DR   Wikidata; Q54743920
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian; French Canadian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M64 ! AG11366
SX   Male
AG   54Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11421
AC   CVCL_2J02
DR   Coriell; AG11421
DR   Wikidata; Q54743921
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11422
AC   CVCL_2J03
SY   AG11422A
DR   CLO; CLO_0021575
DR   Coriell; AG11422
DR   Wikidata; Q54743925
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11426
AC   CVCL_2J04
SY   AG11426A
DR   CLO; CLO_0021578
DR   Coriell; AG11426
DR   Wikidata; Q54743927
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11427
AC   CVCL_2J05
SY   AG11427A
DR   CLO; CLO_0021577
DR   Coriell; AG11427
DR   Wikidata; Q54743928
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11455
AC   CVCL_4M70
SY   AG11455A
DR   CLO; CLO_0021572
DR   Coriell; AG11455
DR   Wikidata; Q54743930
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11466
AC   CVCL_2J06
DR   CLO; CLO_0021571
DR   Coriell; AG11466
DR   Wikidata; Q54743933
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11467
AC   CVCL_2J07
SY   AG11467A
DR   CLO; CLO_0021574
DR   Coriell; AG11467
DR   Wikidata; Q54743934
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11481
AC   CVCL_2D97
SY   GRC#1340
DR   CLO; CLO_0021573
DR   Coriell; AG11481
DR   Wikidata; Q54743935
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG11481).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11482
AC   CVCL_2D98
SY   AG11482A; GRC#1341
DR   CLO; CLO_0021570
DR   Coriell; AG11482
DR   Wikidata; Q54743938
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG11482).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11483
AC   CVCL_2D99
SY   GRC#1342
DR   CLO; CLO_0021568
DR   Coriell; AG11483
DR   Wikidata; Q54743940
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG11483).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11484
AC   CVCL_2E00
SY   GRC#1343
DR   CLO; CLO_0021567
DR   Coriell; AG11484
DR   GEO; GSM3124586
DR   Wikidata; Q54743942
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG11484).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11485
AC   CVCL_2E01
SY   GRC#1344
DR   CLO; CLO_0021559
DR   Coriell; AG11485
DR   Wikidata; Q54743945
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG11485).
CC   Karyotypic information: 46,XY [16%]; 46,XY,t(1;12)(q25;q13) [84%] (Coriell=AG11485).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11486
AC   CVCL_2E02
SY   GRC#1345
DR   CLO; CLO_0021560
DR   Coriell; AG11486
DR   Wikidata; Q54743948
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 52 PDL (Coriell=AG11486).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11487
AC   CVCL_2E03
SY   GRC#1346
DR   CLO; CLO_0021561
DR   Coriell; AG11487
DR   Wikidata; Q54743951
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG11487).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11488
AC   CVCL_L629
SY   GRC#1230
DR   CLO; CLO_0021562
DR   Coriell; AG11488
DR   Wikidata; Q54743953
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG11488).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L630 ! AG07135
OI   CVCL_L631 ! AG07143
OI   CVCL_L632 ! AG12788
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG11489
AC   CVCL_2E04
SY   GRC#1229
DR   CLO; CLO_0021563
DR   Coriell; AG11489
DR   Wikidata; Q54743954
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11489).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11490
AC   CVCL_2E05
SY   GRC#1226
DR   CLO; CLO_0021564
DR   Coriell; AG11490
DR   Wikidata; Q54743956
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG11490).
CC   Karyotypic information: 46,XY [2%]; 46,XY,t(1;15;22) [98%] (Coriell=AG11490).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11498
AC   CVCL_H766
DR   CLO; CLO_0021565
DR   Coriell; AG11498
DR   GEO; GSM88283
DR   GEO; GSM88284
DR   GEO; GSM88285
DR   GEO; GSM88301
DR   GEO; GSM88302
DR   GEO; GSM88303
DR   Wikidata; Q54743960
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
RX   PubMed=15268757;
RX   PubMed=16126733;
RX   PubMed=28855503;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; Coriell=AG11498).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   AG11506
AC   CVCL_2J08
DR   CLO; CLO_0021566
DR   Coriell; AG11506
DR   Wikidata; Q54743962
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11513
AC   CVCL_0Q97
DR   CLO; CLO_0022604
DR   Coriell; AG11513
DR   GEO; GSM88286
DR   GEO; GSM88287
DR   GEO; GSM88288
DR   GEO; GSM88304
DR   GEO; GSM88305
DR   GEO; GSM88306
DR   GEO; GSM3124693
DR   Wikidata; Q54743964
RX   CelloPub=CLPUB00597;
RX   PubMed=12714972;
RX   PubMed=15268757;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; Coriell=AG11513).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y2M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   AG11514
AC   CVCL_4M71
DR   CLO; CLO_0022605
DR   Coriell; AG11514
DR   Wikidata; Q54743968
RX   CelloPub=CLPUB00597;
CC   Part of: German Alzheimer disease kindred subcollection.
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11552
AC   CVCL_X877
DR   CLO; CLO_0022593
DR   Coriell; AG11552
DR   Wikidata; Q54743969
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG11555
AC   CVCL_2E06
SY   GRC#0926
DR   CLO; CLO_0022595
DR   Coriell; AG11555
DR   Wikidata; Q54743971
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 13 PDL (Coriell=AG11555).
CC   Karyotypic information: 46,XY [42%]; 47,XY,+18 [58%] (Coriell=AG11555).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A63 ! AG04350
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11556
AC   CVCL_L627
SY   GRC#0923
DR   CLO; CLO_0022639
DR   Coriell; AG11556
DR   GEO; GSM3124579
DR   Wikidata; Q54743972
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG11556).
CC   Karyotypic information: 46,XY [80%]; 46,XY,t(1;3) [16%]; 46,XY,t(7;14) [4%] (Coriell=AG11556).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L626 ! AG04462
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   AG11557
AC   CVCL_2E07
SY   GRC#0922
DR   CLO; CLO_0022638
DR   Coriell; AG11557
DR   Wikidata; Q54743973
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 14 PDL (Coriell=AG11557).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A41 ! AG04054
OI   CVCL_2G15 ! AG13442
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11561
AC   CVCL_2E08
SY   GRC#0927
DR   CLO; CLO_0022643
DR   Coriell; AG11561
DR   Wikidata; Q54743974
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG11561).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B26 ! AG05186
OI   CVCL_2G11 ! AG13369
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11564
AC   CVCL_2E09
SY   GRC#0932
DR   CLO; CLO_0022644
DR   Coriell; AG11564
DR   Wikidata; Q54744025
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG11564).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11572
AC   CVCL_0Q98
DR   CLO; CLO_0022645
DR   Coriell; AG11572
DR   Wikidata; Q54744027
RX   CelloPub=CLPUB00597;
RX   PubMed=15130666;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q89 ! AG07493
SX   Female
AG   1Y8M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   AG11607
AC   CVCL_2N15
DR   CLO; CLO_0022647
DR   Coriell; AG11607
DR   Wikidata; Q54744028
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   8W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG11643
AC   CVCL_2E10
SY   GRC#1250
DR   Coriell; AG11643
DR   Wikidata; Q54744030
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG11643; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A52 ! AG04145
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11645
AC   CVCL_2E11
SY   GRC#1264
DR   CLO; CLO_0022650
DR   Coriell; AG11645
DR   Wikidata; Q54744032
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG11645).
CC   Karyotypic information: 46,XY,inv(9)(p11;q12) [82%]; 46,XY,inv(9),t(8;10;14)(p21;p13;q24) [18%] (Coriell=AG11645).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D13 ! AG09698
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11646
AC   CVCL_2E12
SY   GRC#1266
DR   CLO; CLO_0022652
DR   Coriell; AG11646
DR   Wikidata; Q54744034
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG11646).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11647
AC   CVCL_2E13
SY   GRC#1267
DR   CLO; CLO_0022654
DR   Coriell; AG11647
DR   Wikidata; Q54744035
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG11647).
CC   Karyotypic information: 46,XY [80%]; 46,XY,t(2;4)(q31;p16) [20%] (Coriell=AG11647).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11648
AC   CVCL_2E14
SY   GRC#1268
DR   CLO; CLO_0022655
DR   Coriell; AG11648
DR   Wikidata; Q54744038
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG11648).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B72 ! AG06242
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11649
AC   CVCL_2E15
SY   GRC#1272
DR   CLO; CLO_0022657
DR   Coriell; AG11649
DR   Wikidata; Q54744041
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG11649).
CC   Karyotypic information: 46,XY [76%]; 46,XY,t(5;7) [24%] (Coriell=AG11649).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11650
AC   CVCL_2E16
SY   GRC#1273
DR   CLO; CLO_0022616
DR   Coriell; AG11650
DR   Wikidata; Q54744043
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG11650).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11651
AC   CVCL_2E17
SY   GRC#1290
DR   CLO; CLO_0022620
DR   Coriell; AG11651
DR   Wikidata; Q54744047
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG11651).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11652
AC   CVCL_2E18
SY   GRC#1303
DR   CLO; CLO_0022621
DR   Coriell; AG11652
DR   Wikidata; Q54744048
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG11652).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11659
AC   CVCL_2J09
DR   CLO; CLO_0022627
DR   Coriell; AG11659
DR   Wikidata; Q54744051
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11663
AC   CVCL_2J10
SY   AG11663A
DR   CLO; CLO_0022629
DR   Coriell; AG11663
DR   Wikidata; Q54744052
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11664
AC   CVCL_2J11
SY   AG11664A
DR   CLO; CLO_0022622
DR   Coriell; AG11664
DR   Wikidata; Q54744056
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11665
AC   CVCL_2J12
SY   AG11665A
DR   CLO; CLO_0022625
DR   Coriell; AG11665
DR   Wikidata; Q54744058
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11670
AC   CVCL_A2NT
DR   Coriell; AG11670
DR   Wikidata; Q105506331
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG11670; probable.
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_A2NU ! AG11673
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   AG11673
AC   CVCL_A2NU
SY   AG11673A
DR   Coriell; AG11673
DR   Wikidata; Q105506334
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG11673; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_A2NT ! AG11670
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   AG11680
AC   CVCL_2J13
DR   CLO; CLO_0022634
DR   Coriell; AG11680
DR   Wikidata; Q54744060
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11681
AC   CVCL_2J14
SY   AG11681B
DR   CLO; CLO_0022637
DR   Coriell; AG11681
DR   Wikidata; Q54744063
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11682
AC   CVCL_2J15
DR   CLO; CLO_0022630
DR   Coriell; AG11682
DR   Wikidata; Q54744065
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11684
AC   CVCL_2J16
DR   CLO; CLO_0022633
DR   Coriell; AG11684
DR   Wikidata; Q54744066
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11693
AC   CVCL_2E19
SY   GRC#0400
DR   CLO; CLO_0022368
DR   Coriell; AG11693
DR   Wikidata; Q54744069
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG11693).
CC   Karyotypic information: 46,XY [36%]; 46,XY,t(14;17)(q22;q12) [64%] (Coriell=AG11693).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A96 ! AG04459
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11694
AC   CVCL_2N33
SY   GRC#0341
DR   CLO; CLO_0022367
DR   Coriell; AG11694
DR   Wikidata; Q54744071
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG11694; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11695
AC   CVCL_2E20
SY   GRC#0796
DR   CLO; CLO_0022366
DR   Coriell; AG11695
DR   Wikidata; Q54744073
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11695).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11696
AC   CVCL_2E21
SY   GRC#0367
DR   CLO; CLO_0022362
DR   Coriell; AG11696
DR   GEO; GSM426273
DR   Wikidata; Q54744076
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG11696).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG11697
AC   CVCL_2E22
DR   CLO; CLO_0022361
DR   Coriell; AG11697
DR   Wikidata; Q54744079
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG11697).
CC   Karyotypic information: 46,XY [78%]; 45,X [16%]; 46,XY,add(1)(q43) [6%] (Coriell=AG11697).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11698
AC   CVCL_2E23
DR   CLO; CLO_0022360
DR   Coriell; AG11698
DR   GEO; GSM3124585
DR   Wikidata; Q54744081
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG11698).
CC   Karyotypic information: 46,XY [68%]; 46,XY,t(2;7)(q22;q31) [32%] (Coriell=AG11698).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG11699
AC   CVCL_2E24
SY   GRC#0491
DR   CLO; CLO_0022359
DR   Coriell; AG11699
DR   Wikidata; Q54744083
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG11699).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11700
AC   CVCL_2E25
SY   GRC#0382
DR   CLO; CLO_0022365
DR   Coriell; AG11700
DR   Wikidata; Q54744085
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG11700).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11701
AC   CVCL_2E26
SY   GRC#0394
DR   CLO; CLO_0022364
DR   Coriell; AG11701
DR   Wikidata; Q54744087
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG11701).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11702
AC   CVCL_2E27
SY   GRC#0348
DR   CLO; CLO_0022363
DR   Coriell; AG11702
DR   Wikidata; Q54744091
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG11702).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11716
AC   CVCL_2J17
DR   CLO; CLO_0022376
DR   Coriell; AG11716
DR   Wikidata; Q54744093
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11717
AC   CVCL_2J18
DR   CLO; CLO_0022375
DR   Coriell; AG11717
DR   Wikidata; Q54744095
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11718
AC   CVCL_2J19
DR   CLO; CLO_0022378
DR   Coriell; AG11718
DR   Wikidata; Q54744097
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11719
AC   CVCL_2J20
DR   CLO; CLO_0022377
DR   Coriell; AG11719
DR   Wikidata; Q54744101
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11721
AC   CVCL_2Q37
DR   CLO; CLO_0022370
DR   Coriell; AG11721
DR   Wikidata; Q54744103
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG11724
AC   CVCL_2E28
SY   GRC#0267
DR   CLO; CLO_0022369
DR   Coriell; AG11724
DR   Wikidata; Q54744104
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG11724).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E31 ! AG11727
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11725
AC   CVCL_2E29
SY   GRC#1182
DR   CLO; CLO_0022372
DR   Coriell; AG11725
DR   GEO; GSM3124605
DR   Wikidata; Q54744107
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11726
AC   CVCL_2E30
SY   GRC#1184
DR   CLO; CLO_0022371
DR   Coriell; AG11726
DR   GEO; GSM426274
DR   Wikidata; Q54744109
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG11726).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG11727
AC   CVCL_2E31
SY   GRC#0335
DR   CLO; CLO_0022374
DR   Coriell; AG11727
DR   Wikidata; Q54744110
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG11727).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E28 ! AG11724
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11728
AC   CVCL_2E32
SY   GRC#0358
DR   CLO; CLO_0022373
DR   Coriell; AG11728
DR   Wikidata; Q54744111
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG11728).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11730
AC   CVCL_2E33
SY   GRC#0373
DR   CLO; CLO_0022388
DR   Coriell; AG11730
DR   GEO; GSM3124610
DR   Wikidata; Q54744163
RX   CelloPub=CLPUB00597;
RX   PubMed=15450399;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [2%]; 45,X [98%] (Coriell=AG11730).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A44 ! AG04057
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11731
AC   CVCL_2E34
SY   GRC#0401
DR   CLO; CLO_0022387
DR   Coriell; AG11731
DR   Wikidata; Q54744164
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG11731).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11732
AC   CVCL_2E35
SY   GRC#0403
DR   CLO; CLO_0022386
DR   Coriell; AG11732
DR   GEO; GSM3124562
DR   Wikidata; Q54744167
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11733
AC   CVCL_2E36
SY   GRC#0407
DR   CLO; CLO_0022385
DR   Coriell; AG11733
DR   Wikidata; Q54744169
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG11733).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11734
AC   CVCL_2E37
SY   GRC#0410
DR   CLO; CLO_0022384
DR   Coriell; AG11734
DR   Wikidata; Q54744170
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11735
AC   CVCL_2E38
SY   GRC#0411
DR   CLO; CLO_0022383
DR   Coriell; AG11735
DR   GEO; GSM3124564
DR   Wikidata; Q54744172
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG11735).
CC   Karyotypic information: 46,XX [93%]; 47,XX,+9 [7%] (Coriell=AG11735).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11736
AC   CVCL_2E39
DR   CLO; CLO_0022382
DR   Coriell; AG11736
DR   Wikidata; Q54744175
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 66 PDL (Coriell=AG11736).
CC   Karyotypic information: 46,XX,t(9;18)(q32;q21) (Coriell=AG11736).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11737
AC   CVCL_2E40
SY   GRC#0681
DR   CLO; CLO_0022381
DR   Coriell; AG11737
DR   Wikidata; Q54744179
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG11737).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11740
AC   CVCL_2E41
SY   GRC#0776
DR   CLO; CLO_0022380
DR   Coriell; AG11740
DR   Wikidata; Q54744180
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG11740).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11743
AC   CVCL_2E42
SY   GRC#1180
DR   CLO; CLO_0022379
DR   Coriell; AG11743
DR   Wikidata; Q54744183
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG11743).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11744
AC   CVCL_2E43
SY   GRC#1304
DR   CLO; CLO_0022408
DR   Coriell; AG11744
DR   GEO; GSM3124607
DR   Wikidata; Q54744185
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG11744).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11745
AC   CVCL_2E44
SY   AG_11745; GRC#1322
DR   CLO; CLO_0022405
DR   Coriell; AG11745
DR   GEO; GSM6358
DR   GEO; GSM6390
DR   GEO; GSM3124574
DR   Wikidata; Q54744187
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11745).
CC   Doubling time: 1.8 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B60 ! AG05838
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG11746
AC   CVCL_2E45
SY   GRC#1325
DR   CLO; CLO_0022399
DR   Coriell; AG11746
DR   Wikidata; Q54744190
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG11746).
CC   Karyotypic information: 46,XY [82%]; 46,XY,t(10;15)(q24;p11) [18%] (Coriell=AG11746).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B50 ! AG05417
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11747
AC   CVCL_2E46
SY   GRC#0694
DR   CLO; CLO_0022398
DR   Coriell; AG11747
DR   Wikidata; Q54744192
RX   CelloPub=CLPUB00597;
RX   PubMed=15450399;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11748
AC   CVCL_2E47
SY   GRC#0953
DR   CLO; CLO_0022402
DR   Coriell; AG11748
DR   GEO; GSM3124612
DR   Wikidata; Q54744194
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG11748).
CC   Karyotypic information: 46,XY [96%]; 47,XYY [4%] (Coriell=AG11748).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG11755
AC   CVCL_4M72
DR   CLO; CLO_0022401
DR   Coriell; AG11755
DR   Wikidata; Q54744195
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (Coriell=AG11755).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG11756
AC   CVCL_4M73
DR   CLO; CLO_0022394
DR   Coriell; AG11756
DR   Wikidata; Q54744199
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11757
AC   CVCL_4M74
DR   CLO; CLO_0022393
DR   Coriell; AG11757
DR   Wikidata; Q54744202
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (Coriell=AG11757).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG11758
AC   CVCL_4M75
DR   CLO; CLO_0022396
DR   Coriell; AG11758
DR   Wikidata; Q54744204
RX   CelloPub=CLPUB00597;
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (Coriell=AG11758).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG11769
AC   CVCL_2J21
DR   CLO; CLO_0022395
DR   Coriell; AG11769
DR   Wikidata; Q54744207
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG11786
AC   CVCL_2E48
SY   GRC#0992
DR   CLO; CLO_0022411
DR   Coriell; AG11786
DR   Wikidata; Q54744209
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11792
AC   CVCL_2E49
SY   GRC#1109
DR   CLO; CLO_0022409
DR   Coriell; AG11792
DR   Wikidata; Q54744212
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (Coriell=AG11792).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11793
AC   CVCL_2E50
SY   GRC#1111
DR   CLO; CLO_0022410
DR   Coriell; AG11793
DR   Wikidata; Q54744214
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG11793).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11794
AC   CVCL_A2CV
SY   GRC#1114
DR   Coriell; AG11794
DR   Wikidata; Q105506337
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG11794; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG11795
AC   CVCL_2E51
DR   CLO; CLO_0022414
DR   Coriell; AG11795
DR   Wikidata; Q54744218
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG11795).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG11796
AC   CVCL_2E52
SY   GRC#1086
DR   CLO; CLO_0022415
DR   Coriell; AG11796
DR   Wikidata; Q54744220
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG11796).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G20 ! AG13927
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11798
AC   CVCL_2E53
SY   GRC#0532
DR   CLO; CLO_0022412
DR   Coriell; AG11798
DR   Wikidata; Q54744221
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG11798).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11799
AC   CVCL_L633
DR   CLO; CLO_0022413
DR   Coriell; AG11799
DR   Wikidata; Q54744224
RX   PubMed=10741968;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG11799).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L634 ! AG13926
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG11801
AC   CVCL_2E54
SY   GRC#1146
DR   CLO; CLO_0022417
DR   Coriell; AG11801
DR   Wikidata; Q54744225
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG11801).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11802
AC   CVCL_2E55
SY   GRC#0272
DR   CLO; CLO_0022418
DR   Coriell; AG11802
DR   Wikidata; Q54744228
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG11802).
CC   Karyotypic information: 46,XY [4%]; 46,XY,dup(1)(q12;q44) [96%] (Coriell=AG11802).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11805
AC   CVCL_2E56
SY   GRC#1152
DR   CLO; CLO_0022416
DR   Coriell; AG11805
DR   Wikidata; Q54744229
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG11805).
CC   Karyotypic information: 46,XY [54%]; 45,X [44%]; 47,XYY [2%] (Coriell=AG11805).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG11808
AC   CVCL_2E57
SY   GRC#0372
DR   CLO; CLO_0022419
DR   Coriell; AG11808
DR   GEO; GSM3124677
DR   Wikidata; Q54744232
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 14 PDL (Coriell=AG11808).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   AG11855
AC   CVCL_A2NV
DR   Coriell; AG11855
DR   Wikidata; Q105506340
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG11855; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A2NW ! AG11856
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG11856
AC   CVCL_A2NW
SY   AG11856A
DR   Coriell; AG11856
DR   Wikidata; Q105506343
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG11856; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A2NV ! AG11855
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12
AC   CVCL_E5RC
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AG12021
AC   CVCL_2Q38
DR   CLO; CLO_0022420
DR   Coriell; AG12021
DR   Wikidata; Q54744235
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   AG12030
AC   CVCL_2J22
SY   AG12030A
DR   CLO; CLO_0022421
DR   Coriell; AG12030
DR   Wikidata; Q54744238
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12031
AC   CVCL_2J23
DR   CLO; CLO_0022422
DR   Coriell; AG12031
DR   Wikidata; Q54744241
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12032
AC   CVCL_2J24
DR   CLO; CLO_0022423
DR   Coriell; AG12032
DR   Wikidata; Q54744245
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12033
AC   CVCL_2J25
DR   CLO; CLO_0022424
DR   Coriell; AG12033
DR   Wikidata; Q54744247
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12034
AC   CVCL_2J26
DR   CLO; CLO_0022425
DR   Coriell; AG12034
DR   Wikidata; Q54744250
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12070
AC   CVCL_0N87
DR   CLO; CLO_0022426
DR   Coriell; AG12070
DR   Wikidata; Q54744251
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG12071
AC   CVCL_2Q39
DR   CLO; CLO_0022427
DR   Coriell; AG12071
DR   Wikidata; Q54744255
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12077
AC   CVCL_2I23
DR   CLO; CLO_0022428
DR   Coriell; AG12077
DR   Wikidata; Q54744257
RX   CelloPub=CLPUB00597;
CC   Doubling time: Slow growth (Coriell=AG12077).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2I24 ! AG12119
OI   CVCL_2I25 ! AG12120
SX   Female
AG   10W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AG12119
AC   CVCL_2I24
SY   AG 12119
DR   CLO; CLO_0022438
DR   Coriell; AG12119
DR   Wikidata; Q54744310
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2I23 ! AG12077
OI   CVCL_2I25 ! AG12120
SX   Female
AG   10W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12120
AC   CVCL_2I25
DR   CLO; CLO_0022435
DR   Coriell; AG12120
DR   Wikidata; Q54744311
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2I23 ! AG12077
OI   CVCL_2I24 ! AG12119
SX   Female
AG   10W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12206
AC   CVCL_A2DM
DR   Coriell; AG12206
DR   Wikidata; Q105506345
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG12206; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N88 ! AG12207
SX   Male
AG   67Y3M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12207
AC   CVCL_0N88
DR   CLO; CLO_0022436
DR   Coriell; AG12207
DR   GEO; GSM3124687
DR   Wikidata; Q54744314
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2DM ! AG12206
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   AG12209
AC   CVCL_A2DL
DR   Coriell; AG12209
DR   Wikidata; Q105506348
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG12209; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y6M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12211
AC   CVCL_0N89
DR   CLO; CLO_0022433
DR   Coriell; AG12211
DR   Wikidata; Q54744315
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG12255
AC   CVCL_A2NZ
DR   Coriell; AG12255
DR   Wikidata; Q105506353
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG12255; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12256
AC   CVCL_UD20
DR   Coriell; AG12256
DR   GEO; GSM349702
DR   Wikidata; Q93319221
RX   CelloPub=CLPUB00597;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG12256; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   AG12257
AC   CVCL_2J27
DR   CLO; CLO_0022434
DR   Coriell; AG12257
DR   Wikidata; Q54744318
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12259
AC   CVCL_2J28
DR   CLO; CLO_0022431
DR   Coriell; AG12259
DR   Wikidata; Q54744319
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12322
AC   CVCL_2E58
SY   GRC#1501
DR   CLO; CLO_0022432
DR   Coriell; AG12322
DR   Wikidata; Q54744321
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG12322).
CC   Karyotypic information: 46,XX [84%]; 47,XX,+18 [16%] (Coriell=AG12322).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D25 ! AG09879
SX   Female
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12327
AC   CVCL_2E59
SY   GRC#1500
DR   CLO; CLO_0022429
DR   Coriell; AG12327
DR   Wikidata; Q54744322
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG12327).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C71 ! AG08792
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12352
AC   CVCL_EF55
DR   Coriell; AG12352
DR   Wikidata; Q54744323
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2Q41 ! AG12357
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   AG12354
AC   CVCL_2Q40
DR   CLO; CLO_0022430
DR   Coriell; AG12354
DR   Wikidata; Q54744325
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12357
AC   CVCL_2Q41
DR   CLO; CLO_0022437
DR   Coriell; AG12357
DR   Wikidata; Q54744327
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_EF55 ! AG12352
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AG12361
AC   CVCL_2E60
SY   GRC#1504
DR   CLO; CLO_0022844
DR   Coriell; AG12361
DR   Wikidata; Q54744328
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG12361).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C68 ! AG08789
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12362
AC   CVCL_2Q42
DR   CLO; CLO_0022841
DR   Coriell; AG12362
DR   Wikidata; Q54744330
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2Q43 ! AG12363
OI   CVCL_2Q45 ! AG12372
OI   CVCL_2Q46 ! AG12417
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12363
AC   CVCL_2Q43
DR   CLO; CLO_0022839
DR   Coriell; AG12363
DR   Wikidata; Q54744331
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2Q42 ! AG12362
OI   CVCL_2Q45 ! AG12372
OI   CVCL_2Q46 ! AG12417
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12364
AC   CVCL_2Q44
DR   CLO; CLO_0022852
DR   Coriell; AG12364
DR   Wikidata; Q54744333
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12372
AC   CVCL_2Q45
DR   CLO; CLO_0022849
DR   Coriell; AG12372
DR   Wikidata; Q54744335
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2Q42 ! AG12362
OI   CVCL_2Q43 ! AG12363
OI   CVCL_2Q46 ! AG12417
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12417
AC   CVCL_2Q46
DR   CLO; CLO_0022847
DR   Coriell; AG12417
DR   Wikidata; Q54744336
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_2Q42 ! AG12362
OI   CVCL_2Q43 ! AG12363
OI   CVCL_2Q45 ! AG12372
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG12427
AC   CVCL_2E61
SY   GRC#0944
DR   CLO; CLO_0022846
DR   Coriell; AG12427
DR   Wikidata; Q54744340
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG12428
AC   CVCL_2E62
DR   CLO; CLO_0022949
DR   Coriell; AG12428
DR   Wikidata; Q54744342
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG12428).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG12429
AC   CVCL_2E63
SY   GRC#0946
DR   CLO; CLO_0022948
DR   Coriell; AG12429
DR   Wikidata; Q54744343
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG12429).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12430
AC   CVCL_2E64
SY   GRC#0947
DR   CLO; CLO_0022950
DR   Coriell; AG12430
DR   Wikidata; Q54744347
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG12430).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12438
AC   CVCL_2E65
SY   GRC#0977
DR   CLO; CLO_0022955
DR   Coriell; AG12438
DR   Wikidata; Q54744350
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [45]; 46,XY,t(1;11)(1pter->1q42::11q11.2->11pter;11qter->11p11.2::1q42->1qter) [5] (Coriell=AG12438).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12443
AC   CVCL_2E66
SY   GRC#1506
DR   CLO; CLO_0022956
DR   Coriell; AG12443
DR   Wikidata; Q54744351
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 53 PDL (Coriell=AG12443).
CC   Karyotypic information: 46,XY [94%]; 46,XY,t(9;20)(q21;p12) [6%] (Coriell=AG12443).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C01 ! AG06879
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12493
AC   CVCL_X755
SY   GRC#1507
DR   CLO; CLO_0022957
DR   Coriell; AG12493
DR   GEO; GSM3124578
DR   Wikidata; Q54744353
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG12493).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X753 ! AG07307
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 13
//
ID   AG12500
AC   CVCL_2Q62
SY   HKC-N2
DR   CLO; CLO_0022958
DR   Coriell; AG12500
DR   Wikidata; Q54744356
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG12500; probable.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2DK ! AG12502
OI   CVCL_2Q63 ! AG12503
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG12502
AC   CVCL_A2DK
SY   HKC-N6
DR   Coriell; AG12502
DR   Wikidata; Q105506355
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG12502; probable.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Q62 ! AG12500
OI   CVCL_2Q63 ! AG12503
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12503
AC   CVCL_2Q63
SY   HKC-N6
DR   CLO; CLO_0022951
DR   Coriell; AG12503
DR   Wikidata; Q54744359
RX   CelloPub=CLPUB00597;
CC   Discontinued: Coriell; AG12503; probable.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Q62 ! AG12500
OI   CVCL_A2DK ! AG12502
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG12587
AC   CVCL_X834
SY   GRC#1510
DR   CLO; CLO_0022952
DR   Coriell; AG12587
DR   GEO; GSM3124600
DR   Wikidata; Q54744361
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG12587).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X832 ! AG05192
OI   CVCL_X833 ! AG09844
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 13
//
ID   AG12588
AC   CVCL_2E67
SY   GRC#1508
DR   CLO; CLO_0022953
DR   Coriell; AG12588
DR   GEO; GSM3124593
DR   Wikidata; Q54744365
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG12588).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B09 ! AG04655
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12589
AC   CVCL_H809
SY   GRC#1509
DR   CLO; CLO_0022954
DR   Coriell; AG12589
DR   Wikidata; Q54744367
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (Coriell=AG12589).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H808 ! AG09878
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   AG12596
AC   CVCL_2E69
SY   GRC#1512
DR   CLO; CLO_0022928
DR   Coriell; AG12596
DR   Wikidata; Q54744369
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (PubMed=9724752); 17 PDL (Coriell=AG12596).
CC   Karyotypic information: 46,XX [86%]; 46,XX,t(3;10) [14%] (Coriell=AG12596).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C31 ! AG07471
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG12597
AC   CVCL_2E70
SY   GRC#1515
DR   CLO; CLO_0022927
DR   Coriell; AG12597
DR   GEO; GSM3124591
DR   Wikidata; Q54744372
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 7 PDL (Coriell=AG12597).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B37 ! AG05270
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12598
AC   CVCL_2E71
SY   GRC#1513
DR   CLO; CLO_0022942
DR   Coriell; AG12598
DR   Wikidata; Q54744374
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 50 PDL (Coriell=AG12598).
CC   Karyotypic information: 46,XX [82%]; 46,X,-X,+mar(X) [12%]; 47,XXX [6%] (Coriell=AG12598).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C32 ! AG07472
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12599
AC   CVCL_2E72
SY   GRC#1514
DR   CLO; CLO_0022940
DR   Coriell; AG12599
DR   GEO; GSM3124596
DR   Wikidata; Q54744375
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG12599).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B25 ! AG05103
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12602
AC   CVCL_2E73
SY   GRC#1517
DR   CLO; CLO_0022941
DR   Coriell; AG12602
DR   GEO; GSM3124580
DR   Wikidata; Q54744378
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG12602).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A89 ! AG04447
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12605
AC   CVCL_2E74
SY   GRC#1516
DR   CLO; CLO_0022937
DR   Coriell; AG12605
DR   Wikidata; Q54744380
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG12605).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A82 ! AG04439
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12614
AC   CVCL_0N90
DR   CLO; CLO_0022939
DR   Coriell; AG12614
DR   Wikidata; Q54744382
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG12657
AC   CVCL_2E75
SY   GRC#1518
DR   CLO; CLO_0022933
DR   Coriell; AG12657
DR   Wikidata; Q54744384
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C81 ! AG08906
OI   CVCL_2D49 ! AG10942
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12660
AC   CVCL_2E76
SY   GRC#1519
DR   CLO; CLO_0022935
DR   Coriell; AG12660
DR   Wikidata; Q54744387
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A47 ! AG04062
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12723
AC   CVCL_0N91
DR   CLO; CLO_0022930
DR   Coriell; AG12723
DR   Wikidata; Q54744390
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian and Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N92 ! AG12724
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG12724
AC   CVCL_0N92
SY   AG12724A
DR   CLO; CLO_0022931
DR   Coriell; AG12724
DR   Wikidata; Q54744392
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian and Indian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N91 ! AG12723
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AG12725
AC   CVCL_0N93
DR   CLO; CLO_0022906
DR   Coriell; AG12725
DR   Wikidata; Q54744436
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian and Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N94 ! AG12726
SX   Female
AG   20Y8M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG12726
AC   CVCL_0N94
DR   CLO; CLO_0022925
DR   Coriell; AG12726
DR   Wikidata; Q54744438
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian and Indian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N93 ! AG12725
SX   Female
AG   20Y8M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG12727
AC   CVCL_0N95
DR   CLO; CLO_0022926
DR   Coriell; AG12727
DR   Wikidata; Q54744441
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N96 ! AG12728
SX   Male
AG   24Y5M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG12728
AC   CVCL_0N96
DR   CLO; CLO_0022907
DR   Coriell; AG12728
DR   Wikidata; Q54744442
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N95 ! AG12727
SX   Male
AG   24Y5M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG12729
AC   CVCL_4M76
DR   CLO; CLO_0022908
DR   Coriell; AG12729
DR   Wikidata; Q54744445
RX   CelloPub=CLPUB00597;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12731
AC   CVCL_4M77
DR   CLO; CLO_0022909
DR   Coriell; AG12731
DR   Wikidata; Q54744448
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12733
AC   CVCL_2E77
SY   GRC#1520
DR   CLO; CLO_0022912
DR   Coriell; AG12733
DR   Wikidata; Q54744449
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG12733).
CC   Karyotypic information: 46,XY [92%]; 46,XY,t(15;17)(q23;q23) [8%] (Coriell=AG12733).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A67 ! AG04354
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12734
AC   CVCL_2J29
DR   CLO; CLO_0022914
DR   Coriell; AG12734
DR   Wikidata; Q54744452
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12735
AC   CVCL_2J30
SY   AG12735A
DR   CLO; CLO_0022916
DR   Coriell; AG12735
DR   Wikidata; Q54744453
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12736
AC   CVCL_2J31
SY   AG12736A
DR   CLO; CLO_0022917
DR   Coriell; AG12736
DR   Wikidata; Q54744457
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12737
AC   CVCL_2J32
DR   CLO; CLO_0022919
DR   Coriell; AG12737
DR   Wikidata; Q54744458
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12738
AC   CVCL_2J33
DR   CLO; CLO_0022905
DR   Coriell; AG12738
DR   Wikidata; Q54744462
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG12786
AC   CVCL_2E78
SY   GRC#1521
DR   CLO; CLO_0022903
DR   Coriell; AG12786
DR   Wikidata; Q54744463
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG12786).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12788
AC   CVCL_L632
SY   GRC#1522
DR   CLO; CLO_0022904
DR   Coriell; AG12788
DR   GEO; GSM3124621
DR   Wikidata; Q54744465
RX   CelloPub=CLPUB00597;
RX   PubMed=10741968;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L630 ! AG07135
OI   CVCL_L631 ! AG07143
OI   CVCL_L629 ! AG11488
SX   Male
AG   90Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   AG12795
AC   CVCL_U316
DR   CLO; CLO_0022890
DR   Coriell; AG12795
DR   GEO; GSM476006
DR   Wikidata; Q54744466
RX   CelloPub=CLPUB00597;
RX   PubMed=10655550;
RX   PubMed=16339323;
RX   PubMed=19966276;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U312 ! AG05231
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   AG12796
AC   CVCL_A2DY
DR   Coriell; AG12796
DR   Wikidata; Q105506358
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Discontinued: Coriell; AG12796; probable.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2DZ ! AG05230
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12797
AC   CVCL_X769
SY   AG12797A
DR   CLO; CLO_0022892
DR   Coriell; AG12797
DR   GEO; GSM476012
DR   GEO; GSM1184272
DR   GEO; GSM1184273
DR   GEO; GSM1535461
DR   GEO; GSM1535471
DR   Wikidata; Q54744468
RX   CelloPub=CLPUB00597;
RX   PubMed=10615119;
RX   PubMed=19966276;
RX   PubMed=24749076;
RX   PubMed=26984941;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=26984941).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X768 ! AG05233
OI   CVCL_X770 ! AG12798
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 14
//
ID   AG12798
AC   CVCL_X770
DR   CLO; CLO_0022886
DR   Coriell; AG12798
DR   Wikidata; Q54744469
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous; Note=Splice acceptor mutation (from autologous cell line AG12797).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X768 ! AG05233
OI   CVCL_X769 ! AG12797
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 11
//
ID   AG12799
AC   CVCL_X836
DR   CLO; CLO_0022888
DR   Coriell; AG12799
DR   Wikidata; Q54744472
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X835 ! AG05229
OI   CVCL_X837 ! AG12800
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG12800
AC   CVCL_X837
DR   CLO; CLO_0022897
DR   Coriell; AG12800
DR   Wikidata; Q54744474
RX   CelloPub=CLPUB00597;
CC   Population: Japanese.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X835 ! AG05229
OI   CVCL_X836 ! AG12799
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG12850
AC   CVCL_2E79
SY   GRC#1523
DR   CLO; CLO_0022899
DR   Coriell; AG12850
DR   GEO; GSM3124599
DR   Wikidata; Q54744476
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG12850).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C97 ! AG09268
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12851
AC   CVCL_2E80
SY   GRC#1524
DR   CLO; CLO_0022893
DR   Coriell; AG12851
DR   Wikidata; Q54744480
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (PubMed=9724752); 18 PDL (Coriell=AG12851).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A88 ! AG04446
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG12927
AC   CVCL_L751
SY   GRC#1525
DR   CLO; CLO_0022682
DR   Coriell; AG12927
DR   Wikidata; Q54744482
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (Coriell=AG12927).
CC   Karyotypic information: 46,XX [62%]; 47,XX,+7 [38%] (Coriell=AG12927).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L750 ! AG07714
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   AG12934
AC   CVCL_2E81
SY   GRC#0330
DR   CLO; CLO_0022681
DR   Coriell; AG12934
DR   Wikidata; Q54744483
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG12934).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12936
AC   CVCL_2E82
SY   GRC#0334
DR   CLO; CLO_0022680
DR   Coriell; AG12936
DR   Wikidata; Q54744486
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG12936).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12937
AC   CVCL_2E83
SY   GRC#0337
DR   CLO; CLO_0022679
DR   Coriell; AG12937
DR   Wikidata; Q54744488
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 52 PDL (Coriell=AG12937).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12938
AC   CVCL_2E84
SY   GRC#0321
DR   CLO; CLO_0022686
DR   Coriell; AG12938
DR   Wikidata; Q54744489
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG12938).
CC   Karyotypic information: 46,XY [49%]; 46,XY,t(7;21)(p12;q21) [51%] (Coriell=AG12938).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12939
AC   CVCL_2E85
SY   GRC#0266
DR   CLO; CLO_0022685
DR   Coriell; AG12939
DR   Wikidata; Q54744491
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG12939).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F76 ! AG13223
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12940
AC   CVCL_2E86
SY   GRC#0269
DR   CLO; CLO_0022684
DR   Coriell; AG12940
DR   Wikidata; Q54744493
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG12940).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12941
AC   CVCL_2E87
SY   GRC#0270
DR   CLO; CLO_0022683
DR   Coriell; AG12941
DR   Wikidata; Q54744495
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG12941).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12942
AC   CVCL_2E88
SY   GRC#0271
DR   CLO; CLO_0022688
DR   Coriell; AG12942
DR   Wikidata; Q54744497
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG12942).
CC   Karyotypic information: 46,XY [86%]; 45,XY,der(9)t(9;15),-15 [8%]; 46,XY,add(8)(pter>q24::?) [6%] (Coriell=AG12942).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12943
AC   CVCL_2E89
SY   GRC#0273
DR   CLO; CLO_0022687
DR   Coriell; AG12943
DR   Wikidata; Q54744502
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG12943).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12944
AC   CVCL_2E90
SY   GRC#0274
DR   CLO; CLO_0022689
DR   Coriell; AG12944
DR   Wikidata; Q54744504
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG12944).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12945
AC   CVCL_2E91
SY   GRC#0275
DR   CLO; CLO_0022691
DR   Coriell; AG12945
DR   Wikidata; Q54744506
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG12945).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12946
AC   CVCL_2E92
SY   GRC#0340
DR   CLO; CLO_0022690
DR   Coriell; AG12946
DR   Wikidata; Q54744509
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG12946).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12947
AC   CVCL_2E93
SY   GRC#0349
DR   CLO; CLO_0022693
DR   Coriell; AG12947
DR   GEO; GSM3124608
DR   Wikidata; Q54744511
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG12947).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12948
AC   CVCL_2E94
SY   GRC#0352
DR   CLO; CLO_0022692
DR   Coriell; AG12948
DR   Wikidata; Q54744512
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG12948).
CC   Karyotypic information: 46,XY [52%]; 46,XY,inv(3)(p11;q21) [48%] (Coriell=AG12948).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12949
AC   CVCL_2E95
SY   GRC#0353
DR   CLO; CLO_0022695
DR   Coriell; AG12949
DR   Wikidata; Q54744516
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG12949).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12950
AC   CVCL_2E96
SY   GRC#0354
DR   CLO; CLO_0022694
DR   Coriell; AG12950
DR   Wikidata; Q54744517
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG12950).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12951
AC   CVCL_2E97
SY   GRC#0356
DR   CLO; CLO_0022697
DR   Coriell; AG12951
DR   Wikidata; Q54744521
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG12951).
CC   Karyotypic information: 46,XY [84%]; 46,XY,t(1;2)(p10;q10) [16%] (Coriell=AG12951).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12952
AC   CVCL_2E98
SY   GRC#0357
DR   CLO; CLO_0022696
DR   Coriell; AG12952
DR   Wikidata; Q54744522
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG12952).
CC   Karyotypic information: 46,XY [88%]; 46,XY,add(9)(p23 or p24) [12%] (Coriell=AG12952).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12953
AC   CVCL_2E99
SY   GRC#0359
DR   CLO; CLO_0022698
DR   Coriell; AG12953
DR   Wikidata; Q54744567
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (Coriell=AG12953).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12954
AC   CVCL_2F00
SY   GRC#0365
DR   CLO; CLO_0022664
DR   Coriell; AG12954
DR   GEO; GSM3124588
DR   Wikidata; Q54744568
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG12954).
CC   Karyotypic information: 46,XY,inv(9)(pter->p11::q13->p11::q13->qter) (Coriell=AG12954).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12955
AC   CVCL_2F01
SY   GRC#0368
DR   CLO; CLO_0022663
DR   Coriell; AG12955
DR   Wikidata; Q54744569
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 48 PDL (Coriell=AG12955).
CC   Karyotypic information: 46,XY [58%]; 45,X [6%]; 46,XY,inv(6)(p21.2;q12) [32%] (Coriell=AG12955).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G29 ! AG14036
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12956
AC   CVCL_2F02
SY   GRC#0380
DR   CLO; CLO_0022662
DR   Coriell; AG12956
DR   Wikidata; Q54744572
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G48 ! AG16102
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12957
AC   CVCL_2F03
SY   GRC#0420
DR   CLO; CLO_0022661
DR   Coriell; AG12957
DR   Wikidata; Q54744575
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 20 PDL (Coriell=AG12957).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12962
AC   CVCL_A2DQ
DR   Coriell; AG12962
DR   Wikidata; Q105506361
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Discontinued: Coriell; AG12962; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y3M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12963
AC   CVCL_A2DR
DR   Coriell; AG12963
DR   Wikidata; Q105506363
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG12963; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG12964
AC   CVCL_2F04
SY   GRC#1526
DR   CLO; CLO_0022660
DR   Coriell; AG12964
DR   Wikidata; Q54744576
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG12964).
CC   Karyotypic information: 46,XY [50%]; 46,XY,t(1;2)(q12;q37) [50%] (Coriell=AG12964).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C62 ! AG08430
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12965
AC   CVCL_2F05
SY   GRC#1527
DR   CLO; CLO_0022659
DR   Coriell; AG12965
DR   Wikidata; Q54744578
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG12965).
CC   Karyotypic information: 46,XY [54%]; 46,XY,t(1;13) [14%]; 46,XY,t(X;1;9;16;20) [28%] (Coriell=AG12965).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A56 ! AG04149
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12981
AC   CVCL_4M78
DR   CLO; CLO_0022668
DR   Coriell; AG12981
DR   Wikidata; Q54744580
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG12982
AC   CVCL_4M79
SY   AG12982A
DR   CLO; CLO_0022667
DR   Coriell; AG12982
DR   Wikidata; Q54744581
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG12983
AC   CVCL_A2DP
DR   Coriell; AG12983
DR   Wikidata; Q105506368
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG12983; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y11M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AG12985
AC   CVCL_2F06
SY   GRC#1528
DR   CLO; CLO_0022666
DR   Coriell; AG12985
DR   Wikidata; Q54744583
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG12985).
CC   Karyotypic information: 46,XX [48%]; 46,XX,t(1;8) [46%]; 46,XX,t(1;19) [6%] (Coriell=AG12985).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C92 ! AG09162
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12986
AC   CVCL_A2DS
DR   Coriell; AG12986
DR   Wikidata; Q105506370
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Discontinued: Coriell; AG12986; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12987
AC   CVCL_A2DT
DR   Coriell; AG12987
DR   Wikidata; Q105506372
RX   CelloPub=CLPUB00597;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 50% risk.
CC   Discontinued: Coriell; AG12987; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y8M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AG12988
AC   CVCL_2F07
SY   AG_12988; GRC#1530
DR   CLO; CLO_0022665
DR   Coriell; AG12988
DR   GEO; GSM6359
DR   Wikidata; Q54744585
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG12988).
CC   Doubling time: 2.3 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C59 ! AG08048
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG12989
AC   CVCL_2F08
SY   GRC#1529
DR   CLO; CLO_0022673
DR   Coriell; AG12989
DR   GEO; GSM3124577
DR   Wikidata; Q54744589
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG12989).
CC   Karyotypic information: 46,XY [4%]; 46,XY,t(2;19)(q23;q13.1) [96%] (Coriell=AG12989).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C60 ! AG08049
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG12990
AC   CVCL_4M80
SY   AG12990A
DR   CLO; CLO_0022675
DR   Coriell; AG12990
DR   Wikidata; Q54744590
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG12991
AC   CVCL_4M81
SY   AG12991A
DR   CLO; CLO_0022674
DR   Coriell; AG12991
DR   Wikidata; Q54744592
RX   CelloPub=CLPUB00597;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG12992
AC   CVCL_2F09
SY   GRC#0421
DR   CLO; CLO_0022670
DR   Coriell; AG12992
DR   Wikidata; Q54744593
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG12992).
CC   Doubling time: Slow growth (Coriell=AG12992).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12993
AC   CVCL_2F10
SY   GRC#0423
DR   CLO; CLO_0022669
DR   Coriell; AG12993
DR   Wikidata; Q54744594
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 45 PDL (Coriell=AG12993).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12995
AC   CVCL_2F11
SY   GRC#0425
DR   CLO; CLO_0022672
DR   Coriell; AG12995
DR   Wikidata; Q54744597
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 50 PDL (Coriell=AG12995).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12996
AC   CVCL_2F12
SY   GRC#0427
DR   CLO; CLO_0022671
DR   Coriell; AG12996
DR   Wikidata; Q54744599
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG12996).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12997
AC   CVCL_2F13
SY   GRC#0414
DR   CLO; CLO_0022677
DR   Coriell; AG12997
DR   Wikidata; Q54744600
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 19 PDL (Coriell=AG12997).
CC   Karyotypic information: 46,XY [76%]; 45,X [24%] (Coriell=AG12997).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12998
AC   CVCL_2F14
SY   GRC#0406
DR   CLO; CLO_0022676
DR   Coriell; AG12998
DR   Wikidata; Q54744601
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG12998).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG12999
AC   CVCL_2F15
SY   GRC#0385
DR   CLO; CLO_0022678
DR   Coriell; AG12999
DR   Wikidata; Q54744603
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG12999).
CC   Karyotypic information: 46,XX [42%]; 46,XX,t(3;16) [58%] (Coriell=AG12999).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13000
AC   CVCL_2F16
SY   GRC#0396
DR   CLO; CLO_0022703
DR   Coriell; AG13000
DR   Wikidata; Q54744604
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG13000).
CC   Karyotypic information: 46,XY [88%]; 47,XY,+18 [12%] (Coriell=AG13000).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13001
AC   CVCL_2F17
SY   GRC#0402
DR   CLO; CLO_0022704
DR   Coriell; AG13001
DR   Wikidata; Q54744606
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG13001).
CC   Karyotypic information: 46,X,t(Y;3;5) (Coriell=AG13001).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13002
AC   CVCL_2F18
SY   GRC#0661
DR   CLO; CLO_0022701
DR   Coriell; AG13002
DR   Wikidata; Q54744608
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG13002).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13003
AC   CVCL_2F19
SY   GRC#0667
DR   CLO; CLO_0022702
DR   Coriell; AG13003
DR   Wikidata; Q54744610
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 53 PDL (Coriell=AG13003).
CC   Karyotypic information: 46,XY [94%]; 47,XY,+18 [6%] (Coriell=AG13003).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13004
AC   CVCL_2F20
SY   GRC#0680
DR   CLO; CLO_0022707
DR   Coriell; AG13004
DR   Wikidata; Q54744613
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG13004).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G24 ! AG13975
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13005
AC   CVCL_2F21
SY   GRC#0691
DR   CLO; CLO_0022708
DR   Coriell; AG13005
DR   Wikidata; Q54744614
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG13005).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13006
AC   CVCL_2F22
SY   GRC#0707
DR   CLO; CLO_0022705
DR   Coriell; AG13006
DR   Wikidata; Q54744618
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG13006).
CC   Karyotypic information: 46,XY [75%]; 45,X [5%]; 46,X,t(Y;2) [20%] (Coriell=AG13006).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13007
AC   CVCL_2F23
SY   GRC#0779
DR   CLO; CLO_0022706
DR   Coriell; AG13007
DR   Wikidata; Q54744620
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG13007).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13008
AC   CVCL_2F24
SY   GRC#0785
DR   CLO; CLO_0022699
DR   Coriell; AG13008
DR   Wikidata; Q54744621
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG13008).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13009
AC   CVCL_2F25
SY   GRC#0790
DR   CLO; CLO_0022700
DR   Coriell; AG13009
DR   Wikidata; Q54744623
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG13009).
CC   Karyotypic information: 46,XY,inv(9)(p11;q13) (Coriell=AG13009).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13011
AC   CVCL_2F26
SY   GRC#1090
DR   CLO; CLO_0022136
DR   Coriell; AG13011
DR   Wikidata; Q54744624
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG13011).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13014
AC   CVCL_A2CW
SY   GRC#1099
DR   Coriell; AG13014
DR   Wikidata; Q105506376
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG13014; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AG13017
AC   CVCL_0N97
SY   AG13017A
DR   CLO; CLO_0022135
DR   Coriell; AG13017
DR   Wikidata; Q54744626
RX   CelloPub=CLPUB00597;
RX   PubMed=9447232;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y9M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG13018
AC   CVCL_2F27
SY   GRC#1531
DR   CLO; CLO_0022134
DR   Coriell; AG13018
DR   GEO; GSM3124597
DR   Wikidata; Q54744628
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG13018).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B83 ! AG06287
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG13065
AC   CVCL_2F28
SY   GRC#1533
DR   CLO; CLO_0022133
DR   Coriell; AG13065
DR   GEO; GSM3124594
DR   Wikidata; Q54744630
RX   CelloPub=CLPUB00597;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 13 PDL (Coriell=AG13065).
CC   Karyotypic information: 46,XY [95%]; 46,XY,der(14;22)(q10;q10),+14 [5%] (Coriell=AG13065).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B27 ! AG05188
OI   CVCL_2B53 ! AG05805
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG13066
AC   CVCL_2F29
SY   GRC#1532
DR   CLO; CLO_0022132
DR   Coriell; AG13066
DR   GEO; GSM426275
DR   GEO; GSM3124581
DR   Wikidata; Q54744631
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG13066).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C54 ! AG07999
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG13067
AC   CVCL_2F30
SY   GRC#1534
DR   CLO; CLO_0022131
DR   Coriell; AG13067
DR   Wikidata; Q54744634
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 19 PDL (Coriell=AG13067).
CC   Karyotypic information: 46,XY [74%]; 46,XY,t(5;12) [26%] (Coriell=AG13067).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B96 ! AG06307
OI   CVCL_2D48 ! AG10941
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13074
AC   CVCL_X801
DR   CLO; CLO_0022155
DR   Coriell; AG13074
DR   GEO; GSE123028
DR   Wikidata; Q54744636
RX   CelloPub=CLPUB00597;
RX   PubMed=28190458;
RX   PubMed=30510006;
RX   PubMed=31582743;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [30%]; 47,XX,+18 [70%]; mosaic (Coriell=AG13074).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 10
//
ID   AG13075
AC   CVCL_2F31
SY   GRC#1536
DR   CLO; CLO_0022156
DR   Coriell; AG13075
DR   Wikidata; Q54744640
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG13075).
CC   Karyotypic information: 46,XY [91%]; 46,XY,t(2;6) [9%] (Coriell=AG13075).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B10 ! AG04656
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13076
AC   CVCL_2F32
SY   GRC#1537
DR   CLO; CLO_0022157
DR   Coriell; AG13076
DR   Wikidata; Q54744641
RX   CelloPub=CLPUB00597;
RX   PubMed=15450399;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG13076).
CC   Karyotypic information: 46,XY [88%]; 46,XY,t(7;14) [12%] (Coriell=AG13076).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A91 ! AG04454
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13077
AC   CVCL_2F33
SY   GRC#1535
DR   CLO; CLO_0022158
DR   Coriell; AG13077
DR   Wikidata; Q54744695
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (PubMed=9724752).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C07 ! AG06952
OI   CVCL_2D61 ! AG11020
SX   Female
AG   85Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG13084
AC   CVCL_2F34
SY   GRC#1538
DR   CLO; CLO_0022148
DR   Coriell; AG13084
DR   Wikidata; Q54744697
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG13084).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B89 ! AG06294
OI   CVCL_2D12 ! AG09697
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13087
AC   CVCL_2F35
SY   GRC#0663
DR   CLO; CLO_0022150
DR   Coriell; AG13087
DR   Wikidata; Q54744699
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG13087).
CC   Karyotypic information: 46,XY [64%]; 46,XY,t(2;15) [36%] (Coriell=AG13087).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13089
AC   CVCL_2F36
SY   AG13089A; GRC#0682
DR   CLO; CLO_0022149
DR   Coriell; AG13089
DR   Wikidata; Q54744701
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG13089).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13090
AC   CVCL_2F37
SY   GRC#0685
DR   CLO; CLO_0022152
DR   Coriell; AG13090
DR   Wikidata; Q54744703
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG13090).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13091
AC   CVCL_2F38
SY   GRC#0692
DR   CLO; CLO_0022151
DR   Coriell; AG13091
DR   Wikidata; Q54744707
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG13091).
CC   Karyotypic information: 46,XY [81%]; 46,XY,t(3;13) [5%]; 46,XY,t(3;14) [7%]; 46,XY,t(9;13) [7%] (Coriell=AG13091).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13092
AC   CVCL_2F39
SY   GRC#0697
DR   CLO; CLO_0022154
DR   Coriell; AG13092
DR   Wikidata; Q54744708
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=AG13092).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13093
AC   CVCL_2F40
SY   GRC#0704
DR   CLO; CLO_0022153
DR   Coriell; AG13093
DR   Wikidata; Q54744710
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG13093).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13094
AC   CVCL_2F41
SY   GRC#0705
DR   CLO; CLO_0022146
DR   Coriell; AG13094
DR   Wikidata; Q54744714
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG13094).
CC   Karyotypic information: 46,XY [92%]; 46,XY,der(15;17)(p10;q10),+17 [8%] (Coriell=AG13094).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13095
AC   CVCL_2F42
SY   GRC#0721
DR   CLO; CLO_0022147
DR   Coriell; AG13095
DR   Wikidata; Q54744715
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 40 PDL (Coriell=AG13095).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13096
AC   CVCL_2F43
SY   GRC#0777
DR   CLO; CLO_0022145
DR   Coriell; AG13096
DR   Wikidata; Q54744717
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG13096).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13097
AC   CVCL_2F44
SY   GRC#0778
DR   CLO; CLO_0022140
DR   Coriell; AG13097
DR   Wikidata; Q54744719
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 30 PDL (Coriell=AG13097).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G41 ! AG14421
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13098
AC   CVCL_2F45
SY   GRC#0780
DR   CLO; CLO_0022139
DR   Coriell; AG13098
DR   Wikidata; Q54744720
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG13098).
CC   Karyotypic information: 46,XY [62%]; 46,XY,t(2;11)(p13;q23) [38%] (Coriell=AG13098).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13099
AC   CVCL_2F46
SY   GRC#0781
DR   CLO; CLO_0022138
DR   Coriell; AG13099
DR   Wikidata; Q54744723
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 72 PDL (Coriell=AG13099).
CC   Karyotypic information: 46,XY,9qh+ (Coriell=AG13099).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13100
AC   CVCL_2F47
SY   GRC#0782
DR   CLO; CLO_0022137
DR   Coriell; AG13100
DR   Wikidata; Q54744725
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG13100).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13101
AC   CVCL_2F48
SY   GRC#0784
DR   CLO; CLO_0022144
DR   Coriell; AG13101
DR   Wikidata; Q54744727
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG13101).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13102
AC   CVCL_2F49
DR   CLO; CLO_0022143
DR   Coriell; AG13102
DR   Wikidata; Q54744729
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 37 PDL (Coriell=AG13102).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13103
AC   CVCL_2F50
SY   GRC#0788
DR   CLO; CLO_0022142
DR   Coriell; AG13103
DR   Wikidata; Q54744731
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 23 PDL (Coriell=AG13103).
CC   Doubling time: Slow growth (Coriell=AG13103).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13104
AC   CVCL_2F51
SY   GRC#0791
DR   CLO; CLO_0022141
DR   Coriell; AG13104
DR   Wikidata; Q54744733
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 31 PDL (Coriell=AG13104).
CC   Karyotypic information: 46,XY [52%]; 46,XY,t(10;16) [48%] (Coriell=AG13104).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13105
AC   CVCL_2F52
SY   GRC#0792
DR   CLO; CLO_0022110
DR   Coriell; AG13105
DR   Wikidata; Q54744735
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG13105).
CC   Karyotypic information: 46,XY [88%]; 46,XY,t(14;17) [12%] (Coriell=AG13105).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G21 ! AG13962
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13106
AC   CVCL_2F53
SY   GRC#0794
DR   CLO; CLO_0022109
DR   Coriell; AG13106
DR   Wikidata; Q54744737
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG13106).
CC   Karyotypic information: 46,XY [88%]; 45,X [12%] (Coriell=AG13106).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13108
AC   CVCL_2F54
SY   GRC#1113
DR   CLO; CLO_0022100
DR   Coriell; AG13108
DR   Wikidata; Q54744739
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG13108).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13129
AC   CVCL_2F55
SY   GRC#1539
DR   CLO; CLO_0022105
DR   Coriell; AG13129
DR   GEO; GSM3124620
DR   Wikidata; Q54744742
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=14662655;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (PubMed=9724752).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B18 ! AG05096
SX   Male
AG   89Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   AG13144
AC   CVCL_2F56
SY   AG_13144
DR   CLO; CLO_0022106
DR   Coriell; AG13144
DR   GEO; GSM6360
DR   GEO; GSM3124601
DR   Wikidata; Q54744743
RX   PubMed=12840040;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 11 PDL (Coriell=AG13144).
CC   Doubling time: 2.8 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B63 ! AG05844
OI   CVCL_2D93 ! AG11362
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG13145
AC   CVCL_2F57
SY   GRC#1541
DR   CLO; CLO_0022107
DR   Coriell; AG13145
DR   GEO; GSM426259
DR   Wikidata; Q54744747
RX   CelloPub=CLPUB00597;
RX   PubMed=14662655;
RX   PubMed=16081512;
RX   PubMed=18368133;
RX   PubMed=18470933;
RX   PubMed=18955168;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B49 ! AG05416
OI   CVCL_2D95 ! AG11364
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   AG13146
AC   CVCL_2F58
SY   GRC#1542
DR   CLO; CLO_0022108
DR   Coriell; AG13146
DR   Wikidata; Q54744750
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (Coriell=AG13146).
CC   Karyotypic information: 46,XY [89.4%]; 46,XY,t(1;3) [5.3%]; 46,XY,t(1;7) [5.3%] (Coriell=AG13146).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C10 ! AG06957
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13150
AC   CVCL_2F59
SY   GRC#1544
DR   CLO; CLO_0022101
DR   Coriell; AG13150
DR   GEO; GSM426276
DR   Wikidata; Q54744751
RX   CelloPub=CLPUB00597;
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=AG13150).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C67 ! AG08692
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG13151
AC   CVCL_2F60
SY   GRC#1543
DR   CLO; CLO_0022102
DR   Coriell; AG13151
DR   Wikidata; Q54744753
RX   CelloPub=CLPUB00597;
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG13151).
CC   Doubling time: 4.4 days (PubMed=12840040).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B67 ! AG06235
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG13152
AC   CVCL_2F61
SY   GRC#1546
DR   CLO; CLO_0022103
DR   Coriell; AG13152
DR   Wikidata; Q54744756
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (PubMed=9724752); 6 PDL (Coriell=AG13152).
CC   Karyotypic information: 46,XY [94%]; 45,X [6%] (Coriell=AG13152).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B00 ! AG04552
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG13153
AC   CVCL_2F62
SY   AG_13153; GRC#1545
DR   CLO; CLO_0022104
DR   Coriell; AG13153
DR   GEO; GSM6361
DR   GEO; GSM6389
DR   GEO; GSM244117
DR   GEO; GSM244118
DR   GEO; GSM3124570
DR   Wikidata; Q54744757
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
RX   PubMed=12840040;
RX   PubMed=16081512;
RX   PubMed=18368133;
RX   PubMed=18631391;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (PubMed=9724752).
CC   Doubling time: 2.3 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B66 ! AG06234
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 16
//
ID   AG13156
AC   CVCL_2F63
SY   GRC#1547
DR   CLO; CLO_0022099
DR   Coriell; AG13156
DR   Wikidata; Q54744762
RX   CelloPub=CLPUB00597;
RX   PubMed=9724752;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 42 PDL (PubMed=9724752); 37 PDL (Coriell=AG13156).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A83 ! AG04441
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   AG13197
AC   CVCL_2F64
SY   GRC#1549
DR   CLO; CLO_0022095
DR   Coriell; AG13197
DR   Wikidata; Q54744763
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (Coriell=AG13197).
CC   Karyotypic information: 46,XY [96%]; 47,XY,+20,t(7;22)(p11;q13) [4%] (Coriell=AG13197).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C52 ! AG07997
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13198
AC   CVCL_2F65
SY   GRC#1548
DR   CLO; CLO_0022096
DR   Coriell; AG13198
DR   Wikidata; Q54744766
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (Coriell=AG13198).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B44 ! AG05410
OI   CVCL_2C44 ! AG07723
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13207
AC   CVCL_0Q99
DR   CLO; CLO_0022093
DR   Coriell; AG13207
DR   Wikidata; Q54744768
RX   CelloPub=CLPUB00597;
RX   PubMed=12768443;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121565; Neonatal progeroid syndrome
DI   ORDO; Orphanet_3455; Wiedemann-Rautenstrauch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG13208
AC   CVCL_2F66
DR   CLO; CLO_0022094
DR   Coriell; AG13208
DR   GEO; GSM3124671
DR   Wikidata; Q54744769
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG13208).
CC   Karyotypic information: 46,XY [90%]; 45,X [10%] (Coriell=AG13208).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13209
AC   CVCL_2F67
SY   GRC#1141
DR   CLO; CLO_0022091
DR   Coriell; AG13209
DR   Wikidata; Q54744773
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG13209).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13210
AC   CVCL_2F68
DR   CLO; CLO_0022092
DR   Coriell; AG13210
DR   Wikidata; Q54744775
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,add(15)(p13) (Coriell=AG13210).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13213
AC   CVCL_2F69
DR   CLO; CLO_0022121
DR   Coriell; AG13213
DR   Wikidata; Q54744776
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG13213).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13216
AC   CVCL_2F70
DR   CLO; CLO_0022122
DR   Coriell; AG13216
DR   Wikidata; Q54744779
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 33 PDL (Coriell=AG13216).
CC   Karyotypic information: 46,XY [96%]; 45,XY,-19 [4%] (Coriell=AG13216).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13217
AC   CVCL_2F71
SY   GRC#1210
DR   CLO; CLO_0022123
DR   Coriell; AG13217
DR   Wikidata; Q54744781
RX   CelloPub=CLPUB00597;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 39 PDL (Coriell=AG13217).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13218
AC   CVCL_2F72
DR   CLO; CLO_0022124
DR   Coriell; AG13218
DR   Wikidata; Q54744836
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 41 PDL (Coriell=AG13218).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13219
AC   CVCL_2F73
DR   CLO; CLO_0022125
DR   Coriell; AG13219
DR   Wikidata; Q54744837
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 54 PDL (Coriell=AG13219).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13220
AC   CVCL_2F74
DR   CLO; CLO_0022126
DR   Coriell; AG13220
DR   Wikidata; Q54744839
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG13220).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13222
AC   CVCL_2F75
DR   CLO; CLO_0022127
DR   Coriell; AG13222
DR   Wikidata; Q54744841
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=AG13222).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13223
AC   CVCL_2F76
DR   CLO; CLO_0022128
DR   Coriell; AG13223
DR   Wikidata; Q54744843
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG13223).
CC   Karyotypic information: 46,XY [24%]; 46,XY,t(12;18)(q13 or q14;q21) [76%] (Coriell=AG13223).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E85 ! AG12939
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13224
AC   CVCL_2F77
DR   CLO; CLO_0022129
DR   Coriell; AG13224
DR   Wikidata; Q54744845
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 19 PDL (Coriell=AG13224).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13225
AC   CVCL_2F78
DR   CLO; CLO_0022130
DR   Coriell; AG13225
DR   GEO; GSM3124590
DR   Wikidata; Q54744847
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 35 PDL (Coriell=AG13225).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13226
AC   CVCL_2F79
DR   CLO; CLO_0022113
DR   Coriell; AG13226
DR   Wikidata; Q54744849
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=AG13226).
CC   Karyotypic information: 46,XY [62%]; 46,XY,t(3;17)(p21;q21) [38%] (Coriell=AG13226).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13227
AC   CVCL_2F80
DR   CLO; CLO_0022114
DR   Coriell; AG13227
DR   Wikidata; Q54744853
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG13227).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13228
AC   CVCL_2F81
DR   CLO; CLO_0022111
DR   Coriell; AG13228
DR   Wikidata; Q54744855
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG13228).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13229
AC   CVCL_2F82
DR   CLO; CLO_0022112
DR   Coriell; AG13229
DR   Wikidata; Q54744856
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 46 PDL (Coriell=AG13229).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13230
AC   CVCL_2F83
DR   CLO; CLO_0022117
DR   Coriell; AG13230
DR   Wikidata; Q54744859
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG13230).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13231
AC   CVCL_2F84
DR   CLO; CLO_0022118
DR   Coriell; AG13231
DR   Wikidata; Q54744860
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 7 PDL (Coriell=AG13231).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13233
AC   CVCL_2F85
DR   CLO; CLO_0022115
DR   Coriell; AG13233
DR   Wikidata; Q54744862
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG13233).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13234
AC   CVCL_2F86
DR   CLO; CLO_0022116
DR   Coriell; AG13234
DR   GEO; GSM3124572
DR   Wikidata; Q54744866
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 9 PDL (Coriell=AG13234).
CC   Karyotypic information: 46,XY; 46,XY,t(16;19); 46,XY,inv(1),t(7;14;15) (Coriell=AG13234).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13235
AC   CVCL_2F87
DR   CLO; CLO_0022119
DR   Coriell; AG13235
DR   Wikidata; Q54744867
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13237
AC   CVCL_2F88
DR   CLO; CLO_0022120
DR   Coriell; AG13237
DR   Wikidata; Q54744869
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 11 PDL (Coriell=AG13237).
CC   Karyotypic information: 46,XY [38%]; 46,XY,t(15;20)(p10;q10) [62%] (Coriell=AG13237).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13244
AC   CVCL_2F89
DR   CLO; CLO_0021964
DR   Coriell; AG13244
DR   GEO; GSM3124575
DR   Wikidata; Q54744871
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG13244).
CC   Karyotypic information: 46,XY [96%]; 46,XY,t(6;16)(p13;p21) [4%] (Coriell=AG13244).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C12 ! AG06962
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13245
AC   CVCL_2F90
DR   CLO; CLO_0021968
DR   Coriell; AG13245
DR   Wikidata; Q54744873
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (Coriell=AG13245).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B94 ! AG06305
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13246
AC   CVCL_2F91
DR   CLO; CLO_0021967
DR   Coriell; AG13246
DR   Wikidata; Q54744874
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 12 PDL (Coriell=AG13246).
CC   Karyotypic information: 46,XX [78%]; 46,XX,t(1;15)(q1?;q4?),t(11;19)(q12;q12) [22%] (Coriell=AG13246).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B40 ! AG05275
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13274
AC   CVCL_2Q47
DR   CLO; CLO_0021966
DR   Coriell; AG13274
DR   Wikidata; Q54744876
RX   CelloPub=CLPUB00597;
RX   PubMed=21518243;
CC   Group: Endangered species/breed cell line.
CC   Discontinued: Coriell; AG13274; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=424585; ! Ailurus styani (Chinese red panda)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   AG13283
AC   CVCL_4M82
DR   CLO; CLO_0021965
DR   Coriell; AG13283
DR   Wikidata; Q54744880
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG13285
AC   CVCL_2F92
DR   CLO; CLO_0021962
DR   Coriell; AG13285
DR   Wikidata; Q54744881
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 21 PDL (Coriell=AG13285).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B45 ! AG05411
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13292
AC   CVCL_2F93
DR   CLO; CLO_0021961
DR   Coriell; AG13292
DR   Wikidata; Q54744884
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG13292).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B79 ! AG06282
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13297
AC   CVCL_2F94
DR   CLO; CLO_0021960
DR   Coriell; AG13297
DR   Wikidata; Q54744886
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 12 PDL (Coriell=AG13297).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B04 ! AG04556
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13299
AC   CVCL_2F96
DR   CLO; CLO_0021959
DR   Coriell; AG13299
DR   Wikidata; Q54744888
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 12 PDL (Coriell=AG13299).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F95 ! AG05412
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13300
AC   CVCL_2F97
DR   CLO; CLO_0021963
DR   Coriell; AG13300
DR   Wikidata; Q54744890
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (Coriell=AG13300).
CC   Karyotypic information: 46,XX [30%]; 46,XX,t(1;1)t(3;9) [34%]; 46,XX,t(2;10),del(13) [36%] (Coriell=AG13300).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C29 ! AG07309
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13308
AC   CVCL_2F98
DR   CLO; CLO_0021974
DR   Coriell; AG13308
DR   Wikidata; Q54744893
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 13 PDL (Coriell=AG13308).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B81 ! AG06284
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13329
AC   CVCL_2F99
DR   CLO; CLO_0021973
DR   Coriell; AG13329
DR   Wikidata; Q54744895
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG13329).
CC   Karyotypic information: 46,XY [52%]; 46,XY,t(8;12)(p21;p11) [34%]; 46,XY,add(8)(p23) [14%] (Coriell=AG13329).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C11 ! AG06959
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13333
AC   CVCL_2G00
DR   CLO; CLO_0021976
DR   Coriell; AG13333
DR   Wikidata; Q54744897
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 11 PDL (Coriell=AG13333).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C88 ! AG09157
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13334
AC   CVCL_2G01
DR   CLO; CLO_0021975
DR   Coriell; AG13334
DR   Wikidata; Q54744899
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG13334).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A58 ! AG04151
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13337
AC   CVCL_2G02
DR   CLO; CLO_0021978
DR   Coriell; AG13337
DR   Wikidata; Q54744900
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG13337).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C63 ! AG08431
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13345
AC   CVCL_2G03
DR   CLO; CLO_0021977
DR   Coriell; AG13345
DR   Wikidata; Q54744901
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG13345).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A98 ! AG04461
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13346
AC   CVCL_4M83
DR   CLO; CLO_0021970
DR   Coriell; AG13346
DR   Wikidata; Q54744904
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG13348
AC   CVCL_2G04
DR   CLO; CLO_0021969
DR   Coriell; AG13348
DR   Wikidata; Q54744905
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 12 PDL (Coriell=AG13348).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A73 ! AG04380
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13349
AC   CVCL_2G05
DR   CLO; CLO_0021972
DR   Coriell; AG13349
DR   GEO; GSM244119
DR   GEO; GSM244120
DR   GEO; GSM3124614
DR   Wikidata; Q54744908
RX   PubMed=18631391;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B38 ! AG05271
OI   CVCL_2C47 ! AG07801
OI   CVCL_2D74 ! AG11157
SX   Male
AG   86Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13353
AC   CVCL_2G06
DR   CLO; CLO_0021971
DR   Coriell; AG13353
DR   Wikidata; Q54744911
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG13353; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B48 ! AG05415
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13354
AC   CVCL_2G07
DR   CLO; CLO_0021988
DR   Coriell; AG13354
DR   Wikidata; Q54744913
RX   PubMed=14662655;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 20 PDL (Coriell=AG13354).
CC   Karyotypic information: 46,XY [94%]; 45,X [6%] (Coriell=AG13354).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   AG13358
AC   CVCL_2G08
DR   CLO; CLO_0021987
DR   Coriell; AG13358
DR   Wikidata; Q54744915
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 12 PDL (Coriell=AG13358).
CC   Karyotypic information: 46,XX [66%]; 47,XXX [34%] (Coriell=AG13358).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C30 ! AG07310
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13364
AC   CVCL_2G09
DR   CLO; CLO_0021986
DR   Coriell; AG13364
DR   Wikidata; Q54744916
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 7 PDL (Coriell=AG13364).
CC   Karyotypic information: 46,XX [90%]; 45,X [10%] (Coriell=AG13364).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C13 ! AG07118
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13367
AC   CVCL_2G10
DR   CLO; CLO_0021985
DR   Coriell; AG13367
DR   Wikidata; Q54744974
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (Coriell=AG13367).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A65 ! AG04352
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13369
AC   CVCL_2G11
DR   CLO; CLO_0021984
DR   Coriell; AG13369
DR   GEO; GSM244121
DR   GEO; GSM244122
DR   Wikidata; Q54744975
RX   PubMed=18631391;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=AG13369).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B26 ! AG05186
OI   CVCL_2E08 ! AG11561
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13407
AC   CVCL_2G12
DR   CLO; CLO_0021983
DR   Coriell; AG13407
DR   Wikidata; Q54744976
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG13407).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13414
AC   CVCL_2G13
DR   CLO; CLO_0021982
DR   Coriell; AG13414
DR   Wikidata; Q54744980
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=AG13414).
CC   Karyotypic information: 46,XY [42%]; 46,XY,t(1;2;3;16) [50%]; 46,Y,t(X;11;17) [8%] (Coriell=AG13414).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C75 ! AG08818
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13429
AC   CVCL_X878
DR   CLO; CLO_0021981
DR   Coriell; AG13429
DR   Wikidata; Q54744981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG13432
AC   CVCL_2G14
DR   CLO; CLO_0021980
DR   Coriell; AG13432
DR   Wikidata; Q54744983
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 15 PDL (Coriell=AG13432).
CC   Karyotypic information: 46,XY [92%]; 46,XY,der(15)t(2;15)(q11.2;p12) [8%] (Coriell=AG13432).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13442
AC   CVCL_2G15
DR   CLO; CLO_0021979
DR   Coriell; AG13442
DR   Wikidata; Q54744985
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=AG13442).
CC   Karyotypic information: 46,XY [94%]; 46,XY,t(1;16)(q21;p13) [6%] (Coriell=AG13442).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A41 ! AG04054
OI   CVCL_2E07 ! AG11557
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13443
AC   CVCL_2G16
DR   CLO; CLO_0022269
DR   Coriell; AG13443
DR   Wikidata; Q54744988
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG13443).
CC   Karyotypic information: 46,XX,9qh+ (Coriell=AG13443).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13453
AC   CVCL_X879
DR   CLO; CLO_0022270
DR   Coriell; AG13453
DR   Wikidata; Q54744990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG13455
AC   CVCL_X880
DR   CLO; CLO_0022271
DR   Coriell; AG13455
DR   Wikidata; Q54744991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG13518
AC   CVCL_4P94
DR   Coriell; AG13518
DR   Wikidata; Q54744994
CC   Part of: Canadian Alzheimer disease kindred subcollection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from inference of kindred).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG13565
AC   CVCL_0N98
DR   Coriell; AG13565
DR   Wikidata; Q54744995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   AG13778
AC   CVCL_2G17
DR   CLO; CLO_0022272
DR   Coriell; AG13778
DR   Wikidata; Q54744997
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Senescence: Senesces at 22 PDL (Coriell=AG13778).
CC   Karyotypic information: 46,XX [70%]; 46,XX,t(3;12) [10%] 46,XX,t(10;13) [20%] (Coriell=AG13778).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13781
AC   CVCL_2G18
DR   CLO; CLO_0022273
DR   Coriell; AG13781
DR   Wikidata; Q54745000
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 8 PDL (Coriell=AG13781).
CC   Karyotypic information: 46,XX,t(9;18)(q32;q21) [94%]; 46,XX,t(1;9;18) [6%] (Coriell=AG13781).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D17 ! AG09854
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13865
AC   CVCL_2G19
DR   CLO; CLO_0022355
DR   Coriell; AG13865
DR   Wikidata; Q54745002
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 32 PDL (Coriell=AG13865).
CC   Karyotypic information: 46,XX [82%]; 46,XX,t(1;9),t(11;13) [6%]; 46,XX,t(4;6)(p16;p21),add(14)(qter)? [6%]; 47,XXX,t(1;4) [6%] (Coriell=AG13865).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13901
AC   CVCL_X881
DR   CLO; CLO_0022356
DR   Coriell; AG13901
DR   Wikidata; Q54745004
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X882 ! AG13902
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG13902
AC   CVCL_X882
DR   CLO; CLO_0022357
DR   Coriell; AG13902
DR   Wikidata; Q54745007
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X881 ! AG13901
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG13926
AC   CVCL_L634
DR   CLO; CLO_0022354
DR   Coriell; AG13926
DR   Wikidata; Q54745009
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 16 PDL (Coriell=AG13926).
CC   Karyotypic information: 46,XY,t(16;19)(p11;q13) [96%]; 46,XY,t(4;15)(q13;p11) [4%] (Coriell=AG13926).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L633 ! AG11799
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   AG13927
AC   CVCL_2G20
SY   AG_13927
DR   CLO; CLO_0022353
DR   Coriell; AG13927
DR   GEO; GSM6362
DR   Wikidata; Q54745010
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (Coriell=AG13927).
CC   Doubling time: 2.8 days (PubMed=12840040).
CC   Karyotypic information: 46,XX [96%]; 46,XX,t(2;6)(p16;p21) [4%] (Coriell=AG13927).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2E52 ! AG11796
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG13962
AC   CVCL_2G21
DR   CLO; CLO_0022352
DR   Coriell; AG13962
DR   GEO; GSM3124582
DR   Wikidata; Q54745011
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG13962).
CC   Karyotypic information: 46,XY [74%]; 46,XY,t(2;9)(q14;q21) [14%]; 46,XY,t(1;4;5;14) [12%] (Coriell=AG13962).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F52 ! AG13105
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13967
AC   CVCL_2G22
DR   CLO; CLO_0022349
DR   Coriell; AG13967
DR   GEO; GSM3124576
DR   Wikidata; Q54745013
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 17 PDL (Coriell=AG13967).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG13968
AC   CVCL_2G23
SY   AG_13968
DR   CLO; CLO_0022348
DR   Coriell; AG13968
DR   GEO; GSM6363
DR   Wikidata; Q54745015
RX   PubMed=12840040;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 13 PDL (Coriell=AG13968).
CC   Doubling time: 2.3 days (PubMed=12840040).
CC   Karyotypic information: 46,XX [96%]; 46,XX,add(13)(q34) [4%] (Coriell=AG13968).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2B32 ! AG05245
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG13975
AC   CVCL_2G24
DR   CLO; CLO_0022351
DR   Coriell; AG13975
DR   Wikidata; Q54745016
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 6 PDL (Coriell=AG13975).
CC   Karyotypic information: 46,XY [76%]; 46,XY,t(11;13)(q12;q21) [24%] (Coriell=AG13975).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F20 ! AG13004
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13983
AC   CVCL_2G25
DR   CLO; CLO_0022350
DR   Coriell; AG13983
DR   Wikidata; Q54745020
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 8 PDL (Coriell=AG13983).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13990
AC   CVCL_2G26
DR   CLO; CLO_0022346
DR   Coriell; AG13990
DR   Wikidata; Q54745023
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 7 PDL (Coriell=AG13990).
CC   Karyotypic information: 46,XX [92%]; 46,XX,inv(4)(p16;q27) [8%] (Coriell=AG13990).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13993
AC   CVCL_2G27
DR   CLO; CLO_0022347
DR   Coriell; AG13993
DR   Wikidata; Q54745026
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 12 PDL (Coriell=AG13993).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D63 ! AG11073
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG13994
AC   CVCL_2G28
DR   CLO; CLO_0022344
DR   Coriell; AG13994
DR   Wikidata; Q54745027
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 9 PDL (Coriell=AG13994).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14036
AC   CVCL_2G29
DR   CLO; CLO_0022345
DR   Coriell; AG14036
DR   Wikidata; Q54745029
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG14036).
CC   Karyotypic information: 46,XY [24%]; 46,XY,t(1;12)(p31;q21) [76%] (Coriell=AG14036).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F01 ! AG12955
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14048
AC   CVCL_2G30
DR   CLO; CLO_0022343
DR   Coriell; AG14048
DR   Wikidata; Q54745032
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 13 PDL (Coriell=AG14048).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A90 ! AG04453
OI   CVCL_2D34 ! AG10047
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14099
AC   CVCL_2G31
DR   Coriell; AG14099
DR   Wikidata; Q54745034
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG14099; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A57 ! AG04150
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14133
AC   CVCL_0N99
DR   CLO; CLO_0022342
DR   Coriell; AG14133
DR   Wikidata; Q54745035
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG14135
AC   CVCL_2G32
DR   CLO; CLO_0022341
DR   Coriell; AG14135
DR   Wikidata; Q54745038
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 10 PDL (Coriell=AG14135).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14149
AC   CVCL_4M84
DR   CLO; CLO_0022340
DR   Coriell; AG14149
DR   Wikidata; Q54745041
CC   Population: Caucasian.
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M55 ! AG10987
SX   Sex unspecified
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG14176
AC   CVCL_4M85
DR   CLO; CLO_0022339
DR   Coriell; AG14176
DR   Wikidata; Q54745042
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14177
AC   CVCL_X776
DR   Coriell; AG14177
DR   Wikidata; Q54745044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG14181
AC   CVCL_2G33
DR   CLO; CLO_0022338
DR   Coriell; AG14181
DR   Wikidata; Q54745045
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 19 PDL (Coriell=AG14181).
CC   Karyotypic information: 46,XX [24%]; 46,XX,t(5;13)(q12;p13) [76%] (Coriell=AG14181).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14240
AC   CVCL_2G34
DR   CLO; CLO_0022337
DR   Coriell; AG14240
DR   Wikidata; Q54745046
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 7 PDL (Coriell=AG14240).
CC   Karyotypic information: 46,XY [96%]; 46,XY,t(1;2)(q42;q21) [4%] (Coriell=AG14240).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14244
AC   CVCL_4M86
DR   CLO; CLO_0022334
DR   Coriell; AG14244
DR   Wikidata; Q54745047
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=30699343).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4M59 ! AG11009
SX   Female
AG   92Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   AG14245
AC   CVCL_2G35
DR   CLO; CLO_0022335
DR   Coriell; AG14245
DR   Wikidata; Q54745050
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 51 PDL (Coriell=AG14245).
CC   Karyotypic information: 46,XY [82%]; 46,XY,t(2;6)(q21;q21),t(11;16)(p11.2;q12.1) [18%] (Coriell=AG14245).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2C69 ! AG08790
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14249
AC   CVCL_X777
DR   Coriell; AG14249
DR   Wikidata; Q54745053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG14251
AC   CVCL_2G36
DR   CLO; CLO_0022336
DR   Coriell; AG14251
DR   GEO; GSM244123
DR   GEO; GSM244124
DR   GEO; GSM3124598
DR   Wikidata; Q54745147
RX   PubMed=18631391;
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 36 PDL (Coriell=AG14251).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A93 ! AG04456
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG14252
AC   CVCL_2G37
DR   CLO; CLO_0022327
DR   Coriell; AG14252
DR   Wikidata; Q54745148
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 49 PDL (Coriell=AG14252).
CC   Karyotypic information: 46,XX [44%]; 46,XX,t(2;15;17) [56%] (Coriell=AG14252).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14253
AC   CVCL_4M87
DR   CLO; CLO_0022326
DR   Coriell; AG14253
DR   Wikidata; Q54745149
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14254
AC   CVCL_4M88
DR   CLO; CLO_0022329
DR   Coriell; AG14254
DR   Wikidata; Q54745153
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14262
AC   CVCL_X774
DR   CLO; CLO_0022328
DR   Coriell; AG14262
DR   Wikidata; Q54745157
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X775 ! AG14263
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG14263
AC   CVCL_X775
DR   CLO; CLO_0022331
DR   Coriell; AG14263
DR   Wikidata; Q54745158
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast of breast; CL=CL_4006000.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X774 ! AG14262
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 9
//
ID   AG14271
AC   CVCL_X756
DR   CLO; CLO_0022330
DR   Coriell; AG14271
DR   Wikidata; Q54745160
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 56 PDL (Coriell=AG14271).
CC   Karyotypic information: 46,XX [90%]; 46,XX,t(5;12)(q34;q21) [10%] (Coriell=AG14271).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X754 ! AG07308
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG14284
AC   CVCL_2G38
DR   CLO; CLO_0022333
DR   Coriell; AG14284
DR   Wikidata; Q54745163
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 47 PDL (Coriell=AG14284).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14285
AC   CVCL_2G39
DR   CLO; CLO_0022332
DR   Coriell; AG14285
DR   Wikidata; Q54745166
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=AG14285).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14298
AC   CVCL_2G40
DR   CLO; CLO_0022324
DR   Coriell; AG14298
DR   Wikidata; Q54745168
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 27 PDL (Coriell=AG14298).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14390
AC   CVCL_0P01
DR   CLO; CLO_0022325
DR   Coriell; AG14390
DR   Wikidata; Q54745171
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   AG14412
AC   CVCL_0P02
DR   CLO; CLO_0022315
DR   Coriell; AG14412
DR   Wikidata; Q54745173
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   AG14421
AC   CVCL_2G41
DR   CLO; CLO_0022319
DR   Coriell; AG14421
DR   Wikidata; Q54745175
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 11 PDL (Coriell=AG14421).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F44 ! AG13097
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14422
AC   CVCL_2G42
DR   CLO; CLO_0022318
DR   Coriell; AG14422
DR   Wikidata; Q54745176
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 55 PDL (Coriell=AG14422).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14424
AC   CVCL_U317
SY   SUG17802
DR   CLO; CLO_0022317
DR   Coriell; AG14424
DR   Wikidata; Q54745177
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg889Ter (c.2665C>T); ClinVar=VCV000404045; Zygosity=Heterozygous (Coriell=AG14424).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Unexplicit; Ex19-23del; Zygosity=Heterozygous (Coriell=AG14424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   AG14425
AC   CVCL_U318
SY   JO1050
DR   CLO; CLO_0022316
DR   Coriell; AG14425
DR   Wikidata; Q54745179
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=AG14425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   AG14426
AC   CVCL_U319
SY   LGS90610
DR   CLO; CLO_0022323
DR   Coriell; AG14426
DR   Wikidata; Q54745185
RX   PubMed=10606667;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   AG14429
AC   CVCL_2G43
DR   CLO; CLO_0022322
DR   Coriell; AG14429
DR   Wikidata; Q54745191
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=AG14429).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14435
AC   CVCL_4M89
DR   CLO; CLO_0022321
DR   Coriell; AG14435
DR   Wikidata; Q54745170
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14446
AC   CVCL_2G44
DR   CLO; CLO_0022320
DR   Coriell; AG14446
DR   GEO; GSM426277
DR   Wikidata; Q54745194
RX   PubMed=19727395;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 24 PDL (Coriell=AG14446).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   AG14449
AC   CVCL_2Y83
DR   CLO; CLO_0022314
DR   Coriell; AG14449
DR   Wikidata; Q54745198
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y84 ! AG14473
SX   Sex unspecified
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14460
AC   CVCL_X778
DR   Coriell; AG14460
DR   Wikidata; Q54745203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG14461
AC   CVCL_X779
DR   Coriell; AG14461
DR   Wikidata; Q54745206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   AG14473
AC   CVCL_2Y84
SY   AG14473A
DR   CLO; CLO_0022312
DR   Coriell; AG14473
DR   Wikidata; Q54745209
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y83 ! AG14449
SX   Sex unspecified
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG14486
AC   CVCL_0P03
DR   CLO; CLO_0022313
DR   Coriell; AG14486
DR   Wikidata; Q54745215
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   AG14497
AC   CVCL_4M90
DR   CLO; CLO_0022308
DR   Coriell; AG14497
DR   Wikidata; Q54745218
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14531
AC   CVCL_4M91
DR   CLO; CLO_0022309
DR   Coriell; AG14531
DR   Wikidata; Q54745222
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14534
AC   CVCL_0P04
DR   CLO; CLO_0022310
DR   Coriell; AG14534
DR   Wikidata; Q54745226
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P05 ! AG14572
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   AG14539
AC   CVCL_4M92
DR   CLO; CLO_0022311
DR   Coriell; AG14539
DR   Wikidata; Q54745231
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG14572
AC   CVCL_0P05
DR   CLO; CLO_0022304
DR   Coriell; AG14572
DR   Wikidata; Q54745235
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P04 ! AG14534
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG14580
AC   CVCL_0P06
DR   CLO; CLO_0022305
DR   Coriell; AG14580
DR   Wikidata; Q54745239
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG14591
AC   CVCL_0P07
DR   CLO; CLO_0022306
DR   Coriell; AG14591
DR   Wikidata; Q54745243
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG14607
AC   CVCL_0P08
DR   CLO; CLO_0022307
DR   Coriell; AG14607
DR   Wikidata; Q54745247
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG14608
AC   CVCL_0P09
DR   CLO; CLO_0022303
DR   Coriell; AG14608
DR   Wikidata; Q54745252
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG14612
AC   CVCL_0L69
DR   CLO; CLO_0022301
DR   Coriell; AG14612
DR   Wikidata; Q54745254
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14613
AC   CVCL_0L70
DR   CLO; CLO_0022302
DR   Coriell; AG14613
DR   Wikidata; Q54745259
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14614
AC   CVCL_0L71
DR   CLO; CLO_0022299
DR   Coriell; AG14614
DR   Wikidata; Q54745262
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14615
AC   CVCL_0L72
DR   CLO; CLO_0022300
DR   Coriell; AG14615
DR   Wikidata; Q54745265
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14616
AC   CVCL_0L73
DR   CLO; CLO_0022297
DR   Coriell; AG14616
DR   Wikidata; Q54745269
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14617
AC   CVCL_0L74
DR   CLO; CLO_0022298
DR   Coriell; AG14617
DR   Wikidata; Q54745275
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14642
AC   CVCL_2G45
DR   CLO; CLO_0022295
DR   Coriell; AG14642
DR   Wikidata; Q54745437
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Senescence: Senesces at 26 PDL (Coriell=AG14642).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG14718
AC   CVCL_2J34
DR   CLO; CLO_0022296
DR   Coriell; AG14718
DR   Wikidata; Q54745441
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14719
AC   CVCL_2J35
DR   CLO; CLO_0022294
DR   Coriell; AG14719
DR   Wikidata; Q54745445
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14724
AC   CVCL_2J36
DR   CLO; CLO_0022290
DR   Coriell; AG14724
DR   Wikidata; Q54745449
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG14725
AC   CVCL_2J37
DR   CLO; CLO_0022291
DR   Coriell; AG14725
DR   Wikidata; Q54745452
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG14730
AC   CVCL_2J38
DR   CLO; CLO_0022292
DR   Coriell; AG14730
DR   Wikidata; Q54745457
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14731
AC   CVCL_2J39
DR   CLO; CLO_0022293
DR   Coriell; AG14731
DR   Wikidata; Q54745458
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14735
AC   CVCL_0L75
DR   CLO; CLO_0022284
DR   Coriell; AG14735
DR   Wikidata; Q54745462
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14737
AC   CVCL_0L76
DR   CLO; CLO_0022285
DR   Coriell; AG14737
DR   Wikidata; Q54745465
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14738
AC   CVCL_0L77
DR   CLO; CLO_0022286
DR   Coriell; AG14738
DR   Wikidata; Q54745466
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14739
AC   CVCL_0L78
DR   CLO; CLO_0022287
DR   Coriell; AG14739
DR   Wikidata; Q54745469
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14740
AC   CVCL_0L79
DR   CLO; CLO_0022288
DR   Coriell; AG14740
DR   Wikidata; Q54745471
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14741
AC   CVCL_0L80
DR   CLO; CLO_0022289
DR   Coriell; AG14741
DR   Wikidata; Q54745474
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14742
AC   CVCL_0L81
DR   CLO; CLO_0022279
DR   Coriell; AG14742
DR   Wikidata; Q54745475
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14743
AC   CVCL_0L82
DR   CLO; CLO_0022282
DR   Coriell; AG14743
DR   Wikidata; Q54745479
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14744
AC   CVCL_0L83
DR   CLO; CLO_0022283
DR   Coriell; AG14744
DR   Wikidata; Q54745481
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14745
AC   CVCL_0L84
DR   CLO; CLO_0022280
DR   Coriell; AG14745
DR   Wikidata; Q54745482
CC   Part of: Sardinian population of great age.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   AG14748
AC   CVCL_2J40
DR   CLO; CLO_0022281
DR   Coriell; AG14748
DR   Wikidata; Q54745485
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14750
AC   CVCL_2J41
DR   CLO; CLO_0022276
DR   Coriell; AG14750
DR   Wikidata; Q54745487
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14751
AC   CVCL_2J42
DR   CLO; CLO_0022277
DR   Coriell; AG14751
DR   Wikidata; Q54745491
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14752
AC   CVCL_2J43
DR   CLO; CLO_0022274
DR   Coriell; AG14752
DR   Wikidata; Q54745493
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14756
AC   CVCL_2J44
DR   CLO; CLO_0022275
DR   Coriell; AG14756
DR   Wikidata; Q54745495
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14757
AC   CVCL_2J45
DR   CLO; CLO_0022278
DR   Coriell; AG14757
DR   Wikidata; Q54745498
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14774
AC   CVCL_2J46
DR   CLO; CLO_0022176
DR   Coriell; AG14774
DR   Wikidata; Q54745500
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14775
AC   CVCL_2J47
DR   CLO; CLO_0022175
DR   Coriell; AG14775
DR   Wikidata; Q54745502
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14776
AC   CVCL_2J48
DR   CLO; CLO_0022180
DR   Coriell; AG14776
DR   Wikidata; Q54745505
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14777
AC   CVCL_2J49
DR   CLO; CLO_0022179
DR   Coriell; AG14777
DR   Wikidata; Q54745507
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14778
AC   CVCL_2J50
DR   CLO; CLO_0022178
DR   Coriell; AG14778
DR   GEO; GSM1116553
DR   GEO; GSM1116554
DR   GEO; GSM1116577
DR   GEO; GSM1116578
DR   GEO; GSM1116579
DR   GEO; GSM1116580
DR   Wikidata; Q54745509
RX   PubMed=23943852;
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   AG14784
AC   CVCL_2J51
DR   CLO; CLO_0022177
DR   Coriell; AG14784
DR   Wikidata; Q54745512
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14785
AC   CVCL_2J52
DR   CLO; CLO_0022184
DR   Coriell; AG14785
DR   Wikidata; Q54745514
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14786
AC   CVCL_2J53
DR   CLO; CLO_0022183
DR   Coriell; AG14786
DR   Wikidata; Q54745515
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14789
AC   CVCL_2J54
DR   CLO; CLO_0022182
DR   Coriell; AG14789
DR   Wikidata; Q54745516
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14790
AC   CVCL_2J55
DR   CLO; CLO_0022181
DR   Coriell; AG14790
DR   Wikidata; Q54745519
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14798
AC   CVCL_2J56
DR   CLO; CLO_0018987
DR   Coriell; AG14798
DR   Wikidata; Q54745521
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14799
AC   CVCL_2J57
DR   CLO; CLO_0018986
DR   Coriell; AG14799
DR   Wikidata; Q54745522
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14800
AC   CVCL_2J58
DR   CLO; CLO_0018985
DR   Coriell; AG14800
DR   Wikidata; Q54745524
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14801
AC   CVCL_2J59
DR   CLO; CLO_0018984
DR   Coriell; AG14801
DR   Wikidata; Q54745526
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14802
AC   CVCL_2J60
DR   CLO; CLO_0018915
DR   Coriell; AG14802
DR   Wikidata; Q54745527
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14803
AC   CVCL_2J61
DR   CLO; CLO_0018917
DR   Coriell; AG14803
DR   Wikidata; Q54745528
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14812
AC   CVCL_2J62
DR   CLO; CLO_0018920
DR   Coriell; AG14812
DR   Wikidata; Q54745530
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14813
AC   CVCL_2J63
DR   CLO; CLO_0018924
DR   Coriell; AG14813
DR   Wikidata; Q54745569
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14814
AC   CVCL_2J64
DR   CLO; CLO_0018925
DR   Coriell; AG14814
DR   Wikidata; Q54745571
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14815
AC   CVCL_2J65
DR   CLO; CLO_0018926
DR   Coriell; AG14815
DR   Wikidata; Q54745575
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14816
AC   CVCL_2J66
DR   CLO; CLO_0018904
DR   Coriell; AG14816
DR   Wikidata; Q54745577
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14828
AC   CVCL_2J67
DR   CLO; CLO_0018908
DR   Coriell; AG14828
DR   Wikidata; Q54745579
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14829
AC   CVCL_2J68
DR   CLO; CLO_0018906
DR   Coriell; AG14829
DR   Wikidata; Q54745582
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14830
AC   CVCL_2J69
DR   CLO; CLO_0018913
DR   Coriell; AG14830
DR   Wikidata; Q54745584
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14831
AC   CVCL_2J70
DR   CLO; CLO_0018910
DR   Coriell; AG14831
DR   Wikidata; Q54745587
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14832
AC   CVCL_2J71
DR   CLO; CLO_0018951
DR   Coriell; AG14832
DR   GEO; GSM1116555
DR   GEO; GSM1116556
DR   GEO; GSM1116581
DR   GEO; GSM1116582
DR   GEO; GSM1116583
DR   GEO; GSM1116584
DR   Wikidata; Q54745589
RX   PubMed=23943852;
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   AG14833
AC   CVCL_2J72
DR   CLO; CLO_0018954
DR   Coriell; AG14833
DR   Wikidata; Q54745591
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14834
AC   CVCL_2J73
DR   CLO; CLO_0018946
DR   Coriell; AG14834
DR   Wikidata; Q54745593
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14835
AC   CVCL_2J74
DR   CLO; CLO_0018948
DR   Coriell; AG14835
DR   Wikidata; Q54745594
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14836
AC   CVCL_2J75
DR   CLO; CLO_0018957
DR   Coriell; AG14836
DR   Wikidata; Q54745597
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14839
AC   CVCL_2J76
DR   CLO; CLO_0018934
DR   Coriell; AG14839
DR   Wikidata; Q54745599
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14840
AC   CVCL_2J77
DR   CLO; CLO_0018933
DR   Coriell; AG14840
DR   Wikidata; Q54745601
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14841
AC   CVCL_2J78
DR   CLO; CLO_0018943
DR   Coriell; AG14841
DR   Wikidata; Q54745604
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14842
AC   CVCL_2J79
DR   CLO; CLO_0018942
DR   Coriell; AG14842
DR   Wikidata; Q54745606
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14843
AC   CVCL_2J80
DR   CLO; CLO_0018939
DR   Coriell; AG14843
DR   Wikidata; Q54745608
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14844
AC   CVCL_2J81
DR   CLO; CLO_0018937
DR   Coriell; AG14844
DR   Wikidata; Q54745610
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14846
AC   CVCL_2J82
DR   CLO; CLO_0018610
DR   Coriell; AG14846
DR   Wikidata; Q54745612
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14847
AC   CVCL_2J83
DR   CLO; CLO_0018607
DR   Coriell; AG14847
DR   Wikidata; Q54745614
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14848
AC   CVCL_2J84
DR   CLO; CLO_0018605
DR   Coriell; AG14848
DR   Wikidata; Q54745615
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14858
AC   CVCL_2J85
DR   CLO; CLO_0018603
DR   Coriell; AG14858
DR   Wikidata; Q54745617
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14859
AC   CVCL_2J86
DR   CLO; CLO_0018627
DR   Coriell; AG14859
DR   Wikidata; Q54745620
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14860
AC   CVCL_2J87
DR   CLO; CLO_0018619
DR   Coriell; AG14860
DR   Wikidata; Q54745622
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14884
AC   CVCL_2J88
DR   CLO; CLO_0018621
DR   Coriell; AG14884
DR   Wikidata; Q54745624
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14885
AC   CVCL_2J89
DR   CLO; CLO_0018615
DR   Coriell; AG14885
DR   Wikidata; Q54745626
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14886
AC   CVCL_2J90
DR   CLO; CLO_0018618
DR   Coriell; AG14886
DR   Wikidata; Q54745629
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14887
AC   CVCL_2J91
DR   CLO; CLO_0018612
DR   Coriell; AG14887
DR   Wikidata; Q54745632
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14888
AC   CVCL_2J92
DR   CLO; CLO_0018614
DR   Coriell; AG14888
DR   Wikidata; Q54745634
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14939
AC   CVCL_0L68
DR   CLO; CLO_0018648
DR   Coriell; AG14939
DR   Wikidata; Q54745637
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   60Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   AG14947
AC   CVCL_2J93
DR   CLO; CLO_0018645
DR   Coriell; AG14947
DR   Wikidata; Q54745639
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14948
AC   CVCL_2J94
DR   CLO; CLO_0018650
DR   Coriell; AG14948
DR   Wikidata; Q54745641
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14949
AC   CVCL_2J95
DR   CLO; CLO_0018660
DR   Coriell; AG14949
DR   Wikidata; Q54745643
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14953
AC   CVCL_2J96
DR   CLO; CLO_0018663
DR   Coriell; AG14953
DR   Wikidata; Q54745645
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14977
AC   CVCL_2J97
DR   CLO; CLO_0018668
DR   Coriell; AG14977
DR   Wikidata; Q54745646
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14980
AC   CVCL_2J98
SY   AG14980A
DR   CLO; CLO_0018670
DR   Coriell; AG14980
DR   Wikidata; Q54745648
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14981
AC   CVCL_2J99
DR   CLO; CLO_0018653
DR   Coriell; AG14981
DR   Wikidata; Q54745650
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14984
AC   CVCL_2K00
DR   CLO; CLO_0018655
DR   Coriell; AG14984
DR   Wikidata; Q54745651
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14985
AC   CVCL_2K01
DR   CLO; CLO_0018657
DR   Coriell; AG14985
DR   Wikidata; Q54745655
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14986
AC   CVCL_2K02
DR   CLO; CLO_0018659
DR   Coriell; AG14986
DR   Wikidata; Q54745710
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14987
AC   CVCL_2K03
DR   CLO; CLO_0018515
DR   Coriell; AG14987
DR   Wikidata; Q54745712
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14988
AC   CVCL_2K04
DR   CLO; CLO_0018512
DR   Coriell; AG14988
DR   Wikidata; Q54745714
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14994
AC   CVCL_2K05
DR   CLO; CLO_0018548
DR   Coriell; AG14994
DR   Wikidata; Q54745716
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG14995
AC   CVCL_2K06
DR   CLO; CLO_0018531
DR   Coriell; AG14995
DR   Wikidata; Q54745718
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15007
AC   CVCL_2K07
DR   CLO; CLO_0018534
DR   Coriell; AG15007
DR   Wikidata; Q54745719
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15008
AC   CVCL_2K08
DR   CLO; CLO_0018526
DR   Coriell; AG15008
DR   Wikidata; Q54745721
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15011
AC   CVCL_2K09
DR   CLO; CLO_0018530
DR   Coriell; AG15011
DR   Wikidata; Q54745725
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15013
AC   CVCL_2K10
DR   CLO; CLO_0018542
DR   Coriell; AG15013
DR   Wikidata; Q54745726
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15014
AC   CVCL_2K11
DR   CLO; CLO_0018545
DR   Coriell; AG15014
DR   GEO; GSM1116557
DR   GEO; GSM1116558
DR   GEO; GSM1116585
DR   GEO; GSM1116586
DR   GEO; GSM1116587
DR   GEO; GSM1116588
DR   Wikidata; Q54745727
RX   PubMed=23943852;
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   AG15015
AC   CVCL_2K12
DR   CLO; CLO_0018535
DR   Coriell; AG15015
DR   Wikidata; Q54745729
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15016
AC   CVCL_2K13
DR   CLO; CLO_0018539
DR   Coriell; AG15016
DR   Wikidata; Q54745732
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15017
AC   CVCL_2K14
DR   CLO; CLO_0018559
DR   Coriell; AG15017
DR   Wikidata; Q54745734
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15018
AC   CVCL_2K15
DR   CLO; CLO_0018588
DR   Coriell; AG15018
DR   Wikidata; Q54745736
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15022
AC   CVCL_2K16
DR   CLO; CLO_0018589
DR   Coriell; AG15022
DR   Wikidata; Q54745738
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15023
AC   CVCL_2K17
DR   CLO; CLO_0018573
DR   Coriell; AG15023
DR   Wikidata; Q54745741
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15032
AC   CVCL_2K18
SY   AG15032A
DR   CLO; CLO_0018575
DR   Coriell; AG15032
DR   Wikidata; Q54745744
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15033
AC   CVCL_2K19
DR   CLO; CLO_0018576
DR   Coriell; AG15033
DR   GEO; GSM1116559
DR   GEO; GSM1116560
DR   GEO; GSM1116589
DR   GEO; GSM1116590
DR   GEO; GSM1116591
DR   GEO; GSM1116592
DR   Wikidata; Q54745747
RX   PubMed=23943852;
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   AG15044
AC   CVCL_2K20
DR   CLO; CLO_0018578
DR   Coriell; AG15044
DR   Wikidata; Q54745750
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15045
AC   CVCL_2K21
DR   CLO; CLO_0018580
DR   Coriell; AG15045
DR   Wikidata; Q54745751
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15046
AC   CVCL_2K22
DR   CLO; CLO_0018583
DR   Coriell; AG15046
DR   Wikidata; Q54745754
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15057
AC   CVCL_2K23
DR   CLO; CLO_0018584
DR   Coriell; AG15057
DR   Wikidata; Q54745756
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15058
AC   CVCL_2K24
DR   CLO; CLO_0018586
DR   Coriell; AG15058
DR   Wikidata; Q54745757
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15059
AC   CVCL_2K25
DR   CLO; CLO_0018756
DR   Coriell; AG15059
DR   Wikidata; Q54745760
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15060
AC   CVCL_2K26
DR   CLO; CLO_0018754
DR   Coriell; AG15060
DR   Wikidata; Q54745761
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15090
AC   CVCL_2K27
DR   CLO; CLO_0018752
DR   Coriell; AG15090
DR   Wikidata; Q54745762
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15091
AC   CVCL_2K28
DR   CLO; CLO_0018779
DR   Coriell; AG15091
DR   Wikidata; Q54745763
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15107
AC   CVCL_2K29
DR   CLO; CLO_0018778
DR   Coriell; AG15107
DR   Wikidata; Q54745766
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15108
AC   CVCL_2K30
DR   CLO; CLO_0018775
DR   Coriell; AG15108
DR   Wikidata; Q54745769
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15109
AC   CVCL_2K31
DR   CLO; CLO_0018772
DR   Coriell; AG15109
DR   Wikidata; Q54745770
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15110
AC   CVCL_2K32
DR   CLO; CLO_0018769
DR   Coriell; AG15110
DR   Wikidata; Q54745772
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15111
AC   CVCL_2K33
DR   CLO; CLO_0018767
DR   Coriell; AG15111
DR   Wikidata; Q54745775
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15173
AC   CVCL_2K34
DR   CLO; CLO_0018766
DR   Coriell; AG15173
DR   Wikidata; Q54745777
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15174
AC   CVCL_2K35
DR   CLO; CLO_0018793
DR   Coriell; AG15174
DR   Wikidata; Q54745779
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15448
AC   CVCL_2K36
DR   CLO; CLO_0018790
DR   Coriell; AG15448
DR   Wikidata; Q54745782
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15449
AC   CVCL_2K37
DR   CLO; CLO_0018796
DR   Coriell; AG15449
DR   Wikidata; Q54745783
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15450
AC   CVCL_2K38
DR   CLO; CLO_0018795
DR   Coriell; AG15450
DR   Wikidata; Q54745784
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15693
AC   CVCL_0L65
DR   CLO; CLO_0018807
DR   Coriell; AG15693
DR   GEO; GSM1052415
DR   Wikidata; Q54745786
RX   PubMed=23257959;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   AG15694
AC   CVCL_0L66
DR   Coriell; AG15694
DR   GEO; GSM1052413
DR   Wikidata; Q54745789
RX   PubMed=23257959;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   AG15695
AC   CVCL_0L67
DR   CLO; CLO_0018804
DR   Coriell; AG15695
DR   GEO; GSM1052414
DR   Wikidata; Q54745791
RX   PubMed=23257959;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   AG15749
AC   CVCL_2K39
DR   CLO; CLO_0018810
DR   Coriell; AG15749
DR   Wikidata; Q54745845
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15767
AC   CVCL_2K40
DR   CLO; CLO_0018809
DR   Coriell; AG15767
DR   Wikidata; Q54745846
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15781
AC   CVCL_2K41
DR   CLO; CLO_0018803
DR   Coriell; AG15781
DR   Wikidata; Q54745849
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15782
AC   CVCL_2K42
DR   CLO; CLO_0018802
DR   Coriell; AG15782
DR   Wikidata; Q54745850
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15783
AC   CVCL_2K43
DR   CLO; CLO_0018689
DR   Coriell; AG15783
DR   Wikidata; Q54745853
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15784
AC   CVCL_2K44
DR   CLO; CLO_0018698
DR   Coriell; AG15784
DR   Wikidata; Q54745855
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15787
AC   CVCL_2K45
DR   CLO; CLO_0018696
DR   Coriell; AG15787
DR   Wikidata; Q54745859
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15791
AC   CVCL_2K46
DR   CLO; CLO_0018694
DR   Coriell; AG15791
DR   Wikidata; Q54745862
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15792
AC   CVCL_2K47
DR   CLO; CLO_0018691
DR   Coriell; AG15792
DR   Wikidata; Q54745864
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15793
AC   CVCL_2K48
DR   CLO; CLO_0018709
DR   Coriell; AG15793
DR   Wikidata; Q54745866
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15796
AC   CVCL_2K49
DR   CLO; CLO_0018705
DR   Coriell; AG15796
DR   Wikidata; Q54745867
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15798
AC   CVCL_2K50
DR   CLO; CLO_0018704
DR   Coriell; AG15798
DR   Wikidata; Q54745869
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15799
AC   CVCL_2K51
DR   CLO; CLO_0018701
DR   Coriell; AG15799
DR   Wikidata; Q54745870
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15801
AC   CVCL_2K52
DR   CLO; CLO_0018712
DR   Coriell; AG15801
DR   Wikidata; Q54745873
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15803
AC   CVCL_1M79
DR   CLO; CLO_0019525
DR   Coriell; AG15803
DR   Wikidata; Q54745874
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG15804
AC   CVCL_1M82
DR   CLO; CLO_0019520
DR   Coriell; AG15804
DR   Wikidata; Q54745877
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG15826
AC   CVCL_2Q48
DR   CLO; CLO_0019523
DR   Coriell; AG15826
DR   Wikidata; Q54745878
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG15829
AC   CVCL_1M83
DR   CLO; CLO_0019546
DR   Coriell; AG15829
DR   Wikidata; Q54745879
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG15830
AC   CVCL_1M84
DR   CLO; CLO_0019551
DR   Coriell; AG15830
DR   Wikidata; Q54745882
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG15831
AC   CVCL_1M85
DR   CLO; CLO_0019554
DR   Coriell; AG15831
DR   Wikidata; Q54745884
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG15865
AC   CVCL_2Q49
DR   CLO; CLO_0019556
DR   Coriell; AG15865
DR   Wikidata; Q54745886
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_2Q50 ! AG15866
SX   Male
AG   13W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   AG15866
AC   CVCL_2Q50
DR   CLO; CLO_0019540
DR   Coriell; AG15866
DR   Wikidata; Q54745887
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_2Q49 ! AG15865
SX   Male
AG   13W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   AG15867
AC   CVCL_2Q51
DR   CLO; CLO_0019543
DR   Coriell; AG15867
DR   Wikidata; Q54745890
CC   Group: Endangered species/breed cell line.
CC   Group: Reptilian cell line.
CC   Discontinued: Coriell; AG15867; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=66189; ! Chelonoidis niger (Galapagos giant tortoise)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG15868
AC   CVCL_2Q52
DR   CLO; CLO_0019545
DR   Coriell; AG15868
DR   Wikidata; Q54745892
CC   Group: Endangered species/breed cell line.
CC   Group: Reptilian cell line.
CC   Discontinued: Coriell; AG15868; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=66189; ! Chelonoidis niger (Galapagos giant tortoise)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG15881
AC   CVCL_2I76
DR   Coriell; AG15881
DR   Wikidata; Q54745894
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG15897
AC   CVCL_2Q53
DR   CLO; CLO_0019530
DR   Coriell; AG15897
DR   Wikidata; Q54745897
CC   Karyotypic information: 63-64,XXXX,-2,+3,+5,-7,+10,+11,-13,-14,-16,+mar1,+mar2,+mar3,+mar4 cpk[9] (Coriell=AG15897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG15898
AC   CVCL_2I77
DR   Coriell; AG15898
DR   Wikidata; Q54745900
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG15899
AC   CVCL_2K53
DR   CLO; CLO_0019528
DR   Coriell; AG15899
DR   Wikidata; Q54745901
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15914
AC   CVCL_1M78
DR   CLO; CLO_0019533
DR   Coriell; AG15914
DR   Wikidata; Q54745905
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   AG15982
AC   CVCL_2K54
DR   CLO; CLO_0019532
DR   Coriell; AG15982
DR   Wikidata; Q54745906
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG15991
AC   CVCL_1M80
DR   CLO; CLO_0019585
DR   Coriell; AG15991
DR   Wikidata; Q54745908
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG15995
AC   CVCL_1M81
DR   CLO; CLO_0019588
DR   Coriell; AG15995
DR   Wikidata; Q54745911
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG15997
AC   CVCL_2K55
DR   CLO; CLO_0019578
DR   Coriell; AG15997
DR   Wikidata; Q54745913
CC   Part of: Intra-abdominal fat and risk of disease in adolescents study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG16030
AC   CVCL_2G46
DR   CLO; CLO_0019581
DR   Coriell; AG16030
DR   Wikidata; Q54745915
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D36 ! AG10049
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16086
AC   CVCL_2G47
DR   CLO; CLO_0019573
DR   Coriell; AG16086
DR   GEO; GSM3124686
DR   Wikidata; Q54745917
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Southeast Asian; Filipino.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG16102
AC   CVCL_2G48
SY   AG16102A
DR   CLO; CLO_0019575
DR   Coriell; AG16102
DR   GEO; GSM3124692
DR   Wikidata; Q54745920
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2F02 ! AG12956
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   AG16104
AC   CVCL_2G49
DR   CLO; CLO_0019566
DR   Coriell; AG16104
DR   Wikidata; Q54745924
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: African American.
CC   Karyotypic information: 46,XX,inv(9)(pter->p11::q13->p11::q13->qter) (Coriell=AG16104).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16146
AC   CVCL_2G50
DR   CLO; CLO_0019564
DR   Coriell; AG16146
DR   Wikidata; Q54745925
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16273
AC   CVCL_2Q54
DR   CLO; CLO_0019562
DR   Coriell; AG16273
DR   Wikidata; Q54745928
CC   Karyotypic information: 22,XX [30]; 23,XX,+6 [20] (Coriell=AG16273).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG16358
AC   CVCL_2G51
DR   CLO; CLO_0019561
DR   Coriell; AG16358
DR   GEO; GSM3124583
DR   Wikidata; Q54745931
RX   PubMed=30567591;
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [33]; 46,XX,t(6;22)(p10;q10) [3]; 46,XX,t(8;18)(q21;p11) [14] (Coriell=AG16358).
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: The donor has a history of radiation exposure at work (Coriell=AG16358).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AG16359
AC   CVCL_2G52
DR   CLO; CLO_0019559
DR   Coriell; AG16359
DR   Wikidata; Q54745980
CC   Part of: Baltimore Longitudinal Study of Aging (BLSA) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2D42 ! AG10883
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16360
AC   CVCL_X883
DR   CLO; CLO_0019608
DR   Coriell; AG16360
DR   Wikidata; Q54745983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16408
AC   CVCL_V977
DR   CLO; CLO_0019610
DR   Coriell; AG16408
DR   Wikidata; Q54745984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V978 ! AG16409
OI   CVCL_V979 ! AG16410
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AG16409
AC   CVCL_V978
DR   CLO; CLO_0019613
DR   Coriell; AG16409
DR   GEO; GSM3124561
DR   Wikidata; Q54745987
RX   PubMed=22720000;
RX   PubMed=23001818;
RX   PubMed=28855503;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V977 ! AG16408
OI   CVCL_V979 ! AG16410
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   AG16410
AC   CVCL_V979
DR   Coriell; AG16410
DR   Wikidata; Q54745990
CC   Discontinued: Coriell; AG16410; probable.
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V977 ! AG16408
OI   CVCL_V978 ! AG16409
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 5
//
ID   AG16504
AC   CVCL_X802
DR   CLO; CLO_0019617
DR   Coriell; AG16504
DR   Wikidata; Q54745991
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M95 ! AG20457
OI   CVCL_1M96 ! AG22339
OI   CVCL_7310 ! GM00967
OI   CVCL_7316 ! GM01310
OI   CVCL_7531 ! GM13335
OI   CVCL_7532 ! GM13336
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   AG16516
AC   CVCL_X884
DR   CLO; CLO_0019618
DR   Coriell; AG16516
DR   Wikidata; Q54745995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16618
AC   CVCL_V980
DR   Coriell; AG16618
DR   Wikidata; Q54745996
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG16618; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AG16639
AC   CVCL_2K56
DR   CLO; CLO_0019594
DR   Coriell; AG16639
DR   Wikidata; Q54745998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG16640
AC   CVCL_2K57
DR   CLO; CLO_0019592
DR   Coriell; AG16640
DR   Wikidata; Q54745999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG16641
AC   CVCL_2K58
DR   CLO; CLO_0019598
DR   Coriell; AG16641
DR   Wikidata; Q54746001
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: Caucasian; Dutch/German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16642
AC   CVCL_2K59
DR   CLO; CLO_0019595
DR   Coriell; AG16642
DR   Wikidata; Q54746002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG16644
AC   CVCL_2K60
DR   Coriell; AG16644
DR   Wikidata; Q54746004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG16655
AC   CVCL_2K61
DR   CLO; CLO_0019602
DR   Coriell; AG16655
DR   Wikidata; Q54746005
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16657
AC   CVCL_2K62
DR   CLO; CLO_0019599
DR   Coriell; AG16657
DR   Wikidata; Q54746006
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16662
AC   CVCL_2K63
DR   CLO; CLO_0019645
DR   Coriell; AG16662
DR   Wikidata; Q54746007
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16665
AC   CVCL_2K64
DR   CLO; CLO_0019648
DR   Coriell; AG16665
DR   Wikidata; Q54746008
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16698
AC   CVCL_2K65
DR   CLO; CLO_0019638
DR   Coriell; AG16698
DR   Wikidata; Q54746010
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16704
AC   CVCL_X798
DR   CLO; CLO_0019643
DR   Coriell; AG16704
DR   Wikidata; Q54746011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16710
AC   CVCL_X795
DR   CLO; CLO_0019624
DR   Coriell; AG16710
DR   Wikidata; Q54746012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16711
AC   CVCL_X796
DR   CLO; CLO_0019622
DR   Coriell; AG16711
DR   Wikidata; Q54746013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16714
AC   CVCL_X797
DR   CLO; CLO_0019621
DR   Coriell; AG16714
DR   Wikidata; Q54746015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16729
AC   CVCL_2K66
DR   CLO; CLO_0019632
DR   Coriell; AG16729
DR   Wikidata; Q54746017
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16730
AC   CVCL_2K67
DR   CLO; CLO_0019630
DR   Coriell; AG16730
DR   Wikidata; Q54746018
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2L56 ! AG20429
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16731
AC   CVCL_2Q70
DR   CLO; CLO_0019628
DR   Coriell; AG16731
DR   Wikidata; Q54746019
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG16731; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG16741
AC   CVCL_2K68
DR   CLO; CLO_0019626
DR   Coriell; AG16741
DR   Wikidata; Q54746020
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16742
AC   CVCL_2K69
DR   CLO; CLO_0019248
DR   Coriell; AG16742
DR   Wikidata; Q54746022
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16743
AC   CVCL_2K70
DR   CLO; CLO_0019247
DR   Coriell; AG16743
DR   Wikidata; Q54746023
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16744
AC   CVCL_2K71
DR   CLO; CLO_0019244
DR   Coriell; AG16744
DR   Wikidata; Q54746024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG16747
AC   CVCL_2K72
DR   CLO; CLO_0019266
DR   Coriell; AG16747
DR   Wikidata; Q54746026
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16748
AC   CVCL_2K73
DR   CLO; CLO_0019268
DR   Coriell; AG16748
DR   Wikidata; Q54746027
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16758
AC   CVCL_2K74
DR   CLO; CLO_0019261
DR   Coriell; AG16758
DR   Wikidata; Q54746030
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16759
AC   CVCL_2K75
DR   CLO; CLO_0019262
DR   Coriell; AG16759
DR   Wikidata; Q54746031
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16777
AC   CVCL_V458
DR   CLO; CLO_0019255
DR   Coriell; AG16777
DR   Wikidata; Q54746033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   AG16778
AC   CVCL_X799
DR   CLO; CLO_0019257
DR   Coriell; AG16778
DR   Wikidata; Q54746035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16782
AC   CVCL_X800
DR   CLO; CLO_0019253
DR   Coriell; AG16782
DR   Wikidata; Q54746036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16803
AC   CVCL_2K76
DR   CLO; CLO_0019254
DR   Coriell; AG16803
DR   Wikidata; Q54746039
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: Caucasian; Dutch/German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16804
AC   CVCL_2K77
DR   CLO; CLO_0019275
DR   Coriell; AG16804
DR   Wikidata; Q54746040
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16819
AC   CVCL_2K78
DR   CLO; CLO_0019274
DR   Coriell; AG16819
DR   Wikidata; Q54746042
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16820
AC   CVCL_2K79
DR   CLO; CLO_0019281
DR   Coriell; AG16820
DR   Wikidata; Q54746043
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16821
AC   CVCL_2K80
DR   CLO; CLO_0019289
DR   Coriell; AG16821
DR   Wikidata; Q54746073
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16850
AC   CVCL_2K81
DR   CLO; CLO_0019293
DR   Coriell; AG16850
DR   Wikidata; Q54746075
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16858
AC   CVCL_2K82
DR   CLO; CLO_0019295
DR   Coriell; AG16858
DR   Wikidata; Q54746077
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16863
AC   CVCL_2K83
DR   CLO; CLO_0019300
DR   Coriell; AG16863
DR   Wikidata; Q54746079
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16892
AC   CVCL_2K84
DR   CLO; CLO_0019282
DR   Coriell; AG16892
DR   Wikidata; Q54746080
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16893
AC   CVCL_2K85
DR   CLO; CLO_0019284
DR   Coriell; AG16893
DR   Wikidata; Q54746082
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2L55 ! AG20428
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16894
AC   CVCL_2K86
DR   CLO; CLO_0019286
DR   Coriell; AG16894
DR   Wikidata; Q54746084
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16895
AC   CVCL_2K87
DR   CLO; CLO_0019288
DR   Coriell; AG16895
DR   Wikidata; Q54746085
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16896
AC   CVCL_2K88
DR   CLO; CLO_0019308
DR   Coriell; AG16896
DR   Wikidata; Q54746086
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: Caucasian; Dutch/Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16897
AC   CVCL_2K89
DR   CLO; CLO_0019318
DR   Coriell; AG16897
DR   Wikidata; Q54746091
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16898
AC   CVCL_2K90
DR   CLO; CLO_0019320
DR   Coriell; AG16898
DR   Wikidata; Q54746092
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16899
AC   CVCL_2K91
DR   CLO; CLO_0019328
DR   Coriell; AG16899
DR   Wikidata; Q54746093
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16900
AC   CVCL_2K92
DR   CLO; CLO_0019329
DR   Coriell; AG16900
DR   Wikidata; Q54746097
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16901
AC   CVCL_2K93
DR   CLO; CLO_0019323
DR   Coriell; AG16901
DR   Wikidata; Q54746098
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: Caucasian; Dutch/Scottish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16903
AC   CVCL_2K94
DR   CLO; CLO_0019324
DR   Coriell; AG16903
DR   Wikidata; Q54746099
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16904
AC   CVCL_2K95
DR   CLO; CLO_0019339
DR   Coriell; AG16904
DR   Wikidata; Q54746102
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16905
AC   CVCL_2K96
DR   CLO; CLO_0019342
DR   Coriell; AG16905
DR   Wikidata; Q54746104
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   101Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16906
AC   CVCL_2K97
DR   CLO; CLO_0019331
DR   Coriell; AG16906
DR   Wikidata; Q54746105
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16907
AC   CVCL_2K98
DR   CLO; CLO_0019334
DR   Coriell; AG16907
DR   Wikidata; Q54746108
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16908
AC   CVCL_2K99
DR   CLO; CLO_0019353
DR   Coriell; AG16908
DR   Wikidata; Q54746109
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16909
AC   CVCL_2L00
DR   CLO; CLO_0019355
DR   Coriell; AG16909
DR   Wikidata; Q54746111
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16911
AC   CVCL_2L01
DR   CLO; CLO_0019356
DR   Coriell; AG16911
DR   Wikidata; Q54746112
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16912
AC   CVCL_2L02
DR   CLO; CLO_0019359
DR   Coriell; AG16912
DR   Wikidata; Q54746114
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16913
AC   CVCL_2L03
DR   CLO; CLO_0019362
DR   Coriell; AG16913
DR   Wikidata; Q54746116
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16914
AC   CVCL_2L04
DR   CLO; CLO_0019364
DR   Coriell; AG16914
DR   Wikidata; Q54746119
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16915
AC   CVCL_2L05
DR   CLO; CLO_0019365
DR   Coriell; AG16915
DR   Wikidata; Q54746120
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: Caucasian; Dutch/French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2L53 ! AG20426
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16926
AC   CVCL_2L06
DR   CLO; CLO_0019367
DR   Coriell; AG16926
DR   Wikidata; Q54746121
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16927
AC   CVCL_2L07
DR   CLO; CLO_0019370
DR   Coriell; AG16927
DR   Wikidata; Q54746123
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16928
AC   CVCL_2L08
DR   CLO; CLO_0019371
DR   Coriell; AG16928
DR   Wikidata; Q54746124
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16929
AC   CVCL_2L09
DR   CLO; CLO_0019397
DR   Coriell; AG16929
DR   Wikidata; Q54746126
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16930
AC   CVCL_2L10
DR   CLO; CLO_0019395
DR   Coriell; AG16930
DR   Wikidata; Q54746128
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16931
AC   CVCL_2L11
DR   CLO; CLO_0019393
DR   Coriell; AG16931
DR   Wikidata; Q54746130
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16932
AC   CVCL_2L12
DR   CLO; CLO_0019391
DR   Coriell; AG16932
DR   Wikidata; Q54746131
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16933
AC   CVCL_2L13
DR   CLO; CLO_0019390
DR   Coriell; AG16933
DR   Wikidata; Q54746133
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16935
AC   CVCL_2L14
DR   CLO; CLO_0019386
DR   Coriell; AG16935
DR   Wikidata; Q54746135
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16936
AC   CVCL_2L15
DR   CLO; CLO_0019384
DR   Coriell; AG16936
DR   Wikidata; Q54746136
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16937
AC   CVCL_2L16
DR   CLO; CLO_0019381
DR   Coriell; AG16937
DR   Wikidata; Q54746138
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16938
AC   CVCL_2L17
DR   CLO; CLO_0019379
DR   Coriell; AG16938
DR   Wikidata; Q54746142
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16939
AC   CVCL_2L18
DR   CLO; CLO_0019377
DR   Coriell; AG16939
DR   Wikidata; Q54746144
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16940
AC   CVCL_2L19
DR   CLO; CLO_0011773
DR   Coriell; AG16940
DR   Wikidata; Q54746146
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16941
AC   CVCL_2L20
DR   CLO; CLO_0011772
DR   Coriell; AG16941
DR   Wikidata; Q54746197
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16942
AC   CVCL_2L21
DR   CLO; CLO_0011771
DR   Coriell; AG16942
DR   Wikidata; Q54746200
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16943
AC   CVCL_2L22
DR   CLO; CLO_0011770
DR   Coriell; AG16943
DR   Wikidata; Q54746202
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16944
AC   CVCL_X885
DR   CLO; CLO_0011769
DR   Coriell; AG16944
DR   Wikidata; Q54746205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16945
AC   CVCL_X886
DR   CLO; CLO_0011781
DR   Coriell; AG16945
DR   Wikidata; Q54746208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG16973
AC   CVCL_2L23
DR   CLO; CLO_0011780
DR   Coriell; AG16973
DR   Wikidata; Q54746210
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16974
AC   CVCL_2L24
DR   CLO; CLO_0011779
DR   Coriell; AG16974
DR   Wikidata; Q54746212
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16976
AC   CVCL_2L25
DR   CLO; CLO_0011778
DR   Coriell; AG16976
DR   Wikidata; Q54746215
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16977
AC   CVCL_2L26
DR   CLO; CLO_0011777
DR   Coriell; AG16977
DR   Wikidata; Q54746217
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16978
AC   CVCL_2L27
DR   CLO; CLO_0011795
DR   Coriell; AG16978
DR   Wikidata; Q54746218
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16981
AC   CVCL_2L28
DR   CLO; CLO_0011794
DR   Coriell; AG16981
DR   Wikidata; Q54746219
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16982
AC   CVCL_2L29
DR   CLO; CLO_0011791
DR   Coriell; AG16982
DR   Wikidata; Q54746221
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16983
AC   CVCL_2L30
DR   CLO; CLO_0011790
DR   Coriell; AG16983
DR   Wikidata; Q54746223
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16984
AC   CVCL_2L31
DR   CLO; CLO_0011793
DR   Coriell; AG16984
DR   Wikidata; Q54746225
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16985
AC   CVCL_2L32
DR   CLO; CLO_0011792
DR   Coriell; AG16985
DR   Wikidata; Q54746227
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16986
AC   CVCL_2L33
DR   CLO; CLO_0011799
DR   Coriell; AG16986
DR   Wikidata; Q54746229
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16987
AC   CVCL_2L34
DR   CLO; CLO_0011798
DR   Coriell; AG16987
DR   Wikidata; Q54746230
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16988
AC   CVCL_2L35
DR   CLO; CLO_0011801
DR   Coriell; AG16988
DR   Wikidata; Q54746234
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16989
AC   CVCL_2L36
DR   CLO; CLO_0011800
DR   Coriell; AG16989
DR   Wikidata; Q54746236
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG16990
AC   CVCL_2L37
DR   CLO; CLO_0011804
DR   Coriell; AG16990
DR   Wikidata; Q54746237
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG16991
AC   CVCL_2L38
DR   CLO; CLO_0011803
DR   Coriell; AG16991
DR   Wikidata; Q54746240
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17484
AC   CVCL_X887
DR   CLO; CLO_0011802
DR   Coriell; AG17484
DR   Wikidata; Q54746242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG17485
AC   CVCL_X888
DR   CLO; CLO_0011808
DR   Coriell; AG17485
DR   Wikidata; Q54746243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG17487
AC   CVCL_X889
DR   CLO; CLO_0011807
DR   Coriell; AG17487
DR   Wikidata; Q54746246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG17500
AC   CVCL_2Q64
DR   Coriell; AG17500
DR   Wikidata; Q54746249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG17510
AC   CVCL_2L39
DR   CLO; CLO_0011806
DR   Coriell; AG17510
DR   Wikidata; Q54746252
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17511
AC   CVCL_EF54
DR   Coriell; AG17511
DR   Wikidata; Q54746253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   AG17512
AC   CVCL_4P95
DR   Coriell; AG17512
DR   Wikidata; Q54746255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG17514
AC   CVCL_4P96
DR   Coriell; AG17514
DR   Wikidata; Q54746257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG17524
AC   CVCL_X815
DR   CLO; CLO_0011805
DR   Coriell; AG17524
DR   Wikidata; Q54746260
RX   PubMed=23001818;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1391-1G>A (g.2626G>A); ClinVar=VCV000006067; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG17524).
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.His831Argfs*52 (c.2492_2493delAT) (2-BP DEL,NT2492); ClinVar=VCV000006064; Zygosity=Heterozygous (Coriell=AG17524).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   AG17529
AC   CVCL_4P97
DR   Coriell; AG17529
DR   Wikidata; Q54746262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG17574
AC   CVCL_4P98
DR   Coriell; AG17574
DR   Wikidata; Q54746263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG17665
AC   CVCL_2L40
DR   CLO; CLO_0011811
DR   Coriell; AG17665
DR   Wikidata; Q54746266
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17666
AC   CVCL_2L41
DR   CLO; CLO_0011810
DR   Coriell; AG17666
DR   Wikidata; Q54746267
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17715
AC   CVCL_2L42
DR   CLO; CLO_0011809
DR   Coriell; AG17715
DR   Wikidata; Q54746269
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17716
AC   CVCL_2L43
DR   CLO; CLO_0011813
DR   Coriell; AG17716
DR   Wikidata; Q54746270
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17717
AC   CVCL_2L44
DR   CLO; CLO_0011812
DR   Coriell; AG17717
DR   Wikidata; Q54746273
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17718
AC   CVCL_2L45
DR   CLO; CLO_0011815
DR   Coriell; AG17718
DR   Wikidata; Q54746274
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17727
AC   CVCL_2L46
DR   CLO; CLO_0011814
DR   Coriell; AG17727
DR   Wikidata; Q54746275
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17728
AC   CVCL_2L47
DR   CLO; CLO_0011817
DR   Coriell; AG17728
DR   Wikidata; Q54746279
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17862
AC   CVCL_2L48
DR   CLO; CLO_0011816
DR   Coriell; AG17862
DR   Wikidata; Q54746325
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG17870
AC   CVCL_2Q25
SY   ASC-13
DR   CLO; CLO_0011819
DR   Coriell; AG17870
DR   Wikidata; Q54746328
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Sacral area, skin, adipose tissue; UBERON=UBERON_8480024+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG17874
AC   CVCL_2Q55
DR   CLO; CLO_0011818
DR   Coriell; AG17874
DR   Wikidata; Q54746330
CC   Group: Non-human primate cell line.
CC   Doubling time: Slow growth (Coriell=AG17874).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG17875
AC   CVCL_0L56
SY   ASC-14
DR   CLO; CLO_0011821
DR   Coriell; AG17875
DR   Wikidata; Q54746332
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0L57 ! AG17928
SX   Female
AG   53Y
CA   Somatic stem cell
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   AG17902
AC   CVCL_2Q26
SY   ASC-16
DR   CLO; CLO_0011820
DR   Coriell; AG17902
DR   Wikidata; Q54746333
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Arm, skin, adipose tissue; UBERON=UBERON_0002427+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG17907
AC   CVCL_2Q27
SY   ASC-17
DR   CLO; CLO_0011722
DR   Coriell; AG17907
DR   Wikidata; Q54746336
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Thigh, skin, adipose tissue; UBERON=UBERON_0004262+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG17928
AC   CVCL_0L57
SY   ASC-18
DR   CLO; CLO_0011730
DR   Coriell; AG17928
DR   Wikidata; Q54746338
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Abdomen, skin, adipose tissue; UBERON=UBERON_0001416+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0L56 ! AG17875
SX   Female
AG   53Y
CA   Somatic stem cell
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   AG17929
AC   CVCL_2Q28
SY   ASC-19
DR   CLO; CLO_0011731
DR   Coriell; AG17929
DR   Wikidata; Q54746340
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Abdomen, skin, adipose tissue; UBERON=UBERON_0001416+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG17930
AC   CVCL_2Q29
SY   ASC-20
DR   CLO; CLO_0011728
DR   Coriell; AG17930
DR   Wikidata; Q54746342
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Abdomen, skin, adipose tissue; UBERON=UBERON_0001416+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG18170
AC   CVCL_2Q78
DR   Coriell; AG18170
DR   Wikidata; Q54746345
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18171
AC   CVCL_2Q79
DR   Coriell; AG18171
DR   Wikidata; Q54746348
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18173
AC   CVCL_0K01
DR   Coriell; AG18173
DR   Wikidata; Q54746350
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18175
AC   CVCL_0K02
DR   Coriell; AG18175
DR   Wikidata; Q54746355
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18176
AC   CVCL_0K03
DR   Coriell; AG18176
DR   Wikidata; Q54746356
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18177
AC   CVCL_0K04
DR   Coriell; AG18177
DR   Wikidata; Q54746359
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18179
AC   CVCL_0K05
DR   Coriell; AG18179
DR   Wikidata; Q54746360
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   104Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18181
AC   CVCL_2Q80
DR   Coriell; AG18181
DR   Wikidata; Q54746364
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18182
AC   CVCL_2Q81
DR   Coriell; AG18182
DR   Wikidata; Q54746366
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18183
AC   CVCL_2Q82
DR   Coriell; AG18183
DR   Wikidata; Q54746368
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18184
AC   CVCL_2Q83
DR   Coriell; AG18184
DR   Wikidata; Q54746371
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18185
AC   CVCL_2Q84
DR   Coriell; AG18185
DR   Wikidata; Q54746374
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18186
AC   CVCL_2Q85
DR   Coriell; AG18186
DR   Wikidata; Q54746376
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18187
AC   CVCL_2Q86
DR   Coriell; AG18187
DR   Wikidata; Q54746378
CC   Population: Native North American; Alaskan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18188
AC   CVCL_2Q87
DR   Coriell; AG18188
DR   Wikidata; Q54746380
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18189
AC   CVCL_2Q88
DR   Coriell; AG18189
DR   Wikidata; Q54746381
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18190
AC   CVCL_2Q89
DR   Coriell; AG18190
DR   Wikidata; Q54746384
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18191
AC   CVCL_2Q90
DR   Coriell; AG18191
DR   Wikidata; Q54746385
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18192
AC   CVCL_2Q91
DR   Coriell; AG18192
DR   Wikidata; Q54746388
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18193
AC   CVCL_2Q92
DR   Coriell; AG18193
DR   Wikidata; Q54746392
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18194
AC   CVCL_2Q93
DR   Coriell; AG18194
DR   Wikidata; Q54746393
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18195
AC   CVCL_2Q94
DR   Coriell; AG18195
DR   Wikidata; Q54746394
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18196
AC   CVCL_2Q95
DR   Coriell; AG18196
DR   Wikidata; Q54746397
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18197
AC   CVCL_2Q96
DR   Coriell; AG18197
DR   Wikidata; Q54746399
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18198
AC   CVCL_2Q97
DR   Coriell; AG18198
DR   Wikidata; Q54746400
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18199
AC   CVCL_2Q98
DR   Coriell; AG18199
DR   Wikidata; Q54746401
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18200
AC   CVCL_2Q99
DR   Coriell; AG18200
DR   Wikidata; Q54746403
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18201
AC   CVCL_2R00
DR   Coriell; AG18201
DR   Wikidata; Q54746406
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18202
AC   CVCL_2R01
DR   Coriell; AG18202
DR   Wikidata; Q54746408
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18203
AC   CVCL_2R02
DR   Coriell; AG18203
DR   Wikidata; Q54746409
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18205
AC   CVCL_0K06
DR   Coriell; AG18205
DR   Wikidata; Q54746413
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   104Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18206
AC   CVCL_0K07
DR   Coriell; AG18206
DR   Wikidata; Q54746459
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18208
AC   CVCL_2R03
DR   Coriell; AG18208
DR   Wikidata; Q54746462
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18209
AC   CVCL_2R04
DR   Coriell; AG18209
DR   Wikidata; Q54746463
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18210
AC   CVCL_2R05
DR   Coriell; AG18210
DR   Wikidata; Q54746465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG18211
AC   CVCL_2R06
DR   Coriell; AG18211
DR   Wikidata; Q54746468
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18212
AC   CVCL_2R07
DR   Coriell; AG18212
DR   Wikidata; Q54746470
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18213
AC   CVCL_2R08
DR   Coriell; AG18213
DR   Wikidata; Q54746471
CC   Population: African American.
CC   Karyotypic information: 47,XX,+12 [2]; 46,XX [48] (Coriell=AG18213).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18215
AC   CVCL_2R09
DR   Coriell; AG18215
DR   Wikidata; Q54746473
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18216
AC   CVCL_2R10
DR   Coriell; AG18216
DR   Wikidata; Q54746476
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18217
AC   CVCL_2R11
DR   Coriell; AG18217
DR   Wikidata; Q54746479
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18218
AC   CVCL_2R12
DR   Coriell; AG18218
DR   Wikidata; Q54746480
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18219
AC   CVCL_2R13
DR   Coriell; AG18219
DR   Wikidata; Q54746482
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18220
AC   CVCL_2R14
DR   Coriell; AG18220
DR   Wikidata; Q54746484
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18221
AC   CVCL_2R15
DR   Coriell; AG18221
DR   Wikidata; Q54746487
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18222
AC   CVCL_2R16
DR   Coriell; AG18222
DR   Wikidata; Q54746489
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18223
AC   CVCL_2R17
DR   Coriell; AG18223
DR   Wikidata; Q54746492
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18224
AC   CVCL_2R18
DR   Coriell; AG18224
DR   Wikidata; Q54746494
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18225
AC   CVCL_2R19
DR   Coriell; AG18225
DR   Wikidata; Q54746496
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18226
AC   CVCL_2R20
DR   Coriell; AG18226
DR   Wikidata; Q54746498
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18227
AC   CVCL_2R21
DR   Coriell; AG18227
DR   Wikidata; Q54746501
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18228
AC   CVCL_2R22
DR   Coriell; AG18228
DR   Wikidata; Q54746503
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18229
AC   CVCL_2R23
DR   Coriell; AG18229
DR   Wikidata; Q54746504
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18230
AC   CVCL_2R24
DR   Coriell; AG18230
DR   Wikidata; Q54746508
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18231
AC   CVCL_0K08
DR   Coriell; AG18231
DR   Wikidata; Q54746510
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18232
AC   CVCL_2R25
DR   Coriell; AG18232
DR   Wikidata; Q54746512
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18233
AC   CVCL_2R26
DR   Coriell; AG18233
DR   Wikidata; Q54746514
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18234
AC   CVCL_2R27
DR   Coriell; AG18234
DR   Wikidata; Q54746516
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18235
AC   CVCL_2R28
DR   Coriell; AG18235
DR   Wikidata; Q54746519
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18236
AC   CVCL_2R29
DR   Coriell; AG18236
DR   Wikidata; Q54746520
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18237
AC   CVCL_2R30
DR   Coriell; AG18237
DR   Wikidata; Q54746521
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18238
AC   CVCL_2R31
DR   Coriell; AG18238
DR   Wikidata; Q54746525
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18239
AC   CVCL_2R32
DR   Coriell; AG18239
DR   Wikidata; Q54746526
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18240
AC   CVCL_2R33
DR   Coriell; AG18240
DR   Wikidata; Q54746528
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18242
AC   CVCL_2R34
DR   Coriell; AG18242
DR   Wikidata; Q54746529
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18243
AC   CVCL_2R35
DR   Coriell; AG18243
DR   Wikidata; Q54746531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG18244
AC   CVCL_2R36
DR   Coriell; AG18244
DR   Wikidata; Q54746532
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18245
AC   CVCL_2R37
DR   Coriell; AG18245
DR   Wikidata; Q54746533
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18246
AC   CVCL_2R38
DR   Coriell; AG18246
DR   Wikidata; Q54746535
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18247
AC   CVCL_2R39
DR   Coriell; AG18247
DR   Wikidata; Q54746538
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18248
AC   CVCL_2R40
DR   Coriell; AG18248
DR   Wikidata; Q54746541
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18249
AC   CVCL_2R41
DR   Coriell; AG18249
DR   Wikidata; Q54746596
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18250
AC   CVCL_2R42
DR   Coriell; AG18250
DR   Wikidata; Q54746597
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18251
AC   CVCL_2R43
DR   Coriell; AG18251
DR   Wikidata; Q54746600
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18252
AC   CVCL_2R44
DR   Coriell; AG18252
DR   Wikidata; Q54746603
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18253
AC   CVCL_2R45
DR   Coriell; AG18253
DR   Wikidata; Q54746604
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18254
AC   CVCL_2R46
DR   Coriell; AG18254
DR   Wikidata; Q54746606
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18255
AC   CVCL_2R47
DR   Coriell; AG18255
DR   Wikidata; Q54746608
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18256
AC   CVCL_2R48
DR   Coriell; AG18256
DR   Wikidata; Q54746609
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18257
AC   CVCL_2R49
DR   Coriell; AG18257
DR   Wikidata; Q54746610
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18258
AC   CVCL_0K09
DR   Coriell; AG18258
DR   Wikidata; Q54746614
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18261
AC   CVCL_2R50
DR   Coriell; AG18261
DR   Wikidata; Q54746616
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18262
AC   CVCL_2R51
DR   Coriell; AG18262
DR   Wikidata; Q54746617
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18263
AC   CVCL_2R52
DR   Coriell; AG18263
DR   Wikidata; Q54746619
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18264
AC   CVCL_2R53
DR   Coriell; AG18264
DR   Wikidata; Q54746621
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18265
AC   CVCL_2R54
DR   Coriell; AG18265
DR   Wikidata; Q54746624
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18266
AC   CVCL_2R55
DR   Coriell; AG18266
DR   Wikidata; Q54746625
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18267
AC   CVCL_2R56
DR   Coriell; AG18267
DR   Wikidata; Q54746626
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18268
AC   CVCL_2R57
DR   Coriell; AG18268
DR   Wikidata; Q54746629
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18269
AC   CVCL_2R58
DR   Coriell; AG18269
DR   Wikidata; Q54746630
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18270
AC   CVCL_2R59
DR   Coriell; AG18270
DR   Wikidata; Q54746633
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18271
AC   CVCL_2R60
DR   Coriell; AG18271
DR   Wikidata; Q54746635
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18273
AC   CVCL_2R61
DR   Coriell; AG18273
DR   Wikidata; Q54746636
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18275
AC   CVCL_2R62
DR   Coriell; AG18275
DR   Wikidata; Q54746637
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18276
AC   CVCL_2R63
DR   Coriell; AG18276
DR   Wikidata; Q54746640
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18277
AC   CVCL_2R64
DR   Coriell; AG18277
DR   Wikidata; Q54746641
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18278
AC   CVCL_2R65
DR   Coriell; AG18278
DR   Wikidata; Q54746642
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18279
AC   CVCL_2R66
DR   Coriell; AG18279
DR   Wikidata; Q54746645
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18280
AC   CVCL_2R67
DR   Coriell; AG18280
DR   Wikidata; Q54746646
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18281
AC   CVCL_2R68
DR   Coriell; AG18281
DR   Wikidata; Q54746649
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18282
AC   CVCL_2R69
DR   Coriell; AG18282
DR   Wikidata; Q54746651
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18283
AC   CVCL_2R70
DR   Coriell; AG18283
DR   Wikidata; Q54746653
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18285
AC   CVCL_2R71
DR   Coriell; AG18285
DR   Wikidata; Q54746655
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18286
AC   CVCL_2R72
DR   Coriell; AG18286
DR   Wikidata; Q54746656
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18287
AC   CVCL_2R73
DR   Coriell; AG18287
DR   Wikidata; Q54746657
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18288
AC   CVCL_2R74
DR   Coriell; AG18288
DR   Wikidata; Q54746660
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18289
AC   CVCL_2R75
DR   Coriell; AG18289
DR   Wikidata; Q54746661
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18290
AC   CVCL_2R76
DR   Coriell; AG18290
DR   Wikidata; Q54746664
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18291
AC   CVCL_2R77
DR   Coriell; AG18291
DR   Wikidata; Q54746665
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18292
AC   CVCL_2R78
DR   Coriell; AG18292
DR   Wikidata; Q54746668
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18293
AC   CVCL_2R79
DR   Coriell; AG18293
DR   Wikidata; Q54746671
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18294
AC   CVCL_2R80
DR   Coriell; AG18294
DR   Wikidata; Q54746729
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18295
AC   CVCL_2R81
DR   Coriell; AG18295
DR   Wikidata; Q54746732
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18296
AC   CVCL_2R82
DR   Coriell; AG18296
DR   Wikidata; Q54746737
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18297
AC   CVCL_2R83
DR   Coriell; AG18297
DR   Wikidata; Q54746741
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18298
AC   CVCL_2R84
DR   Coriell; AG18298
DR   Wikidata; Q54746743
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18299
AC   CVCL_2R85
DR   Coriell; AG18299
DR   Wikidata; Q54746744
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18300
AC   CVCL_2R86
DR   Coriell; AG18300
DR   Wikidata; Q54746747
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18301
AC   CVCL_2R87
DR   Coriell; AG18301
DR   Wikidata; Q54746749
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18302
AC   CVCL_2R88
DR   Coriell; AG18302
DR   Wikidata; Q54746751
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18303
AC   CVCL_2R89
DR   Coriell; AG18303
DR   Wikidata; Q54746753
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18304
AC   CVCL_2R90
DR   Coriell; AG18304
DR   Wikidata; Q54746755
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18305
AC   CVCL_2R91
DR   Coriell; AG18305
DR   Wikidata; Q54746757
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18306
AC   CVCL_2R92
DR   Coriell; AG18306
DR   Wikidata; Q54746759
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18307
AC   CVCL_2R93
DR   Coriell; AG18307
DR   Wikidata; Q54746761
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG18354
AC   CVCL_V981
DR   Coriell; AG18354
DR   Wikidata; Q54746762
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG18354; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   AG18355
AC   CVCL_V982
DR   Coriell; AG18355
DR   Wikidata; Q54746765
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG18355; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   AG18356
AC   CVCL_V983
DR   Coriell; AG18356
DR   Wikidata; Q54746766
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG18356; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   AG18357
AC   CVCL_V984
DR   Coriell; AG18357
DR   Wikidata; Q54746770
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG18357; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   AG18358
AC   CVCL_V985
SY   Min18358; Min 18358
DR   Coriell; AG18358
DR   GEO; GSM945680
DR   GEO; GSM1204870
DR   GEO; GSM1468858
DR   GEO; GSM1468866
DR   GEO; GSM1468874
DR   GEO; GSM1468882
DR   GEO; GSM1468890
DR   GEO; GSM1468898
DR   PRIDE; PXD000419
DR   Wikidata; Q54746772
RX   PubMed=22720000;
RX   PubMed=22797897;
RX   PubMed=24136357;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; AG18358; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   AG18359
AC   CVCL_V986
SY   Min18359; Min 18359
DR   ArrayExpress; E-MTAB-1511
DR   Coriell; AG18359
DR   GEO; GSM945678
DR   GEO; GSM1204869
DR   GEO; GSM1468859
DR   GEO; GSM1468867
DR   GEO; GSM1468875
DR   GEO; GSM1468883
DR   GEO; GSM1468891
DR   GEO; GSM1468899
DR   PRIDE; PXD000419
DR   Wikidata; Q54746775
RX   PubMed=22720000;
RX   PubMed=22797897;
RX   PubMed=24136357;
RX   PubMed=24380390;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; AG18359; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   AG18371
AC   CVCL_X816
DR   CLO; CLO_0011729
DR   Coriell; AG18371
DR   GEO; GSM476017
DR   Wikidata; Q54746778
RX   PubMed=19966276;
RX   PubMed=23001818;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1483+27_1483+37del (c.1483+25del11) (g.2746del11); ClinVar=VCV002431799; Zygosity=Homozygous (Coriell=AG18371).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 13
//
ID   AG18372
AC   CVCL_X817
DR   CLO; CLO_0011726
DR   Coriell; AG18372
DR   Wikidata; Q54746779
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1483+27_1483+37del (c.1483+25del11) (g.2746del11); ClinVar=VCV002431799; Zygosity=Heterozygous (Coriell=AG18372).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X818 ! AG18373
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   AG18373
AC   CVCL_X818
DR   CLO; CLO_0011727
DR   Coriell; AG18373
DR   Wikidata; Q54746781
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1483+27_1483+37del (c.1483+25del11) (g.2746del11); ClinVar=VCV002431799; Zygosity=Heterozygous (Coriell=AG18373).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X817 ! AG18372
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   AG18374
AC   CVCL_X819
DR   CLO; CLO_0011724
DR   Coriell; AG18374
DR   Wikidata; Q54746783
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1391-1G>A (g.2626G>A); ClinVar=VCV000006067; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG18374).
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.Cys525Alafs*33 (c.1573delT) (g.2886delT); ClinVar=VCV000006066; Zygosity=Heterozygous (Coriell=AG18374).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X820 ! AG18375
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   AG18375
AC   CVCL_X820
DR   CLO; CLO_0011725
DR   Coriell; AG18375
DR   GEO; GSM476018
DR   Wikidata; Q54746784
RX   PubMed=19966276;
RX   PubMed=23001818;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+7 [43]; 48,XY,+7,+7 [3]; 48,XXY,+7 [2]; 46,XY [2] (Coriell=AG18375).
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1391-1G>A (g.2626G>A); ClinVar=VCV000006067; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG18375).
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.Cys525Alafs*33 (c.1573delT) (g.2886delT); ClinVar=VCV000006066; Zygosity=Heterozygous (Coriell=AG18375).
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X819 ! AG18374
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 16
//
ID   AG18376
AC   CVCL_X821
DR   CLO; CLO_0011723
DR   Coriell; AG18376
DR   Wikidata; Q54746787
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1391-1G>A (g.2626G>A); ClinVar=VCV000006067; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG18376).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X823 ! AG18459
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   AG18377
AC   CVCL_X822
DR   CLO; CLO_0011733
DR   Coriell; AG18377
DR   Wikidata; Q54746789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG18380
AC   CVCL_HJ52
DR   Coriell; AG18380
DR   Wikidata; Q54746791
CC   Derived from site: In situ; Hip, skin, adipose tissue; UBERON=UBERON_0001554+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG18459
AC   CVCL_X823
DR   CLO; CLO_0011732
DR   Coriell; AG18459
DR   Wikidata; Q54746792
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1391-1G>A (g.2626G>A); ClinVar=VCV000006067; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG18459).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X821 ! AG18376
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   AG18462
AC   CVCL_0K10
DR   Coriell; AG18462
DR   Wikidata; Q54746793
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18463
AC   CVCL_0K11
DR   Coriell; AG18463
DR   Wikidata; Q54746795
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18465
AC   CVCL_X824
DR   CLO; CLO_0011738
DR   Coriell; AG18465
DR   Wikidata; Q54746798
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.Gln810Ter (c.2428C>T) (g.4503C>T); Zygosity=Homozygous (Coriell=AG18465).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 12
//
ID   AG18466
AC   CVCL_X825
DR   CLO; CLO_0011739
DR   Coriell; AG18466
DR   Wikidata; Q54746799
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.Gln810Ter (c.2428C>T) (g.4503C>T); Zygosity=Heterozygous (Coriell=AG18466).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   AG18469
AC   CVCL_X826
DR   CLO; CLO_0011740
DR   Coriell; AG18469
DR   Wikidata; Q54746802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG18471
AC   CVCL_X827
DR   CLO; CLO_0011741
DR   Coriell; AG18471
DR   Wikidata; Q54746804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   AG18490
AC   CVCL_0K12
DR   Coriell; AG18490
DR   Wikidata; Q54746806
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18491
AC   CVCL_0K13
DR   Coriell; AG18491
DR   Wikidata; Q54746807
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18919
AC   CVCL_0K14
DR   Coriell; AG18919
DR   Wikidata; Q54746809
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG18928
AC   CVCL_2Q30
SY   ASC-31
DR   CLO; CLO_0011734
DR   Coriell; AG18928
DR   Wikidata; Q54746810
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Buttock, adipose tissue; UBERON=UBERON_0013691+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 10
//
ID   AG19013
AC   CVCL_0K15
DR   Coriell; AG19013
DR   Wikidata; Q54746812
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19032
AC   CVCL_0K16
DR   Coriell; AG19032
DR   Wikidata; Q54746853
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19053
AC   CVCL_0K17
DR   Coriell; AG19053
DR   Wikidata; Q54746856
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19231
AC   CVCL_0K18
DR   Coriell; AG19231
DR   Wikidata; Q54746858
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19232
AC   CVCL_0K19
DR   Coriell; AG19232
DR   Wikidata; Q54746862
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19233
AC   CVCL_0K20
DR   Coriell; AG19233
DR   Wikidata; Q54746863
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19234
AC   CVCL_0K21
DR   Coriell; AG19234
DR   Wikidata; Q54746864
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19267
AC   CVCL_0K22
DR   Coriell; AG19267
DR   Wikidata; Q54746866
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19282
AC   CVCL_2Q65
DR   CLO; CLO_0011735
DR   Coriell; AG19282
DR   Wikidata; Q54746868
RX   PubMed=19046453;
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Q66 ! AG19284
OI   CVCL_2Q67 ! AG19285
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19284
AC   CVCL_2Q66
DR   Coriell; AG19284
DR   Wikidata; Q54746871
RX   PubMed=19046453;
CC   Population: Caucasian.
CC   Derived from site: In situ; Achilles tendon; UBERON=UBERON_0003701.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Q65 ! AG19282
OI   CVCL_2Q67 ! AG19285
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19285
AC   CVCL_2Q67
DR   CLO; CLO_0011736
DR   Coriell; AG19285
DR   Wikidata; Q54746872
RX   PubMed=19046453;
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Q65 ! AG19282
OI   CVCL_2Q66 ! AG19284
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19289
AC   CVCL_2Q68
DR   CLO; CLO_0011737
DR   Coriell; AG19289
DR   Wikidata; Q54746875
RX   PubMed=19046453;
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19290
AC   CVCL_0K23
DR   Coriell; AG19290
DR   Wikidata; Q54746876
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19297
AC   CVCL_0K24
DR   Coriell; AG19297
DR   Wikidata; Q54746877
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19298
AC   CVCL_0K25
DR   Coriell; AG19298
DR   Wikidata; Q54746879
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19299
AC   CVCL_0K26
DR   Coriell; AG19299
DR   Wikidata; Q54746880
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   108Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19300
AC   CVCL_0K27
DR   Coriell; AG19300
DR   Wikidata; Q54746883
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19301
AC   CVCL_0K28
DR   Coriell; AG19301
DR   Wikidata; Q54746884
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19302
AC   CVCL_0K29
DR   Coriell; AG19302
DR   Wikidata; Q54746886
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19303
AC   CVCL_0K30
DR   Coriell; AG19303
DR   Wikidata; Q54746888
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19304
AC   CVCL_2Q31
SY   ASC-32
DR   CLO; CLO_0011744
DR   Coriell; AG19304
DR   Wikidata; Q54746891
RX   CelloPub=CLPUB00809;
RX   PubMed=24092797;
CC   Derived from site: In situ; Abdomen, skin, adipose tissue; UBERON=UBERON_0001416+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG19305
AC   CVCL_0K31
DR   Coriell; AG19305
DR   Wikidata; Q54746892
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19306
AC   CVCL_0K32
DR   Coriell; AG19306
DR   Wikidata; Q54746895
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19336
AC   CVCL_0K33
DR   Coriell; AG19336
DR   Wikidata; Q54746897
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19337
AC   CVCL_0K34
DR   Coriell; AG19337
DR   Wikidata; Q54746898
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19340
AC   CVCL_0K35
DR   Coriell; AG19340
DR   Wikidata; Q54746902
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19341
AC   CVCL_0K36
DR   Coriell; AG19341
DR   Wikidata; Q54746905
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19342
AC   CVCL_0K37
DR   Coriell; AG19342
DR   Wikidata; Q54746906
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19343
AC   CVCL_0K38
DR   Coriell; AG19343
DR   Wikidata; Q54746910
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19361
AC   CVCL_0K39
DR   Coriell; AG19361
DR   Wikidata; Q54746911
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19363
AC   CVCL_0K40
DR   Coriell; AG19363
DR   Wikidata; Q54746912
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19364
AC   CVCL_0K41
DR   Coriell; AG19364
DR   Wikidata; Q54746914
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19365
AC   CVCL_0K42
DR   Coriell; AG19365
DR   Wikidata; Q54746915
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19366
AC   CVCL_0K43
DR   Coriell; AG19366
DR   Wikidata; Q54746919
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19367
AC   CVCL_0K44
DR   Coriell; AG19367
DR   Wikidata; Q54746920
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19368
AC   CVCL_0K45
DR   Coriell; AG19368
DR   Wikidata; Q54746922
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19387
AC   CVCL_0K46
DR   Coriell; AG19387
DR   Wikidata; Q54746925
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19388
AC   CVCL_0K47
DR   Coriell; AG19388
DR   Wikidata; Q54746927
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19389
AC   CVCL_0K48
DR   Coriell; AG19389
DR   Wikidata; Q54746930
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19405
AC   CVCL_0K49
DR   Coriell; AG19405
DR   Wikidata; Q54746932
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19406
AC   CVCL_2R94
DR   Coriell; AG19406
DR   Wikidata; Q54746933
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19407
AC   CVCL_2R95
DR   Coriell; AG19407
DR   Wikidata; Q54746983
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19408
AC   CVCL_2R96
DR   Coriell; AG19408
DR   Wikidata; Q54746986
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19409
AC   CVCL_2R97
DR   Coriell; AG19409
DR   Wikidata; Q54746989
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19410
AC   CVCL_2R98
DR   Coriell; AG19410
DR   Wikidata; Q54746990
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19411
AC   CVCL_2R99
DR   Coriell; AG19411
DR   Wikidata; Q54746991
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19412
AC   CVCL_2S00
DR   Coriell; AG19412
DR   Wikidata; Q54746994
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19413
AC   CVCL_2S01
DR   Coriell; AG19413
DR   Wikidata; Q54746995
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19414
AC   CVCL_2S02
DR   Coriell; AG19414
DR   Wikidata; Q54746997
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19415
AC   CVCL_2S03
DR   Coriell; AG19415
DR   Wikidata; Q54747000
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19416
AC   CVCL_2S04
DR   Coriell; AG19416
DR   Wikidata; Q54747001
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19417
AC   CVCL_2S05
DR   Coriell; AG19417
DR   Wikidata; Q54747002
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19418
AC   CVCL_2S06
DR   Coriell; AG19418
DR   Wikidata; Q54747004
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19419
AC   CVCL_2S07
DR   Coriell; AG19419
DR   Wikidata; Q54747005
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19420
AC   CVCL_2S08
DR   Coriell; AG19420
DR   Wikidata; Q54747007
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19421
AC   CVCL_2S09
DR   Coriell; AG19421
DR   Wikidata; Q54747009
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19422
AC   CVCL_0K50
DR   Coriell; AG19422
DR   Wikidata; Q54747010
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19423
AC   CVCL_2S10
DR   Coriell; AG19423
DR   Wikidata; Q54747013
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19424
AC   CVCL_2S11
DR   Coriell; AG19424
DR   Wikidata; Q54747015
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19425
AC   CVCL_2S12
DR   Coriell; AG19425
DR   Wikidata; Q54747017
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19426
AC   CVCL_0K51
DR   Coriell; AG19426
DR   Wikidata; Q54747019
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19427
AC   CVCL_0K52
DR   Coriell; AG19427
DR   Wikidata; Q54747020
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19442
AC   CVCL_0K53
DR   Coriell; AG19442
DR   Wikidata; Q54747021
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19458
AC   CVCL_0K54
DR   Coriell; AG19458
DR   Wikidata; Q54747023
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19459
AC   CVCL_0K55
DR   Coriell; AG19459
DR   Wikidata; Q54747025
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19460
AC   CVCL_0K56
DR   Coriell; AG19460
DR   Wikidata; Q54747028
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19477
AC   CVCL_0K57
DR   Coriell; AG19477
DR   Wikidata; Q54747030
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   105Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19479
AC   CVCL_0K58
DR   Coriell; AG19479
DR   Wikidata; Q54747031
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19486
AC   CVCL_0K59
DR   Coriell; AG19486
DR   Wikidata; Q54747033
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19487
AC   CVCL_0K60
DR   Coriell; AG19487
DR   Wikidata; Q54747034
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19488
AC   CVCL_0K61
DR   Coriell; AG19488
DR   Wikidata; Q54747035
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19489
AC   CVCL_0K62
DR   Coriell; AG19489
DR   Wikidata; Q54747037
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19492
AC   CVCL_0K63
DR   Coriell; AG19492
DR   Wikidata; Q54747039
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19494
AC   CVCL_2S13
DR   Coriell; AG19494
DR   Wikidata; Q54747041
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19495
AC   CVCL_2S14
DR   Coriell; AG19495
DR   Wikidata; Q54747043
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19496
AC   CVCL_2S15
DR   Coriell; AG19496
DR   Wikidata; Q54747045
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19497
AC   CVCL_2S16
DR   Coriell; AG19497
DR   Wikidata; Q54747047
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19498
AC   CVCL_2S17
DR   Coriell; AG19498
DR   Wikidata; Q54747050
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19499
AC   CVCL_2S18
DR   Coriell; AG19499
DR   Wikidata; Q54747051
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19500
AC   CVCL_2S19
DR   Coriell; AG19500
DR   Wikidata; Q54747053
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19501
AC   CVCL_0K64
DR   Coriell; AG19501
DR   Wikidata; Q54747055
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19502
AC   CVCL_0K65
DR   Coriell; AG19502
DR   Wikidata; Q54747150
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19503
AC   CVCL_2S20
DR   Coriell; AG19503
DR   Wikidata; Q54747153
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19504
AC   CVCL_2S21
DR   Coriell; AG19504
DR   Wikidata; Q54747156
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19505
AC   CVCL_2S22
DR   Coriell; AG19505
DR   Wikidata; Q54747157
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19506
AC   CVCL_2S23
DR   Coriell; AG19506
DR   Wikidata; Q54747158
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19507
AC   CVCL_2S24
DR   Coriell; AG19507
DR   Wikidata; Q54747160
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19508
AC   CVCL_2S25
DR   Coriell; AG19508
DR   Wikidata; Q54747162
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19509
AC   CVCL_0K66
DR   Coriell; AG19509
DR   Wikidata; Q54747165
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19510
AC   CVCL_0K67
DR   Coriell; AG19510
DR   Wikidata; Q54747166
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19511
AC   CVCL_0K68
DR   Coriell; AG19511
DR   Wikidata; Q54747168
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19512
AC   CVCL_0K69
DR   Coriell; AG19512
DR   Wikidata; Q54747170
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19513
AC   CVCL_0K70
DR   Coriell; AG19513
DR   Wikidata; Q54747171
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19514
AC   CVCL_0K71
DR   Coriell; AG19514
DR   Wikidata; Q54747174
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19515
AC   CVCL_2S26
DR   Coriell; AG19515
DR   Wikidata; Q54747175
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19516
AC   CVCL_2S27
DR   Coriell; AG19516
DR   Wikidata; Q54747177
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19517
AC   CVCL_2S28
DR   Coriell; AG19517
DR   Wikidata; Q54747179
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19518
AC   CVCL_2S29
DR   Coriell; AG19518
DR   Wikidata; Q54747181
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19519
AC   CVCL_2S30
DR   Coriell; AG19519
DR   Wikidata; Q54747182
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19520
AC   CVCL_2S31
DR   Coriell; AG19520
DR   Wikidata; Q54747184
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19521
AC   CVCL_2S32
DR   Coriell; AG19521
DR   Wikidata; Q54747188
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19522
AC   CVCL_2S33
DR   Coriell; AG19522
DR   Wikidata; Q54747189
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19523
AC   CVCL_2S34
DR   Coriell; AG19523
DR   Wikidata; Q54747191
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19524
AC   CVCL_2S35
DR   Coriell; AG19524
DR   Wikidata; Q54747194
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19525
AC   CVCL_2S36
DR   Coriell; AG19525
DR   Wikidata; Q54747195
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19526
AC   CVCL_2S37
DR   Coriell; AG19526
DR   Wikidata; Q54747197
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19527
AC   CVCL_0K72
DR   Coriell; AG19527
DR   Wikidata; Q54747199
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19528
AC   CVCL_0K73
DR   Coriell; AG19528
DR   Wikidata; Q54747201
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19529
AC   CVCL_2S38
DR   Coriell; AG19529
DR   Wikidata; Q54747203
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19530
AC   CVCL_2S39
DR   Coriell; AG19530
DR   Wikidata; Q54747204
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19532
AC   CVCL_2S40
DR   Coriell; AG19532
DR   Wikidata; Q54747206
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19533
AC   CVCL_2S41
DR   Coriell; AG19533
DR   Wikidata; Q54747208
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19534
AC   CVCL_2S42
DR   Coriell; AG19534
DR   Wikidata; Q54747210
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19535
AC   CVCL_2S43
DR   Coriell; AG19535
DR   Wikidata; Q54747213
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19536
AC   CVCL_2S44
DR   Coriell; AG19536
DR   Wikidata; Q54747214
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19538
AC   CVCL_2S45
DR   Coriell; AG19538
DR   Wikidata; Q54747218
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19539
AC   CVCL_2S46
DR   Coriell; AG19539
DR   Wikidata; Q54747219
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19540
AC   CVCL_2S47
DR   Coriell; AG19540
DR   Wikidata; Q54747221
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19541
AC   CVCL_0K74
DR   Coriell; AG19541
DR   Wikidata; Q54747223
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19544
AC   CVCL_0K75
DR   Coriell; AG19544
DR   Wikidata; Q54747226
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   105Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19575
AC   CVCL_0K76
DR   Coriell; AG19575
DR   Wikidata; Q54747228
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19576
AC   CVCL_0K77
DR   Coriell; AG19576
DR   Wikidata; Q54747318
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19577
AC   CVCL_0K78
DR   Coriell; AG19577
DR   Wikidata; Q54747320
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19578
AC   CVCL_0K79
DR   Coriell; AG19578
DR   Wikidata; Q54747321
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19579
AC   CVCL_2S48
DR   Coriell; AG19579
DR   Wikidata; Q54747322
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19580
AC   CVCL_2S49
DR   Coriell; AG19580
DR   Wikidata; Q54747324
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19581
AC   CVCL_2S50
DR   Coriell; AG19581
DR   Wikidata; Q54747326
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19582
AC   CVCL_2S51
DR   Coriell; AG19582
DR   Wikidata; Q54747328
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19583
AC   CVCL_2S52
DR   Coriell; AG19583
DR   Wikidata; Q54747329
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19584
AC   CVCL_2S53
DR   Coriell; AG19584
DR   Wikidata; Q54747331
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19585
AC   CVCL_2S54
DR   Coriell; AG19585
DR   Wikidata; Q54747332
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19586
AC   CVCL_2S55
DR   Coriell; AG19586
DR   Wikidata; Q54747334
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19587
AC   CVCL_2S56
DR   Coriell; AG19587
DR   Wikidata; Q54747337
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19588
AC   CVCL_2S57
DR   Coriell; AG19588
DR   Wikidata; Q54747338
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19589
AC   CVCL_2S58
DR   Coriell; AG19589
DR   Wikidata; Q54747339
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19590
AC   CVCL_2S59
DR   Coriell; AG19590
DR   Wikidata; Q54747343
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19591
AC   CVCL_0K80
DR   Coriell; AG19591
DR   Wikidata; Q54747346
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19592
AC   CVCL_0K81
DR   Coriell; AG19592
DR   Wikidata; Q54747348
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19594
AC   CVCL_0K82
DR   Coriell; AG19594
DR   Wikidata; Q54747350
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19595
AC   CVCL_0K83
DR   Coriell; AG19595
DR   Wikidata; Q54747353
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19596
AC   CVCL_0K84
DR   Coriell; AG19596
DR   Wikidata; Q54747354
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19597
AC   CVCL_0K85
DR   Coriell; AG19597
DR   Wikidata; Q54747356
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19598
AC   CVCL_0K86
DR   Coriell; AG19598
DR   Wikidata; Q54747358
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19599
AC   CVCL_0K87
DR   Coriell; AG19599
DR   Wikidata; Q54747362
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19600
AC   CVCL_0K88
DR   Coriell; AG19600
DR   Wikidata; Q54747364
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19601
AC   CVCL_2S60
DR   Coriell; AG19601
DR   Wikidata; Q54747366
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19602
AC   CVCL_2S61
DR   Coriell; AG19602
DR   Wikidata; Q54747368
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19603
AC   CVCL_2S62
DR   Coriell; AG19603
DR   Wikidata; Q54747370
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19604
AC   CVCL_2S63
DR   Coriell; AG19604
DR   Wikidata; Q54747371
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19605
AC   CVCL_2S64
DR   Coriell; AG19605
DR   Wikidata; Q54747373
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19606
AC   CVCL_2S65
DR   Coriell; AG19606
DR   Wikidata; Q54747376
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19607
AC   CVCL_2S66
DR   Coriell; AG19607
DR   Wikidata; Q54747377
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19608
AC   CVCL_2S67
DR   Coriell; AG19608
DR   Wikidata; Q54747379
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19609
AC   CVCL_2S68
DR   Coriell; AG19609
DR   Wikidata; Q54747381
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19610
AC   CVCL_2S69
DR   Coriell; AG19610
DR   Wikidata; Q54747383
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19611
AC   CVCL_0K89
DR   Coriell; AG19611
DR   Wikidata; Q54747384
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19612
AC   CVCL_0K90
DR   Coriell; AG19612
DR   Wikidata; Q54747386
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19613
AC   CVCL_2S70
DR   Coriell; AG19613
DR   Wikidata; Q54747389
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19614
AC   CVCL_2S71
DR   Coriell; AG19614
DR   Wikidata; Q54747392
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19615
AC   CVCL_2S72
DR   Coriell; AG19615
DR   Wikidata; Q54747393
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19616
AC   CVCL_2S73
DR   Coriell; AG19616
DR   Wikidata; Q54747394
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19617
AC   CVCL_2S74
DR   Coriell; AG19617
DR   Wikidata; Q54747492
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19618
AC   CVCL_2S75
DR   Coriell; AG19618
DR   Wikidata; Q54747495
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19619
AC   CVCL_2S76
DR   Coriell; AG19619
DR   Wikidata; Q54747496
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19620
AC   CVCL_2S77
DR   Coriell; AG19620
DR   Wikidata; Q54747498
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19621
AC   CVCL_2S78
DR   Coriell; AG19621
DR   Wikidata; Q54747500
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19622
AC   CVCL_2S79
DR   Coriell; AG19622
DR   Wikidata; Q54747501
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19623
AC   CVCL_2S80
DR   Coriell; AG19623
DR   Wikidata; Q54747504
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG19626
AC   CVCL_0K91
DR   Coriell; AG19626
DR   Wikidata; Q54747505
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19627
AC   CVCL_0K92
DR   Coriell; AG19627
DR   Wikidata; Q54747509
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19628
AC   CVCL_0K93
DR   Coriell; AG19628
DR   Wikidata; Q54747511
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19630
AC   CVCL_0K94
DR   Coriell; AG19630
DR   Wikidata; Q54747512
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19631
AC   CVCL_0K95
DR   Coriell; AG19631
DR   Wikidata; Q54747513
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19635
AC   CVCL_0K96
DR   Coriell; AG19635
DR   Wikidata; Q54747518
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19636
AC   CVCL_0K97
DR   Coriell; AG19636
DR   Wikidata; Q54747520
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19641
AC   CVCL_2Q72
DR   CLO; CLO_0011743
DR   Coriell; AG19641
DR   Wikidata; Q54747521
RX   PubMed=19046453;
CC   Population: African American.
CC   Doubling time: Slow growth (Coriell=AG19641).
CC   Derived from site: In situ; Ischium, skin; UBERON=UBERON_0001415.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Q73 ! AG19642
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG19642
AC   CVCL_2Q73
DR   CLO; CLO_0011742
DR   Coriell; AG19642
DR   Wikidata; Q54747524
RX   PubMed=19046453;
CC   Population: African American.
CC   Derived from site: In situ; Ischium, skin; UBERON=UBERON_0001415.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Q72 ! AG19641
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG19644
AC   CVCL_2Q74
DR   CLO; CLO_0011747
DR   Coriell; AG19644
DR   Wikidata; Q54747527
RX   PubMed=19046453;
CC   Population: African American.
CC   Derived from site: In situ; Ischium, skin; UBERON=UBERON_0001415.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG19820
AC   CVCL_HJ53
DR   Coriell; AG19820
DR   Wikidata; Q54747529
CC   Karyotypic information: 47,XX,+18 [2]; 46,XX [48] (Coriell=AG19820).
CC   Derived from site: In situ; Breast, adipose tissue; UBERON=UBERON_0000310+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG19910
AC   CVCL_U320
DR   CLO; CLO_0011748
DR   Coriell; AG19910
DR   Wikidata; Q54747531
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   AG19911
AC   CVCL_U283
DR   CLO; CLO_0011745
DR   Coriell; AG19911
DR   GEO; GSM1052416
DR   Wikidata; Q54747533
RX   PubMed=23257959;
CC   Population: Caucasian; Portuguese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   AG19912
AC   CVCL_U292
DR   CLO; CLO_0011746
DR   Coriell; AG19912
DR   Wikidata; Q54747536
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   AG19925
AC   CVCL_0K98
DR   Coriell; AG19925
DR   Wikidata; Q54747537
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19979
AC   CVCL_0K99
DR   Coriell; AG19979
DR   Wikidata; Q54747539
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19980
AC   CVCL_0L00
DR   Coriell; AG19980
DR   Wikidata; Q54747541
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19981
AC   CVCL_0L01
DR   Coriell; AG19981
DR   Wikidata; Q54747543
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19986
AC   CVCL_0L02
DR   Coriell; AG19986
DR   Wikidata; Q54747545
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19987
AC   CVCL_0L03
DR   Coriell; AG19987
DR   Wikidata; Q54747547
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19990
AC   CVCL_0L04
DR   Coriell; AG19990
DR   Wikidata; Q54747549
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19991
AC   CVCL_0L05
DR   Coriell; AG19991
DR   Wikidata; Q54747552
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19992
AC   CVCL_0L06
DR   Coriell; AG19992
DR   Wikidata; Q54747554
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19993
AC   CVCL_0L07
DR   Coriell; AG19993
DR   Wikidata; Q54747555
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19994
AC   CVCL_0L08
DR   Coriell; AG19994
DR   Wikidata; Q54747557
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG19998
AC   CVCL_0L09
DR   Coriell; AG19998
DR   Wikidata; Q54747561
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20003
AC   CVCL_0L10
DR   Coriell; AG20003
DR   Wikidata; Q54747563
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20006
AC   CVCL_0L11
DR   Coriell; AG20006
DR   Wikidata; Q54747566
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20014
AC   CVCL_0L12
DR   Coriell; AG20014
DR   Wikidata; Q54747567
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20023
AC   CVCL_0L13
DR   Coriell; AG20023
DR   Wikidata; Q54747571
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20025
AC   CVCL_0L14
DR   Coriell; AG20025
DR   Wikidata; Q54747573
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20028
AC   CVCL_0L15
DR   Coriell; AG20028
DR   Wikidata; Q54747576
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20029
AC   CVCL_0L16
DR   Coriell; AG20029
DR   Wikidata; Q54747577
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20030
AC   CVCL_0L17
DR   Coriell; AG20030
DR   Wikidata; Q54747664
CC   Part of: University of Georgia centenarian study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG20036
AC   CVCL_0L18
DR   Coriell; AG20036
DR   Wikidata; Q54747665
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20050
AC   CVCL_0L19
DR   Coriell; AG20050
DR   Wikidata; Q54747668
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20051
AC   CVCL_0L20
DR   Coriell; AG20051
DR   Wikidata; Q54747669
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   108Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20052
AC   CVCL_0L21
DR   Coriell; AG20052
DR   Wikidata; Q54747671
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20062
AC   CVCL_0L22
DR   Coriell; AG20062
DR   Wikidata; Q54747672
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20077
AC   CVCL_0L23
DR   Coriell; AG20077
DR   Wikidata; Q54747674
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20093
AC   CVCL_0L24
DR   Coriell; AG20093
DR   Wikidata; Q54747676
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20094
AC   CVCL_0L25
DR   Coriell; AG20094
DR   Wikidata; Q54747677
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20095
AC   CVCL_0L26
DR   Coriell; AG20095
DR   Wikidata; Q54747682
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20096
AC   CVCL_0L27
DR   Coriell; AG20096
DR   Wikidata; Q54747683
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20097
AC   CVCL_0L28
DR   Coriell; AG20097
DR   Wikidata; Q54747686
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20098
AC   CVCL_0L29
DR   Coriell; AG20098
DR   Wikidata; Q54747689
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   104Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20099
AC   CVCL_0L30
DR   Coriell; AG20099
DR   Wikidata; Q54747690
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20115
AC   CVCL_0L31
DR   Coriell; AG20115
DR   Wikidata; Q54747691
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20116
AC   CVCL_0L32
DR   Coriell; AG20116
DR   Wikidata; Q54747694
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20119
AC   CVCL_0L33
DR   Coriell; AG20119
DR   Wikidata; Q54747695
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20121
AC   CVCL_0L34
DR   Coriell; AG20121
DR   Wikidata; Q54747696
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20134
AC   CVCL_0L35
DR   Coriell; AG20134
DR   Wikidata; Q54747697
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   104Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20135
AC   CVCL_0L36
DR   Coriell; AG20135
DR   Wikidata; Q54747700
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20137
AC   CVCL_0L37
DR   Coriell; AG20137
DR   Wikidata; Q54747701
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20138
AC   CVCL_0L38
DR   Coriell; AG20138
DR   Wikidata; Q54747703
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20139
AC   CVCL_0L39
DR   Coriell; AG20139
DR   Wikidata; Q54747706
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20154
AC   CVCL_0L40
DR   Coriell; AG20154
DR   Wikidata; Q54747708
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20169
AC   CVCL_0L41
DR   Coriell; AG20169
DR   Wikidata; Q54747709
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20205
AC   CVCL_0L42
DR   Coriell; AG20205
DR   Wikidata; Q54747710
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20211
AC   CVCL_0L43
DR   Coriell; AG20211
DR   Wikidata; Q54747712
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20221
AC   CVCL_0L44
DR   Coriell; AG20221
DR   Wikidata; Q54747714
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20224
AC   CVCL_0L45
DR   Coriell; AG20224
DR   Wikidata; Q54747717
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20227
AC   CVCL_0L46
DR   Coriell; AG20227
DR   Wikidata; Q54747718
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20228
AC   CVCL_0L47
DR   Coriell; AG20228
DR   Wikidata; Q54747720
CC   Part of: University of Georgia centenarian study.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20229
AC   CVCL_0L48
DR   Coriell; AG20229
DR   Wikidata; Q54747722
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20257
AC   CVCL_0L49
DR   Coriell; AG20257
DR   Wikidata; Q54747723
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20262
AC   CVCL_0L50
DR   Coriell; AG20262
DR   Wikidata; Q54747724
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20308
AC   CVCL_0L51
DR   Coriell; AG20308
DR   Wikidata; Q54747726
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20323
AC   CVCL_0L52
DR   Coriell; AG20323
DR   Wikidata; Q54747728
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20353
AC   CVCL_0L53
DR   Coriell; AG20353
DR   Wikidata; Q54747730
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20354
AC   CVCL_0L54
DR   Coriell; AG20354
DR   Wikidata; Q54747732
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20367
AC   CVCL_2Q32
SY   ASC-7
DR   CLO; CLO_0011750
DR   Coriell; AG20367
DR   Wikidata; Q54747734
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Thigh, adipose tissue; UBERON=UBERON_0000376+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG20368
AC   CVCL_2Q33
SY   ASC-9
DR   CLO; CLO_0011751
DR   Coriell; AG20368
DR   Wikidata; Q54747736
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Abdomen, adipose tissue; UBERON=UBERON_0014455.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG20369
AC   CVCL_2Q34
SY   ASC-12
DR   CLO; CLO_0011749
DR   Coriell; AG20369
DR   Wikidata; Q54747825
RX   CelloPub=CLPUB00809;
CC   Senescence: Senesces at 16 PDL (Coriell=AG20369).
CC   Discontinued: Coriell; AG20369; probable.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 12
//
ID   AG20370
AC   CVCL_0L55
DR   Coriell; AG20370
DR   Wikidata; Q54747827
CC   Part of: University of Georgia centenarian study.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AG20405
AC   CVCL_4P99
DR   Coriell; AG20405
DR   Wikidata; Q54747828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20420
AC   CVCL_4Q00
DR   Coriell; AG20420
DR   Wikidata; Q54747830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20422
AC   CVCL_2L49
DR   CLO; CLO_0011753
DR   Coriell; AG20422
DR   Wikidata; Q54747832
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20423
AC   CVCL_2L50
DR   CLO; CLO_0011752
DR   Coriell; AG20423
DR   Wikidata; Q54747833
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20424
AC   CVCL_2L51
DR   CLO; CLO_0011755
DR   Coriell; AG20424
DR   Wikidata; Q54747836
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20425
AC   CVCL_2L52
DR   CLO; CLO_0011754
DR   Coriell; AG20425
DR   Wikidata; Q54747839
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20426
AC   CVCL_2L53
DR   CLO; CLO_0011756
DR   Coriell; AG20426
DR   Wikidata; Q54747840
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Population: Caucasian; Dutch/French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2L05 ! AG16915
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AG20427
AC   CVCL_2L54
DR   CLO; CLO_0011757
DR   Coriell; AG20427
DR   Wikidata; Q54747844
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20428
AC   CVCL_2L55
DR   CLO; CLO_0011758
DR   Coriell; AG20428
DR   Wikidata; Q54747845
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2K85 ! AG16893
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20429
AC   CVCL_2L56
DR   CLO; CLO_0011759
DR   Coriell; AG20429
DR   Wikidata; Q54747847
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2K67 ! AG16730
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20430
AC   CVCL_2L57
DR   CLO; CLO_0011760
DR   Coriell; AG20430
DR   Wikidata; Q54747848
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20439
AC   CVCL_X803
DR   CLO; CLO_0011761
DR   Coriell; AG20439
DR   Wikidata; Q54747851
CC   Discontinued: Coriell; AG20439; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X804 ! AG20440
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 9
//
ID   AG20440
AC   CVCL_X804
DR   CLO; CLO_0011087
DR   Coriell; AG20440
DR   Wikidata; Q54747853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X803 ! AG20439
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 10
//
ID   AG20441
AC   CVCL_X805
DR   CLO; CLO_0011088
DR   Coriell; AG20441
DR   Wikidata; Q54747855
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 11
//
ID   AG20442
AC   CVCL_X806
DR   CLO; CLO_0011090
DR   Coriell; AG20442
DR   Wikidata; Q54747857
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X805 ! AG20441
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 10
//
ID   AG20443
AC   CVCL_N797
SY   PF43
DR   CLO; CLO_0011092
DR   Coriell; AG20443
DR   ENCODE; ENCBS289AAA
DR   GEO; GSM1008561
DR   Wikidata; Q54747858
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/FibroP_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N798 ! AG20444
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   AG20444
AC   CVCL_N798
DR   CLO; CLO_0011095
DR   Coriell; AG20444
DR   Wikidata; Q54747859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N797 ! AG20443
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   AG20445
AC   CVCL_X807
DR   CLO; CLO_0011100
DR   Coriell; AG20445
DR   Wikidata; Q54747862
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 9
//
ID   AG20446
AC   CVCL_L781
DR   CLO; CLO_0011099
DR   Coriell; AG20446
DR   Wikidata; Q54747863
RX   PubMed=18691744;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L782 ! AG20447
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   AG20447
AC   CVCL_L782
DR   CLO; CLO_0011102
DR   Coriell; AG20447
DR   Wikidata; Q54747866
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L781 ! AG20446
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   AG20449
AC   CVCL_2L58
DR   CLO; CLO_0011101
DR   Coriell; AG20449
DR   Wikidata; Q54747869
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20450
AC   CVCL_2L59
DR   CLO; CLO_0011103
DR   Coriell; AG20450
DR   Wikidata; Q54747870
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20452
AC   CVCL_2L60
DR   CLO; CLO_0011064
DR   Coriell; AG20452
DR   Wikidata; Q54747872
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20453
AC   CVCL_2L61
DR   CLO; CLO_0011065
DR   Coriell; AG20453
DR   Wikidata; Q54747874
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20454
AC   CVCL_2L62
DR   CLO; CLO_0011074
DR   Coriell; AG20454
DR   Wikidata; Q54747876
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20455
AC   CVCL_2L63
DR   CLO; CLO_0011076
DR   Coriell; AG20455
DR   Wikidata; Q54747878
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20456
AC   CVCL_0P10
DR   Coriell; AG20456
DR   Wikidata; Q54747880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AG20457
AC   CVCL_1M95
DR   Coriell; AG20457
DR   Wikidata; Q54747882
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X802 ! AG16504
OI   CVCL_1M96 ! AG22339
OI   CVCL_7310 ! GM00967
OI   CVCL_7316 ! GM01310
OI   CVCL_7531 ! GM13335
OI   CVCL_7532 ! GM13336
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG20464
AC   CVCL_4Q01
DR   Coriell; AG20464
DR   Wikidata; Q54747885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20465
AC   CVCL_4Q02
DR   Coriell; AG20465
DR   Wikidata; Q54747887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20468
AC   CVCL_HJ54
DR   Coriell; AG20468
DR   Wikidata; Q54747889
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG20469
AC   CVCL_HJ55
DR   Coriell; AG20469
DR   Wikidata; Q54747891
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG20470
AC   CVCL_2Q35
SY   ASC-22
DR   CLO; CLO_0011070
DR   Coriell; AG20470
DR   Wikidata; Q54747894
RX   CelloPub=CLPUB00809;
CC   Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG20471
AC   CVCL_2Q36
SY   ASC-23
DR   CLO; CLO_0011072
DR   Coriell; AG20471
DR   Wikidata; Q54747895
RX   CelloPub=CLPUB00809;
RX   PubMed=24092797;
CC   Derived from site: In situ; Abdomen, skin, adipose tissue; UBERON=UBERON_0001416+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Somatic stem cell
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 9
//
ID   AG20472
AC   CVCL_HJ56
DR   Coriell; AG20472
DR   Wikidata; Q54747898
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG20473
AC   CVCL_4Q03
DR   Coriell; AG20473
DR   Wikidata; Q54747900
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 9
//
ID   AG20487
AC   CVCL_4Q04
DR   Coriell; AG20487
DR   Wikidata; Q54747902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20497
AC   CVCL_4Q05
DR   Coriell; AG20497
DR   Wikidata; Q54747903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20499
AC   CVCL_4Q06
DR   Coriell; AG20499
DR   Wikidata; Q54748003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20500
AC   CVCL_4Q07
DR   Coriell; AG20500
DR   Wikidata; Q54748004
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20578
AC   CVCL_4Q08
DR   Coriell; AG20578
DR   Wikidata; Q54748005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20579
AC   CVCL_4Q09
DR   Coriell; AG20579
DR   Wikidata; Q54748008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20583
AC   CVCL_4Q10
DR   Coriell; AG20583
DR   Wikidata; Q54748009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20584
AC   CVCL_4Q11
DR   Coriell; AG20584
DR   Wikidata; Q54748013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20600
AC   CVCL_V974
DR   Coriell; AG20600
DR   Wikidata; Q54748015
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG20600; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AG20605
AC   CVCL_4Q12
DR   Coriell; AG20605
DR   Wikidata; Q54748018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20606
AC   CVCL_2L64
DR   CLO; CLO_0011082
DR   Coriell; AG20606
DR   Wikidata; Q54748020
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: This is currently the human cell line originating from the oldest donor (114 year old).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   114Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 11
//
ID   AG20607
AC   CVCL_2L65
DR   CLO; CLO_0011081
DR   Coriell; AG20607
DR   Wikidata; Q54748021
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20608
AC   CVCL_2L66
DR   CLO; CLO_0011080
DR   Coriell; AG20608
DR   Wikidata; Q54748024
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20609
AC   CVCL_2L67
DR   CLO; CLO_0011079
DR   Coriell; AG20609
DR   Wikidata; Q54748025
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20610
AC   CVCL_2L68
DR   CLO; CLO_0011281
DR   Coriell; AG20610
DR   Wikidata; Q54748028
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20618
AC   CVCL_2L69
DR   CLO; CLO_0011282
DR   Coriell; AG20618
DR   Wikidata; Q54748029
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20619
AC   CVCL_2L70
DR   CLO; CLO_0011283
DR   Coriell; AG20619
DR   Wikidata; Q54748031
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20620
AC   CVCL_2L71
DR   CLO; CLO_0011284
DR   Coriell; AG20620
DR   Wikidata; Q54748033
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20621
AC   CVCL_2L72
DR   CLO; CLO_0011285
DR   Coriell; AG20621
DR   Wikidata; Q54748035
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20623
AC   CVCL_2L73
DR   CLO; CLO_0011286
DR   Coriell; AG20623
DR   Wikidata; Q54748036
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20625
AC   CVCL_2L74
DR   CLO; CLO_0011287
DR   Coriell; AG20625
DR   Wikidata; Q54748037
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20626
AC   CVCL_2L75
DR   Coriell; AG20626
DR   Wikidata; Q54748039
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20627
AC   CVCL_2L76
DR   CLO; CLO_0011288
DR   Coriell; AG20627
DR   Wikidata; Q54748041
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   105Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20628
AC   CVCL_2L77
DR   CLO; CLO_0011289
DR   Coriell; AG20628
DR   Wikidata; Q54748043
CC   Part of: National Institute on Aging (NIA) longevity collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG20629
AC   CVCL_4Q13
DR   Coriell; AG20629
DR   Wikidata; Q54748045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20698
AC   CVCL_4Q14
DR   Coriell; AG20698
DR   Wikidata; Q54748046
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20699
AC   CVCL_4Q15
DR   Coriell; AG20699
DR   Wikidata; Q54748047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20716
AC   CVCL_HJ51
DR   Coriell; AG20716
DR   Wikidata; Q54748050
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Bairdii, stock BW.
OX   NCBI_TaxID=10042; ! Peromyscus maniculatus (North American deer mouse)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 10
//
ID   AG20725
AC   CVCL_2Q75
DR   Coriell; AG20725
DR   Wikidata; Q54748053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   97Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20727
AC   CVCL_4Q16
DR   Coriell; AG20727
DR   Wikidata; Q54748054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20728
AC   CVCL_4Q17
DR   Coriell; AG20728
DR   Wikidata; Q54748058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20749
AC   CVCL_4Q18
DR   Coriell; AG20749
DR   Wikidata; Q54748060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20788
AC   CVCL_HJ57
DR   Coriell; AG20788
DR   Wikidata; Q54748062
CC   Derived from site: In situ; Arm, adipose tissue; UBERON=UBERON_0001460+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG20789
AC   CVCL_4Q19
DR   Coriell; AG20789
DR   Wikidata; Q54748064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20840
AC   CVCL_4Q20
DR   Coriell; AG20840
DR   Wikidata; Q54748067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20843
AC   CVCL_4Q21
DR   Coriell; AG20843
DR   Wikidata; Q54748069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20931
AC   CVCL_4Q22
DR   Coriell; AG20931
DR   Wikidata; Q54748072
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20934
AC   CVCL_4Q23
DR   Coriell; AG20934
DR   Wikidata; Q54748074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20939
AC   CVCL_4Q24
DR   Coriell; AG20939
DR   Wikidata; Q54748075
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20940
AC   CVCL_4Q25
DR   Coriell; AG20940
DR   Wikidata; Q54748077
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20962
AC   CVCL_4Q26
DR   Coriell; AG20962
DR   Wikidata; Q54748079
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG20963
AC   CVCL_4Q27
DR   Coriell; AG20963
DR   Wikidata; Q54748081
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG21151
AC   CVCL_4Q28
DR   Coriell; AG21151
DR   Wikidata; Q54748129
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG21152
AC   CVCL_HJ58
DR   Coriell; AG21152
DR   Wikidata; Q54748132
CC   Derived from site: In situ; Thigh, skin, adipose tissue; UBERON=UBERON_0004262+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AG21156
AC   CVCL_2Y79
DR   CLO; CLO_0011290
DR   Coriell; AG21156
DR   Wikidata; Q54748133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG21157
AC   CVCL_2Y80
DR   CLO; CLO_0011291
DR   Coriell; AG21157
DR   Wikidata; Q54748136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG21158
AC   CVCL_2Y81
DR   CLO; CLO_0011294
DR   Coriell; AG21158
DR   Wikidata; Q54748137
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Heterozygous; Note=ApoE2 allele (Coriell=AG21158).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y82 ! AG21159
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   AG21159
AC   CVCL_2Y82
DR   CLO; CLO_0011295
DR   Coriell; AG21159
DR   Wikidata; Q54748138
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Heterozygous; Note=ApoE2 allele (Coriell=AG21159).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y81 ! AG21158
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   AG21193
AC   CVCL_EF57
DR   Coriell; AG21193
DR   Wikidata; Q54748142
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ64 ! AG21196
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21196
AC   CVCL_HJ64
DR   Coriell; AG21196
DR   Wikidata; Q54748144
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF57 ! AG21193
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21197
AC   CVCL_EF58
DR   Coriell; AG21197
DR   Wikidata; Q54748145
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ65 ! AG21200
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21200
AC   CVCL_HJ65
DR   Coriell; AG21200
DR   Wikidata; Q54748147
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF58 ! AG21197
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21201
AC   CVCL_EF59
DR   Coriell; AG21201
DR   Wikidata; Q54748150
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ66 ! AG21204
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21204
AC   CVCL_HJ66
DR   Coriell; AG21204
DR   Wikidata; Q54748151
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF59 ! AG21201
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21205
AC   CVCL_EF60
DR   Coriell; AG21205
DR   Wikidata; Q54748152
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ67 ! AG21208
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21208
AC   CVCL_HJ67
DR   Coriell; AG21208
DR   Wikidata; Q54748155
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF60 ! AG21205
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21209
AC   CVCL_EF61
DR   Coriell; AG21209
DR   Wikidata; Q54748157
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ68 ! AG21212
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21212
AC   CVCL_HJ68
DR   Coriell; AG21212
DR   Wikidata; Q54748158
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF61 ! AG21209
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21222
AC   CVCL_4Q29
DR   Coriell; AG21222
DR   Wikidata; Q54748159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG21229
AC   CVCL_EF62
DR   Coriell; AG21229
DR   Wikidata; Q54748162
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ69 ! AG21232
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21232
AC   CVCL_HJ69
DR   Coriell; AG21232
DR   Wikidata; Q54748164
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF62 ! AG21229
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21233
AC   CVCL_EF63
DR   Coriell; AG21233
DR   Wikidata; Q54748166
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ70 ! AG21236
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21236
AC   CVCL_HJ70
DR   Coriell; AG21236
DR   Wikidata; Q54748167
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF63 ! AG21233
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21237
AC   CVCL_EF64
DR   Coriell; AG21237
DR   Wikidata; Q54748169
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ71 ! AG21240
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21240
AC   CVCL_HJ71
DR   Coriell; AG21240
DR   Wikidata; Q54748171
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF64 ! AG21237
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21241
AC   CVCL_EF65
DR   Coriell; AG21241
DR   Wikidata; Q54748173
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ72 ! AG21244
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21244
AC   CVCL_HJ72
DR   Coriell; AG21244
DR   Wikidata; Q54748175
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF65 ! AG21241
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21245
AC   CVCL_EF66
DR   Coriell; AG21245
DR   Wikidata; Q54748177
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   AG21264
AC   CVCL_EF67
DR   Coriell; AG21264
DR   Wikidata; Q54748179
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   AG21268
AC   CVCL_EF68
DR   Coriell; AG21268
DR   Wikidata; Q54748181
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_HJ73 ! AG21271
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   AG21271
AC   CVCL_HJ73
DR   Coriell; AG21271
DR   Wikidata; Q54748183
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_EF68 ! AG21268
SX   Male
AG   4M
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   AG21272
AC   CVCL_EF69
DR   Coriell; AG21272
DR   Wikidata; Q54748186
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   AG21276
AC   CVCL_EF70
DR   Coriell; AG21276
DR   Wikidata; Q54748187
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   AG21280
AC   CVCL_EF71
DR   Coriell; AG21280
DR   Wikidata; Q54748188
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   AG21329
AC   CVCL_2Q56
DR   Coriell; AG21329
DR   Wikidata; Q54748191
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG21704
AC   CVCL_2Y37
DR   Coriell; AG21704
DR   Wikidata; Q54748193
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG21706
AC   CVCL_H767
DR   Coriell; AG21706
DR   Wikidata; Q54748196
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H768 ! AG21707
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   AG21707
AC   CVCL_H768
DR   Coriell; AG21707
DR   Wikidata; Q54748198
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H767 ! AG21706
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   AG21708
AC   CVCL_2Y38
DR   Coriell; AG21708
DR   Wikidata; Q54748201
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG21712
AC   CVCL_2Y39
DR   Coriell; AG21712
DR   Wikidata; Q54748202
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG21753
AC   CVCL_2Y40
DR   Coriell; AG21753
DR   Wikidata; Q54748204
RX   PubMed=28855503;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y69 ! AG22172
OI   CVCL_2Y70 ! AG22173
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG21754
AC   CVCL_2Y41
DR   Coriell; AG21754
DR   Wikidata; Q54748206
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y71 ! AG22174
OI   CVCL_2Y72 ! AG22175
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG21765
AC   CVCL_LK50
DR   Coriell; AG21765
DR   Wikidata; Q54748252
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; AG21765; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   AG21801
AC   CVCL_2Y42
DR   Coriell; AG21801
DR   Wikidata; Q54748255
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y43 ! AG21802
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21802
AC   CVCL_2Y43
DR   Coriell; AG21802
DR   Wikidata; Q54748257
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y42 ! AG21801
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21803
AC   CVCL_2Y44
DR   Coriell; AG21803
DR   Wikidata; Q54748259
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y45 ! AG21804
OI   CVCL_2Y46 ! AG21805
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG21804
AC   CVCL_2Y45
DR   Coriell; AG21804
DR   Wikidata; Q54748261
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y44 ! AG21803
OI   CVCL_2Y46 ! AG21805
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21805
AC   CVCL_2Y46
DR   Coriell; AG21805
DR   Wikidata; Q54748263
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y44 ! AG21803
OI   CVCL_2Y45 ! AG21804
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21820
AC   CVCL_2Q76
DR   Coriell; AG21820
DR   Wikidata; Q54748265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG21821
AC   CVCL_2Y47
DR   Coriell; AG21821
DR   Wikidata; Q54748266
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y48 ! AG21822
OI   CVCL_2Y49 ! AG21823
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG21822
AC   CVCL_2Y48
DR   Coriell; AG21822
DR   Wikidata; Q54748267
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y47 ! AG21821
OI   CVCL_2Y49 ! AG21823
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21823
AC   CVCL_2Y49
DR   Coriell; AG21823
DR   Wikidata; Q54748269
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y47 ! AG21821
OI   CVCL_2Y48 ! AG21822
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21834
AC   CVCL_2Y50
DR   Coriell; AG21834
DR   Wikidata; Q54748270
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG21837
AC   CVCL_H769
DR   Coriell; AG21837
DR   Wikidata; Q54748271
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H770 ! AG21838
OI   CVCL_H771 ! AG21839
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   AG21838
AC   CVCL_H770
DR   Coriell; AG21838
DR   Wikidata; Q54748272
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H769 ! AG21837
OI   CVCL_H771 ! AG21839
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   AG21839
AC   CVCL_H771
DR   Coriell; AG21839
DR   Wikidata; Q54748274
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H769 ! AG21837
OI   CVCL_H770 ! AG21838
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   AG21840
AC   CVCL_2Y51
DR   Coriell; AG21840
DR   Wikidata; Q54748275
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y52 ! AG21841
OI   CVCL_2Y53 ! AG21842
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG21841
AC   CVCL_2Y52
DR   Coriell; AG21841
DR   Wikidata; Q54748278
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y51 ! AG21840
OI   CVCL_2Y53 ! AG21842
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21842
AC   CVCL_2Y53
DR   Coriell; AG21842
DR   Wikidata; Q54748279
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y51 ! AG21840
OI   CVCL_2Y52 ! AG21841
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21857
AC   CVCL_2Y54
DR   Coriell; AG21857
DR   Wikidata; Q54748281
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y55 ! AG21858
OI   CVCL_2Y56 ! AG21859
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21858
AC   CVCL_2Y55
DR   Coriell; AG21858
DR   Wikidata; Q54748285
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y54 ! AG21857
OI   CVCL_2Y56 ! AG21859
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG21859
AC   CVCL_2Y56
DR   Coriell; AG21859
DR   Wikidata; Q54748286
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y54 ! AG21857
OI   CVCL_2Y55 ! AG21858
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21860
AC   CVCL_2Y57
DR   Coriell; AG21860
DR   Wikidata; Q54748289
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y58 ! AG21861
OI   CVCL_2Y59 ! AG21862
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG21861
AC   CVCL_2Y58
DR   Coriell; AG21861
DR   Wikidata; Q54748290
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y57 ! AG21860
OI   CVCL_2Y59 ! AG21862
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG21862
AC   CVCL_2Y59
DR   Coriell; AG21862
DR   Wikidata; Q54748292
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y57 ! AG21860
OI   CVCL_2Y58 ! AG21861
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22007
AC   CVCL_2Y60
DR   Coriell; AG22007
DR   Wikidata; Q54748294
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y61 ! AG22008
OI   CVCL_2Y62 ! AG22009
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22008
AC   CVCL_2Y61
DR   Coriell; AG22008
DR   Wikidata; Q54748295
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y60 ! AG22007
OI   CVCL_2Y62 ! AG22009
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG22009
AC   CVCL_2Y62
DR   Coriell; AG22009
DR   Wikidata; Q54748297
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y60 ! AG22007
OI   CVCL_2Y61 ! AG22008
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22042
AC   CVCL_2Y63
DR   Coriell; AG22042
DR   Wikidata; Q54748299
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y65 ! AG22054
OI   CVCL_2Y66 ! AG22055
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG22050
AC   CVCL_2Y64
DR   Coriell; AG22050
DR   Wikidata; Q54748301
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y67 ! AG22056
OI   CVCL_2Y68 ! AG22057
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG22054
AC   CVCL_2Y65
DR   Coriell; AG22054
DR   Wikidata; Q54748303
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y63 ! AG22042
OI   CVCL_2Y66 ! AG22055
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22055
AC   CVCL_2Y66
DR   Coriell; AG22055
DR   Wikidata; Q54748304
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y63 ! AG22042
OI   CVCL_2Y65 ! AG22054
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22056
AC   CVCL_2Y67
DR   Coriell; AG22056
DR   Wikidata; Q54748305
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y64 ! AG22050
OI   CVCL_2Y68 ! AG22057
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22057
AC   CVCL_2Y68
DR   Coriell; AG22057
DR   Wikidata; Q54748306
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y64 ! AG22050
OI   CVCL_2Y67 ! AG22056
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22097
AC   CVCL_4Q30
DR   Coriell; AG22097
DR   Wikidata; Q54748307
RX   PubMed=19046453;
CC   Population: African American.
CC   Donor information: Donor was bedbound with bilateral ischial ulcers and multiple sclerosis.
CC   Derived from site: In situ; Ischium, skin; Note=From a right ischial pressure ulcer; UBERON=UBERON_0001415.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG22105
AC   CVCL_4Q31
DR   Coriell; AG22105
DR   Wikidata; Q54748308
RX   PubMed=19046453;
CC   Derived from site: In situ; Foot, skin; UBERON=UBERON_0001513.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22107
AC   CVCL_4Q32
DR   Coriell; AG22107
DR   Wikidata; Q54748309
RX   PubMed=19046453;
CC   Population: African American.
CC   Donor information: Donor has history of diabetes mellitus; chronic renal failure; neurogenic bladder; fourniers gangrene and multiple ulcers.
CC   Derived from site: In situ; Ischium, skin; Note=From a right ischial pressure wound; UBERON=UBERON_0001415.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22117
AC   CVCL_1M86
DR   Coriell; AG22117
DR   Wikidata; Q54748310
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M87 ! AG22118
OI   CVCL_1M88 ! AG22119
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22118
AC   CVCL_1M87
DR   Coriell; AG22118
DR   Wikidata; Q54748314
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M86 ! AG22117
OI   CVCL_1M88 ! AG22119
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22119
AC   CVCL_1M88
DR   Coriell; AG22119
DR   Wikidata; Q54748316
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M86 ! AG22117
OI   CVCL_1M87 ! AG22118
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22139
AC   CVCL_4Q33
DR   Coriell; AG22139
DR   Wikidata; Q54748319
RX   PubMed=19046453;
CC   Population: Caucasian.
CC   Derived from site: In situ; Buttock, skin; Note=From an ulcer; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Q34 ! AG22140
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG22140
AC   CVCL_4Q34
DR   Coriell; AG22140
DR   Wikidata; Q54748320
RX   PubMed=19046453;
CC   Population: Caucasian.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Q33 ! AG22139
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG22144
AC   CVCL_1M89
DR   Coriell; AG22144
DR   Wikidata; Q54748417
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M90 ! AG22145
OI   CVCL_1M91 ! AG22146
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22145
AC   CVCL_1M90
DR   Coriell; AG22145
DR   Wikidata; Q54748420
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M89 ! AG22144
OI   CVCL_1M91 ! AG22146
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22146
AC   CVCL_1M91
DR   Coriell; AG22146
DR   Wikidata; Q54748421
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M89 ! AG22144
OI   CVCL_1M90 ! AG22145
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22151
AC   CVCL_H772
DR   Coriell; AG22151
DR   Wikidata; Q54748424
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H773 ! AG22152
OI   CVCL_H774 ! AG22153
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   AG22152
AC   CVCL_H773
DR   Coriell; AG22152
DR   Wikidata; Q54748426
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H772 ! AG22151
OI   CVCL_H774 ! AG22153
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   AG22153
AC   CVCL_H774
DR   Coriell; AG22153
DR   Wikidata; Q54748428
RX   PubMed=28855503;
RX   PubMed=35628639;
CC   Senescence: Senesces at the 18th passage (PubMed=35628639).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H772 ! AG22151
OI   CVCL_H773 ! AG22152
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   AG22160
AC   CVCL_4Q35
DR   Coriell; AG22160
DR   Wikidata; Q54748430
RX   PubMed=19046453;
CC   Derived from site: In situ; Toe, skin; UBERON=UBERON_0003530.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF53 ! AG22161
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22161
AC   CVCL_EF53
DR   Coriell; AG22161
DR   Wikidata; Q54748431
RX   PubMed=19046453;
CC   Derived from site: In situ; Toe, skin; Note=From an ulcer; UBERON=UBERON_0003530.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Q35 ! AG22160
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   AG22172
AC   CVCL_2Y69
DR   Coriell; AG22172
DR   Wikidata; Q54748434
CC   Discontinued: Coriell; AG22172; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y40 ! AG21753
OI   CVCL_2Y70 ! AG22173
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG22173
AC   CVCL_2Y70
DR   Coriell; AG22173
DR   Wikidata; Q54748435
CC   Discontinued: Coriell; AG22173; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y40 ! AG21753
OI   CVCL_2Y69 ! AG22172
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG22174
AC   CVCL_2Y71
DR   Coriell; AG22174
DR   Wikidata; Q54748438
CC   Discontinued: Coriell; AG22174; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y41 ! AG21754
OI   CVCL_2Y72 ! AG22175
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG22175
AC   CVCL_2Y72
DR   Coriell; AG22175
DR   Wikidata; Q54748439
CC   Discontinued: Coriell; AG22175; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y41 ! AG21754
OI   CVCL_2Y71 ! AG22174
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AG22177
AC   CVCL_2Q77
DR   Coriell; AG22177
DR   Wikidata; Q54748442
RX   PubMed=19046453;
CC   Population: African American.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AG22282
AC   CVCL_1M92
DR   Coriell; AG22282
DR   Wikidata; Q54748444
CC   Population: Asian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M93 ! AG22283
OI   CVCL_1M94 ! AG22284
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22283
AC   CVCL_1M93
DR   Coriell; AG22283
DR   Wikidata; Q54748446
CC   Population: Asian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M92 ! AG22282
OI   CVCL_1M94 ! AG22284
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22284
AC   CVCL_1M94
DR   Coriell; AG22284
DR   Wikidata; Q54748449
CC   Population: Asian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1M92 ! AG22282
OI   CVCL_1M93 ! AG22283
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   AG22292
AC   CVCL_HJ63
DR   Coriell; AG22292
DR   Wikidata; Q54748452
CC   Senescence: Senesces at 14 PDL (Coriell=AG22292).
CC   Derived from site: In situ; Omentum, adipose tissue; UBERON=UBERON_0010414.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5W
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   AG22339
AC   CVCL_1M96
DR   Coriell; AG22339
DR   Wikidata; Q54748454
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X802 ! AG16504
OI   CVCL_1M95 ! AG20457
OI   CVCL_7310 ! GM00967
OI   CVCL_7316 ! GM01310
OI   CVCL_7531 ! GM13335
OI   CVCL_7532 ! GM13336
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AG22341
AC   CVCL_EF72
DR   Coriell; AG22341
DR   Wikidata; Q54748455
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Insignis, stock IS.
OX   NCBI_TaxID=42520; ! Peromyscus californicus (California mouse)
OI   CVCL_EF73 ! AG22342
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   AG22342
AC   CVCL_EF73
DR   Coriell; AG22342
DR   Wikidata; Q54748457
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Insignis, stock IS.
OX   NCBI_TaxID=42520; ! Peromyscus californicus (California mouse)
OI   CVCL_EF72 ! AG22341
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   AG22348
AC   CVCL_EF74
DR   Coriell; AG22348
DR   Wikidata; Q54748459
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Subgriseus, stock PO.
OX   NCBI_TaxID=42413; ! Peromyscus polionotus (Oldfield mouse)
OI   CVCL_HJ49 ! AG22349
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   AG22349
AC   CVCL_HJ49
DR   Coriell; AG22349
DR   Wikidata; Q54748460
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Subgriseus, stock PO.
OX   NCBI_TaxID=42413; ! Peromyscus polionotus (Oldfield mouse)
OI   CVCL_EF74 ! AG22348
SX   Female
AG   4M
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 9
//
ID   AG22353
AC   CVCL_EF75
DR   Coriell; AG22353
DR   Wikidata; Q54748461
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Stock LL.
OX   NCBI_TaxID=10041; ! Peromyscus leucopus (White-footed mouse)
OI   CVCL_EF76 ! AG22354
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   AG22354
AC   CVCL_EF76
DR   Coriell; AG22354
DR   Wikidata; Q54748465
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Stock LL.
OX   NCBI_TaxID=10041; ! Peromyscus leucopus (White-footed mouse)
OI   CVCL_EF75 ! AG22353
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   AG22359
AC   CVCL_EF77
DR   Coriell; AG22359
DR   Wikidata; Q54748466
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Bairdii, stock BW.
OX   NCBI_TaxID=10042; ! Peromyscus maniculatus (North American deer mouse)
OI   CVCL_HJ50 ! AG22362
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   AG22362
AC   CVCL_HJ50
DR   Coriell; AG22362
DR   Wikidata; Q54748467
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Bairdii, stock BW.
OX   NCBI_TaxID=10042; ! Peromyscus maniculatus (North American deer mouse)
OI   CVCL_EF77 ! AG22359
SX   Female
AG   5M
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 9
//
ID   AG22584
AC   CVCL_2Y73
DR   Coriell; AG22584
DR   Wikidata; Q54748470
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y74 ! AG22586
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22586
AC   CVCL_2Y74
DR   Coriell; AG22586
DR   Wikidata; Q54748471
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y73 ! AG22584
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22615
AC   CVCL_EF78
DR   Coriell; AG22615
DR   Wikidata; Q54748472
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Stock LL.
OX   NCBI_TaxID=10041; ! Peromyscus leucopus (White-footed mouse)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   AG22618
AC   CVCL_EF79
DR   Coriell; AG22618
DR   Wikidata; Q54748475
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Bairdii, stock BW.
OX   NCBI_TaxID=10042; ! Peromyscus maniculatus (North American deer mouse)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   AG22619
AC   CVCL_EF80
DR   Coriell; AG22619
DR   Wikidata; Q54748476
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Bairdii, stock BW.
OX   NCBI_TaxID=10042; ! Peromyscus maniculatus (North American deer mouse)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   AG22620
AC   CVCL_EF81
DR   Coriell; AG22620
DR   Wikidata; Q54748478
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Insignis, stock IS.
OX   NCBI_TaxID=42520; ! Peromyscus californicus (California mouse)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   AG22621
AC   CVCL_EF82
DR   Coriell; AG22621
DR   Wikidata; Q54748481
CC   From: Peromyscus Genetic Stock Center, University of South Carolina; Columbia; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Insignis, stock IS.
OX   NCBI_TaxID=42520; ! Peromyscus californicus (California mouse)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   AG22716
AC   CVCL_2Y75
DR   Coriell; AG22716
DR   Wikidata; Q54748482
CC   Senescence: Senesces at 28 PDL (Coriell=AG22716).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y76 ! AG22717
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG22717
AC   CVCL_2Y76
DR   Coriell; AG22717
DR   Wikidata; Q54748484
CC   Senescence: Senesces at 27 PDL (Coriell=AG22717).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y75 ! AG22716
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG22719
AC   CVCL_H775
DR   Coriell; AG22719
DR   Wikidata; Q54748485
CC   Senescence: Senesces at 25 PDL (Coriell=AG22719).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H776 ! AG22720
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   AG22720
AC   CVCL_H776
DR   Coriell; AG22720
DR   Wikidata; Q54748486
CC   Senescence: Senesces at 29 PDL (Coriell=AG22720).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H775 ! AG22719
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   AG22723
AC   CVCL_2Y77
DR   Coriell; AG22723
DR   Wikidata; Q54748487
CC   Senescence: Senesces at 26 PDL (Coriell=AG22723).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y78 ! AG22724
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   AG22724
AC   CVCL_2Y78
DR   Coriell; AG22724
DR   Wikidata; Q54748489
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y77 ! AG22723
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   AG22787
AC   CVCL_0U79
DR   Coriell; AG22787
DR   Wikidata; Q54748492
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22787).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22791
AC   CVCL_B5LP
DR   Coriell; AG22791
DR   Wikidata; Q111732880
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22791).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   AG22795
AC   CVCL_0U58
DR   Coriell; AG22795
DR   Wikidata; Q54748578
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22795).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22799
AC   CVCL_UY36
DR   Coriell; AG22799
DR   Wikidata; Q93322615
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22799).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG22803
AC   CVCL_0U59
DR   Coriell; AG22803
DR   Wikidata; Q54748582
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22803).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22808
AC   CVCL_0U60
DR   Coriell; AG22808
DR   Wikidata; Q54748584
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22808).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22812
AC   CVCL_0U61
DR   Coriell; AG22812
DR   Wikidata; Q54748585
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22812).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22816
AC   CVCL_0U62
DR   Coriell; AG22816
DR   Wikidata; Q54748587
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22816).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22820
AC   CVCL_UY37
DR   Coriell; AG22820
DR   Wikidata; Q93322634
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22820).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG22824
AC   CVCL_0U63
DR   Coriell; AG22824
DR   Wikidata; Q54748589
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22824).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22830
AC   CVCL_0U64
DR   Coriell; AG22830
DR   Wikidata; Q54748591
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22830).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22834
AC   CVCL_0U65
DR   Coriell; AG22834
DR   Wikidata; Q54748592
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22834).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22838
AC   CVCL_0U66
DR   Coriell; AG22838
DR   Wikidata; Q54748594
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22838).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22842
AC   CVCL_0U67
DR   Coriell; AG22842
DR   Wikidata; Q54748596
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22842).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22846
AC   CVCL_0U77
DR   Coriell; AG22846
DR   Wikidata; Q54748597
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22846).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22850
AC   CVCL_0U68
DR   Coriell; AG22850
DR   Wikidata; Q54748598
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22850).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22854
AC   CVCL_0U69
DR   Coriell; AG22854
DR   Wikidata; Q54748601
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22854).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22858
AC   CVCL_0U70
DR   Coriell; AG22858
DR   Wikidata; Q54748603
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22858).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22866
AC   CVCL_0U71
DR   Coriell; AG22866
DR   Wikidata; Q54748606
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22866).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22874
AC   CVCL_0U72
DR   Coriell; AG22874
DR   Wikidata; Q54748607
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22874).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22882
AC   CVCL_0U73
DR   Coriell; AG22882
DR   Wikidata; Q54748609
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22882).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG22886
AC   CVCL_UY38
DR   Coriell; AG22886
DR   Wikidata; Q93322685
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22886).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG22890
AC   CVCL_0U74
DR   Coriell; AG22890
DR   Wikidata; Q54748611
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG22890).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG23 AGM BLCL
AC   CVCL_SA48
SY   AG23
DR   Wikidata; Q54748613
RX   PubMed=22264516;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Discontinued: NHPRR; Catalog number 142.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   AG23013
AC   CVCL_UY17
DR   Coriell; AG23013
DR   Wikidata; Q93322694
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23013).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23017
AC   CVCL_0U75
DR   Coriell; AG23017
DR   Wikidata; Q54748615
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23017).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   AG23029
AC   CVCL_UY18
DR   Coriell; AG23029
DR   Wikidata; Q93322701
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23029).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23033
AC   CVCL_UY19
DR   Coriell; AG23033
DR   Wikidata; Q93322703
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23033).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23037
AC   CVCL_UY20
DR   Coriell; AG23037
DR   Wikidata; Q93322705
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23037).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23041
AC   CVCL_UY21
DR   Coriell; AG23041
DR   Wikidata; Q93322707
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23041).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23045
AC   CVCL_UY22
DR   Coriell; AG23045
DR   Wikidata; Q93322709
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23045).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23049
AC   CVCL_UY23
DR   Coriell; AG23049
DR   Wikidata; Q93322711
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23049).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23059
AC   CVCL_UY24
DR   Coriell; AG23059
DR   Wikidata; Q93322713
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23059).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23063
AC   CVCL_UY25
DR   Coriell; AG23063
DR   Wikidata; Q93322716
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23063).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23067
AC   CVCL_UY26
DR   Coriell; AG23067
DR   Wikidata; Q93322719
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23067).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23071
AC   CVCL_UY27
DR   Coriell; AG23071
DR   Wikidata; Q93322721
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23071).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23075
AC   CVCL_UY28
DR   Coriell; AG23075
DR   Wikidata; Q93322724
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23075).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23078
AC   CVCL_HJ59
DR   Coriell; AG23078
DR   Wikidata; Q54748617
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23078).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 8
//
ID   AG23105
AC   CVCL_UY29
DR   Coriell; AG23105
DR   Wikidata; Q93322729
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23105).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23109
AC   CVCL_UY30
DR   Coriell; AG23109
DR   Wikidata; Q93322731
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23109).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23113
AC   CVCL_UY31
DR   Coriell; AG23113
DR   Wikidata; Q93322733
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23113).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23117
AC   CVCL_UY32
DR   Coriell; AG23117
DR   Wikidata; Q93322735
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23117).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23121
AC   CVCL_UY33
DR   Coriell; AG23121
DR   Wikidata; Q93322737
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23121).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23124
AC   CVCL_HJ60
DR   Coriell; AG23124
DR   Wikidata; Q54748618
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23124).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 8
//
ID   AG23129
AC   CVCL_UY34
DR   Coriell; AG23129
DR   Wikidata; Q93322744
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23129).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23133
AC   CVCL_UY35
DR   Coriell; AG23133
DR   Wikidata; Q93322746
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG23133).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   AG23140
AC   CVCL_HJ61
DR   Coriell; AG23140
DR   Wikidata; Q54748620
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23140).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 8
//
ID   AG23144
AC   CVCL_HJ62
DR   Coriell; AG23144
DR   Wikidata; Q54748622
CC   Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection.
CC   Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Heterozygous (Coriell=AG23144).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Ames dwarf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2Y
CA   Somatic stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 8
//
ID   AG24047
AC   CVCL_YU47
DR   Coriell; AG24047
DR   Wikidata; Q93322757
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24048
AC   CVCL_YU48
DR   Coriell; AG24048
DR   Wikidata; Q93322759
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24049
AC   CVCL_YU49
DR   Coriell; AG24049
DR   Wikidata; Q93322761
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24050
AC   CVCL_YU50
DR   Coriell; AG24050
DR   Wikidata; Q93322763
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24051
AC   CVCL_YU51
DR   Coriell; AG24051
DR   Wikidata; Q93322765
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24053
AC   CVCL_YU52
DR   Coriell; AG24053
DR   Wikidata; Q93322767
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24054
AC   CVCL_YU53
DR   Coriell; AG24054
DR   Wikidata; Q93322769
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24055
AC   CVCL_YU54
DR   Coriell; AG24055
DR   Wikidata; Q93322771
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24056
AC   CVCL_YU55
DR   Coriell; AG24056
DR   Wikidata; Q93322773
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24057
AC   CVCL_YU56
DR   Coriell; AG24057
DR   Wikidata; Q93322776
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24058
AC   CVCL_YU57
DR   Coriell; AG24058
DR   Wikidata; Q93322778
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24059
AC   CVCL_YU58
DR   Coriell; AG24059
DR   Wikidata; Q93322780
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24060
AC   CVCL_YU59
DR   Coriell; AG24060
DR   Wikidata; Q93322782
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24062
AC   CVCL_YU60
DR   Coriell; AG24062
DR   Wikidata; Q93322785
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24063
AC   CVCL_YU61
DR   Coriell; AG24063
DR   Wikidata; Q93322787
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24064
AC   CVCL_YU62
DR   Coriell; AG24064
DR   Wikidata; Q93322789
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24065
AC   CVCL_YU63
DR   Coriell; AG24065
DR   Wikidata; Q93322791
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24077
AC   CVCL_YU64
DR   Coriell; AG24077
DR   Wikidata; Q93322793
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24078
AC   CVCL_YU65
DR   Coriell; AG24078
DR   Wikidata; Q93322795
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24081
AC   CVCL_YU66
DR   Coriell; AG24081
DR   Wikidata; Q93322797
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24083
AC   CVCL_YU67
DR   Coriell; AG24083
DR   Wikidata; Q93322799
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24084
AC   CVCL_YU68
DR   Coriell; AG24084
DR   Wikidata; Q93322801
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24085
AC   CVCL_YU69
DR   Coriell; AG24085
DR   Wikidata; Q93322803
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24086
AC   CVCL_YU70
DR   Coriell; AG24086
DR   Wikidata; Q93322806
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24087
AC   CVCL_YU71
DR   Coriell; AG24087
DR   Wikidata; Q93322808
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24090
AC   CVCL_YU72
DR   Coriell; AG24090
DR   Wikidata; Q93322810
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24091
AC   CVCL_YU73
DR   Coriell; AG24091
DR   Wikidata; Q93322812
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24092
AC   CVCL_YU74
DR   Coriell; AG24092
DR   Wikidata; Q93322815
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24093
AC   CVCL_YU75
DR   Coriell; AG24093
DR   Wikidata; Q93322818
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24096
AC   CVCL_YU76
DR   Coriell; AG24096
DR   Wikidata; Q93322820
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24098
AC   CVCL_YU77
DR   Coriell; AG24098
DR   Wikidata; Q93322822
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24100
AC   CVCL_YU78
DR   Coriell; AG24100
DR   Wikidata; Q93322824
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24101
AC   CVCL_YU79
DR   Coriell; AG24101
DR   Wikidata; Q93322826
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24102
AC   CVCL_YU80
DR   Coriell; AG24102
DR   Wikidata; Q93322828
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24103
AC   CVCL_YU81
DR   Coriell; AG24103
DR   Wikidata; Q93322830
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24104
AC   CVCL_YU82
DR   Coriell; AG24104
DR   Wikidata; Q93322832
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24105
AC   CVCL_YU83
DR   Coriell; AG24105
DR   Wikidata; Q93322834
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24106
AC   CVCL_YU84
DR   Coriell; AG24106
DR   Wikidata; Q93322836
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24107
AC   CVCL_YU85
DR   Coriell; AG24107
DR   Wikidata; Q93322838
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24108
AC   CVCL_YU86
DR   Coriell; AG24108
DR   Wikidata; Q93322840
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24109
AC   CVCL_YU87
DR   Coriell; AG24109
DR   Wikidata; Q93322843
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24111
AC   CVCL_YU88
DR   Coriell; AG24111
DR   Wikidata; Q93322845
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24112
AC   CVCL_YU89
DR   Coriell; AG24112
DR   Wikidata; Q93322847
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24113
AC   CVCL_YU90
DR   Coriell; AG24113
DR   Wikidata; Q93322849
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24114
AC   CVCL_YU91
DR   Coriell; AG24114
DR   Wikidata; Q93322851
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24115
AC   CVCL_YU92
DR   Coriell; AG24115
DR   Wikidata; Q93322853
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24116
AC   CVCL_YU93
DR   Coriell; AG24116
DR   Wikidata; Q93322855
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24117
AC   CVCL_YU94
DR   Coriell; AG24117
DR   Wikidata; Q93322857
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24118
AC   CVCL_YU95
DR   Coriell; AG24118
DR   Wikidata; Q93322859
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24119
AC   CVCL_YU96
DR   Coriell; AG24119
DR   Wikidata; Q93322861
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24120
AC   CVCL_YU97
DR   Coriell; AG24120
DR   Wikidata; Q93322863
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24121
AC   CVCL_YU98
DR   Coriell; AG24121
DR   Wikidata; Q93322865
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24122
AC   CVCL_YU99
DR   Coriell; AG24122
DR   Wikidata; Q93322867
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24123
AC   CVCL_YV00
DR   Coriell; AG24123
DR   Wikidata; Q93322870
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24124
AC   CVCL_YV01
DR   Coriell; AG24124
DR   Wikidata; Q93322872
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24125
AC   CVCL_YV02
DR   Coriell; AG24125
DR   Wikidata; Q93322874
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24126
AC   CVCL_YV03
DR   Coriell; AG24126
DR   Wikidata; Q93322876
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24127
AC   CVCL_YV04
DR   Coriell; AG24127
DR   Wikidata; Q93322878
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24128
AC   CVCL_YV05
DR   Coriell; AG24128
DR   Wikidata; Q93322880
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24130
AC   CVCL_YV06
DR   Coriell; AG24130
DR   Wikidata; Q93322882
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24131
AC   CVCL_YV07
DR   Coriell; AG24131
DR   Wikidata; Q93322884
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24132
AC   CVCL_YV08
DR   Coriell; AG24132
DR   Wikidata; Q93322886
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24133
AC   CVCL_YV09
DR   Coriell; AG24133
DR   Wikidata; Q93322888
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24134
AC   CVCL_YV10
DR   Coriell; AG24134
DR   Wikidata; Q93322890
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24135
AC   CVCL_YV11
DR   Coriell; AG24135
DR   Wikidata; Q93322892
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24136
AC   CVCL_YV12
DR   Coriell; AG24136
DR   Wikidata; Q93322895
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24137
AC   CVCL_YV13
DR   Coriell; AG24137
DR   Wikidata; Q93322897
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24138
AC   CVCL_YV14
DR   Coriell; AG24138
DR   Wikidata; Q93322900
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24139
AC   CVCL_YV15
DR   Coriell; AG24139
DR   Wikidata; Q93322902
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24141
AC   CVCL_YV16
DR   Coriell; AG24141
DR   Wikidata; Q93322904
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24142
AC   CVCL_YV17
DR   Coriell; AG24142
DR   Wikidata; Q93322906
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24144
AC   CVCL_YV18
DR   Coriell; AG24144
DR   Wikidata; Q93322908
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24146
AC   CVCL_YV19
DR   Coriell; AG24146
DR   Wikidata; Q93322910
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24147
AC   CVCL_YV20
DR   Coriell; AG24147
DR   Wikidata; Q93322912
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24148
AC   CVCL_YV21
DR   Coriell; AG24148
DR   Wikidata; Q93322914
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24149
AC   CVCL_YV22
DR   Coriell; AG24149
DR   Wikidata; Q93322916
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24150
AC   CVCL_YV23
DR   Coriell; AG24150
DR   Wikidata; Q93322918
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24151
AC   CVCL_YV24
DR   Coriell; AG24151
DR   Wikidata; Q93322920
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24152
AC   CVCL_YV25
DR   Coriell; AG24152
DR   Wikidata; Q93322922
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24153
AC   CVCL_YV26
DR   Coriell; AG24153
DR   Wikidata; Q93322925
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24154
AC   CVCL_YV27
DR   Coriell; AG24154
DR   Wikidata; Q93322927
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24155
AC   CVCL_YV28
DR   Coriell; AG24155
DR   Wikidata; Q93322929
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24156
AC   CVCL_YV29
DR   Coriell; AG24156
DR   Wikidata; Q93322931
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24157
AC   CVCL_YX73
DR   Coriell; AG24157
DR   Wikidata; Q93322933
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24158
AC   CVCL_YV30
DR   Coriell; AG24158
DR   Wikidata; Q93322935
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24159
AC   CVCL_YV31
DR   Coriell; AG24159
DR   Wikidata; Q93322937
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24160
AC   CVCL_YV32
DR   Coriell; AG24160
DR   Wikidata; Q93322939
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24161
AC   CVCL_YV33
DR   Coriell; AG24161
DR   Wikidata; Q93322941
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24162
AC   CVCL_YV34
DR   Coriell; AG24162
DR   Wikidata; Q93322943
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24163
AC   CVCL_YV35
DR   Coriell; AG24163
DR   Wikidata; Q93322945
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24164
AC   CVCL_YV36
DR   Coriell; AG24164
DR   Wikidata; Q93322948
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24165
AC   CVCL_YV37
DR   Coriell; AG24165
DR   Wikidata; Q93322952
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24166
AC   CVCL_YV38
DR   Coriell; AG24166
DR   Wikidata; Q93322954
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24167
AC   CVCL_YV39
DR   Coriell; AG24167
DR   Wikidata; Q93322956
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24168
AC   CVCL_YV40
DR   Coriell; AG24168
DR   Wikidata; Q93322958
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24170
AC   CVCL_YV41
DR   Coriell; AG24170
DR   Wikidata; Q93322960
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24172
AC   CVCL_YV42
DR   Coriell; AG24172
DR   Wikidata; Q93322962
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24174
AC   CVCL_YV43
DR   Coriell; AG24174
DR   Wikidata; Q93322964
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24176
AC   CVCL_YV44
DR   Coriell; AG24176
DR   Wikidata; Q93322966
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24177
AC   CVCL_YV45
DR   Coriell; AG24177
DR   Wikidata; Q93322968
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24178
AC   CVCL_YV46
DR   Coriell; AG24178
DR   Wikidata; Q93322970
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24179
AC   CVCL_YV47
DR   Coriell; AG24179
DR   Wikidata; Q93322972
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24180
AC   CVCL_YV48
DR   Coriell; AG24180
DR   Wikidata; Q93322974
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24181
AC   CVCL_YV49
DR   Coriell; AG24181
DR   Wikidata; Q93322976
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24182
AC   CVCL_YV50
DR   Coriell; AG24182
DR   Wikidata; Q93322979
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24183
AC   CVCL_YV51
DR   Coriell; AG24183
DR   Wikidata; Q93322981
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24184
AC   CVCL_YV52
DR   Coriell; AG24184
DR   Wikidata; Q93322983
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24185
AC   CVCL_YV53
DR   Coriell; AG24185
DR   Wikidata; Q93322985
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24186
AC   CVCL_YV54
DR   Coriell; AG24186
DR   Wikidata; Q93322987
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24187
AC   CVCL_YV55
DR   Coriell; AG24187
DR   Wikidata; Q93322989
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24188
AC   CVCL_YV56
DR   Coriell; AG24188
DR   Wikidata; Q93322991
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24189
AC   CVCL_YV57
DR   Coriell; AG24189
DR   Wikidata; Q93322992
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24190
AC   CVCL_YV58
DR   Coriell; AG24190
DR   Wikidata; Q93322993
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24191
AC   CVCL_YV59
DR   Coriell; AG24191
DR   Wikidata; Q93322995
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24192
AC   CVCL_YV60
DR   Coriell; AG24192
DR   Wikidata; Q93322997
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24193
AC   CVCL_YV61
DR   Coriell; AG24193
DR   Wikidata; Q93322998
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24194
AC   CVCL_YV62
DR   Coriell; AG24194
DR   Wikidata; Q93322999
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24195
AC   CVCL_YV63
DR   Coriell; AG24195
DR   Wikidata; Q93323000
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24196
AC   CVCL_YV64
DR   Coriell; AG24196
DR   Wikidata; Q93323001
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24197
AC   CVCL_YV65
DR   Coriell; AG24197
DR   Wikidata; Q93323002
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24198
AC   CVCL_YV66
DR   Coriell; AG24198
DR   Wikidata; Q93323003
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24199
AC   CVCL_YV67
DR   Coriell; AG24199
DR   Wikidata; Q93323004
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24200
AC   CVCL_YV68
DR   Coriell; AG24200
DR   Wikidata; Q93323006
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24202
AC   CVCL_YV69
DR   Coriell; AG24202
DR   Wikidata; Q93323008
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24203
AC   CVCL_YV70
DR   Coriell; AG24203
DR   Wikidata; Q93323010
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24204
AC   CVCL_YV71
DR   Coriell; AG24204
DR   Wikidata; Q93323012
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24205
AC   CVCL_YV72
DR   Coriell; AG24205
DR   Wikidata; Q93323014
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24206
AC   CVCL_YV73
DR   Coriell; AG24206
DR   Wikidata; Q93323016
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24207
AC   CVCL_YV74
DR   Coriell; AG24207
DR   Wikidata; Q93323018
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24208
AC   CVCL_YV75
DR   Coriell; AG24208
DR   Wikidata; Q93323020
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24209
AC   CVCL_YV76
DR   Coriell; AG24209
DR   Wikidata; Q93323022
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24210
AC   CVCL_YV77
DR   Coriell; AG24210
DR   Wikidata; Q93323024
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24211
AC   CVCL_YV78
DR   Coriell; AG24211
DR   Wikidata; Q93323027
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24212
AC   CVCL_YV79
DR   Coriell; AG24212
DR   Wikidata; Q93323029
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24213
AC   CVCL_YV80
DR   Coriell; AG24213
DR   Wikidata; Q93323030
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24214
AC   CVCL_YV81
DR   Coriell; AG24214
DR   Wikidata; Q93323032
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24215
AC   CVCL_YV82
DR   Coriell; AG24215
DR   Wikidata; Q93323033
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24216
AC   CVCL_YV83
DR   Coriell; AG24216
DR   Wikidata; Q93323034
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24218
AC   CVCL_YV84
DR   Coriell; AG24218
DR   Wikidata; Q93323036
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24219
AC   CVCL_YV85
DR   Coriell; AG24219
DR   Wikidata; Q93323037
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24220
AC   CVCL_YV86
DR   Coriell; AG24220
DR   Wikidata; Q93323038
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24221
AC   CVCL_YV87
DR   Coriell; AG24221
DR   Wikidata; Q93323039
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24222
AC   CVCL_YV88
DR   Coriell; AG24222
DR   Wikidata; Q93323040
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24223
AC   CVCL_YV89
DR   Coriell; AG24223
DR   Wikidata; Q93323041
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24226
AC   CVCL_YV90
DR   Coriell; AG24226
DR   Wikidata; Q93323043
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24227
AC   CVCL_YV91
DR   Coriell; AG24227
DR   Wikidata; Q93323045
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24228
AC   CVCL_YV92
DR   Coriell; AG24228
DR   Wikidata; Q93323047
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24230
AC   CVCL_YV93
DR   Coriell; AG24230
DR   Wikidata; Q93323049
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24232
AC   CVCL_YV94
DR   Coriell; AG24232
DR   Wikidata; Q93323051
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24233
AC   CVCL_YV95
DR   Coriell; AG24233
DR   Wikidata; Q93323053
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24234
AC   CVCL_YV96
DR   Coriell; AG24234
DR   Wikidata; Q93323055
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24235
AC   CVCL_YV97
DR   Coriell; AG24235
DR   Wikidata; Q93323058
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24236
AC   CVCL_YV98
DR   Coriell; AG24236
DR   Wikidata; Q93323060
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24237
AC   CVCL_YV99
DR   Coriell; AG24237
DR   Wikidata; Q93323062
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24238
AC   CVCL_YW00
DR   Coriell; AG24238
DR   Wikidata; Q93323064
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24239
AC   CVCL_YW01
DR   Coriell; AG24239
DR   Wikidata; Q93323066
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24240
AC   CVCL_YW02
DR   Coriell; AG24240
DR   Wikidata; Q93323068
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24241
AC   CVCL_YW03
DR   Coriell; AG24241
DR   Wikidata; Q93323070
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24242
AC   CVCL_YW04
DR   Coriell; AG24242
DR   Wikidata; Q93323072
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24243
AC   CVCL_YW05
DR   Coriell; AG24243
DR   Wikidata; Q93323074
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24244
AC   CVCL_YW06
DR   Coriell; AG24244
DR   Wikidata; Q93323076
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24245
AC   CVCL_YW07
DR   Coriell; AG24245
DR   Wikidata; Q93323077
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24246
AC   CVCL_YW08
DR   Coriell; AG24246
DR   Wikidata; Q93323078
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24247
AC   CVCL_YW09
DR   Coriell; AG24247
DR   Wikidata; Q93323079
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24248
AC   CVCL_YW10
DR   Coriell; AG24248
DR   Wikidata; Q93323081
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24249
AC   CVCL_YW11
DR   Coriell; AG24249
DR   Wikidata; Q93323082
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24250
AC   CVCL_YW12
DR   Coriell; AG24250
DR   Wikidata; Q93323083
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24252
AC   CVCL_YW13
DR   Coriell; AG24252
DR   Wikidata; Q93323084
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24253
AC   CVCL_YW14
DR   Coriell; AG24253
DR   Wikidata; Q93323085
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24254
AC   CVCL_YW15
DR   Coriell; AG24254
DR   Wikidata; Q93323086
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24255
AC   CVCL_YW16
DR   Coriell; AG24255
DR   Wikidata; Q93323087
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24256
AC   CVCL_YW17
DR   Coriell; AG24256
DR   Wikidata; Q93323088
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24257
AC   CVCL_YW18
DR   Coriell; AG24257
DR   Wikidata; Q93323089
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24258
AC   CVCL_YW19
DR   Coriell; AG24258
DR   Wikidata; Q93323090
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24259
AC   CVCL_YW20
DR   Coriell; AG24259
DR   Wikidata; Q93323091
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24260
AC   CVCL_YW21
DR   Coriell; AG24260
DR   Wikidata; Q93323092
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24261
AC   CVCL_YW22
DR   Coriell; AG24261
DR   Wikidata; Q93323093
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24262
AC   CVCL_YW23
DR   Coriell; AG24262
DR   Wikidata; Q93323094
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24263
AC   CVCL_YW24
DR   Coriell; AG24263
DR   Wikidata; Q93323095
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24266
AC   CVCL_YW25
DR   Coriell; AG24266
DR   Wikidata; Q93323096
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24267
AC   CVCL_YW26
DR   Coriell; AG24267
DR   Wikidata; Q93323097
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24268
AC   CVCL_YW27
DR   Coriell; AG24268
DR   Wikidata; Q93323098
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24269
AC   CVCL_YW28
DR   Coriell; AG24269
DR   Wikidata; Q93323099
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24270
AC   CVCL_YW29
DR   Coriell; AG24270
DR   Wikidata; Q93323100
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24272
AC   CVCL_YW30
DR   Coriell; AG24272
DR   Wikidata; Q93323101
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24273
AC   CVCL_YW31
DR   Coriell; AG24273
DR   Wikidata; Q93323102
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24274
AC   CVCL_YW32
DR   Coriell; AG24274
DR   Wikidata; Q93323103
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24275
AC   CVCL_YW33
DR   Coriell; AG24275
DR   Wikidata; Q93323105
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24276
AC   CVCL_YW34
DR   Coriell; AG24276
DR   Wikidata; Q93323106
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24277
AC   CVCL_YW35
DR   Coriell; AG24277
DR   Wikidata; Q93323107
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24278
AC   CVCL_YW36
DR   Coriell; AG24278
DR   Wikidata; Q93323108
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24279
AC   CVCL_YW37
DR   Coriell; AG24279
DR   Wikidata; Q93323109
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24280
AC   CVCL_YW38
DR   Coriell; AG24280
DR   Wikidata; Q93323110
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24281
AC   CVCL_YW39
DR   Coriell; AG24281
DR   Wikidata; Q93323111
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24282
AC   CVCL_YW40
DR   Coriell; AG24282
DR   Wikidata; Q93323112
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24283
AC   CVCL_YW41
DR   Coriell; AG24283
DR   Wikidata; Q93323114
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24285
AC   CVCL_YW42
DR   Coriell; AG24285
DR   Wikidata; Q93323116
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24286
AC   CVCL_YW43
DR   Coriell; AG24286
DR   Wikidata; Q93323118
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24287
AC   CVCL_YW44
DR   Coriell; AG24287
DR   Wikidata; Q93323119
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24288
AC   CVCL_YW45
DR   Coriell; AG24288
DR   Wikidata; Q93323122
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24289
AC   CVCL_YW46
DR   Coriell; AG24289
DR   Wikidata; Q93323125
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24290
AC   CVCL_YW47
DR   Coriell; AG24290
DR   Wikidata; Q93323127
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24291
AC   CVCL_YW48
DR   Coriell; AG24291
DR   Wikidata; Q93323129
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24292
AC   CVCL_YW49
DR   Coriell; AG24292
DR   Wikidata; Q93323131
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24293
AC   CVCL_YW50
DR   Coriell; AG24293
DR   Wikidata; Q93323133
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24295
AC   CVCL_YW51
DR   Coriell; AG24295
DR   Wikidata; Q93323135
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24296
AC   CVCL_YW52
DR   Coriell; AG24296
DR   Wikidata; Q93323138
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24297
AC   CVCL_YW53
DR   Coriell; AG24297
DR   Wikidata; Q93323140
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24298
AC   CVCL_YW54
DR   Coriell; AG24298
DR   Wikidata; Q93323142
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24300
AC   CVCL_YW55
DR   Coriell; AG24300
DR   Wikidata; Q93323144
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24301
AC   CVCL_YW56
DR   Coriell; AG24301
DR   Wikidata; Q93323146
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24302
AC   CVCL_YW57
DR   Coriell; AG24302
DR   Wikidata; Q93323148
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24303
AC   CVCL_YW58
DR   Coriell; AG24303
DR   Wikidata; Q93323151
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24304
AC   CVCL_YW59
DR   Coriell; AG24304
DR   Wikidata; Q93323153
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24305
AC   CVCL_YW60
DR   Coriell; AG24305
DR   Wikidata; Q93323154
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24306
AC   CVCL_YW61
DR   Coriell; AG24306
DR   Wikidata; Q93323155
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24307
AC   CVCL_YW62
DR   Coriell; AG24307
DR   Wikidata; Q93323156
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24308
AC   CVCL_YW63
DR   Coriell; AG24308
DR   Wikidata; Q93323157
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24309
AC   CVCL_YW64
DR   Coriell; AG24309
DR   Wikidata; Q93323158
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24310
AC   CVCL_YW65
DR   Coriell; AG24310
DR   Wikidata; Q93323159
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24311
AC   CVCL_YW66
DR   Coriell; AG24311
DR   Wikidata; Q93323160
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24313
AC   CVCL_YW67
DR   Coriell; AG24313
DR   Wikidata; Q93323161
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24314
AC   CVCL_YW68
DR   Coriell; AG24314
DR   Wikidata; Q93323162
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24315
AC   CVCL_YW69
DR   Coriell; AG24315
DR   Wikidata; Q93323163
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24316
AC   CVCL_YW70
DR   Coriell; AG24316
DR   Wikidata; Q93323164
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24318
AC   CVCL_YW71
DR   Coriell; AG24318
DR   Wikidata; Q93323165
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24320
AC   CVCL_YW72
DR   Coriell; AG24320
DR   Wikidata; Q93323167
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24321
AC   CVCL_YW73
DR   Coriell; AG24321
DR   Wikidata; Q93323168
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24322
AC   CVCL_YW74
DR   Coriell; AG24322
DR   Wikidata; Q93323170
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24323
AC   CVCL_YW75
DR   Coriell; AG24323
DR   Wikidata; Q93323171
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24324
AC   CVCL_YW76
DR   Coriell; AG24324
DR   Wikidata; Q93323172
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24325
AC   CVCL_YW77
DR   Coriell; AG24325
DR   Wikidata; Q93323173
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24326
AC   CVCL_YW78
DR   Coriell; AG24326
DR   Wikidata; Q93323174
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24327
AC   CVCL_YW79
DR   Coriell; AG24327
DR   Wikidata; Q93323175
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24329
AC   CVCL_YW80
DR   Coriell; AG24329
DR   Wikidata; Q93323176
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24331
AC   CVCL_YW81
DR   Coriell; AG24331
DR   Wikidata; Q93323177
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24332
AC   CVCL_YW82
DR   Coriell; AG24332
DR   Wikidata; Q93323179
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24333
AC   CVCL_YW83
DR   Coriell; AG24333
DR   Wikidata; Q93323181
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24335
AC   CVCL_YW84
DR   Coriell; AG24335
DR   Wikidata; Q93323183
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24336
AC   CVCL_YW85
DR   Coriell; AG24336
DR   Wikidata; Q93323186
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24337
AC   CVCL_YW86
DR   Coriell; AG24337
DR   Wikidata; Q93323189
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24338
AC   CVCL_YW87
DR   Coriell; AG24338
DR   Wikidata; Q93323191
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24339
AC   CVCL_YW88
DR   Coriell; AG24339
DR   Wikidata; Q93323193
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24340
AC   CVCL_YW89
DR   Coriell; AG24340
DR   Wikidata; Q93323195
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24341
AC   CVCL_YW90
DR   Coriell; AG24341
DR   Wikidata; Q93323197
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24343
AC   CVCL_YW91
DR   Coriell; AG24343
DR   Wikidata; Q93323199
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24345
AC   CVCL_YW92
DR   Coriell; AG24345
DR   Wikidata; Q93323201
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24346
AC   CVCL_YW93
DR   Coriell; AG24346
DR   Wikidata; Q93323203
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24351
AC   CVCL_YW94
DR   Coriell; AG24351
DR   Wikidata; Q93323205
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24352
AC   CVCL_YW95
DR   Coriell; AG24352
DR   Wikidata; Q93323207
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24354
AC   CVCL_YW96
DR   Coriell; AG24354
DR   Wikidata; Q93323209
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24357
AC   CVCL_YW97
DR   Coriell; AG24357
DR   Wikidata; Q93323211
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24358
AC   CVCL_YW98
DR   Coriell; AG24358
DR   Wikidata; Q93323214
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24359
AC   CVCL_YW99
DR   Coriell; AG24359
DR   Wikidata; Q93323216
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24363
AC   CVCL_YX00
DR   Coriell; AG24363
DR   Wikidata; Q93323218
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24364
AC   CVCL_YX01
DR   Coriell; AG24364
DR   Wikidata; Q93323220
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24368
AC   CVCL_YX02
DR   Coriell; AG24368
DR   Wikidata; Q93323222
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24369
AC   CVCL_YX03
DR   Coriell; AG24369
DR   Wikidata; Q93323224
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24370
AC   CVCL_YX04
DR   Coriell; AG24370
DR   Wikidata; Q93323226
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24371
AC   CVCL_YX05
DR   Coriell; AG24371
DR   Wikidata; Q93323228
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24373
AC   CVCL_YX06
DR   Coriell; AG24373
DR   Wikidata; Q93323230
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24374
AC   CVCL_YX07
DR   Coriell; AG24374
DR   Wikidata; Q93323232
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24375
AC   CVCL_YX08
DR   Coriell; AG24375
DR   Wikidata; Q93323234
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24377
AC   CVCL_YX09
DR   Coriell; AG24377
DR   Wikidata; Q93323236
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24379
AC   CVCL_YX10
DR   Coriell; AG24379
DR   Wikidata; Q93323237
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24380
AC   CVCL_YX11
DR   Coriell; AG24380
DR   Wikidata; Q93323239
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24381
AC   CVCL_YX12
DR   Coriell; AG24381
DR   Wikidata; Q93323240
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24382
AC   CVCL_YX13
DR   Coriell; AG24382
DR   Wikidata; Q93323241
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24383
AC   CVCL_YX14
DR   Coriell; AG24383
DR   Wikidata; Q93323242
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24384
AC   CVCL_YX15
DR   Coriell; AG24384
DR   Wikidata; Q93323243
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24385
AC   CVCL_YX16
DR   Coriell; AG24385
DR   Wikidata; Q93323244
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24386
AC   CVCL_YX17
DR   Coriell; AG24386
DR   Wikidata; Q93323245
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24387
AC   CVCL_YX18
DR   Coriell; AG24387
DR   Wikidata; Q93323246
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24388
AC   CVCL_YX19
DR   Coriell; AG24388
DR   Wikidata; Q93323247
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24390
AC   CVCL_YX20
DR   Coriell; AG24390
DR   Wikidata; Q93323248
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24391
AC   CVCL_YX21
DR   Coriell; AG24391
DR   Wikidata; Q93323249
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24393
AC   CVCL_YX22
DR   Coriell; AG24393
DR   Wikidata; Q93323250
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24394
AC   CVCL_YX23
DR   Coriell; AG24394
DR   Wikidata; Q93323252
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24395
AC   CVCL_YX24
DR   Coriell; AG24395
DR   Wikidata; Q93323254
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24396
AC   CVCL_YX25
DR   Coriell; AG24396
DR   Wikidata; Q93323255
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24397
AC   CVCL_YX26
DR   Coriell; AG24397
DR   Wikidata; Q93323256
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24398
AC   CVCL_YX27
DR   Coriell; AG24398
DR   Wikidata; Q93323257
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24399
AC   CVCL_YX28
DR   Coriell; AG24399
DR   Wikidata; Q93323258
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24400
AC   CVCL_YX29
DR   Coriell; AG24400
DR   Wikidata; Q93323259
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24401
AC   CVCL_YX30
DR   Coriell; AG24401
DR   Wikidata; Q93323260
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24402
AC   CVCL_YX31
DR   Coriell; AG24402
DR   Wikidata; Q93323262
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24403
AC   CVCL_YX32
DR   Coriell; AG24403
DR   Wikidata; Q93323263
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24404
AC   CVCL_YX33
DR   Coriell; AG24404
DR   Wikidata; Q93323264
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24405
AC   CVCL_YX34
DR   Coriell; AG24405
DR   Wikidata; Q93323265
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24406
AC   CVCL_YX35
DR   Coriell; AG24406
DR   Wikidata; Q93323266
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24407
AC   CVCL_YX36
DR   Coriell; AG24407
DR   Wikidata; Q93323268
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24408
AC   CVCL_YX37
DR   Coriell; AG24408
DR   Wikidata; Q93323269
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24409
AC   CVCL_YX38
DR   Coriell; AG24409
DR   Wikidata; Q93323270
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24410
AC   CVCL_YX39
DR   Coriell; AG24410
DR   Wikidata; Q93323271
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24411
AC   CVCL_YX40
DR   Coriell; AG24411
DR   Wikidata; Q93323272
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24412
AC   CVCL_YX41
DR   Coriell; AG24412
DR   Wikidata; Q93323274
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24413
AC   CVCL_YX42
DR   Coriell; AG24413
DR   Wikidata; Q93323275
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24414
AC   CVCL_YX43
DR   Coriell; AG24414
DR   Wikidata; Q93323276
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24415
AC   CVCL_YX44
DR   Coriell; AG24415
DR   Wikidata; Q93323277
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24416
AC   CVCL_YX45
DR   Coriell; AG24416
DR   Wikidata; Q93323278
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24417
AC   CVCL_YX46
DR   Coriell; AG24417
DR   Wikidata; Q93323279
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24418
AC   CVCL_YX47
DR   Coriell; AG24418
DR   Wikidata; Q93323280
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24420
AC   CVCL_YX48
DR   Coriell; AG24420
DR   Wikidata; Q93323282
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24421
AC   CVCL_YX49
DR   Coriell; AG24421
DR   Wikidata; Q93323283
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24423
AC   CVCL_YX50
DR   Coriell; AG24423
DR   Wikidata; Q93323284
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24424
AC   CVCL_YX51
DR   Coriell; AG24424
DR   Wikidata; Q93323285
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24425
AC   CVCL_YX52
DR   Coriell; AG24425
DR   Wikidata; Q93323286
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24426
AC   CVCL_YX53
DR   Coriell; AG24426
DR   Wikidata; Q93323287
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24427
AC   CVCL_YX54
DR   Coriell; AG24427
DR   Wikidata; Q93323288
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24428
AC   CVCL_YX55
DR   Coriell; AG24428
DR   Wikidata; Q93323289
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24429
AC   CVCL_YX56
DR   Coriell; AG24429
DR   Wikidata; Q93323290
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24430
AC   CVCL_YX57
DR   Coriell; AG24430
DR   Wikidata; Q93323291
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24432
AC   CVCL_YX58
DR   Coriell; AG24432
DR   Wikidata; Q93323292
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24433
AC   CVCL_YX59
DR   Coriell; AG24433
DR   Wikidata; Q93323293
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24434
AC   CVCL_YX60
DR   Coriell; AG24434
DR   Wikidata; Q93323294
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24435
AC   CVCL_YX61
DR   Coriell; AG24435
DR   Wikidata; Q93323296
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24436
AC   CVCL_YX62
DR   Coriell; AG24436
DR   Wikidata; Q93323297
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24437
AC   CVCL_YX63
DR   Coriell; AG24437
DR   Wikidata; Q93323298
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24438
AC   CVCL_YX64
DR   Coriell; AG24438
DR   Wikidata; Q93323299
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24439
AC   CVCL_YX65
DR   Coriell; AG24439
DR   Wikidata; Q93323300
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24440
AC   CVCL_YX66
DR   Coriell; AG24440
DR   Wikidata; Q93323301
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24441
AC   CVCL_YX67
DR   Coriell; AG24441
DR   Wikidata; Q93323302
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24442
AC   CVCL_YX68
DR   Coriell; AG24442
DR   Wikidata; Q93323303
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24444
AC   CVCL_B0IW
DR   Coriell; AG24444
DR   Wikidata; Q108819828
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AG24445
AC   CVCL_YX69
DR   Coriell; AG24445
DR   Wikidata; Q93323304
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24447
AC   CVCL_B0IV
DR   Coriell; AG24447
DR   Wikidata; Q108819829
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AG24454
AC   CVCL_YX70
DR   Coriell; AG24454
DR   Wikidata; Q93323305
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24457
AC   CVCL_B0IU
DR   Coriell; AG24457
DR   Wikidata; Q108819830
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AG24458
AC   CVCL_YX71
DR   Coriell; AG24458
DR   Wikidata; Q93323306
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG24459
AC   CVCL_B0IS
DR   Coriell; AG24459
DR   Wikidata; Q108819831
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >100Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AG24460
AC   CVCL_B0IT
DR   Coriell; AG24460
DR   Wikidata; Q108819832
CC   Part of: 90+ study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AG24465
AC   CVCL_UY15
DR   Coriell; AG24465
DR   Wikidata; Q93323307
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Leu528Cysfs*29 (c.1578delC); ClinVar=VCV000624320; Zygosity=Heterozygous (Coriell=AG24465).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg741Ter (c.2221C>T); ClinVar=VCV000528094; Zygosity=Heterozygous (Coriell=AG24465).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   AG24467
AC   CVCL_UY16
DR   Coriell; AG24467
DR   Wikidata; Q93323309
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Asn1197Thrfs*2 (c.3590delA); ClinVar=VCV000038890; Zygosity=Homozygous (Coriell=AG24467).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   AG25367
AC   CVCL_LE07
SY   AG25367*B
DR   Coriell; AG25367
DR   Wikidata; Q54748624
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (Coriell=AG25367).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T877 ! AG07768
SX   Female
AG   30Y6M
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   AG25370
AC   CVCL_LE08
SY   AG25370*B; AG25370*D
DR   Coriell; AG25370
DR   Wikidata; Q54748625
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (Coriell=AG25370).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T872 ! AG09908
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   AG26671
AC   CVCL_UX48
DR   Coriell; AG26671
DR   Wikidata; Q93323311
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26672
AC   CVCL_UX49
DR   Coriell; AG26672
DR   Wikidata; Q93323312
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26675
AC   CVCL_YL78
DR   Coriell; AG26675
DR   Wikidata; Q93323313
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26676
AC   CVCL_YL79
DR   Coriell; AG26676
DR   Wikidata; Q93323314
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26677
AC   CVCL_YL80
DR   Coriell; AG26677
DR   Wikidata; Q93323316
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26684
AC   CVCL_UX50
DR   Coriell; AG26684
DR   Wikidata; Q93323317
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26687
AC   CVCL_UX51
DR   Coriell; AG26687
DR   Wikidata; Q93323318
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26692
AC   CVCL_YL81
DR   Coriell; AG26692
DR   Wikidata; Q93323319
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26701
AC   CVCL_UX52
DR   Coriell; AG26701
DR   Wikidata; Q93323320
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26702
AC   CVCL_UX53
DR   Coriell; AG26702
DR   Wikidata; Q93323321
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26710
AC   CVCL_UX54
DR   Coriell; AG26710
DR   Wikidata; Q93323322
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26712
AC   CVCL_UX55
DR   Coriell; AG26712
DR   Wikidata; Q93323323
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26733
AC   CVCL_UX56
DR   Coriell; AG26733
DR   Wikidata; Q93323324
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26743
AC   CVCL_YL82
DR   Coriell; AG26743
DR   Wikidata; Q93323325
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26747
AC   CVCL_UX57
DR   Coriell; AG26747
DR   Wikidata; Q93323326
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26751
AC   CVCL_YL83
DR   Coriell; AG26751
DR   Wikidata; Q93323327
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26766
AC   CVCL_UX58
DR   Coriell; AG26766
DR   Wikidata; Q93323328
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26769
AC   CVCL_UX59
DR   Coriell; AG26769
DR   Wikidata; Q93323330
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26779
AC   CVCL_UX60
DR   Coriell; AG26779
DR   Wikidata; Q93323331
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26781
AC   CVCL_UX61
DR   Coriell; AG26781
DR   Wikidata; Q93323332
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26783
AC   CVCL_UX62
DR   Coriell; AG26783
DR   Wikidata; Q93323333
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26787
AC   CVCL_UX63
DR   Coriell; AG26787
DR   Wikidata; Q93323334
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26789
AC   CVCL_UX64
DR   Coriell; AG26789
DR   Wikidata; Q93323336
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26790
AC   CVCL_UX65
DR   Coriell; AG26790
DR   Wikidata; Q93323338
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26791
AC   CVCL_UX66
DR   Coriell; AG26791
DR   Wikidata; Q93323340
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26805
AC   CVCL_UX67
DR   Coriell; AG26805
DR   Wikidata; Q93323342
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26809
AC   CVCL_UX68
DR   Coriell; AG26809
DR   Wikidata; Q93323344
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26812
AC   CVCL_UX69
DR   Coriell; AG26812
DR   Wikidata; Q93323346
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26813
AC   CVCL_UX70
DR   Coriell; AG26813
DR   Wikidata; Q93323349
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26826
AC   CVCL_YL84
DR   Coriell; AG26826
DR   Wikidata; Q93323351
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26827
AC   CVCL_YL85
DR   Coriell; AG26827
DR   Wikidata; Q93323354
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26829
AC   CVCL_UX71
DR   Coriell; AG26829
DR   Wikidata; Q93323356
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26832
AC   CVCL_UX72
DR   Coriell; AG26832
DR   Wikidata; Q93323359
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26834
AC   CVCL_YL86
DR   Coriell; AG26834
DR   Wikidata; Q93323361
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26842
AC   CVCL_UX73
DR   Coriell; AG26842
DR   Wikidata; Q93323364
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26843
AC   CVCL_YL87
DR   Coriell; AG26843
DR   Wikidata; Q93323366
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26844
AC   CVCL_UX74
DR   Coriell; AG26844
DR   Wikidata; Q93323368
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26845
AC   CVCL_UX75
DR   Coriell; AG26845
DR   Wikidata; Q93323370
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26847
AC   CVCL_UX76
DR   Coriell; AG26847
DR   Wikidata; Q93323372
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26848
AC   CVCL_UX77
DR   Coriell; AG26848
DR   Wikidata; Q93323374
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26849
AC   CVCL_UX78
DR   Coriell; AG26849
DR   Wikidata; Q93323377
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26855
AC   CVCL_YL88
DR   Coriell; AG26855
DR   Wikidata; Q93323379
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26856
AC   CVCL_UX79
DR   Coriell; AG26856
DR   Wikidata; Q93323381
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26859
AC   CVCL_UX80
DR   Coriell; AG26859
DR   Wikidata; Q93323383
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26863
AC   CVCL_UX81
DR   Coriell; AG26863
DR   Wikidata; Q93323386
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26864
AC   CVCL_UX82
DR   Coriell; AG26864
DR   Wikidata; Q93323389
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26865
AC   CVCL_YL89
DR   Coriell; AG26865
DR   Wikidata; Q93323391
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26866
AC   CVCL_YL90
DR   Coriell; AG26866
DR   Wikidata; Q93323393
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26869
AC   CVCL_YL91
DR   Coriell; AG26869
DR   Wikidata; Q93323395
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26871
AC   CVCL_YL92
DR   Coriell; AG26871
DR   Wikidata; Q93323397
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26875
AC   CVCL_YL93
DR   Coriell; AG26875
DR   Wikidata; Q93323399
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26876
AC   CVCL_UX83
DR   Coriell; AG26876
DR   Wikidata; Q93323402
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26878
AC   CVCL_YL94
DR   Coriell; AG26878
DR   Wikidata; Q93323404
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26880
AC   CVCL_UX84
DR   Coriell; AG26880
DR   Wikidata; Q93323406
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26882
AC   CVCL_YL95
DR   Coriell; AG26882
DR   Wikidata; Q93323408
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26883
AC   CVCL_UX85
DR   Coriell; AG26883
DR   Wikidata; Q93323410
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26887
AC   CVCL_YL96
DR   Coriell; AG26887
DR   Wikidata; Q93323413
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26888
AC   CVCL_UX86
DR   Coriell; AG26888
DR   Wikidata; Q93323416
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26891
AC   CVCL_UX87
DR   Coriell; AG26891
DR   Wikidata; Q93323418
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26892
AC   CVCL_UX88
DR   Coriell; AG26892
DR   Wikidata; Q93323420
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26893
AC   CVCL_YL97
DR   Coriell; AG26893
DR   Wikidata; Q93323422
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26896
AC   CVCL_YL98
DR   Coriell; AG26896
DR   Wikidata; Q93323425
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26898
AC   CVCL_UX89
DR   Coriell; AG26898
DR   Wikidata; Q93323429
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26899
AC   CVCL_UX90
DR   Coriell; AG26899
DR   Wikidata; Q93323431
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26901
AC   CVCL_YL99
DR   Coriell; AG26901
DR   Wikidata; Q93323433
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26904
AC   CVCL_YM00
DR   Coriell; AG26904
DR   Wikidata; Q93323435
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26906
AC   CVCL_UX91
DR   Coriell; AG26906
DR   Wikidata; Q93323437
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26908
AC   CVCL_UX92
DR   Coriell; AG26908
DR   Wikidata; Q93323440
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26910
AC   CVCL_YM01
DR   Coriell; AG26910
DR   Wikidata; Q93323442
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26913
AC   CVCL_UX93
DR   Coriell; AG26913
DR   Wikidata; Q93323444
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26914
AC   CVCL_YM02
DR   Coriell; AG26914
DR   Wikidata; Q93323447
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26915
AC   CVCL_UX94
DR   Coriell; AG26915
DR   Wikidata; Q93323448
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26916
AC   CVCL_UX95
DR   Coriell; AG26916
DR   Wikidata; Q93323449
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26918
AC   CVCL_UX96
DR   Coriell; AG26918
DR   Wikidata; Q93323450
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   97Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26924
AC   CVCL_UX97
DR   Coriell; AG26924
DR   Wikidata; Q93323451
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26925
AC   CVCL_UX98
DR   Coriell; AG26925
DR   Wikidata; Q93323452
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26931
AC   CVCL_UX99
DR   Coriell; AG26931
DR   Wikidata; Q93323453
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26937
AC   CVCL_YM03
DR   Coriell; AG26937
DR   Wikidata; Q93323454
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26939
AC   CVCL_UY00
DR   Coriell; AG26939
DR   Wikidata; Q93323455
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26950
AC   CVCL_UY01
DR   Coriell; AG26950
DR   Wikidata; Q93323456
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26951
AC   CVCL_YM04
DR   Coriell; AG26951
DR   Wikidata; Q93323457
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26958
AC   CVCL_YM05
DR   Coriell; AG26958
DR   Wikidata; Q93323458
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG26959
AC   CVCL_UY02
DR   Coriell; AG26959
DR   Wikidata; Q93323460
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26970
AC   CVCL_UY03
DR   Coriell; AG26970
DR   Wikidata; Q93323462
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26974
AC   CVCL_UY04
DR   Coriell; AG26974
DR   Wikidata; Q93323464
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26978
AC   CVCL_UY05
DR   Coriell; AG26978
DR   Wikidata; Q93323466
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26980
AC   CVCL_UY06
DR   Coriell; AG26980
DR   Wikidata; Q93323468
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26988
AC   CVCL_UY07
DR   Coriell; AG26988
DR   Wikidata; Q93323470
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26992
AC   CVCL_UY08
DR   Coriell; AG26992
DR   Wikidata; Q93323472
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG26997
AC   CVCL_UY09
DR   Coriell; AG26997
DR   Wikidata; Q93323474
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG27009
AC   CVCL_XC55
DR   Coriell; AG27009
DR   Wikidata; Q93323477
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AG27045
AC   CVCL_UY10
DR   Coriell; AG27045
DR   Wikidata; Q93323479
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG27068
AC   CVCL_UY11
DR   Coriell; AG27068
DR   Wikidata; Q93323481
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG27076
AC   CVCL_UY12
DR   Coriell; AG27076
DR   Wikidata; Q93323483
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG27090
AC   CVCL_UY13
DR   Coriell; AG27090
DR   Wikidata; Q93323485
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG27095
AC   CVCL_UY14
DR   Coriell; AG27095
DR   Wikidata; Q93323489
CC   Part of: Tulane University longevity study.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AG27099
AC   CVCL_YM59
DR   Coriell; AG27099
DR   Wikidata; Q93323491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   99Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   AG27221
AC   CVCL_UX47
SY   AG27221*B
DR   Coriell; AG27221
DR   Wikidata; Q93323493
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG27221).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F261 ! GM01972
SX   Female
AG   13Y10M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   AG27252
AC   CVCL_WT87
DR   Coriell; AG27252
DR   Wikidata; Q93323495
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   AG27253
AC   CVCL_WT88
DR   Coriell; AG27253
DR   Wikidata; Q93323498
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   AG27297
AC   CVCL_WT89
DR   Coriell; AG27297
DR   Wikidata; Q93323500
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   AG27298
AC   CVCL_WT90
DR   Coriell; AG27298
DR   Wikidata; Q93323502
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   AG27415
AC   CVCL_WT86
SY   AG27415*B
DR   Coriell; AG27415
DR   Wikidata; Q93323504
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   AG27427
AC   CVCL_WU12
SY   AG27427*B
DR   Coriell; AG27427
DR   Wikidata; Q93323506
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Glu578Val (c.1733A>T); ClinVar=VCV000066863; Zygosity=Heterozygous (Coriell=AG27427).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U311 ! AG04110
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   AG27590
AC   CVCL_YM60
SY   AG27590*B
DR   Coriell; AG27590
DR   Wikidata; Q93323509
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG27590).
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L616 ! AG03199
SX   Female
AG   10Y8M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   AG27602
AC   CVCL_A9ZQ
SY   AG27602*B
DR   Coriell; AG27602
DR   Wikidata; Q102113503
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2A92 ! AG04455
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   AG27605
AC   CVCL_A9ZR
SY   AG27605*B
DR   Coriell; AG27605
DR   Wikidata; Q102113505
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K36 ! AG08243
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AG27606
AC   CVCL_B5PP
SY   AG27606*B
DR   Coriell; AG27606
DR   Wikidata; Q111732881
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X842 ! AG07376
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   AG27607
AC   CVCL_YN67
SY   AG27607*C
DR   Coriell; AG27607
DR   Wikidata; Q93323511
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Heterozygous; Note=ApoE2 allele (Coriell=AG27607).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2Y81 ! AG21158
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   AG27608
AC   CVCL_B5PQ
SY   AG27608*B
DR   Coriell; AG27608
DR   Wikidata; Q111732882
RX   PubMed=30699343;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K61 ! AG08509
SX   Male
AG   72Y10M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   AG27609
AC   CVCL_B5PR
SY   AG27609*B
DR   Coriell; AG27609
DR   Wikidata; Q111732884
RX   PubMed=30699343;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=30699343).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M37 ! AG10788
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   AG27611
AC   CVCL_B5PS
SY   AG27611*B
DR   Coriell; AG27611
DR   Wikidata; Q111732885
RX   PubMed=30699343;
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4L66 ! AG09173
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   AG27703
AC   CVCL_B5PT
SY   AG27703*B
DR   Coriell; AG27703
DR   Wikidata; Q111732887
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+21 (Coriell=AG27703).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X872 ! AG08942
SX   Male
AG   20Y4M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG27711
AC   CVCL_YX72
SY   AG27711*B
DR   Coriell; AG27711
DR   Wikidata; Q93323513
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K41 ! AG08259
SX   Male
AG   90Y11M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 30-01-24; Version: 7
//
ID   AG27875
AC   CVCL_B5PU
SY   AG27875*B
DR   Coriell; AG27875
DR   Wikidata; Q111732889
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0J88 ! AG06103
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28041
AC   CVCL_B5PG
SY   AG28041*B
DR   Coriell; AG28041
DR   Wikidata; Q111732890
CC   Population: African American.
CC   Karyotypic information: 46,XX,inv(9)(pter->p11::q13->p11::q13->qter) (Coriell=AG28041).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G49 ! AG16104
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28049
AC   CVCL_B5PH
SY   AG28049*B
DR   Coriell; AG28049
DR   Wikidata; Q111732891
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2B39 ! AG05274
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28057
AC   CVCL_B5PI
SY   AG28057*B
DR   Coriell; AG28057
DR   Wikidata; Q111732892
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2A75 ! AG04382
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28205
AC   CVCL_B5PJ
SY   AG28205*B
DR   Coriell; AG28205
DR   Wikidata; Q111732893
RX   PubMed=30699343;
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K24 ! AG08125
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28262
AC   CVCL_B5PK
SY   AG28262*B
DR   Coriell; AG28262
DR   Wikidata; Q111732894
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G47 ! AG16086
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28269
AC   CVCL_B5PL
SY   AG28269*B
DR   Coriell; AG28269
DR   Wikidata; Q111732895
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G48 ! AG16102
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28278
AC   CVCL_B5PM
SY   AG28278*B
DR   Coriell; AG28278
DR   Wikidata; Q111732896
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AG28336
AC   CVCL_C7PA
SY   AG28336*B
DR   Coriell; AG28336
DR   Wikidata; Q123030655
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L781 ! AG20446
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   AG28340
AC   CVCL_B5PN
SY   AG28340*B
DR   Coriell; AG28340
DR   Wikidata; Q111732897
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG28340).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H766 ! AG11498
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   AG28346
AC   CVCL_C7PB
SY   AG28346*B
DR   Coriell; AG28346
DR   Wikidata; Q123030656
CC   Population: African American.
CC   Donor information: Donor has history of diabetes mellitus; chronic renal failure; neurogenic bladder; fourniers gangrene and multiple ulcers.
CC   Derived from site: In situ; Ischium, skin; Note=From a right ischial pressure wound; UBERON=UBERON_0001415.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Q32 ! AG22107
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AG28369
AC   CVCL_C7PC
SY   AG28369*B
DR   Coriell; AG28369
DR   Wikidata; Q123030657
CC   Population: African American.
CC   Donor information: Donor was bedbound with bilateral ischial ulcers and multiple sclerosis.
CC   Derived from site: In situ; Ischium, skin; Note=From a right ischial pressure ulcer; UBERON=UBERON_0001415.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Q30 ! AG22097
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AG28462
AC   CVCL_C7PE
SY   AG28462*B
DR   Coriell; AG28462
DR   Wikidata; Q123030658
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1483+27_1483+37del (c.1483+25del11) (g.2746del11); ClinVar=VCV002431799; Zygosity=Homozygous (Coriell=AG28462).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X816 ! AG18371
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   AG28585
AC   CVCL_C7PF
SY   AG28585*B
DR   Coriell; AG28585
DR   Wikidata; Q123030659
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0N81 ! AG10213
SX   Male
AG   8Y9M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AG28599
AC   CVCL_C7PG
SY   AG28599*B
DR   Coriell; AG28599
DR   Wikidata; Q123030660
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N795 ! AG08395
SX   Female
AG   85Y9M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   AG28801
AC   CVCL_C7PH
SY   AG28801*B
DR   Coriell; AG28801
DR   Wikidata; Q123030661
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X793 ! AG06922
SX   Male
AG   1Y8M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AG28851
AC   CVCL_C7PI
SY   AG28851*B
DR   Coriell; AG28851
DR   Wikidata; Q123030662
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0D97 ! AG02222
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AG28869
AC   CVCL_C7PJ
SY   AG28869*B
DR   Coriell; AG28869
DR   Wikidata; Q123030664
CC   Population: Caucasian.
CC   Derived from site: In situ; Toe, skin; UBERON=UBERON_0003530.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L242 ! AG09309
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AG28929
AC   CVCL_D3AR
SY   AG28929*B
DR   Coriell; AG28929
DR   Wikidata; Q127380208
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G85 ! AG06083
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   AG29046
AC   CVCL_D3AM
SY   AG29046*B
DR   Coriell; AG29046
DR   Wikidata; Q127380209
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G87 ! AG06085
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   AG29054
AC   CVCL_D3AP
SY   AG29054*B
DR   Coriell; AG29054
DR   Wikidata; Q127380212
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G50 ! AG16146
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   AG29059
AC   CVCL_D3AQ
SY   AG29059*B
DR   Coriell; AG29059
DR   Wikidata; Q127380214
CC   Population: African American.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H804 ! AG08044
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   AG5
AC   CVCL_E9ZT
SY   AG5-B8
DR   ABCD; ABCD_BF019
RX   PubMed=32302507;
RX   PubMed=32579494;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_156221; 1,3-bis(6-isocyanatohexyl)-1,3-diazetidine-2,4-dione (Hexamethylene diisocyanate (HDI) uretdione) (Note=Also reacts with monomer hexamethylene diisocyanate and isocyanurate homopolymer (biuret)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AG6
AC   CVCL_E5RH
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AG876
AC   CVCL_A422
SY   Ag876; AG-876; Ag-876; AG 876; AG-876 BL; AG876BL
DR   Cosmic; 931115
DR   Wikidata; Q54748628
RX   PubMed=205793;
RX   PubMed=2052620;
RX   PubMed=3026973;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=6286763;
RX   PubMed=8220424;
RX   PubMed=8344493;
RX   PubMed=8515068;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9563901;
RX   PubMed=12133989;
RX   PubMed=16490228;
RX   PubMed=24590883;
CC   Population: African; Ghanaian.
CC   Virology: Contains a complete EBV genome (strain AG876) which has been sequenced (PubMed=16490228).
CC   Doubling time: 21 hours (PubMed=8402660).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   AGA-1
AC   CVCL_C4CQ
DR   Wikidata; Q116048481
RX   PubMed=8150984;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_30853; Glycyrrhetinic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4CP ! Sp2/0-Ag14-K13
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AGA-3
AC   CVCL_C4CR
DR   Wikidata; Q116048482
RX   PubMed=8150984;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_30853; Glycyrrhetinic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4CP ! Sp2/0-Ag14-K13
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AGA-6
AC   CVCL_C4CS
DR   Wikidata; Q116048483
RX   PubMed=8150984;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_30853; Glycyrrhetinic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4CP ! Sp2/0-Ag14-K13
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Agarabi CHO
AC   CVCL_A4AR
DR   ATCC; CRL-3440
DR   Wikidata; Q105506379
RX   PubMed=29086492;
CC   Characteristics: Parent cell line was stably transfected with a two-vector system expressing a model mouse-human chimeric IgG1 antibody.
CC   Doubling time: 22-28 hours (ATCC=CRL-3440).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   AGB43
AC   CVCL_U846
DR   CLO; CLO_0050342
DR   RCB; RCB2042
DR   Wikidata; Q54748630
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_18318; Galactosylceramide sulfate (Sulfatide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   AGC-78
AC   CVCL_B6D3
DR   Wikidata; Q111732899
RX   Patent=EP0336405B1;
RX   PubMed=1369279;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1812.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50165.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cell line A431.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z044 ! TAW-925
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   AGE
AC   CVCL_Z433
SY   Anthonomus Grandis Embryo
DR   ICLDB; age
DR   Wikidata; Q54748631
RX   CelloPub=CLPUB00183;
RX   PubMed=1522049;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Ebony.
OX   NCBI_TaxID=7044; ! Anthonomus grandis (Mexican cotton boll weevil)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AGE1.CR
AC   CVCL_S509
SY   CR; CR.HS; 17A02 clone H
DR   FCS-free; 122-23-201-3-4-3
DR   FCS-free; 234-23-478-1-4-12
DR   Wikidata; Q54748632
RX   DOI=10.17169/refubium-4684;
RX   Patent=WO2009156155A1;
RX   PubMed=19071186;
RX   PubMed=19531390;
RX   PubMed=25903999;
RX   PubMed=26814192;
WW   Provider; ProBioGen; -; https://www.probiogen.de/virus-production-cell-lines.html
CC   Group: Bird cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: ProBioGen AG; Berlin; Germany.
CC   Doubling time: 23 hours (PubMed=19531390).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
CC   Breed/subspecies: ST4 compact; VBO=VBO_0017525.
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 20
//
ID   AGE1.CR.pIX
AC   CVCL_S508
SY   CR.pIX; CR.MCX; 17A11 clone B
DR   FCS-free; 122-23-201-3-4-3
DR   FCS-free; 234-23-478-1-4-12
DR   Wikidata; Q54748635
RX   DOI=10.17169/refubium-4684;
RX   Patent=WO2009156155A1;
RX   PubMed=19071186;
RX   PubMed=19531390;
RX   PubMed=25077436;
RX   PubMed=25903999;
RX   PubMed=26814192;
WW   Provider; ProBioGen; -; https://www.probiogen.de/virus-production-cell-lines.html
WW   Provider; ProBioGen; -; https://www.probiogen.de/virus-production-cell-lines.html?file=files/images/content/02%20technology/PDF/Factsheet%20AGE.1%202018.pdf
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: ProBioGen AG; Berlin; Germany.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2749.
CC   Virology: Permissive for a wide spectrum of animal and human viruses including influenza (broad strain spectrum), rabies virus, Newcastle disease virus (NDV), duck and goose parvovirus, egg drop syndrome virus (EDS), avian infectious bursal disease virus (IBDV), turkey rhinotracheitis virus (TRT), Marek's disease virus (MDV), vesicular stomatitis virus (VSV) and herpesvirus of turkey (HVT) (ProBioGen).
CC   Doubling time: 35 hours (PubMed=19531390).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
CC   Breed/subspecies: ST4 compact; VBO=VBO_0017525.
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
HI   CVCL_S509 ! AGE1.CR
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 23
//
ID   AGE1.CS
AC   CVCL_S510
SY   CS; 12A05 clone A
DR   Wikidata; Q54748637
RX   Patent=WO2009156155A1;
RX   PubMed=19071186;
WW   Provider; ProBioGen; -; https://www.probiogen.de/virus-production-cell-lines.html
CC   Group: Bird cell line.
CC   From: ProBioGen AG; Berlin; Germany.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Somite; UBERON=UBERON_0002329.
CC   Breed/subspecies: ST4 compact; VBO=VBO_0017525.
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   AGE1.CS.pIX
AC   CVCL_B0LQ
SY   17A11 clone A
DR   Wikidata; Q108819833
RX   Patent=WO2009156155A1;
CC   Group: Bird cell line.
CC   From: ProBioGen AG; Berlin; Germany.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Somite; UBERON=UBERON_0002329.
CC   Breed/subspecies: ST4 compact; VBO=VBO_0017525.
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
HI   CVCL_S510 ! AGE1.CS
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   AGE1.HN
AC   CVCL_DF60
DR   Wikidata; Q54748639
RX   DOI=10.1002/elsc.201200111;
RX   PubMed=21188421;
RX   PubMed=21842438;
RX   PubMed=22373415;
WW   Provider; ProBioGen; -; https://www.probiogen.de/virus-production-cell-lines.html
CC   From: ProBioGen AG; Berlin; Germany.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Omics: Proteomics; Subcellular; Mitochondrion; 2DE-MS.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 10
//
ID   AGE1.HN.AAT
AC   CVCL_DF61
DR   Wikidata; Q54748640
RX   DOI=10.1002/elsc.201200111;
RX   PubMed=21842438;
RX   PubMed=22373196;
RX   PubMed=22373444;
CC   From: ProBioGen AG; Berlin; Germany.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8941; SERPINA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DF60 ! AGE1.HN
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   AGF II
AC   CVCL_R872
SY   AGFII; Anabarilius Grahami Fin II
DR   Wikidata; Q54748643
RX   PubMed=23266987;
CC   Group: Fish cell line.
CC   Doubling time: 51.1 hours (PubMed=23266987).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=495550; ! Anabarilius grahami (Kanglang fish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   AGF2
AC   CVCL_Z434
SY   AGF
DR   ICLDB; agf2
DR   Wikidata; Q54748646
RX   CelloPub=CLPUB00183;
RX   PubMed=1522049;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Ebony.
OX   NCBI_TaxID=7044; ! Anthonomus grandis (Mexican cotton boll weevil)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   AGH-OG3
AC   CVCL_A9NC
SY   AGH-OG-3
DR   CCRID; 3101MOUSCSP231
DR   GEO; GSM1464569
DR   Wikidata; Q108819834
RX   PubMed=26165924;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   AGLCL [Human 1989]
AC   CVCL_2296
DR   CLO; CLO_0001685
DR   CLDB; cl257
DR   ECACC; 89120566
DR   Wikidata; Q54748649
RX   PubMed=2577272;
RX   PubMed=23226101;
RX   PubMed=24244370;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=24244370).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=89120566
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13,14
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2582 ! LUDLU-1
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   AGLCL [Human 1993]
AC   CVCL_9Y82
DR   Wikidata; Q54748650
RX   PubMed=8396561;
RX   PubMed=9560199;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AGM-1
AC   CVCL_C3BQ
DR   Wikidata; Q114310534
RX   PubMed=7896755;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61048; Ganglioside GM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   AGM-10
AC   CVCL_E6M4
RX   PubMed=6086534;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-12
AC   CVCL_E6M5
RX   PubMed=6086534;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-13
AC   CVCL_E6M6
RX   PubMed=6086534;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-16
AC   CVCL_E6M7
RX   PubMed=6086534;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-2
AC   CVCL_C3BR
DR   Wikidata; Q114310535
RX   PubMed=7896755;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61048; Ganglioside GM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   AGM-2206
AC   CVCL_E6IN
RX   PubMed=6086534;
RX   PubMed=6243826;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-3
AC   CVCL_C3BS
DR   Wikidata; Q114310537
RX   PubMed=7896755;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61048; Ganglioside GM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   AGM-6
AC   CVCL_E6M1
RX   PubMed=6086534;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-7
AC   CVCL_E6M2
RX   PubMed=6086534;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-8
AC   CVCL_E6M3
RX   PubMed=6086534;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 2169989; Cercopithecine gammaherpesvirus 14.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AGM-S3
AC   CVCL_5240
DR   Wikidata; Q54748652
RX   PubMed=9731061;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AGM-S3
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   AgMES
AC   CVCL_RY74
SY   African green Monkey Embryonic Stem
DR   JCRB; JCRB1618
DR   Wikidata; Q54748653
RX   PubMed=19955206;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 4
//
ID   AGMK1-9T7
AC   CVCL_JF55
DR   Wikidata; Q54748699
RX   PubMed=28434690;
RX   PubMed=38060571;
CC   Group: Non-human primate cell line.
CC   Characteristics: Tumorigenic in nude mice (PubMed=28434690).
CC   Doubling time: 96.7 hours (Note=At 10th passage), 85.3 hours (Note=At 20th passage), 28.9 hours (Note=At 30th passage), 18.3 hours (Note=At 40th passage) (PubMed=28434690).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: GLI1+ perivascular renal progenitor cell.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   AgMM
AC   CVCL_C0WQ
DR   Wikidata; Q114310538
RX   PubMed=35477969;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: hb:Yob-D transgenic.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
SX   Male
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   AGN2a
AC   CVCL_6246
DR   Lonza; 956
DR   Wikidata; Q54748701
RX   PubMed=12798304;
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   Agnes
AC   CVCL_1Q43
SY   NK-55; NK55
DR   Wikidata; Q54748703
RX   PubMed=4907973;
RX   PubMed=5021706;
RX   PubMed=11515428;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   AGP01
AC   CVCL_IK53
DR   Wikidata; Q54748707
RX   PubMed=19837275;
RX   PubMed=27920471;
RX   PubMed=30598579;
RX   PubMed=31207347;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   AGP01 PIWIL1 KO
AC   CVCL_UK16
DR   ABM; T6410
DR   Wikidata; Q93323546
RX   PubMed=30598579;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9007; PIWIL1.
CC   Discontinued: ABM; T6410; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IK53 ! AGP01
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   AGPN
AC   CVCL_X981
SY   CB-AGPN; CBAGPN
DR   cancercelllines; CVCL_X981
DR   Cell_Model_Passport; SIDM01544
DR   Cosmic; 2228214
DR   DepMap; ACH-001022
DR   Wikidata; Q54748709
RX   PubMed=2174908;
RX   PubMed=25010205;
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 13
ST   D18S51: 17,18
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,20
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 9
//
ID   AGS
AC   CVCL_0139
DR   BTO; BTO_0001007
DR   CLO; CLO_0001686
DR   EFO; EFO_0002109
DR   MCCL; MCC:0000032
DR   CLDB; cl258
DR   CLDB; cl5134
DR   AddexBio; C0023004/4958
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1739
DR   BCRC; 60102
DR   BCRJ; 0311
DR   BioGRID_ORCS_Cell_line; 332
DR   BioSample; SAMN03471028
DR   BioSample; SAMN03471416
DR   BioSample; SAMN10988305
DR   cancercelllines; CVCL_0139
DR   CCRID; 1101HUM-PUMC000480
DR   CCRID; 3101HUMTCHu232
DR   CCRID; 4201HUM-CCTCC00247
DR   CCTCC; GDC0247
DR   Cell_Model_Passport; SIDM00850
DR   ChEMBL-Cells; CHEMBL3308078
DR   ChEMBL-Targets; CHEMBL613860
DR   CLS; 300408
DR   Cosmic; 685586
DR   Cosmic; 848149
DR   Cosmic; 868235
DR   Cosmic; 873708
DR   Cosmic; 887255
DR   Cosmic; 888819
DR   Cosmic; 906790
DR   Cosmic; 1067211
DR   Cosmic; 1090463
DR   Cosmic; 1187266
DR   Cosmic; 1294957
DR   Cosmic; 1482073
DR   Cosmic; 1518239
DR   Cosmic; 1582429
DR   Cosmic; 1627261
DR   Cosmic; 1995340
DR   Cosmic; 2036659
DR   Cosmic; 2069770
DR   Cosmic; 2484954
DR   Cosmic; 2823227
DR   Cosmic-CLP; 906790
DR   DepMap; ACH-000880
DR   ECACC; 89090402
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906790
DR   GEO; GSM267417
DR   GEO; GSM267424
DR   GEO; GSM267431
DR   GEO; GSM267438
DR   GEO; GSM552354
DR   GEO; GSM562392
DR   GEO; GSM618009
DR   GEO; GSM618010
DR   GEO; GSM618011
DR   GEO; GSM618012
DR   GEO; GSM827400
DR   GEO; GSM828792
DR   GEO; GSM843440
DR   GEO; GSM886864
DR   GEO; GSM887929
DR   GEO; GSM1237672
DR   GEO; GSM1237697
DR   GEO; GSM1250894
DR   GEO; GSM1250895
DR   GEO; GSM1250896
DR   GEO; GSM1250897
DR   GEO; GSM1374389
DR   GEO; GSM1374390
DR   GEO; GSM1669595
DR   GEO; GSM2983073
DR   GEO; GSM2983074
DR   GEO; GSM2983075
DR   GEO; GSM2983076
DR   IARC_TP53; 21171
DR   IBRC; C10071
DR   IGRhCellID; AGS
DR   IZSLER; BS TCL 135
DR   KCB; KCB 200708YJ
DR   KCLB; 21739
DR   LiGeA; CCLE_280
DR   LINCS_HMS; 50004
DR   LINCS_LDP; LCL-1893
DR   Lonza; 727
DR   NCBI_Iran; C131
DR   PharmacoDB; AGS_56_2019
DR   PRIDE; PXD000722
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0139
DR   PubChem_Cell_line; CVCL_0139
DR   TOKU-E; 522
DR   Ubigene; YC-C003
DR   Wikidata; Q54748713
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   DOI=10.21203/rs.3.rs-1302156/v1;
RX   PubMed=1370612;
RX   PubMed=6678861;
RX   PubMed=6831414;
RX   PubMed=10402490;
RX   PubMed=15767549;
RX   PubMed=17509637;
RX   PubMed=18804159;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27445371;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=29717028;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34466148;
RX   PubMed=35122114;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/gastric-xenograft-model/ags-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Population: Caucasian.
CC   Virology: Persistently infected with parainfluenza virus type 5 (PIV5) strain PIV5-AGS (PubMed=17509637; PubMed=27445371).
CC   Doubling time: 24 hours (PubMed=1370612; PubMed=6831414); 22 hours (PubMed=25984343); 20 hours (PubMed=29435981); 24.16 +- 0.07 hours (PubMed=35122114); ~20 hours (ATCC=CRL-1739).
CC   HLA typing: A*02:01,02:01; B*52:01,52:01; C*03:03,03:03; DQB1*04:01,04:01 (PubMed=25960936).
CC   HLA typing: A*02:01,02:01; B*52:01,52:01; C*03:03,03:03; DQB1*04:02,04:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (ATCC=CRL-1739; Cosmic-CLP=906790; DepMap=ACH-000880).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=906790; DepMap=ACH-000880).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (Cosmic-CLP=906790; DepMap=ACH-000880).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (Cosmic-CLP=906790; DepMap=ACH-000880).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000880).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1370612).
CC   Omics: Genomics; ChIP-seq; GATA4.
CC   Omics: Genomics; ChIP-seq; GATA6.
CC   Omics: Genomics; ChIP-seq; KLF5.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.44%; Native American=32.25%; East Asian, North=5.38%; East Asian, South=0%; South Asian=0.23%; European, North=27.58%; European, South=31.12% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): AddexBio=C0023004/4958; ATCC=CRL-1739; BCRC=60102; CCRID; CLS=300408; Cosmic-CLP=906790; ECACC=89090402; IZSLER=BS TCL 135; KCLB=21739; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 15
ST   D12S391: 19,20
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 13.2,16
ST   D1S1656: 14,16
ST   D21S11: 29
ST   D22S1045: 15
ST   D2S1338: 20,22
ST   D2S441: 10,14
ST   D3S1358: 15.2 (KCLB=21739)
ST   D3S1358: 16 (ATCC=CRL-1739; CCRID; CLS=300408; Technion Genomics Center)
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 13,16
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   AGS fat-1
AC   CVCL_E6ZF
DR   ABM; T6269
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Population: Caucasian.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6269).
CC   Doubling time: 18-26 hours (ABM=T6269).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   AGS NOD1 KO clone 41A8
AC   CVCL_VP28
SY   AGS NOD1 KO (Clone 41A8); NOD1 KO clone#1
DR   cancercelllines; CVCL_VP28
DR   CancerTools; 153733
DR   Wikidata; Q93323548
DR   Ximbio; 153733
RX   PubMed=29392836;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16390; NOD1.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   AGS NOD1 KO clone 41H8
AC   CVCL_VP29
SY   AGS NOD1 KO (Clone 41H8); NOD1 KO clone#2
DR   cancercelllines; CVCL_VP29
DR   CancerTools; 153734
DR   Wikidata; Q93323549
DR   Ximbio; 153734
RX   PubMed=29392836;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16390; NOD1.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   AGS-1
AC   CVCL_F0QN
RX   PubMed=6678861;
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-10
AC   CVCL_F0QV
RX   PubMed=6678861;
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-11
AC   CVCL_F0QW
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-12
AC   CVCL_F0QX
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-2
AC   CVCL_F0QP
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 37 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-3
AC   CVCL_F0QQ
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-4
AC   CVCL_F0QR
RX   PubMed=6678861;
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-5FU-R
AC   CVCL_B7H2
SY   AGS-R
DR   cancercelllines; CVCL_B7H2
DR   Wikidata; Q112929199
RX   DOI=10.21203/rs.3.rs-1302156/v1;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   AGS-6
AC   CVCL_F0QS
RX   PubMed=6678861;
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-7
AC   CVCL_F0QT
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-8
AC   CVCL_F0QU
RX   PubMed=6831414;
CC   Population: Caucasian.
CC   Doubling time: 29 hours (PubMed=6831414).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AGS-EGFP
AC   CVCL_C8W4
DR   Ubigene; YC-C003-EGFP-P
DR   Wikidata; Q123030665
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   AGS-Luc
AC   CVCL_C8VS
DR   Ubigene; YC-C003-Luc-P
DR   Wikidata; Q123030666
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   AGS-Luc2
AC   CVCL_A4BR
DR   ATCC; CRL-1739-LUC2
DR   cancercelllines; CVCL_A4BR
DR   Wikidata; Q105506382
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1739-LUC2).
CC   Doubling time: ~24 hours (ATCC=CRL-1739-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): ATCC=CRL-1739-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   AGS-NSC
AC   CVCL_E929
SY   agsNSC; Arctic Ground Squirrel-Neural Stem Cells
DR   Millipore; SCCE002
DR   Wikidata; Q54748715
CC   Characteristics: Can be used to screen drugs, genes and proteins for protective changes caused by oxygen and/or glucose deprivation.
CC   Discontinued: Millipore; SCCE002; true.
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9999; ! Urocitellus parryii (Arctic ground squirrel)
SX   Sex unspecified
AG   Adult
CA   Somatic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   AGS-PTX-R
AC   CVCL_B7H3
SY   AGS-R
DR   cancercelllines; CVCL_B7H3
DR   Wikidata; Q112929200
RX   PubMed=35122114;
CC   Population: Caucasian.
CC   Doubling time: 25.6-25.8 hours (PubMed=35122114).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   AGS/Cas9-hyg
AC   CVCL_C9DJ
DR   GeneCopoeia; SL520
DR   Wikidata; Q123030667
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL520).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   AGS/EPI
AC   CVCL_Y085
DR   cancercelllines; CVCL_Y085
DR   Wikidata; Q54748717
RX   PubMed=25169536;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_47898; 4'-epidoxorubicin (Epirubicin).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 14
//
ID   AGY-101
AC   CVCL_Z852
SY   AGY 101; AGY101
DR   Wikidata; Q54748718
RX   CelloPub=CLPUB00785;
RX   PubMed=2563994;
RX   PubMed=6137452;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   AGY-104
AC   CVCL_Z851
SY   AGY 104
DR   Wikidata; Q54748720
RX   CelloPub=CLPUB00785;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   AGY-109
AC   CVCL_Z850
SY   AGY 109
DR   Wikidata; Q54748722
RX   CelloPub=CLPUB00785;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   AGY-502
AC   CVCL_Z849
SY   AGY 502; AGY502
DR   Wikidata; Q54748724
RX   CelloPub=CLPUB00785;
RX   PubMed=2563994;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   AGZY83-a
AC   CVCL_6878
SY   AGZY-83-a; AGZY 83-a; AGZY83a
DR   Cosmic; 2664116
DR   Wikidata; Q54748727
RX   PubMed=3113841;
RX   PubMed=3471311;
RX   PubMed=14989933;
CC   Population: Chinese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   AH.H8
AC   CVCL_XH87
DR   Wikidata; Q93323554
RX   PubMed=9759867;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   AH016
AC   CVCL_A8X4
DR   GEO; GSM2055805
DR   Wikidata; Q102113506
RX   PubMed=28827786;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   AH016-3
AC   CVCL_A8X5
SY   iPS-AH016-3; AH016 control iPSc clone 3; CTL5
DR   GEO; GSM2055806
DR   GEO; GSM2055813
DR   Wikidata; Q102113507
RX   PubMed=28591653;
RX   PubMed=28827786;
RX   PubMed=30503143;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X4 ! AH016
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   AH016-6
AC   CVCL_A8Z4
DR   Wikidata; Q102113508
RX   PubMed=30503143;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X4 ! AH016
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   AH100B-TC
AC   CVCL_F977
SY   AH100B; AH-100B
DR   TKG; TKG 0042
DR   TKG; TKG 0527
DR   Wikidata; Q54748729
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH107B-TC
AC   CVCL_F978
SY   AH107B; AH-107B
DR   TKG; TKG 0043
DR   TKG; TKG 0528
DR   Wikidata; Q54748730
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH108A-TC
AC   CVCL_F979
SY   AH108A; AH-108A
DR   TKG; TKG 0044
DR   TKG; TKG 0682
DR   Wikidata; Q54748733
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH108AF-TC
AC   CVCL_F980
SY   AH108AF; AH-108AF
DR   TKG; TKG 0045
DR   TKG; TKG 0683
DR   Wikidata; Q54748734
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F979 ! AH108A-TC
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH1091B-TC
AC   CVCL_4U61
SY   AH1091BTC
DR   TKG; TKG 0076
DR   Wikidata; Q54748738
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F994 ! AH602-TC
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   AH109A-TC
AC   CVCL_F981
SY   AH109A; AH-109A; AH 109A
DR   TKG; TKG 0046
DR   TKG; TKG 0529
DR   Wikidata; Q54748736
RX   PubMed=710800;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   AH125
AC   CVCL_D263
DR   ChEMBL-Cells; CHEMBL3308598
DR   ChEMBL-Targets; CHEMBL614569
DR   PubChem_Cell_line; CVCL_D263
DR   Wikidata; Q54748741
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   AH129-4
AC   CVCL_5F98
DR   Wikidata; Q54748743
RX   PubMed=23023130;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   AH129-5
AC   CVCL_5F99
DR   Wikidata; Q54748745
RX   PubMed=23023130;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   AH129-N1
AC   CVCL_5G00
DR   Wikidata; Q54748746
RX   PubMed=23023130;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   AH129-NC1
AC   CVCL_5G01
DR   Wikidata; Q54748750
RX   PubMed=23023130;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   AH13-TC
AC   CVCL_F963
SY   AH13; AH-13; AH 13
DR   TKG; TKG 0001
DR   TKG; TKG 0542
DR   Wikidata; Q54748751
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   AH13/6MP-R-TC
AC   CVCL_F964
SY   AH13/6MP-R; AH13M; AH13M-TC
DR   TKG; TKG 0004
DR   TKG; TKG 0676
DR   Wikidata; Q54748754
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F963 ! AH13-TC
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   AH13/MMC-R-TC
AC   CVCL_G368
SY   AH13/MMC-R; AH13C; AH13C-TC
DR   TKG; TKG 0002
DR   TKG; TKG 0677
DR   Wikidata; Q54748757
CC   Selected for resistance to: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F963 ! AH13-TC
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   AH13/NMO-R-TC
AC   CVCL_F965
SY   AH13/NMO-R; AH13R; AH13R-TC
DR   TKG; TKG 0003
DR   TKG; TKG 0678
DR   Wikidata; Q54748759
CC   Selected for resistance to: ChEBI; CHEBI_82354; Nitrogen mustard N-oxide.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F963 ! AH13-TC
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   AH130
AC   CVCL_4367
SY   Yoshida AH-130; Yoshida AH130; AH-130; AH 130; AH-130 Yoshida; AH130-TC; AH130/P
DR   BTO; BTO_0000593
DR   CLS; 500412
DR   TKG; TKG 0530
DR   Wikidata; Q54748762
RX   PubMed=710800;
RX   PubMed=13549114;
RX   PubMed=14247586;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   AH130/5A
AC   CVCL_4U53
DR   Wikidata; Q54748764
RX   PubMed=9045901;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4367 ! AH130
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 9
//
ID   AH130FG-TC
AC   CVCL_F982
SY   AH130FG; AH-130F(G); AH-130FG
DR   TKG; TKG 0051
DR   TKG; TKG 0673
DR   Wikidata; Q54748767
RX   PubMed=14247586;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4367 ! AH130
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   AH130FN II-TC
AC   CVCL_F987
SY   AH130FN II
DR   TKG; TKG 0055
DR   TKG; TKG 0689
DR   Wikidata; Q54748771
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5683 ! AH130FN-TC
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   AH130FN-TC
AC   CVCL_5683
SY   AH130FN; AH-130F(N); AH-130FN; AH-130 FN; AH 130 FN
DR   CLS; 500451
DR   TKG; TKG 0053
DR   TKG; TKG 0667
DR   Wikidata; Q54748769
RX   PubMed=710800;
RX   PubMed=14247586;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4367 ! AH130
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   AH131A-TC
AC   CVCL_F984
SY   AH131A; AH-131A
DR   TKG; TKG 0057
DR   TKG; TKG 0531
DR   Wikidata; Q54748774
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F985 ! AH131B-TC
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH131B-TC
AC   CVCL_F985
SY   AH131B; AH-131B
DR   TKG; TKG 0532
DR   TKG; TKG 0690
DR   Wikidata; Q54748777
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F984 ! AH131A-TC
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH136B-TC
AC   CVCL_F986
SY   AH136B; AH-136B
DR   TKG; TKG 0059
DR   TKG; TKG 0684
DR   Wikidata; Q54748778
RX   PubMed=193549;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   AH143A-TC
AC   CVCL_F995
SY   AH143A; AH-143A
DR   TKG; TKG 0060
DR   TKG; TKG 0533
DR   Wikidata; Q54748783
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   AH150A-TC
AC   CVCL_F983
SY   AH150A; AH-150A
DR   TKG; TKG 0062
DR   TKG; TKG 0685
DR   Wikidata; Q54748784
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   AH173-TC
AC   CVCL_H702
SY   AH173; AH-173
DR   TKG; TKG 0063
DR   TKG; TKG 0675
DR   Wikidata; Q54748786
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH21-TC
AC   CVCL_G369
SY   AH21; AH-21
DR   TKG; TKG 0005
DR   TKG; TKG 0543
DR   Wikidata; Q54748790
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AH225A-TC
AC   CVCL_H701
SY   AH225A; AH-225A
DR   TKG; TKG 0065
DR   TKG; TKG 0534
DR   Wikidata; Q54748832
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH272-TC
AC   CVCL_5241
SY   AH272; AH-272
DR   CLO; CLO_0050615
DR   RCB; RCB2908
DR   TKG; TKG 0066
DR   TKG; TKG 0535
DR   Wikidata; Q54748834
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   AH311-TC
AC   CVCL_H700
SY   AH311; AH-311
DR   TKG; TKG 0068
DR   TKG; TKG 0536
DR   Wikidata; Q54748835
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AH34-TC
AC   CVCL_F967
SY   AH34; AH-34
DR   TKG; TKG 0006
DR   TKG; TKG 0640
DR   Wikidata; Q54748838
RX   PubMed=72015;
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   AH35TC2-TC
AC   CVCL_0J73
SY   AH35TC2; AH-35TC2
DR   TKG; TKG 0007
DR   TKG; TKG 0544
DR   Wikidata; Q54748839
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   AH3683-TC
AC   CVCL_F992
SY   AH3683; AH-3683
DR   TKG; TKG 0078
DR   TKG; TKG 0687
DR   Wikidata; Q54748841
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH371A-TC
AC   CVCL_H698
SY   AH371A; AH-371A
DR   TKG; TKG 0070
DR   TKG; TKG 0537
DR   Wikidata; Q54748842
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH3924A-TC
AC   CVCL_F991
SY   AH3924A; AH-3924A
DR   TKG; TKG 0079
DR   TKG; TKG 0539
DR   Wikidata; Q54748845
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH414-TC
AC   CVCL_F996
SY   AH414; AH-414; AH 414
DR   TKG; TKG 0072
DR   TKG; TKG 0686
DR   Wikidata; Q54748846
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   AH41A-TC
AC   CVCL_0J62
SY   AH41A; AH-41A
DR   TKG; TKG 0009
DR   TKG; TKG 0545
DR   Wikidata; Q54748848
RX   PubMed=710800;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0J63 ! AH41B-TC
OI   CVCL_0J64 ! AH41C-TC
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   AH41B-TC
AC   CVCL_0J63
SY   AH41B; AH-41B
DR   TKG; TKG 0010
DR   TKG; TKG 0546
DR   Wikidata; Q54748850
RX   PubMed=72015;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0J62 ! AH41A-TC
OI   CVCL_0J64 ! AH41C-TC
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   AH41C-TC
AC   CVCL_0J64
SY   AH41C; AH-41C
DR   TKG; TKG 0011
DR   TKG; TKG 0668
DR   Wikidata; Q54748852
RX   PubMed=710800;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0J62 ! AH41A-TC
OI   CVCL_0J63 ! AH41B-TC
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   AH42B-TC
AC   CVCL_0J61
SY   AH42B; AH-42B
DR   TKG; TKG 0012
DR   TKG; TKG 0669
DR   Wikidata; Q54748854
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   AH44-TC
AC   CVCL_F968
SY   AH44; AH-44
DR   TKG; TKG 0013
DR   TKG; TKG 0547
DR   Wikidata; Q54748855
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH6
AC   CVCL_C4DI
DR   ABCD; ABCD_AG201
DR   Wikidata; Q116048484
RX   PubMed=23295252;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53218; Diphenylmethane-4,4'-diisocyanate (Methylene diphenyl diisocyanate; MDI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AH601.P3
AC   CVCL_U216
SY   AH601.P3(JTC27)
DR   JCRB; JCRB0132.2
DR   JCRB; JCRB0132.3
DR   JCRB; NIHS0211
DR   JCRB; NIHS0357
DR   Wikidata; Q54748861
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Discontinued: JCRB; NIHS0211; true.
CC   Discontinued: JCRB; NIHS0357; true.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2085 ! JTC-27
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   AH602-TC
AC   CVCL_F994
SY   AH602; AH-602; AH 602
DR   TKG; TKG 0074
DR   TKG; TKG 0674
DR   Wikidata; Q54748862
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   AH60C-TC
AC   CVCL_F969
SY   AH60C; AH-60C
DR   TKG; TKG 0017
DR   TKG; TKG 0548
DR   Wikidata; Q54748863
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH61B-TC
AC   CVCL_F998
SY   AH61B; AH-61B
DR   TKG; TKG 0018
DR   TKG; TKG 0679
DR   Wikidata; Q54748865
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH62-TC
AC   CVCL_F970
SY   AH62; AH-62
DR   TKG; TKG 0019
DR   TKG; TKG 0549
DR   Wikidata; Q54748868
RX   PubMed=710800;
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AH63F-TC
AC   CVCL_F997
SY   AH63F; AH-63F
DR   TKG; TKG 0021
DR   TKG; TKG 0550
DR   Wikidata; Q54748870
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AH64B-TC
AC   CVCL_0J57
SY   AH64B; AH-64B
DR   TKG; TKG 0026
DR   TKG; TKG 0670
DR   Wikidata; Q54748871
RX   PubMed=72015;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0J58 ! AH64C-1-TC
OI   CVCL_0J59 ! AH64C-2-TC
OI   CVCL_0J60 ! AH64D-TC
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   AH64C-1-TC
AC   CVCL_0J58
SY   AH64C-1; AH-64C-1
DR   TKG; TKG 0029
DR   TKG; TKG 0680
DR   Wikidata; Q54748873
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0J57 ! AH64B-TC
OI   CVCL_0J59 ! AH64C-2-TC
OI   CVCL_0J60 ! AH64D-TC
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   AH64C-2-TC
AC   CVCL_0J59
SY   AH64C-2; AH-64C-2
DR   TKG; TKG 0030
DR   TKG; TKG 0681
DR   Wikidata; Q54748875
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0J57 ! AH64B-TC
OI   CVCL_0J58 ! AH64C-1-TC
OI   CVCL_0J60 ! AH64D-TC
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   AH64D-TC
AC   CVCL_0J60
SY   AH64D; AH-64D
DR   TKG; TKG 0035
DR   TKG; TKG 0551
DR   Wikidata; Q54748877
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0J57 ! AH64B-TC
OI   CVCL_0J58 ! AH64C-1-TC
OI   CVCL_0J59 ! AH64C-2-TC
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   AH66-TC
AC   CVCL_4368
SY   AH-66-TC; AH66tc; AH-66; AH-66 Yoshida; Yoshida AH-66; Yoshida AH66; AH 66; AH66
DR   BTO; BTO_0001552
DR   JCRB; JCRB0411
DR   TKG; TKG 0037
DR   TKG; TKG 0552
DR   Wikidata; Q54748880
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   AH66F-TC
AC   CVCL_G360
SY   AH66F; AH-66F; AH 66F
DR   TKG; TKG 0038
DR   TKG; TKG 0524
DR   Wikidata; Q54748881
RX   PubMed=710800;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4368 ! AH66-TC
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   AH70B-TC
AC   CVCL_G284
SY   AH70Btc; AH70B; AH-70B
DR   JCRB; JCRB0412
DR   TKG; TKG 0040
DR   TKG; TKG 0525
DR   Wikidata; Q54748883
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AH7974-TC
AC   CVCL_F989
SY   AH7974; AH-7974; AH 7974
DR   TKG; TKG 0080
DR   TKG; TKG 0540
DR   Wikidata; Q54748885
RX   PubMed=193549;
RX   PubMed=710800;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   AH7974F-TC
AC   CVCL_F990
SY   AH7974F; AH-7974F
DR   TKG; TKG 0081
DR   TKG; TKG 0541
DR   Wikidata; Q54748886
RX   PubMed=710800;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F989 ! AH7974-TC
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   AH9
AC   CVCL_B3NI
DR   Wikidata; Q110432570
RX   Patent=WO2022166353A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.20287.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9F6Z8; Acinetobacter baumannii beta-lactamase IMP-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   AH927
AC   CVCL_UG12
SY   AH-927
DR   Wikidata; Q93323775
RX   PubMed=8138999;
RX   PubMed=12186908;
RX   PubMed=21029758;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_UG19 ! CF927
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   AH927-FR5E
AC   CVCL_UG14
SY   AH927-fCCR5-EGFP; FR5E
DR   Wikidata; Q93323779
RX   PubMed=12186908;
CC   Characteristics: Transduced with a cat CCR5-eGFP fusion protein (PubMed=12186908).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:112741; Cat CCR5.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_UG12 ! AH927
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   AH927-FX4P
AC   CVCL_UG13
SY   AH927-fCXCR4-EGFP; FX4P
DR   Wikidata; Q93323781
RX   PubMed=12186908;
CC   Characteristics: Transduced with a cat CXCR4-eGFP fusion protein (PubMed=12186908).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:61299; Cat CXCR4.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_UG12 ! AH927
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   AH927-HX4P
AC   CVCL_E9Y9
SY   AH927-hCXCR4-EGFP; HX4P
RX   PubMed=12186908;
CC   Characteristics: Transduced with a human CXCR4-eGFP fusion protein (PubMed=12186908).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_UG12 ! AH927
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AH99-TC
AC   CVCL_G285
SY   AH99; AH-99
DR   TKG; TKG 0041
DR   TKG; TKG 0526
DR   Wikidata; Q54748888
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AHAP
AC   CVCL_5G38
SY   Atlantic Herring AdipoPancreatic
DR   Wikidata; Q54748890
RX   DOI=10.3354/ab00317;
CC   Group: Fish cell line.
CC   Doubling time: ~2 weeks (DOI=10.3354/ab00317).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Pancreas, adipose tissue; UBERON=UBERON_0015454.
OX   NCBI_TaxID=7950; ! Clupea harengus (Atlantic herring)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 12
//
ID   AHE-1
AC   CVCL_LK89
DR   Wikidata; Q54748891
RX   PubMed=3518877;
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   AHFiPS19
AC   CVCL_DQ86
DR   Wikidata; Q54748893
RX   PubMed=27346195;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
CC   Breed/subspecies: Mef2c-AHF-Cre x Ai6(RCLZsGreen) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 6
//
ID   AHFiPS7
AC   CVCL_DQ87
DR   Wikidata; Q54748895
RX   PubMed=27346195;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Mef2c-AHF-Cre x Ai6(RCLZsGreen) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 6
//
ID   AHGFP-2
AC   CVCL_5G02
DR   Wikidata; Q54748897
RX   PubMed=23023130;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   AHGFP-4
AC   CVCL_5G03
DR   Wikidata; Q54748899
RX   PubMed=23023130;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   AHGFP-6
AC   CVCL_5G04
DR   Wikidata; Q54748903
RX   PubMed=23023130;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   AHH-1
AC   CVCL_3640
SY   AHH1
DR   BTO; BTO_0006377
DR   CLO; CLO_0001688
DR   ATCC; CRL-8146
DR   BioSample; SAMN03471195
DR   Wikidata; Q54748905
RX   Patent=US4532204;
RX   PubMed=2307151;
RX   PubMed=8236284;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8146.
CC   Population: Caucasian.
CC   Doubling time: 16-19 hours (PubMed=8236284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-8146; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8146
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 10
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2710 ! RPMI-1788
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   AHH-1 TK+/-
AC   CVCL_UU61
SY   AHH-1 tk+/-; AHH-1 tk +/-
DR   IARC_TP53; 7283
DR   Wikidata; Q93323819
RX   PubMed=2307151;
RX   PubMed=7739402;
RX   PubMed=7923587;
RX   PubMed=8625943;
RX   PubMed=8841477;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=8841477).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3640 ! AHH-1
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   AHH-1 TK+/- h1A1
AC   CVCL_E7AI
SY   h1A1
RX   PubMed=7923587;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU61 ! AHH-1 TK+/-
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AHH-1 TK+/- h1A1v2
AC   CVCL_E7AJ
SY   h1A1v2
RX   PubMed=7923587;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing two copies of CYP1A1 (PubMed=7923587).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU61 ! AHH-1 TK+/-
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AHH-1 TK+/- h1A2v2
AC   CVCL_E7AK
SY   h1A2v2
RX   PubMed=7923587;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing two copies of CYP1A2 (PubMed=7923587).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU61 ! AHH-1 TK+/-
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AHH-1 TK+/- h1B1/OR
AC   CVCL_C7JT
SY   h1B1/OR
DR   Wikidata; Q117704458
RX   PubMed=9106248;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2597; CYP1B1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU61 ! AHH-1 TK+/-
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   AHH-1 TK+/- L3
AC   CVCL_UU62
SY   L3
DR   Wikidata; Q93323821
RX   PubMed=1793807;
RX   PubMed=2706743;
RX   PubMed=7739402;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU61 ! AHH-1 TK+/-
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   AHJNMUi001-A
AC   CVCL_E3QT
DR   BioSamples; SAMEA115926307
DR   hPSCreg; AHJNMUi001-A
CC   From: Affiliated hospital of Jining medical university; Jining City; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Ala274Asp (c.821C>A); Zygosity=Unspecified (hPSCreg=AHJNMUi001-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   AHL-1
AC   CVCL_4611
SY   AHL 1; AHL1; Armenian Hamster Lung-1
DR   CLO; CLO_0001689
DR   CLDB; cl261
DR   ATCC; CCL-195
DR   ECACC; 90120504
DR   Wikidata; Q18205164
RX   CelloPub=CLPUB00292;
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=7065527;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/AHL-1_cells
CC   Senescence: Senesces at ~56 PDL (CelloPub=CLPUB00292).
CC   Discontinued: ECACC; 90120504; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   AHM-1
AC   CVCL_B0P4
DR   Wikidata; Q108819835
RX   Patent=EP0124301A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8220.
CC   Characteristics: Produces IgA lambda.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   AHM-3D3
AC   CVCL_B0P5
DR   Wikidata; Q108819836
RX   Patent=EP0124301A1;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8221.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0P4 ! AHM-1
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   AHMUe001-A
AC   CVCL_C9LY
DR   BioSamples; SAMEA113676224
DR   hPSCreg; AHMUe001-A
DR   Wikidata; Q123030668
CC   From: Anhui Medical University; Anhui; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   AHMUe002-A
AC   CVCL_C9LZ
DR   hPSCreg; AHMUe002-A
DR   Wikidata; Q123030669
CC   From: Anhui Medical University; Anhui; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   AHMUi001-A
AC   CVCL_C1SF
SY   AHMUMTi002-1
DR   BioSamples; SAMEA110176023
DR   hPSCreg; AHMUi001-A
DR   Wikidata; Q114310539
RX   PubMed=35905669;
CC   From: Anhui Medical University; Anhui; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7455; MT-ND1; Simple; p.Ser110Asn (m.3635G>A); ClinVar=VCV000065518; Zygosity=Homoplasmic (PubMed=35905669).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AHMUi002-A
AC   CVCL_C1SG
SY   AHMUMTi001-1
DR   BioSamples; SAMEA112885460
DR   hPSCreg; AHMUi002-A
DR   Wikidata; Q114310540
CC   From: Anhui Medical University; Anhui; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   AHMUi003-A
AC   CVCL_C1SH
SY   AHMUMTi003-1
DR   hPSCreg; AHMUi003-A
DR   Wikidata; Q114310541
CC   From: Anhui Medical University; Anhui; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   AHMUi004-A
AC   CVCL_C1SI
SY   AHMUMTi004-1
DR   BioSamples; SAMEA112795990
DR   hPSCreg; AHMUi004-A
DR   Wikidata; Q114310542
CC   From: Anhui Medical University; Anhui; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   AHMUi005-A
AC   CVCL_C1SJ
SY   AHMUMTi005-1
DR   hPSCreg; AHMUi005-A
DR   Wikidata; Q114310543
CC   From: Anhui Medical University; Anhui; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   AHOL1
AC   CVCL_XH23
SY   Astrocytoma Ophir Loyola Hospital 1
DR   Wikidata; Q93323829
RX   PubMed=21061448;
RX   PubMed=33470396;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   AHPEN
AC   CVCL_VU44
DR   IPD-IMGT/HLA; 13562
DR   Wikidata; Q93323831
RX   CelloPub=CLPUB00478;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:11N,02:06; B*08:01,44:02; C*05,07; DQB1*02,06; DRB1*03:01:01,13:01; DRB3*01:01 (IPD-IMGT/HLA=13562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 6
//
ID   AHQUi001-A
AC   CVCL_YK97
SY   IPS35-2
DR   BioSamples; SAMEA6516971
DR   hPSCreg; AHQUi001-A
DR   SKIP; SKIP005782
DR   Wikidata; Q93323833
RX   PubMed=32353702;
CC   From: Affiliated Hospital of Qingdao University; Qingdao; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6677; LPL; Simple; p.Cys310Arg (c.928T>C); ClinVar=VCV000226449; Zygosity=Heterozygous (PubMed=32353702).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84771; Hyperlipoproteinemia, type I
DI   ORDO; Orphanet_309015; Familial lipoprotein lipase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   AHQUi001-A-1
AC   CVCL_A1MV
SY   IPS35-2-R
DR   BioSamples; SAMEA7655488
DR   hPSCreg; AHQUi001-A-1
DR   Wikidata; Q102113510
RX   PubMed=33592566;
CC   From: Affiliated Hospital of Qingdao University; Qingdao; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6677; LPL; Simple_corrected; p.Cys310Arg (c.928T>C); ClinVar=VCV000226449; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33592566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84771; Hyperlipoproteinemia, type I
DI   ORDO; Orphanet_309015; Familial lipoprotein lipase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YK97 ! AHQUi001-A
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AHT-107
AC   CVCL_WX13
SY   AHT107
DR   Wikidata; Q93323835
RX   Patent=US5631349;
RX   PubMed=2469650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 86041802.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   AHT-54
AC   CVCL_WX14
SY   AHT54
DR   Wikidata; Q93323837
RX   Patent=US5631349;
RX   PubMed=2469650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 86041801.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   AHT-C2-H12
AC   CVCL_XX89
DR   Wikidata; Q93323839
RX   Patent=US5843674;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4824.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14679; Human TYR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   AHT-C2-H31
AC   CVCL_XX90
DR   Wikidata; Q93323841
RX   Patent=US5843674;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4801.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14679; Human TYR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   AHZC 88
AC   CVCL_B5DK
SY   AHZC88
DR   Wikidata; Q110432571
RX   CelloPub=CLPUB00674;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 4 to 38 Celsius, the optimal temperature is 27 Celsius CelloPub=CLPUB00674).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
HI   CVCL_R992 ! ZC-7901
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   AI mAb 17
AC   CVCL_F0HW
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 23
AC   CVCL_F0HX
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 24
AC   CVCL_F0HY
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 27
AC   CVCL_F0HZ
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 28
AC   CVCL_F0I0
RX   PubMed=1999172;
RX   PubMed=12470663;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR (AA 36-35)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 29
AC   CVCL_F0I1
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 3
AC   CVCL_F0HS
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 4
AC   CVCL_F0HT
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 5
AC   CVCL_F0HU
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI mAb 7
AC   CVCL_F0HV
RX   PubMed=1999172;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody anti-TSH 7 (Note=Also reacts with human TSHR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AI0009
AC   CVCL_8B79
DR   ECACC; 90102303
DR   Wikidata; Q54748911
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(6;11)(q14.2;q25) (ECACC=90102303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90102303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   AI0249
AC   CVCL_8B80
DR   ECACC; 95031607
DR   Wikidata; Q54748955
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   AI03e-DCXYFP
AC   CVCL_UB70
SY   DCX Cit/Y
DR   WiCell; ai03e-dcxyfp
DR   Wikidata; Q93323852
RX   PubMed=28094016;
CC   Registration: Swiss research registry; BAG-hES-IMP-0108.
CC   Characteristics: Using TALEN a FLAG-citrine-P2A-PuroR construct was introduced at the C-terminal end of the single copy DCX.
CC   Genetic integration: Method=TALEN; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   AI06e-SOX2YFP
AC   CVCL_UB71
SY   SOX2 Cit/+
DR   WiCell; ai06e-sox2yfp
DR   Wikidata; Q93323854
RX   PubMed=28094016;
CC   Registration: Swiss research registry; BAG-hES-IMP-0107.
CC   Characteristics: Using TALEN a FLAG-citrine-P2A-PuroR construct was introduced at the C-terminal end of one allele of SOX2.
CC   Genetic integration: Method=TALEN; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   AI07e-Timothy
AC   CVCL_UB72
DR   WiCell; ai07e-timothy
DR   Wikidata; Q93323856
RX   PubMed=25765640;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple_edited; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Homozygous; Note=By TALEN (WiCell=ai07e-timothy).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   AI08e-PAX6YFP
AC   CVCL_UB73
SY   PAX6 Cit/+
DR   WiCell; ai08e-pax6yfp
DR   Wikidata; Q93323858
RX   PubMed=28094016;
CC   Registration: Swiss research registry; BAG-hES-IMP-0065.
CC   Characteristics: Using TALEN a FLAG-citrine-P2A-PuroR construct was introduced at the C-terminal end of one allele of PAX6.
CC   Genetic integration: Method=TALEN; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   AI09e-KCTD13a
AC   CVCL_UB74
DR   WiCell; ai09e-kctd13a
DR   Wikidata; Q93323860
RX   PubMed=25765640;
CC   Knockout cell: Method=TALEN; HGNC; HGNC:22234; KCTD13 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 6
//
ID   AI10e-KCTD13b
AC   CVCL_UB75
DR   WiCell; ai10e-kctd13b
DR   Wikidata; Q93323861
RX   PubMed=25765640;
CC   Knockout cell: Method=TALEN; HGNC; HGNC:22234; KCTD13.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 5
//
ID   AI11e-OTX2YFP
AC   CVCL_UB76
SY   AI11e-OTX2-YFP; OTX2 Cit/+
DR   WiCell; ai11e-otx2yfp
DR   Wikidata; Q93323864
RX   PubMed=28094016;
CC   Registration: Swiss research registry; BAG-hES-IMP-0109.
CC   Characteristics: Using TALEN a FLAG-citrine-P2A-PuroR construct was introduced at the C-terminal end of one allele of OTX2.
CC   Genetic integration: Method=TALEN; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   AI12e-HOPX-CIT+/-
AC   CVCL_UB77
DR   WiCell; ai12e-hopx-cit
DR   Wikidata; Q93323866
CC   Characteristics: Using TALEN a FLAG-citrine-P2A-PuroR construct was introduced at the C-terminal end of one allele of HOPX.
CC   Genetic integration: Method=TALEN; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   AI13e-HOPX-CIT+/+
AC   CVCL_UB78
DR   WiCell; ai13e-hopx-cit
DR   Wikidata; Q93323868
CC   Characteristics: Using TALEN a FLAG-citrine-P2A-PuroR construct was introduced at the C-terminal end of both alleles of HOPX.
CC   Genetic integration: Method=TALEN; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   AI206
AC   CVCL_B4JR
DR   Wikidata; Q110432572
RX   PubMed=1707933;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody YH206.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   AI21
AC   CVCL_C5QZ
SY   AH mAb1
DR   Wikidata; Q116048486
RX   PubMed=3325836;
RX   PubMed=6729408;
RX   PubMed=7140816;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Anti-idiotypic against human anti-acetylcholine receptor auto-antibodies.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AIA1
AC   CVCL_B7I4
SY   Asian-derived Immortalized ASC 1
DR   Wikidata; Q112929201
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IB ! AIK2
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIA2
AC   CVCL_B7I5
SY   Asian-derived Immortalized ASC 2
DR   Wikidata; Q112929202
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IB ! AIK2
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIA3
AC   CVCL_B7I6
SY   Asian-derived Immortalized ASC 3
DR   Wikidata; Q112929203
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IB ! AIK2
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIBNi001-A
AC   CVCL_A0LY
SY   GENIE 1
DR   hPSCreg; AIBNi001-A
DR   Wikidata; Q108819837
RX   PubMed=34649201;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AIBNi002-A
AC   CVCL_A0LZ
SY   GENIE 38
DR   hPSCreg; AIBNi002-A
DR   Wikidata; Q108819838
RX   PubMed=34649201;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AIBNi003-A
AC   CVCL_A0YC
SY   GENIE 68
DR   hPSCreg; AIBNi003-A
DR   Wikidata; Q108819839
RX   PubMed=34649201;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AIBNi004-A
AC   CVCL_A0YD
SY   GENIE 69
DR   hPSCreg; AIBNi004-A
DR   Wikidata; Q108819840
RX   PubMed=34649201;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AIBNi005-A
AC   CVCL_A0YE
SY   GENIE 70
DR   hPSCreg; AIBNi005-A
DR   Wikidata; Q108819841
RX   PubMed=34649201;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AIBNi006-A
AC   CVCL_A0YF
SY   GENIE 74
DR   hPSCreg; AIBNi006-A
DR   Wikidata; Q108819842
RX   PubMed=34649201;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   AIBNi007-A
AC   CVCL_A0YG
SY   GENIE 11
DR   hPSCreg; AIBNi007-A
DR   Wikidata; Q108819843
RX   PubMed=35074713;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   AIBNi008-A
AC   CVCL_A0YH
SY   GENIE 29
DR   hPSCreg; AIBNi008-A
DR   Wikidata; Q108819844
RX   PubMed=35074713;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   AIBNi009-A
AC   CVCL_A0YI
SY   GENIE 49
DR   hPSCreg; AIBNi009-A
DR   Wikidata; Q108819845
RX   PubMed=35074713;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   AIBNi010-A
AC   CVCL_A0YJ
SY   GENIE 75
DR   hPSCreg; AIBNi010-A
DR   Wikidata; Q108819846
RX   PubMed=35074713;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   AIBNi011-A
AC   CVCL_A0YK
SY   GENIE 81
DR   hPSCreg; AIBNi011-A
DR   Wikidata; Q108819847
RX   PubMed=35074713;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   AIBNi012-A
AC   CVCL_A0YL
SY   GENIE 116
DR   hPSCreg; AIBNi012-A
DR   Wikidata; Q108819848
RX   PubMed=35074713;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   AIBNi013-A
AC   CVCL_B3PZ
SY   hONS-derived Control iPSC; Control HL iPSC
DR   hPSCreg; AIBNi013-A
DR   Wikidata; Q110432573
RX   PubMed=34507143;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Derived from site: In situ; Nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   AIBNi014-A
AC   CVCL_B3PY
SY   hONS-derived A-T iPSC; A-T HL iPSC
DR   hPSCreg; AIBNi014-A
DR   Wikidata; Q110432574
RX   PubMed=34507142;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.1236-3dupT; ClinVar=VCV000181847; Zygosity=Homozygous (PubMed=34507142).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu2135_Arg2136insTer (c.6404_6405insTT) (p.Arg2136fs); ClinVar=VCV000220763; Zygosity=Heterozygous (PubMed=34507142).
CC   Derived from site: In situ; Nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   AIBNi015-A
AC   CVCL_C1SK
SY   SPG1-AU01C15
DR   BioSamples; SAMEA111323972
DR   hPSCreg; AIBNi015-A
DR   Wikidata; Q114310547
RX   PubMed=36166872;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:20582; CYP2U1; Simple; p.Pro459Leu (c.1376C>T); ClinVar=VCV000571544; Zygosity=Heterozygous (PubMed=36166872).
CC   Sequence variation: Mutation; HGNC; HGNC:20582; CYP2U1; Simple; p.Arg488Trp (c.1462C>T); ClinVar=VCV000039504; Zygosity=Heterozygous (PubMed=36166872).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C190870; Spastic paraplegia 56
DI   ORDO; Orphanet_320411; Autosomal recessive spastic paraplegia type 56
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIBNi016-A
AC   CVCL_C1SL
SY   SPG2-S376C1
DR   BioSamples; SAMEA111323975
DR   hPSCreg; AIBNi016-A
DR   Wikidata; Q114310550
RX   PubMed=36166872;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:20582; CYP2U1; Simple; p.Ile158Serfs*2 (c.471delC); ClinVar=VCV000655971; Zygosity=Heterozygous (PubMed=36166872).
CC   Sequence variation: Mutation; HGNC; HGNC:20582; CYP2U1; Simple; p.Leu362Pro (c.1085T>C); Zygosity=Heterozygous (PubMed=36166872).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C190870; Spastic paraplegia 56
DI   ORDO; Orphanet_320411; Autosomal recessive spastic paraplegia type 56
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIBNi017-A
AC   CVCL_C1SM
SY   SPGh1-S075mC2
DR   BioSamples; SAMEA111323977
DR   hPSCreg; AIBNi017-A
DR   Wikidata; Q114310552
RX   PubMed=36166872;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:20582; CYP2U1; Simple; p.Ile158Serfs*2 (c.471delC); ClinVar=VCV000655971; Zygosity=Heterozygous (PubMed=36166872).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIBNi018-A
AC   CVCL_C1SN
SY   SPGh2-S964pC6
DR   BioSamples; SAMEA111323979
DR   hPSCreg; AIBNi018-A
DR   Wikidata; Q114310555
RX   PubMed=36166872;
CC   From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:20582; CYP2U1; Simple; p.Leu362Pro (c.1085T>C); Zygosity=Heterozygous (PubMed=36166872).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AICD2.M1
AC   CVCL_KS86
SY   AICD2.M1 1H10; 1H10; 1 H 10
DR   Wikidata; Q54748956
RX   Patent=US5798229;
RX   PubMed=9341747;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2118.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AICD2.M2
AC   CVCL_KS87
SY   AICD2.M2 7D3; 7D3; 7 D 3
DR   Wikidata; Q54748959
RX   Patent=US5798229;
RX   PubMed=9341747;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2119.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AICD58.1
AC   CVCL_KT10
SY   PAK
DR   Wikidata; Q54748960
RX   Patent=WO1992004463A1;
RX   PubMed=1385151;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 90082401.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AICD58.10
AC   CVCL_KT19
SY   1D12
DR   Wikidata; Q54748962
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.11
AC   CVCL_KT20
SY   1F2
DR   Wikidata; Q54748964
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.12
AC   CVCL_KT21
SY   1F4
DR   Wikidata; Q54748965
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.13
AC   CVCL_KT22
SY   1F12
DR   Wikidata; Q54748968
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.14
AC   CVCL_KT23
SY   1H10
DR   Wikidata; Q54748969
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.15
AC   CVCL_KT24
SY   2A2
DR   Wikidata; Q54748973
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.16
AC   CVCL_KT25
SY   2B3
DR   Wikidata; Q54748974
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.2
AC   CVCL_KT11
SY   1A2
DR   Wikidata; Q54748975
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.3
AC   CVCL_KT12
SY   1A3
DR   Wikidata; Q54748978
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.4
AC   CVCL_KT13
SY   1A6
DR   Wikidata; Q54748980
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.5
AC   CVCL_KT14
SY   1A10
DR   Wikidata; Q54748981
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.6
AC   CVCL_KT15
SY   1C3
DR   Wikidata; Q54748984
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.7
AC   CVCL_KT16
SY   1C4
DR   Wikidata; Q54748985
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.8
AC   CVCL_KT17
SY   1C5
DR   Wikidata; Q54748987
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICD58.9
AC   CVCL_KT18
SY   1C7
DR   Wikidata; Q54748989
RX   PubMed=1385151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AICHI-4
AC   CVCL_5G39
DR   Wikidata; Q54748991
RX   PubMed=5728341;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a B-lymphoblastoid cell line (PubMed=29533902).
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=5728341).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 10
//
ID   AIDHC-00138
AC   CVCL_C1YU
DR   Wikidata; Q114310558
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 6,12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-13010
AC   CVCL_C1YG
DR   Wikidata; Q114310560
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1YH ! AIDHC-15224
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-13148
AC   CVCL_C1YV
DR   Wikidata; Q114310565
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-13219
AC   CVCL_C1YW
DR   Wikidata; Q114310569
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-13303
AC   CVCL_C1YX
DR   Wikidata; Q114310570
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C2993; Down syndrome
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-13822
AC   CVCL_C1YY
DR   Wikidata; Q114310573
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-14338
AC   CVCL_C1YZ
DR   Wikidata; Q114310576
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-14531
AC   CVCL_C1Z0
DR   Wikidata; Q114310577
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Extensive; Zygosity=Unspecified; Note=6 copies (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-14697
AC   CVCL_C1Z1
DR   Wikidata; Q114310578
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Heterozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 12
ST   D5S818: 11,13
ST   D7S820: 12
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-15224
AC   CVCL_C1YH
DR   Wikidata; Q114310579
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1YG ! AIDHC-13010
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-NFC1
AC   CVCL_C1Z2
DR   Wikidata; Q114310580
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NFC2
AC   CVCL_C1Z3
DR   Wikidata; Q114310582
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NFC3
AC   CVCL_C1Z4
DR   Wikidata; Q114310583
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NFC4
AC   CVCL_C1Z5
DR   Wikidata; Q114310584
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,15
ST   D16S539: 8,9
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NFC5
AC   CVCL_C1Z6
DR   Wikidata; Q114310585
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NFC6
AC   CVCL_C1Z7
DR   Wikidata; Q114310586
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NFC7
AC   CVCL_C1Z8
DR   Wikidata; Q114310587
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NFC8
AC   CVCL_C1Z9
DR   Wikidata; Q114310588
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D5S818: 9
ST   D7S820: 7,9
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-NMC1
AC   CVCL_C1ZA
DR   Wikidata; Q114310589
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-NMC2
AC   CVCL_C1ZB
DR   Wikidata; Q114310590
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Heterozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-NMC3
AC   CVCL_C1ZC
DR   Wikidata; Q114310591
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Heterozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-NMC5
AC   CVCL_C1ZD
DR   Wikidata; Q114310592
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 12,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-NMC7
AC   CVCL_C1ZE
DR   Wikidata; Q114310593
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 8,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,8
ST   TPOX: 11,12
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-NMC8
AC   CVCL_C1ZF
DR   Wikidata; Q114310595
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SC1
AC   CVCL_C1ZG
DR   Wikidata; Q114310596
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-SC2
AC   CVCL_C1ZH
DR   Wikidata; Q114310600
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AIDHC-SP22
AC   CVCL_C1ZI
DR   Wikidata; Q114310603
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP23
AC   CVCL_C1ZJ
DR   Wikidata; Q114310606
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 19,20
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP24
AC   CVCL_C1ZK
DR   Wikidata; Q114310609
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP25
AC   CVCL_C1ZL
DR   Wikidata; Q114310610
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP26
AC   CVCL_C1ZM
DR   Wikidata; Q114310611
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP27
AC   CVCL_C1ZN
DR   Wikidata; Q114310612
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 6,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 16,20
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP31
AC   CVCL_C1ZP
DR   Wikidata; Q114310613
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Heterozygous (PubMed=28284873).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Simple; p.Ala2Gly (c.5C>G) (38C-G); ClinVar=VCV000009168; Zygosity=Heterozygous (PubMed=28284873).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   AIDHC-SP32
AC   CVCL_C1ZQ
DR   Wikidata; Q114310614
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,15
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP33
AC   CVCL_C1ZR
DR   Wikidata; Q114310615
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP34
AC   CVCL_C1ZS
DR   Wikidata; Q114310616
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 8,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP35
AC   CVCL_C1ZT
DR   Wikidata; Q114310617
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP4
AC   CVCL_C1ZU
DR   Wikidata; Q114310618
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIDHC-SP5
AC   CVCL_C1ZV
DR   Wikidata; Q114310619
RX   PubMed=28284873;
CC   From: Nemours Children's Hospital; Wilmington; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AIF1
AC   CVCL_B7I7
SY   Asian-derived Immortalized Fibroblast 1
DR   Wikidata; Q112929204
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IB ! AIK2
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIF2
AC   CVCL_B7I8
SY   Asian-derived Immortalized Fibroblast 2
DR   Wikidata; Q112929205
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IB ! AIK2
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIF3
AC   CVCL_B7I9
SY   Asian-derived Immortalized Fibroblast 3
DR   Wikidata; Q112929206
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IB ! AIK2
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIIB2
AC   CVCL_E4R6
DR   DSHB; AIIB2
RX   Patent=WO2009009114A2;
RX   PubMed=2351695;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29 (Note=Also reacts with bovine, canine, mouse and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   AIK-T4
AC   CVCL_1B42
DR   ChEMBL-Cells; CHEMBL3307276
DR   ChEMBL-Targets; CHEMBL614024
DR   PubChem_Cell_line; CVCL_1B42
DR   Wikidata; Q54748994
RX   PubMed=8608235;
RX   PubMed=16827800;
CC   Virology: Contains an EBV genome in an episomal form (PubMed=8608235).
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Unexplicit; Ex18del; Zygosity=Heterozygous (PubMed=16827800).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C162687; Severe chronic active EBV infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1B43 ! AIK-T8
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 6
//
ID   AIK-T8
AC   CVCL_1B43
DR   ChEMBL-Cells; CHEMBL3308406
DR   ChEMBL-Targets; CHEMBL613504
DR   PubChem_Cell_line; CVCL_1B43
DR   Wikidata; Q54748996
RX   PubMed=8608235;
CC   Virology: Contains an EBV genome in an episomal form (PubMed=8608235).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C162687; Severe chronic active EBV infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1B42 ! AIK-T4
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   AIK1
AC   CVCL_B7IA
SY   Asian-derived Immortalized Keratinocyte 1
DR   Wikidata; Q112929207
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IB ! AIK2
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIK2
AC   CVCL_B7IB
SY   Asian-derived Immortalized Keratinocyte 2
DR   Wikidata; Q112929208
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IC ! AIK3
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AIK3
AC   CVCL_B7IC
SY   Asian-derived Immortalized Keratinocyte 3
DR   Wikidata; Q112929209
RX   PubMed=34602549;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7I4 ! AIA1
OI   CVCL_B7I5 ! AIA2
OI   CVCL_B7I6 ! AIA3
OI   CVCL_B7I7 ! AIF1
OI   CVCL_B7I8 ! AIF2
OI   CVCL_B7I9 ! AIF3
OI   CVCL_B7IA ! AIK1
OI   CVCL_B7IB ! AIK2
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   AILNCaP
AC   CVCL_U984
SY   AI LNCaP; AI-LNCaP; Androgen-Independent LNCaP
DR   BTO; BTO_0004799
DR   cancercelllines; CVCL_U984
DR   Wikidata; Q54748998
RX   PubMed=16931574;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   Ainv15
AC   CVCL_6563
SY   AinV15; Ain V15
DR   CLO; CLO_0001690
DR   ATCC; SCRC-1029
DR   Wikidata; Q54749002
RX   PubMed=11955444;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Discontinued: ATCC; SCRC-1029; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X727 ! E14-nlsrtTA-7
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   Ainv18
AC   CVCL_2G81
SY   AinV18; Ain V18; Ainv-18; Ainv 18
DR   Wikidata; Q54749004
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X727 ! E14-nlsrtTA-7
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   AIP KO MEF
AC   CVCL_UJ02
SY   Aip-Null MEF; AIP Knock-out Fibroblasts
DR   ATCC; CRL-3288
DR   Wikidata; Q93323928
RX   PubMed=19850893;
RX   PubMed=24662816;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109622; Aip.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Met1_Lys302del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   AIP WT MEF
AC   CVCL_UJ03
SY   AIP Wild-type Fibroblasts
DR   ATCC; CRL-3287
DR   Wikidata; Q93323929
RX   PubMed=19850893;
RX   PubMed=24662816;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Met1_Lys302del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   aIR-1
AC   CVCL_K040
SY   anti-IR-1; alpha IR-1; alphaIR-1
DR   CLO; CLO_0009734
DR   ATCC; HB-175
DR   Wikidata; Q54749006
RX   PubMed=6304046;
RX   PubMed=7115369;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06213; Human INSR/CD220.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   aIR-2
AC   CVCL_K041
SY   anti-IR-2; alpha IR-2; alphaIR-2
DR   Wikidata; Q54749007
RX   PubMed=6304046;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   aIR-3
AC   CVCL_K042
SY   anti-IR-3; alpha IR-3; alphaIR-3
DR   Wikidata; Q54749009
RX   PubMed=6304046;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08069; Human IGF1R/CD221.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AIS-C3
AC   CVCL_UV23
DR   Wikidata; Q93323933
RX   PubMed=231040;
RX   PubMed=663800;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z223 ! ATC-15
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   AIW002-02/ASAH1-KO
AC   CVCL_C0KA
SY   ASAH1-KO/AIW002-02
DR   Wikidata; Q112929210
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:735; ASAH1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/ATXN3-KO
AC   CVCL_C0KB
SY   Ataxin-3-KO/AIW002-02
DR   Wikidata; Q112929211
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7106; ATXN3.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/C9orf72-KO
AC   CVCL_C0KC
SY   C9ORF72-KO/AIW002-02
DR   Wikidata; Q112929212
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/FMR1-KO
AC   CVCL_E6KU
SY   FMR1-KO/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/FUS-H517Q
AC   CVCL_E6KR
SY   FUS-H517Q/AIW002-02; AIW002-02 FUS-H517Q clone B10
RX   PubMed=34500068;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.His517Asp (c.1549C>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34500068).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34500068
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 12,16
ST   D21S11: 29,32.2
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/FUS-KO
AC   CVCL_C0KD
SY   FUS-KO/AIW002-02
DR   Wikidata; Q112929213
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/GALC-KO
AC   CVCL_C0KE
SY   GALC-KO/AIW002-02
DR   Wikidata; Q112929214
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4115; GALC.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/GBA-KO
AC   CVCL_C0KF
SY   GBA-KO/AIW002-02; AIW002-02-GBA-KO
DR   Wikidata; Q112929215
WW   Info; McGill; -; https://www.mcgill.ca/neuro/files/neuro/gba-ko-aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   AIW002-02/LRRK2-KO
AC   CVCL_C0KG
SY   LRRK2-KO/AIW002-02
DR   Wikidata; Q112929216
WW   Info; McGill; -; https://www.mcgill.ca/neuro/files/neuro/lrrk2-ko-aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/MAPT-KO
AC   CVCL_C0KH
SY   MAPT-KO/AIW002-02
DR   Wikidata; Q112929217
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/MAPT-P301L
AC   CVCL_E6KS
SY   MAPT-P301L/AIW002-02
WW   Info; McGill; -; https://www.mcgill.ca/neuro/files/neuro/mapt-ko-aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/OPTN-KO
AC   CVCL_C0KI
SY   OPTN-KO/AIW002-02
DR   Wikidata; Q112929219
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17142; OPTN.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/PINK1-3flag
AC   CVCL_E6KT
SY   PINK1-3flag/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a 3flag was introduced at the C-terminus of PINK1 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/PRKN-A401D
AC   CVCL_E6L8
SY   PRKN-A401D/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Ala401Asp; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/PRKN-W403A
AC   CVCL_E6L9
SY   PRKN-W403A/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Trp403Ala; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/PRKN-Y143D
AC   CVCL_E6LA
SY   PRKN-Y143D/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Tyr143Asp; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/PRKN-V393D
AC   CVCL_E6LE
SY   PRKN-V393D/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Val143Asp; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/SMPD1-KO
AC   CVCL_C0KJ
SY   SMPD1-KO/AIW002-02
DR   Wikidata; Q112929220
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/SNCA-A30P
AC   CVCL_E6LF
SY   SNCA-A30P/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/SNCA-A53T
AC   CVCL_E6LG
SY   SNCA-A53T/AIW002-02; AIW002-02-SNCA-A53T
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/SNCA-E46K
AC   CVCL_E6LH
SY   SNCA-E46K/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Glu46Lys (c.136G>A); ClinVar=VCV000014010; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/SNCA-KO
AC   CVCL_C0KK
SY   SNCA-KO/AIW002-02
DR   Wikidata; Q112929221
WW   Info; McGill; -; https://www.mcgill.ca/neuro/files/neuro/snca-ko-aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AIW002-02/SOD1-G93A
AC   CVCL_E6LI
SY   SOD1-G93A/AIW002-02; AIW002-02 SOD1-G94A clone B6
RX   PubMed=34500068;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Gly94Asp (c.281G>A) (G93D); ClinVar=VCV001072003; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34500068).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34500068
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 12,16
ST   D21S11: 29,32.2
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/TARDBP-A382T
AC   CVCL_E6LJ
SY   TARDBP-A382T/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_edited; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/TARDBP-G348C
AC   CVCL_E6LK
SY   TARDBP-G348C/AIW002-02
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_edited; p.Gly348Cys (c.1042G>T); ClinVar=VCV000005234; Zygosity=Unspecified; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AIW002-02/USP19-KO
AC   CVCL_C0KL
SY   USP19-KO/AIW002-02
DR   Wikidata; Q112929222
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12617; USP19.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AJ10
AC   CVCL_KB58
DR   Wikidata; Q54749010
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8341.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AJ17
AC   CVCL_KB59
DR   Wikidata; Q54749013
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8342.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AJ2
AC   CVCL_KB60
DR   Wikidata; Q54749015
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8338.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   AJ225
AC   CVCL_KB61
DR   Wikidata; Q54749017
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8344.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AJ425
AC   CVCL_KB62
DR   Wikidata; Q54749019
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8345.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen MSK10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AJ60
AC   CVCL_KB63
DR   Wikidata; Q54749021
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8343.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AJ8
AC   CVCL_N321
DR   Wikidata; Q54749023
RX   Patent=US4642291;
RX   Patent=US4935344;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8339.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   AJ9
AC   CVCL_KB64
DR   Wikidata; Q54749024
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8340.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen MSK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AJC001-5
AC   CVCL_C0KM
DR   Wikidata; Q112929224
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0KN ! AJG001-C4
OI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   AJD002-3
AC   CVCL_C0KR
DR   Wikidata; Q112929225
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34287353
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D21S11: 28,30
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0KS ! TD-03
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   AJG001-C4
AC   CVCL_C0KN
SY   AJG-001-C4
DR   Wikidata; Q112929226
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0KM ! AJC001-5
OI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   AJi
AC   CVCL_YZ05
DR   Wikidata; Q98125467
RX   PubMed=32094589;
CC   Group: Bat cell line.
CC   Doubling time: 1.5-2 days (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Doubling time and age of donor from personal communication of Letko, Michael.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9417; ! Artibeus jamaicensis (Jamaican fruit-eating bat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   Ak-1
AC   CVCL_E2WV
SY   AK-1
DR   RIKEN_BRC_EPD; rpc00061
RX   PubMed=10540749;
RX   PubMed=10557230;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Petiole; PO=PO_0020038.
CC   Derived from site: In situ; Vascular leaf; PO=PO_0009025.
OX   NCBI_TaxID=46348; ! Glycyrrhiza echinata (Licorice)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   AK-5
AC   CVCL_C0P8
DR   Wikidata; Q112929227
RX   PubMed=3457975;
CC   Miscellaneous: This is not a cell line but a transplantable tumor that originally arose in a rats given an intraperitoneal injection with the cell-free ascitic fluid of a chemically induced, established ascites liver tumor ZAH (PubMed=3457975).
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60419; Rat histiocytic sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AK-5 clone BC-7
AC   CVCL_C0P9
DR   Wikidata; Q112929228
RX   PubMed=2276992;
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60419; Rat histiocytic sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0P8 ! AK-5
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AK-5 clone BC-8
AC   CVCL_C0PA
SY   BC-8; BC-8/AK-5
DR   Wikidata; Q112929229
RX   PubMed=2276992;
RX   PubMed=10456335;
RX   PubMed=11598802;
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60419; Rat histiocytic sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0P8 ! AK-5
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AK-5 clone BE-5
AC   CVCL_C0PB
DR   Wikidata; Q112929230
RX   PubMed=2276992;
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60419; Rat histiocytic sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0P8 ! AK-5
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AK-5 clone EC-2
AC   CVCL_C0PC
DR   Wikidata; Q112929231
RX   PubMed=2276992;
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60419; Rat histiocytic sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0P8 ! AK-5
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AK-5 clone FB-11
AC   CVCL_C0PD
DR   Wikidata; Q112929232
RX   PubMed=2276992;
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60419; Rat histiocytic sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0P8 ! AK-5
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   AK-Caren
AC   CVCL_ZI22
DR   Wikidata; Q98125468
RX   PubMed=3026973;
RX   PubMed=6231253;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   AK-D
AC   CVCL_3641
SY   AKD
DR   BTO; BTO_0006378
DR   CLO; CLO_0001692
DR   CLDB; cl263
DR   CLDB; cl5135
DR   ATCC; CCL-150
DR   ECACC; 89071903
DR   Wikidata; Q54749026
RX   PubMed=1271751;
RX   PubMed=7065527;
RX   PubMed=7989438;
CC   Virology: Susceptible to infection by panleukopenia, feline herpes and feline picornaviruses (ECACC=89071903).
CC   Virology: Susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   55FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   AK.F12
AC   CVCL_XH88
DR   Wikidata; Q93323959
RX   PubMed=9759867;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   AK10F6
AC   CVCL_XG54
SY   10F6
DR   Wikidata; Q93323961
RX   PubMed=17786932;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   AK1G4
AC   CVCL_XG55
SY   1G4
DR   Wikidata; Q93323963
RX   PubMed=17786932;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   AK1H3
AC   CVCL_XG56
SY   1H3
DR   Wikidata; Q93323965
RX   PubMed=17786932;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   AK28
AC   CVCL_LC42
DR   JCRB; JCRB1726
DR   Wikidata; Q54749028
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.1845+2T>C; ClinVar=VCV000252070; Zygosity=Heterozygous; Note=Splice donor mutation (JCRB=JCRB1726).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   AK2A1
AC   CVCL_XG57
SY   2A1
DR   Wikidata; Q93323972
RX   PubMed=17786932;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   AK2C5
AC   CVCL_XG58
SY   2C5
DR   Wikidata; Q93323974
RX   PubMed=17786932;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   AK3D9
AC   CVCL_XG59
SY   3D9
DR   Wikidata; Q93323976
RX   PubMed=17786932;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   AK7
AC   CVCL_RP64
SY   AK7 ES
DR   MMRRC; MMRRC:015891-UCD
DR   Wikidata; Q54749029
RX   PubMed=23653301;
RX   PubMed=25277546;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   AK7B4
AC   CVCL_XG60
SY   7B4
DR   Wikidata; Q93323988
RX   PubMed=17786932;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   Akata
AC   CVCL_0148
SY   AKATA; Akata-BL; Akata BL; Akata-EC; Akata-Early Culture
DR   MCCL; MCC:0000041
DR   cancercelllines; CVCL_0148
DR   Cosmic; 931094
DR   Cosmic; 2301567
DR   IARC_TP53; 698
DR   JCRB; JCRB1763
DR   NCBI_Iran; C451
DR   TOKU-E; 3580
DR   Wikidata; Q54749080
RX   PubMed=1647567;
RX   PubMed=1915267;
RX   PubMed=9473234;
RX   PubMed=9973220;
RX   PubMed=11559830;
RX   PubMed=23152513;
RX   PubMed=25787276;
RX   PubMed=28960205;
CC   Population: Japanese.
CC   Virology: Contains a complete EBV genome (strain Akata) which has been sequenced (PubMed=23152513; PubMed=25787276).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (PubMed=1915267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1763
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   Akata (-) EBV-neoR
AC   CVCL_A2HR
DR   JCRB; JCRB1827
DR   Wikidata; Q105506385
RX   PubMed=8794379;
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome contains a neo gene (PubMed=8794379).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1827
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN89 ! Akata-EBV-N
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   Akata 2A8
AC   CVCL_6247
SY   2A8
DR   Lonza; 137
DR   Wikidata; Q54749082
RX   PubMed=9593003;
RX   PubMed=10022853;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Virology: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Akata 2C1
AC   CVCL_6248
SY   2C1
DR   Wikidata; Q54749084
RX   PubMed=9593003;
RX   PubMed=10022853;
CC   Population: Japanese.
CC   Virology: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   Akata 3F2
AC   CVCL_6249
SY   3F2
DR   Wikidata; Q54749085
RX   PubMed=9593003;
RX   PubMed=10022853;
CC   Population: Japanese.
CC   Virology: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   Akata delta1 EBER2(+)
AC   CVCL_B6R3
DR   JCRB; JCRB1860
DR   Wikidata; Q111732900
RX   PubMed=17686859;
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2 and which was knocked-in for EBER2 only.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1860
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3LU ! Akata EBER(-) EBV
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 10
//
ID   Akata delta2 EBER1(+)
AC   CVCL_B3MK
DR   JCRB; JCRB1851
DR   Wikidata; Q110432575
RX   PubMed=17686859;
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2 and which was knocked-in for EBER1 only.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1851
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3LU ! Akata EBER(-) EBV
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 10
//
ID   Akata deltagp85
AC   CVCL_B6R7
DR   JCRB; JCRB1871
DR   Wikidata; Q111732902
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for BXLF2/gp85.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1871
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN89 ! Akata-EBV-N
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   Akata deltaLMP2A
AC   CVCL_B6R4
DR   JCRB; JCRB1861
DR   Wikidata; Q111732903
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for LMP2A.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1861
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN89 ! Akata-EBV-N
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   Akata EBER(-) EBV
AC   CVCL_B3LU
DR   cancercelllines; CVCL_B3LU
DR   JCRB; JCRB1832
DR   Wikidata; Q110432576
RX   PubMed=17686859;
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1832
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN89 ! Akata-EBV-N
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 10
//
ID   Akata EBER(+) EBV
AC   CVCL_B3M6
DR   JCRB; JCRB1844
DR   Wikidata; Q110432578
RX   PubMed=17686859;
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2 and which was knocked-in for both EBERs.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1844
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3LU ! Akata EBER(-) EBV
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   Akata EG
AC   CVCL_6250
DR   Wikidata; Q54749087
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   Akata ZKO
AC   CVCL_B6R6
SY   Akata/ZKO-EBV
DR   JCRB; JCRB1869
DR   Wikidata; Q111732904
RX   PubMed=19553389;
CC   Population: Japanese.
CC   Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for BZLF1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1869
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN89 ! Akata-EBV-N
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   Akata-EBV-N
AC   CVCL_VN89
SY   Akata-
DR   cancercelllines; CVCL_VN89
DR   JCRB; JCRB1765
DR   Wikidata; Q93324016
RX   PubMed=8057484;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1765
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 12
//
ID   Akata-EBV-P
AC   CVCL_VN87
DR   JCRB; JCRB1762
DR   Wikidata; Q93324018
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1762
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   Akata-eGFP-EBV
AC   CVCL_VN88
DR   JCRB; JCRB1764
DR   Wikidata; Q93324020
RX   PubMed=11562531;
CC   Population: Japanese.
CC   Virology: EBV-negative clone re-infected with a recombinant EBV in which eGFP was integrated in the BXLF1 gene.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   AKG
AC   CVCL_WH02
DR   cancercelllines; CVCL_WH02
DR   IARC_TP53; 13990
DR   Wikidata; Q93324023
RX   PubMed=9723033;
RX   PubMed=10841287;
RX   PubMed=26919099;
CC   Doubling time: ~36 hours (PubMed=9723033); 42 hours (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Leu1061Pro (c.3182T>C); ClinVar=VCV000134079; Zygosity=Unspecified (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1170Ala (c.3508C>G); ClinVar=VCV000134082; Zygosity=Unspecified (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=10841287).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   AKG HR
AC   CVCL_WH03
DR   cancercelllines; CVCL_WH03
DR   Wikidata; Q93324025
RX   PubMed=26919099;
CC   Doubling time: 33 hours (PubMed=26919099).
CC   Selected for resistance to: DrugBank; DB00072; Trastuzumab (Herceptin).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Leu1061Pro (c.3182T>C); ClinVar=VCV000134079; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1170Ala (c.3508C>G); ClinVar=VCV000134082; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WH02 ! AKG
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   AKH14
AC   CVCL_D5XZ
DR   Wikidata; Q127380215
RX   DOI=10.25365/thesis.6275;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XY ! AKH4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AKH4
AC   CVCL_D5XY
DR   Wikidata; Q127380216
RX   DOI=10.25365/thesis.6275;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XZ ! AKH14
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AKI
AC   CVCL_8170
DR   BioSample; SAMN03151663
DR   IARC_TP53; 21172
DR   RCB; RCB0408
DR   Wikidata; Q54749095
RX   PubMed=3145150;
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 42 year old male patient with a melanoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00172.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0408; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   AKIBA
AC   CVCL_E453
DR   dbMHC; 48471
DR   ECACC; 94022520
DR   IHW; IHW09286
DR   IPD-IMGT/HLA; 10239
DR   Wikidata; Q54749097
RX   PubMed=16702430;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01; B*52:01:01:02; C*12:02:02:01; DPA1*02:01:01:01; DPB1*09:01:01; DQA1*01:03; DQB1*06:01:01/06:01:15; DRB1*15:02:01; DRB5*01:02; DRB6*02 (IPD-IMGT/HLA=10239).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   AKIL-1
AC   CVCL_VV43
SY   AKR IL-2 dependent Leukemia-1
DR   Wikidata; Q93324047
RX   PubMed=6605296;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKIL-1.E8
AC   CVCL_VV44
SY   AKR IL-2 dependent Leukemia-1.E8
DR   Wikidata; Q93324050
RX   CelloPub=CLPUB00480;
RX   PubMed=3493298;
RX   PubMed=6605296;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VV43 ! AKIL-1
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKIL-20
AC   CVCL_VV45
SY   AKR IL-2 dependent Leukemia-20
DR   Wikidata; Q93324053
RX   CelloPub=CLPUB00480;
RX   PubMed=3493298;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKIL-3
AC   CVCL_VV46
SY   AKR IL-2 dependent Leukemia-3
DR   Wikidata; Q93324055
RX   PubMed=6605296;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKIL-3.H5
AC   CVCL_VV47
SY   AKR IL-2 dependent Leukemia-3.H5
DR   Wikidata; Q93324057
RX   CelloPub=CLPUB00480;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VV46 ! AKIL-3
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKIL-6
AC   CVCL_VV48
SY   AKR IL-2 dependent Leukemia-6
DR   Wikidata; Q93324059
RX   PubMed=6605296;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKIL-6.A3
AC   CVCL_VV49
SY   AKR IL-2 dependent Leukemia-6.A3
DR   Wikidata; Q93324061
RX   CelloPub=CLPUB00480;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VV48 ! AKIL-6
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKIL-6.D12
AC   CVCL_VV50
SY   AKR IL-2 dependent Leukemia-6.D12
DR   Wikidata; Q93324063
RX   CelloPub=CLPUB00480;
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: AKR.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VV48 ! AKIL-6
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   AKL3H6
AC   CVCL_C4LS
DR   ABCD; ABCD_AI259
DR   Wikidata; Q116048487
RX   PubMed=12505721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61930; N(6)-acetyl-L-lysine residue.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AKL5C1
AC   CVCL_C4LT
DR   ABCD; ABCD_AI258
DR   Wikidata; Q116048488
RX   PubMed=12505721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61930; N(6)-acetyl-L-lysine residue.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AkO
AC   CVCL_B7LL
DR   Wikidata; Q112929233
RX   PubMed=9536093;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Gln55Ter (c.163C>T); ClinVar=VCV000007652; Zygosity=Homozygous (PubMed=9536093).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   AKOSi001-A
AC   CVCL_UL88
SY   iPS GM18455-1; GM18455-1 (NPC2); NPC2 (p.E20X;C47F); NPC2 (c.58G>C;c.140G>T)
DR   hPSCreg; AKOSi001-A
DR   Wikidata; Q93324065
RX   PubMed=31669975;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; p.Glu20Ter (c.58G>T); ClinVar=VCV000008477; Zygosity=Heterozygous (PubMed=31669975).
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; p.Cys47Phe (c.140G>T); ClinVar=VCV000549984; Zygosity=Heterozygous (PubMed=31669975).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126865; Niemann-Pick disease, type C2
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA79 ! GM18455
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   AKOSi002-A
AC   CVCL_YB81
SY   iPS GM05257-11; iPS 002-A
DR   hPSCreg; AKOSi002-A
DR   Wikidata; Q93324067
RX   PubMed=32028086;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Glu1064Ala (c.3191A>C); ClinVar=VCV000370081; Zygosity=Heterozygous (PubMed=32028086).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (PubMed=32028086).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P48 ! GM05257
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AKOSi003-A
AC   CVCL_YB82
SY   iPS F0101990-1; iPS 003-A
DR   hPSCreg; AKOSi003-A
DR   Wikidata; Q93324069
RX   PubMed=32028086;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Met769Val (c.2305A>G); ClinVar=VCV000035706; Zygosity=Homozygous (PubMed=32028086).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AKOSi004-A
AC   CVCL_A4DI
SY   iPS DD-NPC1-12; iPS 004-A
DR   hPSCreg; AKOSi004-A
DR   Wikidata; Q105506389
RX   PubMed=33360098;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Gly992Arg (c.2974G>C); ClinVar=VCV000002969; Zygosity=Heterozygous (PubMed=33360098).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Val1023Serfs*15 (c.3066_3073delinsT); Zygosity=Heterozygous (PubMed=33360098).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   AKOSi005-A
AC   CVCL_A4DJ
SY   iPS CTRL28-5; iPS 005-A
DR   hPSCreg; AKOSi005-A
DR   Wikidata; Q105506393
RX   PubMed=33360098;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AKOSi006-A
AC   CVCL_A4DG
SY   iPS GM18453-S4; iPS 006-A
DR   hPSCreg; AKOSi006-A
DR   Wikidata; Q105506395
RX   PubMed=33099109;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (PubMed=33099109).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA78 ! GM18453
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   AKOSi007-A
AC   CVCL_A4DH
SY   iPS GM08398-S14; iPS 007-A
DR   hPSCreg; AKOSi007-A
DR   Wikidata; Q105506398
RX   PubMed=33099109;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7481 ! GM08398
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   AKOSi008-A
AC   CVCL_A1VW
SY   iPS D1-12; iPS 008-A
DR   hPSCreg; AKOSi008-A
DR   Wikidata; Q105506401
RX   PubMed=33197697;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Homozygous (PubMed=33197697).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   AKOSi009-A
AC   CVCL_A1VV
SY   iPS GM23251-4; iPS 009-A
DR   hPSCreg; AKOSi009-A
DR   Wikidata; Q105506404
RX   PubMed=33197697;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F110 ! GM23251
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   AKOSi010-A
AC   CVCL_C1SP
SY   iPSC FAHN1-S43
DR   hPSCreg; AKOSi010-A
DR   Wikidata; Q114310620
RX   PubMed=35843022;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:21197; FA2H; Simple; p.Gly45Arg (c.133G>A); ClinVar=VCV001344330; Zygosity=Heterozygous (PubMed=35843022).
CC   Sequence variation: Mutation; HGNC; HGNC:21197; FA2H; Simple; p.His319Arg (c.956A>G); ClinVar=VCV001344335; Zygosity=Heterozygous (PubMed=35843022).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C188989; Spastic paraplegia 35
DI   ORDO; Orphanet_171629; Autosomal recessive spastic paraplegia type 35
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   AKOSi011-A
AC   CVCL_C9HV
SY   FAHN13_1
DR   hPSCreg; AKOSi011-A
DR   Wikidata; Q123030670
RX   PubMed=37573804;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:21197; FA2H; Simple; p.Asp35Tyr (c.103G>T); ClinVar=VCV000001044; Zygosity=Heterozygous (PubMed=37573804).
CC   Sequence variation: Mutation; HGNC; HGNC:21197; FA2H; Simple; p.Pro65Ser (c.193C>T); Zygosity=Heterozygous (PubMed=37573804).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C188989; Spastic paraplegia 35
DI   ORDO; Orphanet_171629; Autosomal recessive spastic paraplegia type 35
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AKOSi012-A
AC   CVCL_C9HW
SY   FAHN18_1
DR   hPSCreg; AKOSi012-A
DR   Wikidata; Q123030671
RX   PubMed=37573804;
CC   From: Albrecht-Kossel Institute for Neuroregeneration, University Medicine Rostock; Rostock; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:21197; FA2H; Simple; p.Tyr231His (c.691T>C); ClinVar=VCV000241464; Zygosity=Homozygous (PubMed=37573804).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C188989; Spastic paraplegia 35
DI   ORDO; Orphanet_171629; Autosomal recessive spastic paraplegia type 35
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AKR-2B
AC   CVCL_4103
SY   AKR mouse embryo cells clone 2B
DR   CLO; CLO_0001701
DR   EFO; EFO_0022815
DR   CLDB; cl264
DR   ECACC; 91061307
DR   TOKU-E; 4150
DR   Wikidata; Q54749100
RX   PubMed=196768;
RX   PubMed=679187;
RX   PubMed=2706619;
RX   PubMed=3465719;
RX   PubMed=4332980;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AKR-2B
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: AKR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15-18FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   AKR-MCA
AC   CVCL_Y466
DR   Wikidata; Q54749102
RX   PubMed=196768;
RX   PubMed=679187;
RX   PubMed=2706619;
RX   PubMed=6265069;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: AKR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4103 ! AKR-2B
SX   Sex unspecified
AG   15-18FD
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 10
//
ID   AKR/11D
AC   CVCL_3341
SY   AKR/11-D; 11D12
DR   CLO; CLO_0001693
DR   CLDB; cl4924
DR   ICLC; ATL98007
DR   Wikidata; Q54749104
RX   PubMed=1401954;
RX   PubMed=7517914;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   AKR/12B-1
AC   CVCL_3342
DR   CLO; CLO_0001694
DR   CLDB; cl4939
DR   ICLC; ATL98005
DR   Wikidata; Q54749107
RX   PubMed=1401954;
RX   PubMed=7517914;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   AKR/12B-2
AC   CVCL_3343
DR   CLO; CLO_0001695
DR   CLDB; cl4925
DR   ICLC; ATL98008
DR   Wikidata; Q54749110
RX   PubMed=1401954;
RX   PubMed=7517914;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   AKR/12B-3
AC   CVCL_3344
DR   CLO; CLO_0001696
DR   CLDB; cl4926
DR   ICLC; ATL98009
DR   Wikidata; Q54749113
RX   PubMed=1401954;
RX   PubMed=7517914;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   AKR/13B
AC   CVCL_3345
DR   CLO; CLO_0001697
DR   CLDB; cl4927
DR   ICLC; ATL98006
DR   Wikidata; Q54749115
RX   PubMed=1401954;
RX   PubMed=7517914;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   AKR/14C
AC   CVCL_3346
SY   14C6
DR   CLO; CLO_0001698
DR   CLDB; cl4928
DR   ICLC; ATL98010
DR   Wikidata; Q54749117
RX   PubMed=1401954;
RX   PubMed=7517914;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   AKR/JA.Sp
AC   CVCL_6564
DR   CLO; CLO_0001699
DR   ATCC; CRL-6320
DR   Wikidata; Q54749118
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6320; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: AKR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   AKR/JB.Sp
AC   CVCL_S401
DR   ATCC; CRL-6321
DR   Wikidata; Q54749119
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6321; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: AKR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   AKR1.G.1.OUAR.1.26
AC   CVCL_6565
SY   AKR1.G.1.OVAR.1.26; AKR1(Thy-1-a) TGr; AKR1; AKR/1
DR   CLO; CLO_0001700
DR   ATCC; TIB-232
DR   Wikidata; Q54749122
RX   DOI=10.1007/BF01561574;
RX   PubMed=1401954;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   AKU-MY01
AC   CVCL_ZV95
SY   Aku-MY01
DR   Wikidata; Q102113511
RX   DOI=10.1182/blood-2019-132238;
CC   Doubling time: 48-53 hours (DOI=10.1182/blood-2019-132238).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   Akuba
AC   CVCL_W933
AS   CVCL_W745
SY   AKUBA; AKUA; AK 778; AK778
DR   cancercelllines; CVCL_W933
DR   Cosmic; 931113
DR   Cosmic; 2808221
DR   IARC_TP53; 7394
DR   Wikidata; Q54749033
RX   PubMed=170370;
RX   PubMed=1325212;
RX   PubMed=3026973;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=4122458;
RX   PubMed=4364259;
RX   PubMed=6286763;
RX   PubMed=7316467;
RX   PubMed=7519050;
RX   PubMed=7757991;
RX   PubMed=8176200;
RX   PubMed=8220424;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8568269;
RX   PubMed=9473234;
RX   PubMed=24590883;
CC   Population: African; Kenyan.
CC   Doubling time: 21 hours (PubMed=8402660).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=7519050).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=7757991; PubMed=8402660).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 17
//
ID   AL #1
AC   CVCL_C7SA
DR   Wikidata; Q123030672
RX   PubMed=994214;
RX   PubMed=4524119;
CC   Doubling time: 28 hours (Note=At 83th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AL 1-27
AC   CVCL_J741
SY   A 127; A127; M-11
DR   CLO; CLO_0001702
DR   ATCC; HB-8441
DR   Wikidata; Q54749127
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8441.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   Al Ke
AC   CVCL_3642
DR   CLO; CLO_0001703
DR   ATCC; CRL-1325
DR   Wikidata; Q54749130
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Al Pos
AC   CVCL_4J63
DR   ATCC; CRL-1120
DR   Wikidata; Q54749133
CC   Discontinued: ATCC; CRL-1120; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 8
//
ID   AL-1
AC   CVCL_A0QY
DR   Wikidata; Q108819849
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Acholeplasma laidlawii.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   AL-10
AC   CVCL_A7RI
DR   IHW; IHW09480
DR   Wikidata; Q107113353
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*26:01:01:01; B*38:01:01; C*12:03:01:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:02:01; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   AL-2
AC   CVCL_A0QZ
DR   Wikidata; Q108819850
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Acholeplasma laidlawii.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   AL-3
AC   CVCL_A0RA
DR   Wikidata; Q108819851
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Acholeplasma laidlawii.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   AL-3-11A
AC   CVCL_DE34
SY   Alginate-donor 3-clone 11A
DR   Wikidata; Q54749135
RX   PubMed=20020445;
CC   Doubling time: 1.5-3 days (PubMed=20020445).
CC   Transformant: Ad5-SV40 hybrid virus.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Knee, articular cartilage; UBERON=UBERON_0001465+UBERON_0010996.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   AL-4-17
AC   CVCL_DE35
SY   Alginate-donor 4-clone 17
DR   Wikidata; Q54749138
RX   PubMed=20020445;
CC   Doubling time: 1.5-3 days (PubMed=20020445).
CC   Transformant: Ad5-SV40 hybrid virus.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Knee, articular cartilage; UBERON=UBERON_0001465+UBERON_0010996.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   AL/N
AC   CVCL_6312
SY   N AL/N
DR   CLO; CLO_0001704
DR   ATCC; CRL-6506
DR   Wikidata; Q54749140
RX   PubMed=4302577;
RX   PubMed=4331720;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6506; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AL/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   AL/N-E
AC   CVCL_B6MK
DR   Wikidata; Q111732905
RX   PubMed=4302577;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: AL/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6312 ! AL/N
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AL/N-F
AC   CVCL_B6ML
DR   Wikidata; Q111732906
RX   PubMed=4302577;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: AL/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6312 ! AL/N
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AL07
AC   CVCL_A1TM
DR   Wikidata; Q105506406
RX   PubMed=32927240;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <12FW
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 9
//
ID   AL1
AC   CVCL_X931
SY   AL-1
DR   CGH-DB; 9189-4
DR   Wikidata; Q54749144
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4177061;
RX   PubMed=4321974;
RX   PubMed=5902320;
CC   Population: African; Nigerian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone, jaw; UBERON=UBERON_0001708.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 10
//
ID   AL11
AC   CVCL_C4LU
DR   ABCD; ABCD_AI260
DR   Wikidata; Q116048489
RX   PubMed=12505721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61930; N(6)-acetyl-L-lysine residue.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AL1405
AC   CVCL_VL88
DR   Wikidata; Q93324166
RX   PubMed=450131;
RX   PubMed=7301938;
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   AL1665
AC   CVCL_VL84
DR   Wikidata; Q93324168
RX   PubMed=22282976;
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   AL1899
AC   CVCL_VL91
DR   Wikidata; Q93324171
RX   PubMed=450131;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   AL2
AC   CVCL_C5UY
DR   Wikidata; Q116048490
RX   PubMed=6576989;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AL2322
AC   CVCL_VL85
DR   Wikidata; Q93324173
RX   PubMed=22282976;
CC   Donor information: Established from a patient suffering from acute lymphocytic leukemia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   AL2642
AC   CVCL_VL86
DR   Wikidata; Q93324175
RX   PubMed=22282976;
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   AL2673
AC   CVCL_VL90
DR   Wikidata; Q93324177
RX   PubMed=450131;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   AL3
AC   CVCL_C5UZ
DR   Wikidata; Q116048491
RX   PubMed=6576989;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AL377
AC   CVCL_VL89
DR   Wikidata; Q93324179
RX   PubMed=450131;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   AL3D5
AC   CVCL_C4LV
DR   ABCD; ABCD_AI261
DR   Wikidata; Q116048493
RX   PubMed=12505721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61930; N(6)-acetyl-L-lysine residue.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   AL4
AC   CVCL_C5V0
DR   Wikidata; Q116048494
RX   PubMed=6576989;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   AL409
AC   CVCL_VL87
DR   Wikidata; Q93324181
RX   PubMed=22282976;
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   AL5
AC   CVCL_C5V1
DR   Wikidata; Q116048495
RX   PubMed=6576989;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AL639
AC   CVCL_VL93
DR   Wikidata; Q93324183
RX   PubMed=450131;
RX   PubMed=7301938;
CC   Donor information: Established from a patient suffering from acute monomyelogenous leukemia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   ALA
AC   CVCL_J358
SY   Ala; HCT-ALA; HCT ALA
DR   cancercelllines; CVCL_J358
DR   ColonAtlas; ALA
DR   Cosmic; 711270
DR   Cosmic; 887234
DR   Cosmic; 1479575
DR   IARC_TP53; 6473
DR   Wikidata; Q54749147
RX   PubMed=3349466;
RX   PubMed=7329817;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11526487;
RX   PubMed=20570890;
RX   PubMed=24042735;
RX   PubMed=25944804;
CC   Doubling time: 51.58 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Unspecified (PubMed=9000147).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   AlAb
AC   CVCL_U957
SY   ALAB; Alab; A1Ab
DR   ATCC; CRL-7715
DR   cancercelllines; CVCL_U957
DR   CLS; 300280
DR   Cosmic; 1218871
DR   GEO; GSM783944
DR   Progenetix; CVCL_U957
DR   Wikidata; Q54749148
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=77569;
RX   PubMed=212193;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4329447;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=14490970;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   HLA typing: A*02,09; B*w15; C*w02,w06 (PubMed=77569).
CC   Discontinued: ATCC; CRL-7715; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=300280
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 15,17
ST   D21S11: 27,30.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 18
//
ID   ALB1
AC   CVCL_C5DY
DR   Wikidata; Q116048496
RX   PubMed=2409408;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ALB2
AC   CVCL_C5DZ
DR   Wikidata; Q116048498
RX   PubMed=2409408;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ALB6
AC   CVCL_C5E0
DR   Wikidata; Q116048499
RX   PubMed=2409408;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21926; Human CD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ALB7
AC   CVCL_C5E1
DR   Wikidata; Q116048500
RX   PubMed=2409408;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25063; Human CD24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ALB8
AC   CVCL_C5E2
DR   Wikidata; Q116048502
RX   PubMed=2409408;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25063; Human CD24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ALB9
AC   CVCL_C5E3
DR   Wikidata; Q116048504
RX   PubMed=2409408;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25063; Human CD24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ALBA
AC   CVCL_F698
DR   IPD-IMGT/HLA; 12067
DR   Wikidata; Q54749151
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,32; B*44:19N,82:02; C*04,05 (IPD-IMGT/HLA=12067).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   ALC [Mouse ameloblast]
AC   CVCL_1947
SY   Ameloblast-Lineage Cells
DR   BTO; BTO_0006379
DR   Wikidata; Q54749152
RX   PubMed=12927794;
RX   PubMed=25120490;
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
CC   Cell type: Ameloblast; CL=CL_0000059.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Newborn
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   ALC [Mouse bone marrow]
AC   CVCL_0E84
DR   Wikidata; Q54749154
RX   PubMed=2435412;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   ALC 10.1
AC   CVCL_A8Q9
DR   Wikidata; Q102113512
RX   PubMed=7821375;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8R0 ! ALC 10.2
SX   Sex unspecified
AG   54Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ALC 10.2
AC   CVCL_A8R0
DR   Wikidata; Q102113514
RX   PubMed=7821375;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8Q9 ! ALC 10.1
SX   Sex unspecified
AG   54Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ALC 2.1
AC   CVCL_A8R1
DR   Wikidata; Q102113516
RX   PubMed=7821375;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8R2 ! ALC 2.2
SX   Sex unspecified
AG   76Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ALC 2.2
AC   CVCL_A8R2
DR   Wikidata; Q102113517
RX   PubMed=7821375;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8R1 ! ALC 2.1
SX   Sex unspecified
AG   76Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ALC 4.1
AC   CVCL_A8R3
DR   Wikidata; Q102113518
RX   PubMed=7821375;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8R4 ! ALC 4.2
SX   Sex unspecified
AG   18Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ALC 4.2
AC   CVCL_A8R4
DR   Wikidata; Q102113520
RX   PubMed=7821375;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8R3 ! ALC 4.1
SX   Sex unspecified
AG   18Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ALD FiPS1-Ep6F-11
AC   CVCL_E7AC
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+ALD+FiPS1-Ep6F-11+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ALD%2520FiPS1-Ep6F-11%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D21S11: 29,31.2
ST   D5S818: 11,13
ST   D7S820: 7,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ALD FiPS2-Ep6F-11
AC   CVCL_E7AB
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+ALD+FiPS2-Ep6F-11+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ALD%2520FiPS2-Ep6F-11%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   AlDo
AC   CVCL_LC71
DR   cancercelllines; CVCL_LC71
DR   GEO; GSM1904842
DR   Progenetix; CVCL_LC71
DR   Wikidata; Q54749156
RX   PubMed=23563200;
RX   PubMed=30873613;
CC   Doubling time: 7 days (PubMed=30873613).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Back, skin; UBERON=UBERON_0001068.
ST   Source(s): PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 30.2,33.2
ST   D3S1358: 15.2,17
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 8,9
ST   Penta E: 5,17
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,19
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   Alex1
AC   CVCL_C6VY
DR   SKIP; SKIP000909
DR   Wikidata; Q123030673
RX   PubMed=27402089;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg239Cys (c.729C>T); ClinVar=VCV000016167; Zygosity=Heterozygous (PubMed=27402089).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U890 ! GM16825
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Alex2
AC   CVCL_C6VZ
DR   SKIP; SKIP000910
DR   Wikidata; Q123030674
RX   PubMed=27402089;
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Glu69Lys (c.205G>A); ClinVar=VCV000190333; Zygosity=Heterozygous (PubMed=27402089).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   Alex3
AC   CVCL_C6W0
DR   SKIP; SKIP000911
DR   Wikidata; Q123030675
RX   PubMed=27402089;
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg276Leu (c.827G>T); ClinVar=VCV000016177; Zygosity=Heterozygous (PubMed=27402089).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   ALF [Acanthopagrus latus]
AC   CVCL_B6Y4
SY   Acanthopagrus Latus Fin
DR   Wikidata; Q111732907
RX   DOI=10.1016/j.aquaculture.2021.737801;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8177; ! Acanthopagrus latus (Yellowfin seabream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ALF [Human gastric carcinoma]
AC   CVCL_M035
DR   Wikidata; Q54749160
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Miscellaneous: Only mentioned as a stomach cancer cell line in PubMed=15767549.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 12
//
ID   Ali-BL
AC   CVCL_7172
SY   Ali
DR   Wikidata; Q54749163
RX   PubMed=9882297;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   ALKO
AC   CVCL_5I28
SY   Astrocyte LKB1 knock out
DR   Kerafast; EB9001-FP
DR   Wikidata; Q54749164
CC   From: Feinstein, Douglas Lawrence; University of Illinois at Chicago; Chicago; USA.
CC   Doubling time: 18-24 hours (Kerafast=EB9001-FP).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1341870; Stk11.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   ALL
AC   CVCL_B5ED
SY   Acanthopagrus Latus Liver
DR   Wikidata; Q110432579
RX   PubMed=34624134;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV), red-spotted grouper nervous necrosis virus (RGNNV) and largemouth bass virus (LMBV) (PubMed=34624134).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8177; ! Acanthopagrus latus (Yellowfin seabream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   ALL-1
AC   CVCL_QW61
DR   Cosmic; 2348804
DR   Wikidata; Q54749167
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2039829;
RX   PubMed=2825022;
RX   PubMed=3496132;
RX   PubMed=3513189;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15302850;
CC   Characteristics: Can be differentiated into dendritic-like cells in culture with a combination of cytokines (IL1B, IL3, IL7, TNF, KITLG and CD40LG) (PubMed=15302850).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 12
//
ID   ALL-2
AC   CVCL_QW62
DR   Wikidata; Q54749169
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3496132;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (from child cell line ALL-2B).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   ALL-2B
AC   CVCL_QW67
DR   Wikidata; Q54749171
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2039829;
RX   PubMed=14671638;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QW62 ! ALL-2
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   ALL-3
AC   CVCL_QW63
DR   Wikidata; Q54749223
RX   PubMed=2039829;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ALL-7031-B
AC   CVCL_0B39
SY   7031-B
DR   Wikidata; Q54749225
RX   PubMed=3495441;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   ALL-PO
AC   CVCL_1069
SY   ALLPO; AllPO
DR   CLO; CLO_0001705
DR   CLDB; cl5399
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1069
DR   Cell_Model_Passport; SIDM00211
DR   ChEMBL-Cells; CHEMBL3308227
DR   ChEMBL-Targets; CHEMBL2366294
DR   Cosmic; 910944
DR   Cosmic-CLP; 910944
DR   DepMap; ACH-002209
DR   EGA; EGAS00001000978
DR   GDSC; 910944
DR   GEO; GSM1669596
DR   GEO; GSM5137706
DR   GEO; GSM5137750
DR   IARC_TP53; 21173
DR   ICLC; HTL01003
DR   LINCS_LDP; LCL-1043
DR   PharmacoDB; ALLPO_58_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1069
DR   Wikidata; Q54749226
RX   PubMed=9444945;
RX   PubMed=14671638;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638; PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=910944).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.07%; East Asian, North=2.2%; East Asian, South=1.8%; South Asian=1.45%; European, North=52.99%; European, South=41.49% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=910944; ICLC=HTL01003
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   ALL-SIL
AC   CVCL_1805
SY   ALLSIL; SIL-ALL; Sil-ALL
DR   BTO; BTO_0005360
DR   CLO; CLO_0037168
DR   EFO; EFO_0022414
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473514
DR   BioSample; SAMN10988449
DR   cancercelllines; CVCL_1805
DR   Cell_Model_Passport; SIDM00994
DR   Cosmic; 721715
DR   Cosmic; 913404
DR   Cosmic; 933537
DR   Cosmic; 996306
DR   Cosmic; 998724
DR   Cosmic; 1037687
DR   Cosmic; 1115585
DR   Cosmic; 1175126
DR   Cosmic; 1224372
DR   Cosmic; 1330498
DR   Cosmic; 1524789
DR   Cosmic; 1641391
DR   Cosmic; 1664519
DR   Cosmic; 1760517
DR   Cosmic; 2165718
DR   Cosmic; 2602907
DR   Cosmic-CLP; 1295740
DR   DepMap; ACH-000105
DR   DSMZ; ACC-511
DR   DSMZCellDive; ACC-511
DR   EGA; EGAS00001000978
DR   GDSC; 1295740
DR   GEO; GSM1669597
DR   GEO; GSM5137707
DR   LiGeA; CCLE_156
DR   LINCS_LDP; LCL-2059
DR   PharmacoDB; ALLSIL_59_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1805
DR   Wikidata; Q54749231
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=10071127;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=15361874;
RX   PubMed=15472075;
RX   PubMed=17117183;
RX   PubMed=22675565;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/all-sil/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 64 hours (PubMed=17117183); ~48 hours (DSMZ=ACC-511).
CC   HLA typing: A*02:01,30:02; B*14:02,15:01; C*03:03,08:02; DQB1*06:07;06:07; DRB1*15:01;15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:8064; NUP214; Name(s)=NUP214-ABL1; Note=NUP214 exon 32 fused to ABL1 exon 2 (PubMed=15361874; PubMed=35354797; DSMZ=ACC-511).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2474fs*4 (c.7418_7419insGG); Zygosity=Heterozygous (PubMed=15472075).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=1.38%; Native American=0%; East Asian, North=1.27%; East Asian, South=1.49%; South Asian=5.24%; European, North=39.53%; European, South=51.09% (PubMed=30894373).
CC   Misspelling: AL:L-SIL; Cosmic=913404.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=1295740; DSMZ=ACC-511
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 12,17
ST   D21S11: 29,31
ST   D2S1338: 17,23
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 21
ST   Penta D: 10,15
ST   Penta E: 7,17
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   ALL-VG
AC   CVCL_C1ME
DR   Wikidata; Q114310621
RX   PubMed=18656692;
RX   PubMed=28650474;
CC   Karyotypic information: 45,XY,der(1)t(1;9),der(9)t(9;13),-13,der(16)t(16;22) (PubMed=18656692).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1785; CDKN1B; Zygosity=Unspecified (PubMed=18656692).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=18656692).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (PubMed=18656692).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:3495; ETV6; Name(s)=ETV6-ABL1 (PubMed=18656692; PubMed=28650474).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   ALL-VG TKI-resistant
AC   CVCL_C1MF
DR   cancercelllines; CVCL_C1MF
DR   Wikidata; Q114310623
RX   PubMed=28650474;
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1785; CDKN1B; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:3495; ETV6; Name(s)=ETV6-ABL1 (PubMed=28650474).
CC   Sequence variation: Mutation; HGNC; HGNC:4396; GNB1; Simple; p.Lys89Met (c.266A>T); ClinVar=VCV001360749; Zygosity=Heterozygous; Note=Involved in imatinib resistance (PubMed=28650474).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1ME ! ALL-VG
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   ALL/MIK
AC   CVCL_W883
SY   ALL:MIK
DR   Wikidata; Q54749233
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1884023;
RX   PubMed=8167560;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=8167560).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=8167560; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 17
//
ID   AllSi-Heart
AC   CVCL_DA19
DR   Wikidata; Q54749236
RX   DOI=10.1007/s11434-011-4622-9;
CC   Group: Endangered species/breed cell line.
CC   Group: Reptilian cell line.
CC   Doubling time: ~36 hours (DOI=10.1007/s11434-011-4622-9).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=38654; ! Alligator sinensis (Chinese alligator)
OI   CVCL_DA20 ! AllSi-Liver
OI   CVCL_DA21 ! AllSi-Muscle
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   AllSi-Liver
AC   CVCL_DA20
DR   Wikidata; Q54749237
RX   DOI=10.1007/s11434-011-4622-9;
CC   Group: Endangered species/breed cell line.
CC   Group: Reptilian cell line.
CC   Doubling time: ~36 hours (DOI=10.1007/s11434-011-4622-9).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=38654; ! Alligator sinensis (Chinese alligator)
OI   CVCL_DA19 ! AllSi-Heart
OI   CVCL_DA21 ! AllSi-Muscle
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   AllSi-Muscle
AC   CVCL_DA21
DR   Wikidata; Q54749240
RX   DOI=10.1007/s11434-011-4622-9;
CC   Group: Endangered species/breed cell line.
CC   Group: Reptilian cell line.
CC   Doubling time: ~36 hours (DOI=10.1007/s11434-011-4622-9).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=38654; ! Alligator sinensis (Chinese alligator)
OI   CVCL_DA19 ! AllSi-Heart
OI   CVCL_DA20 ! AllSi-Liver
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ALMC-1
AC   CVCL_M525
SY   ALMC1
DR   GEO; GSE54507
DR   Millipore; SCC430
DR   Wikidata; Q54749243
RX   CelloPub=CLPUB00604;
RX   DOI=10.1182/blood.V112.11.2732.2732;
RX   PubMed=18567838;
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG lambda.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from primary systemic amyloidosis which relapsed with multiple myeloma.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M526 ! ALMC-2
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   ALMC-2
AC   CVCL_M526
SY   ALMC2
DR   Wikidata; Q54749244
RX   CelloPub=CLPUB00604;
RX   DOI=10.1182/blood.V112.11.2732.2732;
RX   PubMed=18567838;
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=25015330;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG lambda.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from primary systemic amyloidosis which relapsed with multiple myeloma.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M525 ! ALMC-1
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   Alo 39
AC   CVCL_VP89
SY   Alo-39; ALO-39; ALVE39
DR   Wikidata; Q93324261
RX   PubMed=10837406;
RX   PubMed=16638848;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP90 ! Alo 40
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   Alo 40
AC   CVCL_VP90
SY   Alo40; ALVE40
DR   Wikidata; Q93324262
RX   PubMed=10837406;
RX   PubMed=16638848;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP89 ! Alo 39
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   alpha Pro13
AC   CVCL_C8AB
SY   alpha Pro-13; alpha Pro 13; alphaPro13
DR   Wikidata; Q123030676
RX   PubMed=2787412;
RX   PubMed=6375858;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human prostate antigen p40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   alpha Pro15
AC   CVCL_C8AC
SY   alpha Pro-15; alpha Pro 15; alphaPro15
DR   Wikidata; Q123030677
RX   PubMed=2787412;
RX   PubMed=6375858;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human prostate antigen p40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   alpha Pro17
AC   CVCL_C8AD
SY   alpha Pro-17; alpha Pro 17; alphaPro17
DR   Wikidata; Q123030678
RX   PubMed=2787412;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown prostate antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   alpha Pro3
AC   CVCL_C8A9
SY   alpha Pro-3; alpha Pro 3; alphaPro3
DR   Wikidata; Q123030679
RX   PubMed=6174221;
RX   PubMed=6188529;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human prostate antigen p54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   alpha Pro5
AC   CVCL_C8AA
SY   alpha Pro-5; alpha Pro 5; alphaPro5
DR   Wikidata; Q123030680
RX   PubMed=6188529;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human prostate antigen p54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   alpha T1
AC   CVCL_AW09
DR   Wikidata; Q54749249
RX   PubMed=2562221;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Cryaa-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   alpha T2 line 4
AC   CVCL_C4KS
SY   alphaT2 line 4
DR   Wikidata; Q116048506
RX   PubMed=1694016;
RX   PubMed=2562221;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Cryaa-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   alpha T2 line 6
AC   CVCL_AW10
SY   alphaT2 line 6
DR   Wikidata; Q54749251
RX   PubMed=1694016;
RX   PubMed=2562221;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Cryaa-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   alpha wheat HBZ#10-1
AC   CVCL_C7KR
DR   Wikidata; Q123030681
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#12-1
AC   CVCL_C7KS
DR   Wikidata; Q123030682
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#14-1
AC   CVCL_C7KT
DR   Wikidata; Q123030683
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#1-1
AC   CVCL_C7KK
DR   Wikidata; Q123030684
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#2-1
AC   CVCL_C7KL
DR   Wikidata; Q123030685
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#5-1
AC   CVCL_C7KM
DR   Wikidata; Q123030686
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#6-1
AC   CVCL_C7KN
DR   Wikidata; Q123030688
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#7-1
AC   CVCL_C7KP
DR   Wikidata; Q123030689
RX   Patent=JP2016114360A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE ABP-01969.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha wheat HBZ#8-1
AC   CVCL_C7KQ
DR   Wikidata; Q123030690
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Alpha-8-D5
AC   CVCL_ZF09
DR   Wikidata; Q98125469
RX   PubMed=19454181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02475; Pig CRYAA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   alpha-ACE 3.1.1
AC   CVCL_K122
SY   ACE 3.1.1; a-ACE 3.1.1
DR   CLO; CLO_0009730
DR   ATCC; HB-8191
DR   Wikidata; Q54749246
RX   Patent=US4582790;
RX   PubMed=6296854;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8191.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P47820; Rat Ace.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   alpha-Mel/11
AC   CVCL_B5J9
DR   Wikidata; Q111732908
RX   PubMed=6155995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   alpha-Mel/12
AC   CVCL_B5JA
DR   Wikidata; Q111732909
RX   PubMed=6155995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   alpha-Mel/14
AC   CVCL_B5JB
DR   Wikidata; Q111732910
RX   PubMed=6155995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   alpha-Mel/34
AC   CVCL_B5JC
DR   Wikidata; Q111732912
RX   PubMed=6155995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   alpha-Mel/37
AC   CVCL_B5JD
DR   Wikidata; Q111732913
RX   PubMed=6155995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   alpha-Mel/5
AC   CVCL_B5J7
DR   Wikidata; Q111732914
RX   PubMed=6155995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   alpha-Mel/7
AC   CVCL_B5J8
DR   Wikidata; Q111732915
RX   PubMed=6155995;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   Alpha-SN4-1
AC   CVCL_C7J2
DR   Wikidata; Q123030691
RX   PubMed=20568998;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7KZF4; Human SND1 (Note=Recognizes TNase-like domain 4. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Alpha-SN4-2
AC   CVCL_C7J3
DR   Wikidata; Q123030692
RX   PubMed=20568998;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KZF4; Human SND1 (Note=Recognizes TNase-like domain 4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Alpha-SN4-3
AC   CVCL_C7J4
DR   Wikidata; Q123030693
RX   PubMed=20568998;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KZF4; Human SND1 (Note=Recognizes TNase-like domain 4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Alpha-SN4-4
AC   CVCL_C7J5
DR   Wikidata; Q123030694
RX   PubMed=20568998;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KZF4; Human SND1 (Note=Recognizes TNase-like domain 4. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Alpha-SN4-5
AC   CVCL_C7J6
DR   Wikidata; Q123030695
RX   PubMed=20568998;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KZF4; Human SND1 (Note=Recognizes TNase-like domain 4. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Alpha-TSH
AC   CVCL_U364
SY   alpha TSH
DR   Wikidata; Q54749254
RX   PubMed=1704102;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   Alpha-TSN-1
AC   CVCL_C7J7
DR   Wikidata; Q123030696
RX   PubMed=20568998;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KZF4; Human SND1 (Note=Recognizes Tudor domain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Alpha-TSN-2
AC   CVCL_C7J8
DR   Wikidata; Q123030697
RX   PubMed=20568998;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KZF4; Human SND1 (Note=Recognizes Tudor domain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   alpha40T
AC   CVCL_B7FV
SY   LSTC-40T
DR   Wikidata; Q112929234
RX   PubMed=67703;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   alpha48T
AC   CVCL_B7FW
SY   LSTC-48T
DR   Wikidata; Q112929235
RX   PubMed=67703;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   alphaA1
AC   CVCL_UV26
DR   Wikidata; Q93324266
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_37415; Alpha-amanitin.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   alphaA2
AC   CVCL_UV27
DR   Wikidata; Q93324267
RX   PubMed=231040;
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_37415; Alpha-amanitin.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   alphaA3
AC   CVCL_UV28
DR   Wikidata; Q93324268
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_37415; Alpha-amanitin.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   AlphaHT+N1
AC   CVCL_C4ZI
DR   Wikidata; Q116048507
RX   PubMed=1725170;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AlphaHT+N2
AC   CVCL_C4ZJ
DR   Wikidata; Q116048508
RX   PubMed=1725170;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   AlphaHT+N3
AC   CVCL_C4ZK
DR   Wikidata; Q116048509
RX   PubMed=1725170;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AlphaHT+N4
AC   CVCL_C4ZL
DR   Wikidata; Q116048510
RX   PubMed=1725170;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   alphaPIG-AT25-miPSC
AC   CVCL_IS70
DR   Wikidata; Q54749257
RX   PubMed=27879210;
CC   Characteristics: Transduced with an alphaPIG vector that contains a myosin-alpha promoter controlling the expression of a PuroR-IRES-EGFP construct. Also contains a pSV40-neo cassette (PubMed=27879210).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IS69 ! TiB7-4
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 12
//
ID   AlphaT1-1
AC   CVCL_U463
SY   Alpha-T1-1
DR   Wikidata; Q54749260
RX   PubMed=8898243;
RX   PubMed=15541569;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6 x BALB/c transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_U355 ! TalphaT1
SX   Sex unspecified
AG   67D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   AlphaT3-1
AC   CVCL_0149
SY   AlphaT31; alphaT3-1; alpha T3-1; alpha-T3-1; aT3-1
DR   BTO; BTO_0003566
DR   EFO; EFO_0022819
DR   MCCL; MCC:0000042
DR   Wikidata; Q54749261
RX   PubMed=1704103;
RX   PubMed=8898243;
RX   PubMed=15541569;
RX   PubMed=31020055;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6 x BALB/c transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   alphaTC1
AC   CVCL_B035
SY   alpha-TC1; alpha TC1; aTC1
DR   Wikidata; Q54749264
RX   PubMed=2156740;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic alpha cell; CL=CL_0002351.
CC   Breed/subspecies: C57BL/6 x DBA/2.
DI   NCIt; C34051; Mouse islet cell adenoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unpecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   alphaTC1 Clone 6
AC   CVCL_B036
SY   alpha TC1 clone 6; alphaTC clone 6; alpha-TC1.6; alphaTC1.6; alpha-TC1-6; alpha TC1-6; alpha TC1.6; aTC1 Clone 6; aTC1-6
DR   BTO; BTO_0002982
DR   ATCC; CRL-2934
DR   TOKU-E; 4124
DR   Wikidata; Q54749266
RX   PubMed=2108069;
RX   PubMed=34871457;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic alpha cell; CL=CL_0002351.
CC   Breed/subspecies: C57BL/6 x DBA/2.
DI   NCIt; C34051; Mouse islet cell adenoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B035 ! alphaTC1
SX   Sex unspecified
AG   Age unpecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   alphaTC1 Clone 9
AC   CVCL_0150
SY   alpha TC1 clone 9; alphaTC clone 9; alpha-TC1.9; alphaTC1.9; alpha-TC1-9; aTC1 Clone 9; aTC1-9
DR   BTO; BTO_0002981
DR   CLO; CLO_0009736
DR   MCCL; MCC:0000495
DR   AddexBio; C0018021/5023
DR   ATCC; CRL-2350
DR   Wikidata; Q54749268
RX   PubMed=2108069;
RX   PubMed=36180704;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/crl-2350-growth-and-morphology
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic alpha cell; CL=CL_0002351.
CC   Breed/subspecies: C57BL/6 x DBA/2.
DI   NCIt; C34051; Mouse islet cell adenoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B035 ! alphaTC1
SX   Sex unspecified
AG   Age unpecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   alphaTC1-6 ins2:eGFP
AC   CVCL_B6YB
SY   ins2:eGFP alphaTC1-6; pcDNA3.1-Puro-ins2-eGFP alphaTC1-6
DR   Wikidata; Q111732917
RX   PubMed=34871457;
CC   Characteristics: Transfected with a PuroR-ins2-eGFP construct where the expression of the eGFP gene is under the control of the mouse ins2 promoter (PubMed=34871457).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic alpha cell; CL=CL_0002351.
CC   Breed/subspecies: C57BL/6 x DBA/2.
DI   NCIt; C34051; Mouse islet cell adenoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B036 ! alphaTC1 Clone 6
SX   Sex unspecified
AG   Age unpecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   alphaTN4
AC   CVCL_AW08
DR   Wikidata; Q54749272
RX   PubMed=1694016;
RX   PubMed=2178867;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Cryaa-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4KS ! alpha T2 line 4
SX   Sex unspecified
AG   2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   alphaTN4-1
AC   CVCL_D858
SY   alpha TN4-1
DR   BTO; BTO_0001872
DR   Wikidata; Q54749275
RX   PubMed=1694016;
RX   PubMed=9990330;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Cryaa-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AW08 ! alphaTN4
SX   Sex unspecified
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   alphaTN4-1-26
AC   CVCL_B5M8
DR   Wikidata; Q111732918
RX   PubMed=9990330;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2279; Cat.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Cryaa-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D858 ! alphaTN4-1
SX   Sex unspecified
AG   2M
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   alphaTN6
AC   CVCL_AW11
DR   Wikidata; Q54749277
RX   PubMed=1694016;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Cryaa-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AW10 ! alpha T2 line 6
SX   Sex unspecified
AG   11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   ALS-002
AC   CVCL_RL05
DR   SKIP; SKIP001317
DR   Wikidata; Q54749279
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (PubMed=24139042).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ALS-004
AC   CVCL_RL06
DR   SKIP; SKIP001316
DR   Wikidata; Q54749281
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (PubMed=24139042).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ALS-017
AC   CVCL_RL07
DR   SKIP; SKIP001319
DR   Wikidata; Q54749282
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (PubMed=24139042).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ALS-028
AC   CVCL_RL08
DR   SKIP; SKIP001318
DR   Wikidata; Q54749285
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (PubMed=24139042).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   ALS-033
AC   CVCL_RL09
DR   SKIP; SKIP001314
DR   Wikidata; Q54749287
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24139042).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   ALS-034
AC   CVCL_RL10
DR   SKIP; SKIP001315
DR   Wikidata; Q54749289
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24139042).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   ALS-050
AC   CVCL_RL11
SY   ALS-50; ALS50; HEL13.1; UHi002-A
DR   BioSamples; SAMEA5236073
DR   hPSCreg; UHi002-A
DR   SKIP; SKIP001312
DR   Wikidata; Q54749292
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24139042).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   ALS-075
AC   CVCL_RL12
SY   ALS75; HEL15.14; UHi003-A
DR   BioSamples; SAMEA5236711
DR   hPSCreg; UHi003-A
DR   SKIP; SKIP001313
DR   Wikidata; Q54749294
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24139042).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   ALS-077
AC   CVCL_RL13
DR   Wikidata; Q54749295
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24139042).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   ALS-078
AC   CVCL_RL14
DR   Wikidata; Q54749300
RX   PubMed=24139042;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24139042).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   ALS-iPS1
AC   CVCL_L641
DR   SKIP; SKIP005479
DR   Wikidata; Q54749301
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*02,31; B*75,48 (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 12,13
ST   D19S433: 14.2,15
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D6S1043: 13,14
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 10,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L642 ! ALS-iPS2
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   ALS-iPS2
AC   CVCL_L642
DR   SKIP; SKIP005480
DR   Wikidata; Q54749303
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*02,31; B*75,48 (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 12,13
ST   D19S433: 14.2,15
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D6S1043: 13,14
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 10,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L641 ! ALS-iPS1
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   ALS11
AC   CVCL_UF83
SY   sALS line 11
DR   Wikidata; Q93324329
RX   PubMed=24379375;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24379375).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   ALS183
AC   CVCL_UF85
SY   fALS line 183
DR   Wikidata; Q93324331
RX   PubMed=24379375;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24379375).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   ALS201
AC   CVCL_UF86
SY   fALS line 201
DR   Wikidata; Q93324333
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Varcianna, Andre E.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   ALS3410v1
AC   CVCL_ZC74
SY   fALS line 3410v1
DR   Wikidata; Q98125470
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZC75 ! ALS3410v2
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   ALS3410v2
AC   CVCL_ZC75
SY   fALS line 3410v2
DR   Wikidata; Q98125471
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZC74 ! ALS3410v1
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   ALS78
AC   CVCL_UF84
SY   fALS line 78
DR   Wikidata; Q93324335
RX   PubMed=24379375;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24379375).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   ALST
AC   CVCL_W778
DR   Wikidata; Q54749306
RX   PubMed=10972993;
RX   PubMed=11793438;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   ALT
AC   CVCL_Y087
DR   BCRC; 60581
DR   Wikidata; Q54749309
RX   PubMed=21894147;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2D
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   ALT-F
AC   CVCL_B328
SY   ALTF
DR   Cosmic; 889538
DR   Wikidata; Q54749310
RX   PubMed=7960578;
RX   PubMed=11964082;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B329 ! ALT-G
OI   CVCL_B330 ! ALT-I
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   ALT-G
AC   CVCL_B329
SY   ALTG
DR   Cosmic; 889539
DR   Wikidata; Q54749313
RX   PubMed=7960578;
RX   PubMed=11964082;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B328 ! ALT-F
OI   CVCL_B330 ! ALT-I
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   ALT-I
AC   CVCL_B330
SY   ALTI
DR   Cosmic; 889537
DR   Cosmic; 902792
DR   Wikidata; Q54749317
RX   PubMed=7960578;
RX   PubMed=11964082;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B328 ! ALT-F
OI   CVCL_B329 ! ALT-G
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 8
//
ID   ALTS1C1
AC   CVCL_Y088
DR   ABM; T8239
DR   BCRC; 60582
DR   Wikidata; Q54749369
RX   PubMed=21894147;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y087 ! ALT
SX   Male
AG   2D
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   ALTS1C1-SDFkd
AC   CVCL_GT22
SY   ALTS1C1 (SDFkd)
DR   BCRC; 60608
DR   Wikidata; Q54749370
RX   PubMed=21894147;
CC   Knockout cell: Method=siRNA knockdown; MGI; MGI:103556; Cxcl12.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y088 ! ALTS1C1
SX   Male
AG   2D
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ALVA-101
AC   CVCL_4735
SY   ALVA 101; ALVA101; American Lake VA-101
DR   BioSample; SAMN03151888
DR   cancercelllines; CVCL_4735
DR   Wikidata; Q54749372
RX   PubMed=1958578;
RX   PubMed=8561862;
RX   PubMed=9018337;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=15643172;
RX   PubMed=20143388;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200517/http://capcelllines.ca:80/details.asp?id=170
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00176.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=8561862).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   ALVA-31
AC   CVCL_4737
SY   ALVA 31; ALVA31; American Lake VA-31
DR   BTO; BTO_0003850
DR   BioSample; SAMN03151889
DR   cancercelllines; CVCL_4737
DR   Wikidata; Q54749373
RX   CelloPub=CLPUB00698;
RX   PubMed=7681207;
RX   PubMed=8561862;
RX   PubMed=11304728;
RX   PubMed=12725112;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=11304728; PubMed=20143388; CelloPub=CLPUB00698). Originally thought to originate from the tumor mass removed during a radical prostatectomy in a patient with well differentiated, stage B2, adenocarcinoma of the prostate.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00173.
CC   Population: Caucasian.
CC   Doubling time: ~26 hours (PubMed=7681207); 23 hours (PubMed=8561862).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=11304728).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=11304728
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 15
ST   D21S11: 29,31.2
ST   D3S1358: 16
ST   D5S818: 13,14
ST   D7S820: 8,11,12
ST   D8S1179: 13
ST   FGA: 24
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   ALVA-38
AC   CVCL_Y656
SY   ALVA38; American Lake VA-38
DR   Wikidata; Q54749376
RX   PubMed=8561862;
CC   Doubling time: 23 hours (PubMed=8561862).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   ALVA-41
AC   CVCL_4734
SY   ALVA 41; ALVA41; American Lake VA-41
DR   BTO; BTO_0002006
DR   BioSample; SAMN03151890
DR   cancercelllines; CVCL_4734
DR   Wikidata; Q54749378
RX   CelloPub=CLPUB00698;
RX   PubMed=1958578;
RX   PubMed=7533340;
RX   PubMed=8561862;
RX   PubMed=11304728;
RX   PubMed=12725112;
RX   PubMed=15643172;
RX   PubMed=20143388;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200531/http://capcelllines.ca:80/details.asp?id=84
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=11304728; PubMed=20143388; CelloPub=CLPUB00698). Originally thought to originate from the bone metastasis in a patient with well differentiated, stage B2, adenocarcinoma of the prostate.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00174.
CC   Population: Caucasian.
CC   Doubling time: 22-24 hours (PubMed=7533340); 20 hours (PubMed=8561862).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=11304728).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=11304728
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 14,15
ST   D21S11: 29,31.2
ST   D3S1358: 16,17
ST   D5S818: 13,14
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   ALVA-55
AC   CVCL_4736
SY   ALVA55; American Lake VA-55
DR   BioSample; SAMN03151891
DR   cancercelllines; CVCL_4736
DR   Wikidata; Q54749381
RX   PubMed=8561862;
RX   PubMed=14518029;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388). Originally thought to originate from the lymph node metastasis in a patient with well differentiated, stage B2, adenocarcinoma of the prostate.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00175.
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=8561862).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   ALYaAK
AC   CVCL_UT94
DR   JCRB; KURB1985
DR   Wikidata; Q93324389
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   ALZ-50
AC   CVCL_A2IQ
SY   Alz-50; Alz 50; ALZ50; Alz50
DR   ATCC; HB-9205
DR   Wikidata; Q105506411
RX   Patent=US5811310;
RX   PubMed=1698946;
RX   PubMed=3083509;
RX   PubMed=3435070;
RX   PubMed=9130141;
WW   Provider; AlzForum; -; https://www.alzforum.org/antibodies/tau-alz50-0
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9205.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   ALZ.1
AC   CVCL_W671
DR   IZSLER; BS ALZ 1
DR   Wikidata; Q54749383
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.10
AC   CVCL_W679
DR   IZSLER; BS ALZ 10
DR   Wikidata; Q54749384
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.11
AC   CVCL_W680
DR   IZSLER; BS ALZ 11
DR   Wikidata; Q54749386
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.12
AC   CVCL_W681
DR   IZSLER; BS ALZ 12
DR   Wikidata; Q54749390
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.13
AC   CVCL_W682
DR   IZSLER; BS ALZ 13
DR   Wikidata; Q54749391
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.14
AC   CVCL_W683
DR   IZSLER; BS ALZ 14
DR   Wikidata; Q54749395
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.15
AC   CVCL_W684
DR   IZSLER; BS ALZ 15
DR   Wikidata; Q54749397
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.16
AC   CVCL_W685
DR   IZSLER; BS ALZ 16
DR   Wikidata; Q54749398
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.17
AC   CVCL_W686
DR   IZSLER; BS ALZ 17
DR   Wikidata; Q54749399
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.18
AC   CVCL_W687
DR   IZSLER; BS ALZ 18
DR   Wikidata; Q54749401
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.19
AC   CVCL_W688
DR   IZSLER; BS ALZ 19
DR   Wikidata; Q54749404
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.2
AC   CVCL_W672
DR   IZSLER; BS ALZ 2
DR   Wikidata; Q54749406
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.20
AC   CVCL_W689
DR   IZSLER; BS ALZ 20
DR   Wikidata; Q54749409
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.21
AC   CVCL_W690
DR   IZSLER; BS ALZ 21
DR   Wikidata; Q54749410
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.22
AC   CVCL_W691
DR   IZSLER; BS ALZ 22
DR   Wikidata; Q54749411
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.23
AC   CVCL_W692
DR   IZSLER; BS ALZ 23
DR   Wikidata; Q54749413
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.24
AC   CVCL_W693
DR   IZSLER; BS ALZ 24
DR   Wikidata; Q54749414
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.25
AC   CVCL_W694
DR   IZSLER; BS ALZ 25
DR   Wikidata; Q54749415
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.26
AC   CVCL_W695
DR   IZSLER; BS ALZ 26
DR   Wikidata; Q54749419
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.27
AC   CVCL_W696
DR   IZSLER; BS ALZ 27
DR   Wikidata; Q54749420
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.28
AC   CVCL_W697
DR   IZSLER; BS ALZ 28
DR   Wikidata; Q54749422
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.29
AC   CVCL_W698
DR   IZSLER; BS ALZ 29
DR   Wikidata; Q54749425
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.3
AC   CVCL_W673
DR   IZSLER; BS ALZ 3
DR   Wikidata; Q54749426
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.30
AC   CVCL_W699
DR   IZSLER; BS ALZ 30
DR   Wikidata; Q54749428
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.31
AC   CVCL_W700
DR   IZSLER; BS ALZ 31
DR   Wikidata; Q54749431
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.32
AC   CVCL_W701
DR   IZSLER; BS ALZ 32
DR   Wikidata; Q54749432
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.33
AC   CVCL_W702
DR   IZSLER; BS ALZ 33
DR   Wikidata; Q54749434
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.34
AC   CVCL_W703
DR   IZSLER; BS ALZ 34
DR   Wikidata; Q54749436
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.35
AC   CVCL_W704
DR   IZSLER; BS ALZ 35
DR   Wikidata; Q54749437
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.38
AC   CVCL_W705
DR   IZSLER; BS ALZ 38
DR   Wikidata; Q54749439
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.39
AC   CVCL_W706
DR   IZSLER; BS ALZ 39
DR   Wikidata; Q54749441
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.4
AC   CVCL_W674
DR   IZSLER; BS ALZ 4
DR   Wikidata; Q54749443
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.40
AC   CVCL_W707
DR   IZSLER; BS ALZ 40
DR   Wikidata; Q54749445
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.41
AC   CVCL_W708
DR   IZSLER; BS ALZ 41
DR   Wikidata; Q54749524
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.42
AC   CVCL_W709
DR   IZSLER; BS ALZ 42
DR   Wikidata; Q54749526
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.43
AC   CVCL_W710
DR   IZSLER; BS ALZ 43
DR   Wikidata; Q54749529
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.44
AC   CVCL_W711
DR   IZSLER; BS ALZ 44
DR   Wikidata; Q54749531
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.5
AC   CVCL_W675
DR   IZSLER; BS ALZ 5
DR   Wikidata; Q54749532
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.6
AC   CVCL_W676
DR   IZSLER; BS ALZ 6
DR   Wikidata; Q54749533
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.7
AC   CVCL_W677
DR   IZSLER; BS ALZ 7
DR   Wikidata; Q54749535
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ALZ.9
AC   CVCL_W678
DR   IZSLER; BS ALZ 9
DR   Wikidata; Q54749538
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   AM
AC   CVCL_E454
SY   AMR
DR   dbMHC; 48472
DR   ECACC; 94022521
DR   IHW; IHW09206
DR   IPD-IMGT/HLA; 10244
DR   Wikidata; Q54749539
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:05,32:01:01; B*49:01,40:01; C*07:01,03:04; DPB1*02:01:02,04:01 (IPD-IMGT/HLA=10244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022521; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   Am Coo
AC   CVCL_3306
DR   CLO; CLO_0001707
DR   ATCC; CRL-1286
DR   Wikidata; Q54749540
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Am II
AC   CVCL_HF26
SY   AM II; AmII
DR   Wikidata; Q54749542
RX   PubMed=516912;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   Am Ric
AC   CVCL_3307
DR   CLO; CLO_0001708
DR   ATCC; CRL-1129
DR   Wikidata; Q54749544
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Am Tim
AC   CVCL_U765
DR   ATCC; CRL-1270
DR   Wikidata; Q54749546
CC   Discontinued: ATCC; CRL-1270; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   AM-1
AC   CVCL_4Z40
DR   Cosmic; 2163016
DR   Cosmic; 2209114
DR   Wikidata; Q54749549
RX   PubMed=9682983;
RX   PubMed=23706918;
RX   PubMed=32348439;
RX   PubMed=36452176;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: Ameloblast; CL=CL_0000059.
DI   NCIt; C39753; Plexiform ameloblastoma
DI   ORDO; Orphanet_314419; Ameloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   AM-3
AC   CVCL_A5XS
DR   Wikidata; Q107113354
RX   PubMed=23706918;
RX   PubMed=32348439;
RX   PubMed=36452176;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Met1_Ala159del).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: Ameloblast; CL=CL_0000059.
DI   NCIt; C27397; Follicular ameloblastoma
DI   ORDO; Orphanet_314419; Ameloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   AM-38
AC   CVCL_1070
SY   AM38; AM
DR   CLO; CLO_0009880
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 829
DR   BioSample; SAMN03470932
DR   BioSample; SAMN10987853
DR   cancercelllines; CVCL_1070
DR   Cell_Model_Passport; SIDM00492
DR   CGH-DB; 139-1
DR   ChEMBL-Cells; CHEMBL3308829
DR   ChEMBL-Targets; CHEMBL2366192
DR   Cosmic; 685873
DR   Cosmic; 910933
DR   Cosmic; 1746962
DR   Cosmic; 2302334
DR   Cosmic; 2367507
DR   Cosmic; 2516013
DR   Cosmic-CLP; 910933
DR   DepMap; ACH-000269
DR   EGA; EGAS00001000978
DR   GDSC; 910933
DR   GEO; GSM326247
DR   GEO; GSM886866
DR   GEO; GSM887931
DR   GEO; GSM1669598
DR   IARC_TP53; 21174
DR   JCRB; IFO50492
DR   LiGeA; CCLE_669
DR   LINCS_LDP; LCL-1366
DR   PharmacoDB; AM38_60_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1070
DR   PubChem_Cell_line; CVCL_1070
DR   Wikidata; Q54749551
RX   PubMed=7947440;
RX   PubMed=8145054;
RX   PubMed=12068308;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=7947440; PubMed=8145054); 72 hours (PubMed=25984343).
CC   HLA typing: A*24:02,26:01; B*15:07,35:01; C*03:03,03:03; DQA1*03:02,04:01; DQB1*03:02,04:01; DRB1*04:05,14:103 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=910933; DepMap=ACH-000269).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.14%; Native American=0%; East Asian, North=90.78%; East Asian, South=5.24%; South Asian=0%; European, North=0%; European, South=2.85% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left occipital lobe; UBERON=UBERON_0002806.
ST   Source(s): Cosmic-CLP=910933; JCRB=IFO50492; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 5,18
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17 (JCRB=IFO50492; PubMed=25877200)
ST   vWA: 17,18 (Cosmic-CLP=910933)
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   AM-C6SC8
AC   CVCL_1948
SY   AMC6SC8; AMc6sc8
DR   CLO; CLO_0001712
DR   CLDB; cl266
DR   DSMZ; ACC-152
DR   DSMZCellDive; ACC-152
DR   Wikidata; Q54749555
RX   DOI=10.1007/BF03191992;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_HF26 ! Am II
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   AM-HLH
AC   CVCL_IP72
DR   DSMZ; ACC-908
DR   DSMZCellDive; ACC-908
DR   Wikidata; Q54749556
RX   PubMed=27813134;
RX   PubMed=29533902;
CC   Population: Japanese.
CC   Virology: Contains multiple copies of integrated EBV genomes.
CC   Doubling time: 35-40 hours (PubMed=27813134); ~48 hours (DSMZ=ACC-908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-908
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D16S539: 8
ST   D18S51: 13,15
ST   D19S433: 13
ST   D21S11: 33.2
ST   D2S1338: 20
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 19
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 12
//
ID   AM-iPS-1
AC   CVCL_D904
SY   Mint; AM-iPS-01
DR   SKIP; SKIP000365
DR   Wikidata; Q54749559
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-10
AC   CVCL_D905
SY   Angelica
DR   SKIP; SKIP000370
DR   Wikidata; Q54749562
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-11
AC   CVCL_D906
SY   Oregano
DR   SKIP; SKIP000371
DR   Wikidata; Q54749563
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-12
AC   CVCL_D907
SY   Fennel
DR   SKIP; SKIP000372
DR   Wikidata; Q54749566
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-13
AC   CVCL_D908
SY   Basil; AM-iPS#13
DR   GEO; GSM607984
DR   SKIP; SKIP000363
DR   Wikidata; Q54749568
RX   PubMed=21155951;
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,19
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 8,13
ST   Penta E: 16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   AM-iPS-15
AC   CVCL_D909
SY   Anise
DR   SKIP; SKIP000373
DR   Wikidata; Q54749569
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-16
AC   CVCL_D910
SY   Parsley
DR   SKIP; SKIP000374
DR   Wikidata; Q54749572
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   AM-iPS-17
AC   CVCL_D911
SY   Myrtle
DR   SKIP; SKIP000375
DR   Wikidata; Q54749574
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-18
AC   CVCL_D912
SY   Savory
DR   SKIP; SKIP000376
DR   Wikidata; Q54749576
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-19
AC   CVCL_D913
SY   Chamomile
DR   SKIP; SKIP000377
DR   Wikidata; Q54749577
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   AM-iPS-2
AC   CVCL_D914
SY   Clary; AM-iPS-02; AM-iPS#2
DR   SKIP; SKIP000366
DR   Wikidata; Q54749580
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   AM-iPS-20
AC   CVCL_D915
SY   Lovage; AM-iPS#20
DR   GEO; GSM520674
DR   GEO; GSM520675
DR   GEO; GSM520676
DR   GEO; GSM520677
DR   GEO; GSM520678
DR   GEO; GSM520679
DR   GEO; GSM607985
DR   SKIP; SKIP000364
DR   Wikidata; Q54749582
RX   PubMed=21155951;
RX   PubMed=21637780;
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,19
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 8,13
ST   Penta E: 16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   AM-iPS-3
AC   CVCL_D916
SY   Sage; AM-iPS-03; AM-iPS#3
DR   GEO; GSM520671
DR   GEO; GSM520672
DR   GEO; GSM520673
DR   GEO; GSM607978
DR   SKIP; SKIP000359
DR   Wikidata; Q54749585
RX   PubMed=21155951;
RX   PubMed=21637780;
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,19
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 8,13
ST   Penta E: 16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   AM-iPS-4
AC   CVCL_D917
SY   Laurier; AM-iPS-04
DR   SKIP; SKIP000367
DR   Wikidata; Q54749588
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   AM-iPS-5
AC   CVCL_D918
SY   Chives; AM-iPS-05; AM-iPS#5
DR   GEO; GSM520680
DR   GEO; GSM520681
DR   GEO; GSM520682
DR   GEO; GSM607979
DR   SKIP; SKIP000360
DR   Wikidata; Q54749589
RX   PubMed=21155951;
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,19
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 8,13
ST   Penta E: 16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   AM-iPS-6
AC   CVCL_D919
SY   Hyssop; AM-iPS-06; AM-iPS#6
DR   GEO; GSM607980
DR   SKIP; SKIP000361
DR   Wikidata; Q54749592
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,19
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 8,13
ST   Penta E: 16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   AM-iPS-7
AC   CVCL_D920
SY   Marry; AM-iPS-07; AM-iPS#7
DR   GEO; GSM520683
DR   GEO; GSM520684
DR   GEO; GSM520685
DR   GEO; GSM520706
DR   GEO; GSM520707
DR   GEO; GSM520708
DR   SKIP; SKIP000368
DR   Wikidata; Q54749593
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   AM-iPS-8
AC   CVCL_D921
SY   Thyme; AM-iPS-08; AM-iPS#8
DR   GEO; GSM520686
DR   GEO; GSM520687
DR   GEO; GSM520688
DR   GEO; GSM607981
DR   GEO; GSM607982
DR   GEO; GSM607983
DR   GEO; GSM608024
DR   SKIP; SKIP000362
DR   Wikidata; Q54749597
RX   PubMed=21155951;
RX   PubMed=21637780;
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,19
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 8,13
ST   Penta E: 16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   AM-iPS-9
AC   CVCL_D922
SY   Sorrel; AM-iPS-09
DR   SKIP; SKIP000369
DR   Wikidata; Q54749598
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D691 ! AM936EP
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   AM0249
AC   CVCL_8B81
DR   ECACC; 92060801
DR   Wikidata; Q54749600
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 6,XX,-16,+der(16),t(9;16)(p;p13.3); de novo (ECACC=92060801).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   AM1
AC   CVCL_C5CS
DR   Wikidata; Q116048511
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM1-2E10
AC   CVCL_RT39
DR   Wikidata; Q54749603
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4141.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_140163; Cyclosporin A metabolite M17 (AM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM1-3B1
AC   CVCL_RT40
DR   Wikidata; Q54749604
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4154.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140163; Cyclosporin A metabolite M17 (AM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM1-7F5
AC   CVCL_RT41
DR   Wikidata; Q54749605
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4142.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_140163; Cyclosporin A metabolite M17 (AM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   Am1010
AC   CVCL_W188
DR   Wikidata; Q54749652
RX   PubMed=20418894;
RX   PubMed=26004767;
CC   Population: Chinese.
CC   Doubling time: 42.395 hours (PubMed=20418894).
CC   Karyotypic information: Tetraploid karyotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Upper arm, skeletal muscle; UBERON=UBERON_0004255.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   Am1010-GFP
AC   CVCL_ZZ60
DR   Wikidata; Q102113522
RX   PubMed=26004767;
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Upper arm, skeletal muscle; UBERON=UBERON_0004255.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W188 ! Am1010
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   Am1010-RFP
AC   CVCL_ZZ61
DR   Wikidata; Q102113524
RX   PubMed=26004767;
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: Metastatic; Upper arm, skeletal muscle; UBERON=UBERON_0004255.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W188 ! Am1010
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   AM14-1C4
AC   CVCL_VV30
SY   AM14.1C4
DR   Wikidata; Q93324701
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:106651; Ly6e.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: Ly-6E.1/LacZ (BL1b) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Stromal cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   AM19-1-5B3
AC   CVCL_RT42
DR   Wikidata; Q54749655
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4147.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140158; Cyclosporin A metabolite M8 (AM19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM19-1-5D2
AC   CVCL_RT43
DR   Wikidata; Q54749657
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4163.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140158; Cyclosporin A metabolite M8 (AM19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM19-1-7E12
AC   CVCL_RT44
DR   Wikidata; Q54749659
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4161.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_140158; Cyclosporin A metabolite M8 (AM19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM19-9-1D8
AC   CVCL_RT46
DR   Wikidata; Q54749664
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4148.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140158; Cyclosporin A metabolite M8 (AM19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM19-9-1E11
AC   CVCL_RT45
DR   Wikidata; Q54749662
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4149.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140158; Cyclosporin A metabolite M8 (AM19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM19-9-2G9
AC   CVCL_RT47
DR   Wikidata; Q54749666
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4160.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140158; Cyclosporin A metabolite M8 (AM19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM19-9-5A6
AC   CVCL_RT48
DR   Wikidata; Q54749669
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4150.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140158; Cyclosporin A metabolite M8 (AM19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM2 [Mouse hybridoma]
AC   CVCL_WN52
SY   AM-2
DR   Wikidata; Q93324738
RX   CelloPub=CLPUB00726;
RX   PubMed=3762712;
CC   Group: Space-flown cell line (cellonaut).
CC   Monoclonal antibody isotype: Not specified.
CC   Anecdotal: Have been flown in space on shuttle flight STS-61A (Spacelab D-1) to study antibody production in microgravity (PubMed=3762712).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 5
//
ID   AM2 [Mouse hybridoma against bovine MPO]
AC   CVCL_C5CT
DR   Wikidata; Q116048512
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM20-1B4
AC   CVCL_VV31
SY   AM20.1B4
DR   Wikidata; Q93324741
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   AM3
AC   CVCL_C5CU
DR   Wikidata; Q116048513
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM30-3F4
AC   CVCL_VV32
SY   AM30.3F4
DR   Wikidata; Q93324743
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VV33 ! AM30-3F5
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   AM30-3F5
AC   CVCL_VV33
SY   AM30.3F5
DR   Wikidata; Q93324745
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VV32 ! AM30-3F4
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   aM346C7C1
AC   CVCL_K043
SY   alphaM346C7C1; anti M346C7C1; 6C7/C1
DR   CLO; CLO_0009735
DR   ATCC; HB-11124
DR   Wikidata; Q54749670
RX   PubMed=7905220;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11124.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q1X7X6; Escherichia coli fimbrial adhesin fedF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AM4
AC   CVCL_C5CV
DR   Wikidata; Q116048514
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM5
AC   CVCL_C5CW
DR   Wikidata; Q116048515
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM6
AC   CVCL_C5CX
DR   Wikidata; Q116048516
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM7
AC   CVCL_C5CY
DR   Wikidata; Q116048517
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM8
AC   CVCL_C5CZ
DR   Wikidata; Q116048518
RX   PubMed=7502483;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6QPT4; Bovine MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AM9-1-2A11
AC   CVCL_RT49
DR   Wikidata; Q54749673
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4143.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   AM9-1-3C1
AC   CVCL_RT50
DR   Wikidata; Q54749674
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4155.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM9-1-4D6
AC   CVCL_RT51
DR   Wikidata; Q54749676
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4156.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM9-1-6D4
AC   CVCL_RT52
DR   Wikidata; Q54749678
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4157.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM9-1-7D2
AC   CVCL_RT53
DR   ATCC; PTA-4144
DR   Wikidata; Q54749680
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4144.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   AM9-9-11G9
AC   CVCL_RT54
DR   Wikidata; Q54749683
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4158.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM9-9-11H11
AC   CVCL_RT55
DR   Wikidata; Q54749685
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4159.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM9-9-4F5
AC   CVCL_RT56
DR   Wikidata; Q54749686
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4145.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM9-9-6C3
AC   CVCL_RT57
DR   Wikidata; Q54749689
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4146.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_140152; Cyclosporin A metabolite M1 (AM9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   AM936EP
AC   CVCL_D691
DR   GEO; GSM520689
DR   GEO; GSM520690
DR   GEO; GSM520691
DR   GEO; GSM607977
DR   GEO; GSM1906541
DR   Wikidata; Q54749691
RX   PubMed=21155951;
RX   PubMed=21637780;
RX   PubMed=23631808;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,19
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 8,13
ST   Penta E: 16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   AM952F
AC   CVCL_LM86
SY   AM95; TNGB-66061; 66061
DR   CLO; CLO_0001711
DR   CLDB; cl269
DR   TNGB; 66061
DR   Wikidata; Q54749692
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   AMab-6
AC   CVCL_D3CY
DR   Wikidata; Q127380217
RX   PubMed=27788029;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P46100; Human ATRX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   AMACR, clone G8
AC   CVCL_B6JJ
SY   G8
DR   Wikidata; Q111732919
RX   Patent=RU2636042;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-166.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UHK6; Human AMACR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   AMAI
AC   CVCL_E455
SY   AMAL
DR   dbMHC; 48473
DR   ECACC; 94070701
DR   IHW; IHW09010
DR   IPD-IMGT/HLA; 10246
DR   Wikidata; Q54749695
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=1363422;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Algerian.
CC   HLA typing: A*68:02:01:01; B*53:01:01; C*04:01:01:01; DPA1*03:01; DPB1*105:01; DQA1*01:02:01; DQB1*06:02:01; DRA*01:01; DRB1*15:03:01; DRB5*01:01; DRB6*02:01 (IPD-IMGT/HLA=10246).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Misspelling: AMA1; PubMed=28360230.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   AMALA
AC   CVCL_E456
SY   AZL
DR   CLDB; cl7225
DR   dbMHC; 48474
DR   ECACC; 88052064
DR   ICLC; HTL14002
DR   IHW; IHW09064
DR   IPD-IMGT/HLA; 10247
DR   PRIDE; PXD001205
DR   Wikidata; Q54749696
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=7652742;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=25502872;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Native South American; Warao.
CC   HLA typing: A*02:17:02; B*15:01:01:01; C*03:03:01:01; DPA1*01:03:01; DPB1*04:02:01; DQA1*05:01:01,05:03; DQB1*03:01:01; DRA*01:02; DRB1*14:02:01; DRB3*01:01 (IPD-IMGT/HLA=10247).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   AMC-106
AC   CVCL_9477
SY   AMC106
DR   Cosmic; 1109110
DR   Cosmic; 1543773
DR   GEO; GSM692873
DR   Wikidata; Q54749697
RX   PubMed=7838528;
RX   PubMed=20655465;
RX   PubMed=22213050;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   AMC-60-TC
AC   CVCL_F917
SY   AMC-60
DR   TKG; TKG 0114
DR   TKG; TKG 0647
DR   Wikidata; Q54749698
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   AMC-hES1
AC   CVCL_B524
DR   Wikidata; Q54749701
RX   PubMed=18033671;
CC   From: Asan Medical Center; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   AMC-hES2
AC   CVCL_B525
DR   Wikidata; Q54749703
RX   PubMed=18033671;
CC   From: Asan Medical Center; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   AMC-HN-1
AC   CVCL_5959
SY   Amc-HN-1; AMC-HN1; Asian Medical Center-Head and Neck cancer-1
DR   Wikidata; Q54749706
RX   PubMed=9349880;
CC   Population: Korean.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   AMC-HN-2
AC   CVCL_5960
SY   Amc-HN-2; AMC-HN2; Asian Medical Center-Head and Neck cancer-2
DR   Wikidata; Q54749707
RX   PubMed=9349880;
CC   Population: Korean.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   AMC-HN-3
AC   CVCL_5961
SY   Amc-HN-3; AMC-HN3; Asian Medical Center-Head and Neck cancer-3
DR   cancercelllines; CVCL_5961
DR   Wikidata; Q54749709
RX   PubMed=9349880;
RX   PubMed=24336076;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=24336076).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   AMC-HN-4
AC   CVCL_5962
SY   Amc-HN-4; AMC-HN4; Asian Medical Center-Head and Neck cancer-4
DR   Wikidata; Q54749712
RX   PubMed=9349880;
CC   Population: Korean.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   AMC-HN-5
AC   CVCL_5963
SY   Amc-HN-5; AMC-HN5; Asian Medical Center-Head and Neck cancer-5
DR   Wikidata; Q54749713
RX   PubMed=9349880;
CC   Population: Korean.
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
DI   NCIt; C8192; Nasal cavity squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   AMC-HN-6
AC   CVCL_5964
SY   Amc-HN-6; AMC-HN6; Asian Medical Center-Head and Neck cancer-6
DR   cancercelllines; CVCL_5964
DR   Wikidata; Q54749717
RX   PubMed=9349880;
RX   PubMed=24336076;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=24336076).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   AMC-HN-7
AC   CVCL_5965
SY   Amc-HN-7; AMC-HN7; Asian Medical Center-Head and Neck cancer-7
DR   cancercelllines; CVCL_5965
DR   Wikidata; Q54749719
RX   PubMed=9349880;
RX   PubMed=24336076;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Gly (c.470T>G); ClinVar=VCV000915695; Zygosity=Heterozygous (PubMed=24336076).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   AMC-HN-8
AC   CVCL_5966
SY   Amc-HN-8; AMC-HN8; Asian Medical Center-Head and Neck cancer-8
DR   Wikidata; Q54749721
RX   PubMed=9349880;
RX   PubMed=24336076;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly293del (c.877_879delGGG); Zygosity=Unspecified (PubMed=24336076).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   AMC-HN-9
AC   CVCL_5967
SY   Amc-HN-9; AMC-HN9; Asian Medical Center-Head and Neck cancer-9
DR   Wikidata; Q54749724
RX   PubMed=9349880;
RX   PubMed=11039880;
RX   PubMed=24336076;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=24336076).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   AMC-iPSC-C22
AC   CVCL_UG68
SY   AMC-C22
DR   Wikidata; Q93324885
RX   PubMed=20139068;
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Mesenchymal stem cell of amnion; CL=CL_0002537.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG69 ! AMC-iPSC-C27
OI   CVCL_UG70 ! AMC-iPSC-C28
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   AMC-iPSC-C27
AC   CVCL_UG69
SY   AMC-C27
DR   Wikidata; Q93324888
RX   PubMed=20139068;
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Mesenchymal stem cell of amnion; CL=CL_0002537.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG68 ! AMC-iPSC-C22
OI   CVCL_UG70 ! AMC-iPSC-C28
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   AMC-iPSC-C28
AC   CVCL_UG70
SY   AMC-C28
DR   Wikidata; Q93324890
RX   PubMed=20139068;
RX   PubMed=21949351;
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Mesenchymal stem cell of amnion; CL=CL_0002537.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG68 ! AMC-iPSC-C22
OI   CVCL_UG69 ! AMC-iPSC-C27
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   AMCC-1
AC   CVCL_D6DD
DR   Wikidata; Q127380218
RX   CelloPub=CLPUB00767;
RX   PubMed=3240127;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft that was obtain by transplantation of the tumor cells in nude mice (CelloPub=CLPUB00767).
CC   Doubling time: 33.6 hours (CelloPub=CLPUB00767).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AMCPAC01
AC   CVCL_JX52
DR   cancercelllines; CVCL_JX52
DR   Cosmic; 2754409
DR   Wikidata; Q54749725
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 68 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.384_393del10; Zygosity=Unspecified (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   AMCPAC02
AC   CVCL_JX53
DR   cancercelllines; CVCL_JX53
DR   Cosmic; 2754410
DR   Wikidata; Q54749727
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 87 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   AMCPAC03
AC   CVCL_JX54
DR   cancercelllines; CVCL_JX54
DR   Cosmic; 2754411
DR   Wikidata; Q54749728
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 68 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   AMCPAC04
AC   CVCL_JX55
DR   ABM; T8222
DR   cancercelllines; CVCL_JX55
DR   Cosmic; 2754412
DR   Wikidata; Q54749729
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Unspecified (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   AMCPAC05
AC   CVCL_JX56
DR   cancercelllines; CVCL_JX56
DR   Cosmic; 2754413
DR   Wikidata; Q54749732
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 75 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly60_Gln61insLeu (c.180_181insCTA); Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Unspecified (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   AMCPAC06
AC   CVCL_JX57
DR   cancercelllines; CVCL_JX57
DR   Cosmic; 2754414
DR   Wikidata; Q54749773
RX   PubMed=28435405;
CC   Population: Korean.
CC   Doubling time: 51 hours (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=28435405).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified (PubMed=28435405).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   Amdur II
AC   CVCL_3643
AS   CVCL_AW71
SY   AmdurII; AMDURII; GM00050; GM0050; GM-50
DR   CLO; CLO_0001713
DR   CLO; CLO_0025172
DR   CLDB; cl270
DR   CLDB; cl271
DR   ATCC; CCL-124
DR   BioSample; SAMN03151822
DR   BioSample; SAMN03472704
DR   Coriell; GM00050
DR   ECACC; 90112605
DR   IZSLER; BS CL 2
DR   KCLB; 10124
DR   Wikidata; Q54749775
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=5788784;
RX   PubMed=14505435;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00289.
CC   Population: Caucasian.
CC   Senescence: Senesces at ~40 PDL (ATCC=CCL-124).
CC   Discontinued: ECACC; 90112605; true.
CC   Discontinued: KCLB; 10124; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-124; IZSLER=BS CL 2
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 12,17
ST   D19S433: 14,16
ST   D21S11: 28,30
ST   D2S1338: 19,25
ST   D3S1358: 14,17
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   D8S1179: 11,14
ST   FGA: 20,23
ST   Penta D: 11,13
ST   Penta E: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   AME-1 [Human ameloblastoma]
AC   CVCL_C0W0
DR   Wikidata; Q114310624
RX   PubMed=25099616;
RX   PubMed=34060687;
CC   Caution: Indicated as originating from a male patient in PubMed=25099616 and from a female patient in PubMed=34060687.
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: Ameloblast; CL=CL_0000059.
DI   NCIt; C27397; Follicular ameloblastoma
DI   ORDO; Orphanet_314419; Ameloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   AME-1 [Human gastric carcinoma]
AC   CVCL_JM02
DR   Wikidata; Q54749777
RX   PubMed=14745610;
CC   Population: Japanese.
CC   Characteristics: Produces high level of AFP.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   AmE-711
AC   CVCL_2H47
SY   AME-711; AmE711; Apis melliferea Embryos July-11
DR   ICLDB; ame-711
DR   Wikidata; Q54749780
RX   PubMed=23894551;
RX   PubMed=26923109;
RX   PubMed=32093360;
RX   PubMed=36263950;
WW   Info; -; -; https://beeinformed.org/2013/11/18/new-cell-cultures-advance-honey-bee-science/
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Virology: Persistently infected with deformed wing virus (DWV) isolate DWV-AmE711 (PubMed=26923109).
CC   Doubling time: ~4 days (PubMed=23894551).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7460; ! Apis mellifera (Honeybee)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   AME-HPV
AC   CVCL_C0W1
DR   Wikidata; Q114310625
RX   PubMed=25099616;
RX   PubMed=34060687;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: Ameloblast; CL=CL_0000059.
DI   NCIt; C27397; Follicular ameloblastoma
DI   ORDO; Orphanet_314419; Ameloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0W0 ! AME-1 [Human ameloblastoma]
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   AME-hTERT
AC   CVCL_C0W2
DR   Wikidata; Q114310626
RX   PubMed=34060687;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: Ameloblast; CL=CL_0000059.
DI   NCIt; C27397; Follicular ameloblastoma
DI   ORDO; Orphanet_314419; Ameloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0W0 ! AME-1 [Human ameloblastoma]
SX   Female
AG   44Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   AMI005AN
AC   CVCL_F547
SY   TER202; Extract 271
DR   IPD-IMGT/HLA; 11803
DR   Wikidata; Q54749781
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,23:01; B*44:09,44:13; C*04:01,05:01 (IPD-IMGT/HLA=11803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   AMJ13
AC   CVCL_4U92
DR   Wikidata; Q54749784
RX   PubMed=26300657;
CC   Population: Iraqi.
CC   Doubling time: 22 hours (PubMed=26300657).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   AMJ2-C10
AC   CVCL_0P77
SY   AMJ2C10; Alveolar Macrophage J2-immortalized-Clone 10
DR   Wikidata; Q54749786
RX   PubMed=1879973;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AMJ2-C11
AC   CVCL_5913
SY   AMJ2C11; Alveolar Macrophage J2-immortalized-Clone 11
DR   CLO; CLO_0001714
DR   ATCC; CRL-2456
DR   BCRJ; 0039
DR   Wikidata; Q54749788
RX   PubMed=1879973;
RX   PubMed=9338148;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   AMJ2-C20
AC   CVCL_0P78
SY   AMJ2C20; Alveolar Macrophage J2-immortalized-Clone 20
DR   Wikidata; Q54749791
RX   PubMed=1879973;
RX   PubMed=9338148;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   AMJ2-C8
AC   CVCL_5914
SY   AMJ2C8; Alveolar Macrophage J2-immortalized-Clone 8
DR   CLO; CLO_0001715
DR   ATCC; CRL-2455
DR   Wikidata; Q54749793
RX   PubMed=1879973;
RX   PubMed=9338148;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   AML-004
AC   CVCL_LK51
SY   AML004
DR   Wikidata; Q54749795
RX   PubMed=28934678;
CC   Doubling time: ~15 hours (PubMed=28934678).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   AML-1
AC   CVCL_S481
DR   Wikidata; Q54749797
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3496132;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   AML-1-104
AC   CVCL_D5E0
DR   Wikidata; Q127380221
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-1-116
AC   CVCL_D5E1
DR   Wikidata; Q127380223
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-1-201
AC   CVCL_D5E2
DR   Wikidata; Q127380224
RX   PubMed=6574189;
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-1-211
AC   CVCL_D5E3
DR   Wikidata; Q127380226
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-1-22
AC   CVCL_D5E4
DR   Wikidata; Q127380227
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-1-99
AC   CVCL_D5E5
DR   Wikidata; Q127380228
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-193
AC   CVCL_1071
SY   AML193
DR   BTO; BTO_0006203
DR   CLO; CLO_0001718
DR   EFO; EFO_0022399
DR   CLDB; cl272
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-9589
DR   ATCC; HTB-188
DR   BCRJ; 0040
DR   BioSample; SAMN01821616
DR   BioSample; SAMN03471219
DR   BioSample; SAMN10987604
DR   cancercelllines; CVCL_1071
DR   CCRID; 3101HUMTCHu207
DR   Cell_Model_Passport; SIDM01525
DR   Cosmic; 724816
DR   Cosmic; 787420
DR   Cosmic; 949089
DR   Cosmic; 975238
DR   Cosmic; 1012057
DR   Cosmic; 1281305
DR   Cosmic; 2306199
DR   Cosmic; 2750853
DR   DepMap; ACH-000557
DR   DSMZ; ACC-549
DR   DSMZCellDive; ACC-549
DR   GEO; GSM886867
DR   GEO; GSM887932
DR   IARC_TP53; 27144
DR   LiGeA; CCLE_497
DR   Lonza; 1685
DR   PharmacoDB; AML193_61_2019
DR   Progenetix; CVCL_1071
DR   Wikidata; Q54749799
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2015403;
RX   PubMed=2656885;
RX   PubMed=3496132;
RX   PubMed=9195772;
RX   PubMed=12068308;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=21989985;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AML-193
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9589.
CC   Population: African American and Caucasian.
CC   Characteristics: CSF2, IL3 and IL6 dependent.
CC   Doubling time: 65 hours (PubMed=25984343); ~50-60 hours (DSMZ=ACC-549).
CC   HLA typing: A*68:02,74:01; B*15:10,15:10; C*03:02,08:02; DQA1*04:01,05:02; DQB1*06:07,06:07; DRB1*12:02,13:27 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:25657; BCORL1; Simple; p.Arg784Ter (c.2350C>T); Zygosity=Unspecified (PubMed=21989985; DepMap=ACH-000557).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Val (c.38G>T); ClinVar=VCV000375876; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-000557).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+2T>G (IVS9+2T>G); ClinVar=VCV000635384; Zygosity=Unspecified; Note=Splice donor mutation (DepMap=ACH-000557).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=65.28%; Native American=0%; East Asian, North=3.56%; East Asian, South=0%; South Asian=0%; European, North=14.42%; European, South=16.74% (PubMed=30894373).
CC   Discontinued: BCRJ; 0040; probable.
CC   Discontinued: ATCC; HTB-188; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-9589; DSMZ=ACC-549
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30.2,31.2
ST   D2S1338: 19,20
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 21,26 (ATCC=CRL-9589)
ST   FGA: 21,26.1 (DSMZ=ACC-549)
ST   Penta D: 2.2,13 (ATCC=CRL-9589)
ST   Penta D: 3,13 (DSMZ=ACC-549)
ST   Penta E: 8,16
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   AML-2-17
AC   CVCL_D5E6
DR   Wikidata; Q127380229
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-2-23
AC   CVCL_D5E7
DR   Wikidata; Q127380230
RX   PubMed=2441245;
RX   PubMed=3894519;
RX   PubMed=6752945;
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgG1 (PubMed=6948897); IgG3 (PubMed=2441245).
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-2-30
AC   CVCL_D5E8
DR   Wikidata; Q127380231
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML-2-9
AC   CVCL_D5E9
DR   Wikidata; Q127380232
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AML10
AC   CVCL_UI48
DR   cancercelllines; CVCL_UI48
DR   Cosmic; 1760554
DR   Wikidata; Q93324954
RX   PubMed=22272203;
RX   PubMed=22675565;
CC   Sequence variation: Mutation; HGNC; HGNC:12440; TYK2; Simple; p.Arg243Trp (c.727C>T); ClinVar=VCV000890826; Zygosity=Unspecified (PubMed=22675565).
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   AML12
AC   CVCL_0140
SY   AML-12; AML 12; Alpha Mouse Liver 12
DR   BTO; BTO_0003449
DR   CLO; CLO_0001716
DR   MCCL; MCC:0000033
DR   ATCC; CRL-2254
DR   BCRC; 60326
DR   BCRJ; 0354
DR   CCRID; 3101MOUSCSP550
DR   CLS; 300643
DR   GEO; GSE87156
DR   GEO; GSM294842
DR   GEO; GSM296415
DR   GEO; GSM296416
DR   GEO; GSM296417
DR   GEO; GSM1374079
DR   GEO; GSM1374080
DR   GEO; GSM1374081
DR   GEO; GSM1374082
DR   GEO; GSM1374083
DR   GEO; GSM1374084
DR   IZSLER; BS CL 161
DR   Ubigene; YC-D022
DR   Wikidata; Q54749800
RX   PubMed=7904757;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-2254
CC   Doubling time: 37 hours (PubMed=7904757).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
ST   Source(s): Ubigene=YC-D022
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 16
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 19
ST   Mouse STR 15-3: 21.3
ST   Mouse STR 18-3: 21
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   AML14 [Human leukemia]
AC   CVCL_8286
DR   ABM; T8171
DR   Cosmic; 975237
DR   Cosmic; 1281304
DR   Kerafast; EWR001
DR   Wikidata; Q54749802
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8027673;
RX   PubMed=8443379;
RX   PubMed=9474744;
CC   Characteristics: Can be induced to eosinophilic differentiation with CSF2, IL3 and IL5 (Kerafast=EWR001).
CC   Doubling time: 24-36 hours (PubMed=8443379).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   AML14 [Mouse liver]
AC   CVCL_K234
SY   AML-14; AML 14; Alpha Mouse Liver 14
DR   Wikidata; Q54749805
RX   PubMed=7904757;
CC   Doubling time: 32 hours (PubMed=7904757).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   AML14.3D10
AC   CVCL_0141
SY   AML14-3D10; AML143D10
DR   MCCL; MCC:0000034
DR   ABM; T8172
DR   GEO; GSM1374391
DR   Kerafast; EWR002
DR   Wikidata; Q54749806
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9474744;
CC   Doubling time: 48 hours (Kerafast=EWR002).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8286 ! AML14 [Human leukemia]
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   AML14.3D10/CCCKR3 Clone 16
AC   CVCL_6337
SY   AML14/CCCKR3.16
DR   CLO; CLO_0001717
DR   ATCC; CRL-12079
DR   BioSample; SAMN03471345
DR   Wikidata; Q54749808
RX   Patent=US6271347;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12079.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-12079; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-12079
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 10,14
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0141 ! AML14.3D10
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   AML14.eos
AC   CVCL_ZC59
SY   Differentiated AML14
DR   Kerafast; EWR003
DR   Wikidata; Q98125472
RX   PubMed=8027673;
CC   Characteristics: Cytokine-induced fully differentiated eosinophilic myelocyte subline of AML14. Proliferates and maintains a differentiated phenotype only if supplemented with CSF2, IL3 and IL5 (Kerafast=EWR003).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8286 ! AML14 [Human leukemia]
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AMN iPSC-3
AC   CVCL_B941
DR   Wikidata; Q54749809
RX   PubMed=21721033;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Unexplicit; Ex8-10del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21721033
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 12,18
ST   D19S433: 12,14
ST   D21S11: 30,32.2
ST   D2S1338: 25,26
ST   D3S1358: 14,16
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   D8S1179: 10,11
ST   FGA: 20,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W059 ! GM17819
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   AMO1
AC   CVCL_1806
SY   AMo1; AMO-1
DR   CLO; CLO_0037047
DR   EFO; EFO_0006534
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-1088
DR   BioSample; SAMN03472930
DR   BioSample; SAMN03473529
DR   BioSample; SAMN10989573
DR   cancercelllines; CVCL_1806
DR   CCRID; 1101HUM-PUMC000683
DR   Cell_Model_Passport; SIDM00993
DR   CGH-DB; 9156-4
DR   ChEMBL-Cells; CHEMBL4523527
DR   ChEMBL-Targets; CHEMBL4523558
DR   Cosmic; 1483074
DR   Cosmic; 1889514
DR   Cosmic; 2131561
DR   Cosmic; 2391800
DR   Cosmic; 2809758
DR   Cosmic-CLP; 1295741
DR   DepMap; ACH-000838
DR   DSMZ; ACC-538
DR   DSMZCellDive; ACC-538
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1295741
DR   GEO; GSM143353
DR   GEO; GSM290285
DR   GEO; GSM562822
DR   GEO; GSM886868
DR   GEO; GSM887933
DR   GEO; GSM1374392
DR   GEO; GSM1669599
DR   IARC_TP53; 28503
DR   IBRC; C10685
DR   LiGeA; CCLE_604
DR   LINCS_LDP; LCL-1539
DR   PharmacoDB; AMO1_62_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1806
DR   PubChem_Cell_line; CVCL_1806
DR   Wikidata; Q54749810
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8426482;
RX   PubMed=9738977;
RX   PubMed=10936422;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=15215163;
RX   PubMed=17171682;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: ~24 hours (PubMed=8426482); ~70-90 hours (DSMZ=ACC-538).
CC   HLA typing: A*26:03,33; B*44,54:01; C*01:02/03,14:02/03 (Direct_author_submission).
CC   HLA typing: A*26:03,33:03; B*44:03,54:01; C*14:03,14:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5719; IGKJ1 + HGNC; HGNC:5743; IGKV1-8; Name(s)=IGKV1-8-IGKJ1 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5720; IGKJ2 + HGNC; HGNC:5817; IGKV3-20; Name(s)=IGKV3-20-IGKJ2 (CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Gln312del (c.932_934AGC[1]) (c.935_937delAGC); ClinVar=VCV000418060; Zygosity=Heterozygous (Cosmic-CLP=1295741).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (Cosmic-CLP=1295741; DepMap=ACH-000838).
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Cys712Tyr (c.2135G>A); Zygosity=Heterozygous (Cosmic-CLP=1295741; DepMap=ACH-000838).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Gln1699Ter (c.5095C>T); Zygosity=Heterozygous (Cosmic-CLP=1295741; DepMap=ACH-000838).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.35%; Native American=0%; East Asian, North=79.12%; East Asian, South=17.86%; South Asian=0%; European, North=0%; European, South=1.66% (PubMed=30894373).
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): CCRID=1101HUM-PUMC000683; Cosmic-CLP=1295741; DSMZ=ACC-538; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,19
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 15,18
ST   D19S433: 15.2 (CCRID=1101HUM-PUMC000683)
ST   D19S433: 16 (DSMZ=ACC-538)
ST   D21S11: 30,33.2
ST   D2S1338: 19
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D6S1043: 11,19
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 19,24
ST   Penta D: 9,15
ST   Penta E: 11
ST   TH01: 7,9
ST   TPOX: 8 (PubMed=25877200)
ST   TPOX: 8,9 (CCRID=1101HUM-PUMC000683; Cosmic-CLP=1295741; DSMZ=ACC-538)
ST   vWA: 17,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   aMoC1
AC   CVCL_A5HM
SY   adult Mouse Colon 1
DR   Wikidata; Q107113355
RX   PubMed=21597185;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Colon, intestinal crypt; UBERON=UBERON_0013485.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   AMOC-2
AC   CVCL_C830
SY   AMOC2; Aichi Medical university Ovarian Carcinoma-2
DR   Wikidata; Q54749812
RX   PubMed=2794621;
RX   PubMed=9433040;
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft established in BALB/c nu/nu mice.
CC   Doubling time: 21.5-26.4 hours (PubMed=9433040).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   AMOC-2 Subclone #10
AC   CVCL_AT98
DR   Wikidata; Q54749814
RX   PubMed=9433040;
CC   Population: Japanese.
CC   Doubling time: 26.89 hours (PubMed=9433040).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C830 ! AMOC-2
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   AMOC-2 Subclone #11
AC   CVCL_AT99
DR   Wikidata; Q54749816
RX   PubMed=9433040;
CC   Population: Japanese.
CC   Doubling time: 23.26 hours (PubMed=9433040).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C830 ! AMOC-2
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   AMOC-2 Subclone #2
AC   CVCL_AT95
DR   Wikidata; Q54749819
RX   PubMed=9433040;
CC   Population: Japanese.
CC   Doubling time: 32.58 hours (PubMed=9433040).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C830 ! AMOC-2
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   AMOC-2 Subclone #4
AC   CVCL_AT96
DR   Wikidata; Q54749821
RX   PubMed=9433040;
CC   Population: Japanese.
CC   Doubling time: 30.06 hours (PubMed=9433040).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C830 ! AMOC-2
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   AMOC-2 Subclone #6
AC   CVCL_AT97
DR   Wikidata; Q54749822
RX   PubMed=9433040;
CC   Population: Japanese.
CC   Doubling time: 25.40 hours (PubMed=9433040).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C830 ! AMOC-2
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   AMOS-III
AC   CVCL_0E45
SY   AMOS III; AII MS Oral Squamous cell carcinoma-III
DR   Wikidata; Q54749825
RX   Patent=US6730514;
RX   PubMed=13679204;
CC   Group: Patented cell line.
CC   Population: Indian.
CC   Doubling time: 34-36 hours (PubMed=13679204).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Alafs*180 (c.518insC); Zygosity=Unspecified (PubMed=13679204).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   aMoS7
AC   CVCL_A5HN
SY   adult Mouse Small intestine 7
DR   Wikidata; Q107113356
RX   PubMed=21597185;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, ileum, intestinal crypt; UBERON=UBERON_0013481.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   AmphoPack-293
AC   CVCL_WI47
SY   AmphoPack 293; Amphopack HEK 293
DR   Wikidata; Q93325018
WW   Provider; Takara Bio; 631505; https://www.takarabio.com/documents/Certificate%20of%20Analysis/631505/631505-101513.pdf
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q89683; Murine leukemia virus (isolate 4070A) env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; A7UJ19; Murine leukemia virus (isolate 4070A) gag-pol.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   Ampli-GPE
AC   CVCL_4104
DR   CLO; CLO_0001719
DR   CLDB; cl273
DR   ECACC; 95050229
DR   Wikidata; Q54749827
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   AMR10
AC   CVCL_U845
DR   Wikidata; Q54749828
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27499; Ganglioside GM4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   AMR19
AC   CVCL_U831
DR   CLO; CLO_0050334
DR   RCB; RCB2016
DR   Wikidata; Q54749831
RX   PubMed=8026889;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Ganglioside GD3-lactone (GD3-L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   AMR20
AC   CVCL_U832
DR   CLO; CLO_0050341
DR   RCB; RCB2041
DR   Wikidata; Q54749833
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_36498; Galactosylceramide (GalCer).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   AMR38
AC   CVCL_U833
DR   Wikidata; Q54749836
RX   PubMed=8026889;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_141641; Ganglioside GM1-lactone (GM1-L; Siagoside).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   AMR40
AC   CVCL_U834
DR   Wikidata; Q54749838
RX   PubMed=8026889;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Ganglioside GD1a-lactone (GD1a-L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   AMS 9.1.1.1
AC   CVCL_K123
DR   CLO; CLO_0001720
DR   ATCC; HB-161
DR   Wikidata; Q54749839
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse IgD (allotype a, Igh-5.4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AMS3
AC   CVCL_H629
DR   Wikidata; Q54749840
RX   PubMed=7949120;
RX   PubMed=8183550;
RX   PubMed=15356658;
CC   Population: Japanese.
CC   Characteristics: Established from a patient-derived xenograft established in SCID mice (PubMed=8183550).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=7949120).
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   Amsalem
AC   CVCL_B386
DR   ATCC; CRL-2628
DR   Wikidata; Q54749842
RX   PubMed=2981779;
RX   PubMed=6181032;
CC   Doubling time: 36-48 hours (PubMed=2981779).
CC   Discontinued: ATCC; CRL-2628; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   AMT-13
AC   CVCL_C5QV
SY   AMT13
DR   Wikidata; Q116048520
RX   PubMed=2983999;
RX   PubMed=6425405;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   AMU-AML1
AC   CVCL_M584
SY   Aichi Medical University-Acute Myeloid Leukemia 1
DR   Wikidata; Q54749843
RX   PubMed=21965128;
CC   Population: Japanese.
CC   Doubling time: ~96 hours (PubMed=21965128).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   AMU-ML1
AC   CVCL_M583
DR   Wikidata; Q54749845
RX   DOI=10.1182/blood.V118.21.5210.5210;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5853; IGL; Name(s)=IGL-BCL2 (DOI=10.1182/blood.V118.21.5210.5210).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1001; BCL6 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL6 (DOI=10.1182/blood.V118.21.5210.5210).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (DOI=10.1182/blood.V118.21.5210.5210).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C131913; High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   AMUFAHi001-A
AC   CVCL_A8KW
SY   AY0913-iPSC
DR   BioSamples; SAMEA8409914
DR   hPSCreg; AMUFAHi001-A
DR   Wikidata; Q108819852
RX   PubMed=34088001;
CC   From: The First Affiliated Hospital of Anhui Medical University; Anhui; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:18576; CCNO; Simple; p.Gln88Argfs*8 (c.253_257GGCCC[3]) (c.258_262dupGGCCC) (c.262_263insGGCCC); ClinVar=VCV000139600; Zygosity=Homozygous (PubMed=34088001).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34088001
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 17,18
ST   D13S317: 10
ST   D16S539: 9,12
ST   D18S51: 14,19
ST   D19S433: 12,13.2
ST   D21S11: 28,29,30
ST   D2S1338: 25,26
ST   D3S1358: 15
ST   D5S818: 10
ST   D6S1043: 12,14
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 23,25
ST   Penta D: 9,11
ST   Penta E: 11,21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C172393; Primary ciliary dyskinesia 29
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   AMUFAHi002-A
AC   CVCL_B7ET
SY   AY20210813
DR   BioSamples; SAMEA13819042
DR   hPSCreg; AMUFAHi002-A
DR   Wikidata; Q112929236
RX   PubMed=35914484;
CC   From: The First Affiliated Hospital of Anhui Medical University; Anhui; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26862; Polycystic ovary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   AMUFAHi003-A
AC   CVCL_B7EU
DR   BioSamples; SAMEA13189994
DR   hPSCreg; AMUFAHi003-A
DR   Wikidata; Q112929237
RX   PubMed=35397397;
CC   From: The First Affiliated Hospital of Anhui Medical University; Anhui; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:33630; PATL2; Simple; c.223-14_223-2delCCCTCCTGTTCCA; ClinVar=VCV000444049; Zygosity=Heterozygous (PubMed=35397397).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188145; Oocyte maturation defect-4
DI   ORDO; Orphanet_488191; Female infertility due to oocyte meiotic arrest
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   An Bay
AC   CVCL_U667
DR   ATCC; CRL-1256
DR   Wikidata; Q54749848
CC   Discontinued: ATCC; CRL-1256; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   An Na
AC   CVCL_U766
DR   ATCC; CRL-1183
DR   Wikidata; Q54749850
CC   Discontinued: ATCC; CRL-1183; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   An Zan
AC   CVCL_3644
DR   CLO; CLO_0001721
DR   ATCC; CRL-1266
DR   Wikidata; Q54749893
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   AN01
AC   CVCL_F1CZ
DR   ABCD; ABCD_BF037
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN02
AC   CVCL_F1D0
SY   AN01
DR   ABCD; ABCD_BF036
RX   PubMed=3375235;
RX   PubMed=6509025;
RX   PubMed=7126647;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
CC   Caution: What was named AN01 (PubMed=7126647) was later renamed AN02 (PubMed=3375235).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN03
AC   CVCL_F1D1
DR   ABCD; ABCD_BF038
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN04
AC   CVCL_F1D2
DR   ABCD; ABCD_BF039
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN05
AC   CVCL_F1D3
DR   ABCD; ABCD_BF040
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN06
AC   CVCL_F1D4
DR   ABCD; ABCD_BF041
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN07
AC   CVCL_F1D5
DR   ABCD; ABCD_BF042
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN08
AC   CVCL_F1D6
DR   ABCD; ABCD_BF043
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN09
AC   CVCL_F1D7
DR   ABCD; ABCD_BF044
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN1.1
AC   CVCL_A9K3
DR   Wikidata; Q102113525
RX   PubMed=37712227;
WW   Provider; WUSTL; T019532; https://wustl.resoluteinnovation.com/technologies/T019532_ipsc-line-an1-1
CC   Miscellaneous: Age of donor from personal communication of Maxwell, Kristina G.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=37712227
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,14
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 16,16.2
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   AN10
AC   CVCL_F1D8
DR   ABCD; ABCD_BF045
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN11
AC   CVCL_F1D9
DR   ABCD; ABCD_BF046
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN12
AC   CVCL_F1DA
DR   ABCD; ABCD_BF047
RX   PubMed=3375235;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_44491; 4-({5-[(2-aminoethyl)amino]-2,4-dinitrophenyl}amino)-TEMPO (DNP-SL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AN3-CA
AC   CVCL_0028
SY   AN3_CA; AN3 CA; AN3 Ca; AN3CA; AN-3; AN3; Acanthosis Nigricans 3rd attempt-CArcinoma
DR   BTO; BTO_0001771
DR   CLO; CLO_0001722
DR   CLO; CLO_0037160
DR   EFO; EFO_0002110
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-111
DR   BCRJ; 0363
DR   BioSample; SAMN03471092
DR   BioSample; SAMN03473131
DR   BioSample; SAMN03473336
DR   BioSample; SAMN10988375
DR   cancercelllines; CVCL_0028
DR   CCRID; 4201HUM-CCTCC00127
DR   CCTCC; GDC0127
DR   Cell_Model_Passport; SIDM00901
DR   ChEMBL-Cells; CHEMBL3308708
DR   ChEMBL-Targets; CHEMBL1075392
DR   CLS; 300119
DR   Cosmic; 687550
DR   Cosmic; 699283
DR   Cosmic; 713473
DR   Cosmic; 713495
DR   Cosmic; 809134
DR   Cosmic; 846176
DR   Cosmic; 871551
DR   Cosmic; 889116
DR   Cosmic; 910781
DR   Cosmic; 980634
DR   Cosmic; 1007162
DR   Cosmic; 1057760
DR   Cosmic; 1066221
DR   Cosmic; 1070810
DR   Cosmic; 1102376
DR   Cosmic; 1105620
DR   Cosmic; 1177683
DR   Cosmic; 1223484
DR   Cosmic; 1434192
DR   Cosmic; 1576450
DR   Cosmic; 1622894
DR   Cosmic; 1696752
DR   Cosmic; 2030460
DR   Cosmic; 2646618
DR   Cosmic-CLP; 910781
DR   DepMap; ACH-000940
DR   DSMZ; ACC-267
DR   DSMZCellDive; ACC-267
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910781
DR   GEO; GSM374970
DR   GEO; GSM375429
DR   GEO; GSM827494
DR   GEO; GSM886869
DR   GEO; GSM887934
DR   GEO; GSM1669600
DR   GEO; GSM3161710
DR   GEO; GSM3161711
DR   GEO; GSM7701431
DR   GEO; GSM7701432
DR   IARC_TP53; 21175
DR   IGRhCellID; AN3CA
DR   IZSLER; BS TCL 200
DR   LiGeA; CCLE_574
DR   LINCS_LDP; LCL-1499
DR   PharmacoDB; AN3CA_63_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0028
DR   PubChem_Cell_line; CVCL_0028
DR   TOKU-E; 543
DR   Wikidata; Q54749896
RX   PubMed=327080;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=11668190;
RX   PubMed=14207855;
RX   PubMed=16957166;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20218740;
RX   PubMed=20944090;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Population: Caucasian.
CC   Doubling time: ~45-50 hours (CLS=300119); ~55 hours (DSMZ=ACC-267).
CC   HLA typing: A*11:01,11:01; B*15:11,58:01; C*05:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro373Ser (c.1117C>T); Zygosity=Heterozygous (ATCC=HTB-111).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg557_Lys561delArgGluIleAspLysinsGln (c.1670_1681delGAGAAATTGACA); Zygosity=Heterozygous (ATCC=HTB-111).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Glnfs*4 (c.389delG); ClinVar=VCV000192224; Zygosity=Homozygous (PubMed=20944090; ATCC=HTB-111).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly389Trp (c.1165G>T); ClinVar=VCV000156517; Zygosity=Heterozygous (ATCC=HTB-111).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.36%; Native American=0%; East Asian, North=0.85%; East Asian, South=1.08%; South Asian=3.21%; European, North=62.96%; European, South=31.54% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-111; CLS=300119; Cosmic-CLP=910781; DSMZ=ACC-267; IZSLER=BS TCL 200; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,14 (DSMZ=ACC-267)
ST   CSF1PO: 12,14,15 (ATCC=HTB-111; CLS=300119; Cosmic-CLP=910781; IZSLER=BS TCL 200; PubMed=25877200)
ST   D13S317: 12,14
ST   D16S539: 10,14 (ATCC=HTB-111; CLS=300119; DSMZ=ACC-267; PubMed=25877200)
ST   D16S539: 10,14,15 (Cosmic-CLP=910781; IZSLER=BS TCL 200)
ST   D18S51: 15,18
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 11,14
ST   D7S820: 7,7.1,10 (ATCC=HTB-111; PubMed=25877200)
ST   D7S820: 7,10 (CLS=300119; Cosmic-CLP=910781; IZSLER=BS TCL 200)
ST   D7S820: 7.1,10 (DSMZ=ACC-267)
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 9,16
ST   TH01: 9.3,10
ST   TPOX: 8,10
ST   vWA: 14,20
DI   NCIt; C26687; Acanthosis nigricans
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   AN4;11
AC   CVCL_AY52
SY   AN4-11
DR   Cosmic; 2393013
DR   Wikidata; Q54749899
RX   PubMed=8353274;
RX   PubMed=8358709;
CC   Characteristics: Established from a tumor produced by injection of the leukemic cells into the peritoneum of SCID mice (PubMed=8353274).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4; Note=In frame (PubMed=8358709).
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 8
//
ID   AN4Rppc7
AC   CVCL_JQ60
DR   Wikidata; Q54749900
RX   PubMed=11568460;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: B6SJLF1/J transgenic P450scc/SV40 + P450c11B3/intron/neo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 8
//
ID   AN51
AC   CVCL_E4CD
SY   AN 51
RX   PubMed=6459115;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P07359; Human GP1BA/CD42b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ANA-1 [Human fibroblast]
AC   CVCL_ZR64
DR   Wikidata; Q98125474
RX   PubMed=6403037;
RX   PubMed=6492896;
RX   PubMed=7163956;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   ANA-1 [Mouse macrophage]
AC   CVCL_0142
SY   Ana-1; ANA1
DR   BTO; BTO_0002775
DR   MCCL; MCC:0000035
DR   CLS; 305172
DR   KCB; KCB 200784YJ
DR   Wikidata; Q54749902
RX   PubMed=2778838;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Transformant: Recombinant retrovirus J2.
CC   Discontinued: CLS; 305172; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Ana-104
AC   CVCL_Z534
SY   Ana 104; Ana104
DR   Wikidata; Q29582984
RX   CelloPub=CLPUB00189;
RX   CelloPub=CLPUB00190;
RX   DOI=10.3969/j.issn.1673-5234.2000.04.020;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
OX   NCBI_TaxID=74872; ! Anopheles anthropophagus (Asian malaria mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 8
//
ID   ANAD 63
AC   CVCL_VP94
SY   ANAD-63; ANAD63
DR   Wikidata; Q93325102
RX   CelloPub=CLPUB00440;
RX   PubMed=10837406;
RX   PubMed=21863025;
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu59_Ile66del; Zygosity=Unspecified (CelloPub=CLPUB00440).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   ANBL-6
AC   CVCL_5425
SY   ANBL6
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_5425
DR   Cosmic; 720790
DR   Cosmic; 1170891
DR   Cosmic; 2081377
DR   Cosmic; 2367285
DR   IARC_TP53; 28510
DR   Millipore; SCC429
DR   Wikidata; Q54749908
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8221668;
RX   PubMed=8943038;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=11154231;
RX   PubMed=11157491;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=19344406;
RX   PubMed=21173094;
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=25015330;
RX   PubMed=25688540;
RX   PubMed=32123307;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=ANBL-6
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Caucasian.
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,03; B*51,52; C*12:02,12:03 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Unspecified (PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Tyr425Thrfs*36 (c.1272delC); Zygosity=Homozygous (PubMed=17692805).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Millipore=SCC429
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12,13
ST   D18S51: 13,15
ST   D21S11: 28,30
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 20,23,24
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M523 ! ANBM-6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   ANBL-6 BR
AC   CVCL_QZ43
DR   cancercelllines; CVCL_QZ43
DR   Wikidata; Q54749909
RX   PubMed=19344406;
CC   Population: Caucasian.
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Tyr425Thrfs*36 (c.1272delC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5425 ! ANBL-6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   ANBL-6-luc
AC   CVCL_B7F5
DR   cancercelllines; CVCL_B7F5
DR   Wikidata; Q112929238
RX   PubMed=32123307;
CC   Population: Caucasian.
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Tyr425Thrfs*36 (c.1272delC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = effLuc).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5425 ! ANBL-6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   ANBM-6
AC   CVCL_M523
SY   ANBM6
DR   Wikidata; Q54749912
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8221668;
RX   PubMed=9022078;
RX   PubMed=10936422;
CC   Population: Caucasian.
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5425 ! ANBL-6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   AND-1
AC   CVCL_B526
SY   AND1; GRA-1; ESe029-A
DR   BioSamples; SAMEA7772668
DR   GEO; GSM569197
DR   GEO; GSM569198
DR   hPSCreg; ESe029-A
DR   SKIP; SKIP002540
DR   Wikidata; Q54749914
RX   PubMed=19401322;
RX   PubMed=20641038;
RX   PubMed=20736931;
RX   PubMed=21936705;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/AND-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/anexo_and_1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   HLA typing: A*24:02,33:01; B*07:02,44:03; C*02:20,07:02; DQB1*03:01,03:01; DRB1*11:01,11:02 (BNLC).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   AND-1 EGFP-2A-SCL
AC   CVCL_A8HQ
SY   AND1 EGFP-2A-SCL; AND1 pRRL-EF1a-EGFP-2A-SCL-PGK-Neo
DR   Wikidata; Q107113357
RX   PubMed=22491213;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud_deposito_AND_1_EGFP-2A-SCL.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_AND1_EGFP-2A-SCL.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-SCL-PGKp-Neo construct.
CC   Karyotypic information: 47,XY,-1,+der(1)dup(1q11->1qter::1q11->1qter)-7,+i(7)p,+13 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   AND-1 FLT3 D835
AC   CVCL_V161
SY   AND1-FLT3 D835; AND-1 FLT3-TKD; AND1-FLT3 TKD
DR   Wikidata; Q54749916
RX   PubMed=23479570;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Dossier-AND1-FLT3-D835.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transduced with a pRRL-EF1a-FLT3 D835-PGKp-GFP construct.
CC   Karyotypic information: 46,XY,+i(7)p(11),-7 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Asp835Xaa).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   AND-1 FLT3 ITD
AC   CVCL_V160
SY   AND-1 FLT3-ITD; AND1-FLT3 ITD
DR   Wikidata; Q54749918
RX   PubMed=23479570;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   Characteristics: Transduced with a pRRL-EF1a-FLT3 ITD-PGKp-GFP construct.
CC   Karyotypic information: 46,XY,+i(7)p(11),-7 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   AND-1 MLLAF4
AC   CVCL_V162
SY   AND-1-MLLAF4; AND1-MLLAF4
DR   Wikidata; Q54749919
RX   PubMed=23479570;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Dossier-AND1-MLLAF4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transduced with a pRRL-EF1a-MLLAF4-PGKp-Neo construct.
CC   Karyotypic information: 46,XY,+i(7)p(11),-7 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7135; AFF1 (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   AND-1 MLLAF4 FLT3 D835
AC   CVCL_V163
SY   AND1-MLLAF4 FLT3 D835; AND1-MLLAF4/FLT3-TKD
DR   Wikidata; Q54749922
RX   PubMed=23479570;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Dossier-AND1-FLT3-D835.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transduced with both a pRRL-EF1a-MLLAF4-PGKp-Neo and a pRRL-EF1a-FLT3 D835-PGKp-GFP constructs.
CC   Karyotypic information: 46,XY,+i(7)p(11),-7 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7135; AFF1 (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Asp835Xaa).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   AND-1 MLLAF4 FLT3 ITD
AC   CVCL_V164
SY   AND1-MLLAF4 FLT3 ITD; AND1-MLLAF4/FLT3-ITD
DR   Wikidata; Q54749924
RX   PubMed=23479570;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Dossier_AND1-MLLAF4-FLT3-ITD.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transduced with both a pRRL-EF1a-MLLAF4-PGKp-Neo and a pRRL-EF1a-FLT3 ITD-PGKp-GFP constructs.
CC   Karyotypic information: 46,XY,+i(7)p(11),-7 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7135; AFF1 (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   AND-1 NEO
AC   CVCL_XJ48
SY   AND 1 NEO; AND1 NEO; AND1 pRRL-EF1a-PGK-Neo
DR   Wikidata; Q93325139
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud_deposito_AND1_Neo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transfected with a pRRL-EF1a-PGKp-Neo construct.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   AND-1 WASKO C1.1
AC   CVCL_V158
DR   Wikidata; Q54749925
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud-Deposito-Lineas-Celulares-AND-1-WASKO-C1-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:12731; WAS.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   AND-1 WASKO C1.2
AC   CVCL_V159
DR   Wikidata; Q54749928
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud-Deposito-Lineas-Celulares-AND-1-WASKO-C1-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:12731; WAS.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B526 ! AND-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   AND-2
AC   CVCL_B527
SY   AND2; GRA-2
DR   Wikidata; Q54749931
RX   PubMed=19401322;
RX   PubMed=20641038;
RX   PubMed=20736931;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/AND-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/anexo_and_2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   HLA typing: A*02:01,24:02; B*27:05,40:02; C*02:02,04:01; DQB1*02:01,03:01; DRB1*03:01,11:01 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   AND-3
AC   CVCL_B528
SY   AND3; GRA-3
DR   Wikidata; Q54749932
RX   PubMed=19401322;
RX   PubMed=20641038;
RX   PubMed=20736931;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/AND-3%2520corregido.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_AND_3%2520corregido.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   HLA typing: A*01:01,02:01; B*56:01,57:01; C*01:02,07:01; DQB1*02:01,05:01; DRB1*01:01,03:01 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   AND1
AC   CVCL_UE02
SY   AND 1
DR   Wikidata; Q93325144
RX   PubMed=3013426;
RX   PubMed=8543165;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   ANDP
AC   CVCL_F823
DR   IPD-IMGT/HLA; 10250
DR   Wikidata; Q54749936
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02,32:01; B*08:01,18:01; C*07:01,12:05; DPB1*01:01,04:01; DQB1*02:01,03:01; DRB1*03:01,11:01; DRB3*01:01,02:01 (IPD-IMGT/HLA=10250).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   ANE58
AC   CVCL_Z178
SY   ANE 58; ANE 64
DR   Wikidata; Q54749939
RX   PubMed=2766897;
RX   PubMed=6644089;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=23140894;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Miscellaneous: Called ANE 64 in the original publication (PubMed=6644089), but seems to have been called ANE58/ANE 58 since in all other publications from the same authors.
OX   NCBI_TaxID=60253; ! Dermacentor nitens (Tropical horse tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Anglne
AC   CVCL_U287
DR   CCRID; 4201HUM-CCTCC00049
DR   CCTCC; GDC0049
DR   CLS; 305144
DR   Wikidata; Q54749941
RX   PubMed=26116706;
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D12S391: 16,24
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 16
ST   D21S11: 31.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D6S1043: 11
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   ANGM-CSS
AC   CVCL_2297
SY   ANGMCSS
DR   cancercelllines; CVCL_2297
DR   Cell_Model_Passport; SIDM01524
DR   DepMap; ACH-001329
DR   ECACC; 08040401
DR   Wikidata; Q54749944
RX   PubMed=24366606;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~60 hours (PubMed=24366606).
CC   Karyotypic information: Near tetraploid karyotype.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left temporo-occipital lobe.
ST   Source(s): DepMap=ACH-001329
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 10,13
ST   Penta E: 7,10
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   ANGM5
AC   CVCL_ZV39
DR   Wikidata; Q98125475
RX   PubMed=26300657;
RX   PubMed=27512663;
CC   Population: Iraqi.
CC   Doubling time: 22 hours (PubMed=26300657).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   Angu-BL
AC   CVCL_7173
SY   Angu
DR   Wikidata; Q54749947
RX   PubMed=9882297;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Angus
AC   CVCL_WS61
DR   Wikidata; Q93325148
RX   PubMed=31175136;
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Gly12Asp (c.35G>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Breed/subspecies: Scottish Terrier; VBO=VBO_0201198.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 231
ST   Dog FHC2054: 156
ST   Dog FHC2079: 272,280
ST   Dog PEZ1: 123,128
ST   Dog PEZ3: 121,131
ST   Dog PEZ5: 111
ST   Dog PEZ6: 176,210
ST   Dog PEZ8: 241
ST   Dog PEZ12: 281
ST   Dog PEZ20: 176
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   Anip-973
AC   CVCL_6879
SY   Anip 973; ANIP 973; Anip[973]; Anip973; ANIP973
DR   Wikidata; Q54749949
RX   PubMed=14989933;
RX   PubMed=17650408;
RX   PubMed=19080366;
RX   PubMed=20723345;
CC   Population: Chinese.
CC   Doubling time: 23.45 hours (PubMed=17650408).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6878 ! AGZY83-a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   Anip973/CDDP
AC   CVCL_W193
DR   Wikidata; Q54749952
RX   PubMed=20723345;
RX   PubMed=20738915;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6879 ! Anip-973
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   Anip973/NVB
AC   CVCL_W194
SY   Anip973/Navelbine
DR   Wikidata; Q54749953
RX   PubMed=17650408;
RX   PubMed=20738915;
RX   PubMed=22429577;
CC   Population: Chinese.
CC   Doubling time: 24.21 hours (PubMed=17650408).
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6879 ! Anip-973
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 11
//
ID   Anip973R
AC   CVCL_D7EF
RX   PubMed=19080366;
CC   Population: Chinese.
CC   Characteristics: Radioresistant. The parent cell line was irradiated with 60 Gy in 4 Gy fractions (PubMed=19080366).
CC   Selected for resistance to: NCIt; C17262; X-Ray.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6879 ! Anip-973
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Anjou 65
AC   CVCL_3645
SY   ANJOU 65; Anjou-65
DR   CLO; CLO_0001724
DR   ATCC; CRL-11269
DR   BioSample; SAMN03471333
DR   Wikidata; Q28197162
RX   Patent=WO1994019478A1;
RX   PubMed=7690960;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-90.html
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11269.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: ATCC; CRL-11269; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-11269
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12,14
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   ANN-1
AC   CVCL_9242
DR   CLO; CLO_0001725
DR   ChEMBL-Cells; CHEMBL3307385
DR   ChEMBL-Targets; CHEMBL614520
DR   PubChem_Cell_line; CVCL_9242
DR   Wikidata; Q54749960
RX   PubMed=163444;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 15
//
ID   Annah
AC   CVCL_ZU72
SY   NK6; NK-6; NK 6b; NK6b
DR   Wikidata; Q98125477
RX   PubMed=4174339;
RX   PubMed=4878906;
RX   PubMed=5021706;
RX   PubMed=11515428;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   ANO
AC   CVCL_F533
SY   Extract 282; Extract 357
DR   IPD-IMGT/HLA; 12178
DR   Wikidata; Q54749961
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,02:17; B*08:09,18:01; C*07:01; DQB1*05:03:01,06:03; DRB1*13:AB,14:AH; DRB3*02 (IPD-IMGT/HLA=12178).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   Anr13-1
AC   CVCL_4575
DR   CLO; CLO_0050620
DR   RCB; RCB0451
DR   Wikidata; Q54749963
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4107 ! ARLJ 301-3
SX   Male
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   Anr4
AC   CVCL_4105
DR   CLO; CLO_0001726
DR   CLO; CLO_0050621
DR   CLDB; cl277
DR   ChEMBL-Cells; CHEMBL3308415
DR   ChEMBL-Targets; CHEMBL614521
DR   ECACC; 90071808
DR   PubChem_Cell_line; CVCL_4105
DR   RCB; RCB0449
DR   Wikidata; Q54749965
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4107 ! ARLJ 301-3
SX   Male
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Anr9-1
AC   CVCL_4576
DR   CLO; CLO_0050619
DR   RCB; RCB0450
DR   Wikidata; Q54749967
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4107 ! ARLJ 301-3
SX   Male
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   aNS-1
AC   CVCL_A5DW
SY   ANS-1
DR   Wikidata; Q107113358
RX   PubMed=16766697;
RX   PubMed=20085655;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/animal-stem-cells-catalogue-isenet.pdf
CC   Doubling time: ~30 hours (PubMed=16766697).
CC   Derived from site: In situ; Brain, subventricular zone; UBERON=UBERON_0014940.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   Anso-242
AC   CVCL_Z536
SY   Anso 242; Anso242
DR   Wikidata; Q54749968
RX   CelloPub=CLPUB00190;
RX   DOI=10.3969/j.issn.1673-5234.2000.04.020;
CC   Group: Insect cell line.
OX   NCBI_TaxID=74873; ! Anopheles sinensis (Mosquito)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   anti-130-kDa Mesothelial-Ciliated Cells
AC   CVCL_L580
DR   CLO; CLO_0001729
DR   ATCC; CRL-2401
DR   Wikidata; Q54749972
RX   PubMed=7603040;
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   anti-1F7
AC   CVCL_C7I9
SY   1F7
DR   Wikidata; Q123030698
RX   Patent=US5120642;
RX   PubMed=2479677;
RX   PubMed=24502396;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10297.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   Anti-6330403k07Rik
AC   CVCL_A7DK
DR   RCB; RCB4683
DR   Wikidata; Q107113360
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8VBZ2; Mouse 6330403k07Rik.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Anti-alpha(1)1C6F4
AC   CVCL_U847
SY   1C6F4
DR   CLO; CLO_0050312
DR   RCB; RCB1240
DR   Wikidata; Q54749973
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(10)10E3B7
AC   CVCL_U848
SY   10E3B7
DR   Wikidata; Q54749976
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(2)E2B5
AC   CVCL_U849
SY   E2B5
DR   Wikidata; Q54749977
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(3)7E7C2
AC   CVCL_U850
SY   7E7C2
DR   Wikidata; Q54749979
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(4)11D9G5
AC   CVCL_U851
SY   11D9G5
DR   CLO; CLO_0050346
DR   RCB; RCB1243
DR   Wikidata; Q54749982
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(5)11D10B6
AC   CVCL_U852
SY   11D10B6
DR   CLO; CLO_0050347
DR   RCB; RCB1244
DR   Wikidata; Q54749983
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(6)11D10F7
AC   CVCL_U853
SY   11D10F7
DR   Wikidata; Q54749986
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(7)7C9A10
AC   CVCL_U854
SY   7C9A10
DR   CLO; CLO_0050344
DR   RCB; RCB1246
DR   Wikidata; Q54750039
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(8)9F3A6
AC   CVCL_U855
SY   9F3A6
DR   CLO; CLO_0050313
DR   RCB; RCB1247
DR   Wikidata; Q54750041
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha(9)12G8B11
AC   CVCL_U856
SY   12G8B11
DR   CLO; CLO_0050348
DR   RCB; RCB1248
DR   Wikidata; Q54750042
RX   PubMed=2544482;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0C216; Clostridium perfringens plc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-alpha2Ct
AC   CVCL_E8H6
DR   ABCD; ABCD_AX044
RX   PubMed=18650436;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; P08123; Human COL1A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   anti-alphaA-crystallin
AC   CVCL_U830
SY   2G6B6
DR   CLO; CLO_0050315
DR   RCB; RCB1303
DR   Wikidata; Q54750045
RX   PubMed=7832826;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02504; Chicken CRYAA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   anti-alphaB-crystallin
AC   CVCL_U813
SY   2D2B6
DR   CLO; CLO_0050304
DR   RCB; RCB1304
DR   Wikidata; Q54750047
RX   PubMed=7832826;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q05713; Chicken CRYAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   anti-beta5-crystallin
AC   CVCL_U826
DR   CLO; CLO_0050305
DR   RCB; RCB1305
DR   Wikidata; Q54750049
RX   PubMed=7832826;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   anti-beta6-crystallin
AC   CVCL_U827
DR   CLO; CLO_0050306
DR   RCB; RCB1306
DR   Wikidata; Q54750052
RX   PubMed=7832826;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   anti-beta8-crystallin
AC   CVCL_WI43
DR   Wikidata; Q93325229
RX   PubMed=7832826;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   anti-BL2
AC   CVCL_F1KE
RX   PubMed=6190520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06734; Human FCER2/CD23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   anti-DAB2IP
AC   CVCL_E2YU
RX   PubMed=26301928;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5VWQ8; Human DAB2IP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   anti-delta-crystallin
AC   CVCL_U829
SY   1A4B12
DR   CLO; CLO_0050322
DR   RCB; RCB1308
DR   Wikidata; Q54750054
RX   PubMed=7832826;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02521; Chicken DLS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-Dgcr14
AC   CVCL_A7DL
DR   RCB; RCB4685
DR   Wikidata; Q107113361
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O70279; Mouse Ess2/Dgcr14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Anti-ESAT-6
AC   CVCL_C6VA
DR   Wikidata; Q117704191
RX   PubMed=25550937;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P9WNK7; Mycobacterium tuberculosis ESAT-6 (esxA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Anti-FHA(1)1C6
AC   CVCL_U639
SY   1C6
DR   CLO; CLO_0050394
DR   RCB; RCB1239
DR   Wikidata; Q54750057
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12255; Bordetella pertussis filamentous hemagglutinin (fhaB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-FHA(2)2E9
AC   CVCL_U640
SY   2E9
DR   CLO; CLO_0050393
DR   RCB; RCB1238
DR   Wikidata; Q54750059
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12255; Bordetella pertussis filamentous hemagglutinin (fhaB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Anti-FXYD6
AC   CVCL_C5EC
DR   Wikidata; Q116048522
RX   PubMed=22008078;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H0Q3; Human FXYD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   anti-gamma1-crystallin
AC   CVCL_U828
SY   gamma0
DR   CLO; CLO_0050307
DR   RCB; RCB1307
DR   Wikidata; Q54750061
RX   PubMed=7832826;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q8QFU3; Cynops pyrrhogaster gamma-crystallin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   anti-GEA-49
AC   CVCL_F0VQ
SY   anti-GEA.49
RX   PubMed=2189826;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human GEA-49 glycoprotein on the apical plasma membrane of glandular epithelia.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Anti-L10
AC   CVCL_C8JW
DR   Wikidata; Q123030699
RX   PubMed=1939233;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P0A7J3; Escherichia coli rplJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Anti-L9
AC   CVCL_C8JV
DR   Wikidata; Q123030700
RX   PubMed=1939233;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0A7R1; Escherichia coli rplI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   anti-MERS CoV P1
AC   CVCL_A0IB
DR   Wikidata; Q108819853
RX   Patent=WO2016080701A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00331.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   anti-MERS CoV P3
AC   CVCL_A0IC
DR   Wikidata; Q108819854
RX   Patent=WO2016080701A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00332.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Anti-morphine
AC   CVCL_E2QW
RX   PubMed=26301931;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Anti-My-10 clone 28/8/8/14/4
AC   CVCL_L094
SY   My10
DR   CLO; CLO_0001731
DR   ATCC; HB-8483
DR   KCLB; 88483
DR   Wikidata; Q54750062
RX   Patent=US4714680;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8483.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28906; Human CD34.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   Anti-NG-R1
AC   CVCL_B6LT
DR   Wikidata; Q111732921
RX   PubMed=24610346;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_77149; Notoginsenoside R1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   Anti-P2X7 clone 5
AC   CVCL_E7PY
SY   Clone 5
DR   ABCD; ABCD_BE630
RX   PubMed=39940947;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Z1M0; Mouse P2rx7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Anti-P2X7 clone 18
AC   CVCL_E7PZ
SY   Clone 18
RX   PubMed=39940947;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Z1M0; Mouse P2rx7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   anti-p56lck
AC   CVCL_D5AI
DR   Wikidata; Q127380233
RX   PubMed=2017663;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06239; Human LCK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Anti-PF
AC   CVCL_B6M9
DR   Wikidata; Q111732922
RX   PubMed=25856441;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_7889; Paeoniflorin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   Anti-PT-S1-10D6
AC   CVCL_U641
SY   10D6
DR   CLO; CLO_0050358
DR   RCB; RCB1208
DR   Wikidata; Q54750064
RX   PubMed=1698179;
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-PT-S1-1B7
AC   CVCL_U642
SY   1B7
DR   CLO; CLO_0050345
DR   RCB; RCB1205
DR   Wikidata; Q54750066
RX   PubMed=1698179;
RX   PubMed=1894382;
RX   PubMed=6094351;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-PT-S1-3F10
AC   CVCL_U643
SY   3F10
DR   CLO; CLO_0050402
DR   RCB; RCB1212
DR   Wikidata; Q54750068
RX   PubMed=1698179;
RX   PubMed=1894382;
RX   PubMed=6094351;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-PT-S1-4D10
AC   CVCL_U644
SY   4D10
DR   CLO; CLO_0050399
DR   RCB; RCB1214
DR   Wikidata; Q54750070
RX   PubMed=1698179;
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-PT-S1-8G4
AC   CVCL_U645
SY   8G4
DR   CLO; CLO_0050359
DR   RCB; RCB1209
DR   Wikidata; Q54750072
RX   PubMed=1698179;
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-PT-S2-3A12
AC   CVCL_U646
SY   3A12
DR   CLO; CLO_0050309
DR   RCB; RCB1220
DR   Wikidata; Q54750074
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04978; Bordetella pertussis ptxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   Anti-PT-S2-9G8
AC   CVCL_U647
SY   9G8
DR   CLO; CLO_0050401
DR   RCB; RCB1222
DR   Wikidata; Q54750077
RX   PubMed=1698179;
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04978; Bordetella pertussis ptxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-PT-S23-11E6
AC   CVCL_U648
SY   11E6
DR   CLO; CLO_0050308
DR   RCB; RCB1215
DR   Wikidata; Q54750078
RX   PubMed=1698179;
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   Anti-PT-S3-7E10
AC   CVCL_U649
SY   7E10
DR   CLO; CLO_0050310
DR   RCB; RCB1223
DR   Wikidata; Q54750080
RX   PubMed=1698179;
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04979; Bordetella pertussis ptxC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Anti-PT-S4-1H2
AC   CVCL_U861
SY   1H2
DR   CLO; CLO_0050400
DR   RCB; RCB1233
DR   Wikidata; Q54750083
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A3R5; Bordetella pertussis ptxD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   Anti-PT-S4-7F2
AC   CVCL_U650
SY   7F2
DR   CLO; CLO_0050311
DR   RCB; RCB1229
DR   Wikidata; Q54750085
RX   PubMed=1894382;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A3R5; Bordetella pertussis ptxD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   Anti-rcanIL1beta, clone 11
AC   CVCL_F0BI
SY   Anti-IL1beta, clone 11
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q28292; Dog IL1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-rcanIL1beta, clone 47
AC   CVCL_F0BJ
SY   Anti-IL1beta, clone 47
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q28292; Dog IL1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-rcanIL1beta, clone 5
AC   CVCL_F0BH
SY   Anti-IL1beta, clone 5
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q28292; Dog IL1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-rcanTNF, clone 12
AC   CVCL_F0BM
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51742; Dog TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-rcanTNF, clone 13
AC   CVCL_F0BN
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51742; Dog TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-rcanTNF, clone 21
AC   CVCL_F0BP
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51742; Dog TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-rcanTNF, clone 7
AC   CVCL_F0BK
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51742; Dog TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-rcanTNF, clone 8
AC   CVCL_F0BL
RX   PubMed=15982477;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51742; Dog TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   anti-Rf
AC   CVCL_B6G3
DR   Wikidata; Q111732923
RX   PubMed=10823656;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_67986; Ginsenoside Rf.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   anti-S6K2/B2
AC   CVCL_B6WB
SY   B2
DR   Wikidata; Q111732925
RX   PubMed=22894784;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9UBS0; Human RPS6KB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   anti-SAG1
AC   CVCL_E8PU
RX   PubMed=32216700;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13664; Toxoplasma gondii major surface antigen p30 (Note=Immunized with the peptide 63-KKSTAAVILTPTENHFTLK-81).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Anti-SC35
AC   CVCL_L674
DR   CLO; CLO_0001732
DR   ATCC; CRL-2031
DR   BCRC; 60171
DR   Wikidata; Q54750087
RX   PubMed=2137203;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01130; Human SRSF2/SC35.
CC   Misspelling: Anti-SSC35; BCRC=60171.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   anti-SNAP-11
AC   CVCL_E6JL
RX   PubMed=27187007;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P16455; Human MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag; Immunized with 146-HRVVSSSGAVGGYEGGLC-163).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   anti-SR
AC   CVCL_G689
SY   1H4; 1H4G7
DR   CLO; CLO_0001733
DR   ATCC; CRL-2383
DR   Wikidata; Q54750089
RX   PubMed=9159396;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   anti-SRp20
AC   CVCL_G690
SY   7B4; 7B4A12
DR   CLO; CLO_0001734
DR   ATCC; CRL-2384
DR   Wikidata; Q54750091
RX   PubMed=9159396;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P84103; Human SRSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   Anti-thaumatin clone 21
AC   CVCL_KR57
DR   Wikidata; Q54750093
RX   Patent=US4770993;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8921.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02883; Thaumatococcus daniellii thaumatin-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   Anti-thaumatin clone 3
AC   CVCL_KR58
DR   Wikidata; Q54750094
RX   Patent=US4770993;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8922.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02883; Thaumatococcus daniellii thaumatin-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   Anti-theta(1)3H10
AC   CVCL_U857
SY   3H10
DR   CLO; CLO_0050314
DR   ABCD; ABCD_AV988
DR   RCB; RCB1250
DR   Wikidata; Q54750096
RX   DOI=10.1007/BF01577135;
RX   PubMed=32891180;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   anti-ULBP6/2/5
AC   CVCL_F0AD
SY   WT-anti-ULBP6/2/5
DR   ABCD; ABCD_BF023
RX   PubMed=40116579;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q5VY80; Human RAET1L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   anti-Y 29/55
AC   CVCL_UZ13
SY   anti-Y29/55
DR   Wikidata; Q93325298
RX   PubMed=6175400;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human antigen on malignant B-lymphocytes from patients with chronic lymphocytic leukemia.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UZ12 ! P3-Ag8-gamma1-
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 5
//
ID   Antibody 2.06
AC   CVCL_L673
DR   CLO; CLO_0001730
DR   ATCC; HB-104
DR   Wikidata; Q54750098
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   AO
AC   CVCL_D631
DR   BioSample; SAMN03151664
DR   Wikidata; Q54750101
RX   PubMed=1246601;
RX   PubMed=4128382;
RX   PubMed=4472134;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00033.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   AO-40.10
AC   CVCL_C6WR
SY   AO-40
DR   Wikidata; Q117704193
RX   PubMed=6166712;
RX   PubMed=32419056;
CC   Characteristics: Hybrid of the T-cell hybridoma FS6-14.13 Ag2.1 with T-cell blasts from chicken ovalbumin (cOVA)-immunized B10.A (H-2a) mice. Produces IL-2 in response to antigen stimulation (ovalbumin) plus irradiated B10.A spleen cells (PubMed=6166712).
CC   Doubling time: ~12 hours (PubMed=6166712).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M112 ! FS6-14.13 Ag2.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Ao/I
AC   CVCL_AV09
DR   Wikidata; Q54750104
RX   CelloPub=CLPUB00496;
RX   PubMed=26820856;
CC   Group: Insect cell line.
CC   Doubling time: ~30 hours (CelloPub=CLPUB00496).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=480707; ! Adoxophyes orana (Summer fruit tortrix moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   AO10
AC   CVCL_KB65
SY   AO-10
DR   Wikidata; Q54750106
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8346.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 110 kDa cell surface glycoprotein (Gp110).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AO122
AC   CVCL_KB66
DR   Wikidata; Q54750108
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8349.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16112; Human ACAN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AO2V4
AC   CVCL_Z597
DR   Wikidata; Q54750110
RX   PubMed=8943096;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8567 ! SK-AO2
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   AO50
AC   CVCL_KB67
DR   Wikidata; Q54750113
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8347.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AO92
AC   CVCL_KB68
DR   Wikidata; Q54750114
RX   Patent=US4642291;
RX   PubMed=6182568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8348.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   AOBA-1
AC   CVCL_VI71
SY   Adult Olfactory Bulb Astrocyte-1
DR   Wikidata; Q93325335
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOBA-2
AC   CVCL_VI72
SY   Adult Olfactory Bulb Astrocyte-2
DR   Wikidata; Q93325337
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOBA-3
AC   CVCL_VI73
SY   Adult Olfactory Bulb Astrocyte-3
DR   Wikidata; Q93325339
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOBA-4
AC   CVCL_VI74
SY   Adult Olfactory Bulb Astrocyte-4
DR   Wikidata; Q93325341
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOBEC-1
AC   CVCL_VI75
SY   Adult Olfactory Bulb Ensheathing Cell-1
DR   Wikidata; Q93325342
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOBEC-2
AC   CVCL_VI76
SY   Adult Olfactory Bulb Ensheathing Cell-2
DR   Wikidata; Q93325345
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOBEC-3
AC   CVCL_VI77
SY   Adult Olfactory Bulb Ensheathing Cell-3
DR   Wikidata; Q93325347
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOBEC-4
AC   CVCL_VI78
SY   Adult Olfactory Bulb Ensheathing Cell-4
DR   Wikidata; Q93325349
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >1M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   AOC31
AC   CVCL_RX28
DR   Wikidata; Q54750115
RX   PubMed=12208054;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_RX29 ! AOC39
OI   CVCL_E7RB ! AOC42
OI   CVCL_RX30 ! AOC45
OI   CVCL_RX31 ! AOC49
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   AOC39
AC   CVCL_RX29
DR   Wikidata; Q54750118
RX   PubMed=12208054;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_RX28 ! AOC31
OI   CVCL_E7RB ! AOC42
OI   CVCL_RX30 ! AOC45
OI   CVCL_RX31 ! AOC49
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   AOC42
AC   CVCL_E7RB
SY   AOC-42
DR   ABM; T0448
RX   PubMed=12208054;
CC   Doubling time: 50-60 hours (ABM=T0448).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_RX28 ! AOC31
OI   CVCL_RX29 ! AOC39
OI   CVCL_RX30 ! AOC45
OI   CVCL_RX31 ! AOC49
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   AOC45
AC   CVCL_RX30
SY   AOC-45
DR   Wikidata; Q54750119
RX   PubMed=12208054;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_RX28 ! AOC31
OI   CVCL_RX29 ! AOC39
OI   CVCL_E7RB ! AOC42
OI   CVCL_RX31 ! AOC49
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   AOC49
AC   CVCL_RX31
DR   Wikidata; Q54750167
RX   PubMed=12208054;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_RX28 ! AOC31
OI   CVCL_RX29 ! AOC39
OI   CVCL_E7RB ! AOC42
OI   CVCL_RX30 ! AOC45
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   AOF
AC   CVCL_VN98
SY   Astronotus Ocellatus Fin
DR   Wikidata; Q93325367
RX   PubMed=30047007;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 20 to 37 Celsius, the optimal growth temperature is 28 Celsius.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=50733; ! Astronotus ocellatus (Oscar)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   AOK-B50
AC   CVCL_8171
DR   BTO; BTO_0003851
DR   Wikidata; Q54750169
RX   PubMed=8386606;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P25107; Didelphis virginiana PTH1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   AOUMEYi001-A
AC   CVCL_D6IB
DR   hPSCreg; AOUMEYi001-A
DR   Wikidata; Q127380234
RX   PubMed=38323760;
CC   From: Meyer Children's Hospital IRCCS; Firenze; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23161; ALG8; Simple; p.Leu149Arg (c.445T>G); ClinVar=VCV001310520; Zygosity=Heterozygous (PubMed=38323760).
CC   Sequence variation: Mutation; HGNC; HGNC:23161; ALG8; Simple; p.Thr327Arg (c.980C>G); ClinVar=VCV001032157; Zygosity=Heterozygous (PubMed=38323760).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206097; Congenital disorder of glycosylation type Ih
DI   ORDO; Orphanet_79325; ALG8-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   AOUMEYi002-A
AC   CVCL_D6IC
DR   BioSamples; SAMEA115493381
DR   hPSCreg; AOUMEYi002-A
DR   Wikidata; Q127380235
RX   PubMed=38703669;
CC   From: Meyer Children's Hospital IRCCS; Firenze; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10872; ST3GAL5; Simple; p.Gly342Ser (c.1024G>A); ClinVar=VCV000828145; Zygosity=Heterozygous; Note=De novo mutation (PubMed=38703669).
CC   Sequence variation: Mutation; HGNC; HGNC:10872; ST3GAL5; Simple; p.His389Arg (c.1166A>G); Zygosity=Heterozygous (PubMed=38703669).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206525; Salt and pepper developmental regression syndrome
DI   ORDO; Orphanet_370933; GM3 synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   AOVC1
AC   CVCL_A1UI
SY   ECC2
DR   cancercelllines; CVCL_A1UI
DR   Cell_Model_Passport; SIDM01985
DR   DepMap; ACH-001997
DR   Wikidata; Q105506803
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (DepMap=ACH-001997).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Unspecified (DepMap=ACH-001997).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
ST   Source(s): DepMap=ACH-001997
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 15,16
ST   D21S11: 29,31
ST   D3S1358: 14,16
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 14,16
ST   FGA: 21
ST   Penta D: 9,14
ST   Penta E: 13,16
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   AOXlar7y
AC   CVCL_WC97
SY   Acipenser OXyrinchus larvae no7, trypsin-digestion
DR   Wikidata; Q93325377
RX   DOI=10.3354/ab00383;
RX   PubMed=30862517;
RX   PubMed=34822677;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 25 Celsius (PubMed=30862517).
CC   Doubling time: 110 hours (PubMed=30862517).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
OX   NCBI_TaxID=36177; ! Acipenser oxyrinchus (Atlantic sturgeon)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   AP
AC   CVCL_E457
DR   dbMHC; 48475
DR   IHW; IHW09229
DR   IPD-IMGT/HLA; 10251
DR   Wikidata; Q54750173
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:07,33:01; B*46,58:01; C*01:02:01,03:02:01; DPB1*04:01 (IPD-IMGT/HLA=10251).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   AP-1
AC   CVCL_HF85
DR   Wikidata; Q54750175
RX   PubMed=25137137;
CC   Doubling time: 3.342 days (PubMed=25137137).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   AP-1 LUCPorter
AC   CVCL_W339
SY   AP-1 LUCPorter stable reporter cell line
DR   Wikidata; Q54750177
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   AP-1060
AC   CVCL_1807
DR   BioSample; SAMN03473492
DR   Cosmic; 2750857
DR   DSMZ; ACC-593
DR   DSMZCellDive; ACC-593
DR   Wikidata; Q54750179
RX   PubMed=15116119;
RX   PubMed=29119387;
RX   PubMed=36982453;
CC   Doubling time: ~48 hours (PubMed=15116119); ~80-100 hours (DSMZ=ACC-593).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Homozygous (PubMed=29119387).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:8033; NTRK3; Name(s)=ETV6-NTRK3, TEL-TRKC (PubMed=29119387).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=15116119).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Pro408Ser (c.1222C>T); Zygosity=Unspecified; Note=Equivalent to p.Pro900Ser in the PML-RARA fusion protein (PubMed=15116119).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-593
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 14,19
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 17,23
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 19,24
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   AP-16
AC   CVCL_5432
DR   JCRB; IFO50424
DR   Wikidata; Q54750180
RX   PubMed=8391585;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AP-16
CC   Doubling time: ~23 hours (PubMed=8391585); ~1.1 days (Note=Lot 03282005) (JCRB=IFO50424).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Immature astrocyte; CL=CL_0002626.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   AP-18
AC   CVCL_X041
DR   Wikidata; Q54750182
RX   PubMed=16210832;
RX   PubMed=19947910;
CC   Doubling time: 50-60 hours (PubMed=16210832).
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: C3H/HeNCrlBR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 30-01-24; Version: 7
//
ID   AP-217
AC   CVCL_A052
SY   AP217
DR   Cosmic; 1012058
DR   Wikidata; Q54750183
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9279364;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=16408098;
CC   Population: Caucasian.
CC   Doubling time: 24-30 hours (PubMed=9279364).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=9279364; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   AP-3
AC   CVCL_J157
SY   AP3
DR   CLO; CLO_0001736
DR   ATCC; HB-242
DR   Wikidata; Q54750185
RX   PubMed=3155488;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   AP-5
AC   CVCL_KT04
SY   AP5
DR   Wikidata; Q54750187
RX   PubMed=1715887;
RX   PubMed=7538128;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AP-64
AC   CVCL_Z826
DR   Wikidata; Q54750191
RX   PubMed=9768180;
CC   Group: Insect cell line.
OX   NCBI_TaxID=316597; ! Aedes pseudoscutellaris (Mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   AP.6
AC   CVCL_G634
SY   AP6
DR   CLO; CLO_0001735
DR   ATCC; CRL-2227
DR   Wikidata; Q54750192
RX   PubMed=2574457;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95782; Human AP2A1 (Note=Also reacts with many other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   AP106
AC   CVCL_F534
DR   IPD-IMGT/HLA; 10252
DR   Wikidata; Q54750193
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQB1*05:03:02 (IPD-IMGT/HLA=10252).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   AP109
AC   CVCL_F535
DR   IPD-IMGT/HLA; 10253
DR   Wikidata; Q54750195
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQB1*05:03:02 (IPD-IMGT/HLA=10253).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   AP110
AC   CVCL_F536
DR   IPD-IMGT/HLA; 10254
DR   Wikidata; Q54750196
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQB1*05:03:02 (IPD-IMGT/HLA=10254).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   AP115
AC   CVCL_F537
DR   IPD-IMGT/HLA; 10255
DR   Wikidata; Q54750199
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQB1*05:03:02 (IPD-IMGT/HLA=10255).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   AP18F
AC   CVCL_XD38
DR   JCRB; KURB1536
DR   Wikidata; Q93325442
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP18M
AC   CVCL_XD39
DR   JCRB; KURB1537
DR   Wikidata; Q93325444
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP18P
AC   CVCL_XD40
DR   JCRB; KURB1534
DR   Wikidata; Q93325448
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AP18S
AC   CVCL_XD41
DR   JCRB; KURB1535
DR   Wikidata; Q93325450
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP19P
AC   CVCL_JG71
DR   JCRB; JCRB3032
DR   JCRB; KURB1638
DR   Wikidata; Q54750201
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1638; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3032
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_182040; Aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   AP2 [Human parotid gland adenoma]
AC   CVCL_W419
DR   Wikidata; Q54750203
RX   PubMed=9230912;
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C4650; Parotid gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   AP2 [Mouse hybridoma against HSV-2 MCP]
AC   CVCL_E2V3
RX   PubMed=6296279;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P89442; Human herpesvirus 2 (HHV-2) major capsid protein (MCP) (Note=Also reacts with human herpesvirus 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   AP22P
AC   CVCL_VH94
DR   JCRB; KURB1403
DR   Wikidata; Q54750205
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.4168-2A>G (IVS41-2A>G) (p.Gly1390_Glu1420del); ClinVar=VCV000864280; Zygosity=Heterozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   AP22P(SVT)
AC   CVCL_VH95
DR   JCRB; KURB1404
DR   Wikidata; Q54750207
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.4168-2A>G (IVS41-2A>G) (p.Gly1390_Glu1420del); ClinVar=VCV000864280; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH94 ! AP22P
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   AP23P
AC   CVCL_VH96
DR   JCRB; KURB1409
DR   Wikidata; Q54750209
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2606-2A>T (IVS27-2A>T) (p.Phe868_Gln869del); ClinVar=VCV000555572; Zygosity=Heterozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   AP23P(SVT)
AC   CVCL_VH97
DR   JCRB; KURB1410
DR   Wikidata; Q54750212
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2606-2A>T (IVS27-2A>T) (p.Phe868_Gln869del); ClinVar=VCV000555572; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH96 ! AP23P
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 15
//
ID   AP25B
AC   CVCL_XD31
DR   JCRB; KURB1540
DR   Wikidata; Q93325462
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP25B(SVT)
AC   CVCL_XD32
DR   JCRB; KURB1541
DR   Wikidata; Q93325463
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD31 ! AP25B
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   AP25F
AC   CVCL_XD33
DR   JCRB; KURB1542
DR   Wikidata; Q93325464
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP25F(SVT)
AC   CVCL_XD34
DR   JCRB; KURB1543
DR   Wikidata; Q93325465
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD33 ! AP25F
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   AP25M
AC   CVCL_XD35
DR   JCRB; KURB1544
DR   Wikidata; Q93325466
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP25M(SVT)
AC   CVCL_XD36
DR   JCRB; KURB1545
DR   Wikidata; Q93325467
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD35 ! AP25M
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   AP25P
AC   CVCL_JG72
DR   JCRB; KURB1538
DR   Wikidata; Q54750213
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   AP25P(SVT)
AC   CVCL_XD37
DR   JCRB; KURB1539
DR   Wikidata; Q93325469
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JG72 ! AP25P
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   AP284
AC   CVCL_VS60
DR   Wikidata; Q93325470
RX   PubMed=2906628;
RX   PubMed=30773217;
CC   Characteristics: Able to present antigens and activate T lymphocytes.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/Rij x CBA/Rij.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AP284.B11
AC   CVCL_VS61
DR   Wikidata; Q93325471
RX   PubMed=2906628;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/Rij x CBA/Rij.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VS62 ! AP284.D4
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AP284.D4
AC   CVCL_VS62
SY   AP284-D4
DR   Wikidata; Q93325472
RX   PubMed=2785339;
RX   PubMed=2906628;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/Rij x CBA/Rij.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VS60 ! AP284
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   AP2F
AC   CVCL_ZY21
SY   AP02F
DR   JCRB; KURB1485
DR   Wikidata; Q102113526
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Gln356Ter (c.1066C>T); ClinVar=VCV000006715; Zygosity=Heterozygous (PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP2F(SVT)
AC   CVCL_ZY22
DR   JCRB; KURB1486
DR   Wikidata; Q102113527
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Gln356Ter (c.1066C>T); ClinVar=VCV000006715; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY21 ! AP2F
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   AP2M
AC   CVCL_ZY23
SY   AP02M
DR   JCRB; KURB1487
DR   Wikidata; Q102113528
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP2M(SVT)
AC   CVCL_ZY24
DR   JCRB; KURB1488
DR   Wikidata; Q102113529
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY23 ! AP2M
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   AP2P
AC   CVCL_ZY19
SY   AP02P
DR   JCRB; KURB1483
DR   Wikidata; Q102113530
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10807541).
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Gln356Ter (c.1066C>T); ClinVar=VCV000006715; Zygosity=Heterozygous (PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP2P(SVT)
AC   CVCL_ZY20
DR   JCRB; KURB1484
DR   Wikidata; Q102113532
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Gln356Ter (c.1066C>T); ClinVar=VCV000006715; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY19 ! AP2P
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   AP3
AC   CVCL_LI52
DR   Wikidata; Q54750214
RX   PubMed=19154479;
CC   Population: Korean.
CC   Doubling time: 72 hours (PubMed=19154479).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
DI   NCIt; C6194; Collecting duct carcinoma
DI   ORDO; Orphanet_247203; Collecting duct carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   AP31P
AC   CVCL_VH88
DR   JCRB; KURB1413
DR   Wikidata; Q54750218
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2504+134A>G (IVS26+134A>G); ClinVar=VCV000974137; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2606-2A>T (IVS27-2A>T) (p.Phe868_Gln869del); ClinVar=VCV000555572; Zygosity=Heterozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   AP31P(SVT)
AC   CVCL_VH89
DR   JCRB; KURB1414
DR   Wikidata; Q54750220
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2504+134A>G (IVS26+134A>G); ClinVar=VCV000974137; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2606-2A>T (IVS27-2A>T) (p.Phe868_Gln869del); ClinVar=VCV000555572; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH88 ! AP31P
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   AP35P
AC   CVCL_VH98
DR   JCRB; KURB1423
DR   Wikidata; Q54750221
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.4168-2A>G (IVS41-2A>G) (p.Gly1390_Glu1420del); ClinVar=VCV000864280; Zygosity=Heterozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   AP35P(SVT)
AC   CVCL_VH99
DR   JCRB; KURB1424
DR   Wikidata; Q54750222
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.4168-2A>G (IVS41-2A>G) (p.Gly1390_Glu1420del); ClinVar=VCV000864280; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH98 ! AP35P
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   AP36P
AC   CVCL_VH85
DR   JCRB; KURB1429
DR   Wikidata; Q54750224
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2606-2A>T (IVS27-2A>T) (p.Phe868_Gln869del); ClinVar=VCV000555572; Zygosity=Heterozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   AP37F
AC   CVCL_XD27
DR   JCRB; JCRB3058
DR   JCRB; KURB1551
DR   Wikidata; Q93325494
CC   Population: Japanese.
CC   Discontinued: JCRB; JCRB3058; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP37M(L)
AC   CVCL_XD30
DR   JCRB; KURB1553
DR   Wikidata; Q93325496
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP37P
AC   CVCL_JH25
DR   JCRB; JCRB3054
DR   JCRB; KURB1546
DR   Wikidata; Q54750226
RX   PubMed=10090479;
RX   PubMed=12065746;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12065746).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Ter (c.8504C>G) (8732C>A); ClinVar=VCV000267091; Zygosity=Heterozygous (PubMed=12065746).
CC   Discontinued: JCRB; JCRB3054; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WD00 ! AP37P(L)
OI   CVCL_A6IQ ! FA-AML1
OI   CVCL_JH26 ! FA-AML1A
OI   CVCL_A6IR ! FA-AML1C
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   AP37P(L)
AC   CVCL_WD00
DR   JCRB; JCRB3056
DR   JCRB; KURB1549
DR   Wikidata; Q93325504
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (from autologous cell line AP37P).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Ter (c.8504C>G) (8732C>A); ClinVar=VCV000267091; Zygosity=Heterozygous (from autologous cell line AP37P).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; JCRB3056; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JH25 ! AP37P
OI   CVCL_A6IQ ! FA-AML1
OI   CVCL_JH26 ! FA-AML1A
OI   CVCL_A6IR ! FA-AML1C
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   AP37S(L)
AC   CVCL_XD29
DR   JCRB; JCRB3062
DR   JCRB; KURB1550
DR   Wikidata; Q93325506
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; JCRB3062; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP38B
AC   CVCL_JG61
DR   JCRB; JCRB3030
DR   JCRB; KURB1435
DR   Wikidata; Q54750228
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1435; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3030
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 4,9
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 8
//
ID   AP38B(SVT)
AC   CVCL_JH15
DR   JCRB; JCRB3023
DR   JCRB; KURB1436
DR   Wikidata; Q54750230
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; KURB1436; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3023
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 4,9
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JG61 ! AP38B
SX   Male
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 11
//
ID   AP38M
AC   CVCL_JH13
DR   JCRB; JCRB3029
DR   JCRB; KURB1438
DR   Wikidata; Q54750231
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1438; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3029
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 11,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   AP38M(SVT)
AC   CVCL_JH14
DR   JCRB; JCRB3024
DR   JCRB; KURB1439
DR   Wikidata; Q54750233
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; KURB1439; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3024
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 11,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JH13 ! AP38M
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 11
//
ID   AP38P
AC   CVCL_JG62
DR   JCRB; KURB1431
DR   Wikidata; Q54750235
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Donor information: Established from monozygotic twin of AP38S (Cellosaurus=CVCL_JG63).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   AP38P(SVT)
AC   CVCL_JG64
DR   JCRB; JCRB3026
DR   JCRB; KURB1432
DR   Wikidata; Q54750237
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; KURB1432; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3026
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 9
ST   D16S539: 11,14
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JG62 ! AP38P
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 14
//
ID   AP38S
AC   CVCL_JG63
DR   JCRB; JCRB3031
DR   JCRB; KURB1433
DR   Wikidata; Q54750239
CC   Population: Japanese.
CC   Donor information: Established from monozygotic twin of AP38P (Cellosaurus=CVCL_JG62).
CC   Discontinued: JCRB; KURB1433; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3031
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 9
ST   D16S539: 11,14
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   AP38S(SVT)
AC   CVCL_JH12
DR   JCRB; JCRB3025
DR   JCRB; KURB1434
DR   Wikidata; Q54750240
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; KURB1434; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3025
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 9
ST   D16S539: 11,14
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JG63 ! AP38S
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 12
//
ID   AP39F
AC   CVCL_XD45
DR   JCRB; KURB1647
DR   Wikidata; Q93325544
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP39F(SVT)
AC   CVCL_XD46
DR   JCRB; KURB1648
DR   Wikidata; Q93325546
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD45 ! AP39F
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   AP39P
AC   CVCL_XD42
SY   N0611
DR   JCRB; JCRB3068
DR   JCRB; KURB1642
DR   Wikidata; Q93325548
RX   PubMed=33355142;
RX   PubMed=33512438;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33355142).
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Ala278Pro (c.832G>C); ClinVar=VCV000995827; Zygosity=Heterozygous (PubMed=33355142).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33355142).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3068
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XD44 ! AP39P(L)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   AP39P-iPSC#1
AC   CVCL_B5M2
DR   Wikidata; Q111732927
RX   PubMed=33512438;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33512438).
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Ala278Pro (c.832G>C); ClinVar=VCV000995827; Zygosity=Heterozygous (PubMed=33512438).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD42 ! AP39P
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   AP39P-iPSC#2
AC   CVCL_B5M4
DR   Wikidata; Q111732929
RX   PubMed=33512438;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33512438).
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Ala278Pro (c.832G>C); ClinVar=VCV000995827; Zygosity=Heterozygous (PubMed=33512438).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD42 ! AP39P
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   AP39P(L)
AC   CVCL_XD44
DR   JCRB; JCRB3063
DR   JCRB; KURB1644
DR   Wikidata; Q93325550
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (from autologous cell line AP39P).
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Ala278Pro (c.832G>C); ClinVar=VCV000995827; Zygosity=Heterozygous (from autologous cell line AP39P).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (from autologous cell line AP39P).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB3063
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XD42 ! AP39P
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   AP39P(SVT)
AC   CVCL_XD43
DR   JCRB; JCRB3067
DR   JCRB; KURB1643
DR   Wikidata; Q93325552
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Ala278Pro (c.832G>C); ClinVar=VCV000995827; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3067
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD42 ! AP39P
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   AP39S
AC   CVCL_JH16
DR   JCRB; JCRB3034
DR   JCRB; KURB1645
DR   Wikidata; Q54750285
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1645; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3034
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   AP39S(SVT)
AC   CVCL_JH17
DR   JCRB; KURB1646
DR   Wikidata; Q54750286
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JH16 ! AP39S
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 9
//
ID   AP3M
AC   CVCL_XE07
DR   JCRB; KURB1662
DR   Wikidata; Q93325557
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   AP3P
AC   CVCL_XE08
DR   JCRB; KURB1661
DR   Wikidata; Q93325558
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_182040; Aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AP48P
AC   CVCL_JG73
DR   JCRB; KURB1440
DR   Wikidata; Q54750288
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Arg435Cys (c.1303C>T); ClinVar=VCV000555603; Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   AP48P(SVT)-1
AC   CVCL_ZX12
DR   JCRB; KURB1441
DR   Wikidata; Q102113533
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Arg435Cys (c.1303C>T); ClinVar=VCV000555603; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JG73 ! AP48P
SX   Male
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   AP48P(SVT)-2
AC   CVCL_ZX13
DR   JCRB; KURB1442
DR   Wikidata; Q102113534
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Arg435Cys (c.1303C>T); ClinVar=VCV000555603; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JG73 ! AP48P
SX   Male
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   AP49P
AC   CVCL_VH86
DR   JCRB; KURB1443
DR   Wikidata; Q54750289
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   AP49P(SVT)
AC   CVCL_VH87
DR   JCRB; KURB1444
DR   Wikidata; Q54750290
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH86 ! AP49P
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   AP57P
AC   CVCL_B5LY
SY   N0614
DR   JCRB; KURB1653
DR   Wikidata; Q111732930
RX   PubMed=33355142;
RX   PubMed=33512438;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33355142).
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33355142).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33355142).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 6
//
ID   AP57P(SVT)
AC   CVCL_B5LZ
DR   JCRB; KURB1654
DR   Wikidata; Q111732932
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5LY ! AP57P
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 8
//
ID   AP630
AC   CVCL_F538
SY   TER199; Extract 292
DR   IPD-IMGT/HLA; 10256
DR   Wikidata; Q54750292
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*03:01:01:01,66:01; B*07:02,81:01; C*15:05,18:01; DPB1*01:01,18:01; DQA1*01,04:01; DQB1*05:01,04:02; DRB1*03:02,12:01; DRB3*01:01,02:02 (IPD-IMGT/HLA=10256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   AP63P
AC   CVCL_ZX10
DR   JCRB; KURB1453
DR   Wikidata; Q102113536
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10807541).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Leu1082Pro (c.3245C>T); Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP63P(SVT)
AC   CVCL_ZX11
DR   JCRB; KURB1454
DR   Wikidata; Q102113537
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Leu1082Pro (c.3245C>T); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX10 ! AP63P
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   AP65F
AC   CVCL_ZY25
DR   JCRB; KURB1565
DR   Wikidata; Q102113538
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   AP65F(SVT)
AC   CVCL_ZY26
DR   JCRB; KURB1566
DR   Wikidata; Q102113540
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY25 ! AP65F
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   AP65M
AC   CVCL_ZY27
DR   JCRB; KURB1567
DR   Wikidata; Q102113542
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   AP65M(SVT)
AC   CVCL_ZY28
DR   JCRB; KURB1568
DR   Wikidata; Q102113543
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY27 ! AP65M
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   AP65P
AC   CVCL_ZY29
DR   JCRB; KURB1562
DR   Wikidata; Q102113545
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY30 ! AP65P(L)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   AP65P(L)
AC   CVCL_ZY30
DR   JCRB; KURB1564
DR   Wikidata; Q102113546
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY29 ! AP65P
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   AP65P(SVT)
AC   CVCL_ZY31
DR   JCRB; KURB1563
DR   Wikidata; Q102113547
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY29 ! AP65P
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   AP66F
AC   CVCL_ZY06
DR   JCRB; KURB1496
DR   Wikidata; Q102113548
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY07 ! AP66F(L)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP66F(L)
AC   CVCL_ZY07
DR   JCRB; KURB1498
DR   Wikidata; Q102113549
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (from autologous cell line AP66F).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY06 ! AP66F
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP66F(SVT)
AC   CVCL_ZY08
DR   JCRB; KURB1497
DR   Wikidata; Q102113550
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY06 ! AP66F
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   AP66M
AC   CVCL_ZY09
DR   JCRB; KURB1499
DR   Wikidata; Q102113551
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY10 ! AP66M(L)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP66M(L)
AC   CVCL_ZY10
DR   JCRB; KURB1501
DR   Wikidata; Q102113552
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (from autologous cell line AP66M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY09 ! AP66M
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP66M(SVT)
AC   CVCL_ZY11
DR   JCRB; KURB1500
DR   Wikidata; Q102113554
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY09 ! AP66M
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   AP66P
AC   CVCL_ZY12
DR   JCRB; KURB1489
DR   Wikidata; Q102113556
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY13 ! AP66P(L)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP66P(L)
AC   CVCL_ZY13
DR   JCRB; KURB1491
DR   Wikidata; Q102113558
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from autologous cell line AP66P).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY12 ! AP66P
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP66P(SVT)
AC   CVCL_ZY14
DR   JCRB; KURB1490
DR   Wikidata; Q102113559
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY12 ! AP66P
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   AP66S
AC   CVCL_ZY15
DR   JCRB; KURB1492
DR   Wikidata; Q102113561
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY16 ! AP66S(L)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   AP66S hTERT
AC   CVCL_ZY18
DR   JCRB; JCRB3066
DR   JCRB; KURB1494
DR   Wikidata; Q102113562
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3066
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14.1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY15 ! AP66S
SX   Female
AG   9Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   AP66S(L)
AC   CVCL_ZY16
DR   JCRB; KURB1495
DR   Wikidata; Q102113563
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY15 ! AP66S
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   AP66S(SVT)
AC   CVCL_ZY17
DR   JCRB; KURB1493
DR   Wikidata; Q102113564
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY15 ! AP66S
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   AP68P
AC   CVCL_ZX08
DR   JCRB; KURB1455
DR   Wikidata; Q102113565
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10807541;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Arg435Cys (c.1303C>T); ClinVar=VCV000555603; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10807541).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10807541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   AP68P(SVT)
AC   CVCL_ZX09
DR   JCRB; KURB1456
DR   Wikidata; Q102113566
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Arg435Cys (c.1303C>T); ClinVar=VCV000555603; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX08 ! AP68P
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   AP7
AC   CVCL_E2V4
RX   CelloPub=CLPUB00775;
RX   PubMed=6308140;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q69467; Human herpesvirus 2 (HHV-2) glycoprotein D (gD) (Note=Also reacts with human herpesvirus 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   AP78F
AC   CVCL_JH18
DR   JCRB; KURB1572
DR   Wikidata; Q54750294
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AP78M
AC   CVCL_JH19
DR   JCRB; KURB1574
DR   Wikidata; Q54750296
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AP78P
AC   CVCL_JH20
DR   JCRB; JCRB3033
DR   JCRB; KURB1570
DR   Wikidata; Q54750298
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.1360_2014del (Ex15-22del); Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11).
CC   Discontinued: JCRB; KURB1570; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3033
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   AP7P
AC   CVCL_J287
SY   AP07P
DR   BioSample; SAMN03472407
DR   JCRB; JCRB3011
DR   JCRB; KURB1401
DR   Wikidata; Q54750300
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2152_2778del (Ex24-28del); Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Discontinued: JCRB; KURB1401; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3011
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 10
ST   D7S820: 10,12
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   AP7P(SVT)
AC   CVCL_L454
DR   JCRB; KURB1402
DR   Wikidata; Q54750301
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2152_2778del (Ex24-28del); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J287 ! AP7P
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 20
//
ID   AP8
AC   CVCL_LI53
DR   Wikidata; Q54750304
RX   PubMed=19154479;
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=19154479).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
DI   NCIt; C6194; Collecting duct carcinoma
DI   ORDO; Orphanet_247203; Collecting duct carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   APA
AC   CVCL_E458
SY   TER224; TER-224; Ter 224; TER452; TER-452; Ter 452; Extract 61; Extract 258
DR   dbMHC; 48476
DR   ECACC; 94022522
DR   IHW; IHW09237
DR   IPD-IMGT/HLA; 10257
DR   Wikidata; Q54750305
RX   PubMed=29171935;
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/356cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Chinese.
CC   HLA typing: A*11:01:01:07,24:03:01:01; B*15:02:01,55:02:01:01; C*08:01:01,12:03:01:01; DPA1*02:02:02; DPB1*05:01:01; DQA1*01:01:01,01:02:01; DQB1*05:03:01,06:01:01/06:01:15; DRB1*14:05:01,15:01:01; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=10257).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   Apa 1.3
AC   CVCL_F1YC
SY   Apa 1; Apa1; Ptc (Apa 1)
DR   DSHB; Drosophila-Ptc-Apa-1
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P18502; Drosophila melanogaster ptc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   APA5
AC   CVCL_KB07
DR   RCB; RCB4482
DR   Wikidata; Q54750307
RX   PubMed=8875964;
RX   PubMed=11413086;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P26618; Mouse Pdgfra/Cd140a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   APB5
AC   CVCL_KB08
DR   RCB; RCB4483
DR   Wikidata; Q54750309
RX   PubMed=11413086;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05622; Mouse Pdgfrb/Cd140b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   APC-NT 2E7
AC   CVCL_VP53
SY   2E7
DR   Wikidata; Q93325616
RX   PubMed=24156781;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P25054; Human APC (Note=Recognizes N-terminal region p.Met1_Ala61).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   APC-NT 6D12
AC   CVCL_VP54
SY   6D12
DR   Wikidata; Q93325619
RX   PubMed=24156781;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P25054; Human APC (Note=Recognizes N-terminal region p.Met1_Ala61).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   APC-NT 6G6
AC   CVCL_VP55
SY   6G6
DR   Wikidata; Q93325621
RX   PubMed=24156781;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P25054; Human APC (Note=Recognizes N-terminal region p.Met1_Ala61).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   APC-NT 8D9
AC   CVCL_VP56
SY   8D9
DR   Wikidata; Q93325623
RX   PubMed=24156781;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; P25054; Human APC (Note=Recognizes N-terminal region p.Met1_Ala61).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   APC-NT 9G11
AC   CVCL_VP57
SY   9G11
DR   Wikidata; Q93325625
RX   PubMed=24156781;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P25054; Human APC (Note=Recognizes N-terminal region p.Met1_Ala61).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   APD
AC   CVCL_E459
SY   GM06817; GM06817A
DR   CLO; CLO_0036534
DR   Coriell; GM06817
DR   dbMHC; 48477
DR   ECACC; 94071427
DR   IHW; IHW09291
DR   IPD-IMGT/HLA; 10258
DR   Wikidata; Q54750311
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=6417008;
RX   PubMed=18193213;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*01:01:01:01; B*40:01:02:01; C*06:02:01:01; DPA1*01:03; DPB1*04:02:01; DQA1*01:03; DQB1*06:03:01; DRB1*13:01:01 (IPD-IMGT/HLA=10258).
CC   HLA typing: A*01:01:01:01; B*40:01:02; C*06:02:01:01; DPA1*01:03:01:05; DPB1*04:02:01:01; DQA1*01:03:01; DQB1*06:03:01; DRB1*13:01:01; DRB3*02:02:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   APE1
AC   CVCL_Z272
DR   Wikidata; Q54750312
RX   PubMed=8907121;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=247271; ! Antitrogus parvulus (Childers canegrub)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   APH-R
AC   CVCL_A3AU
SY   PH-R
DR   CCLV; CCLV-RIE 0958
DR   Wikidata; Q105506416
RX   PubMed=23893605;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
AG   Adult
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   APHL1
AC   CVCL_Z273
DR   Wikidata; Q54750314
RX   PubMed=8907121;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=247271; ! Antitrogus parvulus (Childers canegrub)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   APM-1
AC   CVCL_A6KA
DR   Wikidata; Q107113362
RX   PubMed=2715345;
RX   PubMed=2810888;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   APM-2
AC   CVCL_A6KB
DR   Wikidata; Q107113363
RX   PubMed=2715345;
RX   PubMed=2810888;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   APM-3
AC   CVCL_A6KC
DR   Wikidata; Q107113364
RX   PubMed=2715345;
RX   PubMed=2810888;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   APO-P
AC   CVCL_D5JF
DR   Wikidata; Q127380236
RX   DOI=10.1007/BF02822702;
RX   DOI=10.1016/S0074-7696(08)62455-9;
RX   PubMed=16666458;
RX   PubMed=16667897;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (PubMed=16666458).
CC   Characteristics: Capable of growth in vitamin-free medium (PubMed=16667897).
CC   Doubling time: 8-14 days (PubMed=16666458).
CC   Derived from site: In situ; Cotyledon; PO=PO_0020030.
CC   Derived from site: In situ; Hypocotyl; PO=PO_0020100.
OX   NCBI_TaxID=158579; ! Amaranthus powellii (Powell's amaranth)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   APP1E111
AC   CVCL_RN66
SY   APP1E 111
DR   SKIP; SKIP001105
DR   Wikidata; Q54750316
RX   PubMed=23434393;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Glu693del (c.2079_2081delAGA); Zygosity=Homozygous (PubMed=23434393).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN67 ! APP1E211
OI   CVCL_RN68 ! APP1E311
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   APP1E211
AC   CVCL_RN67
SY   APP1E 211
DR   Wikidata; Q54750317
RX   PubMed=23434393;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Glu693del (c.2079_2081delAGA); Zygosity=Homozygous (PubMed=23434393).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN66 ! APP1E111
OI   CVCL_RN68 ! APP1E311
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   APP1E311
AC   CVCL_RN68
SY   APP1E 311
DR   Wikidata; Q54750320
RX   PubMed=23434393;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Glu693del (c.2079_2081delAGA); Zygosity=Homozygous (PubMed=23434393).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN66 ! APP1E111
OI   CVCL_RN67 ! APP1E211
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   APP2E22
AC   CVCL_RN69
SY   APP2E 22
DR   Wikidata; Q54750322
RX   PubMed=23434393;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Leu (c.2149G>C); ClinVar=VCV000018105; Zygosity=Heterozygous (PubMed=23434393).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN70 ! APP2E26
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   APP2E26
AC   CVCL_RN70
SY   APP2E 26
DR   Wikidata; Q54750324
RX   PubMed=23434393;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Leu (c.2149G>C); ClinVar=VCV000018105; Zygosity=Heterozygous (PubMed=23434393).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN69 ! APP2E22
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   Applied StemCell CF1-MEF irradiated
AC   CVCL_RX71
DR   Wikidata; Q54750325
WW   Provider; ASC; ASF-1213 to ASF-1217; https://appliedstemcell.com/mef-feeder-cells/
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation.
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   Applied StemCell CF1-MEF mitomycin-treated
AC   CVCL_RX72
DR   Wikidata; Q54750330
WW   Provider; ASC; ASF-1223 to ASF-1226; https://appliedstemcell.com/mef-feeder-cells/
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   Applied StemCell DR4-MEF irradiated
AC   CVCL_E8D2
WW   Provider; ASC; ASF-1013 to ASF-1016; https://appliedstemcell.com/mef-feeder-cells/
CC   Characteristics: Expresses transgenes that make this cell line resistant to three different drugs: geneticin (G418), puromycin and hygromycin. KO of Hprt1 makes the cell line resistant to 6-tioguanine (PubMed=9278500).
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation.
CC   Knockout cell: Method=KO mouse; MGI; MGI:96217; Hprt1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: DR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Applied StemCell DR4-MEF mitomycin-treated
AC   CVCL_E8D3
WW   Provider; ASC; ASF-1023 to ASF-1026; https://appliedstemcell.com/mef-feeder-cells/
CC   Characteristics: Expresses transgenes that make this cell line resistant to three different drugs: geneticin (G418), puromycin and hygromycin. KO of Hprt1 makes the cell line resistant to 6-tioguanine (PubMed=9278500).
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Knockout cell: Method=KO mouse; MGI; MGI:96217; Hprt1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: DR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   APS 11
AC   CVCL_F1EE
RX   PubMed=10340748;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49768; Human PSEN1 (Note=Immunized with 21-HLSNTVRSQNDNRE-34).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   APS 18
AC   CVCL_F1EF
RX   PubMed=10340748;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49768; Human PSEN1 (Note=Immunized with 313-SKYNAESTERESQDTVAENDDG-334).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   APS 21
AC   CVCL_F1EG
RX   PubMed=10340748;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49810; Human PSEN2 (Note=Immunized with 35-QEGRQGPEDGENTA-45).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   APS 26
AC   CVCL_F1EH
RX   PubMed=10340748;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49810; Human PSEN2 (Note=Immunized with 317-LPYDPEMEEDSYDSFGEP-334).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AQ
AC   CVCL_M613
DR   Cosmic; 848245
DR   Wikidata; Q54750332
RX   PubMed=10632461;
RX   PubMed=11854598;
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   AQH-hET-GBE1-Y34*
AC   CVCL_ZF59
DR   Wikidata; Q98125478
RX   PubMed=32366884;
CC   Sequence variation: Mutation; VGNC; VGNC:18263; GBE1; Simple; p.Tyr34Ter (c.102C>A); Zygosity=Heterozygous (PubMed=32366884).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: American Quarter Horse; VBO=VBO_0001057.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   AQH-hET-GBE1-Y34* corrected
AC   CVCL_ZF60
DR   Wikidata; Q98125479
RX   PubMed=32366884;
CC   Sequence variation: Mutation; VGNC; VGNC:18263; GBE1; Simple_corrected; p.Tyr34Ter (c.102C>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32366884).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: American Quarter Horse; VBO=VBO_0001057.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
HI   CVCL_ZF59 ! AQH-hET-GBE1-Y34*
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   AQP4(C9401-A3-29)
AC   CVCL_A6YU
SY   C9401-A3-29; C9401
DR   RCB; RCB4870
DR   Wikidata; Q107113365
RX   PubMed=23746426;
RX   PubMed=26398585;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(D12092-1C3-02)
AC   CVCL_A6YV
SY   D12092-1C3-02; D12092
DR   RCB; RCB4871
DR   Wikidata; Q107113366
RX   PubMed=23746426;
RX   PubMed=26398585;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(D15107-3D7-33)
AC   CVCL_A6YQ
SY   D15107-3D7-33; D15107
DR   RCB; RCB4872
DR   Wikidata; Q107113367
RX   PubMed=23746426;
RX   PubMed=26398585;
RX   PubMed=26637322;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (Note=Isoform M23. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5206-1B10-8)
AC   CVCL_A6YW
SY   E5206-1B10-8; E5206
DR   RCB; RCB4879
DR   Wikidata; Q107113368
RX   PubMed=23909421;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23. Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5209-1C8-22)
AC   CVCL_A6YX
SY   E5209-1C8-22; E5209
DR   RCB; RCB4880
DR   Wikidata; Q107113369
RX   PubMed=28955892;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5413-1G11-49)
AC   CVCL_A6YY
SY   E5413-1G11-49; E5413
DR   RCB; RCB4882
DR   Wikidata; Q107113370
RX   PubMed=28955892;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5415A-1H6-68)
AC   CVCL_A6YZ
SY   E5415A-1H6-68; E5415A
DR   RCB; RCB4883
DR   Wikidata; Q107113371
RX   PubMed=26637322;
RX   PubMed=28955892;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5415B-1H7-79)
AC   CVCL_A6ZA
SY   E5415B-1H7-79; E5415B
DR   RCB; RCB4884
DR   Wikidata; Q107113373
RX   PubMed=28955892;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5504-2G2-105)
AC   CVCL_A6ZB
SY   E5504-2G2-105; E5504
DR   RCB; RCB4887
DR   Wikidata; Q107113374
RX   PubMed=28955892;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5505-3D12-129)
AC   CVCL_A6ZC
SY   E5505-3D12-129; E5505
DR   RCB; RCB4886
DR   Wikidata; Q107113375
RX   PubMed=28955892;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AQP4(E5507-3A1-113)
AC   CVCL_A6ZD
SY   E5507-3A1-113; E5507
DR   RCB; RCB4885
DR   Wikidata; Q107113376
RX   PubMed=28955892;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   AR
AC   CVCL_E6X9
RX   PubMed=9384677;
RX   PubMed=12836015;
RX   PubMed=15365776;
CC   HLA typing: A*03,03; B*07,51; DQB1*06:02,06:03; DRB1*13:01,15:01:01 (PubMed=12836015).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ar Bo
AC   CVCL_U767
DR   ATCC; CRL-1272
DR   Wikidata; Q54750334
CC   Discontinued: ATCC; CRL-1272; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Ar Ke-2
AC   CVCL_3646
DR   CLO; CLO_0001739
DR   ATCC; CRL-1324
DR   Wikidata; Q54750336
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Ar Lip
AC   CVCL_Y115
DR   ATCC; CRL-1233
DR   Wikidata; Q54750338
CC   Discontinued: ATCC; CRL-1233; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   Ar Mor
AC   CVCL_U768
DR   ATCC; CRL-1221
DR   Wikidata; Q54750339
RX   PubMed=273925;
RX   PubMed=3860870;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=7301938;
CC   Discontinued: ATCC; CRL-1221; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   Ar-13
AC   CVCL_0I23
DR   Wikidata; Q54750341
RX   PubMed=25761724;
CC   Group: Insect cell line.
CC   Doubling time: 3 days (PubMed=25761724).
OX   NCBI_TaxID=124917; ! Armigeres subalbatus (Mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   Ar-3
AC   CVCL_0I24
DR   Wikidata; Q54750344
RX   PubMed=25761724;
CC   Group: Insect cell line.
CC   Doubling time: 2.7 days (PubMed=25761724).
OX   NCBI_TaxID=124917; ! Armigeres subalbatus (Mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   AR-5
AC   CVCL_F824
DR   Wikidata; Q54750345
RX   PubMed=9886832;
CC   Doubling time: ~2 days (PubMed=9886832).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic amygdala; UBERON=UBERON_0001876.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   19FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   AR-C40
AC   CVCL_8172
DR   Wikidata; Q54750349
RX   PubMed=8386606;
CC   Genetic integration: Method=Transfection; Gene=RGD; 3442; Pth1r.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   AR-EcoScreen
AC   CVCL_8544
DR   JCRB; JCRB1328
DR   Wikidata; Q54750350
RX   PubMed=15110108;
RX   PubMed=15713541;
WW   Info; OECD; -; https://www.oecd.org/env/ehs/testing/Doc-id-381084-Draft-TG-AR-STTA-clean.pdf
CC   Biotechnology: Used in the AR STTA bioassay for the rapid evaluation of in vitro androgen receptor transcriptional activation.
CC   Characteristics: The luciferase reporter gene is under the control of a construct bearing four tandem repeats of a prostate C3 gene androgen-responsive element driven by a minimal heat shock protein promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   AR-EcoScreen GR KO M1
AC   CVCL_VN86
SY   AR-EcoScreen GR KnockOut Mutant 1
DR   JCRB; JCRB1761
DR   Wikidata; Q93325715
RX   PubMed=28803809;
CC   Characteristics: Used for rapid evaluation of in vitro androgen receptor transcriptional activation. The NR3C1/GR knockout renders the AR-EcoScreen assay insensitive to glucocorticoid activation.
CC   Characteristics: The luciferase reporter gene is under the control of a construct bearing four tandem repeats of a prostate C3 gene androgen-responsive element driven by a minimal heat shock protein promoter.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8544 ! AR-EcoScreen
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   AR1034ZIMA
AC   CVCL_A9PP
DR   GEO; GSM1342468
DR   GEO; GSM1342470
DR   Wikidata; Q102113567
RX   PubMed=24713299;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   AR230
AC   CVCL_9478
SY   AR-230
DR   Cosmic; 787490
DR   Cosmic; 1026575
DR   Cosmic; 2364007
DR   Wikidata; Q54750353
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7606740;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=Mu-BCR transcript (PubMed=7606740; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   AR230-r
AC   CVCL_DP56
DR   ATCC; CRL-3346
DR   Wikidata; Q54750355
RX   PubMed=10910924;
CC   Population: Japanese.
CC   Doubling time: ~30-48 hours (ATCC=CRL-3346).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=Mu-BCR transcript (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3346
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9478 ! AR230
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   AR230-rn
AC   CVCL_DP53
DR   Wikidata; Q54750358
RX   PubMed=19047160;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=Mu-BCR transcript (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9478 ! AR230
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   AR230-s
AC   CVCL_UC13
DR   ATCC; CRL-3345
DR   Wikidata; Q93325730
RX   PubMed=10910924;
CC   Population: Japanese.
CC   Characteristics: Clone of AR230 used as a control cell line for studies using AR230-s which is resistant to imatinib.
CC   Doubling time: ~30-48 hours (ATCC=CRL-3345).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=Mu-BCR transcript (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3345
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9478 ! AR230
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   AR300
AC   CVCL_JY57
DR   Wikidata; Q54750359
RX   PubMed=3021747;
RX   PubMed=8389452;
CC   Selected for resistance to: ChEBI; CHEBI_138016; 5-(N-methyl-N-propyl)amiloride (MPA).
CC   Sequence variation: Mutation; UniProtKB; P48761; Slc9a1; Simple; p.Leu167Phe (c.499C>T); Zygosity=Homozygous (PubMed=8389452).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_JY56 ! AR40
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   AR40
AC   CVCL_JY56
DR   Wikidata; Q54750360
RX   PubMed=3021747;
RX   PubMed=8389452;
CC   Selected for resistance to: ChEBI; CHEBI_138016; 5-(N-methyl-N-propyl)amiloride (MPA).
CC   Sequence variation: Mutation; UniProtKB; P48761; Slc9a1; Simple; p.Leu167Phe (c.499C>T); Zygosity=Heterozygous (PubMed=8389452).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2886 ! Dede
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   AR40A603.13
AC   CVCL_LB97
DR   Wikidata; Q54750400
RX   Patent=US7348413;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 280104-04.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Human antigen on prostate cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   AR42J
AC   CVCL_0143
SY   AR4-2J; AR-42J
DR   BTO; BTO_0001928
DR   CLO; CLO_0001740
DR   EFO; EFO_0022814
DR   MCCL; MCC:0000036
DR   CLDB; cl280
DR   CLDB; cl281
DR   AddexBio; C0018004/24
DR   ATCC; CRL-1492
DR   BCRC; 60160
DR   CCTCC; GDC0147
DR   ChEMBL-Cells; CHEMBL3307902
DR   ChEMBL-Targets; CHEMBL614271
DR   CLS; 500478
DR   ECACC; 93100618
DR   PubChem_Cell_line; CVCL_0143
DR   TOKU-E; 555
DR   Wikidata; Q54750403
RX   CelloPub=CLPUB00018;
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=1371645;
RX   PubMed=7517639;
RX   PubMed=11453651;
RX   PubMed=17392489;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-crl-1492-growth-and-morphology
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-364.html
CC   Transformant: ChEBI; CHEBI_74846; Azaserine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_3488 ! ARIP
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   AR42J-B13
AC   CVCL_0E02
SY   AR42J-B-13; B-13
DR   ECACC; 20100101
DR   Wikidata; Q54750404
RX   DOI=10.1039/c4tx00214h;
RX   PubMed=8756573;
RX   PubMed=20685382;
CC   Characteristics: When exposed to glucocorticoid, trans-differentiates into hepatocyte-like (B-13/H) cells. B-13/H cells express a variety of liver-enriched and liver-specific genes, many at levels similar to hepatocytes in vivo (PubMed=20685382).
CC   Transformant: ChEBI; CHEBI_74846; Azaserine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0143 ! AR42J
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   AR47A6.4.2
AC   CVCL_LH69
DR   Wikidata; Q54750406
RX   Patent=US7420040;
RX   Patent=US20080131428;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 141205-05.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   AR51A165.2
AC   CVCL_C4YJ
DR   Wikidata; Q116048523
RX   Patent=US8129502;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 180706-02.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on endometroid adenocarcinoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   AR52A301.5
AC   CVCL_LH70
DR   Wikidata; Q54750410
RX   Patent=US7420041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 141205-03.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   AR53A10.11
AC   CVCL_LB98
DR   Wikidata; Q54750411
RX   Patent=US7456016;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 141205-04.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human antigen on ovarian cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   AR58A258.8
AC   CVCL_LB99
DR   Wikidata; Q54750412
RX   Patent=US7452978;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 290605-01.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   AR58A314.1
AC   CVCL_LC00
DR   Wikidata; Q54750415
RX   Patent=US7485300;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 141205-02.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on metastatic colon cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   ARA
AC   CVCL_F548
SY   TER219; TER-219; Ter 219; TER281; TER-281; Ter 281; TER426; TER-426; Ter 426; Extract 157
DR   IPD-IMGT/HLA; 10260
DR   Wikidata; Q54750417
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/343cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,24:02; B*07:02,40:06; C*07:02,12:02; DPB1*02:01,14:01; DQA1*01:03,02:01; DQB1*06:03,02:02; DRB1*13:10,07:01; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=10260).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   ARA-10
AC   CVCL_A053
SY   Ara-10; ARA 10; ARA10; Ara10
DR   Cosmic; 801734
DR   Wikidata; Q54750418
RX   PubMed=6193516;
RX   PubMed=6582512;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 9
//
ID   ARA-M1
AC   CVCL_XG99
DR   Wikidata; Q93325785
RX   Patent=WO2006050667A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200413.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   ARA-M5
AC   CVCL_XH00
DR   Wikidata; Q93325787
RX   Patent=WO2006050667A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200414.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   ARA-M7
AC   CVCL_XH01
DR   Wikidata; Q93325788
RX   Patent=WO2006050667A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200415.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22303; Human ACHE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   ARAC-8C
AC   CVCL_GZ09
SY   CCRF-CEM-AraC-8C; CEM/ARAC-8C; AraC-8C; Ara-C/8C
DR   cancercelllines; CVCL_GZ09
DR   TOKU-E; 4127
DR   Wikidata; Q54750420
RX   PubMed=2842332;
RX   PubMed=18279955;
WW   Provider; ICOregon; 1626-A; https://web.archive.org/web/20230206214932/http://icoregon.technologypublisher.com/technology/18057
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   ARAC-8D
AC   CVCL_GZ10
SY   CCRF-CEM-AraC-8D; CEM-AraC-8D; AraC-8D; Ara-C/8D
DR   cancercelllines; CVCL_GZ10
DR   Wikidata; Q54750421
RX   PubMed=2842332;
RX   PubMed=18279955;
WW   Provider; ICOregon; 1626-C; https://web.archive.org/web/20230205100833/http://icoregon.technologypublisher.com/technology/18059
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   ARAC25
AC   CVCL_F540
DR   IPD-IMGT/HLA; 10262
DR   Wikidata; Q54750424
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*08:11,10:01 (IPD-IMGT/HLA=10262).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   Aramis
AC   CVCL_M600
SY   ARAMIS
DR   Wikidata; Q54750427
RX   PubMed=12193296;
RX   PubMed=15320967;
CC   Doubling time: ~2 weeks (Note=In 5% FCS) (PubMed=15320967).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   ARB8
AC   CVCL_RS44
SY   Aequidens Rivulatus Brain 8
DR   Wikidata; Q54750429
RX   PubMed=29399816;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=242820; ! Andinoacara rivulatus (Green terror)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
//
ID   ARBO
AC   CVCL_E460
DR   dbMHC; 48478
DR   IHW; IHW09102
DR   IPD-IMGT/HLA; 11614
DR   Wikidata; Q54750430
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*03:01:01:01; B*58:02:01; C*06:02:01:01; DPB1*13:01:01/107:01,04:01:01; DQB1*02:02:01,05:03:01; DRB1*09:01:02/09:21 (IPD-IMGT/HLA=11614).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Arbo
AC   CVCL_C5U2
DR   Wikidata; Q116048524
RX   DOI=10.1158/1538-7445.AM2022-3160;
RX   PubMed=36467812;
CC   Doubling time: 48 hours (DOI=10.1158/1538-7445.AM2022-3160; PubMed=36467812).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1853Asn (c.5557G>A); ClinVar=VCV000128458; Zygosity=Unspecified (PubMed=36467812).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asn1983Ser (c.5948A>G); Zygosity=Unspecified (PubMed=36467812).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Arg2400Ter (c.7198C>T); ClinVar=VCV000518450; Zygosity=Unspecified (DOI=10.1158/1538-7445.AM2022-3160; PubMed=36467812).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu206Ter (c.617T>A); Zygosity=Unspecified (PubMed=36467812).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Safa, Firas M.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 14,15
ST   D5S818: 9,11
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 21,25
ST   Penta D: 13,14
ST   Penta E: 10,12
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   ARBO C11
AC   CVCL_8832
DR   Wikidata; Q54750433
RX   PubMed=638021;
CC   Derived from site: In situ; Brain, periventricular region; UBERON=UBERON_0014932.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8833 ! ARBO C9
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 6
//
ID   ARBO C9
AC   CVCL_8833
DR   Wikidata; Q54750435
RX   PubMed=638021;
RX   PubMed=3081277;
RX   PubMed=6141541;
RX   PubMed=7190976;
RX   PubMed=7371757;
CC   Derived from site: In situ; Brain, periventricular region; UBERON=UBERON_0014932.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8832 ! ARBO C11
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   ARCaP
AC   CVCL_4830
SY   MDA-PCa-1; MDA-Pca-1; MDA PCa 1; M.D. Anderson-Prostate Cancer-1
DR   cancercelllines; CVCL_4830
DR   IARC_TP53; 18890
DR   TOKU-E; 4101
DR   Wikidata; Q54750438
RX   CelloPub=CLPUB00698;
RX   PubMed=8986779;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=15643172;
RX   PubMed=16902972;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200724/http://capcelllines.ca:80/details.asp?id=85
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=14518029).
CC   Caution: While some papers (PubMed=14518029; PubMed=14518030) believe that ARCaP and MDA-PCa-1 are two separate cell lines originating from the same patient, the current view is that ARCaP was renamed MDA-PCa-1 when further prostate cancer cell lines (MDA-PCa-2a/2b) were established at MD Anderson.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=14518029
ST   Amelogenin: X,Y
ST   D13S317: 11
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 21
ST   vWA: 18,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   ARCaP clone IF3
AC   CVCL_E7VG
RX   PubMed=16902972;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4830 ! ARCaP
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ARCaP clone IIC11
AC   CVCL_E7VH
RX   PubMed=16902972;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4830 ! ARCaP
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ARCaP clone IID4
AC   CVCL_E7VI
RX   PubMed=16902972;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4830 ! ARCaP
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ARCaPE
AC   CVCL_E7VJ
SY   ARCaP(E); ARCaP clone IF11; ARCaP Epithelial
DR   GEO; GSM4306193
DR   GEO; GSM4306194
DR   GEO; GSM4306195
RX   PubMed=16902972;
RX   PubMed=21625216;
RX   PubMed=32231998;
CC   Population: Caucasian.
CC   Characteristics: Exhibits a cobblestone shaped morphology. Undergoes epithelial to mesenchymal transition (EMT) through cellular interaction with host bone and adrenal gland (PubMed=16902972).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; miRNA profiling; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4830 ! ARCaP
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ARCaPE-shEPLIN
AC   CVCL_E7VL
SY   ARCaPE-shRNA clone #102)
RX   PubMed=21625216;
WW   Provider; Emory OTT; RT006; https://emoryott.technologypublisher.com/techcase/RT006
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:24636; LIMA1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7VJ ! ARCaPE
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ARCaPM
AC   CVCL_E7VK
SY   ARCaP(M); ARCaP clone IA8; ARCaP Mesenchymal
DR   GEO; GSM4306196
DR   GEO; GSM4306197
DR   GEO; GSM4306198
RX   PubMed=16902972;
RX   PubMed=21625216;
RX   PubMed=32231998;
CC   Population: Caucasian.
CC   Characteristics: Exhibits a spindle shaped mesenchymal morphology. Compared to parent cell line exhibits decreased cell adhesion and increased metastasis to bone and adrenal gland (PubMed=16902972).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; miRNA profiling; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4830 ! ARCaP
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ARD
AC   CVCL_XD83
SY   ard-1
DR   CCRID; 1101HUM-PUMC000681
DR   GEO; GSM2774119
DR   GEO; GSM2774122
DR   GEO; GSM2774124
DR   GEO; GSM2774126
DR   Wikidata; Q93325829
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8427968;
RX   PubMed=14555701;
RX   PubMed=14760100;
RX   PubMed=29045832;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   From: Epstein, Joshua; Myeloma and Transplantation Research Center, Arkansas Cancer Research Center; Little Rock; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:12637; KDM6A; Zygosity=Homozygous (PubMed=29045832).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (CelloPub=CLPUB00604).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): CCRID=1101HUM-PUMC000681
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18.3,22
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 28,31.2
ST   D2S1338: 20,21
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D6S1043: 19
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 18,19,24
ST   Penta E: 7,15
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D523 ! ARP-1
OI   CVCL_D569 ! CAG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   ARD-EZH2i-R
AC   CVCL_A5RY
SY   ARD_EZH2i_R; ARD-R
DR   GEO; GSM2774138
DR   GEO; GSM2774141
DR   GEO; GSM2774143
DR   GEO; GSM2774146
DR   Wikidata; Q107113377
RX   PubMed=29045832;
CC   Selected for resistance to: ChEBI; CHEBI_167693; 1-isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide (GSK343).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12637; KDM6A; Zygosity=Homozygous (PubMed=29045832).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD83 ! ARD
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   ARD-pUTX
AC   CVCL_A5RZ
DR   GEO; GSM2774100
DR   GEO; GSM2774102
DR   GEO; GSM2774105
DR   GEO; GSM2774107
DR   GEO; GSM2774110
DR   GEO; GSM2774112
DR   GEO; GSM2774114
DR   GEO; GSM2774117
DR   Wikidata; Q107113378
RX   PubMed=29045832;
CC   Characteristics: KDM6A/UTX expression is inducible by doxycycline (PubMed=29045832).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12637; KDM6A; Zygosity=Homozygous (PubMed=29045832).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12637; KDM6A.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD83 ! ARD
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   ARE/LULS41
AC   CVCL_UD42
DR   Wikidata; Q93325832
RX   PubMed=29886187;
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34604; ! Argas reflexus (European pigeon tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   ARH-77
AC   CVCL_1072
SY   ARH 77; ARH77
DR   BTO; BTO_0002992
DR   CLO; CLO_0001744
DR   CLO; CLO_0001745
DR   EFO; EFO_0002111
DR   CLDB; cl285
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1621
DR   BCRC; 60385
DR   BioGRID_ORCS_Cell_line; 831
DR   BioSample; SAMN03471407
DR   CCRID; 4201HUM-CCTCC00218
DR   CCTCC; GDC0218
DR   Cell_Model_Passport; SIDM00900
DR   ChEMBL-Cells; CHEMBL3308536
DR   ChEMBL-Targets; CHEMBL2366241
DR   CLS; 300306
DR   Cosmic; 759914
DR   Cosmic; 886086
DR   Cosmic; 888020
DR   Cosmic; 906765
DR   Cosmic; 919148
DR   Cosmic; 999792
DR   Cosmic-CLP; 906765
DR   DepMap; ACH-002210
DR   DSMZ; ACC-512
DR   DSMZCellDive; ACC-512
DR   ECACC; 88121201
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10840-111E3
DR   GDSC; 906765
DR   GEO; GSM1374393
DR   GEO; GSM1669601
DR   IARC_TP53; 21176
DR   IGRhCellID; ARH77
DR   LINCS_LDP; LCL-2041
DR   Lonza; 593
DR   PharmacoDB; ARH77_64_2019
DR   PubChem_Cell_line; CVCL_1072
DR   Wikidata; Q54750440
RX   DOI=10.1007/0-306-46877-8_4;
RX   Patent=US4730036;
RX   PubMed=566614;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4042077;
RX   PubMed=6605913;
RX   PubMed=7140810;
RX   PubMed=7579375;
RX   PubMed=8051085;
RX   PubMed=9510473;
RX   PubMed=10516762;
RX   PubMed=10936422;
RX   PubMed=14555701;
RX   PubMed=18262052;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-for-atcc-crl-1621
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=4042077; PubMed=7579375; PubMed=10516762).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 110.4 hours (PubMed=566614); ~30 hours (DSMZ=ACC-512).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (Cosmic-CLP=906765).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.24%; Native American=0.38%; East Asian, North=0%; East Asian, South=2.18%; South Asian=8.63%; European, North=25.32%; European, South=61.25% (PubMed=30894373).
CC   Misspelling: AHR 77; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1621; CLS=300306; Cosmic-CLP=906765; DSMZ=ACC-512; ECACC=88121201
ST   Amelogenin: X
ST   CSF1PO: 6,10
ST   D12S391: 19,20
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11,19
ST   D7S820: 7,12
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   ARH-77 clone A5P3
AC   CVCL_A5YK
SY   ARH-77A5P3; A5P3
DR   Wikidata; Q107113379
RX   PubMed=8051085;
RX   PubMed=11001907;
CC   Problematic cell line: Misclassified. Parent cell line (ARH-77) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1349162; Sdc1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1072 ! ARH-77
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   ARH-DR
AC   CVCL_W396
DR   Wikidata; Q54750442
RX   CelloPub=CLPUB00019;
RX   PubMed=10936422;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   ARIP
AC   CVCL_3488
AS   CVCL_7243
SY   AR4-IP; AR41P; AR4IP
DR   CLO; CLO_0001741
DR   CLO; CLO_0001746
DR   CLDB; cl282
DR   ATCC; CRL-1674
DR   ChEMBL-Cells; CHEMBL3308355
DR   ChEMBL-Targets; CHEMBL613534
DR   PubChem_Cell_line; CVCL_3488
DR   TOKU-E; 557
DR   Wikidata; Q54750446
RX   CelloPub=CLPUB00018;
CC   Transformant: ChEBI; CHEBI_74846; Azaserine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0143 ! AR42J
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   ARIP/PDX-1
AC   CVCL_S556
DR   Wikidata; Q54750447
RX   PubMed=11249068;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 62387; Pdx1.
CC   Transformant: ChEBI; CHEBI_74846; Azaserine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3488 ! ARIP
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   ARK
AC   CVCL_A760
SY   Ark; ark; ARK-B
DR   BTO; BTO_0003930
DR   cancercelllines; CVCL_A760
DR   Cosmic; 720774
DR   Cosmic; 760398
DR   Cosmic; 2302413
DR   Cosmic; 2367270
DR   Wikidata; Q54750449
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8051085;
RX   PubMed=8427968;
RX   PubMed=8943038;
RX   PubMed=10936422;
RX   PubMed=11001907;
RX   PubMed=11157491;
RX   PubMed=11167840;
RX   PubMed=14555701;
RX   PubMed=15381930;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=11157491).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   ARL-14
AC   CVCL_4Z19
SY   ARL 14; Adult Rat Liver-14
DR   Wikidata; Q54750451
RX   PubMed=427743;
RX   PubMed=2903442;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   ARL-15
AC   CVCL_0D75
SY   ARL 15; Adult Rat Liver-15
DR   Wikidata; Q54750454
RX   PubMed=40692;
RX   PubMed=427743;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   ARL-15C1
AC   CVCL_0D77
DR   BTO; BTO_0005448
DR   Wikidata; Q54750456
RX   PubMed=2870063;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0D75 ! ARL-15
SX   Male
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   ARL-16
AC   CVCL_0D76
SY   ARL 16; Adult Rat Liver-16
DR   Wikidata; Q54750460
RX   PubMed=40692;
RX   PubMed=427743;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   ARL-16T2
AC   CVCL_0D78
DR   BTO; BTO_0005449
DR   Wikidata; Q54750461
RX   PubMed=2870063;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0D76 ! ARL-16
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   ARL-18
AC   CVCL_4Z20
SY   ARL 18; Adult Rat Liver-18
DR   Wikidata; Q54750462
RX   PubMed=427743;
RX   PubMed=2903442;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   ARL-19
AC   CVCL_4Z21
SY   ARL 19; Adult Rat Liver-19
DR   Wikidata; Q54750464
RX   PubMed=2903442;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   ARL-6
AC   CVCL_4106
SY   ARL 6; Adult Rat Liver-6
DR   CLO; CLO_0001747
DR   CLDB; cl286
DR   ECACC; 87050701
DR   Wikidata; Q54750465
RX   PubMed=40692;
RX   PubMed=427743;
RX   PubMed=2903442;
RX   PubMed=4373256;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   ARLJ 301-3
AC   CVCL_4107
SY   ARLJ301-3
DR   CLO; CLO_0001748
DR   CLO; CLO_0050623
DR   CLDB; cl287
DR   ECACC; 90071806
DR   JCRB; JCRB0248
DR   RCB; RCB0447
DR   Wikidata; Q54750468
RX   DOI=10.15114/tr.22.87;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   ARLJ 301-3TR1
AC   CVCL_5243
SY   ARLJ301-3TR1
DR   CLO; CLO_0050622
DR   RCB; RCB0448
DR   Wikidata; Q54750469
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4107 ! ARLJ 301-3
SX   Male
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   ARM-C
AC   CVCL_IW83
DR   cancercelllines; CVCL_IW83
DR   Wikidata; Q54750471
RX   PubMed=23372829;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=23372829).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW84 ! ARM-E
OI   CVCL_IW85 ! ARM-G
OI   CVCL_IW86 ! ARM-H
OI   CVCL_IW87 ! ARM-X
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   ARM-E
AC   CVCL_IW84
DR   cancercelllines; CVCL_IW84
DR   Wikidata; Q54750473
RX   PubMed=23372829;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=23372829).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW83 ! ARM-C
OI   CVCL_IW85 ! ARM-G
OI   CVCL_IW86 ! ARM-H
OI   CVCL_IW87 ! ARM-X
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   ARM-G
AC   CVCL_IW85
DR   cancercelllines; CVCL_IW85
DR   Wikidata; Q54750474
RX   PubMed=23372829;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=23372829).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW83 ! ARM-C
OI   CVCL_IW84 ! ARM-E
OI   CVCL_IW86 ! ARM-H
OI   CVCL_IW87 ! ARM-X
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   ARM-H
AC   CVCL_IW86
DR   cancercelllines; CVCL_IW86
DR   Wikidata; Q54750475
RX   PubMed=23372829;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=23372829).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW83 ! ARM-C
OI   CVCL_IW84 ! ARM-E
OI   CVCL_IW85 ! ARM-G
OI   CVCL_IW87 ! ARM-X
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   ARM-X
AC   CVCL_IW87
DR   cancercelllines; CVCL_IW87
DR   Wikidata; Q54750478
RX   PubMed=23372829;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=23372829).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW83 ! ARM-C
OI   CVCL_IW84 ! ARM-E
OI   CVCL_IW85 ! ARM-G
OI   CVCL_IW86 ! ARM-H
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   ARM193
AC   CVCL_B992
DR   CLO; CLO_0050317
DR   RCB; RCB0002
DR   Wikidata; Q54750529
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0A7G6; Escherichia coli recA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   ARM321
AC   CVCL_B993
DR   CLO; CLO_0050290
DR   RCB; RCB0115
DR   Wikidata; Q54750532
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A7G6; Escherichia coli recA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   ARMD1-hiPSC1
AC   CVCL_B960
SY   ARMD.1.H.iPSC.1
DR   RSCB; RSCB0120
DR   Wikidata; Q54750533
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B962 ! ARMD1-hiPSC2
OI   CVCL_B963 ! ARMD1-hiPSC4
OI   CVCL_B964 ! ARMD1-hiPSC5
OI   CVCL_B965 ! ARMD1-hiPSC8
OI   CVCL_B966 ! ARMD1-hiPSC9
OI   CVCL_B961 ! ARMD1-hiPSC11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ARMD1-hiPSC11
AC   CVCL_B961
SY   ARMD.1.H.iPSC.11
DR   RSCB; RSCB0126
DR   Wikidata; Q54750536
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B960 ! ARMD1-hiPSC1
OI   CVCL_B962 ! ARMD1-hiPSC2
OI   CVCL_B963 ! ARMD1-hiPSC4
OI   CVCL_B964 ! ARMD1-hiPSC5
OI   CVCL_B965 ! ARMD1-hiPSC8
OI   CVCL_B966 ! ARMD1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ARMD1-hiPSC2
AC   CVCL_B962
SY   ARMD.1.H.iPSC.2; RIi013-A
DR   hPSCreg; RIi013-A
DR   RSCB; RSCB0121
DR   SKIP; SKIP002408
DR   Wikidata; Q54750538
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B960 ! ARMD1-hiPSC1
OI   CVCL_B963 ! ARMD1-hiPSC4
OI   CVCL_B964 ! ARMD1-hiPSC5
OI   CVCL_B965 ! ARMD1-hiPSC8
OI   CVCL_B966 ! ARMD1-hiPSC9
OI   CVCL_B961 ! ARMD1-hiPSC11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   ARMD1-hiPSC4
AC   CVCL_B963
SY   ARMD.1.H.iPSC.4
DR   RSCB; RSCB0122
DR   Wikidata; Q54750540
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B960 ! ARMD1-hiPSC1
OI   CVCL_B962 ! ARMD1-hiPSC2
OI   CVCL_B964 ! ARMD1-hiPSC5
OI   CVCL_B965 ! ARMD1-hiPSC8
OI   CVCL_B966 ! ARMD1-hiPSC9
OI   CVCL_B961 ! ARMD1-hiPSC11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ARMD1-hiPSC5
AC   CVCL_B964
SY   ARMD.1.H.iPSC.5
DR   RSCB; RSCB0123
DR   Wikidata; Q54750541
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B960 ! ARMD1-hiPSC1
OI   CVCL_B962 ! ARMD1-hiPSC2
OI   CVCL_B963 ! ARMD1-hiPSC4
OI   CVCL_B965 ! ARMD1-hiPSC8
OI   CVCL_B966 ! ARMD1-hiPSC9
OI   CVCL_B961 ! ARMD1-hiPSC11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ARMD1-hiPSC8
AC   CVCL_B965
SY   ARMD.1.H.iPSC.8
DR   RSCB; RSCB0124
DR   Wikidata; Q54750542
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B960 ! ARMD1-hiPSC1
OI   CVCL_B962 ! ARMD1-hiPSC2
OI   CVCL_B963 ! ARMD1-hiPSC4
OI   CVCL_B964 ! ARMD1-hiPSC5
OI   CVCL_B966 ! ARMD1-hiPSC9
OI   CVCL_B961 ! ARMD1-hiPSC11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ARMD1-hiPSC9
AC   CVCL_B966
SY   ARMD.1.H.iPSC.9
DR   RSCB; RSCB0125
DR   Wikidata; Q54750543
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B960 ! ARMD1-hiPSC1
OI   CVCL_B962 ! ARMD1-hiPSC2
OI   CVCL_B963 ! ARMD1-hiPSC4
OI   CVCL_B964 ! ARMD1-hiPSC5
OI   CVCL_B965 ! ARMD1-hiPSC8
OI   CVCL_B961 ! ARMD1-hiPSC11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ARMS1
AC   CVCL_UF74
DR   Wikidata; Q93325944
RX   PubMed=9823299;
RX   PubMed=23665679;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=23665679).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   ARNT
AC   CVCL_E461
SY   ARENT; GM03153; GM03153B
DR   CLO; CLO_0013523
DR   Coriell; GM03153
DR   dbMHC; 48479
DR   ECACC; 94071428
DR   IHW; IHW09292
DR   IPD-IMGT/HLA; 10264
DR   Wikidata; Q54750544
RX   CelloPub=CLPUB00447;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Danish.
CC   HLA typing: A*02; B*38,39; DPA1*01:03; DPB1*02:01,20:01:01; DQA1*01:03; DRB1*13:01; DRB3*01:01 (IPD-IMGT/HLA=10264).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   ARO
AC   CVCL_0144
SY   ARO 81-1; ARO81-1; ARO-81; ARO81; UCLA-RO 81; UCLA RO-81-A-1; UCLA RO-81A-1
DR   BTO; BTO_0002306
DR   MCCL; MCC:0000037
DR   BioSample; SAMN03151786
DR   BioSample; SAMN03151787
DR   cancercelllines; CVCL_0144
DR   CCRID; 3101HUMSCSP576
DR   CGH-DB; 55-1
DR   ChEMBL-Cells; CHEMBL3307996
DR   ChEMBL-Targets; CHEMBL612590
DR   Cosmic; 685603
DR   Cosmic; 755291
DR   Cosmic; 849972
DR   Cosmic; 886550
DR   Cosmic; 888094
DR   Cosmic; 888277
DR   Cosmic; 891254
DR   Cosmic; 913250
DR   Cosmic; 918184
DR   Cosmic; 931242
DR   Cosmic; 990532
DR   Cosmic; 1005458
DR   Cosmic; 1094760
DR   Cosmic; 1152116
DR   Cosmic; 1155329
DR   Cosmic; 1162836
DR   Cosmic; 1184761
DR   Cosmic; 1699417
DR   Cosmic; 2050371
DR   IARC_TP53; 2122
DR   PubChem_Cell_line; CVCL_0144
DR   TOKU-E; 4069
DR   Wikidata; Q54750547
RX   PubMed=2551628;
RX   PubMed=8423216;
RX   PubMed=11439348;
RX   PubMed=14522906;
RX   PubMed=15613457;
RX   PubMed=16924234;
RX   PubMed=18713817;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
CC   From: Juillard, Guy Jean-Felix; University of California, Los Angeles; Los Angeles; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00177.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=8423216; PubMed=14522906).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=18713817; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,22
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   ARP-1
AC   CVCL_D523
SY   ARP1; AR-P1; ARP
DR   BTO; BTO_0003931
DR   EFO; EFO_0022413
DR   Cosmic; 2367264
DR   GEO; GSM2774095
DR   GEO; GSM2774097
DR   GEO; GSM2774129
DR   GEO; GSM2774131
DR   GEO; GSM2774134
DR   GEO; GSM2774136
DR   Wikidata; Q54750549
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=7949178;
RX   PubMed=10936422;
RX   PubMed=14555701;
RX   PubMed=14760100;
RX   PubMed=18647998;
RX   PubMed=29045832;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA kappa.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (CelloPub=CLPUB00604).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XD83 ! ARD
OI   CVCL_D569 ! CAG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   ARPE-19
AC   CVCL_0145
SY   ARPE19; Adult Retinal Pigment Epithelial cell line-19; NTC-200; NTC200
DR   BTO; BTO_0002335
DR   CLO; CLO_0001749
DR   EFO; EFO_0006271
DR   MCCL; MCC:0000038
DR   ATCC; CRL-2302
DR   BCRC; 60383
DR   BCRJ; 0041
DR   BioSample; SAMN03471862
DR   CCRID; 3101HUMGNHu45
DR   CCRID; 4201HUM-CCTCC00323
DR   CCTCC; GDC0323
DR   ChEMBL-Cells; CHEMBL4295388
DR   ChEMBL-Targets; CHEMBL4296399
DR   CLS; 305025
DR   ENCODE; ENCBS054LTE
DR   ENCODE; ENCBS534TJM
DR   GEO; GSM1227434
DR   IZSLER; BS CL 193
DR   Lonza; 871
DR   MetaboLights; MTBLS213
DR   PRIDE; PXD006125
DR   PRIDE; PXD006269
DR   PRIDE; PXD009607
DR   PubChem_Cell_line; CVCL_0145
DR   Ubigene; YC-C033
DR   Wikidata; Q28812659
RX   DOI=10.5897/IJBMBR2013.0154;
RX   PubMed=8698076;
RX   PubMed=11504951;
RX   PubMed=14551534;
RX   PubMed=16262907;
RX   PubMed=21697133;
RX   PubMed=24251032;
RX   PubMed=25177495;
RX   PubMed=27499609;
RX   PubMed=28978645;
RX   PubMed=29476476;
RX   PubMed=30167441;
RX   PubMed=31254428;
RX   PubMed=31412689;
WW   Info; LRI; -; https://web.archive.org/web/20100714222125/http://www.lerner.ccf.org/eye/crabb/research/gel_arpe19_cell.php
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-617.html
CC   Doubling time: 55 hours (Note=From cell counting), 65 hours (Note=From absorbance) (DOI=10.5897/IJBMBR2013.0154).
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Anecdotal: The number 19 in the cell line name is due to the fact that this cell line was established from a 19-year-old male who died from head trauma in a motor vehicle accident.
CC   Misspelling: APRE-19; Note=Occasionally.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
ST   Source(s): ATCC=CRL-2302; CLS=305025; PubMed=27499609; PubMed=31412689
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 21,22
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D6S1043: 17,19
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   ARPE-19 ULK1 KO
AC   CVCL_F1YP
SY   ULK1-KO ARPE-19
RX   DOI=10.1101/2025.11.07.687251;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ARPE-19-Luc
AC   CVCL_C8UR
DR   Ubigene; YC-C033-Luc-P
DR   Wikidata; Q123030701
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   ARPE-19/CNTF
AC   CVCL_IQ60
SY   ARPE/CNTF; ARPE-P444; NTC-201; NTC201
DR   Wikidata; Q54750555
RX   Patent=US6361771;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2524.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2169; CNTF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   ARPE-19/CNTF-10
AC   CVCL_IQ63
SY   NTC-201-10
DR   Wikidata; Q54750557
RX   CelloPub=CLPUB00369;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2169; CNTF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ60 ! ARPE-19/CNTF
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   ARPE-19/CNTF-6A
AC   CVCL_IQ64
SY   NTC-201-6A
DR   Wikidata; Q54750558
RX   CelloPub=CLPUB00369;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2169; CNTF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ60 ! ARPE-19/CNTF
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   ARPE-19/EGFP
AC   CVCL_IQ61
SY   ARPE/GFP; P-393-1; NTC200p393(1)
DR   Wikidata; Q54750560
RX   Patent=US6361771;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2522.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 10
//
ID   ARPE-19/GDNF
AC   CVCL_IQ62
SY   ARPE/GDNF; ARPE-19/p559; NTC200p559
DR   Wikidata; Q54750563
RX   Patent=US6361771;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2523.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4232; GDNF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   ARPE-19/HPV-16
AC   CVCL_6338
DR   CLO; CLO_0001750
DR   ATCC; CRL-2502
DR   Wikidata; Q54750565
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
ST   Source(s): ATCC=CRL-2502
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   ARR
AC   CVCL_WV44
DR   Wikidata; Q93325957
RX   CelloPub=CLPUB00519;
RX   PubMed=17170727;
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 05-10-23; Version: 5
//
ID   ARSA-/- immortalized MSC
AC   CVCL_YP18
DR   Wikidata; Q93325958
RX   PubMed=28762252;
CC   Sequence variation: Mutation; HGNC; HGNC:713; ARSA; Simple; p.Arg246His (c.737G>A) (p.Arg244His, c.731G>A); ClinVar=VCV000068148; Zygosity=Heterozygous (PubMed=28762252).
CC   Sequence variation: Mutation; HGNC; HGNC:713; ARSA; Simple; p.Glu309Lys (c.925G>A) (p.Glu307Lys, c.919G>A); ClinVar=VCV000068162; Zygosity=Heterozygous (PubMed=28762252).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   ARSI
AC   CVCL_D3X9
DR   Wikidata; Q127380237
RX   PubMed=36084691;
CC   Characteristics: Established from a xenograft that was obtain by transplantation of the tumor cells in female immunodeficient NSG (NOD.Cg-Prkdc[scid] l2rg[tm1Wjll]/SzJ) mouse (PubMed=36084691).
CC   Doubling time: ~24 hours (PubMed=36084691).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6119; IRF4; Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196Cys (c.587A>G); Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:6119; IRF4; Simple; p.Gln60Lys (c.178C>A); Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:6119; IRF4; Simple; p.Ser104Arg (c.312C>A); Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar= VCV000037055; Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; p.Glu123Gln (c.367G>C); Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; p.Pro124Ser (c.370C>T); Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; p.His159Tyr (c.475C>T); Zygosity=Heterozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; p.Ser166Phe (c.497C>T); Zygosity=Homozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; p.Leu220Val (c.658C>G); Zygosity=Homozygous (PubMed=36084691).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; p.Glu226Lys (c.676G>A); Zygosity=Homozygous (PubMed=36084691).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C45194; Primary cutaneous diffuse large B-cell lymphoma, leg type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   ART [Acipenser]
AC   CVCL_B5DQ
SY   Acipenser Ruthenus Testis
DR   Wikidata; Q110432580
RX   PubMed=30484862;
CC   Group: Fish cell line.
CC   Doubling time: 55.57 hours (PubMed=30484862).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7906; ! Acipenser ruthenus (Sterlet sturgeon)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ART [Human OVCAR-8 contaminated cell line]
AC   CVCL_B0CC
DR   ATCC; CRL-3468
DR   cancercelllines; CVCL_B0CC
DR   Wikidata; Q108819855
RX   PubMed=23843634;
RX   PubMed=29091757;
CC   Problematic cell line: Contaminated. Parent cell line (NCI-ADR-RES) has been shown to be a OVCAR-8 derivative.
CC   Population: Caucasian.
CC   Characteristics: Engineered to overexpress the SV40 large T antigen.
CC   Virology: Can be used to evaluate the infectious entry of polyomaviruses (BKPyV, JCPyV, SV40, MCPyV) and human papillomaviruses. Pathogenic variants of the JCPyV virus previously believed to be non-infectious can infect this cell line (ATCC=CRL-3468).
CC   Doubling time: ~34 hours (ATCC=CRL-3468).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST   Source(s): ATCC=CRL-3468
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 12
ST   D7S820: 20
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1629 ! OVCAR-8
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 12
//
ID   ART-18
AC   CVCL_C5QU
SY   ART18
DR   Wikidata; Q116048525
RX   PubMed=6401187;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26897; Rat Il2ra/Cd25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ART1
AC   CVCL_C1J8
SY   ART
DR   Wikidata; Q114310627
RX   PubMed=4333769;
RX   PubMed=7316467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic myeloid leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AS [C.sanguinolenta]
AC   CVCL_D5ED
SY   Aceratagallia sanguinolenta
DR   Wikidata; Q127380238
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=4889430;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1655906; ! Ceratagallia sanguinolenta (Clover leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AS [Human neuroblastoma]
AC   CVCL_S099
DR   Wikidata; Q54750567
RX   PubMed=7073944;
CC   Doubling time: 35.8 hours (PubMed=7073944).
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y9M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   AS [Human rhabdoid tumor]
AC   CVCL_B3QE
DR   Cosmic; 802254
DR   Wikidata; Q110432581
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   AS [Salmo]
AC   CVCL_6F68
SY   Atlantic Salmon
DR   Wikidata; Q54750570
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1139/f73-152;
CC   Group: Fish cell line.
CC   Doubling time: 19.5 hours (DOI=10.1139/f73-152).
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Parr
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 8
//
ID   AS 2
AC   CVCL_XH98
DR   Wikidata; Q93325960
RX   Patent=EP0112741A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-208.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03300; Poliovirus type 1 (strain Mahoney) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   AS 3
AC   CVCL_XH99
DR   Wikidata; Q93325961
RX   Patent=EP0112741A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-209.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03300; Poliovirus type 1 (strain Mahoney) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   AS iPS del 1-0
AC   CVCL_U498
SY   ASdel1-0; AG1-0
DR   Kerafast; ECN001
DR   Kerafast; ECN014
DR   SKIP; SKIP003252
DR   Wikidata; Q54750572
RX   PubMed=20876107;
CC   Discontinued: Kerafast; ECN001; true.
CC   Discontinued: Kerafast; ECN014; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U499 ! AS iPS del 1-1
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   AS iPS del 1-1
AC   CVCL_U499
SY   ASdel1-1
DR   Wikidata; Q54750575
RX   PubMed=20876107;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U498 ! AS iPS del 1-0
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AS iPS del 2-0
AC   CVCL_U500
SY   ASdel2-0
DR   Wikidata; Q54750577
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I46 ! WG1631
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AS iPS del 2-3
AC   CVCL_U501
SY   ASdel2-3
DR   Wikidata; Q54750580
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I46 ! WG1631
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   AS-1
AC   CVCL_DC71
DR   Wikidata; Q54750582
RX   Patent=US5024946;
RX   PubMed=2470715;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8118.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2710 ! RPMI-1788
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   AS-8
AC   CVCL_E2WB
DR   BTO; BTO_0005303
RX   PubMed=12177505;
RX   PubMed=12232424;
CC   Group: Plant cell line.
CC   Characteristics: Transgenic tobacco cell line lacking the alternative oxidase AOX (PubMed=12177505).
CC   Derived from site: In situ; Vascular leaf; PO=PO_0009025.
CC   Breed/subspecies: Cultivar Petit Havana SR1.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   AS-D-653-TC
AC   CVCL_F988
SY   AS-D-653
DR   TKG; TKG 0117
DR   TKG; TKG 0671
DR   Wikidata; Q54750584
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   AS-E2
AC   CVCL_6769
DR   Cosmic; 787421
DR   Cosmic; 975239
DR   Cosmic; 1012059
DR   Cosmic; 1281306
DR   Cosmic; 2306200
DR   RCB; RCB5257
DR   Wikidata; Q54750585
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9369430;
RX   PubMed=9419420;
RX   PubMed=16408098;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=AS-E2
CC   Population: Japanese.
CC   Characteristics: EPO dependent.
CC   Doubling time: ~49 hours (PubMed=9369430).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68693; Adult pure erythroid leukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   AS-FPH0
AC   CVCL_A2EX
DR   Wikidata; Q105506418
RX   PubMed=32885737;
CC   Doubling time: 57.6 hours (PubMed=32885737).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: American shorthair; VBO=VBO_0100018.
DI   NCIt; C176702; Feline progressive histiocytosis
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   AS-H 1
AC   CVCL_Z499
DR   Wikidata; Q54750590
RX   DOI=10.1080/03235409009438961;
CC   Group: Insect cell line.
CC   Doubling time: 2.2 days (DOI=10.1080/03235409009438961).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=47767; ! Agrotis segetum (Turnip moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AS-H 4
AC   CVCL_Z500
DR   Wikidata; Q54750591
RX   DOI=10.1080/03235409009438961;
CC   Group: Insect cell line.
CC   Doubling time: 2.5 days (DOI=10.1080/03235409009438961).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=47767; ! Agrotis segetum (Turnip moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   AS-M
AC   CVCL_8656
DR   Wikidata; Q54750593
RX   PubMed=14741847;
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   AS-M.5
AC   CVCL_8657
SY   AS.M-5
DR   Wikidata; Q54750595
RX   PubMed=14741847;
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8656 ! AS-M
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   AS-M.5 SOCS3-Luc clone E
AC   CVCL_RN36
DR   Wikidata; Q54750597
RX   CelloPub=CLPUB00415;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:19391; SOCS3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8657 ! AS-M.5
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   AS034
AC   CVCL_B340
SY   AS 034; CEBe002-A
DR   ArrayExpress; E-MTAB-5367
DR   hPSCreg; CEBe002-A
DR   SKIP; SKIP001761
DR   Wikidata; Q54750599
RX   PubMed=15153613;
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   AS034.1
AC   CVCL_B341
SY   CEBe002-A-1; CEBe003-A
DR   BioSamples; SAMEA104620496
DR   hPSCreg; CEBe002-A-1
DR   SKIP; SKIP001762
DR   Wikidata; Q54750602
RX   PubMed=15153613;
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B340 ! AS034
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   AS034.1.1
AC   CVCL_B342
SY   CEBe003-A-3; CEBe005-A
DR   BioSamples; SAMEA104620498
DR   hPSCreg; CEBe002-A-3
DR   SKIP; SKIP001764
DR   Wikidata; Q54750604
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B341 ! AS034.1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   AS034.2
AC   CVCL_B343
SY   CEBe002-A-2; CEBe004-A
DR   hPSCreg; CEBe002-A-2
DR   SKIP; SKIP001763
DR   Wikidata; Q54750608
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B340 ! AS034
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   AS038
AC   CVCL_B344
SY   AS 038; CEBe006-A
DR   hPSCreg; CEBe006-A
DR   SKIP; SKIP001765
DR   Wikidata; Q54750609
RX   PubMed=15153613;
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   AS079
AC   CVCL_B345
SY   CEBe008-A
DR   hPSCreg; CEBe008-A
DR   SKIP; SKIP001767
DR   Wikidata; Q54750611
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   AS094
AC   CVCL_B346
DR   Wikidata; Q54750612
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   AS11
AC   CVCL_KC01
DR   Wikidata; Q54750660
RX   PubMed=8882729;
RX   PubMed=9084877;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09525; Human ANXA4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AS17
AC   CVCL_8536
DR   JCRB; JCRB1392
DR   Wikidata; Q54750662
RX   PubMed=8882729;
RX   PubMed=9084877;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P09525; Human ANXA4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   AS283A
AC   CVCL_A761
SY   As283A; AS283
DR   cancercelllines; CVCL_A761
DR   Cosmic; 1515198
DR   GEO; GSM1177942
DR   GEO; GSM1177943
DR   IARC_TP53; 134
DR   Wikidata; Q54750664
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=8176200;
RX   PubMed=8344493;
RX   PubMed=8515068;
RX   PubMed=8568269;
RX   PubMed=9973220;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu206Trpfs*41 (c.617delT); ClinVar=VCV002109844; Zygosity=Unspecified (PubMed=2052620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   AS3
AC   CVCL_ZP33
DR   Wikidata; Q98125483
RX   PubMed=3029584;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AS3-SVwt
AC   CVCL_ZP34
DR   Wikidata; Q98125487
RX   PubMed=3029584;
RX   PubMed=8392442;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP33 ! AS3
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   As4.1
AC   CVCL_0151
SY   As41; Clone 4.1
DR   CLO; CLO_0001753
DR   MCCL; MCC:0000043
DR   ATCC; CRL-2193
DR   Wikidata; Q54750665
RX   PubMed=2174057;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Ren-2d promoter-TAg transgenic.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   AS550
AC   CVCL_ZR68
DR   Wikidata; Q98125491
RX   PubMed=19934020;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=19934020).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   AS551
AC   CVCL_ZR69
DR   Wikidata; Q98125495
RX   PubMed=19934020;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ile456del (c.1361_1363TCA[2]) (1439_1441delTCA); ClinVar=VCV000620626; Zygosity=Heterozygous (PubMed=19934020).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   AS552
AC   CVCL_ZR70
DR   Wikidata; Q98125496
RX   PubMed=19934020;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ile456del (c.1361_1363TCA[2]) (1439_1441delTCA); ClinVar=VCV000620626; Zygosity=Heterozygous (PubMed=19934020).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=19934020).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   AS553
AC   CVCL_ZR71
DR   Wikidata; Q98125497
RX   PubMed=19934020;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ile456del (c.1361_1363TCA[2]) (1439_1441delTCA); ClinVar=VCV000620626; Zygosity=Heterozygous (PubMed=19934020).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=19934020).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   ASA
AC   CVCL_UW34
DR   Wikidata; Q93326026
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   ASAN-PaCa
AC   CVCL_GP71
SY   ASAN PaCa
DR   ABM; T8009
DR   cancercelllines; CVCL_GP71
DR   Cosmic; 2566118
DR   Wikidata; Q54750668
RX   PubMed=27518460;
CC   Problematic cell line: Contaminated. Shown to be a T3M-4 derivative (Direct_author_submission). Originally thought to originate from a 61 year old Caucasian female patient with a pancreatic intraductal papillary-mucinous carcinoma.
CC   Population: Japanese.
CC   Doubling time: 20 hours (PubMed=27518460).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous; Note=1 of 3 alleles (PubMed=27518460).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=27518460).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile and contamination by T3M-4 from personal communication of Giese, Nathalia A.
CC   Discontinued: ABM; T8009; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 32.2,33.2
ST   D2S1338: 17,25
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 16
ST   FGA: 25,26
ST   Penta D: 10
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 18,19,21
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4056 ! T3M-4
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 17
//
ID   Asano
AC   CVCL_D299
DR   Cosmic; 945372
DR   Wikidata; Q54750669
RX   PubMed=8980248;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=8980248).
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   ASB-10W
AC   CVCL_8626
DR   Wikidata; Q54750673
RX   PubMed=4052977;
CC   Karyotypic information: Has a chromosome 11 trisomy (PubMed=4052977).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   ASB-410
AC   CVCL_8648
DR   Wikidata; Q54750677
RX   PubMed=4052977;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   ASB-XIII
AC   CVCL_5685
SY   ASB XIII
DR   Wikidata; Q54750678
RX   PubMed=6652624;
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21770; Squamous cell carcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   ASB-XIV
AC   CVCL_5686
SY   ASB XIV
DR   CLS; 400120
DR   Wikidata; Q54750682
RX   PubMed=6652624;
CC   Doubling time: ~70 hours (CLS=400120).
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
ST   Source(s): CLS=400120
ST   Mouse STR 1-1: 14,16,17
ST   Mouse STR 1-2: 16,17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 20.3,21.3,22.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 17,18,19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 24.2,25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 15,16
ST   Mouse STR 13-1: 15.2,16.2
ST   Mouse STR 15-3: 23.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 17,18
ST   Mouse STR 19-2: 13,14
ST   Mouse STR X-1: 25,26
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   ASBB
AC   CVCL_A017
SY   ASBB-1; Asian Sea Bass Brain
DR   Wikidata; Q54750684
RX   CelloPub=CLPUB00463;
RX   CelloPub=CLPUB00637;
RX   PubMed=21082288;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 20 to 30 Celsius, the optimal temperature is 25 Celsius (CelloPub=CLPUB00637).
CC   Virology: Susceptible to infection by nodavirus (RGNNV genotype) (PubMed=21082288).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   ASC clone 23
AC   CVCL_D6RQ
SY   ASC23
RX   PubMed=30089820;
CC   From: Department of Functional Genomics - Human Molecular Genetics, University Medicine Greifswald; Greifswald; Germany.
CC   Population: Palestinian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   ASC-17D
AC   CVCL_6D60
SY   Adult Sertoli Cell-17 clone D
DR   Wikidata; Q54750688
RX   PubMed=8562702;
RX   PubMed=15716129;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   ASC/TERT300
AC   CVCL_B5T1
DR   Evercyte; CHT-001-0300
DR   Wikidata; Q111732933
CC   Doubling time: 30-36 hours (Evercyte=CHT-001-0300).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile, sex and age of donor from personal communication of Evercyte.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): Evercyte=CHT-001-0300
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 10,13
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   ASC52telo
AC   CVCL_U602
AS   CVCL_9Q54
SY   ASC/TERT1
DR   ATCC; SCRC-4000
DR   BioSample; SAMN03471937
DR   Evercyte; CHT-001-0005
DR   GEO; GSM7701466
DR   GEO; GSM7701467
DR   Wikidata; Q54750689
RX   PubMed=19125642;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Evercyte=CHT-001-0005).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): ATCC=SCRC-4000
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 15
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 12,14
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   ASC57telo
AC   CVCL_U603
DR   ATCC; SCRC-4001
DR   BioSample; SAMN03471938
DR   Wikidata; Q54750690
RX   PubMed=19125642;
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (ATCC=SCRC-4001).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): ATCC=SCRC-4001
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   ASCC
AC   CVCL_C1JH
SY   Alpaca Skin Stromal Cells
DR   Wikidata; Q114310628
RX   PubMed=25140515;
CC   Virology: Susceptible to infection by bovine herpesvirus-1 (BoHV-1), bovine viral diarrhea virus and caprine herpesvirus-1 and the endocellular parasite Neospora caninum (PubMed=25140515).
CC   Doubling time: 28.21 hours (PubMed=25140515).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV40T/neo).
CC   Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=30538; ! Vicugna pacos (Alpaca)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   ASCF
AC   CVCL_B7MX
SY   Atlantic Salmon Caudal Fin
DR   Wikidata; Q112929239
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Miscellaneous: Age at sampling from personal communication of Pham, Phuc H.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Smolt
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 6
//
ID   ASE [Anopheles]
AC   CVCL_A0DV
DR   Wikidata; Q108819856
RX   PubMed=18588503;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
OX   NCBI_TaxID=30069; ! Anopheles stephensi (Indo-Pakistan malaria mosquito)
HI   CVCL_Z356 ! LSTM-AS-43
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   ASE [Salmo]
AC   CVCL_6G15
SY   Atlantic Salmon Embryo
DR   Wikidata; Q54750692
RX   CelloPub=CLPUB00103;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   ASE-14
AC   CVCL_C0XJ
SY   ASE14; Amblyomma Sculptum Embryonic 14th passage
DR   Wikidata; Q114310629
RX   PubMed=35427959;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Doubling time: 3-4 days (PubMed=35427959).
OX   NCBI_TaxID=1581419; ! Amblyomma sculptum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   ASEC-1
AC   CVCL_E5UU
SY   Anolis Sagrei Embryonic Cell line-1
DR   ABM; T0591
DR   GEO; GSM7749194
DR   GEO; GSM7749195
DR   GEO; GSM7749196
DR   GEO; GSM7749197
DR   GEO; GSM7749198
DR   GEO; GSM7749199
DR   GEO; GSM7749200
DR   GEO; GSM7749201
DR   GEO; GSM7749202
RX   PubMed=39576177;
CC   Group: Reptilian cell line.
CC   Doubling time: 20.7 hours (PubMed=39576177).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Embryonic trunk; UBERON=UBERON_0002100.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=38937; ! Anolis sagrei (Bahaman brown anole)
SX   Male
AG   Embryo stage 6
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ASEC-1 ift88 KO clone #28
AC   CVCL_E5V2
SY   ift88-2/-4
DR   ABM; T3846
RX   PubMed=39576177;
CC   Group: Reptilian cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G1KAS9; IFT88 (Note=Not from Anolis sagrei but from Anolis carolinensis, the closest currently available sequenced species).
CC   Derived from site: In situ; Embryonic trunk; UBERON=UBERON_0002100.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=38937; ! Anolis sagrei (Bahaman brown anole)
HI   CVCL_E5UU ! ASEC-1
SX   Male
AG   Embryo stage 6
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ASEC-1 ift88 KO clone #30
AC   CVCL_E5V3
SY   ift88+1/-5
DR   ABM; T3847
RX   PubMed=39576177;
CC   Group: Reptilian cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G1KAS9; IFT88 (Note=Not from Anolis sagrei but from Anolis carolinensis, the closest currently available sequenced species).
CC   Derived from site: In situ; Embryonic trunk; UBERON=UBERON_0002100.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=38937; ! Anolis sagrei (Bahaman brown anole)
HI   CVCL_E5UU ! ASEC-1
SX   Male
AG   Embryo stage 6
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ASF
AC   CVCL_C5TW
SY   Atlantic Salmon Fin
DR   Wikidata; Q116048526
RX   DOI=10.1007/s11802-022-4875-8;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 10 to 28 Celsius, the optimal growth temperature is 20 Celsius (DOI=10.1007/s11802-022-4875-8).
CC   Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV) and red-spotted grouper nervous necrosis virus (RGNNV) (DOI=10.1007/s11802-022-4875-8).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ASF-1
AC   CVCL_S925
DR   Wikidata; Q54750695
RX   PubMed=6767657;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal trunk; UBERON=UBERON_0002100+UBERON_0006071.
OX   NCBI_TaxID=34773; ! Alosa sapidissima (American shad)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 9
//
ID   ASF-4-1
AC   CVCL_2854
SY   ASF 4-1
DR   BioSample; SAMN03472790
DR   JCRB; IFO50418
DR   Wikidata; Q54750697
RX   PubMed=27073551;
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Doubling time: 2-2.5 days (Note=Lot 07222002) (JCRB=IFO50418).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=IFO50418
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   36Y2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   ASF-4-2
AC   CVCL_2855
DR   JCRB; IFO50419
DR   RCB; RCB3579
DR   Wikidata; Q54750699
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Doubling time: ~60 hours (Note=Lot 08062002) (JCRB=IFO50419).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=IFO50419
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   47Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   ASF-4-3L
AC   CVCL_8497
DR   JCRB; JCRB1431
DR   RCB; RCB3580
DR   Wikidata; Q54750701
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Senescence: Senesces at ~52 PDL (JCRB=JCRB1431).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1431
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   56Y9M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   ASF-4-4L1
AC   CVCL_8498
DR   JCRB; JCRB1441
DR   RCB; RCB3582
DR   Wikidata; Q54750702
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Senescence: Senesces at 41 PDL (JCRB=JCRB1441).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1441
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   62Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   ASF-4-4L2
AC   CVCL_8499
DR   JCRB; JCRB1442
DR   RCB; RCB3583
DR   Wikidata; Q54750704
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Senescence: Senesces at ~48 PDL (JCRB=JCRB1442).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1442
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   62Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   ASF-4-4R2
AC   CVCL_8500
DR   JCRB; JCRB1446
DR   RCB; RCB3585
DR   Wikidata; Q54750706
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Discontinued: JCRB; JCRB1446; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   62Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   ASF-4-5L1
AC   CVCL_JG42
DR   JCRB; JCRB1705
DR   Wikidata; Q54750707
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Senescence: Senesces at ~45 PDL (JCRB=JCRB1705).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1705
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   67Y4M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   ASF-4-5L2
AC   CVCL_JG43
DR   JCRB; JCRB1703
DR   Wikidata; Q54750709
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Senescence: Senesces at ~40 PDL (JCRB=JCRB1703).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1703
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   67Y4M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   ASF-4-5R1
AC   CVCL_JG44
DR   JCRB; JCRB1709
DR   Wikidata; Q54750711
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Senescence: Senesces at ~55 PDL (JCRB=JCRB1709).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1709
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2854 ! ASF-4-1
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
SX   Male
AG   67Y4M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   ASG-10
AC   CVCL_B5YZ
SY   ASG10; Atlantic Salmon Gill-10
DR   PRIDE; PXD044533
DR   Wikidata; Q111732935
RX   PubMed=29444101;
RX   PubMed=37916189;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV), infectious pancreatic necrosis virus (IPNV), Pacific salmon paramyxovirus (PSPV), Atlantic salmon reovirus TS (TSRV) and viral hemorrhagic septicemia virus (VHSV) (PubMed=29444101).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
OI   CVCL_B5Z0 ! ASG-13
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ASG-13
AC   CVCL_B5Z0
SY   ASG13; Atlantic Salmon Gill-13
DR   Wikidata; Q111732936
RX   PubMed=29444101;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV), infectious pancreatic necrosis virus (IPNV), Pacific salmon paramyxovirus (PSPV), Atlantic salmon reovirus TS (TSRV) and viral hemorrhagic septicemia virus (VHSV) (PubMed=29444101).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
OI   CVCL_B5YZ ! ASG-10
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   ASGRCi001-A
AC   CVCL_YB75
SY   F3-2#5 CHR
DR   BioSamples; SAMEA6245087
DR   hPSCreg; ASGRCi001-A
DR   Wikidata; Q93326114
RX   PubMed=33096384;
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ASGRCi002-A
AC   CVCL_YB76
SY   F3-3#1 CHR
DR   BioSamples; SAMEA6246680
DR   hPSCreg; ASGRCi002-A
DR   Wikidata; Q93326116
RX   PubMed=33096384;
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ASGRCi003-A
AC   CVCL_YB77
SY   F3-4#5 CHR
DR   BioSamples; SAMEA6246777
DR   hPSCreg; ASGRCi003-A
DR   Wikidata; Q93326118
RX   PubMed=33096384;
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ASGRCi004-A
AC   CVCL_YB78
SY   0118 CHR
DR   BioSamples; SAMEA6285361
DR   hPSCreg; ASGRCi004-A
DR   Wikidata; Q93326120
RX   PubMed=33370876;
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ASGRCi005-A
AC   CVCL_YB79
SY   0622 CHR
DR   BioSamples; SAMEA6285363
DR   hPSCreg; ASGRCi005-A
DR   Wikidata; Q93326123
RX   PubMed=33370876;
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ASGRCi006-A
AC   CVCL_YB80
SY   0808 CHR
DR   BioSamples; SAMEA6285365
DR   hPSCreg; ASGRCi006-A
DR   Wikidata; Q93326125
RX   PubMed=33370876;
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ASGRCi007-A
AC   CVCL_ZW14
SY   T2D19#2 XY-CHR
DR   BioSamples; SAMEA7151723
DR   hPSCreg; ASGRCi007-A
DR   Wikidata; Q102113569
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ASGRCi008-A
AC   CVCL_C7RG
SY   mRNA iPSC 1-3
DR   hPSCreg; ASGRCi008-A
DR   Wikidata; Q117704195
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   ASGRCi009-A
AC   CVCL_C9M0
DR   hPSCreg; ASGRCi009-A
DR   Wikidata; Q123030702
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ASGRCi010-A
AC   CVCL_C9M1
DR   hPSCreg; ASGRCi010-A
DR   Wikidata; Q123030703
CC   From: Genomics Research Center, Academia Sinica; Taipei; Taiwan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ASH
AC   CVCL_R966
SY   Atlantic Salmon Heart
DR   Wikidata; Q54750713
RX   PubMed=6767657;
CC   Group: Fish cell line.
CC   From: Gillespie, James Howard; Cornell University College of Veterinary Medicine; Ithaca; USA.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   ASHe
AC   CVCL_A5TA
SY   Atlantic Salmon Heart endothelium
DR   Wikidata; Q107113380
RX   PubMed=27586265;
RX   PubMed=28882807;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Parr
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ASH-3
AC   CVCL_2856
SY   ASH3
DR   CLO; CLO_0037151
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470933
DR   cancercelllines; CVCL_2856
DR   Cell_Model_Passport; SIDM00491
DR   Cosmic; 2054110
DR   Cosmic-CLP; 1290722
DR   DepMap; ACH-001443
DR   EGA; EGAS00001000978
DR   GDSC; 1290722
DR   GEO; GSM827189
DR   GEO; GSM1669602
DR   JCRB; JCRB1073
DR   JCRB; NIHS0269
DR   LINCS_LDP; LCL-1682
DR   PharmacoDB; ASH3_65_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2856
DR   Wikidata; Q54750715
RX   PubMed=11686581;
RX   PubMed=20215515;
RX   PubMed=23833040;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 84 hours (PubMed=11686581); 43-47 hours (Note=Lot 12072015) (JCRB=JCRB1073).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23833040).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.181A>G); Zygosity=Heterozygous (PubMed=30737244; Cosmic-CLP=1290722; DepMap=ACH-001443).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Phe241fs (c.724dupG); Zygosity=Homozygous (PubMed=30737244; Cosmic-CLP=1290722; DepMap=ACH-001443).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Homozygous (PubMed=30737244; Cosmic-CLP=1290722; DepMap=ACH-001443).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.08%; East Asian, North=79.16%; East Asian, South=20.41%; South Asian=0.34%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0269; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=1290722; DepMap=ACH-001443; JCRB=JCRB1073; PubMed=25877200; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 13,17
ST   D19S433: 13,15.2
ST   D21S11: 28
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 16
ST   FGA: 20,22
ST   Penta D: 10,11
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   ASH-S2
AC   CVCL_C549
SY   ASHS2
DR   CCRID; 5301OVI-KCB97001ZJ
DR   KCB; KCB 97001ZJ
DR   Wikidata; Q54750718
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30527; ! Ovis ammon (Argali)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   ASH-S3
AC   CVCL_C550
SY   ASHS3
DR   CCRID; 5301OVI-KCB97004ZJ
DR   KCB; KCB 97004ZJ
DR   Wikidata; Q54750720
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30527; ! Ovis ammon (Argali)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   ASimf20
AC   CVCL_AZ82
SY   Atlantic Salmon intestinal myofibroblast 20
DR   Wikidata; Q54750721
RX   CelloPub=CLPUB00326;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Myofibroblast; CL=CL_0000186.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 8
//
ID   ASK
AC   CVCL_4108
SY   Atlantic Salmon Kidney
DR   CLO; CLO_0001755
DR   ATCC; CRL-2747
DR   CCLV; CCLV-RIE 0926
DR   GEO; GSM281567
DR   GEO; GSM281568
DR   GEO; GSM281569
DR   GEO; GSM281570
DR   GEO; GSM281571
DR   GEO; GSM281572
DR   Wikidata; Q54750723
RX   PubMed=10785858;
RX   PubMed=15825496;
RX   PubMed=18534703;
RX   PubMed=19941903;
RX   PubMed=30537062;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Aska-SS
AC   CVCL_6C43
SY   Aska (SS); Aska; ASKA
DR   EFO; EFO_0022567
DR   GEO; GSM2887614
DR   GEO; GSM2887615
DR   PharmacoDB; ASKA_66_2019
DR   RCB; RCB3576
DR   Wikidata; Q54750727
RX   PubMed=20518020;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=20518020).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   ASL
AC   CVCL_E7GR
SY   Acanthopagrus Schlegelii Liver
RX   DOI=10.1016/j.aqrep.2022.101213;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 20 to 28 Celsius, the optimal growth temperature is 28 Celsius (DOI=10.1016/j.aqrep.2022.101213).
CC   Virology: Susceptible to infection by red-spotted grouper nervous necrosis virus (RGNNV) (DOI=10.1016/j.aqrep.2022.101213).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=72011; ! Acanthopagrus schlegelii (Black porgy)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ASMF
AC   CVCL_A6SE
SY   Apodemus Speciosus Muscle Fibroblast
DR   RCB; RCB3516
DR   Wikidata; Q107113381
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=105296; ! Apodemus speciosus (Large Japanese field mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   ASO
AC   CVCL_R967
SY   Atlantic Salmon Ovary
DR   Wikidata; Q54750729
RX   PubMed=6767657;
CC   Group: Fish cell line.
CC   From: Gillespie, James Howard; Cornell University College of Veterinary Medicine; Ithaca; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   Asp-86
AC   CVCL_E1GP
DR   BTO; BTO_0005616
DR   RIKEN_BRC_EPD; rpc00010
RX   PubMed=7600611;
RX   PubMed=10734215;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
OX   NCBI_TaxID=4686; ! Asparagus officinalis (Garden asparagus)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   ASP1-UPIC
AC   CVCL_C3G3
SY   Alport Syndrome Patient 1-Urine Podocyte Immortalized Cell line
DR   GEO; GSM3933297
DR   GEO; GSM3933298
DR   GEO; GSM3933299
DR   Wikidata; Q114310630
RX   PubMed=32652570;
CC   Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Glu647Argfs*45 (c.1937dupG); ClinVar=VCV000949881; Zygosity=Heterozygous (PubMed=32652570).
CC   Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Gly1602Alafs*13 (c.4803delT); ClinVar=VCV000550931; Zygosity=Heterozygous (PubMed=32652570).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte; CL=CL_0000653.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Conditionally immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   ASP2-UPIC
AC   CVCL_C3G4
SY   Alport Syndrome Patient 2-Urine Podocyte Immortalized Cell line
DR   GEO; GSM3933294
DR   GEO; GSM3933295
DR   GEO; GSM3933296
DR   Wikidata; Q114310631
RX   PubMed=32652570;
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly926Alafs*70 (c.2777del); Zygosity=Heterozygous (PubMed=32652570).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte; CL=CL_0000653.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Conditionally immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   ASP3-UPIC
AC   CVCL_C3G5
SY   Alport Syndrome Patient 3-Urine Podocyte Immortalized Cell line
DR   GEO; GSM3933300
DR   GEO; GSM3933301
DR   GEO; GSM3933302
DR   Wikidata; Q114310632
RX   PubMed=32652570;
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly849Glu (c.2546G>A); Zygosity=Hemizygous (PubMed=32652570).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte; CL=CL_0000653.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Conditionally immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   ASP309
AC   CVCL_AZ83
SY   Atlantic Salmon Pituitary 309
DR   Wikidata; Q54750731
RX   CelloPub=CLPUB00327;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Doubling time: 9 days (CelloPub=CLPUB00327).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   ASP409
AC   CVCL_AZ84
SY   Atlantic Salmon Pituitary 409
DR   Wikidata; Q54750734
RX   CelloPub=CLPUB00327;
CC   Group: Fish cell line.
CC   Doubling time: 3 days (CelloPub=CLPUB00327).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   AsPC-1
AC   CVCL_0152
SY   AsPc-1; Aspc-1; ASPC-1; As-PC1; ASPC1; AsPC1; Aspc1; AsPc1
DR   BTO; BTO_0001864
DR   CLO; CLO_0001756
DR   EFO; EFO_0002112
DR   MCCL; MCC:0000044
DR   CLDB; cl289
DR   AddexBio; C0018023/5061
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1682
DR   BCRC; 60494
DR   BioGRID_ORCS_Cell_line; 259
DR   BioSample; SAMN03471961
DR   BioSample; SAMN10988235
DR   cancercelllines; CVCL_0152
DR   CCRID; 1101HUM-PUMC000214
DR   CCRID; 3101HUMTCHu8
DR   Cell_Model_Passport; SIDM00899
DR   CGH-DB; 160-1
DR   CGH-DB; 9271-4
DR   ChEMBL-Cells; CHEMBL3307994
DR   ChEMBL-Targets; CHEMBL612588
DR   CLS; 300158
DR   Cosmic; 707247
DR   Cosmic; 710851
DR   Cosmic; 724645
DR   Cosmic; 808166
DR   Cosmic; 868239
DR   Cosmic; 872994
DR   Cosmic; 910702
DR   Cosmic; 913308
DR   Cosmic; 918050
DR   Cosmic; 922255
DR   Cosmic; 923164
DR   Cosmic; 932514
DR   Cosmic; 933515
DR   Cosmic; 947398
DR   Cosmic; 948371
DR   Cosmic; 948740
DR   Cosmic; 949230
DR   Cosmic; 1006364
DR   Cosmic; 1090374
DR   Cosmic; 1108341
DR   Cosmic; 1198210
DR   Cosmic; 1320465
DR   Cosmic; 1366285
DR   Cosmic; 1477433
DR   Cosmic; 1571783
DR   Cosmic; 1644318
DR   Cosmic; 1995341
DR   Cosmic; 2434085
DR   Cosmic; 2668289
DR   Cosmic-CLP; 910702
DR   DepMap; ACH-000222
DR   ECACC; 96020930
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910702
DR   GEO; GSM206446
DR   GEO; GSM383935
DR   GEO; GSM495808
DR   GEO; GSM621911
DR   GEO; GSM784702
DR   GEO; GSM886870
DR   GEO; GSM887935
DR   GEO; GSM1024396
DR   GEO; GSM1177959
DR   GEO; GSM1177960
DR   GEO; GSM1177961
DR   GEO; GSM1374394
DR   GEO; GSM1374395
DR   GEO; GSM1374396
DR   GEO; GSM1588607
DR   GEO; GSM1588619
DR   GEO; GSM1669603
DR   GEO; GSM1906985
DR   GEO; GSM1906986
DR   GEO; GSM1906987
DR   IARC_TP53; 311
DR   IARC_TP53; 21127
DR   IBRC; C10154
DR   IGRhCellID; AsPC1
DR   IZSLER; BS TCL 171
DR   KCLB; 21682
DR   LiGeA; CCLE_008
DR   LINCS_LDP; LCL-1730
DR   NCBI_Iran; C558
DR   PharmacoDB; AsPC1_67_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   PRIDE; PXD032263
DR   Progenetix; CVCL_0152
DR   PubChem_Cell_line; CVCL_0152
DR   SKY/M-FISH/CGH; 1997
DR   Wikidata; Q54750736
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/2324-9293.1000104;
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=1630814;
RX   PubMed=1764370;
RX   PubMed=4023565;
RX   PubMed=6582512;
RX   PubMed=7182348;
RX   PubMed=7972006;
RX   PubMed=8026879;
RX   PubMed=8194712;
RX   PubMed=8286197;
RX   PubMed=9331070;
RX   PubMed=9665481;
RX   PubMed=10027410;
RX   PubMed=10408907;
RX   PubMed=11115575;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12692724;
RX   PubMed=14695172;
RX   PubMed=15126341;
RX   PubMed=15367885;
RX   PubMed=15688027;
RX   PubMed=15770730;
RX   PubMed=16912165;
RX   PubMed=18298655;
RX   PubMed=18380791;
RX   PubMed=20037478;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20418756;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26586397;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=27910856;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32782605;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/AsPC1.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=66
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/pancreatic-xenograft-models/aspc-1-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~38-40 hours (PubMed=7182348); 46 hours (PubMed=25984343).
CC   HLA typing: A*01:01,26:01; B*15:01,15:01; C*03:04,03:04 (PubMed=26589293).
CC   HLA typing: A*01:01:01,02:01:01; B*15:01:01; C*03:03:01,03:04:01; DPB1*04:01:01G,10:01:01G; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:04:01; DRB1*04:01:01,13:02:01 (CLS=300158).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (PubMed=9331070).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (PubMed=11787853; DepMap=ACH-000222).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=8026879; PubMed=11115575; PubMed=11169959; PubMed=11787853; PubMed=15367885; PubMed=21607521; Cosmic-CLP=910702; DepMap=ACH-000222).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (PubMed=10408907; PubMed=18380791; Cosmic-CLP=910702; DepMap=ACH-000222).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (PubMed=8026879; PubMed=11169959; PubMed=11787853; PubMed=15367885; PubMed=21607521; Cosmic-CLP=910702; DepMap=ACH-000222).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.97%; Native American=0%; East Asian, North=3.23%; East Asian, South=0%; South Asian=0%; European, North=58.23%; European, South=37.57% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at c.818G>A in PubMed=1630814.
CC   Misspelling: ASPC; GEO=GSM383935.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-1682; CCRID; CLS=300158; Cosmic-CLP=910702; ECACC=96020930; IZSLER=BS TCL 171; KCLB=21682; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,13 (ATCC=CRL-1682; CCRID; CLS=300158; Cosmic-CLP=910702; IZSLER=BS TCL 171; KCLB=21682; PubMed=25877200; Technion Genomics Center)
ST   CSF1PO: 11,13 (ECACC=96020930)
ST   D10S1248: 13,14
ST   D12S391: 19
ST   D13S317: 9,12 (ATCC=CRL-1682; CCRID; Cosmic-CLP=910702; ECACC=96020930; IZSLER=BS TCL 171; KCLB=21682; PubMed=25877200; Technion Genomics Center)
ST   D13S317: 12 (CLS=300158)
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 14
ST   D1S1656: 12,18.3
ST   D21S11: 28,30
ST   D22S1045: 15
ST   D2S1338: 22,23
ST   D2S441: 11,14
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 11,20
ST   D7S820: 12,13
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 5,12
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   AsPC-1 SPINK1 #10
AC   CVCL_C3NE
DR   ABM; T3154
DR   Wikidata; Q116048527
RX   PubMed=26586397;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral CMV-SPINK1-2A-eGFP construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11244; SPINK1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   AsPC-1/CMV-Luc
AC   CVCL_J243
DR   cancercelllines; CVCL_J243
DR   JCRB; JCRB1454
DR   JCRB; NIHS0697
DR   Wikidata; Q54750738
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1454).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0697; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1454
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 27
//
ID   ASPC-3L
AC   CVCL_B7RF
DR   Wikidata; Q112929240
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   AsPC1-R
AC   CVCL_XX79
DR   cancercelllines; CVCL_XX79
DR   GEO; GSM1906988
DR   GEO; GSM1906989
DR   GEO; GSM1906990
DR   Wikidata; Q93326176
RX   PubMed=27910856;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   AsPC1/GFP
AC   CVCL_E6XM
SY   AsPC1 / GFP
WW   Provider; GenTarget; SC062-G; https://www.gentarget.com/product/human-aspc1-gfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-eGFP-Rsv-PuroR construct (GenTarget=SC062-G).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   AsPC1/Luciferase-2A-GFP
AC   CVCL_E6XP
SY   AsPC1 / Luciferase & GFP
WW   Provider; GenTarget; SC062-LG; https://www.gentarget.com/product/human-aspc1-luciferase-gfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-2A-eGFP-Rsv-PuroR construct (GenTarget=SC062-LG).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   AsPC1/RFP
AC   CVCL_E6XN
SY   AsPC1 / RFP
WW   Provider; GenTarget; SC062-R; https://www.gentarget.com/product/human-aspc1-rfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-RFP-Rsv-PuroR construct (GenTarget=SC062-R).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ASPS-1
AC   CVCL_S738
SY   Alveolar Soft Part Sarcoma-1
DR   GEO; GSM1676317
DR   GEO; GSM1701624
DR   NCI-DTP; ASPS-1
DR   Wikidata; Q54750740
RX   PubMed=21552147;
RX   PubMed=26351324;
RX   PubMed=32596059;
CC   Doubling time: ~3 days (PubMed=21552147).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13825; ASPSCR1 + HGNC; HGNC:11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3 (PubMed=21552147).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3750; Alveolar soft part sarcoma
DI   ORDO; Orphanet_163699; Alveolar soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   ASPS-KY
AC   CVCL_S737
DR   cancercelllines; CVCL_S737
DR   Cosmic; 1333043
DR   Wikidata; Q54750743
RX   CelloPub=CLPUB00020;
RX   PubMed=19380023;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13825; ASPSCR1 + HGNC; HGNC:11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3 (PubMed=19380023).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala189Val (c.566C>T); ClinVar=VCV000012382; Zygosity=Unspecified (CelloPub=CLPUB00020).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (CelloPub=CLPUB00020).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3750; Alveolar soft part sarcoma
DI   ORDO; Orphanet_163699; Alveolar soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   Asra-EPS
AC   CVCL_W949
DR   Wikidata; Q54750744
RX   PubMed=23915498;
CC   Doubling time: 38 hours (PubMed=23915498).
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   AST [Human LCL]
AC   CVCL_B7M1
DR   Wikidata; Q112929241
RX   PubMed=10663561;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu1051_Asp1078del (c.3153_3236del84); Zygosity=Heterozygous (PubMed=10663561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   AST [Human neuroblastoma]
AC   CVCL_S100
DR   Wikidata; Q54750779
RX   PubMed=7073944;
CC   Doubling time: 40.7 hours (PubMed=7073944).
CC   Derived from site: In situ; Chest; UBERON=UBERON_0001443.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   Ast-1
AC   CVCL_LK72
SY   AST-1; Astrocytoma-1
DR   Wikidata; Q54750782
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   AST-1
AC   CVCL_0G16
DR   Wikidata; Q54750784
RX   PubMed=1319986;
RX   PubMed=9738977;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=1319986).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   Ast718
AC   CVCL_A3BB
SY   AST 718
DR   Wikidata; Q105506420
RX   PubMed=7623068;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   Ast812
AC   CVCL_A3BA
SY   AST 812
DR   Wikidata; Q105506424
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7623068;
RX   PubMed=9268730;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   ASTC-a-1
AC   CVCL_C867
SY   ASTCa1
DR   BTO; BTO_0005015
DR   Wikidata; Q54750797
RX   PubMed=15958279;
RX   PubMed=20714087;
CC   From: Department of Medicine; Jinan University; China.
CC   Population: Chinese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   ASTC-a-1 SCAT3
AC   CVCL_A8JW
DR   Wikidata; Q108819857
RX   PubMed=15958279;
RX   PubMed=20714087;
CC   Population: Chinese.
CC   Characteristics: Transfected with the SCAT3 reporter for caspase activation. SCAT3 comprises the ECFP (enhanced cyan fluorescent protein) and Venus proteins linked by an 18 amino acid peptide that includes DEVD, a CASP3 cleavage sequence.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 27HOS; ECFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C867 ! ASTC-a-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   Astro 1
AC   CVCL_6A98
DR   Wikidata; Q54750786
RX   PubMed=8365576;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <10D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   Astro 2
AC   CVCL_6A99
DR   Wikidata; Q54750787
RX   PubMed=8365576;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <10D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   Astro 3
AC   CVCL_6B00
DR   Wikidata; Q54750790
RX   PubMed=8365576;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <10D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   Astro 4
AC   CVCL_6B01
DR   Wikidata; Q54750791
RX   PubMed=8365576;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <10D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   Astro.4U
AC   CVCL_AQ52
DR   Wikidata; Q54750793
RX   PubMed=32150624;
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20170912220829/http://axiogenesis.com/products/neuronal-cells/astro-4u-hipsc-astrocytes.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E61 ! Dopa.4U
OI   CVCL_1E62 ! Peri.4U
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 6
//
ID   ASUi001-A
AC   CVCL_QY80
SY   ASU-160; 160-IPSC
DR   BioSamples; SAMEA104237464
DR   hPSCreg; ASUi001-A
DR   Wikidata; Q54750799
RX   PubMed=29034886;
CC   From: Arizona State University; Tempe; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=29034886).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ASUi002-A
AC   CVCL_QY81
SY   ASU-384; 384-IPSC
DR   hPSCreg; ASUi002-A
DR   Wikidata; Q54750801
RX   PubMed=29034886;
CC   From: Arizona State University; Tempe; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=29034886).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   ASUi003-A
AC   CVCL_VE13
SY   ASUi003; ASU-188; 188-iPSC
DR   hPSCreg; ASUi003-A
DR   SKIP; SKIP003088
DR   Wikidata; Q54750803
RX   PubMed=29246571;
CC   From: Arizona State University; Tempe; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=29246571).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   ASUi004-A
AC   CVCL_VE14
SY   ASUi004; ASU-414; 414-iPSC
DR   hPSCreg; ASUi004-A
DR   SKIP; SKIP003090
DR   Wikidata; Q54750807
RX   PubMed=29246571;
CC   From: Arizona State University; Tempe; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=29246571).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   ASUi005-A
AC   CVCL_UD82
SY   ASU-161
DR   hPSCreg; ASUi005-A
DR   Wikidata; Q93326225
RX   PubMed=30296667;
CC   From: Arizona State University; Tempe; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=30296667).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   ASUi006-A
AC   CVCL_UD83
SY   ASU-487
DR   hPSCreg; ASUi006-A
DR   Wikidata; Q93326227
RX   PubMed=30296667;
CC   From: Arizona State University; Tempe; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=30296667).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   ASZ001
AC   CVCL_6251
DR   Lonza; 778
DR   Wikidata; Q54750808
RX   PubMed=16881970;
CC   Knockout cell: Method=KO mouse; MGI; MGI:105373; Ptch1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: Ptch1tm1Mps/J.
DI   NCIt; C134570; Mouse basal cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   AT
AC   CVCL_E462
SY   Extract 444
DR   dbMHC; 48480
DR   ECACC; 94022523
DR   IHW; IHW09221
DR   IPD-IMGT/HLA; 10268
DR   Wikidata; Q54750810
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/339cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:06; B*59:01,51:01; C*01:02,14; DPB1*02:01:02 (IPD-IMGT/HLA=10268).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   AT 36-38
AC   CVCL_A0UR
SY   AT36-38; 38D7
DR   CCRID; 4201PAT-CCTCC01301
DR   Wikidata; Q108819858
RX   Patent=CN110054688B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018196.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A6NLP5; Human TTC36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   AT(L)5KY
AC   CVCL_2857
DR   JCRB; JCRB0331
DR   JCRB; KURB1795
DR   Wikidata; Q54750811
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Heterozygous (from autologous cell line AT5KY).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Incorrectly indicated as originating from a male patient in JCRB=KURB1795.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0331
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D5S818: 10,14
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G64 ! AT5KY
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   AT(L)6KY
AC   CVCL_2858
DR   BioSample; SAMN03471622
DR   JCRB; JCRB0332
DR   JCRB; KURB1800
DR   Wikidata; Q54750813
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.332del165 (g.484C>T) (Ex7del); Zygosity=Heterozygous (from autologous cell line AT6KY).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0332
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G66 ! AT6KY
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   AT(L)7KY
AC   CVCL_2859
DR   BioSample; SAMN03471624
DR   JCRB; JCRB0333
DR   JCRB; KURB1806
DR   Wikidata; Q54750816
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Virology: Infected by human herpesvirus 7 (HHV-7) (PubMed=29892436).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.2125del126 (Ex16del); Zygosity=Heterozygous (from autologous cell line AT7KY).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; KURB1806; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0333
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 9,12
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G68 ! AT7KY
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   AT(L)7KYM
AC   CVCL_JK47
DR   JCRB; KURB1809
DR   Wikidata; Q54750818
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (from autologous cell line AT7KYM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JK48 ! AT7KYM
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   AT-1 [Human ataxia telangiectasia]
AC   CVCL_6271
DR   Lonza; 739
DR   Wikidata; Q54750820
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   AT-1 [Mouse cardiomyocyte]
AC   CVCL_JK52
DR   Wikidata; Q54750822
RX   PubMed=1954678;
RX   PubMed=10908350;
CC   Characteristics: From transgenic mice expressing a fusion gene comprised of the atrial natriuretic factor (ANF) promoter and the SV40 early region.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, left atrium; UBERON=UBERON_0002079.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: C3HeB/FeJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0303 ! HL-1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   AT-2
AC   CVCL_JK53
DR   Wikidata; Q54750828
RX   PubMed=1377879;
RX   PubMed=8498581;
RX   PubMed=10908350;
CC   Characteristics: From transgenic mice expressing a fusion gene comprised of the rat alpha-cardiac myosin heavy chain promoter and the SV40 early region (MHC-TAG).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: C3HeB/FeJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   AT-3
AC   CVCL_VR89
DR   ABM; T8054
DR   Millipore; SCC178
DR   Wikidata; Q93326263
RX   PubMed=17709499;
WW   Provider; NCI TTC; TAB-4380/E-240-2016-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4380
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: B6.FVB-Tg(MMTV-PyVT)634Mul/LellJ (MTAG).
ST   Source(s): Millipore=SCC178
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   AT-LD2
AC   CVCL_VL02
SY   ATLD2
DR   Wikidata; Q93326264
RX   PubMed=10612394;
RX   PubMed=12446774;
RX   PubMed=15574327;
CC   Sequence variation: Mutation; HGNC; HGNC:7230; MRE11; Simple; p.Arg633Ter (c.1897C>T); ClinVar=VCV000008782; Zygosity=Homozygous (PubMed=10612394).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C132224; Ataxia-telangiectasia-like disorder 1
DI   ORDO; Orphanet_251347; Ataxia-telangiectasia-like disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   AT-LD2-hTERT
AC   CVCL_VL03
DR   Wikidata; Q93326265
RX   PubMed=12446774;
CC   Sequence variation: Mutation; HGNC; HGNC:7230; MRE11; Simple; p.Arg633Ter (c.1897C>T); ClinVar=VCV000008782; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C132224; Ataxia-telangiectasia-like disorder 1
DI   ORDO; Orphanet_251347; Ataxia-telangiectasia-like disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VL02 ! AT-LD2
SX   Male
AG   20Y
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   AT-MS-1
AC   CVCL_W198
DR   Wikidata; Q54750831
RX   PubMed=3572602;
RX   PubMed=3761063;
CC   Population: Japanese.
CC   Doubling time: ~43 hours (PubMed=3761063).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   AT-PDH1TKB
AC   CVCL_L558
DR   CLO; CLO_0050715
DR   BioSample; SAMN03472287
DR   RCB; RCB0546
DR   Wikidata; Q54750833
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0546
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C103968; Pyruvate dehydrogenase deficiency
DI   ORDO; Orphanet_765; Pyruvate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 12
//
ID   AT101RM
AC   CVCL_XX61
SY   Ataxia Telangiectasia 101 RoMa
DR   Wikidata; Q93326267
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp488Ter (c.1463G>A); ClinVar=VCV000246090; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT105RM
AC   CVCL_XY14
SY   Ataxia Telangiectasia 105 RoMa
DR   Wikidata; Q93326268
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1267_Val1268insTer (c.3802delG) (p.Val1268Terfs); ClinVar=VCV000127374; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT106RM
AC   CVCL_XX60
SY   Ataxia Telangiectasia 106 RoMa
DR   Wikidata; Q93326269
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.His231Arg (c.692A>G); ClinVar=VCV000142096; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT12RM
AC   CVCL_XY54
SY   Ataxia Telangiectasia 12 RoMa
DR   Wikidata; Q93326270
RX   PubMed=8845835;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8269del403; Zygosity=Homozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT13ABR
AC   CVCL_IW68
SY   Ataxia Telangiectasia 13 Australia BRisbane
DR   Wikidata; Q54750835
RX   PubMed=9150358;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   AT13LA
AC   CVCL_1L72
SY   Ataxia Telangiectasia 13 Los Angeles; GM13328
DR   CLO; CLO_0013246
DR   BioSample; SAMN00802307
DR   Coriell; GM13328
DR   Wikidata; Q54846465
RX   PubMed=8808599;
RX   PubMed=16166284;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1921Ter (c.5763-1050A>G) (IVS40+1126A>G) (5762ins137); ClinVar=VCV000003021; Zygosity=Heterozygous (PubMed=8808599).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.7630-2A>C (IVS53-2A>C) (IVS51-2A>C) (L2544del53); ClinVar=VCV000127447; Zygosity=Heterozygous; Note=Causes in-frame skipping of exon 54 (Leu2544del53) (PubMed=8808599).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 18
//
ID   AT13RM
AC   CVCL_XX52
SY   Ataxia Telangiectasia 13 RoMa
DR   Wikidata; Q93326271
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Tyr731Ter (c.2192dupA); ClinVar=VCV000633063; Zygosity=Heterozygous (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2849Ter (c.8545C>T); ClinVar=VCV000133637; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT14LA
AC   CVCL_1L65
SY   Ataxia Telangiectasia 14 Los Angeles; GM11255
DR   CLO; CLO_0025959
DR   Coriell; GM11255
DR   Wikidata; Q54844942
RX   PubMed=16166284;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu2007Argfs*11 (c.6015dupC) (6015insC); ClinVar=VCV000490638; Zygosity=Heterozygous (Coriell=GM11255).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser2855_Val2856delinsArgIle (c.8565_8566delTGinsAA) (8565TG>AA); ClinVar=VCV000140897; Zygosity=Heterozygous (Coriell=GM11255).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   AT14RM
AC   CVCL_XX54
SY   Ataxia Telangiectasia 14 RoMa
DR   Wikidata; Q93326272
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.3109delG; Zygosity=Heterozygous (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Met2384fs*1 (c.7146delA); Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT15RM
AC   CVCL_XF16
SY   Ataxia Telangiectasia 15 RoMa
DR   Wikidata; Q93326273
RX   PubMed=10864201;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu43Leu (c.129T>C); Zygosity=Heterozygous (PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   AT16LA
AC   CVCL_1L71
SY   Ataxia Telangiectasia 16 Los Angeles; GM13326
DR   CLO; CLO_0013248
DR   BioSample; SAMN00802303
DR   Coriell; GM13326
DR   Wikidata; Q54846463
RX   PubMed=8808599;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp393_Glu394delinsTer (c.1179_1180delGG) (p.Trp393Terfs); ClinVar=VCV000231937; Zygosity=Heterozygous (PubMed=8808599).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Heterozygous (PubMed=8808599).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   AT16RM
AC   CVCL_XX59
SY   Ataxia Telangiectasia 16 RoMa
DR   Wikidata; Q93326274
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu43Pro (c.128T>C); Zygosity=Heterozygous (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4842delA; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT17BI
AC   CVCL_D5IB
DR   JCRB; KURB1824
DR   Wikidata; Q127380239
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AT17BISV
AC   CVCL_D5IC
DR   JCRB; JCRB3080
DR   JCRB; KURB1825
DR   Wikidata; Q127380240
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: JCRB; KURB1825; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3080
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5IB ! AT17BI
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   AT181TO
AC   CVCL_ZS13
SY   Ataxia Telangiectasia 181 TOronto
DR   Wikidata; Q98125500
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   AT18RM
AC   CVCL_XX57
SY   Ataxia Telangiectasia 18 RoMa
DR   Wikidata; Q93326275
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ala1299Cysfs*3 (c.3894dupT); ClinVar=VCV000141534; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT19RM
AC   CVCL_XY21
SY   Ataxia Telangiectasia 19 RoMa
DR   Wikidata; Q93326277
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2993Ter (c.8977C>T); ClinVar=VCV000186330; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT1ABR
AC   CVCL_M911
SY   Ataxia Telangiectasia 1 Australia BRisbane
DR   BTO; BTO_0006125
DR   Wikidata; Q54750838
RX   PubMed=2836804;
RX   PubMed=6197197;
RX   PubMed=6228733;
RX   PubMed=6504056;
RX   PubMed=7433105;
RX   PubMed=7792600;
RX   PubMed=8845835;
RX   PubMed=9150358;
RX   PubMed=9168117;
RX   PubMed=11080496;
RX   PubMed=12195425;
RX   PubMed=16166284;
RX   PubMed=21149446;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Homozygous (PubMed=7792600; PubMed=9150358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   AT1BE
AC   CVCL_X707
SY   Ataxia Telangiectasia 1 BEthesda
DR   ATCC; CRL-1312
DR   Wikidata; Q54750839
RX   PubMed=865488;
CC   Discontinued: ATCC; CRL-1312; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 8
//
ID   AT1BI
AC   CVCL_WX42
SY   Ataxia Telangiectasia 1 BIrmingham
DR   Wikidata; Q93326278
RX   PubMed=837385;
RX   PubMed=1196376;
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AT1BR
AC   CVCL_WX69
SY   AT1Br; AT1 BR; Ataxia Telangiectasia 1 BRighton; BM0020
DR   Wikidata; Q93326280
RX   PubMed=2903889;
RX   PubMed=7836839;
RX   PubMed=10987302;
RX   PubMed=11452007;
RX   PubMed=12082606;
RX   PubMed=15574327;
RX   PubMed=16714754;
RX   PubMed=16874298;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT25 ! AT1BR LCL
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AT1BR LCL
AC   CVCL_ZT25
SY   Ataxia Telangiectasia 1 BRighton LCL; LB57; 57
DR   Wikidata; Q98125501
RX   PubMed=7836839;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX69 ! AT1BR
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AT1BR44neo
AC   CVCL_C1HN
SY   AT1BR44 neo
DR   Wikidata; Q114310633
RX   CelloPub=CLPUB00712;
RX   PubMed=9357546;
RX   PubMed=19935656;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WX69 ! AT1BR
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   AT1KY
AC   CVCL_RW78
SY   Ataxia Telangiectasia 1 KYoto
DR   JCRB; KURB1773
DR   Wikidata; Q54750842
RX   PubMed=9600235;
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (PubMed=9600235).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2629Serfs*24 (c.7881_7885TATTA[1]) (c.7883_7887delTTATA); ClinVar=VCV000230200; Zygosity=Heterozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   AT1KY TERT
AC   CVCL_RW79
SY   AT1KY/TERT
DR   JCRB; JCRB3059
DR   JCRB; KURB1774
DR   Wikidata; Q54750844
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2629Serfs*24 (c.7881_7885TATTA[1]) (c.7883_7887delTTATA); ClinVar=VCV000230200; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; KURB1774; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3059
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 10
ST   D7S820: 9,12
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW78 ! AT1KY
SX   Female
AG   7Y
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   AT1KYF
AC   CVCL_RW84
SY   FAT1/2KY; Ataxia Telangiectasia 1/2 KYoto Father
DR   JCRB; KURB1781
DR   Wikidata; Q54750846
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2629Serfs*24 (c.7881_7885TATTA[1]) (c.7883_7887delTTATA); ClinVar=VCV000230200; Zygosity=Heterozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   AT1KYM
AC   CVCL_RW82
SY   MAT1/2KY; Ataxia Telangiectasia 1/2 KYoto Mother
DR   JCRB; KURB1783
DR   Wikidata; Q54750848
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   AT1LA
AC   CVCL_1L67
SY   Ataxia Telangiectasia 1 Los Angeles; GM11260
DR   CLO; CLO_0025961
DR   Coriell; GM11260
DR   Wikidata; Q54844944
RX   PubMed=16166284;
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   AT1LO
AC   CVCL_ZS12
SY   Ataxia Telangiectasia 1 LOndon
DR   Wikidata; Q98125502
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AT1OS
AC   CVCL_2860
SY   Ataxia Telangiectasia 1 OSaka
DR   BioSample; SAMN03471616
DR   JCRB; JCRB0308
DR   Wikidata; Q54750849
RX   PubMed=6876478;
RX   PubMed=9600235;
RX   PubMed=14570874;
RX   PubMed=27197874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (PubMed=9600235).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0308
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,12
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   AT1OS SV
AC   CVCL_ZY35
DR   JCRB; KURB3011
DR   Wikidata; Q102113570
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2860 ! AT1OS
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   AT1OS TERT
AC   CVCL_RW89
SY   AT1OS/TERT
DR   JCRB; KURB1768
DR   Wikidata; Q54750852
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2860 ! AT1OS
SX   Male
AG   10Y
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   AT1OS(SVT)-1
AC   CVCL_D5IA
DR   JCRB; JCRB3076
DR   JCRB; KURB1766
DR   Wikidata; Q127380241
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,12
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2860 ! AT1OS
SX   Male
AG   10Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   AT1PX
AC   CVCL_1L49
SY   GM07481; GM07481A
DR   CLO; CLO_0016486
DR   Coriell; GM07481
DR   Wikidata; Q54842782
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AT21RM
AC   CVCL_XF17
SY   Ataxia Telangiectasia 21 RoMa
DR   Wikidata; Q93326284
RX   PubMed=8845835;
RX   PubMed=10864201;
RX   PubMed=17124347;
RX   PubMed=25942615;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Unexplicit; IVS18+1delG (p.Lys793_Leu822del30, c.2377_2466del90); Zygosity=Homozygous (PubMed=8845835; PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT22IJE-T
AC   CVCL_D566
DR   Wikidata; Q54750854
RX   PubMed=2539904;
RX   PubMed=9244351;
RX   PubMed=9357546;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu762Valfs*2 (c.2282_2283CT[1]) (c.2284_2285delCT); ClinVar=VCV000141325; Zygosity=Unspecified (PubMed=9244351).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   AT22IJE-T pEBS7
AC   CVCL_F635
SY   GM16666; pEBS
DR   CLO; CLO_0017459
DR   Coriell; GM16666
DR   Wikidata; Q54848692
RX   PubMed=9244351;
RX   PubMed=19962312;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu762Valfs*2 (c.2282_2283CT[1]) (c.2284_2285delCT); ClinVar=VCV000141325; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D566 ! AT22IJE-T
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   AT22IJE-T pEBS7-YZ3
AC   CVCL_XG29
SY   YZ3
DR   Wikidata; Q93326286
RX   PubMed=9244351;
RX   PubMed=19962312;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:795; ATM.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D566 ! AT22IJE-T
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   AT22IJE-T pEBS7-YZ5
AC   CVCL_F636
SY   GM16667; YZ5
DR   CLO; CLO_0017460
DR   Coriell; GM16667
DR   Wikidata; Q54848694
RX   PubMed=9244351;
RX   PubMed=19962312;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:795; ATM.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D566 ! AT22IJE-T
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   AT22RM
AC   CVCL_XY47
SY   Ataxia Telangiectasia 22 RoMa
DR   Wikidata; Q93326287
RX   PubMed=8845835;
RX   PubMed=9050866;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2506Thrfs (c.7517_7520delGAGA) (7517del4); Zygosity=Homozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT24
AC   CVCL_M974
SY   A-T24
DR   Wikidata; Q54750855
RX   PubMed=12080467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   AT24RM
AC   CVCL_WW18
SY   Ataxia Telangiectasia 24 RoMa
DR   Wikidata; Q93326289
RX   PubMed=8845835;
RX   PubMed=9244351;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Cys252_Glu253delinsTer (c.756_757delTG) (p.Cys252Terfs); ClinVar=VCV000231178; Zygosity=Homozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT25ABR
AC   CVCL_VL07
SY   Ataxia Telangiectasia 25 Australia BRisbane
DR   BTO; BTO_0006126
DR   Wikidata; Q93326290
RX   PubMed=21149446;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   AT25BI
AC   CVCL_ZN48
SY   Ataxia Telangiectasia 25 BIrmingham
DR   Wikidata; Q98125503
RX   PubMed=2903889;
RX   PubMed=7836839;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT27 ! AT25BI LCL
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   AT25BI LCL
AC   CVCL_ZT27
SY   Ataxia Telangiectasia 25 BIrmingham LCL; LB108; 108
DR   Wikidata; Q98125504
RX   PubMed=7836839;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN48 ! AT25BI
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AT25RM
AC   CVCL_XY10
SY   Ataxia Telangiectasia 25 RoMa
DR   Wikidata; Q93326291
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Val835Serfs*7 (c.2502dupA) (2501insA); ClinVar=VCV000127351; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT26RM
AC   CVCL_XX50
SY   Ataxia Telangiectasia 26 RoMa
DR   Wikidata; Q93326292
RX   PubMed=8845835;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln414Ter (c.1240C>T); ClinVar=VCV000236671; Zygosity=Heterozygous (PubMed=8845835; PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT27RM
AC   CVCL_XF18
SY   Ataxia Telangiectasia 27 RoMa
DR   Wikidata; Q93326294
RX   PubMed=10864201;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   AT27RMO
AC   CVCL_IW73
SY   Ataxia Telangiectasia 27 Russia MOscow
DR   Wikidata; Q54750859
RX   PubMed=9150358;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Homozygous (PubMed=9150358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   AT28RM
AC   CVCL_XF19
SY   Ataxia Telangiectasia 28 RoMa
DR   Wikidata; Q93326301
RX   PubMed=8845835;
RX   PubMed=10864201;
RX   PubMed=17124347;
RX   PubMed=25942615;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2598Ter (c.7792C>T); ClinVar=VCV000265383; Zygosity=Heterozygous (PubMed=10864201).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2762Alafs*6 (c.8283_8284delTC); ClinVar=VCV000482713; Zygosity=Heterozygous (PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   AT29RM
AC   CVCL_XY48
SY   Ataxia Telangiectasia 29 RoMa
DR   Wikidata; Q93326303
RX   PubMed=8845835;
RX   PubMed=9050866;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro1480Tyrfs*5 (c.4611_4611+9del10) (c.4437_4611del175); Zygosity=Homozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT2ABR
AC   CVCL_IW69
SY   Ataxia Telangiectasia 2 Australia BRisbane
DR   Wikidata; Q54750861
RX   PubMed=2825700;
RX   PubMed=6197197;
RX   PubMed=7433105;
RX   PubMed=7792600;
RX   PubMed=9150358;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Homozygous (PubMed=7792600; PubMed=9150358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   AT2BE
AC   CVCL_V560
SY   Ataxia Telangiectasia 2 BEthesda; Se Pan
DR   ATCC; CRL-1343
DR   Wikidata; Q54750862
RX   PubMed=643622;
RX   PubMed=865488;
RX   PubMed=2973075;
RX   PubMed=3337113;
RX   PubMed=6810166;
RX   PubMed=7374661;
RX   PubMed=7471105;
RX   PubMed=9650596;
CC   Discontinued: ATCC; CRL-1343; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   AT2BI LCL
AC   CVCL_7321
SY   Ataxia Telangiectasia 2 BIrmingham LCL; GM01525; GM-1525; GM 1525; GM1525; GM01525C; GM-1525C; GM 1525C
DR   CLO; CLO_0031475
DR   BioSample; SAMN00806892
DR   Coriell; GM01525
DR   JCRB; KURB1106
DR   Wikidata; Q54836882
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=837385;
RX   PubMed=1561323;
RX   PubMed=6197197;
RX   PubMed=7539412;
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2136Ter (c.6404_6405insTT) (p.Leu2135_Arg2136insTer) (6404insTT); ClinVar=VCV000220763; Zygosity=Heterozygous (Coriell=GM01525).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: GM1524; Note=In Patent US5955279.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 28
//
ID   AT2BR
AC   CVCL_WY25
SY   Ataxia Telangiectasia 2 BRighton
DR   Wikidata; Q93326315
RX   PubMed=2903889;
RX   PubMed=7792600;
RX   PubMed=7836839;
RX   PubMed=10987302;
RX   PubMed=16714754;
RX   PubMed=18079351;
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Homozygous (PubMed=7792600).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2564 ! AT2BR LCL
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   AT2BR LCL
AC   CVCL_2564
SY   Ataxia Telangiectasia 2 BRighton LCL; LB58; 58
DR   ECACC; 98062325
DR   Wikidata; Q54902072
RX   PubMed=7836839;
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Homozygous (from autologous cell line AT2BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY25 ! AT2BR
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   AT2EM
AC   CVCL_A1JX
DR   Wikidata; Q102113571
RX   PubMed=8609460;
CC   Doubling time: 90 hours (PubMed=8609460).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   AT2KY
AC   CVCL_2861
SY   Ataxia Telangiectasia 2 KYoto
DR   BioSample; SAMN03471619
DR   JCRB; JCRB0316
DR   JCRB; KURB1777
DR   JCRB; KURB1778
DR   Wikidata; Q54750865
RX   PubMed=1978855;
RX   PubMed=8845835;
RX   PubMed=9600235;
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (PubMed=9600235).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2629Serfs*24 (c.7881_7885TATTA[1]) (c.7883_7887delTTATA); ClinVar=VCV000230200; Zygosity=Heterozygous (PubMed=9600235).
CC   Misspelling: JCRB316; Note=Based on the JCRB catalog number.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0316
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 9,12
ST   vWA: 18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   AT2KY TERT
AC   CVCL_L457
SY   AT2KY/TERT
DR   JCRB; KURB1779
DR   Wikidata; Q54750906
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2629Serfs*24 (c.7881_7885TATTA[1]) (c.7883_7887delTTATA); ClinVar=VCV000230200; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2861 ! AT2KY
SX   Female
AG   4Y
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 18
//
ID   AT2KYSV
AC   CVCL_RW85
DR   JCRB; JCRB3061
DR   JCRB; KURB1780
DR   Wikidata; Q54750907
RX   PubMed=1944350;
RX   PubMed=1978855;
CC   Population: Japanese.
CC   Doubling time: 23 hours (Note=At 135th passage) (PubMed=1978855).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2629Serfs*24 (c.7881_7885TATTA[1]) (c.7883_7887delTTATA); ClinVar=VCV000230200; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: JCRB; KURB1780; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3061
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 9,12
ST   vWA: 18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2861 ! AT2KY
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 18
//
ID   AT2KYSVTG
AC   CVCL_D5ID
DR   Wikidata; Q127380242
RX   PubMed=1944350;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2629Serfs*24 (c.7881_7885TATTA[1]) (c.7883_7887delTTATA); ClinVar=VCV000230200; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW85 ! AT2KYSV
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 5
//
ID   AT2LA
AC   CVCL_1L63
SY   Ataxia Telangiectasia 2 Los Angeles; GM11253
DR   CLO; CLO_0022967
DR   Coriell; GM11253
DR   Wikidata; Q54844940
RX   PubMed=16166284;
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   AT2SF
AC   CVCL_V575
SY   Ataxia Telangiectasia 2 San Fransisco
DR   Wikidata; Q54750909
RX   PubMed=2903889;
RX   PubMed=2987007;
RX   PubMed=8845835;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Phe1774Lysfs*17 (c.5320_5326del) (c.5320del7); Zygosity=Heterozygous (PubMed=8845835).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2769Ter (c.8307G>A); ClinVar=VCV000189104; Zygosity=Heterozygous (PubMed=8845835).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   AT3'
AC   CVCL_VN46
DR   JCRB; JCRB3053
DR   JCRB; KURB2935
DR   Wikidata; Q93326322
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2935; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 9
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 8
//
ID   AT31LA
AC   CVCL_1L69
SY   Ataxia Telangiectasia 31 Los Angeles; GM11265
DR   CLO; CLO_0025970
DR   Coriell; GM11265
DR   Wikidata; Q54844947
RX   PubMed=8808599;
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1991Ter (c.5971G>T); ClinVar=VCV000453606; Zygosity=Heterozygous (Coriell=GM11265).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Heterozygous (PubMed=8808599).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   AT31RM
AC   CVCL_XF20
SY   Ataxia Telangiectasia 31 RoMa
DR   Wikidata; Q93326323
RX   PubMed=9497252;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1192Lys (c.3576G>A) (3403del174) (Ex26del); ClinVar=VCV000003035; Zygosity=Homozygous (PubMed=9497252).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   AT32RM
AC   CVCL_XF21
SY   Ataxia Telangiectasia 32 RoMa
DR   Wikidata; Q93326324
RX   PubMed=10864201;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1267_Val1268insTer (c.3802delG) (p.Val1268Terfs); ClinVar=VCV000127374; Zygosity=Homozygous (PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT34LA
AC   CVCL_1L70
SY   Ataxia Telangiectasia 34 Los Angeles; GM11266
DR   CLO; CLO_0025967
DR   Coriell; GM11266
DR   Wikidata; Q54844948
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8988-1G>C (IVS64-1G>C) (8988del13) (p.Ser2996Ter); ClinVar=VCV000181987; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM11266).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   AT35RM
AC   CVCL_XF22
SY   Ataxia Telangiectasia 35 RoMa
DR   Wikidata; Q93326326
RX   PubMed=9497252;
RX   PubMed=10864201;
RX   PubMed=12105990;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1192Lys (c.3576G>A) (3403del174) (Ex26del); ClinVar=VCV000003035; Zygosity=Heterozygous (PubMed=9497252; PubMed=10864201; PubMed=12105990).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp1858Ter (c.5574G>A); ClinVar=VCV001380184; Zygosity=Heterozygous (PubMed=9497252; PubMed=10864201; PubMed=12105990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT3ABR
AC   CVCL_M912
SY   Ataxia Telangiectasia 3 Australia BRisbane
DR   EFO; EFO_0022451
DR   Wikidata; Q54750911
RX   PubMed=2825700;
RX   PubMed=2836804;
RX   PubMed=6197197;
RX   PubMed=6228733;
RX   PubMed=6504056;
RX   PubMed=7433105;
RX   PubMed=8808599;
RX   PubMed=9150358;
RX   PubMed=9168117;
RX   PubMed=11080496;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys2756Ter (c.8266A>T); ClinVar=VCV000135780; Zygosity=Heterozygous (PubMed=9150358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   AT3B-1
AC   CVCL_3489
SY   AT3B1
DR   CLO; CLO_0001760
DR   ATCC; CRL-2375
DR   ChEMBL-Cells; CHEMBL3308085
DR   ChEMBL-Targets; CHEMBL613873
DR   PubChem_Cell_line; CVCL_3489
DR   Wikidata; Q54750914
RX   PubMed=9494564;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0146 ! R-3327-AT-3
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   AT3B-2
AC   CVCL_Y657
DR   Wikidata; Q54750915
RX   PubMed=9494564;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0146 ! R-3327-AT-3
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   AT3BE
AC   CVCL_X705
SY   AT3Be; Ataxia Telangiectasia 3 BEthesda; NeNo
DR   ATCC; CRL-1347
DR   Wikidata; Q54750917
CC   Discontinued: ATCC; CRL-1347; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 8
//
ID   AT3BI
AC   CVCL_V545
SY   Ataxia Telangiectasia 3 BIrmingham
DR   JCRB; KURB1821
DR   Wikidata; Q54750918
RX   PubMed=450131;
RX   PubMed=837385;
RX   PubMed=1196376;
RX   PubMed=2987007;
RX   PubMed=3337113;
RX   PubMed=7067035;
RX   PubMed=7471105;
RX   PubMed=7471106;
RX   PubMed=7779715;
RX   PubMed=9650596;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   AT3BISV
AC   CVCL_C1HI
DR   Wikidata; Q114310634
RX   PubMed=9357546;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V545 ! AT3BI
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   AT3BR
AC   CVCL_WX70
SY   AT 3BR; Ataxia Telangiectasia 3 BRighton; BM0026
DR   Wikidata; Q93326330
RX   PubMed=7836839;
RX   PubMed=11452007;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT65 ! AT3BR LCL
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AT3BR LCL
AC   CVCL_ZT65
SY   Ataxia Telangiectasia 3 BRighton LCL; LB62; 62
DR   Wikidata; Q98125505
RX   PubMed=7836839;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX70 ! AT3BR
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AT3KY
AC   CVCL_1G69
SY   Ataxia Telangiectasia 3 KYoto
DR   JCRB; KURB1786
DR   Wikidata; Q54750920
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1637_Leu1668del32 (c.4910del96) (Ex35del); Zygosity=Homozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   AT3KYM
AC   CVCL_RW83
SY   MAT3/4KY
DR   JCRB; KURB1789
DR   Wikidata; Q54750922
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1637_Leu1668del32 (c.4910del96) (Ex35del); Zygosity=Heterozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   AT3LA
AC   CVCL_B5ME
DR   Wikidata; Q112127961
RX   PubMed=3337113;
RX   PubMed=7792600;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M910 ! AT3LA LCL
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AT3LA LCL
AC   CVCL_M910
SY   Ataxia Telangiectasia 3 Los Angeles LCL; GM11261
DR   CLO; CLO_0025973
DR   BioSample; SAMN00800515
DR   Coriell; GM11261
DR   Wikidata; Q54844945
RX   PubMed=8808599;
RX   PubMed=9150358;
RX   PubMed=9168117;
RX   PubMed=16166284;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5ME ! AT3LA
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 17
//
ID   AT3NG
AC   CVCL_A0EV
SY   Ataxia Telangiectasia 3 NijmeGen
DR   Wikidata; Q108819859
RX   PubMed=7792600;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser2860del (c.8575TCT[1]) (c.8578_8580delTCT) (Ser1512del); ClinVar=VCV000003018; Zygosity=Homozygous (PubMed=7792600).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   AT3RM
AC   CVCL_XY12
SY   Ataxia Telangiectasia 3 RoMa
DR   Wikidata; Q93326334
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1192Lys (c.3576G>A) (3403del174) (Ex26del); ClinVar=VCV000003035; Zygosity=Heterozygous (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1615Leufs*19 (c.4842_4843insCT) (c.4842insCT); ClinVar=VCV000233353; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   AT40RM
AC   CVCL_XX55
SY   Ataxia Telangiectasia 40 RoMa
DR   Wikidata; Q93326335
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Phe1209Tyrfs*19 (c.3626_3627delTT) (3625delTT); ClinVar=VCV000187552; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT41RM
AC   CVCL_WW19
SY   Ataxia Telangiectasia 41 RoMa
DR   Wikidata; Q93326336
RX   PubMed=8845835;
RX   PubMed=9244351;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu2904Gly (c.8711A>G); ClinVar=VCV000186276; Zygosity=Homozygous (PubMed=8845835; PubMed=9244351).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT42RM
AC   CVCL_XF24
SY   Ataxia Telangiectasia 42 RoMa
DR   Wikidata; Q93326337
RX   PubMed=9497252;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1192Lys (c.3576G>A) (3403del174) (Ex26del); ClinVar=VCV000003035; Zygosity=Heterozygous (PubMed=9497252; PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp1858Ter (c.5574G>A); ClinVar=VCV001380184; Zygosity=Heterozygous (PubMed=9497252; PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   AT43RM
AC   CVCL_XF23
SY   Ataxia Telangiectasia 43 RoMa
DR   Wikidata; Q93326338
RX   PubMed=8845835;
RX   PubMed=10864201;
RX   PubMed=12105990;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2506Thrfs (c.7517_7520delGAGA) (7517del4); Zygosity=Homozygous (PubMed=8845835; PubMed=10864201; PubMed=12105990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT44RM
AC   CVCL_XF25
SY   Ataxia Telangiectasia 44 RoMa
DR   Wikidata; Q93326339
RX   PubMed=10864201;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.1607+1G>T (IVS12+1G>T); ClinVar=VCV000220555; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   AT45LA
AC   CVCL_N319
SY   Ataxia Telangiectasia 45 Los Angeles
DR   Wikidata; Q54750925
RX   PubMed=9150358;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg982fs (c.2945delT); Zygosity=Heterozygous (PubMed=9150358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   AT45RM
AC   CVCL_XY20
SY   Ataxia Telangiectasia 45 RoMa
DR   Wikidata; Q93326341
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu2945Valfs*10 (c.8833_8834delCT); ClinVar=VCV000186546; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT4ABR
AC   CVCL_N288
SY   Ataxia Telangiectasia 4 Australia BRisbane
DR   Wikidata; Q54750927
RX   PubMed=2836804;
RX   PubMed=6228733;
RX   PubMed=6504056;
RX   PubMed=7433105;
RX   PubMed=9150358;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   AT4BE
AC   CVCL_F083
SY   AT4Be; Ataxia Telangiectasia 4 BEthesda; GM03487; GM 3487; GM3487; GM03487C; GM03487E
DR   CLO; CLO_0017006
DR   BioSample; SAMN00808422
DR   Coriell; GM03487
DR   Wikidata; Q54838090
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
RX   PubMed=7104995;
RX   PubMed=11172010;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser381Argfs*27 (c.1139_1142dupACAG) (c.1141_1142ins4); ClinVar=VCV000280044; Zygosity=Heterozygous (Coriell=GM03487).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys2756Ter (c.8266A>T); ClinVar=VCV000135780; Zygosity=Heterozygous (Coriell=GM03487).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7377 ! AT4BE LCL
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   AT4BE LCL
AC   CVCL_7377
SY   AT4Be LCL; Ataxia Telangiectasia 4 BEthesda LCL; GM03189; GM-03189; GM 3189; GM3189; GM03189B; GM03189D; GM3189D
DR   CLO; CLO_0013410
DR   BioSample; SAMN00808282
DR   Coriell; GM03189
DR   GEO; GSM1116569
DR   GEO; GSM1116570
DR   GEO; GSM1116637
DR   GEO; GSM1116638
DR   GEO; GSM1116639
DR   GEO; GSM1116640
DR   Wikidata; Q54837925
RX   CelloPub=CLPUB00447;
RX   PubMed=6173245;
RX   PubMed=8808599;
RX   PubMed=16166284;
RX   PubMed=16874298;
RX   PubMed=23943852;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser381Argfs*27 (c.1139_1142dupACAG) (c.1141_1142ins4); ClinVar=VCV000280044; Zygosity=Heterozygous (Coriell=GM03189).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys2756Ter (c.8266A>T); ClinVar=VCV000135780; Zygosity=Heterozygous (Coriell=GM03189).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F083 ! AT4BE
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   AT4BI
AC   CVCL_V546
SY   Ataxia Telangiectasia 4 BIrmingham
DR   JCRB; KURB1761
DR   Wikidata; Q54750928
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=837385;
RX   PubMed=865488;
RX   PubMed=1196376;
RX   PubMed=2903889;
RX   PubMed=2973075;
RX   PubMed=3337113;
RX   PubMed=6810166;
RX   PubMed=6876478;
RX   PubMed=7471106;
RX   PubMed=9650596;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   AT4BI(SV)
AC   CVCL_4Y28
DR   JCRB; JCRB3079
DR   JCRB; KURB1762
DR   Wikidata; Q54750929
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: JCRB; KURB1762; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3079
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V546 ! AT4BI
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 11
//
ID   AT4BINE1-3
AC   CVCL_C1HJ
DR   Wikidata; Q114310635
RX   PubMed=2903889;
RX   PubMed=9357546;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V546 ! AT4BI
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   AT4BR
AC   CVCL_ZT63
SY   Ataxia Telangiectasia 4 BRighton
DR   Wikidata; Q98125507
RX   PubMed=7836839;
RX   PubMed=8794843;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT64 ! AT4BR LCL
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 6
//
ID   AT4BR LCL
AC   CVCL_ZT64
SY   Ataxia Telangiectasia 4 BRighton LCL; LB244; 244
DR   Wikidata; Q98125508
RX   PubMed=7836839;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT63 ! AT4BR
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AT4JTO
AC   CVCL_M812
SY   Ataxia Telangiectasia 4 Japan TOkyo
DR   JCRB; JCRB3052
DR   JCRB; KURB1810
DR   Wikidata; Q54750932
RX   PubMed=7057793;
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Heterozygous (PubMed=9600235).
CC   Discontinued: JCRB; KURB1810; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3052
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   AT4JTO(SV)
AC   CVCL_ZN19
DR   JCRB; JCRB3078
DR   JCRB; KURB1811
DR   Wikidata; Q98125512
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; KURB1811; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3078
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M812 ! AT4JTO
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   AT4JTOM
AC   CVCL_RW81
SY   MAT4JTO; Ataxia Telangiectasia 4 Japan TOkyo Mother
DR   JCRB; JCRB3051
DR   JCRB; KURB1812
DR   Wikidata; Q54750934
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1812; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3051
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   AT4JTOM(SV)
AC   CVCL_ZN20
DR   JCRB; JCRB3077
DR   JCRB; KURB1813
DR   Wikidata; Q98125515
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3077
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW81 ! AT4JTOM
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   AT4KY
AC   CVCL_1G70
SY   Ataxia Telangiectasia 4 KYoto
DR   JCRB; KURB1787
DR   Wikidata; Q54750936
RX   PubMed=9600235;
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1637_Leu1668del32 (c.4910del96) (Ex35del); Zygosity=Homozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   AT4KY TERT
AC   CVCL_1G71
SY   AT4KY/TERT
DR   JCRB; KURB1788
DR   Wikidata; Q54750939
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1637_Leu1668del32 (c.4910del96) (Ex35del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1G70 ! AT4KY
SX   Male
AG   Children
CA   Telomerase immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   AT4LA
AC   CVCL_B5MD
SY   Ataxia Telangiectasia 4 Los Angeles
DR   Wikidata; Q112127962
RX   PubMed=7792600;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M957 ! AT4LA LCL
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AT4LA LCL
AC   CVCL_M957
SY   Ataxia Telangiectasia 4 Los Angeles LCL; GM13327
DR   CLO; CLO_0013249
DR   BioSample; SAMN00802305
DR   Coriell; GM13327
DR   Wikidata; Q54846464
RX   PubMed=9150358;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5MD ! AT4LA
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   AT4RM
AC   CVCL_XX56
SY   Ataxia Telangiectasia 4 RoMa
DR   Wikidata; Q93326361
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1267_Val1268insTer (c.3802delG) (p.Val1268Terfs); ClinVar=VCV000127374; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT506.C2
AC   CVCL_JY79
DR   cancercelllines; CVCL_JY79
DR   Wikidata; Q54750940
CC   From: Burger, Christa; Merck Serono; Darmstadt; Germany.
CC   Population: Caucasian.
CC   Characteristics: Serves as a beta-catenin reporter cell line. Transfected with a firefly luciferase reporter gene under the control of a minimal CMV promoter and tandem repeats of the TCF/LEF transcriptional response element (TRE).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   AT50RM
AC   CVCL_XY15
SY   Ataxia Telangiectasia 50 RoMa
DR   Wikidata; Q93326369
RX   PubMed=8845835;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.5319+2T>C (IVS37+2T>C) (c.5178_5319del142); ClinVar=VCV000479006; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=8845835; PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1898Ter (c.5692C>T); ClinVar=VCV000482526; Zygosity=Heterozygous (PubMed=8845835; PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT52RM
AC   CVCL_XF26
SY   Ataxia Telangiectasia 52 RoMa
DR   Wikidata; Q93326371
RX   PubMed=10864201;
RX   PubMed=12105990;
RX   PubMed=17124347;
RX   PubMed=21112256;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2443Ter (c.7327C>T); ClinVar=VCV000003036; Zygosity=Heterozygous (PubMed=10864201; PubMed=12105990).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8365delA; Zygosity=Heterozygous (PubMed=10864201; PubMed=12105990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   AT53RM
AC   CVCL_XF27
SY   Ataxia Telangiectasia 53 RoMa
DR   Wikidata; Q93326374
RX   PubMed=9497252;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ala1812_Phe1813delinsVal (c.5435_5437delCTT); ClinVar=VCV001747513; Zygosity=Heterozygous (PubMed=9497252).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.6573-9G>A (IVS47-9G>A); ClinVar=VCV000642095; Zygosity=Heterozygous; Note=Activates a cryptic splice site (PubMed=9497252).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   AT54RM
AC   CVCL_XF28
SY   Ataxia Telangiectasia 54 RoMa
DR   Wikidata; Q93326376
RX   PubMed=10864201;
RX   PubMed=12105990;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2598Ter (c.7792C>T); ClinVar=VCV000265383; Zygosity=Heterozygous (PubMed=10864201; PubMed=12105990).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2762Alafs*6 (c.8283_8284delTC); ClinVar=VCV000482713; Zygosity=Heterozygous (PubMed=10864201; PubMed=12105990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT57RM
AC   CVCL_XF29
SY   Ataxia Telangiectasia 57 RoMa
DR   Wikidata; Q93326378
RX   PubMed=8845835;
RX   PubMed=10864201;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser151Terfs (c.450_453delTTCT); Zygosity=Heterozygous (PubMed=8845835; PubMed=10864201; PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2506Thrfs (c.7517_7520delGAGA) (7517del4); Zygosity=Heterozygous (PubMed=8845835; PubMed=10864201; PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT58RM
AC   CVCL_XF30
SY   Ataxia Telangiectasia 58 RoMa
DR   Wikidata; Q93326380
RX   PubMed=10864201;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys750Lys (c.2250G>A); ClinVar=VCV000003044; Zygosity=Heterozygous; Note=Causes skipping of exon 14 (p.Ile709_Lys750del, c.2125_2250del) (PubMed=10864201; PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp2708Asn (c.8122G>A); ClinVar=VCV000142791; Zygosity=Heterozygous (PubMed=10864201; PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   AT59
AC   CVCL_M972
SY   AT-59; AT 59; A-T59
DR   Wikidata; Q54750943
RX   PubMed=12080467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   AT59RM
AC   CVCL_XY49
SY   Ataxia Telangiectasia 59 RoMa
DR   Wikidata; Q93326386
RX   PubMed=8845835;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2506Thrfs (c.7517_7520delGAGA) (7517del4); Zygosity=Homozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT5ABR
AC   CVCL_M913
SY   Ataxia Telangiectasia 5 Australia BRisbane
DR   Wikidata; Q54750945
RX   PubMed=6197197;
RX   PubMed=6228733;
RX   PubMed=6504056;
RX   PubMed=7433105;
RX   PubMed=9150358;
RX   PubMed=9168117;
RX   PubMed=17347666;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   AT5BE LCL
AC   CVCL_A2PJ
SY   AT5Be LCL; Ataxia Telangiectasia 5 BEthesda LCL; GM02928; GM 2928
DR   Coriell; GM02928
DR   Wikidata; Q105506428
RX   PubMed=6173245;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02928; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AT5BI
AC   CVCL_7441
SY   AT 5BI; Ataxia Telangiectasia 5 BIrmingham; GM05823; GM5823; GM05823A; GM5823A; GM05823C
DR   CLO; CLO_0024679
DR   Coriell; GM05823
DR   JCRB; KURB1822
DR   Wikidata; Q54750947
RX   CelloPub=CLPUB00447;
RX   PubMed=450131;
RX   PubMed=2903889;
RX   PubMed=2973075;
RX   PubMed=3337113;
RX   PubMed=6442144;
RX   PubMed=6600729;
RX   PubMed=6810166;
RX   PubMed=6843573;
RX   PubMed=7067035;
RX   PubMed=7471105;
RX   PubMed=7471106;
RX   PubMed=7792600;
RX   PubMed=8808599;
RX   PubMed=8845835;
RX   PubMed=10987302;
RX   PubMed=11219864;
RX   PubMed=11313956;
RX   PubMed=12082606;
RX   PubMed=15574327;
RX   PubMed=18079351;
RX   PubMed=19896956;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu2427_Arg2428del (c.7278_7283delCCTTAG); ClinVar=VCV000003020; Zygosity=Heterozygous (PubMed=7792600; PubMed=8845835).
CC   Misspelling: AT5B1; Note=Occasionally.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   AT5BIVA
AC   CVCL_7442
SY   AT5BiSv40; AT5BISV40; ATSV1; GM05849; GM5849; GM5849C; GM05849A; GM05849B
DR   CLO; CLO_0024705
DR   EFO; EFO_0022392
DR   Coriell; GM05849
DR   Lonza; 258
DR   TOKU-E; 4105
DR   Wikidata; Q54750948
RX   CelloPub=CLPUB00447;
RX   PubMed=2821020;
RX   PubMed=2903889;
RX   PubMed=2987007;
RX   PubMed=3023120;
RX   PubMed=9357546;
RX   PubMed=9650596;
RX   PubMed=11172010;
RX   PubMed=12419185;
RX   PubMed=14555701;
RX   PubMed=18757420;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu2427_Arg2428del (c.7278_7283delCCTTAG); ClinVar=VCV000003020; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: GM5489; PubMed=2987007.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7441 ! AT5BI
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   AT5BR
AC   CVCL_WX71
SY   AT 5BR; Ataxia Telangiectasia 5 BRighton
DR   Wikidata; Q93326404
RX   PubMed=7836839;
RX   PubMed=12082606;
RX   PubMed=15574327;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1921Ter (c.5763-1050A>G) (IVS40+1126A>G) (5762ins137); ClinVar=VCV000003021; Zygosity=Unspecified (PubMed=12082606).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT24 ! AT5BR LCL
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   AT5BR LCL
AC   CVCL_ZT24
SY   Ataxia Telangiectasia 5 BRighton LCL; LB433; 433
DR   Wikidata; Q98125517
RX   PubMed=7836839;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1921Ter (c.5763-1050A>G) (IVS40+1126A>G) (5762ins137); ClinVar=VCV000003021; Zygosity=Unspecified (from autologous cell line AT5BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX71 ! AT5BR
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   AT5KY
AC   CVCL_1G64
SY   Ataxia Telangiectasia 5 KYoto
DR   JCRB; KURB1791
DR   Wikidata; Q54750951
RX   PubMed=9600235;
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Heterozygous (PubMed=9600235).
CC   Caution: Incorrectly indicated as originating from a male patient in JCRB=KURB1791.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2857 ! AT(L)5KY
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   AT5KY TERT
AC   CVCL_1G65
SY   AT5KY/TERT
DR   JCRB; KURB1793
DR   Wikidata; Q54750952
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: Incorrectly indicated as originating from a male patient in JCRB=KURB1793.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1G64 ! AT5KY
SX   Female
AG   10Y
CA   Telomerase immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   AT5LA
AC   CVCL_B5MC
SY   Ataxia Telangiectasia 5 Los Angeles
DR   Wikidata; Q111732941
RX   PubMed=3337113;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   AT5RM
AC   CVCL_XY52
SY   Ataxia Telangiectasia 5 RoMa
DR   Wikidata; Q93326415
RX   PubMed=8845835;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Tyr705Thrfs*30 (c.2113delT); ClinVar=VCV000216850; Zygosity=Heterozygous (PubMed=8845835).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser1993Argfs*23 (c.5979_5983delTAAAG) (5979delTAAAG); ClinVar=VCV000233016; Zygosity=Heterozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT61RM
AC   CVCL_XY16
SY   Ataxia Telangiectasia 61 RoMa
DR   Wikidata; Q93326419
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser1993Argfs*23 (c.5979_5983delTAAAG) (5979delTAAAG); ClinVar=VCV000233016; Zygosity=Heterozygous (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2305Ter (c.6913C>T); ClinVar=VCV000482710; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT65RM
AC   CVCL_XF31
SY   Ataxia Telangiectasia 65 RoMa
DR   Wikidata; Q93326421
RX   PubMed=10864201;
RX   PubMed=12105990;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.6573-9G>A (IVS47-9G>A); ClinVar=VCV000642095; Zygosity=Heterozygous; Note=Activates a cryptic splice site (PubMed=10864201).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Met2938Ilefs (c.8814_8824delGAGAAACTCTC) (8814del11); ClinVar=VCV000370841; Zygosity=Heterozygous (PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   AT68RM
AC   CVCL_XF32
SY   Ataxia Telangiectasia 68 RoMa
DR   Wikidata; Q93326423
RX   PubMed=10864201;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   AT6ABR
AC   CVCL_IW70
SY   Ataxia Telangiectasia 6 Australia BRisbane
DR   Wikidata; Q54750959
RX   PubMed=6228733;
RX   PubMed=6504056;
RX   PubMed=9150358;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Cys2824Tyr (c.8471G>A); ClinVar=VCV000234209; Zygosity=Heterozygous (PubMed=9150358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   AT6BE LCL
AC   CVCL_A2PK
SY   AT6Be LCL; Ataxia Telangiectasia 6 BEthesda LCL; GM02929; GM 2929
DR   Coriell; GM02929
DR   Wikidata; Q105506432
RX   PubMed=6173245;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02929; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   AT6BI
AC   CVCL_WX40
SY   Ataxia Telangiectasia 6 BIrmingham
DR   Wikidata; Q93326429
RX   PubMed=837385;
RX   PubMed=3337113;
RX   PubMed=7471106;
RX   PubMed=7792600;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu2427_Arg2428del (c.7278_7283delCCTTAG); ClinVar=VCV000003020; Zygosity=Heterozygous (PubMed=7792600).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   AT6BR
AC   CVCL_ZN47
SY   Ataxia Telangiectasia 6 BRighton
DR   Wikidata; Q98125518
RX   PubMed=12082606;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1921Ter (c.5763-1050A>G) (IVS40+1126A>G) (5762ins137); ClinVar=VCV000003021; Zygosity=Unspecified (PubMed=12082606).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2563 ! AT6BR LCL
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   AT6BR LCL
AC   CVCL_2563
SY   Ataxia Telangiectasia 6 BRighton LCL; LB541; 541
DR   ECACC; 98062326
DR   Wikidata; Q54902071
RX   PubMed=12082606;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1921Ter (c.5763-1050A>G) (IVS40+1126A>G) (5762ins137); ClinVar=VCV000003021; Zygosity=Unspecified (from autologous cell line AT6BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN47 ! AT6BR
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   AT6KY
AC   CVCL_1G66
SY   Ataxia Telangiectasia 6 KYoto
DR   JCRB; KURB1796
DR   Wikidata; Q54750962
RX   PubMed=9600235;
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.332del165 (g.484C>T) (Ex7del); Zygosity=Heterozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2858 ! AT(L)6KY
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   AT6KY TERT
AC   CVCL_1G67
SY   AT6KY/TERT
DR   JCRB; KURB1797
DR   Wikidata; Q54750964
RX   PubMed=14570874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.332del165 (g.484C>T) (Ex7del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1G66 ! AT6KY
SX   Male
AG   8Y
CA   Telomerase immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   AT6KYM
AC   CVCL_RW80
SY   MAT6KY; Ataxia Telangiectasia 6 KYoto Mother
DR   JCRB; KURB1801
DR   Wikidata; Q54750966
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   AT6LA
AC   CVCL_1L64
SY   Ataxia Telangiectasia 6 Los Angeles; GM11254
DR   CLO; CLO_0022968
DR   Coriell; GM11254
DR   Wikidata; Q54844941
RX   PubMed=8808599;
RX   PubMed=16166284;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.2467del372 (Ex19-20del); Zygosity=Heterozygous (PubMed=16166284).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8786+1G>A (IVS62+1G>A) (c.8672del115) (G2891fsX); ClinVar=VCV000127463; Zygosity=Heterozygous; Note=Splice donor mutation. Causes in-frame skipping of exon 62 (PubMed=16166284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   AT6RM
AC   CVCL_XY09
SY   Ataxia Telangiectasia 6 RoMa
DR   Wikidata; Q93326444
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro795Thr (c.2385C>A); Zygosity=Heterozygous (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1978Ter (c.5932G>T); ClinVar=VCV000127414; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT71RM
AC   CVCL_XY18
SY   Ataxia Telangiectasia 71 RoMa
DR   Wikidata; Q93326446
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.7789-3T>G (IVS54-3T>G); ClinVar=VCV000219629; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT73RM
AC   CVCL_XX51
SY   Ataxia Telangiectasia 73 RoMa
DR   Wikidata; Q93326449
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys750Lys (c.2250G>A); ClinVar=VCV000003044; Zygosity=Heterozygous; Note=Causes skipping of exon 14 (p.Ile709_Lys750del, c.2125_2250del) (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg805Ter (c.2413C>T); ClinVar=VCV000216021; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT74RM
AC   CVCL_XF33
SY   Ataxia Telangiectasia 74 RoMa
DR   Wikidata; Q93326451
RX   PubMed=10864201;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.3993ins29; Zygosity=Homozygous (PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   AT76LA
AC   CVCL_N320
SY   Ataxia Telangiectasia 76 Los Angeles
DR   Wikidata; Q54750954
RX   PubMed=9150358;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   AT76RM
AC   CVCL_XY17
SY   Ataxia Telangiectasia 76 RoMa
DR   Wikidata; Q93326458
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2506Thrfs (c.7517_7520delGAGA) (7517del4); Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT79LA
AC   CVCL_IW74
SY   Ataxia Telangiectasia 79 Los Angeles
DR   Wikidata; Q54750956
RX   PubMed=9150358;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   AT79RM
AC   CVCL_XX53
SY   Ataxia Telangiectasia 79 RoMa
DR   Wikidata; Q93326464
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.2718_2721delGGCC; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT7BI
AC   CVCL_1G63
SY   AT7Bi; Ataxia Telangiectasia 7 BIrmingham
DR   Wikidata; Q54750968
RX   PubMed=2903889;
RX   PubMed=7471106;
RX   PubMed=7836839;
RX   PubMed=15574327;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT26 ! AT7BI LCL
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   AT7BI LCL
AC   CVCL_ZT26
SY   Ataxia Telangiectasia 7 BIrmingham LCL; LB54; 54
DR   Wikidata; Q98125519
RX   PubMed=7836839;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G63 ! AT7BI
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   AT7KY
AC   CVCL_1G68
SY   Ataxia Telangiectasia 7 KYoto
DR   JCRB; KURB1804
DR   Wikidata; Q54750970
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.2125del126 (Ex16del); Zygosity=Heterozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2859 ! AT(L)7KY
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   AT7KYM
AC   CVCL_JK48
SY   MAT7KY
DR   JCRB; KURB1807
DR   Wikidata; Q54750972
RX   PubMed=9600235;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1550Argfs*13 (c.4649delA); Zygosity=Heterozygous (PubMed=9600235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JK47 ! AT(L)7KYM
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   AT7LA
AC   CVCL_H134
SY   Ataxia Telangiectasia 7 Los Angeles; GM00717; GM-717; GM 717; GM717; GM00717A; GM-0717A; GM 717A; GM717A
DR   CLO; CLO_0028790
DR   Coriell; GM00717
DR   Wikidata; Q54836411
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=1561323;
RX   PubMed=2805228;
RX   PubMed=6197197;
RX   PubMed=6504056;
RX   PubMed=7539412;
RX   PubMed=8808599;
RX   PubMed=18634022;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu522Ilefs (c.1564_1565delGA) (1563_1564delAG); ClinVar=VCV000127340; Zygosity=Homozygous; Note=Produces no detectable ATM protein by conventional immunoblotting (PubMed=8808599; PubMed=18634022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   AT7RM
AC   CVCL_XY50
SY   Ataxia Telangiectasia 7 RoMa
DR   Wikidata; Q93326479
RX   PubMed=8845835;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.5320del3556; Zygosity=Heterozygous (PubMed=8845835).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2506Thrfs (c.7517_7520delGAGA) (7517del4); Zygosity=Heterozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   AT805
AC   CVCL_8068
DR   CLO; CLO_0050533
DR   RCB; RCB1788
DR   Wikidata; Q54750976
CC   Breed/subspecies: 129.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   AT81RM
AC   CVCL_XX58
SY   Ataxia Telangiectasia 81 RoMa
DR   Wikidata; Q93326486
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr1743Thr (c.5229A>T); Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT85RM
AC   CVCL_XY13
SY   Ataxia Telangiectasia 85 RoMa
DR   Wikidata; Q93326488
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1192Lys (c.3576G>A) (3403del174) (Ex26del); ClinVar=VCV000003035; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT8ABR
AC   CVCL_IW71
SY   Ataxia Telangiectasia 8 Australia BRisbane
DR   Wikidata; Q54750978
RX   PubMed=2825700;
RX   PubMed=2836804;
RX   PubMed=9150358;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   AT8BI
AC   CVCL_B5MB
SY   Ataxia Telangiectasia 8 BIrmingham
DR   Wikidata; Q111732943
RX   PubMed=3337113;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000187275; Zygosity=Unspecified (from autologous cell line AT8BI LCL).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7322 ! AT8BI LCL
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   AT8BI LCL
AC   CVCL_7322
SY   Ataxia Telangiectasia 8 BIrmingham LCL; GM01526; GM-1526; GM 1526; GM1526; GM01526B; GM-1526B; GM 1526B; GM01526C
DR   CLO; CLO_0031476
DR   BioSample; SAMN00806894
DR   BioSample; SAMN03472405
DR   Coriell; GM01526
DR   JCRB; JCRB3008
DR   JCRB; KURB3012
DR   Wikidata; Q54836883
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=1561323;
RX   PubMed=6228733;
RX   PubMed=6504056;
RX   PubMed=7539412;
RX   PubMed=16166284;
RX   PubMed=29892436;
CC   Population: Caucasian.
CC   HLA typing: A*09,10; B*w17,13(w40) (Coriell=GM01526).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000187275; Zygosity=Unspecified (Coriell=GM01526).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; KURB3012; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB3008
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5MB ! AT8BI
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   AT8RM
AC   CVCL_XY51
SY   Ataxia Telangiectasia 8 RoMa
DR   Wikidata; Q93326496
RX   PubMed=8845835;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2506Thrfs (c.7517_7520delGAGA) (7517del4); Zygosity=Heterozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT90RM
AC   CVCL_XY19
SY   Ataxia Telangiectasia 90 RoMa
DR   Wikidata; Q93326498
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.6442delA; Zygosity=Heterozygous (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2762Alafs*6 (c.8283_8284delTC); ClinVar=VCV000482713; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT95RM
AC   CVCL_XX62
SY   Ataxia Telangiectasia 95 RoMa
DR   Wikidata; Q93326501
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.1607+1G>T (IVS12+1G>T); ClinVar=VCV000220555; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=17124347).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1192Lys (c.3576G>A) (3403del174) (Ex26del); ClinVar=VCV000003035; Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   AT95TO
AC   CVCL_WX48
SY   Ataxia Telangiectasia 95 TOronto
DR   Wikidata; Q93326504
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AT96RM
AC   CVCL_XY11
SY   Ataxia Telangiectasia 96 RoMa
DR   Wikidata; Q93326507
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser1037Serfs*2 (c.3111delT); Zygosity=Heterozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT97RM
AC   CVCL_XX48
SY   Ataxia Telangiectasia 97 RoMa
DR   Wikidata; Q93326509
RX   PubMed=17124347;
RX   PubMed=25942615;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Phe239Leufs*15 (c.717_720delCCTC); ClinVar=VCV000142709; Zygosity=Homozygous (PubMed=17124347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   AT97TO
AC   CVCL_WX49
SY   Ataxia Telangiectasia 97 TOronto
DR   Wikidata; Q93326511
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   AT9ABR
AC   CVCL_IW72
SY   Ataxia Telangiectasia 9 Australia BRisbane
DR   Wikidata; Q54750981
RX   PubMed=9150358;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   AT9RM
AC   CVCL_W150
AS   CVCL_XF34
SY   Ataxia Telangiectasia 9 RoMa; GM15785
DR   CLO; CLO_0027731
DR   Coriell; GM15785
DR   Wikidata; Q54848198
RX   PubMed=9497252;
RX   PubMed=10864201;
RX   PubMed=17124347;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg3047Ter (c.9139C>T); ClinVar=VCV000003029; Zygosity=Homozygous (PubMed=9497252; PubMed=10864201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   ATAP120
AC   CVCL_ZX78
DR   Wikidata; Q102113572
RX   PubMed=1321125;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25116; Human F2R (Note=Recognizes N-terminal region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   ATAP138
AC   CVCL_ZX79
DR   Wikidata; Q102113573
RX   PubMed=1321125;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25116; Human F2R (Note=Recognizes N-terminal region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   ATAP2
AC   CVCL_ZX80
DR   Wikidata; Q102113574
RX   PubMed=1321125;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25116; Human F2R (Note=Recognizes N-terminal region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   ATC-10
AC   CVCL_Z222
SY   ATC 10; ATC10; Singh's Aedes aegyptic cell line; A. aegypti Singh; ATP-10
DR   CLO; CLO_0001670
DR   CLDB; cl248
DR   ATCC; CCL-125
DR   ECACC; 87091801
DR   Wikidata; Q54750983
RX   CelloPub=CLPUB00178;
RX   CelloPub=CLPUB00466;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.2307/3576172;
RX   PubMed=2563994;
RX   PubMed=5142320;
RX   PubMed=5142332;
RX   PubMed=6126429;
RX   PubMed=6137452;
RX   PubMed=6468178;
RX   PubMed=6852197;
RX   PubMed=15038778;
RX   PubMed=16037617;
RX   PubMed=16409117;
RX   PubMed=16593348;
RX   PubMed=19159646;
WW   Info; -; -; https://garfield.library.upenn.edu/classics1984/A1984SB92200002.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_72b2b87ee3
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_dba68c637d
CC   Group: Insect cell line.
CC   Karyotypic information: 55% diploid, 30% haploid (PubMed=6852197).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   ATC-121
AC   CVCL_Z224
SY   ATC No. 121
DR   Wikidata; Q54750985
RX   CelloPub=CLPUB00179;
RX   CelloPub=CLPUB00683;
RX   PubMed=5142332;
RX   PubMed=6468178;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Chikungunya virus, Japanese encephalitis virus (JEV), West Nile virus (WNV) and Chandipura virus (CelloPub=CLPUB00683).
OX   NCBI_TaxID=317808; ! Aedes vittatus (Mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 10
//
ID   ATC-136
AC   CVCL_Z225
SY   ATC No. 136
DR   Wikidata; Q54750986
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   PubMed=5142332;
RX   PubMed=5544717;
RX   PubMed=6468178;
RX   PubMed=6852197;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Karyotypic information: 50% diploid, 20% haploid (PubMed=6852197).
OX   NCBI_TaxID=69821; ! Aedes w-albus (Mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   ATC-137
AC   CVCL_Z226
DR   Wikidata; Q54751045
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   PubMed=5544717;
RX   PubMed=16037617;
CC   Group: Insect cell line.
OX   NCBI_TaxID=69821; ! Aedes w-albus (Mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   ATC-15
AC   CVCL_Z223
SY   ATC 15; ATC15; Singh's Aedes albopictus cell line; Aa
DR   CLO; CLO_0001627
DR   CLO; CLO_0001671
DR   CLDB; cl226
DR   CLDB; cl249
DR   CLDB; cl250
DR   ATCC; CCL-126
DR   ECACC; 90100401
DR   IZSLER; BS CL 1
DR   Wikidata; Q54751046
RX   CelloPub=CLPUB00178;
RX   CelloPub=CLPUB00466;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1111/j.1439-0418.1981.tb04507.x;
RX   PubMed=5142320;
RX   PubMed=6126429;
RX   PubMed=6468178;
RX   PubMed=6852197;
RX   PubMed=8799737;
RX   PubMed=16037617;
WW   Info; -; -; https://garfield.library.upenn.edu/classics1984/A1984SB92200002.pdf
CC   Group: Insect cell line.
CC   Karyotypic information: 55% diploid, 12% haploid (PubMed=6852197).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   ATC-173
AC   CVCL_Z227
DR   Wikidata; Q54751050
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   PubMed=4691922;
RX   PubMed=6468178;
RX   PubMed=6852197;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Karyotypic information: 52% diploid, 15% haploid (PubMed=6852197).
OX   NCBI_TaxID=1579489; ! Aedes novalbopictus (Mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ATC-176
AC   CVCL_Z228
DR   Wikidata; Q54751052
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   PubMed=4691922;
CC   Group: Insect cell line.
OX   NCBI_TaxID=1579489; ! Aedes novalbopictus (Mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   ATC-281/282
AC   CVCL_Z911
DR   Wikidata; Q54751053
RX   CelloPub=CLPUB00496;
RX   PubMed=608719;
RX   PubMed=791861;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=1134476; ! Haemaphysalis spinigera (Tick)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   ATC-304
AC   CVCL_Z912
DR   Wikidata; Q54751054
RX   CelloPub=CLPUB00496;
RX   PubMed=791861;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=1256039; ! Haemaphysalis obesa (Asian obese-hirsute haemaphysalid)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   ATC-307
AC   CVCL_Z913
DR   Wikidata; Q54751058
RX   CelloPub=CLPUB00496;
RX   PubMed=791861;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus (Brown dog tick)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   ATC-308
AC   CVCL_Z914
DR   Wikidata; Q54751059
RX   CelloPub=CLPUB00496;
RX   PubMed=791861;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus (Brown dog tick)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   ATC-309
AC   CVCL_Z915
DR   Wikidata; Q54751061
RX   CelloPub=CLPUB00496;
RX   PubMed=608719;
RX   PubMed=791861;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=1134476; ! Haemaphysalis spinigera (Tick)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   ATC-310
AC   CVCL_1B74
DR   Wikidata; Q54751062
RX   PubMed=791861;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=1256039; ! Haemaphysalis obesa (Asian obese-hirsute haemaphysalid)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 7
//
ID   ATC-311
AC   CVCL_Z916
DR   Wikidata; Q54751065
RX   CelloPub=CLPUB00496;
RX   PubMed=791861;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=1256039; ! Haemaphysalis obesa (Asian obese-hirsute haemaphysalid)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   ATC-415
AC   CVCL_Z229
DR   Wikidata; Q54751066
RX   DOI=10.1007/BF01666018;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=69822; ! Culex bitaeniorhynchus (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ATC1
AC   CVCL_C755
DR   Wikidata; Q54751067
RX   PubMed=11196467;
RX   PubMed=15666850;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal cortex; UBERON=UBERON_0001235.
CC   Breed/subspecies: Akr1b7 promoter-T-Ag transgenic.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   ATC7G
AC   CVCL_C8RS
DR   Wikidata; Q123030704
RX   PubMed=15666850;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal cortex; UBERON=UBERON_0001235.
CC   Breed/subspecies: Akr1b7 promoter-T-Ag transgenic.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   ATCC-BXS0114
AC   CVCL_X497
DR   ATCC; ACS-1028
DR   SKIP; SKIP001142
DR   SKIP; SKIP003280
DR   Wikidata; Q54751071
CC   Population: African American.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   ATCC-BXS0115
AC   CVCL_0A06
DR   ATCC; ACS-1029
DR   SKIP; SKIP003281
DR   Wikidata; Q54751072
CC   Population: Hispanic.
CC   Discontinued: ATCC; ACS-1029; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 12
//
ID   ATCC-BXS0116
AC   CVCL_0A07
DR   ATCC; ACS-1030
DR   SKIP; SKIP001140
DR   SKIP; SKIP003282
DR   Wikidata; Q54751075
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ATCC-BXS0117
AC   CVCL_0A08
DR   ATCC; ACS-1031
DR   SKIP; SKIP003283
DR   Wikidata; Q54751077
RX   DOI=10.13140/RG.2.2.19897.98401;
CC   Population: Asian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=ACS-1031
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 12
//
ID   ATCC-BYS0110
AC   CVCL_X496
DR   ATCC; ACS-1024
DR   SKIP; SKIP003284
DR   Wikidata; Q54751079
RX   DOI=10.13140/RG.2.2.19897.98401;
CC   Population: African American.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   ATCC-BYS0111
AC   CVCL_0A04
DR   ATCC; ACS-1025
DR   SKIP; SKIP003285
DR   Wikidata; Q54751082
CC   Population: Hispanic.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=ACS-1025
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 11
//
ID   ATCC-BYS0112
AC   CVCL_0A05
DR   ATCC; ACS-1026
DR   SKIP; SKIP003286
DR   Wikidata; Q54751084
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ATCC-BYS0113
AC   CVCL_0A03
DR   ATCC; ACS-1027
DR   SKIP; SKIP001308
DR   SKIP; SKIP003287
DR   Wikidata; Q54751085
CC   Population: Asian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=ACS-1027
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 11
//
ID   ATCC-CYS0105
AC   CVCL_X498
DR   ATCC; ACS-1021
DR   SKIP; SKIP001141
DR   SKIP; SKIP004329
DR   Wikidata; Q54751088
CC   Discontinued: ATCC; ACS-1021; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
ST   Source(s): ATCC=ACS-1021
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 9,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   ATCC-DYP0250
AC   CVCL_C250
DR   ATCC; ACS-1004
DR   SKIP; SKIP001307
DR   SKIP; SKIP003553
DR   Wikidata; Q54751090
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ATCC=ACS-1004).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2381 ! CCD-186Sk
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   ATCC-DYP0530
AC   CVCL_C251
SY   iPSDYP0530
DR   ATCC; ACS-1014
DR   CCRID; 3101HUMSCSP1302
DR   SKIP; SKIP001309
DR   SKIP; SKIP004337
DR   Wikidata; Q54751093
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C254 ! ATCC-DYR0530
OI   CVCL_C255 ! ATCC-DYS0530
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   ATCC-DYP0730
AC   CVCL_C252
SY   iPSDYP0730
DR   ATCC; ACS-1003
DR   CCRID; 3101HUMSCSP1303
DR   SKIP; SKIP001306
DR   SKIP; SKIP004334
DR   Wikidata; Q54751095
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2430 ! Detroit 532
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 16
//
ID   ATCC-DYR0100
AC   CVCL_C253
SY   iPSDYR0100; ATCC-DYR0100-A; DYR0100; CNNDi001-A
DR   ATCC; ACS-1011
DR   BioSamples; SAMEA14515044
DR   CCRID; 3101HUMSCSP1301
DR   hPSCreg; CNNDi001-A
DR   SKIP; SKIP004426
DR   Wikidata; Q54751096
RX   PubMed=36521383;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=ACS-1011
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 15
//
ID   ATCC-DYR0530
AC   CVCL_C254
DR   ATCC; ACS-1012
DR   SKIP; SKIP004338
DR   Wikidata; Q54751098
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C251 ! ATCC-DYP0530
OI   CVCL_C255 ! ATCC-DYS0530
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   ATCC-DYS0100
AC   CVCL_X499
DR   ATCC; ACS-1019
DR   SKIP; SKIP001138
DR   SKIP; SKIP004425
DR   Wikidata; Q54751101
RX   DOI=10.13140/RG.2.2.19897.98401;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=ACS-1019
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 13
//
ID   ATCC-DYS0530
AC   CVCL_C255
DR   ATCC; ACS-1013
DR   SKIP; SKIP001136
DR   SKIP; SKIP004339
DR   Wikidata; Q54751102
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=ACS-1013
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C251 ! ATCC-DYP0530
OI   CVCL_C254 ! ATCC-DYR0530
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   ATCC-HYR0103
AC   CVCL_C256
DR   ATCC; ACS-1007
DR   SKIP; SKIP001137
DR   SKIP; SKIP004446
DR   Wikidata; Q54751104
CC   Population: Hispanic.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=ACS-1007
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X500 ! ATCC-HYS0103
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
ID   ATCC-HYS0103
AC   CVCL_X500
DR   ATCC; ACS-1020
DR   SKIP; SKIP001139
DR   SKIP; SKIP004447
DR   Wikidata; Q54751107
CC   Population: Hispanic.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=ACS-1020
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C256 ! ATCC-HYR0103
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 12
//
ID   ATCe-rSD78
AC   CVCL_QX31
DR   Wikidata; Q54751108
RX   PubMed=28677536;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Sprague Dawley Tg(GFP)1BalRrrc; RS=RS_0000682.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   ATCe-rWK1
AC   CVCL_QX32
DR   Wikidata; Q54751110
RX   PubMed=28677536;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 7
//
ID   ATCi-Ai6IslCre10
AC   CVCL_UG38
DR   Wikidata; Q93326674
RX   PubMed=30343102;
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
CC   Breed/subspecies: Ai6 x Isl1-Cre.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UG39 ! ATCi-Ai6IslCre35
OI   CVCL_UG40 ! ATCi-Ai6IslCre74
OI   CVCL_UG41 ! ATCi-Ai6IslCre80
SX   Male
AG   1M2W
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   ATCi-Ai6IslCre35
AC   CVCL_UG39
DR   Wikidata; Q93326676
RX   PubMed=30343102;
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
CC   Breed/subspecies: Ai6 x Isl1-Cre.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UG38 ! ATCi-Ai6IslCre10
OI   CVCL_UG40 ! ATCi-Ai6IslCre74
OI   CVCL_UG41 ! ATCi-Ai6IslCre80
SX   Male
AG   1M2W
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   ATCi-Ai6IslCre74
AC   CVCL_UG40
DR   Wikidata; Q93326678
RX   PubMed=30343102;
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ai6 x Isl1-Cre.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UG38 ! ATCi-Ai6IslCre10
OI   CVCL_UG39 ! ATCi-Ai6IslCre35
OI   CVCL_UG41 ! ATCi-Ai6IslCre80
SX   Male
AG   1M2W
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   ATCi-Ai6IslCre80
AC   CVCL_UG41
DR   Wikidata; Q93326680
RX   PubMed=30343102;
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ai6 x Isl1-Cre.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UG38 ! ATCi-Ai6IslCre10
OI   CVCL_UG39 ! ATCi-Ai6IslCre35
OI   CVCL_UG40 ! ATCi-Ai6IslCre74
SX   Male
AG   1M2W
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   ATCi-MF1
AC   CVCL_QX30
DR   Wikidata; Q54751113
RX   PubMed=28677526;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   ATCi-rSD95
AC   CVCL_QW41
DR   Wikidata; Q54751115
RX   PubMed=28677538;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Embryonic trunk; UBERON=UBERON_0002100.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Sprague Dawley Tg(GFP)1BalRrrc; RS=RS_0000682.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   15-16FD
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   ATCi001-A
AC   CVCL_B3XP
DR   hPSCreg; ATCi001-A
DR   Wikidata; Q110432582
RX   PubMed=34736036;
CC   From: Aegicare (Shenzhen) Technology Co; Shenzhen; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:30224; SLC52A2; Simple; p.Ala26Profs*42 (c.75_76insCCTGG); Zygosity=Heterozygous (PubMed=34736036).
CC   Sequence variation: Mutation; HGNC; HGNC:30224; SLC52A2; Simple; p.Cys278delinsCysLeuLeuGly (c.832_833insGCCTGCTGG); Zygosity=Heterozygous (PubMed=34736036).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183529; Brown-Vialetto-van Laere syndrome 2
DI   ORDO; Orphanet_572543; RFVT2-related riboflavin transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ATCi002-A
AC   CVCL_B6RJ
DR   BioSamples; SAMEA12057079
DR   hPSCreg; ATCi002-A
DR   Wikidata; Q111732944
RX   PubMed=35168097;
CC   From: Aegicare (Shenzhen) Technology Co; Shenzhen; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4452; GPC4; Simple; c.877+1G>A; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=35168097).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C186306; Keipert syndrome
DI   ORDO; Orphanet_2662; Keipert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   ATCi003-A
AC   CVCL_C6TH
DR   hPSCreg; ATCi003-A
DR   Wikidata; Q117704197
CC   From: Aegicare (Shenzhen) Technology Co; Shenzhen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   ATDC-5
AC   CVCL_3894
SY   ATDC5
DR   BTO; BTO_0001929
DR   CLO; CLO_0050536
DR   CLS; 305427
DR   ECACC; 99072806
DR   Lonza; 227
DR   RCB; RCB0565
DR   Wikidata; Q54751118
RX   PubMed=2201423;
RX   PubMed=23192741;
CC   Breed/subspecies: 129.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8068 ! AT805
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Atg3^(+/+)MEF
AC   CVCL_1T21
SY   Atg3 +/+ MEFs
DR   RCB; RCB3708
DR   Wikidata; Q54751120
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2FW
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   Atg3^(-/-)MEF
AC   CVCL_1T22
SY   Atg3 -/- MEFs
DR   RCB; RCB3709
DR   Wikidata; Q54751122
CC   Knockout cell: Method=KO mouse; MGI; MGI:1915091; Atg3.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2FW
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   Atg5^(+/+)MEF
AC   CVCL_0J74
SY   Atg5WT_A
DR   RCB; RCB2710
DR   Wikidata; Q54751124
RX   PubMed=15525940;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Atg5^(-/-)MEF
AC   CVCL_0J75
SY   Atg5KO_A
DR   RCB; RCB2711
DR   Wikidata; Q54751126
RX   PubMed=15525940;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Atg7^(+/+)MEF
AC   CVCL_VQ60
SY   Atg7 +/+ MEFs
DR   RCB; RCB3706
DR   Wikidata; Q93326713
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   Atg7^(-/-)MEF
AC   CVCL_VQ61
SY   Atg7 -/- MEFs
DR   RCB; RCB3707
DR   Wikidata; Q93326715
CC   Knockout cell: Method=KO mouse; MGI; MGI:1921494; Atg7.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   ATH15BE
AC   CVCL_F084
SY   ATH15Be; Ataxia Telangiectasia Heterozygote 15 BEthesda; GM03488; GM 3488; GM3488; GM03488A
DR   CLO; CLO_0017005
DR   BioSample; SAMN00808423
DR   Coriell; GM03488
DR   Wikidata; Q54838091
RX   CelloPub=CLPUB00447;
RX   PubMed=7104995;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser381Argfs*27 (c.1139_1142dupACAG) (c.1141_1142ins4); ClinVar=VCV000280044; Zygosity=Heterozygous (Coriell=GM03488).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F085 ! ATH15BE LCL
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   ATH15BE LCL
AC   CVCL_F085
SY   ATH15Be LCL; Ataxia Telangiectasia Heterozygote 15 BEthesda LCL; GM03187; GM 3187; GM03187A
DR   CLO; CLO_0013412
DR   BioSample; SAMN00808280
DR   Coriell; GM03187
DR   Wikidata; Q54837913
RX   CelloPub=CLPUB00447;
RX   PubMed=6173245;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser381Argfs*27 (c.1139_1142dupACAG) (c.1141_1142ins4); ClinVar=VCV000280044; Zygosity=Heterozygous (Coriell=GM03187).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F084 ! ATH15BE
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   ATH16BE
AC   CVCL_F086
SY   ATH16Be; Ataxia Telangiectasia Heterozygote 16 BEthesda; GM03489; GM 3489; GM3489; GM03489A
DR   CLO; CLO_0016997
DR   BioSample; SAMN00808424
DR   Coriell; GM03489
DR   Wikidata; Q54838092
RX   CelloPub=CLPUB00447;
RX   PubMed=7104995;
RX   PubMed=11172010;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys2756Ter (c.8266A>T); ClinVar=VCV000135780; Zygosity=Heterozygous (Coriell=GM03489).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F087 ! ATH16BE LCL
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   ATH16BE LCL
AC   CVCL_F087
SY   ATH16Be LCL; Ataxia Telangiectasia Heterozygote 16 BEthesda LCL; GM03188; GM 3188; GM03188A
DR   CLO; CLO_0013413
DR   BioSample; SAMN00808281
DR   Coriell; GM03188
DR   GEO; GSM1116563
DR   GEO; GSM1116564
DR   GEO; GSM1116605
DR   GEO; GSM1116606
DR   GEO; GSM1116607
DR   GEO; GSM1116608
DR   Wikidata; Q54837923
RX   CelloPub=CLPUB00447;
RX   PubMed=6173245;
RX   PubMed=23943852;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys2756Ter (c.8266A>T); ClinVar=VCV000135780; Zygosity=Heterozygous (Coriell=GM03188).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F086 ! ATH16BE
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   ATH19BE LCL
AC   CVCL_A2PL
SY   ATH19Be LCL; Ataxia Telangiectasia Heterozygote 19 BEthesda LCL; GM02930; GM 2930
DR   Coriell; GM02930
DR   Wikidata; Q105506435
RX   PubMed=6173245;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02930; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   ATH1ABR
AC   CVCL_RP08
SY   Ataxia Telangiectasia Heterozygote 1 Australia BRisbane
DR   Wikidata; Q54751221
RX   PubMed=6228733;
RX   PubMed=12195425;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Heterozygous (PubMed=12195425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   ATH20BE LCL
AC   CVCL_A2PM
SY   ATH20Be LCL; Ataxia Telangiectasia Heterozygote 19 BEthesda LCL; GM03227; GM 3227
DR   Coriell; GM03227
DR   Wikidata; Q105506439
RX   PubMed=6173245;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03227; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   ATH2ABR
AC   CVCL_RP09
SY   Ataxia Telangiectasia Heterozygote 2 Australia BRisbane
DR   Wikidata; Q54751224
RX   PubMed=12195425;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Heterozygous (PubMed=12195425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   ATH3ABR
AC   CVCL_RN90
SY   Ataxia Telangiectasia Heterozygote 3 Australia BRisbane
DR   Wikidata; Q54751227
RX   PubMed=6197197;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   ATH7BI
AC   CVCL_WX50
SY   Ataxia Telangiectasia Heterozygote 7 BIrmingham
DR   Wikidata; Q93326719
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   ATH8
AC   CVCL_5206
SY   ATH-8
DR   ChEMBL-Cells; CHEMBL3307903
DR   ChEMBL-Targets; CHEMBL614273
DR   PubChem_Cell_line; CVCL_5206
DR   Wikidata; Q54751228
RX   PubMed=2884263;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=ATH8
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   ATH8ABR
AC   CVCL_RN91
SY   Ataxia Telangiectasia Heterozygote 8 Australia BRisbane
DR   Wikidata; Q54751230
RX   PubMed=6197197;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   ATH96TO
AC   CVCL_WX51
DR   Wikidata; Q93326720
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   ATHM4BI
AC   CVCL_WY86
DR   Wikidata; Q93326722
RX   DOI=10.1007/978-1-4757-1117-2_12;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Athos
AC   CVCL_2298
SY   ATHOS
DR   CLO; CLO_0001763
DR   CLDB; cl294
DR   ECACC; 93122325
DR   Wikidata; Q54751232
RX   PubMed=1726925;
RX   PubMed=7687180;
RX   PubMed=8514246;
CC   Characteristics: Derived from parent cell line after withdrawal of thyroid stimulating hormone (TSH) (PubMed=7687180).
CC   Misspelling: ARTHOS; PubMed=1726925.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2695 ! Porthos
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   ATiPS-024
AC   CVCL_Y524
SY   AT-iPS-024; AT1OS-iPS_024
DR   SKIP; SKIP000392
DR   Wikidata; Q54751235
RX   PubMed=24970375;
RX   PubMed=27197874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2860 ! AT1OS
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 11
//
ID   ATiPS-262
AC   CVCL_Y525
SY   AT-iPS-262; AT1OS-iPS_262
DR   SKIP; SKIP000393
DR   Wikidata; Q54751236
RX   PubMed=24970375;
RX   PubMed=27197874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2860 ! AT1OS
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 11
//
ID   ATiPS-263
AC   CVCL_Y526
SY   AT-iPS-263; AT1OS-iPS_263
DR   SKIP; SKIP000394
DR   Wikidata; Q54751240
RX   PubMed=24970375;
RX   PubMed=27197874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2860 ! AT1OS
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 11
//
ID   ATiPS-264
AC   CVCL_Y527
SY   AT-iPS-264; AT1OS-iPS_264
DR   SKIP; SKIP000395
DR   Wikidata; Q54751242
RX   PubMed=24970375;
RX   PubMed=27197874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.4612del165 (Ex33del); Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2860 ! AT1OS
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 11
//
ID   ATL-10Y
AC   CVCL_A415
DR   Wikidata; Q54751245
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   ATL-11-6
AC   CVCL_A6SM
SY   ATL-11-6(+)
DR   RCB; RCB3561
DR   Wikidata; Q107113382
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-12A
AC   CVCL_JF72
SY   ATL-12A(+); ATL-12; ATL12A; ATL12
DR   RCB; RCB3562
DR   Wikidata; Q54751246
RX   PubMed=2866223;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   ATL-13
AC   CVCL_A6SN
DR   Wikidata; Q107113383
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-14T
AC   CVCL_A6SP
DR   Wikidata; Q107113385
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-16T
AC   CVCL_0147
SY   ATL-16T(-); ATL16T
DR   MCCL; MCC:0000040
DR   RCB; RCB3554
DR   Wikidata; Q54751251
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   ATL-17-2
AC   CVCL_6D78
SY   ATL-17-2(+)
DR   RCB; RCB3564
DR   Wikidata; Q54751252
RX   PubMed=2972890;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6SQ ! ATL-17C
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   ATL-17C
AC   CVCL_A6SQ
SY   ATL-17C(+)
DR   RCB; RCB3563
DR   Wikidata; Q107113386
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D78 ! ATL-17-2
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-18C
AC   CVCL_A6SR
SY   ATL-18C(+); ATL-18T
DR   RCB; RCB3565
DR   Wikidata; Q107113387
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-1K
AC   CVCL_A406
DR   RCB; RCB5263
DR   Wikidata; Q54751255
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 15
//
ID   ATL-2
AC   CVCL_8338
SY   ATL-2(+); ATL2
DR   RCB; RCB3545
DR   Wikidata; Q54751258
RX   PubMed=2866223;
RX   PubMed=9116292;
RX   PubMed=11021758;
RX   PubMed=11737246;
RX   PubMed=16314839;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   ATL-2(-)
AC   CVCL_A6TF
DR   RCB; RCB3546
DR   Wikidata; Q107113388
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8338 ! ATL-2
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-2/ADM cl-1
AC   CVCL_A7QA
DR   Wikidata; Q107113389
RX   PubMed=9116292;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8338 ! ATL-2
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   ATL-2/ADM cl-2
AC   CVCL_A7QB
DR   Wikidata; Q107113390
RX   PubMed=9116292;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8338 ! ATL-2
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   ATL-20
AC   CVCL_A6SS
DR   Wikidata; Q107113391
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-21C
AC   CVCL_VQ15
SY   ATL-21C(+)
DR   RCB; RCB3551
DR   Wikidata; Q93326733
RX   PubMed=16242045;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   ATL-21C(-)/2
AC   CVCL_A6TI
DR   RCB; RCB3552
DR   Wikidata; Q107113392
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency. Cultured for 2 years without IL2.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ15 ! ATL-21C
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-21C(-)/3.8
AC   CVCL_A6TQ
DR   Wikidata; Q107113393
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency. Cultured for 3.8 years without IL2.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ15 ! ATL-21C
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-21C(-)/8.9
AC   CVCL_A6TP
DR   RCB; RCB3553
DR   Wikidata; Q107113394
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency. Cultured for 8.9 years without IL2.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ15 ! ATL-21C
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-23
AC   CVCL_A6ST
SY   ATL-23(+); ATL-23T
DR   RCB; RCB3566
DR   Wikidata; Q107113395
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-26C
AC   CVCL_A6SU
SY   ATL-26C(+)
DR   RCB; RCB3567
DR   Wikidata; Q107113396
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-2M
AC   CVCL_A407
DR   Wikidata; Q54751260
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   ATL-35T
AC   CVCL_8339
SY   ATL-35T(-); ATL35T
DR   RCB; RCB3555
DR   Wikidata; Q54751262
RX   PubMed=16242045;
RX   PubMed=16314839;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ATL-3I
AC   CVCL_A408
DR   RCB; RCB5264
DR   Wikidata; Q54751265
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 15
//
ID   ATL-40T
AC   CVCL_A6SW
DR   Wikidata; Q107113397
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-41T
AC   CVCL_A6SX
DR   Wikidata; Q107113398
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-42T
AC   CVCL_A6SL
SY   ATL-42T(+)
DR   RCB; RCB3568
DR   Wikidata; Q107113399
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ATL-43T
AC   CVCL_8340
SY   ATL43T
DR   Wikidata; Q54751266
RX   PubMed=7662981;
RX   PubMed=10706122;
RX   PubMed=15638850;
RX   PubMed=16314839;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ATL-45T
AC   CVCL_A6TD
DR   Wikidata; Q107113402
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-46T
AC   CVCL_A6SZ
SY   ATL-46T(+)
DR   RCB; RCB3569
DR   Wikidata; Q107113403
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-48T
AC   CVCL_VQ16
SY   ATL-48T(+)
DR   RCB; RCB3535
DR   RCB; RCB3570
DR   Wikidata; Q93326745
RX   PubMed=2889484;
RX   PubMed=10706122;
RX   PubMed=16242045;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   ATL-48Tb(-)
AC   CVCL_A6SH
DR   RCB; RCB3536
DR   Wikidata; Q107113404
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ16 ! ATL-48T
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ATL-4K
AC   CVCL_A409
DR   Wikidata; Q54751271
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   ATL-55T
AC   CVCL_VQ17
SY   ATL-55T(+)
DR   RCB; RCB3537
DR   Wikidata; Q93326751
RX   PubMed=2889484;
RX   PubMed=10706122;
RX   PubMed=16242045;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   ATL-55T(-)
AC   CVCL_A6SG
DR   RCB; RCB3538
DR   Wikidata; Q107113405
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ17 ! ATL-55T
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ATL-5S
AC   CVCL_A410
DR   RCB; RCB5265
DR   Wikidata; Q54751272
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 15
//
ID   ATL-5T
AC   CVCL_X530
SY   ATL5T
DR   CGH-DB; 9029-4
DR   Wikidata; Q54751275
RX   PubMed=2890613;
RX   PubMed=9738977;
RX   PubMed=10570904;
CC   Population: Japanese.
CC   Doubling time: 58 hours (PubMed=2890613).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   ATL-6
AC   CVCL_A6SV
SY   ATL-6(+)
DR   RCB; RCB3559
DR   Wikidata; Q107113406
RX   PubMed=6327813;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   ATL-67T
AC   CVCL_A6SY
SY   ATL-67T(+)
DR   RCB; RCB3571
DR   Wikidata; Q107113407
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-6A
AC   CVCL_A411
DR   Wikidata; Q54751277
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   ATL-7
AC   CVCL_JF71
SY   ATL-7(+); ATL7
DR   RCB; RCB3560
DR   Wikidata; Q54751278
RX   PubMed=2866223;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   ATL-72/2
AC   CVCL_A6TA
SY   ATL-72/2(+)
DR   RCB; RCB3541
DR   Wikidata; Q107113408
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6TB ! ATL-72b
OI   CVCL_A6TC ! ATL-72T
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-72/2(-)
AC   CVCL_A6TE
DR   RCB; RCB3542
DR   Wikidata; Q107113409
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6TA ! ATL-72/2
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-72b
AC   CVCL_A6TB
SY   ATL-72b(+)
DR   RCB; RCB3549
DR   Wikidata; Q107113410
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6TA ! ATL-72/2
OI   CVCL_A6TC ! ATL-72T
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-72b(-)
AC   CVCL_A6TN
DR   RCB; RCB3550
DR   Wikidata; Q107113411
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6TB ! ATL-72b
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-72T
AC   CVCL_A6TC
SY   ATL-72T(+)
DR   RCB; RCB3572
DR   Wikidata; Q107113412
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6TA ! ATL-72/2
OI   CVCL_A6TB ! ATL-72b
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   ATL-7S
AC   CVCL_A412
DR   Wikidata; Q54751281
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   ATL-8K
AC   CVCL_A413
DR   Wikidata; Q54751283
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   ATL-9Y
AC   CVCL_A414
DR   Wikidata; Q54751284
RX   PubMed=6193528;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   ATL2ABR
AC   CVCL_ZT68
SY   Ataxia Telangiectasia-Like 2 Australia BRisbane
DR   Wikidata; Q98125520
RX   PubMed=16540636;
RX   PubMed=17347666;
RX   PubMed=25868131;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173403; Ataxia-oculomotor apraxia type 3
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW04 ! PSF [Human AOA3 fibroblast]
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   ATLAN1010 fibroblast
AC   CVCL_A9F2
DR   Wikidata; Q102113575
RX   PubMed=12927431;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Leu (c.398G>T); ClinVar=VCV000014488; Zygosity=Heterozygous (PubMed=12927431).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9F3 ! ATLAN1010 LCL
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   ATLAN1010 LCL
AC   CVCL_A9F3
DR   Wikidata; Q102113576
RX   PubMed=12927431;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Leu (c.398G>T); ClinVar=VCV000014488; Zygosity=Heterozygous (PubMed=12927431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9F2 ! ATLAN1010 fibroblast
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   ATM192
AC   CVCL_C5IC
DR   Wikidata; Q116048528
RX   PubMed=8913785;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11597; Human CETP (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ATN-1
AC   CVCL_1073
SY   ATN1
DR   CLO; CLO_0050985
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472143
DR   cancercelllines; CVCL_1073
DR   Cell_Model_Passport; SIDM00233
DR   ChEMBL-Cells; CHEMBL3308183
DR   ChEMBL-Targets; CHEMBL2366277
DR   Cosmic; 910687
DR   Cosmic-CLP; 910687
DR   DepMap; ACH-002058
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10421-106C7
DR   GDSC; 910687
DR   GEO; GSM1669604
DR   IARC_TP53; 21177
DR   LINCS_LDP; LCL-1025
DR   PharmacoDB; ATN1_68_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1073
DR   RCB; RCB1440
DR   Wikidata; Q54751288
RX   PubMed=3260813;
RX   PubMed=9738977;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=3260813).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Leu (c.814G>C); ClinVar=VCV000574679; Zygosity=Homozygous (Cosmic-CLP=910687; DepMap=ACH-002058).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.05%; East Asian, North=78.58%; East Asian, South=17.98%; South Asian=1.43%; European, North=0%; European, South=1.95% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=910687; RCB=RCB1440
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 10,13
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14,18
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   ATRFLOX
AC   CVCL_2299
SY   ATRFLOX [Mutatect]; ATRflox/-
DR   CLO; CLO_0001764
DR   EFO; EFO_0006535
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-2780
DR   BioSample; SAMN03472971
DR   cancercelllines; CVCL_2299
DR   ColonAtlas; ATRFLOX
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   PharmacoDB; ATRFLOX_69_2019
DR   Wikidata; Q54751289
RX   PubMed=11721054;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Caucasian.
CC   Characteristics: One copy of the ATR gene has been disrupted while lox sites have been added flanking exon 2 of the 2nd allele thus making it susceptible to Cre-mediated deletion.
CC   HLA typing: A*01:01,02:01; B*18:01,45:01; C*05:01,07:06 (PubMed=26589293).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:882; ATR (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2780; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 7,9
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,19
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   Atrt95
AC   CVCL_M154
DR   Wikidata; Q54751293
RX   PubMed=9786246;
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   ATS8
AC   CVCL_A2IP
SY   AT8
DR   Wikidata; Q105506442
RX   Patent=US8163873;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 91100806.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT (Note=Phosphorylated on p.Ser199 and/or p.Ser202).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   AtT-20
AC   CVCL_2300
SY   AtT 20; ATT-20; AtT20
DR   BTO; BTO_0001077
DR   CLO; CLO_0001765
DR   CLO; CLO_0001766
DR   EFO; EFO_0022777
DR   CLDB; cl296
DR   ATCC; CCL-89
DR   BCRC; 60244
DR   CCRID; 1101MOU-PUMC000061
DR   CCRID; 3101MOUTCM1
DR   CCRID; 5301MOU-KCB93012YJ
DR   ChEMBL-Cells; CHEMBL3307387
DR   ChEMBL-Targets; CHEMBL614523
DR   CLS; 305161
DR   ECACC; 87021902
DR   GEO; GSM635464
DR   GEO; GSM635465
DR   GEO; GSM635466
DR   GEO; GSM635467
DR   IZSLER; BS TCL 149
DR   JCRB; JCRB9098
DR   KCB; KCB 93012YJ
DR   Lonza; 228
DR   PubChem_Cell_line; CVCL_2300
DR   TOKU-E; 566
DR   TOKU-E; 4284
DR   Wikidata; Q54751294
RX   DOI=10.1007/BF02618370;
RX   PubMed=2177466;
RX   PubMed=6317196;
RX   PubMed=8383976;
RX   PubMed=13874682;
RX   PubMed=15541569;
RX   PubMed=21214938;
RX   PubMed=25277546;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-156.html
WW   Provider; Procell; -; https://www.procell.com.cn/view/526.html
CC   Characteristics: Produces adrenocorticotropic hormone (ACTH) (ATCC=CCL-89).
CC   Doubling time: ~3 days (Note=Lot 11152004) (JCRB=JCRB9098).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
ST   Source(s): Procell
ST   Mouse STR 1-1: 11,15
ST   Mouse STR 1-2: 13,17
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 10,14
ST   Mouse STR 4-2: 18.3
ST   Mouse STR 5-5: 16,18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 13,15
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 15
ST   Mouse STR 11-2: 15,16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 17.2,18.2
ST   Mouse STR 15-3: 17,22.3
ST   Mouse STR 17-2: 14
ST   Mouse STR 18-3: 17,18
ST   Mouse STR 19-2: 11,12
ST   Mouse STR X-1: 25
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   AtT-20-CB1
AC   CVCL_XA99
DR   Wikidata; Q93326813
RX   PubMed=31412133;
CC   Characteristics: Transfected with the pFRT/lacZeo2 plasmid.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA98 ! AtT-20-FlpIn
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   AtT-20-FlpIn
AC   CVCL_XA98
DR   Wikidata; Q93326815
RX   PubMed=31412133;
CC   Characteristics: Transfected with the pFRT/lacZeo2 plasmid.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2300 ! AtT-20
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   AtT-20-R1
AC   CVCL_F0KW
RX   PubMed=2191273;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W08 ! AtT-20/D16v
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AtT-20/D16-16
AC   CVCL_GZ35
DR   TOKU-E; 3994
DR   Wikidata; Q54751296
RX   PubMed=2575458;
RX   PubMed=6250490;
RX   PubMed=6300893;
CC   Characteristics: Produces adrenocorticotropic hormone (ACTH) (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Misspelling: AtT-20/D16-8; TOKU-E=3994.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W08 ! AtT-20/D16v
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   AtT-20/D16v
AC   CVCL_4W08
SY   AtT-20/D-16v; AtT-20/D 16v; AtT20D16v
DR   Wikidata; Q54751300
RX   PubMed=4312019;
RX   PubMed=6250490;
RX   PubMed=11383478;
CC   Characteristics: Produces adrenocorticotropic hormone (ACTH) (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2300 ! AtT-20
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   AtT-20/D16v-F2
AC   CVCL_4109
SY   AtT20D16v-F2
DR   CLO; CLO_0001767
DR   CLDB; cl295
DR   ATCC; CRL-1795
DR   ECACC; 94050406
DR   IZSLER; BS TCL 144
DR   TOKU-E; 567
DR   Wikidata; Q54751301
CC   Characteristics: Produces adrenocorticotropic hormone (ACTH) (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W08 ! AtT-20/D16v
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   AtT-20/HNP
AC   CVCL_C6XD
DR   Wikidata; Q117704199
RX   PubMed=8329717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2761; DEFA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2300 ! AtT-20
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   AtT-20ins
AC   CVCL_1G40
SY   AtT-20 ins
DR   Wikidata; Q54751303
RX   PubMed=1309953;
RX   PubMed=8325893;
RX   PubMed=8433987;
RX   PubMed=8697299;
CC   Characteristics: Expression of INS is driven by the RSV LTR (PubMed=1309953).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2300 ! AtT-20
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   AtT-20ins hGLUT-1 1-12
AC   CVCL_F0KU
SY   1-12
RX   PubMed=8325893;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11005; SLC2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1G40 ! AtT-20ins
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AtT-20ins hGLUT-1 1-2
AC   CVCL_F0KR
SY   1-2
RX   PubMed=8325893;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11005; SLC2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1G40 ! AtT-20ins
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AtT-20ins hGLUT-1 1-5
AC   CVCL_F0KS
SY   1-5
RX   PubMed=8325893;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11005; SLC2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1G40 ! AtT-20ins
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AtT-20ins hGLUT-1 1-8
AC   CVCL_F0KT
SY   1-8
RX   PubMed=8325893;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11005; SLC2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1G40 ! AtT-20ins
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AtT-20ins hGLUT-1 2-10
AC   CVCL_F0KV
SY   2-10
RX   PubMed=8325893;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11005; SLC2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1G40 ! AtT-20ins
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   AtT-20ins4b/1
AC   CVCL_1G39
DR   Wikidata; Q54751307
RX   PubMed=6317196;
CC   Characteristics: Expression of INS is driven by a SV40 promoter (PubMed=6317196).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2300 ! AtT-20
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   AtT20PL
AC   CVCL_ZW07
SY   AtT20 PL; AtT20 POMC-Luciferase
DR   Wikidata; Q102113578
RX   PubMed=9112388;
RX   PubMed=11578527;
CC   Characteristics: Expression of luciferase is under the control of the rat POMC promoter.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W08 ! AtT-20/D16v
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   ATTC1
AC   CVCL_VZ62
SY   Albuginea Tunica Testis Cat 1
DR   IBRC; C11095
DR   Wikidata; Q93326843
CC   Derived from site: In situ; Testis, tunica albuginea; UBERON=UBERON_0006610.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_VY51 ! EPTC1
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   ATTC2
AC   CVCL_VZ63
SY   Albuginea Tunica Testis Cat 2
DR   IBRC; C11087
DR   Wikidata; Q93326845
CC   Derived from site: In situ; Testis, tunica albuginea; UBERON=UBERON_0006610.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_VY52 ! EPTC2
OI   CVCL_VZ64 ! SMTC2
OI   CVCL_VZ65 ! VTTC2
SX   Male
AG   6Y6M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   ATTR3
AC   CVCL_D2WJ
DR   Wikidata; Q127380243
RX   PubMed=30032658;
WW   Provider; CReM; 659; https://stemcellbank.bu.edu/Catalog/Item/Details/659
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Leu78His (c.233T>A) (L78H); ClinVar=VCV000013420; Zygosity=Heterozygous (PubMed=30032658).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   ATTR5
AC   CVCL_D2WK
SY   ATTR5-2
DR   Wikidata; Q127380244
RX   PubMed=30032658;
WW   Provider; CReM; 661; https://stemcellbank.bu.edu/Catalog/Item/Details/661
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Val142Ile (c.424G>A) (V122I); ClinVar=VCV000013426; Zygosity=Heterozygous (PubMed=30032658).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_85451; ATTRV122I amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   ATU
AC   CVCL_B7M3
DR   Wikidata; Q112929242
RX   PubMed=10663561;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu1051_Asp1078del (c.3153_3236del84); Zygosity=Homozygous (PubMed=10663561).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   ATW
AC   CVCL_UD50
DR   Wikidata; Q93326847
RX   PubMed=1997098;
RX   PubMed=2789934;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 3
//
ID   ATX-01
AC   CVCL_WA38
SY   ATaXia-01
DR   IBRC; C10883
DR   Wikidata; Q93326850
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ATYAMA
AC   CVCL_JH27
DR   JCRB; JCRB3042
DR   JCRB; KURB1828
DR   Wikidata; Q54751308
CC   Population: Japanese.
CC   Discontinued: JCRB; JCRB3042; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   AU-565/Cas9-hyg
AC   CVCL_C9DE
DR   GeneCopoeia; SL574
DR   Wikidata; Q123030705
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL574).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1074 ! AU565
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   AU-BEK
AC   CVCL_6533
SY   AUBEK; Aubek; Auburn University-Bovine Embryonic Kidney
DR   CLO; CLO_0001770
DR   CLDB; cl297
DR   Wikidata; Q54751309
RX   PubMed=4798380;
CC   Misspelling: Aubeck; Note=In some Patents such as US5804430.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Mixed sex
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   AU10000
AC   CVCL_2N35
DR   CLO; CLO_0011292
DR   Coriell; AU10000
DR   Wikidata; Q54751355
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10001
AC   CVCL_2N36
DR   CLO; CLO_0011293
DR   Coriell; AU10001
DR   Wikidata; Q54751357
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10002
AC   CVCL_2N37
DR   CLO; CLO_0011298
DR   Coriell; AU10002
DR   Wikidata; Q54751358
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10003
AC   CVCL_2N38
DR   CLO; CLO_0011299
DR   Coriell; AU10003
DR   Wikidata; Q54751360
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of AU10004 (Cellosaurus=CVCL_2N39).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AU10004
AC   CVCL_2N39
DR   CLO; CLO_0011296
DR   Coriell; AU10004
DR   Wikidata; Q54751362
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of AU10003 (Cellosaurus=CVCL_2N38).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AU10005
AC   CVCL_2N40
DR   CLO; CLO_0011297
DR   Coriell; AU10005
DR   Wikidata; Q54751364
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10006
AC   CVCL_2N41
DR   CLO; CLO_0011300
DR   Coriell; AU10006
DR   Wikidata; Q54751366
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10007
AC   CVCL_2N42
DR   CLO; CLO_0011330
DR   Coriell; AU10007
DR   Wikidata; Q54751368
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10008
AC   CVCL_2N43
DR   CLO; CLO_0011329
DR   Coriell; AU10008
DR   Wikidata; Q54751369
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97179; Pervasive developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10009
AC   CVCL_2N44
DR   CLO; CLO_0011328
DR   Coriell; AU10009
DR   Wikidata; Q54751372
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10010
AC   CVCL_2N45
DR   CLO; CLO_0011327
DR   Coriell; AU10010
DR   Wikidata; Q54751374
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of AU10011 (Cellosaurus=CVCL_2N46).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AU10011
AC   CVCL_2N46
DR   CLO; CLO_0011326
DR   Coriell; AU10011
DR   Wikidata; Q54751375
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of AU10010 (Cellosaurus=CVCL_2N45).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AU10012
AC   CVCL_2N47
DR   CLO; CLO_0011325
DR   Coriell; AU10012
DR   Wikidata; Q54751377
CC   Part of: Autism Research Resource.
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10013
AC   CVCL_2N48
DR   CLO; CLO_0011324
DR   Coriell; AU10013
DR   Wikidata; Q54751380
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10014
AC   CVCL_2N49
DR   CLO; CLO_0011323
DR   Coriell; AU10014
DR   Wikidata; Q54751381
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10015
AC   CVCL_2N50
DR   CLO; CLO_0011322
DR   Coriell; AU10015
DR   Wikidata; Q54751383
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10016
AC   CVCL_2N51
DR   CLO; CLO_0011321
DR   Coriell; AU10016
DR   Wikidata; Q54751385
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10017
AC   CVCL_2N52
DR   CLO; CLO_0011338
DR   Coriell; AU10017
DR   Wikidata; Q54751388
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10018
AC   CVCL_2N53
DR   CLO; CLO_0011340
DR   Coriell; AU10018
DR   Wikidata; Q54751391
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10019
AC   CVCL_2N54
DR   CLO; CLO_0011339
DR   Coriell; AU10019
DR   Wikidata; Q54751394
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10020
AC   CVCL_2N55
DR   CLO; CLO_0011335
DR   Coriell; AU10020
DR   Wikidata; Q54751396
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10021
AC   CVCL_2N56
DR   CLO; CLO_0011334
DR   Coriell; AU10021
DR   Wikidata; Q54751399
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10022
AC   CVCL_2N57
DR   CLO; CLO_0011337
DR   Coriell; AU10022
DR   Wikidata; Q54751401
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10023
AC   CVCL_2N58
DR   CLO; CLO_0011336
DR   Coriell; AU10023
DR   Wikidata; Q54751403
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10024
AC   CVCL_2N59
DR   CLO; CLO_0011332
DR   Coriell; AU10024
DR   Wikidata; Q54751404
CC   Part of: Autism Research Resource.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10025
AC   CVCL_2N60
DR   CLO; CLO_0011331
DR   Coriell; AU10025
DR   Wikidata; Q54751405
CC   Part of: Autism Research Resource.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10026
AC   CVCL_2N61
DR   CLO; CLO_0011333
DR   Coriell; AU10026
DR   Wikidata; Q54751406
CC   Part of: Autism Research Resource.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10027
AC   CVCL_2N62
DR   CLO; CLO_0011306
DR   Coriell; AU10027
DR   Wikidata; Q54751408
CC   Part of: Autism Research Resource.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10028
AC   CVCL_2N63
DR   CLO; CLO_0011305
DR   Coriell; AU10028
DR   Wikidata; Q54751410
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10029
AC   CVCL_2N64
DR   CLO; CLO_0011304
DR   Coriell; AU10029
DR   Wikidata; Q54751414
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10030
AC   CVCL_2N65
DR   CLO; CLO_0011303
DR   Coriell; AU10030
DR   Wikidata; Q54751415
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of AU10031 (Cellosaurus=CVCL_2N66).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AU10031
AC   CVCL_2N66
DR   CLO; CLO_0011310
DR   Coriell; AU10031
DR   Wikidata; Q54751418
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of AU10030 (Cellosaurus=CVCL_2N65).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   AU10032
AC   CVCL_2N67
DR   CLO; CLO_0011309
DR   Coriell; AU10032
DR   Wikidata; Q54751419
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10033
AC   CVCL_2N68
DR   CLO; CLO_0011308
DR   Coriell; AU10033
DR   Wikidata; Q54751420
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10034
AC   CVCL_2N69
DR   CLO; CLO_0011307
DR   Coriell; AU10034
DR   Wikidata; Q54751421
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10035
AC   CVCL_2N70
DR   CLO; CLO_0011302
DR   Coriell; AU10035
DR   Wikidata; Q54751423
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10036
AC   CVCL_2N71
DR   CLO; CLO_0011301
DR   Coriell; AU10036
DR   Wikidata; Q54751424
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10037
AC   CVCL_2N72
DR   CLO; CLO_0011320
DR   Coriell; AU10037
DR   Wikidata; Q54751425
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97179; Pervasive developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10038
AC   CVCL_2N73
DR   CLO; CLO_0011313
DR   Coriell; AU10038
DR   Wikidata; Q54751428
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10039
AC   CVCL_2N74
DR   CLO; CLO_0011312
DR   Coriell; AU10039
DR   Wikidata; Q54751429
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10040
AC   CVCL_2N75
DR   CLO; CLO_0011315
DR   Coriell; AU10040
DR   Wikidata; Q54751467
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10041
AC   CVCL_2N76
DR   CLO; CLO_0011314
DR   Coriell; AU10041
DR   Wikidata; Q54751469
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10042
AC   CVCL_2N77
DR   CLO; CLO_0011317
DR   Coriell; AU10042
DR   Wikidata; Q54751472
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10043
AC   CVCL_2N78
DR   CLO; CLO_0011316
DR   Coriell; AU10043
DR   Wikidata; Q54751473
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10044
AC   CVCL_2N79
DR   CLO; CLO_0011319
DR   Coriell; AU10044
DR   Wikidata; Q54751476
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10045
AC   CVCL_2N80
DR   CLO; CLO_0011318
DR   Coriell; AU10045
DR   Wikidata; Q54751477
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10047
AC   CVCL_2N81
DR   CLO; CLO_0011311
DR   Coriell; AU10047
DR   Wikidata; Q54751480
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10048
AC   CVCL_2N82
DR   CLO; CLO_0011370
DR   Coriell; AU10048
DR   Wikidata; Q54751483
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10049
AC   CVCL_2N83
DR   CLO; CLO_0011369
DR   Coriell; AU10049
DR   Wikidata; Q54751485
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10050
AC   CVCL_2N84
DR   CLO; CLO_0011367
DR   Coriell; AU10050
DR   Wikidata; Q54751486
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10051
AC   CVCL_2N85
DR   CLO; CLO_0011368
DR   Coriell; AU10051
DR   Wikidata; Q54751489
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10052
AC   CVCL_2N86
DR   CLO; CLO_0011365
DR   Coriell; AU10052
DR   Wikidata; Q54751491
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10053
AC   CVCL_2N87
DR   CLO; CLO_0011366
DR   Coriell; AU10053
DR   Wikidata; Q54751493
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10054
AC   CVCL_2N88
DR   CLO; CLO_0011363
DR   Coriell; AU10054
DR   Wikidata; Q54751495
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10055
AC   CVCL_2N89
DR   CLO; CLO_0011364
DR   Coriell; AU10055
DR   Wikidata; Q54751498
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10056
AC   CVCL_2N90
DR   CLO; CLO_0011361
DR   Coriell; AU10056
DR   Wikidata; Q54751501
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10057
AC   CVCL_2N91
DR   CLO; CLO_0011362
DR   Coriell; AU10057
DR   Wikidata; Q54751502
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10058
AC   CVCL_2N92
DR   CLO; CLO_0011378
DR   Coriell; AU10058
DR   Wikidata; Q54751504
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10059
AC   CVCL_2N93
DR   CLO; CLO_0011380
DR   Coriell; AU10059
DR   Wikidata; Q54751505
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10060
AC   CVCL_2N94
DR   CLO; CLO_0011379
DR   Coriell; AU10060
DR   Wikidata; Q54751508
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10061
AC   CVCL_2N95
DR   CLO; CLO_0011374
DR   Coriell; AU10061
DR   Wikidata; Q54751510
CC   Part of: Autism Research Resource.
CC   Population: Caribbean; Trinidadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AU10062
AC   CVCL_2N96
DR   CLO; CLO_0011375
DR   Coriell; AU10062
DR   Wikidata; Q54751511
CC   Part of: Autism Research Resource.
CC   Population: Caucasian; Czechoslovakian/Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10063
AC   CVCL_2N97
DR   CLO; CLO_0011376
DR   Coriell; AU10063
DR   Wikidata; Q54751513
CC   Part of: Autism Research Resource.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AU10064
AC   CVCL_2N98
DR   CLO; CLO_0011377
DR   Coriell; AU10064
DR   Wikidata; Q54751515
CC   Part of: Autism Research Resource.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97179; Pervasive developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AU10065
AC   CVCL_2N99
DR   CLO; CLO_0011371
DR   Coriell; AU10065
DR   Wikidata; Q54751516
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10066
AC   CVCL_2P00
DR   CLO; CLO_0011372
DR   Coriell; AU10066
DR   Wikidata; Q54751519
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10067
AC   CVCL_2P01
DR   CLO; CLO_0011373
DR   Coriell; AU10067
DR   Wikidata; Q54751520
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10068
AC   CVCL_2P02
DR   CLO; CLO_0011350
DR   Coriell; AU10068
DR   Wikidata; Q54751522
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10069
AC   CVCL_2P03
DR   CLO; CLO_0011349
DR   Coriell; AU10069
DR   Wikidata; Q54751525
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10070
AC   CVCL_2P04
DR   CLO; CLO_0011348
DR   Coriell; AU10070
DR   Wikidata; Q54751526
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10071
AC   CVCL_2P05
DR   CLO; CLO_0011347
DR   Coriell; AU10071
DR   Wikidata; Q54751529
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10072
AC   CVCL_2P06
DR   CLO; CLO_0011343
DR   Coriell; AU10072
DR   Wikidata; Q54751531
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10073
AC   CVCL_2P07
DR   CLO; CLO_0011344
DR   Coriell; AU10073
DR   Wikidata; Q54751532
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10074
AC   CVCL_2P08
DR   CLO; CLO_0011341
DR   Coriell; AU10074
DR   Wikidata; Q54751534
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10075
AC   CVCL_2P09
DR   CLO; CLO_0011342
DR   Coriell; AU10075
DR   Wikidata; Q54751536
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10076
AC   CVCL_2P10
DR   CLO; CLO_0011345
DR   Coriell; AU10076
DR   Wikidata; Q54751537
CC   Part of: Autism Research Resource.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10077
AC   CVCL_2P11
DR   CLO; CLO_0011346
DR   Coriell; AU10077
DR   Wikidata; Q54751541
CC   Part of: Autism Research Resource.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AU10078
AC   CVCL_2P12
DR   CLO; CLO_0011356
DR   Coriell; AU10078
DR   Wikidata; Q54751542
CC   Part of: Autism Research Resource.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AU10079
AC   CVCL_2P13
DR   CLO; CLO_0011358
DR   Coriell; AU10079
DR   Wikidata; Q54751544
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10080
AC   CVCL_2P14
DR   CLO; CLO_0011357
DR   Coriell; AU10080
DR   Wikidata; Q54751546
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10081
AC   CVCL_2P15
DR   CLO; CLO_0011360
DR   Coriell; AU10081
DR   Wikidata; Q54751594
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10082
AC   CVCL_2P16
DR   CLO; CLO_0011359
DR   Coriell; AU10082
DR   Wikidata; Q54751595
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10083
AC   CVCL_2P17
DR   CLO; CLO_0011351
DR   Coriell; AU10083
DR   Wikidata; Q54751597
CC   Part of: Autism Research Resource.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10084
AC   CVCL_2P18
DR   CLO; CLO_0011352
DR   Coriell; AU10084
DR   Wikidata; Q54751599
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10085
AC   CVCL_2P19
DR   CLO; CLO_0011353
DR   Coriell; AU10085
DR   Wikidata; Q54751601
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10086
AC   CVCL_2P20
DR   CLO; CLO_0011354
DR   Coriell; AU10086
DR   Wikidata; Q54751604
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10087
AC   CVCL_2P21
DR   CLO; CLO_0011355
DR   Coriell; AU10087
DR   Wikidata; Q54751605
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10088
AC   CVCL_2P22
DR   CLO; CLO_0010938
DR   Coriell; AU10088
DR   Wikidata; Q54751607
CC   Part of: Autism Research Resource.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AU10089
AC   CVCL_2P23
DR   CLO; CLO_0010939
DR   Coriell; AU10089
DR   Wikidata; Q54751609
CC   Part of: Autism Research Resource.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AU10090
AC   CVCL_2P24
DR   CLO; CLO_0010940
DR   Coriell; AU10090
DR   Wikidata; Q54751611
CC   Part of: Autism Research Resource.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   AU10091
AC   CVCL_2P25
DR   CLO; CLO_0010934
DR   Coriell; AU10091
DR   Wikidata; Q54751612
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10092
AC   CVCL_2P26
DR   CLO; CLO_0010935
DR   Coriell; AU10092
DR   Wikidata; Q54751614
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10093
AC   CVCL_2P27
DR   CLO; CLO_0010936
DR   Coriell; AU10093
DR   Wikidata; Q54751616
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10094
AC   CVCL_2P28
DR   CLO; CLO_0010937
DR   Coriell; AU10094
DR   Wikidata; Q54751618
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10095
AC   CVCL_2P29
DR   CLO; CLO_0010926
DR   Coriell; AU10095
DR   Wikidata; Q54751620
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10096
AC   CVCL_2P30
DR   CLO; CLO_0010929
DR   Coriell; AU10096
DR   Wikidata; Q54751621
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10097
AC   CVCL_2P31
DR   CLO; CLO_0010931
DR   Coriell; AU10097
DR   Wikidata; Q54751624
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10098
AC   CVCL_2P32
DR   CLO; CLO_0010959
DR   Coriell; AU10098
DR   Wikidata; Q54751626
CC   Part of: Autism Research Resource.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AU10099
AC   CVCL_2P33
DR   CLO; CLO_0010960
DR   Coriell; AU10099
DR   Wikidata; Q54751628
CC   Part of: Autism Research Resource.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AU10100
AC   CVCL_2P34
DR   CLO; CLO_0010957
DR   Coriell; AU10100
DR   Wikidata; Q54751631
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10101
AC   CVCL_2P35
DR   CLO; CLO_0010958
DR   Coriell; AU10101
DR   Wikidata; Q54751632
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10102
AC   CVCL_2P36
DR   CLO; CLO_0010955
DR   Coriell; AU10102
DR   Wikidata; Q54751633
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10103
AC   CVCL_2P37
DR   CLO; CLO_0010956
DR   Coriell; AU10103
DR   Wikidata; Q54751635
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10104
AC   CVCL_2P38
DR   CLO; CLO_0010953
DR   Coriell; AU10104
DR   Wikidata; Q54751636
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10105
AC   CVCL_2P39
DR   CLO; CLO_0010954
DR   Coriell; AU10105
DR   Wikidata; Q54751638
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10106
AC   CVCL_2P40
DR   CLO; CLO_0010949
DR   Coriell; AU10106
DR   Wikidata; Q54751640
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10107
AC   CVCL_2P41
DR   CLO; CLO_0010951
DR   Coriell; AU10107
DR   Wikidata; Q54751641
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10108
AC   CVCL_2P42
DR   CLO; CLO_0010966
DR   Coriell; AU10108
DR   Wikidata; Q54751642
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10109
AC   CVCL_2P43
DR   CLO; CLO_0010967
DR   Coriell; AU10109
DR   Wikidata; Q54751644
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10110
AC   CVCL_2P44
DR   CLO; CLO_0010968
DR   Coriell; AU10110
DR   Wikidata; Q54751645
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10111
AC   CVCL_2P45
DR   CLO; CLO_0010969
DR   Coriell; AU10111
DR   Wikidata; Q54751647
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10112
AC   CVCL_2P46
DR   CLO; CLO_0010970
DR   Coriell; AU10112
DR   Wikidata; Q54751651
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10113
AC   CVCL_2P47
DR   CLO; CLO_0010961
DR   Coriell; AU10113
DR   Wikidata; Q54751652
CC   Part of: Autism Research Resource.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10114
AC   CVCL_2P48
DR   CLO; CLO_0010962
DR   Coriell; AU10114
DR   Wikidata; Q54751653
CC   Part of: Autism Research Resource.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10115
AC   CVCL_2P49
DR   CLO; CLO_0010963
DR   Coriell; AU10115
DR   Wikidata; Q54751656
CC   Part of: Autism Research Resource.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10116
AC   CVCL_2P50
DR   CLO; CLO_0010964
DR   Coriell; AU10116
DR   Wikidata; Q54751657
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10117
AC   CVCL_2P51
DR   CLO; CLO_0010965
DR   Coriell; AU10117
DR   Wikidata; Q54751660
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10118
AC   CVCL_2P52
DR   CLO; CLO_0010975
DR   Coriell; AU10118
DR   Wikidata; Q54751661
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10119
AC   CVCL_2P53
DR   CLO; CLO_0010976
DR   Coriell; AU10119
DR   Wikidata; Q54751663
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10120
AC   CVCL_2P54
DR   CLO; CLO_0010979
DR   Coriell; AU10120
DR   Wikidata; Q54751665
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10121
AC   CVCL_2P55
DR   CLO; CLO_0010980
DR   Coriell; AU10121
DR   Wikidata; Q54751718
CC   Part of: Autism Research Resource.
CC   Population: Caucasian; English.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10124
AC   CVCL_2P56
DR   CLO; CLO_0010977
DR   Coriell; AU10124
DR   Wikidata; Q54751720
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10125
AC   CVCL_2P57
DR   CLO; CLO_0010978
DR   Coriell; AU10125
DR   Wikidata; Q54751722
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10126
AC   CVCL_2P58
DR   CLO; CLO_0010973
DR   Coriell; AU10126
DR   Wikidata; Q54751725
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10128
AC   CVCL_2P59
DR   CLO; CLO_0010974
DR   Coriell; AU10128
DR   Wikidata; Q54751727
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10129
AC   CVCL_2P60
DR   CLO; CLO_0010971
DR   Coriell; AU10129
DR   Wikidata; Q54751729
CC   Part of: Autism Research Resource.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10130
AC   CVCL_2P61
DR   CLO; CLO_0010972
DR   Coriell; AU10130
DR   Wikidata; Q54751731
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10131
AC   CVCL_2P62
DR   CLO; CLO_0010987
DR   Coriell; AU10131
DR   Wikidata; Q54751732
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10132
AC   CVCL_2P63
DR   CLO; CLO_0010986
DR   Coriell; AU10132
DR   Wikidata; Q54751734
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10133
AC   CVCL_2P64
DR   CLO; CLO_0010985
DR   Coriell; AU10133
DR   Wikidata; Q54751736
CC   Part of: Autism Research Resource.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   AU10134
AC   CVCL_2P65
DR   CLO; CLO_0010984
DR   Coriell; AU10134
DR   Wikidata; Q54751738
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10135
AC   CVCL_2P66
DR   CLO; CLO_0010983
DR   Coriell; AU10135
DR   Wikidata; Q54751739
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10136
AC   CVCL_2P67
DR   CLO; CLO_0010982
DR   Coriell; AU10136
DR   Wikidata; Q54751741
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10137
AC   CVCL_2P68
DR   CLO; CLO_0010981
DR   Coriell; AU10137
DR   Wikidata; Q54751743
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10138
AC   CVCL_2P69
DR   CLO; CLO_0010990
DR   Coriell; AU10138
DR   Wikidata; Q54751745
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10139
AC   CVCL_2P70
DR   CLO; CLO_0010989
DR   Coriell; AU10139
DR   Wikidata; Q54751747
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10140
AC   CVCL_2P71
DR   CLO; CLO_0010988
DR   Coriell; AU10140
DR   Wikidata; Q54751749
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10141
AC   CVCL_2P72
DR   CLO; CLO_0010996
DR   Coriell; AU10141
DR   Wikidata; Q54751751
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10142
AC   CVCL_2P73
DR   CLO; CLO_0010995
DR   Coriell; AU10142
DR   Wikidata; Q54751755
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10143
AC   CVCL_2P74
DR   CLO; CLO_0010998
DR   Coriell; AU10143
DR   Wikidata; Q54751757
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10144
AC   CVCL_2P75
DR   CLO; CLO_0010997
DR   Coriell; AU10144
DR   Wikidata; Q54751761
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10145
AC   CVCL_2P76
DR   CLO; CLO_0010992
DR   Coriell; AU10145
DR   Wikidata; Q54751762
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10146
AC   CVCL_2P77
DR   CLO; CLO_0010991
DR   Coriell; AU10146
DR   Wikidata; Q54751765
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10147
AC   CVCL_2P78
DR   CLO; CLO_0010994
DR   Coriell; AU10147
DR   Wikidata; Q54751767
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10148
AC   CVCL_2P79
DR   CLO; CLO_0010993
DR   Coriell; AU10148
DR   Wikidata; Q54751770
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10149
AC   CVCL_2P80
DR   CLO; CLO_0011000
DR   Coriell; AU10149
DR   Wikidata; Q54751771
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10150
AC   CVCL_2P81
DR   CLO; CLO_0010999
DR   Coriell; AU10150
DR   Wikidata; Q54751773
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10151
AC   CVCL_2P82
DR   CLO; CLO_0011010
DR   Coriell; AU10151
DR   Wikidata; Q54751777
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10152
AC   CVCL_2P83
DR   CLO; CLO_0011004
DR   Coriell; AU10152
DR   Wikidata; Q54751778
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10153
AC   CVCL_2P84
DR   CLO; CLO_0011003
DR   Coriell; AU10153
DR   Wikidata; Q54751781
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10154
AC   CVCL_2P85
DR   CLO; CLO_0011002
DR   Coriell; AU10154
DR   Wikidata; Q54751782
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10155
AC   CVCL_2P86
DR   CLO; CLO_0011001
DR   Coriell; AU10155
DR   Wikidata; Q54751786
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10156
AC   CVCL_2P87
DR   CLO; CLO_0011008
DR   Coriell; AU10156
DR   Wikidata; Q54751788
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10157
AC   CVCL_2P88
DR   CLO; CLO_0011007
DR   Coriell; AU10157
DR   Wikidata; Q54751790
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10158
AC   CVCL_2P89
DR   CLO; CLO_0011006
DR   Coriell; AU10158
DR   Wikidata; Q54751792
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10159
AC   CVCL_2P90
DR   CLO; CLO_0011005
DR   Coriell; AU10159
DR   Wikidata; Q54751793
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10160
AC   CVCL_2P91
DR   CLO; CLO_0011009
DR   Coriell; AU10160
DR   Wikidata; Q54751794
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10161
AC   CVCL_2P92
DR   CLO; CLO_0011019
DR   Coriell; AU10161
DR   Wikidata; Q54751795
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10162
AC   CVCL_2P93
DR   CLO; CLO_0011020
DR   Coriell; AU10162
DR   Wikidata; Q54751800
CC   Part of: Autism Research Resource.
CC   Population: Native North American; Laguna Pueblo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10163
AC   CVCL_2P94
DR   CLO; CLO_0011012
DR   Coriell; AU10163
DR   Wikidata; Q54751801
CC   Part of: Autism Research Resource.
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10164
AC   CVCL_2P95
DR   CLO; CLO_0011011
DR   Coriell; AU10164
DR   Wikidata; Q54751845
CC   Part of: Autism Research Resource.
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10165
AC   CVCL_2P96
DR   CLO; CLO_0011014
DR   Coriell; AU10165
DR   Wikidata; Q54751847
CC   Part of: Autism Research Resource.
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10166
AC   CVCL_2P97
DR   CLO; CLO_0011013
DR   Coriell; AU10166
DR   Wikidata; Q54751849
CC   Part of: Autism Research Resource.
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10167
AC   CVCL_2P98
DR   CLO; CLO_0011016
DR   Coriell; AU10167
DR   Wikidata; Q54751852
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10168
AC   CVCL_2P99
DR   CLO; CLO_0011015
DR   Coriell; AU10168
DR   Wikidata; Q54751853
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10169
AC   CVCL_2Q00
DR   CLO; CLO_0011018
DR   Coriell; AU10169
DR   Wikidata; Q54751855
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10170
AC   CVCL_2Q01
DR   CLO; CLO_0011017
DR   Coriell; AU10170
DR   Wikidata; Q54751858
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10171
AC   CVCL_2Q02
DR   CLO; CLO_0011030
DR   Coriell; AU10171
DR   Wikidata; Q54751859
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10172
AC   CVCL_2Q03
DR   CLO; CLO_0011029
DR   Coriell; AU10172
DR   Wikidata; Q54751861
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10173
AC   CVCL_2Q04
DR   CLO; CLO_0011028
DR   Coriell; AU10173
DR   Wikidata; Q54751863
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10174
AC   CVCL_2Q05
DR   CLO; CLO_0011026
DR   Coriell; AU10174
DR   Wikidata; Q54751864
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10175
AC   CVCL_2Q06
DR   CLO; CLO_0011027
DR   Coriell; AU10175
DR   Wikidata; Q54751865
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10176
AC   CVCL_2Q07
DR   CLO; CLO_0011024
DR   Coriell; AU10176
DR   Wikidata; Q54751866
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10177
AC   CVCL_2Q08
DR   CLO; CLO_0011025
DR   Coriell; AU10177
DR   Wikidata; Q54751868
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10178
AC   CVCL_2Q09
DR   CLO; CLO_0011022
DR   Coriell; AU10178
DR   Wikidata; Q54751870
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10179
AC   CVCL_2Q10
DR   CLO; CLO_0011023
DR   Coriell; AU10179
DR   Wikidata; Q54751871
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10180
AC   CVCL_2Q11
DR   CLO; CLO_0011021
DR   Coriell; AU10180
DR   Wikidata; Q54751873
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10181
AC   CVCL_2Q12
DR   CLO; CLO_0011038
DR   Coriell; AU10181
DR   Wikidata; Q54751876
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10182
AC   CVCL_2Q13
DR   CLO; CLO_0011037
DR   Coriell; AU10182
DR   Wikidata; Q54751878
CC   Part of: Autism Research Resource.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10183
AC   CVCL_2Q14
DR   CLO; CLO_0011040
DR   Coriell; AU10183
DR   Wikidata; Q54751879
CC   Part of: Autism Research Resource.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10184
AC   CVCL_2Q15
DR   CLO; CLO_0011039
DR   Coriell; AU10184
DR   Wikidata; Q54751881
CC   Part of: Autism Research Resource.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU10185
AC   CVCL_2Q16
DR   CLO; CLO_0011033
DR   Coriell; AU10185
DR   Wikidata; Q54751883
CC   Part of: Autism Research Resource.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   AU16
AC   CVCL_C5WI
DR   Wikidata; Q116048530
RX   PubMed=2897994;
RX   PubMed=7907126;
CC   Characteristics: IL2 dependent.
CC   Characteristics: Cytotoxic activity on melanoma cells (PubMed=7907126).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Dendritic epidermal T-cell; CL=CL_0000916.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   AU4
AC   CVCL_C5WJ
DR   Wikidata; Q116048531
RX   PubMed=2897994;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Dendritic epidermal T-cell; CL=CL_0000916.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   AU565
AC   CVCL_1074
SY   AU-565; AU 565
DR   BTO; BTO_0004737
DR   CLO; CLO_0001769
DR   EFO; EFO_0001087
DR   AddexBio; C0006010/4900
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-2351
DR   BioGRID_ORCS_Cell_line; 333
DR   BioSample; SAMN03470878
DR   BioSample; SAMN03471449
DR   BioSample; SAMN10987882
DR   cancercelllines; CVCL_1074
DR   Cell_Model_Passport; SIDM00898
DR   ChEMBL-Cells; CHEMBL3308095
DR   ChEMBL-Targets; CHEMBL1075393
DR   Cosmic; 687462
DR   Cosmic; 910704
DR   Cosmic; 1136358
DR   Cosmic; 1176652
DR   Cosmic; 1309002
DR   Cosmic; 1995342
DR   Cosmic; 2165002
DR   Cosmic-CLP; 910704
DR   DepMap; ACH-000248
DR   EGA; EGAS00001000978
DR   GDSC; 910704
DR   GEO; GSM274658
DR   GEO; GSM344340
DR   GEO; GSM344390
DR   GEO; GSM843441
DR   GEO; GSM843442
DR   GEO; GSM847196
DR   GEO; GSM847451
DR   GEO; GSM886871
DR   GEO; GSM887936
DR   GEO; GSM1053701
DR   GEO; GSM1172851
DR   GEO; GSM1172939
DR   GEO; GSM1238118
DR   GEO; GSM1421428
DR   GEO; GSM1669605
DR   GEO; GSM2258812
DR   GEO; GSM2258813
DR   GEO; GSM2258814
DR   GEO; GSM2258815
DR   GEO; GSM2258816
DR   GEO; GSM2258817
DR   GEO; GSM2258818
DR   GEO; GSM2258819
DR   GEO; GSM2258820
DR   GEO; GSM2258821
DR   GEO; GSM2258822
DR   GEO; GSM2258823
DR   GEO; GSM2258824
DR   GEO; GSM2258825
DR   GEO; GSM2258826
DR   GEO; GSM2258827
DR   GEO; GSM2258828
DR   GEO; GSM2258829
DR   GEO; GSM2258923
DR   GEO; GSM2258924
DR   GEO; GSM2258925
DR   IARC_TP53; 21178
DR   LiGeA; CCLE_052
DR   LINCS_HMS; 50091
DR   LINCS_LDP; LCL-1462
DR   PharmacoDB; AU565_70_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1074
DR   PubChem_Cell_line; CVCL_1074
DR   SLKBase; 3384
DR   Wikidata; Q54751885
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: MET genetic alteration cell panel (ATCC TCP-1036).
CC   Population: Caucasian.
CC   Doubling time: 46.31 hours (JWGray panel).
CC   HLA typing: A*02:01,03:01; B*14:01,40:01; C*03:04,08:02; DQB1*05:01,06:04 (PubMed=25960936).
CC   HLA typing: A*02:01,03:01; B*14:02,40:07; C*03:04,08:02; DQA1*02:01,02:01; DQB1*06:04,06:04; DRB1*11:30,11:30 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (ATCC=CRL-2351).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.17%; Native American=0%; East Asian, North=1.67%; East Asian, South=0%; South Asian=0.01%; European, North=64.07%; European, South=34.08% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006010/4900; ATCC=CRL-2351; Cosmic-CLP=910704; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 10,13
ST   D19S433: 14
ST   D21S11: 30,30.2
ST   D2S1338: 20,25
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 9,12
ST   D8S1179: 11,12 (PubMed=25877200)
ST   D8S1179: 12 (ATCC=CRL-2351)
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   AUC
AC   CVCL_AV82
SY   GM00328; GM-328; GM0328; GM328
DR   CLO; CLO_0025538
DR   Coriell; GM00328
DR   Wikidata; Q54751888
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2475503;
RX   PubMed=2837086;
RX   PubMed=5231733;
CC   Discontinued: Coriell; GM00328; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98944; Hereditary orotic aciduria
DI   ORDO; Orphanet_30; Hereditary orotic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   AUi001-A
AC   CVCL_A0MC
DR   BioSamples; SAMEA9000723
DR   hPSCreg; AUi001-A
DR   Wikidata; Q108819860
CC   From: Aarhus University; Aarhus; Denmark.
CC   Population: Caucasian; Danish.
CC   Sequence variation: Mutation; HGNC; HGNC:6118; IRF3; Simple; p.Arg285Gln (c.854G>A); ClinVar=VCV000208454; Zygosity=Heterozygous (hPSCreg=AUi001-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84762; Herpes simplex encephalitis
DI   ORDO; Orphanet_1930; Herpes simplex virus encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   AUi002-A
AC   CVCL_A0MD
DR   hPSCreg; AUi002-A
DR   Wikidata; Q108819861
CC   From: Aarhus University; Aarhus; Denmark.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   AUS40010
AC   CVCL_VI08
DR   Wikidata; Q54751890
RX   PubMed=9230208;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg389Glufs*4 (c.1165delA); ClinVar=VCV000238117; Zygosity=Heterozygous (PubMed=9230208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   AUS40025
AC   CVCL_VI09
DR   Wikidata; Q54751892
RX   PubMed=9230208;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg389Glufs*4 (c.1165delA); ClinVar=VCV000238117; Zygosity=Heterozygous (PubMed=9230208).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln1153fs*1158 (c.3572+2T>A); Zygosity=Heterozygous (PubMed=9230208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   AuxB1 DeltaP-gp B1
AC   CVCL_C7GJ
DR   Wikidata; Q117704201
RX   PubMed=35381425;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; P21448; Abcb1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AuxB1 DeltaP-gp B2
AC   CVCL_C7GK
DR   Wikidata; Q117704202
RX   PubMed=35381425;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; P21448; Abcb1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   AV036
AC   CVCL_UI92
DR   Wikidata; Q93327475
RX   PubMed=15645491;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.631+2T>G (IVS7+2T>G); ClinVar=VCV000009349; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=15645491).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (PubMed=15645491).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI93 ! SB1685CB
OI   CVCL_UI94 ! SB1690CB
SX   Male
AG   1Y2M
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   AV1F1
AC   CVCL_XE95
DR   CCRID; 4201PAT-CCTCC00232
DR   Wikidata; Q93327476
RX   Patent=CN101575375A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200804.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6Q788; Human APOA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   AV2G1
AC   CVCL_XE96
DR   CCRID; 4201PAT-CCTCC00231
DR   Wikidata; Q93327477
RX   Patent=CN101575375A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200805.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6Q788; Human APOA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   AV3
AC   CVCL_1904
SY   AV 3; AV-3
DR   CLO; CLO_0001771
DR   CLO; CLO_0001772
DR   CLO; CLO_0001773
DR   CLDB; cl298
DR   CLDB; cl299
DR   ATCC; CCL-21
DR   BioSample; SAMN03151665
DR   BioSample; SAMN03471470
DR   ECACC; 88102402
DR   IZSLER; BS CL 3
DR   KCLB; 10021
DR   Wikidata; Q54751895
RX   DOI=10.1007/BF02618370;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=5668122;
RX   PubMed=14185313;
RX   PubMed=20143388;
RX   PubMed=23925245;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00001.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Discontinued: KCLB; 10021; probable.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-21; ECACC=88102402; IZSLER=BS CL 3
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3 (ATCC=CCL-21)
ST   D13S317: 14 (ECACC=88102402; IZSLER=BS CL 3)
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Ava-BL
AC   CVCL_7174
DR   Wikidata; Q54751896
RX   PubMed=12219084;
RX   PubMed=16051863;
RX   PubMed=28960205;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   AVAS12
AC   CVCL_KB09
SY   Avas12
DR   RCB; RCB4484
DR   Wikidata; Q54751898
RX   PubMed=9493833;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35918; Mouse Kdr/Cd309.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   AVC1
AC   CVCL_W927
DR   cancercelllines; CVCL_W927
DR   Cosmic; 966783
DR   PRIDE; PXD002657
DR   Wikidata; Q54751902
RX   PubMed=14677066;
RX   PubMed=26951071;
CC   Doubling time: 24 +- 1 hours (PubMed=14677066).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=14677066).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   AVE,G
AC   CVCL_E463
SY   AVE, G
DR   dbMHC; 48481
DR   IHW; IHW09120
DR   IPD-IMGT/HLA; 10274
DR   Wikidata; Q54751908
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02,31; B*27:05,40:01; C*02:02; DPB1*02:01:02,11:01:01; DQA1*05:01,02:01; DQB1*02:01,03:01; DRB1*07,11:01:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=10274).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   AVE-115
AC   CVCL_4631
DR   CLO; CLO_0001774
DR   ATCC; CRL-6507
DR   Wikidata; Q54751904
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6507; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   AVG-16
AC   CVCL_4110
DR   ECACC; 06062701
DR   Wikidata; Q54751910
RX   PubMed=16848633;
RX   PubMed=26667575;
CC   Characteristics: Requires a media supplement called Ovagrow-S2A for continuous growth, but the company (Aivogen AG) producing this media does not exist anymore (Direct_author_submission).
CC   Miscellaneous: Media supplement from personal communication of Horisberger, Michel A.
CC   Discontinued: ECACC; 06062701; true.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   4-5M
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   AVL
AC   CVCL_E464
SY   GM06823; GM06823A
DR   CLO; CLO_0036529
DR   Coriell; GM06823
DR   IHW; 9w 0301
DR   IPD-IMGT/HLA; 10275
DR   Wikidata; Q54751913
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=6417008;
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*01; B*08; C*07 (PubMed=6417008).
CC   HLA typing: DRB1*03:01:01:01; DRB2*01:01; DRB3*01:01:02:01 (IPD-IMGT/HLA=10275).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Indicated as originating from a female in Coriell and from a male in IPD-IMGT/HLA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 19
//
ID   AVL/CTVM13
AC   CVCL_Z140
DR   Wikidata; Q54751915
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34610; ! Amblyomma variegatum (Tropical bont tick)
SX   Sex unspecified
AG   Moulting larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   AVL/CTVM17
AC   CVCL_Z141
SY   AVL/CTVM 17
DR   ECACC; 94022811
DR   Wikidata; Q54751918
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022811; true.
OX   NCBI_TaxID=34610; ! Amblyomma variegatum (Tropical bont tick)
SX   Sex unspecified
AG   Moulting larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   AVL3-MEL
AC   CVCL_VU91
SY   AVL3-Mel
DR   Wikidata; Q93327485
RX   PubMed=10352307;
RX   PubMed=11751535;
RX   PubMed=14871852;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   AVND-3C8
AC   CVCL_XX91
SY   3C8
DR   CCRID; 4201PAT-CCTCC00253
DR   Wikidata; Q93327487
RX   Patent=CN101481416A;
RX   PubMed=15847176;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200835.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Acute viral necrosis virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   AVO
AC   CVCL_EI30
DR   Cosmic; 1071907
DR   Cosmic; 1176607
DR   Wikidata; Q54751920
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 4
//
ID   AVP-Ser18del-iPSC
AC   CVCL_JJ78
SY   AVP-Ser18del-iPSCs
DR   Wikidata; Q54751922
RX   PubMed=28413003;
CC   From: Department of Paediatrics, Aarhus University Hospital; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:894; AVP; Simple; p.Ser18del (c.52_54delTCC) (g.276_278delTCC); Zygosity=Heterozygous (PubMed=28413003).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   AVS
AC   CVCL_HC48
DR   Wikidata; Q54751923
RX   PubMed=15220421;
CC   Transformant: NCBI_TaxID; 10623; Cottontail rabbit papillomavirus (Kappapapillomavirus 2).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
ID   AW 10498
AC   CVCL_D651
DR   Wikidata; Q54751927
RX   PubMed=1691185;
CC   Population: Indian.
CC   Doubling time: 52.2 hours (PubMed=1691185).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 11
//
ID   AW 13516
AC   CVCL_D652
SY   AW13516
DR   Wikidata; Q54751977
RX   PubMed=1691185;
CC   Population: Indian.
CC   Doubling time: 35.5 hours (PubMed=1691185).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 11
//
ID   AW 8507
AC   CVCL_D653
SY   AW8507
DR   Wikidata; Q54751979
RX   PubMed=1691185;
CC   Population: Indian.
CC   Doubling time: 31.9 hours (PubMed=1691185).
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 11
//
ID   AW 9803
AC   CVCL_D654
DR   Wikidata; Q54751982
RX   PubMed=1691185;
CC   Population: Indian.
CC   Doubling time: 66 hours (PubMed=1691185).
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   AW-EBV-LCL
AC   CVCL_L559
DR   CLO; CLO_0051003
DR   BioSample; SAMN03472140
DR   RCB; RCB1437
DR   Wikidata; Q54751983
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1437
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 7,10
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 12
//
ID   Aw3.18.14
AC   CVCL_J158
DR   CLO; CLO_0001775
DR   ATCC; CRL-2826
DR   Wikidata; Q54751986
RX   PubMed=9208845;
CC   Doubling time: 14 hours (ATCC=CRL-2826).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ (Note=Recognizes peptide 66-80 bound to MHC class II I-Ak).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   AWCA
AC   CVCL_ER22
SY   CC-1
DR   Wikidata; Q54751987
RX   PubMed=1691480;
RX   PubMed=8764055;
CC   Virology: Contains 2 copies of the HPV18 genome.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 8
//
ID   AWELLS
AC   CVCL_E465
SY   Awells; WEL,AK; WEL, AK
DR   dbMHC; 48482
DR   ECACC; 94082236
DR   IHW; IHW09090
DR   IPD-IMGT/HLA; 11615
DR   Wikidata; Q54751988
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01; B*44:02:01:01; C*05:01:01:02; DPB1*04:01:01,14:01:01; DQA1*03; DQB1*03:01:01; DRB1*04:01:01; DRB4*01:01 (IPD-IMGT/HLA=11615).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   Awia-BL
AC   CVCL_ZU71
DR   Wikidata; Q98125521
RX   PubMed=17001014;
RX   PubMed=28960205;
CC   Population: African; Ugandan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
ID   AWT KoTa
AC   CVCL_A7PD
DR   JCRB; KURB2102
DR   Wikidata; Q107113413
CC   Population: Japanese.
CC   Karyotypic information: 46,XY,del(11)(p13) (JCRB=KURB2102).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   AX-EA1-G1
AC   CVCL_B0UU
SY   9F6
DR   Wikidata; Q108819862
RX   Patent=US7618783;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2632.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P94217; Bacillus anthracis S-layer protein EA1 (eag).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   AX0049
AC   CVCL_8B82
DR   ECACC; 91041816
DR   Wikidata; Q54751990
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(1)(pter->cen->q21::q24->qter) (ECACC=91041816).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   AX0050
AC   CVCL_8B83
DR   ECACC; 91041817
DR   Wikidata; Q54751993
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041817; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   AX0051
AC   CVCL_8B84
DR   ECACC; 91041818
DR   Wikidata; Q54751995
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041818; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   AX0052
AC   CVCL_8B85
DR   ECACC; 91041819
DR   Wikidata; Q54751996
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041819; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   AX0664
AC   CVCL_E5SW
WW   Provider; Axol; -; https://axolbio.com/shop/central_nervous_system_cells/microglia/cryopreserved-human-ipsc-derived-microglia-1m-cells/
CC   Miscellaneous: Derived from a fibroblast-derived induced pluripotent stem cell (Axol).
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-50Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ax223
AC   CVCL_XE24
DR   Wikidata; Q93327533
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10853.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax225
AC   CVCL_XE25
DR   Wikidata; Q93327535
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10855.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax232
AC   CVCL_XE26
DR   Wikidata; Q93327537
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10854.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax258
AC   CVCL_XE27
DR   Wikidata; Q93327539
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10856.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax284
AC   CVCL_XE28
DR   Wikidata; Q93327540
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10857.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax285
AC   CVCL_XE29
DR   Wikidata; Q93327541
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10858.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax292
AC   CVCL_XE30
DR   Wikidata; Q93327542
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10859.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax51
AC   CVCL_XE31
DR   Wikidata; Q93327543
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10851.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax7
AC   CVCL_XE32
DR   Wikidata; Q93327544
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10850.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Ax96
AC   CVCL_XE33
DR   Wikidata; Q93327545
RX   Patent=US9175091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10852.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   AXiAEC
AC   CVCL_C1LZ
DR   Wikidata; Q114310636
RX   PubMed=35832493;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=35832493).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 1 pneumocyte; CL=CL_0002062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   AY-11
AC   CVCL_6G28
SY   AY 11; AY11; T 11
DR   Wikidata; Q54751999
RX   PubMed=7298281;
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64161; Transitional cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   AY-27
AC   CVCL_S825
SY   AY 27; AY27
DR   ChEMBL-Cells; CHEMBL4482253
DR   Millipore; SCC254
DR   PubChem_Cell_line; CVCL_S825
DR   Wikidata; Q54752001
RX   PubMed=2936252;
RX   PubMed=2981157;
RX   PubMed=7298281;
RX   PubMed=10574249;
RX   PubMed=20404568;
RX   PubMed=21424013;
RX   PubMed=29732388;
CC   Characteristics: Tumorigenic.
CC   Doubling time: 0.927 +- 0.206 days (PubMed=2936252).
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64161; Transitional cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   AY0001
AC   CVCL_8B86
DR   ECACC; 90112812
DR   Wikidata; Q54752002
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(4;?)(p1.16;?); de novo (ECACC=90112812).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   AY31
AC   CVCL_6G27
SY   AY 31; AY-31
DR   Wikidata; Q54752006
RX   PubMed=7298281;
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64161; Transitional cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   AY32
AC   CVCL_6F40
SY   AY 32; AY-32
DR   Wikidata; Q54752009
RX   PubMed=2981157;
RX   PubMed=7298281;
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64146; Squamous cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   AY33
AC   CVCL_6F41
SY   AY 33; AY-33
DR   Wikidata; Q54752012
RX   PubMed=2981157;
RX   PubMed=7298281;
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64161; Transitional cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   AY34
AC   CVCL_6F42
SY   AY 34; AY-34
DR   Wikidata; Q54752014
RX   PubMed=2981157;
RX   PubMed=7298281;
RX   PubMed=7448785;
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64161; Transitional cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   AZ-521
AC   CVCL_2862
SY   AZ 521; AZ521
DR   CLO; CLO_0037137
DR   CLO; CLO_0050792
DR   EFO; EFO_0002814
DR   BioSample; SAMN03151798
DR   cancercelllines; CVCL_2862
DR   Cell_Model_Passport; SIDM01934
DR   CGH-DB; 136-1
DR   ChEMBL-Cells; CHEMBL3307904
DR   ChEMBL-Targets; CHEMBL614274
DR   Cosmic; 877047
DR   Cosmic; 889108
DR   Cosmic; 918495
DR   Cosmic; 1066228
DR   Cosmic; 1077281
DR   Cosmic; 1187267
DR   Cosmic; 1482080
DR   Cosmic; 1518246
DR   Cosmic; 2484969
DR   DepMap; ACH-001015
DR   FANTOM5_SSTAR; 10549-107H9
DR   GEO; GSM552355
DR   GEO; GSM562393
DR   GEO; GSM827401
DR   GEO; GSM843443
DR   GEO; GSM886872
DR   GEO; GSM887937
DR   GEO; GSM1374397
DR   IARC_TP53; 21179
DR   JCRB; JCRB0061
DR   LINCS_LDP; LCL-1533
DR   PharmacoDB; AZ521_72_2019
DR   Progenetix; CVCL_2862
DR   PubChem_Cell_line; CVCL_2862
DR   RCB; RCB2087
DR   TKG; TKG 0185
DR   Wikidata; Q54752018
RX   PubMed=1370612;
RX   PubMed=15723654;
RX   PubMed=15767549;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25343454;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; RCB; -; https://cell.brc.riken.jp/en/announcement/az521
CC   Problematic cell line: Contaminated. Shown to be a Hutu 80 derivative (see JCRB web site).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00369.
CC   Doubling time: ~30 hours (Note=Lot 11162006) (JCRB=JCRB0061).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Phe (c.110C>T); ClinVar=VCV000017586; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1370612).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=78.39%; Native American=0%; East Asian, North=1.7%; East Asian, South=0%; South Asian=0.23%; European, North=10.56%; European, South=9.12% (PubMed=30894373).
CC   Discontinued: RCB; RCB2087; true.
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
ST   Source(s): JCRB=JCRB0061; RCB=RCB2087; TKG=TKG 0185
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C7889; Duodenal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1301 ! HuTu 80
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   AZ-H3c
AC   CVCL_9480
SY   AZ-H3C
DR   cancercelllines; CVCL_9480
DR   Wikidata; Q54752019
RX   PubMed=8609064;
CC   Problematic cell line: Contaminated. Parent cell line (AZ-521) has been shown to be a Hutu 80 derivative.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Phe (c.110C>T); ClinVar=VCV000017586; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
DI   NCIt; C7889; Duodenal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2862 ! AZ-521
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   AZ-H6c
AC   CVCL_9479
SY   AZ-H6C
DR   cancercelllines; CVCL_9479
DR   Cosmic; 873709
DR   Cosmic; 888822
DR   Cosmic; 1122337
DR   Cosmic; 1187268
DR   Cosmic; 1518243
DR   Wikidata; Q54752021
RX   PubMed=8609064;
CC   Problematic cell line: Contaminated. Parent cell line (AZ-521) has been shown to be a Hutu 80 derivative.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Phe (c.110C>T); ClinVar=VCV000017586; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
DI   NCIt; C7889; Duodenal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2862 ! AZ-521
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   AZ125
AC   CVCL_F1XS
RX   PubMed=8393354;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03206; Epstein-Barr virus (strain B95-8) lytic switch protein ZEBRA/BZLF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AZ130
AC   CVCL_F1XR
DR   ABCD; ABCD_BG442
RX   PubMed=8393354;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03206; Epstein-Barr virus (strain B95-8) lytic switch protein ZEBRA/BZLF1.
CC   Caution: Isotype of the mAB from this hybridoma and that produced by AZ94 (Cellosaurus=CVCL_F1XT) were probably inversed in PubMed=8393354.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AZ303
AC   CVCL_D300
DR   Wikidata; Q54752024
RX   PubMed=1423308;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D301 ! AZ382
OI   CVCL_D303 ! AZ390
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   AZ364
AC   CVCL_D302
DR   Wikidata; Q54752026
RX   PubMed=1423308;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   AZ382
AC   CVCL_D301
DR   Wikidata; Q54752029
RX   PubMed=1423308;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D300 ! AZ303
OI   CVCL_D303 ! AZ390
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   AZ390
AC   CVCL_D303
DR   Wikidata; Q54752030
RX   PubMed=1423308;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D300 ! AZ303
OI   CVCL_D301 ! AZ382
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   AZ402
AC   CVCL_D304
DR   Wikidata; Q54752034
RX   PubMed=1423308;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   AZ403
AC   CVCL_D305
DR   Wikidata; Q54752036
RX   PubMed=1423308;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   AZ418
AC   CVCL_D306
DR   Wikidata; Q54752039
RX   PubMed=1423308;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D307 ! AZ419
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   AZ419
AC   CVCL_D307
DR   Wikidata; Q54752041
RX   PubMed=1423308;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D306 ! AZ418
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   AZ94
AC   CVCL_F1XT
RX   PubMed=8393354;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P03206; Epstein-Barr virus (strain B95-8) lytic switch protein ZEBRA/BZLF1.
CC   Caution: Isotype of the mAB from this hybridoma and that produced by AZ130 (Cellosaurus=CVCL_F1XR) were probably inversed in PubMed=8393354.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   AZa6#11
AC   CVCL_C8LR
DR   Wikidata; Q123030706
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#14
AC   CVCL_C8LS
DR   Wikidata; Q123030707
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#15
AC   CVCL_C8LT
DR   Wikidata; Q123030708
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#21
AC   CVCL_C8LU
DR   Wikidata; Q123030709
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#210
AC   CVCL_C8LV
DR   Wikidata; Q123030710
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#26
AC   CVCL_C8LW
DR   Wikidata; Q123030711
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#29
AC   CVCL_C8LX
DR   Wikidata; Q123030712
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#31
AC   CVCL_C8LY
DR   Wikidata; Q123030713
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#33
AC   CVCL_C8LZ
DR   Wikidata; Q123030714
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#34
AC   CVCL_C8M0
DR   Wikidata; Q123030715
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZa6#35
AC   CVCL_C8M1
DR   Wikidata; Q123030716
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#11
AC   CVCL_C8M2
DR   Wikidata; Q123030718
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#22
AC   CVCL_C8M3
DR   Wikidata; Q123030719
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#23
AC   CVCL_C8M4
DR   Wikidata; Q123030720
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#24
AC   CVCL_C8M5
DR   Wikidata; Q123030721
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#27
AC   CVCL_C8M6
DR   Wikidata; Q123030723
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#37
AC   CVCL_C8M7
DR   Wikidata; Q123030725
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#38
AC   CVCL_C8M8
DR   Wikidata; Q123030726
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZb6#43
AC   CVCL_C8M9
DR   Wikidata; Q123030727
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZc6#22
AC   CVCL_C8MA
DR   Wikidata; Q123030728
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZc6#24
AC   CVCL_C8MB
DR   Wikidata; Q123030729
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZc6#24b
AC   CVCL_C8MC
DR   Wikidata; Q123030730
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZc6#25
AC   CVCL_C8MD
DR   Wikidata; Q123030731
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZc6#27
AC   CVCL_C8ME
DR   Wikidata; Q123030732
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZc6#31
AC   CVCL_C8MF
DR   Wikidata; Q123030733
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AzcHAT-15X
AC   CVCL_XG09
DR   Wikidata; Q93327586
RX   PubMed=1688246;
CC   Characteristics: Deficient in HPRT.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG08 ! AzcHAT-8X
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   AzcHAT-1X
AC   CVCL_XG06
DR   Wikidata; Q93327589
RX   PubMed=1688246;
CC   Characteristics: Deficient in HPRT.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG05 ! 4TG-11
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   AzcHAT-1X100C
AC   CVCL_XG10
DR   Wikidata; Q93327591
RX   PubMed=1688246;
CC   Characteristics: Deficient in HPRT.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG06 ! AzcHAT-1X
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   AzcHAT-1X400C
AC   CVCL_XG11
DR   Wikidata; Q93327593
RX   PubMed=1688246;
CC   Characteristics: Deficient in HPRT.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG06 ! AzcHAT-1X
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   AzcHAT-4X
AC   CVCL_XG07
DR   Wikidata; Q93327595
RX   PubMed=1688246;
CC   Characteristics: Deficient in HPRT.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG06 ! AzcHAT-1X
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   AzcHAT-8X
AC   CVCL_XG08
DR   Wikidata; Q93327597
RX   PubMed=1688246;
CC   Characteristics: Deficient in HPRT.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG07 ! AzcHAT-4X
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   AZH
AC   CVCL_E466
DR   dbMHC; 48483
DR   ECACC; 94071439
DR   IHW; IHW09293
DR   IPD-IMGT/HLA; 10278
DR   Wikidata; Q54752044
RX   PubMed=28360230;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Jewish.
CC   HLA typing: A*24; B*56; C*01; DPB1*03:01; DQA1*01:02:01; DQB1*05:02:01; DRB1*16:01:01; DRB5*02:02 (IPD-IMGT/HLA=10278).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   AZo6#31
AC   CVCL_C8MG
DR   Wikidata; Q123030734
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#32
AC   CVCL_C8MH
DR   Wikidata; Q123030735
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#41
AC   CVCL_C8MI
DR   Wikidata; Q123030736
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#410
AC   CVCL_C8MJ
DR   Wikidata; Q123030737
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#42
AC   CVCL_C8MK
DR   Wikidata; Q123030738
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#43
AC   CVCL_C8ML
DR   Wikidata; Q123030739
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#44
AC   CVCL_C8MM
DR   Wikidata; Q123030740
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#45
AC   CVCL_C8MN
DR   Wikidata; Q123030741
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#46
AC   CVCL_C8MP
DR   Wikidata; Q123030742
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#47
AC   CVCL_C8MQ
DR   Wikidata; Q123030743
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#48
AC   CVCL_C8MR
DR   Wikidata; Q123030744
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZo6#49
AC   CVCL_C8MS
DR   Wikidata; Q123030745
RX   PubMed=22244174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_40909; Azoxystrobin (Amistar).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   AZP-01
AC   CVCL_WA39
SY   AZoosPermia-01
DR   IBRC; C10649
DR   Wikidata; Q93327605
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   AZP-02
AC   CVCL_WA40
SY   AZoosPermia-02
DR   IBRC; C10650
DR   Wikidata; Q93327608
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   Azr3
AC   CVCL_5A63
DR   Wikidata; Q54752046
RX   PubMed=954094;
CC   Selected for resistance to: ChEBI; CHEBI_6198; (S)-azetidine-2-carboxylic acid (AZCA).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A61 ! V79 A3
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   Azr7
AC   CVCL_5A64
DR   Wikidata; Q54752048
RX   PubMed=954094;
CC   Selected for resistance to: ChEBI; CHEBI_6198; (S)-azetidine-2-carboxylic acid (AZCA).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A61 ! V79 A3
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   B 5
AC   CVCL_J748
SY   B5; M-28
DR   CLO; CLO_0001818
DR   Wikidata; Q54752051
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8453.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   B-1-1 [Mouse hybridoma against EBV]
AC   CVCL_F0WW
RX   PubMed=6177865;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Epstein-Barr virus (strain B95-8) 212/236 kDa membrane antigen complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   B-1-1 [Mouse/rat hybridoma against Ig lambda chain]
AC   CVCL_D6TQ
SY   B-l-1; B1.1
RX   PubMed=6432681;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Mouse Ig lambda light chains (Note=Reacts with free and bound lambda chains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   B-1-A-2
AC   CVCL_U224
SY   B-1
DR   JCRB; JCRB0243
DR   Wikidata; Q54752052
RX   PubMed=3643104;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   B-187
AC   CVCL_B7RJ
DR   Wikidata; Q112929243
RX   PubMed=6307565;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7RI ! BES-1
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   B-23
AC   CVCL_L176
DR   KCLB; 60049
DR   Wikidata; Q54752056
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 6
//
ID   B-29
AC   CVCL_W182
DR   ATCC; CRL-6325
DR   Wikidata; Q54752058
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Discontinued: ATCC; CRL-6325; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/Crgl.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5840 ! Mm5MT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   B-3
AC   CVCL_6367
AS   CVCL_8482
SY   HLE-B3; HLE B-3; HLEB-3; HLEB3; HLEC-B3
DR   BTO; BTO_0002221
DR   CLO; CLO_0001812
DR   ATCC; CRL-3603
DR   ATCC; CRL-11421
DR   BioSample; SAMN03471336
DR   Wikidata; Q54752060
RX   Patent=US5643782;
RX   PubMed=8206728;
RX   PubMed=14578405;
CC   Group: Patented cell line.
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11421.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-11421; true.
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
ST   Source(s): ATCC=CRL-3603
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-12M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   B-4
AC   CVCL_D851
SY   HLE-B4
DR   Wikidata; Q54752062
RX   PubMed=8206728;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5-12M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   B-63
AC   CVCL_4502
DR   CLO; CLO_0001824
DR   CLDB; cl5136
DR   ATCC; CRL-6326
DR   IZSLER; BS TCL 137
DR   Wikidata; Q54752065
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6326; true.
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 6
//
ID   B-ATL1
AC   CVCL_JF59
DR   Wikidata; Q54752069
RX   PubMed=6092185;
CC   Population: Japanese.
CC   Doubling time: 23 hours (PubMed=6092185).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   B-ATL2
AC   CVCL_JF60
DR   Wikidata; Q54752117
RX   PubMed=6092185;
CC   Population: Japanese.
CC   Doubling time: 19 hours (PubMed=6092185).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   B-ATL3
AC   CVCL_JF61
DR   Wikidata; Q54752118
RX   PubMed=6092185;
CC   Population: Japanese.
CC   Doubling time: 38 hours (PubMed=6092185).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   B-ATL4
AC   CVCL_JF62
DR   Wikidata; Q54752121
RX   PubMed=6092185;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=6092185).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   B-ATL5
AC   CVCL_JF63
DR   Wikidata; Q54752122
RX   PubMed=6092185;
CC   Population: Japanese.
CC   Doubling time: 53 hours (PubMed=6092185).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   B-ATL6
AC   CVCL_JF64
DR   Wikidata; Q54752123
RX   PubMed=6092185;
CC   Population: Japanese.
CC   Doubling time: 31 hours (PubMed=6092185).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   B-ATL7
AC   CVCL_JF65
DR   Wikidata; Q54752126
RX   PubMed=6092185;
CC   Population: Japanese.
CC   Doubling time: 20 hours (PubMed=6092185).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   B-C9921F
AC   CVCL_LM93
SY   TNGB-67035; 67035
DR   TNGB; 67035
DR   Wikidata; Q54752129
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18-22FW
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   B-CPAP
AC   CVCL_0153
SY   BC-PAP; BCPAP
DR   BTO; BTO_0004736
DR   CLO; CLO_0001906
DR   MCCL; MCC:0000045
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471001
DR   BioSample; SAMN10989558
DR   cancercelllines; CVCL_0153
DR   CCRID; 3101HUMSCSP543
DR   Cell_Model_Passport; SIDM00992
DR   ChEMBL-Cells; CHEMBL3308356
DR   ChEMBL-Targets; CHEMBL1075394
DR   CLS; 305081
DR   Cosmic; 755292
DR   Cosmic; 849970
DR   Cosmic; 924104
DR   Cosmic; 928836
DR   Cosmic; 931241
DR   Cosmic; 1084279
DR   Cosmic; 1162847
DR   Cosmic; 1237447
DR   Cosmic; 1239965
DR   Cosmic; 1280047
DR   Cosmic; 1507369
DR   Cosmic; 1533552
DR   Cosmic; 1536122
DR   Cosmic; 1889007
DR   Cosmic; 2036692
DR   Cosmic; 2054086
DR   Cosmic; 2319847
DR   Cosmic; 2613253
DR   Cosmic; 2791089
DR   Cosmic-CLP; 924104
DR   DepMap; ACH-000456
DR   DSMZ; ACC-273
DR   DSMZCellDive; ACC-273
DR   EGA; EGAS00001000978
DR   GDSC; 924104
DR   GEO; GSM886875
DR   GEO; GSM887940
DR   GEO; GSM1669612
DR   IARC_TP53; 25011
DR   LiGeA; CCLE_362
DR   LINCS_LDP; LCL-1687
DR   NCBI_Iran; C596
DR   PharmacoDB; BCPAP_82_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0153
DR   PubChem_Cell_line; CVCL_0153
DR   Wikidata; Q54752132
RX   PubMed=1297527;
RX   PubMed=8156527;
RX   PubMed=11439348;
RX   PubMed=14522906;
RX   PubMed=15172756;
RX   PubMed=17725429;
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=19087340;
RX   PubMed=20164919;
RX   PubMed=21868764;
RX   PubMed=22087789;
RX   PubMed=22460905;
RX   PubMed=23162534;
RX   PubMed=23833040;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28775782;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=32666385;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (DSMZ=ACC-273).
CC   HLA typing: A*02:01,33:01; B*18:01,35:01; C*04:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=23162534; PubMed=23833040; PubMed=30737244; Cosmic-CLP=924104; DepMap=ACH-000456).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Tyr (c.775G>T); ClinVar=VCV000634680; Zygosity=Homozygous (PubMed=14522906; PubMed=23162534; PubMed=30737244; Cosmic-CLP=924104; DepMap=ACH-000456).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.56%; Native American=1.26%; East Asian, North=0.45%; East Asian, South=1.09%; South Asian=1.92%; European, North=43.75%; European, South=50.97% (PubMed=30894373).
CC   Caution: Originally classified a thyroid gland papillary carcinoma (PTC) but is now considered to be a poorly differentiated thyroid gland carcinoma (PDTC) (PubMed=23162534).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=924104; DSMZ=ACC-273; PubMed=18713817; PubMed=21868764; PubMed=25877200; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 13.2,15 (PubMed=25877200)
ST   D19S433: 14,15 (DSMZ=ACC-273)
ST   D21S11: 30 (DSMZ=ACC-273)
ST   D21S11: 30,31.2 (PubMed=18713817; PubMed=25877200; PubMed=30737244)
ST   D2S1338: 18
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   Penta D: 10,11
ST   Penta E: 5,12 (DSMZ=ACC-273)
ST   Penta E: 5,12,17 (PubMed=25877200)
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   B-HM8
AC   CVCL_J313
DR   Wikidata; Q54752134
RX   PubMed=6819484;
RX   PubMed=8996567;
CC   Characteristics: Lost its original pigmentation and has remained amelanotic since (PubMed=8996567).
CC   Doubling time: 70.5 hours (PubMed=6819484).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   B-LCL #1038-153 1
AC   CVCL_VP69
SY   B-LCL #1038-3162JN16
DR   Wikidata; Q93327698
CC   Population: Caucasian.
CC   HLA typing: A*02,31; B*15,57; C*03,06; DRB1*15,13 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8EW ! B-LCL #1038-153 2
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-153 2
AC   CVCL_E8EW
SY   B-LCL #1038-4553JA20
WW   Provider; Cellero; 1038-4553JA20; https://web.archive.org/web/20220122015245/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-4553ja20/
CC   Population: Caucasian.
CC   HLA typing: A*02:01,31:01; B*15:01,57:01; C*03:03,06:02; DRB1*15:01,13:01 (Cellero=1038-4553JA20).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP69 ! B-LCL #1038-153 1
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL #1038-165 1
AC   CVCL_VP65
SY   B-LCL #1038-2755JA15
DR   Wikidata; Q93327701
CC   Population: Caucasian.
CC   HLA typing: A*11,24; B*07,35; C*04,07; DRB1*11,14 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8EY ! B-LCL #1038-165 2
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-165 2
AC   CVCL_E8EY
SY   B-LCL #1038-4382JY19
WW   Provider; Cellero; 1038-4382JY19; https://web.archive.org/web/20220122032039/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-4382jy19/
CC   Population: Caucasian.
CC   HLA typing: A*11,24; B*07,35; C*04,07; DRB1*11,15 (Cellero=1038-4382JY19).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP65 ! B-LCL #1038-165 1
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL #1038-205
AC   CVCL_VP64
SY   B-LCL #1038-2750JA15
DR   Wikidata; Q93327703
WW   Provider; Cellero; 1038-2750JA15; https://web.archive.org/web/20220122014926/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-2750ja15/
CC   Population: Caucasian.
CC   HLA typing: A*01,03; B*15,37; C*03,06; DRB1*07,13 (Cellero=1038-2750JA15).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-206 1
AC   CVCL_VP62
SY   B-LCL #1038-2742JA15
DR   Wikidata; Q93327705
CC   Population: Caucasian.
CC   HLA typing: A*03,11; B*07,51; C*07,15; DRB1*04:01,04:04 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8EX ! B-LCL #1038-206 2
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-206 2
AC   CVCL_E8EX
SY   B-LCL #1038-4414AU19
WW   Provider; Cellero; 1038-4414AU19; https://web.archive.org/web/20220122013909/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-4414au19/
CC   Population: Caucasian.
CC   HLA typing: A*03:01,11:01; B*07:02,51:01; C*07:01,15:02; DRB1*04:01,04:04 (Cellero=1038-4414AU19).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP62 ! B-LCL #1038-206 1
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL #1038-213
AC   CVCL_VP72
SY   B-LCL #1038-3774DE17
DR   Wikidata; Q93327708
CC   Population: Caucasian.
CC   HLA typing: A*02,02; B*35,56; C*01,04; DRB1*01,11 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-222 1
AC   CVCL_VP63
SY   B-LCL #1038-2743JA15
DR   Wikidata; Q93327710
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*15,27:05; C*02,03; DRB1*04:01,07:01 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ES ! B-LCL #1038-222 2
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-222 2
AC   CVCL_E8ES
SY   B-LCL #1038-5040FE21
WW   Provider; Cellero; 1038-5040FE21; https://web.archive.org/web/20220122014218/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-5040fe21/
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*15:01,27:05; C*02:02,03:04; DRB1*04:01,07:01 (Cellero=1038-5040FE21).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP63 ! B-LCL #1038-222 1
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL #1038-224 1
AC   CVCL_VP67
SY   B-LCL #1038-3089MA16
DR   Wikidata; Q93327712
WW   Provider; Cellero; 1038-3089MA16; https://web.archive.org/web/20220122014720/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-3089ma16/
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07,15; C*03,07; DRB1*13,15 (Cellero=1038-3089MA16).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ET ! B-LCL #1038-224 2
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-224 2
AC   CVCL_E8ET
SY   B-LCL #1038-5047MA21
WW   Provider; Cellero; 1038-5047MA21; https://web.archive.org/web/20220122021207/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-5047ma21/
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07:02,15:01; C*03:03,07:02; DRB1*13:01,15:01 (Cellero=1038-5047MA21).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP67 ! B-LCL #1038-224 1
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL #1038-228
AC   CVCL_VP66
SY   B-LCL #1038-2782MA15
DR   Wikidata; Q93327714
CC   Population: Caucasian.
CC   HLA typing: A*02:01,30; B*18,44; C*05,05; DRB1*03,15 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-287
AC   CVCL_VP70
SY   B-LCL #1038-3267JY16
DR   Wikidata; Q93327716
CC   Population: Caucasian.
CC   HLA typing: A*03,68; B*15,44; C*03,07; DRB1*01,15 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-3 1
AC   CVCL_VP73
SY   B-LCL #1038-3900AP18
DR   Wikidata; Q93327719
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*14,27:05; DRB1*14,15:01 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8EU ! B-LCL #1038-3 2
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-3 2
AC   CVCL_E8EU
SY   B-LCL #1038-5046FE21
WW   Provider; Cellero; 1038-5046FE21; https://web.archive.org/web/20220122021325/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-5046fe21/
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*14,27:05; DRB1*14,15:01 (Cellero=1038-5046FE21).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP73 ! B-LCL #1038-3 1
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL #1038-333
AC   CVCL_VP68
SY   B-LCL #1038-3161JN16
DR   Wikidata; Q93327721
WW   Provider; Cellero; 1038-3161JN16; https://web.archive.org/web/20220122021751/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-3161jn16/
CC   Population: Caucasian.
CC   HLA typing: A*03:01,34:01; B*35:01,40:02; C*04:01,15:02; DRB1*04,07 (Cellero).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-358
AC   CVCL_VP71
SY   B-LCL #1038-3754NV17; LCL-358
DR   Wikidata; Q93327723
WW   Provider; Cellero; 1038-3754NV17; https://web.archive.org/web/20220122024915/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-3754nv17/
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*15:01,44:02; C*03:03,05:01; DRB1*01:03,04:04 (Cellero=1038-3754NV17).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   B-LCL #1038-521
AC   CVCL_E8EV
SY   B-LCL #1038-5029FE21
WW   Provider; Cellero; 1038-5029FE21; https://web.archive.org/web/20220122025749/https://cellero.com/products/b-cells/b-lymphoblastoid-cells/b-lcl-1038-5029fe21/
CC   Population: Caucasian.
CC   HLA typing: A*11:01,11:01; B*27:05,40:01; C*01:02,15:02; DRB1*04:01,11:03 (Cellero=1038-5029FE21).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL-CDG1
AC   CVCL_C0VF
SY   CDG-LCL1; CDG-LCL I; LCL-1
DR   CLS; 302012
DR   Wikidata; Q112929244
RX   PubMed=9719677;
RX   PubMed=34420056;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Val231Met (c.691G>A); ClinVar=VCV000007719; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302012
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 15,19
ST   D21S11: 31
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 20,22
ST   Penta D: 11,12
ST   Penta E: 10
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   B-LCL-CDG10
AC   CVCL_C0VI
SY   LCL-10
DR   Wikidata; Q112929245
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Gln33Ter (c.97C>T); ClinVar=VCV000803211; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Val44Ala (c.131T>C); ClinVar=VCV000007725; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG11
AC   CVCL_C0VJ
SY   LCL-11
DR   Wikidata; Q112929246
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Tyr64Cys (c.191A>G); Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG12
AC   CVCL_C0VK
SY   LCL-12
DR   Wikidata; Q112929247
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Pro113Leu (c.338C>T); ClinVar=VCV000007723; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Phe207Ser (c.620T>C); ClinVar=VCV000189141; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG13
AC   CVCL_C0VL
SY   LCL-13
DR   Wikidata; Q112929248
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Pro113Leu (c.338C>T); ClinVar=VCV000007723; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Thr118Ser (c.353C>T); Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Pro184Asp (c.550C>A); Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG14
AC   CVCL_C0VM
SY   LCL-14
DR   Wikidata; Q112929249
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Phe157Ser (c.470T>C); ClinVar=VCV000188763; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg162Trp (c.484C>T); ClinVar=VCV000007709; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG15
AC   CVCL_C0VN
SY   LCL-15
DR   Wikidata; Q112929251
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Leu32Arg (c.95_96delinsGC) (c.95TA>GC); ClinVar=VCV000092807; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Phe207Ser (c.620T>C); ClinVar=VCV000189141; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG16
AC   CVCL_C0VP
SY   LCL-16
DR   Wikidata; Q112929252
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Leu32Arg (c.95_96delinsGC) (c.95TA>GC); ClinVar=VCV000092807; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Phe157Ser (c.470T>C); ClinVar=VCV000188763; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG17
AC   CVCL_C0VQ
SY   LCL-17
DR   Wikidata; Q112929253
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg123Gln (c.368G>A); ClinVar=VCV000265255; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Cys241Ser (c.722G>C); ClinVar=VCV000007717; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG18
AC   CVCL_C0VR
SY   LCL-18
DR   Wikidata; Q112929254
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Gly214Ser (c.640G>A); ClinVar=VCV000553503; Zygosity=Homozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG19
AC   CVCL_C0VS
SY   LCL-19
DR   Wikidata; Q112929255
RX   PubMed=34420056;
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Cys241Ser (c.722G>C); ClinVar=VCV000007717; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   B-LCL-CDG2
AC   CVCL_A9Y1
SY   CDG-LCL2; CDG-LCL II; LCL-2
DR   CLS; 302013
DR   Wikidata; Q102113579
RX   PubMed=9719677;
RX   PubMed=34420056;
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,31:01:02; B*40:01:02,44:02:01; C*03:04:01,05:01:01; DPB1*04:02:01,06:01:01; DQA1*03:01:01,03:02:01; DQB1*03:02:01,03:03:02; DRB1*04:04:01,09:01:02 (CLS=302013).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Asp188Gly (c.563A>G); ClinVar=VCV000007712; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302013
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,14
ST   D16S539: 13,14
ST   D18S51: 16,17
ST   D21S11: 29,31.2
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   B-LCL-CDG3
AC   CVCL_C0VC
SY   CDG-LCL3; CDG-LCL III; LCL-3
DR   CLS; 302014
DR   Wikidata; Q112929256
RX   PubMed=9719677;
RX   PubMed=34420056;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (PubMed=34420056).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Asp188Gly (c.563A>G); ClinVar=VCV000007712; Zygosity=Heterozygous (PubMed=34420056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302014
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 12,14
ST   D21S11: 28,32.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,16
ST   FGA: 21,23
ST   Penta D: 10,11
ST   Penta E: 11,18
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   B-LCL-CDG4
AC   CVCL_A9Y2
DR   CLS; 302015
DR   Wikidata; Q102113580
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,24:02:01; B*08:01:01,18:01:01; C*07:01:01,12:03:01; DPB1*03:01:01,04:02:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01 (CLS=302015).
CC   Sequence variation: Mutation; HGNC; HGNC:10702; SEC23B; Unexplicit; Not described; Zygosity=Homozygous (CLS=302015).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302015
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,14
ST   D8S1179: 13
ST   FGA: 23,23.2
ST   Penta D: 8,12
ST   Penta E: 7,19
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C175991; Congenital dyserythropoietic anemia type II
DI   ORDO; Orphanet_98873; Congenital dyserythropoietic anemia type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   B-LCL-CDG5
AC   CVCL_C0VD
DR   CLS; 302016
DR   Wikidata; Q112929257
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302016
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 14,16
ST   D21S11: 30,30.2
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 6
//
ID   B-LCL-CDG6
AC   CVCL_C0VE
DR   CLS; 302017
DR   Wikidata; Q112929258
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302017
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 9,13
ST   Penta E: 13,20
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 6
//
ID   B-LCL-CDG7
AC   CVCL_A9Y3
DR   CLS; 302018
DR   Wikidata; Q102113581
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10702; SEC23B; Unexplicit; Not described; Zygosity=Homozygous (CLS=302018).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302018
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D21S11: 30
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 21,24
ST   Penta D: 9,14
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C175991; Congenital dyserythropoietic anemia type II
DI   ORDO; Orphanet_98873; Congenital dyserythropoietic anemia type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   B-LCL-HROC06
AC   CVCL_B7FD
SY   Bc HROC06
DR   CLS; 302065
DR   Wikidata; Q112929259
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302065
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 18
ST   D21S11: 27,30
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   B-LCL-HROC10
AC   CVCL_B4GP
SY   Bc HROC10
DR   CLS; 302143
DR   Wikidata; Q110432584
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,24:02:01; B*08:01:01,27:05:02; C*01:02:01,07:01:01; DPB1*02:02:01,04:01:01; DQA1*01:01:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*01:01:01,03:01:01 (CLS=302143).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302143
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D21S11: 30,30.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23,25
ST   Penta D: 9,11
ST   Penta E: 15,16
ST   TPOX: 8,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   B-LCL-HROC102
AC   CVCL_A7UM
SY   Bc HROC102
DR   CLS; 302001
DR   Wikidata; Q107113414
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302001
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 30,33.2
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 21,25
ST   Penta D: 8,12
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC103
AC   CVCL_B7FE
SY   Bc HROC103
DR   CLS; 302020
DR   Wikidata; Q112929260
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*07:02:01,13:02:01; C*06:02:01,07:02:01; DPB1*04:01:01,13:01:01G; DQB1*02:02:01,06:02:01; DRB1*07:01:01,15:01:01 (CLS=302020).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302020
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D21S11: 29,31
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 24
ST   Penta D: 7,14
ST   Penta E: 7,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D10 ! HROC103 T0 M1
OI   CVCL_1V01 ! HROC103Met
SX   Male
AG   44-48Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   B-LCL-HROC112
AC   CVCL_C8Z4
SY   B-LCL CO112; Bc HROC112
DR   CLS; 302023
DR   Wikidata; Q123030747
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: B-LCL-HROC112 (Cellosaurus=CVCL_C8Z4) and HROC112Met T0 M2 (Cellosaurus=CVCL_1U83) are from 2 different donors.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302023
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 12,16
ST   D21S11: 30,30.2
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 20,24
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 4
//
ID   B-LCL-HROC113
AC   CVCL_YD52
SY   B-LCL CO113; Bc HROC113
DR   CLS; 300898
DR   Wikidata; Q93327725
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01:01,02:01:01:01; B*08:01:01:01,38:01:01:01; C*07:01:01:01,12:03:01:01; DPB1*04:01:01:02,04:01:01:05; DQA1*01:02:01:01,02:01:01:01; DQB1*02:02:01:01,06:02:01:01; DRB1*07:01:01:01,15:01:01:01 (CLS=300898).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=300898
ST   Amelogenin: X,Y
ST   CSF1PO: 7
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 10.2,18
ST   D21S11: 28,29
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 8,9
ST   Penta E: 7,13
ST   TH01: 7,8
ST   TPOX: 7,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S852 ! HROC113
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 11
//
ID   B-LCL-HROC117
AC   CVCL_A8RK
SY   Bc HROC117
DR   CLS; 302024
DR   Wikidata; Q108819863
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302024
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC118
AC   CVCL_B7FF
SY   Bc HROC118
DR   CLS; 302025
DR   Wikidata; Q112929261
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,23:01:01; B*49:01:01,57:01:01; C*06:02:01,07:01:01; DPB1*02:01:02,03:01:01; DQB1*05:01:01,06:02:01; DRB1*01:01:01,15:01:01 (CLS=302025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: CLS; 302025; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302025
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 16,19
ST   D5S818: 9,12
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 20,24
ST   Penta D: 11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   B-LCL-HROC130
AC   CVCL_B7FG
SY   Bc HROC130
DR   CLS; 302032
DR   Wikidata; Q112929262
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*07:02:01; C*07:02:01; DPB1*04:01:01G,04:02:01G; DQB1*03:01:01,06:02:01; DRB1*12:01:01,15:01:01 (CLS=302032).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   B-LCL-HROC173
AC   CVCL_E6AX
SY   TiBc HROC173
DR   CLS; 302039
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D15 ! HROC173
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL-HROC18
AC   CVCL_C0UD
SY   Bc HROC18
DR   Wikidata; Q112929263
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D21S11: 30,33.2
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0B45 ! HROC18
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   B-LCL-HROC195
AC   CVCL_B7FC
SY   Bc HROC195
DR   CLS; 302043
DR   Wikidata; Q112929264
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,68:01:02; B*08:01:01,51:01:01; C*07:01:01,15:02:01; DPB1*02:01:02,13:01:01; DQA1*01:03:01,05:05:01; DQB1*03:01:01,06:03:01; DRB1*08:04:01,13:01:01 (CLS=302043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   B-LCL-HROC24
AC   CVCL_YD57
SY   B-LCL CO24; Bc HROC24
DR   CLS; 300861
DR   Wikidata; Q93327728
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,30:02:01; B*18:01:01,38:01:01; C*05:01:01,12:03:01; DPB1*02:02:01,03:01:01; DQA1*01:03:01,05:01:01; DQB1*02:01:01,06:03:01; DRB1*03:01:01,13:01:01 (CLS=300861).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=300861; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 7,13 (CLS=300861)
ST   D13S317: 8 (Direct_author_submission)
ST   D16S539: 9,11
ST   D21S11: 27,28
ST   D5S818: 10,11 (CLS=300861)
ST   D5S818: 11,12 (Direct_author_submission)
ST   D7S820: 10,14 (Direct_author_submission)
ST   D7S820: 11,13 (CLS=300861)
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18 (Direct_author_submission)
ST   vWA: 16,20 (CLS=300861)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S853 ! HROC24
OI   CVCL_1U80 ! HROC24 T1 M1
OI   CVCL_AN14 ! HROC24 T3 M1 #2
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 11
//
ID   B-LCL-HROC277
AC   CVCL_YD54
SY   B-LCL CO277; Bc HROC277
DR   CLS; 300867
DR   Wikidata; Q93327731
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,32:01:01; B*15:17:01,35:03:01; C*04:01:01,07:01:02; DPB1*02:01:02,350:01; DQA1*01:02:01,05:05:01; DQB1*13:01:01,06:04:01; DRB1*11:01:06,13:02:01 (CLS=300867).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U86 ! HROC277 T0 M1
OI   CVCL_1U87 ! HROC277Met1 T0 M2
OI   CVCL_1U88 ! HROC277Met2
OI   CVCL_AP59 ! HROC277Met2 T0 M1
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 10
//
ID   B-LCL-HROC278
AC   CVCL_A7UL
SY   Bc HROC278
DR   CLS; 302051
DR   Wikidata; Q107113416
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:03:01,25:01:01; B*07:02:01,18:01:01; C*07:02:01,12:03:01; DPB1*02:01:02,04:01:02; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:02:01; DRB1*04:01:01,15:01:01 (CLS=302051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U89 ! HROC278 T0 M1
OI   CVCL_1U90 ! HROC278Met T2 M2
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   B-LCL-HROC285
AC   CVCL_E6AW
SY   B-LCL CO285; Bc HROC285
DR   CLS; 300869
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U92 ! HROC285 T0 M2
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL-HROC313
AC   CVCL_A8RL
SY   Bc HROC313
DR   CLS; 302058
DR   Wikidata; Q108819864
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,40:01:02; C*03:04:01,07:01:01; DPA1*04:01:01G,05:01:01G; DQA1*04:01:01,05:01:01; DQB1*02:01:01,04:02:01; DRB1*03:01:01,08:01:01 (CLS=302058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302058
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,16
ST   D21S11: 29,31.2
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20,24
ST   Penta D: 11,16
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U98 ! HROC313Met
OI   CVCL_AP60 ! HROC313Met1 T0 M1
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC32
AC   CVCL_YD55
SY   B-LCL CO32; Bc HROC32
DR   CLS; 300862
DR   Wikidata; Q93327733
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,51:01:01; C*07:01:01,14:02:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,11:01:01 (CLS=300862).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=300862
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 31
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12
ST   FGA: 18,19
ST   Penta D: 12
ST   Penta E: 10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D06 ! HROC32
OI   CVCL_1D07 ! HROC32 T3 M1
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 11
//
ID   B-LCL-HROC39
AC   CVCL_YD56
SY   B-LCL CO39; Bc HROC39
DR   CLS; 300863
DR   Wikidata; Q93327735
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=300863
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U81 ! HROC39
OI   CVCL_1U82 ! HROC39 T0 M2
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 11
//
ID   B-LCL-HROC43
AC   CVCL_A7UN
SY   Bc HROC43
DR   CLS; 302067
DR   Wikidata; Q107113417
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*15:01:01,37:01:01; C*03:03:01,06:02:01; DPB1*01:01:01,05:01:01; DQA1*01:05:01,05:05:01; DQB1*03:01:01,05:01:01; DRB1*10:01:01,12:01:01 (CLS=302067).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302067
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D21S11: 31.2
ST   D5S818: 11,12
ST   D7S820: 13
ST   TH01: 10
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D20 ! HROC43
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC46
AC   CVCL_A7UP
SY   Bc HROC46
DR   CLS; 302068
DR   Wikidata; Q107113419
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*07:02:01,08:01:01; C*07:01:01,07:02:01; DPB1*01:01:01,19:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01 (CLS=302068).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D21 ! HROC46 T0 M1
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   B-LCL-HROC50
AC   CVCL_A7UQ
SY   Bc HROC50
DR   CLS; 302069
DR   Wikidata; Q107113420
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,03:01:01; B*07:02:01,27:01:01; C*06:02:01,07:02:01; DPB1*04:01:01; DQA1*01:02:01,02:01:01; DQB1*03:03:02,06:02:01; DRB1*07:01:01,15:01:01 (CLS=302069).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8.3,10.3
ST   vWA: 16,17.1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G02 ! HROC50 T1 M5
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC57
AC   CVCL_A7UR
SY   Bc HROC57; TiBcHROC57
DR   CLS; 302072
DR   Wikidata; Q107113421
RX   PubMed=22393427;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,27:01:01; C*06:02:01,07:01:01; DPB1*02:01:02,04:01:01; DQA1*02:01:01,05:01:01; DQB1*02:01:01,03:03:02; DRB1*03:01:01,07:01:01 (CLS=302072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 13.2,17.1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G03 ! HROC57
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC59
AC   CVCL_A7US
SY   Bc HROC59; TiBcHROC59
DR   CLS; 302073
DR   Wikidata; Q107113422
RX   PubMed=22393427;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,24:02:01; B*01:02:01,27:05:02; C*02:02:02,07:02:01; DPB1*04:01:01,14:01:01; DQA1*01:02:01,03:03:01; DQB1*03:02:01,06:02:01; DRB1*04:01:01,15:01:01 (CLS=302073).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 6,8
ST   TPOX: 10.3
ST   vWA: 18.1,19.1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G04 ! HROC59 T1 M1
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC60
AC   CVCL_A7UT
SY   Bc HROC60; TiBcHROC60
DR   CLS; 302004
DR   Wikidata; Q107113423
RX   PubMed=22393427;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,11:01:01; B*20:02:01,55:01:01; C*03:03:01,05:01:01; DPB1*04:01:01; DQA1*01:01:01,01:03:01; DQB1*05:01:01,06:03:01; DRB1*01:01:01,13:01:01 (CLS=302004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302004
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 28
ST   D2S1338: 17,24
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 20,21
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G05 ! HROC60
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   B-LCL-HROC68
AC   CVCL_A7UU
SY   Bc HROC68; TiBcHROC68
DR   CLS; 302078
DR   Wikidata; Q107113424
RX   PubMed=22393427;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,29:02:01; B*13:02:01,47:03:01; C*06:02:01,16:01:01; DPB1*01:01:01,04:01:01; DQA1*02:01:01; DQB1*02:02:01; DRB1*07:01:01 (CLS=302078).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   B-LCL-HROC69
AC   CVCL_YD53
SY   B-LCL CO69; Bc HROC69; TiBcHROC69
DR   CLS; 300864
DR   Wikidata; Q93327738
RX   PubMed=22393427;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G06 ! HROC69
OI   CVCL_1G07 ! HROC69 T0 M2
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 10
//
ID   B-LCL-HROC72
AC   CVCL_E6AZ
DR   CLS; 302082
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL-HROC75
AC   CVCL_C0W6
SY   Bc HROC75
DR   CLS; 302084
DR   Wikidata; Q114310638
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,17.1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   B-LCL-HROG04
AC   CVCL_C7GY
SY   Bc HROG04
DR   CLS; 302107
DR   Wikidata; Q117704205
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,51:01:01; C*07:01:01,15:02:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,11:01:01 (CLS=302107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U39 ! HROG04
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   B-LCL-HROM01
AC   CVCL_E6AY
SY   TiBc HROM
DR   CLS; 302079
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B-LCL-PB16
AC   CVCL_B7FH
DR   CLS; 302145
DR   Wikidata; Q112929265
CC   HLA typing: A*01:01:01,24:02:01; B*08:01:01,27:05:02; C*02:02:02,07:01:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01; DQB1*02:01:01; DRB1*03:01:01 (CLS=302145).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   B-LSDM7
AC   CVCL_C6JP
DR   Wikidata; Q116048532
RX   PubMed=35563747;
CC   Derived from site: In situ; Lung; Note=From a bronchoalveolar lavage; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   B-R18
AC   CVCL_CW55
SY   BR18
DR   NCBI_Iran; H168
DR   Wikidata; Q54752135
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 5
//
ID   B-R939F
AC   CVCL_LM92
SY   B-R93f; TNGB-67642; 67642
DR   CLO; CLO_0002026
DR   CLDB; cl325
DR   TNGB; 67642
DR   Wikidata; Q54752138
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18-22FW
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   B-THP-1
AC   CVCL_0R19
DR   BEI_Resources; ARP-9940
DR   cancercelllines; CVCL_0R19
DR   Wikidata; Q54752139
RX   PubMed=10721995;
RX   PubMed=14972530;
CC   Problematic cell line: Misidentified. Originally thought to be THP-1 (PubMed=10721995) but later shown to be a derivative of Raji (PubMed=14972530).
CC   Population: African; Nigerian.
CC   Doubling time: ~20 hours (BEI_Resources=ARP-9940).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 21
//
ID   B-THP-1/DC-SIGN
AC   CVCL_0R20
SY   B-THP-1 DC-SIGN+
DR   BEI_Resources; ARP-9941
DR   cancercelllines; CVCL_0R20
DR   Wikidata; Q54752142
RX   PubMed=14972530;
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0R19 ! B-THP-1
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   B-thy-ts.1
AC   CVCL_4W00
SY   Bthy.ts1
DR   Wikidata; Q54752143
RX   PubMed=1374682;
CC   Doubling time: ~2 days (Note=In 10% FCS) (PubMed=1374682).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3D
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   B. A.
AC   CVCL_C8NJ
DR   Wikidata; Q123030750
RX   PubMed=1374683;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   B. D.
AC   CVCL_C8NK
DR   Wikidata; Q123030751
RX   PubMed=1374683;
CC   Doubling time: 80.0 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   B.ab.-1
AC   CVCL_F0GC
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-10
AC   CVCL_F0GL
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-2
AC   CVCL_F0GD
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-3
AC   CVCL_F0GE
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-4
AC   CVCL_F0GF
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-5
AC   CVCL_F0GG
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-6
AC   CVCL_F0GH
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-7
AC   CVCL_F0GI
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-8
AC   CVCL_F0GJ
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B.ab.-9
AC   CVCL_F0GK
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Brucela abortus LPS (Note=Also reacts with Yersinia enterocolitica O:9 LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B/B
AC   CVCL_C2VY
DR   ICLDB; bb
DR   Wikidata; Q114310639
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=180277; ! Opodiphthera eucalypti (Emperor gum moth)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   B/C.Li
AC   CVCL_6F06
SY   B/CLi; B/cLi; B/CL1
DR   ATCC; CRL-6328
DR   ATCC; CRL-6330
DR   Wikidata; Q54752145
RX   PubMed=4366196;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6328; true.
CC   Discontinued: ATCC; CRL-6330; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   B/C.Ov
AC   CVCL_6F07
SY   B/c OV
DR   Wikidata; Q54752148
RX   PubMed=4366196;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   B/C.Sk
AC   CVCL_7244
SY   B/c SK
DR   CLO; CLO_0001779
DR   CLDB; cl329
DR   ATCC; CRL-6329
DR   ECACC; 86111901
DR   Wikidata; Q54752149
RX   PubMed=4366196;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6329; true.
CC   Discontinued: ECACC; 86111901; true.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Breed/subspecies: BALB/cCRGL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   B/C3T3.We
AC   CVCL_5925
DR   CLO; CLO_0001780
DR   ATCC; CRL-6327
DR   Wikidata; Q54752152
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6327; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   B/CMBA.Ov
AC   CVCL_5926
DR   CLO; CLO_0001781
DR   ATCC; CRL-6331
DR   Wikidata; Q54752156
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6331; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S247 ! B/CMBA.Sp
OI   CVCL_S353 ! B/CMBA.Ut
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   B/CMBA.Sp
AC   CVCL_S247
DR   ATCC; CRL-6332
DR   Wikidata; Q54752157
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6332; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5926 ! B/CMBA.Ov
OI   CVCL_S353 ! B/CMBA.Ut
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   B/CMBA.Ut
AC   CVCL_S353
DR   ATCC; CRL-6333
DR   Wikidata; Q54752160
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6333; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5926 ! B/CMBA.Ov
OI   CVCL_S247 ! B/CMBA.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   B/CWE
AC   CVCL_5927
DR   CLO; CLO_0001782
DR   ATCC; CRL-6334
DR   Wikidata; Q54752162
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6334; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   B/ME.8.10.B6
AC   CVCL_E5UV
RX   PubMed=3376424;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_23965; Estradiol.
CC   Monoclonal antibody target: ChEBI; CHEBI_17263; Estrone.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4QE ! B/MF-2
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B/MF-2
AC   CVCL_C4QE
DR   Wikidata; Q116048533
RX   PubMed=3685639;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   B/MT.4A.17.H5.A5
AC   CVCL_C4QF
DR   ABCD; ABCD_AE768
DR   Wikidata; Q116048534
RX   PubMed=1584233;
RX   PubMed=3685639;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17347; Testosterone (Note=Also recognizes dihydrotestosterone).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4QE ! B/MF-2
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   B'SYS CHO alpha1beta2gamma2 GABA(A)
AC   CVCL_C0XQ
DR   Wikidata; Q114310640
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_gaba_a1b2g2.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4075; GABRA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4082; GABRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 10
//
ID   B'SYS CHO ASIC1a
AC   CVCL_C0XR
DR   Wikidata; Q114310641
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_asic_1a.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:100; ASIC1 (Note=Isoform 1/Asic1a).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS CHO ASIC1b
AC   CVCL_C0XS
DR   Wikidata; Q114310642
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_asic_1b_1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:100; ASIC1 (Note=Isoform 3/Asic1b).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO ASIC3
AC   CVCL_C0XT
DR   Wikidata; Q114310643
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_asic3.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:101; ASIC3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO GlyRalpha3
AC   CVCL_C0XU
DR   Wikidata; Q114310644
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_glyr_a3.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4328; GLRA3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS CHO hERG-Duo
AC   CVCL_C0XV
SY   CHO hERG DUO
DR   Wikidata; Q114310645
RX   PubMed=25228880;
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_herg-duo_2016.pdf
CC   Characteristics: KCNH2 was transfected twice.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6251; KCNH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 10
//
ID   B'SYS CHO Kir2.1
AC   CVCL_C0XW
DR   Wikidata; Q114310646
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kir2.1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6263; KCNJ2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS CHO Kv1.1
AC   CVCL_C0XX
DR   Wikidata; Q114310647
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv1.x_1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6218; KCNA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv1.2
AC   CVCL_C0XY
DR   Wikidata; Q114310648
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv1.x_1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6220; KCNA2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv1.3
AC   CVCL_C0XZ
DR   Wikidata; Q114310649
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv1.x_1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6221; KCNA3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv1.4
AC   CVCL_C0Y0
DR   Wikidata; Q114310650
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv1.x_1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6222; KCNA4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv1.5
AC   CVCL_C0Y1
DR   Wikidata; Q114310651
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv1.x_1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6224; KCNA5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv1.6
AC   CVCL_C0Y2
DR   Wikidata; Q114310652
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv1.x_1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6225; KCNA6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv2.1
AC   CVCL_C0Y3
DR   Wikidata; Q114310653
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_kv2.1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6231; KCNB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv4.3
AC   CVCL_C0Y4
DR   Wikidata; Q114310655
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv4.3.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6239; KCND3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv4.3/KChiP2
AC   CVCL_C0Y5
SY   B'SYS CHO Kv4.3 / KChiP2
DR   Wikidata; Q114310656
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv4.3_kchip.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6239; KCND3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15522; KCNIP2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C0Y4 ! B'SYS CHO Kv4.3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 10
//
ID   B'SYS CHO Kv7.2
AC   CVCL_C0Y6
DR   Wikidata; Q114310657
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_cho_kv7.2.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6296; KCNQ2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Kv7.2/3
AC   CVCL_C0Y7
DR   Wikidata; Q114310658
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_kv7.2_7.3.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6296; KCNQ2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6297; KCNQ3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS CHO KvLQT1/minK
AC   CVCL_C0Y8
DR   Wikidata; Q114310659
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_kvlqt1_mink_q-patch.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6240; KCNE1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6294; KCNQ1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 10
//
ID   B'SYS CHO Nav1.2
AC   CVCL_C0Y9
DR   Wikidata; Q114310660
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_nav1.2.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10588; SCN2A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Nav1.4
AC   CVCL_C0YA
DR   Wikidata; Q114310661
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_nav1.4.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10591; SCN4A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Nav1.5 Duo
AC   CVCL_C0YB
DR   Wikidata; Q114310662
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_nav1.5_duo_2016.pdf
CC   Characteristics: SCN5A was transfected twice.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10593; SCN5A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS CHO Nav1.7
AC   CVCL_C0YC
DR   Wikidata; Q114310663
WW   Provider; B'SYS; -; https://www.bsys.ch/media/b_sys_cho_nav1.7_assay.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10597; SCN9A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO Nav1.8/beta3
AC   CVCL_C0YD
DR   Wikidata; Q114310664
WW   Provider; B'SYS; -; https://www.bsys.ch/media/cho_nav1.8.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10582; SCN10A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20665; SCN3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 10
//
ID   B'SYS CHO P2X1
AC   CVCL_C0YE
DR   Wikidata; Q114310665
WW   Provider; B'SYS; -; https://www.bsys.ch/media/p2x_cell_lines.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8533; P2RX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS CHO P2X2
AC   CVCL_C0YF
DR   Wikidata; Q114310666
WW   Provider; B'SYS; -; https://www.bsys.ch/media/p2x_cell_lines.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   B'SYS CHO P2X3
AC   CVCL_C0YG
DR   Wikidata; Q114310667
WW   Provider; B'SYS; -; https://www.bsys.ch/media/p2x_cell_lines.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8534; P2RX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS HEK 293 Cav3.2
AC   CVCL_C0YH
SY   B'SYS HEK Cav3.2
DR   Wikidata; Q114310668
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_hek_cav3.2.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1395; CACNA1H.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   B'SYS HEK 293 hERG
AC   CVCL_C0YI
SY   B'SYS HEK hERG
DR   Wikidata; Q114310669
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_hek_herg.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6251; KCNH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   B'SYS HEK 293 K2P18.1
AC   CVCL_C0YJ
DR   Wikidata; Q114310670
WW   Provider; B'SYS; -; https://www.bsys.ch/media/hek_k2p18.1_tresk.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19439; KCNK18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS HEK 293 KvLQT1/minK
AC   CVCL_C0YK
SY   B'SYS HEK 293 Kv7.1/minK
DR   Wikidata; Q114310671
WW   Provider; B'SYS; -; https://www.bsys.ch/media/bsys_hek_kvlqt1_mink.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6240; KCNE1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6294; KCNQ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   B'SYS HEK 293 NMDA NR1/NR2A
AC   CVCL_C9D2
SY   B'SYS HEK293 NMDA NR1/NR2A; HEK NR1/NR2A
DR   Wikidata; Q123030752
WW   Provider; B'SYS; -; https://www.bsys.ch/media/hek_nmda_duo_2016.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4584; GRIN1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4585; GRIN2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   B'SYS HEK 293 NMDA NR1/NR2B
AC   CVCL_C9D3
SY   B'SYS HEK293 NMDA NR1/NR2B; HEK NR1/NR2B
DR   Wikidata; Q123030753
WW   Provider; B'SYS; -; https://www.bsys.ch/media/hek_nmda_duo_2016.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4584; GRIN1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4586; GRIN2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   B'SYS HEK 293 NMDA NR1/NR2D
AC   CVCL_C9D4
SY   B'SYS HEK293 NMDA NR1/NR2D; HEK NR1/NR2D
DR   Wikidata; Q123030754
WW   Provider; B'SYS; -; https://www.bsys.ch/media/hek_nmda_duo_2016.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4584; GRIN1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4588; GRIN2D.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   B'SYS HEK 293 P2X4
AC   CVCL_C0YL
DR   Wikidata; Q114310672
WW   Provider; B'SYS; -; https://www.bsys.ch/media/p2x_cell_lines.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8535; P2RX4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   B'SYS HEK 293 P2X7
AC   CVCL_C0YM
DR   Wikidata; Q114310673
WW   Provider; B'SYS; -; https://www.bsys.ch/media/p2x_cell_lines.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8537; P2RX7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   B'SYS HEK 293T TRPM8
AC   CVCL_C9E8
SY   B'SYS HEK TRPM8
DR   Wikidata; Q123030755
WW   Provider; B'SYS; -; https://www.bsys.ch/media/hek_trpm8.pdf
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17961; TRPM8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   B'SYS LTK alpha1beta2gamma2 GABA(A)
AC   CVCL_C9E7
DR   Wikidata; Q123030756
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4075; GABRA1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4082; GABRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Cell line information from personal communication of Braksator, Ellen.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   B0001
AC   CVCL_T365
DR   RCB; GMC0038
DR   Wikidata; Q54752163
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: RCB; GMC0038; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T364 ! A0001
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0006
AC   CVCL_T336
DR   CLO; CLO_0050480
DR   RCB; GMC0003
DR   Wikidata; Q54752165
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0010
AC   CVCL_T353
DR   CLO; CLO_0050487
DR   RCB; GMC0025
DR   Wikidata; Q54752167
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T352 ! A0010
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0022
AC   CVCL_T344
DR   CLO; CLO_0050494
DR   RCB; GMC0016
DR   Wikidata; Q54752170
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T345 ! A0022
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0026
AC   CVCL_T363
DR   CLO; CLO_0050491
DR   RCB; GMC0035
DR   Wikidata; Q54752173
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T362 ! A0026
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   B0031
AC   CVCL_T339
DR   CLO; CLO_0050481
DR   RCB; GMC0005
DR   Wikidata; Q54752176
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (from autologous cell line A0031).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (from autologous cell line A0031).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T338 ! A0031
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   B0036
AC   CVCL_T349
DR   CLO; CLO_0050486
DR   RCB; GMC0023
DR   Wikidata; Q54752177
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   35Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0042
AC   CVCL_T342
DR   CLO; CLO_0050482
DR   RCB; GMC0015
DR   Wikidata; Q54752180
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T343 ! A0042
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0045
AC   CVCL_T361
DR   RCB; GMC0034
DR   Wikidata; Q54752184
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0050
AC   CVCL_T355
DR   CLO; CLO_0050489
DR   RCB; GMC0030
DR   Wikidata; Q54752185
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T354 ! A0050
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0055
AC   CVCL_T347
DR   CLO; CLO_0050483
DR   RCB; GMC0017
DR   Wikidata; Q54752188
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T346 ! A0055
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0058
AC   CVCL_T358
DR   CLO; CLO_0050488
DR   RCB; GMC0029
DR   Wikidata; Q54752189
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T357 ! A0058
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0072
AC   CVCL_T351
DR   CLO; CLO_0050485
DR   RCB; GMC0020
DR   Wikidata; Q54752192
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T350 ! A0072
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0076
AC   CVCL_T356
DR   CLO; CLO_0050496
DR   RCB; GMC0026
DR   Wikidata; Q54752195
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0078
AC   CVCL_T359
DR   CLO; CLO_0050490
DR   RCB; GMC0032
DR   Wikidata; Q54752197
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0082
AC   CVCL_T334
DR   CLO; CLO_0050479
DR   RCB; GMC0001
DR   Wikidata; Q54752202
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T335 ! A0082
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0086
AC   CVCL_T360
DR   RCB; GMC0033
DR   Wikidata; Q54752204
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0090
AC   CVCL_T348
DR   CLO; CLO_0050484
DR   RCB; GMC0019
DR   Wikidata; Q54752207
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B0096
AC   CVCL_T340
DR   CLO; CLO_0050495
DR   RCB; GMC0013
DR   Wikidata; Q54752253
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   B02/GFP.2
AC   CVCL_5T77
DR   cancercelllines; CVCL_5T77
DR   Wikidata; Q54752256
RX   PubMed=11697798;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5T76 ! MDA-MB-231/B02
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 19
//
ID   B0317047
AC   CVCL_8B87
DR   ECACC; 03091135
DR   Wikidata; Q54752258
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,add(5)(p15); de novo (ECACC=03091135).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   B0403741
AC   CVCL_8B88
DR   ECACC; 04022036
DR   Wikidata; Q54752259
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   B1 [Human hepatocellular carcinoma]
AC   CVCL_A1AS
DR   cancercelllines; CVCL_A1AS
DR   Wikidata; Q102113582
RX   PubMed=31063779;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/B1
CC   From: Grasl-Kraupp, Bettina; Medical University of Vienna; Vienna; Austria.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Unspecified (PubMed=31063779).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   B1 [Human leukemia]
AC   CVCL_QW66
SY   B-1
DR   Cosmic; 1037743
DR   Cosmic; 1524791
DR   Cosmic; 2393012
DR   Wikidata; Q54752263
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1423625;
RX   PubMed=1648979;
RX   PubMed=8358709;
RX   PubMed=14671638;
CC   Doubling time: 40-50 hours (PubMed=1648979).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4; Note=In frame (PubMed=1423625; PubMed=8358709).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   B1 [Mouse embryonal carcinoma]
AC   CVCL_1N71
SY   AG13176
DR   CLO; CLO_0022089
DR   Coriell; AG13176
DR   Wikidata; Q54752266
RX   CelloPub=CLPUB00597;
RX   PubMed=2791350;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: CBA.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N70 ! H6
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 6
//
ID   B1 [Pig]
AC   CVCL_F749
DR   Wikidata; Q54752269
RX   PubMed=2394515;
RX   PubMed=7951345;
CC   Doubling time: 20 hours (PubMed=2394515).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   B1 NIH
AC   CVCL_J977
SY   B1
DR   ATCC; HB-10572
DR   Wikidata; Q54752271
RX   Patent=US5612032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10572.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   B1-23
AC   CVCL_A3CI
DR   Wikidata; Q105506446
RX   CelloPub=CLPUB00603;
RX   Patent=US10604565;
RX   Patent=US10781251;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3142.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q99988; Human GDF15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   B1-46
AC   CVCL_C4BP
DR   Wikidata; Q116048535
RX   PubMed=97089;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   B1-48
AC   CVCL_C4BQ
DR   Wikidata; Q116048537
RX   PubMed=97089;
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   B1-52
AC   CVCL_C4BR
DR   Wikidata; Q116048538
RX   PubMed=97089;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   B1-8
AC   CVCL_C4BN
DR   EFO; EFO_0022810
DR   Wikidata; Q116048539
RX   PubMed=97089;
RX   PubMed=398773;
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   B1.1
AC   CVCL_B0WQ
DR   Wikidata; Q108819865
RX   PubMed=6822659;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   B1.12
AC   CVCL_A2DD
DR   Wikidata; Q105506450
RX   PubMed=6846329;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   B1(NG)C39D
AC   CVCL_1N73
SY   AG13177
DR   CLO; CLO_0022090
DR   Coriell; AG13177
DR   Wikidata; Q54752273
RX   CelloPub=CLPUB00597;
RX   PubMed=2321096;
RX   PubMed=2791350;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Breed/subspecies: CBA.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N71 ! B1 [Mouse embryonal carcinoma]
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 6
//
ID   B10
AC   CVCL_E8HQ
RX   PubMed=24111866;
RX   PubMed=29634395;
RX   PubMed=34170192;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05228; Plasmodium falciparum histidine-rich protein PfHRP-III (HRP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B103
AC   CVCL_D538
SY   B-103
DR   BTO; BTO_0004397
DR   AddexBio; C0005003/25
DR   ChEMBL-Cells; CHEMBL3307905
DR   ChEMBL-Targets; CHEMBL614275
DR   PubChem_Cell_line; CVCL_D538
DR   Wikidata; Q54752276
RX   PubMed=4151463;
RX   PubMed=19386608;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   B103-p2y5
AC   CVCL_E5J5
RX   PubMed=19386608;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15520; LPAR6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D538 ! B103
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   B103-vector
AC   CVCL_E5J6
RX   PubMed=19386608;
CC   Characteristics: Control cell line for B103-p2y5 (Cellosaurus=CVCL_E5J5) (PubMed=19386608).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D538 ! B103
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   B104 [Human lymphoma]
AC   CVCL_M498
DR   JCRB; JCRB0117
DR   JCRB; NIHS0144
DR   Wikidata; Q54752277
RX   PubMed=1729359;
RX   PubMed=1988498;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0117
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C27907; B-cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   B104 [Rat neuroblastoma]
AC   CVCL_0154
SY   B-104; B104c7
DR   CLO; CLO_0001783
DR   EFO; EFO_0022820
DR   MCCL; MCC:0000046
DR   CLDB; cl4955
DR   ChEMBL-Cells; CHEMBL3307277
DR   ChEMBL-Targets; CHEMBL614025
DR   ICLC; ATL99008
DR   Wikidata; Q54752280
RX   PubMed=178672;
RX   PubMed=284369;
RX   PubMed=4151463;
WW   Info; Protocol Online; -; http://www.protocol-online.org/biology-forums-2/posts/10837.html
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Misspelling: 8104; Note=Occasionally.
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   B104-1-1
AC   CVCL_0396
DR   CLO; CLO_0001784
DR   CLDB; cl4944
DR   ATCC; CRL-1887
DR   BCRJ; 0272
DR   ICLC; ATL98015
DR   Wikidata; Q54752283
RX   PubMed=6095109;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   B104-F
AC   CVCL_C9BS
DR   Wikidata; Q123030757
RX   PubMed=178672;
CC   Doubling time: ~18 hours (PubMed=178672).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0154 ! B104 [Rat neuroblastoma]
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   B104-R3
AC   CVCL_2863
DR   JCRB; JCRB0117.1
DR   Wikidata; Q54752285
CC   Population: Japanese.
CC   Discontinued: JCRB; JCRB0117.1; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27907; B-cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M498 ! B104 [Human lymphoma]
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   B10R
AC   CVCL_0155
DR   MCCL; MCC:0000047
DR   Wikidata; Q54752288
RX   PubMed=1856597;
RX   PubMed=9490047;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/10A Bcgr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   B10S
AC   CVCL_0156
DR   MCCL; MCC:0000048
DR   Wikidata; Q54752291
RX   PubMed=1856597;
RX   PubMed=9490047;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/10A Bcgs.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   B11 [Mouse hybridoma against human SERPINC1]
AC   CVCL_C4ZE
DR   Wikidata; Q116048540
RX   PubMed=1804774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01008; Human SERPINC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   B11 [Mouse hybridoma against mouse Odc]
AC   CVCL_B038
DR   CLO; CLO_0001785
DR   ATCC; HB-8372
DR   Wikidata; Q54752293
RX   Patent=US4637984;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8372.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P00860; Mouse Odc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   B11 [Mouse hybridoma against P.falciparum HRP3]
AC   CVCL_E8HR
RX   PubMed=24111866;
RX   PubMed=29634395;
RX   PubMed=34170192;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05228; Plasmodium falciparum histidine-rich protein PfHRP-III (HRP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B113
AC   CVCL_KS97
DR   Wikidata; Q54752296
RX   PubMed=17288597;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   B117H
AC   CVCL_Y506
DR   EFO; EFO_0002040
DR   Wikidata; Q54752298
RX   PubMed=16647569;
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y505 ! B117p
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   B117p
AC   CVCL_Y505
SY   B117P
DR   EFO; EFO_0002041
DR   Wikidata; Q54752299
RX   PubMed=16647569;
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   B119-iPSC
AC   CVCL_DE33
DR   Wikidata; Q54752308
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=25843045).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD48 ! ND29369
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   B11d-ii-FAF 28 clone 237
AC   CVCL_WN69
SY   B-11-d-ii-FAF-28 clone 237; B 11 d-ii-FAF 28, clone No. 237; B 11 d-ii-FAF28 237; Strain 237
DR   Wikidata; Q93327973
RX   PubMed=563224;
RX   PubMed=1035117;
RX   PubMed=5065687;
CC   Group: Space-flown cell line (cellonaut).
CC   Anecdotal: Have been flown in space on Cosmos-782 to study growth in microgravity (PubMed=563224).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_WN54 ! FAF-28
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   B11d-ii-FAF 28 clone 431
AC   CVCL_WN70
SY   B-11-d-ii-FAF-28 clone 431
DR   Wikidata; Q93327974
RX   PubMed=5065687;
RX   PubMed=8316622;
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_WN54 ! FAF-28
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   B11F7
AC   CVCL_B039
DR   ATCC; CRL-2944
DR   Wikidata; Q54752310
RX   PubMed=2582290;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P20916; Human MAG (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   B11UVres
AC   CVCL_JM03
DR   Wikidata; Q54752314
RX   PubMed=8603488;
CC   Doubling time: 27 hours (PubMed=8603488).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   B12
AC   CVCL_4111
SY   B-12
DR   BTO; BTO_0005450
DR   CLO; CLO_0001786
DR   CLDB; cl331
DR   ECACC; 85042303
DR   Wikidata; Q54752315
RX   PubMed=4151463;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   B12-11
AC   CVCL_C623
DR   SKIP; SKIP003271
DR   Wikidata; Q54752317
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B12-2
AC   CVCL_C620
DR   SKIP; SKIP003266
DR   Wikidata; Q54752318
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B12-3
AC   CVCL_C621
DR   SKIP; SKIP003260
DR   Wikidata; Q54752319
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B12-6
AC   CVCL_C622
DR   SKIP; SKIP003257
DR   Wikidata; Q54752322
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B12.F8
AC   CVCL_2301
DR   ECACC; 11060102
DR   Wikidata; Q54752324
CC   Monoclonal antibody isotype: IgG1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=11060102
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2404 ! CM3.B6
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   B120
AC   CVCL_C3XB
DR   Wikidata; Q116048541
RX   PubMed=2478447;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07700; Meleagris gallopavo ADRB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   B1203L
AC   CVCL_8658
DR   CLO; CLO_0050057
DR   BioSample; SAMN03471929
DR   RCB; RCB2818
DR   Wikidata; Q54752326
RX   PubMed=11267941;
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=19799608;
RX   PubMed=38639832;
CC   Population: Chinese; Han and Lao.
CC   HLA typing: A*24:02,24:02; B*52:01,54:01; C*12:02,01:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2818
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 9,10
ST   vWA: 18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   B1203L-CD80
AC   CVCL_A5AR
DR   Wikidata; Q107113425
RX   PubMed=11267941;
CC   Population: Chinese; Han and Lao.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8658 ! B1203L
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   B124-1
AC   CVCL_C624
DR   SKIP; SKIP003268
DR   Wikidata; Q54752327
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B124-10
AC   CVCL_C626
DR   SKIP; SKIP003259
DR   Wikidata; Q54752330
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B124-13
AC   CVCL_C627
DR   SKIP; SKIP003273
DR   Wikidata; Q54752332
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B124-2
AC   CVCL_C625
DR   SKIP; SKIP003272
DR   Wikidata; Q54752333
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   B13
AC   CVCL_4W12
SY   B-13
DR   BCRJ; 0043
DR   Wikidata; Q54752334
RX   PubMed=2469765;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=B13
CC   Characteristics: IL5 dependent.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   B13.29
AC   CVCL_B953
SY   Clone 9.9
DR   Wikidata; Q54752338
RX   PubMed=3491732;
RX   PubMed=3500054;
CC   Characteristics: IL6 dependent.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on mature granulocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 6
//
ID   B13B
AC   CVCL_CY49
DR   ATCC; CRL-2636
DR   Wikidata; Q54752340
RX   PubMed=11401970;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
CC   Discontinued: ATCC; CRL-2636; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   B14-150
AC   CVCL_L858
SY   B-14-150; B14150; UCW 104
DR   CLO; CLO_0001788
DR   CLDB; cl332
DR   ATCC; CCL-14.1
DR   Wikidata; Q54752386
RX   DOI=10.1007/BF02618370;
RX   PubMed=5833550;
RX   PubMed=6965094;
CC   Selected for resistance to: ChEBI; CHEBI_147675; 5-iodo-2'-deoxyuridine (IUdR).
CC   Misspelling: B14I50; Note=Occasionally.
CC   Discontinued: ATCC; CCL-14.1; true.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4584 ! B14FAF28-G3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   B14.2
AC   CVCL_J941
DR   Wikidata; Q54752388
RX   PubMed=6789331;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B140H
AC   CVCL_Y508
DR   EFO; EFO_0002042
DR   Wikidata; Q54752302
RX   PubMed=16647569;
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y507 ! B140p
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   B140p
AC   CVCL_Y507
SY   B140P
DR   EFO; EFO_0002043
DR   Wikidata; Q54752304
RX   PubMed=16647569;
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   B14FAF28-G3
AC   CVCL_4584
SY   B14FAF28 clone G3; B14 FAF 28-G3; B14 FAF-28 clone G3; B14 FAF28 clone G3; B14-FAF-G3
DR   CLO; CLO_0001789
DR   CLDB; cl333
DR   ATCC; CCL-14
DR   ECACC; 91010302
DR   Wikidata; Q54752390
RX   DOI=10.1007/BF02618370;
RX   PubMed=14185313;
CC   Discontinued: ECACC; 91010302; true.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_WN54 ! FAF-28
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   B151K12
AC   CVCL_U121
DR   CLO; CLO_0050246
DR   RCB; RCB0793
DR   Wikidata; Q54752393
RX   PubMed=2440025;
RX   PubMed=6159416;
CC   Characteristics: T-cell hybridoma. Produces Il5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U120 ! BW5147-AZG(R),OU(R)
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   B152
AC   CVCL_WM85
DR   ATCC; HB-12467
DR   Wikidata; Q93328005
RX   Patent=US6339143;
RX   PubMed=10451222;
RX   PubMed=12850278;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12467.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Binds to the O-glycan on Ser-132).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   B157
AC   CVCL_6276
DR   Lonza; 1017
DR   Wikidata; Q54752395
RX   PubMed=16136460;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   B16
AC   CVCL_F936
SY   B-16; B16 melanoma; B16 subline B78; B78
DR   CLO; CLO_0050752
DR   EFO; EFO_0022766
DR   CCRID; 1101MOU-PUMC000215
DR   CCRID; 1101MOU-PUMC000324
DR   CCRID; 3101MOUTCM2
DR   CCRID; 5301MOU-KCB14029YJ
DR   ChEMBL-Cells; CHEMBL3308454
DR   ChEMBL-Targets; CHEMBL381
DR   CLS; 305154
DR   JCRB; JCRB0202
DR   KCB; KCB 2014029YJ
DR   KCB; KCB 93030YJ
DR   PubChem_Cell_line; CVCL_F936
DR   RCB; RCB1283
DR   TKG; TKG 0144
DR   TOKU-E; 3564
DR   Wikidata; Q25112368
RX   PubMed=1109790;
RX   PubMed=4981070;
RX   PubMed=5513504;
RX   PubMed=6498800;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/B16_Melanoma
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/b16-xenograft-model/
CC   Doubling time: ~28 hours (Note=Lot 07242000), 20-21 hours (Note=Lot 06122003), ~1 day (Note=Lot 10062005), ~20 hours (Note=Lot 03232009), ~27 hours (Note=Lot 03312017), ~33 hours (Note=Lot 01122021) (JCRB=JCRB0202).
CC   Miscellaneous: This line seems to be the B78 line described in PubMed=4981070 which itself seems to be derived from the HFH-18 line that itself originate from a B16 melanoma.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS32 ! HFH-18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   B16 melanoma 4A5
AC   CVCL_4612
SY   B164A5; B16-4A5
DR   CLO; CLO_0001790
DR   CLO; CLO_0050758
DR   CLDB; cl335
DR   ChEMBL-Cells; CHEMBL4651378
DR   ECACC; 94042254
DR   IZSLER; BS TCL 184
DR   PubChem_Cell_line; CVCL_4612
DR   RCB; RCB0557
DR   Wikidata; Q54752401
RX   PubMed=23890195;
RX   PubMed=33596583;
CC   Doubling time: 24 hours (PubMed=23890195).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=33596583).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   B16 melanoma/lacZ
AC   CVCL_L291
DR   CLO; CLO_0050753
DR   RCB; RCB1284
DR   Wikidata; Q54752402
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   B16-A
AC   CVCL_8298
DR   CLO; CLO_0001791
DR   CLDB; cl336
DR   Wikidata; Q54752404
RX   PubMed=6644070;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   B16-B
AC   CVCL_8299
DR   Wikidata; Q54752408
RX   PubMed=6644070;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   B16-BL6
AC   CVCL_0157
SY   B16/BL6; B16 BL6; B16BL6; B16BL-6; BL6; BL-6; B16-F10-BL6
DR   BTO; BTO_0002808
DR   CLO; CLO_0050759
DR   MCCL; MCC:0000049
DR   ChEMBL-Cells; CHEMBL4295415
DR   ChEMBL-Targets; CHEMBL4296400
DR   KCLB; 80006
DR   NCI-DTP; B16BL-6
DR   PubChem_Cell_line; CVCL_0157
DR   RCB; RCB2638
DR   TKG; TKG 0598
DR   Wikidata; Q54752412
RX   PubMed=2297053;
RX   PubMed=3370643;
RX   PubMed=7370995;
RX   PubMed=11833741;
CC   Characteristics: Highly invasive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   B16-Blue IFN-alpha/beta
AC   CVCL_X605
DR   InvivoGen; bb-ifnt1
DR   Wikidata; Q54752414
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-alpha/beta-inducible ISG54 promoter enhanced by a multimeric ISRE (InvivoGen=bb-ifnt1).
CC   Knockout cell: Method=Not specified; MGI; MGI:107655; Ifngr1.
CC   Knockout cell: Method=Not specified; MGI; MGI:107654; Ifngr2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0158 ! B16-F1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   B16-Blue IFN-gamma
AC   CVCL_X604
DR   InvivoGen; bb-ifng
DR   Wikidata; Q54752416
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter fused to 4 IFNG-activated sites (GAS) (InvivoGen=bb-ifng).
CC   Knockout cell: Method=Not specified; MGI; MGI:107658; Ifnar1.
CC   Knockout cell: Method=Not specified; MGI; MGI:1098243; Ifnar2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0158 ! B16-F1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   B16-Blue ISG
AC   CVCL_X602
DR   InvivoGen; bb-ifnabg
DR   Wikidata; Q54752418
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE (InvivoGen=bb-ifnabg).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0158 ! B16-F1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   B16-Blue ISG-KO-STING
AC   CVCL_X603
DR   InvivoGen; bb-kostg
DR   Wikidata; Q54752421
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE (InvivoGen=bb-kostg).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X602 ! B16-Blue ISG
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 14
//
ID   B16-C2M
AC   CVCL_H720
SY   B16 C2M; B16C2M; C2M
DR   TKG; TKG 0346
DR   Wikidata; Q54752423
RX   PubMed=4209534;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   B16-C2W
AC   CVCL_H721
SY   B16 C2W; B16C2W; C2W
DR   TKG; TKG 0666
DR   Wikidata; Q54752424
RX   PubMed=4209534;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   B16-F0
AC   CVCL_0604
SY   B16/F0; B16F0
DR   BTO; BTO_0000576
DR   CLO; CLO_0001792
DR   CLDB; cl340
DR   ATCC; CRL-6322
DR   BCRC; 60029
DR   BCRJ; 0044
DR   BioSample; SAMN11397653
DR   CCRID; 4201MOU-CCTCC00038
DR   CCTCC; GDC0038
DR   ChEMBL-Cells; CHEMBL4295400
DR   ChEMBL-Targets; CHEMBL4296401
DR   CLS; 300308
DR   ECACC; 92101204
DR   Lonza; 873
DR   PubChem_Cell_line; CVCL_0604
DR   Wikidata; Q54752428
RX   PubMed=1109790;
RX   PubMed=11833741;
RX   PubMed=31220119;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 17,18
ST   Mouse STR 1-2: 19,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 16,20
ST   Mouse STR 6-4: 18,19,20
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17,18
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,16,17,18
ST   Mouse STR 18-3: 15,16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   B16-F0-Luc
AC   CVCL_4W99
DR   JCRB; JCRB1474
DR   JCRB; NIHS0698
DR   Wikidata; Q54752432
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0698; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0604 ! B16-F0
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   B16-F1
AC   CVCL_0158
SY   B16/F1; B16 F1; B16F1
DR   BTO; BTO_0003853
DR   CLO; CLO_0001793
DR   CLO; CLO_0050764
DR   EFO; EFO_0022821
DR   MCCL; MCC:0000050
DR   CLDB; cl337
DR   CLDB; cl338
DR   ATCC; CRL-6323
DR   BCRC; 60030
DR   BCRJ; 0045
DR   BioSample; SAMN11397654
DR   CCRID; 1101MOU-PUMC000365
DR   CCRID; 4201MOU-CCTCC00039
DR   CCTCC; GDC0039
DR   ChEMBL-Cells; CHEMBL4295385
DR   ChEMBL-Targets; CHEMBL4296402
DR   CLS; 400122
DR   ECACC; 92101203
DR   KCLB; 80007
DR   Lonza; 1278
DR   NCI-DTP; B16F1
DR   PRIDE; PXD018083
DR   PubChem_Cell_line; CVCL_0158
DR   RCB; RCB2649
DR   TKG; TKG 0347
DR   TOKU-E; 581
DR   Wikidata; Q54752433
RX   PubMed=210294;
RX   PubMed=1109790;
RX   PubMed=6498800;
RX   PubMed=6539703;
RX   PubMed=11833741;
RX   PubMed=22797548;
RX   PubMed=25277546;
RX   PubMed=31220119;
RX   PubMed=33596583;
CC   Characteristics: Obtained from the pulmonary melanoma module of the 1st serial passage of the B16-F0 parent cell line in C57BL/6 mice.
CC   Characteristics: Has a low metastatic potential.
CC   Doubling time: 22 hours (PubMed=1109790).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=33596583).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: CLS; 400122; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 17,18
ST   Mouse STR 1-2: 19,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 16,20
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17,18
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,16,17
ST   Mouse STR 18-3: 15,16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0604 ! B16-F0
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   B16-F1-Luc2
AC   CVCL_A4CK
DR   ATCC; CRL-6323-LUC2
DR   Wikidata; Q105506455
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-6323-LUC2).
CC   Doubling time: ~11 hours (ATCC=CRL-6323-LUC2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0158 ! B16-F1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   B16-F10
AC   CVCL_0159
SY   B16/F10; B16 F10; B16F10; B16 melanoma F10
DR   BTO; BTO_0002014
DR   CLO; CLO_0001794
DR   CLO; CLO_0050763
DR   EFO; EFO_0022759
DR   MCCL; MCC:0000051
DR   CLDB; cl339
DR   CLDB; cl4967
DR   AddexBio; C0012005/5003
DR   ATCC; CRL-6475
DR   BCRC; 60031
DR   BCRJ; 0046
DR   BioGRID_ORCS_Cell_line; 737
DR   CCRID; 1101MOU-PUMC000473
DR   CCRID; 3101MOUTCM36
DR   CCRID; 6101MOU-CERC000106
DR   ChEMBL-Cells; CHEMBL3307762
DR   ChEMBL-Targets; CHEMBL612656
DR   CLS; 305157
DR   ICLC; ATL99010
DR   KCB; KCB 2014047YJ
DR   KCLB; 80008
DR   Lonza; 998
DR   NCBI_Iran; C540
DR   NCI-DTP; B16F10
DR   PRIDE; PXD008733
DR   PubChem_Cell_line; CVCL_0159
DR   RCB; RCB2630
DR   TKG; TKG 0348
DR   Ubigene; YC-A011
DR   Wikidata; Q54752438
RX   PubMed=210294;
RX   PubMed=1109790;
RX   PubMed=6539703;
RX   PubMed=11833741;
RX   PubMed=23890195;
RX   PubMed=25277546;
RX   PubMed=30084848;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-1.html
WW   Provider; BRICS; BRICS0131; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3934
CC   Characteristics: Obtained from the pulmonary melanoma module of the 10th serial passage of the B16-F0 parent cell line in C57BL/6 mice.
CC   Characteristics: Has a high metastatic potential.
CC   Doubling time: 17 hours (PubMed=1109790); 17.2 hours (PubMed=23890195).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Ubigene=YC-A011
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 16,20
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 18-3: 15,16
ST   Mouse STR X-1: 28
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UJ41 ! B16-F5
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   B16-F10 B2m-KO
AC   CVCL_D0P3
SY   B16 B2M-KO
DR   Wikidata; Q123030758
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Miscellaneous: Cell line information from personal communication of Comin-Anduix, Begonya.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   B16-F10 Pbrm1 KO 1
AC   CVCL_E3VN
SY   B16 PBRM1 KO1; B16-F10 knockout for PBRM1 clone 1; B16-F10 knockout for PBRM1 clone B4
DR   CancerTools; 161888
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1923998; Pbrm1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10 Pbrm1 KO 2
AC   CVCL_E3VP
SY   B16 PBRM1 KO2; B16-F10 knockout for PBRM1 clone 2; B16-F10 knockout for PBRM1 clone B25
DR   CancerTools; 161889
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1923998; Pbrm1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10-EGFP
AC   CVCL_XB96
DR   Ubigene; YC-A011-EGFP-P
DR   Wikidata; Q93328087
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   B16-F10-Lr6
AC   CVCL_U240
SY   B16-F10-LR6; B16-F10Lr6; B16F10Lr6; B16FLr6; B16-FLr6; F10 Lr6; Lr6
DR   ATCC; CRL-6324
DR   NCI-DTP; B16FLr6
DR   Wikidata; Q54752439
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6324; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   B16-F10-Luc
AC   CVCL_C8XU
DR   Ubigene; YC-A011-Luc-P
DR   Wikidata; Q123030759
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   B16-F10-Luc 1-#3
AC   CVCL_4Y00
SY   B16F10-Luc 1-#3
DR   JCRB; JCRB1465
DR   JCRB; NIHS0699
DR   Wikidata; Q54752441
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0699; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   B16-F10-luc-G5
AC   CVCL_5J39
SY   B16F10-luc-G5; B16F10lucG5
DR   Revvity/PerkinElmer; 119269
DR   Wikidata; Q54752443
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119269; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   B16-F10-Luc2 [ATCC]
AC   CVCL_A4CJ
DR   ATCC; CRL-6475-LUC2
DR   Wikidata; Q105506458
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-6475-LUC2).
CC   Doubling time: ~12 hours (ATCC=CRL-6475-LUC2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   B16-F10-luc2 [Caliper]
AC   CVCL_5J17
DR   ChEMBL-Cells; CHEMBL4482993
DR   ChEMBL-Targets; CHEMBL4483227
DR   PubChem_Cell_line; CVCL_5J17
DR   Revvity/PerkinElmer; 124734
DR   Wikidata; Q54752445
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124734; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   B16-F10-mCherry
AC   CVCL_XB95
DR   CCRID; 1101MOU-PUMC000624
DR   Wikidata; Q93328109
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   B16-F10-Nex2
AC   CVCL_F942
SY   B16F10-Nex2; B16F10-NEX2; B16F10Nex2; B16Nex2; Nex2
DR   BTO; BTO_0003424
DR   BCRJ; 0342
DR   ChEMBL-Cells; CHEMBL4482994
DR   ChEMBL-Targets; CHEMBL4483228
DR   PubChem_Cell_line; CVCL_F942
DR   Wikidata; Q54752446
RX   PubMed=12470474;
RX   PubMed=15457088;
RX   PubMed=20689762;
CC   Characteristics: Melanotic. Shows low immunogenicity and moderate virulence. Forms subcutaneous tumours which are lethal, but do not metastasize to the lung unless injected intravenously (PubMed=15457088).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   B16-F10-Nex3
AC   CVCL_C3Q0
SY   B16F10-NEX3; B16F10(nex3)
DR   Wikidata; Q116048542
RX   PubMed=12470474;
CC   Characteristics: Amelanotic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   B16-F10-Nex4
AC   CVCL_C3Q1
SY   B16F10-NEX4
DR   Wikidata; Q116048543
RX   PubMed=12470474;
CC   Characteristics: The parent cell line was inoculated subcutaneously in C57BL/6 mice and the in vivo developing tumor cell were recultivated to produce this cell line (PubMed=12470474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F942 ! B16-F10-Nex2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   B16-F10-Red-FLuc
AC   CVCL_5I87
SY   B16F10-Red-FLuc; B16F10 Red-FLuc; Bioware Brite B16F10 Red-FLuc; IVISbrite B16F10 Red F-luc
DR   Revvity/PerkinElmer; BW124734
DR   Wikidata; Q54752449
CC   Doubling time: 15 hours (Revvity/PerkinElmer=BW124734).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 9
//
ID   B16-F10-tdT
AC   CVCL_XB97
DR   CCRID; 1101MOU-PUMC000623
DR   Wikidata; Q93328121
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   B16-F10.9
AC   CVCL_E3VQ
SY   F10.9; Clone F10.9
DR   CancerTools; 160882
DR   Ximbio; 160882
RX   PubMed=1906054;
RX   PubMed=2639904;
CC   Characteristics: Highly metastatic. Expresses low level of MHC class I antigens (PubMed=1906054; PubMed=2639904).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10.9.K1
AC   CVCL_E3VS
SY   F10.9.K1; K1
RX   PubMed=2639904;
CC   Characteristics: High expression of H2-Kb (PubMed=2639904).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1 (Note=Allele H2-K1*02 (H2-Kb)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3VQ ! B16-F10.9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10.9.K13
AC   CVCL_E3VT
SY   F10.9.K13; K13
RX   PubMed=2639904;
CC   Characteristics: High expression of H2-Kb (PubMed=2639904).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1 (Note=Allele H2-K1*02 (H2-Kb)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3VQ ! B16-F10.9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10.9.K17
AC   CVCL_E3VU
SY   F10.9.K17; K17
RX   PubMed=2639904;
CC   Characteristics: Low expression of H2-Kb (PubMed=2639904).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1 (Note=Allele H2-K1*02 (H2-Kb)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3VQ ! B16-F10.9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10.9.KG1
AC   CVCL_E3VV
SY   F10.9.KG1; KG1
RX   PubMed=2639904;
CC   Characteristics: Moderate expression of H2-Kb (PubMed=2639904).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1 (Note=Allele H2-K1*02 (H2-Kb)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3VQ ! B16-F10.9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10.9.neo
AC   CVCL_E3VR
SY   F10.9.neo; F10.9-Neo
RX   PubMed=2639904;
CC   Characteristics: Control cell line for B16-F10.9.K1 (Cellosaurus=CVCL_E3VS), B16-F10.9.K13 (Cellosaurus=CVCL_E3VT), B16-F10.9.K17 (Cellosaurus=CVCL_E3VU) and B16-F10.9.KG1 (Cellosaurus=CVCL_E3VV) (PubMed=2639904).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3VQ ! B16-F10.9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   B16-F10/CMV-Luc#2
AC   CVCL_JG40
DR   JCRB; JCRB1675
DR   Wikidata; Q54752451
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1675).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   B16-F10/EF1a-Luc#1
AC   CVCL_JG94
DR   JCRB; JCRB1680
DR   Wikidata; Q54752452
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   B16-F5
AC   CVCL_UJ41
DR   Wikidata; Q93328133
RX   PubMed=210294;
RX   PubMed=1109790;
CC   Characteristics: Obtained from the pulmonary melanoma module of the 5th serial passage of the B16-F0 parent cell line in C57BL/6 mice.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0158 ! B16-F1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   B16-FLT3L
AC   CVCL_IJ12
SY   B16-Flt3l; B16FLT3
DR   Wikidata; Q54752455
RX   PubMed=10866317;
RX   PubMed=23890195;
CC   Doubling time: 18.4 hours (PubMed=23890195).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95560; Flt3l.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   B16-MO4
AC   CVCL_WM78
SY   B16-OVA M04; B16-OVA MO4; B16 clone M04; M04; MO4
DR   BioGRID_ORCS_Cell_line; 1264
DR   Millipore; SCC420
DR   Wikidata; Q93328141
RX   PubMed=7585145;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (Millipore=SCC420).
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC420
ST   Mouse STR 1-1: 17,18
ST   Mouse STR 1-2: 19,20
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 16,20
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15,16
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17,18
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,16,17
ST   Mouse STR 18-3: 15,16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   B16-MO5
AC   CVCL_WM77
SY   B16.MO5; B16 MO5; MO5; M05
DR   Wikidata; Q93328143
RX   PubMed=8551233;
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   B16-R1
AC   CVCL_ZF67
DR   Wikidata; Q98125522
RX   PubMed=22797548;
CC   Characteristics: Established from lymph nodes metastatic cells obtained by intradermal injection of the parent cell line in the backskin of C57BL/6 mice.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0158 ! B16-F1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   B16-R2
AC   CVCL_ZF68
DR   Wikidata; Q98125523
RX   PubMed=22797548;
CC   Characteristics: Established from lymph nodes metastatic cells obtained by intradermal injection of the parent cell line in the backskin of C57BL/6 mice.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZF67 ! B16-R1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   B16-R2L
AC   CVCL_ZF69
DR   Wikidata; Q98125527
RX   PubMed=22797548;
CC   Characteristics: Established from lung metastatic cells obtained by intradermal injection of the parent cell line in the backskin of C57BL/6 mice.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZF67 ! B16-R1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   B16/F10-Luc-RFP
AC   CVCL_B7NS
SY   Luciferase/tdTomato Dual-Reporter B16/F10 Cell Line
DR   Wikidata; Q112929266
WW   Provider; ALSTEM; LRL05; https://www.alstembio.com/web/product_details.php?id=40
CC   Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   B16.1#1B2
AC   CVCL_XK78
SY   PAb7
DR   Wikidata; Q93328145
RX   Patent=US4172124;
RX   PubMed=79181;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#1B6
AC   CVCL_XK79
DR   Wikidata; Q93328149
RX   Patent=US4172124;
RX   PubMed=79181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#1C1
AC   CVCL_XK80
DR   Wikidata; Q93328152
RX   Patent=US4172124;
RX   PubMed=79181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#1C5
AC   CVCL_XK81
SY   PAb5
DR   Wikidata; Q93328155
RX   Patent=US4172124;
RX   PubMed=79181;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#2A2
AC   CVCL_XK82
SY   PAb2
DR   Wikidata; Q93328157
RX   Patent=US4172124;
RX   PubMed=79181;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#2A3
AC   CVCL_XK83
SY   PAb6
DR   Wikidata; Q93328159
RX   Patent=US4172124;
RX   PubMed=79181;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#2A5
AC   CVCL_XK84
DR   Wikidata; Q93328161
RX   Patent=US4172124;
RX   PubMed=79181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#2C4
AC   CVCL_XK85
SY   PAb3
DR   Wikidata; Q93328163
RX   Patent=US4172124;
RX   PubMed=79181;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#2D2
AC   CVCL_XK86
DR   Wikidata; Q93328165
RX   Patent=US4172124;
RX   PubMed=79181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B16.1#2D5
AC   CVCL_XK87
SY   PAb4
DR   Wikidata; Q93328167
RX   Patent=US4172124;
RX   PubMed=79181;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   B1647
AC   CVCL_3357
DR   CLDB; cl7141
DR   ICLC; HTL03004
DR   Wikidata; Q54752456
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9332307;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ICLC=HTL03004
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D21S11: 30,31
ST   D5S818: 8,10
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   B16F10-B7H6
AC   CVCL_VA21
SY   B16F10/B7H6
DR   Wikidata; Q54752459
RX   PubMed=25830550;
RX   PubMed=29453518;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:42400; NCR3LG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   B16F10-eGFP-Puro
AC   CVCL_QZ86
DR   Imanis; CL053
DR   Wikidata; Q54752462
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL053).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   B16F10-Fluc-hNIS
AC   CVCL_D5KB
DR   Imanis; CL139
DR   Wikidata; Q127380245
CC   Characteristics: Reporter cell line, transduced with the LV-Luc2-P2A-hNIS vector encoding for luciferase linked via a P2A cleavage peptide to the human SLC5A5 gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL139).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   B16F10-Fluc-Neo/eGFP-Puro
AC   CVCL_QZ87
DR   Imanis; CL068
DR   Wikidata; Q54752464
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL068).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   B16F10-Fluc-Neo/iRFP-Puro
AC   CVCL_QZ88
DR   Imanis; CL110
DR   Wikidata; Q54752466
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-iRFP-P2A-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL110).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   B16F10-Fluc-Neo/mNIS-Puro
AC   CVCL_QZ89
DR   Imanis; CL069
DR   Wikidata; Q54752468
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-mNIS-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-mNIS-PGKp-Puro encodes for mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL069).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   B16F10-Fluc-Puro
AC   CVCL_QZ90
DR   Imanis; CL052
DR   Wikidata; Q54752469
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL052).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   B16F10-iRFP-Puro
AC   CVCL_QZ91
DR   Imanis; CL099
DR   Wikidata; Q54752472
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Puro vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL099).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   B16F10-mNIS (monoclonal)
AC   CVCL_QZ92
DR   Imanis; CL118
DR   Wikidata; Q54752475
CC   Characteristics: Transduced with the LV-mNIS vector encoding mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL118).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   B16F10-mNIS-Neo/eGFP-Puro
AC   CVCL_QZ93
DR   Imanis; CL067
DR   Wikidata; Q54752476
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL067).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   B16F10-mNIS-Neo/iRFP-Puro
AC   CVCL_QZ94
DR   Imanis; CL109
DR   Wikidata; Q54752478
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-iRFP-P2A-Puro vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL109).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   B16F10-mNIS-Puro
AC   CVCL_QZ95
DR   Imanis; CL057
DR   Wikidata; Q54752523
CC   Characteristics: Reporter cell line, transduced with the LV-mNIS-PGKp-Puro vector encoding for mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL057).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   B16F10/mGM
AC   CVCL_L292
SY   B16-GMCSF; B16GMCSF; B16-GM; B16GM
DR   CLO; CLO_0050762
DR   RCB; RCB1158
DR   TOKU-E; 4042
DR   Wikidata; Q54752525
RX   PubMed=9886252;
RX   PubMed=23890195;
CC   Doubling time: 17.9 hours (PubMed=23890195).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339752; Csf2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   B16V
AC   CVCL_1950
SY   B-16V
DR   CLO; CLO_0001795
DR   CLDB; cl341
DR   DSMZ; ACC-370
DR   DSMZCellDive; ACC-370
DR   Wikidata; Q54752528
RX   PubMed=3730255;
CC   Doubling time: 15 +- 1.64 hours (PubMed=3730255); ~20 hours (DSMZ=ACC-370).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   B16VDXR
AC   CVCL_F937
SY   B16VDxR
DR   CLO; CLO_0001796
DR   CLDB; cl342
DR   Wikidata; Q54752531
RX   PubMed=3730255;
RX   PubMed=3741758;
CC   Doubling time: 25 +- 1.75 hours (PubMed=3730255).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1950 ! B16V
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   B18
AC   CVCL_V065
DR   CLO; CLO_0001797
DR   CLDB; cl343
DR   IHW; 11w 8122
DR   Wikidata; Q54752533
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   B19
AC   CVCL_V066
DR   CLO; CLO_0001798
DR   CLDB; cl344
DR   IHW; 11w 8124
DR   Wikidata; Q54752537
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   B1A2A
AC   CVCL_L928
DR   Wikidata; Q54752538
RX   PubMed=5062896;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_L927 ! BHK 21/13 subline B1
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   B1A2A5
AC   CVCL_L929
SY   Line A-5; A5 subline; GM00511; GM-511; GM0511; GM511
DR   CLO; CLO_0025932
DR   Coriell; GM00511
DR   Wikidata; Q54752541
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=5062896;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_L928 ! B1A2A
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   B1B3
AC   CVCL_G635
SY   464 B1B3; 464B1B3
DR   CLO; CLO_0001800
DR   ATCC; CRL-2249
DR   Wikidata; Q54752543
RX   PubMed=3973009;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B1B6
AC   CVCL_G636
SY   464 B1B6; 464B1B6
DR   CLO; CLO_0001801
DR   ATCC; CRL-2248
DR   Wikidata; Q54752546
RX   PubMed=3973009;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B1BC CL
AC   CVCL_E7HP
RX   PubMed=37344100;
CC   Characteristics: Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B1C3
AC   CVCL_UV24
DR   Wikidata; Q93328264
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV23 ! AIS-C3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   B1C4
AC   CVCL_UV25
DR   Wikidata; Q93328266
RX   CelloPub=CLPUB00466;
RX   PubMed=231040;
RX   PubMed=663800;
RX   PubMed=664253;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV23 ! AIS-C3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   B1C8
AC   CVCL_C6V8
DR   Wikidata; Q117704206
RX   Patent=CN110878309B;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P9WNK7; Mycobacterium tuberculosis ESAT-6 (esxA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 3
//
ID   B1D6
AC   CVCL_L832
DR   ECACC; 98042014
DR   Wikidata; Q54752548
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07355; Human ANXA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   B1E3
AC   CVCL_ZC48
DR   Wikidata; Q98125531
RX   PubMed=1717839;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   B1OXI
AC   CVCL_6C17
SY   B1oxi
DR   Wikidata; Q54752550
RX   CelloPub=CLPUB00293;
RX   PubMed=20444515;
RX   PubMed=22193509;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of chicken origin but found to be a porcine cell line (PubMed=22193509).
CC   Misspelling: B10XI; PubMed=22193509.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 8
//
ID   B2.1
AC   CVCL_B0WR
DR   Wikidata; Q108819866
RX   PubMed=6822659;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   B2.10
AC   CVCL_A2DE
DR   Wikidata; Q105506461
RX   PubMed=6846329;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   B2.12
AC   CVCL_A2DF
DR   Wikidata; Q105506465
RX   PubMed=3156882;
RX   PubMed=6846329;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   B2-1
AC   CVCL_4503
SY   cl. B2-1
DR   CLO; CLO_0001805
DR   CLDB; cl346
DR   ATCC; CRL-8085
DR   IZSLER; BS CL 122
DR   Wikidata; Q54752552
RX   Patent=US4465769;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8085.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y303 ! 10E2 [Mouse embryo]
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   B2-17
AC   CVCL_2864
DR   CLO; CLO_0009881
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03151975
DR   cancercelllines; CVCL_2864
DR   Cell_Model_Passport; SIDM00110
DR   Cosmic; 911904
DR   Cosmic; 2367508
DR   IARC_TP53; 21180
DR   JCRB; IFO50361
DR   LINCS_LDP; LCL-1367
DR   Wikidata; Q54752556
RX   CelloPub=CLPUB00152;
RX   PubMed=20164919;
CC   Population: Caucasian.
CC   Doubling time: 48 hours (CelloPub=CLPUB00152).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Was incorrectly reported to be a U-251MG contaminated cell line by ICLAC while it was specifically derived from U-251MG as described in the original publication (CelloPub=CLPUB00152).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): JCRB=IFO50361
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   B2.6.2
AC   CVCL_D3F5
DR   Wikidata; Q127380246
RX   PubMed=1380254;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15692; Human VEGFA (Note=Does not recognize VEGF121).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   B2.Bm
AC   CVCL_R940
DR   ATCC; CRL-6021
DR   Wikidata; Q54752558
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6021; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_3647 ! B2.Ln
OI   CVCL_3648 ! B2.Sp
OI   CVCL_3649 ! B2.Sp/Thy
OI   CVCL_S316 ! B2.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   B2.Ln
AC   CVCL_3647
DR   CLO; CLO_0001802
DR   ATCC; CRL-6022
DR   Wikidata; Q54752560
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6022; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_R940 ! B2.Bm
OI   CVCL_3648 ! B2.Sp
OI   CVCL_3649 ! B2.Sp/Thy
OI   CVCL_S316 ! B2.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   B2.Sp
AC   CVCL_3648
DR   CLO; CLO_0001803
DR   CLDB; cl347
DR   ATCC; CRL-6023
DR   ECACC; 90030906
DR   Wikidata; Q54752562
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6023; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_R940 ! B2.Bm
OI   CVCL_3647 ! B2.Ln
OI   CVCL_3649 ! B2.Sp/Thy
OI   CVCL_S316 ! B2.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   B2.Sp/Thy
AC   CVCL_3649
DR   CLO; CLO_0001804
DR   ATCC; CRL-6024
DR   Wikidata; Q54752565
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6024; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_R940 ! B2.Bm
OI   CVCL_3647 ! B2.Ln
OI   CVCL_3648 ! B2.Sp
OI   CVCL_S316 ! B2.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   B2.Thy
AC   CVCL_S316
DR   ATCC; CRL-6025
DR   Wikidata; Q54752567
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6025; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_R940 ! B2.Bm
OI   CVCL_3647 ! B2.Ln
OI   CVCL_3648 ! B2.Sp
OI   CVCL_3649 ! B2.Sp/Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   B20-CA2
AC   CVCL_B0MC
DR   Wikidata; Q108819867
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB (Note=Also recognizes CGB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B203L
AC   CVCL_U097
DR   Wikidata; Q54752569
RX   PubMed=11267941;
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:012; B*15:01,54:01; C*01:02,03:04 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   B203L-CD80
AC   CVCL_A5AS
DR   Wikidata; Q107113426
RX   PubMed=11267941;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U097 ! B203L
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   B207
AC   CVCL_WM86
DR   CCTCC; GDC0222
DR   Wikidata; Q93328310
RX   Patent=US6339143;
RX   PubMed=10451222;
RX   PubMed=12850278;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1626.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 8
//
ID   B21-2
AC   CVCL_9164
DR   CLO; CLO_0001806
DR   ATCC; TIB-229
DR   Wikidata; Q54752572
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   B22D2
AC   CVCL_D7E4
RX   Patent=US8685399;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02548; Human PAX5 (Note=Recognizes AA 370-375).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   B239
AC   CVCL_L055
DR   Cell_Model_Passport; SIDM01684
DR   Wikidata; Q54752574
RX   PubMed=1664237;
RX   PubMed=9680106;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L056 ! B240
OI   CVCL_1835 ! NALM-19
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   B24-BF10
AC   CVCL_B0M5
DR   Wikidata; Q108819868
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B240
AC   CVCL_L056
DR   Cell_Model_Passport; SIDM01683
DR   Wikidata; Q54752577
RX   PubMed=1664237;
RX   PubMed=9680106;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L055 ! B239
OI   CVCL_1835 ! NALM-19
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   B25-AB1
AC   CVCL_B0ML
DR   Wikidata; Q108819869
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0429.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B25-AD5
AC   CVCL_B0MM
DR   Wikidata; Q108819870
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0430.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B25-BB1
AC   CVCL_B0MN
DR   Wikidata; Q108819871
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0431.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B25-BI8
AC   CVCL_B0MP
DR   Wikidata; Q108819872
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0432.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B25-CF11
AC   CVCL_B0MQ
DR   Wikidata; Q108819873
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0433.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B25.2
AC   CVCL_J942
DR   CLO; CLO_0001808
DR   ATCC; HB-8107
DR   Wikidata; Q54752579
RX   Patent=US4522918;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8107.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   B250
AC   CVCL_L054
DR   Wikidata; Q54752580
RX   PubMed=1817649;
RX   PubMed=9680106;
CC   Population: Japanese.
CC   Doubling time: 30-36 hours (PubMed=1817649).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1836 ! NALM-20
OI   CVCL_1837 ! NALM-21
OI   CVCL_5662 ! NALM-22
OI   CVCL_5663 ! NALM-23
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   B262
AC   CVCL_QX01
DR   Wikidata; Q54752582
RX   PubMed=1667895;
RX   PubMed=9680106;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3888 ! NALM-24
OI   CVCL_5664 ! NALM-25
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   B27-AC9
AC   CVCL_B0MD
DR   Wikidata; Q108819874
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B27-AD10
AC   CVCL_B0M9
DR   Wikidata; Q108819875
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B27-BH2
AC   CVCL_B0M7
DR   Wikidata; Q108819876
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B27-CE8
AC   CVCL_B0M8
DR   Wikidata; Q108819877
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B27-FG11
AC   CVCL_B0MA
DR   Wikidata; Q108819878
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B27M1
AC   CVCL_J172
DR   CLO; CLO_0001809
DR   ATCC; HB-157
DR   Wikidata; Q54752586
RX   PubMed=6166821;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J171 ! Sp2/08A2
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B27M2
AC   CVCL_J173
DR   CLO; CLO_0001810
DR   ATCC; HB-165
DR   Wikidata; Q54752588
RX   PubMed=6981637;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J171 ! Sp2/08A2
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B2905
AC   CVCL_B0CG
SY   Melanoma model 4; M4
DR   ATCC; CRL-3476
DR   GEO; GSM4301285
DR   Wikidata; Q108819879
RX   PubMed=32284588;
CC   Doubling time: ~16 hours (ATCC=CRL-3476).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 Hgftg.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   B2BC CL
AC   CVCL_E7HQ
RX   PubMed=37344100;
CC   Characteristics: Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E7HR ! B3BC CL
OI   CVCL_E7HS ! B4BC CL
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B2LT1
AC   CVCL_HE71
DR   Wikidata; Q54752593
RX   Patent=US6825394;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 97032720.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   50D
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   B2M-/- Elf1
AC   CVCL_YY07
DR   WiCell; b2m-elf1
DR   Wikidata; Q98125532
RX   PubMed=28504668;
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=b2m-elf1
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 15,18
ST   D21S11: 29,31
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 5,12
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C115 ! Elf1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   B2M-/Edimer(preCre)Elf1
AC   CVCL_YY08
DR   WiCell; b2m-edimer-pre-cre-elf1
DR   Wikidata; Q98125533
RX   PubMed=28504668;
CC   Characteristics: Using a rAAV, the second B2M allele has been edited to express B2M covalently linked at the C-terminus to a flexible (G4S)4 linker followed by HLA-E. A HyTK-Neo selection cassette has not been removed by Cre-recombinase.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:914; B2M (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C115 ! Elf1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   B2M-/Edimer Elf1
AC   CVCL_YY09
DR   WiCell; b2m-edimer-elf1
DR   Wikidata; Q98125535
RX   PubMed=28504668;
CC   Characteristics: Using a rAAV, the second B2M allele has been edited to express B2M covalently linked at the C-terminus to a flexible (G4S)4 linker followed by HLA-E.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:914; B2M (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C115 ! Elf1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   B2M-/Etrimer Elf1
AC   CVCL_YY10
DR   WiCell; b2m-etrimer-elf1
DR   Wikidata; Q98125536
RX   PubMed=28504668;
CC   Characteristics: Using a rAAV, the second B2M allele has been edited to express the signal sequence of HLA-G followed by a flexible (G4S)3 linker followed by B2M covalently linked at the C-terminus to a flexible (G4S)4 linker followed by HLA-E.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:914; B2M (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C115 ! Elf1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   B3
AC   CVCL_RP56
SY   STATegra Control cells
DR   GEO; GSM1954299
DR   GEO; GSM1954300
DR   GEO; GSM1954301
DR   GEO; GSM1954302
DR   GEO; GSM1954303
DR   GEO; GSM1954304
DR   GEO; GSM1954305
DR   GEO; GSM1954306
DR   GEO; GSM1954307
DR   GEO; GSM1954308
DR   GEO; GSM1954309
DR   GEO; GSM1954310
DR   GEO; GSM1954311
DR   GEO; GSM1954312
DR   GEO; GSM1954313
DR   GEO; GSM1954314
DR   GEO; GSM1954315
DR   GEO; GSM1954316
DR   GEO; GSM1954349
DR   GEO; GSM1954350
DR   GEO; GSM1954351
DR   GEO; GSM1954352
DR   GEO; GSM1954353
DR   GEO; GSM1954354
DR   GEO; GSM1954355
DR   GEO; GSM1954356
DR   GEO; GSM1954357
DR   GEO; GSM1954358
DR   GEO; GSM1954359
DR   GEO; GSM1954360
DR   GEO; GSM1954361
DR   GEO; GSM1954362
DR   GEO; GSM1954363
DR   GEO; GSM1954364
DR   GEO; GSM1954365
DR   GEO; GSM1954366
DR   GEO; GSM1954385
DR   GEO; GSM1954386
DR   GEO; GSM1954387
DR   GEO; GSM1954388
DR   GEO; GSM1954389
DR   GEO; GSM1954390
DR   GEO; GSM1954391
DR   GEO; GSM1954392
DR   GEO; GSM1954393
DR   GEO; GSM1954394
DR   GEO; GSM1954395
DR   GEO; GSM1954396
DR   GEO; GSM1954397
DR   GEO; GSM1954398
DR   GEO; GSM1954399
DR   GEO; GSM1954400
DR   GEO; GSM1954401
DR   GEO; GSM1954402
DR   GEO; GSM1954785
DR   GEO; GSM1954786
DR   GEO; GSM1954787
DR   GEO; GSM1954788
DR   GEO; GSM1954789
DR   GEO; GSM1954790
DR   GEO; GSM1954791
DR   GEO; GSM1954792
DR   GEO; GSM1954793
DR   GEO; GSM1954794
DR   GEO; GSM1954795
DR   GEO; GSM1954796
DR   GEO; GSM1954797
DR   GEO; GSM1954798
DR   GEO; GSM1954799
DR   GEO; GSM1954800
DR   GEO; GSM1954801
DR   GEO; GSM1954802
DR   MetaboLights; MTBLS283
DR   PRIDE; PXD003263
DR   Wikidata; Q54752594
RX   PubMed=7794821;
RX   PubMed=9413993;
RX   PubMed=23303821;
WW   Info; -; -; https://web.archive.org/web/20210509141008/http://www.stategra.eu/the-b3-system/
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96561; Il7.
CC   Omics: Metabolomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: 10-III-42 transgenic Tg(H2-Ea-Il7)10Rhdr.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   B3 HA-159A Ikaros-IRES-GFP
AC   CVCL_RP58
DR   GEO; GSM934760
DR   GEO; GSM934761
DR   Wikidata; Q54752597
RX   PubMed=23303821;
CC   Characteristics: Transfected with a fusion protein of hemagglutinin-tagged wild type Ikaros (HA-Ikaros) and the estrogen receptor hormone-binding domain (ERt2), followed by an internal ribosomal entry site (IRES) and GFP.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13176; IKZF1 (Note=With p.Asn159Ala).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96561; Il7.
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: 10-III-42 transgenic Tg(H2-Ea-Il7)10Rhdr.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RP56 ! B3
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   B3 HA-Ikaros-IRES-GFP
AC   CVCL_RP57
SY   STATegra Ikaros cells
DR   GEO; GSE75390
DR   GEO; GSM934758
DR   GEO; GSM934759
DR   GEO; GSM934762
DR   GEO; GSM934763
DR   GEO; GSM934764
DR   GEO; GSM934765
DR   GEO; GSM934766
DR   GEO; GSM934767
DR   GEO; GSM1954317
DR   GEO; GSM1954318
DR   GEO; GSM1954319
DR   GEO; GSM1954320
DR   GEO; GSM1954321
DR   GEO; GSM1954322
DR   GEO; GSM1954323
DR   GEO; GSM1954324
DR   GEO; GSM1954325
DR   GEO; GSM1954326
DR   GEO; GSM1954327
DR   GEO; GSM1954328
DR   GEO; GSM1954329
DR   GEO; GSM1954330
DR   GEO; GSM1954331
DR   GEO; GSM1954332
DR   GEO; GSM1954333
DR   GEO; GSM1954334
DR   GEO; GSM1954367
DR   GEO; GSM1954368
DR   GEO; GSM1954369
DR   GEO; GSM1954370
DR   GEO; GSM1954371
DR   GEO; GSM1954372
DR   GEO; GSM1954373
DR   GEO; GSM1954374
DR   GEO; GSM1954375
DR   GEO; GSM1954376
DR   GEO; GSM1954377
DR   GEO; GSM1954378
DR   GEO; GSM1954379
DR   GEO; GSM1954380
DR   GEO; GSM1954381
DR   GEO; GSM1954382
DR   GEO; GSM1954383
DR   GEO; GSM1954384
DR   GEO; GSM1954403
DR   GEO; GSM1954404
DR   GEO; GSM1954405
DR   GEO; GSM1954406
DR   GEO; GSM1954407
DR   GEO; GSM1954408
DR   GEO; GSM1954409
DR   GEO; GSM1954410
DR   GEO; GSM1954411
DR   GEO; GSM1954412
DR   GEO; GSM1954413
DR   GEO; GSM1954414
DR   GEO; GSM1954415
DR   GEO; GSM1954416
DR   GEO; GSM1954417
DR   GEO; GSM1954418
DR   GEO; GSM1954419
DR   GEO; GSM1954420
DR   GEO; GSM1954803
DR   GEO; GSM1954804
DR   GEO; GSM1954805
DR   GEO; GSM1954806
DR   GEO; GSM1954807
DR   GEO; GSM1954808
DR   GEO; GSM1954809
DR   GEO; GSM1954810
DR   GEO; GSM1954811
DR   GEO; GSM1954812
DR   GEO; GSM1954813
DR   GEO; GSM1954814
DR   GEO; GSM1954815
DR   GEO; GSM1954816
DR   GEO; GSM1954817
DR   GEO; GSM1954818
DR   GEO; GSM1954819
DR   GEO; GSM1954820
DR   MetaboLights; MTBLS283
DR   PRIDE; PXD003263
DR   Wikidata; Q54752596
RX   PubMed=23303821;
WW   Info; -; -; https://web.archive.org/web/20210509141008/http://www.stategra.eu/the-b3-system/
CC   Characteristics: Transfected with a fusion protein of hemagglutinin-tagged wild type Ikaros (HA-Ikaros) and the estrogen receptor hormone-binding domain (ERt2), followed by an internal ribosomal entry site (IRES) and GFP.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13176; IKZF1.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96561; Il7.
CC   Omics: Metabolomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: 10-III-42 transgenic Tg(H2-Ea-Il7)10Rhdr.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RP56 ! B3
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   B3 NIH
AC   CVCL_J978
SY   B3
DR   ATCC; HB-10573
DR   Wikidata; Q54752601
RX   Patent=US5612032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10573.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   B3-17
AC   CVCL_C0E9
DR   Wikidata; Q112929267
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13688; Human CEACAM1/CD66a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   B3-B5
AC   CVCL_C5NE
DR   Wikidata; Q116048544
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   B3.1
AC   CVCL_B0WS
DR   Wikidata; Q108819880
RX   PubMed=6822659;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   B3.2
AC   CVCL_T690
SY   B 3.2
DR   Wikidata; Q54752609
RX   PubMed=1811155;
RX   PubMed=3419920;
CC   Group: Amphibian cell line.
CC   From: Weber, Rudolf Heinrich; University of Bern; Bern; Switzerland.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 13
//
ID   B3.2(tTA)1
AC   CVCL_6E63
DR   Wikidata; Q54752610
RX   PubMed=9542626;
CC   Group: Amphibian cell line.
CC   Characteristics: Expresses the tetracycline-controlled transactivator (tTA).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_T690 ! B3.2
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   B3/25
AC   CVCL_G096
DR   CLO; CLO_0001813
DR   ATCC; CRL-8034
DR   ECACC; 94050507
DR   Wikidata; Q54752603
RX   Patent=US4626507;
RX   Patent=US5667781;
RX   PubMed=6265934;
RX   PubMed=7412870;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8034.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   B3/AN
AC   CVCL_3358
DR   CLO; CLO_0001814
DR   CLDB; cl349
DR   CLDB; cl350
DR   ECACC; 94031009
DR   ICLC; ATL97004
DR   Wikidata; Q54752605
CC   Discontinued: ECACC; 94031009; true.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   B301
AC   CVCL_M579
DR   Wikidata; Q54752611
RX   PubMed=10925292;
CC   Population: Caribbean; Haitian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cardiac transplant patient (PubMed=10925292).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0106 ! VG-1
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   B3180
AC   CVCL_AW12
DR   Wikidata; Q54752614
RX   PubMed=16136460;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   B32-BC11
AC   CVCL_B0MB
DR   Wikidata; Q108819881
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B32-BD11
AC   CVCL_B0MI
DR   Wikidata; Q108819882
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B32-BF2
AC   CVCL_B0MJ
DR   Wikidata; Q108819883
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B32-BG4
AC   CVCL_B0MK
DR   Wikidata; Q108819884
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B35
AC   CVCL_1951
DR   BTO; BTO_0002649
DR   CLO; CLO_0001815
DR   ATCC; CRL-2754
DR   Lonza; 1397
DR   TOKU-E; 596
DR   Wikidata; Q54752661
RX   PubMed=4151463;
RX   PubMed=12884695;
RX   PubMed=21541302;
WW   Info; -; -; https://web.archive.org/web/20150310222251/http://cellbiology.med.unsw.edu.au/units/lab/cells/cell_B35.htm
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-211.html
CC   Characteristics: Useful in the molecular analysis of endocytosis and of signaling pathways, in particular those that guide axonal outgrowth and cell motility (PubMed=12884695).
CC   Characteristics: Can be induced to differentiate reversibly, extending long neurites when grown in low serum or treated with dibutyryl cAMP (PubMed=12884695).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   B35 rKcnc1
AC   CVCL_E7ZL
SY   B35 Kv3.1
RX   PubMed=21541302;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2955; Kcnc1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1951 ! B35
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   B35 rKcnc1 N220Q
AC   CVCL_E7ZM
SY   B35 Kv3.1 N220Q
RX   PubMed=21541302;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2955; Kcnc1 (Note=With p.Asn220Gln).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1951 ! B35
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   B35 rKcnc1 N220Q/N229Q
AC   CVCL_E7ZN
SY   B35 Kv3.1 N220Q/N229Q
RX   PubMed=21541302;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2955; Kcnc1 (Note=With p.Asn220Gln and p.Asn229Gln).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1951 ! B35
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   B35 rKcnc1 N229Q
AC   CVCL_E7ZP
SY   B35 Kv3.1 N229Q
RX   PubMed=21541302;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2955; Kcnc1 (Note=With p.Asn229Gln).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1951 ! B35
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   B35M
AC   CVCL_D319
SY   B35 M; B-35M; 35M
DR   CGH-DB; 9190-4
DR   Wikidata; Q54752663
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4166872;
RX   PubMed=4169243;
RX   PubMed=4366935;
RX   PubMed=4866767;
RX   PubMed=5260617;
RX   PubMed=6929725;
CC   Doubling time: ~21 hours (PubMed=4166872).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   B37.3
AC   CVCL_A2DG
DR   Wikidata; Q105506469
RX   PubMed=6846329;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   B38.1
AC   CVCL_J943
DR   CLO; CLO_0001816
DR   ATCC; HB-8110
DR   Wikidata; Q54752664
RX   Patent=US4522918;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8110.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   B39.1
AC   CVCL_J944
DR   Wikidata; Q54752666
RX   PubMed=6789331;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B391
AC   CVCL_QX02
DR   Wikidata; Q54752668
RX   PubMed=9680106;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5667 ! NALM-29
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   B3B7
AC   CVCL_E8B5
SY   MAR1 clone B3 subclone B7
RX   DOI=10.1016/B978-012442710-5.50265-3;
RX   PubMed=1343098;
RX   PubMed=7620321;
RX   PubMed=9914916;
RX   PubMed=19273061;
WW   Provider; URMC; -; https://www.urmc.rochester.edu/microbiology-immunology/research/xenopus-laevis/models/cell-lines
CC   Group: Amphibian cell line.
CC   Characteristics: Does not express MHC class I or MHC class II molecules (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Displays a dual B-cell and T-cell phenotype (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: ff.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_E8B4 ! MAR1 clone B3
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B3BC CL
AC   CVCL_E7HR
RX   PubMed=37344100;
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E7HQ ! B2BC CL
OI   CVCL_E7HS ! B4BC CL
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B3D
AC   CVCL_G638
DR   CLO; CLO_0001817
DR   ATCC; CRL-2634
DR   Wikidata; Q54752669
RX   PubMed=11401970;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q48245; Helicobacter pylori vacA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B3D3
AC   CVCL_E8B6
SY   MAR1 clone B3 subclone D3
RX   PubMed=1343098;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: ff.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_E8B4 ! MAR1 clone B3
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B3F6.17
AC   CVCL_B0P2
SY   CR-10
DR   Wikidata; Q108819885
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3319.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   B3Z
AC   CVCL_6277
DR   Lonza; 1535
DR   Wikidata; Q54752672
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   B4.14
AC   CVCL_VS66
DR   Wikidata; Q93328417
RX   PubMed=8543166;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-212.html
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03347; HIV-1 isolate BH10 gag.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03366; HIV-1 isolate BH10 pol.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04616; HIV-1 isolate BH10 rev.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_VS65 ! CMT3
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   B4.2
AC   CVCL_YB02
DR   ABCD; ABCD_AK422
DR   Wikidata; Q93328419
RX   DOI=10.24450/journals/abrep.2019.e58;
RX   PubMed=27187592;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O77257; Dictyostelium discoideum sctA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   B4.3.1
AC   CVCL_D3F6
DR   Wikidata; Q127380247
RX   PubMed=1380254;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15692; Human VEGFA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   B40-AA3
AC   CVCL_B0MR
DR   Wikidata; Q108819886
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0434.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B40-AE6
AC   CVCL_B0MS
DR   Wikidata; Q108819887
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0435.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B40-DE8
AC   CVCL_B0MT
DR   Wikidata; Q108819888
RX   Patent=DD279410A1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0436.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B406
AC   CVCL_WM87
SY   KB12
DR   Wikidata; Q93328421
RX   Patent=US7232891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3832.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 5
//
ID   B407
AC   CVCL_L601
DR   Wikidata; Q54752673
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10848782;
CC   Population: Japanese.
CC   Doubling time: ~32 hours (PubMed=10848782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5842 ! MOLP-5
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   B408
AC   CVCL_WM88
SY   KB21
DR   Wikidata; Q93328427
RX   Patent=US7232891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3833.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 5
//
ID   B409
AC   CVCL_WM89
SY   KB31
DR   Wikidata; Q93328429
RX   Patent=US7232891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3834.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 5
//
ID   B411-4
AC   CVCL_WT35
DR   Wikidata; Q93328431
RX   PubMed=4366935;
RX   PubMed=6929725;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   B413
AC   CVCL_WM90
DR   Wikidata; Q93328433
RX   Patent=US7232891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3835.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 5
//
ID   B422
AC   CVCL_L076
DR   Wikidata; Q54752674
RX   PubMed=15863212;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L077 ! B423
OI   CVCL_7922 ! MOLM-17
OI   CVCL_7923 ! MOLM-18
SX   Male
AG   60-61Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   B423
AC   CVCL_L077
DR   Wikidata; Q54752676
RX   PubMed=15863212;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L076 ! B422
OI   CVCL_7922 ! MOLM-17
OI   CVCL_7923 ! MOLM-18
SX   Male
AG   60-61Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   B436
AC   CVCL_KS98
DR   Wikidata; Q54752677
RX   Patent=WO2004018997A2;
RX   PubMed=17288597;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 first 12 residues).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   B45
AC   CVCL_A8VM
DR   Wikidata; Q108819889
RX   PubMed=22514610;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: INRA Sy derived homozygous clone B45.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   B46M
AC   CVCL_D320
DR   CGH-DB; 9191-4
DR   Wikidata; Q54752682
RX   DOI=10.1266/jjg.47.211;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4366935;
RX   PubMed=5566367;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   B48
AC   CVCL_E4RL
SY   anti-MBP hybridoma
DR   ABCD; ABCD_AW485
RX   PubMed=26311203;
RX   PubMed=33896065;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P0AEX9; Escherichia coli malE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   B4B5C5
AC   CVCL_WZ99
DR   CCRID; 6101MOU-CERC000018
DR   Wikidata; Q93328451
RX   PubMed=17549792;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14602; Human EIF1AY.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   B4B8
AC   CVCL_0B35
SY   B4B8-3
DR   Wikidata; Q54752683
RX   PubMed=10399955;
RX   PubMed=15868906;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 5
//
ID   B4BC CL
AC   CVCL_E7HS
RX   PubMed=37344100;
CC   Characteristics: Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E7HQ ! B2BC CL
OI   CVCL_E7HR ! B3BC CL
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   b5
AC   CVCL_A7WE
SY   mAb-b5
DR   BEI_Resources; MRA-662
DR   Wikidata; Q107113427
RX   PubMed=3315732;
RX   PubMed=9010839;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08168; Plasmodium berghei 58 kDa phosphoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   B5 NIH
AC   CVCL_J979
SY   B5
DR   CLO; CLO_0001819
DR   ATCC; HB-10569
DR   Wikidata; Q54752685
RX   Patent=US5612032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10569.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   B50
AC   CVCL_4112
SY   B-50
DR   BTO; BTO_0002665
DR   CLO; CLO_0001820
DR   CLDB; cl351
DR   CLDB; cl5139
DR   ECACC; 85042302
DR   IZSLER; BS TCL 115
DR   Wikidata; Q54752687
RX   PubMed=4151463;
RX   PubMed=12884695;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   B50.1
AC   CVCL_J945
DR   Wikidata; Q54752690
RX   PubMed=6789331;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B50.4
AC   CVCL_J946
DR   Wikidata; Q54752691
RX   Patent=US4522918;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8111.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   B503
AC   CVCL_IQ96
DR   Wikidata; Q54752693
RX   Patent=US7034124;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11999.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   B504
AC   CVCL_IQ97
DR   Wikidata; Q54752696
RX   Patent=US7034124;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12001.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   B505
AC   CVCL_J976
DR   CLO; CLO_0001821
DR   ATCC; HB-12000
DR   Wikidata; Q54752698
RX   Patent=US7034124;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12000.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   B509
AC   CVCL_IQ98
DR   Wikidata; Q54752699
RX   Patent=US7034124;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12002.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01229; Human LHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   B514L
AC   CVCL_TZ86
DR   Wikidata; Q54752701
RX   PubMed=17511773;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   B53-12
AC   CVCL_C4BT
DR   Wikidata; Q116048545
RX   PubMed=97089;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   B53-8
AC   CVCL_C4BS
DR   Wikidata; Q116048547
RX   PubMed=97089;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   B57
AC   CVCL_A8VN
DR   Wikidata; Q108819890
RX   PubMed=22514610;
RX   PubMed=29921219;
CC   Group: Fish cell line.
CC   Virology: Not susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: INRA Sy derived homozygous clone B57.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   B59.2
AC   CVCL_A2DH
DR   Wikidata; Q105506471
RX   PubMed=3156882;
RX   PubMed=6846329;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   B5BC CL
AC   CVCL_E7HT
RX   PubMed=37344100;
CC   Characteristics: Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B5KTu
AC   CVCL_IQ00
DR   Wikidata; Q54752702
RX   DOI=10.1007/978-1-4612-0411-4_26;
RX   PubMed=1638679;
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4688 ! 184B5
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   B6 [Contaminated chicken cell line]
AC   CVCL_6C18
DR   Wikidata; Q54752707
RX   PubMed=20444515;
RX   PubMed=22193509;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of chicken origin but found to be a porcine cell line (PubMed=22193509).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 8
//
ID   B6 [Human trophoblast]
AC   CVCL_L814
DR   Wikidata; Q54752705
RX   PubMed=8671449;
CC   Doubling time: 48 hours (PubMed=8671449).
CC   Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 9
//
ID   B6 [Mouse hybridoma against human PR1]
AC   CVCL_E4C9
SY   PR1
DR   ABCD; ABCD_AN180
RX   Patent=US5489525;
RX   PubMed=7686582;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11145.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen PR1 expressed on surface of prostate cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   B6-1153
AC   CVCL_RP71
DR   Wikidata; Q54752711
RX   PubMed=1560546;
RX   PubMed=2830334;
RX   PubMed=25277546;
CC   Transformant: NCBI_TaxID; 11794; Duplan murine leukemia virus (Note=Strain LP-BM5).
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: C57BL/6NJ.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   B6-1710
AC   CVCL_RP72
DR   Wikidata; Q54752713
RX   PubMed=1560546;
RX   PubMed=2830334;
RX   PubMed=20217872;
RX   PubMed=25277546;
CC   Transformant: NCBI_TaxID; 11794; Duplan murine leukemia virus (Note=Strain LP-BM5).
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: C57BL/6NJ.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   B6-206
AC   CVCL_RP77
DR   Wikidata; Q54752715
RX   PubMed=21422172;
RX   PubMed=25277546;
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: C57BL/6NJ.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 4
//
ID   B6-207
AC   CVCL_RP78
DR   Wikidata; Q54752716
RX   PubMed=20217872;
RX   PubMed=21422172;
RX   PubMed=25277546;
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: C57BL/6NJ.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 4
//
ID   B6-6
AC   CVCL_K094
DR   RCB; AES0172
DR   SKIP; SKIP002923
DR   Wikidata; Q54752721
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6NCrSlc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 6
//
ID   B6-6(feeder-free)
AC   CVCL_RH43
DR   RCB; AES0187
DR   SKIP; SKIP002930
DR   Wikidata; Q54752722
RX   PubMed=24268252;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Can be maintained in undifferentiated state on hydroxyapatite coated with gelatin.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6NCrSlc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K094 ! B6-6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   B6-RPE07
AC   CVCL_DF62
DR   Wikidata; Q54752725
RX   PubMed=18421091;
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   B6-White
AC   CVCL_E267
DR   Millipore; SCR011
DR   Wikidata; Q54752726
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 tyrc-2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   B6.1
AC   CVCL_WI49
DR   Wikidata; Q93328536
RX   PubMed=91527;
RX   PubMed=2230118;
RX   PubMed=6970130;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   B6.1.1
AC   CVCL_F732
DR   CancerTools; 151488
DR   Wikidata; Q54752729
DR   Ximbio; 151488
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   B6.1.2
AC   CVCL_WI50
DR   Wikidata; Q93328542
RX   PubMed=91527;
RX   PubMed=6970130;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WI49 ! B6.1
SX   Female
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   B6.1.2.TG5
AC   CVCL_WI51
DR   Wikidata; Q93328544
RX   PubMed=6970130;
CC   Characteristics: IL2 dependent.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WI50 ! B6.1.2
SX   Female
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   B6.1.SF.1
AC   CVCL_WI52
SY   B6.1.SF.1.2
DR   Wikidata; Q93328547
RX   PubMed=6333421;
RX   PubMed=6436236;
RX   PubMed=6970130;
RX   PubMed=6979720;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WI49 ! B6.1
SX   Female
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   B6.1.SF.1 VV6
AC   CVCL_WI53
SY   VV6; VV 6
DR   Wikidata; Q93328549
RX   PubMed=6333421;
RX   PubMed=6436236;
RX   PubMed=6970130;
CC   Characteristics: Deficient in UDP-GalNAc:beta-galactose beta 1,4-N-acetylgalactosaminyltransferase (PubMed=6436236).
CC   Characteristics: IL2 dependent.
CC   Selected for resistance to: UniProtKB; P56625; Vicia villosa lectin B4.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WI52 ! B6.1.SF.1
SX   Female
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   B6.2
AC   CVCL_J947
DR   CLO; CLO_0001822
DR   ATCC; HB-8106
DR   Wikidata; Q54752732
RX   Patent=US4522918;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8106.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   B6/BLU
AC   CVCL_C258
DR   ATCC; SCRC-1019
DR   CCRID; 3101MOUSCSP226
DR   Wikidata; Q54752734
CC   Characteristics: The transgenic mice contains a HS-2-HBB-LacZ construct.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:4827; HBB.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Tac transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   B6/FA
AC   CVCL_8834
DR   CLO; CLO_0001823
DR   CLDB; cl353
DR   ECACC; 94031008
DR   Wikidata; Q54752735
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: ECACC; 94031008; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   B65
AC   CVCL_4113
DR   CLO; CLO_0001825
DR   CLDB; cl352
DR   ECACC; 85042305
DR   Lonza; 299
DR   NCBI_Iran; C134
DR   Wikidata; Q54752737
RX   PubMed=4151463;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-525.html
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   B66BA
AC   CVCL_JW72
DR   Wikidata; Q54752739
RX   PubMed=2463079;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: SENCAR.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 6
//
ID   B6B11
AC   CVCL_9V32
DR   ATCC; HB-12481
DR   Wikidata; Q54752785
RX   Patent=US7220559;
RX   PubMed=12454369;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12481.
CC   Doubling time: 20-22 hours (PubMed=12454369).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
HI   CVCL_0014 ! RPMI-8226
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   B6BC CL
AC   CVCL_E7HN
SY   B6BC
RX   PubMed=37344100;
WW   Provider; Inserm Transfert; RT00656; https://technology-offers.inserm-transfert.com/offer/b6bc-cell-line/
CC   Characteristics: Hormone receptor-positive. Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E7HU ! B7BC CL
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B6D4
AC   CVCL_ZN83
DR   Wikidata; Q98125537
RX   PubMed=6593712;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04062; Human GBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   B6fc-1
AC   CVCL_F038
DR   RCB; AES0037
DR   RCB; RCB2186
DR   SKIP; SKIP001691
DR   Wikidata; Q54752787
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2186; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   B6fc-2
AC   CVCL_F039
DR   RCB; AES0038
DR   RCB; RCB2187
DR   SKIP; SKIP001692
DR   Wikidata; Q54752790
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2187; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   B6ft-1
AC   CVCL_F036
DR   RCB; AES0035
DR   RCB; RCB2184
DR   SKIP; SKIP001689
DR   Wikidata; Q54752791
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2184; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   B6ft-2
AC   CVCL_F037
DR   RCB; AES0036
DR   RCB; RCB2185
DR   SKIP; SKIP001690
DR   Wikidata; Q54752794
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2185; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   B6G-2
AC   CVCL_D275
DR   RCB; AES0003
DR   RCB; RCB2001
DR   SKIP; SKIP001635
DR   Wikidata; Q54752796
RX   PubMed=15830376;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: RCB; RCB2001; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   B6G7.10
AC   CVCL_B0P3
SY   CR-4
DR   Wikidata; Q108819891
RX   Patent=US8673303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3313.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13385; Human TDGF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   B6H12.2
AC   CVCL_J980
SY   B6H12
DR   CLO; CLO_0001827
DR   ATCC; HB-9771
DR   Wikidata; Q54752798
RX   Patent=US6111080;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9771.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
CC   Discontinued: ATCC; HB-9771; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   B6J-23^(UTR)
AC   CVCL_0J02
SY   B6J-23 (UTR)
DR   RCB; AES0143
DR   SKIP; SKIP003033
DR   Wikidata; Q54752800
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   B6J-S1^(UTR)
AC   CVCL_0J03
SY   B6J-S1 (UTR)
DR   RCB; AES0140
DR   SKIP; SKIP003031
DR   Wikidata; Q54752803
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   B6MP102
AC   CVCL_WN53
DR   Wikidata; Q93328608
RX   PubMed=1640164;
RX   PubMed=2826627;
RX   PubMed=11537959;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: CSF1 dependent.
CC   Anecdotal: Have been flown in space on shuttle flights STS-37, STS-43 and STS-50 to study cytokine secretion in microgravity (PubMed=1640164).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   B6mt-1
AC   CVCL_F034
DR   RCB; AES0033
DR   RCB; RCB2182
DR   SKIP; SKIP001687
DR   Wikidata; Q54752805
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2182; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   B6mt-2
AC   CVCL_F035
DR   RCB; AES0034
DR   RCB; RCB2183
DR   SKIP; SKIP001688
DR   Wikidata; Q54752807
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2183; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   B6MYC-CaP
AC   CVCL_DF38
DR   Wikidata; Q54752808
RX   PubMed=27225803;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: B6MYC (FVB Hi-Myc x C57BL/6N).
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   18M
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   B6N-22^(UTR)
AC   CVCL_0J04
SY   B6N-22 (UTR)
DR   RCB; AES0144
DR   SKIP; SKIP003034
DR   Wikidata; Q54752812
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6NCrlCrlj.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   B6NJ-22^(UTR)
AC   CVCL_0J05
SY   B6NJ-22 (UTR)
DR   RCB; AES0141
DR   SKIP; SKIP003032
DR   Wikidata; Q54752813
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6NCrlCrlj x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   B6SUtA
AC   CVCL_5981
SY   B6SUt-A; B6SUtA cl 27
DR   Wikidata; Q54752815
RX   PubMed=6574462;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=B6SUt-A
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: B6.S.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   B6SUtA1
AC   CVCL_D635
DR   BTO; BTO_0005321
DR   Wikidata; Q54752818
RX   PubMed=2649169;
CC   Characteristics: CSF2 and IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: B6.S.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5981 ! B6SUtA
CA   Factor-dependent cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   B6Tert-1
AC   CVCL_6880
DR   BTO; BTO_0005021
DR   Wikidata; Q54752820
RX   PubMed=16772430;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L814 ! B6 [Human trophoblast]
SX   Male
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   B6YD10
AC   CVCL_DB47
DR   ATCC; HB-18
DR   Wikidata; Q54752824
CC   Monoclonal antibody isotype: IgG2.
CC   Discontinued: ATCC; HB-18; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   B6YH4
AC   CVCL_DB48
DR   ATCC; HB-17
DR   CCTCC; GDC0017
DR   Wikidata; Q54752825
CC   Monoclonal antibody isotype: IgG2.
CC   Discontinued: ATCC; HB-17; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   B7
AC   CVCL_E8HP
RX   PubMed=24111866;
RX   PubMed=29634395;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05228; Plasmodium falciparum histidine-rich protein PFHRP-III (HRP3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   B7-24-E1G4
AC   CVCL_J981
SY   B7-24
DR   CLO; CLO_0001829
DR   ATCC; HB-11341
DR   Wikidata; Q54752828
RX   Patent=US5677165;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11341.
CC   Registration: Chiron Master Culture Collection; CMCC 11060 (CMCC #11060).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P33681; Human CD80.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   B72.3
AC   CVCL_G097
DR   CLO; CLO_0001828
DR   ABCD; ABCD_AJ341
DR   ATCC; HB-8108
DR   Wikidata; Q54752829
RX   Patent=US4522918;
RX   PubMed=3396010;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8108.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   B76.1/Huh7
AC   CVCL_U443
SY   B76.1/Huh-7; B76.1
DR   cancercelllines; CVCL_U443
DR   Wikidata; Q54752833
RX   PubMed=12097587;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U442 ! B76/Huh7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   B76/Huh7
AC   CVCL_U442
SY   B76
DR   cancercelllines; CVCL_U442
DR   Wikidata; Q54752832
RX   PubMed=12097587;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   B77-A31
AC   CVCL_LF96
DR   Wikidata; Q54752834
RX   PubMed=4359949;
CC   From: Vogt, Peter Klaus; The Scripps Research Institute; La Jolla; USA.
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 (B77)).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 11
//
ID   B78/TNF
AC   CVCL_0160
DR   MCCL; MCC:0000052
DR   Wikidata; Q54752835
RX   PubMed=11228537;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11892; TNF.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8341 ! B78H1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   B78H1
AC   CVCL_8341
SY   B-78-H1
DR   CLO; CLO_0001830
DR   CLDB; cl355
DR   Wikidata; Q54752836
RX   PubMed=6324393;
WW   Provider; Metalab; -; https://web.archive.org/web/20170423083439/http://lollini.it/b78.htm
CC   Characteristics: Unlike B16, B78H1 cells are MHC class I negative even after interferon-gamma induction.
CC   Characteristics: Amelanotic clone of B16.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   B7BC CL
AC   CVCL_E7HU
RX   PubMed=37344100;
CC   Characteristics: Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E7HN ! B6BC CL
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B7E11
AC   CVCL_0B36
SY   B7E11-4
DR   Wikidata; Q54752839
RX   PubMed=10399955;
RX   PubMed=15868906;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 5
//
ID   B7E3
AC   CVCL_0B37
SY   B7E3-4
DR   BTO; BTO_0005554
DR   Wikidata; Q54752843
RX   PubMed=10399955;
RX   PubMed=15868906;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 5
//
ID   B8-24-3
AC   CVCL_G639
DR   CLO; CLO_0001832
DR   ATCC; TIB-139
DR   Wikidata; Q54752845
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B80-PT3
AC   CVCL_DP15
DR   Wikidata; Q54752847
RX   PubMed=11281650;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A283 ! Bre-80
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   B80-TERT1
AC   CVCL_DP16
DR   Wikidata; Q54752850
RX   PubMed=11791183;
RX   PubMed=18451136;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A283 ! Bre-80
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   B80-TERT2
AC   CVCL_DP17
DR   Wikidata; Q54752852
RX   PubMed=11791183;
RX   PubMed=18451136;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A283 ! Bre-80
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   B80-TERT3a
AC   CVCL_DP18
DR   Wikidata; Q54752854
RX   PubMed=11791183;
RX   PubMed=18451136;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A283 ! Bre-80
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   B80-TERT3b
AC   CVCL_DP19
DR   Wikidata; Q54752855
RX   PubMed=11791183;
RX   PubMed=18451136;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A283 ! Bre-80
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   B82
AC   CVCL_4114
SY   B82 (Hamprecht); B-82; GM00347; GM-347; GM0347; GM347; GM00347A; GM 0347A
DR   CLO; CLO_0001831
DR   CLO; CLO_0025567
DR   CLDB; cl356
DR   CCRID; 4201MOU-CCTCC00021
DR   CCTCC; GDC0021
DR   CLS; 305173
DR   Coriell; GM00347
DR   ECACC; 08062522
DR   ECACC; 85011408
DR   JCRB; JCRB0212
DR   Wikidata; Q54752856
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-219.html
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Miscellaneous: ECACC has two catalogue entries for B82 which differ in that they were deposited by different groups: B82 (ECACC=85011408) and B82 (Hamprecht) (ECACC=08062522).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   B82CAPR
AC   CVCL_A7QI
SY   B82CAP
DR   Wikidata; Q107113428
RX   PubMed=6285531;
RX   PubMed=8824267;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4114 ! B82
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   B84-15
AC   CVCL_6A88
DR   Wikidata; Q54752861
RX   PubMed=4333982;
RX   PubMed=4357683;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9521; ! Saimiri sciureus (Common squirrel monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   B84.1
AC   CVCL_J948
DR   Wikidata; Q54752862
RX   PubMed=6789331;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   B85
AC   CVCL_WW76
SY   B-85
DR   Wikidata; Q93328962
RX   CelloPub=CLPUB00085;
RX   PubMed=2939141;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=10695022;
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*15 (PubMed=2939141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_5660 ! NALM-12
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   B8B3
AC   CVCL_ZN84
DR   Wikidata; Q98125539
RX   PubMed=6593712;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04062; Human GBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   B8BC CL
AC   CVCL_E7HV
RX   PubMed=37344100;
CC   Characteristics: Tumorigenic. Will induce tumors when injected subcutaneously in the mammary fat pad of immunocompetent tumor-naive C57BL/6 mice (PubMed=37344100).
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   13-16W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   B9
AC   CVCL_1952
DR   CLO; CLO_0001836
DR   CLDB; cl360
DR   CLDB; cl4929
DR   CLDB; cl5051
DR   ATCC; CRL-2344
DR   DSMZ; ACC-211
DR   DSMZCellDive; ACC-211
DR   ECACC; 12121201
DR   ECACC; 96080128
DR   ICLC; HYL98004
DR   IZSLER; BS Hy 55
DR   Wikidata; Q54752865
RX   PubMed=3263920;
RX   PubMed=3500054;
RX   PubMed=7730664;
RX   PubMed=8034982;
RX   PubMed=8267637;
RX   PubMed=8398901;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=B9
CC   Characteristics: Used for measuring the biological activity of IL6. This is called the B9 hybridoma assay.
CC   Characteristics: IL6 dependent.
CC   Doubling time: ~30-50 hours (DSMZ=ACC-211).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on mature granulocytes.
CC   Discontinued: ATCC; CRL-2344; true.
CC   Discontinued: ECACC; 96080128; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B953 ! B13.29
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   B9-1-3
AC   CVCL_C557
SY   B9.1.3
DR   Wikidata; Q54752866
RX   PubMed=7730664;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=B9-1-3
CC   Characteristics: IL13 dependent.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on mature granulocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1952 ! B9
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   B9-11
AC   CVCL_C558
SY   B9.11
DR   Wikidata; Q54752867
RX   PubMed=8034982;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=B9-11
CC   Characteristics: Used for measuring the biological activity of IL11 (PubMed=8034982).
CC   Characteristics: IL6 and IL11 dependent.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on mature granulocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1952 ! B9
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   B9-AA1
AC   CVCL_B0MH
DR   Wikidata; Q108819892
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also binds FSHB, LHB and TSHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B9-AA4
AC   CVCL_B0MG
DR   Wikidata; Q108819893
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B9-AB9
AC   CVCL_B0ME
DR   Wikidata; Q108819894
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also binds FSHB, LHB and TSHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B9-BA8
AC   CVCL_B0M6
DR   Wikidata; Q108819895
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   B9-BG4
AC   CVCL_B0MF
DR   Wikidata; Q108819896
RX   PubMed=7681037;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   B9-TY1
AC   CVCL_C559
DR   Wikidata; Q54752914
RX   PubMed=8398901;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=B9-TY1
CC   Characteristics: IL6 or IL11 dependent.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on mature granulocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1952 ! B9
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   B9013HCB
AC   CVCL_B0CH
SY   Melanoma model 2; M2
DR   ATCC; CRL-3474
DR   GEO; GSM4301283
DR   Wikidata; Q108819897
RX   PubMed=32284588;
CC   Doubling time: ~24-36 hours (ATCC=CRL-3474).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 BrafCA/+, Cdkn2aflox/+, Tyr-CreERT2-tg, Hgftg.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   B901L
AC   CVCL_U098
DR   Cosmic; 1513406
DR   RCB; RCB3530
DR   Wikidata; Q54752916
RX   PubMed=11267941;
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=21498706;
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka and Japanese.
CC   HLA typing: A*02:06,26:01; B*39:01,40:06; C*07:02,08:01 (PubMed=12114371).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (PubMed=21498706).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   B901L-CD80
AC   CVCL_A5AT
DR   Wikidata; Q107113429
RX   PubMed=11267941;
CC   Population: Chinese/Asian ethnic group; Hakka and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U098 ! B901L
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   B92
AC   CVCL_4115
DR   CLO; CLO_0001837
DR   CLDB; cl361
DR   ECACC; 85042304
DR   NCBI_Iran; C132
DR   Wikidata; Q54752918
RX   PubMed=4151463;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C121567; Rat neuroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   B95-8
AC   CVCL_1953
SY   B95.8; B 95.8; B 95-8; B-95-8; B958; GM07404; GM07404A; GM07404D
DR   BTO; BTO_0000107
DR   CLO; CLO_0001776
DR   CLO; CLO_0001838
DR   EFO; EFO_0022801
DR   CLDB; cl364
DR   CLDB; cl365
DR   CLDB; cl366
DR   CLDB; cl367
DR   CLDB; cl368
DR   CLDB; cl369
DR   ArrayExpress; E-MTAB-1511
DR   ATCC; CRL-1612
DR   BCRJ; 0042
DR   CCRID; 3101MONGNO3
DR   CCRID; 4201MON-CCTCC00015
DR   CCRID; 5301MON-KCB93008YJ
DR   CCTCC; GDC0015
DR   ChEMBL-Cells; CHEMBL3307906
DR   ChEMBL-Targets; CHEMBL614276
DR   CLS; 305152
DR   CLS; 601102
DR   Coriell; GM07404
DR   DSMZ; ACC-100
DR   DSMZCellDive; ACC-100
DR   ECACC; 85011419
DR   IBRC; C10050
DR   ICLC; ATL95004
DR   IZSLER; BS CL 110
DR   JCRB; JCRB9123
DR   KCB; KCB 91004YJ
DR   KCB; KCB 93008YJ
DR   KCLB; 21612
DR   NCBI_Iran; C110
DR   PubChem_Cell_line; CVCL_1953
DR   TKG; TKG 0186
DR   TOKU-E; 3559
DR   Wikidata; Q54752921
RX   CelloPub=CLPUB00447;
RX   PubMed=2153236;
RX   PubMed=2824833;
RX   PubMed=3017841;
RX   PubMed=3145248;
RX   PubMed=4333982;
RX   PubMed=4346033;
RX   PubMed=4357683;
RX   PubMed=6265077;
RX   PubMed=6294325;
RX   PubMed=20454443;
RX   PubMed=24380390;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/obtaining-b95-8-atcc-crl-1612-cells
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/b95-8/
WW   Provider; Vircell; -; https://www.vircell.com/en/products/b95-8-cell-line
CC   Group: Non-human primate cell line.
CC   Characteristics: Was established by exposure to extracts of the 883L cell line (Cellosaurus=CVCL_6A87).
CC   Virology: This cell line sheds the Epstein-Barr virus (EBV) strain B95-8 and is often used to transform human or other primates B lymphocytes.
CC   Doubling time: ~41 hours (DSMZ=ACC-100).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Discontinued: ATCC; CRL-1612; true.
CC   Discontinued: CLS; 305152; true.
CC   Discontinued: Coriell; GM07404; probable.
CC   Discontinued: KCLB; 21612; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 33
//
ID   B95a
AC   CVCL_4116
DR   CLO; CLO_0001839
DR   CLDB; cl5156
DR   ECACC; 01092505
DR   IZSLER; BS CL 140
DR   Wikidata; Q54752923
RX   PubMed=1900885;
RX   PubMed=2153236;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
HI   CVCL_1953 ! B95-8
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   B9V
AC   CVCL_AZ85
DR   Wikidata; Q54752924
RX   PubMed=8041783;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   BA
AC   CVCL_U803
DR   cancercelllines; CVCL_U803
DR   Cosmic; 928723
DR   Wikidata; Q54752925
RX   PubMed=9354451;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=9354451).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   BA 68.1
AC   CVCL_LN07
DR   Wikidata; Q54752928
RX   DOI=10.1007/978-3-642-85791-1_7;
CC   Group: Amphibian cell line.
CC   Doubling time: ~30 hours (DOI=10.1007/978-3-642-85791-1_7).
OX   NCBI_TaxID=8389; ! Anaxyrus americanus (American toad)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   Ba Del
AC   CVCL_0F48
DR   ATCC; CRL-1141
DR   Wikidata; Q54752929
RX   PubMed=273925;
RX   PubMed=865488;
RX   PubMed=6409440;
CC   Discontinued: ATCC; CRL-1141; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   Ba Pot
AC   CVCL_1477
DR   CLO; CLO_0001841
DR   ATCC; CRL-1280
DR   BioSample; SAMN03473640
DR   Wikidata; Q54752931
RX   PubMed=1054840;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1280
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 22,23
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 20,25
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Ba-1
AC   CVCL_B0JD
DR   Wikidata; Q108819898
RX   CelloPub=CLPUB00647;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Brucella abortus (strain S99) 38-45 kDa component of smooth lipopolysaccharide (Note=Also reacts with Brucella melitensis 16M and Brucella suis).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ba-2
AC   CVCL_B0JE
DR   Wikidata; Q108819899
RX   CelloPub=CLPUB00647;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Brucella abortus (strain S99) 38-45 kDa component of smooth lipopolysaccharide (Note=Also reacts with Brucella melitensis 16M and Brucella suis).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ba-3
AC   CVCL_B0JF
DR   Wikidata; Q108819900
RX   CelloPub=CLPUB00647;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Brucella abortus (strain S99) 38-45 kDa component of smooth lipopolysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ba-4
AC   CVCL_B0JG
DR   Wikidata; Q108819901
RX   CelloPub=CLPUB00647;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Brucella abortus (strain S99) major outer membrane 25-27 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ba-5
AC   CVCL_B0JH
DR   Wikidata; Q108819902
RX   CelloPub=CLPUB00647;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Brucella abortus (strain S99) major outer membrane 25-27 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ba-6
AC   CVCL_B0JI
DR   Wikidata; Q108819903
RX   CelloPub=CLPUB00647;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Brucella abortus (strain S99) major outer membrane 36-38 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   BA-D5
AC   CVCL_1954
DR   CLO; CLO_0001847
DR   CLDB; cl371
DR   ABCD; ABCD_AW215
DR   ATCC; HB-287
DR   DSHB; BA-D5
DR   DSMZ; ACC-75
DR   DSMZCellDive; ACC-75
DR   Wikidata; Q54752934
CC   Doubling time: ~25 hours (DSMZ=ACC-75).
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9BE39; Bovine MYH7 (Note=Also reacts with other mammalian species and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 10
//
ID   BA-F8
AC   CVCL_1955
DR   CLO; CLO_0001852
DR   CLDB; cl372
DR   DSHB; BA-F8
DR   DSMZ; ACC-154
DR   DSMZCellDive; ACC-154
DR   Wikidata; Q54752935
CC   Doubling time: ~30 hours (DSMZ=ACC-154).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BE39; Bovine MYH7 (Note=Also reacts with other mammalian species, fish and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 9
//
ID   BA-G5
AC   CVCL_G695
DR   CLO; CLO_0001854
DR   ATCC; HB-276
DR   Wikidata; Q54752937
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; F1N2G0; Bovine MYH6 (Note=Also reacts with other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   BA-HAN-1
AC   CVCL_0Q47
DR   Wikidata; Q54752939
RX   CelloPub=CLPUB00569;
RX   PubMed=2900572;
CC   Doubling time: 16 hours (PubMed=2900572).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   BA-HAN-1A
AC   CVCL_0Q48
SY   BA-HAN-1 subpopulation A
DR   Wikidata; Q54752941
RX   PubMed=2900572;
RX   PubMed=8422707;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0Q47 ! BA-HAN-1
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   BA-HAN-1B
AC   CVCL_0Q49
SY   BA-Han-1B; BA-HAN-1 subpopulation B
DR   Wikidata; Q54752944
RX   PubMed=2900572;
RX   PubMed=8422707;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0Q47 ! BA-HAN-1
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   BA-HAN-1C
AC   CVCL_0Q50
SY   BA-Han-1C; BA-HAN-1 subpopulation C
DR   Wikidata; Q54752947
RX   PubMed=2272313;
RX   PubMed=2900572;
RX   PubMed=8422707;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0Q47 ! BA-HAN-1
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   Ba/ER
AC   CVCL_6C87
DR   RCB; RCB4623
DR   Wikidata; Q54752948
RX   PubMed=10915858;
CC   Characteristics: EPO or IL3 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95408; Epor.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   Ba/F3
AC   CVCL_0161
SY   BA/F3; BaF3; BAF3; Baf3
DR   BTO; BTO_0001516
DR   CLO; CLO_0001842
DR   CLO; CLO_0051421
DR   EFO; EFO_0022749
DR   MCCL; MCC:0000053
DR   BioGRID_ORCS_Cell_line; 221
DR   CCRID; 1101MOU-PUMC000095
DR   ChEMBL-Cells; CHEMBL3307634
DR   ChEMBL-Targets; CHEMBL614524
DR   CLS; 305224
DR   DSMZ; ACC-300
DR   DSMZCellDive; ACC-300
DR   Lonza; 693
DR   PRIDE; PXD000461
DR   PubChem_Cell_line; CVCL_0161
DR   RCB; RCB0805
DR   RCB; RCB4476
DR   TOKU-E; 3694
DR   TOKU-E; 4128
DR   Ubigene; YC-C094
DR   Wikidata; Q54752952
RX   PubMed=17133113;
RX   PubMed=25277546;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BaF3
WW   Info; RCB; -; https://cell.brc.riken.jp/en/rcb/baf3
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-429.html
CC   Characteristics: IL3 dependent.
CC   Doubling time: ~20 hours (DSMZ=ACC-300).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Neve, Richard M.; STR performed by Labcorp Cell Line Testing.
CC   Caution: Originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse (PubMed=25277546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
ST   Source(s): Direct_author_submission; DSMZ=ACC-300; Ubigene=YC-C094
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18 (DSMZ=ACC-300)
ST   Mouse STR 6-4: 18.3 (Ubigene=YC-C094)
ST   Mouse STR 6-4: 19 (Direct_author_submission)
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 24.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   Ba/F3 AXL
AC   CVCL_UE62
SY   Ba/F3-AXL
DR   KYinno; KC-0388
DR   Wikidata; Q93329099
CC   Doubling time: ~20 hours (KYinno=KC-0388).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:905; AXL.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 BCR-ABL
AC   CVCL_UE63
DR   KYinno; KC-0106
DR   Wikidata; Q93329101
CC   Doubling time: ~20 hours (KYinno=KC-0106).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0106; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 BCR-ABL-T315I
AC   CVCL_UE64
SY   Ba/F3 BCR-ABL T315I; Ba/F3-BCR-ABL-T315I
DR   KYinno; KC-0107
DR   Wikidata; Q93329103
CC   Doubling time: ~20 hours (KYinno=KC-0107).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion; with p.Thr315Ile).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 BTK C481S
AC   CVCL_UE65
DR   KYinno; KC-0391
DR   Wikidata; Q93329105
CC   Doubling time: ~20 hours (KYinno=KC-0391).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1133; BTK (Note=With p.Cys481Ser).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0391; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 c-Kit D816V
AC   CVCL_UE66
SY   Ba/F3-cKit-D816V
DR   KYinno; KC-0138
DR   Wikidata; Q93329107
CC   Doubling time: ~20 hours (KYinno=KC-0138).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=With p.Asp816Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 c-Kit D816Y
AC   CVCL_XZ00
SY   Ba/F3-cKit-D816Y
DR   KYinno; KC-1253
DR   Wikidata; Q93329109
CC   Doubling time: ~20 hours (KYinno=KC-1253).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=With p.Asp816Tr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 c-Kit V560G
AC   CVCL_XZ01
DR   KYinno; KC-0139
DR   Wikidata; Q93329111
CC   Doubling time: ~20 hours (KYinno=KC-0139).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=With p.Val560Gly).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0139; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 CSF1R
AC   CVCL_UE67
DR   KYinno; KC-1147
DR   Wikidata; Q93329113
CC   Doubling time: ~20 hours (KYinno=KC-1147).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2433; CSF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1147; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR [KYinno]
AC   CVCL_UA04
SY   Ba/F3 EGFR-WT
DR   KYinno; KC-0108
DR   Wikidata; Q93329115
CC   Doubling time: ~20 hours (KYinno=KC-0108).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0108; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR [MD Anderson]
AC   CVCL_E3NM
SY   Ba/F3 EGFR-WT
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR [Taiho Pharmaceutical]
AC   CVCL_E6DF
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR [Yonsei University]
AC   CVCL_E6D0
SY   Ba/F3 hEGFR
RX   PubMed=39874964;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-A763_Y764insFQEA [KYinno]
AC   CVCL_XZ02
SY   Ba/F3-EGFR-A763-Y764insFQEA
DR   KYinno; KC-1262
DR   Wikidata; Q93329117
CC   Doubling time: ~20 hours (KYinno=KC-1262).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val763_Tyr764insPheGlnGluAla).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-A763_Y764insFQEA [Taiho Pharmaceutical]
AC   CVCL_E6DG
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ala763insPheGlnGluAla (c.2290_2291insTCCAGGAAGCCT)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-A763insFQEA
AC   CVCL_E3L1
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ala763insPheGlnGluAla (c.2290_2291insTCCAGGAAGCCT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-A763insLQEA
AC   CVCL_E3L2
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ala763insLeuGlnGluAla (c.2289_2290insCTCCAGGAAGCC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-A767insASV
AC   CVCL_E3L3
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ala767insAlaSerVal).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-A767insTLA
AC   CVCL_E3L4
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ala767insThrLeuAla (c.2302_2303insCGCTGGCCA)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-C797S/L858R [KYinno]
AC   CVCL_UA16
SY   Ba/F3 EGFR-L858R/C797S; Ba/F3-EGFR-C797S-L858R
DR   KYinno; KC-0118
DR   Wikidata; Q93329122
CC   Doubling time: ~20 hours (KYinno=KC-0118).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Cys797Ser (c.2389T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-C797S/L858R [MD Anderson]
AC   CVCL_E3L5
SY   Ba/F3 EGFR-L858R/C797S
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Cys797Ser (c.2389T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-D761N
AC   CVCL_E3L6
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp761Asn (c.2281G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-D770_N771insG
AC   CVCL_E6DH
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insGly (c.2310_2311insGGT)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-D770_N771insSVD [KYinno]
AC   CVCL_UA06
SY   Ba/F3 EGFR-D770-N771ins_SVD; Ba/F3-EGFR-D770-N771insSVD
DR   KYinno; KC-0125
DR   Wikidata; Q93329124
CC   Doubling time: ~20 hours (KYinno=KC-0125).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insSerValAsp (c.2311_2312insGCGTGGACA)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 EGFR-D770_N771insSVD [Taiho Pharmaceutical]
AC   CVCL_E6DI
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insSerValAsp (c.2311_2312insGCGTGGACA)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-D770delinsGY
AC   CVCL_E3L7
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770delinsGlyTyr (c.2308_2309insGTT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-D770insG
AC   CVCL_E3L8
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770insGly (c.2310_2311insGGT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-D770insNPG
AC   CVCL_E3L9
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770insAsnProGly).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-D770insY/H773Y
AC   CVCL_E3LA
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770insTyr (c.2310_2311insTAC) and p.His773Tyr (c.2317C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Del19
AC   CVCL_UA07
SY   Ba/F3-EGFR-Del19
DR   KYinno; KC-0112
DR   Wikidata; Q93329126
CC   Doubling time: ~20 hours (KYinno=KC-0112).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-Del19/C797S
AC   CVCL_UA08
SY   Ba/F3-EGFR-Del19-C797S
DR   KYinno; KC-0115
DR   Wikidata; Q93329128
CC   Doubling time: ~20 hours (KYinno=KC-0115).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-Del19/T790M
AC   CVCL_UA09
DR   KYinno; KC-0113
DR   Wikidata; Q93329130
CC   Doubling time: ~20 hours (KYinno=KC-0113).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0113; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-Del19/T790M/C797S
AC   CVCL_UA10
SY   Ba/F3-EGFR-Del19-T790M-C797S
DR   KYinno; KC-0116
DR   Wikidata; Q93329132
CC   Doubling time: ~20 hours (KYinno=KC-0116).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del, p.Thr790Met (c.2369C>T) and p.Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-Del19/T790M/L858R
AC   CVCL_UA11
SY   Ba/F3 EGFR-Del19/L858R/T790M; Ba/F3-EGFR-Del19-L858R-T790M
DR   KYinno; KC-0126
DR   Wikidata; Q93329134
CC   Doubling time: ~20 hours (KYinno=KC-0126).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del, p.Thr790Met (c.2369C>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-E709A
AC   CVCL_E3LB
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu709Ala (c.2126A>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-E709A/G719S
AC   CVCL_E3LC
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu709Ala (c.2126A>C) and p.Gly719Ser (c.2155G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-E709K
AC   CVCL_E3LD
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu709Lys (c.2125G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-E709K/G719S
AC   CVCL_E3LE
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu709Lys (c.2125G>A) and p.Gly719Ser (c.2155G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-E709K/L858R
AC   CVCL_E3LF
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu709Lys (c.2125G>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-E709_T710delinsD
AC   CVCL_E3LG
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu709_Thr710delinsAsp (c.2127_2129del)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del [MD Anderson]
AC   CVCL_E3LH
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del [Taiho Pharmaceutical]
AC   CVCL_E6DJ
SY   Ba/F3 EGFR-delE746_A750
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-Ex19del/C797S
AC   CVCL_E3LI
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=with p.Glu746_Ala750del and p.Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/G724S
AC   CVCL_E3LJ
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=with p.Glu746_Ala750del and p.Gly724Ser (c.2170G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/G724S/T790M
AC   CVCL_E3LK
SY   Ba/F3 EGFR-Ex19del/T790M/G724S
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del, p.Gly724Ser (c.2170G>A) and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/G796S
AC   CVCL_E3LL
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Gly796Ser (c.2386G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/L718Q
AC   CVCL_E3LM
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Leu718Gln (c.2153T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/L718V
AC   CVCL_E3LN
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Leu718Val (c.2152C>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/L718V/T790M
AC   CVCL_E3LP
SY   Ba/F3 EGFR-Ex19del/T790M/L718V
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del, p.Leu718Val (c.2152C>G) and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/L792H
AC   CVCL_E3LQ
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Leu792His (c.2375T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/T790M [MD Anderson]
AC   CVCL_E3LR
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/T790M [Taiho Pharmaceutical]
AC   CVCL_E6DK
SY   Ba/F3 EGFR-delE746_A750 + T790M
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-Ex19del/T790M/C797S
AC   CVCL_E3LS
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del, p.Thr790Met (c.2369C>T) and p.Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/T790M/L792H
AC   CVCL_E3LT
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del, p.Thr790Met (c.2369C>T) and p.Leu792His (c.2375T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-Ex19del/T854I
AC   CVCL_E3LU
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Thr854Ile (c.2561C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G719A
AC   CVCL_E3LV
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ala (c.2156G>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G719A/S768I
AC   CVCL_E6D1
SY   Ba/F3 hEGFR G719A/S768I
RX   PubMed=39874964;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ala (c.2156G>C) and p.Ser768Ile (c.2303G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-G719A/L861Q
AC   CVCL_E3LW
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ala (c.2156G>C) and p.Leu861Gln (c.2582T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G719A/R776C
AC   CVCL_E3LX
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ala (c.2156G>C) and p.Arg776Cys (c.2326C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G719A/T790M
AC   CVCL_E3LY
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ala (c.2156G>C) and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G719D-C797S
AC   CVCL_UA05
SY   Ba/F3-EGFR-C797S-G719D; Ba/F3 EGFR-C797S
DR   KYinno; KC-0117
DR   Wikidata; Q93329120
CC   Doubling time: ~20 hours (KYinno=KC-0117).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Asp and p.Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-G719S [KYinno]
AC   CVCL_UA12
SY   Ba/F3-EGFR-G719S
DR   KYinno; KC-0110
DR   Wikidata; Q93329137
CC   Doubling time: ~20 hours (KYinno=KC-0110).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ser (c.2155G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-G719S [MD Anderson]
AC   CVCL_E3LZ
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ser (c.2155G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G719S [Yonsei University]
AC   CVCL_E6D2
SY   Ba/F3 hEGFR G719S
RX   PubMed=39874964;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ser (c.2155G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-G719S/S768I
AC   CVCL_E6D3
SY   Ba/F3 hEGFR G719S/S768I
RX   PubMed=39874964;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ser (c.2155G>A) and p.Ser768Ile (c.2303G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-G724S
AC   CVCL_E3M0
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly724Ser (c.2170G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G724S/L858R
AC   CVCL_E3M1
SY   Ba/F3 EGFR-L858R/G724S
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly724Ser (c.2170G>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G724S/N771dupN
AC   CVCL_E3M2
SY   Ba/F3 EGFR-N771dupN/G724S
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly724Ser (c.2170G>A) and p.Asn771dup (c.2314_2315insAAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G724S/T790M
AC   CVCL_E3M3
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly724Ser (c.2170G>A) and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-G796S/L858R
AC   CVCL_E3M4
SY   Ba/F3 EGFR-L858R/G796S
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly796Ser (c.2386G>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-H773_V774insNPH [Kyonno]
AC   CVCL_UA14
SY   Ba/F3 EGFR-H773-V774ins_NPH
DR   KYinno; KC-0124
DR   Wikidata; Q93329139
CC   Doubling time: ~20 hours (KYinno=KC-0124).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insAsnProHis (p.Asn771_His773dup) (c.2311_2319dup)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 EGFR-H773_V774insNPH [Taiho Pharmaceutical]
AC   CVCL_E6DL
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insAsnProHis (p.Asn771_His773dup) (c.2311_2319dup)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-H773_V774insPH
AC   CVCL_E6DM
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insProHis (p.Pro772_His773dup) (c.2314_2319dup)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-H773insAH
AC   CVCL_E3M5
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773insAlaHis (c.2320_2321insCCCACG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-H773insH
AC   CVCL_E3M6
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773insHis (c.2319_2320insCAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-H773insNPH
AC   CVCL_E3M7
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773insAsnProHis (c.2319_2320insAACCCCCAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-I740dupIPVAK
AC   CVCL_E3M8
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ile740dupIleProValAlaLys (c.2214_2231dup).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-K754E
AC   CVCL_E3M9
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Lys754Glu (c.2260A>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-K757R
AC   CVCL_E3MA
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Lys754Arg (c.2270A>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L718Q
AC   CVCL_E3MB
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu718Gln (c.2153T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L718Q/L858R
AC   CVCL_E3MC
SY   Ba/F3 EGFR-L858R/L718Q
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu718Gln (c.2153T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L718Q/T790M
AC   CVCL_E3MD
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu718Gln (c.2153T>A) and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L718Q/T790M/L858R
AC   CVCL_E3ME
SY   Ba/F3 EGFR-L858R/T790M/L718Q
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu718Gln (c.2153T>A), p.Thr790Met (c.2369C>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L718V
AC   CVCL_E3MF
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu718Val (c.2152C>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L718V/L858R
AC   CVCL_E3MG
SY   Ba/F3 EGFR-L858R/L718V
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu718Val (c.2152C>G) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L718V/T790M/L858R
AC   CVCL_E3MH
SY   Ba/F3 EGFR-L858R/T790M/L718V
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu718Val (c.2152C>G), p.Thr790Met (c.2369C>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L747P
AC   CVCL_E3MI
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu747Pro (c.2239_2240TT>CC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L747S
AC   CVCL_E3MJ
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu747Ser (c.2240T>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L747_K754delinsATSPE
AC   CVCL_E3MK
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu747_Lys754delinsAlaThrSerProGlu (c.2239_2260delinsGCAACATCTCCGG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L792H/L858R
AC   CVCL_E3ML
SY   Ba/F3 EGFR-L858R/L792H
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu792His (c.2375T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L833F
AC   CVCL_E3MM
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu833Phe (c.2499G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L833V
AC   CVCL_E3MN
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu833Val (c.2497T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L858R [KYinno]
AC   CVCL_UA15
SY   Ba/F3-EGFR-L858R
DR   KYinno; KC-0114
DR   Wikidata; Q93329141
CC   Doubling time: ~20 hours (KYinno=KC-0114).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-L858R [MD Anderson]
AC   CVCL_E3MP
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L858R/T790M/V843I
AC   CVCL_E3MQ
SY   Ba/F3 EGFR-T790M/V843I/L858R
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T), p.Val843Ile (c.2527G>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L861Q [KYinno]
AC   CVCL_UA18
SY   Ba/F3-EGFR-L861Q
DR   KYinno; KC-0119
DR   Wikidata; Q93329143
CC   Doubling time: ~20 hours (KYinno=KC-0119).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu861Gln (c.2582T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-L861Q [MD Anderson]
AC   CVCL_E3MR
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu861Gln (c.2582T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-L861R
AC   CVCL_E3MS
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu861Arg (c.2582T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-N771insHH
AC   CVCL_E3MT
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asn771insHisHis (c.2314_2315insACCACC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-N771insSVDNR
AC   CVCL_E3MU
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asn771insSerValAspAsnArg (c.2312_2315ACCC>GCGTGGACAACCG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-P772insDNP
AC   CVCL_E3MV
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Pro772insAspAsnPro (c.2316_2317insGACAACCCC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-R776C
AC   CVCL_E3MW
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Arg776Cys (c.2326C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-R776H
AC   CVCL_E3MX
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Arg776His (c.2327G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S720P
AC   CVCL_E3MY
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser720Pro (c.2158T>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S768I [MD Anderson]
AC   CVCL_E3MZ
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768Ile (c.2303G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S768I [Yonsei University]
AC   CVCL_E6D4
SY   Ba/F3 hEGFR S768I
RX   PubMed=39874964;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768Ile (c.2303G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-S768I/L858R
AC   CVCL_E6D5
SY   Ba/F3 hEGFR S768I/L858R
RX   PubMed=39874964;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768Ile (c.2303G>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-S768I/T790M
AC   CVCL_E3N0
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768Ile (c.2303G>T) and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S768I/V769L
AC   CVCL_E3N1
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768Ile (c.2303G>T) and p.Val769Leu (c.2305G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S768I/V774M
AC   CVCL_E3N2
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768Ile (c.2303G>T) and p.Val774Met (c.2320G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S768dupSVD
AC   CVCL_E3N3
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768dupSerValAsp (c.2303_2304dupAGCGTGGAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S768dupSVD/V769M
AC   CVCL_E3N4
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768dupSerValAsp (c.2303_2304dupAGCGTGGAC) and p.Val769Met (c.2305G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S784F
AC   CVCL_E3N5
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser784Phe (c.2351C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S784F/L858R
AC   CVCL_E3N6
SY   Ba/F3 EGFR-L858R/S784F
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser784Phe (c.2351C>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-S811F
AC   CVCL_E3N7
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser811Phe (c.2432C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-T725M
AC   CVCL_E3N8
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr725Met (c.2174C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-T263P/G719S
AC   CVCL_UA13
SY   Ba/F3 EGFR-G719S/T263P; Ba/F3-EGFR-G719S-T263P
DR   KYinno; KC-0111
DR   Wikidata; Q93329145
CC   Doubling time: ~20 hours (KYinno=KC-0111).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr263Pro and p.Gly719Ser (c.2155G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-T790M [KYinno]
AC   CVCL_UA19
SY   Ba/F3-EGFR-T790M
DR   KYinno; KC-0109
DR   Wikidata; Q93329147
CC   Doubling time: ~20 hours (KYinno=KC-0109).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-T790M [MD Anderson]
AC   CVCL_E3N9
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-T790M/C797S
AC   CVCL_UA20
SY   Ba/F3-EGFR-T790M-C797S
DR   KYinno; KC-0120
DR   Wikidata; Q93329149
CC   Doubling time: ~20 hours (KYinno=KC-0120).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T) and p.Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-T790M/C797S/L858R [KYinno]
AC   CVCL_UA21
SY   Ba/F3 EGFR-T790M/L858R/C797S; Ba/F3-EGFR-T790M-C797S-L858R
DR   KYinno; KC-0122
DR   Wikidata; Q93329151
CC   Doubling time: ~20 hours (KYinno=KC-0122).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T), p.Cys797Ser (c.2389T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-T790M/C797S/L858R [MD Anderson]
AC   CVCL_E3NA
SY   Ba/F3 EGFR-L858R/T790M/C797S
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T), p.Cys797Ser (c.2389T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-T790M/L792H/L858R
AC   CVCL_E3NB
SY   Ba/F3 EGFR-L858R/T790M/L792H
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T), p.Leu792His (c.2375T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-T790M/L858R [KYinno]
AC   CVCL_UA17
SY   Ba/F3 EGFR-L858R/T790M; Ba/F3-EGFR-T790M-L858R
DR   KYinno; KC-0121
DR   Wikidata; Q93329154
CC   Doubling time: ~20 hours (KYinno=KC-0121).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-T790M/L858R [MD Anderson]
AC   CVCL_E3NC
SY   Ba/F3 EGFR-L858R/T790M
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-T790M/L861Q
AC   CVCL_UA22
SY   Ba/F3-EGFR-T790M-L861Q
DR   KYinno; KC-0123
DR   Wikidata; Q93329156
CC   Doubling time: ~20 hours (KYinno=KC-0123).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T) and p.Leu861Gln (c.2582T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EGFR-V769L
AC   CVCL_E3ND
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769Leu (c.2305G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V769_D770insASV [MD Anderson]
AC   CVCL_E3NE
SY   Ba/F3 EGFR-V769insASV
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769insAlaSerVal (c.2308_2309insCCAGCGTGG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V769_D770insASV [Taiho Pharmaceutical]
AC   CVCL_E6DN
SY   Ba/F3 EGFR-V769insASV
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769insAlaSerVal (c.2308_2309insCCAGCGTGG)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 EGFR-V769insGSV
AC   CVCL_E3NF
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769insGlySerVal (c.2308_2309insGCAGCGTGG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V769insGVV
AC   CVCL_E3NG
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769insGlyValVal (c.2308_2309insGGGTCGTGG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V769insMASVD
AC   CVCL_E3NH
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769insMetAlaSerValAsp c.2307_2308insATGGCCAGCGTGGAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V774M
AC   CVCL_E3NI
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val774Met (c.2320G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V774insHV
AC   CVCL_E3NJ
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val774insHisVal (c.2321_2322insCCACGT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V774insPR
AC   CVCL_E3NK
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val774insProArg (c.2322_2323insCCACGT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR-V834L/L858R
AC   CVCL_E3NL
SY   Ba/F3 EGFR-L858R/V834L
RX   PubMed=34526717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val834Leu (c.2500G>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Ba/F3 EGFR vIII
AC   CVCL_UA23
SY   Ba/F3 EGFR-VIII; Ba/F3-EGFRvIII; Ba/F3 EGFR-v3
DR   KYinno; KC-0127
DR   Wikidata; Q93329158
CC   Doubling time: ~20 hours (KYinno=KC-0127).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 EGFR-V769_D770insASV
AC   CVCL_XZ03
DR   KYinno; KC-1050
DR   Wikidata; Q93329160
CC   Doubling time: ~20 hours (KYinno=KC-1050).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769_Asp770insAlaSerVal (c.2308_2309insCCAGCGTGG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1050; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 EML4-ALK
AC   CVCL_UE68
SY   Ba/F3 EML4-ALK-WT; Ba/F3-EML4-ALK-WT
DR   KYinno; KC-0101
DR   Wikidata; Q93329162
CC   Doubling time: ~20 hours (KYinno=KC-0101).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EML4-ALK-C1156Y
AC   CVCL_UE69
SY   Ba/F3-EML4-ALK-C1156Y
DR   KYinno; KC-0104
DR   Wikidata; Q93329165
CC   Doubling time: ~20 hours (KYinno=KC-0104).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Cys1156Tyr).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EML4-ALK-D1203N-E1210K
AC   CVCL_XZ04
DR   KYinno; KC-0253
DR   Wikidata; Q93329167
CC   Doubling time: ~20 hours (KYinno=KC-0253).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Asp1203Asn and p.Glu1210Lys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0253; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 EML4-ALK-F1174C-D1203N
AC   CVCL_XZ05
SY   Ba/F3-EML4-ALK-D1203N-F1174C
DR   KYinno; KC-0252
DR   Wikidata; Q93329169
CC   Doubling time: ~20 hours (KYinno=KC-0252).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Phe1174Cys and p.Asp1203Asn).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 EML4-ALK-F1174L
AC   CVCL_UE70
SY   Ba/F3-EML4-ALK-F1174L
DR   KYinno; KC-0103
DR   Wikidata; Q93329171
CC   Doubling time: ~20 hours (KYinno=KC-0103).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Phe1174Leu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EML4-ALK-G1202Del
AC   CVCL_XZ06
SY   Ba/F3-EML4-ALK-G1202Del
DR   KYinno; KC-0250
DR   Wikidata; Q93329173
CC   Doubling time: ~20 hours (KYinno=KC-0250).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Gly1202del).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 EML4-ALK-G1202R
AC   CVCL_UE71
SY   Ba/F3-EML4-ALK-G1202R
DR   KYinno; KC-0105
DR   Wikidata; Q93329175
CC   Doubling time: ~20 hours (KYinno=KC-0105).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Gly1202Arg).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 EML4-ALK-G1269A
AC   CVCL_XZ07
DR   KYinno; KC-1208
DR   Wikidata; Q93329177
CC   Doubling time: ~20 hours (KYinno=KC-1208).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Gly1269Ala).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1208; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 EML4-ALK-L1196M
AC   CVCL_UE72
SY   Ba/F3-EML4-ALK-L1196M
DR   KYinno; KC-0102
DR   Wikidata; Q93329179
CC   Doubling time: ~20 hours (KYinno=KC-0102).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:427; ALK (Note=EML4-ALK fusion; with p.Leu1196Met).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1316; EML4 (Note=EML4-ALK fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 ERBB2-A775_G776insYVMA
AC   CVCL_UE73
SY   Ba/F3 ERBB2 A775_G776insYVMA; Ba/F3-ERBB2-A775-G776insYVMA
DR   KYinno; KC-1027
DR   Wikidata; Q93329181
CC   Doubling time: ~20 hours (KYinno=KC-1027).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Ala775_Gly776insTyrValMetAla (c.2324_2325insATACGTGATGGC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 ERBB2-L755P
AC   CVCL_XZ08
SY   Ba/F3-ERBB2-L755P
DR   KYinno; KC-1248
DR   Wikidata; Q93329184
CC   Doubling time: ~20 hours (KYinno=KC-1248).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Leu755Pro).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 ERBB2-V777L
AC   CVCL_XZ09
SY   Ba/F3-ERBB2-V777L
DR   KYinno; KC-1263
DR   Wikidata; Q93329185
CC   Doubling time: ~20 hours (KYinno=KC-1263).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Val777Leu (c.2329G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 ETV6-NTRK2
AC   CVCL_UE74
SY   Ba/F3-ETV6-NTRK2
DR   KYinno; KC-1015
DR   Wikidata; Q93329187
CC   Doubling time: ~20 hours (KYinno=KC-1015).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3495; ETV6 (Note=ETV6-NTRK2 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8032; NTRK2 (Note=ETV6-NTRK2 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 ETV6-NTRK2-G639R
AC   CVCL_UE76
SY   Ba/F3-ETV6-NTRK2-G639R
DR   KYinno; KC-1024
DR   Wikidata; Q93329189
CC   Doubling time: ~20 hours (KYinno=KC-1024).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8032; NTRK2 (Note=ETV6-NTRK2 fusion; with p.Gly623Arg (G639R)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3495; ETV6 (Note=ETV6-NTRK2 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 ETV6-NTRK2-G709C
AC   CVCL_UE75
SY   BaF3 ETV6-NTRK2 G709C
DR   KYinno; KC-1030
DR   Wikidata; Q93329192
CC   Doubling time: ~20 hours (KYinno=KC-1030).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8032; NTRK2 (Note=ETV6-NTRK2 fusion; with p.Gly693Cys (G709C)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3495; ETV6 (Note=ETV6-NTRK2 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1030; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 ETV6-NTRK3
AC   CVCL_UE77
SY   Ba/F3-ETV6-NTRK3
DR   KYinno; KC-0390
DR   Wikidata; Q93329194
CC   Doubling time: ~20 hours (KYinno=KC-0390).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3495; ETV6 (Note=ETV6-NTRK3 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8033; NTRK3 (Note=ETV6-NTRK3 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 ETV6-NTRK3-G623R
AC   CVCL_UE78
DR   KYinno; KC-0299
DR   Wikidata; Q93329196
CC   Doubling time: ~20 hours (KYinno=KC-0299).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8033; NTRK3 (Note=ETV6-NTRK3 fusion; with p.Gly623Arg (G639R)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3495; ETV6 (Note=ETV6-NTRK3 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0299; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 13
//
ID   Ba/F3 ETV6-NTRK3-G696A
AC   CVCL_XZ10
DR   KYinno; KC-1023
DR   Wikidata; Q93329198
CC   Doubling time: ~20 hours (KYinno=KC-1023).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8033; NTRK3 (Note=ETV6-NTRK3 fusion; with p.Gly696Ala).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3495; ETV6 (Note=ETV6-NTRK3 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FIP1L1-PDGFRA-D842V
AC   CVCL_XZ11
SY   Ba/F3-FIP1L1-PDGFRa-D842V
DR   KYinno; KC-1293
DR   Wikidata; Q93329200
CC   Doubling time: ~20 hours (KYinno=KC-1293).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8803; PDGFRA (Note=FIP1L1-PDGFRA fusion; with p.Asp842Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19124; FIP1L1 (Note=FIP1L1-PDGFRA fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FLT3 [KYinno]
AC   CVCL_UE79
SY   Ba/F3-FLT3
DR   KYinno; KC-0129
DR   Wikidata; Q93329202
CC   Doubling time: ~20 hours (KYinno=KC-0129).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 FLT3 [Malmo]
AC   CVCL_E6Y6
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-D835V
AC   CVCL_UE80
SY   Ba/F3-FLT3-D835V
DR   KYinno; KC-0980
DR   Wikidata; Q93329205
CC   Doubling time: ~20 hours (KYinno=KC-0980).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Asp835Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FLT3-D835Y
AC   CVCL_UE81
DR   KYinno; KC-0356
DR   Wikidata; Q93329207
CC   Doubling time: ~20 hours (KYinno=KC-0356).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Asp835Tyr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0356; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FLT3-ITD [KYinno]
AC   CVCL_UE82
SY   Ba/F3-FLT3-ITD
DR   KYinno; KC-0130
DR   Wikidata; Q93329209
CC   Doubling time: ~20 hours (KYinno=KC-0130).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 FLT3-ITD [Malmo]
AC   CVCL_E6Y7
RX   PubMed=19438505;
RX   PubMed=28271164;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-A848P
AC   CVCL_XZ12
DR   KYinno; KC-1196
DR   Wikidata; Q93329211
CC   Doubling time: ~20 hours (KYinno=KC-1196).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Ala848Pro).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1196; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-D835Del
AC   CVCL_XZ13
DR   KYinno; KC-1197
DR   Wikidata; Q93329213
CC   Doubling time: ~20 hours (KYinno=KC-1197).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asp835del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1197; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-D835F
AC   CVCL_XZ14
DR   KYinno; KC-1198
DR   Wikidata; Q93329215
CC   Doubling time: ~20 hours (KYinno=KC-1198).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asp835Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1198; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-D835H
AC   CVCL_XZ15
DR   KYinno; KC-1199
DR   Wikidata; Q93329218
CC   Doubling time: ~20 hours (KYinno=KC-1199).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asp835His).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1199; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-D835I
AC   CVCL_XZ16
DR   KYinno; KC-1200
DR   Wikidata; Q93329220
CC   Doubling time: ~20 hours (KYinno=KC-1200).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asp835Ile).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1200; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-D835V
AC   CVCL_UE83
DR   KYinno; KC-0981
DR   Wikidata; Q93329222
CC   Doubling time: ~20 hours (KYinno=KC-0981).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asp835Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FLT3-ITD-D835Y
AC   CVCL_UE84
DR   KYinno; KC-0357
DR   Wikidata; Q93329224
CC   Doubling time: ~20 hours (KYinno=KC-0357).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asp835Tyr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0357; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FLT3-ITD-D849G
AC   CVCL_XZ17
DR   KYinno; KC-1201
DR   Wikidata; Q93329226
CC   Doubling time: ~20 hours (KYinno=KC-1201).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asp849Gly).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1201; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-F691I
AC   CVCL_XZ18
DR   KYinno; KC-1217
DR   Wikidata; Q93329228
CC   Doubling time: ~20 hours (KYinno=KC-1217).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Phe691Ile).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1217; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-F691L
AC   CVCL_UE85
SY   Ba/F3-FLT3-ITD-F691L
DR   KYinno; KC-0131
DR   Wikidata; Q93329231
CC   Doubling time: ~20 hours (KYinno=KC-0131).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Phe691Leu).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FLT3-ITD-N767D
AC   CVCL_XZ19
DR   KYinno; KC-1202
DR   Wikidata; Q93329232
CC   Doubling time: ~20 hours (KYinno=KC-1202).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Asn767Asp).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1202; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-Y768F
AC   CVCL_E6Y8
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr768Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y768F/Y955F
AC   CVCL_E6Y9
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD, p.Tyr768Phe and p.Tyr955Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y768F/Y955F/Y969F
AC   CVCL_E6YA
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD, p.Tyr768Phe, p.Tyr955Phe and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y768F/Y969F
AC   CVCL_E6YB
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD, p.Tyr768Phe and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y842C [KYinno]
AC   CVCL_XZ20
DR   KYinno; KC-1203
DR   Wikidata; Q93329235
CC   Doubling time: ~20 hours (KYinno=KC-1203).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr842Cys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1203; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 FLT3-ITD-Y842C [Malmo]
AC   CVCL_E6YC
DR   ABM; T3681
RX   PubMed=38001685;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr842Cys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y842F
AC   CVCL_E6YD
DR   ABM; T3682
RX   PubMed=28271164;
RX   PubMed=38001685;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr842Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y842H
AC   CVCL_XZ21
DR   KYinno; KC-1204
DR   Wikidata; Q93329237
CC   Doubling time: ~20 hours (KYinno=KC-1204).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr842His).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1204; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 FLT3-ITD-Y955F
AC   CVCL_E6YE
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr955Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y955F/Y969F
AC   CVCL_E6YF
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD, p.Tyr955Phe and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-ITD-Y969F
AC   CVCL_E6YG
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y726F
AC   CVCL_E6YH
DR   ABM; T3687
RX   PubMed=19477218;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr726Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y768F
AC   CVCL_E6YI
DR   ABM; T3684
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr768Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y768F/Y955F
AC   CVCL_E6YJ
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr768Phe and p.Tyr955Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: Cell line has been lost (personal communication of Chu, Heidi from ABM).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y768F/Y955F/Y969F
AC   CVCL_E6YK
DR   ABM; T3690
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr768Phe, p.Tyr955Phe and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y768F/Y969F
AC   CVCL_E6YL
DR   ABM; T3688
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr768Phe and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y842F
AC   CVCL_E6YM
SY   Ba/F3 FLT3-WT/Y842F
DR   ABM; T3683
RX   PubMed=28271164;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr842Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y955F
AC   CVCL_E6YN
DR   ABM; T3685
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr955Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y955F/Y969F
AC   CVCL_E6YP
DR   ABM; T3689
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With p.Tyr955Phe and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 FLT3-Y969F
AC   CVCL_E6YQ
DR   ABM; T3686
RX   PubMed=19438505;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3765; FLT3 (Note=With ITD and p.Tyr969Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   BaF3 HER2
AC   CVCL_XZ22
SY   Ba/F3-ERBB2
DR   KYinno; KC-0134
DR   Wikidata; Q93329239
CC   Doubling time: ~20 hours (KYinno=KC-0134).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 KIF5B-RET
AC   CVCL_UE86
DR   KYinno; KC-1041
DR   Wikidata; Q93329241
CC   Doubling time: ~20 hours (KYinno=KC-1041).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6324; KIF5B (Note=KIF5B-RET fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9967; RET (Note=KIF5B-RET fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 KIF5B-RET-F744I/G810A
AC   CVCL_XZ23
SY   Ba/F3-KIF5B-RET-G810A-F744I; Ba/F3-KIF5B-RET-G810A
DR   KYinno; KC-1168
DR   Wikidata; Q93329243
CC   Doubling time: ~20 hours (KYinno=KC-1168).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9967; RET (Note=KIF5B-RET fusion; with p.Phe744Ile and p.Gly810Ala).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6324; KIF5B (Note=KIF5B-RET fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 KIF5B-RET-V804E
AC   CVCL_XZ24
SY   Ba/F3-KIF5B-RET-V804E
DR   KYinno; KC-1169
DR   Wikidata; Q93329245
CC   Doubling time: ~20 hours (KYinno=KC-1169).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9967; RET (Note=KIF5B-RET fusion; with p.Val804Glu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6324; KIF5B (Note=KIF5B-RET fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 KIF5B-RET-V804L
AC   CVCL_XZ25
SY   Ba/F3-KIF5B-RET-V804L
DR   KYinno; KC-1170
DR   Wikidata; Q93329247
CC   Doubling time: ~20 hours (KYinno=KC-1170).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9967; RET (Note=KIF5B-RET fusion; with p.Val804Leu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6324; KIF5B (Note=KIF5B-RET fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 KIF5B-RET-V804M
AC   CVCL_XZ26
SY   Ba/F3-KIF5B-RET-V804M
DR   KYinno; KC-1171
DR   Wikidata; Q93329250
CC   Doubling time: ~20 hours (KYinno=KC-1171).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9967; RET (Note=KIF5B-RET fusion; with p.Val804Met).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6324; KIF5B (Note=KIF5B-RET fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 KIT isoform 1
AC   CVCL_E6XW
SY   Ba/F3 c-KIT GNNK+ WT
DR   ABM; T3042
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 1 = GNNK+).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 1 N705A
AC   CVCL_E6XX
SY   Ba/F3 c-KIT GNNK+ N705A
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 1 = GNNK+ with p.Asn705Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 1 N705A/N938A
AC   CVCL_E6XY
SY   Ba/F3 c-KIT GNNK+ N705A/N938A
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 1 = GNNK+ with p.Asn705Ala and p.Asn938Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 1 N938A
AC   CVCL_E6XZ
SY   Ba/F3 c-KIT GNNK+ N938A
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 1 = GNNK+ with p.Asn938Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 2
AC   CVCL_E6Y0
SY   Ba/F3 c-KIT GNNK- WT
DR   ABM; T3041
RX   PubMed=17904548;
RX   PubMed=18697750;
RX   PubMed=26040420;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 2 = GNNK-).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 2 D816V
AC   CVCL_E6Y1
SY   Ba/F3 c-KIT/D816V
DR   ABM; T3040
RX   PubMed=26040420;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 2 = GNNK- with p.Asp816Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 2 N705A
AC   CVCL_E6Y3
SY   Ba/F3 c-KIT GNNK- N705A
RX   PubMed=17904548;
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 2 = GNNK- with p.Asn705Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 2 N705A/N938A
AC   CVCL_E6Y4
SY   Ba/F3 c-KIT GNNK- N705A/N938A
RX   PubMed=17904548;
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 2 = GNNK- with p.Asn705Ala and p.Asn938Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 2 N938A
AC   CVCL_E6Y5
SY   Ba/F3 c-KIT GNNK- N938A
RX   PubMed=17904548;
RX   PubMed=18697750;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 2 = GNNK- with p.Asn938Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 KIT isoform 2 V560D
AC   CVCL_E6Y2
SY   Ba/F3 c-KIT/V560D
DR   ABM; T3055
RX   PubMed=26040420;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=Isoform 2 = GNNK- with p.Val560Asp).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3 LMNA-NTRK1
AC   CVCL_UE87
SY   Ba/F3-LMNA-NTRK1
DR   KYinno; KC-1013
DR   Wikidata; Q93329252
CC   Doubling time: ~20 hours (KYinno=KC-1013).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6636; LMNA (Note=LMNA-NTRK1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8031; NTRK1 (Note=LMNA-NTRK1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 LMNA-NTRK1-F589L
AC   CVCL_UE88
DR   KYinno; KC-0365
DR   Wikidata; Q93329255
CC   Doubling time: ~20 hours (KYinno=KC-0365).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8031; NTRK1 (Note=LMNA-NTRK1 fusion; with p.Phe589Leu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6636; LMNA (Note=LMNA-NTRK1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0365; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 LMNA-NTRK1-G595R
AC   CVCL_UE89
DR   KYinno; KC-0364
DR   Wikidata; Q93329256
CC   Doubling time: ~20 hours (KYinno=KC-0364).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8031; NTRK1 (Note=LMNA-NTRK1 fusion; with p.Gly595Arg).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6636; LMNA (Note=LMNA-NTRK1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-0364; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 LMNA-NTRK1-G667A
AC   CVCL_XZ27
SY   Ba/F3-LMNA-NTRK1-G667A
DR   KYinno; KC-1026
DR   Wikidata; Q93329258
CC   Doubling time: ~20 hours (KYinno=KC-1026).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8031; NTRK1 (Note=LMNA-NTRK1 fusion; with p.Gly667Ala).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6636; LMNA (Note=LMNA-NTRK1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   Ba/F3 LMNA-NTRK1-G667C
AC   CVCL_UE90
SY   Ba/F3-LMNA-NTRK1-G667C
DR   KYinno; KC-0389
DR   Wikidata; Q93329260
CC   Doubling time: ~20 hours (KYinno=KC-0389).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8031; NTRK1 (Note=LMNA-NTRK1 fusion; with p.Gly667Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6636; LMNA (Note=LMNA-NTRK1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3 P95HER2
AC   CVCL_XZ28
SY   Ba/F3-P95ERBB2
DR   KYinno; KC-0135
DR   Wikidata; Q93329263
CC   Doubling time: ~20 hours (KYinno=KC-0135).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=Isoform CTF-611/P95HER2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 PDGFRA-D842V
AC   CVCL_XZ29
SY   Ba/F3-PDGFRa-D842V
DR   KYinno; KC-1247
DR   Wikidata; Q93329265
CC   Doubling time: ~20 hours (KYinno=KC-1247).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8803; PDGFRA (Note=With p.Asp842Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 PIM1
AC   CVCL_XZ30
DR   KYinno; KC-1173
DR   Wikidata; Q93329267
CC   Doubling time: ~20 hours (KYinno=KC-1173).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8986; PIM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Discontinued: KYinno; KC-1173; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   Ba/F3 SLC34A2-ROS1
AC   CVCL_UE91
SY   Ba/F3-SLC34A2-ROS1
DR   KYinno; KC-0132
DR   Wikidata; Q93329269
CC   Doubling time: ~20 hours (KYinno=KC-0132).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10261; ROS1 (Note=SLC34A2-ROS1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11020; SLC34A2 (Note=SLC34A2-ROS1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 13
//
ID   Ba/F3 SLC34A2-ROS1-G2032R
AC   CVCL_UE92
SY   Ba/F3-SLC34A2-ROS1-G2032R
DR   KYinno; KC-0133
DR   Wikidata; Q93329271
CC   Doubling time: ~20 hours (KYinno=KC-0133).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10261; ROS1 (Note=SLC34A2-ROS1 fusion; with p.Gly2032Arg).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11020; SLC34A2 (Note=SLC34A2-ROS1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   Ba/F3-CD112delta
AC   CVCL_E8G8
RX   PubMed=23600509;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97822; Nectin2 (Note=Isoform delta; with a N-terminal FLAG tag).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ba/F3-CD155
AC   CVCL_E8G9
RX   PubMed=23600509;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:107741; Pvr (Note=With a N-terminal FLAG tag).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ba/F3-CL1
AC   CVCL_T765
DR   RCB; RCB4474
DR   Wikidata; Q54752953
CC   Characteristics: IL3 dependent.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 7
//
ID   Ba/F3-DNAM-1
AC   CVCL_E8G7
RX   PubMed=23600509;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:3039602; Cd226 (Note=With a N-terminal FLAG tag).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ba/F3-hGHR
AC   CVCL_K247
DR   Wikidata; Q54752955
RX   PubMed=9440818;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4263; GHR.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   Ba/F3-LP
AC   CVCL_E7I9
SY   Ba/F-LP
RX   PubMed=12668884;
RX   PubMed=12824168;
WW   Provider; Inserm Transfert; RT00003; https://technology-offers.inserm-transfert.com/offer/stable-human-prolactin-receptor-ba-f3-cell/
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9446; PRLR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Ba/F3-Mpl
AC   CVCL_0183
SY   BaF3/Mpl; BaF3/mpl; BaF3-mpl; BAF3MpI
DR   MCCL; MCC:0000074
DR   Wikidata; Q54752958
RX   PubMed=9122198;
CC   Characteristics: IL3 dependent.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   Ba/F3-mTIGIT
AC   CVCL_E8GA
RX   PubMed=29648914;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:3642260; Tigit (Note=With a N-terminal FLAG tag).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BA/F3/Cas9-hyg
AC   CVCL_C9FI
DR   GeneCopoeia; SL567
DR   Wikidata; Q123030760
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL567).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   Ba/F3GR
AC   CVCL_8789
DR   Wikidata; Q54752960
RX   PubMed=7531988;
CC   Characteristics: CSF3 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   Ba/F3IL-5R
AC   CVCL_8790
DR   Wikidata; Q54752962
RX   PubMed=11480567;
CC   Characteristics: IL5 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96558; Il5ra.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   Ba/F3MR
AC   CVCL_8791
DR   Wikidata; Q54752963
RX   PubMed=7531988;
CC   Characteristics: CSF1 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339758; Csf1r.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   BA3
AC   CVCL_HF39
DR   Kerafast; EGA927
DR   Wikidata; Q54752966
RX   PubMed=26586283;
CC   Group: Bird cell line.
CC   Group: Vaccine production cell line.
CC   Doubling time: 21 hours (PubMed=26586283); 24-36 hours (Kerafast=EGA927).
CC   Discontinued: Kerafast; EGA927; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Australorp; VBO=VBO_0000461.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   11FD
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 8
//
ID   BA5
AC   CVCL_E9ZU
SY   BA5-C5
DR   ABCD; ABCD_BF020
RX   PubMed=32302507;
RX   PubMed=32579494;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_156221; 1,3-bis(6-isocyanatohexyl)-1,3-diazetidine-2,4-dione (Hexamethylene diisocyanate (HDI) uretdione) (Note=Also reacts with monomer hexamethylene diisocyanate and isocyanurate homopolymer (biuret)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BA54g
AC   CVCL_XH57
SY   BA54G
DR   Wikidata; Q93329276
RX   Patent=US20130273062;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4171.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P49961; Human ENTPD1/CD39.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BA7
AC   CVCL_E5RF
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BA7.3C.9
AC   CVCL_K124
DR   CLO; CLO_0001844
DR   ATCC; HB-10716
DR   Wikidata; Q54752969
RX   Patent=US5919911;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10716.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10721; Human KIT/CD117.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   BA8
AC   CVCL_F0HL
RX   PubMed=9570567;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BA886
AC   CVCL_A7TV
SY   BA 886; Bovine Aorta 886
DR   Wikidata; Q107113430
RX   CelloPub=CLPUB00632;
RX   PubMed=9429251;
RX   PubMed=12234001;
RX   PubMed=29017825;
RX   PubMed=33389257;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   BA987
AC   CVCL_A7TW
SY   BA 987; Bovine Aorta 987
DR   Wikidata; Q107113432
RX   CelloPub=CLPUB00632;
RX   PubMed=8300237;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632; PubMed=8300237).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A7TX ! BPA987
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BAAn1F
AC   CVCL_6E13
SY   ABAn1F; Branchial Arches Acipenser naccarii 1F
DR   Wikidata; Q54752970
RX   DOI=10.1111/j.1439-0426.2010.01408.x;
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
CC   Group: Fish cell line.
CC   Misspelling: ABA1F; DOI=10.1111/j.1439-0426.2010.01411.x.
CC   Derived from site: In situ; Bone, branchial arch; UBERON=UBERON_0002539.
OX   NCBI_TaxID=42330; ! Acipenser naccarii (Adriatic sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 11
//
ID   BAASf
AC   CVCL_A8VP
SY   Bulbus Arteriosus of Atlantic Salmon fibroblasts
DR   Wikidata; Q108819904
RX   PubMed=28882807;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart, bulbus arteriosus; UBERON=UBERON_0004152.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   BAB/BM
AC   CVCL_Y452
DR   ATCC; CRL-6298
DR   Wikidata; Q54752973
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6298; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C134766; Baboon lymphoma
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   BAB1
AC   CVCL_C6M1
DR   ABCD; ABCD_AA497
DR   Wikidata; Q116048548
RX   PubMed=8752951;
RX   PubMed=10620703;
CC   Doubling time: ~16 hours (PubMed=8752951).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15494; Betula pendula major pollen allergen Bet v 1-A.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6M2 ! BAB2
OI   CVCL_C6M3 ! BAB3
OI   CVCL_C6M4 ! BAB4
OI   CVCL_C6M5 ! BAB5
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BAB2
AC   CVCL_C6M2
DR   ABCD; ABCD_AA498
DR   Wikidata; Q116048549
RX   PubMed=8752951;
RX   PubMed=10620703;
CC   Doubling time: ~16 hours (PubMed=8752951).
CC   Monoclonal antibody isotype: IgG4, kappa.
CC   Monoclonal antibody target: UniProtKB; P15494; Betula pendula major pollen allergen Bet v 1-A.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6M1 ! BAB1
OI   CVCL_C6M3 ! BAB3
OI   CVCL_C6M4 ! BAB4
OI   CVCL_C6M5 ! BAB5
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BAB281
AC   CVCL_C0BX
SY   Bab281
DR   Wikidata; Q112929268
RX   PubMed=9314561;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O76036; Human NCR1/CD335.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   BAB3
AC   CVCL_C6M3
DR   ABCD; ABCD_AA499
DR   Wikidata; Q116048551
RX   PubMed=8752951;
RX   PubMed=10620703;
CC   Doubling time: ~16 hours (PubMed=8752951).
CC   Monoclonal antibody isotype: IgG4, lambda.
CC   Monoclonal antibody target: UniProtKB; P15494; Betula pendula major pollen allergen Bet v 1-A.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6M1 ! BAB1
OI   CVCL_C6M2 ! BAB2
OI   CVCL_C6M4 ! BAB4
OI   CVCL_C6M5 ! BAB5
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BAB4
AC   CVCL_C6M4
DR   ABCD; ABCD_AA500
DR   Wikidata; Q116048552
RX   PubMed=8752951;
RX   PubMed=10620703;
CC   Doubling time: ~16 hours (PubMed=8752951).
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P15494; Betula pendula major pollen allergen Bet v 1-A.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6M1 ! BAB1
OI   CVCL_C6M2 ! BAB2
OI   CVCL_C6M3 ! BAB3
OI   CVCL_C6M5 ! BAB5
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BAB5
AC   CVCL_C6M5
DR   ABCD; ABCD_AA501
DR   Wikidata; Q116048553
RX   PubMed=8752951;
RX   PubMed=10620703;
CC   Doubling time: ~16 hours (PubMed=8752951).
CC   Monoclonal antibody isotype: IgG4, kappa.
CC   Monoclonal antibody target: UniProtKB; P15494; Betula pendula major pollen allergen Bet v 1-A.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6M1 ! BAB1
OI   CVCL_C6M2 ! BAB2
OI   CVCL_C6M3 ! BAB3
OI   CVCL_C6M4 ! BAB4
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BABB35A4
AC   CVCL_C3TQ
SY   Babb35A4; BABB 35
DR   Wikidata; Q116048555
RX   Patent=US5171685;
RX   PubMed=2473398;
RX   PubMed=3410541;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10115.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BN13; Babesia bovis merozoite surface antigen 1 (MSA-1) (Bo42).
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5171685 and PubMed=2473398 and to be P3X63Ag8.653 in PubMed=3410541.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   BABB75A4
AC   CVCL_C3TR
SY   BABB75; BABB 75
DR   Wikidata; Q116048557
RX   Patent=US5171685;
RX   PubMed=2473398;
RX   PubMed=3410541;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q17115; Babesia bovis 60 kDa merozoite surface protein rap-1 (Bv60).
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5171685 and PubMed=2473398 and to be P3X63Ag8.653 in PubMed=3410541.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BABB90C4
AC   CVCL_C3TS
SY   BABB90C; BABB 90
DR   Wikidata; Q116048558
RX   Patent=US5171685;
RX   PubMed=3410541;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10117.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Babesia bovis merozoite 85 kDa surface antigen.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5171685 and to be P3X63Ag8.653 in PubMed=3410541.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   BABB93A1
AC   CVCL_C3TT
SY   BABB93A; BABB 93
DR   Wikidata; Q116048559
RX   Patent=US5171685;
RX   PubMed=3410541;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10112.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Babesia bovis merozoite 145 kDa surface antigen.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5171685 and to be P3X63Ag8.653 in PubMed=3410541.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   BabESC-15
AC   CVCL_B5FJ
SY   B15
DR   GEO; GSM5027858
DR   GEO; GSM5027859
DR   GEO; GSM5027860
DR   GEO; GSM5027861
DR   GEO; GSM5027862
DR   GEO; GSM5027878
DR   GEO; GSM5027879
DR   GEO; GSM5027880
DR   GEO; GSM5027884
DR   GEO; GSM5027885
DR   GEO; GSM5027886
DR   GEO; GSM5027890
DR   GEO; GSM5027891
DR   GEO; GSM5027892
DR   GEO; GSM5027896
DR   GEO; GSM5027897
DR   GEO; GSM5027898
DR   GEO; GSM5027926
DR   GEO; GSM5027927
DR   GEO; GSM5027928
DR   GEO; GSM5027945
DR   GEO; GSM5027946
DR   GEO; GSM5027947
DR   GEO; GSM5027948
DR   GEO; GSM5027949
DR   GEO; GSM5027950
DR   Wikidata; Q110432585
RX   PubMed=19393591;
RX   PubMed=34864219;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   BabESC-4
AC   CVCL_B5FI
SY   B4
DR   GEO; GSM5027853
DR   GEO; GSM5027854
DR   GEO; GSM5027855
DR   GEO; GSM5027856
DR   GEO; GSM5027857
DR   GEO; GSM5027875
DR   GEO; GSM5027876
DR   GEO; GSM5027877
DR   GEO; GSM5027881
DR   GEO; GSM5027882
DR   GEO; GSM5027883
DR   GEO; GSM5027887
DR   GEO; GSM5027888
DR   GEO; GSM5027889
DR   GEO; GSM5027893
DR   GEO; GSM5027894
DR   GEO; GSM5027895
DR   GEO; GSM5027923
DR   GEO; GSM5027924
DR   GEO; GSM5027925
DR   GEO; GSM5027939
DR   GEO; GSM5027940
DR   GEO; GSM5027941
DR   GEO; GSM5027942
DR   GEO; GSM5027943
DR   GEO; GSM5027944
DR   Wikidata; Q110432586
RX   PubMed=19393591;
RX   PubMed=34864219;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   BAC1
AC   CVCL_6770
DR   Wikidata; Q54752975
RX   PubMed=6319490;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c x A.CA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   BAC1.2F5
AC   CVCL_6771
SY   Bac1.2F5; Bac12F5; Bac 1.2F5; Bac1 2F5
DR   EFO; EFO_0022802
DR   Wikidata; Q54752977
RX   PubMed=3031090;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BAC1.2F5
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c x A.CA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6770 ! BAC1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   BACA
AC   CVCL_L311
DR   Wikidata; Q54752979
RX   PubMed=21801068;
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   Bad KO SV40 MEF
AC   CVCL_U624
DR   ATCC; CRL-2909
DR   Wikidata; Q54752981
CC   Knockout cell: Method=KO mouse; MGI; MGI:1096330; Bad.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   BADA.20
AC   CVCL_5G11
SY   BADA20
DR   ABM; T0863
DR   Wikidata; Q54752983
RX   PubMed=10906754;
RX   PubMed=15541571;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   BADCPPF1-151K
AC   CVCL_XB64
SY   HB BADCPPF1-151K; Clone 151K
DR   ATCC; HB-8961
DR   CCRID; 4201PAT-CCTCC00092
DR   Wikidata; Q93329315
RX   Patent=US5552286;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8961.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BADCPPF1-28A
AC   CVCL_XB65
SY   HB BADCPPF1-28A; Clone 28A
DR   ATCC; HB-8957
DR   CCRID; 4201PAT-CCTCC00088
DR   Wikidata; Q93329317
RX   Patent=US5552286;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8957.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BADCPPF1-35B
AC   CVCL_XB66
SY   HB BADCPPF1-35B; Clone 35B
DR   ATCC; HB-8960
DR   CCRID; 4201PAT-CCTCC00091
DR   Wikidata; Q93329319
RX   Patent=US5552286;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8960.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BADCPPF1-4C
AC   CVCL_XB67
SY   HB BADCPPF1-4C; Clone 4C
DR   ATCC; HB-8962
DR   CCRID; 4201PAT-CCTCC00093
DR   Wikidata; Q93329321
RX   Patent=US5552286;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8962.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BADCPPF1-63D
AC   CVCL_XB68
SY   HB BADCPPF1-63D; Clone 63D
DR   ATCC; HB-8958
DR   CCRID; 4201PAT-CCTCC00089
DR   Wikidata; Q93329324
RX   Patent=US5552286;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8958.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BADCPPF1-75A
AC   CVCL_XB69
SY   HB BADCPPF1-75A; Clone 75A
DR   ATCC; HB-8959
DR   CCRID; 4201PAT-CCTCC00090
DR   Wikidata; Q93329326
RX   Patent=US5552286;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8959.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BAE-1
AC   CVCL_3359
AS   CVCL_4505
SY   BAE; Bovine Aortic Endothelium-1
DR   CLO; CLO_0001848
DR   CLO; CLO_0001849
DR   CLDB; cl377
DR   CLDB; cl378
DR   CLDB; cl380
DR   CLDB; cl5157
DR   CLDB; cl5253
DR   ECACC; 88031149
DR   ICLC; AL00004
DR   IZSLER; BS PRC 42
DR   NCBI_Iran; C188
DR   Wikidata; Q54752985
RX   PubMed=187876;
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   BAEC
AC   CVCL_4690
DR   BTO; BTO_0003247
DR   CLO; CLO_0001850
DR   EFO; EFO_0022822
DR   CLDB; cl381
DR   Wikidata; Q54752987
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-161.html
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   BAEC-1
AC   CVCL_0162
SY   BAEC1; BAEC 1; Bovine Aortic Endothelial Cells-1
DR   CLO; CLO_0001851
DR   MCCL; MCC:0000054
DR   CLDB; cl382
DR   Wikidata; Q54752988
RX   PubMed=3543523;
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   BaF-B03
AC   CVCL_0072
SY   BAF-B03; BAF/B03
DR   Wikidata; Q54752990
CC   Characteristics: IL3 dependent.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   Baf3/WSX E63x7 sort
AC   CVCL_K248
DR   Wikidata; Q54752994
RX   Patent=US7524937;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12015.
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6554; LEPR.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   BAG-12G2
AC   CVCL_1956
DR   CLO; CLO_0001853
DR   CLDB; cl7079
DR   DSMZ; ACC-470
DR   DSMZCellDive; ACC-470
DR   Wikidata; Q54752995
CC   Doubling time: ~24 hours (DSMZ=ACC-470).
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   BAG-85D10
AC   CVCL_1957
DR   CLO; CLO_0001855
DR   DSMZ; ACC-471
DR   DSMZCellDive; ACC-471
DR   Wikidata; Q54753048
CC   Doubling time: ~72 hours (DSMZ=ACC-471).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16284; Human PECAM1/CD31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Bag1KO-mESC
AC   CVCL_QX66
DR   Wikidata; Q54753049
RX   PubMed=28677535;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108047; Bag1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   BAG50
AC   CVCL_C4P6
DR   Wikidata; Q116048561
RX   PubMed=36175578;
CC   Group: Cancer stem cell line.
CC   Doubling time: ~30 hours (PubMed=36175578).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): PubMed=36175578
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 15
ST   D16S539: 10
ST   D18S51: 16,18
ST   D19S433: 14,16.2
ST   D21S11: 31.2
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 12,13
ST   D8S1179: 17
ST   FGA: 26
ST   SE33: 11
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 15.2
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BAI,FL
AC   CVCL_E467
SY   BAI, FL
DR   dbMHC; 48484
DR   ECACC; 94082266
DR   IHW; IHW09166
DR   IPD-IMGT/HLA; 11709
DR   Wikidata; Q54753051
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*08,15; DPB1*02:01,04:01; DQA1*02:01,03; DQB1*02:01,03:01; DRB1*04:01,03:01; DRB4*01:01 (IPD-IMGT/HLA=11709).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082266; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   BAI,JE
AC   CVCL_E468
SY   BAI, JE
DR   dbMHC; 48485
DR   ECACC; 94082267
DR   IHW; IHW09167
DR   IPD-IMGT/HLA; 11710
DR   Wikidata; Q54753053
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*44:02; C*05,07; DPB1*03:01,04:01; DQA1*03; DQB1*03:01,03:02; DRB1*04:01; DRB4*01:01 (IPD-IMGT/HLA=11710).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BAI,NJ
AC   CVCL_E469
SY   BAI, NJ
DR   dbMHC; 48486
DR   ECACC; 94082268
DR   IHW; IHW09168
DR   IPD-IMGT/HLA; 11711
DR   Wikidata; Q54753055
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*08,15; C*03,07; DPB1*03:01,04:01; DQA1*03; DQB1*03:02; DRB1*04:01; DRB4*01:01 (IPD-IMGT/HLA=11711).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Bak KO SV40 MEF
AC   CVCL_U625
DR   ATCC; CRL-2912
DR   Wikidata; Q54753057
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   BAL-KHc
AC   CVCL_QX98
SY   BAL-KH clumps
DR   Wikidata; Q54753060
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2709874;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=2709874).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C884 ! BAL-KHs
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   BAL-KHs
AC   CVCL_C884
SY   BAL-KH; BAL-KH suspension
DR   Cosmic; 996305
DR   Cosmic; 998722
DR   Cosmic; 1037705
DR   Wikidata; Q54753062
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2709874;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=2709874).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX98 ! BAL-KHc
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   BALB SFME
AC   CVCL_9102
SY   Balb SFME; BALB/c SFME; BALB/c Serum Free Mouse Embryo; SFME
DR   CLO; CLO_0001857
DR   ATCC; CRL-9392
DR   Wikidata; Q54753065
RX   Patent=US5602025;
RX   PubMed=1973170;
RX   PubMed=2011405;
RX   PubMed=3494308;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9392.
CC   Discontinued: ATCC; CRL-9392; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   16FD
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   BALB-G-M
AC   CVCL_C5SS
SY   Balb-G-M
DR   Wikidata; Q116048562
RX   PubMed=7341770;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BALB-MC
AC   CVCL_J361
SY   BALB/c-MC; Balb/c-MC
DR   JCRB; JCRB0233.0
DR   Wikidata; Q54753067
RX   PubMed=3680103;
CC   Doubling time: ~18-23 hours (PubMed=3680103); ~26-33 hours (Note=Lot 02162015) (JCRB=JCRB0233.0).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cHe.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y5M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   BALB-MC.D3
AC   CVCL_J362
DR   JCRB; FDSC0002
DR   JCRB; JCRB0233.1
DR   Wikidata; Q54753069
CC   Discontinued: JCRB; FDSC0002; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cHe.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J361 ! BALB-MC
SX   Female
AG   1Y5M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   BALB-MC.E12
AC   CVCL_J363
DR   JCRB; FDSC0003
DR   JCRB; JCRB0233.2
DR   Wikidata; Q54753072
CC   Discontinued: JCRB; FDSC0003; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cHe.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J361 ! BALB-MC
SX   Female
AG   1Y5M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   BALB/3T12-3
AC   CVCL_0637
SY   BALB/c 3T12-3; Balb/3T12-3; BALB 3T12-3; BALB/3T12; Balb 3T12; 3T12-3; 3T12
DR   BTO; BTO_0000111
DR   CLO; CLO_0001856
DR   CLO; CLO_0001858
DR   CLDB; cl383
DR   CLDB; cl384
DR   ATCC; CCL-164
DR   ECACC; 90030803
DR   IZSLER; BS CL 5
DR   KCLB; 10164
DR   Wikidata; Q54753076
RX   PubMed=4301006;
RX   PubMed=4301647;
RX   PubMed=4359949;
CC   Discontinued: ECACC; 90030803; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   BALB/3T3 A31-1-1
AC   CVCL_J646
SY   Balb/c 3T3 A31-I-1; A31-1-1; 1-1
DR   JCRB; IFO50070
DR   JCRB; IFO50298
DR   JCRB; JCRB0601
DR   JCRB; JCRB1356
DR   JCRB; NIHS0590
DR   Wikidata; Q54753078
RX   PubMed=27844419;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419). Therefore this cell line is not a clone of BALB/3T3 clone A31 (Cellosaurus=CVCL_0184) as originally reported.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00528.
CC   Discontinued: JCRB; NIHS0590; true.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   BALB/3T3 A31-1-13
AC   CVCL_L996
SY   Balb/c 3T3 A31-1-13; A31-1-13
DR   JCRB; IFO50299
DR   Wikidata; Q54753079
RX   PubMed=27844419;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419). Therefore this cell line is not a clone of BALB/3T3 clone A31 (Cellosaurus=CVCL_0184) as originally reported.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00529.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   BALB/3T3 clone A31
AC   CVCL_0184
SY   BALB/c 3T3 clone A31; Balb/c3T3; BALB/c 3T3; Balb/c 3T3; BALB/3T3; Balb/3T3-4-Cl31; 3T3 clone A31; BALB/3T3 cl. A31; BALB 3T3 clone A31; BALB/3T3 (clone A31); B/C3T3; 3T3-A31; 3T3(A31); A31; A31N
DR   BTO; BTO_0000218
DR   CLO; CLO_0001346
DR   CLO; CLO_0001859
DR   CLO; CLO_0050542
DR   MCCL; MCC:0000075
DR   CLDB; cl385
DR   CLDB; cl386
DR   CLDB; cl387
DR   CLDB; cl388
DR   CLDB; cl389
DR   CLDB; cl7216
DR   ATCC; CCL-163
DR   ATCC; CRL-6587
DR   ATCC; CRL-6588
DR   BCRC; 60009
DR   BCRJ; 0047
DR   BioSample; SAMN11397624
DR   CCRID; 1101MOU-PUMC000186
DR   CCRID; 1102MOU-NIFDC00085
DR   CCRID; 3101MOUGNM3
DR   CCRID; 4201MOU-CCTCC00224
DR   CCTCC; GDC0224
DR   ChEMBL-Cells; CHEMBL3308086
DR   ChEMBL-Targets; CHEMBL613876
DR   CLS; 305155
DR   ECACC; 86110401
DR   ICLC; AL09001
DR   IZSLER; BS CL 4
DR   JCRB; JCRB9005
DR   KCB; KCB 200713YJ
DR   KCLB; 10163
DR   Lonza; 1351
DR   MeSH; D041702
DR   NCBI_Iran; C162
DR   PubChem_Cell_line; CVCL_0184
DR   RCB; RCB0005
DR   RCB; RCB2647
DR   TKG; TKG 0187
DR   TOKU-E; 615
DR   TOKU-E; 3612
DR   Wikidata; Q28334278
RX   PubMed=50878;
RX   PubMed=182373;
RX   PubMed=4301006;
RX   PubMed=4359949;
RX   PubMed=4792350;
RX   PubMed=4798834;
RX   PubMed=10848989;
RX   PubMed=22576795;
RX   PubMed=25277546;
RX   PubMed=31220119;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-ccl-163-growth-and-morphology
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-255.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 30-32 hours (Note=At 33 Celsius) (PubMed=4798834); 24 hours (Note=At 38 Celsius) (PubMed=182373).
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: BABL/3T3; KCB=KCB 200713YJ.
CC   Discontinued: ATCC; CRL-6587; true.
CC   Discontinued: ATCC; CRL-6588; true.
CC   Discontinued: BioSample; SAMN11397624; true.
CC   Discontinued: RCB; RCB2647; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   BALB/3T3 clone A31 H
AC   CVCL_B5VL
SY   Clone H
DR   Wikidata; Q111732945
RX   PubMed=50878;
RX   PubMed=701383;
CC   Transformant: ChEBI; CHEBI_189529; Nitrosocarbaryl.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 NTG2
AC   CVCL_B5VH
SY   NTG2
DR   Wikidata; Q111732946
RX   PubMed=1028169;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 THO2
AC   CVCL_B5VI
SY   THO2; THO-2
DR   Wikidata; Q111732947
RX   PubMed=701383;
RX   PubMed=1028169;
RX   PubMed=6933701;
CC   Characteristics: Deficient in hypoxanthine-guanine phosphoribosyltransferase (HGPRT).
CC   Doubling time: 30 hours (PubMed=1028169); 16 hours (Note=In 10% FBS), 20.4 hours (Note=In 1% FBS) (PubMed=701383).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VH ! BALB/3T3 clone A31 NTG2
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 Ts-1
AC   CVCL_B5VD
SY   Ts-1
DR   Wikidata; Q111732948
RX   PubMed=4798834;
CC   Characteristics: Temperature sensitive. At the non-permissive temperature (38-38.5 Celsius) cell division cease (PubMed=4798834).
CC   Doubling time: 30-32 hours (Note=At 33 Celsius), 22-24 hours (Note=At 38.5 Celsius) (PubMed=4798834).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 ts2
AC   CVCL_B5VE
SY   ts-2; ts2
DR   Wikidata; Q111732949
RX   CelloPub=CLPUB00677;
RX   PubMed=182373;
RX   PubMed=6933701;
CC   Characteristics: Temperature sensitive. At the non-permissive temperature of 38 Celsius cease to proliferate due to a defect in DNA synthesis (PubMed=182373).
CC   Doubling time: 35-40 hours (Note=At 33 Celsius) (PubMed=182373).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 ts2-TG-31
AC   CVCL_B5VJ
SY   ts2-TG-31; ts2-TGr31
DR   Wikidata; Q111732950
RX   PubMed=6933701;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VE ! BALB/3T3 clone A31 ts2
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 ts2-TGO
AC   CVCL_B5VK
SY   ts2-TGO; 2TGO-13
DR   Wikidata; Q111732951
RX   CelloPub=CLPUB00677;
RX   PubMed=6933701;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VJ ! BALB/3T3 clone A31 ts2-TG-31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 ts2R
AC   CVCL_B5VF
SY   ts2R
DR   Wikidata; Q111732952
RX   PubMed=6933701;
CC   Characteristics: Revertant of parent cell line, no longer temperature sensitive (PubMed=6933701).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VE ! BALB/3T3 clone A31 ts2
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31 ts20
AC   CVCL_B385
AS   CVCL_D594
SY   ts20; Ts20; TS-20; A31N-ts20; A31N ts20; A31Nts20
DR   BTO; BTO_0004582
DR   BTO; BTO_0005283
DR   Wikidata; Q54606748
RX   PubMed=2995094;
RX   PubMed=6092941;
RX   PubMed=6933701;
RX   PubMed=8114731;
RX   PubMed=10848989;
CC   Characteristics: Temperature sensitive phenotype.
CC   Characteristics: In this cell line Uba1 is heat-inactivatable (PubMed=10848989).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   BALB/3T3 clone A31 ts22
AC   CVCL_B5VG
SY   ts22
DR   Wikidata; Q111732953
RX   PubMed=6933701;
RX   PubMed=8114731;
CC   Characteristics: Temperature sensitive (PubMed=6933701).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BALB/3T3 clone A31T
AC   CVCL_A5PN
SY   Clone A31T; 3T3 T
DR   BTO; BTO_0004005
DR   Wikidata; Q107113433
RX   PubMed=593321;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BALB/3T3-APR-MUC1 cl.16
AC   CVCL_4E32
SY   BALB/3T3-APR-MUC1 clone 16
DR   RCB; RCB2632
DR   TKG; TKG 0566
DR   Wikidata; Q54753082
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Problematic cell line: Misidentified/contaminated. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (DOI=10.4051/ibc.2010.2.4.0014). It is therefore not a BALB/3T3 derivative.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Discontinued: RCB; RCB2632; true.
CC   Discontinued: TKG; TKG 0566; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   BALB/42
AC   CVCL_C0PH
SY   Balb/42
DR   Wikidata; Q112929269
RX   DOI=10.1016/B978-0-7506-0421-5.50008-8;
RX   DOI=10.1016/B978-0-7506-1103-9.50010-x;
RX   PubMed=1851133;
CC   Doubling time: ~27 hours (PubMed=1851133).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pUK42).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   BALB/B 0.75BAE A.1R.1 HD A.8
AC   CVCL_9096
DR   CLO; CLO_0001860
DR   ATCC; TIB-84
DR   Wikidata; Q54753087
RX   PubMed=723934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: ChEBI; CHEBI_142240; Benz[a]anthracene 5,6-oxide (Epoxy-5,6-dihydrobenz(a)anthracene).
CC   Breed/subspecies: BALB.B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K167 ! BALB/B CL.6
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   BALB/B CL.6
AC   CVCL_K167
DR   Wikidata; Q54753088
RX   PubMed=723934;
CC   Breed/subspecies: BALB.B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   BALB/c 10CrMCA A.2R.1
AC   CVCL_9097
DR   CLO; CLO_0001861
DR   ATCC; TIB-86
DR   Wikidata; Q54753090
RX   PubMed=723934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9101 ! BALB/c CL.7
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   BALB/c 10ME HD A.5R.1
AC   CVCL_9098
DR   CLO; CLO_0001862
DR   ATCC; TIB-85
DR   Wikidata; Q54753092
RX   PubMed=723934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: ChEBI; CHEBI_142244; 11,12-epoxy-methylcholanthrene (11,12-dihydro-11,12-epoxy-3-methylcholanthrene).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9101 ! BALB/c CL.7
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   BALB/c AMuLV A.3R.1
AC   CVCL_9099
DR   CLO; CLO_0001863
DR   ATCC; TIB-87
DR   Wikidata; Q54753093
RX   PubMed=723934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9101 ! BALB/c CL.7
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   BALB/c AMuLV A.6R.1
AC   CVCL_9100
DR   CLO; CLO_0001864
DR   ATCC; TIB-90
DR   Wikidata; Q54753096
RX   PubMed=723934;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-337.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9101 ! BALB/c CL.7
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   BALB/c CL.7
AC   CVCL_9101
DR   CLO; CLO_0001865
DR   ATCC; TIB-80
DR   Wikidata; Q54753098
RX   PubMed=723934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   BALB/cJ-line I
AC   CVCL_2H84
SY   BALB/c-I
DR   Wikidata; Q54753100
RX   PubMed=8840532;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000651P9productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/cJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   BALB/Edeltat
AC   CVCL_C0PI
SY   Balb/Edt
DR   Wikidata; Q112929270
RX   DOI=10.1016/B978-0-7506-0421-5.50008-8;
RX   DOI=10.1016/B978-0-7506-1103-9.50010-x;
RX   PubMed=1851133;
CC   Doubling time: ~27 hours (PubMed=1851133).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pUKdeltat).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   BALB/Eori-
AC   CVCL_C0PJ
DR   Wikidata; Q112929271
RX   DOI=10.1016/B978-0-7506-0421-5.50008-8;
CC   Doubling time: 96 hours (Note=At 27th passage), 48 hours (Note=After 27th passage) (DOI=10.1016/B978-0-7506-0421-5.50008-8).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pUKEori-).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   BALB/MK
AC   CVCL_1B29
SY   BALB-MK; Balb/Mk
DR   ChEMBL-Cells; CHEMBL3307298
DR   ChEMBL-Targets; CHEMBL614065
DR   PubChem_Cell_line; CVCL_1B29
DR   Wikidata; Q54753104
RX   PubMed=6297803;
CC   Characteristics: EGF dependent.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1-2D
CA   Factor-dependent cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   BALB/MK-1
AC   CVCL_1B30
SY   BALB/MK1
DR   Wikidata; Q54753105
RX   PubMed=6297803;
CC   Characteristics: EGF dependent.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1B29 ! BALB/MK
SX   Sex unspecified
AG   1-2D
CA   Factor-dependent cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   BALB/MK-2
AC   CVCL_U622
SY   BALB/MK2; Balb/MK-2
DR   Wikidata; Q54753107
RX   PubMed=2506887;
RX   PubMed=6297803;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-254.html
CC   Characteristics: EGF dependent.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1B29 ! BALB/MK
SX   Sex unspecified
AG   1-2D
CA   Factor-dependent cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   BALENLM 17
AC   CVCL_9474
SY   BALENLM-17; Balenlm 17; BAL-17; Bal-17; Bal 17; Bal17; BAL17
DR   Wikidata; Q54753109
RX   PubMed=310843;
RX   PubMed=3020122;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 10
//
ID   BALL-1
AC   CVCL_1075
SY   Ball-1; Ball 1; BALL1; B-cell Acute Lymphoblastic Leukemia-1
DR   BTO; BTO_0001148
DR   CLO; CLO_0037300
DR   CLO; CLO_0051004
DR   CLO; CLO_0051005
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471059
DR   BioSample; SAMN03472350
DR   cancercelllines; CVCL_1075
DR   CCRID; 5301HUM-KCB94007YJ
DR   Cell_Model_Passport; SIDM00287
DR   ChEMBL-Cells; CHEMBL3308839
DR   ChEMBL-Targets; CHEMBL2366269
DR   CLS; 305084
DR   Cosmic; 910705
DR   Cosmic; 919134
DR   Cosmic; 999755
DR   Cosmic; 999762
DR   Cosmic; 1150902
DR   Cosmic-CLP; 910705
DR   DepMap; ACH-002211
DR   DSMZ; ACC-742
DR   DSMZCellDive; ACC-742
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10455-106G5
DR   GDSC; 910705
DR   GEO; GSM827223
DR   GEO; GSM1669606
DR   IARC_TP53; 21184
DR   JCRB; JCRB0071
DR   KCB; KCB 94007YJ
DR   LINCS_LDP; LCL-1005
DR   PharmacoDB; BALL1_73_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1075
DR   PubChem_Cell_line; CVCL_1075
DR   RCB; RCB0256
DR   RCB; RCB1882
DR   TKG; TKG 0467
DR   Wikidata; Q54753112
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   DOI=10.4044/joma1947.92.5-6_763;
RX   PubMed=195075;
RX   PubMed=197412;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6582512;
RX   PubMed=8139288;
RX   PubMed=8156010;
RX   PubMed=8957066;
RX   PubMed=9290701;
RX   PubMed=9510473;
RX   PubMed=15901131;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 80 hours (Note=In RPMI 1640 + 20% HCS), 66 hours (Note=In RPMI 1640 + 20% FCS) (PubMed=195075); ~48-72 hours (DSMZ=ACC-742).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Gly (c.842A>G); ClinVar=VCV000141141; Zygosity=Homozygous (PubMed=15901131; Cosmic-CLP=910705).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.09%; East Asian, South=18.9%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CCRID=5301HUM-KCB94007YJ; Cosmic-CLP=910705; DSMZ=ACC-742; JCRB=JCRB0071; RCB=RCB0256; TKG=TKG 0467
ST   Amelogenin: X (JCRB=JCRB0071; TKG=TKG 0467)
ST   Amelogenin: X,Y (CCRID=5301HUM-KCB94007YJ; Cosmic-CLP=910705; DSMZ=ACC-742; RCB=RCB0256)
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 12,13 (CCRID=5301HUM-KCB94007YJ)
ST   D18S51: 13 (DSMZ=ACC-742)
ST   D19S433: 13,15.2 (CCRID=5301HUM-KCB94007YJ)
ST   D19S433: 13,16 (DSMZ=ACC-742)
ST   D21S11: 30
ST   D2S1338: 19,22
ST   D3S1358: 16
ST   D5S818: 10,12,13 (RCB=RCB0256)
ST   D5S818: 10,13 (CCRID=5301HUM-KCB94007YJ; Cosmic-CLP=910705; DSMZ=ACC-742; JCRB=JCRB0071; TKG=TKG 0467)
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 14,16
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   BALL-1/CD20-KO
AC   CVCL_A8V6
SY   BINDS-24
DR   cancercelllines; CVCL_A8V6
DR   Wikidata; Q102113583
RX   PubMed=32667234;
RX   PubMed=32724441;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7315; MS4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Gly (c.842A>G); ClinVar=VCV000141141; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1075 ! BALL-1
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   BALL-2
AC   CVCL_B388
SY   B-cell Acute Lymphoblastic Leukemia-2
DR   Wikidata; Q54753114
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1650133;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=1650133).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   BALM-1
AC   CVCL_5687
SY   BALM 1; BALM1
DR   Cosmic; 919143
DR   Cosmic; 998720
DR   Cosmic; 999759
DR   Cosmic; 1037695
DR   Wikidata; Q54753116
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=406986;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3106068;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=8957066;
RX   PubMed=9510473;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5696 ! BALM-2
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   BALM-10
AC   CVCL_5688
DR   Cosmic; 999788
DR   Wikidata; Q54753119
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=10695022;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5707 ! BALM-9
OI   CVCL_5689 ! BALM-11
OI   CVCL_5690 ! BALM-12
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BALM-11
AC   CVCL_5689
DR   Cosmic; 999789
DR   Wikidata; Q54753121
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5707 ! BALM-9
OI   CVCL_5688 ! BALM-10
OI   CVCL_5690 ! BALM-12
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BALM-12
AC   CVCL_5690
DR   Cosmic; 999790
DR   Wikidata; Q54753125
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5707 ! BALM-9
OI   CVCL_5688 ! BALM-10
OI   CVCL_5689 ! BALM-11
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BALM-13
AC   CVCL_5691
SY   Balm13
DR   Cosmic; 998713
DR   Cosmic; 999785
DR   Cosmic; 1037698
DR   JCRB; JCRB1791
DR   Wikidata; Q54753126
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=9183631;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1791
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5692 ! BALM-14
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   BALM-14
AC   CVCL_5692
SY   BALM14
DR   Cosmic; 998714
DR   Cosmic; 999786
DR   Cosmic; 1037699
DR   JCRB; JCRB1804
DR   Wikidata; Q54753129
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=9183631;
RX   PubMed=10233379;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1804
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5691 ! BALM-13
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BALM-16
AC   CVCL_5693
DR   Cosmic; 999761
DR   JCRB; JCRB1795
DR   Wikidata; Q54753131
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9447837;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 32 hours (PubMed=9447837).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1795
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   BALM-18
AC   CVCL_5694
DR   JCRB; JCRB1796
DR   Wikidata; Q54753133
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10374849;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 36 hours (PubMed=10374849).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1796
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,20
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BALM-19
AC   CVCL_5695
DR   JCRB; JCRB1798
DR   Wikidata; Q54753136
RX   PubMed=12703546;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=12703546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1798
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5697 ! BALM-20
OI   CVCL_5698 ! BALM-21
OI   CVCL_5699 ! BALM-22
OI   CVCL_5700 ! BALM-23
OI   CVCL_5702 ! BALM-26
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   BALM-2
AC   CVCL_5696
SY   BALM 2; BALM2
DR   Wikidata; Q54753137
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=406986;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6929725;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5687 ! BALM-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   BALM-20
AC   CVCL_5697
DR   JCRB; JCRB1797
DR   Wikidata; Q54753188
RX   PubMed=12703546;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=12703546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1797
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5695 ! BALM-19
OI   CVCL_5698 ! BALM-21
OI   CVCL_5699 ! BALM-22
OI   CVCL_5700 ! BALM-23
OI   CVCL_5702 ! BALM-26
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   BALM-21
AC   CVCL_5698
DR   JCRB; JCRB1817
DR   Wikidata; Q54753192
RX   PubMed=12703546;
CC   Population: Japanese.
CC   Doubling time: 23 hours (PubMed=12703546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1817
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5695 ! BALM-19
OI   CVCL_5697 ! BALM-20
OI   CVCL_5699 ! BALM-22
OI   CVCL_5700 ! BALM-23
OI   CVCL_5702 ! BALM-26
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   BALM-22
AC   CVCL_5699
DR   JCRB; JCRB1813
DR   Wikidata; Q54753194
RX   PubMed=12703546;
CC   Population: Japanese.
CC   Doubling time: 80 hours (PubMed=12703546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5695 ! BALM-19
OI   CVCL_5697 ! BALM-20
OI   CVCL_5698 ! BALM-21
OI   CVCL_5700 ! BALM-23
OI   CVCL_5702 ! BALM-26
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BALM-23
AC   CVCL_5700
DR   JCRB; JCRB1800
DR   Wikidata; Q54753196
RX   PubMed=12703546;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=12703546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1800
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5695 ! BALM-19
OI   CVCL_5697 ! BALM-20
OI   CVCL_5698 ! BALM-21
OI   CVCL_5699 ! BALM-22
OI   CVCL_5702 ! BALM-26
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   BALM-24
AC   CVCL_B3M5
DR   JCRB; JCRB1843
DR   Wikidata; Q110432587
RX   PubMed=12764385;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
ID   BALM-25
AC   CVCL_5701
DR   JCRB; JCRB1801
DR   Wikidata; Q54753199
RX   PubMed=15160921;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 30 hours (PubMed=15160921).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1801
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BALM-26
AC   CVCL_5702
DR   JCRB; JCRB1803
DR   Wikidata; Q54753200
RX   PubMed=12703546;
CC   Population: Japanese.
CC   Doubling time: 35 hours (PubMed=12703546).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1803
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5695 ! BALM-19
OI   CVCL_5697 ! BALM-20
OI   CVCL_5698 ! BALM-21
OI   CVCL_5699 ! BALM-22
OI   CVCL_5700 ! BALM-23
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   BALM-27
AC   CVCL_5703
DR   JCRB; JCRB1821
DR   Wikidata; Q54753203
RX   PubMed=12389627;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 32 hours (PubMed=12389627).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1821
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   BALM-3
AC   CVCL_5426
SY   BALM 3; BALM3
DR   Cosmic; 999782
DR   Wikidata; Q54753205
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=160894;
RX   PubMed=2939141;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (PubMed=160894).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5427 ! BALM-4
OI   CVCL_5205 ! BALM-5
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   BALM-4
AC   CVCL_5427
SY   BALM 4; BALM4
DR   Cosmic; 999783
DR   Wikidata; Q54753207
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=160894;
RX   PubMed=2939141;
RX   PubMed=2985879;
RX   PubMed=3106068;
RX   PubMed=3159941;
RX   PubMed=3874327;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BALM-4
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (PubMed=160894).
CC   HLA typing: A*02; B*13,44 (PubMed=2939141).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5426 ! BALM-3
OI   CVCL_5205 ! BALM-5
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   BALM-5
AC   CVCL_5205
DR   Cosmic; 999784
DR   Wikidata; Q54753209
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=160894;
RX   PubMed=2939141;
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (PubMed=160894).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5426 ! BALM-3
OI   CVCL_5427 ! BALM-4
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   BALM-6
AC   CVCL_5704
DR   Cosmic; 801723
DR   Cosmic; 996303
DR   Cosmic; 998721
DR   Cosmic; 999760
DR   Cosmic; 1037696
DR   JCRB; JCRB1783
DR   Wikidata; Q54753211
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=1390421;
RX   PubMed=10233379;
RX   PubMed=10637496;
RX   PubMed=14504097;
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=1390421).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1783
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5705 ! BALM-7
OI   CVCL_5706 ! BALM-8
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   BALM-7
AC   CVCL_5705
DR   JCRB; JCRB1782
DR   Wikidata; Q54753214
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1390421;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1782
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5704 ! BALM-6
OI   CVCL_5706 ! BALM-8
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   BALM-8
AC   CVCL_5706
DR   JCRB; JCRB1784
DR   Wikidata; Q54753216
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1390421;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1784
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5704 ! BALM-6
OI   CVCL_5705 ! BALM-7
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   BALM-9
AC   CVCL_5707
SY   BALM9; Balm9
DR   cancercelllines; CVCL_5707
DR   Cosmic; 801724
DR   Cosmic; 998712
DR   Cosmic; 999787
DR   Cosmic; 1037697
DR   Cosmic; 2297028
DR   GEO; GSM115808
DR   JCRB; JCRB1785
DR   Progenetix; CVCL_5707
DR   Wikidata; Q54753219
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=8618450;
RX   PubMed=10233379;
RX   PubMed=10695022;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=16960149;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1785
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5688 ! BALM-10
OI   CVCL_5689 ! BALM-11
OI   CVCL_5690 ! BALM-12
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   BALM-9K
AC   CVCL_5708
SY   BALM-9 K
DR   JCRB; JCRB1787
DR   Wikidata; Q54753222
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=8618450;
RX   PubMed=10695022;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1787
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5707 ! BALM-9
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BALM-9KL
AC   CVCL_5709
SY   BALM-9 KL
DR   JCRB; JCRB1788
DR   Wikidata; Q54753223
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=8618450;
RX   PubMed=10695022;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1788
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5707 ! BALM-9
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BALM-9L
AC   CVCL_QX21
SY   BALM-9 L
DR   JCRB; JCRB1794
DR   Wikidata; Q54753226
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=8618450;
RX   PubMed=10695022;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1794
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5707 ! BALM-9
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 9
//
ID   BALM-9N
AC   CVCL_5710
SY   BALM-9 N
DR   JCRB; JCRB1790
DR   Wikidata; Q54753229
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=8618450;
RX   PubMed=10695022;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1790
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5707 ! BALM-9
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BAM [Mouse chondrosarcoma]
AC   CVCL_0J39
DR   Wikidata; Q54753230
RX   PubMed=1560787;
CC   Breed/subspecies: ST/Eh.
DI   NCIt; C24018; Mouse chondrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3506 ! EHS
OI   CVCL_0J38 ! EHSPEL
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   BAM [Mouse macrophage]
AC   CVCL_6772
DR   Wikidata; Q54753231
RX   PubMed=6319490;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   BAM1
AC   CVCL_0J21
DR   Wikidata; Q54753232
RX   PubMed=6300147;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BAM3
AC   CVCL_0J22
DR   Wikidata; Q54753235
RX   PubMed=6300147;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Ban
AC   CVCL_WH94
DR   Wikidata; Q93329726
RX   DOI=10.11418/jtca1981.17.3_95;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   Bang/FeT-J
AC   CVCL_V315
DR   Wikidata; Q54753236
RX   Patent=US5846825;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11975.
CC   Characteristics: IL2 independent.
CC   Virology: Persistently infected by feline immunodeficiency virus (FIV) isolate Bangston.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_3687 ! FeT-J
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   BAOEC
AC   CVCL_4117
SY   Bovine AOrtal Endothelial Cells
DR   CLO; CLO_0001867
DR   CLDB; cl391
DR   ECACC; 86123102
DR   Wikidata; Q54753238
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (ECACC=86123102).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 7
//
ID   Bar-1
AC   CVCL_UR55
DR   Wikidata; Q93329737
RX   PubMed=15664728;
CC   Senescence: Senesces at 62 PDL (PubMed=15664728).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   BAR-T
AC   CVCL_4M95
DR   Wikidata; Q54753240
RX   PubMed=17509124;
RX   PubMed=19673046;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Esophagus, epithelium; Note=From a Barrett esophagus; UBERON=UBERON_0001976.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 10
//
ID   BARB3
AC   CVCL_XI26
SY   Barb3
DR   Wikidata; Q93329744
RX   Patent=WO2009087173A2;
RX   Patent=WO2009104100A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2859.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   BARB4
AC   CVCL_XI27
SY   Barb4
DR   Wikidata; Q93329746
RX   Patent=WO2009087577A2;
RX   Patent=WO2009104100A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2876.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q92804; Human TAF15.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BARF7
AC   CVCL_0F74
SY   BARF 7; GM14052
DR   CLO; CLO_0033779
DR   ATCC; CRL-2789
DR   Coriell; GM14052
DR   Wikidata; Q54753241
RX   PubMed=2612208;
RX   PubMed=8314575;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: ATCC; CRL-2789; true.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   Bartlett 96
AC   CVCL_X852
SY   BARTLETT 96
DR   Wikidata; Q28198446
RX   Patent=WO1994019478A1;
RX   PubMed=7690960;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3645 ! Anjou 65
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 12
//
ID   Basc-2
AC   CVCL_C8IK
DR   Wikidata; Q123030761
RX   PubMed=75945;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Basc-5
AC   CVCL_C8IL
DR   Wikidata; Q123030762
RX   PubMed=6988327;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   BAT,J
AC   CVCL_E470
SY   BAT, J
DR   dbMHC; 48487
DR   ECACC; 94082214
DR   IHW; IHW09115
DR   IPD-IMGT/HLA; 11660
DR   Wikidata; Q54753248
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02:01:01:01,31:01:02; B*40:01,44:02:01:01; C*05:01; DPB1*01:01:01,03:01; DQA1*01:01,03; DQB1*03:02,05:03; DRB1*04:04,14:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11660).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BAT085
AC   CVCL_F1Z6
RX   PubMed=1370558;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with isolate MN).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BAT123
AC   CVCL_F1Z7
DR   ABCD; ABCD_AE277
RX   PubMed=2480382;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BATkl2
AC   CVCL_VU18
DR   Wikidata; Q93329763
RX   DOI=10.1101/565168;
CC   Characteristics: FGF2 dependent.
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BAU
AC   CVCL_E471
DR   IHW; 9w 0501
DR   IPD-IMGT/HLA; 10297
DR   Wikidata; Q54753249
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: B*44:02:01:01 (IPD-IMGT/HLA=10297).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   Bax Bak DKO SV40 MEF
AC   CVCL_U626
DR   ATCC; CRL-2913
DR   Wikidata; Q54753251
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   Bax KO SV40 MEF
AC   CVCL_U627
SY   BAX KO SV40 MEF
DR   ATCC; CRL-2910
DR   Wikidata; Q54753252
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   BAX KO (C57)
AC   CVCL_C0L2
SY   BAX KO (C57) Macrophage Cell Line
DR   Kerafast; ENH169-FP
DR   Wikidata; Q112929272
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Bay91
AC   CVCL_M658
SY   Bay9I; BAY-91
DR   Wikidata; Q54753253
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8683996;
RX   PubMed=16809887;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Bayer/BCIRL-AtE2-1201-TR
AC   CVCL_C2T2
DR   ICLDB; bayerbcirl-ate2-1201-tr
DR   Wikidata; Q114310674
CC   Group: Insect cell line.
CC   From: Reall, Tamra; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=236421; ! Anasa tristis (Squash bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   Bayer/BCIRL-SfAO-0806-TR
AC   CVCL_XA41
SY   BAYER/BCIRL-SfAO-0806-TR; SfAO-0806-TR
DR   ICLDB; bayerbcirl-sfao-0806-tr
DR   Wikidata; Q93329786
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 66.8 hours (Note=At 49th passage) (PubMed=31410641).
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfAO2-0714-TR
AC   CVCL_XA40
SY   BAYER/BCIRL-SfAO2-0714-TR; SfAO2-0714-TR
DR   ICLDB; bayerbcirl-sfao2-0714-tr
DR   Wikidata; Q93329788
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 34.4 hours (Note=At 38th passage) (PubMed=31410641).
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfAO2-0813-TR
AC   CVCL_XA42
SY   BAYER/BCIRL-SfAO2-0813-TR; SfAO2-0813-TR
DR   ICLDB; bayerbcirl-sfao2-0813-tr
DR   Wikidata; Q93329790
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 138.5 hours (Note=At 26th passage) (PubMed=31410641).
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C11-TR
AC   CVCL_XA49
SY   BAYER/BCIRL-SfNS-0624-C11; SfNS-0624-C11
DR   ICLDB; bayerbcirl-sfns-0624-c11-tr
DR   Wikidata; Q93329793
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C11a-TR
AC   CVCL_C2UF
SY   SfNS-0624-C11a
DR   ICLDB; bayerbcirl-sfns-0624-c11a-tr
DR   Wikidata; Q114310676
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA49 ! Bayer/BCIRL-SfNS-0624-C11-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS-0624-C11c-TR
AC   CVCL_C2UG
SY   SfNS-0624-C11c
DR   ICLDB; bayerbcirl-sfns-0624-c11c-tr
DR   Wikidata; Q114310677
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA49 ! Bayer/BCIRL-SfNS-0624-C11-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS-0624-C13-TR
AC   CVCL_XA50
SY   BAYER/BCIRL-SfNS-0624-C13; SfNS-0624-C13
DR   ICLDB; bayerbcirl-sfns-0624-c13-tr
DR   Wikidata; Q93329795
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C15-TR
AC   CVCL_XA51
SY   BAYER/BCIRL-SfNS-0624-C15; SfNS-0624-C15
DR   ICLDB; bayerbcirl-sfns-0624-c15-tr
DR   Wikidata; Q93329797
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C17-TR
AC   CVCL_C2UH
SY   SfNS-0624-C17
DR   ICLDB; bayerbcirl-sfns-0624-c17-tr
DR   Wikidata; Q114310678
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS-0624-C2-TR
AC   CVCL_XA44
SY   BAYER/BCIRL-SfNS-0624-C2; SfNS-0624-C2
DR   ICLDB; bayerbcirl-sfns-0624-c2-tr
DR   Wikidata; Q93329799
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C3-TR
AC   CVCL_XA45
SY   BAYER/BCIRL-SfNS-0624-C3; SfNS-0624-C3
DR   ICLDB; bayerbcirl-sfns-0624-c3-tr
DR   Wikidata; Q93329802
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C4-TR
AC   CVCL_C2UI
SY   SfNS-0624-C4
DR   ICLDB; bayerbcirl-sfns-0624-c4-tr
DR   Wikidata; Q114310679
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS-0624-C5-TR
AC   CVCL_XA46
SY   BAYER/BCIRL-SfNS-0624-C5; SfNS-0624-C5
DR   ICLDB; bayerbcirl-sfns-0624-c5-tr
DR   Wikidata; Q93329804
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C5a-TR
AC   CVCL_C2UJ
SY   SfNS-0624-C5a-TR
DR   ICLDB; bayerbcirl-sfns-0624-c5a-tr
DR   Wikidata; Q114310680
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA46 ! Bayer/BCIRL-SfNS-0624-C5-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS-0624-C6-TR
AC   CVCL_XA47
SY   BAYER/BCIRL-SfNS-0624-C6; SfNS-0624-C6
DR   ICLDB; bayerbcirl-sfns-0624-c6-tr
DR   Wikidata; Q93329806
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-C8-TR
AC   CVCL_XA48
SY   BAYER/BCIRL-SfNS-0624-C8; SfNS-0624-C8
DR   ICLDB; bayerbcirl-sfns-0624-c8-tr
DR   Wikidata; Q93329808
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA43 ! Bayer/BCIRL-SfNS-0624-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0624-TR
AC   CVCL_XA43
SY   BAYER/BCIRL-SfNS-0624-TR; SfNS-0624-TR
DR   ICLDB; bayerbcirl-sfns-0624-tr
DR   Wikidata; Q93329811
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 37.3 hours (Note=At 11th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS-0806-TR
AC   CVCL_XA62
SY   BAYER/BCIRL-SfNS-0806-TR; SfNS-0806-TR
DR   ICLDB; bayerbcirl-sfns-0806-tr
DR   Wikidata; Q93329813
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 67.0 hours (Note=At 41th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS1-0714-C34-TR
AC   CVCL_C2UC
SY   SfNS1-0714-C34
DR   ICLDB; bayerbcirl-sfns1-0714-c34-tr
DR   Wikidata; Q114310681
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA52 ! Bayer/BCIRL-SfNS1-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS1-0714-C36-TR
AC   CVCL_XA53
SY   BAYER/BCIRL-SfNS1-0714-C36; SfNS1-0714-C36
DR   ICLDB; bayerbcirl-sfns1-0714-c36-tr
DR   Wikidata; Q93329815
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA52 ! Bayer/BCIRL-SfNS1-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS1-0714-C37-TR
AC   CVCL_XA54
SY   BAYER/BCIRL-SfNS1-0714-C37; SfNS1-0714-C37
DR   ICLDB; bayerbcirl-sfns1-0714-c37-tr
DR   Wikidata; Q93329817
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA52 ! Bayer/BCIRL-SfNS1-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS1-0714-C38-TR
AC   CVCL_C2UB
SY   SfNS1-0714-C38
DR   ICLDB; bayerbcirl-sfns1-0714-c38-tr
DR   Wikidata; Q114310682
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA52 ! Bayer/BCIRL-SfNS1-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS1-0714-C40-TR
AC   CVCL_C2UA
SY   SfNS1-0714-C40
DR   ICLDB; bayerbcirl-sfns1-0714-c40-tr
DR   Wikidata; Q114310683
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA52 ! Bayer/BCIRL-SfNS1-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS1-0714-C46-TR
AC   CVCL_XA55
SY   BAYER/BCIRL-SfNS1-0714-C46; SfNS1-0714-C46
DR   ICLDB; bayerbcirl-sfns1-0714-c46-tr
DR   Wikidata; Q93329820
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA52 ! Bayer/BCIRL-SfNS1-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS1-0714-C46a-TR
AC   CVCL_C2U9
SY   SfNS1-0714-C46a
DR   ICLDB; bayerbcirl-sfns1-0714-c46a-tr
DR   Wikidata; Q114310684
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA55 ! Bayer/BCIRL-SfNS1-0714-C46-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS1-0714-C46c-TR
AC   CVCL_C2U8
SY   SfNS1-0714-C46c
DR   ICLDB; bayerbcirl-sfns1-0714-c46c-tr
DR   Wikidata; Q114310685
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA55 ! Bayer/BCIRL-SfNS1-0714-C46-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS1-0714-C47-TR
AC   CVCL_XA56
SY   BAYER/BCIRL-SfNS1-0714-C47; SfNS1-0714-C47
DR   ICLDB; bayerbcirl-sfns1-0714-c47-tr
DR   Wikidata; Q93329822
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA52 ! Bayer/BCIRL-SfNS1-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS1-0714-TR
AC   CVCL_XA52
SY   BAYER/BCIRL-SfNS1-0714-TR; SfNS1-0714-TR
DR   ICLDB; bayerbcirl-sfns1-0714-tr
DR   Wikidata; Q93329824
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 56.4 hours (Note=At 42th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   BAYER/BCIRL-SfNS1-0813-TR
AC   CVCL_XA63
SY   Bayer/BCIRL-SfNS1-0813-TR; SfNS1-0813-TR
DR   ICLDB; bayerbcirl-sfns1-0813-tr
DR   Wikidata; Q93329827
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 34.1 hours (Note=At 41th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS2-0714-C12-TR
AC   CVCL_XA58
SY   BAYER/BCIRL-SfNS2-0714-C12; SfNS2-0714-C12
DR   ICLDB; bayerbcirl-sfns2-0714-c12-tr
DR   Wikidata; Q93329829
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA57 ! Bayer/BCIRL-SfNS2-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS2-0714-C31-TR
AC   CVCL_XA59
SY   BAYER/BCIRL-SfNS2-0714-C31; SfNS2-0714-C31
DR   ICLDB; bayerbcirl-sfns2-0714-c31-tr
DR   Wikidata; Q93329831
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA57 ! Bayer/BCIRL-SfNS2-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS2-0714-C43-TR
AC   CVCL_XA60
SY   BAYER/BCIRL-SfNS2-0714-C43; SfNS2-0714-C43
DR   ICLDB; bayerbcirl-sfns2-0714-c43-tr
DR   Wikidata; Q93329833
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA57 ! Bayer/BCIRL-SfNS2-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS2-0714-C44-TR
AC   CVCL_XA61
SY   BAYER/BCIRL-SfNS2-0714-C44; SfNS2-0714-C44
DR   ICLDB; bayerbcirl-sfns2-0714-c44-tr
DR   Wikidata; Q93329835
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA57 ! Bayer/BCIRL-SfNS2-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS2-0714-C44b-TR
AC   CVCL_C2UE
SY   SfNS2-0714-C44b
DR   ICLDB; bayerbcirl-sfns2-0714-c44b-tr
DR   Wikidata; Q114310686
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA61 ! Bayer/BCIRL-SfNS2-0714-C44-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS2-0714-C48-TR
AC   CVCL_C2UD
SY   SfNS2-0714-C48
DR   ICLDB; bayerbcirl-sfns2-0714-c48-tr
DR   Wikidata; Q114310687
CC   Group: Insect cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_XA57 ! Bayer/BCIRL-SfNS2-0714-TR
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Bayer/BCIRL-SfNS2-0714-TR
AC   CVCL_XA57
SY   BAYER/BCIRL-SfNS2-0714-TR; SfNS2-0714-TR
DR   ICLDB; bayerbcirl-sfns2-0714-tr
DR   Wikidata; Q93329838
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 37.3 hours (Note=At 57th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS2-0813-TR
AC   CVCL_XA64
SY   BAYER/BCIRL-SfNS2-0813-TR; SfNS2-0813-TR
DR   ICLDB; bayerbcirl-sfns2-0813-tr
DR   Wikidata; Q93329841
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 46.4 hours (Note=At 58th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS2-0827-TR
AC   CVCL_XA65
SY   BAYER/BCIRL-SfNS2-0827-TR; SfNS2-0827-TR
DR   ICLDB; bayerbcirl-sfns2-0827-tr
DR   Wikidata; Q93329843
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 100.9 hours (Note=At 65th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS3-0827-TR
AC   CVCL_XA66
SY   BAYER/BCIRL-SfNS3-0827-TR; SfNS3-0827-TR
DR   ICLDB; bayerbcirl-sfns3-0827-trl
DR   Wikidata; Q93329845
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 141.1 hours (Note=At 58th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfNS4-0827-TR
AC   CVCL_XA67
SY   BAYER/BCIRL-SfNS4-0827-TR; SfNS4-0827-TR
DR   ICLDB; bayerbcirl-sfns4-0827-tr
DR   Wikidata; Q93329848
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 127.8 hours (Note=At 47th passage) (PubMed=31410641).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfTS-0331-CLG
AC   CVCL_XA68
SY   BAYER/BCIRL-SfTS-0331-CLG; SfTS-0331-CLG
DR   ICLDB; bayerbcirl-sfts-0331-clg
DR   Wikidata; Q93329850
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 75.6 hours (Note=At 59th passage) (PubMed=31410641).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfTS-0403-CLG
AC   CVCL_XA69
SY   BAYER/BCIRL-SfTS-0403-CLG; SfTS-0403-CLG
DR   ICLDB; bayerbcirl-sfts-0403-clg
DR   Wikidata; Q93329852
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 119.3 hours (Note=At 63th passage) (PubMed=31410641).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfTS-0624-TR
AC   CVCL_XA70
SY   BAYER/BCIRL-SfTS-0624-TR; SfTS-0624-TR
DR   ICLDB; bayerbcirl-sfts-0624-tr
DR   Wikidata; Q93329854
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 91.3 hours (Note=At 32th passage) (PubMed=31410641).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Bayer/BCIRL-SfTS2-0714-TR
AC   CVCL_XA71
SY   BAYER/BCIRL-SfTS2-0714-TR; SfTS2-0714-TR
DR   ICLDB; bcirl-sfts2-0714-tr
DR   Wikidata; Q93329857
RX   PubMed=31410641;
CC   Group: Insect cell line.
CC   Doubling time: 47.6 hours (Note=At 48th passage) (PubMed=31410641).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   BayGenomics ES cell line BGA185
AC   CVCL_LP71
SY   BGA185
DR   MMRRC; MMRRC:010000-UCD
DR   Wikidata; Q54753255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104517; Xrcc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA188
AC   CVCL_LP72
SY   BGA188
DR   MMRRC; MMRRC:010002-UCD
DR   Wikidata; Q54753258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384822; Ap1ar.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA206
AC   CVCL_LP73
SY   BGA206
DR   MMRRC; MMRRC:010008-UCD
DR   Wikidata; Q54753259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97791; Ptbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA212
AC   CVCL_LP74
SY   BGA212
DR   MMRRC; MMRRC:010010-UCD
DR   Wikidata; Q54753262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914852; Necap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA215
AC   CVCL_LP75
SY   BGA215
DR   MMRRC; MMRRC:010012-UCD
DR   Wikidata; Q54753264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA219
AC   CVCL_LP76
SY   BGA219
DR   MMRRC; MMRRC:010014-UCD
DR   Wikidata; Q54753265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA257
AC   CVCL_LP77
SY   BGA257
DR   MMRRC; MMRRC:010025-UCD
DR   Wikidata; Q54753267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96622; Itpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA258
AC   CVCL_LP78
SY   BGA258
DR   MMRRC; MMRRC:010026-UCD
DR   Wikidata; Q54753270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890169; Erbin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA276
AC   CVCL_LP79
SY   BGA276
DR   MMRRC; MMRRC:010030-UCD
DR   Wikidata; Q54753273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201670; Psmd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA287
AC   CVCL_LP80
SY   BGA287
DR   MMRRC; MMRRC:010033-UCD
DR   Wikidata; Q54753322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444236; Ubn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA299
AC   CVCL_LP81
SY   BGA299
DR   MMRRC; MMRRC:010038-UCD
DR   Wikidata; Q54753323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA302
AC   CVCL_LP82
SY   BGA302
DR   MMRRC; MMRRC:010040-UCD
DR   Wikidata; Q54753324
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA310
AC   CVCL_LP83
SY   BGA310
DR   MMRRC; MMRRC:010043-UCD
DR   Wikidata; Q54753326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328306; Orc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA318
AC   CVCL_LP84
SY   BGA318
DR   MMRRC; MMRRC:010045-UCD
DR   Wikidata; Q54753327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924933; Ehmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA332
AC   CVCL_LP85
SY   BGA332
DR   MMRRC; MMRRC:010051-UCD
DR   Wikidata; Q54753331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343135; Ndufs4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA340
AC   CVCL_LP86
SY   BGA340
DR   MMRRC; MMRRC:010055-UCD
DR   Wikidata; Q54753333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923723; Supt3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA341
AC   CVCL_LP87
SY   BGA341
DR   MMRRC; MMRRC:010056-UCD
DR   Wikidata; Q54753334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA350
AC   CVCL_LP88
SY   BGA350
DR   MMRRC; MMRRC:010062-UCD
DR   Wikidata; Q54753337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA355
AC   CVCL_LP89
SY   BGA355
DR   MMRRC; MMRRC:010065-UCD
DR   Wikidata; Q54753341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917057; Trim32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA391
AC   CVCL_LP90
SY   BGA391
DR   MMRRC; MMRRC:010076-UCD
DR   Wikidata; Q54753342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270849; Rps6kb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA395
AC   CVCL_LP91
SY   BGA395
DR   MMRRC; MMRRC:010078-UCD
DR   Wikidata; Q54753344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444236; Ubn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA407
AC   CVCL_LP92
SY   BGA407
DR   MMRRC; MMRRC:010085-UCD
DR   Wikidata; Q54753346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921453; Eif4enif1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA418
AC   CVCL_LP93
SY   BGA418
DR   MMRRC; MMRRC:010089-UCD
DR   Wikidata; Q54753348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA419
AC   CVCL_LP94
SY   BGA419
DR   MMRRC; MMRRC:010090-UCD
DR   Wikidata; Q54753349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA423
AC   CVCL_LP95
SY   BGA423
DR   MMRRC; MMRRC:010091-UCD
DR   Wikidata; Q54753351
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1195458; Abce1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA428
AC   CVCL_LP96
SY   BGA428
DR   MMRRC; MMRRC:010094-UCD
DR   Wikidata; Q54753352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88071; Arnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA434
AC   CVCL_LP97
SY   BGA434
DR   MMRRC; MMRRC:010096-UCD
DR   Wikidata; Q54753354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA465
AC   CVCL_LP98
SY   BGA465
DR   MMRRC; MMRRC:010105-UCD
DR   Wikidata; Q54753356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890494; Laptm4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA474
AC   CVCL_LP99
SY   BGA474
DR   MMRRC; MMRRC:010108-UCD
DR   Wikidata; Q54753359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342005; Mthfd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA493
AC   CVCL_LQ00
SY   BGA493
DR   MMRRC; MMRRC:010116-UCD
DR   Wikidata; Q54753361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA505
AC   CVCL_LQ01
SY   BGA505
DR   MMRRC; MMRRC:010121-UCD
DR   Wikidata; Q54753363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88192; Smarca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA510
AC   CVCL_LQ02
SY   BGA510
DR   MMRRC; MMRRC:010124-UCD
DR   Wikidata; Q54753364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916976; Smyd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA513
AC   CVCL_LQ03
SY   BGA513
DR   MMRRC; MMRRC:010127-UCD
DR   Wikidata; Q54753365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858330; Nxf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA514
AC   CVCL_LQ04
SY   BGA514
DR   MMRRC; MMRRC:010128-UCD
DR   Wikidata; Q54753366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97837; Qk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA523
AC   CVCL_LQ05
SY   BGA523
DR   MMRRC; MMRRC:010134-UCD
DR   Wikidata; Q54753368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA526
AC   CVCL_LQ06
SY   BGA526
DR   MMRRC; MMRRC:010135-UCD
DR   Wikidata; Q54753370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339639; Ogt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA534
AC   CVCL_LQ07
SY   BGA534
DR   MMRRC; MMRRC:010140-UCD
DR   Wikidata; Q54753371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88568; Cux1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA536
AC   CVCL_LQ08
SY   BGA536
DR   MMRRC; MMRRC:010141-UCD
DR   Wikidata; Q54753374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3647820; Hectd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA539
AC   CVCL_LQ09
SY   BGA539
DR   MMRRC; MMRRC:010144-UCD
DR   Wikidata; Q54753375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA543
AC   CVCL_LQ10
SY   BGA543
DR   MMRRC; MMRRC:010145-UCD
DR   Wikidata; Q54753377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349767; Polk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA544
AC   CVCL_LQ11
SY   BGA544
DR   MMRRC; MMRRC:010146-UCD
DR   Wikidata; Q54753379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA556
AC   CVCL_LQ12
SY   BGA556
DR   MMRRC; MMRRC:010151-UCD
DR   Wikidata; Q54753380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914838; Rnf41.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA558
AC   CVCL_LQ13
SY   BGA558
DR   MMRRC; MMRRC:010152-UCD
DR   Wikidata; Q54753383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915080; Rer1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA563
AC   CVCL_LQ14
SY   BGA563
DR   MMRRC; MMRRC:010154-UCD
DR   Wikidata; Q54753386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920977; Mcmbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA567
AC   CVCL_LQ15
SY   BGA567
DR   MMRRC; MMRRC:010156-UCD
DR   Wikidata; Q54753388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA575
AC   CVCL_LQ16
SY   BGA575
DR   MMRRC; MMRRC:010162-UCD
DR   Wikidata; Q54753390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA578
AC   CVCL_LQ17
SY   BGA578
DR   MMRRC; MMRRC:010163-UCD
DR   Wikidata; Q54753392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448542; Samd4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA585
AC   CVCL_LQ18
SY   BGA585
DR   MMRRC; MMRRC:010164-UCD
DR   Wikidata; Q54753394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183441; Psat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA613
AC   CVCL_LQ19
SY   BGA613
DR   MMRRC; MMRRC:010168-UCD
DR   Wikidata; Q54753395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443878; Slc4a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA626
AC   CVCL_LQ20
SY   BGA626
DR   MMRRC; MMRRC:010171-UCD
DR   Wikidata; Q54753448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGA637
AC   CVCL_LQ21
SY   BGA637
DR   MMRRC; MMRRC:010173-UCD
DR   Wikidata; Q54753450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919297; Ddx42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB001
AC   CVCL_LQ22
SY   BGB001
DR   MMRRC; MMRRC:010176-UCD
DR   Wikidata; Q54753452
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922867; Rps25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB002
AC   CVCL_LQ23
SY   BGB002
DR   MMRRC; MMRRC:010177-UCD
DR   Wikidata; Q54753453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB003
AC   CVCL_LQ24
SY   BGB003
DR   MMRRC; MMRRC:010178-UCD
DR   Wikidata; Q54753454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB005
AC   CVCL_LQ25
SY   BGB005
DR   MMRRC; MMRRC:010179-UCD
DR   Wikidata; Q54753458
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB007
AC   CVCL_LQ26
SY   BGB007
DR   MMRRC; MMRRC:010180-UCD
DR   Wikidata; Q54753460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341870; Stk11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB015
AC   CVCL_LQ27
SY   BGB015
DR   MMRRC; MMRRC:010182-UCD
DR   Wikidata; Q54753461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924039; Mzt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB038
AC   CVCL_LQ28
SY   BGB038
DR   MMRRC; MMRRC:010184-UCD
DR   Wikidata; Q54753462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861942; Gtf2ird1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB042
AC   CVCL_LQ29
SY   BGB042
DR   MMRRC; MMRRC:010185-UCD
DR   Wikidata; Q54753466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3644008; Ccdc85c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB066
AC   CVCL_LQ30
SY   BGB066
DR   MMRRC; MMRRC:010188-UCD
DR   Wikidata; Q54753468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB067
AC   CVCL_LQ31
SY   BGB067
DR   MMRRC; MMRRC:010189-UCD
DR   Wikidata; Q54753470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914587; Cstf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB068
AC   CVCL_LQ32
SY   BGB068
DR   MMRRC; MMRRC:010190-UCD
DR   Wikidata; Q54753471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450915; Sec23ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB069
AC   CVCL_LQ33
SY   BGB069
DR   MMRRC; MMRRC:010191-UCD
DR   Wikidata; Q54753475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97572; Phb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB070
AC   CVCL_LQ34
SY   BGB070
DR   MMRRC; MMRRC:010192-UCD
DR   Wikidata; Q54753477
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444453; Arhgef10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB076
AC   CVCL_LQ35
SY   BGB076
DR   MMRRC; MMRRC:010193-UCD
DR   Wikidata; Q54753479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB085
AC   CVCL_LQ36
SY   BGB085
DR   MMRRC; MMRRC:010194-UCD
DR   Wikidata; Q54753480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446089; Flnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB088
AC   CVCL_LQ37
SY   BGB088
DR   MMRRC; MMRRC:010195-UCD
DR   Wikidata; Q54753481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928277; Afg3l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB112
AC   CVCL_LQ38
SY   BGB112
DR   MMRRC; MMRRC:010196-UCD
DR   Wikidata; Q54753484
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922088; Naa15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB113
AC   CVCL_LQ39
SY   BGB113
DR   MMRRC; MMRRC:010197-UCD
DR   Wikidata; Q54753486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104889; Ubp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB116
AC   CVCL_LQ40
SY   BGB116
DR   MMRRC; MMRRC:010198-UCD
DR   Wikidata; Q54753488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB118
AC   CVCL_LQ41
SY   BGB118
DR   MMRRC; MMRRC:010199-UCD
DR   Wikidata; Q54753489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343085; Spop.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB123
AC   CVCL_LQ42
SY   BGB123
DR   MMRRC; MMRRC:010200-UCD
DR   Wikidata; Q54753492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928744; Vapb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB135
AC   CVCL_LQ43
SY   BGB135
DR   MMRRC; MMRRC:010202-UCD
DR   Wikidata; Q54753494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388633; Cltc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB147
AC   CVCL_LQ44
SY   BGB147
DR   MMRRC; MMRRC:010204-UCD
DR   Wikidata; Q54753496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888993; Api5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB158
AC   CVCL_LQ45
SY   BGB158
DR   MMRRC; MMRRC:010206-UCD
DR   Wikidata; Q54753497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929512; Litaf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB160
AC   CVCL_LQ46
SY   BGB160
DR   MMRRC; MMRRC:010208-UCD
DR   Wikidata; Q54753500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136841; Morc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB163
AC   CVCL_LQ47
SY   BGB163
DR   MMRRC; MMRRC:010209-UCD
DR   Wikidata; Q54753502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917758; Bbx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB186
AC   CVCL_LQ48
SY   BGB186
DR   MMRRC; MMRRC:010213-UCD
DR   Wikidata; Q54753503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924823; Vps33a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB191
AC   CVCL_LQ49
SY   BGB191
DR   MMRRC; MMRRC:010214-UCD
DR   Wikidata; Q54753506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914552; Zc3h13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB197
AC   CVCL_LQ50
SY   BGB197
DR   MMRRC; MMRRC:010215-UCD
DR   Wikidata; Q54753509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384933; Wrap53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB200
AC   CVCL_LQ51
SY   BGB200
DR   MMRRC; MMRRC:010217-UCD
DR   Wikidata; Q54753511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB201
AC   CVCL_LQ52
SY   BGB201
DR   MMRRC; MMRRC:010218-UCD
DR   Wikidata; Q54753513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915301; Nutf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB202
AC   CVCL_LQ53
SY   BGB202
DR   MMRRC; MMRRC:010219-UCD
DR   Wikidata; Q54753514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917678; Polr3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB273
AC   CVCL_LQ54
SY   BGB273
DR   MMRRC; MMRRC:010220-UCD
DR   Wikidata; Q54753516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB278
AC   CVCL_LQ55
SY   BGB278
DR   MMRRC; MMRRC:010221-UCD
DR   Wikidata; Q54753519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916013; 1110038B12Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB287
AC   CVCL_LQ56
SY   BGB287
DR   MMRRC; MMRRC:010224-UCD
DR   Wikidata; Q54753520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB306
AC   CVCL_LQ57
SY   BGB306
DR   MMRRC; MMRRC:010225-UCD
DR   Wikidata; Q54753521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926465; Hnrnpm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB307
AC   CVCL_LQ58
SY   BGB307
DR   MMRRC; MMRRC:010226-UCD
DR   Wikidata; Q54753524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99523; Prdx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB312
AC   CVCL_LQ59
SY   BGB312
DR   MMRRC; MMRRC:011129-UCD
DR   Wikidata; Q54753525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934031; Pi4k2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB318
AC   CVCL_LQ60
SY   BGB318
DR   MMRRC; MMRRC:010228-UCD
DR   Wikidata; Q54753579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3041235; Ska3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB338
AC   CVCL_LQ61
SY   BGB338
DR   MMRRC; MMRRC:010229-UCD
DR   Wikidata; Q54753582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106381; Nopchap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line BGB340
AC   CVCL_LQ62
SY   BGB340
DR   MMRRC; MMRRC:010230-UCD
DR   Wikidata; Q54753584
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915486; Gtsf1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB424
AC   CVCL_LQ63
SY   BGB424
DR   MMRRC; MMRRC:010330-UCD
DR   Wikidata; Q54753587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384560; Aars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB429
AC   CVCL_LQ64
SY   BGB429
DR   MMRRC; MMRRC:010331-UCD
DR   Wikidata; Q54753589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB472
AC   CVCL_LQ65
SY   BGB472
DR   MMRRC; MMRRC:010332-UCD
DR   Wikidata; Q54753590
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915031; Ilf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB482
AC   CVCL_LQ66
SY   BGB482
DR   MMRRC; MMRRC:010333-UCD
DR   Wikidata; Q54753592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590652; Txlng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB486
AC   CVCL_LQ67
SY   BGB486
DR   MMRRC; MMRRC:010334-UCD
DR   Wikidata; Q54753593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915031; Ilf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB500
AC   CVCL_LQ68
SY   BGB500
DR   MMRRC; MMRRC:010336-UCD
DR   Wikidata; Q54753595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915031; Ilf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB524
AC   CVCL_LQ69
SY   BGB524
DR   MMRRC; MMRRC:010338-UCD
DR   Wikidata; Q54753596
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB533
AC   CVCL_LQ70
SY   BGB533
DR   MMRRC; MMRRC:010341-UCD
DR   Wikidata; Q54753597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919837; Pan3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB541
AC   CVCL_LQ71
SY   BGB541
DR   MMRRC; MMRRC:010343-UCD
DR   Wikidata; Q54753599
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923998; Pbrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB544
AC   CVCL_LQ72
SY   BGB544
DR   MMRRC; MMRRC:010344-UCD
DR   Wikidata; Q54753601
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889364; Akirin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB551
AC   CVCL_LQ73
SY   BGB551
DR   MMRRC; MMRRC:010345-UCD
DR   Wikidata; Q54753602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919847; Auts2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB561
AC   CVCL_LQ74
SY   BGB561
DR   MMRRC; MMRRC:010347-UCD
DR   Wikidata; Q54753604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444008; Bptf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB581
AC   CVCL_LQ75
SY   BGB581
DR   MMRRC; MMRRC:010349-UCD
DR   Wikidata; Q54753607
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108088; Gab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB599
AC   CVCL_LQ76
SY   BGB599
DR   MMRRC; MMRRC:010351-UCD
DR   Wikidata; Q54753609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106442; Vkorc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB615
AC   CVCL_LQ77
SY   BGB615
DR   MMRRC; MMRRC:010354-UCD
DR   Wikidata; Q54753611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202301; Itch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGB654
AC   CVCL_LQ78
SY   BGB654
DR   MMRRC; MMRRC:010357-UCD
DR   Wikidata; Q54753613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443079; Klhl26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC001
AC   CVCL_LQ79
SY   BGC001
DR   MMRRC; MMRRC:011020-UCD
DR   Wikidata; Q54753614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859162; Rnf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC020
AC   CVCL_LQ80
SY   BGC020
DR   MMRRC; MMRRC:011025-UCD
DR   Wikidata; Q54753616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924203; Emsy.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC030
AC   CVCL_LQ81
SY   BGC030
DR   MMRRC; MMRRC:011026-UCD
DR   Wikidata; Q54753618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC099
AC   CVCL_LQ82
SY   BGC099
DR   MMRRC; MMRRC:011027-UCD
DR   Wikidata; Q54753619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385184; Ahcyl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC102
AC   CVCL_LQ83
SY   BGC102
DR   MMRRC; MMRRC:011028-UCD
DR   Wikidata; Q54753621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87860; Abl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC110
AC   CVCL_LQ84
SY   BGC110
DR   MMRRC; MMRRC:011030-UCD
DR   Wikidata; Q54753623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144566; Tsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC125
AC   CVCL_LQ85
SY   BGC125
DR   MMRRC; MMRRC:011033-UCD
DR   Wikidata; Q54753626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685387; Atp13a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC132
AC   CVCL_LQ86
SY   BGC132
DR   MMRRC; MMRRC:011034-UCD
DR   Wikidata; Q54753628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446126; Phf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC147
AC   CVCL_LQ87
SY   BGC147
DR   MMRRC; MMRRC:011035-UCD
DR   Wikidata; Q54753630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925953; Zfp972.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC165
AC   CVCL_LQ88
SY   BGC165
DR   MMRRC; MMRRC:011036-UCD
DR   Wikidata; Q54753631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC167
AC   CVCL_LQ89
SY   BGC167
DR   MMRRC; MMRRC:011037-UCD
DR   Wikidata; Q54753633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96952; Mdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC171
AC   CVCL_LQ90
SY   BGC171
DR   MMRRC; MMRRC:011038-UCD
DR   Wikidata; Q54753635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC356
AC   CVCL_LQ91
SY   BGC356
DR   MMRRC; MMRRC:011042-UCD
DR   Wikidata; Q54753637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC367
AC   CVCL_LQ92
SY   BGC367
DR   MMRRC; MMRRC:011043-UCD
DR   Wikidata; Q54753638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC377
AC   CVCL_LQ93
SY   BGC377
DR   MMRRC; MMRRC:011044-UCD
DR   Wikidata; Q54753642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914339; Psmc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC378
AC   CVCL_LQ94
SY   BGC378
DR   MMRRC; MMRRC:011045-UCD
DR   Wikidata; Q54753644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC379
AC   CVCL_LQ95
SY   BGC379
DR   MMRRC; MMRRC:011046-UCD
DR   Wikidata; Q54753645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC380
AC   CVCL_LQ96
SY   BGC380
DR   MMRRC; MMRRC:011047-UCD
DR   Wikidata; Q54753647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC386
AC   CVCL_LQ97
SY   BGC386
DR   MMRRC; MMRRC:011048-UCD
DR   Wikidata; Q54753648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC388
AC   CVCL_LQ98
SY   BGC388
DR   MMRRC; MMRRC:011049-UCD
DR   Wikidata; Q54753650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349722; Pabpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC389
AC   CVCL_LQ99
SY   BGC389
DR   MMRRC; MMRRC:011050-UCD
DR   Wikidata; Q54753652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913435; Virma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC390
AC   CVCL_LR00
SY   BGC390
DR   MMRRC; MMRRC:011051-UCD
DR   Wikidata; Q54753743
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108087; Hars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC393
AC   CVCL_LR01
SY   BGC393
DR   MMRRC; MMRRC:011052-UCD
DR   Wikidata; Q54753745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342005; Mthfd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC397
AC   CVCL_LR02
SY   BGC397
DR   MMRRC; MMRRC:011053-UCD
DR   Wikidata; Q54753747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC400
AC   CVCL_LR03
SY   BGC400
DR   MMRRC; MMRRC:011055-UCD
DR   Wikidata; Q54753749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915010; Slc38a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC410
AC   CVCL_LR04
SY   BGC410
DR   MMRRC; MMRRC:011058-UCD
DR   Wikidata; Q54753753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC411
AC   CVCL_LR05
SY   BGC411
DR   MMRRC; MMRRC:011059-UCD
DR   Wikidata; Q54753755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC413
AC   CVCL_LR06
SY   BGC413
DR   MMRRC; MMRRC:011060-UCD
DR   Wikidata; Q54753757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC417
AC   CVCL_LR07
SY   BGC417
DR   MMRRC; MMRRC:011061-UCD
DR   Wikidata; Q54753760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC420
AC   CVCL_LR08
SY   BGC420
DR   MMRRC; MMRRC:011062-UCD
DR   Wikidata; Q54753762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC424
AC   CVCL_LR09
SY   BGC424
DR   MMRRC; MMRRC:011065-UCD
DR   Wikidata; Q54753764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101920; Ap2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC425
AC   CVCL_LR10
SY   BGC425
DR   MMRRC; MMRRC:011066-UCD
DR   Wikidata; Q54753765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC428
AC   CVCL_LR11
SY   BGC428
DR   MMRRC; MMRRC:011067-UCD
DR   Wikidata; Q54753766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC434
AC   CVCL_LR12
SY   BGC434
DR   MMRRC; MMRRC:011072-UCD
DR   Wikidata; Q54753768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC435
AC   CVCL_LR13
SY   BGC435
DR   MMRRC; MMRRC:011073-UCD
DR   Wikidata; Q54753771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC456
AC   CVCL_LR14
SY   BGC456
DR   MMRRC; MMRRC:011078-UCD
DR   Wikidata; Q54753772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153049; Klf16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC458
AC   CVCL_LR15
SY   BGC458
DR   MMRRC; MMRRC:011079-UCD
DR   Wikidata; Q54753775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC459
AC   CVCL_LR16
SY   BGC459
DR   MMRRC; MMRRC:011080-UCD
DR   Wikidata; Q54753777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC464
AC   CVCL_LR17
SY   BGC464
DR   MMRRC; MMRRC:011082-UCD
DR   Wikidata; Q54753778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339795; Smc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC468
AC   CVCL_LR18
SY   BGC468
DR   MMRRC; MMRRC:011084-UCD
DR   Wikidata; Q54753781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891925; Hnrnph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC474
AC   CVCL_LR19
SY   BGC474
DR   MMRRC; MMRRC:011085-UCD
DR   Wikidata; Q54753783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC479
AC   CVCL_LR20
SY   BGC479
DR   MMRRC; MMRRC:011086-UCD
DR   Wikidata; Q54753786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151172; Mta3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC482
AC   CVCL_LR21
SY   BGC482
DR   MMRRC; MMRRC:011088-UCD
DR   Wikidata; Q54753789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914290; Ddx17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC483
AC   CVCL_LR22
SY   BGC483
DR   MMRRC; MMRRC:011089-UCD
DR   Wikidata; Q54753790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99173; Zfp26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC485
AC   CVCL_LR23
SY   BGC485
DR   MMRRC; MMRRC:011090-UCD
DR   Wikidata; Q54753791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95281; Ect2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC487
AC   CVCL_LR24
SY   BGC487
DR   MMRRC; MMRRC:011091-UCD
DR   Wikidata; Q54753793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159711; Usp33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC489
AC   CVCL_LR25
SY   BGC489
DR   MMRRC; MMRRC:011092-UCD
DR   Wikidata; Q54753795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC500
AC   CVCL_LR26
SY   BGC500
DR   MMRRC; MMRRC:011093-UCD
DR   Wikidata; Q54753797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108088; Gab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC518
AC   CVCL_LR27
SY   BGC518
DR   MMRRC; MMRRC:011097-UCD
DR   Wikidata; Q54753799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915403; Gtf2e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC520
AC   CVCL_LR28
SY   BGC520
DR   MMRRC; MMRRC:011098-UCD
DR   Wikidata; Q54753801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105926; Rab5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC522
AC   CVCL_LR29
SY   BGC522
DR   MMRRC; MMRRC:011099-UCD
DR   Wikidata; Q54753802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99523; Prdx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line BGC532
AC   CVCL_LR30
SY   BGC532
DR   MMRRC; MMRRC:011102-UCD
DR   Wikidata; Q54753803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA003
AC   CVCL_LR31
SY   CSA003
DR   MMRRC; MMRRC:012058-UCD
DR   Wikidata; Q54753807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA004
AC   CVCL_LR32
SY   CSA004
DR   MMRRC; MMRRC:012059-UCD
DR   Wikidata; Q54753809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143886; Dot1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA005
AC   CVCL_LR33
SY   CSA005
DR   MMRRC; MMRRC:012060-UCD
DR   Wikidata; Q54753810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97346; Nktr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA006
AC   CVCL_LR34
SY   CSA006
DR   MMRRC; MMRRC:012061-UCD
DR   Wikidata; Q54753813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA007
AC   CVCL_LR35
SY   CSA007
DR   MMRRC; MMRRC:012062-UCD
DR   Wikidata; Q54753814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA008
AC   CVCL_LR36
SY   CSA008
DR   MMRRC; MMRRC:012063-UCD
DR   Wikidata; Q54753817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA012
AC   CVCL_LR37
SY   CSA012
DR   MMRRC; MMRRC:012064-UCD
DR   Wikidata; Q54753820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88031; Anxa7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA014
AC   CVCL_LR38
SY   CSA014
DR   MMRRC; MMRRC:012066-UCD
DR   Wikidata; Q54753822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443564; Ambra1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA015
AC   CVCL_LR39
SY   CSA015
DR   MMRRC; MMRRC:012067-UCD
DR   Wikidata; Q54753824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA017
AC   CVCL_LR40
SY   CSA017
DR   MMRRC; MMRRC:012068-UCD
DR   Wikidata; Q54753926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA019
AC   CVCL_LR41
SY   CSA019
DR   MMRRC; MMRRC:012070-UCD
DR   Wikidata; Q54753928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA021
AC   CVCL_LR42
SY   CSA021
DR   MMRRC; MMRRC:012072-UCD
DR   Wikidata; Q54753930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343297; Drg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA022
AC   CVCL_LR43
SY   CSA022
DR   MMRRC; MMRRC:012073-UCD
DR   Wikidata; Q54753932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922855; Kdm5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA023
AC   CVCL_LR44
SY   CSA023
DR   MMRRC; MMRRC:012074-UCD
DR   Wikidata; Q54753934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917140; Zfp219.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA024
AC   CVCL_LR45
SY   CSA024
DR   MMRRC; MMRRC:012075-UCD
DR   Wikidata; Q54753936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA025
AC   CVCL_LR46
SY   CSA025
DR   MMRRC; MMRRC:012076-UCD
DR   Wikidata; Q54753939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99523; Prdx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA026
AC   CVCL_LR47
SY   CSA026
DR   MMRRC; MMRRC:012077-UCD
DR   Wikidata; Q54753940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913815; Zkscan8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA029
AC   CVCL_LR48
SY   CSA029
DR   MMRRC; MMRRC:012079-UCD
DR   Wikidata; Q54753941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917689; Taf15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA032
AC   CVCL_LR49
SY   CSA032
DR   MMRRC; MMRRC:012080-UCD
DR   Wikidata; Q54753943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922832; Relch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSA035
AC   CVCL_LR50
SY   CSA035
DR   MMRRC; MMRRC:012082-UCD
DR   Wikidata; Q54753944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858415; Ddx20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA036
AC   CVCL_LR51
SY   CSA036
DR   MMRRC; MMRRC:012083-UCD
DR   Wikidata; Q54753945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95654; Gart.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA038
AC   CVCL_LR52
SY   CSA038
DR   MMRRC; MMRRC:012084-UCD
DR   Wikidata; Q54753946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448506; Pi4ka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA039
AC   CVCL_LR53
SY   CSA039
DR   MMRRC; MMRRC:012085-UCD
DR   Wikidata; Q54753948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330281; Cd2ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA041
AC   CVCL_LR54
SY   CSA041
DR   MMRRC; MMRRC:012086-UCD
DR   Wikidata; Q54753950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109336; Etv6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA046
AC   CVCL_LR55
SY   CSA046
DR   MMRRC; MMRRC:012088-UCD
DR   Wikidata; Q54753953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924270; Atl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA047
AC   CVCL_LR56
SY   CSA047
DR   MMRRC; MMRRC:012089-UCD
DR   Wikidata; Q54753954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202880; Traf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA048
AC   CVCL_LR57
SY   CSA048
DR   MMRRC; MMRRC:012090-UCD
DR   Wikidata; Q54753956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443858; Pcif1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA049
AC   CVCL_LR58
SY   CSA049
DR   MMRRC; MMRRC:012091-UCD
DR   Wikidata; Q54753959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354723; Pnpla6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA050
AC   CVCL_LR59
SY   CSA050
DR   MMRRC; MMRRC:012092-UCD
DR   Wikidata; Q54753960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA051
AC   CVCL_LR60
SY   CSA051
DR   MMRRC; MMRRC:012093-UCD
DR   Wikidata; Q54753961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385621; Nup153.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA055
AC   CVCL_LR61
SY   CSA055
DR   MMRRC; MMRRC:012094-UCD
DR   Wikidata; Q54753965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88251; Calm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA056
AC   CVCL_LR62
SY   CSA056
DR   MMRRC; MMRRC:012095-UCD
DR   Wikidata; Q54753967
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918972; Cic.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA057
AC   CVCL_LR63
SY   CSA057
DR   MMRRC; MMRRC:012096-UCD
DR   Wikidata; Q54753969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443858; Pcif1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA058
AC   CVCL_LR64
SY   CSA058
DR   MMRRC; MMRRC:012097-UCD
DR   Wikidata; Q54753972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277223; Atxn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA060
AC   CVCL_LR65
SY   CSA060
DR   MMRRC; MMRRC:012098-UCD
DR   Wikidata; Q54753974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925123; Zbtb44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA064
AC   CVCL_LR66
SY   CSA064
DR   MMRRC; MMRRC:012099-UCD
DR   Wikidata; Q54753976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105369; Cbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA066
AC   CVCL_LR67
SY   CSA066
DR   MMRRC; MMRRC:012100-UCD
DR   Wikidata; Q54753979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88251; Calm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA074
AC   CVCL_LR68
SY   CSA074
DR   MMRRC; MMRRC:012102-UCD
DR   Wikidata; Q54753981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105037; Ddx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA075
AC   CVCL_LR69
SY   CSA075
DR   MMRRC; MMRRC:012103-UCD
DR   Wikidata; Q54753983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918049; Cep192.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA077
AC   CVCL_LR70
SY   CSA077
DR   MMRRC; MMRRC:012104-UCD
DR   Wikidata; Q54753986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2660884; Csnk1g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA078
AC   CVCL_LR71
SY   CSA078
DR   MMRRC; MMRRC:012105-UCD
DR   Wikidata; Q54753989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2660884; Csnk1g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA080
AC   CVCL_LR72
SY   CSA080
DR   MMRRC; MMRRC:012107-UCD
DR   Wikidata; Q54753992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921802; Nipal3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA082
AC   CVCL_LR73
SY   CSA082
DR   MMRRC; MMRRC:012108-UCD
DR   Wikidata; Q54753995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103012; E2f4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA085
AC   CVCL_LR74
SY   CSA085
DR   MMRRC; MMRRC:012110-UCD
DR   Wikidata; Q54753999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178598; Bloc1s5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA086
AC   CVCL_LR75
SY   CSA086
DR   MMRRC; MMRRC:012111-UCD
DR   Wikidata; Q54754002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA089
AC   CVCL_LR76
SY   CSA089
DR   MMRRC; MMRRC:012112-UCD
DR   Wikidata; Q54754004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA092
AC   CVCL_LR77
SY   CSA092
DR   MMRRC; MMRRC:012113-UCD
DR   Wikidata; Q54754006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98858; Psmd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA098
AC   CVCL_LR78
SY   CSA098
DR   MMRRC; MMRRC:012115-UCD
DR   Wikidata; Q54754008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346072; Psmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA100
AC   CVCL_LR79
SY   CSA100
DR   MMRRC; MMRRC:012116-UCD
DR   Wikidata; Q54754010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144585; Slc16a6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA101
AC   CVCL_LR80
SY   CSA101
DR   MMRRC; MMRRC:012117-UCD
DR   Wikidata; Q54754059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918972; Cic.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA105
AC   CVCL_LR81
SY   CSA105
DR   MMRRC; MMRRC:012118-UCD
DR   Wikidata; Q54754061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA106
AC   CVCL_LR82
SY   CSA106
DR   MMRRC; MMRRC:012119-UCD
DR   Wikidata; Q54754063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444639; Fbxo38.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA107
AC   CVCL_LR83
SY   CSA107
DR   MMRRC; MMRRC:012120-UCD
DR   Wikidata; Q54754066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103263; Mcf2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA108
AC   CVCL_LR84
SY   CSA108
DR   MMRRC; MMRRC:012121-UCD
DR   Wikidata; Q54754070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329038; Mllt10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA109
AC   CVCL_LR85
SY   CSA109
DR   MMRRC; MMRRC:012122-UCD
DR   Wikidata; Q54754072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146350; Scaf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA111
AC   CVCL_LR86
SY   CSA111
DR   MMRRC; MMRRC:012123-UCD
DR   Wikidata; Q54754076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450151; Cog3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA119
AC   CVCL_LR87
SY   CSA119
DR   MMRRC; MMRRC:012126-UCD
DR   Wikidata; Q54754077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA121
AC   CVCL_LR88
SY   CSA121
DR   MMRRC; MMRRC:012127-UCD
DR   Wikidata; Q54754079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA122
AC   CVCL_LR89
SY   CSA122
DR   MMRRC; MMRRC:012128-UCD
DR   Wikidata; Q54754082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098275; Gse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA124
AC   CVCL_LR90
SY   CSA124
DR   MMRRC; MMRRC:012129-UCD
DR   Wikidata; Q54754084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106281; Ilrun.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSA125
AC   CVCL_LR91
SY   CSA125
DR   MMRRC; MMRRC:012130-UCD
DR   Wikidata; Q54754087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109301; Papola.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA128
AC   CVCL_LR92
SY   CSA128
DR   MMRRC; MMRRC:012132-UCD
DR   Wikidata; Q54754089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109602; Gphn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA130
AC   CVCL_LR93
SY   CSA130
DR   MMRRC; MMRRC:012134-UCD
DR   Wikidata; Q54754091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA131
AC   CVCL_LR94
SY   CSA131
DR   MMRRC; MMRRC:012135-UCD
DR   Wikidata; Q54754093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA140
AC   CVCL_LR95
SY   CSA140
DR   MMRRC; MMRRC:012139-UCD
DR   Wikidata; Q54754094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925953; Zfp972.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA141
AC   CVCL_LR96
SY   CSA141
DR   MMRRC; MMRRC:012140-UCD
DR   Wikidata; Q54754097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328328; Map7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA142
AC   CVCL_LR97
SY   CSA142
DR   MMRRC; MMRRC:012141-UCD
DR   Wikidata; Q54754100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA143
AC   CVCL_LR98
SY   CSA143
DR   MMRRC; MMRRC:012142-UCD
DR   Wikidata; Q54754101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202301; Itch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA145
AC   CVCL_LR99
SY   CSA145
DR   MMRRC; MMRRC:012144-UCD
DR   Wikidata; Q54754104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913208; Carm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA146
AC   CVCL_LS00
SY   CSA146
DR   MMRRC; MMRRC:012145-UCD
DR   Wikidata; Q54754105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354946; Mapk6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA148
AC   CVCL_LS01
SY   CSA148
DR   MMRRC; MMRRC:012147-UCD
DR   Wikidata; Q54754109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA151
AC   CVCL_LS02
SY   CSA151
DR   MMRRC; MMRRC:012149-UCD
DR   Wikidata; Q54754112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2686934; Zfhx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA153
AC   CVCL_LS03
SY   CSA153
DR   MMRRC; MMRRC:012151-UCD
DR   Wikidata; Q54754113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144724; Ttc7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA155
AC   CVCL_LS04
SY   CSA155
DR   MMRRC; MMRRC:012153-UCD
DR   Wikidata; Q54754116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA161
AC   CVCL_LS05
SY   CSA161
DR   MMRRC; MMRRC:012154-UCD
DR   Wikidata; Q54754117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443226; Pde12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA164
AC   CVCL_LS06
SY   CSA164
DR   MMRRC; MMRRC:012156-UCD
DR   Wikidata; Q54754120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA168
AC   CVCL_LS07
SY   CSA168
DR   MMRRC; MMRRC:012157-UCD
DR   Wikidata; Q54754121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97856; Rara.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA169
AC   CVCL_LS08
SY   CSA169
DR   MMRRC; MMRRC:012158-UCD
DR   Wikidata; Q54754124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920977; Mcmbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA170
AC   CVCL_LS09
SY   CSA170
DR   MMRRC; MMRRC:012159-UCD
DR   Wikidata; Q54754127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSA171
AC   CVCL_LS10
SY   CSA171
DR   MMRRC; MMRRC:012160-UCD
DR   Wikidata; Q54754129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181074; Acbd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSB001
AC   CVCL_LS11
SY   CSB001
DR   MMRRC; MMRRC:012163-UCD
DR   Wikidata; Q54754131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917579; Gon4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC002
AC   CVCL_LS12
SY   CSC002
DR   MMRRC; MMRRC:012164-UCD
DR   Wikidata; Q54754132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859026; Cnot4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC003
AC   CVCL_LS13
SY   CSC003
DR   MMRRC; MMRRC:012165-UCD
DR   Wikidata; Q54754134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107926; Rock2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC004
AC   CVCL_LS14
SY   CSC004
DR   MMRRC; MMRRC:012166-UCD
DR   Wikidata; Q54754135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC006
AC   CVCL_LS15
SY   CSC006
DR   MMRRC; MMRRC:012167-UCD
DR   Wikidata; Q54754139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915512; Agpat4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC007
AC   CVCL_LS16
SY   CSC007
DR   MMRRC; MMRRC:012168-UCD
DR   Wikidata; Q54754141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920997; Shld1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSC010
AC   CVCL_LS17
SY   CSC010
DR   MMRRC; MMRRC:012171-UCD
DR   Wikidata; Q54754143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC011
AC   CVCL_LS18
SY   CSC011
DR   MMRRC; MMRRC:012172-UCD
DR   Wikidata; Q54754146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914309; Ola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC012
AC   CVCL_LS19
SY   CSC012
DR   MMRRC; MMRRC:012173-UCD
DR   Wikidata; Q54754149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351455; Rpl13a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC014
AC   CVCL_LS20
SY   CSC014
DR   MMRRC; MMRRC:012174-UCD
DR   Wikidata; Q54754199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682305; Rsf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC017
AC   CVCL_LS21
SY   CSC017
DR   MMRRC; MMRRC:012177-UCD
DR   Wikidata; Q54754202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103147; Dync1h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC018
AC   CVCL_LS22
SY   CSC018
DR   MMRRC; MMRRC:012178-UCD
DR   Wikidata; Q54754203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915512; Agpat4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC020
AC   CVCL_LS23
SY   CSC020
DR   MMRRC; MMRRC:012179-UCD
DR   Wikidata; Q54754204
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926465; Hnrnpm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC025
AC   CVCL_LS24
SY   CSC025
DR   MMRRC; MMRRC:012184-UCD
DR   Wikidata; Q54754207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684894; Nhs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC027
AC   CVCL_LS25
SY   CSC027
DR   MMRRC; MMRRC:012186-UCD
DR   Wikidata; Q54754209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643401; Gm8935.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC028
AC   CVCL_LS26
SY   CSC028
DR   MMRRC; MMRRC:012187-UCD
DR   Wikidata; Q54754213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136825; N4bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC031
AC   CVCL_LS27
SY   CSC031
DR   MMRRC; MMRRC:012189-UCD
DR   Wikidata; Q54754214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914345; Trak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC032
AC   CVCL_LS28
SY   CSC032
DR   MMRRC; MMRRC:012190-UCD
DR   Wikidata; Q54754216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351655; Shroom3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC038
AC   CVCL_LS29
SY   CSC038
DR   MMRRC; MMRRC:012191-UCD
DR   Wikidata; Q54754218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888697; Taf9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC043
AC   CVCL_LS30
SY   CSC043
DR   MMRRC; MMRRC:012194-UCD
DR   Wikidata; Q54754220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914869; Nob1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC044
AC   CVCL_LS31
SY   CSC044
DR   MMRRC; MMRRC:012195-UCD
DR   Wikidata; Q54754221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97874; Rb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC047
AC   CVCL_LS32
SY   CSC047
DR   MMRRC; MMRRC:012196-UCD
DR   Wikidata; Q54754223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916043; Rab3gap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC049
AC   CVCL_LS33
SY   CSC049
DR   MMRRC; MMRRC:012197-UCD
DR   Wikidata; Q54754224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443304; Map1s.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC051
AC   CVCL_LS34
SY   CSC051
DR   MMRRC; MMRRC:012199-UCD
DR   Wikidata; Q54754227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3051596; Znhit3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC055
AC   CVCL_LS35
SY   CSC055
DR   MMRRC; MMRRC:012201-UCD
DR   Wikidata; Q54754229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933947; Rtn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC063
AC   CVCL_LS36
SY   CSC063
DR   MMRRC; MMRRC:012203-UCD
DR   Wikidata; Q54754230
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103147; Dync1h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC064
AC   CVCL_LS37
SY   CSC064
DR   MMRRC; MMRRC:012204-UCD
DR   Wikidata; Q54754231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC069
AC   CVCL_LS38
SY   CSC069
DR   MMRRC; MMRRC:012205-UCD
DR   Wikidata; Q54754232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441842; Serinc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC076
AC   CVCL_LS39
SY   CSC076
DR   MMRRC; MMRRC:012207-UCD
DR   Wikidata; Q54754236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC085
AC   CVCL_LS40
SY   CSC085
DR   MMRRC; MMRRC:012210-UCD
DR   Wikidata; Q54754237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921802; Nipal3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC086
AC   CVCL_LS41
SY   CSC086
DR   MMRRC; MMRRC:012211-UCD
DR   Wikidata; Q54754239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343135; Ndufs4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC090
AC   CVCL_LS42
SY   CSC090
DR   MMRRC; MMRRC:012213-UCD
DR   Wikidata; Q54754242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99470; Dnajc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC093
AC   CVCL_LS43
SY   CSC093
DR   MMRRC; MMRRC:012214-UCD
DR   Wikidata; Q54754243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109301; Papola.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC099
AC   CVCL_LS44
SY   CSC099
DR   MMRRC; MMRRC:012215-UCD
DR   Wikidata; Q54754244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353593; Lcmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC100
AC   CVCL_LS45
SY   CSC100
DR   MMRRC; MMRRC:012216-UCD
DR   Wikidata; Q54754247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353593; Lcmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC104
AC   CVCL_LS46
SY   CSC104
DR   MMRRC; MMRRC:012218-UCD
DR   Wikidata; Q54754249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913667; Mat2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC117
AC   CVCL_LS47
SY   CSC117
DR   MMRRC; MMRRC:012223-UCD
DR   Wikidata; Q54754252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914736; Polr3g.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC119
AC   CVCL_LS48
SY   CSC119
DR   MMRRC; MMRRC:012224-UCD
DR   Wikidata; Q54754256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC120
AC   CVCL_LS49
SY   CSC120
DR   MMRRC; MMRRC:012225-UCD
DR   Wikidata; Q54754259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC121
AC   CVCL_LS50
SY   CSC121
DR   MMRRC; MMRRC:012226-UCD
DR   Wikidata; Q54754262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139135; Anapc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC123
AC   CVCL_LS51
SY   CSC123
DR   MMRRC; MMRRC:012228-UCD
DR   Wikidata; Q54754263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913963; Actr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC127
AC   CVCL_LS52
SY   CSC127
DR   MMRRC; MMRRC:012230-UCD
DR   Wikidata; Q54754267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97495; Pbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC128
AC   CVCL_LS53
SY   CSC128
DR   MMRRC; MMRRC:012231-UCD
DR   Wikidata; Q54754270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890773; Actn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC130
AC   CVCL_LS54
SY   CSC130
DR   MMRRC; MMRRC:012232-UCD
DR   Wikidata; Q54754271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC132
AC   CVCL_LS55
SY   CSC132
DR   MMRRC; MMRRC:012234-UCD
DR   Wikidata; Q54754273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC146
AC   CVCL_LS56
SY   CSC146
DR   MMRRC; MMRRC:012238-UCD
DR   Wikidata; Q54754277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861942; Gtf2ird1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC152
AC   CVCL_LS57
SY   CSC152
DR   MMRRC; MMRRC:012241-UCD
DR   Wikidata; Q54754280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921570; Wdr33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC156
AC   CVCL_LS58
SY   CSC156
DR   MMRRC; MMRRC:012242-UCD
DR   Wikidata; Q54754284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC159
AC   CVCL_LS59
SY   CSC159
DR   MMRRC; MMRRC:012243-UCD
DR   Wikidata; Q54754285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343135; Ndufs4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC160
AC   CVCL_LS60
SY   CSC160
DR   MMRRC; MMRRC:012244-UCD
DR   Wikidata; Q54754332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343135; Ndufs4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC165
AC   CVCL_LS61
SY   CSC165
DR   MMRRC; MMRRC:012246-UCD
DR   Wikidata; Q54754334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88039; Apc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC167
AC   CVCL_LS62
SY   CSC167
DR   MMRRC; MMRRC:012248-UCD
DR   Wikidata; Q54754337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2652875; Wnk3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC168
AC   CVCL_LS63
SY   CSC168
DR   MMRRC; MMRRC:012249-UCD
DR   Wikidata; Q54754340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3702875; Gm14325.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC171
AC   CVCL_LS64
SY   CSC171
DR   MMRRC; MMRRC:012250-UCD
DR   Wikidata; Q54754342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC172
AC   CVCL_LS65
SY   CSC172
DR   MMRRC; MMRRC:012251-UCD
DR   Wikidata; Q54754343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343135; Ndufs4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC175
AC   CVCL_LS66
SY   CSC175
DR   MMRRC; MMRRC:012253-UCD
DR   Wikidata; Q54754346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC180
AC   CVCL_LS67
SY   CSC180
DR   MMRRC; MMRRC:012255-UCD
DR   Wikidata; Q54754348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914869; Nob1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC182
AC   CVCL_LS68
SY   CSC182
DR   MMRRC; MMRRC:012256-UCD
DR   Wikidata; Q54754349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333855; Atox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSC183
AC   CVCL_LS69
SY   CSC183
DR   MMRRC; MMRRC:012257-UCD
DR   Wikidata; Q54754354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347095; Adgre5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD001
AC   CVCL_LS70
SY   CSD001
DR   MMRRC; MMRRC:012588-UCD
DR   Wikidata; Q54754356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045362; 1600029O15Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD006
AC   CVCL_LS71
SY   CSD006
DR   MMRRC; MMRRC:012589-UCD
DR   Wikidata; Q54754359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD015
AC   CVCL_LS72
SY   CSD015
DR   MMRRC; MMRRC:012592-UCD
DR   Wikidata; Q54754361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100865; Rbm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD016
AC   CVCL_LS73
SY   CSD016
DR   MMRRC; MMRRC:012593-UCD
DR   Wikidata; Q54754362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384589; Herc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD018
AC   CVCL_LS74
SY   CSD018
DR   MMRRC; MMRRC:012594-UCD
DR   Wikidata; Q54754365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD019
AC   CVCL_LS75
SY   CSD019
DR   MMRRC; MMRRC:012595-UCD
DR   Wikidata; Q54754367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353593; Lcmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD020
AC   CVCL_LS76
SY   CSD020
DR   MMRRC; MMRRC:012596-UCD
DR   Wikidata; Q54754368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353593; Lcmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD021
AC   CVCL_LS77
SY   CSD021
DR   MMRRC; MMRRC:012597-UCD
DR   Wikidata; Q54754370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450166; Arhgap32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD022
AC   CVCL_LS78
SY   CSD022
DR   MMRRC; MMRRC:012598-UCD
DR   Wikidata; Q54754373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676921; Focad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD024
AC   CVCL_LS79
SY   CSD024
DR   MMRRC; MMRRC:012599-UCD
DR   Wikidata; Q54754378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98354; Sos1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD025
AC   CVCL_LS80
SY   CSD025
DR   MMRRC; MMRRC:012600-UCD
DR   Wikidata; Q54754379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140327; Phactr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD029
AC   CVCL_LS81
SY   CSD029
DR   MMRRC; MMRRC:012601-UCD
DR   Wikidata; Q54754380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD030
AC   CVCL_LS82
SY   CSD030
DR   MMRRC; MMRRC:012602-UCD
DR   Wikidata; Q54754381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD031
AC   CVCL_LS83
SY   CSD031
DR   MMRRC; MMRRC:012603-UCD
DR   Wikidata; Q54754383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD032
AC   CVCL_LS84
SY   CSD032
DR   MMRRC; MMRRC:012604-UCD
DR   Wikidata; Q54754386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194490; Diaph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD033
AC   CVCL_LS85
SY   CSD033
DR   MMRRC; MMRRC:012605-UCD
DR   Wikidata; Q54754388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD039
AC   CVCL_LS86
SY   CSD039
DR   MMRRC; MMRRC:012606-UCD
DR   Wikidata; Q54754390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922832; Relch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSD041
AC   CVCL_LS87
SY   CSD041
DR   MMRRC; MMRRC:012608-UCD
DR   Wikidata; Q54754394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104683; Fnta.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD043
AC   CVCL_LS88
SY   CSD043
DR   MMRRC; MMRRC:012610-UCD
DR   Wikidata; Q54754396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD044
AC   CVCL_LS89
SY   CSD044
DR   MMRRC; MMRRC:012611-UCD
DR   Wikidata; Q54754398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD045
AC   CVCL_LS90
SY   CSD045
DR   MMRRC; MMRRC:012612-UCD
DR   Wikidata; Q54754400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD056
AC   CVCL_LS91
SY   CSD056
DR   MMRRC; MMRRC:012616-UCD
DR   Wikidata; Q54754402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD059
AC   CVCL_LS92
SY   CSD059
DR   MMRRC; MMRRC:012617-UCD
DR   Wikidata; Q54754404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102465; Tex2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD060
AC   CVCL_LS93
SY   CSD060
DR   MMRRC; MMRRC:012618-UCD
DR   Wikidata; Q54754407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313288; Incenp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD065
AC   CVCL_LS94
SY   CSD065
DR   MMRRC; MMRRC:012621-UCD
DR   Wikidata; Q54754409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD071
AC   CVCL_LS95
SY   CSD071
DR   MMRRC; MMRRC:012623-UCD
DR   Wikidata; Q54754410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923864; Immt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD072
AC   CVCL_LS96
SY   CSD072
DR   MMRRC; MMRRC:012624-UCD
DR   Wikidata; Q54754413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD073
AC   CVCL_LS97
SY   CSD073
DR   MMRRC; MMRRC:012625-UCD
DR   Wikidata; Q54754416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098280; Crebbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD075
AC   CVCL_LS98
SY   CSD075
DR   MMRRC; MMRRC:012626-UCD
DR   Wikidata; Q54754417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914304; Paics.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD077
AC   CVCL_LS99
SY   CSD077
DR   MMRRC; MMRRC:012627-UCD
DR   Wikidata; Q54754419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD085
AC   CVCL_LT00
SY   CSD085
DR   MMRRC; MMRRC:012630-UCD
DR   Wikidata; Q54754471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914304; Paics.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD093
AC   CVCL_LT01
SY   CSD093
DR   MMRRC; MMRRC:012632-UCD
DR   Wikidata; Q54754473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD096
AC   CVCL_LT02
SY   CSD096
DR   MMRRC; MMRRC:012633-UCD
DR   Wikidata; Q54754475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914339; Psmc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD097
AC   CVCL_LT03
SY   CSD097
DR   MMRRC; MMRRC:012634-UCD
DR   Wikidata; Q54754478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921461; 1700017B05Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD099
AC   CVCL_LT04
SY   CSD099
DR   MMRRC; MMRRC:012635-UCD
DR   Wikidata; Q54754480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914144; Wwp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD100
AC   CVCL_LT05
SY   CSD100
DR   MMRRC; MMRRC:012636-UCD
DR   Wikidata; Q54754482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD103
AC   CVCL_LT06
SY   CSD103
DR   MMRRC; MMRRC:012637-UCD
DR   Wikidata; Q54754485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD108
AC   CVCL_LT07
SY   CSD108
DR   MMRRC; MMRRC:012638-UCD
DR   Wikidata; Q54754486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914093; Dolpp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD115
AC   CVCL_LT08
SY   CSD115
DR   MMRRC; MMRRC:012639-UCD
DR   Wikidata; Q54754488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95728; Gli2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD116
AC   CVCL_LT09
SY   CSD116
DR   MMRRC; MMRRC:012640-UCD
DR   Wikidata; Q54754490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926048; Eml4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD119
AC   CVCL_LT10
SY   CSD119
DR   MMRRC; MMRRC:012642-UCD
DR   Wikidata; Q54754491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203522; Magi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD141
AC   CVCL_LT11
SY   CSD141
DR   MMRRC; MMRRC:012644-UCD
DR   Wikidata; Q54754493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD143
AC   CVCL_LT12
SY   CSD143
DR   MMRRC; MMRRC:012645-UCD
DR   Wikidata; Q54754496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD145
AC   CVCL_LT13
SY   CSD145
DR   MMRRC; MMRRC:012646-UCD
DR   Wikidata; Q54754499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD147
AC   CVCL_LT14
SY   CSD147
DR   MMRRC; MMRRC:012647-UCD
DR   Wikidata; Q54754500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681865; Zfat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD148
AC   CVCL_LT15
SY   CSD148
DR   MMRRC; MMRRC:012648-UCD
DR   Wikidata; Q54754504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104884; Psmb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD156
AC   CVCL_LT16
SY   CSD156
DR   MMRRC; MMRRC:012649-UCD
DR   Wikidata; Q54754506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103561; Kpna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD157
AC   CVCL_LT17
SY   CSD157
DR   MMRRC; MMRRC:012650-UCD
DR   Wikidata; Q54754507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924909; Slc25a36.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD158
AC   CVCL_LT18
SY   CSD158
DR   MMRRC; MMRRC:012651-UCD
DR   Wikidata; Q54754509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD163
AC   CVCL_LT19
SY   CSD163
DR   MMRRC; MMRRC:012653-UCD
DR   Wikidata; Q54754510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD164
AC   CVCL_LT20
SY   CSD164
DR   MMRRC; MMRRC:012654-UCD
DR   Wikidata; Q54754511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD169
AC   CVCL_LT21
SY   CSD169
DR   MMRRC; MMRRC:012657-UCD
DR   Wikidata; Q54754513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD173
AC   CVCL_LT22
SY   CSD173
DR   MMRRC; MMRRC:012658-UCD
DR   Wikidata; Q54754516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD174
AC   CVCL_LT23
SY   CSD174
DR   MMRRC; MMRRC:012659-UCD
DR   Wikidata; Q54754517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD178
AC   CVCL_LT24
SY   CSD178
DR   MMRRC; MMRRC:012661-UCD
DR   Wikidata; Q54754520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443564; Ambra1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD185
AC   CVCL_LT25
SY   CSD185
DR   MMRRC; MMRRC:012663-UCD
DR   Wikidata; Q54754521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045391; Lin52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD188
AC   CVCL_LT26
SY   CSD188
DR   MMRRC; MMRRC:012664-UCD
DR   Wikidata; Q54754523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD196
AC   CVCL_LT27
SY   CSD196
DR   MMRRC; MMRRC:012667-UCD
DR   Wikidata; Q54754526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD197
AC   CVCL_LT28
SY   CSD197
DR   MMRRC; MMRRC:012668-UCD
DR   Wikidata; Q54754527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914811; Wdr48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD204
AC   CVCL_LT29
SY   CSD204
DR   MMRRC; MMRRC:012671-UCD
DR   Wikidata; Q54754529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107891; Nop2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD220
AC   CVCL_LT30
SY   CSD220
DR   MMRRC; MMRRC:012673-UCD
DR   Wikidata; Q54754531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384782; Slc25a38.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD224
AC   CVCL_LT31
SY   CSD224
DR   MMRRC; MMRRC:012674-UCD
DR   Wikidata; Q54754534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915345; Ociad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD225
AC   CVCL_LT32
SY   CSD225
DR   MMRRC; MMRRC:012675-UCD
DR   Wikidata; Q54754536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD226
AC   CVCL_LT33
SY   CSD226
DR   MMRRC; MMRRC:012676-UCD
DR   Wikidata; Q54754539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384560; Aars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD228
AC   CVCL_LT34
SY   CSD228
DR   MMRRC; MMRRC:012677-UCD
DR   Wikidata; Q54754541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928753; Pfdn5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD230
AC   CVCL_LT35
SY   CSD230
DR   MMRRC; MMRRC:012678-UCD
DR   Wikidata; Q54754542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919563; Fryl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD232
AC   CVCL_LT36
SY   CSD232
DR   MMRRC; MMRRC:012679-UCD
DR   Wikidata; Q54754545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD233
AC   CVCL_LT37
SY   CSD233
DR   MMRRC; MMRRC:012680-UCD
DR   Wikidata; Q54754547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861100; Ubr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD237
AC   CVCL_LT38
SY   CSD237
DR   MMRRC; MMRRC:012683-UCD
DR   Wikidata; Q54754549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917599; Copb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD241
AC   CVCL_LT39
SY   CSD241
DR   MMRRC; MMRRC:012685-UCD
DR   Wikidata; Q54754552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922542; Prkd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD243
AC   CVCL_LT40
SY   CSD243
DR   MMRRC; MMRRC:012686-UCD
DR   Wikidata; Q54754603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139764; Sec24b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD244
AC   CVCL_LT41
SY   CSD244
DR   MMRRC; MMRRC:012687-UCD
DR   Wikidata; Q54754605
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD245
AC   CVCL_LT42
SY   CSD245
DR   MMRRC; MMRRC:012688-UCD
DR   Wikidata; Q54754607
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917649; Wwtr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD247
AC   CVCL_LT43
SY   CSD247
DR   MMRRC; MMRRC:012689-UCD
DR   Wikidata; Q54754608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039376; Dnph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD256
AC   CVCL_LT44
SY   CSD256
DR   MMRRC; MMRRC:012690-UCD
DR   Wikidata; Q54754612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890212; Porcn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD262
AC   CVCL_LT45
SY   CSD262
DR   MMRRC; MMRRC:012693-UCD
DR   Wikidata; Q54754613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276124; Ep400.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD264
AC   CVCL_LT46
SY   CSD264
DR   MMRRC; MMRRC:012694-UCD
DR   Wikidata; Q54754616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931797; Ckap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD273
AC   CVCL_LT47
SY   CSD273
DR   MMRRC; MMRRC:012758-UCD
DR   Wikidata; Q54754619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146350; Scaf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD280
AC   CVCL_LT48
SY   CSD280
DR   MMRRC; MMRRC:012759-UCD
DR   Wikidata; Q54754620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914504; Bmerb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSD281
AC   CVCL_LT49
SY   CSD281
DR   MMRRC; MMRRC:012760-UCD
DR   Wikidata; Q54754621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD282
AC   CVCL_LT50
SY   CSD282
DR   MMRRC; MMRRC:012761-UCD
DR   Wikidata; Q54754623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861100; Ubr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD284
AC   CVCL_LT51
SY   CSD284
DR   MMRRC; MMRRC:012762-UCD
DR   Wikidata; Q54754625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338056; Klf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD288
AC   CVCL_LT52
SY   CSD288
DR   MMRRC; MMRRC:012763-UCD
DR   Wikidata; Q54754627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107889; Exosc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD290
AC   CVCL_LT53
SY   CSD290
DR   MMRRC; MMRRC:012764-UCD
DR   Wikidata; Q54754628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD292
AC   CVCL_LT54
SY   CSD292
DR   MMRRC; MMRRC:012765-UCD
DR   Wikidata; Q54754631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD296
AC   CVCL_LT55
SY   CSD296
DR   MMRRC; MMRRC:012766-UCD
DR   Wikidata; Q54754634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858222; Septin9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSD297
AC   CVCL_LT56
SY   CSD297
DR   MMRRC; MMRRC:012767-UCD
DR   Wikidata; Q54754637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108295; Pxn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD298
AC   CVCL_LT57
SY   CSD298
DR   MMRRC; MMRRC:012768-UCD
DR   Wikidata; Q54754638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924769; Zfp266.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD301
AC   CVCL_LT58
SY   CSD301
DR   MMRRC; MMRRC:012770-UCD
DR   Wikidata; Q54754640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919891; Mob2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD303
AC   CVCL_LT59
SY   CSD303
DR   MMRRC; MMRRC:012771-UCD
DR   Wikidata; Q54754643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88473; Cox4i1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD306
AC   CVCL_LT60
SY   CSD306
DR   MMRRC; MMRRC:012772-UCD
DR   Wikidata; Q54754644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95301; Eif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD309
AC   CVCL_LT61
SY   CSD309
DR   MMRRC; MMRRC:012773-UCD
DR   Wikidata; Q54754646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183747; Fgd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD314
AC   CVCL_LT62
SY   CSD314
DR   MMRRC; MMRRC:012776-UCD
DR   Wikidata; Q54754649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928268; Ireb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD322
AC   CVCL_LT63
SY   CSD322
DR   MMRRC; MMRRC:012778-UCD
DR   Wikidata; Q54754650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651985; Zfp988.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD327
AC   CVCL_LT64
SY   CSD327
DR   MMRRC; MMRRC:012779-UCD
DR   Wikidata; Q54754654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD329
AC   CVCL_LT65
SY   CSD329
DR   MMRRC; MMRRC:012780-UCD
DR   Wikidata; Q54754656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914737; Dhx40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD330
AC   CVCL_LT66
SY   CSD330
DR   MMRRC; MMRRC:012781-UCD
DR   Wikidata; Q54754658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD333
AC   CVCL_LT67
SY   CSD333
DR   MMRRC; MMRRC:012782-UCD
DR   Wikidata; Q54754661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446143; Zfc3h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD334
AC   CVCL_LT68
SY   CSD334
DR   MMRRC; MMRRC:012783-UCD
DR   Wikidata; Q54754663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384836; Nepro.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD339
AC   CVCL_LT69
SY   CSD339
DR   MMRRC; MMRRC:012784-UCD
DR   Wikidata; Q54754664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670178; Med13l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD341
AC   CVCL_LT70
SY   CSD341
DR   MMRRC; MMRRC:012785-UCD
DR   Wikidata; Q54754666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107157; Sin3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD349
AC   CVCL_LT71
SY   CSD349
DR   MMRRC; MMRRC:012786-UCD
DR   Wikidata; Q54754669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321398; F11r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD351
AC   CVCL_LT72
SY   CSD351
DR   MMRRC; MMRRC:012787-UCD
DR   Wikidata; Q54754670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139369; Rtel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD352
AC   CVCL_LT73
SY   CSD352
DR   MMRRC; MMRRC:012788-UCD
DR   Wikidata; Q54754672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681865; Zfat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD355
AC   CVCL_LT74
SY   CSD355
DR   MMRRC; MMRRC:012789-UCD
DR   Wikidata; Q54754673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919318; Cnot2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD359
AC   CVCL_LT75
SY   CSD359
DR   MMRRC; MMRRC:012790-UCD
DR   Wikidata; Q54754674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD365
AC   CVCL_LT76
SY   CSD365
DR   MMRRC; MMRRC:012791-UCD
DR   Wikidata; Q54754677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD368
AC   CVCL_LT77
SY   CSD368
DR   MMRRC; MMRRC:012792-UCD
DR   Wikidata; Q54754678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD369
AC   CVCL_LT78
SY   CSD369
DR   MMRRC; MMRRC:012793-UCD
DR   Wikidata; Q54754682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921677; Eaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD374
AC   CVCL_LT79
SY   CSD374
DR   MMRRC; MMRRC:012794-UCD
DR   Wikidata; Q54754685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914496; Resf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSD378
AC   CVCL_LT80
SY   CSD378
DR   MMRRC; MMRRC:012796-UCD
DR   Wikidata; Q54754742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97891; Rfc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD385
AC   CVCL_LT81
SY   CSD385
DR   MMRRC; MMRRC:012797-UCD
DR   Wikidata; Q54754745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD390
AC   CVCL_LT82
SY   CSD390
DR   MMRRC; MMRRC:012798-UCD
DR   Wikidata; Q54754747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD400
AC   CVCL_LT83
SY   CSD400
DR   MMRRC; MMRRC:012801-UCD
DR   Wikidata; Q54754748
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm2097 (MGI:3780264) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSD402
AC   CVCL_LT84
SY   CSD402
DR   MMRRC; MMRRC:012802-UCD
DR   Wikidata; Q54754751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104582; Eps15l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD404
AC   CVCL_LT85
SY   CSD404
DR   MMRRC; MMRRC:012803-UCD
DR   Wikidata; Q54754754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349423; Racgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD407
AC   CVCL_LT86
SY   CSD407
DR   MMRRC; MMRRC:012804-UCD
DR   Wikidata; Q54754758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450915; Sec23ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSD410
AC   CVCL_LT87
SY   CSD410
DR   MMRRC; MMRRC:012805-UCD
DR   Wikidata; Q54754760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE001
AC   CVCL_LT88
SY   CSE001
DR   MMRRC; MMRRC:012258-UCD
DR   Wikidata; Q54754762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923012; Aftph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE003
AC   CVCL_LT89
SY   CSE003
DR   MMRRC; MMRRC:012259-UCD
DR   Wikidata; Q54754764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE006
AC   CVCL_LT90
SY   CSE006
DR   MMRRC; MMRRC:012260-UCD
DR   Wikidata; Q54754765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103296; Nfatc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE009
AC   CVCL_LT91
SY   CSE009
DR   MMRRC; MMRRC:012262-UCD
DR   Wikidata; Q54754767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201408; Srpk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE011
AC   CVCL_LT92
SY   CSE011
DR   MMRRC; MMRRC:012263-UCD
DR   Wikidata; Q54754768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3779598; Gm6445.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE012
AC   CVCL_LT93
SY   CSE012
DR   MMRRC; MMRRC:012264-UCD
DR   Wikidata; Q54754770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109520; Pafah1b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE017
AC   CVCL_LT94
SY   CSE017
DR   MMRRC; MMRRC:012267-UCD
DR   Wikidata; Q54754772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE019
AC   CVCL_LT95
SY   CSE019
DR   MMRRC; MMRRC:012268-UCD
DR   Wikidata; Q54754773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145955; Prkaa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE020
AC   CVCL_LT96
SY   CSE020
DR   MMRRC; MMRRC:012269-UCD
DR   Wikidata; Q54754775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE022
AC   CVCL_LT97
SY   CSE022
DR   MMRRC; MMRRC:012270-UCD
DR   Wikidata; Q54754777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE023
AC   CVCL_LT98
SY   CSE023
DR   MMRRC; MMRRC:012271-UCD
DR   Wikidata; Q54754779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913275; Rcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE025
AC   CVCL_LT99
SY   CSE025
DR   MMRRC; MMRRC:012273-UCD
DR   Wikidata; Q54754780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE031
AC   CVCL_LU00
SY   CSE031
DR   MMRRC; MMRRC:012275-UCD
DR   Wikidata; Q54754784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109634; Terf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE032
AC   CVCL_LU01
SY   CSE032
DR   MMRRC; MMRRC:012276-UCD
DR   Wikidata; Q54754785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449307; Upf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE033
AC   CVCL_LU02
SY   CSE033
DR   MMRRC; MMRRC:012277-UCD
DR   Wikidata; Q54754788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE034
AC   CVCL_LU03
SY   CSE034
DR   MMRRC; MMRRC:012278-UCD
DR   Wikidata; Q54754789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE038
AC   CVCL_LU04
SY   CSE038
DR   MMRRC; MMRRC:012279-UCD
DR   Wikidata; Q54754792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE039
AC   CVCL_LU05
SY   CSE039
DR   MMRRC; MMRRC:012280-UCD
DR   Wikidata; Q54754794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE040
AC   CVCL_LU06
SY   CSE040
DR   MMRRC; MMRRC:012281-UCD
DR   Wikidata; Q54754797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449307; Upf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE042
AC   CVCL_LU07
SY   CSE042
DR   MMRRC; MMRRC:012283-UCD
DR   Wikidata; Q54754798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384931; Dhrs7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE043
AC   CVCL_LU08
SY   CSE043
DR   MMRRC; MMRRC:012284-UCD
DR   Wikidata; Q54754800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE046
AC   CVCL_LU09
SY   CSE046
DR   MMRRC; MMRRC:012286-UCD
DR   Wikidata; Q54754804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446634; Ago3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE047
AC   CVCL_LU10
SY   CSE047
DR   MMRRC; MMRRC:012287-UCD
DR   Wikidata; Q54754805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88474; Cox5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE048
AC   CVCL_LU11
SY   CSE048
DR   MMRRC; MMRRC:012288-UCD
DR   Wikidata; Q54754808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE052
AC   CVCL_LU12
SY   CSE052
DR   MMRRC; MMRRC:012290-UCD
DR   Wikidata; Q54754809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE056
AC   CVCL_LU13
SY   CSE056
DR   MMRRC; MMRRC:012291-UCD
DR   Wikidata; Q54754812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE062
AC   CVCL_LU14
SY   CSE062
DR   MMRRC; MMRRC:012294-UCD
DR   Wikidata; Q54754814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443272; B230354K17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE064
AC   CVCL_LU15
SY   CSE064
DR   MMRRC; MMRRC:012295-UCD
DR   Wikidata; Q54754815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE068
AC   CVCL_LU16
SY   CSE068
DR   MMRRC; MMRRC:012296-UCD
DR   Wikidata; Q54754818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE069
AC   CVCL_LU17
SY   CSE069
DR   MMRRC; MMRRC:012297-UCD
DR   Wikidata; Q54754819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE070
AC   CVCL_LU18
SY   CSE070
DR   MMRRC; MMRRC:012298-UCD
DR   Wikidata; Q54754822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE072
AC   CVCL_LU19
SY   CSE072
DR   MMRRC; MMRRC:012299-UCD
DR   Wikidata; Q54754823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914457; Lsm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE073
AC   CVCL_LU20
SY   CSE073
DR   MMRRC; MMRRC:012300-UCD
DR   Wikidata; Q54754873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913937; Tbc1d15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE075
AC   CVCL_LU21
SY   CSE075
DR   MMRRC; MMRRC:012301-UCD
DR   Wikidata; Q54754875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE076
AC   CVCL_LU22
SY   CSE076
DR   MMRRC; MMRRC:012302-UCD
DR   Wikidata; Q54754878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE077
AC   CVCL_LU23
SY   CSE077
DR   MMRRC; MMRRC:012303-UCD
DR   Wikidata; Q54754880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202402; Pde7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE080
AC   CVCL_LU24
SY   CSE080
DR   MMRRC; MMRRC:012304-UCD
DR   Wikidata; Q54754881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE087
AC   CVCL_LU25
SY   CSE087
DR   MMRRC; MMRRC:012695-UCD
DR   Wikidata; Q54754884
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE097
AC   CVCL_LU26
SY   CSE097
DR   MMRRC; MMRRC:012697-UCD
DR   Wikidata; Q54754886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97791; Ptbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE105
AC   CVCL_LU27
SY   CSE105
DR   MMRRC; MMRRC:012701-UCD
DR   Wikidata; Q54754890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103575; Skp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSE107
AC   CVCL_LU28
SY   CSE107
DR   MMRRC; MMRRC:012703-UCD
DR   Wikidata; Q54754892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE108
AC   CVCL_LU29
SY   CSE108
DR   MMRRC; MMRRC:012704-UCD
DR   Wikidata; Q54754893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890508; Zmpste24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE115
AC   CVCL_LU30
SY   CSE115
DR   MMRRC; MMRRC:012707-UCD
DR   Wikidata; Q54754895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE119
AC   CVCL_LU31
SY   CSE119
DR   MMRRC; MMRRC:012710-UCD
DR   Wikidata; Q54754898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE120
AC   CVCL_LU32
SY   CSE120
DR   MMRRC; MMRRC:012711-UCD
DR   Wikidata; Q54754899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143362; Zfp809.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE124
AC   CVCL_LU33
SY   CSE124
DR   MMRRC; MMRRC:012712-UCD
DR   Wikidata; Q54754901
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE125
AC   CVCL_LU34
SY   CSE125
DR   MMRRC; MMRRC:012713-UCD
DR   Wikidata; Q54754902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE129
AC   CVCL_LU35
SY   CSE129
DR   MMRRC; MMRRC:012716-UCD
DR   Wikidata; Q54754903
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916979; 2410003L11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE136
AC   CVCL_LU36
SY   CSE136
DR   MMRRC; MMRRC:012719-UCD
DR   Wikidata; Q54754906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE151
AC   CVCL_LU37
SY   CSE151
DR   MMRRC; MMRRC:012725-UCD
DR   Wikidata; Q54754908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145242; Arrdc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSE513
AC   CVCL_LU38
SY   CSE513
DR   MMRRC; MMRRC:017183-UCD
DR   Wikidata; Q54754910
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145242; Arrdc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF005
AC   CVCL_LU39
SY   CSF005
DR   MMRRC; MMRRC:012727-UCD
DR   Wikidata; Q54754913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF008
AC   CVCL_LU40
SY   CSF008
DR   MMRRC; MMRRC:012728-UCD
DR   Wikidata; Q54754914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277120; Arfip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF010
AC   CVCL_LU41
SY   CSF010
DR   MMRRC; MMRRC:012729-UCD
DR   Wikidata; Q54754917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3712454; Zfp980.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF019
AC   CVCL_LU42
SY   CSF019
DR   MMRRC; MMRRC:012732-UCD
DR   Wikidata; Q54754920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914290; Ddx17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF022
AC   CVCL_LU43
SY   CSF022
DR   MMRRC; MMRRC:012734-UCD
DR   Wikidata; Q54754922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914290; Ddx17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF026
AC   CVCL_LU44
SY   CSF026
DR   MMRRC; MMRRC:012735-UCD
DR   Wikidata; Q54754924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443272; B230354K17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF027
AC   CVCL_LU45
SY   CSF027
DR   MMRRC; MMRRC:012736-UCD
DR   Wikidata; Q54754926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF033
AC   CVCL_LU46
SY   CSF033
DR   MMRRC; MMRRC:012739-UCD
DR   Wikidata; Q54754928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929091; Sinhcaf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSF038
AC   CVCL_LU47
SY   CSF038
DR   MMRRC; MMRRC:012742-UCD
DR   Wikidata; Q54754930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889276; Dgke.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF039
AC   CVCL_LU48
SY   CSF039
DR   MMRRC; MMRRC:012743-UCD
DR   Wikidata; Q54754931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF040
AC   CVCL_LU49
SY   CSF040
DR   MMRRC; MMRRC:012744-UCD
DR   Wikidata; Q54754934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF046
AC   CVCL_LU50
SY   CSF046
DR   MMRRC; MMRRC:012747-UCD
DR   Wikidata; Q54754937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSF047
AC   CVCL_LU51
SY   CSF047
DR   MMRRC; MMRRC:012748-UCD
DR   Wikidata; Q54754938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926143; Cnot10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG001
AC   CVCL_LU52
SY   CSG001
DR   MMRRC; MMRRC:014128-UCD
DR   Wikidata; Q54754941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919979; Cdc42se2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG002
AC   CVCL_LU53
SY   CSG002
DR   MMRRC; MMRRC:014129-UCD
DR   Wikidata; Q54754942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921584; Ranbp10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG006
AC   CVCL_LU54
SY   CSG006
DR   MMRRC; MMRRC:014131-UCD
DR   Wikidata; Q54754943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384939; Fam222b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG007
AC   CVCL_LU55
SY   CSG007
DR   MMRRC; MMRRC:014132-UCD
DR   Wikidata; Q54754946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679003; Dcun1d3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG008
AC   CVCL_LU56
SY   CSG008
DR   MMRRC; MMRRC:014133-UCD
DR   Wikidata; Q54754947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141161; Tyw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG009
AC   CVCL_LU57
SY   CSG009
DR   MMRRC; MMRRC:014134-UCD
DR   Wikidata; Q54754949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145578; Slain1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG010
AC   CVCL_LU58
SY   CSG010
DR   MMRRC; MMRRC:014135-UCD
DR   Wikidata; Q54754952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151172; Mta3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG011
AC   CVCL_LU59
SY   CSG011
DR   MMRRC; MMRRC:014136-UCD
DR   Wikidata; Q54754954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG013
AC   CVCL_LU60
SY   CSG013
DR   MMRRC; MMRRC:014137-UCD
DR   Wikidata; Q54755010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915248; Retreg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG014
AC   CVCL_LU61
SY   CSG014
DR   MMRRC; MMRRC:014138-UCD
DR   Wikidata; Q54755012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG015
AC   CVCL_LU62
SY   CSG015
DR   MMRRC; MMRRC:014139-UCD
DR   Wikidata; Q54755013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95728; Gli2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG019
AC   CVCL_LU63
SY   CSG019
DR   MMRRC; MMRRC:014143-UCD
DR   Wikidata; Q54755014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG021
AC   CVCL_LU64
SY   CSG021
DR   MMRRC; MMRRC:014144-UCD
DR   Wikidata; Q54755017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345192; Psmd13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG024
AC   CVCL_LU65
SY   CSG024
DR   MMRRC; MMRRC:014146-UCD
DR   Wikidata; Q54755018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG025
AC   CVCL_LU66
SY   CSG025
DR   MMRRC; MMRRC:014147-UCD
DR   Wikidata; Q54755020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926082; Cacul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG026
AC   CVCL_LU67
SY   CSG026
DR   MMRRC; MMRRC:014148-UCD
DR   Wikidata; Q54755023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG029
AC   CVCL_LU68
SY   CSG029
DR   MMRRC; MMRRC:014150-UCD
DR   Wikidata; Q54755027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144529; Cnot6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG030
AC   CVCL_LU69
SY   CSG030
DR   MMRRC; MMRRC:014151-UCD
DR   Wikidata; Q54755029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891832; Patz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG031
AC   CVCL_LU70
SY   CSG031
DR   MMRRC; MMRRC:014152-UCD
DR   Wikidata; Q54755030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444008; Bptf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG033
AC   CVCL_LU71
SY   CSG033
DR   MMRRC; MMRRC:014153-UCD
DR   Wikidata; Q54755032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920075; Mon1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG038
AC   CVCL_LU72
SY   CSG038
DR   MMRRC; MMRRC:014157-UCD
DR   Wikidata; Q54755033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915755; Vps51.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG040
AC   CVCL_LU73
SY   CSG040
DR   MMRRC; MMRRC:014158-UCD
DR   Wikidata; Q54755036
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354962; Copb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG043
AC   CVCL_LU74
SY   CSG043
DR   MMRRC; MMRRC:014159-UCD
DR   Wikidata; Q54755038
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915755; Vps51.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG044
AC   CVCL_LU75
SY   CSG044
DR   MMRRC; MMRRC:014160-UCD
DR   Wikidata; Q54755041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444008; Bptf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG045
AC   CVCL_LU76
SY   CSG045
DR   MMRRC; MMRRC:014161-UCD
DR   Wikidata; Q54755043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353423; Zfp292.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG050
AC   CVCL_LU77
SY   CSG050
DR   MMRRC; MMRRC:014162-UCD
DR   Wikidata; Q54755045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914499; Tbc1d19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG051
AC   CVCL_LU78
SY   CSG051
DR   MMRRC; MMRRC:014163-UCD
DR   Wikidata; Q54755047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858195; Hnrnpu.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG052
AC   CVCL_LU79
SY   CSG052
DR   MMRRC; MMRRC:014164-UCD
DR   Wikidata; Q54755049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103250; Calm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG056
AC   CVCL_LU80
SY   CSG056
DR   MMRRC; MMRRC:014165-UCD
DR   Wikidata; Q54755051
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97175; Map2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG067
AC   CVCL_LU81
SY   CSG067
DR   MMRRC; MMRRC:014169-UCD
DR   Wikidata; Q54755052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109601; Nck1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG072
AC   CVCL_LU82
SY   CSG072
DR   MMRRC; MMRRC:014171-UCD
DR   Wikidata; Q54755053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925219; Trmt13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG077
AC   CVCL_LU83
SY   CSG077
DR   MMRRC; MMRRC:014174-UCD
DR   Wikidata; Q54755056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG079
AC   CVCL_LU84
SY   CSG079
DR   MMRRC; MMRRC:014175-UCD
DR   Wikidata; Q54755058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925237; Ascc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG082
AC   CVCL_LU85
SY   CSG082
DR   MMRRC; MMRRC:014178-UCD
DR   Wikidata; Q54755059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG084
AC   CVCL_LU86
SY   CSG084
DR   MMRRC; MMRRC:014179-UCD
DR   Wikidata; Q54755061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103267; Eif4ebp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG085
AC   CVCL_LU87
SY   CSG085
DR   MMRRC; MMRRC:014180-UCD
DR   Wikidata; Q54755062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109520; Pafah1b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG087
AC   CVCL_LU88
SY   CSG087
DR   MMRRC; MMRRC:014182-UCD
DR   Wikidata; Q54755064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385071; Etf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG089
AC   CVCL_LU89
SY   CSG089
DR   MMRRC; MMRRC:014183-UCD
DR   Wikidata; Q54755066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923864; Immt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG090
AC   CVCL_LU90
SY   CSG090
DR   MMRRC; MMRRC:014184-UCD
DR   Wikidata; Q54755070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG091
AC   CVCL_LU91
SY   CSG091
DR   MMRRC; MMRRC:014185-UCD
DR   Wikidata; Q54755072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104995; Gclm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG092
AC   CVCL_LU92
SY   CSG092
DR   MMRRC; MMRRC:014186-UCD
DR   Wikidata; Q54755073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104995; Gclm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG095
AC   CVCL_LU93
SY   CSG095
DR   MMRRC; MMRRC:014187-UCD
DR   Wikidata; Q54755076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385071; Etf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG100
AC   CVCL_LU94
SY   CSG100
DR   MMRRC; MMRRC:014189-UCD
DR   Wikidata; Q54755077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG104
AC   CVCL_LU95
SY   CSG104
DR   MMRRC; MMRRC:014190-UCD
DR   Wikidata; Q54755080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109629; Atp6ap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG107
AC   CVCL_LU96
SY   CSG107
DR   MMRRC; MMRRC:014192-UCD
DR   Wikidata; Q54755082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921356; Dcaf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG108
AC   CVCL_LU97
SY   CSG108
DR   MMRRC; MMRRC:014193-UCD
DR   Wikidata; Q54755084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913875; Pnisr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG109
AC   CVCL_LU98
SY   CSG109
DR   MMRRC; MMRRC:014194-UCD
DR   Wikidata; Q54755086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916043; Rab3gap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG112
AC   CVCL_LU99
SY   CSG112
DR   MMRRC; MMRRC:014195-UCD
DR   Wikidata; Q54755089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338026; Tom1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG113
AC   CVCL_LV00
SY   CSG113
DR   MMRRC; MMRRC:014196-UCD
DR   Wikidata; Q54755138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384851; Slc39a14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG115
AC   CVCL_LV01
SY   CSG115
DR   MMRRC; MMRRC:014197-UCD
DR   Wikidata; Q54755139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97856; Rara.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG116
AC   CVCL_LV02
SY   CSG116
DR   MMRRC; MMRRC:014198-UCD
DR   Wikidata; Q54755142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139207; Sec16a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG119
AC   CVCL_LV03
SY   CSG119
DR   MMRRC; MMRRC:014199-UCD
DR   Wikidata; Q54755145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673855; Bicral.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG120
AC   CVCL_LV04
SY   CSG120
DR   MMRRC; MMRRC:014200-UCD
DR   Wikidata; Q54755147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923749; Clasp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG121
AC   CVCL_LV05
SY   CSG121
DR   MMRRC; MMRRC:014201-UCD
DR   Wikidata; Q54755148
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270849; Rps6kb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG123
AC   CVCL_LV06
SY   CSG123
DR   MMRRC; MMRRC:014202-UCD
DR   Wikidata; Q54755153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97856; Rara.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG124
AC   CVCL_LV07
SY   CSG124
DR   MMRRC; MMRRC:014203-UCD
DR   Wikidata; Q54755155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448549; Cdk10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG125
AC   CVCL_LV08
SY   CSG125
DR   MMRRC; MMRRC:014204-UCD
DR   Wikidata; Q54755157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3648156; Slc38a6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG128
AC   CVCL_LV09
SY   CSG128
DR   MMRRC; MMRRC:014205-UCD
DR   Wikidata; Q54755159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103306; Tiam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG129
AC   CVCL_LV10
SY   CSG129
DR   MMRRC; MMRRC:014206-UCD
DR   Wikidata; Q54755160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147162; Unc119b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG131
AC   CVCL_LV11
SY   CSG131
DR   MMRRC; MMRRC:014207-UCD
DR   Wikidata; Q54755162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140998; Ube3c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG132
AC   CVCL_LV12
SY   CSG132
DR   MMRRC; MMRRC:014208-UCD
DR   Wikidata; Q54755164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917125; Ndufa11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG133
AC   CVCL_LV13
SY   CSG133
DR   MMRRC; MMRRC:014209-UCD
DR   Wikidata; Q54755165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916303; 1810013L24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG135
AC   CVCL_LV14
SY   CSG135
DR   MMRRC; MMRRC:014211-UCD
DR   Wikidata; Q54755168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG136
AC   CVCL_LV15
SY   CSG136
DR   MMRRC; MMRRC:014212-UCD
DR   Wikidata; Q54755171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919383; Trub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG139
AC   CVCL_LV16
SY   CSG139
DR   MMRRC; MMRRC:014213-UCD
DR   Wikidata; Q54755173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG140
AC   CVCL_LV17
SY   CSG140
DR   MMRRC; MMRRC:014214-UCD
DR   Wikidata; Q54755174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98117; Rps15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG141
AC   CVCL_LV18
SY   CSG141
DR   MMRRC; MMRRC:014215-UCD
DR   Wikidata; Q54755176
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913714; Taf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG143
AC   CVCL_LV19
SY   CSG143
DR   MMRRC; MMRRC:014216-UCD
DR   Wikidata; Q54755179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG146
AC   CVCL_LV20
SY   CSG146
DR   MMRRC; MMRRC:014217-UCD
DR   Wikidata; Q54755180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443419; Rps6kc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG148
AC   CVCL_LV21
SY   CSG148
DR   MMRRC; MMRRC:014219-UCD
DR   Wikidata; Q54755182
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917125; Ndufa11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG149
AC   CVCL_LV22
SY   CSG149
DR   MMRRC; MMRRC:014220-UCD
DR   Wikidata; Q54755184
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925237; Ascc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG151
AC   CVCL_LV23
SY   CSG151
DR   MMRRC; MMRRC:014222-UCD
DR   Wikidata; Q54755186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045391; Lin52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG152
AC   CVCL_LV24
SY   CSG152
DR   MMRRC; MMRRC:014223-UCD
DR   Wikidata; Q54755187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673855; Bicral.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG153
AC   CVCL_LV25
SY   CSG153
DR   MMRRC; MMRRC:014224-UCD
DR   Wikidata; Q54755189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679006; Zfp599.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG155
AC   CVCL_LV26
SY   CSG155
DR   MMRRC; MMRRC:014225-UCD
DR   Wikidata; Q54755191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146388; Ubxn7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG156
AC   CVCL_LV27
SY   CSG156
DR   MMRRC; MMRRC:014226-UCD
DR   Wikidata; Q54755194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918580; Rcbtb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG157
AC   CVCL_LV28
SY   CSG157
DR   MMRRC; MMRRC:014227-UCD
DR   Wikidata; Q54755195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442620; Nup133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG158
AC   CVCL_LV29
SY   CSG158
DR   MMRRC; MMRRC:014228-UCD
DR   Wikidata; Q54755197
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106095; Naca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG162
AC   CVCL_LV30
SY   CSG162
DR   MMRRC; MMRRC:014229-UCD
DR   Wikidata; Q54755200
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923959; Arpc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG163
AC   CVCL_LV31
SY   CSG163
DR   MMRRC; MMRRC:014230-UCD
DR   Wikidata; Q54755202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354165; Thop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG164
AC   CVCL_LV32
SY   CSG164
DR   MMRRC; MMRRC:014231-UCD
DR   Wikidata; Q54755204
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443564; Ambra1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG166
AC   CVCL_LV33
SY   CSG166
DR   MMRRC; MMRRC:014232-UCD
DR   Wikidata; Q54755206
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG169
AC   CVCL_LV34
SY   CSG169
DR   MMRRC; MMRRC:014234-UCD
DR   Wikidata; Q54755208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG173
AC   CVCL_LV35
SY   CSG173
DR   MMRRC; MMRRC:014236-UCD
DR   Wikidata; Q54755211
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG174
AC   CVCL_LV36
SY   CSG174
DR   MMRRC; MMRRC:014237-UCD
DR   Wikidata; Q54755213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923959; Arpc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG176
AC   CVCL_LV37
SY   CSG176
DR   MMRRC; MMRRC:014238-UCD
DR   Wikidata; Q54755214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441773; Pcmtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG177
AC   CVCL_LV38
SY   CSG177
DR   MMRRC; MMRRC:014239-UCD
DR   Wikidata; Q54755217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442521; Cep295.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG180
AC   CVCL_LV39
SY   CSG180
DR   MMRRC; MMRRC:014240-UCD
DR   Wikidata; Q54755218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442513; Eml5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG181
AC   CVCL_LV40
SY   CSG181
DR   MMRRC; MMRRC:014258-UCD
DR   Wikidata; Q54755323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289341; Sf3b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG183
AC   CVCL_LV41
SY   CSG183
DR   MMRRC; MMRRC:014260-UCD
DR   Wikidata; Q54755325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG190
AC   CVCL_LV42
SY   CSG190
DR   MMRRC; MMRRC:014262-UCD
DR   Wikidata; Q54755327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917317; Ermard.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG191
AC   CVCL_LV43
SY   CSG191
DR   MMRRC; MMRRC:014263-UCD
DR   Wikidata; Q54755328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG192
AC   CVCL_LV44
SY   CSG192
DR   MMRRC; MMRRC:014264-UCD
DR   Wikidata; Q54755330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860513; Fnbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG193
AC   CVCL_LV45
SY   CSG193
DR   MMRRC; MMRRC:014265-UCD
DR   Wikidata; Q54755331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG194
AC   CVCL_LV46
SY   CSG194
DR   MMRRC; MMRRC:014266-UCD
DR   Wikidata; Q54755333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144529; Cnot6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG195
AC   CVCL_LV47
SY   CSG195
DR   MMRRC; MMRRC:014267-UCD
DR   Wikidata; Q54755334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104517; Xrcc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG196
AC   CVCL_LV48
SY   CSG196
DR   MMRRC; MMRRC:014268-UCD
DR   Wikidata; Q54755336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450915; Sec23ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG197
AC   CVCL_LV49
SY   CSG197
DR   MMRRC; MMRRC:014269-UCD
DR   Wikidata; Q54755338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107940; Ezh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG199
AC   CVCL_LV50
SY   CSG199
DR   MMRRC; MMRRC:014270-UCD
DR   Wikidata; Q54755341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919654; Wdr44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG201
AC   CVCL_LV51
SY   CSG201
DR   MMRRC; MMRRC:014271-UCD
DR   Wikidata; Q54755343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG203
AC   CVCL_LV52
SY   CSG203
DR   MMRRC; MMRRC:014273-UCD
DR   Wikidata; Q54755345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107931; Sqstm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG204
AC   CVCL_LV53
SY   CSG204
DR   MMRRC; MMRRC:014274-UCD
DR   Wikidata; Q54755347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107931; Sqstm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG206
AC   CVCL_LV54
SY   CSG206
DR   MMRRC; MMRRC:014275-UCD
DR   Wikidata; Q54755350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG209
AC   CVCL_LV55
SY   CSG209
DR   MMRRC; MMRRC:014276-UCD
DR   Wikidata; Q54755352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926045; Armc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG217
AC   CVCL_LV56
SY   CSG217
DR   MMRRC; MMRRC:014280-UCD
DR   Wikidata; Q54755354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147987; Pcyt1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG218
AC   CVCL_LV57
SY   CSG218
DR   MMRRC; MMRRC:014281-UCD
DR   Wikidata; Q54755357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385206; Pabpc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG220
AC   CVCL_LV58
SY   CSG220
DR   MMRRC; MMRRC:014282-UCD
DR   Wikidata; Q54755359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446296; Sik3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG221
AC   CVCL_LV59
SY   CSG221
DR   MMRRC; MMRRC:014283-UCD
DR   Wikidata; Q54755360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913714; Taf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG223
AC   CVCL_LV60
SY   CSG223
DR   MMRRC; MMRRC:014284-UCD
DR   Wikidata; Q54755362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG224
AC   CVCL_LV61
SY   CSG224
DR   MMRRC; MMRRC:014285-UCD
DR   Wikidata; Q54755364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3704127; Zfp808.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG225
AC   CVCL_LV62
SY   CSG225
DR   MMRRC; MMRRC:014286-UCD
DR   Wikidata; Q54755366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913775; Timm50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG234
AC   CVCL_LV63
SY   CSG234
DR   MMRRC; MMRRC:014289-UCD
DR   Wikidata; Q54755369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913435; Virma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG235
AC   CVCL_LV64
SY   CSG235
DR   MMRRC; MMRRC:014290-UCD
DR   Wikidata; Q54755370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99526; Ddx19a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG236
AC   CVCL_LV65
SY   CSG236
DR   MMRRC; MMRRC:014291-UCD
DR   Wikidata; Q54755371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106248; Eif5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG241
AC   CVCL_LV66
SY   CSG241
DR   MMRRC; MMRRC:014294-UCD
DR   Wikidata; Q54755373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG243
AC   CVCL_LV67
SY   CSG243
DR   MMRRC; MMRRC:014295-UCD
DR   Wikidata; Q54755375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG246
AC   CVCL_LV68
SY   CSG246
DR   MMRRC; MMRRC:014298-UCD
DR   Wikidata; Q54755376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913866; Snx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG247
AC   CVCL_LV69
SY   CSG247
DR   MMRRC; MMRRC:014299-UCD
DR   Wikidata; Q54755380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915385; Eif3h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG251
AC   CVCL_LV70
SY   CSG251
DR   MMRRC; MMRRC:014300-UCD
DR   Wikidata; Q54755382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95299; Eif2s1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG253
AC   CVCL_LV71
SY   CSG253
DR   MMRRC; MMRRC:014301-UCD
DR   Wikidata; Q54755383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG254
AC   CVCL_LV72
SY   CSG254
DR   MMRRC; MMRRC:014302-UCD
DR   Wikidata; Q54755386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG256
AC   CVCL_LV73
SY   CSG256
DR   MMRRC; MMRRC:014303-UCD
DR   Wikidata; Q54755388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3588201; Erich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG260
AC   CVCL_LV74
SY   CSG260
DR   MMRRC; MMRRC:014305-UCD
DR   Wikidata; Q54755389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341087; Tnks.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG264
AC   CVCL_LV75
SY   CSG264
DR   MMRRC; MMRRC:014307-UCD
DR   Wikidata; Q54755394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919686; Tbcd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG268
AC   CVCL_LV76
SY   CSG268
DR   MMRRC; MMRRC:014309-UCD
DR   Wikidata; Q54755396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921445; Elp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG271
AC   CVCL_LV77
SY   CSG271
DR   MMRRC; MMRRC:014311-UCD
DR   Wikidata; Q54755398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2155302; Sec63.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG272
AC   CVCL_LV78
SY   CSG272
DR   MMRRC; MMRRC:014312-UCD
DR   Wikidata; Q54755400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103097; Anapc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG273
AC   CVCL_LV79
SY   CSG273
DR   MMRRC; MMRRC:014313-UCD
DR   Wikidata; Q54755401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99211; Zfx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG274
AC   CVCL_LV80
SY   CSG274
DR   MMRRC; MMRRC:014314-UCD
DR   Wikidata; Q54755442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355299; Hnrnpdl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG276
AC   CVCL_LV81
SY   CSG276
DR   MMRRC; MMRRC:014315-UCD
DR   Wikidata; Q54755443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914454; Eif2s2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG279
AC   CVCL_LV82
SY   CSG279
DR   MMRRC; MMRRC:014317-UCD
DR   Wikidata; Q54755444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109404; Nup98.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG280
AC   CVCL_LV83
SY   CSG280
DR   MMRRC; MMRRC:014318-UCD
DR   Wikidata; Q54755447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915312; Btf3l4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG281
AC   CVCL_LV84
SY   CSG281
DR   MMRRC; MMRRC:014319-UCD
DR   Wikidata; Q54755450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG282
AC   CVCL_LV85
SY   CSG282
DR   MMRRC; MMRRC:014320-UCD
DR   Wikidata; Q54755451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444959; Kmt2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG297
AC   CVCL_LV86
SY   CSG297
DR   MMRRC; MMRRC:014325-UCD
DR   Wikidata; Q54755453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351332; Azi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG298
AC   CVCL_LV87
SY   CSG298
DR   MMRRC; MMRRC:014326-UCD
DR   Wikidata; Q54755454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG305
AC   CVCL_LV88
SY   CSG305
DR   MMRRC; MMRRC:014331-UCD
DR   Wikidata; Q54755455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858696; Copg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG309
AC   CVCL_LV89
SY   CSG309
DR   MMRRC; MMRRC:014333-UCD
DR   Wikidata; Q54755458
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444923; Rbm41.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG317
AC   CVCL_LV90
SY   CSG317
DR   MMRRC; MMRRC:014336-UCD
DR   Wikidata; Q54755460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443679; Sipa1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG318
AC   CVCL_LV91
SY   CSG318
DR   MMRRC; MMRRC:014337-UCD
DR   Wikidata; Q54755462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103063; Stat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG320
AC   CVCL_LV92
SY   CSG320
DR   MMRRC; MMRRC:014339-UCD
DR   Wikidata; Q54755465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685106; Mideas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSG324
AC   CVCL_LV93
SY   CSG324
DR   MMRRC; MMRRC:014341-UCD
DR   Wikidata; Q54755466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG326
AC   CVCL_LV94
SY   CSG326
DR   MMRRC; MMRRC:014342-UCD
DR   Wikidata; Q54755468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336175; Kcnk5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG330
AC   CVCL_LV95
SY   CSG330
DR   MMRRC; MMRRC:014344-UCD
DR   Wikidata; Q54755470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261437; Atp5c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG336
AC   CVCL_LV96
SY   CSG336
DR   MMRRC; MMRRC:014345-UCD
DR   Wikidata; Q54755472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95612; Gabpb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG338
AC   CVCL_LV97
SY   CSG338
DR   MMRRC; MMRRC:014347-UCD
DR   Wikidata; Q54755473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107585; Srebf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG339
AC   CVCL_LV98
SY   CSG339
DR   MMRRC; MMRRC:014348-UCD
DR   Wikidata; Q54755475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916075; Mtmr14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG341
AC   CVCL_LV99
SY   CSG341
DR   MMRRC; MMRRC:014349-UCD
DR   Wikidata; Q54755476
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338803; Aire.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG348
AC   CVCL_LW00
SY   CSG348
DR   MMRRC; MMRRC:014354-UCD
DR   Wikidata; Q54755478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924177; Tsacc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG349
AC   CVCL_LW01
SY   CSG349
DR   MMRRC; MMRRC:014355-UCD
DR   Wikidata; Q54755480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923264; Zc3h18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG354
AC   CVCL_LW02
SY   CSG354
DR   MMRRC; MMRRC:014357-UCD
DR   Wikidata; Q54755482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921446; Ttc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG355
AC   CVCL_LW03
SY   CSG355
DR   MMRRC; MMRRC:014358-UCD
DR   Wikidata; Q54755484
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444959; Kmt2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG362
AC   CVCL_LW04
SY   CSG362
DR   MMRRC; MMRRC:014359-UCD
DR   Wikidata; Q54755485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG363
AC   CVCL_LW05
SY   CSG363
DR   MMRRC; MMRRC:014360-UCD
DR   Wikidata; Q54755487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109150; Mnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG367
AC   CVCL_LW06
SY   CSG367
DR   MMRRC; MMRRC:014363-UCD
DR   Wikidata; Q54755489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914210; Mindy3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG370
AC   CVCL_LW07
SY   CSG370
DR   MMRRC; MMRRC:014364-UCD
DR   Wikidata; Q54755491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105921; Zfp97.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG376
AC   CVCL_LW08
SY   CSG376
DR   MMRRC; MMRRC:014368-UCD
DR   Wikidata; Q54755492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925860; Uvrag.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG380
AC   CVCL_LW09
SY   CSG380
DR   MMRRC; MMRRC:014370-UCD
DR   Wikidata; Q54755496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG383
AC   CVCL_LW10
SY   CSG383
DR   MMRRC; MMRRC:014372-UCD
DR   Wikidata; Q54755497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG387
AC   CVCL_LW11
SY   CSG387
DR   MMRRC; MMRRC:014375-UCD
DR   Wikidata; Q54755499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144224; Dnaaf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSG396
AC   CVCL_LW12
SY   CSG396
DR   MMRRC; MMRRC:014380-UCD
DR   Wikidata; Q54755501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG399
AC   CVCL_LW13
SY   CSG399
DR   MMRRC; MMRRC:014382-UCD
DR   Wikidata; Q54755504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105068; Rab7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG400
AC   CVCL_LW14
SY   CSG400
DR   MMRRC; MMRRC:014383-UCD
DR   Wikidata; Q54755506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG413
AC   CVCL_LW15
SY   CSG413
DR   MMRRC; MMRRC:014387-UCD
DR   Wikidata; Q54755507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1195263; Lims1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG418
AC   CVCL_LW16
SY   CSG418
DR   MMRRC; MMRRC:014391-UCD
DR   Wikidata; Q54755509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443049; Phaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSG425
AC   CVCL_LW17
SY   CSG425
DR   MMRRC; MMRRC:014395-UCD
DR   Wikidata; Q54755511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144224; Dnaaf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSG428
AC   CVCL_LW18
SY   CSG428
DR   MMRRC; MMRRC:014398-UCD
DR   Wikidata; Q54755512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88568; Cux1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG429
AC   CVCL_LW19
SY   CSG429
DR   MMRRC; MMRRC:014399-UCD
DR   Wikidata; Q54755513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG430
AC   CVCL_LW20
SY   CSG430
DR   MMRRC; MMRRC:014400-UCD
DR   Wikidata; Q54755600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG434
AC   CVCL_LW21
SY   CSG434
DR   MMRRC; MMRRC:014401-UCD
DR   Wikidata; Q54755604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929285; Orc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG436
AC   CVCL_LW22
SY   CSG436
DR   MMRRC; MMRRC:014403-UCD
DR   Wikidata; Q54755605
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203522; Magi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG438
AC   CVCL_LW23
SY   CSG438
DR   MMRRC; MMRRC:014404-UCD
DR   Wikidata; Q54755608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916471; 2410006H16Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG441
AC   CVCL_LW24
SY   CSG441
DR   MMRRC; MMRRC:014406-UCD
DR   Wikidata; Q54755611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG442
AC   CVCL_LW25
SY   CSG442
DR   MMRRC; MMRRC:014407-UCD
DR   Wikidata; Q54755613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG443
AC   CVCL_LW26
SY   CSG443
DR   MMRRC; MMRRC:014408-UCD
DR   Wikidata; Q54755615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3702045; Bloc1s2-ps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG446
AC   CVCL_LW27
SY   CSG446
DR   MMRRC; MMRRC:014410-UCD
DR   Wikidata; Q54755617
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3026886; Cdin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSG447
AC   CVCL_LW28
SY   CSG447
DR   MMRRC; MMRRC:014411-UCD
DR   Wikidata; Q54755619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG449
AC   CVCL_LW29
SY   CSG449
DR   MMRRC; MMRRC:014413-UCD
DR   Wikidata; Q54755620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039624; Tstd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG452
AC   CVCL_LW30
SY   CSG452
DR   MMRRC; MMRRC:014414-UCD
DR   Wikidata; Q54755621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139083; Cep152.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG454
AC   CVCL_LW31
SY   CSG454
DR   MMRRC; MMRRC:014416-UCD
DR   Wikidata; Q54755626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920014; Csnk1g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG464
AC   CVCL_LW32
SY   CSG464
DR   MMRRC; MMRRC:014420-UCD
DR   Wikidata; Q54755627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889585; Sall1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG466
AC   CVCL_LW33
SY   CSG466
DR   MMRRC; MMRRC:014422-UCD
DR   Wikidata; Q54755630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG473
AC   CVCL_LW34
SY   CSG473
DR   MMRRC; MMRRC:014428-UCD
DR   Wikidata; Q54755632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG478
AC   CVCL_LW35
SY   CSG478
DR   MMRRC; MMRRC:014431-UCD
DR   Wikidata; Q54755633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924270; Atl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG487
AC   CVCL_LW36
SY   CSG487
DR   MMRRC; MMRRC:014437-UCD
DR   Wikidata; Q54755635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97874; Rb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG494
AC   CVCL_LW37
SY   CSG494
DR   MMRRC; MMRRC:014439-UCD
DR   Wikidata; Q54755636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG499
AC   CVCL_LW38
SY   CSG499
DR   MMRRC; MMRRC:014442-UCD
DR   Wikidata; Q54755638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915337; Dcakd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG508
AC   CVCL_LW39
SY   CSG508
DR   MMRRC; MMRRC:014445-UCD
DR   Wikidata; Q54755639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450915; Sec23ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG509
AC   CVCL_LW40
SY   CSG509
DR   MMRRC; MMRRC:014446-UCD
DR   Wikidata; Q54755642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685385; Kalrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG512
AC   CVCL_LW41
SY   CSG512
DR   MMRRC; MMRRC:014448-UCD
DR   Wikidata; Q54755644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681523; Tnpo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG515
AC   CVCL_LW42
SY   CSG515
DR   MMRRC; MMRRC:014449-UCD
DR   Wikidata; Q54755646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107403; Clk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG521
AC   CVCL_LW43
SY   CSG521
DR   MMRRC; MMRRC:014450-UCD
DR   Wikidata; Q54755648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139746; Ankrd13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG525
AC   CVCL_LW44
SY   CSG525
DR   MMRRC; MMRRC:014453-UCD
DR   Wikidata; Q54755649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSG527
AC   CVCL_LW45
SY   CSG527
DR   MMRRC; MMRRC:014454-UCD
DR   Wikidata; Q54755651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH001
AC   CVCL_LW46
SY   CSH001
DR   MMRRC; MMRRC:014719-UCD
DR   Wikidata; Q54755653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913917; Hspbap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH002
AC   CVCL_LW47
SY   CSH002
DR   MMRRC; MMRRC:014720-UCD
DR   Wikidata; Q54755655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3704127; Zfp808.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH003
AC   CVCL_LW48
SY   CSH003
DR   MMRRC; MMRRC:014721-UCD
DR   Wikidata; Q54755657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679002; Prr12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH005
AC   CVCL_LW49
SY   CSH005
DR   MMRRC; MMRRC:014722-UCD
DR   Wikidata; Q54755659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH007
AC   CVCL_LW50
SY   CSH007
DR   MMRRC; MMRRC:014723-UCD
DR   Wikidata; Q54755662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276125; Utf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH014
AC   CVCL_LW51
SY   CSH014
DR   MMRRC; MMRRC:014726-UCD
DR   Wikidata; Q54755664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88251; Calm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH020
AC   CVCL_LW52
SY   CSH020
DR   MMRRC; MMRRC:014728-UCD
DR   Wikidata; Q54755666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107788; Atp1b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH024
AC   CVCL_LW53
SY   CSH024
DR   MMRRC; MMRRC:014729-UCD
DR   Wikidata; Q54755668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106906; Eif4a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH028
AC   CVCL_LW54
SY   CSH028
DR   MMRRC; MMRRC:014730-UCD
DR   Wikidata; Q54755671
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102956; Cdk7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH029
AC   CVCL_LW55
SY   CSH029
DR   MMRRC; MMRRC:014731-UCD
DR   Wikidata; Q54755672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921331; Cep350.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH038
AC   CVCL_LW56
SY   CSH038
DR   MMRRC; MMRRC:014733-UCD
DR   Wikidata; Q54755674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH045
AC   CVCL_LW57
SY   CSH045
DR   MMRRC; MMRRC:014734-UCD
DR   Wikidata; Q54755677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH048
AC   CVCL_LW58
SY   CSH048
DR   MMRRC; MMRRC:014736-UCD
DR   Wikidata; Q54755680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH052
AC   CVCL_LW59
SY   CSH052
DR   MMRRC; MMRRC:014738-UCD
DR   Wikidata; Q54755682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914346; Mmachc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH053
AC   CVCL_LW60
SY   CSH053
DR   MMRRC; MMRRC:014739-UCD
DR   Wikidata; Q54755727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913435; Virma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH055
AC   CVCL_LW61
SY   CSH055
DR   MMRRC; MMRRC:014741-UCD
DR   Wikidata; Q54755728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914928; Lsm3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH059
AC   CVCL_LW62
SY   CSH059
DR   MMRRC; MMRRC:014742-UCD
DR   Wikidata; Q54755731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH063
AC   CVCL_LW63
SY   CSH063
DR   MMRRC; MMRRC:014743-UCD
DR   Wikidata; Q54755732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH066
AC   CVCL_LW64
SY   CSH066
DR   MMRRC; MMRRC:014744-UCD
DR   Wikidata; Q54755734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352483; Mga.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH068
AC   CVCL_LW65
SY   CSH068
DR   MMRRC; MMRRC:014745-UCD
DR   Wikidata; Q54755737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103199; Mcm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH083
AC   CVCL_LW66
SY   CSH083
DR   MMRRC; MMRRC:014750-UCD
DR   Wikidata; Q54755739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98388; Sptbn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH084
AC   CVCL_LW67
SY   CSH084
DR   MMRRC; MMRRC:014751-UCD
DR   Wikidata; Q54755741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387217; Ift52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH091
AC   CVCL_LW68
SY   CSH091
DR   MMRRC; MMRRC:014752-UCD
DR   Wikidata; Q54755743
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH092
AC   CVCL_LW69
SY   CSH092
DR   MMRRC; MMRRC:014753-UCD
DR   Wikidata; Q54755745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916555; Dcps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH096
AC   CVCL_LW70
SY   CSH096
DR   MMRRC; MMRRC:014755-UCD
DR   Wikidata; Q54755746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH097
AC   CVCL_LW71
SY   CSH097
DR   MMRRC; MMRRC:014798-UCD
DR   Wikidata; Q54755748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590652; Txlng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH100
AC   CVCL_LW72
SY   CSH100
DR   MMRRC; MMRRC:014799-UCD
DR   Wikidata; Q54755749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914345; Trak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH103
AC   CVCL_LW73
SY   CSH103
DR   MMRRC; MMRRC:014801-UCD
DR   Wikidata; Q54755752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445020; Exoc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH109
AC   CVCL_LW74
SY   CSH109
DR   MMRRC; MMRRC:014804-UCD
DR   Wikidata; Q54755753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917678; Polr3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH112
AC   CVCL_LW75
SY   CSH112
DR   MMRRC; MMRRC:014805-UCD
DR   Wikidata; Q54755755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH113
AC   CVCL_LW76
SY   CSH113
DR   MMRRC; MMRRC:014806-UCD
DR   Wikidata; Q54755756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH114
AC   CVCL_LW77
SY   CSH114
DR   MMRRC; MMRRC:014807-UCD
DR   Wikidata; Q54755758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925836; Srbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH117
AC   CVCL_LW78
SY   CSH117
DR   MMRRC; MMRRC:014808-UCD
DR   Wikidata; Q54755760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915392; Ino80.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH118
AC   CVCL_LW79
SY   CSH118
DR   MMRRC; MMRRC:014809-UCD
DR   Wikidata; Q54755762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346870; Map2k6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH123
AC   CVCL_LW80
SY   CSH123
DR   MMRRC; MMRRC:014811-UCD
DR   Wikidata; Q54755764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146156; Espl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH124
AC   CVCL_LW81
SY   CSH124
DR   MMRRC; MMRRC:014812-UCD
DR   Wikidata; Q54755765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914179; Asf1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH129
AC   CVCL_LW82
SY   CSH129
DR   MMRRC; MMRRC:014814-UCD
DR   Wikidata; Q54755766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913501; Arfgap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH131
AC   CVCL_LW83
SY   CSH131
DR   MMRRC; MMRRC:014815-UCD
DR   Wikidata; Q54755767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH133
AC   CVCL_LW84
SY   CSH133
DR   MMRRC; MMRRC:014816-UCD
DR   Wikidata; Q54755769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913516; Eapp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH134
AC   CVCL_LW85
SY   CSH134
DR   MMRRC; MMRRC:014817-UCD
DR   Wikidata; Q54755770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917275; Acot7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH135
AC   CVCL_LW86
SY   CSH135
DR   MMRRC; MMRRC:014818-UCD
DR   Wikidata; Q54755772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97547; Pfkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH136
AC   CVCL_LW87
SY   CSH136
DR   MMRRC; MMRRC:014819-UCD
DR   Wikidata; Q54755775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141291; Bud31.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH140
AC   CVCL_LW88
SY   CSH140
DR   MMRRC; MMRRC:014822-UCD
DR   Wikidata; Q54755778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH141
AC   CVCL_LW89
SY   CSH141
DR   MMRRC; MMRRC:014823-UCD
DR   Wikidata; Q54755779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444773; Mavs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH142
AC   CVCL_LW90
SY   CSH142
DR   MMRRC; MMRRC:014824-UCD
DR   Wikidata; Q54755783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920179; Dip2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH144
AC   CVCL_LW91
SY   CSH144
DR   MMRRC; MMRRC:014825-UCD
DR   Wikidata; Q54755784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH147
AC   CVCL_LW92
SY   CSH147
DR   MMRRC; MMRRC:014826-UCD
DR   Wikidata; Q54755785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931123; Inpp4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH148
AC   CVCL_LW93
SY   CSH148
DR   MMRRC; MMRRC:014827-UCD
DR   Wikidata; Q54755786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918677; Ibtk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH149
AC   CVCL_LW94
SY   CSH149
DR   MMRRC; MMRRC:014828-UCD
DR   Wikidata; Q54755789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH150
AC   CVCL_LW95
SY   CSH150
DR   MMRRC; MMRRC:014829-UCD
DR   Wikidata; Q54755791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH154
AC   CVCL_LW96
SY   CSH154
DR   MMRRC; MMRRC:014832-UCD
DR   Wikidata; Q54755793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97502; Pcmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH155
AC   CVCL_LW97
SY   CSH155
DR   MMRRC; MMRRC:014833-UCD
DR   Wikidata; Q54755796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923241; Slain2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH156
AC   CVCL_LW98
SY   CSH156
DR   MMRRC; MMRRC:014834-UCD
DR   Wikidata; Q54755797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH157
AC   CVCL_LW99
SY   CSH157
DR   MMRRC; MMRRC:014835-UCD
DR   Wikidata; Q54755798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH161
AC   CVCL_LX00
SY   CSH161
DR   MMRRC; MMRRC:014836-UCD
DR   Wikidata; Q54755841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277172; Ddx56.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH164
AC   CVCL_LX01
SY   CSH164
DR   MMRRC; MMRRC:014837-UCD
DR   Wikidata; Q54755844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918764; Sfpq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH165
AC   CVCL_LX02
SY   CSH165
DR   MMRRC; MMRRC:014838-UCD
DR   Wikidata; Q54755846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927110; Tmem131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH169
AC   CVCL_LX03
SY   CSH169
DR   MMRRC; MMRRC:014839-UCD
DR   Wikidata; Q54755849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921571; Tipin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH170
AC   CVCL_LX04
SY   CSH170
DR   MMRRC; MMRRC:014840-UCD
DR   Wikidata; Q54755851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442372; Fam168a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH173
AC   CVCL_LX05
SY   CSH173
DR   MMRRC; MMRRC:014842-UCD
DR   Wikidata; Q54755852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH175
AC   CVCL_LX06
SY   CSH175
DR   MMRRC; MMRRC:014843-UCD
DR   Wikidata; Q54755855
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355328; Nasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH177
AC   CVCL_LX07
SY   CSH177
DR   MMRRC; MMRRC:014844-UCD
DR   Wikidata; Q54755857
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914321; Rps6ka6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH178
AC   CVCL_LX08
SY   CSH178
DR   MMRRC; MMRRC:014845-UCD
DR   Wikidata; Q54755859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384298; Sbno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH180
AC   CVCL_LX09
SY   CSH180
DR   MMRRC; MMRRC:014847-UCD
DR   Wikidata; Q54755863
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97346; Nktr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH182
AC   CVCL_LX10
SY   CSH182
DR   MMRRC; MMRRC:014848-UCD
DR   Wikidata; Q54755866
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916873; Zfp33b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH184
AC   CVCL_LX11
SY   CSH184
DR   MMRRC; MMRRC:014850-UCD
DR   Wikidata; Q54755868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679002; Prr12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH185
AC   CVCL_LX12
SY   CSH185
DR   MMRRC; MMRRC:014851-UCD
DR   Wikidata; Q54755870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3578435; L1td1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH187
AC   CVCL_LX13
SY   CSH187
DR   MMRRC; MMRRC:014852-UCD
DR   Wikidata; Q54755873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045391; Lin52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH188
AC   CVCL_LX14
SY   CSH188
DR   MMRRC; MMRRC:014853-UCD
DR   Wikidata; Q54755875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917579; Gon4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH189
AC   CVCL_LX15
SY   CSH189
DR   MMRRC; MMRRC:014854-UCD
DR   Wikidata; Q54755878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH192
AC   CVCL_LX16
SY   CSH192
DR   MMRRC; MMRRC:014855-UCD
DR   Wikidata; Q54755879
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914457; Lsm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH194
AC   CVCL_LX17
SY   CSH194
DR   MMRRC; MMRRC:014856-UCD
DR   Wikidata; Q54755883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916478; Zfp746.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH195
AC   CVCL_LX18
SY   CSH195
DR   MMRRC; MMRRC:014857-UCD
DR   Wikidata; Q54755885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH200
AC   CVCL_LX19
SY   CSH200
DR   MMRRC; MMRRC:014859-UCD
DR   Wikidata; Q54755887
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH201
AC   CVCL_LX20
SY   CSH201
DR   MMRRC; MMRRC:014860-UCD
DR   Wikidata; Q54755889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921404; Unkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH202
AC   CVCL_LX21
SY   CSH202
DR   MMRRC; MMRRC:014861-UCD
DR   Wikidata; Q54755892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH204
AC   CVCL_LX22
SY   CSH204
DR   MMRRC; MMRRC:014862-UCD
DR   Wikidata; Q54755894
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145317; Brd9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH205
AC   CVCL_LX23
SY   CSH205
DR   MMRRC; MMRRC:014863-UCD
DR   Wikidata; Q54755895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH206
AC   CVCL_LX24
SY   CSH206
DR   MMRRC; MMRRC:014864-UCD
DR   Wikidata; Q54755899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182061; Usp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH211
AC   CVCL_LX25
SY   CSH211
DR   MMRRC; MMRRC:014865-UCD
DR   Wikidata; Q54755901
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336881; Mok.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH212
AC   CVCL_LX26
SY   CSH212
DR   MMRRC; MMRRC:014866-UCD
DR   Wikidata; Q54755903
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99204; Zfp57.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH214
AC   CVCL_LX27
SY   CSH214
DR   MMRRC; MMRRC:014867-UCD
DR   Wikidata; Q54755906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346098; Nelfa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH215
AC   CVCL_LX28
SY   CSH215
DR   MMRRC; MMRRC:014868-UCD
DR   Wikidata; Q54755908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443926; Dmxl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH217
AC   CVCL_LX29
SY   CSH217
DR   MMRRC; MMRRC:014870-UCD
DR   Wikidata; Q54755909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443926; Dmxl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH219
AC   CVCL_LX30
SY   CSH219
DR   MMRRC; MMRRC:014871-UCD
DR   Wikidata; Q54755912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH220
AC   CVCL_LX31
SY   CSH220
DR   MMRRC; MMRRC:014872-UCD
DR   Wikidata; Q54755913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917140; Zfp219.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH221
AC   CVCL_LX32
SY   CSH221
DR   MMRRC; MMRRC:014873-UCD
DR   Wikidata; Q54755915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670969; Nrde2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH222
AC   CVCL_LX33
SY   CSH222
DR   MMRRC; MMRRC:014874-UCD
DR   Wikidata; Q54755917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342294; Uri1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH225
AC   CVCL_LX34
SY   CSH225
DR   MMRRC; MMRRC:014875-UCD
DR   Wikidata; Q54755919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH227
AC   CVCL_LX35
SY   CSH227
DR   MMRRC; MMRRC:014876-UCD
DR   Wikidata; Q54755922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929648; Med20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH228
AC   CVCL_LX36
SY   CSH228
DR   MMRRC; MMRRC:014877-UCD
DR   Wikidata; Q54755923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99181; Zfp37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH229
AC   CVCL_LX37
SY   CSH229
DR   MMRRC; MMRRC:014878-UCD
DR   Wikidata; Q54755924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99181; Zfp37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH230
AC   CVCL_LX38
SY   CSH230
DR   MMRRC; MMRRC:014879-UCD
DR   Wikidata; Q54755925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98884; U2af1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH232
AC   CVCL_LX39
SY   CSH232
DR   MMRRC; MMRRC:014880-UCD
DR   Wikidata; Q54755928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914760; Tvp23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH239
AC   CVCL_LX40
SY   CSH239
DR   MMRRC; MMRRC:014882-UCD
DR   Wikidata; Q54755970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346340; Mta2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH244
AC   CVCL_LX41
SY   CSH244
DR   MMRRC; MMRRC:014884-UCD
DR   Wikidata; Q54755971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346340; Mta2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH247
AC   CVCL_LX42
SY   CSH247
DR   MMRRC; MMRRC:014885-UCD
DR   Wikidata; Q54755972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH250
AC   CVCL_LX43
SY   CSH250
DR   MMRRC; MMRRC:014886-UCD
DR   Wikidata; Q54755973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH253
AC   CVCL_LX44
SY   CSH253
DR   MMRRC; MMRRC:014887-UCD
DR   Wikidata; Q54755977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH256
AC   CVCL_LX45
SY   CSH256
DR   MMRRC; MMRRC:014889-UCD
DR   Wikidata; Q54755981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH259
AC   CVCL_LX46
SY   CSH259
DR   MMRRC; MMRRC:014891-UCD
DR   Wikidata; Q54755984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333799; Xrcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH260
AC   CVCL_LX47
SY   CSH260
DR   MMRRC; MMRRC:014892-UCD
DR   Wikidata; Q54755985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924393; Trip11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH266
AC   CVCL_LX48
SY   CSH266
DR   MMRRC; MMRRC:014893-UCD
DR   Wikidata; Q54755987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH267
AC   CVCL_LX49
SY   CSH267
DR   MMRRC; MMRRC:014894-UCD
DR   Wikidata; Q54755990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH268
AC   CVCL_LX50
SY   CSH268
DR   MMRRC; MMRRC:014895-UCD
DR   Wikidata; Q54755993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140050; Ints3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH271
AC   CVCL_LX51
SY   CSH271
DR   MMRRC; MMRRC:014896-UCD
DR   Wikidata; Q54755994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH272
AC   CVCL_LX52
SY   CSH272
DR   MMRRC; MMRRC:014897-UCD
DR   Wikidata; Q54755996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915751; Nsmce2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH273
AC   CVCL_LX53
SY   CSH273
DR   MMRRC; MMRRC:014898-UCD
DR   Wikidata; Q54755998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141959; Alg8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH275
AC   CVCL_LX54
SY   CSH275
DR   MMRRC; MMRRC:014899-UCD
DR   Wikidata; Q54756002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384798; Osgin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH276
AC   CVCL_LX55
SY   CSH276
DR   MMRRC; MMRRC:014900-UCD
DR   Wikidata; Q54756003
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH278
AC   CVCL_LX56
SY   CSH278
DR   MMRRC; MMRRC:014901-UCD
DR   Wikidata; Q54756004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH281
AC   CVCL_LX57
SY   CSH281
DR   MMRRC; MMRRC:014903-UCD
DR   Wikidata; Q54756006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH285
AC   CVCL_LX58
SY   CSH285
DR   MMRRC; MMRRC:014904-UCD
DR   Wikidata; Q54756008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107380; Spag7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH286
AC   CVCL_LX59
SY   CSH286
DR   MMRRC; MMRRC:014905-UCD
DR   Wikidata; Q54756009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352466; Nr2c2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH287
AC   CVCL_LX60
SY   CSH287
DR   MMRRC; MMRRC:014906-UCD
DR   Wikidata; Q54756011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH295
AC   CVCL_LX61
SY   CSH295
DR   MMRRC; MMRRC:014908-UCD
DR   Wikidata; Q54756015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105917; Fer.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH299
AC   CVCL_LX62
SY   CSH299
DR   MMRRC; MMRRC:014909-UCD
DR   Wikidata; Q54756017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH307
AC   CVCL_LX63
SY   CSH307
DR   MMRRC; MMRRC:014912-UCD
DR   Wikidata; Q54756019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922083; Ciapin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH308
AC   CVCL_LX64
SY   CSH308
DR   MMRRC; MMRRC:014913-UCD
DR   Wikidata; Q54756021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918006; Dock4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH310
AC   CVCL_LX65
SY   CSH310
DR   MMRRC; MMRRC:014914-UCD
DR   Wikidata; Q54756023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684864; Pfas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH312
AC   CVCL_LX66
SY   CSH312
DR   MMRRC; MMRRC:014915-UCD
DR   Wikidata; Q54756025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100856; Mras.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH314
AC   CVCL_LX67
SY   CSH314
DR   MMRRC; MMRRC:014916-UCD
DR   Wikidata; Q54756026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926027; Tepsin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH315
AC   CVCL_LX68
SY   CSH315
DR   MMRRC; MMRRC:014917-UCD
DR   Wikidata; Q54756029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444737; Fem1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH316
AC   CVCL_LX69
SY   CSH316
DR   MMRRC; MMRRC:014918-UCD
DR   Wikidata; Q54756031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH320
AC   CVCL_LX70
SY   CSH320
DR   MMRRC; MMRRC:014919-UCD
DR   Wikidata; Q54756033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385139; Rabgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH323
AC   CVCL_LX71
SY   CSH323
DR   MMRRC; MMRRC:014920-UCD
DR   Wikidata; Q54756034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921409; Acbd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH324
AC   CVCL_LX72
SY   CSH324
DR   MMRRC; MMRRC:014921-UCD
DR   Wikidata; Q54756037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921361; Rbm19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH325
AC   CVCL_LX73
SY   CSH325
DR   MMRRC; MMRRC:014922-UCD
DR   Wikidata; Q54756040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH326
AC   CVCL_LX74
SY   CSH326
DR   MMRRC; MMRRC:014923-UCD
DR   Wikidata; Q54756041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH327
AC   CVCL_LX75
SY   CSH327
DR   MMRRC; MMRRC:014924-UCD
DR   Wikidata; Q54756043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145425; Depdc1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH329
AC   CVCL_LX76
SY   CSH329
DR   MMRRC; MMRRC:014926-UCD
DR   Wikidata; Q54756045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384788; Sde2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH331
AC   CVCL_LX77
SY   CSH331
DR   MMRRC; MMRRC:014927-UCD
DR   Wikidata; Q54756046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443446; Scfd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH335
AC   CVCL_LX78
SY   CSH335
DR   MMRRC; MMRRC:014928-UCD
DR   Wikidata; Q54756048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921409; Acbd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH336
AC   CVCL_LX79
SY   CSH336
DR   MMRRC; MMRRC:014929-UCD
DR   Wikidata; Q54756049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921409; Acbd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH337
AC   CVCL_LX80
SY   CSH337
DR   MMRRC; MMRRC:014930-UCD
DR   Wikidata; Q54756101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH338
AC   CVCL_LX81
SY   CSH338
DR   MMRRC; MMRRC:014931-UCD
DR   Wikidata; Q54756102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925920; Plekhj1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH341
AC   CVCL_LX82
SY   CSH341
DR   MMRRC; MMRRC:014932-UCD
DR   Wikidata; Q54756104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96622; Itpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH342
AC   CVCL_LX83
SY   CSH342
DR   MMRRC; MMRRC:014933-UCD
DR   Wikidata; Q54756106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388280; Polr2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH344
AC   CVCL_LX84
SY   CSH344
DR   MMRRC; MMRRC:014934-UCD
DR   Wikidata; Q54756107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919686; Tbcd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH345
AC   CVCL_LX85
SY   CSH345
DR   MMRRC; MMRRC:014935-UCD
DR   Wikidata; Q54756109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921728; Snx29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH346
AC   CVCL_LX86
SY   CSH346
DR   MMRRC; MMRRC:014936-UCD
DR   Wikidata; Q54756113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH347
AC   CVCL_LX87
SY   CSH347
DR   MMRRC; MMRRC:014937-UCD
DR   Wikidata; Q54756114
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH348
AC   CVCL_LX88
SY   CSH348
DR   MMRRC; MMRRC:014938-UCD
DR   Wikidata; Q54756117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921409; Acbd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH349
AC   CVCL_LX89
SY   CSH349
DR   MMRRC; MMRRC:014939-UCD
DR   Wikidata; Q54756118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917394; Lrch3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH351
AC   CVCL_LX90
SY   CSH351
DR   MMRRC; MMRRC:014940-UCD
DR   Wikidata; Q54756119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH352
AC   CVCL_LX91
SY   CSH352
DR   MMRRC; MMRRC:014941-UCD
DR   Wikidata; Q54756121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914289; Rbm25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH354
AC   CVCL_LX92
SY   CSH354
DR   MMRRC; MMRRC:014943-UCD
DR   Wikidata; Q54756123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913917; Hspbap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH356
AC   CVCL_LX93
SY   CSH356
DR   MMRRC; MMRRC:014944-UCD
DR   Wikidata; Q54756125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444554; Mapkap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH358
AC   CVCL_LX94
SY   CSH358
DR   MMRRC; MMRRC:014945-UCD
DR   Wikidata; Q54756128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH360
AC   CVCL_LX95
SY   CSH360
DR   MMRRC; MMRRC:014946-UCD
DR   Wikidata; Q54756131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100851; Elavl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH361
AC   CVCL_LX96
SY   CSH361
DR   MMRRC; MMRRC:014947-UCD
DR   Wikidata; Q54756134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338026; Tom1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH363
AC   CVCL_LX97
SY   CSH363
DR   MMRRC; MMRRC:014948-UCD
DR   Wikidata; Q54756135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108517; Denn2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH364
AC   CVCL_LX98
SY   CSH364
DR   MMRRC; MMRRC:014949-UCD
DR   Wikidata; Q54756137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928380; B4galt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH368
AC   CVCL_LX99
SY   CSH368
DR   MMRRC; MMRRC:014951-UCD
DR   Wikidata; Q54756140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH376
AC   CVCL_LY00
SY   CSH376
DR   MMRRC; MMRRC:014953-UCD
DR   Wikidata; Q54756141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109404; Nup98.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH382
AC   CVCL_LY01
SY   CSH382
DR   MMRRC; MMRRC:014955-UCD
DR   Wikidata; Q54756143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915955; Gtf2f2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH383
AC   CVCL_LY02
SY   CSH383
DR   MMRRC; MMRRC:014956-UCD
DR   Wikidata; Q54756147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919607; 2210016L21Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH385
AC   CVCL_LY03
SY   CSH385
DR   MMRRC; MMRRC:014957-UCD
DR   Wikidata; Q54756148
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443298; Tet2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH387
AC   CVCL_LY04
SY   CSH387
DR   MMRRC; MMRRC:014958-UCD
DR   Wikidata; Q54756150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919054; Mtfr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH388
AC   CVCL_LY05
SY   CSH388
DR   MMRRC; MMRRC:014959-UCD
DR   Wikidata; Q54756152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH389
AC   CVCL_LY06
SY   CSH389
DR   MMRRC; MMRRC:014960-UCD
DR   Wikidata; Q54756153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929494; Arhgap35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH391
AC   CVCL_LY07
SY   CSH391
DR   MMRRC; MMRRC:014961-UCD
DR   Wikidata; Q54756155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933196; Rad54l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH392
AC   CVCL_LY08
SY   CSH392
DR   MMRRC; MMRRC:014962-UCD
DR   Wikidata; Q54756158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919782; Sap130.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH394
AC   CVCL_LY09
SY   CSH394
DR   MMRRC; MMRRC:014964-UCD
DR   Wikidata; Q54756159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139764; Sec24b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH398
AC   CVCL_LY10
SY   CSH398
DR   MMRRC; MMRRC:014965-UCD
DR   Wikidata; Q54756160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147437; Rrp12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH399
AC   CVCL_LY11
SY   CSH399
DR   MMRRC; MMRRC:014966-UCD
DR   Wikidata; Q54756161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289332; Eipr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH401
AC   CVCL_LY12
SY   CSH401
DR   MMRRC; MMRRC:014967-UCD
DR   Wikidata; Q54756164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914186; Asph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH402
AC   CVCL_LY13
SY   CSH402
DR   MMRRC; MMRRC:014968-UCD
DR   Wikidata; Q54756167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141161; Tyw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH403
AC   CVCL_LY14
SY   CSH403
DR   MMRRC; MMRRC:014969-UCD
DR   Wikidata; Q54756169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346834; Nr5a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH404
AC   CVCL_LY15
SY   CSH404
DR   MMRRC; MMRRC:014970-UCD
DR   Wikidata; Q54756171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917294; Tut1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH405
AC   CVCL_LY16
SY   CSH405
DR   MMRRC; MMRRC:014971-UCD
DR   Wikidata; Q54756172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH408
AC   CVCL_LY17
SY   CSH408
DR   MMRRC; MMRRC:014973-UCD
DR   Wikidata; Q54756175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194497; Tgif1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH409
AC   CVCL_LY18
SY   CSH409
DR   MMRRC; MMRRC:014974-UCD
DR   Wikidata; Q54756176
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH410
AC   CVCL_LY19
SY   CSH410
DR   MMRRC; MMRRC:014975-UCD
DR   Wikidata; Q54756177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096570; Tex264.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH411
AC   CVCL_LY20
SY   CSH411
DR   MMRRC; MMRRC:014976-UCD
DR   Wikidata; Q54756224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99135; Xpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH413
AC   CVCL_LY21
SY   CSH413
DR   MMRRC; MMRRC:014978-UCD
DR   Wikidata; Q54756226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385884; Ddx27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH415
AC   CVCL_LY22
SY   CSH415
DR   MMRRC; MMRRC:014979-UCD
DR   Wikidata; Q54756228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH416
AC   CVCL_LY23
SY   CSH416
DR   MMRRC; MMRRC:014980-UCD
DR   Wikidata; Q54756231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH418
AC   CVCL_LY24
SY   CSH418
DR   MMRRC; MMRRC:014981-UCD
DR   Wikidata; Q54756234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388280; Polr2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH424
AC   CVCL_LY25
SY   CSH424
DR   MMRRC; MMRRC:014985-UCD
DR   Wikidata; Q54756235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107788; Atp1b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH426
AC   CVCL_LY26
SY   CSH426
DR   MMRRC; MMRRC:014986-UCD
DR   Wikidata; Q54756236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388280; Polr2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH427
AC   CVCL_LY27
SY   CSH427
DR   MMRRC; MMRRC:014987-UCD
DR   Wikidata; Q54756238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88431; Cnbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH428
AC   CVCL_LY28
SY   CSH428
DR   MMRRC; MMRRC:014988-UCD
DR   Wikidata; Q54756241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH429
AC   CVCL_LY29
SY   CSH429
DR   MMRRC; MMRRC:014989-UCD
DR   Wikidata; Q54756242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446126; Phf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH430
AC   CVCL_LY30
SY   CSH430
DR   MMRRC; MMRRC:014990-UCD
DR   Wikidata; Q54756244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH431
AC   CVCL_LY31
SY   CSH431
DR   MMRRC; MMRRC:014991-UCD
DR   Wikidata; Q54756245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921358; Parn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH432
AC   CVCL_LY32
SY   CSH432
DR   MMRRC; MMRRC:014992-UCD
DR   Wikidata; Q54756248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH436
AC   CVCL_LY33
SY   CSH436
DR   MMRRC; MMRRC:014995-UCD
DR   Wikidata; Q54756250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141466; Bmt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH438
AC   CVCL_LY34
SY   CSH438
DR   MMRRC; MMRRC:014997-UCD
DR   Wikidata; Q54756252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180003; Xpnpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH440
AC   CVCL_LY35
SY   CSH440
DR   MMRRC; MMRRC:014999-UCD
DR   Wikidata; Q54756253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196400; D16Ertd472e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH441
AC   CVCL_LY36
SY   CSH441
DR   MMRRC; MMRRC:015000-UCD
DR   Wikidata; Q54756257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913667; Mat2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH442
AC   CVCL_LY37
SY   CSH442
DR   MMRRC; MMRRC:015001-UCD
DR   Wikidata; Q54756259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890165; Larp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH444
AC   CVCL_LY38
SY   CSH444
DR   MMRRC; MMRRC:015002-UCD
DR   Wikidata; Q54756260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH446
AC   CVCL_LY39
SY   CSH446
DR   MMRRC; MMRRC:015003-UCD
DR   Wikidata; Q54756264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924705; Rlf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH447
AC   CVCL_LY40
SY   CSH447
DR   MMRRC; MMRRC:015004-UCD
DR   Wikidata; Q54756266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890156; Stx8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH449
AC   CVCL_LY41
SY   CSH449
DR   MMRRC; MMRRC:015005-UCD
DR   Wikidata; Q54756269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2663721; Zc3h3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH452
AC   CVCL_LY42
SY   CSH452
DR   MMRRC; MMRRC:015006-UCD
DR   Wikidata; Q54756272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444951; 8030462N17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH453
AC   CVCL_LY43
SY   CSH453
DR   MMRRC; MMRRC:015007-UCD
DR   Wikidata; Q54756273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098233; Impact.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH454
AC   CVCL_LY44
SY   CSH454
DR   MMRRC; MMRRC:015008-UCD
DR   Wikidata; Q54756275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920093; Prdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH455
AC   CVCL_LY45
SY   CSH455
DR   MMRRC; MMRRC:015009-UCD
DR   Wikidata; Q54756277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97758; Prim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH456
AC   CVCL_LY46
SY   CSH456
DR   MMRRC; MMRRC:015010-UCD
DR   Wikidata; Q54756279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH458
AC   CVCL_LY47
SY   CSH458
DR   MMRRC; MMRRC:015012-UCD
DR   Wikidata; Q54756280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309480; Rtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH459
AC   CVCL_LY48
SY   CSH459
DR   MMRRC; MMRRC:015013-UCD
DR   Wikidata; Q54756282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344373; Ubl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH461
AC   CVCL_LY49
SY   CSH461
DR   MMRRC; MMRRC:015015-UCD
DR   Wikidata; Q54756283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH464
AC   CVCL_LY50
SY   CSH464
DR   MMRRC; MMRRC:015017-UCD
DR   Wikidata; Q54756286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95739; Glul.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH465
AC   CVCL_LY51
SY   CSH465
DR   MMRRC; MMRRC:015018-UCD
DR   Wikidata; Q54756287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442988; Arfgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH469
AC   CVCL_LY52
SY   CSH469
DR   MMRRC; MMRRC:015019-UCD
DR   Wikidata; Q54756291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH470
AC   CVCL_LY53
SY   CSH470
DR   MMRRC; MMRRC:015020-UCD
DR   Wikidata; Q54756292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3781595; Dynlt2a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH473
AC   CVCL_LY54
SY   CSH473
DR   MMRRC; MMRRC:015021-UCD
DR   Wikidata; Q54756293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344381; Dnajb6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH474
AC   CVCL_LY55
SY   CSH474
DR   MMRRC; MMRRC:015022-UCD
DR   Wikidata; Q54756295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH475
AC   CVCL_LY56
SY   CSH475
DR   MMRRC; MMRRC:015023-UCD
DR   Wikidata; Q54756298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921728; Snx29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH476
AC   CVCL_LY57
SY   CSH476
DR   MMRRC; MMRRC:015024-UCD
DR   Wikidata; Q54756299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH478
AC   CVCL_LY58
SY   CSH478
DR   MMRRC; MMRRC:015026-UCD
DR   Wikidata; Q54756301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915751; Nsmce2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH479
AC   CVCL_LY59
SY   CSH479
DR   MMRRC; MMRRC:015027-UCD
DR   Wikidata; Q54756303
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444248; Gcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH480
AC   CVCL_LY60
SY   CSH480
DR   MMRRC; MMRRC:015028-UCD
DR   Wikidata; Q54756350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH482
AC   CVCL_LY61
SY   CSH482
DR   MMRRC; MMRRC:015029-UCD
DR   Wikidata; Q54756352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88431; Cnbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH488
AC   CVCL_LY62
SY   CSH488
DR   MMRRC; MMRRC:015031-UCD
DR   Wikidata; Q54756354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH492
AC   CVCL_LY63
SY   CSH492
DR   MMRRC; MMRRC:015032-UCD
DR   Wikidata; Q54756356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH493
AC   CVCL_LY64
SY   CSH493
DR   MMRRC; MMRRC:015033-UCD
DR   Wikidata; Q54756360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2663721; Zc3h3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH498
AC   CVCL_LY65
SY   CSH498
DR   MMRRC; MMRRC:015038-UCD
DR   Wikidata; Q54756362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH499
AC   CVCL_LY66
SY   CSH499
DR   MMRRC; MMRRC:015039-UCD
DR   Wikidata; Q54756365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276124; Ep400.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH501
AC   CVCL_LY67
SY   CSH501
DR   MMRRC; MMRRC:015040-UCD
DR   Wikidata; Q54756367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88042; Apex1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH505
AC   CVCL_LY68
SY   CSH505
DR   MMRRC; MMRRC:015041-UCD
DR   Wikidata; Q54756370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH507
AC   CVCL_LY69
SY   CSH507
DR   MMRRC; MMRRC:015042-UCD
DR   Wikidata; Q54756371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915955; Gtf2f2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH508
AC   CVCL_LY70
SY   CSH508
DR   MMRRC; MMRRC:015043-UCD
DR   Wikidata; Q54756372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH509
AC   CVCL_LY71
SY   CSH509
DR   MMRRC; MMRRC:015044-UCD
DR   Wikidata; Q54756374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925868; Acap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH513
AC   CVCL_LY72
SY   CSH513
DR   MMRRC; MMRRC:015046-UCD
DR   Wikidata; Q54756376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108086; Hdac1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH516
AC   CVCL_LY73
SY   CSH516
DR   MMRRC; MMRRC:015048-UCD
DR   Wikidata; Q54756378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88110; Atp2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH518
AC   CVCL_LY74
SY   CSH518
DR   MMRRC; MMRRC:015049-UCD
DR   Wikidata; Q54756379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH520
AC   CVCL_LY75
SY   CSH520
DR   MMRRC; MMRRC:015050-UCD
DR   Wikidata; Q54756380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH523
AC   CVCL_LY76
SY   CSH523
DR   MMRRC; MMRRC:015051-UCD
DR   Wikidata; Q54756382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916996; Znhit6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH524
AC   CVCL_LY77
SY   CSH524
DR   MMRRC; MMRRC:015052-UCD
DR   Wikidata; Q54756384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915525; Rpa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH527
AC   CVCL_LY78
SY   CSH527
DR   MMRRC; MMRRC:015055-UCD
DR   Wikidata; Q54756385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3527792; Zdhhc18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH528
AC   CVCL_LY79
SY   CSH528
DR   MMRRC; MMRRC:015056-UCD
DR   Wikidata; Q54756387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685335; Mctp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH530
AC   CVCL_LY80
SY   CSH530
DR   MMRRC; MMRRC:015057-UCD
DR   Wikidata; Q54756388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103197; Mcm5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH532
AC   CVCL_LY81
SY   CSH532
DR   MMRRC; MMRRC:015058-UCD
DR   Wikidata; Q54756391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH540
AC   CVCL_LY82
SY   CSH540
DR   MMRRC; MMRRC:015060-UCD
DR   Wikidata; Q54756393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928760; Ruvbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH542
AC   CVCL_LY83
SY   CSH542
DR   MMRRC; MMRRC:015061-UCD
DR   Wikidata; Q54756396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651014; Zfp268.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH543
AC   CVCL_LY84
SY   CSH543
DR   MMRRC; MMRRC:015062-UCD
DR   Wikidata; Q54756398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194490; Diaph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH544
AC   CVCL_LY85
SY   CSH544
DR   MMRRC; MMRRC:015063-UCD
DR   Wikidata; Q54756401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443878; Slc4a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH545
AC   CVCL_LY86
SY   CSH545
DR   MMRRC; MMRRC:015064-UCD
DR   Wikidata; Q54756403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924621; Sec24a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH548
AC   CVCL_LY87
SY   CSH548
DR   MMRRC; MMRRC:015065-UCD
DR   Wikidata; Q54756405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919837; Pan3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH550
AC   CVCL_LY88
SY   CSH550
DR   MMRRC; MMRRC:015066-UCD
DR   Wikidata; Q54756408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913986; Emc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH552
AC   CVCL_LY89
SY   CSH552
DR   MMRRC; MMRRC:015067-UCD
DR   Wikidata; Q54756409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682305; Rsf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH553
AC   CVCL_LY90
SY   CSH553
DR   MMRRC; MMRRC:015068-UCD
DR   Wikidata; Q54756411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH556
AC   CVCL_LY91
SY   CSH556
DR   MMRRC; MMRRC:015070-UCD
DR   Wikidata; Q54756413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928760; Ruvbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH557
AC   CVCL_LY92
SY   CSH557
DR   MMRRC; MMRRC:015071-UCD
DR   Wikidata; Q54756415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH559
AC   CVCL_LY93
SY   CSH559
DR   MMRRC; MMRRC:015072-UCD
DR   Wikidata; Q54756417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922858; Chmp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH561
AC   CVCL_LY94
SY   CSH561
DR   MMRRC; MMRRC:015073-UCD
DR   Wikidata; Q54756419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915098; Ddx55.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH562
AC   CVCL_LY95
SY   CSH562
DR   MMRRC; MMRRC:015074-UCD
DR   Wikidata; Q54756421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919367; Naa50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH563
AC   CVCL_LY96
SY   CSH563
DR   MMRRC; MMRRC:015075-UCD
DR   Wikidata; Q54756422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915955; Gtf2f2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH565
AC   CVCL_LY97
SY   CSH565
DR   MMRRC; MMRRC:015077-UCD
DR   Wikidata; Q54756424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH568
AC   CVCL_LY98
SY   CSH568
DR   MMRRC; MMRRC:015078-UCD
DR   Wikidata; Q54756427
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH571
AC   CVCL_LY99
SY   CSH571
DR   MMRRC; MMRRC:015079-UCD
DR   Wikidata; Q54756429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339970; Rtn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH572
AC   CVCL_LZ00
SY   CSH572
DR   MMRRC; MMRRC:015080-UCD
DR   Wikidata; Q54756517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH573
AC   CVCL_LZ01
SY   CSH573
DR   MMRRC; MMRRC:015081-UCD
DR   Wikidata; Q54756519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH575
AC   CVCL_LZ02
SY   CSH575
DR   MMRRC; MMRRC:015083-UCD
DR   Wikidata; Q54756522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109547; Dnm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH578
AC   CVCL_LZ03
SY   CSH578
DR   MMRRC; MMRRC:015085-UCD
DR   Wikidata; Q54756523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673855; Bicral.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH580
AC   CVCL_LZ04
SY   CSH580
DR   MMRRC; MMRRC:015086-UCD
DR   Wikidata; Q54756524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH583
AC   CVCL_LZ05
SY   CSH583
DR   MMRRC; MMRRC:015087-UCD
DR   Wikidata; Q54756526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926140; Trmt44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH584
AC   CVCL_LZ06
SY   CSH584
DR   MMRRC; MMRRC:015088-UCD
DR   Wikidata; Q54756528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH585
AC   CVCL_LZ07
SY   CSH585
DR   MMRRC; MMRRC:015089-UCD
DR   Wikidata; Q54756530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3697726; Arhgap23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH586
AC   CVCL_LZ08
SY   CSH586
DR   MMRRC; MMRRC:015090-UCD
DR   Wikidata; Q54756531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914473; Rrp15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH587
AC   CVCL_LZ09
SY   CSH587
DR   MMRRC; MMRRC:015091-UCD
DR   Wikidata; Q54756534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859162; Rnf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH589
AC   CVCL_LZ10
SY   CSH589
DR   MMRRC; MMRRC:015092-UCD
DR   Wikidata; Q54756536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH591
AC   CVCL_LZ11
SY   CSH591
DR   MMRRC; MMRRC:015093-UCD
DR   Wikidata; Q54756538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917294; Tut1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH594
AC   CVCL_LZ12
SY   CSH594
DR   MMRRC; MMRRC:015094-UCD
DR   Wikidata; Q54756539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915525; Rpa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH595
AC   CVCL_LZ13
SY   CSH595
DR   MMRRC; MMRRC:015095-UCD
DR   Wikidata; Q54756540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147627; Yars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH598
AC   CVCL_LZ14
SY   CSH598
DR   MMRRC; MMRRC:015097-UCD
DR   Wikidata; Q54756543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH600
AC   CVCL_LZ15
SY   CSH600
DR   MMRRC; MMRRC:015098-UCD
DR   Wikidata; Q54756545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH603
AC   CVCL_LZ16
SY   CSH603
DR   MMRRC; MMRRC:015119-UCD
DR   Wikidata; Q54756547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH606
AC   CVCL_LZ17
SY   CSH606
DR   MMRRC; MMRRC:015259-UCD
DR   Wikidata; Q54756550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098280; Crebbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH607
AC   CVCL_LZ18
SY   CSH607
DR   MMRRC; MMRRC:015260-UCD
DR   Wikidata; Q54756551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685179; Zfp407.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH608
AC   CVCL_LZ19
SY   CSH608
DR   MMRRC; MMRRC:015261-UCD
DR   Wikidata; Q54756553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH609
AC   CVCL_LZ20
SY   CSH609
DR   MMRRC; MMRRC:015262-UCD
DR   Wikidata; Q54756555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH610
AC   CVCL_LZ21
SY   CSH610
DR   MMRRC; MMRRC:015263-UCD
DR   Wikidata; Q54756557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915246; Srsf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH611
AC   CVCL_LZ22
SY   CSH611
DR   MMRRC; MMRRC:015264-UCD
DR   Wikidata; Q54756560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914917; Alkbh8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH612
AC   CVCL_LZ23
SY   CSH612
DR   MMRRC; MMRRC:015265-UCD
DR   Wikidata; Q54756562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109150; Mnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH615
AC   CVCL_LZ24
SY   CSH615
DR   MMRRC; MMRRC:015120-UCD
DR   Wikidata; Q54756565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894678; Aurka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH616
AC   CVCL_LZ25
SY   CSH616
DR   MMRRC; MMRRC:015266-UCD
DR   Wikidata; Q54756567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926956; Zfp296.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH622
AC   CVCL_LZ26
SY   CSH622
DR   MMRRC; MMRRC:015268-UCD
DR   Wikidata; Q54756570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330299; Dyrk1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH624
AC   CVCL_LZ27
SY   CSH624
DR   MMRRC; MMRRC:015269-UCD
DR   Wikidata; Q54756572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH627
AC   CVCL_LZ28
SY   CSH627
DR   MMRRC; MMRRC:015123-UCD
DR   Wikidata; Q54756575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894678; Aurka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH628
AC   CVCL_LZ29
SY   CSH628
DR   MMRRC; MMRRC:015124-UCD
DR   Wikidata; Q54756577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH629
AC   CVCL_LZ30
SY   CSH629
DR   MMRRC; MMRRC:015125-UCD
DR   Wikidata; Q54756579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858216; Ube2k.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH633
AC   CVCL_LZ31
SY   CSH633
DR   MMRRC; MMRRC:015270-UCD
DR   Wikidata; Q54756582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917338; Meaf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH635
AC   CVCL_LZ32
SY   CSH635
DR   MMRRC; MMRRC:015272-UCD
DR   Wikidata; Q54756583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934811; Nucks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH638
AC   CVCL_LZ33
SY   CSH638
DR   MMRRC; MMRRC:015127-UCD
DR   Wikidata; Q54756585
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333818; Rps7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH639
AC   CVCL_LZ34
SY   CSH639
DR   MMRRC; MMRRC:015128-UCD
DR   Wikidata; Q54756587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891995; Mapre1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH640
AC   CVCL_LZ35
SY   CSH640
DR   MMRRC; MMRRC:015129-UCD
DR   Wikidata; Q54756588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH641
AC   CVCL_LZ36
SY   CSH641
DR   MMRRC; MMRRC:015130-UCD
DR   Wikidata; Q54756592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858216; Ube2k.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH642
AC   CVCL_LZ37
SY   CSH642
DR   MMRRC; MMRRC:015131-UCD
DR   Wikidata; Q54756593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH643
AC   CVCL_LZ38
SY   CSH643
DR   MMRRC; MMRRC:015274-UCD
DR   Wikidata; Q54756594
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141207; Kctd10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH644
AC   CVCL_LZ39
SY   CSH644
DR   MMRRC; MMRRC:015275-UCD
DR   Wikidata; Q54756595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444479; Thumpd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH645
AC   CVCL_LZ40
SY   CSH645
DR   MMRRC; MMRRC:015276-UCD
DR   Wikidata; Q54756643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH649
AC   CVCL_LZ41
SY   CSH649
DR   MMRRC; MMRRC:015132-UCD
DR   Wikidata; Q54756644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95485; Fasn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH650
AC   CVCL_LZ42
SY   CSH650
DR   MMRRC; MMRRC:015133-UCD
DR   Wikidata; Q54756646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330839; Lin7c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH651
AC   CVCL_LZ43
SY   CSH651
DR   MMRRC; MMRRC:015134-UCD
DR   Wikidata; Q54756648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859162; Rnf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH653
AC   CVCL_LZ44
SY   CSH653
DR   MMRRC; MMRRC:015136-UCD
DR   Wikidata; Q54756650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH657
AC   CVCL_LZ45
SY   CSH657
DR   MMRRC; MMRRC:015278-UCD
DR   Wikidata; Q54756652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH658
AC   CVCL_LZ46
SY   CSH658
DR   MMRRC; MMRRC:015279-UCD
DR   Wikidata; Q54756654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99433; Arf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH659
AC   CVCL_LZ47
SY   CSH659
DR   MMRRC; MMRRC:015280-UCD
DR   Wikidata; Q54756655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926465; Hnrnpm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH663
AC   CVCL_LZ48
SY   CSH663
DR   MMRRC; MMRRC:015139-UCD
DR   Wikidata; Q54756656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140230; Camta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH664
AC   CVCL_LZ49
SY   CSH664
DR   MMRRC; MMRRC:015140-UCD
DR   Wikidata; Q54756658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101920; Ap2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH665
AC   CVCL_LZ50
SY   CSH665
DR   MMRRC; MMRRC:015141-UCD
DR   Wikidata; Q54756661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140248; Zbtb48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH667
AC   CVCL_LZ51
SY   CSH667
DR   MMRRC; MMRRC:015143-UCD
DR   Wikidata; Q54756663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH669
AC   CVCL_LZ52
SY   CSH669
DR   MMRRC; MMRRC:015281-UCD
DR   Wikidata; Q54756664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104913; Abi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH673
AC   CVCL_LZ53
SY   CSH673
DR   MMRRC; MMRRC:015144-UCD
DR   Wikidata; Q54756666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH674
AC   CVCL_LZ54
SY   CSH674
DR   MMRRC; MMRRC:015145-UCD
DR   Wikidata; Q54756668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927489; Pdlim5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH675
AC   CVCL_LZ55
SY   CSH675
DR   MMRRC; MMRRC:015146-UCD
DR   Wikidata; Q54756670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859162; Rnf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH678
AC   CVCL_LZ56
SY   CSH678
DR   MMRRC; MMRRC:015147-UCD
DR   Wikidata; Q54756672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913894; Uba6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH680
AC   CVCL_LZ57
SY   CSH680
DR   MMRRC; MMRRC:015148-UCD
DR   Wikidata; Q54756673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332234; Zfp148.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH681
AC   CVCL_LZ58
SY   CSH681
DR   MMRRC; MMRRC:015282-UCD
DR   Wikidata; Q54756674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH682
AC   CVCL_LZ59
SY   CSH682
DR   MMRRC; MMRRC:015283-UCD
DR   Wikidata; Q54756676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2674092; Zfp609.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH685
AC   CVCL_LZ60
SY   CSH685
DR   MMRRC; MMRRC:015149-UCD
DR   Wikidata; Q54756677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH688
AC   CVCL_LZ61
SY   CSH688
DR   MMRRC; MMRRC:015150-UCD
DR   Wikidata; Q54756680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098808; Pex5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH689
AC   CVCL_LZ62
SY   CSH689
DR   MMRRC; MMRRC:015151-UCD
DR   Wikidata; Q54756683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651014; Zfp268.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH692
AC   CVCL_LZ63
SY   CSH692
DR   MMRRC; MMRRC:015152-UCD
DR   Wikidata; Q54756686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157980; Vac14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH695
AC   CVCL_LZ64
SY   CSH695
DR   MMRRC; MMRRC:015155-UCD
DR   Wikidata; Q54756688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH696
AC   CVCL_LZ65
SY   CSH696
DR   MMRRC; MMRRC:015156-UCD
DR   Wikidata; Q54756689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH699
AC   CVCL_LZ66
SY   CSH699
DR   MMRRC; MMRRC:015284-UCD
DR   Wikidata; Q54756691
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH700
AC   CVCL_LZ67
SY   CSH700
DR   MMRRC; MMRRC:015158-UCD
DR   Wikidata; Q54756692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH702
AC   CVCL_LZ68
SY   CSH702
DR   MMRRC; MMRRC:015286-UCD
DR   Wikidata; Q54756693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH703
AC   CVCL_LZ69
SY   CSH703
DR   MMRRC; MMRRC:015287-UCD
DR   Wikidata; Q54756694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354165; Thop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH704
AC   CVCL_LZ70
SY   CSH704
DR   MMRRC; MMRRC:015288-UCD
DR   Wikidata; Q54756696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919448; Mtrex.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH707
AC   CVCL_LZ71
SY   CSH707
DR   MMRRC; MMRRC:015289-UCD
DR   Wikidata; Q54756697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922832; Relch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH708
AC   CVCL_LZ72
SY   CSH708
DR   MMRRC; MMRRC:015290-UCD
DR   Wikidata; Q54756700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH710
AC   CVCL_LZ73
SY   CSH710
DR   MMRRC; MMRRC:015160-UCD
DR   Wikidata; Q54756701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915264; Zwilch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH712
AC   CVCL_LZ74
SY   CSH712
DR   MMRRC; MMRRC:015291-UCD
DR   Wikidata; Q54756703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH713
AC   CVCL_LZ75
SY   CSH713
DR   MMRRC; MMRRC:015292-UCD
DR   Wikidata; Q54756704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH715
AC   CVCL_LZ76
SY   CSH715
DR   MMRRC; MMRRC:015293-UCD
DR   Wikidata; Q54756707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH716
AC   CVCL_LZ77
SY   CSH716
DR   MMRRC; MMRRC:015294-UCD
DR   Wikidata; Q54756710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915472; Tubb4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH717
AC   CVCL_LZ78
SY   CSH717
DR   MMRRC; MMRRC:015295-UCD
DR   Wikidata; Q54756711
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3582693; Tor1aip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH722
AC   CVCL_LZ79
SY   CSH722
DR   MMRRC; MMRRC:015164-UCD
DR   Wikidata; Q54756714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH725
AC   CVCL_LZ80
SY   CSH725
DR   MMRRC; MMRRC:015296-UCD
DR   Wikidata; Q54756741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH727
AC   CVCL_LZ81
SY   CSH727
DR   MMRRC; MMRRC:015298-UCD
DR   Wikidata; Q54756744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682334; Smg7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH728
AC   CVCL_LZ82
SY   CSH728
DR   MMRRC; MMRRC:015299-UCD
DR   Wikidata; Q54756745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920093; Prdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH729
AC   CVCL_LZ83
SY   CSH729
DR   MMRRC; MMRRC:015300-UCD
DR   Wikidata; Q54756747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333801; Mrpl10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH733
AC   CVCL_LZ84
SY   CSH733
DR   MMRRC; MMRRC:015166-UCD
DR   Wikidata; Q54756749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH734
AC   CVCL_LZ85
SY   CSH734
DR   MMRRC; MMRRC:015167-UCD
DR   Wikidata; Q54756752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444782; Fkbp15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH737
AC   CVCL_LZ86
SY   CSH737
DR   MMRRC; MMRRC:015168-UCD
DR   Wikidata; Q54756753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925255; Rrn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH740
AC   CVCL_LZ87
SY   CSH740
DR   MMRRC; MMRRC:015301-UCD
DR   Wikidata; Q54756754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349409; Cops3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH743
AC   CVCL_LZ88
SY   CSH743
DR   MMRRC; MMRRC:015304-UCD
DR   Wikidata; Q54756757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346867; Map2k2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH747
AC   CVCL_LZ89
SY   CSH747
DR   MMRRC; MMRRC:015169-UCD
DR   Wikidata; Q54756758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH755
AC   CVCL_LZ90
SY   CSH755
DR   MMRRC; MMRRC:015306-UCD
DR   Wikidata; Q54756762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442833; Bbs9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH756
AC   CVCL_LZ91
SY   CSH756
DR   MMRRC; MMRRC:015307-UCD
DR   Wikidata; Q54756763
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97537; Pecam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH759
AC   CVCL_LZ92
SY   CSH759
DR   MMRRC; MMRRC:015173-UCD
DR   Wikidata; Q54756764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681865; Zfat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH761
AC   CVCL_LZ93
SY   CSH761
DR   MMRRC; MMRRC:015174-UCD
DR   Wikidata; Q54756768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444661; Susd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH764
AC   CVCL_LZ94
SY   CSH764
DR   MMRRC; MMRRC:015309-UCD
DR   Wikidata; Q54756769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98728; Tgfbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH767
AC   CVCL_LZ95
SY   CSH767
DR   MMRRC; MMRRC:015311-UCD
DR   Wikidata; Q54756771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103575; Skp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH769
AC   CVCL_LZ96
SY   CSH769
DR   MMRRC; MMRRC:015175-UCD
DR   Wikidata; Q54756772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643580; Epp13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH772
AC   CVCL_LZ97
SY   CSH772
DR   MMRRC; MMRRC:015176-UCD
DR   Wikidata; Q54756773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913470; Zdhhc12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH775
AC   CVCL_LZ98
SY   CSH775
DR   MMRRC; MMRRC:015312-UCD
DR   Wikidata; Q54756774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923038; Smurf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH779
AC   CVCL_LZ99
SY   CSH779
DR   MMRRC; MMRRC:015314-UCD
DR   Wikidata; Q54756778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106095; Naca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH784
AC   CVCL_MA00
SY   CSH784
DR   MMRRC; MMRRC:015316-UCD
DR   Wikidata; Q54756780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135637; Park7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH790
AC   CVCL_MA01
SY   CSH790
DR   MMRRC; MMRRC:015319-UCD
DR   Wikidata; Q54756782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH800
AC   CVCL_MA02
SY   CSH800
DR   MMRRC; MMRRC:015322-UCD
DR   Wikidata; Q54756785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914513; Zswim6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH801
AC   CVCL_MA03
SY   CSH801
DR   MMRRC; MMRRC:015323-UCD
DR   Wikidata; Q54756787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH802
AC   CVCL_MA04
SY   CSH802
DR   MMRRC; MMRRC:015324-UCD
DR   Wikidata; Q54756789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448541; Caprin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH808
AC   CVCL_MA05
SY   CSH808
DR   MMRRC; MMRRC:015178-UCD
DR   Wikidata; Q54756791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3780541; Lncenc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH809
AC   CVCL_MA06
SY   CSH809
DR   MMRRC; MMRRC:015326-UCD
DR   Wikidata; Q54756792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101920; Ap2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH811
AC   CVCL_MA07
SY   CSH811
DR   MMRRC; MMRRC:015327-UCD
DR   Wikidata; Q54756793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354721; Slc25a13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH812
AC   CVCL_MA08
SY   CSH812
DR   MMRRC; MMRRC:015328-UCD
DR   Wikidata; Q54756796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107628; Prdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH813
AC   CVCL_MA09
SY   CSH813
DR   MMRRC; MMRRC:015329-UCD
DR   Wikidata; Q54756798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924767; Zfyve26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH818
AC   CVCL_MA10
SY   CSH818
DR   MMRRC; MMRRC:015180-UCD
DR   Wikidata; Q54756799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914878; Anp32b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH827
AC   CVCL_MA11
SY   CSH827
DR   MMRRC; MMRRC:015332-UCD
DR   Wikidata; Q54756802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102890; Ccng1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH833
AC   CVCL_MA12
SY   CSH833
DR   MMRRC; MMRRC:015182-UCD
DR   Wikidata; Q54756804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH834
AC   CVCL_MA13
SY   CSH834
DR   MMRRC; MMRRC:015333-UCD
DR   Wikidata; Q54756806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH838
AC   CVCL_MA14
SY   CSH838
DR   MMRRC; MMRRC:015334-UCD
DR   Wikidata; Q54756808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921261; Slc25a27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH839
AC   CVCL_MA15
SY   CSH839
DR   MMRRC; MMRRC:015335-UCD
DR   Wikidata; Q54756810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151172; Mta3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH840
AC   CVCL_MA16
SY   CSH840
DR   MMRRC; MMRRC:015336-UCD
DR   Wikidata; Q54756811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109382; Noct.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH856
AC   CVCL_MA17
SY   CSH856
DR   MMRRC; MMRRC:015184-UCD
DR   Wikidata; Q54756815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137218; Mrpl13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH857
AC   CVCL_MA18
SY   CSH857
DR   MMRRC; MMRRC:015185-UCD
DR   Wikidata; Q54756816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH858
AC   CVCL_MA19
SY   CSH858
DR   MMRRC; MMRRC:015186-UCD
DR   Wikidata; Q54756819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH860
AC   CVCL_MA20
SY   CSH860
DR   MMRRC; MMRRC:015339-UCD
DR   Wikidata; Q54756859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914504; Bmerb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSH864
AC   CVCL_MA21
SY   CSH864
DR   MMRRC; MMRRC:015340-UCD
DR   Wikidata; Q54756862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137218; Mrpl13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH870
AC   CVCL_MA22
SY   CSH870
DR   MMRRC; MMRRC:015187-UCD
DR   Wikidata; Q54756865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344373; Ubl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH873
AC   CVCL_MA23
SY   CSH873
DR   MMRRC; MMRRC:015189-UCD
DR   Wikidata; Q54756866
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894316; Mknk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH874
AC   CVCL_MA24
SY   CSH874
DR   MMRRC; MMRRC:015190-UCD
DR   Wikidata; Q54756868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448541; Caprin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH880
AC   CVCL_MA25
SY   CSH880
DR   MMRRC; MMRRC:015342-UCD
DR   Wikidata; Q54756869
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106095; Naca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH881
AC   CVCL_MA26
SY   CSH881
DR   MMRRC; MMRRC:015343-UCD
DR   Wikidata; Q54756872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921802; Nipal3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH889
AC   CVCL_MA27
SY   CSH889
DR   MMRRC; MMRRC:015191-UCD
DR   Wikidata; Q54756873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924657; Rab35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH891
AC   CVCL_MA28
SY   CSH891
DR   MMRRC; MMRRC:015346-UCD
DR   Wikidata; Q54756875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3029586; Zfp870.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH892
AC   CVCL_MA29
SY   CSH892
DR   MMRRC; MMRRC:015347-UCD
DR   Wikidata; Q54756877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921802; Nipal3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH894
AC   CVCL_MA30
SY   CSH894
DR   MMRRC; MMRRC:015348-UCD
DR   Wikidata; Q54756878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101920; Ap2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH897
AC   CVCL_MA31
SY   CSH897
DR   MMRRC; MMRRC:015350-UCD
DR   Wikidata; Q54756882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931415; Mynn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH900
AC   CVCL_MA32
SY   CSH900
DR   MMRRC; MMRRC:015351-UCD
DR   Wikidata; Q54756883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH902
AC   CVCL_MA33
SY   CSH902
DR   MMRRC; MMRRC:015352-UCD
DR   Wikidata; Q54756886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914404; Mtdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH903
AC   CVCL_MA34
SY   CSH903
DR   MMRRC; MMRRC:015192-UCD
DR   Wikidata; Q54756887
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH904
AC   CVCL_MA35
SY   CSH904
DR   MMRRC; MMRRC:015193-UCD
DR   Wikidata; Q54756889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH906
AC   CVCL_MA36
SY   CSH906
DR   MMRRC; MMRRC:015354-UCD
DR   Wikidata; Q54756891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH909
AC   CVCL_MA37
SY   CSH909
DR   MMRRC; MMRRC:015355-UCD
DR   Wikidata; Q54756894
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH912
AC   CVCL_MA38
SY   CSH912
DR   MMRRC; MMRRC:015356-UCD
DR   Wikidata; Q54756895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107532; Kpnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH913
AC   CVCL_MA39
SY   CSH913
DR   MMRRC; MMRRC:015357-UCD
DR   Wikidata; Q54756897
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH914
AC   CVCL_MA40
SY   CSH914
DR   MMRRC; MMRRC:015358-UCD
DR   Wikidata; Q54756899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927222; Diaph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH924
AC   CVCL_MA41
SY   CSH924
DR   MMRRC; MMRRC:015361-UCD
DR   Wikidata; Q54756902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923241; Slain2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH934
AC   CVCL_MA42
SY   CSH934
DR   MMRRC; MMRRC:015363-UCD
DR   Wikidata; Q54756903
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95917; H2-M5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH945
AC   CVCL_MA43
SY   CSH945
DR   MMRRC; MMRRC:015366-UCD
DR   Wikidata; Q54756906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890651; Brwd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH946
AC   CVCL_MA44
SY   CSH946
DR   MMRRC; MMRRC:015367-UCD
DR   Wikidata; Q54756908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106582; Rfx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH947
AC   CVCL_MA45
SY   CSH947
DR   MMRRC; MMRRC:015368-UCD
DR   Wikidata; Q54756911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH948
AC   CVCL_MA46
SY   CSH948
DR   MMRRC; MMRRC:015369-UCD
DR   Wikidata; Q54756913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670969; Nrde2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH949
AC   CVCL_MA47
SY   CSH949
DR   MMRRC; MMRRC:015370-UCD
DR   Wikidata; Q54756914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98230; Sar1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH951
AC   CVCL_MA48
SY   CSH951
DR   MMRRC; MMRRC:015371-UCD
DR   Wikidata; Q54756916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH960
AC   CVCL_MA49
SY   CSH960
DR   MMRRC; MMRRC:015373-UCD
DR   Wikidata; Q54756919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917476; Rbm3os.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH961
AC   CVCL_MA50
SY   CSH961
DR   MMRRC; MMRRC:015374-UCD
DR   Wikidata; Q54756921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913339; Rmnd5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSH964
AC   CVCL_MA51
SY   CSH964
DR   MMRRC; MMRRC:015375-UCD
DR   Wikidata; Q54756923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354733; Dmrt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI001
AC   CVCL_MA52
SY   CSI001
DR   MMRRC; MMRRC:015508-UCD
DR   Wikidata; Q54756925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138893; Usp6nl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI003
AC   CVCL_MA53
SY   CSI003
DR   MMRRC; MMRRC:015509-UCD
DR   Wikidata; Q54756926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914750; Ccar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI004
AC   CVCL_MA54
SY   CSI004
DR   MMRRC; MMRRC:015510-UCD
DR   Wikidata; Q54756927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277166; Sp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI005
AC   CVCL_MA55
SY   CSI005
DR   MMRRC; MMRRC:015511-UCD
DR   Wikidata; Q54756929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2678085; Sugp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI008
AC   CVCL_MA56
SY   CSI008
DR   MMRRC; MMRRC:015512-UCD
DR   Wikidata; Q54756932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI013
AC   CVCL_MA57
SY   CSI013
DR   MMRRC; MMRRC:015513-UCD
DR   Wikidata; Q54756933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353633; Fus.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI014
AC   CVCL_MA58
SY   CSI014
DR   MMRRC; MMRRC:015514-UCD
DR   Wikidata; Q54756936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351455; Rpl13a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI016
AC   CVCL_MA59
SY   CSI016
DR   MMRRC; MMRRC:015515-UCD
DR   Wikidata; Q54756938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914149; Fip1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI018
AC   CVCL_MA60
SY   CSI018
DR   MMRRC; MMRRC:015516-UCD
DR   Wikidata; Q54757022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106913; Abi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI020
AC   CVCL_MA61
SY   CSI020
DR   MMRRC; MMRRC:015517-UCD
DR   Wikidata; Q54757024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI021
AC   CVCL_MA62
SY   CSI021
DR   MMRRC; MMRRC:015518-UCD
DR   Wikidata; Q54757027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926082; Cacul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI026
AC   CVCL_MA63
SY   CSI026
DR   MMRRC; MMRRC:015520-UCD
DR   Wikidata; Q54757028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI027
AC   CVCL_MA64
SY   CSI027
DR   MMRRC; MMRRC:015521-UCD
DR   Wikidata; Q54757031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333754; Agfg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI028
AC   CVCL_MA65
SY   CSI028
DR   MMRRC; MMRRC:015522-UCD
DR   Wikidata; Q54757033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338056; Klf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI032
AC   CVCL_MA66
SY   CSI032
DR   MMRRC; MMRRC:015524-UCD
DR   Wikidata; Q54757034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI034
AC   CVCL_MA67
SY   CSI034
DR   MMRRC; MMRRC:015526-UCD
DR   Wikidata; Q54757035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914120; Serbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI039
AC   CVCL_MA68
SY   CSI039
DR   MMRRC; MMRRC:015530-UCD
DR   Wikidata; Q54757038
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109318; Myl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI040
AC   CVCL_MA69
SY   CSI040
DR   MMRRC; MMRRC:015531-UCD
DR   Wikidata; Q54757039
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI041
AC   CVCL_MA70
SY   CSI041
DR   MMRRC; MMRRC:015532-UCD
DR   Wikidata; Q54757041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385902; Picalm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI042
AC   CVCL_MA71
SY   CSI042
DR   MMRRC; MMRRC:015533-UCD
DR   Wikidata; Q54757044
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107690; Zfp462.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI043
AC   CVCL_MA72
SY   CSI043
DR   MMRRC; MMRRC:015534-UCD
DR   Wikidata; Q54757046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914120; Serbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI044
AC   CVCL_MA73
SY   CSI044
DR   MMRRC; MMRRC:015535-UCD
DR   Wikidata; Q54757047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI046
AC   CVCL_MA74
SY   CSI046
DR   MMRRC; MMRRC:015536-UCD
DR   Wikidata; Q54757049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI049
AC   CVCL_MA75
SY   CSI049
DR   MMRRC; MMRRC:015538-UCD
DR   Wikidata; Q54757051
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm3811 (MGI:3781984) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSI052
AC   CVCL_MA76
SY   CSI052
DR   MMRRC; MMRRC:015540-UCD
DR   Wikidata; Q54757053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343188; Ube2g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI055
AC   CVCL_MA77
SY   CSI055
DR   MMRRC; MMRRC:015541-UCD
DR   Wikidata; Q54757055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141969; Efl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI056
AC   CVCL_MA78
SY   CSI056
DR   MMRRC; MMRRC:015542-UCD
DR   Wikidata; Q54757057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913875; Pnisr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI057
AC   CVCL_MA79
SY   CSI057
DR   MMRRC; MMRRC:015543-UCD
DR   Wikidata; Q54757060
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI061
AC   CVCL_MA80
SY   CSI061
DR   MMRRC; MMRRC:015545-UCD
DR   Wikidata; Q54757062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681840; Rsl24d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI062
AC   CVCL_MA81
SY   CSI062
DR   MMRRC; MMRRC:015546-UCD
DR   Wikidata; Q54757064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI063
AC   CVCL_MA82
SY   CSI063
DR   MMRRC; MMRRC:015547-UCD
DR   Wikidata; Q54757066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915403; Gtf2e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI064
AC   CVCL_MA83
SY   CSI064
DR   MMRRC; MMRRC:015548-UCD
DR   Wikidata; Q54757069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103185; Uimc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI066
AC   CVCL_MA84
SY   CSI066
DR   MMRRC; MMRRC:015549-UCD
DR   Wikidata; Q54757071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI067
AC   CVCL_MA85
SY   CSI067
DR   MMRRC; MMRRC:015550-UCD
DR   Wikidata; Q54757072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI069
AC   CVCL_MA86
SY   CSI069
DR   MMRRC; MMRRC:015552-UCD
DR   Wikidata; Q54757075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921285; Nol9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI070
AC   CVCL_MA87
SY   CSI070
DR   MMRRC; MMRRC:015553-UCD
DR   Wikidata; Q54757077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI071
AC   CVCL_MA88
SY   CSI071
DR   MMRRC; MMRRC:015554-UCD
DR   Wikidata; Q54757078
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI072
AC   CVCL_MA89
SY   CSI072
DR   MMRRC; MMRRC:015555-UCD
DR   Wikidata; Q54757081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI074
AC   CVCL_MA90
SY   CSI074
DR   MMRRC; MMRRC:015556-UCD
DR   Wikidata; Q54757083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859026; Cnot4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI075
AC   CVCL_MA91
SY   CSI075
DR   MMRRC; MMRRC:015557-UCD
DR   Wikidata; Q54757085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915268; Cert1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSI076
AC   CVCL_MA92
SY   CSI076
DR   MMRRC; MMRRC:015558-UCD
DR   Wikidata; Q54757087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104517; Xrcc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI077
AC   CVCL_MA93
SY   CSI077
DR   MMRRC; MMRRC:015559-UCD
DR   Wikidata; Q54757088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI079
AC   CVCL_MA94
SY   CSI079
DR   MMRRC; MMRRC:015561-UCD
DR   Wikidata; Q54757090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2658986; Wasf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI080
AC   CVCL_MA95
SY   CSI080
DR   MMRRC; MMRRC:015562-UCD
DR   Wikidata; Q54757091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920454; 3110056K07Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI087
AC   CVCL_MA96
SY   CSI087
DR   MMRRC; MMRRC:015566-UCD
DR   Wikidata; Q54757093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442372; Fam168a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI089
AC   CVCL_MA97
SY   CSI089
DR   MMRRC; MMRRC:015568-UCD
DR   Wikidata; Q54757094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI090
AC   CVCL_MA98
SY   CSI090
DR   MMRRC; MMRRC:015569-UCD
DR   Wikidata; Q54757095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351477; Cars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI091
AC   CVCL_MA99
SY   CSI091
DR   MMRRC; MMRRC:015570-UCD
DR   Wikidata; Q54757097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI092
AC   CVCL_MB00
SY   CSI092
DR   MMRRC; MMRRC:015571-UCD
DR   Wikidata; Q54757137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346036; Pin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI095
AC   CVCL_MB01
SY   CSI095
DR   MMRRC; MMRRC:015572-UCD
DR   Wikidata; Q54757139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344347; Synj2bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI100
AC   CVCL_MB02
SY   CSI100
DR   MMRRC; MMRRC:015574-UCD
DR   Wikidata; Q54757141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108466; Ralbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI101
AC   CVCL_MB03
SY   CSI101
DR   MMRRC; MMRRC:015575-UCD
DR   Wikidata; Q54757143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915751; Nsmce2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI103
AC   CVCL_MB04
SY   CSI103
DR   MMRRC; MMRRC:015576-UCD
DR   Wikidata; Q54757146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336214; Khsrp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI104
AC   CVCL_MB05
SY   CSI104
DR   MMRRC; MMRRC:015577-UCD
DR   Wikidata; Q54757149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344406; Ptpn21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI117
AC   CVCL_MB06
SY   CSI117
DR   MMRRC; MMRRC:015579-UCD
DR   Wikidata; Q54757150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914923; Elob.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI124
AC   CVCL_MB07
SY   CSI124
DR   MMRRC; MMRRC:015581-UCD
DR   Wikidata; Q54757152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI125
AC   CVCL_MB08
SY   CSI125
DR   MMRRC; MMRRC:015582-UCD
DR   Wikidata; Q54757154
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919449; Mms19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI127
AC   CVCL_MB09
SY   CSI127
DR   MMRRC; MMRRC:015583-UCD
DR   Wikidata; Q54757157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914750; Ccar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI129
AC   CVCL_MB10
SY   CSI129
DR   MMRRC; MMRRC:015584-UCD
DR   Wikidata; Q54757159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI130
AC   CVCL_MB11
SY   CSI130
DR   MMRRC; MMRRC:015585-UCD
DR   Wikidata; Q54757160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107858; Arhgap39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI132
AC   CVCL_MB12
SY   CSI132
DR   MMRRC; MMRRC:015586-UCD
DR   Wikidata; Q54757163
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI133
AC   CVCL_MB13
SY   CSI133
DR   MMRRC; MMRRC:015587-UCD
DR   Wikidata; Q54757164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349448; Cenph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI137
AC   CVCL_MB14
SY   CSI137
DR   MMRRC; MMRRC:015589-UCD
DR   Wikidata; Q54757166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI138
AC   CVCL_MB15
SY   CSI138
DR   MMRRC; MMRRC:015590-UCD
DR   Wikidata; Q54757168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI139
AC   CVCL_MB16
SY   CSI139
DR   MMRRC; MMRRC:015591-UCD
DR   Wikidata; Q54757169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146285; Nol12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI141
AC   CVCL_MB17
SY   CSI141
DR   MMRRC; MMRRC:015592-UCD
DR   Wikidata; Q54757171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI146
AC   CVCL_MB18
SY   CSI146
DR   MMRRC; MMRRC:015595-UCD
DR   Wikidata; Q54757173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI147
AC   CVCL_MB19
SY   CSI147
DR   MMRRC; MMRRC:015596-UCD
DR   Wikidata; Q54757175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145425; Depdc1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI149
AC   CVCL_MB20
SY   CSI149
DR   MMRRC; MMRRC:015598-UCD
DR   Wikidata; Q54757176
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922066; Tpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI150
AC   CVCL_MB21
SY   CSI150
DR   MMRRC; MMRRC:015599-UCD
DR   Wikidata; Q54757178
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890218; Akap10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI153
AC   CVCL_MB22
SY   CSI153
DR   MMRRC; MMRRC:015601-UCD
DR   Wikidata; Q54757180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100846; Med1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI154
AC   CVCL_MB23
SY   CSI154
DR   MMRRC; MMRRC:015602-UCD
DR   Wikidata; Q54757182
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100846; Med1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI156
AC   CVCL_MB24
SY   CSI156
DR   MMRRC; MMRRC:015603-UCD
DR   Wikidata; Q54757184
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913401; Prr13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI158
AC   CVCL_MB25
SY   CSI158
DR   MMRRC; MMRRC:015604-UCD
DR   Wikidata; Q54757186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914668; Ppil4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI163
AC   CVCL_MB26
SY   CSI163
DR   MMRRC; MMRRC:015607-UCD
DR   Wikidata; Q54757187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289325; Anapc16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI164
AC   CVCL_MB27
SY   CSI164
DR   MMRRC; MMRRC:015608-UCD
DR   Wikidata; Q54757190
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106340; Rcor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI165
AC   CVCL_MB28
SY   CSI165
DR   MMRRC; MMRRC:015609-UCD
DR   Wikidata; Q54757192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI166
AC   CVCL_MB29
SY   CSI166
DR   MMRRC; MMRRC:015610-UCD
DR   Wikidata; Q54757194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99700; Cenpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI167
AC   CVCL_MB30
SY   CSI167
DR   MMRRC; MMRRC:015611-UCD
DR   Wikidata; Q54757195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444233; Ythdf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI170
AC   CVCL_MB31
SY   CSI170
DR   MMRRC; MMRRC:015612-UCD
DR   Wikidata; Q54757197
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95654; Gart.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI171
AC   CVCL_MB32
SY   CSI171
DR   MMRRC; MMRRC:015613-UCD
DR   Wikidata; Q54757199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346858; Mapk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI173
AC   CVCL_MB33
SY   CSI173
DR   MMRRC; MMRRC:015614-UCD
DR   Wikidata; Q54757200
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919185; Cipc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI174
AC   CVCL_MB34
SY   CSI174
DR   MMRRC; MMRRC:015615-UCD
DR   Wikidata; Q54757202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919185; Cipc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI176
AC   CVCL_MB35
SY   CSI176
DR   MMRRC; MMRRC:015616-UCD
DR   Wikidata; Q54757203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384310; Rbm10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI177
AC   CVCL_MB36
SY   CSI177
DR   MMRRC; MMRRC:015617-UCD
DR   Wikidata; Q54757205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107801; Atp5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI178
AC   CVCL_MB37
SY   CSI178
DR   MMRRC; MMRRC:015618-UCD
DR   Wikidata; Q54757208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682307; Ric8b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI179
AC   CVCL_MB38
SY   CSI179
DR   MMRRC; MMRRC:015619-UCD
DR   Wikidata; Q54757209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI180
AC   CVCL_MB39
SY   CSI180
DR   MMRRC; MMRRC:015620-UCD
DR   Wikidata; Q54757211
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI181
AC   CVCL_MB40
SY   CSI181
DR   MMRRC; MMRRC:015621-UCD
DR   Wikidata; Q54757251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443731; Mat2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI182
AC   CVCL_MB41
SY   CSI182
DR   MMRRC; MMRRC:015622-UCD
DR   Wikidata; Q54757252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI183
AC   CVCL_MB42
SY   CSI183
DR   MMRRC; MMRRC:015623-UCD
DR   Wikidata; Q54757255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI184
AC   CVCL_MB43
SY   CSI184
DR   MMRRC; MMRRC:015624-UCD
DR   Wikidata; Q54757257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918885; Mast4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI186
AC   CVCL_MB44
SY   CSI186
DR   MMRRC; MMRRC:015626-UCD
DR   Wikidata; Q54757259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914117; Hmg20a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI189
AC   CVCL_MB45
SY   CSI189
DR   MMRRC; MMRRC:015628-UCD
DR   Wikidata; Q54757260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI191
AC   CVCL_MB46
SY   CSI191
DR   MMRRC; MMRRC:015629-UCD
DR   Wikidata; Q54757264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI193
AC   CVCL_MB47
SY   CSI193
DR   MMRRC; MMRRC:015428-UCD
DR   Wikidata; Q54757267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277977; Ubr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI194
AC   CVCL_MB48
SY   CSI194
DR   MMRRC; MMRRC:015429-UCD
DR   Wikidata; Q54757269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913964; 4921524J17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI197
AC   CVCL_MB49
SY   CSI197
DR   MMRRC; MMRRC:015430-UCD
DR   Wikidata; Q54757271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891295; Ube3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI198
AC   CVCL_MB50
SY   CSI198
DR   MMRRC; MMRRC:015431-UCD
DR   Wikidata; Q54757272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI199
AC   CVCL_MB51
SY   CSI199
DR   MMRRC; MMRRC:015432-UCD
DR   Wikidata; Q54757276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914378; Ube2g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI202
AC   CVCL_MB52
SY   CSI202
DR   MMRRC; MMRRC:015433-UCD
DR   Wikidata; Q54757278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI203
AC   CVCL_MB53
SY   CSI203
DR   MMRRC; MMRRC:015434-UCD
DR   Wikidata; Q54757279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI207
AC   CVCL_MB54
SY   CSI207
DR   MMRRC; MMRRC:015436-UCD
DR   Wikidata; Q54757281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196294; Fubp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI208
AC   CVCL_MB55
SY   CSI208
DR   MMRRC; MMRRC:015437-UCD
DR   Wikidata; Q54757283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI209
AC   CVCL_MB56
SY   CSI209
DR   MMRRC; MMRRC:015438-UCD
DR   Wikidata; Q54757285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351477; Cars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI212
AC   CVCL_MB57
SY   CSI212
DR   MMRRC; MMRRC:015630-UCD
DR   Wikidata; Q54757286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445003; Arhgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI216
AC   CVCL_MB58
SY   CSI216
DR   MMRRC; MMRRC:015440-UCD
DR   Wikidata; Q54757288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI221
AC   CVCL_MB59
SY   CSI221
DR   MMRRC; MMRRC:015441-UCD
DR   Wikidata; Q54757289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932339; Sf3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI222
AC   CVCL_MB60
SY   CSI222
DR   MMRRC; MMRRC:015631-UCD
DR   Wikidata; Q54757292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI224
AC   CVCL_MB61
SY   CSI224
DR   MMRRC; MMRRC:015632-UCD
DR   Wikidata; Q54757295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI226
AC   CVCL_MB62
SY   CSI226
DR   MMRRC; MMRRC:015443-UCD
DR   Wikidata; Q54757296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919394; Slc37a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI228
AC   CVCL_MB63
SY   CSI228
DR   MMRRC; MMRRC:015445-UCD
DR   Wikidata; Q54757299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388633; Cltc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI231
AC   CVCL_MB64
SY   CSI231
DR   MMRRC; MMRRC:015447-UCD
DR   Wikidata; Q54757302
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI234
AC   CVCL_MB65
SY   CSI234
DR   MMRRC; MMRRC:015633-UCD
DR   Wikidata; Q54757305
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI236
AC   CVCL_MB66
SY   CSI236
DR   MMRRC; MMRRC:015448-UCD
DR   Wikidata; Q54757307
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106209; Hells.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI242
AC   CVCL_MB67
SY   CSI242
DR   MMRRC; MMRRC:015449-UCD
DR   Wikidata; Q54757308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921414; Nfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI248
AC   CVCL_MB68
SY   CSI248
DR   MMRRC; MMRRC:015634-UCD
DR   Wikidata; Q54757311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106209; Hells.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI249
AC   CVCL_MB69
SY   CSI249
DR   MMRRC; MMRRC:015451-UCD
DR   Wikidata; Q54757313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933184; Nop58.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI252
AC   CVCL_MB70
SY   CSI252
DR   MMRRC; MMRRC:015452-UCD
DR   Wikidata; Q54757316
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889205; Cpq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI253
AC   CVCL_MB71
SY   CSI253
DR   MMRRC; MMRRC:015453-UCD
DR   Wikidata; Q54757319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891692; Hnrnpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI256
AC   CVCL_MB72
SY   CSI256
DR   MMRRC; MMRRC:015635-UCD
DR   Wikidata; Q54757321
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI258
AC   CVCL_MB73
SY   CSI258
DR   MMRRC; MMRRC:015637-UCD
DR   Wikidata; Q54757323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI263
AC   CVCL_MB74
SY   CSI263
DR   MMRRC; MMRRC:015454-UCD
DR   Wikidata; Q54757326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI266
AC   CVCL_MB75
SY   CSI266
DR   MMRRC; MMRRC:015638-UCD
DR   Wikidata; Q54757327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95659; Gas5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI275
AC   CVCL_MB76
SY   CSI275
DR   MMRRC; MMRRC:015459-UCD
DR   Wikidata; Q54757328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI278
AC   CVCL_MB77
SY   CSI278
DR   MMRRC; MMRRC:015460-UCD
DR   Wikidata; Q54757330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI280
AC   CVCL_MB78
SY   CSI280
DR   MMRRC; MMRRC:015461-UCD
DR   Wikidata; Q54757331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894687; Xrn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI281
AC   CVCL_MB79
SY   CSI281
DR   MMRRC; MMRRC:015462-UCD
DR   Wikidata; Q54757332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913840; Farsa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI283
AC   CVCL_MB80
SY   CSI283
DR   MMRRC; MMRRC:015464-UCD
DR   Wikidata; Q54757367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106013; Slc16a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI286
AC   CVCL_MB81
SY   CSI286
DR   MMRRC; MMRRC:015465-UCD
DR   Wikidata; Q54757368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3588234; 9630014M24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI297
AC   CVCL_MB82
SY   CSI297
DR   MMRRC; MMRRC:015469-UCD
DR   Wikidata; Q54757371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916065; Btbd10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI303
AC   CVCL_MB83
SY   CSI303
DR   MMRRC; MMRRC:015471-UCD
DR   Wikidata; Q54757374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932339; Sf3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI305
AC   CVCL_MB84
SY   CSI305
DR   MMRRC; MMRRC:015472-UCD
DR   Wikidata; Q54757375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353593; Lcmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI307
AC   CVCL_MB85
SY   CSI307
DR   MMRRC; MMRRC:015473-UCD
DR   Wikidata; Q54757376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101949; Rad52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI314
AC   CVCL_MB86
SY   CSI314
DR   MMRRC; MMRRC:015476-UCD
DR   Wikidata; Q54757379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI323
AC   CVCL_MB87
SY   CSI323
DR   MMRRC; MMRRC:015481-UCD
DR   Wikidata; Q54757380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI326
AC   CVCL_MB88
SY   CSI326
DR   MMRRC; MMRRC:015483-UCD
DR   Wikidata; Q54757383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI327
AC   CVCL_MB89
SY   CSI327
DR   MMRRC; MMRRC:015484-UCD
DR   Wikidata; Q54757384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894687; Xrn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI328
AC   CVCL_MB90
SY   CSI328
DR   MMRRC; MMRRC:015485-UCD
DR   Wikidata; Q54757386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920997; Shld1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSI334
AC   CVCL_MB91
SY   CSI334
DR   MMRRC; MMRRC:015487-UCD
DR   Wikidata; Q54757387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2663721; Zc3h3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI339
AC   CVCL_MB92
SY   CSI339
DR   MMRRC; MMRRC:015642-UCD
DR   Wikidata; Q54757388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI340
AC   CVCL_MB93
SY   CSI340
DR   MMRRC; MMRRC:015643-UCD
DR   Wikidata; Q54757389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384876; Cdc73.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI341
AC   CVCL_MB94
SY   CSI341
DR   MMRRC; MMRRC:015644-UCD
DR   Wikidata; Q54757391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919020; Ap2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI344
AC   CVCL_MB95
SY   CSI344
DR   MMRRC; MMRRC:015645-UCD
DR   Wikidata; Q54757393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914132; Bzw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI345
AC   CVCL_MB96
SY   CSI345
DR   MMRRC; MMRRC:015646-UCD
DR   Wikidata; Q54757395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107186; Cct2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI346
AC   CVCL_MB97
SY   CSI346
DR   MMRRC; MMRRC:015647-UCD
DR   Wikidata; Q54757396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI347
AC   CVCL_MB98
SY   CSI347
DR   MMRRC; MMRRC:015648-UCD
DR   Wikidata; Q54757399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105089; Hsd17b4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI348
AC   CVCL_MB99
SY   CSI348
DR   MMRRC; MMRRC:015649-UCD
DR   Wikidata; Q54757401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI358
AC   CVCL_MC00
SY   CSI358
DR   MMRRC; MMRRC:015654-UCD
DR   Wikidata; Q54757403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI362
AC   CVCL_MC01
SY   CSI362
DR   MMRRC; MMRRC:015656-UCD
DR   Wikidata; Q54757406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99670; Dmtn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI367
AC   CVCL_MC02
SY   CSI367
DR   MMRRC; MMRRC:015658-UCD
DR   Wikidata; Q54757409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179432; Mycbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI379
AC   CVCL_MC03
SY   CSI379
DR   MMRRC; MMRRC:015662-UCD
DR   Wikidata; Q54757411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109404; Nup98.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI381
AC   CVCL_MC04
SY   CSI381
DR   MMRRC; MMRRC:015663-UCD
DR   Wikidata; Q54757412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344352; Dido1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI385
AC   CVCL_MC05
SY   CSI385
DR   MMRRC; MMRRC:015666-UCD
DR   Wikidata; Q54757415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI387
AC   CVCL_MC06
SY   CSI387
DR   MMRRC; MMRRC:015668-UCD
DR   Wikidata; Q54757417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916882; Arhgef12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI392
AC   CVCL_MC07
SY   CSI392
DR   MMRRC; MMRRC:015671-UCD
DR   Wikidata; Q54757420
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI393
AC   CVCL_MC08
SY   CSI393
DR   MMRRC; MMRRC:015672-UCD
DR   Wikidata; Q54757421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106209; Hells.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI397
AC   CVCL_MC09
SY   CSI397
DR   MMRRC; MMRRC:015675-UCD
DR   Wikidata; Q54757422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI398
AC   CVCL_MC10
SY   CSI398
DR   MMRRC; MMRRC:015676-UCD
DR   Wikidata; Q54757423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444629; Kctd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI400
AC   CVCL_MC11
SY   CSI400
DR   MMRRC; MMRRC:015677-UCD
DR   Wikidata; Q54757424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917579; Gon4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI401
AC   CVCL_MC12
SY   CSI401
DR   MMRRC; MMRRC:015678-UCD
DR   Wikidata; Q54757425
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106209; Hells.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI404
AC   CVCL_MC13
SY   CSI404
DR   MMRRC; MMRRC:015679-UCD
DR   Wikidata; Q54757426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100836; Kpna6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI405
AC   CVCL_MC14
SY   CSI405
DR   MMRRC; MMRRC:015680-UCD
DR   Wikidata; Q54757427
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI406
AC   CVCL_MC15
SY   CSI406
DR   MMRRC; MMRRC:015681-UCD
DR   Wikidata; Q54757428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105047; Psmc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI408
AC   CVCL_MC16
SY   CSI408
DR   MMRRC; MMRRC:015682-UCD
DR   Wikidata; Q54757430
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353418; Pmm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI409
AC   CVCL_MC17
SY   CSI409
DR   MMRRC; MMRRC:015683-UCD
DR   Wikidata; Q54757431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891704; Hbs1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI413
AC   CVCL_MC18
SY   CSI413
DR   MMRRC; MMRRC:015684-UCD
DR   Wikidata; Q54757433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI416
AC   CVCL_MC19
SY   CSI416
DR   MMRRC; MMRRC:015685-UCD
DR   Wikidata; Q54757436
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI419
AC   CVCL_MC20
SY   CSI419
DR   MMRRC; MMRRC:015686-UCD
DR   Wikidata; Q54757480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98790; Top2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI421
AC   CVCL_MC21
SY   CSI421
DR   MMRRC; MMRRC:015687-UCD
DR   Wikidata; Q54757482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98759; Tjp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI423
AC   CVCL_MC22
SY   CSI423
DR   MMRRC; MMRRC:015688-UCD
DR   Wikidata; Q54757485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106209; Hells.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI429
AC   CVCL_MC23
SY   CSI429
DR   MMRRC; MMRRC:015693-UCD
DR   Wikidata; Q54757487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196439; Cbx7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI430
AC   CVCL_MC24
SY   CSI430
DR   MMRRC; MMRRC:015694-UCD
DR   Wikidata; Q54757488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI433
AC   CVCL_MC25
SY   CSI433
DR   MMRRC; MMRRC:015697-UCD
DR   Wikidata; Q54757491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929701; Metap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI437
AC   CVCL_MC26
SY   CSI437
DR   MMRRC; MMRRC:015699-UCD
DR   Wikidata; Q54757492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329034; Ccne2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI438
AC   CVCL_MC27
SY   CSI438
DR   MMRRC; MMRRC:015700-UCD
DR   Wikidata; Q54757493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109547; Dnm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI442
AC   CVCL_MC28
SY   CSI442
DR   MMRRC; MMRRC:015703-UCD
DR   Wikidata; Q54757495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI443
AC   CVCL_MC29
SY   CSI443
DR   MMRRC; MMRRC:015704-UCD
DR   Wikidata; Q54757496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI444
AC   CVCL_MC30
SY   CSI444
DR   MMRRC; MMRRC:015705-UCD
DR   Wikidata; Q54757498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI449
AC   CVCL_MC31
SY   CSI449
DR   MMRRC; MMRRC:015708-UCD
DR   Wikidata; Q54757500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681865; Zfat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI450
AC   CVCL_MC32
SY   CSI450
DR   MMRRC; MMRRC:015709-UCD
DR   Wikidata; Q54757502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI466
AC   CVCL_MC33
SY   CSI466
DR   MMRRC; MMRRC:015713-UCD
DR   Wikidata; Q54757504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934229; Setdb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI468
AC   CVCL_MC34
SY   CSI468
DR   MMRRC; MMRRC:015714-UCD
DR   Wikidata; Q54757506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385139; Rabgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI471
AC   CVCL_MC35
SY   CSI471
DR   MMRRC; MMRRC:015715-UCD
DR   Wikidata; Q54757508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3763743; Snhg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI474
AC   CVCL_MC36
SY   CSI474
DR   MMRRC; MMRRC:015717-UCD
DR   Wikidata; Q54757510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI475
AC   CVCL_MC37
SY   CSI475
DR   MMRRC; MMRRC:015718-UCD
DR   Wikidata; Q54757513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270841; Cry1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI483
AC   CVCL_MC38
SY   CSI483
DR   MMRRC; MMRRC:015720-UCD
DR   Wikidata; Q54757516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914238; Lap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI484
AC   CVCL_MC39
SY   CSI484
DR   MMRRC; MMRRC:015721-UCD
DR   Wikidata; Q54757517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI486
AC   CVCL_MC40
SY   CSI486
DR   MMRRC; MMRRC:015722-UCD
DR   Wikidata; Q54757520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI492
AC   CVCL_MC41
SY   CSI492
DR   MMRRC; MMRRC:015723-UCD
DR   Wikidata; Q54757522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144243; Clint1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI494
AC   CVCL_MC42
SY   CSI494
DR   MMRRC; MMRRC:015724-UCD
DR   Wikidata; Q54757523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI497
AC   CVCL_MC43
SY   CSI497
DR   MMRRC; MMRRC:015725-UCD
DR   Wikidata; Q54757526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346873; Map3k2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI498
AC   CVCL_MC44
SY   CSI498
DR   MMRRC; MMRRC:015726-UCD
DR   Wikidata; Q54757527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI499
AC   CVCL_MC45
SY   CSI499
DR   MMRRC; MMRRC:015727-UCD
DR   Wikidata; Q54757528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI501
AC   CVCL_MC46
SY   CSI501
DR   MMRRC; MMRRC:015729-UCD
DR   Wikidata; Q54757531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107734; Ap3d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI510
AC   CVCL_MC47
SY   CSI510
DR   MMRRC; MMRRC:015733-UCD
DR   Wikidata; Q54757532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI512
AC   CVCL_MC48
SY   CSI512
DR   MMRRC; MMRRC:015734-UCD
DR   Wikidata; Q54757533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI514
AC   CVCL_MC49
SY   CSI514
DR   MMRRC; MMRRC:015736-UCD
DR   Wikidata; Q54757535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922088; Naa15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI516
AC   CVCL_MC50
SY   CSI516
DR   MMRRC; MMRRC:015737-UCD
DR   Wikidata; Q54757537
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919283; Tsc22d2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI520
AC   CVCL_MC51
SY   CSI520
DR   MMRRC; MMRRC:015739-UCD
DR   Wikidata; Q54757538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344353; Katna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI521
AC   CVCL_MC52
SY   CSI521
DR   MMRRC; MMRRC:015751-UCD
DR   Wikidata; Q54757540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919782; Sap130.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI522
AC   CVCL_MC53
SY   CSI522
DR   MMRRC; MMRRC:015752-UCD
DR   Wikidata; Q54757542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923749; Clasp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI524
AC   CVCL_MC54
SY   CSI524
DR   MMRRC; MMRRC:015753-UCD
DR   Wikidata; Q54757544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931751; Pum2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI527
AC   CVCL_MC55
SY   CSI527
DR   MMRRC; MMRRC:015756-UCD
DR   Wikidata; Q54757546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925678; Pym1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI529
AC   CVCL_MC56
SY   CSI529
DR   MMRRC; MMRRC:015758-UCD
DR   Wikidata; Q54757548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI533
AC   CVCL_MC57
SY   CSI533
DR   MMRRC; MMRRC:015761-UCD
DR   Wikidata; Q54757551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI538
AC   CVCL_MC58
SY   CSI538
DR   MMRRC; MMRRC:015763-UCD
DR   Wikidata; Q54757552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920924; Wdr75.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI539
AC   CVCL_MC59
SY   CSI539
DR   MMRRC; MMRRC:015764-UCD
DR   Wikidata; Q54757553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144564; Fam117a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI540
AC   CVCL_MC60
SY   CSI540
DR   MMRRC; MMRRC:015765-UCD
DR   Wikidata; Q54757591
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104708; Cct3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI541
AC   CVCL_MC61
SY   CSI541
DR   MMRRC; MMRRC:015766-UCD
DR   Wikidata; Q54757593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277958; Pcm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI542
AC   CVCL_MC62
SY   CSI542
DR   MMRRC; MMRRC:015767-UCD
DR   Wikidata; Q54757597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446632; Ago2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI543
AC   CVCL_MC63
SY   CSI543
DR   MMRRC; MMRRC:015768-UCD
DR   Wikidata; Q54757599
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI545
AC   CVCL_MC64
SY   CSI545
DR   MMRRC; MMRRC:015769-UCD
DR   Wikidata; Q54757601
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI548
AC   CVCL_MC65
SY   CSI548
DR   MMRRC; MMRRC:015770-UCD
DR   Wikidata; Q54757603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096570; Tex264.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI549
AC   CVCL_MC66
SY   CSI549
DR   MMRRC; MMRRC:015771-UCD
DR   Wikidata; Q54757606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921428; Stk40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI552
AC   CVCL_MC67
SY   CSI552
DR   MMRRC; MMRRC:015772-UCD
DR   Wikidata; Q54757608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97286; Ncl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI553
AC   CVCL_MC68
SY   CSI553
DR   MMRRC; MMRRC:015773-UCD
DR   Wikidata; Q54757609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI556
AC   CVCL_MC69
SY   CSI556
DR   MMRRC; MMRRC:015774-UCD
DR   Wikidata; Q54757610
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99430; Hira.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI560
AC   CVCL_MC70
SY   CSI560
DR   MMRRC; MMRRC:015777-UCD
DR   Wikidata; Q54757613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94909; Dmd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI566
AC   CVCL_MC71
SY   CSI566
DR   MMRRC; MMRRC:015778-UCD
DR   Wikidata; Q54757614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919378; 2610008E11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI567
AC   CVCL_MC72
SY   CSI567
DR   MMRRC; MMRRC:015779-UCD
DR   Wikidata; Q54757615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI568
AC   CVCL_MC73
SY   CSI568
DR   MMRRC; MMRRC:015780-UCD
DR   Wikidata; Q54757618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI570
AC   CVCL_MC74
SY   CSI570
DR   MMRRC; MMRRC:015782-UCD
DR   Wikidata; Q54757619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923046; Cdyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI571
AC   CVCL_MC75
SY   CSI571
DR   MMRRC; MMRRC:015783-UCD
DR   Wikidata; Q54757621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914855; Akt1s1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI574
AC   CVCL_MC76
SY   CSI574
DR   MMRRC; MMRRC:015785-UCD
DR   Wikidata; Q54757622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859652; Mtx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI575
AC   CVCL_MC77
SY   CSI575
DR   MMRRC; MMRRC:015786-UCD
DR   Wikidata; Q54757624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919367; Naa50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI577
AC   CVCL_MC78
SY   CSI577
DR   MMRRC; MMRRC:015787-UCD
DR   Wikidata; Q54757627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI578
AC   CVCL_MC79
SY   CSI578
DR   MMRRC; MMRRC:015788-UCD
DR   Wikidata; Q54757629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919378; 2610008E11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI580
AC   CVCL_MC80
SY   CSI580
DR   MMRRC; MMRRC:015789-UCD
DR   Wikidata; Q54757630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104816; Hnrnpl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI582
AC   CVCL_MC81
SY   CSI582
DR   MMRRC; MMRRC:015790-UCD
DR   Wikidata; Q54757631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346870; Map2k6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI583
AC   CVCL_MC82
SY   CSI583
DR   MMRRC; MMRRC:015791-UCD
DR   Wikidata; Q54757632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355315; Tmod3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI584
AC   CVCL_MC83
SY   CSI584
DR   MMRRC; MMRRC:015792-UCD
DR   Wikidata; Q54757634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183260; Luc7l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI585
AC   CVCL_MC84
SY   CSI585
DR   MMRRC; MMRRC:015793-UCD
DR   Wikidata; Q54757635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098231; Kif11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI589
AC   CVCL_MC85
SY   CSI589
DR   MMRRC; MMRRC:015795-UCD
DR   Wikidata; Q54757637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI590
AC   CVCL_MC86
SY   CSI590
DR   MMRRC; MMRRC:015796-UCD
DR   Wikidata; Q54757638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916526; Sec62.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI591
AC   CVCL_MC87
SY   CSI591
DR   MMRRC; MMRRC:015797-UCD
DR   Wikidata; Q54757639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI593
AC   CVCL_MC88
SY   CSI593
DR   MMRRC; MMRRC:015798-UCD
DR   Wikidata; Q54757641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI595
AC   CVCL_MC89
SY   CSI595
DR   MMRRC; MMRRC:015799-UCD
DR   Wikidata; Q54757642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923998; Pbrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI596
AC   CVCL_MC90
SY   CSI596
DR   MMRRC; MMRRC:015800-UCD
DR   Wikidata; Q54757644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104816; Hnrnpl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI601
AC   CVCL_MC91
SY   CSI601
DR   MMRRC; MMRRC:015803-UCD
DR   Wikidata; Q54757648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443157; Mib1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI602
AC   CVCL_MC92
SY   CSI602
DR   MMRRC; MMRRC:015804-UCD
DR   Wikidata; Q54757650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925678; Pym1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI604
AC   CVCL_MC93
SY   CSI604
DR   MMRRC; MMRRC:015805-UCD
DR   Wikidata; Q54757653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104816; Hnrnpl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI608
AC   CVCL_MC94
SY   CSI608
DR   MMRRC; MMRRC:015807-UCD
DR   Wikidata; Q54757655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97912; Rheb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI609
AC   CVCL_MC95
SY   CSI609
DR   MMRRC; MMRRC:015808-UCD
DR   Wikidata; Q54757656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97912; Rheb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI610
AC   CVCL_MC96
SY   CSI610
DR   MMRRC; MMRRC:015809-UCD
DR   Wikidata; Q54757658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183260; Luc7l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI612
AC   CVCL_MC97
SY   CSI612
DR   MMRRC; MMRRC:015811-UCD
DR   Wikidata; Q54757660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97912; Rheb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI613
AC   CVCL_MC98
SY   CSI613
DR   MMRRC; MMRRC:015812-UCD
DR   Wikidata; Q54757663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99206; Zfp59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI614
AC   CVCL_MC99
SY   CSI614
DR   MMRRC; MMRRC:015813-UCD
DR   Wikidata; Q54757664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919369; Tpx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI617
AC   CVCL_MD00
SY   CSI617
DR   MMRRC; MMRRC:015815-UCD
DR   Wikidata; Q54757741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923036; Ckap5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI619
AC   CVCL_MD01
SY   CSI619
DR   MMRRC; MMRRC:015816-UCD
DR   Wikidata; Q54757742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916175; Rpap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI620
AC   CVCL_MD02
SY   CSI620
DR   MMRRC; MMRRC:015817-UCD
DR   Wikidata; Q54757745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103267; Eif4ebp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI622
AC   CVCL_MD03
SY   CSI622
DR   MMRRC; MMRRC:015819-UCD
DR   Wikidata; Q54757747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685031; Leo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI625
AC   CVCL_MD04
SY   CSI625
DR   MMRRC; MMRRC:015820-UCD
DR   Wikidata; Q54757749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355328; Nasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI626
AC   CVCL_MD05
SY   CSI626
DR   MMRRC; MMRRC:015821-UCD
DR   Wikidata; Q54757751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI628
AC   CVCL_MD06
SY   CSI628
DR   MMRRC; MMRRC:015823-UCD
DR   Wikidata; Q54757753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921361; Rbm19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI629
AC   CVCL_MD07
SY   CSI629
DR   MMRRC; MMRRC:015824-UCD
DR   Wikidata; Q54757755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157980; Vac14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI630
AC   CVCL_MD08
SY   CSI630
DR   MMRRC; MMRRC:015825-UCD
DR   Wikidata; Q54757757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:893579; Khdrbs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI631
AC   CVCL_MD09
SY   CSI631
DR   MMRRC; MMRRC:015826-UCD
DR   Wikidata; Q54757759
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926082; Cacul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI632
AC   CVCL_MD10
SY   CSI632
DR   MMRRC; MMRRC:015827-UCD
DR   Wikidata; Q54757762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI633
AC   CVCL_MD11
SY   CSI633
DR   MMRRC; MMRRC:015828-UCD
DR   Wikidata; Q54757765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI636
AC   CVCL_MD12
SY   CSI636
DR   MMRRC; MMRRC:015829-UCD
DR   Wikidata; Q54757766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922847; Ndufaf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI637
AC   CVCL_MD13
SY   CSI637
DR   MMRRC; MMRRC:015830-UCD
DR   Wikidata; Q54757769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157980; Vac14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI641
AC   CVCL_MD14
SY   CSI641
DR   MMRRC; MMRRC:015833-UCD
DR   Wikidata; Q54757771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI642
AC   CVCL_MD15
SY   CSI642
DR   MMRRC; MMRRC:015834-UCD
DR   Wikidata; Q54757772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346832; Esrrb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI643
AC   CVCL_MD16
SY   CSI643
DR   MMRRC; MMRRC:015835-UCD
DR   Wikidata; Q54757775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI644
AC   CVCL_MD17
SY   CSI644
DR   MMRRC; MMRRC:015836-UCD
DR   Wikidata; Q54757777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446126; Phf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI645
AC   CVCL_MD18
SY   CSI645
DR   MMRRC; MMRRC:015837-UCD
DR   Wikidata; Q54757778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI646
AC   CVCL_MD19
SY   CSI646
DR   MMRRC; MMRRC:015838-UCD
DR   Wikidata; Q54757782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI647
AC   CVCL_MD20
SY   CSI647
DR   MMRRC; MMRRC:015839-UCD
DR   Wikidata; Q54757783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI648
AC   CVCL_MD21
SY   CSI648
DR   MMRRC; MMRRC:015840-UCD
DR   Wikidata; Q54757784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860267; Set.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI651
AC   CVCL_MD22
SY   CSI651
DR   MMRRC; MMRRC:015841-UCD
DR   Wikidata; Q54757788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921358; Parn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI654
AC   CVCL_MD23
SY   CSI654
DR   MMRRC; MMRRC:015843-UCD
DR   Wikidata; Q54757789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98351; Sod1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI656
AC   CVCL_MD24
SY   CSI656
DR   MMRRC; MMRRC:015844-UCD
DR   Wikidata; Q54757791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338038; Aebp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI657
AC   CVCL_MD25
SY   CSI657
DR   MMRRC; MMRRC:015845-UCD
DR   Wikidata; Q54757793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI661
AC   CVCL_MD26
SY   CSI661
DR   MMRRC; MMRRC:015847-UCD
DR   Wikidata; Q54757794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI662
AC   CVCL_MD27
SY   CSI662
DR   MMRRC; MMRRC:015848-UCD
DR   Wikidata; Q54757796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444248; Gcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSI664
AC   CVCL_MD28
SY   CSI664
DR   MMRRC; MMRRC:015849-UCD
DR   Wikidata; Q54757797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI668
AC   CVCL_MD29
SY   CSI668
DR   MMRRC; MMRRC:015943-UCD
DR   Wikidata; Q54757799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105369; Cbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI670
AC   CVCL_MD30
SY   CSI670
DR   MMRRC; MMRRC:015920-UCD
DR   Wikidata; Q54757801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444207; Vps13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI685
AC   CVCL_MD31
SY   CSI685
DR   MMRRC; MMRRC:015914-UCD
DR   Wikidata; Q54757802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354702; Fbxl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI690
AC   CVCL_MD32
SY   CSI690
DR   MMRRC; MMRRC:015921-UCD
DR   Wikidata; Q54757803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95393; Eno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI692
AC   CVCL_MD33
SY   CSI692
DR   MMRRC; MMRRC:015906-UCD
DR   Wikidata; Q54757804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933161; Trim23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI694
AC   CVCL_MD34
SY   CSI694
DR   MMRRC; MMRRC:015951-UCD
DR   Wikidata; Q54757806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353472; Rpl7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI695
AC   CVCL_MD35
SY   CSI695
DR   MMRRC; MMRRC:015922-UCD
DR   Wikidata; Q54757808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI697
AC   CVCL_MD36
SY   CSI697
DR   MMRRC; MMRRC:015923-UCD
DR   Wikidata; Q54757810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144805; Vipas39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI700
AC   CVCL_MD37
SY   CSI700
DR   MMRRC; MMRRC:015899-UCD
DR   Wikidata; Q54757811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442524; Heatr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI701
AC   CVCL_MD38
SY   CSI701
DR   MMRRC; MMRRC:015907-UCD
DR   Wikidata; Q54757815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104670; Fkbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI702
AC   CVCL_MD39
SY   CSI702
DR   MMRRC; MMRRC:015924-UCD
DR   Wikidata; Q54757816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444268; Fam169a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI707
AC   CVCL_MD40
SY   CSI707
DR   MMRRC; MMRRC:015901-UCD
DR   Wikidata; Q54757899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI709
AC   CVCL_MD41
SY   CSI709
DR   MMRRC; MMRRC:015925-UCD
DR   Wikidata; Q54757900
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353561; Vapa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI713
AC   CVCL_MD42
SY   CSI713
DR   MMRRC; MMRRC:015952-UCD
DR   Wikidata; Q54757902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104670; Fkbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI714
AC   CVCL_MD43
SY   CSI714
DR   MMRRC; MMRRC:015908-UCD
DR   Wikidata; Q54757904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444412; Phf20l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI715
AC   CVCL_MD44
SY   CSI715
DR   MMRRC; MMRRC:015915-UCD
DR   Wikidata; Q54757906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443731; Mat2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI716
AC   CVCL_MD45
SY   CSI716
DR   MMRRC; MMRRC:015927-UCD
DR   Wikidata; Q54757908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98351; Sod1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI717
AC   CVCL_MD46
SY   CSI717
DR   MMRRC; MMRRC:015936-UCD
DR   Wikidata; Q54757909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI721
AC   CVCL_MD47
SY   CSI721
DR   MMRRC; MMRRC:015944-UCD
DR   Wikidata; Q54757911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443731; Mat2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI722
AC   CVCL_MD48
SY   CSI722
DR   MMRRC; MMRRC:015916-UCD
DR   Wikidata; Q54757913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920595; Timm21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI724
AC   CVCL_MD49
SY   CSI724
DR   MMRRC; MMRRC:015937-UCD
DR   Wikidata; Q54757914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI726
AC   CVCL_MD50
SY   CSI726
DR   MMRRC; MMRRC:015917-UCD
DR   Wikidata; Q54757917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI731
AC   CVCL_MD51
SY   CSI731
DR   MMRRC; MMRRC:015929-UCD
DR   Wikidata; Q54757918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI737
AC   CVCL_MD52
SY   CSI737
DR   MMRRC; MMRRC:015938-UCD
DR   Wikidata; Q54757921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384298; Sbno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI738
AC   CVCL_MD53
SY   CSI738
DR   MMRRC; MMRRC:015946-UCD
DR   Wikidata; Q54757923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI739
AC   CVCL_MD54
SY   CSI739
DR   MMRRC; MMRRC:015947-UCD
DR   Wikidata; Q54757924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450915; Sec23ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI740
AC   CVCL_MD55
SY   CSI740
DR   MMRRC; MMRRC:015948-UCD
DR   Wikidata; Q54757927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI742
AC   CVCL_MD56
SY   CSI742
DR   MMRRC; MMRRC:015932-UCD
DR   Wikidata; Q54757929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104670; Fkbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI743
AC   CVCL_MD57
SY   CSI743
DR   MMRRC; MMRRC:015910-UCD
DR   Wikidata; Q54757931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443731; Mat2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI746
AC   CVCL_MD58
SY   CSI746
DR   MMRRC; MMRRC:015933-UCD
DR   Wikidata; Q54757933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916979; 2410003L11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI750
AC   CVCL_MD59
SY   CSI750
DR   MMRRC; MMRRC:015939-UCD
DR   Wikidata; Q54757935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI754
AC   CVCL_MD60
SY   CSI754
DR   MMRRC; MMRRC:015918-UCD
DR   Wikidata; Q54757936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141291; Bud31.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI758
AC   CVCL_MD61
SY   CSI758
DR   MMRRC; MMRRC:015954-UCD
DR   Wikidata; Q54757937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919837; Pan3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI760
AC   CVCL_MD62
SY   CSI760
DR   MMRRC; MMRRC:015955-UCD
DR   Wikidata; Q54757940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349457; Serinc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI761
AC   CVCL_MD63
SY   CSI761
DR   MMRRC; MMRRC:015950-UCD
DR   Wikidata; Q54757942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI763
AC   CVCL_MD64
SY   CSI763
DR   MMRRC; MMRRC:015911-UCD
DR   Wikidata; Q54757943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI765
AC   CVCL_MD65
SY   CSI765
DR   MMRRC; MMRRC:015912-UCD
DR   Wikidata; Q54757946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914436; Rplp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI770
AC   CVCL_MD66
SY   CSI770
DR   MMRRC; MMRRC:015941-UCD
DR   Wikidata; Q54757948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915434; Denr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI771
AC   CVCL_MD67
SY   CSI771
DR   MMRRC; MMRRC:015913-UCD
DR   Wikidata; Q54757949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI772
AC   CVCL_MD68
SY   CSI772
DR   MMRRC; MMRRC:015903-UCD
DR   Wikidata; Q54757950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914436; Rplp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI774
AC   CVCL_MD69
SY   CSI774
DR   MMRRC; MMRRC:016010-UCD
DR   Wikidata; Q54757952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346035; Farsb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI776
AC   CVCL_MD70
SY   CSI776
DR   MMRRC; MMRRC:016011-UCD
DR   Wikidata; Q54757953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98285; Srsf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI777
AC   CVCL_MD71
SY   CSI777
DR   MMRRC; MMRRC:016012-UCD
DR   Wikidata; Q54757954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3763743; Snhg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI782
AC   CVCL_MD72
SY   CSI782
DR   MMRRC; MMRRC:016013-UCD
DR   Wikidata; Q54757955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI784
AC   CVCL_MD73
SY   CSI784
DR   MMRRC; MMRRC:016014-UCD
DR   Wikidata; Q54757958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI785
AC   CVCL_MD74
SY   CSI785
DR   MMRRC; MMRRC:016022-UCD
DR   Wikidata; Q54757959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449311; Gemin5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI786
AC   CVCL_MD75
SY   CSI786
DR   MMRRC; MMRRC:016015-UCD
DR   Wikidata; Q54757960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449311; Gemin5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI788
AC   CVCL_MD76
SY   CSI788
DR   MMRRC; MMRRC:016020-UCD
DR   Wikidata; Q54757963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924621; Sec24a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI796
AC   CVCL_MD77
SY   CSI796
DR   MMRRC; MMRRC:016016-UCD
DR   Wikidata; Q54757965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448458; H2aw.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSI799
AC   CVCL_MD78
SY   CSI799
DR   MMRRC; MMRRC:016018-UCD
DR   Wikidata; Q54757966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349457; Serinc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI802
AC   CVCL_MD79
SY   CSI802
DR   MMRRC; MMRRC:016023-UCD
DR   Wikidata; Q54757969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914595; Herc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI803
AC   CVCL_MD80
SY   CSI803
DR   MMRRC; MMRRC:016024-UCD
DR   Wikidata; Q54758011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI804
AC   CVCL_MD81
SY   CSI804
DR   MMRRC; MMRRC:016017-UCD
DR   Wikidata; Q54758013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101884; Ppard.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI807
AC   CVCL_MD82
SY   CSI807
DR   MMRRC; MMRRC:016019-UCD
DR   Wikidata; Q54758014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104708; Cct3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI808
AC   CVCL_MD83
SY   CSI808
DR   MMRRC; MMRRC:016021-UCD
DR   Wikidata; Q54758015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI809
AC   CVCL_MD84
SY   CSI809
DR   MMRRC; MMRRC:016116-UCD
DR   Wikidata; Q54758017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685031; Leo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI812
AC   CVCL_MD85
SY   CSI812
DR   MMRRC; MMRRC:016071-UCD
DR   Wikidata; Q54758018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI823
AC   CVCL_MD86
SY   CSI823
DR   MMRRC; MMRRC:016038-UCD
DR   Wikidata; Q54758020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916882; Arhgef12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI824
AC   CVCL_MD87
SY   CSI824
DR   MMRRC; MMRRC:016083-UCD
DR   Wikidata; Q54758021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI825
AC   CVCL_MD88
SY   CSI825
DR   MMRRC; MMRRC:016104-UCD
DR   Wikidata; Q54758022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI827
AC   CVCL_MD89
SY   CSI827
DR   MMRRC; MMRRC:016039-UCD
DR   Wikidata; Q54758024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI829
AC   CVCL_MD90
SY   CSI829
DR   MMRRC; MMRRC:016096-UCD
DR   Wikidata; Q54758026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107585; Srebf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI843
AC   CVCL_MD91
SY   CSI843
DR   MMRRC; MMRRC:016119-UCD
DR   Wikidata; Q54758028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI845
AC   CVCL_MD92
SY   CSI845
DR   MMRRC; MMRRC:016040-UCD
DR   Wikidata; Q54758030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI853
AC   CVCL_MD93
SY   CSI853
DR   MMRRC; MMRRC:016098-UCD
DR   Wikidata; Q54758032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673855; Bicral.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI858
AC   CVCL_MD94
SY   CSI858
DR   MMRRC; MMRRC:016075-UCD
DR   Wikidata; Q54758034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI862
AC   CVCL_MD95
SY   CSI862
DR   MMRRC; MMRRC:016759-UCD
DR   Wikidata; Q54758036
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI864
AC   CVCL_MD96
SY   CSI864
DR   MMRRC; MMRRC:016368-UCD
DR   Wikidata; Q54758041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI865
AC   CVCL_MD97
SY   CSI865
DR   MMRRC; MMRRC:016701-UCD
DR   Wikidata; Q54758042
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101757; Cfl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI867
AC   CVCL_MD98
SY   CSI867
DR   MMRRC; MMRRC:016652-UCD
DR   Wikidata; Q54758045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890218; Akap10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI870
AC   CVCL_MD99
SY   CSI870
DR   MMRRC; MMRRC:016489-UCD
DR   Wikidata; Q54758048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105071; Rab4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI872
AC   CVCL_ME00
SY   CSI872
DR   MMRRC; MMRRC:016591-UCD
DR   Wikidata; Q54758050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917302; Prpf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI875
AC   CVCL_ME01
SY   CSI875
DR   MMRRC; MMRRC:016541-UCD
DR   Wikidata; Q54758052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140327; Phactr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI882
AC   CVCL_ME02
SY   CSI882
DR   MMRRC; MMRRC:016656-UCD
DR   Wikidata; Q54758053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673855; Bicral.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI883
AC   CVCL_ME03
SY   CSI883
DR   MMRRC; MMRRC:016592-UCD
DR   Wikidata; Q54758054
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94909; Dmd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI884
AC   CVCL_ME04
SY   CSI884
DR   MMRRC; MMRRC:016657-UCD
DR   Wikidata; Q54758056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI885
AC   CVCL_ME05
SY   CSI885
DR   MMRRC; MMRRC:016432-UCD
DR   Wikidata; Q54758059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387603; Ahsa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSI889
AC   CVCL_ME06
SY   CSI889
DR   MMRRC; MMRRC:016543-UCD
DR   Wikidata; Q54758061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138986; Qser1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ004
AC   CVCL_ME07
SY   CSJ004
DR   MMRRC; MMRRC:016164-UCD
DR   Wikidata; Q54758063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915770; Zfyve21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ006
AC   CVCL_ME08
SY   CSJ006
DR   MMRRC; MMRRC:016165-UCD
DR   Wikidata; Q54758064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ012
AC   CVCL_ME09
SY   CSJ012
DR   MMRRC; MMRRC:016288-UCD
DR   Wikidata; Q54758065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891832; Patz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ014
AC   CVCL_ME10
SY   CSJ014
DR   MMRRC; MMRRC:016244-UCD
DR   Wikidata; Q54758068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ015
AC   CVCL_ME11
SY   CSJ015
DR   MMRRC; MMRRC:016206-UCD
DR   Wikidata; Q54758069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446089; Flnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ017
AC   CVCL_ME12
SY   CSJ017
DR   MMRRC; MMRRC:016265-UCD
DR   Wikidata; Q54758071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ021
AC   CVCL_ME13
SY   CSJ021
DR   MMRRC; MMRRC:016226-UCD
DR   Wikidata; Q54758073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923036; Ckap5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ024
AC   CVCL_ME14
SY   CSJ024
DR   MMRRC; MMRRC:016318-UCD
DR   Wikidata; Q54758074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ034
AC   CVCL_ME15
SY   CSJ034
DR   MMRRC; MMRRC:016289-UCD
DR   Wikidata; Q54758076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ039
AC   CVCL_ME16
SY   CSJ039
DR   MMRRC; MMRRC:016320-UCD
DR   Wikidata; Q54758077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ040
AC   CVCL_ME17
SY   CSJ040
DR   MMRRC; MMRRC:016245-UCD
DR   Wikidata; Q54758079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036237; Rsbn1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ041
AC   CVCL_ME18
SY   CSJ041
DR   MMRRC; MMRRC:016290-UCD
DR   Wikidata; Q54758080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915202; Tomm20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ042
AC   CVCL_ME19
SY   CSJ042
DR   MMRRC; MMRRC:016246-UCD
DR   Wikidata; Q54758082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88016; Ampd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ043
AC   CVCL_ME20
SY   CSJ043
DR   MMRRC; MMRRC:016321-UCD
DR   Wikidata; Q54758122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934811; Nucks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ046
AC   CVCL_ME21
SY   CSJ046
DR   MMRRC; MMRRC:016247-UCD
DR   Wikidata; Q54758125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923520; Cyrib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSJ048
AC   CVCL_ME22
SY   CSJ048
DR   MMRRC; MMRRC:016227-UCD
DR   Wikidata; Q54758127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036237; Rsbn1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ051
AC   CVCL_ME23
SY   CSJ051
DR   MMRRC; MMRRC:016761-UCD
DR   Wikidata; Q54758129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ053
AC   CVCL_ME24
SY   CSJ053
DR   MMRRC; MMRRC:016593-UCD
DR   Wikidata; Q54758131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203522; Magi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ057
AC   CVCL_ME25
SY   CSJ057
DR   MMRRC; MMRRC:016702-UCD
DR   Wikidata; Q54758134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682334; Smg7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ060
AC   CVCL_ME26
SY   CSJ060
DR   MMRRC; MMRRC:016370-UCD
DR   Wikidata; Q54758135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99961; Usf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ068
AC   CVCL_ME27
SY   CSJ068
DR   MMRRC; MMRRC:016371-UCD
DR   Wikidata; Q54758136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ073
AC   CVCL_ME28
SY   CSJ073
DR   MMRRC; MMRRC:016433-UCD
DR   Wikidata; Q54758140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347488; Foxk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ074
AC   CVCL_ME29
SY   CSJ074
DR   MMRRC; MMRRC:016703-UCD
DR   Wikidata; Q54758141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921729; Snx11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ075
AC   CVCL_ME30
SY   CSJ075
DR   MMRRC; MMRRC:016704-UCD
DR   Wikidata; Q54758142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1335094; Septin7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line CSJ077
AC   CVCL_ME31
SY   CSJ077
DR   MMRRC; MMRRC:016372-UCD
DR   Wikidata; Q54758144
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919224; Prmt3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ078
AC   CVCL_ME32
SY   CSJ078
DR   MMRRC; MMRRC:016434-UCD
DR   Wikidata; Q54758145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336880; Eftud2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ079
AC   CVCL_ME33
SY   CSJ079
DR   MMRRC; MMRRC:016705-UCD
DR   Wikidata; Q54758146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930134; Ern1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ080
AC   CVCL_ME34
SY   CSJ080
DR   MMRRC; MMRRC:016492-UCD
DR   Wikidata; Q54758147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ083
AC   CVCL_ME35
SY   CSJ083
DR   MMRRC; MMRRC:016493-UCD
DR   Wikidata; Q54758149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2386251; Eif3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ084
AC   CVCL_ME36
SY   CSJ084
DR   MMRRC; MMRRC:016594-UCD
DR   Wikidata; Q54758151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ087
AC   CVCL_ME37
SY   CSJ087
DR   MMRRC; MMRRC:016595-UCD
DR   Wikidata; Q54758152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859615; Otud5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ088
AC   CVCL_ME38
SY   CSJ088
DR   MMRRC; MMRRC:016659-UCD
DR   Wikidata; Q54758155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ090
AC   CVCL_ME39
SY   CSJ090
DR   MMRRC; MMRRC:016596-UCD
DR   Wikidata; Q54758158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930751; Trpc4ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ092
AC   CVCL_ME40
SY   CSJ092
DR   MMRRC; MMRRC:016494-UCD
DR   Wikidata; Q54758160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917394; Lrch3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ096
AC   CVCL_ME41
SY   CSJ096
DR   MMRRC; MMRRC:016544-UCD
DR   Wikidata; Q54758161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643401; Gm8935.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ097
AC   CVCL_ME42
SY   CSJ097
DR   MMRRC; MMRRC:016597-UCD
DR   Wikidata; Q54758164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ099
AC   CVCL_ME43
SY   CSJ099
DR   MMRRC; MMRRC:016706-UCD
DR   Wikidata; Q54758165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100865; Rbm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ101
AC   CVCL_ME44
SY   CSJ101
DR   MMRRC; MMRRC:016545-UCD
DR   Wikidata; Q54758166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330281; Cd2ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ102
AC   CVCL_ME45
SY   CSJ102
DR   MMRRC; MMRRC:016435-UCD
DR   Wikidata; Q54758169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330281; Cd2ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ106
AC   CVCL_ME46
SY   CSJ106
DR   MMRRC; MMRRC:016707-UCD
DR   Wikidata; Q54758171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107637; Psmb7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ108
AC   CVCL_ME47
SY   CSJ108
DR   MMRRC; MMRRC:016373-UCD
DR   Wikidata; Q54758172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95659; Gas5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ114
AC   CVCL_ME48
SY   CSJ114
DR   MMRRC; MMRRC:016436-UCD
DR   Wikidata; Q54758174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ115
AC   CVCL_ME49
SY   CSJ115
DR   MMRRC; MMRRC:016765-UCD
DR   Wikidata; Q54758175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103234; Herc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ117
AC   CVCL_ME50
SY   CSJ117
DR   MMRRC; MMRRC:016660-UCD
DR   Wikidata; Q54758177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894676; Mast2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ126
AC   CVCL_ME51
SY   CSJ126
DR   MMRRC; MMRRC:016661-UCD
DR   Wikidata; Q54758178
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921358; Parn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ127
AC   CVCL_ME52
SY   CSJ127
DR   MMRRC; MMRRC:016709-UCD
DR   Wikidata; Q54758179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916960; Arap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ130
AC   CVCL_ME53
SY   CSJ130
DR   MMRRC; MMRRC:016375-UCD
DR   Wikidata; Q54758182
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922896; Rai14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ134
AC   CVCL_ME54
SY   CSJ134
DR   MMRRC; MMRRC:016439-UCD
DR   Wikidata; Q54758185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929760; Cdc42ep4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ136
AC   CVCL_ME55
SY   CSJ136
DR   MMRRC; MMRRC:016440-UCD
DR   Wikidata; Q54758186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346877; Map3k7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ137
AC   CVCL_ME56
SY   CSJ137
DR   MMRRC; MMRRC:016599-UCD
DR   Wikidata; Q54758188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ139
AC   CVCL_ME57
SY   CSJ139
DR   MMRRC; MMRRC:016710-UCD
DR   Wikidata; Q54758191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ140
AC   CVCL_ME58
SY   CSJ140
DR   MMRRC; MMRRC:016600-UCD
DR   Wikidata; Q54758192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859637; Nphs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ144
AC   CVCL_ME59
SY   CSJ144
DR   MMRRC; MMRRC:016601-UCD
DR   Wikidata; Q54758195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ145
AC   CVCL_ME60
SY   CSJ145
DR   MMRRC; MMRRC:016497-UCD
DR   Wikidata; Q54758227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ147
AC   CVCL_ME61
SY   CSJ147
DR   MMRRC; MMRRC:016546-UCD
DR   Wikidata; Q54758229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98299; Shmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ148
AC   CVCL_ME62
SY   CSJ148
DR   MMRRC; MMRRC:016662-UCD
DR   Wikidata; Q54758230
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858683; Copg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ150
AC   CVCL_ME63
SY   CSJ150
DR   MMRRC; MMRRC:016711-UCD
DR   Wikidata; Q54758232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ151
AC   CVCL_ME64
SY   CSJ151
DR   MMRRC; MMRRC:016767-UCD
DR   Wikidata; Q54758233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106505; Zmym6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ152
AC   CVCL_ME65
SY   CSJ152
DR   MMRRC; MMRRC:016498-UCD
DR   Wikidata; Q54758235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ153
AC   CVCL_ME66
SY   CSJ153
DR   MMRRC; MMRRC:016499-UCD
DR   Wikidata; Q54758237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446126; Phf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ156
AC   CVCL_ME67
SY   CSJ156
DR   MMRRC; MMRRC:016376-UCD
DR   Wikidata; Q54758239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ158
AC   CVCL_ME68
SY   CSJ158
DR   MMRRC; MMRRC:016441-UCD
DR   Wikidata; Q54758240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ160
AC   CVCL_ME69
SY   CSJ160
DR   MMRRC; MMRRC:016442-UCD
DR   Wikidata; Q54758241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ163
AC   CVCL_ME70
SY   CSJ163
DR   MMRRC; MMRRC:016602-UCD
DR   Wikidata; Q54758244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914304; Paics.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ165
AC   CVCL_ME71
SY   CSJ165
DR   MMRRC; MMRRC:016443-UCD
DR   Wikidata; Q54758246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921455; Acsl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ166
AC   CVCL_ME72
SY   CSJ166
DR   MMRRC; MMRRC:016768-UCD
DR   Wikidata; Q54758247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ167
AC   CVCL_ME73
SY   CSJ167
DR   MMRRC; MMRRC:016603-UCD
DR   Wikidata; Q54758249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351638; Mkln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ173
AC   CVCL_ME74
SY   CSJ173
DR   MMRRC; MMRRC:016604-UCD
DR   Wikidata; Q54758252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342283; Slc12a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ174
AC   CVCL_ME75
SY   CSJ174
DR   MMRRC; MMRRC:016377-UCD
DR   Wikidata; Q54758253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ176
AC   CVCL_ME76
SY   CSJ176
DR   MMRRC; MMRRC:016605-UCD
DR   Wikidata; Q54758254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95654; Gart.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ177
AC   CVCL_ME77
SY   CSJ177
DR   MMRRC; MMRRC:016663-UCD
DR   Wikidata; Q54758257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384993; Paip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ178
AC   CVCL_ME78
SY   CSJ178
DR   MMRRC; MMRRC:016769-UCD
DR   Wikidata; Q54758259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934919; Rnf111.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ179
AC   CVCL_ME79
SY   CSJ179
DR   MMRRC; MMRRC:016712-UCD
DR   Wikidata; Q54758262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096572; Zfand3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ180
AC   CVCL_ME80
SY   CSJ180
DR   MMRRC; MMRRC:016548-UCD
DR   Wikidata; Q54758265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ181
AC   CVCL_ME81
SY   CSJ181
DR   MMRRC; MMRRC:016770-UCD
DR   Wikidata; Q54758266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913809; Metap1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ183
AC   CVCL_ME82
SY   CSJ183
DR   MMRRC; MMRRC:016549-UCD
DR   Wikidata; Q54758269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916175; Rpap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ184
AC   CVCL_ME83
SY   CSJ184
DR   MMRRC; MMRRC:016378-UCD
DR   Wikidata; Q54758270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ185
AC   CVCL_ME84
SY   CSJ185
DR   MMRRC; MMRRC:016550-UCD
DR   Wikidata; Q54758272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354742; Synrg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ186
AC   CVCL_ME85
SY   CSJ186
DR   MMRRC; MMRRC:016771-UCD
DR   Wikidata; Q54758273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924393; Trip11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ188
AC   CVCL_ME86
SY   CSJ188
DR   MMRRC; MMRRC:016379-UCD
DR   Wikidata; Q54758275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3780102; Gm9694.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ191
AC   CVCL_ME87
SY   CSJ191
DR   MMRRC; MMRRC:016772-UCD
DR   Wikidata; Q54758276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ195
AC   CVCL_ME88
SY   CSJ195
DR   MMRRC; MMRRC:016713-UCD
DR   Wikidata; Q54758278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924393; Trip11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ197
AC   CVCL_ME89
SY   CSJ197
DR   MMRRC; MMRRC:016714-UCD
DR   Wikidata; Q54758280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342283; Slc12a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ200
AC   CVCL_ME90
SY   CSJ200
DR   MMRRC; MMRRC:016715-UCD
DR   Wikidata; Q54758281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ201
AC   CVCL_ME91
SY   CSJ201
DR   MMRRC; MMRRC:016716-UCD
DR   Wikidata; Q54758282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447364; Smg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ202
AC   CVCL_ME92
SY   CSJ202
DR   MMRRC; MMRRC:016500-UCD
DR   Wikidata; Q54758283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447364; Smg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ204
AC   CVCL_ME93
SY   CSJ204
DR   MMRRC; MMRRC:016665-UCD
DR   Wikidata; Q54758287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ208
AC   CVCL_ME94
SY   CSJ208
DR   MMRRC; MMRRC:016773-UCD
DR   Wikidata; Q54758288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916960; Arap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ210
AC   CVCL_ME95
SY   CSJ210
DR   MMRRC; MMRRC:016775-UCD
DR   Wikidata; Q54758291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915206; Kmt5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ211
AC   CVCL_ME96
SY   CSJ211
DR   MMRRC; MMRRC:016776-UCD
DR   Wikidata; Q54758293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921285; Nol9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ213
AC   CVCL_ME97
SY   CSJ213
DR   MMRRC; MMRRC:016666-UCD
DR   Wikidata; Q54758296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ214
AC   CVCL_ME98
SY   CSJ214
DR   MMRRC; MMRRC:016380-UCD
DR   Wikidata; Q54758297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ215
AC   CVCL_ME99
SY   CSJ215
DR   MMRRC; MMRRC:016381-UCD
DR   Wikidata; Q54758299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101884; Ppard.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ217
AC   CVCL_MF00
SY   CSJ217
DR   MMRRC; MMRRC:016607-UCD
DR   Wikidata; Q54758334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385207; Gnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ218
AC   CVCL_MF01
SY   CSJ218
DR   MMRRC; MMRRC:016444-UCD
DR   Wikidata; Q54758335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ219
AC   CVCL_MF02
SY   CSJ219
DR   MMRRC; MMRRC:016777-UCD
DR   Wikidata; Q54758337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105047; Psmc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ220
AC   CVCL_MF03
SY   CSJ220
DR   MMRRC; MMRRC:016717-UCD
DR   Wikidata; Q54758339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916334; Fam207a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ221
AC   CVCL_MF04
SY   CSJ221
DR   MMRRC; MMRRC:016382-UCD
DR   Wikidata; Q54758343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923990; Efr3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ222
AC   CVCL_MF05
SY   CSJ222
DR   MMRRC; MMRRC:016608-UCD
DR   Wikidata; Q54758345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924550; Raph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ226
AC   CVCL_MF06
SY   CSJ226
DR   MMRRC; MMRRC:016501-UCD
DR   Wikidata; Q54758346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ227
AC   CVCL_MF07
SY   CSJ227
DR   MMRRC; MMRRC:016383-UCD
DR   Wikidata; Q54758347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336880; Eftud2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ231
AC   CVCL_MF08
SY   CSJ231
DR   MMRRC; MMRRC:016552-UCD
DR   Wikidata; Q54758348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338049; Itsn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ232
AC   CVCL_MF09
SY   CSJ232
DR   MMRRC; MMRRC:016719-UCD
DR   Wikidata; Q54758350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915127; Naa20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ233
AC   CVCL_MF10
SY   CSJ233
DR   MMRRC; MMRRC:016502-UCD
DR   Wikidata; Q54758351
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99204; Zfp57.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ235
AC   CVCL_MF11
SY   CSJ235
DR   MMRRC; MMRRC:016609-UCD
DR   Wikidata; Q54758353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ238
AC   CVCL_MF12
SY   CSJ238
DR   MMRRC; MMRRC:016610-UCD
DR   Wikidata; Q54758354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179381; Prpf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ240
AC   CVCL_MF13
SY   CSJ240
DR   MMRRC; MMRRC:016778-UCD
DR   Wikidata; Q54758357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930134; Ern1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ243
AC   CVCL_MF14
SY   CSJ243
DR   MMRRC; MMRRC:016667-UCD
DR   Wikidata; Q54758359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927110; Tmem131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ248
AC   CVCL_MF15
SY   CSJ248
DR   MMRRC; MMRRC:016720-UCD
DR   Wikidata; Q54758360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926033; Brpf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ249
AC   CVCL_MF16
SY   CSJ249
DR   MMRRC; MMRRC:016668-UCD
DR   Wikidata; Q54758361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914099; Ppp1r2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ251
AC   CVCL_MF17
SY   CSJ251
DR   MMRRC; MMRRC:016445-UCD
DR   Wikidata; Q54758364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261856; Ankle2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ252
AC   CVCL_MF18
SY   CSJ252
DR   MMRRC; MMRRC:016611-UCD
DR   Wikidata; Q54758366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261856; Ankle2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ257
AC   CVCL_MF19
SY   CSJ257
DR   MMRRC; MMRRC:016384-UCD
DR   Wikidata; Q54758367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107940; Ezh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ259
AC   CVCL_MF20
SY   CSJ259
DR   MMRRC; MMRRC:016721-UCD
DR   Wikidata; Q54758369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917799; Tln2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ260
AC   CVCL_MF21
SY   CSJ260
DR   MMRRC; MMRRC:016722-UCD
DR   Wikidata; Q54758370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103306; Tiam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ266
AC   CVCL_MF22
SY   CSJ266
DR   MMRRC; MMRRC:016446-UCD
DR   Wikidata; Q54758373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ267
AC   CVCL_MF23
SY   CSJ267
DR   MMRRC; MMRRC:016385-UCD
DR   Wikidata; Q54758375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384294; Rbm47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ270
AC   CVCL_MF24
SY   CSJ270
DR   MMRRC; MMRRC:016503-UCD
DR   Wikidata; Q54758376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450166; Arhgap32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ274
AC   CVCL_MF25
SY   CSJ274
DR   MMRRC; MMRRC:016386-UCD
DR   Wikidata; Q54758377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921417; Nudt9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ276
AC   CVCL_MF26
SY   CSJ276
DR   MMRRC; MMRRC:016447-UCD
DR   Wikidata; Q54758379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922816; Ing5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ279
AC   CVCL_MF27
SY   CSJ279
DR   MMRRC; MMRRC:016387-UCD
DR   Wikidata; Q54758380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922246; Usp47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ285
AC   CVCL_MF28
SY   CSJ285
DR   MMRRC; MMRRC:016780-UCD
DR   Wikidata; Q54758381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88262; Cap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ286
AC   CVCL_MF29
SY   CSJ286
DR   MMRRC; MMRRC:016724-UCD
DR   Wikidata; Q54758382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ287
AC   CVCL_MF30
SY   CSJ287
DR   MMRRC; MMRRC:016390-UCD
DR   Wikidata; Q54758384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336155; Lss.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ288
AC   CVCL_MF31
SY   CSJ288
DR   MMRRC; MMRRC:016448-UCD
DR   Wikidata; Q54758387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676556; Akap13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ291
AC   CVCL_MF32
SY   CSJ291
DR   MMRRC; MMRRC:016391-UCD
DR   Wikidata; Q54758388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ293
AC   CVCL_MF33
SY   CSJ293
DR   MMRRC; MMRRC:016555-UCD
DR   Wikidata; Q54758390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ295
AC   CVCL_MF34
SY   CSJ295
DR   MMRRC; MMRRC:016449-UCD
DR   Wikidata; Q54758391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ300
AC   CVCL_MF35
SY   CSJ300
DR   MMRRC; MMRRC:016670-UCD
DR   Wikidata; Q54758395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202876; Tcf7l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ301
AC   CVCL_MF36
SY   CSJ301
DR   MMRRC; MMRRC:016392-UCD
DR   Wikidata; Q54758396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444114; Zcchc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ303
AC   CVCL_MF37
SY   CSJ303
DR   MMRRC; MMRRC:016504-UCD
DR   Wikidata; Q54758397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109150; Mnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ306
AC   CVCL_MF38
SY   CSJ306
DR   MMRRC; MMRRC:016450-UCD
DR   Wikidata; Q54758398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676556; Akap13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ309
AC   CVCL_MF39
SY   CSJ309
DR   MMRRC; MMRRC:016726-UCD
DR   Wikidata; Q54758400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105369; Cbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ311
AC   CVCL_MF40
SY   CSJ311
DR   MMRRC; MMRRC:016556-UCD
DR   Wikidata; Q54758433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97316; Nfya.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ313
AC   CVCL_MF41
SY   CSJ313
DR   MMRRC; MMRRC:016395-UCD
DR   Wikidata; Q54758434
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ315
AC   CVCL_MF42
SY   CSJ315
DR   MMRRC; MMRRC:016614-UCD
DR   Wikidata; Q54758436
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ317
AC   CVCL_MF43
SY   CSJ317
DR   MMRRC; MMRRC:016615-UCD
DR   Wikidata; Q54758438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681865; Zfat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ319
AC   CVCL_MF44
SY   CSJ319
DR   MMRRC; MMRRC:016672-UCD
DR   Wikidata; Q54758439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ322
AC   CVCL_MF45
SY   CSJ322
DR   MMRRC; MMRRC:016451-UCD
DR   Wikidata; Q54758441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100863; Kpna3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ325
AC   CVCL_MF46
SY   CSJ325
DR   MMRRC; MMRRC:016781-UCD
DR   Wikidata; Q54758443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ327
AC   CVCL_MF47
SY   CSJ327
DR   MMRRC; MMRRC:016452-UCD
DR   Wikidata; Q54758444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347078; Grk6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ328
AC   CVCL_MF48
SY   CSJ328
DR   MMRRC; MMRRC:016728-UCD
DR   Wikidata; Q54758446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446634; Ago3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ330
AC   CVCL_MF49
SY   CSJ330
DR   MMRRC; MMRRC:016782-UCD
DR   Wikidata; Q54758448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202305; Vps72.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ332
AC   CVCL_MF50
SY   CSJ332
DR   MMRRC; MMRRC:016396-UCD
DR   Wikidata; Q54758449
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line CSJ336
AC   CVCL_MF51
SY   CSJ336
DR   MMRRC; MMRRC:016453-UCD
DR   Wikidata; Q54758451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336155; Lss.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM001
AC   CVCL_MF52
SY   DTM001
DR   MMRRC; MMRRC:000465-UCD
DR   Wikidata; Q54758452
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917490; Ufsp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM005
AC   CVCL_MF53
SY   DTM005
DR   MMRRC; MMRRC:000468-UCD
DR   Wikidata; Q54758454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861380; Sphk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM007
AC   CVCL_MF54
SY   DTM007
DR   MMRRC; MMRRC:000470-UCD
DR   Wikidata; Q54758456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM008
AC   CVCL_MF55
SY   DTM008
DR   MMRRC; MMRRC:000471-UCD
DR   Wikidata; Q54758457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913368; Sarnp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM009
AC   CVCL_MF56
SY   DTM009
DR   MMRRC; MMRRC:000472-UCD
DR   Wikidata; Q54758460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921601; Ddx23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM010
AC   CVCL_MF57
SY   DTM010
DR   MMRRC; MMRRC:000473-UCD
DR   Wikidata; Q54758462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915119; Paip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM011
AC   CVCL_MF58
SY   DTM011
DR   MMRRC; MMRRC:000474-UCD
DR   Wikidata; Q54758465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651986; Zfp985.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM012
AC   CVCL_MF59
SY   DTM012
DR   MMRRC; MMRRC:000475-UCD
DR   Wikidata; Q54758468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107628; Prdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM013
AC   CVCL_MF60
SY   DTM013
DR   MMRRC; MMRRC:000476-UCD
DR   Wikidata; Q54758470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM015
AC   CVCL_MF61
SY   DTM015
DR   MMRRC; MMRRC:000478-UCD
DR   Wikidata; Q54758471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88266; Capns1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM016
AC   CVCL_MF62
SY   DTM016
DR   MMRRC; MMRRC:000479-UCD
DR   Wikidata; Q54758473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443679; Sipa1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM017
AC   CVCL_MF63
SY   DTM017
DR   MMRRC; MMRRC:000480-UCD
DR   Wikidata; Q54758476
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM021
AC   CVCL_MF64
SY   DTM021
DR   MMRRC; MMRRC:000484-UCD
DR   Wikidata; Q54758478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922665; Arhgap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM023
AC   CVCL_MF65
SY   DTM023
DR   MMRRC; MMRRC:000486-UCD
DR   Wikidata; Q54758480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914490; Taok1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM024
AC   CVCL_MF66
SY   DTM024
DR   MMRRC; MMRRC:000487-UCD
DR   Wikidata; Q54758481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916477; Selenot.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM026
AC   CVCL_MF67
SY   DTM026
DR   MMRRC; MMRRC:000488-UCD
DR   Wikidata; Q54758483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3029632; Med13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM030
AC   CVCL_MF68
SY   DTM030
DR   MMRRC; MMRRC:000491-UCD
DR   Wikidata; Q54758485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142716; Gpat4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM033
AC   CVCL_MF69
SY   DTM033
DR   MMRRC; MMRRC:000492-UCD
DR   Wikidata; Q54758486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM034
AC   CVCL_MF70
SY   DTM034
DR   MMRRC; MMRRC:000493-UCD
DR   Wikidata; Q54758488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146189; Topors.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM035
AC   CVCL_MF71
SY   DTM035
DR   MMRRC; MMRRC:000494-UCD
DR   Wikidata; Q54758491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858211; Zranb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM036
AC   CVCL_MF72
SY   DTM036
DR   MMRRC; MMRRC:000495-UCD
DR   Wikidata; Q54758493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99638; Mark2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM037
AC   CVCL_MF73
SY   DTM037
DR   MMRRC; MMRRC:000496-UCD
DR   Wikidata; Q54758495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444951; 8030462N17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM039
AC   CVCL_MF74
SY   DTM039
DR   MMRRC; MMRRC:000497-UCD
DR   Wikidata; Q54758496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920093; Prdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM040
AC   CVCL_MF75
SY   DTM040
DR   MMRRC; MMRRC:000498-UCD
DR   Wikidata; Q54758497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM041
AC   CVCL_MF76
SY   DTM041
DR   MMRRC; MMRRC:000499-UCD
DR   Wikidata; Q54758499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098672; Szrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM043
AC   CVCL_MF77
SY   DTM043
DR   MMRRC; MMRRC:000501-UCD
DR   Wikidata; Q54758502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915393; Herpud2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM044
AC   CVCL_MF78
SY   DTM044
DR   MMRRC; MMRRC:000502-UCD
DR   Wikidata; Q54758503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861601; Cpsf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM049
AC   CVCL_MF79
SY   DTM049
DR   MMRRC; MMRRC:000507-UCD
DR   Wikidata; Q54758507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107423; Numb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM051
AC   CVCL_MF80
SY   DTM051
DR   MMRRC; MMRRC:000508-UCD
DR   Wikidata; Q54758546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3583954; Zfp961.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM057
AC   CVCL_MF81
SY   DTM057
DR   MMRRC; MMRRC:000512-UCD
DR   Wikidata; Q54758549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927243; Rala.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM060
AC   CVCL_MF82
SY   DTM060
DR   MMRRC; MMRRC:000513-UCD
DR   Wikidata; Q54758550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95299; Eif2s1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM061
AC   CVCL_MF83
SY   DTM061
DR   MMRRC; MMRRC:000514-UCD
DR   Wikidata; Q54758551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:91860; Dcaf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM062
AC   CVCL_MF84
SY   DTM062
DR   MMRRC; MMRRC:000515-UCD
DR   Wikidata; Q54758555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442555; Dis3l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM065
AC   CVCL_MF85
SY   DTM065
DR   MMRRC; MMRRC:000518-UCD
DR   Wikidata; Q54758557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099804; Hip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM066
AC   CVCL_MF86
SY   DTM066
DR   MMRRC; MMRRC:000519-UCD
DR   Wikidata; Q54758558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446159; Itpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM071
AC   CVCL_MF87
SY   DTM071
DR   MMRRC; MMRRC:000522-UCD
DR   Wikidata; Q54758560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159342; Pja2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM074
AC   CVCL_MF88
SY   DTM074
DR   MMRRC; MMRRC:000524-UCD
DR   Wikidata; Q54758562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894684; Pa2g4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM076
AC   CVCL_MF89
SY   DTM076
DR   MMRRC; MMRRC:000525-UCD
DR   Wikidata; Q54758563
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102695; Ptprf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM077
AC   CVCL_MF90
SY   DTM077
DR   MMRRC; MMRRC:000526-UCD
DR   Wikidata; Q54758566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861601; Cpsf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM078
AC   CVCL_MF91
SY   DTM078
DR   MMRRC; MMRRC:000527-UCD
DR   Wikidata; Q54758568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923549; Erp44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM079
AC   CVCL_MF92
SY   DTM079
DR   MMRRC; MMRRC:000528-UCD
DR   Wikidata; Q54758569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108420; Nfe2l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM084
AC   CVCL_MF93
SY   DTM084
DR   MMRRC; MMRRC:000532-UCD
DR   Wikidata; Q54758571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202402; Pde7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM087
AC   CVCL_MF94
SY   DTM087
DR   MMRRC; MMRRC:000535-UCD
DR   Wikidata; Q54758573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443930; Lcor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM088
AC   CVCL_MF95
SY   DTM088
DR   MMRRC; MMRRC:000536-UCD
DR   Wikidata; Q54758574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915371; Cep70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM089
AC   CVCL_MF96
SY   DTM089
DR   MMRRC; MMRRC:000537-UCD
DR   Wikidata; Q54758575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM091
AC   CVCL_MF97
SY   DTM091
DR   MMRRC; MMRRC:000538-UCD
DR   Wikidata; Q54758578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM092
AC   CVCL_MF98
SY   DTM092
DR   MMRRC; MMRRC:000539-UCD
DR   Wikidata; Q54758579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107180; Elf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM093
AC   CVCL_MF99
SY   DTM093
DR   MMRRC; MMRRC:000540-UCD
DR   Wikidata; Q54758581
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107629; Luzp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM096
AC   CVCL_MG00
SY   DTM096
DR   MMRRC; MMRRC:000543-UCD
DR   Wikidata; Q54758583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921642; Specc1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM098
AC   CVCL_MG01
SY   DTM098
DR   MMRRC; MMRRC:000545-UCD
DR   Wikidata; Q54758587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916051; Elovl5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM100
AC   CVCL_MG02
SY   DTM100
DR   MMRRC; MMRRC:000546-UCD
DR   Wikidata; Q54758588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM101
AC   CVCL_MG03
SY   DTM101
DR   MMRRC; MMRRC:000547-UCD
DR   Wikidata; Q54758589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140729; Zfand2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM102
AC   CVCL_MG04
SY   DTM102
DR   MMRRC; MMRRC:000548-UCD
DR   Wikidata; Q54758590
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150016; Spred1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM103
AC   CVCL_MG05
SY   DTM103
DR   MMRRC; MMRRC:000549-UCD
DR   Wikidata; Q54758593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915689; Lrrc28.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line DTM104
AC   CVCL_MG06
SY   DTM104
DR   MMRRC; MMRRC:000550-UCD
DR   Wikidata; Q54758594
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894680; Bach1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex124
AC   CVCL_MG07
SY   Ex124
DR   MMRRC; MMRRC:000551-UCD
DR   Wikidata; Q54758595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex125
AC   CVCL_MG08
SY   Ex125
DR   MMRRC; MMRRC:000552-UCD
DR   Wikidata; Q54758597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex126
AC   CVCL_MG09
SY   Ex126
DR   MMRRC; MMRRC:000553-UCD
DR   Wikidata; Q54758599
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex132
AC   CVCL_MG10
SY   Ex132
DR   MMRRC; MMRRC:000555-UCD
DR   Wikidata; Q54758602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143702; Enpp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex136
AC   CVCL_MG11
SY   Ex136
DR   MMRRC; MMRRC:000556-UCD
DR   Wikidata; Q54758603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104903; Gpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex140
AC   CVCL_MG12
SY   Ex140
DR   MMRRC; MMRRC:000557-UCD
DR   Wikidata; Q54758605
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex153
AC   CVCL_MG13
SY   Ex153
DR   MMRRC; MMRRC:000559-UCD
DR   Wikidata; Q54758607
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108077; Nptn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex158
AC   CVCL_MG14
SY   Ex158
DR   MMRRC; MMRRC:000560-UCD
DR   Wikidata; Q54758609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex160
AC   CVCL_MG15
SY   Ex160
DR   MMRRC; MMRRC:000561-UCD
DR   Wikidata; Q54758613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106211; Cdc42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex166
AC   CVCL_MG16
SY   Ex166
DR   MMRRC; MMRRC:000562-UCD
DR   Wikidata; Q54758615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex173
AC   CVCL_MG17
SY   Ex173
DR   MMRRC; MMRRC:000564-UCD
DR   Wikidata; Q54758616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140592; Slc44a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex180
AC   CVCL_MG18
SY   Ex180
DR   MMRRC; MMRRC:000567-UCD
DR   Wikidata; Q54758619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex182
AC   CVCL_MG19
SY   Ex182
DR   MMRRC; MMRRC:000568-UCD
DR   Wikidata; Q54758620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex183
AC   CVCL_MG20
SY   Ex183
DR   MMRRC; MMRRC:000569-UCD
DR   Wikidata; Q54758659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex184
AC   CVCL_MG21
SY   Ex184
DR   MMRRC; MMRRC:000570-UCD
DR   Wikidata; Q54758661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95794; Lrp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex186
AC   CVCL_MG22
SY   Ex186
DR   MMRRC; MMRRC:000571-UCD
DR   Wikidata; Q54758663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138856; Ldlrad3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line EX187
AC   CVCL_MG23
SY   EX187
DR   MMRRC; MMRRC:000572-UCD
DR   Wikidata; Q54758664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298218; Lrp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex190
AC   CVCL_MG24
SY   Ex190
DR   MMRRC; MMRRC:000573-UCD
DR   Wikidata; Q54758665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex192
AC   CVCL_MG25
SY   Ex192
DR   MMRRC; MMRRC:000574-UCD
DR   Wikidata; Q54758669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87961; Agrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex194
AC   CVCL_MG26
SY   Ex194
DR   MMRRC; MMRRC:000575-UCD
DR   Wikidata; Q54758670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104902; Gpc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex197
AC   CVCL_MG27
SY   Ex197
DR   MMRRC; MMRRC:000576-UCD
DR   Wikidata; Q54758672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex200
AC   CVCL_MG28
SY   Ex200
DR   MMRRC; MMRRC:000577-UCD
DR   Wikidata; Q54758674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921867; Scpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex204
AC   CVCL_MG29
SY   Ex204
DR   MMRRC; MMRRC:000578-UCD
DR   Wikidata; Q54758675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex208
AC   CVCL_MG30
SY   Ex208
DR   MMRRC; MMRRC:000581-UCD
DR   Wikidata; Q54758677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860139; Gabbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex241
AC   CVCL_MG31
SY   Ex241
DR   MMRRC; MMRRC:000586-UCD
DR   Wikidata; Q54758680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278343; Nipsnap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex243
AC   CVCL_MG32
SY   Ex243
DR   MMRRC; MMRRC:000587-UCD
DR   Wikidata; Q54758682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95755; Slc2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex245
AC   CVCL_MG33
SY   Ex245
DR   MMRRC; MMRRC:000589-UCD
DR   Wikidata; Q54758685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96392; Icam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex252
AC   CVCL_MG34
SY   Ex252
DR   MMRRC; MMRRC:000590-UCD
DR   Wikidata; Q54758686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex255
AC   CVCL_MG35
SY   Ex255
DR   MMRRC; MMRRC:000591-UCD
DR   Wikidata; Q54758688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202296; Sorl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex256
AC   CVCL_MG36
SY   Ex256
DR   MMRRC; MMRRC:000592-UCD
DR   Wikidata; Q54758690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916176; Ubap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex260
AC   CVCL_MG37
SY   Ex260
DR   MMRRC; MMRRC:000593-UCD
DR   Wikidata; Q54758692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex269
AC   CVCL_MG38
SY   Ex269
DR   MMRRC; MMRRC:000595-UCD
DR   Wikidata; Q54758694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914635; Ubald2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex273
AC   CVCL_MG39
SY   Ex273
DR   MMRRC; MMRRC:000596-UCD
DR   Wikidata; Q54758695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex279
AC   CVCL_MG40
SY   Ex279
DR   MMRRC; MMRRC:000597-UCD
DR   Wikidata; Q54758697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex283
AC   CVCL_MG41
SY   Ex283
DR   MMRRC; MMRRC:000598-UCD
DR   Wikidata; Q54758699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920930; Zbtb8a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex284
AC   CVCL_MG42
SY   Ex284
DR   MMRRC; MMRRC:000599-UCD
DR   Wikidata; Q54758701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex292
AC   CVCL_MG43
SY   Ex292
DR   MMRRC; MMRRC:000601-UCD
DR   Wikidata; Q54758703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298387; Fhl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex297
AC   CVCL_MG44
SY   Ex297
DR   MMRRC; MMRRC:000602-UCD
DR   Wikidata; Q54758704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109520; Pafah1b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex312
AC   CVCL_MG45
SY   Ex312
DR   MMRRC; MMRRC:000607-UCD
DR   Wikidata; Q54758707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919279; Cnpy3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex316
AC   CVCL_MG46
SY   Ex316
DR   MMRRC; MMRRC:000608-UCD
DR   Wikidata; Q54758708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935147; Arid1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex327
AC   CVCL_MG47
SY   Ex327
DR   MMRRC; MMRRC:000610-UCD
DR   Wikidata; Q54758712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684817; Snhg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex331
AC   CVCL_MG48
SY   Ex331
DR   MMRRC; MMRRC:000612-UCD
DR   Wikidata; Q54758714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex332
AC   CVCL_MG49
SY   Ex332
DR   MMRRC; MMRRC:000613-UCD
DR   Wikidata; Q54758715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443487; Trmt61a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex335
AC   CVCL_MG50
SY   Ex335
DR   MMRRC; MMRRC:000614-UCD
DR   Wikidata; Q54758717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex369
AC   CVCL_MG51
SY   Ex369
DR   MMRRC; MMRRC:000615-UCD
DR   Wikidata; Q54758719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex381
AC   CVCL_MG52
SY   Ex381
DR   MMRRC; MMRRC:000617-UCD
DR   Wikidata; Q54758720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914544; Elp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line Ex387
AC   CVCL_MG53
SY   Ex387
DR   MMRRC; MMRRC:000618-UCD
DR   Wikidata; Q54758722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex388
AC   CVCL_MG54
SY   Ex388
DR   MMRRC; MMRRC:000619-UCD
DR   Wikidata; Q54758723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97298; Septin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line Ex400
AC   CVCL_MG55
SY   Ex400
DR   MMRRC; MMRRC:000620-UCD
DR   Wikidata; Q54758726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684817; Snhg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex405
AC   CVCL_MG56
SY   Ex405
DR   MMRRC; MMRRC:000621-UCD
DR   Wikidata; Q54758729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922194; Qtrt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex503
AC   CVCL_MG57
SY   Ex503
DR   MMRRC; MMRRC:000624-UCD
DR   Wikidata; Q54758731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921997; Ddit4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex504
AC   CVCL_MG58
SY   Ex504
DR   MMRRC; MMRRC:000625-UCD
DR   Wikidata; Q54758732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923549; Erp44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Ex510
AC   CVCL_MG59
SY   Ex510
DR   MMRRC; MMRRC:000626-UCD
DR   Wikidata; Q54758734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298218; Lrp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GFP018
AC   CVCL_MG60
SY   GFP018
DR   MMRRC; MMRRC:000633-UCD
DR   Wikidata; Q54758765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109372; Cbx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST001
AC   CVCL_MG61
SY   GST001
DR   MMRRC; MMRRC:000640-UCD
DR   Wikidata; Q54758766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST002
AC   CVCL_MG62
SY   GST002
DR   MMRRC; MMRRC:000641-UCD
DR   Wikidata; Q54758767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98277; Epha4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST003
AC   CVCL_MG63
SY   GST003
DR   MMRRC; MMRRC:000642-UCD
DR   Wikidata; Q54758769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139714; Adgrl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST004
AC   CVCL_MG64
SY   GST004
DR   MMRRC; MMRRC:000643-UCD
DR   Wikidata; Q54758771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST008
AC   CVCL_MG65
SY   GST008
DR   MMRRC; MMRRC:000644-UCD
DR   Wikidata; Q54758773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926157; Atf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST009
AC   CVCL_MG66
SY   GST009
DR   MMRRC; MMRRC:000645-UCD
DR   Wikidata; Q54758775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST011
AC   CVCL_MG67
SY   GST011
DR   MMRRC; MMRRC:000646-UCD
DR   Wikidata; Q54758776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298229; Nid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST012
AC   CVCL_MG68
SY   GST012
DR   MMRRC; MMRRC:000647-UCD
DR   Wikidata; Q54758778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST015
AC   CVCL_MG69
SY   GST015
DR   MMRRC; MMRRC:000648-UCD
DR   Wikidata; Q54758780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST017
AC   CVCL_MG70
SY   GST017
DR   MMRRC; MMRRC:000649-UCD
DR   Wikidata; Q54758782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST033
AC   CVCL_MG71
SY   GST033
DR   MMRRC; MMRRC:000650-UCD
DR   Wikidata; Q54758784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST039
AC   CVCL_MG72
SY   GST039
DR   MMRRC; MMRRC:000652-UCD
DR   Wikidata; Q54758787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100492; Nrp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST042
AC   CVCL_MG73
SY   GST042
DR   MMRRC; MMRRC:000653-UCD
DR   Wikidata; Q54758788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443955; Lrig3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST046
AC   CVCL_MG74
SY   GST046
DR   MMRRC; MMRRC:000656-UCD
DR   Wikidata; Q54758789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST047
AC   CVCL_MG75
SY   GST047
DR   MMRRC; MMRRC:000657-UCD
DR   Wikidata; Q54758791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104669; Man2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST048
AC   CVCL_MG76
SY   GST048
DR   MMRRC; MMRRC:000658-UCD
DR   Wikidata; Q54758793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926157; Atf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST050
AC   CVCL_MG77
SY   GST050
DR   MMRRC; MMRRC:000660-UCD
DR   Wikidata; Q54758795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107476; Stim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST055
AC   CVCL_MG78
SY   GST055
DR   MMRRC; MMRRC:000661-UCD
DR   Wikidata; Q54758796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443162; Uggt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST057
AC   CVCL_MG79
SY   GST057
DR   MMRRC; MMRRC:000662-UCD
DR   Wikidata; Q54758797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST062
AC   CVCL_MG80
SY   GST062
DR   MMRRC; MMRRC:000663-UCD
DR   Wikidata; Q54758798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194891; Gpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST063
AC   CVCL_MG81
SY   GST063
DR   MMRRC; MMRRC:000664-UCD
DR   Wikidata; Q54758799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105088; Ntn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST065
AC   CVCL_MG82
SY   GST065
DR   MMRRC; MMRRC:000665-UCD
DR   Wikidata; Q54758801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104864; Pdia4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST066
AC   CVCL_MG83
SY   GST066
DR   MMRRC; MMRRC:000666-UCD
DR   Wikidata; Q54758802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354756; Crim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST067
AC   CVCL_MG84
SY   GST067
DR   MMRRC; MMRRC:000667-UCD
DR   Wikidata; Q54758803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST070
AC   CVCL_MG85
SY   GST070
DR   MMRRC; MMRRC:000670-UCD
DR   Wikidata; Q54758805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST071
AC   CVCL_MG86
SY   GST071
DR   MMRRC; MMRRC:000671-UCD
DR   Wikidata; Q54758808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289273; Ppp1r10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST073
AC   CVCL_MG87
SY   GST073
DR   MMRRC; MMRRC:000672-UCD
DR   Wikidata; Q54758810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST089
AC   CVCL_MG88
SY   GST089
DR   MMRRC; MMRRC:000676-UCD
DR   Wikidata; Q54758812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95321; Emb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST090
AC   CVCL_MG89
SY   GST090
DR   MMRRC; MMRRC:000677-UCD
DR   Wikidata; Q54758813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919711; Prcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST091
AC   CVCL_MG90
SY   GST091
DR   MMRRC; MMRRC:000678-UCD
DR   Wikidata; Q54758817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96433; Igf1r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST092
AC   CVCL_MG91
SY   GST092
DR   MMRRC; MMRRC:000679-UCD
DR   Wikidata; Q54758819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST093
AC   CVCL_MG92
SY   GST093
DR   MMRRC; MMRRC:000680-UCD
DR   Wikidata; Q54758823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858901; Fut8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST094
AC   CVCL_MG93
SY   GST094
DR   MMRRC; MMRRC:000681-UCD
DR   Wikidata; Q54758825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST098
AC   CVCL_MG94
SY   GST098
DR   MMRRC; MMRRC:000682-UCD
DR   Wikidata; Q54758827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97814; Ptprg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST100
AC   CVCL_MG95
SY   GST100
DR   MMRRC; MMRRC:000683-UCD
DR   Wikidata; Q54758828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104903; Gpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST101
AC   CVCL_MG96
SY   GST101
DR   MMRRC; MMRRC:000684-UCD
DR   Wikidata; Q54758830
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1274781; Robo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST107
AC   CVCL_MG97
SY   GST107
DR   MMRRC; MMRRC:000686-UCD
DR   Wikidata; Q54758831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107559; Sema4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST111
AC   CVCL_MG98
SY   GST111
DR   MMRRC; MMRRC:000687-UCD
DR   Wikidata; Q54758833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87904; Actb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST126
AC   CVCL_MG99
SY   GST126
DR   MMRRC; MMRRC:000689-UCD
DR   Wikidata; Q54758835
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST127
AC   CVCL_MH00
SY   GST127
DR   MMRRC; MMRRC:000690-UCD
DR   Wikidata; Q54758932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105088; Ntn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST139
AC   CVCL_MH01
SY   GST139
DR   MMRRC; MMRRC:000694-UCD
DR   Wikidata; Q54758936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST142
AC   CVCL_MH02
SY   GST142
DR   MMRRC; MMRRC:000696-UCD
DR   Wikidata; Q54758937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138856; Ldlrad3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST151
AC   CVCL_MH03
SY   GST151
DR   MMRRC; MMRRC:000697-UCD
DR   Wikidata; Q54758939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95309; Eif5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST158
AC   CVCL_MH04
SY   GST158
DR   MMRRC; MMRRC:000698-UCD
DR   Wikidata; Q54758941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888921; P3h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST159
AC   CVCL_MH05
SY   GST159
DR   MMRRC; MMRRC:000699-UCD
DR   Wikidata; Q54758942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST160
AC   CVCL_MH06
SY   GST160
DR   MMRRC; MMRRC:000700-UCD
DR   Wikidata; Q54758943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924015; Mlec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST161
AC   CVCL_MH07
SY   GST161
DR   MMRRC; MMRRC:000701-UCD
DR   Wikidata; Q54758947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98658; Tdgf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST166
AC   CVCL_MH08
SY   GST166
DR   MMRRC; MMRRC:000702-UCD
DR   Wikidata; Q54758949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST171
AC   CVCL_MH09
SY   GST171
DR   MMRRC; MMRRC:000705-UCD
DR   Wikidata; Q54758951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926157; Atf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST176
AC   CVCL_MH10
SY   GST176
DR   MMRRC; MMRRC:000706-UCD
DR   Wikidata; Q54758954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109322; Kcnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST178
AC   CVCL_MH11
SY   GST178
DR   MMRRC; MMRRC:000707-UCD
DR   Wikidata; Q54758957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108077; Nptn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST182
AC   CVCL_MH12
SY   GST182
DR   MMRRC; MMRRC:000708-UCD
DR   Wikidata; Q54758959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96435; Igf2r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST184
AC   CVCL_MH13
SY   GST184
DR   MMRRC; MMRRC:000709-UCD
DR   Wikidata; Q54758962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST191
AC   CVCL_MH14
SY   GST191
DR   MMRRC; MMRRC:000710-UCD
DR   Wikidata; Q54758966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96437; Igfbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST193
AC   CVCL_MH15
SY   GST193
DR   MMRRC; MMRRC:000711-UCD
DR   Wikidata; Q54758969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line GST203
AC   CVCL_MH16
SY   GST203
DR   MMRRC; MMRRC:000712-UCD
DR   Wikidata; Q54758972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA004
AC   CVCL_MH17
SY   HMA004
DR   MMRRC; MMRRC:010861-UCD
DR   Wikidata; Q54758974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107716; Myo10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA010
AC   CVCL_MH18
SY   HMA010
DR   MMRRC; MMRRC:010862-UCD
DR   Wikidata; Q54758975
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA013
AC   CVCL_MH19
SY   HMA013
DR   MMRRC; MMRRC:010639-UCD
DR   Wikidata; Q54758978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA032
AC   CVCL_MH20
SY   HMA032
DR   MMRRC; MMRRC:010641-UCD
DR   Wikidata; Q54758981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA043
AC   CVCL_MH21
SY   HMA043
DR   MMRRC; MMRRC:010642-UCD
DR   Wikidata; Q54758983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670969; Nrde2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA058
AC   CVCL_MH22
SY   HMA058
DR   MMRRC; MMRRC:010643-UCD
DR   Wikidata; Q54758984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA065
AC   CVCL_MH23
SY   HMA065
DR   MMRRC; MMRRC:010644-UCD
DR   Wikidata; Q54758986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101816; Msh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA073
AC   CVCL_MH24
SY   HMA073
DR   MMRRC; MMRRC:010863-UCD
DR   Wikidata; Q54758988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926967; Hsd17b12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA086
AC   CVCL_MH25
SY   HMA086
DR   MMRRC; MMRRC:010864-UCD
DR   Wikidata; Q54758991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA095
AC   CVCL_MH26
SY   HMA095
DR   MMRRC; MMRRC:010646-UCD
DR   Wikidata; Q54758994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA097
AC   CVCL_MH27
SY   HMA097
DR   MMRRC; MMRRC:010647-UCD
DR   Wikidata; Q54758996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925953; Zfp972.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA103
AC   CVCL_MH28
SY   HMA103
DR   MMRRC; MMRRC:010648-UCD
DR   Wikidata; Q54758997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333825; Dgat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA113
AC   CVCL_MH29
SY   HMA113
DR   MMRRC; MMRRC:010865-UCD
DR   Wikidata; Q54758999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA121
AC   CVCL_MH30
SY   HMA121
DR   MMRRC; MMRRC:010866-UCD
DR   Wikidata; Q54759000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA134
AC   CVCL_MH31
SY   HMA134
DR   MMRRC; MMRRC:010649-UCD
DR   Wikidata; Q54759001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151233; Dph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA135
AC   CVCL_MH32
SY   HMA135
DR   MMRRC; MMRRC:010867-UCD
DR   Wikidata; Q54759004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349399; Casp8ap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA136
AC   CVCL_MH33
SY   HMA136
DR   MMRRC; MMRRC:010868-UCD
DR   Wikidata; Q54759005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443114; Larp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA140
AC   CVCL_MH34
SY   HMA140
DR   MMRRC; MMRRC:010869-UCD
DR   Wikidata; Q54759008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914144; Wwp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA153
AC   CVCL_MH35
SY   HMA153
DR   MMRRC; MMRRC:010650-UCD
DR   Wikidata; Q54759009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926037; Usp54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA154
AC   CVCL_MH36
SY   HMA154
DR   MMRRC; MMRRC:010651-UCD
DR   Wikidata; Q54759013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA164
AC   CVCL_MH37
SY   HMA164
DR   MMRRC; MMRRC:010653-UCD
DR   Wikidata; Q54759015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA169
AC   CVCL_MH38
SY   HMA169
DR   MMRRC; MMRRC:010654-UCD
DR   Wikidata; Q54759019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354949; Dlc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA172
AC   CVCL_MH39
SY   HMA172
DR   MMRRC; MMRRC:010655-UCD
DR   Wikidata; Q54759020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915467; Prrc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA175
AC   CVCL_MH40
SY   HMA175
DR   MMRRC; MMRRC:010870-UCD
DR   Wikidata; Q54759074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA184
AC   CVCL_MH41
SY   HMA184
DR   MMRRC; MMRRC:010920-UCD
DR   Wikidata; Q54759076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915581; Stn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA185
AC   CVCL_MH42
SY   HMA185
DR   MMRRC; MMRRC:010921-UCD
DR   Wikidata; Q54759081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916969; Cad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA192
AC   CVCL_MH43
SY   HMA192
DR   MMRRC; MMRRC:010656-UCD
DR   Wikidata; Q54759085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929455; Rpl23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA201
AC   CVCL_MH44
SY   HMA201
DR   MMRRC; MMRRC:010923-UCD
DR   Wikidata; Q54759087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914404; Mtdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA204
AC   CVCL_MH45
SY   HMA204
DR   MMRRC; MMRRC:010924-UCD
DR   Wikidata; Q54759091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321393; Timeless.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA208
AC   CVCL_MH46
SY   HMA208
DR   MMRRC; MMRRC:010925-UCD
DR   Wikidata; Q54759093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924933; Ehmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA209
AC   CVCL_MH47
SY   HMA209
DR   MMRRC; MMRRC:010657-UCD
DR   Wikidata; Q54759097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA210
AC   CVCL_MH48
SY   HMA210
DR   MMRRC; MMRRC:010926-UCD
DR   Wikidata; Q54759099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328362; Blm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA218
AC   CVCL_MH49
SY   HMA218
DR   MMRRC; MMRRC:010927-UCD
DR   Wikidata; Q54759101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108390; Kif2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA221
AC   CVCL_MH50
SY   HMA221
DR   MMRRC; MMRRC:010658-UCD
DR   Wikidata; Q54759102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101839; Rpl28.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA234
AC   CVCL_MH51
SY   HMA234
DR   MMRRC; MMRRC:010930-UCD
DR   Wikidata; Q54759104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923844; Dnajc18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA240
AC   CVCL_MH52
SY   HMA240
DR   MMRRC; MMRRC:010931-UCD
DR   Wikidata; Q54759106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA244
AC   CVCL_MH53
SY   HMA244
DR   MMRRC; MMRRC:010932-UCD
DR   Wikidata; Q54759107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA245
AC   CVCL_MH54
SY   HMA245
DR   MMRRC; MMRRC:010661-UCD
DR   Wikidata; Q54759108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA247
AC   CVCL_MH55
SY   HMA247
DR   MMRRC; MMRRC:010933-UCD
DR   Wikidata; Q54759109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA249
AC   CVCL_MH56
SY   HMA249
DR   MMRRC; MMRRC:010934-UCD
DR   Wikidata; Q54759110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145425; Depdc1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA252
AC   CVCL_MH57
SY   HMA252
DR   MMRRC; MMRRC:010935-UCD
DR   Wikidata; Q54759112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289298; Knstrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA253
AC   CVCL_MH58
SY   HMA253
DR   MMRRC; MMRRC:010936-UCD
DR   Wikidata; Q54759113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101849; Rack1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA254
AC   CVCL_MH59
SY   HMA254
DR   MMRRC; MMRRC:010662-UCD
DR   Wikidata; Q54759114
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289298; Knstrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA257
AC   CVCL_MH60
SY   HMA257
DR   MMRRC; MMRRC:010937-UCD
DR   Wikidata; Q54759116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914345; Trak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA263
AC   CVCL_MH61
SY   HMA263
DR   MMRRC; MMRRC:010663-UCD
DR   Wikidata; Q54759117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926157; Atf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA274
AC   CVCL_MH62
SY   HMA274
DR   MMRRC; MMRRC:010939-UCD
DR   Wikidata; Q54759119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353633; Fus.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA290
AC   CVCL_MH63
SY   HMA290
DR   MMRRC; MMRRC:010664-UCD
DR   Wikidata; Q54759121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95739; Glul.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA300
AC   CVCL_MH64
SY   HMA300
DR   MMRRC; MMRRC:010665-UCD
DR   Wikidata; Q54759123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385902; Picalm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA301
AC   CVCL_MH65
SY   HMA301
DR   MMRRC; MMRRC:010666-UCD
DR   Wikidata; Q54759124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201691; Rnf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA310
AC   CVCL_MH66
SY   HMA310
DR   MMRRC; MMRRC:010667-UCD
DR   Wikidata; Q54759127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98241; Stmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA320
AC   CVCL_MH67
SY   HMA320
DR   MMRRC; MMRRC:010668-UCD
DR   Wikidata; Q54759128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039623; Thada.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA321
AC   CVCL_MH68
SY   HMA321
DR   MMRRC; MMRRC:010669-UCD
DR   Wikidata; Q54759130
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443658; Prr14l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA322
AC   CVCL_MH69
SY   HMA322
DR   MMRRC; MMRRC:010670-UCD
DR   Wikidata; Q54759131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915206; Kmt5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA324
AC   CVCL_MH70
SY   HMA324
DR   MMRRC; MMRRC:010671-UCD
DR   Wikidata; Q54759133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921720; Cep72.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA327
AC   CVCL_MH71
SY   HMA327
DR   MMRRC; MMRRC:010672-UCD
DR   Wikidata; Q54759136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107532; Kpnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA329
AC   CVCL_MH72
SY   HMA329
DR   MMRRC; MMRRC:010673-UCD
DR   Wikidata; Q54759138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108295; Pxn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA331
AC   CVCL_MH73
SY   HMA331
DR   MMRRC; MMRRC:010674-UCD
DR   Wikidata; Q54759139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA333
AC   CVCL_MH74
SY   HMA333
DR   MMRRC; MMRRC:010675-UCD
DR   Wikidata; Q54759140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA338
AC   CVCL_MH75
SY   HMA338
DR   MMRRC; MMRRC:010676-UCD
DR   Wikidata; Q54759141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888527; Apba3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA339
AC   CVCL_MH76
SY   HMA339
DR   MMRRC; MMRRC:010677-UCD
DR   Wikidata; Q54759145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA346
AC   CVCL_MH77
SY   HMA346
DR   MMRRC; MMRRC:010678-UCD
DR   Wikidata; Q54759148
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915699; Tbc1d10b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA348
AC   CVCL_MH78
SY   HMA348
DR   MMRRC; MMRRC:010679-UCD
DR   Wikidata; Q54759151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106281; Ilrun.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line HMA351
AC   CVCL_MH79
SY   HMA351
DR   MMRRC; MMRRC:010871-UCD
DR   Wikidata; Q54759154
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104626; Strbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA353
AC   CVCL_MH80
SY   HMA353
DR   MMRRC; MMRRC:010680-UCD
DR   Wikidata; Q54759207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1335094; Septin7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line HMA355
AC   CVCL_MH81
SY   HMA355
DR   MMRRC; MMRRC:010872-UCD
DR   Wikidata; Q54759209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925920; Plekhj1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA362
AC   CVCL_MH82
SY   HMA362
DR   MMRRC; MMRRC:010682-UCD
DR   Wikidata; Q54759212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919806; Zfp566.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA364
AC   CVCL_MH83
SY   HMA364
DR   MMRRC; MMRRC:010683-UCD
DR   Wikidata; Q54759213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105066; Rab10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA365
AC   CVCL_MH84
SY   HMA365
DR   MMRRC; MMRRC:010999-UCD
DR   Wikidata; Q54759215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA367
AC   CVCL_MH85
SY   HMA367
DR   MMRRC; MMRRC:010684-UCD
DR   Wikidata; Q54759216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA368
AC   CVCL_MH86
SY   HMA368
DR   MMRRC; MMRRC:010873-UCD
DR   Wikidata; Q54759219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105968; Txlna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA369
AC   CVCL_MH87
SY   HMA369
DR   MMRRC; MMRRC:011000-UCD
DR   Wikidata; Q54759221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA370
AC   CVCL_MH88
SY   HMA370
DR   MMRRC; MMRRC:010874-UCD
DR   Wikidata; Q54759222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443564; Ambra1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA374
AC   CVCL_MH89
SY   HMA374
DR   MMRRC; MMRRC:010685-UCD
DR   Wikidata; Q54759224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919861; Zfp655.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA377
AC   CVCL_MH90
SY   HMA377
DR   MMRRC; MMRRC:010875-UCD
DR   Wikidata; Q54759226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927167; Morf4l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA379
AC   CVCL_MH91
SY   HMA379
DR   MMRRC; MMRRC:011001-UCD
DR   Wikidata; Q54759228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA386
AC   CVCL_MH92
SY   HMA386
DR   MMRRC; MMRRC:010686-UCD
DR   Wikidata; Q54759231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913628; Micos10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line HMA390
AC   CVCL_MH93
SY   HMA390
DR   MMRRC; MMRRC:010687-UCD
DR   Wikidata; Q54759233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA391
AC   CVCL_MH94
SY   HMA391
DR   MMRRC; MMRRC:010688-UCD
DR   Wikidata; Q54759236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA394
AC   CVCL_MH95
SY   HMA394
DR   MMRRC; MMRRC:010689-UCD
DR   Wikidata; Q54759238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA398
AC   CVCL_MH96
SY   HMA398
DR   MMRRC; MMRRC:010690-UCD
DR   Wikidata; Q54759241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917244; Ddi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA399
AC   CVCL_MH97
SY   HMA399
DR   MMRRC; MMRRC:011002-UCD
DR   Wikidata; Q54759244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914963; Dnajc19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA401
AC   CVCL_MH98
SY   HMA401
DR   MMRRC; MMRRC:010691-UCD
DR   Wikidata; Q54759245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA405
AC   CVCL_MH99
SY   HMA405
DR   MMRRC; MMRRC:010876-UCD
DR   Wikidata; Q54759248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA410
AC   CVCL_MI00
SY   HMA410
DR   MMRRC; MMRRC:010877-UCD
DR   Wikidata; Q54759249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685179; Zfp407.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line HMA411
AC   CVCL_MI01
SY   HMA411
DR   MMRRC; MMRRC:010878-UCD
DR   Wikidata; Q54759250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336175; Kcnk5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA412
AC   CVCL_MI02
SY   HMA412
DR   MMRRC; MMRRC:010693-UCD
DR   Wikidata; Q54759255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913628; Micos10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line HMA413
AC   CVCL_MI03
SY   HMA413
DR   MMRRC; MMRRC:010694-UCD
DR   Wikidata; Q54759256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA414
AC   CVCL_MI04
SY   HMA414
DR   MMRRC; MMRRC:010879-UCD
DR   Wikidata; Q54759260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385286; Pgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA416
AC   CVCL_MI05
SY   HMA416
DR   MMRRC; MMRRC:010880-UCD
DR   Wikidata; Q54759262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443502; Cep95.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA421
AC   CVCL_MI06
SY   HMA421
DR   MMRRC; MMRRC:010695-UCD
DR   Wikidata; Q54759265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94909; Dmd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA427
AC   CVCL_MI07
SY   HMA427
DR   MMRRC; MMRRC:011003-UCD
DR   Wikidata; Q54759269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105128; Rad23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA430
AC   CVCL_MI08
SY   HMA430
DR   MMRRC; MMRRC:011004-UCD
DR   Wikidata; Q54759272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352755; Gtse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA445
AC   CVCL_MI09
SY   HMA445
DR   MMRRC; MMRRC:011007-UCD
DR   Wikidata; Q54759275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929869; Hic2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA449
AC   CVCL_MI10
SY   HMA449
DR   MMRRC; MMRRC:010697-UCD
DR   Wikidata; Q54759278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445003; Arhgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA450
AC   CVCL_MI11
SY   HMA450
DR   MMRRC; MMRRC:010698-UCD
DR   Wikidata; Q54759282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098802; Cdk12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA455
AC   CVCL_MI12
SY   HMA455
DR   MMRRC; MMRRC:010882-UCD
DR   Wikidata; Q54759284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928896; Arpc1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA469
AC   CVCL_MI13
SY   HMA469
DR   MMRRC; MMRRC:010700-UCD
DR   Wikidata; Q54759286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA470
AC   CVCL_MI14
SY   HMA470
DR   MMRRC; MMRRC:010701-UCD
DR   Wikidata; Q54759290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA471
AC   CVCL_MI15
SY   HMA471
DR   MMRRC; MMRRC:011008-UCD
DR   Wikidata; Q54759293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107637; Psmb7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA475
AC   CVCL_MI16
SY   HMA475
DR   MMRRC; MMRRC:011010-UCD
DR   Wikidata; Q54759296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917722; Atad2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA483
AC   CVCL_MI17
SY   HMA483
DR   MMRRC; MMRRC:011012-UCD
DR   Wikidata; Q54759297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA485
AC   CVCL_MI18
SY   HMA485
DR   MMRRC; MMRRC:010703-UCD
DR   Wikidata; Q54759298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919064; Mrps27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA488
AC   CVCL_MI19
SY   HMA488
DR   MMRRC; MMRRC:010704-UCD
DR   Wikidata; Q54759299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914093; Dolpp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA495
AC   CVCL_MI20
SY   HMA495
DR   MMRRC; MMRRC:011013-UCD
DR   Wikidata; Q54759356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97814; Ptprg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA497
AC   CVCL_MI21
SY   HMA497
DR   MMRRC; MMRRC:011014-UCD
DR   Wikidata; Q54759358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927170; Spata5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA500
AC   CVCL_MI22
SY   HMA500
DR   MMRRC; MMRRC:010706-UCD
DR   Wikidata; Q54759361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342772; Klf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA502
AC   CVCL_MI23
SY   HMA502
DR   MMRRC; MMRRC:010707-UCD
DR   Wikidata; Q54759365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353499; Baz1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA513
AC   CVCL_MI24
SY   HMA513
DR   MMRRC; MMRRC:010708-UCD
DR   Wikidata; Q54759367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA527
AC   CVCL_MI25
SY   HMA527
DR   MMRRC; MMRRC:010883-UCD
DR   Wikidata; Q54759369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103250; Calm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA538
AC   CVCL_MI26
SY   HMA538
DR   MMRRC; MMRRC:010941-UCD
DR   Wikidata; Q54759371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289341; Sf3b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA542
AC   CVCL_MI27
SY   HMA542
DR   MMRRC; MMRRC:010942-UCD
DR   Wikidata; Q54759372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA558
AC   CVCL_MI28
SY   HMA558
DR   MMRRC; MMRRC:010884-UCD
DR   Wikidata; Q54759375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA561
AC   CVCL_MI29
SY   HMA561
DR   MMRRC; MMRRC:010885-UCD
DR   Wikidata; Q54759376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA563
AC   CVCL_MI30
SY   HMA563
DR   MMRRC; MMRRC:010944-UCD
DR   Wikidata; Q54759378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913325; Chchd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA566
AC   CVCL_MI31
SY   HMA566
DR   MMRRC; MMRRC:010886-UCD
DR   Wikidata; Q54759379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106498; Rsrp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA568
AC   CVCL_MI32
SY   HMA568
DR   MMRRC; MMRRC:010887-UCD
DR   Wikidata; Q54759383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88261; Canx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line HMA580
AC   CVCL_MI33
SY   HMA580
DR   MMRRC; MMRRC:010946-UCD
DR   Wikidata; Q54759384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98510; Tcf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST005
AC   CVCL_MI34
SY   KST005
DR   MMRRC; MMRRC:000716-UCD
DR   Wikidata; Q54759387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104967; Glg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST011
AC   CVCL_MI35
SY   KST011
DR   MMRRC; MMRRC:000719-UCD
DR   Wikidata; Q54759389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914708; Ergic1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST012
AC   CVCL_MI36
SY   KST012
DR   MMRRC; MMRRC:000720-UCD
DR   Wikidata; Q54759392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95392; Eng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST024
AC   CVCL_MI37
SY   KST024
DR   MMRRC; MMRRC:000726-UCD
DR   Wikidata; Q54759395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336175; Kcnk5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST027
AC   CVCL_MI38
SY   KST027
DR   MMRRC; MMRRC:000727-UCD
DR   Wikidata; Q54759396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139054; Gpr107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST030
AC   CVCL_MI39
SY   KST030
DR   MMRRC; MMRRC:000729-UCD
DR   Wikidata; Q54759399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913522; Cox16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST037
AC   CVCL_MI40
SY   KST037
DR   MMRRC; MMRRC:000732-UCD
DR   Wikidata; Q54759400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914698; Plxdc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST041
AC   CVCL_MI41
SY   KST041
DR   MMRRC; MMRRC:000735-UCD
DR   Wikidata; Q54759402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99154; Zfp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST044
AC   CVCL_MI42
SY   KST044
DR   MMRRC; MMRRC:000736-UCD
DR   Wikidata; Q54759403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST045
AC   CVCL_MI43
SY   KST045
DR   MMRRC; MMRRC:000737-UCD
DR   Wikidata; Q54759406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99256; Hdlbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST046
AC   CVCL_MI44
SY   KST046
DR   MMRRC; MMRRC:000738-UCD
DR   Wikidata; Q54759408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926609; Trp53inp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST048
AC   CVCL_MI45
SY   KST048
DR   MMRRC; MMRRC:000739-UCD
DR   Wikidata; Q54759409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST050
AC   CVCL_MI46
SY   KST050
DR   MMRRC; MMRRC:000741-UCD
DR   Wikidata; Q54759412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138346; Suco.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST059
AC   CVCL_MI47
SY   KST059
DR   MMRRC; MMRRC:000742-UCD
DR   Wikidata; Q54759414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104669; Man2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST061
AC   CVCL_MI48
SY   KST061
DR   MMRRC; MMRRC:000744-UCD
DR   Wikidata; Q54759416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST063
AC   CVCL_MI49
SY   KST063
DR   MMRRC; MMRRC:000746-UCD
DR   Wikidata; Q54759417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918917; Tmem248.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST064
AC   CVCL_MI50
SY   KST064
DR   MMRRC; MMRRC:000747-UCD
DR   Wikidata; Q54759418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926609; Trp53inp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST065
AC   CVCL_MI51
SY   KST065
DR   MMRRC; MMRRC:000748-UCD
DR   Wikidata; Q54759420
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST067
AC   CVCL_MI52
SY   KST067
DR   MMRRC; MMRRC:000749-UCD
DR   Wikidata; Q54759422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347007; Plod2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST085
AC   CVCL_MI53
SY   KST085
DR   MMRRC; MMRRC:000754-UCD
DR   Wikidata; Q54759424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST109
AC   CVCL_MI54
SY   KST109
DR   MMRRC; MMRRC:000756-UCD
DR   Wikidata; Q54759426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST113
AC   CVCL_MI55
SY   KST113
DR   MMRRC; MMRRC:000757-UCD
DR   Wikidata; Q54759428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST145
AC   CVCL_MI56
SY   KST145
DR   MMRRC; MMRRC:000760-UCD
DR   Wikidata; Q54759431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST171
AC   CVCL_MI57
SY   KST171
DR   MMRRC; MMRRC:000763-UCD
DR   Wikidata; Q54759433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST182
AC   CVCL_MI58
SY   KST182
DR   MMRRC; MMRRC:000765-UCD
DR   Wikidata; Q54759435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST184
AC   CVCL_MI59
SY   KST184
DR   MMRRC; MMRRC:000766-UCD
DR   Wikidata; Q54759437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103007; Epb41l4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST211
AC   CVCL_MI60
SY   KST211
DR   MMRRC; MMRRC:000770-UCD
DR   Wikidata; Q54759483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96392; Icam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST212
AC   CVCL_MI61
SY   KST212
DR   MMRRC; MMRRC:000771-UCD
DR   Wikidata; Q54759484
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST213
AC   CVCL_MI62
SY   KST213
DR   MMRRC; MMRRC:000772-UCD
DR   Wikidata; Q54759486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105088; Ntn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST214
AC   CVCL_MI63
SY   KST214
DR   MMRRC; MMRRC:000773-UCD
DR   Wikidata; Q54759487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST216
AC   CVCL_MI64
SY   KST216
DR   MMRRC; MMRRC:000775-UCD
DR   Wikidata; Q54759489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385850; Nomo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST219
AC   CVCL_MI65
SY   KST219
DR   MMRRC; MMRRC:000776-UCD
DR   Wikidata; Q54759491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146443; Xxylt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST222
AC   CVCL_MI66
SY   KST222
DR   MMRRC; MMRRC:000779-UCD
DR   Wikidata; Q54759492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97364; Notch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST223
AC   CVCL_MI67
SY   KST223
DR   MMRRC; MMRRC:000780-UCD
DR   Wikidata; Q54759494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159727; Il17rd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST224
AC   CVCL_MI68
SY   KST224
DR   MMRRC; MMRRC:000781-UCD
DR   Wikidata; Q54759496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95794; Lrp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST226
AC   CVCL_MI69
SY   KST226
DR   MMRRC; MMRRC:000783-UCD
DR   Wikidata; Q54759499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444177; Cachd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST227
AC   CVCL_MI70
SY   KST227
DR   MMRRC; MMRRC:000784-UCD
DR   Wikidata; Q54759500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102768; Mfge8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST228
AC   CVCL_MI71
SY   KST228
DR   MMRRC; MMRRC:000785-UCD
DR   Wikidata; Q54759502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST229
AC   CVCL_MI72
SY   KST229
DR   MMRRC; MMRRC:000786-UCD
DR   Wikidata; Q54759504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860139; Gabbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST231
AC   CVCL_MI73
SY   KST231
DR   MMRRC; MMRRC:000787-UCD
DR   Wikidata; Q54759507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST232
AC   CVCL_MI74
SY   KST232
DR   MMRRC; MMRRC:000788-UCD
DR   Wikidata; Q54759509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST233
AC   CVCL_MI75
SY   KST233
DR   MMRRC; MMRRC:000789-UCD
DR   Wikidata; Q54759511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88613; Ccn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line KST235
AC   CVCL_MI76
SY   KST235
DR   MMRRC; MMRRC:000790-UCD
DR   Wikidata; Q54759513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321398; F11r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST236
AC   CVCL_MI77
SY   KST236
DR   MMRRC; MMRRC:000791-UCD
DR   Wikidata; Q54759514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST237
AC   CVCL_MI78
SY   KST237
DR   MMRRC; MMRRC:000792-UCD
DR   Wikidata; Q54759515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST240
AC   CVCL_MI79
SY   KST240
DR   MMRRC; MMRRC:000793-UCD
DR   Wikidata; Q54759519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99682; Tmbim6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST242
AC   CVCL_MI80
SY   KST242
DR   MMRRC; MMRRC:000794-UCD
DR   Wikidata; Q54759521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98277; Epha4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST243
AC   CVCL_MI81
SY   KST243
DR   MMRRC; MMRRC:000795-UCD
DR   Wikidata; Q54759523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST245
AC   CVCL_MI82
SY   KST245
DR   MMRRC; MMRRC:000796-UCD
DR   Wikidata; Q54759526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915720; Bpnt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line KST246
AC   CVCL_MI83
SY   KST246
DR   MMRRC; MMRRC:000797-UCD
DR   Wikidata; Q54759528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST249
AC   CVCL_MI84
SY   KST249
DR   MMRRC; MMRRC:000799-UCD
DR   Wikidata; Q54759530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST252
AC   CVCL_MI85
SY   KST252
DR   MMRRC; MMRRC:000800-UCD
DR   Wikidata; Q54759533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444465; Frem2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST253
AC   CVCL_MI86
SY   KST253
DR   MMRRC; MMRRC:000801-UCD
DR   Wikidata; Q54759534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST254
AC   CVCL_MI87
SY   KST254
DR   MMRRC; MMRRC:000802-UCD
DR   Wikidata; Q54759537
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928380; B4galt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST256
AC   CVCL_MI88
SY   KST256
DR   MMRRC; MMRRC:000803-UCD
DR   Wikidata; Q54759539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351618; Dnajb9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST257
AC   CVCL_MI89
SY   KST257
DR   MMRRC; MMRRC:000804-UCD
DR   Wikidata; Q54759542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102467; Ptpn14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST258
AC   CVCL_MI90
SY   KST258
DR   MMRRC; MMRRC:000805-UCD
DR   Wikidata; Q54759545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109553; Ctsc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST259
AC   CVCL_MI91
SY   KST259
DR   MMRRC; MMRRC:000806-UCD
DR   Wikidata; Q54759548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST263
AC   CVCL_MI92
SY   KST263
DR   MMRRC; MMRRC:000807-UCD
DR   Wikidata; Q54759549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913355; Ube2d3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST264
AC   CVCL_MI93
SY   KST264
DR   MMRRC; MMRRC:000808-UCD
DR   Wikidata; Q54759551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354756; Crim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST265
AC   CVCL_MI94
SY   KST265
DR   MMRRC; MMRRC:000809-UCD
DR   Wikidata; Q54759554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097159; Neo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST266
AC   CVCL_MI95
SY   KST266
DR   MMRRC; MMRRC:000810-UCD
DR   Wikidata; Q54759556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924015; Mlec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST269
AC   CVCL_MI96
SY   KST269
DR   MMRRC; MMRRC:000812-UCD
DR   Wikidata; Q54759559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107685; Plxna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST270
AC   CVCL_MI97
SY   KST270
DR   MMRRC; MMRRC:000813-UCD
DR   Wikidata; Q54759561
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104652; Capzb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST271
AC   CVCL_MI98
SY   KST271
DR   MMRRC; MMRRC:000814-UCD
DR   Wikidata; Q54759563
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858907; Blcap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST272
AC   CVCL_MI99
SY   KST272
DR   MMRRC; MMRRC:000815-UCD
DR   Wikidata; Q54759566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338031; Spint2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST273
AC   CVCL_MJ00
SY   KST273
DR   MMRRC; MMRRC:000816-UCD
DR   Wikidata; Q54759653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917329; Golm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST274
AC   CVCL_MJ01
SY   KST274
DR   MMRRC; MMRRC:000817-UCD
DR   Wikidata; Q54759654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095733; Pros1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST280
AC   CVCL_MJ02
SY   KST280
DR   MMRRC; MMRRC:000818-UCD
DR   Wikidata; Q54759656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST281
AC   CVCL_MJ03
SY   KST281
DR   MMRRC; MMRRC:000819-UCD
DR   Wikidata; Q54759657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST282
AC   CVCL_MJ04
SY   KST282
DR   MMRRC; MMRRC:000820-UCD
DR   Wikidata; Q54759661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353605; Tor1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST285
AC   CVCL_MJ05
SY   KST285
DR   MMRRC; MMRRC:000821-UCD
DR   Wikidata; Q54759662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST286
AC   CVCL_MJ06
SY   KST286
DR   MMRRC; MMRRC:000822-UCD
DR   Wikidata; Q54759664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88261; Canx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST288
AC   CVCL_MJ07
SY   KST288
DR   MMRRC; MMRRC:000823-UCD
DR   Wikidata; Q54759668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917329; Golm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST290
AC   CVCL_MJ08
SY   KST290
DR   MMRRC; MMRRC:000824-UCD
DR   Wikidata; Q54759670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107685; Plxna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST296
AC   CVCL_MJ09
SY   KST296
DR   MMRRC; MMRRC:000825-UCD
DR   Wikidata; Q54759671
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3603820; Tctn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST300
AC   CVCL_MJ10
SY   KST300
DR   MMRRC; MMRRC:000826-UCD
DR   Wikidata; Q54759673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448326; H3c6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line KST301
AC   CVCL_MJ11
SY   KST301
DR   MMRRC; MMRRC:000827-UCD
DR   Wikidata; Q54759676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96743; Lamb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST302
AC   CVCL_MJ12
SY   KST302
DR   MMRRC; MMRRC:000828-UCD
DR   Wikidata; Q54759677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919711; Prcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST303
AC   CVCL_MJ13
SY   KST303
DR   MMRRC; MMRRC:000829-UCD
DR   Wikidata; Q54759678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919213; Cdca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST304
AC   CVCL_MJ14
SY   KST304
DR   MMRRC; MMRRC:000830-UCD
DR   Wikidata; Q54759681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST307
AC   CVCL_MJ15
SY   KST307
DR   MMRRC; MMRRC:000832-UCD
DR   Wikidata; Q54759682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919849; Pdia5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST308
AC   CVCL_MJ16
SY   KST308
DR   MMRRC; MMRRC:000833-UCD
DR   Wikidata; Q54759684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889505; B3gnt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST310
AC   CVCL_MJ17
SY   KST310
DR   MMRRC; MMRRC:000834-UCD
DR   Wikidata; Q54759685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927167; Morf4l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST311
AC   CVCL_MJ18
SY   KST311
DR   MMRRC; MMRRC:000835-UCD
DR   Wikidata; Q54759689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102551; Ccnf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST314
AC   CVCL_MJ19
SY   KST314
DR   MMRRC; MMRRC:000837-UCD
DR   Wikidata; Q54759690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351664; Ptdss2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST315
AC   CVCL_MJ20
SY   KST315
DR   MMRRC; MMRRC:000838-UCD
DR   Wikidata; Q54759693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926810; Tmeff1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line KST319
AC   CVCL_MJ21
SY   KST319
DR   MMRRC; MMRRC:000840-UCD
DR   Wikidata; Q54759695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277214; Septin11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line KST320
AC   CVCL_MJ22
SY   KST320
DR   MMRRC; MMRRC:000841-UCD
DR   Wikidata; Q54759696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY004
AC   CVCL_MJ23
SY   LRY004
DR   MMRRC; MMRRC:012305-UCD
DR   Wikidata; Q54759698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3605986; Rad54b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY006
AC   CVCL_MJ24
SY   LRY006
DR   MMRRC; MMRRC:012806-UCD
DR   Wikidata; Q54759699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY007
AC   CVCL_MJ25
SY   LRY007
DR   MMRRC; MMRRC:012807-UCD
DR   Wikidata; Q54759703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917829; Zc3h11a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY011
AC   CVCL_MJ26
SY   LRY011
DR   MMRRC; MMRRC:012808-UCD
DR   Wikidata; Q54759704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334462; Copa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY012
AC   CVCL_MJ27
SY   LRY012
DR   MMRRC; MMRRC:012809-UCD
DR   Wikidata; Q54759705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY014
AC   CVCL_MJ28
SY   LRY014
DR   MMRRC; MMRRC:012307-UCD
DR   Wikidata; Q54759706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140230; Camta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY015
AC   CVCL_MJ29
SY   LRY015
DR   MMRRC; MMRRC:012308-UCD
DR   Wikidata; Q54759708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444629; Kctd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY016
AC   CVCL_MJ30
SY   LRY016
DR   MMRRC; MMRRC:012309-UCD
DR   Wikidata; Q54759710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338049; Itsn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY020
AC   CVCL_MJ31
SY   LRY020
DR   MMRRC; MMRRC:012810-UCD
DR   Wikidata; Q54759711
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY025
AC   CVCL_MJ32
SY   LRY025
DR   MMRRC; MMRRC:012310-UCD
DR   Wikidata; Q54759713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929264; Sae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY026
AC   CVCL_MJ33
SY   LRY026
DR   MMRRC; MMRRC:012311-UCD
DR   Wikidata; Q54759715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444188; Dgkh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY027
AC   CVCL_MJ34
SY   LRY027
DR   MMRRC; MMRRC:012312-UCD
DR   Wikidata; Q54759716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096572; Zfand3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY034
AC   CVCL_MJ35
SY   LRY034
DR   MMRRC; MMRRC:012812-UCD
DR   Wikidata; Q54759717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY035
AC   CVCL_MJ36
SY   LRY035
DR   MMRRC; MMRRC:012813-UCD
DR   Wikidata; Q54759719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891995; Mapre1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY036
AC   CVCL_MJ37
SY   LRY036
DR   MMRRC; MMRRC:012814-UCD
DR   Wikidata; Q54759720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858961; Prc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY038
AC   CVCL_MJ38
SY   LRY038
DR   MMRRC; MMRRC:012315-UCD
DR   Wikidata; Q54759722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY039
AC   CVCL_MJ39
SY   LRY039
DR   MMRRC; MMRRC:012316-UCD
DR   Wikidata; Q54759725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914179; Asf1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY041
AC   CVCL_MJ40
SY   LRY041
DR   MMRRC; MMRRC:012317-UCD
DR   Wikidata; Q54759787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY042
AC   CVCL_MJ41
SY   LRY042
DR   MMRRC; MMRRC:012815-UCD
DR   Wikidata; Q54759791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88071; Arnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY044
AC   CVCL_MJ42
SY   LRY044
DR   MMRRC; MMRRC:012816-UCD
DR   Wikidata; Q54759792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3525053; Ppp1r13l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY046
AC   CVCL_MJ43
SY   LRY046
DR   MMRRC; MMRRC:012817-UCD
DR   Wikidata; Q54759794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338049; Itsn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY048
AC   CVCL_MJ44
SY   LRY048
DR   MMRRC; MMRRC:012818-UCD
DR   Wikidata; Q54759796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY049
AC   CVCL_MJ45
SY   LRY049
DR   MMRRC; MMRRC:012318-UCD
DR   Wikidata; Q54759798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY050
AC   CVCL_MJ46
SY   LRY050
DR   MMRRC; MMRRC:012319-UCD
DR   Wikidata; Q54759799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913358; Ndufa9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY051
AC   CVCL_MJ47
SY   LRY051
DR   MMRRC; MMRRC:012320-UCD
DR   Wikidata; Q54759800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103071; Rangap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY052
AC   CVCL_MJ48
SY   LRY052
DR   MMRRC; MMRRC:012321-UCD
DR   Wikidata; Q54759802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916974; Rnaseh2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY056
AC   CVCL_MJ49
SY   LRY056
DR   MMRRC; MMRRC:012819-UCD
DR   Wikidata; Q54759804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LRY069
AC   CVCL_MJ50
SY   LRY069
DR   MMRRC; MMRRC:012820-UCD
DR   Wikidata; Q54759807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328362; Blm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST002
AC   CVCL_MJ51
SY   LST002
DR   MMRRC; MMRRC:000842-UCD
DR   Wikidata; Q54759808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442146; Dnajc16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST008
AC   CVCL_MJ52
SY   LST008
DR   MMRRC; MMRRC:000845-UCD
DR   Wikidata; Q54759811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST011
AC   CVCL_MJ53
SY   LST011
DR   MMRRC; MMRRC:000846-UCD
DR   Wikidata; Q54759813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139054; Gpr107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST012
AC   CVCL_MJ54
SY   LST012
DR   MMRRC; MMRRC:000847-UCD
DR   Wikidata; Q54759815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99431; Arf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST015
AC   CVCL_MJ55
SY   LST015
DR   MMRRC; MMRRC:000848-UCD
DR   Wikidata; Q54759818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST016
AC   CVCL_MJ56
SY   LST016
DR   MMRRC; MMRRC:000849-UCD
DR   Wikidata; Q54759820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443955; Lrig3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST018
AC   CVCL_MJ57
SY   LST018
DR   MMRRC; MMRRC:000850-UCD
DR   Wikidata; Q54759822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108077; Nptn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST020
AC   CVCL_MJ58
SY   LST020
DR   MMRRC; MMRRC:000851-UCD
DR   Wikidata; Q54759824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891468; Lgr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST022
AC   CVCL_MJ59
SY   LST022
DR   MMRRC; MMRRC:000852-UCD
DR   Wikidata; Q54759828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97363; Notch1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST031
AC   CVCL_MJ60
SY   LST031
DR   MMRRC; MMRRC:000854-UCD
DR   Wikidata; Q54759829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST032
AC   CVCL_MJ61
SY   LST032
DR   MMRRC; MMRRC:000855-UCD
DR   Wikidata; Q54759832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891468; Lgr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST038
AC   CVCL_MJ62
SY   LST038
DR   MMRRC; MMRRC:000856-UCD
DR   Wikidata; Q54759833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915088; Dnajb11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST041
AC   CVCL_MJ63
SY   LST041
DR   MMRRC; MMRRC:000857-UCD
DR   Wikidata; Q54759835
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914217; Edem3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST044
AC   CVCL_MJ64
SY   LST044
DR   MMRRC; MMRRC:000859-UCD
DR   Wikidata; Q54759837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894663; Ext1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST045
AC   CVCL_MJ65
SY   LST045
DR   MMRRC; MMRRC:000860-UCD
DR   Wikidata; Q54759839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96605; Itga6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST046
AC   CVCL_MJ66
SY   LST046
DR   MMRRC; MMRRC:000861-UCD
DR   Wikidata; Q54759840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145316; Txndc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST047
AC   CVCL_MJ67
SY   LST047
DR   MMRRC; MMRRC:000862-UCD
DR   Wikidata; Q54759842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354958; Hs6st1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST048
AC   CVCL_MJ68
SY   LST048
DR   MMRRC; MMRRC:000863-UCD
DR   Wikidata; Q54759843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST049
AC   CVCL_MJ69
SY   LST049
DR   MMRRC; MMRRC:000864-UCD
DR   Wikidata; Q54759845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336172; Tbl1x.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST050
AC   CVCL_MJ70
SY   LST050
DR   MMRRC; MMRRC:000865-UCD
DR   Wikidata; Q54759846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443718; Lrig2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST053
AC   CVCL_MJ71
SY   LST053
DR   MMRRC; MMRRC:000866-UCD
DR   Wikidata; Q54759848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST055
AC   CVCL_MJ72
SY   LST055
DR   MMRRC; MMRRC:000867-UCD
DR   Wikidata; Q54759849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894663; Ext1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST056
AC   CVCL_MJ73
SY   LST056
DR   MMRRC; MMRRC:000868-UCD
DR   Wikidata; Q54759851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341628; Atrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST057
AC   CVCL_MJ74
SY   LST057
DR   MMRRC; MMRRC:000869-UCD
DR   Wikidata; Q54759852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107892; Fam3c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST058
AC   CVCL_MJ75
SY   LST058
DR   MMRRC; MMRRC:000870-UCD
DR   Wikidata; Q54759853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST059
AC   CVCL_MJ76
SY   LST059
DR   MMRRC; MMRRC:000871-UCD
DR   Wikidata; Q54759855
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923937; Spcs3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST061
AC   CVCL_MJ77
SY   LST061
DR   MMRRC; MMRRC:000872-UCD
DR   Wikidata; Q54759857
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104967; Glg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST064
AC   CVCL_MJ78
SY   LST064
DR   MMRRC; MMRRC:000873-UCD
DR   Wikidata; Q54759859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894663; Ext1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST065
AC   CVCL_MJ79
SY   LST065
DR   MMRRC; MMRRC:000874-UCD
DR   Wikidata; Q54759862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST067
AC   CVCL_MJ80
SY   LST067
DR   MMRRC; MMRRC:000876-UCD
DR   Wikidata; Q54759904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298218; Lrp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST071
AC   CVCL_MJ81
SY   LST071
DR   MMRRC; MMRRC:000878-UCD
DR   Wikidata; Q54759906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST075
AC   CVCL_MJ82
SY   LST075
DR   MMRRC; MMRRC:000880-UCD
DR   Wikidata; Q54759909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96560; Il6st.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST076
AC   CVCL_MJ83
SY   LST076
DR   MMRRC; MMRRC:000881-UCD
DR   Wikidata; Q54759912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST080
AC   CVCL_MJ84
SY   LST080
DR   MMRRC; MMRRC:000883-UCD
DR   Wikidata; Q54759915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96788; Lifr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST081
AC   CVCL_MJ85
SY   LST081
DR   MMRRC; MMRRC:000884-UCD
DR   Wikidata; Q54759916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88356; Cdh3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST083
AC   CVCL_MJ86
SY   LST083
DR   MMRRC; MMRRC:000886-UCD
DR   Wikidata; Q54759918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96677; Kit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST086
AC   CVCL_MJ87
SY   LST086
DR   MMRRC; MMRRC:000888-UCD
DR   Wikidata; Q54759919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST087
AC   CVCL_MJ88
SY   LST087
DR   MMRRC; MMRRC:000889-UCD
DR   Wikidata; Q54759921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST089
AC   CVCL_MJ89
SY   LST089
DR   MMRRC; MMRRC:000890-UCD
DR   Wikidata; Q54759922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST090
AC   CVCL_MJ90
SY   LST090
DR   MMRRC; MMRRC:000891-UCD
DR   Wikidata; Q54759925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684817; Snhg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST091
AC   CVCL_MJ91
SY   LST091
DR   MMRRC; MMRRC:000892-UCD
DR   Wikidata; Q54759927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95794; Lrp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST092
AC   CVCL_MJ92
SY   LST092
DR   MMRRC; MMRRC:000893-UCD
DR   Wikidata; Q54759930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST093
AC   CVCL_MJ93
SY   LST093
DR   MMRRC; MMRRC:000894-UCD
DR   Wikidata; Q54759932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929270; Dstn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST094
AC   CVCL_MJ94
SY   LST094
DR   MMRRC; MMRRC:000895-UCD
DR   Wikidata; Q54759934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443129; Golm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line LST096
AC   CVCL_MJ95
SY   LST096
DR   MMRRC; MMRRC:000896-UCD
DR   Wikidata; Q54759935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST097
AC   CVCL_MJ96
SY   LST097
DR   MMRRC; MMRRC:000897-UCD
DR   Wikidata; Q54759938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919293; Sulf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST100
AC   CVCL_MJ97
SY   LST100
DR   MMRRC; MMRRC:000898-UCD
DR   Wikidata; Q54759941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST102
AC   CVCL_MJ98
SY   LST102
DR   MMRRC; MMRRC:000899-UCD
DR   Wikidata; Q54759944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST103
AC   CVCL_MJ99
SY   LST103
DR   MMRRC; MMRRC:000900-UCD
DR   Wikidata; Q54759946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97364; Notch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST104
AC   CVCL_MK00
SY   LST104
DR   MMRRC; MMRRC:000901-UCD
DR   Wikidata; Q54759948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST105
AC   CVCL_MK01
SY   LST105
DR   MMRRC; MMRRC:000902-UCD
DR   Wikidata; Q54759949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915213; Npc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST106
AC   CVCL_MK02
SY   LST106
DR   MMRRC; MMRRC:000903-UCD
DR   Wikidata; Q54759951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST107
AC   CVCL_MK03
SY   LST107
DR   MMRRC; MMRRC:000904-UCD
DR   Wikidata; Q54759953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102695; Ptprf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST109
AC   CVCL_MK04
SY   LST109
DR   MMRRC; MMRRC:000905-UCD
DR   Wikidata; Q54759956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891396; Kirrel.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line LST110
AC   CVCL_MK05
SY   LST110
DR   MMRRC; MMRRC:000906-UCD
DR   Wikidata; Q54759958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX002
AC   CVCL_MK06
SY   NPX002
DR   MMRRC; MMRRC:000907-UCD
DR   Wikidata; Q54759960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446175; Spryd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX004
AC   CVCL_MK07
SY   NPX004
DR   MMRRC; MMRRC:000908-UCD
DR   Wikidata; Q54759964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934030; Dleu2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX023
AC   CVCL_MK08
SY   NPX023
DR   MMRRC; MMRRC:000916-UCD
DR   Wikidata; Q54759966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919602; Zfyve27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX025
AC   CVCL_MK09
SY   NPX025
DR   MMRRC; MMRRC:000918-UCD
DR   Wikidata; Q54759967
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931797; Ckap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX039
AC   CVCL_MK10
SY   NPX039
DR   MMRRC; MMRRC:000919-UCD
DR   Wikidata; Q54759969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861380; Sphk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX040
AC   CVCL_MK11
SY   NPX040
DR   MMRRC; MMRRC:000920-UCD
DR   Wikidata; Q54759971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX044
AC   CVCL_MK12
SY   NPX044
DR   MMRRC; MMRRC:000922-UCD
DR   Wikidata; Q54759973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105369; Cbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX053
AC   CVCL_MK13
SY   NPX053
DR   MMRRC; MMRRC:000924-UCD
DR   Wikidata; Q54759975
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923055; Nln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX055
AC   CVCL_MK14
SY   NPX055
DR   MMRRC; MMRRC:000925-UCD
DR   Wikidata; Q54759976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855695; Clasrp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX056
AC   CVCL_MK15
SY   NPX056
DR   MMRRC; MMRRC:000926-UCD
DR   Wikidata; Q54759978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX058
AC   CVCL_MK16
SY   NPX058
DR   MMRRC; MMRRC:000927-UCD
DR   Wikidata; Q54759980
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99256; Hdlbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX067
AC   CVCL_MK17
SY   NPX067
DR   MMRRC; MMRRC:000928-UCD
DR   Wikidata; Q54759981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928373; Dnajc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX071
AC   CVCL_MK18
SY   NPX071
DR   MMRRC; MMRRC:000930-UCD
DR   Wikidata; Q54759983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX078
AC   CVCL_MK19
SY   NPX078
DR   MMRRC; MMRRC:000934-UCD
DR   Wikidata; Q54759984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX083
AC   CVCL_MK20
SY   NPX083
DR   MMRRC; MMRRC:000936-UCD
DR   Wikidata; Q54760029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922873; Tex30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX084
AC   CVCL_MK21
SY   NPX084
DR   MMRRC; MMRRC:000937-UCD
DR   Wikidata; Q54760030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX086
AC   CVCL_MK22
SY   NPX086
DR   MMRRC; MMRRC:000938-UCD
DR   Wikidata; Q54760032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105125; Eif1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX088
AC   CVCL_MK23
SY   NPX088
DR   MMRRC; MMRRC:000940-UCD
DR   Wikidata; Q54760033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924825; Kmt2e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX089
AC   CVCL_MK24
SY   NPX089
DR   MMRRC; MMRRC:000941-UCD
DR   Wikidata; Q54760034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX096
AC   CVCL_MK25
SY   NPX096
DR   MMRRC; MMRRC:000942-UCD
DR   Wikidata; Q54760036
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922974; Ccdc18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX101
AC   CVCL_MK26
SY   NPX101
DR   MMRRC; MMRRC:000944-UCD
DR   Wikidata; Q54760038
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101759; Rnf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX108
AC   CVCL_MK27
SY   NPX108
DR   MMRRC; MMRRC:000946-UCD
DR   Wikidata; Q54760039
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX109
AC   CVCL_MK28
SY   NPX109
DR   MMRRC; MMRRC:000947-UCD
DR   Wikidata; Q54760041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX111
AC   CVCL_MK29
SY   NPX111
DR   MMRRC; MMRRC:000948-UCD
DR   Wikidata; Q54760042
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108515; Cbx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX116
AC   CVCL_MK30
SY   NPX116
DR   MMRRC; MMRRC:000950-UCD
DR   Wikidata; Q54760044
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385025; Alg12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX120
AC   CVCL_MK31
SY   NPX120
DR   MMRRC; MMRRC:000953-UCD
DR   Wikidata; Q54760046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX122
AC   CVCL_MK32
SY   NPX122
DR   MMRRC; MMRRC:000955-UCD
DR   Wikidata; Q54760048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95286; Eed.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX129
AC   CVCL_MK33
SY   NPX129
DR   MMRRC; MMRRC:000960-UCD
DR   Wikidata; Q54760050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914629; Dedd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX139
AC   CVCL_MK34
SY   NPX139
DR   MMRRC; MMRRC:000963-UCD
DR   Wikidata; Q54760052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916740; Zfp524.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX141
AC   CVCL_MK35
SY   NPX141
DR   MMRRC; MMRRC:000964-UCD
DR   Wikidata; Q54760054
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919675; Katnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX142
AC   CVCL_MK36
SY   NPX142
DR   MMRRC; MMRRC:000965-UCD
DR   Wikidata; Q54760057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914413; Ccdc47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX145
AC   CVCL_MK37
SY   NPX145
DR   MMRRC; MMRRC:000966-UCD
DR   Wikidata; Q54760058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919675; Katnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX146
AC   CVCL_MK38
SY   NPX146
DR   MMRRC; MMRRC:000967-UCD
DR   Wikidata; Q54760060
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2149543; Ubap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX206
AC   CVCL_MK39
SY   NPX206
DR   MMRRC; MMRRC:000970-UCD
DR   Wikidata; Q54760061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2667663; Cep68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX207
AC   CVCL_MK40
SY   NPX207
DR   MMRRC; MMRRC:000971-UCD
DR   Wikidata; Q54760062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385025; Alg12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX208
AC   CVCL_MK41
SY   NPX208
DR   MMRRC; MMRRC:000972-UCD
DR   Wikidata; Q54760064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443590; Ddx11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX210
AC   CVCL_MK42
SY   NPX210
DR   MMRRC; MMRRC:000973-UCD
DR   Wikidata; Q54760067
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX230
AC   CVCL_MK43
SY   NPX230
DR   MMRRC; MMRRC:000974-UCD
DR   Wikidata; Q54760069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098230; Cenpe.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX231
AC   CVCL_MK44
SY   NPX231
DR   MMRRC; MMRRC:000975-UCD
DR   Wikidata; Q54760070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922873; Tex30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX232
AC   CVCL_MK45
SY   NPX232
DR   MMRRC; MMRRC:000976-UCD
DR   Wikidata; Q54760071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097667; Ganab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX233
AC   CVCL_MK46
SY   NPX233
DR   MMRRC; MMRRC:000977-UCD
DR   Wikidata; Q54760073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX236
AC   CVCL_MK47
SY   NPX236
DR   MMRRC; MMRRC:000980-UCD
DR   Wikidata; Q54760074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX238
AC   CVCL_MK48
SY   NPX238
DR   MMRRC; MMRRC:000982-UCD
DR   Wikidata; Q54760077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676921; Focad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX240
AC   CVCL_MK49
SY   NPX240
DR   MMRRC; MMRRC:000984-UCD
DR   Wikidata; Q54760080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX242
AC   CVCL_MK50
SY   NPX242
DR   MMRRC; MMRRC:000986-UCD
DR   Wikidata; Q54760081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914418; Lpar6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX246
AC   CVCL_MK51
SY   NPX246
DR   MMRRC; MMRRC:000989-UCD
DR   Wikidata; Q54760082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX266
AC   CVCL_MK52
SY   NPX266
DR   MMRRC; MMRRC:000992-UCD
DR   Wikidata; Q54760083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919675; Katnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX268
AC   CVCL_MK53
SY   NPX268
DR   MMRRC; MMRRC:000994-UCD
DR   Wikidata; Q54760085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88139; Bcl2l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX269
AC   CVCL_MK54
SY   NPX269
DR   MMRRC; MMRRC:000995-UCD
DR   Wikidata; Q54760086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX272
AC   CVCL_MK55
SY   NPX272
DR   MMRRC; MMRRC:000998-UCD
DR   Wikidata; Q54760089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX274
AC   CVCL_MK56
SY   NPX274
DR   MMRRC; MMRRC:001000-UCD
DR   Wikidata; Q54760092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914462; Mrpl55.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX275
AC   CVCL_MK57
SY   NPX275
DR   MMRRC; MMRRC:001001-UCD
DR   Wikidata; Q54760094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926465; Hnrnpm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX302
AC   CVCL_MK58
SY   NPX302
DR   MMRRC; MMRRC:001003-UCD
DR   Wikidata; Q54760098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX304
AC   CVCL_MK59
SY   NPX304
DR   MMRRC; MMRRC:001004-UCD
DR   Wikidata; Q54760099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX305
AC   CVCL_MK60
SY   NPX305
DR   MMRRC; MMRRC:001005-UCD
DR   Wikidata; Q54760139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97803; Ptma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX312
AC   CVCL_MK61
SY   NPX312
DR   MMRRC; MMRRC:001006-UCD
DR   Wikidata; Q54760143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928098; Tspan3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX316
AC   CVCL_MK62
SY   NPX316
DR   MMRRC; MMRRC:001009-UCD
DR   Wikidata; Q54760145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922974; Ccdc18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX317
AC   CVCL_MK63
SY   NPX317
DR   MMRRC; MMRRC:001010-UCD
DR   Wikidata; Q54760146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934029; Usp8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX329
AC   CVCL_MK64
SY   NPX329
DR   MMRRC; MMRRC:001014-UCD
DR   Wikidata; Q54760150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344381; Dnajb6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX331
AC   CVCL_MK65
SY   NPX331
DR   MMRRC; MMRRC:001015-UCD
DR   Wikidata; Q54760151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX332
AC   CVCL_MK66
SY   NPX332
DR   MMRRC; MMRRC:001016-UCD
DR   Wikidata; Q54760152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX336
AC   CVCL_MK67
SY   NPX336
DR   MMRRC; MMRRC:001018-UCD
DR   Wikidata; Q54760155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919675; Katnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX337
AC   CVCL_MK68
SY   NPX337
DR   MMRRC; MMRRC:001019-UCD
DR   Wikidata; Q54760157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144726; Tmem11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX347
AC   CVCL_MK69
SY   NPX347
DR   MMRRC; MMRRC:001020-UCD
DR   Wikidata; Q54760158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922873; Tex30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX349
AC   CVCL_MK70
SY   NPX349
DR   MMRRC; MMRRC:001021-UCD
DR   Wikidata; Q54760161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385025; Alg12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX350
AC   CVCL_MK71
SY   NPX350
DR   MMRRC; MMRRC:001022-UCD
DR   Wikidata; Q54760162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140945; Pds5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX351
AC   CVCL_MK72
SY   NPX351
DR   MMRRC; MMRRC:001023-UCD
DR   Wikidata; Q54760164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384784; Eif4g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX354
AC   CVCL_MK73
SY   NPX354
DR   MMRRC; MMRRC:001024-UCD
DR   Wikidata; Q54760167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349721; Tob1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX357
AC   CVCL_MK74
SY   NPX357
DR   MMRRC; MMRRC:001026-UCD
DR   Wikidata; Q54760169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861380; Sphk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX358
AC   CVCL_MK75
SY   NPX358
DR   MMRRC; MMRRC:001027-UCD
DR   Wikidata; Q54760171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345964; Coro1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX362
AC   CVCL_MK76
SY   NPX362
DR   MMRRC; MMRRC:001028-UCD
DR   Wikidata; Q54760173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349473; Ppp2r5e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX363
AC   CVCL_MK77
SY   NPX363
DR   MMRRC; MMRRC:001029-UCD
DR   Wikidata; Q54760175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106065; Ppm1g.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX366
AC   CVCL_MK78
SY   NPX366
DR   MMRRC; MMRRC:001032-UCD
DR   Wikidata; Q54760177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443590; Ddx11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX367
AC   CVCL_MK79
SY   NPX367
DR   MMRRC; MMRRC:001033-UCD
DR   Wikidata; Q54760179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146423; Mix23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 7
//
ID   BayGenomics ES cell line NPX372
AC   CVCL_MK80
SY   NPX372
DR   MMRRC; MMRRC:001037-UCD
DR   Wikidata; Q54760183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914629; Dedd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX373
AC   CVCL_MK81
SY   NPX373
DR   MMRRC; MMRRC:001038-UCD
DR   Wikidata; Q54760184
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928373; Dnajc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX377
AC   CVCL_MK82
SY   NPX377
DR   MMRRC; MMRRC:001040-UCD
DR   Wikidata; Q54760186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX378
AC   CVCL_MK83
SY   NPX378
DR   MMRRC; MMRRC:001041-UCD
DR   Wikidata; Q54760189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140945; Pds5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX381
AC   CVCL_MK84
SY   NPX381
DR   MMRRC; MMRRC:001042-UCD
DR   Wikidata; Q54760191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929869; Hic2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX384
AC   CVCL_MK85
SY   NPX384
DR   MMRRC; MMRRC:001045-UCD
DR   Wikidata; Q54760194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914282; Snapc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX389
AC   CVCL_MK86
SY   NPX389
DR   MMRRC; MMRRC:001046-UCD
DR   Wikidata; Q54760197
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932915; Ndel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX400
AC   CVCL_MK87
SY   NPX400
DR   MMRRC; MMRRC:001048-UCD
DR   Wikidata; Q54760198
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344353; Katna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX411
AC   CVCL_MK88
SY   NPX411
DR   MMRRC; MMRRC:001049-UCD
DR   Wikidata; Q54760199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385025; Alg12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX427
AC   CVCL_MK89
SY   NPX427
DR   MMRRC; MMRRC:001052-UCD
DR   Wikidata; Q54760203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913495; Hspbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX442
AC   CVCL_MK90
SY   NPX442
DR   MMRRC; MMRRC:001053-UCD
DR   Wikidata; Q54760205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914418; Lpar6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX444
AC   CVCL_MK91
SY   NPX444
DR   MMRRC; MMRRC:001054-UCD
DR   Wikidata; Q54760208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442579; Frmd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX451
AC   CVCL_MK92
SY   NPX451
DR   MMRRC; MMRRC:001056-UCD
DR   Wikidata; Q54760210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890645; Nek7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX467
AC   CVCL_MK93
SY   NPX467
DR   MMRRC; MMRRC:001065-UCD
DR   Wikidata; Q54760212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679003; Dcun1d3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX472
AC   CVCL_MK94
SY   NPX472
DR   MMRRC; MMRRC:001068-UCD
DR   Wikidata; Q54760213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3040699; Wdcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX473
AC   CVCL_MK95
SY   NPX473
DR   MMRRC; MMRRC:001069-UCD
DR   Wikidata; Q54760214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933169; Sacm1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX474
AC   CVCL_MK96
SY   NPX474
DR   MMRRC; MMRRC:001070-UCD
DR   Wikidata; Q54760216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891964; Xrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX476
AC   CVCL_MK97
SY   NPX476
DR   MMRRC; MMRRC:001072-UCD
DR   Wikidata; Q54760218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321389; Vamp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX477
AC   CVCL_MK98
SY   NPX477
DR   MMRRC; MMRRC:001073-UCD
DR   Wikidata; Q54760222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919675; Katnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX480
AC   CVCL_MK99
SY   NPX480
DR   MMRRC; MMRRC:001076-UCD
DR   Wikidata; Q54760223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098703; Sgta.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX481
AC   CVCL_ML00
SY   NPX481
DR   MMRRC; MMRRC:001077-UCD
DR   Wikidata; Q54760265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923055; Nln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX487
AC   CVCL_ML01
SY   NPX487
DR   MMRRC; MMRRC:001081-UCD
DR   Wikidata; Q54760270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914282; Snapc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX490
AC   CVCL_ML02
SY   NPX490
DR   MMRRC; MMRRC:001084-UCD
DR   Wikidata; Q54760272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915358; Snhg17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX491
AC   CVCL_ML03
SY   NPX491
DR   MMRRC; MMRRC:001085-UCD
DR   Wikidata; Q54760274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444450; Fbxl18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX493
AC   CVCL_ML04
SY   NPX493
DR   MMRRC; MMRRC:001086-UCD
DR   Wikidata; Q54760275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3712454; Zfp980.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX494
AC   CVCL_ML05
SY   NPX494
DR   MMRRC; MMRRC:001087-UCD
DR   Wikidata; Q54760278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line NPX496
AC   CVCL_ML06
SY   NPX496
DR   MMRRC; MMRRC:001088-UCD
DR   Wikidata; Q54760279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX497
AC   CVCL_ML07
SY   NPX497
DR   MMRRC; MMRRC:001089-UCD
DR   Wikidata; Q54760281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922974; Ccdc18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX499
AC   CVCL_ML08
SY   NPX499
DR   MMRRC; MMRRC:001091-UCD
DR   Wikidata; Q54760282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385142; Mettl8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX503
AC   CVCL_ML09
SY   NPX503
DR   MMRRC; MMRRC:001093-UCD
DR   Wikidata; Q54760284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861746; Lmbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NPX505
AC   CVCL_ML10
SY   NPX505
DR   MMRRC; MMRRC:001094-UCD
DR   Wikidata; Q54760287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914234; Med19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NST001
AC   CVCL_ML11
SY   NST001
DR   MMRRC; MMRRC:001097-UCD
DR   Wikidata; Q54760289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107658; Ifnar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NST002
AC   CVCL_ML12
SY   NST002
DR   MMRRC; MMRRC:001098-UCD
DR   Wikidata; Q54760291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96560; Il6st.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NST003
AC   CVCL_ML13
SY   NST003
DR   MMRRC; MMRRC:001099-UCD
DR   Wikidata; Q54760292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336175; Kcnk5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NST005
AC   CVCL_ML14
SY   NST005
DR   MMRRC; MMRRC:001100-UCD
DR   Wikidata; Q54760293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97004; Mme.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NST020
AC   CVCL_ML15
SY   NST020
DR   MMRRC; MMRRC:001101-UCD
DR   Wikidata; Q54760296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98341; Snrnp70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line NST024
AC   CVCL_ML16
SY   NST024
DR   MMRRC; MMRRC:001104-UCD
DR   Wikidata; Q54760297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104864; Pdia4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST002
AC   CVCL_ML17
SY   PST002
DR   MMRRC; MMRRC:001110-UCD
DR   Wikidata; Q54760298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST004
AC   CVCL_ML18
SY   PST004
DR   MMRRC; MMRRC:001111-UCD
DR   Wikidata; Q54760301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104556; Cdkn1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST005
AC   CVCL_ML19
SY   PST005
DR   MMRRC; MMRRC:001112-UCD
DR   Wikidata; Q54760303
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST007
AC   CVCL_ML20
SY   PST007
DR   MMRRC; MMRRC:001113-UCD
DR   Wikidata; Q54760306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384573; Ttc13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST008
AC   CVCL_ML21
SY   PST008
DR   MMRRC; MMRRC:001114-UCD
DR   Wikidata; Q54760308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99892; Lama1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST009
AC   CVCL_ML22
SY   PST009
DR   MMRRC; MMRRC:001115-UCD
DR   Wikidata; Q54760309
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039616; Znrf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST019
AC   CVCL_ML23
SY   PST019
DR   MMRRC; MMRRC:001116-UCD
DR   Wikidata; Q54760311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97513; Furin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST024
AC   CVCL_ML24
SY   PST024
DR   MMRRC; MMRRC:001118-UCD
DR   Wikidata; Q54760313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST025
AC   CVCL_ML25
SY   PST025
DR   MMRRC; MMRRC:001119-UCD
DR   Wikidata; Q54760314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914186; Asph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST026
AC   CVCL_ML26
SY   PST026
DR   MMRRC; MMRRC:001120-UCD
DR   Wikidata; Q54760317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87961; Agrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST027
AC   CVCL_ML27
SY   PST027
DR   MMRRC; MMRRC:001121-UCD
DR   Wikidata; Q54760320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST033
AC   CVCL_ML28
SY   PST033
DR   MMRRC; MMRRC:001123-UCD
DR   Wikidata; Q54760322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99460; Notch3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST034
AC   CVCL_ML29
SY   PST034
DR   MMRRC; MMRRC:001124-UCD
DR   Wikidata; Q54760323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST035
AC   CVCL_ML30
SY   PST035
DR   MMRRC; MMRRC:001125-UCD
DR   Wikidata; Q54760325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST036
AC   CVCL_ML31
SY   PST036
DR   MMRRC; MMRRC:001126-UCD
DR   Wikidata; Q54760327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST037
AC   CVCL_ML32
SY   PST037
DR   MMRRC; MMRRC:001127-UCD
DR   Wikidata; Q54760328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST038
AC   CVCL_ML33
SY   PST038
DR   MMRRC; MMRRC:001128-UCD
DR   Wikidata; Q54760329
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98277; Epha4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST040
AC   CVCL_ML34
SY   PST040
DR   MMRRC; MMRRC:001129-UCD
DR   Wikidata; Q54760331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913863; Pigk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST043
AC   CVCL_ML35
SY   PST043
DR   MMRRC; MMRRC:001131-UCD
DR   Wikidata; Q54760333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347007; Plod2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST046
AC   CVCL_ML36
SY   PST046
DR   MMRRC; MMRRC:001132-UCD
DR   Wikidata; Q54760335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917611; Lman1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST055
AC   CVCL_ML37
SY   PST055
DR   MMRRC; MMRRC:001134-UCD
DR   Wikidata; Q54760336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST058
AC   CVCL_ML38
SY   PST058
DR   MMRRC; MMRRC:001135-UCD
DR   Wikidata; Q54760337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST059
AC   CVCL_ML39
SY   PST059
DR   MMRRC; MMRRC:001136-UCD
DR   Wikidata; Q54760340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST061
AC   CVCL_ML40
SY   PST061
DR   MMRRC; MMRRC:001137-UCD
DR   Wikidata; Q54760375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST063
AC   CVCL_ML41
SY   PST063
DR   MMRRC; MMRRC:001138-UCD
DR   Wikidata; Q54760377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST065
AC   CVCL_ML42
SY   PST065
DR   MMRRC; MMRRC:001139-UCD
DR   Wikidata; Q54760378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97364; Notch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST066
AC   CVCL_ML43
SY   PST066
DR   MMRRC; MMRRC:001140-UCD
DR   Wikidata; Q54760379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105377; Adam19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST069
AC   CVCL_ML44
SY   PST069
DR   MMRRC; MMRRC:001141-UCD
DR   Wikidata; Q54760380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97364; Notch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST072
AC   CVCL_ML45
SY   PST072
DR   MMRRC; MMRRC:001142-UCD
DR   Wikidata; Q54760381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST073
AC   CVCL_ML46
SY   PST073
DR   MMRRC; MMRRC:001143-UCD
DR   Wikidata; Q54760383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST076
AC   CVCL_ML47
SY   PST076
DR   MMRRC; MMRRC:001144-UCD
DR   Wikidata; Q54760385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97750; Ppib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST078
AC   CVCL_ML48
SY   PST078
DR   MMRRC; MMRRC:001145-UCD
DR   Wikidata; Q54760389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107373; Dnajc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST079
AC   CVCL_ML49
SY   PST079
DR   MMRRC; MMRRC:001146-UCD
DR   Wikidata; Q54760391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST080
AC   CVCL_ML50
SY   PST080
DR   MMRRC; MMRRC:001147-UCD
DR   Wikidata; Q54760393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96955; Slc3a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST084
AC   CVCL_ML51
SY   PST084
DR   MMRRC; MMRRC:001148-UCD
DR   Wikidata; Q54760396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96743; Lamb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST086
AC   CVCL_ML52
SY   PST086
DR   MMRRC; MMRRC:001149-UCD
DR   Wikidata; Q54760398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST087
AC   CVCL_ML53
SY   PST087
DR   MMRRC; MMRRC:001150-UCD
DR   Wikidata; Q54760399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95835; Hspa5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST088
AC   CVCL_ML54
SY   PST088
DR   MMRRC; MMRRC:001151-UCD
DR   Wikidata; Q54760400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST089
AC   CVCL_ML55
SY   PST089
DR   MMRRC; MMRRC:001152-UCD
DR   Wikidata; Q54760402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929269; Tmed2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST090
AC   CVCL_ML56
SY   PST090
DR   MMRRC; MMRRC:001153-UCD
DR   Wikidata; Q54760403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST092
AC   CVCL_ML57
SY   PST092
DR   MMRRC; MMRRC:001154-UCD
DR   Wikidata; Q54760405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST093
AC   CVCL_ML58
SY   PST093
DR   MMRRC; MMRRC:001155-UCD
DR   Wikidata; Q54760408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST094
AC   CVCL_ML59
SY   PST094
DR   MMRRC; MMRRC:001156-UCD
DR   Wikidata; Q54760410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298218; Lrp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST095
AC   CVCL_ML60
SY   PST095
DR   MMRRC; MMRRC:001157-UCD
DR   Wikidata; Q54760412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105066; Rab10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST096
AC   CVCL_ML61
SY   PST096
DR   MMRRC; MMRRC:001158-UCD
DR   Wikidata; Q54760415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298218; Lrp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST098
AC   CVCL_ML62
SY   PST098
DR   MMRRC; MMRRC:001160-UCD
DR   Wikidata; Q54760417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST099
AC   CVCL_ML63
SY   PST099
DR   MMRRC; MMRRC:001161-UCD
DR   Wikidata; Q54760418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST100
AC   CVCL_ML64
SY   PST100
DR   MMRRC; MMRRC:001162-UCD
DR   Wikidata; Q54760420
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919293; Sulf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST102
AC   CVCL_ML65
SY   PST102
DR   MMRRC; MMRRC:001163-UCD
DR   Wikidata; Q54760422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST103
AC   CVCL_ML66
SY   PST103
DR   MMRRC; MMRRC:001164-UCD
DR   Wikidata; Q54760424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST104
AC   CVCL_ML67
SY   PST104
DR   MMRRC; MMRRC:001165-UCD
DR   Wikidata; Q54760427
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST105
AC   CVCL_ML68
SY   PST105
DR   MMRRC; MMRRC:001166-UCD
DR   Wikidata; Q54760429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914262; Tm9sf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST106
AC   CVCL_ML69
SY   PST106
DR   MMRRC; MMRRC:001167-UCD
DR   Wikidata; Q54760431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST107
AC   CVCL_ML70
SY   PST107
DR   MMRRC; MMRRC:001168-UCD
DR   Wikidata; Q54760434
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST108
AC   CVCL_ML71
SY   PST108
DR   MMRRC; MMRRC:001169-UCD
DR   Wikidata; Q54760437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST111
AC   CVCL_ML72
SY   PST111
DR   MMRRC; MMRRC:001170-UCD
DR   Wikidata; Q54760439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919293; Sulf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST112
AC   CVCL_ML73
SY   PST112
DR   MMRRC; MMRRC:001171-UCD
DR   Wikidata; Q54760440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341628; Atrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST113
AC   CVCL_ML74
SY   PST113
DR   MMRRC; MMRRC:001172-UCD
DR   Wikidata; Q54760441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST115
AC   CVCL_ML75
SY   PST115
DR   MMRRC; MMRRC:001173-UCD
DR   Wikidata; Q54760442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927235; Mbtps1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST116
AC   CVCL_ML76
SY   PST116
DR   MMRRC; MMRRC:001174-UCD
DR   Wikidata; Q54760446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97815; Ptprs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST118
AC   CVCL_ML77
SY   PST118
DR   MMRRC; MMRRC:001175-UCD
DR   Wikidata; Q54760447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919293; Sulf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST120
AC   CVCL_ML78
SY   PST120
DR   MMRRC; MMRRC:001176-UCD
DR   Wikidata; Q54760451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289273; Ppp1r10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST123
AC   CVCL_ML79
SY   PST123
DR   MMRRC; MMRRC:001177-UCD
DR   Wikidata; Q54760453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST124
AC   CVCL_ML80
SY   PST124
DR   MMRRC; MMRRC:001178-UCD
DR   Wikidata; Q54760496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST126
AC   CVCL_ML81
SY   PST126
DR   MMRRC; MMRRC:001179-UCD
DR   Wikidata; Q54760498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST127
AC   CVCL_ML82
SY   PST127
DR   MMRRC; MMRRC:001180-UCD
DR   Wikidata; Q54760500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST128
AC   CVCL_ML83
SY   PST128
DR   MMRRC; MMRRC:001181-UCD
DR   Wikidata; Q54760501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST129
AC   CVCL_ML84
SY   PST129
DR   MMRRC; MMRRC:001182-UCD
DR   Wikidata; Q54760502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104903; Gpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST131
AC   CVCL_ML85
SY   PST131
DR   MMRRC; MMRRC:001183-UCD
DR   Wikidata; Q54760504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927471; Lsr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PST132
AC   CVCL_ML86
SY   PST132
DR   MMRRC; MMRRC:001184-UCD
DR   Wikidata; Q54760507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104902; Gpc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT026
AC   CVCL_ML87
SY   PT026
DR   MMRRC; MMRRC:001185-UCD
DR   Wikidata; Q54760509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT032
AC   CVCL_ML88
SY   PT032
DR   MMRRC; MMRRC:001186-UCD
DR   Wikidata; Q54760511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354737; Kdm2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT036
AC   CVCL_ML89
SY   PT036
DR   MMRRC; MMRRC:001187-UCD
DR   Wikidata; Q54760512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913799; Aggf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT058
AC   CVCL_ML90
SY   PT058
DR   MMRRC; MMRRC:001188-UCD
DR   Wikidata; Q54760514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1340806; Parp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT065
AC   CVCL_ML91
SY   PT065
DR   MMRRC; MMRRC:001189-UCD
DR   Wikidata; Q54760517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933946; Ptov1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT084
AC   CVCL_ML92
SY   PT084
DR   MMRRC; MMRRC:001190-UCD
DR   Wikidata; Q54760519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914750; Ccar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT138
AC   CVCL_ML93
SY   PT138
DR   MMRRC; MMRRC:001191-UCD
DR   Wikidata; Q54760521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328337; Orc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT144
AC   CVCL_ML94
SY   PT144
DR   MMRRC; MMRRC:001192-UCD
DR   Wikidata; Q54760522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448326; H3c6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line PT175
AC   CVCL_ML95
SY   PT175
DR   MMRRC; MMRRC:001193-UCD
DR   Wikidata; Q54760524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT193
AC   CVCL_ML96
SY   PT193
DR   MMRRC; MMRRC:001194-UCD
DR   Wikidata; Q54760526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447762; Yeats2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line PT326
AC   CVCL_ML97
SY   PT326
DR   MMRRC; MMRRC:001197-UCD
DR   Wikidata; Q54760528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918518; Lrrfip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA002
AC   CVCL_ML98
SY   RHA002
DR   MMRRC; MMRRC:010775-UCD
DR   Wikidata; Q54760530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98341; Snrnp70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA003
AC   CVCL_ML99
SY   RHA003
DR   MMRRC; MMRRC:010776-UCD
DR   Wikidata; Q54760532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930780; Myh10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA004
AC   CVCL_MM00
SY   RHA004
DR   MMRRC; MMRRC:010777-UCD
DR   Wikidata; Q54760534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916327; Psmd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA005
AC   CVCL_MM01
SY   RHA005
DR   MMRRC; MMRRC:010778-UCD
DR   Wikidata; Q54760535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917262; Cep85.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA006
AC   CVCL_MM02
SY   RHA006
DR   MMRRC; MMRRC:010779-UCD
DR   Wikidata; Q54760536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103040; Rsu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA007
AC   CVCL_MM03
SY   RHA007
DR   MMRRC; MMRRC:010780-UCD
DR   Wikidata; Q54760538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103040; Rsu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA008
AC   CVCL_MM04
SY   RHA008
DR   MMRRC; MMRRC:010781-UCD
DR   Wikidata; Q54760541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA011
AC   CVCL_MM05
SY   RHA011
DR   MMRRC; MMRRC:010782-UCD
DR   Wikidata; Q54760543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA012
AC   CVCL_MM06
SY   RHA012
DR   MMRRC; MMRRC:010889-UCD
DR   Wikidata; Q54760544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918625; Foxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA015
AC   CVCL_MM07
SY   RHA015
DR   MMRRC; MMRRC:010784-UCD
DR   Wikidata; Q54760545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA025
AC   CVCL_MM08
SY   RHA025
DR   MMRRC; MMRRC:010786-UCD
DR   Wikidata; Q54760548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914182; Rexo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA026
AC   CVCL_MM09
SY   RHA026
DR   MMRRC; MMRRC:010787-UCD
DR   Wikidata; Q54760549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685830; Nsl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA031
AC   CVCL_MM10
SY   RHA031
DR   MMRRC; MMRRC:010788-UCD
DR   Wikidata; Q54760551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA034
AC   CVCL_MM11
SY   RHA034
DR   MMRRC; MMRRC:010789-UCD
DR   Wikidata; Q54760553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922662; 2610021A01Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA035
AC   CVCL_MM12
SY   RHA035
DR   MMRRC; MMRRC:010790-UCD
DR   Wikidata; Q54760554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135637; Park7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA037
AC   CVCL_MM13
SY   RHA037
DR   MMRRC; MMRRC:010791-UCD
DR   Wikidata; Q54760559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915033; Ahctf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA040
AC   CVCL_MM14
SY   RHA040
DR   MMRRC; MMRRC:010792-UCD
DR   Wikidata; Q54760560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346869; Map2k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA041
AC   CVCL_MM15
SY   RHA041
DR   MMRRC; MMRRC:010793-UCD
DR   Wikidata; Q54760562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926162; Sp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA043
AC   CVCL_MM16
SY   RHA043
DR   MMRRC; MMRRC:010794-UCD
DR   Wikidata; Q54760565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99207; Zfp60.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA044
AC   CVCL_MM17
SY   RHA044
DR   MMRRC; MMRRC:010795-UCD
DR   Wikidata; Q54760566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913446; Myo19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA046
AC   CVCL_MM18
SY   RHA046
DR   MMRRC; MMRRC:010796-UCD
DR   Wikidata; Q54760567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109634; Terf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA051
AC   CVCL_MM19
SY   RHA051
DR   MMRRC; MMRRC:010797-UCD
DR   Wikidata; Q54760569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99537; Rabggtb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA052
AC   CVCL_MM20
SY   RHA052
DR   MMRRC; MMRRC:010798-UCD
DR   Wikidata; Q54760608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328362; Blm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA053
AC   CVCL_MM21
SY   RHA053
DR   MMRRC; MMRRC:010799-UCD
DR   Wikidata; Q54760610
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443564; Ambra1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA054
AC   CVCL_MM22
SY   RHA054
DR   MMRRC; MMRRC:010800-UCD
DR   Wikidata; Q54760611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA055
AC   CVCL_MM23
SY   RHA055
DR   MMRRC; MMRRC:010801-UCD
DR   Wikidata; Q54760613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:893579; Khdrbs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA056
AC   CVCL_MM24
SY   RHA056
DR   MMRRC; MMRRC:010802-UCD
DR   Wikidata; Q54760614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928741; Ranbp9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA059
AC   CVCL_MM25
SY   RHA059
DR   MMRRC; MMRRC:010803-UCD
DR   Wikidata; Q54760616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919563; Fryl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA061
AC   CVCL_MM26
SY   RHA061
DR   MMRRC; MMRRC:010804-UCD
DR   Wikidata; Q54760619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA062
AC   CVCL_MM27
SY   RHA062
DR   MMRRC; MMRRC:010805-UCD
DR   Wikidata; Q54760621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922434; Camsap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA064
AC   CVCL_MM28
SY   RHA064
DR   MMRRC; MMRRC:010806-UCD
DR   Wikidata; Q54760622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA065
AC   CVCL_MM29
SY   RHA065
DR   MMRRC; MMRRC:010807-UCD
DR   Wikidata; Q54760624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104816; Hnrnpl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA066
AC   CVCL_MM30
SY   RHA066
DR   MMRRC; MMRRC:010808-UCD
DR   Wikidata; Q54760625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA067
AC   CVCL_MM31
SY   RHA067
DR   MMRRC; MMRRC:010809-UCD
DR   Wikidata; Q54760626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916303; 1810013L24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA069
AC   CVCL_MM32
SY   RHA069
DR   MMRRC; MMRRC:010810-UCD
DR   Wikidata; Q54760628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915149; Cmc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA070
AC   CVCL_MM33
SY   RHA070
DR   MMRRC; MMRRC:010811-UCD
DR   Wikidata; Q54760632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA071
AC   CVCL_MM34
SY   RHA071
DR   MMRRC; MMRRC:010812-UCD
DR   Wikidata; Q54760635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA072
AC   CVCL_MM35
SY   RHA072
DR   MMRRC; MMRRC:010813-UCD
DR   Wikidata; Q54760636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA079
AC   CVCL_MM36
SY   RHA079
DR   MMRRC; MMRRC:010815-UCD
DR   Wikidata; Q54760638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916435; Dtwd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA081
AC   CVCL_MM37
SY   RHA081
DR   MMRRC; MMRRC:010816-UCD
DR   Wikidata; Q54760640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913325; Chchd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA082
AC   CVCL_MM38
SY   RHA082
DR   MMRRC; MMRRC:010817-UCD
DR   Wikidata; Q54760641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA084
AC   CVCL_MM39
SY   RHA084
DR   MMRRC; MMRRC:010818-UCD
DR   Wikidata; Q54760643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA085
AC   CVCL_MM40
SY   RHA085
DR   MMRRC; MMRRC:010819-UCD
DR   Wikidata; Q54760644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA086
AC   CVCL_MM41
SY   RHA086
DR   MMRRC; MMRRC:010820-UCD
DR   Wikidata; Q54760646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347053; Git2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA088
AC   CVCL_MM42
SY   RHA088
DR   MMRRC; MMRRC:010821-UCD
DR   Wikidata; Q54760647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339975; Pak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA089
AC   CVCL_MM43
SY   RHA089
DR   MMRRC; MMRRC:010822-UCD
DR   Wikidata; Q54760650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922088; Naa15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA090
AC   CVCL_MM44
SY   RHA090
DR   MMRRC; MMRRC:010823-UCD
DR   Wikidata; Q54760651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3029414; Brwd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA092
AC   CVCL_MM45
SY   RHA092
DR   MMRRC; MMRRC:010824-UCD
DR   Wikidata; Q54760654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343085; Spop.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA093
AC   CVCL_MM46
SY   RHA093
DR   MMRRC; MMRRC:010825-UCD
DR   Wikidata; Q54760655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA097
AC   CVCL_MM47
SY   RHA097
DR   MMRRC; MMRRC:010826-UCD
DR   Wikidata; Q54760658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330281; Cd2ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA103
AC   CVCL_MM48
SY   RHA103
DR   MMRRC; MMRRC:010827-UCD
DR   Wikidata; Q54760660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929063; Copz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA104
AC   CVCL_MM49
SY   RHA104
DR   MMRRC; MMRRC:010828-UCD
DR   Wikidata; Q54760662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684416; Arap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA105
AC   CVCL_MM50
SY   RHA105
DR   MMRRC; MMRRC:010829-UCD
DR   Wikidata; Q54760665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99954; Ighmbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA106
AC   CVCL_MM51
SY   RHA106
DR   MMRRC; MMRRC:010830-UCD
DR   Wikidata; Q54760668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446089; Flnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA107
AC   CVCL_MM52
SY   RHA107
DR   MMRRC; MMRRC:010831-UCD
DR   Wikidata; Q54760671
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194490; Diaph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA109
AC   CVCL_MM53
SY   RHA109
DR   MMRRC; MMRRC:010832-UCD
DR   Wikidata; Q54760673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107688; Kif3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA110
AC   CVCL_MM54
SY   RHA110
DR   MMRRC; MMRRC:010833-UCD
DR   Wikidata; Q54760674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA114
AC   CVCL_MM55
SY   RHA114
DR   MMRRC; MMRRC:010834-UCD
DR   Wikidata; Q54760676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA122
AC   CVCL_MM56
SY   RHA122
DR   MMRRC; MMRRC:010835-UCD
DR   Wikidata; Q54760677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915770; Zfyve21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA124
AC   CVCL_MM57
SY   RHA124
DR   MMRRC; MMRRC:010836-UCD
DR   Wikidata; Q54760679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA149
AC   CVCL_MM58
SY   RHA149
DR   MMRRC; MMRRC:010838-UCD
DR   Wikidata; Q54760681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915033; Ahctf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA152
AC   CVCL_MM59
SY   RHA152
DR   MMRRC; MMRRC:010839-UCD
DR   Wikidata; Q54760683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103267; Eif4ebp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA154
AC   CVCL_MM60
SY   RHA154
DR   MMRRC; MMRRC:010840-UCD
DR   Wikidata; Q54760714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385848; Bcas3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA158
AC   CVCL_MM61
SY   RHA158
DR   MMRRC; MMRRC:010842-UCD
DR   Wikidata; Q54760716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA161
AC   CVCL_MM62
SY   RHA161
DR   MMRRC; MMRRC:010843-UCD
DR   Wikidata; Q54760718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA162
AC   CVCL_MM63
SY   RHA162
DR   MMRRC; MMRRC:010844-UCD
DR   Wikidata; Q54760719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643133; Gm4924.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA164
AC   CVCL_MM64
SY   RHA164
DR   MMRRC; MMRRC:010845-UCD
DR   Wikidata; Q54760720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99147; Yes1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA167
AC   CVCL_MM65
SY   RHA167
DR   MMRRC; MMRRC:010847-UCD
DR   Wikidata; Q54760722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA172
AC   CVCL_MM66
SY   RHA172
DR   MMRRC; MMRRC:010848-UCD
DR   Wikidata; Q54760724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922434; Camsap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA173
AC   CVCL_MM67
SY   RHA173
DR   MMRRC; MMRRC:010849-UCD
DR   Wikidata; Q54760725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109233; Kif22.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA175
AC   CVCL_MM68
SY   RHA175
DR   MMRRC; MMRRC:010850-UCD
DR   Wikidata; Q54760729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106581; Tsg101.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA179
AC   CVCL_MM69
SY   RHA179
DR   MMRRC; MMRRC:010851-UCD
DR   Wikidata; Q54760731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102467; Ptpn14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA181
AC   CVCL_MM70
SY   RHA181
DR   MMRRC; MMRRC:010852-UCD
DR   Wikidata; Q54760733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144243; Clint1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA183
AC   CVCL_MM71
SY   RHA183
DR   MMRRC; MMRRC:010853-UCD
DR   Wikidata; Q54760738
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA185
AC   CVCL_MM72
SY   RHA185
DR   MMRRC; MMRRC:010855-UCD
DR   Wikidata; Q54760740
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103257; Inpp5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA196
AC   CVCL_MM73
SY   RHA196
DR   MMRRC; MMRRC:010890-UCD
DR   Wikidata; Q54760742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442362; Zfp653.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA197
AC   CVCL_MM74
SY   RHA197
DR   MMRRC; MMRRC:010891-UCD
DR   Wikidata; Q54760744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA199
AC   CVCL_MM75
SY   RHA199
DR   MMRRC; MMRRC:010892-UCD
DR   Wikidata; Q54760745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88192; Smarca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA200
AC   CVCL_MM76
SY   RHA200
DR   MMRRC; MMRRC:010893-UCD
DR   Wikidata; Q54760746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919060; Ranbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA202
AC   CVCL_MM77
SY   RHA202
DR   MMRRC; MMRRC:010894-UCD
DR   Wikidata; Q54760748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338800; Bpnt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA203
AC   CVCL_MM78
SY   RHA203
DR   MMRRC; MMRRC:010895-UCD
DR   Wikidata; Q54760749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87989; Alas1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA209
AC   CVCL_MM79
SY   RHA209
DR   MMRRC; MMRRC:010897-UCD
DR   Wikidata; Q54760752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA210
AC   CVCL_MM80
SY   RHA210
DR   MMRRC; MMRRC:010898-UCD
DR   Wikidata; Q54760754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913489; Rsrc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA211
AC   CVCL_MM81
SY   RHA211
DR   MMRRC; MMRRC:010899-UCD
DR   Wikidata; Q54760755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139369; Rtel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA212
AC   CVCL_MM82
SY   RHA212
DR   MMRRC; MMRRC:010900-UCD
DR   Wikidata; Q54760758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917656; Vps26b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA214
AC   CVCL_MM83
SY   RHA214
DR   MMRRC; MMRRC:010901-UCD
DR   Wikidata; Q54760760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA215
AC   CVCL_MM84
SY   RHA215
DR   MMRRC; MMRRC:010902-UCD
DR   Wikidata; Q54760762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352502; Limd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA216
AC   CVCL_MM85
SY   RHA216
DR   MMRRC; MMRRC:010903-UCD
DR   Wikidata; Q54760765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444989; Spg11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA218
AC   CVCL_MM86
SY   RHA218
DR   MMRRC; MMRRC:010904-UCD
DR   Wikidata; Q54760767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98759; Tjp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA221
AC   CVCL_MM87
SY   RHA221
DR   MMRRC; MMRRC:010905-UCD
DR   Wikidata; Q54760768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913944; Uqcrfs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA224
AC   CVCL_MM88
SY   RHA224
DR   MMRRC; MMRRC:010906-UCD
DR   Wikidata; Q54760769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921778; Mgme1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA225
AC   CVCL_MM89
SY   RHA225
DR   MMRRC; MMRRC:010907-UCD
DR   Wikidata; Q54760770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183747; Fgd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA226
AC   CVCL_MM90
SY   RHA226
DR   MMRRC; MMRRC:010908-UCD
DR   Wikidata; Q54760771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA228
AC   CVCL_MM91
SY   RHA228
DR   MMRRC; MMRRC:010909-UCD
DR   Wikidata; Q54760773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444121; Tanc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RHA230
AC   CVCL_MM92
SY   RHA230
DR   MMRRC; MMRRC:010911-UCD
DR   Wikidata; Q54760774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA001
AC   CVCL_MM93
SY   RRA001
DR   MMRRC; MMRRC:001198-UCD
DR   Wikidata; Q54760778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95606; Xrcc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA002
AC   CVCL_MM94
SY   RRA002
DR   MMRRC; MMRRC:001199-UCD
DR   Wikidata; Q54760779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343188; Ube2g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA003
AC   CVCL_MM95
SY   RRA003
DR   MMRRC; MMRRC:001200-UCD
DR   Wikidata; Q54760780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916491; Polr2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA005
AC   CVCL_MM96
SY   RRA005
DR   MMRRC; MMRRC:001201-UCD
DR   Wikidata; Q54760781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915434; Denr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA006
AC   CVCL_MM97
SY   RRA006
DR   MMRRC; MMRRC:001202-UCD
DR   Wikidata; Q54760782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914410; Eef1g.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA008
AC   CVCL_MM98
SY   RRA008
DR   MMRRC; MMRRC:001203-UCD
DR   Wikidata; Q54760784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA010
AC   CVCL_MM99
SY   RRA010
DR   MMRRC; MMRRC:001204-UCD
DR   Wikidata; Q54760785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA011
AC   CVCL_MN00
SY   RRA011
DR   MMRRC; MMRRC:001205-UCD
DR   Wikidata; Q54760830
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA012
AC   CVCL_MN01
SY   RRA012
DR   MMRRC; MMRRC:001206-UCD
DR   Wikidata; Q54760833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98241; Stmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA013
AC   CVCL_MN02
SY   RRA013
DR   MMRRC; MMRRC:001207-UCD
DR   Wikidata; Q54760834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107750; Dync1i2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA014
AC   CVCL_MN03
SY   RRA014
DR   MMRRC; MMRRC:001208-UCD
DR   Wikidata; Q54760837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351645; Prmt5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA015
AC   CVCL_MN04
SY   RRA015
DR   MMRRC; MMRRC:001209-UCD
DR   Wikidata; Q54760840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446132; Bms1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA016
AC   CVCL_MN05
SY   RRA016
DR   MMRRC; MMRRC:001210-UCD
DR   Wikidata; Q54760841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA017
AC   CVCL_MN06
SY   RRA017
DR   MMRRC; MMRRC:001211-UCD
DR   Wikidata; Q54760842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA018
AC   CVCL_MN07
SY   RRA018
DR   MMRRC; MMRRC:001212-UCD
DR   Wikidata; Q54760844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA019
AC   CVCL_MN08
SY   RRA019
DR   MMRRC; MMRRC:001213-UCD
DR   Wikidata; Q54760847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88141; Bcr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA025
AC   CVCL_MN09
SY   RRA025
DR   MMRRC; MMRRC:001216-UCD
DR   Wikidata; Q54760849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA026
AC   CVCL_MN10
SY   RRA026
DR   MMRRC; MMRRC:001217-UCD
DR   Wikidata; Q54760852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA027
AC   CVCL_MN11
SY   RRA027
DR   MMRRC; MMRRC:001218-UCD
DR   Wikidata; Q54760854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA029
AC   CVCL_MN12
SY   RRA029
DR   MMRRC; MMRRC:001219-UCD
DR   Wikidata; Q54760857
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916229; Nol11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA032
AC   CVCL_MN13
SY   RRA032
DR   MMRRC; MMRRC:001221-UCD
DR   Wikidata; Q54760858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444951; 8030462N17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA033
AC   CVCL_MN14
SY   RRA033
DR   MMRRC; MMRRC:001222-UCD
DR   Wikidata; Q54760859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682305; Rsf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA034
AC   CVCL_MN15
SY   RRA034
DR   MMRRC; MMRRC:001223-UCD
DR   Wikidata; Q54760860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917244; Ddi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA035
AC   CVCL_MN16
SY   RRA035
DR   MMRRC; MMRRC:001224-UCD
DR   Wikidata; Q54760862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929701; Metap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA037
AC   CVCL_MN17
SY   RRA037
DR   MMRRC; MMRRC:001225-UCD
DR   Wikidata; Q54760865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443472; Atf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA038
AC   CVCL_MN18
SY   RRA038
DR   MMRRC; MMRRC:001226-UCD
DR   Wikidata; Q54760867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341087; Tnks.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA039
AC   CVCL_MN19
SY   RRA039
DR   MMRRC; MMRRC:001227-UCD
DR   Wikidata; Q54760869
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921407; Cmtr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA040
AC   CVCL_MN20
SY   RRA040
DR   MMRRC; MMRRC:001228-UCD
DR   Wikidata; Q54760871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA041
AC   CVCL_MN21
SY   RRA041
DR   MMRRC; MMRRC:001229-UCD
DR   Wikidata; Q54760874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924315; Ints7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA042
AC   CVCL_MN22
SY   RRA042
DR   MMRRC; MMRRC:001230-UCD
DR   Wikidata; Q54760876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA045
AC   CVCL_MN23
SY   RRA045
DR   MMRRC; MMRRC:001232-UCD
DR   Wikidata; Q54760877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923749; Clasp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA048
AC   CVCL_MN24
SY   RRA048
DR   MMRRC; MMRRC:001234-UCD
DR   Wikidata; Q54760878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142572; Mtus1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA049
AC   CVCL_MN25
SY   RRA049
DR   MMRRC; MMRRC:001235-UCD
DR   Wikidata; Q54760880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99700; Cenpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA052
AC   CVCL_MN26
SY   RRA052
DR   MMRRC; MMRRC:001236-UCD
DR   Wikidata; Q54760881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913358; Ndufa9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA053
AC   CVCL_MN27
SY   RRA053
DR   MMRRC; MMRRC:001237-UCD
DR   Wikidata; Q54760883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA055
AC   CVCL_MN28
SY   RRA055
DR   MMRRC; MMRRC:001238-UCD
DR   Wikidata; Q54760886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138893; Usp6nl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA056
AC   CVCL_MN29
SY   RRA056
DR   MMRRC; MMRRC:001239-UCD
DR   Wikidata; Q54760888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681271; Pigl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA057
AC   CVCL_MN30
SY   RRA057
DR   MMRRC; MMRRC:001240-UCD
DR   Wikidata; Q54760890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333754; Agfg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA058
AC   CVCL_MN31
SY   RRA058
DR   MMRRC; MMRRC:001241-UCD
DR   Wikidata; Q54760893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444639; Fbxo38.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA060
AC   CVCL_MN32
SY   RRA060
DR   MMRRC; MMRRC:001242-UCD
DR   Wikidata; Q54760895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95728; Gli2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA064
AC   CVCL_MN33
SY   RRA064
DR   MMRRC; MMRRC:001244-UCD
DR   Wikidata; Q54760896
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA070
AC   CVCL_MN34
SY   RRA070
DR   MMRRC; MMRRC:001245-UCD
DR   Wikidata; Q54760899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146388; Ubxn7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA071
AC   CVCL_MN35
SY   RRA071
DR   MMRRC; MMRRC:001246-UCD
DR   Wikidata; Q54760902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA074
AC   CVCL_MN36
SY   RRA074
DR   MMRRC; MMRRC:001247-UCD
DR   Wikidata; Q54760905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442637; Thrap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA075
AC   CVCL_MN37
SY   RRA075
DR   MMRRC; MMRRC:001248-UCD
DR   Wikidata; Q54760906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140327; Phactr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA079
AC   CVCL_MN38
SY   RRA079
DR   MMRRC; MMRRC:001249-UCD
DR   Wikidata; Q54760909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA081
AC   CVCL_MN39
SY   RRA081
DR   MMRRC; MMRRC:001250-UCD
DR   Wikidata; Q54760910
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923957; Clasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA084
AC   CVCL_MN40
SY   RRA084
DR   MMRRC; MMRRC:001251-UCD
DR   Wikidata; Q54760953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA085
AC   CVCL_MN41
SY   RRA085
DR   MMRRC; MMRRC:001252-UCD
DR   Wikidata; Q54760956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146110; Washc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA086
AC   CVCL_MN42
SY   RRA086
DR   MMRRC; MMRRC:001253-UCD
DR   Wikidata; Q54760959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97858; Rarg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA089
AC   CVCL_MN43
SY   RRA089
DR   MMRRC; MMRRC:001255-UCD
DR   Wikidata; Q54760962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096572; Zfand3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA091
AC   CVCL_MN44
SY   RRA091
DR   MMRRC; MMRRC:001256-UCD
DR   Wikidata; Q54760964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919204; Suds3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA094
AC   CVCL_MN45
SY   RRA094
DR   MMRRC; MMRRC:001257-UCD
DR   Wikidata; Q54760966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095419; Kdm6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA095
AC   CVCL_MN46
SY   RRA095
DR   MMRRC; MMRRC:001258-UCD
DR   Wikidata; Q54760968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA096
AC   CVCL_MN47
SY   RRA096
DR   MMRRC; MMRRC:001259-UCD
DR   Wikidata; Q54760970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141503; Pot1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA097
AC   CVCL_MN48
SY   RRA097
DR   MMRRC; MMRRC:001260-UCD
DR   Wikidata; Q54760973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA098
AC   CVCL_MN49
SY   RRA098
DR   MMRRC; MMRRC:001261-UCD
DR   Wikidata; Q54760975
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913563; Smurf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA101
AC   CVCL_MN50
SY   RRA101
DR   MMRRC; MMRRC:001262-UCD
DR   Wikidata; Q54760977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289294; Dop1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRA102
AC   CVCL_MN51
SY   RRA102
DR   MMRRC; MMRRC:001263-UCD
DR   Wikidata; Q54760979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445054; Senp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA103
AC   CVCL_MN52
SY   RRA103
DR   MMRRC; MMRRC:001264-UCD
DR   Wikidata; Q54760982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682307; Ric8b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA104
AC   CVCL_MN53
SY   RRA104
DR   MMRRC; MMRRC:001265-UCD
DR   Wikidata; Q54760984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892003; Tcof1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA107
AC   CVCL_MN54
SY   RRA107
DR   MMRRC; MMRRC:001267-UCD
DR   Wikidata; Q54760986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920453; Zzz3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA109
AC   CVCL_MN55
SY   RRA109
DR   MMRRC; MMRRC:001268-UCD
DR   Wikidata; Q54760987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444177; Cachd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA117
AC   CVCL_MN56
SY   RRA117
DR   MMRRC; MMRRC:001269-UCD
DR   Wikidata; Q54760989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338049; Itsn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA118
AC   CVCL_MN57
SY   RRA118
DR   MMRRC; MMRRC:001270-UCD
DR   Wikidata; Q54760990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926227; Nup160.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA119
AC   CVCL_MN58
SY   RRA119
DR   MMRRC; MMRRC:001271-UCD
DR   Wikidata; Q54760993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892003; Tcof1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA120
AC   CVCL_MN59
SY   RRA120
DR   MMRRC; MMRRC:001272-UCD
DR   Wikidata; Q54760996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916526; Sec62.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA122
AC   CVCL_MN60
SY   RRA122
DR   MMRRC; MMRRC:001273-UCD
DR   Wikidata; Q54760997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917244; Ddi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA123
AC   CVCL_MN61
SY   RRA123
DR   MMRRC; MMRRC:001274-UCD
DR   Wikidata; Q54761000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88350; Cdc25c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA124
AC   CVCL_MN62
SY   RRA124
DR   MMRRC; MMRRC:001275-UCD
DR   Wikidata; Q54761001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA128
AC   CVCL_MN63
SY   RRA128
DR   MMRRC; MMRRC:001277-UCD
DR   Wikidata; Q54761002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442483; Usp37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA129
AC   CVCL_MN64
SY   RRA129
DR   MMRRC; MMRRC:001278-UCD
DR   Wikidata; Q54761004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103296; Nfatc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA134
AC   CVCL_MN65
SY   RRA134
DR   MMRRC; MMRRC:001280-UCD
DR   Wikidata; Q54761005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA136
AC   CVCL_MN66
SY   RRA136
DR   MMRRC; MMRRC:001281-UCD
DR   Wikidata; Q54761007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140475; AU040320.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRA138
AC   CVCL_MN67
SY   RRA138
DR   MMRRC; MMRRC:001283-UCD
DR   Wikidata; Q54761009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915139; Rbm18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB001
AC   CVCL_MN68
SY   RRB001
DR   MMRRC; MMRRC:001284-UCD
DR   Wikidata; Q54761010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446126; Phf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB002
AC   CVCL_MN69
SY   RRB002
DR   MMRRC; MMRRC:001285-UCD
DR   Wikidata; Q54761013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138584; Gigyf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB003
AC   CVCL_MN70
SY   RRB003
DR   MMRRC; MMRRC:001286-UCD
DR   Wikidata; Q54761016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385884; Ddx27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB004
AC   CVCL_MN71
SY   RRB004
DR   MMRRC; MMRRC:001287-UCD
DR   Wikidata; Q54761018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104653; Atp2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB007
AC   CVCL_MN72
SY   RRB007
DR   MMRRC; MMRRC:001288-UCD
DR   Wikidata; Q54761020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930768; Arid3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB008
AC   CVCL_MN73
SY   RRB008
DR   MMRRC; MMRRC:001289-UCD
DR   Wikidata; Q54761023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925678; Pym1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB011
AC   CVCL_MN74
SY   RRB011
DR   MMRRC; MMRRC:001290-UCD
DR   Wikidata; Q54761024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB012
AC   CVCL_MN75
SY   RRB012
DR   MMRRC; MMRRC:001291-UCD
DR   Wikidata; Q54761025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB015
AC   CVCL_MN76
SY   RRB015
DR   MMRRC; MMRRC:001292-UCD
DR   Wikidata; Q54761028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336880; Eftud2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB021
AC   CVCL_MN77
SY   RRB021
DR   MMRRC; MMRRC:001293-UCD
DR   Wikidata; Q54761029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860494; Ddx21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB022
AC   CVCL_MN78
SY   RRB022
DR   MMRRC; MMRRC:001294-UCD
DR   Wikidata; Q54761030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB023
AC   CVCL_MN79
SY   RRB023
DR   MMRRC; MMRRC:001295-UCD
DR   Wikidata; Q54761032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104885; Psma2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB024
AC   CVCL_MN80
SY   RRB024
DR   MMRRC; MMRRC:001296-UCD
DR   Wikidata; Q54761065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915835; Rtn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB025
AC   CVCL_MN81
SY   RRB025
DR   MMRRC; MMRRC:001297-UCD
DR   Wikidata; Q54761066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104729; Akap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB026
AC   CVCL_MN82
SY   RRB026
DR   MMRRC; MMRRC:001298-UCD
DR   Wikidata; Q54761069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919228; Ppp2r2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB027
AC   CVCL_MN83
SY   RRB027
DR   MMRRC; MMRRC:001299-UCD
DR   Wikidata; Q54761070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB030
AC   CVCL_MN84
SY   RRB030
DR   MMRRC; MMRRC:001301-UCD
DR   Wikidata; Q54761073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387629; Tardbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB031
AC   CVCL_MN85
SY   RRB031
DR   MMRRC; MMRRC:001302-UCD
DR   Wikidata; Q54761075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB032
AC   CVCL_MN86
SY   RRB032
DR   MMRRC; MMRRC:001303-UCD
DR   Wikidata; Q54761076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB034
AC   CVCL_MN87
SY   RRB034
DR   MMRRC; MMRRC:001304-UCD
DR   Wikidata; Q54761077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922858; Chmp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB035
AC   CVCL_MN88
SY   RRB035
DR   MMRRC; MMRRC:001305-UCD
DR   Wikidata; Q54761079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929492; Atl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB037
AC   CVCL_MN89
SY   RRB037
DR   MMRRC; MMRRC:001306-UCD
DR   Wikidata; Q54761080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349766; Brd7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB038
AC   CVCL_MN90
SY   RRB038
DR   MMRRC; MMRRC:001307-UCD
DR   Wikidata; Q54761083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894323; Ranbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB043
AC   CVCL_MN91
SY   RRB043
DR   MMRRC; MMRRC:001309-UCD
DR   Wikidata; Q54761084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB044
AC   CVCL_MN92
SY   RRB044
DR   MMRRC; MMRRC:001310-UCD
DR   Wikidata; Q54761086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344352; Dido1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB046
AC   CVCL_MN93
SY   RRB046
DR   MMRRC; MMRRC:001311-UCD
DR   Wikidata; Q54761088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB047
AC   CVCL_MN94
SY   RRB047
DR   MMRRC; MMRRC:001312-UCD
DR   Wikidata; Q54761089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916966; Trip13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB048
AC   CVCL_MN95
SY   RRB048
DR   MMRRC; MMRRC:001313-UCD
DR   Wikidata; Q54761093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137670; Ybx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB049
AC   CVCL_MN96
SY   RRB049
DR   MMRRC; MMRRC:001314-UCD
DR   Wikidata; Q54761094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB050
AC   CVCL_MN97
SY   RRB050
DR   MMRRC; MMRRC:001315-UCD
DR   Wikidata; Q54761097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB051
AC   CVCL_MN98
SY   RRB051
DR   MMRRC; MMRRC:001316-UCD
DR   Wikidata; Q54761099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351652; Tbl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB053
AC   CVCL_MN99
SY   RRB053
DR   MMRRC; MMRRC:001317-UCD
DR   Wikidata; Q54761101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB055
AC   CVCL_MP00
SY   RRB055
DR   MMRRC; MMRRC:001318-UCD
DR   Wikidata; Q54761102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919725; Ssbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB057
AC   CVCL_MP01
SY   RRB057
DR   MMRRC; MMRRC:001320-UCD
DR   Wikidata; Q54761104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88251; Calm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB059
AC   CVCL_MP02
SY   RRB059
DR   MMRRC; MMRRC:001321-UCD
DR   Wikidata; Q54761107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB060
AC   CVCL_MP03
SY   RRB060
DR   MMRRC; MMRRC:001322-UCD
DR   Wikidata; Q54761108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB062
AC   CVCL_MP04
SY   RRB062
DR   MMRRC; MMRRC:001323-UCD
DR   Wikidata; Q54761111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2651932; Lcorl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB063
AC   CVCL_MP05
SY   RRB063
DR   MMRRC; MMRRC:001324-UCD
DR   Wikidata; Q54761113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB064
AC   CVCL_MP06
SY   RRB064
DR   MMRRC; MMRRC:001325-UCD
DR   Wikidata; Q54761115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108451; Acaca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB066
AC   CVCL_MP07
SY   RRB066
DR   MMRRC; MMRRC:001326-UCD
DR   Wikidata; Q54761117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344347; Synj2bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB070
AC   CVCL_MP08
SY   RRB070
DR   MMRRC; MMRRC:001327-UCD
DR   Wikidata; Q54761118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201685; Ctbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB071
AC   CVCL_MP09
SY   RRB071
DR   MMRRC; MMRRC:001328-UCD
DR   Wikidata; Q54761120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB074
AC   CVCL_MP10
SY   RRB074
DR   MMRRC; MMRRC:001329-UCD
DR   Wikidata; Q54761123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444737; Fem1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB075
AC   CVCL_MP11
SY   RRB075
DR   MMRRC; MMRRC:001330-UCD
DR   Wikidata; Q54761125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915206; Kmt5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB078
AC   CVCL_MP12
SY   RRB078
DR   MMRRC; MMRRC:001332-UCD
DR   Wikidata; Q54761126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919725; Ssbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB079
AC   CVCL_MP13
SY   RRB079
DR   MMRRC; MMRRC:001333-UCD
DR   Wikidata; Q54761129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB080
AC   CVCL_MP14
SY   RRB080
DR   MMRRC; MMRRC:001334-UCD
DR   Wikidata; Q54761131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098275; Gse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB082
AC   CVCL_MP15
SY   RRB082
DR   MMRRC; MMRRC:001335-UCD
DR   Wikidata; Q54761132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104816; Hnrnpl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB083
AC   CVCL_MP16
SY   RRB083
DR   MMRRC; MMRRC:001336-UCD
DR   Wikidata; Q54761134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924053; Zfp998.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRB087
AC   CVCL_MP17
SY   RRB087
DR   MMRRC; MMRRC:001337-UCD
DR   Wikidata; Q54761135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB094
AC   CVCL_MP18
SY   RRB094
DR   MMRRC; MMRRC:001339-UCD
DR   Wikidata; Q54761136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB095
AC   CVCL_MP19
SY   RRB095
DR   MMRRC; MMRRC:001340-UCD
DR   Wikidata; Q54761139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB096
AC   CVCL_MP20
SY   RRB096
DR   MMRRC; MMRRC:001341-UCD
DR   Wikidata; Q54761180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB097
AC   CVCL_MP21
SY   RRB097
DR   MMRRC; MMRRC:001342-UCD
DR   Wikidata; Q54761181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB098
AC   CVCL_MP22
SY   RRB098
DR   MMRRC; MMRRC:001343-UCD
DR   Wikidata; Q54761183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB102
AC   CVCL_MP23
SY   RRB102
DR   MMRRC; MMRRC:001344-UCD
DR   Wikidata; Q54761184
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2652854; Smim13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB106
AC   CVCL_MP24
SY   RRB106
DR   MMRRC; MMRRC:001345-UCD
DR   Wikidata; Q54761185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103097; Anapc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB113
AC   CVCL_MP25
SY   RRB113
DR   MMRRC; MMRRC:001346-UCD
DR   Wikidata; Q54761186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108451; Acaca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB114
AC   CVCL_MP26
SY   RRB114
DR   MMRRC; MMRRC:001347-UCD
DR   Wikidata; Q54761188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB116
AC   CVCL_MP27
SY   RRB116
DR   MMRRC; MMRRC:001348-UCD
DR   Wikidata; Q54761189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB120
AC   CVCL_MP28
SY   RRB120
DR   MMRRC; MMRRC:001350-UCD
DR   Wikidata; Q54761192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB129
AC   CVCL_MP29
SY   RRB129
DR   MMRRC; MMRRC:001352-UCD
DR   Wikidata; Q54761194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448561; Ythdc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB166
AC   CVCL_MP30
SY   RRB166
DR   MMRRC; MMRRC:001355-UCD
DR   Wikidata; Q54761195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914077; Ttc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB168
AC   CVCL_MP31
SY   RRB168
DR   MMRRC; MMRRC:001356-UCD
DR   Wikidata; Q54761199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916527; 3300002I08Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB169
AC   CVCL_MP32
SY   RRB169
DR   MMRRC; MMRRC:001357-UCD
DR   Wikidata; Q54761200
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95543; Fkbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB172
AC   CVCL_MP33
SY   RRB172
DR   MMRRC; MMRRC:001358-UCD
DR   Wikidata; Q54761202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB173
AC   CVCL_MP34
SY   RRB173
DR   MMRRC; MMRRC:001359-UCD
DR   Wikidata; Q54761204
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB182
AC   CVCL_MP35
SY   RRB182
DR   MMRRC; MMRRC:001360-UCD
DR   Wikidata; Q54761206
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB185
AC   CVCL_MP36
SY   RRB185
DR   MMRRC; MMRRC:001361-UCD
DR   Wikidata; Q54761207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRB186
AC   CVCL_MP37
SY   RRB186
DR   MMRRC; MMRRC:001362-UCD
DR   Wikidata; Q54761208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442827; Tbc1d32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC002
AC   CVCL_MP38
SY   RRC002
DR   MMRRC; MMRRC:001363-UCD
DR   Wikidata; Q54761211
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108109; Ywhag.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC004
AC   CVCL_MP39
SY   RRC004
DR   MMRRC; MMRRC:001364-UCD
DR   Wikidata; Q54761213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC005
AC   CVCL_MP40
SY   RRC005
DR   MMRRC; MMRRC:001365-UCD
DR   Wikidata; Q54761214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99208; Zfp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC009
AC   CVCL_MP41
SY   RRC009
DR   MMRRC; MMRRC:001367-UCD
DR   Wikidata; Q54761216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889206; Skap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC010
AC   CVCL_MP42
SY   RRC010
DR   MMRRC; MMRRC:001368-UCD
DR   Wikidata; Q54761218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445220; Dcaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC013
AC   CVCL_MP43
SY   RRC013
DR   MMRRC; MMRRC:001369-UCD
DR   Wikidata; Q54761220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929520; Eef1b2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC014
AC   CVCL_MP44
SY   RRC014
DR   MMRRC; MMRRC:001370-UCD
DR   Wikidata; Q54761222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC015
AC   CVCL_MP45
SY   RRC015
DR   MMRRC; MMRRC:001371-UCD
DR   Wikidata; Q54761224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104810; Plaa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC019
AC   CVCL_MP46
SY   RRC019
DR   MMRRC; MMRRC:001372-UCD
DR   Wikidata; Q54761226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96957; Mea1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC020
AC   CVCL_MP47
SY   RRC020
DR   MMRRC; MMRRC:001373-UCD
DR   Wikidata; Q54761230
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923036; Ckap5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC023
AC   CVCL_MP48
SY   RRC023
DR   MMRRC; MMRRC:001374-UCD
DR   Wikidata; Q54761232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC024
AC   CVCL_MP49
SY   RRC024
DR   MMRRC; MMRRC:001375-UCD
DR   Wikidata; Q54761234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99523; Prdx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC027
AC   CVCL_MP50
SY   RRC027
DR   MMRRC; MMRRC:001376-UCD
DR   Wikidata; Q54761235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096340; E2f3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC028
AC   CVCL_MP51
SY   RRC028
DR   MMRRC; MMRRC:001377-UCD
DR   Wikidata; Q54761236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924093; Dtl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC030
AC   CVCL_MP52
SY   RRC030
DR   MMRRC; MMRRC:001378-UCD
DR   Wikidata; Q54761239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914988; Ppid.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC031
AC   CVCL_MP53
SY   RRC031
DR   MMRRC; MMRRC:001379-UCD
DR   Wikidata; Q54761240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105037; Ddx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC032
AC   CVCL_MP54
SY   RRC032
DR   MMRRC; MMRRC:001380-UCD
DR   Wikidata; Q54761243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC036
AC   CVCL_MP55
SY   RRC036
DR   MMRRC; MMRRC:001381-UCD
DR   Wikidata; Q54761245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924093; Dtl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC037
AC   CVCL_MP56
SY   RRC037
DR   MMRRC; MMRRC:001382-UCD
DR   Wikidata; Q54761248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC040
AC   CVCL_MP57
SY   RRC040
DR   MMRRC; MMRRC:001384-UCD
DR   Wikidata; Q54761250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675859; Wapl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC043
AC   CVCL_MP58
SY   RRC043
DR   MMRRC; MMRRC:001385-UCD
DR   Wikidata; Q54761251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102774; Aimp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC044
AC   CVCL_MP59
SY   RRC044
DR   MMRRC; MMRRC:001386-UCD
DR   Wikidata; Q54761253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC045
AC   CVCL_MP60
SY   RRC045
DR   MMRRC; MMRRC:001387-UCD
DR   Wikidata; Q54761303
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923957; Clasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC047
AC   CVCL_MP61
SY   RRC047
DR   MMRRC; MMRRC:001388-UCD
DR   Wikidata; Q54761304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918413; Zfp626.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC049
AC   CVCL_MP62
SY   RRC049
DR   MMRRC; MMRRC:001390-UCD
DR   Wikidata; Q54761307
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102774; Aimp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC051
AC   CVCL_MP63
SY   RRC051
DR   MMRRC; MMRRC:001391-UCD
DR   Wikidata; Q54761309
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926129; Arid1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC052
AC   CVCL_MP64
SY   RRC052
DR   MMRRC; MMRRC:001392-UCD
DR   Wikidata; Q54761311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC053
AC   CVCL_MP65
SY   RRC053
DR   MMRRC; MMRRC:001393-UCD
DR   Wikidata; Q54761313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105056; Cobl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC055
AC   CVCL_MP66
SY   RRC055
DR   MMRRC; MMRRC:001394-UCD
DR   Wikidata; Q54761315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918413; Zfp626.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC057
AC   CVCL_MP67
SY   RRC057
DR   MMRRC; MMRRC:001395-UCD
DR   Wikidata; Q54761316
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889206; Skap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC060
AC   CVCL_MP68
SY   RRC060
DR   MMRRC; MMRRC:001396-UCD
DR   Wikidata; Q54761319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC062
AC   CVCL_MP69
SY   RRC062
DR   MMRRC; MMRRC:001397-UCD
DR   Wikidata; Q54761320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC063
AC   CVCL_MP70
SY   RRC063
DR   MMRRC; MMRRC:001398-UCD
DR   Wikidata; Q54761321
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC064
AC   CVCL_MP71
SY   RRC064
DR   MMRRC; MMRRC:001399-UCD
DR   Wikidata; Q54761323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC065
AC   CVCL_MP72
SY   RRC065
DR   MMRRC; MMRRC:001400-UCD
DR   Wikidata; Q54761325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC067
AC   CVCL_MP73
SY   RRC067
DR   MMRRC; MMRRC:001401-UCD
DR   Wikidata; Q54761326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC069
AC   CVCL_MP74
SY   RRC069
DR   MMRRC; MMRRC:001402-UCD
DR   Wikidata; Q54761328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930715; Ube2d2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC071
AC   CVCL_MP75
SY   RRC071
DR   MMRRC; MMRRC:001403-UCD
DR   Wikidata; Q54761330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920018; Topbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC076
AC   CVCL_MP76
SY   RRC076
DR   MMRRC; MMRRC:001406-UCD
DR   Wikidata; Q54761333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098687; Aak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC077
AC   CVCL_MP77
SY   RRC077
DR   MMRRC; MMRRC:001407-UCD
DR   Wikidata; Q54761335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108466; Ralbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC078
AC   CVCL_MP78
SY   RRC078
DR   MMRRC; MMRRC:001408-UCD
DR   Wikidata; Q54761337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675859; Wapl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC079
AC   CVCL_MP79
SY   RRC079
DR   MMRRC; MMRRC:001409-UCD
DR   Wikidata; Q54761339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3647985; Rpl10l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC083
AC   CVCL_MP80
SY   RRC083
DR   MMRRC; MMRRC:001410-UCD
DR   Wikidata; Q54761342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100851; Elavl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC086
AC   CVCL_MP81
SY   RRC086
DR   MMRRC; MMRRC:001412-UCD
DR   Wikidata; Q54761344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922816; Ing5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC090
AC   CVCL_MP82
SY   RRC090
DR   MMRRC; MMRRC:001413-UCD
DR   Wikidata; Q54761345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919765; Wdr43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC093
AC   CVCL_MP83
SY   RRC093
DR   MMRRC; MMRRC:001414-UCD
DR   Wikidata; Q54761346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC094
AC   CVCL_MP84
SY   RRC094
DR   MMRRC; MMRRC:001415-UCD
DR   Wikidata; Q54761347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC098
AC   CVCL_MP85
SY   RRC098
DR   MMRRC; MMRRC:001416-UCD
DR   Wikidata; Q54761348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109337; Brca2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC100
AC   CVCL_MP86
SY   RRC100
DR   MMRRC; MMRRC:001417-UCD
DR   Wikidata; Q54761350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147627; Yars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC102
AC   CVCL_MP87
SY   RRC102
DR   MMRRC; MMRRC:001418-UCD
DR   Wikidata; Q54761352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC107
AC   CVCL_MP88
SY   RRC107
DR   MMRRC; MMRRC:001420-UCD
DR   Wikidata; Q54761353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919420; Chchd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC108
AC   CVCL_MP89
SY   RRC108
DR   MMRRC; MMRRC:001421-UCD
DR   Wikidata; Q54761355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC120
AC   CVCL_MP90
SY   RRC120
DR   MMRRC; MMRRC:001423-UCD
DR   Wikidata; Q54761358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444989; Spg11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC122
AC   CVCL_MP91
SY   RRC122
DR   MMRRC; MMRRC:001424-UCD
DR   Wikidata; Q54761359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098687; Aak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC124
AC   CVCL_MP92
SY   RRC124
DR   MMRRC; MMRRC:001425-UCD
DR   Wikidata; Q54761361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914617; Paxbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC127
AC   CVCL_MP93
SY   RRC127
DR   MMRRC; MMRRC:001426-UCD
DR   Wikidata; Q54761363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98285; Srsf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC128
AC   CVCL_MP94
SY   RRC128
DR   MMRRC; MMRRC:001427-UCD
DR   Wikidata; Q54761365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC130
AC   CVCL_MP95
SY   RRC130
DR   MMRRC; MMRRC:001428-UCD
DR   Wikidata; Q54761367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443162; Uggt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC133
AC   CVCL_MP96
SY   RRC133
DR   MMRRC; MMRRC:001429-UCD
DR   Wikidata; Q54761369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC134
AC   CVCL_MP97
SY   RRC134
DR   MMRRC; MMRRC:001430-UCD
DR   Wikidata; Q54761371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923206; Srrm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC135
AC   CVCL_MP98
SY   RRC135
DR   MMRRC; MMRRC:001431-UCD
DR   Wikidata; Q54761372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925503; Map4k5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC136
AC   CVCL_MP99
SY   RRC136
DR   MMRRC; MMRRC:001432-UCD
DR   Wikidata; Q54761373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338049; Itsn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC138
AC   CVCL_MQ00
SY   RRC138
DR   MMRRC; MMRRC:001433-UCD
DR   Wikidata; Q54761415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915308; Chd1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC139
AC   CVCL_MQ01
SY   RRC139
DR   MMRRC; MMRRC:001434-UCD
DR   Wikidata; Q54761417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890218; Akap10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC142
AC   CVCL_MQ02
SY   RRC142
DR   MMRRC; MMRRC:001435-UCD
DR   Wikidata; Q54761418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC144
AC   CVCL_MQ03
SY   RRC144
DR   MMRRC; MMRRC:001436-UCD
DR   Wikidata; Q54761421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC146
AC   CVCL_MQ04
SY   RRC146
DR   MMRRC; MMRRC:001437-UCD
DR   Wikidata; Q54761422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108451; Acaca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC147
AC   CVCL_MQ05
SY   RRC147
DR   MMRRC; MMRRC:001438-UCD
DR   Wikidata; Q54761423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141969; Efl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC150
AC   CVCL_MQ06
SY   RRC150
DR   MMRRC; MMRRC:001439-UCD
DR   Wikidata; Q54761424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922387; Rprd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC152
AC   CVCL_MQ07
SY   RRC152
DR   MMRRC; MMRRC:001440-UCD
DR   Wikidata; Q54761427
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918867; Armh3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRC160
AC   CVCL_MQ08
SY   RRC160
DR   MMRRC; MMRRC:001442-UCD
DR   Wikidata; Q54761429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104897; Rest.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC161
AC   CVCL_MQ09
SY   RRC161
DR   MMRRC; MMRRC:001443-UCD
DR   Wikidata; Q54761431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927542; Pitpnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC163
AC   CVCL_MQ10
SY   RRC163
DR   MMRRC; MMRRC:001444-UCD
DR   Wikidata; Q54761432
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98388; Sptbn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC164
AC   CVCL_MQ11
SY   RRC164
DR   MMRRC; MMRRC:001445-UCD
DR   Wikidata; Q54761433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100846; Med1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC165
AC   CVCL_MQ12
SY   RRC165
DR   MMRRC; MMRRC:001446-UCD
DR   Wikidata; Q54761434
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333875; Babam2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC166
AC   CVCL_MQ13
SY   RRC166
DR   MMRRC; MMRRC:001447-UCD
DR   Wikidata; Q54761436
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC175
AC   CVCL_MQ14
SY   RRC175
DR   MMRRC; MMRRC:001450-UCD
DR   Wikidata; Q54761438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098258; Kif15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC183
AC   CVCL_MQ15
SY   RRC183
DR   MMRRC; MMRRC:001452-UCD
DR   Wikidata; Q54761440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97757; Prim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC185
AC   CVCL_MQ16
SY   RRC185
DR   MMRRC; MMRRC:001453-UCD
DR   Wikidata; Q54761442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921772; Morc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC194
AC   CVCL_MQ17
SY   RRC194
DR   MMRRC; MMRRC:001454-UCD
DR   Wikidata; Q54761443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC195
AC   CVCL_MQ18
SY   RRC195
DR   MMRRC; MMRRC:001455-UCD
DR   Wikidata; Q54761445
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277977; Ubr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC199
AC   CVCL_MQ19
SY   RRC199
DR   MMRRC; MMRRC:001456-UCD
DR   Wikidata; Q54761446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889206; Skap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC200
AC   CVCL_MQ20
SY   RRC200
DR   MMRRC; MMRRC:001457-UCD
DR   Wikidata; Q54761448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384768; Hectd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC201
AC   CVCL_MQ21
SY   RRC201
DR   MMRRC; MMRRC:001458-UCD
DR   Wikidata; Q54761451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC203
AC   CVCL_MQ22
SY   RRC203
DR   MMRRC; MMRRC:001459-UCD
DR   Wikidata; Q54761453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913762; Dera.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC205
AC   CVCL_MQ23
SY   RRC205
DR   MMRRC; MMRRC:001460-UCD
DR   Wikidata; Q54761455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC209
AC   CVCL_MQ24
SY   RRC209
DR   MMRRC; MMRRC:001461-UCD
DR   Wikidata; Q54761456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927222; Diaph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC212
AC   CVCL_MQ25
SY   RRC212
DR   MMRRC; MMRRC:001462-UCD
DR   Wikidata; Q54761457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC213
AC   CVCL_MQ26
SY   RRC213
DR   MMRRC; MMRRC:001463-UCD
DR   Wikidata; Q54761459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC216
AC   CVCL_MQ27
SY   RRC216
DR   MMRRC; MMRRC:001464-UCD
DR   Wikidata; Q54761461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915095; Rnf115.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC218
AC   CVCL_MQ28
SY   RRC218
DR   MMRRC; MMRRC:001465-UCD
DR   Wikidata; Q54761464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC221
AC   CVCL_MQ29
SY   RRC221
DR   MMRRC; MMRRC:001466-UCD
DR   Wikidata; Q54761465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC222
AC   CVCL_MQ30
SY   RRC222
DR   MMRRC; MMRRC:001467-UCD
DR   Wikidata; Q54761468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448530; Vps13d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC224
AC   CVCL_MQ31
SY   RRC224
DR   MMRRC; MMRRC:001468-UCD
DR   Wikidata; Q54761470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923215; Zdhhc20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC225
AC   CVCL_MQ32
SY   RRC225
DR   MMRRC; MMRRC:001469-UCD
DR   Wikidata; Q54761472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328310; Zc3h7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC227
AC   CVCL_MQ33
SY   RRC227
DR   MMRRC; MMRRC:001470-UCD
DR   Wikidata; Q54761475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915943; Hnrnpul2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC228
AC   CVCL_MQ34
SY   RRC228
DR   MMRRC; MMRRC:001471-UCD
DR   Wikidata; Q54761476
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3704127; Zfp808.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC229
AC   CVCL_MQ35
SY   RRC229
DR   MMRRC; MMRRC:001472-UCD
DR   Wikidata; Q54761478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153272; Trrap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC230
AC   CVCL_MQ36
SY   RRC230
DR   MMRRC; MMRRC:001473-UCD
DR   Wikidata; Q54761480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929507; Arl6ip6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC231
AC   CVCL_MQ37
SY   RRC231
DR   MMRRC; MMRRC:001474-UCD
DR   Wikidata; Q54761482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919904; Ccdc12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC235
AC   CVCL_MQ38
SY   RRC235
DR   MMRRC; MMRRC:001475-UCD
DR   Wikidata; Q54761483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443472; Atf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC236
AC   CVCL_MQ39
SY   RRC236
DR   MMRRC; MMRRC:001476-UCD
DR   Wikidata; Q54761486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104670; Fkbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC239
AC   CVCL_MQ40
SY   RRC239
DR   MMRRC; MMRRC:001477-UCD
DR   Wikidata; Q54761535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341087; Tnks.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC251
AC   CVCL_MQ41
SY   RRC251
DR   MMRRC; MMRRC:001479-UCD
DR   Wikidata; Q54761536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914265; Ccdc91.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC252
AC   CVCL_MQ42
SY   RRC252
DR   MMRRC; MMRRC:001480-UCD
DR   Wikidata; Q54761538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932915; Ndel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC256
AC   CVCL_MQ43
SY   RRC256
DR   MMRRC; MMRRC:001481-UCD
DR   Wikidata; Q54761541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC263
AC   CVCL_MQ44
SY   RRC263
DR   MMRRC; MMRRC:001482-UCD
DR   Wikidata; Q54761542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921736; Osbpl10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC266
AC   CVCL_MQ45
SY   RRC266
DR   MMRRC; MMRRC:001483-UCD
DR   Wikidata; Q54761543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289321; Mrpl48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC269
AC   CVCL_MQ46
SY   RRC269
DR   MMRRC; MMRRC:001484-UCD
DR   Wikidata; Q54761546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC272
AC   CVCL_MQ47
SY   RRC272
DR   MMRRC; MMRRC:001486-UCD
DR   Wikidata; Q54761547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC273
AC   CVCL_MQ48
SY   RRC273
DR   MMRRC; MMRRC:001487-UCD
DR   Wikidata; Q54761550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC278
AC   CVCL_MQ49
SY   RRC278
DR   MMRRC; MMRRC:001488-UCD
DR   Wikidata; Q54761554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC281
AC   CVCL_MQ50
SY   RRC281
DR   MMRRC; MMRRC:001489-UCD
DR   Wikidata; Q54761556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919318; Cnot2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC282
AC   CVCL_MQ51
SY   RRC282
DR   MMRRC; MMRRC:001490-UCD
DR   Wikidata; Q54761557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915308; Chd1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC284
AC   CVCL_MQ52
SY   RRC284
DR   MMRRC; MMRRC:001491-UCD
DR   Wikidata; Q54761560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC285
AC   CVCL_MQ53
SY   RRC285
DR   MMRRC; MMRRC:001492-UCD
DR   Wikidata; Q54761562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC290
AC   CVCL_MQ54
SY   RRC290
DR   MMRRC; MMRRC:001494-UCD
DR   Wikidata; Q54761564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88529; Cs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC291
AC   CVCL_MQ55
SY   RRC291
DR   MMRRC; MMRRC:001495-UCD
DR   Wikidata; Q54761568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443298; Tet2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC295
AC   CVCL_MQ56
SY   RRC295
DR   MMRRC; MMRRC:001496-UCD
DR   Wikidata; Q54761570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC296
AC   CVCL_MQ57
SY   RRC296
DR   MMRRC; MMRRC:001497-UCD
DR   Wikidata; Q54761573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385066; Rprd1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC297
AC   CVCL_MQ58
SY   RRC297
DR   MMRRC; MMRRC:001498-UCD
DR   Wikidata; Q54761575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRC298
AC   CVCL_MQ59
SY   RRC298
DR   MMRRC; MMRRC:001499-UCD
DR   Wikidata; Q54761577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349406; Ddx3y.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD001
AC   CVCL_MQ60
SY   RRD001
DR   MMRRC; MMRRC:001500-UCD
DR   Wikidata; Q54761580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD002
AC   CVCL_MQ61
SY   RRD002
DR   MMRRC; MMRRC:001501-UCD
DR   Wikidata; Q54761581
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929601; Ndfip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD003
AC   CVCL_MQ62
SY   RRD003
DR   MMRRC; MMRRC:001502-UCD
DR   Wikidata; Q54761582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891925; Hnrnph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD004
AC   CVCL_MQ63
SY   RRD004
DR   MMRRC; MMRRC:001503-UCD
DR   Wikidata; Q54761585
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918779; Kazn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD005
AC   CVCL_MQ64
SY   RRD005
DR   MMRRC; MMRRC:001504-UCD
DR   Wikidata; Q54761586
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933786; Dnaja3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD006
AC   CVCL_MQ65
SY   RRD006
DR   MMRRC; MMRRC:001505-UCD
DR   Wikidata; Q54761590
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446210; Kdm4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD007
AC   CVCL_MQ66
SY   RRD007
DR   MMRRC; MMRRC:001506-UCD
DR   Wikidata; Q54761591
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD008
AC   CVCL_MQ67
SY   RRD008
DR   MMRRC; MMRRC:001507-UCD
DR   Wikidata; Q54761593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD009
AC   CVCL_MQ68
SY   RRD009
DR   MMRRC; MMRRC:001508-UCD
DR   Wikidata; Q54761598
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179288; Rttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD013
AC   CVCL_MQ69
SY   RRD013
DR   MMRRC; MMRRC:001509-UCD
DR   Wikidata; Q54761599
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859026; Cnot4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD017
AC   CVCL_MQ70
SY   RRD017
DR   MMRRC; MMRRC:001510-UCD
DR   Wikidata; Q54761602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD027
AC   CVCL_MQ71
SY   RRD027
DR   MMRRC; MMRRC:001512-UCD
DR   Wikidata; Q54761603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929261; Mtch1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD029
AC   CVCL_MQ72
SY   RRD029
DR   MMRRC; MMRRC:001513-UCD
DR   Wikidata; Q54761606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444098; Heatr5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD031
AC   CVCL_MQ73
SY   RRD031
DR   MMRRC; MMRRC:001515-UCD
DR   Wikidata; Q54761608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145118; Eif2b2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD033
AC   CVCL_MQ74
SY   RRD033
DR   MMRRC; MMRRC:001516-UCD
DR   Wikidata; Q54761609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD034
AC   CVCL_MQ75
SY   RRD034
DR   MMRRC; MMRRC:001517-UCD
DR   Wikidata; Q54761610
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD035
AC   CVCL_MQ76
SY   RRD035
DR   MMRRC; MMRRC:001518-UCD
DR   Wikidata; Q54761612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196294; Fubp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD036
AC   CVCL_MQ77
SY   RRD036
DR   MMRRC; MMRRC:001519-UCD
DR   Wikidata; Q54761614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196294; Fubp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD037
AC   CVCL_MQ78
SY   RRD037
DR   MMRRC; MMRRC:001520-UCD
DR   Wikidata; Q54761615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922088; Naa15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD038
AC   CVCL_MQ79
SY   RRD038
DR   MMRRC; MMRRC:001521-UCD
DR   Wikidata; Q54761619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352757; Iqgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD042
AC   CVCL_MQ80
SY   RRD042
DR   MMRRC; MMRRC:001523-UCD
DR   Wikidata; Q54761653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926950; Zfp236.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD043
AC   CVCL_MQ81
SY   RRD043
DR   MMRRC; MMRRC:001524-UCD
DR   Wikidata; Q54761654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919204; Suds3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD046
AC   CVCL_MQ82
SY   RRD046
DR   MMRRC; MMRRC:001526-UCD
DR   Wikidata; Q54761655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104729; Akap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD048
AC   CVCL_MQ83
SY   RRD048
DR   MMRRC; MMRRC:001527-UCD
DR   Wikidata; Q54761658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD051
AC   CVCL_MQ84
SY   RRD051
DR   MMRRC; MMRRC:001528-UCD
DR   Wikidata; Q54761660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD052
AC   CVCL_MQ85
SY   RRD052
DR   MMRRC; MMRRC:001529-UCD
DR   Wikidata; Q54761663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD057
AC   CVCL_MQ86
SY   RRD057
DR   MMRRC; MMRRC:001532-UCD
DR   Wikidata; Q54761666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861733; Pcnx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD058
AC   CVCL_MQ87
SY   RRD058
DR   MMRRC; MMRRC:001533-UCD
DR   Wikidata; Q54761668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD059
AC   CVCL_MQ88
SY   RRD059
DR   MMRRC; MMRRC:001534-UCD
DR   Wikidata; Q54761669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309489; Cask.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD060
AC   CVCL_MQ89
SY   RRD060
DR   MMRRC; MMRRC:001535-UCD
DR   Wikidata; Q54761672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916334; Fam207a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD065
AC   CVCL_MQ90
SY   RRD065
DR   MMRRC; MMRRC:001536-UCD
DR   Wikidata; Q54761674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929608; Aatf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD069
AC   CVCL_MQ91
SY   RRD069
DR   MMRRC; MMRRC:001538-UCD
DR   Wikidata; Q54761676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD071
AC   CVCL_MQ92
SY   RRD071
DR   MMRRC; MMRRC:001540-UCD
DR   Wikidata; Q54761678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344352; Dido1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD072
AC   CVCL_MQ93
SY   RRD072
DR   MMRRC; MMRRC:001541-UCD
DR   Wikidata; Q54761680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD073
AC   CVCL_MQ94
SY   RRD073
DR   MMRRC; MMRRC:001542-UCD
DR   Wikidata; Q54761682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914172; Rras2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD079
AC   CVCL_MQ95
SY   RRD079
DR   MMRRC; MMRRC:001546-UCD
DR   Wikidata; Q54761684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928484; Nudt3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD080
AC   CVCL_MQ96
SY   RRD080
DR   MMRRC; MMRRC:001547-UCD
DR   Wikidata; Q54761687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD081
AC   CVCL_MQ97
SY   RRD081
DR   MMRRC; MMRRC:001548-UCD
DR   Wikidata; Q54761689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915760; Ints1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD082
AC   CVCL_MQ98
SY   RRD082
DR   MMRRC; MMRRC:001549-UCD
DR   Wikidata; Q54761690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2386741; Slc30a6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD085
AC   CVCL_MQ99
SY   RRD085
DR   MMRRC; MMRRC:001550-UCD
DR   Wikidata; Q54761693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354165; Thop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD086
AC   CVCL_MR00
SY   RRD086
DR   MMRRC; MMRRC:001551-UCD
DR   Wikidata; Q54761695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891925; Hnrnph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD087
AC   CVCL_MR01
SY   RRD087
DR   MMRRC; MMRRC:001552-UCD
DR   Wikidata; Q54761698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346035; Farsb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD088
AC   CVCL_MR02
SY   RRD088
DR   MMRRC; MMRRC:001553-UCD
DR   Wikidata; Q54761699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD089
AC   CVCL_MR03
SY   RRD089
DR   MMRRC; MMRRC:001554-UCD
DR   Wikidata; Q54761703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681865; Zfat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD090
AC   CVCL_MR04
SY   RRD090
DR   MMRRC; MMRRC:001555-UCD
DR   Wikidata; Q54761704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921358; Parn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD092
AC   CVCL_MR05
SY   RRD092
DR   MMRRC; MMRRC:001556-UCD
DR   Wikidata; Q54761706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196463; Fndc3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD093
AC   CVCL_MR06
SY   RRD093
DR   MMRRC; MMRRC:001557-UCD
DR   Wikidata; Q54761707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD099
AC   CVCL_MR07
SY   RRD099
DR   MMRRC; MMRRC:001560-UCD
DR   Wikidata; Q54761709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151152; Baz2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD100
AC   CVCL_MR08
SY   RRD100
DR   MMRRC; MMRRC:001561-UCD
DR   Wikidata; Q54761710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD101
AC   CVCL_MR09
SY   RRD101
DR   MMRRC; MMRRC:001562-UCD
DR   Wikidata; Q54761711
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88110; Atp2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD107
AC   CVCL_MR10
SY   RRD107
DR   MMRRC; MMRRC:001564-UCD
DR   Wikidata; Q54761714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181182; Nup155.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD110
AC   CVCL_MR11
SY   RRD110
DR   MMRRC; MMRRC:001567-UCD
DR   Wikidata; Q54761717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151172; Mta3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD111
AC   CVCL_MR12
SY   RRD111
DR   MMRRC; MMRRC:001568-UCD
DR   Wikidata; Q54761718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914116; Nhlrc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD112
AC   CVCL_MR13
SY   RRD112
DR   MMRRC; MMRRC:001569-UCD
DR   Wikidata; Q54761720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915760; Ints1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD113
AC   CVCL_MR14
SY   RRD113
DR   MMRRC; MMRRC:001570-UCD
DR   Wikidata; Q54761722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098687; Aak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD115
AC   CVCL_MR15
SY   RRD115
DR   MMRRC; MMRRC:001572-UCD
DR   Wikidata; Q54761724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915751; Nsmce2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD119
AC   CVCL_MR16
SY   RRD119
DR   MMRRC; MMRRC:001576-UCD
DR   Wikidata; Q54761726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107566; Kifap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD120
AC   CVCL_MR17
SY   RRD120
DR   MMRRC; MMRRC:001577-UCD
DR   Wikidata; Q54761728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD121
AC   CVCL_MR18
SY   RRD121
DR   MMRRC; MMRRC:001578-UCD
DR   Wikidata; Q54761730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442860; Eda2r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD128
AC   CVCL_MR19
SY   RRD128
DR   MMRRC; MMRRC:001581-UCD
DR   Wikidata; Q54761734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD130
AC   CVCL_MR20
SY   RRD130
DR   MMRRC; MMRRC:001582-UCD
DR   Wikidata; Q54761770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD131
AC   CVCL_MR21
SY   RRD131
DR   MMRRC; MMRRC:001583-UCD
DR   Wikidata; Q54761772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD132
AC   CVCL_MR22
SY   RRD132
DR   MMRRC; MMRRC:001584-UCD
DR   Wikidata; Q54761775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD136
AC   CVCL_MR23
SY   RRD136
DR   MMRRC; MMRRC:001586-UCD
DR   Wikidata; Q54761778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD138
AC   CVCL_MR24
SY   RRD138
DR   MMRRC; MMRRC:001587-UCD
DR   Wikidata; Q54761779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD139
AC   CVCL_MR25
SY   RRD139
DR   MMRRC; MMRRC:001588-UCD
DR   Wikidata; Q54761781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102522; Cacnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD142
AC   CVCL_MR26
SY   RRD142
DR   MMRRC; MMRRC:001589-UCD
DR   Wikidata; Q54761783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD143
AC   CVCL_MR27
SY   RRD143
DR   MMRRC; MMRRC:001590-UCD
DR   Wikidata; Q54761786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859648; Ftsj1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD144
AC   CVCL_MR28
SY   RRD144
DR   MMRRC; MMRRC:001591-UCD
DR   Wikidata; Q54761787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892973; Gpr19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD145
AC   CVCL_MR29
SY   RRD145
DR   MMRRC; MMRRC:001592-UCD
DR   Wikidata; Q54761789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3580376; Lemd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD146
AC   CVCL_MR30
SY   RRD146
DR   MMRRC; MMRRC:001593-UCD
DR   Wikidata; Q54761791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684789; Lrsam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD147
AC   CVCL_MR31
SY   RRD147
DR   MMRRC; MMRRC:001594-UCD
DR   Wikidata; Q54761794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD153
AC   CVCL_MR32
SY   RRD153
DR   MMRRC; MMRRC:001596-UCD
DR   Wikidata; Q54761796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923573; Zdhhc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD156
AC   CVCL_MR33
SY   RRD156
DR   MMRRC; MMRRC:001598-UCD
DR   Wikidata; Q54761798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858683; Copg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD158
AC   CVCL_MR34
SY   RRD158
DR   MMRRC; MMRRC:001600-UCD
DR   Wikidata; Q54761799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700014; Sorbs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD159
AC   CVCL_MR35
SY   RRD159
DR   MMRRC; MMRRC:001601-UCD
DR   Wikidata; Q54761800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD160
AC   CVCL_MR36
SY   RRD160
DR   MMRRC; MMRRC:001602-UCD
DR   Wikidata; Q54761801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101772; Snta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD161
AC   CVCL_MR37
SY   RRD161
DR   MMRRC; MMRRC:001603-UCD
DR   Wikidata; Q54761802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD163
AC   CVCL_MR38
SY   RRD163
DR   MMRRC; MMRRC:001605-UCD
DR   Wikidata; Q54761804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858965; Atf7ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD169
AC   CVCL_MR39
SY   RRD169
DR   MMRRC; MMRRC:001607-UCD
DR   Wikidata; Q54761806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448530; Vps13d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD170
AC   CVCL_MR40
SY   RRD170
DR   MMRRC; MMRRC:001608-UCD
DR   Wikidata; Q54761807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892973; Gpr19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD171
AC   CVCL_MR41
SY   RRD171
DR   MMRRC; MMRRC:001609-UCD
DR   Wikidata; Q54761810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919055; Nup93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD172
AC   CVCL_MR42
SY   RRD172
DR   MMRRC; MMRRC:001610-UCD
DR   Wikidata; Q54761812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD175
AC   CVCL_MR43
SY   RRD175
DR   MMRRC; MMRRC:001612-UCD
DR   Wikidata; Q54761814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917042; Med6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD176
AC   CVCL_MR44
SY   RRD176
DR   MMRRC; MMRRC:001613-UCD
DR   Wikidata; Q54761817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643794; Eif1ad8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRD179
AC   CVCL_MR45
SY   RRD179
DR   MMRRC; MMRRC:001616-UCD
DR   Wikidata; Q54761819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917143; Coa7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD180
AC   CVCL_MR46
SY   RRD180
DR   MMRRC; MMRRC:001617-UCD
DR   Wikidata; Q54761820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345183; Tenm3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD181
AC   CVCL_MR47
SY   RRD181
DR   MMRRC; MMRRC:001618-UCD
DR   Wikidata; Q54761821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338822; Celf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD185
AC   CVCL_MR48
SY   RRD185
DR   MMRRC; MMRRC:001620-UCD
DR   Wikidata; Q54761823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD186
AC   CVCL_MR49
SY   RRD186
DR   MMRRC; MMRRC:001621-UCD
DR   Wikidata; Q54761825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923385; Prex2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD187
AC   CVCL_MR50
SY   RRD187
DR   MMRRC; MMRRC:001622-UCD
DR   Wikidata; Q54761826
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD188
AC   CVCL_MR51
SY   RRD188
DR   MMRRC; MMRRC:001623-UCD
DR   Wikidata; Q54761829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918764; Sfpq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD189
AC   CVCL_MR52
SY   RRD189
DR   MMRRC; MMRRC:001624-UCD
DR   Wikidata; Q54761832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196365; Nus1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD190
AC   CVCL_MR53
SY   RRD190
DR   MMRRC; MMRRC:001625-UCD
DR   Wikidata; Q54761834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442555; Dis3l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD192
AC   CVCL_MR54
SY   RRD192
DR   MMRRC; MMRRC:001626-UCD
DR   Wikidata; Q54761836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922387; Rprd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD195
AC   CVCL_MR55
SY   RRD195
DR   MMRRC; MMRRC:001627-UCD
DR   Wikidata; Q54761837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921991; C2cd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD196
AC   CVCL_MR56
SY   RRD196
DR   MMRRC; MMRRC:001628-UCD
DR   Wikidata; Q54761839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918413; Zfp626.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD197
AC   CVCL_MR57
SY   RRD197
DR   MMRRC; MMRRC:001629-UCD
DR   Wikidata; Q54761840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2686040; Mtx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD201
AC   CVCL_MR58
SY   RRD201
DR   MMRRC; MMRRC:001631-UCD
DR   Wikidata; Q54761843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107532; Kpnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD204
AC   CVCL_MR59
SY   RRD204
DR   MMRRC; MMRRC:001632-UCD
DR   Wikidata; Q54761846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921991; C2cd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD205
AC   CVCL_MR60
SY   RRD205
DR   MMRRC; MMRRC:001633-UCD
DR   Wikidata; Q54761898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108247; Tdg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD212
AC   CVCL_MR61
SY   RRD212
DR   MMRRC; MMRRC:001634-UCD
DR   Wikidata; Q54761900
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914302; Ndc80.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD214
AC   CVCL_MR62
SY   RRD214
DR   MMRRC; MMRRC:001636-UCD
DR   Wikidata; Q54761902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD220
AC   CVCL_MR63
SY   RRD220
DR   MMRRC; MMRRC:001639-UCD
DR   Wikidata; Q54761904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD221
AC   CVCL_MR64
SY   RRD221
DR   MMRRC; MMRRC:001640-UCD
DR   Wikidata; Q54761905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD222
AC   CVCL_MR65
SY   RRD222
DR   MMRRC; MMRRC:001641-UCD
DR   Wikidata; Q54761907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD223
AC   CVCL_MR66
SY   RRD223
DR   MMRRC; MMRRC:001642-UCD
DR   Wikidata; Q54761909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95772; Gnai2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD228
AC   CVCL_MR67
SY   RRD228
DR   MMRRC; MMRRC:001643-UCD
DR   Wikidata; Q54761910
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913762; Dera.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD231
AC   CVCL_MR68
SY   RRD231
DR   MMRRC; MMRRC:001645-UCD
DR   Wikidata; Q54761913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108412; Plpp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD240
AC   CVCL_MR69
SY   RRD240
DR   MMRRC; MMRRC:001646-UCD
DR   Wikidata; Q54761914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104861; Bcat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD241
AC   CVCL_MR70
SY   RRD241
DR   MMRRC; MMRRC:001647-UCD
DR   Wikidata; Q54761915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD242
AC   CVCL_MR71
SY   RRD242
DR   MMRRC; MMRRC:001648-UCD
DR   Wikidata; Q54761916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD252
AC   CVCL_MR72
SY   RRD252
DR   MMRRC; MMRRC:001649-UCD
DR   Wikidata; Q54761918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104728; Caml.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD254
AC   CVCL_MR73
SY   RRD254
DR   MMRRC; MMRRC:001650-UCD
DR   Wikidata; Q54761920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914803; Gstcd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD257
AC   CVCL_MR74
SY   RRD257
DR   MMRRC; MMRRC:001651-UCD
DR   Wikidata; Q54761922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD262
AC   CVCL_MR75
SY   RRD262
DR   MMRRC; MMRRC:001654-UCD
DR   Wikidata; Q54761924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD264
AC   CVCL_MR76
SY   RRD264
DR   MMRRC; MMRRC:001655-UCD
DR   Wikidata; Q54761925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD265
AC   CVCL_MR77
SY   RRD265
DR   MMRRC; MMRRC:001656-UCD
DR   Wikidata; Q54761928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97758; Prim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD280
AC   CVCL_MR78
SY   RRD280
DR   MMRRC; MMRRC:001658-UCD
DR   Wikidata; Q54761929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928268; Ireb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD284
AC   CVCL_MR79
SY   RRD284
DR   MMRRC; MMRRC:001659-UCD
DR   Wikidata; Q54761933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96623; Itpr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD286
AC   CVCL_MR80
SY   RRD286
DR   MMRRC; MMRRC:001660-UCD
DR   Wikidata; Q54761935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD288
AC   CVCL_MR81
SY   RRD288
DR   MMRRC; MMRRC:001661-UCD
DR   Wikidata; Q54761937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97555; Pgk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD299
AC   CVCL_MR82
SY   RRD299
DR   MMRRC; MMRRC:001664-UCD
DR   Wikidata; Q54761939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD301
AC   CVCL_MR83
SY   RRD301
DR   MMRRC; MMRRC:001665-UCD
DR   Wikidata; Q54761941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922832; Relch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRD303
AC   CVCL_MR84
SY   RRD303
DR   MMRRC; MMRRC:001667-UCD
DR   Wikidata; Q54761943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107769; Zfp65.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD306
AC   CVCL_MR85
SY   RRD306
DR   MMRRC; MMRRC:001668-UCD
DR   Wikidata; Q54761944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD307
AC   CVCL_MR86
SY   RRD307
DR   MMRRC; MMRRC:001669-UCD
DR   Wikidata; Q54761947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD310
AC   CVCL_MR87
SY   RRD310
DR   MMRRC; MMRRC:001671-UCD
DR   Wikidata; Q54761948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRD312
AC   CVCL_MR88
SY   RRD312
DR   MMRRC; MMRRC:001672-UCD
DR   Wikidata; Q54761951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136782; BC004004.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE001
AC   CVCL_MR89
SY   RRE001
DR   MMRRC; MMRRC:001674-UCD
DR   Wikidata; Q54761954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329041; Rngtt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE006
AC   CVCL_MR90
SY   RRE006
DR   MMRRC; MMRRC:001677-UCD
DR   Wikidata; Q54761956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096361; Jpt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE007
AC   CVCL_MR91
SY   RRE007
DR   MMRRC; MMRRC:001678-UCD
DR   Wikidata; Q54761957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE008
AC   CVCL_MR92
SY   RRE008
DR   MMRRC; MMRRC:001679-UCD
DR   Wikidata; Q54761959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103006; Epb41l5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE012
AC   CVCL_MR93
SY   RRE012
DR   MMRRC; MMRRC:001683-UCD
DR   Wikidata; Q54761960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346861; Mapk8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE013
AC   CVCL_MR94
SY   RRE013
DR   MMRRC; MMRRC:001684-UCD
DR   Wikidata; Q54761963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888594; Icmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE014
AC   CVCL_MR95
SY   RRE014
DR   MMRRC; MMRRC:001685-UCD
DR   Wikidata; Q54761966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE016
AC   CVCL_MR96
SY   RRE016
DR   MMRRC; MMRRC:001687-UCD
DR   Wikidata; Q54761968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923206; Srrm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE017
AC   CVCL_MR97
SY   RRE017
DR   MMRRC; MMRRC:001688-UCD
DR   Wikidata; Q54761969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE018
AC   CVCL_MR98
SY   RRE018
DR   MMRRC; MMRRC:001689-UCD
DR   Wikidata; Q54761971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919654; Wdr44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE021
AC   CVCL_MR99
SY   RRE021
DR   MMRRC; MMRRC:001692-UCD
DR   Wikidata; Q54761973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE023
AC   CVCL_MS00
SY   RRE023
DR   MMRRC; MMRRC:001694-UCD
DR   Wikidata; Q54762010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914051; Prkrip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE024
AC   CVCL_MS01
SY   RRE024
DR   MMRRC; MMRRC:001695-UCD
DR   Wikidata; Q54762012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922066; Tpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE025
AC   CVCL_MS02
SY   RRE025
DR   MMRRC; MMRRC:001696-UCD
DR   Wikidata; Q54762014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103288; Polr1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE034
AC   CVCL_MS03
SY   RRE034
DR   MMRRC; MMRRC:001701-UCD
DR   Wikidata; Q54762016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917606; St13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE035
AC   CVCL_MS04
SY   RRE035
DR   MMRRC; MMRRC:001702-UCD
DR   Wikidata; Q54762017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448759; Cdv3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE038
AC   CVCL_MS05
SY   RRE038
DR   MMRRC; MMRRC:001705-UCD
DR   Wikidata; Q54762018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914915; Dctn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE040
AC   CVCL_MS06
SY   RRE040
DR   MMRRC; MMRRC:001707-UCD
DR   Wikidata; Q54762019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448759; Cdv3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE042
AC   CVCL_MS07
SY   RRE042
DR   MMRRC; MMRRC:001708-UCD
DR   Wikidata; Q54762021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444584; Mysm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE043
AC   CVCL_MS08
SY   RRE043
DR   MMRRC; MMRRC:001709-UCD
DR   Wikidata; Q54762023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926129; Arid1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE045
AC   CVCL_MS09
SY   RRE045
DR   MMRRC; MMRRC:001710-UCD
DR   Wikidata; Q54762024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918052; Pwwp2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE050
AC   CVCL_MS10
SY   RRE050
DR   MMRRC; MMRRC:001714-UCD
DR   Wikidata; Q54762025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99495; Brd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE053
AC   CVCL_MS11
SY   RRE053
DR   MMRRC; MMRRC:001716-UCD
DR   Wikidata; Q54762027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE054
AC   CVCL_MS12
SY   RRE054
DR   MMRRC; MMRRC:001717-UCD
DR   Wikidata; Q54762030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE056
AC   CVCL_MS13
SY   RRE056
DR   MMRRC; MMRRC:001719-UCD
DR   Wikidata; Q54762034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103199; Mcm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE057
AC   CVCL_MS14
SY   RRE057
DR   MMRRC; MMRRC:001720-UCD
DR   Wikidata; Q54762036
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651986; Zfp985.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE058
AC   CVCL_MS15
SY   RRE058
DR   MMRRC; MMRRC:001721-UCD
DR   Wikidata; Q54762039
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914852; Necap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE061
AC   CVCL_MS16
SY   RRE061
DR   MMRRC; MMRRC:001724-UCD
DR   Wikidata; Q54762040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917890; Dcp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE064
AC   CVCL_MS17
SY   RRE064
DR   MMRRC; MMRRC:001727-UCD
DR   Wikidata; Q54762042
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE067
AC   CVCL_MS18
SY   RRE067
DR   MMRRC; MMRRC:001728-UCD
DR   Wikidata; Q54762045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE069
AC   CVCL_MS19
SY   RRE069
DR   MMRRC; MMRRC:001729-UCD
DR   Wikidata; Q54762046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337008; Ankfy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE070
AC   CVCL_MS20
SY   RRE070
DR   MMRRC; MMRRC:001730-UCD
DR   Wikidata; Q54762048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918348; Cep170.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE071
AC   CVCL_MS21
SY   RRE071
DR   MMRRC; MMRRC:001731-UCD
DR   Wikidata; Q54762050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE072
AC   CVCL_MS22
SY   RRE072
DR   MMRRC; MMRRC:001732-UCD
DR   Wikidata; Q54762052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446159; Itpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE074
AC   CVCL_MS23
SY   RRE074
DR   MMRRC; MMRRC:001734-UCD
DR   Wikidata; Q54762053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE075
AC   CVCL_MS24
SY   RRE075
DR   MMRRC; MMRRC:001735-UCD
DR   Wikidata; Q54762055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918419; Nbas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE076
AC   CVCL_MS25
SY   RRE076
DR   MMRRC; MMRRC:001736-UCD
DR   Wikidata; Q54762057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890614; Dusp12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE078
AC   CVCL_MS26
SY   RRE078
DR   MMRRC; MMRRC:001737-UCD
DR   Wikidata; Q54762059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916625; Btbd9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE079
AC   CVCL_MS27
SY   RRE079
DR   MMRRC; MMRRC:001738-UCD
DR   Wikidata; Q54762060
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE080
AC   CVCL_MS28
SY   RRE080
DR   MMRRC; MMRRC:001739-UCD
DR   Wikidata; Q54762063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE082
AC   CVCL_MS29
SY   RRE082
DR   MMRRC; MMRRC:001741-UCD
DR   Wikidata; Q54762065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE083
AC   CVCL_MS30
SY   RRE083
DR   MMRRC; MMRRC:001742-UCD
DR   Wikidata; Q54762066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE085
AC   CVCL_MS31
SY   RRE085
DR   MMRRC; MMRRC:001743-UCD
DR   Wikidata; Q54762068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE088
AC   CVCL_MS32
SY   RRE088
DR   MMRRC; MMRRC:001745-UCD
DR   Wikidata; Q54762069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE089
AC   CVCL_MS33
SY   RRE089
DR   MMRRC; MMRRC:001746-UCD
DR   Wikidata; Q54762070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914080; Nacc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE091
AC   CVCL_MS34
SY   RRE091
DR   MMRRC; MMRRC:001747-UCD
DR   Wikidata; Q54762072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930140; Wdr6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE094
AC   CVCL_MS35
SY   RRE094
DR   MMRRC; MMRRC:001749-UCD
DR   Wikidata; Q54762074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87930; Adk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE101
AC   CVCL_MS36
SY   RRE101
DR   MMRRC; MMRRC:001753-UCD
DR   Wikidata; Q54762075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107745; Dctn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE106
AC   CVCL_MS37
SY   RRE106
DR   MMRRC; MMRRC:001757-UCD
DR   Wikidata; Q54762077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096397; Polr1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE110
AC   CVCL_MS38
SY   RRE110
DR   MMRRC; MMRRC:001759-UCD
DR   Wikidata; Q54762078
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346865; Mapk14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE111
AC   CVCL_MS39
SY   RRE111
DR   MMRRC; MMRRC:001760-UCD
DR   Wikidata; Q54762080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE112
AC   CVCL_MS40
SY   RRE112
DR   MMRRC; MMRRC:001761-UCD
DR   Wikidata; Q54762116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448759; Cdv3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE114
AC   CVCL_MS41
SY   RRE114
DR   MMRRC; MMRRC:001762-UCD
DR   Wikidata; Q54762120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916241; Ssu72.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE117
AC   CVCL_MS42
SY   RRE117
DR   MMRRC; MMRRC:001764-UCD
DR   Wikidata; Q54762122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107180; Elf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE120
AC   CVCL_MS43
SY   RRE120
DR   MMRRC; MMRRC:001766-UCD
DR   Wikidata; Q54768539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE122
AC   CVCL_MS44
SY   RRE122
DR   MMRRC; MMRRC:001768-UCD
DR   Wikidata; Q54768540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3649996; Dnmt3c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE123
AC   CVCL_MS45
SY   RRE123
DR   MMRRC; MMRRC:001769-UCD
DR   Wikidata; Q54768542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328361; Bard1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE125
AC   CVCL_MS46
SY   RRE125
DR   MMRRC; MMRRC:001771-UCD
DR   Wikidata; Q54768545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144564; Fam117a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE127
AC   CVCL_MS47
SY   RRE127
DR   MMRRC; MMRRC:001772-UCD
DR   Wikidata; Q54768546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159614; Mia2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRE131
AC   CVCL_MS48
SY   RRE131
DR   MMRRC; MMRRC:001775-UCD
DR   Wikidata; Q54768548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917933; Utp20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE133
AC   CVCL_MS49
SY   RRE133
DR   MMRRC; MMRRC:001776-UCD
DR   Wikidata; Q54768550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926135; Coro7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE137
AC   CVCL_MS50
SY   RRE137
DR   MMRRC; MMRRC:001780-UCD
DR   Wikidata; Q54768552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE142
AC   CVCL_MS51
SY   RRE142
DR   MMRRC; MMRRC:001784-UCD
DR   Wikidata; Q54768553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920977; Mcmbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE145
AC   CVCL_MS52
SY   RRE145
DR   MMRRC; MMRRC:001786-UCD
DR   Wikidata; Q54768556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE146
AC   CVCL_MS53
SY   RRE146
DR   MMRRC; MMRRC:001787-UCD
DR   Wikidata; Q54768558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103006; Epb41l5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE148
AC   CVCL_MS54
SY   RRE148
DR   MMRRC; MMRRC:001789-UCD
DR   Wikidata; Q54768560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88255; Anxa6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE150
AC   CVCL_MS55
SY   RRE150
DR   MMRRC; MMRRC:001791-UCD
DR   Wikidata; Q54768562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE153
AC   CVCL_MS56
SY   RRE153
DR   MMRRC; MMRRC:001792-UCD
DR   Wikidata; Q54768565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE156
AC   CVCL_MS57
SY   RRE156
DR   MMRRC; MMRRC:001793-UCD
DR   Wikidata; Q54768567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101357; Ece1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE161
AC   CVCL_MS58
SY   RRE161
DR   MMRRC; MMRRC:001795-UCD
DR   Wikidata; Q54768568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE172
AC   CVCL_MS59
SY   RRE172
DR   MMRRC; MMRRC:001800-UCD
DR   Wikidata; Q54768570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924053; Zfp998.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRE174
AC   CVCL_MS60
SY   RRE174
DR   MMRRC; MMRRC:001802-UCD
DR   Wikidata; Q54768572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106248; Eif5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE176
AC   CVCL_MS61
SY   RRE176
DR   MMRRC; MMRRC:001803-UCD
DR   Wikidata; Q54768573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE177
AC   CVCL_MS62
SY   RRE177
DR   MMRRC; MMRRC:001804-UCD
DR   Wikidata; Q54768574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933169; Sacm1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE179
AC   CVCL_MS63
SY   RRE179
DR   MMRRC; MMRRC:001806-UCD
DR   Wikidata; Q54768575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923046; Cdyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE185
AC   CVCL_MS64
SY   RRE185
DR   MMRRC; MMRRC:001811-UCD
DR   Wikidata; Q54768579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346870; Map2k6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE187
AC   CVCL_MS65
SY   RRE187
DR   MMRRC; MMRRC:001813-UCD
DR   Wikidata; Q54768581
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442789; Rc3h2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE188
AC   CVCL_MS66
SY   RRE188
DR   MMRRC; MMRRC:001814-UCD
DR   Wikidata; Q54768585
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE190
AC   CVCL_MS67
SY   RRE190
DR   MMRRC; MMRRC:001816-UCD
DR   Wikidata; Q54768587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384876; Cdc73.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE192
AC   CVCL_MS68
SY   RRE192
DR   MMRRC; MMRRC:001817-UCD
DR   Wikidata; Q54768588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446632; Ago2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE196
AC   CVCL_MS69
SY   RRE196
DR   MMRRC; MMRRC:001818-UCD
DR   Wikidata; Q54768589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE205
AC   CVCL_MS70
SY   RRE205
DR   MMRRC; MMRRC:001822-UCD
DR   Wikidata; Q54768594
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE206
AC   CVCL_MS71
SY   RRE206
DR   MMRRC; MMRRC:001823-UCD
DR   Wikidata; Q54768595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE213
AC   CVCL_MS72
SY   RRE213
DR   MMRRC; MMRRC:001828-UCD
DR   Wikidata; Q54768597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346865; Mapk14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE217
AC   CVCL_MS73
SY   RRE217
DR   MMRRC; MMRRC:001830-UCD
DR   Wikidata; Q54768600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918850; Ythdf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE220
AC   CVCL_MS74
SY   RRE220
DR   MMRRC; MMRRC:001832-UCD
DR   Wikidata; Q54768601
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE226
AC   CVCL_MS75
SY   RRE226
DR   MMRRC; MMRRC:001835-UCD
DR   Wikidata; Q54768605
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347359; Homer3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE227
AC   CVCL_MS76
SY   RRE227
DR   MMRRC; MMRRC:001836-UCD
DR   Wikidata; Q54768606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858260; Gosr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE228
AC   CVCL_MS77
SY   RRE228
DR   MMRRC; MMRRC:001837-UCD
DR   Wikidata; Q54768607
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE231
AC   CVCL_MS78
SY   RRE231
DR   MMRRC; MMRRC:001840-UCD
DR   Wikidata; Q54768609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109602; Gphn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE232
AC   CVCL_MS79
SY   RRE232
DR   MMRRC; MMRRC:001841-UCD
DR   Wikidata; Q54768611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448759; Cdv3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE233
AC   CVCL_MS80
SY   RRE233
DR   MMRRC; MMRRC:001842-UCD
DR   Wikidata; Q54768612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861099; Ubr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE240
AC   CVCL_MS81
SY   RRE240
DR   MMRRC; MMRRC:001848-UCD
DR   Wikidata; Q54768616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859252; Fmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE241
AC   CVCL_MS82
SY   RRE241
DR   MMRRC; MMRRC:001849-UCD
DR   Wikidata; Q54768618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145219; Iars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE247
AC   CVCL_MS83
SY   RRE247
DR   MMRRC; MMRRC:001854-UCD
DR   Wikidata; Q54768690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918272; Ston2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE248
AC   CVCL_MS84
SY   RRE248
DR   MMRRC; MMRRC:001855-UCD
DR   Wikidata; Q54768692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE249
AC   CVCL_MS85
SY   RRE249
DR   MMRRC; MMRRC:001856-UCD
DR   Wikidata; Q54768695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE250
AC   CVCL_MS86
SY   RRE250
DR   MMRRC; MMRRC:001857-UCD
DR   Wikidata; Q54768697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE255
AC   CVCL_MS87
SY   RRE255
DR   MMRRC; MMRRC:001859-UCD
DR   Wikidata; Q54768699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE261
AC   CVCL_MS88
SY   RRE261
DR   MMRRC; MMRRC:001861-UCD
DR   Wikidata; Q54768700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333811; Mbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE262
AC   CVCL_MS89
SY   RRE262
DR   MMRRC; MMRRC:001862-UCD
DR   Wikidata; Q54768703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE264
AC   CVCL_MS90
SY   RRE264
DR   MMRRC; MMRRC:001863-UCD
DR   Wikidata; Q54768704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442733; Mical3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE265
AC   CVCL_MS91
SY   RRE265
DR   MMRRC; MMRRC:001864-UCD
DR   Wikidata; Q54768706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448759; Cdv3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE267
AC   CVCL_MS92
SY   RRE267
DR   MMRRC; MMRRC:001865-UCD
DR   Wikidata; Q54768707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3645613; Platr25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE271
AC   CVCL_MS93
SY   RRE271
DR   MMRRC; MMRRC:001869-UCD
DR   Wikidata; Q54768711
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108515; Cbx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE273
AC   CVCL_MS94
SY   RRE273
DR   MMRRC; MMRRC:001871-UCD
DR   Wikidata; Q54768712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE275
AC   CVCL_MS95
SY   RRE275
DR   MMRRC; MMRRC:001873-UCD
DR   Wikidata; Q54768713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE276
AC   CVCL_MS96
SY   RRE276
DR   MMRRC; MMRRC:001874-UCD
DR   Wikidata; Q54768715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927489; Pdlim5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE284
AC   CVCL_MS97
SY   RRE284
DR   MMRRC; MMRRC:001880-UCD
DR   Wikidata; Q54768716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE286
AC   CVCL_MS98
SY   RRE286
DR   MMRRC; MMRRC:001882-UCD
DR   Wikidata; Q54768718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109404; Nup98.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE287
AC   CVCL_MS99
SY   RRE287
DR   MMRRC; MMRRC:001883-UCD
DR   Wikidata; Q54768719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197517; Limk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE297
AC   CVCL_MT00
SY   RRE297
DR   MMRRC; MMRRC:001887-UCD
DR   Wikidata; Q54768721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349635; Sec23a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE308
AC   CVCL_MT01
SY   RRE308
DR   MMRRC; MMRRC:001891-UCD
DR   Wikidata; Q54768722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344406; Ptpn21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE309
AC   CVCL_MT02
SY   RRE309
DR   MMRRC; MMRRC:001892-UCD
DR   Wikidata; Q54768724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914105; Tcf25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE310
AC   CVCL_MT03
SY   RRE310
DR   MMRRC; MMRRC:001893-UCD
DR   Wikidata; Q54768726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349410; Triobp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE311
AC   CVCL_MT04
SY   RRE311
DR   MMRRC; MMRRC:001894-UCD
DR   Wikidata; Q54768728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920995; Ubac1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE312
AC   CVCL_MT05
SY   RRE312
DR   MMRRC; MMRRC:001895-UCD
DR   Wikidata; Q54768729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387356; Ggnbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE314
AC   CVCL_MT06
SY   RRE314
DR   MMRRC; MMRRC:001897-UCD
DR   Wikidata; Q54768730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442789; Rc3h2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE320
AC   CVCL_MT07
SY   RRE320
DR   MMRRC; MMRRC:001901-UCD
DR   Wikidata; Q54768732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921807; Ppp6r3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE322
AC   CVCL_MT08
SY   RRE322
DR   MMRRC; MMRRC:001902-UCD
DR   Wikidata; Q54768734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107733; Dctn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE334
AC   CVCL_MT09
SY   RRE334
DR   MMRRC; MMRRC:001906-UCD
DR   Wikidata; Q54768735
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE337
AC   CVCL_MT10
SY   RRE337
DR   MMRRC; MMRRC:001908-UCD
DR   Wikidata; Q54768737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE340
AC   CVCL_MT11
SY   RRE340
DR   MMRRC; MMRRC:001910-UCD
DR   Wikidata; Q54768739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138811; Cdc123.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE342
AC   CVCL_MT12
SY   RRE342
DR   MMRRC; MMRRC:001911-UCD
DR   Wikidata; Q54768741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE343
AC   CVCL_MT13
SY   RRE343
DR   MMRRC; MMRRC:001912-UCD
DR   Wikidata; Q54768742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE346
AC   CVCL_MT14
SY   RRE346
DR   MMRRC; MMRRC:001914-UCD
DR   Wikidata; Q54768744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682314; Zc3h4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE370
AC   CVCL_MT15
SY   RRE370
DR   MMRRC; MMRRC:001928-UCD
DR   Wikidata; Q54768746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918779; Kazn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE373
AC   CVCL_MT16
SY   RRE373
DR   MMRRC; MMRRC:001930-UCD
DR   Wikidata; Q54768748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE374
AC   CVCL_MT17
SY   RRE374
DR   MMRRC; MMRRC:001931-UCD
DR   Wikidata; Q54768749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349406; Ddx3y.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE376
AC   CVCL_MT18
SY   RRE376
DR   MMRRC; MMRRC:001932-UCD
DR   Wikidata; Q54768751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682314; Zc3h4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRE378
AC   CVCL_MT19
SY   RRE378
DR   MMRRC; MMRRC:001933-UCD
DR   Wikidata; Q54768752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF002
AC   CVCL_MT20
SY   RRF002
DR   MMRRC; MMRRC:001934-UCD
DR   Wikidata; Q54768754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927224; Yeats4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF003
AC   CVCL_MT21
SY   RRF003
DR   MMRRC; MMRRC:001935-UCD
DR   Wikidata; Q54768755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891963; Ywhaq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF004
AC   CVCL_MT22
SY   RRF004
DR   MMRRC; MMRRC:001936-UCD
DR   Wikidata; Q54768756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355315; Tmod3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF007
AC   CVCL_MT23
SY   RRF007
DR   MMRRC; MMRRC:001937-UCD
DR   Wikidata; Q54768837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97050; Mdh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF008
AC   CVCL_MT24
SY   RRF008
DR   MMRRC; MMRRC:001938-UCD
DR   Wikidata; Q54768838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103071; Rangap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF010
AC   CVCL_MT25
SY   RRF010
DR   MMRRC; MMRRC:001939-UCD
DR   Wikidata; Q54768842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445102; Dhx33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF011
AC   CVCL_MT26
SY   RRF011
DR   MMRRC; MMRRC:001940-UCD
DR   Wikidata; Q54768844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF013
AC   CVCL_MT27
SY   RRF013
DR   MMRRC; MMRRC:001941-UCD
DR   Wikidata; Q54768847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF014
AC   CVCL_MT28
SY   RRF014
DR   MMRRC; MMRRC:001942-UCD
DR   Wikidata; Q54768848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF015
AC   CVCL_MT29
SY   RRF015
DR   MMRRC; MMRRC:001943-UCD
DR   Wikidata; Q54768850
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685541; Wdtc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF017
AC   CVCL_MT30
SY   RRF017
DR   MMRRC; MMRRC:001944-UCD
DR   Wikidata; Q54768854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891963; Ywhaq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF018
AC   CVCL_MT31
SY   RRF018
DR   MMRRC; MMRRC:001945-UCD
DR   Wikidata; Q54768855
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914295; Riok2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF020
AC   CVCL_MT32
SY   RRF020
DR   MMRRC; MMRRC:001946-UCD
DR   Wikidata; Q54768858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443483; Pdzd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF021
AC   CVCL_MT33
SY   RRF021
DR   MMRRC; MMRRC:001947-UCD
DR   Wikidata; Q54768860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919367; Naa50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF022
AC   CVCL_MT34
SY   RRF022
DR   MMRRC; MMRRC:001948-UCD
DR   Wikidata; Q54768861
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676921; Focad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF023
AC   CVCL_MT35
SY   RRF023
DR   MMRRC; MMRRC:001949-UCD
DR   Wikidata; Q54768864
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913895; Pspc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF024
AC   CVCL_MT36
SY   RRF024
DR   MMRRC; MMRRC:001950-UCD
DR   Wikidata; Q54768865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF025
AC   CVCL_MT37
SY   RRF025
DR   MMRRC; MMRRC:001951-UCD
DR   Wikidata; Q54768866
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF028
AC   CVCL_MT38
SY   RRF028
DR   MMRRC; MMRRC:001952-UCD
DR   Wikidata; Q54768867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261856; Ankle2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF029
AC   CVCL_MT39
SY   RRF029
DR   MMRRC; MMRRC:001953-UCD
DR   Wikidata; Q54768870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF031
AC   CVCL_MT40
SY   RRF031
DR   MMRRC; MMRRC:001954-UCD
DR   Wikidata; Q54768872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289172; Scyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF033
AC   CVCL_MT41
SY   RRF033
DR   MMRRC; MMRRC:001956-UCD
DR   Wikidata; Q54768873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927133; Gmfb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF034
AC   CVCL_MT42
SY   RRF034
DR   MMRRC; MMRRC:001957-UCD
DR   Wikidata; Q54768875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98351; Sod1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF035
AC   CVCL_MT43
SY   RRF035
DR   MMRRC; MMRRC:001958-UCD
DR   Wikidata; Q54768876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918771; Pds5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF037
AC   CVCL_MT44
SY   RRF037
DR   MMRRC; MMRRC:001959-UCD
DR   Wikidata; Q54768878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95286; Eed.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF038
AC   CVCL_MT45
SY   RRF038
DR   MMRRC; MMRRC:001960-UCD
DR   Wikidata; Q54768881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99511; Ptpn11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF041
AC   CVCL_MT46
SY   RRF041
DR   MMRRC; MMRRC:001962-UCD
DR   Wikidata; Q54768882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892003; Tcof1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF043
AC   CVCL_MT47
SY   RRF043
DR   MMRRC; MMRRC:001963-UCD
DR   Wikidata; Q54768884
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147319; Svil.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF047
AC   CVCL_MT48
SY   RRF047
DR   MMRRC; MMRRC:001966-UCD
DR   Wikidata; Q54768886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915268; Cert1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRF049
AC   CVCL_MT49
SY   RRF049
DR   MMRRC; MMRRC:001967-UCD
DR   Wikidata; Q54768890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96836; Lta4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF051
AC   CVCL_MT50
SY   RRF051
DR   MMRRC; MMRRC:001968-UCD
DR   Wikidata; Q54768891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF052
AC   CVCL_MT51
SY   RRF052
DR   MMRRC; MMRRC:001969-UCD
DR   Wikidata; Q54768893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF053
AC   CVCL_MT52
SY   RRF053
DR   MMRRC; MMRRC:001970-UCD
DR   Wikidata; Q54768895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914552; Zc3h13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF055
AC   CVCL_MT53
SY   RRF055
DR   MMRRC; MMRRC:001972-UCD
DR   Wikidata; Q54768898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442925; Atad5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF056
AC   CVCL_MT54
SY   RRF056
DR   MMRRC; MMRRC:001973-UCD
DR   Wikidata; Q54768900
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444236; Ubn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF058
AC   CVCL_MT55
SY   RRF058
DR   MMRRC; MMRRC:001974-UCD
DR   Wikidata; Q54768902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920274; Emc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF060
AC   CVCL_MT56
SY   RRF060
DR   MMRRC; MMRRC:001975-UCD
DR   Wikidata; Q54768903
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF061
AC   CVCL_MT57
SY   RRF061
DR   MMRRC; MMRRC:001976-UCD
DR   Wikidata; Q54768904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF064
AC   CVCL_MT58
SY   RRF064
DR   MMRRC; MMRRC:001977-UCD
DR   Wikidata; Q54768906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915545; Aar2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF067
AC   CVCL_MT59
SY   RRF067
DR   MMRRC; MMRRC:001978-UCD
DR   Wikidata; Q54768907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88393; Chd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF069
AC   CVCL_MT60
SY   RRF069
DR   MMRRC; MMRRC:001979-UCD
DR   Wikidata; Q54768909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2386251; Eif3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF070
AC   CVCL_MT61
SY   RRF070
DR   MMRRC; MMRRC:001980-UCD
DR   Wikidata; Q54768912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF071
AC   CVCL_MT62
SY   RRF071
DR   MMRRC; MMRRC:001981-UCD
DR   Wikidata; Q54768913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920428; Wasl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF072
AC   CVCL_MT63
SY   RRF072
DR   MMRRC; MMRRC:001982-UCD
DR   Wikidata; Q54768956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336214; Khsrp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF073
AC   CVCL_MT64
SY   RRF073
DR   MMRRC; MMRRC:001983-UCD
DR   Wikidata; Q54768957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332234; Zfp148.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF074
AC   CVCL_MT65
SY   RRF074
DR   MMRRC; MMRRC:001984-UCD
DR   Wikidata; Q54768959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF075
AC   CVCL_MT66
SY   RRF075
DR   MMRRC; MMRRC:001985-UCD
DR   Wikidata; Q54768962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917544; Rnf126.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF076
AC   CVCL_MT67
SY   RRF076
DR   MMRRC; MMRRC:001986-UCD
DR   Wikidata; Q54768963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914713; Poc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF077
AC   CVCL_MT68
SY   RRF077
DR   MMRRC; MMRRC:001987-UCD
DR   Wikidata; Q54768964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932404; Phip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF083
AC   CVCL_MT69
SY   RRF083
DR   MMRRC; MMRRC:001991-UCD
DR   Wikidata; Q54768965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914832; Slc25a26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF084
AC   CVCL_MT70
SY   RRF084
DR   MMRRC; MMRRC:001992-UCD
DR   Wikidata; Q54768968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914120; Serbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF085
AC   CVCL_MT71
SY   RRF085
DR   MMRRC; MMRRC:001993-UCD
DR   Wikidata; Q54768971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932404; Phip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF086
AC   CVCL_MT72
SY   RRF086
DR   MMRRC; MMRRC:001994-UCD
DR   Wikidata; Q54768973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145310; Rnf44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF088
AC   CVCL_MT73
SY   RRF088
DR   MMRRC; MMRRC:001995-UCD
DR   Wikidata; Q54768976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643133; Gm4924.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF089
AC   CVCL_MT74
SY   RRF089
DR   MMRRC; MMRRC:001996-UCD
DR   Wikidata; Q54768977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104580; Rapgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF090
AC   CVCL_MT75
SY   RRF090
DR   MMRRC; MMRRC:001997-UCD
DR   Wikidata; Q54768981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918079; Ccdc93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF091
AC   CVCL_MT76
SY   RRF091
DR   MMRRC; MMRRC:001998-UCD
DR   Wikidata; Q54768983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105968; Txlna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF093
AC   CVCL_MT77
SY   RRF093
DR   MMRRC; MMRRC:001999-UCD
DR   Wikidata; Q54768985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861100; Ubr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF094
AC   CVCL_MT78
SY   RRF094
DR   MMRRC; MMRRC:002000-UCD
DR   Wikidata; Q54768986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353653; Glrx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF096
AC   CVCL_MT79
SY   RRF096
DR   MMRRC; MMRRC:002001-UCD
DR   Wikidata; Q54768988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685106; Mideas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRF098
AC   CVCL_MT80
SY   RRF098
DR   MMRRC; MMRRC:002002-UCD
DR   Wikidata; Q54768989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914324; Mon2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF101
AC   CVCL_MT81
SY   RRF101
DR   MMRRC; MMRRC:002004-UCD
DR   Wikidata; Q54768990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915208; U2surp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF103
AC   CVCL_MT82
SY   RRF103
DR   MMRRC; MMRRC:002005-UCD
DR   Wikidata; Q54768991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384788; Sde2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF104
AC   CVCL_MT83
SY   RRF104
DR   MMRRC; MMRRC:002006-UCD
DR   Wikidata; Q54768993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109634; Terf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF106
AC   CVCL_MT84
SY   RRF106
DR   MMRRC; MMRRC:002007-UCD
DR   Wikidata; Q54768995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444268; Fam169a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF108
AC   CVCL_MT85
SY   RRF108
DR   MMRRC; MMRRC:002008-UCD
DR   Wikidata; Q54768996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861099; Ubr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF111
AC   CVCL_MT86
SY   RRF111
DR   MMRRC; MMRRC:002010-UCD
DR   Wikidata; Q54768998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384761; Rapgef6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF112
AC   CVCL_MT87
SY   RRF112
DR   MMRRC; MMRRC:002011-UCD
DR   Wikidata; Q54769000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2176740; Helq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF113
AC   CVCL_MT88
SY   RRF113
DR   MMRRC; MMRRC:002012-UCD
DR   Wikidata; Q54769002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919822; Spats2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF115
AC   CVCL_MT89
SY   RRF115
DR   MMRRC; MMRRC:002013-UCD
DR   Wikidata; Q54769004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917433; Dzip3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF116
AC   CVCL_MT90
SY   RRF116
DR   MMRRC; MMRRC:002014-UCD
DR   Wikidata; Q54769005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921373; Foxp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF117
AC   CVCL_MT91
SY   RRF117
DR   MMRRC; MMRRC:002015-UCD
DR   Wikidata; Q54769007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915208; U2surp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF118
AC   CVCL_MT92
SY   RRF118
DR   MMRRC; MMRRC:002016-UCD
DR   Wikidata; Q54769008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140230; Camta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF122
AC   CVCL_MT93
SY   RRF122
DR   MMRRC; MMRRC:002017-UCD
DR   Wikidata; Q54769010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443143; Wdr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF126
AC   CVCL_MT94
SY   RRF126
DR   MMRRC; MMRRC:002018-UCD
DR   Wikidata; Q54769014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332235; Nrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF127
AC   CVCL_MT95
SY   RRF127
DR   MMRRC; MMRRC:002019-UCD
DR   Wikidata; Q54769015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107940; Ezh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF130
AC   CVCL_MT96
SY   RRF130
DR   MMRRC; MMRRC:002021-UCD
DR   Wikidata; Q54769017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2148176; Snora65.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF131
AC   CVCL_MT97
SY   RRF131
DR   MMRRC; MMRRC:002022-UCD
DR   Wikidata; Q54769019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152345; Taf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF133
AC   CVCL_MT98
SY   RRF133
DR   MMRRC; MMRRC:002023-UCD
DR   Wikidata; Q54769020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109602; Gphn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF136
AC   CVCL_MT99
SY   RRF136
DR   MMRRC; MMRRC:002024-UCD
DR   Wikidata; Q54769021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140230; Camta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF137
AC   CVCL_MU00
SY   RRF137
DR   MMRRC; MMRRC:002025-UCD
DR   Wikidata; Q54769022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919421; Shq1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF138
AC   CVCL_MU01
SY   RRF138
DR   MMRRC; MMRRC:002026-UCD
DR   Wikidata; Q54769024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915095; Rnf115.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF139
AC   CVCL_MU02
SY   RRF139
DR   MMRRC; MMRRC:002027-UCD
DR   Wikidata; Q54769026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF140
AC   CVCL_MU03
SY   RRF140
DR   MMRRC; MMRRC:002028-UCD
DR   Wikidata; Q54769102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342005; Mthfd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF142
AC   CVCL_MU04
SY   RRF142
DR   MMRRC; MMRRC:002029-UCD
DR   Wikidata; Q54769105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3646776; Gm4779.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF146
AC   CVCL_MU05
SY   RRF146
DR   MMRRC; MMRRC:002031-UCD
DR   Wikidata; Q54769106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95281; Ect2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF152
AC   CVCL_MU06
SY   RRF152
DR   MMRRC; MMRRC:002033-UCD
DR   Wikidata; Q54769108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138391; Pid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF154
AC   CVCL_MU07
SY   RRF154
DR   MMRRC; MMRRC:002034-UCD
DR   Wikidata; Q54769110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108076; Frrs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF155
AC   CVCL_MU08
SY   RRF155
DR   MMRRC; MMRRC:002035-UCD
DR   Wikidata; Q54769112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF156
AC   CVCL_MU09
SY   RRF156
DR   MMRRC; MMRRC:002036-UCD
DR   Wikidata; Q54769115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914105; Tcf25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF162
AC   CVCL_MU10
SY   RRF162
DR   MMRRC; MMRRC:002040-UCD
DR   Wikidata; Q54769116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF163
AC   CVCL_MU11
SY   RRF163
DR   MMRRC; MMRRC:002041-UCD
DR   Wikidata; Q54769119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682952; Prdm10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF166
AC   CVCL_MU12
SY   RRF166
DR   MMRRC; MMRRC:002043-UCD
DR   Wikidata; Q54769120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95301; Eif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF167
AC   CVCL_MU13
SY   RRF167
DR   MMRRC; MMRRC:002044-UCD
DR   Wikidata; Q54769122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915984; Ppp4r3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF169
AC   CVCL_MU14
SY   RRF169
DR   MMRRC; MMRRC:002046-UCD
DR   Wikidata; Q54769124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF171
AC   CVCL_MU15
SY   RRF171
DR   MMRRC; MMRRC:002048-UCD
DR   Wikidata; Q54769127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341087; Tnks.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF173
AC   CVCL_MU16
SY   RRF173
DR   MMRRC; MMRRC:002049-UCD
DR   Wikidata; Q54769129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102774; Aimp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF174
AC   CVCL_MU17
SY   RRF174
DR   MMRRC; MMRRC:002050-UCD
DR   Wikidata; Q54769130
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860513; Fnbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF175
AC   CVCL_MU18
SY   RRF175
DR   MMRRC; MMRRC:002051-UCD
DR   Wikidata; Q54769131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF177
AC   CVCL_MU19
SY   RRF177
DR   MMRRC; MMRRC:002052-UCD
DR   Wikidata; Q54769133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913874; Spcs2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF180
AC   CVCL_MU20
SY   RRF180
DR   MMRRC; MMRRC:002055-UCD
DR   Wikidata; Q54769135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928899; Tacc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF181
AC   CVCL_MU21
SY   RRF181
DR   MMRRC; MMRRC:002056-UCD
DR   Wikidata; Q54769137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1340806; Parp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF184
AC   CVCL_MU22
SY   RRF184
DR   MMRRC; MMRRC:002057-UCD
DR   Wikidata; Q54769138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153272; Trrap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF186
AC   CVCL_MU23
SY   RRF186
DR   MMRRC; MMRRC:002058-UCD
DR   Wikidata; Q54769140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894292; Mtr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF187
AC   CVCL_MU24
SY   RRF187
DR   MMRRC; MMRRC:002059-UCD
DR   Wikidata; Q54769143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643401; Gm8935.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF188
AC   CVCL_MU25
SY   RRF188
DR   MMRRC; MMRRC:002060-UCD
DR   Wikidata; Q54769145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918335; Arhgap19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF189
AC   CVCL_MU26
SY   RRF189
DR   MMRRC; MMRRC:002061-UCD
DR   Wikidata; Q54769147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919353; Aplf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF190
AC   CVCL_MU27
SY   RRF190
DR   MMRRC; MMRRC:002062-UCD
DR   Wikidata; Q54769149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353654; Vps26a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF194
AC   CVCL_MU28
SY   RRF194
DR   MMRRC; MMRRC:002064-UCD
DR   Wikidata; Q54769150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104558; Rps6ka1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF197
AC   CVCL_MU29
SY   RRF197
DR   MMRRC; MMRRC:002065-UCD
DR   Wikidata; Q54769152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF200
AC   CVCL_MU30
SY   RRF200
DR   MMRRC; MMRRC:002066-UCD
DR   Wikidata; Q54769155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109547; Dnm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF202
AC   CVCL_MU31
SY   RRF202
DR   MMRRC; MMRRC:002068-UCD
DR   Wikidata; Q54769156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915023; Kat8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF203
AC   CVCL_MU32
SY   RRF203
DR   MMRRC; MMRRC:002069-UCD
DR   Wikidata; Q54769158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333889; Bub1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF204
AC   CVCL_MU33
SY   RRF204
DR   MMRRC; MMRRC:002070-UCD
DR   Wikidata; Q54769161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442377; Ipo11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF205
AC   CVCL_MU34
SY   RRF205
DR   MMRRC; MMRRC:002071-UCD
DR   Wikidata; Q54769162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103574; Amph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF208
AC   CVCL_MU35
SY   RRF208
DR   MMRRC; MMRRC:002074-UCD
DR   Wikidata; Q54769164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347360; Cul3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF209
AC   CVCL_MU36
SY   RRF209
DR   MMRRC; MMRRC:002075-UCD
DR   Wikidata; Q54769167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928760; Ruvbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF210
AC   CVCL_MU37
SY   RRF210
DR   MMRRC; MMRRC:002076-UCD
DR   Wikidata; Q54769168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF211
AC   CVCL_MU38
SY   RRF211
DR   MMRRC; MMRRC:002077-UCD
DR   Wikidata; Q54769170
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF212
AC   CVCL_MU39
SY   RRF212
DR   MMRRC; MMRRC:002078-UCD
DR   Wikidata; Q54769174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913882; Dph6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF214
AC   CVCL_MU40
SY   RRF214
DR   MMRRC; MMRRC:002079-UCD
DR   Wikidata; Q54769175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352465; Nr2c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF215
AC   CVCL_MU41
SY   RRF215
DR   MMRRC; MMRRC:002080-UCD
DR   Wikidata; Q54769177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF217
AC   CVCL_MU42
SY   RRF217
DR   MMRRC; MMRRC:002081-UCD
DR   Wikidata; Q54769179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF218
AC   CVCL_MU43
SY   RRF218
DR   MMRRC; MMRRC:002082-UCD
DR   Wikidata; Q54769222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337994; Bcl10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF220
AC   CVCL_MU44
SY   RRF220
DR   MMRRC; MMRRC:002084-UCD
DR   Wikidata; Q54769223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344361; Arih2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF222
AC   CVCL_MU45
SY   RRF222
DR   MMRRC; MMRRC:002085-UCD
DR   Wikidata; Q54769226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF228
AC   CVCL_MU46
SY   RRF228
DR   MMRRC; MMRRC:002088-UCD
DR   Wikidata; Q54769227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139220; Tm9sf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF229
AC   CVCL_MU47
SY   RRF229
DR   MMRRC; MMRRC:002089-UCD
DR   Wikidata; Q54769229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098275; Gse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF231
AC   CVCL_MU48
SY   RRF231
DR   MMRRC; MMRRC:002091-UCD
DR   Wikidata; Q54769231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918419; Nbas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF233
AC   CVCL_MU49
SY   RRF233
DR   MMRRC; MMRRC:002093-UCD
DR   Wikidata; Q54769232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921446; Ttc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF235
AC   CVCL_MU50
SY   RRF235
DR   MMRRC; MMRRC:002095-UCD
DR   Wikidata; Q54769234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916618; Wdfy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF239
AC   CVCL_MU51
SY   RRF239
DR   MMRRC; MMRRC:002097-UCD
DR   Wikidata; Q54769236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446089; Flnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF241
AC   CVCL_MU52
SY   RRF241
DR   MMRRC; MMRRC:002098-UCD
DR   Wikidata; Q54769239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF242
AC   CVCL_MU53
SY   RRF242
DR   MMRRC; MMRRC:002099-UCD
DR   Wikidata; Q54769241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF245
AC   CVCL_MU54
SY   RRF245
DR   MMRRC; MMRRC:002101-UCD
DR   Wikidata; Q54769243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337041; Serf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF248
AC   CVCL_MU55
SY   RRF248
DR   MMRRC; MMRRC:002103-UCD
DR   Wikidata; Q54769245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096342; Rhoa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF251
AC   CVCL_MU56
SY   RRF251
DR   MMRRC; MMRRC:002105-UCD
DR   Wikidata; Q54769246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683584; Ttc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF253
AC   CVCL_MU57
SY   RRF253
DR   MMRRC; MMRRC:002106-UCD
DR   Wikidata; Q54769248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151013; Erc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF254
AC   CVCL_MU58
SY   RRF254
DR   MMRRC; MMRRC:002107-UCD
DR   Wikidata; Q54769251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444188; Dgkh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF255
AC   CVCL_MU59
SY   RRF255
DR   MMRRC; MMRRC:002108-UCD
DR   Wikidata; Q54769254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913732; Exoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF256
AC   CVCL_MU60
SY   RRF256
DR   MMRRC; MMRRC:002109-UCD
DR   Wikidata; Q54769256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889008; Atp2c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF262
AC   CVCL_MU61
SY   RRF262
DR   MMRRC; MMRRC:002111-UCD
DR   Wikidata; Q54769258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF264
AC   CVCL_MU62
SY   RRF264
DR   MMRRC; MMRRC:002112-UCD
DR   Wikidata; Q54769262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442782; Baz2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF265
AC   CVCL_MU63
SY   RRF265
DR   MMRRC; MMRRC:002113-UCD
DR   Wikidata; Q54769264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441849; Lpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF266
AC   CVCL_MU64
SY   RRF266
DR   MMRRC; MMRRC:002114-UCD
DR   Wikidata; Q54769266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2177178; Dicer1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF267
AC   CVCL_MU65
SY   RRF267
DR   MMRRC; MMRRC:002115-UCD
DR   Wikidata; Q54769267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107634; Larp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF268
AC   CVCL_MU66
SY   RRF268
DR   MMRRC; MMRRC:002116-UCD
DR   Wikidata; Q54769269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913835; Snrnp40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF269
AC   CVCL_MU67
SY   RRF269
DR   MMRRC; MMRRC:002117-UCD
DR   Wikidata; Q54769272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861601; Cpsf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF270
AC   CVCL_MU68
SY   RRF270
DR   MMRRC; MMRRC:002118-UCD
DR   Wikidata; Q54769274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF276
AC   CVCL_MU69
SY   RRF276
DR   MMRRC; MMRRC:002119-UCD
DR   Wikidata; Q54769275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444777; Ncaph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF277
AC   CVCL_MU70
SY   RRF277
DR   MMRRC; MMRRC:002120-UCD
DR   Wikidata; Q54769276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107978; Klc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF278
AC   CVCL_MU71
SY   RRF278
DR   MMRRC; MMRRC:002121-UCD
DR   Wikidata; Q54769277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107978; Klc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF280
AC   CVCL_MU72
SY   RRF280
DR   MMRRC; MMRRC:002123-UCD
DR   Wikidata; Q54769278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF282
AC   CVCL_MU73
SY   RRF282
DR   MMRRC; MMRRC:002125-UCD
DR   Wikidata; Q54769280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036247; Lmtk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF284
AC   CVCL_MU74
SY   RRF284
DR   MMRRC; MMRRC:002126-UCD
DR   Wikidata; Q54769281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF291
AC   CVCL_MU75
SY   RRF291
DR   MMRRC; MMRRC:002129-UCD
DR   Wikidata; Q54769283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858216; Ube2k.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF294
AC   CVCL_MU76
SY   RRF294
DR   MMRRC; MMRRC:002130-UCD
DR   Wikidata; Q54769285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107440; Cep131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF295
AC   CVCL_MU77
SY   RRF295
DR   MMRRC; MMRRC:002131-UCD
DR   Wikidata; Q54769286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF296
AC   CVCL_MU78
SY   RRF296
DR   MMRRC; MMRRC:002132-UCD
DR   Wikidata; Q54769288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890430; Paxip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF299
AC   CVCL_MU79
SY   RRF299
DR   MMRRC; MMRRC:002133-UCD
DR   Wikidata; Q54769289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441717; Eno4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF305
AC   CVCL_MU80
SY   RRF305
DR   MMRRC; MMRRC:002136-UCD
DR   Wikidata; Q54769294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444812; Camkk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF307
AC   CVCL_MU81
SY   RRF307
DR   MMRRC; MMRRC:002137-UCD
DR   Wikidata; Q54769295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915201; Tubb6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF308
AC   CVCL_MU82
SY   RRF308
DR   MMRRC; MMRRC:002138-UCD
DR   Wikidata; Q54769298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147538; Btaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF309
AC   CVCL_MU83
SY   RRF309
DR   MMRRC; MMRRC:002139-UCD
DR   Wikidata; Q54769337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858216; Ube2k.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF312
AC   CVCL_MU84
SY   RRF312
DR   MMRRC; MMRRC:002140-UCD
DR   Wikidata; Q54769340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107186; Cct2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF315
AC   CVCL_MU85
SY   RRF315
DR   MMRRC; MMRRC:002141-UCD
DR   Wikidata; Q54769341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919060; Ranbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF319
AC   CVCL_MU86
SY   RRF319
DR   MMRRC; MMRRC:002142-UCD
DR   Wikidata; Q54769344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99257; Eif3e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF322
AC   CVCL_MU87
SY   RRF322
DR   MMRRC; MMRRC:002143-UCD
DR   Wikidata; Q54769346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448475; Fchsd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF324
AC   CVCL_MU88
SY   RRF324
DR   MMRRC; MMRRC:002144-UCD
DR   Wikidata; Q54769347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919834; Cul4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF328
AC   CVCL_MU89
SY   RRF328
DR   MMRRC; MMRRC:002147-UCD
DR   Wikidata; Q54769349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916340; Ascc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF334
AC   CVCL_MU90
SY   RRF334
DR   MMRRC; MMRRC:002150-UCD
DR   Wikidata; Q54769350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF338
AC   CVCL_MU91
SY   RRF338
DR   MMRRC; MMRRC:002151-UCD
DR   Wikidata; Q54769352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915545; Aar2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF339
AC   CVCL_MU92
SY   RRF339
DR   MMRRC; MMRRC:002152-UCD
DR   Wikidata; Q54769354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919668; Thoc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF342
AC   CVCL_MU93
SY   RRF342
DR   MMRRC; MMRRC:002153-UCD
DR   Wikidata; Q54769356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97758; Prim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF343
AC   CVCL_MU94
SY   RRF343
DR   MMRRC; MMRRC:002154-UCD
DR   Wikidata; Q54769359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151013; Erc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF345
AC   CVCL_MU95
SY   RRF345
DR   MMRRC; MMRRC:002155-UCD
DR   Wikidata; Q54769360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346345; Map2k5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF351
AC   CVCL_MU96
SY   RRF351
DR   MMRRC; MMRRC:002158-UCD
DR   Wikidata; Q54769361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109602; Gphn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF352
AC   CVCL_MU97
SY   RRF352
DR   MMRRC; MMRRC:002159-UCD
DR   Wikidata; Q54769365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF355
AC   CVCL_MU98
SY   RRF355
DR   MMRRC; MMRRC:002160-UCD
DR   Wikidata; Q54769366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145890; Ano6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF357
AC   CVCL_MU99
SY   RRF357
DR   MMRRC; MMRRC:002161-UCD
DR   Wikidata; Q54769367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861601; Cpsf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF358
AC   CVCL_MV00
SY   RRF358
DR   MMRRC; MMRRC:002162-UCD
DR   Wikidata; Q54769369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891692; Hnrnpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF360
AC   CVCL_MV01
SY   RRF360
DR   MMRRC; MMRRC:002163-UCD
DR   Wikidata; Q54769372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915512; Agpat4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF362
AC   CVCL_MV02
SY   RRF362
DR   MMRRC; MMRRC:002164-UCD
DR   Wikidata; Q54769373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178836; Tubgcp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF365
AC   CVCL_MV03
SY   RRF365
DR   MMRRC; MMRRC:002166-UCD
DR   Wikidata; Q54769374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141847; Phrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF367
AC   CVCL_MV04
SY   RRF367
DR   MMRRC; MMRRC:002167-UCD
DR   Wikidata; Q54769375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF370
AC   CVCL_MV05
SY   RRF370
DR   MMRRC; MMRRC:002168-UCD
DR   Wikidata; Q54769377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681124; Urb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF371
AC   CVCL_MV06
SY   RRF371
DR   MMRRC; MMRRC:002169-UCD
DR   Wikidata; Q54769378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917262; Cep85.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF372
AC   CVCL_MV07
SY   RRF372
DR   MMRRC; MMRRC:002170-UCD
DR   Wikidata; Q54769380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146388; Ubxn7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF373
AC   CVCL_MV08
SY   RRF373
DR   MMRRC; MMRRC:002171-UCD
DR   Wikidata; Q54769383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894659; Hbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF374
AC   CVCL_MV09
SY   RRF374
DR   MMRRC; MMRRC:002172-UCD
DR   Wikidata; Q54769384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107708; Ss18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF375
AC   CVCL_MV10
SY   RRF375
DR   MMRRC; MMRRC:002173-UCD
DR   Wikidata; Q54769385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915984; Ppp4r3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF379
AC   CVCL_MV11
SY   RRF379
DR   MMRRC; MMRRC:002175-UCD
DR   Wikidata; Q54769388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108028; Atr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF380
AC   CVCL_MV12
SY   RRF380
DR   MMRRC; MMRRC:002176-UCD
DR   Wikidata; Q54769390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921599; Fhip1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRF381
AC   CVCL_MV13
SY   RRF381
DR   MMRRC; MMRRC:002177-UCD
DR   Wikidata; Q54769392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF382
AC   CVCL_MV14
SY   RRF382
DR   MMRRC; MMRRC:002178-UCD
DR   Wikidata; Q54769394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923809; Atg2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF387
AC   CVCL_MV15
SY   RRF387
DR   MMRRC; MMRRC:002180-UCD
DR   Wikidata; Q54769398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347045; Psmb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF388
AC   CVCL_MV16
SY   RRF388
DR   MMRRC; MMRRC:002181-UCD
DR   Wikidata; Q54769399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109211; Pkn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF390
AC   CVCL_MV17
SY   RRF390
DR   MMRRC; MMRRC:002183-UCD
DR   Wikidata; Q54769401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096327; Axin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF391
AC   CVCL_MV18
SY   RRF391
DR   MMRRC; MMRRC:002184-UCD
DR   Wikidata; Q54769403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF395
AC   CVCL_MV19
SY   RRF395
DR   MMRRC; MMRRC:002185-UCD
DR   Wikidata; Q54769404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036254; Dennd2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF397
AC   CVCL_MV20
SY   RRF397
DR   MMRRC; MMRRC:002186-UCD
DR   Wikidata; Q54769407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99197; Zbtb25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF400
AC   CVCL_MV21
SY   RRF400
DR   MMRRC; MMRRC:002187-UCD
DR   Wikidata; Q54769409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921736; Osbpl10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF401
AC   CVCL_MV22
SY   RRF401
DR   MMRRC; MMRRC:002188-UCD
DR   Wikidata; Q54769411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353448; Eif2ak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF402
AC   CVCL_MV23
SY   RRF402
DR   MMRRC; MMRRC:002189-UCD
DR   Wikidata; Q54769455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF403
AC   CVCL_MV24
SY   RRF403
DR   MMRRC; MMRRC:002190-UCD
DR   Wikidata; Q54769457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921728; Snx29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF405
AC   CVCL_MV25
SY   RRF405
DR   MMRRC; MMRRC:002191-UCD
DR   Wikidata; Q54769459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98179; Rras.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF410
AC   CVCL_MV26
SY   RRF410
DR   MMRRC; MMRRC:002192-UCD
DR   Wikidata; Q54769462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298366; Atf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF416
AC   CVCL_MV27
SY   RRF416
DR   MMRRC; MMRRC:002194-UCD
DR   Wikidata; Q54769464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140230; Camta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF426
AC   CVCL_MV28
SY   RRF426
DR   MMRRC; MMRRC:002197-UCD
DR   Wikidata; Q54769466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145422; AW209491.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF427
AC   CVCL_MV29
SY   RRF427
DR   MMRRC; MMRRC:002198-UCD
DR   Wikidata; Q54769467
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1350328; Ofd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF431
AC   CVCL_MV30
SY   RRF431
DR   MMRRC; MMRRC:002200-UCD
DR   Wikidata; Q54769471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442888; Uhrf1bp1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF432
AC   CVCL_MV31
SY   RRF432
DR   MMRRC; MMRRC:002201-UCD
DR   Wikidata; Q54769472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109352; Ung.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF437
AC   CVCL_MV32
SY   RRF437
DR   MMRRC; MMRRC:002203-UCD
DR   Wikidata; Q54769475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447812; Dennd1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF440
AC   CVCL_MV33
SY   RRF440
DR   MMRRC; MMRRC:002204-UCD
DR   Wikidata; Q54769478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF444
AC   CVCL_MV34
SY   RRF444
DR   MMRRC; MMRRC:002205-UCD
DR   Wikidata; Q54769479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915512; Agpat4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF459
AC   CVCL_MV35
SY   RRF459
DR   MMRRC; MMRRC:002212-UCD
DR   Wikidata; Q54769482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109490; Sms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF462
AC   CVCL_MV36
SY   RRF462
DR   MMRRC; MMRRC:002213-UCD
DR   Wikidata; Q54769483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442988; Arfgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF463
AC   CVCL_MV37
SY   RRF463
DR   MMRRC; MMRRC:002214-UCD
DR   Wikidata; Q54769485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352757; Iqgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF465
AC   CVCL_MV38
SY   RRF465
DR   MMRRC; MMRRC:002215-UCD
DR   Wikidata; Q54769487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF466
AC   CVCL_MV39
SY   RRF466
DR   MMRRC; MMRRC:002216-UCD
DR   Wikidata; Q54769488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF467
AC   CVCL_MV40
SY   RRF467
DR   MMRRC; MMRRC:002217-UCD
DR   Wikidata; Q54769490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921569; Mettl23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF470
AC   CVCL_MV41
SY   RRF470
DR   MMRRC; MMRRC:002219-UCD
DR   Wikidata; Q54769492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921565; Rnf145.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF471
AC   CVCL_MV42
SY   RRF471
DR   MMRRC; MMRRC:002220-UCD
DR   Wikidata; Q54769493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF474
AC   CVCL_MV43
SY   RRF474
DR   MMRRC; MMRRC:002221-UCD
DR   Wikidata; Q54769495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289341; Sf3b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF478
AC   CVCL_MV44
SY   RRF478
DR   MMRRC; MMRRC:002222-UCD
DR   Wikidata; Q54769498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF480
AC   CVCL_MV45
SY   RRF480
DR   MMRRC; MMRRC:002224-UCD
DR   Wikidata; Q54769499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924234; Katnal2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF486
AC   CVCL_MV46
SY   RRF486
DR   MMRRC; MMRRC:002225-UCD
DR   Wikidata; Q54769500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891833; Pfkp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF489
AC   CVCL_MV47
SY   RRF489
DR   MMRRC; MMRRC:002226-UCD
DR   Wikidata; Q54769502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681523; Tnpo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF492
AC   CVCL_MV48
SY   RRF492
DR   MMRRC; MMRRC:002227-UCD
DR   Wikidata; Q54769506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF496
AC   CVCL_MV49
SY   RRF496
DR   MMRRC; MMRRC:002229-UCD
DR   Wikidata; Q54769508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106915; Vdac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF507
AC   CVCL_MV50
SY   RRF507
DR   MMRRC; MMRRC:002232-UCD
DR   Wikidata; Q54769509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445019; Pik3c3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF509
AC   CVCL_MV51
SY   RRF509
DR   MMRRC; MMRRC:002233-UCD
DR   Wikidata; Q54769513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101769; Mcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF510
AC   CVCL_MV52
SY   RRF510
DR   MMRRC; MMRRC:002234-UCD
DR   Wikidata; Q54769514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096397; Polr1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF511
AC   CVCL_MV53
SY   RRF511
DR   MMRRC; MMRRC:002235-UCD
DR   Wikidata; Q54769515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921831; Sbf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF512
AC   CVCL_MV54
SY   RRF512
DR   MMRRC; MMRRC:002236-UCD
DR   Wikidata; Q54769517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF515
AC   CVCL_MV55
SY   RRF515
DR   MMRRC; MMRRC:002238-UCD
DR   Wikidata; Q54769519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107793; Crmp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF516
AC   CVCL_MV56
SY   RRF516
DR   MMRRC; MMRRC:002239-UCD
DR   Wikidata; Q54769520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98105; Rps12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF517
AC   CVCL_MV57
SY   RRF517
DR   MMRRC; MMRRC:002240-UCD
DR   Wikidata; Q54769522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444777; Ncaph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF521
AC   CVCL_MV58
SY   RRF521
DR   MMRRC; MMRRC:002242-UCD
DR   Wikidata; Q54769524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921493; Slx4ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF529
AC   CVCL_MV59
SY   RRF529
DR   MMRRC; MMRRC:002244-UCD
DR   Wikidata; Q54769526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681523; Tnpo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF531
AC   CVCL_MV60
SY   RRF531
DR   MMRRC; MMRRC:002245-UCD
DR   Wikidata; Q54769527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917758; Bbx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF532
AC   CVCL_MV61
SY   RRF532
DR   MMRRC; MMRRC:002246-UCD
DR   Wikidata; Q54769531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146189; Topors.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF537
AC   CVCL_MV62
SY   RRF537
DR   MMRRC; MMRRC:002247-UCD
DR   Wikidata; Q54769533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916177; Ptcd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF540
AC   CVCL_MV63
SY   RRF540
DR   MMRRC; MMRRC:002248-UCD
DR   Wikidata; Q54769640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918839; Slc38a9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF547
AC   CVCL_MV64
SY   RRF547
DR   MMRRC; MMRRC:002251-UCD
DR   Wikidata; Q54769642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334460; Bop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF550
AC   CVCL_MV65
SY   RRF550
DR   MMRRC; MMRRC:002252-UCD
DR   Wikidata; Q54769644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100818; Crcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF551
AC   CVCL_MV66
SY   RRF551
DR   MMRRC; MMRRC:002253-UCD
DR   Wikidata; Q54769646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914544; Elp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRF552
AC   CVCL_MV67
SY   RRF552
DR   MMRRC; MMRRC:002254-UCD
DR   Wikidata; Q54769649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRF562
AC   CVCL_MV68
SY   RRF562
DR   MMRRC; MMRRC:002257-UCD
DR   Wikidata; Q54769650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146565; Nsun3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG003
AC   CVCL_MV69
SY   RRG003
DR   MMRRC; MMRRC:002261-UCD
DR   Wikidata; Q54769652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103234; Herc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG004
AC   CVCL_MV70
SY   RRG004
DR   MMRRC; MMRRC:002262-UCD
DR   Wikidata; Q54769654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG008
AC   CVCL_MV71
SY   RRG008
DR   MMRRC; MMRRC:002263-UCD
DR   Wikidata; Q54769656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429950; Xpo6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG011
AC   CVCL_MV72
SY   RRG011
DR   MMRRC; MMRRC:002264-UCD
DR   Wikidata; Q54769658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG012
AC   CVCL_MV73
SY   RRG012
DR   MMRRC; MMRRC:002265-UCD
DR   Wikidata; Q54769660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442637; Thrap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG017
AC   CVCL_MV74
SY   RRG017
DR   MMRRC; MMRRC:002266-UCD
DR   Wikidata; Q54769661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG027
AC   CVCL_MV75
SY   RRG027
DR   MMRRC; MMRRC:002270-UCD
DR   Wikidata; Q54769663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913787; Pomp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG028
AC   CVCL_MV76
SY   RRG028
DR   MMRRC; MMRRC:002271-UCD
DR   Wikidata; Q54769667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313302; Cenpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG030
AC   CVCL_MV77
SY   RRG030
DR   MMRRC; MMRRC:002272-UCD
DR   Wikidata; Q54769668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG032
AC   CVCL_MV78
SY   RRG032
DR   MMRRC; MMRRC:002273-UCD
DR   Wikidata; Q54769671
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG033
AC   CVCL_MV79
SY   RRG033
DR   MMRRC; MMRRC:002274-UCD
DR   Wikidata; Q54769675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920136; Yju2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRG036
AC   CVCL_MV80
SY   RRG036
DR   MMRRC; MMRRC:002276-UCD
DR   Wikidata; Q54769676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG037
AC   CVCL_MV81
SY   RRG037
DR   MMRRC; MMRRC:002277-UCD
DR   Wikidata; Q54769679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917278; Dop1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRG038
AC   CVCL_MV82
SY   RRG038
DR   MMRRC; MMRRC:002278-UCD
DR   Wikidata; Q54769680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913929; Rae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG041
AC   CVCL_MV83
SY   RRG041
DR   MMRRC; MMRRC:002279-UCD
DR   Wikidata; Q54769684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298390; Swap70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG042
AC   CVCL_MV84
SY   RRG042
DR   MMRRC; MMRRC:002280-UCD
DR   Wikidata; Q54769685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96163; Hmox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG049
AC   CVCL_MV85
SY   RRG049
DR   MMRRC; MMRRC:002281-UCD
DR   Wikidata; Q54769687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151839; Mreg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG051
AC   CVCL_MV86
SY   RRG051
DR   MMRRC; MMRRC:002282-UCD
DR   Wikidata; Q54769690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384924; Ccm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG053
AC   CVCL_MV87
SY   RRG053
DR   MMRRC; MMRRC:002283-UCD
DR   Wikidata; Q54769692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329014; Stam.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG056
AC   CVCL_MV88
SY   RRG056
DR   MMRRC; MMRRC:002284-UCD
DR   Wikidata; Q54769694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353557; Schip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG059
AC   CVCL_MV89
SY   RRG059
DR   MMRRC; MMRRC:002285-UCD
DR   Wikidata; Q54769696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG070
AC   CVCL_MV90
SY   RRG070
DR   MMRRC; MMRRC:002290-UCD
DR   Wikidata; Q54769698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923164; Exoc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG071
AC   CVCL_MV91
SY   RRG071
DR   MMRRC; MMRRC:002291-UCD
DR   Wikidata; Q54769702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931237; Wwox.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG073
AC   CVCL_MV92
SY   RRG073
DR   MMRRC; MMRRC:002292-UCD
DR   Wikidata; Q54769704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429950; Xpo6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG074
AC   CVCL_MV93
SY   RRG074
DR   MMRRC; MMRRC:002293-UCD
DR   Wikidata; Q54769707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277113; Pacs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG100
AC   CVCL_MV94
SY   RRG100
DR   MMRRC; MMRRC:002299-UCD
DR   Wikidata; Q54769709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG112
AC   CVCL_MV95
SY   RRG112
DR   MMRRC; MMRRC:002302-UCD
DR   Wikidata; Q54769710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97838; Eprs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG117
AC   CVCL_MV96
SY   RRG117
DR   MMRRC; MMRRC:002304-UCD
DR   Wikidata; Q54769713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG118
AC   CVCL_MV97
SY   RRG118
DR   MMRRC; MMRRC:002305-UCD
DR   Wikidata; Q54769716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445040; Tyw3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG124
AC   CVCL_MV98
SY   RRG124
DR   MMRRC; MMRRC:002306-UCD
DR   Wikidata; Q54769717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142048; Rnf40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG126
AC   CVCL_MV99
SY   RRG126
DR   MMRRC; MMRRC:002307-UCD
DR   Wikidata; Q54769720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643019; Gm6360.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG127
AC   CVCL_MW00
SY   RRG127
DR   MMRRC; MMRRC:002308-UCD
DR   Wikidata; Q54769721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106463; Washc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG129
AC   CVCL_MW01
SY   RRG129
DR   MMRRC; MMRRC:002310-UCD
DR   Wikidata; Q54769723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG131
AC   CVCL_MW02
SY   RRG131
DR   MMRRC; MMRRC:002311-UCD
DR   Wikidata; Q54769726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109447; Ctcf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG133
AC   CVCL_MW03
SY   RRG133
DR   MMRRC; MMRRC:002313-UCD
DR   Wikidata; Q54769823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442456; Unk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG134
AC   CVCL_MW04
SY   RRG134
DR   MMRRC; MMRRC:002314-UCD
DR   Wikidata; Q54769824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG135
AC   CVCL_MW05
SY   RRG135
DR   MMRRC; MMRRC:002315-UCD
DR   Wikidata; Q54769825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147376; AW554918.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG138
AC   CVCL_MW06
SY   RRG138
DR   MMRRC; MMRRC:002316-UCD
DR   Wikidata; Q54769827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG140
AC   CVCL_MW07
SY   RRG140
DR   MMRRC; MMRRC:002317-UCD
DR   Wikidata; Q54769828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG142
AC   CVCL_MW08
SY   RRG142
DR   MMRRC; MMRRC:002318-UCD
DR   Wikidata; Q54769829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684063; Asxl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG143
AC   CVCL_MW09
SY   RRG143
DR   MMRRC; MMRRC:002319-UCD
DR   Wikidata; Q54769831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG147
AC   CVCL_MW10
SY   RRG147
DR   MMRRC; MMRRC:002321-UCD
DR   Wikidata; Q54769832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109447; Ctcf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG151
AC   CVCL_MW11
SY   RRG151
DR   MMRRC; MMRRC:002322-UCD
DR   Wikidata; Q54769834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643019; Gm6360.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG157
AC   CVCL_MW12
SY   RRG157
DR   MMRRC; MMRRC:002324-UCD
DR   Wikidata; Q54769837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914934; Luc7l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG158
AC   CVCL_MW13
SY   RRG158
DR   MMRRC; MMRRC:002325-UCD
DR   Wikidata; Q54769838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153608; Ube2j2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG159
AC   CVCL_MW14
SY   RRG159
DR   MMRRC; MMRRC:002326-UCD
DR   Wikidata; Q54769841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101877; Tcf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG163
AC   CVCL_MW15
SY   RRG163
DR   MMRRC; MMRRC:002327-UCD
DR   Wikidata; Q54769844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150019; Spred2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG166
AC   CVCL_MW16
SY   RRG166
DR   MMRRC; MMRRC:002328-UCD
DR   Wikidata; Q54769845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG168
AC   CVCL_MW17
SY   RRG168
DR   MMRRC; MMRRC:002329-UCD
DR   Wikidata; Q54769847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG169
AC   CVCL_MW18
SY   RRG169
DR   MMRRC; MMRRC:002330-UCD
DR   Wikidata; Q54769850
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913929; Rae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG171
AC   CVCL_MW19
SY   RRG171
DR   MMRRC; MMRRC:002331-UCD
DR   Wikidata; Q54769852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150019; Spred2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG173
AC   CVCL_MW20
SY   RRG173
DR   MMRRC; MMRRC:002332-UCD
DR   Wikidata; Q54769854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG176
AC   CVCL_MW21
SY   RRG176
DR   MMRRC; MMRRC:002333-UCD
DR   Wikidata; Q54769858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313302; Cenpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG177
AC   CVCL_MW22
SY   RRG177
DR   MMRRC; MMRRC:002334-UCD
DR   Wikidata; Q54769861
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159210; Tiparp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG179
AC   CVCL_MW23
SY   RRG179
DR   MMRRC; MMRRC:002336-UCD
DR   Wikidata; Q54769863
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG184
AC   CVCL_MW24
SY   RRG184
DR   MMRRC; MMRRC:002337-UCD
DR   Wikidata; Q54769864
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344336; Fiz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG185
AC   CVCL_MW25
SY   RRG185
DR   MMRRC; MMRRC:002338-UCD
DR   Wikidata; Q54769868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914705; Klhl13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG188
AC   CVCL_MW26
SY   RRG188
DR   MMRRC; MMRRC:002339-UCD
DR   Wikidata; Q54769869
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344336; Fiz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG193
AC   CVCL_MW27
SY   RRG193
DR   MMRRC; MMRRC:002341-UCD
DR   Wikidata; Q54769871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921772; Morc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG195
AC   CVCL_MW28
SY   RRG195
DR   MMRRC; MMRRC:002342-UCD
DR   Wikidata; Q54769873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923959; Arpc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG197
AC   CVCL_MW29
SY   RRG197
DR   MMRRC; MMRRC:002343-UCD
DR   Wikidata; Q54769874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443876; Zbtb11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG198
AC   CVCL_MW30
SY   RRG198
DR   MMRRC; MMRRC:002344-UCD
DR   Wikidata; Q54769876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921772; Morc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG204
AC   CVCL_MW31
SY   RRG204
DR   MMRRC; MMRRC:002346-UCD
DR   Wikidata; Q54769877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG205
AC   CVCL_MW32
SY   RRG205
DR   MMRRC; MMRRC:002347-UCD
DR   Wikidata; Q54769879
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448541; Caprin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG207
AC   CVCL_MW33
SY   RRG207
DR   MMRRC; MMRRC:002348-UCD
DR   Wikidata; Q54769881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108498; Nbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG209
AC   CVCL_MW34
SY   RRG209
DR   MMRRC; MMRRC:002350-UCD
DR   Wikidata; Q54769883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG216
AC   CVCL_MW35
SY   RRG216
DR   MMRRC; MMRRC:002351-UCD
DR   Wikidata; Q54769884
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429950; Xpo6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG217
AC   CVCL_MW36
SY   RRG217
DR   MMRRC; MMRRC:002352-UCD
DR   Wikidata; Q54769887
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG220
AC   CVCL_MW37
SY   RRG220
DR   MMRRC; MMRRC:002354-UCD
DR   Wikidata; Q54769888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928268; Ireb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG221
AC   CVCL_MW38
SY   RRG221
DR   MMRRC; MMRRC:002355-UCD
DR   Wikidata; Q54769889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG222
AC   CVCL_MW39
SY   RRG222
DR   MMRRC; MMRRC:002356-UCD
DR   Wikidata; Q54769891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924258; Ppp1r12c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG223
AC   CVCL_MW40
SY   RRG223
DR   MMRRC; MMRRC:002357-UCD
DR   Wikidata; Q54769893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924841; Ddx10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG248
AC   CVCL_MW41
SY   RRG248
DR   MMRRC; MMRRC:002358-UCD
DR   Wikidata; Q54769895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG250
AC   CVCL_MW42
SY   RRG250
DR   MMRRC; MMRRC:002359-UCD
DR   Wikidata; Q54769896
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924894; Steep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRG252
AC   CVCL_MW43
SY   RRG252
DR   MMRRC; MMRRC:002360-UCD
DR   Wikidata; Q54769979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106014; Nudc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG255
AC   CVCL_MW44
SY   RRG255
DR   MMRRC; MMRRC:002362-UCD
DR   Wikidata; Q54769981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG257
AC   CVCL_MW45
SY   RRG257
DR   MMRRC; MMRRC:002363-UCD
DR   Wikidata; Q54769983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG259
AC   CVCL_MW46
SY   RRG259
DR   MMRRC; MMRRC:002365-UCD
DR   Wikidata; Q54769985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG260
AC   CVCL_MW47
SY   RRG260
DR   MMRRC; MMRRC:002366-UCD
DR   Wikidata; Q54769986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG262
AC   CVCL_MW48
SY   RRG262
DR   MMRRC; MMRRC:002367-UCD
DR   Wikidata; Q54769988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG269
AC   CVCL_MW49
SY   RRG269
DR   MMRRC; MMRRC:002369-UCD
DR   Wikidata; Q54769989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891150; Styx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG284
AC   CVCL_MW50
SY   RRG284
DR   MMRRC; MMRRC:002372-UCD
DR   Wikidata; Q54769992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918817; Mcm9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG285
AC   CVCL_MW51
SY   RRG285
DR   MMRRC; MMRRC:002373-UCD
DR   Wikidata; Q54769994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388481; Ppp2r5d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG292
AC   CVCL_MW52
SY   RRG292
DR   MMRRC; MMRRC:002374-UCD
DR   Wikidata; Q54769996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107470; Lyar.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG305
AC   CVCL_MW53
SY   RRG305
DR   MMRRC; MMRRC:002375-UCD
DR   Wikidata; Q54769997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141207; Kctd10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG306
AC   CVCL_MW54
SY   RRG306
DR   MMRRC; MMRRC:002376-UCD
DR   Wikidata; Q54769998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG308
AC   CVCL_MW55
SY   RRG308
DR   MMRRC; MMRRC:002377-UCD
DR   Wikidata; Q54770000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG309
AC   CVCL_MW56
SY   RRG309
DR   MMRRC; MMRRC:002378-UCD
DR   Wikidata; Q54770002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442760; Katnip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRG314
AC   CVCL_MW57
SY   RRG314
DR   MMRRC; MMRRC:002379-UCD
DR   Wikidata; Q54770004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2148252; Zfp979.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG316
AC   CVCL_MW58
SY   RRG316
DR   MMRRC; MMRRC:002380-UCD
DR   Wikidata; Q54770006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG319
AC   CVCL_MW59
SY   RRG319
DR   MMRRC; MMRRC:002381-UCD
DR   Wikidata; Q54770007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG328
AC   CVCL_MW60
SY   RRG328
DR   MMRRC; MMRRC:002383-UCD
DR   Wikidata; Q54770009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151839; Mreg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG329
AC   CVCL_MW61
SY   RRG329
DR   MMRRC; MMRRC:002384-UCD
DR   Wikidata; Q54770012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142048; Rnf40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG332
AC   CVCL_MW62
SY   RRG332
DR   MMRRC; MMRRC:002386-UCD
DR   Wikidata; Q54770014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG337
AC   CVCL_MW63
SY   RRG337
DR   MMRRC; MMRRC:002388-UCD
DR   Wikidata; Q54770016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338871; Btrc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG347
AC   CVCL_MW64
SY   RRG347
DR   MMRRC; MMRRC:002390-UCD
DR   Wikidata; Q54770017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344336; Fiz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG348
AC   CVCL_MW65
SY   RRG348
DR   MMRRC; MMRRC:002391-UCD
DR   Wikidata; Q54770020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143994; Psme4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG352
AC   CVCL_MW66
SY   RRG352
DR   MMRRC; MMRRC:002393-UCD
DR   Wikidata; Q54770021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG354
AC   CVCL_MW67
SY   RRG354
DR   MMRRC; MMRRC:002394-UCD
DR   Wikidata; Q54770023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG356
AC   CVCL_MW68
SY   RRG356
DR   MMRRC; MMRRC:002395-UCD
DR   Wikidata; Q54770027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG360
AC   CVCL_MW69
SY   RRG360
DR   MMRRC; MMRRC:002396-UCD
DR   Wikidata; Q54770028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444121; Tanc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG361
AC   CVCL_MW70
SY   RRG361
DR   MMRRC; MMRRC:002397-UCD
DR   Wikidata; Q54770029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313302; Cenpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG363
AC   CVCL_MW71
SY   RRG363
DR   MMRRC; MMRRC:002398-UCD
DR   Wikidata; Q54770032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918954; Arhgef3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG364
AC   CVCL_MW72
SY   RRG364
DR   MMRRC; MMRRC:002399-UCD
DR   Wikidata; Q54770035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684986; Asap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG366
AC   CVCL_MW73
SY   RRG366
DR   MMRRC; MMRRC:002401-UCD
DR   Wikidata; Q54770037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194506; Serpini1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG371
AC   CVCL_MW74
SY   RRG371
DR   MMRRC; MMRRC:002402-UCD
DR   Wikidata; Q54770038
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384864; BC002059.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG381
AC   CVCL_MW75
SY   RRG381
DR   MMRRC; MMRRC:002405-UCD
DR   Wikidata; Q54770041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443623; Raver2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG387
AC   CVCL_MW76
SY   RRG387
DR   MMRRC; MMRRC:002407-UCD
DR   Wikidata; Q54770043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923760; Trappc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG392
AC   CVCL_MW77
SY   RRG392
DR   MMRRC; MMRRC:002408-UCD
DR   Wikidata; Q54770046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670983; BC025920.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG396
AC   CVCL_MW78
SY   RRG396
DR   MMRRC; MMRRC:002410-UCD
DR   Wikidata; Q54770048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352508; Stau2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG397
AC   CVCL_MW79
SY   RRG397
DR   MMRRC; MMRRC:002411-UCD
DR   Wikidata; Q54770049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG398
AC   CVCL_MW80
SY   RRG398
DR   MMRRC; MMRRC:002412-UCD
DR   Wikidata; Q54770051
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG399
AC   CVCL_MW81
SY   RRG399
DR   MMRRC; MMRRC:002413-UCD
DR   Wikidata; Q54770052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG403
AC   CVCL_MW82
SY   RRG403
DR   MMRRC; MMRRC:002415-UCD
DR   Wikidata; Q54770053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG405
AC   CVCL_MW83
SY   RRG405
DR   MMRRC; MMRRC:002416-UCD
DR   Wikidata; Q54770090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932286; Egln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG406
AC   CVCL_MW84
SY   RRG406
DR   MMRRC; MMRRC:002417-UCD
DR   Wikidata; Q54770094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922250; Stk38l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG407
AC   CVCL_MW85
SY   RRG407
DR   MMRRC; MMRRC:002418-UCD
DR   Wikidata; Q54770096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351655; Shroom3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG409
AC   CVCL_MW86
SY   RRG409
DR   MMRRC; MMRRC:002419-UCD
DR   Wikidata; Q54770098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG410
AC   CVCL_MW87
SY   RRG410
DR   MMRRC; MMRRC:002420-UCD
DR   Wikidata; Q54770099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643019; Gm6360.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG412
AC   CVCL_MW88
SY   RRG412
DR   MMRRC; MMRRC:002421-UCD
DR   Wikidata; Q54770101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277143; Gtf2h3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG422
AC   CVCL_MW89
SY   RRG422
DR   MMRRC; MMRRC:002424-UCD
DR   Wikidata; Q54770103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87930; Adk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG427
AC   CVCL_MW90
SY   RRG427
DR   MMRRC; MMRRC:002425-UCD
DR   Wikidata; Q54770106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927617; Dhx38.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG432
AC   CVCL_MW91
SY   RRG432
DR   MMRRC; MMRRC:002426-UCD
DR   Wikidata; Q54770108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922989; Mpp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG435
AC   CVCL_MW92
SY   RRG435
DR   MMRRC; MMRRC:002428-UCD
DR   Wikidata; Q54770111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRG454
AC   CVCL_MW93
SY   RRG454
DR   MMRRC; MMRRC:002432-UCD
DR   Wikidata; Q54770112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915301; Nutf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH008
AC   CVCL_MW94
SY   RRH008
DR   MMRRC; MMRRC:002435-UCD
DR   Wikidata; Q54770115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152345; Taf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH010
AC   CVCL_MW95
SY   RRH010
DR   MMRRC; MMRRC:002437-UCD
DR   Wikidata; Q54770116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914384; Nop56.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH012
AC   CVCL_MW96
SY   RRH012
DR   MMRRC; MMRRC:002438-UCD
DR   Wikidata; Q54770118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338041; Tfg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH013
AC   CVCL_MW97
SY   RRH013
DR   MMRRC; MMRRC:002439-UCD
DR   Wikidata; Q54770119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919815; Uaca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH017
AC   CVCL_MW98
SY   RRH017
DR   MMRRC; MMRRC:002440-UCD
DR   Wikidata; Q54770121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277162; Cdk6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH021
AC   CVCL_MW99
SY   RRH021
DR   MMRRC; MMRRC:002443-UCD
DR   Wikidata; Q54770123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH025
AC   CVCL_MX00
SY   RRH025
DR   MMRRC; MMRRC:002446-UCD
DR   Wikidata; Q54770126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH027
AC   CVCL_MX01
SY   RRH027
DR   MMRRC; MMRRC:002447-UCD
DR   Wikidata; Q54770129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95298; Eif1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH028
AC   CVCL_MX02
SY   RRH028
DR   MMRRC; MMRRC:002448-UCD
DR   Wikidata; Q54770131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685397; Rc3h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH029
AC   CVCL_MX03
SY   RRH029
DR   MMRRC; MMRRC:002449-UCD
DR   Wikidata; Q54770132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098280; Crebbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH031
AC   CVCL_MX04
SY   RRH031
DR   MMRRC; MMRRC:002450-UCD
DR   Wikidata; Q54770133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261910; Pibf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH032
AC   CVCL_MX05
SY   RRH032
DR   MMRRC; MMRRC:002451-UCD
DR   Wikidata; Q54770137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309480; Rtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH037
AC   CVCL_MX06
SY   RRH037
DR   MMRRC; MMRRC:002454-UCD
DR   Wikidata; Q54770138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137336; Baiap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH040
AC   CVCL_MX07
SY   RRH040
DR   MMRRC; MMRRC:002455-UCD
DR   Wikidata; Q54770140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915403; Gtf2e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH047
AC   CVCL_MX08
SY   RRH047
DR   MMRRC; MMRRC:002456-UCD
DR   Wikidata; Q54770142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2148019; Jade3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH048
AC   CVCL_MX09
SY   RRH048
DR   MMRRC; MMRRC:002457-UCD
DR   Wikidata; Q54770144
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921642; Specc1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH049
AC   CVCL_MX10
SY   RRH049
DR   MMRRC; MMRRC:002458-UCD
DR   Wikidata; Q54770146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914451; Glod4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH050
AC   CVCL_MX11
SY   RRH050
DR   MMRRC; MMRRC:002459-UCD
DR   Wikidata; Q54770148
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926045; Armc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH053
AC   CVCL_MX12
SY   RRH053
DR   MMRRC; MMRRC:002460-UCD
DR   Wikidata; Q54770152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH054
AC   CVCL_MX13
SY   RRH054
DR   MMRRC; MMRRC:002461-UCD
DR   Wikidata; Q54770153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349473; Ppp2r5e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH055
AC   CVCL_MX14
SY   RRH055
DR   MMRRC; MMRRC:002462-UCD
DR   Wikidata; Q54770156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99690; Pola2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH059
AC   CVCL_MX15
SY   RRH059
DR   MMRRC; MMRRC:002463-UCD
DR   Wikidata; Q54770157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933972; Tra2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH060
AC   CVCL_MX16
SY   RRH060
DR   MMRRC; MMRRC:002464-UCD
DR   Wikidata; Q54770158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277960; Patj.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH061
AC   CVCL_MX17
SY   RRH061
DR   MMRRC; MMRRC:002465-UCD
DR   Wikidata; Q54770160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105081; Tes.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH062
AC   CVCL_MX18
SY   RRH062
DR   MMRRC; MMRRC:002466-UCD
DR   Wikidata; Q54770161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442153; Gak.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH063
AC   CVCL_MX19
SY   RRH063
DR   MMRRC; MMRRC:002467-UCD
DR   Wikidata; Q54770163
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928760; Ruvbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH065
AC   CVCL_MX20
SY   RRH065
DR   MMRRC; MMRRC:002469-UCD
DR   Wikidata; Q54770166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914792; Cog6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH068
AC   CVCL_MX21
SY   RRH068
DR   MMRRC; MMRRC:002470-UCD
DR   Wikidata; Q54770169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353557; Schip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH069
AC   CVCL_MX22
SY   RRH069
DR   MMRRC; MMRRC:002471-UCD
DR   Wikidata; Q54770170
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353557; Schip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH070
AC   CVCL_MX23
SY   RRH070
DR   MMRRC; MMRRC:002472-UCD
DR   Wikidata; Q54770216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH079
AC   CVCL_MX24
SY   RRH079
DR   MMRRC; MMRRC:002475-UCD
DR   Wikidata; Q54770218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914632; Brd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH080
AC   CVCL_MX25
SY   RRH080
DR   MMRRC; MMRRC:002476-UCD
DR   Wikidata; Q54770219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935145; Mllt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH082
AC   CVCL_MX26
SY   RRH082
DR   MMRRC; MMRRC:002477-UCD
DR   Wikidata; Q54770221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921493; Slx4ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH084
AC   CVCL_MX27
SY   RRH084
DR   MMRRC; MMRRC:002478-UCD
DR   Wikidata; Q54770222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915670; Ankrd13a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH099
AC   CVCL_MX28
SY   RRH099
DR   MMRRC; MMRRC:002479-UCD
DR   Wikidata; Q54770223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99463; Pigh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH102
AC   CVCL_MX29
SY   RRH102
DR   MMRRC; MMRRC:002480-UCD
DR   Wikidata; Q54770225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH119
AC   CVCL_MX30
SY   RRH119
DR   MMRRC; MMRRC:002486-UCD
DR   Wikidata; Q54770226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106203; Skil.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH128
AC   CVCL_MX31
SY   RRH128
DR   MMRRC; MMRRC:002488-UCD
DR   Wikidata; Q54770228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203522; Magi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH131
AC   CVCL_MX32
SY   RRH131
DR   MMRRC; MMRRC:002489-UCD
DR   Wikidata; Q54770231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH136
AC   CVCL_MX33
SY   RRH136
DR   MMRRC; MMRRC:002490-UCD
DR   Wikidata; Q54770233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916658; Dnajc17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH138
AC   CVCL_MX34
SY   RRH138
DR   MMRRC; MMRRC:002491-UCD
DR   Wikidata; Q54770234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917822; Ipo5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH141
AC   CVCL_MX35
SY   RRH141
DR   MMRRC; MMRRC:002492-UCD
DR   Wikidata; Q54770235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH143
AC   CVCL_MX36
SY   RRH143
DR   MMRRC; MMRRC:002493-UCD
DR   Wikidata; Q54770238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3781595; Dynlt2a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRH145
AC   CVCL_MX37
SY   RRH145
DR   MMRRC; MMRRC:002494-UCD
DR   Wikidata; Q54770239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH146
AC   CVCL_MX38
SY   RRH146
DR   MMRRC; MMRRC:002495-UCD
DR   Wikidata; Q54770240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141161; Tyw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH147
AC   CVCL_MX39
SY   RRH147
DR   MMRRC; MMRRC:002496-UCD
DR   Wikidata; Q54770244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098240; Kif16b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH148
AC   CVCL_MX40
SY   RRH148
DR   MMRRC; MMRRC:002497-UCD
DR   Wikidata; Q54770246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH150
AC   CVCL_MX41
SY   RRH150
DR   MMRRC; MMRRC:002498-UCD
DR   Wikidata; Q54770250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH152
AC   CVCL_MX42
SY   RRH152
DR   MMRRC; MMRRC:002499-UCD
DR   Wikidata; Q54770252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915867; Mtcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH154
AC   CVCL_MX43
SY   RRH154
DR   MMRRC; MMRRC:002500-UCD
DR   Wikidata; Q54770255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH156
AC   CVCL_MX44
SY   RRH156
DR   MMRRC; MMRRC:002502-UCD
DR   Wikidata; Q54770257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3697726; Arhgap23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH158
AC   CVCL_MX45
SY   RRH158
DR   MMRRC; MMRRC:002503-UCD
DR   Wikidata; Q54770259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855695; Clasrp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH159
AC   CVCL_MX46
SY   RRH159
DR   MMRRC; MMRRC:002504-UCD
DR   Wikidata; Q54770260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351613; Txnl4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH161
AC   CVCL_MX47
SY   RRH161
DR   MMRRC; MMRRC:002505-UCD
DR   Wikidata; Q54770262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH162
AC   CVCL_MX48
SY   RRH162
DR   MMRRC; MMRRC:002506-UCD
DR   Wikidata; Q54770265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146430; Cblb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH165
AC   CVCL_MX49
SY   RRH165
DR   MMRRC; MMRRC:002507-UCD
DR   Wikidata; Q54770267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385071; Etf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH166
AC   CVCL_MX50
SY   RRH166
DR   MMRRC; MMRRC:002508-UCD
DR   Wikidata; Q54770269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH173
AC   CVCL_MX51
SY   RRH173
DR   MMRRC; MMRRC:002511-UCD
DR   Wikidata; Q54770271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923827; Faf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH176
AC   CVCL_MX52
SY   RRH176
DR   MMRRC; MMRRC:002513-UCD
DR   Wikidata; Q54770272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916023; Zc3hc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH184
AC   CVCL_MX53
SY   RRH184
DR   MMRRC; MMRRC:002517-UCD
DR   Wikidata; Q54770273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921357; Cep55.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH186
AC   CVCL_MX54
SY   RRH186
DR   MMRRC; MMRRC:002518-UCD
DR   Wikidata; Q54770274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915301; Nutf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH187
AC   CVCL_MX55
SY   RRH187
DR   MMRRC; MMRRC:002519-UCD
DR   Wikidata; Q54770277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890222; Midn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH188
AC   CVCL_MX56
SY   RRH188
DR   MMRRC; MMRRC:002520-UCD
DR   Wikidata; Q54770279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682307; Ric8b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH189
AC   CVCL_MX57
SY   RRH189
DR   MMRRC; MMRRC:002521-UCD
DR   Wikidata; Q54770280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH194
AC   CVCL_MX58
SY   RRH194
DR   MMRRC; MMRRC:002524-UCD
DR   Wikidata; Q54770281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH195
AC   CVCL_MX59
SY   RRH195
DR   MMRRC; MMRRC:002525-UCD
DR   Wikidata; Q54770283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH199
AC   CVCL_MX60
SY   RRH199
DR   MMRRC; MMRRC:002526-UCD
DR   Wikidata; Q54770285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87930; Adk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH203
AC   CVCL_MX61
SY   RRH203
DR   MMRRC; MMRRC:002527-UCD
DR   Wikidata; Q54770287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2148019; Jade3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH204
AC   CVCL_MX62
SY   RRH204
DR   MMRRC; MMRRC:002528-UCD
DR   Wikidata; Q54770288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675859; Wapl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH205
AC   CVCL_MX63
SY   RRH205
DR   MMRRC; MMRRC:002529-UCD
DR   Wikidata; Q54770332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894646; Hlcs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH207
AC   CVCL_MX64
SY   RRH207
DR   MMRRC; MMRRC:002530-UCD
DR   Wikidata; Q54770333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151172; Mta3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH208
AC   CVCL_MX65
SY   RRH208
DR   MMRRC; MMRRC:002531-UCD
DR   Wikidata; Q54770335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135960; Slc12a6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH209
AC   CVCL_MX66
SY   RRH209
DR   MMRRC; MMRRC:002532-UCD
DR   Wikidata; Q54770336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921850; Mrpl47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH211
AC   CVCL_MX67
SY   RRH211
DR   MMRRC; MMRRC:002534-UCD
DR   Wikidata; Q54770340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890430; Paxip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH213
AC   CVCL_MX68
SY   RRH213
DR   MMRRC; MMRRC:002535-UCD
DR   Wikidata; Q54770342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928899; Tacc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH221
AC   CVCL_MX69
SY   RRH221
DR   MMRRC; MMRRC:002538-UCD
DR   Wikidata; Q54770343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923827; Faf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH224
AC   CVCL_MX70
SY   RRH224
DR   MMRRC; MMRRC:002539-UCD
DR   Wikidata; Q54770345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914595; Herc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH226
AC   CVCL_MX71
SY   RRH226
DR   MMRRC; MMRRC:002540-UCD
DR   Wikidata; Q54770347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922661; Ccdc191.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH227
AC   CVCL_MX72
SY   RRH227
DR   MMRRC; MMRRC:002541-UCD
DR   Wikidata; Q54770348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921850; Mrpl47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH236
AC   CVCL_MX73
SY   RRH236
DR   MMRRC; MMRRC:002544-UCD
DR   Wikidata; Q54770350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289155; Trmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH237
AC   CVCL_MX74
SY   RRH237
DR   MMRRC; MMRRC:002545-UCD
DR   Wikidata; Q54770353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105921; Zfp97.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH243
AC   CVCL_MX75
SY   RRH243
DR   MMRRC; MMRRC:002547-UCD
DR   Wikidata; Q54770354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH246
AC   CVCL_MX76
SY   RRH246
DR   MMRRC; MMRRC:002549-UCD
DR   Wikidata; Q54770357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH247
AC   CVCL_MX77
SY   RRH247
DR   MMRRC; MMRRC:002550-UCD
DR   Wikidata; Q54770358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925482; Trappc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH252
AC   CVCL_MX78
SY   RRH252
DR   MMRRC; MMRRC:002551-UCD
DR   Wikidata; Q54770361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109349; Atf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH257
AC   CVCL_MX79
SY   RRH257
DR   MMRRC; MMRRC:002554-UCD
DR   Wikidata; Q54770365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138391; Pid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH260
AC   CVCL_MX80
SY   RRH260
DR   MMRRC; MMRRC:002556-UCD
DR   Wikidata; Q54770366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105921; Zfp97.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH262
AC   CVCL_MX81
SY   RRH262
DR   MMRRC; MMRRC:002557-UCD
DR   Wikidata; Q54770369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2687282; Cep104.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH267
AC   CVCL_MX82
SY   RRH267
DR   MMRRC; MMRRC:002559-UCD
DR   Wikidata; Q54770372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH268
AC   CVCL_MX83
SY   RRH268
DR   MMRRC; MMRRC:002560-UCD
DR   Wikidata; Q54770374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341070; Fkbp8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH270
AC   CVCL_MX84
SY   RRH270
DR   MMRRC; MMRRC:002561-UCD
DR   Wikidata; Q54770377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679002; Prr12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH272
AC   CVCL_MX85
SY   RRH272
DR   MMRRC; MMRRC:002562-UCD
DR   Wikidata; Q54770378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276533; Ncoa2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH274
AC   CVCL_MX86
SY   RRH274
DR   MMRRC; MMRRC:002563-UCD
DR   Wikidata; Q54770380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353598; Mapk8ip3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH276
AC   CVCL_MX87
SY   RRH276
DR   MMRRC; MMRRC:002564-UCD
DR   Wikidata; Q54770382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918345; Kif24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH281
AC   CVCL_MX88
SY   RRH281
DR   MMRRC; MMRRC:002565-UCD
DR   Wikidata; Q54770384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180003; Xpnpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH290
AC   CVCL_MX89
SY   RRH290
DR   MMRRC; MMRRC:002569-UCD
DR   Wikidata; Q54770386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353557; Schip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH295
AC   CVCL_MX90
SY   RRH295
DR   MMRRC; MMRRC:002571-UCD
DR   Wikidata; Q54770389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH298
AC   CVCL_MX91
SY   RRH298
DR   MMRRC; MMRRC:002573-UCD
DR   Wikidata; Q54770391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH302
AC   CVCL_MX92
SY   RRH302
DR   MMRRC; MMRRC:002575-UCD
DR   Wikidata; Q54770393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441730; Tbl1xr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH303
AC   CVCL_MX93
SY   RRH303
DR   MMRRC; MMRRC:002576-UCD
DR   Wikidata; Q54770395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441730; Tbl1xr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH305
AC   CVCL_MX94
SY   RRH305
DR   MMRRC; MMRRC:002578-UCD
DR   Wikidata; Q54770397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914172; Rras2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH308
AC   CVCL_MX95
SY   RRH308
DR   MMRRC; MMRRC:002580-UCD
DR   Wikidata; Q54770399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915670; Ankrd13a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH309
AC   CVCL_MX96
SY   RRH309
DR   MMRRC; MMRRC:002581-UCD
DR   Wikidata; Q54770401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333796; Klf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH325
AC   CVCL_MX97
SY   RRH325
DR   MMRRC; MMRRC:002590-UCD
DR   Wikidata; Q54770403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289325; Anapc16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH327
AC   CVCL_MX98
SY   RRH327
DR   MMRRC; MMRRC:002591-UCD
DR   Wikidata; Q54770404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH330
AC   CVCL_MX99
SY   RRH330
DR   MMRRC; MMRRC:002593-UCD
DR   Wikidata; Q54770406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915549; Vps53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH336
AC   CVCL_MY00
SY   RRH336
DR   MMRRC; MMRRC:002595-UCD
DR   Wikidata; Q54770409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140779; Sdad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH342
AC   CVCL_MY01
SY   RRH342
DR   MMRRC; MMRRC:002598-UCD
DR   Wikidata; Q54770411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH348
AC   CVCL_MY02
SY   RRH348
DR   MMRRC; MMRRC:002602-UCD
DR   Wikidata; Q54770413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180003; Xpnpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRH351
AC   CVCL_MY03
SY   RRH351
DR   MMRRC; MMRRC:002603-UCD
DR   Wikidata; Q54770457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI001
AC   CVCL_MY04
SY   RRI001
DR   MMRRC; MMRRC:002604-UCD
DR   Wikidata; Q54770458
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146430; Cblb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI002
AC   CVCL_MY05
SY   RRI002
DR   MMRRC; MMRRC:002605-UCD
DR   Wikidata; Q54770461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109622; Aip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI004
AC   CVCL_MY06
SY   RRI004
DR   MMRRC; MMRRC:002606-UCD
DR   Wikidata; Q54770462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098749; Erc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI014
AC   CVCL_MY07
SY   RRI014
DR   MMRRC; MMRRC:002610-UCD
DR   Wikidata; Q54770464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104560; Nsf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI015
AC   CVCL_MY08
SY   RRI015
DR   MMRRC; MMRRC:002611-UCD
DR   Wikidata; Q54770465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144113; Tmem199.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI017
AC   CVCL_MY09
SY   RRI017
DR   MMRRC; MMRRC:002612-UCD
DR   Wikidata; Q54770468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136980; Kdm5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI018
AC   CVCL_MY10
SY   RRI018
DR   MMRRC; MMRRC:002613-UCD
DR   Wikidata; Q54770471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651978; Zfp984.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI019
AC   CVCL_MY11
SY   RRI019
DR   MMRRC; MMRRC:002614-UCD
DR   Wikidata; Q54770473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96522; Rbpj.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI030
AC   CVCL_MY12
SY   RRI030
DR   MMRRC; MMRRC:002616-UCD
DR   Wikidata; Q54770475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099452; Mtm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI031
AC   CVCL_MY13
SY   RRI031
DR   MMRRC; MMRRC:002617-UCD
DR   Wikidata; Q54770478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105089; Hsd17b4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI032
AC   CVCL_MY14
SY   RRI032
DR   MMRRC; MMRRC:002618-UCD
DR   Wikidata; Q54770479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI033
AC   CVCL_MY15
SY   RRI033
DR   MMRRC; MMRRC:002619-UCD
DR   Wikidata; Q54770481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355274; Uchl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI034
AC   CVCL_MY16
SY   RRI034
DR   MMRRC; MMRRC:002620-UCD
DR   Wikidata; Q54770482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI037
AC   CVCL_MY17
SY   RRI037
DR   MMRRC; MMRRC:002621-UCD
DR   Wikidata; Q54770485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104913; Abi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI039
AC   CVCL_MY18
SY   RRI039
DR   MMRRC; MMRRC:002622-UCD
DR   Wikidata; Q54770488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684817; Snhg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI040
AC   CVCL_MY19
SY   RRI040
DR   MMRRC; MMRRC:002623-UCD
DR   Wikidata; Q54770490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97499; Pcca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI041
AC   CVCL_MY20
SY   RRI041
DR   MMRRC; MMRRC:002624-UCD
DR   Wikidata; Q54770491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385902; Picalm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI045
AC   CVCL_MY21
SY   RRI045
DR   MMRRC; MMRRC:002626-UCD
DR   Wikidata; Q54770494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926879; Taf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI047
AC   CVCL_MY22
SY   RRI047
DR   MMRRC; MMRRC:002627-UCD
DR   Wikidata; Q54770496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142048; Rnf40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI051
AC   CVCL_MY23
SY   RRI051
DR   MMRRC; MMRRC:002628-UCD
DR   Wikidata; Q54770497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI054
AC   CVCL_MY24
SY   RRI054
DR   MMRRC; MMRRC:002629-UCD
DR   Wikidata; Q54770499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930708; Zfp386.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI056
AC   CVCL_MY25
SY   RRI056
DR   MMRRC; MMRRC:002630-UCD
DR   Wikidata; Q54770501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914722; Mtfr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI057
AC   CVCL_MY26
SY   RRI057
DR   MMRRC; MMRRC:002631-UCD
DR   Wikidata; Q54770503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346834; Nr5a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI058
AC   CVCL_MY27
SY   RRI058
DR   MMRRC; MMRRC:002632-UCD
DR   Wikidata; Q54770505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346518; Scamp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI059
AC   CVCL_MY28
SY   RRI059
DR   MMRRC; MMRRC:002633-UCD
DR   Wikidata; Q54770507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351486; Trappc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI060
AC   CVCL_MY29
SY   RRI060
DR   MMRRC; MMRRC:002634-UCD
DR   Wikidata; Q54770508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926952; Cyb5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI061
AC   CVCL_MY30
SY   RRI061
DR   MMRRC; MMRRC:002635-UCD
DR   Wikidata; Q54770512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860512; Prpf40a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI062
AC   CVCL_MY31
SY   RRI062
DR   MMRRC; MMRRC:002636-UCD
DR   Wikidata; Q54770514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926953; Ctdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI064
AC   CVCL_MY32
SY   RRI064
DR   MMRRC; MMRRC:002637-UCD
DR   Wikidata; Q54770515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI065
AC   CVCL_MY33
SY   RRI065
DR   MMRRC; MMRRC:002638-UCD
DR   Wikidata; Q54770516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921446; Ttc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI068
AC   CVCL_MY34
SY   RRI068
DR   MMRRC; MMRRC:002639-UCD
DR   Wikidata; Q54770518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270129; Dnaja1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI069
AC   CVCL_MY35
SY   RRI069
DR   MMRRC; MMRRC:002640-UCD
DR   Wikidata; Q54770520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923401; Cep76.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI072
AC   CVCL_MY36
SY   RRI072
DR   MMRRC; MMRRC:002642-UCD
DR   Wikidata; Q54770522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915770; Zfyve21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI073
AC   CVCL_MY37
SY   RRI073
DR   MMRRC; MMRRC:002643-UCD
DR   Wikidata; Q54770523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446180; Anks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI077
AC   CVCL_MY38
SY   RRI077
DR   MMRRC; MMRRC:002645-UCD
DR   Wikidata; Q54770525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914125; Swt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI083
AC   CVCL_MY39
SY   RRI083
DR   MMRRC; MMRRC:002646-UCD
DR   Wikidata; Q54770527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919205; Ist1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI085
AC   CVCL_MY40
SY   RRI085
DR   MMRRC; MMRRC:002647-UCD
DR   Wikidata; Q54770528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI087
AC   CVCL_MY41
SY   RRI087
DR   MMRRC; MMRRC:002648-UCD
DR   Wikidata; Q54770529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349439; Cops6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI090
AC   CVCL_MY42
SY   RRI090
DR   MMRRC; MMRRC:002649-UCD
DR   Wikidata; Q54770530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921840; Ankrd10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI092
AC   CVCL_MY43
SY   RRI092
DR   MMRRC; MMRRC:002650-UCD
DR   Wikidata; Q54770574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915467; Prrc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI094
AC   CVCL_MY44
SY   RRI094
DR   MMRRC; MMRRC:002651-UCD
DR   Wikidata; Q54770576
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915371; Cep70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI096
AC   CVCL_MY45
SY   RRI096
DR   MMRRC; MMRRC:002652-UCD
DR   Wikidata; Q54770578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429950; Xpo6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI097
AC   CVCL_MY46
SY   RRI097
DR   MMRRC; MMRRC:002653-UCD
DR   Wikidata; Q54770580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI100
AC   CVCL_MY47
SY   RRI100
DR   MMRRC; MMRRC:002654-UCD
DR   Wikidata; Q54770581
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913560; Dpy30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI102
AC   CVCL_MY48
SY   RRI102
DR   MMRRC; MMRRC:002655-UCD
DR   Wikidata; Q54770583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917799; Tln2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI103
AC   CVCL_MY49
SY   RRI103
DR   MMRRC; MMRRC:002656-UCD
DR   Wikidata; Q54770585
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442415; Kat6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI104
AC   CVCL_MY50
SY   RRI104
DR   MMRRC; MMRRC:002657-UCD
DR   Wikidata; Q54770589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334433; Pi4kb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI105
AC   CVCL_MY51
SY   RRI105
DR   MMRRC; MMRRC:002658-UCD
DR   Wikidata; Q54770591
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI107
AC   CVCL_MY52
SY   RRI107
DR   MMRRC; MMRRC:002659-UCD
DR   Wikidata; Q54770592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI108
AC   CVCL_MY53
SY   RRI108
DR   MMRRC; MMRRC:002660-UCD
DR   Wikidata; Q54770594
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916976; Smyd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI109
AC   CVCL_MY54
SY   RRI109
DR   MMRRC; MMRRC:002661-UCD
DR   Wikidata; Q54770597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917822; Ipo5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI110
AC   CVCL_MY55
SY   RRI110
DR   MMRRC; MMRRC:002662-UCD
DR   Wikidata; Q54770598
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202876; Tcf7l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI113
AC   CVCL_MY56
SY   RRI113
DR   MMRRC; MMRRC:002664-UCD
DR   Wikidata; Q54770600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915033; Ahctf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI114
AC   CVCL_MY57
SY   RRI114
DR   MMRRC; MMRRC:002665-UCD
DR   Wikidata; Q54770602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103234; Herc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI118
AC   CVCL_MY58
SY   RRI118
DR   MMRRC; MMRRC:002666-UCD
DR   Wikidata; Q54770604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI125
AC   CVCL_MY59
SY   RRI125
DR   MMRRC; MMRRC:002668-UCD
DR   Wikidata; Q54770608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151013; Erc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI130
AC   CVCL_MY60
SY   RRI130
DR   MMRRC; MMRRC:002670-UCD
DR   Wikidata; Q54770609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916891; Wdr20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI131
AC   CVCL_MY61
SY   RRI131
DR   MMRRC; MMRRC:002671-UCD
DR   Wikidata; Q54770611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443758; Akap17b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI139
AC   CVCL_MY62
SY   RRI139
DR   MMRRC; MMRRC:002672-UCD
DR   Wikidata; Q54770613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913586; Cenpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI143
AC   CVCL_MY63
SY   RRI143
DR   MMRRC; MMRRC:002674-UCD
DR   Wikidata; Q54770615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916706; Commd10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI144
AC   CVCL_MY64
SY   RRI144
DR   MMRRC; MMRRC:002675-UCD
DR   Wikidata; Q54770616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443895; Fry.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI147
AC   CVCL_MY65
SY   RRI147
DR   MMRRC; MMRRC:002676-UCD
DR   Wikidata; Q54770618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443225; Gatad2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI148
AC   CVCL_MY66
SY   RRI148
DR   MMRRC; MMRRC:002677-UCD
DR   Wikidata; Q54770621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309480; Rtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI151
AC   CVCL_MY67
SY   RRI151
DR   MMRRC; MMRRC:002679-UCD
DR   Wikidata; Q54770624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI153
AC   CVCL_MY68
SY   RRI153
DR   MMRRC; MMRRC:002680-UCD
DR   Wikidata; Q54770626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI154
AC   CVCL_MY69
SY   RRI154
DR   MMRRC; MMRRC:002681-UCD
DR   Wikidata; Q54770629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136980; Kdm5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI156
AC   CVCL_MY70
SY   RRI156
DR   MMRRC; MMRRC:002682-UCD
DR   Wikidata; Q54770630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI162
AC   CVCL_MY71
SY   RRI162
DR   MMRRC; MMRRC:002685-UCD
DR   Wikidata; Q54770632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI164
AC   CVCL_MY72
SY   RRI164
DR   MMRRC; MMRRC:002686-UCD
DR   Wikidata; Q54770633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921375; Armc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI166
AC   CVCL_MY73
SY   RRI166
DR   MMRRC; MMRRC:002687-UCD
DR   Wikidata; Q54770634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928899; Tacc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI172
AC   CVCL_MY74
SY   RRI172
DR   MMRRC; MMRRC:002690-UCD
DR   Wikidata; Q54770636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676921; Focad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI175
AC   CVCL_MY75
SY   RRI175
DR   MMRRC; MMRRC:002691-UCD
DR   Wikidata; Q54770639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI179
AC   CVCL_MY76
SY   RRI179
DR   MMRRC; MMRRC:002692-UCD
DR   Wikidata; Q54770641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918335; Arhgap19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI183
AC   CVCL_MY77
SY   RRI183
DR   MMRRC; MMRRC:002693-UCD
DR   Wikidata; Q54770644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385311; Dlat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI189
AC   CVCL_MY78
SY   RRI189
DR   MMRRC; MMRRC:002695-UCD
DR   Wikidata; Q54770647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99430; Hira.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI191
AC   CVCL_MY79
SY   RRI191
DR   MMRRC; MMRRC:002696-UCD
DR   Wikidata; Q54770649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI192
AC   CVCL_MY80
SY   RRI192
DR   MMRRC; MMRRC:002697-UCD
DR   Wikidata; Q54770650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915984; Ppp4r3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI194
AC   CVCL_MY81
SY   RRI194
DR   MMRRC; MMRRC:002699-UCD
DR   Wikidata; Q54770653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922523; Pelp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI203
AC   CVCL_MY82
SY   RRI203
DR   MMRRC; MMRRC:002703-UCD
DR   Wikidata; Q54770655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179381; Prpf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI215
AC   CVCL_MY83
SY   RRI215
DR   MMRRC; MMRRC:002706-UCD
DR   Wikidata; Q54770710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930780; Myh10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI222
AC   CVCL_MY84
SY   RRI222
DR   MMRRC; MMRRC:002707-UCD
DR   Wikidata; Q54770712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87867; Acadm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI224
AC   CVCL_MY85
SY   RRI224
DR   MMRRC; MMRRC:002708-UCD
DR   Wikidata; Q54770714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894676; Mast2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI229
AC   CVCL_MY86
SY   RRI229
DR   MMRRC; MMRRC:002711-UCD
DR   Wikidata; Q54770717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860188; Snx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI232
AC   CVCL_MY87
SY   RRI232
DR   MMRRC; MMRRC:002712-UCD
DR   Wikidata; Q54770719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147870; Lrch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI234
AC   CVCL_MY88
SY   RRI234
DR   MMRRC; MMRRC:002713-UCD
DR   Wikidata; Q54770721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673002; Arhgef17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI236
AC   CVCL_MY89
SY   RRI236
DR   MMRRC; MMRRC:002714-UCD
DR   Wikidata; Q54770724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442220; Zfp182.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI240
AC   CVCL_MY90
SY   RRI240
DR   MMRRC; MMRRC:002715-UCD
DR   Wikidata; Q54770727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101864; Dag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI243
AC   CVCL_MY91
SY   RRI243
DR   MMRRC; MMRRC:002717-UCD
DR   Wikidata; Q54770728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI246
AC   CVCL_MY92
SY   RRI246
DR   MMRRC; MMRRC:002718-UCD
DR   Wikidata; Q54770730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI249
AC   CVCL_MY93
SY   RRI249
DR   MMRRC; MMRRC:002719-UCD
DR   Wikidata; Q54770734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109301; Papola.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI252
AC   CVCL_MY94
SY   RRI252
DR   MMRRC; MMRRC:002720-UCD
DR   Wikidata; Q54770735
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI253
AC   CVCL_MY95
SY   RRI253
DR   MMRRC; MMRRC:002721-UCD
DR   Wikidata; Q54770736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109301; Papola.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI254
AC   CVCL_MY96
SY   RRI254
DR   MMRRC; MMRRC:002722-UCD
DR   Wikidata; Q54770739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI256
AC   CVCL_MY97
SY   RRI256
DR   MMRRC; MMRRC:002724-UCD
DR   Wikidata; Q54770740
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919238; Esco2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI257
AC   CVCL_MY98
SY   RRI257
DR   MMRRC; MMRRC:002725-UCD
DR   Wikidata; Q54770742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445085; Dync2i1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRI260
AC   CVCL_MY99
SY   RRI260
DR   MMRRC; MMRRC:002726-UCD
DR   Wikidata; Q54770743
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI261
AC   CVCL_MZ00
SY   RRI261
DR   MMRRC; MMRRC:002727-UCD
DR   Wikidata; Q54770745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202876; Tcf7l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI265
AC   CVCL_MZ01
SY   RRI265
DR   MMRRC; MMRRC:002728-UCD
DR   Wikidata; Q54770747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925642; Fnbp1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI266
AC   CVCL_MZ02
SY   RRI266
DR   MMRRC; MMRRC:002729-UCD
DR   Wikidata; Q54770748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95753; Glud1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI268
AC   CVCL_MZ03
SY   RRI268
DR   MMRRC; MMRRC:002730-UCD
DR   Wikidata; Q54770749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI269
AC   CVCL_MZ04
SY   RRI269
DR   MMRRC; MMRRC:002731-UCD
DR   Wikidata; Q54770750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI274
AC   CVCL_MZ05
SY   RRI274
DR   MMRRC; MMRRC:002734-UCD
DR   Wikidata; Q54770751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95797; Gpi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI275
AC   CVCL_MZ06
SY   RRI275
DR   MMRRC; MMRRC:002735-UCD
DR   Wikidata; Q54770753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928469; Trip4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI281
AC   CVCL_MZ07
SY   RRI281
DR   MMRRC; MMRRC:002736-UCD
DR   Wikidata; Q54770755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925976; Scaper.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI283
AC   CVCL_MZ08
SY   RRI283
DR   MMRRC; MMRRC:002737-UCD
DR   Wikidata; Q54770756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916891; Wdr20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI288
AC   CVCL_MZ09
SY   RRI288
DR   MMRRC; MMRRC:002738-UCD
DR   Wikidata; Q54770759
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915149; Cmc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI293
AC   CVCL_MZ10
SY   RRI293
DR   MMRRC; MMRRC:002739-UCD
DR   Wikidata; Q54770760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918590; Riok1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI295
AC   CVCL_MZ11
SY   RRI295
DR   MMRRC; MMRRC:002740-UCD
DR   Wikidata; Q54770762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916082; Ldah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI298
AC   CVCL_MZ12
SY   RRI298
DR   MMRRC; MMRRC:002742-UCD
DR   Wikidata; Q54770764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98834; Trp53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI304
AC   CVCL_MZ13
SY   RRI304
DR   MMRRC; MMRRC:002744-UCD
DR   Wikidata; Q54770767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104861; Bcat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI305
AC   CVCL_MZ14
SY   RRI305
DR   MMRRC; MMRRC:002745-UCD
DR   Wikidata; Q54770768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919891; Mob2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI306
AC   CVCL_MZ15
SY   RRI306
DR   MMRRC; MMRRC:002746-UCD
DR   Wikidata; Q54770769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919818; Lin9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI307
AC   CVCL_MZ16
SY   RRI307
DR   MMRRC; MMRRC:002747-UCD
DR   Wikidata; Q54770771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445089; Trappc12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI309
AC   CVCL_MZ17
SY   RRI309
DR   MMRRC; MMRRC:002748-UCD
DR   Wikidata; Q54770773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914321; Rps6ka6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI313
AC   CVCL_MZ18
SY   RRI313
DR   MMRRC; MMRRC:002751-UCD
DR   Wikidata; Q54770775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI314
AC   CVCL_MZ19
SY   RRI314
DR   MMRRC; MMRRC:002752-UCD
DR   Wikidata; Q54770777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI321
AC   CVCL_MZ20
SY   RRI321
DR   MMRRC; MMRRC:002754-UCD
DR   Wikidata; Q54770779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI323
AC   CVCL_MZ21
SY   RRI323
DR   MMRRC; MMRRC:002755-UCD
DR   Wikidata; Q54770780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917598; Ube2cbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI325
AC   CVCL_MZ22
SY   RRI325
DR   MMRRC; MMRRC:002756-UCD
DR   Wikidata; Q54770784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099436; Rad51b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI328
AC   CVCL_MZ23
SY   RRI328
DR   MMRRC; MMRRC:002757-UCD
DR   Wikidata; Q54770821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333879; Ap3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI330
AC   CVCL_MZ24
SY   RRI330
DR   MMRRC; MMRRC:002758-UCD
DR   Wikidata; Q54770823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913355; Ube2d3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI332
AC   CVCL_MZ25
SY   RRI332
DR   MMRRC; MMRRC:002759-UCD
DR   Wikidata; Q54770825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443370; Chtf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI340
AC   CVCL_MZ26
SY   RRI340
DR   MMRRC; MMRRC:002763-UCD
DR   Wikidata; Q54770826
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI342
AC   CVCL_MZ27
SY   RRI342
DR   MMRRC; MMRRC:002764-UCD
DR   Wikidata; Q54770828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913820; Cenpm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI347
AC   CVCL_MZ28
SY   RRI347
DR   MMRRC; MMRRC:002765-UCD
DR   Wikidata; Q54770831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98834; Trp53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI359
AC   CVCL_MZ29
SY   RRI359
DR   MMRRC; MMRRC:002770-UCD
DR   Wikidata; Q54770833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344349; Rnf216.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI363
AC   CVCL_MZ30
SY   RRI363
DR   MMRRC; MMRRC:002772-UCD
DR   Wikidata; Q54770837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344351; Dlg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRI366
AC   CVCL_MZ31
SY   RRI366
DR   MMRRC; MMRRC:002774-UCD
DR   Wikidata; Q54770839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685175; Asxl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI372
AC   CVCL_MZ32
SY   RRI372
DR   MMRRC; MMRRC:002777-UCD
DR   Wikidata; Q54770840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI374
AC   CVCL_MZ33
SY   RRI374
DR   MMRRC; MMRRC:002778-UCD
DR   Wikidata; Q54770841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI375
AC   CVCL_MZ34
SY   RRI375
DR   MMRRC; MMRRC:002779-UCD
DR   Wikidata; Q54770842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2149961; Pawr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI378
AC   CVCL_MZ35
SY   RRI378
DR   MMRRC; MMRRC:002781-UCD
DR   Wikidata; Q54770844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353424; Timm8b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI382
AC   CVCL_MZ36
SY   RRI382
DR   MMRRC; MMRRC:002782-UCD
DR   Wikidata; Q54770848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894308; Rab21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI383
AC   CVCL_MZ37
SY   RRI383
DR   MMRRC; MMRRC:002783-UCD
DR   Wikidata; Q54770849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181182; Nup155.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI386
AC   CVCL_MZ38
SY   RRI386
DR   MMRRC; MMRRC:002784-UCD
DR   Wikidata; Q54770852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101864; Dag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI388
AC   CVCL_MZ39
SY   RRI388
DR   MMRRC; MMRRC:002785-UCD
DR   Wikidata; Q54770854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99211; Zfx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI390
AC   CVCL_MZ40
SY   RRI390
DR   MMRRC; MMRRC:002786-UCD
DR   Wikidata; Q54770855
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913937; Tbc1d15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI395
AC   CVCL_MZ41
SY   RRI395
DR   MMRRC; MMRRC:002787-UCD
DR   Wikidata; Q54770859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353424; Timm8b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI398
AC   CVCL_MZ42
SY   RRI398
DR   MMRRC; MMRRC:002789-UCD
DR   Wikidata; Q54770860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI399
AC   CVCL_MZ43
SY   RRI399
DR   MMRRC; MMRRC:002790-UCD
DR   Wikidata; Q54770863
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88315; Ccnd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI400
AC   CVCL_MZ44
SY   RRI400
DR   MMRRC; MMRRC:002791-UCD
DR   Wikidata; Q54770864
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1314653; Afdn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI404
AC   CVCL_MZ45
SY   RRI404
DR   MMRRC; MMRRC:002792-UCD
DR   Wikidata; Q54770865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3028576; Dhx37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI405
AC   CVCL_MZ46
SY   RRI405
DR   MMRRC; MMRRC:002793-UCD
DR   Wikidata; Q54770869
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338871; Btrc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI407
AC   CVCL_MZ47
SY   RRI407
DR   MMRRC; MMRRC:002794-UCD
DR   Wikidata; Q54770870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138865; Dlgap4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI409
AC   CVCL_MZ48
SY   RRI409
DR   MMRRC; MMRRC:002795-UCD
DR   Wikidata; Q54770872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442836; Brip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI414
AC   CVCL_MZ49
SY   RRI414
DR   MMRRC; MMRRC:002797-UCD
DR   Wikidata; Q54770874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI415
AC   CVCL_MZ50
SY   RRI415
DR   MMRRC; MMRRC:002798-UCD
DR   Wikidata; Q54770877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107460; Cox6b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI416
AC   CVCL_MZ51
SY   RRI416
DR   MMRRC; MMRRC:002799-UCD
DR   Wikidata; Q54770879
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI423
AC   CVCL_MZ52
SY   RRI423
DR   MMRRC; MMRRC:002800-UCD
DR   Wikidata; Q54770880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107930; Pip5k1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI425
AC   CVCL_MZ53
SY   RRI425
DR   MMRRC; MMRRC:002801-UCD
DR   Wikidata; Q54770882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679255; Ssh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI429
AC   CVCL_MZ54
SY   RRI429
DR   MMRRC; MMRRC:002803-UCD
DR   Wikidata; Q54770883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442827; Tbc1d32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI430
AC   CVCL_MZ55
SY   RRI430
DR   MMRRC; MMRRC:002804-UCD
DR   Wikidata; Q54770885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3609241; Lonrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI431
AC   CVCL_MZ56
SY   RRI431
DR   MMRRC; MMRRC:002805-UCD
DR   Wikidata; Q54770886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181182; Nup155.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI434
AC   CVCL_MZ57
SY   RRI434
DR   MMRRC; MMRRC:002806-UCD
DR   Wikidata; Q54770889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917799; Tln2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI436
AC   CVCL_MZ58
SY   RRI436
DR   MMRRC; MMRRC:002807-UCD
DR   Wikidata; Q54770890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277218; Rpap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI439
AC   CVCL_MZ59
SY   RRI439
DR   MMRRC; MMRRC:002808-UCD
DR   Wikidata; Q54770891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443207; Plekhm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI442
AC   CVCL_MZ60
SY   RRI442
DR   MMRRC; MMRRC:002809-UCD
DR   Wikidata; Q54770893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919020; Ap2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI443
AC   CVCL_MZ61
SY   RRI443
DR   MMRRC; MMRRC:002810-UCD
DR   Wikidata; Q54770895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920538; Vps50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI448
AC   CVCL_MZ62
SY   RRI448
DR   MMRRC; MMRRC:002812-UCD
DR   Wikidata; Q54770897
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924841; Ddx10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI454
AC   CVCL_MZ63
SY   RRI454
DR   MMRRC; MMRRC:002814-UCD
DR   Wikidata; Q54770949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923539; Phf14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI455
AC   CVCL_MZ64
SY   RRI455
DR   MMRRC; MMRRC:002815-UCD
DR   Wikidata; Q54770952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442755; Glt1d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI456
AC   CVCL_MZ65
SY   RRI456
DR   MMRRC; MMRRC:002816-UCD
DR   Wikidata; Q54770953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926210; Cenpk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI459
AC   CVCL_MZ66
SY   RRI459
DR   MMRRC; MMRRC:002817-UCD
DR   Wikidata; Q54770958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146322; Deptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI460
AC   CVCL_MZ67
SY   RRI460
DR   MMRRC; MMRRC:002818-UCD
DR   Wikidata; Q54770959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442873; E130114P18Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI462
AC   CVCL_MZ68
SY   RRI462
DR   MMRRC; MMRRC:002819-UCD
DR   Wikidata; Q54770960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919891; Mob2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI464
AC   CVCL_MZ69
SY   RRI464
DR   MMRRC; MMRRC:002820-UCD
DR   Wikidata; Q54770963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108109; Ywhag.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI466
AC   CVCL_MZ70
SY   RRI466
DR   MMRRC; MMRRC:002821-UCD
DR   Wikidata; Q54770964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI467
AC   CVCL_MZ71
SY   RRI467
DR   MMRRC; MMRRC:002822-UCD
DR   Wikidata; Q54770968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98310; Ski.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI468
AC   CVCL_MZ72
SY   RRI468
DR   MMRRC; MMRRC:002823-UCD
DR   Wikidata; Q54770970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI470
AC   CVCL_MZ73
SY   RRI470
DR   MMRRC; MMRRC:002824-UCD
DR   Wikidata; Q54770971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI472
AC   CVCL_MZ74
SY   RRI472
DR   MMRRC; MMRRC:002825-UCD
DR   Wikidata; Q54770973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913895; Pspc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI473
AC   CVCL_MZ75
SY   RRI473
DR   MMRRC; MMRRC:002826-UCD
DR   Wikidata; Q54770976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914125; Swt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI480
AC   CVCL_MZ76
SY   RRI480
DR   MMRRC; MMRRC:002829-UCD
DR   Wikidata; Q54770979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914125; Swt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI481
AC   CVCL_MZ77
SY   RRI481
DR   MMRRC; MMRRC:002830-UCD
DR   Wikidata; Q54770980
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924841; Ddx10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI483
AC   CVCL_MZ78
SY   RRI483
DR   MMRRC; MMRRC:002832-UCD
DR   Wikidata; Q54770984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352757; Iqgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI484
AC   CVCL_MZ79
SY   RRI484
DR   MMRRC; MMRRC:002833-UCD
DR   Wikidata; Q54770986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140230; Camta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI487
AC   CVCL_MZ80
SY   RRI487
DR   MMRRC; MMRRC:002835-UCD
DR   Wikidata; Q54770987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107978; Klc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI492
AC   CVCL_MZ81
SY   RRI492
DR   MMRRC; MMRRC:002838-UCD
DR   Wikidata; Q54770988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914125; Swt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI494
AC   CVCL_MZ82
SY   RRI494
DR   MMRRC; MMRRC:002839-UCD
DR   Wikidata; Q54770990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919070; Dync2i2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRI497
AC   CVCL_MZ83
SY   RRI497
DR   MMRRC; MMRRC:002841-UCD
DR   Wikidata; Q54770993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178798; Vps54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI499
AC   CVCL_MZ84
SY   RRI499
DR   MMRRC; MMRRC:002842-UCD
DR   Wikidata; Q54770994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI500
AC   CVCL_MZ85
SY   RRI500
DR   MMRRC; MMRRC:002843-UCD
DR   Wikidata; Q54770996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261910; Pibf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI504
AC   CVCL_MZ86
SY   RRI504
DR   MMRRC; MMRRC:002846-UCD
DR   Wikidata; Q54770998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916884; Clybl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI505
AC   CVCL_MZ87
SY   RRI505
DR   MMRRC; MMRRC:002847-UCD
DR   Wikidata; Q54770999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890504; Maml1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI506
AC   CVCL_MZ88
SY   RRI506
DR   MMRRC; MMRRC:002848-UCD
DR   Wikidata; Q54771002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924066; Sdccag8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRI507
AC   CVCL_MZ89
SY   RRI507
DR   MMRRC; MMRRC:002849-UCD
DR   Wikidata; Q54771005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107637; Psmb7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ002
AC   CVCL_MZ90
SY   RRJ002
DR   MMRRC; MMRRC:002850-UCD
DR   Wikidata; Q54771006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ003
AC   CVCL_MZ91
SY   RRJ003
DR   MMRRC; MMRRC:002851-UCD
DR   Wikidata; Q54771007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858943; Arl6ip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ004
AC   CVCL_MZ92
SY   RRJ004
DR   MMRRC; MMRRC:002852-UCD
DR   Wikidata; Q54771009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ005
AC   CVCL_MZ93
SY   RRJ005
DR   MMRRC; MMRRC:002853-UCD
DR   Wikidata; Q54771012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921269; Traf3ip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ009
AC   CVCL_MZ94
SY   RRJ009
DR   MMRRC; MMRRC:002854-UCD
DR   Wikidata; Q54771014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934835; Ube2n.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ010
AC   CVCL_MZ95
SY   RRJ010
DR   MMRRC; MMRRC:002855-UCD
DR   Wikidata; Q54771018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923827; Faf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ011
AC   CVCL_MZ96
SY   RRJ011
DR   MMRRC; MMRRC:002856-UCD
DR   Wikidata; Q54771021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ012
AC   CVCL_MZ97
SY   RRJ012
DR   MMRRC; MMRRC:002857-UCD
DR   Wikidata; Q54771024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102956; Cdk7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ015
AC   CVCL_MZ98
SY   RRJ015
DR   MMRRC; MMRRC:002860-UCD
DR   Wikidata; Q54771025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913721; Anp32e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ017
AC   CVCL_MZ99
SY   RRJ017
DR   MMRRC; MMRRC:002861-UCD
DR   Wikidata; Q54771027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109447; Ctcf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ021
AC   CVCL_NA00
SY   RRJ021
DR   MMRRC; MMRRC:002862-UCD
DR   Wikidata; Q54771030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926143; Cnot10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ023
AC   CVCL_NA01
SY   RRJ023
DR   MMRRC; MMRRC:002864-UCD
DR   Wikidata; Q54771032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ025
AC   CVCL_NA02
SY   RRJ025
DR   MMRRC; MMRRC:002866-UCD
DR   Wikidata; Q54771034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ026
AC   CVCL_NA03
SY   RRJ026
DR   MMRRC; MMRRC:002867-UCD
DR   Wikidata; Q54771082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328306; Orc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ027
AC   CVCL_NA04
SY   RRJ027
DR   MMRRC; MMRRC:002868-UCD
DR   Wikidata; Q54771084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101771; Sntb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ028
AC   CVCL_NA05
SY   RRJ028
DR   MMRRC; MMRRC:002869-UCD
DR   Wikidata; Q54771087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930768; Arid3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ029
AC   CVCL_NA06
SY   RRJ029
DR   MMRRC; MMRRC:002870-UCD
DR   Wikidata; Q54771088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889023; Banp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ030
AC   CVCL_NA07
SY   RRJ030
DR   MMRRC; MMRRC:002871-UCD
DR   Wikidata; Q54771089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ031
AC   CVCL_NA08
SY   RRJ031
DR   MMRRC; MMRRC:002872-UCD
DR   Wikidata; Q54771091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918000; Kdsr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ033
AC   CVCL_NA09
SY   RRJ033
DR   MMRRC; MMRRC:002873-UCD
DR   Wikidata; Q54771092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446180; Anks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ039
AC   CVCL_NA10
SY   RRJ039
DR   MMRRC; MMRRC:002875-UCD
DR   Wikidata; Q54771093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921502; Armc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ040
AC   CVCL_NA11
SY   RRJ040
DR   MMRRC; MMRRC:002876-UCD
DR   Wikidata; Q54771095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276124; Ep400.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ041
AC   CVCL_NA12
SY   RRJ041
DR   MMRRC; MMRRC:002877-UCD
DR   Wikidata; Q54771099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ043
AC   CVCL_NA13
SY   RRJ043
DR   MMRRC; MMRRC:002878-UCD
DR   Wikidata; Q54771100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919318; Cnot2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ045
AC   CVCL_NA14
SY   RRJ045
DR   MMRRC; MMRRC:002879-UCD
DR   Wikidata; Q54771101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ047
AC   CVCL_NA15
SY   RRJ047
DR   MMRRC; MMRRC:002881-UCD
DR   Wikidata; Q54771104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ049
AC   CVCL_NA16
SY   RRJ049
DR   MMRRC; MMRRC:002883-UCD
DR   Wikidata; Q54771106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ050
AC   CVCL_NA17
SY   RRJ050
DR   MMRRC; MMRRC:002884-UCD
DR   Wikidata; Q54771107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927344; Gmnn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ054
AC   CVCL_NA18
SY   RRJ054
DR   MMRRC; MMRRC:002885-UCD
DR   Wikidata; Q54771109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913368; Sarnp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ055
AC   CVCL_NA19
SY   RRJ055
DR   MMRRC; MMRRC:002886-UCD
DR   Wikidata; Q54771111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ061
AC   CVCL_NA20
SY   RRJ061
DR   MMRRC; MMRRC:002888-UCD
DR   Wikidata; Q54771114
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ062
AC   CVCL_NA21
SY   RRJ062
DR   MMRRC; MMRRC:002889-UCD
DR   Wikidata; Q54771115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915455; Urm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ063
AC   CVCL_NA22
SY   RRJ063
DR   MMRRC; MMRRC:002890-UCD
DR   Wikidata; Q54771119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ064
AC   CVCL_NA23
SY   RRJ064
DR   MMRRC; MMRRC:002891-UCD
DR   Wikidata; Q54771120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913393; Eef1e1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ065
AC   CVCL_NA24
SY   RRJ065
DR   MMRRC; MMRRC:002892-UCD
DR   Wikidata; Q54771122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261437; Atp5c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ066
AC   CVCL_NA25
SY   RRJ066
DR   MMRRC; MMRRC:002893-UCD
DR   Wikidata; Q54771123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109530; E4f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ067
AC   CVCL_NA26
SY   RRJ067
DR   MMRRC; MMRRC:002894-UCD
DR   Wikidata; Q54771126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926790; Fzr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ068
AC   CVCL_NA27
SY   RRJ068
DR   MMRRC; MMRRC:002895-UCD
DR   Wikidata; Q54771128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99638; Mark2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ072
AC   CVCL_NA28
SY   RRJ072
DR   MMRRC; MMRRC:002896-UCD
DR   Wikidata; Q54771129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107167; Tfdp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ074
AC   CVCL_NA29
SY   RRJ074
DR   MMRRC; MMRRC:002897-UCD
DR   Wikidata; Q54771131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923036; Ckap5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ077
AC   CVCL_NA30
SY   RRJ077
DR   MMRRC; MMRRC:002898-UCD
DR   Wikidata; Q54771133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339951; Cse1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ079
AC   CVCL_NA31
SY   RRJ079
DR   MMRRC; MMRRC:002899-UCD
DR   Wikidata; Q54771135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ081
AC   CVCL_NA32
SY   RRJ081
DR   MMRRC; MMRRC:002901-UCD
DR   Wikidata; Q54771137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107901; Nfyc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ083
AC   CVCL_NA33
SY   RRJ083
DR   MMRRC; MMRRC:002902-UCD
DR   Wikidata; Q54771139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146468; Urb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ084
AC   CVCL_NA34
SY   RRJ084
DR   MMRRC; MMRRC:002903-UCD
DR   Wikidata; Q54771142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442377; Ipo11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ087
AC   CVCL_NA35
SY   RRJ087
DR   MMRRC; MMRRC:002904-UCD
DR   Wikidata; Q54771144
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919765; Wdr43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ088
AC   CVCL_NA36
SY   RRJ088
DR   MMRRC; MMRRC:002905-UCD
DR   Wikidata; Q54771145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ094
AC   CVCL_NA37
SY   RRJ094
DR   MMRRC; MMRRC:002907-UCD
DR   Wikidata; Q54771146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914988; Ppid.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ096
AC   CVCL_NA38
SY   RRJ096
DR   MMRRC; MMRRC:002908-UCD
DR   Wikidata; Q54771148
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98180; Rrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ097
AC   CVCL_NA39
SY   RRJ097
DR   MMRRC; MMRRC:002909-UCD
DR   Wikidata; Q54771149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ098
AC   CVCL_NA40
SY   RRJ098
DR   MMRRC; MMRRC:002910-UCD
DR   Wikidata; Q54771151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332238; Bcl7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ099
AC   CVCL_NA41
SY   RRJ099
DR   MMRRC; MMRRC:002911-UCD
DR   Wikidata; Q54771152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858910; Jmjd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ102
AC   CVCL_NA42
SY   RRJ102
DR   MMRRC; MMRRC:002912-UCD
DR   Wikidata; Q54771155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913976; Nipbl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ103
AC   CVCL_NA43
SY   RRJ103
DR   MMRRC; MMRRC:002913-UCD
DR   Wikidata; Q54771245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ104
AC   CVCL_NA44
SY   RRJ104
DR   MMRRC; MMRRC:002914-UCD
DR   Wikidata; Q54771246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ107
AC   CVCL_NA45
SY   RRJ107
DR   MMRRC; MMRRC:002915-UCD
DR   Wikidata; Q54771250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442117; Pogz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ110
AC   CVCL_NA46
SY   RRJ110
DR   MMRRC; MMRRC:002916-UCD
DR   Wikidata; Q54771251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ114
AC   CVCL_NA47
SY   RRJ114
DR   MMRRC; MMRRC:002917-UCD
DR   Wikidata; Q54771252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917672; Ints2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ115
AC   CVCL_NA48
SY   RRJ115
DR   MMRRC; MMRRC:002918-UCD
DR   Wikidata; Q54771254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930751; Trpc4ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ117
AC   CVCL_NA49
SY   RRJ117
DR   MMRRC; MMRRC:002919-UCD
DR   Wikidata; Q54771256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103241; Slk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ119
AC   CVCL_NA50
SY   RRJ119
DR   MMRRC; MMRRC:002920-UCD
DR   Wikidata; Q54771257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339975; Pak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ120
AC   CVCL_NA51
SY   RRJ120
DR   MMRRC; MMRRC:002921-UCD
DR   Wikidata; Q54771259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ126
AC   CVCL_NA52
SY   RRJ126
DR   MMRRC; MMRRC:002923-UCD
DR   Wikidata; Q54771262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098258; Kif15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ128
AC   CVCL_NA53
SY   RRJ128
DR   MMRRC; MMRRC:002925-UCD
DR   Wikidata; Q54771264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891691; Arpp19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ129
AC   CVCL_NA54
SY   RRJ129
DR   MMRRC; MMRRC:002926-UCD
DR   Wikidata; Q54771265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ135
AC   CVCL_NA55
SY   RRJ135
DR   MMRRC; MMRRC:002928-UCD
DR   Wikidata; Q54771267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916400; Snx4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ136
AC   CVCL_NA56
SY   RRJ136
DR   MMRRC; MMRRC:002929-UCD
DR   Wikidata; Q54771270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921409; Acbd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ138
AC   CVCL_NA57
SY   RRJ138
DR   MMRRC; MMRRC:002930-UCD
DR   Wikidata; Q54771272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443882; Snx30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ139
AC   CVCL_NA58
SY   RRJ139
DR   MMRRC; MMRRC:002931-UCD
DR   Wikidata; Q54771273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ140
AC   CVCL_NA59
SY   RRJ140
DR   MMRRC; MMRRC:002932-UCD
DR   Wikidata; Q54771275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88529; Cs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ141
AC   CVCL_NA60
SY   RRJ141
DR   MMRRC; MMRRC:002933-UCD
DR   Wikidata; Q54771278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2651874; Sesn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ142
AC   CVCL_NA61
SY   RRJ142
DR   MMRRC; MMRRC:002934-UCD
DR   Wikidata; Q54771279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891295; Ube3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ143
AC   CVCL_NA62
SY   RRJ143
DR   MMRRC; MMRRC:002935-UCD
DR   Wikidata; Q54771280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ146
AC   CVCL_NA63
SY   RRJ146
DR   MMRRC; MMRRC:002937-UCD
DR   Wikidata; Q54771282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ147
AC   CVCL_NA64
SY   RRJ147
DR   MMRRC; MMRRC:002938-UCD
DR   Wikidata; Q54771283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138281; Lbr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ153
AC   CVCL_NA65
SY   RRJ153
DR   MMRRC; MMRRC:002940-UCD
DR   Wikidata; Q54771285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917294; Tut1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ155
AC   CVCL_NA66
SY   RRJ155
DR   MMRRC; MMRRC:002942-UCD
DR   Wikidata; Q54771286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ156
AC   CVCL_NA67
SY   RRJ156
DR   MMRRC; MMRRC:002943-UCD
DR   Wikidata; Q54771288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ157
AC   CVCL_NA68
SY   RRJ157
DR   MMRRC; MMRRC:002944-UCD
DR   Wikidata; Q54771289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858964; Actr1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ158
AC   CVCL_NA69
SY   RRJ158
DR   MMRRC; MMRRC:002945-UCD
DR   Wikidata; Q54771291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201691; Rnf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ159
AC   CVCL_NA70
SY   RRJ159
DR   MMRRC; MMRRC:002946-UCD
DR   Wikidata; Q54771293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913964; 4921524J17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ162
AC   CVCL_NA71
SY   RRJ162
DR   MMRRC; MMRRC:002948-UCD
DR   Wikidata; Q54771294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ163
AC   CVCL_NA72
SY   RRJ163
DR   MMRRC; MMRRC:002949-UCD
DR   Wikidata; Q54771296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ165
AC   CVCL_NA73
SY   RRJ165
DR   MMRRC; MMRRC:002950-UCD
DR   Wikidata; Q54771297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916376; Rbis.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRJ167
AC   CVCL_NA74
SY   RRJ167
DR   MMRRC; MMRRC:002952-UCD
DR   Wikidata; Q54771298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915848; Dnajc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ168
AC   CVCL_NA75
SY   RRJ168
DR   MMRRC; MMRRC:002953-UCD
DR   Wikidata; Q54771301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914323; Pi4k2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ171
AC   CVCL_NA76
SY   RRJ171
DR   MMRRC; MMRRC:002955-UCD
DR   Wikidata; Q54771303
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919358; Ddhd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ186
AC   CVCL_NA77
SY   RRJ186
DR   MMRRC; MMRRC:002957-UCD
DR   Wikidata; Q54771305
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2674092; Zfp609.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ187
AC   CVCL_NA78
SY   RRJ187
DR   MMRRC; MMRRC:002958-UCD
DR   Wikidata; Q54771307
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99919; Vcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ198
AC   CVCL_NA79
SY   RRJ198
DR   MMRRC; MMRRC:002962-UCD
DR   Wikidata; Q54771308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916979; 2410003L11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ200
AC   CVCL_NA80
SY   RRJ200
DR   MMRRC; MMRRC:002963-UCD
DR   Wikidata; Q54771311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145245; Srek1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ203
AC   CVCL_NA81
SY   RRJ203
DR   MMRRC; MMRRC:002964-UCD
DR   Wikidata; Q54771313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934835; Ube2n.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ207
AC   CVCL_NA82
SY   RRJ207
DR   MMRRC; MMRRC:002967-UCD
DR   Wikidata; Q54771315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353499; Baz1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ208
AC   CVCL_NA83
SY   RRJ208
DR   MMRRC; MMRRC:002968-UCD
DR   Wikidata; Q54771366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ209
AC   CVCL_NA84
SY   RRJ209
DR   MMRRC; MMRRC:002969-UCD
DR   Wikidata; Q54771369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ216
AC   CVCL_NA85
SY   RRJ216
DR   MMRRC; MMRRC:002972-UCD
DR   Wikidata; Q54771371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1306824; Suclg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ217
AC   CVCL_NA86
SY   RRJ217
DR   MMRRC; MMRRC:002973-UCD
DR   Wikidata; Q54771373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917678; Polr3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ220
AC   CVCL_NA87
SY   RRJ220
DR   MMRRC; MMRRC:002974-UCD
DR   Wikidata; Q54771377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88393; Chd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ221
AC   CVCL_NA88
SY   RRJ221
DR   MMRRC; MMRRC:002975-UCD
DR   Wikidata; Q54771379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151172; Mta3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ223
AC   CVCL_NA89
SY   RRJ223
DR   MMRRC; MMRRC:002976-UCD
DR   Wikidata; Q54771380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921537; Kcmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ225
AC   CVCL_NA90
SY   RRJ225
DR   MMRRC; MMRRC:002977-UCD
DR   Wikidata; Q54771382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151054; Cnnm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ226
AC   CVCL_NA91
SY   RRJ226
DR   MMRRC; MMRRC:002978-UCD
DR   Wikidata; Q54771383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ227
AC   CVCL_NA92
SY   RRJ227
DR   MMRRC; MMRRC:002979-UCD
DR   Wikidata; Q54771385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931237; Wwox.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ233
AC   CVCL_NA93
SY   RRJ233
DR   MMRRC; MMRRC:002982-UCD
DR   Wikidata; Q54771386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445110; Zdhhc17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ234
AC   CVCL_NA94
SY   RRJ234
DR   MMRRC; MMRRC:002983-UCD
DR   Wikidata; Q54771388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915443; Rpl24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ235
AC   CVCL_NA95
SY   RRJ235
DR   MMRRC; MMRRC:002984-UCD
DR   Wikidata; Q54771390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338068; Pdpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ236
AC   CVCL_NA96
SY   RRJ236
DR   MMRRC; MMRRC:002985-UCD
DR   Wikidata; Q54771392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ237
AC   CVCL_NA97
SY   RRJ237
DR   MMRRC; MMRRC:002986-UCD
DR   Wikidata; Q54771394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108109; Ywhag.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ243
AC   CVCL_NA98
SY   RRJ243
DR   MMRRC; MMRRC:002988-UCD
DR   Wikidata; Q54771395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136940; Pias4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ244
AC   CVCL_NA99
SY   RRJ244
DR   MMRRC; MMRRC:002989-UCD
DR   Wikidata; Q54771399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347094; Parg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ248
AC   CVCL_NB00
SY   RRJ248
DR   MMRRC; MMRRC:002991-UCD
DR   Wikidata; Q54771401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443008; Trappc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ249
AC   CVCL_NB01
SY   RRJ249
DR   MMRRC; MMRRC:002992-UCD
DR   Wikidata; Q54771402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925927; Rnf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ250
AC   CVCL_NB02
SY   RRJ250
DR   MMRRC; MMRRC:002993-UCD
DR   Wikidata; Q54771403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ253
AC   CVCL_NB03
SY   RRJ253
DR   MMRRC; MMRRC:002995-UCD
DR   Wikidata; Q54771405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444486; Tarsl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ254
AC   CVCL_NB04
SY   RRJ254
DR   MMRRC; MMRRC:002996-UCD
DR   Wikidata; Q54771406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934835; Ube2n.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ255
AC   CVCL_NB05
SY   RRJ255
DR   MMRRC; MMRRC:002997-UCD
DR   Wikidata; Q54771408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196463; Fndc3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ259
AC   CVCL_NB06
SY   RRJ259
DR   MMRRC; MMRRC:002998-UCD
DR   Wikidata; Q54771411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429762; Rufy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ263
AC   CVCL_NB07
SY   RRJ263
DR   MMRRC; MMRRC:003002-UCD
DR   Wikidata; Q54771413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ266
AC   CVCL_NB08
SY   RRJ266
DR   MMRRC; MMRRC:003003-UCD
DR   Wikidata; Q54771418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ270
AC   CVCL_NB09
SY   RRJ270
DR   MMRRC; MMRRC:003004-UCD
DR   Wikidata; Q54771419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347352; Hunk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ275
AC   CVCL_NB10
SY   RRJ275
DR   MMRRC; MMRRC:003007-UCD
DR   Wikidata; Q54771421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97317; Nfyb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ280
AC   CVCL_NB11
SY   RRJ280
DR   MMRRC; MMRRC:003010-UCD
DR   Wikidata; Q54771422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ285
AC   CVCL_NB12
SY   RRJ285
DR   MMRRC; MMRRC:003013-UCD
DR   Wikidata; Q54771423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333856; Klf9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ288
AC   CVCL_NB13
SY   RRJ288
DR   MMRRC; MMRRC:003014-UCD
DR   Wikidata; Q54771425
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202384; Ddb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ289
AC   CVCL_NB14
SY   RRJ289
DR   MMRRC; MMRRC:003015-UCD
DR   Wikidata; Q54771428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ290
AC   CVCL_NB15
SY   RRJ290
DR   MMRRC; MMRRC:003016-UCD
DR   Wikidata; Q54771430
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926129; Arid1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ291
AC   CVCL_NB16
SY   RRJ291
DR   MMRRC; MMRRC:003017-UCD
DR   Wikidata; Q54771433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039616; Znrf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ292
AC   CVCL_NB17
SY   RRJ292
DR   MMRRC; MMRRC:003018-UCD
DR   Wikidata; Q54771437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590652; Txlng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ295
AC   CVCL_NB18
SY   RRJ295
DR   MMRRC; MMRRC:003019-UCD
DR   Wikidata; Q54771438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387217; Ift52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ297
AC   CVCL_NB19
SY   RRJ297
DR   MMRRC; MMRRC:003021-UCD
DR   Wikidata; Q54771441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201387; Nlk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ299
AC   CVCL_NB20
SY   RRJ299
DR   MMRRC; MMRRC:003022-UCD
DR   Wikidata; Q54771443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ301
AC   CVCL_NB21
SY   RRJ301
DR   MMRRC; MMRRC:003023-UCD
DR   Wikidata; Q54771444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922246; Usp47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ302
AC   CVCL_NB22
SY   RRJ302
DR   MMRRC; MMRRC:003024-UCD
DR   Wikidata; Q54771446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ304
AC   CVCL_NB23
SY   RRJ304
DR   MMRRC; MMRRC:003025-UCD
DR   Wikidata; Q54771497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ309
AC   CVCL_NB24
SY   RRJ309
DR   MMRRC; MMRRC:003027-UCD
DR   Wikidata; Q54771499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ310
AC   CVCL_NB25
SY   RRJ310
DR   MMRRC; MMRRC:003028-UCD
DR   Wikidata; Q54771502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914247; Psmd12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ318
AC   CVCL_NB26
SY   RRJ318
DR   MMRRC; MMRRC:003030-UCD
DR   Wikidata; Q54771503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859150; Akap7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ321
AC   CVCL_NB27
SY   RRJ321
DR   MMRRC; MMRRC:003031-UCD
DR   Wikidata; Q54771505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1306824; Suclg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ324
AC   CVCL_NB28
SY   RRJ324
DR   MMRRC; MMRRC:003032-UCD
DR   Wikidata; Q54771506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ328
AC   CVCL_NB29
SY   RRJ328
DR   MMRRC; MMRRC:003033-UCD
DR   Wikidata; Q54771508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921694; Tasor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRJ329
AC   CVCL_NB30
SY   RRJ329
DR   MMRRC; MMRRC:003034-UCD
DR   Wikidata; Q54771511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99925; Mybl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ331
AC   CVCL_NB31
SY   RRJ331
DR   MMRRC; MMRRC:003036-UCD
DR   Wikidata; Q54771513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919348; Tmem68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ332
AC   CVCL_NB32
SY   RRJ332
DR   MMRRC; MMRRC:003037-UCD
DR   Wikidata; Q54771515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ335
AC   CVCL_NB33
SY   RRJ335
DR   MMRRC; MMRRC:003038-UCD
DR   Wikidata; Q54771517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915395; Etaa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ336
AC   CVCL_NB34
SY   RRJ336
DR   MMRRC; MMRRC:003039-UCD
DR   Wikidata; Q54771518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ339
AC   CVCL_NB35
SY   RRJ339
DR   MMRRC; MMRRC:003040-UCD
DR   Wikidata; Q54771520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202402; Pde7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ340
AC   CVCL_NB36
SY   RRJ340
DR   MMRRC; MMRRC:003041-UCD
DR   Wikidata; Q54771522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ350
AC   CVCL_NB37
SY   RRJ350
DR   MMRRC; MMRRC:003042-UCD
DR   Wikidata; Q54771523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ352
AC   CVCL_NB38
SY   RRJ352
DR   MMRRC; MMRRC:003043-UCD
DR   Wikidata; Q54771524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ354
AC   CVCL_NB39
SY   RRJ354
DR   MMRRC; MMRRC:003045-UCD
DR   Wikidata; Q54771526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442190; Camk1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ357
AC   CVCL_NB40
SY   RRJ357
DR   MMRRC; MMRRC:003046-UCD
DR   Wikidata; Q54771529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384799; Enox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ361
AC   CVCL_NB41
SY   RRJ361
DR   MMRRC; MMRRC:003047-UCD
DR   Wikidata; Q54771530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351664; Ptdss2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ362
AC   CVCL_NB42
SY   RRJ362
DR   MMRRC; MMRRC:003048-UCD
DR   Wikidata; Q54771532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ363
AC   CVCL_NB43
SY   RRJ363
DR   MMRRC; MMRRC:003049-UCD
DR   Wikidata; Q54771535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146430; Cblb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ366
AC   CVCL_NB44
SY   RRJ366
DR   MMRRC; MMRRC:003051-UCD
DR   Wikidata; Q54771539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935145; Mllt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ368
AC   CVCL_NB45
SY   RRJ368
DR   MMRRC; MMRRC:003052-UCD
DR   Wikidata; Q54771541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921344; Tjap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ372
AC   CVCL_NB46
SY   RRJ372
DR   MMRRC; MMRRC:003055-UCD
DR   Wikidata; Q54771543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917264; Kat14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ373
AC   CVCL_NB47
SY   RRJ373
DR   MMRRC; MMRRC:003056-UCD
DR   Wikidata; Q54771545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935145; Mllt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ374
AC   CVCL_NB48
SY   RRJ374
DR   MMRRC; MMRRC:003057-UCD
DR   Wikidata; Q54771547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927489; Pdlim5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ378
AC   CVCL_NB49
SY   RRJ378
DR   MMRRC; MMRRC:003059-UCD
DR   Wikidata; Q54771549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590652; Txlng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ380
AC   CVCL_NB50
SY   RRJ380
DR   MMRRC; MMRRC:003060-UCD
DR   Wikidata; Q54771550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141917; Prkd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ383
AC   CVCL_NB51
SY   RRJ383
DR   MMRRC; MMRRC:003061-UCD
DR   Wikidata; Q54771552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444188; Dgkh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ388
AC   CVCL_NB52
SY   RRJ388
DR   MMRRC; MMRRC:003062-UCD
DR   Wikidata; Q54771554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385619; Klhl12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ392
AC   CVCL_NB53
SY   RRJ392
DR   MMRRC; MMRRC:003063-UCD
DR   Wikidata; Q54771557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919889; Eme2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ393
AC   CVCL_NB54
SY   RRJ393
DR   MMRRC; MMRRC:003064-UCD
DR   Wikidata; Q54771559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ394
AC   CVCL_NB55
SY   RRJ394
DR   MMRRC; MMRRC:003065-UCD
DR   Wikidata; Q54771562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ396
AC   CVCL_NB56
SY   RRJ396
DR   MMRRC; MMRRC:003066-UCD
DR   Wikidata; Q54771564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923539; Phf14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ397
AC   CVCL_NB57
SY   RRJ397
DR   MMRRC; MMRRC:003067-UCD
DR   Wikidata; Q54771567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ398
AC   CVCL_NB58
SY   RRJ398
DR   MMRRC; MMRRC:003068-UCD
DR   Wikidata; Q54771568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ400
AC   CVCL_NB59
SY   RRJ400
DR   MMRRC; MMRRC:003069-UCD
DR   Wikidata; Q54771570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108109; Ywhag.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ401
AC   CVCL_NB60
SY   RRJ401
DR   MMRRC; MMRRC:003070-UCD
DR   Wikidata; Q54771572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344353; Katna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ404
AC   CVCL_NB61
SY   RRJ404
DR   MMRRC; MMRRC:003071-UCD
DR   Wikidata; Q54771574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349417; Zfp346.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ409
AC   CVCL_NB62
SY   RRJ409
DR   MMRRC; MMRRC:003074-UCD
DR   Wikidata; Q54771575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ410
AC   CVCL_NB63
SY   RRJ410
DR   MMRRC; MMRRC:003075-UCD
DR   Wikidata; Q54771614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931028; Recql4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ416
AC   CVCL_NB64
SY   RRJ416
DR   MMRRC; MMRRC:003077-UCD
DR   Wikidata; Q54771616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917262; Cep85.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ417
AC   CVCL_NB65
SY   RRJ417
DR   MMRRC; MMRRC:003078-UCD
DR   Wikidata; Q54771617
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926227; Nup160.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ419
AC   CVCL_NB66
SY   RRJ419
DR   MMRRC; MMRRC:003079-UCD
DR   Wikidata; Q54771620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103234; Herc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ421
AC   CVCL_NB67
SY   RRJ421
DR   MMRRC; MMRRC:003080-UCD
DR   Wikidata; Q54771622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384933; Wrap53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ424
AC   CVCL_NB68
SY   RRJ424
DR   MMRRC; MMRRC:003081-UCD
DR   Wikidata; Q54771624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ434
AC   CVCL_NB69
SY   RRJ434
DR   MMRRC; MMRRC:003085-UCD
DR   Wikidata; Q54771626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ449
AC   CVCL_NB70
SY   RRJ449
DR   MMRRC; MMRRC:003087-UCD
DR   Wikidata; Q54771629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889508; Tbc1d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ450
AC   CVCL_NB71
SY   RRJ450
DR   MMRRC; MMRRC:003088-UCD
DR   Wikidata; Q54771632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346832; Esrrb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ451
AC   CVCL_NB72
SY   RRJ451
DR   MMRRC; MMRRC:003089-UCD
DR   Wikidata; Q54771633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914473; Rrp15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ453
AC   CVCL_NB73
SY   RRJ453
DR   MMRRC; MMRRC:003091-UCD
DR   Wikidata; Q54771636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917581; Shprh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ456
AC   CVCL_NB74
SY   RRJ456
DR   MMRRC; MMRRC:003093-UCD
DR   Wikidata; Q54771638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ458
AC   CVCL_NB75
SY   RRJ458
DR   MMRRC; MMRRC:003094-UCD
DR   Wikidata; Q54771640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930140; Wdr6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ462
AC   CVCL_NB76
SY   RRJ462
DR   MMRRC; MMRRC:003095-UCD
DR   Wikidata; Q54771642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917849; Itprid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRJ463
AC   CVCL_NB77
SY   RRJ463
DR   MMRRC; MMRRC:003096-UCD
DR   Wikidata; Q54771645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384761; Rapgef6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ464
AC   CVCL_NB78
SY   RRJ464
DR   MMRRC; MMRRC:003097-UCD
DR   Wikidata; Q54771646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289308; Tax1bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ465
AC   CVCL_NB79
SY   RRJ465
DR   MMRRC; MMRRC:003098-UCD
DR   Wikidata; Q54771649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159614; Mia2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRJ470
AC   CVCL_NB80
SY   RRJ470
DR   MMRRC; MMRRC:003099-UCD
DR   Wikidata; Q54771651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921494; Atg7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ472
AC   CVCL_NB81
SY   RRJ472
DR   MMRRC; MMRRC:003100-UCD
DR   Wikidata; Q54771655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925288; Mccc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ473
AC   CVCL_NB82
SY   RRJ473
DR   MMRRC; MMRRC:003101-UCD
DR   Wikidata; Q54771656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913830; Esf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ475
AC   CVCL_NB83
SY   RRJ475
DR   MMRRC; MMRRC:003102-UCD
DR   Wikidata; Q54771659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445193; Utp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ477
AC   CVCL_NB84
SY   RRJ477
DR   MMRRC; MMRRC:003103-UCD
DR   Wikidata; Q54771661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99430; Hira.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ478
AC   CVCL_NB85
SY   RRJ478
DR   MMRRC; MMRRC:003104-UCD
DR   Wikidata; Q54771662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3050795; Mrtfb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRJ479
AC   CVCL_NB86
SY   RRJ479
DR   MMRRC; MMRRC:003105-UCD
DR   Wikidata; Q54771664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ488
AC   CVCL_NB87
SY   RRJ488
DR   MMRRC; MMRRC:003112-UCD
DR   Wikidata; Q54771667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95612; Gabpb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ489
AC   CVCL_NB88
SY   RRJ489
DR   MMRRC; MMRRC:003113-UCD
DR   Wikidata; Q54771669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347360; Cul3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ490
AC   CVCL_NB89
SY   RRJ490
DR   MMRRC; MMRRC:003114-UCD
DR   Wikidata; Q54771672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919151; Fam219a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ494
AC   CVCL_NB90
SY   RRJ494
DR   MMRRC; MMRRC:003117-UCD
DR   Wikidata; Q54771673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102956; Cdk7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ495
AC   CVCL_NB91
SY   RRJ495
DR   MMRRC; MMRRC:003118-UCD
DR   Wikidata; Q54771675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101841; Ppm1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ500
AC   CVCL_NB92
SY   RRJ500
DR   MMRRC; MMRRC:003120-UCD
DR   Wikidata; Q54771677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101924; Slc12a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ501
AC   CVCL_NB93
SY   RRJ501
DR   MMRRC; MMRRC:003121-UCD
DR   Wikidata; Q54771678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ502
AC   CVCL_NB94
SY   RRJ502
DR   MMRRC; MMRRC:003122-UCD
DR   Wikidata; Q54771679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ504
AC   CVCL_NB95
SY   RRJ504
DR   MMRRC; MMRRC:003123-UCD
DR   Wikidata; Q54771681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913695; Cyc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ505
AC   CVCL_NB96
SY   RRJ505
DR   MMRRC; MMRRC:003124-UCD
DR   Wikidata; Q54771683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105056; Cobl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ507
AC   CVCL_NB97
SY   RRJ507
DR   MMRRC; MMRRC:003125-UCD
DR   Wikidata; Q54771684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918518; Lrrfip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ510
AC   CVCL_NB98
SY   RRJ510
DR   MMRRC; MMRRC:003127-UCD
DR   Wikidata; Q54771687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ514
AC   CVCL_NB99
SY   RRJ514
DR   MMRRC; MMRRC:003128-UCD
DR   Wikidata; Q54771690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108411; Prkag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ516
AC   CVCL_NC00
SY   RRJ516
DR   MMRRC; MMRRC:003129-UCD
DR   Wikidata; Q54771692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442842; Mtmr9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ519
AC   CVCL_NC01
SY   RRJ519
DR   MMRRC; MMRRC:003130-UCD
DR   Wikidata; Q54771695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96958; Golga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ520
AC   CVCL_NC02
SY   RRJ520
DR   MMRRC; MMRRC:003131-UCD
DR   Wikidata; Q54771696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442401; Ppp1r9a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ523
AC   CVCL_NC03
SY   RRJ523
DR   MMRRC; MMRRC:003132-UCD
DR   Wikidata; Q54771742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913895; Pspc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ526
AC   CVCL_NC04
SY   RRJ526
DR   MMRRC; MMRRC:003133-UCD
DR   Wikidata; Q54771745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98241; Stmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ527
AC   CVCL_NC05
SY   RRJ527
DR   MMRRC; MMRRC:003134-UCD
DR   Wikidata; Q54771747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890470; Pcbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ530
AC   CVCL_NC06
SY   RRJ530
DR   MMRRC; MMRRC:003136-UCD
DR   Wikidata; Q54771751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2652875; Wnk3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ533
AC   CVCL_NC07
SY   RRJ533
DR   MMRRC; MMRRC:003137-UCD
DR   Wikidata; Q54771753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ538
AC   CVCL_NC08
SY   RRJ538
DR   MMRRC; MMRRC:003138-UCD
DR   Wikidata; Q54771756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ543
AC   CVCL_NC09
SY   RRJ543
DR   MMRRC; MMRRC:003139-UCD
DR   Wikidata; Q54771757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ545
AC   CVCL_NC10
SY   RRJ545
DR   MMRRC; MMRRC:003140-UCD
DR   Wikidata; Q54771759
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915401; Wls.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ548
AC   CVCL_NC11
SY   RRJ548
DR   MMRRC; MMRRC:003142-UCD
DR   Wikidata; Q54771761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99948; Zfhx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ551
AC   CVCL_NC12
SY   RRJ551
DR   MMRRC; MMRRC:003143-UCD
DR   Wikidata; Q54771764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146236; Slc45a4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ552
AC   CVCL_NC13
SY   RRJ552
DR   MMRRC; MMRRC:003144-UCD
DR   Wikidata; Q54771766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914672; Dhdds.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ555
AC   CVCL_NC14
SY   RRJ555
DR   MMRRC; MMRRC:003146-UCD
DR   Wikidata; Q54771769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ557
AC   CVCL_NC15
SY   RRJ557
DR   MMRRC; MMRRC:003147-UCD
DR   Wikidata; Q54771772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444188; Dgkh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ558
AC   CVCL_NC16
SY   RRJ558
DR   MMRRC; MMRRC:003148-UCD
DR   Wikidata; Q54771773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700014; Sorbs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ560
AC   CVCL_NC17
SY   RRJ560
DR   MMRRC; MMRRC:003149-UCD
DR   Wikidata; Q54771776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ565
AC   CVCL_NC18
SY   RRJ565
DR   MMRRC; MMRRC:003151-UCD
DR   Wikidata; Q54771778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109127; Tsc22d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ566
AC   CVCL_NC19
SY   RRJ566
DR   MMRRC; MMRRC:003152-UCD
DR   Wikidata; Q54771779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443895; Fry.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ569
AC   CVCL_NC20
SY   RRJ569
DR   MMRRC; MMRRC:003153-UCD
DR   Wikidata; Q54771781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98241; Stmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ571
AC   CVCL_NC21
SY   RRJ571
DR   MMRRC; MMRRC:003154-UCD
DR   Wikidata; Q54771784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932404; Phip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ572
AC   CVCL_NC22
SY   RRJ572
DR   MMRRC; MMRRC:003155-UCD
DR   Wikidata; Q54771785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098240; Kif16b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ574
AC   CVCL_NC23
SY   RRJ574
DR   MMRRC; MMRRC:003157-UCD
DR   Wikidata; Q54771787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917056; Slc39a11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ578
AC   CVCL_NC24
SY   RRJ578
DR   MMRRC; MMRRC:003158-UCD
DR   Wikidata; Q54771789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925503; Map4k5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ579
AC   CVCL_NC25
SY   RRJ579
DR   MMRRC; MMRRC:003159-UCD
DR   Wikidata; Q54771790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98728; Tgfbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ583
AC   CVCL_NC26
SY   RRJ583
DR   MMRRC; MMRRC:003160-UCD
DR   Wikidata; Q54771793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924363; Klhl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ588
AC   CVCL_NC27
SY   RRJ588
DR   MMRRC; MMRRC:003162-UCD
DR   Wikidata; Q54771795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ592
AC   CVCL_NC28
SY   RRJ592
DR   MMRRC; MMRRC:003163-UCD
DR   Wikidata; Q54771796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917822; Ipo5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ593
AC   CVCL_NC29
SY   RRJ593
DR   MMRRC; MMRRC:003164-UCD
DR   Wikidata; Q54771798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202302; Pms1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ595
AC   CVCL_NC30
SY   RRJ595
DR   MMRRC; MMRRC:003165-UCD
DR   Wikidata; Q54771799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913755; Zmynd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ599
AC   CVCL_NC31
SY   RRJ599
DR   MMRRC; MMRRC:003167-UCD
DR   Wikidata; Q54771801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927234; Suclg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ602
AC   CVCL_NC32
SY   RRJ602
DR   MMRRC; MMRRC:003168-UCD
DR   Wikidata; Q54771805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913881; Mfsd14b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ603
AC   CVCL_NC33
SY   RRJ603
DR   MMRRC; MMRRC:003169-UCD
DR   Wikidata; Q54771806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859649; Ctnnal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ605
AC   CVCL_NC34
SY   RRJ605
DR   MMRRC; MMRRC:003171-UCD
DR   Wikidata; Q54771807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102657; Cdc34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ608
AC   CVCL_NC35
SY   RRJ608
DR   MMRRC; MMRRC:003172-UCD
DR   Wikidata; Q54771808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98386; Sptan1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ620
AC   CVCL_NC36
SY   RRJ620
DR   MMRRC; MMRRC:003175-UCD
DR   Wikidata; Q54771810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917394; Lrch3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ622
AC   CVCL_NC37
SY   RRJ622
DR   MMRRC; MMRRC:003176-UCD
DR   Wikidata; Q54771812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103008; Epb41l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ627
AC   CVCL_NC38
SY   RRJ627
DR   MMRRC; MMRRC:003177-UCD
DR   Wikidata; Q54771814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385139; Rabgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ628
AC   CVCL_NC39
SY   RRJ628
DR   MMRRC; MMRRC:003178-UCD
DR   Wikidata; Q54771816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2654703; Otud7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ632
AC   CVCL_NC40
SY   RRJ632
DR   MMRRC; MMRRC:003180-UCD
DR   Wikidata; Q54771818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109367; Impdh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ635
AC   CVCL_NC41
SY   RRJ635
DR   MMRRC; MMRRC:003181-UCD
DR   Wikidata; Q54771821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934950; Csnk1a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ641
AC   CVCL_NC42
SY   RRJ641
DR   MMRRC; MMRRC:003184-UCD
DR   Wikidata; Q54771822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ650
AC   CVCL_NC43
SY   RRJ650
DR   MMRRC; MMRRC:003187-UCD
DR   Wikidata; Q54771871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334462; Copa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ653
AC   CVCL_NC44
SY   RRJ653
DR   MMRRC; MMRRC:003188-UCD
DR   Wikidata; Q54771873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920428; Wasl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ655
AC   CVCL_NC45
SY   RRJ655
DR   MMRRC; MMRRC:003189-UCD
DR   Wikidata; Q54771875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141161; Tyw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ658
AC   CVCL_NC46
SY   RRJ658
DR   MMRRC; MMRRC:003190-UCD
DR   Wikidata; Q54771878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923760; Trappc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ662
AC   CVCL_NC47
SY   RRJ662
DR   MMRRC; MMRRC:003191-UCD
DR   Wikidata; Q54771880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919213; Cdca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ666
AC   CVCL_NC48
SY   RRJ666
DR   MMRRC; MMRRC:003192-UCD
DR   Wikidata; Q54771883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ672
AC   CVCL_NC49
SY   RRJ672
DR   MMRRC; MMRRC:003193-UCD
DR   Wikidata; Q54771885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442697; Zfp473.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ678
AC   CVCL_NC50
SY   RRJ678
DR   MMRRC; MMRRC:003196-UCD
DR   Wikidata; Q54771886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914705; Klhl13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ681
AC   CVCL_NC51
SY   RRJ681
DR   MMRRC; MMRRC:003197-UCD
DR   Wikidata; Q54771889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919862; Hpf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ682
AC   CVCL_NC52
SY   RRJ682
DR   MMRRC; MMRRC:003198-UCD
DR   Wikidata; Q54771892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96628; Jak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ686
AC   CVCL_NC53
SY   RRJ686
DR   MMRRC; MMRRC:003201-UCD
DR   Wikidata; Q54771895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102465; Tex2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ687
AC   CVCL_NC54
SY   RRJ687
DR   MMRRC; MMRRC:003202-UCD
DR   Wikidata; Q54771899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923164; Exoc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ689
AC   CVCL_NC55
SY   RRJ689
DR   MMRRC; MMRRC:003203-UCD
DR   Wikidata; Q54771900
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107629; Luzp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRJ692
AC   CVCL_NC56
SY   RRJ692
DR   MMRRC; MMRRC:003205-UCD
DR   Wikidata; Q54771901
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442833; Bbs9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK001
AC   CVCL_NC57
SY   RRK001
DR   MMRRC; MMRRC:003206-UCD
DR   Wikidata; Q54771905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913721; Anp32e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK003
AC   CVCL_NC58
SY   RRK003
DR   MMRRC; MMRRC:003208-UCD
DR   Wikidata; Q54771907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96163; Hmox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK004
AC   CVCL_NC59
SY   RRK004
DR   MMRRC; MMRRC:003209-UCD
DR   Wikidata; Q54771908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95412; Ercc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK005
AC   CVCL_NC60
SY   RRK005
DR   MMRRC; MMRRC:003210-UCD
DR   Wikidata; Q54771910
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97447; Osbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK006
AC   CVCL_NC61
SY   RRK006
DR   MMRRC; MMRRC:003211-UCD
DR   Wikidata; Q54771912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146388; Ubxn7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK007
AC   CVCL_NC62
SY   RRK007
DR   MMRRC; MMRRC:003212-UCD
DR   Wikidata; Q54771915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104558; Rps6ka1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK009
AC   CVCL_NC63
SY   RRK009
DR   MMRRC; MMRRC:003213-UCD
DR   Wikidata; Q54771916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109353; Ufd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK010
AC   CVCL_NC64
SY   RRK010
DR   MMRRC; MMRRC:003214-UCD
DR   Wikidata; Q54771918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3645495; Alkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK019
AC   CVCL_NC65
SY   RRK019
DR   MMRRC; MMRRC:003215-UCD
DR   Wikidata; Q54771921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98447; Surf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK020
AC   CVCL_NC66
SY   RRK020
DR   MMRRC; MMRRC:003216-UCD
DR   Wikidata; Q54771924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104861; Bcat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK023
AC   CVCL_NC67
SY   RRK023
DR   MMRRC; MMRRC:003218-UCD
DR   Wikidata; Q54771926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924705; Rlf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK025
AC   CVCL_NC68
SY   RRK025
DR   MMRRC; MMRRC:003219-UCD
DR   Wikidata; Q54771929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK028
AC   CVCL_NC69
SY   RRK028
DR   MMRRC; MMRRC:003220-UCD
DR   Wikidata; Q54771931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590554; BC055324.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK030
AC   CVCL_NC70
SY   RRK030
DR   MMRRC; MMRRC:003222-UCD
DR   Wikidata; Q54771933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344694; Chic1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK032
AC   CVCL_NC71
SY   RRK032
DR   MMRRC; MMRRC:003223-UCD
DR   Wikidata; Q54771935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103251; Acly.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK033
AC   CVCL_NC72
SY   RRK033
DR   MMRRC; MMRRC:003224-UCD
DR   Wikidata; Q54771937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107184; Cct7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK038
AC   CVCL_NC73
SY   RRK038
DR   MMRRC; MMRRC:003225-UCD
DR   Wikidata; Q54771940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913489; Rsrc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK043
AC   CVCL_NC74
SY   RRK043
DR   MMRRC; MMRRC:003226-UCD
DR   Wikidata; Q54771942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105128; Rad23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK050
AC   CVCL_NC75
SY   RRK050
DR   MMRRC; MMRRC:003227-UCD
DR   Wikidata; Q54771944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK051
AC   CVCL_NC76
SY   RRK051
DR   MMRRC; MMRRC:003228-UCD
DR   Wikidata; Q54771945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915087; Tiprl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK052
AC   CVCL_NC77
SY   RRK052
DR   MMRRC; MMRRC:003229-UCD
DR   Wikidata; Q54771947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK056
AC   CVCL_NC78
SY   RRK056
DR   MMRRC; MMRRC:003231-UCD
DR   Wikidata; Q54771948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919240; Ddx54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK057
AC   CVCL_NC79
SY   RRK057
DR   MMRRC; MMRRC:003232-UCD
DR   Wikidata; Q54771949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK058
AC   CVCL_NC80
SY   RRK058
DR   MMRRC; MMRRC:003233-UCD
DR   Wikidata; Q54771952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105128; Rad23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK059
AC   CVCL_NC81
SY   RRK059
DR   MMRRC; MMRRC:003234-UCD
DR   Wikidata; Q54771957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351337; Ddx24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK060
AC   CVCL_NC82
SY   RRK060
DR   MMRRC; MMRRC:003235-UCD
DR   Wikidata; Q54771958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926135; Coro7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK062
AC   CVCL_NC83
SY   RRK062
DR   MMRRC; MMRRC:003236-UCD
DR   Wikidata; Q54772017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684063; Asxl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK064
AC   CVCL_NC84
SY   RRK064
DR   MMRRC; MMRRC:003237-UCD
DR   Wikidata; Q54772020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921446; Ttc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK065
AC   CVCL_NC85
SY   RRK065
DR   MMRRC; MMRRC:003238-UCD
DR   Wikidata; Q54772023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921968; Snx16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK067
AC   CVCL_NC86
SY   RRK067
DR   MMRRC; MMRRC:003239-UCD
DR   Wikidata; Q54772024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443386; Dnajc11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK069
AC   CVCL_NC87
SY   RRK069
DR   MMRRC; MMRRC:003241-UCD
DR   Wikidata; Q54772026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106314; Tars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK071
AC   CVCL_NC88
SY   RRK071
DR   MMRRC; MMRRC:003242-UCD
DR   Wikidata; Q54772027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443386; Dnajc11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK072
AC   CVCL_NC89
SY   RRK072
DR   MMRRC; MMRRC:003243-UCD
DR   Wikidata; Q54772031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK073
AC   CVCL_NC90
SY   RRK073
DR   MMRRC; MMRRC:003244-UCD
DR   Wikidata; Q54772034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443386; Dnajc11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK075
AC   CVCL_NC91
SY   RRK075
DR   MMRRC; MMRRC:003245-UCD
DR   Wikidata; Q54772035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196256; Kdm1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK076
AC   CVCL_NC92
SY   RRK076
DR   MMRRC; MMRRC:003246-UCD
DR   Wikidata; Q54772038
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK077
AC   CVCL_NC93
SY   RRK077
DR   MMRRC; MMRRC:003247-UCD
DR   Wikidata; Q54772040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK080
AC   CVCL_NC94
SY   RRK080
DR   MMRRC; MMRRC:003248-UCD
DR   Wikidata; Q54772041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920454; 3110056K07Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK081
AC   CVCL_NC95
SY   RRK081
DR   MMRRC; MMRRC:003249-UCD
DR   Wikidata; Q54772044
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914152; Mtap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK082
AC   CVCL_NC96
SY   RRK082
DR   MMRRC; MMRRC:003250-UCD
DR   Wikidata; Q54772046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK085
AC   CVCL_NC97
SY   RRK085
DR   MMRRC; MMRRC:003251-UCD
DR   Wikidata; Q54772049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927170; Spata5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK086
AC   CVCL_NC98
SY   RRK086
DR   MMRRC; MMRRC:003252-UCD
DR   Wikidata; Q54772050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK089
AC   CVCL_NC99
SY   RRK089
DR   MMRRC; MMRRC:003253-UCD
DR   Wikidata; Q54772052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104558; Rps6ka1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK090
AC   CVCL_ND00
SY   RRK090
DR   MMRRC; MMRRC:003254-UCD
DR   Wikidata; Q54772053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442620; Nup133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK094
AC   CVCL_ND01
SY   RRK094
DR   MMRRC; MMRRC:003255-UCD
DR   Wikidata; Q54772055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445089; Trappc12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK095
AC   CVCL_ND02
SY   RRK095
DR   MMRRC; MMRRC:003256-UCD
DR   Wikidata; Q54772057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888993; Api5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK097
AC   CVCL_ND03
SY   RRK097
DR   MMRRC; MMRRC:003257-UCD
DR   Wikidata; Q54772060
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683537; Tapt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK101
AC   CVCL_ND04
SY   RRK101
DR   MMRRC; MMRRC:003258-UCD
DR   Wikidata; Q54772062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK104
AC   CVCL_ND05
SY   RRK104
DR   MMRRC; MMRRC:003259-UCD
DR   Wikidata; Q54772064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105128; Rad23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK105
AC   CVCL_ND06
SY   RRK105
DR   MMRRC; MMRRC:003260-UCD
DR   Wikidata; Q54772067
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923483; Dnttip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK106
AC   CVCL_ND07
SY   RRK106
DR   MMRRC; MMRRC:003261-UCD
DR   Wikidata; Q54772069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK111
AC   CVCL_ND08
SY   RRK111
DR   MMRRC; MMRRC:003263-UCD
DR   Wikidata; Q54772072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152453; Gsk3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK114
AC   CVCL_ND09
SY   RRK114
DR   MMRRC; MMRRC:003265-UCD
DR   Wikidata; Q54772074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928898; Usp14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK115
AC   CVCL_ND10
SY   RRK115
DR   MMRRC; MMRRC:003266-UCD
DR   Wikidata; Q54772077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98884; U2af1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK116
AC   CVCL_ND11
SY   RRK116
DR   MMRRC; MMRRC:003267-UCD
DR   Wikidata; Q54772079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916327; Psmd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK117
AC   CVCL_ND12
SY   RRK117
DR   MMRRC; MMRRC:003268-UCD
DR   Wikidata; Q54772081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934029; Usp8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK118
AC   CVCL_ND13
SY   RRK118
DR   MMRRC; MMRRC:003269-UCD
DR   Wikidata; Q54772084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932395; Rrbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK119
AC   CVCL_ND14
SY   RRK119
DR   MMRRC; MMRRC:003270-UCD
DR   Wikidata; Q54772085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928484; Nudt3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK121
AC   CVCL_ND15
SY   RRK121
DR   MMRRC; MMRRC:003272-UCD
DR   Wikidata; Q54772087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926143; Cnot10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK122
AC   CVCL_ND16
SY   RRK122
DR   MMRRC; MMRRC:003273-UCD
DR   Wikidata; Q54772090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK125
AC   CVCL_ND17
SY   RRK125
DR   MMRRC; MMRRC:003275-UCD
DR   Wikidata; Q54772093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277218; Rpap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK128
AC   CVCL_ND18
SY   RRK128
DR   MMRRC; MMRRC:003276-UCD
DR   Wikidata; Q54772095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913489; Rsrc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK129
AC   CVCL_ND19
SY   RRK129
DR   MMRRC; MMRRC:003277-UCD
DR   Wikidata; Q54772097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920136; Yju2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRK133
AC   CVCL_ND20
SY   RRK133
DR   MMRRC; MMRRC:003278-UCD
DR   Wikidata; Q54772098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK135
AC   CVCL_ND21
SY   RRK135
DR   MMRRC; MMRRC:003280-UCD
DR   Wikidata; Q54772100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97286; Ncl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK137
AC   CVCL_ND22
SY   RRK137
DR   MMRRC; MMRRC:003282-UCD
DR   Wikidata; Q54772103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915525; Rpa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK138
AC   CVCL_ND23
SY   RRK138
DR   MMRRC; MMRRC:003283-UCD
DR   Wikidata; Q54772143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK141
AC   CVCL_ND24
SY   RRK141
DR   MMRRC; MMRRC:003284-UCD
DR   Wikidata; Q54772146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919834; Cul4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK142
AC   CVCL_ND25
SY   RRK142
DR   MMRRC; MMRRC:003285-UCD
DR   Wikidata; Q54772147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106067; Smc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK143
AC   CVCL_ND26
SY   RRK143
DR   MMRRC; MMRRC:003286-UCD
DR   Wikidata; Q54772150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915943; Hnrnpul2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK149
AC   CVCL_ND27
SY   RRK149
DR   MMRRC; MMRRC:003287-UCD
DR   Wikidata; Q54772151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK152
AC   CVCL_ND28
SY   RRK152
DR   MMRRC; MMRRC:003289-UCD
DR   Wikidata; Q54772152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK154
AC   CVCL_ND29
SY   RRK154
DR   MMRRC; MMRRC:003290-UCD
DR   Wikidata; Q54772156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444248; Gcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRK156
AC   CVCL_ND30
SY   RRK156
DR   MMRRC; MMRRC:003291-UCD
DR   Wikidata; Q54772158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926227; Nup160.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK159
AC   CVCL_ND31
SY   RRK159
DR   MMRRC; MMRRC:003292-UCD
DR   Wikidata; Q54772160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913560; Dpy30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK160
AC   CVCL_ND32
SY   RRK160
DR   MMRRC; MMRRC:003293-UCD
DR   Wikidata; Q54772163
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK162
AC   CVCL_ND33
SY   RRK162
DR   MMRRC; MMRRC:003294-UCD
DR   Wikidata; Q54772164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443665; Numa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK164
AC   CVCL_ND34
SY   RRK164
DR   MMRRC; MMRRC:003295-UCD
DR   Wikidata; Q54772166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919369; Tpx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK165
AC   CVCL_ND35
SY   RRK165
DR   MMRRC; MMRRC:003296-UCD
DR   Wikidata; Q54772170
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913758; Lamtor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK166
AC   CVCL_ND36
SY   RRK166
DR   MMRRC; MMRRC:003297-UCD
DR   Wikidata; Q54772172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK168
AC   CVCL_ND37
SY   RRK168
DR   MMRRC; MMRRC:003298-UCD
DR   Wikidata; Q54772175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK169
AC   CVCL_ND38
SY   RRK169
DR   MMRRC; MMRRC:003299-UCD
DR   Wikidata; Q54772176
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147194; Rbm27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK170
AC   CVCL_ND39
SY   RRK170
DR   MMRRC; MMRRC:003300-UCD
DR   Wikidata; Q54772178
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444496; Prr11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK171
AC   CVCL_ND40
SY   RRK171
DR   MMRRC; MMRRC:003301-UCD
DR   Wikidata; Q54772181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916482; Qrich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK176
AC   CVCL_ND41
SY   RRK176
DR   MMRRC; MMRRC:003302-UCD
DR   Wikidata; Q54772182
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917458; Med23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK177
AC   CVCL_ND42
SY   RRK177
DR   MMRRC; MMRRC:003303-UCD
DR   Wikidata; Q54772185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933204; Rbm5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK178
AC   CVCL_ND43
SY   RRK178
DR   MMRRC; MMRRC:003304-UCD
DR   Wikidata; Q54772187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446163; Fam120a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK179
AC   CVCL_ND44
SY   RRK179
DR   MMRRC; MMRRC:003305-UCD
DR   Wikidata; Q54772188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK181
AC   CVCL_ND45
SY   RRK181
DR   MMRRC; MMRRC:003306-UCD
DR   Wikidata; Q54772191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK184
AC   CVCL_ND46
SY   RRK184
DR   MMRRC; MMRRC:003308-UCD
DR   Wikidata; Q54772194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK186
AC   CVCL_ND47
SY   RRK186
DR   MMRRC; MMRRC:003309-UCD
DR   Wikidata; Q54772195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922066; Tpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK187
AC   CVCL_ND48
SY   RRK187
DR   MMRRC; MMRRC:003310-UCD
DR   Wikidata; Q54772199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99700; Cenpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK189
AC   CVCL_ND49
SY   RRK189
DR   MMRRC; MMRRC:003312-UCD
DR   Wikidata; Q54772201
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98507; Tcf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK190
AC   CVCL_ND50
SY   RRK190
DR   MMRRC; MMRRC:003313-UCD
DR   Wikidata; Q54772203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140796; Slc15a4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK191
AC   CVCL_ND51
SY   RRK191
DR   MMRRC; MMRRC:003314-UCD
DR   Wikidata; Q54772205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87911; Acvr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK193
AC   CVCL_ND52
SY   RRK193
DR   MMRRC; MMRRC:003315-UCD
DR   Wikidata; Q54772207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913348; Chchd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK194
AC   CVCL_ND53
SY   RRK194
DR   MMRRC; MMRRC:003316-UCD
DR   Wikidata; Q54772209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039623; Thada.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK195
AC   CVCL_ND54
SY   RRK195
DR   MMRRC; MMRRC:003317-UCD
DR   Wikidata; Q54772210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK196
AC   CVCL_ND55
SY   RRK196
DR   MMRRC; MMRRC:003318-UCD
DR   Wikidata; Q54772212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201607; Blzf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK197
AC   CVCL_ND56
SY   RRK197
DR   MMRRC; MMRRC:003319-UCD
DR   Wikidata; Q54772214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894681; Usp9x.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK198
AC   CVCL_ND57
SY   RRK198
DR   MMRRC; MMRRC:003320-UCD
DR   Wikidata; Q54772216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88529; Cs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK199
AC   CVCL_ND58
SY   RRK199
DR   MMRRC; MMRRC:003321-UCD
DR   Wikidata; Q54772219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915082; Brix1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK201
AC   CVCL_ND59
SY   RRK201
DR   MMRRC; MMRRC:003322-UCD
DR   Wikidata; Q54772221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99511; Ptpn11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK202
AC   CVCL_ND60
SY   RRK202
DR   MMRRC; MMRRC:003323-UCD
DR   Wikidata; Q54772223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098230; Cenpe.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK203
AC   CVCL_ND61
SY   RRK203
DR   MMRRC; MMRRC:003324-UCD
DR   Wikidata; Q54772226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99638; Mark2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK204
AC   CVCL_ND62
SY   RRK204
DR   MMRRC; MMRRC:003325-UCD
DR   Wikidata; Q54772228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97547; Pfkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK206
AC   CVCL_ND63
SY   RRK206
DR   MMRRC; MMRRC:003327-UCD
DR   Wikidata; Q54772272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK208
AC   CVCL_ND64
SY   RRK208
DR   MMRRC; MMRRC:003328-UCD
DR   Wikidata; Q54772273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK210
AC   CVCL_ND65
SY   RRK210
DR   MMRRC; MMRRC:003329-UCD
DR   Wikidata; Q54772277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890430; Paxip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK212
AC   CVCL_ND66
SY   RRK212
DR   MMRRC; MMRRC:003330-UCD
DR   Wikidata; Q54772279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100818; Crcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK213
AC   CVCL_ND67
SY   RRK213
DR   MMRRC; MMRRC:003331-UCD
DR   Wikidata; Q54772281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337100; Wdr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK218
AC   CVCL_ND68
SY   RRK218
DR   MMRRC; MMRRC:003333-UCD
DR   Wikidata; Q54772283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921078; Dcaf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK220
AC   CVCL_ND69
SY   RRK220
DR   MMRRC; MMRRC:003335-UCD
DR   Wikidata; Q54772285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922832; Relch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRK221
AC   CVCL_ND70
SY   RRK221
DR   MMRRC; MMRRC:003336-UCD
DR   Wikidata; Q54772286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK222
AC   CVCL_ND71
SY   RRK222
DR   MMRRC; MMRRC:003337-UCD
DR   Wikidata; Q54772289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87881; Acp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK223
AC   CVCL_ND72
SY   RRK223
DR   MMRRC; MMRRC:003338-UCD
DR   Wikidata; Q54772291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097668; Upp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK224
AC   CVCL_ND73
SY   RRK224
DR   MMRRC; MMRRC:003339-UCD
DR   Wikidata; Q54772292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK227
AC   CVCL_ND74
SY   RRK227
DR   MMRRC; MMRRC:003340-UCD
DR   Wikidata; Q54772296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346877; Map3k7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK230
AC   CVCL_ND75
SY   RRK230
DR   MMRRC; MMRRC:003341-UCD
DR   Wikidata; Q54772297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924841; Ddx10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK231
AC   CVCL_ND76
SY   RRK231
DR   MMRRC; MMRRC:003342-UCD
DR   Wikidata; Q54772298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924841; Ddx10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK232
AC   CVCL_ND77
SY   RRK232
DR   MMRRC; MMRRC:003343-UCD
DR   Wikidata; Q54772300
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917477; Zfp619.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK233
AC   CVCL_ND78
SY   RRK233
DR   MMRRC; MMRRC:003344-UCD
DR   Wikidata; Q54772302
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106314; Tars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK234
AC   CVCL_ND79
SY   RRK234
DR   MMRRC; MMRRC:003345-UCD
DR   Wikidata; Q54772304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK236
AC   CVCL_ND80
SY   RRK236
DR   MMRRC; MMRRC:003346-UCD
DR   Wikidata; Q54772306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104560; Nsf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK239
AC   CVCL_ND81
SY   RRK239
DR   MMRRC; MMRRC:003348-UCD
DR   Wikidata; Q54772308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684789; Lrsam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK241
AC   CVCL_ND82
SY   RRK241
DR   MMRRC; MMRRC:003349-UCD
DR   Wikidata; Q54772309
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3046173; Nup85.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK243
AC   CVCL_ND83
SY   RRK243
DR   MMRRC; MMRRC:003350-UCD
DR   Wikidata; Q54772310
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98180; Rrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK245
AC   CVCL_ND84
SY   RRK245
DR   MMRRC; MMRRC:003351-UCD
DR   Wikidata; Q54772312
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099786; Dhx15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK246
AC   CVCL_ND85
SY   RRK246
DR   MMRRC; MMRRC:003352-UCD
DR   Wikidata; Q54772313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925953; Zfp972.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK247
AC   CVCL_ND86
SY   RRK247
DR   MMRRC; MMRRC:003353-UCD
DR   Wikidata; Q54772314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922670; Secisbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK249
AC   CVCL_ND87
SY   RRK249
DR   MMRRC; MMRRC:003354-UCD
DR   Wikidata; Q54772316
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104558; Rps6ka1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK250
AC   CVCL_ND88
SY   RRK250
DR   MMRRC; MMRRC:003355-UCD
DR   Wikidata; Q54772318
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK251
AC   CVCL_ND89
SY   RRK251
DR   MMRRC; MMRRC:003356-UCD
DR   Wikidata; Q54772320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153272; Trrap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK254
AC   CVCL_ND90
SY   RRK254
DR   MMRRC; MMRRC:003357-UCD
DR   Wikidata; Q54772322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442377; Ipo11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK255
AC   CVCL_ND91
SY   RRK255
DR   MMRRC; MMRRC:003358-UCD
DR   Wikidata; Q54772323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924203; Emsy.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK256
AC   CVCL_ND92
SY   RRK256
DR   MMRRC; MMRRC:003359-UCD
DR   Wikidata; Q54772325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK260
AC   CVCL_ND93
SY   RRK260
DR   MMRRC; MMRRC:003362-UCD
DR   Wikidata; Q54772326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919765; Wdr43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK261
AC   CVCL_ND94
SY   RRK261
DR   MMRRC; MMRRC:003363-UCD
DR   Wikidata; Q54772328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890467; Vps35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK271
AC   CVCL_ND95
SY   RRK271
DR   MMRRC; MMRRC:003366-UCD
DR   Wikidata; Q54772331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109531; Cdc37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK275
AC   CVCL_ND96
SY   RRK275
DR   MMRRC; MMRRC:003367-UCD
DR   Wikidata; Q54772332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351500; Nup62.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK278
AC   CVCL_ND97
SY   RRK278
DR   MMRRC; MMRRC:003369-UCD
DR   Wikidata; Q54772337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915082; Brix1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK279
AC   CVCL_ND98
SY   RRK279
DR   MMRRC; MMRRC:003370-UCD
DR   Wikidata; Q54772338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915452; Ndufa5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK280
AC   CVCL_ND99
SY   RRK280
DR   MMRRC; MMRRC:003371-UCD
DR   Wikidata; Q54772341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK281
AC   CVCL_NE00
SY   RRK281
DR   MMRRC; MMRRC:003372-UCD
DR   Wikidata; Q54772344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100510; Bub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK287
AC   CVCL_NE01
SY   RRK287
DR   MMRRC; MMRRC:003374-UCD
DR   Wikidata; Q54772345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158736; Senp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK290
AC   CVCL_NE02
SY   RRK290
DR   MMRRC; MMRRC:003375-UCD
DR   Wikidata; Q54772346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919784; Rcc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK291
AC   CVCL_NE03
SY   RRK291
DR   MMRRC; MMRRC:003376-UCD
DR   Wikidata; Q54772394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3780550; Mthfsl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK292
AC   CVCL_NE04
SY   RRK292
DR   MMRRC; MMRRC:003377-UCD
DR   Wikidata; Q54772397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921807; Ppp6r3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK293
AC   CVCL_NE05
SY   RRK293
DR   MMRRC; MMRRC:003378-UCD
DR   Wikidata; Q54772398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917820; Tent4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRK299
AC   CVCL_NE06
SY   RRK299
DR   MMRRC; MMRRC:003381-UCD
DR   Wikidata; Q54772400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK301
AC   CVCL_NE07
SY   RRK301
DR   MMRRC; MMRRC:003382-UCD
DR   Wikidata; Q54772404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK302
AC   CVCL_NE08
SY   RRK302
DR   MMRRC; MMRRC:003383-UCD
DR   Wikidata; Q54772405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384917; Cep290.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK304
AC   CVCL_NE09
SY   RRK304
DR   MMRRC; MMRRC:003384-UCD
DR   Wikidata; Q54772408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929651; Supt20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK309
AC   CVCL_NE10
SY   RRK309
DR   MMRRC; MMRRC:003385-UCD
DR   Wikidata; Q54772409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590652; Txlng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK315
AC   CVCL_NE11
SY   RRK315
DR   MMRRC; MMRRC:003387-UCD
DR   Wikidata; Q54772411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934835; Ube2n.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK322
AC   CVCL_NE12
SY   RRK322
DR   MMRRC; MMRRC:003388-UCD
DR   Wikidata; Q54772413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098824; Odf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK327
AC   CVCL_NE13
SY   RRK327
DR   MMRRC; MMRRC:003390-UCD
DR   Wikidata; Q54772414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920136; Yju2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRK335
AC   CVCL_NE14
SY   RRK335
DR   MMRRC; MMRRC:003392-UCD
DR   Wikidata; Q54772416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447762; Yeats2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK338
AC   CVCL_NE15
SY   RRK338
DR   MMRRC; MMRRC:003394-UCD
DR   Wikidata; Q54772418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309480; Rtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK340
AC   CVCL_NE16
SY   RRK340
DR   MMRRC; MMRRC:003395-UCD
DR   Wikidata; Q54772421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446526; Cpt1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK343
AC   CVCL_NE17
SY   RRK343
DR   MMRRC; MMRRC:003397-UCD
DR   Wikidata; Q54772423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923483; Dnttip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK345
AC   CVCL_NE18
SY   RRK345
DR   MMRRC; MMRRC:003398-UCD
DR   Wikidata; Q54772425
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918521; Gca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK346
AC   CVCL_NE19
SY   RRK346
DR   MMRRC; MMRRC:003399-UCD
DR   Wikidata; Q54772428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923396; Stx16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK349
AC   CVCL_NE20
SY   RRK349
DR   MMRRC; MMRRC:003401-UCD
DR   Wikidata; Q54772431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK350
AC   CVCL_NE21
SY   RRK350
DR   MMRRC; MMRRC:003402-UCD
DR   Wikidata; Q54772432
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276124; Ep400.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK351
AC   CVCL_NE22
SY   RRK351
DR   MMRRC; MMRRC:003403-UCD
DR   Wikidata; Q54772433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913974; Tab3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK354
AC   CVCL_NE23
SY   RRK354
DR   MMRRC; MMRRC:003404-UCD
DR   Wikidata; Q54772435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927222; Diaph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK355
AC   CVCL_NE24
SY   RRK355
DR   MMRRC; MMRRC:003405-UCD
DR   Wikidata; Q54772438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921633; Ubap2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK357
AC   CVCL_NE25
SY   RRK357
DR   MMRRC; MMRRC:003407-UCD
DR   Wikidata; Q54772440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442697; Zfp473.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK359
AC   CVCL_NE26
SY   RRK359
DR   MMRRC; MMRRC:003408-UCD
DR   Wikidata; Q54772442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926129; Arid1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK360
AC   CVCL_NE27
SY   RRK360
DR   MMRRC; MMRRC:003409-UCD
DR   Wikidata; Q54772444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK364
AC   CVCL_NE28
SY   RRK364
DR   MMRRC; MMRRC:003410-UCD
DR   Wikidata; Q54772446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97286; Ncl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK365
AC   CVCL_NE29
SY   RRK365
DR   MMRRC; MMRRC:003411-UCD
DR   Wikidata; Q54772447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95412; Ercc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK366
AC   CVCL_NE30
SY   RRK366
DR   MMRRC; MMRRC:003412-UCD
DR   Wikidata; Q54772451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK368
AC   CVCL_NE31
SY   RRK368
DR   MMRRC; MMRRC:003414-UCD
DR   Wikidata; Q54772454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146974; Safb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK369
AC   CVCL_NE32
SY   RRK369
DR   MMRRC; MMRRC:003415-UCD
DR   Wikidata; Q54772455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927470; Spag5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK370
AC   CVCL_NE33
SY   RRK370
DR   MMRRC; MMRRC:003416-UCD
DR   Wikidata; Q54772459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934229; Setdb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK371
AC   CVCL_NE34
SY   RRK371
DR   MMRRC; MMRRC:003417-UCD
DR   Wikidata; Q54772460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919057; Tars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK372
AC   CVCL_NE35
SY   RRK372
DR   MMRRC; MMRRC:003418-UCD
DR   Wikidata; Q54772461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889276; Dgke.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK373
AC   CVCL_NE36
SY   RRK373
DR   MMRRC; MMRRC:003419-UCD
DR   Wikidata; Q54772464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916375; Cnot8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK374
AC   CVCL_NE37
SY   RRK374
DR   MMRRC; MMRRC:003420-UCD
DR   Wikidata; Q54772467
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK375
AC   CVCL_NE38
SY   RRK375
DR   MMRRC; MMRRC:003421-UCD
DR   Wikidata; Q54772469
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95401; Epb41.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK377
AC   CVCL_NE39
SY   RRK377
DR   MMRRC; MMRRC:003422-UCD
DR   Wikidata; Q54772471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK385
AC   CVCL_NE40
SY   RRK385
DR   MMRRC; MMRRC:003425-UCD
DR   Wikidata; Q54772472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99511; Ptpn11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK387
AC   CVCL_NE41
SY   RRK387
DR   MMRRC; MMRRC:003426-UCD
DR   Wikidata; Q54772475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336201; Sumo3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK388
AC   CVCL_NE42
SY   RRK388
DR   MMRRC; MMRRC:003427-UCD
DR   Wikidata; Q54772477
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106624; Myo9b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK405
AC   CVCL_NE43
SY   RRK405
DR   MMRRC; MMRRC:003433-UCD
DR   Wikidata; Q54772522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913721; Anp32e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK408
AC   CVCL_NE44
SY   RRK408
DR   MMRRC; MMRRC:003435-UCD
DR   Wikidata; Q54772524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278322; Epc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK410
AC   CVCL_NE45
SY   RRK410
DR   MMRRC; MMRRC:003436-UCD
DR   Wikidata; Q54772526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443665; Numa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK418
AC   CVCL_NE46
SY   RRK418
DR   MMRRC; MMRRC:003439-UCD
DR   Wikidata; Q54772528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347075; Nbea.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK420
AC   CVCL_NE47
SY   RRK420
DR   MMRRC; MMRRC:003440-UCD
DR   Wikidata; Q54772532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105128; Rad23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK421
AC   CVCL_NE48
SY   RRK421
DR   MMRRC; MMRRC:003441-UCD
DR   Wikidata; Q54772533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100819; Aff1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK430
AC   CVCL_NE49
SY   RRK430
DR   MMRRC; MMRRC:003444-UCD
DR   Wikidata; Q54772536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK431
AC   CVCL_NE50
SY   RRK431
DR   MMRRC; MMRRC:003445-UCD
DR   Wikidata; Q54772538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099436; Rad51b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK432
AC   CVCL_NE51
SY   RRK432
DR   MMRRC; MMRRC:003446-UCD
DR   Wikidata; Q54772541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK433
AC   CVCL_NE52
SY   RRK433
DR   MMRRC; MMRRC:003447-UCD
DR   Wikidata; Q54772542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915549; Vps53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK446
AC   CVCL_NE53
SY   RRK446
DR   MMRRC; MMRRC:003450-UCD
DR   Wikidata; Q54772544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100818; Crcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK447
AC   CVCL_NE54
SY   RRK447
DR   MMRRC; MMRRC:003451-UCD
DR   Wikidata; Q54772547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK451
AC   CVCL_NE55
SY   RRK451
DR   MMRRC; MMRRC:003452-UCD
DR   Wikidata; Q54772550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3041177; Taok3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK452
AC   CVCL_NE56
SY   RRK452
DR   MMRRC; MMRRC:003453-UCD
DR   Wikidata; Q54772551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97547; Pfkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK453
AC   CVCL_NE57
SY   RRK453
DR   MMRRC; MMRRC:003454-UCD
DR   Wikidata; Q54772552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97547; Pfkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK454
AC   CVCL_NE58
SY   RRK454
DR   MMRRC; MMRRC:003455-UCD
DR   Wikidata; Q54772555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182303; Ddx50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK456
AC   CVCL_NE59
SY   RRK456
DR   MMRRC; MMRRC:003456-UCD
DR   Wikidata; Q54772557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097668; Upp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK457
AC   CVCL_NE60
SY   RRK457
DR   MMRRC; MMRRC:003457-UCD
DR   Wikidata; Q54772558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919240; Ddx54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK459
AC   CVCL_NE61
SY   RRK459
DR   MMRRC; MMRRC:003458-UCD
DR   Wikidata; Q54772559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK461
AC   CVCL_NE62
SY   RRK461
DR   MMRRC; MMRRC:003459-UCD
DR   Wikidata; Q54772562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684789; Lrsam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK464
AC   CVCL_NE63
SY   RRK464
DR   MMRRC; MMRRC:003460-UCD
DR   Wikidata; Q54772565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924054; Kdm4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK467
AC   CVCL_NE64
SY   RRK467
DR   MMRRC; MMRRC:003462-UCD
DR   Wikidata; Q54772567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104653; Atp2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK468
AC   CVCL_NE65
SY   RRK468
DR   MMRRC; MMRRC:003463-UCD
DR   Wikidata; Q54772570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK469
AC   CVCL_NE66
SY   RRK469
DR   MMRRC; MMRRC:003464-UCD
DR   Wikidata; Q54772572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039623; Thada.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK473
AC   CVCL_NE67
SY   RRK473
DR   MMRRC; MMRRC:003466-UCD
DR   Wikidata; Q54772575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194492; Hdgfl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK474
AC   CVCL_NE68
SY   RRK474
DR   MMRRC; MMRRC:003467-UCD
DR   Wikidata; Q54772577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444023; Tdrd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK477
AC   CVCL_NE69
SY   RRK477
DR   MMRRC; MMRRC:003468-UCD
DR   Wikidata; Q54772578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143977; Mbtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK479
AC   CVCL_NE70
SY   RRK479
DR   MMRRC; MMRRC:003470-UCD
DR   Wikidata; Q54772580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928098; Tspan3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK483
AC   CVCL_NE71
SY   RRK483
DR   MMRRC; MMRRC:003471-UCD
DR   Wikidata; Q54772582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333879; Ap3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK484
AC   CVCL_NE72
SY   RRK484
DR   MMRRC; MMRRC:003472-UCD
DR   Wikidata; Q54772584
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917118; Ppie.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK485
AC   CVCL_NE73
SY   RRK485
DR   MMRRC; MMRRC:003473-UCD
DR   Wikidata; Q54772586
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106351; Fam104a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK490
AC   CVCL_NE74
SY   RRK490
DR   MMRRC; MMRRC:003474-UCD
DR   Wikidata; Q54772587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK494
AC   CVCL_NE75
SY   RRK494
DR   MMRRC; MMRRC:003475-UCD
DR   Wikidata; Q54772588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101835; Traf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK495
AC   CVCL_NE76
SY   RRK495
DR   MMRRC; MMRRC:003476-UCD
DR   Wikidata; Q54772589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922945; Rilpl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK500
AC   CVCL_NE77
SY   RRK500
DR   MMRRC; MMRRC:003479-UCD
DR   Wikidata; Q54772592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153887; Eri3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK501
AC   CVCL_NE78
SY   RRK501
DR   MMRRC; MMRRC:003480-UCD
DR   Wikidata; Q54772596
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448530; Vps13d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK505
AC   CVCL_NE79
SY   RRK505
DR   MMRRC; MMRRC:003482-UCD
DR   Wikidata; Q54772597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443926; Dmxl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK507
AC   CVCL_NE80
SY   RRK507
DR   MMRRC; MMRRC:003483-UCD
DR   Wikidata; Q54772599
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194492; Hdgfl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK513
AC   CVCL_NE81
SY   RRK513
DR   MMRRC; MMRRC:003485-UCD
DR   Wikidata; Q54772603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384876; Cdc73.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK515
AC   CVCL_NE82
SY   RRK515
DR   MMRRC; MMRRC:003486-UCD
DR   Wikidata; Q54772604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107185; Cct5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRK517
AC   CVCL_NE83
SY   RRK517
DR   MMRRC; MMRRC:003487-UCD
DR   Wikidata; Q54772647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443713; Ythdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL001
AC   CVCL_NE84
SY   RRL001
DR   MMRRC; MMRRC:003488-UCD
DR   Wikidata; Q54772649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL002
AC   CVCL_NE85
SY   RRL002
DR   MMRRC; MMRRC:003489-UCD
DR   Wikidata; Q54772650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344352; Dido1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL004
AC   CVCL_NE86
SY   RRL004
DR   MMRRC; MMRRC:003490-UCD
DR   Wikidata; Q54772653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106330; Larp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL006
AC   CVCL_NE87
SY   RRL006
DR   MMRRC; MMRRC:003491-UCD
DR   Wikidata; Q54772654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201685; Ctbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL009
AC   CVCL_NE88
SY   RRL009
DR   MMRRC; MMRRC:003492-UCD
DR   Wikidata; Q54772656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL013
AC   CVCL_NE89
SY   RRL013
DR   MMRRC; MMRRC:003494-UCD
DR   Wikidata; Q54772658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL016
AC   CVCL_NE90
SY   RRL016
DR   MMRRC; MMRRC:003495-UCD
DR   Wikidata; Q54772661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99523; Prdx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRL021
AC   CVCL_NE91
SY   RRL021
DR   MMRRC; MMRRC:003497-UCD
DR   Wikidata; Q54772663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443878; Slc4a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM002
AC   CVCL_NE92
SY   RRM002
DR   MMRRC; MMRRC:003498-UCD
DR   Wikidata; Q54772665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917447; Srp68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM003
AC   CVCL_NE93
SY   RRM003
DR   MMRRC; MMRRC:003499-UCD
DR   Wikidata; Q54772667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM004
AC   CVCL_NE94
SY   RRM004
DR   MMRRC; MMRRC:003500-UCD
DR   Wikidata; Q54772668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102706; Fdft1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM005
AC   CVCL_NE95
SY   RRM005
DR   MMRRC; MMRRC:003501-UCD
DR   Wikidata; Q54772670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918893; Zgrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM006
AC   CVCL_NE96
SY   RRM006
DR   MMRRC; MMRRC:003502-UCD
DR   Wikidata; Q54772672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918893; Zgrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM007
AC   CVCL_NE97
SY   RRM007
DR   MMRRC; MMRRC:003503-UCD
DR   Wikidata; Q54772673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889585; Sall1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM010
AC   CVCL_NE98
SY   RRM010
DR   MMRRC; MMRRC:003505-UCD
DR   Wikidata; Q54772675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM011
AC   CVCL_NE99
SY   RRM011
DR   MMRRC; MMRRC:003506-UCD
DR   Wikidata; Q54772677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349767; Polk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM013
AC   CVCL_NF00
SY   RRM013
DR   MMRRC; MMRRC:003507-UCD
DR   Wikidata; Q54772679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447768; Fam193a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM014
AC   CVCL_NF01
SY   RRM014
DR   MMRRC; MMRRC:003508-UCD
DR   Wikidata; Q54772680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88547; Csnk2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM015
AC   CVCL_NF02
SY   RRM015
DR   MMRRC; MMRRC:003509-UCD
DR   Wikidata; Q54772682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924894; Steep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRM017
AC   CVCL_NF03
SY   RRM017
DR   MMRRC; MMRRC:003510-UCD
DR   Wikidata; Q54772684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914127; Crnkl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM019
AC   CVCL_NF04
SY   RRM019
DR   MMRRC; MMRRC:003511-UCD
DR   Wikidata; Q54772686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915848; Dnajc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM021
AC   CVCL_NF05
SY   RRM021
DR   MMRRC; MMRRC:003512-UCD
DR   Wikidata; Q54772687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913776; Tceanc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM023
AC   CVCL_NF06
SY   RRM023
DR   MMRRC; MMRRC:003513-UCD
DR   Wikidata; Q54772689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919094; Nupl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM025
AC   CVCL_NF07
SY   RRM025
DR   MMRRC; MMRRC:003515-UCD
DR   Wikidata; Q54772690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM026
AC   CVCL_NF08
SY   RRM026
DR   MMRRC; MMRRC:003516-UCD
DR   Wikidata; Q54772692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM027
AC   CVCL_NF09
SY   RRM027
DR   MMRRC; MMRRC:003517-UCD
DR   Wikidata; Q54772693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914004; Foxp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM028
AC   CVCL_NF10
SY   RRM028
DR   MMRRC; MMRRC:003518-UCD
DR   Wikidata; Q54772697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97355; Nme1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM029
AC   CVCL_NF11
SY   RRM029
DR   MMRRC; MMRRC:003519-UCD
DR   Wikidata; Q54772698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97355; Nme1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM030
AC   CVCL_NF12
SY   RRM030
DR   MMRRC; MMRRC:003520-UCD
DR   Wikidata; Q54772701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97355; Nme1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM032
AC   CVCL_NF13
SY   RRM032
DR   MMRRC; MMRRC:003521-UCD
DR   Wikidata; Q54772704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347064; Med21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM033
AC   CVCL_NF14
SY   RRM033
DR   MMRRC; MMRRC:003522-UCD
DR   Wikidata; Q54772706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333796; Klf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM035
AC   CVCL_NF15
SY   RRM035
DR   MMRRC; MMRRC:003523-UCD
DR   Wikidata; Q54772708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913776; Tceanc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM036
AC   CVCL_NF16
SY   RRM036
DR   MMRRC; MMRRC:003524-UCD
DR   Wikidata; Q54772709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM039
AC   CVCL_NF17
SY   RRM039
DR   MMRRC; MMRRC:003525-UCD
DR   Wikidata; Q54772712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683592; Dhps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM040
AC   CVCL_NF18
SY   RRM040
DR   MMRRC; MMRRC:003526-UCD
DR   Wikidata; Q54772713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916340; Ascc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM041
AC   CVCL_NF19
SY   RRM041
DR   MMRRC; MMRRC:003527-UCD
DR   Wikidata; Q54772715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651986; Zfp985.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM042
AC   CVCL_NF20
SY   RRM042
DR   MMRRC; MMRRC:003528-UCD
DR   Wikidata; Q54772717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918518; Lrrfip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM044
AC   CVCL_NF21
SY   RRM044
DR   MMRRC; MMRRC:003529-UCD
DR   Wikidata; Q54772721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289172; Scyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM046
AC   CVCL_NF22
SY   RRM046
DR   MMRRC; MMRRC:003530-UCD
DR   Wikidata; Q54772722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922088; Naa15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM047
AC   CVCL_NF23
SY   RRM047
DR   MMRRC; MMRRC:003531-UCD
DR   Wikidata; Q54772772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346832; Esrrb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM048
AC   CVCL_NF24
SY   RRM048
DR   MMRRC; MMRRC:003532-UCD
DR   Wikidata; Q54772773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918917; Tmem248.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM049
AC   CVCL_NF25
SY   RRM049
DR   MMRRC; MMRRC:003533-UCD
DR   Wikidata; Q54772774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98285; Srsf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM050
AC   CVCL_NF26
SY   RRM050
DR   MMRRC; MMRRC:003534-UCD
DR   Wikidata; Q54772776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179717; Glcci1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM051
AC   CVCL_NF27
SY   RRM051
DR   MMRRC; MMRRC:003535-UCD
DR   Wikidata; Q54772777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444490; Syt14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM055
AC   CVCL_NF28
SY   RRM055
DR   MMRRC; MMRRC:003537-UCD
DR   Wikidata; Q54772780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923484; Magi3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM057
AC   CVCL_NF29
SY   RRM057
DR   MMRRC; MMRRC:003539-UCD
DR   Wikidata; Q54772781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM058
AC   CVCL_NF30
SY   RRM058
DR   MMRRC; MMRRC:003540-UCD
DR   Wikidata; Q54772783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925976; Scaper.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM060
AC   CVCL_NF31
SY   RRM060
DR   MMRRC; MMRRC:003541-UCD
DR   Wikidata; Q54772784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343460; Gnpat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM061
AC   CVCL_NF32
SY   RRM061
DR   MMRRC; MMRRC:003542-UCD
DR   Wikidata; Q54772786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103063; Stat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM062
AC   CVCL_NF33
SY   RRM062
DR   MMRRC; MMRRC:003543-UCD
DR   Wikidata; Q54772788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443008; Trappc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM063
AC   CVCL_NF34
SY   RRM063
DR   MMRRC; MMRRC:003544-UCD
DR   Wikidata; Q54772789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97295; Casp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM064
AC   CVCL_NF35
SY   RRM064
DR   MMRRC; MMRRC:003545-UCD
DR   Wikidata; Q54772792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919270; Zfp654.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRM065
AC   CVCL_NF36
SY   RRM065
DR   MMRRC; MMRRC:003546-UCD
DR   Wikidata; Q54772794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM066
AC   CVCL_NF37
SY   RRM066
DR   MMRRC; MMRRC:003547-UCD
DR   Wikidata; Q54772795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137221; Mrpl20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM067
AC   CVCL_NF38
SY   RRM067
DR   MMRRC; MMRRC:003548-UCD
DR   Wikidata; Q54772796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97547; Pfkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM068
AC   CVCL_NF39
SY   RRM068
DR   MMRRC; MMRRC:003549-UCD
DR   Wikidata; Q54772799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444323; A630089N07Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM071
AC   CVCL_NF40
SY   RRM071
DR   MMRRC; MMRRC:003550-UCD
DR   Wikidata; Q54772801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933946; Ptov1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM074
AC   CVCL_NF41
SY   RRM074
DR   MMRRC; MMRRC:003551-UCD
DR   Wikidata; Q54772803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920907; Fbrsl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM076
AC   CVCL_NF42
SY   RRM076
DR   MMRRC; MMRRC:003553-UCD
DR   Wikidata; Q54772804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM077
AC   CVCL_NF43
SY   RRM077
DR   MMRRC; MMRRC:003554-UCD
DR   Wikidata; Q54772805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915848; Dnajc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM078
AC   CVCL_NF44
SY   RRM078
DR   MMRRC; MMRRC:003555-UCD
DR   Wikidata; Q54772807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890081; Foxo3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM081
AC   CVCL_NF45
SY   RRM081
DR   MMRRC; MMRRC:003556-UCD
DR   Wikidata; Q54772809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141070; Ccz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM082
AC   CVCL_NF46
SY   RRM082
DR   MMRRC; MMRRC:003557-UCD
DR   Wikidata; Q54772811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914632; Brd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM083
AC   CVCL_NF47
SY   RRM083
DR   MMRRC; MMRRC:003558-UCD
DR   Wikidata; Q54772813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353654; Vps26a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM084
AC   CVCL_NF48
SY   RRM084
DR   MMRRC; MMRRC:003559-UCD
DR   Wikidata; Q54772814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590554; BC055324.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM086
AC   CVCL_NF49
SY   RRM086
DR   MMRRC; MMRRC:003560-UCD
DR   Wikidata; Q54772818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914497; Mtarc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRM087
AC   CVCL_NF50
SY   RRM087
DR   MMRRC; MMRRC:003561-UCD
DR   Wikidata; Q54772819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103147; Dync1h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM088
AC   CVCL_NF51
SY   RRM088
DR   MMRRC; MMRRC:003562-UCD
DR   Wikidata; Q54772822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3782817; Gm4635.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM089
AC   CVCL_NF52
SY   RRM089
DR   MMRRC; MMRRC:003563-UCD
DR   Wikidata; Q54772823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM093
AC   CVCL_NF53
SY   RRM093
DR   MMRRC; MMRRC:003565-UCD
DR   Wikidata; Q54772826
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445052; Tbck.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM096
AC   CVCL_NF54
SY   RRM096
DR   MMRRC; MMRRC:003566-UCD
DR   Wikidata; Q54772829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140945; Pds5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM097
AC   CVCL_NF55
SY   RRM097
DR   MMRRC; MMRRC:003567-UCD
DR   Wikidata; Q54772831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM102
AC   CVCL_NF56
SY   RRM102
DR   MMRRC; MMRRC:003568-UCD
DR   Wikidata; Q54772832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921092; Neurl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM103
AC   CVCL_NF57
SY   RRM103
DR   MMRRC; MMRRC:003569-UCD
DR   Wikidata; Q54772834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106478; Eif3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM104
AC   CVCL_NF58
SY   RRM104
DR   MMRRC; MMRRC:003570-UCD
DR   Wikidata; Q54772837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916469; Ddah1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM105
AC   CVCL_NF59
SY   RRM105
DR   MMRRC; MMRRC:003571-UCD
DR   Wikidata; Q54772838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926129; Arid1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM106
AC   CVCL_NF60
SY   RRM106
DR   MMRRC; MMRRC:003572-UCD
DR   Wikidata; Q54772839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM107
AC   CVCL_NF61
SY   RRM107
DR   MMRRC; MMRRC:003573-UCD
DR   Wikidata; Q54772840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135604; Gmeb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM110
AC   CVCL_NF62
SY   RRM110
DR   MMRRC; MMRRC:003574-UCD
DR   Wikidata; Q54772842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891112; Gmds.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM117
AC   CVCL_NF63
SY   RRM117
DR   MMRRC; MMRRC:003576-UCD
DR   Wikidata; Q54772938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919831; Edrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM118
AC   CVCL_NF64
SY   RRM118
DR   MMRRC; MMRRC:003577-UCD
DR   Wikidata; Q54772941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM119
AC   CVCL_NF65
SY   RRM119
DR   MMRRC; MMRRC:003578-UCD
DR   Wikidata; Q54772942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM120
AC   CVCL_NF66
SY   RRM120
DR   MMRRC; MMRRC:003579-UCD
DR   Wikidata; Q54772943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919725; Ssbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM121
AC   CVCL_NF67
SY   RRM121
DR   MMRRC; MMRRC:003580-UCD
DR   Wikidata; Q54772946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95804; Gsr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM124
AC   CVCL_NF68
SY   RRM124
DR   MMRRC; MMRRC:003582-UCD
DR   Wikidata; Q54772948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270849; Rps6kb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM126
AC   CVCL_NF69
SY   RRM126
DR   MMRRC; MMRRC:003583-UCD
DR   Wikidata; Q54772949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918984; Pan2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM130
AC   CVCL_NF70
SY   RRM130
DR   MMRRC; MMRRC:003586-UCD
DR   Wikidata; Q54772953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913378; Mrps36.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM132
AC   CVCL_NF71
SY   RRM132
DR   MMRRC; MMRRC:003587-UCD
DR   Wikidata; Q54772955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144305; Nsrp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM133
AC   CVCL_NF72
SY   RRM133
DR   MMRRC; MMRRC:003588-UCD
DR   Wikidata; Q54772956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87948; Adss.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM134
AC   CVCL_NF73
SY   RRM134
DR   MMRRC; MMRRC:003589-UCD
DR   Wikidata; Q54772958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444236; Ubn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM135
AC   CVCL_NF74
SY   RRM135
DR   MMRRC; MMRRC:003590-UCD
DR   Wikidata; Q54772960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444236; Ubn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM136
AC   CVCL_NF75
SY   RRM136
DR   MMRRC; MMRRC:003591-UCD
DR   Wikidata; Q54772961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922928; Ippk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM139
AC   CVCL_NF76
SY   RRM139
DR   MMRRC; MMRRC:003594-UCD
DR   Wikidata; Q54772963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101760; Bicd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM142
AC   CVCL_NF77
SY   RRM142
DR   MMRRC; MMRRC:003595-UCD
DR   Wikidata; Q54772966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM143
AC   CVCL_NF78
SY   RRM143
DR   MMRRC; MMRRC:003596-UCD
DR   Wikidata; Q54772968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM145
AC   CVCL_NF79
SY   RRM145
DR   MMRRC; MMRRC:003597-UCD
DR   Wikidata; Q54772970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183752; Tubgcp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM146
AC   CVCL_NF80
SY   RRM146
DR   MMRRC; MMRRC:003598-UCD
DR   Wikidata; Q54772972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925152; Prune1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM150
AC   CVCL_NF81
SY   RRM150
DR   MMRRC; MMRRC:003599-UCD
DR   Wikidata; Q54772976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139746; Ankrd13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM151
AC   CVCL_NF82
SY   RRM151
DR   MMRRC; MMRRC:003600-UCD
DR   Wikidata; Q54772978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97316; Nfya.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM153
AC   CVCL_NF83
SY   RRM153
DR   MMRRC; MMRRC:003601-UCD
DR   Wikidata; Q54772979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM154
AC   CVCL_NF84
SY   RRM154
DR   MMRRC; MMRRC:003602-UCD
DR   Wikidata; Q54772981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444668; Fnip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM155
AC   CVCL_NF85
SY   RRM155
DR   MMRRC; MMRRC:003603-UCD
DR   Wikidata; Q54772982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917004; Fbxo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM158
AC   CVCL_NF86
SY   RRM158
DR   MMRRC; MMRRC:003604-UCD
DR   Wikidata; Q54772986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447762; Yeats2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM159
AC   CVCL_NF87
SY   RRM159
DR   MMRRC; MMRRC:003605-UCD
DR   Wikidata; Q54772987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95768; Gna13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM162
AC   CVCL_NF88
SY   RRM162
DR   MMRRC; MMRRC:003607-UCD
DR   Wikidata; Q54772989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103038; Stat3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM164
AC   CVCL_NF89
SY   RRM164
DR   MMRRC; MMRRC:003608-UCD
DR   Wikidata; Q54772991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334458; Pex19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM165
AC   CVCL_NF90
SY   RRM165
DR   MMRRC; MMRRC:003609-UCD
DR   Wikidata; Q54772993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354704; Fbxl17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM167
AC   CVCL_NF91
SY   RRM167
DR   MMRRC; MMRRC:003610-UCD
DR   Wikidata; Q54772996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916996; Znhit6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM168
AC   CVCL_NF92
SY   RRM168
DR   MMRRC; MMRRC:003611-UCD
DR   Wikidata; Q54772998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM169
AC   CVCL_NF93
SY   RRM169
DR   MMRRC; MMRRC:003612-UCD
DR   Wikidata; Q54773000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890752; Zfp81.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM174
AC   CVCL_NF94
SY   RRM174
DR   MMRRC; MMRRC:003613-UCD
DR   Wikidata; Q54773001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM176
AC   CVCL_NF95
SY   RRM176
DR   MMRRC; MMRRC:003615-UCD
DR   Wikidata; Q54773002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347043; Orc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM182
AC   CVCL_NF96
SY   RRM182
DR   MMRRC; MMRRC:003617-UCD
DR   Wikidata; Q54773005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM187
AC   CVCL_NF97
SY   RRM187
DR   MMRRC; MMRRC:003619-UCD
DR   Wikidata; Q54773006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM192
AC   CVCL_NF98
SY   RRM192
DR   MMRRC; MMRRC:003621-UCD
DR   Wikidata; Q54773008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444298; G2e3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM195
AC   CVCL_NF99
SY   RRM195
DR   MMRRC; MMRRC:003622-UCD
DR   Wikidata; Q54773010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM201
AC   CVCL_NG00
SY   RRM201
DR   MMRRC; MMRRC:003623-UCD
DR   Wikidata; Q54773012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352754; Clic4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM202
AC   CVCL_NG01
SY   RRM202
DR   MMRRC; MMRRC:003624-UCD
DR   Wikidata; Q54773013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145310; Rnf44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM203
AC   CVCL_NG02
SY   RRM203
DR   MMRRC; MMRRC:003625-UCD
DR   Wikidata; Q54773015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859661; Atp11c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM204
AC   CVCL_NG03
SY   RRM204
DR   MMRRC; MMRRC:003626-UCD
DR   Wikidata; Q54773108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922946; Prpf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM206
AC   CVCL_NG04
SY   RRM206
DR   MMRRC; MMRRC:003627-UCD
DR   Wikidata; Q54773110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM210
AC   CVCL_NG05
SY   RRM210
DR   MMRRC; MMRRC:003628-UCD
DR   Wikidata; Q54773112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321392; Pex7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM212
AC   CVCL_NG06
SY   RRM212
DR   MMRRC; MMRRC:003629-UCD
DR   Wikidata; Q54773115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925860; Uvrag.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM213
AC   CVCL_NG07
SY   RRM213
DR   MMRRC; MMRRC:003630-UCD
DR   Wikidata; Q54773118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270863; Prep.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM217
AC   CVCL_NG08
SY   RRM217
DR   MMRRC; MMRRC:003632-UCD
DR   Wikidata; Q54773121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385139; Rabgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM221
AC   CVCL_NG09
SY   RRM221
DR   MMRRC; MMRRC:003633-UCD
DR   Wikidata; Q54773124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143132; Plekho2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM222
AC   CVCL_NG10
SY   RRM222
DR   MMRRC; MMRRC:003634-UCD
DR   Wikidata; Q54773125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921331; Cep350.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM224
AC   CVCL_NG11
SY   RRM224
DR   MMRRC; MMRRC:003635-UCD
DR   Wikidata; Q54773126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2386741; Slc30a6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM225
AC   CVCL_NG12
SY   RRM225
DR   MMRRC; MMRRC:003636-UCD
DR   Wikidata; Q54773130
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM229
AC   CVCL_NG13
SY   RRM229
DR   MMRRC; MMRRC:003637-UCD
DR   Wikidata; Q54773132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM235
AC   CVCL_NG14
SY   RRM235
DR   MMRRC; MMRRC:003638-UCD
DR   Wikidata; Q54773134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM241
AC   CVCL_NG15
SY   RRM241
DR   MMRRC; MMRRC:003643-UCD
DR   Wikidata; Q54773136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM243
AC   CVCL_NG16
SY   RRM243
DR   MMRRC; MMRRC:003644-UCD
DR   Wikidata; Q54773140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918771; Pds5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM247
AC   CVCL_NG17
SY   RRM247
DR   MMRRC; MMRRC:003647-UCD
DR   Wikidata; Q54773142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM248
AC   CVCL_NG18
SY   RRM248
DR   MMRRC; MMRRC:003648-UCD
DR   Wikidata; Q54773144
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337008; Ankfy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM254
AC   CVCL_NG19
SY   RRM254
DR   MMRRC; MMRRC:003652-UCD
DR   Wikidata; Q54773147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446526; Cpt1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM261
AC   CVCL_NG20
SY   RRM261
DR   MMRRC; MMRRC:003654-UCD
DR   Wikidata; Q54773149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914259; Ttc23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM266
AC   CVCL_NG21
SY   RRM266
DR   MMRRC; MMRRC:003656-UCD
DR   Wikidata; Q54773150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916225; Med27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM268
AC   CVCL_NG22
SY   RRM268
DR   MMRRC; MMRRC:003657-UCD
DR   Wikidata; Q54773153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919448; Mtrex.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRM269
AC   CVCL_NG23
SY   RRM269
DR   MMRRC; MMRRC:003658-UCD
DR   Wikidata; Q54773155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95301; Eif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM270
AC   CVCL_NG24
SY   RRM270
DR   MMRRC; MMRRC:003659-UCD
DR   Wikidata; Q54773157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM275
AC   CVCL_NG25
SY   RRM275
DR   MMRRC; MMRRC:003663-UCD
DR   Wikidata; Q54773159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM277
AC   CVCL_NG26
SY   RRM277
DR   MMRRC; MMRRC:003664-UCD
DR   Wikidata; Q54773162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446163; Fam120a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM278
AC   CVCL_NG27
SY   RRM278
DR   MMRRC; MMRRC:003665-UCD
DR   Wikidata; Q54773165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107736; Dync2h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM279
AC   CVCL_NG28
SY   RRM279
DR   MMRRC; MMRRC:003666-UCD
DR   Wikidata; Q54773167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96009; Hadh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM280
AC   CVCL_NG29
SY   RRM280
DR   MMRRC; MMRRC:003667-UCD
DR   Wikidata; Q54773169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97447; Osbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM285
AC   CVCL_NG30
SY   RRM285
DR   MMRRC; MMRRC:003670-UCD
DR   Wikidata; Q54773170
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920136; Yju2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRM364
AC   CVCL_NG31
SY   RRM364
DR   MMRRC; MMRRC:003671-UCD
DR   Wikidata; Q54773173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930768; Arid3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM374
AC   CVCL_NG32
SY   RRM374
DR   MMRRC; MMRRC:003673-UCD
DR   Wikidata; Q54773174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202876; Tcf7l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM376
AC   CVCL_NG33
SY   RRM376
DR   MMRRC; MMRRC:003675-UCD
DR   Wikidata; Q54773176
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM382
AC   CVCL_NG34
SY   RRM382
DR   MMRRC; MMRRC:003676-UCD
DR   Wikidata; Q54773177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919822; Spats2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM388
AC   CVCL_NG35
SY   RRM388
DR   MMRRC; MMRRC:003677-UCD
DR   Wikidata; Q54773179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925152; Prune1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM390
AC   CVCL_NG36
SY   RRM390
DR   MMRRC; MMRRC:003678-UCD
DR   Wikidata; Q54773180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105089; Hsd17b4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM391
AC   CVCL_NG37
SY   RRM391
DR   MMRRC; MMRRC:003679-UCD
DR   Wikidata; Q54773182
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277216; Gtf2h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM393
AC   CVCL_NG38
SY   RRM393
DR   MMRRC; MMRRC:003680-UCD
DR   Wikidata; Q54773183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890619; Gan.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM394
AC   CVCL_NG39
SY   RRM394
DR   MMRRC; MMRRC:003681-UCD
DR   Wikidata; Q54773186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM401
AC   CVCL_NG40
SY   RRM401
DR   MMRRC; MMRRC:003683-UCD
DR   Wikidata; Q54773187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444412; Phf20l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM402
AC   CVCL_NG41
SY   RRM402
DR   MMRRC; MMRRC:003684-UCD
DR   Wikidata; Q54773190
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM404
AC   CVCL_NG42
SY   RRM404
DR   MMRRC; MMRRC:003685-UCD
DR   Wikidata; Q54773192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918345; Kif24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRM405
AC   CVCL_NG43
SY   RRM405
DR   MMRRC; MMRRC:003686-UCD
DR   Wikidata; Q54773246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913368; Sarnp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN005
AC   CVCL_NG44
SY   RRN005
DR   MMRRC; MMRRC:003689-UCD
DR   Wikidata; Q54773248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890695; Rab9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN016
AC   CVCL_NG45
SY   RRN016
DR   MMRRC; MMRRC:003690-UCD
DR   Wikidata; Q54773249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3646907; Gm6563.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN028
AC   CVCL_NG46
SY   RRN028
DR   MMRRC; MMRRC:003691-UCD
DR   Wikidata; Q54773250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913368; Sarnp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN038
AC   CVCL_NG47
SY   RRN038
DR   MMRRC; MMRRC:003694-UCD
DR   Wikidata; Q54773253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3646907; Gm6563.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN044
AC   CVCL_NG48
SY   RRN044
DR   MMRRC; MMRRC:003695-UCD
DR   Wikidata; Q54773254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN046
AC   CVCL_NG49
SY   RRN046
DR   MMRRC; MMRRC:003696-UCD
DR   Wikidata; Q54773255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146836; Brpf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN049
AC   CVCL_NG50
SY   RRN049
DR   MMRRC; MMRRC:003697-UCD
DR   Wikidata; Q54773258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098658; Stag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN051
AC   CVCL_NG51
SY   RRN051
DR   MMRRC; MMRRC:003698-UCD
DR   Wikidata; Q54773259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN052
AC   CVCL_NG52
SY   RRN052
DR   MMRRC; MMRRC:003699-UCD
DR   Wikidata; Q54773261
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888677; Gigyf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN053
AC   CVCL_NG53
SY   RRN053
DR   MMRRC; MMRRC:003700-UCD
DR   Wikidata; Q54773264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN055
AC   CVCL_NG54
SY   RRN055
DR   MMRRC; MMRRC:003701-UCD
DR   Wikidata; Q54773267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924825; Kmt2e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN056
AC   CVCL_NG55
SY   RRN056
DR   MMRRC; MMRRC:003702-UCD
DR   Wikidata; Q54773271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277143; Gtf2h3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN059
AC   CVCL_NG56
SY   RRN059
DR   MMRRC; MMRRC:003703-UCD
DR   Wikidata; Q54773273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338038; Aebp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN061
AC   CVCL_NG57
SY   RRN061
DR   MMRRC; MMRRC:003704-UCD
DR   Wikidata; Q54773274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344353; Katna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN062
AC   CVCL_NG58
SY   RRN062
DR   MMRRC; MMRRC:003705-UCD
DR   Wikidata; Q54773276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917747; Arhgap17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN063
AC   CVCL_NG59
SY   RRN063
DR   MMRRC; MMRRC:003706-UCD
DR   Wikidata; Q54773277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN064
AC   CVCL_NG60
SY   RRN064
DR   MMRRC; MMRRC:003707-UCD
DR   Wikidata; Q54773279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN066
AC   CVCL_NG61
SY   RRN066
DR   MMRRC; MMRRC:003708-UCD
DR   Wikidata; Q54773281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920930; Zbtb8a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN067
AC   CVCL_NG62
SY   RRN067
DR   MMRRC; MMRRC:003709-UCD
DR   Wikidata; Q54773283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN070
AC   CVCL_NG63
SY   RRN070
DR   MMRRC; MMRRC:003710-UCD
DR   Wikidata; Q54773286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109150; Mnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN072
AC   CVCL_NG64
SY   RRN072
DR   MMRRC; MMRRC:003711-UCD
DR   Wikidata; Q54773288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928469; Trip4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN074
AC   CVCL_NG65
SY   RRN074
DR   MMRRC; MMRRC:003712-UCD
DR   Wikidata; Q54773290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347360; Cul3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN075
AC   CVCL_NG66
SY   RRN075
DR   MMRRC; MMRRC:003713-UCD
DR   Wikidata; Q54773292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914338; Cand2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN078
AC   CVCL_NG67
SY   RRN078
DR   MMRRC; MMRRC:003714-UCD
DR   Wikidata; Q54773294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN081
AC   CVCL_NG68
SY   RRN081
DR   MMRRC; MMRRC:003715-UCD
DR   Wikidata; Q54773297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914389; Mis12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN082
AC   CVCL_NG69
SY   RRN082
DR   MMRRC; MMRRC:003716-UCD
DR   Wikidata; Q54773299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346880; Map3k11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN083
AC   CVCL_NG70
SY   RRN083
DR   MMRRC; MMRRC:003717-UCD
DR   Wikidata; Q54773300
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915126; Coq10b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN084
AC   CVCL_NG71
SY   RRN084
DR   MMRRC; MMRRC:003718-UCD
DR   Wikidata; Q54773304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3583954; Zfp961.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN086
AC   CVCL_NG72
SY   RRN086
DR   MMRRC; MMRRC:003720-UCD
DR   Wikidata; Q54773306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN087
AC   CVCL_NG73
SY   RRN087
DR   MMRRC; MMRRC:003721-UCD
DR   Wikidata; Q54773308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914324; Mon2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN088
AC   CVCL_NG74
SY   RRN088
DR   MMRRC; MMRRC:003722-UCD
DR   Wikidata; Q54773310
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN091
AC   CVCL_NG75
SY   RRN091
DR   MMRRC; MMRRC:003724-UCD
DR   Wikidata; Q54773313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158736; Senp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN092
AC   CVCL_NG76
SY   RRN092
DR   MMRRC; MMRRC:003725-UCD
DR   Wikidata; Q54773316
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915095; Rnf115.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN093
AC   CVCL_NG77
SY   RRN093
DR   MMRRC; MMRRC:003726-UCD
DR   Wikidata; Q54773317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102724; Tpp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN094
AC   CVCL_NG78
SY   RRN094
DR   MMRRC; MMRRC:003727-UCD
DR   Wikidata; Q54773319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289274; Krr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN095
AC   CVCL_NG79
SY   RRN095
DR   MMRRC; MMRRC:003728-UCD
DR   Wikidata; Q54773320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894326; Atp6v1e1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN096
AC   CVCL_NG80
SY   RRN096
DR   MMRRC; MMRRC:003729-UCD
DR   Wikidata; Q54773321
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106624; Myo9b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN098
AC   CVCL_NG81
SY   RRN098
DR   MMRRC; MMRRC:003730-UCD
DR   Wikidata; Q54773324
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387357; Wac.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN099
AC   CVCL_NG82
SY   RRN099
DR   MMRRC; MMRRC:003731-UCD
DR   Wikidata; Q54773325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345186; Blmh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN100
AC   CVCL_NG83
SY   RRN100
DR   MMRRC; MMRRC:003732-UCD
DR   Wikidata; Q54773371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352463; Nr1h2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN101
AC   CVCL_NG84
SY   RRN101
DR   MMRRC; MMRRC:003733-UCD
DR   Wikidata; Q54773373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96623; Itpr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN107
AC   CVCL_NG85
SY   RRN107
DR   MMRRC; MMRRC:003736-UCD
DR   Wikidata; Q54773376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN108
AC   CVCL_NG86
SY   RRN108
DR   MMRRC; MMRRC:003737-UCD
DR   Wikidata; Q54773378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446089; Flnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN111
AC   CVCL_NG87
SY   RRN111
DR   MMRRC; MMRRC:003738-UCD
DR   Wikidata; Q54773380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891112; Gmds.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN121
AC   CVCL_NG88
SY   RRN121
DR   MMRRC; MMRRC:003740-UCD
DR   Wikidata; Q54773382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346875; Map3k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN124
AC   CVCL_NG89
SY   RRN124
DR   MMRRC; MMRRC:003741-UCD
DR   Wikidata; Q54773384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929459; Rabgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN126
AC   CVCL_NG90
SY   RRN126
DR   MMRRC; MMRRC:003742-UCD
DR   Wikidata; Q54773386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345964; Coro1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN127
AC   CVCL_NG91
SY   RRN127
DR   MMRRC; MMRRC:003743-UCD
DR   Wikidata; Q54773389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929869; Hic2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN131
AC   CVCL_NG92
SY   RRN131
DR   MMRRC; MMRRC:003744-UCD
DR   Wikidata; Q54773391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN132
AC   CVCL_NG93
SY   RRN132
DR   MMRRC; MMRRC:003745-UCD
DR   Wikidata; Q54773393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919769; Pip4p2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRN136
AC   CVCL_NG94
SY   RRN136
DR   MMRRC; MMRRC:003746-UCD
DR   Wikidata; Q54773394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN141
AC   CVCL_NG95
SY   RRN141
DR   MMRRC; MMRRC:003749-UCD
DR   Wikidata; Q54773397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891691; Arpp19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN142
AC   CVCL_NG96
SY   RRN142
DR   MMRRC; MMRRC:003750-UCD
DR   Wikidata; Q54773400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN154
AC   CVCL_NG97
SY   RRN154
DR   MMRRC; MMRRC:003753-UCD
DR   Wikidata; Q54773401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153063; Parvb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN156
AC   CVCL_NG98
SY   RRN156
DR   MMRRC; MMRRC:003754-UCD
DR   Wikidata; Q54773402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919790; Heatr6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN158
AC   CVCL_NG99
SY   RRN158
DR   MMRRC; MMRRC:003755-UCD
DR   Wikidata; Q54773405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103185; Uimc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN159
AC   CVCL_NH00
SY   RRN159
DR   MMRRC; MMRRC:003756-UCD
DR   Wikidata; Q54773407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915080; Rer1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN163
AC   CVCL_NH01
SY   RRN163
DR   MMRRC; MMRRC:003758-UCD
DR   Wikidata; Q54773408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919414; Rbmx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN164
AC   CVCL_NH02
SY   RRN164
DR   MMRRC; MMRRC:003759-UCD
DR   Wikidata; Q54773411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104772; Cdk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN167
AC   CVCL_NH03
SY   RRN167
DR   MMRRC; MMRRC:003760-UCD
DR   Wikidata; Q54773413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444661; Susd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN177
AC   CVCL_NH04
SY   RRN177
DR   MMRRC; MMRRC:003761-UCD
DR   Wikidata; Q54773414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933754; Nedd4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN178
AC   CVCL_NH05
SY   RRN178
DR   MMRRC; MMRRC:003762-UCD
DR   Wikidata; Q54773416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036261; Spata5l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN180
AC   CVCL_NH06
SY   RRN180
DR   MMRRC; MMRRC:003763-UCD
DR   Wikidata; Q54773418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700006; Dbnl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN181
AC   CVCL_NH07
SY   RRN181
DR   MMRRC; MMRRC:003764-UCD
DR   Wikidata; Q54773421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443419; Rps6kc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN183
AC   CVCL_NH08
SY   RRN183
DR   MMRRC; MMRRC:003765-UCD
DR   Wikidata; Q54773422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346872; Map3k1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN184
AC   CVCL_NH09
SY   RRN184
DR   MMRRC; MMRRC:003766-UCD
DR   Wikidata; Q54773425
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104560; Nsf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN186
AC   CVCL_NH10
SY   RRN186
DR   MMRRC; MMRRC:003767-UCD
DR   Wikidata; Q54773426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924337; Ankrd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN187
AC   CVCL_NH11
SY   RRN187
DR   MMRRC; MMRRC:003768-UCD
DR   Wikidata; Q54773428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109656; Lasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN196
AC   CVCL_NH12
SY   RRN196
DR   MMRRC; MMRRC:003771-UCD
DR   Wikidata; Q54773431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN197
AC   CVCL_NH13
SY   RRN197
DR   MMRRC; MMRRC:003772-UCD
DR   Wikidata; Q54773433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444222; Tmem104.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN198
AC   CVCL_NH14
SY   RRN198
DR   MMRRC; MMRRC:003773-UCD
DR   Wikidata; Q54773434
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924217; 2700049A03Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN200
AC   CVCL_NH15
SY   RRN200
DR   MMRRC; MMRRC:003774-UCD
DR   Wikidata; Q54773435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3647820; Hectd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN204
AC   CVCL_NH16
SY   RRN204
DR   MMRRC; MMRRC:003777-UCD
DR   Wikidata; Q54773437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097686; H3f3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN206
AC   CVCL_NH17
SY   RRN206
DR   MMRRC; MMRRC:003778-UCD
DR   Wikidata; Q54773438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443390; Lrch1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN207
AC   CVCL_NH18
SY   RRN207
DR   MMRRC; MMRRC:003779-UCD
DR   Wikidata; Q54773440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103007; Epb41l4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN210
AC   CVCL_NH19
SY   RRN210
DR   MMRRC; MMRRC:003780-UCD
DR   Wikidata; Q54773442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045391; Lin52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN212
AC   CVCL_NH20
SY   RRN212
DR   MMRRC; MMRRC:003781-UCD
DR   Wikidata; Q54773445
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913495; Hspbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN214
AC   CVCL_NH21
SY   RRN214
DR   MMRRC; MMRRC:003783-UCD
DR   Wikidata; Q54773447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928760; Ruvbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN215
AC   CVCL_NH22
SY   RRN215
DR   MMRRC; MMRRC:003784-UCD
DR   Wikidata; Q54773448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918867; Armh3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRN216
AC   CVCL_NH23
SY   RRN216
DR   MMRRC; MMRRC:003785-UCD
DR   Wikidata; Q54773491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924145; Bicd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN218
AC   CVCL_NH24
SY   RRN218
DR   MMRRC; MMRRC:003786-UCD
DR   Wikidata; Q54773494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97891; Rfc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN225
AC   CVCL_NH25
SY   RRN225
DR   MMRRC; MMRRC:003787-UCD
DR   Wikidata; Q54773495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147194; Rbm27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN226
AC   CVCL_NH26
SY   RRN226
DR   MMRRC; MMRRC:003788-UCD
DR   Wikidata; Q54773496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913398; Dnajc15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN227
AC   CVCL_NH27
SY   RRN227
DR   MMRRC; MMRRC:003789-UCD
DR   Wikidata; Q54773498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108420; Nfe2l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN237
AC   CVCL_NH28
SY   RRN237
DR   MMRRC; MMRRC:003793-UCD
DR   Wikidata; Q54773500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444412; Phf20l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN240
AC   CVCL_NH29
SY   RRN240
DR   MMRRC; MMRRC:003794-UCD
DR   Wikidata; Q54773502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443076; Cc2d1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN245
AC   CVCL_NH30
SY   RRN245
DR   MMRRC; MMRRC:003798-UCD
DR   Wikidata; Q54773504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914449; Pfdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN247
AC   CVCL_NH31
SY   RRN247
DR   MMRRC; MMRRC:003799-UCD
DR   Wikidata; Q54773508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN250
AC   CVCL_NH32
SY   RRN250
DR   MMRRC; MMRRC:003802-UCD
DR   Wikidata; Q54773509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN252
AC   CVCL_NH33
SY   RRN252
DR   MMRRC; MMRRC:003803-UCD
DR   Wikidata; Q54773510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN255
AC   CVCL_NH34
SY   RRN255
DR   MMRRC; MMRRC:003805-UCD
DR   Wikidata; Q54773514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN257
AC   CVCL_NH35
SY   RRN257
DR   MMRRC; MMRRC:003806-UCD
DR   Wikidata; Q54773515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN258
AC   CVCL_NH36
SY   RRN258
DR   MMRRC; MMRRC:003807-UCD
DR   Wikidata; Q54773518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914216; Trit1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN263
AC   CVCL_NH37
SY   RRN263
DR   MMRRC; MMRRC:003809-UCD
DR   Wikidata; Q54773520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914216; Trit1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN266
AC   CVCL_NH38
SY   RRN266
DR   MMRRC; MMRRC:003810-UCD
DR   Wikidata; Q54773521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915760; Ints1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN268
AC   CVCL_NH39
SY   RRN268
DR   MMRRC; MMRRC:003811-UCD
DR   Wikidata; Q54773523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890651; Brwd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN269
AC   CVCL_NH40
SY   RRN269
DR   MMRRC; MMRRC:003812-UCD
DR   Wikidata; Q54773526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890651; Brwd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN270
AC   CVCL_NH41
SY   RRN270
DR   MMRRC; MMRRC:003813-UCD
DR   Wikidata; Q54773527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384589; Herc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN277
AC   CVCL_NH42
SY   RRN277
DR   MMRRC; MMRRC:003815-UCD
DR   Wikidata; Q54773530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920895; Ddx46.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN280
AC   CVCL_NH43
SY   RRN280
DR   MMRRC; MMRRC:003816-UCD
DR   Wikidata; Q54773534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385851; Fam193b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN282
AC   CVCL_NH44
SY   RRN282
DR   MMRRC; MMRRC:003818-UCD
DR   Wikidata; Q54773535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102705; Gng2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN286
AC   CVCL_NH45
SY   RRN286
DR   MMRRC; MMRRC:003820-UCD
DR   Wikidata; Q54773537
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444431; Rab11fip3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN287
AC   CVCL_NH46
SY   RRN287
DR   MMRRC; MMRRC:003821-UCD
DR   Wikidata; Q54773539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144023; Fbxw11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN290
AC   CVCL_NH47
SY   RRN290
DR   MMRRC; MMRRC:003822-UCD
DR   Wikidata; Q54773540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN291
AC   CVCL_NH48
SY   RRN291
DR   MMRRC; MMRRC:003823-UCD
DR   Wikidata; Q54773541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN293
AC   CVCL_NH49
SY   RRN293
DR   MMRRC; MMRRC:003824-UCD
DR   Wikidata; Q54773543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921346; Hvcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN295
AC   CVCL_NH50
SY   RRN295
DR   MMRRC; MMRRC:003825-UCD
DR   Wikidata; Q54773544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN296
AC   CVCL_NH51
SY   RRN296
DR   MMRRC; MMRRC:003826-UCD
DR   Wikidata; Q54773545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924059; Bri3bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN298
AC   CVCL_NH52
SY   RRN298
DR   MMRRC; MMRRC:003828-UCD
DR   Wikidata; Q54773548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN303
AC   CVCL_NH53
SY   RRN303
DR   MMRRC; MMRRC:003830-UCD
DR   Wikidata; Q54773550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922945; Rilpl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN306
AC   CVCL_NH54
SY   RRN306
DR   MMRRC; MMRRC:003831-UCD
DR   Wikidata; Q54773552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN307
AC   CVCL_NH55
SY   RRN307
DR   MMRRC; MMRRC:003832-UCD
DR   Wikidata; Q54773554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921701; Pgs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN308
AC   CVCL_NH56
SY   RRN308
DR   MMRRC; MMRRC:003833-UCD
DR   Wikidata; Q54773556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918767; Vps35l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRN310
AC   CVCL_NH57
SY   RRN310
DR   MMRRC; MMRRC:003834-UCD
DR   Wikidata; Q54773560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN311
AC   CVCL_NH58
SY   RRN311
DR   MMRRC; MMRRC:003835-UCD
DR   Wikidata; Q54773562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107158; Sin3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN312
AC   CVCL_NH59
SY   RRN312
DR   MMRRC; MMRRC:003836-UCD
DR   Wikidata; Q54773563
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289326; Gpn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN315
AC   CVCL_NH60
SY   RRN315
DR   MMRRC; MMRRC:003838-UCD
DR   Wikidata; Q54773566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929074; Rev1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN317
AC   CVCL_NH61
SY   RRN317
DR   MMRRC; MMRRC:003839-UCD
DR   Wikidata; Q54773568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933532; Slc12a9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN319
AC   CVCL_NH62
SY   RRN319
DR   MMRRC; MMRRC:003841-UCD
DR   Wikidata; Q54773570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88039; Apc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN322
AC   CVCL_NH63
SY   RRN322
DR   MMRRC; MMRRC:003842-UCD
DR   Wikidata; Q54773622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102705; Gng2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN331
AC   CVCL_NH64
SY   RRN331
DR   MMRRC; MMRRC:003845-UCD
DR   Wikidata; Q54773623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914345; Trak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN332
AC   CVCL_NH65
SY   RRN332
DR   MMRRC; MMRRC:003846-UCD
DR   Wikidata; Q54773626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN333
AC   CVCL_NH66
SY   RRN333
DR   MMRRC; MMRRC:003847-UCD
DR   Wikidata; Q54773628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354721; Slc25a13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN339
AC   CVCL_NH67
SY   RRN339
DR   MMRRC; MMRRC:003849-UCD
DR   Wikidata; Q54773630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923784; Osbpl9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN341
AC   CVCL_NH68
SY   RRN341
DR   MMRRC; MMRRC:003850-UCD
DR   Wikidata; Q54773633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144475; Usp32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN343
AC   CVCL_NH69
SY   RRN343
DR   MMRRC; MMRRC:003851-UCD
DR   Wikidata; Q54773635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913755; Zmynd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN346
AC   CVCL_NH70
SY   RRN346
DR   MMRRC; MMRRC:003854-UCD
DR   Wikidata; Q54773637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922144; 4930442H23Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN348
AC   CVCL_NH71
SY   RRN348
DR   MMRRC; MMRRC:003856-UCD
DR   Wikidata; Q54773639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN350
AC   CVCL_NH72
SY   RRN350
DR   MMRRC; MMRRC:003857-UCD
DR   Wikidata; Q54773641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349400; Cops7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN351
AC   CVCL_NH73
SY   RRN351
DR   MMRRC; MMRRC:003858-UCD
DR   Wikidata; Q54773642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96952; Mdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN357
AC   CVCL_NH74
SY   RRN357
DR   MMRRC; MMRRC:003861-UCD
DR   Wikidata; Q54773643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444691; Tfcp2l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN360
AC   CVCL_NH75
SY   RRN360
DR   MMRRC; MMRRC:003863-UCD
DR   Wikidata; Q54773644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916417; Ppp1r12b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN366
AC   CVCL_NH76
SY   RRN366
DR   MMRRC; MMRRC:003865-UCD
DR   Wikidata; Q54773645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346881; Map3k12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN367
AC   CVCL_NH77
SY   RRN367
DR   MMRRC; MMRRC:003866-UCD
DR   Wikidata; Q54773648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353448; Eif2ak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN369
AC   CVCL_NH78
SY   RRN369
DR   MMRRC; MMRRC:003867-UCD
DR   Wikidata; Q54773650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95301; Eif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN374
AC   CVCL_NH79
SY   RRN374
DR   MMRRC; MMRRC:003869-UCD
DR   Wikidata; Q54773652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923809; Atg2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN376
AC   CVCL_NH80
SY   RRN376
DR   MMRRC; MMRRC:003871-UCD
DR   Wikidata; Q54773655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN378
AC   CVCL_NH81
SY   RRN378
DR   MMRRC; MMRRC:003872-UCD
DR   Wikidata; Q54773656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107726; Supt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN384
AC   CVCL_NH82
SY   RRN384
DR   MMRRC; MMRRC:003874-UCD
DR   Wikidata; Q54773658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341788; Pdcd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN388
AC   CVCL_NH83
SY   RRN388
DR   MMRRC; MMRRC:003875-UCD
DR   Wikidata; Q54773660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3708729; Rnps1-ps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRN389
AC   CVCL_NH84
SY   RRN389
DR   MMRRC; MMRRC:003876-UCD
DR   Wikidata; Q54773661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924750; Ppfia1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN391
AC   CVCL_NH85
SY   RRN391
DR   MMRRC; MMRRC:003877-UCD
DR   Wikidata; Q54773664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106913; Abi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN400
AC   CVCL_NH86
SY   RRN400
DR   MMRRC; MMRRC:003881-UCD
DR   Wikidata; Q54773666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353510; Arhgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN401
AC   CVCL_NH87
SY   RRN401
DR   MMRRC; MMRRC:003882-UCD
DR   Wikidata; Q54773668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109352; Ung.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRN407
AC   CVCL_NH88
SY   RRN407
DR   MMRRC; MMRRC:003884-UCD
DR   Wikidata; Q54773670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3697726; Arhgap23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO002
AC   CVCL_NH89
SY   RRO002
DR   MMRRC; MMRRC:003885-UCD
DR   Wikidata; Q54773673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO003
AC   CVCL_NH90
SY   RRO003
DR   MMRRC; MMRRC:003886-UCD
DR   Wikidata; Q54773674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO005
AC   CVCL_NH91
SY   RRO005
DR   MMRRC; MMRRC:003887-UCD
DR   Wikidata; Q54773677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140991; Usp30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO007
AC   CVCL_NH92
SY   RRO007
DR   MMRRC; MMRRC:003888-UCD
DR   Wikidata; Q54773680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135962; Gorasp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO010
AC   CVCL_NH93
SY   RRO010
DR   MMRRC; MMRRC:003889-UCD
DR   Wikidata; Q54773683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO011
AC   CVCL_NH94
SY   RRO011
DR   MMRRC; MMRRC:003890-UCD
DR   Wikidata; Q54773684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333879; Ap3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO013
AC   CVCL_NH95
SY   RRO013
DR   MMRRC; MMRRC:003891-UCD
DR   Wikidata; Q54773685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351623; Pald1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO014
AC   CVCL_NH96
SY   RRO014
DR   MMRRC; MMRRC:003892-UCD
DR   Wikidata; Q54773688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915010; Slc38a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO015
AC   CVCL_NH97
SY   RRO015
DR   MMRRC; MMRRC:003893-UCD
DR   Wikidata; Q54773689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858313; Uba2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO016
AC   CVCL_NH98
SY   RRO016
DR   MMRRC; MMRRC:003894-UCD
DR   Wikidata; Q54773690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO017
AC   CVCL_NH99
SY   RRO017
DR   MMRRC; MMRRC:003895-UCD
DR   Wikidata; Q54773692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO018
AC   CVCL_NI00
SY   RRO018
DR   MMRRC; MMRRC:003896-UCD
DR   Wikidata; Q54773694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933162; Lrba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO019
AC   CVCL_NI01
SY   RRO019
DR   MMRRC; MMRRC:003897-UCD
DR   Wikidata; Q54773697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918177; Setd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO020
AC   CVCL_NI02
SY   RRO020
DR   MMRRC; MMRRC:003898-UCD
DR   Wikidata; Q54773700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913677; Cyb5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO022
AC   CVCL_NI03
SY   RRO022
DR   MMRRC; MMRRC:003899-UCD
DR   Wikidata; Q54773744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101917; Bcap29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO023
AC   CVCL_NI04
SY   RRO023
DR   MMRRC; MMRRC:003900-UCD
DR   Wikidata; Q54773746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341865; Mark3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO024
AC   CVCL_NI05
SY   RRO024
DR   MMRRC; MMRRC:003901-UCD
DR   Wikidata; Q54773747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO026
AC   CVCL_NI06
SY   RRO026
DR   MMRRC; MMRRC:003902-UCD
DR   Wikidata; Q54773749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444236; Ubn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO027
AC   CVCL_NI07
SY   RRO027
DR   MMRRC; MMRRC:003903-UCD
DR   Wikidata; Q54773751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913546; Haus2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO029
AC   CVCL_NI08
SY   RRO029
DR   MMRRC; MMRRC:003904-UCD
DR   Wikidata; Q54773753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097686; H3f3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO030
AC   CVCL_NI09
SY   RRO030
DR   MMRRC; MMRRC:003905-UCD
DR   Wikidata; Q54773756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140950; Tent2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRO031
AC   CVCL_NI10
SY   RRO031
DR   MMRRC; MMRRC:003906-UCD
DR   Wikidata; Q54773757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO032
AC   CVCL_NI11
SY   RRO032
DR   MMRRC; MMRRC:003907-UCD
DR   Wikidata; Q54773758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328362; Blm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO033
AC   CVCL_NI12
SY   RRO033
DR   MMRRC; MMRRC:003908-UCD
DR   Wikidata; Q54773759
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102806; Acvr2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO034
AC   CVCL_NI13
SY   RRO034
DR   MMRRC; MMRRC:003909-UCD
DR   Wikidata; Q54773761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920538; Vps50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO044
AC   CVCL_NI14
SY   RRO044
DR   MMRRC; MMRRC:003912-UCD
DR   Wikidata; Q54773764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98535; Tcp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO045
AC   CVCL_NI15
SY   RRO045
DR   MMRRC; MMRRC:003913-UCD
DR   Wikidata; Q54773765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443472; Atf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO049
AC   CVCL_NI16
SY   RRO049
DR   MMRRC; MMRRC:003915-UCD
DR   Wikidata; Q54773767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914247; Psmd12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO050
AC   CVCL_NI17
SY   RRO050
DR   MMRRC; MMRRC:003916-UCD
DR   Wikidata; Q54773769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344373; Ubl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO051
AC   CVCL_NI18
SY   RRO051
DR   MMRRC; MMRRC:003917-UCD
DR   Wikidata; Q54773772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355322; Exosc10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO057
AC   CVCL_NI19
SY   RRO057
DR   MMRRC; MMRRC:003920-UCD
DR   Wikidata; Q54773774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387188; Slc49a4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRO059
AC   CVCL_NI20
SY   RRO059
DR   MMRRC; MMRRC:003922-UCD
DR   Wikidata; Q54773777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387188; Slc49a4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRO063
AC   CVCL_NI21
SY   RRO063
DR   MMRRC; MMRRC:003923-UCD
DR   Wikidata; Q54773779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95281; Ect2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO067
AC   CVCL_NI22
SY   RRO067
DR   MMRRC; MMRRC:003924-UCD
DR   Wikidata; Q54773780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930780; Myh10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO068
AC   CVCL_NI23
SY   RRO068
DR   MMRRC; MMRRC:003925-UCD
DR   Wikidata; Q54773782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921269; Traf3ip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO069
AC   CVCL_NI24
SY   RRO069
DR   MMRRC; MMRRC:003926-UCD
DR   Wikidata; Q54773784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO072
AC   CVCL_NI25
SY   RRO072
DR   MMRRC; MMRRC:003927-UCD
DR   Wikidata; Q54773785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098824; Odf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO073
AC   CVCL_NI26
SY   RRO073
DR   MMRRC; MMRRC:003928-UCD
DR   Wikidata; Q54773786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448506; Pi4ka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO076
AC   CVCL_NI27
SY   RRO076
DR   MMRRC; MMRRC:003929-UCD
DR   Wikidata; Q54773788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107585; Srebf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO077
AC   CVCL_NI28
SY   RRO077
DR   MMRRC; MMRRC:003930-UCD
DR   Wikidata; Q54773793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO078
AC   CVCL_NI29
SY   RRO078
DR   MMRRC; MMRRC:003931-UCD
DR   Wikidata; Q54773795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO079
AC   CVCL_NI30
SY   RRO079
DR   MMRRC; MMRRC:003932-UCD
DR   Wikidata; Q54773796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384298; Sbno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO085
AC   CVCL_NI31
SY   RRO085
DR   MMRRC; MMRRC:003933-UCD
DR   Wikidata; Q54773797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO086
AC   CVCL_NI32
SY   RRO086
DR   MMRRC; MMRRC:003934-UCD
DR   Wikidata; Q54773798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO087
AC   CVCL_NI33
SY   RRO087
DR   MMRRC; MMRRC:003935-UCD
DR   Wikidata; Q54773799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098268; Kif5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO088
AC   CVCL_NI34
SY   RRO088
DR   MMRRC; MMRRC:003936-UCD
DR   Wikidata; Q54773802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858234; Caprin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO090
AC   CVCL_NI35
SY   RRO090
DR   MMRRC; MMRRC:003937-UCD
DR   Wikidata; Q54773804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385298; Zfp958.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO091
AC   CVCL_NI36
SY   RRO091
DR   MMRRC; MMRRC:003938-UCD
DR   Wikidata; Q54773807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684864; Pfas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO094
AC   CVCL_NI37
SY   RRO094
DR   MMRRC; MMRRC:003939-UCD
DR   Wikidata; Q54773809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442480; Pigv.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO096
AC   CVCL_NI38
SY   RRO096
DR   MMRRC; MMRRC:003941-UCD
DR   Wikidata; Q54773811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO097
AC   CVCL_NI39
SY   RRO097
DR   MMRRC; MMRRC:003942-UCD
DR   Wikidata; Q54773812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890081; Foxo3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO101
AC   CVCL_NI40
SY   RRO101
DR   MMRRC; MMRRC:003944-UCD
DR   Wikidata; Q54773814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927479; Sap30bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO102
AC   CVCL_NI41
SY   RRO102
DR   MMRRC; MMRRC:003945-UCD
DR   Wikidata; Q54773817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO105
AC   CVCL_NI42
SY   RRO105
DR   MMRRC; MMRRC:003946-UCD
DR   Wikidata; Q54773821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO107
AC   CVCL_NI43
SY   RRO107
DR   MMRRC; MMRRC:003947-UCD
DR   Wikidata; Q54773869
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676921; Focad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO108
AC   CVCL_NI44
SY   RRO108
DR   MMRRC; MMRRC:003948-UCD
DR   Wikidata; Q54773870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676556; Akap13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO110
AC   CVCL_NI45
SY   RRO110
DR   MMRRC; MMRRC:003950-UCD
DR   Wikidata; Q54773871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352755; Gtse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO112
AC   CVCL_NI46
SY   RRO112
DR   MMRRC; MMRRC:003951-UCD
DR   Wikidata; Q54773875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO113
AC   CVCL_NI47
SY   RRO113
DR   MMRRC; MMRRC:003952-UCD
DR   Wikidata; Q54773876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444268; Fam169a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO114
AC   CVCL_NI48
SY   RRO114
DR   MMRRC; MMRRC:003953-UCD
DR   Wikidata; Q54773878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341087; Tnks.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO115
AC   CVCL_NI49
SY   RRO115
DR   MMRRC; MMRRC:003954-UCD
DR   Wikidata; Q54773880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104912; Sf3a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO120
AC   CVCL_NI50
SY   RRO120
DR   MMRRC; MMRRC:003956-UCD
DR   Wikidata; Q54773881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344380; Chd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO121
AC   CVCL_NI51
SY   RRO121
DR   MMRRC; MMRRC:003957-UCD
DR   Wikidata; Q54773884
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO122
AC   CVCL_NI52
SY   RRO122
DR   MMRRC; MMRRC:003958-UCD
DR   Wikidata; Q54773886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914247; Psmd12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO123
AC   CVCL_NI53
SY   RRO123
DR   MMRRC; MMRRC:003959-UCD
DR   Wikidata; Q54773888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922855; Kdm5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO124
AC   CVCL_NI54
SY   RRO124
DR   MMRRC; MMRRC:003960-UCD
DR   Wikidata; Q54773892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97346; Nktr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO127
AC   CVCL_NI55
SY   RRO127
DR   MMRRC; MMRRC:003961-UCD
DR   Wikidata; Q54773893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385261; Cnot3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO129
AC   CVCL_NI56
SY   RRO129
DR   MMRRC; MMRRC:003962-UCD
DR   Wikidata; Q54773895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929063; Copz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO132
AC   CVCL_NI57
SY   RRO132
DR   MMRRC; MMRRC:003963-UCD
DR   Wikidata; Q54773896
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO134
AC   CVCL_NI58
SY   RRO134
DR   MMRRC; MMRRC:003965-UCD
DR   Wikidata; Q54773897
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345150; Cdc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO135
AC   CVCL_NI59
SY   RRO135
DR   MMRRC; MMRRC:003966-UCD
DR   Wikidata; Q54773899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919936; Usp24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO138
AC   CVCL_NI60
SY   RRO138
DR   MMRRC; MMRRC:003967-UCD
DR   Wikidata; Q54773901
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO140
AC   CVCL_NI61
SY   RRO140
DR   MMRRC; MMRRC:003968-UCD
DR   Wikidata; Q54773903
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933124; Sh3bp5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO141
AC   CVCL_NI62
SY   RRO141
DR   MMRRC; MMRRC:003969-UCD
DR   Wikidata; Q54773905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914228; Luc7l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO142
AC   CVCL_NI63
SY   RRO142
DR   MMRRC; MMRRC:003970-UCD
DR   Wikidata; Q54773907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109360; Lmo4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO143
AC   CVCL_NI64
SY   RRO143
DR   MMRRC; MMRRC:003971-UCD
DR   Wikidata; Q54773909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO149
AC   CVCL_NI65
SY   RRO149
DR   MMRRC; MMRRC:003973-UCD
DR   Wikidata; Q54773912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443386; Dnajc11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO151
AC   CVCL_NI66
SY   RRO151
DR   MMRRC; MMRRC:003974-UCD
DR   Wikidata; Q54773913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO153
AC   CVCL_NI67
SY   RRO153
DR   MMRRC; MMRRC:003975-UCD
DR   Wikidata; Q54773915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137221; Mrpl20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO154
AC   CVCL_NI68
SY   RRO154
DR   MMRRC; MMRRC:003976-UCD
DR   Wikidata; Q54773917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914080; Nacc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO156
AC   CVCL_NI69
SY   RRO156
DR   MMRRC; MMRRC:003977-UCD
DR   Wikidata; Q54773919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036250; Zfp729a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO157
AC   CVCL_NI70
SY   RRO157
DR   MMRRC; MMRRC:003978-UCD
DR   Wikidata; Q54773922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913963; Actr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO161
AC   CVCL_NI71
SY   RRO161
DR   MMRRC; MMRRC:003980-UCD
DR   Wikidata; Q54773924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88508; Crk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO163
AC   CVCL_NI72
SY   RRO163
DR   MMRRC; MMRRC:003981-UCD
DR   Wikidata; Q54773926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352493; Bag3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO167
AC   CVCL_NI73
SY   RRO167
DR   MMRRC; MMRRC:003982-UCD
DR   Wikidata; Q54773927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO170
AC   CVCL_NI74
SY   RRO170
DR   MMRRC; MMRRC:003983-UCD
DR   Wikidata; Q54773931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351475; Golga5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO171
AC   CVCL_NI75
SY   RRO171
DR   MMRRC; MMRRC:003984-UCD
DR   Wikidata; Q54773932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152345; Taf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO172
AC   CVCL_NI76
SY   RRO172
DR   MMRRC; MMRRC:003985-UCD
DR   Wikidata; Q54773934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO173
AC   CVCL_NI77
SY   RRO173
DR   MMRRC; MMRRC:003986-UCD
DR   Wikidata; Q54773937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO174
AC   CVCL_NI78
SY   RRO174
DR   MMRRC; MMRRC:003987-UCD
DR   Wikidata; Q54773938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO175
AC   CVCL_NI79
SY   RRO175
DR   MMRRC; MMRRC:003988-UCD
DR   Wikidata; Q54773939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO177
AC   CVCL_NI80
SY   RRO177
DR   MMRRC; MMRRC:003989-UCD
DR   Wikidata; Q54773943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339939; Rpa2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO179
AC   CVCL_NI81
SY   RRO179
DR   MMRRC; MMRRC:003990-UCD
DR   Wikidata; Q54773945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO181
AC   CVCL_NI82
SY   RRO181
DR   MMRRC; MMRRC:003991-UCD
DR   Wikidata; Q54773946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88141; Bcr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO183
AC   CVCL_NI83
SY   RRO183
DR   MMRRC; MMRRC:003992-UCD
DR   Wikidata; Q54774002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385621; Nup153.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO184
AC   CVCL_NI84
SY   RRO184
DR   MMRRC; MMRRC:003993-UCD
DR   Wikidata; Q54774004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO199
AC   CVCL_NI85
SY   RRO199
DR   MMRRC; MMRRC:003998-UCD
DR   Wikidata; Q54774007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108091; Bcar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO202
AC   CVCL_NI86
SY   RRO202
DR   MMRRC; MMRRC:003999-UCD
DR   Wikidata; Q54774009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447063; Tenm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO203
AC   CVCL_NI87
SY   RRO203
DR   MMRRC; MMRRC:004000-UCD
DR   Wikidata; Q54774012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920977; Mcmbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO207
AC   CVCL_NI88
SY   RRO207
DR   MMRRC; MMRRC:004003-UCD
DR   Wikidata; Q54774014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO208
AC   CVCL_NI89
SY   RRO208
DR   MMRRC; MMRRC:004004-UCD
DR   Wikidata; Q54774017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443472; Atf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO209
AC   CVCL_NI90
SY   RRO209
DR   MMRRC; MMRRC:004005-UCD
DR   Wikidata; Q54774019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO210
AC   CVCL_NI91
SY   RRO210
DR   MMRRC; MMRRC:004006-UCD
DR   Wikidata; Q54774020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915084; Idh3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO211
AC   CVCL_NI92
SY   RRO211
DR   MMRRC; MMRRC:004007-UCD
DR   Wikidata; Q54774021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2659071; Rapgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO212
AC   CVCL_NI93
SY   RRO212
DR   MMRRC; MMRRC:004008-UCD
DR   Wikidata; Q54774024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346318; Klf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO214
AC   CVCL_NI94
SY   RRO214
DR   MMRRC; MMRRC:004009-UCD
DR   Wikidata; Q54774026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO218
AC   CVCL_NI95
SY   RRO218
DR   MMRRC; MMRRC:004010-UCD
DR   Wikidata; Q54774027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096551; Morf4l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO219
AC   CVCL_NI96
SY   RRO219
DR   MMRRC; MMRRC:004011-UCD
DR   Wikidata; Q54774030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106095; Naca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO220
AC   CVCL_NI97
SY   RRO220
DR   MMRRC; MMRRC:004012-UCD
DR   Wikidata; Q54774032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332235; Nrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO222
AC   CVCL_NI98
SY   RRO222
DR   MMRRC; MMRRC:004013-UCD
DR   Wikidata; Q54774033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO223
AC   CVCL_NI99
SY   RRO223
DR   MMRRC; MMRRC:004014-UCD
DR   Wikidata; Q54774037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO224
AC   CVCL_NJ00
SY   RRO224
DR   MMRRC; MMRRC:004015-UCD
DR   Wikidata; Q54774040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196277; Tmem201.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO225
AC   CVCL_NJ01
SY   RRO225
DR   MMRRC; MMRRC:004016-UCD
DR   Wikidata; Q54774042
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924828; Bcl9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO227
AC   CVCL_NJ02
SY   RRO227
DR   MMRRC; MMRRC:004017-UCD
DR   Wikidata; Q54774043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278321; Epc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO229
AC   CVCL_NJ03
SY   RRO229
DR   MMRRC; MMRRC:004018-UCD
DR   Wikidata; Q54774046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334255; Cyth2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO231
AC   CVCL_NJ04
SY   RRO231
DR   MMRRC; MMRRC:004019-UCD
DR   Wikidata; Q54774047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO232
AC   CVCL_NJ05
SY   RRO232
DR   MMRRC; MMRRC:004020-UCD
DR   Wikidata; Q54774050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO233
AC   CVCL_NJ06
SY   RRO233
DR   MMRRC; MMRRC:004021-UCD
DR   Wikidata; Q54774051
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923988; Paf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO234
AC   CVCL_NJ07
SY   RRO234
DR   MMRRC; MMRRC:004022-UCD
DR   Wikidata; Q54774056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO237
AC   CVCL_NJ08
SY   RRO237
DR   MMRRC; MMRRC:004023-UCD
DR   Wikidata; Q54774057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889576; Cntrl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO240
AC   CVCL_NJ09
SY   RRO240
DR   MMRRC; MMRRC:004024-UCD
DR   Wikidata; Q54774059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO242
AC   CVCL_NJ10
SY   RRO242
DR   MMRRC; MMRRC:004026-UCD
DR   Wikidata; Q54774061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO245
AC   CVCL_NJ11
SY   RRO245
DR   MMRRC; MMRRC:004027-UCD
DR   Wikidata; Q54774063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO248
AC   CVCL_NJ12
SY   RRO248
DR   MMRRC; MMRRC:004029-UCD
DR   Wikidata; Q54774064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151839; Mreg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO252
AC   CVCL_NJ13
SY   RRO252
DR   MMRRC; MMRRC:004030-UCD
DR   Wikidata; Q54774066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924933; Ehmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO261
AC   CVCL_NJ14
SY   RRO261
DR   MMRRC; MMRRC:004033-UCD
DR   Wikidata; Q54774069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97891; Rfc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO266
AC   CVCL_NJ15
SY   RRO266
DR   MMRRC; MMRRC:004034-UCD
DR   Wikidata; Q54774070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO268
AC   CVCL_NJ16
SY   RRO268
DR   MMRRC; MMRRC:004035-UCD
DR   Wikidata; Q54774071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916106; Prrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO270
AC   CVCL_NJ17
SY   RRO270
DR   MMRRC; MMRRC:004036-UCD
DR   Wikidata; Q54774072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO272
AC   CVCL_NJ18
SY   RRO272
DR   MMRRC; MMRRC:004037-UCD
DR   Wikidata; Q54774073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925237; Ascc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO274
AC   CVCL_NJ19
SY   RRO274
DR   MMRRC; MMRRC:004038-UCD
DR   Wikidata; Q54774076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105066; Rab10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO277
AC   CVCL_NJ20
SY   RRO277
DR   MMRRC; MMRRC:004040-UCD
DR   Wikidata; Q54774077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO278
AC   CVCL_NJ21
SY   RRO278
DR   MMRRC; MMRRC:004041-UCD
DR   Wikidata; Q54774079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443483; Pdzd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO279
AC   CVCL_NJ22
SY   RRO279
DR   MMRRC; MMRRC:004042-UCD
DR   Wikidata; Q54774080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919451; Otud6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO284
AC   CVCL_NJ23
SY   RRO284
DR   MMRRC; MMRRC:004043-UCD
DR   Wikidata; Q54774169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918017; Prpf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO290
AC   CVCL_NJ24
SY   RRO290
DR   MMRRC; MMRRC:004045-UCD
DR   Wikidata; Q54774171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1315200; M1ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO293
AC   CVCL_NJ25
SY   RRO293
DR   MMRRC; MMRRC:004046-UCD
DR   Wikidata; Q54774173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109531; Cdc37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO297
AC   CVCL_NJ26
SY   RRO297
DR   MMRRC; MMRRC:004047-UCD
DR   Wikidata; Q54774175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333879; Ap3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO303
AC   CVCL_NJ27
SY   RRO303
DR   MMRRC; MMRRC:004050-UCD
DR   Wikidata; Q54774177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183446; Agap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO305
AC   CVCL_NJ28
SY   RRO305
DR   MMRRC; MMRRC:004051-UCD
DR   Wikidata; Q54774179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918073; Hmgxb4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO307
AC   CVCL_NJ29
SY   RRO307
DR   MMRRC; MMRRC:004052-UCD
DR   Wikidata; Q54774181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153072; Trim37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO320
AC   CVCL_NJ30
SY   RRO320
DR   MMRRC; MMRRC:004055-UCD
DR   Wikidata; Q54774185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3845075; Tnfsfm13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO321
AC   CVCL_NJ31
SY   RRO321
DR   MMRRC; MMRRC:004056-UCD
DR   Wikidata; Q54774186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917747; Arhgap17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO326
AC   CVCL_NJ32
SY   RRO326
DR   MMRRC; MMRRC:004058-UCD
DR   Wikidata; Q54774188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2155865; Rrm2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO327
AC   CVCL_NJ33
SY   RRO327
DR   MMRRC; MMRRC:004059-UCD
DR   Wikidata; Q54774189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO330
AC   CVCL_NJ34
SY   RRO330
DR   MMRRC; MMRRC:004060-UCD
DR   Wikidata; Q54774191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354742; Synrg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO333
AC   CVCL_NJ35
SY   RRO333
DR   MMRRC; MMRRC:004062-UCD
DR   Wikidata; Q54774192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676311; Crybg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO334
AC   CVCL_NJ36
SY   RRO334
DR   MMRRC; MMRRC:004063-UCD
DR   Wikidata; Q54774194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO337
AC   CVCL_NJ37
SY   RRO337
DR   MMRRC; MMRRC:004065-UCD
DR   Wikidata; Q54774195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO339
AC   CVCL_NJ38
SY   RRO339
DR   MMRRC; MMRRC:004066-UCD
DR   Wikidata; Q54774198
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109153; Ktn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO340
AC   CVCL_NJ39
SY   RRO340
DR   MMRRC; MMRRC:004067-UCD
DR   Wikidata; Q54774201
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927489; Pdlim5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO344
AC   CVCL_NJ40
SY   RRO344
DR   MMRRC; MMRRC:004068-UCD
DR   Wikidata; Q54774203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922989; Mpp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO347
AC   CVCL_NJ41
SY   RRO347
DR   MMRRC; MMRRC:004069-UCD
DR   Wikidata; Q54774206
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105982; Rfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO351
AC   CVCL_NJ42
SY   RRO351
DR   MMRRC; MMRRC:004071-UCD
DR   Wikidata; Q54774207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104709; Wbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO353
AC   CVCL_NJ43
SY   RRO353
DR   MMRRC; MMRRC:004072-UCD
DR   Wikidata; Q54774209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384933; Wrap53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO355
AC   CVCL_NJ44
SY   RRO355
DR   MMRRC; MMRRC:004073-UCD
DR   Wikidata; Q54774212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919979; Cdc42se2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO357
AC   CVCL_NJ45
SY   RRO357
DR   MMRRC; MMRRC:004074-UCD
DR   Wikidata; Q54774215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890564; Rcan1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO359
AC   CVCL_NJ46
SY   RRO359
DR   MMRRC; MMRRC:004075-UCD
DR   Wikidata; Q54774216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347064; Med21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO360
AC   CVCL_NJ47
SY   RRO360
DR   MMRRC; MMRRC:004076-UCD
DR   Wikidata; Q54774217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO367
AC   CVCL_NJ48
SY   RRO367
DR   MMRRC; MMRRC:004077-UCD
DR   Wikidata; Q54774220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88190; Braf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO369
AC   CVCL_NJ49
SY   RRO369
DR   MMRRC; MMRRC:004078-UCD
DR   Wikidata; Q54774221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138391; Pid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO378
AC   CVCL_NJ50
SY   RRO378
DR   MMRRC; MMRRC:004079-UCD
DR   Wikidata; Q54774224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858216; Ube2k.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO380
AC   CVCL_NJ51
SY   RRO380
DR   MMRRC; MMRRC:004080-UCD
DR   Wikidata; Q54774225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384993; Paip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO384
AC   CVCL_NJ52
SY   RRO384
DR   MMRRC; MMRRC:004083-UCD
DR   Wikidata; Q54774228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106582; Rfx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO389
AC   CVCL_NJ53
SY   RRO389
DR   MMRRC; MMRRC:004085-UCD
DR   Wikidata; Q54774229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139395; Golga2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO390
AC   CVCL_NJ54
SY   RRO390
DR   MMRRC; MMRRC:004086-UCD
DR   Wikidata; Q54774233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152345; Taf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO403
AC   CVCL_NJ55
SY   RRO403
DR   MMRRC; MMRRC:004087-UCD
DR   Wikidata; Q54774234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261910; Pibf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO407
AC   CVCL_NJ56
SY   RRO407
DR   MMRRC; MMRRC:004088-UCD
DR   Wikidata; Q54774236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO410
AC   CVCL_NJ57
SY   RRO410
DR   MMRRC; MMRRC:004089-UCD
DR   Wikidata; Q54774237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442192; Eea1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO411
AC   CVCL_NJ58
SY   RRO411
DR   MMRRC; MMRRC:004090-UCD
DR   Wikidata; Q54774239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446296; Sik3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO419
AC   CVCL_NJ59
SY   RRO419
DR   MMRRC; MMRRC:004093-UCD
DR   Wikidata; Q54774242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147003; Arhgap28.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO426
AC   CVCL_NJ60
SY   RRO426
DR   MMRRC; MMRRC:004095-UCD
DR   Wikidata; Q54774244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179288; Rttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO427
AC   CVCL_NJ61
SY   RRO427
DR   MMRRC; MMRRC:004096-UCD
DR   Wikidata; Q54774245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442086; Trerf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO431
AC   CVCL_NJ62
SY   RRO431
DR   MMRRC; MMRRC:004098-UCD
DR   Wikidata; Q54774247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98927; Vcl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO439
AC   CVCL_NJ63
SY   RRO439
DR   MMRRC; MMRRC:004101-UCD
DR   Wikidata; Q54774299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922579; Atf7ip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO443
AC   CVCL_NJ64
SY   RRO443
DR   MMRRC; MMRRC:004102-UCD
DR   Wikidata; Q54774301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO448
AC   CVCL_NJ65
SY   RRO448
DR   MMRRC; MMRRC:004105-UCD
DR   Wikidata; Q54774303
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921004; Thap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO449
AC   CVCL_NJ66
SY   RRO449
DR   MMRRC; MMRRC:004106-UCD
DR   Wikidata; Q54774304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347094; Parg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO456
AC   CVCL_NJ67
SY   RRO456
DR   MMRRC; MMRRC:004108-UCD
DR   Wikidata; Q54774306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914446; Ube2t.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO462
AC   CVCL_NJ68
SY   RRO462
DR   MMRRC; MMRRC:004111-UCD
DR   Wikidata; Q54774308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO482
AC   CVCL_NJ69
SY   RRO482
DR   MMRRC; MMRRC:004115-UCD
DR   Wikidata; Q54774311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890695; Rab9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO488
AC   CVCL_NJ70
SY   RRO488
DR   MMRRC; MMRRC:004116-UCD
DR   Wikidata; Q54774313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923760; Trappc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO489
AC   CVCL_NJ71
SY   RRO489
DR   MMRRC; MMRRC:004117-UCD
DR   Wikidata; Q54774314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930618; Krit1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO502
AC   CVCL_NJ72
SY   RRO502
DR   MMRRC; MMRRC:004120-UCD
DR   Wikidata; Q54774317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO504
AC   CVCL_NJ73
SY   RRO504
DR   MMRRC; MMRRC:004121-UCD
DR   Wikidata; Q54774319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929699; Arl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO505
AC   CVCL_NJ74
SY   RRO505
DR   MMRRC; MMRRC:004122-UCD
DR   Wikidata; Q54774320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921807; Ppp6r3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO507
AC   CVCL_NJ75
SY   RRO507
DR   MMRRC; MMRRC:004123-UCD
DR   Wikidata; Q54774322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO513
AC   CVCL_NJ76
SY   RRO513
DR   MMRRC; MMRRC:004124-UCD
DR   Wikidata; Q54774324
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442456; Unk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO514
AC   CVCL_NJ77
SY   RRO514
DR   MMRRC; MMRRC:004125-UCD
DR   Wikidata; Q54774325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446235; Zfp940.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO515
AC   CVCL_NJ78
SY   RRO515
DR   MMRRC; MMRRC:004126-UCD
DR   Wikidata; Q54774328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107690; Zfp462.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO516
AC   CVCL_NJ79
SY   RRO516
DR   MMRRC; MMRRC:004127-UCD
DR   Wikidata; Q54774329
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261827; Dnmt3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO517
AC   CVCL_NJ80
SY   RRO517
DR   MMRRC; MMRRC:004128-UCD
DR   Wikidata; Q54774330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919782; Sap130.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO520
AC   CVCL_NJ81
SY   RRO520
DR   MMRRC; MMRRC:004129-UCD
DR   Wikidata; Q54774333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914643; Cxxc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO522
AC   CVCL_NJ82
SY   RRO522
DR   MMRRC; MMRRC:004130-UCD
DR   Wikidata; Q54774334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO524
AC   CVCL_NJ83
SY   RRO524
DR   MMRRC; MMRRC:004131-UCD
DR   Wikidata; Q54774335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442372; Fam168a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO529
AC   CVCL_NJ84
SY   RRO529
DR   MMRRC; MMRRC:004132-UCD
DR   Wikidata; Q54774338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO531
AC   CVCL_NJ85
SY   RRO531
DR   MMRRC; MMRRC:004133-UCD
DR   Wikidata; Q54774340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442833; Bbs9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO546
AC   CVCL_NJ86
SY   RRO546
DR   MMRRC; MMRRC:004136-UCD
DR   Wikidata; Q54774342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919283; Tsc22d2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO547
AC   CVCL_NJ87
SY   RRO547
DR   MMRRC; MMRRC:004137-UCD
DR   Wikidata; Q54774343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045391; Lin52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO550
AC   CVCL_NJ88
SY   RRO550
DR   MMRRC; MMRRC:004138-UCD
DR   Wikidata; Q54774344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859150; Akap7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO551
AC   CVCL_NJ89
SY   RRO551
DR   MMRRC; MMRRC:004139-UCD
DR   Wikidata; Q54774347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921690; Cmip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO553
AC   CVCL_NJ90
SY   RRO553
DR   MMRRC; MMRRC:004140-UCD
DR   Wikidata; Q54774349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914864; Atp6v1h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO564
AC   CVCL_NJ91
SY   RRO564
DR   MMRRC; MMRRC:004142-UCD
DR   Wikidata; Q54774350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180098; Csad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO574
AC   CVCL_NJ92
SY   RRO574
DR   MMRRC; MMRRC:004143-UCD
DR   Wikidata; Q54774352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO592
AC   CVCL_NJ93
SY   RRO592
DR   MMRRC; MMRRC:004145-UCD
DR   Wikidata; Q54774354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO595
AC   CVCL_NJ94
SY   RRO595
DR   MMRRC; MMRRC:004146-UCD
DR   Wikidata; Q54774355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917285; Rab28.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO600
AC   CVCL_NJ95
SY   RRO600
DR   MMRRC; MMRRC:004148-UCD
DR   Wikidata; Q54774357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO608
AC   CVCL_NJ96
SY   RRO608
DR   MMRRC; MMRRC:004150-UCD
DR   Wikidata; Q54774361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443308; Mcph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO610
AC   CVCL_NJ97
SY   RRO610
DR   MMRRC; MMRRC:004151-UCD
DR   Wikidata; Q54774364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931237; Wwox.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO611
AC   CVCL_NJ98
SY   RRO611
DR   MMRRC; MMRRC:004152-UCD
DR   Wikidata; Q54774366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO614
AC   CVCL_NJ99
SY   RRO614
DR   MMRRC; MMRRC:004154-UCD
DR   Wikidata; Q54774367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2667185; Myo18a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO615
AC   CVCL_NK00
SY   RRO615
DR   MMRRC; MMRRC:004155-UCD
DR   Wikidata; Q54774368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO619
AC   CVCL_NK01
SY   RRO619
DR   MMRRC; MMRRC:004156-UCD
DR   Wikidata; Q54774371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384569; Klhdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO624
AC   CVCL_NK02
SY   RRO624
DR   MMRRC; MMRRC:004158-UCD
DR   Wikidata; Q54774373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103300; Rbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRO626
AC   CVCL_NK03
SY   RRO626
DR   MMRRC; MMRRC:004159-UCD
DR   Wikidata; Q54774424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914053; Hmces.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP008
AC   CVCL_NK04
SY   RRP008
DR   MMRRC; MMRRC:004162-UCD
DR   Wikidata; Q54774427
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916610; 1700008J07Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP009
AC   CVCL_NK05
SY   RRP009
DR   MMRRC; MMRRC:004163-UCD
DR   Wikidata; Q54774429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108074; Sptlc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP011
AC   CVCL_NK06
SY   RRP011
DR   MMRRC; MMRRC:004164-UCD
DR   Wikidata; Q54774431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137355; Trim11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP013
AC   CVCL_NK07
SY   RRP013
DR   MMRRC; MMRRC:004165-UCD
DR   Wikidata; Q54774434
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929492; Atl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP015
AC   CVCL_NK08
SY   RRP015
DR   MMRRC; MMRRC:004166-UCD
DR   Wikidata; Q54774437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP018
AC   CVCL_NK09
SY   RRP018
DR   MMRRC; MMRRC:004167-UCD
DR   Wikidata; Q54774438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP025
AC   CVCL_NK10
SY   RRP025
DR   MMRRC; MMRRC:004169-UCD
DR   Wikidata; Q54774441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442620; Nup133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP029
AC   CVCL_NK11
SY   RRP029
DR   MMRRC; MMRRC:004170-UCD
DR   Wikidata; Q54774443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103071; Rangap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP030
AC   CVCL_NK12
SY   RRP030
DR   MMRRC; MMRRC:004171-UCD
DR   Wikidata; Q54774445
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443207; Plekhm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP033
AC   CVCL_NK13
SY   RRP033
DR   MMRRC; MMRRC:004172-UCD
DR   Wikidata; Q54774447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98535; Tcp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP039
AC   CVCL_NK14
SY   RRP039
DR   MMRRC; MMRRC:004173-UCD
DR   Wikidata; Q54774449
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276539; Ttc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP040
AC   CVCL_NK15
SY   RRP040
DR   MMRRC; MMRRC:004174-UCD
DR   Wikidata; Q54774451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP042
AC   CVCL_NK16
SY   RRP042
DR   MMRRC; MMRRC:004175-UCD
DR   Wikidata; Q54774454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP045
AC   CVCL_NK17
SY   RRP045
DR   MMRRC; MMRRC:004176-UCD
DR   Wikidata; Q54774455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94909; Dmd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP057
AC   CVCL_NK18
SY   RRP057
DR   MMRRC; MMRRC:004179-UCD
DR   Wikidata; Q54774456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354721; Slc25a13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP061
AC   CVCL_NK19
SY   RRP061
DR   MMRRC; MMRRC:004181-UCD
DR   Wikidata; Q54774458
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109349; Atf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP062
AC   CVCL_NK20
SY   RRP062
DR   MMRRC; MMRRC:004182-UCD
DR   Wikidata; Q54774459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915671; Lmbrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP065
AC   CVCL_NK21
SY   RRP065
DR   MMRRC; MMRRC:004184-UCD
DR   Wikidata; Q54774460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858961; Prc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP067
AC   CVCL_NK22
SY   RRP067
DR   MMRRC; MMRRC:004185-UCD
DR   Wikidata; Q54774461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104736; Evi5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP068
AC   CVCL_NK23
SY   RRP068
DR   MMRRC; MMRRC:004186-UCD
DR   Wikidata; Q54774464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448514; R3hdm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP073
AC   CVCL_NK24
SY   RRP073
DR   MMRRC; MMRRC:004187-UCD
DR   Wikidata; Q54774465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891112; Gmds.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP078
AC   CVCL_NK25
SY   RRP078
DR   MMRRC; MMRRC:004189-UCD
DR   Wikidata; Q54774468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP079
AC   CVCL_NK26
SY   RRP079
DR   MMRRC; MMRRC:004190-UCD
DR   Wikidata; Q54774470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP083
AC   CVCL_NK27
SY   RRP083
DR   MMRRC; MMRRC:004192-UCD
DR   Wikidata; Q54774471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP092
AC   CVCL_NK28
SY   RRP092
DR   MMRRC; MMRRC:004193-UCD
DR   Wikidata; Q54774474
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924823; Vps33a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP094
AC   CVCL_NK29
SY   RRP094
DR   MMRRC; MMRRC:004194-UCD
DR   Wikidata; Q54774475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700014; Sorbs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP097
AC   CVCL_NK30
SY   RRP097
DR   MMRRC; MMRRC:004195-UCD
DR   Wikidata; Q54774476
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108415; Pafah1b2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP098
AC   CVCL_NK31
SY   RRP098
DR   MMRRC; MMRRC:004196-UCD
DR   Wikidata; Q54774479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926395; Wtap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP100
AC   CVCL_NK32
SY   RRP100
DR   MMRRC; MMRRC:004197-UCD
DR   Wikidata; Q54774480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919257; Fndc3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP106
AC   CVCL_NK33
SY   RRP106
DR   MMRRC; MMRRC:004198-UCD
DR   Wikidata; Q54774483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104880; Psmb6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP109
AC   CVCL_NK34
SY   RRP109
DR   MMRRC; MMRRC:004200-UCD
DR   Wikidata; Q54774484
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178445; Ppan.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP113
AC   CVCL_NK35
SY   RRP113
DR   MMRRC; MMRRC:004201-UCD
DR   Wikidata; Q54774485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915982; Carmil1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP115
AC   CVCL_NK36
SY   RRP115
DR   MMRRC; MMRRC:004203-UCD
DR   Wikidata; Q54774486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98488; Slc6a6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP117
AC   CVCL_NK37
SY   RRP117
DR   MMRRC; MMRRC:004204-UCD
DR   Wikidata; Q54774487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924705; Rlf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP119
AC   CVCL_NK38
SY   RRP119
DR   MMRRC; MMRRC:004205-UCD
DR   Wikidata; Q54774490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914416; Arl8b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP121
AC   CVCL_NK39
SY   RRP121
DR   MMRRC; MMRRC:004207-UCD
DR   Wikidata; Q54774493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915546; Smu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP123
AC   CVCL_NK40
SY   RRP123
DR   MMRRC; MMRRC:004208-UCD
DR   Wikidata; Q54774494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP124
AC   CVCL_NK41
SY   RRP124
DR   MMRRC; MMRRC:004209-UCD
DR   Wikidata; Q54774496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP132
AC   CVCL_NK42
SY   RRP132
DR   MMRRC; MMRRC:004210-UCD
DR   Wikidata; Q54774500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352483; Mga.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP138
AC   CVCL_NK43
SY   RRP138
DR   MMRRC; MMRRC:004212-UCD
DR   Wikidata; Q54774584
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102718; Vav2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP140
AC   CVCL_NK44
SY   RRP140
DR   MMRRC; MMRRC:004213-UCD
DR   Wikidata; Q54774588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP143
AC   CVCL_NK45
SY   RRP143
DR   MMRRC; MMRRC:004214-UCD
DR   Wikidata; Q54774593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95281; Ect2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP144
AC   CVCL_NK46
SY   RRP144
DR   MMRRC; MMRRC:004215-UCD
DR   Wikidata; Q54774594
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913758; Lamtor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP155
AC   CVCL_NK47
SY   RRP155
DR   MMRRC; MMRRC:004219-UCD
DR   Wikidata; Q54774595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157980; Vac14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP157
AC   CVCL_NK48
SY   RRP157
DR   MMRRC; MMRRC:004220-UCD
DR   Wikidata; Q54774598
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919579; Pcf11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP160
AC   CVCL_NK49
SY   RRP160
DR   MMRRC; MMRRC:004221-UCD
DR   Wikidata; Q54774600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP169
AC   CVCL_NK50
SY   RRP169
DR   MMRRC; MMRRC:004224-UCD
DR   Wikidata; Q54774602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924001; Chd9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP183
AC   CVCL_NK51
SY   RRP183
DR   MMRRC; MMRRC:004226-UCD
DR   Wikidata; Q54774605
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921831; Sbf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP184
AC   CVCL_NK52
SY   RRP184
DR   MMRRC; MMRRC:004227-UCD
DR   Wikidata; Q54774607
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916482; Qrich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP185
AC   CVCL_NK53
SY   RRP185
DR   MMRRC; MMRRC:004228-UCD
DR   Wikidata; Q54774610
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97312; Nfkb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP186
AC   CVCL_NK54
SY   RRP186
DR   MMRRC; MMRRC:004229-UCD
DR   Wikidata; Q54774612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346331; Def8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP195
AC   CVCL_NK55
SY   RRP195
DR   MMRRC; MMRRC:004231-UCD
DR   Wikidata; Q54774614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP196
AC   CVCL_NK56
SY   RRP196
DR   MMRRC; MMRRC:004232-UCD
DR   Wikidata; Q54774615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448530; Vps13d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP197
AC   CVCL_NK57
SY   RRP197
DR   MMRRC; MMRRC:004233-UCD
DR   Wikidata; Q54774618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3603158; Tmem120b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP198
AC   CVCL_NK58
SY   RRP198
DR   MMRRC; MMRRC:004234-UCD
DR   Wikidata; Q54774619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277186; Atg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP200
AC   CVCL_NK59
SY   RRP200
DR   MMRRC; MMRRC:004235-UCD
DR   Wikidata; Q54774622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384579; Msantd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP201
AC   CVCL_NK60
SY   RRP201
DR   MMRRC; MMRRC:004236-UCD
DR   Wikidata; Q54774623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277162; Cdk6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP202
AC   CVCL_NK61
SY   RRP202
DR   MMRRC; MMRRC:004237-UCD
DR   Wikidata; Q54774624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277113; Pacs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP206
AC   CVCL_NK62
SY   RRP206
DR   MMRRC; MMRRC:004239-UCD
DR   Wikidata; Q54774626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP208
AC   CVCL_NK63
SY   RRP208
DR   MMRRC; MMRRC:004240-UCD
DR   Wikidata; Q54774628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196463; Fndc3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP212
AC   CVCL_NK64
SY   RRP212
DR   MMRRC; MMRRC:004243-UCD
DR   Wikidata; Q54774630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341865; Mark3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP213
AC   CVCL_NK65
SY   RRP213
DR   MMRRC; MMRRC:004244-UCD
DR   Wikidata; Q54774633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151152; Baz2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP214
AC   CVCL_NK66
SY   RRP214
DR   MMRRC; MMRRC:004245-UCD
DR   Wikidata; Q54774635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919570; Kifbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRP217
AC   CVCL_NK67
SY   RRP217
DR   MMRRC; MMRRC:004247-UCD
DR   Wikidata; Q54774636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918110; Septin10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRP219
AC   CVCL_NK68
SY   RRP219
DR   MMRRC; MMRRC:004249-UCD
DR   Wikidata; Q54774640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343161; Snf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP223
AC   CVCL_NK69
SY   RRP223
DR   MMRRC; MMRRC:004251-UCD
DR   Wikidata; Q54774641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289230; Pxk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP227
AC   CVCL_NK70
SY   RRP227
DR   MMRRC; MMRRC:004254-UCD
DR   Wikidata; Q54774642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101760; Bicd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP230
AC   CVCL_NK71
SY   RRP230
DR   MMRRC; MMRRC:004255-UCD
DR   Wikidata; Q54774643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923264; Zc3h18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP251
AC   CVCL_NK72
SY   RRP251
DR   MMRRC; MMRRC:004259-UCD
DR   Wikidata; Q54774646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443895; Fry.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP257
AC   CVCL_NK73
SY   RRP257
DR   MMRRC; MMRRC:004260-UCD
DR   Wikidata; Q54774648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107714; Dnah8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP258
AC   CVCL_NK74
SY   RRP258
DR   MMRRC; MMRRC:004261-UCD
DR   Wikidata; Q54774652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298375; Cabin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRP266
AC   CVCL_NK75
SY   RRP266
DR   MMRRC; MMRRC:004263-UCD
DR   Wikidata; Q54774653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917164; Ints4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ001
AC   CVCL_NK76
SY   RRQ001
DR   MMRRC; MMRRC:004266-UCD
DR   Wikidata; Q54774655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926143; Cnot10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ004
AC   CVCL_NK77
SY   RRQ004
DR   MMRRC; MMRRC:004267-UCD
DR   Wikidata; Q54774657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146156; Espl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ007
AC   CVCL_NK78
SY   RRQ007
DR   MMRRC; MMRRC:004268-UCD
DR   Wikidata; Q54774660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928268; Ireb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ010
AC   CVCL_NK79
SY   RRQ010
DR   MMRRC; MMRRC:004269-UCD
DR   Wikidata; Q54774662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098240; Kif16b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ011
AC   CVCL_NK80
SY   RRQ011
DR   MMRRC; MMRRC:004270-UCD
DR   Wikidata; Q54774664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ012
AC   CVCL_NK81
SY   RRQ012
DR   MMRRC; MMRRC:004271-UCD
DR   Wikidata; Q54774666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ014
AC   CVCL_NK82
SY   RRQ014
DR   MMRRC; MMRRC:004272-UCD
DR   Wikidata; Q54774669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890077; Foxo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ015
AC   CVCL_NK83
SY   RRQ015
DR   MMRRC; MMRRC:004273-UCD
DR   Wikidata; Q54774718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107914; Tia1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ016
AC   CVCL_NK84
SY   RRQ016
DR   MMRRC; MMRRC:004274-UCD
DR   Wikidata; Q54774721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197010; Sumo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ018
AC   CVCL_NK85
SY   RRQ018
DR   MMRRC; MMRRC:004275-UCD
DR   Wikidata; Q54774722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916139; Ubac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ021
AC   CVCL_NK86
SY   RRQ021
DR   MMRRC; MMRRC:004277-UCD
DR   Wikidata; Q54774723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921570; Wdr33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ022
AC   CVCL_NK87
SY   RRQ022
DR   MMRRC; MMRRC:004278-UCD
DR   Wikidata; Q54774726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921633; Ubap2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ024
AC   CVCL_NK88
SY   RRQ024
DR   MMRRC; MMRRC:004279-UCD
DR   Wikidata; Q54774727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141625; Nup205.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ026
AC   CVCL_NK89
SY   RRQ026
DR   MMRRC; MMRRC:004281-UCD
DR   Wikidata; Q54774730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915867; Mtcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ028
AC   CVCL_NK90
SY   RRQ028
DR   MMRRC; MMRRC:004282-UCD
DR   Wikidata; Q54774731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353636; Abt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ030
AC   CVCL_NK91
SY   RRQ030
DR   MMRRC; MMRRC:004283-UCD
DR   Wikidata; Q54774734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108086; Hdac1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ031
AC   CVCL_NK92
SY   RRQ031
DR   MMRRC; MMRRC:004284-UCD
DR   Wikidata; Q54774735
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101816; Msh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ032
AC   CVCL_NK93
SY   RRQ032
DR   MMRRC; MMRRC:004285-UCD
DR   Wikidata; Q54774737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:893577; Stx4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ033
AC   CVCL_NK94
SY   RRQ033
DR   MMRRC; MMRRC:004286-UCD
DR   Wikidata; Q54774740
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921020; Wdr70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ034
AC   CVCL_NK95
SY   RRQ034
DR   MMRRC; MMRRC:004287-UCD
DR   Wikidata; Q54774741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443658; Prr14l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ041
AC   CVCL_NK96
SY   RRQ041
DR   MMRRC; MMRRC:004291-UCD
DR   Wikidata; Q54774743
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109257; Smn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ046
AC   CVCL_NK97
SY   RRQ046
DR   MMRRC; MMRRC:004292-UCD
DR   Wikidata; Q54774745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443658; Prr14l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ051
AC   CVCL_NK98
SY   RRQ051
DR   MMRRC; MMRRC:004294-UCD
DR   Wikidata; Q54774746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138261; Smap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ052
AC   CVCL_NK99
SY   RRQ052
DR   MMRRC; MMRRC:004295-UCD
DR   Wikidata; Q54774749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915984; Ppp4r3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ059
AC   CVCL_NL00
SY   RRQ059
DR   MMRRC; MMRRC:004296-UCD
DR   Wikidata; Q54774752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914210; Mindy3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ060
AC   CVCL_NL01
SY   RRQ060
DR   MMRRC; MMRRC:004297-UCD
DR   Wikidata; Q54774753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ061
AC   CVCL_NL02
SY   RRQ061
DR   MMRRC; MMRRC:004298-UCD
DR   Wikidata; Q54774756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683537; Tapt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ062
AC   CVCL_NL03
SY   RRQ062
DR   MMRRC; MMRRC:004299-UCD
DR   Wikidata; Q54774757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917135; Aunip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ067
AC   CVCL_NL04
SY   RRQ067
DR   MMRRC; MMRRC:004301-UCD
DR   Wikidata; Q54774760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924834; Spidr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ069
AC   CVCL_NL05
SY   RRQ069
DR   MMRRC; MMRRC:004303-UCD
DR   Wikidata; Q54774761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109337; Brca2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ088
AC   CVCL_NL06
SY   RRQ088
DR   MMRRC; MMRRC:004309-UCD
DR   Wikidata; Q54774765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096584; Psmd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ090
AC   CVCL_NL07
SY   RRQ090
DR   MMRRC; MMRRC:004311-UCD
DR   Wikidata; Q54774766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328366; Smarcb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ101
AC   CVCL_NL08
SY   RRQ101
DR   MMRRC; MMRRC:004312-UCD
DR   Wikidata; Q54774768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919267; Cyb5r1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ108
AC   CVCL_NL09
SY   RRQ108
DR   MMRRC; MMRRC:004313-UCD
DR   Wikidata; Q54774771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923858; Hectd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ110
AC   CVCL_NL10
SY   RRQ110
DR   MMRRC; MMRRC:004314-UCD
DR   Wikidata; Q54774772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2687282; Cep104.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ113
AC   CVCL_NL11
SY   RRQ113
DR   MMRRC; MMRRC:004315-UCD
DR   Wikidata; Q54774773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913125; Pias1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ114
AC   CVCL_NL12
SY   RRQ114
DR   MMRRC; MMRRC:004316-UCD
DR   Wikidata; Q54774775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ115
AC   CVCL_NL13
SY   RRQ115
DR   MMRRC; MMRRC:004317-UCD
DR   Wikidata; Q54774776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ117
AC   CVCL_NL14
SY   RRQ117
DR   MMRRC; MMRRC:004318-UCD
DR   Wikidata; Q54774779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384298; Sbno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ119
AC   CVCL_NL15
SY   RRQ119
DR   MMRRC; MMRRC:004319-UCD
DR   Wikidata; Q54774780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338037; Rbm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ133
AC   CVCL_NL16
SY   RRQ133
DR   MMRRC; MMRRC:004324-UCD
DR   Wikidata; Q54774781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343188; Ube2g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ134
AC   CVCL_NL17
SY   RRQ134
DR   MMRRC; MMRRC:004325-UCD
DR   Wikidata; Q54774783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145043; Cep170b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ138
AC   CVCL_NL18
SY   RRQ138
DR   MMRRC; MMRRC:004329-UCD
DR   Wikidata; Q54774785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355333; Nckap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ139
AC   CVCL_NL19
SY   RRQ139
DR   MMRRC; MMRRC:004330-UCD
DR   Wikidata; Q54774786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355333; Nckap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ141
AC   CVCL_NL20
SY   RRQ141
DR   MMRRC; MMRRC:004331-UCD
DR   Wikidata; Q54774789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ142
AC   CVCL_NL21
SY   RRQ142
DR   MMRRC; MMRRC:004332-UCD
DR   Wikidata; Q54774790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915867; Mtcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ144
AC   CVCL_NL22
SY   RRQ144
DR   MMRRC; MMRRC:004333-UCD
DR   Wikidata; Q54774791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098684; Eif2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ148
AC   CVCL_NL23
SY   RRQ148
DR   MMRRC; MMRRC:004334-UCD
DR   Wikidata; Q54774867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923580; Sephs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ149
AC   CVCL_NL24
SY   RRQ149
DR   MMRRC; MMRRC:004335-UCD
DR   Wikidata; Q54774870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913867; Ntmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ150
AC   CVCL_NL25
SY   RRQ150
DR   MMRRC; MMRRC:004336-UCD
DR   Wikidata; Q54774873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ161
AC   CVCL_NL26
SY   RRQ161
DR   MMRRC; MMRRC:004338-UCD
DR   Wikidata; Q54774875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683538; Lyrm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ162
AC   CVCL_NL27
SY   RRQ162
DR   MMRRC; MMRRC:004339-UCD
DR   Wikidata; Q54774878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935145; Mllt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ163
AC   CVCL_NL28
SY   RRQ163
DR   MMRRC; MMRRC:004340-UCD
DR   Wikidata; Q54774881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935145; Mllt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ165
AC   CVCL_NL29
SY   RRQ165
DR   MMRRC; MMRRC:004341-UCD
DR   Wikidata; Q54774882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105069; Rab4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ167
AC   CVCL_NL30
SY   RRQ167
DR   MMRRC; MMRRC:004342-UCD
DR   Wikidata; Q54774885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87930; Adk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRQ171
AC   CVCL_NL31
SY   RRQ171
DR   MMRRC; MMRRC:004344-UCD
DR   Wikidata; Q54774887
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98386; Sptan1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR002
AC   CVCL_NL32
SY   RRR002
DR   MMRRC; MMRRC:004346-UCD
DR   Wikidata; Q54774890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101845; Mcm3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR003
AC   CVCL_NL33
SY   RRR003
DR   MMRRC; MMRRC:004347-UCD
DR   Wikidata; Q54774892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137706; Actn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR004
AC   CVCL_NL34
SY   RRR004
DR   MMRRC; MMRRC:004348-UCD
DR   Wikidata; Q54774894
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354737; Kdm2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR005
AC   CVCL_NL35
SY   RRR005
DR   MMRRC; MMRRC:004349-UCD
DR   Wikidata; Q54774897
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920442; Xpot.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR006
AC   CVCL_NL36
SY   RRR006
DR   MMRRC; MMRRC:004350-UCD
DR   Wikidata; Q54774899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR007
AC   CVCL_NL37
SY   RRR007
DR   MMRRC; MMRRC:004351-UCD
DR   Wikidata; Q54774902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194910; Rbbp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR008
AC   CVCL_NL38
SY   RRR008
DR   MMRRC; MMRRC:004352-UCD
DR   Wikidata; Q54774903
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103202; Adsl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR010
AC   CVCL_NL39
SY   RRR010
DR   MMRRC; MMRRC:004353-UCD
DR   Wikidata; Q54774907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR011
AC   CVCL_NL40
SY   RRR011
DR   MMRRC; MMRRC:004354-UCD
DR   Wikidata; Q54774908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR012
AC   CVCL_NL41
SY   RRR012
DR   MMRRC; MMRRC:004355-UCD
DR   Wikidata; Q54774909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105307; Ptpn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR014
AC   CVCL_NL42
SY   RRR014
DR   MMRRC; MMRRC:004356-UCD
DR   Wikidata; Q54774910
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103199; Mcm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR016
AC   CVCL_NL43
SY   RRR016
DR   MMRRC; MMRRC:004357-UCD
DR   Wikidata; Q54774912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194492; Hdgfl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR017
AC   CVCL_NL44
SY   RRR017
DR   MMRRC; MMRRC:004358-UCD
DR   Wikidata; Q54774913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR018
AC   CVCL_NL45
SY   RRR018
DR   MMRRC; MMRRC:004359-UCD
DR   Wikidata; Q54774916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917579; Gon4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR019
AC   CVCL_NL46
SY   RRR019
DR   MMRRC; MMRRC:004360-UCD
DR   Wikidata; Q54774917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894681; Usp9x.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR020
AC   CVCL_NL47
SY   RRR020
DR   MMRRC; MMRRC:004361-UCD
DR   Wikidata; Q54774918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR021
AC   CVCL_NL48
SY   RRR021
DR   MMRRC; MMRRC:004362-UCD
DR   Wikidata; Q54774920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385902; Picalm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR022
AC   CVCL_NL49
SY   RRR022
DR   MMRRC; MMRRC:004363-UCD
DR   Wikidata; Q54774923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95281; Ect2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR023
AC   CVCL_NL50
SY   RRR023
DR   MMRRC; MMRRC:004364-UCD
DR   Wikidata; Q54774925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138261; Smap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR024
AC   CVCL_NL51
SY   RRR024
DR   MMRRC; MMRRC:004365-UCD
DR   Wikidata; Q54774926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918850; Ythdf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR030
AC   CVCL_NL52
SY   RRR030
DR   MMRRC; MMRRC:004366-UCD
DR   Wikidata; Q54774928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107862; Nop16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR031
AC   CVCL_NL53
SY   RRR031
DR   MMRRC; MMRRC:004367-UCD
DR   Wikidata; Q54774930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446630; Ago1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR032
AC   CVCL_NL54
SY   RRR032
DR   MMRRC; MMRRC:004368-UCD
DR   Wikidata; Q54774933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143886; Dot1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR040
AC   CVCL_NL55
SY   RRR040
DR   MMRRC; MMRRC:004370-UCD
DR   Wikidata; Q54774935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328322; Rex2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR043
AC   CVCL_NL56
SY   RRR043
DR   MMRRC; MMRRC:004372-UCD
DR   Wikidata; Q54774938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR044
AC   CVCL_NL57
SY   RRR044
DR   MMRRC; MMRRC:004373-UCD
DR   Wikidata; Q54774941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR045
AC   CVCL_NL58
SY   RRR045
DR   MMRRC; MMRRC:004374-UCD
DR   Wikidata; Q54774942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278328; Dnpep.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR047
AC   CVCL_NL59
SY   RRR047
DR   MMRRC; MMRRC:004375-UCD
DR   Wikidata; Q54774944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR048
AC   CVCL_NL60
SY   RRR048
DR   MMRRC; MMRRC:004376-UCD
DR   Wikidata; Q54774946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR049
AC   CVCL_NL61
SY   RRR049
DR   MMRRC; MMRRC:004377-UCD
DR   Wikidata; Q54774950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914750; Ccar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR051
AC   CVCL_NL62
SY   RRR051
DR   MMRRC; MMRRC:004378-UCD
DR   Wikidata; Q54774951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384876; Cdc73.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR052
AC   CVCL_NL63
SY   RRR052
DR   MMRRC; MMRRC:004379-UCD
DR   Wikidata; Q54774997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR053
AC   CVCL_NL64
SY   RRR053
DR   MMRRC; MMRRC:004380-UCD
DR   Wikidata; Q54774999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR054
AC   CVCL_NL65
SY   RRR054
DR   MMRRC; MMRRC:004381-UCD
DR   Wikidata; Q54775001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330299; Dyrk1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR055
AC   CVCL_NL66
SY   RRR055
DR   MMRRC; MMRRC:004382-UCD
DR   Wikidata; Q54775003
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147987; Pcyt1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR056
AC   CVCL_NL67
SY   RRR056
DR   MMRRC; MMRRC:004383-UCD
DR   Wikidata; Q54775004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3525201; Mdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR057
AC   CVCL_NL68
SY   RRR057
DR   MMRRC; MMRRC:004384-UCD
DR   Wikidata; Q54775006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444782; Fkbp15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR059
AC   CVCL_NL69
SY   RRR059
DR   MMRRC; MMRRC:004386-UCD
DR   Wikidata; Q54775008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921783; Gzf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR061
AC   CVCL_NL70
SY   RRR061
DR   MMRRC; MMRRC:004387-UCD
DR   Wikidata; Q54775009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR062
AC   CVCL_NL71
SY   RRR062
DR   MMRRC; MMRRC:004388-UCD
DR   Wikidata; Q54775012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933169; Sacm1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR064
AC   CVCL_NL72
SY   RRR064
DR   MMRRC; MMRRC:004389-UCD
DR   Wikidata; Q54775014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR065
AC   CVCL_NL73
SY   RRR065
DR   MMRRC; MMRRC:004390-UCD
DR   Wikidata; Q54775015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR066
AC   CVCL_NL74
SY   RRR066
DR   MMRRC; MMRRC:004391-UCD
DR   Wikidata; Q54775019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933184; Nop58.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR067
AC   CVCL_NL75
SY   RRR067
DR   MMRRC; MMRRC:004392-UCD
DR   Wikidata; Q54775020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR068
AC   CVCL_NL76
SY   RRR068
DR   MMRRC; MMRRC:004393-UCD
DR   Wikidata; Q54775023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88393; Chd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR069
AC   CVCL_NL77
SY   RRR069
DR   MMRRC; MMRRC:004394-UCD
DR   Wikidata; Q54775024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385621; Nup153.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR070
AC   CVCL_NL78
SY   RRR070
DR   MMRRC; MMRRC:004395-UCD
DR   Wikidata; Q54775025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103010; Epb41l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR071
AC   CVCL_NL79
SY   RRR071
DR   MMRRC; MMRRC:004396-UCD
DR   Wikidata; Q54775029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197527; Top3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR075
AC   CVCL_NL80
SY   RRR075
DR   MMRRC; MMRRC:004398-UCD
DR   Wikidata; Q54775031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR078
AC   CVCL_NL81
SY   RRR078
DR   MMRRC; MMRRC:004399-UCD
DR   Wikidata; Q54775035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR079
AC   CVCL_NL82
SY   RRR079
DR   MMRRC; MMRRC:004400-UCD
DR   Wikidata; Q54775036
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR082
AC   CVCL_NL83
SY   RRR082
DR   MMRRC; MMRRC:004401-UCD
DR   Wikidata; Q54775037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918771; Pds5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR084
AC   CVCL_NL84
SY   RRR084
DR   MMRRC; MMRRC:004402-UCD
DR   Wikidata; Q54775040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929865; Nampt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR087
AC   CVCL_NL85
SY   RRR087
DR   MMRRC; MMRRC:004403-UCD
DR   Wikidata; Q54775041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR090
AC   CVCL_NL86
SY   RRR090
DR   MMRRC; MMRRC:004404-UCD
DR   Wikidata; Q54775042
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443114; Larp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR091
AC   CVCL_NL87
SY   RRR091
DR   MMRRC; MMRRC:004405-UCD
DR   Wikidata; Q54775044
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934950; Csnk1a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR098
AC   CVCL_NL88
SY   RRR098
DR   MMRRC; MMRRC:004407-UCD
DR   Wikidata; Q54775045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138968; Clp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR099
AC   CVCL_NL89
SY   RRR099
DR   MMRRC; MMRRC:004408-UCD
DR   Wikidata; Q54775047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276124; Ep400.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR100
AC   CVCL_NL90
SY   RRR100
DR   MMRRC; MMRRC:004409-UCD
DR   Wikidata; Q54775048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338037; Rbm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR102
AC   CVCL_NL91
SY   RRR102
DR   MMRRC; MMRRC:004411-UCD
DR   Wikidata; Q54775050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107891; Nop2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR103
AC   CVCL_NL92
SY   RRR103
DR   MMRRC; MMRRC:004412-UCD
DR   Wikidata; Q54775052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99470; Dnajc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR105
AC   CVCL_NL93
SY   RRR105
DR   MMRRC; MMRRC:004413-UCD
DR   Wikidata; Q54775054
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346858; Mapk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR106
AC   CVCL_NL94
SY   RRR106
DR   MMRRC; MMRRC:004414-UCD
DR   Wikidata; Q54775055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR107
AC   CVCL_NL95
SY   RRR107
DR   MMRRC; MMRRC:004415-UCD
DR   Wikidata; Q54775058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924001; Chd9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR108
AC   CVCL_NL96
SY   RRR108
DR   MMRRC; MMRRC:004416-UCD
DR   Wikidata; Q54775059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR109
AC   CVCL_NL97
SY   RRR109
DR   MMRRC; MMRRC:004417-UCD
DR   Wikidata; Q54775061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194910; Rbbp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR112
AC   CVCL_NL98
SY   RRR112
DR   MMRRC; MMRRC:004418-UCD
DR   Wikidata; Q54775063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152895; Helb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR114
AC   CVCL_NL99
SY   RRR114
DR   MMRRC; MMRRC:004419-UCD
DR   Wikidata; Q54775065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96623; Itpr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR115
AC   CVCL_NM00
SY   RRR115
DR   MMRRC; MMRRC:004420-UCD
DR   Wikidata; Q54775067
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328363; Ccnt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR116
AC   CVCL_NM01
SY   RRR116
DR   MMRRC; MMRRC:004421-UCD
DR   Wikidata; Q54775070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388481; Ppp2r5d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR117
AC   CVCL_NM02
SY   RRR117
DR   MMRRC; MMRRC:004422-UCD
DR   Wikidata; Q54775071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR118
AC   CVCL_NM03
SY   RRR118
DR   MMRRC; MMRRC:004423-UCD
DR   Wikidata; Q54775123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446242; Atxn2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR119
AC   CVCL_NM04
SY   RRR119
DR   MMRRC; MMRRC:004424-UCD
DR   Wikidata; Q54775126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR120
AC   CVCL_NM05
SY   RRR120
DR   MMRRC; MMRRC:004425-UCD
DR   Wikidata; Q54775128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919765; Wdr43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR121
AC   CVCL_NM06
SY   RRR121
DR   MMRRC; MMRRC:004426-UCD
DR   Wikidata; Q54775129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR122
AC   CVCL_NM07
SY   RRR122
DR   MMRRC; MMRRC:004427-UCD
DR   Wikidata; Q54775131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919016; Raver1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR124
AC   CVCL_NM08
SY   RRR124
DR   MMRRC; MMRRC:004428-UCD
DR   Wikidata; Q54775133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR125
AC   CVCL_NM09
SY   RRR125
DR   MMRRC; MMRRC:004429-UCD
DR   Wikidata; Q54775137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917497; Psmd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR133
AC   CVCL_NM10
SY   RRR133
DR   MMRRC; MMRRC:004431-UCD
DR   Wikidata; Q54775139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87978; Ak2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR136
AC   CVCL_NM11
SY   RRR136
DR   MMRRC; MMRRC:004432-UCD
DR   Wikidata; Q54775141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444748; Chd7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR139
AC   CVCL_NM12
SY   RRR139
DR   MMRRC; MMRRC:004434-UCD
DR   Wikidata; Q54775142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443386; Dnajc11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR141
AC   CVCL_NM13
SY   RRR141
DR   MMRRC; MMRRC:004435-UCD
DR   Wikidata; Q54775146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105982; Rfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR143
AC   CVCL_NM14
SY   RRR143
DR   MMRRC; MMRRC:004436-UCD
DR   Wikidata; Q54775147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR146
AC   CVCL_NM15
SY   RRR146
DR   MMRRC; MMRRC:004437-UCD
DR   Wikidata; Q54775151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202301; Itch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR148
AC   CVCL_NM16
SY   RRR148
DR   MMRRC; MMRRC:004438-UCD
DR   Wikidata; Q54775153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919228; Ppp2r2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR153
AC   CVCL_NM17
SY   RRR153
DR   MMRRC; MMRRC:004439-UCD
DR   Wikidata; Q54775156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96623; Itpr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR154
AC   CVCL_NM18
SY   RRR154
DR   MMRRC; MMRRC:004440-UCD
DR   Wikidata; Q54775158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915821; 1110002L01Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR155
AC   CVCL_NM19
SY   RRR155
DR   MMRRC; MMRRC:004441-UCD
DR   Wikidata; Q54775160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915821; 1110002L01Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR157
AC   CVCL_NM20
SY   RRR157
DR   MMRRC; MMRRC:004442-UCD
DR   Wikidata; Q54775162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924968; Slf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR158
AC   CVCL_NM21
SY   RRR158
DR   MMRRC; MMRRC:004443-UCD
DR   Wikidata; Q54775164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924968; Slf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR159
AC   CVCL_NM22
SY   RRR159
DR   MMRRC; MMRRC:004444-UCD
DR   Wikidata; Q54775165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923809; Atg2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR160
AC   CVCL_NM23
SY   RRR160
DR   MMRRC; MMRRC:004445-UCD
DR   Wikidata; Q54775167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107428; Cfap20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR162
AC   CVCL_NM24
SY   RRR162
DR   MMRRC; MMRRC:004446-UCD
DR   Wikidata; Q54775168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921355; Gga2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR163
AC   CVCL_NM25
SY   RRR163
DR   MMRRC; MMRRC:004447-UCD
DR   Wikidata; Q54775169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96247; Hsp90ab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR168
AC   CVCL_NM26
SY   RRR168
DR   MMRRC; MMRRC:004450-UCD
DR   Wikidata; Q54775170
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913546; Haus2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR170
AC   CVCL_NM27
SY   RRR170
DR   MMRRC; MMRRC:004452-UCD
DR   Wikidata; Q54775172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147538; Btaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR171
AC   CVCL_NM28
SY   RRR171
DR   MMRRC; MMRRC:004453-UCD
DR   Wikidata; Q54775174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147538; Btaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR173
AC   CVCL_NM29
SY   RRR173
DR   MMRRC; MMRRC:004454-UCD
DR   Wikidata; Q54775175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88141; Bcr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR177
AC   CVCL_NM30
SY   RRR177
DR   MMRRC; MMRRC:004456-UCD
DR   Wikidata; Q54775179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316717; Ifrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR178
AC   CVCL_NM31
SY   RRR178
DR   MMRRC; MMRRC:004457-UCD
DR   Wikidata; Q54775180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261847; Vrk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR179
AC   CVCL_NM32
SY   RRR179
DR   MMRRC; MMRRC:004458-UCD
DR   Wikidata; Q54775182
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR180
AC   CVCL_NM33
SY   RRR180
DR   MMRRC; MMRRC:004459-UCD
DR   Wikidata; Q54775185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146156; Espl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR181
AC   CVCL_NM34
SY   RRR181
DR   MMRRC; MMRRC:004460-UCD
DR   Wikidata; Q54775187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916249; Anapc10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR182
AC   CVCL_NM35
SY   RRR182
DR   MMRRC; MMRRC:004461-UCD
DR   Wikidata; Q54775189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99173; Zfp26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR183
AC   CVCL_NM36
SY   RRR183
DR   MMRRC; MMRRC:004462-UCD
DR   Wikidata; Q54775191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261845; Esyt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR185
AC   CVCL_NM37
SY   RRR185
DR   MMRRC; MMRRC:004463-UCD
DR   Wikidata; Q54775194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922896; Rai14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR187
AC   CVCL_NM38
SY   RRR187
DR   MMRRC; MMRRC:004464-UCD
DR   Wikidata; Q54775195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR188
AC   CVCL_NM39
SY   RRR188
DR   MMRRC; MMRRC:004465-UCD
DR   Wikidata; Q54775196
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR189
AC   CVCL_NM40
SY   RRR189
DR   MMRRC; MMRRC:004466-UCD
DR   Wikidata; Q54775199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99445; Mtpn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR194
AC   CVCL_NM41
SY   RRR194
DR   MMRRC; MMRRC:004467-UCD
DR   Wikidata; Q54775201
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94912; Dnmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR195
AC   CVCL_NM42
SY   RRR195
DR   MMRRC; MMRRC:004468-UCD
DR   Wikidata; Q54775202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179326; Oxr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR196
AC   CVCL_NM43
SY   RRR196
DR   MMRRC; MMRRC:004469-UCD
DR   Wikidata; Q54775253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926227; Nup160.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR198
AC   CVCL_NM44
SY   RRR198
DR   MMRRC; MMRRC:004470-UCD
DR   Wikidata; Q54775256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923012; Aftph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR199
AC   CVCL_NM45
SY   RRR199
DR   MMRRC; MMRRC:004471-UCD
DR   Wikidata; Q54775258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107690; Zfp462.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR203
AC   CVCL_NM46
SY   RRR203
DR   MMRRC; MMRRC:004473-UCD
DR   Wikidata; Q54775259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914595; Herc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR205
AC   CVCL_NM47
SY   RRR205
DR   MMRRC; MMRRC:004474-UCD
DR   Wikidata; Q54775265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104517; Xrcc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR207
AC   CVCL_NM48
SY   RRR207
DR   MMRRC; MMRRC:004476-UCD
DR   Wikidata; Q54775266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR209
AC   CVCL_NM49
SY   RRR209
DR   MMRRC; MMRRC:004477-UCD
DR   Wikidata; Q54775267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR210
AC   CVCL_NM50
SY   RRR210
DR   MMRRC; MMRRC:004478-UCD
DR   Wikidata; Q54775271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136980; Kdm5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR211
AC   CVCL_NM51
SY   RRR211
DR   MMRRC; MMRRC:004479-UCD
DR   Wikidata; Q54775273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921361; Rbm19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR213
AC   CVCL_NM52
SY   RRR213
DR   MMRRC; MMRRC:004480-UCD
DR   Wikidata; Q54775276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR214
AC   CVCL_NM53
SY   RRR214
DR   MMRRC; MMRRC:004481-UCD
DR   Wikidata; Q54775278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097682; Rps5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR215
AC   CVCL_NM54
SY   RRR215
DR   MMRRC; MMRRC:004482-UCD
DR   Wikidata; Q54775281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442192; Eea1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR217
AC   CVCL_NM55
SY   RRR217
DR   MMRRC; MMRRC:004483-UCD
DR   Wikidata; Q54775282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036250; Zfp729a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR219
AC   CVCL_NM56
SY   RRR219
DR   MMRRC; MMRRC:004485-UCD
DR   Wikidata; Q54775284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442401; Ppp1r9a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR221
AC   CVCL_NM57
SY   RRR221
DR   MMRRC; MMRRC:004486-UCD
DR   Wikidata; Q54775286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919784; Rcc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR225
AC   CVCL_NM58
SY   RRR225
DR   MMRRC; MMRRC:004488-UCD
DR   Wikidata; Q54775287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443726; Zswim4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR229
AC   CVCL_NM59
SY   RRR229
DR   MMRRC; MMRRC:004489-UCD
DR   Wikidata; Q54775290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR232
AC   CVCL_NM60
SY   RRR232
DR   MMRRC; MMRRC:004491-UCD
DR   Wikidata; Q54775291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913937; Tbc1d15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR234
AC   CVCL_NM61
SY   RRR234
DR   MMRRC; MMRRC:004492-UCD
DR   Wikidata; Q54775293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR235
AC   CVCL_NM62
SY   RRR235
DR   MMRRC; MMRRC:004493-UCD
DR   Wikidata; Q54775296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1306796; Apaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR236
AC   CVCL_NM63
SY   RRR236
DR   MMRRC; MMRRC:004494-UCD
DR   Wikidata; Q54775297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442401; Ppp1r9a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR237
AC   CVCL_NM64
SY   RRR237
DR   MMRRC; MMRRC:004495-UCD
DR   Wikidata; Q54775299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106624; Myo9b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR241
AC   CVCL_NM65
SY   RRR241
DR   MMRRC; MMRRC:004496-UCD
DR   Wikidata; Q54775301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443623; Raver2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR242
AC   CVCL_NM66
SY   RRR242
DR   MMRRC; MMRRC:004497-UCD
DR   Wikidata; Q54775304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344349; Rnf216.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR244
AC   CVCL_NM67
SY   RRR244
DR   MMRRC; MMRRC:004498-UCD
DR   Wikidata; Q54775306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913895; Pspc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR248
AC   CVCL_NM68
SY   RRR248
DR   MMRRC; MMRRC:004500-UCD
DR   Wikidata; Q54775308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913874; Spcs2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR249
AC   CVCL_NM69
SY   RRR249
DR   MMRRC; MMRRC:004501-UCD
DR   Wikidata; Q54775309
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922855; Kdm5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR256
AC   CVCL_NM70
SY   RRR256
DR   MMRRC; MMRRC:004503-UCD
DR   Wikidata; Q54775312
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR257
AC   CVCL_NM71
SY   RRR257
DR   MMRRC; MMRRC:004504-UCD
DR   Wikidata; Q54775315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159614; Mia2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRR258
AC   CVCL_NM72
SY   RRR258
DR   MMRRC; MMRRC:004505-UCD
DR   Wikidata; Q54775316
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446180; Anks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR265
AC   CVCL_NM73
SY   RRR265
DR   MMRRC; MMRRC:004509-UCD
DR   Wikidata; Q54775317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351331; Chaf1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR266
AC   CVCL_NM74
SY   RRR266
DR   MMRRC; MMRRC:004510-UCD
DR   Wikidata; Q54775320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860078; Txnl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR267
AC   CVCL_NM75
SY   RRR267
DR   MMRRC; MMRRC:004511-UCD
DR   Wikidata; Q54775322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352755; Gtse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR272
AC   CVCL_NM76
SY   RRR272
DR   MMRRC; MMRRC:004512-UCD
DR   Wikidata; Q54775323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384583; Zfp280d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR275
AC   CVCL_NM77
SY   RRR275
DR   MMRRC; MMRRC:004514-UCD
DR   Wikidata; Q54775325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101785; Mybl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR276
AC   CVCL_NM78
SY   RRR276
DR   MMRRC; MMRRC:004515-UCD
DR   Wikidata; Q54775326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890081; Foxo3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR277
AC   CVCL_NM79
SY   RRR277
DR   MMRRC; MMRRC:004516-UCD
DR   Wikidata; Q54775327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445126; Tut4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRR278
AC   CVCL_NM80
SY   RRR278
DR   MMRRC; MMRRC:004517-UCD
DR   Wikidata; Q54775330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890773; Actn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR279
AC   CVCL_NM81
SY   RRR279
DR   MMRRC; MMRRC:004518-UCD
DR   Wikidata; Q54775332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR282
AC   CVCL_NM82
SY   RRR282
DR   MMRRC; MMRRC:004519-UCD
DR   Wikidata; Q54775334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098268; Kif5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR284
AC   CVCL_NM83
SY   RRR284
DR   MMRRC; MMRRC:004520-UCD
DR   Wikidata; Q54775373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855695; Clasrp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR290
AC   CVCL_NM84
SY   RRR290
DR   MMRRC; MMRRC:004522-UCD
DR   Wikidata; Q54775375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109606; Fnbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR291
AC   CVCL_NM85
SY   RRR291
DR   MMRRC; MMRRC:004523-UCD
DR   Wikidata; Q54775377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101816; Msh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR294
AC   CVCL_NM86
SY   RRR294
DR   MMRRC; MMRRC:004524-UCD
DR   Wikidata; Q54775378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR296
AC   CVCL_NM87
SY   RRR296
DR   MMRRC; MMRRC:004526-UCD
DR   Wikidata; Q54775380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR298
AC   CVCL_NM88
SY   RRR298
DR   MMRRC; MMRRC:004528-UCD
DR   Wikidata; Q54775383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349394; Map4k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR300
AC   CVCL_NM89
SY   RRR300
DR   MMRRC; MMRRC:004529-UCD
DR   Wikidata; Q54775385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR301
AC   CVCL_NM90
SY   RRR301
DR   MMRRC; MMRRC:004530-UCD
DR   Wikidata; Q54775387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR307
AC   CVCL_NM91
SY   RRR307
DR   MMRRC; MMRRC:004531-UCD
DR   Wikidata; Q54775389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443699; Fubp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR308
AC   CVCL_NM92
SY   RRR308
DR   MMRRC; MMRRC:004532-UCD
DR   Wikidata; Q54775390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104662; Pml.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR310
AC   CVCL_NM93
SY   RRR310
DR   MMRRC; MMRRC:004533-UCD
DR   Wikidata; Q54775393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR311
AC   CVCL_NM94
SY   RRR311
DR   MMRRC; MMRRC:004534-UCD
DR   Wikidata; Q54775394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919936; Usp24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR315
AC   CVCL_NM95
SY   RRR315
DR   MMRRC; MMRRC:004536-UCD
DR   Wikidata; Q54775396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202876; Tcf7l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR316
AC   CVCL_NM96
SY   RRR316
DR   MMRRC; MMRRC:004537-UCD
DR   Wikidata; Q54775397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444233; Ythdf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR317
AC   CVCL_NM97
SY   RRR317
DR   MMRRC; MMRRC:004538-UCD
DR   Wikidata; Q54775398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR319
AC   CVCL_NM98
SY   RRR319
DR   MMRRC; MMRRC:004540-UCD
DR   Wikidata; Q54775400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098658; Stag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR320
AC   CVCL_NM99
SY   RRR320
DR   MMRRC; MMRRC:004541-UCD
DR   Wikidata; Q54775403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914324; Mon2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR322
AC   CVCL_NN00
SY   RRR322
DR   MMRRC; MMRRC:004542-UCD
DR   Wikidata; Q54775404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926163; Ltn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR323
AC   CVCL_NN01
SY   RRR323
DR   MMRRC; MMRRC:004543-UCD
DR   Wikidata; Q54775405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921268; Als2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR327
AC   CVCL_NN02
SY   RRR327
DR   MMRRC; MMRRC:004545-UCD
DR   Wikidata; Q54775406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913557; Isoc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR328
AC   CVCL_NN03
SY   RRR328
DR   MMRRC; MMRRC:004546-UCD
DR   Wikidata; Q54775409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442310; Ubxn2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR330
AC   CVCL_NN04
SY   RRR330
DR   MMRRC; MMRRC:004547-UCD
DR   Wikidata; Q54775410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919444; Fbxl20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR331
AC   CVCL_NN05
SY   RRR331
DR   MMRRC; MMRRC:004548-UCD
DR   Wikidata; Q54775411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915347; Dynll2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR332
AC   CVCL_NN06
SY   RRR332
DR   MMRRC; MMRRC:004549-UCD
DR   Wikidata; Q54775413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445126; Tut4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRR335
AC   CVCL_NN07
SY   RRR335
DR   MMRRC; MMRRC:004551-UCD
DR   Wikidata; Q54775415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR338
AC   CVCL_NN08
SY   RRR338
DR   MMRRC; MMRRC:004552-UCD
DR   Wikidata; Q54775417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96677; Kit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR339
AC   CVCL_NN09
SY   RRR339
DR   MMRRC; MMRRC:004553-UCD
DR   Wikidata; Q54775419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101816; Msh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR341
AC   CVCL_NN10
SY   RRR341
DR   MMRRC; MMRRC:004554-UCD
DR   Wikidata; Q54775421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917799; Tln2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR343
AC   CVCL_NN11
SY   RRR343
DR   MMRRC; MMRRC:004555-UCD
DR   Wikidata; Q54775424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107547; Zfp101.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR345
AC   CVCL_NN12
SY   RRR345
DR   MMRRC; MMRRC:004556-UCD
DR   Wikidata; Q54775426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96103; Hk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR347
AC   CVCL_NN13
SY   RRR347
DR   MMRRC; MMRRC:004558-UCD
DR   Wikidata; Q54775429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR349
AC   CVCL_NN14
SY   RRR349
DR   MMRRC; MMRRC:004559-UCD
DR   Wikidata; Q54775431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916976; Smyd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR350
AC   CVCL_NN15
SY   RRR350
DR   MMRRC; MMRRC:004560-UCD
DR   Wikidata; Q54775433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR351
AC   CVCL_NN16
SY   RRR351
DR   MMRRC; MMRRC:004561-UCD
DR   Wikidata; Q54775437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98180; Rrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR353
AC   CVCL_NN17
SY   RRR353
DR   MMRRC; MMRRC:004562-UCD
DR   Wikidata; Q54775439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR354
AC   CVCL_NN18
SY   RRR354
DR   MMRRC; MMRRC:004563-UCD
DR   Wikidata; Q54775440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137738; Prcc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR356
AC   CVCL_NN19
SY   RRR356
DR   MMRRC; MMRRC:004564-UCD
DR   Wikidata; Q54775442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105056; Cobl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR358
AC   CVCL_NN20
SY   RRR358
DR   MMRRC; MMRRC:004565-UCD
DR   Wikidata; Q54775445
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97621; Plk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR362
AC   CVCL_NN21
SY   RRR362
DR   MMRRC; MMRRC:004567-UCD
DR   Wikidata; Q54775446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR365
AC   CVCL_NN22
SY   RRR365
DR   MMRRC; MMRRC:004568-UCD
DR   Wikidata; Q54775448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928898; Usp14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR366
AC   CVCL_NN23
SY   RRR366
DR   MMRRC; MMRRC:004569-UCD
DR   Wikidata; Q54775494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137738; Prcc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR372
AC   CVCL_NN24
SY   RRR372
DR   MMRRC; MMRRC:004571-UCD
DR   Wikidata; Q54775495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352499; Ndrg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR376
AC   CVCL_NN25
SY   RRR376
DR   MMRRC; MMRRC:004572-UCD
DR   Wikidata; Q54775499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098240; Kif16b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR379
AC   CVCL_NN26
SY   RRR379
DR   MMRRC; MMRRC:004574-UCD
DR   Wikidata; Q54775501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333766; Epn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR380
AC   CVCL_NN27
SY   RRR380
DR   MMRRC; MMRRC:004575-UCD
DR   Wikidata; Q54775503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104987; Mxd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR383
AC   CVCL_NN28
SY   RRR383
DR   MMRRC; MMRRC:004576-UCD
DR   Wikidata; Q54775504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914832; Slc25a26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR386
AC   CVCL_NN29
SY   RRR386
DR   MMRRC; MMRRC:004577-UCD
DR   Wikidata; Q54775505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096327; Axin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR392
AC   CVCL_NN30
SY   RRR392
DR   MMRRC; MMRRC:004578-UCD
DR   Wikidata; Q54775509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444961; Dennd2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR395
AC   CVCL_NN31
SY   RRR395
DR   MMRRC; MMRRC:004579-UCD
DR   Wikidata; Q54775511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388656; Zfp334.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR396
AC   CVCL_NN32
SY   RRR396
DR   MMRRC; MMRRC:004580-UCD
DR   Wikidata; Q54775514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR398
AC   CVCL_NN33
SY   RRR398
DR   MMRRC; MMRRC:004581-UCD
DR   Wikidata; Q54775518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR399
AC   CVCL_NN34
SY   RRR399
DR   MMRRC; MMRRC:004582-UCD
DR   Wikidata; Q54775520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922004; Dhcr24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR400
AC   CVCL_NN35
SY   RRR400
DR   MMRRC; MMRRC:004583-UCD
DR   Wikidata; Q54775523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333879; Ap3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR402
AC   CVCL_NN36
SY   RRR402
DR   MMRRC; MMRRC:004584-UCD
DR   Wikidata; Q54775525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444236; Ubn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR404
AC   CVCL_NN37
SY   RRR404
DR   MMRRC; MMRRC:004585-UCD
DR   Wikidata; Q54775526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927224; Yeats4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR405
AC   CVCL_NN38
SY   RRR405
DR   MMRRC; MMRRC:004586-UCD
DR   Wikidata; Q54775529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR406
AC   CVCL_NN39
SY   RRR406
DR   MMRRC; MMRRC:004587-UCD
DR   Wikidata; Q54775531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919840; Ppme1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR414
AC   CVCL_NN40
SY   RRR414
DR   MMRRC; MMRRC:004588-UCD
DR   Wikidata; Q54775532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105085; Rbl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR423
AC   CVCL_NN41
SY   RRR423
DR   MMRRC; MMRRC:004590-UCD
DR   Wikidata; Q54775535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922896; Rai14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR424
AC   CVCL_NN42
SY   RRR424
DR   MMRRC; MMRRC:004591-UCD
DR   Wikidata; Q54775538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107760; Chka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR425
AC   CVCL_NN43
SY   RRR425
DR   MMRRC; MMRRC:004592-UCD
DR   Wikidata; Q54775541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355274; Uchl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR426
AC   CVCL_NN44
SY   RRR426
DR   MMRRC; MMRRC:004593-UCD
DR   Wikidata; Q54775543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103202; Adsl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR429
AC   CVCL_NN45
SY   RRR429
DR   MMRRC; MMRRC:004595-UCD
DR   Wikidata; Q54775545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914751; Ccdc50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR430
AC   CVCL_NN46
SY   RRR430
DR   MMRRC; MMRRC:004596-UCD
DR   Wikidata; Q54775548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346875; Map3k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR432
AC   CVCL_NN47
SY   RRR432
DR   MMRRC; MMRRC:004598-UCD
DR   Wikidata; Q54775549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442377; Ipo11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR435
AC   CVCL_NN48
SY   RRR435
DR   MMRRC; MMRRC:004599-UCD
DR   Wikidata; Q54775552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96525; Rbpj-ps3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR437
AC   CVCL_NN49
SY   RRR437
DR   MMRRC; MMRRC:004600-UCD
DR   Wikidata; Q54775554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914803; Gstcd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR440
AC   CVCL_NN50
SY   RRR440
DR   MMRRC; MMRRC:004601-UCD
DR   Wikidata; Q54775555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098258; Kif15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR441
AC   CVCL_NN51
SY   RRR441
DR   MMRRC; MMRRC:004602-UCD
DR   Wikidata; Q54775557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860512; Prpf40a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR445
AC   CVCL_NN52
SY   RRR445
DR   MMRRC; MMRRC:004604-UCD
DR   Wikidata; Q54775559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930134; Ern1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR446
AC   CVCL_NN53
SY   RRR446
DR   MMRRC; MMRRC:004605-UCD
DR   Wikidata; Q54775561
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109520; Pafah1b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR447
AC   CVCL_NN54
SY   RRR447
DR   MMRRC; MMRRC:004606-UCD
DR   Wikidata; Q54775564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918023; Cwf19l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR449
AC   CVCL_NN55
SY   RRR449
DR   MMRRC; MMRRC:004608-UCD
DR   Wikidata; Q54775565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR450
AC   CVCL_NN56
SY   RRR450
DR   MMRRC; MMRRC:004609-UCD
DR   Wikidata; Q54775567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915208; U2surp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR452
AC   CVCL_NN57
SY   RRR452
DR   MMRRC; MMRRC:004610-UCD
DR   Wikidata; Q54775569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919806; Zfp566.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR453
AC   CVCL_NN58
SY   RRR453
DR   MMRRC; MMRRC:004611-UCD
DR   Wikidata; Q54775571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351331; Chaf1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR454
AC   CVCL_NN59
SY   RRR454
DR   MMRRC; MMRRC:004612-UCD
DR   Wikidata; Q54775573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336167; Prkab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR455
AC   CVCL_NN60
SY   RRR455
DR   MMRRC; MMRRC:004613-UCD
DR   Wikidata; Q54775576
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918518; Lrrfip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR458
AC   CVCL_NN61
SY   RRR458
DR   MMRRC; MMRRC:004615-UCD
DR   Wikidata; Q54775577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3652219; Zfp345.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR463
AC   CVCL_NN62
SY   RRR463
DR   MMRRC; MMRRC:004616-UCD
DR   Wikidata; Q54775579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202876; Tcf7l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR464
AC   CVCL_NN63
SY   RRR464
DR   MMRRC; MMRRC:004617-UCD
DR   Wikidata; Q54775635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196453; Klhl7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR467
AC   CVCL_NN64
SY   RRR467
DR   MMRRC; MMRRC:004619-UCD
DR   Wikidata; Q54775636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353606; Siva1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR468
AC   CVCL_NN65
SY   RRR468
DR   MMRRC; MMRRC:004620-UCD
DR   Wikidata; Q54775638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR472
AC   CVCL_NN66
SY   RRR472
DR   MMRRC; MMRRC:004621-UCD
DR   Wikidata; Q54775639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR475
AC   CVCL_NN67
SY   RRR475
DR   MMRRC; MMRRC:004623-UCD
DR   Wikidata; Q54775640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923520; Cyrib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRR476
AC   CVCL_NN68
SY   RRR476
DR   MMRRC; MMRRC:004624-UCD
DR   Wikidata; Q54775643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101919; Ap1g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR477
AC   CVCL_NN69
SY   RRR477
DR   MMRRC; MMRRC:004625-UCD
DR   Wikidata; Q54775645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927138; Net1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR478
AC   CVCL_NN70
SY   RRR478
DR   MMRRC; MMRRC:004626-UCD
DR   Wikidata; Q54775648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178217; Akap9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR479
AC   CVCL_NN71
SY   RRR479
DR   MMRRC; MMRRC:004627-UCD
DR   Wikidata; Q54775650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444266; Ube2o.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR480
AC   CVCL_NN72
SY   RRR480
DR   MMRRC; MMRRC:004628-UCD
DR   Wikidata; Q54775652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96247; Hsp90ab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR483
AC   CVCL_NN73
SY   RRR483
DR   MMRRC; MMRRC:004631-UCD
DR   Wikidata; Q54775654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914128; Riok3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR484
AC   CVCL_NN74
SY   RRR484
DR   MMRRC; MMRRC:004632-UCD
DR   Wikidata; Q54775657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102467; Ptpn14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR487
AC   CVCL_NN75
SY   RRR487
DR   MMRRC; MMRRC:004634-UCD
DR   Wikidata; Q54775659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444490; Syt14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR490
AC   CVCL_NN76
SY   RRR490
DR   MMRRC; MMRRC:004635-UCD
DR   Wikidata; Q54775661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919670; Rbm33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR494
AC   CVCL_NN77
SY   RRR494
DR   MMRRC; MMRRC:004636-UCD
DR   Wikidata; Q54775662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103147; Dync1h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR495
AC   CVCL_NN78
SY   RRR495
DR   MMRRC; MMRRC:004637-UCD
DR   Wikidata; Q54775664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441849; Lpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR497
AC   CVCL_NN79
SY   RRR497
DR   MMRRC; MMRRC:004638-UCD
DR   Wikidata; Q54775668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196368; Carhsp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR499
AC   CVCL_NN80
SY   RRR499
DR   MMRRC; MMRRC:004640-UCD
DR   Wikidata; Q54775670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858965; Atf7ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR502
AC   CVCL_NN81
SY   RRR502
DR   MMRRC; MMRRC:004642-UCD
DR   Wikidata; Q54775672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889508; Tbc1d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR503
AC   CVCL_NN82
SY   RRR503
DR   MMRRC; MMRRC:004643-UCD
DR   Wikidata; Q54775674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444401; Snrnp200.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR504
AC   CVCL_NN83
SY   RRR504
DR   MMRRC; MMRRC:004644-UCD
DR   Wikidata; Q54775677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR507
AC   CVCL_NN84
SY   RRR507
DR   MMRRC; MMRRC:004645-UCD
DR   Wikidata; Q54775680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103202; Adsl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR509
AC   CVCL_NN85
SY   RRR509
DR   MMRRC; MMRRC:004646-UCD
DR   Wikidata; Q54775681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR511
AC   CVCL_NN86
SY   RRR511
DR   MMRRC; MMRRC:004648-UCD
DR   Wikidata; Q54775683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR512
AC   CVCL_NN87
SY   RRR512
DR   MMRRC; MMRRC:004649-UCD
DR   Wikidata; Q54775685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR515
AC   CVCL_NN88
SY   RRR515
DR   MMRRC; MMRRC:004651-UCD
DR   Wikidata; Q54775688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR520
AC   CVCL_NN89
SY   RRR520
DR   MMRRC; MMRRC:004654-UCD
DR   Wikidata; Q54775689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR523
AC   CVCL_NN90
SY   RRR523
DR   MMRRC; MMRRC:004656-UCD
DR   Wikidata; Q54775690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR524
AC   CVCL_NN91
SY   RRR524
DR   MMRRC; MMRRC:004657-UCD
DR   Wikidata; Q54775694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675306; Zfp930.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR527
AC   CVCL_NN92
SY   RRR527
DR   MMRRC; MMRRC:004658-UCD
DR   Wikidata; Q54775695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443713; Ythdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR529
AC   CVCL_NN93
SY   RRR529
DR   MMRRC; MMRRC:004659-UCD
DR   Wikidata; Q54775697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921705; Nsun6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR532
AC   CVCL_NN94
SY   RRR532
DR   MMRRC; MMRRC:004660-UCD
DR   Wikidata; Q54775698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR534
AC   CVCL_NN95
SY   RRR534
DR   MMRRC; MMRRC:004662-UCD
DR   Wikidata; Q54775700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934031; Pi4k2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR540
AC   CVCL_NN96
SY   RRR540
DR   MMRRC; MMRRC:004665-UCD
DR   Wikidata; Q54775702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681836; Polr3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR541
AC   CVCL_NN97
SY   RRR541
DR   MMRRC; MMRRC:004666-UCD
DR   Wikidata; Q54775705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1306824; Suclg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR544
AC   CVCL_NN98
SY   RRR544
DR   MMRRC; MMRRC:004668-UCD
DR   Wikidata; Q54775707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103202; Adsl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR545
AC   CVCL_NN99
SY   RRR545
DR   MMRRC; MMRRC:004669-UCD
DR   Wikidata; Q54775708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR547
AC   CVCL_NP00
SY   RRR547
DR   MMRRC; MMRRC:004671-UCD
DR   Wikidata; Q54775711
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935147; Arid1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR548
AC   CVCL_NP01
SY   RRR548
DR   MMRRC; MMRRC:004672-UCD
DR   Wikidata; Q54775713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107532; Kpnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR550
AC   CVCL_NP02
SY   RRR550
DR   MMRRC; MMRRC:004673-UCD
DR   Wikidata; Q54775717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183436; Nrbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR552
AC   CVCL_NP03
SY   RRR552
DR   MMRRC; MMRRC:004674-UCD
DR   Wikidata; Q54775762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR557
AC   CVCL_NP04
SY   RRR557
DR   MMRRC; MMRRC:004676-UCD
DR   Wikidata; Q54775765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3646776; Gm4779.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR563
AC   CVCL_NP05
SY   RRR563
DR   MMRRC; MMRRC:004677-UCD
DR   Wikidata; Q54775766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349394; Map4k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR564
AC   CVCL_NP06
SY   RRR564
DR   MMRRC; MMRRC:004678-UCD
DR   Wikidata; Q54775767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888677; Gigyf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR565
AC   CVCL_NP07
SY   RRR565
DR   MMRRC; MMRRC:004679-UCD
DR   Wikidata; Q54775768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR568
AC   CVCL_NP08
SY   RRR568
DR   MMRRC; MMRRC:004680-UCD
DR   Wikidata; Q54775772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106264; Trim36.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR569
AC   CVCL_NP09
SY   RRR569
DR   MMRRC; MMRRC:004681-UCD
DR   Wikidata; Q54775773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103202; Adsl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR570
AC   CVCL_NP10
SY   RRR570
DR   MMRRC; MMRRC:004682-UCD
DR   Wikidata; Q54775775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915205; Sugt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR573
AC   CVCL_NP11
SY   RRR573
DR   MMRRC; MMRRC:004683-UCD
DR   Wikidata; Q54775777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105307; Ptpn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR576
AC   CVCL_NP12
SY   RRR576
DR   MMRRC; MMRRC:004684-UCD
DR   Wikidata; Q54775779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR577
AC   CVCL_NP13
SY   RRR577
DR   MMRRC; MMRRC:004685-UCD
DR   Wikidata; Q54775780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR587
AC   CVCL_NP14
SY   RRR587
DR   MMRRC; MMRRC:004690-UCD
DR   Wikidata; Q54775781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888526; Xpo4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR590
AC   CVCL_NP15
SY   RRR590
DR   MMRRC; MMRRC:004691-UCD
DR   Wikidata; Q54775782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446126; Phf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR592
AC   CVCL_NP16
SY   RRR592
DR   MMRRC; MMRRC:004692-UCD
DR   Wikidata; Q54775785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442988; Arfgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR593
AC   CVCL_NP17
SY   RRR593
DR   MMRRC; MMRRC:004693-UCD
DR   Wikidata; Q54775786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914295; Riok2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR598
AC   CVCL_NP18
SY   RRR598
DR   MMRRC; MMRRC:004695-UCD
DR   Wikidata; Q54775789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922855; Kdm5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR599
AC   CVCL_NP19
SY   RRR599
DR   MMRRC; MMRRC:004696-UCD
DR   Wikidata; Q54775790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR600
AC   CVCL_NP20
SY   RRR600
DR   MMRRC; MMRRC:004697-UCD
DR   Wikidata; Q54775792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384756; Phf21a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR601
AC   CVCL_NP21
SY   RRR601
DR   MMRRC; MMRRC:004698-UCD
DR   Wikidata; Q54775794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590652; Txlng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR602
AC   CVCL_NP22
SY   RRR602
DR   MMRRC; MMRRC:004699-UCD
DR   Wikidata; Q54775795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3525201; Mdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR606
AC   CVCL_NP23
SY   RRR606
DR   MMRRC; MMRRC:004701-UCD
DR   Wikidata; Q54775796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147987; Pcyt1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR607
AC   CVCL_NP24
SY   RRR607
DR   MMRRC; MMRRC:004702-UCD
DR   Wikidata; Q54775799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR608
AC   CVCL_NP25
SY   RRR608
DR   MMRRC; MMRRC:004703-UCD
DR   Wikidata; Q54775800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446977; Kif18a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR609
AC   CVCL_NP26
SY   RRR609
DR   MMRRC; MMRRC:004704-UCD
DR   Wikidata; Q54775804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR610
AC   CVCL_NP27
SY   RRR610
DR   MMRRC; MMRRC:004705-UCD
DR   Wikidata; Q54775805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107901; Nfyc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR611
AC   CVCL_NP28
SY   RRR611
DR   MMRRC; MMRRC:004706-UCD
DR   Wikidata; Q54775806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR615
AC   CVCL_NP29
SY   RRR615
DR   MMRRC; MMRRC:004710-UCD
DR   Wikidata; Q54775809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99211; Zfx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR617
AC   CVCL_NP30
SY   RRR617
DR   MMRRC; MMRRC:004711-UCD
DR   Wikidata; Q54775811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3800296; Gm9631.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR620
AC   CVCL_NP31
SY   RRR620
DR   MMRRC; MMRRC:004714-UCD
DR   Wikidata; Q54775812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442988; Arfgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR622
AC   CVCL_NP32
SY   RRR622
DR   MMRRC; MMRRC:004715-UCD
DR   Wikidata; Q54775815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR624
AC   CVCL_NP33
SY   RRR624
DR   MMRRC; MMRRC:004717-UCD
DR   Wikidata; Q54775818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201691; Rnf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR627
AC   CVCL_NP34
SY   RRR627
DR   MMRRC; MMRRC:004719-UCD
DR   Wikidata; Q54775820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104810; Plaa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR629
AC   CVCL_NP35
SY   RRR629
DR   MMRRC; MMRRC:004721-UCD
DR   Wikidata; Q54775823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918685; Arhgap21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR632
AC   CVCL_NP36
SY   RRR632
DR   MMRRC; MMRRC:004722-UCD
DR   Wikidata; Q54775825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR633
AC   CVCL_NP37
SY   RRR633
DR   MMRRC; MMRRC:004723-UCD
DR   Wikidata; Q54775827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855693; Nap1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR634
AC   CVCL_NP38
SY   RRR634
DR   MMRRC; MMRRC:004724-UCD
DR   Wikidata; Q54775829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102467; Ptpn14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR636
AC   CVCL_NP39
SY   RRR636
DR   MMRRC; MMRRC:004725-UCD
DR   Wikidata; Q54775831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334417; Grpel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR639
AC   CVCL_NP40
SY   RRR639
DR   MMRRC; MMRRC:004728-UCD
DR   Wikidata; Q54775833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891832; Patz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR644
AC   CVCL_NP41
SY   RRR644
DR   MMRRC; MMRRC:004730-UCD
DR   Wikidata; Q54775835
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289318; Ccdc43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR647
AC   CVCL_NP42
SY   RRR647
DR   MMRRC; MMRRC:004731-UCD
DR   Wikidata; Q54775837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914538; Srek1ip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR648
AC   CVCL_NP43
SY   RRR648
DR   MMRRC; MMRRC:004732-UCD
DR   Wikidata; Q54775937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442317; Mier3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR650
AC   CVCL_NP44
SY   RRR650
DR   MMRRC; MMRRC:004733-UCD
DR   Wikidata; Q54775938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351657; Abcf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR652
AC   CVCL_NP45
SY   RRR652
DR   MMRRC; MMRRC:004735-UCD
DR   Wikidata; Q54775939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338864; Stau1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR653
AC   CVCL_NP46
SY   RRR653
DR   MMRRC; MMRRC:004736-UCD
DR   Wikidata; Q54775943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917458; Med23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR657
AC   CVCL_NP47
SY   RRR657
DR   MMRRC; MMRRC:004737-UCD
DR   Wikidata; Q54775945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343463; Bub3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR660
AC   CVCL_NP48
SY   RRR660
DR   MMRRC; MMRRC:004739-UCD
DR   Wikidata; Q54775948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917875; Med26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR664
AC   CVCL_NP49
SY   RRR664
DR   MMRRC; MMRRC:004740-UCD
DR   Wikidata; Q54775949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR667
AC   CVCL_NP50
SY   RRR667
DR   MMRRC; MMRRC:004741-UCD
DR   Wikidata; Q54775953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182472; Tpcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR669
AC   CVCL_NP51
SY   RRR669
DR   MMRRC; MMRRC:004742-UCD
DR   Wikidata; Q54775957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139369; Rtel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR671
AC   CVCL_NP52
SY   RRR671
DR   MMRRC; MMRRC:004743-UCD
DR   Wikidata; Q54775959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107901; Nfyc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR673
AC   CVCL_NP53
SY   RRR673
DR   MMRRC; MMRRC:004744-UCD
DR   Wikidata; Q54775961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR674
AC   CVCL_NP54
SY   RRR674
DR   MMRRC; MMRRC:004745-UCD
DR   Wikidata; Q54775963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343188; Ube2g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR675
AC   CVCL_NP55
SY   RRR675
DR   MMRRC; MMRRC:004746-UCD
DR   Wikidata; Q54775965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890520; Vps4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR676
AC   CVCL_NP56
SY   RRR676
DR   MMRRC; MMRRC:004747-UCD
DR   Wikidata; Q54775967
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388633; Cltc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR677
AC   CVCL_NP57
SY   RRR677
DR   MMRRC; MMRRC:004748-UCD
DR   Wikidata; Q54775968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96247; Hsp90ab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR680
AC   CVCL_NP58
SY   RRR680
DR   MMRRC; MMRRC:004749-UCD
DR   Wikidata; Q54775970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443882; Snx30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR688
AC   CVCL_NP59
SY   RRR688
DR   MMRRC; MMRRC:004751-UCD
DR   Wikidata; Q54775971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926048; Eml4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR689
AC   CVCL_NP60
SY   RRR689
DR   MMRRC; MMRRC:004752-UCD
DR   Wikidata; Q54775974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345643; Sufu.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR690
AC   CVCL_NP61
SY   RRR690
DR   MMRRC; MMRRC:004753-UCD
DR   Wikidata; Q54775976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933204; Rbm5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR693
AC   CVCL_NP62
SY   RRR693
DR   MMRRC; MMRRC:004754-UCD
DR   Wikidata; Q54775978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918890; Zfp949.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR694
AC   CVCL_NP63
SY   RRR694
DR   MMRRC; MMRRC:004755-UCD
DR   Wikidata; Q54775981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3800296; Gm9631.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR695
AC   CVCL_NP64
SY   RRR695
DR   MMRRC; MMRRC:004756-UCD
DR   Wikidata; Q54775984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88279; Cbl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR696
AC   CVCL_NP65
SY   RRR696
DR   MMRRC; MMRRC:004757-UCD
DR   Wikidata; Q54775985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3800296; Gm9631.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR698
AC   CVCL_NP66
SY   RRR698
DR   MMRRC; MMRRC:004758-UCD
DR   Wikidata; Q54775987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915545; Aar2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR700
AC   CVCL_NP67
SY   RRR700
DR   MMRRC; MMRRC:004760-UCD
DR   Wikidata; Q54775989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140230; Camta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR703
AC   CVCL_NP68
SY   RRR703
DR   MMRRC; MMRRC:004762-UCD
DR   Wikidata; Q54775992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR705
AC   CVCL_NP69
SY   RRR705
DR   MMRRC; MMRRC:004764-UCD
DR   Wikidata; Q54775995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914265; Ccdc91.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR706
AC   CVCL_NP70
SY   RRR706
DR   MMRRC; MMRRC:004765-UCD
DR   Wikidata; Q54775996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96247; Hsp90ab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR709
AC   CVCL_NP71
SY   RRR709
DR   MMRRC; MMRRC:004767-UCD
DR   Wikidata; Q54775998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR712
AC   CVCL_NP72
SY   RRR712
DR   MMRRC; MMRRC:004768-UCD
DR   Wikidata; Q54776000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3608327; Marchf11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRR713
AC   CVCL_NP73
SY   RRR713
DR   MMRRC; MMRRC:004769-UCD
DR   Wikidata; Q54776002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443386; Dnajc11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR714
AC   CVCL_NP74
SY   RRR714
DR   MMRRC; MMRRC:004770-UCD
DR   Wikidata; Q54776005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR716
AC   CVCL_NP75
SY   RRR716
DR   MMRRC; MMRRC:004771-UCD
DR   Wikidata; Q54776006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR718
AC   CVCL_NP76
SY   RRR718
DR   MMRRC; MMRRC:004772-UCD
DR   Wikidata; Q54776007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196439; Cbx7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR719
AC   CVCL_NP77
SY   RRR719
DR   MMRRC; MMRRC:004773-UCD
DR   Wikidata; Q54776010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104874; Akt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR720
AC   CVCL_NP78
SY   RRR720
DR   MMRRC; MMRRC:004774-UCD
DR   Wikidata; Q54776012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97851; Slc20a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR721
AC   CVCL_NP79
SY   RRR721
DR   MMRRC; MMRRC:004775-UCD
DR   Wikidata; Q54776016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338001; Gdap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR722
AC   CVCL_NP80
SY   RRR722
DR   MMRRC; MMRRC:004776-UCD
DR   Wikidata; Q54776017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR723
AC   CVCL_NP81
SY   RRR723
DR   MMRRC; MMRRC:004777-UCD
DR   Wikidata; Q54776019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448530; Vps13d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR726
AC   CVCL_NP82
SY   RRR726
DR   MMRRC; MMRRC:004779-UCD
DR   Wikidata; Q54776020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR727
AC   CVCL_NP83
SY   RRR727
DR   MMRRC; MMRRC:004780-UCD
DR   Wikidata; Q54776065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385902; Picalm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR730
AC   CVCL_NP84
SY   RRR730
DR   MMRRC; MMRRC:004783-UCD
DR   Wikidata; Q54776068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928738; Slc25a20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR731
AC   CVCL_NP85
SY   RRR731
DR   MMRRC; MMRRC:004784-UCD
DR   Wikidata; Q54776071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441849; Lpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR738
AC   CVCL_NP86
SY   RRR738
DR   MMRRC; MMRRC:004785-UCD
DR   Wikidata; Q54776074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261890; Fbxo28.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR740
AC   CVCL_NP87
SY   RRR740
DR   MMRRC; MMRRC:004786-UCD
DR   Wikidata; Q54776076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890773; Actn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR743
AC   CVCL_NP88
SY   RRR743
DR   MMRRC; MMRRC:004787-UCD
DR   Wikidata; Q54776079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107901; Nfyc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR746
AC   CVCL_NP89
SY   RRR746
DR   MMRRC; MMRRC:004789-UCD
DR   Wikidata; Q54776081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891963; Ywhaq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR748
AC   CVCL_NP90
SY   RRR748
DR   MMRRC; MMRRC:004790-UCD
DR   Wikidata; Q54776083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919790; Heatr6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR754
AC   CVCL_NP91
SY   RRR754
DR   MMRRC; MMRRC:004792-UCD
DR   Wikidata; Q54776086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384756; Phf21a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR757
AC   CVCL_NP92
SY   RRR757
DR   MMRRC; MMRRC:004793-UCD
DR   Wikidata; Q54776087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3800296; Gm9631.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR759
AC   CVCL_NP93
SY   RRR759
DR   MMRRC; MMRRC:004794-UCD
DR   Wikidata; Q54776088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927222; Diaph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR761
AC   CVCL_NP94
SY   RRR761
DR   MMRRC; MMRRC:004796-UCD
DR   Wikidata; Q54776092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR765
AC   CVCL_NP95
SY   RRR765
DR   MMRRC; MMRRC:004798-UCD
DR   Wikidata; Q54776094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137022; Tm2d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR767
AC   CVCL_NP96
SY   RRR767
DR   MMRRC; MMRRC:004800-UCD
DR   Wikidata; Q54776097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196439; Cbx7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR770
AC   CVCL_NP97
SY   RRR770
DR   MMRRC; MMRRC:004803-UCD
DR   Wikidata; Q54776100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355322; Exosc10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR771
AC   CVCL_NP98
SY   RRR771
DR   MMRRC; MMRRC:004804-UCD
DR   Wikidata; Q54776102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919213; Cdca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR772
AC   CVCL_NP99
SY   RRR772
DR   MMRRC; MMRRC:004805-UCD
DR   Wikidata; Q54776103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276116; Ep300.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR774
AC   CVCL_NQ00
SY   RRR774
DR   MMRRC; MMRRC:004806-UCD
DR   Wikidata; Q54776106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337062; Ap3s1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR776
AC   CVCL_NQ01
SY   RRR776
DR   MMRRC; MMRRC:004807-UCD
DR   Wikidata; Q54776108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107428; Cfap20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR778
AC   CVCL_NQ02
SY   RRR778
DR   MMRRC; MMRRC:004808-UCD
DR   Wikidata; Q54776111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104673; Ptpn12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR785
AC   CVCL_NQ03
SY   RRR785
DR   MMRRC; MMRRC:004811-UCD
DR   Wikidata; Q54776114
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916858; Sec24d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR786
AC   CVCL_NQ04
SY   RRR786
DR   MMRRC; MMRRC:004812-UCD
DR   Wikidata; Q54776115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918708; Bcor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR789
AC   CVCL_NQ05
SY   RRR789
DR   MMRRC; MMRRC:004813-UCD
DR   Wikidata; Q54776116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103241; Slk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR792
AC   CVCL_NQ06
SY   RRR792
DR   MMRRC; MMRRC:004816-UCD
DR   Wikidata; Q54776118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914280; Fancl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR793
AC   CVCL_NQ07
SY   RRR793
DR   MMRRC; MMRRC:004817-UCD
DR   Wikidata; Q54776119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106621; Myo1e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR794
AC   CVCL_NQ08
SY   RRR794
DR   MMRRC; MMRRC:004818-UCD
DR   Wikidata; Q54776122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179723; Casc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR799
AC   CVCL_NQ09
SY   RRR799
DR   MMRRC; MMRRC:004820-UCD
DR   Wikidata; Q54776123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR800
AC   CVCL_NQ10
SY   RRR800
DR   MMRRC; MMRRC:004821-UCD
DR   Wikidata; Q54776126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88039; Apc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR804
AC   CVCL_NQ11
SY   RRR804
DR   MMRRC; MMRRC:004823-UCD
DR   Wikidata; Q54776129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104872; Ppp1cc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR805
AC   CVCL_NQ12
SY   RRR805
DR   MMRRC; MMRRC:004824-UCD
DR   Wikidata; Q54776132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR807
AC   CVCL_NQ13
SY   RRR807
DR   MMRRC; MMRRC:004825-UCD
DR   Wikidata; Q54776134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR809
AC   CVCL_NQ14
SY   RRR809
DR   MMRRC; MMRRC:004827-UCD
DR   Wikidata; Q54776137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447834; Fam13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR810
AC   CVCL_NQ15
SY   RRR810
DR   MMRRC; MMRRC:004828-UCD
DR   Wikidata; Q54776139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR811
AC   CVCL_NQ16
SY   RRR811
DR   MMRRC; MMRRC:004829-UCD
DR   Wikidata; Q54776140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354698; Fbxw4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR812
AC   CVCL_NQ17
SY   RRR812
DR   MMRRC; MMRRC:004830-UCD
DR   Wikidata; Q54776142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920274; Emc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR815
AC   CVCL_NQ18
SY   RRR815
DR   MMRRC; MMRRC:004832-UCD
DR   Wikidata; Q54776143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892995; Dnajc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR816
AC   CVCL_NQ19
SY   RRR816
DR   MMRRC; MMRRC:004833-UCD
DR   Wikidata; Q54776145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891700; Ncstn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRR817
AC   CVCL_NQ20
SY   RRR817
DR   MMRRC; MMRRC:004834-UCD
DR   Wikidata; Q54776147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917758; Bbx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS001
AC   CVCL_NQ21
SY   RRS001
DR   MMRRC; MMRRC:004836-UCD
DR   Wikidata; Q54776149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684817; Snhg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS003
AC   CVCL_NQ22
SY   RRS003
DR   MMRRC; MMRRC:004837-UCD
DR   Wikidata; Q54776150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS005
AC   CVCL_NQ23
SY   RRS005
DR   MMRRC; MMRRC:004838-UCD
DR   Wikidata; Q54776192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145425; Depdc1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS008
AC   CVCL_NQ24
SY   RRS008
DR   MMRRC; MMRRC:004840-UCD
DR   Wikidata; Q54776195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384569; Klhdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS009
AC   CVCL_NQ25
SY   RRS009
DR   MMRRC; MMRRC:004841-UCD
DR   Wikidata; Q54776197
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS010
AC   CVCL_NQ26
SY   RRS010
DR   MMRRC; MMRRC:004842-UCD
DR   Wikidata; Q54776198
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97838; Eprs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS011
AC   CVCL_NQ27
SY   RRS011
DR   MMRRC; MMRRC:004843-UCD
DR   Wikidata; Q54776200
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919752; Cwf19l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS012
AC   CVCL_NQ28
SY   RRS012
DR   MMRRC; MMRRC:004844-UCD
DR   Wikidata; Q54776202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332236; Cds2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS014
AC   CVCL_NQ29
SY   RRS014
DR   MMRRC; MMRRC:004845-UCD
DR   Wikidata; Q54776204
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109547; Dnm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS015
AC   CVCL_NQ30
SY   RRS015
DR   MMRRC; MMRRC:004846-UCD
DR   Wikidata; Q54776206
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS018
AC   CVCL_NQ31
SY   RRS018
DR   MMRRC; MMRRC:004847-UCD
DR   Wikidata; Q54776207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347048; Clcn7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS019
AC   CVCL_NQ32
SY   RRS019
DR   MMRRC; MMRRC:004848-UCD
DR   Wikidata; Q54776208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932339; Sf3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS020
AC   CVCL_NQ33
SY   RRS020
DR   MMRRC; MMRRC:004849-UCD
DR   Wikidata; Q54776212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS021
AC   CVCL_NQ34
SY   RRS021
DR   MMRRC; MMRRC:004850-UCD
DR   Wikidata; Q54776213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921020; Wdr70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS022
AC   CVCL_NQ35
SY   RRS022
DR   MMRRC; MMRRC:004851-UCD
DR   Wikidata; Q54776215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919244; Cnn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS024
AC   CVCL_NQ36
SY   RRS024
DR   MMRRC; MMRRC:004852-UCD
DR   Wikidata; Q54776219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915546; Smu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS025
AC   CVCL_NQ37
SY   RRS025
DR   MMRRC; MMRRC:004853-UCD
DR   Wikidata; Q54776220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203484; Zfp638.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS026
AC   CVCL_NQ38
SY   RRS026
DR   MMRRC; MMRRC:004854-UCD
DR   Wikidata; Q54776222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915467; Prrc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS027
AC   CVCL_NQ39
SY   RRS027
DR   MMRRC; MMRRC:004855-UCD
DR   Wikidata; Q54776223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS031
AC   CVCL_NQ40
SY   RRS031
DR   MMRRC; MMRRC:004856-UCD
DR   Wikidata; Q54776226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443114; Larp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS032
AC   CVCL_NQ41
SY   RRS032
DR   MMRRC; MMRRC:004857-UCD
DR   Wikidata; Q54776227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891829; Rbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS034
AC   CVCL_NQ42
SY   RRS034
DR   MMRRC; MMRRC:004858-UCD
DR   Wikidata; Q54776230
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925237; Ascc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS035
AC   CVCL_NQ43
SY   RRS035
DR   MMRRC; MMRRC:004859-UCD
DR   Wikidata; Q54776232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104557; Rps6ka3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS037
AC   CVCL_NQ44
SY   RRS037
DR   MMRRC; MMRRC:004860-UCD
DR   Wikidata; Q54776233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS040
AC   CVCL_NQ45
SY   RRS040
DR   MMRRC; MMRRC:004862-UCD
DR   Wikidata; Q54776236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196908; Tcea3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS041
AC   CVCL_NQ46
SY   RRS041
DR   MMRRC; MMRRC:004863-UCD
DR   Wikidata; Q54776238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3583954; Zfp961.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS042
AC   CVCL_NQ47
SY   RRS042
DR   MMRRC; MMRRC:004864-UCD
DR   Wikidata; Q54776242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100818; Crcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS046
AC   CVCL_NQ48
SY   RRS046
DR   MMRRC; MMRRC:004865-UCD
DR   Wikidata; Q54776243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920018; Topbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS048
AC   CVCL_NQ49
SY   RRS048
DR   MMRRC; MMRRC:004866-UCD
DR   Wikidata; Q54776246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891829; Rbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS052
AC   CVCL_NQ50
SY   RRS052
DR   MMRRC; MMRRC:004867-UCD
DR   Wikidata; Q54776248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158813; Sumo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS054
AC   CVCL_NQ51
SY   RRS054
DR   MMRRC; MMRRC:004868-UCD
DR   Wikidata; Q54776251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915867; Mtcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS055
AC   CVCL_NQ52
SY   RRS055
DR   MMRRC; MMRRC:004869-UCD
DR   Wikidata; Q54776254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914265; Ccdc91.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS056
AC   CVCL_NQ53
SY   RRS056
DR   MMRRC; MMRRC:004870-UCD
DR   Wikidata; Q54776257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS057
AC   CVCL_NQ54
SY   RRS057
DR   MMRRC; MMRRC:004871-UCD
DR   Wikidata; Q54776258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914321; Rps6ka6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS058
AC   CVCL_NQ55
SY   RRS058
DR   MMRRC; MMRRC:004872-UCD
DR   Wikidata; Q54776261
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923827; Faf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS061
AC   CVCL_NQ56
SY   RRS061
DR   MMRRC; MMRRC:004873-UCD
DR   Wikidata; Q54776264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:92356; Csde1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS062
AC   CVCL_NQ57
SY   RRS062
DR   MMRRC; MMRRC:004874-UCD
DR   Wikidata; Q54776267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444343; Nbeal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS064
AC   CVCL_NQ58
SY   RRS064
DR   MMRRC; MMRRC:004875-UCD
DR   Wikidata; Q54776269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS070
AC   CVCL_NQ59
SY   RRS070
DR   MMRRC; MMRRC:004877-UCD
DR   Wikidata; Q54776271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920909; Pdxdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS072
AC   CVCL_NQ60
SY   RRS072
DR   MMRRC; MMRRC:004878-UCD
DR   Wikidata; Q54776273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916188; Aspscr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS073
AC   CVCL_NQ61
SY   RRS073
DR   MMRRC; MMRRC:004879-UCD
DR   Wikidata; Q54776275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS075
AC   CVCL_NQ62
SY   RRS075
DR   MMRRC; MMRRC:004880-UCD
DR   Wikidata; Q54776278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS077
AC   CVCL_NQ63
SY   RRS077
DR   MMRRC; MMRRC:004881-UCD
DR   Wikidata; Q54776322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444188; Dgkh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS078
AC   CVCL_NQ64
SY   RRS078
DR   MMRRC; MMRRC:004882-UCD
DR   Wikidata; Q54776326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915867; Mtcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS080
AC   CVCL_NQ65
SY   RRS080
DR   MMRRC; MMRRC:004883-UCD
DR   Wikidata; Q54776328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676556; Akap13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS081
AC   CVCL_NQ66
SY   RRS081
DR   MMRRC; MMRRC:004884-UCD
DR   Wikidata; Q54776330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS083
AC   CVCL_NQ67
SY   RRS083
DR   MMRRC; MMRRC:004886-UCD
DR   Wikidata; Q54776334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95305; Eif4e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS087
AC   CVCL_NQ68
SY   RRS087
DR   MMRRC; MMRRC:004887-UCD
DR   Wikidata; Q54776336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449121; Nme7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS090
AC   CVCL_NQ69
SY   RRS090
DR   MMRRC; MMRRC:004888-UCD
DR   Wikidata; Q54776338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349394; Map4k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS092
AC   CVCL_NQ70
SY   RRS092
DR   MMRRC; MMRRC:004889-UCD
DR   Wikidata; Q54776339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS093
AC   CVCL_NQ71
SY   RRS093
DR   MMRRC; MMRRC:004890-UCD
DR   Wikidata; Q54776340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926966; Eif3c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS094
AC   CVCL_NQ72
SY   RRS094
DR   MMRRC; MMRRC:004891-UCD
DR   Wikidata; Q54776341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98931; Ezr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS098
AC   CVCL_NQ73
SY   RRS098
DR   MMRRC; MMRRC:004892-UCD
DR   Wikidata; Q54776342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891963; Ywhaq.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS099
AC   CVCL_NQ74
SY   RRS099
DR   MMRRC; MMRRC:004893-UCD
DR   Wikidata; Q54776344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096875; Wdfy3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS100
AC   CVCL_NQ75
SY   RRS100
DR   MMRRC; MMRRC:004894-UCD
DR   Wikidata; Q54776345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS101
AC   CVCL_NQ76
SY   RRS101
DR   MMRRC; MMRRC:004895-UCD
DR   Wikidata; Q54776348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915403; Gtf2e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS102
AC   CVCL_NQ77
SY   RRS102
DR   MMRRC; MMRRC:004896-UCD
DR   Wikidata; Q54776349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108405; Apbb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS103
AC   CVCL_NQ78
SY   RRS103
DR   MMRRC; MMRRC:004897-UCD
DR   Wikidata; Q54776352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS105
AC   CVCL_NQ79
SY   RRS105
DR   MMRRC; MMRRC:004899-UCD
DR   Wikidata; Q54776354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS107
AC   CVCL_NQ80
SY   RRS107
DR   MMRRC; MMRRC:004900-UCD
DR   Wikidata; Q54776357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS108
AC   CVCL_NQ81
SY   RRS108
DR   MMRRC; MMRRC:004901-UCD
DR   Wikidata; Q54776359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915437; Fam135a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS110
AC   CVCL_NQ82
SY   RRS110
DR   MMRRC; MMRRC:004902-UCD
DR   Wikidata; Q54776362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685541; Wdtc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS111
AC   CVCL_NQ83
SY   RRS111
DR   MMRRC; MMRRC:004903-UCD
DR   Wikidata; Q54776364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353654; Vps26a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS112
AC   CVCL_NQ84
SY   RRS112
DR   MMRRC; MMRRC:004904-UCD
DR   Wikidata; Q54776367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916241; Ssu72.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS115
AC   CVCL_NQ85
SY   RRS115
DR   MMRRC; MMRRC:004905-UCD
DR   Wikidata; Q54776370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444661; Susd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS116
AC   CVCL_NQ86
SY   RRS116
DR   MMRRC; MMRRC:004906-UCD
DR   Wikidata; Q54776372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS123
AC   CVCL_NQ87
SY   RRS123
DR   MMRRC; MMRRC:004910-UCD
DR   Wikidata; Q54776374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444631; 4932438A13Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS126
AC   CVCL_NQ88
SY   RRS126
DR   MMRRC; MMRRC:004911-UCD
DR   Wikidata; Q54776375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916188; Aspscr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS131
AC   CVCL_NQ89
SY   RRS131
DR   MMRRC; MMRRC:004912-UCD
DR   Wikidata; Q54776376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS136
AC   CVCL_NQ90
SY   RRS136
DR   MMRRC; MMRRC:004913-UCD
DR   Wikidata; Q54776377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924933; Ehmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS141
AC   CVCL_NQ91
SY   RRS141
DR   MMRRC; MMRRC:004914-UCD
DR   Wikidata; Q54776379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS142
AC   CVCL_NQ92
SY   RRS142
DR   MMRRC; MMRRC:004915-UCD
DR   Wikidata; Q54776380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2655711; Rbm28.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS143
AC   CVCL_NQ93
SY   RRS143
DR   MMRRC; MMRRC:004916-UCD
DR   Wikidata; Q54776382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS144
AC   CVCL_NQ94
SY   RRS144
DR   MMRRC; MMRRC:004917-UCD
DR   Wikidata; Q54776385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444451; Rnf214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS147
AC   CVCL_NQ95
SY   RRS147
DR   MMRRC; MMRRC:004918-UCD
DR   Wikidata; Q54776386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860086; Crlf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS150
AC   CVCL_NQ96
SY   RRS150
DR   MMRRC; MMRRC:004919-UCD
DR   Wikidata; Q54776389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928948; Scamp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS151
AC   CVCL_NQ97
SY   RRS151
DR   MMRRC; MMRRC:004920-UCD
DR   Wikidata; Q54776391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106583; Rfx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS152
AC   CVCL_NQ98
SY   RRS152
DR   MMRRC; MMRRC:004921-UCD
DR   Wikidata; Q54776392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108025; Prkar2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS162
AC   CVCL_NQ99
SY   RRS162
DR   MMRRC; MMRRC:004923-UCD
DR   Wikidata; Q54776395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916851; Dab2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS163
AC   CVCL_NR00
SY   RRS163
DR   MMRRC; MMRRC:004924-UCD
DR   Wikidata; Q54776398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443298; Tet2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS166
AC   CVCL_NR01
SY   RRS166
DR   MMRRC; MMRRC:004926-UCD
DR   Wikidata; Q54776401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178217; Akap9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS169
AC   CVCL_NR02
SY   RRS169
DR   MMRRC; MMRRC:004927-UCD
DR   Wikidata; Q54776402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328787; Smad5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS172
AC   CVCL_NR03
SY   RRS172
DR   MMRRC; MMRRC:004928-UCD
DR   Wikidata; Q54776439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3644026; Fam169b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS186
AC   CVCL_NR04
SY   RRS186
DR   MMRRC; MMRRC:004930-UCD
DR   Wikidata; Q54776440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337062; Ap3s1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS190
AC   CVCL_NR05
SY   RRS190
DR   MMRRC; MMRRC:004932-UCD
DR   Wikidata; Q54776443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923992; Snx27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS213
AC   CVCL_NR06
SY   RRS213
DR   MMRRC; MMRRC:004935-UCD
DR   Wikidata; Q54776445
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2155936; Pask.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS215
AC   CVCL_NR07
SY   RRS215
DR   MMRRC; MMRRC:004936-UCD
DR   Wikidata; Q54776447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346023; Tlk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS216
AC   CVCL_NR08
SY   RRS216
DR   MMRRC; MMRRC:004937-UCD
DR   Wikidata; Q54776448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861100; Ubr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS222
AC   CVCL_NR09
SY   RRS222
DR   MMRRC; MMRRC:004938-UCD
DR   Wikidata; Q54776450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2175912; Arid5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS223
AC   CVCL_NR10
SY   RRS223
DR   MMRRC; MMRRC:004939-UCD
DR   Wikidata; Q54776453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS225
AC   CVCL_NR11
SY   RRS225
DR   MMRRC; MMRRC:004940-UCD
DR   Wikidata; Q54776454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342005; Mthfd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS226
AC   CVCL_NR12
SY   RRS226
DR   MMRRC; MMRRC:004941-UCD
DR   Wikidata; Q54776456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924555; Wdr82.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS227
AC   CVCL_NR13
SY   RRS227
DR   MMRRC; MMRRC:004942-UCD
DR   Wikidata; Q54776457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS228
AC   CVCL_NR14
SY   RRS228
DR   MMRRC; MMRRC:004943-UCD
DR   Wikidata; Q54776459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS231
AC   CVCL_NR15
SY   RRS231
DR   MMRRC; MMRRC:004944-UCD
DR   Wikidata; Q54776460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342291; Rlim.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS235
AC   CVCL_NR16
SY   RRS235
DR   MMRRC; MMRRC:004946-UCD
DR   Wikidata; Q54776461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS238
AC   CVCL_NR17
SY   RRS238
DR   MMRRC; MMRRC:004948-UCD
DR   Wikidata; Q54776462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098672; Szrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS239
AC   CVCL_NR18
SY   RRS239
DR   MMRRC; MMRRC:004949-UCD
DR   Wikidata; Q54776465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS244
AC   CVCL_NR19
SY   RRS244
DR   MMRRC; MMRRC:004950-UCD
DR   Wikidata; Q54776467
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS246
AC   CVCL_NR20
SY   RRS246
DR   MMRRC; MMRRC:004951-UCD
DR   Wikidata; Q54776469
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104976; Ddx6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS250
AC   CVCL_NR21
SY   RRS250
DR   MMRRC; MMRRC:004952-UCD
DR   Wikidata; Q54776472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS252
AC   CVCL_NR22
SY   RRS252
DR   MMRRC; MMRRC:004953-UCD
DR   Wikidata; Q54776473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88353; Cdk11b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS253
AC   CVCL_NR23
SY   RRS253
DR   MMRRC; MMRRC:004954-UCD
DR   Wikidata; Q54776475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138391; Pid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS254
AC   CVCL_NR24
SY   RRS254
DR   MMRRC; MMRRC:004955-UCD
DR   Wikidata; Q54776477
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88190; Braf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS255
AC   CVCL_NR25
SY   RRS255
DR   MMRRC; MMRRC:004956-UCD
DR   Wikidata; Q54776478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921729; Snx11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS260
AC   CVCL_NR26
SY   RRS260
DR   MMRRC; MMRRC:004958-UCD
DR   Wikidata; Q54776480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916225; Med27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS262
AC   CVCL_NR27
SY   RRS262
DR   MMRRC; MMRRC:004959-UCD
DR   Wikidata; Q54776483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3647820; Hectd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS264
AC   CVCL_NR28
SY   RRS264
DR   MMRRC; MMRRC:004960-UCD
DR   Wikidata; Q54776486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443584; L3mbtl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS265
AC   CVCL_NR29
SY   RRS265
DR   MMRRC; MMRRC:004961-UCD
DR   Wikidata; Q54776487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344373; Ubl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS266
AC   CVCL_NR30
SY   RRS266
DR   MMRRC; MMRRC:004962-UCD
DR   Wikidata; Q54776489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104976; Ddx6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS271
AC   CVCL_NR31
SY   RRS271
DR   MMRRC; MMRRC:004963-UCD
DR   Wikidata; Q54776491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS272
AC   CVCL_NR32
SY   RRS272
DR   MMRRC; MMRRC:004964-UCD
DR   Wikidata; Q54776493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100863; Kpna3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS274
AC   CVCL_NR33
SY   RRS274
DR   MMRRC; MMRRC:004965-UCD
DR   Wikidata; Q54776496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918419; Nbas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS275
AC   CVCL_NR34
SY   RRS275
DR   MMRRC; MMRRC:004966-UCD
DR   Wikidata; Q54776498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888526; Xpo4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS276
AC   CVCL_NR35
SY   RRS276
DR   MMRRC; MMRRC:004967-UCD
DR   Wikidata; Q54776499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179288; Rttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS277
AC   CVCL_NR36
SY   RRS277
DR   MMRRC; MMRRC:004968-UCD
DR   Wikidata; Q54776503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928899; Tacc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS282
AC   CVCL_NR37
SY   RRS282
DR   MMRRC; MMRRC:004969-UCD
DR   Wikidata; Q54776505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179327; Mvd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS284
AC   CVCL_NR38
SY   RRS284
DR   MMRRC; MMRRC:004971-UCD
DR   Wikidata; Q54776508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99695; Cttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS287
AC   CVCL_NR39
SY   RRS287
DR   MMRRC; MMRRC:004973-UCD
DR   Wikidata; Q54776512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098236; Cast.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS294
AC   CVCL_NR40
SY   RRS294
DR   MMRRC; MMRRC:004974-UCD
DR   Wikidata; Q54776513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343489; Mpdz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS297
AC   CVCL_NR41
SY   RRS297
DR   MMRRC; MMRRC:004977-UCD
DR   Wikidata; Q54776516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS300
AC   CVCL_NR42
SY   RRS300
DR   MMRRC; MMRRC:004978-UCD
DR   Wikidata; Q54776518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:893579; Khdrbs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS305
AC   CVCL_NR43
SY   RRS305
DR   MMRRC; MMRRC:004979-UCD
DR   Wikidata; Q54776613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS307
AC   CVCL_NR44
SY   RRS307
DR   MMRRC; MMRRC:004980-UCD
DR   Wikidata; Q54776614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914451; Glod4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS310
AC   CVCL_NR45
SY   RRS310
DR   MMRRC; MMRRC:004982-UCD
DR   Wikidata; Q54776616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS313
AC   CVCL_NR46
SY   RRS313
DR   MMRRC; MMRRC:004983-UCD
DR   Wikidata; Q54776618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681271; Pigl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS314
AC   CVCL_NR47
SY   RRS314
DR   MMRRC; MMRRC:004984-UCD
DR   Wikidata; Q54776620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196224; Cdk8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS317
AC   CVCL_NR48
SY   RRS317
DR   MMRRC; MMRRC:004985-UCD
DR   Wikidata; Q54776622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3649821; Gm14411.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS318
AC   CVCL_NR49
SY   RRS318
DR   MMRRC; MMRRC:004986-UCD
DR   Wikidata; Q54776625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347044; Orc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS321
AC   CVCL_NR50
SY   RRS321
DR   MMRRC; MMRRC:004987-UCD
DR   Wikidata; Q54776627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS322
AC   CVCL_NR51
SY   RRS322
DR   MMRRC; MMRRC:004988-UCD
DR   Wikidata; Q54776628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914831; Tbc1d23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS323
AC   CVCL_NR52
SY   RRS323
DR   MMRRC; MMRRC:004989-UCD
DR   Wikidata; Q54776630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098280; Crebbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS325
AC   CVCL_NR53
SY   RRS325
DR   MMRRC; MMRRC:004991-UCD
DR   Wikidata; Q54776631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS326
AC   CVCL_NR54
SY   RRS326
DR   MMRRC; MMRRC:004992-UCD
DR   Wikidata; Q54776633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923827; Faf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS329
AC   CVCL_NR55
SY   RRS329
DR   MMRRC; MMRRC:004993-UCD
DR   Wikidata; Q54776635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859026; Cnot4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS330
AC   CVCL_NR56
SY   RRS330
DR   MMRRC; MMRRC:004994-UCD
DR   Wikidata; Q54776637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925836; Srbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS331
AC   CVCL_NR57
SY   RRS331
DR   MMRRC; MMRRC:004995-UCD
DR   Wikidata; Q54776638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS334
AC   CVCL_NR58
SY   RRS334
DR   MMRRC; MMRRC:004996-UCD
DR   Wikidata; Q54776640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS337
AC   CVCL_NR59
SY   RRS337
DR   MMRRC; MMRRC:004997-UCD
DR   Wikidata; Q54776642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107943; Cct6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS338
AC   CVCL_NR60
SY   RRS338
DR   MMRRC; MMRRC:004998-UCD
DR   Wikidata; Q54776644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS339
AC   CVCL_NR61
SY   RRS339
DR   MMRRC; MMRRC:004999-UCD
DR   Wikidata; Q54776645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136459; Cdc42bpb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS341
AC   CVCL_NR62
SY   RRS341
DR   MMRRC; MMRRC:005000-UCD
DR   Wikidata; Q54776647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS343
AC   CVCL_NR63
SY   RRS343
DR   MMRRC; MMRRC:005001-UCD
DR   Wikidata; Q54776648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102465; Tex2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS344
AC   CVCL_NR64
SY   RRS344
DR   MMRRC; MMRRC:005002-UCD
DR   Wikidata; Q54776651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS345
AC   CVCL_NR65
SY   RRS345
DR   MMRRC; MMRRC:005003-UCD
DR   Wikidata; Q54776652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917829; Zc3h11a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS349
AC   CVCL_NR66
SY   RRS349
DR   MMRRC; MMRRC:005005-UCD
DR   Wikidata; Q54776654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144013; Xpo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS358
AC   CVCL_NR67
SY   RRS358
DR   MMRRC; MMRRC:005007-UCD
DR   Wikidata; Q54776657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913895; Pspc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS360
AC   CVCL_NR68
SY   RRS360
DR   MMRRC; MMRRC:005008-UCD
DR   Wikidata; Q54776660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS364
AC   CVCL_NR69
SY   RRS364
DR   MMRRC; MMRRC:005009-UCD
DR   Wikidata; Q54776661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99146; Ybx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS365
AC   CVCL_NR70
SY   RRS365
DR   MMRRC; MMRRC:005010-UCD
DR   Wikidata; Q54776663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929510; Zfand6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS369
AC   CVCL_NR71
SY   RRS369
DR   MMRRC; MMRRC:005011-UCD
DR   Wikidata; Q54776665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341828; St6galnac3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS377
AC   CVCL_NR72
SY   RRS377
DR   MMRRC; MMRRC:005013-UCD
DR   Wikidata; Q54776667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144157; Usp22.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS380
AC   CVCL_NR73
SY   RRS380
DR   MMRRC; MMRRC:005015-UCD
DR   Wikidata; Q54776670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914006; Cfap97.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS381
AC   CVCL_NR74
SY   RRS381
DR   MMRRC; MMRRC:005016-UCD
DR   Wikidata; Q54776674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97316; Nfya.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS382
AC   CVCL_NR75
SY   RRS382
DR   MMRRC; MMRRC:005017-UCD
DR   Wikidata; Q54776677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97316; Nfya.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS388
AC   CVCL_NR76
SY   RRS388
DR   MMRRC; MMRRC:005019-UCD
DR   Wikidata; Q54776678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97316; Nfya.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS400
AC   CVCL_NR77
SY   RRS400
DR   MMRRC; MMRRC:005021-UCD
DR   Wikidata; Q54776680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922928; Ippk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS405
AC   CVCL_NR78
SY   RRS405
DR   MMRRC; MMRRC:005022-UCD
DR   Wikidata; Q54776682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915205; Sugt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS408
AC   CVCL_NR79
SY   RRS408
DR   MMRRC; MMRRC:005023-UCD
DR   Wikidata; Q54776683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203517; Birc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS409
AC   CVCL_NR80
SY   RRS409
DR   MMRRC; MMRRC:005024-UCD
DR   Wikidata; Q54776686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137355; Trim11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS410
AC   CVCL_NR81
SY   RRS410
DR   MMRRC; MMRRC:005025-UCD
DR   Wikidata; Q54776687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS415
AC   CVCL_NR82
SY   RRS415
DR   MMRRC; MMRRC:005026-UCD
DR   Wikidata; Q54776688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97758; Prim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS419
AC   CVCL_NR83
SY   RRS419
DR   MMRRC; MMRRC:005027-UCD
DR   Wikidata; Q54776733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679787; Nploc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS424
AC   CVCL_NR84
SY   RRS424
DR   MMRRC; MMRRC:005029-UCD
DR   Wikidata; Q54776736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136980; Kdm5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS427
AC   CVCL_NR85
SY   RRS427
DR   MMRRC; MMRRC:005030-UCD
DR   Wikidata; Q54776737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS430
AC   CVCL_NR86
SY   RRS430
DR   MMRRC; MMRRC:005031-UCD
DR   Wikidata; Q54776739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142810; Ppip5k2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS431
AC   CVCL_NR87
SY   RRS431
DR   MMRRC; MMRRC:005032-UCD
DR   Wikidata; Q54776742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442794; Dennd1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS432
AC   CVCL_NR88
SY   RRS432
DR   MMRRC; MMRRC:005033-UCD
DR   Wikidata; Q54776744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS434
AC   CVCL_NR89
SY   RRS434
DR   MMRRC; MMRRC:005034-UCD
DR   Wikidata; Q54776746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338071; Ikbkb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS435
AC   CVCL_NR90
SY   RRS435
DR   MMRRC; MMRRC:005035-UCD
DR   Wikidata; Q54776749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444554; Mapkap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS439
AC   CVCL_NR91
SY   RRS439
DR   MMRRC; MMRRC:005036-UCD
DR   Wikidata; Q54776750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109153; Ktn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS440
AC   CVCL_NR92
SY   RRS440
DR   MMRRC; MMRRC:005037-UCD
DR   Wikidata; Q54776753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99948; Zfhx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS445
AC   CVCL_NR93
SY   RRS445
DR   MMRRC; MMRRC:005039-UCD
DR   Wikidata; Q54776755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS446
AC   CVCL_NR94
SY   RRS446
DR   MMRRC; MMRRC:005040-UCD
DR   Wikidata; Q54776758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS453
AC   CVCL_NR95
SY   RRS453
DR   MMRRC; MMRRC:005043-UCD
DR   Wikidata; Q54776762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104861; Bcat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS455
AC   CVCL_NR96
SY   RRS455
DR   MMRRC; MMRRC:005044-UCD
DR   Wikidata; Q54776765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS464
AC   CVCL_NR97
SY   RRS464
DR   MMRRC; MMRRC:005045-UCD
DR   Wikidata; Q54776766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106639; Mthfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS466
AC   CVCL_NR98
SY   RRS466
DR   MMRRC; MMRRC:005046-UCD
DR   Wikidata; Q54776768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201408; Srpk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS469
AC   CVCL_NR99
SY   RRS469
DR   MMRRC; MMRRC:005048-UCD
DR   Wikidata; Q54776771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679787; Nploc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS472
AC   CVCL_NS00
SY   RRS472
DR   MMRRC; MMRRC:005049-UCD
DR   Wikidata; Q54776774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916891; Wdr20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS474
AC   CVCL_NS01
SY   RRS474
DR   MMRRC; MMRRC:005050-UCD
DR   Wikidata; Q54776777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915301; Nutf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS475
AC   CVCL_NS02
SY   RRS475
DR   MMRRC; MMRRC:005051-UCD
DR   Wikidata; Q54776778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157166; Rp9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS478
AC   CVCL_NS03
SY   RRS478
DR   MMRRC; MMRRC:005053-UCD
DR   Wikidata; Q54776780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932610; Noc3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS482
AC   CVCL_NS04
SY   RRS482
DR   MMRRC; MMRRC:005055-UCD
DR   Wikidata; Q54776782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277218; Rpap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS491
AC   CVCL_NS05
SY   RRS491
DR   MMRRC; MMRRC:005058-UCD
DR   Wikidata; Q54776783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933162; Lrba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS496
AC   CVCL_NS06
SY   RRS496
DR   MMRRC; MMRRC:005061-UCD
DR   Wikidata; Q54776785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS498
AC   CVCL_NS07
SY   RRS498
DR   MMRRC; MMRRC:005062-UCD
DR   Wikidata; Q54776788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919241; Ercc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS501
AC   CVCL_NS08
SY   RRS501
DR   MMRRC; MMRRC:005064-UCD
DR   Wikidata; Q54776790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS502
AC   CVCL_NS09
SY   RRS502
DR   MMRRC; MMRRC:005065-UCD
DR   Wikidata; Q54776792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676921; Focad.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS508
AC   CVCL_NS10
SY   RRS508
DR   MMRRC; MMRRC:005067-UCD
DR   Wikidata; Q54776795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145645; Exoc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS510
AC   CVCL_NS11
SY   RRS510
DR   MMRRC; MMRRC:005069-UCD
DR   Wikidata; Q54776796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442362; Zfp653.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS512
AC   CVCL_NS12
SY   RRS512
DR   MMRRC; MMRRC:005070-UCD
DR   Wikidata; Q54776798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860486; Tdp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS514
AC   CVCL_NS13
SY   RRS514
DR   MMRRC; MMRRC:005071-UCD
DR   Wikidata; Q54776801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918771; Pds5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS515
AC   CVCL_NS14
SY   RRS515
DR   MMRRC; MMRRC:005072-UCD
DR   Wikidata; Q54776803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894676; Mast2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS519
AC   CVCL_NS15
SY   RRS519
DR   MMRRC; MMRRC:005073-UCD
DR   Wikidata; Q54776805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919241; Ercc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS528
AC   CVCL_NS16
SY   RRS528
DR   MMRRC; MMRRC:005077-UCD
DR   Wikidata; Q54776807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98354; Sos1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS529
AC   CVCL_NS17
SY   RRS529
DR   MMRRC; MMRRC:005078-UCD
DR   Wikidata; Q54776809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446180; Anks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS530
AC   CVCL_NS18
SY   RRS530
DR   MMRRC; MMRRC:005079-UCD
DR   Wikidata; Q54776810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933196; Rad54l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS532
AC   CVCL_NS19
SY   RRS532
DR   MMRRC; MMRRC:005080-UCD
DR   Wikidata; Q54776813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918767; Vps35l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRS534
AC   CVCL_NS20
SY   RRS534
DR   MMRRC; MMRRC:005081-UCD
DR   Wikidata; Q54776814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444022; Mapk1ip1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS535
AC   CVCL_NS21
SY   RRS535
DR   MMRRC; MMRRC:005082-UCD
DR   Wikidata; Q54776815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443036; Dnajc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS543
AC   CVCL_NS22
SY   RRS543
DR   MMRRC; MMRRC:005084-UCD
DR   Wikidata; Q54776816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98386; Sptan1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS545
AC   CVCL_NS23
SY   RRS545
DR   MMRRC; MMRRC:005085-UCD
DR   Wikidata; Q54776867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923792; Hibch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS547
AC   CVCL_NS24
SY   RRS547
DR   MMRRC; MMRRC:005086-UCD
DR   Wikidata; Q54776870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923164; Exoc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS549
AC   CVCL_NS25
SY   RRS549
DR   MMRRC; MMRRC:005088-UCD
DR   Wikidata; Q54776871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919725; Ssbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS552
AC   CVCL_NS26
SY   RRS552
DR   MMRRC; MMRRC:005089-UCD
DR   Wikidata; Q54776872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890564; Rcan1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS553
AC   CVCL_NS27
SY   RRS553
DR   MMRRC; MMRRC:005090-UCD
DR   Wikidata; Q54776874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107793; Crmp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS555
AC   CVCL_NS28
SY   RRS555
DR   MMRRC; MMRRC:005092-UCD
DR   Wikidata; Q54776876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105307; Ptpn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS556
AC   CVCL_NS29
SY   RRS556
DR   MMRRC; MMRRC:005093-UCD
DR   Wikidata; Q54776878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921807; Ppp6r3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS558
AC   CVCL_NS30
SY   RRS558
DR   MMRRC; MMRRC:005094-UCD
DR   Wikidata; Q54776880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107476; Stim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS561
AC   CVCL_NS31
SY   RRS561
DR   MMRRC; MMRRC:005096-UCD
DR   Wikidata; Q54776882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2149543; Ubap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS564
AC   CVCL_NS32
SY   RRS564
DR   MMRRC; MMRRC:005097-UCD
DR   Wikidata; Q54776883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913976; Nipbl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS565
AC   CVCL_NS33
SY   RRS565
DR   MMRRC; MMRRC:005098-UCD
DR   Wikidata; Q54776886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923661; Ift43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS571
AC   CVCL_NS34
SY   RRS571
DR   MMRRC; MMRRC:005100-UCD
DR   Wikidata; Q54776888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS575
AC   CVCL_NS35
SY   RRS575
DR   MMRRC; MMRRC:005101-UCD
DR   Wikidata; Q54776890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915095; Rnf115.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS576
AC   CVCL_NS36
SY   RRS576
DR   MMRRC; MMRRC:005102-UCD
DR   Wikidata; Q54776891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384756; Phf21a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS577
AC   CVCL_NS37
SY   RRS577
DR   MMRRC; MMRRC:005103-UCD
DR   Wikidata; Q54776894
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109153; Ktn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS582
AC   CVCL_NS38
SY   RRS582
DR   MMRRC; MMRRC:005105-UCD
DR   Wikidata; Q54776895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925939; Naa35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS590
AC   CVCL_NS39
SY   RRS590
DR   MMRRC; MMRRC:005110-UCD
DR   Wikidata; Q54776896
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924165; Mnd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS596
AC   CVCL_NS40
SY   RRS596
DR   MMRRC; MMRRC:005111-UCD
DR   Wikidata; Q54776899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS606
AC   CVCL_NS41
SY   RRS606
DR   MMRRC; MMRRC:005112-UCD
DR   Wikidata; Q54776902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351651; Yme1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS609
AC   CVCL_NS42
SY   RRS609
DR   MMRRC; MMRRC:005114-UCD
DR   Wikidata; Q54776905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS610
AC   CVCL_NS43
SY   RRS610
DR   MMRRC; MMRRC:005115-UCD
DR   Wikidata; Q54776907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104583; Eps15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS612
AC   CVCL_NS44
SY   RRS612
DR   MMRRC; MMRRC:005116-UCD
DR   Wikidata; Q54776908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443517; Hnrnpul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS613
AC   CVCL_NS45
SY   RRS613
DR   MMRRC; MMRRC:005117-UCD
DR   Wikidata; Q54776909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676556; Akap13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS614
AC   CVCL_NS46
SY   RRS614
DR   MMRRC; MMRRC:005118-UCD
DR   Wikidata; Q54776911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921446; Ttc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS618
AC   CVCL_NS47
SY   RRS618
DR   MMRRC; MMRRC:005119-UCD
DR   Wikidata; Q54776912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860197; Wdr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS623
AC   CVCL_NS48
SY   RRS623
DR   MMRRC; MMRRC:005121-UCD
DR   Wikidata; Q54776913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS624
AC   CVCL_NS49
SY   RRS624
DR   MMRRC; MMRRC:005122-UCD
DR   Wikidata; Q54776914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927222; Diaph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS625
AC   CVCL_NS50
SY   RRS625
DR   MMRRC; MMRRC:005123-UCD
DR   Wikidata; Q54776915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888594; Icmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS626
AC   CVCL_NS51
SY   RRS626
DR   MMRRC; MMRRC:005124-UCD
DR   Wikidata; Q54776921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101838; Tbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS629
AC   CVCL_NS52
SY   RRS629
DR   MMRRC; MMRRC:005125-UCD
DR   Wikidata; Q54776923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99400; Atp7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS630
AC   CVCL_NS53
SY   RRS630
DR   MMRRC; MMRRC:005126-UCD
DR   Wikidata; Q54776926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140983; Fam185a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS631
AC   CVCL_NS54
SY   RRS631
DR   MMRRC; MMRRC:005127-UCD
DR   Wikidata; Q54776928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891964; Xrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS634
AC   CVCL_NS55
SY   RRS634
DR   MMRRC; MMRRC:005129-UCD
DR   Wikidata; Q54776933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916356; Stoml1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS637
AC   CVCL_NS56
SY   RRS637
DR   MMRRC; MMRRC:005130-UCD
DR   Wikidata; Q54776936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914496; Resf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRS638
AC   CVCL_NS57
SY   RRS638
DR   MMRRC; MMRRC:005131-UCD
DR   Wikidata; Q54776938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS639
AC   CVCL_NS58
SY   RRS639
DR   MMRRC; MMRRC:005132-UCD
DR   Wikidata; Q54776941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916139; Ubac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS642
AC   CVCL_NS59
SY   RRS642
DR   MMRRC; MMRRC:005134-UCD
DR   Wikidata; Q54776944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916356; Stoml1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS645
AC   CVCL_NS60
SY   RRS645
DR   MMRRC; MMRRC:005135-UCD
DR   Wikidata; Q54776947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914496; Resf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRS647
AC   CVCL_NS61
SY   RRS647
DR   MMRRC; MMRRC:005136-UCD
DR   Wikidata; Q54776950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916139; Ubac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS666
AC   CVCL_NS62
SY   RRS666
DR   MMRRC; MMRRC:005141-UCD
DR   Wikidata; Q54776952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS672
AC   CVCL_NS63
SY   RRS672
DR   MMRRC; MMRRC:005143-UCD
DR   Wikidata; Q54777006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS674
AC   CVCL_NS64
SY   RRS674
DR   MMRRC; MMRRC:005144-UCD
DR   Wikidata; Q54777009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913415; Bccip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS675
AC   CVCL_NS65
SY   RRS675
DR   MMRRC; MMRRC:005145-UCD
DR   Wikidata; Q54777010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106341; Atp5o.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS676
AC   CVCL_NS66
SY   RRS676
DR   MMRRC; MMRRC:005146-UCD
DR   Wikidata; Q54777011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194912; Rbbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS678
AC   CVCL_NS67
SY   RRS678
DR   MMRRC; MMRRC:005147-UCD
DR   Wikidata; Q54777012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141625; Nup205.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS683
AC   CVCL_NS68
SY   RRS683
DR   MMRRC; MMRRC:005148-UCD
DR   Wikidata; Q54777015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88568; Cux1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS685
AC   CVCL_NS69
SY   RRS685
DR   MMRRC; MMRRC:005150-UCD
DR   Wikidata; Q54777017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913667; Mat2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS687
AC   CVCL_NS70
SY   RRS687
DR   MMRRC; MMRRC:005151-UCD
DR   Wikidata; Q54777019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS688
AC   CVCL_NS71
SY   RRS688
DR   MMRRC; MMRRC:005152-UCD
DR   Wikidata; Q54777022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924968; Slf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS689
AC   CVCL_NS72
SY   RRS689
DR   MMRRC; MMRRC:005153-UCD
DR   Wikidata; Q54777026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103198; Cdc25a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS693
AC   CVCL_NS73
SY   RRS693
DR   MMRRC; MMRRC:005154-UCD
DR   Wikidata; Q54777028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106008; Anxa5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS697
AC   CVCL_NS74
SY   RRS697
DR   MMRRC; MMRRC:005155-UCD
DR   Wikidata; Q54777030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919020; Ap2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS699
AC   CVCL_NS75
SY   RRS699
DR   MMRRC; MMRRC:005157-UCD
DR   Wikidata; Q54777032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS701
AC   CVCL_NS76
SY   RRS701
DR   MMRRC; MMRRC:005158-UCD
DR   Wikidata; Q54777034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384939; Fam222b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS702
AC   CVCL_NS77
SY   RRS702
DR   MMRRC; MMRRC:005159-UCD
DR   Wikidata; Q54777035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107637; Psmb7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS703
AC   CVCL_NS78
SY   RRS703
DR   MMRRC; MMRRC:005160-UCD
DR   Wikidata; Q54777037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921487; Tubgcp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS708
AC   CVCL_NS79
SY   RRS708
DR   MMRRC; MMRRC:005161-UCD
DR   Wikidata; Q54777039
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS711
AC   CVCL_NS80
SY   RRS711
DR   MMRRC; MMRRC:005162-UCD
DR   Wikidata; Q54777040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923257; Zmym2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS716
AC   CVCL_NS81
SY   RRS716
DR   MMRRC; MMRRC:005163-UCD
DR   Wikidata; Q54777044
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919488; Tbc1d5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS720
AC   CVCL_NS82
SY   RRS720
DR   MMRRC; MMRRC:005164-UCD
DR   Wikidata; Q54777047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88451; Col18a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS723
AC   CVCL_NS83
SY   RRS723
DR   MMRRC; MMRRC:005165-UCD
DR   Wikidata; Q54777049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919979; Cdc42se2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS726
AC   CVCL_NS84
SY   RRS726
DR   MMRRC; MMRRC:005167-UCD
DR   Wikidata; Q54777052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929063; Copz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS728
AC   CVCL_NS85
SY   RRS728
DR   MMRRC; MMRRC:005168-UCD
DR   Wikidata; Q54777053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88451; Col18a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS729
AC   CVCL_NS86
SY   RRS729
DR   MMRRC; MMRRC:005169-UCD
DR   Wikidata; Q54777055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346873; Map3k2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS730
AC   CVCL_NS87
SY   RRS730
DR   MMRRC; MMRRC:005170-UCD
DR   Wikidata; Q54777057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180003; Xpnpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS732
AC   CVCL_NS88
SY   RRS732
DR   MMRRC; MMRRC:005172-UCD
DR   Wikidata; Q54777058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919241; Ercc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS733
AC   CVCL_NS89
SY   RRS733
DR   MMRRC; MMRRC:005173-UCD
DR   Wikidata; Q54777062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS734
AC   CVCL_NS90
SY   RRS734
DR   MMRRC; MMRRC:005174-UCD
DR   Wikidata; Q54777064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS735
AC   CVCL_NS91
SY   RRS735
DR   MMRRC; MMRRC:005175-UCD
DR   Wikidata; Q54777067
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS736
AC   CVCL_NS92
SY   RRS736
DR   MMRRC; MMRRC:005176-UCD
DR   Wikidata; Q54777069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917347; Sash1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS737
AC   CVCL_NS93
SY   RRS737
DR   MMRRC; MMRRC:005177-UCD
DR   Wikidata; Q54777071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442782; Baz2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS739
AC   CVCL_NS94
SY   RRS739
DR   MMRRC; MMRRC:005178-UCD
DR   Wikidata; Q54777074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442912; Zcchc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS740
AC   CVCL_NS95
SY   RRS740
DR   MMRRC; MMRRC:005179-UCD
DR   Wikidata; Q54777075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107585; Srebf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS746
AC   CVCL_NS96
SY   RRS746
DR   MMRRC; MMRRC:005181-UCD
DR   Wikidata; Q54777078
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97806; Ptpn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS748
AC   CVCL_NS97
SY   RRS748
DR   MMRRC; MMRRC:005182-UCD
DR   Wikidata; Q54777079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109331; Nxn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS754
AC   CVCL_NS98
SY   RRS754
DR   MMRRC; MMRRC:005185-UCD
DR   Wikidata; Q54777082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683538; Lyrm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS759
AC   CVCL_NS99
SY   RRS759
DR   MMRRC; MMRRC:005187-UCD
DR   Wikidata; Q54777084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321393; Timeless.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS761
AC   CVCL_NT00
SY   RRS761
DR   MMRRC; MMRRC:005188-UCD
DR   Wikidata; Q54777088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914705; Klhl13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS763
AC   CVCL_NT01
SY   RRS763
DR   MMRRC; MMRRC:005189-UCD
DR   Wikidata; Q54777091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS767
AC   CVCL_NT02
SY   RRS767
DR   MMRRC; MMRRC:005190-UCD
DR   Wikidata; Q54777095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913353; Naxd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS774
AC   CVCL_NT03
SY   RRS774
DR   MMRRC; MMRRC:005191-UCD
DR   Wikidata; Q54777151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107862; Nop16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS780
AC   CVCL_NT04
SY   RRS780
DR   MMRRC; MMRRC:005192-UCD
DR   Wikidata; Q54777153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917447; Srp68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS785
AC   CVCL_NT05
SY   RRS785
DR   MMRRC; MMRRC:005193-UCD
DR   Wikidata; Q54777155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915408; Tecr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS786
AC   CVCL_NT06
SY   RRS786
DR   MMRRC; MMRRC:005194-UCD
DR   Wikidata; Q54777159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915408; Tecr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS789
AC   CVCL_NT07
SY   RRS789
DR   MMRRC; MMRRC:005195-UCD
DR   Wikidata; Q54777161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929459; Rabgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS794
AC   CVCL_NT08
SY   RRS794
DR   MMRRC; MMRRC:005196-UCD
DR   Wikidata; Q54777162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929618; Stard3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS800
AC   CVCL_NT09
SY   RRS800
DR   MMRRC; MMRRC:005199-UCD
DR   Wikidata; Q54777167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099818; Pkd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS805
AC   CVCL_NT10
SY   RRS805
DR   MMRRC; MMRRC:005201-UCD
DR   Wikidata; Q54777168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353655; Usp25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS812
AC   CVCL_NT11
SY   RRS812
DR   MMRRC; MMRRC:005202-UCD
DR   Wikidata; Q54777169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS815
AC   CVCL_NT12
SY   RRS815
DR   MMRRC; MMRRC:005203-UCD
DR   Wikidata; Q54777172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS819
AC   CVCL_NT13
SY   RRS819
DR   MMRRC; MMRRC:005205-UCD
DR   Wikidata; Q54777173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920243; Appl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS822
AC   CVCL_NT14
SY   RRS822
DR   MMRRC; MMRRC:005206-UCD
DR   Wikidata; Q54777177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2677480; Thoc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS823
AC   CVCL_NT15
SY   RRS823
DR   MMRRC; MMRRC:005207-UCD
DR   Wikidata; Q54777180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS824
AC   CVCL_NT16
SY   RRS824
DR   MMRRC; MMRRC:005208-UCD
DR   Wikidata; Q54777181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933163; Trim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS826
AC   CVCL_NT17
SY   RRS826
DR   MMRRC; MMRRC:005209-UCD
DR   Wikidata; Q54777183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915147; Rnmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS837
AC   CVCL_NT18
SY   RRS837
DR   MMRRC; MMRRC:005213-UCD
DR   Wikidata; Q54777185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107629; Luzp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS841
AC   CVCL_NT19
SY   RRS841
DR   MMRRC; MMRRC:005215-UCD
DR   Wikidata; Q54777188
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm3813 (MGI:3781985) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRS851
AC   CVCL_NT20
SY   RRS851
DR   MMRRC; MMRRC:005217-UCD
DR   Wikidata; Q54777189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924256; Ddrgk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS858
AC   CVCL_NT21
SY   RRS858
DR   MMRRC; MMRRC:005221-UCD
DR   Wikidata; Q54777193
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921717; Pus10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS864
AC   CVCL_NT22
SY   RRS864
DR   MMRRC; MMRRC:005222-UCD
DR   Wikidata; Q54777196
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917870; Ube2v2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS868
AC   CVCL_NT23
SY   RRS868
DR   MMRRC; MMRRC:005223-UCD
DR   Wikidata; Q54777197
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97891; Rfc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS870
AC   CVCL_NT24
SY   RRS870
DR   MMRRC; MMRRC:005224-UCD
DR   Wikidata; Q54777198
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS873
AC   CVCL_NT25
SY   RRS873
DR   MMRRC; MMRRC:005226-UCD
DR   Wikidata; Q54777202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342335; Asap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS874
AC   CVCL_NT26
SY   RRS874
DR   MMRRC; MMRRC:005227-UCD
DR   Wikidata; Q54777205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99147; Yes1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS876
AC   CVCL_NT27
SY   RRS876
DR   MMRRC; MMRRC:005228-UCD
DR   Wikidata; Q54777207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342335; Asap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS879
AC   CVCL_NT28
SY   RRS879
DR   MMRRC; MMRRC:005229-UCD
DR   Wikidata; Q54777210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927225; Tbc1d8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS882
AC   CVCL_NT29
SY   RRS882
DR   MMRRC; MMRRC:005230-UCD
DR   Wikidata; Q54777213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891112; Gmds.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRS890
AC   CVCL_NT30
SY   RRS890
DR   MMRRC; MMRRC:005234-UCD
DR   Wikidata; Q54777217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915549; Vps53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT001
AC   CVCL_NT31
SY   RRT001
DR   MMRRC; MMRRC:005235-UCD
DR   Wikidata; Q54777218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT002
AC   CVCL_NT32
SY   RRT002
DR   MMRRC; MMRRC:005236-UCD
DR   Wikidata; Q54777220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917262; Cep85.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT003
AC   CVCL_NT33
SY   RRT003
DR   MMRRC; MMRRC:005237-UCD
DR   Wikidata; Q54777221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919451; Otud6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT008
AC   CVCL_NT34
SY   RRT008
DR   MMRRC; MMRRC:005238-UCD
DR   Wikidata; Q54777224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99430; Hira.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT009
AC   CVCL_NT35
SY   RRT009
DR   MMRRC; MMRRC:005239-UCD
DR   Wikidata; Q54777225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142808; Cog4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT010
AC   CVCL_NT36
SY   RRT010
DR   MMRRC; MMRRC:005240-UCD
DR   Wikidata; Q54777228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT011
AC   CVCL_NT37
SY   RRT011
DR   MMRRC; MMRRC:005241-UCD
DR   Wikidata; Q54777229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT014
AC   CVCL_NT38
SY   RRT014
DR   MMRRC; MMRRC:005243-UCD
DR   Wikidata; Q54777233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108515; Cbx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT020
AC   CVCL_NT39
SY   RRT020
DR   MMRRC; MMRRC:005244-UCD
DR   Wikidata; Q54777235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT021
AC   CVCL_NT40
SY   RRT021
DR   MMRRC; MMRRC:005245-UCD
DR   Wikidata; Q54777237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT022
AC   CVCL_NT41
SY   RRT022
DR   MMRRC; MMRRC:005246-UCD
DR   Wikidata; Q54777239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT032
AC   CVCL_NT42
SY   RRT032
DR   MMRRC; MMRRC:005248-UCD
DR   Wikidata; Q54777240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT033
AC   CVCL_NT43
SY   RRT033
DR   MMRRC; MMRRC:005249-UCD
DR   Wikidata; Q54777279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT034
AC   CVCL_NT44
SY   RRT034
DR   MMRRC; MMRRC:005250-UCD
DR   Wikidata; Q54777280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145374; Dhx29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT035
AC   CVCL_NT45
SY   RRT035
DR   MMRRC; MMRRC:005251-UCD
DR   Wikidata; Q54777282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918995; Cul2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT039
AC   CVCL_NT46
SY   RRT039
DR   MMRRC; MMRRC:005252-UCD
DR   Wikidata; Q54777283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919055; Nup93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT040
AC   CVCL_NT47
SY   RRT040
DR   MMRRC; MMRRC:005253-UCD
DR   Wikidata; Q54777286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919904; Ccdc12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT043
AC   CVCL_NT48
SY   RRT043
DR   MMRRC; MMRRC:005254-UCD
DR   Wikidata; Q54777288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354737; Kdm2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT047
AC   CVCL_NT49
SY   RRT047
DR   MMRRC; MMRRC:005255-UCD
DR   Wikidata; Q54777290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916487; Gtpbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT048
AC   CVCL_NT50
SY   RRT048
DR   MMRRC; MMRRC:005256-UCD
DR   Wikidata; Q54777292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923784; Osbpl9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT049
AC   CVCL_NT51
SY   RRT049
DR   MMRRC; MMRRC:005257-UCD
DR   Wikidata; Q54777294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT051
AC   CVCL_NT52
SY   RRT051
DR   MMRRC; MMRRC:005258-UCD
DR   Wikidata; Q54777295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96960; Rab8a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT053
AC   CVCL_NT53
SY   RRT053
DR   MMRRC; MMRRC:005259-UCD
DR   Wikidata; Q54777297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT054
AC   CVCL_NT54
SY   RRT054
DR   MMRRC; MMRRC:005260-UCD
DR   Wikidata; Q54777298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT055
AC   CVCL_NT55
SY   RRT055
DR   MMRRC; MMRRC:005261-UCD
DR   Wikidata; Q54777299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914167; Chordc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT057
AC   CVCL_NT56
SY   RRT057
DR   MMRRC; MMRRC:005262-UCD
DR   Wikidata; Q54777301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923041; Fbxw8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT058
AC   CVCL_NT57
SY   RRT058
DR   MMRRC; MMRRC:005263-UCD
DR   Wikidata; Q54777302
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921494; Atg7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT059
AC   CVCL_NT58
SY   RRT059
DR   MMRRC; MMRRC:005264-UCD
DR   Wikidata; Q54777305
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916327; Psmd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT060
AC   CVCL_NT59
SY   RRT060
DR   MMRRC; MMRRC:005265-UCD
DR   Wikidata; Q54777307
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384568; Kank2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT061
AC   CVCL_NT60
SY   RRT061
DR   MMRRC; MMRRC:005266-UCD
DR   Wikidata; Q54777308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT063
AC   CVCL_NT61
SY   RRT063
DR   MMRRC; MMRRC:005267-UCD
DR   Wikidata; Q54777310
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196624; Tcea1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT064
AC   CVCL_NT62
SY   RRT064
DR   MMRRC; MMRRC:005268-UCD
DR   Wikidata; Q54777312
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915867; Mtcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT065
AC   CVCL_NT63
SY   RRT065
DR   MMRRC; MMRRC:005269-UCD
DR   Wikidata; Q54777313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917819; Wdr36.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT066
AC   CVCL_NT64
SY   RRT066
DR   MMRRC; MMRRC:005270-UCD
DR   Wikidata; Q54777315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917819; Wdr36.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT067
AC   CVCL_NT65
SY   RRT067
DR   MMRRC; MMRRC:005271-UCD
DR   Wikidata; Q54777317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT068
AC   CVCL_NT66
SY   RRT068
DR   MMRRC; MMRRC:005272-UCD
DR   Wikidata; Q54777319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916990; Dph5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT083
AC   CVCL_NT67
SY   RRT083
DR   MMRRC; MMRRC:005274-UCD
DR   Wikidata; Q54777322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201409; Pknox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT086
AC   CVCL_NT68
SY   RRT086
DR   MMRRC; MMRRC:005275-UCD
DR   Wikidata; Q54777323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT092
AC   CVCL_NT69
SY   RRT092
DR   MMRRC; MMRRC:005276-UCD
DR   Wikidata; Q54777325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT102
AC   CVCL_NT70
SY   RRT102
DR   MMRRC; MMRRC:005278-UCD
DR   Wikidata; Q54777326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT103
AC   CVCL_NT71
SY   RRT103
DR   MMRRC; MMRRC:005279-UCD
DR   Wikidata; Q54777329
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT104
AC   CVCL_NT72
SY   RRT104
DR   MMRRC; MMRRC:005280-UCD
DR   Wikidata; Q54777330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925123; Zbtb44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT105
AC   CVCL_NT73
SY   RRT105
DR   MMRRC; MMRRC:005281-UCD
DR   Wikidata; Q54777331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT110
AC   CVCL_NT74
SY   RRT110
DR   MMRRC; MMRRC:005283-UCD
DR   Wikidata; Q54777333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915261; Snrpg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT113
AC   CVCL_NT75
SY   RRT113
DR   MMRRC; MMRRC:005284-UCD
DR   Wikidata; Q54777336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289172; Scyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT114
AC   CVCL_NT76
SY   RRT114
DR   MMRRC; MMRRC:005285-UCD
DR   Wikidata; Q54777338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388481; Ppp2r5d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT115
AC   CVCL_NT77
SY   RRT115
DR   MMRRC; MMRRC:005286-UCD
DR   Wikidata; Q54777339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446632; Ago2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT116
AC   CVCL_NT78
SY   RRT116
DR   MMRRC; MMRRC:005287-UCD
DR   Wikidata; Q54777341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922250; Stk38l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT117
AC   CVCL_NT79
SY   RRT117
DR   MMRRC; MMRRC:005288-UCD
DR   Wikidata; Q54777342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917799; Tln2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT120
AC   CVCL_NT80
SY   RRT120
DR   MMRRC; MMRRC:005289-UCD
DR   Wikidata; Q54777345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT124
AC   CVCL_NT81
SY   RRT124
DR   MMRRC; MMRRC:005290-UCD
DR   Wikidata; Q54777346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT125
AC   CVCL_NT82
SY   RRT125
DR   MMRRC; MMRRC:005291-UCD
DR   Wikidata; Q54777348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97852; Rap1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT128
AC   CVCL_NT83
SY   RRT128
DR   MMRRC; MMRRC:005292-UCD
DR   Wikidata; Q54777393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914974; Pop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT131
AC   CVCL_NT84
SY   RRT131
DR   MMRRC; MMRRC:005293-UCD
DR   Wikidata; Q54777394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201610; Tex9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT132
AC   CVCL_NT85
SY   RRT132
DR   MMRRC; MMRRC:005294-UCD
DR   Wikidata; Q54777396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109564; Kif5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT133
AC   CVCL_NT86
SY   RRT133
DR   MMRRC; MMRRC:005295-UCD
DR   Wikidata; Q54777397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444957; Taf6l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT134
AC   CVCL_NT87
SY   RRT134
DR   MMRRC; MMRRC:005296-UCD
DR   Wikidata; Q54777399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928760; Ruvbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT136
AC   CVCL_NT88
SY   RRT136
DR   MMRRC; MMRRC:005297-UCD
DR   Wikidata; Q54777401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922152; Ccdc171.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT139
AC   CVCL_NT89
SY   RRT139
DR   MMRRC; MMRRC:005298-UCD
DR   Wikidata; Q54777403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106209; Hells.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT142
AC   CVCL_NT90
SY   RRT142
DR   MMRRC; MMRRC:005300-UCD
DR   Wikidata; Q54777404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919955; Zcchc17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT143
AC   CVCL_NT91
SY   RRT143
DR   MMRRC; MMRRC:005301-UCD
DR   Wikidata; Q54777406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919955; Zcchc17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT146
AC   CVCL_NT92
SY   RRT146
DR   MMRRC; MMRRC:005302-UCD
DR   Wikidata; Q54777408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922570; Etnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT149
AC   CVCL_NT93
SY   RRT149
DR   MMRRC; MMRRC:005303-UCD
DR   Wikidata; Q54777411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913696; Exosc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT151
AC   CVCL_NT94
SY   RRT151
DR   MMRRC; MMRRC:005304-UCD
DR   Wikidata; Q54777413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT152
AC   CVCL_NT95
SY   RRT152
DR   MMRRC; MMRRC:005305-UCD
DR   Wikidata; Q54777414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140050; Ints3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT153
AC   CVCL_NT96
SY   RRT153
DR   MMRRC; MMRRC:005306-UCD
DR   Wikidata; Q54777417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894687; Xrn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT154
AC   CVCL_NT97
SY   RRT154
DR   MMRRC; MMRRC:005307-UCD
DR   Wikidata; Q54777419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321159; Ppp2ca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT156
AC   CVCL_NT98
SY   RRT156
DR   MMRRC; MMRRC:005308-UCD
DR   Wikidata; Q54777421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354737; Kdm2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT158
AC   CVCL_NT99
SY   RRT158
DR   MMRRC; MMRRC:005309-UCD
DR   Wikidata; Q54777423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917338; Meaf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT159
AC   CVCL_NU00
SY   RRT159
DR   MMRRC; MMRRC:005310-UCD
DR   Wikidata; Q54777424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921450; Khdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRT161
AC   CVCL_NU01
SY   RRT161
DR   MMRRC; MMRRC:005311-UCD
DR   Wikidata; Q54777426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444207; Vps13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT164
AC   CVCL_NU02
SY   RRT164
DR   MMRRC; MMRRC:005314-UCD
DR   Wikidata; Q54777429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97805; Ptpn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT167
AC   CVCL_NU03
SY   RRT167
DR   MMRRC; MMRRC:005315-UCD
DR   Wikidata; Q54777430
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921020; Wdr70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT168
AC   CVCL_NU04
SY   RRT168
DR   MMRRC; MMRRC:005316-UCD
DR   Wikidata; Q54777432
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449121; Nme7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT170
AC   CVCL_NU05
SY   RRT170
DR   MMRRC; MMRRC:005317-UCD
DR   Wikidata; Q54777435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107183; Cct8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT172
AC   CVCL_NU06
SY   RRT172
DR   MMRRC; MMRRC:005318-UCD
DR   Wikidata; Q54777439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138080; Utp25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRT173
AC   CVCL_NU07
SY   RRT173
DR   MMRRC; MMRRC:005319-UCD
DR   Wikidata; Q54777442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108498; Nbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT176
AC   CVCL_NU08
SY   RRT176
DR   MMRRC; MMRRC:005321-UCD
DR   Wikidata; Q54777445
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT177
AC   CVCL_NU09
SY   RRT177
DR   MMRRC; MMRRC:005322-UCD
DR   Wikidata; Q54777446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179288; Rttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT180
AC   CVCL_NU10
SY   RRT180
DR   MMRRC; MMRRC:005323-UCD
DR   Wikidata; Q54777447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921537; Kcmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT183
AC   CVCL_NU11
SY   RRT183
DR   MMRRC; MMRRC:005324-UCD
DR   Wikidata; Q54777449
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT189
AC   CVCL_NU12
SY   RRT189
DR   MMRRC; MMRRC:005325-UCD
DR   Wikidata; Q54777452
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT195
AC   CVCL_NU13
SY   RRT195
DR   MMRRC; MMRRC:005327-UCD
DR   Wikidata; Q54777454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109656; Lasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT203
AC   CVCL_NU14
SY   RRT203
DR   MMRRC; MMRRC:005330-UCD
DR   Wikidata; Q54777455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920442; Xpot.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT204
AC   CVCL_NU15
SY   RRT204
DR   MMRRC; MMRRC:005331-UCD
DR   Wikidata; Q54777459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103257; Inpp5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT211
AC   CVCL_NU16
SY   RRT211
DR   MMRRC; MMRRC:005332-UCD
DR   Wikidata; Q54777463
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670178; Med13l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT212
AC   CVCL_NU17
SY   RRT212
DR   MMRRC; MMRRC:005333-UCD
DR   Wikidata; Q54777464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2663721; Zc3h3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT216
AC   CVCL_NU18
SY   RRT216
DR   MMRRC; MMRRC:005336-UCD
DR   Wikidata; Q54777466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349635; Sec23a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT219
AC   CVCL_NU19
SY   RRT219
DR   MMRRC; MMRRC:005338-UCD
DR   Wikidata; Q54777467
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179432; Mycbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT223
AC   CVCL_NU20
SY   RRT223
DR   MMRRC; MMRRC:005339-UCD
DR   Wikidata; Q54777470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935147; Arid1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT224
AC   CVCL_NU21
SY   RRT224
DR   MMRRC; MMRRC:005340-UCD
DR   Wikidata; Q54777471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924386; Cep78.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT226
AC   CVCL_NU22
SY   RRT226
DR   MMRRC; MMRRC:005341-UCD
DR   Wikidata; Q54777473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916858; Sec24d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT229
AC   CVCL_NU23
SY   RRT229
DR   MMRRC; MMRRC:005343-UCD
DR   Wikidata; Q54777521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351605; Rpl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT230
AC   CVCL_NU24
SY   RRT230
DR   MMRRC; MMRRC:005344-UCD
DR   Wikidata; Q54777523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916976; Smyd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT234
AC   CVCL_NU25
SY   RRT234
DR   MMRRC; MMRRC:005347-UCD
DR   Wikidata; Q54777524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99495; Brd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT235
AC   CVCL_NU26
SY   RRT235
DR   MMRRC; MMRRC:005348-UCD
DR   Wikidata; Q54777526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87929; Adh5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT236
AC   CVCL_NU27
SY   RRT236
DR   MMRRC; MMRRC:005349-UCD
DR   Wikidata; Q54777528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202876; Tcf7l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT240
AC   CVCL_NU28
SY   RRT240
DR   MMRRC; MMRRC:005350-UCD
DR   Wikidata; Q54777531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146350; Scaf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT251
AC   CVCL_NU29
SY   RRT251
DR   MMRRC; MMRRC:005353-UCD
DR   Wikidata; Q54777533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT253
AC   CVCL_NU30
SY   RRT253
DR   MMRRC; MMRRC:005354-UCD
DR   Wikidata; Q54777534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351486; Trappc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT256
AC   CVCL_NU31
SY   RRT256
DR   MMRRC; MMRRC:005356-UCD
DR   Wikidata; Q54777536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924841; Ddx10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT259
AC   CVCL_NU32
SY   RRT259
DR   MMRRC; MMRRC:005357-UCD
DR   Wikidata; Q54777538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT262
AC   CVCL_NU33
SY   RRT262
DR   MMRRC; MMRRC:005358-UCD
DR   Wikidata; Q54777540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914724; Snap29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT264
AC   CVCL_NU34
SY   RRT264
DR   MMRRC; MMRRC:005359-UCD
DR   Wikidata; Q54777541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924550; Raph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT271
AC   CVCL_NU35
SY   RRT271
DR   MMRRC; MMRRC:005360-UCD
DR   Wikidata; Q54777543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387357; Wac.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT272
AC   CVCL_NU36
SY   RRT272
DR   MMRRC; MMRRC:005361-UCD
DR   Wikidata; Q54777547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202400; Supt5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT274
AC   CVCL_NU37
SY   RRT274
DR   MMRRC; MMRRC:005362-UCD
DR   Wikidata; Q54777550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914491; Smc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT280
AC   CVCL_NU38
SY   RRT280
DR   MMRRC; MMRRC:005364-UCD
DR   Wikidata; Q54777551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889276; Dgke.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT283
AC   CVCL_NU39
SY   RRT283
DR   MMRRC; MMRRC:005365-UCD
DR   Wikidata; Q54777552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102726; Dck.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT284
AC   CVCL_NU40
SY   RRT284
DR   MMRRC; MMRRC:005366-UCD
DR   Wikidata; Q54777555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449311; Gemin5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT285
AC   CVCL_NU41
SY   RRT285
DR   MMRRC; MMRRC:005367-UCD
DR   Wikidata; Q54777558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913917; Hspbap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT286
AC   CVCL_NU42
SY   RRT286
DR   MMRRC; MMRRC:005368-UCD
DR   Wikidata; Q54777560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448514; R3hdm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT289
AC   CVCL_NU43
SY   RRT289
DR   MMRRC; MMRRC:005369-UCD
DR   Wikidata; Q54777563
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442117; Pogz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT290
AC   CVCL_NU44
SY   RRT290
DR   MMRRC; MMRRC:005370-UCD
DR   Wikidata; Q54777564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923802; Plekha5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT293
AC   CVCL_NU45
SY   RRT293
DR   MMRRC; MMRRC:005372-UCD
DR   Wikidata; Q54777568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT300
AC   CVCL_NU46
SY   RRT300
DR   MMRRC; MMRRC:005373-UCD
DR   Wikidata; Q54777570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344363; Arih1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT305
AC   CVCL_NU47
SY   RRT305
DR   MMRRC; MMRRC:005374-UCD
DR   Wikidata; Q54777571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT307
AC   CVCL_NU48
SY   RRT307
DR   MMRRC; MMRRC:005376-UCD
DR   Wikidata; Q54777574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929865; Nampt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT317
AC   CVCL_NU49
SY   RRT317
DR   MMRRC; MMRRC:005377-UCD
DR   Wikidata; Q54777577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915265; Trap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT320
AC   CVCL_NU50
SY   RRT320
DR   MMRRC; MMRRC:005379-UCD
DR   Wikidata; Q54777578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889002; Wdr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT324
AC   CVCL_NU51
SY   RRT324
DR   MMRRC; MMRRC:005380-UCD
DR   Wikidata; Q54777579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT325
AC   CVCL_NU52
SY   RRT325
DR   MMRRC; MMRRC:005381-UCD
DR   Wikidata; Q54777581
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684060; Akap11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT326
AC   CVCL_NU53
SY   RRT326
DR   MMRRC; MMRRC:005382-UCD
DR   Wikidata; Q54777584
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT330
AC   CVCL_NU54
SY   RRT330
DR   MMRRC; MMRRC:005383-UCD
DR   Wikidata; Q54777585
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151839; Mreg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT336
AC   CVCL_NU55
SY   RRT336
DR   MMRRC; MMRRC:005384-UCD
DR   Wikidata; Q54777587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT341
AC   CVCL_NU56
SY   RRT341
DR   MMRRC; MMRRC:005386-UCD
DR   Wikidata; Q54777589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139309; Garnl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT342
AC   CVCL_NU57
SY   RRT342
DR   MMRRC; MMRRC:005387-UCD
DR   Wikidata; Q54777592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039590; Tmtc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT343
AC   CVCL_NU58
SY   RRT343
DR   MMRRC; MMRRC:005388-UCD
DR   Wikidata; Q54777594
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107777; Atp5j.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT345
AC   CVCL_NU59
SY   RRT345
DR   MMRRC; MMRRC:005389-UCD
DR   Wikidata; Q54777597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915192; Atp5g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT348
AC   CVCL_NU60
SY   RRT348
DR   MMRRC; MMRRC:005392-UCD
DR   Wikidata; Q54777600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT349
AC   CVCL_NU61
SY   RRT349
DR   MMRRC; MMRRC:005393-UCD
DR   Wikidata; Q54777601
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448419; H4c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRT350
AC   CVCL_NU62
SY   RRT350
DR   MMRRC; MMRRC:005394-UCD
DR   Wikidata; Q54777602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349457; Serinc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT351
AC   CVCL_NU63
SY   RRT351
DR   MMRRC; MMRRC:005395-UCD
DR   Wikidata; Q54777641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923864; Immt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT353
AC   CVCL_NU64
SY   RRT353
DR   MMRRC; MMRRC:005396-UCD
DR   Wikidata; Q54777643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448419; H4c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRT358
AC   CVCL_NU65
SY   RRT358
DR   MMRRC; MMRRC:005398-UCD
DR   Wikidata; Q54777645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107943; Cct6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT360
AC   CVCL_NU66
SY   RRT360
DR   MMRRC; MMRRC:005400-UCD
DR   Wikidata; Q54777648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450915; Sec23ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT363
AC   CVCL_NU67
SY   RRT363
DR   MMRRC; MMRRC:005401-UCD
DR   Wikidata; Q54777651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277178; Fam91a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT373
AC   CVCL_NU68
SY   RRT373
DR   MMRRC; MMRRC:005403-UCD
DR   Wikidata; Q54777653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT374
AC   CVCL_NU69
SY   RRT374
DR   MMRRC; MMRRC:005404-UCD
DR   Wikidata; Q54777655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684957; Rexo4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT382
AC   CVCL_NU70
SY   RRT382
DR   MMRRC; MMRRC:005406-UCD
DR   Wikidata; Q54777657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140945; Pds5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT390
AC   CVCL_NU71
SY   RRT390
DR   MMRRC; MMRRC:005408-UCD
DR   Wikidata; Q54777659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914596; Daam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT394
AC   CVCL_NU72
SY   RRT394
DR   MMRRC; MMRRC:005409-UCD
DR   Wikidata; Q54777661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349452; Polr3e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT396
AC   CVCL_NU73
SY   RRT396
DR   MMRRC; MMRRC:005411-UCD
DR   Wikidata; Q54777663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924053; Zfp998.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRT397
AC   CVCL_NU74
SY   RRT397
DR   MMRRC; MMRRC:005412-UCD
DR   Wikidata; Q54777665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140998; Ube3c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT398
AC   CVCL_NU75
SY   RRT398
DR   MMRRC; MMRRC:005413-UCD
DR   Wikidata; Q54777666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT399
AC   CVCL_NU76
SY   RRT399
DR   MMRRC; MMRRC:005414-UCD
DR   Wikidata; Q54777668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT400
AC   CVCL_NU77
SY   RRT400
DR   MMRRC; MMRRC:005415-UCD
DR   Wikidata; Q54777670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95781; Gnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT415
AC   CVCL_NU78
SY   RRT415
DR   MMRRC; MMRRC:005419-UCD
DR   Wikidata; Q54777672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107184; Cct7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT416
AC   CVCL_NU79
SY   RRT416
DR   MMRRC; MMRRC:005420-UCD
DR   Wikidata; Q54777673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT428
AC   CVCL_NU80
SY   RRT428
DR   MMRRC; MMRRC:005422-UCD
DR   Wikidata; Q54777675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443627; Plekhm3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT430
AC   CVCL_NU81
SY   RRT430
DR   MMRRC; MMRRC:005423-UCD
DR   Wikidata; Q54777677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354737; Kdm2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT432
AC   CVCL_NU82
SY   RRT432
DR   MMRRC; MMRRC:005424-UCD
DR   Wikidata; Q54777678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT447
AC   CVCL_NU83
SY   RRT447
DR   MMRRC; MMRRC:005426-UCD
DR   Wikidata; Q54777680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144727; Ddx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT449
AC   CVCL_NU84
SY   RRT449
DR   MMRRC; MMRRC:005427-UCD
DR   Wikidata; Q54777682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919742; Smg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT464
AC   CVCL_NU85
SY   RRT464
DR   MMRRC; MMRRC:005429-UCD
DR   Wikidata; Q54777684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670178; Med13l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT473
AC   CVCL_NU86
SY   RRT473
DR   MMRRC; MMRRC:005431-UCD
DR   Wikidata; Q54777685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107158; Sin3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT475
AC   CVCL_NU87
SY   RRT475
DR   MMRRC; MMRRC:005433-UCD
DR   Wikidata; Q54777688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101857; Usp15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT480
AC   CVCL_NU88
SY   RRT480
DR   MMRRC; MMRRC:005434-UCD
DR   Wikidata; Q54777690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921571; Tipin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT481
AC   CVCL_NU89
SY   RRT481
DR   MMRRC; MMRRC:005435-UCD
DR   Wikidata; Q54777692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917057; Trim32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT483
AC   CVCL_NU90
SY   RRT483
DR   MMRRC; MMRRC:005436-UCD
DR   Wikidata; Q54777693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446630; Ago1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT484
AC   CVCL_NU91
SY   RRT484
DR   MMRRC; MMRRC:005437-UCD
DR   Wikidata; Q54777696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446630; Ago1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT485
AC   CVCL_NU92
SY   RRT485
DR   MMRRC; MMRRC:005438-UCD
DR   Wikidata; Q54777699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891037; Mtrr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT486
AC   CVCL_NU93
SY   RRT486
DR   MMRRC; MMRRC:005439-UCD
DR   Wikidata; Q54777701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891037; Mtrr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT487
AC   CVCL_NU94
SY   RRT487
DR   MMRRC; MMRRC:005440-UCD
DR   Wikidata; Q54777703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333796; Klf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT488
AC   CVCL_NU95
SY   RRT488
DR   MMRRC; MMRRC:005441-UCD
DR   Wikidata; Q54777706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333796; Klf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT490
AC   CVCL_NU96
SY   RRT490
DR   MMRRC; MMRRC:005442-UCD
DR   Wikidata; Q54777707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919765; Wdr43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT491
AC   CVCL_NU97
SY   RRT491
DR   MMRRC; MMRRC:005443-UCD
DR   Wikidata; Q54777710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913892; Ctnnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT492
AC   CVCL_NU98
SY   RRT492
DR   MMRRC; MMRRC:005444-UCD
DR   Wikidata; Q54777712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913892; Ctnnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT493
AC   CVCL_NU99
SY   RRT493
DR   MMRRC; MMRRC:005445-UCD
DR   Wikidata; Q54777716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT494
AC   CVCL_NV00
SY   RRT494
DR   MMRRC; MMRRC:005446-UCD
DR   Wikidata; Q54777717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT495
AC   CVCL_NV01
SY   RRT495
DR   MMRRC; MMRRC:005447-UCD
DR   Wikidata; Q54777718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99257; Eif3e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT496
AC   CVCL_NV02
SY   RRT496
DR   MMRRC; MMRRC:005448-UCD
DR   Wikidata; Q54777719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99257; Eif3e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT498
AC   CVCL_NV03
SY   RRT498
DR   MMRRC; MMRRC:005449-UCD
DR   Wikidata; Q54777762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97537; Pecam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT499
AC   CVCL_NV04
SY   RRT499
DR   MMRRC; MMRRC:005450-UCD
DR   Wikidata; Q54777765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97537; Pecam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT500
AC   CVCL_NV05
SY   RRT500
DR   MMRRC; MMRRC:005451-UCD
DR   Wikidata; Q54777767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106918; Hif1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT502
AC   CVCL_NV06
SY   RRT502
DR   MMRRC; MMRRC:005453-UCD
DR   Wikidata; Q54777770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT503
AC   CVCL_NV07
SY   RRT503
DR   MMRRC; MMRRC:005454-UCD
DR   Wikidata; Q54777772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT506
AC   CVCL_NV08
SY   RRT506
DR   MMRRC; MMRRC:005457-UCD
DR   Wikidata; Q54777775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098268; Kif5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT507
AC   CVCL_NV09
SY   RRT507
DR   MMRRC; MMRRC:005458-UCD
DR   Wikidata; Q54777776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098268; Kif5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT508
AC   CVCL_NV10
SY   RRT508
DR   MMRRC; MMRRC:005459-UCD
DR   Wikidata; Q54777779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98241; Stmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT509
AC   CVCL_NV11
SY   RRT509
DR   MMRRC; MMRRC:005460-UCD
DR   Wikidata; Q54777782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98241; Stmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT510
AC   CVCL_NV12
SY   RRT510
DR   MMRRC; MMRRC:005461-UCD
DR   Wikidata; Q54777783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT511
AC   CVCL_NV13
SY   RRT511
DR   MMRRC; MMRRC:005462-UCD
DR   Wikidata; Q54777787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137670; Ybx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT513
AC   CVCL_NV14
SY   RRT513
DR   MMRRC; MMRRC:005464-UCD
DR   Wikidata; Q54777788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT517
AC   CVCL_NV15
SY   RRT517
DR   MMRRC; MMRRC:005466-UCD
DR   Wikidata; Q54777790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449121; Nme7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT524
AC   CVCL_NV16
SY   RRT524
DR   MMRRC; MMRRC:005469-UCD
DR   Wikidata; Q54777792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT532
AC   CVCL_NV17
SY   RRT532
DR   MMRRC; MMRRC:005470-UCD
DR   Wikidata; Q54777793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919904; Ccdc12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT533
AC   CVCL_NV18
SY   RRT533
DR   MMRRC; MMRRC:005471-UCD
DR   Wikidata; Q54777796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT536
AC   CVCL_NV19
SY   RRT536
DR   MMRRC; MMRRC:005473-UCD
DR   Wikidata; Q54777798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99430; Hira.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT549
AC   CVCL_NV20
SY   RRT549
DR   MMRRC; MMRRC:005475-UCD
DR   Wikidata; Q54777799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196624; Tcea1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT550
AC   CVCL_NV21
SY   RRT550
DR   MMRRC; MMRRC:005476-UCD
DR   Wikidata; Q54777802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914167; Chordc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT552
AC   CVCL_NV22
SY   RRT552
DR   MMRRC; MMRRC:005478-UCD
DR   Wikidata; Q54777803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919055; Nup93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT555
AC   CVCL_NV23
SY   RRT555
DR   MMRRC; MMRRC:005480-UCD
DR   Wikidata; Q54777804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3028642; Iqgap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT580
AC   CVCL_NV24
SY   RRT580
DR   MMRRC; MMRRC:005483-UCD
DR   Wikidata; Q54777806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923264; Zc3h18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT582
AC   CVCL_NV25
SY   RRT582
DR   MMRRC; MMRRC:005484-UCD
DR   Wikidata; Q54777808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330276; Cops2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT583
AC   CVCL_NV26
SY   RRT583
DR   MMRRC; MMRRC:005485-UCD
DR   Wikidata; Q54777810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95753; Glud1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT586
AC   CVCL_NV27
SY   RRT586
DR   MMRRC; MMRRC:005486-UCD
DR   Wikidata; Q54777812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103234; Herc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT590
AC   CVCL_NV28
SY   RRT590
DR   MMRRC; MMRRC:005487-UCD
DR   Wikidata; Q54777814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97815; Ptprs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT591
AC   CVCL_NV29
SY   RRT591
DR   MMRRC; MMRRC:005488-UCD
DR   Wikidata; Q54777816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921571; Tipin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT592
AC   CVCL_NV30
SY   RRT592
DR   MMRRC; MMRRC:005489-UCD
DR   Wikidata; Q54777818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921571; Tipin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT603
AC   CVCL_NV31
SY   RRT603
DR   MMRRC; MMRRC:005491-UCD
DR   Wikidata; Q54777819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351477; Cars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT616
AC   CVCL_NV32
SY   RRT616
DR   MMRRC; MMRRC:005492-UCD
DR   Wikidata; Q54777820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT618
AC   CVCL_NV33
SY   RRT618
DR   MMRRC; MMRRC:005493-UCD
DR   Wikidata; Q54777825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109233; Kif22.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT627
AC   CVCL_NV34
SY   RRT627
DR   MMRRC; MMRRC:005495-UCD
DR   Wikidata; Q54777827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88311; Ccnb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT650
AC   CVCL_NV35
SY   RRT650
DR   MMRRC; MMRRC:005496-UCD
DR   Wikidata; Q54777829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137670; Ybx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT660
AC   CVCL_NV36
SY   RRT660
DR   MMRRC; MMRRC:005500-UCD
DR   Wikidata; Q54777833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445052; Tbck.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT661
AC   CVCL_NV37
SY   RRT661
DR   MMRRC; MMRRC:005501-UCD
DR   Wikidata; Q54777834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916477; Selenot.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT669
AC   CVCL_NV38
SY   RRT669
DR   MMRRC; MMRRC:005502-UCD
DR   Wikidata; Q54777836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915208; U2surp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT670
AC   CVCL_NV39
SY   RRT670
DR   MMRRC; MMRRC:005503-UCD
DR   Wikidata; Q54777839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137670; Ybx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT682
AC   CVCL_NV40
SY   RRT682
DR   MMRRC; MMRRC:005506-UCD
DR   Wikidata; Q54777841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201610; Tex9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT686
AC   CVCL_NV41
SY   RRT686
DR   MMRRC; MMRRC:005507-UCD
DR   Wikidata; Q54777844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341865; Mark3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT691
AC   CVCL_NV42
SY   RRT691
DR   MMRRC; MMRRC:005509-UCD
DR   Wikidata; Q54777846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT699
AC   CVCL_NV43
SY   RRT699
DR   MMRRC; MMRRC:005513-UCD
DR   Wikidata; Q54777888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931035; Nelfb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT701
AC   CVCL_NV44
SY   RRT701
DR   MMRRC; MMRRC:005514-UCD
DR   Wikidata; Q54777892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445054; Senp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRT702
AC   CVCL_NV45
SY   RRT702
DR   MMRRC; MMRRC:005515-UCD
DR   Wikidata; Q54777893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137670; Ybx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU003
AC   CVCL_NV46
SY   RRU003
DR   MMRRC; MMRRC:005518-UCD
DR   Wikidata; Q54777895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387217; Ift52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU004
AC   CVCL_NV47
SY   RRU004
DR   MMRRC; MMRRC:005519-UCD
DR   Wikidata; Q54777898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915867; Mtcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU005
AC   CVCL_NV48
SY   RRU005
DR   MMRRC; MMRRC:005520-UCD
DR   Wikidata; Q54777900
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU006
AC   CVCL_NV49
SY   RRU006
DR   MMRRC; MMRRC:005521-UCD
DR   Wikidata; Q54777904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346074; Fxr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU007
AC   CVCL_NV50
SY   RRU007
DR   MMRRC; MMRRC:005522-UCD
DR   Wikidata; Q54777905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349394; Map4k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU008
AC   CVCL_NV51
SY   RRU008
DR   MMRRC; MMRRC:005523-UCD
DR   Wikidata; Q54777907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU009
AC   CVCL_NV52
SY   RRU009
DR   MMRRC; MMRRC:005524-UCD
DR   Wikidata; Q54777909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922462; Rnf121.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU011
AC   CVCL_NV53
SY   RRU011
DR   MMRRC; MMRRC:005526-UCD
DR   Wikidata; Q54777911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929955; Akr1a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU013
AC   CVCL_NV54
SY   RRU013
DR   MMRRC; MMRRC:005527-UCD
DR   Wikidata; Q54777912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU014
AC   CVCL_NV55
SY   RRU014
DR   MMRRC; MMRRC:005528-UCD
DR   Wikidata; Q54777913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU015
AC   CVCL_NV56
SY   RRU015
DR   MMRRC; MMRRC:005529-UCD
DR   Wikidata; Q54777915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935147; Arid1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU017
AC   CVCL_NV57
SY   RRU017
DR   MMRRC; MMRRC:005530-UCD
DR   Wikidata; Q54777918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921633; Ubap2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU019
AC   CVCL_NV58
SY   RRU019
DR   MMRRC; MMRRC:005531-UCD
DR   Wikidata; Q54777920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU022
AC   CVCL_NV59
SY   RRU022
DR   MMRRC; MMRRC:005532-UCD
DR   Wikidata; Q54777922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919240; Ddx54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU027
AC   CVCL_NV60
SY   RRU027
DR   MMRRC; MMRRC:005533-UCD
DR   Wikidata; Q54777926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU029
AC   CVCL_NV61
SY   RRU029
DR   MMRRC; MMRRC:005534-UCD
DR   Wikidata; Q54777927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109606; Fnbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU030
AC   CVCL_NV62
SY   RRU030
DR   MMRRC; MMRRC:005535-UCD
DR   Wikidata; Q54777929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889276; Dgke.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU031
AC   CVCL_NV63
SY   RRU031
DR   MMRRC; MMRRC:005536-UCD
DR   Wikidata; Q54777932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU035
AC   CVCL_NV64
SY   RRU035
DR   MMRRC; MMRRC:005537-UCD
DR   Wikidata; Q54777933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU036
AC   CVCL_NV65
SY   RRU036
DR   MMRRC; MMRRC:005538-UCD
DR   Wikidata; Q54777935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95768; Gna13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU042
AC   CVCL_NV66
SY   RRU042
DR   MMRRC; MMRRC:005539-UCD
DR   Wikidata; Q54777937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920336; Rps6ka5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU047
AC   CVCL_NV67
SY   RRU047
DR   MMRRC; MMRRC:005541-UCD
DR   Wikidata; Q54777938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925836; Srbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU049
AC   CVCL_NV68
SY   RRU049
DR   MMRRC; MMRRC:005543-UCD
DR   Wikidata; Q54777940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU050
AC   CVCL_NV69
SY   RRU050
DR   MMRRC; MMRRC:005544-UCD
DR   Wikidata; Q54777942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309480; Rtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU051
AC   CVCL_NV70
SY   RRU051
DR   MMRRC; MMRRC:005545-UCD
DR   Wikidata; Q54777945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158736; Senp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU053
AC   CVCL_NV71
SY   RRU053
DR   MMRRC; MMRRC:005546-UCD
DR   Wikidata; Q54777946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU055
AC   CVCL_NV72
SY   RRU055
DR   MMRRC; MMRRC:005547-UCD
DR   Wikidata; Q54777947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447768; Fam193a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU060
AC   CVCL_NV73
SY   RRU060
DR   MMRRC; MMRRC:005550-UCD
DR   Wikidata; Q54777948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914132; Bzw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU061
AC   CVCL_NV74
SY   RRU061
DR   MMRRC; MMRRC:005551-UCD
DR   Wikidata; Q54777950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443816; Snx8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU067
AC   CVCL_NV75
SY   RRU067
DR   MMRRC; MMRRC:005554-UCD
DR   Wikidata; Q54777953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140050; Ints3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU069
AC   CVCL_NV76
SY   RRU069
DR   MMRRC; MMRRC:005555-UCD
DR   Wikidata; Q54777954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913808; Lars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU070
AC   CVCL_NV77
SY   RRU070
DR   MMRRC; MMRRC:005556-UCD
DR   Wikidata; Q54777955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921456; Sipa1l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU077
AC   CVCL_NV78
SY   RRU077
DR   MMRRC; MMRRC:005559-UCD
DR   Wikidata; Q54777958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU083
AC   CVCL_NV79
SY   RRU083
DR   MMRRC; MMRRC:005560-UCD
DR   Wikidata; Q54777959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347053; Git2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU084
AC   CVCL_NV80
SY   RRU084
DR   MMRRC; MMRRC:005561-UCD
DR   Wikidata; Q54777961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924113; Dcun1d5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU085
AC   CVCL_NV81
SY   RRU085
DR   MMRRC; MMRRC:005562-UCD
DR   Wikidata; Q54777963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU099
AC   CVCL_NV82
SY   RRU099
DR   MMRRC; MMRRC:005564-UCD
DR   Wikidata; Q54777965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1340806; Parp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU103
AC   CVCL_NV83
SY   RRU103
DR   MMRRC; MMRRC:005566-UCD
DR   Wikidata; Q54778055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913906; Eef1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU122
AC   CVCL_NV84
SY   RRU122
DR   MMRRC; MMRRC:005569-UCD
DR   Wikidata; Q54778057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100495; Atp5pb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRU128
AC   CVCL_NV85
SY   RRU128
DR   MMRRC; MMRRC:005570-UCD
DR   Wikidata; Q54778060
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU152
AC   CVCL_NV86
SY   RRU152
DR   MMRRC; MMRRC:005575-UCD
DR   Wikidata; Q54778063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97517; Cdk17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU153
AC   CVCL_NV87
SY   RRU153
DR   MMRRC; MMRRC:005576-UCD
DR   Wikidata; Q54778066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU154
AC   CVCL_NV88
SY   RRU154
DR   MMRRC; MMRRC:005577-UCD
DR   Wikidata; Q54778068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU155
AC   CVCL_NV89
SY   RRU155
DR   MMRRC; MMRRC:005578-UCD
DR   Wikidata; Q54778071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU156
AC   CVCL_NV90
SY   RRU156
DR   MMRRC; MMRRC:005579-UCD
DR   Wikidata; Q54778072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2386251; Eif3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU161
AC   CVCL_NV91
SY   RRU161
DR   MMRRC; MMRRC:005580-UCD
DR   Wikidata; Q54778074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142347; Zfp568.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU165
AC   CVCL_NV92
SY   RRU165
DR   MMRRC; MMRRC:005582-UCD
DR   Wikidata; Q54778076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351315; Eloa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU167
AC   CVCL_NV93
SY   RRU167
DR   MMRRC; MMRRC:005583-UCD
DR   Wikidata; Q54778081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104861; Bcat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU170
AC   CVCL_NV94
SY   RRU170
DR   MMRRC; MMRRC:005584-UCD
DR   Wikidata; Q54778082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914195; Sdha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU178
AC   CVCL_NV95
SY   RRU178
DR   MMRRC; MMRRC:005587-UCD
DR   Wikidata; Q54778084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101769; Mcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU200
AC   CVCL_NV96
SY   RRU200
DR   MMRRC; MMRRC:005593-UCD
DR   Wikidata; Q54778086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3652185; Gm14322.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU209
AC   CVCL_NV97
SY   RRU209
DR   MMRRC; MMRRC:005596-UCD
DR   Wikidata; Q54778087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916188; Aspscr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU210
AC   CVCL_NV98
SY   RRU210
DR   MMRRC; MMRRC:005597-UCD
DR   Wikidata; Q54778089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU215
AC   CVCL_NV99
SY   RRU215
DR   MMRRC; MMRRC:005598-UCD
DR   Wikidata; Q54778091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920037; Ndc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU216
AC   CVCL_NW00
SY   RRU216
DR   MMRRC; MMRRC:005599-UCD
DR   Wikidata; Q54778093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU225
AC   CVCL_NW01
SY   RRU225
DR   MMRRC; MMRRC:005600-UCD
DR   Wikidata; Q54778096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448514; R3hdm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU229
AC   CVCL_NW02
SY   RRU229
DR   MMRRC; MMRRC:005602-UCD
DR   Wikidata; Q54778098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099804; Hip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU242
AC   CVCL_NW03
SY   RRU242
DR   MMRRC; MMRRC:005605-UCD
DR   Wikidata; Q54778099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429950; Xpo6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU243
AC   CVCL_NW04
SY   RRU243
DR   MMRRC; MMRRC:005606-UCD
DR   Wikidata; Q54778102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106014; Nudc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU248
AC   CVCL_NW05
SY   RRU248
DR   MMRRC; MMRRC:005608-UCD
DR   Wikidata; Q54778104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU249
AC   CVCL_NW06
SY   RRU249
DR   MMRRC; MMRRC:005609-UCD
DR   Wikidata; Q54778105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU278
AC   CVCL_NW07
SY   RRU278
DR   MMRRC; MMRRC:005616-UCD
DR   Wikidata; Q54778107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146901; Trip10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU282
AC   CVCL_NW08
SY   RRU282
DR   MMRRC; MMRRC:005617-UCD
DR   Wikidata; Q54778109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152345; Taf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU286
AC   CVCL_NW09
SY   RRU286
DR   MMRRC; MMRRC:005618-UCD
DR   Wikidata; Q54778110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100818; Crcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU298
AC   CVCL_NW10
SY   RRU298
DR   MMRRC; MMRRC:005619-UCD
DR   Wikidata; Q54778113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99400; Atp7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU300
AC   CVCL_NW11
SY   RRU300
DR   MMRRC; MMRRC:005620-UCD
DR   Wikidata; Q54778114
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889023; Banp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU302
AC   CVCL_NW12
SY   RRU302
DR   MMRRC; MMRRC:005622-UCD
DR   Wikidata; Q54778117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342294; Uri1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU308
AC   CVCL_NW13
SY   RRU308
DR   MMRRC; MMRRC:005624-UCD
DR   Wikidata; Q54778119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU314
AC   CVCL_NW14
SY   RRU314
DR   MMRRC; MMRRC:005626-UCD
DR   Wikidata; Q54778120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU317
AC   CVCL_NW15
SY   RRU317
DR   MMRRC; MMRRC:005627-UCD
DR   Wikidata; Q54778121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU327
AC   CVCL_NW16
SY   RRU327
DR   MMRRC; MMRRC:005628-UCD
DR   Wikidata; Q54778124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU332
AC   CVCL_NW17
SY   RRU332
DR   MMRRC; MMRRC:005629-UCD
DR   Wikidata; Q54778126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923747; Ppp1r11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU333
AC   CVCL_NW18
SY   RRU333
DR   MMRRC; MMRRC:005630-UCD
DR   Wikidata; Q54778127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915217; Pold3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU338
AC   CVCL_NW19
SY   RRU338
DR   MMRRC; MMRRC:005632-UCD
DR   Wikidata; Q54778128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917349; Smc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU340
AC   CVCL_NW20
SY   RRU340
DR   MMRRC; MMRRC:005633-UCD
DR   Wikidata; Q54778129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU345
AC   CVCL_NW21
SY   RRU345
DR   MMRRC; MMRRC:005635-UCD
DR   Wikidata; Q54778131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179723; Casc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU347
AC   CVCL_NW22
SY   RRU347
DR   MMRRC; MMRRC:005636-UCD
DR   Wikidata; Q54778133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915295; Rtraf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU351
AC   CVCL_NW23
SY   RRU351
DR   MMRRC; MMRRC:005638-UCD
DR   Wikidata; Q54778206
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447364; Smg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU354
AC   CVCL_NW24
SY   RRU354
DR   MMRRC; MMRRC:005640-UCD
DR   Wikidata; Q54778209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918398; Mier1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU356
AC   CVCL_NW25
SY   RRU356
DR   MMRRC; MMRRC:005642-UCD
DR   Wikidata; Q54778212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97758; Prim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU357
AC   CVCL_NW26
SY   RRU357
DR   MMRRC; MMRRC:005643-UCD
DR   Wikidata; Q54778213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384811; Kbtbd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU358
AC   CVCL_NW27
SY   RRU358
DR   MMRRC; MMRRC:005644-UCD
DR   Wikidata; Q54778215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108088; Gab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU362
AC   CVCL_NW28
SY   RRU362
DR   MMRRC; MMRRC:005646-UCD
DR   Wikidata; Q54778217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU364
AC   CVCL_NW29
SY   RRU364
DR   MMRRC; MMRRC:005648-UCD
DR   Wikidata; Q54778218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104636; Tle1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU366
AC   CVCL_NW30
SY   RRU366
DR   MMRRC; MMRRC:005649-UCD
DR   Wikidata; Q54778220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922855; Kdm5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU368
AC   CVCL_NW31
SY   RRU368
DR   MMRRC; MMRRC:005650-UCD
DR   Wikidata; Q54778222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923714; Knl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU369
AC   CVCL_NW32
SY   RRU369
DR   MMRRC; MMRRC:005651-UCD
DR   Wikidata; Q54778224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108403; Polr1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU372
AC   CVCL_NW33
SY   RRU372
DR   MMRRC; MMRRC:005652-UCD
DR   Wikidata; Q54778227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446526; Cpt1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU377
AC   CVCL_NW34
SY   RRU377
DR   MMRRC; MMRRC:005653-UCD
DR   Wikidata; Q54778229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918518; Lrrfip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU379
AC   CVCL_NW35
SY   RRU379
DR   MMRRC; MMRRC:005654-UCD
DR   Wikidata; Q54778232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917029; Pphln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU380
AC   CVCL_NW36
SY   RRU380
DR   MMRRC; MMRRC:005655-UCD
DR   Wikidata; Q54778234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384298; Sbno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU386
AC   CVCL_NW37
SY   RRU386
DR   MMRRC; MMRRC:005658-UCD
DR   Wikidata; Q54778236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924001; Chd9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU387
AC   CVCL_NW38
SY   RRU387
DR   MMRRC; MMRRC:005659-UCD
DR   Wikidata; Q54778238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334460; Bop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU388
AC   CVCL_NW39
SY   RRU388
DR   MMRRC; MMRRC:005660-UCD
DR   Wikidata; Q54778239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU389
AC   CVCL_NW40
SY   RRU389
DR   MMRRC; MMRRC:005661-UCD
DR   Wikidata; Q54778240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916610; 1700008J07Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU390
AC   CVCL_NW41
SY   RRU390
DR   MMRRC; MMRRC:005662-UCD
DR   Wikidata; Q54778244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099804; Hip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU391
AC   CVCL_NW42
SY   RRU391
DR   MMRRC; MMRRC:005663-UCD
DR   Wikidata; Q54778247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU393
AC   CVCL_NW43
SY   RRU393
DR   MMRRC; MMRRC:005664-UCD
DR   Wikidata; Q54778249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915408; Tecr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU395
AC   CVCL_NW44
SY   RRU395
DR   MMRRC; MMRRC:005665-UCD
DR   Wikidata; Q54778251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441849; Lpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU396
AC   CVCL_NW45
SY   RRU396
DR   MMRRC; MMRRC:005666-UCD
DR   Wikidata; Q54778252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890773; Actn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU397
AC   CVCL_NW46
SY   RRU397
DR   MMRRC; MMRRC:005667-UCD
DR   Wikidata; Q54778255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915511; Cep57l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU399
AC   CVCL_NW47
SY   RRU399
DR   MMRRC; MMRRC:005668-UCD
DR   Wikidata; Q54778257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU401
AC   CVCL_NW48
SY   RRU401
DR   MMRRC; MMRRC:005669-UCD
DR   Wikidata; Q54778259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU402
AC   CVCL_NW49
SY   RRU402
DR   MMRRC; MMRRC:005670-UCD
DR   Wikidata; Q54778262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98728; Tgfbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU403
AC   CVCL_NW50
SY   RRU403
DR   MMRRC; MMRRC:005671-UCD
DR   Wikidata; Q54778265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351315; Eloa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU407
AC   CVCL_NW51
SY   RRU407
DR   MMRRC; MMRRC:005672-UCD
DR   Wikidata; Q54778267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333796; Klf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU408
AC   CVCL_NW52
SY   RRU408
DR   MMRRC; MMRRC:005673-UCD
DR   Wikidata; Q54778268
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913557; Isoc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU410
AC   CVCL_NW53
SY   RRU410
DR   MMRRC; MMRRC:005674-UCD
DR   Wikidata; Q54778270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926395; Wtap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU412
AC   CVCL_NW54
SY   RRU412
DR   MMRRC; MMRRC:005675-UCD
DR   Wikidata; Q54778273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929722; Anapc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU414
AC   CVCL_NW55
SY   RRU414
DR   MMRRC; MMRRC:005677-UCD
DR   Wikidata; Q54778275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443205; Rbm15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU415
AC   CVCL_NW56
SY   RRU415
DR   MMRRC; MMRRC:005678-UCD
DR   Wikidata; Q54778278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349427; Exo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU416
AC   CVCL_NW57
SY   RRU416
DR   MMRRC; MMRRC:005679-UCD
DR   Wikidata; Q54778279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923728; Haus8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU419
AC   CVCL_NW58
SY   RRU419
DR   MMRRC; MMRRC:005680-UCD
DR   Wikidata; Q54778281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442415; Kat6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU421
AC   CVCL_NW59
SY   RRU421
DR   MMRRC; MMRRC:005681-UCD
DR   Wikidata; Q54778283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914393; Ikzf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU422
AC   CVCL_NW60
SY   RRU422
DR   MMRRC; MMRRC:005682-UCD
DR   Wikidata; Q54778286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921446; Ttc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU423
AC   CVCL_NW61
SY   RRU423
DR   MMRRC; MMRRC:005683-UCD
DR   Wikidata; Q54778288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU424
AC   CVCL_NW62
SY   RRU424
DR   MMRRC; MMRRC:005684-UCD
DR   Wikidata; Q54778291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927224; Yeats4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU438
AC   CVCL_NW63
SY   RRU438
DR   MMRRC; MMRRC:005688-UCD
DR   Wikidata; Q54778342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917799; Tln2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU439
AC   CVCL_NW64
SY   RRU439
DR   MMRRC; MMRRC:005689-UCD
DR   Wikidata; Q54778344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99173; Zfp26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU442
AC   CVCL_NW65
SY   RRU442
DR   MMRRC; MMRRC:005690-UCD
DR   Wikidata; Q54778345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102695; Ptprf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU445
AC   CVCL_NW66
SY   RRU445
DR   MMRRC; MMRRC:005693-UCD
DR   Wikidata; Q54778349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353557; Schip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU446
AC   CVCL_NW67
SY   RRU446
DR   MMRRC; MMRRC:005694-UCD
DR   Wikidata; Q54778351
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918850; Ythdf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU448
AC   CVCL_NW68
SY   RRU448
DR   MMRRC; MMRRC:005696-UCD
DR   Wikidata; Q54778353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344352; Dido1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU450
AC   CVCL_NW69
SY   RRU450
DR   MMRRC; MMRRC:005697-UCD
DR   Wikidata; Q54778355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU451
AC   CVCL_NW70
SY   RRU451
DR   MMRRC; MMRRC:005698-UCD
DR   Wikidata; Q54778356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98790; Top2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU453
AC   CVCL_NW71
SY   RRU453
DR   MMRRC; MMRRC:005699-UCD
DR   Wikidata; Q54778358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928469; Trip4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU456
AC   CVCL_NW72
SY   RRU456
DR   MMRRC; MMRRC:005700-UCD
DR   Wikidata; Q54778360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2652875; Wnk3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU458
AC   CVCL_NW73
SY   RRU458
DR   MMRRC; MMRRC:005701-UCD
DR   Wikidata; Q54778361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933972; Tra2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU459
AC   CVCL_NW74
SY   RRU459
DR   MMRRC; MMRRC:005702-UCD
DR   Wikidata; Q54778363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442220; Zfp182.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU462
AC   CVCL_NW75
SY   RRU462
DR   MMRRC; MMRRC:005704-UCD
DR   Wikidata; Q54778366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344349; Rnf216.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU465
AC   CVCL_NW76
SY   RRU465
DR   MMRRC; MMRRC:005706-UCD
DR   Wikidata; Q54778367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3650650; Zfp534.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU466
AC   CVCL_NW77
SY   RRU466
DR   MMRRC; MMRRC:005707-UCD
DR   Wikidata; Q54778369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446159; Itpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU468
AC   CVCL_NW78
SY   RRU468
DR   MMRRC; MMRRC:005708-UCD
DR   Wikidata; Q54778370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU469
AC   CVCL_NW79
SY   RRU469
DR   MMRRC; MMRRC:005709-UCD
DR   Wikidata; Q54778372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917856; Zfp398.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU470
AC   CVCL_NW80
SY   RRU470
DR   MMRRC; MMRRC:005710-UCD
DR   Wikidata; Q54778373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179288; Rttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU471
AC   CVCL_NW81
SY   RRU471
DR   MMRRC; MMRRC:005711-UCD
DR   Wikidata; Q54778375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU473
AC   CVCL_NW82
SY   RRU473
DR   MMRRC; MMRRC:005712-UCD
DR   Wikidata; Q54778377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913586; Cenpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU475
AC   CVCL_NW83
SY   RRU475
DR   MMRRC; MMRRC:005713-UCD
DR   Wikidata; Q54778379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442782; Baz2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU479
AC   CVCL_NW84
SY   RRU479
DR   MMRRC; MMRRC:005714-UCD
DR   Wikidata; Q54778381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914155; Plin3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU481
AC   CVCL_NW85
SY   RRU481
DR   MMRRC; MMRRC:005715-UCD
DR   Wikidata; Q54778384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888594; Icmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU483
AC   CVCL_NW86
SY   RRU483
DR   MMRRC; MMRRC:005716-UCD
DR   Wikidata; Q54778386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442377; Ipo11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU486
AC   CVCL_NW87
SY   RRU486
DR   MMRRC; MMRRC:005718-UCD
DR   Wikidata; Q54778388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338068; Pdpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU487
AC   CVCL_NW88
SY   RRU487
DR   MMRRC; MMRRC:005719-UCD
DR   Wikidata; Q54778389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU488
AC   CVCL_NW89
SY   RRU488
DR   MMRRC; MMRRC:005720-UCD
DR   Wikidata; Q54778391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107236; Lsg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU489
AC   CVCL_NW90
SY   RRU489
DR   MMRRC; MMRRC:005721-UCD
DR   Wikidata; Q54778392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138605; Rabif.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU493
AC   CVCL_NW91
SY   RRU493
DR   MMRRC; MMRRC:005723-UCD
DR   Wikidata; Q54778393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU496
AC   CVCL_NW92
SY   RRU496
DR   MMRRC; MMRRC:005724-UCD
DR   Wikidata; Q54778395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1340806; Parp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU497
AC   CVCL_NW93
SY   RRU497
DR   MMRRC; MMRRC:005725-UCD
DR   Wikidata; Q54778397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932404; Phip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU502
AC   CVCL_NW94
SY   RRU502
DR   MMRRC; MMRRC:005726-UCD
DR   Wikidata; Q54778399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU506
AC   CVCL_NW95
SY   RRU506
DR   MMRRC; MMRRC:005727-UCD
DR   Wikidata; Q54778401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914410; Eef1g.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU509
AC   CVCL_NW96
SY   RRU509
DR   MMRRC; MMRRC:005729-UCD
DR   Wikidata; Q54778404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:893577; Stx4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU513
AC   CVCL_NW97
SY   RRU513
DR   MMRRC; MMRRC:005730-UCD
DR   Wikidata; Q54778406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924054; Kdm4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU514
AC   CVCL_NW98
SY   RRU514
DR   MMRRC; MMRRC:005731-UCD
DR   Wikidata; Q54778407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916401; Lzic.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU515
AC   CVCL_NW99
SY   RRU515
DR   MMRRC; MMRRC:005732-UCD
DR   Wikidata; Q54778412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95742; Glo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU519
AC   CVCL_NX00
SY   RRU519
DR   MMRRC; MMRRC:005734-UCD
DR   Wikidata; Q54778413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933134; Tusc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU520
AC   CVCL_NX01
SY   RRU520
DR   MMRRC; MMRRC:005735-UCD
DR   Wikidata; Q54778414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU521
AC   CVCL_NX02
SY   RRU521
DR   MMRRC; MMRRC:005736-UCD
DR   Wikidata; Q54778416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106624; Myo9b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU528
AC   CVCL_NX03
SY   RRU528
DR   MMRRC; MMRRC:005739-UCD
DR   Wikidata; Q54778505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU529
AC   CVCL_NX04
SY   RRU529
DR   MMRRC; MMRRC:005740-UCD
DR   Wikidata; Q54778509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104517; Xrcc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU530
AC   CVCL_NX05
SY   RRU530
DR   MMRRC; MMRRC:005741-UCD
DR   Wikidata; Q54778511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU532
AC   CVCL_NX06
SY   RRU532
DR   MMRRC; MMRRC:005742-UCD
DR   Wikidata; Q54778512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU533
AC   CVCL_NX07
SY   RRU533
DR   MMRRC; MMRRC:005743-UCD
DR   Wikidata; Q54778515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915317; Mrnip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU537
AC   CVCL_NX08
SY   RRU537
DR   MMRRC; MMRRC:005745-UCD
DR   Wikidata; Q54778516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924705; Rlf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU538
AC   CVCL_NX09
SY   RRU538
DR   MMRRC; MMRRC:005746-UCD
DR   Wikidata; Q54778519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860197; Wdr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU542
AC   CVCL_NX10
SY   RRU542
DR   MMRRC; MMRRC:005747-UCD
DR   Wikidata; Q54778522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443805; Bnc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU543
AC   CVCL_NX11
SY   RRU543
DR   MMRRC; MMRRC:005748-UCD
DR   Wikidata; Q54778523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109519; Msh3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU544
AC   CVCL_NX12
SY   RRU544
DR   MMRRC; MMRRC:005749-UCD
DR   Wikidata; Q54778526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682937; Zfp341.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU546
AC   CVCL_NX13
SY   RRU546
DR   MMRRC; MMRRC:005750-UCD
DR   Wikidata; Q54778528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95781; Gnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU548
AC   CVCL_NX14
SY   RRU548
DR   MMRRC; MMRRC:005751-UCD
DR   Wikidata; Q54778529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU558
AC   CVCL_NX15
SY   RRU558
DR   MMRRC; MMRRC:005754-UCD
DR   Wikidata; Q54778531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098597; Ift81.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU563
AC   CVCL_NX16
SY   RRU563
DR   MMRRC; MMRRC:005755-UCD
DR   Wikidata; Q54778533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95286; Eed.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU566
AC   CVCL_NX17
SY   RRU566
DR   MMRRC; MMRRC:005757-UCD
DR   Wikidata; Q54778535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU568
AC   CVCL_NX18
SY   RRU568
DR   MMRRC; MMRRC:005758-UCD
DR   Wikidata; Q54778536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921633; Ubap2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU573
AC   CVCL_NX19
SY   RRU573
DR   MMRRC; MMRRC:005759-UCD
DR   Wikidata; Q54778538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU580
AC   CVCL_NX20
SY   RRU580
DR   MMRRC; MMRRC:005761-UCD
DR   Wikidata; Q54778541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385237; Aimp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU584
AC   CVCL_NX21
SY   RRU584
DR   MMRRC; MMRRC:005762-UCD
DR   Wikidata; Q54778542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU590
AC   CVCL_NX22
SY   RRU590
DR   MMRRC; MMRRC:005766-UCD
DR   Wikidata; Q54778544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916977; Usp46.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU591
AC   CVCL_NX23
SY   RRU591
DR   MMRRC; MMRRC:005767-UCD
DR   Wikidata; Q54778545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931237; Wwox.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU593
AC   CVCL_NX24
SY   RRU593
DR   MMRRC; MMRRC:005768-UCD
DR   Wikidata; Q54778547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919782; Sap130.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU598
AC   CVCL_NX25
SY   RRU598
DR   MMRRC; MMRRC:005769-UCD
DR   Wikidata; Q54778551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384569; Klhdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU602
AC   CVCL_NX26
SY   RRU602
DR   MMRRC; MMRRC:005771-UCD
DR   Wikidata; Q54778552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353427; Eif2ak4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU608
AC   CVCL_NX27
SY   RRU608
DR   MMRRC; MMRRC:005772-UCD
DR   Wikidata; Q54778554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919016; Raver1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU609
AC   CVCL_NX28
SY   RRU609
DR   MMRRC; MMRRC:005773-UCD
DR   Wikidata; Q54778556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919016; Raver1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU613
AC   CVCL_NX29
SY   RRU613
DR   MMRRC; MMRRC:005774-UCD
DR   Wikidata; Q54778558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916411; Manbal.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU615
AC   CVCL_NX30
SY   RRU615
DR   MMRRC; MMRRC:005775-UCD
DR   Wikidata; Q54778560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923159; Vmp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU618
AC   CVCL_NX31
SY   RRU618
DR   MMRRC; MMRRC:005776-UCD
DR   Wikidata; Q54778563
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU620
AC   CVCL_NX32
SY   RRU620
DR   MMRRC; MMRRC:005777-UCD
DR   Wikidata; Q54778564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU621
AC   CVCL_NX33
SY   RRU621
DR   MMRRC; MMRRC:005778-UCD
DR   Wikidata; Q54778566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914172; Rras2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU622
AC   CVCL_NX34
SY   RRU622
DR   MMRRC; MMRRC:005779-UCD
DR   Wikidata; Q54778567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182543; Grhl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU623
AC   CVCL_NX35
SY   RRU623
DR   MMRRC; MMRRC:005780-UCD
DR   Wikidata; Q54778570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913833; Exosc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU624
AC   CVCL_NX36
SY   RRU624
DR   MMRRC; MMRRC:005781-UCD
DR   Wikidata; Q54778571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU628
AC   CVCL_NX37
SY   RRU628
DR   MMRRC; MMRRC:005783-UCD
DR   Wikidata; Q54778572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU629
AC   CVCL_NX38
SY   RRU629
DR   MMRRC; MMRRC:005784-UCD
DR   Wikidata; Q54778574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341200; Pwp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU630
AC   CVCL_NX39
SY   RRU630
DR   MMRRC; MMRRC:005785-UCD
DR   Wikidata; Q54778576
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145425; Depdc1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU634
AC   CVCL_NX40
SY   RRU634
DR   MMRRC; MMRRC:005787-UCD
DR   Wikidata; Q54778579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU637
AC   CVCL_NX41
SY   RRU637
DR   MMRRC; MMRRC:005788-UCD
DR   Wikidata; Q54778580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918079; Ccdc93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU643
AC   CVCL_NX42
SY   RRU643
DR   MMRRC; MMRRC:005791-UCD
DR   Wikidata; Q54778582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915229; Atad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU646
AC   CVCL_NX43
SY   RRU646
DR   MMRRC; MMRRC:005792-UCD
DR   Wikidata; Q54778677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444304; Vps13a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU647
AC   CVCL_NX44
SY   RRU647
DR   MMRRC; MMRRC:005793-UCD
DR   Wikidata; Q54778679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929215; Vps41.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU652
AC   CVCL_NX45
SY   RRU652
DR   MMRRC; MMRRC:005796-UCD
DR   Wikidata; Q54778682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385325; Pnpla7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU653
AC   CVCL_NX46
SY   RRU653
DR   MMRRC; MMRRC:005797-UCD
DR   Wikidata; Q54778683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109352; Ung.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU661
AC   CVCL_NX47
SY   RRU661
DR   MMRRC; MMRRC:005799-UCD
DR   Wikidata; Q54778684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353606; Siva1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU665
AC   CVCL_NX48
SY   RRU665
DR   MMRRC; MMRRC:005800-UCD
DR   Wikidata; Q54778685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141505; Parp11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU666
AC   CVCL_NX49
SY   RRU666
DR   MMRRC; MMRRC:005801-UCD
DR   Wikidata; Q54778686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351656; Abcf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU668
AC   CVCL_NX50
SY   RRU668
DR   MMRRC; MMRRC:005802-UCD
DR   Wikidata; Q54778688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRU671
AC   CVCL_NX51
SY   RRU671
DR   MMRRC; MMRRC:005803-UCD
DR   Wikidata; Q54778690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681271; Pigl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX012
AC   CVCL_NX52
SY   RRX012
DR   MMRRC; MMRRC:005804-UCD
DR   Wikidata; Q54778692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX032
AC   CVCL_NX53
SY   RRX032
DR   MMRRC; MMRRC:005808-UCD
DR   Wikidata; Q54778695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916241; Ssu72.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX045
AC   CVCL_NX54
SY   RRX045
DR   MMRRC; MMRRC:005809-UCD
DR   Wikidata; Q54778697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444918; Fbxo46.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX055
AC   CVCL_NX55
SY   RRX055
DR   MMRRC; MMRRC:005810-UCD
DR   Wikidata; Q54778698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109336; Etv6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX057
AC   CVCL_NX56
SY   RRX057
DR   MMRRC; MMRRC:005811-UCD
DR   Wikidata; Q54778700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX078
AC   CVCL_NX57
SY   RRX078
DR   MMRRC; MMRRC:005815-UCD
DR   Wikidata; Q54778702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915205; Sugt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX082
AC   CVCL_NX58
SY   RRX082
DR   MMRRC; MMRRC:005816-UCD
DR   Wikidata; Q54778704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103257; Inpp5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX085
AC   CVCL_NX59
SY   RRX085
DR   MMRRC; MMRRC:005818-UCD
DR   Wikidata; Q54778705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104899; Mob4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX108
AC   CVCL_NX60
SY   RRX108
DR   MMRRC; MMRRC:010232-UCD
DR   Wikidata; Q54778706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137512; Arid4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX115
AC   CVCL_NX61
SY   RRX115
DR   MMRRC; MMRRC:010233-UCD
DR   Wikidata; Q54778709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442184; Flcn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX123
AC   CVCL_NX62
SY   RRX123
DR   MMRRC; MMRRC:010235-UCD
DR   Wikidata; Q54778712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277223; Atxn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX125
AC   CVCL_NX63
SY   RRX125
DR   MMRRC; MMRRC:010236-UCD
DR   Wikidata; Q54778714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX127
AC   CVCL_NX64
SY   RRX127
DR   MMRRC; MMRRC:010237-UCD
DR   Wikidata; Q54778715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313291; Vezf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX130
AC   CVCL_NX65
SY   RRX130
DR   MMRRC; MMRRC:010238-UCD
DR   Wikidata; Q54778718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313302; Cenpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX136
AC   CVCL_NX66
SY   RRX136
DR   MMRRC; MMRRC:010239-UCD
DR   Wikidata; Q54778720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX137
AC   CVCL_NX67
SY   RRX137
DR   MMRRC; MMRRC:010240-UCD
DR   Wikidata; Q54778722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859661; Atp11c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX144
AC   CVCL_NX68
SY   RRX144
DR   MMRRC; MMRRC:010241-UCD
DR   Wikidata; Q54778723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95792; Got2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX150
AC   CVCL_NX69
SY   RRX150
DR   MMRRC; MMRRC:010242-UCD
DR   Wikidata; Q54778728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685992; Bclaf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX154
AC   CVCL_NX70
SY   RRX154
DR   MMRRC; MMRRC:010244-UCD
DR   Wikidata; Q54778729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922312; Sf3a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX169
AC   CVCL_NX71
SY   RRX169
DR   MMRRC; MMRRC:010245-UCD
DR   Wikidata; Q54778730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99887; Pitpna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX193
AC   CVCL_NX72
SY   RRX193
DR   MMRRC; MMRRC:010248-UCD
DR   Wikidata; Q54778731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919765; Wdr43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX302
AC   CVCL_NX73
SY   RRX302
DR   MMRRC; MMRRC:010249-UCD
DR   Wikidata; Q54778733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203484; Zfp638.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX310
AC   CVCL_NX74
SY   RRX310
DR   MMRRC; MMRRC:010250-UCD
DR   Wikidata; Q54778736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926967; Hsd17b12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX325
AC   CVCL_NX75
SY   RRX325
DR   MMRRC; MMRRC:010253-UCD
DR   Wikidata; Q54778738
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136825; N4bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX337
AC   CVCL_NX76
SY   RRX337
DR   MMRRC; MMRRC:010255-UCD
DR   Wikidata; Q54778741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924367; Zfp934.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX343
AC   CVCL_NX77
SY   RRX343
DR   MMRRC; MMRRC:010256-UCD
DR   Wikidata; Q54778743
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700009; Sh3gl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX347
AC   CVCL_NX78
SY   RRX347
DR   MMRRC; MMRRC:010257-UCD
DR   Wikidata; Q54778746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916338; Snapc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX349
AC   CVCL_NX79
SY   RRX349
DR   MMRRC; MMRRC:010258-UCD
DR   Wikidata; Q54778747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352501; Bcar3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX350
AC   CVCL_NX80
SY   RRX350
DR   MMRRC; MMRRC:010259-UCD
DR   Wikidata; Q54778748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102706; Fdft1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX352
AC   CVCL_NX81
SY   RRX352
DR   MMRRC; MMRRC:010260-UCD
DR   Wikidata; Q54778751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX358
AC   CVCL_NX82
SY   RRX358
DR   MMRRC; MMRRC:010261-UCD
DR   Wikidata; Q54778754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914320; Lsm14a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX365
AC   CVCL_NX83
SY   RRX365
DR   MMRRC; MMRRC:010263-UCD
DR   Wikidata; Q54778807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX366
AC   CVCL_NX84
SY   RRX366
DR   MMRRC; MMRRC:010264-UCD
DR   Wikidata; Q54778809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRX375
AC   CVCL_NX85
SY   RRX375
DR   MMRRC; MMRRC:010265-UCD
DR   Wikidata; Q54778811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385071; Etf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY002
AC   CVCL_NX86
SY   RRY002
DR   MMRRC; MMRRC:005819-UCD
DR   Wikidata; Q54778814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914037; Gskip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY010
AC   CVCL_NX87
SY   RRY010
DR   MMRRC; MMRRC:005821-UCD
DR   Wikidata; Q54778816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109547; Dnm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY017
AC   CVCL_NX88
SY   RRY017
DR   MMRRC; MMRRC:005822-UCD
DR   Wikidata; Q54778817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926079; Tsc22d4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY030
AC   CVCL_NX89
SY   RRY030
DR   MMRRC; MMRRC:005823-UCD
DR   Wikidata; Q54778818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY050
AC   CVCL_NX90
SY   RRY050
DR   MMRRC; MMRRC:005825-UCD
DR   Wikidata; Q54778819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929282; Ptges3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY059
AC   CVCL_NX91
SY   RRY059
DR   MMRRC; MMRRC:005826-UCD
DR   Wikidata; Q54778823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923784; Osbpl9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY061
AC   CVCL_NX92
SY   RRY061
DR   MMRRC; MMRRC:005827-UCD
DR   Wikidata; Q54778825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100846; Med1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY066
AC   CVCL_NX93
SY   RRY066
DR   MMRRC; MMRRC:005828-UCD
DR   Wikidata; Q54778826
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145645; Exoc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY069
AC   CVCL_NX94
SY   RRY069
DR   MMRRC; MMRRC:005830-UCD
DR   Wikidata; Q54778829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919891; Mob2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY071
AC   CVCL_NX95
SY   RRY071
DR   MMRRC; MMRRC:005831-UCD
DR   Wikidata; Q54778830
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107716; Myo10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY091
AC   CVCL_NX96
SY   RRY091
DR   MMRRC; MMRRC:005833-UCD
DR   Wikidata; Q54778832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445019; Pik3c3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY092
AC   CVCL_NX97
SY   RRY092
DR   MMRRC; MMRRC:005834-UCD
DR   Wikidata; Q54778834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384560; Aars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY104
AC   CVCL_NX98
SY   RRY104
DR   MMRRC; MMRRC:005836-UCD
DR   Wikidata; Q54778836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916378; Zfp507.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY107
AC   CVCL_NX99
SY   RRY107
DR   MMRRC; MMRRC:005837-UCD
DR   Wikidata; Q54778840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915723; Mob1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY115
AC   CVCL_NY00
SY   RRY115
DR   MMRRC; MMRRC:005839-UCD
DR   Wikidata; Q54778841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859730; Sh3glb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY122
AC   CVCL_NY01
SY   RRY122
DR   MMRRC; MMRRC:005840-UCD
DR   Wikidata; Q54778845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914917; Alkbh8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY128
AC   CVCL_NY02
SY   RRY128
DR   MMRRC; MMRRC:005841-UCD
DR   Wikidata; Q54778846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY132
AC   CVCL_NY03
SY   RRY132
DR   MMRRC; MMRRC:005842-UCD
DR   Wikidata; Q54778848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY135
AC   CVCL_NY04
SY   RRY135
DR   MMRRC; MMRRC:005843-UCD
DR   Wikidata; Q54778849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104537; Brca1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY138
AC   CVCL_NY05
SY   RRY138
DR   MMRRC; MMRRC:005845-UCD
DR   Wikidata; Q54778851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2177178; Dicer1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY145
AC   CVCL_NY06
SY   RRY145
DR   MMRRC; MMRRC:005847-UCD
DR   Wikidata; Q54778854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY156
AC   CVCL_NY07
SY   RRY156
DR   MMRRC; MMRRC:005848-UCD
DR   Wikidata; Q54778856
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm2393 (MGI:3780561) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRY158
AC   CVCL_NY08
SY   RRY158
DR   MMRRC; MMRRC:005849-UCD
DR   Wikidata; Q54778858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY175
AC   CVCL_NY09
SY   RRY175
DR   MMRRC; MMRRC:005850-UCD
DR   Wikidata; Q54778860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104652; Capzb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY178
AC   CVCL_NY10
SY   RRY178
DR   MMRRC; MMRRC:005852-UCD
DR   Wikidata; Q54778862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103202; Adsl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY179
AC   CVCL_NY11
SY   RRY179
DR   MMRRC; MMRRC:005853-UCD
DR   Wikidata; Q54778865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925836; Srbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY185
AC   CVCL_NY12
SY   RRY185
DR   MMRRC; MMRRC:005854-UCD
DR   Wikidata; Q54778866
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY208
AC   CVCL_NY13
SY   RRY208
DR   MMRRC; MMRRC:005857-UCD
DR   Wikidata; Q54778870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95281; Ect2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY209
AC   CVCL_NY14
SY   RRY209
DR   MMRRC; MMRRC:005858-UCD
DR   Wikidata; Q54778871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141161; Tyw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY210
AC   CVCL_NY15
SY   RRY210
DR   MMRRC; MMRRC:005859-UCD
DR   Wikidata; Q54778876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY226
AC   CVCL_NY16
SY   RRY226
DR   MMRRC; MMRRC:005860-UCD
DR   Wikidata; Q54778877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY240
AC   CVCL_NY17
SY   RRY240
DR   MMRRC; MMRRC:005861-UCD
DR   Wikidata; Q54778880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670178; Med13l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY250
AC   CVCL_NY18
SY   RRY250
DR   MMRRC; MMRRC:005863-UCD
DR   Wikidata; Q54778881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918625; Foxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY252
AC   CVCL_NY19
SY   RRY252
DR   MMRRC; MMRRC:005864-UCD
DR   Wikidata; Q54778882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923012; Aftph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY257
AC   CVCL_NY20
SY   RRY257
DR   MMRRC; MMRRC:005865-UCD
DR   Wikidata; Q54778883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354949; Dlc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY261
AC   CVCL_NY21
SY   RRY261
DR   MMRRC; MMRRC:005866-UCD
DR   Wikidata; Q54778885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101934; Tfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY262
AC   CVCL_NY22
SY   RRY262
DR   MMRRC; MMRRC:005867-UCD
DR   Wikidata; Q54778888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923864; Immt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY264
AC   CVCL_NY23
SY   RRY264
DR   MMRRC; MMRRC:005868-UCD
DR   Wikidata; Q54778928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914638; Rab5if.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRY265
AC   CVCL_NY24
SY   RRY265
DR   MMRRC; MMRRC:005869-UCD
DR   Wikidata; Q54778931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927616; Trps1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY272
AC   CVCL_NY25
SY   RRY272
DR   MMRRC; MMRRC:005870-UCD
DR   Wikidata; Q54778933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138327; Phlpp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY275
AC   CVCL_NY26
SY   RRY275
DR   MMRRC; MMRRC:005872-UCD
DR   Wikidata; Q54778934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913748; Dda1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY279
AC   CVCL_NY27
SY   RRY279
DR   MMRRC; MMRRC:005873-UCD
DR   Wikidata; Q54778936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442860; Eda2r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY282
AC   CVCL_NY28
SY   RRY282
DR   MMRRC; MMRRC:005874-UCD
DR   Wikidata; Q54778938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384569; Klhdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY310
AC   CVCL_NY29
SY   RRY310
DR   MMRRC; MMRRC:005875-UCD
DR   Wikidata; Q54778939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443034; Mtmr12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY338
AC   CVCL_NY30
SY   RRY338
DR   MMRRC; MMRRC:005877-UCD
DR   Wikidata; Q54778942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277958; Pcm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY352
AC   CVCL_NY31
SY   RRY352
DR   MMRRC; MMRRC:005878-UCD
DR   Wikidata; Q54778945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136459; Cdc42bpb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY357
AC   CVCL_NY32
SY   RRY357
DR   MMRRC; MMRRC:005879-UCD
DR   Wikidata; Q54778947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180003; Xpnpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY361
AC   CVCL_NY33
SY   RRY361
DR   MMRRC; MMRRC:005880-UCD
DR   Wikidata; Q54778950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107532; Kpnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY372
AC   CVCL_NY34
SY   RRY372
DR   MMRRC; MMRRC:005881-UCD
DR   Wikidata; Q54778952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3647820; Hectd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY376
AC   CVCL_NY35
SY   RRY376
DR   MMRRC; MMRRC:005882-UCD
DR   Wikidata; Q54778954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3046173; Nup85.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY379
AC   CVCL_NY36
SY   RRY379
DR   MMRRC; MMRRC:005884-UCD
DR   Wikidata; Q54778956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444268; Fam169a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY414
AC   CVCL_NY37
SY   RRY414
DR   MMRRC; MMRRC:005887-UCD
DR   Wikidata; Q54778958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353561; Vapa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY420
AC   CVCL_NY38
SY   RRY420
DR   MMRRC; MMRRC:005888-UCD
DR   Wikidata; Q54778961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95886; H13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY422
AC   CVCL_NY39
SY   RRY422
DR   MMRRC; MMRRC:005889-UCD
DR   Wikidata; Q54778964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95886; H13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY429
AC   CVCL_NY40
SY   RRY429
DR   MMRRC; MMRRC:005890-UCD
DR   Wikidata; Q54778966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY441
AC   CVCL_NY41
SY   RRY441
DR   MMRRC; MMRRC:005891-UCD
DR   Wikidata; Q54778968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100863; Kpna3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY446
AC   CVCL_NY42
SY   RRY446
DR   MMRRC; MMRRC:005892-UCD
DR   Wikidata; Q54778970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY454
AC   CVCL_NY43
SY   RRY454
DR   MMRRC; MMRRC:005893-UCD
DR   Wikidata; Q54778972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY459
AC   CVCL_NY44
SY   RRY459
DR   MMRRC; MMRRC:005895-UCD
DR   Wikidata; Q54778973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347488; Foxk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY463
AC   CVCL_NY45
SY   RRY463
DR   MMRRC; MMRRC:005896-UCD
DR   Wikidata; Q54778975
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336172; Tbl1x.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY465
AC   CVCL_NY46
SY   RRY465
DR   MMRRC; MMRRC:005897-UCD
DR   Wikidata; Q54778977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923661; Ift43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY470
AC   CVCL_NY47
SY   RRY470
DR   MMRRC; MMRRC:005898-UCD
DR   Wikidata; Q54778979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100863; Kpna3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY476
AC   CVCL_NY48
SY   RRY476
DR   MMRRC; MMRRC:005899-UCD
DR   Wikidata; Q54778981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441856; Sf3b2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY490
AC   CVCL_NY49
SY   RRY490
DR   MMRRC; MMRRC:005901-UCD
DR   Wikidata; Q54778982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445107; Tmem245.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY492
AC   CVCL_NY50
SY   RRY492
DR   MMRRC; MMRRC:005902-UCD
DR   Wikidata; Q54778985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917866; Sugp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY496
AC   CVCL_NY51
SY   RRY496
DR   MMRRC; MMRRC:005903-UCD
DR   Wikidata; Q54778986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY535
AC   CVCL_NY52
SY   RRY535
DR   MMRRC; MMRRC:005904-UCD
DR   Wikidata; Q54778988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441730; Tbl1xr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY540
AC   CVCL_NY53
SY   RRY540
DR   MMRRC; MMRRC:005905-UCD
DR   Wikidata; Q54778990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349475; Ppp2r5c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY563
AC   CVCL_NY54
SY   RRY563
DR   MMRRC; MMRRC:005907-UCD
DR   Wikidata; Q54778991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136459; Cdc42bpb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY566
AC   CVCL_NY55
SY   RRY566
DR   MMRRC; MMRRC:005908-UCD
DR   Wikidata; Q54778994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY581
AC   CVCL_NY56
SY   RRY581
DR   MMRRC; MMRRC:005909-UCD
DR   Wikidata; Q54778997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY587
AC   CVCL_NY57
SY   RRY587
DR   MMRRC; MMRRC:005910-UCD
DR   Wikidata; Q54778998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919293; Sulf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRY604
AC   CVCL_NY58
SY   RRY604
DR   MMRRC; MMRRC:005912-UCD
DR   Wikidata; Q54779000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ003
AC   CVCL_NY59
SY   RRZ003
DR   MMRRC; MMRRC:005913-UCD
DR   Wikidata; Q54779002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349427; Exo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ009
AC   CVCL_NY60
SY   RRZ009
DR   MMRRC; MMRRC:005915-UCD
DR   Wikidata; Q54779003
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442355; Kdm4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ011
AC   CVCL_NY61
SY   RRZ011
DR   MMRRC; MMRRC:005916-UCD
DR   Wikidata; Q54779005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101785; Mybl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ012
AC   CVCL_NY62
SY   RRZ012
DR   MMRRC; MMRRC:005917-UCD
DR   Wikidata; Q54779007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107412; Ube2e3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ018
AC   CVCL_NY63
SY   RRZ018
DR   MMRRC; MMRRC:005918-UCD
DR   Wikidata; Q54779056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923257; Zmym2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ021
AC   CVCL_NY64
SY   RRZ021
DR   MMRRC; MMRRC:005919-UCD
DR   Wikidata; Q54779057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3694697; Mfap1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ026
AC   CVCL_NY65
SY   RRZ026
DR   MMRRC; MMRRC:005921-UCD
DR   Wikidata; Q54779058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ027
AC   CVCL_NY66
SY   RRZ027
DR   MMRRC; MMRRC:005922-UCD
DR   Wikidata; Q54779059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344406; Ptpn21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ028
AC   CVCL_NY67
SY   RRZ028
DR   MMRRC; MMRRC:005923-UCD
DR   Wikidata; Q54779061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ035
AC   CVCL_NY68
SY   RRZ035
DR   MMRRC; MMRRC:005926-UCD
DR   Wikidata; Q54779063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450151; Cog3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ039
AC   CVCL_NY69
SY   RRZ039
DR   MMRRC; MMRRC:005927-UCD
DR   Wikidata; Q54779065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98341; Snrnp70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ048
AC   CVCL_NY70
SY   RRZ048
DR   MMRRC; MMRRC:005928-UCD
DR   Wikidata; Q54779068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919792; Pgam5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ054
AC   CVCL_NY71
SY   RRZ054
DR   MMRRC; MMRRC:005929-UCD
DR   Wikidata; Q54779069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ062
AC   CVCL_NY72
SY   RRZ062
DR   MMRRC; MMRRC:005931-UCD
DR   Wikidata; Q54779071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346858; Mapk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ071
AC   CVCL_NY73
SY   RRZ071
DR   MMRRC; MMRRC:005933-UCD
DR   Wikidata; Q54779073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ074
AC   CVCL_NY74
SY   RRZ074
DR   MMRRC; MMRRC:005934-UCD
DR   Wikidata; Q54779074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915783; Mphosph6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ080
AC   CVCL_NY75
SY   RRZ080
DR   MMRRC; MMRRC:005936-UCD
DR   Wikidata; Q54779076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ090
AC   CVCL_NY76
SY   RRZ090
DR   MMRRC; MMRRC:005937-UCD
DR   Wikidata; Q54779077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384863; Tbl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ092
AC   CVCL_NY77
SY   RRZ092
DR   MMRRC; MMRRC:005938-UCD
DR   Wikidata; Q54779081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442653; Rbm48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ100
AC   CVCL_NY78
SY   RRZ100
DR   MMRRC; MMRRC:005939-UCD
DR   Wikidata; Q54779083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ103
AC   CVCL_NY79
SY   RRZ103
DR   MMRRC; MMRRC:005940-UCD
DR   Wikidata; Q54779084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151152; Baz2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ104
AC   CVCL_NY80
SY   RRZ104
DR   MMRRC; MMRRC:005941-UCD
DR   Wikidata; Q54779088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917606; St13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ105
AC   CVCL_NY81
SY   RRZ105
DR   MMRRC; MMRRC:005942-UCD
DR   Wikidata; Q54779089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147538; Btaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ115
AC   CVCL_NY82
SY   RRZ115
DR   MMRRC; MMRRC:005943-UCD
DR   Wikidata; Q54779090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ121
AC   CVCL_NY83
SY   RRZ121
DR   MMRRC; MMRRC:005944-UCD
DR   Wikidata; Q54779094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098231; Kif11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ124
AC   CVCL_NY84
SY   RRZ124
DR   MMRRC; MMRRC:005945-UCD
DR   Wikidata; Q54779095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109369; Hp1bp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ132
AC   CVCL_NY85
SY   RRZ132
DR   MMRRC; MMRRC:005946-UCD
DR   Wikidata; Q54779097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039623; Thada.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ134
AC   CVCL_NY86
SY   RRZ134
DR   MMRRC; MMRRC:005947-UCD
DR   Wikidata; Q54779100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103067; Atrx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ138
AC   CVCL_NY87
SY   RRZ138
DR   MMRRC; MMRRC:005948-UCD
DR   Wikidata; Q54779101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ141
AC   CVCL_NY88
SY   RRZ141
DR   MMRRC; MMRRC:005949-UCD
DR   Wikidata; Q54779103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ148
AC   CVCL_NY89
SY   RRZ148
DR   MMRRC; MMRRC:005950-UCD
DR   Wikidata; Q54779105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384879; Prmt7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ150
AC   CVCL_NY90
SY   RRZ150
DR   MMRRC; MMRRC:005951-UCD
DR   Wikidata; Q54779107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915020; Caap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ154
AC   CVCL_NY91
SY   RRZ154
DR   MMRRC; MMRRC:005952-UCD
DR   Wikidata; Q54779111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351655; Shroom3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ155
AC   CVCL_NY92
SY   RRZ155
DR   MMRRC; MMRRC:005953-UCD
DR   Wikidata; Q54779113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103040; Rsu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ161
AC   CVCL_NY93
SY   RRZ161
DR   MMRRC; MMRRC:005954-UCD
DR   Wikidata; Q54779117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88393; Chd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ163
AC   CVCL_NY94
SY   RRZ163
DR   MMRRC; MMRRC:005955-UCD
DR   Wikidata; Q54779118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924992; Fbxo42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ178
AC   CVCL_NY95
SY   RRZ178
DR   MMRRC; MMRRC:005956-UCD
DR   Wikidata; Q54779121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ184
AC   CVCL_NY96
SY   RRZ184
DR   MMRRC; MMRRC:005957-UCD
DR   Wikidata; Q54779123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ194
AC   CVCL_NY97
SY   RRZ194
DR   MMRRC; MMRRC:005958-UCD
DR   Wikidata; Q54779125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914632; Brd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ199
AC   CVCL_NY98
SY   RRZ199
DR   MMRRC; MMRRC:005959-UCD
DR   Wikidata; Q54779126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ200
AC   CVCL_NY99
SY   RRZ200
DR   MMRRC; MMRRC:005960-UCD
DR   Wikidata; Q54779128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915283; Cox19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ211
AC   CVCL_NZ00
SY   RRZ211
DR   MMRRC; MMRRC:005962-UCD
DR   Wikidata; Q54779131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88192; Smarca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ224
AC   CVCL_NZ01
SY   RRZ224
DR   MMRRC; MMRRC:005964-UCD
DR   Wikidata; Q54779132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923206; Srrm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ226
AC   CVCL_NZ02
SY   RRZ226
DR   MMRRC; MMRRC:005965-UCD
DR   Wikidata; Q54779134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921584; Ranbp10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ227
AC   CVCL_NZ03
SY   RRZ227
DR   MMRRC; MMRRC:005966-UCD
DR   Wikidata; Q54779183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103071; Rangap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ229
AC   CVCL_NZ04
SY   RRZ229
DR   MMRRC; MMRRC:005967-UCD
DR   Wikidata; Q54779185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146974; Safb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ232
AC   CVCL_NZ05
SY   RRZ232
DR   MMRRC; MMRRC:005968-UCD
DR   Wikidata; Q54779186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ233
AC   CVCL_NZ06
SY   RRZ233
DR   MMRRC; MMRRC:005969-UCD
DR   Wikidata; Q54779188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914247; Psmd12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ234
AC   CVCL_NZ07
SY   RRZ234
DR   MMRRC; MMRRC:005970-UCD
DR   Wikidata; Q54779191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917275; Acot7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ235
AC   CVCL_NZ08
SY   RRZ235
DR   MMRRC; MMRRC:005971-UCD
DR   Wikidata; Q54779192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918052; Pwwp2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ243
AC   CVCL_NZ09
SY   RRZ243
DR   MMRRC; MMRRC:005972-UCD
DR   Wikidata; Q54779194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429770; Nle1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ246
AC   CVCL_NZ10
SY   RRZ246
DR   MMRRC; MMRRC:005974-UCD
DR   Wikidata; Q54779198
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914440; Eif4e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ249
AC   CVCL_NZ11
SY   RRZ249
DR   MMRRC; MMRRC:005975-UCD
DR   Wikidata; Q54779201
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927479; Sap30bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ253
AC   CVCL_NZ12
SY   RRZ253
DR   MMRRC; MMRRC:005976-UCD
DR   Wikidata; Q54779203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ254
AC   CVCL_NZ13
SY   RRZ254
DR   MMRRC; MMRRC:005977-UCD
DR   Wikidata; Q54779206
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858730; Vamp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ260
AC   CVCL_NZ14
SY   RRZ260
DR   MMRRC; MMRRC:005978-UCD
DR   Wikidata; Q54779207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3026886; Cdin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRZ266
AC   CVCL_NZ15
SY   RRZ266
DR   MMRRC; MMRRC:005979-UCD
DR   Wikidata; Q54779209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103239; Tfap4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ268
AC   CVCL_NZ16
SY   RRZ268
DR   MMRRC; MMRRC:005980-UCD
DR   Wikidata; Q54779211
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917623; Gpatch2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ274
AC   CVCL_NZ17
SY   RRZ274
DR   MMRRC; MMRRC:005982-UCD
DR   Wikidata; Q54779212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347094; Parg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ280
AC   CVCL_NZ18
SY   RRZ280
DR   MMRRC; MMRRC:005983-UCD
DR   Wikidata; Q54779214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137379; Med15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ287
AC   CVCL_NZ19
SY   RRZ287
DR   MMRRC; MMRRC:005984-UCD
DR   Wikidata; Q54779216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137379; Med15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ288
AC   CVCL_NZ20
SY   RRZ288
DR   MMRRC; MMRRC:005985-UCD
DR   Wikidata; Q54779217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106908; Srpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ296
AC   CVCL_NZ21
SY   RRZ296
DR   MMRRC; MMRRC:005986-UCD
DR   Wikidata; Q54779220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144726; Tmem11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ298
AC   CVCL_NZ22
SY   RRZ298
DR   MMRRC; MMRRC:005987-UCD
DR   Wikidata; Q54779222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97542; Pepd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ301
AC   CVCL_NZ23
SY   RRZ301
DR   MMRRC; MMRRC:005988-UCD
DR   Wikidata; Q54779223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ307
AC   CVCL_NZ24
SY   RRZ307
DR   MMRRC; MMRRC:005990-UCD
DR   Wikidata; Q54779225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346858; Mapk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ315
AC   CVCL_NZ25
SY   RRZ315
DR   MMRRC; MMRRC:005991-UCD
DR   Wikidata; Q54779227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917600; Basp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ316
AC   CVCL_NZ26
SY   RRZ316
DR   MMRRC; MMRRC:005992-UCD
DR   Wikidata; Q54779229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197514; Pole2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ326
AC   CVCL_NZ27
SY   RRZ326
DR   MMRRC; MMRRC:005994-UCD
DR   Wikidata; Q54779231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98341; Snrnp70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ340
AC   CVCL_NZ28
SY   RRZ340
DR   MMRRC; MMRRC:005995-UCD
DR   Wikidata; Q54779232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144423; Arhgap44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ363
AC   CVCL_NZ29
SY   RRZ363
DR   MMRRC; MMRRC:005996-UCD
DR   Wikidata; Q54779234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104860; Fxr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ384
AC   CVCL_NZ30
SY   RRZ384
DR   MMRRC; MMRRC:005998-UCD
DR   Wikidata; Q54779235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145895; Slc38a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ410
AC   CVCL_NZ31
SY   RRZ410
DR   MMRRC; MMRRC:005999-UCD
DR   Wikidata; Q54779237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3588234; 9630014M24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ425
AC   CVCL_NZ32
SY   RRZ425
DR   MMRRC; MMRRC:006002-UCD
DR   Wikidata; Q54779239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921537; Kcmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ433
AC   CVCL_NZ33
SY   RRZ433
DR   MMRRC; MMRRC:006003-UCD
DR   Wikidata; Q54779242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923802; Plekha5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ438
AC   CVCL_NZ34
SY   RRZ438
DR   MMRRC; MMRRC:006004-UCD
DR   Wikidata; Q54779243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ449
AC   CVCL_NZ35
SY   RRZ449
DR   MMRRC; MMRRC:006005-UCD
DR   Wikidata; Q54779246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109242; Spin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ462
AC   CVCL_NZ36
SY   RRZ462
DR   MMRRC; MMRRC:006006-UCD
DR   Wikidata; Q54779248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924933; Ehmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ491
AC   CVCL_NZ37
SY   RRZ491
DR   MMRRC; MMRRC:006007-UCD
DR   Wikidata; Q54779252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ501
AC   CVCL_NZ38
SY   RRZ501
DR   MMRRC; MMRRC:010266-UCD
DR   Wikidata; Q54779253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105072; Rab22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ506
AC   CVCL_NZ39
SY   RRZ506
DR   MMRRC; MMRRC:010267-UCD
DR   Wikidata; Q54779255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859920; Ebag9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ508
AC   CVCL_NZ40
SY   RRZ508
DR   MMRRC; MMRRC:010268-UCD
DR   Wikidata; Q54779258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3042273; Nsfl1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ510
AC   CVCL_NZ41
SY   RRZ510
DR   MMRRC; MMRRC:010269-UCD
DR   Wikidata; Q54779260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444401; Snrnp200.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ512
AC   CVCL_NZ42
SY   RRZ512
DR   MMRRC; MMRRC:010270-UCD
DR   Wikidata; Q54779263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143977; Mbtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ528
AC   CVCL_NZ43
SY   RRZ528
DR   MMRRC; MMRRC:010274-UCD
DR   Wikidata; Q54779348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107889; Exosc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ557
AC   CVCL_NZ44
SY   RRZ557
DR   MMRRC; MMRRC:010280-UCD
DR   Wikidata; Q54779350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194492; Hdgfl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ563
AC   CVCL_NZ45
SY   RRZ563
DR   MMRRC; MMRRC:010281-UCD
DR   Wikidata; Q54779353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926231; Tdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ573
AC   CVCL_NZ46
SY   RRZ573
DR   MMRRC; MMRRC:010283-UCD
DR   Wikidata; Q54779356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334460; Bop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ579
AC   CVCL_NZ47
SY   RRZ579
DR   MMRRC; MMRRC:010285-UCD
DR   Wikidata; Q54779357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328362; Blm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ586
AC   CVCL_NZ48
SY   RRZ586
DR   MMRRC; MMRRC:010286-UCD
DR   Wikidata; Q54779358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924053; Zfp998.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RRZ587
AC   CVCL_NZ49
SY   RRZ587
DR   MMRRC; MMRRC:010287-UCD
DR   Wikidata; Q54779359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ588
AC   CVCL_NZ50
SY   RRZ588
DR   MMRRC; MMRRC:010288-UCD
DR   Wikidata; Q54779361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918843; Llgl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ596
AC   CVCL_NZ51
SY   RRZ596
DR   MMRRC; MMRRC:010291-UCD
DR   Wikidata; Q54779363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338938; Bmpr1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ597
AC   CVCL_NZ52
SY   RRZ597
DR   MMRRC; MMRRC:010292-UCD
DR   Wikidata; Q54779365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915467; Prrc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ604
AC   CVCL_NZ53
SY   RRZ604
DR   MMRRC; MMRRC:010296-UCD
DR   Wikidata; Q54779368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ624
AC   CVCL_NZ54
SY   RRZ624
DR   MMRRC; MMRRC:010297-UCD
DR   Wikidata; Q54779370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ625
AC   CVCL_NZ55
SY   RRZ625
DR   MMRRC; MMRRC:010298-UCD
DR   Wikidata; Q54779371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105066; Rab10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ634
AC   CVCL_NZ56
SY   RRZ634
DR   MMRRC; MMRRC:010302-UCD
DR   Wikidata; Q54779373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929261; Mtch1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ638
AC   CVCL_NZ57
SY   RRZ638
DR   MMRRC; MMRRC:010304-UCD
DR   Wikidata; Q54779375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146322; Deptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ642
AC   CVCL_NZ58
SY   RRZ642
DR   MMRRC; MMRRC:010305-UCD
DR   Wikidata; Q54779376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ644
AC   CVCL_NZ59
SY   RRZ644
DR   MMRRC; MMRRC:010306-UCD
DR   Wikidata; Q54779379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135608; Pard3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ655
AC   CVCL_NZ60
SY   RRZ655
DR   MMRRC; MMRRC:010308-UCD
DR   Wikidata; Q54779382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914454; Eif2s2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ657
AC   CVCL_NZ61
SY   RRZ657
DR   MMRRC; MMRRC:010309-UCD
DR   Wikidata; Q54779384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ663
AC   CVCL_NZ62
SY   RRZ663
DR   MMRRC; MMRRC:010311-UCD
DR   Wikidata; Q54779387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344415; Dmtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ668
AC   CVCL_NZ63
SY   RRZ668
DR   MMRRC; MMRRC:010312-UCD
DR   Wikidata; Q54779390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138605; Rabif.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ670
AC   CVCL_NZ64
SY   RRZ670
DR   MMRRC; MMRRC:010313-UCD
DR   Wikidata; Q54779391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196624; Tcea1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ672
AC   CVCL_NZ65
SY   RRZ672
DR   MMRRC; MMRRC:010314-UCD
DR   Wikidata; Q54779393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95640; Gapdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ673
AC   CVCL_NZ66
SY   RRZ673
DR   MMRRC; MMRRC:010315-UCD
DR   Wikidata; Q54779394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918084; Spag9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ678
AC   CVCL_NZ67
SY   RRZ678
DR   MMRRC; MMRRC:006008-UCD
DR   Wikidata; Q54779396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ679
AC   CVCL_NZ68
SY   RRZ679
DR   MMRRC; MMRRC:006009-UCD
DR   Wikidata; Q54779398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3645888; Gm6712.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ683
AC   CVCL_NZ69
SY   RRZ683
DR   MMRRC; MMRRC:006011-UCD
DR   Wikidata; Q54779400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858230; Sart3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ698
AC   CVCL_NZ70
SY   RRZ698
DR   MMRRC; MMRRC:006015-UCD
DR   Wikidata; Q54779403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670969; Nrde2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ699
AC   CVCL_NZ71
SY   RRZ699
DR   MMRRC; MMRRC:006016-UCD
DR   Wikidata; Q54779405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ700
AC   CVCL_NZ72
SY   RRZ700
DR   MMRRC; MMRRC:006017-UCD
DR   Wikidata; Q54779407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926609; Trp53inp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ702
AC   CVCL_NZ73
SY   RRZ702
DR   MMRRC; MMRRC:006018-UCD
DR   Wikidata; Q54779408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102657; Cdc34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ712
AC   CVCL_NZ74
SY   RRZ712
DR   MMRRC; MMRRC:006019-UCD
DR   Wikidata; Q54779411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918073; Hmgxb4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ713
AC   CVCL_NZ75
SY   RRZ713
DR   MMRRC; MMRRC:006020-UCD
DR   Wikidata; Q54779413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RRZ714
AC   CVCL_NZ76
SY   RRZ714
DR   MMRRC; MMRRC:006021-UCD
DR   Wikidata; Q54779414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915446; Hsbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST005
AC   CVCL_NZ77
SY   RST005
DR   MMRRC; MMRRC:006023-UCD
DR   Wikidata; Q54779418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102695; Ptprf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST007
AC   CVCL_NZ78
SY   RST007
DR   MMRRC; MMRRC:006024-UCD
DR   Wikidata; Q54779420
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST008
AC   CVCL_NZ79
SY   RST008
DR   MMRRC; MMRRC:006025-UCD
DR   Wikidata; Q54779423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST009
AC   CVCL_NZ80
SY   RST009
DR   MMRRC; MMRRC:006026-UCD
DR   Wikidata; Q54779425
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST011
AC   CVCL_NZ81
SY   RST011
DR   MMRRC; MMRRC:006027-UCD
DR   Wikidata; Q54779426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST018
AC   CVCL_NZ82
SY   RST018
DR   MMRRC; MMRRC:006028-UCD
DR   Wikidata; Q54779429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST019
AC   CVCL_NZ83
SY   RST019
DR   MMRRC; MMRRC:006029-UCD
DR   Wikidata; Q54779479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST020
AC   CVCL_NZ84
SY   RST020
DR   MMRRC; MMRRC:006030-UCD
DR   Wikidata; Q54779482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102695; Ptprf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST022
AC   CVCL_NZ85
SY   RST022
DR   MMRRC; MMRRC:006031-UCD
DR   Wikidata; Q54779485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97527; Pdgfa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST027
AC   CVCL_NZ86
SY   RST027
DR   MMRRC; MMRRC:006032-UCD
DR   Wikidata; Q54779486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST035
AC   CVCL_NZ87
SY   RST035
DR   MMRRC; MMRRC:006033-UCD
DR   Wikidata; Q54779488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108076; Frrs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST050
AC   CVCL_NZ88
SY   RST050
DR   MMRRC; MMRRC:006034-UCD
DR   Wikidata; Q54779489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST053
AC   CVCL_NZ89
SY   RST053
DR   MMRRC; MMRRC:006035-UCD
DR   Wikidata; Q54779491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST059
AC   CVCL_NZ90
SY   RST059
DR   MMRRC; MMRRC:006036-UCD
DR   Wikidata; Q54779493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97750; Ppib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST061
AC   CVCL_NZ91
SY   RST061
DR   MMRRC; MMRRC:006037-UCD
DR   Wikidata; Q54779495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST063
AC   CVCL_NZ92
SY   RST063
DR   MMRRC; MMRRC:006038-UCD
DR   Wikidata; Q54779497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104967; Glg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST066
AC   CVCL_NZ93
SY   RST066
DR   MMRRC; MMRRC:006039-UCD
DR   Wikidata; Q54779500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913522; Cox16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST067
AC   CVCL_NZ94
SY   RST067
DR   MMRRC; MMRRC:006040-UCD
DR   Wikidata; Q54779501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924059; Bri3bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST069
AC   CVCL_NZ95
SY   RST069
DR   MMRRC; MMRRC:006041-UCD
DR   Wikidata; Q54779503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104669; Man2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST072
AC   CVCL_NZ96
SY   RST072
DR   MMRRC; MMRRC:006042-UCD
DR   Wikidata; Q54779505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329016; Sel1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST076
AC   CVCL_NZ97
SY   RST076
DR   MMRRC; MMRRC:006043-UCD
DR   Wikidata; Q54779506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97750; Ppib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST082
AC   CVCL_NZ98
SY   RST082
DR   MMRRC; MMRRC:006044-UCD
DR   Wikidata; Q54779507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923206; Srrm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST083
AC   CVCL_NZ99
SY   RST083
DR   MMRRC; MMRRC:006045-UCD
DR   Wikidata; Q54779509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277969; Zfp143.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST084
AC   CVCL_PA00
SY   RST084
DR   MMRRC; MMRRC:006046-UCD
DR   Wikidata; Q54779511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105369; Cbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST085
AC   CVCL_PA01
SY   RST085
DR   MMRRC; MMRRC:006047-UCD
DR   Wikidata; Q54779515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913522; Cox16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST086
AC   CVCL_PA02
SY   RST086
DR   MMRRC; MMRRC:006048-UCD
DR   Wikidata; Q54779516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96743; Lamb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST087
AC   CVCL_PA03
SY   RST087
DR   MMRRC; MMRRC:006049-UCD
DR   Wikidata; Q54779518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924301; Os9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST092
AC   CVCL_PA04
SY   RST092
DR   MMRRC; MMRRC:006050-UCD
DR   Wikidata; Q54779520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104967; Glg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST097
AC   CVCL_PA05
SY   RST097
DR   MMRRC; MMRRC:006051-UCD
DR   Wikidata; Q54779524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443272; B230354K17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST098
AC   CVCL_PA06
SY   RST098
DR   MMRRC; MMRRC:006052-UCD
DR   Wikidata; Q54779526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST100
AC   CVCL_PA07
SY   RST100
DR   MMRRC; MMRRC:006053-UCD
DR   Wikidata; Q54779530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99892; Lama1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST101
AC   CVCL_PA08
SY   RST101
DR   MMRRC; MMRRC:006054-UCD
DR   Wikidata; Q54779533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104652; Capzb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST102
AC   CVCL_PA09
SY   RST102
DR   MMRRC; MMRRC:006055-UCD
DR   Wikidata; Q54779534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST105
AC   CVCL_PA10
SY   RST105
DR   MMRRC; MMRRC:006056-UCD
DR   Wikidata; Q54779536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST106
AC   CVCL_PA11
SY   RST106
DR   MMRRC; MMRRC:006057-UCD
DR   Wikidata; Q54779537
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347007; Plod2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST108
AC   CVCL_PA12
SY   RST108
DR   MMRRC; MMRRC:006059-UCD
DR   Wikidata; Q54779539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST114
AC   CVCL_PA13
SY   RST114
DR   MMRRC; MMRRC:006060-UCD
DR   Wikidata; Q54779541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107532; Kpnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST117
AC   CVCL_PA14
SY   RST117
DR   MMRRC; MMRRC:006061-UCD
DR   Wikidata; Q54779544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST120
AC   CVCL_PA15
SY   RST120
DR   MMRRC; MMRRC:006062-UCD
DR   Wikidata; Q54779546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST121
AC   CVCL_PA16
SY   RST121
DR   MMRRC; MMRRC:006063-UCD
DR   Wikidata; Q54779548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST122
AC   CVCL_PA17
SY   RST122
DR   MMRRC; MMRRC:006064-UCD
DR   Wikidata; Q54779551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98085; Rpn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST123
AC   CVCL_PA18
SY   RST123
DR   MMRRC; MMRRC:006065-UCD
DR   Wikidata; Q54779552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST124
AC   CVCL_PA19
SY   RST124
DR   MMRRC; MMRRC:006066-UCD
DR   Wikidata; Q54779555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST125
AC   CVCL_PA20
SY   RST125
DR   MMRRC; MMRRC:006067-UCD
DR   Wikidata; Q54779556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST129
AC   CVCL_PA21
SY   RST129
DR   MMRRC; MMRRC:006068-UCD
DR   Wikidata; Q54779559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98085; Rpn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST130
AC   CVCL_PA22
SY   RST130
DR   MMRRC; MMRRC:006069-UCD
DR   Wikidata; Q54779562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST132
AC   CVCL_PA23
SY   RST132
DR   MMRRC; MMRRC:006070-UCD
DR   Wikidata; Q54779612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894652; Usp10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST133
AC   CVCL_PA24
SY   RST133
DR   MMRRC; MMRRC:006071-UCD
DR   Wikidata; Q54779613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103561; Kpna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST134
AC   CVCL_PA25
SY   RST134
DR   MMRRC; MMRRC:006072-UCD
DR   Wikidata; Q54779617
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345162; Adam23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST135
AC   CVCL_PA26
SY   RST135
DR   MMRRC; MMRRC:006073-UCD
DR   Wikidata; Q54779618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST139
AC   CVCL_PA27
SY   RST139
DR   MMRRC; MMRRC:006074-UCD
DR   Wikidata; Q54779621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97750; Ppib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST142
AC   CVCL_PA28
SY   RST142
DR   MMRRC; MMRRC:006075-UCD
DR   Wikidata; Q54779624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108088; Gab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST146
AC   CVCL_PA29
SY   RST146
DR   MMRRC; MMRRC:006076-UCD
DR   Wikidata; Q54779625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441844; Tmem87a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST153
AC   CVCL_PA30
SY   RST153
DR   MMRRC; MMRRC:006077-UCD
DR   Wikidata; Q54779627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88451; Col18a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST154
AC   CVCL_PA31
SY   RST154
DR   MMRRC; MMRRC:006078-UCD
DR   Wikidata; Q54779630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST155
AC   CVCL_PA32
SY   RST155
DR   MMRRC; MMRRC:006079-UCD
DR   Wikidata; Q54779632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST157
AC   CVCL_PA33
SY   RST157
DR   MMRRC; MMRRC:006080-UCD
DR   Wikidata; Q54779634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921867; Scpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST159
AC   CVCL_PA34
SY   RST159
DR   MMRRC; MMRRC:006081-UCD
DR   Wikidata; Q54779636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88451; Col18a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST161
AC   CVCL_PA35
SY   RST161
DR   MMRRC; MMRRC:006082-UCD
DR   Wikidata; Q54779637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST162
AC   CVCL_PA36
SY   RST162
DR   MMRRC; MMRRC:006083-UCD
DR   Wikidata; Q54779639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343877; Rpl10a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST163
AC   CVCL_PA37
SY   RST163
DR   MMRRC; MMRRC:006084-UCD
DR   Wikidata; Q54779641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST167
AC   CVCL_PA38
SY   RST167
DR   MMRRC; MMRRC:006085-UCD
DR   Wikidata; Q54779644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST168
AC   CVCL_PA39
SY   RST168
DR   MMRRC; MMRRC:006086-UCD
DR   Wikidata; Q54779646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914217; Edem3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST170
AC   CVCL_PA40
SY   RST170
DR   MMRRC; MMRRC:006087-UCD
DR   Wikidata; Q54779648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442146; Dnajc16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST175
AC   CVCL_PA41
SY   RST175
DR   MMRRC; MMRRC:006088-UCD
DR   Wikidata; Q54779649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927235; Mbtps1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST176
AC   CVCL_PA42
SY   RST176
DR   MMRRC; MMRRC:006089-UCD
DR   Wikidata; Q54779651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298229; Nid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST178
AC   CVCL_PA43
SY   RST178
DR   MMRRC; MMRRC:006090-UCD
DR   Wikidata; Q54779654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443191; Nceh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST181
AC   CVCL_PA44
SY   RST181
DR   MMRRC; MMRRC:006091-UCD
DR   Wikidata; Q54779655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST182
AC   CVCL_PA45
SY   RST182
DR   MMRRC; MMRRC:006092-UCD
DR   Wikidata; Q54779656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927169; B4galt5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST186
AC   CVCL_PA46
SY   RST186
DR   MMRRC; MMRRC:006093-UCD
DR   Wikidata; Q54779658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST188
AC   CVCL_PA47
SY   RST188
DR   MMRRC; MMRRC:006094-UCD
DR   Wikidata; Q54779661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97281; Ncam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST196
AC   CVCL_PA48
SY   RST196
DR   MMRRC; MMRRC:006095-UCD
DR   Wikidata; Q54779663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351605; Rpl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST197
AC   CVCL_PA49
SY   RST197
DR   MMRRC; MMRRC:006096-UCD
DR   Wikidata; Q54779664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88047; Aplp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST199
AC   CVCL_PA50
SY   RST199
DR   MMRRC; MMRRC:006098-UCD
DR   Wikidata; Q54779665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914873; Tm7sf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST201
AC   CVCL_PA51
SY   RST201
DR   MMRRC; MMRRC:006100-UCD
DR   Wikidata; Q54779668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST202
AC   CVCL_PA52
SY   RST202
DR   MMRRC; MMRRC:006101-UCD
DR   Wikidata; Q54779671
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927235; Mbtps1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST203
AC   CVCL_PA53
SY   RST203
DR   MMRRC; MMRRC:006102-UCD
DR   Wikidata; Q54779673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88356; Cdh3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST204
AC   CVCL_PA54
SY   RST204
DR   MMRRC; MMRRC:006103-UCD
DR   Wikidata; Q54779675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST205
AC   CVCL_PA55
SY   RST205
DR   MMRRC; MMRRC:006104-UCD
DR   Wikidata; Q54779677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351651; Yme1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST207
AC   CVCL_PA56
SY   RST207
DR   MMRRC; MMRRC:006105-UCD
DR   Wikidata; Q54779679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST208
AC   CVCL_PA57
SY   RST208
DR   MMRRC; MMRRC:006106-UCD
DR   Wikidata; Q54779681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST209
AC   CVCL_PA58
SY   RST209
DR   MMRRC; MMRRC:006107-UCD
DR   Wikidata; Q54779682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138856; Ldlrad3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST211
AC   CVCL_PA59
SY   RST211
DR   MMRRC; MMRRC:006108-UCD
DR   Wikidata; Q54779686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST214
AC   CVCL_PA60
SY   RST214
DR   MMRRC; MMRRC:006109-UCD
DR   Wikidata; Q54779687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444465; Frem2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST216
AC   CVCL_PA61
SY   RST216
DR   MMRRC; MMRRC:006110-UCD
DR   Wikidata; Q54779689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929895; Clstn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST219
AC   CVCL_PA62
SY   RST219
DR   MMRRC; MMRRC:006111-UCD
DR   Wikidata; Q54779691
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88252; Calr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST220
AC   CVCL_PA63
SY   RST220
DR   MMRRC; MMRRC:006112-UCD
DR   Wikidata; Q54779780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915358; Snhg17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST225
AC   CVCL_PA64
SY   RST225
DR   MMRRC; MMRRC:006114-UCD
DR   Wikidata; Q54779782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST226
AC   CVCL_PA65
SY   RST226
DR   MMRRC; MMRRC:006115-UCD
DR   Wikidata; Q54779785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98834; Trp53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST227
AC   CVCL_PA66
SY   RST227
DR   MMRRC; MMRRC:006116-UCD
DR   Wikidata; Q54779786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1350921; Fkbp9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST228
AC   CVCL_PA67
SY   RST228
DR   MMRRC; MMRRC:006117-UCD
DR   Wikidata; Q54779787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914195; Sdha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST229
AC   CVCL_PA68
SY   RST229
DR   MMRRC; MMRRC:006118-UCD
DR   Wikidata; Q54779791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298229; Nid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST235
AC   CVCL_PA69
SY   RST235
DR   MMRRC; MMRRC:006119-UCD
DR   Wikidata; Q54779793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107559; Sema4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST236
AC   CVCL_PA70
SY   RST236
DR   MMRRC; MMRRC:006120-UCD
DR   Wikidata; Q54779794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST238
AC   CVCL_PA71
SY   RST238
DR   MMRRC; MMRRC:006121-UCD
DR   Wikidata; Q54779796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104903; Gpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST240
AC   CVCL_PA72
SY   RST240
DR   MMRRC; MMRRC:006122-UCD
DR   Wikidata; Q54779799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST244
AC   CVCL_PA73
SY   RST244
DR   MMRRC; MMRRC:006123-UCD
DR   Wikidata; Q54779800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97748; Ctsa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST245
AC   CVCL_PA74
SY   RST245
DR   MMRRC; MMRRC:006124-UCD
DR   Wikidata; Q54779804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST249
AC   CVCL_PA75
SY   RST249
DR   MMRRC; MMRRC:006126-UCD
DR   Wikidata; Q54779805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST250
AC   CVCL_PA76
SY   RST250
DR   MMRRC; MMRRC:006127-UCD
DR   Wikidata; Q54779807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST255
AC   CVCL_PA77
SY   RST255
DR   MMRRC; MMRRC:006128-UCD
DR   Wikidata; Q54779811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST256
AC   CVCL_PA78
SY   RST256
DR   MMRRC; MMRRC:006129-UCD
DR   Wikidata; Q54779813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108515; Cbx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST259
AC   CVCL_PA79
SY   RST259
DR   MMRRC; MMRRC:006130-UCD
DR   Wikidata; Q54779814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345162; Adam23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST260
AC   CVCL_PA80
SY   RST260
DR   MMRRC; MMRRC:006131-UCD
DR   Wikidata; Q54779817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST262
AC   CVCL_PA81
SY   RST262
DR   MMRRC; MMRRC:006133-UCD
DR   Wikidata; Q54779818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST264
AC   CVCL_PA82
SY   RST264
DR   MMRRC; MMRRC:006134-UCD
DR   Wikidata; Q54779819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915831; Tmed10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST265
AC   CVCL_PA83
SY   RST265
DR   MMRRC; MMRRC:006135-UCD
DR   Wikidata; Q54779822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97748; Ctsa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST267
AC   CVCL_PA84
SY   RST267
DR   MMRRC; MMRRC:006137-UCD
DR   Wikidata; Q54779826
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST268
AC   CVCL_PA85
SY   RST268
DR   MMRRC; MMRRC:006138-UCD
DR   Wikidata; Q54779829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST271
AC   CVCL_PA86
SY   RST271
DR   MMRRC; MMRRC:006139-UCD
DR   Wikidata; Q54779831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929282; Ptges3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST272
AC   CVCL_PA87
SY   RST272
DR   MMRRC; MMRRC:006140-UCD
DR   Wikidata; Q54779832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST273
AC   CVCL_PA88
SY   RST273
DR   MMRRC; MMRRC:006141-UCD
DR   Wikidata; Q54779835
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039616; Znrf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST276
AC   CVCL_PA89
SY   RST276
DR   MMRRC; MMRRC:006142-UCD
DR   Wikidata; Q54779837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST278
AC   CVCL_PA90
SY   RST278
DR   MMRRC; MMRRC:006143-UCD
DR   Wikidata; Q54779839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST279
AC   CVCL_PA91
SY   RST279
DR   MMRRC; MMRRC:006144-UCD
DR   Wikidata; Q54779842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95392; Eng.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST284
AC   CVCL_PA92
SY   RST284
DR   MMRRC; MMRRC:006146-UCD
DR   Wikidata; Q54779843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88047; Aplp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST286
AC   CVCL_PA93
SY   RST286
DR   MMRRC; MMRRC:006147-UCD
DR   Wikidata; Q54779846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914873; Tm7sf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST288
AC   CVCL_PA94
SY   RST288
DR   MMRRC; MMRRC:006148-UCD
DR   Wikidata; Q54779848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST291
AC   CVCL_PA95
SY   RST291
DR   MMRRC; MMRRC:006149-UCD
DR   Wikidata; Q54779851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST292
AC   CVCL_PA96
SY   RST292
DR   MMRRC; MMRRC:006150-UCD
DR   Wikidata; Q54779853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST293
AC   CVCL_PA97
SY   RST293
DR   MMRRC; MMRRC:006151-UCD
DR   Wikidata; Q54779856
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889844; Sumf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST295
AC   CVCL_PA98
SY   RST295
DR   MMRRC; MMRRC:006152-UCD
DR   Wikidata; Q54779858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442146; Dnajc16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST296
AC   CVCL_PA99
SY   RST296
DR   MMRRC; MMRRC:006153-UCD
DR   Wikidata; Q54779860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST297
AC   CVCL_PB00
SY   RST297
DR   MMRRC; MMRRC:006154-UCD
DR   Wikidata; Q54779862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143702; Enpp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST302
AC   CVCL_PB01
SY   RST302
DR   MMRRC; MMRRC:006156-UCD
DR   Wikidata; Q54779865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST303
AC   CVCL_PB02
SY   RST303
DR   MMRRC; MMRRC:006157-UCD
DR   Wikidata; Q54779867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST307
AC   CVCL_C321
SY   RST307; RST-307; RST 307
DR   BTO; BTO_0005137
DR   MMRRC; MMRRC:006159-UCD
DR   Wikidata; Q54779916
RX   PubMed=12520002;
RX   PubMed=19380613;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917745; Atp6ap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   BayGenomics ES cell line RST308
AC   CVCL_PB03
SY   RST308
DR   MMRRC; MMRRC:006160-UCD
DR   Wikidata; Q54779918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST313
AC   CVCL_PB04
SY   RST313
DR   MMRRC; MMRRC:006162-UCD
DR   Wikidata; Q54779920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345162; Adam23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST316
AC   CVCL_PB05
SY   RST316
DR   MMRRC; MMRRC:006163-UCD
DR   Wikidata; Q54779922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95797; Gpi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST317
AC   CVCL_PB06
SY   RST317
DR   MMRRC; MMRRC:006164-UCD
DR   Wikidata; Q54779923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96435; Igf2r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST319
AC   CVCL_PB07
SY   RST319
DR   MMRRC; MMRRC:006165-UCD
DR   Wikidata; Q54779924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST321
AC   CVCL_PB08
SY   RST321
DR   MMRRC; MMRRC:006166-UCD
DR   Wikidata; Q54779926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914217; Edem3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST323
AC   CVCL_PB09
SY   RST323
DR   MMRRC; MMRRC:006167-UCD
DR   Wikidata; Q54779928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST325
AC   CVCL_PB10
SY   RST325
DR   MMRRC; MMRRC:006168-UCD
DR   Wikidata; Q54779931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927235; Mbtps1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST337
AC   CVCL_PB11
SY   RST337
DR   MMRRC; MMRRC:006170-UCD
DR   Wikidata; Q54779932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923206; Srrm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST338
AC   CVCL_PB12
SY   RST338
DR   MMRRC; MMRRC:006171-UCD
DR   Wikidata; Q54779933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860765; Extl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST339
AC   CVCL_PB13
SY   RST339
DR   MMRRC; MMRRC:006172-UCD
DR   Wikidata; Q54779935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST341
AC   CVCL_PB14
SY   RST341
DR   MMRRC; MMRRC:006173-UCD
DR   Wikidata; Q54779937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST343
AC   CVCL_PB15
SY   RST343
DR   MMRRC; MMRRC:006175-UCD
DR   Wikidata; Q54779939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3603204; Piezo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST350
AC   CVCL_PB16
SY   RST350
DR   MMRRC; MMRRC:006177-UCD
DR   Wikidata; Q54779942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST353
AC   CVCL_PB17
SY   RST353
DR   MMRRC; MMRRC:006178-UCD
DR   Wikidata; Q54779943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103268; Dnajc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST355
AC   CVCL_PB18
SY   RST355
DR   MMRRC; MMRRC:006179-UCD
DR   Wikidata; Q54779944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3652219; Zfp345.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST357
AC   CVCL_PB19
SY   RST357
DR   MMRRC; MMRRC:006180-UCD
DR   Wikidata; Q54779946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891468; Lgr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST373
AC   CVCL_PB20
SY   RST373
DR   MMRRC; MMRRC:006182-UCD
DR   Wikidata; Q54779949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138856; Ldlrad3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST376
AC   CVCL_PB21
SY   RST376
DR   MMRRC; MMRRC:006184-UCD
DR   Wikidata; Q54779952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST377
AC   CVCL_PB22
SY   RST377
DR   MMRRC; MMRRC:006185-UCD
DR   Wikidata; Q54779954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97004; Mme.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST380
AC   CVCL_PB23
SY   RST380
DR   MMRRC; MMRRC:006186-UCD
DR   Wikidata; Q54779955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106419; Itfg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST382
AC   CVCL_PB24
SY   RST382
DR   MMRRC; MMRRC:006187-UCD
DR   Wikidata; Q54779957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST383
AC   CVCL_PB25
SY   RST383
DR   MMRRC; MMRRC:006188-UCD
DR   Wikidata; Q54779959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926810; Tmeff1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST385
AC   CVCL_PB26
SY   RST385
DR   MMRRC; MMRRC:006189-UCD
DR   Wikidata; Q54779961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST387
AC   CVCL_PB27
SY   RST387
DR   MMRRC; MMRRC:006190-UCD
DR   Wikidata; Q54779964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST388
AC   CVCL_PB28
SY   RST388
DR   MMRRC; MMRRC:006191-UCD
DR   Wikidata; Q54779965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST389
AC   CVCL_PB29
SY   RST389
DR   MMRRC; MMRRC:006192-UCD
DR   Wikidata; Q54779967
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108076; Frrs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST390
AC   CVCL_PB30
SY   RST390
DR   MMRRC; MMRRC:006193-UCD
DR   Wikidata; Q54779970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924015; Mlec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST395
AC   CVCL_PB31
SY   RST395
DR   MMRRC; MMRRC:006195-UCD
DR   Wikidata; Q54779972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST396
AC   CVCL_PB32
SY   RST396
DR   MMRRC; MMRRC:006196-UCD
DR   Wikidata; Q54779973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST397
AC   CVCL_PB33
SY   RST397
DR   MMRRC; MMRRC:006197-UCD
DR   Wikidata; Q54779977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST398
AC   CVCL_PB34
SY   RST398
DR   MMRRC; MMRRC:006198-UCD
DR   Wikidata; Q54779978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194891; Gpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST399
AC   CVCL_PB35
SY   RST399
DR   MMRRC; MMRRC:006199-UCD
DR   Wikidata; Q54779981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890373; Cemip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RST401
AC   CVCL_PB36
SY   RST401
DR   MMRRC; MMRRC:006200-UCD
DR   Wikidata; Q54779982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96677; Kit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST403
AC   CVCL_PB37
SY   RST403
DR   MMRRC; MMRRC:006201-UCD
DR   Wikidata; Q54779984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST406
AC   CVCL_PB38
SY   RST406
DR   MMRRC; MMRRC:006203-UCD
DR   Wikidata; Q54779986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106906; Eif4a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST407
AC   CVCL_PB39
SY   RST407
DR   MMRRC; MMRRC:006204-UCD
DR   Wikidata; Q54779987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST408
AC   CVCL_PB40
SY   RST408
DR   MMRRC; MMRRC:006205-UCD
DR   Wikidata; Q54779989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96435; Igf2r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST409
AC   CVCL_PB41
SY   RST409
DR   MMRRC; MMRRC:006206-UCD
DR   Wikidata; Q54779992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST411
AC   CVCL_PB42
SY   RST411
DR   MMRRC; MMRRC:006208-UCD
DR   Wikidata; Q54780090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918917; Tmem248.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST412
AC   CVCL_PB43
SY   RST412
DR   MMRRC; MMRRC:006209-UCD
DR   Wikidata; Q54780092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106653; Epcam.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST413
AC   CVCL_PB44
SY   RST413
DR   MMRRC; MMRRC:006210-UCD
DR   Wikidata; Q54780095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106653; Epcam.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST416
AC   CVCL_PB45
SY   RST416
DR   MMRRC; MMRRC:006211-UCD
DR   Wikidata; Q54780097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST417
AC   CVCL_PB46
SY   RST417
DR   MMRRC; MMRRC:006212-UCD
DR   Wikidata; Q54780099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309516; Tpst2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST418
AC   CVCL_PB47
SY   RST418
DR   MMRRC; MMRRC:006213-UCD
DR   Wikidata; Q54780101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914186; Asph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST421
AC   CVCL_PB48
SY   RST421
DR   MMRRC; MMRRC:006214-UCD
DR   Wikidata; Q54780102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927110; Tmem131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST422
AC   CVCL_PB49
SY   RST422
DR   MMRRC; MMRRC:006215-UCD
DR   Wikidata; Q54780106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923549; Erp44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST423
AC   CVCL_PB50
SY   RST423
DR   MMRRC; MMRRC:006216-UCD
DR   Wikidata; Q54780107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96522; Rbpj.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST424
AC   CVCL_PB51
SY   RST424
DR   MMRRC; MMRRC:006217-UCD
DR   Wikidata; Q54780108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441844; Tmem87a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST426
AC   CVCL_PB52
SY   RST426
DR   MMRRC; MMRRC:006219-UCD
DR   Wikidata; Q54780110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921867; Scpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST428
AC   CVCL_PB53
SY   RST428
DR   MMRRC; MMRRC:006220-UCD
DR   Wikidata; Q54780113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98084; Rpn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST429
AC   CVCL_PB54
SY   RST429
DR   MMRRC; MMRRC:006221-UCD
DR   Wikidata; Q54780116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104902; Gpc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST430
AC   CVCL_PB55
SY   RST430
DR   MMRRC; MMRRC:006222-UCD
DR   Wikidata; Q54780118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855698; Reck.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST431
AC   CVCL_PB56
SY   RST431
DR   MMRRC; MMRRC:006223-UCD
DR   Wikidata; Q54780119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923549; Erp44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST433
AC   CVCL_PB57
SY   RST433
DR   MMRRC; MMRRC:006224-UCD
DR   Wikidata; Q54780120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST434
AC   CVCL_PB58
SY   RST434
DR   MMRRC; MMRRC:006225-UCD
DR   Wikidata; Q54780123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916863; Pofut2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST435
AC   CVCL_PB59
SY   RST435
DR   MMRRC; MMRRC:006226-UCD
DR   Wikidata; Q54780125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST436
AC   CVCL_PB60
SY   RST436
DR   MMRRC; MMRRC:006227-UCD
DR   Wikidata; Q54780127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914325; Magt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST437
AC   CVCL_PB61
SY   RST437
DR   MMRRC; MMRRC:006228-UCD
DR   Wikidata; Q54780129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST438
AC   CVCL_PB62
SY   RST438
DR   MMRRC; MMRRC:006229-UCD
DR   Wikidata; Q54780132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914325; Magt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST440
AC   CVCL_PB63
SY   RST440
DR   MMRRC; MMRRC:006231-UCD
DR   Wikidata; Q54780133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101357; Ece1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST442
AC   CVCL_PB64
SY   RST442
DR   MMRRC; MMRRC:006232-UCD
DR   Wikidata; Q54780136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST445
AC   CVCL_PB65
SY   RST445
DR   MMRRC; MMRRC:006234-UCD
DR   Wikidata; Q54780138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST448
AC   CVCL_PB66
SY   RST448
DR   MMRRC; MMRRC:006235-UCD
DR   Wikidata; Q54780140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138856; Ldlrad3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST450
AC   CVCL_PB67
SY   RST450
DR   MMRRC; MMRRC:006236-UCD
DR   Wikidata; Q54780144
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914705; Klhl13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST453
AC   CVCL_PB68
SY   RST453
DR   MMRRC; MMRRC:006238-UCD
DR   Wikidata; Q54780146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139220; Tm9sf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST454
AC   CVCL_PB69
SY   RST454
DR   MMRRC; MMRRC:006239-UCD
DR   Wikidata; Q54780148
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST455
AC   CVCL_PB70
SY   RST455
DR   MMRRC; MMRRC:006240-UCD
DR   Wikidata; Q54780149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST456
AC   CVCL_PB71
SY   RST456
DR   MMRRC; MMRRC:006241-UCD
DR   Wikidata; Q54780152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95640; Gapdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST458
AC   CVCL_PB72
SY   RST458
DR   MMRRC; MMRRC:006242-UCD
DR   Wikidata; Q54780155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST462
AC   CVCL_PB73
SY   RST462
DR   MMRRC; MMRRC:006243-UCD
DR   Wikidata; Q54780157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932040; Sil1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST463
AC   CVCL_PB74
SY   RST463
DR   MMRRC; MMRRC:006244-UCD
DR   Wikidata; Q54780160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3763743; Snhg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST464
AC   CVCL_PB75
SY   RST464
DR   MMRRC; MMRRC:006245-UCD
DR   Wikidata; Q54780162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST465
AC   CVCL_PB76
SY   RST465
DR   MMRRC; MMRRC:006246-UCD
DR   Wikidata; Q54780164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST467
AC   CVCL_PB77
SY   RST467
DR   MMRRC; MMRRC:006247-UCD
DR   Wikidata; Q54780166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99894; Hnrnpk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST470
AC   CVCL_PB78
SY   RST470
DR   MMRRC; MMRRC:006249-UCD
DR   Wikidata; Q54780169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88108; Atp1b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST471
AC   CVCL_PB79
SY   RST471
DR   MMRRC; MMRRC:006250-UCD
DR   Wikidata; Q54780171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347007; Plod2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST474
AC   CVCL_PB80
SY   RST474
DR   MMRRC; MMRRC:006251-UCD
DR   Wikidata; Q54780173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST475
AC   CVCL_PB81
SY   RST475
DR   MMRRC; MMRRC:006252-UCD
DR   Wikidata; Q54780175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST477
AC   CVCL_PB82
SY   RST477
DR   MMRRC; MMRRC:006253-UCD
DR   Wikidata; Q54780216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97783; Psap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST478
AC   CVCL_PB83
SY   RST478
DR   MMRRC; MMRRC:006254-UCD
DR   Wikidata; Q54780217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927947; Selenof.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST483
AC   CVCL_PB84
SY   RST483
DR   MMRRC; MMRRC:006255-UCD
DR   Wikidata; Q54780218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST485
AC   CVCL_PB85
SY   RST485
DR   MMRRC; MMRRC:006257-UCD
DR   Wikidata; Q54780221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338881; St14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST488
AC   CVCL_PB86
SY   RST488
DR   MMRRC; MMRRC:006258-UCD
DR   Wikidata; Q54780222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97364; Notch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST489
AC   CVCL_PB87
SY   RST489
DR   MMRRC; MMRRC:006259-UCD
DR   Wikidata; Q54780223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104967; Glg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST490
AC   CVCL_PB88
SY   RST490
DR   MMRRC; MMRRC:006260-UCD
DR   Wikidata; Q54780225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194508; Ddost.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST491
AC   CVCL_PB89
SY   RST491
DR   MMRRC; MMRRC:006261-UCD
DR   Wikidata; Q54780226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914111; Dnajc10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST495
AC   CVCL_PB90
SY   RST495
DR   MMRRC; MMRRC:006262-UCD
DR   Wikidata; Q54780227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096335; Adam17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST498
AC   CVCL_PB91
SY   RST498
DR   MMRRC; MMRRC:006264-UCD
DR   Wikidata; Q54780229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108079; Sdf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST499
AC   CVCL_PB92
SY   RST499
DR   MMRRC; MMRRC:006265-UCD
DR   Wikidata; Q54780232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST501
AC   CVCL_PB93
SY   RST501
DR   MMRRC; MMRRC:006266-UCD
DR   Wikidata; Q54780233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST502
AC   CVCL_PB94
SY   RST502
DR   MMRRC; MMRRC:006267-UCD
DR   Wikidata; Q54780235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96392; Icam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST503
AC   CVCL_PB95
SY   RST503
DR   MMRRC; MMRRC:006268-UCD
DR   Wikidata; Q54780237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST504
AC   CVCL_PB96
SY   RST504
DR   MMRRC; MMRRC:006269-UCD
DR   Wikidata; Q54780238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST505
AC   CVCL_PB97
SY   RST505
DR   MMRRC; MMRRC:006270-UCD
DR   Wikidata; Q54780239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104903; Gpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST507
AC   CVCL_PB98
SY   RST507
DR   MMRRC; MMRRC:006271-UCD
DR   Wikidata; Q54780242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443399; Tmem131l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST510
AC   CVCL_PB99
SY   RST510
DR   MMRRC; MMRRC:006272-UCD
DR   Wikidata; Q54780244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST512
AC   CVCL_PC00
SY   RST512
DR   MMRRC; MMRRC:006273-UCD
DR   Wikidata; Q54780245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442146; Dnajc16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST513
AC   CVCL_PC01
SY   RST513
DR   MMRRC; MMRRC:006274-UCD
DR   Wikidata; Q54780248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST515
AC   CVCL_PC02
SY   RST515
DR   MMRRC; MMRRC:006275-UCD
DR   Wikidata; Q54780249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933820; Jam2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST516
AC   CVCL_PC03
SY   RST516
DR   MMRRC; MMRRC:006276-UCD
DR   Wikidata; Q54780251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST517
AC   CVCL_PC04
SY   RST517
DR   MMRRC; MMRRC:006277-UCD
DR   Wikidata; Q54780253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST521
AC   CVCL_PC05
SY   RST521
DR   MMRRC; MMRRC:006279-UCD
DR   Wikidata; Q54780256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST523
AC   CVCL_PC06
SY   RST523
DR   MMRRC; MMRRC:006280-UCD
DR   Wikidata; Q54780257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST525
AC   CVCL_PC07
SY   RST525
DR   MMRRC; MMRRC:006281-UCD
DR   Wikidata; Q54780260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443696; Emc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST526
AC   CVCL_PC08
SY   RST526
DR   MMRRC; MMRRC:006282-UCD
DR   Wikidata; Q54780262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3780541; Lncenc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST527
AC   CVCL_PC09
SY   RST527
DR   MMRRC; MMRRC:006283-UCD
DR   Wikidata; Q54780263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST528
AC   CVCL_PC10
SY   RST528
DR   MMRRC; MMRRC:006284-UCD
DR   Wikidata; Q54780265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3763743; Snhg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST529
AC   CVCL_PC11
SY   RST529
DR   MMRRC; MMRRC:006285-UCD
DR   Wikidata; Q54780268
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST538
AC   CVCL_PC12
SY   RST538
DR   MMRRC; MMRRC:006289-UCD
DR   Wikidata; Q54780269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST539
AC   CVCL_PC13
SY   RST539
DR   MMRRC; MMRRC:006290-UCD
DR   Wikidata; Q54780271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443162; Uggt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST540
AC   CVCL_PC14
SY   RST540
DR   MMRRC; MMRRC:006291-UCD
DR   Wikidata; Q54780273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107685; Plxna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST543
AC   CVCL_PC15
SY   RST543
DR   MMRRC; MMRRC:006292-UCD
DR   Wikidata; Q54780277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87961; Agrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST544
AC   CVCL_PC16
SY   RST544
DR   MMRRC; MMRRC:006293-UCD
DR   Wikidata; Q54780281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914186; Asph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST546
AC   CVCL_PC17
SY   RST546
DR   MMRRC; MMRRC:006294-UCD
DR   Wikidata; Q54780282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921819; Ttc17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST547
AC   CVCL_PC18
SY   RST547
DR   MMRRC; MMRRC:006295-UCD
DR   Wikidata; Q54780283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87961; Agrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST553
AC   CVCL_PC19
SY   RST553
DR   MMRRC; MMRRC:006296-UCD
DR   Wikidata; Q54780285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914328; Pgp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST554
AC   CVCL_PC20
SY   RST554
DR   MMRRC; MMRRC:006297-UCD
DR   Wikidata; Q54780287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST556
AC   CVCL_PC21
SY   RST556
DR   MMRRC; MMRRC:006298-UCD
DR   Wikidata; Q54780288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106653; Epcam.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST557
AC   CVCL_PC22
SY   RST557
DR   MMRRC; MMRRC:006299-UCD
DR   Wikidata; Q54780334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95705; B4galt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST560
AC   CVCL_PC23
SY   RST560
DR   MMRRC; MMRRC:006300-UCD
DR   Wikidata; Q54780335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST561
AC   CVCL_PC24
SY   RST561
DR   MMRRC; MMRRC:006301-UCD
DR   Wikidata; Q54780336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926157; Atf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST562
AC   CVCL_PC25
SY   RST562
DR   MMRRC; MMRRC:006302-UCD
DR   Wikidata; Q54780338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST564
AC   CVCL_PC26
SY   RST564
DR   MMRRC; MMRRC:006303-UCD
DR   Wikidata; Q54780342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929940; Bcam.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST570
AC   CVCL_PC27
SY   RST570
DR   MMRRC; MMRRC:006306-UCD
DR   Wikidata; Q54780344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST571
AC   CVCL_PC28
SY   RST571
DR   MMRRC; MMRRC:006307-UCD
DR   Wikidata; Q54780346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST573
AC   CVCL_PC29
SY   RST573
DR   MMRRC; MMRRC:006308-UCD
DR   Wikidata; Q54780347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST575
AC   CVCL_PC30
SY   RST575
DR   MMRRC; MMRRC:006309-UCD
DR   Wikidata; Q54780350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST579
AC   CVCL_PC31
SY   RST579
DR   MMRRC; MMRRC:006311-UCD
DR   Wikidata; Q54780352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894663; Ext1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST586
AC   CVCL_PC32
SY   RST586
DR   MMRRC; MMRRC:006313-UCD
DR   Wikidata; Q54780353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST587
AC   CVCL_PC33
SY   RST587
DR   MMRRC; MMRRC:006314-UCD
DR   Wikidata; Q54780356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST590
AC   CVCL_PC34
SY   RST590
DR   MMRRC; MMRRC:006315-UCD
DR   Wikidata; Q54780358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920014; Csnk1g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST592
AC   CVCL_PC35
SY   RST592
DR   MMRRC; MMRRC:006316-UCD
DR   Wikidata; Q54780359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102695; Ptprf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST596
AC   CVCL_PC36
SY   RST596
DR   MMRRC; MMRRC:006318-UCD
DR   Wikidata; Q54780360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104669; Man2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST601
AC   CVCL_PC37
SY   RST601
DR   MMRRC; MMRRC:006320-UCD
DR   Wikidata; Q54780361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST602
AC   CVCL_PC38
SY   RST602
DR   MMRRC; MMRRC:006321-UCD
DR   Wikidata; Q54780363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914140; Lman2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST604
AC   CVCL_PC39
SY   RST604
DR   MMRRC; MMRRC:006322-UCD
DR   Wikidata; Q54780364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST605
AC   CVCL_PC40
SY   RST605
DR   MMRRC; MMRRC:006323-UCD
DR   Wikidata; Q54780367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441844; Tmem87a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST606
AC   CVCL_PC41
SY   RST606
DR   MMRRC; MMRRC:006324-UCD
DR   Wikidata; Q54780370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104903; Gpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST612
AC   CVCL_PC42
SY   RST612
DR   MMRRC; MMRRC:006325-UCD
DR   Wikidata; Q54780372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891468; Lgr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST613
AC   CVCL_PC43
SY   RST613
DR   MMRRC; MMRRC:006326-UCD
DR   Wikidata; Q54780375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95834; Pdia3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST620
AC   CVCL_PC44
SY   RST620
DR   MMRRC; MMRRC:006327-UCD
DR   Wikidata; Q54780376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95286; Eed.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST624
AC   CVCL_PC45
SY   RST624
DR   MMRRC; MMRRC:006328-UCD
DR   Wikidata; Q54780377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97464; P4hb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST626
AC   CVCL_PC46
SY   RST626
DR   MMRRC; MMRRC:006329-UCD
DR   Wikidata; Q54780380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101864; Dag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST630
AC   CVCL_PC47
SY   RST630
DR   MMRRC; MMRRC:006331-UCD
DR   Wikidata; Q54780381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441844; Tmem87a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST631
AC   CVCL_PC48
SY   RST631
DR   MMRRC; MMRRC:006332-UCD
DR   Wikidata; Q54780382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298204; Ppt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST634
AC   CVCL_PC49
SY   RST634
DR   MMRRC; MMRRC:006333-UCD
DR   Wikidata; Q54780386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915720; Bpnt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line RST639
AC   CVCL_PC50
SY   RST639
DR   MMRRC; MMRRC:006334-UCD
DR   Wikidata; Q54780387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST640
AC   CVCL_PC51
SY   RST640
DR   MMRRC; MMRRC:006335-UCD
DR   Wikidata; Q54780388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST641
AC   CVCL_PC52
SY   RST641
DR   MMRRC; MMRRC:006336-UCD
DR   Wikidata; Q54780389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST642
AC   CVCL_PC53
SY   RST642
DR   MMRRC; MMRRC:006337-UCD
DR   Wikidata; Q54780390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST643
AC   CVCL_PC54
SY   RST643
DR   MMRRC; MMRRC:006338-UCD
DR   Wikidata; Q54780392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441844; Tmem87a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST646
AC   CVCL_PC55
SY   RST646
DR   MMRRC; MMRRC:006339-UCD
DR   Wikidata; Q54780394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915096; Tmem39a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST647
AC   CVCL_PC56
SY   RST647
DR   MMRRC; MMRRC:006340-UCD
DR   Wikidata; Q54780397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108050; Ext2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST648
AC   CVCL_PC57
SY   RST648
DR   MMRRC; MMRRC:006341-UCD
DR   Wikidata; Q54780400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST651
AC   CVCL_PC58
SY   RST651
DR   MMRRC; MMRRC:006342-UCD
DR   Wikidata; Q54780401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST652
AC   CVCL_PC59
SY   RST652
DR   MMRRC; MMRRC:006343-UCD
DR   Wikidata; Q54780404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST653
AC   CVCL_PC60
SY   RST653
DR   MMRRC; MMRRC:006344-UCD
DR   Wikidata; Q54780408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST654
AC   CVCL_PC61
SY   RST654
DR   MMRRC; MMRRC:006345-UCD
DR   Wikidata; Q54780410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST655
AC   CVCL_PC62
SY   RST655
DR   MMRRC; MMRRC:006346-UCD
DR   Wikidata; Q54780447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924059; Bri3bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST656
AC   CVCL_PC63
SY   RST656
DR   MMRRC; MMRRC:006347-UCD
DR   Wikidata; Q54780449
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443718; Lrig2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST657
AC   CVCL_PC64
SY   RST657
DR   MMRRC; MMRRC:006348-UCD
DR   Wikidata; Q54780450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95298; Eif1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST658
AC   CVCL_PC65
SY   RST658
DR   MMRRC; MMRRC:006349-UCD
DR   Wikidata; Q54780451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927110; Tmem131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST659
AC   CVCL_PC66
SY   RST659
DR   MMRRC; MMRRC:006350-UCD
DR   Wikidata; Q54780455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923159; Vmp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST664
AC   CVCL_PC67
SY   RST664
DR   MMRRC; MMRRC:006352-UCD
DR   Wikidata; Q54780456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87904; Actb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST665
AC   CVCL_PC68
SY   RST665
DR   MMRRC; MMRRC:006353-UCD
DR   Wikidata; Q54780459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385850; Nomo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST667
AC   CVCL_PC69
SY   RST667
DR   MMRRC; MMRRC:006354-UCD
DR   Wikidata; Q54780461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139714; Adgrl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST669
AC   CVCL_PC70
SY   RST669
DR   MMRRC; MMRRC:006355-UCD
DR   Wikidata; Q54780462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST670
AC   CVCL_PC71
SY   RST670
DR   MMRRC; MMRRC:006356-UCD
DR   Wikidata; Q54780465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87904; Actb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST671
AC   CVCL_PC72
SY   RST671
DR   MMRRC; MMRRC:006357-UCD
DR   Wikidata; Q54780466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87904; Actb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST672
AC   CVCL_PC73
SY   RST672
DR   MMRRC; MMRRC:006358-UCD
DR   Wikidata; Q54780468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97388; Nucb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST673
AC   CVCL_PC74
SY   RST673
DR   MMRRC; MMRRC:006359-UCD
DR   Wikidata; Q54780472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST676
AC   CVCL_PC75
SY   RST676
DR   MMRRC; MMRRC:006360-UCD
DR   Wikidata; Q54780473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST677
AC   CVCL_PC76
SY   RST677
DR   MMRRC; MMRRC:006361-UCD
DR   Wikidata; Q54780475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST681
AC   CVCL_PC77
SY   RST681
DR   MMRRC; MMRRC:006362-UCD
DR   Wikidata; Q54780479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST688
AC   CVCL_PC78
SY   RST688
DR   MMRRC; MMRRC:006363-UCD
DR   Wikidata; Q54780480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST689
AC   CVCL_PC79
SY   RST689
DR   MMRRC; MMRRC:006364-UCD
DR   Wikidata; Q54780481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST691
AC   CVCL_PC80
SY   RST691
DR   MMRRC; MMRRC:006365-UCD
DR   Wikidata; Q54780483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST693
AC   CVCL_PC81
SY   RST693
DR   MMRRC; MMRRC:006366-UCD
DR   Wikidata; Q54780485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107804; Tuba1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST696
AC   CVCL_PC82
SY   RST696
DR   MMRRC; MMRRC:006367-UCD
DR   Wikidata; Q54780487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST703
AC   CVCL_PC83
SY   RST703
DR   MMRRC; MMRRC:006368-UCD
DR   Wikidata; Q54780489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST705
AC   CVCL_PC84
SY   RST705
DR   MMRRC; MMRRC:006369-UCD
DR   Wikidata; Q54780491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST707
AC   CVCL_PC85
SY   RST707
DR   MMRRC; MMRRC:006370-UCD
DR   Wikidata; Q54780492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST718
AC   CVCL_PC86
SY   RST718
DR   MMRRC; MMRRC:006371-UCD
DR   Wikidata; Q54780495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST719
AC   CVCL_PC87
SY   RST719
DR   MMRRC; MMRRC:006372-UCD
DR   Wikidata; Q54780497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST725
AC   CVCL_PC88
SY   RST725
DR   MMRRC; MMRRC:006373-UCD
DR   Wikidata; Q54780500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST727
AC   CVCL_PC89
SY   RST727
DR   MMRRC; MMRRC:006375-UCD
DR   Wikidata; Q54780503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341830; Eif2ak3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST732
AC   CVCL_PC90
SY   RST732
DR   MMRRC; MMRRC:006377-UCD
DR   Wikidata; Q54780504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921867; Scpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST733
AC   CVCL_PC91
SY   RST733
DR   MMRRC; MMRRC:006378-UCD
DR   Wikidata; Q54780507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST734
AC   CVCL_PC92
SY   RST734
DR   MMRRC; MMRRC:006379-UCD
DR   Wikidata; Q54780510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST735
AC   CVCL_PC93
SY   RST735
DR   MMRRC; MMRRC:006380-UCD
DR   Wikidata; Q54780512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST736
AC   CVCL_PC94
SY   RST736
DR   MMRRC; MMRRC:006381-UCD
DR   Wikidata; Q54780514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST737
AC   CVCL_PC95
SY   RST737
DR   MMRRC; MMRRC:006382-UCD
DR   Wikidata; Q54780517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST738
AC   CVCL_PC96
SY   RST738
DR   MMRRC; MMRRC:006383-UCD
DR   Wikidata; Q54780518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109207; Eif4g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST743
AC   CVCL_PC97
SY   RST743
DR   MMRRC; MMRRC:006384-UCD
DR   Wikidata; Q54780521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99894; Hnrnpk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST744
AC   CVCL_PC98
SY   RST744
DR   MMRRC; MMRRC:006385-UCD
DR   Wikidata; Q54780523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST749
AC   CVCL_PC99
SY   RST749
DR   MMRRC; MMRRC:006388-UCD
DR   Wikidata; Q54780527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST752
AC   CVCL_PD00
SY   RST752
DR   MMRRC; MMRRC:006389-UCD
DR   Wikidata; Q54780528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333805; Srsf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST753
AC   CVCL_PD01
SY   RST753
DR   MMRRC; MMRRC:006390-UCD
DR   Wikidata; Q54780531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914347; Rps10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST760
AC   CVCL_PD02
SY   RST760
DR   MMRRC; MMRRC:006391-UCD
DR   Wikidata; Q54780566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889844; Sumf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST768
AC   CVCL_PD03
SY   RST768
DR   MMRRC; MMRRC:006393-UCD
DR   Wikidata; Q54780569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927110; Tmem131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST769
AC   CVCL_PD04
SY   RST769
DR   MMRRC; MMRRC:006394-UCD
DR   Wikidata; Q54780573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99894; Hnrnpk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line RST770
AC   CVCL_PD05
SY   RST770
DR   MMRRC; MMRRC:006395-UCD
DR   Wikidata; Q54780574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894663; Ext1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line ST484
AC   CVCL_PD06
SY   ST484
DR   MMRRC; MMRRC:006398-UCD
DR   Wikidata; Q54780575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102695; Ptprf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line ST497
AC   CVCL_PD07
SY   ST497
DR   MMRRC; MMRRC:006399-UCD
DR   Wikidata; Q54780576
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98277; Epha4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line ST514
AC   CVCL_PD08
SY   ST514
DR   MMRRC; MMRRC:006400-UCD
DR   Wikidata; Q54780580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105088; Ntn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line ST519
AC   CVCL_PD09
SY   ST519
DR   MMRRC; MMRRC:006401-UCD
DR   Wikidata; Q54780582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line ST531
AC   CVCL_PD10
SY   ST531
DR   MMRRC; MMRRC:006402-UCD
DR   Wikidata; Q54780585
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line ST567
AC   CVCL_PD11
SY   ST567
DR   MMRRC; MMRRC:006404-UCD
DR   Wikidata; Q54780587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95321; Emb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line ST629
AC   CVCL_PD12
SY   ST629
DR   MMRRC; MMRRC:006405-UCD
DR   Wikidata; Q54780590
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105088; Ntn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA004
AC   CVCL_PD13
SY   STA004
DR   MMRRC; MMRRC:006407-UCD
DR   Wikidata; Q54780593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443699; Fubp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA005
AC   CVCL_PD14
SY   STA005
DR   MMRRC; MMRRC:006408-UCD
DR   Wikidata; Q54780595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97364; Notch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA006
AC   CVCL_PD15
SY   STA006
DR   MMRRC; MMRRC:006409-UCD
DR   Wikidata; Q54780596
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA011
AC   CVCL_PD16
SY   STA011
DR   MMRRC; MMRRC:006410-UCD
DR   Wikidata; Q54780597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926252; Gipc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA018
AC   CVCL_PD17
SY   STA018
DR   MMRRC; MMRRC:006412-UCD
DR   Wikidata; Q54780599
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm2050 (MGI:3780218) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line STA020
AC   CVCL_PD18
SY   STA020
DR   MMRRC; MMRRC:006413-UCD
DR   Wikidata; Q54780603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388280; Polr2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA021
AC   CVCL_PD19
SY   STA021
DR   MMRRC; MMRRC:006414-UCD
DR   Wikidata; Q54780604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97838; Eprs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA027
AC   CVCL_PD20
SY   STA027
DR   MMRRC; MMRRC:006415-UCD
DR   Wikidata; Q54780606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA028
AC   CVCL_PD21
SY   STA028
DR   MMRRC; MMRRC:006416-UCD
DR   Wikidata; Q54780609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105968; Txlna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA029
AC   CVCL_PD22
SY   STA029
DR   MMRRC; MMRRC:006417-UCD
DR   Wikidata; Q54780611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA031
AC   CVCL_PD23
SY   STA031
DR   MMRRC; MMRRC:006418-UCD
DR   Wikidata; Q54780612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109349; Atf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA034
AC   CVCL_PD24
SY   STA034
DR   MMRRC; MMRRC:006419-UCD
DR   Wikidata; Q54780616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA054
AC   CVCL_PD25
SY   STA054
DR   MMRRC; MMRRC:006427-UCD
DR   Wikidata; Q54780618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349767; Polk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA057
AC   CVCL_PD26
SY   STA057
DR   MMRRC; MMRRC:006428-UCD
DR   Wikidata; Q54780619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927344; Gmnn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA066
AC   CVCL_PD27
SY   STA066
DR   MMRRC; MMRRC:006433-UCD
DR   Wikidata; Q54780621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927167; Morf4l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA067
AC   CVCL_PD28
SY   STA067
DR   MMRRC; MMRRC:006434-UCD
DR   Wikidata; Q54780624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920247; Kantr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA072
AC   CVCL_PD29
SY   STA072
DR   MMRRC; MMRRC:006435-UCD
DR   Wikidata; Q54780625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA075
AC   CVCL_PD30
SY   STA075
DR   MMRRC; MMRRC:006436-UCD
DR   Wikidata; Q54780628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:93830; Adipor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA078
AC   CVCL_PD31
SY   STA078
DR   MMRRC; MMRRC:006437-UCD
DR   Wikidata; Q54780632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922066; Tpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA082
AC   CVCL_PD32
SY   STA082
DR   MMRRC; MMRRC:006438-UCD
DR   Wikidata; Q54780634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914228; Luc7l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA084
AC   CVCL_PD33
SY   STA084
DR   MMRRC; MMRRC:006439-UCD
DR   Wikidata; Q54780637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2175912; Arid5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA093
AC   CVCL_PD34
SY   STA093
DR   MMRRC; MMRRC:006442-UCD
DR   Wikidata; Q54780638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95301; Eif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA094
AC   CVCL_PD35
SY   STA094
DR   MMRRC; MMRRC:006443-UCD
DR   Wikidata; Q54780639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA100
AC   CVCL_PD36
SY   STA100
DR   MMRRC; MMRRC:006446-UCD
DR   Wikidata; Q54780640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442943; Zfp668.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA103
AC   CVCL_PD37
SY   STA103
DR   MMRRC; MMRRC:006447-UCD
DR   Wikidata; Q54780641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925503; Map4k5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA104
AC   CVCL_PD38
SY   STA104
DR   MMRRC; MMRRC:006448-UCD
DR   Wikidata; Q54780643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915208; U2surp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA107
AC   CVCL_PD39
SY   STA107
DR   MMRRC; MMRRC:006451-UCD
DR   Wikidata; Q54780646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914119; Zfp869.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STA117
AC   CVCL_PD40
SY   STA117
DR   MMRRC; MMRRC:006455-UCD
DR   Wikidata; Q54780648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101884; Ppard.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STB015
AC   CVCL_PD41
SY   STB015
DR   MMRRC; MMRRC:010423-UCD
DR   Wikidata; Q54780650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STB050
AC   CVCL_PD42
SY   STB050
DR   MMRRC; MMRRC:010425-UCD
DR   Wikidata; Q54780693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915546; Smu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STB080
AC   CVCL_PD43
SY   STB080
DR   MMRRC; MMRRC:010427-UCD
DR   Wikidata; Q54780694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STB129
AC   CVCL_PD44
SY   STB129
DR   MMRRC; MMRRC:010429-UCD
DR   Wikidata; Q54780696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STB249
AC   CVCL_PD45
SY   STB249
DR   MMRRC; MMRRC:010457-UCD
DR   Wikidata; Q54780697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384569; Klhdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line STB609
AC   CVCL_PD46
SY   STB609
DR   MMRRC; MMRRC:010430-UCD
DR   Wikidata; Q54780699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA010
AC   CVCL_PD47
SY   SYA010
DR   MMRRC; MMRRC:016099-UCD
DR   Wikidata; Q54780702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA011
AC   CVCL_PD48
SY   SYA011
DR   MMRRC; MMRRC:016122-UCD
DR   Wikidata; Q54780703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA012
AC   CVCL_PD49
SY   SYA012
DR   MMRRC; MMRRC:016042-UCD
DR   Wikidata; Q54780705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA013
AC   CVCL_PD50
SY   SYA013
DR   MMRRC; MMRRC:016064-UCD
DR   Wikidata; Q54780708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA043
AC   CVCL_PD51
SY   SYA043
DR   MMRRC; MMRRC:016087-UCD
DR   Wikidata; Q54780709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA045
AC   CVCL_PD52
SY   SYA045
DR   MMRRC; MMRRC:016056-UCD
DR   Wikidata; Q54780712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3763743; Snhg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA056
AC   CVCL_PD53
SY   SYA056
DR   MMRRC; MMRRC:016066-UCD
DR   Wikidata; Q54780714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA061
AC   CVCL_PD54
SY   SYA061
DR   MMRRC; MMRRC:016111-UCD
DR   Wikidata; Q54780718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443590; Ddx11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA072
AC   CVCL_PD55
SY   SYA072
DR   MMRRC; MMRRC:016057-UCD
DR   Wikidata; Q54780722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA073
AC   CVCL_PD56
SY   SYA073
DR   MMRRC; MMRRC:016067-UCD
DR   Wikidata; Q54780724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA074
AC   CVCL_PD57
SY   SYA074
DR   MMRRC; MMRRC:016078-UCD
DR   Wikidata; Q54780725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA077
AC   CVCL_PD58
SY   SYA077
DR   MMRRC; MMRRC:016090-UCD
DR   Wikidata; Q54780728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153063; Parvb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA089
AC   CVCL_PD59
SY   SYA089
DR   MMRRC; MMRRC:016113-UCD
DR   Wikidata; Q54780729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329034; Ccne2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA102
AC   CVCL_PD60
SY   SYA102
DR   MMRRC; MMRRC:016092-UCD
DR   Wikidata; Q54780731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA108
AC   CVCL_PD61
SY   SYA108
DR   MMRRC; MMRRC:016102-UCD
DR   Wikidata; Q54780733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA110
AC   CVCL_PD62
SY   SYA110
DR   MMRRC; MMRRC:016093-UCD
DR   Wikidata; Q54780736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921807; Ppp6r3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA111
AC   CVCL_PD63
SY   SYA111
DR   MMRRC; MMRRC:016094-UCD
DR   Wikidata; Q54780739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354175; Txnrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA112
AC   CVCL_PD64
SY   SYA112
DR   MMRRC; MMRRC:016114-UCD
DR   Wikidata; Q54780742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684817; Snhg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA113
AC   CVCL_PD65
SY   SYA113
DR   MMRRC; MMRRC:016047-UCD
DR   Wikidata; Q54780745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA117
AC   CVCL_PD66
SY   SYA117
DR   MMRRC; MMRRC:016048-UCD
DR   Wikidata; Q54780747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144224; Dnaaf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line SYA125
AC   CVCL_PD67
SY   SYA125
DR   MMRRC; MMRRC:016211-UCD
DR   Wikidata; Q54780750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87859; Abl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA126
AC   CVCL_PD68
SY   SYA126
DR   MMRRC; MMRRC:016248-UCD
DR   Wikidata; Q54780752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914923; Elob.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA128
AC   CVCL_PD69
SY   SYA128
DR   MMRRC; MMRRC:016293-UCD
DR   Wikidata; Q54780753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920832; Camkmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA132
AC   CVCL_PD70
SY   SYA132
DR   MMRRC; MMRRC:016294-UCD
DR   Wikidata; Q54780756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95286; Eed.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA134
AC   CVCL_PD71
SY   SYA134
DR   MMRRC; MMRRC:016212-UCD
DR   Wikidata; Q54780758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914923; Elob.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA135
AC   CVCL_PD72
SY   SYA135
DR   MMRRC; MMRRC:016173-UCD
DR   Wikidata; Q54780761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108451; Acaca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA137
AC   CVCL_PD73
SY   SYA137
DR   MMRRC; MMRRC:016270-UCD
DR   Wikidata; Q54780764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384993; Paip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA138
AC   CVCL_PD74
SY   SYA138
DR   MMRRC; MMRRC:016322-UCD
DR   Wikidata; Q54780766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203484; Zfp638.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA140
AC   CVCL_PD75
SY   SYA140
DR   MMRRC; MMRRC:016249-UCD
DR   Wikidata; Q54780768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA142
AC   CVCL_PD76
SY   SYA142
DR   MMRRC; MMRRC:016250-UCD
DR   Wikidata; Q54780770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915984; Ppp4r3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA144
AC   CVCL_PD77
SY   SYA144
DR   MMRRC; MMRRC:016174-UCD
DR   Wikidata; Q54780773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141847; Phrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA146
AC   CVCL_PD78
SY   SYA146
DR   MMRRC; MMRRC:016296-UCD
DR   Wikidata; Q54780774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446249; Edc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA147
AC   CVCL_PD79
SY   SYA147
DR   MMRRC; MMRRC:016175-UCD
DR   Wikidata; Q54780777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929264; Sae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA153
AC   CVCL_PD80
SY   SYA153
DR   MMRRC; MMRRC:016251-UCD
DR   Wikidata; Q54780780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921700; Pank2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA162
AC   CVCL_PD81
SY   SYA162
DR   MMRRC; MMRRC:016229-UCD
DR   Wikidata; Q54780781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918272; Ston2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA169
AC   CVCL_PD82
SY   SYA169
DR   MMRRC; MMRRC:016272-UCD
DR   Wikidata; Q54780815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929264; Sae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA170
AC   CVCL_PD83
SY   SYA170
DR   MMRRC; MMRRC:016193-UCD
DR   Wikidata; Q54780816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA173
AC   CVCL_PD84
SY   SYA173
DR   MMRRC; MMRRC:016253-UCD
DR   Wikidata; Q54780818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA176
AC   CVCL_PD85
SY   SYA176
DR   MMRRC; MMRRC:016297-UCD
DR   Wikidata; Q54780820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921355; Gga2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA183
AC   CVCL_PD86
SY   SYA183
DR   MMRRC; MMRRC:016231-UCD
DR   Wikidata; Q54780821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925771; B230219D22Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA185
AC   CVCL_PD87
SY   SYA185
DR   MMRRC; MMRRC:016176-UCD
DR   Wikidata; Q54780823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88192; Smarca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA187
AC   CVCL_PD88
SY   SYA187
DR   MMRRC; MMRRC:016194-UCD
DR   Wikidata; Q54780827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913466; Bsdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA191
AC   CVCL_PD89
SY   SYA191
DR   MMRRC; MMRRC:016325-UCD
DR   Wikidata; Q54780828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918019; Nolc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA196
AC   CVCL_PD90
SY   SYA196
DR   MMRRC; MMRRC:016195-UCD
DR   Wikidata; Q54780831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA202
AC   CVCL_PD91
SY   SYA202
DR   MMRRC; MMRRC:016232-UCD
DR   Wikidata; Q54780833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894697; Rad54l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA207
AC   CVCL_PD92
SY   SYA207
DR   MMRRC; MMRRC:016254-UCD
DR   Wikidata; Q54780836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913917; Hspbap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA208
AC   CVCL_PD93
SY   SYA208
DR   MMRRC; MMRRC:016275-UCD
DR   Wikidata; Q54780839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039623; Thada.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA210
AC   CVCL_PD94
SY   SYA210
DR   MMRRC; MMRRC:016276-UCD
DR   Wikidata; Q54780841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA212
AC   CVCL_PD95
SY   SYA212
DR   MMRRC; MMRRC:016298-UCD
DR   Wikidata; Q54780843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA217
AC   CVCL_PD96
SY   SYA217
DR   MMRRC; MMRRC:016277-UCD
DR   Wikidata; Q54780844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA222
AC   CVCL_PD97
SY   SYA222
DR   MMRRC; MMRRC:016299-UCD
DR   Wikidata; Q54780845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914923; Elob.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA224
AC   CVCL_PD98
SY   SYA224
DR   MMRRC; MMRRC:016300-UCD
DR   Wikidata; Q54780847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA225
AC   CVCL_PD99
SY   SYA225
DR   MMRRC; MMRRC:016327-UCD
DR   Wikidata; Q54780851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917433; Dzip3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA226
AC   CVCL_PE00
SY   SYA226
DR   MMRRC; MMRRC:016196-UCD
DR   Wikidata; Q54780852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443298; Tet2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA228
AC   CVCL_PE01
SY   SYA228
DR   MMRRC; MMRRC:016301-UCD
DR   Wikidata; Q54780853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88266; Capns1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA242
AC   CVCL_PE02
SY   SYA242
DR   MMRRC; MMRRC:016255-UCD
DR   Wikidata; Q54780855
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140359; Tmem64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA245
AC   CVCL_PE03
SY   SYA245
DR   MMRRC; MMRRC:016328-UCD
DR   Wikidata; Q54780858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145578; Slain1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA247
AC   CVCL_PE04
SY   SYA247
DR   MMRRC; MMRRC:016214-UCD
DR   Wikidata; Q54780860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA252
AC   CVCL_PE05
SY   SYA252
DR   MMRRC; MMRRC:016256-UCD
DR   Wikidata; Q54780862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3027896; Ppp4r2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA253
AC   CVCL_PE06
SY   SYA253
DR   MMRRC; MMRRC:016177-UCD
DR   Wikidata; Q54780863
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA254
AC   CVCL_PE07
SY   SYA254
DR   MMRRC; MMRRC:016197-UCD
DR   Wikidata; Q54780864
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444008; Bptf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA262
AC   CVCL_PE08
SY   SYA262
DR   MMRRC; MMRRC:016303-UCD
DR   Wikidata; Q54780866
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441773; Pcmtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA264
AC   CVCL_PE09
SY   SYA264
DR   MMRRC; MMRRC:016278-UCD
DR   Wikidata; Q54780869
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA268
AC   CVCL_PE10
SY   SYA268
DR   MMRRC; MMRRC:016158-UCD
DR   Wikidata; Q54780872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA276
AC   CVCL_PE11
SY   SYA276
DR   MMRRC; MMRRC:016279-UCD
DR   Wikidata; Q54780874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3615624; Atg4a-ps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA278
AC   CVCL_PE12
SY   SYA278
DR   MMRRC; MMRRC:016216-UCD
DR   Wikidata; Q54780876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861607; Gbf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA280
AC   CVCL_PE13
SY   SYA280
DR   MMRRC; MMRRC:016280-UCD
DR   Wikidata; Q54780877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913917; Hspbap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA282
AC   CVCL_PE14
SY   SYA282
DR   MMRRC; MMRRC:016233-UCD
DR   Wikidata; Q54780880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA283
AC   CVCL_PE15
SY   SYA283
DR   MMRRC; MMRRC:016198-UCD
DR   Wikidata; Q54780881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA285
AC   CVCL_PE16
SY   SYA285
DR   MMRRC; MMRRC:016159-UCD
DR   Wikidata; Q54780882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109529; Dpf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA297
AC   CVCL_PE17
SY   SYA297
DR   MMRRC; MMRRC:016234-UCD
DR   Wikidata; Q54780884
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444354; Arid4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA298
AC   CVCL_PE18
SY   SYA298
DR   MMRRC; MMRRC:016258-UCD
DR   Wikidata; Q54780886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913915; Msantd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA299
AC   CVCL_PE19
SY   SYA299
DR   MMRRC; MMRRC:016281-UCD
DR   Wikidata; Q54780888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97594; Prkacb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA300
AC   CVCL_PE20
SY   SYA300
DR   MMRRC; MMRRC:016304-UCD
DR   Wikidata; Q54780890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97594; Prkacb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA301
AC   CVCL_PE21
SY   SYA301
DR   MMRRC; MMRRC:016305-UCD
DR   Wikidata; Q54780891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA303
AC   CVCL_PE22
SY   SYA303
DR   MMRRC; MMRRC:016306-UCD
DR   Wikidata; Q54780936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926162; Sp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA309
AC   CVCL_PE23
SY   SYA309
DR   MMRRC; MMRRC:016181-UCD
DR   Wikidata; Q54780937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104811; Sub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA313
AC   CVCL_PE24
SY   SYA313
DR   MMRRC; MMRRC:016282-UCD
DR   Wikidata; Q54780939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447364; Smg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA318
AC   CVCL_PE25
SY   SYA318
DR   MMRRC; MMRRC:016235-UCD
DR   Wikidata; Q54780943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA319
AC   CVCL_PE26
SY   SYA319
DR   MMRRC; MMRRC:016259-UCD
DR   Wikidata; Q54780945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919891; Mob2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA320
AC   CVCL_PE27
SY   SYA320
DR   MMRRC; MMRRC:016236-UCD
DR   Wikidata; Q54780946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929183; Tsc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA323
AC   CVCL_PE28
SY   SYA323
DR   MMRRC; MMRRC:016160-UCD
DR   Wikidata; Q54780948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2687042; Ppp1r37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA326
AC   CVCL_PE29
SY   SYA326
DR   MMRRC; MMRRC:016218-UCD
DR   Wikidata; Q54780950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104537; Brca1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA334
AC   CVCL_PE30
SY   SYA334
DR   MMRRC; MMRRC:016201-UCD
DR   Wikidata; Q54780952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913937; Tbc1d15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA336
AC   CVCL_PE31
SY   SYA336
DR   MMRRC; MMRRC:016161-UCD
DR   Wikidata; Q54780954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107726; Supt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA337
AC   CVCL_PE32
SY   SYA337
DR   MMRRC; MMRRC:016238-UCD
DR   Wikidata; Q54780957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109233; Kif22.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA338
AC   CVCL_PE33
SY   SYA338
DR   MMRRC; MMRRC:016182-UCD
DR   Wikidata; Q54780960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922989; Mpp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA341
AC   CVCL_PE34
SY   SYA341
DR   MMRRC; MMRRC:016183-UCD
DR   Wikidata; Q54780962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915038; Sfr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA352
AC   CVCL_PE35
SY   SYA352
DR   MMRRC; MMRRC:016219-UCD
DR   Wikidata; Q54780964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096572; Zfand3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA356
AC   CVCL_PE36
SY   SYA356
DR   MMRRC; MMRRC:016185-UCD
DR   Wikidata; Q54780966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA358
AC   CVCL_PE37
SY   SYA358
DR   MMRRC; MMRRC:016239-UCD
DR   Wikidata; Q54780968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA359
AC   CVCL_PE38
SY   SYA359
DR   MMRRC; MMRRC:016240-UCD
DR   Wikidata; Q54780970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858232; Nudt5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA361
AC   CVCL_PE39
SY   SYA361
DR   MMRRC; MMRRC:016310-UCD
DR   Wikidata; Q54780972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924295; Bcl7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA364
AC   CVCL_PE40
SY   SYA364
DR   MMRRC; MMRRC:016311-UCD
DR   Wikidata; Q54780973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA369
AC   CVCL_PE41
SY   SYA369
DR   MMRRC; MMRRC:016261-UCD
DR   Wikidata; Q54780976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351660; Csnk1e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA372
AC   CVCL_PE42
SY   SYA372
DR   MMRRC; MMRRC:016162-UCD
DR   Wikidata; Q54780977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444720; Smcr8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA376
AC   CVCL_PE43
SY   SYA376
DR   MMRRC; MMRRC:016284-UCD
DR   Wikidata; Q54780979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108025; Prkar2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA377
AC   CVCL_PE44
SY   SYA377
DR   MMRRC; MMRRC:016186-UCD
DR   Wikidata; Q54780980
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919822; Spats2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA379
AC   CVCL_PE45
SY   SYA379
DR   MMRRC; MMRRC:016187-UCD
DR   Wikidata; Q54780983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685013; Cog7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA388
AC   CVCL_PE46
SY   SYA388
DR   MMRRC; MMRRC:016222-UCD
DR   Wikidata; Q54780985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA390
AC   CVCL_PE47
SY   SYA390
DR   MMRRC; MMRRC:016286-UCD
DR   Wikidata; Q54780986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700012; Ostf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA393
AC   CVCL_PE48
SY   SYA393
DR   MMRRC; MMRRC:016241-UCD
DR   Wikidata; Q54780987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926143; Cnot10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA394
AC   CVCL_PE49
SY   SYA394
DR   MMRRC; MMRRC:016203-UCD
DR   Wikidata; Q54780990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA397
AC   CVCL_PE50
SY   SYA397
DR   MMRRC; MMRRC:016287-UCD
DR   Wikidata; Q54780992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA398
AC   CVCL_PE51
SY   SYA398
DR   MMRRC; MMRRC:016224-UCD
DR   Wikidata; Q54780994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921356; Dcaf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA401
AC   CVCL_PE52
SY   SYA401
DR   MMRRC; MMRRC:016315-UCD
DR   Wikidata; Q54780997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446190; Nup188.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA403
AC   CVCL_PE53
SY   SYA403
DR   MMRRC; MMRRC:016204-UCD
DR   Wikidata; Q54781000
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm3941 (MGI:3782115) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line SYA405
AC   CVCL_PE54
SY   SYA405
DR   MMRRC; MMRRC:016317-UCD
DR   Wikidata; Q54781001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98444; Surf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA410
AC   CVCL_PE55
SY   SYA410
DR   MMRRC; MMRRC:016188-UCD
DR   Wikidata; Q54781003
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA411
AC   CVCL_PE56
SY   SYA411
DR   MMRRC; MMRRC:016262-UCD
DR   Wikidata; Q54781006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103262; Yap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA416
AC   CVCL_PE57
SY   SYA416
DR   MMRRC; MMRRC:016163-UCD
DR   Wikidata; Q54781007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line SYA418
AC   CVCL_PE58
SY   SYA418
DR   MMRRC; MMRRC:016263-UCD
DR   Wikidata; Q54781011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA004
AC   CVCL_PE59
SY   TEA004
DR   MMRRC; MMRRC:006458-UCD
DR   Wikidata; Q54781013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA005
AC   CVCL_PE60
SY   TEA005
DR   MMRRC; MMRRC:006459-UCD
DR   Wikidata; Q54781015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889002; Wdr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA006
AC   CVCL_PE61
SY   TEA006
DR   MMRRC; MMRRC:006460-UCD
DR   Wikidata; Q54781017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA007
AC   CVCL_PE62
SY   TEA007
DR   MMRRC; MMRRC:006461-UCD
DR   Wikidata; Q54781062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921565; Rnf145.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA009
AC   CVCL_PE63
SY   TEA009
DR   MMRRC; MMRRC:006462-UCD
DR   Wikidata; Q54781064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915512; Agpat4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA010
AC   CVCL_PE64
SY   TEA010
DR   MMRRC; MMRRC:006463-UCD
DR   Wikidata; Q54781066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347043; Orc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA011
AC   CVCL_PE65
SY   TEA011
DR   MMRRC; MMRRC:006464-UCD
DR   Wikidata; Q54781067
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353655; Usp25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA013
AC   CVCL_PE66
SY   TEA013
DR   MMRRC; MMRRC:006465-UCD
DR   Wikidata; Q54781069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138584; Gigyf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA015
AC   CVCL_PE67
SY   TEA015
DR   MMRRC; MMRRC:006466-UCD
DR   Wikidata; Q54781071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107940; Ezh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA017
AC   CVCL_PE68
SY   TEA017
DR   MMRRC; MMRRC:006467-UCD
DR   Wikidata; Q54781072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA020
AC   CVCL_PE69
SY   TEA020
DR   MMRRC; MMRRC:006468-UCD
DR   Wikidata; Q54781074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355272; Csnk1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA021
AC   CVCL_PE70
SY   TEA021
DR   MMRRC; MMRRC:006469-UCD
DR   Wikidata; Q54781078
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96269; Ranbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA022
AC   CVCL_PE71
SY   TEA022
DR   MMRRC; MMRRC:006470-UCD
DR   Wikidata; Q54781081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96269; Ranbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA023
AC   CVCL_PE72
SY   TEA023
DR   MMRRC; MMRRC:006471-UCD
DR   Wikidata; Q54781083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96269; Ranbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA025
AC   CVCL_PE73
SY   TEA025
DR   MMRRC; MMRRC:006472-UCD
DR   Wikidata; Q54781085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA028
AC   CVCL_PE74
SY   TEA028
DR   MMRRC; MMRRC:006473-UCD
DR   Wikidata; Q54781086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA030
AC   CVCL_PE75
SY   TEA030
DR   MMRRC; MMRRC:006474-UCD
DR   Wikidata; Q54781090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146808; Safb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA031
AC   CVCL_PE76
SY   TEA031
DR   MMRRC; MMRRC:006475-UCD
DR   Wikidata; Q54781093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923998; Pbrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA033
AC   CVCL_PE77
SY   TEA033
DR   MMRRC; MMRRC:006476-UCD
DR   Wikidata; Q54781095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342295; Celf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA034
AC   CVCL_PE78
SY   TEA034
DR   MMRRC; MMRRC:006477-UCD
DR   Wikidata; Q54781096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342295; Celf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA035
AC   CVCL_PE79
SY   TEA035
DR   MMRRC; MMRRC:006478-UCD
DR   Wikidata; Q54781100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447063; Tenm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA036
AC   CVCL_PE80
SY   TEA036
DR   MMRRC; MMRRC:006479-UCD
DR   Wikidata; Q54781102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894649; Ppfibp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA037
AC   CVCL_PE81
SY   TEA037
DR   MMRRC; MMRRC:006480-UCD
DR   Wikidata; Q54781104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447063; Tenm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA038
AC   CVCL_PE82
SY   TEA038
DR   MMRRC; MMRRC:006481-UCD
DR   Wikidata; Q54781106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA041
AC   CVCL_PE83
SY   TEA041
DR   MMRRC; MMRRC:006483-UCD
DR   Wikidata; Q54781107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88548; Csnk2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA043
AC   CVCL_PE84
SY   TEA043
DR   MMRRC; MMRRC:006484-UCD
DR   Wikidata; Q54781108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098258; Kif15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA044
AC   CVCL_PE85
SY   TEA044
DR   MMRRC; MMRRC:006485-UCD
DR   Wikidata; Q54781110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA045
AC   CVCL_PE86
SY   TEA045
DR   MMRRC; MMRRC:006486-UCD
DR   Wikidata; Q54781113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA046
AC   CVCL_PE87
SY   TEA046
DR   MMRRC; MMRRC:006487-UCD
DR   Wikidata; Q54781117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916327; Psmd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA047
AC   CVCL_PE88
SY   TEA047
DR   MMRRC; MMRRC:006488-UCD
DR   Wikidata; Q54781119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095419; Kdm6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA050
AC   CVCL_PE89
SY   TEA050
DR   MMRRC; MMRRC:006489-UCD
DR   Wikidata; Q54781120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346834; Nr5a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA051
AC   CVCL_PE90
SY   TEA051
DR   MMRRC; MMRRC:006490-UCD
DR   Wikidata; Q54781122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA052
AC   CVCL_PE91
SY   TEA052
DR   MMRRC; MMRRC:006491-UCD
DR   Wikidata; Q54781124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446143; Zfc3h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA054
AC   CVCL_PE92
SY   TEA054
DR   MMRRC; MMRRC:006492-UCD
DR   Wikidata; Q54781125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA055
AC   CVCL_PE93
SY   TEA055
DR   MMRRC; MMRRC:006493-UCD
DR   Wikidata; Q54781128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918667; Gpatch8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA056
AC   CVCL_PE94
SY   TEA056
DR   MMRRC; MMRRC:006494-UCD
DR   Wikidata; Q54781131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196439; Cbx7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA057
AC   CVCL_PE95
SY   TEA057
DR   MMRRC; MMRRC:006495-UCD
DR   Wikidata; Q54781132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385848; Bcas3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA058
AC   CVCL_PE96
SY   TEA058
DR   MMRRC; MMRRC:006496-UCD
DR   Wikidata; Q54781134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA059
AC   CVCL_PE97
SY   TEA059
DR   MMRRC; MMRRC:006497-UCD
DR   Wikidata; Q54781137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277119; Zfp105.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA060
AC   CVCL_PE98
SY   TEA060
DR   MMRRC; MMRRC:006498-UCD
DR   Wikidata; Q54781140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922589; Mphosph8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA061
AC   CVCL_PE99
SY   TEA061
DR   MMRRC; MMRRC:006499-UCD
DR   Wikidata; Q54781141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923749; Clasp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA062
AC   CVCL_PF00
SY   TEA062
DR   MMRRC; MMRRC:006500-UCD
DR   Wikidata; Q54781142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448480; Fancd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA063
AC   CVCL_PF01
SY   TEA063
DR   MMRRC; MMRRC:006501-UCD
DR   Wikidata; Q54781145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913732; Exoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA065
AC   CVCL_PF02
SY   TEA065
DR   MMRRC; MMRRC:006502-UCD
DR   Wikidata; Q54781190
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338037; Rbm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA071
AC   CVCL_PF03
SY   TEA071
DR   MMRRC; MMRRC:006504-UCD
DR   Wikidata; Q54781192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA073
AC   CVCL_PF04
SY   TEA073
DR   MMRRC; MMRRC:006506-UCD
DR   Wikidata; Q54781194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138584; Gigyf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA074
AC   CVCL_PF05
SY   TEA074
DR   MMRRC; MMRRC:006507-UCD
DR   Wikidata; Q54781196
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915434; Denr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA075
AC   CVCL_PF06
SY   TEA075
DR   MMRRC; MMRRC:006508-UCD
DR   Wikidata; Q54781199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915434; Denr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA078
AC   CVCL_PF07
SY   TEA078
DR   MMRRC; MMRRC:006510-UCD
DR   Wikidata; Q54781202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925905; Eif3j1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA080
AC   CVCL_PF08
SY   TEA080
DR   MMRRC; MMRRC:006511-UCD
DR   Wikidata; Q54781203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914595; Herc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA082
AC   CVCL_PF09
SY   TEA082
DR   MMRRC; MMRRC:006513-UCD
DR   Wikidata; Q54781205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925905; Eif3j1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA084
AC   CVCL_PF10
SY   TEA084
DR   MMRRC; MMRRC:006514-UCD
DR   Wikidata; Q54781208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919908; 2700097O09Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA085
AC   CVCL_PF11
SY   TEA085
DR   MMRRC; MMRRC:006515-UCD
DR   Wikidata; Q54781209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA088
AC   CVCL_PF12
SY   TEA088
DR   MMRRC; MMRRC:006517-UCD
DR   Wikidata; Q54781210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916471; 2410006H16Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA089
AC   CVCL_PF13
SY   TEA089
DR   MMRRC; MMRRC:006518-UCD
DR   Wikidata; Q54781214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA090
AC   CVCL_PF14
SY   TEA090
DR   MMRRC; MMRRC:006519-UCD
DR   Wikidata; Q54781215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA091
AC   CVCL_PF15
SY   TEA091
DR   MMRRC; MMRRC:006520-UCD
DR   Wikidata; Q54781216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99700; Cenpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA092
AC   CVCL_PF16
SY   TEA092
DR   MMRRC; MMRRC:006521-UCD
DR   Wikidata; Q54781218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444222; Tmem104.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA097
AC   CVCL_PF17
SY   TEA097
DR   MMRRC; MMRRC:006522-UCD
DR   Wikidata; Q54781219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA099
AC   CVCL_PF18
SY   TEA099
DR   MMRRC; MMRRC:006523-UCD
DR   Wikidata; Q54781222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA101
AC   CVCL_PF19
SY   TEA101
DR   MMRRC; MMRRC:006524-UCD
DR   Wikidata; Q54781223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA104
AC   CVCL_PF20
SY   TEA104
DR   MMRRC; MMRRC:006526-UCD
DR   Wikidata; Q54781225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106913; Abi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA105
AC   CVCL_PF21
SY   TEA105
DR   MMRRC; MMRRC:006527-UCD
DR   Wikidata; Q54781226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443446; Scfd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA106
AC   CVCL_PF22
SY   TEA106
DR   MMRRC; MMRRC:006528-UCD
DR   Wikidata; Q54781229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108247; Tdg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA107
AC   CVCL_PF23
SY   TEA107
DR   MMRRC; MMRRC:006529-UCD
DR   Wikidata; Q54781232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA112
AC   CVCL_PF24
SY   TEA112
DR   MMRRC; MMRRC:006531-UCD
DR   Wikidata; Q54781234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098583; Stag2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA113
AC   CVCL_PF25
SY   TEA113
DR   MMRRC; MMRRC:006532-UCD
DR   Wikidata; Q54781236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA120
AC   CVCL_PF26
SY   TEA120
DR   MMRRC; MMRRC:006534-UCD
DR   Wikidata; Q54781237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914309; Ola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA121
AC   CVCL_PF27
SY   TEA121
DR   MMRRC; MMRRC:006535-UCD
DR   Wikidata; Q54781239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914309; Ola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA124
AC   CVCL_PF28
SY   TEA124
DR   MMRRC; MMRRC:006538-UCD
DR   Wikidata; Q54781241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039562; Taf9b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA127
AC   CVCL_PF29
SY   TEA127
DR   MMRRC; MMRRC:006539-UCD
DR   Wikidata; Q54781243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289341; Sf3b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA128
AC   CVCL_PF30
SY   TEA128
DR   MMRRC; MMRRC:006540-UCD
DR   Wikidata; Q54781244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104669; Man2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA131
AC   CVCL_PF31
SY   TEA131
DR   MMRRC; MMRRC:006542-UCD
DR   Wikidata; Q54781246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA132
AC   CVCL_PF32
SY   TEA132
DR   MMRRC; MMRRC:006543-UCD
DR   Wikidata; Q54781248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917029; Pphln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA134
AC   CVCL_PF33
SY   TEA134
DR   MMRRC; MMRRC:006544-UCD
DR   Wikidata; Q54781249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA138
AC   CVCL_PF34
SY   TEA138
DR   MMRRC; MMRRC:006546-UCD
DR   Wikidata; Q54781251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA140
AC   CVCL_PF35
SY   TEA140
DR   MMRRC; MMRRC:006548-UCD
DR   Wikidata; Q54781254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA141
AC   CVCL_PF36
SY   TEA141
DR   MMRRC; MMRRC:006549-UCD
DR   Wikidata; Q54781256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923749; Clasp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA146
AC   CVCL_PF37
SY   TEA146
DR   MMRRC; MMRRC:006551-UCD
DR   Wikidata; Q54781257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919840; Ppme1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA148
AC   CVCL_PF38
SY   TEA148
DR   MMRRC; MMRRC:006552-UCD
DR   Wikidata; Q54781258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919840; Ppme1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA150
AC   CVCL_PF39
SY   TEA150
DR   MMRRC; MMRRC:006553-UCD
DR   Wikidata; Q54781259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384874; Tmem51.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA153
AC   CVCL_PF40
SY   TEA153
DR   MMRRC; MMRRC:006554-UCD
DR   Wikidata; Q54781260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA154
AC   CVCL_PF41
SY   TEA154
DR   MMRRC; MMRRC:006555-UCD
DR   Wikidata; Q54781263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA155
AC   CVCL_PF42
SY   TEA155
DR   MMRRC; MMRRC:006556-UCD
DR   Wikidata; Q54781311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA160
AC   CVCL_PF43
SY   TEA160
DR   MMRRC; MMRRC:006558-UCD
DR   Wikidata; Q54781315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA162
AC   CVCL_PF44
SY   TEA162
DR   MMRRC; MMRRC:006560-UCD
DR   Wikidata; Q54781316
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341830; Eif2ak3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA164
AC   CVCL_PF45
SY   TEA164
DR   MMRRC; MMRRC:006562-UCD
DR   Wikidata; Q54781319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914282; Snapc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA167
AC   CVCL_PF46
SY   TEA167
DR   MMRRC; MMRRC:006564-UCD
DR   Wikidata; Q54781321
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921867; Scpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA168
AC   CVCL_PF47
SY   TEA168
DR   MMRRC; MMRRC:006565-UCD
DR   Wikidata; Q54781322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA169
AC   CVCL_PF48
SY   TEA169
DR   MMRRC; MMRRC:006566-UCD
DR   Wikidata; Q54781325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA171
AC   CVCL_PF49
SY   TEA171
DR   MMRRC; MMRRC:006568-UCD
DR   Wikidata; Q54781326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA172
AC   CVCL_PF50
SY   TEA172
DR   MMRRC; MMRRC:006569-UCD
DR   Wikidata; Q54781329
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914647; Erp29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA173
AC   CVCL_PF51
SY   TEA173
DR   MMRRC; MMRRC:006570-UCD
DR   Wikidata; Q54781331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109207; Eif4g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA175
AC   CVCL_PF52
SY   TEA175
DR   MMRRC; MMRRC:006571-UCD
DR   Wikidata; Q54781332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109336; Etv6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA178
AC   CVCL_PF53
SY   TEA178
DR   MMRRC; MMRRC:006574-UCD
DR   Wikidata; Q54781334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99894; Hnrnpk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA179
AC   CVCL_PF54
SY   TEA179
DR   MMRRC; MMRRC:006575-UCD
DR   Wikidata; Q54781336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA183
AC   CVCL_PF55
SY   TEA183
DR   MMRRC; MMRRC:006579-UCD
DR   Wikidata; Q54781339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA186
AC   CVCL_PF56
SY   TEA186
DR   MMRRC; MMRRC:006580-UCD
DR   Wikidata; Q54781341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333805; Srsf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA188
AC   CVCL_PF57
SY   TEA188
DR   MMRRC; MMRRC:006581-UCD
DR   Wikidata; Q54781343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA189
AC   CVCL_PF58
SY   TEA189
DR   MMRRC; MMRRC:006582-UCD
DR   Wikidata; Q54781346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA190
AC   CVCL_PF59
SY   TEA190
DR   MMRRC; MMRRC:006583-UCD
DR   Wikidata; Q54781348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95518; Fgf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA194
AC   CVCL_PF60
SY   TEA194
DR   MMRRC; MMRRC:006584-UCD
DR   Wikidata; Q54781349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917567; Arl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA197
AC   CVCL_PF61
SY   TEA197
DR   MMRRC; MMRRC:006586-UCD
DR   Wikidata; Q54781352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107768; Zfp87.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA200
AC   CVCL_PF62
SY   TEA200
DR   MMRRC; MMRRC:006587-UCD
DR   Wikidata; Q54781354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927110; Tmem131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA201
AC   CVCL_PF63
SY   TEA201
DR   MMRRC; MMRRC:006588-UCD
DR   Wikidata; Q54781356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99894; Hnrnpk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA202
AC   CVCL_PF64
SY   TEA202
DR   MMRRC; MMRRC:006589-UCD
DR   Wikidata; Q54781358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894663; Ext1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA204
AC   CVCL_PF65
SY   TEA204
DR   MMRRC; MMRRC:006590-UCD
DR   Wikidata; Q54781360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918180; Nol8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA205
AC   CVCL_PF66
SY   TEA205
DR   MMRRC; MMRRC:006591-UCD
DR   Wikidata; Q54781362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355328; Nasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA214
AC   CVCL_PF67
SY   TEA214
DR   MMRRC; MMRRC:006594-UCD
DR   Wikidata; Q54781363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918667; Gpatch8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA217
AC   CVCL_PF68
SY   TEA217
DR   MMRRC; MMRRC:006596-UCD
DR   Wikidata; Q54781365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442483; Usp37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA218
AC   CVCL_PF69
SY   TEA218
DR   MMRRC; MMRRC:006597-UCD
DR   Wikidata; Q54781366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2660884; Csnk1g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA225
AC   CVCL_PF70
SY   TEA225
DR   MMRRC; MMRRC:006598-UCD
DR   Wikidata; Q54781369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line TEA231
AC   CVCL_PF71
SY   TEA231
DR   MMRRC; MMRRC:006601-UCD
DR   Wikidata; Q54781370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921500; Stimate.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XA008
AC   CVCL_PF72
SY   XA008
DR   MMRRC; MMRRC:006603-UCD
DR   Wikidata; Q54781374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919016; Raver1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA010
AC   CVCL_PF73
SY   XA010
DR   MMRRC; MMRRC:006604-UCD
DR   Wikidata; Q54781377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA013
AC   CVCL_PF74
SY   XA013
DR   MMRRC; MMRRC:006606-UCD
DR   Wikidata; Q54781378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933972; Tra2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA014
AC   CVCL_PF75
SY   XA014
DR   MMRRC; MMRRC:006607-UCD
DR   Wikidata; Q54781379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098672; Szrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA016
AC   CVCL_PF76
SY   XA016
DR   MMRRC; MMRRC:006608-UCD
DR   Wikidata; Q54781381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA018
AC   CVCL_PF77
SY   XA018
DR   MMRRC; MMRRC:006609-UCD
DR   Wikidata; Q54781384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88039; Apc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA020
AC   CVCL_PF78
SY   XA020
DR   MMRRC; MMRRC:006610-UCD
DR   Wikidata; Q54781386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443882; Snx30.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA021
AC   CVCL_PF79
SY   XA021
DR   MMRRC; MMRRC:006611-UCD
DR   Wikidata; Q54781388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107428; Cfap20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA022
AC   CVCL_PF80
SY   XA022
DR   MMRRC; MMRRC:006612-UCD
DR   Wikidata; Q54781390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446217; Phf13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA024
AC   CVCL_PF81
SY   XA024
DR   MMRRC; MMRRC:006613-UCD
DR   Wikidata; Q54781391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197010; Sumo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA026
AC   CVCL_PF82
SY   XA026
DR   MMRRC; MMRRC:006614-UCD
DR   Wikidata; Q54781437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890081; Foxo3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA028
AC   CVCL_PF83
SY   XA028
DR   MMRRC; MMRRC:006615-UCD
DR   Wikidata; Q54781438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA029
AC   CVCL_PF84
SY   XA029
DR   MMRRC; MMRRC:006616-UCD
DR   Wikidata; Q54781442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446217; Phf13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA030
AC   CVCL_PF85
SY   XA030
DR   MMRRC; MMRRC:006617-UCD
DR   Wikidata; Q54781443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107460; Cox6b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA031
AC   CVCL_PF86
SY   XA031
DR   MMRRC; MMRRC:006618-UCD
DR   Wikidata; Q54781446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98759; Tjp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA033
AC   CVCL_PF87
SY   XA033
DR   MMRRC; MMRRC:006619-UCD
DR   Wikidata; Q54781447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443069; Ppwd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA034
AC   CVCL_PF88
SY   XA034
DR   MMRRC; MMRRC:006620-UCD
DR   Wikidata; Q54781451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98759; Tjp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA037
AC   CVCL_PF89
SY   XA037
DR   MMRRC; MMRRC:006622-UCD
DR   Wikidata; Q54781453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XA045
AC   CVCL_PF90
SY   XA045
DR   MMRRC; MMRRC:006624-UCD
DR   Wikidata; Q54781456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261758; Suz12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA051
AC   CVCL_PF91
SY   XA051
DR   MMRRC; MMRRC:006626-UCD
DR   Wikidata; Q54781458
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106209; Hells.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA052
AC   CVCL_PF92
SY   XA052
DR   MMRRC; MMRRC:006627-UCD
DR   Wikidata; Q54781460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146423; Mix23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 7
//
ID   BayGenomics ES cell line XA053
AC   CVCL_PF93
SY   XA053
DR   MMRRC; MMRRC:006628-UCD
DR   Wikidata; Q54781461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88357; Cdk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA059
AC   CVCL_PF94
SY   XA059
DR   MMRRC; MMRRC:006630-UCD
DR   Wikidata; Q54781464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109211; Pkn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA072
AC   CVCL_PF95
SY   XA072
DR   MMRRC; MMRRC:006632-UCD
DR   Wikidata; Q54781466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA093
AC   CVCL_PF96
SY   XA093
DR   MMRRC; MMRRC:006633-UCD
DR   Wikidata; Q54781467
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925255; Rrn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA124
AC   CVCL_PF97
SY   XA124
DR   MMRRC; MMRRC:006638-UCD
DR   Wikidata; Q54781470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913868; Snrnp27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA125
AC   CVCL_PF98
SY   XA125
DR   MMRRC; MMRRC:006639-UCD
DR   Wikidata; Q54781472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913325; Chchd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA129
AC   CVCL_PF99
SY   XA129
DR   MMRRC; MMRRC:006641-UCD
DR   Wikidata; Q54781473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104662; Pml.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA130
AC   CVCL_PG00
SY   XA130
DR   MMRRC; MMRRC:006642-UCD
DR   Wikidata; Q54781476
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96795; Lmnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA131
AC   CVCL_PG01
SY   XA131
DR   MMRRC; MMRRC:006643-UCD
DR   Wikidata; Q54781479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684817; Snhg3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA134
AC   CVCL_PG02
SY   XA134
DR   MMRRC; MMRRC:006644-UCD
DR   Wikidata; Q54781481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA135
AC   CVCL_PG03
SY   XA135
DR   MMRRC; MMRRC:006645-UCD
DR   Wikidata; Q54781482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298366; Atf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA136
AC   CVCL_PG04
SY   XA136
DR   MMRRC; MMRRC:006646-UCD
DR   Wikidata; Q54781485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA139
AC   CVCL_PG05
SY   XA139
DR   MMRRC; MMRRC:006647-UCD
DR   Wikidata; Q54781486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA140
AC   CVCL_PG06
SY   XA140
DR   MMRRC; MMRRC:006648-UCD
DR   Wikidata; Q54781489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202384; Ddb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA142
AC   CVCL_PG07
SY   XA142
DR   MMRRC; MMRRC:006649-UCD
DR   Wikidata; Q54781491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154441; Nop53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA143
AC   CVCL_PG08
SY   XA143
DR   MMRRC; MMRRC:006650-UCD
DR   Wikidata; Q54781493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923164; Exoc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA144
AC   CVCL_PG09
SY   XA144
DR   MMRRC; MMRRC:006651-UCD
DR   Wikidata; Q54781495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA146
AC   CVCL_PG10
SY   XA146
DR   MMRRC; MMRRC:006652-UCD
DR   Wikidata; Q54781498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88071; Arnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA147
AC   CVCL_PG11
SY   XA147
DR   MMRRC; MMRRC:006653-UCD
DR   Wikidata; Q54781500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446180; Anks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA152
AC   CVCL_PG12
SY   XA152
DR   MMRRC; MMRRC:006654-UCD
DR   Wikidata; Q54781503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96795; Lmnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA153
AC   CVCL_PG13
SY   XA153
DR   MMRRC; MMRRC:006655-UCD
DR   Wikidata; Q54781504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925212; Scaf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA155
AC   CVCL_PG14
SY   XA155
DR   MMRRC; MMRRC:006656-UCD
DR   Wikidata; Q54781506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916428; Snx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA158
AC   CVCL_PG15
SY   XA158
DR   MMRRC; MMRRC:006657-UCD
DR   Wikidata; Q54781508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100499; Vps4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA168
AC   CVCL_PG16
SY   XA168
DR   MMRRC; MMRRC:006658-UCD
DR   Wikidata; Q54781511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA182
AC   CVCL_PG17
SY   XA182
DR   MMRRC; MMRRC:006659-UCD
DR   Wikidata; Q54781512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444233; Ythdf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA189
AC   CVCL_PG18
SY   XA189
DR   MMRRC; MMRRC:006660-UCD
DR   Wikidata; Q54781513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919670; Rbm33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA206
AC   CVCL_PG19
SY   XA206
DR   MMRRC; MMRRC:006661-UCD
DR   Wikidata; Q54781515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181182; Nup155.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA208
AC   CVCL_PG20
SY   XA208
DR   MMRRC; MMRRC:006662-UCD
DR   Wikidata; Q54781517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA209
AC   CVCL_PG21
SY   XA209
DR   MMRRC; MMRRC:006663-UCD
DR   Wikidata; Q54781518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA217
AC   CVCL_PG22
SY   XA217
DR   MMRRC; MMRRC:006664-UCD
DR   Wikidata; Q54781565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109634; Terf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA232
AC   CVCL_PG23
SY   XA232
DR   MMRRC; MMRRC:006665-UCD
DR   Wikidata; Q54781566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922928; Ippk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA246
AC   CVCL_PG24
SY   XA246
DR   MMRRC; MMRRC:006666-UCD
DR   Wikidata; Q54781567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA255
AC   CVCL_PG25
SY   XA255
DR   MMRRC; MMRRC:006667-UCD
DR   Wikidata; Q54781569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2668828; H3c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XA262
AC   CVCL_PG26
SY   XA262
DR   MMRRC; MMRRC:006668-UCD
DR   Wikidata; Q54781572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:891995; Mapre1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA271
AC   CVCL_PG27
SY   XA271
DR   MMRRC; MMRRC:006669-UCD
DR   Wikidata; Q54781575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103561; Kpna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA274
AC   CVCL_PG28
SY   XA274
DR   MMRRC; MMRRC:006670-UCD
DR   Wikidata; Q54781576
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917029; Pphln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA275
AC   CVCL_PG29
SY   XA275
DR   MMRRC; MMRRC:006671-UCD
DR   Wikidata; Q54781579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137706; Actn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA278
AC   CVCL_PG30
SY   XA278
DR   MMRRC; MMRRC:006672-UCD
DR   Wikidata; Q54781581
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA287
AC   CVCL_PG31
SY   XA287
DR   MMRRC; MMRRC:006673-UCD
DR   Wikidata; Q54781582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98809; Tpm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA295
AC   CVCL_PG32
SY   XA295
DR   MMRRC; MMRRC:006674-UCD
DR   Wikidata; Q54781583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923827; Faf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA298
AC   CVCL_PG33
SY   XA298
DR   MMRRC; MMRRC:006675-UCD
DR   Wikidata; Q54781586
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA305
AC   CVCL_PG34
SY   XA305
DR   MMRRC; MMRRC:006676-UCD
DR   Wikidata; Q54781588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA307
AC   CVCL_PG35
SY   XA307
DR   MMRRC; MMRRC:006677-UCD
DR   Wikidata; Q54781589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916176; Ubap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA308
AC   CVCL_PG36
SY   XA308
DR   MMRRC; MMRRC:006678-UCD
DR   Wikidata; Q54781592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441849; Lpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA311
AC   CVCL_PG37
SY   XA311
DR   MMRRC; MMRRC:006679-UCD
DR   Wikidata; Q54781595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341788; Pdcd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA320
AC   CVCL_PG38
SY   XA320
DR   MMRRC; MMRRC:006681-UCD
DR   Wikidata; Q54781596
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107183; Cct8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA322
AC   CVCL_PG39
SY   XA322
DR   MMRRC; MMRRC:006682-UCD
DR   Wikidata; Q54781597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1335094; Septin7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XA360
AC   CVCL_PG40
SY   XA360
DR   MMRRC; MMRRC:006683-UCD
DR   Wikidata; Q54781600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138856; Ldlrad3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA425
AC   CVCL_PG41
SY   XA425
DR   MMRRC; MMRRC:006685-UCD
DR   Wikidata; Q54781602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915142; Coa6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA436
AC   CVCL_PG42
SY   XA436
DR   MMRRC; MMRRC:006686-UCD
DR   Wikidata; Q54781603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA440
AC   CVCL_PG43
SY   XA440
DR   MMRRC; MMRRC:006687-UCD
DR   Wikidata; Q54781606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA449
AC   CVCL_PG44
SY   XA449
DR   MMRRC; MMRRC:006688-UCD
DR   Wikidata; Q54781609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894293; Smad4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA479
AC   CVCL_PG45
SY   XA479
DR   MMRRC; MMRRC:006689-UCD
DR   Wikidata; Q54781611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343131; Timm17a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA481
AC   CVCL_PG46
SY   XA481
DR   MMRRC; MMRRC:006690-UCD
DR   Wikidata; Q54781613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA487
AC   CVCL_PG47
SY   XA487
DR   MMRRC; MMRRC:006691-UCD
DR   Wikidata; Q54781615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA546
AC   CVCL_PG48
SY   XA546
DR   MMRRC; MMRRC:006692-UCD
DR   Wikidata; Q54781618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919174; Tube1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA571
AC   CVCL_PG49
SY   XA571
DR   MMRRC; MMRRC:006693-UCD
DR   Wikidata; Q54781621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444520; Nhlrc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA709
AC   CVCL_PG50
SY   XA709
DR   MMRRC; MMRRC:006695-UCD
DR   Wikidata; Q54781622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA712
AC   CVCL_PG51
SY   XA712
DR   MMRRC; MMRRC:006696-UCD
DR   Wikidata; Q54781624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XA721
AC   CVCL_PG52
SY   XA721
DR   MMRRC; MMRRC:006697-UCD
DR   Wikidata; Q54781625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB006BC3
AC   CVCL_PG53
SY   XB006BC3
DR   MMRRC; MMRRC:006701-UCD
DR   Wikidata; Q54781626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109211; Pkn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB010B
AC   CVCL_PG54
SY   XB010B
DR   MMRRC; MMRRC:006702-UCD
DR   Wikidata; Q54781629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352754; Clic4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB011B
AC   CVCL_PG55
SY   XB011B
DR   MMRRC; MMRRC:006703-UCD
DR   Wikidata; Q54781630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1195458; Abce1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB012
AC   CVCL_PG56
SY   XB012
DR   MMRRC; MMRRC:006704-UCD
DR   Wikidata; Q54781631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104560; Nsf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB015
AC   CVCL_PG57
SY   XB015
DR   MMRRC; MMRRC:006705-UCD
DR   Wikidata; Q54781633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927167; Morf4l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB022
AC   CVCL_PG58
SY   XB022
DR   MMRRC; MMRRC:006709-UCD
DR   Wikidata; Q54781634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442035; Atp5g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB025B
AC   CVCL_PG59
SY   XB025B
DR   MMRRC; MMRRC:006710-UCD
DR   Wikidata; Q54781637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB039
AC   CVCL_PG60
SY   XB039
DR   MMRRC; MMRRC:006713-UCD
DR   Wikidata; Q54781640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336201; Sumo3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB040A
AC   CVCL_PG61
SY   XB040A
DR   MMRRC; MMRRC:006714-UCD
DR   Wikidata; Q54781641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196624; Tcea1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB042A
AC   CVCL_PG62
SY   XB042A
DR   MMRRC; MMRRC:006715-UCD
DR   Wikidata; Q54781684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB044
AC   CVCL_PG63
SY   XB044
DR   MMRRC; MMRRC:006716-UCD
DR   Wikidata; Q54781686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926228; Serinc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB045
AC   CVCL_PG64
SY   XB045
DR   MMRRC; MMRRC:006717-UCD
DR   Wikidata; Q54781687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926228; Serinc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB050A
AC   CVCL_PG65
SY   XB050A
DR   MMRRC; MMRRC:006720-UCD
DR   Wikidata; Q54781688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106014; Nudc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB051
AC   CVCL_PG66
SY   XB051
DR   MMRRC; MMRRC:006721-UCD
DR   Wikidata; Q54781691
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3704127; Zfp808.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB063
AC   CVCL_PG67
SY   XB063
DR   MMRRC; MMRRC:006722-UCD
DR   Wikidata; Q54781694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB065A
AC   CVCL_PG68
SY   XB065A
DR   MMRRC; MMRRC:006723-UCD
DR   Wikidata; Q54781695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB066
AC   CVCL_PG69
SY   XB066
DR   MMRRC; MMRRC:006724-UCD
DR   Wikidata; Q54781698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277103; Nudcd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB067A
AC   CVCL_PG70
SY   XB067A
DR   MMRRC; MMRRC:006725-UCD
DR   Wikidata; Q54781700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913333; Setd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB076B
AC   CVCL_PG71
SY   XB076B
DR   MMRRC; MMRRC:006728-UCD
DR   Wikidata; Q54781702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894649; Ppfibp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB078
AC   CVCL_PG72
SY   XB078
DR   MMRRC; MMRRC:006729-UCD
DR   Wikidata; Q54781704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442035; Atp5g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB085
AC   CVCL_PG73
SY   XB085
DR   MMRRC; MMRRC:006731-UCD
DR   Wikidata; Q54781705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923512; Pfdn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB089B
AC   CVCL_PG74
SY   XB089B
DR   MMRRC; MMRRC:006732-UCD
DR   Wikidata; Q54781708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914617; Paxbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB091B
AC   CVCL_PG75
SY   XB091B
DR   MMRRC; MMRRC:006733-UCD
DR   Wikidata; Q54781710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107943; Cct6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB093B
AC   CVCL_PG76
SY   XB093B
DR   MMRRC; MMRRC:006734-UCD
DR   Wikidata; Q54781711
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443957; Zfp516.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB097
AC   CVCL_PG77
SY   XB097
DR   MMRRC; MMRRC:006735-UCD
DR   Wikidata; Q54781713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB098
AC   CVCL_PG78
SY   XB098
DR   MMRRC; MMRRC:006736-UCD
DR   Wikidata; Q54781715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298366; Atf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB105
AC   CVCL_PG79
SY   XB105
DR   MMRRC; MMRRC:006737-UCD
DR   Wikidata; Q54781717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352465; Nr2c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB108
AC   CVCL_PG80
SY   XB108
DR   MMRRC; MMRRC:006738-UCD
DR   Wikidata; Q54781720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894649; Ppfibp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB114
AC   CVCL_PG81
SY   XB114
DR   MMRRC; MMRRC:006739-UCD
DR   Wikidata; Q54781721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914769; Dennd4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB120
AC   CVCL_PG82
SY   XB120
DR   MMRRC; MMRRC:006740-UCD
DR   Wikidata; Q54781724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338068; Pdpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB130
AC   CVCL_PG83
SY   XB130
DR   MMRRC; MMRRC:006741-UCD
DR   Wikidata; Q54781727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915142; Coa6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB134
AC   CVCL_PG84
SY   XB134
DR   MMRRC; MMRRC:006742-UCD
DR   Wikidata; Q54781729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB150
AC   CVCL_PG85
SY   XB150
DR   MMRRC; MMRRC:006743-UCD
DR   Wikidata; Q54781730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919742; Smg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB151
AC   CVCL_PG86
SY   XB151
DR   MMRRC; MMRRC:006744-UCD
DR   Wikidata; Q54781732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97758; Prim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB152
AC   CVCL_PG87
SY   XB152
DR   MMRRC; MMRRC:006745-UCD
DR   Wikidata; Q54781734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108025; Prkar2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB154
AC   CVCL_PG88
SY   XB154
DR   MMRRC; MMRRC:006746-UCD
DR   Wikidata; Q54781737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB155
AC   CVCL_PG89
SY   XB155
DR   MMRRC; MMRRC:006747-UCD
DR   Wikidata; Q54781739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858496; Deaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB173
AC   CVCL_PG90
SY   XB173
DR   MMRRC; MMRRC:006749-UCD
DR   Wikidata; Q54781741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158400; Wdr18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB175
AC   CVCL_PG91
SY   XB175
DR   MMRRC; MMRRC:006750-UCD
DR   Wikidata; Q54781743
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342005; Mthfd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB193
AC   CVCL_PG92
SY   XB193
DR   MMRRC; MMRRC:006751-UCD
DR   Wikidata; Q54781744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB200
AC   CVCL_PG93
SY   XB200
DR   MMRRC; MMRRC:006753-UCD
DR   Wikidata; Q54781749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB204
AC   CVCL_PG94
SY   XB204
DR   MMRRC; MMRRC:006755-UCD
DR   Wikidata; Q54781750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202384; Ddb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB206
AC   CVCL_PG95
SY   XB206
DR   MMRRC; MMRRC:006756-UCD
DR   Wikidata; Q54781751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96795; Lmnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB216
AC   CVCL_PG96
SY   XB216
DR   MMRRC; MMRRC:006758-UCD
DR   Wikidata; Q54781754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336201; Sumo3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB223
AC   CVCL_PG97
SY   XB223
DR   MMRRC; MMRRC:006760-UCD
DR   Wikidata; Q54781756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97831; Ppa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB224
AC   CVCL_PG98
SY   XB224
DR   MMRRC; MMRRC:006761-UCD
DR   Wikidata; Q54781757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB228
AC   CVCL_PG99
SY   XB228
DR   MMRRC; MMRRC:006762-UCD
DR   Wikidata; Q54781760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150019; Spred2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB238
AC   CVCL_PH00
SY   XB238
DR   MMRRC; MMRRC:006763-UCD
DR   Wikidata; Q54781762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB250
AC   CVCL_PH01
SY   XB250
DR   MMRRC; MMRRC:006766-UCD
DR   Wikidata; Q54781765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914820; Slc39a9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB261
AC   CVCL_PH02
SY   XB261
DR   MMRRC; MMRRC:006768-UCD
DR   Wikidata; Q54781807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB264
AC   CVCL_PH03
SY   XB264
DR   MMRRC; MMRRC:006769-UCD
DR   Wikidata; Q54781809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891832; Patz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB269
AC   CVCL_PH04
SY   XB269
DR   MMRRC; MMRRC:006770-UCD
DR   Wikidata; Q54781811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098533; Ints9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB276
AC   CVCL_PH05
SY   XB276
DR   MMRRC; MMRRC:006771-UCD
DR   Wikidata; Q54781814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919725; Ssbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB278
AC   CVCL_PH06
SY   XB278
DR   MMRRC; MMRRC:006772-UCD
DR   Wikidata; Q54781815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144726; Tmem11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB281
AC   CVCL_PH07
SY   XB281
DR   MMRRC; MMRRC:006774-UCD
DR   Wikidata; Q54781818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384586; Armc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB282
AC   CVCL_PH08
SY   XB282
DR   MMRRC; MMRRC:006775-UCD
DR   Wikidata; Q54781820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB289
AC   CVCL_PH09
SY   XB289
DR   MMRRC; MMRRC:006776-UCD
DR   Wikidata; Q54781822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915095; Rnf115.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB294
AC   CVCL_PH10
SY   XB294
DR   MMRRC; MMRRC:006777-UCD
DR   Wikidata; Q54781825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB295
AC   CVCL_PH11
SY   XB295
DR   MMRRC; MMRRC:006778-UCD
DR   Wikidata; Q54781828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442035; Atp5g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB300
AC   CVCL_PH12
SY   XB300
DR   MMRRC; MMRRC:006779-UCD
DR   Wikidata; Q54781831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929063; Copz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB308B
AC   CVCL_PH13
SY   XB308B
DR   MMRRC; MMRRC:006781-UCD
DR   Wikidata; Q54781833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB315
AC   CVCL_PH14
SY   XB315
DR   MMRRC; MMRRC:006782-UCD
DR   Wikidata; Q54781834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913892; Ctnnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB322
AC   CVCL_PH15
SY   XB322
DR   MMRRC; MMRRC:006784-UCD
DR   Wikidata; Q54781836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385923; Hexim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB323
AC   CVCL_PH16
SY   XB323
DR   MMRRC; MMRRC:006785-UCD
DR   Wikidata; Q54781839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3041259; Mettl25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB338
AC   CVCL_PH17
SY   XB338
DR   MMRRC; MMRRC:006788-UCD
DR   Wikidata; Q54781841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924053; Zfp998.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB339
AC   CVCL_PH18
SY   XB339
DR   MMRRC; MMRRC:006789-UCD
DR   Wikidata; Q54781845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137706; Actn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB341
AC   CVCL_PH19
SY   XB341
DR   MMRRC; MMRRC:006790-UCD
DR   Wikidata; Q54781846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB358
AC   CVCL_PH20
SY   XB358
DR   MMRRC; MMRRC:006792-UCD
DR   Wikidata; Q54781849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276125; Utf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB359
AC   CVCL_PH21
SY   XB359
DR   MMRRC; MMRRC:006793-UCD
DR   Wikidata; Q54781851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB396
AC   CVCL_PH22
SY   XB396
DR   MMRRC; MMRRC:006796-UCD
DR   Wikidata; Q54781852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387466; Pank4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB398
AC   CVCL_PH23
SY   XB398
DR   MMRRC; MMRRC:006798-UCD
DR   Wikidata; Q54781854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB399
AC   CVCL_PH24
SY   XB399
DR   MMRRC; MMRRC:006799-UCD
DR   Wikidata; Q54781857
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB400
AC   CVCL_PH25
SY   XB400
DR   MMRRC; MMRRC:006800-UCD
DR   Wikidata; Q54781859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB409
AC   CVCL_PH26
SY   XB409
DR   MMRRC; MMRRC:006801-UCD
DR   Wikidata; Q54781861
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB410
AC   CVCL_PH27
SY   XB410
DR   MMRRC; MMRRC:006802-UCD
DR   Wikidata; Q54781862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97803; Ptma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB412
AC   CVCL_PH28
SY   XB412
DR   MMRRC; MMRRC:006804-UCD
DR   Wikidata; Q54781865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353427; Eif2ak4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB417
AC   CVCL_PH29
SY   XB417
DR   MMRRC; MMRRC:006805-UCD
DR   Wikidata; Q54781868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919221; Zswim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB418
AC   CVCL_PH30
SY   XB418
DR   MMRRC; MMRRC:006806-UCD
DR   Wikidata; Q54781870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921662; Gle1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB419
AC   CVCL_PH31
SY   XB419
DR   MMRRC; MMRRC:006807-UCD
DR   Wikidata; Q54781871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB421
AC   CVCL_PH32
SY   XB421
DR   MMRRC; MMRRC:006809-UCD
DR   Wikidata; Q54781875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385206; Pabpc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB424
AC   CVCL_PH33
SY   XB424
DR   MMRRC; MMRRC:006810-UCD
DR   Wikidata; Q54781876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2677212; Bend3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB425
AC   CVCL_PH34
SY   XB425
DR   MMRRC; MMRRC:006811-UCD
DR   Wikidata; Q54781878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298366; Atf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB428
AC   CVCL_PH35
SY   XB428
DR   MMRRC; MMRRC:006812-UCD
DR   Wikidata; Q54781880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934835; Ube2n.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB429
AC   CVCL_PH36
SY   XB429
DR   MMRRC; MMRRC:006813-UCD
DR   Wikidata; Q54781881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102724; Tpp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB430
AC   CVCL_PH37
SY   XB430
DR   MMRRC; MMRRC:006814-UCD
DR   Wikidata; Q54781884
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915943; Hnrnpul2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB432
AC   CVCL_PH38
SY   XB432
DR   MMRRC; MMRRC:006815-UCD
DR   Wikidata; Q54781886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154263; Bicra.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB437
AC   CVCL_PH39
SY   XB437
DR   MMRRC; MMRRC:006816-UCD
DR   Wikidata; Q54781887
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344349; Rnf216.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB442
AC   CVCL_PH40
SY   XB442
DR   MMRRC; MMRRC:006818-UCD
DR   Wikidata; Q54781891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278321; Epc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB443
AC   CVCL_PH41
SY   XB443
DR   MMRRC; MMRRC:006819-UCD
DR   Wikidata; Q54781892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB452
AC   CVCL_PH42
SY   XB452
DR   MMRRC; MMRRC:006822-UCD
DR   Wikidata; Q54781945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103267; Eif4ebp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB453
AC   CVCL_PH43
SY   XB453
DR   MMRRC; MMRRC:006823-UCD
DR   Wikidata; Q54781947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107760; Chka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB454
AC   CVCL_PH44
SY   XB454
DR   MMRRC; MMRRC:006824-UCD
DR   Wikidata; Q54781948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914962; Slc25a37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB455
AC   CVCL_PH45
SY   XB455
DR   MMRRC; MMRRC:006825-UCD
DR   Wikidata; Q54781951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685992; Bclaf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB456
AC   CVCL_PH46
SY   XB456
DR   MMRRC; MMRRC:006826-UCD
DR   Wikidata; Q54781953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916214; Ctc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB457
AC   CVCL_PH47
SY   XB457
DR   MMRRC; MMRRC:006827-UCD
DR   Wikidata; Q54781954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3028576; Dhx37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB461
AC   CVCL_PH48
SY   XB461
DR   MMRRC; MMRRC:006828-UCD
DR   Wikidata; Q54781957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346872; Map3k1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB462
AC   CVCL_PH49
SY   XB462
DR   MMRRC; MMRRC:006829-UCD
DR   Wikidata; Q54781959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107689; Kif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB464
AC   CVCL_PH50
SY   XB464
DR   MMRRC; MMRRC:006830-UCD
DR   Wikidata; Q54781960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298366; Atf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB465
AC   CVCL_PH51
SY   XB465
DR   MMRRC; MMRRC:006831-UCD
DR   Wikidata; Q54781962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384313; Rrp9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB466
AC   CVCL_PH52
SY   XB466
DR   MMRRC; MMRRC:006832-UCD
DR   Wikidata; Q54781963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918490; Osbpl7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB468
AC   CVCL_PH53
SY   XB468
DR   MMRRC; MMRRC:006833-UCD
DR   Wikidata; Q54781965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB469
AC   CVCL_PH54
SY   XB469
DR   MMRRC; MMRRC:006834-UCD
DR   Wikidata; Q54781968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104558; Rps6ka1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB470
AC   CVCL_PH55
SY   XB470
DR   MMRRC; MMRRC:006835-UCD
DR   Wikidata; Q54781971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924054; Kdm4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB471
AC   CVCL_PH56
SY   XB471
DR   MMRRC; MMRRC:006836-UCD
DR   Wikidata; Q54781972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB472
AC   CVCL_PH57
SY   XB472
DR   MMRRC; MMRRC:006837-UCD
DR   Wikidata; Q54781973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890430; Paxip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB475
AC   CVCL_PH58
SY   XB475
DR   MMRRC; MMRRC:006838-UCD
DR   Wikidata; Q54781975
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB476
AC   CVCL_PH59
SY   XB476
DR   MMRRC; MMRRC:006839-UCD
DR   Wikidata; Q54781977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918850; Ythdf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB479
AC   CVCL_PH60
SY   XB479
DR   MMRRC; MMRRC:006840-UCD
DR   Wikidata; Q54781978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924025; Slc10a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB481
AC   CVCL_PH61
SY   XB481
DR   MMRRC; MMRRC:006841-UCD
DR   Wikidata; Q54781980
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154441; Nop53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB482
AC   CVCL_PH62
SY   XB482
DR   MMRRC; MMRRC:006842-UCD
DR   Wikidata; Q54781981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB484
AC   CVCL_PH63
SY   XB484
DR   MMRRC; MMRRC:006843-UCD
DR   Wikidata; Q54781984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338049; Itsn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB485
AC   CVCL_PH64
SY   XB485
DR   MMRRC; MMRRC:006844-UCD
DR   Wikidata; Q54781987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB486
AC   CVCL_PH65
SY   XB486
DR   MMRRC; MMRRC:006845-UCD
DR   Wikidata; Q54781989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444248; Gcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB487
AC   CVCL_PH66
SY   XB487
DR   MMRRC; MMRRC:006846-UCD
DR   Wikidata; Q54781992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2386741; Slc30a6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB498
AC   CVCL_PH67
SY   XB498
DR   MMRRC; MMRRC:006848-UCD
DR   Wikidata; Q54781994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97842; Rab1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB500
AC   CVCL_PH68
SY   XB500
DR   MMRRC; MMRRC:006849-UCD
DR   Wikidata; Q54781996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929091; Sinhcaf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB502
AC   CVCL_PH69
SY   XB502
DR   MMRRC; MMRRC:006850-UCD
DR   Wikidata; Q54781999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385621; Nup153.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB503
AC   CVCL_PH70
SY   XB503
DR   MMRRC; MMRRC:006851-UCD
DR   Wikidata; Q54782002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890357; Igf2bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB514
AC   CVCL_PH71
SY   XB514
DR   MMRRC; MMRRC:006855-UCD
DR   Wikidata; Q54782003
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384569; Klhdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB515
AC   CVCL_PH72
SY   XB515
DR   MMRRC; MMRRC:006856-UCD
DR   Wikidata; Q54782005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442035; Atp5g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB516
AC   CVCL_PH73
SY   XB516
DR   MMRRC; MMRRC:006857-UCD
DR   Wikidata; Q54782008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915142; Coa6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB518
AC   CVCL_PH74
SY   XB518
DR   MMRRC; MMRRC:006858-UCD
DR   Wikidata; Q54782011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920026; Sass6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB522
AC   CVCL_PH75
SY   XB522
DR   MMRRC; MMRRC:006859-UCD
DR   Wikidata; Q54782015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97838; Eprs.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB523
AC   CVCL_PH76
SY   XB523
DR   MMRRC; MMRRC:006860-UCD
DR   Wikidata; Q54782017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB538
AC   CVCL_PH77
SY   XB538
DR   MMRRC; MMRRC:006861-UCD
DR   Wikidata; Q54782019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354736; Kdm2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB539
AC   CVCL_PH78
SY   XB539
DR   MMRRC; MMRRC:006862-UCD
DR   Wikidata; Q54782022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914195; Sdha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB551
AC   CVCL_PH79
SY   XB551
DR   MMRRC; MMRRC:006863-UCD
DR   Wikidata; Q54782024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB556
AC   CVCL_PH80
SY   XB556
DR   MMRRC; MMRRC:006865-UCD
DR   Wikidata; Q54782027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919936; Usp24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB557
AC   CVCL_PH81
SY   XB557
DR   MMRRC; MMRRC:006866-UCD
DR   Wikidata; Q54782028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB563
AC   CVCL_PH82
SY   XB563
DR   MMRRC; MMRRC:006867-UCD
DR   Wikidata; Q54782079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3527792; Zdhhc18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB566
AC   CVCL_PH83
SY   XB566
DR   MMRRC; MMRRC:006869-UCD
DR   Wikidata; Q54782080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152895; Helb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB572
AC   CVCL_PH84
SY   XB572
DR   MMRRC; MMRRC:006870-UCD
DR   Wikidata; Q54782081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB577
AC   CVCL_PH85
SY   XB577
DR   MMRRC; MMRRC:006871-UCD
DR   Wikidata; Q54782082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140843; Noc4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB580
AC   CVCL_PH86
SY   XB580
DR   MMRRC; MMRRC:006872-UCD
DR   Wikidata; Q54782083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921452; Fblim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB582
AC   CVCL_PH87
SY   XB582
DR   MMRRC; MMRRC:006873-UCD
DR   Wikidata; Q54782086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105072; Rab22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB583
AC   CVCL_PH88
SY   XB583
DR   MMRRC; MMRRC:006874-UCD
DR   Wikidata; Q54782087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914393; Ikzf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB586
AC   CVCL_PH89
SY   XB586
DR   MMRRC; MMRRC:006875-UCD
DR   Wikidata; Q54782089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136841; Morc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB589
AC   CVCL_PH90
SY   XB589
DR   MMRRC; MMRRC:006876-UCD
DR   Wikidata; Q54782092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106181; Mybbp1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB591
AC   CVCL_PH91
SY   XB591
DR   MMRRC; MMRRC:006877-UCD
DR   Wikidata; Q54782094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925212; Scaf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB592
AC   CVCL_PH92
SY   XB592
DR   MMRRC; MMRRC:006878-UCD
DR   Wikidata; Q54782096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927155; Clptm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB593
AC   CVCL_PH93
SY   XB593
DR   MMRRC; MMRRC:006879-UCD
DR   Wikidata; Q54782099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914418; Lpar6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB595
AC   CVCL_PH94
SY   XB595
DR   MMRRC; MMRRC:006880-UCD
DR   Wikidata; Q54782100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB599
AC   CVCL_PH95
SY   XB599
DR   MMRRC; MMRRC:006881-UCD
DR   Wikidata; Q54782103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923549; Erp44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB600
AC   CVCL_PH96
SY   XB600
DR   MMRRC; MMRRC:006882-UCD
DR   Wikidata; Q54782104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105125; Eif1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB604
AC   CVCL_PH97
SY   XB604
DR   MMRRC; MMRRC:006883-UCD
DR   Wikidata; Q54782105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919240; Ddx54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB608
AC   CVCL_PH98
SY   XB608
DR   MMRRC; MMRRC:006884-UCD
DR   Wikidata; Q54782107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB610
AC   CVCL_PH99
SY   XB610
DR   MMRRC; MMRRC:006885-UCD
DR   Wikidata; Q54782109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919787; Cdca2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB611
AC   CVCL_PI00
SY   XB611
DR   MMRRC; MMRRC:006886-UCD
DR   Wikidata; Q54782113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103010; Epb41l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB612
AC   CVCL_PI01
SY   XB612
DR   MMRRC; MMRRC:006887-UCD
DR   Wikidata; Q54782116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924337; Ankrd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB613
AC   CVCL_PI02
SY   XB613
DR   MMRRC; MMRRC:006888-UCD
DR   Wikidata; Q54782117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333873; Cog1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB614
AC   CVCL_PI03
SY   XB614
DR   MMRRC; MMRRC:006889-UCD
DR   Wikidata; Q54782120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919936; Usp24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB616
AC   CVCL_PI04
SY   XB616
DR   MMRRC; MMRRC:006890-UCD
DR   Wikidata; Q54782123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915943; Hnrnpul2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB620
AC   CVCL_PI05
SY   XB620
DR   MMRRC; MMRRC:006892-UCD
DR   Wikidata; Q54782126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB621
AC   CVCL_PI06
SY   XB621
DR   MMRRC; MMRRC:006893-UCD
DR   Wikidata; Q54782127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147194; Rbm27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB623
AC   CVCL_PI07
SY   XB623
DR   MMRRC; MMRRC:006894-UCD
DR   Wikidata; Q54782129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917834; Pak4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB626
AC   CVCL_PI08
SY   XB626
DR   MMRRC; MMRRC:006896-UCD
DR   Wikidata; Q54782132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700006; Dbnl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB627
AC   CVCL_PI09
SY   XB627
DR   MMRRC; MMRRC:006897-UCD
DR   Wikidata; Q54782134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB631
AC   CVCL_PI10
SY   XB631
DR   MMRRC; MMRRC:006899-UCD
DR   Wikidata; Q54782136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB632
AC   CVCL_PI11
SY   XB632
DR   MMRRC; MMRRC:006900-UCD
DR   Wikidata; Q54782137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB634
AC   CVCL_PI12
SY   XB634
DR   MMRRC; MMRRC:006901-UCD
DR   Wikidata; Q54782139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921367; Actr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB637
AC   CVCL_PI13
SY   XB637
DR   MMRRC; MMRRC:006902-UCD
DR   Wikidata; Q54782141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919725; Ssbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB645
AC   CVCL_PI14
SY   XB645
DR   MMRRC; MMRRC:006903-UCD
DR   Wikidata; Q54782143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278322; Epc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB646
AC   CVCL_PI15
SY   XB646
DR   MMRRC; MMRRC:006904-UCD
DR   Wikidata; Q54782146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927865; Zfp280b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB651
AC   CVCL_PI16
SY   XB651
DR   MMRRC; MMRRC:006906-UCD
DR   Wikidata; Q54782147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB655
AC   CVCL_PI17
SY   XB655
DR   MMRRC; MMRRC:006907-UCD
DR   Wikidata; Q54782149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB656
AC   CVCL_PI18
SY   XB656
DR   MMRRC; MMRRC:006908-UCD
DR   Wikidata; Q54782150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109353; Ufd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB657
AC   CVCL_PI19
SY   XB657
DR   MMRRC; MMRRC:006909-UCD
DR   Wikidata; Q54782153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB659
AC   CVCL_PI20
SY   XB659
DR   MMRRC; MMRRC:006910-UCD
DR   Wikidata; Q54782155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB660
AC   CVCL_PI21
SY   XB660
DR   MMRRC; MMRRC:006911-UCD
DR   Wikidata; Q54782157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB663
AC   CVCL_PI22
SY   XB663
DR   MMRRC; MMRRC:006912-UCD
DR   Wikidata; Q54782243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101921; Ap2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB665
AC   CVCL_PI23
SY   XB665
DR   MMRRC; MMRRC:006913-UCD
DR   Wikidata; Q54782245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB675
AC   CVCL_PI24
SY   XB675
DR   MMRRC; MMRRC:006917-UCD
DR   Wikidata; Q54782246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB677
AC   CVCL_PI25
SY   XB677
DR   MMRRC; MMRRC:006918-UCD
DR   Wikidata; Q54782247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935147; Arid1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB678
AC   CVCL_PI26
SY   XB678
DR   MMRRC; MMRRC:006919-UCD
DR   Wikidata; Q54782250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108069; Ccna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB680
AC   CVCL_PI27
SY   XB680
DR   MMRRC; MMRRC:006920-UCD
DR   Wikidata; Q54782251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933204; Rbm5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB683
AC   CVCL_PI28
SY   XB683
DR   MMRRC; MMRRC:006921-UCD
DR   Wikidata; Q54782254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB686
AC   CVCL_PI29
SY   XB686
DR   MMRRC; MMRRC:006922-UCD
DR   Wikidata; Q54782255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB691
AC   CVCL_PI30
SY   XB691
DR   MMRRC; MMRRC:006923-UCD
DR   Wikidata; Q54782257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446217; Phf13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB695
AC   CVCL_PI31
SY   XB695
DR   MMRRC; MMRRC:006924-UCD
DR   Wikidata; Q54782260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB696
AC   CVCL_PI32
SY   XB696
DR   MMRRC; MMRRC:006925-UCD
DR   Wikidata; Q54782261
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB697
AC   CVCL_PI33
SY   XB697
DR   MMRRC; MMRRC:006926-UCD
DR   Wikidata; Q54782263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914449; Pfdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB699
AC   CVCL_PI34
SY   XB699
DR   MMRRC; MMRRC:006927-UCD
DR   Wikidata; Q54782266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345643; Sufu.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB700
AC   CVCL_PI35
SY   XB700
DR   MMRRC; MMRRC:006928-UCD
DR   Wikidata; Q54782267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913835; Snrnp40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB702
AC   CVCL_PI36
SY   XB702
DR   MMRRC; MMRRC:006929-UCD
DR   Wikidata; Q54782270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914709; Nvl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB705
AC   CVCL_PI37
SY   XB705
DR   MMRRC; MMRRC:006930-UCD
DR   Wikidata; Q54782271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684864; Pfas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB708
AC   CVCL_PI38
SY   XB708
DR   MMRRC; MMRRC:006931-UCD
DR   Wikidata; Q54782273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107428; Cfap20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB713
AC   CVCL_PI39
SY   XB713
DR   MMRRC; MMRRC:006932-UCD
DR   Wikidata; Q54782275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341200; Pwp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB718
AC   CVCL_PI40
SY   XB718
DR   MMRRC; MMRRC:006935-UCD
DR   Wikidata; Q54782276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927479; Sap30bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB720
AC   CVCL_PI41
SY   XB720
DR   MMRRC; MMRRC:006936-UCD
DR   Wikidata; Q54782278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB723
AC   CVCL_PI42
SY   XB723
DR   MMRRC; MMRRC:006937-UCD
DR   Wikidata; Q54782281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344373; Ubl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB726
AC   CVCL_PI43
SY   XB726
DR   MMRRC; MMRRC:006938-UCD
DR   Wikidata; Q54782282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97803; Ptma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB729
AC   CVCL_PI44
SY   XB729
DR   MMRRC; MMRRC:006939-UCD
DR   Wikidata; Q54782283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915202; Tomm20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB730
AC   CVCL_PI45
SY   XB730
DR   MMRRC; MMRRC:006940-UCD
DR   Wikidata; Q54782285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB732
AC   CVCL_PI46
SY   XB732
DR   MMRRC; MMRRC:006941-UCD
DR   Wikidata; Q54782288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB733
AC   CVCL_PI47
SY   XB733
DR   MMRRC; MMRRC:006942-UCD
DR   Wikidata; Q54782291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106014; Nudc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB737
AC   CVCL_PI48
SY   XB737
DR   MMRRC; MMRRC:006943-UCD
DR   Wikidata; Q54782295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444207; Vps13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB742
AC   CVCL_PI49
SY   XB742
DR   MMRRC; MMRRC:006945-UCD
DR   Wikidata; Q54782296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145541; H3c8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB743
AC   CVCL_PI50
SY   XB743
DR   MMRRC; MMRRC:006946-UCD
DR   Wikidata; Q54782297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385865; Ice1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB744
AC   CVCL_PI51
SY   XB744
DR   MMRRC; MMRRC:006947-UCD
DR   Wikidata; Q54782300
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918040; Ubr5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB745
AC   CVCL_PI52
SY   XB745
DR   MMRRC; MMRRC:006948-UCD
DR   Wikidata; Q54782301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB748
AC   CVCL_PI53
SY   XB748
DR   MMRRC; MMRRC:006949-UCD
DR   Wikidata; Q54782303
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449057; Gars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB749
AC   CVCL_PI54
SY   XB749
DR   MMRRC; MMRRC:006950-UCD
DR   Wikidata; Q54782304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2677212; Bend3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB751
AC   CVCL_PI55
SY   XB751
DR   MMRRC; MMRRC:006951-UCD
DR   Wikidata; Q54782308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338056; Klf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB754
AC   CVCL_PI56
SY   XB754
DR   MMRRC; MMRRC:006952-UCD
DR   Wikidata; Q54782310
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913543; Snhg16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XB759
AC   CVCL_PI57
SY   XB759
DR   MMRRC; MMRRC:006954-UCD
DR   Wikidata; Q54782313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB761
AC   CVCL_PI58
SY   XB761
DR   MMRRC; MMRRC:006955-UCD
DR   Wikidata; Q54782315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039600; Fbxl19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB769
AC   CVCL_PI59
SY   XB769
DR   MMRRC; MMRRC:006956-UCD
DR   Wikidata; Q54782316
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB770
AC   CVCL_PI60
SY   XB770
DR   MMRRC; MMRRC:006957-UCD
DR   Wikidata; Q54782318
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB774
AC   CVCL_PI61
SY   XB774
DR   MMRRC; MMRRC:006959-UCD
DR   Wikidata; Q54782320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107428; Cfap20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB776
AC   CVCL_PI62
SY   XB776
DR   MMRRC; MMRRC:006960-UCD
DR   Wikidata; Q54782367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB777
AC   CVCL_PI63
SY   XB777
DR   MMRRC; MMRRC:006961-UCD
DR   Wikidata; Q54782369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103561; Kpna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB780
AC   CVCL_PI64
SY   XB780
DR   MMRRC; MMRRC:006963-UCD
DR   Wikidata; Q54782370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914404; Mtdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB784
AC   CVCL_PI65
SY   XB784
DR   MMRRC; MMRRC:006964-UCD
DR   Wikidata; Q54782371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB786
AC   CVCL_PI66
SY   XB786
DR   MMRRC; MMRRC:006965-UCD
DR   Wikidata; Q54782373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB787
AC   CVCL_PI67
SY   XB787
DR   MMRRC; MMRRC:006966-UCD
DR   Wikidata; Q54782376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB789
AC   CVCL_PI68
SY   XB789
DR   MMRRC; MMRRC:006967-UCD
DR   Wikidata; Q54782378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104689; Cct4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB793
AC   CVCL_PI69
SY   XB793
DR   MMRRC; MMRRC:006968-UCD
DR   Wikidata; Q54782383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103561; Kpna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB794
AC   CVCL_PI70
SY   XB794
DR   MMRRC; MMRRC:006969-UCD
DR   Wikidata; Q54782384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109275; Trim24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB795
AC   CVCL_PI71
SY   XB795
DR   MMRRC; MMRRC:006970-UCD
DR   Wikidata; Q54782386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3605986; Rad54b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB802
AC   CVCL_PI72
SY   XB802
DR   MMRRC; MMRRC:006971-UCD
DR   Wikidata; Q54782389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB804
AC   CVCL_PI73
SY   XB804
DR   MMRRC; MMRRC:006972-UCD
DR   Wikidata; Q54782391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107428; Cfap20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB812
AC   CVCL_PI74
SY   XB812
DR   MMRRC; MMRRC:006974-UCD
DR   Wikidata; Q54782393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894323; Ranbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB814
AC   CVCL_PI75
SY   XB814
DR   MMRRC; MMRRC:006975-UCD
DR   Wikidata; Q54782394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448492; Kdm6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB818
AC   CVCL_PI76
SY   XB818
DR   MMRRC; MMRRC:006976-UCD
DR   Wikidata; Q54782397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB820
AC   CVCL_PI77
SY   XB820
DR   MMRRC; MMRRC:006977-UCD
DR   Wikidata; Q54782399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107846; Prmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB822
AC   CVCL_PI78
SY   XB822
DR   MMRRC; MMRRC:006978-UCD
DR   Wikidata; Q54782400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916229; Nol11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB828
AC   CVCL_PI79
SY   XB828
DR   MMRRC; MMRRC:006979-UCD
DR   Wikidata; Q54782402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351331; Chaf1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB829
AC   CVCL_PI80
SY   XB829
DR   MMRRC; MMRRC:006980-UCD
DR   Wikidata; Q54782403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB830
AC   CVCL_PI81
SY   XB830
DR   MMRRC; MMRRC:006981-UCD
DR   Wikidata; Q54782406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343095; Emc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB831
AC   CVCL_PI82
SY   XB831
DR   MMRRC; MMRRC:006982-UCD
DR   Wikidata; Q54782409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98847; Kdm3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB837
AC   CVCL_PI83
SY   XB837
DR   MMRRC; MMRRC:006983-UCD
DR   Wikidata; Q54782410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915142; Coa6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB840
AC   CVCL_PI84
SY   XB840
DR   MMRRC; MMRRC:006984-UCD
DR   Wikidata; Q54782413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107738; Dync1li2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB843
AC   CVCL_PI85
SY   XB843
DR   MMRRC; MMRRC:006985-UCD
DR   Wikidata; Q54782414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151013; Erc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB844
AC   CVCL_PI86
SY   XB844
DR   MMRRC; MMRRC:006986-UCD
DR   Wikidata; Q54782415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444576; Kif20b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB848
AC   CVCL_PI87
SY   XB848
DR   MMRRC; MMRRC:006987-UCD
DR   Wikidata; Q54782417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923523; Ndfip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB850
AC   CVCL_PI88
SY   XB850
DR   MMRRC; MMRRC:006988-UCD
DR   Wikidata; Q54782421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442035; Atp5g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB856
AC   CVCL_PI89
SY   XB856
DR   MMRRC; MMRRC:006989-UCD
DR   Wikidata; Q54782422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB857
AC   CVCL_PI90
SY   XB857
DR   MMRRC; MMRRC:006990-UCD
DR   Wikidata; Q54782423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442035; Atp5g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB864
AC   CVCL_PI91
SY   XB864
DR   MMRRC; MMRRC:006991-UCD
DR   Wikidata; Q54782426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB865
AC   CVCL_PI92
SY   XB865
DR   MMRRC; MMRRC:006992-UCD
DR   Wikidata; Q54782427
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337994; Bcl10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB867
AC   CVCL_PI93
SY   XB867
DR   MMRRC; MMRRC:006993-UCD
DR   Wikidata; Q54782429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928268; Ireb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB873
AC   CVCL_PI94
SY   XB873
DR   MMRRC; MMRRC:006994-UCD
DR   Wikidata; Q54782431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917672; Ints2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB877
AC   CVCL_PI95
SY   XB877
DR   MMRRC; MMRRC:006995-UCD
DR   Wikidata; Q54782433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914449; Pfdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB878
AC   CVCL_PI96
SY   XB878
DR   MMRRC; MMRRC:006996-UCD
DR   Wikidata; Q54782435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332234; Zfp148.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB879
AC   CVCL_PI97
SY   XB879
DR   MMRRC; MMRRC:006997-UCD
DR   Wikidata; Q54782436
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858417; Sec61a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB880
AC   CVCL_PI98
SY   XB880
DR   MMRRC; MMRRC:006998-UCD
DR   Wikidata; Q54782440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB882
AC   CVCL_PI99
SY   XB882
DR   MMRRC; MMRRC:006999-UCD
DR   Wikidata; Q54782441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924054; Kdm4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XB883
AC   CVCL_PJ00
SY   XB883
DR   MMRRC; MMRRC:007000-UCD
DR   Wikidata; Q54782442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98869; Tuba1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC041
AC   CVCL_PJ01
SY   XC041
DR   MMRRC; MMRRC:007002-UCD
DR   Wikidata; Q54782444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183149; Nadk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC048
AC   CVCL_PJ02
SY   XC048
DR   MMRRC; MMRRC:007004-UCD
DR   Wikidata; Q54782491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1321159; Ppp2ca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC050
AC   CVCL_PJ03
SY   XC050
DR   MMRRC; MMRRC:007005-UCD
DR   Wikidata; Q54782494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858943; Arl6ip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC051
AC   CVCL_PJ04
SY   XC051
DR   MMRRC; MMRRC:007006-UCD
DR   Wikidata; Q54782496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC054
AC   CVCL_PJ05
SY   XC054
DR   MMRRC; MMRRC:007007-UCD
DR   Wikidata; Q54782498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309465; Slc12a4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC055
AC   CVCL_PJ06
SY   XC055
DR   MMRRC; MMRRC:007008-UCD
DR   Wikidata; Q54782500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC059
AC   CVCL_PJ07
SY   XC059
DR   MMRRC; MMRRC:007009-UCD
DR   Wikidata; Q54782502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915062; Ubxn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC060
AC   CVCL_PJ08
SY   XC060
DR   MMRRC; MMRRC:007010-UCD
DR   Wikidata; Q54782503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC067
AC   CVCL_PJ09
SY   XC067
DR   MMRRC; MMRRC:007011-UCD
DR   Wikidata; Q54782507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915127; Naa20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC100
AC   CVCL_PJ10
SY   XC100
DR   MMRRC; MMRRC:007012-UCD
DR   Wikidata; Q54782508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138811; Cdc123.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC104
AC   CVCL_PJ11
SY   XC104
DR   MMRRC; MMRRC:007013-UCD
DR   Wikidata; Q54782510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC113
AC   CVCL_PJ12
SY   XC113
DR   MMRRC; MMRRC:007015-UCD
DR   Wikidata; Q54782513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3039600; Fbxl19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC129
AC   CVCL_PJ13
SY   XC129
DR   MMRRC; MMRRC:007019-UCD
DR   Wikidata; Q54782514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179288; Rttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC149
AC   CVCL_PJ14
SY   XC149
DR   MMRRC; MMRRC:007024-UCD
DR   Wikidata; Q54782516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145597; Mbnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC165
AC   CVCL_PJ15
SY   XC165
DR   MMRRC; MMRRC:007026-UCD
DR   Wikidata; Q54782518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276539; Ttc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC166
AC   CVCL_PJ16
SY   XC166
DR   MMRRC; MMRRC:007027-UCD
DR   Wikidata; Q54782520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3704127; Zfp808.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC172
AC   CVCL_PJ17
SY   XC172
DR   MMRRC; MMRRC:007028-UCD
DR   Wikidata; Q54782523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925503; Map4k5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC181
AC   CVCL_PJ18
SY   XC181
DR   MMRRC; MMRRC:007031-UCD
DR   Wikidata; Q54782524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105968; Txlna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC186
AC   CVCL_PJ19
SY   XC186
DR   MMRRC; MMRRC:007032-UCD
DR   Wikidata; Q54782525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC187
AC   CVCL_PJ20
SY   XC187
DR   MMRRC; MMRRC:007033-UCD
DR   Wikidata; Q54782526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135937; Sbk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC188
AC   CVCL_PJ21
SY   XC188
DR   MMRRC; MMRRC:007034-UCD
DR   Wikidata; Q54782527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135937; Sbk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC190
AC   CVCL_PJ22
SY   XC190
DR   MMRRC; MMRRC:007035-UCD
DR   Wikidata; Q54782529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC191
AC   CVCL_PJ23
SY   XC191
DR   MMRRC; MMRRC:007036-UCD
DR   Wikidata; Q54782531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178103; Arhgdia.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC193
AC   CVCL_PJ24
SY   XC193
DR   MMRRC; MMRRC:007038-UCD
DR   Wikidata; Q54782534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC195
AC   CVCL_PJ25
SY   XC195
DR   MMRRC; MMRRC:007040-UCD
DR   Wikidata; Q54782536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101771; Sntb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC196
AC   CVCL_PJ26
SY   XC196
DR   MMRRC; MMRRC:007041-UCD
DR   Wikidata; Q54782537
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917113; Ttc39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC197
AC   CVCL_PJ27
SY   XC197
DR   MMRRC; MMRRC:007042-UCD
DR   Wikidata; Q54782539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC201
AC   CVCL_PJ28
SY   XC201
DR   MMRRC; MMRRC:007043-UCD
DR   Wikidata; Q54782540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925212; Scaf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC204
AC   CVCL_PJ29
SY   XC204
DR   MMRRC; MMRRC:007044-UCD
DR   Wikidata; Q54782542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC205
AC   CVCL_PJ30
SY   XC205
DR   MMRRC; MMRRC:007045-UCD
DR   Wikidata; Q54782546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387591; Arcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC209
AC   CVCL_PJ31
SY   XC209
DR   MMRRC; MMRRC:007046-UCD
DR   Wikidata; Q54782549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC210
AC   CVCL_PJ32
SY   XC210
DR   MMRRC; MMRRC:007047-UCD
DR   Wikidata; Q54782551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914162; Bzw2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC211
AC   CVCL_PJ33
SY   XC211
DR   MMRRC; MMRRC:007048-UCD
DR   Wikidata; Q54782553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99146; Ybx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC215
AC   CVCL_PJ34
SY   XC215
DR   MMRRC; MMRRC:007050-UCD
DR   Wikidata; Q54782555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182061; Usp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC223
AC   CVCL_PJ35
SY   XC223
DR   MMRRC; MMRRC:007051-UCD
DR   Wikidata; Q54782556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138584; Gigyf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC228
AC   CVCL_PJ36
SY   XC228
DR   MMRRC; MMRRC:007052-UCD
DR   Wikidata; Q54782558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328328; Map7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC233
AC   CVCL_PJ37
SY   XC233
DR   MMRRC; MMRRC:007054-UCD
DR   Wikidata; Q54782560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC239
AC   CVCL_PJ38
SY   XC239
DR   MMRRC; MMRRC:007055-UCD
DR   Wikidata; Q54782566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC240
AC   CVCL_PJ39
SY   XC240
DR   MMRRC; MMRRC:007056-UCD
DR   Wikidata; Q54782568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98345; Snrpd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC243
AC   CVCL_PJ40
SY   XC243
DR   MMRRC; MMRRC:007057-UCD
DR   Wikidata; Q54782571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153049; Klf16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC245
AC   CVCL_PJ41
SY   XC245
DR   MMRRC; MMRRC:007058-UCD
DR   Wikidata; Q54782573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442377; Ipo11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC246
AC   CVCL_PJ42
SY   XC246
DR   MMRRC; MMRRC:007059-UCD
DR   Wikidata; Q54782618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919806; Zfp566.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC247
AC   CVCL_PJ43
SY   XC247
DR   MMRRC; MMRRC:007060-UCD
DR   Wikidata; Q54782620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914852; Necap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC248
AC   CVCL_PJ44
SY   XC248
DR   MMRRC; MMRRC:007061-UCD
DR   Wikidata; Q54782623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC249
AC   CVCL_PJ45
SY   XC249
DR   MMRRC; MMRRC:007062-UCD
DR   Wikidata; Q54782625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446163; Fam120a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC252
AC   CVCL_PJ46
SY   XC252
DR   MMRRC; MMRRC:007063-UCD
DR   Wikidata; Q54782627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC254
AC   CVCL_PJ47
SY   XC254
DR   MMRRC; MMRRC:007064-UCD
DR   Wikidata; Q54782628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104626; Strbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC260
AC   CVCL_PJ48
SY   XC260
DR   MMRRC; MMRRC:007065-UCD
DR   Wikidata; Q54782632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141847; Phrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC262
AC   CVCL_PJ49
SY   XC262
DR   MMRRC; MMRRC:007066-UCD
DR   Wikidata; Q54782634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860611; Pdlim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC264
AC   CVCL_PJ50
SY   XC264
DR   MMRRC; MMRRC:007067-UCD
DR   Wikidata; Q54782636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC265
AC   CVCL_PJ51
SY   XC265
DR   MMRRC; MMRRC:007068-UCD
DR   Wikidata; Q54782638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919224; Prmt3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC266
AC   CVCL_PJ52
SY   XC266
DR   MMRRC; MMRRC:007069-UCD
DR   Wikidata; Q54782640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384768; Hectd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC267
AC   CVCL_PJ53
SY   XC267
DR   MMRRC; MMRRC:007070-UCD
DR   Wikidata; Q54782643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC268
AC   CVCL_PJ54
SY   XC268
DR   MMRRC; MMRRC:007071-UCD
DR   Wikidata; Q54782645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107887; Gtf3c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC269
AC   CVCL_PJ55
SY   XC269
DR   MMRRC; MMRRC:007072-UCD
DR   Wikidata; Q54782647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917822; Ipo5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC270
AC   CVCL_PJ56
SY   XC270
DR   MMRRC; MMRRC:007073-UCD
DR   Wikidata; Q54782648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC271
AC   CVCL_PJ57
SY   XC271
DR   MMRRC; MMRRC:007074-UCD
DR   Wikidata; Q54782652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108074; Sptlc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC272
AC   CVCL_PJ58
SY   XC272
DR   MMRRC; MMRRC:007075-UCD
DR   Wikidata; Q54782654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333803; Top3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC277
AC   CVCL_PJ59
SY   XC277
DR   MMRRC; MMRRC:007076-UCD
DR   Wikidata; Q54782656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353418; Pmm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC281
AC   CVCL_PJ60
SY   XC281
DR   MMRRC; MMRRC:007077-UCD
DR   Wikidata; Q54782658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183454; Rab40c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC282
AC   CVCL_PJ61
SY   XC282
DR   MMRRC; MMRRC:007078-UCD
DR   Wikidata; Q54782660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103006; Epb41l5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC283
AC   CVCL_PJ62
SY   XC283
DR   MMRRC; MMRRC:007079-UCD
DR   Wikidata; Q54782661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353418; Pmm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC285
AC   CVCL_PJ63
SY   XC285
DR   MMRRC; MMRRC:007081-UCD
DR   Wikidata; Q54782663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC288
AC   CVCL_PJ64
SY   XC288
DR   MMRRC; MMRRC:007082-UCD
DR   Wikidata; Q54782666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194490; Diaph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC290
AC   CVCL_PJ65
SY   XC290
DR   MMRRC; MMRRC:007084-UCD
DR   Wikidata; Q54782668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894835; Rbbp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC291
AC   CVCL_PJ66
SY   XC291
DR   MMRRC; MMRRC:007085-UCD
DR   Wikidata; Q54782670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2651932; Lcorl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC292
AC   CVCL_PJ67
SY   XC292
DR   MMRRC; MMRRC:007086-UCD
DR   Wikidata; Q54782673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC293
AC   CVCL_PJ68
SY   XC293
DR   MMRRC; MMRRC:007087-UCD
DR   Wikidata; Q54782675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137706; Actn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC294
AC   CVCL_PJ69
SY   XC294
DR   MMRRC; MMRRC:007088-UCD
DR   Wikidata; Q54782677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102774; Aimp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC295
AC   CVCL_PJ70
SY   XC295
DR   MMRRC; MMRRC:007089-UCD
DR   Wikidata; Q54782678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC296
AC   CVCL_PJ71
SY   XC296
DR   MMRRC; MMRRC:007090-UCD
DR   Wikidata; Q54782680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388633; Cltc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC297
AC   CVCL_PJ72
SY   XC297
DR   MMRRC; MMRRC:007091-UCD
DR   Wikidata; Q54782682
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926162; Sp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC298
AC   CVCL_PJ73
SY   XC298
DR   MMRRC; MMRRC:007092-UCD
DR   Wikidata; Q54782684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203522; Magi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC299
AC   CVCL_PJ74
SY   XC299
DR   MMRRC; MMRRC:007093-UCD
DR   Wikidata; Q54782685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917720; Rprd1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC300
AC   CVCL_PJ75
SY   XC300
DR   MMRRC; MMRRC:007094-UCD
DR   Wikidata; Q54782687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928744; Vapb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC302
AC   CVCL_PJ76
SY   XC302
DR   MMRRC; MMRRC:007096-UCD
DR   Wikidata; Q54782690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103232; Grb10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC303
AC   CVCL_PJ77
SY   XC303
DR   MMRRC; MMRRC:007097-UCD
DR   Wikidata; Q54782692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC304
AC   CVCL_PJ78
SY   XC304
DR   MMRRC; MMRRC:007098-UCD
DR   Wikidata; Q54782694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC305
AC   CVCL_PJ79
SY   XC305
DR   MMRRC; MMRRC:007099-UCD
DR   Wikidata; Q54782697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC306
AC   CVCL_PJ80
SY   XC306
DR   MMRRC; MMRRC:007100-UCD
DR   Wikidata; Q54782699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC310
AC   CVCL_PJ81
SY   XC310
DR   MMRRC; MMRRC:007102-UCD
DR   Wikidata; Q54782701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC311
AC   CVCL_PJ82
SY   XC311
DR   MMRRC; MMRRC:007103-UCD
DR   Wikidata; Q54782746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC313
AC   CVCL_PJ83
SY   XC313
DR   MMRRC; MMRRC:007104-UCD
DR   Wikidata; Q54782750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143362; Zfp809.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC314
AC   CVCL_PJ84
SY   XC314
DR   MMRRC; MMRRC:007105-UCD
DR   Wikidata; Q54782751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88494; Creb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC316
AC   CVCL_PJ85
SY   XC316
DR   MMRRC; MMRRC:007106-UCD
DR   Wikidata; Q54782753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC322
AC   CVCL_PJ86
SY   XC322
DR   MMRRC; MMRRC:007107-UCD
DR   Wikidata; Q54782754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:91860; Dcaf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC324
AC   CVCL_PJ87
SY   XC324
DR   MMRRC; MMRRC:007108-UCD
DR   Wikidata; Q54782756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675859; Wapl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC326
AC   CVCL_PJ88
SY   XC326
DR   MMRRC; MMRRC:007109-UCD
DR   Wikidata; Q54782758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC327
AC   CVCL_PJ89
SY   XC327
DR   MMRRC; MMRRC:007110-UCD
DR   Wikidata; Q54782759
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC331
AC   CVCL_PJ90
SY   XC331
DR   MMRRC; MMRRC:007112-UCD
DR   Wikidata; Q54782762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107163; Ppp3cb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC333
AC   CVCL_PJ91
SY   XC333
DR   MMRRC; MMRRC:007113-UCD
DR   Wikidata; Q54782764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914320; Lsm14a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC334
AC   CVCL_PJ92
SY   XC334
DR   MMRRC; MMRRC:007114-UCD
DR   Wikidata; Q54782765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC335
AC   CVCL_PJ93
SY   XC335
DR   MMRRC; MMRRC:007115-UCD
DR   Wikidata; Q54782768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338037; Rbm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC337
AC   CVCL_PJ94
SY   XC337
DR   MMRRC; MMRRC:007116-UCD
DR   Wikidata; Q54782769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99833; Rab23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC338
AC   CVCL_PJ95
SY   XC338
DR   MMRRC; MMRRC:007117-UCD
DR   Wikidata; Q54782772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99532; Mef2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC339
AC   CVCL_PJ96
SY   XC339
DR   MMRRC; MMRRC:007118-UCD
DR   Wikidata; Q54782773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142567; Arhgef18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC341
AC   CVCL_PJ97
SY   XC341
DR   MMRRC; MMRRC:007119-UCD
DR   Wikidata; Q54782775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC343
AC   CVCL_PJ98
SY   XC343
DR   MMRRC; MMRRC:007120-UCD
DR   Wikidata; Q54782776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442401; Ppp1r9a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC345
AC   CVCL_PJ99
SY   XC345
DR   MMRRC; MMRRC:007121-UCD
DR   Wikidata; Q54782779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC347
AC   CVCL_PQ00
SY   XC347
DR   MMRRC; MMRRC:007122-UCD
DR   Wikidata; Q54782780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914149; Fip1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC348
AC   CVCL_PQ01
SY   XC348
DR   MMRRC; MMRRC:007123-UCD
DR   Wikidata; Q54782783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC350
AC   CVCL_PQ02
SY   XC350
DR   MMRRC; MMRRC:007125-UCD
DR   Wikidata; Q54782785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920336; Rps6ka5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC351
AC   CVCL_PQ03
SY   XC351
DR   MMRRC; MMRRC:007126-UCD
DR   Wikidata; Q54782789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137357; Trim33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC354
AC   CVCL_PQ04
SY   XC354
DR   MMRRC; MMRRC:007127-UCD
DR   Wikidata; Q54782790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107606; Srebf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC356
AC   CVCL_PQ05
SY   XC356
DR   MMRRC; MMRRC:007128-UCD
DR   Wikidata; Q54782793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919404; Zfp157.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC358
AC   CVCL_PQ06
SY   XC358
DR   MMRRC; MMRRC:007129-UCD
DR   Wikidata; Q54782795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC361
AC   CVCL_PQ07
SY   XC361
DR   MMRRC; MMRRC:007130-UCD
DR   Wikidata; Q54782798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC366
AC   CVCL_PQ08
SY   XC366
DR   MMRRC; MMRRC:007131-UCD
DR   Wikidata; Q54782799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859162; Rnf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC368
AC   CVCL_PQ09
SY   XC368
DR   MMRRC; MMRRC:007132-UCD
DR   Wikidata; Q54782801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94909; Dmd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC370
AC   CVCL_PQ10
SY   XC370
DR   MMRRC; MMRRC:007133-UCD
DR   Wikidata; Q54782802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923241; Slain2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC372
AC   CVCL_PQ11
SY   XC372
DR   MMRRC; MMRRC:007134-UCD
DR   Wikidata; Q54782806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927110; Tmem131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC373
AC   CVCL_PQ12
SY   XC373
DR   MMRRC; MMRRC:007135-UCD
DR   Wikidata; Q54782807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95556; Flna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC376
AC   CVCL_PQ13
SY   XC376
DR   MMRRC; MMRRC:007136-UCD
DR   Wikidata; Q54782811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC380
AC   CVCL_PQ14
SY   XC380
DR   MMRRC; MMRRC:007137-UCD
DR   Wikidata; Q54782814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99157; Zfp12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC389
AC   CVCL_PQ15
SY   XC389
DR   MMRRC; MMRRC:007139-UCD
DR   Wikidata; Q54782815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926129; Arid1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC390
AC   CVCL_PQ16
SY   XC390
DR   MMRRC; MMRRC:007140-UCD
DR   Wikidata; Q54782816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934811; Nucks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC392
AC   CVCL_PQ17
SY   XC392
DR   MMRRC; MMRRC:007141-UCD
DR   Wikidata; Q54782820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC396
AC   CVCL_PQ18
SY   XC396
DR   MMRRC; MMRRC:007142-UCD
DR   Wikidata; Q54782821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106918; Hif1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC398
AC   CVCL_PQ19
SY   XC398
DR   MMRRC; MMRRC:007143-UCD
DR   Wikidata; Q54782823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC402
AC   CVCL_PQ20
SY   XC402
DR   MMRRC; MMRRC:007144-UCD
DR   Wikidata; Q54782825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97583; Pik3r1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC411
AC   CVCL_PQ21
SY   XC411
DR   MMRRC; MMRRC:007146-UCD
DR   Wikidata; Q54782827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919449; Mms19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC416
AC   CVCL_PQ22
SY   XC416
DR   MMRRC; MMRRC:007149-UCD
DR   Wikidata; Q54782877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914416; Arl8b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC417
AC   CVCL_PQ23
SY   XC417
DR   MMRRC; MMRRC:007150-UCD
DR   Wikidata; Q54782879
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3027003; Ino80d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC419
AC   CVCL_PQ24
SY   XC419
DR   MMRRC; MMRRC:007151-UCD
DR   Wikidata; Q54782881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916610; 1700008J07Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC420
AC   CVCL_PQ25
SY   XC420
DR   MMRRC; MMRRC:007152-UCD
DR   Wikidata; Q54782885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920442; Xpot.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC421
AC   CVCL_PQ26
SY   XC421
DR   MMRRC; MMRRC:007153-UCD
DR   Wikidata; Q54782886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914265; Ccdc91.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC423
AC   CVCL_PQ27
SY   XC423
DR   MMRRC; MMRRC:007154-UCD
DR   Wikidata; Q54782890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC424
AC   CVCL_PQ28
SY   XC424
DR   MMRRC; MMRRC:007155-UCD
DR   Wikidata; Q54782893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328306; Orc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC425
AC   CVCL_PQ29
SY   XC425
DR   MMRRC; MMRRC:007156-UCD
DR   Wikidata; Q54782895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC426
AC   CVCL_PQ30
SY   XC426
DR   MMRRC; MMRRC:007157-UCD
DR   Wikidata; Q54782898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915984; Ppp4r3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC428
AC   CVCL_PQ31
SY   XC428
DR   MMRRC; MMRRC:007158-UCD
DR   Wikidata; Q54782901
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC431
AC   CVCL_PQ32
SY   XC431
DR   MMRRC; MMRRC:007159-UCD
DR   Wikidata; Q54782902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923935; Eif4g3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC434
AC   CVCL_PQ33
SY   XC434
DR   MMRRC; MMRRC:007160-UCD
DR   Wikidata; Q54782907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921593; Crtc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC436
AC   CVCL_PQ34
SY   XC436
DR   MMRRC; MMRRC:007161-UCD
DR   Wikidata; Q54782909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353653; Glrx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC440
AC   CVCL_PQ35
SY   XC440
DR   MMRRC; MMRRC:007162-UCD
DR   Wikidata; Q54782911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442951; Zfp574.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC444
AC   CVCL_PQ36
SY   XC444
DR   MMRRC; MMRRC:007163-UCD
DR   Wikidata; Q54782912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC445
AC   CVCL_PQ37
SY   XC445
DR   MMRRC; MMRRC:007164-UCD
DR   Wikidata; Q54782914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108426; Kif1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC446
AC   CVCL_PQ38
SY   XC446
DR   MMRRC; MMRRC:007165-UCD
DR   Wikidata; Q54782916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913540; Atp6v1g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC448
AC   CVCL_PQ39
SY   XC448
DR   MMRRC; MMRRC:007166-UCD
DR   Wikidata; Q54782918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859353; Mkrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC449
AC   CVCL_PQ40
SY   XC449
DR   MMRRC; MMRRC:007167-UCD
DR   Wikidata; Q54782920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95301; Eif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC452
AC   CVCL_PQ41
SY   XC452
DR   MMRRC; MMRRC:007168-UCD
DR   Wikidata; Q54782923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346832; Esrrb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC453
AC   CVCL_PQ42
SY   XC453
DR   MMRRC; MMRRC:007169-UCD
DR   Wikidata; Q54782925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC455
AC   CVCL_PQ43
SY   XC455
DR   MMRRC; MMRRC:007171-UCD
DR   Wikidata; Q54782927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC456
AC   CVCL_PQ44
SY   XC456
DR   MMRRC; MMRRC:007172-UCD
DR   Wikidata; Q54782930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109275; Trim24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC471
AC   CVCL_PQ45
SY   XC471
DR   MMRRC; MMRRC:007174-UCD
DR   Wikidata; Q54782933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447670; Mgrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC472
AC   CVCL_PQ46
SY   XC472
DR   MMRRC; MMRRC:007175-UCD
DR   Wikidata; Q54782934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920159; Chmp1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC475
AC   CVCL_PQ47
SY   XC475
DR   MMRRC; MMRRC:007176-UCD
DR   Wikidata; Q54782938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316728; Gspt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC484
AC   CVCL_PQ48
SY   XC484
DR   MMRRC; MMRRC:007177-UCD
DR   Wikidata; Q54782939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145901; Mfsd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC485
AC   CVCL_PQ49
SY   XC485
DR   MMRRC; MMRRC:007178-UCD
DR   Wikidata; Q54782940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385848; Bcas3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC490
AC   CVCL_PQ50
SY   XC490
DR   MMRRC; MMRRC:007180-UCD
DR   Wikidata; Q54782941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC491
AC   CVCL_PQ51
SY   XC491
DR   MMRRC; MMRRC:007181-UCD
DR   Wikidata; Q54782943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153063; Parvb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC493
AC   CVCL_PQ52
SY   XC493
DR   MMRRC; MMRRC:007182-UCD
DR   Wikidata; Q54782946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC499
AC   CVCL_PQ53
SY   XC499
DR   MMRRC; MMRRC:007185-UCD
DR   Wikidata; Q54782949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC500
AC   CVCL_PQ54
SY   XC500
DR   MMRRC; MMRRC:007186-UCD
DR   Wikidata; Q54782951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913989; Rcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC502
AC   CVCL_PQ55
SY   XC502
DR   MMRRC; MMRRC:007188-UCD
DR   Wikidata; Q54782954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98166; Rps8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC504
AC   CVCL_PQ56
SY   XC504
DR   MMRRC; MMRRC:007190-UCD
DR   Wikidata; Q54782955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442401; Ppp1r9a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC505
AC   CVCL_PQ57
SY   XC505
DR   MMRRC; MMRRC:007191-UCD
DR   Wikidata; Q54782956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC506
AC   CVCL_PQ58
SY   XC506
DR   MMRRC; MMRRC:007192-UCD
DR   Wikidata; Q54782958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC510
AC   CVCL_PQ59
SY   XC510
DR   MMRRC; MMRRC:007193-UCD
DR   Wikidata; Q54782960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353655; Usp25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC512
AC   CVCL_PQ60
SY   XC512
DR   MMRRC; MMRRC:007195-UCD
DR   Wikidata; Q54782961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137092; Eefsec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC514
AC   CVCL_PQ61
SY   XC514
DR   MMRRC; MMRRC:007197-UCD
DR   Wikidata; Q54782964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194490; Diaph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC520
AC   CVCL_PQ62
SY   XC520
DR   MMRRC; MMRRC:007198-UCD
DR   Wikidata; Q54783008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC521
AC   CVCL_PQ63
SY   XC521
DR   MMRRC; MMRRC:007199-UCD
DR   Wikidata; Q54783010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC523
AC   CVCL_PQ64
SY   XC523
DR   MMRRC; MMRRC:007200-UCD
DR   Wikidata; Q54783012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC532
AC   CVCL_PQ65
SY   XC532
DR   MMRRC; MMRRC:007201-UCD
DR   Wikidata; Q54783013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913750; Slc30a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC533
AC   CVCL_PQ66
SY   XC533
DR   MMRRC; MMRRC:007202-UCD
DR   Wikidata; Q54783016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC549
AC   CVCL_PQ67
SY   XC549
DR   MMRRC; MMRRC:007204-UCD
DR   Wikidata; Q54783017
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447063; Tenm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC553
AC   CVCL_PQ68
SY   XC553
DR   MMRRC; MMRRC:007206-UCD
DR   Wikidata; Q54783018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC565
AC   CVCL_PQ69
SY   XC565
DR   MMRRC; MMRRC:007207-UCD
DR   Wikidata; Q54783022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932915; Ndel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC570
AC   CVCL_PQ70
SY   XC570
DR   MMRRC; MMRRC:007208-UCD
DR   Wikidata; Q54783024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924876; Smpd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC571
AC   CVCL_PQ71
SY   XC571
DR   MMRRC; MMRRC:007209-UCD
DR   Wikidata; Q54783026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97842; Rab1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC574
AC   CVCL_PQ72
SY   XC574
DR   MMRRC; MMRRC:007210-UCD
DR   Wikidata; Q54783029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC580
AC   CVCL_PQ73
SY   XC580
DR   MMRRC; MMRRC:007212-UCD
DR   Wikidata; Q54783031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108064; Siah1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC583
AC   CVCL_PQ74
SY   XC583
DR   MMRRC; MMRRC:007213-UCD
DR   Wikidata; Q54783033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923998; Pbrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC586
AC   CVCL_PQ75
SY   XC586
DR   MMRRC; MMRRC:007215-UCD
DR   Wikidata; Q54783035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC587
AC   CVCL_PQ76
SY   XC587
DR   MMRRC; MMRRC:007216-UCD
DR   Wikidata; Q54783037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384768; Hectd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC588
AC   CVCL_PQ77
SY   XC588
DR   MMRRC; MMRRC:007217-UCD
DR   Wikidata; Q54783040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384768; Hectd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC591
AC   CVCL_PQ78
SY   XC591
DR   MMRRC; MMRRC:007218-UCD
DR   Wikidata; Q54783041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95556; Flna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC593
AC   CVCL_PQ79
SY   XC593
DR   MMRRC; MMRRC:007219-UCD
DR   Wikidata; Q54783043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95556; Flna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC597
AC   CVCL_PQ80
SY   XC597
DR   MMRRC; MMRRC:007221-UCD
DR   Wikidata; Q54783045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC598
AC   CVCL_PQ81
SY   XC598
DR   MMRRC; MMRRC:007222-UCD
DR   Wikidata; Q54783047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915149; Cmc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC603
AC   CVCL_PQ82
SY   XC603
DR   MMRRC; MMRRC:007224-UCD
DR   Wikidata; Q54783050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920336; Rps6ka5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC610
AC   CVCL_PQ83
SY   XC610
DR   MMRRC; MMRRC:007225-UCD
DR   Wikidata; Q54783051
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926194; Tnip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC614
AC   CVCL_PQ84
SY   XC614
DR   MMRRC; MMRRC:007226-UCD
DR   Wikidata; Q54783053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918963; Cdc40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC620
AC   CVCL_PQ85
SY   XC620
DR   MMRRC; MMRRC:007227-UCD
DR   Wikidata; Q54783056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC621
AC   CVCL_PQ86
SY   XC621
DR   MMRRC; MMRRC:007228-UCD
DR   Wikidata; Q54783059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC629
AC   CVCL_PQ87
SY   XC629
DR   MMRRC; MMRRC:007229-UCD
DR   Wikidata; Q54783061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917498; Dazap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC630
AC   CVCL_PQ88
SY   XC630
DR   MMRRC; MMRRC:007230-UCD
DR   Wikidata; Q54783063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95556; Flna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC631
AC   CVCL_PQ89
SY   XC631
DR   MMRRC; MMRRC:007231-UCD
DR   Wikidata; Q54783066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95556; Flna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC632
AC   CVCL_PQ90
SY   XC632
DR   MMRRC; MMRRC:007232-UCD
DR   Wikidata; Q54783070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC644
AC   CVCL_PQ91
SY   XC644
DR   MMRRC; MMRRC:007233-UCD
DR   Wikidata; Q54783072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385848; Bcas3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC646
AC   CVCL_PQ92
SY   XC646
DR   MMRRC; MMRRC:007234-UCD
DR   Wikidata; Q54783073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC651
AC   CVCL_PQ93
SY   XC651
DR   MMRRC; MMRRC:007235-UCD
DR   Wikidata; Q54783076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918348; Cep170.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC652
AC   CVCL_PQ94
SY   XC652
DR   MMRRC; MMRRC:007236-UCD
DR   Wikidata; Q54783079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC653
AC   CVCL_PQ95
SY   XC653
DR   MMRRC; MMRRC:007237-UCD
DR   Wikidata; Q54783080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181074; Acbd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC656
AC   CVCL_PQ96
SY   XC656
DR   MMRRC; MMRRC:007238-UCD
DR   Wikidata; Q54783082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442859; Rnft2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC657
AC   CVCL_PQ97
SY   XC657
DR   MMRRC; MMRRC:007239-UCD
DR   Wikidata; Q54783085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920037; Ndc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC668
AC   CVCL_PQ98
SY   XC668
DR   MMRRC; MMRRC:007242-UCD
DR   Wikidata; Q54783089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC671
AC   CVCL_PQ99
SY   XC671
DR   MMRRC; MMRRC:007243-UCD
DR   Wikidata; Q54783090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC674
AC   CVCL_PK00
SY   XC674
DR   MMRRC; MMRRC:007245-UCD
DR   Wikidata; Q54783092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106918; Hif1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC676
AC   CVCL_PK01
SY   XC676
DR   MMRRC; MMRRC:007246-UCD
DR   Wikidata; Q54783094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143340; Zfp445.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC677
AC   CVCL_PK02
SY   XC677
DR   MMRRC; MMRRC:007247-UCD
DR   Wikidata; Q54783146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC678
AC   CVCL_PK03
SY   XC678
DR   MMRRC; MMRRC:007248-UCD
DR   Wikidata; Q54783150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915498; 2410080I02Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC681
AC   CVCL_PK04
SY   XC681
DR   MMRRC; MMRRC:007249-UCD
DR   Wikidata; Q54783152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC683
AC   CVCL_PK05
SY   XC683
DR   MMRRC; MMRRC:007250-UCD
DR   Wikidata; Q54783157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913099; Psrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC684
AC   CVCL_PK06
SY   XC684
DR   MMRRC; MMRRC:007251-UCD
DR   Wikidata; Q54783158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC686
AC   CVCL_PK07
SY   XC686
DR   MMRRC; MMRRC:007252-UCD
DR   Wikidata; Q54783159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914648; Srpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC687
AC   CVCL_PK08
SY   XC687
DR   MMRRC; MMRRC:007253-UCD
DR   Wikidata; Q54783161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387123; Lnpep.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC693
AC   CVCL_PK09
SY   XC693
DR   MMRRC; MMRRC:007257-UCD
DR   Wikidata; Q54783163
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346862; Mapk9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC694
AC   CVCL_PK10
SY   XC694
DR   MMRRC; MMRRC:007258-UCD
DR   Wikidata; Q54783166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC697
AC   CVCL_PK11
SY   XC697
DR   MMRRC; MMRRC:007259-UCD
DR   Wikidata; Q54783167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC699
AC   CVCL_PK12
SY   XC699
DR   MMRRC; MMRRC:007260-UCD
DR   Wikidata; Q54783169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95556; Flna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC701
AC   CVCL_PK13
SY   XC701
DR   MMRRC; MMRRC:007261-UCD
DR   Wikidata; Q54783172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC705
AC   CVCL_PK14
SY   XC705
DR   MMRRC; MMRRC:007263-UCD
DR   Wikidata; Q54783175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446163; Fam120a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC706
AC   CVCL_PK15
SY   XC706
DR   MMRRC; MMRRC:007264-UCD
DR   Wikidata; Q54783178
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388633; Cltc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC709
AC   CVCL_PK16
SY   XC709
DR   MMRRC; MMRRC:007265-UCD
DR   Wikidata; Q54783179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916906; Pir.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC710
AC   CVCL_PK17
SY   XC710
DR   MMRRC; MMRRC:007266-UCD
DR   Wikidata; Q54783181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920336; Rps6ka5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC712
AC   CVCL_PK18
SY   XC712
DR   MMRRC; MMRRC:007267-UCD
DR   Wikidata; Q54783183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447670; Mgrn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC715
AC   CVCL_PK19
SY   XC715
DR   MMRRC; MMRRC:007268-UCD
DR   Wikidata; Q54783185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC716
AC   CVCL_PK20
SY   XC716
DR   MMRRC; MMRRC:007269-UCD
DR   Wikidata; Q54783189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC719
AC   CVCL_PK21
SY   XC719
DR   MMRRC; MMRRC:007270-UCD
DR   Wikidata; Q54783190
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915498; 2410080I02Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC720
AC   CVCL_PK22
SY   XC720
DR   MMRRC; MMRRC:007271-UCD
DR   Wikidata; Q54783193
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99532; Mef2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC728
AC   CVCL_PK23
SY   XC728
DR   MMRRC; MMRRC:007273-UCD
DR   Wikidata; Q54783195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349658; Cul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC730
AC   CVCL_PK24
SY   XC730
DR   MMRRC; MMRRC:007274-UCD
DR   Wikidata; Q54783199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94909; Dmd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC738
AC   CVCL_PK25
SY   XC738
DR   MMRRC; MMRRC:007276-UCD
DR   Wikidata; Q54783201
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC739
AC   CVCL_PK26
SY   XC739
DR   MMRRC; MMRRC:007277-UCD
DR   Wikidata; Q54783203
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC740
AC   CVCL_PK27
SY   XC740
DR   MMRRC; MMRRC:007278-UCD
DR   Wikidata; Q54783205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC741
AC   CVCL_PK28
SY   XC741
DR   MMRRC; MMRRC:007279-UCD
DR   Wikidata; Q54783208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC742
AC   CVCL_PK29
SY   XC742
DR   MMRRC; MMRRC:007280-UCD
DR   Wikidata; Q54783210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC745
AC   CVCL_PK30
SY   XC745
DR   MMRRC; MMRRC:007282-UCD
DR   Wikidata; Q54783212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203522; Magi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC749
AC   CVCL_PK31
SY   XC749
DR   MMRRC; MMRRC:007283-UCD
DR   Wikidata; Q54783216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146350; Scaf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC750
AC   CVCL_PK32
SY   XC750
DR   MMRRC; MMRRC:007284-UCD
DR   Wikidata; Q54783218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915498; 2410080I02Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC755
AC   CVCL_PK33
SY   XC755
DR   MMRRC; MMRRC:007285-UCD
DR   Wikidata; Q54783219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2667663; Cep68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC757
AC   CVCL_PK34
SY   XC757
DR   MMRRC; MMRRC:007286-UCD
DR   Wikidata; Q54783222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2667663; Cep68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC758
AC   CVCL_PK35
SY   XC758
DR   MMRRC; MMRRC:007287-UCD
DR   Wikidata; Q54783223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137357; Trim33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC762
AC   CVCL_PK36
SY   XC762
DR   MMRRC; MMRRC:007288-UCD
DR   Wikidata; Q54783224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2667663; Cep68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC763
AC   CVCL_PK37
SY   XC763
DR   MMRRC; MMRRC:007289-UCD
DR   Wikidata; Q54783227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC765
AC   CVCL_PK38
SY   XC765
DR   MMRRC; MMRRC:007290-UCD
DR   Wikidata; Q54783231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929996; Trpm7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC766
AC   CVCL_PK39
SY   XC766
DR   MMRRC; MMRRC:007291-UCD
DR   Wikidata; Q54783234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920159; Chmp1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC768
AC   CVCL_PK40
SY   XC768
DR   MMRRC; MMRRC:007292-UCD
DR   Wikidata; Q54783235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921361; Rbm19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC769
AC   CVCL_PK41
SY   XC769
DR   MMRRC; MMRRC:007293-UCD
DR   Wikidata; Q54783239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153049; Klf16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC772
AC   CVCL_PK42
SY   XC772
DR   MMRRC; MMRRC:007294-UCD
DR   Wikidata; Q54783294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC775
AC   CVCL_PK43
SY   XC775
DR   MMRRC; MMRRC:007295-UCD
DR   Wikidata; Q54783295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926048; Eml4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC776
AC   CVCL_PK44
SY   XC776
DR   MMRRC; MMRRC:007296-UCD
DR   Wikidata; Q54783298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC777
AC   CVCL_PK45
SY   XC777
DR   MMRRC; MMRRC:007297-UCD
DR   Wikidata; Q54783301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC778
AC   CVCL_PK46
SY   XC778
DR   MMRRC; MMRRC:007298-UCD
DR   Wikidata; Q54783302
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC780
AC   CVCL_PK47
SY   XC780
DR   MMRRC; MMRRC:007299-UCD
DR   Wikidata; Q54783304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC782
AC   CVCL_PK48
SY   XC782
DR   MMRRC; MMRRC:007300-UCD
DR   Wikidata; Q54783306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC784
AC   CVCL_PK49
SY   XC784
DR   MMRRC; MMRRC:007302-UCD
DR   Wikidata; Q54783307
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC786
AC   CVCL_PK50
SY   XC786
DR   MMRRC; MMRRC:007303-UCD
DR   Wikidata; Q54783309
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC787
AC   CVCL_PK51
SY   XC787
DR   MMRRC; MMRRC:007304-UCD
DR   Wikidata; Q54783313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC788
AC   CVCL_PK52
SY   XC788
DR   MMRRC; MMRRC:007305-UCD
DR   Wikidata; Q54783315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC791
AC   CVCL_PK53
SY   XC791
DR   MMRRC; MMRRC:007307-UCD
DR   Wikidata; Q54783317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917338; Meaf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC792
AC   CVCL_PK54
SY   XC792
DR   MMRRC; MMRRC:007308-UCD
DR   Wikidata; Q54783319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC793
AC   CVCL_PK55
SY   XC793
DR   MMRRC; MMRRC:007309-UCD
DR   Wikidata; Q54783321
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150037; Mta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC796
AC   CVCL_PK56
SY   XC796
DR   MMRRC; MMRRC:007310-UCD
DR   Wikidata; Q54783323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC797
AC   CVCL_PK57
SY   XC797
DR   MMRRC; MMRRC:007311-UCD
DR   Wikidata; Q54783324
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC798
AC   CVCL_PK58
SY   XC798
DR   MMRRC; MMRRC:007312-UCD
DR   Wikidata; Q54783326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914116; Nhlrc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC807
AC   CVCL_PK59
SY   XC807
DR   MMRRC; MMRRC:007313-UCD
DR   Wikidata; Q54783331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914320; Lsm14a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC808
AC   CVCL_PK60
SY   XC808
DR   MMRRC; MMRRC:007314-UCD
DR   Wikidata; Q54783332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914782; Mfap1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC809
AC   CVCL_PK61
SY   XC809
DR   MMRRC; MMRRC:007315-UCD
DR   Wikidata; Q54783334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926048; Eml4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC815
AC   CVCL_PK62
SY   XC815
DR   MMRRC; MMRRC:007316-UCD
DR   Wikidata; Q54783336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442951; Zfp574.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC819
AC   CVCL_PK63
SY   XC819
DR   MMRRC; MMRRC:007317-UCD
DR   Wikidata; Q54783338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913989; Rcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC820
AC   CVCL_PK64
SY   XC820
DR   MMRRC; MMRRC:007318-UCD
DR   Wikidata; Q54783340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105066; Rab10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC821
AC   CVCL_PK65
SY   XC821
DR   MMRRC; MMRRC:007319-UCD
DR   Wikidata; Q54783342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC823
AC   CVCL_PK66
SY   XC823
DR   MMRRC; MMRRC:007320-UCD
DR   Wikidata; Q54783343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95556; Flna.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC827
AC   CVCL_PK67
SY   XC827
DR   MMRRC; MMRRC:007322-UCD
DR   Wikidata; Q54783346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913750; Slc30a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC832
AC   CVCL_PK68
SY   XC832
DR   MMRRC; MMRRC:007323-UCD
DR   Wikidata; Q54783349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917579; Gon4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC840
AC   CVCL_PK69
SY   XC840
DR   MMRRC; MMRRC:007324-UCD
DR   Wikidata; Q54783350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC841
AC   CVCL_PK70
SY   XC841
DR   MMRRC; MMRRC:007325-UCD
DR   Wikidata; Q54783352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC845
AC   CVCL_PK71
SY   XC845
DR   MMRRC; MMRRC:007327-UCD
DR   Wikidata; Q54783355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919824; Zc3h14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC846
AC   CVCL_PK72
SY   XC846
DR   MMRRC; MMRRC:007328-UCD
DR   Wikidata; Q54783357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682305; Rsf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC847
AC   CVCL_PK73
SY   XC847
DR   MMRRC; MMRRC:007329-UCD
DR   Wikidata; Q54783359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC851
AC   CVCL_PK74
SY   XC851
DR   MMRRC; MMRRC:007331-UCD
DR   Wikidata; Q54783360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915498; 2410080I02Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC853
AC   CVCL_PK75
SY   XC853
DR   MMRRC; MMRRC:007333-UCD
DR   Wikidata; Q54783364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917794; Tmem242.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC874
AC   CVCL_PK76
SY   XC874
DR   MMRRC; MMRRC:007334-UCD
DR   Wikidata; Q54783367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108086; Hdac1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC898
AC   CVCL_PK77
SY   XC898
DR   MMRRC; MMRRC:007335-UCD
DR   Wikidata; Q54783369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915149; Cmc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC901
AC   CVCL_PK78
SY   XC901
DR   MMRRC; MMRRC:007336-UCD
DR   Wikidata; Q54783371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917338; Meaf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XC904
AC   CVCL_PK79
SY   XC904
DR   MMRRC; MMRRC:007337-UCD
DR   Wikidata; Q54783373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD005
AC   CVCL_PK80
SY   XD005
DR   MMRRC; MMRRC:007340-UCD
DR   Wikidata; Q54783374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99212; Zfy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD006
AC   CVCL_PK81
SY   XD006
DR   MMRRC; MMRRC:007341-UCD
DR   Wikidata; Q54783377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD007
AC   CVCL_PK82
SY   XD007
DR   MMRRC; MMRRC:007342-UCD
DR   Wikidata; Q54783418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917483; Cd2bp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD013
AC   CVCL_PK83
SY   XD013
DR   MMRRC; MMRRC:007344-UCD
DR   Wikidata; Q54783421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289234; Rhpn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD015
AC   CVCL_PK84
SY   XD015
DR   MMRRC; MMRRC:007345-UCD
DR   Wikidata; Q54783423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98884; U2af1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD019
AC   CVCL_PK85
SY   XD019
DR   MMRRC; MMRRC:007346-UCD
DR   Wikidata; Q54783425
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD024
AC   CVCL_PK86
SY   XD024
DR   MMRRC; MMRRC:007347-UCD
DR   Wikidata; Q54783426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045391; Lin52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD028
AC   CVCL_PK87
SY   XD028
DR   MMRRC; MMRRC:007348-UCD
DR   Wikidata; Q54783428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202875; Btf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD039
AC   CVCL_PK88
SY   XD039
DR   MMRRC; MMRRC:007350-UCD
DR   Wikidata; Q54783429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97583; Pik3r1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD044
AC   CVCL_PK89
SY   XD044
DR   MMRRC; MMRRC:007351-UCD
DR   Wikidata; Q54783431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99212; Zfy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD045
AC   CVCL_PK90
SY   XD045
DR   MMRRC; MMRRC:007352-UCD
DR   Wikidata; Q54783433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99212; Zfy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD046
AC   CVCL_PK91
SY   XD046
DR   MMRRC; MMRRC:007353-UCD
DR   Wikidata; Q54783435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108517; Denn2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XD053
AC   CVCL_PK92
SY   XD053
DR   MMRRC; MMRRC:007354-UCD
DR   Wikidata; Q54783437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD059
AC   CVCL_PK93
SY   XD059
DR   MMRRC; MMRRC:007357-UCD
DR   Wikidata; Q54783439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919205; Ist1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD060
AC   CVCL_PK94
SY   XD060
DR   MMRRC; MMRRC:007358-UCD
DR   Wikidata; Q54783441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107846; Prmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD061
AC   CVCL_PK95
SY   XD061
DR   MMRRC; MMRRC:007359-UCD
DR   Wikidata; Q54783443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202875; Btf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD062
AC   CVCL_PK96
SY   XD062
DR   MMRRC; MMRRC:007360-UCD
DR   Wikidata; Q54783444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919218; Wdr73.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD073
AC   CVCL_PK97
SY   XD073
DR   MMRRC; MMRRC:007362-UCD
DR   Wikidata; Q54783447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914633; Carnmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD074
AC   CVCL_PK98
SY   XD074
DR   MMRRC; MMRRC:007363-UCD
DR   Wikidata; Q54783450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342283; Slc12a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD075
AC   CVCL_PK99
SY   XD075
DR   MMRRC; MMRRC:007364-UCD
DR   Wikidata; Q54783451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD076
AC   CVCL_PL00
SY   XD076
DR   MMRRC; MMRRC:007365-UCD
DR   Wikidata; Q54783453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446089; Flnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD077
AC   CVCL_PL01
SY   XD077
DR   MMRRC; MMRRC:007366-UCD
DR   Wikidata; Q54783455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD079
AC   CVCL_PL02
SY   XD079
DR   MMRRC; MMRRC:007367-UCD
DR   Wikidata; Q54783457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890165; Larp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD081
AC   CVCL_PL03
SY   XD081
DR   MMRRC; MMRRC:007368-UCD
DR   Wikidata; Q54783459
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109238; Sem1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD082
AC   CVCL_PL04
SY   XD082
DR   MMRRC; MMRRC:007369-UCD
DR   Wikidata; Q54783461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916327; Psmd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD083
AC   CVCL_PL05
SY   XD083
DR   MMRRC; MMRRC:007370-UCD
DR   Wikidata; Q54783463
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99523; Prdx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD084
AC   CVCL_PL06
SY   XD084
DR   MMRRC; MMRRC:007371-UCD
DR   Wikidata; Q54783465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928744; Vapb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD085
AC   CVCL_PL07
SY   XD085
DR   MMRRC; MMRRC:007372-UCD
DR   Wikidata; Q54783468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923957; Clasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD088
AC   CVCL_PL08
SY   XD088
DR   MMRRC; MMRRC:007373-UCD
DR   Wikidata; Q54783471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917606; St13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD089
AC   CVCL_PL09
SY   XD089
DR   MMRRC; MMRRC:007374-UCD
DR   Wikidata; Q54783474
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD091
AC   CVCL_PL10
SY   XD091
DR   MMRRC; MMRRC:007375-UCD
DR   Wikidata; Q54783475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD092
AC   CVCL_PL11
SY   XD092
DR   MMRRC; MMRRC:007376-UCD
DR   Wikidata; Q54783477
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927479; Sap30bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD093
AC   CVCL_PL12
SY   XD093
DR   MMRRC; MMRRC:007377-UCD
DR   Wikidata; Q54783479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107708; Ss18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD094
AC   CVCL_PL13
SY   XD094
DR   MMRRC; MMRRC:007378-UCD
DR   Wikidata; Q54783481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87978; Ak2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD095
AC   CVCL_PL14
SY   XD095
DR   MMRRC; MMRRC:007379-UCD
DR   Wikidata; Q54783483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919908; 2700097O09Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD096
AC   CVCL_PL15
SY   XD096
DR   MMRRC; MMRRC:007380-UCD
DR   Wikidata; Q54783486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298224; Pip5k1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD099
AC   CVCL_PL16
SY   XD099
DR   MMRRC; MMRRC:007381-UCD
DR   Wikidata; Q54783489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914631; Med4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD100
AC   CVCL_PL17
SY   XD100
DR   MMRRC; MMRRC:007382-UCD
DR   Wikidata; Q54783490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443390; Lrch1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD102
AC   CVCL_PL18
SY   XD102
DR   MMRRC; MMRRC:007383-UCD
DR   Wikidata; Q54783491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387357; Wac.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD103
AC   CVCL_PL19
SY   XD103
DR   MMRRC; MMRRC:007384-UCD
DR   Wikidata; Q54783494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD104
AC   CVCL_PL20
SY   XD104
DR   MMRRC; MMRRC:007385-UCD
DR   Wikidata; Q54783497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97549; Pfn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD105
AC   CVCL_PL21
SY   XD105
DR   MMRRC; MMRRC:007386-UCD
DR   Wikidata; Q54783498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920036; Tdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD106
AC   CVCL_PL22
SY   XD106
DR   MMRRC; MMRRC:007387-UCD
DR   Wikidata; Q54783544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444554; Mapkap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD107
AC   CVCL_PL23
SY   XD107
DR   MMRRC; MMRRC:007388-UCD
DR   Wikidata; Q54783546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915363; Cops8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD108
AC   CVCL_PL24
SY   XD108
DR   MMRRC; MMRRC:007389-UCD
DR   Wikidata; Q54783549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD109
AC   CVCL_PL25
SY   XD109
DR   MMRRC; MMRRC:007390-UCD
DR   Wikidata; Q54783551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859026; Cnot4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD111
AC   CVCL_PL26
SY   XD111
DR   MMRRC; MMRRC:007391-UCD
DR   Wikidata; Q54783553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926953; Ctdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD114
AC   CVCL_PL27
SY   XD114
DR   MMRRC; MMRRC:007392-UCD
DR   Wikidata; Q54783557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD117
AC   CVCL_PL28
SY   XD117
DR   MMRRC; MMRRC:007393-UCD
DR   Wikidata; Q54783558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD118
AC   CVCL_PL29
SY   XD118
DR   MMRRC; MMRRC:007394-UCD
DR   Wikidata; Q54783562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921537; Kcmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD120
AC   CVCL_PL30
SY   XD120
DR   MMRRC; MMRRC:007395-UCD
DR   Wikidata; Q54783565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682313; Zfp335.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD121
AC   CVCL_PL31
SY   XD121
DR   MMRRC; MMRRC:007396-UCD
DR   Wikidata; Q54783566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924483; Fam118b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD123
AC   CVCL_PL32
SY   XD123
DR   MMRRC; MMRRC:007397-UCD
DR   Wikidata; Q54783568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104583; Eps15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD124
AC   CVCL_PL33
SY   XD124
DR   MMRRC; MMRRC:007398-UCD
DR   Wikidata; Q54783571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445126; Tut4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XD125
AC   CVCL_PL34
SY   XD125
DR   MMRRC; MMRRC:007399-UCD
DR   Wikidata; Q54783572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919455; Eml2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD127
AC   CVCL_PL35
SY   XD127
DR   MMRRC; MMRRC:007401-UCD
DR   Wikidata; Q54783574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448476; Smagp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD130
AC   CVCL_PL36
SY   XD130
DR   MMRRC; MMRRC:007403-UCD
DR   Wikidata; Q54783577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD135
AC   CVCL_PL37
SY   XD135
DR   MMRRC; MMRRC:007404-UCD
DR   Wikidata; Q54783578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915815; Mrps18a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD137
AC   CVCL_PL38
SY   XD137
DR   MMRRC; MMRRC:007405-UCD
DR   Wikidata; Q54783579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915815; Mrps18a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD139
AC   CVCL_PL39
SY   XD139
DR   MMRRC; MMRRC:007406-UCD
DR   Wikidata; Q54783583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD140
AC   CVCL_PL40
SY   XD140
DR   MMRRC; MMRRC:007407-UCD
DR   Wikidata; Q54783584
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD141
AC   CVCL_PL41
SY   XD141
DR   MMRRC; MMRRC:007408-UCD
DR   Wikidata; Q54783588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913355; Ube2d3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD143
AC   CVCL_PL42
SY   XD143
DR   MMRRC; MMRRC:007410-UCD
DR   Wikidata; Q54783589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD148
AC   CVCL_PL43
SY   XD148
DR   MMRRC; MMRRC:007412-UCD
DR   Wikidata; Q54783590
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346040; Mpdu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD150
AC   CVCL_PL44
SY   XD150
DR   MMRRC; MMRRC:007413-UCD
DR   Wikidata; Q54783593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929261; Mtch1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD151
AC   CVCL_PL45
SY   XD151
DR   MMRRC; MMRRC:007414-UCD
DR   Wikidata; Q54783594
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD155
AC   CVCL_PL46
SY   XD155
DR   MMRRC; MMRRC:007416-UCD
DR   Wikidata; Q54783598
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107585; Srebf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD156
AC   CVCL_PL47
SY   XD156
DR   MMRRC; MMRRC:007417-UCD
DR   Wikidata; Q54783599
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914535; Cwc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD158
AC   CVCL_PL48
SY   XD158
DR   MMRRC; MMRRC:007418-UCD
DR   Wikidata; Q54783601
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442153; Gak.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD161
AC   CVCL_PL49
SY   XD161
DR   MMRRC; MMRRC:007420-UCD
DR   Wikidata; Q54783604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD164
AC   CVCL_PL50
SY   XD164
DR   MMRRC; MMRRC:007421-UCD
DR   Wikidata; Q54783606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338944; Acvr1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD165
AC   CVCL_PL51
SY   XD165
DR   MMRRC; MMRRC:007422-UCD
DR   Wikidata; Q54783609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916832; Plekhm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD170
AC   CVCL_PL52
SY   XD170
DR   MMRRC; MMRRC:007423-UCD
DR   Wikidata; Q54783610
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921443; Ccdc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD177
AC   CVCL_PL53
SY   XD177
DR   MMRRC; MMRRC:007424-UCD
DR   Wikidata; Q54783612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915308; Chd1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD183
AC   CVCL_PL54
SY   XD183
DR   MMRRC; MMRRC:007427-UCD
DR   Wikidata; Q54783614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343094; Kat2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD184
AC   CVCL_PL55
SY   XD184
DR   MMRRC; MMRRC:007428-UCD
DR   Wikidata; Q54783615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918779; Kazn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD185
AC   CVCL_PL56
SY   XD185
DR   MMRRC; MMRRC:007429-UCD
DR   Wikidata; Q54783618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD186
AC   CVCL_PL57
SY   XD186
DR   MMRRC; MMRRC:007430-UCD
DR   Wikidata; Q54783620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922246; Usp47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD191
AC   CVCL_PL58
SY   XD191
DR   MMRRC; MMRRC:007433-UCD
DR   Wikidata; Q54783623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916249; Anapc10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XD200
AC   CVCL_PL59
SY   XD200
DR   MMRRC; MMRRC:007436-UCD
DR   Wikidata; Q54783625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919204; Suds3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE001
AC   CVCL_PL60
SY   XE001
DR   MMRRC; MMRRC:007437-UCD
DR   Wikidata; Q54783628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277172; Ddx56.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE002
AC   CVCL_PL61
SY   XE002
DR   MMRRC; MMRRC:007438-UCD
DR   Wikidata; Q54783629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE003
AC   CVCL_PL62
SY   XE003
DR   MMRRC; MMRRC:007439-UCD
DR   Wikidata; Q54783678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE004
AC   CVCL_PL63
SY   XE004
DR   MMRRC; MMRRC:007440-UCD
DR   Wikidata; Q54783680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE005
AC   CVCL_PL64
SY   XE005
DR   MMRRC; MMRRC:007441-UCD
DR   Wikidata; Q54783683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923264; Zc3h18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE006
AC   CVCL_PL65
SY   XE006
DR   MMRRC; MMRRC:007442-UCD
DR   Wikidata; Q54783685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351502; Nup50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE009
AC   CVCL_PL66
SY   XE009
DR   MMRRC; MMRRC:007443-UCD
DR   Wikidata; Q54783686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE010
AC   CVCL_PL67
SY   XE010
DR   MMRRC; MMRRC:007444-UCD
DR   Wikidata; Q54783690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444951; 8030462N17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE012
AC   CVCL_PL68
SY   XE012
DR   MMRRC; MMRRC:007445-UCD
DR   Wikidata; Q54783692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929091; Sinhcaf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XE013
AC   CVCL_PL69
SY   XE013
DR   MMRRC; MMRRC:007446-UCD
DR   Wikidata; Q54783694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917132; Ints14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE014
AC   CVCL_PL70
SY   XE014
DR   MMRRC; MMRRC:007447-UCD
DR   Wikidata; Q54783695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96412; Ide.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE016
AC   CVCL_PL71
SY   XE016
DR   MMRRC; MMRRC:007448-UCD
DR   Wikidata; Q54783697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE017
AC   CVCL_PL72
SY   XE017
DR   MMRRC; MMRRC:007449-UCD
DR   Wikidata; Q54783698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE018
AC   CVCL_PL73
SY   XE018
DR   MMRRC; MMRRC:007450-UCD
DR   Wikidata; Q54783701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921414; Nfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE019
AC   CVCL_PL74
SY   XE019
DR   MMRRC; MMRRC:007451-UCD
DR   Wikidata; Q54783703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387123; Lnpep.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE021
AC   CVCL_PL75
SY   XE021
DR   MMRRC; MMRRC:007452-UCD
DR   Wikidata; Q54783704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347070; Psma7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE022
AC   CVCL_PL76
SY   XE022
DR   MMRRC; MMRRC:007453-UCD
DR   Wikidata; Q54783706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE024
AC   CVCL_PL77
SY   XE024
DR   MMRRC; MMRRC:007454-UCD
DR   Wikidata; Q54783707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE025
AC   CVCL_PL78
SY   XE025
DR   MMRRC; MMRRC:007455-UCD
DR   Wikidata; Q54783709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354742; Synrg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE027
AC   CVCL_PL79
SY   XE027
DR   MMRRC; MMRRC:007456-UCD
DR   Wikidata; Q54783710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE029
AC   CVCL_PL80
SY   XE029
DR   MMRRC; MMRRC:007457-UCD
DR   Wikidata; Q54783713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE030
AC   CVCL_PL81
SY   XE030
DR   MMRRC; MMRRC:007458-UCD
DR   Wikidata; Q54783715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387464; Pank3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE031
AC   CVCL_PL82
SY   XE031
DR   MMRRC; MMRRC:007459-UCD
DR   Wikidata; Q54783717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442372; Fam168a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE033
AC   CVCL_PL83
SY   XE033
DR   MMRRC; MMRRC:007460-UCD
DR   Wikidata; Q54783719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159614; Mia2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XE034
AC   CVCL_PL84
SY   XE034
DR   MMRRC; MMRRC:007461-UCD
DR   Wikidata; Q54783720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917029; Pphln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE036
AC   CVCL_PL85
SY   XE036
DR   MMRRC; MMRRC:007462-UCD
DR   Wikidata; Q54783722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE039
AC   CVCL_PL86
SY   XE039
DR   MMRRC; MMRRC:007464-UCD
DR   Wikidata; Q54783723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE041
AC   CVCL_PL87
SY   XE041
DR   MMRRC; MMRRC:007465-UCD
DR   Wikidata; Q54783725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916303; 1810013L24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE042
AC   CVCL_PL88
SY   XE042
DR   MMRRC; MMRRC:007466-UCD
DR   Wikidata; Q54783726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182061; Usp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE043
AC   CVCL_PL89
SY   XE043
DR   MMRRC; MMRRC:007467-UCD
DR   Wikidata; Q54783729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673855; Bicral.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE045
AC   CVCL_PL90
SY   XE045
DR   MMRRC; MMRRC:007468-UCD
DR   Wikidata; Q54783732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE047
AC   CVCL_PL91
SY   XE047
DR   MMRRC; MMRRC:007469-UCD
DR   Wikidata; Q54783733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920037; Ndc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE048
AC   CVCL_PL92
SY   XE048
DR   MMRRC; MMRRC:007470-UCD
DR   Wikidata; Q54783736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101816; Msh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE049
AC   CVCL_PL93
SY   XE049
DR   MMRRC; MMRRC:007471-UCD
DR   Wikidata; Q54783739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443713; Ythdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE051
AC   CVCL_PL94
SY   XE051
DR   MMRRC; MMRRC:007472-UCD
DR   Wikidata; Q54783740
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE056
AC   CVCL_PL95
SY   XE056
DR   MMRRC; MMRRC:007473-UCD
DR   Wikidata; Q54783744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929091; Sinhcaf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XE057
AC   CVCL_PL96
SY   XE057
DR   MMRRC; MMRRC:007474-UCD
DR   Wikidata; Q54783745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE058
AC   CVCL_PL97
SY   XE058
DR   MMRRC; MMRRC:007475-UCD
DR   Wikidata; Q54783747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE061
AC   CVCL_PL98
SY   XE061
DR   MMRRC; MMRRC:007477-UCD
DR   Wikidata; Q54783749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916043; Rab3gap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE062
AC   CVCL_PL99
SY   XE062
DR   MMRRC; MMRRC:007478-UCD
DR   Wikidata; Q54783751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855693; Nap1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE067
AC   CVCL_PM00
SY   XE067
DR   MMRRC; MMRRC:007480-UCD
DR   Wikidata; Q54783754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384993; Paip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE068
AC   CVCL_PM01
SY   XE068
DR   MMRRC; MMRRC:007481-UCD
DR   Wikidata; Q54783755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355333; Nckap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE071
AC   CVCL_PM02
SY   XE071
DR   MMRRC; MMRRC:007483-UCD
DR   Wikidata; Q54783800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE072
AC   CVCL_PM03
SY   XE072
DR   MMRRC; MMRRC:007484-UCD
DR   Wikidata; Q54783803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202397; Ints6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE075
AC   CVCL_PM04
SY   XE075
DR   MMRRC; MMRRC:007485-UCD
DR   Wikidata; Q54783804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108089; Erh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE077
AC   CVCL_PM05
SY   XE077
DR   MMRRC; MMRRC:007486-UCD
DR   Wikidata; Q54783807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890613; Pes1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE080
AC   CVCL_PM06
SY   XE080
DR   MMRRC; MMRRC:007488-UCD
DR   Wikidata; Q54783810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921537; Kcmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE082
AC   CVCL_PM07
SY   XE082
DR   MMRRC; MMRRC:007489-UCD
DR   Wikidata; Q54783812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354949; Dlc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE084
AC   CVCL_PM08
SY   XE084
DR   MMRRC; MMRRC:007490-UCD
DR   Wikidata; Q54783815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE085
AC   CVCL_PM09
SY   XE085
DR   MMRRC; MMRRC:007491-UCD
DR   Wikidata; Q54783816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354736; Kdm2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE087
AC   CVCL_PM10
SY   XE087
DR   MMRRC; MMRRC:007492-UCD
DR   Wikidata; Q54783817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE089
AC   CVCL_PM11
SY   XE089
DR   MMRRC; MMRRC:007494-UCD
DR   Wikidata; Q54783818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914144; Wwp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE090
AC   CVCL_PM12
SY   XE090
DR   MMRRC; MMRRC:007495-UCD
DR   Wikidata; Q54783820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE093
AC   CVCL_PM13
SY   XE093
DR   MMRRC; MMRRC:007496-UCD
DR   Wikidata; Q54783821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE095
AC   CVCL_PM14
SY   XE095
DR   MMRRC; MMRRC:007497-UCD
DR   Wikidata; Q54783824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182036; Gin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE101
AC   CVCL_PM15
SY   XE101
DR   MMRRC; MMRRC:007498-UCD
DR   Wikidata; Q54783826
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105128; Rad23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE107
AC   CVCL_PM16
SY   XE107
DR   MMRRC; MMRRC:007501-UCD
DR   Wikidata; Q54783827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE115
AC   CVCL_PM17
SY   XE115
DR   MMRRC; MMRRC:007503-UCD
DR   Wikidata; Q54783829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442757; Zfp667.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE117
AC   CVCL_PM18
SY   XE117
DR   MMRRC; MMRRC:007504-UCD
DR   Wikidata; Q54783832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917338; Meaf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE118
AC   CVCL_PM19
SY   XE118
DR   MMRRC; MMRRC:007505-UCD
DR   Wikidata; Q54783834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917599; Copb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE120
AC   CVCL_PM20
SY   XE120
DR   MMRRC; MMRRC:007506-UCD
DR   Wikidata; Q54783839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE121
AC   CVCL_PM21
SY   XE121
DR   MMRRC; MMRRC:007507-UCD
DR   Wikidata; Q54783840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316740; Morc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE124
AC   CVCL_PM22
SY   XE124
DR   MMRRC; MMRRC:007509-UCD
DR   Wikidata; Q54783844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917623; Gpatch2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE129
AC   CVCL_PM23
SY   XE129
DR   MMRRC; MMRRC:007510-UCD
DR   Wikidata; Q54783845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339977; Agtrap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE133
AC   CVCL_PM24
SY   XE133
DR   MMRRC; MMRRC:007511-UCD
DR   Wikidata; Q54783848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355333; Nckap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE134
AC   CVCL_PM25
SY   XE134
DR   MMRRC; MMRRC:007512-UCD
DR   Wikidata; Q54783849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387464; Pank3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE136
AC   CVCL_PM26
SY   XE136
DR   MMRRC; MMRRC:007513-UCD
DR   Wikidata; Q54783852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE140
AC   CVCL_PM27
SY   XE140
DR   MMRRC; MMRRC:007515-UCD
DR   Wikidata; Q54783853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384298; Sbno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE141
AC   CVCL_PM28
SY   XE141
DR   MMRRC; MMRRC:007516-UCD
DR   Wikidata; Q54783855
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE143
AC   CVCL_PM29
SY   XE143
DR   MMRRC; MMRRC:007517-UCD
DR   Wikidata; Q54783856
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338944; Acvr1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE145
AC   CVCL_PM30
SY   XE145
DR   MMRRC; MMRRC:007518-UCD
DR   Wikidata; Q54783859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921747; Zfp710.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE146
AC   CVCL_PM31
SY   XE146
DR   MMRRC; MMRRC:007519-UCD
DR   Wikidata; Q54783860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE147
AC   CVCL_PM32
SY   XE147
DR   MMRRC; MMRRC:007520-UCD
DR   Wikidata; Q54783861
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928380; B4galt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE148
AC   CVCL_PM33
SY   XE148
DR   MMRRC; MMRRC:007521-UCD
DR   Wikidata; Q54783864
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102956; Cdk7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE149
AC   CVCL_PM34
SY   XE149
DR   MMRRC; MMRRC:007522-UCD
DR   Wikidata; Q54783865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE150
AC   CVCL_PM35
SY   XE150
DR   MMRRC; MMRRC:007523-UCD
DR   Wikidata; Q54783867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE151
AC   CVCL_PM36
SY   XE151
DR   MMRRC; MMRRC:007524-UCD
DR   Wikidata; Q54783868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE152
AC   CVCL_PM37
SY   XE152
DR   MMRRC; MMRRC:007525-UCD
DR   Wikidata; Q54783870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE153
AC   CVCL_PM38
SY   XE153
DR   MMRRC; MMRRC:007526-UCD
DR   Wikidata; Q54783873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201685; Ctbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE154
AC   CVCL_PM39
SY   XE154
DR   MMRRC; MMRRC:007527-UCD
DR   Wikidata; Q54783874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88110; Atp2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE160
AC   CVCL_PM40
SY   XE160
DR   MMRRC; MMRRC:007528-UCD
DR   Wikidata; Q54783877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95632; Gad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE163
AC   CVCL_PM41
SY   XE163
DR   MMRRC; MMRRC:007529-UCD
DR   Wikidata; Q54783879
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE164
AC   CVCL_PM42
SY   XE164
DR   MMRRC; MMRRC:007530-UCD
DR   Wikidata; Q54783922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926879; Taf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE180
AC   CVCL_PM43
SY   XE180
DR   MMRRC; MMRRC:007533-UCD
DR   Wikidata; Q54783923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925255; Rrn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE182
AC   CVCL_PM44
SY   XE182
DR   MMRRC; MMRRC:007534-UCD
DR   Wikidata; Q54783926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924621; Sec24a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE184
AC   CVCL_PM45
SY   XE184
DR   MMRRC; MMRRC:007536-UCD
DR   Wikidata; Q54783928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE187
AC   CVCL_PM46
SY   XE187
DR   MMRRC; MMRRC:007537-UCD
DR   Wikidata; Q54783930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3651014; Zfp268.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XE188
AC   CVCL_PM47
SY   XE188
DR   MMRRC; MMRRC:007538-UCD
DR   Wikidata; Q54783931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE192
AC   CVCL_PM48
SY   XE192
DR   MMRRC; MMRRC:007539-UCD
DR   Wikidata; Q54783935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141101; Depdc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE193
AC   CVCL_PM49
SY   XE193
DR   MMRRC; MMRRC:007540-UCD
DR   Wikidata; Q54783937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE196
AC   CVCL_PM50
SY   XE196
DR   MMRRC; MMRRC:007541-UCD
DR   Wikidata; Q54783939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917758; Bbx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE198
AC   CVCL_PM51
SY   XE198
DR   MMRRC; MMRRC:007542-UCD
DR   Wikidata; Q54783941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102467; Ptpn14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE199
AC   CVCL_PM52
SY   XE199
DR   MMRRC; MMRRC:007543-UCD
DR   Wikidata; Q54783943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE201
AC   CVCL_PM53
SY   XE201
DR   MMRRC; MMRRC:007544-UCD
DR   Wikidata; Q54783946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926879; Taf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE205
AC   CVCL_PM54
SY   XE205
DR   MMRRC; MMRRC:007545-UCD
DR   Wikidata; Q54783948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2687042; Ppp1r37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE207
AC   CVCL_PM55
SY   XE207
DR   MMRRC; MMRRC:007546-UCD
DR   Wikidata; Q54783949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141969; Efl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE208
AC   CVCL_PM56
SY   XE208
DR   MMRRC; MMRRC:007547-UCD
DR   Wikidata; Q54783953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338944; Acvr1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE209
AC   CVCL_PM57
SY   XE209
DR   MMRRC; MMRRC:007548-UCD
DR   Wikidata; Q54783955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2687042; Ppp1r37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE210
AC   CVCL_PM58
SY   XE210
DR   MMRRC; MMRRC:007549-UCD
DR   Wikidata; Q54783956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109268; Vasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE220
AC   CVCL_PM59
SY   XE220
DR   MMRRC; MMRRC:007551-UCD
DR   Wikidata; Q54783958
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201787; Socs2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE222
AC   CVCL_PM60
SY   XE222
DR   MMRRC; MMRRC:007552-UCD
DR   Wikidata; Q54783959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE223
AC   CVCL_PM61
SY   XE223
DR   MMRRC; MMRRC:007553-UCD
DR   Wikidata; Q54783962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE227
AC   CVCL_PM62
SY   XE227
DR   MMRRC; MMRRC:007555-UCD
DR   Wikidata; Q54783963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE228
AC   CVCL_PM63
SY   XE228
DR   MMRRC; MMRRC:007556-UCD
DR   Wikidata; Q54783965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE229
AC   CVCL_PM64
SY   XE229
DR   MMRRC; MMRRC:007557-UCD
DR   Wikidata; Q54783967
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE234
AC   CVCL_PM65
SY   XE234
DR   MMRRC; MMRRC:007560-UCD
DR   Wikidata; Q54783968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3649576; Gm14393.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE237
AC   CVCL_PM66
SY   XE237
DR   MMRRC; MMRRC:007561-UCD
DR   Wikidata; Q54783971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE239
AC   CVCL_PM67
SY   XE239
DR   MMRRC; MMRRC:007562-UCD
DR   Wikidata; Q54783973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855693; Nap1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE242
AC   CVCL_PM68
SY   XE242
DR   MMRRC; MMRRC:007564-UCD
DR   Wikidata; Q54783976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338944; Acvr1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE243
AC   CVCL_PM69
SY   XE243
DR   MMRRC; MMRRC:007565-UCD
DR   Wikidata; Q54783978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99960; Ewsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE245
AC   CVCL_PM70
SY   XE245
DR   MMRRC; MMRRC:007566-UCD
DR   Wikidata; Q54783979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE248
AC   CVCL_PM71
SY   XE248
DR   MMRRC; MMRRC:007567-UCD
DR   Wikidata; Q54783983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE249
AC   CVCL_PM72
SY   XE249
DR   MMRRC; MMRRC:007568-UCD
DR   Wikidata; Q54783985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE253
AC   CVCL_PM73
SY   XE253
DR   MMRRC; MMRRC:007569-UCD
DR   Wikidata; Q54783986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE260
AC   CVCL_PM74
SY   XE260
DR   MMRRC; MMRRC:007571-UCD
DR   Wikidata; Q54783989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387123; Lnpep.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE262
AC   CVCL_PM75
SY   XE262
DR   MMRRC; MMRRC:007572-UCD
DR   Wikidata; Q54783991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917623; Gpatch2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE266
AC   CVCL_PM76
SY   XE266
DR   MMRRC; MMRRC:007573-UCD
DR   Wikidata; Q54783994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2687042; Ppp1r37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE268
AC   CVCL_PM77
SY   XE268
DR   MMRRC; MMRRC:007574-UCD
DR   Wikidata; Q54783995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141101; Depdc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE269
AC   CVCL_PM78
SY   XE269
DR   MMRRC; MMRRC:007575-UCD
DR   Wikidata; Q54783998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141101; Depdc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE279
AC   CVCL_PM79
SY   XE279
DR   MMRRC; MMRRC:007578-UCD
DR   Wikidata; Q54783999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914144; Wwp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE282
AC   CVCL_PM80
SY   XE282
DR   MMRRC; MMRRC:007579-UCD
DR   Wikidata; Q54784001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88190; Braf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE293
AC   CVCL_PM81
SY   XE293
DR   MMRRC; MMRRC:007582-UCD
DR   Wikidata; Q54784004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE295
AC   CVCL_PM82
SY   XE295
DR   MMRRC; MMRRC:007583-UCD
DR   Wikidata; Q54784088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928380; B4galt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE296
AC   CVCL_PM83
SY   XE296
DR   MMRRC; MMRRC:007584-UCD
DR   Wikidata; Q54784090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE297
AC   CVCL_PM84
SY   XE297
DR   MMRRC; MMRRC:007585-UCD
DR   Wikidata; Q54784092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE307
AC   CVCL_PM85
SY   XE307
DR   MMRRC; MMRRC:007587-UCD
DR   Wikidata; Q54784094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE315
AC   CVCL_PM86
SY   XE315
DR   MMRRC; MMRRC:007590-UCD
DR   Wikidata; Q54784096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933162; Lrba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE323
AC   CVCL_PM87
SY   XE323
DR   MMRRC; MMRRC:007592-UCD
DR   Wikidata; Q54784097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE324
AC   CVCL_PM88
SY   XE324
DR   MMRRC; MMRRC:007593-UCD
DR   Wikidata; Q54784100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE327
AC   CVCL_PM89
SY   XE327
DR   MMRRC; MMRRC:007594-UCD
DR   Wikidata; Q54784102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338944; Acvr1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE328
AC   CVCL_PM90
SY   XE328
DR   MMRRC; MMRRC:007595-UCD
DR   Wikidata; Q54784105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95654; Gart.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE330
AC   CVCL_PM91
SY   XE330
DR   MMRRC; MMRRC:007596-UCD
DR   Wikidata; Q54784107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929091; Sinhcaf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XE332
AC   CVCL_PM92
SY   XE332
DR   MMRRC; MMRRC:007597-UCD
DR   Wikidata; Q54784109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE337
AC   CVCL_PM93
SY   XE337
DR   MMRRC; MMRRC:007599-UCD
DR   Wikidata; Q54784111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157980; Vac14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE338
AC   CVCL_PM94
SY   XE338
DR   MMRRC; MMRRC:007600-UCD
DR   Wikidata; Q54784112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE342
AC   CVCL_PM95
SY   XE342
DR   MMRRC; MMRRC:007601-UCD
DR   Wikidata; Q54784113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE344
AC   CVCL_PM96
SY   XE344
DR   MMRRC; MMRRC:007602-UCD
DR   Wikidata; Q54784115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446632; Ago2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE345
AC   CVCL_PM97
SY   XE345
DR   MMRRC; MMRRC:007603-UCD
DR   Wikidata; Q54784116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE347
AC   CVCL_PM98
SY   XE347
DR   MMRRC; MMRRC:007604-UCD
DR   Wikidata; Q54784119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE354
AC   CVCL_PM99
SY   XE354
DR   MMRRC; MMRRC:007605-UCD
DR   Wikidata; Q54784120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096342; Rhoa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE355
AC   CVCL_PN00
SY   XE355
DR   MMRRC; MMRRC:007606-UCD
DR   Wikidata; Q54784122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE356
AC   CVCL_PN01
SY   XE356
DR   MMRRC; MMRRC:007607-UCD
DR   Wikidata; Q54784124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:5141924; Pakap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XE360
AC   CVCL_PN02
SY   XE360
DR   MMRRC; MMRRC:007608-UCD
DR   Wikidata; Q54784126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920442; Xpot.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE362
AC   CVCL_PN03
SY   XE362
DR   MMRRC; MMRRC:007609-UCD
DR   Wikidata; Q54784128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330281; Cd2ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE363
AC   CVCL_PN04
SY   XE363
DR   MMRRC; MMRRC:007610-UCD
DR   Wikidata; Q54784129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE366
AC   CVCL_PN05
SY   XE366
DR   MMRRC; MMRRC:007612-UCD
DR   Wikidata; Q54784131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913964; 4921524J17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE367
AC   CVCL_PN06
SY   XE367
DR   MMRRC; MMRRC:007613-UCD
DR   Wikidata; Q54784133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99695; Cttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE368
AC   CVCL_PN07
SY   XE368
DR   MMRRC; MMRRC:007614-UCD
DR   Wikidata; Q54784134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859866; Cdc20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE369
AC   CVCL_PN08
SY   XE369
DR   MMRRC; MMRRC:007615-UCD
DR   Wikidata; Q54784136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922387; Rprd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE370
AC   CVCL_PN09
SY   XE370
DR   MMRRC; MMRRC:007616-UCD
DR   Wikidata; Q54784139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388633; Cltc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE372
AC   CVCL_PN10
SY   XE372
DR   MMRRC; MMRRC:007617-UCD
DR   Wikidata; Q54784143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676556; Akap13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE374
AC   CVCL_PN11
SY   XE374
DR   MMRRC; MMRRC:007618-UCD
DR   Wikidata; Q54784145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141625; Nup205.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE377
AC   CVCL_PN12
SY   XE377
DR   MMRRC; MMRRC:007619-UCD
DR   Wikidata; Q54784147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330281; Cd2ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE378
AC   CVCL_PN13
SY   XE378
DR   MMRRC; MMRRC:007620-UCD
DR   Wikidata; Q54784150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109153; Ktn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE379
AC   CVCL_PN14
SY   XE379
DR   MMRRC; MMRRC:007621-UCD
DR   Wikidata; Q54784151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914552; Zc3h13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE380
AC   CVCL_PN15
SY   XE380
DR   MMRRC; MMRRC:007622-UCD
DR   Wikidata; Q54784152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139354; Arfgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE381
AC   CVCL_PN16
SY   XE381
DR   MMRRC; MMRRC:007623-UCD
DR   Wikidata; Q54784153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289147; E2f7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE382
AC   CVCL_PN17
SY   XE382
DR   MMRRC; MMRRC:007624-UCD
DR   Wikidata; Q54784156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914116; Nhlrc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE383
AC   CVCL_PN18
SY   XE383
DR   MMRRC; MMRRC:007625-UCD
DR   Wikidata; Q54784158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE387
AC   CVCL_PN19
SY   XE387
DR   MMRRC; MMRRC:007627-UCD
DR   Wikidata; Q54784160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE388
AC   CVCL_PN20
SY   XE388
DR   MMRRC; MMRRC:007628-UCD
DR   Wikidata; Q54784163
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277166; Sp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE390
AC   CVCL_PN21
SY   XE390
DR   MMRRC; MMRRC:007629-UCD
DR   Wikidata; Q54784165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921997; Ddit4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE393
AC   CVCL_PN22
SY   XE393
DR   MMRRC; MMRRC:007630-UCD
DR   Wikidata; Q54784209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE394
AC   CVCL_PN23
SY   XE394
DR   MMRRC; MMRRC:007631-UCD
DR   Wikidata; Q54784211
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE395
AC   CVCL_PN24
SY   XE395
DR   MMRRC; MMRRC:007632-UCD
DR   Wikidata; Q54784219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923714; Knl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE398
AC   CVCL_PN25
SY   XE398
DR   MMRRC; MMRRC:007633-UCD
DR   Wikidata; Q54784221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE399
AC   CVCL_PN26
SY   XE399
DR   MMRRC; MMRRC:007634-UCD
DR   Wikidata; Q54784222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387357; Wac.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE400
AC   CVCL_PN27
SY   XE400
DR   MMRRC; MMRRC:007635-UCD
DR   Wikidata; Q54784223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102579; Nmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE402
AC   CVCL_PN28
SY   XE402
DR   MMRRC; MMRRC:007636-UCD
DR   Wikidata; Q54784225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891763; Ppp4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE403
AC   CVCL_PN29
SY   XE403
DR   MMRRC; MMRRC:007637-UCD
DR   Wikidata; Q54784228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891763; Ppp4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE404
AC   CVCL_PN30
SY   XE404
DR   MMRRC; MMRRC:007638-UCD
DR   Wikidata; Q54784229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139054; Gpr107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE405
AC   CVCL_PN31
SY   XE405
DR   MMRRC; MMRRC:007639-UCD
DR   Wikidata; Q54784232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE408
AC   CVCL_PN32
SY   XE408
DR   MMRRC; MMRRC:007640-UCD
DR   Wikidata; Q54784234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385207; Gnl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE409
AC   CVCL_PN33
SY   XE409
DR   MMRRC; MMRRC:007641-UCD
DR   Wikidata; Q54784236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916066; Ppil1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE410
AC   CVCL_PN34
SY   XE410
DR   MMRRC; MMRRC:007642-UCD
DR   Wikidata; Q54784237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933137; Cttnbp2nl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE411
AC   CVCL_PN35
SY   XE411
DR   MMRRC; MMRRC:007643-UCD
DR   Wikidata; Q54784240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE413
AC   CVCL_PN36
SY   XE413
DR   MMRRC; MMRRC:007644-UCD
DR   Wikidata; Q54784241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926465; Hnrnpm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE414
AC   CVCL_PN37
SY   XE414
DR   MMRRC; MMRRC:007645-UCD
DR   Wikidata; Q54784243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917678; Polr3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE417
AC   CVCL_PN38
SY   XE417
DR   MMRRC; MMRRC:007647-UCD
DR   Wikidata; Q54784244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE419
AC   CVCL_PN39
SY   XE419
DR   MMRRC; MMRRC:007648-UCD
DR   Wikidata; Q54784249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098267; Ogdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE420
AC   CVCL_PN40
SY   XE420
DR   MMRRC; MMRRC:007649-UCD
DR   Wikidata; Q54784252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE421
AC   CVCL_PN41
SY   XE421
DR   MMRRC; MMRRC:007650-UCD
DR   Wikidata; Q54784253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE422
AC   CVCL_PN42
SY   XE422
DR   MMRRC; MMRRC:007651-UCD
DR   Wikidata; Q54784255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE423
AC   CVCL_PN43
SY   XE423
DR   MMRRC; MMRRC:007652-UCD
DR   Wikidata; Q54784256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337096; Rnf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE426
AC   CVCL_PN44
SY   XE426
DR   MMRRC; MMRRC:007653-UCD
DR   Wikidata; Q54784260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108025; Prkar2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE427
AC   CVCL_PN45
SY   XE427
DR   MMRRC; MMRRC:007654-UCD
DR   Wikidata; Q54784262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916303; 1810013L24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE430
AC   CVCL_PN46
SY   XE430
DR   MMRRC; MMRRC:007655-UCD
DR   Wikidata; Q54784263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920185; Ddx41.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE433
AC   CVCL_PN47
SY   XE433
DR   MMRRC; MMRRC:007656-UCD
DR   Wikidata; Q54784264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914751; Ccdc50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE434
AC   CVCL_PN48
SY   XE434
DR   MMRRC; MMRRC:007657-UCD
DR   Wikidata; Q54784267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926227; Nup160.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE436
AC   CVCL_PN49
SY   XE436
DR   MMRRC; MMRRC:007658-UCD
DR   Wikidata; Q54784268
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924270; Atl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE439
AC   CVCL_PN50
SY   XE439
DR   MMRRC; MMRRC:007659-UCD
DR   Wikidata; Q54784270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349399; Casp8ap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE440
AC   CVCL_PN51
SY   XE440
DR   MMRRC; MMRRC:007660-UCD
DR   Wikidata; Q54784272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196337; Brms1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE444
AC   CVCL_PN52
SY   XE444
DR   MMRRC; MMRRC:007661-UCD
DR   Wikidata; Q54784274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96250; Hsp90aa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE448
AC   CVCL_PN53
SY   XE448
DR   MMRRC; MMRRC:007662-UCD
DR   Wikidata; Q54784276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146388; Ubxn7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE450
AC   CVCL_PN54
SY   XE450
DR   MMRRC; MMRRC:007663-UCD
DR   Wikidata; Q54784277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE451
AC   CVCL_PN55
SY   XE451
DR   MMRRC; MMRRC:007664-UCD
DR   Wikidata; Q54784280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3588234; 9630014M24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE453
AC   CVCL_PN56
SY   XE453
DR   MMRRC; MMRRC:007665-UCD
DR   Wikidata; Q54784282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107207; Coq7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE454
AC   CVCL_PN57
SY   XE454
DR   MMRRC; MMRRC:007666-UCD
DR   Wikidata; Q54784286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444593; Pptc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE455
AC   CVCL_PN58
SY   XE455
DR   MMRRC; MMRRC:007667-UCD
DR   Wikidata; Q54784288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109198; Eif4ebp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE457
AC   CVCL_PN59
SY   XE457
DR   MMRRC; MMRRC:007668-UCD
DR   Wikidata; Q54784289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891189; Ensa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE458
AC   CVCL_PN60
SY   XE458
DR   MMRRC; MMRRC:007669-UCD
DR   Wikidata; Q54784293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109584; Prpf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE461
AC   CVCL_PN61
SY   XE461
DR   MMRRC; MMRRC:007670-UCD
DR   Wikidata; Q54784295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915472; Tubb4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE462
AC   CVCL_PN62
SY   XE462
DR   MMRRC; MMRRC:007671-UCD
DR   Wikidata; Q54784345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181074; Acbd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE464
AC   CVCL_PN63
SY   XE464
DR   MMRRC; MMRRC:007672-UCD
DR   Wikidata; Q54784347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE465
AC   CVCL_PN64
SY   XE465
DR   MMRRC; MMRRC:007673-UCD
DR   Wikidata; Q54784350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861942; Gtf2ird1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE466
AC   CVCL_PN65
SY   XE466
DR   MMRRC; MMRRC:007674-UCD
DR   Wikidata; Q54784351
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924093; Dtl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE467
AC   CVCL_PN66
SY   XE467
DR   MMRRC; MMRRC:007675-UCD
DR   Wikidata; Q54784354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE468
AC   CVCL_PN67
SY   XE468
DR   MMRRC; MMRRC:007676-UCD
DR   Wikidata; Q54784355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE469
AC   CVCL_PN68
SY   XE469
DR   MMRRC; MMRRC:007677-UCD
DR   Wikidata; Q54784357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE472
AC   CVCL_PN69
SY   XE472
DR   MMRRC; MMRRC:007679-UCD
DR   Wikidata; Q54784359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE473
AC   CVCL_PN70
SY   XE473
DR   MMRRC; MMRRC:007680-UCD
DR   Wikidata; Q54784361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102774; Aimp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE475
AC   CVCL_PN71
SY   XE475
DR   MMRRC; MMRRC:007681-UCD
DR   Wikidata; Q54784363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106330; Larp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE476
AC   CVCL_PN72
SY   XE476
DR   MMRRC; MMRRC:007682-UCD
DR   Wikidata; Q54784365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137357; Trim33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE478
AC   CVCL_PN73
SY   XE478
DR   MMRRC; MMRRC:007683-UCD
DR   Wikidata; Q54784367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105098; Ube3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE480
AC   CVCL_PN74
SY   XE480
DR   MMRRC; MMRRC:007684-UCD
DR   Wikidata; Q54784369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3505790; Fcho2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE482
AC   CVCL_PN75
SY   XE482
DR   MMRRC; MMRRC:007686-UCD
DR   Wikidata; Q54784371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277223; Atxn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE484
AC   CVCL_PN76
SY   XE484
DR   MMRRC; MMRRC:007687-UCD
DR   Wikidata; Q54784373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE487
AC   CVCL_PN77
SY   XE487
DR   MMRRC; MMRRC:007688-UCD
DR   Wikidata; Q54784376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925906; Brd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE489
AC   CVCL_PN78
SY   XE489
DR   MMRRC; MMRRC:007690-UCD
DR   Wikidata; Q54784377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927479; Sap30bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE491
AC   CVCL_PN79
SY   XE491
DR   MMRRC; MMRRC:007691-UCD
DR   Wikidata; Q54784378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277212; Zfp644.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE492
AC   CVCL_PN80
SY   XE492
DR   MMRRC; MMRRC:007692-UCD
DR   Wikidata; Q54784381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE493
AC   CVCL_PN81
SY   XE493
DR   MMRRC; MMRRC:007693-UCD
DR   Wikidata; Q54784383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859646; Golga4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE494
AC   CVCL_PN82
SY   XE494
DR   MMRRC; MMRRC:007694-UCD
DR   Wikidata; Q54784385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891704; Hbs1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE495
AC   CVCL_PN83
SY   XE495
DR   MMRRC; MMRRC:007695-UCD
DR   Wikidata; Q54784388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104900; Nup88.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE496
AC   CVCL_PN84
SY   XE496
DR   MMRRC; MMRRC:007696-UCD
DR   Wikidata; Q54784391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309478; Baz1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE498
AC   CVCL_PN85
SY   XE498
DR   MMRRC; MMRRC:007697-UCD
DR   Wikidata; Q54784392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE499
AC   CVCL_PN86
SY   XE499
DR   MMRRC; MMRRC:007698-UCD
DR   Wikidata; Q54784395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096572; Zfand3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE501
AC   CVCL_PN87
SY   XE501
DR   MMRRC; MMRRC:007699-UCD
DR   Wikidata; Q54784398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926967; Hsd17b12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE502
AC   CVCL_PN88
SY   XE502
DR   MMRRC; MMRRC:007700-UCD
DR   Wikidata; Q54784400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE504
AC   CVCL_PN89
SY   XE504
DR   MMRRC; MMRRC:007701-UCD
DR   Wikidata; Q54784402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE506
AC   CVCL_PN90
SY   XE506
DR   MMRRC; MMRRC:007702-UCD
DR   Wikidata; Q54784404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926045; Armc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE508
AC   CVCL_PN91
SY   XE508
DR   MMRRC; MMRRC:007703-UCD
DR   Wikidata; Q54784407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923402; Utp18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE509
AC   CVCL_PN92
SY   XE509
DR   MMRRC; MMRRC:007704-UCD
DR   Wikidata; Q54784409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929608; Aatf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE515
AC   CVCL_PN93
SY   XE515
DR   MMRRC; MMRRC:007705-UCD
DR   Wikidata; Q54784410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915392; Ino80.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE516
AC   CVCL_PN94
SY   XE516
DR   MMRRC; MMRRC:007706-UCD
DR   Wikidata; Q54784412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926045; Armc9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE517
AC   CVCL_PN95
SY   XE517
DR   MMRRC; MMRRC:007707-UCD
DR   Wikidata; Q54784414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923385; Prex2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE518
AC   CVCL_PN96
SY   XE518
DR   MMRRC; MMRRC:007708-UCD
DR   Wikidata; Q54784416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918817; Mcm9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE519
AC   CVCL_PN97
SY   XE519
DR   MMRRC; MMRRC:007709-UCD
DR   Wikidata; Q54784419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE521
AC   CVCL_PN98
SY   XE521
DR   MMRRC; MMRRC:007710-UCD
DR   Wikidata; Q54784422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE527
AC   CVCL_PN99
SY   XE527
DR   MMRRC; MMRRC:007711-UCD
DR   Wikidata; Q54784424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE529
AC   CVCL_PP00
SY   XE529
DR   MMRRC; MMRRC:007713-UCD
DR   Wikidata; Q54784425
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE532
AC   CVCL_PP01
SY   XE532
DR   MMRRC; MMRRC:007714-UCD
DR   Wikidata; Q54784429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143340; Zfp445.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE534
AC   CVCL_PP02
SY   XE534
DR   MMRRC; MMRRC:007715-UCD
DR   Wikidata; Q54784481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036240; Zfp939.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE537
AC   CVCL_PP03
SY   XE537
DR   MMRRC; MMRRC:007716-UCD
DR   Wikidata; Q54784487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE538
AC   CVCL_PP04
SY   XE538
DR   MMRRC; MMRRC:007717-UCD
DR   Wikidata; Q54784488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE541
AC   CVCL_PP05
SY   XE541
DR   MMRRC; MMRRC:007718-UCD
DR   Wikidata; Q54784491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918708; Bcor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE542
AC   CVCL_PP06
SY   XE542
DR   MMRRC; MMRRC:007719-UCD
DR   Wikidata; Q54784493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913744; Prelid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE543
AC   CVCL_PP07
SY   XE543
DR   MMRRC; MMRRC:007720-UCD
DR   Wikidata; Q54784496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE544
AC   CVCL_PP08
SY   XE544
DR   MMRRC; MMRRC:007721-UCD
DR   Wikidata; Q54784497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3645888; Gm6712.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE545
AC   CVCL_PP09
SY   XE545
DR   MMRRC; MMRRC:007722-UCD
DR   Wikidata; Q54784501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913993; Rnf220.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE550
AC   CVCL_PP10
SY   XE550
DR   MMRRC; MMRRC:007724-UCD
DR   Wikidata; Q54784503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97887; Rdx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE565
AC   CVCL_PP11
SY   XE565
DR   MMRRC; MMRRC:007725-UCD
DR   Wikidata; Q54784505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918972; Cic.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE566
AC   CVCL_PP12
SY   XE566
DR   MMRRC; MMRRC:007726-UCD
DR   Wikidata; Q54784507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE569
AC   CVCL_PP13
SY   XE569
DR   MMRRC; MMRRC:007727-UCD
DR   Wikidata; Q54784510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138281; Lbr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE574
AC   CVCL_PP14
SY   XE574
DR   MMRRC; MMRRC:007728-UCD
DR   Wikidata; Q54784512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE579
AC   CVCL_PP15
SY   XE579
DR   MMRRC; MMRRC:007730-UCD
DR   Wikidata; Q54784514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098231; Kif11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE580
AC   CVCL_PP16
SY   XE580
DR   MMRRC; MMRRC:007731-UCD
DR   Wikidata; Q54784515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921407; Cmtr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE591
AC   CVCL_PP17
SY   XE591
DR   MMRRC; MMRRC:007733-UCD
DR   Wikidata; Q54784517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346834; Nr5a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE592
AC   CVCL_PP18
SY   XE592
DR   MMRRC; MMRRC:007734-UCD
DR   Wikidata; Q54784520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685988; 8030474K03Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE594
AC   CVCL_PP19
SY   XE594
DR   MMRRC; MMRRC:007735-UCD
DR   Wikidata; Q54784522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096342; Rhoa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE595
AC   CVCL_PP20
SY   XE595
DR   MMRRC; MMRRC:007736-UCD
DR   Wikidata; Q54784525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681840; Rsl24d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE596
AC   CVCL_PP21
SY   XE596
DR   MMRRC; MMRRC:007737-UCD
DR   Wikidata; Q54784527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921407; Cmtr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE617
AC   CVCL_PP22
SY   XE617
DR   MMRRC; MMRRC:007739-UCD
DR   Wikidata; Q54784529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88190; Braf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE622
AC   CVCL_PP23
SY   XE622
DR   MMRRC; MMRRC:007740-UCD
DR   Wikidata; Q54784530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146388; Ubxn7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE630
AC   CVCL_PP24
SY   XE630
DR   MMRRC; MMRRC:007743-UCD
DR   Wikidata; Q54784533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919563; Fryl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE642
AC   CVCL_PP25
SY   XE642
DR   MMRRC; MMRRC:007745-UCD
DR   Wikidata; Q54784534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98790; Top2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE643
AC   CVCL_PP26
SY   XE643
DR   MMRRC; MMRRC:007746-UCD
DR   Wikidata; Q54784535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929212; Ap3m1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE644
AC   CVCL_PP27
SY   XE644
DR   MMRRC; MMRRC:007747-UCD
DR   Wikidata; Q54784538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142651; Prmt9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE661
AC   CVCL_PP28
SY   XE661
DR   MMRRC; MMRRC:007749-UCD
DR   Wikidata; Q54784539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106687; Pon2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE663
AC   CVCL_PP29
SY   XE663
DR   MMRRC; MMRRC:007750-UCD
DR   Wikidata; Q54784541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE664
AC   CVCL_PP30
SY   XE664
DR   MMRRC; MMRRC:007751-UCD
DR   Wikidata; Q54784544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE666
AC   CVCL_PP31
SY   XE666
DR   MMRRC; MMRRC:007752-UCD
DR   Wikidata; Q54784547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924270; Atl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE668
AC   CVCL_PP32
SY   XE668
DR   MMRRC; MMRRC:007753-UCD
DR   Wikidata; Q54784548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE670
AC   CVCL_PP33
SY   XE670
DR   MMRRC; MMRRC:007754-UCD
DR   Wikidata; Q54784550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE671
AC   CVCL_PP34
SY   XE671
DR   MMRRC; MMRRC:007755-UCD
DR   Wikidata; Q54784553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE673
AC   CVCL_PP35
SY   XE673
DR   MMRRC; MMRRC:007756-UCD
DR   Wikidata; Q54784555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE676
AC   CVCL_PP36
SY   XE676
DR   MMRRC; MMRRC:007757-UCD
DR   Wikidata; Q54784558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE678
AC   CVCL_PP37
SY   XE678
DR   MMRRC; MMRRC:007758-UCD
DR   Wikidata; Q54784560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919204; Suds3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE680
AC   CVCL_PP38
SY   XE680
DR   MMRRC; MMRRC:007759-UCD
DR   Wikidata; Q54784564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444061; Ss18l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE681
AC   CVCL_PP39
SY   XE681
DR   MMRRC; MMRRC:007760-UCD
DR   Wikidata; Q54784565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159210; Tiparp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE685
AC   CVCL_PP40
SY   XE685
DR   MMRRC; MMRRC:007761-UCD
DR   Wikidata; Q54784568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE686
AC   CVCL_PP41
SY   XE686
DR   MMRRC; MMRRC:007762-UCD
DR   Wikidata; Q54784571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE690
AC   CVCL_PP42
SY   XE690
DR   MMRRC; MMRRC:007763-UCD
DR   Wikidata; Q54784619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096881; Eef1a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE693
AC   CVCL_PP43
SY   XE693
DR   MMRRC; MMRRC:007764-UCD
DR   Wikidata; Q54784622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108057; Rpl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE699
AC   CVCL_PP44
SY   XE699
DR   MMRRC; MMRRC:007766-UCD
DR   Wikidata; Q54784624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96995; Kmt2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE701
AC   CVCL_PP45
SY   XE701
DR   MMRRC; MMRRC:007767-UCD
DR   Wikidata; Q54784625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE704
AC   CVCL_PP46
SY   XE704
DR   MMRRC; MMRRC:007769-UCD
DR   Wikidata; Q54784630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE705
AC   CVCL_PP47
SY   XE705
DR   MMRRC; MMRRC:007770-UCD
DR   Wikidata; Q54784632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95476; Fabp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE707
AC   CVCL_PP48
SY   XE707
DR   MMRRC; MMRRC:007771-UCD
DR   Wikidata; Q54784633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE726
AC   CVCL_PP49
SY   XE726
DR   MMRRC; MMRRC:007774-UCD
DR   Wikidata; Q54784637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135637; Park7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE728
AC   CVCL_PP50
SY   XE728
DR   MMRRC; MMRRC:007775-UCD
DR   Wikidata; Q54784639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928373; Dnajc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE732
AC   CVCL_PP51
SY   XE732
DR   MMRRC; MMRRC:007776-UCD
DR   Wikidata; Q54784644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914176; Trmt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE738
AC   CVCL_PP52
SY   XE738
DR   MMRRC; MMRRC:007779-UCD
DR   Wikidata; Q54784645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346832; Esrrb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE743
AC   CVCL_PP53
SY   XE743
DR   MMRRC; MMRRC:007780-UCD
DR   Wikidata; Q54784647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923035; Klhl24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE744
AC   CVCL_PP54
SY   XE744
DR   MMRRC; MMRRC:007781-UCD
DR   Wikidata; Q54784649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109275; Trim24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE746
AC   CVCL_PP55
SY   XE746
DR   MMRRC; MMRRC:007782-UCD
DR   Wikidata; Q54784652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444218; Ahdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE747
AC   CVCL_PP56
SY   XE747
DR   MMRRC; MMRRC:007783-UCD
DR   Wikidata; Q54784656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97537; Pecam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE749
AC   CVCL_PP57
SY   XE749
DR   MMRRC; MMRRC:007784-UCD
DR   Wikidata; Q54784658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918625; Foxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE751
AC   CVCL_PP58
SY   XE751
DR   MMRRC; MMRRC:007785-UCD
DR   Wikidata; Q54784659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096342; Rhoa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE752
AC   CVCL_PP59
SY   XE752
DR   MMRRC; MMRRC:007786-UCD
DR   Wikidata; Q54784661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE754
AC   CVCL_PP60
SY   XE754
DR   MMRRC; MMRRC:007787-UCD
DR   Wikidata; Q54784662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE755
AC   CVCL_PP61
SY   XE755
DR   MMRRC; MMRRC:007788-UCD
DR   Wikidata; Q54784664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE756
AC   CVCL_PP62
SY   XE756
DR   MMRRC; MMRRC:007789-UCD
DR   Wikidata; Q54784665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE757
AC   CVCL_PP63
SY   XE757
DR   MMRRC; MMRRC:007790-UCD
DR   Wikidata; Q54784667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE758
AC   CVCL_PP64
SY   XE758
DR   MMRRC; MMRRC:007791-UCD
DR   Wikidata; Q54784671
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE759
AC   CVCL_PP65
SY   XE759
DR   MMRRC; MMRRC:007792-UCD
DR   Wikidata; Q54784673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE760
AC   CVCL_PP66
SY   XE760
DR   MMRRC; MMRRC:007793-UCD
DR   Wikidata; Q54784674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE761
AC   CVCL_PP67
SY   XE761
DR   MMRRC; MMRRC:007794-UCD
DR   Wikidata; Q54784676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE762
AC   CVCL_PP68
SY   XE762
DR   MMRRC; MMRRC:007795-UCD
DR   Wikidata; Q54784679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE763
AC   CVCL_PP69
SY   XE763
DR   MMRRC; MMRRC:007796-UCD
DR   Wikidata; Q54784681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE764
AC   CVCL_PP70
SY   XE764
DR   MMRRC; MMRRC:007797-UCD
DR   Wikidata; Q54784684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE765
AC   CVCL_PP71
SY   XE765
DR   MMRRC; MMRRC:007798-UCD
DR   Wikidata; Q54784686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE767
AC   CVCL_PP72
SY   XE767
DR   MMRRC; MMRRC:007799-UCD
DR   Wikidata; Q54784688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97286; Ncl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE769
AC   CVCL_PP73
SY   XE769
DR   MMRRC; MMRRC:007800-UCD
DR   Wikidata; Q54784692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923799; Cecr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE772
AC   CVCL_PP74
SY   XE772
DR   MMRRC; MMRRC:007801-UCD
DR   Wikidata; Q54784693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931751; Pum2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE775
AC   CVCL_PP75
SY   XE775
DR   MMRRC; MMRRC:007802-UCD
DR   Wikidata; Q54784694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE777
AC   CVCL_PP76
SY   XE777
DR   MMRRC; MMRRC:007803-UCD
DR   Wikidata; Q54784696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333787; Inppl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE778
AC   CVCL_PP77
SY   XE778
DR   MMRRC; MMRRC:007804-UCD
DR   Wikidata; Q54784698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE780
AC   CVCL_PP78
SY   XE780
DR   MMRRC; MMRRC:007805-UCD
DR   Wikidata; Q54784700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922003; Trmo.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE782
AC   CVCL_PP79
SY   XE782
DR   MMRRC; MMRRC:007806-UCD
DR   Wikidata; Q54784702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442782; Baz2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE786
AC   CVCL_PP80
SY   XE786
DR   MMRRC; MMRRC:007807-UCD
DR   Wikidata; Q54784705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385292; Tnrc6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE788
AC   CVCL_PP81
SY   XE788
DR   MMRRC; MMRRC:007809-UCD
DR   Wikidata; Q54784707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105072; Rab22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE790
AC   CVCL_PP82
SY   XE790
DR   MMRRC; MMRRC:007810-UCD
DR   Wikidata; Q54784752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE791
AC   CVCL_PP83
SY   XE791
DR   MMRRC; MMRRC:007811-UCD
DR   Wikidata; Q54784755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE792
AC   CVCL_PP84
SY   XE792
DR   MMRRC; MMRRC:007812-UCD
DR   Wikidata; Q54784756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098687; Aak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE793
AC   CVCL_PP85
SY   XE793
DR   MMRRC; MMRRC:007813-UCD
DR   Wikidata; Q54784758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE795
AC   CVCL_PP86
SY   XE795
DR   MMRRC; MMRRC:007814-UCD
DR   Wikidata; Q54784759
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE796
AC   CVCL_PP87
SY   XE796
DR   MMRRC; MMRRC:007815-UCD
DR   Wikidata; Q54784760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE797
AC   CVCL_PP88
SY   XE797
DR   MMRRC; MMRRC:007816-UCD
DR   Wikidata; Q54784761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE798
AC   CVCL_PP89
SY   XE798
DR   MMRRC; MMRRC:007817-UCD
DR   Wikidata; Q54784762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE799
AC   CVCL_PP90
SY   XE799
DR   MMRRC; MMRRC:007818-UCD
DR   Wikidata; Q54784764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE800
AC   CVCL_PP91
SY   XE800
DR   MMRRC; MMRRC:007819-UCD
DR   Wikidata; Q54784766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE802
AC   CVCL_PP92
SY   XE802
DR   MMRRC; MMRRC:007821-UCD
DR   Wikidata; Q54784767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139883; Zbtb10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE804
AC   CVCL_PP93
SY   XE804
DR   MMRRC; MMRRC:007822-UCD
DR   Wikidata; Q54784768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929455; Rpl23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE819
AC   CVCL_PP94
SY   XE819
DR   MMRRC; MMRRC:007823-UCD
DR   Wikidata; Q54784770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921446; Ttc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE820
AC   CVCL_PP95
SY   XE820
DR   MMRRC; MMRRC:007824-UCD
DR   Wikidata; Q54784772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100537; Mid1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE826
AC   CVCL_PP96
SY   XE826
DR   MMRRC; MMRRC:007827-UCD
DR   Wikidata; Q54784774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE827
AC   CVCL_PP97
SY   XE827
DR   MMRRC; MMRRC:007828-UCD
DR   Wikidata; Q54784777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE828
AC   CVCL_PP98
SY   XE828
DR   MMRRC; MMRRC:007829-UCD
DR   Wikidata; Q54784778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE829
AC   CVCL_PP99
SY   XE829
DR   MMRRC; MMRRC:007830-UCD
DR   Wikidata; Q54784781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE830
AC   CVCL_PR00
SY   XE830
DR   MMRRC; MMRRC:007831-UCD
DR   Wikidata; Q54784782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE831
AC   CVCL_PR01
SY   XE831
DR   MMRRC; MMRRC:007832-UCD
DR   Wikidata; Q54784784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE832
AC   CVCL_PR02
SY   XE832
DR   MMRRC; MMRRC:007833-UCD
DR   Wikidata; Q54784787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE835
AC   CVCL_PR03
SY   XE835
DR   MMRRC; MMRRC:007834-UCD
DR   Wikidata; Q54784788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921173; Tmco1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE839
AC   CVCL_PR04
SY   XE839
DR   MMRRC; MMRRC:007835-UCD
DR   Wikidata; Q54784792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351320; Trp53bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE841
AC   CVCL_PR05
SY   XE841
DR   MMRRC; MMRRC:007836-UCD
DR   Wikidata; Q54784793
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921407; Cmtr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE842
AC   CVCL_PR06
SY   XE842
DR   MMRRC; MMRRC:007837-UCD
DR   Wikidata; Q54784794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351320; Trp53bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE848
AC   CVCL_PR07
SY   XE848
DR   MMRRC; MMRRC:007838-UCD
DR   Wikidata; Q54784796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927479; Sap30bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE850
AC   CVCL_PR08
SY   XE850
DR   MMRRC; MMRRC:007839-UCD
DR   Wikidata; Q54784799
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE853
AC   CVCL_PR09
SY   XE853
DR   MMRRC; MMRRC:007841-UCD
DR   Wikidata; Q54784802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351320; Trp53bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE856
AC   CVCL_PR10
SY   XE856
DR   MMRRC; MMRRC:007842-UCD
DR   Wikidata; Q54784805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE858
AC   CVCL_PR11
SY   XE858
DR   MMRRC; MMRRC:007843-UCD
DR   Wikidata; Q54784807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE859
AC   CVCL_PR12
SY   XE859
DR   MMRRC; MMRRC:007844-UCD
DR   Wikidata; Q54784809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97887; Rdx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE861
AC   CVCL_PR13
SY   XE861
DR   MMRRC; MMRRC:007845-UCD
DR   Wikidata; Q54784811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351320; Trp53bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE862
AC   CVCL_PR14
SY   XE862
DR   MMRRC; MMRRC:007846-UCD
DR   Wikidata; Q54784813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351320; Trp53bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE863
AC   CVCL_PR15
SY   XE863
DR   MMRRC; MMRRC:007847-UCD
DR   Wikidata; Q54784815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098687; Aak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE868
AC   CVCL_PR16
SY   XE868
DR   MMRRC; MMRRC:007849-UCD
DR   Wikidata; Q54784816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096342; Rhoa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE871
AC   CVCL_PR17
SY   XE871
DR   MMRRC; MMRRC:007850-UCD
DR   Wikidata; Q54784817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE876
AC   CVCL_PR18
SY   XE876
DR   MMRRC; MMRRC:007852-UCD
DR   Wikidata; Q54784819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139369; Rtel1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XE878
AC   CVCL_PR19
SY   XE878
DR   MMRRC; MMRRC:007853-UCD
DR   Wikidata; Q54784820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF002
AC   CVCL_PR20
SY   XF002
DR   MMRRC; MMRRC:007855-UCD
DR   Wikidata; Q54784821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270126; Ulk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF003
AC   CVCL_PR21
SY   XF003
DR   MMRRC; MMRRC:007856-UCD
DR   Wikidata; Q54784822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442153; Gak.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF013
AC   CVCL_PR22
SY   XF013
DR   MMRRC; MMRRC:007858-UCD
DR   Wikidata; Q54784872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF014
AC   CVCL_PR23
SY   XF014
DR   MMRRC; MMRRC:007859-UCD
DR   Wikidata; Q54784876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917394; Lrch3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF015
AC   CVCL_PR24
SY   XF015
DR   MMRRC; MMRRC:007860-UCD
DR   Wikidata; Q54784877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF016
AC   CVCL_PR25
SY   XF016
DR   MMRRC; MMRRC:007861-UCD
DR   Wikidata; Q54784879
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94912; Dnmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF020
AC   CVCL_PR26
SY   XF020
DR   MMRRC; MMRRC:007862-UCD
DR   Wikidata; Q54784881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95481; Ptk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF021
AC   CVCL_PR27
SY   XF021
DR   MMRRC; MMRRC:007863-UCD
DR   Wikidata; Q54784883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933527; Srrt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF022
AC   CVCL_PR28
SY   XF022
DR   MMRRC; MMRRC:007864-UCD
DR   Wikidata; Q54784886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109582; Polr2j.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF028
AC   CVCL_PR29
SY   XF028
DR   MMRRC; MMRRC:007867-UCD
DR   Wikidata; Q54784888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140248; Zbtb48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF031
AC   CVCL_PR30
SY   XF031
DR   MMRRC; MMRRC:007868-UCD
DR   Wikidata; Q54784889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98658; Tdgf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF042
AC   CVCL_PR31
SY   XF042
DR   MMRRC; MMRRC:007871-UCD
DR   Wikidata; Q54784892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449307; Upf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF043
AC   CVCL_PR32
SY   XF043
DR   MMRRC; MMRRC:007872-UCD
DR   Wikidata; Q54784893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104633; Tle4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF048
AC   CVCL_PR33
SY   XF048
DR   MMRRC; MMRRC:007876-UCD
DR   Wikidata; Q54784895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924261; Ticrr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF054
AC   CVCL_PR34
SY   XF054
DR   MMRRC; MMRRC:007880-UCD
DR   Wikidata; Q54784897
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137512; Arid4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF060
AC   CVCL_PR35
SY   XF060
DR   MMRRC; MMRRC:007883-UCD
DR   Wikidata; Q54784898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933549; Slmap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF062
AC   CVCL_PR36
SY   XF062
DR   MMRRC; MMRRC:007884-UCD
DR   Wikidata; Q54784899
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF065
AC   CVCL_PR37
SY   XF065
DR   MMRRC; MMRRC:007885-UCD
DR   Wikidata; Q54784902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102706; Fdft1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF099
AC   CVCL_PR38
SY   XF099
DR   MMRRC; MMRRC:007891-UCD
DR   Wikidata; Q54784904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934950; Csnk1a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF102
AC   CVCL_PR39
SY   XF102
DR   MMRRC; MMRRC:007894-UCD
DR   Wikidata; Q54784907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF104
AC   CVCL_PR40
SY   XF104
DR   MMRRC; MMRRC:007896-UCD
DR   Wikidata; Q54784908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387203; Ppat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF122
AC   CVCL_PR41
SY   XF122
DR   MMRRC; MMRRC:007901-UCD
DR   Wikidata; Q54784911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF124
AC   CVCL_PR42
SY   XF124
DR   MMRRC; MMRRC:007902-UCD
DR   Wikidata; Q54784913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137738; Prcc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF125
AC   CVCL_PR43
SY   XF125
DR   MMRRC; MMRRC:007903-UCD
DR   Wikidata; Q54784915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99257; Eif3e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF127
AC   CVCL_PR44
SY   XF127
DR   MMRRC; MMRRC:007904-UCD
DR   Wikidata; Q54784917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF155
AC   CVCL_PR45
SY   XF155
DR   MMRRC; MMRRC:007908-UCD
DR   Wikidata; Q54784918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137512; Arid4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF162
AC   CVCL_PR46
SY   XF162
DR   MMRRC; MMRRC:007910-UCD
DR   Wikidata; Q54784920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443584; L3mbtl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF164
AC   CVCL_PR47
SY   XF164
DR   MMRRC; MMRRC:007911-UCD
DR   Wikidata; Q54784922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF165
AC   CVCL_PR48
SY   XF165
DR   MMRRC; MMRRC:007912-UCD
DR   Wikidata; Q54784924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926082; Cacul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF166
AC   CVCL_PR49
SY   XF166
DR   MMRRC; MMRRC:007913-UCD
DR   Wikidata; Q54784927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99430; Hira.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF168
AC   CVCL_PR50
SY   XF168
DR   MMRRC; MMRRC:007914-UCD
DR   Wikidata; Q54784928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101785; Mybl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF172
AC   CVCL_PR51
SY   XF172
DR   MMRRC; MMRRC:007916-UCD
DR   Wikidata; Q54784931
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889001; Nub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF174
AC   CVCL_PR52
SY   XF174
DR   MMRRC; MMRRC:007918-UCD
DR   Wikidata; Q54784932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923802; Plekha5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF175
AC   CVCL_PR53
SY   XF175
DR   MMRRC; MMRRC:007919-UCD
DR   Wikidata; Q54784935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919906; Ints8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF176
AC   CVCL_PR54
SY   XF176
DR   MMRRC; MMRRC:007920-UCD
DR   Wikidata; Q54784937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF185
AC   CVCL_PR55
SY   XF185
DR   MMRRC; MMRRC:007925-UCD
DR   Wikidata; Q54784939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347044; Orc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF186
AC   CVCL_PR56
SY   XF186
DR   MMRRC; MMRRC:007926-UCD
DR   Wikidata; Q54784941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924705; Rlf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF191
AC   CVCL_PR57
SY   XF191
DR   MMRRC; MMRRC:007927-UCD
DR   Wikidata; Q54784942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101786; Mtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF196
AC   CVCL_PR58
SY   XF196
DR   MMRRC; MMRRC:007930-UCD
DR   Wikidata; Q54784943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF202
AC   CVCL_PR59
SY   XF202
DR   MMRRC; MMRRC:007933-UCD
DR   Wikidata; Q54784947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444855; Klhl20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF203
AC   CVCL_PR60
SY   XF203
DR   MMRRC; MMRRC:007934-UCD
DR   Wikidata; Q54784948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351658; Abcf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF204
AC   CVCL_PR61
SY   XF204
DR   MMRRC; MMRRC:007935-UCD
DR   Wikidata; Q54784949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916471; 2410006H16Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF207
AC   CVCL_PR62
SY   XF207
DR   MMRRC; MMRRC:007936-UCD
DR   Wikidata; Q54784991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF209
AC   CVCL_PR63
SY   XF209
DR   MMRRC; MMRRC:007938-UCD
DR   Wikidata; Q54784993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925868; Acap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF210
AC   CVCL_PR64
SY   XF210
DR   MMRRC; MMRRC:007939-UCD
DR   Wikidata; Q54784995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101769; Mcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF217
AC   CVCL_PR65
SY   XF217
DR   MMRRC; MMRRC:007941-UCD
DR   Wikidata; Q54784998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098672; Szrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF224
AC   CVCL_PR66
SY   XF224
DR   MMRRC; MMRRC:007944-UCD
DR   Wikidata; Q54784999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918677; Ibtk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF225
AC   CVCL_PR67
SY   XF225
DR   MMRRC; MMRRC:007945-UCD
DR   Wikidata; Q54785000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2672032; Fmr1nb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF226
AC   CVCL_PR68
SY   XF226
DR   MMRRC; MMRRC:007946-UCD
DR   Wikidata; Q54785002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF231
AC   CVCL_PR69
SY   XF231
DR   MMRRC; MMRRC:007947-UCD
DR   Wikidata; Q54785004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF241
AC   CVCL_PR70
SY   XF241
DR   MMRRC; MMRRC:007949-UCD
DR   Wikidata; Q54785005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2684913; Nol10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF255
AC   CVCL_PR71
SY   XF255
DR   MMRRC; MMRRC:007954-UCD
DR   Wikidata; Q54785006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF270
AC   CVCL_PR72
SY   XF270
DR   MMRRC; MMRRC:007955-UCD
DR   Wikidata; Q54785007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136957; Clmn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF287
AC   CVCL_PR73
SY   XF287
DR   MMRRC; MMRRC:007959-UCD
DR   Wikidata; Q54785008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF288
AC   CVCL_PR74
SY   XF288
DR   MMRRC; MMRRC:007960-UCD
DR   Wikidata; Q54785009
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158400; Wdr18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF292
AC   CVCL_PR75
SY   XF292
DR   MMRRC; MMRRC:007964-UCD
DR   Wikidata; Q54785011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351485; Phlda3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF301
AC   CVCL_PR76
SY   XF301
DR   MMRRC; MMRRC:007968-UCD
DR   Wikidata; Q54785012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95305; Eif4e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF302
AC   CVCL_PR77
SY   XF302
DR   MMRRC; MMRRC:007969-UCD
DR   Wikidata; Q54785014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914880; Samd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF310
AC   CVCL_PR78
SY   XF310
DR   MMRRC; MMRRC:007974-UCD
DR   Wikidata; Q54785015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151013; Erc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF311
AC   CVCL_PR79
SY   XF311
DR   MMRRC; MMRRC:007975-UCD
DR   Wikidata; Q54785016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344403; Cfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF315
AC   CVCL_PR80
SY   XF315
DR   MMRRC; MMRRC:007976-UCD
DR   Wikidata; Q54785018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098672; Szrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF320
AC   CVCL_PR81
SY   XF320
DR   MMRRC; MMRRC:007977-UCD
DR   Wikidata; Q54785021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95757; Slc2a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF325
AC   CVCL_PR82
SY   XF325
DR   MMRRC; MMRRC:007980-UCD
DR   Wikidata; Q54785023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF326
AC   CVCL_PR83
SY   XF326
DR   MMRRC; MMRRC:007981-UCD
DR   Wikidata; Q54785025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109339; Eya3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF338
AC   CVCL_PR84
SY   XF338
DR   MMRRC; MMRRC:007985-UCD
DR   Wikidata; Q54785028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF344
AC   CVCL_PR85
SY   XF344
DR   MMRRC; MMRRC:007986-UCD
DR   Wikidata; Q54785029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97306; Nf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF345
AC   CVCL_PR86
SY   XF345
DR   MMRRC; MMRRC:007987-UCD
DR   Wikidata; Q54785030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF353
AC   CVCL_PR87
SY   XF353
DR   MMRRC; MMRRC:007991-UCD
DR   Wikidata; Q54785033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97542; Pepd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF357
AC   CVCL_PR88
SY   XF357
DR   MMRRC; MMRRC:007993-UCD
DR   Wikidata; Q54785035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139054; Gpr107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF360
AC   CVCL_PR89
SY   XF360
DR   MMRRC; MMRRC:007995-UCD
DR   Wikidata; Q54785037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF368
AC   CVCL_PR90
SY   XF368
DR   MMRRC; MMRRC:007997-UCD
DR   Wikidata; Q54785040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917029; Pphln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF405
AC   CVCL_PR91
SY   XF405
DR   MMRRC; MMRRC:008009-UCD
DR   Wikidata; Q54785043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF409
AC   CVCL_PR92
SY   XF409
DR   MMRRC; MMRRC:008011-UCD
DR   Wikidata; Q54785045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914449; Pfdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF410
AC   CVCL_PR93
SY   XF410
DR   MMRRC; MMRRC:008012-UCD
DR   Wikidata; Q54785047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347043; Orc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF421
AC   CVCL_PR94
SY   XF421
DR   MMRRC; MMRRC:008014-UCD
DR   Wikidata; Q54785049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349216; Abcd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF423
AC   CVCL_PR95
SY   XF423
DR   MMRRC; MMRRC:008016-UCD
DR   Wikidata; Q54785051
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891693; Mtmr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF425
AC   CVCL_PR96
SY   XF425
DR   MMRRC; MMRRC:008017-UCD
DR   Wikidata; Q54785053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338037; Rbm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF430
AC   CVCL_PR97
SY   XF430
DR   MMRRC; MMRRC:008018-UCD
DR   Wikidata; Q54785056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933162; Lrba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF445
AC   CVCL_PR98
SY   XF445
DR   MMRRC; MMRRC:008022-UCD
DR   Wikidata; Q54785059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888697; Taf9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF452
AC   CVCL_PR99
SY   XF452
DR   MMRRC; MMRRC:008025-UCD
DR   Wikidata; Q54785061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442675; Rfx7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF485
AC   CVCL_PS00
SY   XF485
DR   MMRRC; MMRRC:008027-UCD
DR   Wikidata; Q54785063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347093; Fto.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF488
AC   CVCL_PS01
SY   XF488
DR   MMRRC; MMRRC:008028-UCD
DR   Wikidata; Q54785065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915848; Dnajc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF501
AC   CVCL_PS02
SY   XF501
DR   MMRRC; MMRRC:008030-UCD
DR   Wikidata; Q54785104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF502
AC   CVCL_PS03
SY   XF502
DR   MMRRC; MMRRC:008031-UCD
DR   Wikidata; Q54785105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342295; Celf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF503
AC   CVCL_PS04
SY   XF503
DR   MMRRC; MMRRC:008032-UCD
DR   Wikidata; Q54785107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96522; Rbpj.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF516
AC   CVCL_PS05
SY   XF516
DR   MMRRC; MMRRC:008037-UCD
DR   Wikidata; Q54785108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891693; Mtmr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF518
AC   CVCL_PS06
SY   XF518
DR   MMRRC; MMRRC:008039-UCD
DR   Wikidata; Q54785110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333796; Klf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF521
AC   CVCL_PS07
SY   XF521
DR   MMRRC; MMRRC:008040-UCD
DR   Wikidata; Q54785113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349393; Polr2f.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF522
AC   CVCL_PS08
SY   XF522
DR   MMRRC; MMRRC:008041-UCD
DR   Wikidata; Q54785117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915205; Sugt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF523
AC   CVCL_PS09
SY   XF523
DR   MMRRC; MMRRC:008042-UCD
DR   Wikidata; Q54785118
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915205; Sugt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF572
AC   CVCL_PS10
SY   XF572
DR   MMRRC; MMRRC:008047-UCD
DR   Wikidata; Q54785122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913443; Pithd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF574
AC   CVCL_PS11
SY   XF574
DR   MMRRC; MMRRC:008048-UCD
DR   Wikidata; Q54785123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF575
AC   CVCL_PS12
SY   XF575
DR   MMRRC; MMRRC:008049-UCD
DR   Wikidata; Q54785124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96952; Mdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF579
AC   CVCL_PS13
SY   XF579
DR   MMRRC; MMRRC:008050-UCD
DR   Wikidata; Q54785126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918625; Foxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF580
AC   CVCL_PS14
SY   XF580
DR   MMRRC; MMRRC:008051-UCD
DR   Wikidata; Q54785127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920196; Lrrc47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF586
AC   CVCL_PS15
SY   XF586
DR   MMRRC; MMRRC:008056-UCD
DR   Wikidata; Q54785128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344403; Cfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF590
AC   CVCL_PS16
SY   XF590
DR   MMRRC; MMRRC:008059-UCD
DR   Wikidata; Q54785129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918771; Pds5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XF596
AC   CVCL_PS17
SY   XF596
DR   MMRRC; MMRRC:008062-UCD
DR   Wikidata; Q54785132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347488; Foxk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG001
AC   CVCL_PS18
SY   XG001
DR   MMRRC; MMRRC:008063-UCD
DR   Wikidata; Q54785134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445054; Senp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG003
AC   CVCL_PS19
SY   XG003
DR   MMRRC; MMRRC:008064-UCD
DR   Wikidata; Q54785135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915751; Nsmce2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG005
AC   CVCL_PS20
SY   XG005
DR   MMRRC; MMRRC:008065-UCD
DR   Wikidata; Q54785137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG006
AC   CVCL_PS21
SY   XG006
DR   MMRRC; MMRRC:008066-UCD
DR   Wikidata; Q54785140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG007
AC   CVCL_PS22
SY   XG007
DR   MMRRC; MMRRC:008067-UCD
DR   Wikidata; Q54785141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137357; Trim33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG012
AC   CVCL_PS23
SY   XG012
DR   MMRRC; MMRRC:008068-UCD
DR   Wikidata; Q54785142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194490; Diaph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG013
AC   CVCL_PS24
SY   XG013
DR   MMRRC; MMRRC:008069-UCD
DR   Wikidata; Q54785146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922662; 2610021A01Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG014
AC   CVCL_PS25
SY   XG014
DR   MMRRC; MMRRC:008070-UCD
DR   Wikidata; Q54785147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915147; Rnmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG015
AC   CVCL_PS26
SY   XG015
DR   MMRRC; MMRRC:008071-UCD
DR   Wikidata; Q54785149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338049; Itsn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG016
AC   CVCL_PS27
SY   XG016
DR   MMRRC; MMRRC:008072-UCD
DR   Wikidata; Q54785150
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG017
AC   CVCL_PS28
SY   XG017
DR   MMRRC; MMRRC:008073-UCD
DR   Wikidata; Q54785151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107738; Dync1li2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG018
AC   CVCL_PS29
SY   XG018
DR   MMRRC; MMRRC:008074-UCD
DR   Wikidata; Q54785153
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861100; Ubr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG019
AC   CVCL_PS30
SY   XG019
DR   MMRRC; MMRRC:008075-UCD
DR   Wikidata; Q54785155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923784; Osbpl9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG021
AC   CVCL_PS31
SY   XG021
DR   MMRRC; MMRRC:008076-UCD
DR   Wikidata; Q54785159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929510; Zfand6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG022
AC   CVCL_PS32
SY   XG022
DR   MMRRC; MMRRC:008077-UCD
DR   Wikidata; Q54785160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101920; Ap2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG023
AC   CVCL_PS33
SY   XG023
DR   MMRRC; MMRRC:008078-UCD
DR   Wikidata; Q54785162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444008; Bptf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG026
AC   CVCL_PS34
SY   XG026
DR   MMRRC; MMRRC:008079-UCD
DR   Wikidata; Q54785164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG029
AC   CVCL_PS35
SY   XG029
DR   MMRRC; MMRRC:008080-UCD
DR   Wikidata; Q54785166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102666; Ppp5c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG031
AC   CVCL_PS36
SY   XG031
DR   MMRRC; MMRRC:008081-UCD
DR   Wikidata; Q54785168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107585; Srebf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG034
AC   CVCL_PS37
SY   XG034
DR   MMRRC; MMRRC:008082-UCD
DR   Wikidata; Q54785171
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG038
AC   CVCL_PS38
SY   XG038
DR   MMRRC; MMRRC:008083-UCD
DR   Wikidata; Q54785173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG039
AC   CVCL_PS39
SY   XG039
DR   MMRRC; MMRRC:008084-UCD
DR   Wikidata; Q54785174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914099; Ppp1r2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG040
AC   CVCL_PS40
SY   XG040
DR   MMRRC; MMRRC:008085-UCD
DR   Wikidata; Q54785176
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344381; Dnajb6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG042
AC   CVCL_PS41
SY   XG042
DR   MMRRC; MMRRC:008086-UCD
DR   Wikidata; Q54785178
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441773; Pcmtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG045
AC   CVCL_PS42
SY   XG045
DR   MMRRC; MMRRC:008088-UCD
DR   Wikidata; Q54785217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95728; Gli2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG046
AC   CVCL_PS43
SY   XG046
DR   MMRRC; MMRRC:008089-UCD
DR   Wikidata; Q54785219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922083; Ciapin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG047
AC   CVCL_PS44
SY   XG047
DR   MMRRC; MMRRC:008090-UCD
DR   Wikidata; Q54785220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922874; Metap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG048
AC   CVCL_PS45
SY   XG048
DR   MMRRC; MMRRC:008091-UCD
DR   Wikidata; Q54785223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108086; Hdac1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG049
AC   CVCL_PS46
SY   XG049
DR   MMRRC; MMRRC:008092-UCD
DR   Wikidata; Q54785225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3505790; Fcho2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG051
AC   CVCL_PS47
SY   XG051
DR   MMRRC; MMRRC:008093-UCD
DR   Wikidata; Q54785226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG052
AC   CVCL_PS48
SY   XG052
DR   MMRRC; MMRRC:008094-UCD
DR   Wikidata; Q54785228
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106264; Trim36.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG054
AC   CVCL_PS49
SY   XG054
DR   MMRRC; MMRRC:008095-UCD
DR   Wikidata; Q54785231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353561; Vapa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG055
AC   CVCL_PS50
SY   XG055
DR   MMRRC; MMRRC:008096-UCD
DR   Wikidata; Q54785232
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925771; B230219D22Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG056
AC   CVCL_PS51
SY   XG056
DR   MMRRC; MMRRC:008097-UCD
DR   Wikidata; Q54785234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108086; Hdac1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG057
AC   CVCL_PS52
SY   XG057
DR   MMRRC; MMRRC:008098-UCD
DR   Wikidata; Q54785235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG058
AC   CVCL_PS53
SY   XG058
DR   MMRRC; MMRRC:008099-UCD
DR   Wikidata; Q54785237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151114; Dgcr8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG059
AC   CVCL_PS54
SY   XG059
DR   MMRRC; MMRRC:008100-UCD
DR   Wikidata; Q54785238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG060
AC   CVCL_PS55
SY   XG060
DR   MMRRC; MMRRC:008101-UCD
DR   Wikidata; Q54785239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298375; Cabin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG061
AC   CVCL_PS56
SY   XG061
DR   MMRRC; MMRRC:008102-UCD
DR   Wikidata; Q54785240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG063
AC   CVCL_PS57
SY   XG063
DR   MMRRC; MMRRC:008103-UCD
DR   Wikidata; Q54785242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298398; Mcm7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG064
AC   CVCL_PS58
SY   XG064
DR   MMRRC; MMRRC:008104-UCD
DR   Wikidata; Q54785243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448506; Pi4ka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG066
AC   CVCL_PS59
SY   XG066
DR   MMRRC; MMRRC:008105-UCD
DR   Wikidata; Q54785245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG068
AC   CVCL_PS60
SY   XG068
DR   MMRRC; MMRRC:008106-UCD
DR   Wikidata; Q54785247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928488; Akap8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG069
AC   CVCL_PS61
SY   XG069
DR   MMRRC; MMRRC:008107-UCD
DR   Wikidata; Q54785248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG070
AC   CVCL_PS62
SY   XG070
DR   MMRRC; MMRRC:008108-UCD
DR   Wikidata; Q54785249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916303; 1810013L24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG071
AC   CVCL_PS63
SY   XG071
DR   MMRRC; MMRRC:008109-UCD
DR   Wikidata; Q54785250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG072
AC   CVCL_PS64
SY   XG072
DR   MMRRC; MMRRC:008110-UCD
DR   Wikidata; Q54785253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889364; Akirin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG073
AC   CVCL_PS65
SY   XG073
DR   MMRRC; MMRRC:008111-UCD
DR   Wikidata; Q54785256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG075
AC   CVCL_PS66
SY   XG075
DR   MMRRC; MMRRC:008112-UCD
DR   Wikidata; Q54785258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443812; Phf21b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG077
AC   CVCL_PS67
SY   XG077
DR   MMRRC; MMRRC:008113-UCD
DR   Wikidata; Q54785259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342248; Slc25a17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG078
AC   CVCL_PS68
SY   XG078
DR   MMRRC; MMRRC:008114-UCD
DR   Wikidata; Q54785260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917900; Zcchc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG079
AC   CVCL_PS69
SY   XG079
DR   MMRRC; MMRRC:008115-UCD
DR   Wikidata; Q54785263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922670; Secisbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG080
AC   CVCL_PS70
SY   XG080
DR   MMRRC; MMRRC:008116-UCD
DR   Wikidata; Q54785265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG082
AC   CVCL_PS71
SY   XG082
DR   MMRRC; MMRRC:008117-UCD
DR   Wikidata; Q54785266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98927; Vcl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG084
AC   CVCL_PS72
SY   XG084
DR   MMRRC; MMRRC:008118-UCD
DR   Wikidata; Q54785269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG087
AC   CVCL_PS73
SY   XG087
DR   MMRRC; MMRRC:008119-UCD
DR   Wikidata; Q54785271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG090
AC   CVCL_PS74
SY   XG090
DR   MMRRC; MMRRC:008120-UCD
DR   Wikidata; Q54785272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923046; Cdyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG091
AC   CVCL_PS75
SY   XG091
DR   MMRRC; MMRRC:008121-UCD
DR   Wikidata; Q54785273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923046; Cdyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG093
AC   CVCL_PS76
SY   XG093
DR   MMRRC; MMRRC:008122-UCD
DR   Wikidata; Q54785275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG094
AC   CVCL_PS77
SY   XG094
DR   MMRRC; MMRRC:008123-UCD
DR   Wikidata; Q54785276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183260; Luc7l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG095
AC   CVCL_PS78
SY   XG095
DR   MMRRC; MMRRC:008124-UCD
DR   Wikidata; Q54785279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG096
AC   CVCL_PS79
SY   XG096
DR   MMRRC; MMRRC:008125-UCD
DR   Wikidata; Q54785281
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682937; Zfp341.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG098
AC   CVCL_PS80
SY   XG098
DR   MMRRC; MMRRC:008126-UCD
DR   Wikidata; Q54785283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915955; Gtf2f2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG099
AC   CVCL_PS81
SY   XG099
DR   MMRRC; MMRRC:008127-UCD
DR   Wikidata; Q54785284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387179; Tut7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XG100
AC   CVCL_PS82
SY   XG100
DR   MMRRC; MMRRC:008128-UCD
DR   Wikidata; Q54785326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915403; Gtf2e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG103
AC   CVCL_PS83
SY   XG103
DR   MMRRC; MMRRC:008129-UCD
DR   Wikidata; Q54785327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG105
AC   CVCL_PS84
SY   XG105
DR   MMRRC; MMRRC:008130-UCD
DR   Wikidata; Q54785329
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100494; Ercc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG106
AC   CVCL_PS85
SY   XG106
DR   MMRRC; MMRRC:008131-UCD
DR   Wikidata; Q54785330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG107
AC   CVCL_PS86
SY   XG107
DR   MMRRC; MMRRC:008132-UCD
DR   Wikidata; Q54785331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG108
AC   CVCL_PS87
SY   XG108
DR   MMRRC; MMRRC:008133-UCD
DR   Wikidata; Q54785335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG112
AC   CVCL_PS88
SY   XG112
DR   MMRRC; MMRRC:008134-UCD
DR   Wikidata; Q54785337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917689; Taf15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG115
AC   CVCL_PS89
SY   XG115
DR   MMRRC; MMRRC:008135-UCD
DR   Wikidata; Q54785338
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1195458; Abce1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG116
AC   CVCL_PS90
SY   XG116
DR   MMRRC; MMRRC:008136-UCD
DR   Wikidata; Q54785343
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923257; Zmym2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG121
AC   CVCL_PS91
SY   XG121
DR   MMRRC; MMRRC:008137-UCD
DR   Wikidata; Q54785344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG122
AC   CVCL_PS92
SY   XG122
DR   MMRRC; MMRRC:008138-UCD
DR   Wikidata; Q54785346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261758; Suz12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG123
AC   CVCL_PS93
SY   XG123
DR   MMRRC; MMRRC:008139-UCD
DR   Wikidata; Q54785347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG125
AC   CVCL_PS94
SY   XG125
DR   MMRRC; MMRRC:008141-UCD
DR   Wikidata; Q54785350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG126
AC   CVCL_PS95
SY   XG126
DR   MMRRC; MMRRC:008142-UCD
DR   Wikidata; Q54785353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349409; Cops3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG127
AC   CVCL_PS96
SY   XG127
DR   MMRRC; MMRRC:008143-UCD
DR   Wikidata; Q54785354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG128
AC   CVCL_PS97
SY   XG128
DR   MMRRC; MMRRC:008144-UCD
DR   Wikidata; Q54785358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918722; Usp19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG129
AC   CVCL_PS98
SY   XG129
DR   MMRRC; MMRRC:008145-UCD
DR   Wikidata; Q54785360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913482; Znrd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XG130
AC   CVCL_PS99
SY   XG130
DR   MMRRC; MMRRC:008146-UCD
DR   Wikidata; Q54785362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG131
AC   CVCL_PT00
SY   XG131
DR   MMRRC; MMRRC:008147-UCD
DR   Wikidata; Q54785363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144243; Clint1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG134
AC   CVCL_PT01
SY   XG134
DR   MMRRC; MMRRC:008148-UCD
DR   Wikidata; Q54785365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924337; Ankrd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG136
AC   CVCL_PT02
SY   XG136
DR   MMRRC; MMRRC:008149-UCD
DR   Wikidata; Q54785367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913128; Bet1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG137
AC   CVCL_PT03
SY   XG137
DR   MMRRC; MMRRC:008150-UCD
DR   Wikidata; Q54785369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923799; Cecr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG138
AC   CVCL_PT04
SY   XG138
DR   MMRRC; MMRRC:008151-UCD
DR   Wikidata; Q54785370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917747; Arhgap17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG139
AC   CVCL_PT05
SY   XG139
DR   MMRRC; MMRRC:008152-UCD
DR   Wikidata; Q54785372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096566; Pias2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG140
AC   CVCL_PT06
SY   XG140
DR   MMRRC; MMRRC:008153-UCD
DR   Wikidata; Q54785374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103264; Arhgef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG142
AC   CVCL_PT07
SY   XG142
DR   MMRRC; MMRRC:008154-UCD
DR   Wikidata; Q54785375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444207; Vps13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG143
AC   CVCL_PT08
SY   XG143
DR   MMRRC; MMRRC:008155-UCD
DR   Wikidata; Q54785378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919824; Zc3h14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG144
AC   CVCL_PT09
SY   XG144
DR   MMRRC; MMRRC:008156-UCD
DR   Wikidata; Q54785380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921605; Smchd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG145
AC   CVCL_PT10
SY   XG145
DR   MMRRC; MMRRC:008157-UCD
DR   Wikidata; Q54785381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858202; Rab11a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG146
AC   CVCL_PT11
SY   XG146
DR   MMRRC; MMRRC:008158-UCD
DR   Wikidata; Q54785385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277166; Sp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG147
AC   CVCL_PT12
SY   XG147
DR   MMRRC; MMRRC:008159-UCD
DR   Wikidata; Q54785386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98299; Shmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG149
AC   CVCL_PT13
SY   XG149
DR   MMRRC; MMRRC:008160-UCD
DR   Wikidata; Q54785388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913482; Znrd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XG150
AC   CVCL_PT14
SY   XG150
DR   MMRRC; MMRRC:008161-UCD
DR   Wikidata; Q54785389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355328; Nasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG155
AC   CVCL_PT15
SY   XG155
DR   MMRRC; MMRRC:008162-UCD
DR   Wikidata; Q54785390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107690; Zfp462.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG157
AC   CVCL_PT16
SY   XG157
DR   MMRRC; MMRRC:008164-UCD
DR   Wikidata; Q54785392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151172; Mta3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG161
AC   CVCL_PT17
SY   XG161
DR   MMRRC; MMRRC:008165-UCD
DR   Wikidata; Q54785395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443807; Osbpl8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG163
AC   CVCL_PT18
SY   XG163
DR   MMRRC; MMRRC:008166-UCD
DR   Wikidata; Q54785396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443926; Dmxl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG164
AC   CVCL_PT19
SY   XG164
DR   MMRRC; MMRRC:008167-UCD
DR   Wikidata; Q54785399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442191; Dusp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG167
AC   CVCL_PT20
SY   XG167
DR   MMRRC; MMRRC:008168-UCD
DR   Wikidata; Q54785401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG169
AC   CVCL_PT21
SY   XG169
DR   MMRRC; MMRRC:008169-UCD
DR   Wikidata; Q54785403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913275; Rcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG171
AC   CVCL_PT22
SY   XG171
DR   MMRRC; MMRRC:008170-UCD
DR   Wikidata; Q54785450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860197; Wdr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG173
AC   CVCL_PT23
SY   XG173
DR   MMRRC; MMRRC:008171-UCD
DR   Wikidata; Q54785452
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95791; Got1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG175
AC   CVCL_PT24
SY   XG175
DR   MMRRC; MMRRC:008172-UCD
DR   Wikidata; Q54785454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913466; Bsdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG177
AC   CVCL_PT25
SY   XG177
DR   MMRRC; MMRRC:008174-UCD
DR   Wikidata; Q54785455
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182465; Vrk3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG178
AC   CVCL_PT26
SY   XG178
DR   MMRRC; MMRRC:008175-UCD
DR   Wikidata; Q54785456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107185; Cct5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG179
AC   CVCL_PT27
SY   XG179
DR   MMRRC; MMRRC:008176-UCD
DR   Wikidata; Q54785457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99147; Yes1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG181
AC   CVCL_PT28
SY   XG181
DR   MMRRC; MMRRC:008177-UCD
DR   Wikidata; Q54785460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG182
AC   CVCL_PT29
SY   XG182
DR   MMRRC; MMRRC:008178-UCD
DR   Wikidata; Q54785462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891840; Ncbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG183
AC   CVCL_PT30
SY   XG183
DR   MMRRC; MMRRC:008179-UCD
DR   Wikidata; Q54785463
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138271; Gorab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG186
AC   CVCL_PT31
SY   XG186
DR   MMRRC; MMRRC:008181-UCD
DR   Wikidata; Q54785465
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096867; Etv5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG188
AC   CVCL_PT32
SY   XG188
DR   MMRRC; MMRRC:008182-UCD
DR   Wikidata; Q54785466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG189
AC   CVCL_PT33
SY   XG189
DR   MMRRC; MMRRC:008183-UCD
DR   Wikidata; Q54785468
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG190
AC   CVCL_PT34
SY   XG190
DR   MMRRC; MMRRC:008184-UCD
DR   Wikidata; Q54785470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329014; Stam.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG191
AC   CVCL_PT35
SY   XG191
DR   MMRRC; MMRRC:008185-UCD
DR   Wikidata; Q54785471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920955; Mark4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG193
AC   CVCL_PT36
SY   XG193
DR   MMRRC; MMRRC:008186-UCD
DR   Wikidata; Q54785472
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921620; Rptor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG194
AC   CVCL_PT37
SY   XG194
DR   MMRRC; MMRRC:008187-UCD
DR   Wikidata; Q54785476
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141969; Efl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG195
AC   CVCL_PT38
SY   XG195
DR   MMRRC; MMRRC:008188-UCD
DR   Wikidata; Q54785478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921456; Sipa1l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG196
AC   CVCL_PT39
SY   XG196
DR   MMRRC; MMRRC:008189-UCD
DR   Wikidata; Q54785480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345144; Spry4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG198
AC   CVCL_PT40
SY   XG198
DR   MMRRC; MMRRC:008190-UCD
DR   Wikidata; Q54785482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913411; Pop4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG199
AC   CVCL_PT41
SY   XG199
DR   MMRRC; MMRRC:008191-UCD
DR   Wikidata; Q54785484
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG203
AC   CVCL_PT42
SY   XG203
DR   MMRRC; MMRRC:008192-UCD
DR   Wikidata; Q54785487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919865; Anks3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG204
AC   CVCL_PT43
SY   XG204
DR   MMRRC; MMRRC:008193-UCD
DR   Wikidata; Q54785489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914176; Trmt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG205
AC   CVCL_PT44
SY   XG205
DR   MMRRC; MMRRC:008194-UCD
DR   Wikidata; Q54785491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG207
AC   CVCL_PT45
SY   XG207
DR   MMRRC; MMRRC:008195-UCD
DR   Wikidata; Q54785495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98809; Tpm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG213
AC   CVCL_PT46
SY   XG213
DR   MMRRC; MMRRC:008196-UCD
DR   Wikidata; Q54785497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG214
AC   CVCL_PT47
SY   XG214
DR   MMRRC; MMRRC:008197-UCD
DR   Wikidata; Q54785501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104810; Plaa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG215
AC   CVCL_PT48
SY   XG215
DR   MMRRC; MMRRC:008198-UCD
DR   Wikidata; Q54785502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG216
AC   CVCL_PT49
SY   XG216
DR   MMRRC; MMRRC:008199-UCD
DR   Wikidata; Q54785504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG218
AC   CVCL_PT50
SY   XG218
DR   MMRRC; MMRRC:008200-UCD
DR   Wikidata; Q54785505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931237; Wwox.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG219
AC   CVCL_PT51
SY   XG219
DR   MMRRC; MMRRC:008201-UCD
DR   Wikidata; Q54785507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929494; Arhgap35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG221
AC   CVCL_PT52
SY   XG221
DR   MMRRC; MMRRC:008202-UCD
DR   Wikidata; Q54785508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859320; Cyhr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG226
AC   CVCL_PT53
SY   XG226
DR   MMRRC; MMRRC:008204-UCD
DR   Wikidata; Q54785512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443816; Snx8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG232
AC   CVCL_PT54
SY   XG232
DR   MMRRC; MMRRC:008205-UCD
DR   Wikidata; Q54785514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933765; Btbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG233
AC   CVCL_PT55
SY   XG233
DR   MMRRC; MMRRC:008206-UCD
DR   Wikidata; Q54785517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916962; Prpf38a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG235
AC   CVCL_PT56
SY   XG235
DR   MMRRC; MMRRC:008207-UCD
DR   Wikidata; Q54785519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276124; Ep400.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG236
AC   CVCL_PT57
SY   XG236
DR   MMRRC; MMRRC:008208-UCD
DR   Wikidata; Q54785520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685055; Dusp27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG237
AC   CVCL_PT58
SY   XG237
DR   MMRRC; MMRRC:008209-UCD
DR   Wikidata; Q54785523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG239
AC   CVCL_PT59
SY   XG239
DR   MMRRC; MMRRC:008210-UCD
DR   Wikidata; Q54785525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG240
AC   CVCL_PT60
SY   XG240
DR   MMRRC; MMRRC:008211-UCD
DR   Wikidata; Q54785526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG241
AC   CVCL_PT61
SY   XG241
DR   MMRRC; MMRRC:008212-UCD
DR   Wikidata; Q54785528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682313; Zfp335.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG243
AC   CVCL_PT62
SY   XG243
DR   MMRRC; MMRRC:008213-UCD
DR   Wikidata; Q54785578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG248
AC   CVCL_PT63
SY   XG248
DR   MMRRC; MMRRC:008214-UCD
DR   Wikidata; Q54785579
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915403; Gtf2e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG252
AC   CVCL_PT64
SY   XG252
DR   MMRRC; MMRRC:008215-UCD
DR   Wikidata; Q54785581
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915127; Naa20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG253
AC   CVCL_PT65
SY   XG253
DR   MMRRC; MMRRC:008216-UCD
DR   Wikidata; Q54785583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97578; Phkb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG255
AC   CVCL_PT66
SY   XG255
DR   MMRRC; MMRRC:008217-UCD
DR   Wikidata; Q54785585
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106095; Naca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG257
AC   CVCL_PT67
SY   XG257
DR   MMRRC; MMRRC:008218-UCD
DR   Wikidata; Q54785587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG260
AC   CVCL_PT68
SY   XG260
DR   MMRRC; MMRRC:008220-UCD
DR   Wikidata; Q54785590
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG262
AC   CVCL_PT69
SY   XG262
DR   MMRRC; MMRRC:008221-UCD
DR   Wikidata; Q54785592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG264
AC   CVCL_PT70
SY   XG264
DR   MMRRC; MMRRC:008222-UCD
DR   Wikidata; Q54785593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277166; Sp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG265
AC   CVCL_PT71
SY   XG265
DR   MMRRC; MMRRC:008223-UCD
DR   Wikidata; Q54785595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913411; Pop4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG266
AC   CVCL_PT72
SY   XG266
DR   MMRRC; MMRRC:008224-UCD
DR   Wikidata; Q54785597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915120; Enoph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG268
AC   CVCL_PT73
SY   XG268
DR   MMRRC; MMRRC:008225-UCD
DR   Wikidata; Q54785599
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924261; Ticrr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG269
AC   CVCL_PT74
SY   XG269
DR   MMRRC; MMRRC:008226-UCD
DR   Wikidata; Q54785601
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915120; Enoph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG270
AC   CVCL_PT75
SY   XG270
DR   MMRRC; MMRRC:008227-UCD
DR   Wikidata; Q54785603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135606; Pard6g.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG271
AC   CVCL_PT76
SY   XG271
DR   MMRRC; MMRRC:008228-UCD
DR   Wikidata; Q54785604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG273
AC   CVCL_PT77
SY   XG273
DR   MMRRC; MMRRC:008229-UCD
DR   Wikidata; Q54785607
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG274
AC   CVCL_PT78
SY   XG274
DR   MMRRC; MMRRC:008230-UCD
DR   Wikidata; Q54785608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915047; Snrnp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG278
AC   CVCL_PT79
SY   XG278
DR   MMRRC; MMRRC:008231-UCD
DR   Wikidata; Q54785610
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915986; Tyw5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG279
AC   CVCL_PT80
SY   XG279
DR   MMRRC; MMRRC:008232-UCD
DR   Wikidata; Q54785613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450166; Arhgap32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG280
AC   CVCL_PT81
SY   XG280
DR   MMRRC; MMRRC:008233-UCD
DR   Wikidata; Q54785615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921414; Nfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG281
AC   CVCL_PT82
SY   XG281
DR   MMRRC; MMRRC:008234-UCD
DR   Wikidata; Q54785618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG282
AC   CVCL_PT83
SY   XG282
DR   MMRRC; MMRRC:008235-UCD
DR   Wikidata; Q54785620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932404; Phip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG286
AC   CVCL_PT84
SY   XG286
DR   MMRRC; MMRRC:008236-UCD
DR   Wikidata; Q54785622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG289
AC   CVCL_PT85
SY   XG289
DR   MMRRC; MMRRC:008237-UCD
DR   Wikidata; Q54785624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920538; Vps50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG292
AC   CVCL_PT86
SY   XG292
DR   MMRRC; MMRRC:008238-UCD
DR   Wikidata; Q54785626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104819; Hnrnpa2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG293
AC   CVCL_PT87
SY   XG293
DR   MMRRC; MMRRC:008239-UCD
DR   Wikidata; Q54785628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104819; Hnrnpa2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG294
AC   CVCL_PT88
SY   XG294
DR   MMRRC; MMRRC:008240-UCD
DR   Wikidata; Q54785631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG298
AC   CVCL_PT89
SY   XG298
DR   MMRRC; MMRRC:008243-UCD
DR   Wikidata; Q54785632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859646; Golga4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG299
AC   CVCL_PT90
SY   XG299
DR   MMRRC; MMRRC:008244-UCD
DR   Wikidata; Q54785634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102581; Rdh11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG302
AC   CVCL_PT91
SY   XG302
DR   MMRRC; MMRRC:008245-UCD
DR   Wikidata; Q54785636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG303
AC   CVCL_PT92
SY   XG303
DR   MMRRC; MMRRC:008246-UCD
DR   Wikidata; Q54785637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918040; Ubr5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG304
AC   CVCL_PT93
SY   XG304
DR   MMRRC; MMRRC:008247-UCD
DR   Wikidata; Q54785639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG307
AC   CVCL_PT94
SY   XG307
DR   MMRRC; MMRRC:008248-UCD
DR   Wikidata; Q54785640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919837; Pan3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG309
AC   CVCL_PT95
SY   XG309
DR   MMRRC; MMRRC:008249-UCD
DR   Wikidata; Q54785642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2687042; Ppp1r37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG310
AC   CVCL_PT96
SY   XG310
DR   MMRRC; MMRRC:008250-UCD
DR   Wikidata; Q54785645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681840; Rsl24d1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG311
AC   CVCL_PT97
SY   XG311
DR   MMRRC; MMRRC:008251-UCD
DR   Wikidata; Q54785646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG312
AC   CVCL_PT98
SY   XG312
DR   MMRRC; MMRRC:008252-UCD
DR   Wikidata; Q54785648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG315
AC   CVCL_PT99
SY   XG315
DR   MMRRC; MMRRC:008254-UCD
DR   Wikidata; Q54785651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448487; Fam168b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG316
AC   CVCL_PU00
SY   XG316
DR   MMRRC; MMRRC:008255-UCD
DR   Wikidata; Q54785653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140050; Ints3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG320
AC   CVCL_PU01
SY   XG320
DR   MMRRC; MMRRC:008257-UCD
DR   Wikidata; Q54785656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3780541; Lncenc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG322
AC   CVCL_PU02
SY   XG322
DR   MMRRC; MMRRC:008258-UCD
DR   Wikidata; Q54785705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG323
AC   CVCL_PU03
SY   XG323
DR   MMRRC; MMRRC:008259-UCD
DR   Wikidata; Q54785706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926082; Cacul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG324
AC   CVCL_PU04
SY   XG324
DR   MMRRC; MMRRC:008260-UCD
DR   Wikidata; Q54785707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG326
AC   CVCL_PU05
SY   XG326
DR   MMRRC; MMRRC:008261-UCD
DR   Wikidata; Q54785710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919369; Tpx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG329
AC   CVCL_PU06
SY   XG329
DR   MMRRC; MMRRC:008263-UCD
DR   Wikidata; Q54785713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG334
AC   CVCL_PU07
SY   XG334
DR   MMRRC; MMRRC:008265-UCD
DR   Wikidata; Q54785714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891037; Mtrr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG335
AC   CVCL_PU08
SY   XG335
DR   MMRRC; MMRRC:008266-UCD
DR   Wikidata; Q54785716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913721; Anp32e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG337
AC   CVCL_PU09
SY   XG337
DR   MMRRC; MMRRC:008267-UCD
DR   Wikidata; Q54785717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921694; Tasor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XG339
AC   CVCL_PU10
SY   XG339
DR   MMRRC; MMRRC:008268-UCD
DR   Wikidata; Q54785719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914869; Nob1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG349
AC   CVCL_PU11
SY   XG349
DR   MMRRC; MMRRC:008270-UCD
DR   Wikidata; Q54785721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139746; Ankrd13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG352
AC   CVCL_PU12
SY   XG352
DR   MMRRC; MMRRC:008271-UCD
DR   Wikidata; Q54785724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG355
AC   CVCL_PU13
SY   XG355
DR   MMRRC; MMRRC:008273-UCD
DR   Wikidata; Q54785725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918047; Ankib1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG358
AC   CVCL_PU14
SY   XG358
DR   MMRRC; MMRRC:008274-UCD
DR   Wikidata; Q54785727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142808; Cog4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG362
AC   CVCL_PU15
SY   XG362
DR   MMRRC; MMRRC:008275-UCD
DR   Wikidata; Q54785729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351663; Skp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG364
AC   CVCL_PU16
SY   XG364
DR   MMRRC; MMRRC:008276-UCD
DR   Wikidata; Q54785730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101884; Ppard.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG365
AC   CVCL_PU17
SY   XG365
DR   MMRRC; MMRRC:008277-UCD
DR   Wikidata; Q54785731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG366
AC   CVCL_PU18
SY   XG366
DR   MMRRC; MMRRC:008278-UCD
DR   Wikidata; Q54785733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921409; Acbd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG368
AC   CVCL_PU19
SY   XG368
DR   MMRRC; MMRRC:008279-UCD
DR   Wikidata; Q54785736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444248; Gcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XG369
AC   CVCL_PU20
SY   XG369
DR   MMRRC; MMRRC:008280-UCD
DR   Wikidata; Q54785738
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107403; Clk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG370
AC   CVCL_PU21
SY   XG370
DR   MMRRC; MMRRC:008281-UCD
DR   Wikidata; Q54785741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107307; Ing4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG371
AC   CVCL_PU22
SY   XG371
DR   MMRRC; MMRRC:008282-UCD
DR   Wikidata; Q54785744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444804; Bod1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG372
AC   CVCL_PU23
SY   XG372
DR   MMRRC; MMRRC:008283-UCD
DR   Wikidata; Q54785745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG373
AC   CVCL_PU24
SY   XG373
DR   MMRRC; MMRRC:008284-UCD
DR   Wikidata; Q54785746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG374
AC   CVCL_PU25
SY   XG374
DR   MMRRC; MMRRC:008285-UCD
DR   Wikidata; Q54785750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934811; Nucks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG375
AC   CVCL_PU26
SY   XG375
DR   MMRRC; MMRRC:008286-UCD
DR   Wikidata; Q54785753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3040703; Zfp874a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG376
AC   CVCL_PU27
SY   XG376
DR   MMRRC; MMRRC:008287-UCD
DR   Wikidata; Q54785754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3040703; Zfp874a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG378
AC   CVCL_PU28
SY   XG378
DR   MMRRC; MMRRC:008288-UCD
DR   Wikidata; Q54785756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927347; Smarce1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG379
AC   CVCL_PU29
SY   XG379
DR   MMRRC; MMRRC:008289-UCD
DR   Wikidata; Q54785758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG381
AC   CVCL_PU30
SY   XG381
DR   MMRRC; MMRRC:008290-UCD
DR   Wikidata; Q54785760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915589; Ccdc88c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG383
AC   CVCL_PU31
SY   XG383
DR   MMRRC; MMRRC:008291-UCD
DR   Wikidata; Q54785761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449313; Gemin4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG385
AC   CVCL_PU32
SY   XG385
DR   MMRRC; MMRRC:008292-UCD
DR   Wikidata; Q54785764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145578; Slain1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG386
AC   CVCL_PU33
SY   XG386
DR   MMRRC; MMRRC:008293-UCD
DR   Wikidata; Q54785765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183691; Nav2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG389
AC   CVCL_PU34
SY   XG389
DR   MMRRC; MMRRC:008294-UCD
DR   Wikidata; Q54785766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933185; Ctps2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG390
AC   CVCL_PU35
SY   XG390
DR   MMRRC; MMRRC:008295-UCD
DR   Wikidata; Q54785768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918413; Zfp626.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG391
AC   CVCL_PU36
SY   XG391
DR   MMRRC; MMRRC:008296-UCD
DR   Wikidata; Q54785769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924315; Ints7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG418
AC   CVCL_PU37
SY   XG418
DR   MMRRC; MMRRC:008298-UCD
DR   Wikidata; Q54785772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95728; Gli2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG426
AC   CVCL_PU38
SY   XG426
DR   MMRRC; MMRRC:008300-UCD
DR   Wikidata; Q54785773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG429
AC   CVCL_PU39
SY   XG429
DR   MMRRC; MMRRC:008302-UCD
DR   Wikidata; Q54785776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928469; Trip4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG431
AC   CVCL_PU40
SY   XG431
DR   MMRRC; MMRRC:008303-UCD
DR   Wikidata; Q54785778
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG434
AC   CVCL_PU41
SY   XG434
DR   MMRRC; MMRRC:008304-UCD
DR   Wikidata; Q54785780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG435
AC   CVCL_PU42
SY   XG435
DR   MMRRC; MMRRC:008305-UCD
DR   Wikidata; Q54785840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387357; Wac.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG438
AC   CVCL_PU43
SY   XG438
DR   MMRRC; MMRRC:008306-UCD
DR   Wikidata; Q54785841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106594; Gk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG442
AC   CVCL_PU44
SY   XG442
DR   MMRRC; MMRRC:008308-UCD
DR   Wikidata; Q54785844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444343; Nbeal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG445
AC   CVCL_PU45
SY   XG445
DR   MMRRC; MMRRC:008309-UCD
DR   Wikidata; Q54785847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96245; Hspa9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG446
AC   CVCL_PU46
SY   XG446
DR   MMRRC; MMRRC:008310-UCD
DR   Wikidata; Q54785848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929494; Arhgap35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG447
AC   CVCL_PU47
SY   XG447
DR   MMRRC; MMRRC:008311-UCD
DR   Wikidata; Q54785849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926048; Eml4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG451
AC   CVCL_PU48
SY   XG451
DR   MMRRC; MMRRC:008313-UCD
DR   Wikidata; Q54785851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107726; Supt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG453
AC   CVCL_PU49
SY   XG453
DR   MMRRC; MMRRC:008314-UCD
DR   Wikidata; Q54785855
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100510; Bub1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG454
AC   CVCL_PU50
SY   XG454
DR   MMRRC; MMRRC:008315-UCD
DR   Wikidata; Q54785856
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG456
AC   CVCL_PU51
SY   XG456
DR   MMRRC; MMRRC:008316-UCD
DR   Wikidata; Q54785857
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916327; Psmd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG458
AC   CVCL_PU52
SY   XG458
DR   MMRRC; MMRRC:008317-UCD
DR   Wikidata; Q54785858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG460
AC   CVCL_PU53
SY   XG460
DR   MMRRC; MMRRC:008318-UCD
DR   Wikidata; Q54785860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109584; Prpf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG461
AC   CVCL_PU54
SY   XG461
DR   MMRRC; MMRRC:008319-UCD
DR   Wikidata; Q54785863
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG464
AC   CVCL_PU55
SY   XG464
DR   MMRRC; MMRRC:008321-UCD
DR   Wikidata; Q54785865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354755; Fbxo15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG466
AC   CVCL_PU56
SY   XG466
DR   MMRRC; MMRRC:008322-UCD
DR   Wikidata; Q54785867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG468
AC   CVCL_PU57
SY   XG468
DR   MMRRC; MMRRC:008323-UCD
DR   Wikidata; Q54785870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG469
AC   CVCL_PU58
SY   XG469
DR   MMRRC; MMRRC:008324-UCD
DR   Wikidata; Q54785871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180003; Xpnpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG470
AC   CVCL_PU59
SY   XG470
DR   MMRRC; MMRRC:008325-UCD
DR   Wikidata; Q54785873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913915; Msantd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG471
AC   CVCL_PU60
SY   XG471
DR   MMRRC; MMRRC:008326-UCD
DR   Wikidata; Q54785876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG476
AC   CVCL_PU61
SY   XG476
DR   MMRRC; MMRRC:008328-UCD
DR   Wikidata; Q54785877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928375; Arpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG478
AC   CVCL_PU62
SY   XG478
DR   MMRRC; MMRRC:008330-UCD
DR   Wikidata; Q54785881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG481
AC   CVCL_PU63
SY   XG481
DR   MMRRC; MMRRC:008331-UCD
DR   Wikidata; Q54785883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924337; Ankrd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG485
AC   CVCL_PU64
SY   XG485
DR   MMRRC; MMRRC:008333-UCD
DR   Wikidata; Q54785885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88407; Ckb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG488
AC   CVCL_PU65
SY   XG488
DR   MMRRC; MMRRC:008334-UCD
DR   Wikidata; Q54785886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354713; Acsl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG492
AC   CVCL_PU66
SY   XG492
DR   MMRRC; MMRRC:008335-UCD
DR   Wikidata; Q54785889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921453; Eif4enif1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG493
AC   CVCL_PU67
SY   XG493
DR   MMRRC; MMRRC:008336-UCD
DR   Wikidata; Q54785891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3029414; Brwd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG494
AC   CVCL_PU68
SY   XG494
DR   MMRRC; MMRRC:008337-UCD
DR   Wikidata; Q54785894
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG495
AC   CVCL_PU69
SY   XG495
DR   MMRRC; MMRRC:008338-UCD
DR   Wikidata; Q54785896
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914394; Lrrc40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG496
AC   CVCL_PU70
SY   XG496
DR   MMRRC; MMRRC:008339-UCD
DR   Wikidata; Q54785897
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196373; Reps1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG499
AC   CVCL_PU71
SY   XG499
DR   MMRRC; MMRRC:008340-UCD
DR   Wikidata; Q54785898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139764; Sec24b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG500
AC   CVCL_PU72
SY   XG500
DR   MMRRC; MMRRC:008341-UCD
DR   Wikidata; Q54785902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103007; Epb41l4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG501
AC   CVCL_PU73
SY   XG501
DR   MMRRC; MMRRC:008342-UCD
DR   Wikidata; Q54785904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926950; Zfp236.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG502
AC   CVCL_PU74
SY   XG502
DR   MMRRC; MMRRC:008343-UCD
DR   Wikidata; Q54785905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99542; Usf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG506
AC   CVCL_PU75
SY   XG506
DR   MMRRC; MMRRC:008344-UCD
DR   Wikidata; Q54785906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG507
AC   CVCL_PU76
SY   XG507
DR   MMRRC; MMRRC:008345-UCD
DR   Wikidata; Q54785907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924049; Tmem234.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG510
AC   CVCL_PU77
SY   XG510
DR   MMRRC; MMRRC:008346-UCD
DR   Wikidata; Q54785910
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347053; Git2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG512
AC   CVCL_PU78
SY   XG512
DR   MMRRC; MMRRC:008347-UCD
DR   Wikidata; Q54785913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG514
AC   CVCL_PU79
SY   XG514
DR   MMRRC; MMRRC:008348-UCD
DR   Wikidata; Q54785914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917497; Psmd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG515
AC   CVCL_PU80
SY   XG515
DR   MMRRC; MMRRC:008349-UCD
DR   Wikidata; Q54785915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860493; Arhgef7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG518
AC   CVCL_PU81
SY   XG518
DR   MMRRC; MMRRC:008350-UCD
DR   Wikidata; Q54785916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347053; Git2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG519
AC   CVCL_PU82
SY   XG519
DR   MMRRC; MMRRC:008351-UCD
DR   Wikidata; Q54786022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913993; Rnf220.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG520
AC   CVCL_PU83
SY   XG520
DR   MMRRC; MMRRC:008352-UCD
DR   Wikidata; Q54786024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG521
AC   CVCL_PU84
SY   XG521
DR   MMRRC; MMRRC:008353-UCD
DR   Wikidata; Q54786026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138982; Znfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG523
AC   CVCL_PU85
SY   XG523
DR   MMRRC; MMRRC:008354-UCD
DR   Wikidata; Q54786028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892979; Chm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG525
AC   CVCL_PU86
SY   XG525
DR   MMRRC; MMRRC:008355-UCD
DR   Wikidata; Q54786030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441773; Pcmtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG527
AC   CVCL_PU87
SY   XG527
DR   MMRRC; MMRRC:008357-UCD
DR   Wikidata; Q54786032
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107595; Sp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG533
AC   CVCL_PU88
SY   XG533
DR   MMRRC; MMRRC:008359-UCD
DR   Wikidata; Q54786037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG537
AC   CVCL_PU89
SY   XG537
DR   MMRRC; MMRRC:008361-UCD
DR   Wikidata; Q54786039
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443272; B230354K17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG543
AC   CVCL_PU90
SY   XG543
DR   MMRRC; MMRRC:008364-UCD
DR   Wikidata; Q54786041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344313; Zeb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG550
AC   CVCL_PU91
SY   XG550
DR   MMRRC; MMRRC:008366-UCD
DR   Wikidata; Q54786043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384761; Rapgef6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG552
AC   CVCL_PU92
SY   XG552
DR   MMRRC; MMRRC:008368-UCD
DR   Wikidata; Q54786045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894652; Usp10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG556
AC   CVCL_PU93
SY   XG556
DR   MMRRC; MMRRC:008369-UCD
DR   Wikidata; Q54786047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442372; Fam168a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG557
AC   CVCL_PU94
SY   XG557
DR   MMRRC; MMRRC:008370-UCD
DR   Wikidata; Q54786048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384909; Micu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG558
AC   CVCL_PU95
SY   XG558
DR   MMRRC; MMRRC:008371-UCD
DR   Wikidata; Q54786051
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917275; Acot7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG561
AC   CVCL_PU96
SY   XG561
DR   MMRRC; MMRRC:008372-UCD
DR   Wikidata; Q54786053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333879; Ap3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG563
AC   CVCL_PU97
SY   XG563
DR   MMRRC; MMRRC:008373-UCD
DR   Wikidata; Q54786055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924281; Slc9a8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG564
AC   CVCL_PU98
SY   XG564
DR   MMRRC; MMRRC:008374-UCD
DR   Wikidata; Q54786056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920362; Abracl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG565
AC   CVCL_PU99
SY   XG565
DR   MMRRC; MMRRC:008375-UCD
DR   Wikidata; Q54786057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88451; Col18a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG567
AC   CVCL_PV00
SY   XG567
DR   MMRRC; MMRRC:008376-UCD
DR   Wikidata; Q54786058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924281; Slc9a8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG571
AC   CVCL_PV01
SY   XG571
DR   MMRRC; MMRRC:008379-UCD
DR   Wikidata; Q54786061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916218; Cdan1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG578
AC   CVCL_PV02
SY   XG578
DR   MMRRC; MMRRC:008381-UCD
DR   Wikidata; Q54786063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921382; Rnf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG586
AC   CVCL_PV03
SY   XG586
DR   MMRRC; MMRRC:008383-UCD
DR   Wikidata; Q54786064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919847; Auts2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG587
AC   CVCL_PV04
SY   XG587
DR   MMRRC; MMRRC:008384-UCD
DR   Wikidata; Q54786067
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344380; Chd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG588
AC   CVCL_PV05
SY   XG588
DR   MMRRC; MMRRC:008385-UCD
DR   Wikidata; Q54786070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG591
AC   CVCL_PV06
SY   XG591
DR   MMRRC; MMRRC:008386-UCD
DR   Wikidata; Q54786072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG592
AC   CVCL_PV07
SY   XG592
DR   MMRRC; MMRRC:008387-UCD
DR   Wikidata; Q54786075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG593
AC   CVCL_PV08
SY   XG593
DR   MMRRC; MMRRC:008388-UCD
DR   Wikidata; Q54786078
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106613; Dvl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG595
AC   CVCL_PV09
SY   XG595
DR   MMRRC; MMRRC:008389-UCD
DR   Wikidata; Q54786079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890577; Srsf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG597
AC   CVCL_PV10
SY   XG597
DR   MMRRC; MMRRC:008390-UCD
DR   Wikidata; Q54786081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG598
AC   CVCL_PV11
SY   XG598
DR   MMRRC; MMRRC:008391-UCD
DR   Wikidata; Q54786084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG599
AC   CVCL_PV12
SY   XG599
DR   MMRRC; MMRRC:008392-UCD
DR   Wikidata; Q54786086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153887; Eri3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG600
AC   CVCL_PV13
SY   XG600
DR   MMRRC; MMRRC:008393-UCD
DR   Wikidata; Q54786089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914176; Trmt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG602
AC   CVCL_PV14
SY   XG602
DR   MMRRC; MMRRC:008395-UCD
DR   Wikidata; Q54786091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG604
AC   CVCL_PV15
SY   XG604
DR   MMRRC; MMRRC:008396-UCD
DR   Wikidata; Q54786094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914357; Ankrd12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG606
AC   CVCL_PV16
SY   XG606
DR   MMRRC; MMRRC:008397-UCD
DR   Wikidata; Q54786096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443306; Tom1l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG607
AC   CVCL_PV17
SY   XG607
DR   MMRRC; MMRRC:008398-UCD
DR   Wikidata; Q54786097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG608
AC   CVCL_PV18
SY   XG608
DR   MMRRC; MMRRC:008399-UCD
DR   Wikidata; Q54786099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916455; Zfp748.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG611
AC   CVCL_PV19
SY   XG611
DR   MMRRC; MMRRC:008400-UCD
DR   Wikidata; Q54786100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95757; Slc2a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG614
AC   CVCL_PV20
SY   XG614
DR   MMRRC; MMRRC:008401-UCD
DR   Wikidata; Q54786103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682305; Rsf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG616
AC   CVCL_PV21
SY   XG616
DR   MMRRC; MMRRC:008402-UCD
DR   Wikidata; Q54786104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682305; Rsf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG621
AC   CVCL_PV22
SY   XG621
DR   MMRRC; MMRRC:008404-UCD
DR   Wikidata; Q54786154
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG623
AC   CVCL_PV23
SY   XG623
DR   MMRRC; MMRRC:008405-UCD
DR   Wikidata; Q54786156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915301; Nutf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG637
AC   CVCL_PV24
SY   XG637
DR   MMRRC; MMRRC:008407-UCD
DR   Wikidata; Q54786157
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG638
AC   CVCL_PV25
SY   XG638
DR   MMRRC; MMRRC:008408-UCD
DR   Wikidata; Q54786161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921285; Nol9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG639
AC   CVCL_PV26
SY   XG639
DR   MMRRC; MMRRC:008409-UCD
DR   Wikidata; Q54786164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95654; Gart.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG643
AC   CVCL_PV27
SY   XG643
DR   MMRRC; MMRRC:008410-UCD
DR   Wikidata; Q54786165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG647
AC   CVCL_PV28
SY   XG647
DR   MMRRC; MMRRC:008411-UCD
DR   Wikidata; Q54786168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG649
AC   CVCL_PV29
SY   XG649
DR   MMRRC; MMRRC:008412-UCD
DR   Wikidata; Q54786169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG653
AC   CVCL_PV30
SY   XG653
DR   MMRRC; MMRRC:008415-UCD
DR   Wikidata; Q54786172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG654
AC   CVCL_PV31
SY   XG654
DR   MMRRC; MMRRC:008416-UCD
DR   Wikidata; Q54786174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG655
AC   CVCL_PV32
SY   XG655
DR   MMRRC; MMRRC:008417-UCD
DR   Wikidata; Q54786176
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG656
AC   CVCL_PV33
SY   XG656
DR   MMRRC; MMRRC:008418-UCD
DR   Wikidata; Q54786178
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344415; Dmtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG661
AC   CVCL_PV34
SY   XG661
DR   MMRRC; MMRRC:008422-UCD
DR   Wikidata; Q54786182
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924049; Tmem234.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG664
AC   CVCL_PV35
SY   XG664
DR   MMRRC; MMRRC:008424-UCD
DR   Wikidata; Q54786183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG665
AC   CVCL_PV36
SY   XG665
DR   MMRRC; MMRRC:008425-UCD
DR   Wikidata; Q54786185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922083; Ciapin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG667
AC   CVCL_PV37
SY   XG667
DR   MMRRC; MMRRC:008426-UCD
DR   Wikidata; Q54786188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921382; Rnf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG668
AC   CVCL_PV38
SY   XG668
DR   MMRRC; MMRRC:008427-UCD
DR   Wikidata; Q54786191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103239; Tfap4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG669
AC   CVCL_PV39
SY   XG669
DR   MMRRC; MMRRC:008428-UCD
DR   Wikidata; Q54786193
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88071; Arnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG670
AC   CVCL_PV40
SY   XG670
DR   MMRRC; MMRRC:008429-UCD
DR   Wikidata; Q54786195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914185; Cir1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG677
AC   CVCL_PV41
SY   XG677
DR   MMRRC; MMRRC:008431-UCD
DR   Wikidata; Q54786196
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95390; En2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG682
AC   CVCL_PV42
SY   XG682
DR   MMRRC; MMRRC:008432-UCD
DR   Wikidata; Q54786198
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1306795; Akap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG691
AC   CVCL_PV43
SY   XG691
DR   MMRRC; MMRRC:008434-UCD
DR   Wikidata; Q54786199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894697; Rad54l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG694
AC   CVCL_PV44
SY   XG694
DR   MMRRC; MMRRC:008435-UCD
DR   Wikidata; Q54786204
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106913; Abi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG696
AC   CVCL_PV45
SY   XG696
DR   MMRRC; MMRRC:008436-UCD
DR   Wikidata; Q54786205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG697
AC   CVCL_PV46
SY   XG697
DR   MMRRC; MMRRC:008437-UCD
DR   Wikidata; Q54786208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153608; Ube2j2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG698
AC   CVCL_PV47
SY   XG698
DR   MMRRC; MMRRC:008438-UCD
DR   Wikidata; Q54786210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99147; Yes1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG702
AC   CVCL_PV48
SY   XG702
DR   MMRRC; MMRRC:008440-UCD
DR   Wikidata; Q54786212
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891748; Maea.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG708
AC   CVCL_PV49
SY   XG708
DR   MMRRC; MMRRC:008441-UCD
DR   Wikidata; Q54786214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919224; Prmt3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG716
AC   CVCL_PV50
SY   XG716
DR   MMRRC; MMRRC:008444-UCD
DR   Wikidata; Q54786215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182472; Tpcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG718
AC   CVCL_PV51
SY   XG718
DR   MMRRC; MMRRC:008445-UCD
DR   Wikidata; Q54786217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445094; Plekha7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG725
AC   CVCL_PV52
SY   XG725
DR   MMRRC; MMRRC:008446-UCD
DR   Wikidata; Q54786218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915120; Enoph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG732
AC   CVCL_PV53
SY   XG732
DR   MMRRC; MMRRC:008448-UCD
DR   Wikidata; Q54786221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919055; Nup93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG733
AC   CVCL_PV54
SY   XG733
DR   MMRRC; MMRRC:008449-UCD
DR   Wikidata; Q54786223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919055; Nup93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG734
AC   CVCL_PV55
SY   XG734
DR   MMRRC; MMRRC:008450-UCD
DR   Wikidata; Q54786224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343489; Mpdz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG736
AC   CVCL_PV56
SY   XG736
DR   MMRRC; MMRRC:008451-UCD
DR   Wikidata; Q54786226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG740
AC   CVCL_PV57
SY   XG740
DR   MMRRC; MMRRC:008453-UCD
DR   Wikidata; Q54786229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3028576; Dhx37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG743
AC   CVCL_PV58
SY   XG743
DR   MMRRC; MMRRC:008454-UCD
DR   Wikidata; Q54786231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918817; Mcm9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG745
AC   CVCL_PV59
SY   XG745
DR   MMRRC; MMRRC:008455-UCD
DR   Wikidata; Q54786233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105050; Mtf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG748
AC   CVCL_PV60
SY   XG748
DR   MMRRC; MMRRC:008456-UCD
DR   Wikidata; Q54786235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99695; Cttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG752
AC   CVCL_PV61
SY   XG752
DR   MMRRC; MMRRC:008458-UCD
DR   Wikidata; Q54786237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145578; Slain1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG753
AC   CVCL_PV62
SY   XG753
DR   MMRRC; MMRRC:008459-UCD
DR   Wikidata; Q54786285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG754
AC   CVCL_PV63
SY   XG754
DR   MMRRC; MMRRC:008460-UCD
DR   Wikidata; Q54786288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2450166; Arhgap32.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG755
AC   CVCL_PV64
SY   XG755
DR   MMRRC; MMRRC:008461-UCD
DR   Wikidata; Q54786289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858202; Rab11a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG756
AC   CVCL_PV65
SY   XG756
DR   MMRRC; MMRRC:008462-UCD
DR   Wikidata; Q54786290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859646; Golga4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG757
AC   CVCL_PV66
SY   XG757
DR   MMRRC; MMRRC:008463-UCD
DR   Wikidata; Q54786294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137336; Baiap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG759
AC   CVCL_PV67
SY   XG759
DR   MMRRC; MMRRC:008464-UCD
DR   Wikidata; Q54786296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442211; Prrg4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG765
AC   CVCL_PV68
SY   XG765
DR   MMRRC; MMRRC:008465-UCD
DR   Wikidata; Q54786298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929706; Ranbp17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG769
AC   CVCL_PV69
SY   XG769
DR   MMRRC; MMRRC:008467-UCD
DR   Wikidata; Q54786299
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338801; Cyfip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG772
AC   CVCL_PV70
SY   XG772
DR   MMRRC; MMRRC:008468-UCD
DR   Wikidata; Q54786303
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153049; Klf16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG775
AC   CVCL_PV71
SY   XG775
DR   MMRRC; MMRRC:008469-UCD
DR   Wikidata; Q54786305
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443300; Cpped1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG778
AC   CVCL_PV72
SY   XG778
DR   MMRRC; MMRRC:008470-UCD
DR   Wikidata; Q54786307
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107726; Supt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG785
AC   CVCL_PV73
SY   XG785
DR   MMRRC; MMRRC:008471-UCD
DR   Wikidata; Q54786310
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG788
AC   CVCL_PV74
SY   XG788
DR   MMRRC; MMRRC:008473-UCD
DR   Wikidata; Q54786311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG792
AC   CVCL_PV75
SY   XG792
DR   MMRRC; MMRRC:008474-UCD
DR   Wikidata; Q54786314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913565; Senp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG797
AC   CVCL_PV76
SY   XG797
DR   MMRRC; MMRRC:008475-UCD
DR   Wikidata; Q54786317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927222; Diaph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG801
AC   CVCL_PV77
SY   XG801
DR   MMRRC; MMRRC:008476-UCD
DR   Wikidata; Q54786318
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894313; Rab6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG803
AC   CVCL_PV78
SY   XG803
DR   MMRRC; MMRRC:008477-UCD
DR   Wikidata; Q54786321
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98241; Stmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG804
AC   CVCL_PV79
SY   XG804
DR   MMRRC; MMRRC:008478-UCD
DR   Wikidata; Q54786322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913809; Metap1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG806
AC   CVCL_PV80
SY   XG806
DR   MMRRC; MMRRC:008479-UCD
DR   Wikidata; Q54786325
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99532; Mef2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG809
AC   CVCL_PV81
SY   XG809
DR   MMRRC; MMRRC:008481-UCD
DR   Wikidata; Q54786326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344415; Dmtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG813
AC   CVCL_PV82
SY   XG813
DR   MMRRC; MMRRC:008483-UCD
DR   Wikidata; Q54786328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333879; Ap3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG814
AC   CVCL_PV83
SY   XG814
DR   MMRRC; MMRRC:008484-UCD
DR   Wikidata; Q54786330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920453; Zzz3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG815
AC   CVCL_PV84
SY   XG815
DR   MMRRC; MMRRC:008485-UCD
DR   Wikidata; Q54786332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890393; Zfp277.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG816
AC   CVCL_PV85
SY   XG816
DR   MMRRC; MMRRC:008486-UCD
DR   Wikidata; Q54786334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923484; Magi3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG817
AC   CVCL_PV86
SY   XG817
DR   MMRRC; MMRRC:008487-UCD
DR   Wikidata; Q54786337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99542; Usf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG818
AC   CVCL_PV87
SY   XG818
DR   MMRRC; MMRRC:008488-UCD
DR   Wikidata; Q54786340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105066; Rab10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG821
AC   CVCL_PV88
SY   XG821
DR   MMRRC; MMRRC:008489-UCD
DR   Wikidata; Q54786342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG823
AC   CVCL_PV89
SY   XG823
DR   MMRRC; MMRRC:008490-UCD
DR   Wikidata; Q54786345
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102670; Ddx4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG830
AC   CVCL_PV90
SY   XG830
DR   MMRRC; MMRRC:008491-UCD
DR   Wikidata; Q54786347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99542; Usf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG831
AC   CVCL_PV91
SY   XG831
DR   MMRRC; MMRRC:008492-UCD
DR   Wikidata; Q54786348
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG833
AC   CVCL_PV92
SY   XG833
DR   MMRRC; MMRRC:008493-UCD
DR   Wikidata; Q54786350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3647701; Gm9222.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG836
AC   CVCL_PV93
SY   XG836
DR   MMRRC; MMRRC:008495-UCD
DR   Wikidata; Q54786352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88353; Cdk11b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG839
AC   CVCL_PV94
SY   XG839
DR   MMRRC; MMRRC:008497-UCD
DR   Wikidata; Q54786354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108515; Cbx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG841
AC   CVCL_PV95
SY   XG841
DR   MMRRC; MMRRC:008498-UCD
DR   Wikidata; Q54786355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104557; Rps6ka3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG843
AC   CVCL_PV96
SY   XG843
DR   MMRRC; MMRRC:008499-UCD
DR   Wikidata; Q54786357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG846
AC   CVCL_PV97
SY   XG846
DR   MMRRC; MMRRC:008500-UCD
DR   Wikidata; Q54786361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG847
AC   CVCL_PV98
SY   XG847
DR   MMRRC; MMRRC:008501-UCD
DR   Wikidata; Q54786362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107185; Cct5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG848
AC   CVCL_PV99
SY   XG848
DR   MMRRC; MMRRC:008502-UCD
DR   Wikidata; Q54786365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933947; Rtn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG849
AC   CVCL_PW00
SY   XG849
DR   MMRRC; MMRRC:008503-UCD
DR   Wikidata; Q54786367
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG853
AC   CVCL_PW01
SY   XG853
DR   MMRRC; MMRRC:008505-UCD
DR   Wikidata; Q54786369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG856
AC   CVCL_PW02
SY   XG856
DR   MMRRC; MMRRC:008506-UCD
DR   Wikidata; Q54786412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202400; Supt5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG862
AC   CVCL_PW03
SY   XG862
DR   MMRRC; MMRRC:008508-UCD
DR   Wikidata; Q54786413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG866
AC   CVCL_PW04
SY   XG866
DR   MMRRC; MMRRC:008510-UCD
DR   Wikidata; Q54786416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923046; Cdyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG868
AC   CVCL_PW05
SY   XG868
DR   MMRRC; MMRRC:008511-UCD
DR   Wikidata; Q54786418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG870
AC   CVCL_PW06
SY   XG870
DR   MMRRC; MMRRC:008512-UCD
DR   Wikidata; Q54786419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3647701; Gm9222.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG873
AC   CVCL_PW07
SY   XG873
DR   MMRRC; MMRRC:008514-UCD
DR   Wikidata; Q54786423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG876
AC   CVCL_PW08
SY   XG876
DR   MMRRC; MMRRC:008515-UCD
DR   Wikidata; Q54786424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915342; Ncbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG877
AC   CVCL_PW09
SY   XG877
DR   MMRRC; MMRRC:008516-UCD
DR   Wikidata; Q54786428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107605; Npat.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG879
AC   CVCL_PW10
SY   XG879
DR   MMRRC; MMRRC:008517-UCD
DR   Wikidata; Q54786431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG881
AC   CVCL_PW11
SY   XG881
DR   MMRRC; MMRRC:008518-UCD
DR   Wikidata; Q54786432
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96245; Hspa9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG883
AC   CVCL_PW12
SY   XG883
DR   MMRRC; MMRRC:008519-UCD
DR   Wikidata; Q54786435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96245; Hspa9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG885
AC   CVCL_PW13
SY   XG885
DR   MMRRC; MMRRC:008520-UCD
DR   Wikidata; Q54786437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145219; Iars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG888
AC   CVCL_PW14
SY   XG888
DR   MMRRC; MMRRC:008522-UCD
DR   Wikidata; Q54786438
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG889
AC   CVCL_PW15
SY   XG889
DR   MMRRC; MMRRC:008523-UCD
DR   Wikidata; Q54786440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336880; Eftud2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG898
AC   CVCL_PW16
SY   XG898
DR   MMRRC; MMRRC:008524-UCD
DR   Wikidata; Q54786442
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153887; Eri3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG901
AC   CVCL_PW17
SY   XG901
DR   MMRRC; MMRRC:008526-UCD
DR   Wikidata; Q54786443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923605; Tgds.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG905
AC   CVCL_PW18
SY   XG905
DR   MMRRC; MMRRC:008527-UCD
DR   Wikidata; Q54786445
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG908
AC   CVCL_PW19
SY   XG908
DR   MMRRC; MMRRC:008528-UCD
DR   Wikidata; Q54786447
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146005; Mtbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG909
AC   CVCL_PW20
SY   XG909
DR   MMRRC; MMRRC:008529-UCD
DR   Wikidata; Q54786449
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443306; Tom1l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG914
AC   CVCL_PW21
SY   XG914
DR   MMRRC; MMRRC:008530-UCD
DR   Wikidata; Q54786454
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG918
AC   CVCL_PW22
SY   XG918
DR   MMRRC; MMRRC:008532-UCD
DR   Wikidata; Q54786457
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103560; Kpna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG920
AC   CVCL_PW23
SY   XG920
DR   MMRRC; MMRRC:008533-UCD
DR   Wikidata; Q54786458
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448542; Samd4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG924
AC   CVCL_PW24
SY   XG924
DR   MMRRC; MMRRC:008534-UCD
DR   Wikidata; Q54786462
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153608; Ube2j2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG925
AC   CVCL_PW25
SY   XG925
DR   MMRRC; MMRRC:008535-UCD
DR   Wikidata; Q54786463
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106426; Tmem170.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG926
AC   CVCL_PW26
SY   XG926
DR   MMRRC; MMRRC:008536-UCD
DR   Wikidata; Q54786464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277958; Pcm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG930
AC   CVCL_PW27
SY   XG930
DR   MMRRC; MMRRC:008539-UCD
DR   Wikidata; Q54786466
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153608; Ube2j2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG931
AC   CVCL_PW28
SY   XG931
DR   MMRRC; MMRRC:008540-UCD
DR   Wikidata; Q54786470
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925212; Scaf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG934
AC   CVCL_PW29
SY   XG934
DR   MMRRC; MMRRC:008541-UCD
DR   Wikidata; Q54786473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG936
AC   CVCL_PW30
SY   XG936
DR   MMRRC; MMRRC:008542-UCD
DR   Wikidata; Q54786475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345144; Spry4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG941
AC   CVCL_PW31
SY   XG941
DR   MMRRC; MMRRC:008544-UCD
DR   Wikidata; Q54786478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923799; Cecr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG944
AC   CVCL_PW32
SY   XG944
DR   MMRRC; MMRRC:008545-UCD
DR   Wikidata; Q54786481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923784; Osbpl9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG945
AC   CVCL_PW33
SY   XG945
DR   MMRRC; MMRRC:008546-UCD
DR   Wikidata; Q54786483
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG947
AC   CVCL_PW34
SY   XG947
DR   MMRRC; MMRRC:008548-UCD
DR   Wikidata; Q54786486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277214; Septin11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XG948
AC   CVCL_PW35
SY   XG948
DR   MMRRC; MMRRC:008549-UCD
DR   Wikidata; Q54786487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG951
AC   CVCL_PW36
SY   XG951
DR   MMRRC; MMRRC:008550-UCD
DR   Wikidata; Q54786488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923455; Stard3nl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG955
AC   CVCL_PW37
SY   XG955
DR   MMRRC; MMRRC:008551-UCD
DR   Wikidata; Q54786491
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914556; Zc2hc1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG956
AC   CVCL_PW38
SY   XG956
DR   MMRRC; MMRRC:008552-UCD
DR   Wikidata; Q54786493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919942; Hnrnpll.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XG958
AC   CVCL_PW39
SY   XG958
DR   MMRRC; MMRRC:008553-UCD
DR   Wikidata; Q54786496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH001
AC   CVCL_PW40
SY   XH001
DR   MMRRC; MMRRC:008554-UCD
DR   Wikidata; Q54786497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88110; Atp2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH003
AC   CVCL_PW41
SY   XH003
DR   MMRRC; MMRRC:008555-UCD
DR   Wikidata; Q54786499
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354736; Kdm2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH004
AC   CVCL_PW42
SY   XH004
DR   MMRRC; MMRRC:008556-UCD
DR   Wikidata; Q54786538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182061; Usp7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH005
AC   CVCL_PW43
SY   XH005
DR   MMRRC; MMRRC:008557-UCD
DR   Wikidata; Q54786541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861100; Ubr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH007
AC   CVCL_PW44
SY   XH007
DR   MMRRC; MMRRC:008558-UCD
DR   Wikidata; Q54786542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919002; Gtf3c2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH008
AC   CVCL_PW45
SY   XH008
DR   MMRRC; MMRRC:008559-UCD
DR   Wikidata; Q54786545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927086; Ube4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH010
AC   CVCL_PW46
SY   XH010
DR   MMRRC; MMRRC:008560-UCD
DR   Wikidata; Q54786549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915010; Slc38a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH014
AC   CVCL_PW47
SY   XH014
DR   MMRRC; MMRRC:008561-UCD
DR   Wikidata; Q54786550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH017
AC   CVCL_PW48
SY   XH017
DR   MMRRC; MMRRC:008562-UCD
DR   Wikidata; Q54786552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH020
AC   CVCL_PW49
SY   XH020
DR   MMRRC; MMRRC:008563-UCD
DR   Wikidata; Q54786554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445220; Dcaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH022
AC   CVCL_PW50
SY   XH022
DR   MMRRC; MMRRC:008564-UCD
DR   Wikidata; Q54786556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919787; Cdca2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH024
AC   CVCL_PW51
SY   XH024
DR   MMRRC; MMRRC:008565-UCD
DR   Wikidata; Q54786559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH027
AC   CVCL_PW52
SY   XH027
DR   MMRRC; MMRRC:008566-UCD
DR   Wikidata; Q54786560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH028
AC   CVCL_PW53
SY   XH028
DR   MMRRC; MMRRC:008567-UCD
DR   Wikidata; Q54786562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH029
AC   CVCL_PW54
SY   XH029
DR   MMRRC; MMRRC:008568-UCD
DR   Wikidata; Q54786565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860236; Rabep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH031
AC   CVCL_PW55
SY   XH031
DR   MMRRC; MMRRC:008569-UCD
DR   Wikidata; Q54786566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH034
AC   CVCL_PW56
SY   XH034
DR   MMRRC; MMRRC:008570-UCD
DR   Wikidata; Q54786569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139207; Sec16a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH037
AC   CVCL_PW57
SY   XH037
DR   MMRRC; MMRRC:008571-UCD
DR   Wikidata; Q54786571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447364; Smg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH038
AC   CVCL_PW58
SY   XH038
DR   MMRRC; MMRRC:008572-UCD
DR   Wikidata; Q54786574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913808; Lars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH040
AC   CVCL_PW59
SY   XH040
DR   MMRRC; MMRRC:008573-UCD
DR   Wikidata; Q54786577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2386621; Cpne1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH041
AC   CVCL_PW60
SY   XH041
DR   MMRRC; MMRRC:008574-UCD
DR   Wikidata; Q54786578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922088; Naa15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH043
AC   CVCL_PW61
SY   XH043
DR   MMRRC; MMRRC:008575-UCD
DR   Wikidata; Q54786582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH045
AC   CVCL_PW62
SY   XH045
DR   MMRRC; MMRRC:008576-UCD
DR   Wikidata; Q54786584
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH046
AC   CVCL_PW63
SY   XH046
DR   MMRRC; MMRRC:008577-UCD
DR   Wikidata; Q54786586
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914934; Luc7l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH051
AC   CVCL_PW64
SY   XH051
DR   MMRRC; MMRRC:008578-UCD
DR   Wikidata; Q54786588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441787; Washc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH052
AC   CVCL_PW65
SY   XH052
DR   MMRRC; MMRRC:008579-UCD
DR   Wikidata; Q54786589
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH053
AC   CVCL_PW66
SY   XH053
DR   MMRRC; MMRRC:008580-UCD
DR   Wikidata; Q54786592
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH054
AC   CVCL_PW67
SY   XH054
DR   MMRRC; MMRRC:008581-UCD
DR   Wikidata; Q54786595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860606; Akap8l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH056
AC   CVCL_PW68
SY   XH056
DR   MMRRC; MMRRC:008582-UCD
DR   Wikidata; Q54786597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3616079; Dnaaf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH057
AC   CVCL_PW69
SY   XH057
DR   MMRRC; MMRRC:008583-UCD
DR   Wikidata; Q54786600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925212; Scaf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH058
AC   CVCL_PW70
SY   XH058
DR   MMRRC; MMRRC:008584-UCD
DR   Wikidata; Q54786602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142567; Arhgef18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH060
AC   CVCL_PW71
SY   XH060
DR   MMRRC; MMRRC:008585-UCD
DR   Wikidata; Q54786604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924315; Ints7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH061
AC   CVCL_PW72
SY   XH061
DR   MMRRC; MMRRC:008586-UCD
DR   Wikidata; Q54786606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914595; Herc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH062
AC   CVCL_PW73
SY   XH062
DR   MMRRC; MMRRC:008587-UCD
DR   Wikidata; Q54786607
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914868; Aasdhppt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH063
AC   CVCL_PW74
SY   XH063
DR   MMRRC; MMRRC:008588-UCD
DR   Wikidata; Q54786609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351657; Abcf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH064
AC   CVCL_PW75
SY   XH064
DR   MMRRC; MMRRC:008589-UCD
DR   Wikidata; Q54786612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443114; Larp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH065
AC   CVCL_PW76
SY   XH065
DR   MMRRC; MMRRC:008590-UCD
DR   Wikidata; Q54786613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443114; Larp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH066
AC   CVCL_PW77
SY   XH066
DR   MMRRC; MMRRC:008591-UCD
DR   Wikidata; Q54786615
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934835; Ube2n.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH068
AC   CVCL_PW78
SY   XH068
DR   MMRRC; MMRRC:008592-UCD
DR   Wikidata; Q54786618
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH069
AC   CVCL_PW79
SY   XH069
DR   MMRRC; MMRRC:008593-UCD
DR   Wikidata; Q54786619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103067; Atrx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH070
AC   CVCL_PW80
SY   XH070
DR   MMRRC; MMRRC:008594-UCD
DR   Wikidata; Q54786621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH071
AC   CVCL_PW81
SY   XH071
DR   MMRRC; MMRRC:008595-UCD
DR   Wikidata; Q54786622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH073
AC   CVCL_PW82
SY   XH073
DR   MMRRC; MMRRC:008596-UCD
DR   Wikidata; Q54786672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925349; Atrip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH074
AC   CVCL_PW83
SY   XH074
DR   MMRRC; MMRRC:008597-UCD
DR   Wikidata; Q54786676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95610; Gabpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH076
AC   CVCL_PW84
SY   XH076
DR   MMRRC; MMRRC:008598-UCD
DR   Wikidata; Q54786679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138584; Gigyf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH077
AC   CVCL_PW85
SY   XH077
DR   MMRRC; MMRRC:008599-UCD
DR   Wikidata; Q54786680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH078
AC   CVCL_PW86
SY   XH078
DR   MMRRC; MMRRC:008600-UCD
DR   Wikidata; Q54786681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261847; Vrk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH079
AC   CVCL_PW87
SY   XH079
DR   MMRRC; MMRRC:008601-UCD
DR   Wikidata; Q54786683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913714; Taf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH081
AC   CVCL_PW88
SY   XH081
DR   MMRRC; MMRRC:008602-UCD
DR   Wikidata; Q54786685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141847; Phrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH083
AC   CVCL_PW89
SY   XH083
DR   MMRRC; MMRRC:008603-UCD
DR   Wikidata; Q54786687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913743; Mrpl51.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH084
AC   CVCL_PW90
SY   XH084
DR   MMRRC; MMRRC:008604-UCD
DR   Wikidata; Q54786689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277223; Atxn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH085
AC   CVCL_PW91
SY   XH085
DR   MMRRC; MMRRC:008605-UCD
DR   Wikidata; Q54786691
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151114; Dgcr8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH090
AC   CVCL_PW92
SY   XH090
DR   MMRRC; MMRRC:008606-UCD
DR   Wikidata; Q54786692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH099
AC   CVCL_PW93
SY   XH099
DR   MMRRC; MMRRC:008607-UCD
DR   Wikidata; Q54786694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH102
AC   CVCL_PW94
SY   XH102
DR   MMRRC; MMRRC:008608-UCD
DR   Wikidata; Q54786695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH108
AC   CVCL_PW95
SY   XH108
DR   MMRRC; MMRRC:008610-UCD
DR   Wikidata; Q54786700
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH111
AC   CVCL_PW96
SY   XH111
DR   MMRRC; MMRRC:008611-UCD
DR   Wikidata; Q54786701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH119
AC   CVCL_PW97
SY   XH119
DR   MMRRC; MMRRC:008613-UCD
DR   Wikidata; Q54786703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921571; Tipin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH123
AC   CVCL_PW98
SY   XH123
DR   MMRRC; MMRRC:008615-UCD
DR   Wikidata; Q54786706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104729; Akap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH125
AC   CVCL_PW99
SY   XH125
DR   MMRRC; MMRRC:008616-UCD
DR   Wikidata; Q54786708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97286; Ncl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH127
AC   CVCL_PX00
SY   XH127
DR   MMRRC; MMRRC:008618-UCD
DR   Wikidata; Q54786710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924057; Phf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH131
AC   CVCL_PX01
SY   XH131
DR   MMRRC; MMRRC:008620-UCD
DR   Wikidata; Q54786713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313286; Eif2b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH133
AC   CVCL_PX02
SY   XH133
DR   MMRRC; MMRRC:008622-UCD
DR   Wikidata; Q54786715
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137379; Med15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH136
AC   CVCL_PX03
SY   XH136
DR   MMRRC; MMRRC:008623-UCD
DR   Wikidata; Q54786719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926462; Hnrnph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH137
AC   CVCL_PX04
SY   XH137
DR   MMRRC; MMRRC:008624-UCD
DR   Wikidata; Q54786722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95541; Fkbp1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH142
AC   CVCL_PX05
SY   XH142
DR   MMRRC; MMRRC:008627-UCD
DR   Wikidata; Q54786723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918052; Pwwp2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH144
AC   CVCL_PX06
SY   XH144
DR   MMRRC; MMRRC:008628-UCD
DR   Wikidata; Q54786726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96269; Ranbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH145
AC   CVCL_PX07
SY   XH145
DR   MMRRC; MMRRC:008629-UCD
DR   Wikidata; Q54786730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929264; Sae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH147
AC   CVCL_PX08
SY   XH147
DR   MMRRC; MMRRC:008631-UCD
DR   Wikidata; Q54786731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88353; Cdk11b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH148
AC   CVCL_PX09
SY   XH148
DR   MMRRC; MMRRC:008632-UCD
DR   Wikidata; Q54786733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88261; Canx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH152
AC   CVCL_PX10
SY   XH152
DR   MMRRC; MMRRC:008633-UCD
DR   Wikidata; Q54786734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934606; Alms1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH153
AC   CVCL_PX11
SY   XH153
DR   MMRRC; MMRRC:008634-UCD
DR   Wikidata; Q54786737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97616; Plcg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH154
AC   CVCL_PX12
SY   XH154
DR   MMRRC; MMRRC:008635-UCD
DR   Wikidata; Q54786740
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH155
AC   CVCL_PX13
SY   XH155
DR   MMRRC; MMRRC:008636-UCD
DR   Wikidata; Q54786742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140779; Sdad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH156
AC   CVCL_PX14
SY   XH156
DR   MMRRC; MMRRC:008637-UCD
DR   Wikidata; Q54786744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH157
AC   CVCL_PX15
SY   XH157
DR   MMRRC; MMRRC:008638-UCD
DR   Wikidata; Q54786747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151114; Dgcr8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH177
AC   CVCL_PX16
SY   XH177
DR   MMRRC; MMRRC:008639-UCD
DR   Wikidata; Q54786748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914469; Med18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH178
AC   CVCL_PX17
SY   XH178
DR   MMRRC; MMRRC:008640-UCD
DR   Wikidata; Q54786750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859162; Rnf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH180
AC   CVCL_PX18
SY   XH180
DR   MMRRC; MMRRC:008641-UCD
DR   Wikidata; Q54786752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH182
AC   CVCL_PX19
SY   XH182
DR   MMRRC; MMRRC:008642-UCD
DR   Wikidata; Q54786754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183260; Luc7l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH183
AC   CVCL_PX20
SY   XH183
DR   MMRRC; MMRRC:008643-UCD
DR   Wikidata; Q54786756
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH184
AC   CVCL_PX21
SY   XH184
DR   MMRRC; MMRRC:008644-UCD
DR   Wikidata; Q54786758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH185
AC   CVCL_PX22
SY   XH185
DR   MMRRC; MMRRC:008645-UCD
DR   Wikidata; Q54786807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95610; Gabpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH186
AC   CVCL_PX23
SY   XH186
DR   MMRRC; MMRRC:008646-UCD
DR   Wikidata; Q54786808
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH188
AC   CVCL_PX24
SY   XH188
DR   MMRRC; MMRRC:008647-UCD
DR   Wikidata; Q54786810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH189
AC   CVCL_PX25
SY   XH189
DR   MMRRC; MMRRC:008648-UCD
DR   Wikidata; Q54786812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443564; Ambra1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH191
AC   CVCL_PX26
SY   XH191
DR   MMRRC; MMRRC:008649-UCD
DR   Wikidata; Q54786813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH192
AC   CVCL_PX27
SY   XH192
DR   MMRRC; MMRRC:008650-UCD
DR   Wikidata; Q54786814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858965; Atf7ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH194
AC   CVCL_PX28
SY   XH194
DR   MMRRC; MMRRC:008651-UCD
DR   Wikidata; Q54786817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109152; Lig3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH196
AC   CVCL_PX29
SY   XH196
DR   MMRRC; MMRRC:008652-UCD
DR   Wikidata; Q54786818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860494; Ddx21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH199
AC   CVCL_PX30
SY   XH199
DR   MMRRC; MMRRC:008653-UCD
DR   Wikidata; Q54786819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927489; Pdlim5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH201
AC   CVCL_PX31
SY   XH201
DR   MMRRC; MMRRC:008654-UCD
DR   Wikidata; Q54786820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH202
AC   CVCL_PX32
SY   XH202
DR   MMRRC; MMRRC:008655-UCD
DR   Wikidata; Q54786823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919563; Fryl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH203
AC   CVCL_PX33
SY   XH203
DR   MMRRC; MMRRC:008656-UCD
DR   Wikidata; Q54786825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444008; Bptf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH204
AC   CVCL_PX34
SY   XH204
DR   MMRRC; MMRRC:008657-UCD
DR   Wikidata; Q54786828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920093; Prdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH205
AC   CVCL_PX35
SY   XH205
DR   MMRRC; MMRRC:008658-UCD
DR   Wikidata; Q54786829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95480; Fancc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH206
AC   CVCL_PX36
SY   XH206
DR   MMRRC; MMRRC:008659-UCD
DR   Wikidata; Q54786832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105926; Rab5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH207
AC   CVCL_PX37
SY   XH207
DR   MMRRC; MMRRC:008660-UCD
DR   Wikidata; Q54786834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH209
AC   CVCL_PX38
SY   XH209
DR   MMRRC; MMRRC:008661-UCD
DR   Wikidata; Q54786836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919933; Proser1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH211
AC   CVCL_PX39
SY   XH211
DR   MMRRC; MMRRC:008663-UCD
DR   Wikidata; Q54786837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933765; Btbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH212
AC   CVCL_PX40
SY   XH212
DR   MMRRC; MMRRC:008664-UCD
DR   Wikidata; Q54786838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921831; Sbf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH213
AC   CVCL_PX41
SY   XH213
DR   MMRRC; MMRRC:008665-UCD
DR   Wikidata; Q54786842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH214
AC   CVCL_PX42
SY   XH214
DR   MMRRC; MMRRC:008666-UCD
DR   Wikidata; Q54786843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914487; Cul4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH215
AC   CVCL_PX43
SY   XH215
DR   MMRRC; MMRRC:008667-UCD
DR   Wikidata; Q54786844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685179; Zfp407.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XH216
AC   CVCL_PX44
SY   XH216
DR   MMRRC; MMRRC:008668-UCD
DR   Wikidata; Q54786847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH218
AC   CVCL_PX45
SY   XH218
DR   MMRRC; MMRRC:008669-UCD
DR   Wikidata; Q54786849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429765; Dock1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH221
AC   CVCL_PX46
SY   XH221
DR   MMRRC; MMRRC:008670-UCD
DR   Wikidata; Q54786851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1315202; Slit3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH222
AC   CVCL_PX47
SY   XH222
DR   MMRRC; MMRRC:008671-UCD
DR   Wikidata; Q54786853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183260; Luc7l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH223
AC   CVCL_PX48
SY   XH223
DR   MMRRC; MMRRC:008672-UCD
DR   Wikidata; Q54786857
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920194; 2900026A02Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH226
AC   CVCL_PX49
SY   XH226
DR   MMRRC; MMRRC:008673-UCD
DR   Wikidata; Q54786859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH227
AC   CVCL_PX50
SY   XH227
DR   MMRRC; MMRRC:008674-UCD
DR   Wikidata; Q54786862
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921451; Cep97.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH228
AC   CVCL_PX51
SY   XH228
DR   MMRRC; MMRRC:008675-UCD
DR   Wikidata; Q54786864
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099790; Plk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH230
AC   CVCL_PX52
SY   XH230
DR   MMRRC; MMRRC:008676-UCD
DR   Wikidata; Q54786866
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096573; Utp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH232
AC   CVCL_PX53
SY   XH232
DR   MMRRC; MMRRC:008677-UCD
DR   Wikidata; Q54786868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343188; Ube2g2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH236
AC   CVCL_PX54
SY   XH236
DR   MMRRC; MMRRC:008678-UCD
DR   Wikidata; Q54786869
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915545; Aar2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH237
AC   CVCL_PX55
SY   XH237
DR   MMRRC; MMRRC:008679-UCD
DR   Wikidata; Q54786872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH239
AC   CVCL_PX56
SY   XH239
DR   MMRRC; MMRRC:008680-UCD
DR   Wikidata; Q54786875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932404; Phip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH241
AC   CVCL_PX57
SY   XH241
DR   MMRRC; MMRRC:008681-UCD
DR   Wikidata; Q54786877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924295; Bcl7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH243
AC   CVCL_PX58
SY   XH243
DR   MMRRC; MMRRC:008682-UCD
DR   Wikidata; Q54786878
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923041; Fbxw8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH249
AC   CVCL_PX59
SY   XH249
DR   MMRRC; MMRRC:008683-UCD
DR   Wikidata; Q54786881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924057; Phf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH251
AC   CVCL_PX60
SY   XH251
DR   MMRRC; MMRRC:008684-UCD
DR   Wikidata; Q54786883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH252
AC   CVCL_PX61
SY   XH252
DR   MMRRC; MMRRC:008685-UCD
DR   Wikidata; Q54786885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107760; Chka.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH253
AC   CVCL_PX62
SY   XH253
DR   MMRRC; MMRRC:008686-UCD
DR   Wikidata; Q54786941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136459; Cdc42bpb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH256
AC   CVCL_PX63
SY   XH256
DR   MMRRC; MMRRC:008687-UCD
DR   Wikidata; Q54786943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922858; Chmp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH261
AC   CVCL_PX64
SY   XH261
DR   MMRRC; MMRRC:008688-UCD
DR   Wikidata; Q54786945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916401; Lzic.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH264
AC   CVCL_PX65
SY   XH264
DR   MMRRC; MMRRC:008690-UCD
DR   Wikidata; Q54786946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102718; Vav2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH265
AC   CVCL_PX66
SY   XH265
DR   MMRRC; MMRRC:008691-UCD
DR   Wikidata; Q54786949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924203; Emsy.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH266
AC   CVCL_PX67
SY   XH266
DR   MMRRC; MMRRC:008692-UCD
DR   Wikidata; Q54786951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH267
AC   CVCL_PX68
SY   XH267
DR   MMRRC; MMRRC:008693-UCD
DR   Wikidata; Q54786954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341087; Tnks.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH268
AC   CVCL_PX69
SY   XH268
DR   MMRRC; MMRRC:008694-UCD
DR   Wikidata; Q54786955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH271
AC   CVCL_PX70
SY   XH271
DR   MMRRC; MMRRC:008695-UCD
DR   Wikidata; Q54786959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916862; Kansl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH279
AC   CVCL_PX71
SY   XH279
DR   MMRRC; MMRRC:008697-UCD
DR   Wikidata; Q54786962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH282
AC   CVCL_PX72
SY   XH282
DR   MMRRC; MMRRC:008698-UCD
DR   Wikidata; Q54786964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH285
AC   CVCL_PX73
SY   XH285
DR   MMRRC; MMRRC:008699-UCD
DR   Wikidata; Q54786966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH287
AC   CVCL_PX74
SY   XH287
DR   MMRRC; MMRRC:008700-UCD
DR   Wikidata; Q54786968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920460; Nup54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH290
AC   CVCL_PX75
SY   XH290
DR   MMRRC; MMRRC:008701-UCD
DR   Wikidata; Q54786971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913392; Cox7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH291
AC   CVCL_PX76
SY   XH291
DR   MMRRC; MMRRC:008702-UCD
DR   Wikidata; Q54786973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109299; Polr2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH296
AC   CVCL_PX77
SY   XH296
DR   MMRRC; MMRRC:008704-UCD
DR   Wikidata; Q54786976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH297
AC   CVCL_PX78
SY   XH297
DR   MMRRC; MMRRC:008705-UCD
DR   Wikidata; Q54786978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442306; Fancm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH303
AC   CVCL_PX79
SY   XH303
DR   MMRRC; MMRRC:008706-UCD
DR   Wikidata; Q54786979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913941; Gapvd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH307
AC   CVCL_PX80
SY   XH307
DR   MMRRC; MMRRC:008707-UCD
DR   Wikidata; Q54786982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346036; Pin1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH309
AC   CVCL_PX81
SY   XH309
DR   MMRRC; MMRRC:008708-UCD
DR   Wikidata; Q54786983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH312
AC   CVCL_PX82
SY   XH312
DR   MMRRC; MMRRC:008709-UCD
DR   Wikidata; Q54786986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858304; Ctps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH314
AC   CVCL_PX83
SY   XH314
DR   MMRRC; MMRRC:008710-UCD
DR   Wikidata; Q54786988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH316
AC   CVCL_PX84
SY   XH316
DR   MMRRC; MMRRC:008711-UCD
DR   Wikidata; Q54786991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925237; Ascc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH320
AC   CVCL_PX85
SY   XH320
DR   MMRRC; MMRRC:008712-UCD
DR   Wikidata; Q54786992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914803; Gstcd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH324
AC   CVCL_PX86
SY   XH324
DR   MMRRC; MMRRC:008714-UCD
DR   Wikidata; Q54786997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922387; Rprd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH325
AC   CVCL_PX87
SY   XH325
DR   MMRRC; MMRRC:008715-UCD
DR   Wikidata; Q54786998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1335094; Septin7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XH327
AC   CVCL_PX88
SY   XH327
DR   MMRRC; MMRRC:008716-UCD
DR   Wikidata; Q54787000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH329
AC   CVCL_PX89
SY   XH329
DR   MMRRC; MMRRC:008717-UCD
DR   Wikidata; Q54787002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914694; Ilkap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH331
AC   CVCL_PX90
SY   XH331
DR   MMRRC; MMRRC:008719-UCD
DR   Wikidata; Q54787005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918040; Ubr5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH332
AC   CVCL_PX91
SY   XH332
DR   MMRRC; MMRRC:008720-UCD
DR   Wikidata; Q54787008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917034; 1500009L16Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH334
AC   CVCL_PX92
SY   XH334
DR   MMRRC; MMRRC:008721-UCD
DR   Wikidata; Q54787010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920159; Chmp1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH337
AC   CVCL_PX93
SY   XH337
DR   MMRRC; MMRRC:008722-UCD
DR   Wikidata; Q54787014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682334; Smg7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH339
AC   CVCL_PX94
SY   XH339
DR   MMRRC; MMRRC:008724-UCD
DR   Wikidata; Q54787016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99260; Prkci.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH340
AC   CVCL_PX95
SY   XH340
DR   MMRRC; MMRRC:008725-UCD
DR   Wikidata; Q54787018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153049; Klf16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH346
AC   CVCL_PX96
SY   XH346
DR   MMRRC; MMRRC:008726-UCD
DR   Wikidata; Q54787020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:892979; Chm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH348
AC   CVCL_PX97
SY   XH348
DR   MMRRC; MMRRC:008727-UCD
DR   Wikidata; Q54787023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH359
AC   CVCL_PX98
SY   XH359
DR   MMRRC; MMRRC:008728-UCD
DR   Wikidata; Q54787025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098265; Kif13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH368
AC   CVCL_PX99
SY   XH368
DR   MMRRC; MMRRC:008729-UCD
DR   Wikidata; Q54787027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916979; 2410003L11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH374
AC   CVCL_PY00
SY   XH374
DR   MMRRC; MMRRC:008730-UCD
DR   Wikidata; Q54787029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH392
AC   CVCL_PY01
SY   XH392
DR   MMRRC; MMRRC:008731-UCD
DR   Wikidata; Q54787031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH400
AC   CVCL_PY02
SY   XH400
DR   MMRRC; MMRRC:008732-UCD
DR   Wikidata; Q54787090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916979; 2410003L11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH403
AC   CVCL_PY03
SY   XH403
DR   MMRRC; MMRRC:008733-UCD
DR   Wikidata; Q54787091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH413
AC   CVCL_PY04
SY   XH413
DR   MMRRC; MMRRC:008734-UCD
DR   Wikidata; Q54787094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914454; Eif2s2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH421
AC   CVCL_PY05
SY   XH421
DR   MMRRC; MMRRC:008736-UCD
DR   Wikidata; Q54787095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH429
AC   CVCL_PY06
SY   XH429
DR   MMRRC; MMRRC:008737-UCD
DR   Wikidata; Q54787098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930708; Zfp386.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH430
AC   CVCL_PY07
SY   XH430
DR   MMRRC; MMRRC:008738-UCD
DR   Wikidata; Q54787099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917829; Zc3h11a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH431
AC   CVCL_PY08
SY   XH431
DR   MMRRC; MMRRC:008739-UCD
DR   Wikidata; Q54787101
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923998; Pbrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH442
AC   CVCL_PY09
SY   XH442
DR   MMRRC; MMRRC:008741-UCD
DR   Wikidata; Q54787103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100494; Ercc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH445
AC   CVCL_PY10
SY   XH445
DR   MMRRC; MMRRC:008742-UCD
DR   Wikidata; Q54787106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH457
AC   CVCL_PY11
SY   XH457
DR   MMRRC; MMRRC:008743-UCD
DR   Wikidata; Q54787108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932395; Rrbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH462
AC   CVCL_PY12
SY   XH462
DR   MMRRC; MMRRC:008744-UCD
DR   Wikidata; Q54787110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914163; Kdelr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH464
AC   CVCL_PY13
SY   XH464
DR   MMRRC; MMRRC:008745-UCD
DR   Wikidata; Q54787113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858746; Kat6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH465
AC   CVCL_PY14
SY   XH465
DR   MMRRC; MMRRC:008746-UCD
DR   Wikidata; Q54787115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925055; Esco1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH466
AC   CVCL_PY15
SY   XH466
DR   MMRRC; MMRRC:008747-UCD
DR   Wikidata; Q54787117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935147; Arid1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH470
AC   CVCL_PY16
SY   XH470
DR   MMRRC; MMRRC:008748-UCD
DR   Wikidata; Q54787119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95909; Slc39a7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH471
AC   CVCL_PY17
SY   XH471
DR   MMRRC; MMRRC:008749-UCD
DR   Wikidata; Q54787120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104558; Rps6ka1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH472
AC   CVCL_PY18
SY   XH472
DR   MMRRC; MMRRC:008750-UCD
DR   Wikidata; Q54787123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914707; Frmd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH473
AC   CVCL_PY19
SY   XH473
DR   MMRRC; MMRRC:008751-UCD
DR   Wikidata; Q54787125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915984; Ppp4r3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH474
AC   CVCL_PY20
SY   XH474
DR   MMRRC; MMRRC:008752-UCD
DR   Wikidata; Q54787128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103250; Calm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH482
AC   CVCL_PY21
SY   XH482
DR   MMRRC; MMRRC:008753-UCD
DR   Wikidata; Q54787131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917758; Bbx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH485
AC   CVCL_PY22
SY   XH485
DR   MMRRC; MMRRC:008754-UCD
DR   Wikidata; Q54787133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3648690; Zfp975.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH505
AC   CVCL_PY23
SY   XH505
DR   MMRRC; MMRRC:008755-UCD
DR   Wikidata; Q54787138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108411; Prkag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH507
AC   CVCL_PY24
SY   XH507
DR   MMRRC; MMRRC:008756-UCD
DR   Wikidata; Q54787139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352762; Scmh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH508
AC   CVCL_PY25
SY   XH508
DR   MMRRC; MMRRC:008757-UCD
DR   Wikidata; Q54787142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341087; Tnks.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH511
AC   CVCL_PY26
SY   XH511
DR   MMRRC; MMRRC:008758-UCD
DR   Wikidata; Q54787144
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97312; Nfkb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH512
AC   CVCL_PY27
SY   XH512
DR   MMRRC; MMRRC:008759-UCD
DR   Wikidata; Q54787147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH513
AC   CVCL_PY28
SY   XH513
DR   MMRRC; MMRRC:008760-UCD
DR   Wikidata; Q54787149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928373; Dnajc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH517
AC   CVCL_PY29
SY   XH517
DR   MMRRC; MMRRC:008761-UCD
DR   Wikidata; Q54787151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919861; Zfp655.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH521
AC   CVCL_PY30
SY   XH521
DR   MMRRC; MMRRC:008762-UCD
DR   Wikidata; Q54787152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96433; Igf1r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH522
AC   CVCL_PY31
SY   XH522
DR   MMRRC; MMRRC:008763-UCD
DR   Wikidata; Q54787154
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925503; Map4k5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH524
AC   CVCL_PY32
SY   XH524
DR   MMRRC; MMRRC:008764-UCD
DR   Wikidata; Q54787156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141969; Efl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH527
AC   CVCL_PY33
SY   XH527
DR   MMRRC; MMRRC:008765-UCD
DR   Wikidata; Q54787158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926879; Taf8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH528
AC   CVCL_PY34
SY   XH528
DR   MMRRC; MMRRC:008766-UCD
DR   Wikidata; Q54787160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924093; Dtl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH531
AC   CVCL_PY35
SY   XH531
DR   MMRRC; MMRRC:008768-UCD
DR   Wikidata; Q54787161
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346006; Ptpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH534
AC   CVCL_PY36
SY   XH534
DR   MMRRC; MMRRC:008769-UCD
DR   Wikidata; Q54787164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH537
AC   CVCL_PY37
SY   XH537
DR   MMRRC; MMRRC:008771-UCD
DR   Wikidata; Q54787166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443967; Dpp9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH538
AC   CVCL_PY38
SY   XH538
DR   MMRRC; MMRRC:008772-UCD
DR   Wikidata; Q54787167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH540
AC   CVCL_PY39
SY   XH540
DR   MMRRC; MMRRC:008773-UCD
DR   Wikidata; Q54787169
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH542
AC   CVCL_PY40
SY   XH542
DR   MMRRC; MMRRC:008774-UCD
DR   Wikidata; Q54787170
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH543
AC   CVCL_PY41
SY   XH543
DR   MMRRC; MMRRC:008775-UCD
DR   Wikidata; Q54787173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913666; Ndufa7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH580
AC   CVCL_PY42
SY   XH580
DR   MMRRC; MMRRC:008776-UCD
DR   Wikidata; Q54787223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144243; Clint1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH583
AC   CVCL_PY43
SY   XH583
DR   MMRRC; MMRRC:008777-UCD
DR   Wikidata; Q54787226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH584
AC   CVCL_PY44
SY   XH584
DR   MMRRC; MMRRC:008778-UCD
DR   Wikidata; Q54787227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316687; Nap1l4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH585
AC   CVCL_PY45
SY   XH585
DR   MMRRC; MMRRC:008779-UCD
DR   Wikidata; Q54787229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098275; Gse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH587
AC   CVCL_PY46
SY   XH587
DR   MMRRC; MMRRC:008780-UCD
DR   Wikidata; Q54787231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138811; Cdc123.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH594
AC   CVCL_PY47
SY   XH594
DR   MMRRC; MMRRC:008781-UCD
DR   Wikidata; Q54787233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916507; Elf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH604
AC   CVCL_PY48
SY   XH604
DR   MMRRC; MMRRC:008783-UCD
DR   Wikidata; Q54787235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH606
AC   CVCL_PY49
SY   XH606
DR   MMRRC; MMRRC:008784-UCD
DR   Wikidata; Q54787237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443807; Osbpl8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH607
AC   CVCL_PY50
SY   XH607
DR   MMRRC; MMRRC:008785-UCD
DR   Wikidata; Q54787239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH608
AC   CVCL_PY51
SY   XH608
DR   MMRRC; MMRRC:008786-UCD
DR   Wikidata; Q54787241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH609
AC   CVCL_PY52
SY   XH609
DR   MMRRC; MMRRC:008787-UCD
DR   Wikidata; Q54787244
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926967; Hsd17b12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH610
AC   CVCL_PY53
SY   XH610
DR   MMRRC; MMRRC:008788-UCD
DR   Wikidata; Q54787246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141920; Wtip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH615
AC   CVCL_PY54
SY   XH615
DR   MMRRC; MMRRC:008790-UCD
DR   Wikidata; Q54787248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316740; Morc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH616
AC   CVCL_PY55
SY   XH616
DR   MMRRC; MMRRC:008791-UCD
DR   Wikidata; Q54787250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920992; Lima1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH617
AC   CVCL_PY56
SY   XH617
DR   MMRRC; MMRRC:008792-UCD
DR   Wikidata; Q54787254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141920; Wtip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH618
AC   CVCL_PY57
SY   XH618
DR   MMRRC; MMRRC:008793-UCD
DR   Wikidata; Q54787256
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95817; Grik4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH621
AC   CVCL_PY58
SY   XH621
DR   MMRRC; MMRRC:008795-UCD
DR   Wikidata; Q54787257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916199; Zfas1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH623
AC   CVCL_PY59
SY   XH623
DR   MMRRC; MMRRC:008796-UCD
DR   Wikidata; Q54787260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97583; Pik3r1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH626
AC   CVCL_PY60
SY   XH626
DR   MMRRC; MMRRC:008797-UCD
DR   Wikidata; Q54787262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3643401; Gm8935.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH627
AC   CVCL_PY61
SY   XH627
DR   MMRRC; MMRRC:008798-UCD
DR   Wikidata; Q54787264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346006; Ptpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH629
AC   CVCL_PY62
SY   XH629
DR   MMRRC; MMRRC:008799-UCD
DR   Wikidata; Q54787265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913758; Lamtor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH636
AC   CVCL_PY63
SY   XH636
DR   MMRRC; MMRRC:008800-UCD
DR   Wikidata; Q54787267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921802; Nipal3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH641
AC   CVCL_PY64
SY   XH641
DR   MMRRC; MMRRC:008802-UCD
DR   Wikidata; Q54787268
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921361; Rbm19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH649
AC   CVCL_PY65
SY   XH649
DR   MMRRC; MMRRC:008803-UCD
DR   Wikidata; Q54787272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923046; Cdyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH651
AC   CVCL_PY66
SY   XH651
DR   MMRRC; MMRRC:008804-UCD
DR   Wikidata; Q54787274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97615; Plcg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH654
AC   CVCL_PY67
SY   XH654
DR   MMRRC; MMRRC:008806-UCD
DR   Wikidata; Q54787275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98294; Shb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH655
AC   CVCL_PY68
SY   XH655
DR   MMRRC; MMRRC:008807-UCD
DR   Wikidata; Q54787276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3040674; Zfp708.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH657
AC   CVCL_PY69
SY   XH657
DR   MMRRC; MMRRC:008808-UCD
DR   Wikidata; Q54787277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183453; Dlgap5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH658
AC   CVCL_PY70
SY   XH658
DR   MMRRC; MMRRC:008809-UCD
DR   Wikidata; Q54787280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH662
AC   CVCL_PY71
SY   XH662
DR   MMRRC; MMRRC:008810-UCD
DR   Wikidata; Q54787282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3033336; Szt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH664
AC   CVCL_PY72
SY   XH664
DR   MMRRC; MMRRC:008811-UCD
DR   Wikidata; Q54787283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138982; Znfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH666
AC   CVCL_PY73
SY   XH666
DR   MMRRC; MMRRC:008812-UCD
DR   Wikidata; Q54787284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH670
AC   CVCL_PY74
SY   XH670
DR   MMRRC; MMRRC:008813-UCD
DR   Wikidata; Q54787286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100520; Twf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH675
AC   CVCL_PY75
SY   XH675
DR   MMRRC; MMRRC:008814-UCD
DR   Wikidata; Q54787290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH676
AC   CVCL_PY76
SY   XH676
DR   MMRRC; MMRRC:008815-UCD
DR   Wikidata; Q54787291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338944; Acvr1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH677
AC   CVCL_PY77
SY   XH677
DR   MMRRC; MMRRC:008816-UCD
DR   Wikidata; Q54787292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH679
AC   CVCL_PY78
SY   XH679
DR   MMRRC; MMRRC:008817-UCD
DR   Wikidata; Q54787295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106381; Nopchap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XH683
AC   CVCL_PY79
SY   XH683
DR   MMRRC; MMRRC:008818-UCD
DR   Wikidata; Q54787296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH684
AC   CVCL_PY80
SY   XH684
DR   MMRRC; MMRRC:008819-UCD
DR   Wikidata; Q54787298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860197; Wdr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH685
AC   CVCL_PY81
SY   XH685
DR   MMRRC; MMRRC:008820-UCD
DR   Wikidata; Q54787302
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106264; Trim36.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH687
AC   CVCL_PY82
SY   XH687
DR   MMRRC; MMRRC:008821-UCD
DR   Wikidata; Q54787344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH688
AC   CVCL_PY83
SY   XH688
DR   MMRRC; MMRRC:008822-UCD
DR   Wikidata; Q54787346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443306; Tom1l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH690
AC   CVCL_PY84
SY   XH690
DR   MMRRC; MMRRC:008823-UCD
DR   Wikidata; Q54787351
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH693
AC   CVCL_PY85
SY   XH693
DR   MMRRC; MMRRC:008824-UCD
DR   Wikidata; Q54787353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH694
AC   CVCL_PY86
SY   XH694
DR   MMRRC; MMRRC:008825-UCD
DR   Wikidata; Q54787356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99260; Prkci.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH698
AC   CVCL_PY87
SY   XH698
DR   MMRRC; MMRRC:008826-UCD
DR   Wikidata; Q54787358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141989; Grwd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH706
AC   CVCL_PY88
SY   XH706
DR   MMRRC; MMRRC:008827-UCD
DR   Wikidata; Q54787360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918272; Ston2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH708
AC   CVCL_PY89
SY   XH708
DR   MMRRC; MMRRC:008828-UCD
DR   Wikidata; Q54787362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147437; Rrp12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH711
AC   CVCL_PY90
SY   XH711
DR   MMRRC; MMRRC:008829-UCD
DR   Wikidata; Q54787363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917882; 5730507C01Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH715
AC   CVCL_PY91
SY   XH715
DR   MMRRC; MMRRC:008830-UCD
DR   Wikidata; Q54787365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH718
AC   CVCL_PY92
SY   XH718
DR   MMRRC; MMRRC:008831-UCD
DR   Wikidata; Q54787368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860078; Txnl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH719
AC   CVCL_PY93
SY   XH719
DR   MMRRC; MMRRC:008832-UCD
DR   Wikidata; Q54787370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH723
AC   CVCL_PY94
SY   XH723
DR   MMRRC; MMRRC:008833-UCD
DR   Wikidata; Q54787371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138865; Dlgap4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH724
AC   CVCL_PY95
SY   XH724
DR   MMRRC; MMRRC:008834-UCD
DR   Wikidata; Q54787373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH725
AC   CVCL_PY96
SY   XH725
DR   MMRRC; MMRRC:008835-UCD
DR   Wikidata; Q54787374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH726
AC   CVCL_PY97
SY   XH726
DR   MMRRC; MMRRC:008836-UCD
DR   Wikidata; Q54787375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913894; Uba6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH732
AC   CVCL_PY98
SY   XH732
DR   MMRRC; MMRRC:008839-UCD
DR   Wikidata; Q54787377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914295; Riok2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH734
AC   CVCL_PY99
SY   XH734
DR   MMRRC; MMRRC:008840-UCD
DR   Wikidata; Q54787378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH737
AC   CVCL_PZ00
SY   XH737
DR   MMRRC; MMRRC:008841-UCD
DR   Wikidata; Q54787380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919742; Smg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH740
AC   CVCL_PZ01
SY   XH740
DR   MMRRC; MMRRC:008842-UCD
DR   Wikidata; Q54787382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97316; Nfya.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH741
AC   CVCL_PZ02
SY   XH741
DR   MMRRC; MMRRC:008843-UCD
DR   Wikidata; Q54787384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447063; Tenm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH743
AC   CVCL_PZ03
SY   XH743
DR   MMRRC; MMRRC:008844-UCD
DR   Wikidata; Q54787386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106613; Dvl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH746
AC   CVCL_PZ04
SY   XH746
DR   MMRRC; MMRRC:008845-UCD
DR   Wikidata; Q54787388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3040693; Zmiz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH751
AC   CVCL_PZ05
SY   XH751
DR   MMRRC; MMRRC:008846-UCD
DR   Wikidata; Q54787389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344347; Synj2bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH752
AC   CVCL_PZ06
SY   XH752
DR   MMRRC; MMRRC:008847-UCD
DR   Wikidata; Q54787391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH754
AC   CVCL_PZ07
SY   XH754
DR   MMRRC; MMRRC:008848-UCD
DR   Wikidata; Q54787392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915171; Ube2f.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH755
AC   CVCL_PZ08
SY   XH755
DR   MMRRC; MMRRC:008849-UCD
DR   Wikidata; Q54787394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96952; Mdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH759
AC   CVCL_PZ09
SY   XH759
DR   MMRRC; MMRRC:008850-UCD
DR   Wikidata; Q54787396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107891; Nop2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH775
AC   CVCL_PZ10
SY   XH775
DR   MMRRC; MMRRC:008852-UCD
DR   Wikidata; Q54787398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923957; Clasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH779
AC   CVCL_PZ11
SY   XH779
DR   MMRRC; MMRRC:008853-UCD
DR   Wikidata; Q54787401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH782
AC   CVCL_PZ12
SY   XH782
DR   MMRRC; MMRRC:008854-UCD
DR   Wikidata; Q54787403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346006; Ptpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH786
AC   CVCL_PZ13
SY   XH786
DR   MMRRC; MMRRC:008855-UCD
DR   Wikidata; Q54787405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926129; Arid1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH789
AC   CVCL_PZ14
SY   XH789
DR   MMRRC; MMRRC:008856-UCD
DR   Wikidata; Q54787408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914398; Ramac.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XH798
AC   CVCL_PZ15
SY   XH798
DR   MMRRC; MMRRC:008857-UCD
DR   Wikidata; Q54787409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88473; Cox4i1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH801
AC   CVCL_PZ16
SY   XH801
DR   MMRRC; MMRRC:008858-UCD
DR   Wikidata; Q54787412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913937; Tbc1d15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH802
AC   CVCL_PZ17
SY   XH802
DR   MMRRC; MMRRC:008859-UCD
DR   Wikidata; Q54787415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913937; Tbc1d15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH803
AC   CVCL_PZ18
SY   XH803
DR   MMRRC; MMRRC:008860-UCD
DR   Wikidata; Q54787417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913224; Hs1bp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH804
AC   CVCL_PZ19
SY   XH804
DR   MMRRC; MMRRC:008861-UCD
DR   Wikidata; Q54787418
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH805
AC   CVCL_PZ20
SY   XH805
DR   MMRRC; MMRRC:008862-UCD
DR   Wikidata; Q54787420
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385902; Picalm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH809
AC   CVCL_PZ21
SY   XH809
DR   MMRRC; MMRRC:008863-UCD
DR   Wikidata; Q54787421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144013; Xpo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH811
AC   CVCL_PZ22
SY   XH811
DR   MMRRC; MMRRC:008864-UCD
DR   Wikidata; Q54787471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352755; Gtse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH812
AC   CVCL_PZ23
SY   XH812
DR   MMRRC; MMRRC:008865-UCD
DR   Wikidata; Q54787475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179288; Rttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH814
AC   CVCL_PZ24
SY   XH814
DR   MMRRC; MMRRC:008866-UCD
DR   Wikidata; Q54787477
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109519; Msh3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH815
AC   CVCL_PZ25
SY   XH815
DR   MMRRC; MMRRC:008867-UCD
DR   Wikidata; Q54787478
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889642; Elp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH816
AC   CVCL_PZ26
SY   XH816
DR   MMRRC; MMRRC:008868-UCD
DR   Wikidata; Q54787481
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103040; Rsu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH817
AC   CVCL_PZ27
SY   XH817
DR   MMRRC; MMRRC:008869-UCD
DR   Wikidata; Q54787482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103040; Rsu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH819
AC   CVCL_PZ28
SY   XH819
DR   MMRRC; MMRRC:008870-UCD
DR   Wikidata; Q54787484
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95770; Gna15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH820
AC   CVCL_PZ29
SY   XH820
DR   MMRRC; MMRRC:008871-UCD
DR   Wikidata; Q54787485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98285; Srsf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH845
AC   CVCL_PZ30
SY   XH845
DR   MMRRC; MMRRC:008872-UCD
DR   Wikidata; Q54787486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102944; Ube2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH846
AC   CVCL_PZ31
SY   XH846
DR   MMRRC; MMRRC:008873-UCD
DR   Wikidata; Q54787489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH847
AC   CVCL_PZ32
SY   XH847
DR   MMRRC; MMRRC:008874-UCD
DR   Wikidata; Q54787492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH848
AC   CVCL_PZ33
SY   XH848
DR   MMRRC; MMRRC:008875-UCD
DR   Wikidata; Q54787493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109452; Smad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH849
AC   CVCL_PZ34
SY   XH849
DR   MMRRC; MMRRC:008876-UCD
DR   Wikidata; Q54787494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858419; Bysl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH850
AC   CVCL_PZ35
SY   XH850
DR   MMRRC; MMRRC:008877-UCD
DR   Wikidata; Q54787497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913687; Fis1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH852
AC   CVCL_PZ36
SY   XH852
DR   MMRRC; MMRRC:008879-UCD
DR   Wikidata; Q54787498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98759; Tjp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH853
AC   CVCL_PZ37
SY   XH853
DR   MMRRC; MMRRC:008880-UCD
DR   Wikidata; Q54787500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098258; Kif15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH855
AC   CVCL_PZ38
SY   XH855
DR   MMRRC; MMRRC:008882-UCD
DR   Wikidata; Q54787503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145578; Slain1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH856
AC   CVCL_PZ39
SY   XH856
DR   MMRRC; MMRRC:008883-UCD
DR   Wikidata; Q54787506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96239; Hsf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH857
AC   CVCL_PZ40
SY   XH857
DR   MMRRC; MMRRC:008884-UCD
DR   Wikidata; Q54787508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914632; Brd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH859
AC   CVCL_PZ41
SY   XH859
DR   MMRRC; MMRRC:008885-UCD
DR   Wikidata; Q54787513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917167; Nabp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH862
AC   CVCL_PZ42
SY   XH862
DR   MMRRC; MMRRC:008887-UCD
DR   Wikidata; Q54787514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95485; Fasn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH863
AC   CVCL_PZ43
SY   XH863
DR   MMRRC; MMRRC:008888-UCD
DR   Wikidata; Q54787515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88071; Arnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH865
AC   CVCL_PZ44
SY   XH865
DR   MMRRC; MMRRC:008889-UCD
DR   Wikidata; Q54787517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH866
AC   CVCL_PZ45
SY   XH866
DR   MMRRC; MMRRC:008890-UCD
DR   Wikidata; Q54787520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104652; Capzb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH881
AC   CVCL_PZ46
SY   XH881
DR   MMRRC; MMRRC:008891-UCD
DR   Wikidata; Q54787521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH886
AC   CVCL_PZ47
SY   XH886
DR   MMRRC; MMRRC:008892-UCD
DR   Wikidata; Q54787524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH891
AC   CVCL_PZ48
SY   XH891
DR   MMRRC; MMRRC:008893-UCD
DR   Wikidata; Q54787525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921285; Nol9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH892
AC   CVCL_PZ49
SY   XH892
DR   MMRRC; MMRRC:008894-UCD
DR   Wikidata; Q54787527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700012; Ostf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH895
AC   CVCL_PZ50
SY   XH895
DR   MMRRC; MMRRC:008896-UCD
DR   Wikidata; Q54787528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137355; Trim11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH897
AC   CVCL_PZ51
SY   XH897
DR   MMRRC; MMRRC:008897-UCD
DR   Wikidata; Q54787530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673965; Tmem60.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH901
AC   CVCL_PZ52
SY   XH901
DR   MMRRC; MMRRC:008898-UCD
DR   Wikidata; Q54787532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921461; 1700017B05Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH905
AC   CVCL_PZ53
SY   XH905
DR   MMRRC; MMRRC:008900-UCD
DR   Wikidata; Q54787533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181182; Nup155.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH908
AC   CVCL_PZ54
SY   XH908
DR   MMRRC; MMRRC:008901-UCD
DR   Wikidata; Q54787535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH920
AC   CVCL_PZ55
SY   XH920
DR   MMRRC; MMRRC:008902-UCD
DR   Wikidata; Q54787537
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH922
AC   CVCL_PZ56
SY   XH922
DR   MMRRC; MMRRC:008903-UCD
DR   Wikidata; Q54787539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443876; Zbtb11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH923
AC   CVCL_PZ57
SY   XH923
DR   MMRRC; MMRRC:008904-UCD
DR   Wikidata; Q54787540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924057; Phf12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH925
AC   CVCL_PZ58
SY   XH925
DR   MMRRC; MMRRC:008906-UCD
DR   Wikidata; Q54787541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338068; Pdpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH930
AC   CVCL_PZ59
SY   XH930
DR   MMRRC; MMRRC:008908-UCD
DR   Wikidata; Q54787545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH952
AC   CVCL_PZ60
SY   XH952
DR   MMRRC; MMRRC:008909-UCD
DR   Wikidata; Q54787546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924234; Katnal2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XH984
AC   CVCL_PZ61
SY   XH984
DR   MMRRC; MMRRC:008910-UCD
DR   Wikidata; Q54787547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI223
AC   CVCL_PZ62
SY   XI223
DR   MMRRC; MMRRC:008911-UCD
DR   Wikidata; Q54787593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913666; Ndufa7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI250
AC   CVCL_PZ63
SY   XI250
DR   MMRRC; MMRRC:008912-UCD
DR   Wikidata; Q54787595
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889023; Banp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI253
AC   CVCL_PZ64
SY   XI253
DR   MMRRC; MMRRC:008913-UCD
DR   Wikidata; Q54787597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913906; Eef1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI335
AC   CVCL_PZ65
SY   XI335
DR   MMRRC; MMRRC:008915-UCD
DR   Wikidata; Q54787598
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443241; Ndufs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI339
AC   CVCL_PZ66
SY   XI339
DR   MMRRC; MMRRC:008916-UCD
DR   Wikidata; Q54787602
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914120; Serbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI340
AC   CVCL_PZ67
SY   XI340
DR   MMRRC; MMRRC:008917-UCD
DR   Wikidata; Q54787604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313286; Eif2b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI346
AC   CVCL_PZ68
SY   XI346
DR   MMRRC; MMRRC:008920-UCD
DR   Wikidata; Q54787605
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI369
AC   CVCL_PZ69
SY   XI369
DR   MMRRC; MMRRC:008923-UCD
DR   Wikidata; Q54787606
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919849; Pdia5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI374
AC   CVCL_PZ70
SY   XI374
DR   MMRRC; MMRRC:008925-UCD
DR   Wikidata; Q54787608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442372; Fam168a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI401
AC   CVCL_PZ71
SY   XI401
DR   MMRRC; MMRRC:008928-UCD
DR   Wikidata; Q54787609
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI402
AC   CVCL_PZ72
SY   XI402
DR   MMRRC; MMRRC:008929-UCD
DR   Wikidata; Q54787613
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278322; Epc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI426
AC   CVCL_PZ73
SY   XI426
DR   MMRRC; MMRRC:008930-UCD
DR   Wikidata; Q54787614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109349; Atf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI444
AC   CVCL_PZ74
SY   XI444
DR   MMRRC; MMRRC:008932-UCD
DR   Wikidata; Q54787616
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913906; Eef1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI445
AC   CVCL_PZ75
SY   XI445
DR   MMRRC; MMRRC:008933-UCD
DR   Wikidata; Q54787617
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913906; Eef1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI446
AC   CVCL_PZ76
SY   XI446
DR   MMRRC; MMRRC:008934-UCD
DR   Wikidata; Q54787620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96622; Itpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI447
AC   CVCL_PZ77
SY   XI447
DR   MMRRC; MMRRC:008935-UCD
DR   Wikidata; Q54787621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928380; B4galt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI452
AC   CVCL_PZ78
SY   XI452
DR   MMRRC; MMRRC:008936-UCD
DR   Wikidata; Q54787622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI456
AC   CVCL_PZ79
SY   XI456
DR   MMRRC; MMRRC:008937-UCD
DR   Wikidata; Q54787624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI459
AC   CVCL_PZ80
SY   XI459
DR   MMRRC; MMRRC:008938-UCD
DR   Wikidata; Q54787627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917829; Zc3h11a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI469
AC   CVCL_PZ81
SY   XI469
DR   MMRRC; MMRRC:008939-UCD
DR   Wikidata; Q54787629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444576; Kif20b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI470
AC   CVCL_PZ82
SY   XI470
DR   MMRRC; MMRRC:008940-UCD
DR   Wikidata; Q54787631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919742; Smg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI473
AC   CVCL_PZ83
SY   XI473
DR   MMRRC; MMRRC:008941-UCD
DR   Wikidata; Q54787634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914120; Serbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI478
AC   CVCL_PZ84
SY   XI478
DR   MMRRC; MMRRC:008942-UCD
DR   Wikidata; Q54787635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919742; Smg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XI486
AC   CVCL_PZ85
SY   XI486
DR   MMRRC; MMRRC:008943-UCD
DR   Wikidata; Q54787637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889272; Cadm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ018
AC   CVCL_PZ86
SY   XJ018
DR   MMRRC; MMRRC:008945-UCD
DR   Wikidata; Q54787639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ022
AC   CVCL_PZ87
SY   XJ022
DR   MMRRC; MMRRC:008946-UCD
DR   Wikidata; Q54787641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918367; Rbbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ023
AC   CVCL_PZ88
SY   XJ023
DR   MMRRC; MMRRC:008947-UCD
DR   Wikidata; Q54787644
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925349; Atrip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ042
AC   CVCL_PZ89
SY   XJ042
DR   MMRRC; MMRRC:008948-UCD
DR   Wikidata; Q54787647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3029632; Med13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ059
AC   CVCL_PZ90
SY   XJ059
DR   MMRRC; MMRRC:008949-UCD
DR   Wikidata; Q54787648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88451; Col18a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ075
AC   CVCL_PZ91
SY   XJ075
DR   MMRRC; MMRRC:008950-UCD
DR   Wikidata; Q54787649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ080
AC   CVCL_PZ92
SY   XJ080
DR   MMRRC; MMRRC:008951-UCD
DR   Wikidata; Q54787652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104729; Akap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ101
AC   CVCL_PZ93
SY   XJ101
DR   MMRRC; MMRRC:008952-UCD
DR   Wikidata; Q54787653
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182799; Kat7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ116
AC   CVCL_PZ94
SY   XJ116
DR   MMRRC; MMRRC:008954-UCD
DR   Wikidata; Q54787656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925201; Cyp20a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ119
AC   CVCL_PZ95
SY   XJ119
DR   MMRRC; MMRRC:008956-UCD
DR   Wikidata; Q54787659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858683; Copg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ130
AC   CVCL_PZ96
SY   XJ130
DR   MMRRC; MMRRC:008957-UCD
DR   Wikidata; Q54787661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924514; Zfp142.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ132
AC   CVCL_PZ97
SY   XJ132
DR   MMRRC; MMRRC:008958-UCD
DR   Wikidata; Q54787664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096398; Cd81.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ135
AC   CVCL_PZ98
SY   XJ135
DR   MMRRC; MMRRC:008959-UCD
DR   Wikidata; Q54787665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934811; Nucks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ139
AC   CVCL_PZ99
SY   XJ139
DR   MMRRC; MMRRC:008961-UCD
DR   Wikidata; Q54787667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109299; Polr2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ144
AC   CVCL_QA00
SY   XJ144
DR   MMRRC; MMRRC:008963-UCD
DR   Wikidata; Q54787669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142973; Lars2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ154
AC   CVCL_QA01
SY   XJ154
DR   MMRRC; MMRRC:008964-UCD
DR   Wikidata; Q54787672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95654; Gart.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ178
AC   CVCL_QA02
SY   XJ178
DR   MMRRC; MMRRC:008965-UCD
DR   Wikidata; Q54787708
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918040; Ubr5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ183
AC   CVCL_QA03
SY   XJ183
DR   MMRRC; MMRRC:008967-UCD
DR   Wikidata; Q54787710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140103; Nmd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ191
AC   CVCL_QA04
SY   XJ191
DR   MMRRC; MMRRC:008969-UCD
DR   Wikidata; Q54787712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445220; Dcaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ195
AC   CVCL_QA05
SY   XJ195
DR   MMRRC; MMRRC:008970-UCD
DR   Wikidata; Q54787713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861099; Ubr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ196
AC   CVCL_QA06
SY   XJ196
DR   MMRRC; MMRRC:008971-UCD
DR   Wikidata; Q54787714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919583; Palld.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ197
AC   CVCL_QA07
SY   XJ197
DR   MMRRC; MMRRC:008972-UCD
DR   Wikidata; Q54787716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858304; Ctps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ198
AC   CVCL_QA08
SY   XJ198
DR   MMRRC; MMRRC:008973-UCD
DR   Wikidata; Q54787719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ199
AC   CVCL_QA09
SY   XJ199
DR   MMRRC; MMRRC:008974-UCD
DR   Wikidata; Q54787720
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ201
AC   CVCL_QA10
SY   XJ201
DR   MMRRC; MMRRC:008975-UCD
DR   Wikidata; Q54787722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931751; Pum2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ205
AC   CVCL_QA11
SY   XJ205
DR   MMRRC; MMRRC:008977-UCD
DR   Wikidata; Q54787725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346098; Nelfa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XJ208
AC   CVCL_QA12
SY   XJ208
DR   MMRRC; MMRRC:008978-UCD
DR   Wikidata; Q54787726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926185; Saal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK001
AC   CVCL_QA13
SY   XK001
DR   MMRRC; MMRRC:008979-UCD
DR   Wikidata; Q54787727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88393; Chd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK007
AC   CVCL_QA14
SY   XK007
DR   MMRRC; MMRRC:008981-UCD
DR   Wikidata; Q54787730
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914322; Cdc37l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK018
AC   CVCL_QA15
SY   XK018
DR   MMRRC; MMRRC:008982-UCD
DR   Wikidata; Q54787732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858964; Actr1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK021
AC   CVCL_QA16
SY   XK021
DR   MMRRC; MMRRC:008983-UCD
DR   Wikidata; Q54787734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK022
AC   CVCL_QA17
SY   XK022
DR   MMRRC; MMRRC:008984-UCD
DR   Wikidata; Q54787736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106621; Myo1e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK049
AC   CVCL_QA18
SY   XK049
DR   MMRRC; MMRRC:008985-UCD
DR   Wikidata; Q54787738
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915527; 2310057M21Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK050
AC   CVCL_QA19
SY   XK050
DR   MMRRC; MMRRC:008986-UCD
DR   Wikidata; Q54787739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97547; Pfkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK051
AC   CVCL_QA20
SY   XK051
DR   MMRRC; MMRRC:008987-UCD
DR   Wikidata; Q54787741
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930197; Ncapg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK052
AC   CVCL_QA21
SY   XK052
DR   MMRRC; MMRRC:008988-UCD
DR   Wikidata; Q54787744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97805; Ptpn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK053
AC   CVCL_QA22
SY   XK053
DR   MMRRC; MMRRC:008989-UCD
DR   Wikidata; Q54787745
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351331; Chaf1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK055
AC   CVCL_QA23
SY   XK055
DR   MMRRC; MMRRC:008990-UCD
DR   Wikidata; Q54787747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143994; Psme4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK056
AC   CVCL_QA24
SY   XK056
DR   MMRRC; MMRRC:008991-UCD
DR   Wikidata; Q54787748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88302; Ccnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK057
AC   CVCL_QA25
SY   XK057
DR   MMRRC; MMRRC:008992-UCD
DR   Wikidata; Q54787750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917349; Smc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK059
AC   CVCL_QA26
SY   XK059
DR   MMRRC; MMRRC:008993-UCD
DR   Wikidata; Q54787752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88547; Csnk2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK062
AC   CVCL_QA27
SY   XK062
DR   MMRRC; MMRRC:008995-UCD
DR   Wikidata; Q54787754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK065
AC   CVCL_QA28
SY   XK065
DR   MMRRC; MMRRC:008997-UCD
DR   Wikidata; Q54787755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK066
AC   CVCL_QA29
SY   XK066
DR   MMRRC; MMRRC:008998-UCD
DR   Wikidata; Q54787757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913284; Psmd14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK068
AC   CVCL_QA30
SY   XK068
DR   MMRRC; MMRRC:008999-UCD
DR   Wikidata; Q54787760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919592; Lsm12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK069
AC   CVCL_QA31
SY   XK069
DR   MMRRC; MMRRC:009000-UCD
DR   Wikidata; Q54787761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK070
AC   CVCL_QA32
SY   XK070
DR   MMRRC; MMRRC:009001-UCD
DR   Wikidata; Q54787764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98341; Snrnp70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK071
AC   CVCL_QA33
SY   XK071
DR   MMRRC; MMRRC:009002-UCD
DR   Wikidata; Q54787765
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98388; Sptbn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK072
AC   CVCL_QA34
SY   XK072
DR   MMRRC; MMRRC:009003-UCD
DR   Wikidata; Q54787767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920538; Vps50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK073
AC   CVCL_QA35
SY   XK073
DR   MMRRC; MMRRC:009004-UCD
DR   Wikidata; Q54787770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914489; Rpf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK074
AC   CVCL_QA36
SY   XK074
DR   MMRRC; MMRRC:009005-UCD
DR   Wikidata; Q54787772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK078
AC   CVCL_QA37
SY   XK078
DR   MMRRC; MMRRC:009007-UCD
DR   Wikidata; Q54787774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443584; L3mbtl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK080
AC   CVCL_QA38
SY   XK080
DR   MMRRC; MMRRC:009008-UCD
DR   Wikidata; Q54787775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK081
AC   CVCL_QA39
SY   XK081
DR   MMRRC; MMRRC:009009-UCD
DR   Wikidata; Q54787776
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926082; Cacul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK082
AC   CVCL_QA40
SY   XK082
DR   MMRRC; MMRRC:009010-UCD
DR   Wikidata; Q54787777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99430; Hira.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK084
AC   CVCL_QA41
SY   XK084
DR   MMRRC; MMRRC:009011-UCD
DR   Wikidata; Q54787779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101785; Mybl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK088
AC   CVCL_QA42
SY   XK088
DR   MMRRC; MMRRC:009012-UCD
DR   Wikidata; Q54787866
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK089
AC   CVCL_QA43
SY   XK089
DR   MMRRC; MMRRC:009013-UCD
DR   Wikidata; Q54787868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913606; Knop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK090
AC   CVCL_QA44
SY   XK090
DR   MMRRC; MMRRC:009014-UCD
DR   Wikidata; Q54787871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919369; Tpx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK091
AC   CVCL_QA45
SY   XK091
DR   MMRRC; MMRRC:009015-UCD
DR   Wikidata; Q54787873
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920196; Lrrc47.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK093
AC   CVCL_QA46
SY   XK093
DR   MMRRC; MMRRC:009016-UCD
DR   Wikidata; Q54787875
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158813; Sumo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK094
AC   CVCL_QA47
SY   XK094
DR   MMRRC; MMRRC:009017-UCD
DR   Wikidata; Q54787876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919765; Wdr43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK096
AC   CVCL_QA48
SY   XK096
DR   MMRRC; MMRRC:009018-UCD
DR   Wikidata; Q54787877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917887; Ankrd26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK097
AC   CVCL_QA49
SY   XK097
DR   MMRRC; MMRRC:009019-UCD
DR   Wikidata; Q54787880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351658; Abcf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK098
AC   CVCL_QA50
SY   XK098
DR   MMRRC; MMRRC:009020-UCD
DR   Wikidata; Q54787882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916471; 2410006H16Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK101
AC   CVCL_QA51
SY   XK101
DR   MMRRC; MMRRC:009021-UCD
DR   Wikidata; Q54787883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK103
AC   CVCL_QA52
SY   XK103
DR   MMRRC; MMRRC:009023-UCD
DR   Wikidata; Q54787885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925868; Acap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK104
AC   CVCL_QA53
SY   XK104
DR   MMRRC; MMRRC:009024-UCD
DR   Wikidata; Q54787887
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101769; Mcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK109
AC   CVCL_QA54
SY   XK109
DR   MMRRC; MMRRC:009026-UCD
DR   Wikidata; Q54787889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858216; Ube2k.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK113
AC   CVCL_QA55
SY   XK113
DR   MMRRC; MMRRC:009027-UCD
DR   Wikidata; Q54787891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK115
AC   CVCL_QA56
SY   XK115
DR   MMRRC; MMRRC:009028-UCD
DR   Wikidata; Q54787892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2674092; Zfp609.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK121
AC   CVCL_QA57
SY   XK121
DR   MMRRC; MMRRC:009029-UCD
DR   Wikidata; Q54787894
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK122
AC   CVCL_QA58
SY   XK122
DR   MMRRC; MMRRC:009030-UCD
DR   Wikidata; Q54787898
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99400; Atp7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK123
AC   CVCL_QA59
SY   XK123
DR   MMRRC; MMRRC:009031-UCD
DR   Wikidata; Q54787901
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK127
AC   CVCL_QA60
SY   XK127
DR   MMRRC; MMRRC:009032-UCD
DR   Wikidata; Q54787904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277958; Pcm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK131
AC   CVCL_QA61
SY   XK131
DR   MMRRC; MMRRC:009033-UCD
DR   Wikidata; Q54787905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK134
AC   CVCL_QA62
SY   XK134
DR   MMRRC; MMRRC:009034-UCD
DR   Wikidata; Q54787907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196391; Pole.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK135
AC   CVCL_QA63
SY   XK135
DR   MMRRC; MMRRC:009035-UCD
DR   Wikidata; Q54787908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443205; Rbm15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK136
AC   CVCL_QA64
SY   XK136
DR   MMRRC; MMRRC:009036-UCD
DR   Wikidata; Q54787910
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913355; Ube2d3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK138
AC   CVCL_QA65
SY   XK138
DR   MMRRC; MMRRC:009037-UCD
DR   Wikidata; Q54787911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK142
AC   CVCL_QA66
SY   XK142
DR   MMRRC; MMRRC:009040-UCD
DR   Wikidata; Q54787913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443732; Dna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK143
AC   CVCL_QA67
SY   XK143
DR   MMRRC; MMRRC:009041-UCD
DR   Wikidata; Q54787915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK146
AC   CVCL_QA68
SY   XK146
DR   MMRRC; MMRRC:009042-UCD
DR   Wikidata; Q54787918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106906; Eif4a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK147
AC   CVCL_QA69
SY   XK147
DR   MMRRC; MMRRC:009043-UCD
DR   Wikidata; Q54787919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102724; Tpp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK148
AC   CVCL_QA70
SY   XK148
DR   MMRRC; MMRRC:009044-UCD
DR   Wikidata; Q54787922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88547; Csnk2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK150
AC   CVCL_QA71
SY   XK150
DR   MMRRC; MMRRC:009045-UCD
DR   Wikidata; Q54787925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK151
AC   CVCL_QA72
SY   XK151
DR   MMRRC; MMRRC:009046-UCD
DR   Wikidata; Q54787927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385139; Rabgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK152
AC   CVCL_QA73
SY   XK152
DR   MMRRC; MMRRC:009047-UCD
DR   Wikidata; Q54787930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098693; Tet1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK153
AC   CVCL_QA74
SY   XK153
DR   MMRRC; MMRRC:009048-UCD
DR   Wikidata; Q54787932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933973; Rbfox2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK155
AC   CVCL_QA75
SY   XK155
DR   MMRRC; MMRRC:009050-UCD
DR   Wikidata; Q54787933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339951; Cse1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK156
AC   CVCL_QA76
SY   XK156
DR   MMRRC; MMRRC:009051-UCD
DR   Wikidata; Q54787935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915205; Sugt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK157
AC   CVCL_QA77
SY   XK157
DR   MMRRC; MMRRC:009052-UCD
DR   Wikidata; Q54787939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK163
AC   CVCL_QA78
SY   XK163
DR   MMRRC; MMRRC:009053-UCD
DR   Wikidata; Q54787940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK164
AC   CVCL_QA79
SY   XK164
DR   MMRRC; MMRRC:009054-UCD
DR   Wikidata; Q54787943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK165
AC   CVCL_QA80
SY   XK165
DR   MMRRC; MMRRC:009055-UCD
DR   Wikidata; Q54787946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK166
AC   CVCL_QA81
SY   XK166
DR   MMRRC; MMRRC:009056-UCD
DR   Wikidata; Q54787949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK167
AC   CVCL_QA82
SY   XK167
DR   MMRRC; MMRRC:009057-UCD
DR   Wikidata; Q54787996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105976; Myo5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK168
AC   CVCL_QA83
SY   XK168
DR   MMRRC; MMRRC:009058-UCD
DR   Wikidata; Q54787998
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108426; Kif1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK169
AC   CVCL_QA84
SY   XK169
DR   MMRRC; MMRRC:009059-UCD
DR   Wikidata; Q54788000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK171
AC   CVCL_QA85
SY   XK171
DR   MMRRC; MMRRC:009060-UCD
DR   Wikidata; Q54788001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446190; Nup188.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK172
AC   CVCL_QA86
SY   XK172
DR   MMRRC; MMRRC:009061-UCD
DR   Wikidata; Q54788003
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK176
AC   CVCL_QA87
SY   XK176
DR   MMRRC; MMRRC:009062-UCD
DR   Wikidata; Q54788005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98086; Polr2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK177
AC   CVCL_QA88
SY   XK177
DR   MMRRC; MMRRC:009063-UCD
DR   Wikidata; Q54788006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106035; Mki67.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK181
AC   CVCL_QA89
SY   XK181
DR   MMRRC; MMRRC:009064-UCD
DR   Wikidata; Q54788008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK182
AC   CVCL_QA90
SY   XK182
DR   MMRRC; MMRRC:009065-UCD
DR   Wikidata; Q54788010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924705; Rlf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK185
AC   CVCL_QA91
SY   XK185
DR   MMRRC; MMRRC:009066-UCD
DR   Wikidata; Q54788012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919349; Elp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK187
AC   CVCL_QA92
SY   XK187
DR   MMRRC; MMRRC:009067-UCD
DR   Wikidata; Q54788014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103575; Skp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XK191
AC   CVCL_QA93
SY   XK191
DR   MMRRC; MMRRC:009069-UCD
DR   Wikidata; Q54788016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK192
AC   CVCL_QA94
SY   XK192
DR   MMRRC; MMRRC:009070-UCD
DR   Wikidata; Q54788018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183260; Luc7l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK195
AC   CVCL_QA95
SY   XK195
DR   MMRRC; MMRRC:009072-UCD
DR   Wikidata; Q54788020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924337; Ankrd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK197
AC   CVCL_QA96
SY   XK197
DR   MMRRC; MMRRC:009073-UCD
DR   Wikidata; Q54788022
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104670; Fkbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK198
AC   CVCL_QA97
SY   XK198
DR   MMRRC; MMRRC:009074-UCD
DR   Wikidata; Q54788024
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448526; Gmps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK199
AC   CVCL_QA98
SY   XK199
DR   MMRRC; MMRRC:009075-UCD
DR   Wikidata; Q54788026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK202
AC   CVCL_QA99
SY   XK202
DR   MMRRC; MMRRC:009076-UCD
DR   Wikidata; Q54788028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891691; Arpp19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK203
AC   CVCL_QB00
SY   XK203
DR   MMRRC; MMRRC:009077-UCD
DR   Wikidata; Q54788030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97451; Otx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK204
AC   CVCL_QB01
SY   XK204
DR   MMRRC; MMRRC:009078-UCD
DR   Wikidata; Q54788031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK206
AC   CVCL_QB02
SY   XK206
DR   MMRRC; MMRRC:009080-UCD
DR   Wikidata; Q54788034
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344373; Ubl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK207
AC   CVCL_QB03
SY   XK207
DR   MMRRC; MMRRC:009081-UCD
DR   Wikidata; Q54788036
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913937; Tbc1d15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK210
AC   CVCL_QB04
SY   XK210
DR   MMRRC; MMRRC:009082-UCD
DR   Wikidata; Q54788038
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK211
AC   CVCL_QB05
SY   XK211
DR   MMRRC; MMRRC:009083-UCD
DR   Wikidata; Q54788041
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349394; Map4k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK216
AC   CVCL_QB06
SY   XK216
DR   MMRRC; MMRRC:009084-UCD
DR   Wikidata; Q54788043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3590554; BC055324.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK217
AC   CVCL_QB07
SY   XK217
DR   MMRRC; MMRRC:009085-UCD
DR   Wikidata; Q54788045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923356; Kdm3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK218
AC   CVCL_QB08
SY   XK218
DR   MMRRC; MMRRC:009086-UCD
DR   Wikidata; Q54788046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355328; Nasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK223
AC   CVCL_QB09
SY   XK223
DR   MMRRC; MMRRC:009087-UCD
DR   Wikidata; Q54788051
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443028; Taf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK226
AC   CVCL_QB10
SY   XK226
DR   MMRRC; MMRRC:009088-UCD
DR   Wikidata; Q54788052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK227
AC   CVCL_QB11
SY   XK227
DR   MMRRC; MMRRC:009089-UCD
DR   Wikidata; Q54788055
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925939; Naa35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK228
AC   CVCL_QB12
SY   XK228
DR   MMRRC; MMRRC:009090-UCD
DR   Wikidata; Q54788058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99511; Ptpn11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK231
AC   CVCL_QB13
SY   XK231
DR   MMRRC; MMRRC:009091-UCD
DR   Wikidata; Q54788060
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352466; Nr2c2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK232
AC   CVCL_QB14
SY   XK232
DR   MMRRC; MMRRC:009092-UCD
DR   Wikidata; Q54788062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914595; Herc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK242
AC   CVCL_QB15
SY   XK242
DR   MMRRC; MMRRC:009093-UCD
DR   Wikidata; Q54788064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK248
AC   CVCL_QB16
SY   XK248
DR   MMRRC; MMRRC:009095-UCD
DR   Wikidata; Q54788066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447876; Sec22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK249
AC   CVCL_QB17
SY   XK249
DR   MMRRC; MMRRC:009096-UCD
DR   Wikidata; Q54788068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK257
AC   CVCL_QB18
SY   XK257
DR   MMRRC; MMRRC:009097-UCD
DR   Wikidata; Q54788069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK258
AC   CVCL_QB19
SY   XK258
DR   MMRRC; MMRRC:009098-UCD
DR   Wikidata; Q54788073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927165; Mettl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK277
AC   CVCL_QB20
SY   XK277
DR   MMRRC; MMRRC:009101-UCD
DR   Wikidata; Q54788074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK280
AC   CVCL_QB21
SY   XK280
DR   MMRRC; MMRRC:009102-UCD
DR   Wikidata; Q54788075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914429; Ccdc25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK283
AC   CVCL_QB22
SY   XK283
DR   MMRRC; MMRRC:009103-UCD
DR   Wikidata; Q54788172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102956; Cdk7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK284
AC   CVCL_QB23
SY   XK284
DR   MMRRC; MMRRC:009104-UCD
DR   Wikidata; Q54788174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277218; Rpap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK286
AC   CVCL_QB24
SY   XK286
DR   MMRRC; MMRRC:009105-UCD
DR   Wikidata; Q54788177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929658; Tbk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK287
AC   CVCL_QB25
SY   XK287
DR   MMRRC; MMRRC:009106-UCD
DR   Wikidata; Q54788179
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920907; Fbrsl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK293
AC   CVCL_QB26
SY   XK293
DR   MMRRC; MMRRC:009107-UCD
DR   Wikidata; Q54788180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK294
AC   CVCL_QB27
SY   XK294
DR   MMRRC; MMRRC:009108-UCD
DR   Wikidata; Q54788183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK301
AC   CVCL_QB28
SY   XK301
DR   MMRRC; MMRRC:009109-UCD
DR   Wikidata; Q54788185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921633; Ubap2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk303
AC   CVCL_QB29
SY   Xk303
DR   MMRRC; MMRRC:009942-UCD
DR   Wikidata; Q54788187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917933; Utp20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK308
AC   CVCL_QB30
SY   XK308
DR   MMRRC; MMRRC:009111-UCD
DR   Wikidata; Q54788190
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918079; Ccdc93.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK309
AC   CVCL_QB31
SY   XK309
DR   MMRRC; MMRRC:009112-UCD
DR   Wikidata; Q54788191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925868; Acap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk314
AC   CVCL_QB32
SY   Xk314
DR   MMRRC; MMRRC:009943-UCD
DR   Wikidata; Q54788192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914447; Zcrb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk316
AC   CVCL_QB33
SY   Xk316
DR   MMRRC; MMRRC:009944-UCD
DR   Wikidata; Q54788194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145130; Cog5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk318
AC   CVCL_QB34
SY   Xk318
DR   MMRRC; MMRRC:009945-UCD
DR   Wikidata; Q54788197
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919433; Snx6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk320
AC   CVCL_QB35
SY   Xk320
DR   MMRRC; MMRRC:009946-UCD
DR   Wikidata; Q54788199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144865; Tecpr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk321
AC   CVCL_QB36
SY   Xk321
DR   MMRRC; MMRRC:009947-UCD
DR   Wikidata; Q54788201
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914081; Cab39l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk324
AC   CVCL_QB37
SY   Xk324
DR   MMRRC; MMRRC:009949-UCD
DR   Wikidata; Q54788202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914789; Dock6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk325
AC   CVCL_QB38
SY   Xk325
DR   MMRRC; MMRRC:009950-UCD
DR   Wikidata; Q54788206
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922088; Naa15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK326
AC   CVCL_QB39
SY   XK326
DR   MMRRC; MMRRC:009114-UCD
DR   Wikidata; Q54788207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143994; Psme4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK328
AC   CVCL_QB40
SY   XK328
DR   MMRRC; MMRRC:009115-UCD
DR   Wikidata; Q54788209
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921393; Opa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK329
AC   CVCL_QB41
SY   XK329
DR   MMRRC; MMRRC:009116-UCD
DR   Wikidata; Q54788210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK330
AC   CVCL_QB42
SY   XK330
DR   MMRRC; MMRRC:009117-UCD
DR   Wikidata; Q54788214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140592; Slc44a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK333
AC   CVCL_QB43
SY   XK333
DR   MMRRC; MMRRC:009118-UCD
DR   Wikidata; Q54788215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK334
AC   CVCL_QB44
SY   XK334
DR   MMRRC; MMRRC:009119-UCD
DR   Wikidata; Q54788217
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441849; Lpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK335
AC   CVCL_QB45
SY   XK335
DR   MMRRC; MMRRC:009120-UCD
DR   Wikidata; Q54788219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924337; Ankrd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK338
AC   CVCL_QB46
SY   XK338
DR   MMRRC; MMRRC:009122-UCD
DR   Wikidata; Q54788221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914782; Mfap1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk343
AC   CVCL_QB47
SY   Xk343
DR   MMRRC; MMRRC:009952-UCD
DR   Wikidata; Q54788224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144865; Tecpr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk346
AC   CVCL_QB48
SY   Xk346
DR   MMRRC; MMRRC:009954-UCD
DR   Wikidata; Q54788225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444188; Dgkh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk348
AC   CVCL_QB49
SY   Xk348
DR   MMRRC; MMRRC:009955-UCD
DR   Wikidata; Q54788229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442366; Peak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line Xk351
AC   CVCL_QB50
SY   Xk351
DR   MMRRC; MMRRC:009957-UCD
DR   Wikidata; Q54788230
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343094; Kat2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK355
AC   CVCL_QB51
SY   XK355
DR   MMRRC; MMRRC:009123-UCD
DR   Wikidata; Q54788231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351625; Nbn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK358
AC   CVCL_QB52
SY   XK358
DR   MMRRC; MMRRC:009124-UCD
DR   Wikidata; Q54788233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894652; Usp10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK359
AC   CVCL_QB53
SY   XK359
DR   MMRRC; MMRRC:009125-UCD
DR   Wikidata; Q54788234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441849; Lpp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK366
AC   CVCL_QB54
SY   XK366
DR   MMRRC; MMRRC:009126-UCD
DR   Wikidata; Q54788237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK367
AC   CVCL_QB55
SY   XK367
DR   MMRRC; MMRRC:009127-UCD
DR   Wikidata; Q54788239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923294; Ncapg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK373
AC   CVCL_QB56
SY   XK373
DR   MMRRC; MMRRC:009128-UCD
DR   Wikidata; Q54788240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675669; Nusap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK376
AC   CVCL_QB57
SY   XK376
DR   MMRRC; MMRRC:009129-UCD
DR   Wikidata; Q54788241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927170; Spata5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK377
AC   CVCL_QB58
SY   XK377
DR   MMRRC; MMRRC:009130-UCD
DR   Wikidata; Q54788243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921537; Kcmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK378
AC   CVCL_QB59
SY   XK378
DR   MMRRC; MMRRC:009131-UCD
DR   Wikidata; Q54788245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137512; Arid4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK381
AC   CVCL_QB60
SY   XK381
DR   MMRRC; MMRRC:009132-UCD
DR   Wikidata; Q54788247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861774; Rbms1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK383
AC   CVCL_QB61
SY   XK383
DR   MMRRC; MMRRC:009133-UCD
DR   Wikidata; Q54788249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915309; Tm9sf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK388
AC   CVCL_QB62
SY   XK388
DR   MMRRC; MMRRC:009134-UCD
DR   Wikidata; Q54788327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154263; Bicra.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK392
AC   CVCL_QB63
SY   XK392
DR   MMRRC; MMRRC:009135-UCD
DR   Wikidata; Q54788328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88261; Canx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK393
AC   CVCL_QB64
SY   XK393
DR   MMRRC; MMRRC:009136-UCD
DR   Wikidata; Q54788330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917818; Cpne3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK394
AC   CVCL_QB65
SY   XK394
DR   MMRRC; MMRRC:009137-UCD
DR   Wikidata; Q54788332
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK403
AC   CVCL_QB66
SY   XK403
DR   MMRRC; MMRRC:009138-UCD
DR   Wikidata; Q54788334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444748; Chd7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK405
AC   CVCL_QB67
SY   XK405
DR   MMRRC; MMRRC:009139-UCD
DR   Wikidata; Q54788337
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444207; Vps13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK406
AC   CVCL_QB68
SY   XK406
DR   MMRRC; MMRRC:009140-UCD
DR   Wikidata; Q54788339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK409
AC   CVCL_QB69
SY   XK409
DR   MMRRC; MMRRC:009142-UCD
DR   Wikidata; Q54788340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3708729; Rnps1-ps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XK411
AC   CVCL_QB70
SY   XK411
DR   MMRRC; MMRRC:009144-UCD
DR   Wikidata; Q54788342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916249; Anapc10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK413
AC   CVCL_QB71
SY   XK413
DR   MMRRC; MMRRC:009145-UCD
DR   Wikidata; Q54788344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921493; Slx4ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK417
AC   CVCL_QB72
SY   XK417
DR   MMRRC; MMRRC:009147-UCD
DR   Wikidata; Q54788346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442980; Dennd6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK421
AC   CVCL_QB73
SY   XK421
DR   MMRRC; MMRRC:009150-UCD
DR   Wikidata; Q54788347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK423
AC   CVCL_QB74
SY   XK423
DR   MMRRC; MMRRC:009152-UCD
DR   Wikidata; Q54788350
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919398; Tdrp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK427
AC   CVCL_QB75
SY   XK427
DR   MMRRC; MMRRC:009154-UCD
DR   Wikidata; Q54788352
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154405; Map4k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK429
AC   CVCL_QB76
SY   XK429
DR   MMRRC; MMRRC:009155-UCD
DR   Wikidata; Q54788354
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276124; Ep400.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK430
AC   CVCL_QB77
SY   XK430
DR   MMRRC; MMRRC:009156-UCD
DR   Wikidata; Q54788356
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919736; Obi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XK440
AC   CVCL_QB78
SY   XK440
DR   MMRRC; MMRRC:009157-UCD
DR   Wikidata; Q54788360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99832; Sec13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK442
AC   CVCL_QB79
SY   XK442
DR   MMRRC; MMRRC:009158-UCD
DR   Wikidata; Q54788362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313261; Sptbn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK445
AC   CVCL_QB80
SY   XK445
DR   MMRRC; MMRRC:009159-UCD
DR   Wikidata; Q54788365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921690; Cmip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK448
AC   CVCL_QB81
SY   XK448
DR   MMRRC; MMRRC:009160-UCD
DR   Wikidata; Q54788366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97758; Prim2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK451
AC   CVCL_QB82
SY   XK451
DR   MMRRC; MMRRC:009161-UCD
DR   Wikidata; Q54788368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK452
AC   CVCL_QB83
SY   XK452
DR   MMRRC; MMRRC:009162-UCD
DR   Wikidata; Q54788371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444575; Soga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK460
AC   CVCL_QB84
SY   XK460
DR   MMRRC; MMRRC:009163-UCD
DR   Wikidata; Q54788372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK463
AC   CVCL_QB85
SY   XK463
DR   MMRRC; MMRRC:009164-UCD
DR   Wikidata; Q54788376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101760; Sfswap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK464
AC   CVCL_QB86
SY   XK464
DR   MMRRC; MMRRC:009165-UCD
DR   Wikidata; Q54788378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928484; Nudt3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK491
AC   CVCL_QB87
SY   XK491
DR   MMRRC; MMRRC:009166-UCD
DR   Wikidata; Q54788383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK492
AC   CVCL_QB88
SY   XK492
DR   MMRRC; MMRRC:009167-UCD
DR   Wikidata; Q54788384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107749; Tpd52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK495
AC   CVCL_QB89
SY   XK495
DR   MMRRC; MMRRC:009168-UCD
DR   Wikidata; Q54788387
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK499
AC   CVCL_QB90
SY   XK499
DR   MMRRC; MMRRC:009170-UCD
DR   Wikidata; Q54788388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK500
AC   CVCL_QB91
SY   XK500
DR   MMRRC; MMRRC:009171-UCD
DR   Wikidata; Q54788390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925868; Acap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK506
AC   CVCL_QB92
SY   XK506
DR   MMRRC; MMRRC:009176-UCD
DR   Wikidata; Q54788391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK507
AC   CVCL_QB93
SY   XK507
DR   MMRRC; MMRRC:009177-UCD
DR   Wikidata; Q54788393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919257; Fndc3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK510
AC   CVCL_QB94
SY   XK510
DR   MMRRC; MMRRC:009180-UCD
DR   Wikidata; Q54788395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890218; Akap10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK512
AC   CVCL_QB95
SY   XK512
DR   MMRRC; MMRRC:009181-UCD
DR   Wikidata; Q54788398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098240; Kif16b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK514
AC   CVCL_QB96
SY   XK514
DR   MMRRC; MMRRC:009182-UCD
DR   Wikidata; Q54788400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146430; Cblb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK515
AC   CVCL_QB97
SY   XK515
DR   MMRRC; MMRRC:009183-UCD
DR   Wikidata; Q54788403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351611; Exoc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK516
AC   CVCL_QB98
SY   XK516
DR   MMRRC; MMRRC:009184-UCD
DR   Wikidata; Q54788404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK517
AC   CVCL_QB99
SY   XK517
DR   MMRRC; MMRRC:009185-UCD
DR   Wikidata; Q54788406
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444268; Fam169a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK518
AC   CVCL_QC00
SY   XK518
DR   MMRRC; MMRRC:009186-UCD
DR   Wikidata; Q54788407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143994; Psme4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK521
AC   CVCL_QC01
SY   XK521
DR   MMRRC; MMRRC:009187-UCD
DR   Wikidata; Q54788409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330299; Dyrk1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK522
AC   CVCL_QC02
SY   XK522
DR   MMRRC; MMRRC:009188-UCD
DR   Wikidata; Q54788501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142523; Crtc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK523
AC   CVCL_QC03
SY   XK523
DR   MMRRC; MMRRC:009189-UCD
DR   Wikidata; Q54788504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99400; Atp7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK524
AC   CVCL_QC04
SY   XK524
DR   MMRRC; MMRRC:009190-UCD
DR   Wikidata; Q54788505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK525
AC   CVCL_QC05
SY   XK525
DR   MMRRC; MMRRC:009191-UCD
DR   Wikidata; Q54788508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917887; Ankrd26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK527
AC   CVCL_QC06
SY   XK527
DR   MMRRC; MMRRC:009192-UCD
DR   Wikidata; Q54788509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347045; Psmb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK529
AC   CVCL_QC07
SY   XK529
DR   MMRRC; MMRRC:009193-UCD
DR   Wikidata; Q54788513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860486; Tdp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK530
AC   CVCL_QC08
SY   XK530
DR   MMRRC; MMRRC:009194-UCD
DR   Wikidata; Q54788514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918006; Dock4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK531
AC   CVCL_QC09
SY   XK531
DR   MMRRC; MMRRC:009195-UCD
DR   Wikidata; Q54788516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918006; Dock4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK535
AC   CVCL_QC10
SY   XK535
DR   MMRRC; MMRRC:009196-UCD
DR   Wikidata; Q54788518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK536
AC   CVCL_QC11
SY   XK536
DR   MMRRC; MMRRC:009197-UCD
DR   Wikidata; Q54788519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK538
AC   CVCL_QC12
SY   XK538
DR   MMRRC; MMRRC:009198-UCD
DR   Wikidata; Q54788521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK542
AC   CVCL_QC13
SY   XK542
DR   MMRRC; MMRRC:009200-UCD
DR   Wikidata; Q54788522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97054; Mov10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK546
AC   CVCL_QC14
SY   XK546
DR   MMRRC; MMRRC:009201-UCD
DR   Wikidata; Q54788523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098264; Kif13a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK550
AC   CVCL_QC15
SY   XK550
DR   MMRRC; MMRRC:009202-UCD
DR   Wikidata; Q54788525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442620; Nup133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK551
AC   CVCL_QC16
SY   XK551
DR   MMRRC; MMRRC:009203-UCD
DR   Wikidata; Q54788528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444023; Tdrd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK552
AC   CVCL_QC17
SY   XK552
DR   MMRRC; MMRRC:009204-UCD
DR   Wikidata; Q54788530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923334; Ptbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK553
AC   CVCL_QC18
SY   XK553
DR   MMRRC; MMRRC:009205-UCD
DR   Wikidata; Q54788534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK554
AC   CVCL_QC19
SY   XK554
DR   MMRRC; MMRRC:009206-UCD
DR   Wikidata; Q54788535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347045; Psmb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK567
AC   CVCL_QC20
SY   XK567
DR   MMRRC; MMRRC:009207-UCD
DR   Wikidata; Q54788538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922033; Fbf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK569
AC   CVCL_QC21
SY   XK569
DR   MMRRC; MMRRC:009208-UCD
DR   Wikidata; Q54788539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916885; Dapk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK570
AC   CVCL_QC22
SY   XK570
DR   MMRRC; MMRRC:009209-UCD
DR   Wikidata; Q54788541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88175; Manba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK571
AC   CVCL_QC23
SY   XK571
DR   MMRRC; MMRRC:009210-UCD
DR   Wikidata; Q54788544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860206; Ammecr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK574
AC   CVCL_QC24
SY   XK574
DR   MMRRC; MMRRC:009211-UCD
DR   Wikidata; Q54788546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919369; Tpx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK575
AC   CVCL_QC25
SY   XK575
DR   MMRRC; MMRRC:009212-UCD
DR   Wikidata; Q54788548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196316; R3hcc1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK578
AC   CVCL_QC26
SY   XK578
DR   MMRRC; MMRRC:009213-UCD
DR   Wikidata; Q54788549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106330; Larp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK579
AC   CVCL_QC27
SY   XK579
DR   MMRRC; MMRRC:009214-UCD
DR   Wikidata; Q54788552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926188; Fbxo34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK580
AC   CVCL_QC28
SY   XK580
DR   MMRRC; MMRRC:009215-UCD
DR   Wikidata; Q54788554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3694236; 6820431F20Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK581
AC   CVCL_QC29
SY   XK581
DR   MMRRC; MMRRC:009216-UCD
DR   Wikidata; Q54788556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143994; Psme4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK582
AC   CVCL_QC30
SY   XK582
DR   MMRRC; MMRRC:009217-UCD
DR   Wikidata; Q54788558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894652; Usp10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK583
AC   CVCL_QC31
SY   XK583
DR   MMRRC; MMRRC:009218-UCD
DR   Wikidata; Q54788559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143994; Psme4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK584
AC   CVCL_QC32
SY   XK584
DR   MMRRC; MMRRC:009219-UCD
DR   Wikidata; Q54788562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK586
AC   CVCL_QC33
SY   XK586
DR   MMRRC; MMRRC:009221-UCD
DR   Wikidata; Q54788564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333813; Mbd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK588
AC   CVCL_QC34
SY   XK588
DR   MMRRC; MMRRC:009222-UCD
DR   Wikidata; Q54788565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK589
AC   CVCL_QC35
SY   XK589
DR   MMRRC; MMRRC:009223-UCD
DR   Wikidata; Q54788568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK590
AC   CVCL_QC36
SY   XK590
DR   MMRRC; MMRRC:009224-UCD
DR   Wikidata; Q54788570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK593
AC   CVCL_QC37
SY   XK593
DR   MMRRC; MMRRC:009225-UCD
DR   Wikidata; Q54788572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930140; Wdr6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK594
AC   CVCL_QC38
SY   XK594
DR   MMRRC; MMRRC:009226-UCD
DR   Wikidata; Q54788575
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104913; Abi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK595
AC   CVCL_QC39
SY   XK595
DR   MMRRC; MMRRC:009227-UCD
DR   Wikidata; Q54788577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444207; Vps13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK596
AC   CVCL_QC40
SY   XK596
DR   MMRRC; MMRRC:009228-UCD
DR   Wikidata; Q54788580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444207; Vps13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK597
AC   CVCL_QC41
SY   XK597
DR   MMRRC; MMRRC:009229-UCD
DR   Wikidata; Q54788582
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924363; Klhl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK603
AC   CVCL_QC42
SY   XK603
DR   MMRRC; MMRRC:009231-UCD
DR   Wikidata; Q54788623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101783; Plk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK681
AC   CVCL_QC43
SY   XK681
DR   MMRRC; MMRRC:009232-UCD
DR   Wikidata; Q54788625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102706; Fdft1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK682
AC   CVCL_QC44
SY   XK682
DR   MMRRC; MMRRC:009233-UCD
DR   Wikidata; Q54788626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913872; Ubr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK683
AC   CVCL_QC45
SY   XK683
DR   MMRRC; MMRRC:009234-UCD
DR   Wikidata; Q54788628
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096566; Pias2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK687
AC   CVCL_QC46
SY   XK687
DR   MMRRC; MMRRC:009235-UCD
DR   Wikidata; Q54788630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444098; Heatr5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK712
AC   CVCL_QC47
SY   XK712
DR   MMRRC; MMRRC:009238-UCD
DR   Wikidata; Q54788632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336993; Ap4e1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK714
AC   CVCL_QC48
SY   XK714
DR   MMRRC; MMRRC:009239-UCD
DR   Wikidata; Q54788635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK730
AC   CVCL_QC49
SY   XK730
DR   MMRRC; MMRRC:009240-UCD
DR   Wikidata; Q54788636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351511; Psmd7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK731
AC   CVCL_QC50
SY   XK731
DR   MMRRC; MMRRC:009241-UCD
DR   Wikidata; Q54788638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK732
AC   CVCL_QC51
SY   XK732
DR   MMRRC; MMRRC:009242-UCD
DR   Wikidata; Q54788640
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099804; Hip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK733
AC   CVCL_QC52
SY   XK733
DR   MMRRC; MMRRC:009243-UCD
DR   Wikidata; Q54788641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916658; Dnajc17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK737
AC   CVCL_QC53
SY   XK737
DR   MMRRC; MMRRC:009246-UCD
DR   Wikidata; Q54788643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339984; Pak2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK742
AC   CVCL_QC54
SY   XK742
DR   MMRRC; MMRRC:009248-UCD
DR   Wikidata; Q54788647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926788; Apip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK744
AC   CVCL_QC55
SY   XK744
DR   MMRRC; MMRRC:009250-UCD
DR   Wikidata; Q54788649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443008; Trappc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK751
AC   CVCL_QC56
SY   XK751
DR   MMRRC; MMRRC:009251-UCD
DR   Wikidata; Q54788652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915205; Sugt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK752
AC   CVCL_QC57
SY   XK752
DR   MMRRC; MMRRC:009252-UCD
DR   Wikidata; Q54788654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106484; Rufy3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XK758
AC   CVCL_QC58
SY   XK758
DR   MMRRC; MMRRC:009253-UCD
DR   Wikidata; Q54788655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443008; Trappc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL002
AC   CVCL_QC59
SY   XL002
DR   MMRRC; MMRRC:009255-UCD
DR   Wikidata; Q54788657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338037; Rbm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL004
AC   CVCL_QC60
SY   XL004
DR   MMRRC; MMRRC:009257-UCD
DR   Wikidata; Q54788659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339639; Ogt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL005
AC   CVCL_QC61
SY   XL005
DR   MMRRC; MMRRC:009258-UCD
DR   Wikidata; Q54788661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915389; Tox4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL006
AC   CVCL_QC62
SY   XL006
DR   MMRRC; MMRRC:009259-UCD
DR   Wikidata; Q54788663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915033; Ahctf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL009
AC   CVCL_QC63
SY   XL009
DR   MMRRC; MMRRC:009260-UCD
DR   Wikidata; Q54788666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890357; Igf2bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL011
AC   CVCL_QC64
SY   XL011
DR   MMRRC; MMRRC:009261-UCD
DR   Wikidata; Q54788669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355322; Exosc10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL013
AC   CVCL_QC65
SY   XL013
DR   MMRRC; MMRRC:009263-UCD
DR   Wikidata; Q54788671
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:893577; Stx4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL015
AC   CVCL_QC66
SY   XL015
DR   MMRRC; MMRRC:009264-UCD
DR   Wikidata; Q54788673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109656; Lasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL017
AC   CVCL_QC67
SY   XL017
DR   MMRRC; MMRRC:009265-UCD
DR   Wikidata; Q54788675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106478; Eif3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL018
AC   CVCL_QC68
SY   XL018
DR   MMRRC; MMRRC:009266-UCD
DR   Wikidata; Q54788678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338037; Rbm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL021
AC   CVCL_QC69
SY   XL021
DR   MMRRC; MMRRC:009268-UCD
DR   Wikidata; Q54788679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL023
AC   CVCL_QC70
SY   XL023
DR   MMRRC; MMRRC:009269-UCD
DR   Wikidata; Q54788681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347043; Orc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL025
AC   CVCL_QC71
SY   XL025
DR   MMRRC; MMRRC:009270-UCD
DR   Wikidata; Q54788684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107716; Myo10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL026
AC   CVCL_QC72
SY   XL026
DR   MMRRC; MMRRC:009271-UCD
DR   Wikidata; Q54788686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914869; Nob1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL027
AC   CVCL_QC73
SY   XL027
DR   MMRRC; MMRRC:009272-UCD
DR   Wikidata; Q54788687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL028
AC   CVCL_QC74
SY   XL028
DR   MMRRC; MMRRC:009273-UCD
DR   Wikidata; Q54788691
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152414; Ipo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL030
AC   CVCL_QC75
SY   XL030
DR   MMRRC; MMRRC:009274-UCD
DR   Wikidata; Q54788693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL031
AC   CVCL_QC76
SY   XL031
DR   MMRRC; MMRRC:009275-UCD
DR   Wikidata; Q54788695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914302; Ndc80.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL033
AC   CVCL_QC77
SY   XL033
DR   MMRRC; MMRRC:009276-UCD
DR   Wikidata; Q54788696
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447364; Smg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL034
AC   CVCL_QC78
SY   XL034
DR   MMRRC; MMRRC:009277-UCD
DR   Wikidata; Q54788699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924288; Arfgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL035
AC   CVCL_QC79
SY   XL035
DR   MMRRC; MMRRC:009278-UCD
DR   Wikidata; Q54788702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL036
AC   CVCL_QC80
SY   XL036
DR   MMRRC; MMRRC:009279-UCD
DR   Wikidata; Q54788703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL037
AC   CVCL_QC81
SY   XL037
DR   MMRRC; MMRRC:009280-UCD
DR   Wikidata; Q54788705
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915264; Zwilch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL040
AC   CVCL_QC82
SY   XL040
DR   MMRRC; MMRRC:009281-UCD
DR   Wikidata; Q54788810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197519; Bcl2l11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL041
AC   CVCL_QC83
SY   XL041
DR   MMRRC; MMRRC:009282-UCD
DR   Wikidata; Q54788811
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL042
AC   CVCL_QC84
SY   XL042
DR   MMRRC; MMRRC:009283-UCD
DR   Wikidata; Q54788812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923356; Kdm3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL045
AC   CVCL_QC85
SY   XL045
DR   MMRRC; MMRRC:009284-UCD
DR   Wikidata; Q54788814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929264; Sae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL046
AC   CVCL_QC86
SY   XL046
DR   MMRRC; MMRRC:009285-UCD
DR   Wikidata; Q54788815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98931; Ezr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL047
AC   CVCL_QC87
SY   XL047
DR   MMRRC; MMRRC:009286-UCD
DR   Wikidata; Q54788817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL049
AC   CVCL_QC88
SY   XL049
DR   MMRRC; MMRRC:009288-UCD
DR   Wikidata; Q54788818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920026; Sass6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL051
AC   CVCL_QC89
SY   XL051
DR   MMRRC; MMRRC:009289-UCD
DR   Wikidata; Q54788819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921075; Ppp1r21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL052
AC   CVCL_QC90
SY   XL052
DR   MMRRC; MMRRC:009290-UCD
DR   Wikidata; Q54788822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107752; Myo1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL055
AC   CVCL_QC91
SY   XL055
DR   MMRRC; MMRRC:009292-UCD
DR   Wikidata; Q54788825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96677; Kit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL056
AC   CVCL_QC92
SY   XL056
DR   MMRRC; MMRRC:009293-UCD
DR   Wikidata; Q54788827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88547; Csnk2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL057
AC   CVCL_QC93
SY   XL057
DR   MMRRC; MMRRC:009294-UCD
DR   Wikidata; Q54788830
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924054; Kdm4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL058
AC   CVCL_QC94
SY   XL058
DR   MMRRC; MMRRC:009295-UCD
DR   Wikidata; Q54788832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146156; Espl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL060
AC   CVCL_QC95
SY   XL060
DR   MMRRC; MMRRC:009296-UCD
DR   Wikidata; Q54788835
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136773; Cwc22.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL061
AC   CVCL_QC96
SY   XL061
DR   MMRRC; MMRRC:009297-UCD
DR   Wikidata; Q54788837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98927; Vcl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL062
AC   CVCL_QC97
SY   XL062
DR   MMRRC; MMRRC:009298-UCD
DR   Wikidata; Q54788838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858317; Timm23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL063
AC   CVCL_QC98
SY   XL063
DR   MMRRC; MMRRC:009299-UCD
DR   Wikidata; Q54788839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142347; Zfp568.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL064
AC   CVCL_QC99
SY   XL064
DR   MMRRC; MMRRC:009300-UCD
DR   Wikidata; Q54788842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197519; Bcl2l11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL065
AC   CVCL_QD00
SY   XL065
DR   MMRRC; MMRRC:009301-UCD
DR   Wikidata; Q54788844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL066
AC   CVCL_QD01
SY   XL066
DR   MMRRC; MMRRC:009302-UCD
DR   Wikidata; Q54788847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914750; Ccar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL067
AC   CVCL_QD02
SY   XL067
DR   MMRRC; MMRRC:009303-UCD
DR   Wikidata; Q54788849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1306778; Map1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL068
AC   CVCL_QD03
SY   XL068
DR   MMRRC; MMRRC:009304-UCD
DR   Wikidata; Q54788850
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL069
AC   CVCL_QD04
SY   XL069
DR   MMRRC; MMRRC:009305-UCD
DR   Wikidata; Q54788853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3780541; Lncenc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL073
AC   CVCL_QD05
SY   XL073
DR   MMRRC; MMRRC:009306-UCD
DR   Wikidata; Q54788854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL074
AC   CVCL_QD06
SY   XL074
DR   MMRRC; MMRRC:009307-UCD
DR   Wikidata; Q54788858
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL075
AC   CVCL_QD07
SY   XL075
DR   MMRRC; MMRRC:009308-UCD
DR   Wikidata; Q54788860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917606; St13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL078
AC   CVCL_QD08
SY   XL078
DR   MMRRC; MMRRC:009309-UCD
DR   Wikidata; Q54788861
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101769; Mcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL079
AC   CVCL_QD09
SY   XL079
DR   MMRRC; MMRRC:009310-UCD
DR   Wikidata; Q54788865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL080
AC   CVCL_QD10
SY   XL080
DR   MMRRC; MMRRC:009311-UCD
DR   Wikidata; Q54788868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388633; Cltc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL083
AC   CVCL_QD11
SY   XL083
DR   MMRRC; MMRRC:009312-UCD
DR   Wikidata; Q54788870
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346035; Farsb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL087
AC   CVCL_QD12
SY   XL087
DR   MMRRC; MMRRC:009313-UCD
DR   Wikidata; Q54788872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309528; Ppp1r12a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL088
AC   CVCL_QD13
SY   XL088
DR   MMRRC; MMRRC:009314-UCD
DR   Wikidata; Q54788874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309528; Ppp1r12a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL140
AC   CVCL_QD14
SY   XL140
DR   MMRRC; MMRRC:009315-UCD
DR   Wikidata; Q54788876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915560; Zmym1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL142
AC   CVCL_QD15
SY   XL142
DR   MMRRC; MMRRC:009316-UCD
DR   Wikidata; Q54788879
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929472; Uqcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL144
AC   CVCL_QD16
SY   XL144
DR   MMRRC; MMRRC:009317-UCD
DR   Wikidata; Q54788881
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918667; Gpatch8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL154
AC   CVCL_QD17
SY   XL154
DR   MMRRC; MMRRC:009321-UCD
DR   Wikidata; Q54788883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915301; Nutf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL162
AC   CVCL_QD18
SY   XL162
DR   MMRRC; MMRRC:009323-UCD
DR   Wikidata; Q54788886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105089; Hsd17b4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL165
AC   CVCL_QD19
SY   XL165
DR   MMRRC; MMRRC:009324-UCD
DR   Wikidata; Q54788889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917129; Golph3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL166
AC   CVCL_QD20
SY   XL166
DR   MMRRC; MMRRC:009325-UCD
DR   Wikidata; Q54788892
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95481; Ptk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL167
AC   CVCL_QD21
SY   XL167
DR   MMRRC; MMRRC:009326-UCD
DR   Wikidata; Q54788893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL169
AC   CVCL_QD22
SY   XL169
DR   MMRRC; MMRRC:009328-UCD
DR   Wikidata; Q54788943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098824; Odf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL179
AC   CVCL_QD23
SY   XL179
DR   MMRRC; MMRRC:009331-UCD
DR   Wikidata; Q54788947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443816; Snx8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL236
AC   CVCL_QD24
SY   XL236
DR   MMRRC; MMRRC:009333-UCD
DR   Wikidata; Q54788948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137738; Prcc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL240
AC   CVCL_QD25
SY   XL240
DR   MMRRC; MMRRC:009335-UCD
DR   Wikidata; Q54788950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919451; Otud6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL241
AC   CVCL_QD26
SY   XL241
DR   MMRRC; MMRRC:009336-UCD
DR   Wikidata; Q54788953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913435; Virma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL243
AC   CVCL_QD27
SY   XL243
DR   MMRRC; MMRRC:009337-UCD
DR   Wikidata; Q54788955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87930; Adk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL244
AC   CVCL_QD28
SY   XL244
DR   MMRRC; MMRRC:009338-UCD
DR   Wikidata; Q54788957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917275; Acot7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL275
AC   CVCL_QD29
SY   XL275
DR   MMRRC; MMRRC:009339-UCD
DR   Wikidata; Q54788959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108109; Ywhag.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL512
AC   CVCL_QD30
SY   XL512
DR   MMRRC; MMRRC:009341-UCD
DR   Wikidata; Q54788963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351500; Nup62.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL515
AC   CVCL_QD31
SY   XL515
DR   MMRRC; MMRRC:009342-UCD
DR   Wikidata; Q54788965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2674092; Zfp609.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL516
AC   CVCL_QD32
SY   XL516
DR   MMRRC; MMRRC:009343-UCD
DR   Wikidata; Q54788969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354737; Kdm2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL525
AC   CVCL_QD33
SY   XL525
DR   MMRRC; MMRRC:009345-UCD
DR   Wikidata; Q54788971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101919; Ap1g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL526
AC   CVCL_QD34
SY   XL526
DR   MMRRC; MMRRC:009346-UCD
DR   Wikidata; Q54788973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918639; Chd6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL528
AC   CVCL_QD35
SY   XL528
DR   MMRRC; MMRRC:009347-UCD
DR   Wikidata; Q54788974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098258; Kif15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL529
AC   CVCL_QD36
SY   XL529
DR   MMRRC; MMRRC:009348-UCD
DR   Wikidata; Q54788978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919449; Mms19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL530
AC   CVCL_QD37
SY   XL530
DR   MMRRC; MMRRC:009349-UCD
DR   Wikidata; Q54788980
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444266; Ube2o.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL531
AC   CVCL_QD38
SY   XL531
DR   MMRRC; MMRRC:009350-UCD
DR   Wikidata; Q54788982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL541
AC   CVCL_QD39
SY   XL541
DR   MMRRC; MMRRC:009354-UCD
DR   Wikidata; Q54788984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429770; Nle1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL543
AC   CVCL_QD40
SY   XL543
DR   MMRRC; MMRRC:009355-UCD
DR   Wikidata; Q54788986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145099; Mis18bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL544
AC   CVCL_QD41
SY   XL544
DR   MMRRC; MMRRC:009356-UCD
DR   Wikidata; Q54788987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2429950; Xpo6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL545
AC   CVCL_QD42
SY   XL545
DR   MMRRC; MMRRC:009357-UCD
DR   Wikidata; Q54788988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316717; Ifrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL571
AC   CVCL_QD43
SY   XL571
DR   MMRRC; MMRRC:009359-UCD
DR   Wikidata; Q54788990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141867; Inpp5f.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL573
AC   CVCL_QD44
SY   XL573
DR   MMRRC; MMRRC:009360-UCD
DR   Wikidata; Q54788993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891840; Ncbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL575
AC   CVCL_QD45
SY   XL575
DR   MMRRC; MMRRC:009361-UCD
DR   Wikidata; Q54788995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446526; Cpt1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL577
AC   CVCL_QD46
SY   XL577
DR   MMRRC; MMRRC:009362-UCD
DR   Wikidata; Q54788997
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923497; Inka2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XL629
AC   CVCL_QD47
SY   XL629
DR   MMRRC; MMRRC:009364-UCD
DR   Wikidata; Q54788999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289265; Tbc1d22a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL635
AC   CVCL_QD48
SY   XL635
DR   MMRRC; MMRRC:009366-UCD
DR   Wikidata; Q54789001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL637
AC   CVCL_QD49
SY   XL637
DR   MMRRC; MMRRC:009367-UCD
DR   Wikidata; Q54789005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919283; Tsc22d2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL643
AC   CVCL_QD50
SY   XL643
DR   MMRRC; MMRRC:009371-UCD
DR   Wikidata; Q54789006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923784; Osbpl9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL738
AC   CVCL_QD51
SY   XL738
DR   MMRRC; MMRRC:009375-UCD
DR   Wikidata; Q54789010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861728; Wwp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL742
AC   CVCL_QD52
SY   XL742
DR   MMRRC; MMRRC:009376-UCD
DR   Wikidata; Q54789011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL772
AC   CVCL_QD53
SY   XL772
DR   MMRRC; MMRRC:009377-UCD
DR   Wikidata; Q54789013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918667; Gpatch8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL783
AC   CVCL_QD54
SY   XL783
DR   MMRRC; MMRRC:009380-UCD
DR   Wikidata; Q54789014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918457; Nudt4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL784
AC   CVCL_QD55
SY   XL784
DR   MMRRC; MMRRC:009381-UCD
DR   Wikidata; Q54789016
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147870; Lrch2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL785
AC   CVCL_QD56
SY   XL785
DR   MMRRC; MMRRC:009382-UCD
DR   Wikidata; Q54789018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL788
AC   CVCL_QD57
SY   XL788
DR   MMRRC; MMRRC:009385-UCD
DR   Wikidata; Q54789020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926884; Huwe1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL791
AC   CVCL_QD58
SY   XL791
DR   MMRRC; MMRRC:009386-UCD
DR   Wikidata; Q54789021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925976; Scaper.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL794
AC   CVCL_QD59
SY   XL794
DR   MMRRC; MMRRC:009388-UCD
DR   Wikidata; Q54789023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915963; Ifitm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL795
AC   CVCL_QD60
SY   XL795
DR   MMRRC; MMRRC:009389-UCD
DR   Wikidata; Q54789026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL796
AC   CVCL_QD61
SY   XL796
DR   MMRRC; MMRRC:009390-UCD
DR   Wikidata; Q54789027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338889; Uhrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL797
AC   CVCL_QD62
SY   XL797
DR   MMRRC; MMRRC:009391-UCD
DR   Wikidata; Q54789071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919151; Fam219a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL798
AC   CVCL_QD63
SY   XL798
DR   MMRRC; MMRRC:009392-UCD
DR   Wikidata; Q54789073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861728; Wwp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL799
AC   CVCL_QD64
SY   XL799
DR   MMRRC; MMRRC:009393-UCD
DR   Wikidata; Q54789075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99638; Mark2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL802
AC   CVCL_QD65
SY   XL802
DR   MMRRC; MMRRC:009395-UCD
DR   Wikidata; Q54789076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159344; Vangl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL817
AC   CVCL_QD66
SY   XL817
DR   MMRRC; MMRRC:009396-UCD
DR   Wikidata; Q54789080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889023; Banp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL818
AC   CVCL_QD67
SY   XL818
DR   MMRRC; MMRRC:009397-UCD
DR   Wikidata; Q54789081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921527; Chic2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL821
AC   CVCL_QD68
SY   XL821
DR   MMRRC; MMRRC:009398-UCD
DR   Wikidata; Q54789083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922552; Asxl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL823
AC   CVCL_QD69
SY   XL823
DR   MMRRC; MMRRC:009399-UCD
DR   Wikidata; Q54789085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446526; Cpt1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL826
AC   CVCL_QD70
SY   XL826
DR   MMRRC; MMRRC:009401-UCD
DR   Wikidata; Q54789086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387217; Ift52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL909
AC   CVCL_QD71
SY   XL909
DR   MMRRC; MMRRC:009402-UCD
DR   Wikidata; Q54789088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347044; Orc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL911
AC   CVCL_QD72
SY   XL911
DR   MMRRC; MMRRC:009403-UCD
DR   Wikidata; Q54789090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL913
AC   CVCL_QD73
SY   XL913
DR   MMRRC; MMRRC:009405-UCD
DR   Wikidata; Q54789091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443432; Foxj3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL914
AC   CVCL_QD74
SY   XL914
DR   MMRRC; MMRRC:009406-UCD
DR   Wikidata; Q54789094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443432; Foxj3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL916
AC   CVCL_QD75
SY   XL916
DR   MMRRC; MMRRC:009407-UCD
DR   Wikidata; Q54789096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104878; Prkar1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL919
AC   CVCL_QD76
SY   XL919
DR   MMRRC; MMRRC:009409-UCD
DR   Wikidata; Q54789097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922566; Taf1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL920
AC   CVCL_QD77
SY   XL920
DR   MMRRC; MMRRC:009410-UCD
DR   Wikidata; Q54789098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917933; Utp20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL922
AC   CVCL_QD78
SY   XL922
DR   MMRRC; MMRRC:009411-UCD
DR   Wikidata; Q54789099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925542; Orai1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL923
AC   CVCL_QD79
SY   XL923
DR   MMRRC; MMRRC:009412-UCD
DR   Wikidata; Q54789102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106184; Npm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL924
AC   CVCL_QD80
SY   XL924
DR   MMRRC; MMRRC:009413-UCD
DR   Wikidata; Q54789105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL931
AC   CVCL_QD81
SY   XL931
DR   MMRRC; MMRRC:009417-UCD
DR   Wikidata; Q54789106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923969; Kansl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL933
AC   CVCL_QD82
SY   XL933
DR   MMRRC; MMRRC:009419-UCD
DR   Wikidata; Q54789108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929492; Atl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL934
AC   CVCL_QD83
SY   XL934
DR   MMRRC; MMRRC:009420-UCD
DR   Wikidata; Q54789110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917140; Zfp219.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL945
AC   CVCL_QD84
SY   XL945
DR   MMRRC; MMRRC:009423-UCD
DR   Wikidata; Q54789111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443138; Mphosph9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL952
AC   CVCL_QD85
SY   XL952
DR   MMRRC; MMRRC:009427-UCD
DR   Wikidata; Q54789114
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916192; Chmp2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL954
AC   CVCL_QD86
SY   XL954
DR   MMRRC; MMRRC:009428-UCD
DR   Wikidata; Q54789116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL958
AC   CVCL_QD87
SY   XL958
DR   MMRRC; MMRRC:009429-UCD
DR   Wikidata; Q54789119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99526; Ddx19a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL960
AC   CVCL_QD88
SY   XL960
DR   MMRRC; MMRRC:009430-UCD
DR   Wikidata; Q54789120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202879; Tcf7l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL961
AC   CVCL_QD89
SY   XL961
DR   MMRRC; MMRRC:009431-UCD
DR   Wikidata; Q54789122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109377; Ell.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL964
AC   CVCL_QD90
SY   XL964
DR   MMRRC; MMRRC:009432-UCD
DR   Wikidata; Q54789126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108405; Apbb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL965
AC   CVCL_QD91
SY   XL965
DR   MMRRC; MMRRC:009433-UCD
DR   Wikidata; Q54789127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143333; Exog.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL978
AC   CVCL_QD92
SY   XL978
DR   MMRRC; MMRRC:009437-UCD
DR   Wikidata; Q54789128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99137; Xrcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL988
AC   CVCL_QD93
SY   XL988
DR   MMRRC; MMRRC:009438-UCD
DR   Wikidata; Q54789129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923164; Exoc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XL989
AC   CVCL_QD94
SY   XL989
DR   MMRRC; MMRRC:009439-UCD
DR   Wikidata; Q54789132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105982; Rfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM047
AC   CVCL_QD95
SY   XM047
DR   MMRRC; MMRRC:009443-UCD
DR   Wikidata; Q54789133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96677; Kit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM051
AC   CVCL_QD96
SY   XM051
DR   MMRRC; MMRRC:009444-UCD
DR   Wikidata; Q54789137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM052
AC   CVCL_QD97
SY   XM052
DR   MMRRC; MMRRC:009445-UCD
DR   Wikidata; Q54789138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919000; R3hdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM060
AC   CVCL_QD98
SY   XM060
DR   MMRRC; MMRRC:009446-UCD
DR   Wikidata; Q54789139
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442675; Rfx7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM062
AC   CVCL_QD99
SY   XM062
DR   MMRRC; MMRRC:009447-UCD
DR   Wikidata; Q54789142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM063
AC   CVCL_QE00
SY   XM063
DR   MMRRC; MMRRC:009448-UCD
DR   Wikidata; Q54789144
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289164; Ncaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM067
AC   CVCL_QE01
SY   XM067
DR   MMRRC; MMRRC:009451-UCD
DR   Wikidata; Q54789146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95481; Ptk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM071
AC   CVCL_QE02
SY   XM071
DR   MMRRC; MMRRC:009453-UCD
DR   Wikidata; Q54789247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140729; Zfand2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM073
AC   CVCL_QE03
SY   XM073
DR   MMRRC; MMRRC:009454-UCD
DR   Wikidata; Q54789248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920243; Appl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM074
AC   CVCL_QE04
SY   XM074
DR   MMRRC; MMRRC:009455-UCD
DR   Wikidata; Q54789250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442860; Eda2r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM081
AC   CVCL_QE05
SY   XM081
DR   MMRRC; MMRRC:009456-UCD
DR   Wikidata; Q54789251
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443472; Atf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM083
AC   CVCL_QE06
SY   XM083
DR   MMRRC; MMRRC:009458-UCD
DR   Wikidata; Q54789254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444959; Kmt2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM084
AC   CVCL_QE07
SY   XM084
DR   MMRRC; MMRRC:009459-UCD
DR   Wikidata; Q54789255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137738; Prcc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM087
AC   CVCL_QE08
SY   XM087
DR   MMRRC; MMRRC:009461-UCD
DR   Wikidata; Q54789257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM091
AC   CVCL_QE09
SY   XM091
DR   MMRRC; MMRRC:009462-UCD
DR   Wikidata; Q54789258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928750; Rab2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM102
AC   CVCL_QE10
SY   XM102
DR   MMRRC; MMRRC:009463-UCD
DR   Wikidata; Q54789260
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM103
AC   CVCL_QE11
SY   XM103
DR   MMRRC; MMRRC:009464-UCD
DR   Wikidata; Q54789261
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096573; Utp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM104
AC   CVCL_QE12
SY   XM104
DR   MMRRC; MMRRC:009465-UCD
DR   Wikidata; Q54789263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929264; Sae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM106
AC   CVCL_QE13
SY   XM106
DR   MMRRC; MMRRC:009466-UCD
DR   Wikidata; Q54789266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918971; Fam13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM109
AC   CVCL_QE14
SY   XM109
DR   MMRRC; MMRRC:009467-UCD
DR   Wikidata; Q54789267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098240; Kif16b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM110
AC   CVCL_QE15
SY   XM110
DR   MMRRC; MMRRC:009468-UCD
DR   Wikidata; Q54789269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102579; Nmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM140
AC   CVCL_QE16
SY   XM140
DR   MMRRC; MMRRC:009472-UCD
DR   Wikidata; Q54789272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917483; Cd2bp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM150
AC   CVCL_QE17
SY   XM150
DR   MMRRC; MMRRC:009474-UCD
DR   Wikidata; Q54789274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915560; Zmym1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM151
AC   CVCL_QE18
SY   XM151
DR   MMRRC; MMRRC:009475-UCD
DR   Wikidata; Q54789276
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99256; Hdlbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM155
AC   CVCL_QE19
SY   XM155
DR   MMRRC; MMRRC:009477-UCD
DR   Wikidata; Q54789278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM157
AC   CVCL_QE20
SY   XM157
DR   MMRRC; MMRRC:009478-UCD
DR   Wikidata; Q54789279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM162
AC   CVCL_QE21
SY   XM162
DR   MMRRC; MMRRC:009480-UCD
DR   Wikidata; Q54789282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925237; Ascc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM163
AC   CVCL_QE22
SY   XM163
DR   MMRRC; MMRRC:009481-UCD
DR   Wikidata; Q54789284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM165
AC   CVCL_QE23
SY   XM165
DR   MMRRC; MMRRC:009482-UCD
DR   Wikidata; Q54789286
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98927; Vcl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM167
AC   CVCL_QE24
SY   XM167
DR   MMRRC; MMRRC:009483-UCD
DR   Wikidata; Q54789288
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916944; Tatdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM172
AC   CVCL_QE25
SY   XM172
DR   MMRRC; MMRRC:009484-UCD
DR   Wikidata; Q54789292
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446296; Sik3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM173
AC   CVCL_QE26
SY   XM173
DR   MMRRC; MMRRC:009485-UCD
DR   Wikidata; Q54789293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384875; Cdk5rap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM177
AC   CVCL_QE27
SY   XM177
DR   MMRRC; MMRRC:009487-UCD
DR   Wikidata; Q54789294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913892; Ctnnbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM179
AC   CVCL_QE28
SY   XM179
DR   MMRRC; MMRRC:009488-UCD
DR   Wikidata; Q54789295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444959; Kmt2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM182
AC   CVCL_QE29
SY   XM182
DR   MMRRC; MMRRC:009489-UCD
DR   Wikidata; Q54789296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890222; Midn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM183
AC   CVCL_QE30
SY   XM183
DR   MMRRC; MMRRC:009490-UCD
DR   Wikidata; Q54789297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890222; Midn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM184
AC   CVCL_QE31
SY   XM184
DR   MMRRC; MMRRC:009491-UCD
DR   Wikidata; Q54789298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338881; St14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM188
AC   CVCL_QE32
SY   XM188
DR   MMRRC; MMRRC:009492-UCD
DR   Wikidata; Q54789301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261820; Cand1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM190
AC   CVCL_QE33
SY   XM190
DR   MMRRC; MMRRC:009493-UCD
DR   Wikidata; Q54789302
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm2393 (MGI:3780561) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XM192
AC   CVCL_QE34
SY   XM192
DR   MMRRC; MMRRC:009494-UCD
DR   Wikidata; Q54789306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923272; 5830417I10Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM194
AC   CVCL_QE35
SY   XM194
DR   MMRRC; MMRRC:009496-UCD
DR   Wikidata; Q54789308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915913; Slc25a25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM195
AC   CVCL_QE36
SY   XM195
DR   MMRRC; MMRRC:009497-UCD
DR   Wikidata; Q54789311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444188; Dgkh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM209
AC   CVCL_QE37
SY   XM209
DR   MMRRC; MMRRC:009499-UCD
DR   Wikidata; Q54789312
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88274; Ctnna1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM215
AC   CVCL_QE38
SY   XM215
DR   MMRRC; MMRRC:009501-UCD
DR   Wikidata; Q54789313
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919933; Proser1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM219
AC   CVCL_QE39
SY   XM219
DR   MMRRC; MMRRC:009502-UCD
DR   Wikidata; Q54789314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685106; Mideas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XM220
AC   CVCL_QE40
SY   XM220
DR   MMRRC; MMRRC:009503-UCD
DR   Wikidata; Q54789315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261827; Dnmt3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM221
AC   CVCL_QE41
SY   XM221
DR   MMRRC; MMRRC:009504-UCD
DR   Wikidata; Q54789317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM222
AC   CVCL_QE42
SY   XM222
DR   MMRRC; MMRRC:009505-UCD
DR   Wikidata; Q54789358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM223
AC   CVCL_QE43
SY   XM223
DR   MMRRC; MMRRC:009506-UCD
DR   Wikidata; Q54789359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919933; Proser1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM225
AC   CVCL_QE44
SY   XM225
DR   MMRRC; MMRRC:009507-UCD
DR   Wikidata; Q54789360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442153; Gak.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM230
AC   CVCL_QE45
SY   XM230
DR   MMRRC; MMRRC:009509-UCD
DR   Wikidata; Q54789362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109656; Lasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM231
AC   CVCL_QE46
SY   XM231
DR   MMRRC; MMRRC:009510-UCD
DR   Wikidata; Q54789364
RX   PubMed=12520002;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Caution: Was said to be a knockout for Gm2393 (MGI:3780561) which is no longer considered a gene by MGI.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XM232
AC   CVCL_QE47
SY   XM232
DR   MMRRC; MMRRC:009511-UCD
DR   Wikidata; Q54789366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM233
AC   CVCL_QE48
SY   XM233
DR   MMRRC; MMRRC:009512-UCD
DR   Wikidata; Q54789369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109367; Impdh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM234
AC   CVCL_QE49
SY   XM234
DR   MMRRC; MMRRC:009513-UCD
DR   Wikidata; Q54789372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931237; Wwox.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM235
AC   CVCL_QE50
SY   XM235
DR   MMRRC; MMRRC:009514-UCD
DR   Wikidata; Q54789375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924053; Zfp998.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XM238
AC   CVCL_QE51
SY   XM238
DR   MMRRC; MMRRC:009516-UCD
DR   Wikidata; Q54789378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921456; Sipa1l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM243
AC   CVCL_QE52
SY   XM243
DR   MMRRC; MMRRC:009517-UCD
DR   Wikidata; Q54789379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913963; Actr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM244
AC   CVCL_QE53
SY   XM244
DR   MMRRC; MMRRC:009518-UCD
DR   Wikidata; Q54789383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045391; Lin52.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM248
AC   CVCL_QE54
SY   XM248
DR   MMRRC; MMRRC:009519-UCD
DR   Wikidata; Q54789384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098240; Kif16b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM250
AC   CVCL_QE55
SY   XM250
DR   MMRRC; MMRRC:009520-UCD
DR   Wikidata; Q54789386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109606; Fnbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM255
AC   CVCL_QE56
SY   XM255
DR   MMRRC; MMRRC:009521-UCD
DR   Wikidata; Q54789389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917579; Gon4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM256
AC   CVCL_QE57
SY   XM256
DR   MMRRC; MMRRC:009522-UCD
DR   Wikidata; Q54789391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449057; Gars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM258
AC   CVCL_QE58
SY   XM258
DR   MMRRC; MMRRC:009523-UCD
DR   Wikidata; Q54789393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109606; Fnbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM260
AC   CVCL_QE59
SY   XM260
DR   MMRRC; MMRRC:009524-UCD
DR   Wikidata; Q54789395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913963; Actr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM261
AC   CVCL_QE60
SY   XM261
DR   MMRRC; MMRRC:009525-UCD
DR   Wikidata; Q54789398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913963; Actr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM263
AC   CVCL_QE61
SY   XM263
DR   MMRRC; MMRRC:009526-UCD
DR   Wikidata; Q54789400
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3646700; Amt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM265
AC   CVCL_QE62
SY   XM265
DR   MMRRC; MMRRC:009527-UCD
DR   Wikidata; Q54789402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858216; Ube2k.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM266
AC   CVCL_QE63
SY   XM266
DR   MMRRC; MMRRC:009528-UCD
DR   Wikidata; Q54789404
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890222; Midn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM268
AC   CVCL_QE64
SY   XM268
DR   MMRRC; MMRRC:009529-UCD
DR   Wikidata; Q54789407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919433; Snx6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM269
AC   CVCL_QE65
SY   XM269
DR   MMRRC; MMRRC:009530-UCD
DR   Wikidata; Q54789408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277178; Fam91a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM270
AC   CVCL_QE66
SY   XM270
DR   MMRRC; MMRRC:009531-UCD
DR   Wikidata; Q54789410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915095; Rnf115.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XM274
AC   CVCL_QE67
SY   XM274
DR   MMRRC; MMRRC:009532-UCD
DR   Wikidata; Q54789411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105037; Ddx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN010
AC   CVCL_QE68
SY   XN010
DR   MMRRC; MMRRC:009536-UCD
DR   Wikidata; Q54789414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261758; Suz12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN014
AC   CVCL_QE69
SY   XN014
DR   MMRRC; MMRRC:009539-UCD
DR   Wikidata; Q54789416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN017
AC   CVCL_QE70
SY   XN017
DR   MMRRC; MMRRC:009541-UCD
DR   Wikidata; Q54789419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096397; Polr1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN019
AC   CVCL_QE71
SY   XN019
DR   MMRRC; MMRRC:009542-UCD
DR   Wikidata; Q54789421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN022
AC   CVCL_QE72
SY   XN022
DR   MMRRC; MMRRC:009543-UCD
DR   Wikidata; Q54789424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103067; Atrx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN029
AC   CVCL_QE73
SY   XN029
DR   MMRRC; MMRRC:009548-UCD
DR   Wikidata; Q54789426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338068; Pdpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN033
AC   CVCL_QE74
SY   XN033
DR   MMRRC; MMRRC:009551-UCD
DR   Wikidata; Q54789428
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932610; Noc3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN124
AC   CVCL_QE75
SY   XN124
DR   MMRRC; MMRRC:009557-UCD
DR   Wikidata; Q54789430
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88190; Braf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN126
AC   CVCL_QE76
SY   XN126
DR   MMRRC; MMRRC:009559-UCD
DR   Wikidata; Q54789433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97245; Mxi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN128
AC   CVCL_QE77
SY   XN128
DR   MMRRC; MMRRC:009561-UCD
DR   Wikidata; Q54789435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918040; Ubr5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN152
AC   CVCL_QE78
SY   XN152
DR   MMRRC; MMRRC:009574-UCD
DR   Wikidata; Q54789436
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929658; Tbk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN155
AC   CVCL_QE79
SY   XN155
DR   MMRRC; MMRRC:009577-UCD
DR   Wikidata; Q54789439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925764; Arhgap10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN156
AC   CVCL_QE80
SY   XN156
DR   MMRRC; MMRRC:009578-UCD
DR   Wikidata; Q54789441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88115; Atp5a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN157
AC   CVCL_QE81
SY   XN157
DR   MMRRC; MMRRC:009579-UCD
DR   Wikidata; Q54789444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106330; Larp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN161
AC   CVCL_QE82
SY   XN161
DR   MMRRC; MMRRC:009582-UCD
DR   Wikidata; Q54789488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109433; Oaz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN165
AC   CVCL_QE83
SY   XN165
DR   MMRRC; MMRRC:009586-UCD
DR   Wikidata; Q54789489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333856; Klf9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN187
AC   CVCL_QE84
SY   XN187
DR   MMRRC; MMRRC:009603-UCD
DR   Wikidata; Q54789492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858260; Gosr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN188
AC   CVCL_QE85
SY   XN188
DR   MMRRC; MMRRC:009604-UCD
DR   Wikidata; Q54789493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914472; Srfbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN191
AC   CVCL_QE86
SY   XN191
DR   MMRRC; MMRRC:009606-UCD
DR   Wikidata; Q54789496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924050; Usp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN195
AC   CVCL_QE87
SY   XN195
DR   MMRRC; MMRRC:009608-UCD
DR   Wikidata; Q54789498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919885; Lins1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN196
AC   CVCL_QE88
SY   XN196
DR   MMRRC; MMRRC:009609-UCD
DR   Wikidata; Q54789500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919421; Shq1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN199
AC   CVCL_QE89
SY   XN199
DR   MMRRC; MMRRC:009612-UCD
DR   Wikidata; Q54789501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277166; Sp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN217
AC   CVCL_QE90
SY   XN217
DR   MMRRC; MMRRC:009621-UCD
DR   Wikidata; Q54789503
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107995; Upf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN237
AC   CVCL_QE91
SY   XN237
DR   MMRRC; MMRRC:009622-UCD
DR   Wikidata; Q54789506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107502; H1f3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XN242
AC   CVCL_QE92
SY   XN242
DR   MMRRC; MMRRC:009624-UCD
DR   Wikidata; Q54789507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915261; Snrpg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN245
AC   CVCL_QE93
SY   XN245
DR   MMRRC; MMRRC:009626-UCD
DR   Wikidata; Q54789512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446190; Nup188.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN246
AC   CVCL_QE94
SY   XN246
DR   MMRRC; MMRRC:009627-UCD
DR   Wikidata; Q54789513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158736; Senp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN248
AC   CVCL_QE95
SY   XN248
DR   MMRRC; MMRRC:009628-UCD
DR   Wikidata; Q54789516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104861; Bcat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN253
AC   CVCL_QE96
SY   XN253
DR   MMRRC; MMRRC:009632-UCD
DR   Wikidata; Q54789518
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098658; Stag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN254
AC   CVCL_QE97
SY   XN254
DR   MMRRC; MMRRC:009633-UCD
DR   Wikidata; Q54789521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN256
AC   CVCL_QE98
SY   XN256
DR   MMRRC; MMRRC:009634-UCD
DR   Wikidata; Q54789524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858313; Uba2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN258
AC   CVCL_QE99
SY   XN258
DR   MMRRC; MMRRC:009636-UCD
DR   Wikidata; Q54789525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183683; Nav1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN259
AC   CVCL_QF00
SY   XN259
DR   MMRRC; MMRRC:009637-UCD
DR   Wikidata; Q54789527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919654; Wdr44.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN260
AC   CVCL_QF01
SY   XN260
DR   MMRRC; MMRRC:009638-UCD
DR   Wikidata; Q54789529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929266; Snd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN263
AC   CVCL_QF02
SY   XN263
DR   MMRRC; MMRRC:009640-UCD
DR   Wikidata; Q54789532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442377; Ipo11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN265
AC   CVCL_QF03
SY   XN265
DR   MMRRC; MMRRC:009642-UCD
DR   Wikidata; Q54789535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95659; Gas5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN269
AC   CVCL_QF04
SY   XN269
DR   MMRRC; MMRRC:009644-UCD
DR   Wikidata; Q54789538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913506; Ssr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN275
AC   CVCL_QF05
SY   XN275
DR   MMRRC; MMRRC:009648-UCD
DR   Wikidata; Q54789540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917716; Ckap2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN277
AC   CVCL_QF06
SY   XN277
DR   MMRRC; MMRRC:009649-UCD
DR   Wikidata; Q54789541
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN286
AC   CVCL_QF07
SY   XN286
DR   MMRRC; MMRRC:009651-UCD
DR   Wikidata; Q54789543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97860; Rasa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN291
AC   CVCL_QF08
SY   XN291
DR   MMRRC; MMRRC:009655-UCD
DR   Wikidata; Q54789546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298379; Matr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN293
AC   CVCL_QF09
SY   XN293
DR   MMRRC; MMRRC:009657-UCD
DR   Wikidata; Q54789548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95485; Fasn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN297
AC   CVCL_QF10
SY   XN297
DR   MMRRC; MMRRC:009659-UCD
DR   Wikidata; Q54789551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97847; Raf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN359
AC   CVCL_QF11
SY   XN359
DR   MMRRC; MMRRC:009675-UCD
DR   Wikidata; Q54789553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334460; Bop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN360
AC   CVCL_QF12
SY   XN360
DR   MMRRC; MMRRC:009676-UCD
DR   Wikidata; Q54789555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917895; Oip5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN369
AC   CVCL_QF13
SY   XN369
DR   MMRRC; MMRRC:009679-UCD
DR   Wikidata; Q54789556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859293; Atxn10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN374
AC   CVCL_QF14
SY   XN374
DR   MMRRC; MMRRC:009681-UCD
DR   Wikidata; Q54789558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96977; Mgmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN377
AC   CVCL_QF15
SY   XN377
DR   MMRRC; MMRRC:009682-UCD
DR   Wikidata; Q54789560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344403; Cfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN380
AC   CVCL_QF16
SY   XN380
DR   MMRRC; MMRRC:009683-UCD
DR   Wikidata; Q54789562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103300; Rbl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN383
AC   CVCL_QF17
SY   XN383
DR   MMRRC; MMRRC:009685-UCD
DR   Wikidata; Q54789564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442637; Thrap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN384
AC   CVCL_QF18
SY   XN384
DR   MMRRC; MMRRC:009686-UCD
DR   Wikidata; Q54789567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101857; Usp15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN389
AC   CVCL_QF19
SY   XN389
DR   MMRRC; MMRRC:009688-UCD
DR   Wikidata; Q54789569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925270; 4930522L14Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN390
AC   CVCL_QF20
SY   XN390
DR   MMRRC; MMRRC:009689-UCD
DR   Wikidata; Q54789571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922847; Ndufaf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN392
AC   CVCL_QF21
SY   XN392
DR   MMRRC; MMRRC:009690-UCD
DR   Wikidata; Q54789573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107440; Cep131.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN413
AC   CVCL_QF22
SY   XN413
DR   MMRRC; MMRRC:009695-UCD
DR   Wikidata; Q54789627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925828; Cnih4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN432
AC   CVCL_QF23
SY   XN432
DR   MMRRC; MMRRC:009699-UCD
DR   Wikidata; Q54789629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN436
AC   CVCL_QF24
SY   XN436
DR   MMRRC; MMRRC:009700-UCD
DR   Wikidata; Q54789631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN441
AC   CVCL_QF25
SY   XN441
DR   MMRRC; MMRRC:009701-UCD
DR   Wikidata; Q54789633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919924; Adipor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN443
AC   CVCL_QF26
SY   XN443
DR   MMRRC; MMRRC:009703-UCD
DR   Wikidata; Q54789637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138271; Gorab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN444
AC   CVCL_QF27
SY   XN444
DR   MMRRC; MMRRC:009704-UCD
DR   Wikidata; Q54789638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN450
AC   CVCL_QF28
SY   XN450
DR   MMRRC; MMRRC:009705-UCD
DR   Wikidata; Q54789641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933111; Apobec3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN462
AC   CVCL_QF29
SY   XN462
DR   MMRRC; MMRRC:009707-UCD
DR   Wikidata; Q54789643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337100; Wdr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN464
AC   CVCL_QF30
SY   XN464
DR   MMRRC; MMRRC:009708-UCD
DR   Wikidata; Q54789646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448490; Sbno2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN475
AC   CVCL_QF31
SY   XN475
DR   MMRRC; MMRRC:009710-UCD
DR   Wikidata; Q54789648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96522; Rbpj.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN477
AC   CVCL_QF32
SY   XN477
DR   MMRRC; MMRRC:009711-UCD
DR   Wikidata; Q54789650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385848; Bcas3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN479
AC   CVCL_QF33
SY   XN479
DR   MMRRC; MMRRC:009713-UCD
DR   Wikidata; Q54789656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343135; Ndufs4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN487
AC   CVCL_QF34
SY   XN487
DR   MMRRC; MMRRC:009716-UCD
DR   Wikidata; Q54789657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098815; Cdc23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN495
AC   CVCL_QF35
SY   XN495
DR   MMRRC; MMRRC:009718-UCD
DR   Wikidata; Q54789658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98759; Tjp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN528
AC   CVCL_QF36
SY   XN528
DR   MMRRC; MMRRC:009723-UCD
DR   Wikidata; Q54789663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858965; Atf7ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN536
AC   CVCL_QF37
SY   XN536
DR   MMRRC; MMRRC:009724-UCD
DR   Wikidata; Q54789666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445220; Dcaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN537
AC   CVCL_QF38
SY   XN537
DR   MMRRC; MMRRC:009725-UCD
DR   Wikidata; Q54789667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87860; Abl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN551
AC   CVCL_QF39
SY   XN551
DR   MMRRC; MMRRC:009728-UCD
DR   Wikidata; Q54789669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106214; Jrk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN567
AC   CVCL_QF40
SY   XN567
DR   MMRRC; MMRRC:009730-UCD
DR   Wikidata; Q54789672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97744; Por.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN572
AC   CVCL_QF41
SY   XN572
DR   MMRRC; MMRRC:009733-UCD
DR   Wikidata; Q54789673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN573
AC   CVCL_QF42
SY   XN573
DR   MMRRC; MMRRC:009734-UCD
DR   Wikidata; Q54789675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926007; Rictor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN606
AC   CVCL_QF43
SY   XN606
DR   MMRRC; MMRRC:009737-UCD
DR   Wikidata; Q54789676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN619
AC   CVCL_QF44
SY   XN619
DR   MMRRC; MMRRC:009738-UCD
DR   Wikidata; Q54789677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201387; Nlk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN628
AC   CVCL_QF45
SY   XN628
DR   MMRRC; MMRRC:009740-UCD
DR   Wikidata; Q54789679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920977; Mcmbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN632
AC   CVCL_QF46
SY   XN632
DR   MMRRC; MMRRC:009742-UCD
DR   Wikidata; Q54789680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102749; Trim25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN639
AC   CVCL_QF47
SY   XN639
DR   MMRRC; MMRRC:009745-UCD
DR   Wikidata; Q54789681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3027003; Ino80d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN660
AC   CVCL_QF48
SY   XN660
DR   MMRRC; MMRRC:009751-UCD
DR   Wikidata; Q54789684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137336; Baiap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN675
AC   CVCL_QF49
SY   XN675
DR   MMRRC; MMRRC:009756-UCD
DR   Wikidata; Q54789686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915527; 2310057M21Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN685
AC   CVCL_QF50
SY   XN685
DR   MMRRC; MMRRC:009759-UCD
DR   Wikidata; Q54789687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915549; Vps53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN687
AC   CVCL_QF51
SY   XN687
DR   MMRRC; MMRRC:009761-UCD
DR   Wikidata; Q54789690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2670178; Med13l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN695
AC   CVCL_QF52
SY   XN695
DR   MMRRC; MMRRC:009765-UCD
DR   Wikidata; Q54789691
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN700
AC   CVCL_QF53
SY   XN700
DR   MMRRC; MMRRC:009768-UCD
DR   Wikidata; Q54789692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918398; Mier1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN711
AC   CVCL_QF54
SY   XN711
DR   MMRRC; MMRRC:009775-UCD
DR   Wikidata; Q54789695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261425; Drosha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN712
AC   CVCL_QF55
SY   XN712
DR   MMRRC; MMRRC:009776-UCD
DR   Wikidata; Q54789697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914216; Trit1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN713
AC   CVCL_QF56
SY   XN713
DR   MMRRC; MMRRC:009777-UCD
DR   Wikidata; Q54789699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97744; Por.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN716
AC   CVCL_QF57
SY   XN716
DR   MMRRC; MMRRC:009778-UCD
DR   Wikidata; Q54789701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347478; Foxn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN727
AC   CVCL_QF58
SY   XN727
DR   MMRRC; MMRRC:009781-UCD
DR   Wikidata; Q54789704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682314; Zc3h4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN734
AC   CVCL_QF59
SY   XN734
DR   MMRRC; MMRRC:009784-UCD
DR   Wikidata; Q54789707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN750
AC   CVCL_QF60
SY   XN750
DR   MMRRC; MMRRC:009789-UCD
DR   Wikidata; Q54789709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108403; Polr1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN763
AC   CVCL_QF61
SY   XN763
DR   MMRRC; MMRRC:009793-UCD
DR   Wikidata; Q54789710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385848; Bcas3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN858
AC   CVCL_QF62
SY   XN858
DR   MMRRC; MMRRC:009804-UCD
DR   Wikidata; Q54789777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918040; Ubr5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN864
AC   CVCL_QF63
SY   XN864
DR   MMRRC; MMRRC:009807-UCD
DR   Wikidata; Q54789780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103287; Zrsr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN869
AC   CVCL_QF64
SY   XN869
DR   MMRRC; MMRRC:009810-UCD
DR   Wikidata; Q54789782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN874
AC   CVCL_QF65
SY   XN874
DR   MMRRC; MMRRC:009812-UCD
DR   Wikidata; Q54789786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913843; Diablo.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XN886
AC   CVCL_QF66
SY   XN886
DR   MMRRC; MMRRC:009816-UCD
DR   Wikidata; Q54789789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442308; Arl15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST002
AC   CVCL_QF67
SY   XST002
DR   MMRRC; MMRRC:009819-UCD
DR   Wikidata; Q54789791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95834; Pdia3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST003
AC   CVCL_QF68
SY   XST003
DR   MMRRC; MMRRC:009820-UCD
DR   Wikidata; Q54789794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328318; Atp6v0e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST004
AC   CVCL_QF69
SY   XST004
DR   MMRRC; MMRRC:009821-UCD
DR   Wikidata; Q54789795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST006
AC   CVCL_QF70
SY   XST006
DR   MMRRC; MMRRC:009822-UCD
DR   Wikidata; Q54789796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST007
AC   CVCL_QF71
SY   XST007
DR   MMRRC; MMRRC:009823-UCD
DR   Wikidata; Q54789798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915309; Tm9sf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST008
AC   CVCL_QF72
SY   XST008
DR   MMRRC; MMRRC:009824-UCD
DR   Wikidata; Q54789800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917611; Lman1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST009
AC   CVCL_QF73
SY   XST009
DR   MMRRC; MMRRC:009825-UCD
DR   Wikidata; Q54789803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST010
AC   CVCL_QF74
SY   XST010
DR   MMRRC; MMRRC:009826-UCD
DR   Wikidata; Q54789805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917611; Lman1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST013
AC   CVCL_QF75
SY   XST013
DR   MMRRC; MMRRC:009828-UCD
DR   Wikidata; Q54789807
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298218; Lrp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST015
AC   CVCL_QF76
SY   XST015
DR   MMRRC; MMRRC:009830-UCD
DR   Wikidata; Q54789809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328318; Atp6v0e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST016
AC   CVCL_QF77
SY   XST016
DR   MMRRC; MMRRC:009831-UCD
DR   Wikidata; Q54789812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST018
AC   CVCL_QF78
SY   XST018
DR   MMRRC; MMRRC:009832-UCD
DR   Wikidata; Q54789815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328318; Atp6v0e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST019
AC   CVCL_QF79
SY   XST019
DR   MMRRC; MMRRC:009833-UCD
DR   Wikidata; Q54789816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST020
AC   CVCL_QF80
SY   XST020
DR   MMRRC; MMRRC:009834-UCD
DR   Wikidata; Q54789818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104860; Fxr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST022
AC   CVCL_QF81
SY   XST022
DR   MMRRC; MMRRC:009836-UCD
DR   Wikidata; Q54789821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST027
AC   CVCL_QF82
SY   XST027
DR   MMRRC; MMRRC:009837-UCD
DR   Wikidata; Q54789824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST028
AC   CVCL_QF83
SY   XST028
DR   MMRRC; MMRRC:009838-UCD
DR   Wikidata; Q54789825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST029
AC   CVCL_QF84
SY   XST029
DR   MMRRC; MMRRC:009839-UCD
DR   Wikidata; Q54789827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST030
AC   CVCL_QF85
SY   XST030
DR   MMRRC; MMRRC:009840-UCD
DR   Wikidata; Q54789829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST032
AC   CVCL_QF86
SY   XST032
DR   MMRRC; MMRRC:009841-UCD
DR   Wikidata; Q54789832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST033
AC   CVCL_QF87
SY   XST033
DR   MMRRC; MMRRC:009842-UCD
DR   Wikidata; Q54789834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST034
AC   CVCL_QF88
SY   XST034
DR   MMRRC; MMRRC:009843-UCD
DR   Wikidata; Q54789836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST035
AC   CVCL_QF89
SY   XST035
DR   MMRRC; MMRRC:009844-UCD
DR   Wikidata; Q54789837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST038
AC   CVCL_QF90
SY   XST038
DR   MMRRC; MMRRC:009845-UCD
DR   Wikidata; Q54789839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096342; Rhoa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST040
AC   CVCL_QF91
SY   XST040
DR   MMRRC; MMRRC:009846-UCD
DR   Wikidata; Q54789841
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196466; Dsg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST043
AC   CVCL_QF92
SY   XST043
DR   MMRRC; MMRRC:009847-UCD
DR   Wikidata; Q54789842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913936; Dcbld1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST047
AC   CVCL_QF93
SY   XST047
DR   MMRRC; MMRRC:009848-UCD
DR   Wikidata; Q54789845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST050
AC   CVCL_QF94
SY   XST050
DR   MMRRC; MMRRC:009849-UCD
DR   Wikidata; Q54789847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914199; Trim59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST052
AC   CVCL_QF95
SY   XST052
DR   MMRRC; MMRRC:009850-UCD
DR   Wikidata; Q54789849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST053
AC   CVCL_QF96
SY   XST053
DR   MMRRC; MMRRC:009851-UCD
DR   Wikidata; Q54789851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96604; Itga5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST057
AC   CVCL_QF97
SY   XST057
DR   MMRRC; MMRRC:009852-UCD
DR   Wikidata; Q54789853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2148019; Jade3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST060
AC   CVCL_QF98
SY   XST060
DR   MMRRC; MMRRC:009853-UCD
DR   Wikidata; Q54789854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104902; Gpc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST061
AC   CVCL_QF99
SY   XST061
DR   MMRRC; MMRRC:009854-UCD
DR   Wikidata; Q54789856
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309463; Hspa13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST064
AC   CVCL_QG00
SY   XST064
DR   MMRRC; MMRRC:009855-UCD
DR   Wikidata; Q54789859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST067
AC   CVCL_QG01
SY   XST067
DR   MMRRC; MMRRC:009857-UCD
DR   Wikidata; Q54789860
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST069
AC   CVCL_QG02
SY   XST069
DR   MMRRC; MMRRC:009859-UCD
DR   Wikidata; Q54789925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95321; Emb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST071
AC   CVCL_QG03
SY   XST071
DR   MMRRC; MMRRC:009860-UCD
DR   Wikidata; Q54789927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST074
AC   CVCL_QG04
SY   XST074
DR   MMRRC; MMRRC:009861-UCD
DR   Wikidata; Q54789930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96748; Lamp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST075
AC   CVCL_QG05
SY   XST075
DR   MMRRC; MMRRC:009862-UCD
DR   Wikidata; Q54789932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST077
AC   CVCL_QG06
SY   XST077
DR   MMRRC; MMRRC:009863-UCD
DR   Wikidata; Q54789934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97464; P4hb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST078
AC   CVCL_QG07
SY   XST078
DR   MMRRC; MMRRC:009864-UCD
DR   Wikidata; Q54789937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914186; Asph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST079
AC   CVCL_QG08
SY   XST079
DR   MMRRC; MMRRC:009865-UCD
DR   Wikidata; Q54789941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107405; Lefty1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST081
AC   CVCL_QG09
SY   XST081
DR   MMRRC; MMRRC:009866-UCD
DR   Wikidata; Q54789943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST085
AC   CVCL_QG10
SY   XST085
DR   MMRRC; MMRRC:009867-UCD
DR   Wikidata; Q54789947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST087
AC   CVCL_QG11
SY   XST087
DR   MMRRC; MMRRC:009868-UCD
DR   Wikidata; Q54789950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918711; Ptk7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST088
AC   CVCL_QG12
SY   XST088
DR   MMRRC; MMRRC:009869-UCD
DR   Wikidata; Q54789953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST092
AC   CVCL_QG13
SY   XST092
DR   MMRRC; MMRRC:009870-UCD
DR   Wikidata; Q54789954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098672; Szrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST094
AC   CVCL_QG14
SY   XST094
DR   MMRRC; MMRRC:009872-UCD
DR   Wikidata; Q54789955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST097
AC   CVCL_QG15
SY   XST097
DR   MMRRC; MMRRC:009873-UCD
DR   Wikidata; Q54789959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST100
AC   CVCL_QG16
SY   XST100
DR   MMRRC; MMRRC:009874-UCD
DR   Wikidata; Q54789962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1345162; Adam23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST101
AC   CVCL_QG17
SY   XST101
DR   MMRRC; MMRRC:009875-UCD
DR   Wikidata; Q54789964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST102
AC   CVCL_QG18
SY   XST102
DR   MMRRC; MMRRC:009876-UCD
DR   Wikidata; Q54789967
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96392; Icam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST103
AC   CVCL_QG19
SY   XST103
DR   MMRRC; MMRRC:009877-UCD
DR   Wikidata; Q54789969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96955; Slc3a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST104
AC   CVCL_QG20
SY   XST104
DR   MMRRC; MMRRC:009878-UCD
DR   Wikidata; Q54789973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST106
AC   CVCL_QG21
SY   XST106
DR   MMRRC; MMRRC:009879-UCD
DR   Wikidata; Q54789975
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97750; Ppib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST108
AC   CVCL_QG22
SY   XST108
DR   MMRRC; MMRRC:009880-UCD
DR   Wikidata; Q54789977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST111
AC   CVCL_QG23
SY   XST111
DR   MMRRC; MMRRC:009883-UCD
DR   Wikidata; Q54789978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST113
AC   CVCL_QG24
SY   XST113
DR   MMRRC; MMRRC:009884-UCD
DR   Wikidata; Q54789980
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96788; Lifr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST114
AC   CVCL_QG25
SY   XST114
DR   MMRRC; MMRRC:009885-UCD
DR   Wikidata; Q54789982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924042; Spring1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XST117
AC   CVCL_QG26
SY   XST117
DR   MMRRC; MMRRC:009887-UCD
DR   Wikidata; Q54789984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST119
AC   CVCL_QG27
SY   XST119
DR   MMRRC; MMRRC:009889-UCD
DR   Wikidata; Q54789987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095418; Tfpi.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST120
AC   CVCL_QG28
SY   XST120
DR   MMRRC; MMRRC:009890-UCD
DR   Wikidata; Q54789988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST121
AC   CVCL_QG29
SY   XST121
DR   MMRRC; MMRRC:009891-UCD
DR   Wikidata; Q54789990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106419; Itfg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST124
AC   CVCL_QG30
SY   XST124
DR   MMRRC; MMRRC:009893-UCD
DR   Wikidata; Q54789993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105382; Lama5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST127
AC   CVCL_QG31
SY   XST127
DR   MMRRC; MMRRC:009894-UCD
DR   Wikidata; Q54789995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST128
AC   CVCL_QG32
SY   XST128
DR   MMRRC; MMRRC:009895-UCD
DR   Wikidata; Q54789996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96765; Ldlr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST129
AC   CVCL_QG33
SY   XST129
DR   MMRRC; MMRRC:009896-UCD
DR   Wikidata; Q54790000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST130
AC   CVCL_QG34
SY   XST130
DR   MMRRC; MMRRC:009897-UCD
DR   Wikidata; Q54790002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88354; Cdh1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST131
AC   CVCL_QG35
SY   XST131
DR   MMRRC; MMRRC:009898-UCD
DR   Wikidata; Q54790005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST132
AC   CVCL_QG36
SY   XST132
DR   MMRRC; MMRRC:009899-UCD
DR   Wikidata; Q54790007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103310; Ptprk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST133
AC   CVCL_QG37
SY   XST133
DR   MMRRC; MMRRC:009900-UCD
DR   Wikidata; Q54790008
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139714; Adgrl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST137
AC   CVCL_QG38
SY   XST137
DR   MMRRC; MMRRC:009901-UCD
DR   Wikidata; Q54790010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99894; Hnrnpk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST139
AC   CVCL_QG39
SY   XST139
DR   MMRRC; MMRRC:009902-UCD
DR   Wikidata; Q54790011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95566; Fn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST141
AC   CVCL_QG40
SY   XST141
DR   MMRRC; MMRRC:009903-UCD
DR   Wikidata; Q54790015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST142
AC   CVCL_QG41
SY   XST142
DR   MMRRC; MMRRC:009904-UCD
DR   Wikidata; Q54790018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354385; Ero1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XST143
AC   CVCL_QG42
SY   XST143
DR   MMRRC; MMRRC:009905-UCD
DR   Wikidata; Q54790076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860139; Gabbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST161
AC   CVCL_QG43
SY   XST161
DR   MMRRC; MMRRC:009906-UCD
DR   Wikidata; Q54790077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924059; Bri3bp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST163
AC   CVCL_QG44
SY   XST163
DR   MMRRC; MMRRC:009908-UCD
DR   Wikidata; Q54790081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2159727; Il17rd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST164
AC   CVCL_QG45
SY   XST164
DR   MMRRC; MMRRC:009909-UCD
DR   Wikidata; Q54790083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST165
AC   CVCL_QG46
SY   XST165
DR   MMRRC; MMRRC:009910-UCD
DR   Wikidata; Q54790085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196458; Scarb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST167
AC   CVCL_QG47
SY   XST167
DR   MMRRC; MMRRC:009911-UCD
DR   Wikidata; Q54790088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3580376; Lemd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST168
AC   CVCL_QG48
SY   XST168
DR   MMRRC; MMRRC:009912-UCD
DR   Wikidata; Q54790092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919727; Tmem87b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST169
AC   CVCL_QG49
SY   XST169
DR   MMRRC; MMRRC:009913-UCD
DR   Wikidata; Q54790094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443162; Uggt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST170
AC   CVCL_QG50
SY   XST170
DR   MMRRC; MMRRC:009914-UCD
DR   Wikidata; Q54790096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97591; Pkm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST171
AC   CVCL_QG51
SY   XST171
DR   MMRRC; MMRRC:009915-UCD
DR   Wikidata; Q54790098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354385; Ero1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line XST172
AC   CVCL_QG52
SY   XST172
DR   MMRRC; MMRRC:009916-UCD
DR   Wikidata; Q54790100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST173
AC   CVCL_QG53
SY   XST173
DR   MMRRC; MMRRC:009917-UCD
DR   Wikidata; Q54790103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102493; mt-Rnr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST176
AC   CVCL_QG54
SY   XST176
DR   MMRRC; MMRRC:009918-UCD
DR   Wikidata; Q54790105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914217; Edem3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST180
AC   CVCL_QG55
SY   XST180
DR   MMRRC; MMRRC:009920-UCD
DR   Wikidata; Q54790108
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88451; Col18a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST181
AC   CVCL_QG56
SY   XST181
DR   MMRRC; MMRRC:009921-UCD
DR   Wikidata; Q54790111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST184
AC   CVCL_QG57
SY   XST184
DR   MMRRC; MMRRC:009922-UCD
DR   Wikidata; Q54790113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109177; Cd59a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST185
AC   CVCL_QG58
SY   XST185
DR   MMRRC; MMRRC:009923-UCD
DR   Wikidata; Q54790116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927947; Selenof.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST186
AC   CVCL_QG59
SY   XST186
DR   MMRRC; MMRRC:009924-UCD
DR   Wikidata; Q54790117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104967; Glg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST187
AC   CVCL_QG60
SY   XST187
DR   MMRRC; MMRRC:009925-UCD
DR   Wikidata; Q54790119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97822; Nectin2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST189
AC   CVCL_QG61
SY   XST189
DR   MMRRC; MMRRC:009927-UCD
DR   Wikidata; Q54790122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST190
AC   CVCL_QG62
SY   XST190
DR   MMRRC; MMRRC:009928-UCD
DR   Wikidata; Q54790125
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST192
AC   CVCL_QG63
SY   XST192
DR   MMRRC; MMRRC:009930-UCD
DR   Wikidata; Q54790128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST193
AC   CVCL_QG64
SY   XST193
DR   MMRRC; MMRRC:009931-UCD
DR   Wikidata; Q54790130
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99914; Lamc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST197
AC   CVCL_QG65
SY   XST197
DR   MMRRC; MMRRC:009935-UCD
DR   Wikidata; Q54790132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96435; Igf2r.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST200
AC   CVCL_QG66
SY   XST200
DR   MMRRC; MMRRC:009937-UCD
DR   Wikidata; Q54790133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96257; Hspg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST205
AC   CVCL_QG67
SY   XST205
DR   MMRRC; MMRRC:009939-UCD
DR   Wikidata; Q54790135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST206
AC   CVCL_QG68
SY   XST206
DR   MMRRC; MMRRC:009940-UCD
DR   Wikidata; Q54790138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98341; Snrnp70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line XST208
AC   CVCL_QG69
SY   XST208
DR   MMRRC; MMRRC:009941-UCD
DR   Wikidata; Q54790140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349164; Sdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA006
AC   CVCL_QG70
SY   YHA006
DR   MMRRC; MMRRC:010458-UCD
DR   Wikidata; Q54790142
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442563; Naa25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA007
AC   CVCL_QG71
SY   YHA007
DR   MMRRC; MMRRC:010459-UCD
DR   Wikidata; Q54790143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA061
AC   CVCL_QG72
SY   YHA061
DR   MMRRC; MMRRC:010460-UCD
DR   Wikidata; Q54790145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103561; Kpna2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA095
AC   CVCL_QG73
SY   YHA095
DR   MMRRC; MMRRC:010502-UCD
DR   Wikidata; Q54790147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917171; Hnrnpa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA109
AC   CVCL_QG74
SY   YHA109
DR   MMRRC; MMRRC:010483-UCD
DR   Wikidata; Q54790149
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA114
AC   CVCL_QG75
SY   YHA114
DR   MMRRC; MMRRC:010485-UCD
DR   Wikidata; Q54790151
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95486; Fbl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA122
AC   CVCL_QG76
SY   YHA122
DR   MMRRC; MMRRC:010487-UCD
DR   Wikidata; Q54790152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97842; Rab1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA129
AC   CVCL_QG77
SY   YHA129
DR   MMRRC; MMRRC:010503-UCD
DR   Wikidata; Q54790154
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924933; Ehmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA144
AC   CVCL_QG78
SY   YHA144
DR   MMRRC; MMRRC:010489-UCD
DR   Wikidata; Q54790158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441931; D030028A08Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA146
AC   CVCL_QG79
SY   YHA146
DR   MMRRC; MMRRC:010490-UCD
DR   Wikidata; Q54790159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA151
AC   CVCL_QG80
SY   YHA151
DR   MMRRC; MMRRC:010492-UCD
DR   Wikidata; Q54790162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924223; Fbxo21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA153
AC   CVCL_QG81
SY   YHA153
DR   MMRRC; MMRRC:010493-UCD
DR   Wikidata; Q54790164
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106478; Eif3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA157
AC   CVCL_QG82
SY   YHA157
DR   MMRRC; MMRRC:010494-UCD
DR   Wikidata; Q54790215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA161
AC   CVCL_QG83
SY   YHA161
DR   MMRRC; MMRRC:010495-UCD
DR   Wikidata; Q54790218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925678; Pym1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA164
AC   CVCL_QG84
SY   YHA164
DR   MMRRC; MMRRC:010496-UCD
DR   Wikidata; Q54790219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916482; Qrich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA168
AC   CVCL_QG85
SY   YHA168
DR   MMRRC; MMRRC:010497-UCD
DR   Wikidata; Q54790220
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914504; Bmerb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YHA169
AC   CVCL_QG86
SY   YHA169
DR   MMRRC; MMRRC:011415-UCD
DR   Wikidata; Q54790223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA171
AC   CVCL_QG87
SY   YHA171
DR   MMRRC; MMRRC:010573-UCD
DR   Wikidata; Q54790225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328361; Bard1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA178
AC   CVCL_QG88
SY   YHA178
DR   MMRRC; MMRRC:010504-UCD
DR   Wikidata; Q54790227
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA182
AC   CVCL_QG89
SY   YHA182
DR   MMRRC; MMRRC:010505-UCD
DR   Wikidata; Q54790229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95453; Smarcad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA183
AC   CVCL_QG90
SY   YHA183
DR   MMRRC; MMRRC:010506-UCD
DR   Wikidata; Q54790231
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860197; Wdr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA184
AC   CVCL_QG91
SY   YHA184
DR   MMRRC; MMRRC:010507-UCD
DR   Wikidata; Q54790234
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860513; Fnbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA186
AC   CVCL_QG92
SY   YHA186
DR   MMRRC; MMRRC:010508-UCD
DR   Wikidata; Q54790236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98847; Kdm3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA189
AC   CVCL_QG93
SY   YHA189
DR   MMRRC; MMRRC:010510-UCD
DR   Wikidata; Q54790238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685869; Dpy19l4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA190
AC   CVCL_QG94
SY   YHA190
DR   MMRRC; MMRRC:010511-UCD
DR   Wikidata; Q54790241
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA194
AC   CVCL_QG95
SY   YHA194
DR   MMRRC; MMRRC:010575-UCD
DR   Wikidata; Q54790243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914872; Mxra7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA195
AC   CVCL_QG96
SY   YHA195
DR   MMRRC; MMRRC:010512-UCD
DR   Wikidata; Q54790245
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA196
AC   CVCL_QG97
SY   YHA196
DR   MMRRC; MMRRC:010513-UCD
DR   Wikidata; Q54790247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138986; Qser1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA197
AC   CVCL_QG98
SY   YHA197
DR   MMRRC; MMRRC:010514-UCD
DR   Wikidata; Q54790249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95486; Fbl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA199
AC   CVCL_QG99
SY   YHA199
DR   MMRRC; MMRRC:010515-UCD
DR   Wikidata; Q54790253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858303; Srrm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA201
AC   CVCL_QH00
SY   YHA201
DR   MMRRC; MMRRC:010516-UCD
DR   Wikidata; Q54790257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139714; Adgrl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA210
AC   CVCL_QH01
SY   YHA210
DR   MMRRC; MMRRC:010517-UCD
DR   Wikidata; Q54790259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442115; Wdr59.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA213
AC   CVCL_QH02
SY   YHA213
DR   MMRRC; MMRRC:010518-UCD
DR   Wikidata; Q54790262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA216
AC   CVCL_QH03
SY   YHA216
DR   MMRRC; MMRRC:010519-UCD
DR   Wikidata; Q54790264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107410; Zbtb17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA230
AC   CVCL_QH04
SY   YHA230
DR   MMRRC; MMRRC:010521-UCD
DR   Wikidata; Q54790267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA234
AC   CVCL_QH05
SY   YHA234
DR   MMRRC; MMRRC:010522-UCD
DR   Wikidata; Q54790269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95486; Fbl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA237
AC   CVCL_QH06
SY   YHA237
DR   MMRRC; MMRRC:010524-UCD
DR   Wikidata; Q54790270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3704127; Zfp808.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA239
AC   CVCL_QH07
SY   YHA239
DR   MMRRC; MMRRC:010525-UCD
DR   Wikidata; Q54790272
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95390; En2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA242
AC   CVCL_QH08
SY   YHA242
DR   MMRRC; MMRRC:010526-UCD
DR   Wikidata; Q54790274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916482; Qrich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA243
AC   CVCL_QH09
SY   YHA243
DR   MMRRC; MMRRC:010576-UCD
DR   Wikidata; Q54790275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA247
AC   CVCL_QH10
SY   YHA247
DR   MMRRC; MMRRC:010527-UCD
DR   Wikidata; Q54790280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA252
AC   CVCL_QH11
SY   YHA252
DR   MMRRC; MMRRC:010528-UCD
DR   Wikidata; Q54790282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916482; Qrich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA254
AC   CVCL_QH12
SY   YHA254
DR   MMRRC; MMRRC:010529-UCD
DR   Wikidata; Q54790284
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101917; Bcap29.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA266
AC   CVCL_QH13
SY   YHA266
DR   MMRRC; MMRRC:010498-UCD
DR   Wikidata; Q54790287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855692; Nono.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA268
AC   CVCL_QH14
SY   YHA268
DR   MMRRC; MMRRC:010499-UCD
DR   Wikidata; Q54790290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA275
AC   CVCL_QH15
SY   YHA275
DR   MMRRC; MMRRC:010710-UCD
DR   Wikidata; Q54790291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA277
AC   CVCL_QH16
SY   YHA277
DR   MMRRC; MMRRC:010711-UCD
DR   Wikidata; Q54790293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108051; Smad2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA278
AC   CVCL_QH17
SY   YHA278
DR   MMRRC; MMRRC:010712-UCD
DR   Wikidata; Q54790297
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920174; Anln.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA279
AC   CVCL_QH18
SY   YHA279
DR   MMRRC; MMRRC:010713-UCD
DR   Wikidata; Q54790298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446634; Ago3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA284
AC   CVCL_QH19
SY   YHA284
DR   MMRRC; MMRRC:010714-UCD
DR   Wikidata; Q54790300
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913964; 4921524J17Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA285
AC   CVCL_QH20
SY   YHA285
DR   MMRRC; MMRRC:010715-UCD
DR   Wikidata; Q54790302
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276116; Ep300.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA286
AC   CVCL_QH21
SY   YHA286
DR   MMRRC; MMRRC:010716-UCD
DR   Wikidata; Q54790304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA287
AC   CVCL_QH22
SY   YHA287
DR   MMRRC; MMRRC:010717-UCD
DR   Wikidata; Q54790358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA289
AC   CVCL_QH23
SY   YHA289
DR   MMRRC; MMRRC:010718-UCD
DR   Wikidata; Q54790359
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87930; Adk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA292
AC   CVCL_QH24
SY   YHA292
DR   MMRRC; MMRRC:010719-UCD
DR   Wikidata; Q54790360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098672; Szrd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA293
AC   CVCL_QH25
SY   YHA293
DR   MMRRC; MMRRC:010720-UCD
DR   Wikidata; Q54790362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104860; Fxr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA296
AC   CVCL_QH26
SY   YHA296
DR   MMRRC; MMRRC:010722-UCD
DR   Wikidata; Q54790365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA299
AC   CVCL_QH27
SY   YHA299
DR   MMRRC; MMRRC:010723-UCD
DR   Wikidata; Q54790366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922863; Med25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA307
AC   CVCL_QH28
SY   YHA307
DR   MMRRC; MMRRC:010724-UCD
DR   Wikidata; Q54790368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180003; Xpnpep1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA315
AC   CVCL_QH29
SY   YHA315
DR   MMRRC; MMRRC:010725-UCD
DR   Wikidata; Q54790369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA318
AC   CVCL_QH30
SY   YHA318
DR   MMRRC; MMRRC:010726-UCD
DR   Wikidata; Q54790373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA328
AC   CVCL_QH31
SY   YHA328
DR   MMRRC; MMRRC:010728-UCD
DR   Wikidata; Q54790374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920524; Gpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA339
AC   CVCL_QH32
SY   YHA339
DR   MMRRC; MMRRC:010729-UCD
DR   Wikidata; Q54790375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448542; Samd4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA352
AC   CVCL_QH33
SY   YHA352
DR   MMRRC; MMRRC:011416-UCD
DR   Wikidata; Q54790377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140998; Ube3c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA365
AC   CVCL_QH34
SY   YHA365
DR   MMRRC; MMRRC:010735-UCD
DR   Wikidata; Q54790378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353633; Fus.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA367
AC   CVCL_QH35
SY   YHA367
DR   MMRRC; MMRRC:011417-UCD
DR   Wikidata; Q54790382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA368
AC   CVCL_QH36
SY   YHA368
DR   MMRRC; MMRRC:011418-UCD
DR   Wikidata; Q54790383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276116; Ep300.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA398
AC   CVCL_QH37
SY   YHA398
DR   MMRRC; MMRRC:010740-UCD
DR   Wikidata; Q54790385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA404
AC   CVCL_QH38
SY   YHA404
DR   MMRRC; MMRRC:010741-UCD
DR   Wikidata; Q54790388
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA405
AC   CVCL_QH39
SY   YHA405
DR   MMRRC; MMRRC:010742-UCD
DR   Wikidata; Q54790390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443455; Dse.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA406
AC   CVCL_QH40
SY   YHA406
DR   MMRRC; MMRRC:010743-UCD
DR   Wikidata; Q54790392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143755; AU041133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA407
AC   CVCL_QH41
SY   YHA407
DR   MMRRC; MMRRC:010744-UCD
DR   Wikidata; Q54790394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143755; AU041133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA408
AC   CVCL_QH42
SY   YHA408
DR   MMRRC; MMRRC:010745-UCD
DR   Wikidata; Q54790395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109606; Fnbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA415
AC   CVCL_QH43
SY   YHA415
DR   MMRRC; MMRRC:010747-UCD
DR   Wikidata; Q54790396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921456; Sipa1l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA421
AC   CVCL_QH44
SY   YHA421
DR   MMRRC; MMRRC:010749-UCD
DR   Wikidata; Q54790398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142347; Zfp568.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA424
AC   CVCL_QH45
SY   YHA424
DR   MMRRC; MMRRC:010751-UCD
DR   Wikidata; Q54790401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA427
AC   CVCL_QH46
SY   YHA427
DR   MMRRC; MMRRC:010752-UCD
DR   Wikidata; Q54790403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913435; Virma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA428
AC   CVCL_QH47
SY   YHA428
DR   MMRRC; MMRRC:010753-UCD
DR   Wikidata; Q54790407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97891; Rfc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA429
AC   CVCL_QH48
SY   YHA429
DR   MMRRC; MMRRC:010754-UCD
DR   Wikidata; Q54790409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA436
AC   CVCL_QH49
SY   YHA436
DR   MMRRC; MMRRC:010756-UCD
DR   Wikidata; Q54790411
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA437
AC   CVCL_QH50
SY   YHA437
DR   MMRRC; MMRRC:010757-UCD
DR   Wikidata; Q54790412
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99462; Pigf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA448
AC   CVCL_QH51
SY   YHA448
DR   MMRRC; MMRRC:010761-UCD
DR   Wikidata; Q54790414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346873; Map3k2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA449
AC   CVCL_QH52
SY   YHA449
DR   MMRRC; MMRRC:010762-UCD
DR   Wikidata; Q54790416
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354708; Fbxo31.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA461
AC   CVCL_QH53
SY   YHA461
DR   MMRRC; MMRRC:010858-UCD
DR   Wikidata; Q54790419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384583; Zfp280d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHA462
AC   CVCL_QH54
SY   YHA462
DR   MMRRC; MMRRC:010914-UCD
DR   Wikidata; Q54790421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917875; Med26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB001
AC   CVCL_QH55
SY   YHB001
DR   MMRRC; MMRRC:011419-UCD
DR   Wikidata; Q54790424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB002
AC   CVCL_QH56
SY   YHB002
DR   MMRRC; MMRRC:011420-UCD
DR   Wikidata; Q54790426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196439; Cbx7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB003
AC   CVCL_QH57
SY   YHB003
DR   MMRRC; MMRRC:011421-UCD
DR   Wikidata; Q54790429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860513; Fnbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB004
AC   CVCL_QH58
SY   YHB004
DR   MMRRC; MMRRC:011422-UCD
DR   Wikidata; Q54790431
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88090; Ass1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB005
AC   CVCL_QH59
SY   YHB005
DR   MMRRC; MMRRC:011423-UCD
DR   Wikidata; Q54790433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917498; Dazap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB006
AC   CVCL_QH60
SY   YHB006
DR   MMRRC; MMRRC:011424-UCD
DR   Wikidata; Q54790436
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB007
AC   CVCL_QH61
SY   YHB007
DR   MMRRC; MMRRC:011425-UCD
DR   Wikidata; Q54790437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97447; Osbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB008
AC   CVCL_QH62
SY   YHB008
DR   MMRRC; MMRRC:011426-UCD
DR   Wikidata; Q54790488
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB009
AC   CVCL_QH63
SY   YHB009
DR   MMRRC; MMRRC:011427-UCD
DR   Wikidata; Q54790490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446089; Flnb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB010
AC   CVCL_QH64
SY   YHB010
DR   MMRRC; MMRRC:011428-UCD
DR   Wikidata; Q54790492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355328; Nasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB011
AC   CVCL_QH65
SY   YHB011
DR   MMRRC; MMRRC:011429-UCD
DR   Wikidata; Q54790493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355328; Nasp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB012
AC   CVCL_QH66
SY   YHB012
DR   MMRRC; MMRRC:011430-UCD
DR   Wikidata; Q54790497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107628; Prdm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB013
AC   CVCL_QH67
SY   YHB013
DR   MMRRC; MMRRC:011431-UCD
DR   Wikidata; Q54790500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109419; Faf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB017
AC   CVCL_QH68
SY   YHB017
DR   MMRRC; MMRRC:011432-UCD
DR   Wikidata; Q54790502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923356; Kdm3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB022
AC   CVCL_QH69
SY   YHB022
DR   MMRRC; MMRRC:011433-UCD
DR   Wikidata; Q54790505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919421; Shq1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB023
AC   CVCL_QH70
SY   YHB023
DR   MMRRC; MMRRC:011434-UCD
DR   Wikidata; Q54790508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443012; Tns3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB024
AC   CVCL_QH71
SY   YHB024
DR   MMRRC; MMRRC:011435-UCD
DR   Wikidata; Q54790510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387357; Wac.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB028
AC   CVCL_QH72
SY   YHB028
DR   MMRRC; MMRRC:011173-UCD
DR   Wikidata; Q54790511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916139; Ubac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB030
AC   CVCL_QH73
SY   YHB030
DR   MMRRC; MMRRC:011174-UCD
DR   Wikidata; Q54790513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922865; Zfp933.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB033
AC   CVCL_QH74
SY   YHB033
DR   MMRRC; MMRRC:011436-UCD
DR   Wikidata; Q54790515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929282; Ptges3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB035
AC   CVCL_QH75
SY   YHB035
DR   MMRRC; MMRRC:011438-UCD
DR   Wikidata; Q54790517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB036
AC   CVCL_QH76
SY   YHB036
DR   MMRRC; MMRRC:011439-UCD
DR   Wikidata; Q54790519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB037
AC   CVCL_QH77
SY   YHB037
DR   MMRRC; MMRRC:011175-UCD
DR   Wikidata; Q54790522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918017; Prpf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB038
AC   CVCL_QH78
SY   YHB038
DR   MMRRC; MMRRC:011176-UCD
DR   Wikidata; Q54790524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916083; Pdcl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB039
AC   CVCL_QH79
SY   YHB039
DR   MMRRC; MMRRC:011177-UCD
DR   Wikidata; Q54790527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916083; Pdcl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB040
AC   CVCL_QH80
SY   YHB040
DR   MMRRC; MMRRC:011178-UCD
DR   Wikidata; Q54790528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916083; Pdcl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB042
AC   CVCL_QH81
SY   YHB042
DR   MMRRC; MMRRC:011179-UCD
DR   Wikidata; Q54790529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923041; Fbxw8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB044
AC   CVCL_QH82
SY   YHB044
DR   MMRRC; MMRRC:011440-UCD
DR   Wikidata; Q54790534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916083; Pdcl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB047
AC   CVCL_QH83
SY   YHB047
DR   MMRRC; MMRRC:011442-UCD
DR   Wikidata; Q54790535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88353; Cdk11b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB049
AC   CVCL_QH84
SY   YHB049
DR   MMRRC; MMRRC:011206-UCD
DR   Wikidata; Q54790536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915122; Nsmce4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB050
AC   CVCL_QH85
SY   YHB050
DR   MMRRC; MMRRC:011207-UCD
DR   Wikidata; Q54790539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387367; Rbm45.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB052
AC   CVCL_QH86
SY   YHB052
DR   MMRRC; MMRRC:011208-UCD
DR   Wikidata; Q54790540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344403; Cfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB053
AC   CVCL_QH87
SY   YHB053
DR   MMRRC; MMRRC:011209-UCD
DR   Wikidata; Q54790542
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB054
AC   CVCL_QH88
SY   YHB054
DR   MMRRC; MMRRC:011210-UCD
DR   Wikidata; Q54790545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344403; Cfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB055
AC   CVCL_QH89
SY   YHB055
DR   MMRRC; MMRRC:011211-UCD
DR   Wikidata; Q54790547
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB056
AC   CVCL_QH90
SY   YHB056
DR   MMRRC; MMRRC:011212-UCD
DR   Wikidata; Q54790549
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB057
AC   CVCL_QH91
SY   YHB057
DR   MMRRC; MMRRC:011213-UCD
DR   Wikidata; Q54790552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921361; Rbm19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB060
AC   CVCL_QH92
SY   YHB060
DR   MMRRC; MMRRC:011215-UCD
DR   Wikidata; Q54790554
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB062
AC   CVCL_QH93
SY   YHB062
DR   MMRRC; MMRRC:011216-UCD
DR   Wikidata; Q54790558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924093; Dtl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB063
AC   CVCL_QH94
SY   YHB063
DR   MMRRC; MMRRC:011217-UCD
DR   Wikidata; Q54790559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443658; Prr14l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB064
AC   CVCL_QH95
SY   YHB064
DR   MMRRC; MMRRC:011218-UCD
DR   Wikidata; Q54790561
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913466; Bsdc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB065
AC   CVCL_QH96
SY   YHB065
DR   MMRRC; MMRRC:011219-UCD
DR   Wikidata; Q54790564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106095; Naca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB067
AC   CVCL_QH97
SY   YHB067
DR   MMRRC; MMRRC:011220-UCD
DR   Wikidata; Q54790566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914535; Cwc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB068
AC   CVCL_QH98
SY   YHB068
DR   MMRRC; MMRRC:011221-UCD
DR   Wikidata; Q54790569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB069
AC   CVCL_QH99
SY   YHB069
DR   MMRRC; MMRRC:011222-UCD
DR   Wikidata; Q54790570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916428; Snx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB073
AC   CVCL_QI00
SY   YHB073
DR   MMRRC; MMRRC:011224-UCD
DR   Wikidata; Q54790571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445193; Utp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB075
AC   CVCL_QI01
SY   YHB075
DR   MMRRC; MMRRC:011226-UCD
DR   Wikidata; Q54790573
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB076
AC   CVCL_QI02
SY   YHB076
DR   MMRRC; MMRRC:011227-UCD
DR   Wikidata; Q54790660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333833; Cbfa2t2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB080
AC   CVCL_QI03
SY   YHB080
DR   MMRRC; MMRRC:011228-UCD
DR   Wikidata; Q54790663
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99211; Zfx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB081
AC   CVCL_QI04
SY   YHB081
DR   MMRRC; MMRRC:011229-UCD
DR   Wikidata; Q54790664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107891; Nop2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB082
AC   CVCL_QI05
SY   YHB082
DR   MMRRC; MMRRC:011230-UCD
DR   Wikidata; Q54790665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675669; Nusap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB083
AC   CVCL_QI06
SY   YHB083
DR   MMRRC; MMRRC:011231-UCD
DR   Wikidata; Q54790667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB084
AC   CVCL_QI07
SY   YHB084
DR   MMRRC; MMRRC:011232-UCD
DR   Wikidata; Q54790668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923876; Msi2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB085
AC   CVCL_QI08
SY   YHB085
DR   MMRRC; MMRRC:011233-UCD
DR   Wikidata; Q54790669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352502; Limd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB091
AC   CVCL_QI09
SY   YHB091
DR   MMRRC; MMRRC:011236-UCD
DR   Wikidata; Q54790672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860489; Ptbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB094
AC   CVCL_QI10
SY   YHB094
DR   MMRRC; MMRRC:011237-UCD
DR   Wikidata; Q54790674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98341; Snrnp70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB095
AC   CVCL_QI11
SY   YHB095
DR   MMRRC; MMRRC:011238-UCD
DR   Wikidata; Q54790676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891037; Mtrr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB097
AC   CVCL_QI12
SY   YHB097
DR   MMRRC; MMRRC:011239-UCD
DR   Wikidata; Q54790679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB098
AC   CVCL_QI13
SY   YHB098
DR   MMRRC; MMRRC:011240-UCD
DR   Wikidata; Q54790680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178836; Tubgcp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB099
AC   CVCL_QI14
SY   YHB099
DR   MMRRC; MMRRC:011241-UCD
DR   Wikidata; Q54790681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB100
AC   CVCL_QI15
SY   YHB100
DR   MMRRC; MMRRC:011242-UCD
DR   Wikidata; Q54790683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919228; Ppp2r2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB101
AC   CVCL_QI16
SY   YHB101
DR   MMRRC; MMRRC:011243-UCD
DR   Wikidata; Q54790685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB102
AC   CVCL_QI17
SY   YHB102
DR   MMRRC; MMRRC:011244-UCD
DR   Wikidata; Q54790686
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444896; Enox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB103
AC   CVCL_QI18
SY   YHB103
DR   MMRRC; MMRRC:011245-UCD
DR   Wikidata; Q54790688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183446; Agap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB104
AC   CVCL_QI19
SY   YHB104
DR   MMRRC; MMRRC:011246-UCD
DR   Wikidata; Q54790690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB105
AC   CVCL_QI20
SY   YHB105
DR   MMRRC; MMRRC:011247-UCD
DR   Wikidata; Q54790692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB106
AC   CVCL_QI21
SY   YHB106
DR   MMRRC; MMRRC:011248-UCD
DR   Wikidata; Q54790695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387629; Tardbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB109
AC   CVCL_QI22
SY   YHB109
DR   MMRRC; MMRRC:011249-UCD
DR   Wikidata; Q54790698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915122; Nsmce4a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB110
AC   CVCL_QI23
SY   YHB110
DR   MMRRC; MMRRC:011250-UCD
DR   Wikidata; Q54790699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346865; Mapk14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB112
AC   CVCL_QI24
SY   YHB112
DR   MMRRC; MMRRC:011251-UCD
DR   Wikidata; Q54790702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB114
AC   CVCL_QI25
SY   YHB114
DR   MMRRC; MMRRC:011252-UCD
DR   Wikidata; Q54790704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914789; Dock6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB116
AC   CVCL_QI26
SY   YHB116
DR   MMRRC; MMRRC:011253-UCD
DR   Wikidata; Q54790707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924223; Fbxo21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB117
AC   CVCL_QI27
SY   YHB117
DR   MMRRC; MMRRC:011254-UCD
DR   Wikidata; Q54790709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920538; Vps50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB119
AC   CVCL_QI28
SY   YHB119
DR   MMRRC; MMRRC:011256-UCD
DR   Wikidata; Q54790710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB121
AC   CVCL_QI29
SY   YHB121
DR   MMRRC; MMRRC:011257-UCD
DR   Wikidata; Q54790712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109337; Brca2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB122
AC   CVCL_QI30
SY   YHB122
DR   MMRRC; MMRRC:011258-UCD
DR   Wikidata; Q54790713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387123; Lnpep.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB123
AC   CVCL_QI31
SY   YHB123
DR   MMRRC; MMRRC:011259-UCD
DR   Wikidata; Q54790716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194490; Diaph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB127
AC   CVCL_QI32
SY   YHB127
DR   MMRRC; MMRRC:011261-UCD
DR   Wikidata; Q54790717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183752; Tubgcp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB130
AC   CVCL_QI33
SY   YHB130
DR   MMRRC; MMRRC:011262-UCD
DR   Wikidata; Q54790719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144837; Ptpn23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB132
AC   CVCL_QI34
SY   YHB132
DR   MMRRC; MMRRC:011263-UCD
DR   Wikidata; Q54790722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344403; Cfdp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB135
AC   CVCL_QI35
SY   YHB135
DR   MMRRC; MMRRC:011264-UCD
DR   Wikidata; Q54790724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB138
AC   CVCL_QI36
SY   YHB138
DR   MMRRC; MMRRC:011265-UCD
DR   Wikidata; Q54790727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB146
AC   CVCL_QI37
SY   YHB146
DR   MMRRC; MMRRC:011268-UCD
DR   Wikidata; Q54790728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB147
AC   CVCL_QI38
SY   YHB147
DR   MMRRC; MMRRC:011269-UCD
DR   Wikidata; Q54790729
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924767; Zfyve26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB149
AC   CVCL_QI39
SY   YHB149
DR   MMRRC; MMRRC:011270-UCD
DR   Wikidata; Q54790733
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95401; Epb41.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB151
AC   CVCL_QI40
SY   YHB151
DR   MMRRC; MMRRC:011271-UCD
DR   Wikidata; Q54790734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB156
AC   CVCL_QI41
SY   YHB156
DR   MMRRC; MMRRC:011273-UCD
DR   Wikidata; Q54790736
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3644008; Ccdc85c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB164
AC   CVCL_QI42
SY   YHB164
DR   MMRRC; MMRRC:011274-UCD
DR   Wikidata; Q54790787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931053; Marchf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YHB165
AC   CVCL_QI43
SY   YHB165
DR   MMRRC; MMRRC:011275-UCD
DR   Wikidata; Q54790790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2652885; Tbc1d2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB166
AC   CVCL_QI44
SY   YHB166
DR   MMRRC; MMRRC:011276-UCD
DR   Wikidata; Q54790791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338944; Acvr1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB169
AC   CVCL_QI45
SY   YHB169
DR   MMRRC; MMRRC:011277-UCD
DR   Wikidata; Q54790795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB170
AC   CVCL_QI46
SY   YHB170
DR   MMRRC; MMRRC:011278-UCD
DR   Wikidata; Q54790796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913917; Hspbap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB171
AC   CVCL_QI47
SY   YHB171
DR   MMRRC; MMRRC:011279-UCD
DR   Wikidata; Q54790797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107186; Cct2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB175
AC   CVCL_QI48
SY   YHB175
DR   MMRRC; MMRRC:011281-UCD
DR   Wikidata; Q54790800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB178
AC   CVCL_QI49
SY   YHB178
DR   MMRRC; MMRRC:011282-UCD
DR   Wikidata; Q54790801
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890496; Elac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB179
AC   CVCL_QI50
SY   YHB179
DR   MMRRC; MMRRC:011283-UCD
DR   Wikidata; Q54790805
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB182
AC   CVCL_QI51
SY   YHB182
DR   MMRRC; MMRRC:011284-UCD
DR   Wikidata; Q54790806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919837; Pan3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB184
AC   CVCL_QI52
SY   YHB184
DR   MMRRC; MMRRC:011285-UCD
DR   Wikidata; Q54790809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB185
AC   CVCL_QI53
SY   YHB185
DR   MMRRC; MMRRC:011286-UCD
DR   Wikidata; Q54790810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449121; Nme7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB189
AC   CVCL_QI54
SY   YHB189
DR   MMRRC; MMRRC:011287-UCD
DR   Wikidata; Q54790812
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109130; Stip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB191
AC   CVCL_QI55
SY   YHB191
DR   MMRRC; MMRRC:011289-UCD
DR   Wikidata; Q54790813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916963; Pin4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB193
AC   CVCL_QI56
SY   YHB193
DR   MMRRC; MMRRC:011290-UCD
DR   Wikidata; Q54790816
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914713; Poc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB201
AC   CVCL_QI57
SY   YHB201
DR   MMRRC; MMRRC:011292-UCD
DR   Wikidata; Q54790818
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444133; Heatr5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB205
AC   CVCL_QI58
SY   YHB205
DR   MMRRC; MMRRC:011293-UCD
DR   Wikidata; Q54790822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107572; Xiap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB207
AC   CVCL_QI59
SY   YHB207
DR   MMRRC; MMRRC:011294-UCD
DR   Wikidata; Q54790824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261775; Atg14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB208
AC   CVCL_QI60
SY   YHB208
DR   MMRRC; MMRRC:011295-UCD
DR   Wikidata; Q54790827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918625; Foxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB209
AC   CVCL_QI61
SY   YHB209
DR   MMRRC; MMRRC:011296-UCD
DR   Wikidata; Q54790829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100836; Kpna6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB218
AC   CVCL_QI62
SY   YHB218
DR   MMRRC; MMRRC:011299-UCD
DR   Wikidata; Q54790831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924270; Atl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB219
AC   CVCL_QI63
SY   YHB219
DR   MMRRC; MMRRC:011300-UCD
DR   Wikidata; Q54790832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136959; Bcl2l13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB220
AC   CVCL_QI64
SY   YHB220
DR   MMRRC; MMRRC:011301-UCD
DR   Wikidata; Q54790835
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB224
AC   CVCL_QI65
SY   YHB224
DR   MMRRC; MMRRC:011303-UCD
DR   Wikidata; Q54790837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921570; Wdr33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB226
AC   CVCL_QI66
SY   YHB226
DR   MMRRC; MMRRC:011304-UCD
DR   Wikidata; Q54790838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349410; Triobp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB227
AC   CVCL_QI67
SY   YHB227
DR   MMRRC; MMRRC:011180-UCD
DR   Wikidata; Q54790840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109602; Gphn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB228
AC   CVCL_QI68
SY   YHB228
DR   MMRRC; MMRRC:011305-UCD
DR   Wikidata; Q54790842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95659; Gas5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB229
AC   CVCL_QI69
SY   YHB229
DR   MMRRC; MMRRC:011306-UCD
DR   Wikidata; Q54790843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB232
AC   CVCL_QI70
SY   YHB232
DR   MMRRC; MMRRC:011307-UCD
DR   Wikidata; Q54790847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443265; Tnrc6c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB233
AC   CVCL_QI71
SY   YHB233
DR   MMRRC; MMRRC:011308-UCD
DR   Wikidata; Q54790849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447794; Sfmbt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB234
AC   CVCL_QI72
SY   YHB234
DR   MMRRC; MMRRC:011309-UCD
DR   Wikidata; Q54790850
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB235
AC   CVCL_QI73
SY   YHB235
DR   MMRRC; MMRRC:011310-UCD
DR   Wikidata; Q54790853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB238
AC   CVCL_QI74
SY   YHB238
DR   MMRRC; MMRRC:011311-UCD
DR   Wikidata; Q54790854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB239
AC   CVCL_QI75
SY   YHB239
DR   MMRRC; MMRRC:011312-UCD
DR   Wikidata; Q54790856
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106581; Tsg101.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB244
AC   CVCL_QI76
SY   YHB244
DR   MMRRC; MMRRC:011313-UCD
DR   Wikidata; Q54790859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921450; Khdc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YHB247
AC   CVCL_QI77
SY   YHB247
DR   MMRRC; MMRRC:011314-UCD
DR   Wikidata; Q54790861
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98759; Tjp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB248
AC   CVCL_QI78
SY   YHB248
DR   MMRRC; MMRRC:011315-UCD
DR   Wikidata; Q54790863
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB251
AC   CVCL_QI79
SY   YHB251
DR   MMRRC; MMRRC:011181-UCD
DR   Wikidata; Q54790867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB253
AC   CVCL_QI80
SY   YHB253
DR   MMRRC; MMRRC:011182-UCD
DR   Wikidata; Q54790868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388280; Polr2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB257
AC   CVCL_QI81
SY   YHB257
DR   MMRRC; MMRRC:011183-UCD
DR   Wikidata; Q54790871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446979; Kif18b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB259
AC   CVCL_QI82
SY   YHB259
DR   MMRRC; MMRRC:011317-UCD
DR   Wikidata; Q54790917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137357; Trim33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB262
AC   CVCL_QI83
SY   YHB262
DR   MMRRC; MMRRC:011318-UCD
DR   Wikidata; Q54790919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147627; Yars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB267
AC   CVCL_QI84
SY   YHB267
DR   MMRRC; MMRRC:011319-UCD
DR   Wikidata; Q54790921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144117; Smg6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB273
AC   CVCL_QI85
SY   YHB273
DR   MMRRC; MMRRC:011322-UCD
DR   Wikidata; Q54790923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924281; Slc9a8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB279
AC   CVCL_QI86
SY   YHB279
DR   MMRRC; MMRRC:011323-UCD
DR   Wikidata; Q54790924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921358; Parn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB280
AC   CVCL_QI87
SY   YHB280
DR   MMRRC; MMRRC:011324-UCD
DR   Wikidata; Q54790925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3027896; Ppp4r2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB286
AC   CVCL_QI88
SY   YHB286
DR   MMRRC; MMRRC:011326-UCD
DR   Wikidata; Q54790929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444959; Kmt2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB287
AC   CVCL_QI89
SY   YHB287
DR   MMRRC; MMRRC:011444-UCD
DR   Wikidata; Q54790930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB289
AC   CVCL_QI90
SY   YHB289
DR   MMRRC; MMRRC:011327-UCD
DR   Wikidata; Q54790932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB290
AC   CVCL_QI91
SY   YHB290
DR   MMRRC; MMRRC:011328-UCD
DR   Wikidata; Q54790933
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443658; Prr14l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB291
AC   CVCL_QI92
SY   YHB291
DR   MMRRC; MMRRC:011329-UCD
DR   Wikidata; Q54790937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931751; Pum2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB295
AC   CVCL_QI93
SY   YHB295
DR   MMRRC; MMRRC:011331-UCD
DR   Wikidata; Q54790938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916083; Pdcl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB300
AC   CVCL_QI94
SY   YHB300
DR   MMRRC; MMRRC:011332-UCD
DR   Wikidata; Q54790941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916083; Pdcl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB304
AC   CVCL_QI95
SY   YHB304
DR   MMRRC; MMRRC:011334-UCD
DR   Wikidata; Q54790943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924223; Fbxo21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB305
AC   CVCL_QI96
SY   YHB305
DR   MMRRC; MMRRC:011335-UCD
DR   Wikidata; Q54790945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103075; Wee1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB306
AC   CVCL_QI97
SY   YHB306
DR   MMRRC; MMRRC:011336-UCD
DR   Wikidata; Q54790947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914789; Dock6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB307
AC   CVCL_QI98
SY   YHB307
DR   MMRRC; MMRRC:011337-UCD
DR   Wikidata; Q54790950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914789; Dock6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB308
AC   CVCL_QI99
SY   YHB308
DR   MMRRC; MMRRC:011338-UCD
DR   Wikidata; Q54790953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2683486; Rere.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB310
AC   CVCL_QJ00
SY   YHB310
DR   MMRRC; MMRRC:011339-UCD
DR   Wikidata; Q54790956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB312
AC   CVCL_QJ01
SY   YHB312
DR   MMRRC; MMRRC:011340-UCD
DR   Wikidata; Q54790959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916083; Pdcl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB313
AC   CVCL_QJ02
SY   YHB313
DR   MMRRC; MMRRC:011341-UCD
DR   Wikidata; Q54790961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347070; Psma7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB315
AC   CVCL_QJ03
SY   YHB315
DR   MMRRC; MMRRC:011342-UCD
DR   Wikidata; Q54790963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140796; Slc15a4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB317
AC   CVCL_QJ04
SY   YHB317
DR   MMRRC; MMRRC:011344-UCD
DR   Wikidata; Q54790966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99948; Zfhx3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB322
AC   CVCL_QJ05
SY   YHB322
DR   MMRRC; MMRRC:011347-UCD
DR   Wikidata; Q54790969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183446; Agap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB323
AC   CVCL_QJ06
SY   YHB323
DR   MMRRC; MMRRC:011348-UCD
DR   Wikidata; Q54790972
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096566; Pias2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB324
AC   CVCL_QJ07
SY   YHB324
DR   MMRRC; MMRRC:011349-UCD
DR   Wikidata; Q54790974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB325
AC   CVCL_QJ08
SY   YHB325
DR   MMRRC; MMRRC:011350-UCD
DR   Wikidata; Q54790977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB326
AC   CVCL_QJ09
SY   YHB326
DR   MMRRC; MMRRC:011351-UCD
DR   Wikidata; Q54790979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB327
AC   CVCL_QJ10
SY   YHB327
DR   MMRRC; MMRRC:011352-UCD
DR   Wikidata; Q54790981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673709; Kntc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB328
AC   CVCL_QJ11
SY   YHB328
DR   MMRRC; MMRRC:011353-UCD
DR   Wikidata; Q54790984
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB331
AC   CVCL_QJ12
SY   YHB331
DR   MMRRC; MMRRC:011354-UCD
DR   Wikidata; Q54790986
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB333
AC   CVCL_QJ13
SY   YHB333
DR   MMRRC; MMRRC:011356-UCD
DR   Wikidata; Q54790989
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147679; Patl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB336
AC   CVCL_QJ14
SY   YHB336
DR   MMRRC; MMRRC:011357-UCD
DR   Wikidata; Q54790993
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921452; Fblim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB347
AC   CVCL_QJ15
SY   YHB347
DR   MMRRC; MMRRC:011361-UCD
DR   Wikidata; Q54790994
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB348
AC   CVCL_QJ16
SY   YHB348
DR   MMRRC; MMRRC:011362-UCD
DR   Wikidata; Q54790995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913763; Tab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB353
AC   CVCL_QJ17
SY   YHB353
DR   MMRRC; MMRRC:011363-UCD
DR   Wikidata; Q54791000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3027896; Ppp4r2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB356
AC   CVCL_QJ18
SY   YHB356
DR   MMRRC; MMRRC:011364-UCD
DR   Wikidata; Q54791001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927222; Diaph3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB357
AC   CVCL_QJ19
SY   YHB357
DR   MMRRC; MMRRC:011365-UCD
DR   Wikidata; Q54791002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB362
AC   CVCL_QJ20
SY   YHB362
DR   MMRRC; MMRRC:011367-UCD
DR   Wikidata; Q54791005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917900; Zcchc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB367
AC   CVCL_QJ21
SY   YHB367
DR   MMRRC; MMRRC:011368-UCD
DR   Wikidata; Q54791006
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921452; Fblim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB369
AC   CVCL_QJ22
SY   YHB369
DR   MMRRC; MMRRC:011369-UCD
DR   Wikidata; Q54791059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183747; Fgd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB374
AC   CVCL_QJ23
SY   YHB374
DR   MMRRC; MMRRC:011371-UCD
DR   Wikidata; Q54791060
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921452; Fblim1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB376
AC   CVCL_QJ24
SY   YHB376
DR   MMRRC; MMRRC:011372-UCD
DR   Wikidata; Q54791062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB379
AC   CVCL_QJ25
SY   YHB379
DR   MMRRC; MMRRC:011373-UCD
DR   Wikidata; Q54791065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919445; Supt7l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB380
AC   CVCL_QJ26
SY   YHB380
DR   MMRRC; MMRRC:011374-UCD
DR   Wikidata; Q54791066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914789; Dock6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB381
AC   CVCL_QJ27
SY   YHB381
DR   MMRRC; MMRRC:011375-UCD
DR   Wikidata; Q54791068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914789; Dock6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB383
AC   CVCL_QJ28
SY   YHB383
DR   MMRRC; MMRRC:011376-UCD
DR   Wikidata; Q54791070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914633; Carnmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB384
AC   CVCL_QJ29
SY   YHB384
DR   MMRRC; MMRRC:011377-UCD
DR   Wikidata; Q54791071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385071; Etf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB386
AC   CVCL_QJ30
SY   YHB386
DR   MMRRC; MMRRC:011378-UCD
DR   Wikidata; Q54791074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096368; Ap1b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB390
AC   CVCL_QJ31
SY   YHB390
DR   MMRRC; MMRRC:011379-UCD
DR   Wikidata; Q54791076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921487; Tubgcp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB391
AC   CVCL_QJ32
SY   YHB391
DR   MMRRC; MMRRC:011380-UCD
DR   Wikidata; Q54791077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB392
AC   CVCL_QJ33
SY   YHB392
DR   MMRRC; MMRRC:011381-UCD
DR   Wikidata; Q54791080
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB395
AC   CVCL_QJ34
SY   YHB395
DR   MMRRC; MMRRC:011184-UCD
DR   Wikidata; Q54791082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858907; Blcap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB396
AC   CVCL_QJ35
SY   YHB396
DR   MMRRC; MMRRC:011383-UCD
DR   Wikidata; Q54791083
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914134; Appbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB397
AC   CVCL_QJ36
SY   YHB397
DR   MMRRC; MMRRC:011445-UCD
DR   Wikidata; Q54791085
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB403
AC   CVCL_QJ37
SY   YHB403
DR   MMRRC; MMRRC:011446-UCD
DR   Wikidata; Q54791088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107606; Srebf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB404
AC   CVCL_QJ38
SY   YHB404
DR   MMRRC; MMRRC:011447-UCD
DR   Wikidata; Q54791089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB407
AC   CVCL_QJ39
SY   YHB407
DR   MMRRC; MMRRC:011449-UCD
DR   Wikidata; Q54791091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100836; Kpna6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB409
AC   CVCL_QJ40
SY   YHB409
DR   MMRRC; MMRRC:011450-UCD
DR   Wikidata; Q54791092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924223; Fbxo21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB416
AC   CVCL_QJ41
SY   YHB416
DR   MMRRC; MMRRC:011454-UCD
DR   Wikidata; Q54791094
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB417
AC   CVCL_QJ42
SY   YHB417
DR   MMRRC; MMRRC:011455-UCD
DR   Wikidata; Q54791095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924223; Fbxo21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB424
AC   CVCL_QJ43
SY   YHB424
DR   MMRRC; MMRRC:011458-UCD
DR   Wikidata; Q54791099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB426
AC   CVCL_QJ44
SY   YHB426
DR   MMRRC; MMRRC:011460-UCD
DR   Wikidata; Q54791100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB427
AC   CVCL_QJ45
SY   YHB427
DR   MMRRC; MMRRC:011461-UCD
DR   Wikidata; Q54791102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915403; Gtf2e2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB431
AC   CVCL_QJ46
SY   YHB431
DR   MMRRC; MMRRC:011186-UCD
DR   Wikidata; Q54791105
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB433
AC   CVCL_QJ47
SY   YHB433
DR   MMRRC; MMRRC:011463-UCD
DR   Wikidata; Q54791107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385071; Etf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB436
AC   CVCL_QJ48
SY   YHB436
DR   MMRRC; MMRRC:011464-UCD
DR   Wikidata; Q54791109
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB437
AC   CVCL_QJ49
SY   YHB437
DR   MMRRC; MMRRC:011465-UCD
DR   Wikidata; Q54791112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB438
AC   CVCL_QJ50
SY   YHB438
DR   MMRRC; MMRRC:011384-UCD
DR   Wikidata; Q54791113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB439
AC   CVCL_QJ51
SY   YHB439
DR   MMRRC; MMRRC:011466-UCD
DR   Wikidata; Q54791116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHB440
AC   CVCL_QJ52
SY   YHB440
DR   MMRRC; MMRRC:011385-UCD
DR   Wikidata; Q54791117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277961; Plec.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC001
AC   CVCL_QJ53
SY   YHC001
DR   MMRRC; MMRRC:012323-UCD
DR   Wikidata; Q54791121
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914149; Fip1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC007
AC   CVCL_QJ54
SY   YHC007
DR   MMRRC; MMRRC:012821-UCD
DR   Wikidata; Q54791123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353499; Baz1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC008
AC   CVCL_QJ55
SY   YHC008
DR   MMRRC; MMRRC:012822-UCD
DR   Wikidata; Q54791126
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC013
AC   CVCL_QJ56
SY   YHC013
DR   MMRRC; MMRRC:012324-UCD
DR   Wikidata; Q54791128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443730; Tnrc6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC014
AC   CVCL_QJ57
SY   YHC014
DR   MMRRC; MMRRC:012325-UCD
DR   Wikidata; Q54791130
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921361; Rbm19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC015
AC   CVCL_QJ58
SY   YHC015
DR   MMRRC; MMRRC:012326-UCD
DR   Wikidata; Q54791132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923119; Arl5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC017
AC   CVCL_QJ59
SY   YHC017
DR   MMRRC; MMRRC:012327-UCD
DR   Wikidata; Q54791133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC018
AC   CVCL_QJ60
SY   YHC018
DR   MMRRC; MMRRC:012328-UCD
DR   Wikidata; Q54791135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385001; Fermt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC020
AC   CVCL_QJ61
SY   YHC020
DR   MMRRC; MMRRC:012329-UCD
DR   Wikidata; Q54791138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100851; Elavl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC022
AC   CVCL_QJ62
SY   YHC022
DR   MMRRC; MMRRC:012330-UCD
DR   Wikidata; Q54791181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914324; Mon2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC023
AC   CVCL_QJ63
SY   YHC023
DR   MMRRC; MMRRC:012331-UCD
DR   Wikidata; Q54791184
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203522; Magi1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC024
AC   CVCL_QJ64
SY   YHC024
DR   MMRRC; MMRRC:012332-UCD
DR   Wikidata; Q54791187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929264; Sae1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC028
AC   CVCL_QJ65
SY   YHC028
DR   MMRRC; MMRRC:012334-UCD
DR   Wikidata; Q54791188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443065; Agps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC029
AC   CVCL_QJ66
SY   YHC029
DR   MMRRC; MMRRC:012335-UCD
DR   Wikidata; Q54791190
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924567; Miga1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC032
AC   CVCL_QJ67
SY   YHC032
DR   MMRRC; MMRRC:012337-UCD
DR   Wikidata; Q54791191
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99695; Cttn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC036
AC   CVCL_QJ68
SY   YHC036
DR   MMRRC; MMRRC:012338-UCD
DR   Wikidata; Q54791194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC037
AC   CVCL_QJ69
SY   YHC037
DR   MMRRC; MMRRC:012339-UCD
DR   Wikidata; Q54791195
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917887; Ankrd26.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC040
AC   CVCL_QJ70
SY   YHC040
DR   MMRRC; MMRRC:012340-UCD
DR   Wikidata; Q54791197
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914182; Rexo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC042
AC   CVCL_QJ71
SY   YHC042
DR   MMRRC; MMRRC:012341-UCD
DR   Wikidata; Q54791199
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925255; Rrn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC043
AC   CVCL_QJ72
SY   YHC043
DR   MMRRC; MMRRC:012342-UCD
DR   Wikidata; Q54791201
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202880; Traf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC044
AC   CVCL_QJ73
SY   YHC044
DR   MMRRC; MMRRC:012343-UCD
DR   Wikidata; Q54791202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88141; Bcr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC046
AC   CVCL_QJ74
SY   YHC046
DR   MMRRC; MMRRC:012344-UCD
DR   Wikidata; Q54791204
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344352; Dido1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC048
AC   CVCL_QJ75
SY   YHC048
DR   MMRRC; MMRRC:012345-UCD
DR   Wikidata; Q54791205
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC049
AC   CVCL_QJ76
SY   YHC049
DR   MMRRC; MMRRC:012346-UCD
DR   Wikidata; Q54791207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891704; Hbs1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC051
AC   CVCL_QJ77
SY   YHC051
DR   MMRRC; MMRRC:012347-UCD
DR   Wikidata; Q54791208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925255; Rrn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC053
AC   CVCL_QJ78
SY   YHC053
DR   MMRRC; MMRRC:012348-UCD
DR   Wikidata; Q54791210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100518; Smad7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC056
AC   CVCL_QJ79
SY   YHC056
DR   MMRRC; MMRRC:012350-UCD
DR   Wikidata; Q54791213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915080; Rer1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC063
AC   CVCL_QJ80
SY   YHC063
DR   MMRRC; MMRRC:012354-UCD
DR   Wikidata; Q54791215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858259; Tomm40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC064
AC   CVCL_QJ81
SY   YHC064
DR   MMRRC; MMRRC:012355-UCD
DR   Wikidata; Q54791216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100865; Rbm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC065
AC   CVCL_QJ82
SY   YHC065
DR   MMRRC; MMRRC:012356-UCD
DR   Wikidata; Q54791218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098275; Gse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC069
AC   CVCL_QJ83
SY   YHC069
DR   MMRRC; MMRRC:012358-UCD
DR   Wikidata; Q54791219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC070
AC   CVCL_QJ84
SY   YHC070
DR   MMRRC; MMRRC:012359-UCD
DR   Wikidata; Q54791221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921638; Dpp8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC071
AC   CVCL_QJ85
SY   YHC071
DR   MMRRC; MMRRC:012360-UCD
DR   Wikidata; Q54791222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913392; Cox7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC072
AC   CVCL_QJ86
SY   YHC072
DR   MMRRC; MMRRC:012361-UCD
DR   Wikidata; Q54791223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913392; Cox7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC074
AC   CVCL_QJ87
SY   YHC074
DR   MMRRC; MMRRC:012362-UCD
DR   Wikidata; Q54791225
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333780; Rps19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC075
AC   CVCL_QJ88
SY   YHC075
DR   MMRRC; MMRRC:012363-UCD
DR   Wikidata; Q54791226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446193; Tnks1bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC076
AC   CVCL_QJ89
SY   YHC076
DR   MMRRC; MMRRC:012364-UCD
DR   Wikidata; Q54791229
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858259; Tomm40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC077
AC   CVCL_QJ90
SY   YHC077
DR   MMRRC; MMRRC:012365-UCD
DR   Wikidata; Q54791230
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917866; Sugp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC078
AC   CVCL_QJ91
SY   YHC078
DR   MMRRC; MMRRC:012366-UCD
DR   Wikidata; Q54791233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923517; Fads1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC080
AC   CVCL_QJ92
SY   YHC080
DR   MMRRC; MMRRC:012368-UCD
DR   Wikidata; Q54791235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344381; Dnajb6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC081
AC   CVCL_QJ93
SY   YHC081
DR   MMRRC; MMRRC:012369-UCD
DR   Wikidata; Q54791237
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889505; B3gnt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC082
AC   CVCL_QJ94
SY   YHC082
DR   MMRRC; MMRRC:012370-UCD
DR   Wikidata; Q54791240
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC083
AC   CVCL_QJ95
SY   YHC083
DR   MMRRC; MMRRC:012371-UCD
DR   Wikidata; Q54791242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC084
AC   CVCL_QJ96
SY   YHC084
DR   MMRRC; MMRRC:012372-UCD
DR   Wikidata; Q54791243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913392; Cox7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC086
AC   CVCL_QJ97
SY   YHC086
DR   MMRRC; MMRRC:012374-UCD
DR   Wikidata; Q54791246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC090
AC   CVCL_QJ98
SY   YHC090
DR   MMRRC; MMRRC:012375-UCD
DR   Wikidata; Q54791248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861453; Actl6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC091
AC   CVCL_QJ99
SY   YHC091
DR   MMRRC; MMRRC:012376-UCD
DR   Wikidata; Q54791252
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC094
AC   CVCL_QK00
SY   YHC094
DR   MMRRC; MMRRC:012377-UCD
DR   Wikidata; Q54791254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96995; Kmt2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC102
AC   CVCL_QK01
SY   YHC102
DR   MMRRC; MMRRC:012379-UCD
DR   Wikidata; Q54791257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108177; Dhx9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC103
AC   CVCL_QK02
SY   YHC103
DR   MMRRC; MMRRC:012380-UCD
DR   Wikidata; Q54791312
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3782666; Gm4482.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC106
AC   CVCL_QK03
SY   YHC106
DR   MMRRC; MMRRC:012382-UCD
DR   Wikidata; Q54791314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858259; Tomm40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC111
AC   CVCL_QK04
SY   YHC111
DR   MMRRC; MMRRC:012384-UCD
DR   Wikidata; Q54791315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914189; Aagab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC112
AC   CVCL_QK05
SY   YHC112
DR   MMRRC; MMRRC:012385-UCD
DR   Wikidata; Q54791317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC116
AC   CVCL_QK06
SY   YHC116
DR   MMRRC; MMRRC:012387-UCD
DR   Wikidata; Q54791319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446296; Sik3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC117
AC   CVCL_QK07
SY   YHC117
DR   MMRRC; MMRRC:012388-UCD
DR   Wikidata; Q54791322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC118
AC   CVCL_QK08
SY   YHC118
DR   MMRRC; MMRRC:012389-UCD
DR   Wikidata; Q54791324
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95288; Eef2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC119
AC   CVCL_QK09
SY   YHC119
DR   MMRRC; MMRRC:012390-UCD
DR   Wikidata; Q54791326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919420; Chchd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC120
AC   CVCL_QK10
SY   YHC120
DR   MMRRC; MMRRC:012391-UCD
DR   Wikidata; Q54791328
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC127
AC   CVCL_QK11
SY   YHC127
DR   MMRRC; MMRRC:012393-UCD
DR   Wikidata; Q54791330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921294; Ttf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC128
AC   CVCL_QK12
SY   YHC128
DR   MMRRC; MMRRC:012394-UCD
DR   Wikidata; Q54791331
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101921; Ap2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC129
AC   CVCL_QK13
SY   YHC129
DR   MMRRC; MMRRC:012395-UCD
DR   Wikidata; Q54791334
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858195; Hnrnpu.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC131
AC   CVCL_QK14
SY   YHC131
DR   MMRRC; MMRRC:012397-UCD
DR   Wikidata; Q54791336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918667; Gpatch8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC136
AC   CVCL_QK15
SY   YHC136
DR   MMRRC; MMRRC:012400-UCD
DR   Wikidata; Q54791339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385848; Bcas3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC137
AC   CVCL_QK16
SY   YHC137
DR   MMRRC; MMRRC:012401-UCD
DR   Wikidata; Q54791341
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107801; Atp5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC138
AC   CVCL_QK17
SY   YHC138
DR   MMRRC; MMRRC:012402-UCD
DR   Wikidata; Q54791344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926078; Rhot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC139
AC   CVCL_QK18
SY   YHC139
DR   MMRRC; MMRRC:012403-UCD
DR   Wikidata; Q54791346
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922570; Etnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC140
AC   CVCL_QK19
SY   YHC140
DR   MMRRC; MMRRC:012404-UCD
DR   Wikidata; Q54791349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142786; Tango6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC144
AC   CVCL_QK20
SY   YHC144
DR   MMRRC; MMRRC:012407-UCD
DR   Wikidata; Q54791351
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2177308; Znrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC145
AC   CVCL_QK21
SY   YHC145
DR   MMRRC; MMRRC:012408-UCD
DR   Wikidata; Q54791353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917689; Taf15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC146
AC   CVCL_QK22
SY   YHC146
DR   MMRRC; MMRRC:012409-UCD
DR   Wikidata; Q54791355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2667663; Cep68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC149
AC   CVCL_QK23
SY   YHC149
DR   MMRRC; MMRRC:012410-UCD
DR   Wikidata; Q54791357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC151
AC   CVCL_QK24
SY   YHC151
DR   MMRRC; MMRRC:012411-UCD
DR   Wikidata; Q54791361
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339973; Ilf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC152
AC   CVCL_QK25
SY   YHC152
DR   MMRRC; MMRRC:012412-UCD
DR   Wikidata; Q54791363
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446159; Itpk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC154
AC   CVCL_QK26
SY   YHC154
DR   MMRRC; MMRRC:012414-UCD
DR   Wikidata; Q54791364
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351455; Rpl13a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC157
AC   CVCL_QK27
SY   YHC157
DR   MMRRC; MMRRC:012416-UCD
DR   Wikidata; Q54791365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349423; Racgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC158
AC   CVCL_QK28
SY   YHC158
DR   MMRRC; MMRRC:012417-UCD
DR   Wikidata; Q54791370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1195276; Bloc1s1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC159
AC   CVCL_QK29
SY   YHC159
DR   MMRRC; MMRRC:012418-UCD
DR   Wikidata; Q54791371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104670; Fkbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC160
AC   CVCL_QK30
SY   YHC160
DR   MMRRC; MMRRC:012419-UCD
DR   Wikidata; Q54791374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915020; Caap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC161
AC   CVCL_QK31
SY   YHC161
DR   MMRRC; MMRRC:012420-UCD
DR   Wikidata; Q54791376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106356; D11Wsu47e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC162
AC   CVCL_QK32
SY   YHC162
DR   MMRRC; MMRRC:012421-UCD
DR   Wikidata; Q54791377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919318; Cnot2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC163
AC   CVCL_QK33
SY   YHC163
DR   MMRRC; MMRRC:012422-UCD
DR   Wikidata; Q54791379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443111; Abcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC167
AC   CVCL_QK34
SY   YHC167
DR   MMRRC; MMRRC:012423-UCD
DR   Wikidata; Q54791380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109486; Prdx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC168
AC   CVCL_QK35
SY   YHC168
DR   MMRRC; MMRRC:012424-UCD
DR   Wikidata; Q54791381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC170
AC   CVCL_QK36
SY   YHC170
DR   MMRRC; MMRRC:012425-UCD
DR   Wikidata; Q54791383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2183446; Agap3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC177
AC   CVCL_QK37
SY   YHC177
DR   MMRRC; MMRRC:012427-UCD
DR   Wikidata; Q54791385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142347; Zfp568.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC179
AC   CVCL_QK38
SY   YHC179
DR   MMRRC; MMRRC:012428-UCD
DR   Wikidata; Q54791386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC181
AC   CVCL_QK39
SY   YHC181
DR   MMRRC; MMRRC:012429-UCD
DR   Wikidata; Q54791389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC182
AC   CVCL_QK40
SY   YHC182
DR   MMRRC; MMRRC:012430-UCD
DR   Wikidata; Q54791390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351825; Cstf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC194
AC   CVCL_QK41
SY   YHC194
DR   MMRRC; MMRRC:012433-UCD
DR   Wikidata; Q54791395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925112; Thyn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC200
AC   CVCL_QK42
SY   YHC200
DR   MMRRC; MMRRC:012435-UCD
DR   Wikidata; Q54791446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924367; Zfp934.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC201
AC   CVCL_QK43
SY   YHC201
DR   MMRRC; MMRRC:012436-UCD
DR   Wikidata; Q54791448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926967; Hsd17b12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC202
AC   CVCL_QK44
SY   YHC202
DR   MMRRC; MMRRC:012437-UCD
DR   Wikidata; Q54791450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95769; Gna14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC203
AC   CVCL_QK45
SY   YHC203
DR   MMRRC; MMRRC:012438-UCD
DR   Wikidata; Q54791453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917193; Lrch4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC206
AC   CVCL_QK46
SY   YHC206
DR   MMRRC; MMRRC:012440-UCD
DR   Wikidata; Q54791456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC209
AC   CVCL_QK47
SY   YHC209
DR   MMRRC; MMRRC:012442-UCD
DR   Wikidata; Q54791458
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891693; Mtmr7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC213
AC   CVCL_QK48
SY   YHC213
DR   MMRRC; MMRRC:012443-UCD
DR   Wikidata; Q54791460
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276539; Ttc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC214
AC   CVCL_QK49
SY   YHC214
DR   MMRRC; MMRRC:012444-UCD
DR   Wikidata; Q54791461
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC215
AC   CVCL_QK50
SY   YHC215
DR   MMRRC; MMRRC:012445-UCD
DR   Wikidata; Q54791464
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC217
AC   CVCL_QK51
SY   YHC217
DR   MMRRC; MMRRC:012446-UCD
DR   Wikidata; Q54791467
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108088; Gab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC218
AC   CVCL_QK52
SY   YHC218
DR   MMRRC; MMRRC:012447-UCD
DR   Wikidata; Q54791469
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927551; Osbpl1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC219
AC   CVCL_QK53
SY   YHC219
DR   MMRRC; MMRRC:012448-UCD
DR   Wikidata; Q54791471
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917498; Dazap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC220
AC   CVCL_QK54
SY   YHC220
DR   MMRRC; MMRRC:012449-UCD
DR   Wikidata; Q54791473
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923241; Slain2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC222
AC   CVCL_QK55
SY   YHC222
DR   MMRRC; MMRRC:012451-UCD
DR   Wikidata; Q54791475
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914189; Aagab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC225
AC   CVCL_QK56
SY   YHC225
DR   MMRRC; MMRRC:012452-UCD
DR   Wikidata; Q54791479
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924367; Zfp934.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC234
AC   CVCL_QK57
SY   YHC234
DR   MMRRC; MMRRC:012455-UCD
DR   Wikidata; Q54791480
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC236
AC   CVCL_QK58
SY   YHC236
DR   MMRRC; MMRRC:012456-UCD
DR   Wikidata; Q54791482
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2153049; Klf16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC237
AC   CVCL_QK59
SY   YHC237
DR   MMRRC; MMRRC:012457-UCD
DR   Wikidata; Q54791485
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC239
AC   CVCL_QK60
SY   YHC239
DR   MMRRC; MMRRC:012458-UCD
DR   Wikidata; Q54791486
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926082; Cacul1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC240
AC   CVCL_QK61
SY   YHC240
DR   MMRRC; MMRRC:012459-UCD
DR   Wikidata; Q54791487
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858230; Sart3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC243
AC   CVCL_QK62
SY   YHC243
DR   MMRRC; MMRRC:012460-UCD
DR   Wikidata; Q54791489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443502; Cep95.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC246
AC   CVCL_QK63
SY   YHC246
DR   MMRRC; MMRRC:012463-UCD
DR   Wikidata; Q54791490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194912; Rbbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC247
AC   CVCL_QK64
SY   YHC247
DR   MMRRC; MMRRC:012464-UCD
DR   Wikidata; Q54791492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95804; Gsr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC248
AC   CVCL_QK65
SY   YHC248
DR   MMRRC; MMRRC:012465-UCD
DR   Wikidata; Q54791495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2178103; Arhgdia.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC251
AC   CVCL_QK66
SY   YHC251
DR   MMRRC; MMRRC:012466-UCD
DR   Wikidata; Q54791496
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913617; 2310022A10Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC253
AC   CVCL_QK67
SY   YHC253
DR   MMRRC; MMRRC:012467-UCD
DR   Wikidata; Q54791497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC256
AC   CVCL_QK68
SY   YHC256
DR   MMRRC; MMRRC:012469-UCD
DR   Wikidata; Q54791500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289280; Zfp410.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC257
AC   CVCL_QK69
SY   YHC257
DR   MMRRC; MMRRC:012470-UCD
DR   Wikidata; Q54791502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098808; Pex5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC260
AC   CVCL_QK70
SY   YHC260
DR   MMRRC; MMRRC:012471-UCD
DR   Wikidata; Q54791504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921197; 4930430F08Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC262
AC   CVCL_QK71
SY   YHC262
DR   MMRRC; MMRRC:012472-UCD
DR   Wikidata; Q54791506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921197; 4930430F08Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC264
AC   CVCL_QK72
SY   YHC264
DR   MMRRC; MMRRC:012474-UCD
DR   Wikidata; Q54791508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928268; Ireb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC268
AC   CVCL_QK73
SY   YHC268
DR   MMRRC; MMRRC:012476-UCD
DR   Wikidata; Q54791510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339984; Pak2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC271
AC   CVCL_QK74
SY   YHC271
DR   MMRRC; MMRRC:012478-UCD
DR   Wikidata; Q54791513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444453; Arhgef10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC272
AC   CVCL_QK75
SY   YHC272
DR   MMRRC; MMRRC:012479-UCD
DR   Wikidata; Q54791516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915033; Ahctf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC273
AC   CVCL_QK76
SY   YHC273
DR   MMRRC; MMRRC:012480-UCD
DR   Wikidata; Q54791517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC274
AC   CVCL_QK77
SY   YHC274
DR   MMRRC; MMRRC:012481-UCD
DR   Wikidata; Q54791520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC276
AC   CVCL_QK78
SY   YHC276
DR   MMRRC; MMRRC:012483-UCD
DR   Wikidata; Q54791522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926465; Hnrnpm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC279
AC   CVCL_QK79
SY   YHC279
DR   MMRRC; MMRRC:012484-UCD
DR   Wikidata; Q54791524
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98105; Rps12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC280
AC   CVCL_QK80
SY   YHC280
DR   MMRRC; MMRRC:012485-UCD
DR   Wikidata; Q54791525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444155; Nmnat2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC281
AC   CVCL_QK81
SY   YHC281
DR   MMRRC; MMRRC:012486-UCD
DR   Wikidata; Q54791529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:700009; Sh3gl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC285
AC   CVCL_QK82
SY   YHC285
DR   MMRRC; MMRRC:012487-UCD
DR   Wikidata; Q54791572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104982; Cebpg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC286
AC   CVCL_QK83
SY   YHC286
DR   MMRRC; MMRRC:012488-UCD
DR   Wikidata; Q54791574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC288
AC   CVCL_QK84
SY   YHC288
DR   MMRRC; MMRRC:012489-UCD
DR   Wikidata; Q54791576
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101920; Ap2a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC292
AC   CVCL_QK85
SY   YHC292
DR   MMRRC; MMRRC:012490-UCD
DR   Wikidata; Q54791578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889341; Hacd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC299
AC   CVCL_QK86
SY   YHC299
DR   MMRRC; MMRRC:012491-UCD
DR   Wikidata; Q54791580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109153; Ktn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC305
AC   CVCL_QK87
SY   YHC305
DR   MMRRC; MMRRC:012493-UCD
DR   Wikidata; Q54791583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC307
AC   CVCL_QK88
SY   YHC307
DR   MMRRC; MMRRC:012494-UCD
DR   Wikidata; Q54791587
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC312
AC   CVCL_QK89
SY   YHC312
DR   MMRRC; MMRRC:012495-UCD
DR   Wikidata; Q54791588
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277223; Atxn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC313
AC   CVCL_QK90
SY   YHC313
DR   MMRRC; MMRRC:012496-UCD
DR   Wikidata; Q54791591
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928739; Dnajb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC314
AC   CVCL_QK91
SY   YHC314
DR   MMRRC; MMRRC:012497-UCD
DR   Wikidata; Q54791593
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927551; Osbpl1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC315
AC   CVCL_QK92
SY   YHC315
DR   MMRRC; MMRRC:012498-UCD
DR   Wikidata; Q54791597
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915301; Nutf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC316
AC   CVCL_QK93
SY   YHC316
DR   MMRRC; MMRRC:012499-UCD
DR   Wikidata; Q54791598
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929701; Metap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC319
AC   CVCL_QK94
SY   YHC319
DR   MMRRC; MMRRC:012501-UCD
DR   Wikidata; Q54791600
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443679; Sipa1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC321
AC   CVCL_QK95
SY   YHC321
DR   MMRRC; MMRRC:012503-UCD
DR   Wikidata; Q54791603
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC325
AC   CVCL_QK96
SY   YHC325
DR   MMRRC; MMRRC:012504-UCD
DR   Wikidata; Q54791604
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88026; Ank3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC328
AC   CVCL_QK97
SY   YHC328
DR   MMRRC; MMRRC:012505-UCD
DR   Wikidata; Q54791605
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289280; Zfp410.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC332
AC   CVCL_QK98
SY   YHC332
DR   MMRRC; MMRRC:012507-UCD
DR   Wikidata; Q54791608
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201691; Rnf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC333
AC   CVCL_QK99
SY   YHC333
DR   MMRRC; MMRRC:012508-UCD
DR   Wikidata; Q54791610
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139714; Adgrl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC334
AC   CVCL_QL00
SY   YHC334
DR   MMRRC; MMRRC:012509-UCD
DR   Wikidata; Q54791611
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104897; Rest.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC336
AC   CVCL_QL01
SY   YHC336
DR   MMRRC; MMRRC:012510-UCD
DR   Wikidata; Q54791612
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC339
AC   CVCL_QL02
SY   YHC339
DR   MMRRC; MMRRC:012511-UCD
DR   Wikidata; Q54791614
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109211; Pkn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC341
AC   CVCL_QL03
SY   YHC341
DR   MMRRC; MMRRC:012512-UCD
DR   Wikidata; Q54791617
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98397; Src.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC342
AC   CVCL_QL04
SY   YHC342
DR   MMRRC; MMRRC:012513-UCD
DR   Wikidata; Q54791620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913687; Fis1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC344
AC   CVCL_QL05
SY   YHC344
DR   MMRRC; MMRRC:012514-UCD
DR   Wikidata; Q54791622
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913915; Msantd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC345
AC   CVCL_QL06
SY   YHC345
DR   MMRRC; MMRRC:012515-UCD
DR   Wikidata; Q54791623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444812; Camkk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC349
AC   CVCL_QL07
SY   YHC349
DR   MMRRC; MMRRC:012517-UCD
DR   Wikidata; Q54791625
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388280; Polr2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC350
AC   CVCL_QL08
SY   YHC350
DR   MMRRC; MMRRC:012518-UCD
DR   Wikidata; Q54791627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342292; Hspa4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC351
AC   CVCL_QL09
SY   YHC351
DR   MMRRC; MMRRC:012519-UCD
DR   Wikidata; Q54791630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860493; Arhgef7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC352
AC   CVCL_QL10
SY   YHC352
DR   MMRRC; MMRRC:012520-UCD
DR   Wikidata; Q54791631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919670; Rbm33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC353
AC   CVCL_QL11
SY   YHC353
DR   MMRRC; MMRRC:012521-UCD
DR   Wikidata; Q54791633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC354
AC   CVCL_QL12
SY   YHC354
DR   MMRRC; MMRRC:012522-UCD
DR   Wikidata; Q54791634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922670; Secisbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC355
AC   CVCL_QL13
SY   YHC355
DR   MMRRC; MMRRC:012523-UCD
DR   Wikidata; Q54791635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444008; Bptf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC357
AC   CVCL_QL14
SY   YHC357
DR   MMRRC; MMRRC:012525-UCD
DR   Wikidata; Q54791637
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921437; Katnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC360
AC   CVCL_QL15
SY   YHC360
DR   MMRRC; MMRRC:012526-UCD
DR   Wikidata; Q54791639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349473; Ppp2r5e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC361
AC   CVCL_QL16
SY   YHC361
DR   MMRRC; MMRRC:012527-UCD
DR   Wikidata; Q54791642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920428; Wasl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC362
AC   CVCL_QL17
SY   YHC362
DR   MMRRC; MMRRC:012528-UCD
DR   Wikidata; Q54791643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928679; Dpys.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC367
AC   CVCL_QL18
SY   YHC367
DR   MMRRC; MMRRC:012531-UCD
DR   Wikidata; Q54791646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140494; Ppp1r8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC369
AC   CVCL_QL19
SY   YHC369
DR   MMRRC; MMRRC:012533-UCD
DR   Wikidata; Q54791648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918052; Pwwp2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC370
AC   CVCL_QL20
SY   YHC370
DR   MMRRC; MMRRC:012534-UCD
DR   Wikidata; Q54791650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923046; Cdyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC374
AC   CVCL_QL21
SY   YHC374
DR   MMRRC; MMRRC:012537-UCD
DR   Wikidata; Q54791652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347046; Cop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YHC375
AC   CVCL_QL22
SY   YHC375
DR   MMRRC; MMRRC:012538-UCD
DR   Wikidata; Q54791704
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917866; Sugp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC376
AC   CVCL_QL23
SY   YHC376
DR   MMRRC; MMRRC:012539-UCD
DR   Wikidata; Q54791706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336175; Kcnk5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC382
AC   CVCL_QL24
SY   YHC382
DR   MMRRC; MMRRC:012540-UCD
DR   Wikidata; Q54791710
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919670; Rbm33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC383
AC   CVCL_QL25
SY   YHC383
DR   MMRRC; MMRRC:012541-UCD
DR   Wikidata; Q54791712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147611; Spindoc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YHC388
AC   CVCL_QL26
SY   YHC388
DR   MMRRC; MMRRC:012543-UCD
DR   Wikidata; Q54791714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101841; Ppm1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC395
AC   CVCL_QL27
SY   YHC395
DR   MMRRC; MMRRC:012546-UCD
DR   Wikidata; Q54791716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915031; Ilf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC401
AC   CVCL_QL28
SY   YHC401
DR   MMRRC; MMRRC:012548-UCD
DR   Wikidata; Q54791717
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139746; Ankrd13c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC405
AC   CVCL_QL29
SY   YHC405
DR   MMRRC; MMRRC:012549-UCD
DR   Wikidata; Q54791719
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347046; Cop1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YHC407
AC   CVCL_QL30
SY   YHC407
DR   MMRRC; MMRRC:012550-UCD
DR   Wikidata; Q54791721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3027003; Ino80d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC409
AC   CVCL_QL31
SY   YHC409
DR   MMRRC; MMRRC:012551-UCD
DR   Wikidata; Q54791724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924085; 2900052L18Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC410
AC   CVCL_QL32
SY   YHC410
DR   MMRRC; MMRRC:012552-UCD
DR   Wikidata; Q54791726
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289147; E2f7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC415
AC   CVCL_QL33
SY   YHC415
DR   MMRRC; MMRRC:012553-UCD
DR   Wikidata; Q54791728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914803; Gstcd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC417
AC   CVCL_QL34
SY   YHC417
DR   MMRRC; MMRRC:012554-UCD
DR   Wikidata; Q54791731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88431; Cnbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC419
AC   CVCL_QL35
SY   YHC419
DR   MMRRC; MMRRC:012555-UCD
DR   Wikidata; Q54791732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88568; Cux1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC421
AC   CVCL_QL36
SY   YHC421
DR   MMRRC; MMRRC:012556-UCD
DR   Wikidata; Q54791735
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859333; Nfat5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC426
AC   CVCL_QL37
SY   YHC426
DR   MMRRC; MMRRC:012559-UCD
DR   Wikidata; Q54791737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88568; Cux1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC431
AC   CVCL_QL38
SY   YHC431
DR   MMRRC; MMRRC:012560-UCD
DR   Wikidata; Q54791739
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC432
AC   CVCL_QL39
SY   YHC432
DR   MMRRC; MMRRC:012561-UCD
DR   Wikidata; Q54791740
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442842; Mtmr9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC435
AC   CVCL_QL40
SY   YHC435
DR   MMRRC; MMRRC:012563-UCD
DR   Wikidata; Q54791742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107891; Nop2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC436
AC   CVCL_QL41
SY   YHC436
DR   MMRRC; MMRRC:012564-UCD
DR   Wikidata; Q54791743
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917132; Ints14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC439
AC   CVCL_QL42
SY   YHC439
DR   MMRRC; MMRRC:012565-UCD
DR   Wikidata; Q54791746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387591; Arcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC441
AC   CVCL_QL43
SY   YHC441
DR   MMRRC; MMRRC:012566-UCD
DR   Wikidata; Q54791749
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449975; Iqgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC442
AC   CVCL_QL44
SY   YHC442
DR   MMRRC; MMRRC:012567-UCD
DR   Wikidata; Q54791750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98117; Rps15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC444
AC   CVCL_QL45
SY   YHC444
DR   MMRRC; MMRRC:012568-UCD
DR   Wikidata; Q54791753
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925112; Thyn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC445
AC   CVCL_QL46
SY   YHC445
DR   MMRRC; MMRRC:012569-UCD
DR   Wikidata; Q54791755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918249; Naa40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC446
AC   CVCL_QL47
SY   YHC446
DR   MMRRC; MMRRC:012570-UCD
DR   Wikidata; Q54791757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918249; Naa40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC454
AC   CVCL_QL48
SY   YHC454
DR   MMRRC; MMRRC:012573-UCD
DR   Wikidata; Q54791758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914132; Bzw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC459
AC   CVCL_QL49
SY   YHC459
DR   MMRRC; MMRRC:012575-UCD
DR   Wikidata; Q54791760
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC460
AC   CVCL_QL50
SY   YHC460
DR   MMRRC; MMRRC:012576-UCD
DR   Wikidata; Q54791762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861942; Gtf2ird1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC465
AC   CVCL_QL51
SY   YHC465
DR   MMRRC; MMRRC:012579-UCD
DR   Wikidata; Q54791764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339951; Cse1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC470
AC   CVCL_QL52
SY   YHC470
DR   MMRRC; MMRRC:012581-UCD
DR   Wikidata; Q54791766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144724; Ttc7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC472
AC   CVCL_QL53
SY   YHC472
DR   MMRRC; MMRRC:012582-UCD
DR   Wikidata; Q54791767
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095411; Nup214.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHC475
AC   CVCL_QL54
SY   YHC475
DR   MMRRC; MMRRC:012584-UCD
DR   Wikidata; Q54791768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922845; Mzt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD004
AC   CVCL_QL55
SY   YHD004
DR   MMRRC; MMRRC:014468-UCD
DR   Wikidata; Q54791769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88393; Chd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD005
AC   CVCL_QL56
SY   YHD005
DR   MMRRC; MMRRC:014469-UCD
DR   Wikidata; Q54791774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339951; Cse1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD007
AC   CVCL_QL57
SY   YHD007
DR   MMRRC; MMRRC:014470-UCD
DR   Wikidata; Q54791775
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918023; Cwf19l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD008
AC   CVCL_QL58
SY   YHD008
DR   MMRRC; MMRRC:014471-UCD
DR   Wikidata; Q54791777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143977; Mbtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD011
AC   CVCL_QL59
SY   YHD011
DR   MMRRC; MMRRC:014473-UCD
DR   Wikidata; Q54791781
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922471; Dpp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD013
AC   CVCL_QL60
SY   YHD013
DR   MMRRC; MMRRC:014475-UCD
DR   Wikidata; Q54791782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914504; Bmerb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YHD015
AC   CVCL_QL61
SY   YHD015
DR   MMRRC; MMRRC:014477-UCD
DR   Wikidata; Q54791783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346834; Nr5a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD018
AC   CVCL_QL62
SY   YHD018
DR   MMRRC; MMRRC:014479-UCD
DR   Wikidata; Q54791821
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD019
AC   CVCL_QL63
SY   YHD019
DR   MMRRC; MMRRC:014480-UCD
DR   Wikidata; Q54791823
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921605; Smchd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD020
AC   CVCL_QL64
SY   YHD020
DR   MMRRC; MMRRC:014481-UCD
DR   Wikidata; Q54791824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918335; Arhgap19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD021
AC   CVCL_QL65
SY   YHD021
DR   MMRRC; MMRRC:014482-UCD
DR   Wikidata; Q54791825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929668; Rnf14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD022
AC   CVCL_QL66
SY   YHD022
DR   MMRRC; MMRRC:014483-UCD
DR   Wikidata; Q54791827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341857; Mad1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD026
AC   CVCL_QL67
SY   YHD026
DR   MMRRC; MMRRC:014486-UCD
DR   Wikidata; Q54791829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD028
AC   CVCL_QL68
SY   YHD028
DR   MMRRC; MMRRC:014487-UCD
DR   Wikidata; Q54791830
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1278322; Epc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD032
AC   CVCL_QL69
SY   YHD032
DR   MMRRC; MMRRC:014488-UCD
DR   Wikidata; Q54791833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106095; Naca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD033
AC   CVCL_QL70
SY   YHD033
DR   MMRRC; MMRRC:014489-UCD
DR   Wikidata; Q54791834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD034
AC   CVCL_QL71
SY   YHD034
DR   MMRRC; MMRRC:014490-UCD
DR   Wikidata; Q54791836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD035
AC   CVCL_QL72
SY   YHD035
DR   MMRRC; MMRRC:014491-UCD
DR   Wikidata; Q54791837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309511; Cdc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD037
AC   CVCL_QL73
SY   YHD037
DR   MMRRC; MMRRC:014492-UCD
DR   Wikidata; Q54791838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894835; Rbbp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD038
AC   CVCL_QL74
SY   YHD038
DR   MMRRC; MMRRC:014493-UCD
DR   Wikidata; Q54791840
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139207; Sec16a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD040
AC   CVCL_QL75
SY   YHD040
DR   MMRRC; MMRRC:014495-UCD
DR   Wikidata; Q54791842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101898; Pou2f1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD041
AC   CVCL_QL76
SY   YHD041
DR   MMRRC; MMRRC:014496-UCD
DR   Wikidata; Q54791843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339984; Pak2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD044
AC   CVCL_QL77
SY   YHD044
DR   MMRRC; MMRRC:014498-UCD
DR   Wikidata; Q54791845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924203; Emsy.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD048
AC   CVCL_QL78
SY   YHD048
DR   MMRRC; MMRRC:014499-UCD
DR   Wikidata; Q54791846
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104288; Pms2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD050
AC   CVCL_QL79
SY   YHD050
DR   MMRRC; MMRRC:014500-UCD
DR   Wikidata; Q54791849
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441844; Tmem87a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD051
AC   CVCL_QL80
SY   YHD051
DR   MMRRC; MMRRC:014501-UCD
DR   Wikidata; Q54791853
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95485; Fasn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD052
AC   CVCL_QL81
SY   YHD052
DR   MMRRC; MMRRC:014502-UCD
DR   Wikidata; Q54791854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913337; Emc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD054
AC   CVCL_QL82
SY   YHD054
DR   MMRRC; MMRRC:014503-UCD
DR   Wikidata; Q54791856
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929492; Atl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD056
AC   CVCL_QL83
SY   YHD056
DR   MMRRC; MMRRC:014504-UCD
DR   Wikidata; Q54791859
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913809; Metap1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD059
AC   CVCL_QL84
SY   YHD059
DR   MMRRC; MMRRC:014507-UCD
DR   Wikidata; Q54791861
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2150152; Ubqln4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD061
AC   CVCL_QL85
SY   YHD061
DR   MMRRC; MMRRC:014509-UCD
DR   Wikidata; Q54791863
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685031; Leo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD064
AC   CVCL_QL86
SY   YHD064
DR   MMRRC; MMRRC:014511-UCD
DR   Wikidata; Q54791865
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922896; Rai14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD069
AC   CVCL_QL87
SY   YHD069
DR   MMRRC; MMRRC:014512-UCD
DR   Wikidata; Q54791867
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD072
AC   CVCL_QL88
SY   YHD072
DR   MMRRC; MMRRC:014514-UCD
DR   Wikidata; Q54791868
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109580; Sf3b4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD079
AC   CVCL_QL89
SY   YHD079
DR   MMRRC; MMRRC:014516-UCD
DR   Wikidata; Q54791871
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442697; Zfp473.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD080
AC   CVCL_QL90
SY   YHD080
DR   MMRRC; MMRRC:014517-UCD
DR   Wikidata; Q54791872
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2177308; Znrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD085
AC   CVCL_QL91
SY   YHD085
DR   MMRRC; MMRRC:014520-UCD
DR   Wikidata; Q54791874
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352483; Mga.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD088
AC   CVCL_QL92
SY   YHD088
DR   MMRRC; MMRRC:014522-UCD
DR   Wikidata; Q54791876
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD090
AC   CVCL_QL93
SY   YHD090
DR   MMRRC; MMRRC:014524-UCD
DR   Wikidata; Q54791877
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104871; Ppp1cb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD091
AC   CVCL_QL94
SY   YHD091
DR   MMRRC; MMRRC:014525-UCD
DR   Wikidata; Q54791880
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328328; Map7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD092
AC   CVCL_QL95
SY   YHD092
DR   MMRRC; MMRRC:014526-UCD
DR   Wikidata; Q54791883
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858896; Spast.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD094
AC   CVCL_QL96
SY   YHD094
DR   MMRRC; MMRRC:014527-UCD
DR   Wikidata; Q54791884
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD096
AC   CVCL_QL97
SY   YHD096
DR   MMRRC; MMRRC:014529-UCD
DR   Wikidata; Q54791886
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109601; Nck1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD097
AC   CVCL_QL98
SY   YHD097
DR   MMRRC; MMRRC:014530-UCD
DR   Wikidata; Q54791888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD098
AC   CVCL_QL99
SY   YHD098
DR   MMRRC; MMRRC:014531-UCD
DR   Wikidata; Q54791889
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100520; Twf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD099
AC   CVCL_QM00
SY   YHD099
DR   MMRRC; MMRRC:014532-UCD
DR   Wikidata; Q54791891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD102
AC   CVCL_QM01
SY   YHD102
DR   MMRRC; MMRRC:014534-UCD
DR   Wikidata; Q54791894
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD105
AC   CVCL_QM02
SY   YHD105
DR   MMRRC; MMRRC:014537-UCD
DR   Wikidata; Q54791942
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3714357; Srp54b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD106
AC   CVCL_QM03
SY   YHD106
DR   MMRRC; MMRRC:014538-UCD
DR   Wikidata; Q54791944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103267; Eif4ebp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD109
AC   CVCL_QM04
SY   YHD109
DR   MMRRC; MMRRC:014539-UCD
DR   Wikidata; Q54791945
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442456; Unk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD110
AC   CVCL_QM05
SY   YHD110
DR   MMRRC; MMRRC:014540-UCD
DR   Wikidata; Q54791946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914535; Cwc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD111
AC   CVCL_QM06
SY   YHD111
DR   MMRRC; MMRRC:014541-UCD
DR   Wikidata; Q54791948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105128; Rad23b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD112
AC   CVCL_QM07
SY   YHD112
DR   MMRRC; MMRRC:014542-UCD
DR   Wikidata; Q54791949
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD114
AC   CVCL_QM08
SY   YHD114
DR   MMRRC; MMRRC:014544-UCD
DR   Wikidata; Q54791952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97621; Plk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD115
AC   CVCL_QM09
SY   YHD115
DR   MMRRC; MMRRC:014545-UCD
DR   Wikidata; Q54791954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109490; Sms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD116
AC   CVCL_QM10
SY   YHD116
DR   MMRRC; MMRRC:014546-UCD
DR   Wikidata; Q54791955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD117
AC   CVCL_QM11
SY   YHD117
DR   MMRRC; MMRRC:014547-UCD
DR   Wikidata; Q54791957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922858; Chmp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD118
AC   CVCL_QM12
SY   YHD118
DR   MMRRC; MMRRC:014548-UCD
DR   Wikidata; Q54791960
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351331; Chaf1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD119
AC   CVCL_QM13
SY   YHD119
DR   MMRRC; MMRRC:014549-UCD
DR   Wikidata; Q54791961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97621; Plk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD121
AC   CVCL_QM14
SY   YHD121
DR   MMRRC; MMRRC:014550-UCD
DR   Wikidata; Q54791962
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD122
AC   CVCL_QM15
SY   YHD122
DR   MMRRC; MMRRC:014551-UCD
DR   Wikidata; Q54791966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351329; Rps11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD123
AC   CVCL_QM16
SY   YHD123
DR   MMRRC; MMRRC:014552-UCD
DR   Wikidata; Q54791967
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921700; Pank2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD124
AC   CVCL_QM17
SY   YHD124
DR   MMRRC; MMRRC:014553-UCD
DR   Wikidata; Q54791969
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD125
AC   CVCL_QM18
SY   YHD125
DR   MMRRC; MMRRC:014554-UCD
DR   Wikidata; Q54791973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD126
AC   CVCL_QM19
SY   YHD126
DR   MMRRC; MMRRC:014555-UCD
DR   Wikidata; Q54791974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915392; Ino80.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD130
AC   CVCL_QM20
SY   YHD130
DR   MMRRC; MMRRC:014557-UCD
DR   Wikidata; Q54791976
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109519; Msh3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD131
AC   CVCL_QM21
SY   YHD131
DR   MMRRC; MMRRC:014558-UCD
DR   Wikidata; Q54791977
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332659; Bnip3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD132
AC   CVCL_QM22
SY   YHD132
DR   MMRRC; MMRRC:014559-UCD
DR   Wikidata; Q54791978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933181; Eif3d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD133
AC   CVCL_QM23
SY   YHD133
DR   MMRRC; MMRRC:014560-UCD
DR   Wikidata; Q54791982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387629; Tardbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD136
AC   CVCL_QM24
SY   YHD136
DR   MMRRC; MMRRC:014561-UCD
DR   Wikidata; Q54791985
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD137
AC   CVCL_QM25
SY   YHD137
DR   MMRRC; MMRRC:014562-UCD
DR   Wikidata; Q54791987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353423; Zfp292.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD139
AC   CVCL_QM26
SY   YHD139
DR   MMRRC; MMRRC:014564-UCD
DR   Wikidata; Q54791990
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859162; Rnf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD140
AC   CVCL_QM27
SY   YHD140
DR   MMRRC; MMRRC:014565-UCD
DR   Wikidata; Q54791992
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099832; Tln1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD141
AC   CVCL_QM28
SY   YHD141
DR   MMRRC; MMRRC:014566-UCD
DR   Wikidata; Q54791995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD145
AC   CVCL_QM29
SY   YHD145
DR   MMRRC; MMRRC:014567-UCD
DR   Wikidata; Q54791996
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924054; Kdm4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD146
AC   CVCL_QM30
SY   YHD146
DR   MMRRC; MMRRC:014568-UCD
DR   Wikidata; Q54791999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915455; Urm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD147
AC   CVCL_QM31
SY   YHD147
DR   MMRRC; MMRRC:014569-UCD
DR   Wikidata; Q54792000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353499; Baz1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD148
AC   CVCL_QM32
SY   YHD148
DR   MMRRC; MMRRC:014570-UCD
DR   Wikidata; Q54792001
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151152; Baz2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD149
AC   CVCL_QM33
SY   YHD149
DR   MMRRC; MMRRC:014571-UCD
DR   Wikidata; Q54792004
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141625; Nup205.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD152
AC   CVCL_QM34
SY   YHD152
DR   MMRRC; MMRRC:014572-UCD
DR   Wikidata; Q54792005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139054; Gpr107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD154
AC   CVCL_QM35
SY   YHD154
DR   MMRRC; MMRRC:014573-UCD
DR   Wikidata; Q54792007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD155
AC   CVCL_QM36
SY   YHD155
DR   MMRRC; MMRRC:014574-UCD
DR   Wikidata; Q54792010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD156
AC   CVCL_QM37
SY   YHD156
DR   MMRRC; MMRRC:014575-UCD
DR   Wikidata; Q54792011
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925055; Esco1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD157
AC   CVCL_QM38
SY   YHD157
DR   MMRRC; MMRRC:014576-UCD
DR   Wikidata; Q54792013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352755; Gtse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD158
AC   CVCL_QM39
SY   YHD158
DR   MMRRC; MMRRC:014577-UCD
DR   Wikidata; Q54792014
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104872; Ppp1cc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD159
AC   CVCL_QM40
SY   YHD159
DR   MMRRC; MMRRC:014578-UCD
DR   Wikidata; Q54792020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD160
AC   CVCL_QM41
SY   YHD160
DR   MMRRC; MMRRC:014579-UCD
DR   Wikidata; Q54792021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2449313; Gemin4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD164
AC   CVCL_QM42
SY   YHD164
DR   MMRRC; MMRRC:014581-UCD
DR   Wikidata; Q54792061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921414; Nfx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD165
AC   CVCL_QM43
SY   YHD165
DR   MMRRC; MMRRC:014582-UCD
DR   Wikidata; Q54792063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107532; Kpnb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD167
AC   CVCL_QM44
SY   YHD167
DR   MMRRC; MMRRC:014583-UCD
DR   Wikidata; Q54792064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109580; Sf3b4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD168
AC   CVCL_QM45
SY   YHD168
DR   MMRRC; MMRRC:014584-UCD
DR   Wikidata; Q54792065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD171
AC   CVCL_QM46
SY   YHD171
DR   MMRRC; MMRRC:014585-UCD
DR   Wikidata; Q54792067
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2651932; Lcorl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD172
AC   CVCL_QM47
SY   YHD172
DR   MMRRC; MMRRC:014586-UCD
DR   Wikidata; Q54792068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2651932; Lcorl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD174
AC   CVCL_QM48
SY   YHD174
DR   MMRRC; MMRRC:014587-UCD
DR   Wikidata; Q54792069
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97537; Pecam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD176
AC   CVCL_QM49
SY   YHD176
DR   MMRRC; MMRRC:014589-UCD
DR   Wikidata; Q54792072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109326; Bnip3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD179
AC   CVCL_QM50
SY   YHD179
DR   MMRRC; MMRRC:014591-UCD
DR   Wikidata; Q54792075
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD180
AC   CVCL_QM51
SY   YHD180
DR   MMRRC; MMRRC:014592-UCD
DR   Wikidata; Q54792076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98886; U2af2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD181
AC   CVCL_QM52
SY   YHD181
DR   MMRRC; MMRRC:014593-UCD
DR   Wikidata; Q54792079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919669; Fam72a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD182
AC   CVCL_QM53
SY   YHD182
DR   MMRRC; MMRRC:014594-UCD
DR   Wikidata; Q54792081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104819; Hnrnpa2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD183
AC   CVCL_QM54
SY   YHD183
DR   MMRRC; MMRRC:014595-UCD
DR   Wikidata; Q54792084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934606; Alms1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD185
AC   CVCL_QM55
SY   YHD185
DR   MMRRC; MMRRC:014597-UCD
DR   Wikidata; Q54792086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446132; Bms1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD191
AC   CVCL_QM56
SY   YHD191
DR   MMRRC; MMRRC:014599-UCD
DR   Wikidata; Q54792088
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101772; Snta1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD192
AC   CVCL_QM57
SY   YHD192
DR   MMRRC; MMRRC:014600-UCD
DR   Wikidata; Q54792090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913617; 2310022A10Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD195
AC   CVCL_QM58
SY   YHD195
DR   MMRRC; MMRRC:014601-UCD
DR   Wikidata; Q54792091
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926153; Wrnip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD196
AC   CVCL_QM59
SY   YHD196
DR   MMRRC; MMRRC:014602-UCD
DR   Wikidata; Q54792093
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202400; Supt5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD198
AC   CVCL_QM60
SY   YHD198
DR   MMRRC; MMRRC:014603-UCD
DR   Wikidata; Q54792096
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346078; Twf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD208
AC   CVCL_QM61
SY   YHD208
DR   MMRRC; MMRRC:014605-UCD
DR   Wikidata; Q54792098
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338864; Stau1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD210
AC   CVCL_QM62
SY   YHD210
DR   MMRRC; MMRRC:014606-UCD
DR   Wikidata; Q54792099
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146468; Urb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD214
AC   CVCL_QM63
SY   YHD214
DR   MMRRC; MMRRC:014607-UCD
DR   Wikidata; Q54792103
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388097; Taf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD215
AC   CVCL_QM64
SY   YHD215
DR   MMRRC; MMRRC:014608-UCD
DR   Wikidata; Q54792104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918771; Pds5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD217
AC   CVCL_QM65
SY   YHD217
DR   MMRRC; MMRRC:014609-UCD
DR   Wikidata; Q54792107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104673; Ptpn12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD218
AC   CVCL_QM66
SY   YHD218
DR   MMRRC; MMRRC:014610-UCD
DR   Wikidata; Q54792110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3646907; Gm6563.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD219
AC   CVCL_QM67
SY   YHD219
DR   MMRRC; MMRRC:014611-UCD
DR   Wikidata; Q54792112
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146370; Cggbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD221
AC   CVCL_QM68
SY   YHD221
DR   MMRRC; MMRRC:014612-UCD
DR   Wikidata; Q54792113
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98299; Shmt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD223
AC   CVCL_QM69
SY   YHD223
DR   MMRRC; MMRRC:014613-UCD
DR   Wikidata; Q54792116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104631; Utrn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD225
AC   CVCL_QM70
SY   YHD225
DR   MMRRC; MMRRC:014614-UCD
DR   Wikidata; Q54792119
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD226
AC   CVCL_QM71
SY   YHD226
DR   MMRRC; MMRRC:014615-UCD
DR   Wikidata; Q54792120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202301; Itch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD229
AC   CVCL_QM72
SY   YHD229
DR   MMRRC; MMRRC:014616-UCD
DR   Wikidata; Q54792122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921020; Wdr70.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD232
AC   CVCL_QM73
SY   YHD232
DR   MMRRC; MMRRC:014617-UCD
DR   Wikidata; Q54792124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922004; Dhcr24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD234
AC   CVCL_QM74
SY   YHD234
DR   MMRRC; MMRRC:014618-UCD
DR   Wikidata; Q54792127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917317; Ermard.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD235
AC   CVCL_QM75
SY   YHD235
DR   MMRRC; MMRRC:014619-UCD
DR   Wikidata; Q54792128
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94909; Dmd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD237
AC   CVCL_QM76
SY   YHD237
DR   MMRRC; MMRRC:014621-UCD
DR   Wikidata; Q54792131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD241
AC   CVCL_QM77
SY   YHD241
DR   MMRRC; MMRRC:014623-UCD
DR   Wikidata; Q54792132
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913208; Carm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD246
AC   CVCL_QM78
SY   YHD246
DR   MMRRC; MMRRC:014625-UCD
DR   Wikidata; Q54792133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97547; Pfkl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD247
AC   CVCL_QM79
SY   YHD247
DR   MMRRC; MMRRC:014626-UCD
DR   Wikidata; Q54792134
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104537; Brca1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD248
AC   CVCL_QM80
SY   YHD248
DR   MMRRC; MMRRC:014627-UCD
DR   Wikidata; Q54792136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298227; Mcm6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD250
AC   CVCL_QM81
SY   YHD250
DR   MMRRC; MMRRC:014628-UCD
DR   Wikidata; Q54792138
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917890; Dcp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD252
AC   CVCL_QM82
SY   YHD252
DR   MMRRC; MMRRC:014629-UCD
DR   Wikidata; Q54792233
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD255
AC   CVCL_QM83
SY   YHD255
DR   MMRRC; MMRRC:014630-UCD
DR   Wikidata; Q54792235
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925177; Ccdc88a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD256
AC   CVCL_QM84
SY   YHD256
DR   MMRRC; MMRRC:014631-UCD
DR   Wikidata; Q54792236
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349473; Ppp2r5e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD257
AC   CVCL_QM85
SY   YHD257
DR   MMRRC; MMRRC:014632-UCD
DR   Wikidata; Q54792238
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444629; Kctd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD258
AC   CVCL_QM86
SY   YHD258
DR   MMRRC; MMRRC:014633-UCD
DR   Wikidata; Q54792239
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861100; Ubr3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD259
AC   CVCL_QM87
SY   YHD259
DR   MMRRC; MMRRC:014634-UCD
DR   Wikidata; Q54792242
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891704; Hbs1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD268
AC   CVCL_QM88
SY   YHD268
DR   MMRRC; MMRRC:014637-UCD
DR   Wikidata; Q54792243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD269
AC   CVCL_QM89
SY   YHD269
DR   MMRRC; MMRRC:014638-UCD
DR   Wikidata; Q54792246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921285; Nol9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD270
AC   CVCL_QM90
SY   YHD270
DR   MMRRC; MMRRC:014639-UCD
DR   Wikidata; Q54792247
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916482; Qrich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD273
AC   CVCL_QM91
SY   YHD273
DR   MMRRC; MMRRC:014641-UCD
DR   Wikidata; Q54792250
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861776; Rbms2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD274
AC   CVCL_QM92
SY   YHD274
DR   MMRRC; MMRRC:014642-UCD
DR   Wikidata; Q54792254
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919016; Raver1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD276
AC   CVCL_QM93
SY   YHD276
DR   MMRRC; MMRRC:014643-UCD
DR   Wikidata; Q54792257
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890619; Gan.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD279
AC   CVCL_QM94
SY   YHD279
DR   MMRRC; MMRRC:014645-UCD
DR   Wikidata; Q54792259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918817; Mcm9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD284
AC   CVCL_QM95
SY   YHD284
DR   MMRRC; MMRRC:014647-UCD
DR   Wikidata; Q54792262
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913974; Tab3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD285
AC   CVCL_QM96
SY   YHD285
DR   MMRRC; MMRRC:014648-UCD
DR   Wikidata; Q54792264
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88016; Ampd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD288
AC   CVCL_QM97
SY   YHD288
DR   MMRRC; MMRRC:014650-UCD
DR   Wikidata; Q54792266
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144564; Fam117a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD289
AC   CVCL_QM98
SY   YHD289
DR   MMRRC; MMRRC:014651-UCD
DR   Wikidata; Q54792267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103248; Phc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD294
AC   CVCL_QM99
SY   YHD294
DR   MMRRC; MMRRC:014653-UCD
DR   Wikidata; Q54792270
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD299
AC   CVCL_QN00
SY   YHD299
DR   MMRRC; MMRRC:014655-UCD
DR   Wikidata; Q54792273
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917030; Smap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD303
AC   CVCL_QN01
SY   YHD303
DR   MMRRC; MMRRC:014659-UCD
DR   Wikidata; Q54792274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97890; Rad51.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD305
AC   CVCL_QN02
SY   YHD305
DR   MMRRC; MMRRC:014660-UCD
DR   Wikidata; Q54792275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95281; Ect2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD306
AC   CVCL_QN03
SY   YHD306
DR   MMRRC; MMRRC:014661-UCD
DR   Wikidata; Q54792277
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917799; Tln2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD307
AC   CVCL_QN04
SY   YHD307
DR   MMRRC; MMRRC:014662-UCD
DR   Wikidata; Q54792278
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD309
AC   CVCL_QN05
SY   YHD309
DR   MMRRC; MMRRC:014664-UCD
DR   Wikidata; Q54792280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD311
AC   CVCL_QN06
SY   YHD311
DR   MMRRC; MMRRC:014666-UCD
DR   Wikidata; Q54792283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD313
AC   CVCL_QN07
SY   YHD313
DR   MMRRC; MMRRC:014668-UCD
DR   Wikidata; Q54792285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919045; Pitpnc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD314
AC   CVCL_QN08
SY   YHD314
DR   MMRRC; MMRRC:014669-UCD
DR   Wikidata; Q54792287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96067; Htt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD319
AC   CVCL_QN09
SY   YHD319
DR   MMRRC; MMRRC:014670-UCD
DR   Wikidata; Q54792290
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924378; Crebrf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD335
AC   CVCL_QN10
SY   YHD335
DR   MMRRC; MMRRC:014676-UCD
DR   Wikidata; Q54792293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103188; Nfib.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD340
AC   CVCL_QN11
SY   YHD340
DR   MMRRC; MMRRC:014678-UCD
DR   Wikidata; Q54792294
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109637; Erf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD342
AC   CVCL_QN12
SY   YHD342
DR   MMRRC; MMRRC:014680-UCD
DR   Wikidata; Q54792296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135605; Pard6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD343
AC   CVCL_QN13
SY   YHD343
DR   MMRRC; MMRRC:014681-UCD
DR   Wikidata; Q54792298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445193; Utp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD344
AC   CVCL_QN14
SY   YHD344
DR   MMRRC; MMRRC:014682-UCD
DR   Wikidata; Q54792301
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445193; Utp6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD348
AC   CVCL_QN15
SY   YHD348
DR   MMRRC; MMRRC:014685-UCD
DR   Wikidata; Q54792302
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444798; Atad2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD353
AC   CVCL_QN16
SY   YHD353
DR   MMRRC; MMRRC:014686-UCD
DR   Wikidata; Q54792304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2661061; Dsg4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD355
AC   CVCL_QN17
SY   YHD355
DR   MMRRC; MMRRC:014687-UCD
DR   Wikidata; Q54792306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104819; Hnrnpa2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD356
AC   CVCL_QN18
SY   YHD356
DR   MMRRC; MMRRC:014688-UCD
DR   Wikidata; Q54792308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441683; Tlk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD360
AC   CVCL_QN19
SY   YHD360
DR   MMRRC; MMRRC:014691-UCD
DR   Wikidata; Q54792312
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914318; Dynlrb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD361
AC   CVCL_QN20
SY   YHD361
DR   MMRRC; MMRRC:014692-UCD
DR   Wikidata; Q54792314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922896; Rai14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD364
AC   CVCL_QN21
SY   YHD364
DR   MMRRC; MMRRC:014693-UCD
DR   Wikidata; Q54792315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135605; Pard6b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD368
AC   CVCL_QN22
SY   YHD368
DR   MMRRC; MMRRC:014695-UCD
DR   Wikidata; Q54792365
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97616; Plcg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD369
AC   CVCL_QN23
SY   YHD369
DR   MMRRC; MMRRC:014696-UCD
DR   Wikidata; Q54792366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923990; Efr3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD372
AC   CVCL_QN24
SY   YHD372
DR   MMRRC; MMRRC:014699-UCD
DR   Wikidata; Q54792368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915385; Eif3h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD374
AC   CVCL_QN25
SY   YHD374
DR   MMRRC; MMRRC:014700-UCD
DR   Wikidata; Q54792369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD375
AC   CVCL_QN26
SY   YHD375
DR   MMRRC; MMRRC:014701-UCD
DR   Wikidata; Q54792370
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202400; Supt5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD381
AC   CVCL_QN27
SY   YHD381
DR   MMRRC; MMRRC:014704-UCD
DR   Wikidata; Q54792373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917770; Glipr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD383
AC   CVCL_QN28
SY   YHD383
DR   MMRRC; MMRRC:014705-UCD
DR   Wikidata; Q54792375
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675859; Wapl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD384
AC   CVCL_QN29
SY   YHD384
DR   MMRRC; MMRRC:014706-UCD
DR   Wikidata; Q54792376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915345; Ociad1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD385
AC   CVCL_QN30
SY   YHD385
DR   MMRRC; MMRRC:014756-UCD
DR   Wikidata; Q54792377
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107745; Dctn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD386
AC   CVCL_QN31
SY   YHD386
DR   MMRRC; MMRRC:014757-UCD
DR   Wikidata; Q54792379
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107745; Dctn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD387
AC   CVCL_QN32
SY   YHD387
DR   MMRRC; MMRRC:014758-UCD
DR   Wikidata; Q54792381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103198; Cdc25a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD388
AC   CVCL_QN33
SY   YHD388
DR   MMRRC; MMRRC:014759-UCD
DR   Wikidata; Q54792383
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309480; Rtf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD391
AC   CVCL_QN34
SY   YHD391
DR   MMRRC; MMRRC:014760-UCD
DR   Wikidata; Q54792386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923041; Fbxw8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD392
AC   CVCL_QN35
SY   YHD392
DR   MMRRC; MMRRC:014761-UCD
DR   Wikidata; Q54792389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3780541; Lncenc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD400
AC   CVCL_QN36
SY   YHD400
DR   MMRRC; MMRRC:014764-UCD
DR   Wikidata; Q54792390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD401
AC   CVCL_QN37
SY   YHD401
DR   MMRRC; MMRRC:014765-UCD
DR   Wikidata; Q54792393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109443; Gtpbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD402
AC   CVCL_QN38
SY   YHD402
DR   MMRRC; MMRRC:014766-UCD
DR   Wikidata; Q54792394
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915120; Enoph1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD405
AC   CVCL_QN39
SY   YHD405
DR   MMRRC; MMRRC:014767-UCD
DR   Wikidata; Q54792396
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD406
AC   CVCL_QN40
SY   YHD406
DR   MMRRC; MMRRC:014768-UCD
DR   Wikidata; Q54792398
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD407
AC   CVCL_QN41
SY   YHD407
DR   MMRRC; MMRRC:014769-UCD
DR   Wikidata; Q54792399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446180; Anks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD409
AC   CVCL_QN42
SY   YHD409
DR   MMRRC; MMRRC:014770-UCD
DR   Wikidata; Q54792401
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447063; Tenm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD411
AC   CVCL_QN43
SY   YHD411
DR   MMRRC; MMRRC:014771-UCD
DR   Wikidata; Q54792402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921294; Ttf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD412
AC   CVCL_QN44
SY   YHD412
DR   MMRRC; MMRRC:014772-UCD
DR   Wikidata; Q54792405
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD416
AC   CVCL_QN45
SY   YHD416
DR   MMRRC; MMRRC:014773-UCD
DR   Wikidata; Q54792407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316708; Ifrd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD417
AC   CVCL_QN46
SY   YHD417
DR   MMRRC; MMRRC:014774-UCD
DR   Wikidata; Q54792410
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354948; Klf13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD419
AC   CVCL_QN47
SY   YHD419
DR   MMRRC; MMRRC:014775-UCD
DR   Wikidata; Q54792413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443930; Lcor.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD420
AC   CVCL_QN48
SY   YHD420
DR   MMRRC; MMRRC:014776-UCD
DR   Wikidata; Q54792415
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2180699; Mtmr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD426
AC   CVCL_QN49
SY   YHD426
DR   MMRRC; MMRRC:014777-UCD
DR   Wikidata; Q54792417
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351337; Ddx24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD429
AC   CVCL_QN50
SY   YHD429
DR   MMRRC; MMRRC:014778-UCD
DR   Wikidata; Q54792420
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913459; Inip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD431
AC   CVCL_QN51
SY   YHD431
DR   MMRRC; MMRRC:014779-UCD
DR   Wikidata; Q54792421
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109637; Erf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD432
AC   CVCL_QN52
SY   YHD432
DR   MMRRC; MMRRC:014780-UCD
DR   Wikidata; Q54792423
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109637; Erf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD434
AC   CVCL_QN53
SY   YHD434
DR   MMRRC; MMRRC:014781-UCD
DR   Wikidata; Q54792426
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334448; Aspm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD437
AC   CVCL_QN54
SY   YHD437
DR   MMRRC; MMRRC:014783-UCD
DR   Wikidata; Q54792429
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385297; Tpcn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD438
AC   CVCL_QN55
SY   YHD438
DR   MMRRC; MMRRC:014784-UCD
DR   Wikidata; Q54792432
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1350917; Rps3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD443
AC   CVCL_QN56
SY   YHD443
DR   MMRRC; MMRRC:014785-UCD
DR   Wikidata; Q54792433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346868; Map2k3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD445
AC   CVCL_QN57
SY   YHD445
DR   MMRRC; MMRRC:014786-UCD
DR   Wikidata; Q54792435
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855688; Vti1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD447
AC   CVCL_QN58
SY   YHD447
DR   MMRRC; MMRRC:014787-UCD
DR   Wikidata; Q54792437
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2175912; Arid5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD449
AC   CVCL_QN59
SY   YHD449
DR   MMRRC; MMRRC:014788-UCD
DR   Wikidata; Q54792439
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108295; Pxn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD454
AC   CVCL_QN60
SY   YHD454
DR   MMRRC; MMRRC:014790-UCD
DR   Wikidata; Q54792441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99256; Hdlbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD457
AC   CVCL_QN61
SY   YHD457
DR   MMRRC; MMRRC:014456-UCD
DR   Wikidata; Q54792443
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096875; Wdfy3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YHD460
AC   CVCL_QN62
SY   YHD460
DR   MMRRC; MMRRC:014458-UCD
DR   Wikidata; Q54792489
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA001
AC   CVCL_QN63
SY   YTA001
DR   MMRRC; MMRRC:016397-UCD
DR   Wikidata; Q54792490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA002
AC   CVCL_QN64
SY   YTA002
DR   MMRRC; MMRRC:016505-UCD
DR   Wikidata; Q54792493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA004
AC   CVCL_QN65
SY   YTA004
DR   MMRRC; MMRRC:017056-UCD
DR   Wikidata; Q54792494
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA005
AC   CVCL_QN66
SY   YTA005
DR   MMRRC; MMRRC:016729-UCD
DR   Wikidata; Q54792497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922312; Sf3a3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA007
AC   CVCL_QN67
SY   YTA007
DR   MMRRC; MMRRC:016616-UCD
DR   Wikidata; Q54792501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679923; Ttc37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA011
AC   CVCL_QN68
SY   YTA011
DR   MMRRC; MMRRC:016558-UCD
DR   Wikidata; Q54792502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353633; Fus.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA014
AC   CVCL_QN69
SY   YTA014
DR   MMRRC; MMRRC:016730-UCD
DR   Wikidata; Q54792504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA015
AC   CVCL_QN70
SY   YTA015
DR   MMRRC; MMRRC:016673-UCD
DR   Wikidata; Q54792508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103267; Eif4ebp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA017
AC   CVCL_QN71
SY   YTA017
DR   MMRRC; MMRRC:016398-UCD
DR   Wikidata; Q54792510
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142347; Zfp568.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA019
AC   CVCL_QN72
SY   YTA019
DR   MMRRC; MMRRC:016399-UCD
DR   Wikidata; Q54792513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102944; Ube2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA021
AC   CVCL_QN73
SY   YTA021
DR   MMRRC; MMRRC:016559-UCD
DR   Wikidata; Q54792515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101921; Ap2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA022
AC   CVCL_QN74
SY   YTA022
DR   MMRRC; MMRRC:016674-UCD
DR   Wikidata; Q54792517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87989; Alas1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA023
AC   CVCL_QN75
SY   YTA023
DR   MMRRC; MMRRC:016560-UCD
DR   Wikidata; Q54792520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385902; Picalm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA024
AC   CVCL_QN76
SY   YTA024
DR   MMRRC; MMRRC:016731-UCD
DR   Wikidata; Q54792522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1194921; Ttk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA025
AC   CVCL_QN77
SY   YTA025
DR   MMRRC; MMRRC:016506-UCD
DR   Wikidata; Q54792525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA028
AC   CVCL_QN78
SY   YTA028
DR   MMRRC; MMRRC:016617-UCD
DR   Wikidata; Q54792527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923802; Plekha5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA029
AC   CVCL_QN79
SY   YTA029
DR   MMRRC; MMRRC:016454-UCD
DR   Wikidata; Q54792529
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914404; Mtdh.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA030
AC   CVCL_QN80
SY   YTA030
DR   MMRRC; MMRRC:016783-UCD
DR   Wikidata; Q54792531
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916065; Btbd10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA031
AC   CVCL_QN81
SY   YTA031
DR   MMRRC; MMRRC:017024-UCD
DR   Wikidata; Q54792534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA034
AC   CVCL_QN82
SY   YTA034
DR   MMRRC; MMRRC:016507-UCD
DR   Wikidata; Q54792536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923304; Prrc2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA035
AC   CVCL_QN83
SY   YTA035
DR   MMRRC; MMRRC:016562-UCD
DR   Wikidata; Q54792538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926163; Ltn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA036
AC   CVCL_QN84
SY   YTA036
DR   MMRRC; MMRRC:016732-UCD
DR   Wikidata; Q54792539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894689; Ywhae.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA037
AC   CVCL_QN85
SY   YTA037
DR   MMRRC; MMRRC:016400-UCD
DR   Wikidata; Q54792540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA038
AC   CVCL_QN86
SY   YTA038
DR   MMRRC; MMRRC:016401-UCD
DR   Wikidata; Q54792543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2441772; Eif5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA039
AC   CVCL_QN87
SY   YTA039
DR   MMRRC; MMRRC:016784-UCD
DR   Wikidata; Q54792545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915031; Ilf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA041
AC   CVCL_QN88
SY   YTA041
DR   MMRRC; MMRRC:016508-UCD
DR   Wikidata; Q54792548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929492; Atl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA042
AC   CVCL_QN89
SY   YTA042
DR   MMRRC; MMRRC:016455-UCD
DR   Wikidata; Q54792550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104560; Nsf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA043
AC   CVCL_QN90
SY   YTA043
DR   MMRRC; MMRRC:016733-UCD
DR   Wikidata; Q54792551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929286; Amotl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA044
AC   CVCL_QN91
SY   YTA044
DR   MMRRC; MMRRC:016509-UCD
DR   Wikidata; Q54792553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1861437; Gsk3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA046
AC   CVCL_QN92
SY   YTA046
DR   MMRRC; MMRRC:016402-UCD
DR   Wikidata; Q54792557
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915149; Cmc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA048
AC   CVCL_QN93
SY   YTA048
DR   MMRRC; MMRRC:016511-UCD
DR   Wikidata; Q54792559
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA049
AC   CVCL_QN94
SY   YTA049
DR   MMRRC; MMRRC:016456-UCD
DR   Wikidata; Q54792562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682334; Smg7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA050
AC   CVCL_QN95
SY   YTA050
DR   MMRRC; MMRRC:016457-UCD
DR   Wikidata; Q54792564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385071; Etf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA052
AC   CVCL_QN96
SY   YTA052
DR   MMRRC; MMRRC:016785-UCD
DR   Wikidata; Q54792565
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932576; Akap12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA054
AC   CVCL_QN97
SY   YTA054
DR   MMRRC; MMRRC:016618-UCD
DR   Wikidata; Q54792568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107585; Srebf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA055
AC   CVCL_QN98
SY   YTA055
DR   MMRRC; MMRRC:016512-UCD
DR   Wikidata; Q54792571
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919787; Cdca2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA056
AC   CVCL_QN99
SY   YTA056
DR   MMRRC; MMRRC:016404-UCD
DR   Wikidata; Q54792572
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145219; Iars.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA058
AC   CVCL_QP00
SY   YTA058
DR   MMRRC; MMRRC:016513-UCD
DR   Wikidata; Q54792574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446126; Phf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA059
AC   CVCL_QP01
SY   YTA059
DR   MMRRC; MMRRC:016676-UCD
DR   Wikidata; Q54792577
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA061
AC   CVCL_QP02
SY   YTA061
DR   MMRRC; MMRRC:016734-UCD
DR   Wikidata; Q54792619
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926209; Dek.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA062
AC   CVCL_QP03
SY   YTA062
DR   MMRRC; MMRRC:016786-UCD
DR   Wikidata; Q54792620
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918677; Ibtk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA063
AC   CVCL_QP04
SY   YTA063
DR   MMRRC; MMRRC:016619-UCD
DR   Wikidata; Q54792621
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA065
AC   CVCL_QP05
SY   YTA065
DR   MMRRC; MMRRC:016787-UCD
DR   Wikidata; Q54792623
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97824; Pvt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA067
AC   CVCL_QP06
SY   YTA067
DR   MMRRC; MMRRC:016735-UCD
DR   Wikidata; Q54792624
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99240; Ddx39b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA068
AC   CVCL_QP07
SY   YTA068
DR   MMRRC; MMRRC:017015-UCD
DR   Wikidata; Q54792626
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87930; Adk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA070
AC   CVCL_QP08
SY   YTA070
DR   MMRRC; MMRRC:016736-UCD
DR   Wikidata; Q54792627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2179723; Casc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA071
AC   CVCL_QP09
SY   YTA071
DR   MMRRC; MMRRC:016788-UCD
DR   Wikidata; Q54792629
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343961; Msh6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA072
AC   CVCL_QP10
SY   YTA072
DR   MMRRC; MMRRC:016458-UCD
DR   Wikidata; Q54792631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138865; Dlgap4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA073
AC   CVCL_QP11
SY   YTA073
DR   MMRRC; MMRRC:016563-UCD
DR   Wikidata; Q54792632
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338026; Tom1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA074
AC   CVCL_QP12
SY   YTA074
DR   MMRRC; MMRRC:016405-UCD
DR   Wikidata; Q54792635
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926209; Dek.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA076
AC   CVCL_QP13
SY   YTA076
DR   MMRRC; MMRRC:016789-UCD
DR   Wikidata; Q54792636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913910; Sltm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA077
AC   CVCL_QP14
SY   YTA077
DR   MMRRC; MMRRC:016620-UCD
DR   Wikidata; Q54792638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA078
AC   CVCL_QP15
SY   YTA078
DR   MMRRC; MMRRC:016677-UCD
DR   Wikidata; Q54792639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922546; Cep43.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA080
AC   CVCL_QP16
SY   YTA080
DR   MMRRC; MMRRC:016460-UCD
DR   Wikidata; Q54792641
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913910; Sltm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA081
AC   CVCL_QP17
SY   YTA081
DR   MMRRC; MMRRC:016406-UCD
DR   Wikidata; Q54792642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107887; Gtf3c1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA082
AC   CVCL_QP18
SY   YTA082
DR   MMRRC; MMRRC:016737-UCD
DR   Wikidata; Q54792645
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1101358; Npepps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA084
AC   CVCL_QP19
SY   YTA084
DR   MMRRC; MMRRC:016461-UCD
DR   Wikidata; Q54792647
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913910; Sltm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA085
AC   CVCL_QP20
SY   YTA085
DR   MMRRC; MMRRC:016462-UCD
DR   Wikidata; Q54792648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442620; Nup133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA086
AC   CVCL_QP21
SY   YTA086
DR   MMRRC; MMRRC:016678-UCD
DR   Wikidata; Q54792650
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914743; Mettl16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA087
AC   CVCL_QP22
SY   YTA087
DR   MMRRC; MMRRC:016622-UCD
DR   Wikidata; Q54792651
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA088
AC   CVCL_QP23
SY   YTA088
DR   MMRRC; MMRRC:016679-UCD
DR   Wikidata; Q54792654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA091
AC   CVCL_QP24
SY   YTA091
DR   MMRRC; MMRRC:016515-UCD
DR   Wikidata; Q54792655
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916176; Ubap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA092
AC   CVCL_QP25
SY   YTA092
DR   MMRRC; MMRRC:016680-UCD
DR   Wikidata; Q54792659
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104689; Cct4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA097
AC   CVCL_QP26
SY   YTA097
DR   MMRRC; MMRRC:016623-UCD
DR   Wikidata; Q54792660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921268; Als2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA098
AC   CVCL_QP27
SY   YTA098
DR   MMRRC; MMRRC:016739-UCD
DR   Wikidata; Q54792662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA100
AC   CVCL_QP28
SY   YTA100
DR   MMRRC; MMRRC:016407-UCD
DR   Wikidata; Q54792664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384725; Zfp553.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA103
AC   CVCL_QP29
SY   YTA103
DR   MMRRC; MMRRC:016740-UCD
DR   Wikidata; Q54792667
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387601; Hrob.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA104
AC   CVCL_QP30
SY   YTA104
DR   MMRRC; MMRRC:016516-UCD
DR   Wikidata; Q54792668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA105
AC   CVCL_QP31
SY   YTA105
DR   MMRRC; MMRRC:016741-UCD
DR   Wikidata; Q54792670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914934; Luc7l3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA106
AC   CVCL_QP32
SY   YTA106
DR   MMRRC; MMRRC:016517-UCD
DR   Wikidata; Q54792672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277214; Septin11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA107
AC   CVCL_QP33
SY   YTA107
DR   MMRRC; MMRRC:016408-UCD
DR   Wikidata; Q54792673
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA109
AC   CVCL_QP34
SY   YTA109
DR   MMRRC; MMRRC:016624-UCD
DR   Wikidata; Q54792675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339956; Cdyl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA111
AC   CVCL_QP35
SY   YTA111
DR   MMRRC; MMRRC:016565-UCD
DR   Wikidata; Q54792678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98788; Top1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA112
AC   CVCL_QP36
SY   YTA112
DR   MMRRC; MMRRC:016409-UCD
DR   Wikidata; Q54792679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385139; Rabgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA117
AC   CVCL_QP37
SY   YTA117
DR   MMRRC; MMRRC:016410-UCD
DR   Wikidata; Q54792680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924140; Memo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA118
AC   CVCL_QP38
SY   YTA118
DR   MMRRC; MMRRC:016742-UCD
DR   Wikidata; Q54792681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA121
AC   CVCL_QP39
SY   YTA121
DR   MMRRC; MMRRC:016681-UCD
DR   Wikidata; Q54792683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109473; Usp34.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA123
AC   CVCL_QP40
SY   YTA123
DR   MMRRC; MMRRC:016791-UCD
DR   Wikidata; Q54792684
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384849; Tnpo2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA124
AC   CVCL_QP41
SY   YTA124
DR   MMRRC; MMRRC:016464-UCD
DR   Wikidata; Q54792685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388280; Polr2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA125
AC   CVCL_QP42
SY   YTA125
DR   MMRRC; MMRRC:016465-UCD
DR   Wikidata; Q54792721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932610; Noc3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA126
AC   CVCL_QP43
SY   YTA126
DR   MMRRC; MMRRC:016566-UCD
DR   Wikidata; Q54792722
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353651; Gnl3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA127
AC   CVCL_QP44
SY   YTA127
DR   MMRRC; MMRRC:016626-UCD
DR   Wikidata; Q54792723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143854; Nup107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA130
AC   CVCL_QP45
SY   YTA130
DR   MMRRC; MMRRC:016682-UCD
DR   Wikidata; Q54792725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102956; Cdk7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA132
AC   CVCL_QP46
SY   YTA132
DR   MMRRC; MMRRC:016411-UCD
DR   Wikidata; Q54792727
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859328; Cpsf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA133
AC   CVCL_QP47
SY   YTA133
DR   MMRRC; MMRRC:016466-UCD
DR   Wikidata; Q54792731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107741; Pvr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA134
AC   CVCL_QP48
SY   YTA134
DR   MMRRC; MMRRC:016412-UCD
DR   Wikidata; Q54792732
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921590; Ahcyl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA135
AC   CVCL_QP49
SY   YTA135
DR   MMRRC; MMRRC:016413-UCD
DR   Wikidata; Q54792734
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914475; Rnpc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA136
AC   CVCL_QP50
SY   YTA136
DR   MMRRC; MMRRC:016793-UCD
DR   Wikidata; Q54792737
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913731; Rps21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA138
AC   CVCL_QP51
SY   YTA138
DR   MMRRC; MMRRC:016683-UCD
DR   Wikidata; Q54792738
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349717; Ncor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA139
AC   CVCL_QP52
SY   YTA139
DR   MMRRC; MMRRC:016467-UCD
DR   Wikidata; Q54792742
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA140
AC   CVCL_QP53
SY   YTA140
DR   MMRRC; MMRRC:016468-UCD
DR   Wikidata; Q54792744
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353561; Vapa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA142
AC   CVCL_QP54
SY   YTA142
DR   MMRRC; MMRRC:016684-UCD
DR   Wikidata; Q54792746
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA143
AC   CVCL_QP55
SY   YTA143
DR   MMRRC; MMRRC:016469-UCD
DR   Wikidata; Q54792747
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036237; Rsbn1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA144
AC   CVCL_QP56
SY   YTA144
DR   MMRRC; MMRRC:017016-UCD
DR   Wikidata; Q54792748
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA145
AC   CVCL_QP57
SY   YTA145
DR   MMRRC; MMRRC:016794-UCD
DR   Wikidata; Q54792750
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353448; Eif2ak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA146
AC   CVCL_QP58
SY   YTA146
DR   MMRRC; MMRRC:016470-UCD
DR   Wikidata; Q54792751
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196256; Kdm1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA148
AC   CVCL_QP59
SY   YTA148
DR   MMRRC; MMRRC:016685-UCD
DR   Wikidata; Q54792752
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341890; Zfr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA149
AC   CVCL_QP60
SY   YTA149
DR   MMRRC; MMRRC:016471-UCD
DR   Wikidata; Q54792754
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679002; Prr12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA150
AC   CVCL_QP61
SY   YTA150
DR   MMRRC; MMRRC:016472-UCD
DR   Wikidata; Q54792755
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104872; Ppp1cc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA151
AC   CVCL_QP62
SY   YTA151
DR   MMRRC; MMRRC:016567-UCD
DR   Wikidata; Q54792757
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA153
AC   CVCL_QP63
SY   YTA153
DR   MMRRC; MMRRC:016743-UCD
DR   Wikidata; Q54792758
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103257; Inpp5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA154
AC   CVCL_QP64
SY   YTA154
DR   MMRRC; MMRRC:016568-UCD
DR   Wikidata; Q54792761
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104537; Brca1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA155
AC   CVCL_QP65
SY   YTA155
DR   MMRRC; MMRRC:016569-UCD
DR   Wikidata; Q54792762
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918972; Cic.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA156
AC   CVCL_QP66
SY   YTA156
DR   MMRRC; MMRRC:016570-UCD
DR   Wikidata; Q54792764
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926162; Sp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA159
AC   CVCL_QP67
SY   YTA159
DR   MMRRC; MMRRC:016571-UCD
DR   Wikidata; Q54792766
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97621; Plk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA162
AC   CVCL_QP68
SY   YTA162
DR   MMRRC; MMRRC:016744-UCD
DR   Wikidata; Q54792768
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109281; Pkp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA163
AC   CVCL_QP69
SY   YTA163
DR   MMRRC; MMRRC:016795-UCD
DR   Wikidata; Q54792769
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443564; Ambra1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA164
AC   CVCL_QP70
SY   YTA164
DR   MMRRC; MMRRC:016627-UCD
DR   Wikidata; Q54792770
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891704; Hbs1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA165
AC   CVCL_QP71
SY   YTA165
DR   MMRRC; MMRRC:016415-UCD
DR   Wikidata; Q54792773
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA169
AC   CVCL_QP72
SY   YTA169
DR   MMRRC; MMRRC:016629-UCD
DR   Wikidata; Q54792774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA170
AC   CVCL_QP73
SY   YTA170
DR   MMRRC; MMRRC:016416-UCD
DR   Wikidata; Q54792777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA171
AC   CVCL_QP74
SY   YTA171
DR   MMRRC; MMRRC:016474-UCD
DR   Wikidata; Q54792780
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99495; Brd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA172
AC   CVCL_QP75
SY   YTA172
DR   MMRRC; MMRRC:016475-UCD
DR   Wikidata; Q54792782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349722; Pabpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA173
AC   CVCL_QP76
SY   YTA173
DR   MMRRC; MMRRC:016630-UCD
DR   Wikidata; Q54792784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860267; Set.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA174
AC   CVCL_QP77
SY   YTA174
DR   MMRRC; MMRRC:016686-UCD
DR   Wikidata; Q54792786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103147; Dync1h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA175
AC   CVCL_QP78
SY   YTA175
DR   MMRRC; MMRRC:016572-UCD
DR   Wikidata; Q54792787
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3045309; A930007A09Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA176
AC   CVCL_QP79
SY   YTA176
DR   MMRRC; MMRRC:016573-UCD
DR   Wikidata; Q54792788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894687; Xrn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA180
AC   CVCL_QP80
SY   YTA180
DR   MMRRC; MMRRC:016519-UCD
DR   Wikidata; Q54792789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352757; Iqgap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA182
AC   CVCL_QP81
SY   YTA182
DR   MMRRC; MMRRC:016520-UCD
DR   Wikidata; Q54792791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289273; Ppp1r10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA183
AC   CVCL_QP82
SY   YTA183
DR   MMRRC; MMRRC:016476-UCD
DR   Wikidata; Q54792882
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA185
AC   CVCL_QP83
SY   YTA185
DR   MMRRC; MMRRC:016746-UCD
DR   Wikidata; Q54792885
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351656; Abcf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA187
AC   CVCL_QP84
SY   YTA187
DR   MMRRC; MMRRC:016574-UCD
DR   Wikidata; Q54792887
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA189
AC   CVCL_QP85
SY   YTA189
DR   MMRRC; MMRRC:016796-UCD
DR   Wikidata; Q54792888
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2182465; Vrk3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA190
AC   CVCL_QP86
SY   YTA190
DR   MMRRC; MMRRC:016417-UCD
DR   Wikidata; Q54792890
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA191
AC   CVCL_QP87
SY   YTA191
DR   MMRRC; MMRRC:016575-UCD
DR   Wikidata; Q54792891
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346869; Map2k4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA193
AC   CVCL_QP88
SY   YTA193
DR   MMRRC; MMRRC:016418-UCD
DR   Wikidata; Q54792893
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98658; Tdgf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA197
AC   CVCL_QP89
SY   YTA197
DR   MMRRC; MMRRC:016631-UCD
DR   Wikidata; Q54792895
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918699; Eef1aknmt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA199
AC   CVCL_QP90
SY   YTA199
DR   MMRRC; MMRRC:016521-UCD
DR   Wikidata; Q54792896
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2136841; Morc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA201
AC   CVCL_QP91
SY   YTA201
DR   MMRRC; MMRRC:016797-UCD
DR   Wikidata; Q54792897
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914694; Ilkap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA202
AC   CVCL_QP92
SY   YTA202
DR   MMRRC; MMRRC:016522-UCD
DR   Wikidata; Q54792900
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925836; Srbd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA203
AC   CVCL_QP93
SY   YTA203
DR   MMRRC; MMRRC:016477-UCD
DR   Wikidata; Q54792902
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109198; Eif4ebp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA204
AC   CVCL_QP94
SY   YTA204
DR   MMRRC; MMRRC:016632-UCD
DR   Wikidata; Q54792904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353561; Vapa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA208
AC   CVCL_QP95
SY   YTA208
DR   MMRRC; MMRRC:016419-UCD
DR   Wikidata; Q54792907
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443312; Zscan22.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA209
AC   CVCL_QP96
SY   YTA209
DR   MMRRC; MMRRC:016576-UCD
DR   Wikidata; Q54792908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276545; Nsd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA210
AC   CVCL_QP97
SY   YTA210
DR   MMRRC; MMRRC:016523-UCD
DR   Wikidata; Q54792911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA211
AC   CVCL_QP98
SY   YTA211
DR   MMRRC; MMRRC:016633-UCD
DR   Wikidata; Q54792912
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935145; Mllt6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA212
AC   CVCL_QP99
SY   YTA212
DR   MMRRC; MMRRC:016478-UCD
DR   Wikidata; Q54792914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346834; Nr5a2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA214
AC   CVCL_QQ00
SY   YTA214
DR   MMRRC; MMRRC:016687-UCD
DR   Wikidata; Q54792916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444268; Fam169a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA215
AC   CVCL_QQ01
SY   YTA215
DR   MMRRC; MMRRC:016688-UCD
DR   Wikidata; Q54792917
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889206; Skap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA221
AC   CVCL_QQ02
SY   YTA221
DR   MMRRC; MMRRC:016689-UCD
DR   Wikidata; Q54792919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA222
AC   CVCL_QQ03
SY   YTA222
DR   MMRRC; MMRRC:016634-UCD
DR   Wikidata; Q54792922
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932339; Sf3b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA224
AC   CVCL_QQ04
SY   YTA224
DR   MMRRC; MMRRC:016420-UCD
DR   Wikidata; Q54792923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98354; Sos1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA225
AC   CVCL_QQ05
SY   YTA225
DR   MMRRC; MMRRC:016748-UCD
DR   Wikidata; Q54792924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98858; Psmd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA226
AC   CVCL_QQ06
SY   YTA226
DR   MMRRC; MMRRC:016421-UCD
DR   Wikidata; Q54792925
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141847; Phrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA227
AC   CVCL_QQ07
SY   YTA227
DR   MMRRC; MMRRC:016749-UCD
DR   Wikidata; Q54792927
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA231
AC   CVCL_QQ08
SY   YTA231
DR   MMRRC; MMRRC:016798-UCD
DR   Wikidata; Q54792929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102666; Ppp5c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA237
AC   CVCL_QQ09
SY   YTA237
DR   MMRRC; MMRRC:016690-UCD
DR   Wikidata; Q54792930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931237; Wwox.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA238
AC   CVCL_QQ10
SY   YTA238
DR   MMRRC; MMRRC:016423-UCD
DR   Wikidata; Q54792934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930948; Gar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA242
AC   CVCL_QQ11
SY   YTA242
DR   MMRRC; MMRRC:016577-UCD
DR   Wikidata; Q54792936
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932101; Ankrd17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA243
AC   CVCL_QQ12
SY   YTA243
DR   MMRRC; MMRRC:016578-UCD
DR   Wikidata; Q54792938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA244
AC   CVCL_QQ13
SY   YTA244
DR   MMRRC; MMRRC:016750-UCD
DR   Wikidata; Q54792939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139360; Sall4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA247
AC   CVCL_QQ14
SY   YTA247
DR   MMRRC; MMRRC:016751-UCD
DR   Wikidata; Q54792940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA250
AC   CVCL_QQ15
SY   YTA250
DR   MMRRC; MMRRC:016524-UCD
DR   Wikidata; Q54792944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1888520; Brd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA251
AC   CVCL_QQ16
SY   YTA251
DR   MMRRC; MMRRC:016424-UCD
DR   Wikidata; Q54792946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919667; Zfta.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA252
AC   CVCL_QQ17
SY   YTA252
DR   MMRRC; MMRRC:016580-UCD
DR   Wikidata; Q54792947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096573; Utp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA254
AC   CVCL_QQ18
SY   YTA254
DR   MMRRC; MMRRC:016581-UCD
DR   Wikidata; Q54792948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289273; Ppp1r10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA255
AC   CVCL_QQ19
SY   YTA255
DR   MMRRC; MMRRC:016525-UCD
DR   Wikidata; Q54792950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA256
AC   CVCL_QQ20
SY   YTA256
DR   MMRRC; MMRRC:016582-UCD
DR   Wikidata; Q54792953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442524; Heatr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA257
AC   CVCL_QQ21
SY   YTA257
DR   MMRRC; MMRRC:016636-UCD
DR   Wikidata; Q54792955
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924161; Brd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA258
AC   CVCL_QQ22
SY   YTA258
DR   MMRRC; MMRRC:016526-UCD
DR   Wikidata; Q54792995
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675859; Wapl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA259
AC   CVCL_QQ23
SY   YTA259
DR   MMRRC; MMRRC:016752-UCD
DR   Wikidata; Q54792999
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100846; Med1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA261
AC   CVCL_QQ24
SY   YTA261
DR   MMRRC; MMRRC:016799-UCD
DR   Wikidata; Q54793000
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924113; Dcun1d5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA263
AC   CVCL_QQ25
SY   YTA263
DR   MMRRC; MMRRC:016800-UCD
DR   Wikidata; Q54793002
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA264
AC   CVCL_QQ26
SY   YTA264
DR   MMRRC; MMRRC:016637-UCD
DR   Wikidata; Q54793005
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926139; Wsb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA267
AC   CVCL_QQ27
SY   YTA267
DR   MMRRC; MMRRC:016425-UCD
DR   Wikidata; Q54793007
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926139; Wsb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA270
AC   CVCL_QQ28
SY   YTA270
DR   MMRRC; MMRRC:016583-UCD
DR   Wikidata; Q54793010
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1328363; Ccnt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA273
AC   CVCL_QQ29
SY   YTA273
DR   MMRRC; MMRRC:016753-UCD
DR   Wikidata; Q54793012
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1316728; Gspt1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA274
AC   CVCL_QQ30
SY   YTA274
DR   MMRRC; MMRRC:016527-UCD
DR   Wikidata; Q54793013
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA276
AC   CVCL_QQ31
SY   YTA276
DR   MMRRC; MMRRC:016801-UCD
DR   Wikidata; Q54793015
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA279
AC   CVCL_QQ32
SY   YTA279
DR   MMRRC; MMRRC:016479-UCD
DR   Wikidata; Q54793019
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA280
AC   CVCL_QQ33
SY   YTA280
DR   MMRRC; MMRRC:016691-UCD
DR   Wikidata; Q54793021
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931520; Dbr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA282
AC   CVCL_QQ34
SY   YTA282
DR   MMRRC; MMRRC:016426-UCD
DR   Wikidata; Q54793023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144243; Clint1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA284
AC   CVCL_QQ35
SY   YTA284
DR   MMRRC; MMRRC:016802-UCD
DR   Wikidata; Q54793025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443764; Iqcb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA285
AC   CVCL_QQ36
SY   YTA285
DR   MMRRC; MMRRC:016754-UCD
DR   Wikidata; Q54793026
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298398; Mcm7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA287
AC   CVCL_QQ37
SY   YTA287
DR   MMRRC; MMRRC:016803-UCD
DR   Wikidata; Q54793029
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298398; Mcm7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA290
AC   CVCL_QQ38
SY   YTA290
DR   MMRRC; MMRRC:016692-UCD
DR   Wikidata; Q54793031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1329037; Strap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA291
AC   CVCL_QQ39
SY   YTA291
DR   MMRRC; MMRRC:016693-UCD
DR   Wikidata; Q54793033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931027; Stx12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA292
AC   CVCL_QQ40
SY   YTA292
DR   MMRRC; MMRRC:016639-UCD
DR   Wikidata; Q54793035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA293
AC   CVCL_QQ41
SY   YTA293
DR   MMRRC; MMRRC:016804-UCD
DR   Wikidata; Q54793037
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349722; Pabpc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA296
AC   CVCL_QQ42
SY   YTA296
DR   MMRRC; MMRRC:016640-UCD
DR   Wikidata; Q54793039
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147437; Rrp12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA297
AC   CVCL_QQ43
SY   YTA297
DR   MMRRC; MMRRC:016480-UCD
DR   Wikidata; Q54793042
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144224; Dnaaf10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA299
AC   CVCL_QQ44
SY   YTA299
DR   MMRRC; MMRRC:016805-UCD
DR   Wikidata; Q54793043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA302
AC   CVCL_QQ45
SY   YTA302
DR   MMRRC; MMRRC:016641-UCD
DR   Wikidata; Q54793046
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2675859; Wapl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA303
AC   CVCL_QQ46
SY   YTA303
DR   MMRRC; MMRRC:016694-UCD
DR   Wikidata; Q54793048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97891; Rfc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA304
AC   CVCL_QQ47
SY   YTA304
DR   MMRRC; MMRRC:016528-UCD
DR   Wikidata; Q54793049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103296; Nfatc3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA308
AC   CVCL_QQ48
SY   YTA308
DR   MMRRC; MMRRC:016643-UCD
DR   Wikidata; Q54793052
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100836; Kpna6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA309
AC   CVCL_QQ49
SY   YTA309
DR   MMRRC; MMRRC:016695-UCD
DR   Wikidata; Q54793053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA310
AC   CVCL_QQ50
SY   YTA310
DR   MMRRC; MMRRC:016529-UCD
DR   Wikidata; Q54793056
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915467; Prrc2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA311
AC   CVCL_QQ51
SY   YTA311
DR   MMRRC; MMRRC:016644-UCD
DR   Wikidata; Q54793058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919725; Ssbp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA312
AC   CVCL_QQ52
SY   YTA312
DR   MMRRC; MMRRC:016530-UCD
DR   Wikidata; Q54793059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97960; Rnps1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA317
AC   CVCL_QQ53
SY   YTA317
DR   MMRRC; MMRRC:016755-UCD
DR   Wikidata; Q54793061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921700; Pank2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA321
AC   CVCL_QQ54
SY   YTA321
DR   MMRRC; MMRRC:016586-UCD
DR   Wikidata; Q54793062
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918023; Cwf19l2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA326
AC   CVCL_QQ55
SY   YTA326
DR   MMRRC; MMRRC:016587-UCD
DR   Wikidata; Q54793065
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914324; Mon2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA327
AC   CVCL_QQ56
SY   YTA327
DR   MMRRC; MMRRC:016645-UCD
DR   Wikidata; Q54793066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858961; Prc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA330
AC   CVCL_QQ57
SY   YTA330
DR   MMRRC; MMRRC:016646-UCD
DR   Wikidata; Q54793068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109584; Prpf4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA331
AC   CVCL_QQ58
SY   YTA331
DR   MMRRC; MMRRC:016806-UCD
DR   Wikidata; Q54793071
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107342; Zfp64.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA332
AC   CVCL_QQ59
SY   YTA332
DR   MMRRC; MMRRC:016481-UCD
DR   Wikidata; Q54793072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930134; Ern1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA334
AC   CVCL_QQ60
SY   YTA334
DR   MMRRC; MMRRC:016647-UCD
DR   Wikidata; Q54793074
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA337
AC   CVCL_QQ61
SY   YTA337
DR   MMRRC; MMRRC:016696-UCD
DR   Wikidata; Q54793077
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918952; Cdc5l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA340
AC   CVCL_QQ62
SY   YTA340
DR   MMRRC; MMRRC:016429-UCD
DR   Wikidata; Q54793115
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145245; Srek1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA341
AC   CVCL_QQ63
SY   YTA341
DR   MMRRC; MMRRC:016648-UCD
DR   Wikidata; Q54793116
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138741; Hnrnpf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA342
AC   CVCL_QQ64
SY   YTA342
DR   MMRRC; MMRRC:016532-UCD
DR   Wikidata; Q54793117
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95278; Epha2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA343
AC   CVCL_QQ65
SY   YTA343
DR   MMRRC; MMRRC:016430-UCD
DR   Wikidata; Q54793120
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA344
AC   CVCL_QQ66
SY   YTA344
DR   MMRRC; MMRRC:016533-UCD
DR   Wikidata; Q54793122
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036234; Hdac4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA345
AC   CVCL_QQ67
SY   YTA345
DR   MMRRC; MMRRC:016807-UCD
DR   Wikidata; Q54793123
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106478; Eif3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA349
AC   CVCL_QQ68
SY   YTA349
DR   MMRRC; MMRRC:016431-UCD
DR   Wikidata; Q54793124
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3029414; Brwd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA350
AC   CVCL_QQ69
SY   YTA350
DR   MMRRC; MMRRC:016649-UCD
DR   Wikidata; Q54793127
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA353
AC   CVCL_QQ70
SY   YTA353
DR   MMRRC; MMRRC:016534-UCD
DR   Wikidata; Q54793129
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339951; Cse1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA355
AC   CVCL_QQ71
SY   YTA355
DR   MMRRC; MMRRC:016535-UCD
DR   Wikidata; Q54793131
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890396; Suv39h2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA357
AC   CVCL_QQ72
SY   YTA357
DR   MMRRC; MMRRC:016483-UCD
DR   Wikidata; Q54793133
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87989; Alas1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA358
AC   CVCL_QQ73
SY   YTA358
DR   MMRRC; MMRRC:016697-UCD
DR   Wikidata; Q54793135
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929095; Uso1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA359
AC   CVCL_QQ74
SY   YTA359
DR   MMRRC; MMRRC:016588-UCD
DR   Wikidata; Q54793136
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929004; Stk4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA360
AC   CVCL_QQ75
SY   YTA360
DR   MMRRC; MMRRC:016808-UCD
DR   Wikidata; Q54793137
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103250; Calm2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA363
AC   CVCL_QQ76
SY   YTA363
DR   MMRRC; MMRRC:016758-UCD
DR   Wikidata; Q54793140
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107637; Psmb7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA364
AC   CVCL_QQ77
SY   YTA364
DR   MMRRC; MMRRC:016484-UCD
DR   Wikidata; Q54793141
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA365
AC   CVCL_QQ78
SY   YTA365
DR   MMRRC; MMRRC:016698-UCD
DR   Wikidata; Q54793143
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA367
AC   CVCL_QQ79
SY   YTA367
DR   MMRRC; MMRRC:016699-UCD
DR   Wikidata; Q54793145
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347352; Hunk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA369
AC   CVCL_QQ80
SY   YTA369
DR   MMRRC; MMRRC:016485-UCD
DR   Wikidata; Q54793146
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA370
AC   CVCL_QQ81
SY   YTA370
DR   MMRRC; MMRRC:016590-UCD
DR   Wikidata; Q54793147
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929608; Aatf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA371
AC   CVCL_QQ82
SY   YTA371
DR   MMRRC; MMRRC:016537-UCD
DR   Wikidata; Q54793148
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858304; Ctps.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA374
AC   CVCL_QQ83
SY   YTA374
DR   MMRRC; MMRRC:016486-UCD
DR   Wikidata; Q54793152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921793; Zfp871.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA375
AC   CVCL_QQ84
SY   YTA375
DR   MMRRC; MMRRC:016651-UCD
DR   Wikidata; Q54793154
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920924; Wdr75.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA378
AC   CVCL_QQ85
SY   YTA378
DR   MMRRC; MMRRC:016487-UCD
DR   Wikidata; Q54793156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914513; Zswim6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA379
AC   CVCL_QQ86
SY   YTA379
DR   MMRRC; MMRRC:016700-UCD
DR   Wikidata; Q54793159
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99778; Gpd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA380
AC   CVCL_QQ87
SY   YTA380
DR   MMRRC; MMRRC:016760-UCD
DR   Wikidata; Q54793160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109637; Erf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA385
AC   CVCL_QQ88
SY   YTA385
DR   MMRRC; MMRRC:016488-UCD
DR   Wikidata; Q54793162
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2181074; Acbd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA387
AC   CVCL_QQ89
SY   YTA387
DR   MMRRC; MMRRC:016369-UCD
DR   Wikidata; Q54793165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915206; Kmt5a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA389
AC   CVCL_QQ90
SY   YTA389
DR   MMRRC; MMRRC:016539-UCD
DR   Wikidata; Q54793167
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385066; Rprd1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA390
AC   CVCL_QQ91
SY   YTA390
DR   MMRRC; MMRRC:017025-UCD
DR   Wikidata; Q54793170
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98342; Snrpb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA392
AC   CVCL_QQ92
SY   YTA392
DR   MMRRC; MMRRC:016538-UCD
DR   Wikidata; Q54793172
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443008; Trappc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA393
AC   CVCL_QQ93
SY   YTA393
DR   MMRRC; MMRRC:016654-UCD
DR   Wikidata; Q54793174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914371; Mastl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA398
AC   CVCL_QQ94
SY   YTA398
DR   MMRRC; MMRRC:016899-UCD
DR   Wikidata; Q54793175
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351660; Csnk1e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA399
AC   CVCL_QQ95
SY   YTA399
DR   MMRRC; MMRRC:016933-UCD
DR   Wikidata; Q54793177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916303; 1810013L24Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA400
AC   CVCL_QQ96
SY   YTA400
DR   MMRRC; MMRRC:016934-UCD
DR   Wikidata; Q54793180
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3042141; Traf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA401
AC   CVCL_QQ97
SY   YTA401
DR   MMRRC; MMRRC:016955-UCD
DR   Wikidata; Q54793181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855693; Nap1l1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA403
AC   CVCL_QQ98
SY   YTA403
DR   MMRRC; MMRRC:016878-UCD
DR   Wikidata; Q54793184
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2156528; Elovl6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA404
AC   CVCL_QQ99
SY   YTA404
DR   MMRRC; MMRRC:016923-UCD
DR   Wikidata; Q54793186
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA406
AC   CVCL_QR00
SY   YTA406
DR   MMRRC; MMRRC:016900-UCD
DR   Wikidata; Q54793187
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923957; Clasp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA407
AC   CVCL_QR01
SY   YTA407
DR   MMRRC; MMRRC:016879-UCD
DR   Wikidata; Q54793190
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203520; Dapk3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA408
AC   CVCL_QR02
SY   YTA408
DR   MMRRC; MMRRC:016912-UCD
DR   Wikidata; Q54793243
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894652; Usp10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA410
AC   CVCL_QR03
SY   YTA410
DR   MMRRC; MMRRC:016913-UCD
DR   Wikidata; Q54793246
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924177; Tsacc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA411
AC   CVCL_QR04
SY   YTA411
DR   MMRRC; MMRRC:016956-UCD
DR   Wikidata; Q54793248
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385089; Cbwd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA415
AC   CVCL_QR05
SY   YTA415
DR   MMRRC; MMRRC:016936-UCD
DR   Wikidata; Q54793249
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3588201; Erich1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA416
AC   CVCL_QR06
SY   YTA416
DR   MMRRC; MMRRC:016925-UCD
DR   Wikidata; Q54793253
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA422
AC   CVCL_QR07
SY   YTA422
DR   MMRRC; MMRRC:016957-UCD
DR   Wikidata; Q54793255
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA425
AC   CVCL_QR08
SY   YTA425
DR   MMRRC; MMRRC:016914-UCD
DR   Wikidata; Q54793258
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338069; Itsn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA428
AC   CVCL_QR09
SY   YTA428
DR   MMRRC; MMRRC:016958-UCD
DR   Wikidata; Q54793259
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99778; Gpd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA429
AC   CVCL_QR10
SY   YTA429
DR   MMRRC; MMRRC:016888-UCD
DR   Wikidata; Q54793261
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890695; Rab9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA432
AC   CVCL_QR11
SY   YTA432
DR   MMRRC; MMRRC:016938-UCD
DR   Wikidata; Q54793263
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445179; Tmem184b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA434
AC   CVCL_QR12
SY   YTA434
DR   MMRRC; MMRRC:016901-UCD
DR   Wikidata; Q54793265
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923241; Slain2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA435
AC   CVCL_QR13
SY   YTA435
DR   MMRRC; MMRRC:016880-UCD
DR   Wikidata; Q54793267
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103251; Acly.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA438
AC   CVCL_QR14
SY   YTA438
DR   MMRRC; MMRRC:016869-UCD
DR   Wikidata; Q54793269
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921537; Kcmf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA441
AC   CVCL_QR15
SY   YTA441
DR   MMRRC; MMRRC:016881-UCD
DR   Wikidata; Q54793271
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99256; Hdlbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA442
AC   CVCL_QR16
SY   YTA442
DR   MMRRC; MMRRC:016926-UCD
DR   Wikidata; Q54793274
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151055; Cnnm3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA444
AC   CVCL_QR17
SY   YTA444
DR   MMRRC; MMRRC:016890-UCD
DR   Wikidata; Q54793275
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921487; Tubgcp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA445
AC   CVCL_QR18
SY   YTA445
DR   MMRRC; MMRRC:016902-UCD
DR   Wikidata; Q54793279
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97552; Pgam1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA447
AC   CVCL_QR19
SY   YTA447
DR   MMRRC; MMRRC:016939-UCD
DR   Wikidata; Q54793280
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346040; Mpdu1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA448
AC   CVCL_QR20
SY   YTA448
DR   MMRRC; MMRRC:016940-UCD
DR   Wikidata; Q54793282
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102944; Ube2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA449
AC   CVCL_QR21
SY   YTA449
DR   MMRRC; MMRRC:016903-UCD
DR   Wikidata; Q54793283
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679002; Prr12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA451
AC   CVCL_QR22
SY   YTA451
DR   MMRRC; MMRRC:016959-UCD
DR   Wikidata; Q54793285
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925835; Jade1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA455
AC   CVCL_QR23
SY   YTA455
DR   MMRRC; MMRRC:016943-UCD
DR   Wikidata; Q54793287
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99150; Yy1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA456
AC   CVCL_QR24
SY   YTA456
DR   MMRRC; MMRRC:016960-UCD
DR   Wikidata; Q54793289
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891706; Spen.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA465
AC   CVCL_QR25
SY   YTA465
DR   MMRRC; MMRRC:016973-UCD
DR   Wikidata; Q54793291
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919367; Naa50.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA466
AC   CVCL_QR26
SY   YTA466
DR   MMRRC; MMRRC:016961-UCD
DR   Wikidata; Q54793293
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914110; Tanc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA467
AC   CVCL_QR27
SY   YTA467
DR   MMRRC; MMRRC:016915-UCD
DR   Wikidata; Q54793295
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143362; Zfp809.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA470
AC   CVCL_QR28
SY   YTA470
DR   MMRRC; MMRRC:016916-UCD
DR   Wikidata; Q54793296
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109637; Erf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA472
AC   CVCL_QR29
SY   YTA472
DR   MMRRC; MMRRC:016962-UCD
DR   Wikidata; Q54793298
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA473
AC   CVCL_QR30
SY   YTA473
DR   MMRRC; MMRRC:016870-UCD
DR   Wikidata; Q54793300
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95773; Gnai3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA474
AC   CVCL_QR31
SY   YTA474
DR   MMRRC; MMRRC:016871-UCD
DR   Wikidata; Q54793304
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1314653; Afdn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA475
AC   CVCL_QR32
SY   YTA475
DR   MMRRC; MMRRC:016904-UCD
DR   Wikidata; Q54793306
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA476
AC   CVCL_QR33
SY   YTA476
DR   MMRRC; MMRRC:016927-UCD
DR   Wikidata; Q54793308
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918965; Dhx35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA477
AC   CVCL_QR34
SY   YTA477
DR   MMRRC; MMRRC:016944-UCD
DR   Wikidata; Q54793309
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915309; Tm9sf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA478
AC   CVCL_QR35
SY   YTA478
DR   MMRRC; MMRRC:016928-UCD
DR   Wikidata; Q54793311
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921700; Pank2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA479
AC   CVCL_QR36
SY   YTA479
DR   MMRRC; MMRRC:016872-UCD
DR   Wikidata; Q54793314
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA487
AC   CVCL_QR37
SY   YTA487
DR   MMRRC; MMRRC:016963-UCD
DR   Wikidata; Q54793315
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925177; Ccdc88a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA490
AC   CVCL_QR38
SY   YTA490
DR   MMRRC; MMRRC:016929-UCD
DR   Wikidata; Q54793318
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107934; Mdm4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA497
AC   CVCL_QR39
SY   YTA497
DR   MMRRC; MMRRC:016893-UCD
DR   Wikidata; Q54793320
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923038; Smurf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA499
AC   CVCL_QR40
SY   YTA499
DR   MMRRC; MMRRC:016930-UCD
DR   Wikidata; Q54793322
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444248; Gcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA502
AC   CVCL_QR41
SY   YTA502
DR   MMRRC; MMRRC:016873-UCD
DR   Wikidata; Q54793323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1352459; Nr6a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA503
AC   CVCL_QR42
SY   YTA503
DR   MMRRC; MMRRC:016945-UCD
DR   Wikidata; Q54793371
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915031; Ilf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA504
AC   CVCL_QR43
SY   YTA504
DR   MMRRC; MMRRC:016965-UCD
DR   Wikidata; Q54793372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923241; Slain2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA506
AC   CVCL_QR44
SY   YTA506
DR   MMRRC; MMRRC:016894-UCD
DR   Wikidata; Q54793374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104872; Ppp1cc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA509
AC   CVCL_QR45
SY   YTA509
DR   MMRRC; MMRRC:016883-UCD
DR   Wikidata; Q54793376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926967; Hsd17b12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA516
AC   CVCL_QR46
SY   YTA516
DR   MMRRC; MMRRC:016919-UCD
DR   Wikidata; Q54793378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890222; Midn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA523
AC   CVCL_QR47
SY   YTA523
DR   MMRRC; MMRRC:016884-UCD
DR   Wikidata; Q54793380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913963; Actr2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA524
AC   CVCL_QR48
SY   YTA524
DR   MMRRC; MMRRC:016966-UCD
DR   Wikidata; Q54793382
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA528
AC   CVCL_QR49
SY   YTA528
DR   MMRRC; MMRRC:016874-UCD
DR   Wikidata; Q54793384
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923264; Zc3h18.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA529
AC   CVCL_QR50
SY   YTA529
DR   MMRRC; MMRRC:016974-UCD
DR   Wikidata; Q54793386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97451; Otx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA535
AC   CVCL_QR51
SY   YTA535
DR   MMRRC; MMRRC:016906-UCD
DR   Wikidata; Q54793389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201408; Srpk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA540
AC   CVCL_QR52
SY   YTA540
DR   MMRRC; MMRRC:016921-UCD
DR   Wikidata; Q54793391
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88108; Atp1b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA541
AC   CVCL_QR53
SY   YTA541
DR   MMRRC; MMRRC:016968-UCD
DR   Wikidata; Q54793393
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309489; Cask.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA542
AC   CVCL_QR54
SY   YTA542
DR   MMRRC; MMRRC:016907-UCD
DR   Wikidata; Q54793395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98510; Tcf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA543
AC   CVCL_QR55
SY   YTA543
DR   MMRRC; MMRRC:016947-UCD
DR   Wikidata; Q54793397
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333856; Klf9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA544
AC   CVCL_QR56
SY   YTA544
DR   MMRRC; MMRRC:016948-UCD
DR   Wikidata; Q54793399
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1206040; Vps26c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA546
AC   CVCL_QR57
SY   YTA546
DR   MMRRC; MMRRC:016931-UCD
DR   Wikidata; Q54793402
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99187; Zfp42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA553
AC   CVCL_QR58
SY   YTA553
DR   MMRRC; MMRRC:016969-UCD
DR   Wikidata; Q54793403
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309489; Cask.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA554
AC   CVCL_QR59
SY   YTA554
DR   MMRRC; MMRRC:016908-UCD
DR   Wikidata; Q54793407
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98510; Tcf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA555
AC   CVCL_QR60
SY   YTA555
DR   MMRRC; MMRRC:016970-UCD
DR   Wikidata; Q54793408
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333856; Klf9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA556
AC   CVCL_QR61
SY   YTA556
DR   MMRRC; MMRRC:016949-UCD
DR   Wikidata; Q54793409
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1206040; Vps26c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTA565
AC   CVCL_QR62
SY   YTA565
DR   MMRRC; MMRRC:016875-UCD
DR   Wikidata; Q54793413
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916412; Sec31a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA566
AC   CVCL_QR63
SY   YTA566
DR   MMRRC; MMRRC:016971-UCD
DR   Wikidata; Q54793414
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197010; Sumo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA568
AC   CVCL_QR64
SY   YTA568
DR   MMRRC; MMRRC:016910-UCD
DR   Wikidata; Q54793419
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339970; Rtn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA569
AC   CVCL_QR65
SY   YTA569
DR   MMRRC; MMRRC:016950-UCD
DR   Wikidata; Q54793420
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289341; Sf3b3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA570
AC   CVCL_QR66
SY   YTA570
DR   MMRRC; MMRRC:016951-UCD
DR   Wikidata; Q54793422
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913125; Pias1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA572
AC   CVCL_QR67
SY   YTA572
DR   MMRRC; MMRRC:016876-UCD
DR   Wikidata; Q54793424
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97621; Plk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA574
AC   CVCL_QR68
SY   YTA574
DR   MMRRC; MMRRC:016972-UCD
DR   Wikidata; Q54793427
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354949; Dlc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA575
AC   CVCL_QR69
SY   YTA575
DR   MMRRC; MMRRC:016887-UCD
DR   Wikidata; Q54793430
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1354949; Dlc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA578
AC   CVCL_QR70
SY   YTA578
DR   MMRRC; MMRRC:016932-UCD
DR   Wikidata; Q54793432
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA579
AC   CVCL_QR71
SY   YTA579
DR   MMRRC; MMRRC:016877-UCD
DR   Wikidata; Q54793433
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330281; Cd2ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA581
AC   CVCL_QR72
SY   YTA581
DR   MMRRC; MMRRC:016953-UCD
DR   Wikidata; Q54793436
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101757; Cfl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA585
AC   CVCL_QR73
SY   YTA585
DR   MMRRC; MMRRC:016898-UCD
DR   Wikidata; Q54793440
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA586
AC   CVCL_QR74
SY   YTA586
DR   MMRRC; MMRRC:016911-UCD
DR   Wikidata; Q54793441
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923792; Hibch.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA589
AC   CVCL_QR75
SY   YTA589
DR   MMRRC; MMRRC:017049-UCD
DR   Wikidata; Q54793444
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99211; Zfx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA594
AC   CVCL_QR76
SY   YTA594
DR   MMRRC; MMRRC:017008-UCD
DR   Wikidata; Q54793446
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922471; Dpp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTA596
AC   CVCL_QR77
SY   YTA596
DR   MMRRC; MMRRC:017031-UCD
DR   Wikidata; Q54793448
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098275; Gse1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB002
AC   CVCL_QR78
SY   YTB002
DR   MMRRC; MMRRC:017021-UCD
DR   Wikidata; Q54793450
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918398; Mier1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB003
AC   CVCL_QR79
SY   YTB003
DR   MMRRC; MMRRC:017009-UCD
DR   Wikidata; Q54793451
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108074; Sptlc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB004
AC   CVCL_QR80
SY   YTB004
DR   MMRRC; MMRRC:017050-UCD
DR   Wikidata; Q54793453
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98354; Sos1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB006
AC   CVCL_QR81
SY   YTB006
DR   MMRRC; MMRRC:017041-UCD
DR   Wikidata; Q54793456
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929274; 1110004F10Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB007
AC   CVCL_QR82
SY   YTB007
DR   MMRRC; MMRRC:017051-UCD
DR   Wikidata; Q54793497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913099; Psrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB009
AC   CVCL_QR83
SY   YTB009
DR   MMRRC; MMRRC:017010-UCD
DR   Wikidata; Q54793500
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925152; Prune1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB011
AC   CVCL_QR84
SY   YTB011
DR   MMRRC; MMRRC:017018-UCD
DR   Wikidata; Q54793501
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890218; Akap10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB012
AC   CVCL_QR85
SY   YTB012
DR   MMRRC; MMRRC:017032-UCD
DR   Wikidata; Q54793502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289273; Ppp1r10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB013
AC   CVCL_QR86
SY   YTB013
DR   MMRRC; MMRRC:017042-UCD
DR   Wikidata; Q54793505
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105313; Cit.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB014
AC   CVCL_QR87
SY   YTB014
DR   MMRRC; MMRRC:017043-UCD
DR   Wikidata; Q54793507
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931053; Marchf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTB019
AC   CVCL_QR88
SY   YTB019
DR   MMRRC; MMRRC:017022-UCD
DR   Wikidata; Q54793509
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442117; Pogz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB020
AC   CVCL_QR89
SY   YTB020
DR   MMRRC; MMRRC:017044-UCD
DR   Wikidata; Q54793511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97178; Map4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB023
AC   CVCL_QR90
SY   YTB023
DR   MMRRC; MMRRC:017033-UCD
DR   Wikidata; Q54793512
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915821; 1110002L01Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB024
AC   CVCL_QR91
SY   YTB024
DR   MMRRC; MMRRC:017028-UCD
DR   Wikidata; Q54793513
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109152; Lig3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB025
AC   CVCL_QR92
SY   YTB025
DR   MMRRC; MMRRC:017052-UCD
DR   Wikidata; Q54793515
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341788; Pdcd11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB026
AC   CVCL_QR93
SY   YTB026
DR   MMRRC; MMRRC:017034-UCD
DR   Wikidata; Q54793516
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925152; Prune1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB029
AC   CVCL_QR94
SY   YTB029
DR   MMRRC; MMRRC:017046-UCD
DR   Wikidata; Q54793519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921409; Acbd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB032
AC   CVCL_QR95
SY   YTB032
DR   MMRRC; MMRRC:017019-UCD
DR   Wikidata; Q54793522
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913452; 1110059G10Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB034
AC   CVCL_QR96
SY   YTB034
DR   MMRRC; MMRRC:017029-UCD
DR   Wikidata; Q54793523
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890156; Stx8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB036
AC   CVCL_QR97
SY   YTB036
DR   MMRRC; MMRRC:017047-UCD
DR   Wikidata; Q54793526
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925152; Prune1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB037
AC   CVCL_QR98
SY   YTB037
DR   MMRRC; MMRRC:017035-UCD
DR   Wikidata; Q54793528
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927868; Pex14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB038
AC   CVCL_QR99
SY   YTB038
DR   MMRRC; MMRRC:017040-UCD
DR   Wikidata; Q54793530
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB039
AC   CVCL_QS00
SY   YTB039
DR   MMRRC; MMRRC:017053-UCD
DR   Wikidata; Q54793534
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918398; Mier1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB043
AC   CVCL_QS01
SY   YTB043
DR   MMRRC; MMRRC:017012-UCD
DR   Wikidata; Q54793536
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB045
AC   CVCL_QS02
SY   YTB045
DR   MMRRC; MMRRC:017023-UCD
DR   Wikidata; Q54793537
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921256; Dnm1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB047
AC   CVCL_QS03
SY   YTB047
DR   MMRRC; MMRRC:017030-UCD
DR   Wikidata; Q54793540
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448487; Fam168b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB048
AC   CVCL_QS04
SY   YTB048
DR   MMRRC; MMRRC:017054-UCD
DR   Wikidata; Q54793544
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106281; Ilrun.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTB050
AC   CVCL_QS05
SY   YTB050
DR   MMRRC; MMRRC:017036-UCD
DR   Wikidata; Q54793545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891751; Gps2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB051
AC   CVCL_QS06
SY   YTB051
DR   MMRRC; MMRRC:017013-UCD
DR   Wikidata; Q54793548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385189; Rap1gds1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB055
AC   CVCL_QS07
SY   YTB055
DR   MMRRC; MMRRC:017055-UCD
DR   Wikidata; Q54793551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890393; Zfp277.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB057
AC   CVCL_QS08
SY   YTB057
DR   MMRRC; MMRRC:017037-UCD
DR   Wikidata; Q54793553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289273; Ppp1r10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTB059
AC   CVCL_QS09
SY   YTB059
DR   MMRRC; MMRRC:017014-UCD
DR   Wikidata; Q54793555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444748; Chd7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC001
AC   CVCL_QS10
SY   YTC001
DR   MMRRC; MMRRC:017078-UCD
DR   Wikidata; Q54793556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346872; Map3k1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC004
AC   CVCL_QS11
SY   YTC004
DR   MMRRC; MMRRC:017187-UCD
DR   Wikidata; Q54793558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2135610; Dync1li1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC005
AC   CVCL_QS12
SY   YTC005
DR   MMRRC; MMRRC:017096-UCD
DR   Wikidata; Q54793561
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442620; Nup133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC007
AC   CVCL_QS13
SY   YTC007
DR   MMRRC; MMRRC:017140-UCD
DR   Wikidata; Q54793562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201691; Rnf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC008
AC   CVCL_QS14
SY   YTC008
DR   MMRRC; MMRRC:017188-UCD
DR   Wikidata; Q54793567
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108559; Macf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC009
AC   CVCL_QS15
SY   YTC009
DR   MMRRC; MMRRC:017079-UCD
DR   Wikidata; Q54793568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95610; Gabpa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC010
AC   CVCL_QS16
SY   YTC010
DR   MMRRC; MMRRC:017189-UCD
DR   Wikidata; Q54793570
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC011
AC   CVCL_QS17
SY   YTC011
DR   MMRRC; MMRRC:017121-UCD
DR   Wikidata; Q54793574
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139764; Sec24b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC012
AC   CVCL_QS18
SY   YTC012
DR   MMRRC; MMRRC:017161-UCD
DR   Wikidata; Q54793576
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332659; Bnip3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC013
AC   CVCL_QS19
SY   YTC013
DR   MMRRC; MMRRC:017141-UCD
DR   Wikidata; Q54793578
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99660; Pola1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC015
AC   CVCL_QS20
SY   YTC015
DR   MMRRC; MMRRC:017110-UCD
DR   Wikidata; Q54793580
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916889; Exosc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC016
AC   CVCL_QS21
SY   YTC016
DR   MMRRC; MMRRC:017097-UCD
DR   Wikidata; Q54793583
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101769; Mcl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC017
AC   CVCL_QS22
SY   YTC017
DR   MMRRC; MMRRC:017111-UCD
DR   Wikidata; Q54793627
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919570; Kifbp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC019
AC   CVCL_QS23
SY   YTC019
DR   MMRRC; MMRRC:017122-UCD
DR   Wikidata; Q54793630
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444593; Pptc7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC020
AC   CVCL_QS24
SY   YTC020
DR   MMRRC; MMRRC:017190-UCD
DR   Wikidata; Q54793631
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC023
AC   CVCL_QS25
SY   YTC023
DR   MMRRC; MMRRC:017191-UCD
DR   Wikidata; Q54793633
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC024
AC   CVCL_QS26
SY   YTC024
DR   MMRRC; MMRRC:017162-UCD
DR   Wikidata; Q54793634
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921605; Smchd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC029
AC   CVCL_QS27
SY   YTC029
DR   MMRRC; MMRRC:017113-UCD
DR   Wikidata; Q54793636
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338041; Tfg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC032
AC   CVCL_QS28
SY   YTC032
DR   MMRRC; MMRRC:017211-UCD
DR   Wikidata; Q54793638
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107380; Spag7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC033
AC   CVCL_QS29
SY   YTC033
DR   MMRRC; MMRRC:017124-UCD
DR   Wikidata; Q54793639
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102722; Pcnt.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC034
AC   CVCL_QS30
SY   YTC034
DR   MMRRC; MMRRC:017125-UCD
DR   Wikidata; Q54793642
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC035
AC   CVCL_QS31
SY   YTC035
DR   MMRRC; MMRRC:017098-UCD
DR   Wikidata; Q54793643
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922816; Ing5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC037
AC   CVCL_QS32
SY   YTC037
DR   MMRRC; MMRRC:017192-UCD
DR   Wikidata; Q54793646
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918305; Nemf.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC038
AC   CVCL_QS33
SY   YTC038
DR   MMRRC; MMRRC:017114-UCD
DR   Wikidata; Q54793648
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923666; Polr1has.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC040
AC   CVCL_QS34
SY   YTC040
DR   MMRRC; MMRRC:017126-UCD
DR   Wikidata; Q54793649
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2139054; Gpr107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC041
AC   CVCL_QS35
SY   YTC041
DR   MMRRC; MMRRC:017142-UCD
DR   Wikidata; Q54793652
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137624; Pom121.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC042
AC   CVCL_QS36
SY   YTC042
DR   MMRRC; MMRRC:017193-UCD
DR   Wikidata; Q54793657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3040701; Zfp459.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC043
AC   CVCL_QS37
SY   YTC043
DR   MMRRC; MMRRC:017127-UCD
DR   Wikidata; Q54793658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353448; Eif2ak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC045
AC   CVCL_QS38
SY   YTC045
DR   MMRRC; MMRRC:017194-UCD
DR   Wikidata; Q54793661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100887; Elavl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC046
AC   CVCL_QS39
SY   YTC046
DR   MMRRC; MMRRC:017163-UCD
DR   Wikidata; Q54793662
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097711; Degs1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC047
AC   CVCL_QS40
SY   YTC047
DR   MMRRC; MMRRC:017128-UCD
DR   Wikidata; Q54793665
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141070; Ccz1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC049
AC   CVCL_QS41
SY   YTC049
DR   MMRRC; MMRRC:017143-UCD
DR   Wikidata; Q54793666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349409; Cops3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC051
AC   CVCL_QS42
SY   YTC051
DR   MMRRC; MMRRC:017212-UCD
DR   Wikidata; Q54793668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270126; Ulk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC055
AC   CVCL_QS43
SY   YTC055
DR   MMRRC; MMRRC:017115-UCD
DR   Wikidata; Q54793669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC057
AC   CVCL_QS44
SY   YTC057
DR   MMRRC; MMRRC:017164-UCD
DR   Wikidata; Q54793674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC059
AC   CVCL_QS45
SY   YTC059
DR   MMRRC; MMRRC:017080-UCD
DR   Wikidata; Q54793675
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926421; Tcerg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC060
AC   CVCL_QS46
SY   YTC060
DR   MMRRC; MMRRC:017081-UCD
DR   Wikidata; Q54793676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894313; Rab6a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC061
AC   CVCL_QS47
SY   YTC061
DR   MMRRC; MMRRC:017195-UCD
DR   Wikidata; Q54793677
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924621; Sec24a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC062
AC   CVCL_QS48
SY   YTC062
DR   MMRRC; MMRRC:017082-UCD
DR   Wikidata; Q54793679
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC063
AC   CVCL_QS49
SY   YTC063
DR   MMRRC; MMRRC:017196-UCD
DR   Wikidata; Q54793680
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332234; Zfp148.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC065
AC   CVCL_QS50
SY   YTC065
DR   MMRRC; MMRRC:017099-UCD
DR   Wikidata; Q54793683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2152346; Taf4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC066
AC   CVCL_QS51
SY   YTC066
DR   MMRRC; MMRRC:017165-UCD
DR   Wikidata; Q54793685
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95454; Etl4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC068
AC   CVCL_QS52
SY   YTC068
DR   MMRRC; MMRRC:017166-UCD
DR   Wikidata; Q54793687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384583; Zfp280d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC071
AC   CVCL_QS53
SY   YTC071
DR   MMRRC; MMRRC:017197-UCD
DR   Wikidata; Q54793690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036237; Rsbn1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC072
AC   CVCL_QS54
SY   YTC072
DR   MMRRC; MMRRC:017167-UCD
DR   Wikidata; Q54793692
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442092; Wnk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC075
AC   CVCL_QS55
SY   YTC075
DR   MMRRC; MMRRC:017068-UCD
DR   Wikidata; Q54793694
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916979; 2410003L11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC076
AC   CVCL_QS56
SY   YTC076
DR   MMRRC; MMRRC:017069-UCD
DR   Wikidata; Q54793697
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916979; 2410003L11Rik.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC079
AC   CVCL_QS57
SY   YTC079
DR   MMRRC; MMRRC:017083-UCD
DR   Wikidata; Q54793699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914552; Zc3h13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC080
AC   CVCL_QS58
SY   YTC080
DR   MMRRC; MMRRC:017147-UCD
DR   Wikidata; Q54793701
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384159; Gga3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC081
AC   CVCL_QS59
SY   YTC081
DR   MMRRC; MMRRC:017070-UCD
DR   Wikidata; Q54793702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929705; Xpo7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC082
AC   CVCL_QS60
SY   YTC082
DR   MMRRC; MMRRC:017129-UCD
DR   Wikidata; Q54793703
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC085
AC   CVCL_QS61
SY   YTC085
DR   MMRRC; MMRRC:017117-UCD
DR   Wikidata; Q54793706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932139; Oga.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC087
AC   CVCL_QS62
SY   YTC087
DR   MMRRC; MMRRC:017101-UCD
DR   Wikidata; Q54793779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442040; G3bp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC088
AC   CVCL_QS63
SY   YTC088
DR   MMRRC; MMRRC:017102-UCD
DR   Wikidata; Q54793782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147679; Patl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC090
AC   CVCL_QS64
SY   YTC090
DR   MMRRC; MMRRC:017119-UCD
DR   Wikidata; Q54793784
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445220; Dcaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC091
AC   CVCL_QS65
SY   YTC091
DR   MMRRC; MMRRC:017103-UCD
DR   Wikidata; Q54793785
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921407; Cmtr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC095
AC   CVCL_QS66
SY   YTC095
DR   MMRRC; MMRRC:017084-UCD
DR   Wikidata; Q54793788
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860606; Akap8l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC096
AC   CVCL_QS67
SY   YTC096
DR   MMRRC; MMRRC:017168-UCD
DR   Wikidata; Q54793789
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919228; Ppp2r2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC098
AC   CVCL_QS68
SY   YTC098
DR   MMRRC; MMRRC:017104-UCD
DR   Wikidata; Q54793791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141161; Tyw1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC100
AC   CVCL_QS69
SY   YTC100
DR   MMRRC; MMRRC:017169-UCD
DR   Wikidata; Q54793792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC101
AC   CVCL_QS70
SY   YTC101
DR   MMRRC; MMRRC:017130-UCD
DR   Wikidata; Q54793795
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097691; Hdac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC102
AC   CVCL_QS71
SY   YTC102
DR   MMRRC; MMRRC:017131-UCD
DR   Wikidata; Q54793797
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915033; Ahctf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC103
AC   CVCL_QS72
SY   YTC103
DR   MMRRC; MMRRC:017149-UCD
DR   Wikidata; Q54793798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1097691; Hdac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC106
AC   CVCL_QS73
SY   YTC106
DR   MMRRC; MMRRC:017150-UCD
DR   Wikidata; Q54793800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341822; Eif4h.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC107
AC   CVCL_QS74
SY   YTC107
DR   MMRRC; MMRRC:017170-UCD
DR   Wikidata; Q54793802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145955; Prkaa1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC108
AC   CVCL_QS75
SY   YTC108
DR   MMRRC; MMRRC:017132-UCD
DR   Wikidata; Q54793803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890773; Actn4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC109
AC   CVCL_QS76
SY   YTC109
DR   MMRRC; MMRRC:017200-UCD
DR   Wikidata; Q54793804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC112
AC   CVCL_QS77
SY   YTC112
DR   MMRRC; MMRRC:017071-UCD
DR   Wikidata; Q54793806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919449; Mms19.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC113
AC   CVCL_QS78
SY   YTC113
DR   MMRRC; MMRRC:017201-UCD
DR   Wikidata; Q54793809
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930089; Mcm3ap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC116
AC   CVCL_QS79
SY   YTC116
DR   MMRRC; MMRRC:017087-UCD
DR   Wikidata; Q54793810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894293; Smad4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC117
AC   CVCL_QS80
SY   YTC117
DR   MMRRC; MMRRC:017088-UCD
DR   Wikidata; Q54793813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919686; Tbcd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC118
AC   CVCL_QS81
SY   YTC118
DR   MMRRC; MMRRC:017171-UCD
DR   Wikidata; Q54793814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104819; Hnrnpa2b1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC119
AC   CVCL_QS82
SY   YTC119
DR   MMRRC; MMRRC:017133-UCD
DR   Wikidata; Q54793815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101816; Msh2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC121
AC   CVCL_QS83
SY   YTC121
DR   MMRRC; MMRRC:017134-UCD
DR   Wikidata; Q54793819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913948; Cpsf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC125
AC   CVCL_QS84
SY   YTC125
DR   MMRRC; MMRRC:017091-UCD
DR   Wikidata; Q54793822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926159; Mdn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC126
AC   CVCL_QS85
SY   YTC126
DR   MMRRC; MMRRC:017172-UCD
DR   Wikidata; Q54793824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138080; Utp25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC130
AC   CVCL_QS86
SY   YTC130
DR   MMRRC; MMRRC:017173-UCD
DR   Wikidata; Q54793826
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443699; Fubp3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC131
AC   CVCL_QS87
SY   YTC131
DR   MMRRC; MMRRC:017135-UCD
DR   Wikidata; Q54793827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146808; Safb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC132
AC   CVCL_QS88
SY   YTC132
DR   MMRRC; MMRRC:017092-UCD
DR   Wikidata; Q54793828
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917274; Mcm10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC134
AC   CVCL_QS89
SY   YTC134
DR   MMRRC; MMRRC:017072-UCD
DR   Wikidata; Q54793830
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096875; Wdfy3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC137
AC   CVCL_QS90
SY   YTC137
DR   MMRRC; MMRRC:017174-UCD
DR   Wikidata; Q54793831
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914473; Rrp15.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC138
AC   CVCL_QS91
SY   YTC138
DR   MMRRC; MMRRC:017152-UCD
DR   Wikidata; Q54793834
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918367; Rbbp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC141
AC   CVCL_QS92
SY   YTC141
DR   MMRRC; MMRRC:017153-UCD
DR   Wikidata; Q54793836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927344; Gmnn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC142
AC   CVCL_QS93
SY   YTC142
DR   MMRRC; MMRRC:017120-UCD
DR   Wikidata; Q54793837
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97887; Rdx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC143
AC   CVCL_QS94
SY   YTC143
DR   MMRRC; MMRRC:017136-UCD
DR   Wikidata; Q54793839
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913355; Ube2d3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC144
AC   CVCL_QS95
SY   YTC144
DR   MMRRC; MMRRC:017106-UCD
DR   Wikidata; Q54793843
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924621; Sec24a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC145
AC   CVCL_QS96
SY   YTC145
DR   MMRRC; MMRRC:017203-UCD
DR   Wikidata; Q54793845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442040; G3bp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC146
AC   CVCL_QS97
SY   YTC146
DR   MMRRC; MMRRC:017154-UCD
DR   Wikidata; Q54793847
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3644000; Gm9008.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC147
AC   CVCL_QS98
SY   YTC147
DR   MMRRC; MMRRC:017137-UCD
DR   Wikidata; Q54793848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC150
AC   CVCL_QS99
SY   YTC150
DR   MMRRC; MMRRC:017204-UCD
DR   Wikidata; Q54793850
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921605; Smchd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC151
AC   CVCL_QT00
SY   YTC151
DR   MMRRC; MMRRC:017093-UCD
DR   Wikidata; Q54793852
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915814; Nufip2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC152
AC   CVCL_QT01
SY   YTC152
DR   MMRRC; MMRRC:017107-UCD
DR   Wikidata; Q54793854
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101876; Tead1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC153
AC   CVCL_QT02
SY   YTC153
DR   MMRRC; MMRRC:017176-UCD
DR   Wikidata; Q54793909
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1931749; Pum1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC154
AC   CVCL_QT03
SY   YTC154
DR   MMRRC; MMRRC:017205-UCD
DR   Wikidata; Q54793913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443480; Setx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC155
AC   CVCL_QT04
SY   YTC155
DR   MMRRC; MMRRC:017155-UCD
DR   Wikidata; Q54793914
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107889; Exosc5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC158
AC   CVCL_QT05
SY   YTC158
DR   MMRRC; MMRRC:017206-UCD
DR   Wikidata; Q54793918
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC161
AC   CVCL_QT06
SY   YTC161
DR   MMRRC; MMRRC:017073-UCD
DR   Wikidata; Q54793919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890165; Larp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC162
AC   CVCL_QT07
SY   YTC162
DR   MMRRC; MMRRC:017156-UCD
DR   Wikidata; Q54793920
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98790; Top2a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC163
AC   CVCL_QT08
SY   YTC163
DR   MMRRC; MMRRC:017074-UCD
DR   Wikidata; Q54793921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339951; Cse1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC165
AC   CVCL_QT09
SY   YTC165
DR   MMRRC; MMRRC:017138-UCD
DR   Wikidata; Q54793924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96013; Hat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC166
AC   CVCL_QT10
SY   YTC166
DR   MMRRC; MMRRC:017207-UCD
DR   Wikidata; Q54793926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921570; Wdr33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC167
AC   CVCL_QT11
SY   YTC167
DR   MMRRC; MMRRC:017177-UCD
DR   Wikidata; Q54793928
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890948; Supt16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC169
AC   CVCL_QT12
SY   YTC169
DR   MMRRC; MMRRC:029213-UCD
DR   Wikidata; Q54793930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916366; Ubr4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC173
AC   CVCL_QT13
SY   YTC173
DR   MMRRC; MMRRC:029208-UCD
DR   Wikidata; Q54793932
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108074; Sptlc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC176
AC   CVCL_QT14
SY   YTC176
DR   MMRRC; MMRRC:029198-UCD
DR   Wikidata; Q54793934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2177308; Znrf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC179
AC   CVCL_QT15
SY   YTC179
DR   MMRRC; MMRRC:029214-UCD
DR   Wikidata; Q54793938
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2653690; Agap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC180
AC   CVCL_QT16
SY   YTC180
DR   MMRRC; MMRRC:029204-UCD
DR   Wikidata; Q54793940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC182
AC   CVCL_QT17
SY   YTC182
DR   MMRRC; MMRRC:029209-UCD
DR   Wikidata; Q54793941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919936; Usp24.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC186
AC   CVCL_QT18
SY   YTC186
DR   MMRRC; MMRRC:029199-UCD
DR   Wikidata; Q54793943
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915161; Zfp169.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC189
AC   CVCL_QT19
SY   YTC189
DR   MMRRC; MMRRC:029192-UCD
DR   Wikidata; Q54793944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915438; Sympk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC190
AC   CVCL_QT20
SY   YTC190
DR   MMRRC; MMRRC:029210-UCD
DR   Wikidata; Q54793946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921605; Smchd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC191
AC   CVCL_QT21
SY   YTC191
DR   MMRRC; MMRRC:029217-UCD
DR   Wikidata; Q54793947
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC192
AC   CVCL_QT22
SY   YTC192
DR   MMRRC; MMRRC:029218-UCD
DR   Wikidata; Q54793948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107892; Fam3c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC193
AC   CVCL_QT23
SY   YTC193
DR   MMRRC; MMRRC:029215-UCD
DR   Wikidata; Q54793952
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108088; Gab1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC197
AC   CVCL_QT24
SY   YTC197
DR   MMRRC; MMRRC:029188-UCD
DR   Wikidata; Q54793953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920336; Rps6ka5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC198
AC   CVCL_QT25
SY   YTC198
DR   MMRRC; MMRRC:029194-UCD
DR   Wikidata; Q54793956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915751; Nsmce2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC199
AC   CVCL_QT26
SY   YTC199
DR   MMRRC; MMRRC:029195-UCD
DR   Wikidata; Q54793959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353448; Eif2ak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC201
AC   CVCL_QT27
SY   YTC201
DR   MMRRC; MMRRC:029219-UCD
DR   Wikidata; Q54793961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99690; Pola2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC203
AC   CVCL_QT28
SY   YTC203
DR   MMRRC; MMRRC:029189-UCD
DR   Wikidata; Q54793964
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336175; Kcnk5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC204
AC   CVCL_QT29
SY   YTC204
DR   MMRRC; MMRRC:029196-UCD
DR   Wikidata; Q54793966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3042141; Traf7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC205
AC   CVCL_QT30
SY   YTC205
DR   MMRRC; MMRRC:029200-UCD
DR   Wikidata; Q54793968
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97577; Phka2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC206
AC   CVCL_QT31
SY   YTC206
DR   MMRRC; MMRRC:029205-UCD
DR   Wikidata; Q54793971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913809; Metap1d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC207
AC   CVCL_QT32
SY   YTC207
DR   MMRRC; MMRRC:029220-UCD
DR   Wikidata; Q54793974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333856; Klf9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC209
AC   CVCL_QT33
SY   YTC209
DR   MMRRC; MMRRC:029197-UCD
DR   Wikidata; Q54793975
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2385096; Pprc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC210
AC   CVCL_QT34
SY   YTC210
DR   MMRRC; MMRRC:029201-UCD
DR   Wikidata; Q54793978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104708; Cct3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC212
AC   CVCL_QT35
SY   YTC212
DR   MMRRC; MMRRC:029211-UCD
DR   Wikidata; Q54793979
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096342; Rhoa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC217
AC   CVCL_QT36
SY   YTC217
DR   MMRRC; MMRRC:029206-UCD
DR   Wikidata; Q54793981
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923038; Smurf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC218
AC   CVCL_QT37
SY   YTC218
DR   MMRRC; MMRRC:029221-UCD
DR   Wikidata; Q54793982
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923038; Smurf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC222
AC   CVCL_QT38
SY   YTC222
DR   MMRRC; MMRRC:029190-UCD
DR   Wikidata; Q54793983
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98927; Vcl.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC226
AC   CVCL_QT39
SY   YTC226
DR   MMRRC; MMRRC:029191-UCD
DR   Wikidata; Q54793987
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143977; Mbtd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC227
AC   CVCL_QT40
SY   YTC227
DR   MMRRC; MMRRC:029207-UCD
DR   Wikidata; Q54793988
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1930768; Arid3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC230
AC   CVCL_QT41
SY   YTC230
DR   MMRRC; MMRRC:029288-UCD
DR   Wikidata; Q54793991
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929706; Ranbp17.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC231
AC   CVCL_QT42
SY   YTC231
DR   MMRRC; MMRRC:029289-UCD
DR   Wikidata; Q54794040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353499; Baz1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC232
AC   CVCL_QT43
SY   YTC232
DR   MMRRC; MMRRC:029273-UCD
DR   Wikidata; Q54794042
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916996; Znhit6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC233
AC   CVCL_QT44
SY   YTC233
DR   MMRRC; MMRRC:029298-UCD
DR   Wikidata; Q54794044
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384818; Mtss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC235
AC   CVCL_QT45
SY   YTC235
DR   MMRRC; MMRRC:029299-UCD
DR   Wikidata; Q54794045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196274; Cdca8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC236
AC   CVCL_QT46
SY   YTC236
DR   MMRRC; MMRRC:029262-UCD
DR   Wikidata; Q54794047
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276116; Ep300.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC238
AC   CVCL_QT47
SY   YTC238
DR   MMRRC; MMRRC:029274-UCD
DR   Wikidata; Q54794048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914729; Tmem183a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC240
AC   CVCL_QT48
SY   YTC240
DR   MMRRC; MMRRC:029246-UCD
DR   Wikidata; Q54794049
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201408; Srpk2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC242
AC   CVCL_QT49
SY   YTC242
DR   MMRRC; MMRRC:029275-UCD
DR   Wikidata; Q54794053
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921134; Zdbf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC243
AC   CVCL_QT50
SY   YTC243
DR   MMRRC; MMRRC:029276-UCD
DR   Wikidata; Q54794054
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922858; Chmp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC245
AC   CVCL_QT51
SY   YTC245
DR   MMRRC; MMRRC:029263-UCD
DR   Wikidata; Q54794057
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444748; Chd7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC246
AC   CVCL_QT52
SY   YTC246
DR   MMRRC; MMRRC:029277-UCD
DR   Wikidata; Q54794058
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105037; Ddx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC247
AC   CVCL_QT53
SY   YTC247
DR   MMRRC; MMRRC:029311-UCD
DR   Wikidata; Q54794059
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196274; Cdca8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC248
AC   CVCL_QT54
SY   YTC248
DR   MMRRC; MMRRC:029300-UCD
DR   Wikidata; Q54794061
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916176; Ubap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC249
AC   CVCL_QT55
SY   YTC249
DR   MMRRC; MMRRC:029278-UCD
DR   Wikidata; Q54794063
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917274; Mcm10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC250
AC   CVCL_QT56
SY   YTC250
DR   MMRRC; MMRRC:029264-UCD
DR   Wikidata; Q54794064
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107929; Pip5k1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC251
AC   CVCL_QT57
SY   YTC251
DR   MMRRC; MMRRC:029301-UCD
DR   Wikidata; Q54794066
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138986; Qser1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC256
AC   CVCL_QT58
SY   YTC256
DR   MMRRC; MMRRC:029238-UCD
DR   Wikidata; Q54794068
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915434; Denr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC257
AC   CVCL_QT59
SY   YTC257
DR   MMRRC; MMRRC:029291-UCD
DR   Wikidata; Q54794070
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1890218; Akap10.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC259
AC   CVCL_QT60
SY   YTC259
DR   MMRRC; MMRRC:029279-UCD
DR   Wikidata; Q54794072
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916380; Vps13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC260
AC   CVCL_QT61
SY   YTC260
DR   MMRRC; MMRRC:029292-UCD
DR   Wikidata; Q54794073
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99690; Pola2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC262
AC   CVCL_QT62
SY   YTC262
DR   MMRRC; MMRRC:029302-UCD
DR   Wikidata; Q54794076
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3644000; Gm9008.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC263
AC   CVCL_QT63
SY   YTC263
DR   MMRRC; MMRRC:029280-UCD
DR   Wikidata; Q54794078
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3644000; Gm9008.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC264
AC   CVCL_QT64
SY   YTC264
DR   MMRRC; MMRRC:029281-UCD
DR   Wikidata; Q54794079
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913747; Cmss1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC266
AC   CVCL_QT65
SY   YTC266
DR   MMRRC; MMRRC:029282-UCD
DR   Wikidata; Q54794081
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926967; Hsd17b12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC267
AC   CVCL_QT66
SY   YTC267
DR   MMRRC; MMRRC:029283-UCD
DR   Wikidata; Q54794082
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929059; Rybp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC268
AC   CVCL_QT67
SY   YTC268
DR   MMRRC; MMRRC:029256-UCD
DR   Wikidata; Q54794084
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333803; Top3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC269
AC   CVCL_QT68
SY   YTC269
DR   MMRRC; MMRRC:029247-UCD
DR   Wikidata; Q54794086
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917580; Bclaf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC270
AC   CVCL_QT69
SY   YTC270
DR   MMRRC; MMRRC:029314-UCD
DR   Wikidata; Q54794087
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858500; Diaph2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC271
AC   CVCL_QT70
SY   YTC271
DR   MMRRC; MMRRC:029284-UCD
DR   Wikidata; Q54794089
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919064; Mrps27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC273
AC   CVCL_QT71
SY   YTC273
DR   MMRRC; MMRRC:029248-UCD
DR   Wikidata; Q54794090
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444798; Atad2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC276
AC   CVCL_QT72
SY   YTC276
DR   MMRRC; MMRRC:029239-UCD
DR   Wikidata; Q54794092
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918843; Llgl2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC277
AC   CVCL_QT73
SY   YTC277
DR   MMRRC; MMRRC:029315-UCD
DR   Wikidata; Q54794095
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC278
AC   CVCL_QT74
SY   YTC278
DR   MMRRC; MMRRC:029240-UCD
DR   Wikidata; Q54794097
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC280
AC   CVCL_QT75
SY   YTC280
DR   MMRRC; MMRRC:029316-UCD
DR   Wikidata; Q54794100
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104580; Rapgef1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC281
AC   CVCL_QT76
SY   YTC281
DR   MMRRC; MMRRC:029293-UCD
DR   Wikidata; Q54794102
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104872; Ppp1cc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC282
AC   CVCL_QT77
SY   YTC282
DR   MMRRC; MMRRC:029317-UCD
DR   Wikidata; Q54794104
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444098; Heatr5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC284
AC   CVCL_QT78
SY   YTC284
DR   MMRRC; MMRRC:029318-UCD
DR   Wikidata; Q54794106
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98388; Sptbn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC289
AC   CVCL_QT79
SY   YTC289
DR   MMRRC; MMRRC:029249-UCD
DR   Wikidata; Q54794107
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1309481; Trip12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC290
AC   CVCL_QT80
SY   YTC290
DR   MMRRC; MMRRC:029294-UCD
DR   Wikidata; Q54794110
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916023; Zc3hc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC293
AC   CVCL_QT81
SY   YTC293
DR   MMRRC; MMRRC:029303-UCD
DR   Wikidata; Q54794111
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96522; Rbpj.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC295
AC   CVCL_QT82
SY   YTC295
DR   MMRRC; MMRRC:029304-UCD
DR   Wikidata; Q54794152
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924053; Zfp998.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC298
AC   CVCL_QT83
SY   YTC298
DR   MMRRC; MMRRC:029319-UCD
DR   Wikidata; Q54794155
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098641; Wasf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC299
AC   CVCL_QT84
SY   YTC299
DR   MMRRC; MMRRC:029266-UCD
DR   Wikidata; Q54794156
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914356; Zbtb8os.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC301
AC   CVCL_QT85
SY   YTC301
DR   MMRRC; MMRRC:029320-UCD
DR   Wikidata; Q54794158
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916023; Zc3hc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC302
AC   CVCL_QT86
SY   YTC302
DR   MMRRC; MMRRC:029250-UCD
DR   Wikidata; Q54794160
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916023; Zc3hc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC306
AC   CVCL_QT87
SY   YTC306
DR   MMRRC; MMRRC:029257-UCD
DR   Wikidata; Q54794163
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103147; Dync1h1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC307
AC   CVCL_QT88
SY   YTC307
DR   MMRRC; MMRRC:029285-UCD
DR   Wikidata; Q54794165
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928744; Vapb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC309
AC   CVCL_QT89
SY   YTC309
DR   MMRRC; MMRRC:029305-UCD
DR   Wikidata; Q54794166
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384495; Mrtfa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC310
AC   CVCL_QT90
SY   YTC310
DR   MMRRC; MMRRC:029306-UCD
DR   Wikidata; Q54794168
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917171; Hnrnpa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC317
AC   CVCL_QT91
SY   YTC317
DR   MMRRC; MMRRC:029251-UCD
DR   Wikidata; Q54794173
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916139; Ubac2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC318
AC   CVCL_QT92
SY   YTC318
DR   MMRRC; MMRRC:029252-UCD
DR   Wikidata; Q54794174
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105369; Cbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC319
AC   CVCL_QT93
SY   YTC319
DR   MMRRC; MMRRC:029243-UCD
DR   Wikidata; Q54794177
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444248; Gcn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC321
AC   CVCL_QT94
SY   YTC321
DR   MMRRC; MMRRC:029253-UCD
DR   Wikidata; Q54794178
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922896; Rai14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC322
AC   CVCL_QT95
SY   YTC322
DR   MMRRC; MMRRC:029286-UCD
DR   Wikidata; Q54794181
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103067; Atrx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC324
AC   CVCL_QT96
SY   YTC324
DR   MMRRC; MMRRC:029307-UCD
DR   Wikidata; Q54794183
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925705; Helz.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC328
AC   CVCL_QT97
SY   YTC328
DR   MMRRC; MMRRC:029321-UCD
DR   Wikidata; Q54794185
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922858; Chmp4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC331
AC   CVCL_QT98
SY   YTC331
DR   MMRRC; MMRRC:029269-UCD
DR   Wikidata; Q54794188
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915396; Arl13b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC333
AC   CVCL_QT99
SY   YTC333
DR   MMRRC; MMRRC:029322-UCD
DR   Wikidata; Q54794189
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1343463; Bub3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC335
AC   CVCL_QU00
SY   YTC335
DR   MMRRC; MMRRC:029259-UCD
DR   Wikidata; Q54794192
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921991; C2cd5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC336
AC   CVCL_QU01
SY   YTC336
DR   MMRRC; MMRRC:029323-UCD
DR   Wikidata; Q54794194
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2681836; Polr3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC337
AC   CVCL_QU02
SY   YTC337
DR   MMRRC; MMRRC:029324-UCD
DR   Wikidata; Q54794196
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929871; Terf2ip.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC339
AC   CVCL_QU03
SY   YTC339
DR   MMRRC; MMRRC:029244-UCD
DR   Wikidata; Q54794198
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336196; Tsix.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC340
AC   CVCL_QU04
SY   YTC340
DR   MMRRC; MMRRC:029270-UCD
DR   Wikidata; Q54794200
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC343
AC   CVCL_QU05
SY   YTC343
DR   MMRRC; MMRRC:029296-UCD
DR   Wikidata; Q54794202
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333799; Xrcc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC344
AC   CVCL_QU06
SY   YTC344
DR   MMRRC; MMRRC:029245-UCD
DR   Wikidata; Q54794204
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1928898; Usp14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC345
AC   CVCL_QU07
SY   YTC345
DR   MMRRC; MMRRC:029271-UCD
DR   Wikidata; Q54794207
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342294; Uri1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC347
AC   CVCL_QU08
SY   YTC347
DR   MMRRC; MMRRC:029287-UCD
DR   Wikidata; Q54794208
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146156; Espl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC348
AC   CVCL_QU09
SY   YTC348
DR   MMRRC; MMRRC:029308-UCD
DR   Wikidata; Q54794210
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915092; Nop9.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC349
AC   CVCL_QU10
SY   YTC349
DR   MMRRC; MMRRC:029254-UCD
DR   Wikidata; Q54794211
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917485; Poc1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC350
AC   CVCL_QU11
SY   YTC350
DR   MMRRC; MMRRC:029325-UCD
DR   Wikidata; Q54794213
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109130; Stip1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC352
AC   CVCL_QU12
SY   YTC352
DR   MMRRC; MMRRC:029255-UCD
DR   Wikidata; Q54794214
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346832; Esrrb.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC356
AC   CVCL_QU13
SY   YTC356
DR   MMRRC; MMRRC:029297-UCD
DR   Wikidata; Q54794215
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC357
AC   CVCL_QU14
SY   YTC357
DR   MMRRC; MMRRC:029272-UCD
DR   Wikidata; Q54794216
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107750; Dync1i2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC360
AC   CVCL_QU15
SY   YTC360
DR   MMRRC; MMRRC:029260-UCD
DR   Wikidata; Q54794218
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109606; Fnbp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC362
AC   CVCL_QU16
SY   YTC362
DR   MMRRC; MMRRC:029352-UCD
DR   Wikidata; Q54794219
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3714357; Srp54b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC363
AC   CVCL_QU17
SY   YTC363
DR   MMRRC; MMRRC:029418-UCD
DR   Wikidata; Q54794221
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444022; Mapk1ip1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC364
AC   CVCL_QU18
SY   YTC364
DR   MMRRC; MMRRC:029353-UCD
DR   Wikidata; Q54794222
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1347343; Usp5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC365
AC   CVCL_QU19
SY   YTC365
DR   MMRRC; MMRRC:029449-UCD
DR   Wikidata; Q54794223
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915035; Zmym4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC366
AC   CVCL_QU20
SY   YTC366
DR   MMRRC; MMRRC:029419-UCD
DR   Wikidata; Q54794224
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036237; Rsbn1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC367
AC   CVCL_QU21
SY   YTC367
DR   MMRRC; MMRRC:029420-UCD
DR   Wikidata; Q54794226
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109605; Srgap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC368
AC   CVCL_QU22
SY   YTC368
DR   MMRRC; MMRRC:029450-UCD
DR   Wikidata; Q54794317
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2157953; Rbm39.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC371
AC   CVCL_QU23
SY   YTC371
DR   MMRRC; MMRRC:029354-UCD
DR   Wikidata; Q54794319
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894684; Pa2g4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC374
AC   CVCL_QU24
SY   YTC374
DR   MMRRC; MMRRC:029452-UCD
DR   Wikidata; Q54794321
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333803; Top3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC376
AC   CVCL_QU25
SY   YTC376
DR   MMRRC; MMRRC:029332-UCD
DR   Wikidata; Q54794323
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC377
AC   CVCL_QU26
SY   YTC377
DR   MMRRC; MMRRC:029453-UCD
DR   Wikidata; Q54794326
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442572; Stk38.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC379
AC   CVCL_QU27
SY   YTC379
DR   MMRRC; MMRRC:029333-UCD
DR   Wikidata; Q54794327
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342307; Drg2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC380
AC   CVCL_QU28
SY   YTC380
DR   MMRRC; MMRRC:029454-UCD
DR   Wikidata; Q54794329
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109382; Noct.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC383
AC   CVCL_QU29
SY   YTC383
DR   MMRRC; MMRRC:029334-UCD
DR   Wikidata; Q54794330
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1349473; Ppp2r5e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC384
AC   CVCL_QU30
SY   YTC384
DR   MMRRC; MMRRC:029455-UCD
DR   Wikidata; Q54794333
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925152; Prune1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC385
AC   CVCL_QU31
SY   YTC385
DR   MMRRC; MMRRC:029355-UCD
DR   Wikidata; Q54794335
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143755; AU041133.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC386
AC   CVCL_QU32
SY   YTC386
DR   MMRRC; MMRRC:029335-UCD
DR   Wikidata; Q54794336
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109211; Pkn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC389
AC   CVCL_QU33
SY   YTC389
DR   MMRRC; MMRRC:029356-UCD
DR   Wikidata; Q54794339
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922542; Prkd3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC390
AC   CVCL_QU34
SY   YTC390
DR   MMRRC; MMRRC:029435-UCD
DR   Wikidata; Q54794340
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147679; Patl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC391
AC   CVCL_QU35
SY   YTC391
DR   MMRRC; MMRRC:029436-UCD
DR   Wikidata; Q54794342
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2147679; Patl1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC392
AC   CVCL_QU36
SY   YTC392
DR   MMRRC; MMRRC:029456-UCD
DR   Wikidata; Q54794344
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384583; Zfp280d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC393
AC   CVCL_QU37
SY   YTC393
DR   MMRRC; MMRRC:029457-UCD
DR   Wikidata; Q54794347
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1934811; Nucks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC394
AC   CVCL_QU38
SY   YTC394
DR   MMRRC; MMRRC:029357-UCD
DR   Wikidata; Q54794349
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144013; Xpo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC395
AC   CVCL_QU39
SY   YTC395
DR   MMRRC; MMRRC:029391-UCD
DR   Wikidata; Q54794351
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144113; Tmem199.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC396
AC   CVCL_QU40
SY   YTC396
DR   MMRRC; MMRRC:029358-UCD
DR   Wikidata; Q54794353
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889206; Skap2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC397
AC   CVCL_QU41
SY   YTC397
DR   MMRRC; MMRRC:029367-UCD
DR   Wikidata; Q54794355
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1859252; Fmn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC400
AC   CVCL_QU42
SY   YTC400
DR   MMRRC; MMRRC:029369-UCD
DR   Wikidata; Q54794357
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918779; Kazn.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC401
AC   CVCL_QU43
SY   YTC401
DR   MMRRC; MMRRC:029392-UCD
DR   Wikidata; Q54794358
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC402
AC   CVCL_QU44
SY   YTC402
DR   MMRRC; MMRRC:029370-UCD
DR   Wikidata; Q54794360
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2158502; Usp48.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC403
AC   CVCL_QU45
SY   YTC403
DR   MMRRC; MMRRC:029458-UCD
DR   Wikidata; Q54794362
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101919; Ap1g1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC404
AC   CVCL_QU46
SY   YTC404
DR   MMRRC; MMRRC:029336-UCD
DR   Wikidata; Q54794366
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036237; Rsbn1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC405
AC   CVCL_QU47
SY   YTC405
DR   MMRRC; MMRRC:029371-UCD
DR   Wikidata; Q54794368
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:87948; Adss.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC406
AC   CVCL_QU48
SY   YTC406
DR   MMRRC; MMRRC:029359-UCD
DR   Wikidata; Q54794369
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923356; Kdm3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC407
AC   CVCL_QU49
SY   YTC407
DR   MMRRC; MMRRC:029372-UCD
DR   Wikidata; Q54794372
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99431; Arf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC409
AC   CVCL_QU50
SY   YTC409
DR   MMRRC; MMRRC:029337-UCD
DR   Wikidata; Q54794373
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277223; Atxn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC410
AC   CVCL_QU51
SY   YTC410
DR   MMRRC; MMRRC:029373-UCD
DR   Wikidata; Q54794374
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102685; Cdc27.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC411
AC   CVCL_QU52
SY   YTC411
DR   MMRRC; MMRRC:029459-UCD
DR   Wikidata; Q54794376
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145977; Dip2b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC412
AC   CVCL_QU53
SY   YTC412
DR   MMRRC; MMRRC:029338-UCD
DR   Wikidata; Q54794378
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1855699; Vti1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC413
AC   CVCL_QU54
SY   YTC413
DR   MMRRC; MMRRC:029421-UCD
DR   Wikidata; Q54794380
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914824; Alg13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC415
AC   CVCL_QU55
SY   YTC415
DR   MMRRC; MMRRC:029339-UCD
DR   Wikidata; Q54794381
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036237; Rsbn1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC417
AC   CVCL_QU56
SY   YTC417
DR   MMRRC; MMRRC:029361-UCD
DR   Wikidata; Q54794385
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346341; Rnf13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC418
AC   CVCL_QU57
SY   YTC418
DR   MMRRC; MMRRC:029437-UCD
DR   Wikidata; Q54794386
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1197010; Sumo1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC421
AC   CVCL_QU58
SY   YTC421
DR   MMRRC; MMRRC:029374-UCD
DR   Wikidata; Q54794389
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442456; Unk.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC423
AC   CVCL_QU59
SY   YTC423
DR   MMRRC; MMRRC:029375-UCD
DR   Wikidata; Q54794390
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103234; Herc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC424
AC   CVCL_QU60
SY   YTC424
DR   MMRRC; MMRRC:029438-UCD
DR   Wikidata; Q54794392
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95301; Eif3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC425
AC   CVCL_QU61
SY   YTC425
DR   MMRRC; MMRRC:029460-UCD
DR   Wikidata; Q54794395
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914186; Asph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC427
AC   CVCL_QU62
SY   YTC427
DR   MMRRC; MMRRC:029376-UCD
DR   Wikidata; Q54794490
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC430
AC   CVCL_QU63
SY   YTC430
DR   MMRRC; MMRRC:029406-UCD
DR   Wikidata; Q54794492
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913435; Virma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC431
AC   CVCL_QU64
SY   YTC431
DR   MMRRC; MMRRC:029377-UCD
DR   Wikidata; Q54794493
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443336; Gk5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC434
AC   CVCL_QU65
SY   YTC434
DR   MMRRC; MMRRC:029407-UCD
DR   Wikidata; Q54794495
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1261847; Vrk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC436
AC   CVCL_QU66
SY   YTC436
DR   MMRRC; MMRRC:029394-UCD
DR   Wikidata; Q54794497
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107690; Zfp462.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC437
AC   CVCL_QU67
SY   YTC437
DR   MMRRC; MMRRC:029340-UCD
DR   Wikidata; Q54794498
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105037; Ddx5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC440
AC   CVCL_QU68
SY   YTC440
DR   MMRRC; MMRRC:029422-UCD
DR   Wikidata; Q54794502
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141625; Nup205.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC441
AC   CVCL_QU69
SY   YTC441
DR   MMRRC; MMRRC:029439-UCD
DR   Wikidata; Q54794504
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC442
AC   CVCL_QU70
SY   YTC442
DR   MMRRC; MMRRC:029423-UCD
DR   Wikidata; Q54794506
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929472; Uqcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC444
AC   CVCL_QU71
SY   YTC444
DR   MMRRC; MMRRC:029409-UCD
DR   Wikidata; Q54794508
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95393; Eno1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC445
AC   CVCL_QU72
SY   YTC445
DR   MMRRC; MMRRC:029395-UCD
DR   Wikidata; Q54794511
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338041; Tfg.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC446
AC   CVCL_QU73
SY   YTC446
DR   MMRRC; MMRRC:029424-UCD
DR   Wikidata; Q54794514
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1330294; Hnrnpab.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC447
AC   CVCL_QU74
SY   YTC447
DR   MMRRC; MMRRC:029396-UCD
DR   Wikidata; Q54794517
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142572; Mtus1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC449
AC   CVCL_QU75
SY   YTC449
DR   MMRRC; MMRRC:029379-UCD
DR   Wikidata; Q54794519
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920460; Nup54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC450
AC   CVCL_QU76
SY   YTC450
DR   MMRRC; MMRRC:029341-UCD
DR   Wikidata; Q54794520
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927197; Shoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC453
AC   CVCL_QU77
SY   YTC453
DR   MMRRC; MMRRC:029380-UCD
DR   Wikidata; Q54794521
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2676556; Akap13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC454
AC   CVCL_QU78
SY   YTC454
DR   MMRRC; MMRRC:029363-UCD
DR   Wikidata; Q54794525
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2446180; Anks1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC455
AC   CVCL_QU79
SY   YTC455
DR   MMRRC; MMRRC:029425-UCD
DR   Wikidata; Q54794527
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858907; Blcap.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC457
AC   CVCL_QU80
SY   YTC457
DR   MMRRC; MMRRC:029971-UCD
DR   Wikidata; Q54794532
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929092; Rbm14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC461
AC   CVCL_QU81
SY   YTC461
DR   MMRRC; MMRRC:029461-UCD
DR   Wikidata; Q54794533
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1203524; Smarcc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC463
AC   CVCL_QU82
SY   YTC463
DR   MMRRC; MMRRC:029440-UCD
DR   Wikidata; Q54794535
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98447; Surf6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC466
AC   CVCL_QU83
SY   YTC466
DR   MMRRC; MMRRC:029462-UCD
DR   Wikidata; Q54794538
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106340; Rcor1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC467
AC   CVCL_QU84
SY   YTC467
DR   MMRRC; MMRRC:029381-UCD
DR   Wikidata; Q54794539
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202402; Pde7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC468
AC   CVCL_QU85
SY   YTC468
DR   MMRRC; MMRRC:029364-UCD
DR   Wikidata; Q54794543
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202402; Pde7a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC470
AC   CVCL_QU86
SY   YTC470
DR   MMRRC; MMRRC:029441-UCD
DR   Wikidata; Q54794545
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448567; Chd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC471
AC   CVCL_QU87
SY   YTC471
DR   MMRRC; MMRRC:029427-UCD
DR   Wikidata; Q54794546
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142572; Mtus1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC472
AC   CVCL_QU88
SY   YTC472
DR   MMRRC; MMRRC:029463-UCD
DR   Wikidata; Q54794548
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1860513; Fnbp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC473
AC   CVCL_QU89
SY   YTC473
DR   MMRRC; MMRRC:029972-UCD
DR   Wikidata; Q54794550
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443207; Plekhm1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC476
AC   CVCL_QU90
SY   YTC476
DR   MMRRC; MMRRC:029464-UCD
DR   Wikidata; Q54794551
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344381; Dnajb6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC478
AC   CVCL_QU91
SY   YTC478
DR   MMRRC; MMRRC:029410-UCD
DR   Wikidata; Q54794552
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933162; Lrba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC479
AC   CVCL_QU92
SY   YTC479
DR   MMRRC; MMRRC:029382-UCD
DR   Wikidata; Q54794553
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891829; Rbx1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC481
AC   CVCL_QU93
SY   YTC481
DR   MMRRC; MMRRC:029968-UCD
DR   Wikidata; Q54794555
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270863; Prep.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC482
AC   CVCL_QU94
SY   YTC482
DR   MMRRC; MMRRC:029411-UCD
DR   Wikidata; Q54794556
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99919; Vcp.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC483
AC   CVCL_QU95
SY   YTC483
DR   MMRRC; MMRRC:029442-UCD
DR   Wikidata; Q54794558
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914130; Rsrc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC485
AC   CVCL_QU96
SY   YTC485
DR   MMRRC; MMRRC:029342-UCD
DR   Wikidata; Q54794560
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922066; Tpr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC486
AC   CVCL_QU97
SY   YTC486
DR   MMRRC; MMRRC:029443-UCD
DR   Wikidata; Q54794562
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915364; Pwwp3a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC487
AC   CVCL_QU98
SY   YTC487
DR   MMRRC; MMRRC:029343-UCD
DR   Wikidata; Q54794564
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106621; Myo1e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC488
AC   CVCL_QU99
SY   YTC488
DR   MMRRC; MMRRC:029344-UCD
DR   Wikidata; Q54794566
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919257; Fndc3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC489
AC   CVCL_QV00
SY   YTC489
DR   MMRRC; MMRRC:029345-UCD
DR   Wikidata; Q54794568
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915434; Denr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC490
AC   CVCL_QV01
SY   YTC490
DR   MMRRC; MMRRC:029412-UCD
DR   Wikidata; Q54794569
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141625; Nup205.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC492
AC   CVCL_QV02
SY   YTC492
DR   MMRRC; MMRRC:029365-UCD
DR   Wikidata; Q54794654
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442326; Zbtb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC494
AC   CVCL_QV03
SY   YTC494
DR   MMRRC; MMRRC:029466-UCD
DR   Wikidata; Q54794656
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99778; Gpd2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC497
AC   CVCL_QV04
SY   YTC497
DR   MMRRC; MMRRC:029397-UCD
DR   Wikidata; Q54794657
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108405; Apbb2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC499
AC   CVCL_QV05
SY   YTC499
DR   MMRRC; MMRRC:029413-UCD
DR   Wikidata; Q54794658
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914357; Ankrd12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC500
AC   CVCL_QV06
SY   YTC500
DR   MMRRC; MMRRC:029444-UCD
DR   Wikidata; Q54794660
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1339951; Cse1l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC503
AC   CVCL_QV07
SY   YTC503
DR   MMRRC; MMRRC:029414-UCD
DR   Wikidata; Q54794661
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1924992; Fbxo42.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC504
AC   CVCL_QV08
SY   YTC504
DR   MMRRC; MMRRC:029399-UCD
DR   Wikidata; Q54794664
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC505
AC   CVCL_QV09
SY   YTC505
DR   MMRRC; MMRRC:029400-UCD
DR   Wikidata; Q54794666
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338056; Klf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC506
AC   CVCL_QV10
SY   YTC506
DR   MMRRC; MMRRC:029429-UCD
DR   Wikidata; Q54794668
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2140651; C77080.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC508
AC   CVCL_QV11
SY   YTC508
DR   MMRRC; MMRRC:029384-UCD
DR   Wikidata; Q54794669
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196246; Znrf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC510
AC   CVCL_QV12
SY   YTC510
DR   MMRRC; MMRRC:029415-UCD
DR   Wikidata; Q54794670
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95753; Glud1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC511
AC   CVCL_QV13
SY   YTC511
DR   MMRRC; MMRRC:029445-UCD
DR   Wikidata; Q54794672
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95753; Glud1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC512
AC   CVCL_QV14
SY   YTC512
DR   MMRRC; MMRRC:029416-UCD
DR   Wikidata; Q54794674
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338056; Klf5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC513
AC   CVCL_QV15
SY   YTC513
DR   MMRRC; MMRRC:029417-UCD
DR   Wikidata; Q54794676
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99147; Yes1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC516
AC   CVCL_QV16
SY   YTC516
DR   MMRRC; MMRRC:029446-UCD
DR   Wikidata; Q54794678
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1342294; Uri1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC518
AC   CVCL_QV17
SY   YTC518
DR   MMRRC; MMRRC:029447-UCD
DR   Wikidata; Q54794681
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917900; Zcchc8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC520
AC   CVCL_QV18
SY   YTC520
DR   MMRRC; MMRRC:029347-UCD
DR   Wikidata; Q54794683
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC521
AC   CVCL_QV19
SY   YTC521
DR   MMRRC; MMRRC:029430-UCD
DR   Wikidata; Q54794687
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685179; Zfp407.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC524
AC   CVCL_QV20
SY   YTC524
DR   MMRRC; MMRRC:029401-UCD
DR   Wikidata; Q54794688
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098283; Per1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC526
AC   CVCL_QV21
SY   YTC526
DR   MMRRC; MMRRC:029431-UCD
DR   Wikidata; Q54794689
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919670; Rbm33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC527
AC   CVCL_QV22
SY   YTC527
DR   MMRRC; MMRRC:029402-UCD
DR   Wikidata; Q54794690
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107795; Hnrnpc.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC528
AC   CVCL_QV23
SY   YTC528
DR   MMRRC; MMRRC:029348-UCD
DR   Wikidata; Q54794693
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC531
AC   CVCL_QV24
SY   YTC531
DR   MMRRC; MMRRC:029467-UCD
DR   Wikidata; Q54794695
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202722; Gtf2i.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC532
AC   CVCL_QV25
SY   YTC532
DR   MMRRC; MMRRC:029433-UCD
DR   Wikidata; Q54794698
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918614; Jmjd1c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC534
AC   CVCL_QV26
SY   YTC534
DR   MMRRC; MMRRC:029349-UCD
DR   Wikidata; Q54794699
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107202; Atm.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC535
AC   CVCL_QV27
SY   YTC535
DR   MMRRC; MMRRC:029403-UCD
DR   Wikidata; Q54794702
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921765; Cdkal1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC536
AC   CVCL_QV28
SY   YTC536
DR   MMRRC; MMRRC:029385-UCD
DR   Wikidata; Q54794706
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1355321; Chek2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC537
AC   CVCL_QV29
SY   YTC537
DR   MMRRC; MMRRC:029404-UCD
DR   Wikidata; Q54794707
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919670; Rbm33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC538
AC   CVCL_QV30
SY   YTC538
DR   MMRRC; MMRRC:029366-UCD
DR   Wikidata; Q54794709
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919670; Rbm33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC542
AC   CVCL_QV31
SY   YTC542
DR   MMRRC; MMRRC:029532-UCD
DR   Wikidata; Q54794712
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2154441; Nop53.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC543
AC   CVCL_QV32
SY   YTC543
DR   MMRRC; MMRRC:029469-UCD
DR   Wikidata; Q54794713
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC544
AC   CVCL_QV33
SY   YTC544
DR   MMRRC; MMRRC:029510-UCD
DR   Wikidata; Q54794714
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC549
AC   CVCL_QV34
SY   YTC549
DR   MMRRC; MMRRC:029511-UCD
DR   Wikidata; Q54794716
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1201686; Ctbp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC550
AC   CVCL_QV35
SY   YTC550
DR   MMRRC; MMRRC:029524-UCD
DR   Wikidata; Q54794718
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107231; Dlg1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC551
AC   CVCL_QV36
SY   YTC551
DR   MMRRC; MMRRC:029544-UCD
DR   Wikidata; Q54794721
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351465; G3bp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC555
AC   CVCL_QV37
SY   YTC555
DR   MMRRC; MMRRC:029558-UCD
DR   Wikidata; Q54794723
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC556
AC   CVCL_QV38
SY   YTC556
DR   MMRRC; MMRRC:029545-UCD
DR   Wikidata; Q54794724
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2448542; Samd4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC557
AC   CVCL_QV39
SY   YTC557
DR   MMRRC; MMRRC:029559-UCD
DR   Wikidata; Q54794725
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1332659; Bnip3l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC559
AC   CVCL_QV40
SY   YTC559
DR   MMRRC; MMRRC:029533-UCD
DR   Wikidata; Q54794728
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913732; Exoc2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC560
AC   CVCL_QV41
SY   YTC560
DR   MMRRC; MMRRC:029534-UCD
DR   Wikidata; Q54794731
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138080; Utp25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC561
AC   CVCL_QV42
SY   YTC561
DR   MMRRC; MMRRC:029470-UCD
DR   Wikidata; Q54794771
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276535; Ncoa3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC563
AC   CVCL_QV43
SY   YTC563
DR   MMRRC; MMRRC:029535-UCD
DR   Wikidata; Q54794772
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913840; Farsa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC565
AC   CVCL_QV44
SY   YTC565
DR   MMRRC; MMRRC:029513-UCD
DR   Wikidata; Q54794774
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353448; Eif2ak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC571
AC   CVCL_QV45
SY   YTC571
DR   MMRRC; MMRRC:029569-UCD
DR   Wikidata; Q54794777
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2679923; Ttc37.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC580
AC   CVCL_QV46
SY   YTC580
DR   MMRRC; MMRRC:029536-UCD
DR   Wikidata; Q54794779
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1338822; Celf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC582
AC   CVCL_QV47
SY   YTC582
DR   MMRRC; MMRRC:029525-UCD
DR   Wikidata; Q54794782
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88549; Csrp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC584
AC   CVCL_QV48
SY   YTC584
DR   MMRRC; MMRRC:029560-UCD
DR   Wikidata; Q54794783
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104556; Cdkn1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC585
AC   CVCL_QV49
SY   YTC585
DR   MMRRC; MMRRC:029486-UCD
DR   Wikidata; Q54794786
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442372; Fam168a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC586
AC   CVCL_QV50
SY   YTC586
DR   MMRRC; MMRRC:029487-UCD
DR   Wikidata; Q54794790
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346870; Map2k6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC588
AC   CVCL_QV51
SY   YTC588
DR   MMRRC; MMRRC:029488-UCD
DR   Wikidata; Q54794791
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC592
AC   CVCL_QV52
SY   YTC592
DR   MMRRC; MMRRC:029501-UCD
DR   Wikidata; Q54794792
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC593
AC   CVCL_QV53
SY   YTC593
DR   MMRRC; MMRRC:029546-UCD
DR   Wikidata; Q54794794
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC596
AC   CVCL_QV54
SY   YTC596
DR   MMRRC; MMRRC:029537-UCD
DR   Wikidata; Q54794796
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100860; Frs2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC598
AC   CVCL_QV55
SY   YTC598
DR   MMRRC; MMRRC:029472-UCD
DR   Wikidata; Q54794798
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1353448; Eif2ak1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC599
AC   CVCL_QV56
SY   YTC599
DR   MMRRC; MMRRC:029489-UCD
DR   Wikidata; Q54794800
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384583; Zfp280d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC601
AC   CVCL_QV57
SY   YTC601
DR   MMRRC; MMRRC:029473-UCD
DR   Wikidata; Q54794802
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351663; Skp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC602
AC   CVCL_QV58
SY   YTC602
DR   MMRRC; MMRRC:029547-UCD
DR   Wikidata; Q54794803
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351663; Skp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC607
AC   CVCL_QV59
SY   YTC607
DR   MMRRC; MMRRC:029548-UCD
DR   Wikidata; Q54794804
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104627; Dst.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC608
AC   CVCL_QV60
SY   YTC608
DR   MMRRC; MMRRC:029561-UCD
DR   Wikidata; Q54794806
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384583; Zfp280d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC611
AC   CVCL_QV61
SY   YTC611
DR   MMRRC; MMRRC:029474-UCD
DR   Wikidata; Q54794810
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:94865; Dbi.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC614
AC   CVCL_QV62
SY   YTC614
DR   MMRRC; MMRRC:029475-UCD
DR   Wikidata; Q54794813
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351663; Skp2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC615
AC   CVCL_QV63
SY   YTC615
DR   MMRRC; MMRRC:029515-UCD
DR   Wikidata; Q54794814
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107380; Spag7.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC617
AC   CVCL_QV64
SY   YTC617
DR   MMRRC; MMRRC:029476-UCD
DR   Wikidata; Q54794815
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443448; Ccdc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC618
AC   CVCL_QV65
SY   YTC618
DR   MMRRC; MMRRC:029477-UCD
DR   Wikidata; Q54794817
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333870; Ate1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC622
AC   CVCL_QV66
SY   YTC622
DR   MMRRC; MMRRC:029490-UCD
DR   Wikidata; Q54794819
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1929455; Rpl23.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC623
AC   CVCL_QV67
SY   YTC623
DR   MMRRC; MMRRC:029478-UCD
DR   Wikidata; Q54794820
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442402; Cnot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC628
AC   CVCL_QV68
SY   YTC628
DR   MMRRC; MMRRC:029479-UCD
DR   Wikidata; Q54794822
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2141787; C87436.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC629
AC   CVCL_QV69
SY   YTC629
DR   MMRRC; MMRRC:029504-UCD
DR   Wikidata; Q54794824
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC630
AC   CVCL_QV70
SY   YTC630
DR   MMRRC; MMRRC:029516-UCD
DR   Wikidata; Q54794825
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC632
AC   CVCL_QV71
SY   YTC632
DR   MMRRC; MMRRC:029538-UCD
DR   Wikidata; Q54794827
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99201; Zfp54.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC637
AC   CVCL_QV72
SY   YTC637
DR   MMRRC; MMRRC:029527-UCD
DR   Wikidata; Q54794829
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2445096; Dhtkd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC638
AC   CVCL_QV73
SY   YTC638
DR   MMRRC; MMRRC:029517-UCD
DR   Wikidata; Q54794832
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104813; Jarid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC641
AC   CVCL_QV74
SY   YTC641
DR   MMRRC; MMRRC:029564-UCD
DR   Wikidata; Q54794833
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC642
AC   CVCL_QV75
SY   YTC642
DR   MMRRC; MMRRC:029539-UCD
DR   Wikidata; Q54794836
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC644
AC   CVCL_QV76
SY   YTC644
DR   MMRRC; MMRRC:029550-UCD
DR   Wikidata; Q54794838
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917378; Oxsr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC647
AC   CVCL_QV77
SY   YTC647
DR   MMRRC; MMRRC:029491-UCD
DR   Wikidata; Q54794842
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933277; Gtf2a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC648
AC   CVCL_QV78
SY   YTC648
DR   MMRRC; MMRRC:029566-UCD
DR   Wikidata; Q54794844
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:98372; Sp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC649
AC   CVCL_QV79
SY   YTC649
DR   MMRRC; MMRRC:029492-UCD
DR   Wikidata; Q54794845
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1095403; Sf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC650
AC   CVCL_QV80
SY   YTC650
DR   MMRRC; MMRRC:029493-UCD
DR   Wikidata; Q54794848
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2667663; Cep68.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC653
AC   CVCL_QV81
SY   YTC653
DR   MMRRC; MMRRC:029551-UCD
DR   Wikidata; Q54794851
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921633; Ubap2l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC654
AC   CVCL_QV82
SY   YTC654
DR   MMRRC; MMRRC:029552-UCD
DR   Wikidata; Q54794904
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1270153; Zfp106.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC662
AC   CVCL_QV83
SY   YTC662
DR   MMRRC; MMRRC:029518-UCD
DR   Wikidata; Q54794905
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108360; Enah.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC673
AC   CVCL_QV84
SY   YTC673
DR   MMRRC; MMRRC:029953-UCD
DR   Wikidata; Q54794906
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2138080; Utp25.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC674
AC   CVCL_QV85
SY   YTC674
DR   MMRRC; MMRRC:029977-UCD
DR   Wikidata; Q54794908
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107595; Sp4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC678
AC   CVCL_QV86
SY   YTC678
DR   MMRRC; MMRRC:029973-UCD
DR   Wikidata; Q54794911
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1351329; Rps11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC679
AC   CVCL_QV87
SY   YTC679
DR   MMRRC; MMRRC:029528-UCD
DR   Wikidata; Q54794913
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915095; Rnf115.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC681
AC   CVCL_QV88
SY   YTC681
DR   MMRRC; MMRRC:029482-UCD
DR   Wikidata; Q54794915
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444518; Samd12.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC683
AC   CVCL_QV89
SY   YTC683
DR   MMRRC; MMRRC:029553-UCD
DR   Wikidata; Q54794916
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914769; Dennd4c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC687
AC   CVCL_QV90
SY   YTC687
DR   MMRRC; MMRRC:029567-UCD
DR   Wikidata; Q54794919
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1925219; Trmt13.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC689
AC   CVCL_QV91
SY   YTC689
DR   MMRRC; MMRRC:029505-UCD
DR   Wikidata; Q54794921
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891217; Zfp423.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC692
AC   CVCL_QV92
SY   YTC692
DR   MMRRC; MMRRC:029529-UCD
DR   Wikidata; Q54794923
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2388481; Ppp2r5d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC694
AC   CVCL_QV93
SY   YTC694
DR   MMRRC; MMRRC:029568-UCD
DR   Wikidata; Q54794924
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:101835; Traf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC707
AC   CVCL_QV94
SY   YTC707
DR   MMRRC; MMRRC:029496-UCD
DR   Wikidata; Q54794926
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917184; Trmt10b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC719
AC   CVCL_QV95
SY   YTC719
DR   MMRRC; MMRRC:029519-UCD
DR   Wikidata; Q54794929
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917184; Trmt10b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC720
AC   CVCL_QV96
SY   YTC720
DR   MMRRC; MMRRC:029497-UCD
DR   Wikidata; Q54794930
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1891703; Gpa33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC725
AC   CVCL_QV97
SY   YTC725
DR   MMRRC; MMRRC:029554-UCD
DR   Wikidata; Q54794934
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104667; Hmmr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC727
AC   CVCL_QV98
SY   YTC727
DR   MMRRC; MMRRC:029530-UCD
DR   Wikidata; Q54794935
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918850; Ythdf3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC730
AC   CVCL_QV99
SY   YTC730
DR   MMRRC; MMRRC:029508-UCD
DR   Wikidata; Q54794937
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1932535; Glis2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC732
AC   CVCL_QW00
SY   YTC732
DR   MMRRC; MMRRC:029509-UCD
DR   Wikidata; Q54794939
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917184; Trmt10b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC737
AC   CVCL_QW01
SY   YTC737
DR   MMRRC; MMRRC:029555-UCD
DR   Wikidata; Q54794940
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444777; Ncaph.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC745
AC   CVCL_QW02
SY   YTC745
DR   MMRRC; MMRRC:029531-UCD
DR   Wikidata; Q54794941
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921134; Zdbf2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC747
AC   CVCL_QW03
SY   YTC747
DR   MMRRC; MMRRC:029556-UCD
DR   Wikidata; Q54794944
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914737; Dhx40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC748
AC   CVCL_QW04
SY   YTC748
DR   MMRRC; MMRRC:029500-UCD
DR   Wikidata; Q54794946
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346873; Map3k2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC751
AC   CVCL_QW05
SY   YTC751
DR   MMRRC; MMRRC:029468-UCD
DR   Wikidata; Q54794948
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107690; Zfp462.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC752
AC   CVCL_QW06
SY   YTC752
DR   MMRRC; MMRRC:029520-UCD
DR   Wikidata; Q54794950
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1336168; Cradd.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC753
AC   CVCL_QW07
SY   YTC753
DR   MMRRC; MMRRC:029557-UCD
DR   Wikidata; Q54794951
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143854; Nup107.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC756
AC   CVCL_QW08
SY   YTC756
DR   MMRRC; MMRRC:029521-UCD
DR   Wikidata; Q54794953
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917758; Bbx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC758
AC   CVCL_QW09
SY   YTC758
DR   MMRRC; MMRRC:029543-UCD
DR   Wikidata; Q54794954
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918019; Nolc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC760
AC   CVCL_QW10
SY   YTC760
DR   MMRRC; MMRRC:029522-UCD
DR   Wikidata; Q54794956
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921572; Cxxc1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC765
AC   CVCL_QW11
SY   YTC765
DR   MMRRC; MMRRC:029978-UCD
DR   Wikidata; Q54794957
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858259; Tomm40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC769
AC   CVCL_QW12
SY   YTC769
DR   MMRRC; MMRRC:029974-UCD
DR   Wikidata; Q54794959
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1099442; Atxn3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC770
AC   CVCL_QW13
SY   YTC770
DR   MMRRC; MMRRC:029955-UCD
DR   Wikidata; Q54794961
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921579; Inava.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   BayGenomics ES cell line YTC771
AC   CVCL_QW14
SY   YTC771
DR   MMRRC; MMRRC:029975-UCD
DR   Wikidata; Q54794963
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88549; Csrp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC773
AC   CVCL_QW15
SY   YTC773
DR   MMRRC; MMRRC:029960-UCD
DR   Wikidata; Q54794965
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97805; Ptpn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC776
AC   CVCL_QW16
SY   YTC776
DR   MMRRC; MMRRC:029961-UCD
DR   Wikidata; Q54794966
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346858; Mapk1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC781
AC   CVCL_QW17
SY   YTC781
DR   MMRRC; MMRRC:029963-UCD
DR   Wikidata; Q54794970
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918685; Arhgap21.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC782
AC   CVCL_QW18
SY   YTC782
DR   MMRRC; MMRRC:029969-UCD
DR   Wikidata; Q54794971
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917936; Dusp16.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC783
AC   CVCL_QW19
SY   YTC783
DR   MMRRC; MMRRC:029964-UCD
DR   Wikidata; Q54794973
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC785
AC   CVCL_QW20
SY   YTC785
DR   MMRRC; MMRRC:029979-UCD
DR   Wikidata; Q54794974
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915209; Puf60.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC786
AC   CVCL_QW21
SY   YTC786
DR   MMRRC; MMRRC:029980-UCD
DR   Wikidata; Q54794978
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97805; Ptpn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC787
AC   CVCL_QW22
SY   YTC787
DR   MMRRC; MMRRC:029957-UCD
DR   Wikidata; Q54795018
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333803; Top3b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC796
AC   CVCL_QW23
SY   YTC796
DR   MMRRC; MMRRC:029965-UCD
DR   Wikidata; Q54795020
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1337080; Ncor2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC798
AC   CVCL_QW24
SY   YTC798
DR   MMRRC; MMRRC:029970-UCD
DR   Wikidata; Q54795023
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97805; Ptpn1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC799
AC   CVCL_QW25
SY   YTC799
DR   MMRRC; MMRRC:029954-UCD
DR   Wikidata; Q54795025
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444098; Heatr5b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC802
AC   CVCL_QW26
SY   YTC802
DR   MMRRC; MMRRC:029950-UCD
DR   Wikidata; Q54795027
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444430; Pomt2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC803
AC   CVCL_QW27
SY   YTC803
DR   MMRRC; MMRRC:029951-UCD
DR   Wikidata; Q54795028
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921344; Tjap1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC807
AC   CVCL_QW28
SY   YTC807
DR   MMRRC; MMRRC:029983-UCD
DR   Wikidata; Q54795030
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915955; Gtf2f2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC812
AC   CVCL_QW29
SY   YTC812
DR   MMRRC; MMRRC:029958-UCD
DR   Wikidata; Q54795031
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107164; Ppp3ca.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC813
AC   CVCL_QW30
SY   YTC813
DR   MMRRC; MMRRC:029976-UCD
DR   Wikidata; Q54795033
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918313; Zfp597.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC814
AC   CVCL_QW31
SY   YTC814
DR   MMRRC; MMRRC:029967-UCD
DR   Wikidata; Q54795035
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918025; Zmynd8.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC815
AC   CVCL_QW32
SY   YTC815
DR   MMRRC; MMRRC:029952-UCD
DR   Wikidata; Q54795036
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96136; Hmgn2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC816
AC   CVCL_QW33
SY   YTC816
DR   MMRRC; MMRRC:029920-UCD
DR   Wikidata; Q54795039
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098658; Stag1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC822
AC   CVCL_QW34
SY   YTC822
DR   MMRRC; MMRRC:029926-UCD
DR   Wikidata; Q54795040
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914320; Lsm14a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC827
AC   CVCL_QW35
SY   YTC827
DR   MMRRC; MMRRC:029923-UCD
DR   Wikidata; Q54795043
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926078; Rhot1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC830
AC   CVCL_QW36
SY   YTC830
DR   MMRRC; MMRRC:029929-UCD
DR   Wikidata; Q54795045
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096376; Exoc4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC833
AC   CVCL_QW37
SY   YTC833
DR   MMRRC; MMRRC:029922-UCD
DR   Wikidata; Q54795048
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914737; Dhx40.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BayGenomics ES cell line YTC837
AC   CVCL_QW38
SY   YTC837
DR   MMRRC; MMRRC:029859-UCD
DR   Wikidata; Q54795050
RX   PubMed=12520002;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917758; Bbx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   BB [Ameiurus]
AC   CVCL_4118
SY   Brown Bullhead
DR   CLO; CLO_0001869
DR   CLDB; cl394
DR   CLDB; cl395
DR   ATCC; CCL-59
DR   ECACC; 87101201
DR   IZSLER; BS CL 6
DR   Wikidata; Q54795053
RX   CelloPub=CLPUB00103;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.3354/dao001209;
CC   Group: Fish cell line.
CC   Characteristics: Grows at 4 to 34 Celsius with an optimum of between 25 and 30 Celsius (ATCC=CCL-59).
CC   Derived from site: In situ; Caudal trunk; UBERON=UBERON_0002100+UBERON_0006071.
OX   NCBI_TaxID=27778; ! Ameiurus nebulosus (Brown bullhead)
SX   Sex unspecified
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   BB [Human macrophage]
AC   CVCL_C0PE
DR   Wikidata; Q112929273
RX   PubMed=6316162;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   BB [Human ovarian carcinoma]
AC   CVCL_A1GW
DR   Wikidata; Q102113584
RX   PubMed=19414332;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BB [Lates]
AC   CVCL_HG34
SY   Barramundi Brain
DR   Wikidata; Q54795052
RX   PubMed=16060261;
RX   PubMed=16698284;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 20 to 30 Celsius, the optimal growth temperature is 28 Celsius (PubMed=16060261).
CC   Virology: Persistantly infected by nervous necrosis virus (NNV) (PubMed=16060261; PubMed=16698284).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 8
//
ID   Bb(ApMC1)
AC   CVCL_9Y66
DR   CLO; CLO_0001870
DR   CLDB; cl396
DR   Wikidata; Q54795055
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7119; ! Antheraea pernyi (Chinese oak silk moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BB0111
AC   CVCL_8B89
DR   ECACC; 93090516
DR   Wikidata; Q54795056
RX   PubMed=16152642;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,r(14) (PubMed=16152642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93090516; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185638; Ring chromosome 14 syndrome
DI   ORDO; Orphanet_1440; Ring chromosome 14 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BB1
AC   CVCL_E5RJ
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BB11
AC   CVCL_B0D2
SY   CDB.BB11.BC6
DR   Wikidata; Q108819905
RX   Patent=US6307025;
RX   PubMed=1697461;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10220.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BB132-EBV
AC   CVCL_6F65
DR   Wikidata; Q54795057
RX   PubMed=14762065;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M777 ! BB132-MEL
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BB132-MEL
AC   CVCL_M777
DR   Cosmic; 753530
DR   IARC_TP53; 21185
DR   Wikidata; Q54795059
RX   PubMed=14762065;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F65 ! BB132-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   BB2
AC   CVCL_A8P4
DR   ABCD; ABCD_HY001
DR   ECACC; 19072501
DR   Wikidata; Q102113586
RX   PubMed=8813669;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0CX57; Saccharomyces cerevisiae TY1A-A (Note=Immunized with 25-EVHTNQDPLD-34 = Ty1 Tag).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 6
//
ID   BB30-HNC
AC   CVCL_1076
SY   BB30 HNC; BB30HNC; BB30-SCCHN
DR   CLO; CLO_0009939
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 832
DR   cancercelllines; CVCL_1076
DR   Cell_Model_Passport; SIDM00172
DR   ChEMBL-Cells; CHEMBL3308548
DR   ChEMBL-Targets; CHEMBL2366271
DR   Cosmic; 753531
DR   Cosmic; 1995343
DR   Cosmic-CLP; 753531
DR   DepMap; ACH-002212
DR   EGA; EGAS00001000978
DR   GDSC; 753531
DR   GEO; GSM1669607
DR   IARC_TP53; 21186
DR   LINCS_LDP; LCL-1573
DR   PharmacoDB; BB30HNC_74_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1076
DR   Wikidata; Q54795061
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser144Ter (c.431C>G); Zygosity=Heterozygous (Cosmic-CLP=753531; DepMap=ACH-002212).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.96+2T>G (IVS3+2T>G); ClinVar=VCV002592148; Zygosity=Heterozygous; Note=Splice donor mutation (Cosmic-CLP=753531; DepMap=ACH-002212).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>A); Zygosity=Heterozygous (Cosmic-CLP=753531; DepMap=ACH-002212).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.71%; Native American=0%; East Asian, North=0.53%; East Asian, South=0%; South Asian=0.89%; European, North=70.27%; European, South=27.6% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753531
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,14
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU86 ! BB30-PBL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   BB30-PBL
AC   CVCL_VU86
SY   BB30PBL
DR   Cell_Model_Passport; SIDM01638
DR   DepMap; ACH-002342
DR   Wikidata; Q93423376
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1076 ! BB30-HNC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   BB49-EBV
AC   CVCL_VU51
SY   BB49EBV
DR   Cell_Model_Passport; SIDM01722
DR   DepMap; ACH-002343
DR   Wikidata; Q93423379
RX   PubMed=9271594;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1077 ! BB49-HNC
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   BB49-HNC
AC   CVCL_1077
SY   BB49 HNC; BB49HNC; BB49-SCCHN
DR   CLO; CLO_0009940
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1077
DR   Cell_Model_Passport; SIDM00174
DR   ChEMBL-Cells; CHEMBL3308282
DR   ChEMBL-Targets; CHEMBL2366295
DR   Cosmic; 753532
DR   Cosmic; 2116768
DR   Cosmic-CLP; 753532
DR   DepMap; ACH-002213
DR   EGA; EGAS00001000978
DR   GDSC; 753532
DR   GEO; GSM1669608
DR   IARC_TP53; 21187
DR   LINCS_LDP; LCL-1574
DR   PharmacoDB; BB49HNC_75_2019
DR   PubChem_Cell_line; CVCL_1077
DR   Wikidata; Q54795063
RX   PubMed=9271594;
RX   PubMed=11751535;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.66%; Native American=0.55%; East Asian, North=0.98%; East Asian, South=0%; South Asian=2.14%; European, North=57.6%; European, South=38.06% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753532
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 7,9
ST   vWA: 15,19
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU51 ! BB49-EBV
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   BB5
AC   CVCL_E5R6
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BB64-EBV
AC   CVCL_S693
DR   Wikidata; Q54795066
RX   PubMed=10661410;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E907 ! BB64-RCC
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   BB64-RCC
AC   CVCL_E907
SY   BB64 RCC; BB64; JAUP
DR   Wikidata; Q54795068
RX   PubMed=9637538;
RX   PubMed=10074909;
RX   PubMed=10661410;
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*23,26; B*44,51; C*01,04 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S693 ! BB64-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   BB65
AC   CVCL_C8RL
DR   Wikidata; Q123030763
RX   PubMed=185295;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: BALB.B.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   BB65-EBV
AC   CVCL_6F66
SY   BB65EBV
DR   Cell_Model_Passport; SIDM01721
DR   DepMap; ACH-002344
DR   Wikidata; Q54795071
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1078 ! BB65-RCC
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   BB65-RCC
AC   CVCL_1078
SY   BB65 RCC; BB65RCC; BB65; CAJE
DR   CLO; CLO_0009975
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1078
DR   Cell_Model_Passport; SIDM00191
DR   ChEMBL-Cells; CHEMBL3308283
DR   ChEMBL-Targets; CHEMBL2366247
DR   Cosmic; 753533
DR   Cosmic-CLP; 753533
DR   DepMap; ACH-002090
DR   EGA; EGAS00001000978
DR   GDSC; 753533
DR   GEO; GSM1669609
DR   IARC_TP53; 21188
DR   IARC_TP53; 26919
DR   LINCS_LDP; LCL-1763
DR   PharmacoDB; BB65RCC_76_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1078
DR   Wikidata; Q54795073
RX   PubMed=10074909;
RX   PubMed=14762065;
RX   PubMed=15585611;
RX   PubMed=18698046;
RX   PubMed=20164919;
RX   PubMed=22892449;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   HLA typing: A*02,26; B*44,49; C*07,16 (PubMed=15585611).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (Cosmic-CLP=753533).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.53%; Native American=1.94%; East Asian, North=1.65%; East Asian, South=0%; South Asian=0.38%; European, North=59.69%; European, South=35.82% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=753533
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 12,13
ST   D5S818: 11,14
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F66 ! BB65-EBV
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   BB7.1
AC   CVCL_7245
DR   CLO; CLO_0001871
DR   ATCC; HB-56
DR   Wikidata; Q54795077
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   BB7.2
AC   CVCL_7246
DR   CLO; CLO_0001872
DR   ATCC; HB-82
DR   NCBI_Iran; H152
DR   Wikidata; Q54795078
RX   PubMed=95015;
RX   PubMed=7035415;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes allele A*02).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   BB7.3
AC   CVCL_CW41
DR   Wikidata; Q54795081
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   BB7.4
AC   CVCL_CW42
DR   Wikidata; Q54795083
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   BB7.5
AC   CVCL_7247
DR   CLO; CLO_0001873
DR   ATCC; HB-120
DR   Wikidata; Q54795085
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   BB7.6
AC   CVCL_7248
DR   CLO; CLO_0001874
DR   ATCC; HB-115
DR   Wikidata; Q54795086
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   BB7.7
AC   CVCL_7249
DR   CLO; CLO_0001875
DR   ATCC; HB-94
DR   Wikidata; Q54795089
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   BB7.8
AC   CVCL_CW43
DR   Wikidata; Q54795091
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   BB88
AC   CVCL_3490
DR   CLO; CLO_0001877
DR   ATCC; TIB-55
DR   Wikidata; Q54795093
RX   PubMed=185295;
RX   PubMed=564410;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: BALB.B.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   BB90-MEL
AC   CVCL_VU92
SY   BB 90 MEL; DEZE
DR   IPD-IMGT/HLA; 12039
DR   Wikidata; Q93423445
RX   PubMed=10885573;
RX   PubMed=11751535;
RX   PubMed=14707109;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*02:01,26:01; B*15:01,44:02; C*03:04,05:03 (IPD-IMGT/HLA=12039).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   BBA4
AC   CVCL_T978
DR   ECACC; 00020912
DR   Wikidata; Q54795096
RX   PubMed=2606940;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Trypanosoma brucei brucei antigen on basal bodies.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   BBANTWi001-A
AC   CVCL_ZX25
SY   iPSC_FB_M45-50_C9
DR   BioSamples; SAMEA9269222
DR   hPSCreg; BBANTWi001-A
DR   Wikidata; Q102113587
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian; Belgian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX26 ! BBANTWi001-B
OI   CVCL_ZX27 ! BBANTWi001-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   BBANTWi001-B
AC   CVCL_ZX26
SY   iPSC_FB_M45-50_C15
DR   BioSamples; SAMEA9269224
DR   hPSCreg; BBANTWi001-B
DR   Wikidata; Q102113588
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian; Belgian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX25 ! BBANTWi001-A
OI   CVCL_ZX27 ! BBANTWi001-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   BBANTWi001-C
AC   CVCL_ZX27
SY   iPSC_FB_M45-50_C3
DR   BioSamples; SAMEA9269364
DR   hPSCreg; BBANTWi001-C
DR   Wikidata; Q102113589
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian; Belgian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX25 ! BBANTWi001-A
OI   CVCL_ZX26 ! BBANTWi001-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   BBANTWi002-A
AC   CVCL_ZX28
SY   iPSC_PBMC_M45-50_B1_C4
DR   hPSCreg; BBANTWi002-A
DR   Wikidata; Q102113590
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX29 ! BBANTWi002-B
OI   CVCL_ZX30 ! BBANTWi002-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi002-B
AC   CVCL_ZX29
SY   iPSC_PBMC_M45-50_B1_C7
DR   hPSCreg; BBANTWi002-B
DR   Wikidata; Q102113591
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX28 ! BBANTWi002-A
OI   CVCL_ZX30 ! BBANTWi002-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi002-C
AC   CVCL_ZX30
SY   iPSC_PBMC_M45-50_B1_C11
DR   hPSCreg; BBANTWi002-C
DR   Wikidata; Q102113592
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX28 ! BBANTWi002-A
OI   CVCL_ZX29 ! BBANTWi002-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi003-A
AC   CVCL_ZX31
SY   iPSC_PBMC_VG-4F_C1
DR   hPSCreg; BBANTWi003-A
DR   Wikidata; Q102113594
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX32 ! BBANTWi003-B
OI   CVCL_ZX33 ! BBANTWi003-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi003-B
AC   CVCL_ZX32
SY   iPSC_PBMC_VG-4F_C2
DR   hPSCreg; BBANTWi003-B
DR   Wikidata; Q102113595
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX31 ! BBANTWi003-A
OI   CVCL_ZX33 ! BBANTWi003-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi003-C
AC   CVCL_ZX33
SY   iPSC_PBMC_VG-4F_C6
DR   hPSCreg; BBANTWi003-C
DR   Wikidata; Q102113596
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX31 ! BBANTWi003-A
OI   CVCL_ZX32 ! BBANTWi003-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi004-A
AC   CVCL_ZX34
SY   iPSC_PBMC_VH-2M_C1
DR   hPSCreg; BBANTWi004-A
DR   Wikidata; Q102113597
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX35 ! BBANTWi004-B
OI   CVCL_ZX36 ! BBANTWi004-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi004-B
AC   CVCL_ZX35
SY   iPSC_PBMC_VH-2M_C5
DR   hPSCreg; BBANTWi004-B
DR   Wikidata; Q102113598
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX34 ! BBANTWi004-A
OI   CVCL_ZX36 ! BBANTWi004-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi004-C
AC   CVCL_ZX36
SY   iPSC_PBMC_VH-2M_C7
DR   hPSCreg; BBANTWi004-C
DR   Wikidata; Q102113600
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX34 ! BBANTWi004-A
OI   CVCL_ZX35 ! BBANTWi004-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi005-A
AC   CVCL_ZX37
SY   iPSC_PBMC_VG-2M_C2
DR   hPSCreg; BBANTWi005-A
DR   Wikidata; Q102113601
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX38 ! BBANTWi005-B
OI   CVCL_ZX39 ! BBANTWi005-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi005-B
AC   CVCL_ZX38
SY   iPSC_PBMC_VG-2M_C3
DR   hPSCreg; BBANTWi005-B
DR   Wikidata; Q102113602
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX37 ! BBANTWi005-A
OI   CVCL_ZX39 ! BBANTWi005-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi005-C
AC   CVCL_ZX39
SY   iPSC_PBMC_VG-2M_C8
DR   hPSCreg; BBANTWi005-C
DR   Wikidata; Q102113603
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX37 ! BBANTWi005-A
OI   CVCL_ZX38 ! BBANTWi005-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BBANTWi006-A
AC   CVCL_B3NL
SY   iPSC_BrS9_FB_C7; BrS9 C7
DR   BioSamples; SAMEA9372404
DR   hPSCreg; BBANTWi006-A
DR   Wikidata; Q110432589
RX   PubMed=35247843;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian; Belgian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; c.4714+95GGGT[3] (c.4813+3_4813+6dupGGGT); ClinVar=VCV000254157; Zygosity=Heterozygous (PubMed=35247843).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   BBANTWi007-A
AC   CVCL_B3NM
SY   iPSC_BrS10_FB_C3; BrS10 C3
DR   BioSamples; SAMEA11423532
DR   hPSCreg; BBANTWi007-A
DR   Wikidata; Q110432591
RX   PubMed=35247843;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian; Belgian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; c.4714+95GGGT[3] (c.4813+3_4813+6dupGGGT); ClinVar=VCV000254157; Zygosity=Heterozygous (PubMed=35247843).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   BBANTWi008-A
AC   CVCL_B7E0
SY   iPSC_PBMC_LDS_SMAD3_T1_C11; iPSC_PBMC_LDS_SMAD3_T1_Clone 11; CMGANTi001-A
DR   BioSamples; SAMEA13601154
DR   hPSCreg; BBANTWi008-A
DR   Wikidata; Q112929274
RX   PubMed=36219981;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6769; SMAD3; Simple; p.Arg287Gln (c.860G>A); ClinVar=VCV000180524; Zygosity=Heterozygous (PubMed=36219981).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C186786; Loeys-Dietz syndrome type 3
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   BBANTWi009-A
AC   CVCL_C0C7
DR   BioSamples; SAMEA14207933
DR   hPSCreg; BBANTWi009-A
DR   Wikidata; Q112929275
RX   PubMed=36599284;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1044; BGN; Simple; chrX:g.153502980_153530518del (27.5kb deletion); ClinVar=VCV000265797; Zygosity=Hemizygous (PubMed=36599284).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C187989; Meester-Loeys syndrome
DI   ORDO; Orphanet_622925; X-linked severe syndromic thoracic aortic aneurysm and dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   BBANTWi010-A
AC   CVCL_C0C8
SY   iPSC_PBMC_LDS_TGFB3_KE2M_C9
DR   BioSamples; SAMEA14416997
DR   hPSCreg; BBANTWi010-A
DR   Wikidata; Q112929276
RX   PubMed=36356561;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11769; TGFB3; Simple; p.Asp263His (c.787G>C); ClinVar=VCV000203492; Zygosity=Heterozygous (PubMed=36356561).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188143; Loeys-Dietz syndrome type 5
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   BBANTWi011-A
AC   CVCL_C1KJ
SY   iPSC_PBMC_IPO8_p.(Arg474*)
DR   BioSamples; SAMEA112651399
DR   hPSCreg; BBANTWi011-A
DR   Wikidata; Q114310688
RX   PubMed=36905820;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:9853; IPO8; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV001047908; Zygosity=Homozygous (PubMed=36905820).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198610; VISS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   BBANTWi012-A
AC   CVCL_E3QU
SY   F1990.01 C3
DR   BioSamples; SAMEA115499867
DR   hPSCreg; BBANTWi012-A
RX   PubMed=39167847;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BBANTWi012-A-1
AC   CVCL_E3QV
SY   TTN_E48_V4623*
DR   BioSamples; SAMEA115499230
DR   hPSCreg; BBANTWi012-A-1
RX   PubMed=39167847;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Val4623Ter (c.13836_13837insGATACATACAA); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39167847).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3QU ! BBANTWi012-A
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BBANTWi012-A-2
AC   CVCL_E3QW
SY   iPSC_FB_F19901C3_TTN_E48_L4612*; TTN_E48_L4612*
DR   BioSamples; SAMEA115501150
DR   hPSCreg; BBANTWi012-A-2
RX   PubMed=39167847;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Leu4612Ter (c.13836_13837del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39167847).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3QU ! BBANTWi012-A
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BBANTWi012-A-3
AC   CVCL_E3QX
SY   iPSC_FB_F19901C3_TTN_E357_E33459*_N33456N_C30; TTN_E357_E33459*_N33456N
DR   hPSCreg; BBANTWi012-A-3
RX   PubMed=39167847;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Asn33456Asn (c.100368C>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39167847).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Glu33459Ter (c.100373_100374insT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39167847).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3QU ! BBANTWi012-A
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   BBANTWi012-A-4
AC   CVCL_E3QY
SY   iPSC_FB_F19901C3_TTN_E357_V33467*_N33456N_C3; TTN_E357_V33467*_N33456N
DR   BioSamples; SAMEA115501575
DR   hPSCreg; BBANTWi012-A-4
RX   PubMed=39167847;
CC   From: Biobank Antwerpen; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Asn33456Asn (c.100368C>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39167847).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Val33467Ter (c.100373delT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39167847).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3QU ! BBANTWi012-A
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   BBdF-1
AC   CVCL_C5YP
SY   Barilius Bendelisis Fin-1
DR   NRFC; NRFC061
DR   Wikidata; Q116048564
RX   DOI=10.2478/cjf-2021-0002;
WW   Provider; NRFC; NRFC061; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC061.
CC   Characteristics: Optimal growth at 28 Celsius (DOI=10.2478/cjf-2021-0002).
CC   Doubling time: 68 hours (DOI=10.2478/cjf-2021-0002).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=209118; ! Barilius bendelisis (Hamilton's barila)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   BBEC-SV
AC   CVCL_C4L6
SY   Bovine Brain Endothelial cells-SV40 transformed
DR   Wikidata; Q116048565
RX   PubMed=9156338;
RX   PubMed=12958429;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   BBf
AC   CVCL_4230
SY   Black Bear fibroblast; KCB 85015
DR   CLO; CLO_0007082
DR   CLDB; cl3012
DR   ECACC; 93052110
DR   KCB; KCB 85015
DR   Wikidata; Q54795097
CC   Discontinued: ECACC; 93052110; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9642; ! Ursus thibetanus (Asiatic black bear)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   BBF
AC   CVCL_8659
DR   cancercelllines; CVCL_8659
DR   Wikidata; Q54795144
RX   PubMed=15956410;
CC   Population: African; Kenyan.
CC   Virology: Supports human herpesvirus 8 (HHV-8/KSHV) replication.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   BBG-12
AC   CVCL_B0C1
DR   Wikidata; Q108819906
RX   Patent=EP0239776B1;
RX   PubMed=3781626;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10102.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Porphyromonas gingivalis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BBG-25
AC   CVCL_B0C2
DR   Wikidata; Q108819907
RX   PubMed=3429637;
RX   PubMed=3781626;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Porphyromonas gingivalis lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BBG-30
AC   CVCL_B0C3
DR   Wikidata; Q108819908
RX   Patent=EP0239776B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10103.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Porphyromonas gingivalis fimbriae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BBG-31
AC   CVCL_B0C4
DR   Wikidata; Q108819909
RX   Patent=EP0239776B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10104.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Porphyromonas gingivalis fimbriae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BBG-42
AC   CVCL_B0C5
DR   Wikidata; Q108819910
RX   Patent=EP0239776B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10105.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Porphyromonas gingivalis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BBG1
AC   CVCL_8606
SY   BBG-1
DR   Cosmic; 1238080
DR   IARC_TP53; 26982
DR   Wikidata; Q54795145
RX   PubMed=10706463;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   BBLC1.1
AC   CVCL_C5XJ
DR   ABCD; ABCD_AE623
DR   Wikidata; Q116048566
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBLC107.5
AC   CVCL_C5XL
DR   Wikidata; Q116048567
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBLC259.11
AC   CVCL_C5XM
DR   Wikidata; Q116048568
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBLC310.2
AC   CVCL_C5XN
DR   ABCD; ABCD_AE629
DR   Wikidata; Q116048569
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBLC326.4
AC   CVCL_C5XP
DR   Wikidata; Q116048570
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBLC434.22
AC   CVCL_C5XQ
DR   Wikidata; Q116048571
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBLC44.1
AC   CVCL_C5XK
DR   Wikidata; Q116048572
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBLC508.17
AC   CVCL_C5XR
DR   Wikidata; Q116048573
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BBm
AC   CVCL_4399
SY   Bovine Bone marrow
DR   BTO; BTO_0003356
DR   CLO; CLO_0001883
DR   ATCC; CRL-6016
DR   Wikidata; Q54795147
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6016; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_3655 ! BLn
OI   CVCL_R939 ! BPf
OI   CVCL_3657 ! BSp
OI   CVCL_5244 ! BThy
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   BBM
AC   CVCL_4400
SY   BEAS-2B/BBM
DR   BTO; BTO_0003355
DR   CLO; CLO_0001884
DR   ATCC; CRL-9482
DR   Wikidata; Q54795149
RX   Patent=US4885238;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9482.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7553; MYC.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-9482
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 13
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   BBM.1
AC   CVCL_4506
SY   BBM-1
DR   CLO; CLO_0001885
DR   ABCD; ABCD_AA502
DR   ATCC; HB-28
DR   Wikidata; Q54795152
RX   PubMed=91522;
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   BBM.1 clone E9
AC   CVCL_4507
DR   CLO; CLO_0001886
DR   CLDB; cl5158
DR   IZSLER; BS Hy 4
DR   Wikidata; Q54795154
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4506 ! BBM.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   BBN963
AC   CVCL_C0CS
DR   ABM; T8244
DR   Wikidata; Q112929277
RX   PubMed=29784854;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   BBr0015
AC   CVCL_VA42
DR   ECACC; 15042415
DR   Wikidata; Q54795156
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BBrMEC
AC   CVCL_A1BE
SY   Bovine Brain Microvascular Endothelial Cells
DR   ABM; T0829
DR   Wikidata; Q102113604
RX   PubMed=32722052;
CC   Doubling time: 48 hours (PubMed=32722052).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal brain, endothelium; UBERON=UBERON_0006238+UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: Montbeliarde; VBO=VBO_0000306.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A1BF ! BIntMEC
OI   CVCL_A1BG ! BLuMEC
OI   CVCL_A1BH ! BMLNMEC
OI   CVCL_A1BI ! BOvMEC
OI   CVCL_A1BJ ! BSkMEC
OI   CVCL_A1BK ! BUcEC
SX   Female
AG   6FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   BBSSPAi001-A
AC   CVCL_E3QZ
SY   Ctrl FiPS1-Sv4F-25
DR   hPSCreg; BBSSPAi001-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo+Dep%C3%B3sito+Ctrl+FiPS1sv4F25+BBSSPA.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento+Dep%C3%B3sito+Ctrl+FiPS1sv4F25+BBSSPA_F.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Biobanco del Sistema Sanitario Publico de Andalucia (BBSSPA); Granada; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D19S433: 13,16
ST   D21S11: 28,29
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   BBSSPAi002-A
AC   CVCL_E7TV
SY   AD-PBiPS1-Sv4F-1
DR   hPSCreg; BBSSPAi002-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/ANEXOS+DEP%C3%93SITO_AD-PBiPS1-Sv4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/DOCUMENTO+DEP%C3%93SITO_AD-PBiPS1-Sv4F-1_F.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Biobanco del Sistema Sanitario Publico de Andalucia (BBSSPA); Granada; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 13,16
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   bBU1-CDX2G
AC   CVCL_D3BZ
SY   bBU1c2 CDX2-eGFP; BU1CG
DR   Wikidata; Q127380248
RX   PubMed=31924806;
WW   Provider; CReM; 505; https://stemcellbank.bu.edu/Catalog/Item/Details/505
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a 2A-eGFP-polyA construct was integrated at the C-terminus of CDX2 (PubMed=31924806).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW24 ! CREM001i-bBU1C2
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   bBU1c2:N1
AC   CVCL_D2YD
SY   bBU1c2 N1; BU1-TetOn:NICD1
DR   Wikidata; Q127380249
RX   PubMed=36332629;
WW   Provider; CReM; 781; https://stemcellbank.bu.edu/Catalog/Item/Details/781
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Under the control of doxycycline expresses the intracellular domain of the NOTCH1 receptor (NICD1). Using ZFN a construct containing a reverse tetracycline-controlled transactivator (rtTA), NICD1 and puroR was inserted in the AAVS1 safe harbor locus (PubMed=36332629).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:7881; NOTCH1 (Note=With p.Met1_Arg1762del = NICD1).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW24 ! CREM001i-bBU1C2
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   BBWV-22K3-9B
AC   CVCL_U122
DR   CLO; CLO_0050327
DR   RCB; RCB1914
DR   Wikidata; Q54795157
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; R4V130; Broad bean wilt virus 2 small capsid protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   BBWV-22K5-12A
AC   CVCL_U123
DR   CLO; CLO_0050329
DR   RCB; RCB1915
DR   Wikidata; Q54795159
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; R4V130; Broad bean wilt virus 2 small capsid protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   BBWV-22K6-2A
AC   CVCL_U124
DR   CLO; CLO_0050328
DR   RCB; RCB1916
DR   Wikidata; Q54795162
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; R4V130; Broad bean wilt virus 2 small capsid protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   BC 1217
AC   CVCL_M380
SY   Bc 1217; BC1217
DR   Wikidata; Q54795163
RX   PubMed=3471855;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   BC-009
AC   CVCL_U286
DR   CCTCC; GDC0197
DR   Wikidata; Q54795166
CC   Population: Chinese.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000195). It was the sole source of information for this entry.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   BC-019
AC   CVCL_U250
DR   CCTCC; GDC0198
DR   Wikidata; Q54795169
RX   PubMed=19121212;
CC   Population: Chinese.
CC   Doubling time: 36 hours (PubMed=19121212).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
ID   BC-020
AC   CVCL_U251
DR   CCTCC; GDC0199
DR   Wikidata; Q54795171
RX   PubMed=19121212;
CC   Population: Chinese.
CC   Doubling time: 35 hours (PubMed=19121212).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
ID   BC-021
AC   CVCL_U252
DR   CCTCC; GDC0200
DR   Wikidata; Q54795174
RX   PubMed=19121212;
CC   Population: Chinese.
CC   Doubling time: 46 hours (PubMed=19121212).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 15
//
ID   BC-022
AC   CVCL_U253
DR   CCTCC; GDC0201
DR   Wikidata; Q54795175
CC   Population: Chinese.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000199). It was the sole source of information for this entry.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   BC-023
AC   CVCL_U254
DR   CCTCC; GDC0202
DR   Wikidata; Q54795176
RX   PubMed=30662642;
CC   Population: Chinese.
CC   Doubling time: 35 hours (Note=At 23th passage) (PubMed=30662642).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C9119; Breast medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   BC-024
AC   CVCL_U255
DR   CCTCC; GDC0203
DR   Wikidata; Q54795178
RX   PubMed=30662642;
CC   Population: Chinese.
CC   Doubling time: 39 hours (Note=At 34th passage) (PubMed=30662642).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   BC-025
AC   CVCL_U256
DR   CCTCC; GDC0204
DR   Wikidata; Q54795180
CC   Population: Chinese.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000202). It was the sole source of information for this entry.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   BC-027
AC   CVCL_U257
DR   CCTCC; GDC0205
DR   Wikidata; Q54795182
CC   Population: Chinese.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000203). It was the sole source of information for this entry.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   BC-028
AC   CVCL_U258
DR   CCTCC; GDC0206
DR   Wikidata; Q54795184
CC   Population: Chinese.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000204). It was the sole source of information for this entry.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   BC-034
AC   CVCL_YP93
DR   Wikidata; Q93423639
RX   PubMed=30662642;
CC   Population: Chinese.
CC   Doubling time: 33 hours (Note=At 27th passage) (PubMed=30662642).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   BC-1
AC   CVCL_1079
SY   BC1
DR   BTO; BTO_0002720
DR   CLO; CLO_0001887
DR   EFO; EFO_0002044
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2230
DR   BioSample; SAMN03471843
DR   BioSample; SAMN03473432
DR   BioSamples; SAMEA365796
DR   BioSamples; SAMEA365808
DR   cancercelllines; CVCL_1079
DR   Cell_Model_Passport; SIDM00896
DR   ChEMBL-Cells; CHEMBL3307907
DR   ChEMBL-Targets; CHEMBL614277
DR   Cosmic; 687602
DR   Cosmic; 910919
DR   Cosmic; 1515186
DR   Cosmic; 1588556
DR   Cosmic-CLP; 910919
DR   DepMap; ACH-002214
DR   DSMZ; ACC-677
DR   DSMZCellDive; ACC-677
DR   EGA; EGAS00001000978
DR   GDSC; 910919
DR   GEO; GSM33136
DR   GEO; GSM38792
DR   GEO; GSM38793
DR   GEO; GSM634731
DR   GEO; GSM710417
DR   GEO; GSM710433
DR   GEO; GSM1669610
DR   GEO; GSM3150236
DR   IARC_TP53; 21189
DR   IARC_TP53; 23656
DR   IGRhCellID; BC1
DR   LINCS_LDP; LCL-1956
DR   Lonza; 914
DR   PharmacoDB; BC1_77_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1079
DR   PubChem_Cell_line; CVCL_1079
DR   Wikidata; Q54795185
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5908773;
RX   PubMed=7670109;
RX   PubMed=8523568;
RX   PubMed=9766492;
RX   PubMed=15613351;
RX   PubMed=17121789;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21685375;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=36094314;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BC-1
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~35-48 hours (DSMZ=ACC-677).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.64%; East Asian, North=0.52%; East Asian, South=0%; South Asian=0.4%; European, North=67.92%; European, South=30.53% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2230; Cosmic-CLP=910919; DSMZ=ACC-677
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 19,23
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 11
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,20
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4221 ! HBL-6
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   BC-2
AC   CVCL_1856
SY   BC2
DR   BTO; BTO_0002721
DR   CLO; CLO_0001889
DR   EFO; EFO_0002045
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2231
DR   BioSample; SAMN03471845
DR   BioSamples; SAMEA365820
DR   BioSamples; SAMEA365831
DR   cancercelllines; CVCL_1856
DR   Cosmic; 1238076
DR   Cosmic; 1515187
DR   Cosmic; 1588557
DR   DSMZ; ACC-678
DR   DSMZCellDive; ACC-678
DR   GDSC; 1295743
DR   GEO; GSM38794
DR   GEO; GSM38795
DR   GEO; GSM634732
DR   GEO; GSM710418
DR   GEO; GSM710434
DR   IARC_TP53; 26978
DR   IGRhCellID; BC2
DR   LINCS_LDP; LCL-1957
DR   PharmacoDB; BC2_78_2019
DR   Progenetix; CVCL_1856
DR   Wikidata; Q54795187
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5908773;
RX   PubMed=7670109;
RX   PubMed=9766492;
RX   PubMed=15613351;
RX   PubMed=19608668;
RX   PubMed=20215515;
RX   PubMed=21685375;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BC-2
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/d21d6b39-b480-4ad4-8785-cc7a70c91788
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-2231.
CC   Doubling time: ~50-70 hours (DSMZ=ACC-678).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2231; DSMZ=ACC-678
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 18,19
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   Penta D: 10,13
ST   Penta E: 13
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 14,19
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   BC-3
AC   CVCL_1080
SY   BC3
DR   BTO; BTO_0002722
DR   CLO; CLO_0001891
DR   EFO; EFO_0002046
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2277
DR   ATCC; CRL-3615
DR   BioGRID_ORCS_Cell_line; 1098
DR   BioSample; SAMN03472835
DR   BioSamples; SAMEA365848
DR   BioSamples; SAMEA365859
DR   cancercelllines; CVCL_1080
DR   CCRID; 3101HUMSCSP5016
DR   CCTCC; GDC0221
DR   Cell_Model_Passport; SIDM00895
DR   ChEMBL-Cells; CHEMBL3308890
DR   ChEMBL-Targets; CHEMBL2366371
DR   Cosmic; 687836
DR   Cosmic; 910918
DR   Cosmic; 1238077
DR   Cosmic; 1515188
DR   Cosmic; 1588558
DR   Cosmic-CLP; 910918
DR   DepMap; ACH-002215
DR   DSMZ; ACC-679
DR   DSMZCellDive; ACC-679
DR   GDSC; 910918
DR   GEO; GSM33135
DR   GEO; GSM38796
DR   GEO; GSM38797
DR   GEO; GSM634733
DR   GEO; GSM710419
DR   GEO; GSM710435
DR   GEO; GSM1669611
DR   GEO; GSM3150237
DR   IARC_TP53; 21190
DR   IARC_TP53; 26979
DR   IGRhCellID; BC3
DR   LINCS_LDP; LCL-1948
DR   PharmacoDB; BC3_79_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1080
DR   PubChem_Cell_line; CVCL_1080
DR   Wikidata; Q54795189
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5908773;
RX   PubMed=8839859;
RX   PubMed=9766492;
RX   PubMed=15613351;
RX   PubMed=17121789;
RX   PubMed=19608668;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21685375;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/d21d6b39-b480-4ad4-8785-cc7a70c91788
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-2277.
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-679).
CC   HLA typing: A*02:05:01,03:01:01; B*14:02:01,50:01:01; C*06:02:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,104:01; DQA1*02:01:01,01:01:02; DQB1*02:02:01,05:01:01; DRA*01:01:01,01:01:01; DRB1*01:02:01,07:01:01 (DSMZCellDive=ACC-679).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19608668).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=7.13%; Native American=1.02%; East Asian, North=6.58%; East Asian, South=0%; South Asian=6.31%; European, North=25.3%; European, South=53.67% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-2277; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3615; Cosmic-CLP=910918; DSMZ=ACC-679
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,21.2
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 14,16
ST   FGA: 18,22
ST   Penta D: 8,13
ST   Penta E: 7,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J72 ! KS-1 [Human primary effusion lymphoma]
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   BC-3C
AC   CVCL_1958
SY   BC3c
DR   CLO; CLO_0001893
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 506
DR   BioSample; SAMN03473550
DR   BioSample; SAMN10988581
DR   cancercelllines; CVCL_1958
DR   Cell_Model_Passport; SIDM01523
DR   Cosmic; 1046690
DR   Cosmic; 1285112
DR   Cosmic; 1286004
DR   Cosmic; 2050437
DR   Cosmic; 2057442
DR   Cosmic; 2444240
DR   Cosmic; 2685938
DR   DepMap; ACH-000593
DR   DSMZ; ACC-450
DR   DSMZCellDive; ACC-450
DR   GEO; GSM886873
DR   GEO; GSM887938
DR   IARC_TP53; 30018
DR   LiGeA; CCLE_276
DR   PharmacoDB; BC3C_80_2019
DR   Progenetix; CVCL_1958
DR   Wikidata; Q54795193
RX   PubMed=9794224;
RX   PubMed=22460905;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~25-30 hours (DSMZ=ACC-450).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.78%; Native American=0.28%; East Asian, North=4.58%; East Asian, South=0%; South Asian=3.73%; European, North=37.13%; European, South=52.49% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DSMZ=ACC-450
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   Penta D: 13,14
ST   Penta E: 12,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   BC-5
AC   CVCL_B040
SY   BC5
DR   EFO; EFO_0002047
DR   BioSamples; SAMEA365869
DR   BioSamples; SAMEA365880
DR   cancercelllines; CVCL_B040
DR   Cosmic; 1588559
DR   GEO; GSM38798
DR   GEO; GSM38799
DR   GEO; GSM634734
DR   GEO; GSM710420
DR   GEO; GSM710436
DR   Progenetix; CVCL_B040
DR   Wikidata; Q54795195
RX   PubMed=15613351;
RX   PubMed=21685375;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   BC-DS
AC   CVCL_WX21
SY   BCap37-Dose Stimulated
DR   Wikidata; Q93423704
RX   PubMed=26782109;
CC   Problematic cell line: Contaminated. Parent cell line (BCaP-37) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 43.8 +- 3.3 hours (PubMed=26782109).
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0164 ! BCaP-37
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   BC-H1
AC   CVCL_B7J5
DR   Wikidata; Q112929278
RX   PubMed=9892213;
CC   HLA typing: DRB1*07,11 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   BC-K1
AC   CVCL_B7J6
DR   Wikidata; Q112929279
RX   PubMed=9892213;
CC   Senescence: SV40-transformed but with a finite life span.
CC   HLA typing: DRB1*03,14 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   BC-KP
AC   CVCL_JG74
DR   JCRB; JCRB3018
DR   JCRB; KURB2713
DR   Wikidata; Q54795197
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2713; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3018
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   BC-M1 [Human breast carcinoma Germany]
AC   CVCL_AS91
DR   Wikidata; Q54795201
RX   PubMed=19714817;
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   BC-M1 [Human breast carcinoma Taiwan]
AC   CVCL_AS89
SY   BEC-M1
DR   Wikidata; Q54795202
RX   PubMed=8083436;
RX   PubMed=15642166;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 32 hours (PubMed=8083436).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   BC-PAK1
AC   CVCL_B7IM
SY   BC-PAK-1
DR   cancercelllines; CVCL_B7IM
DR   Wikidata; Q112929280
RX   CelloPub=CLPUB00697;
RX   PubMed=34495459;
CC   Population: Pakistani.
CC   Characteristics: ER-positive, PR-positive and ERBB2-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:14214; CIC; Simple; p.Ala1591Alafs*28 (c.4773T>TGC); Zygosity=Heterozygous (PubMed=34495459).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Tyr987Ter (c.2961C>G); ClinVar=VCV000694634; Zygosity=Heterozygous (PubMed=34495459).
CC   Sequence variation: Mutation; HGNC; HGNC:8554; PABPC1; Simple; p.Lys333Lysfs*21 (c.999delT); Zygosity=Heterozygous (PubMed=34495459).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   BC-TS
AC   CVCL_WX22
SY   BCap37-Time Stimulated
DR   Wikidata; Q93423746
RX   PubMed=26782109;
CC   Problematic cell line: Contaminated. Parent cell line (BCaP-37) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 35.0 +- 3.9 hours (PubMed=26782109).
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0164 ! BCaP-37
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   BC1 [Human NSC]
AC   CVCL_RX99
SY   BC1 hIPSC; HIP Neural Stem Cells (BC1 line)
DR   Wikidata; Q54795203
RX   PubMed=26411797;
CC   Discontinued: Thermo Fisher/MTI-GlobalStem; Catalog number N7800200/GSC-4311.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   BC1 [Mouse hybridoma against human neuroblastomas]
AC   CVCL_E3ZR
RX   PubMed=3943922;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen found in some neuroblastoma and melanoma, glioma, myeloid and B cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BC12
AC   CVCL_U335
SY   BC-12; BC12TC
DR   TKG; TKG 0121
DR   Wikidata; Q54795206
RX   PubMed=381090;
RX   PubMed=3918910;
RX   PubMed=7721336;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   BC16.1
AC   CVCL_M898
SY   BC16_1
DR   Cosmic; 1093985
DR   GEO; GSM136252
DR   Wikidata; Q54795209
RX   PubMed=8041746;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Indicated (PubMed=8041746) to be established from normal human bladder epithelial tissue but used in many studies as a bladder cancer cell line.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   BC16A
AC   CVCL_3491
DR   CLO; CLO_0001888
DR   ATCC; TIB-59
DR   Wikidata; Q54795211
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   BC18
AC   CVCL_A9ET
DR   Wikidata; Q108819911
RX   PubMed=2147949;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BC203
AC   CVCL_B0CY
DR   Wikidata; Q108819912
RX   Patent=US6677124;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3515.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BC215
AC   CVCL_Y281
DR   Wikidata; Q54795215
RX   PubMed=543011;
RX   PubMed=6085723;
RX   PubMed=6480290;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   BC25B11.2C
AC   CVCL_ZZ33
DR   Wikidata; Q102113606
WW   Provider; OSU CFAES; T2003-056; https://dev.innovatehosted.com/available_technologies/37408/Mouse-Hybridoma-BC25B112C-Secreting-Monoclonal-Antibodies-to-Bovine-Coronavirus
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Bovine coronavirus DB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   BC3
AC   CVCL_2099
SY   BC-3
DR   CLO; CLO_0001890
DR   ABCD; ABCD_AH438
DR   ATCC; HB-10166
DR   Wikidata; Q54795217
RX   Patent=WO1991001752A1;
RX   PubMed=2147949;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10166.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07766; Human CD3E.
CC   Discontinued: ATCC; HB-10166; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   BC31
AC   CVCL_9U95
DR   TKG; TKG 0324
DR   Wikidata; Q54795221
RX   PubMed=381090;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   BC31ad
AC   CVCL_ZF55
SY   BC31 adhesive
DR   Wikidata; Q98125540
RX   PubMed=7721336;
RX   PubMed=7959900;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9U95 ! BC31
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   BC31ad clone C19
AC   CVCL_ZF57
SY   C19; Clone C19
DR   Wikidata; Q98125541
RX   PubMed=7721336;
RX   PubMed=7959900;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_ZF55 ! BC31ad
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   BC31nonad
AC   CVCL_ZF56
SY   BC31 non-adhesive
DR   Wikidata; Q98125543
RX   PubMed=7721336;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9U95 ! BC31
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   BC35
AC   CVCL_U336
SY   BC-35
DR   TKG; TKG 0122
DR   Wikidata; Q54795226
RX   PubMed=381090;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   BC3A
AC   CVCL_6567
SY   BC-3A
DR   CLO; CLO_0001892
DR   ATCC; TIB-60
DR   Wikidata; Q54795227
RX   PubMed=185295;
RX   PubMed=564410;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   BC3A1
AC   CVCL_C3XT
DR   Wikidata; Q116048574
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BC3H1
AC   CVCL_0163
SY   BC3 H1; BC3H-1; BC-3H-1; BC-3-H-I
DR   BTO; BTO_0000115
DR   CLO; CLO_0001894
DR   MCCL; MCC:0000055
DR   CLDB; cl398
DR   CLDB; cl399
DR   CLDB; cl5161
DR   ATCC; CRL-1443
DR   CCRID; 1101MOU-PUMC000096
DR   DSMZ; ACC-171
DR   DSMZCellDive; ACC-171
DR   ECACC; 86093001
DR   IZSLER; BS TCL 145
DR   KCLB; 21443
DR   Wikidata; Q54795220
RX   PubMed=2715180;
RX   PubMed=4363958;
RX   PubMed=10852349;
RX   PubMed=24055552;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-222.html
CC   Characteristics: Closely resemble cells in an arrested state of skeletal muscle differentiation (PubMed=2715180).
CC   Characteristics: The scorpion toxin Acra3 exerts a very strong cytotoxic effect this cell line (PubMed=24055552).
CC   Doubling time: ~70 hours (DSMZ=ACC-171).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C3H.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   BC3H1#1
AC   CVCL_A5LH
DR   Wikidata; Q107113434
RX   PubMed=10852349;
CC   Characteristics: Spontaneously fusing clone of BC3H1. Can form multinucleated myocytes (PubMed=10852349).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C3H.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0163 ! BC3H1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   BC4
AC   CVCL_E3ZQ
RX   PubMed=3943922;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen found in some neuroblastoma and melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BC43
AC   CVCL_9U96
DR   TKG; TKG 0325
DR   Wikidata; Q54795228
RX   PubMed=381090;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   BC44
AC   CVCL_D724
DR   Cosmic; 1696918
DR   Wikidata; Q54795279
RX   PubMed=22669776;
RX   PubMed=29732388;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22669776).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   BC47
AC   CVCL_U337
SY   BC-47; BC47TC
DR   TKG; TKG 0123
DR   Wikidata; Q54795280
RX   PubMed=381090;
RX   PubMed=3918910;
RX   PubMed=7721336;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   BC4B12
AC   CVCL_C3XU
DR   Wikidata; Q116048576
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BC50
AC   CVCL_U338
SY   BC-50; BC50TC
DR   TKG; TKG 0124
DR   Wikidata; Q54795281
RX   PubMed=381090;
RX   PubMed=3918910;
RX   PubMed=7721336;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   BC6023
AC   CVCL_VA43
DR   ECACC; 15102917
DR   Wikidata; Q54795284
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6046
AC   CVCL_VA44
DR   ECACC; 15102918
DR   Wikidata; Q54795285
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6055
AC   CVCL_VA45
DR   ECACC; 15092901
DR   Wikidata; Q54795288
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6062
AC   CVCL_VA46
DR   ECACC; 15102919
DR   Wikidata; Q54795290
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6071
AC   CVCL_VA47
DR   ECACC; 15092902
DR   Wikidata; Q54795291
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6073
AC   CVCL_VA48
DR   ECACC; 15102920
DR   Wikidata; Q54795292
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC61
AC   CVCL_D725
DR   cancercelllines; CVCL_D725
DR   Cosmic; 1696919
DR   GEO; GSM1567853
DR   GEO; GSM1574567
DR   Wikidata; Q54795296
RX   PubMed=22669776;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22669776).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly370Cys (c.1108G>T); ClinVar=VCV000016359; Zygosity=Unspecified (PubMed=22669776).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   BC6125
AC   CVCL_VA49
DR   ECACC; 15102921
DR   Wikidata; Q54795297
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6141
AC   CVCL_VA50
DR   ECACC; 15102922
DR   Wikidata; Q54795299
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6231
AC   CVCL_VA51
DR   ECACC; 15092903
DR   Wikidata; Q54795302
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6263
AC   CVCL_VA52
DR   ECACC; 15102923
DR   Wikidata; Q54795304
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6309
AC   CVCL_VA53
DR   ECACC; 15092904
DR   Wikidata; Q54795305
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6325
AC   CVCL_VA54
DR   ECACC; 15092905
DR   Wikidata; Q54795307
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6434
AC   CVCL_VA55
DR   ECACC; 15092906
DR   Wikidata; Q54795309
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6448
AC   CVCL_VA56
DR   ECACC; 15102925
DR   Wikidata; Q54795311
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC6505
AC   CVCL_VA57
DR   ECACC; 15102926
DR   Wikidata; Q54795314
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BC7
AC   CVCL_1E03
DR   BEI_Resources; ARP-11434
DR   cancercelllines; CVCL_1E03
DR   Wikidata; Q54795315
RX   PubMed=8929542;
RX   PubMed=11264379;
CC   Population: Caucasian.
CC   Characteristics: CD4 negative.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   BC7/CCR5
AC   CVCL_ZX81
DR   cancercelllines; CVCL_ZX81
DR   Wikidata; Q102113607
RX   PubMed=11264379;
CC   Population: Caucasian.
CC   Characteristics: CD4 negative.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E03 ! BC7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   BC8 [Mouse myeloma against human PTPRC]
AC   CVCL_DD26
DR   ATCC; HB-10507
DR   Wikidata; Q54795317
RX   Patent=US5273738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10507.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   BC8 [Mouse hybridoma against MDI]
AC   CVCL_C4DJ
DR   Wikidata; Q116048577
RX   PubMed=23295252;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53218; Diphenylmethane-4,4'-diisocyanate (Methylene diphenyl diisocyanate; MDI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BC9
AC   CVCL_G192
DR   ECACC; 95030301
DR   Wikidata; Q54795319
RX   PubMed=1459585;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q06599; Bovine TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   BC9-E5
AC   CVCL_G193
DR   CLO; CLO_0001900
DR   ATCC; CRL-1670
DR   Wikidata; Q54795321
RX   PubMed=6833281;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   BCA 227
AC   CVCL_C7H6
DR   Wikidata; Q117704207
RX   PubMed=1997195;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human 71 kDa protein expressed by tumor cells of epithelial origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   BCa-11
AC   CVCL_M364
SY   Breast Carcinoma-11
DR   Wikidata; Q54795324
RX   PubMed=17959394;
CC   Population: Indian.
CC   Doubling time: 96 hours (PubMed=17959394).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=17959394).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   BCa-15
AC   CVCL_M365
SY   Breast Carcinoma-15
DR   Wikidata; Q54795328
RX   PubMed=17959394;
CC   Population: Indian.
CC   Doubling time: 60 hours (PubMed=17959394).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=17959394).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   BcaCD885
AC   CVCL_D655
DR   Cosmic; 851223
DR   Wikidata; Q54795331
RX   PubMed=10889927;
CC   Population: Chinese.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   BCaP-37
AC   CVCL_0164
SY   BCap-37; Bcap-37; BCaP 37; BCap 37; Bcap 37; BCAP37; Bcap37
DR   MCCL; MCC:0000056
DR   CCTCC; GDC0206
DR   ChEMBL-Cells; CHEMBL3308069
DR   ChEMBL-Targets; CHEMBL613842
DR   PubChem_Cell_line; CVCL_0164
DR   TOKU-E; 4153
DR   Wikidata; Q54795332
RX   CelloPub=CLPUB00522;
RX   PubMed=4017778;
RX   PubMed=24009699;
RX   PubMed=26116706;
RX   PubMed=26782109;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a breast squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00625.
CC   Population: African American.
CC   Doubling time: 34.1 +- 2.3 hours (PubMed=26782109).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Glycomics; N-glycan profiling.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000700009). It was one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   BCBL-1
AC   CVCL_0165
SY   BCBL1; BCBL; Body Cavity Based Lymphoma-1
DR   BTO; BTO_0002727
DR   EFO; EFO_0002048
DR   MCCL; MCC:0000057
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BEI_Resources; ARP-3233
DR   BioSample; SAMN03473436
DR   BioSamples; SAMEA365914
DR   BioSamples; SAMEA365927
DR   cancercelllines; CVCL_0165
DR   Cosmic; 1238078
DR   Cosmic; 1515185
DR   Cosmic; 1588560
DR   DSMZ; ACC-683
DR   DSMZCellDive; ACC-683
DR   GEO; GSM33134
DR   GEO; GSM38800
DR   GEO; GSM38801
DR   GEO; GSM634735
DR   GEO; GSM710421
DR   GEO; GSM710437
DR   GEO; GSM1265856
DR   GEO; GSM1265857
DR   GEO; GSM1265858
DR   GEO; GSM1265859
DR   GEO; GSM1265860
DR   GEO; GSM1265868
DR   GEO; GSM3150238
DR   IARC_TP53; 26980
DR   Lonza; 238
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_0165
DR   TOKU-E; 4070
DR   Wikidata; Q54795334
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8612236;
RX   PubMed=9375005;
RX   PubMed=9766492;
RX   PubMed=15613351;
RX   PubMed=17121789;
RX   PubMed=17324269;
RX   PubMed=19521981;
RX   PubMed=19608668;
RX   PubMed=21685375;
RX   PubMed=28196595;
RX   PubMed=31160637;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BCBL-1
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: ~50 hours (DSMZ=ACC-683).
CC   HLA typing: A*01:01:01,31:01:02; B*51:01:01,55:01:01; C*03:03:01,15:02:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,04:01:01; DQA1*01:02:01,01:04:01; DQB1*05:03:01,06:02:01; DRA*01:01:01,01:02:03; DRB1*14:54:01,15:01:01 (DSMZCellDive=ACC-683).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>A); ClinVar=VCV000480961; Zygosity=Heterozygous (PubMed=17121789).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-683
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 16
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 14
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   BCBL-2
AC   CVCL_A5ZN
SY   Body Cavity Based Lymphoma-2
DR   Wikidata; Q107113435
RX   PubMed=8612236;
RX   PubMed=9766492;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   BCC-1/KMC
AC   CVCL_A033
SY   BCC1/KMC
DR   BioSample; SAMN03151666
DR   Wikidata; Q54795337
RX   PubMed=8007045;
RX   PubMed=10508494;
RX   PubMed=17587681;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 65 year old female patient with a skin basal cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00112.
CC   Population: African American.
CC   Doubling time: 38.86 hours (Note=At 3rd passage) (PubMed=8007045).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   BCC/P
AC   CVCL_DQ00
SY   BCC/Permanent
DR   Wikidata; Q54795338
RX   PubMed=27356577;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   bcd mab23
AC   CVCL_B389
DR   CLO; CLO_0001901
DR   ATCC; CRL-2107
DR   Wikidata; Q54795341
RX   PubMed=3383244;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09081; Drosophila melanogaster bcd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   BCE C/D-1b
AC   CVCL_2865
SY   Bovine Corneal Endothelial C/D-1b
DR   CLO; CLO_0001902
DR   CLDB; cl5162
DR   ATCC; CRL-2048
DR   BCRC; 60044
DR   IZSLER; BS CL 142
DR   JCRB; JCRB9129
DR   Wikidata; Q54795342
CC   Doubling time: ~55 hours (Note=At 70th passage), 30 hours (Note=At 90th passage) (ATCC=CRL-2048).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   BCEC-1
AC   CVCL_A2GE
SY   Bovine Caruncular Epithelial Cell line-1
DR   Wikidata; Q105506474
RX   PubMed=17850864;
RX   PubMed=29017582;
CC   Characteristics: Susceptible to infection by Neospora caninum isolates Nc-Spain7 and Nc-Spain1H (PubMed=29017582).
CC   Derived from site: In situ; Placenta, caruncle; UBERON=UBERON_0017259.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   BCEFi
AC   CVCL_B6MM
SY   Breast-derived CEF immortal
DR   Wikidata; Q111732954
RX   PubMed=11237869;
RX   PubMed=11420679;
RX   PubMed=11513975;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BCF1
AC   CVCL_C5FR
DR   Wikidata; Q116048578
RX   PubMed=1371253;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01495; Centruroides noxius toxin Cn2.
CC   Monoclonal antibody target: UniProtKB; P80076; Centruroides noxius toxin Cn3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BCF2
AC   CVCL_C5FS
DR   Wikidata; Q116048579
RX   PubMed=1371253;
RX   PubMed=10451557;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01495; Centruroides noxius toxin Cn2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BCF23
AC   CVCL_C8D0
SY   Bactrian Camel Fibroblast 23
DR   Wikidata; Q123030764
RX   PubMed=37374120;
CC   Group: Endangered species/breed cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Testis, epididymis, epithelium; UBERON=UBERON_0004544.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   2Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   BCF3
AC   CVCL_C5FT
DR   Wikidata; Q116048580
RX   PubMed=1371253;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01495; Centruroides noxius toxin Cn2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BCF7
AC   CVCL_C5FU
DR   Wikidata; Q116048581
RX   PubMed=1371253;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01495; Centruroides noxius toxin Cn2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BCF8
AC   CVCL_C5FV
DR   Wikidata; Q116048582
RX   PubMed=1371253;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01495; Centruroides noxius toxin Cn2.
CC   Monoclonal antibody target: UniProtKB; P80076; Centruroides noxius toxin Cn3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BCF9
AC   CVCL_C5FW
DR   Wikidata; Q116048584
RX   PubMed=1371253;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01495; Centruroides noxius toxin Cn2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BCfc-2
AC   CVCL_C322
DR   RCB; AES0024
DR   RCB; RCB2173
DR   SKIP; SKIP001678
DR   Wikidata; Q54795345
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2173; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BCft-1
AC   CVCL_C323
DR   RCB; AES0022
DR   RCB; RCB2171
DR   SKIP; SKIP001677
DR   Wikidata; Q54795349
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2171; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BCH
AC   CVCL_B7K8
DR   Wikidata; Q112929281
RX   PubMed=1852002;
RX   PubMed=1864634;
RX   PubMed=9099848;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Glu381Ter (c.1141G>T) (G1256T); ClinVar=VCV000009541; Zygosity=Heterozygous (PubMed=9099848).
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; c.3317+1G>A (IVS18DS,G-A,+1) (del3349-3432); ClinVar=VCV000009542; Zygosity=Heterozygous (PubMed=9099848).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   BCH-30
AC   CVCL_UE98
DR   PRIDE; PXD006215
DR   Wikidata; Q93424028
RX   PubMed=28446606;
CC   Population: Caucasian; Spanish.
CC   HLA typing: A*02:01; B*51:08,40:01; C*16:02,03 (PubMed=28446606).
CC   Sequence variation: Mutation; HGNC; HGNC:18173; ERAP1; Simple; p.Met349Val (c.1045A>G); ClinVar=VCV002688496; Zygosity=Homozygous; Note=Allele ERAP1*001/Hap10 (PubMed=28446606).
CC   Sequence variation: Mutation; HGNC; HGNC:18173; ERAP1; Simple; p.Lys528Arg (c.1583A>G); ClinVar=VCV002688359; Zygosity=Homozygous; Note=Allele ERAP1*001/Hap10 (PubMed=28446606).
CC   Sequence variation: Mutation; HGNC; HGNC:18173; ERAP1; Simple; p.Asp575Asn (c.1723G>A); ClinVar=VCV002688495; Zygosity=Homozygous; Note=Allele ERAP1*001/Hap10 (PubMed=28446606).
CC   Sequence variation: Mutation; HGNC; HGNC:18173; ERAP1; Simple; p.Arg725Gln (c.2174G>A); ClinVar=VCV002688505; Zygosity=Homozygous; Note=Allele ERAP1*001/Hap10 (PubMed=28446606).
CC   Sequence variation: Mutation; HGNC; HGNC:18173; ERAP1; Simple; p.Gln730Glu (c.2188C>G); ClinVar=VCV002688532; Zygosity=Homozygous; Note=Allele ERAP1*001/Hap10 (PubMed=28446606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 10
//
ID   BCH-N-AD
AC   CVCL_B7KB
SY   Birmingham Children's Hospital-Neuroblastoma-AD
DR   CancerTools; 160622
DR   Wikidata; Q112929282
DR   Ximbio; 160622
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   BCH-N-DR
AC   CVCL_B7KC
SY   Birmingham Children's Hospital-Neuroblastoma-DR
DR   CancerTools; 160623
DR   Wikidata; Q112929283
DR   Ximbio; 160623
RX   PubMed=11675134;
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   BCH-N-DW
AC   CVCL_B7KD
SY   Birmingham Children's Hospital-Neuroblastoma-DW
DR   CancerTools; 160624
DR   Wikidata; Q112929284
DR   Ximbio; 160624
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   BCH-N-JW
AC   CVCL_B7KE
SY   Birmingham Children's Hospital-Neuroblastoma-JW
DR   CancerTools; 160625
DR   Wikidata; Q112929285
DR   Ximbio; 160625
RX   PubMed=11675134;
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   BCH-N-KB
AC   CVCL_B7KF
SY   Birmingham Children's Hospital-Neuroblastoma-KB
DR   CancerTools; 160626
DR   Wikidata; Q112929286
DR   Ximbio; 160626
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   BCH-N-KE
AC   CVCL_B7KG
SY   Birmingham Children's Hospital-Neuroblastoma-KE
DR   CancerTools; 160627
DR   Wikidata; Q112929287
DR   Ximbio; 160627
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   BCH-N-LR
AC   CVCL_B7KH
SY   Birmingham Children's Hospital-Neuroblastoma-LR
DR   CancerTools; 160628
DR   Wikidata; Q112929288
DR   Ximbio; 160628
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   BCH-N-MS
AC   CVCL_B7KI
SY   Birmingham Children's Hospital-Neuroblastoma-MS
DR   CancerTools; 160629
DR   Wikidata; Q112929289
DR   Ximbio; 160629
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   BCH-N-NS
AC   CVCL_B7KJ
SY   Birmingham Children's Hospital-Neuroblastoma-NS
DR   CancerTools; 160630
DR   Wikidata; Q112929290
DR   Ximbio; 160630
RX   PubMed=17506115;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   BCH-N-SL
AC   CVCL_B7KK
SY   Birmingham Children's Hospital-Neuroblastoma-SL
DR   CancerTools; 160631
DR   Wikidata; Q112929291
DR   Ximbio; 160631
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 4
//
ID   BCH-P-SS
AC   CVCL_B7LF
SY   Birmingham Children's Hospital-PNET-SS
DR   CancerTools; 160632
DR   Wikidata; Q112929292
DR   Ximbio; 160632
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   BCH-RB31
AC   CVCL_B7KL
SY   Birmingham Children's Hospital-Retinoblastoma 31
DR   CancerTools; 160635
DR   Wikidata; Q112929293
DR   Ximbio; 160635
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Asp1581Glyfs*15 (c.4742_4976del) (p.Asp1547Glyfs*15, c.4640_4874del); Zygosity=Unspecified (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser347fs (c.1039dupT); ClinVar=VCV002920668; Zygosity=Unspecified (CHECT).
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y7M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB32
AC   CVCL_B7KM
SY   Birmingham Children's Hospital-Retinoblastoma 32
DR   CancerTools; 160617
DR   Wikidata; Q112929294
DR   Ximbio; 160617
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Gln308Ter (c.922C>T); ClinVar=VCV002094186; Zygosity=Unspecified (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB33
AC   CVCL_B7KN
SY   Birmingham Children's Hospital-Retinoblastoma 33
DR   CancerTools; 160603
DR   Wikidata; Q112929295
DR   Ximbio; 160603
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB34
AC   CVCL_B7KP
SY   Birmingham Children's Hospital-Retinoblastoma 34
DR   CancerTools; 160608
DR   Wikidata; Q112929296
DR   Ximbio; 160608
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB35
AC   CVCL_B7KQ
SY   Birmingham Children's Hospital-Retinoblastoma 35
DR   CancerTools; 160636
DR   Wikidata; Q112929297
DR   Ximbio; 160636
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Cys1080Ter (c.3238_3239ins); Zygosity=Unspecified (CHECT).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y2M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB36
AC   CVCL_B7KR
SY   Birmingham Children's Hospital-Retinoblastoma 36
DR   CancerTools; 160607
DR   Wikidata; Q112929298
DR   Ximbio; 160607
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Leu1284Serfs*1 (c.4211_4791del) (p.Leu1250Serfs*1, c.4109_4689del); Zygosity=Unspecified (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg251Ter (c.751C>T); ClinVar=VCV000428681; Zygosity=Heterozygous (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Heterozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y7M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB37
AC   CVCL_B7KS
SY   Birmingham Children's Hospital-Retinoblastoma 37
DR   CancerTools; 160597
DR   Wikidata; Q112929299
DR   Ximbio; 160597
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Val1237Glyfs*8 (c.3709dupG) (p.Val1203Glyfs*8, c.3607dupG); Zygosity=Unspecified (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln62Ter (c.184C>T); ClinVar=VCV001417347; Zygosity=Homozygous (CHECT).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y1M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB38
AC   CVCL_B7KT
SY   Birmingham Children's Hospital-Retinoblastoma 38
DR   CancerTools; 160613
DR   Wikidata; Q112929300
DR   Ximbio; 160613
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Leu775Ter (c.2324T>A); Zygosity=Unspecified (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1961-1G>T; ClinVar=VCV000930927; Zygosity=Heterozygous; Note=Splice acceptor mutation (CHECT).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB39
AC   CVCL_B7KU
SY   Birmingham Children's Hospital-Retinoblastoma 39
DR   CancerTools; 160619
DR   Wikidata; Q112929301
DR   Ximbio; 160619
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Glu1114Ter (c.3340G>T); Zygosity=Unspecified (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln354Glufs*7 (c.1060_1061delCA); ClinVar=VCV000126828; Zygosity=Homozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB40
AC   CVCL_B7KV
SY   Birmingham Children's Hospital-Retinoblastoma 40
DR   CancerTools; 160611
DR   Wikidata; Q112929302
DR   Ximbio; 160611
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB41
AC   CVCL_B7KW
SY   Birmingham Children's Hospital-Retinoblastoma 41
DR   CancerTools; 160634
DR   Wikidata; Q112929303
DR   Ximbio; 160634
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB42
AC   CVCL_B7KX
SY   Birmingham Children's Hospital-Retinoblastoma 42
DR   CancerTools; 160616
DR   Wikidata; Q112929304
DR   Ximbio; 160616
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Heterozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB43
AC   CVCL_B7KY
SY   Birmingham Children's Hospital-Retinoblastoma 43
DR   CancerTools; 160610
DR   Wikidata; Q112929305
DR   Ximbio; 160610
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y7M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB44
AC   CVCL_B7KZ
SY   Birmingham Children's Hospital-Retinoblastoma 44
DR   CancerTools; 160598
DR   Wikidata; Q112929306
DR   Ximbio; 160598
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB45
AC   CVCL_B7L0
SY   Birmingham Children's Hospital-Retinoblastoma 45
DR   CancerTools; 160618
DR   Wikidata; Q112929307
DR   Ximbio; 160618
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Unspecified (CHECT).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB46
AC   CVCL_B7L1
SY   Birmingham Children's Hospital-Retinoblastoma 46
DR   CancerTools; 160609
DR   Wikidata; Q112929308
DR   Ximbio; 160609
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Ser1127Argfs*25 (c.3381_3402del); Zygosity=Unspecified (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex24-27del; Zygosity=Unspecified (CHECT).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y2M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB47
AC   CVCL_B7L2
SY   Birmingham Children's Hospital-Retinoblastoma 47
DR   CancerTools; 160599
DR   Wikidata; Q112929309
DR   Ximbio; 160599
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT).
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y11M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB48
AC   CVCL_B7L3
SY   Birmingham Children's Hospital-Retinoblastoma 48
DR   CancerTools; 160606
DR   Wikidata; Q112929310
DR   Ximbio; 160606
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 4
//
ID   BCH-RB49
AC   CVCL_B7L4
SY   Birmingham Children's Hospital-Retinoblastoma 49
DR   CancerTools; 160614
DR   Wikidata; Q112929311
DR   Ximbio; 160614
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000092839; Zygosity=Homozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y4M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB50
AC   CVCL_B7L5
SY   Birmingham Children's Hospital-Retinoblastoma 50
DR   CancerTools; 160604
DR   Wikidata; Q112929312
DR   Ximbio; 160604
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Glu1114Serfs*45 (c.3340delG); Zygosity=Unspecified (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB51
AC   CVCL_B7L6
SY   Birmingham Children's Hospital-Retinoblastoma 51
DR   CancerTools; 160612
DR   Wikidata; Q112929313
DR   Ximbio; 160612
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln685Ter (c.2053C>T); ClinVar=VCV000237668; Zygosity=Heterozygous (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2520+1G>C; ClinVar=VCV003237106; Note=Splice donor mutation; Zygosity=Mosaic (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB52
AC   CVCL_B7L7
SY   Birmingham Children's Hospital-Retinoblastoma 52
DR   CancerTools; 160615
DR   Wikidata; Q112929314
DR   Ximbio; 160615
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.380+1G>A; ClinVar=VCV000428727; Note=Splice donor mutation; Zygosity=Heterozygous (CHECT).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg787Ter (c.2359C>T); ClinVar=VCV000013073; Zygosity=Heterozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB53
AC   CVCL_B7L8
SY   Birmingham Children's Hospital-Retinoblastoma 53
DR   CancerTools; 160621
DR   Wikidata; Q112929315
DR   Ximbio; 160621
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg255Ter (c.763C>T); ClinVar=VCV000126820; Zygosity=Unspecified (CHECT).
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y10M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB54
AC   CVCL_B7L9
SY   Birmingham Children's Hospital-Retinoblastoma 54
DR   CancerTools; 160602
DR   Wikidata; Q112929316
DR   Ximbio; 160602
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg418Serfs*9 (c.1251_1252delAA); ClinVar=VCV000428712; Zygosity=Homozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y9M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB55
AC   CVCL_B7LA
SY   Birmingham Children's Hospital-Retinoblastoma 55
DR   CancerTools; 160600
DR   Wikidata; Q112929317
DR   Ximbio; 160600
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Homozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y3M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB56
AC   CVCL_B7LB
SY   Birmingham Children's Hospital-Retinoblastoma 56
DR   CancerTools; 160601
DR   Wikidata; Q112929318
DR   Ximbio; 160601
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser485Tyrfs*9 (c.1454_1457delCTTT); ClinVar=VCV000847352; Zygosity=Homozygous (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y5M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB57
AC   CVCL_B7LC
SY   Birmingham Children's Hospital-Retinoblastoma 57
DR   CancerTools; 160620
DR   Wikidata; Q112929319
DR   Ximbio; 160620
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Mosaic (CHECT).
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB58
AC   CVCL_B7LD
SY   Birmingham Children's Hospital-Retinoblastoma 58
DR   CancerTools; 160633
DR   Wikidata; Q112929320
DR   Ximbio; 160633
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH-RB59
AC   CVCL_B7LE
SY   Birmingham Children's Hospital-Retinoblastoma 59
DR   CancerTools; 160605
DR   Wikidata; Q112929321
DR   Ximbio; 160605
WW   Info; -; -; https://chect.org.uk/wp-content/uploads/2022/01/McConville_Final-Report-Tables-Figures_final.pdf
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BCH001
AC   CVCL_A8ZD
SY   BCH001-iPSC; iPSC-RET
DR   Wikidata; Q108819913
RX   PubMed=34087988;
CC   From: Beijing Children's Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; c.2608-125C>T; Zygosity=Heterozygous (PubMed=34087988).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34087988
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D12S391: 18,20
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 14,15.2
ST   D21S11: 30,32.2
ST   D2S1338: 18,23
ST   D2S441: 11.3,12
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D6S1043: 13,19
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 12,23
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y2M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   BCH869
AC   CVCL_C1MH
SY   BT869; Boston Children's Hospital 869
DR   cancercelllines; CVCL_C1MH
DR   GEO; GSM5434606
DR   GEO; GSM5434607
DR   GEO; GSM5434608
DR   GEO; GSM5434609
DR   GEO; GSM5434610
DR   GEO; GSM5434611
DR   GEO; GSM5434612
DR   GEO; GSM5434613
DR   GEO; GSM5434614
DR   GEO; GSM5434615
DR   GEO; GSM5434616
DR   GEO; GSM5434617
DR   Millipore; SCC218
DR   Wikidata; Q114310689
RX   Patent=US20200384022;
RX   PubMed=29674595;
RX   PubMed=29760046;
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Unspecified (PubMed=29674595).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (Patent=US20200384022; PubMed=29674595).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu39Lys (c.115G>A); Zygosity=Unspecified (PubMed=29674595).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly1007Arg (c.3019G>C); Zygosity=Unspecified (PubMed=29674595).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Gln510fs (c.1529delA); Zygosity=Unspecified (PubMed=29674595).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): Millipore=SCC218
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D18S51: 16,19
ST   D21S11: 30,30.2
ST   D3S1358: 16,18
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 11,12
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BCHCNi001-A
AC   CVCL_B5RW
DR   hPSCreg; BCHCNi001-A
DR   Wikidata; Q111732955
RX   PubMed=34953328;
CC   From: Department of Neurology, Beijing Children's Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:25695; CARS2; Simple; p.Gly476Arg (c.1426G>A); Zygosity=Homozygous (PubMed=34953328).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185238; Combined oxidative phosphorylation deficiency 27
DI   ORDO; Orphanet_477774; Combined oxidative phosphorylation defect type 27
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   BCHi001-A
AC   CVCL_A7JZ
SY   HNDS0022-01 #A
DR   hPSCreg; BCHi001-A
DR   Wikidata; Q107113436
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Val718Met (c.2152G>A); ClinVar=VCV000143796; Zygosity=Mosaic (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KA ! BCHi001-B
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi001-B
AC   CVCL_A7KA
SY   HNDS0022-01 #D
DR   hPSCreg; BCHi001-B
DR   Wikidata; Q107113437
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient that is mosaic for a CDKL5 p.Val718Met mutation, but this cell line does not contain this mutation.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JZ ! BCHi001-A
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   BCHi002-A
AC   CVCL_A7KB
SY   HNDS0039-01 #B
DR   hPSCreg; BCHi002-A
DR   Wikidata; Q107113438
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg558Thrfs*9 (c.1671dupA) (c.1671_1672insA); ClinVar=VCV000156643; Zygosity=Heterozygous (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KC ! BCHi002-B
SX   Female
AG   3Y1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi002-B
AC   CVCL_A7KC
SY   HNDS0039-01 #C
DR   hPSCreg; BCHi002-B
DR   Wikidata; Q107113439
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg558Thrfs*9 (c.1671dupA) (c.1671_1672insA); ClinVar=VCV000156643; Zygosity=Heterozygous (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KB ! BCHi002-A
SX   Female
AG   3Y1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi003-A
AC   CVCL_A7KD
SY   HNDS0059-01 #A
DR   hPSCreg; BCHi003-A
DR   Wikidata; Q107113440
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient that is mosaic for a CDKL5 p.Leu629Ter mutation, but this cell line does not contain this mutation.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KE ! BCHi003-B
SX   Male
AG   2Y11M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   BCHi003-B
AC   CVCL_A7KE
SY   HNDS0059-01 #C
DR   hPSCreg; BCHi003-B
DR   Wikidata; Q107113441
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Leu629Ter (c.1886T>A); Zygosity=Mosaic (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KD ! BCHi003-A
SX   Male
AG   2Y11M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi004-A
AC   CVCL_A7KF
SY   HNDS0050-01 #D
DR   hPSCreg; BCHi004-A
DR   Wikidata; Q107113442
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient that is mosaic for a CDKL5 p.Asp135Gly mutation, but this cell line does not contain this mutation.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KG ! BCHi004-B
SX   Male
AG   26Y10M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   BCHi004-B
AC   CVCL_A7KG
SY   HNDS0050-01 #E
DR   hPSCreg; BCHi004-B
DR   Wikidata; Q107113443
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Asp135Gly (c.404A>G); Zygosity=Mosaic (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KF ! BCHi004-A
SX   Male
AG   26Y10M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi005-A
AC   CVCL_A7KH
SY   HNDS0083-01 #B
DR   hPSCreg; BCHi005-A
DR   Wikidata; Q107113444
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg550Ter (c.1648C>T); ClinVar=VCV000143780; Zygosity=Heterozygous (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KI ! BCHi005-B
SX   Female
AG   1Y10M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi005-B
AC   CVCL_A7KI
SY   HNDS0083-01 #D
DR   hPSCreg; BCHi005-B
DR   Wikidata; Q107113445
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg550Ter (c.1648C>T); ClinVar=VCV000143780; Zygosity=Heterozygous (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KH ! BCHi005-A
SX   Female
AG   1Y10M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi006-A
AC   CVCL_A7KJ
SY   MAN0855-01 #A
DR   hPSCreg; BCHi006-A
DR   Wikidata; Q107113447
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Asp471Glufs*37 (c.1412delA); Zygosity=Heterozygous (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KK ! BCHi006-B
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi006-B
AC   CVCL_A7KK
SY   MAN0855-01 #D
DR   hPSCreg; BCHi006-B
DR   Wikidata; Q107113448
RX   PubMed=33714067;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Asp471Glufs*37 (c.1412delA); Zygosity=Heterozygous (PubMed=33714067).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KJ ! BCHi006-A
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BCHi007-A
AC   CVCL_D6RV
SY   HNDS0005-01 #B
DR   BioSamples; SAMEA115476580
DR   hPSCreg; BCHi007-A
RX   PubMed=38677032;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple; p.Gly409Asp (c.1226G>A); ClinVar=VCV000001359; Zygosity=Homozygous (PubMed=38677032).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206527; Succinic semialdehyde dehydrogenase deficiency
DI   ORDO; Orphanet_22; Succinic semialdehyde dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BCHi007-A-1
AC   CVCL_D6RW
SY   HNDS0005-01 #B2 +/+
DR   BioSamples; SAMEA115476582
DR   hPSCreg; BCHi007-A-1
RX   PubMed=38677032;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple_corrected; p.Gly409Asp (c.1226G>A); ClinVar=VCV000001359; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38677032).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206527; Succinic semialdehyde dehydrogenase deficiency
DI   ORDO; Orphanet_22; Succinic semialdehyde dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6RV ! BCHi007-A
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BCHi008-A
AC   CVCL_E3R0
SY   HNDS005-02 #A
DR   hPSCreg; BCHi008-A
CC   From: Children's Hospital Boston; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BCHi009-A
AC   CVCL_D6RX
SY   HNDS0002-01 #D
DR   BioSamples; SAMEA115476583
DR   hPSCreg; BCHi009-A
RX   PubMed=38677032;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple; p.Trp204Ter (c.612G>A); ClinVar=VCV000001357; Zygosity=Homozygous (PubMed=38677032).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206527; Succinic semialdehyde dehydrogenase deficiency
DI   ORDO; Orphanet_22; Succinic semialdehyde dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BCHi009-A-1
AC   CVCL_D6RY
SY   HNDS0002-01 #D CC26 +/+
DR   BioSamples; SAMEA115476585
DR   hPSCreg; BCHi009-A-1
RX   PubMed=38677032;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple_corrected; p.Trp204Ter (c.612G>A); ClinVar=VCV000001357; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38677032).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206527; Succinic semialdehyde dehydrogenase deficiency
DI   ORDO; Orphanet_22; Succinic semialdehyde dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6RX ! BCHi009-A
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BCHi010-A
AC   CVCL_E3R1
SY   HNDS002-03 #A
DR   hPSCreg; BCHi010-A
CC   From: Children's Hospital Boston; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BCHi011-A
AC   CVCL_D6RZ
SY   HNDS0003-01 #F
DR   BioSamples; SAMEA115476586
DR   hPSCreg; BCHi011-A
RX   PubMed=38677032;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple; p.Trp204Ter (c.612G>A); ClinVar=VCV000001357; Zygosity=Heterozygous (PubMed=38677032).
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple; p.Arg412Ter (c.1234C>T); ClinVar=VCV000001358; Zygosity=Heterozygous (PubMed=38677032).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206527; Succinic semialdehyde dehydrogenase deficiency
DI   ORDO; Orphanet_22; Succinic semialdehyde dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BCHi011-A-1
AC   CVCL_D6S0
SY   HNDS0003-01 #F CC39 +/+
DR   BioSamples; SAMEA115476588
DR   hPSCreg; BCHi011-A-1
RX   PubMed=38677032;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple_corrected; p.Trp204Ter (c.612G>A); ClinVar=VCV000001357; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38677032).
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple_corrected; p.Arg412Ter (c.1234C>T); ClinVar=VCV000001358; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38677032).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206527; Succinic semialdehyde dehydrogenase deficiency
DI   ORDO; Orphanet_22; Succinic semialdehyde dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6RZ ! BCHi011-A
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BCHi012-A
AC   CVCL_E3R2
SY   HNDS003-03 #B
DR   hPSCreg; BCHi012-A
CC   From: Children's Hospital Boston; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BCHi013-A
AC   CVCL_E3R3
SY   HNDS0143-01#A
DR   BioSamples; SAMEA115294446
DR   hPSCreg; BCHi013-A
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BCHNCi003-A
AC   CVCL_D0VM
DR   BioSamples; SAMEA114246936
DR   hPSCreg; BCHNCi003-A
DR   Wikidata; Q123030765
RX   PubMed=37769383;
CC   From: Department of Neurology, Beijing Children's Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:21606; MPC1; Simple; p.Ala70Thr (c.208G>A); ClinVar=VCV001236162; Zygosity=Heterozygous (PubMed=37769383).
CC   Sequence variation: Mutation; HGNC; HGNC:21606; MPC1; Simple; p.Arg97Gln (c.290G>A); ClinVar=VCV001236163; Zygosity=Heterozygous (PubMed=37769383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202117; Mitochondrial pyruvate carrier deficiency
DI   ORDO; Orphanet_447784; Mitochondrial pyruvate carrier deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BCHNDi001-A
AC   CVCL_D6NP
DR   BioSamples; SAMEA114745477
DR   hPSCreg; BCHNDi001-A
RX   PubMed=38387170;
CC   From: Department of Neurology, Beijing Children's Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:25576; NAXD; Simple; p.Thr35Phefs*63 (c.102_103delAT) (c.101_102delTA); ClinVar=VCV001703003; Zygosity=Heterozygous (PubMed=38387170).
CC   Sequence variation: Mutation; HGNC; HGNC:25576; NAXD; Simple; p.Ile106Met (c.318C>G); ClinVar=VCV001703002; Zygosity=Heterozygous (PubMed=38387170).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206115; Early-onset progressive encephalopathy with brain edema and/or leukoencephalopathy 2
DI   ORDO; Orphanet_555402; NAD(P)HX dehydratase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BCHNEi001-A
AC   CVCL_C4S7
SY   BCHNCi001-A
DR   BioSamples; SAMEA111439174
DR   hPSCreg; BCHNCi001-A
DR   hPSCreg; BCHNEi001-A
DR   Wikidata; Q116048585
RX   PubMed=36283272;
CC   From: Department of Neurology, Beijing Children's Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1424; CAD; Simple; p.Tyr36Tyrfs*15 (c.108delC); Zygosity=Heterozygous (PubMed=36283272).
CC   Sequence variation: Mutation; HGNC; HGNC:1424; CAD; Simple; p.Val1259Met (c.3775G>A); Zygosity=Heterozygous (PubMed=36283272).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C190868; Developmental and epileptic encephalopathy 50
DI   ORDO; Orphanet_448010; CAD-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   BCHNEi002-A
AC   CVCL_C4S8
SY   BCHNCi002-A
DR   hPSCreg; BCHNCi002-A
DR   hPSCreg; BCHNEi002-A
DR   Wikidata; Q116048586
CC   From: Department of Neurology, Beijing Children's Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BCHNEUi001-A
AC   CVCL_XJ15
SY   HNDS_0052-01
DR   hPSCreg; BCHNEUi001-A
DR   Wikidata; Q93424032
RX   PubMed=31525725;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; p.Thr387Argfs*30 (c.1160_1161delCA); ClinVar=VCV000156414; Zygosity=Heterozygous (PubMed=31525725).
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; p.Arg449Ter (c.1345A>T); ClinVar=VCV000521444; Zygosity=Heterozygous (PubMed=31525725).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164224; Spastic paraplegia 47
DI   ORDO; Orphanet_280763; Severe intellectual disability and progressive spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   BCHNEUi002-A
AC   CVCL_XJ16
SY   HNDS_0052-03
DR   hPSCreg; BCHNEUi002-A
DR   Wikidata; Q93424036
RX   PubMed=31525725;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; p.Thr387Argfs*30 (c.1160_1161delCA); ClinVar=VCV000156414; Zygosity=Heterozygous (PubMed=31525725).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   BCHNEUi003-A
AC   CVCL_XJ17
SY   HNDS_0054-01
DR   hPSCreg; BCHNEUi003-A
DR   Wikidata; Q93424040
RX   PubMed=31525725;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; c.114-2A>C; ClinVar=VCV000252667; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31525725).
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; p.Asn178Glufs*20 (c.530_531insA); ClinVar=VCV000252668; Zygosity=Heterozygous (PubMed=31525725).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164224; Spastic paraplegia 47
DI   ORDO; Orphanet_280763; Severe intellectual disability and progressive spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   BCHNEUi004-A
AC   CVCL_XJ18
SY   HNDS_0054-02
DR   hPSCreg; BCHNEUi004-A
DR   Wikidata; Q93424043
RX   PubMed=31525725;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; c.114-2A>C; ClinVar=VCV000252667; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31525725).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   BCHNEUi005-A
AC   CVCL_XJ19
SY   HNDS_0058-01
DR   hPSCreg; BCHNEUi005-A
DR   Wikidata; Q93424046
RX   PubMed=31525725;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; p.Arg406Ter (c.1216C>T); ClinVar=VCV000422147; Zygosity=Heterozygous (PubMed=31525725).
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; p.Leu443Pro (c.1328T>C); ClinVar=VCV000389026; Zygosity=Heterozygous (PubMed=31525725).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164224; Spastic paraplegia 47
DI   ORDO; Orphanet_280763; Severe intellectual disability and progressive spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y9M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   BCHNEUi006-A
AC   CVCL_XJ20
SY   HNDS_0058-02
DR   hPSCreg; BCHNEUi006-A
DR   Wikidata; Q93424049
RX   PubMed=31525725;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:572; AP4B1; Simple; p.Leu443Pro (c.1328T>C); ClinVar=VCV000389026; Zygosity=Heterozygous (PubMed=31525725).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   BCHNEUi007-A
AC   CVCL_A8KX
SY   DEF_1726-01; HNC_1726_01
DR   hPSCreg; BCHNEUi007-A
DR   Wikidata; Q108819914
RX   PubMed=34087981;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Glu232Glyfs*21 (c.694dupG); ClinVar=VCV000818030; Zygosity=Heterozygous (PubMed=34087981).
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000561150; Zygosity=Heterozygous (PubMed=34087981).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179863; Spastic paraplegia 50
DI   ORDO; Orphanet_210141; Inherited congenital spastic tetraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BCHNEUi008-A
AC   CVCL_A8KY
SY   DEF_1726-03; HNC_1726_03
DR   hPSCreg; BCHNEUi008-A
DR   Wikidata; Q108819915
RX   PubMed=34087981;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Glu232Glyfs*21 (c.694dupG); ClinVar=VCV000818030; Zygosity=Heterozygous (PubMed=34087981).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BCHNEUi009-A
AC   CVCL_A8KZ
SY   DEF_1779-01; HNC_1779_01
DR   hPSCreg; BCHNEUi009-A
DR   Wikidata; Q108819916
RX   PubMed=34087981;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Thr69Pro (c.205A>C); ClinVar=VCV001306889; Zygosity=Heterozygous (PubMed=34087981).
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; c.1025+2dupT; ClinVar=rs750223135; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34087981).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179863; Spastic paraplegia 50
DI   ORDO; Orphanet_210141; Inherited congenital spastic tetraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   BCHNEUi010-A
AC   CVCL_A8LA
SY   DEF_1779-03; HNC_1779_03
DR   hPSCreg; BCHNEUi010-A
DR   Wikidata; Q108819917
RX   PubMed=34087981;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; c.1025+2dupT; ClinVar=rs750223135; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34087981).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   BCHNEUi011-A
AC   CVCL_A8LB
SY   DEF_1586-01; HNC_1586_01
DR   hPSCreg; BCHNEUi011-A
DR   Wikidata; Q108819918
RX   PubMed=34087981;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Asn73Lysfs*43 (c.218dupA); ClinVar=VCV000450739; Zygosity=Heterozygous (PubMed=34087981).
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Tyr284Ser (c.851A>C); ClinVar=VCV000471069; Zygosity=Heterozygous (PubMed=34087981).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179863; Spastic paraplegia 50
DI   ORDO; Orphanet_210141; Inherited congenital spastic tetraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BCHNEUi012-A
AC   CVCL_A8LC
SY   DEF_1586-03; HNC_1586_03
DR   hPSCreg; BCHNEUi012-A
DR   Wikidata; Q108819919
RX   PubMed=34087981;
CC   From: Department of Neurology, Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Asn73Lysfs*43 (c.218dupA); ClinVar=VCV000450739; Zygosity=Heterozygous (PubMed=34087981).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BCHNi001-A
AC   CVCL_A0LI
SY   BCHi001-A
DR   BioSamples; SAMEA9465455
DR   hPSCreg; BCHNi001-A
DR   Wikidata; Q108819920
RX   PubMed=34146953;
CC   From: Department of Nephrology, Beijing Children's Hospital Affiliated to Capital Medical University; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:18758; BBS7; Simple; p.Asp252Asn (c.754G>A); Zygosity=Heterozygous (PubMed=34146953).
CC   Sequence variation: Mutation; HGNC; HGNC:18758; BBS7; Simple; c.849+1G>C; ClinVar=VCV001507819; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34146953).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BCHSCTi001-A
AC   CVCL_B0P8
SY   HA-iPSC
DR   hPSCreg; BCHSCTi001-A
DR   Wikidata; Q108819921
RX   PubMed=34496342;
CC   From: Department of Hematopoietic Stem Cell Transplatation, Beijing Children's Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3546; F8; Simple; p.Arg391Cys (c.1171C>T); ClinVar=VCV000010125; Zygosity=Hemizygous (PubMed=34496342).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   BCi-NS1
AC   CVCL_T028
SY   Basal Cells immortalized-NonSmoker 1
DR   Wikidata; Q54795350
RX   PubMed=24298994;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   BCi-NS1.1
AC   CVCL_T029
SY   Basal Cells immortalized-NonSmoker 1.1
DR   Wikidata; Q54795353
RX   PubMed=24298994;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T028 ! BCi-NS1
SX   Male
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   bciPSC-A1
AC   CVCL_C8DC
DR   Wikidata; Q123030766
RX   PubMed=36768240;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
OI   CVCL_C8DD ! bciPSC-A2
OI   CVCL_C8DE ! bciPSC-A3
OI   CVCL_C8DF ! bciPSC-A6
OI   CVCL_C8DG ! bciPSC-A7
OI   CVCL_C8DH ! bciPSC-A23
OI   CVCL_C8DI ! bciPSC-B13
SX   Sex unspecified
AG   3FM
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   bciPSC-A2
AC   CVCL_C8DD
DR   Wikidata; Q123030767
RX   PubMed=36768240;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
OI   CVCL_C8DC ! bciPSC-A1
OI   CVCL_C8DE ! bciPSC-A3
OI   CVCL_C8DF ! bciPSC-A6
OI   CVCL_C8DG ! bciPSC-A7
OI   CVCL_C8DH ! bciPSC-A23
OI   CVCL_C8DI ! bciPSC-B13
SX   Sex unspecified
AG   3FM
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   bciPSC-A23
AC   CVCL_C8DH
DR   Wikidata; Q123030768
RX   PubMed=36768240;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
OI   CVCL_C8DC ! bciPSC-A1
OI   CVCL_C8DD ! bciPSC-A2
OI   CVCL_C8DE ! bciPSC-A3
OI   CVCL_C8DF ! bciPSC-A6
OI   CVCL_C8DG ! bciPSC-A7
OI   CVCL_C8DI ! bciPSC-B13
SX   Sex unspecified
AG   3FM
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   bciPSC-A3
AC   CVCL_C8DE
DR   Wikidata; Q123030769
RX   PubMed=36768240;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
OI   CVCL_C8DC ! bciPSC-A1
OI   CVCL_C8DD ! bciPSC-A2
OI   CVCL_C8DF ! bciPSC-A6
OI   CVCL_C8DG ! bciPSC-A7
OI   CVCL_C8DH ! bciPSC-A23
OI   CVCL_C8DI ! bciPSC-B13
SX   Sex unspecified
AG   3FM
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   bciPSC-A6
AC   CVCL_C8DF
DR   Wikidata; Q123030771
RX   PubMed=36768240;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
OI   CVCL_C8DC ! bciPSC-A1
OI   CVCL_C8DD ! bciPSC-A2
OI   CVCL_C8DE ! bciPSC-A3
OI   CVCL_C8DG ! bciPSC-A7
OI   CVCL_C8DH ! bciPSC-A23
OI   CVCL_C8DI ! bciPSC-B13
SX   Sex unspecified
AG   3FM
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   bciPSC-A7
AC   CVCL_C8DG
DR   Wikidata; Q123030772
RX   PubMed=36768240;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
OI   CVCL_C8DC ! bciPSC-A1
OI   CVCL_C8DD ! bciPSC-A2
OI   CVCL_C8DE ! bciPSC-A3
OI   CVCL_C8DF ! bciPSC-A6
OI   CVCL_C8DH ! bciPSC-A23
OI   CVCL_C8DI ! bciPSC-B13
SX   Sex unspecified
AG   3FM
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   bciPSC-B13
AC   CVCL_C8DI
DR   Wikidata; Q123030774
RX   PubMed=36768240;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
OI   CVCL_C8DC ! bciPSC-A1
OI   CVCL_C8DD ! bciPSC-A2
OI   CVCL_C8DE ! bciPSC-A3
OI   CVCL_C8DF ! bciPSC-A6
OI   CVCL_C8DG ! bciPSC-A7
OI   CVCL_C8DH ! bciPSC-A23
SX   Sex unspecified
AG   3FM
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   BCIRL-AG-AM1
AC   CVCL_Z395
SY   BCIRL-AgAM1; BCIRL-AG-AM
DR   ICLDB; bcirl-agam1
DR   Wikidata; Q54795356
RX   DOI=10.1016/0022-2011(89)90145-6;
RX   DOI=10.1016/0022-2011(91)90151-F;
RX   PubMed=8799737;
RX   PubMed=10777062;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=129554; ! Anticarsia gemmatalis (Velvetbean caterpillar moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-AtE-CLG11
AC   CVCL_IV46
SY   AtE-CLG11
DR   ICLDB; bcirl-ate-clg11
DR   Wikidata; Q54795357
RX   PubMed=28205141;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=236421; ! Anasa tristis (Squash bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-AtE-CLG15
AC   CVCL_IV47
SY   AtE-CLG15
DR   ICLDB; bcirl-ate-clg15
DR   Wikidata; Q54795360
RX   PubMed=28205141;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=236421; ! Anasa tristis (Squash bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-AtE-CLG15A
AC   CVCL_IV48
SY   AtE-CLG15A; BCIRL-AtE-CLG15, subline A
DR   ICLDB; bcirl-ate-clg15a
DR   Wikidata; Q54795361
RX   PubMed=28205141;
CC   Group: Insect cell line.
CC   Doubling time: 190 hours (PubMed=28205141).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=236421; ! Anasa tristis (Squash bug)
HI   CVCL_IV47 ! BCIRL-AtE-CLG15
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-AtE-CLG15B
AC   CVCL_C2UV
SY   AtE-CLG15B; BCIRL-AtE-CLG15, subline B
DR   ICLDB; bcirl-ate-clg15b
DR   Wikidata; Q114310691
RX   PubMed=28205141;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=236421; ! Anasa tristis (Squash bug)
HI   CVCL_IV47 ! BCIRL-AtE-CLG15
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS
AC   CVCL_B0WH
SY   AtuE-1127
DR   ICLDB; bcirl-atue-1127-sgs
DR   Wikidata; Q108819922
RX   CelloPub=CLPUB00649;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   BCIRL-AtuE-1127-SGS A10
AC   CVCL_C2V5
DR   ICLDB; bcirl-atue-1127-sgs-a10
DR   Wikidata; Q114310693
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS A3
AC   CVCL_C2V6
DR   ICLDB; bcirl-atue-1127-sgs-a3
DR   Wikidata; Q114310694
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS B15
AC   CVCL_C2V7
DR   ICLDB; bcirl-atue-1127-sgs-b15
DR   Wikidata; Q114310695
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS B7
AC   CVCL_C2V8
DR   ICLDB; bcirl-atue-1127-sgs-b7
DR   Wikidata; Q114310696
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS C1
AC   CVCL_C2V9
DR   ICLDB; bcirl-atue-1127-sgs-c1
DR   Wikidata; Q114310697
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS C10R
AC   CVCL_C2VA
DR   ICLDB; bcirl-atue-1127-sgs-c10r
DR   Wikidata; Q114310698
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS C11
AC   CVCL_C2VB
DR   ICLDB; bcirl-atue-1127-sgs-c11
DR   Wikidata; Q114310699
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS C3
AC   CVCL_C2VC
DR   ICLDB; bcirl-atue-1127-sgs-c3
DR   Wikidata; Q114310700
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS D3a
AC   CVCL_C2VD
DR   ICLDB; bcirl-atue-1127-sgs-d3a
DR   Wikidata; Q114310701
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS D3b
AC   CVCL_C2VE
DR   ICLDB; bcirl-atue-1127-sgs-d3b
DR   Wikidata; Q114310702
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS D5
AC   CVCL_C2VF
DR   ICLDB; bcirl-atue-1127-sgs-d5
DR   Wikidata; Q114310703
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS E1
AC   CVCL_C2VG
DR   ICLDB; bcirl-atue-1127-sgs-e1
DR   Wikidata; Q114310704
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS H12
AC   CVCL_C2VH
DR   ICLDB; bcirl-atue-1127-sgs-h12
DR   Wikidata; Q114310705
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS H3
AC   CVCL_C2VI
DR   ICLDB; bcirl-atue-1127-sgs-h3
DR   Wikidata; Q114310706
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuE-1127-SGS H8
AC   CVCL_C2VJ
DR   ICLDB; bcirl-atue-1127-sgs-h8
DR   Wikidata; Q114310707
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WH ! BCIRL-AtuE-1127-SGS
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuNE-1129-SGS
AC   CVCL_B0WI
SY   AtuNE-1129
DR   ICLDB; bcirl-atune-1129-sgs
DR   Wikidata; Q108819923
RX   CelloPub=CLPUB00649;
CC   Group: Insect cell line.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
SX   Sex unspecified
AG   Embryonic stage and neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   BCIRL-AtuNE-1129-SGS D12
AC   CVCL_C2UQ
SY   AtuNE-1129-D12
DR   ICLDB; bcirl-atune-1129-sgs-d12
DR   Wikidata; Q114310708
CC   Group: Insect cell line.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WI ! BCIRL-AtuNE-1129-SGS
SX   Sex unspecified
AG   Embryonic stage and neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuNE-1129-SGS D6
AC   CVCL_C2UR
SY   AtuNE-1129-D6
DR   ICLDB; bcirl-atune-1129-sgs-d6
DR   Wikidata; Q114310709
CC   Group: Insect cell line.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WI ! BCIRL-AtuNE-1129-SGS
SX   Sex unspecified
AG   Embryonic stage and neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-AtuNE-1129-SGS F10
AC   CVCL_C2US
SY   AtuNE-1129-F10
DR   ICLDB; bcirl-atune-1129-sgs-f10
DR   Wikidata; Q114310710
CC   Group: Insect cell line.
OX   NCBI_TaxID=116153; ! Aethina tumida (Small hive beetle)
HI   CVCL_B0WI ! BCIRL-AtuNE-1129-SGS
SX   Sex unspecified
AG   Embryonic stage and neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-Cc-AM
AC   CVCL_Z421
SY   BCIRL-Cc-AM/JG Line A
DR   ICLDB; bcirl-cc-am
DR   Wikidata; Q54795401
RX   PubMed=22580906;
CC   Group: Insect cell line.
CC   Doubling time: 176.6 hours (Note=With daily medium change), 204.3 hours (Note=With weekly medium change) (PubMed=22580906).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=59379; ! Cactoblastis cactorum (Cactus moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BCIRL-Cc-JG
AC   CVCL_Z422
SY   BCIRL-Cc-AM/JG Line J
DR   ICLDB; bcirl-cc-jg
DR   Wikidata; Q54795403
RX   PubMed=22580906;
CC   Group: Insect cell line.
CC   Doubling time: 192.6 hours (Note=With daily medium change), 112 hours (Note=With weekly medium change) (PubMed=22580906).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=59379; ! Cactoblastis cactorum (Cactus moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BCIRL-DP-AM/JG
AC   CVCL_Z403
SY   BCIRL-Dp-AM/JG
DR   ICLDB; bcirl-dp-amjg
DR   Wikidata; Q54795404
RX   DOI=10.1303/aez.2009.331;
CC   Group: Insect cell line.
CC   Doubling time: 32 hours (DOI=10.1303/aez.2009.331).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13037; ! Danaus plexippus (Monarch butterfly)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL-HA-AM1
AC   CVCL_Z402
SY   BCIRL-HaAM1
DR   ICLDB; bcirl-haam1
DR   Wikidata; Q54795407
RX   DOI=10.1007/BF02619571;
RX   PubMed=8799737;
RX   PubMed=15038778;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Misspelling: BCRIL-HA-AM1; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL-HiE0122021-SGS
AC   CVCL_E1P6
RX   PubMed=38935254;
CC   Group: Insect cell line.
CC   Doubling time: 118 hours (PubMed=38935254).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=343691; ! Hermetia illucens (Black soldier fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BCIRL-HS-AM1
AC   CVCL_Z396
SY   BCIRL-HsAM1
DR   ICLDB; bcirl-hsam1
DR   Wikidata; Q54795409
RX   DOI=10.1016/0022-2011(89)90145-6;
RX   DOI=10.1016/0022-2011(91)90151-F;
RX   Patent=US5405770;
RX   PubMed=8799737;
RX   PubMed=10852353;
RX   PubMed=16409117;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=38041; ! Heliothis subflexa (Subflexus straw moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BCIRL-HV-AM-CL1
AC   CVCL_Z846
SY   BCIRL-HV-AMCL1
DR   ICLDB; bcirl-hv-am-cl1
DR   Wikidata; Q54795411
RX   PubMed=10777062;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
HI   CVCL_Z397 ! BCIRL-HV-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-HV-AM-CL2
AC   CVCL_Z858
SY   BCIRL-HV-AMCL2
DR   ICLDB; bcirl-hv-am-cl2
DR   Wikidata; Q54795412
RX   PubMed=10777062;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
HI   CVCL_Z397 ! BCIRL-HV-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-HV-AM-CL3
AC   CVCL_Z636
SY   BCIRL-HV-AMCL3
DR   ICLDB; bcirl-hv-am-cl3
DR   Wikidata; Q54795415
RX   PubMed=10777062;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
HI   CVCL_Z397 ! BCIRL-HV-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-HV-AM-CL5
AC   CVCL_Z637
SY   BCIRL-HV-AMCL5
DR   ICLDB; bcirl-hv-am-cl5
DR   Wikidata; Q54795416
RX   PubMed=10777062;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
HI   CVCL_Z397 ! BCIRL-HV-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-HV-AM-CL7
AC   CVCL_Z638
SY   BCIRL-HV-AMCL7
DR   ICLDB; bcirl-hv-am-cl7
DR   Wikidata; Q54795418
RX   PubMed=10777062;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
HI   CVCL_Z397 ! BCIRL-HV-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-HV-AM1
AC   CVCL_Z397
SY   BCIRL-Hv-AM1; BCIRL-HvAM1; HVAM1; HvAM1
DR   BTO; BTO_0006427
DR   ICLDB; bcirl-hv-am1
DR   Wikidata; Q54795420
RX   DOI=10.1007/BF02628399;
RX   DOI=10.1016/0022-2011(81)90084-7;
RX   DOI=10.1016/0022-2011(89)90145-6;
RX   DOI=10.1016/0022-2011(91)90151-F;
RX   DOI=10.1303/aez.18.262;
RX   DOI=10.3923/jas.2007.4040.4043;
RX   PubMed=8799737;
RX   PubMed=10777062;
RX   PubMed=10852353;
RX   PubMed=16409117;
RX   PubMed=23891577;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   BCIRL-HV-AM2
AC   CVCL_Z398
SY   BCIRL-HvAM2
DR   BTO; BTO_0006426
DR   ICLDB; bcirl-hv-am2
DR   Wikidata; Q54795421
RX   DOI=10.1007/BF02628399;
RX   DOI=10.1303/aez.18.262;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   BCIRL-HZ-AM1
AC   CVCL_Z399
SY   BCIRL-Hz-AM1; BCIRL-HZAM1; BCIRL-HzAM1; Hz-AM1; HZBCIRLAM1; AM1; Hz1
DR   BTO; BTO_0006423
DR   ICLDB; bcirl-hz-am1
DR   Wikidata; Q54795425
RX   DOI=10.1007/BF02626179;
RX   DOI=10.1016/0022-2011(81)90084-7;
RX   DOI=10.1016/0022-2011(89)90145-6;
RX   DOI=10.1016/0022-2011(91)90151-F;
RX   DOI=10.1303/aez.18.262;
RX   PubMed=1367489;
RX   PubMed=2022870;
RX   PubMed=8799737;
RX   PubMed=10777062;
RX   PubMed=15038778;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Doubling time: 22 hours (PubMed=2022870).
CC   Misspelling: BCRIL-HzAM1; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   BCIRL-HZ-AM1-A11
AC   CVCL_Z977
SY   BCIRL-HZ-AM1-11; HzAM1-A11; HZ-A11; BCIRL-HZ-AM1-CLA11; BCIRL-HZ-AM1CLA11; BCIRL-HzAM1-CLA11; BCIRL-HzAM1-Clone A11
DR   ICLDB; bcirl-hzam1-cla11-or-clone-a11
DR   Wikidata; Q54795427
RX   DOI=10.1303/aez.2001.349;
RX   PubMed=2022870;
RX   PubMed=8799737;
RX   PubMed=10475263;
RX   PubMed=15038778;
CC   Group: Insect cell line.
CC   Doubling time: 36 hours (PubMed=2022870).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z399 ! BCIRL-HZ-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL-HZ-AM1-A4
AC   CVCL_ZF43
SY   AM1-A4
DR   ICLDB; bcirl-hz-am1-a4
DR   Wikidata; Q98125544
RX   PubMed=2022870;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z399 ! BCIRL-HZ-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   BCIRL-HZ-AM1-A7
AC   CVCL_ZF44
SY   AM1-A7
DR   ICLDB; bcirl-hz-am1-a7
DR   Wikidata; Q98125545
RX   PubMed=2022870;
CC   Group: Insect cell line.
CC   Doubling time: 34 hours (PubMed=2022870).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z399 ! BCIRL-HZ-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   BCIRL-HZ-AM1-B3
AC   CVCL_ZF45
SY   AM1-B3; Hz1b3; BCIRL-Hz1b3
DR   ICLDB; bcirl-hz1b3
DR   Wikidata; Q98125547
RX   DOI=10.1007/BF02626179;
RX   PubMed=2022870;
CC   Group: Insect cell line.
CC   Doubling time: 24 hours (PubMed=2022870).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z399 ! BCIRL-HZ-AM1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   BCIRL-HZ-AM2
AC   CVCL_Z400
SY   BCIRL-Hz-AM2; BCIRL-HzAM2; AM2
DR   BTO; BTO_0006424
DR   ICLDB; bcirl-hz-am2
DR   Wikidata; Q54795429
RX   DOI=10.1016/0022-2011(81)90084-7;
RX   DOI=10.1303/aez.18.262;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   BCIRL-HZ-AM3
AC   CVCL_Z401
SY   BCIRL-Hz-AM3; BCIRL-HzAM3; AM3; Hz3
DR   BTO; BTO_0006425
DR   ICLDB; bcirl-hz-am3
DR   Wikidata; Q54795431
RX   DOI=10.1007/BF02626179;
RX   DOI=10.1016/0022-2011(81)90084-7;
RX   DOI=10.1016/0022-2011(89)90145-6;
RX   DOI=10.1303/aez.18.262;
RX   PubMed=2022870;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   BCIRL-HZ-AM3-F9
AC   CVCL_ZF42
SY   AM3-F9
DR   Wikidata; Q98125548
RX   PubMed=2022870;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z401 ! BCIRL-HZ-AM3
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-HZ-FB33
AC   CVCL_ZF00
SY   BCIRL-HzFB33; BCIRL-HZFB33; HZ-FB33; FB33
DR   ICLDB; bcirl-hzfb33
DR   Wikidata; Q98125549
RX   PubMed=10852353;
RX   PubMed=12642108;
RX   PubMed=15038778;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Providence virus (PubMed=12642108).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 7
//
ID   BCIRL-HZ-MG8
AC   CVCL_ZF01
SY   BCIRL-HzMG8; BCIRL-HZMG8; MG8
DR   ICLDB; bcirl-hzmg8
DR   Wikidata; Q98125550
RX   PubMed=12642108;
RX   PubMed=15038778;
RX   PubMed=20702652;
CC   Group: Insect cell line.
CC   Virology: Persistently infected by Providence virus (PubMed=12642108; PubMed=20702652).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   BCIRL-Lepd-SL1
AC   CVCL_Z247
DR   Wikidata; Q54795434
RX   DOI=10.1303/aez.2002.447;
RX   PubMed=15038778;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Doubling time: 3.4 days (Note=At 56th passage), 2.3 days (Note=At 111th passage) (DOI=10.1303/aez.2002.447).
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   BCIRL-PX-EM1
AC   CVCL_ZF02
SY   PX-EM1
DR   Wikidata; Q98125553
RX   PubMed=10852353;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-PX2-HNU3
AC   CVCL_Z570
SY   BCIRL-Px2-HNU3; BCIRL-PX-HNU3; BCIRL-Px-HNU3
DR   ICLDB; bcirl-px2-hnu3
DR   Wikidata; Q54795436
RX   DOI=10.1016/0022-2011(89)90145-6;
RX   DOI=10.1016/0022-2011(91)90151-F;
RX   DOI=10.19603/j.cnki.1000-1190.1983.03.014;
RX   DOI=10.19603/j.cnki.1000-1190.1995.04.025;
RX   DOI=10.3923/jas.2007.4040.4043;
RX   PubMed=1367489;
RX   PubMed=8799737;
CC   Group: Insect cell line.
CC   Doubling time: 30 +- 2.06 hours (DOI=10.19603/j.cnki.1000-1190.1983.03.014).
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   BCIRL-SerFB-0128-YL
AC   CVCL_C2T8
SY   SerFB-0128
DR   ICLDB; bcirl-serfb-0128-yl
DR   Wikidata; Q114310711
RX   PubMed=30353276;
CC   Group: Insect cell line.
CC   Doubling time: 42 hours (PubMed=30353276).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=37547; ! Spodoptera eridania (Southern armyworm)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-SerFB-0129A-YL
AC   CVCL_C2T9
SY   SerFB-0129A
DR   ICLDB; bcirl-serfb-0129a-yl
DR   Wikidata; Q114310712
RX   PubMed=30353276;
CC   Group: Insect cell line.
CC   Doubling time: 75 hours (PubMed=30353276).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=37547; ! Spodoptera eridania (Southern armyworm)
OI   CVCL_C2TA ! BCIRL-SerFB-0129B-YL
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-SerFB-0129B-YL
AC   CVCL_C2TA
SY   SerFB-0129B
DR   ICLDB; bcirl-serfb-0129b-yl
DR   Wikidata; Q114310713
RX   PubMed=30353276;
CC   Group: Insect cell line.
CC   Doubling time: 75 hours (PubMed=30353276).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=37547; ! Spodoptera eridania (Southern armyworm)
OI   CVCL_C2T9 ! BCIRL-SerFB-0129A-YL
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-SerNS-0128-YL
AC   CVCL_C2TB
SY   SerNS-0128
DR   ICLDB; bcirl-serns-0128-yl
DR   Wikidata; Q114310714
RX   PubMed=30353276;
CC   Group: Insect cell line.
CC   Doubling time: 110 hours (PubMed=30353276).
CC   Derived from site: In situ; Nervous tissue; UBERON=UBERON_0003714.
OX   NCBI_TaxID=37547; ! Spodoptera eridania (Southern armyworm)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-SerNS-0129-YL
AC   CVCL_C2TC
SY   SerNS-0129
DR   ICLDB; bcirl-serns-0129-yl
DR   Wikidata; Q114310715
RX   PubMed=30353276;
CC   Group: Insect cell line.
CC   Doubling time: 76 hours (PubMed=30353276).
CC   Derived from site: In situ; Nervous tissue; UBERON=UBERON_0003714.
OX   NCBI_TaxID=37547; ! Spodoptera eridania (Southern armyworm)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-SerTS-0128-YL
AC   CVCL_C2TD
SY   SerTS-0128
DR   ICLDB; bcirl-serts-0128-yl
DR   Wikidata; Q114310716
RX   PubMed=30353276;
CC   Group: Insect cell line.
CC   Doubling time: 45 hours (PubMed=30353276).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=37547; ! Spodoptera eridania (Southern armyworm)
SX   Male
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-SerTS-0129-YL
AC   CVCL_C2TE
SY   SerTS-0129
DR   ICLDB; bcirl-serts-0129-yl
DR   Wikidata; Q114310718
RX   PubMed=30353276;
CC   Group: Insect cell line.
CC   Doubling time: 63 hours (PubMed=30353276).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=37547; ! Spodoptera eridania (Southern armyworm)
SX   Male
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BCIRL-Sf4FB-0614-SGS
AC   CVCL_B0WG
SY   Sf4FB-0614-SGS
DR   ICLDB; bcirl-sf4fb-0614-sgs
DR   Wikidata; Q108819924
RX   PubMed=34519097;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BCIRL-Sf4NS-0614-SGS
AC   CVCL_C2U3
SY   Sf4NS-0614-SGS
DR   ICLDB; bcirl-sf4ns-0614-sgs
DR   Wikidata; Q114310719
CC   Group: Insect cell line.
CC   From: Saathoff, Stephen G.; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   BCIRL-Sf5NS-TS-0615-SGS
AC   CVCL_C2UL
SY   Sf5NS-TS-0615-SGS
DR   ICLDB; bcirl-sf5ns-ts-0615-sgs
DR   Wikidata; Q114310720
CC   Group: Insect cell line.
CC   From: Saathoff, Stephen G.; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   BCIRL-Sf5TS-0615-SGS
AC   CVCL_C2U4
SY   Sf5TS-0615-SGS
DR   ICLDB; bcirl-sf5ts-0615-sgs
DR   Wikidata; Q114310721
CC   Group: Insect cell line.
CC   From: Saathoff, Stephen G.; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   BCIRL-SfFB-0518-YL
AC   CVCL_C2U2
SY   SfFB-0518
DR   ICLDB; bcirl-sffb-0518-yl
DR   Wikidata; Q114310722
CC   Group: Insect cell line.
CC   From: Li, Yao-Fa; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   BCIRL-SfFB(susp)-0518-YL
AC   CVCL_C2UM
SY   SfFB-0518S
DR   ICLDB; bcirl-sffbsusp-0518-yl
DR   Wikidata; Q114310723
CC   Group: Insect cell line.
CC   From: Li, Yao-Fa; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C2U2 ! BCIRL-SfFB-0518-YL
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   BCIRL-SfNS-0518-YL
AC   CVCL_C2U0
SY   SfNS-0518
DR   ICLDB; bcirl-sfns-0518-yl
DR   Wikidata; Q114310724
CC   Group: Insect cell line.
CC   From: Li, Yao-Fa; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Nervous system; UBERON=UBERON_0001016.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   BCIRL-SfNS-0518A-YL
AC   CVCL_C2U1
SY   SfNS-0518A
DR   ICLDB; bcirl-sfns-0518a-yl
DR   Wikidata; Q114310725
CC   Group: Insect cell line.
CC   From: Li, Yao-Fa; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Nervous system; UBERON=UBERON_0001016.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C2U0 ! BCIRL-SfNS-0518-YL
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   BCIRL-SfNS-0518B-YL
AC   CVCL_B0WF
SY   SfNS-0518B
DR   ICLDB; bcirl-sfns-0518b-yl
DR   Wikidata; Q108819925
RX   PubMed=34519097;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Nervous system; UBERON=UBERON_0001016.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C2U0 ! BCIRL-SfNS-0518-YL
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BCIRL-SfTS-0518-YL
AC   CVCL_C2U6
SY   SfTS-0518
DR   ICLDB; bcirl-sfts-0518-yl
DR   Wikidata; Q114310726
CC   Group: Insect cell line.
CC   From: Li, Yao-Fa; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   BCIRL-SO3-HNU1
AC   CVCL_Z567
DR   ICLDB; bcirl-so3-hnu1
DR   Wikidata; Q54795438
RX   DOI=10.19603/j.cnki.1000-1190.1984.03.015;
CC   Group: Insect cell line.
CC   Doubling time: 47 +- 3.2 hours (DOI=10.19603/j.cnki.1000-1190.1984.03.015).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=42029; ! Spodoptera ornithogalli (Yellow-striped armyworm moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   BCIRL-SO4-HNU4
AC   CVCL_Z568
DR   ICLDB; bcirl-so4-hnu4
DR   Wikidata; Q54795440
RX   DOI=10.19603/j.cnki.1000-1190.1984.03.015;
CC   Group: Insect cell line.
CC   Doubling time: 54 +- 5.07 hours (DOI=10.19603/j.cnki.1000-1190.1984.03.015).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=42029; ! Spodoptera ornithogalli (Yellow-striped armyworm moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   BCIRL-TcA-CLG1
AC   CVCL_Z276
SY   TcA
DR   ICLDB; bcirl-tca-clg1
DR   Wikidata; Q54795442
RX   PubMed=22752637;
RX   PubMed=25354547;
CC   Group: Insect cell line.
CC   Doubling time: 155.2 hours (PubMed=22752637).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7070; ! Tribolium castaneum (Red flour beetle)
SX   Sex unspecified
AG   Late pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   BCIRL/AMCY-AfOV-CLG
AC   CVCL_Z656
SY   AfOV
DR   ICLDB; bcirlamcy-afov-clg
DR   Wikidata; Q54795444
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=56368; ! Anagrapha falcifera (Celery looper moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-AfTS-CLG
AC   CVCL_Z657
SY   AfTS
DR   ICLDB; bcirlamcy-afts-clg
DR   Wikidata; Q54795446
RX   PubMed=11515970;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=56368; ! Anagrapha falcifera (Celery looper moth)
SX   Male
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-AgE-CLG
AC   CVCL_Z658
SY   AgE
DR   ICLDB; bcirlamcy-age-clg
DR   Wikidata; Q54795447
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=129554; ! Anticarsia gemmatalis (Velvetbean caterpillar moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-AgOV-CLG1
AC   CVCL_Z659
SY   AgOV1
DR   ICLDB; bcirlamcy-agov-clg1
DR   Wikidata; Q54795448
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=129554; ! Anticarsia gemmatalis (Velvetbean caterpillar moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-AgOV-CLG2
AC   CVCL_Z660
SY   AgOV2
DR   ICLDB; bcirlamcy-agov-clg2
DR   Wikidata; Q54795453
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=129554; ! Anticarsia gemmatalis (Velvetbean caterpillar moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-AgOV-CLG3
AC   CVCL_Z661
SY   AgOV3
DR   ICLDB; bcirlamcy-agov-clg3
DR   Wikidata; Q54795455
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=129554; ! Anticarsia gemmatalis (Velvetbean caterpillar moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-AiOV-CLG
AC   CVCL_Z662
SY   AiOV
DR   ICLDB; bcirlamcy-aiov-clg
DR   Wikidata; Q54795457
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=56364; ! Agrotis ipsilon (Black cutworm moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-AiTS-CLG
AC   CVCL_Z663
SY   AiTS
DR   ICLDB; bcirlamcy-aits-clg
DR   Wikidata; Q54795458
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=56364; ! Agrotis ipsilon (Black cutworm moth)
SX   Male
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-HvE-CLG1
AC   CVCL_Z664
SY   HvE1
DR   ICLDB; bcirlamcy-hve-clg1
DR   Wikidata; Q54795461
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HvE-CLG2
AC   CVCL_Z665
SY   HvE2
DR   ICLDB; bcirlamcy-hve-clg2
DR   Wikidata; Q54795463
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HvE-CLG3
AC   CVCL_Z666
SY   HvE3
DR   ICLDB; bcirlamcy-hve-clg3
DR   Wikidata; Q54795466
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HvOV-CLG
AC   CVCL_Z667
SY   HvOV
DR   ICLDB; bcirlamcy-hvov-clg
DR   Wikidata; Q54795468
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-HvTS-GES
AC   CVCL_Z668
SY   HvTS
DR   ICLDB; bcirlamcy-hvts-ges
DR   Wikidata; Q54795472
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-HzE-CLG1
AC   CVCL_Z669
SY   HzE1
DR   ICLDB; bcirlamcy-hze-clg1
DR   Wikidata; Q54795475
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HzE-CLG2
AC   CVCL_Z670
SY   HzE2
DR   ICLDB; bcirlamcy-hze-clg2
DR   Wikidata; Q54795479
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HzE-CLG3
AC   CVCL_Z671
SY   HzE3
DR   ICLDB; bcirlamcy-hze-clg3
DR   Wikidata; Q54795480
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HzE-CLG5
AC   CVCL_Z672
SY   HzE5
DR   ICLDB; bcirlamcy-hze-clg5
DR   Wikidata; Q54795484
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HzE-CLG6
AC   CVCL_Z673
SY   HzE6
DR   ICLDB; bcirlamcy-hze-clg6
DR   Wikidata; Q54795486
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HzE-CLG7
AC   CVCL_Z674
SY   HzE7
DR   ICLDB; bcirlamcy-hze-clg7
DR   Wikidata; Q54795488
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HzE-CLG8
AC   CVCL_Z675
SY   HzE8
DR   ICLDB; bcirlamcy-hze-clg8
DR   Wikidata; Q54795537
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-HzE-CLG9
AC   CVCL_Z676
SY   HzE9
DR   ICLDB; bcirlamcy-hze-clg9
DR   Wikidata; Q54795538
RX   PubMed=11515970;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-OnFB-GES1
AC   CVCL_Z677
SY   OnFB1
DR   Wikidata; Q54795542
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=29057; ! Ostrinia nubilalis (European corn borer)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-OnFB-GES3
AC   CVCL_Z678
SY   OnFB3
DR   Wikidata; Q54795543
RX   PubMed=11515970;
RX   PubMed=11515971;
RX   PubMed=26820856;
CC   Group: Insect cell line.
CC   Misspelling: BCIRL/AMCY-OnFB-GES2; PubMed=26820856.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=29057; ! Ostrinia nubilalis (European corn borer)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   BCIRL/AMCY-PxE-CLG
AC   CVCL_Z679
SY   PxE
DR   ICLDB; bcirlamcy-pxe-clg
DR   Wikidata; Q54795545
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-PxLP-CLG
AC   CVCL_Z680
SY   PxLP
DR   ICLDB; bcirlamcy-pxlp-clg
DR   Wikidata; Q54795548
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   BCIRL/AMCY-SeE-CLG1
AC   CVCL_Z681
SY   BCIRL/AMCY-Se-E1; SeE1
DR   ICLDB; bcirlamcy-see-clg1
DR   Wikidata; Q54795550
RX   PubMed=10777062;
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-SeE-CLG4
AC   CVCL_Z682
SY   SeE4
DR   ICLDB; bcirlamcy-see-clg4
DR   Wikidata; Q54795552
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-SeE-CLG5
AC   CVCL_Z683
SY   BCIRL/AMCY-Se-E5; SeE5
DR   ICLDB; bcirlamcy-see-clg5
DR   Wikidata; Q54795555
RX   PubMed=10777062;
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-SfTS-GES
AC   CVCL_Z684
SY   SfTS
DR   ICLDB; bcirlamcy-sfts-ges
DR   Wikidata; Q54795556
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-TnE-CLG1
AC   CVCL_Z685
SY   TnE1
DR   ICLDB; bcirlamcy-tne-clg1
DR   Wikidata; Q54795558
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-TnE-CLG1MK
AC   CVCL_Z686
SY   TnE1MK
DR   ICLDB; bcirlamcy-tne-clg1mk
DR   Wikidata; Q54795559
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-TnE-CLG2
AC   CVCL_Z687
SY   TnE2
DR   ICLDB; bcirlamcy-tne-clg2
DR   Wikidata; Q54795561
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-TnE-CLG2MK
AC   CVCL_Z688
SY   TnE2MK
DR   ICLDB; bcirlamcy-tne-clg2mk
DR   Wikidata; Q54795565
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-TnE-CLG3
AC   CVCL_Z689
SY   TnE3
DR   ICLDB; bcirlamcy-tne-clg3
DR   Wikidata; Q54795569
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/AMCY-TnTS-GES1
AC   CVCL_Z690
SY   TnTS1
DR   ICLDB; bcirlamcy-tnts-ges1
DR   Wikidata; Q54795572
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/AMCY-TnTS-GES3
AC   CVCL_Z691
SY   TnTS3
DR   ICLDB; bcirlamcy-tnts-ges3
DR   Wikidata; Q54795573
RX   PubMed=11515970;
RX   PubMed=11515971;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BCIRL/RP-HvE-CLG1
AC   CVCL_Z639
DR   ICLDB; bcirlrp-hve-clg1
DR   Wikidata; Q54795575
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-CLG4
AC   CVCL_Z640
DR   ICLDB; bcirlrp-hve-clg4
DR   Wikidata; Q54795578
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-CLG5
AC   CVCL_Z641
DR   ICLDB; bcirlrp-hve-clg5
DR   Wikidata; Q54795581
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-CLG6
AC   CVCL_Z642
SY   HvE-CLG6
DR   ICLDB; bcirlrp-hve-clg6
DR   Wikidata; Q54795584
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-CLG7
AC   CVCL_Z643
DR   ICLDB; bcirlrp-hve-clg7
DR   Wikidata; Q54795586
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-HN11
AC   CVCL_Z644
DR   ICLDB; bcirlrp-hve-hn11
DR   Wikidata; Q54795588
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-HN12
AC   CVCL_Z645
DR   ICLDB; bcirlrp-hve-hn12
DR   Wikidata; Q54795590
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-HN14
AC   CVCL_Z646
DR   ICLDB; bcirlrp-hve-hn14
DR   Wikidata; Q54795592
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-HN16
AC   CVCL_Z647
DR   ICLDB; bcirlrp-hve-hn16
DR   Wikidata; Q54795594
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-HN2
AC   CVCL_Z648
DR   ICLDB; bcirlrp-hve-hn2
DR   Wikidata; Q54795595
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvE-HN3
AC   CVCL_Z649
DR   ICLDB; bcirlrp-hve-hn3
DR   Wikidata; Q54795598
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvVNC-WG1
AC   CVCL_Z650
DR   ICLDB; bcirlrp-hvvnc-wg1
DR   Wikidata; Q54795600
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvVNC-WG2
AC   CVCL_Z651
DR   ICLDB; bcirlrp-hvvnc-wg2
DR   Wikidata; Q54795601
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCIRL/RP-HvVNC-WG3
AC   CVCL_Z652
DR   ICLDB; bcirlrp-hvvnc-wg3
DR   Wikidata; Q54795604
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BCJ-4T
AC   CVCL_VP49
SY   BCJ4T
DR   ABM; T8320
DR   Wikidata; Q93424553
CC   Doubling time: 29.2 hours (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 23,25
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 7
//
ID   BCK
AC   CVCL_E472
SY   TER99; TER166; TER243
DR   dbMHC; 48488
DR   ECACC; 94050326
DR   IHW; IHW09262
DR   IPD-IMGT/HLA; 10300
DR   Wikidata; Q54795605
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01:01,32:01; B*27:08,15:01:01:01; C*06:02,03:04:01; DPB1*02:01:02,04:02; DQA1*01:02,05:01; DQB1*05:02,03:01; DRB1*11:01,15:01; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=10300).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   BCK4
AC   CVCL_A9A5
SY   BCK-4
DR   GEO; GSE101742
DR   Wikidata; Q102113608
RX   PubMed=23247610;
RX   PubMed=25757734;
RX   PubMed=27565181;
RX   PubMed=29176653;
RX   PubMed=30228172;
RX   PubMed=30317423;
CC   Characteristics: ER-positive, PR-positive and ERBB2-negative. Has mucinous features. Established from a mouse xenograft.
CC   Doubling time: ~120 hours (PubMed=23247610).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Atkinson, Jennifer M.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 13
ST   D18S51: 13,14
ST   D21S11: 30,30.2
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,16
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 7,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   BCKN-1
AC   CVCL_9637
SY   BCKN1
DR   EFO; EFO_0002049
DR   BioSamples; SAMEA365939
DR   BioSamples; SAMEA365949
DR   GEO; GSM38802
DR   GEO; GSM38803
DR   Wikidata; Q54795609
RX   PubMed=15613351;
RX   PubMed=18230756;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8285; AIDS-related immunoblastic lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   Bcl-2 KO SV40 MEF
AC   CVCL_U628
DR   ATCC; CRL-2908
DR   Wikidata; Q54795610
CC   Knockout cell: Method=KO mouse; MGI; MGI:88138; Bcl2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   Bcl-x-KO MEF
AC   CVCL_HC60
SY   MEF Bcl-xL-KO
DR   Kerafast; EUL012
DR   Wikidata; Q54795611
RX   PubMed=22573883;
CC   Doubling time: 24 hours (Kerafast=EUL012).
CC   Knockout cell: Method=KO mouse; MGI; MGI:88139; Bcl2l1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   Bcl-x-KO MEF Bcl-xL expressing
AC   CVCL_HC61
DR   Kerafast; EUL011
DR   Wikidata; Q54795614
RX   PubMed=22573883;
CC   Doubling time: 24 hours (Kerafast=EUL011).
CC   Knockout cell: Method=KO mouse; MGI; MGI:88139; Bcl2l1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:992; BCL2L1 (Note=Isoform Bcl-xL).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HC60 ! Bcl-x-KO MEF
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   BCL1
AC   CVCL_0166
SY   BCL-1; BCL 1
DR   MCCL; MCC:0000058
DR   ChEMBL-Cells; CHEMBL3307956
DR   ChEMBL-Targets; CHEMBL612420
DR   PubChem_Cell_line; CVCL_0166
DR   Wikidata; Q54795615
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BCL1
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-450.html
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   BCL1 clone 5B1b
AC   CVCL_4119
DR   CLO; CLO_0001903
DR   ATCC; TIB-197
DR   BioSample; SAMN11397657
DR   Lonza; 1255
DR   NCBI_Iran; C551
DR   Wikidata; Q54795618
RX   PubMed=31220119;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 14
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 24,25
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0166 ! BCL1
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   BCL1 clone CW13.20-3B3
AC   CVCL_4120
AS   CVCL_6484
SY   BCL1 clone CW13.20.3B3; BCL1 clone CW13.20; BCL1.3B3; CW13.20-3B3; CW13 clone 20-3B3
DR   CLO; CLO_0001904
DR   CLO; CLO_0002649
DR   CLDB; cl404
DR   ATCC; CRL-1669
DR   ECACC; 90061904
DR   JCRB; JCRB9117
DR   Lonza; 237
DR   Wikidata; Q54795619
RX   PubMed=6601774;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0166 ! BCL1
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   BCL1-B20
AC   CVCL_B994
DR   CLO; CLO_0051571
DR   RCB; RCB2618
DR   TKG; TKG 0435
DR   Wikidata; Q54795621
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0166 ! BCL1
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   BCL2 (AAA) Jurkat
AC   CVCL_U618
DR   ATCC; CRL-2902
DR   cancercelllines; CVCL_U618
DR   Wikidata; Q54795665
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2902
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 7,10,11
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   BCL2 (S70A) Jurkat
AC   CVCL_U619
DR   ATCC; CRL-2900
DR   cancercelllines; CVCL_U619
DR   Wikidata; Q54795667
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Ser70Ala).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2900
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 21
//
ID   BCL2 (S87A) Jurkat
AC   CVCL_U620
DR   ATCC; CRL-2901
DR   cancercelllines; CVCL_U620
DR   Wikidata; Q54795668
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Ser87Ala).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2901
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 21
//
ID   BCL2 Jurkat
AC   CVCL_U617
DR   ATCC; CRL-2899
DR   cancercelllines; CVCL_U617
DR   Wikidata; Q54795671
RX   PubMed=10567572;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2899
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 21
//
ID   BCLC-1
AC   CVCL_LC46
SY   Barcelona Clinic Liver Cancer-1
DR   Wikidata; Q54795673
RX   PubMed=28751105;
CC   Virology: Permissive for hepatitis C virus (HCV) entry and replication.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   BCLC-10
AC   CVCL_LC52
SY   Barcelona Clinic Liver Cancer-10
DR   Wikidata; Q54795675
RX   PubMed=28751105;
CC   Virology: Permissive for hepatitis C virus (HCV) entry and replication.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   BCLC-2
AC   CVCL_LC47
SY   Barcelona Clinic Liver Cancer-2
DR   Wikidata; Q54795677
RX   PubMed=28751105;
CC   Virology: Permissive for hepatitis C virus (HCV) entry and replication.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   BCLC-3
AC   CVCL_LC48
SY   Barcelona Clinic Liver Cancer-3
DR   Wikidata; Q54795678
RX   PubMed=28751105;
CC   Virology: Permissive for hepatitis C virus (HCV) entry and replication.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   BCLC-4
AC   CVCL_LC49
SY   Barcelona Clinic Liver Cancer-4
DR   Wikidata; Q54795680
RX   PubMed=28751105;
CC   Virology: Permissive for hepatitis C virus (HCV) entry and replication.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   BCLC-5
AC   CVCL_LC50
SY   Barcelona Clinic Liver Cancer-5
DR   Wikidata; Q54795684
RX   PubMed=28751105;
CC   Virology: Permissive for hepatitis C virus (HCV) entry and replication.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   BCLC-5-C8.1
AC   CVCL_C8JL
DR   Wikidata; Q123030775
RX   PubMed=28751105;
CC   Characteristics: Transfected with a construct containing a neomycin resistance selectable marker (SGR-JFH1-neo) and cured of HCV RNA by interferon-alpha treatment (PubMed=28751105).
CC   Virology: More permissive for hepatitis C virus (HCV) RNA replication than the parental cells (PubMed=28751105).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LC50 ! BCLC-5
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   BCLC-5-C8.1/miR122
AC   CVCL_C8JN
DR   Wikidata; Q123030776
RX   PubMed=28751105;
CC   Characteristics: Transfected with a construct containing a neomycin resistance selectable marker (SGR-JFH1-neo) and cured of HCV RNA by interferon-alpha treatment and with a construct containing miR122 and GFP (PubMed=28751105).
CC   Virology: Exhibits enhanced hepatitis C virus (HCV) RNA replication compared to parent cell line (PubMed=28751105).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:31501; MIR122.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8JL ! BCLC-5-C8.1
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   BCLC-5-D6.1
AC   CVCL_C8JM
DR   Wikidata; Q123030777
RX   PubMed=28751105;
CC   Characteristics: Transfected with a construct containing a neomycin resistance selectable marker (SGR-JFH1-neo) and cured of HCV RNA by interferon-alpha treatment (PubMed=28751105).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LC50 ! BCLC-5
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   BCLC-6
AC   CVCL_LC51
SY   Barcelona Clinic Liver Cancer-6
DR   Wikidata; Q54795686
RX   PubMed=28751105;
CC   Virology: Permissive for hepatitis C virus (HCV) entry and replication.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   NCIt; C2951; Cirrhosis
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   BCLC-9
AC   CVCL_9483
SY   Barcelona Clinic Liver Cancer-9
DR   cancercelllines; CVCL_9483
DR   IARC_TP53; 20737
DR   Wikidata; Q54795691
RX   PubMed=15041736;
RX   PubMed=28751105;
CC   Characteristics: Established from a xenograft produced by implantation of tumor cells in the liver of a Swiss nude mice.
CC   Doubling time: 27.7 hours (Note=At 17th passage) (PubMed=15041736).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Arg (c.575A>G); ClinVar=VCV000182931; Zygosity=Unspecified (PubMed=15041736).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Tyr (c.725G>A); ClinVar=VCV000012354; Zygosity=Unspecified (PubMed=15041736).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   BCM-1
AC   CVCL_M003
SY   BrdU-treated CM-1
DR   Wikidata; Q54795692
RX   PubMed=7068778;
RX   PubMed=8360273;
CC   Characteristics: Pigmented (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_H244 ! RPMI-3460/CM1
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   BCMi001-A
AC   CVCL_VT10
SY   HSCC-003iPS-Sc5; M22 hiPSC line clone 5; M22c5
DR   BioSamples; SAMEA5843921
DR   hPSCreg; BCMi001-A
DR   Wikidata; Q93424743
RX   PubMed=28878117;
RX   PubMed=30075114;
CC   From: Baylor College of Medicine; Houston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT11 ! BCMi001-B
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   BCMi001-B
AC   CVCL_VT11
SY   HSCC-003iPS-Sc8; M22 hiPSC line clone 8; M22c8
DR   BioSamples; SAMEA7333955
DR   hPSCreg; BCMi001-B
DR   Wikidata; Q93424747
RX   PubMed=30075114;
CC   From: Baylor College of Medicine; Houston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT10 ! BCMi001-A
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   BCMi002-A
AC   CVCL_B3NN
SY   LZ02
DR   BioSamples; SAMEA9691068
DR   hPSCreg; BCMi002-A
DR   Wikidata; Q110432592
CC   From: Baylor College of Medicine; Houston; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   BCMi003-A
AC   CVCL_C9M2
DR   BioSamples; SAMEA114562337
DR   hPSCreg; BCMi003-A
DR   Wikidata; Q123030778
RX   PubMed=38154383;
CC   From: Baylor College of Medicine; Houston; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Hemizygous (PubMed=38154383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   BCMi004-A
AC   CVCL_C9M3
DR   BioSamples; SAMEA114594404
DR   hPSCreg; BCMi004-A
DR   Wikidata; Q123030779
RX   PubMed=38154383;
CC   From: Baylor College of Medicine; Houston; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Hemizygous (PubMed=38154383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   BCMi005-A
AC   CVCL_C9M4
DR   BioSamples; SAMEA114594406
DR   hPSCreg; BCMi005-A
DR   Wikidata; Q123030780
RX   PubMed=38154383;
CC   From: Baylor College of Medicine; Houston; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Hemizygous (PubMed=38154383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   BCMi006-A
AC   CVCL_C9M5
DR   BioSamples; SAMEA114594408
DR   hPSCreg; BCMi006-A
DR   Wikidata; Q123030781
RX   PubMed=38154383;
CC   From: Baylor College of Medicine; Houston; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Hemizygous (PubMed=38154383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   BCMi007-A
AC   CVCL_C9M6
DR   BioSamples; SAMEA114594410
DR   hPSCreg; BCMi007-A
DR   Wikidata; Q123030782
RX   PubMed=38154383;
CC   From: Baylor College of Medicine; Houston; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Hemizygous (PubMed=38154383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   BCmt-1
AC   CVCL_C324
DR   RCB; AES0020
DR   RCB; RCB2169
DR   SKIP; SKIP001619
DR   Wikidata; Q54795695
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2169; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BCmt-2
AC   CVCL_C325
DR   RCB; AES0021
DR   RCB; RCB2170
DR   SKIP; SKIP001640
DR   Wikidata; Q54795698
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2170; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BCN
AC   CVCL_HX06
DR   ArrayExpress; E-TABM-1088
DR   Cosmic; 2809777
DR   IARC_TP53; 28506
DR   Wikidata; Q54795699
RX   PubMed=10583232;
RX   PubMed=16956823;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*11,26; B*13,27; C*02:02,06:02 (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   BCN132.1.2B5
AC   CVCL_E9U8
DR   DSHB; Anti-KCNJ6-BCN132.1.2B5
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P48051; Human KCNJ6 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN14.1.1A2
AC   CVCL_E9UH
DR   DSHB; Anti-PVALB-BCN14.1.1A2
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20472; Human PVALB (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN14.1.1C9
AC   CVCL_E9UI
DR   DSHB; Anti-PVALB-BCN14.1.1C9
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20472; Human PVALB (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN148.1.2H5
AC   CVCL_E9U4
DR   DSHB; Anti-GLUL-BCN148.1.2H5
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15104; Human GLUL (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN150.2.1G3
AC   CVCL_E9TT
DR   DSHB; Anti-ALDH1L1-BCN150.2.1G3
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O75891; Human ALDH1L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN163.1.1B1
AC   CVCL_E9U7
DR   DSHB; Anti-KCNIP2-BCN163.1.1B1
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9NS61; Human KCNIP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN17.1.3F8
AC   CVCL_E9UC
DR   DSHB; Anti-NOVA1-BCN17.1.3F8
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P51513; Human NOVA1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN17.2.1C8
AC   CVCL_E9UD
DR   DSHB; Anti-NOVA1-BCN17.2.1C8
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P51513; Human NOVA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN195.1.1A11
AC   CVCL_E9U1
DR   DSHB; Anti-CNR1-BCN195.1.1A11
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P21554; Human CNR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN2.1.2C7
AC   CVCL_E9UP
DR   DSHB; Anti-TPH2-BCN2.1.2C7
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IWU9; Human TPH2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN201.1.1A7
AC   CVCL_E9U5
DR   DSHB; Anti-GRIA1-BCN201.1.1A7
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P42261; Human GRIA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN201.1.1G9
AC   CVCL_E9U6
DR   DSHB; Anti-GRIA1-BCN201.1.1G9
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P42261; Human GRIA1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN21.2.1A11
AC   CVCL_E9UJ
DR   DSHB; Anti-RBFOX3-BCN21.2.1A11
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NFN3; Human RBFOX3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN21.2.2B9
AC   CVCL_E9UK
DR   DSHB; Anti-RBFOX3-BCN21.2.2B9
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NFN3; Human RBFOX3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN267.2.3C4
AC   CVCL_E9UE
DR   DSHB; Anti-OCLN-BCN267.2.3C4
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16625; Human OCLN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN3.1.1B7
AC   CVCL_E9TR
DR   DSHB; Anti-ALDH1A1-BCN3.1.1B7
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00352; Human ALDH1A1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN3.2.1C3
AC   CVCL_E9TS
DR   DSHB; Anti-ALDH1A1-BCN3.2.1C3
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00352; Human ALDH1A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN32.1.3C5
AC   CVCL_E9U0
DR   DSHB; Anti-CAMK2A-BCN32.1.3C5
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UQM7; Human CAMK2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN33.1.1F12
AC   CVCL_E9UM
DR   DSHB; Anti-TH-BCN33.1.1F12
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07101; Human TH (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN37.1.1C8
AC   CVCL_E9UQ
DR   DSHB; Anti-UCHL1-BCN37.1.1C8
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09936; Human UCHL1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN37.1.2G7
AC   CVCL_E9UR
DR   DSHB; Anti-UCHL1-BCN37.1.2G7
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09936; Human UCHL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN4.2.3B2
AC   CVCL_E9TY
DR   DSHB; Anti-CALB2-BCN4.2.3B2
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P22676; Human CALB2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN402.2.2H8
AC   CVCL_E9UL
DR   DSHB; Anti-RBFOX3-BCN402.2.2H8
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NFN3; Human RBFOX3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN411.2.2E4
AC   CVCL_E9UF
DR   DSHB; Anti-PDLIM5-BCN411.2.2E4
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96HC4; Human PDLIM5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN45.2.4C12
AC   CVCL_E9U2
DR   DSHB; Anti-DCN-BCN45.2.4C12
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07585; Human DCN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN49.2.3D1
AC   CVCL_E9U3
DR   DSHB; Anti-GAD1-BCN49.2.3D1
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q99259; Human GAD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN51.2.1A12
AC   CVCL_E9UG
DR   DSHB; Anti-PPP1R1B-BCN51.2.1A12
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UD71; Human PPP1R1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN53.1.1D10
AC   CVCL_E9UN
DR   DSHB; Anti-TH-BCN53.1.1D10
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07101; Human TH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN62.1.1B1
AC   CVCL_E9TV
DR   DSHB; Anti-C1QL3-BCN62.1.1B1
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5VWW1; Human C1QL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN62.2.2A3
AC   CVCL_E9TU
DR   DSHB; Anti-C1QL2-BCN62.2.2A3
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7Z5L3; Human C1QL2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN64.1.2C1
AC   CVCL_E9U9
DR   DSHB; Anti-MAP2-BCN64.1.2C1
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P11137; Human MAP2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN64.2.1G12
AC   CVCL_E9UA
DR   DSHB; Anti-MAP2-BCN64.2.1G12
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P11137; Human MAP2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN8.1.1E11
AC   CVCL_E9UB
DR   DSHB; Anti-MBP-BCN8.1.1E11
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02686; Human MBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN87.2.1D8
AC   CVCL_E9TZ
DR   DSHB; Anti-CALB2-BCN87.2.1D8
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P22676; Human CALB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN96.1.1C8
AC   CVCL_E9TW
DR   DSHB; Anti-CALB1-BCN96.1.1C8
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P05937; Human CALB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCN96.1.1F5
AC   CVCL_E9TX
DR   DSHB; Anti-CALB1-BCN96.1.1F5
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05937; Human CALB1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BCNS1BI
AC   CVCL_WX43
SY   BCNS1 BI; Basal Cell Naevus Syndrome 1 BIrmingham
DR   Wikidata; Q93424766
RX   PubMed=837385;
RX   PubMed=1196376;
RX   PubMed=2973075;
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   BCNS1KO
AC   CVCL_2866
DR   BioSample; SAMN03470934
DR   JCRB; JCRB0324
DR   Wikidata; Q54795701
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0324; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 16,19
ST   D19S433: 13,14.2
ST   D21S11: 29,32
ST   D2S1338: 17,23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 12,14
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BCNS1KO hTERT
AC   CVCL_F008
DR   JCRB; JCRB3009
DR   JCRB; KURB2738
DR   Wikidata; Q54795704
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; KURB2738; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3009
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2866 ! BCNS1KO
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   BCNS1KO(SVT)-1
AC   CVCL_A1IG
DR   JCRB; KURB2736
DR   Wikidata; Q102113609
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2866 ! BCNS1KO
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   BCNS1KO(SVT)-2
AC   CVCL_A1IH
DR   JCRB; KURB2737
DR   Wikidata; Q102113610
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2866 ! BCNS1KO
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   BCNS2BI
AC   CVCL_WX44
SY   BCNS2 BI; Basal Cell Naevus Syndrome 2 BIrmingham
DR   Wikidata; Q93424777
RX   PubMed=837385;
RX   PubMed=1196376;
RX   PubMed=2973075;
RX   PubMed=7471106;
CC   Caution: Indicated as originating from a female in PubMed=1196376 and from a male in PubMed=7471106.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   BCNS3BI
AC   CVCL_WX45
SY   BCNS3 BI; Basal Cell Naevus Syndrome 3 BIrmingham
DR   Wikidata; Q93424780
RX   PubMed=837385;
RX   PubMed=1196376;
RX   PubMed=2973075;
RX   PubMed=7471106;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   BCP-1
AC   CVCL_0107
SY   BCP1
DR   BTO; BTO_0002728
DR   CLO; CLO_0001905
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2294
DR   BioSample; SAMN03471861
DR   BioSample; SAMN10987880
DR   cancercelllines; CVCL_0107
DR   Cell_Model_Passport; SIDM01530
DR   Cosmic; 683661
DR   Cosmic; 1238079
DR   Cosmic; 1588555
DR   DepMap; ACH-000923
DR   GEO; GSM634737
DR   GEO; GSM710423
DR   GEO; GSM710439
DR   GEO; GSM886874
DR   GEO; GSM887939
DR   GEO; GSM3150239
DR   IARC_TP53; 26981
DR   LiGeA; CCLE_346
DR   PharmacoDB; BCP1_81_2019
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_0107
DR   Wikidata; Q4835216
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8705864;
RX   PubMed=9473233;
RX   PubMed=9766492;
RX   PubMed=15613351;
RX   PubMed=17121789;
RX   PubMed=19608668;
RX   PubMed=21685375;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BCP-1
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/BCP-1_cells
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*24:02,68:01; B*38:01,44:02; C*05:01,12:03 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=19608668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (PubMed=19608668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Asn (c.775G>A); Zygosity=Heterozygous (PubMed=19608668; DepMap=ACH-000923).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.81%; Native American=0.07%; East Asian, North=2%; East Asian, South=0.6%; South Asian=8.1%; European, North=24.92%; European, South=62.51% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2294
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 20,22.2
ST   Penta D: 8,13
ST   Penta E: 10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   BCPAP-R
AC   CVCL_A8S1
DR   cancercelllines; CVCL_A8S1
DR   Wikidata; Q102113611
RX   PubMed=32666385;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Tyr (c.775G>T); ClinVar=VCV000634680; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0153 ! B-CPAP
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   BCPb8
AC   CVCL_6F37
DR   Wikidata; Q54795710
RX   PubMed=15619669;
RX   PubMed=21082283;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Dental follicle; UBERON=UBERON_0008969.
CC   Cell type: Precementoblast; CL=CL_0007002.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BCRTi001-A
AC   CVCL_9S03
SY   P01-1
DR   BioSamples; SAMEA5889524
DR   hPSCreg; BCRTi001-A
DR   SKIP; SKIP002625
DR   Wikidata; Q54795712
RX   PubMed=27345784;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=27345784).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   BCRTi002-A
AC   CVCL_9S04
SY   P02-1
DR   hPSCreg; BCRTi002-A
DR   SKIP; SKIP002626
DR   Wikidata; Q54795714
RX   PubMed=27345784;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=27345784).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   BCRTi004-A
AC   CVCL_9S05
DR   BioSamples; SAMEA4084802
DR   hPSCreg; BCRTi004-A
DR   SKIP; SKIP002669
DR   Wikidata; Q54795715
RX   PubMed=27345798;
RX   PubMed=27345993;
RX   PubMed=27638042;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   BCRTi005-A
AC   CVCL_9S06
DR   BioSamples; SAMEA8072696
DR   hPSCreg; BCRTi005-A
DR   SKIP; SKIP002670
DR   Wikidata; Q54795717
RX   PubMed=28677531;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=28677531
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   DXS101: 25
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   BCRTi006-A
AC   CVCL_C6SR
DR   BioSamples; SAMEA112294705
DR   hPSCreg; BCRTi006-A
DR   Wikidata; Q117704208
RX   PubMed=36958215;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12338; TRPC6; Simple; p.Val691Lysfs*2 (c.2060_2070dupAAGTGAAATCA); Zygosity=Heterozygous (PubMed=36958215).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C205635; Focal segmental glomerulosclerosis 2
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   BCRTi007-A
AC   CVCL_C7RH
DR   BioSamples; SAMEA112359774
DR   hPSCreg; BCRTi007-A
DR   Wikidata; Q117704209
RX   PubMed=36947994;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   BCRTi008-A
AC   CVCL_C7RI
DR   BioSamples; SAMEA112638676
DR   hPSCreg; BCRTi008-A
DR   Wikidata; Q117704210
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   BCRTi009-A
AC   CVCL_C7RJ
DR   BioSamples; SAMEA112638680
DR   hPSCreg; BCRTi009-A
DR   Wikidata; Q117704211
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84417; Diabetic nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   BCRTi010-A
AC   CVCL_C7RK
DR   BioSamples; SAMEA112641225
DR   hPSCreg; BCRTi010-A
DR   Wikidata; Q117704212
RX   PubMed=37619442;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   BCRTi011-A
AC   CVCL_C7RL
DR   BioSamples; SAMEA112641309
DR   hPSCreg; BCRTi011-A
DR   Wikidata; Q117704213
RX   PubMed=37619442;
CC   From: Berlin-Brandenburg Center for Regenerative Therapies; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Tyr489Cys (c.466A>G); ClinVar=VCV000000354; Zygosity=Heterozygous (PubMed=37619442).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg652Cys (c.1954C>T); ClinVar=VCV000185762; Zygosity=Heterozygous (PubMed=37619442).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   BCS-1
AC   CVCL_M004
SY   BrdU-treated CS-1
DR   Wikidata; Q54795720
RX   PubMed=7068778;
RX   PubMed=8360273;
CC   Characteristics: Pigmented (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_H244 ! RPMI-3460/CM1
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   BCS-6
AC   CVCL_M578
SY   BCS6
DR   Wikidata; Q54795721
RX   PubMed=15613351;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   BCS-TC2
AC   CVCL_B041
DR   BTO; BTO_0002141
DR   Wikidata; Q54795723
RX   PubMed=1366654;
CC   Doubling time: 38 hours (PubMed=1366654).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   BCSP31-1E5
AC   CVCL_XF05
SY   1E5
DR   Wikidata; Q93424842
RX   PubMed=21603860;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A3T2; Brucella melitensis bv. 1 31 kDa immunogenic protein (bcsP31).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 4
//
ID   BCSP31-1F1
AC   CVCL_XF06
SY   Bcsp31-1F1; 1F1
DR   CCRID; 4201PAT-CCTCC00233
DR   Wikidata; Q93424843
RX   Patent=CN101270160B;
RX   PubMed=21603860;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200806.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A3T2; Brucella melitensis bv. 1 31 kDa immunogenic protein (bcsP31).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 6
//
ID   BCWM.1
AC   CVCL_A035
SY   BCWM-1; BCWM_1; BCWM1; Bing Center for Waldenstrom's Macroglobulinemia.1
DR   BTO; BTO_0005177
DR   CLO; CLO_0009833
DR   cancercelllines; CVCL_A035
DR   Cosmic; 1762456
DR   Cosmic; 2645642
DR   LINCS_HMS; 51097
DR   LINCS_LDP; LCL-2094
DR   Wikidata; Q54795725
RX   PubMed=17761288;
RX   PubMed=18650470;
RX   PubMed=22950966;
RX   PubMed=23321251;
RX   PubMed=25382610;
RX   PubMed=25853860;
RX   PubMed=28548645;
RX   PubMed=40254718;
CC   Doubling time: 3 days (PubMed=17761288).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (PubMed=23321251).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   BCWM.1/BR
AC   CVCL_VJ29
SY   BCWM1-BR; BC/BR
DR   cancercelllines; CVCL_VJ29
DR   Wikidata; Q93424846
RX   PubMed=25382610;
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A035 ! BCWM.1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   BCWM.1/IR
AC   CVCL_VJ30
SY   BCWM_1/IR; BC/IR
DR   cancercelllines; CVCL_VJ30
DR   Cosmic; 2645643
DR   Wikidata; Q93424848
RX   PubMed=25382610;
RX   PubMed=28548645;
CC   Selected for resistance to: ChEBI; CHEBI_76612; Ibrutinib (Imbruvica).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A035 ! BCWM.1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   BCWM.2
AC   CVCL_E8TQ
SY   Bing Center for Waldenstrom's Macroglobulinemia.2
RX   DOI=10.1182/blood-2023-190147;
RX   PubMed=40254718;
CC   Doubling time: 3 days (PubMed=40254718).
CC   Sequence variation: Mutation; HGNC; HGNC:6735; LYN; Simple; p.Ile318Asn (c.953>A) (I297N); Zygosity=Heterozygous (PubMed=40254718).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Ser230Asn (c.689G>A) (S243N); ClinVar=VCV003764990; Zygosity=Heterozygous (PubMed=40254718).
CC   Sequence variation: Mutation; HGNC; HGNC:11241; SPI1; Simple; p.Gln226Glu (c.676G>C); Zygosity=Heterozygous (PubMed=40254718).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BD [Dog histiocytic sarcoma]
AC   CVCL_RY00
DR   Wikidata; Q54795728
RX   PubMed=29490634;
CC   Doubling time: ~36 hours (PubMed=29490634).
CC   Breed/subspecies: Bernese mountain dog; VBO=VBO_0200161.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 4
//
ID   BD [Human B-cell IHW]
AC   CVCL_F568
SY   TER338
DR   IPD-IMGT/HLA; 10301
DR   Wikidata; Q54795730
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*02:01,06:01; DQA1*03:01,05:01; DQB1*02:01,03:02; DRB1*03:01,04:04; DRB3*01:01:03; DRB4*01:03 (IPD-IMGT/HLA=10301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   BD-2.118
AC   CVCL_C4UQ
DR   Wikidata; Q116048587
RX   PubMed=6159300;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BD-215
AC   CVCL_1857
SY   BD215
DR   CLO; CLO_0001907
DR   EFO; EFO_0022616
DR   BioSample; SAMN03473577
DR   DSMZ; ACC-398
DR   DSMZCellDive; ACC-398
DR   Wikidata; Q54795734
RX   PubMed=7689011;
RX   PubMed=20454443;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-398).
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Arg185Ter (c.553C>T); ClinVar=VCV000012044; Zygosity=Homozygous (PubMed=7689011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-398
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 13,17
ST   D19S433: 13,16
ST   D21S11: 28,31
ST   D2S1338: 22,23
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 7,12
ST   D8S1179: 15
ST   FGA: 21,23
ST   Penta D: 10
ST   Penta E: 7,19
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 18
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   Bd-Egg-B
AC   CVCL_F0G0
CC   Group: Insect cell line.
CC   Doubling time: 50.6 hours (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Li, Zi-Niu.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=27457; ! Bactrocera dorsalis (Oriental fruit fly)
SX   Mixed sex
AG   Embryonic stage 6-12 hours
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BD.SP.
AC   CVCL_Y451
DR   ATCC; CRL-6296
DR   Wikidata; Q54795737
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6296; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=326577; ! Bdeogale nigripes (Black-footed mongoose)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   BD01s-p
AC   CVCL_F1GC
WW   Provider; ARI-TOX MWCB; BD01s-p; https://aritox.com/mwcb/mwcb-bd01s-p/
CC   Group: Cetacean cell line.
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=1086039; ! Tursiops australis (Burrunan dolphin)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BD0245
AC   CVCL_8B90
DR   ECACC; 92042906
DR   Wikidata; Q54795738
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BD0419
AC   CVCL_8B91
DR   ECACC; 92102013
DR   Wikidata; Q54795740
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102013; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BD0437
AC   CVCL_8B92
DR   ECACC; 92111009
DR   Wikidata; Q54795743
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BD04s-p
AC   CVCL_F1GD
WW   Provider; ARI-TOX MWCB; BD04s-p; https://aritox.com/mwcb/mwcb-bd04s-p/
CC   Group: Cetacean cell line.
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=1086039; ! Tursiops australis (Burrunan dolphin)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BD0952
AC   CVCL_GR83
SY   BD952
DR   ECACC; 94031517
DR   TOKU-E; 4016
DR   Wikidata; Q54795746
RX   PubMed=14630800;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94031517; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129026; Fanconi anemia, complementation group I
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   BD1
AC   CVCL_B5B1
DR   Wikidata; Q110432593
RX   DOI=10.1021/jf00066a055;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27827; Paraoxon.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   BD129fc-1
AC   CVCL_C326
DR   RCB; AES0027
DR   RCB; RCB2176
DR   SKIP; SKIP001681
DR   Wikidata; Q54795749
CC   Discontinued: RCB; RCB2176; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BD129fc-2
AC   CVCL_C327
DR   RCB; AES0028
DR   RCB; RCB2177
DR   SKIP; SKIP001682
DR   Wikidata; Q54795751
CC   Discontinued: RCB; RCB2177; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BD129mt-1
AC   CVCL_C328
DR   RCB; AES0025
DR   RCB; RCB2174
DR   SKIP; SKIP001679
DR   Wikidata; Q54795754
CC   Discontinued: RCB; RCB2174; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BD129mt-2
AC   CVCL_C329
DR   RCB; AES0026
DR   RCB; RCB2175
DR   SKIP; SKIP001680
DR   Wikidata; Q54795756
CC   Discontinued: RCB; RCB2175; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: (C57BL/6 x DBA/2) x 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BD1B
AC   CVCL_A6ZN
DR   RCB; RCB5290
DR   Wikidata; Q107113450
RX   PubMed=10906147;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9R100; Mouse Cdh17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   BD5-2d
AC   CVCL_K125
DR   CLO; CLO_0001908
DR   ATCC; HB-9689
DR   Wikidata; Q54795758
RX   Patent=US5604107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9689.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   BD6
AC   CVCL_E5QU
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BD9-D12
AC   CVCL_A6KP
DR   Wikidata; Q107113451
RX   DOI=10.1007/978-94-011-2044-9_87;
RX   PubMed=1368811;
RX   PubMed=1576323;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: Human antigen on lung cancer cell line A-549.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6KJ ! A4H12
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   BDCM
AC   CVCL_4613
SY   B-cell with DC Morphology
DR   CLO; CLO_0001910
DR   EFO; EFO_0002113
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2740
DR   BioSample; SAMN03471781
DR   BioSample; SAMN10988332
DR   cancercelllines; CVCL_4613
DR   Cell_Model_Passport; SIDM01522
DR   DepMap; ACH-000080
DR   GEO; GSM886876
DR   GEO; GSM887941
DR   IARC_TP53; 30019
DR   IGRhCellID; BDCM
DR   LiGeA; CCLE_759
DR   LINCS_LDP; LCL-1049
DR   PharmacoDB; BDCM_83_2019
DR   Progenetix; CVCL_4613
DR   Wikidata; Q54795803
RX   PubMed=12437665;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.02%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=2.51%; European, North=70.49%; European, South=26.97% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2740
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 12,18
ST   D19S433: 13,13.1,14
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 10,17
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   BDE/CTVM12
AC   CVCL_Z142
DR   Wikidata; Q54795807
RX   PubMed=20388200;
RX   PubMed=22743047;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60189; ! Rhipicephalus decoloratus (African blue tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   BDE/CTVM14
AC   CVCL_Z143
SY   BDE/CTVM 14
DR   ECACC; 94022808
DR   Wikidata; Q54795809
RX   PubMed=20388200;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022808; true.
OX   NCBI_TaxID=60189; ! Rhipicephalus decoloratus (African blue tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   BDE/CTVM16
AC   CVCL_Z144
DR   Wikidata; Q54795811
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60189; ! Rhipicephalus decoloratus (African blue tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   BDE1
AC   CVCL_AS28
SY   BDE 1
DR   Wikidata; Q54795814
RX   PubMed=7680017;
RX   PubMed=16344070;
RX   PubMed=18081149;
CC   Doubling time: 30 hours (PubMed=7680017); ~25 hours (PubMed=18081149).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   BDE1.1
AC   CVCL_E9YL
RX   PubMed=7680017;
RX   PubMed=10816384;
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_AS28 ! BDE1
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BDE1.2
AC   CVCL_E9YM
RX   PubMed=7680017;
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_AS28 ! BDE1
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BDE1.3
AC   CVCL_E9YN
RX   PubMed=7680017;
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_AS28 ! BDE1
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BDE1.4
AC   CVCL_E9YP
RX   PubMed=7680017;
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_AS28 ! BDE1
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BDE2
AC   CVCL_E9YI
SY   BDE 2
RX   PubMed=7680017;
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BDE3
AC   CVCL_E9YJ
SY   BDE 3
RX   PubMed=7680017;
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BDE4
AC   CVCL_E9YK
SY   BDE 4
RX   PubMed=7680017;
CC   Doubling time: 54 hours (PubMed=7680017).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BDEneu
AC   CVCL_AS29
DR   Wikidata; Q54795815
RX   PubMed=16344070;
RX   PubMed=18081149;
CC   Doubling time: ~17-19 hours (PubMed=18081149).
CC   Genetic integration: Method=Transduction; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_AS28 ! BDE1
SX   Male
AG   8-10W
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   BDEsp
AC   CVCL_AS30
DR   Wikidata; Q54795818
RX   PubMed=18081149;
CC   Characteristics: Spontaneous neoplastically transformed cholangiocytes capable of forming tumors after cell transplantation into the liver of isogenic rats.
CC   Doubling time: ~20 hours (PubMed=18081149).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_AS28 ! BDE1
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   BDF1/52
AC   CVCL_C4TL
SY   52
DR   Wikidata; Q116048588
RX   PubMed=6215989;
CC   Characteristics: Recognizes the terpolymer Glu60-Ala30-Tyr10, known as GAT.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   BDF1/56
AC   CVCL_C4TM
SY   56
DR   Wikidata; Q116048589
RX   PubMed=6215989;
CC   Characteristics: Recognizes ovalbumin.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   BDF1/E3
AC   CVCL_C4TN
SY   E3
DR   Wikidata; Q116048590
RX   PubMed=6215989;
CC   Characteristics: Recognizes the terpolymer Glu60-Ala30-Tyr10, known as GAT.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BDfc-1
AC   CVCL_C330
DR   RCB; AES0018
DR   RCB; RCB2167
DR   SKIP; SKIP001620
DR   Wikidata; Q54795819
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2167; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BDft-1
AC   CVCL_C331
DR   RCB; AES0017
DR   RCB; RCB2166
DR   SKIP; SKIP001621
DR   Wikidata; Q54795822
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2166; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BDM-1
AC   CVCL_0J24
DR   Wikidata; Q54795824
RX   PubMed=3142956;
CC   Characteristics: CSF1 and CSF2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   BDM-2
AC   CVCL_0J25
DR   Wikidata; Q54795825
RX   PubMed=3142956;
CC   Characteristics: CSF1 and CSF2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   BDM-3 [Mouse ESC]
AC   CVCL_0J20
DR   Wikidata; Q54795826
RX   PubMed=8987502;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   BDM-3 [Mouse macrophage]
AC   CVCL_0J26
DR   Wikidata; Q54795828
RX   PubMed=3142956;
CC   Characteristics: CSF2 and IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   BDmt-1
AC   CVCL_C332
DR   RCB; AES0015
DR   RCB; RCB2164
DR   SKIP; SKIP001623
DR   Wikidata; Q54795830
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2164; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BDmt-2
AC   CVCL_C333
DR   RCB; AES0016
DR   RCB; RCB2165
DR   SKIP; SKIP001622
DR   Wikidata; Q54795831
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2165; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BDmto-1
AC   CVCL_F048
DR   RCB; AES0051
DR   RCB; RCB2200
DR   SKIP; SKIP001661
DR   Wikidata; Q54795833
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2200; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BDmto-2
AC   CVCL_F049
DR   RCB; AES0052
DR   RCB; RCB2201
DR   SKIP; SKIP001662
DR   Wikidata; Q54795834
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2201; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BDRPDP
AC   CVCL_XB70
DR   CCRID; 4201PAT-CCTCC00157
DR   Wikidata; Q93425004
RX   Patent=CN1286971C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200501.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5S1V8; Influenza A virus (strain A/Chicken/China/HSS2004 H9N2) nucleoprotein (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 6
//
ID   BDRXN
AC   CVCL_XB71
DR   CCRID; 4201PAT-CCTCC00175
DR   Wikidata; Q93425006
RX   Patent=CN100482787C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200522.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_9328; Sulfadiazine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   BDRXN-2
AC   CVCL_XB72
DR   CCRID; 4201PAT-CCTCC00200
DR   Wikidata; Q93425009
RX   Patent=CN100396774C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200629.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_35358; Sulfonamide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   BE [Human colon carcinoma]
AC   CVCL_H580
DR   cancercelllines; CVCL_H580
DR   ChEMBL-Cells; CHEMBL3307709
DR   ChEMBL-Targets; CHEMBL614798
DR   Cosmic; 724835
DR   GEO; GSM1374398
DR   GEO; GSM1374399
DR   PubChem_Cell_line; CVCL_H580
DR   Wikidata; Q54795836
RX   PubMed=626984;
RX   PubMed=1737339;
RX   PubMed=6256643;
RX   PubMed=9865924;
RX   PubMed=12068308;
RX   PubMed=22282976;
CC   Part of: KuDOS 95 cell line panel.
CC   From: Giovanella, Beppino Carlo; St. Joseph's Hospital Cancer Research Laboratory; Houston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=12068308).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   BE [Human melanoma]
AC   CVCL_9U99
SY   BEmel
DR   Wikidata; Q54795839
RX   PubMed=9331097;
RX   PubMed=10395702;
RX   PubMed=11016658;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   Be Ar
AC   CVCL_3329
SY   BeAr
DR   CLO; CLO_0001912
DR   ATCC; CRL-1167
DR   Wikidata; Q54795841
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Heterozygous (from familial inference of XP8BE; XP9BE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Be Cal
AC   CVCL_U685
DR   ATCC; CRL-1171
DR   Wikidata; Q54795843
CC   Discontinued: ATCC; CRL-1171; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Be Jar
AC   CVCL_U769
DR   ATCC; CRL-1143
DR   Wikidata; Q54795845
CC   Discontinued: ATCC; CRL-1143; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Be Sal
AC   CVCL_3330
DR   CLO; CLO_0001913
DR   ATCC; CRL-1140
DR   Wikidata; Q54795848
CC   Discontinued: ATCC; CRL-1140; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Be Tim
AC   CVCL_3331
SY   XPH11F
DR   CLO; CLO_0001914
DR   ATCC; CRL-1254
DR   Wikidata; Q54795849
CC   Discontinued: ATCC; CRL-1254; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BE(2)-C/ADR(5)
AC   CVCL_V006
SY   Be2-C/ADR5; Be2C/ADR5
DR   cancercelllines; CVCL_V006
DR   Cosmic; 922660
DR   Wikidata; Q54795863
RX   PubMed=8665486;
RX   PubMed=15390183;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   BE(2)-C/ACT(0.2)
AC   CVCL_V007
DR   cancercelllines; CVCL_V007
DR   Wikidata; Q54795864
RX   PubMed=8660514;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   BE(2)-C/CHC(1)
AC   CVCL_V008
DR   cancercelllines; CVCL_V008
DR   Wikidata; Q54795866
RX   PubMed=8660514;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   BE(2)-C/CHCb
AC   CVCL_V009
DR   cancercelllines; CVCL_V009
DR   Wikidata; Q54795868
RX   PubMed=8660514;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   BE(2)-C/CHCg
AC   CVCL_V010
DR   cancercelllines; CVCL_V010
DR   Wikidata; Q54795870
RX   PubMed=8660514;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   BE-13
AC   CVCL_1081
SY   Be-13; BE13; Be13
DR   CLO; CLO_0001921
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03151896
DR   cancercelllines; CVCL_1081
DR   Cell_Model_Passport; SIDM01245
DR   ChEMBL-Cells; CHEMBL3308184
DR   ChEMBL-Targets; CHEMBL2366303
DR   Cosmic; 906763
DR   Cosmic; 1115589
DR   Cosmic; 1151773
DR   Cosmic; 1330495
DR   Cosmic; 1760518
DR   Cosmic; 2165705
DR   Cosmic; 2602909
DR   Cosmic-CLP; 906763
DR   DepMap; ACH-002216
DR   DSMZ; ACC-396
DR   DSMZCellDive; ACC-396
DR   EGA; EGAS00001000978
DR   GDSC; 906763
DR   GEO; GSM1669613
DR   GEO; GSM5137751
DR   IARC_TP53; 21650
DR   LINCS_LDP; LCL-1044
DR   PharmacoDB; BE13_84_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1081
DR   Wikidata; Q54795852
RX   CelloPub=CLPUB00700;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1727382;
RX   PubMed=2144611;
RX   PubMed=6181032;
RX   PubMed=6331881;
RX   PubMed=12592342;
RX   PubMed=15361874;
RX   PubMed=15472075;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=22675565;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Peer derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 11 year old patient with T-ALL.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00178.
CC   Population: Caucasian.
CC   Doubling time: ~40-60 hours (DSMZ=ACC-396).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:8064; NUP214; Name(s)=NUP214-ABL1; Note=NUP214 exon 34 fused to ABL1 exon 2 (PubMed=15361874; PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=906763).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.02%; Native American=1.38%; East Asian, North=0%; East Asian, South=1.18%; South Asian=10.89%; European, North=13.65%; European, South=69.88% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=906763; DSMZ=ACC-396
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 8,13
ST   D18S51: 11,15
ST   D19S433: 13,17
ST   D21S11: 28,33.2
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 11,13
ST   Penta E: 12,15
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1913 ! Peer
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   BE-NQ2
AC   CVCL_H581
DR   Wikidata; Q54795854
RX   PubMed=11377380;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2874; NQO1.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H580 ! BE [Human colon carcinoma]
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   BE-NQ3
AC   CVCL_H582
DR   Wikidata; Q54795855
RX   PubMed=11377380;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2874; NQO1.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H580 ! BE [Human colon carcinoma]
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   BE-NQ4
AC   CVCL_H583
DR   Wikidata; Q54795858
RX   PubMed=11377380;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2874; NQO1.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H580 ! BE [Human colon carcinoma]
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   BE-NQ5
AC   CVCL_H584
DR   Wikidata; Q54795859
RX   PubMed=11377380;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2874; NQO1.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H580 ! BE [Human colon carcinoma]
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   BE-NQ7
AC   CVCL_H585
SY   BE-NQ
DR   ChEMBL-Cells; CHEMBL3307688
DR   ChEMBL-Targets; CHEMBL614702
DR   PubChem_Cell_line; CVCL_H585
DR   Wikidata; Q54795861
RX   PubMed=9865924;
RX   PubMed=11377380;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2874; NQO1.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H580 ! BE [Human colon carcinoma]
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   BE0002
AC   CVCL_8B93
DR   ECACC; 91082308
DR   Wikidata; Q54795872
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BE10
AC   CVCL_8804
DR   Wikidata; Q54795873
RX   PubMed=3081277;
RX   PubMed=7193044;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   BE10-7
AC   CVCL_4121
SY   BE 10-7
DR   CLO; CLO_0001917
DR   CLDB; cl408
DR   ECACC; 93040125
DR   Wikidata; Q54795874
RX   PubMed=7193044;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8804 ! BE10
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   BE10-Early
AC   CVCL_8808
SY   BE10 early
DR   ECACC; 93040118
DR   Wikidata; Q54795875
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Discontinued: ECACC; 93040118; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8804 ! BE10
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   BE10-Intermediate
AC   CVCL_8809
SY   BE10 intermediate
DR   CLO; CLO_0001918
DR   CLDB; cl409
DR   ECACC; 93040119
DR   Wikidata; Q54795876
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8808 ! BE10-Early
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   BE10-Late
AC   CVCL_8810
SY   BE10 late
DR   CLO; CLO_0001919
DR   CLDB; cl410
DR   ECACC; 93040120
DR   Wikidata; Q54795917
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8809 ! BE10-Intermediate
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   BE11
AC   CVCL_8805
DR   TOKU-E; 4111
DR   Wikidata; Q54795919
RX   PubMed=3081277;
RX   PubMed=7193044;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   BE11-Early
AC   CVCL_4122
SY   BE11 (Early); BE11-1
DR   CLO; CLO_0001920
DR   CLDB; cl411
DR   ECACC; 93040121
DR   Wikidata; Q54795921
RX   PubMed=7193044;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8805 ! BE11
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   BE2 [Mouse hybridoma against glycosphingolipids]
AC   CVCL_J749
DR   CLO; CLO_0001922
DR   ATCC; TIB-182
DR   Wikidata; Q54795922
RX   PubMed=7287743;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Glycosphingolipids having type II chain H structure.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   BE2 [Mouse hybridoma against vaccinia A56R]
AC   CVCL_E5S0
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; Q01218; Vaccinia virus hemagglutinin OPG185 (A56R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BE2-IA10
AC   CVCL_C4R4
SY   BE2; BSA-GD-BE2-IA10; A10
DR   ABCD; ABCD_AH958
DR   Wikidata; Q116048591
RX   PubMed=4021995;
RX   PubMed=6759173;
RX   PubMed=15585315;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   BE26
AC   CVCL_8806
DR   Wikidata; Q54795926
RX   PubMed=7193044;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   BE27
AC   CVCL_8807
DR   Wikidata; Q54795927
RX   PubMed=7193044;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   BE29G1
AC   CVCL_9165
DR   CLO; CLO_0001923
DR   ATCC; HB-233
DR   Wikidata; Q54795929
RX   PubMed=1672331;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13597; Mouse Icam1/Cd54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   BE3
AC   CVCL_JY35
SY   BE-3; Barret's Esophagus-3
DR   EFO; EFO_0022455
DR   Wikidata; Q54795931
RX   PubMed=20075370;
ST   Source(s): PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 17
ST   D21S11: 30.2
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 10,16
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 5
//
ID   BE3F9
AC   CVCL_G640
DR   CLO; CLO_0001924
DR   ATCC; HB-133
DR   Wikidata; Q54795933
RX   PubMed=6193965;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01317; Bovine INS (Note=Also reacts with other species including human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   BE41
AC   CVCL_E3DX
RX   PubMed=10771091;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Characteristics: Transfected with a GFP N-terminally tagged with peroxisomal PTS2 signal and C-terminally tagged with a PTS1 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3DV ! CHOPS12a
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BEA,PL
AC   CVCL_E473
SY   BEA, PL
DR   dbMHC; 48489
DR   ECACC; 94082237
DR   IHW; IHW09138
DR   IPD-IMGT/HLA; 11681
DR   Wikidata; Q54795935
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02,29; B*44:03; C*03; DPA1*01:03:01,02:01:01; DPB1*04:01,10:01; DQA1*03:01,02:01; DQB1*02:02,03:02; DRB1*04:01,07; DRB4*01:01 (IPD-IMGT/HLA=11681).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   Bear
AC   CVCL_0D14
SY   BEAR
DR   Wikidata; Q54795937
RX   CelloPub=CLPUB00708;
RX   PubMed=12944992;
RX   PubMed=35053440;
CC   Omics: Genomics; Whole genome sequencing.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   BEAS-2B
AC   CVCL_0168
SY   Beas-2B; BEAS 2B; BEAS2B; Beas2B; Bronchial Epithelium transformed with Ad12-SV40 2B
DR   BTO; BTO_0002923
DR   CLO; CLO_0001925
DR   EFO; EFO_0001089
DR   MCCL; MCC:0000060
DR   AddexBio; T0007001/26
DR   ATCC; CRL-3588
DR   ATCC; CRL-9609
DR   BCRJ; 0395
DR   BioSample; SAMN03471073
DR   BioSample; SAMN03472862
DR   cancercelllines; CVCL_0168
DR   CCRID; 3101HUMSCSP5067
DR   CCRID; 5301HUM-KCB09022YJ
DR   CCTCC; GDC0139
DR   ChEMBL-Cells; CHEMBL4295386
DR   ChEMBL-Targets; CHEMBL4296403
DR   CLS; 300311
DR   ECACC; 95102433
DR   GEO; GSE33520
DR   GEO; GSM139654
DR   GEO; GSM139655
DR   GEO; GSM139656
DR   GEO; GSM139657
DR   GEO; GSM139659
DR   GEO; GSM139660
DR   GEO; GSM139661
DR   GEO; GSM139663
DR   GEO; GSM139664
DR   GEO; GSM139666
DR   GEO; GSM171836
DR   GEO; GSM171837
DR   GEO; GSM253389
DR   GEO; GSM827258
DR   GEO; GSM3138797
DR   GEO; GSM3138798
DR   GEO; GSM3138799
DR   GEO; GSM3138800
DR   GEO; GSM3138801
DR   GEO; GSM3138802
DR   GEO; GSM3138803
DR   GEO; GSM3138804
DR   GEO; GSM3138805
DR   IARC_TP53; 23556
DR   KCB; KCB 200922YJ
DR   Kerafast; ENH021-FP
DR   Lonza; 343
DR   NCBI_Iran; C561
DR   PRIDE; PXD003503
DR   Progenetix; CVCL_0168
DR   PubChem_Cell_line; CVCL_0168
DR   Ubigene; YC-B005
DR   Wikidata; Q54795940
RX   DOI=10.1007/978-1-4612-0411-4_25;
RX   Patent=US4885238;
RX   Patent=US5506131;
RX   PubMed=2450641;
RX   PubMed=2539488;
RX   PubMed=2846394;
RX   PubMed=7972006;
RX   PubMed=8504475;
RX   PubMed=12894236;
RX   PubMed=15463957;
RX   PubMed=17331233;
RX   PubMed=20215515;
RX   PubMed=22521957;
RX   PubMed=25524072;
RX   PubMed=25877200;
RX   PubMed=31156620;
RX   PubMed=31900469;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/crl-9609-growth-and-morphology
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-39.html
CC   Group: Patented cell line.
CC   Part of: Small cell lung cancer p53 hotspot mutation cell panel (ATCC TCP-2040).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9609.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-9609; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-3588; CCRID; ECACC=95102433; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D10S1248: 14,15
ST   D12S391: 17,18
ST   D13S317: 13
ST   D16S539: 11,12 (PubMed=25877200)
ST   D16S539: 12 (ATCC=CRL-3588; CCRID; ECACC=95102433; Technion Genomics Center)
ST   D18S51: 18,19
ST   D19S433: 13.2 (PubMed=25877200)
ST   D19S433: 13.2,15.2 (CCRID; Technion Genomics Center)
ST   D1S1656: 14,15
ST   D21S11: 28,30
ST   D22S1045: 14,16
ST   D2S1338: 22,23
ST   D2S441: 11,11.3
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   DYS391: 10
ST   FGA: 20,24
ST   Penta D: 2.2,13
ST   Penta E: 5,8
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0171 ! BET-1A
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   BEAS-2B IRF1 KO
AC   CVCL_C2UN
SY   BEAS-2B-IRF1 KO; IRF1 KO BEAS-2B
DR   GEO; GSM3138806
DR   GEO; GSM3138807
DR   GEO; GSM3138808
DR   GEO; GSM3138809
DR   GEO; GSM3138810
DR   GEO; GSM3138811
DR   GEO; GSM3138812
DR   GEO; GSM3138813
DR   GEO; GSM3138814
DR   Wikidata; Q114310727
RX   PubMed=31156620;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   BEAS-2B NNKA
AC   CVCL_E6CY
RX   PubMed=1323115;
CC   Characteristics: Very tumorigenic. Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to beeswax pellets containing tobacco-specific N-nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK) (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B NNKB
AC   CVCL_E6CZ
RX   PubMed=1323115;
CC   Characteristics: Very tumorigenic. Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to beeswax pellets containing tobacco-specific N-nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK) (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B-BW 1799
AC   CVCL_E6CS
DR   ABM; T0795
RX   PubMed=1323115;
CC   Characteristics: Control cell line for the cell lines exposed to cigarette smoke condensate (CSC) or to N-nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK). Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to blank beeswax pellets (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B-CSC 1170-I
AC   CVCL_E6CT
DR   ABM; T0797
RX   PubMed=1323115;
CC   Characteristics: Very tumorigenic. Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to beeswax pellets containing cigarette smoke condensate (CSC) (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B-CSC 1170-II
AC   CVCL_E6CU
RX   PubMed=1323115;
CC   Characteristics: Marginally tumorigenic. Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to beeswax pellets containing cigarette smoke condensate (CSC) (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B-CSC 1196
AC   CVCL_E6CV
DR   ABM; T0794
RX   PubMed=1323115;
CC   Characteristics: Not tumorigenic. Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to beeswax pellets containing cigarette smoke condensate (CSC) (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B-CSC 1198
AC   CVCL_E6CW
DR   ABM; T0796
RX   PubMed=1323115;
CC   Characteristics: Not tumorigenic. Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to beeswax pellets containing cigarette smoke condensate (CSC) (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B-CSC A
AC   CVCL_E6CX
RX   PubMed=1323115;
CC   Characteristics: Very tumorigenic. Derived from xenografts produced by the parent cell line grown in deepithelialized rat tracheas that were subcutaneously transplanted into athymic nude mice and exposed to beeswax pellets containing cigarette smoke condensate (CSC) (PubMed=1323115).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BEAS-2B-Luc
AC   CVCL_C8VT
DR   Ubigene; YC-B005-Luc
DR   Wikidata; Q123030784
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   BEAS-2B/c-myc
AC   CVCL_LJ64
SY   BEAS 2B-c-myc; 2B-myc
DR   Wikidata; Q54795944
RX   Patent=US5443954;
RX   PubMed=1712250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9869.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7553; MYC.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   BEAS-2B/c-raf-1
AC   CVCL_LJ65
SY   BEAS 2B-c-raf-1; 2B-raf
DR   Wikidata; Q54795948
RX   Patent=US5443954;
RX   PubMed=1712250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9864.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   BEAS-2B/c-raf-1/c-myc
AC   CVCL_LJ66
SY   2B-raf/myc; RMT-1
DR   Wikidata; Q54795949
RX   Patent=US5443954;
RX   PubMed=1712250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9868.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   BEAS-2B/CYP1A2
AC   CVCL_WZ50
SY   B-1A2
DR   Wikidata; Q93425303
RX   PubMed=22743290;
RX   PubMed=23602888;
RX   PubMed=24114584;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   BEAS-2B/CYP2A13
AC   CVCL_WZ48
SY   B-2A13
DR   CCRID; 4201PAT-CCTCC00427
DR   Wikidata; Q93425306
RX   Patent=CN102168061B;
RX   PubMed=22743290;
RX   PubMed=23602888;
RX   PubMed=24114584;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2010127.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2608; CYP2A13.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 12
//
ID   BEAS-2B/CYP2A6
AC   CVCL_WZ49
SY   B-2A6
DR   Wikidata; Q93425310
RX   PubMed=22743290;
RX   PubMed=23602888;
RX   PubMed=24114584;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   BEAS-2B/EJ-ras
AC   CVCL_LJ61
SY   BEAS 2B/EJ-ras
DR   Wikidata; Q54795952
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9866.
CC   Characteristics: Tumorigenic derivative of BEAS-2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   BEAS-2B/N-ras
AC   CVCL_LJ62
SY   BEAS 2B/N-ras
DR   Wikidata; Q54795954
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9870.
CC   Characteristics: Tumorigenic derivative of BEAS-2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gly12Asp).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   BEAS-2B/R1
AC   CVCL_UR57
SY   BEAS-2B-R1; BEAS-2B R1; R1
DR   Wikidata; Q93425330
RX   PubMed=2846394;
RX   PubMed=8504475;
RX   PubMed=12894236;
CC   Characteristics: Partially resistant to retinoic acid.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   BEAS-2B/S6
AC   CVCL_LJ63
SY   BEAS 2B-S6; S6
DR   Wikidata; Q54795955
RX   Patent=US5443954;
RX   PubMed=2846394;
RX   PubMed=8504475;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9867.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   BEB
AC   CVCL_E9XA
SY   Breast Epithelium Benign
RX   Patent=US4780412;
RX   PubMed=3920046;
RX   PubMed=6123842;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-221.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BEC2
AC   CVCL_RQ14
SY   BEC-2
DR   Wikidata; Q54795957
RX   Patent=US5529922;
RX   PubMed=2056117;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10153.
CC   Characteristics: Was investigated under the name Mitumomab for the treatment of small cell lung carcinoma in combination with BCG vaccination.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody R24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 5
//
ID   BEC3
AC   CVCL_RQ15
DR   Wikidata; Q54795958
RX   PubMed=2056117;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody R24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   BECK-1
AC   CVCL_A4BJ
SY   BECK-1732; Beck-1732
DR   ATCC; CRL-3384
DR   cancercelllines; CVCL_A4BJ
DR   Wikidata; Q105506478
RX   PubMed=30862722;
CC   Karyotypic information: 49~50,XX,+18,+i(21)(q10)x2,+mar[30] (PubMed=30862722).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (ATCC=CRL-3384).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (ATCC=CRL-3384).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000177778; Zygosity=Unspecified (ATCC=CRL-3384).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-3384
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   Becker
AC   CVCL_1093
SY   BECKER; AK
DR   CLO; CLO_0009882
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 834
DR   BioSample; SAMN03472775
DR   BioSample; SAMN10987667
DR   cancercelllines; CVCL_1093
DR   Cell_Model_Passport; SIDM00490
DR   CGH-DB; 140-1
DR   ChEMBL-Cells; CHEMBL3308229
DR   ChEMBL-Targets; CHEMBL2366230
DR   Cosmic; 906746
DR   Cosmic; 2367509
DR   Cosmic-CLP; 906746
DR   DepMap; ACH-001016
DR   EGA; EGAS00001000978
DR   GDSC; 906746
DR   GEO; GSM886877
DR   GEO; GSM887942
DR   GEO; GSM1669615
DR   IARC_TP53; 21201
DR   JCRB; IFO50289
DR   LINCS_LDP; LCL-1368
DR   PharmacoDB; Becker_86_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1093
DR   PubChem_Cell_line; CVCL_1093
DR   Wikidata; Q54795960
RX   PubMed=283420;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=906746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.35%; Native American=0.96%; East Asian, North=1.31%; East Asian, South=0.09%; South Asian=10.35%; European, North=21.76%; European, South=65.17% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=906746; JCRB=IFO50289
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 10,14
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   BEF-1
AC   CVCL_YD09
SY   Burbot Embryonic Fibroblastic-1
DR   Wikidata; Q93425370
RX   PubMed=20597426;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=69944; ! Lota lota (Burbot)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   BEG-2
AC   CVCL_D5ZK
SY   BEG 2
DR   Wikidata; Q127380250
RX   PubMed=1845365;
RX   PubMed=2312159;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H615 ! GM1500-6TG-A11
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BEGC
AC   CVCL_D4Z4
SY   Bovine Endometrial Gland Cell line
DR   Wikidata; Q127380252
RX   DOI=10.1016/j.placenta.2017.07.145;
RX   PubMed=29941175;
CC   Derived from site: In situ; Uterus, endometrial gland; UBERON=UBERON_0002451.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   BEI
AC   CVCL_E474
DR   dbMHC; 48490
DR   ECACC; 86072902
DR   IHW; IHW09294
DR   IPD-IMGT/HLA; 10304
DR   Wikidata; Q54795962
RX   PubMed=28360230;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02; B*57; C*06; DPB1*05:01,04:01; DQA1*02:01; DQB1*02:01:01 (IPD-IMGT/HLA=10304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   BEL-1
AC   CVCL_0081
SY   BEL1
DR   Cosmic; 2542842
DR   DSMZ; ACC-968
DR   Wikidata; Q54795965
RX   PubMed=14671638;
RX   PubMed=15327532;
CC   Doubling time: 38 +- 2 hours (PubMed=15327532); ~48 hours (DSMZ=ACC-968).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-968
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 12,15
ST   D21S11: 28,29
ST   D2S1338: 18,20
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 20,21
ST   Penta D: 13
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   BEL-7402
AC   CVCL_5492
SY   Bel-7402; BEL 7402; Bel 7402; BEL7402; Bel7402
DR   BTO; BTO_0004050
DR   EFO; EFO_0022709
DR   ChEMBL-Cells; CHEMBL3307770
DR   ChEMBL-Targets; CHEMBL614279
DR   Cosmic; 1499247
DR   Cosmic; 2773179
DR   GEO; GSM936754
DR   GEO; GSM1374400
DR   PRIDE; PXD015917
DR   PubChem_Cell_line; CVCL_5492
DR   TOKU-E; 3571
DR   Wikidata; Q54795968
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=1849045;
RX   PubMed=6154311;
RX   PubMed=6275024;
RX   PubMed=14571772;
RX   PubMed=23167424;
RX   PubMed=23505090;
RX   PubMed=28807831;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 53 year old male patient with a hepatocellular carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00549.
CC   Population: African American.
CC   Doubling time: 20 hours (PubMed=6154311); 31.2 +- 1.1 hours (PubMed=23167424).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3131C0001000700010, 3142C0001000000035). They were the sole source for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   BEL-7402/5-FU
AC   CVCL_5493
SY   Bel7402/5-FU; BEL-7402/FU; Bel/5Fu
DR   ChEMBL-Cells; CHEMBL4482981
DR   ChEMBL-Targets; CHEMBL4483230
DR   PRIDE; PXD015917
DR   PubChem_Cell_line; CVCL_5493
DR   Wikidata; Q54795970
RX   PubMed=16696913;
RX   PubMed=23167424;
CC   Problematic cell line: Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 42.3 +- 3.3 hours (PubMed=23167424).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5492 ! BEL-7402
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   BEL-7402/5'-DFUR
AC   CVCL_M184
DR   Wikidata; Q54795971
RX   PubMed=19033114;
CC   Problematic cell line: Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31521; Doxifluridine (5'-deoxy-5-fluorouridine; 5'DFUR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5492 ! BEL-7402
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   BEL-7404
AC   CVCL_6568
SY   Bel-7404; BEL 7404; Bel 7404; BEL7404; Bel7404; 7404
DR   BTO; BTO_0005814
DR   ChEMBL-Cells; CHEMBL3307908
DR   ChEMBL-Targets; CHEMBL614280
DR   GEO; GSM743502
DR   GEO; GSM936755
DR   GEO; GSM1374401
DR   PubChem_Cell_line; CVCL_6568
DR   Wikidata; Q54795973
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6154311;
RX   PubMed=6275024;
RX   PubMed=11774261;
RX   PubMed=23505090;
RX   PubMed=28807831;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 69 year old male patient with a hepatocellular carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00550.
CC   Population: African American.
CC   Doubling time: 26 hours (PubMed=6154311).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000700064). It was the sole source for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   BEL-7404-CP.3
AC   CVCL_IP16
SY   BEL7404-CP.3; 7404-CP.3
DR   Wikidata; Q54795975
RX   PubMed=7710928;
CC   Problematic cell line: Contaminated. Parent cell line (BEL-7404) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6568 ! BEL-7404
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   BEL-7404-CP1
AC   CVCL_IP07
SY   BEL7404-CP1; 7404-CP1
DR   Wikidata; Q54795978
RX   PubMed=7710928;
CC   Problematic cell line: Contaminated. Grand-parent cell line (BEL-7404) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IP16 ! BEL-7404-CP.3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   BEL-7404-CP20
AC   CVCL_IP09
SY   BEL7404-CP20; 7404-CP20
DR   BTO; BTO_0006380
DR   GEO; GSM743503
DR   Wikidata; Q54795979
RX   PubMed=7710928;
RX   PubMed=9443404;
RX   PubMed=22571463;
CC   Problematic cell line: Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IP08 ! BEL-7404-CP7.5
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   BEL-7404-CP7.5
AC   CVCL_IP08
SY   BEL7404-CP7.5; 7404-CP7.5
DR   Wikidata; Q54795982
RX   PubMed=7710928;
CC   Problematic cell line: Contaminated. Ancestral cell line (BEL-7404) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IP07 ! BEL-7404-CP1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   BEL-7405
AC   CVCL_6569
SY   Bel-7405; BEL 7405; Bel 7405; BEL7405
DR   GEO; GSM1374402
DR   Wikidata; Q54795985
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6154311;
RX   PubMed=6275024;
WW   Provider; Shanghai Yansheng; -; https://www.gkzhan.com/st51173/product_1330826.html
CC   Population: Chinese.
CC   Doubling time: 23 hours (PubMed=6154311).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   BEL-A
AC   CVCL_JM04
SY   BEL-A2; Bristol Erythroid Line-Adult
DR   Wikidata; Q54795987
RX   CelloPub=CLPUB00710;
RX   PubMed=28290447;
RX   PubMed=31753923;
WW   Info; -; -; https://www.sciencealert.com/immortal-stem-cells-let-scientists-create-an-unlimited-supply-of-artificial-blood
CC   Characteristics: Differentiates efficiently into mature, functional reticulocytes.
CC   Doubling time: 20 hours (PubMed=28290447); 18.7 +- 2.0 hours (PubMed=31753923).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 14
//
ID   BEL-A 4x KO
AC   CVCL_C0XH
DR   Wikidata; Q114310728
RX   CelloPub=CLPUB00710;
RX   PubMed=29700043;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4035; ACKR1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4012; FUT1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4703; GYPB.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6308; KEL.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0XD ! BEL-A GPB KO
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A 5x KO
AC   CVCL_C0XI
SY   5x KO BEL-A; 5x KO #4 BEL-A
DR   PRIDE; PXD009291
DR   Wikidata; Q114310729
RX   CelloPub=CLPUB00710;
RX   PubMed=29700043;
CC   Characteristics: Completely deficient in blood groups encoded by five different genes that encode antigens responsible for the most common transfusion incompatibilities.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4035; ACKR1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4012; FUT1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4703; GYPB.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6308; KEL.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10006; RHAG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0XH ! BEL-A 4x KO
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A ACKR1 KO
AC   CVCL_C0X9
SY   ACKR1 KO BEL-A
DR   Wikidata; Q114310730
RX   PubMed=29700043;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4035; ACKR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A BSG KO
AC   CVCL_C0XA
SY   Basigin KO BEL-A
DR   Wikidata; Q114310731
RX   CelloPub=CLPUB00710;
RX   PubMed=31444345;
CC   Group: Malaria research cell line.
CC   Characteristics: Induced differentiated reticulocytes are completely refractory to invasion by Plasmodium falciparum (PubMed=31444345).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 9
//
ID   BEL-A2 clone 79
AC   CVCL_C0X7
SY   BEL-A2 clone #79
DR   PRIDE; PXD009291
DR   Wikidata; Q114310732
RX   CelloPub=CLPUB00710;
RX   PubMed=29700043;
RX   PubMed=31444345;
CC   Group: Malaria research cell line.
CC   Characteristics: Induced differentiated reticulocytes can sustain invasion and growth of Plasmodium falciparum (PubMed=31444345).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JM04 ! BEL-A
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A FUT1 KO
AC   CVCL_C0XB
SY   FUT1 KO BEL-A
DR   Wikidata; Q114310733
RX   PubMed=29700043;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4012; FUT1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A GPA KO
AC   CVCL_C0XC
SY   GPA KO BEL-A
DR   Wikidata; Q114310734
RX   CelloPub=CLPUB00710;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4702; GYPA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A GPB KO
AC   CVCL_C0XD
SY   GPB KO BEL-A
DR   Wikidata; Q114310735
RX   CelloPub=CLPUB00710;
RX   PubMed=29700043;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4703; GYPB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A KEL KO
AC   CVCL_C0XE
SY   KEL KO BEL-A
DR   Wikidata; Q114310736
RX   PubMed=29700043;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6308; KEL.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A RHAG KO
AC   CVCL_C0XF
SY   RhAG KO BEL-A
DR   Wikidata; Q114310737
RX   CelloPub=CLPUB00710;
RX   PubMed=29700043;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10006; RHAG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL-A RHCE KO
AC   CVCL_C0XG
SY   RhCE KO BEL-A
DR   Wikidata; Q114310738
RX   CelloPub=CLPUB00710;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10008; RHCE.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0X7 ! BEL-A2 clone 79
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   BEL5GB
AC   CVCL_E475
SY   BEL5 GB; TER260; TER-260; Ter 260; TER304; TER-304; Ter 304; TER424; TER-424; Ter 424; Terasaki B-cell 260
DR   dbMHC; 48491
DR   ECACC; 96070216
DR   IHW; IHW09320
DR   IPD-IMGT/HLA; 10306
DR   Wikidata; Q54795989
RX   PubMed=29171935;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/342cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Irish.
CC   HLA typing: A*02:01:01:01,29:02:01:01; B*44:02:01:01,44:03:01:01; C*05:01:01:02,16:01:01:01; DPB1*02:01:02/02:01:19,04:01:01; DQA1*02:01:01:02,03:03; DQB1*02:02:01,03:01:01; DRB1*04:16,07:01:01; DRB4*01:01:01:01,01:03:01:01 (IPD-IMGT/HLA=10306).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   BEL6KG
AC   CVCL_E476
DR   dbMHC; 48492
DR   ECACC; 94122028
DR   IHW; IHW09321
DR   IPD-IMGT/HLA; 10307
DR   Wikidata; Q54795990
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02; B*44,49; C*05,07; DRB1*11:07,04; DRB3*02:02 (IPD-IMGT/HLA=10307).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   BEL7MON
AC   CVCL_E477
SY   TER328; TER-328; Ter 328; TER407; TER-407; Ter 407; TER501; TER-501; Ter-501; Ter 501
DR   dbMHC; 48493
DR   ECACC; 94122029
DR   IHW; IHW09322
DR   IPD-IMGT/HLA; 10308
DR   Wikidata; Q54795991
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/334cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/381cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01; B*44:02:01:03,51:01:01:01; C*07:674; DPA1*01:03:01:03; DPB1*03:01:01; DQA1*03:03:01,05:05:01:01; DQB1*03:01:01:01,03:01:01:03; DRB1*11:09,04:07:01; DRB3*02:02:01:02; DRB4*01:03:01:01 (IPD-IMGT/HLA=10308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   BEL8-CC
AC   CVCL_E478
DR   dbMHC; 48494
DR   ECACC; 94122030
DR   IHW; IHW09323
DR   IPD-IMGT/HLA; 10309
DR   Wikidata; Q54795994
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02; B*07,44; C*05,07; DPA1*01:03:01; DPB1*02:01:02,20:01:01; DQA1*01:01; DQB1*05:01; DRB1*01:01,01:03 (IPD-IMGT/HLA=10309).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   BELA1
AC   CVCL_A9KQ
SY   BALB/c DEN-induced Lung Adenocarcinoma 1
DR   Wikidata; Q108819926
RX   PubMed=30828726;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>C); Zygosity=Heterozygous (PubMed=30828726).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BELA2
AC   CVCL_A9KR
SY   BALB/c DEN-induced Lung Adenocarcinoma 2
DR   Wikidata; Q108819927
RX   PubMed=30828726;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>C); Zygosity=Heterozygous (PubMed=30828726).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BEN
AC   CVCL_1082
DR   BTO; BTO_0000253
DR   CLO; CLO_0001926
DR   EFO; EFO_0006537
DR   CLDB; cl414
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473096
DR   BioSample; SAMN03473332
DR   BioSample; SAMN10988541
DR   cancercelllines; CVCL_1082
DR   Cell_Model_Passport; SIDM00990
DR   ChEMBL-Cells; CHEMBL3308709
DR   ChEMBL-Targets; CHEMBL1075395
DR   Cosmic; 753534
DR   Cosmic; 1188583
DR   Cosmic; 1995344
DR   Cosmic; 2058651
DR   Cosmic-CLP; 753534
DR   DepMap; ACH-000603
DR   DSMZ; ACC-254
DR   DSMZCellDive; ACC-254
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753534
DR   GEO; GSM784239
DR   GEO; GSM827594
DR   GEO; GSM886878
DR   GEO; GSM887943
DR   GEO; GSM1669616
DR   IARC_TP53; 21181
DR   LiGeA; CCLE_786
DR   LINCS_LDP; LCL-1602
DR   PharmacoDB; BEN_87_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1082
DR   PubChem_Cell_line; CVCL_1082
DR   Wikidata; Q54795995
RX   PubMed=1233082;
RX   PubMed=7171457;
RX   PubMed=10908148;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 3.5 days (PubMed=1233082); ~40-50 hours (DSMZ=ACC-254).
CC   HLA typing: A*24:02,24:02; B*44:03,44:03; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (Cosmic-CLP=753534).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.03%; Native American=0%; East Asian, North=4.23%; East Asian, South=0%; South Asian=0%; European, North=59.95%; European, South=33.78% (PubMed=30894373).
CC   Misspelling: 1BEN; Cosmic=1188583.
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
ST   Source(s): Cosmic-CLP=753534; DSMZ=ACC-254; PubMed=25877200
ST   Amelogenin: X (DSMZ=ACC-254)
ST   Amelogenin: X,Y (Cosmic-CLP=753534; PubMed=25877200)
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15,16,18
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 8
ST   FGA: 21,25
ST   Penta D: 12
ST   Penta E: 20
ST   TH01: 6
ST   TPOX: 8,9 (Cosmic-CLP=753534; DSMZ=ACC-254)
ST   TPOX: 9 (PubMed=25877200)
ST   vWA: 15
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   Ben-Men-1
AC   CVCL_1959
SY   BEN-MEN-1; BenMen 1; Benign-Meningioma-1
DR   BTO; BTO_0004399
DR   BioSample; SAMN03473495
DR   DSMZ; ACC-599
DR   DSMZCellDive; ACC-599
DR   Wikidata; Q54795998
RX   PubMed=15965488;
RX   PubMed=23151902;
RX   PubMed=28552950;
CC   Doubling time: 25.6 hours (PubMed=15965488); ~40-50 hours (DSMZ=ACC-599).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Leu214fs*6 (c.640delC); Zygosity=Hemizygous (PubMed=23151902; PubMed=28552950).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, falx cerebri; UBERON=UBERON_0006059.
ST   Source(s): DSMZ=ACC-599
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 11,12
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4329; Meningothelial meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   Ben-Men-1-LucB
AC   CVCL_JK01
DR   Wikidata; Q54796000
RX   PubMed=23151902;
RX   PubMed=25596744;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Leu214fs*6 (c.640delC); Zygosity=Hemizygous (PubMed=23151902).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, falx cerebri; UBERON=UBERON_0006059.
DI   NCIt; C4329; Meningothelial meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1959 ! Ben-Men-1
SX   Female
AG   68Y
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   BEND
AC   CVCL_0169
SY   Bovine ENDometrial cells
DR   CLO; CLO_0001927
DR   MCCL; MCC:0000061
DR   ATCC; CRL-2398
DR   Wikidata; Q54796039
RX   PubMed=9348245;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   bEnd.1
AC   CVCL_U212
SY   bEnd1; brain-derived Endothelial cells.1
DR   KCB; KCB 202016YJ
DR   Wikidata; Q54796040
RX   PubMed=2379237;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 12
//
ID   bEnd.3
AC   CVCL_0170
SY   bEND.3; b.End3; Bend.3; bEnd3; BEND-3; BEND3; brain-derived Endothelial cells.3
DR   BTO; BTO_0003353
DR   CLO; CLO_0001777
DR   CLO; CLO_0001928
DR   MCCL; MCC:0000496
DR   CLDB; cl5049
DR   AddexBio; C0005030/5019
DR   ATCC; CRL-2299
DR   BCRC; 60515
DR   CCRID; 3101MOUSCSP5267
DR   CCRID; 3101MOUTCM40
DR   CCRID; 6101MOU-CERC000126
DR   ECACC; 96091929
DR   JCRB; NIHS0319
DR   Wikidata; Q52183429
RX   PubMed=2379237;
RX   PubMed=14568334;
RX   PubMed=22224974;
RX   PubMed=25282873;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-2299
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/BEnd.3
CC   Characteristics: Widely used for blood vascular research.
CC   Doubling time: 26-30 hours (PubMed=14568334).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Discontinued: JCRB; NIHS0319; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 22
//
ID   bEnd.4
AC   CVCL_6275
SY   brain-derived Endothelial cells.4
DR   Wikidata; Q54796045
RX   PubMed=2379237;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   bEnd.5
AC   CVCL_2252
SY   b.End5; bEND5; brain-derived Endothelial cells.5
DR   CLO; CLO_0001778
DR   ECACC; 96091930
DR   Wikidata; Q54796047
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   BEP1B
AC   CVCL_B4IR
DR   Wikidata; Q110432594
RX   PubMed=1717149;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E77 ! BEP2D
OI   CVCL_6E78 ! BEP3D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   BEP2D
AC   CVCL_6E77
DR   GEO; GSM3611827
DR   GEO; GSM3611828
DR   GEO; GSM3611829
DR   Wikidata; Q54796049
RX   DOI=10.1007/978-1-4612-0411-4_11;
RX   DOI=10.3760/cma.j.issn.0254-5098.2003.04.001;
RX   PubMed=1717149;
RX   PubMed=8118924;
RX   PubMed=9214610;
RX   PubMed=10426802;
RX   PubMed=10657959;
RX   PubMed=11538954;
RX   PubMed=12548635;
RX   PubMed=24944801;
RX   PubMed=31158229;
CC   Doubling time: 35 hours (PubMed=8118924).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): PubMed=31158229
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D10S1248: 14,15
ST   D12S391: 17,18
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 18,19
ST   D19S433: 13.2,15.2
ST   D1S1656: 14
ST   D21S11: 28,30
ST   D22S1045: 14,16
ST   D2S1338: 22,23
ST   D2S441: 11,11.3
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D6S1043: 12,18
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   DYS391: 10
ST   FGA: 20,24
ST   Penta D: 2.2,13
ST   Penta E: 5,8
ST   SE33: 20.2,28.2
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4IR ! BEP1B
OI   CVCL_6E78 ! BEP3D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   BEP2D Fe60T1
AC   CVCL_B4IS
SY   Fe60T1
DR   Wikidata; Q110432595
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129641; Iron-56 ion irradiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   BEP2D Fe60T2
AC   CVCL_B4IT
SY   Fe60T2
DR   Wikidata; Q110432596
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129641; Iron-56 ion irradiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   BEP2D Fe60T3
AC   CVCL_B4IU
SY   Fe60T3
DR   Wikidata; Q110432597
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129641; Iron-56 ion irradiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   BEP2D Fe60T4
AC   CVCL_B4IV
SY   Fe60T4
DR   Wikidata; Q110432598
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129641; Iron-56 ion irradiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   BEP2D H1A
AC   CVCL_B4IW
SY   H1A
DR   Wikidata; Q110432599
RX   PubMed=8118924;
RX   PubMed=11538954;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D H1ATBA1
AC   CVCL_B4IX
SY   H1ATBA1
DR   Wikidata; Q110432600
RX   PubMed=9214610;
RX   PubMed=10657959;
RX   PubMed=11538954;
CC   Characteristics: Tumorigenic in nude mice.
CC   Karyotypic information: Has lost chromosome Y (PubMed=9214610).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4IW ! BEP2D H1A
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D H1ATN
AC   CVCL_B4IY
SY   H1ATN
DR   Wikidata; Q110432602
RX   PubMed=9214610;
RX   PubMed=10426802;
RX   PubMed=10657959;
CC   Characteristics: Tumorigenic in nude mice.
CC   Karyotypic information: Has lost chromosome Y (PubMed=9214610).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4IW ! BEP2D H1A
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D H1B
AC   CVCL_B4IZ
SY   H1B
DR   Wikidata; Q110432603
RX   PubMed=8118924;
RX   PubMed=11538954;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D H2B
AC   CVCL_B4J0
SY   H2B
DR   Wikidata; Q110432604
RX   PubMed=8118924;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D H2BFT
AC   CVCL_B4J1
SY   H2BFT
DR   Wikidata; Q110432605
RX   PubMed=8118924;
RX   PubMed=11538954;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J0 ! BEP2D H2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D H2BT
AC   CVCL_B4J2
SY   H2BT
DR   Wikidata; Q110432606
RX   PubMed=9214610;
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Karyotypic information: Has lost chromosome Y (PubMed=9214610).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J0 ! BEP2D H2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D H2BT2L
AC   CVCL_B4J3
SY   H2BT2L
DR   Wikidata; Q110432607
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=10426802).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J2 ! BEP2D H2BT
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   BEP2D H3A
AC   CVCL_B4J4
SY   H3A
DR   Wikidata; Q110432608
RX   PubMed=8118924;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R15H
AC   CVCL_6E79
SY   R15H
DR   Wikidata; Q54796050
RX   PubMed=12548635;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   BEP2D R15H20
AC   CVCL_6E80
SY   R15H20
DR   Wikidata; Q54796053
RX   DOI=10.3760/cma.j.issn.0254-5098.2003.04.001;
RX   PubMed=12548635;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E79 ! BEP2D R15H
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   BEP2D R15H35
AC   CVCL_6E81
SY   R15H35; RHT35
DR   Wikidata; Q54796054
RX   DOI=10.3760/cma.j.issn.0254-5098.2003.04.001;
RX   PubMed=12428918;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E79 ! BEP2D R15H
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   BEP2D R2D6
AC   CVCL_B4J5
SY   R2D6
DR   Wikidata; Q110432609
RX   PubMed=8118924;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30
AC   CVCL_B4J6
SY   R30
DR   Wikidata; Q110432610
RX   PubMed=11538954;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30-2C
AC   CVCL_B4JK
SY   R30-2C
DR   Wikidata; Q110432611
RX   PubMed=10657959;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30-3C
AC   CVCL_B4JL
SY   R30-3C
DR   Wikidata; Q110432612
RX   PubMed=10657959;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30-4B
AC   CVCL_B4JM
SY   R30-4B
DR   Wikidata; Q110432613
RX   PubMed=10657959;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30-5B
AC   CVCL_B4JN
SY   R30-5B
DR   Wikidata; Q110432615
RX   PubMed=10657959;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30-6A
AC   CVCL_B4JP
SY   R30-6A
DR   Wikidata; Q110432616
RX   PubMed=10657959;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30T1
AC   CVCL_B4J7
SY   R30T1
DR   Wikidata; Q110432617
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30T1L
AC   CVCL_B4JD
SY   R30T1L
DR   Wikidata; Q110432618
RX   PubMed=9214610;
RX   PubMed=10657959;
CC   Characteristics: Tumorigenic in nude mice.
CC   Karyotypic information: Has lost chromosome Y (PubMed=9214610).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J7 ! BEP2D R30T1
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30T1L2A
AC   CVCL_B4JE
SY   R30T1L2A
DR   Wikidata; Q110432619
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Unspecified (PubMed=10426802).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4JD ! BEP2D R30T1L
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   BEP2D R30T2
AC   CVCL_B4J8
SY   R30T2
DR   Wikidata; Q110432620
RX   PubMed=9214610;
RX   PubMed=10657959;
CC   Characteristics: Tumorigenic in nude mice.
CC   Karyotypic information: Has lost chromosome Y (PubMed=9214610).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30T3
AC   CVCL_B4J9
SY   R30T3
DR   Wikidata; Q110432621
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30T3L
AC   CVCL_B4JF
SY   R30T3L
DR   Wikidata; Q110432622
RX   PubMed=9214610;
RX   PubMed=10657959;
CC   Characteristics: Tumorigenic in nude mice.
CC   Karyotypic information: Has lost chromosome Y (PubMed=9214610).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J9 ! BEP2D R30T3
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30T5
AC   CVCL_B4JA
SY   R30T5
DR   Wikidata; Q110432623
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4J6 ! BEP2D R30
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R30T5L2
AC   CVCL_B4JG
SY   R30T5L2
DR   Wikidata; Q110432624
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Asn (c.417G>T); ClinVar=VCV000584923; Zygosity=Unspecified (PubMed=10426802).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4JA ! BEP2D R30T5
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   BEP2D R30T5L2P
AC   CVCL_B4JH
SY   R30T5L2P
DR   Wikidata; Q110432625
RX   PubMed=10426802;
CC   Characteristics: Tumorigenic in nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Asn (c.417G>T); ClinVar=VCV000584923; Zygosity=Unspecified (PubMed=10426802).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4JG ! BEP2D R30T5L2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   BEP2D R3D7
AC   CVCL_B4JB
SY   R3D7
DR   Wikidata; Q110432626
RX   PubMed=8118924;
CC   Characteristics: Tumorigenic in nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R5D7
AC   CVCL_B4JC
SY   R5D7
DR   Wikidata; Q110432627
RX   PubMed=8118924;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R5D7A2C
AC   CVCL_B4JI
SY   R5D7A2C
DR   Wikidata; Q110432629
RX   PubMed=8118924;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4JC ! BEP2D R5D7
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP2D R5D7A4C
AC   CVCL_B4JJ
SY   R5D7A4C
DR   Wikidata; Q110432630
RX   PubMed=8118924;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C16279; Alpha radiation.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4JC ! BEP2D R5D7
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   BEP3D
AC   CVCL_6E78
DR   Wikidata; Q54796057
RX   DOI=10.1007/978-1-4612-0411-4_11;
RX   PubMed=1717149;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4IR ! BEP1B
OI   CVCL_6E77 ! BEP2D
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   Bequit
AC   CVCL_B7K5
SY   AB; Ab
DR   Wikidata; Q112929322
RX   PubMed=1538137;
RX   PubMed=1852002;
RX   PubMed=7951244;
RX   PubMed=9806546;
RX   PubMed=10072068;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; c.338-25_338del (752delG26bp) (752delG-25) (26-BP DEL, NT752) (I5E6-25_I5E6+1); ClinVar=VCV001435455; Zygosity=Homozygous (PubMed=9806546; PubMed=10072068).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: Beguit; PubMed=1538137.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   BER
AC   CVCL_E479
DR   dbMHC; 48495
DR   ECACC; 8805209
DR   IHW; IHW09093
DR   IPD-IMGT/HLA; 11616
DR   Wikidata; Q54796059
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; German.
CC   HLA typing: A*02:01:01:01,02:01:01:08; B*13:02:01; C*06:02:01:01; DPA1*01; DPB1*04:01:01,02:01:02/02:01:19; DQA1*02:01; DQB1*02:02:01; DRA*01:01; DRB1*07:01:01; DRB4*01:01 (IPD-IMGT/HLA=11616).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   BER 5
AC   CVCL_A8R5
DR   Wikidata; Q102113612
RX   PubMed=7821375;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   29Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   BER 5(SV40)
AC   CVCL_A8R6
SY   BER 5SV40
DR   Wikidata; Q102113613
RX   PubMed=7821375;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8R5 ! BER 5
SX   Sex unspecified
AG   29Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   Ber Lin
AC   CVCL_3650
DR   CLO; CLO_0001929
DR   ATCC; CRL-1132
DR   Wikidata; Q54796060
CC   Discontinued: ATCC; CRL-1132; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   BER-40
AC   CVCL_HA73
SY   BER40
DR   Wikidata; Q54796062
RX   PubMed=1459197;
RX   PubMed=12204114;
RX   PubMed=19023417;
CC   Group: Non-human primate cell line.
CC   Selected for resistance to: ChEBI; CHEBI_48080; Brefeldin A (BFA).
CC   Sequence variation: Mutation; UniProtKB; A0A0D9QZH2; GBF1; Simple; p.Ala796Glu (c.2387C>A) (A795E); Zygosity=Heterozygous; Note=Responsible for BFA resistance (PubMed=19023417).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   BER-DSRCT
AC   CVCL_B5EH
DR   Wikidata; Q110432631
RX   PubMed=23759995;
RX   PubMed=34841430;
CC   Doubling time: 30.5 hours (PubMed=34841430).
CC   Karyotypic information: Near triploid karyotype (PubMed=34841430).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex7-WT1 Ex8 fusion (PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro2139Leufs*9; Zygosity=Unspecified (PubMed=34841430).
DI   NCIt; C27373; Adult desmoplastic small round cell tumor
DI   ORDO; Orphanet_83469; Desmoplastic small round cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   BER1
AC   CVCL_YD99
DR   Wikidata; Q93425661
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   BERB
AC   CVCL_LJ68
DR   Wikidata; Q54796065
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10635.
CC   Characteristics: Weakly tumorigenic derivative of BEAS-2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   BERB subclone 2
AC   CVCL_LJ69
SY   BERB (subclone 2)
DR   Wikidata; Q54796066
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10634.
CC   Characteristics: Weakly tumorigenic derivative of BEAS-2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ68 ! BERB
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   BERP35T1
AC   CVCL_B7GL
DR   GEO; GSM3611830
DR   GEO; GSM3611831
DR   GEO; GSM3611832
DR   Wikidata; Q112929323
RX   PubMed=12428918;
RX   PubMed=24944801;
RX   PubMed=31158229;
CC   Characteristics: Established from tumors obtained from xenografts of the parent cell line implanted in BALB/c nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E81 ! BEP2D R15H35
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   BERP35T4
AC   CVCL_B7GM
DR   GEO; GSM3611833
DR   GEO; GSM3611834
DR   GEO; GSM3611835
DR   Wikidata; Q112929324
RX   PubMed=12428918;
RX   PubMed=31158229;
CC   Characteristics: Established from tumors obtained from xenografts of the parent cell line implanted in BALB/c nude mice.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E81 ! BEP2D R15H35
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   BES-1
AC   CVCL_B7RI
DR   Wikidata; Q112929325
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6307565;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7RJ ! B-187
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   BES-1A1.6
AC   CVCL_H532
DR   ATCC; CRL-9608
DR   Wikidata; Q54796068
RX   Patent=US4885238;
RX   PubMed=2450641;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9608.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   Bet-1
AC   CVCL_8835
DR   CLO; CLO_0001930
DR   ATCC; HB-100
DR   Wikidata; Q54796070
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mouse IgM (allotype Igh-6.5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   BET-1A
AC   CVCL_0171
SY   BET1A; Bronchial Epithelium transformed with pRSV-T 1A
DR   MCCL; MCC:0000062
DR   Wikidata; Q54796072
RX   Patent=US4885238;
RX   PubMed=2450641;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9442.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   Bet-2
AC   CVCL_8836
DR   CLO; CLO_0001931
DR   ATCC; HB-88
DR   Wikidata; Q54796074
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mouse IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   BET-2A
AC   CVCL_H533
SY   BET2A; Bronchial Epithelium transformed with pRSV-T 2A
DR   ATCC; CRL-9443
DR   Wikidata; Q54796075
RX   Patent=US4885238;
RX   Patent=US5443954;
RX   PubMed=2450641;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9443.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   BET-3A
AC   CVCL_6F09
SY   Bet-3A; Bronchial Epithelium transformed with pRSV-T 3A
DR   Wikidata; Q54796078
RX   PubMed=8050498;
RX   PubMed=9175740;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F10 ! BET-3B
OI   CVCL_UI61 ! BET-3K
OI   CVCL_6F11 ! BET-3M
OI   CVCL_UI62 ! BFT-3B
OI   CVCL_UI63 ! BFT-3K
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   BET-3B
AC   CVCL_6F10
SY   Bet-3B; Bronchial Epithelium transformed with pRSV-T 3B
DR   Wikidata; Q54796081
RX   PubMed=8050498;
RX   PubMed=9175740;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F09 ! BET-3A
OI   CVCL_UI61 ! BET-3K
OI   CVCL_6F11 ! BET-3M
OI   CVCL_UI62 ! BFT-3B
OI   CVCL_UI63 ! BFT-3K
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   BET-3K
AC   CVCL_UI61
SY   Bronchial Epithelium transformed with pRSV-T 3K
DR   Wikidata; Q93425701
RX   PubMed=8220580;
RX   PubMed=9328464;
RX   PubMed=19935656;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F09 ! BET-3A
OI   CVCL_6F10 ! BET-3B
OI   CVCL_6F11 ! BET-3M
OI   CVCL_UI62 ! BFT-3B
OI   CVCL_UI63 ! BFT-3K
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   BET-3M
AC   CVCL_6F11
SY   Bronchial Epithelium transformed with pRSV-T 3M
DR   Wikidata; Q54796084
RX   CelloPub=CLPUB00712;
RX   PubMed=8220580;
RX   PubMed=9175740;
RX   PubMed=19935656;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F09 ! BET-3A
OI   CVCL_6F10 ! BET-3B
OI   CVCL_UI61 ! BET-3K
OI   CVCL_UI62 ! BFT-3B
OI   CVCL_UI63 ! BFT-3K
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   Beta
AC   CVCL_R799
DR   Wikidata; Q54796086
RX   PubMed=8891732;
CC   Group: Non-human primate cell line.
CC   From: Watkins, David; University of Wisconsin; Madison; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   Beta-9-F10
AC   CVCL_ZF10
DR   Wikidata; Q98125557
RX   PubMed=19454181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Pig beta-crystallin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   Beta-HC13
AC   CVCL_GZ36
SY   beta-HC13; betaHC13; beta HC13; HC13
DR   TOKU-E; 4057
DR   Wikidata; Q54796089
RX   PubMed=8391634;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIP1Tag2.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   Beta-HC8
AC   CVCL_GZ37
SY   beta-HC8; betaHC8
DR   Wikidata; Q54796090
RX   PubMed=8391634;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIP1Tag2.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   Beta-LG MAb 100
AC   CVCL_D6F4
SY   100
DR   Wikidata; Q127380253
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 102
AC   CVCL_D6F5
SY   102
DR   Wikidata; Q127380254
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat, horse, pig and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 105
AC   CVCL_D6F6
SY   105
DR   Wikidata; Q127380255
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes better variant B than variant A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 109
AC   CVCL_D6F7
SY   109
DR   Wikidata; Q127380256
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 111
AC   CVCL_D6F8
SY   111
DR   Wikidata; Q127380257
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 116
AC   CVCL_D6F9
SY   116
DR   Wikidata; Q127380258
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 120
AC   CVCL_D6FA
SY   120
DR   Wikidata; Q127380260
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 121
AC   CVCL_D6FB
SY   121
DR   Wikidata; Q127380262
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 123
AC   CVCL_D6FC
SY   123
DR   Wikidata; Q127380263
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 124
AC   CVCL_D6FD
SY   124
DR   Wikidata; Q127380264
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes better variant B than variant A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 126
AC   CVCL_D6FE
SY   126
DR   Wikidata; Q127380265
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes better variant B than variant A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 128
AC   CVCL_D6FF
SY   128
DR   Wikidata; Q127380266
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 129
AC   CVCL_D6FG
SY   129
DR   Wikidata; Q127380267
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 13
AC   CVCL_D6DX
SY   13
DR   Wikidata; Q127380268
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 134
AC   CVCL_D6FH
SY   134
DR   Wikidata; Q127380269
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 137
AC   CVCL_D6FI
SY   137
DR   Wikidata; Q127380270
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 138
AC   CVCL_D6FJ
SY   138
DR   Wikidata; Q127380271
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes better variant B than variant A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 14
AC   CVCL_D6DY
SY   14
DR   Wikidata; Q127380272
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 140
AC   CVCL_D6FK
SY   140
DR   Wikidata; Q127380273
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 143
AC   CVCL_D6FL
SY   143
DR   Wikidata; Q127380274
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 147
AC   CVCL_D6FM
SY   147
DR   Wikidata; Q127380276
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 153
AC   CVCL_D6FN
SY   153
DR   Wikidata; Q127380277
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 154
AC   CVCL_D6FP
SY   154
DR   Wikidata; Q127380278
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 155
AC   CVCL_D6FQ
SY   155
DR   Wikidata; Q127380279
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 156
AC   CVCL_D6FR
SY   156
DR   Wikidata; Q127380280
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes better variant A than variant B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 17
AC   CVCL_D6DZ
SY   17
DR   Wikidata; Q127380281
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes at the same level variants A and B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 18
AC   CVCL_D6E0
SY   18
DR   Wikidata; Q127380282
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 19
AC   CVCL_D6E1
SY   19
DR   Wikidata; Q127380283
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 20
AC   CVCL_D6E2
SY   20
DR   Wikidata; Q127380285
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 25
AC   CVCL_D6E3
SY   25
DR   Wikidata; Q127380286
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 26
AC   CVCL_D6E4
SY   26
DR   Wikidata; Q127380287
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 27
AC   CVCL_D6E5
SY   27
DR   Wikidata; Q127380288
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 28
AC   CVCL_D6E6
SY   28
DR   Wikidata; Q127380291
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 29
AC   CVCL_D6E7
SY   29
DR   Wikidata; Q127380292
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 3
AC   CVCL_D6DU
SY   3
DR   Wikidata; Q127380293
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes at the same level variants A and B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 31
AC   CVCL_D6E8
SY   31
DR   Wikidata; Q127380294
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 34
AC   CVCL_D6E9
SY   34
DR   Wikidata; Q127380295
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 36
AC   CVCL_D6EA
SY   36
DR   Wikidata; Q127380296
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 37
AC   CVCL_D6EB
SY   37
DR   Wikidata; Q127380297
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 38
AC   CVCL_D6EC
SY   38
DR   Wikidata; Q127380299
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 45
AC   CVCL_D6ED
SY   45
DR   Wikidata; Q127380300
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes better variant A than variant B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 46
AC   CVCL_D6EE
SY   46
DR   Wikidata; Q127380301
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 47
AC   CVCL_D6EF
SY   47
DR   Wikidata; Q127380302
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes at the same level variants A and B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 48
AC   CVCL_D6EG
SY   48
DR   Wikidata; Q127380303
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 49
AC   CVCL_D6EH
SY   49
DR   Wikidata; Q127380304
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 50
AC   CVCL_D6EI
SY   50
DR   Wikidata; Q127380305
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 51
AC   CVCL_D6EJ
SY   51
DR   Wikidata; Q127380306
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 56
AC   CVCL_D6EK
SY   56
DR   Wikidata; Q127380307
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 60
AC   CVCL_D6EL
SY   60
DR   Wikidata; Q127380308
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 61
AC   CVCL_D6EM
SY   61
DR   Wikidata; Q127380309
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 63
AC   CVCL_D6EN
SY   63
DR   Wikidata; Q127380310
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 64
AC   CVCL_D6EP
SY   64
DR   Wikidata; Q127380311
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 65
AC   CVCL_D6EQ
SY   65
DR   Wikidata; Q127380312
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 66
AC   CVCL_D6ER
SY   66
DR   Wikidata; Q127380313
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 7
AC   CVCL_D6DV
SY   7
DR   Wikidata; Q127380314
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 70
AC   CVCL_D6ES
SY   70
DR   Wikidata; Q127380315
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 71
AC   CVCL_D6ET
SY   71
DR   Wikidata; Q127380316
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 73
AC   CVCL_D6EU
SY   73
DR   Wikidata; Q127380317
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 75
AC   CVCL_D6EV
SY   75
DR   Wikidata; Q127380318
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 79
AC   CVCL_D6EW
SY   79
DR   Wikidata; Q127380319
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 8
AC   CVCL_D6DW
SY   8
DR   Wikidata; Q127380320
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 81
AC   CVCL_D6EX
SY   81
DR   Wikidata; Q127380321
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 86
AC   CVCL_D6EY
SY   86
DR   Wikidata; Q127380323
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 87
AC   CVCL_D6EZ
SY   87
DR   Wikidata; Q127380325
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 88
AC   CVCL_D6F0
SY   88
DR   Wikidata; Q127380326
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Recognizes better variant B than variant A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 91
AC   CVCL_D6F1
SY   91
DR   Wikidata; Q127380327
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 93
AC   CVCL_D6F2
SY   93
DR   Wikidata; Q127380328
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-LG MAb 96
AC   CVCL_D6F3
SY   96
DR   Wikidata; Q127380329
RX   PubMed=9313138;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB (Note=Also reacts with goat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Beta-TC-1
AC   CVCL_W951
SY   beta TC1; BetaTC1
DR   Wikidata; Q54796092
RX   PubMed=2848253;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIPTag4.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   Beta-TC-2
AC   CVCL_HF33
SY   beta TC2; BetaTC2
DR   Wikidata; Q54796095
RX   PubMed=2848253;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIPTag2.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Beta-TC-3
AC   CVCL_0172
SY   beta-TC-3; beta-TC3; beta TC3; BETA-TC-3; BETATC3; BetaTC3; betaTC3; bTC3
DR   BTO; BTO_0002993
DR   CLO; CLO_0001932
DR   MCCL; MCC:0000063
DR   ChEMBL-Cells; CHEMBL3308357
DR   ChEMBL-Targets; CHEMBL614063
DR   DSMZ; ACC-324
DR   DSMZCellDive; ACC-324
DR   IBRC; C10109
DR   PubChem_Cell_line; CVCL_0172
DR   TOKU-E; 4054
DR   Wikidata; Q54796097
RX   PubMed=1710218;
RX   PubMed=2848253;
RX   PubMed=22538498;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-210.html
CC   Doubling time: ~34 hours (DSMZ=ACC-324).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIPTag2.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Beta-TC-6
AC   CVCL_0605
SY   beta-TC-6; beta-TC6; beta TC6; BetaTC6; betaTC6
DR   BTO; BTO_0003428
DR   CLO; CLO_0001933
DR   ATCC; CRL-3605
DR   ATCC; CRL-11506
DR   CCRID; 3101MOUSCSP5061
DR   CCRID; 3101MOUTCM34
DR   ChEMBL-Cells; CHEMBL3308358
DR   ChEMBL-Targets; CHEMBL614357
DR   CLS; 305181
DR   GEO; GSE70960
DR   IZSLER; BS TCL 222
DR   KCB; KCB 2010190YJ
DR   Lonza; 1688
DR   PubChem_Cell_line; CVCL_0605
DR   Wikidata; Q54796099
RX   Patent=US5773255;
RX   PubMed=7533732;
RX   PubMed=7958492;
RX   PubMed=8697299;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11506.
CC   Characteristics: Secretes insulin in response to glucose challenge. But this phenotype is unstable.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; ChIP-seq; BMAL1.
CC   Omics: Genomics; ChIP-seq; CLOCK.
CC   Omics: Genomics; ChIP-seq; H2A.Z.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; PDX1.
CC   Discontinued: ATCC; CRL-11506; true.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIP1Tag2.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Beta-TC-6-F7
AC   CVCL_JJ87
SY   beta TC-6 F7; Beta-TC6-F7; beta TC6-F7; BetaTC6-F7; betaTC6-F7; Beta-TC6 clone F7-1
DR   Wikidata; Q54796101
RX   Patent=US5773255;
RX   PubMed=7958492;
RX   PubMed=9612223;
CC   Group: Patented cell line.
CC   Characteristics: Like parent cell line secretes insulin in response to glucose challenge, but this phenotype is stable over a long time in culture. High glucokinase activity, low hexokinase activity.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: (C57BL/6J x DBA/2J)F2 transgenic RIP1Tag2.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0605 ! Beta-TC-6
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   Beta-TC-7
AC   CVCL_0J72
SY   beta-TC7; BetaTC7
DR   Wikidata; Q54796104
RX   PubMed=8495813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C3HeB/FeJ transgenic RIPTag.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   Beta-TC-tet
AC   CVCL_0185
SY   BetaTCtet; betaTC-tet
DR   MCCL; MCC:0000076
DR   ATCC; CRL-3237
DR   Wikidata; Q54796105
RX   PubMed=7724601;
RX   PubMed=11900281;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=betaTC-tet
CC   Characteristics: Expression of the SV40 T-antigen is under the control of the tet operator sequence. Shows growth arrest and further differentiation upon addition of 5 ng/ml tetracycline (PubMed=7724601).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C3HeB/FeJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   betaG 11/3E9
AC   CVCL_C1JV
SY   betaG11/3E9
DR   Wikidata; Q114310739
RX   PubMed=9166666;
CC   Characteristics: Transfected with both a pCB6-INS-Neo and a pRIP7-INS-HygroR constructs. Expresses 27 times more insulin than the grand-parent cell line (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C1JU ! betaG I/17
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   betaG 111/228
AC   CVCL_C1JL
SY   betaG111/228
DR   Wikidata; Q114310740
RX   PubMed=9166666;
CC   Characteristics: Transfected with both a pCMV8-INS-IRES-Neo and a pCMV8-INS-IRES-PuroR constructs. Expresses 60 times more insulin than the grand-parent cell line (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C1JK ! betaG 18/3E1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   betaG 18/3E1
AC   CVCL_C1JK
SY   betaG18/3E1
DR   Wikidata; Q114310741
RX   PubMed=9166666;
CC   Characteristics: Transfected with a pCMV8-INS-IRES-Neo construct (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U435 ! RIN 1046-38
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   betaG 23/21
AC   CVCL_C1JW
SY   betaG23/21
DR   Wikidata; Q114310742
RX   PubMed=9166666;
CC   Characteristics: Transfected with both a pCB6-INS-Neo and a pCMV8-GK-IRES-GPT constructs (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2670; Gck.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C1JU ! betaG I/17
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   betaG 40/107
AC   CVCL_C1JX
SY   betaG40/107
DR   Wikidata; Q114310743
RX   PubMed=9166666;
CC   Characteristics: Transfected with both a pCB6-INS-Neo and a PCB7-GK-HygroR constructs (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2670; Gck.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C1JU ! betaG I/17
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   betaG 40/110
AC   CVCL_C1JZ
SY   betaG40/110; BG 40/110
DR   Wikidata; Q114310744
RX   PubMed=9166666;
RX   PubMed=9166667;
CC   Characteristics: Transfected with both a pCB6-INS-Neo and a PCB7-GK-HygroR constructs (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2670; Gck.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C1JU ! betaG I/17
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   betaG 49/206
AC   CVCL_C1JY
SY   betaG49/206; BG 49/206
DR   Wikidata; Q114310745
RX   PubMed=9166666;
RX   PubMed=9166667;
CC   Characteristics: Transfected with a pCB6-INS-Neo, a pCMV8-GK-IRES-GPT and a pCB7-GLUT2-HygroR constructs (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2670; Gck.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C1JW ! betaG 23/21
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   betaG I/17
AC   CVCL_C1JU
SY   betaG 1/17; BG I/17
DR   Wikidata; Q114310746
RX   PubMed=9166666;
RX   PubMed=9166667;
CC   Characteristics: Transfected with a pCB6-INS-Neo construct. Expresses 10 times more insulin than the parent cell line (PubMed=9166666).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U435 ! RIN 1046-38
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   BEVA
AC   CVCL_M705
DR   cancercelllines; CVCL_M705
DR   Cosmic; 2297013
DR   GEO; GSM119482
DR   Progenetix; CVCL_M705
DR   Wikidata; Q54796108
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9293903;
RX   PubMed=16960149;
CC   Doubling time: ~72 hours (PubMed=9293903).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   BEVA-FBS
AC   CVCL_6G76
DR   Wikidata; Q54796110
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9293903;
CC   Characteristics: Adapted to growth in FBS.
CC   Doubling time: ~96 hours (PubMed=9293903).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M705 ! BEVA
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BeWo
AC   CVCL_0044
SY   BEWO; Be Wo; Be-Wo
DR   BTO; BTO_0000798
DR   CLO; CLO_0001934
DR   CLO; CLO_0001935
DR   CLO; CLO_0050014
DR   EFO; EFO_0002050
DR   CLDB; cl415
DR   CLDB; cl416
DR   AddexBio; C0030001/4905
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CCL-98
DR   BCRC; 60073
DR   BCRJ; 0048
DR   BioSample; SAMN01821537
DR   BioSample; SAMN01821617
DR   BioSample; SAMN03471293
DR   cancercelllines; CVCL_0044
DR   CCRID; 1101HUM-PUMC000156
DR   CCRID; 4201HUM-CCTCC00072
DR   CCTCC; GDC0072
DR   Cell_Model_Passport; SIDM00692
DR   ChEMBL-Cells; CHEMBL3308359
DR   ChEMBL-Targets; CHEMBL614525
DR   CLS; 300123
DR   DSMZ; ACC-458
DR   DSMZCellDive; ACC-458
DR   ECACC; 86082803
DR   FANTOM5_SSTAR; 10423-106C9
DR   GEO; GSM48269
DR   GEO; GSM48270
DR   GEO; GSM48271
DR   GEO; GSM48272
DR   GEO; GSM48273
DR   GEO; GSM7701452
DR   GEO; GSM7701456
DR   IARC_TP53; 21200
DR   IGRhCellID; BeWo
DR   IPD-IMGT/HLA; 10312
DR   IZSLER; BS TCL 3
DR   JCRB; JCRB9111
DR   KCLB; 10098
DR   LINCS_LDP; LCL-1293
DR   Lonza; 1449
DR   Progenetix; CVCL_0044
DR   PubChem_Cell_line; CVCL_0044
DR   RCB; RCB1644
DR   RCB; RCB3678
DR   TKG; TKG 0567
DR   TOKU-E; 661
DR   Ubigene; YC-D018
DR   Wikidata; Q54796111
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=2720636;
RX   PubMed=2878840;
RX   PubMed=3518877;
RX   PubMed=4038916;
RX   PubMed=4299001;
RX   PubMed=5753554;
RX   PubMed=6174649;
RX   PubMed=6682628;
RX   PubMed=6988327;
RX   PubMed=7153601;
RX   PubMed=7819056;
RX   PubMed=7937597;
RX   PubMed=11897413;
RX   PubMed=16797695;
RX   PubMed=16957166;
RX   PubMed=20215515;
RX   PubMed=28161053;
RX   PubMed=32178868;
RX   PubMed=33096371;
RX   PubMed=33810901;
WW   Info; -; -; https://web.archive.org/web/20141030051820/http://www2.kumc.edu/soalab/LabLinks/recipes/bewo.htm
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-163.html
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Characteristics: Cells were initially transplanted to the cheek pouch of a hamster and maintained by serial passage for 8 years prior to the establishment of the cell line.
CC   Doubling time: ~30 hours (DSMZ=ACC-458).
CC   HLA typing: C*04:01:01:01,07:01 (IPD-IMGT/HLA=10312).
CC   Karyotypic information: Near triploid karyotype (PubMed=33096371).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
ST   Source(s): AddexBio=C0030001/4905; ATCC=CCL-98; CCRID; CLS=300123; DSMZ=ACC-458; ECACC=86082803; IZSLER=BS TCL 3; KCLB=10098; PubMed=33810901; RCB=RCB1644; TKG=TKG 0567
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 17,24
ST   D13S317: 9,11
ST   D16S539: 13,14
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D1S1656: 14,16
ST   D21S11: 30
ST   D22S1045: 15
ST   D2S1338: 21,24
ST   D2S441: 14
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 22,23 (KCLB=10098)
ST   FGA: 22,23,24 (ATCC=CCL-98; CCRID; CLS=300123; DSMZ=ACC-458; PubMed=33810901)
ST   Penta D: 9,12
ST   Penta E: 8,12
ST   SE33: 15,25.2
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   BeWo b24
AC   CVCL_LB82
SY   BeWo clone b24
DR   Wikidata; Q54796114
RX   PubMed=2400396;
RX   PubMed=2730581;
RX   PubMed=3597399;
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, forms confluent monolayers amenable to drug transport studies.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 9
//
ID   BeWo b30
AC   CVCL_LB83
SY   BeWo clone b30; BeWo cells subclone b30
DR   AddexBio; C0030002/4906
DR   Wikidata; Q54796115
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=2153559;
RX   PubMed=9374645;
RX   PubMed=18815225;
RX   PubMed=28724925;
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, forms confluent monolayers amenable to drug transport studies.
CC   Doubling time: 2.29 +- 0.13 days (PubMed=28724925).
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
ST   Source(s): AddexBio=C0030002/4906
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 13,14
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 12
//
ID   Bewo31
AC   CVCL_XF88
DR   Wikidata; Q93425711
RX   PubMed=19416964;
CC   Population: Caucasian.
CC   Characteristics: Stably expresses HA-tagged GCM1 under the control of the CMV promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4197; GCM1.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   BexBra1
AC   CVCL_VP38
DR   Wikidata; Q93425712
RX   PubMed=19915932;
CC   Doubling time: 58 hours (PubMed=19915932).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=19915932
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,20
ST   D19S433: 12,13
ST   D21S11: 29,32.2
ST   D2S1338: 21,23
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   BexBra2
AC   CVCL_VP39
DR   Wikidata; Q93425713
RX   PubMed=19915932;
CC   Doubling time: 96 hours (PubMed=19915932).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=19915932
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 12,17
ST   D19S433: 13,15.2
ST   D21S11: 31.2
ST   D2S1338: 17,24
ST   D3S1358: 18
ST   D5S818: 9
ST   D7S820: 12,13
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   BexBra4
AC   CVCL_VP40
DR   Wikidata; Q93425714
RX   PubMed=19915932;
CC   Doubling time: 43 hours (PubMed=19915932).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=19915932
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,14
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 15,16.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 17,18
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 14,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   BF-11
AC   CVCL_7250
DR   CLO; CLO_0001936
DR   ATCC; CRL-8164
DR   ECACC; 95050413
DR   Wikidata; Q54796118
RX   Patent=US4558005;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8164.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01588; Human EPO.
CC   Discontinued: ATCC; CRL-8164; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   BF-2
AC   CVCL_4123
SY   BF2; Bluegill Fry-2
DR   CLO; CLO_0001937
DR   CLDB; cl418
DR   CLDB; cl5163
DR   ATCC; CCL-91
DR   BCRC; 60105
DR   CCLV; CCLV-RIE 0193
DR   ECACC; 00021712
DR   ECACC; 00021713
DR   ECACC; 87032603
DR   IZSLER; BS CL 102
DR   Wikidata; Q54796119
RX   CelloPub=CLPUB00436;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=5674065;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal trunk; UBERON=UBERON_0002100+UBERON_0006071.
OX   NCBI_TaxID=13106; ! Lepomis macrochirus (Bluegill)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   BF-32
AC   CVCL_1960
DR   CLO; CLO_0001938
DR   DSHB; BF-32
DR   DSMZ; ACC-272
DR   DSMZCellDive; ACC-272
DR   Wikidata; Q54796121
RX   PubMed=3305517;
CC   Doubling time: ~34 hours (DSMZ=ACC-272).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q9BE41; Bovine MYH2 (Note=Also reacts with human, mouse, rat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 8
//
ID   BF-34
AC   CVCL_1961
DR   CLO; CLO_0001939
DR   CLDB; cl419
DR   DSMZ; ACC-156
DR   DSMZCellDive; ACC-156
DR   Wikidata; Q54796161
RX   PubMed=3305517;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-156).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine neonatal myosin heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   BF-45
AC   CVCL_1962
DR   CLO; CLO_0001940
DR   CLDB; cl421
DR   ATCC; HB-278
DR   DSHB; BF-45
DR   DSMZ; ACC-221
DR   DSMZCellDive; ACC-221
DR   Wikidata; Q54796163
RX   PubMed=3282936;
RX   PubMed=3305517;
CC   Doubling time: ~45 hours (DSMZ=ACC-221).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A6QPA6; Bovine MYH3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 8
//
ID   BF-B6
AC   CVCL_KA95
DR   ATCC; HB-279
DR   Wikidata; Q54796165
RX   PubMed=3282936;
RX   PubMed=3305517;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine embryonic myosin heavy chain.
CC   Discontinued: ATCC; HB-279; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   BF-F3
AC   CVCL_1963
DR   CLO; CLO_0001946
DR   CLDB; cl422
DR   ABCD; ABCD_AW217
DR   ATCC; HB-283
DR   DSHB; BF-F3
DR   DSMZ; ACC-212
DR   DSMZCellDive; ACC-212
DR   Wikidata; Q54796166
RX   PubMed=3305517;
CC   Doubling time: 20-30 hours (DSMZ=ACC-212).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; E1BP87; Bovine MYH4 (Note=Also reacts with mouse, pig, rat and sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 9
//
ID   BF-G6
AC   CVCL_1964
DR   CLO; CLO_0001947
DR   DSHB; BF-G6
DR   DSMZ; ACC-274
DR   DSMZCellDive; ACC-274
DR   Wikidata; Q54796169
RX   PubMed=3282936;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-274).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A6QPA6; Bovine MYH3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 9
//
ID   BF1
AC   CVCL_E5QJ
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Bf1-Venus K/I EB3
AC   CVCL_0I99
SY   Bf1-Venus K/I EB3 clone #2-1
DR   RCB; AES0173
DR   SKIP; SKIP002924
DR   Wikidata; Q54796170
RX   PubMed=18983967;
CC   Characteristics: Using homologous recombination, a PGKp-neo-Venus construct was inserted at the N-terminus of the Foxg1(Bf1) locus (PubMed=18983967).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J647 ! EB3 [Mouse ESC]
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   BF10
AC   CVCL_C5P3
DR   Wikidata; Q116048592
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13068; Lactococcus lactis subsp. lactis nisin-A (nisA).
CC   Monoclonal antibody target: UniProtKB; P29559; Lactococcus lactis subsp. lactis nisin-Z (nisZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BF15#2
AC   CVCL_A4IU
SY   HIPS BF15#2
DR   SKIP; SKIP003122
DR   Wikidata; Q105506481
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   From: Delia, Domenico; National Cancer Institute; Milan; Italy.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   BF2
AC   CVCL_C5P4
DR   Wikidata; Q116048593
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13068; Lactococcus lactis subsp. lactis nisin-A (nisA).
CC   Monoclonal antibody target: UniProtKB; P29559; Lactococcus lactis subsp. lactis nisin-Z (nisZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BF24
AC   CVCL_X687
SY   BF-24
DR   BEI_Resources; ARP-1296
DR   cancercelllines; CVCL_X687
DR   Wikidata; Q54796173
RX   PubMed=2789383;
CC   Population: Japanese.
CC   Characteristics: Contains stably integrated, silent copies of the HIV-1 LTR promoter linked to the CAT gene (PubMed=2789383).
CC   Virology: Sensitive indicator cell line for HIV-1 Tat. When infected by HIV-1, BF24 produces high levels of chloramphenicol acetyl transferase (CAT) (BEI_Resources=ARP-1296).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   BF6
AC   CVCL_C5P5
DR   Wikidata; Q116048594
RX   DOI=10.1021/jf9602232;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13068; Lactococcus lactis subsp. lactis nisin-A (nisA).
CC   Monoclonal antibody target: UniProtKB; P29559; Lactococcus lactis subsp. lactis nisin-Z (nisZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BF8
AC   CVCL_E5QW
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BF9
AC   CVCL_E5R9
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BFA
AC   CVCL_4124
SY   Bovine Fetal Aorta
DR   CLO; CLO_0001945
DR   CLDB; cl426
DR   CLS; 600124
DR   ECACC; 87022601
DR   NCBI_Iran; C608
DR   Wikidata; Q54796175
CC   Discontinued: CLS; 600124; true.
CC   Derived from site: In situ; Fetal aorta; UBERON=UBERON_0000947.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   BFAE-12d
AC   CVCL_ZJ59
SY   Bovine Fetal Aortic Endothelial-12d
DR   Wikidata; Q98125559
RX   PubMed=2981236;
CC   Senescence: Senesces at 65 PDL (PubMed=2981236).
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7FM
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   BFAE-39
AC   CVCL_2I22
SY   Bovine Fetal Aortic Endothelial-39; AG07680; AG07680A; AG07680B
DR   CLO; CLO_0032941
DR   Coriell; AG07680
DR   Wikidata; Q54741101
RX   CelloPub=CLPUB00597;
RX   PubMed=2981236;
CC   Senescence: Senesces at 86-95 PDL (PubMed=2981236).
CC   Caution: Indicated to be of female origin in PubMed=2981236, but karyotype from Coriell shows X,Y.
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_2I17 ! AG04762
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   BFAE-39b
AC   CVCL_2L79
SY   Bovine Fetal Aortic Endothelial-39b; AG07681
DR   CLO; CLO_0032943
DR   Coriell; AG07681
DR   Wikidata; Q54741102
RX   CelloPub=CLPUB00597;
RX   PubMed=2981236;
RX   PubMed=6715012;
CC   Senescence: Senesces at 87 PDL (PubMed=2981236).
CC   Caution: Indicated to be of female origin in PubMed=2981236, but karyotype from Coriell shows X,Y.
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2I22 ! BFAE-39
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   BFAE-39e
AC   CVCL_2L80
SY   Bovine Fetal Aortic Endothelial-39e; AG07682; AG07682A
DR   CLO; CLO_0032945
DR   Coriell; AG07682
DR   Wikidata; Q54741105
RX   CelloPub=CLPUB00597;
RX   PubMed=2981236;
RX   PubMed=6715012;
CC   Senescence: Senesces at 54 PDL (PubMed=2981236). But said to be immortal (PubMed=6715012).
CC   Caution: Indicated to be of female origin in PubMed=2981236, but karyotype from Coriell shows X,Y.
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2I22 ! BFAE-39
SX   Male
AG   18FW
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   BFAE-39g
AC   CVCL_ZJ57
SY   Bovine Fetal Aortic Endothelial-39g
DR   Wikidata; Q98125560
RX   PubMed=2981236;
CC   Senescence: Senesces at 54 PDL (PubMed=2981236).
CC   Caution: Indicated to be of female origin in PubMed=2981236, but karyotype of parent cell line from Coriell shows X,Y.
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2I22 ! BFAE-39
SX   Male
AG   18FW
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 9
//
ID   BFAE-39h
AC   CVCL_ZJ58
SY   Bovine Fetal Aortic Endothelial-39h
DR   Wikidata; Q98125561
RX   PubMed=2981236;
CC   Senescence: Senesces at 48 PDL (PubMed=2981236).
CC   Caution: Indicated to be of female origin in PubMed=2981236, but karyotype of parent cell line from Coriell shows X,Y.
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2I22 ! BFAE-39
SX   Male
AG   18FW
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 9
//
ID   BFAE-39k
AC   CVCL_2L81
SY   BFAE-39K; Bovine Fetal Aortic Endothelial-39k; AG07683
DR   CLO; CLO_0032947
DR   Coriell; AG07683
DR   Wikidata; Q54741107
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2I22 ! BFAE-39
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   BFAE-45
AC   CVCL_2L82
SY   Bovine Fetal Aortic Endothelial-45; AG07684
DR   CLO; CLO_0032928
DR   Coriell; AG07684
DR   Wikidata; Q54741108
RX   CelloPub=CLPUB00597;
RX   PubMed=2981236;
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   BFC-1
AC   CVCL_0173
SY   BFC1
DR   MCCL; MCC:0000064
DR   Wikidata; Q54796177
RX   PubMed=2877896;
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BFC012
AC   CVCL_U461
DR   TOKU-E; 4109
DR   Wikidata; Q54796181
RX   PubMed=9108096;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-437.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   BFC023
AC   CVCL_9U85
DR   Wikidata; Q54796182
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   bfd03
AC   CVCL_C4YB
DR   ABCD; ABCD_AE586
DR   Wikidata; Q116048596
RX   PubMed=8496596;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   bfd05
AC   CVCL_C4YC
DR   ABCD; ABCD_AE590
DR   Wikidata; Q116048597
RX   PubMed=8496596;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9160; Single-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   bfd37
AC   CVCL_C4YD
DR   ABCD; ABCD_AE588
DR   Wikidata; Q116048598
RX   PubMed=8496596;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   bfd38
AC   CVCL_C4YE
DR   ABCD; ABCD_AE587
DR   Wikidata; Q116048599
RX   PubMed=8496596;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   bfd39
AC   CVCL_C4YF
DR   Wikidata; Q116048600
RX   PubMed=8496596;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9160; Single-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   bfd89
AC   CVCL_C4YG
DR   ABCD; ABCD_AE589
DR   Wikidata; Q116048601
RX   PubMed=8496596;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9160; Single-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Bff-K4DT
AC   CVCL_XH42
SY   Bonin flying fox-K4DT
DR   Wikidata; Q93425774
RX   PubMed=31449544;
CC   Group: Bat cell line.
CC   Group: Endangered species/breed cell line.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=1496133; ! Pteropus pselaphon (Bonin flying fox)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   BFF_NCC1
AC   CVCL_JH58
SY   Bovine Fetal Fibroblasts_NCC1
DR   Wikidata; Q54796184
RX   PubMed=24589663;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_JJ85 ! BFF_NCC2
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   BFF_NCC2
AC   CVCL_JJ85
SY   Bovine Fetal Fibroblasts_NCC2
DR   Wikidata; Q54796187
RX   PubMed=24589663;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_JH58 ! BFF_NCC1
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   BFH12
AC   CVCL_JQ51
SY   Bovine Foetal Hepatocyte 12
DR   Wikidata; Q54796189
RX   PubMed=27071625;
RX   PubMed=30617848;
RX   PubMed=38528259;
RX   PubMed=38648904;
CC   Characteristics: Can be used for applications requiring a bovine hepatocyte-derived cell line with long cultivability and high reproducibility.
CC   Senescence: SV40-transformed but with a finite life span. Dies out during passages 40-45.
CC   Doubling time: 23.5 hours (Note=At 11th passage), 25.6 hours (Note=At 31th passage) (PubMed=27071625).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRetro-E2 SV40).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   BFH12 CYP1A1 KO
AC   CVCL_D7FR
RX   PubMed=38528259;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:110232; CYP1A1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRetro-E2 SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_JQ51 ! BFH12
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   BFH12 CYP3A74 KO
AC   CVCL_E7BR
RX   PubMed=38648904;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:110267; CYP3A74.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRetro-E2 SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_JQ51 ! BFH12
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BFIB1
AC   CVCL_B6XK
SY   Bovine uterine FIBroblast clone 1
DR   Wikidata; Q111732956
RX   PubMed=35064470;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BFIB2
AC   CVCL_B6XL
SY   Bovine uterine FIBroblast clone 2
DR   Wikidata; Q111732957
RX   PubMed=35064470;
CC   Doubling time: 28.35 hours (PubMed=35064470).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BFIB3
AC   CVCL_B6XM
SY   Bovine uterine FIBroblast clone 3
DR   Wikidata; Q111732958
RX   PubMed=35064470;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BFL-5
AC   CVCL_5T90
SY   Bovine Fetal Liver-5
DR   Wikidata; Q54796190
RX   PubMed=26659396;
CC   Characteristics: Requires feeder cells.
CC   Miscellaneous: Breed from personal communication of Talbot, Neil C.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5N24 ! BFL-6
OI   CVCL_5T91 ! BFL-7
OI   CVCL_5N25 ! BFL-9
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   BFL-6
AC   CVCL_5N24
SY   Bovine Fetal Liver-6
DR   Wikidata; Q54796192
RX   PubMed=26659396;
CC   Characteristics: Requires feeder cells.
CC   Miscellaneous: Breed from personal communication of Talbot, Neil C.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5T90 ! BFL-5
OI   CVCL_5T91 ! BFL-7
OI   CVCL_5N25 ! BFL-9
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   BFL-7
AC   CVCL_5T91
SY   Bovine Fetal Liver-7
DR   Wikidata; Q54796194
RX   PubMed=26659396;
CC   Characteristics: Requires feeder cells.
CC   Miscellaneous: Breed from personal communication of Talbot, Neil C.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5T90 ! BFL-5
OI   CVCL_5N24 ! BFL-6
OI   CVCL_5N25 ! BFL-9
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   BFL-9
AC   CVCL_5N25
SY   Bovine Fetal Liver-9
DR   Wikidata; Q54796196
RX   PubMed=26659396;
CC   Characteristics: Requires feeder cells.
CC   Doubling time: 3-4 days (PubMed=26659396).
CC   Miscellaneous: Breed from personal communication of Talbot, Neil C.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5T90 ! BFL-5
OI   CVCL_5N24 ! BFL-6
OI   CVCL_5T91 ! BFL-7
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   BFL.1
AC   CVCL_XY27
DR   Wikidata; Q93425817
RX   PubMed=7479770;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   BFO
AC   CVCL_IN45
SY   Barfin Flounder Ovary
DR   Wikidata; Q54796198
RX   DOI=10.1007/s11802-015-2920-6;
CC   Group: Fish cell line.
CC   Doubling time: 32.7 hours (Note=At 60th passage) (DOI=10.1007/s11802-015-2920-6).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=98923; ! Verasper moseri (Barfin flounder)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 6
//
ID   BFR-K1
AC   CVCL_A9IW
DR   CCRID; 5301BOV-KCB0007KZJ
DR   KCB; KCB 200007KZJ
DR   Wikidata; Q108819928
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=30520; ! Bos gaurus frontalis (Domestic gayal)
OI   CVCL_A9IX ! BFR-L1
OI   CVCL_A9IY ! BFR-S3
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   BFR-L1
AC   CVCL_A9IX
DR   CCRID; 5301BOV-KCB0007LZJ
DR   KCB; KCB 200007LZJ
DR   Wikidata; Q108819929
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=30520; ! Bos gaurus frontalis (Domestic gayal)
OI   CVCL_A9IW ! BFR-K1
OI   CVCL_A9IY ! BFR-S3
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BFR-S3
AC   CVCL_A9IY
DR   CCRID; 5301BOV-KCB0007SZJ
DR   KCB; KCB 200007SZJ
DR   Wikidata; Q108819930
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30520; ! Bos gaurus frontalis (Domestic gayal)
OI   CVCL_A9IW ! BFR-K1
OI   CVCL_A9IX ! BFR-L1
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BFR87-124
AC   CVCL_XC60
SY   HB BFR 87-124; BFR 87-124
DR   CCRID; 4201PAT-CCTCC00036
DR   Wikidata; Q93425821
RX   Patent=EP0328248A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89010302.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01227; Sheep FSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BFR87-70
AC   CVCL_XC61
SY   HB BFR 87-70; BFR 87-70
DR   CCRID; 4201PAT-CCTCC00035
DR   Wikidata; Q93425822
RX   Patent=EP0328248A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89010301.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01227; Sheep FSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BFSF_OMKS_1
AC   CVCL_B5BZ
DR   Wikidata; Q110432632
RX   PubMed=34839950;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89462; ! Bubalus bubalis (Domestic water buffalo)
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   BFSF_OMKS_2
AC   CVCL_B5C0
DR   Wikidata; Q110432633
RX   PubMed=34839950;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89462; ! Bubalus bubalis (Domestic water buffalo)
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   BFT-3B
AC   CVCL_UI62
SY   Bronchial Fibroblasts transformed with pRSV-T 3B
DR   Wikidata; Q93425824
RX   PubMed=8220580;
RX   PubMed=9328464;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F09 ! BET-3A
OI   CVCL_6F10 ! BET-3B
OI   CVCL_UI61 ! BET-3K
OI   CVCL_6F11 ! BET-3M
OI   CVCL_UI63 ! BFT-3K
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   BFT-3K
AC   CVCL_UI63
SY   Bronchial Fibroblasts transformed with pRSV-T 3K
DR   Wikidata; Q93425827
RX   PubMed=8220580;
RX   PubMed=9328464;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F09 ! BET-3A
OI   CVCL_6F10 ! BET-3B
OI   CVCL_UI61 ! BET-3K
OI   CVCL_6F11 ! BET-3M
OI   CVCL_UI62 ! BFT-3B
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   BFTC-905
AC   CVCL_1083
SY   BFTC 905; BFTC905; Black Foot disease Transitional Carcinoma 905
DR   CLO; CLO_0001948
DR   EFO; EFO_0002115
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRC; 60068
DR   BioGRID_ORCS_Cell_line; 507
DR   BioSample; SAMN03471907
DR   BioSample; SAMN10988546
DR   cancercelllines; CVCL_1083
DR   Cell_Model_Passport; SIDM00989
DR   ChEMBL-Cells; CHEMBL3308470
DR   ChEMBL-Targets; CHEMBL1075396
DR   Cosmic; 910926
DR   Cosmic; 1046686
DR   Cosmic; 1285113
DR   Cosmic; 1286006
DR   Cosmic; 2050438
DR   Cosmic; 2057443
DR   Cosmic; 2444237
DR   Cosmic; 2685939
DR   Cosmic-CLP; 910926
DR   DepMap; ACH-000802
DR   DSMZ; ACC-361
DR   DSMZCellDive; ACC-361
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910926
DR   GEO; GSM827159
DR   GEO; GSM886879
DR   GEO; GSM887944
DR   GEO; GSM1374403
DR   GEO; GSM1669617
DR   IARC_TP53; 21182
DR   IGRhCellID; BFTC905
DR   LiGeA; CCLE_190
DR   LINCS_LDP; LCL-1710
DR   PharmacoDB; BFTC905_88_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1083
DR   PubChem_Cell_line; CVCL_1083
DR   Wikidata; Q54796201
RX   PubMed=8712703;
RX   PubMed=15846775;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Chinese; Taiwan.
CC   Doubling time: 21.4 hours (PubMed=8712703); ~60-90 hours (DSMZ=ACC-361).
CC   HLA typing: A*02:07,24:02; B*27:04,40:01; C*07:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (Cosmic-CLP=910926; DepMap=ACH-000802).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=910926; DepMap=ACH-000802).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.82%; Native American=0%; East Asian, North=33.39%; East Asian, South=61.81%; South Asian=0%; European, North=0%; European, South=3.98% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Cosmic-CLP=910926; DSMZ=ACC-361; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   BFTC-905-compact
AC   CVCL_M888
DR   cancercelllines; CVCL_M888
DR   Wikidata; Q54796203
RX   PubMed=18398596;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1083 ! BFTC-905
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   BFTC-905-diffuse
AC   CVCL_M889
DR   cancercelllines; CVCL_M889
DR   Wikidata; Q54796205
RX   PubMed=18398596;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Differs from the BFTC-905-compact cell line by growing in a less organized, 'diffuse' manner, which involves colonies of cells exhibiting apparently normal cell-to-cell adhesion as well as individual cells outside of them (PubMed=18398596).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1083 ! BFTC-905
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   BFTC-905-diffuse M
AC   CVCL_M890
DR   cancercelllines; CVCL_M890
DR   Wikidata; Q54796207
RX   PubMed=18398596;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Differs from the BFTC-905-compact cell line by growing in a less organized, 'diffuse' manner, which involves colonies of cells exhibiting apparently normal cell-to-cell adhesion as well as individual cells outside of them (PubMed=18398596).
CC   Karyotypic information: Hypertetraploid karyotype (PubMed=18398596).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1083 ! BFTC-905
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   BFTC-905-DOXO-II
AC   CVCL_4V69
DR   cancercelllines; CVCL_4V69
DR   Wikidata; Q54796208
RX   PubMed=25566959;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1083 ! BFTC-905
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   BFTC-909
AC   CVCL_1084
SY   BFTC 909; BFTC909; Black Foot disease Transitional Carcinoma 909
DR   CLO; CLO_0001949
DR   EFO; EFO_0006538
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRC; 60069
DR   BioGRID_ORCS_Cell_line; 508
DR   BioSample; SAMN03473206
DR   BioSample; SAMN10988547
DR   cancercelllines; CVCL_1084
DR   Cell_Model_Passport; SIDM00988
DR   ChEMBL-Cells; CHEMBL3308710
DR   ChEMBL-Targets; CHEMBL1075397
DR   Cosmic; 910698
DR   Cosmic; 1046687
DR   Cosmic; 1285114
DR   Cosmic; 1286007
DR   Cosmic; 2050439
DR   Cosmic; 2685940
DR   Cosmic-CLP; 910698
DR   DepMap; ACH-000792
DR   DSMZ; ACC-367
DR   DSMZCellDive; ACC-367
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910698
DR   GEO; GSM886880
DR   GEO; GSM887945
DR   GEO; GSM1669618
DR   IARC_TP53; 4367
DR   IARC_TP53; 21183
DR   LiGeA; CCLE_090
DR   LINCS_LDP; LCL-1921
DR   PharmacoDB; BFTC909_89_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1084
DR   PubChem_Cell_line; CVCL_1084
DR   Wikidata; Q54796210
RX   PubMed=8712703;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23599788;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Chinese; Taiwan.
CC   Doubling time: 49.4 hours (PubMed=8712703); ~50 hours (DSMZ=ACC-367).
CC   HLA typing: A*02:07,26:01; B*08:01,46:01; C*01:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2151; CNGB1 + HGNC; HGNC:6326; KIFC3; Name(s)=KIFC3-CNGB1 (PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Heterozygous (Cosmic-CLP=910698).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=27.83%; East Asian, South=71.15%; South Asian=0%; European, North=0%; European, South=1.02% (PubMed=30894373).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
ST   Source(s): BCRC=60069; Cosmic-CLP=910698; DSMZ=ACC-367; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,13
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 28,29
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 24,25.2 (DSMZ=ACC-367)
ST   FGA: 25.2 (PubMed=25877200)
ST   Penta D: 9,11
ST   Penta E: 12,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C7355; Renal pelvis urothelial carcinoma
DI   ORDO; Orphanet_598216; Upper tract urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   BFTC-909 pBabeAR1
AC   CVCL_YB38
SY   BFTC 909 pBabeAR1
DR   cancercelllines; CVCL_YB38
DR   Wikidata; Q93425847
RX   PubMed=23599788;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2151; CNGB1 + HGNC; HGNC:6326; KIFC3; Name(s)=KIFC3-CNGB1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C7355; Renal pelvis urothelial carcinoma
DI   ORDO; Orphanet_598216; Upper tract urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1084 ! BFTC-909
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   BFTC-909 pBabeAR2
AC   CVCL_YB39
SY   BFTC 909 pBabeAR2
DR   cancercelllines; CVCL_YB39
DR   Wikidata; Q93425849
RX   PubMed=23599788;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2151; CNGB1 + HGNC; HGNC:6326; KIFC3; Name(s)=KIFC3-CNGB1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C7355; Renal pelvis urothelial carcinoma
DI   ORDO; Orphanet_598216; Upper tract urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1084 ! BFTC-909
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   BFVSBi001-A
AC   CVCL_C9M7
SY   VS-1
DR   BioSamples; SAMEA112856582
DR   hPSCreg; BFVSBi001-A
DR   Wikidata; Q123030785
RX   PubMed=38199067;
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:8021; NT5E; Simple; p.Thr376Ala (c.1126A>G); ClinVar=VCV001175159; Zygosity=Homozygous (PubMed=38199067).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201591; Arterial calcification due to deficiency of CD73
DI   ORDO; Orphanet_289601; Hereditary arterial and articular multiple calcification syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   BFVSBi002-A
AC   CVCL_C9M8
SY   VS-4
DR   BioSamples; SAMEA112856586
DR   hPSCreg; BFVSBi002-A
DR   Wikidata; Q123030786
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201591; Arterial calcification due to deficiency of CD73
DI   ORDO; Orphanet_289601; Hereditary arterial and articular multiple calcification syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   BFVSBi003-A
AC   CVCL_E4FK
SY   VS-18
DR   BioSamples; SAMEA115544327
DR   hPSCreg; BFVSBi003-A
RX   PubMed=38944978;
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Asn76Asp (c.226A>G); ClinVar=VCV000519601; Zygosity=Heterozygous (PubMed=38944978).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BFVSBi004-A
AC   CVCL_E4FL
SY   VS-19
DR   BioSamples; SAMEA115544329
DR   hPSCreg; BFVSBi004-A
RX   PubMed=38944978;
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Asn76Asp (c.226A>G); ClinVar=VCV000519601; Zygosity=Heterozygous (PubMed=38944978).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BFVSBi005-A
AC   CVCL_E4FM
DR   BioSamples; SAMEA116349292
DR   hPSCreg; BFVSBi005-A
RX   PubMed=39823918;
CC   Group: SARS-CoV-2 research cell line.
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179263; Post-acute sequelae of COVID-19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   BFVSBi006-A
AC   CVCL_E4FN
DR   BioSamples; SAMEA116350013
DR   hPSCreg; BFVSBi006-A
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35114; Varicose vein
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BFVSBi007-A
AC   CVCL_F0RM
DR   BioSamples; SAMEA117512090
DR   hPSCreg; BFVSBi007-A
RX   PubMed=40795579;
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Donor information: Established from a melanoma patient treated with an immune checkpoint inhibitor (ICI). The treatment resulted in a potentially life-threatening syndrome involving myasthenia gravis, myositis, and myocarditis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   NCIt; C34831; Myocarditis
DI   NCIt; C27578; Myositis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BG/F
AC   CVCL_K223
SY   BlueGill/Fin
DR   Wikidata; Q54796213
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=2919396;
CC   Group: Fish cell line.
CC   Doubling time: 26 hours (Note=At 34th passage) (PubMed=2919396).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=13106; ! Lepomis macrochirus (Bluegill)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   BG/G
AC   CVCL_K224
SY   BlueGill/Gill
DR   Wikidata; Q54796215
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=2919396;
CC   Group: Fish cell line.
CC   Doubling time: 18-20 hours (Note=At 36th passage) (PubMed=2919396).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=13106; ! Lepomis macrochirus (Bluegill)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   BG01
AC   CVCL_9726
SY   hESBGN-01; HESBGN-01; BGN-01; BGO1; VIACe001-A; BresaGen 01
DR   EFO; EFO_0007071
DR   ENCODE; ENCBS742FEC
DR   GEO; GSM383872
DR   GEO; GSM384094
DR   GEO; GSM500932
DR   GEO; GSM856719
DR   GEO; GSM862730
DR   GEO; GSM1272755
DR   GEO; GSM1272756
DR   GEO; GSM1272757
DR   GEO; GSM1272758
DR   GEO; GSM1272759
DR   GEO; GSM1272760
DR   hPSCreg; VIACe001-A
DR   SKIP; SKIP001938
DR   TOKU-E; 4082
DR   WiCell; bg01
DR   Wikidata; Q54796217
RX   PubMed=12968106;
RX   PubMed=15153607;
RX   PubMed=15684826;
RX   PubMed=16919167;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=18772870;
RX   PubMed=23117585;
RX   PubMed=24172903;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/6
WW   Provider; BresaGen; -; https://web.archive.org/web/20150322205439/http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
CC   From: ViaCyte, Inc. (originally from BresaGen); San Diego; USA.
CC   HLA typing: A*02,03; B*35,49; C*04,07; DQB1*02,03; DRB1*03,04; DRB3*01 (PubMed=16919167).
CC   HLA typing: A*02:01,03:01; B*35:03,49:01; C*04:01,07:01; DQB1*02:01,03:01; DRB1*03:01,04:05 (PubMed=15684826).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=15684826; PubMed=16919167; WiCell=bg01
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 19
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 22
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   BG01V
AC   CVCL_9727
SY   hESC BG01V; hES BG01V; VIACe001-A-2
DR   CLO; CLO_0003716
DR   ATCC; SCRC-2002
DR   BioSample; SAMN03471936
DR   CCRID; 3101HUMSCSP305
DR   hPSCreg; VIACe001-A-2
DR   SKIP; SKIP002023
DR   TOKU-E; 1448
DR   Wikidata; Q54796220
RX   PubMed=15798361;
RX   PubMed=16293579;
RX   PubMed=16919167;
WW   Provider; Thermo Fisher; R7799105/GSC-1103; https://www.thermofisher.com/order/catalog/product/R7799105
CC   From: National Institute on Drug Abuse; Bethesda; USA.
CC   HLA typing: A*02,03; B*35,49; C*04,07; DQB1*02,03; DRB1*03,04; DRB3*01 (PubMed=16919167).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): ATCC=SCRC-2002; PubMed=15798361; PubMed=16919167
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 19
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 13,14
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9726 ! BG01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   BG01V/hOG
AC   CVCL_9728
SY   VIACe001-A-1
DR   hPSCreg; VIACe001-A-1
DR   SKIP; SKIP002022
DR   Wikidata; Q54796221
RX   PubMed=23089476;
WW   Provider; Thermo Fisher; R7799105; https://www.thermofisher.com/order/catalog/product/R7799105
CC   Characteristics: Transfected with the gene for emerald GFP (EmGFP) under the control of a Oct-4 promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9727 ! BG01V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   BG02
AC   CVCL_9729
SY   BG02ES; hESBGN-02; HESBGN-02; BGN-02; VIACe002-A; BresaGen 02
DR   EFO; EFO_0002778
DR   BioSample; SAMN03471900
DR   ENCODE; ENCBS274AAA
DR   ENCODE; ENCBS275AAA
DR   ENCODE; ENCBS276AAA
DR   ENCODE; ENCBS277AAA
DR   ENCODE; ENCBS278AAA
DR   ENCODE; ENCBS279AAA
DR   ENCODE; ENCBS280AAA
DR   ENCODE; ENCBS281AAA
DR   GEO; GSM472944
DR   GEO; GSM500933
DR   GEO; GSM500934
DR   GEO; GSM856720
DR   GEO; GSM862731
DR   GEO; GSM923453
DR   hPSCreg; VIACe002-A
DR   SKIP; SKIP001939
DR   WiCell; bg02
DR   Wikidata; Q54796222
RX   PubMed=12968106;
RX   PubMed=15153607;
RX   PubMed=15684826;
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=23117585;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/BG02ES_and_H9ES_Myers_protocols.pdf
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/affy/11
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/11
WW   Provider; BresaGen; -; https://web.archive.org/web/20150322205439/http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   From: ViaCyte, Inc. (originally from BresaGen); San Diego; USA.
CC   HLA typing: A*24,68; B*35:11,35; C*03,04; DQB1*03,06:01; DRB1*15,16:02; DRB5*01 (PubMed=16919167).
CC   HLA typing: A*24:02,68:01; B*35:03:35:11; C*03:04,04:01; DQB1*03:01,06:01; DRB1*15:02,16:02 (PubMed=15684826).
CC   Omics: Transcriptomics; Massively parallel signature sequencing (MPSS).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=15684826; PubMed=16919167; WiCell=bg02
ST   Amelogenin: X,Y
ST   CSF1PO: 8,10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 13,14.2
ST   D21S11: 27,30
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 12,14
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   BG03
AC   CVCL_9730
SY   hESBGN-03; HESBGN-03; BGN-03; VIACe003-A; BresaGen 03
DR   EFO; EFO_0002960
DR   BioSample; SAMN03471901
DR   GEO; GSM856721
DR   GEO; GSM862729
DR   hPSCreg; VIACe003-A
DR   SKIP; SKIP001940
DR   WiCell; bg03
DR   Wikidata; Q54796226
RX   PubMed=12968106;
RX   PubMed=15684826;
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=23117585;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/agilent/1
WW   Provider; BresaGen; -; https://web.archive.org/web/20150322205439/http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
CC   From: ViaCyte, Inc. (originally from BresaGen); San Diego; USA.
CC   HLA typing: A*24,68; B*44:44; C*05; DQB1*03; DRB1*04,04 (PubMed=16919167).
CC   HLA typing: A*02:01,32:01; B*44:02; C*05:AC; DQB1*03:01,03:02; DRB1*04:01 (PubMed=15684826).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=15684826; PubMed=16919167; WiCell=bg03
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 21,24
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   BG04
AC   CVCL_9731
SY   hESBGN-04; HESBGN-04; BGN-04; VIACe004-A; BresaGen 04
DR   hPSCreg; VIACe004-A
DR   SKIP; SKIP002021
DR   Wikidata; Q54796228
RX   PubMed=12968106;
WW   Provider; BresaGen; -; https://web.archive.org/web/20150322205439/http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
CC   From: ViaCyte, Inc. (originally from BresaGen); San Diego; USA.
CC   Miscellaneous: Cell line has been lost (BresaGen).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   BG1
AC   CVCL_6570
SY   BG-1; BG-I; Bowman Gray-1; BG-1 FR
DR   BTO; BTO_0000177
DR   BioSample; SAMN03151838
DR   CancerTools; 153873
DR   ChEMBL-Cells; CHEMBL3307815
DR   ChEMBL-Targets; CHEMBL613537
DR   Cosmic; 844351
DR   Cosmic; 1709248
DR   GEO; GSM851910
DR   Millipore; SCC415
DR   PubChem_Cell_line; CVCL_6570
DR   Wikidata; Q54796229
RX   PubMed=2910432;
RX   PubMed=9698466;
RX   PubMed=9769151;
RX   PubMed=22328975;
RX   PubMed=22710073;
RX   PubMed=25321415;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by MCF-7 (PubMed=22710073; PubMed=25321415).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00456.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Millipore=SCC415; PubMed=25321415
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 29,33.2 (PubMed=25321415)
ST   D21S11: 29,33.2,34.2 (Millipore=SCC415)
ST   D2S1338: 22,23
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 11,12
ST   Penta E: 7,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   BG11
AC   CVCL_C3LN
DR   Wikidata; Q116048602
RX   CelloPub=CLPUB00723;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BG1LucERbc9
AC   CVCL_DD13
SY   BG1LucERbetac9
DR   Wikidata; Q54796234
RX   CelloPub=CLPUB00334;
RX   PubMed=26139245;
CC   Problematic cell line: Contaminated. Parent cell line (VM7Luc4E2) shown to be a MCF-7 derivative.
CC   Population: Caucasian.
CC   Characteristics: Developed to be used for identifying estrogen receptor agonists and antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of estrogen response elements (EREs) upstream of the mouse mammary tumor viral (MMTV) promoter.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3468; ESR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6571 ! VM7Luc4E2
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 13
//
ID   BG3
AC   CVCL_E5S6
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16715; Vaccinia virus major core protein OPG136 (A10L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BG3C8
AC   CVCL_UW58
DR   Wikidata; Q93425908
RX   PubMed=3305281;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on basal cells of stratified epithelia.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 5
//
ID   BG9
AC   CVCL_E5QS
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BGA
AC   CVCL_YP00
SY   Bone Gambusia Affinis
DR   Wikidata; Q93425910
RX   PubMed=31845349;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by redspotted grouper nervous necrosis virus (RGNNV) and striped jack nervous necrosis virus (SJNNV).
CC   Derived from site: In situ; Bone, vertebra; UBERON=UBERON_0002412.
OX   NCBI_TaxID=33528; ! Gambusia affinis (Western mosquitofish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   bGB1
AC   CVCL_IR46
DR   Wikidata; Q54796275
RX   PubMed=20978004;
CC   Omics: Variations; SNP array analysis.
CC   Caution: Was originally classified as originating from a glioblastoma but seems to be from a malignant glioneuronal tumor (MGNT) which is a cancer type not recognized by WHO and NCIt.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C92550; Glioneuronal tumor with neuropil-like islands
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3Y8M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   BGC-1
AC   CVCL_6572
SY   Bovine Granulosa Cell line-1
DR   Wikidata; Q54796236
RX   PubMed=2170405;
RX   PubMed=15541573;
CC   Doubling time: 23.5 hours (PubMed=2170405).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   BGC-823
AC   CVCL_3360
SY   BGC823
DR   BTO; BTO_0003878
DR   CLO; CLO_0001952
DR   CCTCC; GDC0151
DR   Cell_Model_Passport; SIDM01938
DR   ChEMBL-Cells; CHEMBL3307635
DR   ChEMBL-Targets; CHEMBL614526
DR   Cosmic; 2267322
DR   DepMap; ACH-001017
DR   GEO; GSM828793
DR   GEO; GSM843444
DR   GEO; GSM1374404
DR   IARC_TP53; 24859
DR   ICLC; HTL98007
DR   PharmacoDB; BGC823_90_2019
DR   PubChem_Cell_line; CVCL_3360
DR   Wikidata; Q54796238
RX   PubMed=10374555;
RX   PubMed=16344271;
RX   PubMed=26116706;
RX   PubMed=28851942;
RX   PubMed=29717028;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706; PubMed=28851942). Originally thought to be a gastric adenocarcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00570.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=65.99%; Native American=0.77%; East Asian, North=2.9%; East Asian, South=0%; South Asian=0%; European, North=16.38%; European, South=13.96% (PubMed=30894373).
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3111C0001CCC000062, 3131C0001000700011). They were one of the sources for the STR profile of this entry.
CC   Misspelling: BSG823; Note=Occasionally.
CC   Discontinued: ICLC; HTL98007; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706; PubMed=28851942; PubMed=29717028
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13 (CCRID; PubMed=28851942; PubMed=29717028)
ST   D19S433: 13,14 (PubMed=26116706)
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21 (CCRID; PubMed=26116706; PubMed=28851942)
ST   FGA: 21,24 (PubMed=29717028)
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   BGC-823/DOX
AC   CVCL_E8Z4
RX   PubMed=10374555;
CC   Problematic cell line: Contaminated. Parent cell line (BGC-823) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3360 ! BGC-823
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Bge
AC   CVCL_T034
SY   Biomphalaria glabrata embryonic
DR   CLO; CLO_0001953
DR   BEI_Resources; NR-21959
DR   Wikidata; Q54796239
RX   DOI=10.1007/BF00919721;
RX   DOI=10.1016/B978-0-12-470270-7.50011-2;
RX   PubMed=24198436;
CC   Group: Mollusk cell line.
CC   Discontinued: BEI_Resources; NR-21959; true.
OX   NCBI_TaxID=6526; ! Biomphalaria glabrata (Bloodfluke planorb)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   BGE
AC   CVCL_E480
DR   dbMHC; 48496
DR   ECACC; 85121708
DR   IHW; IHW09295
DR   IPD-IMGT/HLA; 10314
DR   Wikidata; Q54796240
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*01:01:01:01,02:01:01:01; B*52:01:01:01; C*12:02:02:01; DPB1*04:01:01; DQB1*06:01:01/06:01:15; DRB1*15:02:01; DRB5*01:02 (IPD-IMGT/HLA=10314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   Bge 1
AC   CVCL_UA33
SY   Bge isolate SL; Bge SL; Bge isolate Sam Loker
DR   Wikidata; Q93425936
RX   PubMed=19133265;
RX   PubMed=24198436;
RX   PubMed=25907768;
CC   Group: Mollusk cell line.
CC   Doubling time: 108 hours (PubMed=25907768).
OX   NCBI_TaxID=6526; ! Biomphalaria glabrata (Bloodfluke planorb)
HI   CVCL_T034 ! Bge
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 5
//
ID   Bge 2
AC   CVCL_UA34
SY   Bge isolate CB; Bge CB; Bge isolate Christopher Bayne
DR   Wikidata; Q93425939
RX   PubMed=19133265;
RX   PubMed=24198436;
RX   PubMed=25907768;
CC   Group: Mollusk cell line.
CC   Doubling time: 157 hours (PubMed=25907768).
OX   NCBI_TaxID=6526; ! Biomphalaria glabrata (Bloodfluke planorb)
HI   CVCL_T034 ! Bge
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 5
//
ID   Bge 3
AC   CVCL_UA35
SY   Bge3; Bge isolate ATCC CRL-1494
DR   ATCC; CRL-1494
DR   Wikidata; Q93425941
RX   PubMed=30180879;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_272c049ae7
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_835140c56f
CC   Group: Mollusk cell line.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ATCC; CRL-1494; true.
OX   NCBI_TaxID=6526; ! Biomphalaria glabrata (Bloodfluke planorb)
HI   CVCL_T034 ! Bge
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 5
//
ID   Bge isolate UK
AC   CVCL_UA36
SY   Bge UK
DR   BEI_Resources; NR-40248
DR   Wikidata; Q93425943
RX   PubMed=25907768;
CC   Group: Mollusk cell line.
CC   Doubling time: 40-56 hours (PubMed=25907768).
OX   NCBI_TaxID=6526; ! Biomphalaria glabrata (Bloodfluke planorb)
HI   CVCL_T034 ! Bge
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   BGF
AC   CVCL_R833
SY   Banded Grouper Fin
DR   Wikidata; Q54796272
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   BgII,VF9/2d
AC   CVCL_B0C0
SY   BGII, VF9/2D
DR   Wikidata; Q108819931
RX   Patent=US5665559;
RX   PubMed=8020250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9968.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Porphyromonas gingivalis (strain ATCC 33277 / DSM 20709 / CIP 103683 / JCM 12257 / NCTC 11834 / 2561).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   BGK
AC   CVCL_R834
SY   Banded Grouper Kidney
DR   Wikidata; Q54796276
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   BGM
AC   CVCL_4125
AS   CVCL_4789
SY   Buffalo Green Monkey cells; BGMK; Buffalo Green Monkey Kidney cells
DR   CLO; CLO_0001955
DR   CLDB; cl432
DR   CLDB; cl433
DR   CLDB; cl435
DR   CLDB; cl436
DR   CLDB; cl437
DR   BCRJ; 0049
DR   BCRJ; 0313
DR   CCLV; CCLV-RIE 0136
DR   CLS; 302158
DR   ECACC; 90092601
DR   IZSLER; BS CL 7
DR   Wikidata; Q54796277
RX   PubMed=3010860;
RX   PubMed=4993582;
RX   PubMed=16494729;
RX   PubMed=28046048;
RX   PubMed=33389257;
RX   PubMed=34737324;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/buffalo-green-monkey-kidney-bgmk-cells
WW   Provider; Vircell; -; https://www.vircell.com/en/products/bgm-cell-line
CC   Group: Non-human primate cell line.
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=16494729).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Caution: Assignment to Chlorocebus pygerythrus instead of Chlorocebus aethiops by PubMed=34737324.
CC   Discontinued: BCRJ; 0049; probable.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   BGUi001-A
AC   CVCL_A9XC
SY   BGU01iPORCTR; BGU001iPOR CTR; BGU01iPORhet
DR   BioSamples; SAMEA7873753
DR   hPSCreg; BGUi001-A
DR   Wikidata; Q102113614
RX   PubMed=32905996;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:9208; POR; Simple; p.Gly536Arg (c.1606G>A) (p.Gly539Arg, c.1615G>A) (1697G>A); ClinVar=VCV000016915; Zygosity=Heterozygous (PubMed=32905996).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   BGUi002-A
AC   CVCL_A9XD
SY   BGU02iPOR; BGU002iPOR
DR   BioSamples; SAMEA8072993
DR   hPSCreg; BGUi002-A
DR   Wikidata; Q102113615
RX   PubMed=32905996;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:9208; POR; Simple; p.Gly536Arg (c.1606G>A) (p.Gly539Arg, c.1615G>A) (1697G>A); ClinVar=VCV000016915; Zygosity=Homozygous (PubMed=32905996).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174439; Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
DI   ORDO; Orphanet_95699; Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   BGUi003-A
AC   CVCL_A9XE
SY   BGU03iPOR; BGU003iPOR
DR   BioSamples; SAMEA8072994
DR   hPSCreg; BGUi003-A
DR   Wikidata; Q102113617
RX   PubMed=32905996;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:9208; POR; Simple; p.Gly536Arg (c.1606G>A) (p.Gly539Arg, c.1615G>A) (1697G>A); ClinVar=VCV000016915; Zygosity=Homozygous (PubMed=32905996).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174439; Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
DI   ORDO; Orphanet_95699; Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   BGUi004-A
AC   CVCL_A9XA
SY   BGU101iCCHS; BGU101iCCHS25
DR   BioSamples; SAMEA8072981
DR   hPSCreg; BGUi004-A
DR   Wikidata; Q102113618
RX   PubMed=32822965;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Simple; p.Ala260(5_9) (c.765_779dup); ClinVar=VCV000006008; Zygosity=Heterozygous (PubMed=32822965).
CC   Donor information: Established from monozygotic twin of BGUi005-A (Cellosaurus=CVCL_A9XB).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 10
//
ID   BGUi005-A
AC   CVCL_A9XB
SY   BGU102iCCHS; BGU102iCCHS25
DR   BioSamples; SAMEA8072982
DR   hPSCreg; BGUi005-A
DR   Wikidata; Q102113621
RX   PubMed=32822965;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Simple; p.Ala260(5_9) (c.765_779dup); ClinVar=VCV000006008; Zygosity=Heterozygous (PubMed=32822965).
CC   Donor information: Established from monozygotic twin of BGUi004-A (Cellosaurus=CVCL_A9XA).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 10
//
ID   BGUi006-A
AC   CVCL_A4ZJ
SY   BGU06iFD_CTR; BGU06iFDN CTR
DR   hPSCreg; BGUi006-A
DR   Wikidata; Q107113452
RX   PubMed=34419746;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous (PubMed=34419746).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   BGUi007-A
AC   CVCL_A4ZK
SY   BGU07iFD; BGU07iFDN
DR   hPSCreg; BGUi007-A
DR   Wikidata; Q107113454
RX   PubMed=34419746;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous (PubMed=34419746).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   BGUi008-A
AC   CVCL_A4ZL
SY   DCM-C1; DCM-C
DR   BioSamples; SAMEA8093252
DR   hPSCreg; BGUi008-A
DR   Wikidata; Q107113455
RX   PubMed=34088011;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Heterozygous (PubMed=34088011).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8XI ! BGUi008-B
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   BGUi008-B
AC   CVCL_A8XI
SY   DCM-C2
DR   Wikidata; Q108819932
RX   PubMed=34088011;
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Heterozygous (PubMed=34088011).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4ZL ! BGUi008-A
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BGUi009-A
AC   CVCL_A4ZM
SY   DCM-O1; DCM-O
DR   BioSamples; SAMEA8093253
DR   hPSCreg; BGUi009-A
DR   Wikidata; Q107113456
RX   PubMed=34088011;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8XF ! BGUi009-B
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   BGUi009-B
AC   CVCL_A8XF
SY   DCM-O7
DR   Wikidata; Q108819933
RX   PubMed=34088011;
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4ZM ! BGUi009-A
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   BGUi010-A
AC   CVCL_A4ZN
SY   DCM-R4; DCM-R
DR   BioSamples; SAMEA8093254
DR   hPSCreg; BGUi010-A
DR   Wikidata; Q107113457
RX   PubMed=34088011;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8XJ ! BGUi010-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   BGUi010-B
AC   CVCL_A8XJ
SY   DCM-R7
DR   Wikidata; Q108819934
RX   PubMed=34088011;
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Bedouin.
CC   Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4ZN ! BGUi010-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BGUi011-A
AC   CVCL_A4YK
SY   BGU01iGRIN2D
DR   BioSamples; SAMEA8073002
DR   hPSCreg; BGUi011-A
DR   Wikidata; Q107113458
RX   PubMed=33482465;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4588; GRIN2D; Simple; p.Val667Ile (c.1999G>A); ClinVar=VCV000267211; Zygosity=Heterozygous (PubMed=33482465).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177545; Developmental and epileptic encephalopathy 46
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   BGUi012-A
AC   CVCL_A4YL
SY   BGU02iGRIN2DCTR
DR   BioSamples; SAMEA8073005
DR   hPSCreg; BGUi012-A
DR   Wikidata; Q107113459
RX   PubMed=33482465;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   BGUi013-A
AC   CVCL_A4YM
SY   BGU-iPSCs; BGU-hiPS
DR   BioSamples; SAMEA8093240
DR   hPSCreg; BGUi013-A
DR   Wikidata; Q107113460
RX   PubMed=29412740;
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BGUi014-A
AC   CVCL_A4ZP
SY   EMF-iPSCs; BGUiEMF; EMF
DR   BioSamples; SAMEA8093243
DR   hPSCreg; BGUi014-A
DR   Wikidata; Q107113461
RX   PubMed=29412740;
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   BGUi015-A
AC   CVCL_A4YN
SY   BGUiBJ
DR   BioSamples; SAMEA8093244
DR   hPSCreg; BGUi015-A
DR   Wikidata; Q107113462
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   BGUi016-A
AC   CVCL_A8LD
SY   BGU001iSCZ
DR   hPSCreg; BGUi016-A
DR   Wikidata; Q108819935
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi017-A
AC   CVCL_A8LE
DR   hPSCreg; BGUi017-A
DR   Wikidata; Q108819936
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BGUi018-A
AC   CVCL_A8LF
SY   BGU003iSCZ
DR   hPSCreg; BGUi018-A
DR   Wikidata; Q108819937
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi019-A
AC   CVCL_A8LG
SY   BGU004iSCZCTR; BGU004iSCZ CTR
DR   hPSCreg; BGUi019-A
DR   Wikidata; Q108819938
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi020-A
AC   CVCL_A8LH
SY   BGU005iSCZ
DR   hPSCreg; BGUi020-A
DR   Wikidata; Q108819939
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi021-A
AC   CVCL_A8LI
SY   BGU006iSCZCTR; BGU006iSCZ CTR
DR   hPSCreg; BGUi021-A
DR   Wikidata; Q108819940
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi022-A
AC   CVCL_A8LJ
SY   BGU007iSCZ
DR   hPSCreg; BGUi022-A
DR   Wikidata; Q108819941
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi023-A
AC   CVCL_A8LK
SY   BGU008iSCZCTR; BGU008iSCZ CTR
DR   hPSCreg; BGUi023-A
DR   Wikidata; Q108819942
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi024-A
AC   CVCL_A8LL
SY   BGU009iSCZ
DR   hPSCreg; BGUi024-A
DR   Wikidata; Q108819943
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi025-A
AC   CVCL_A8LM
SY   BGU010iSCZCTR; BGU010iSCZ CTR
DR   hPSCreg; BGUi025-A
DR   Wikidata; Q108819944
WW   Provider; BGU; -; https://www.vatinelab.com/about-3
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   BGUi026-A
AC   CVCL_C1NP
DR   BioSamples; SAMEA110132306
DR   hPSCreg; BGUi026-A
DR   Wikidata; Q114310747
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   BGUi027-A
AC   CVCL_C1NQ
DR   BioSamples; SAMEA110148649
DR   hPSCreg; BGUi027-A
DR   Wikidata; Q114310748
CC   From: Ben Gurion University of the Negev; Beer Sheva; Israel.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   BgV
AC   CVCL_5T71
DR   Wikidata; Q54796280
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c H-2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 8
//
ID   BH
AC   CVCL_E481
SY   BH13; BM
DR   dbMHC; 48497
DR   IHW; IHW09046
DR   IPD-IMGT/HLA; 11617
DR   Wikidata; Q54796281
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01; B*13:02:01; C*06:02:01:01; DPA1*01,02; DPB1*04:01:01,17:01; DQA1*02:01; DQB1*02:02:01; DRB1*07:01:01; DRB4*01:01 (IPD-IMGT/HLA=11617).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   BH-E
AC   CVCL_0C06
DR   NCBI_Iran; C567
DR   Wikidata; Q54796284
RX   PubMed=7736387;
RX   PubMed=10100721;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   BH0005
AC   CVCL_8B94
DR   ECACC; 91052404
DR   Wikidata; Q54796286
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BH0008
AC   CVCL_8B95
DR   ECACC; 91062507
DR   Wikidata; Q54796288
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91062507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BH0009
AC   CVCL_8B96
DR   ECACC; 91062508
DR   Wikidata; Q54796291
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0012
AC   CVCL_8B97
DR   ECACC; 91091702
DR   Wikidata; Q54796292
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,X-,+der(X)t(X;15)(p22.33;q25.2)mat (ECACC=91091702).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0013
AC   CVCL_8B98
DR   ECACC; 91091703
DR   Wikidata; Q54796294
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(X;15)(p22.33;q25.2)mat (ECACC=91091703).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BH0015
AC   CVCL_8B99
DR   ECACC; 91112205
DR   Wikidata; Q54796297
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91112205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BH0016
AC   CVCL_8S66
DR   ECACC; 91112206
DR   Wikidata; Q54796299
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91112206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BH0017
AC   CVCL_8S67
DR   ECACC; 91112207
DR   Wikidata; Q54796300
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(X;15)(p22.33;q25.2) (ECACC=91112207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91112207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BH0022
AC   CVCL_8S68
DR   ECACC; 92060308
DR   Wikidata; Q54796303
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Karyotypic information: 46,XY,t(X;15)(p22;qter) (ECACC=92060308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BH0046
AC   CVCL_8S69
DR   ECACC; 94113018
DR   Wikidata; Q54796305
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(9;17)(p13:?q23.3 or 24.1) (ECACC=94113018).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BH0050
AC   CVCL_8S70
DR   ECACC; 95052411
DR   Wikidata; Q54796306
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3267; Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0068
AC   CVCL_8S71
DR   ECACC; 96091306
DR   Wikidata; Q54796309
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,add(2),(q37) (ECACC=96091306).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BH0078
AC   CVCL_8S72
DR   ECACC; 97030411
DR   Wikidata; Q54796310
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X),(q27.3) (ECACC=97030411).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BH0079
AC   CVCL_8S73
DR   ECACC; 97032707
DR   Wikidata; Q54796313
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(Y;14)(p11;p1); de novo (ECACC=97032707).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BH0082
AC   CVCL_8S74
DR   ECACC; 97111303
DR   Wikidata; Q54796315
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;11)(q23;p15.5)mat (ECACC=97111303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BH0083
AC   CVCL_8S75
DR   ECACC; 97111304
DR   Wikidata; Q54796316
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97111304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BH0084
AC   CVCL_8S76
DR   ECACC; 97111305
DR   Wikidata; Q54796319
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(2)(p11;q13),t(3;11)(q23;p15.5) (ECACC=97111305).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97111305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   BH0091
AC   CVCL_8S77
DR   ECACC; 98012319
DR   Wikidata; Q54796320
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98012319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0096
AC   CVCL_8S78
DR   ECACC; 98063003
DR   Wikidata; Q54796321
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98063003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0101
AC   CVCL_8S79
DR   ECACC; 98082703
DR   Wikidata; Q54796323
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98082703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0106
AC   CVCL_8S80
DR   ECACC; 98101809
DR   Wikidata; Q54796324
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98101809; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0109
AC   CVCL_8S81
DR   ECACC; 98112616
DR   Wikidata; Q54796325
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98112616; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0110
AC   CVCL_8S82
DR   ECACC; 99021704
DR   Wikidata; Q54796327
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99021704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0111
AC   CVCL_8S83
DR   ECACC; 99021705
DR   Wikidata; Q54796328
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99021705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0122
AC   CVCL_8S84
DR   ECACC; 00070651
DR   Wikidata; Q54796330
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00070651; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0123
AC   CVCL_8S85
DR   ECACC; 00070652
DR   Wikidata; Q54796332
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00070652; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH0124
AC   CVCL_8S86
DR   ECACC; 00070653
DR   Wikidata; Q54796333
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00070653; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BH10
AC   CVCL_F0HM
RX   PubMed=9570567;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BH24
AC   CVCL_1H22
SY   BH 24
DR   BEI_Resources; ARP-11087
DR   Wikidata; Q54796336
RX   PubMed=15910683;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   BH7
AC   CVCL_E5QR
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Bhas42
AC   CVCL_5494
SY   Bhas 42
DR   JCRB; JCRB0149
DR   Wikidata; Q54796337
RX   PubMed=3141328;
RX   PubMed=21801851;
RX   PubMed=27844419;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Not from strain BALB/c as originally assigned but from a NIH Swiss strain derivative (PubMed=27844419).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00530.
CC   Biotechnology: Part of the 'Bhas 42 cell transformation assay' which is a sensitive short-term system for predicting chemical carcinogenicity (PubMed=21801851).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Ha-Ras.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J646 ! BALB/3T3 A31-1-1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   BHCP
AC   CVCL_6G64
DR   IPD-IMGT/HLA; 12645
DR   Wikidata; Q54796339
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,11; B*51:01:01,15:69; C*02:BC,12:CF; DQB1*06:02,04:02; DRB1*15:01,08:04; DRB5*01 (IPD-IMGT/HLA=12645).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BHD-F59RSVT
AC   CVCL_IR12
DR   cancercelllines; CVCL_IR12
DR   Wikidata; Q54796341
RX   PubMed=27991910;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Glu510del (c.1525GAG[1]) (c.1528_1530delGAG); ClinVar=VCV000253256; Zygosity=Unspecified (PubMed=27991910).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV40gp6).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C28244; Birt-Hogg-Dube syndrome
DI   ORDO; Orphanet_122; Birt-Hogg-Dube syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 14
//
ID   BHD6281
AC   CVCL_D2XH
SY   BHD6281-1; 6281-1
DR   Wikidata; Q127380330
WW   Provider; CReM; 735; https://stemcellbank.bu.edu/Catalog/Item/Details/735
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C28244; Birt-Hogg-Dube syndrome
DI   ORDO; Orphanet_122; Birt-Hogg-Dube syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   BHD6873
AC   CVCL_D2XL
SY   BHD 6873-4; 6873-4
DR   Wikidata; Q127380331
WW   Provider; CReM; 727; https://stemcellbank.bu.edu/Catalog/Item/Details/727
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C28244; Birt-Hogg-Dube syndrome
DI   ORDO; Orphanet_122; Birt-Hogg-Dube syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   BHFTE
AC   CVCL_0E76
SY   BigHorn sheep Fetal Tongue Explant
DR   ATCC; CRL-1941
DR   Wikidata; Q54796342
RX   PubMed=2562198;
CC   Senescence: Can be propagated through at least 23 PDL.
CC   Discontinued: ATCC; CRL-1941; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=112261; ! Ovis canadensis nelsoni (Desert bighorn sheep)
SX   Female
AG   3-4FM
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   BHH2C
AC   CVCL_DD22
DR   Wikidata; Q54796344
RX   PubMed=12021321;
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
HI   CVCL_0421 ! MDBK
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 3
//
ID   BHH3
AC   CVCL_DD23
DR   Wikidata; Q54796372
RX   PubMed=12021321;
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
HI   CVCL_0421 ! MDBK
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 3
//
ID   BHH8
AC   CVCL_DD24
DR   Wikidata; Q54796375
RX   PubMed=12021321;
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
HI   CVCL_0421 ! MDBK
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 3
//
ID   BHK 165-23
AC   CVCL_R995
SY   BHK165-23; 165-23
DR   BTO; BTO_0000674
DR   Wikidata; Q54796376
RX   PubMed=12870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_R994 ! BHK21/C13/SV28
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   BHK 21 C.13/T.6/Ascites
AC   CVCL_WX10
SY   BHK 21/C.13/T.6 Ascites; C13/T6 Ascites
DR   Wikidata; Q93426134
RX   Patent=US3418210;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-10.1.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_LM74 ! BHK21/13/Py6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   BHK 21/13 subline B1
AC   CVCL_L927
SY   Subline B1; Line B-1; GM00348; GM-348; GM348; GM00348A
DR   CLO; CLO_0025564
DR   Coriell; GM00348
DR   Wikidata; Q54796379
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4290606;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   BHK HL-1
AC   CVCL_XY23
SY   HL-1
DR   CCRID; 4201PAT-CCTCC00149
DR   Wikidata; Q93426141
RX   Patent=CN1179976C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200007.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3546; F8.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   BHK TK-
AC   CVCL_4126
DR   CLO; CLO_0001963
DR   CLDB; cl443
DR   ECACC; 85011423
DR   Wikidata; Q54796382
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BHK-21
AC   CVCL_1914
SY   BHK 21; BHK21; Baby Hamster Kidney-21; Baby Hamster Kidney 21; Baby Hamster Kidney from litter No. 21; BHK
DR   EFO; EFO_0022747
DR   ATCC; CRL-6281
DR   ATCC; CRL-6282
DR   Ubigene; YC-A049
DR   Wikidata; Q4838438
RX   PubMed=1263417;
RX   PubMed=6298990;
RX   PubMed=14207308;
RX   PubMed=25903999;
RX   PubMed=34737324;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Baby_hamster_kidney_cell
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 12 hours (PubMed=14207308).
CC   Miscellaneous: Not distributed parent cell line.
CC   Discontinued: ATCC; CRL-6281; true.
CC   Discontinued: ATCC; CRL-6282; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   BHK-21 CIAPIN1+
AC   CVCL_XC59
SY   BHK-21 CIAPIN1 +
DR   CCRID; 4201PAT-CCTCC00481
DR   Wikidata; Q93426153
RX   Patent=CN104450781B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014149.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:28050; CIAPIN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   BHK-21 clone 13
AC   CVCL_1915
SY   BHK 21 clone 13; BHK21 clone 13; BHK-21 (clone 13); BHK 21 (clone 13); BHK21 (clone-13); BHK-21 (C-13); BHK-21 [C-13]; BHK-21(C-13); BHK-21(C13); BHK-21 C-13; BHK-21-C13; BHK-21/C13; BHK 21 CL13; BHK 21 C13; BHK21-C13; BHK-21 C 13; BHK 21/13; BHK21/C13; BHK21/13; BHK21 C13; BHK21C13; C13; BHK-21-ATCC
DR   CLO; CLO_0001957
DR   CLO; CLO_0001958
DR   CLO; CLO_0001959
DR   CLO; CLO_0001965
DR   CLO; CLO_0001966
DR   CLO; CLO_0001967
DR   CLO; CLO_0051403
DR   CLDB; cl439
DR   CLDB; cl444
DR   CLDB; cl445
DR   CLDB; cl446
DR   CLDB; cl447
DR   CLDB; cl448
DR   ATCC; CCL-10
DR   BCRC; 60041
DR   BCRJ; 0050
DR   CCLV; CCLV-RIE 0179
DR   CCLV; CCLV-RIE 0194
DR   CCRID; 1101HAM-PUMC000097
DR   CCRID; 1102HAM-NIFDC00033
DR   CCRID; 3101HAMGNHa10
DR   CCRID; 4201HAM-CCTCC00010
DR   CCRID; 5301HAM-KCB90020YJ
DR   CCTCC; GDC0010
DR   ChEMBL-Cells; CHEMBL3308360
DR   ChEMBL-Targets; CHEMBL614527
DR   CLS; 603126
DR   DSMZ; ACC-61
DR   DSMZCellDive; ACC-61
DR   ECACC; 85011433
DR   ECACC; 93120815
DR   FCS-free; 46-8-338-1-16-3
DR   FCS-free; 46-8-47-1-8-9
DR   IZSLER; BS CL 8
DR   JCRB; JCRB9020
DR   KCB; KCB 90020YJ
DR   KCB; KCB 92005YJ
DR   KCLB; 10010
DR   Lonza; 762
DR   NCBI_Iran; C107
DR   PubChem_Cell_line; CVCL_1915
DR   RCB; RCB1423
DR   TKG; TKG 0308
DR   TOKU-E; 667
DR   Wikidata; Q54796388
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1093/jnci/30.4.795;
RX   Patent=US3228840;
RX   PubMed=4370432;
RX   PubMed=9180260;
RX   PubMed=14207308;
RX   PubMed=14468055;
RX   PubMed=19941903;
RX   PubMed=33389257;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/bhk/bhkcells.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-18.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Baby_hamster_kidney_cell
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-10.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: ~32-50 hours (DSMZ=ACC-61).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1914 ! BHK-21
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   BHK-21 strain 31
AC   CVCL_2303
SY   BHK 21 strain 31; BHK 21 STRAIN 31
DR   CLO; CLO_0001960
DR   CLDB; cl440
DR   ECACC; 93120840
DR   Wikidata; Q54796390
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BHK-21 strain 35
AC   CVCL_2304
SY   BHK 21 strain 35; BHK 21 STRAIN 35
DR   CLO; CLO_0001961
DR   CLDB; cl441
DR   ECACC; 93120841
DR   Wikidata; Q54796392
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BHK-21 strain 38
AC   CVCL_2305
SY   BHK 21 strain 38; BHK 21 STRAIN 38; BHK 38/BS
DR   CLO; CLO_0001962
DR   CLDB; cl442
DR   ECACC; 93120842
DR   IZSLER; BS CL 000
DR   Wikidata; Q54796393
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BHK-21-Bi
AC   CVCL_WN93
SY   BHK-21-Bielefeld
DR   Wikidata; Q93426175
RX   PubMed=9180260;
RX   PubMed=10725223;
CC   Sequence variation: Mutation; UniProtKB; A0A3Q0D700; Ttn; Unexplicit; Partial deletion; Zygosity=Unspecified (PubMed=9180260; PubMed=10725223).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   BHK-21-C5
AC   CVCL_D4ZA
SY   BHK-21 C5; BHK-21C5; BHK-21 (C5)
DR   Wikidata; Q127380332
RX   PubMed=34223718;
RX   PubMed=34824740;
CC   Doubling time: 20.5 hours (PubMed=34223718).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1914 ! BHK-21
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   BHK-21/WI-2
AC   CVCL_HB78
SY   BHK 21/WI-2; BHK21/WI-2; BHK-21 clone WI-2; WI-2
DR   Kerafast; EH1011
DR   Wikidata; Q54796395
RX   PubMed=193466;
RX   PubMed=5320494;
RX   PubMed=20709108;
CC   Virology: Susceptible to infection by human herpesvirus 2 (HHV-2) and Rubella virus (PubMed=193466).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1914 ! BHK-21
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   BHK-21A
AC   CVCL_RQ70
DR   Wikidata; Q54796397
RX   PubMed=7588709;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   BHK-21A EPO40
AC   CVCL_RQ72
SY   EPO40
DR   Wikidata; Q54796400
RX   PubMed=19003352;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3415; EPO.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_RQ70 ! BHK-21A
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   BHK-21A EPO40-ST6NI
AC   CVCL_RQ73
SY   EPO-ST6NI
DR   Wikidata; Q54796402
RX   PubMed=19003352;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10860; ST6GAL1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_RQ72 ! BHK-21A EPO40
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   BHK-21B
AC   CVCL_RQ71
DR   Wikidata; Q54796403
RX   PubMed=7588709;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   BHK-BTV-VP6
AC   CVCL_A9LB
DR   Wikidata; Q108819945
RX   DOI=10.3969/j.issn.1674-7968.2021.04.016;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; G9JKG2; Bluetongue virus serotype 1 (Chinese isolate) protein VP6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   BHK-HVJ
AC   CVCL_W329
DR   CLO; CLO_0001973
DR   CLDB; cl450
DR   Wikidata; Q54796405
RX   PubMed=163346;
RX   PubMed=4559687;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1914 ! BHK-21
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   BHK-IR
AC   CVCL_R858
SY   BHKIR
DR   Wikidata; Q54796406
RX   PubMed=1320025;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   BHK-JC-19
AC   CVCL_HA33
DR   BCRJ; 0053
DR   Wikidata; Q54796408
CC   Discontinued: BCRJ; 0053; probable.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   BHK-M
AC   CVCL_4U20
DR   Wikidata; Q54796409
RX   Patent=US6458563;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4506.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 8
//
ID   BHK-MMP1
AC   CVCL_AB52
DR   Wikidata; Q54796410
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7155; MMP1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   BHK-MMP3
AC   CVCL_AB53
DR   Wikidata; Q54796411
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7173; MMP3.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   BHK-MP1
AC   CVCL_HB79
DR   Wikidata; Q54796412
RX   PubMed=562143;
CC   Virology: In vitro persistently infected by rubella virus strain M33.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_HB78 ! BHK-21/WI-2
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   BHK-MP2
AC   CVCL_HB80
DR   Wikidata; Q54796414
RX   PubMed=562143;
CC   Virology: In vitro persistently infected by rubella virus strain M33.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_HB78 ! BHK-21/WI-2
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   BHK-MS-HA16
AC   CVCL_4U21
DR   Wikidata; Q54796416
RX   Patent=US8986991;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-12461.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_4U20 ! BHK-M
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   BHK-NS5B
AC   CVCL_C8QW
DR   Wikidata; Q123030788
RX   PubMed=20382106;
CC   Characteristics: Transfected with hepatitis C virus NS5B (a RNA-dependent RNA polymerase).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   BHK-NS5B-FRLuc
AC   CVCL_C8QX
DR   Wikidata; Q123030789
RX   PubMed=20382106;
CC   Characteristics: Transfected with a (+)FLuc-(-)UTR-RLuc construct that comprises firefly luciferase (FLuc) and Renilla luciferase (RLuc) in reverse orientation flanked by both negative strands of the HCV 5' and 3' UTRs. The FLuc and RLuc reporter proteins are respectively regulated by host polymerase and NS5B polymerase (PubMed=20382106).
CC   Characteristics: Transfected with hepatitis C virus NS5B (a RNA-dependent RNA polymerase).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_C8QW ! BHK-NS5B
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   BHK-PPI-C16
AC   CVCL_HA57
SY   BHK-21-PPI-C16
DR   Wikidata; Q54796417
RX   PubMed=19002958;
CC   Characteristics: Releases unprocessed proinsulin.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   BHK-PPI-C16-GCK
AC   CVCL_HA58
DR   Wikidata; Q54796418
RX   PubMed=19002958;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4195; GCK.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_HA57 ! BHK-PPI-C16
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 8
//
ID   BHK-PPI-C16-GCK-GLUT
AC   CVCL_HA59
DR   Wikidata; Q54796421
RX   PubMed=19002958;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4195; GCK.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11006; SLC2A2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_HA58 ! BHK-PPI-C16-GCK
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   BHK-RR-B51E
AC   CVCL_1J91
DR   Wikidata; Q54796423
RX   Patent=US7585667;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5257.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1J90 ! BHK-SR19-T7
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 8
//
ID   BHK-SR19-T7
AC   CVCL_1J90
SY   BHK/SR19/T7; BHKSR19-T7
DR   Wikidata; Q54796426
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   BHK/AC9
AC   CVCL_4127
SY   BHK AVRI clone AC9
DR   CLO; CLO_0001964
DR   CLDB; cl451
DR   ECACC; 85040103
DR   Wikidata; Q54796427
RX   PubMed=6245630;
CC   Characteristics: Adapted to growth in suspension.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   BHK/T7-9
AC   CVCL_A8V7
DR   RCB; RCB4942
DR   Wikidata; Q102113622
RX   PubMed=14524622;
RX   PubMed=25003091;
CC   Characteristics: Expression of the T7 RNA polymerase gene is under control of the strong chicken beta-actin promoter (PubMed=14524622).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   BHK21-Hektor
AC   CVCL_AR44
DR   ECACC; 05062301
DR   Wikidata; Q54796428
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in the chemically defined protein- and peptide-free Hektor-G medium from Cell Culture Technologies.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8837 ! BHK21C13-2P
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   BHK21-human GCGR
AC   CVCL_UR37
SY   Glucagon Receptor
DR   ATCC; CRL-3423
DR   Wikidata; Q93426246
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4192; GCGR.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   BHK21-InVitrus
AC   CVCL_6F52
DR   ECACC; 05062302
DR   Wikidata; Q54796429
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8837 ! BHK21C13-2P
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BHK21-MERS-Rep
AC   CVCL_A7MT
DR   Wikidata; Q107113463
RX   PubMed=33616893;
CC   Characteristics: Transfected with a pBAC-CMV-MERS-CoV replicon construct. The MERS-CoV replicon contains the genes encoding the MERS-CoV polyproteins 1a and 1b and the N protein, neo, and the Renilla reniformis renilla-type luciferase (Rluc) gene (PubMed=33616893).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; K9N7C7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) replicase polyprotein 1ab.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   BHK21-pcDNA3.1-HC
AC   CVCL_6369
DR   CLO; CLO_0001970
DR   ATCC; CRL-13001
DR   Wikidata; Q54796431
RX   Patent=US6376218;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-419.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   BHK21/13/Ag clone 4
AC   CVCL_LM73
SY   BHK21/13/Ag4
DR   Wikidata; Q54796433
RX   PubMed=14207308;
RX   PubMed=18630324;
CC   Characteristics: Grows in agar.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   BHK21/13/Py6
AC   CVCL_LM74
SY   BHK-21/py6; C13-TC6; TC6; BHK 21 C.13/T.6; BHK 21 C13/T6; Py-BHK; PyBHK; BHK-py; BHK21/Py
DR   Wikidata; Q54796434
RX   DOI=10.1093/jnci/30.4.795;
RX   PubMed=4370432;
RX   PubMed=6179955;
RX   PubMed=14207308;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   BHK21/C13/SV28
AC   CVCL_R994
SY   C13/SV28; C13/SV; SV28; SV-28
DR   ChEMBL-Cells; CHEMBL3307296
DR   ChEMBL-Targets; CHEMBL614061
DR   PubChem_Cell_line; CVCL_R994
DR   Wikidata; Q54796437
RX   PubMed=4350188;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   BHK21C13-2P
AC   CVCL_8837
SY   BHK-21C13-2P; BHK21-2P (clone-13)
DR   CLO; CLO_0001968
DR   CLO; CLO_0051413
DR   CLDB; cl452
DR   ECACC; 84111301
DR   NCBI_Iran; C108
DR   RCB; RCB0420
DR   Wikidata; Q54796438
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   BHK21C13-3P
AC   CVCL_8838
SY   BHK-21C13-3P
DR   CLO; CLO_0001969
DR   CLDB; cl453
DR   ECACC; 84100501
DR   Wikidata; Q54796441
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BHK570
AC   CVCL_6370
SY   BHK-570; BHK 570
DR   CLO; CLO_0001971
DR   ATCC; CRL-10314
DR   BCRJ; 0051
DR   Wikidata; Q54796442
RX   Patent=US5385831;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10314.
CC   Discontinued: ATCC; CRL-10314; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   BHL-89
AC   CVCL_2306
DR   ECACC; 98070109
DR   Wikidata; Q54796445
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7672713;
CC   Doubling time: 48 hours (PubMed=7672713).
CC   Derived from site: In situ; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BHP 10-3
AC   CVCL_6278
SY   BHP10-3; BHP-10
DR   BioSample; SAMN03151969
DR   Cosmic; 1005449
DR   Cosmic; 1094767
DR   Wikidata; Q54796447
RX   PubMed=9253346;
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00179.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X
ST   D13S317: 11,12
ST   D18S51: 13,16
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 8,10
ST   D7S820: 11
ST   D8S1179: 11,17
ST   FGA: 20,21
ST   vWA: 14,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6298 ! TPC-1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   BHP 14-9
AC   CVCL_6279
SY   BHP14-9; BHP-14
DR   BioSample; SAMN03151827
DR   cancercelllines; CVCL_6279
DR   Cosmic; 1005450
DR   Cosmic; 1094768
DR   Wikidata; Q54796490
RX   PubMed=8675585;
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00180.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 13,17
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   BHP 15-3
AC   CVCL_6280
SY   BHP15-3; BHP-15
DR   cancercelllines; CVCL_6280
DR   Wikidata; Q54796492
RX   PubMed=8675585;
RX   PubMed=28940260;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00555.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=28940260
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 13,17
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   BHP 17-10
AC   CVCL_6281
SY   BHP17-10; BHP-17
DR   BioSample; SAMN03151828
DR   cancercelllines; CVCL_6281
DR   Cosmic; 1005451
DR   Cosmic; 1094769
DR   Wikidata; Q54796494
RX   PubMed=8675585;
RX   PubMed=9253346;
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00181.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 13,17
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   BHP 18-21
AC   CVCL_6282
SY   BHP18-21; BHP-18; BHP18
DR   Cosmic; 1005452
DR   Cosmic; 1094770
DR   Wikidata; Q54796497
RX   DOI=10.1016/j.yamp.2018.07.005;
RX   PubMed=8675585;
RX   PubMed=9253346;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a mixture of M14 and TPC-1 cell lines (DOI=10.1016/j.yamp.2018.07.005). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00571.
ST   Source(s): DOI=10.1016/j.yamp.2018.07.005
ST   Amelogenin: X
ST   D13S317: 11,12
ST   D18S51: 13,16,17
ST   D21S11: 30,31.2
ST   D3S1358: 14,16,17
ST   D5S818: 8,10,11,12
ST   D7S820: 8,10,11
ST   D8S1179: 11,13,17
ST   FGA: 20,21
ST   vWA: 14,16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
HI   CVCL_6298 ! TPC-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   BHP 19-24
AC   CVCL_D017
SY   BHP19-24; BHP-19
DR   Cosmic; 1005453
DR   Cosmic; 1094771
DR   Wikidata; Q54796498
RX   PubMed=8675585;
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   BHP 2-7
AC   CVCL_6283
SY   BHP2-7; BHP-2
DR   BioSample; SAMN03151970
DR   Cosmic; 1005446
DR   Cosmic; 1094764
DR   Lonza; 783
DR   Wikidata; Q54796499
RX   PubMed=9253346;
RX   PubMed=18713817;
RX   PubMed=20143388;
RX   PubMed=21868764;
RX   PubMed=25365311;
RX   PubMed=29066502;
RX   PubMed=31443247;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00182.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817; PubMed=21868764; PubMed=25365311
ST   Amelogenin: X
ST   CSF1PO: 8,10 (PubMed=25365311)
ST   CSF1PO: 11,12 (PubMed=21868764)
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13,16
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 8,10
ST   D7S820: 9,11 (PubMed=25365311)
ST   D7S820: 11 (PubMed=21868764)
ST   FGA: 20,21
ST   TH01: 9 (PubMed=21868764)
ST   TH01: 11 (PubMed=25365311)
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6298 ! TPC-1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   BHP 5-16
AC   CVCL_6284
SY   BHP5-16; BHP-5
DR   EFO; EFO_0022673
DR   BioSample; SAMN03151829
DR   cancercelllines; CVCL_6284
DR   Cosmic; 1005447
DR   Cosmic; 1094765
DR   Wikidata; Q54796503
RX   PubMed=8675585;
RX   PubMed=18713817;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00183.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=18713817; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 13,17
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   BHP 7-13
AC   CVCL_6285
SY   BHP7-13; BPH-7
DR   BioSample; SAMN03151971
DR   Cosmic; 1005448
DR   Cosmic; 1094766
DR   Wikidata; Q54796504
RX   PubMed=9253346;
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=18713817; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00184.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X
ST   D13S317: 11,12
ST   D18S51: 13,16
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 8,10
ST   D7S820: 11
ST   D8S1179: 11,17
ST   FGA: 20,21
ST   vWA: 14,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6298 ! TPC-1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   BHP2-7 Pazopanib selected
AC   CVCL_4W01
DR   Wikidata; Q54796506
RX   PubMed=24628546;
CC   Problematic cell line: Contaminated. Parent cell line (BHP 2-7) has been shown to be a TPC-1 derivative.
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_71219; Pazopanib (Votrient).
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6283 ! BHP 2-7
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   BHSFL
AC   CVCL_A0WR
SY   BigHorn Sheep Fetal Lung
DR   Wikidata; Q108819946
RX   PubMed=20357964;
CC   Virology: Susceptible to infection by bovine parainfluenza virus 3 (BPIV-3), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) (PubMed=20357964).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=112261; ! Ovis canadensis nelsoni (Desert bighorn sheep)
SX   Sex unspecified
AG   3-4FM
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BHSK
AC   CVCL_A0WP
SY   BigHorn Sheep Kidney
DR   Wikidata; Q108819947
RX   PubMed=10826841;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=112261; ! Ovis canadensis nelsoni (Desert bighorn sheep)
OI   CVCL_A0WQ ! BHST
SX   Sex unspecified
AG   5FM
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   BHST
AC   CVCL_A0WQ
SY   BigHorn Sheep Turbinate
DR   Wikidata; Q108819948
RX   PubMed=10826841;
CC   Derived from site: In situ; Fetal nose, nasal cavity, nasal turbinate; UBERON=UBERON_0035612.
OX   NCBI_TaxID=112261; ! Ovis canadensis nelsoni (Desert bighorn sheep)
OI   CVCL_A0WP ! BHSK
SX   Sex unspecified
AG   5FM
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   BHT-101
AC   CVCL_1085
SY   BHT101
DR   BTO; BTO_0002274
DR   CLO; CLO_0001974
DR   EFO; EFO_0002116
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473340
DR   BioSample; SAMN10988574
DR   cancercelllines; CVCL_1085
DR   CCRID; 3101HUMSCSP544
DR   Cell_Model_Passport; SIDM00987
DR   ChEMBL-Cells; CHEMBL3308096
DR   ChEMBL-Targets; CHEMBL1075398
DR   CLS; 305112
DR   Cosmic; 891255
DR   Cosmic; 906696
DR   Cosmic; 1162841
DR   Cosmic; 1239963
DR   Cosmic; 2054079
DR   Cosmic; 2613250
DR   Cosmic-CLP; 906696
DR   DepMap; ACH-000191
DR   DSMZ; ACC-279
DR   DSMZCellDive; ACC-279
DR   EGA; EGAS00001000978
DR   GDSC; 906696
DR   GEO; GSM886881
DR   GEO; GSM887946
DR   GEO; GSM1669619
DR   IARC_TP53; 21193
DR   IGRhCellID; BHT101
DR   LiGeA; CCLE_885
DR   LINCS_LDP; LCL-1688
DR   PharmacoDB; BHT101_91_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1085
DR   PubChem_Cell_line; CVCL_1085
DR   Wikidata; Q54796508
RX   PubMed=8099464;
RX   PubMed=18713817;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23833040;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=8099464); ~2-3 days (DSMZ=ACC-279).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244; Cosmic-CLP=906696; DepMap=ACH-000191).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thr (c.752T>C); ClinVar=VCV000439320; Zygosity=Homozygous (PubMed=30737244; Cosmic-CLP=906696; DepMap=ACH-000191).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.56%; Native American=0.75%; East Asian, North=2.42%; East Asian, South=0%; South Asian=0.87%; European, North=57.43%; European, South=37.97% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=906696; DSMZ=ACC-279; PubMed=18713817; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12 (DSMZ=ACC-279)
ST   CSF1PO: 12,13 (Cosmic-CLP=906696; PubMed=30737244)
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 20,23
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 13,14,15 (PubMed=18713817; PubMed=30737244)
ST   D8S1179: 15 (DSMZ=ACC-279)
ST   FGA: 18,24
ST   Penta D: 9
ST   Penta E: 10,17
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18,19 (PubMed=18713817)
ST   vWA: 19 (Cosmic-CLP=906696; DSMZ=ACC-279; PubMed=30737244)
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   BHY
AC   CVCL_1086
DR   BTO; BTO_0004588
DR   CLO; CLO_0001975
DR   EFO; EFO_0006539
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 334
DR   BioSample; SAMN03473142
DR   BioSample; SAMN10987691
DR   cancercelllines; CVCL_1086
DR   Cell_Model_Passport; SIDM00986
DR   ChEMBL-Cells; CHEMBL3308711
DR   ChEMBL-Targets; CHEMBL1075399
DR   Cosmic; 753535
DR   Cosmic; 2296290
DR   Cosmic-CLP; 753535
DR   DepMap; ACH-000548
DR   DSMZ; ACC-404
DR   DSMZCellDive; ACC-404
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753535
DR   GEO; GSM886882
DR   GEO; GSM887947
DR   GEO; GSM1669620
DR   IARC_TP53; 25036
DR   LiGeA; CCLE_194
DR   LINCS_LDP; LCL-1208
DR   NCBI_Iran; C622
DR   PharmacoDB; BHY_92_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1086
DR   PubChem_Cell_line; CVCL_1086
DR   Wikidata; Q54796512
RX   PubMed=8985100;
RX   PubMed=15800904;
RX   PubMed=17390010;
RX   PubMed=17719389;
RX   PubMed=18423281;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25275298;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~70 hours (DSMZ=ACC-404).
CC   HLA typing: A*24:02,24:02; B*51:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Homozygous (DepMap=ACH-000548).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex6-15del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr118Glnfs*5 (c.351delG) (p.G117fs); Zygosity=Homozygous (PubMed=17390010; Cosmic-CLP=753535; DepMap=ACH-000548).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met160Val (c.478A>G); ClinVar=VCV000444396; Zygosity=Unspecified (PubMed=17390010).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu369Pro (c.1106T>C); Zygosity=Unspecified (PubMed=17390010).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.12%; East Asian, North=81.47%; East Asian, South=16.1%; South Asian=0.22%; European, North=0%; European, South=1.09% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): Cosmic-CLP=753535; DSMZ=ACC-404; PubMed=25275298; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 10 (DSMZ=ACC-404)
ST   D8S1179: 11,14 (PubMed=25275298; PubMed=25877200)
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 14 (PubMed=25275298)
ST   Penta E: 14,20 (DSMZ=ACC-404; PubMed=25877200)
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   BHZ-01
AC   CVCL_WG36
DR   IBRC; C10703
DR   Wikidata; Q93426340
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   BHZ-02
AC   CVCL_WG37
DR   IBRC; C10712
DR   Wikidata; Q93426342
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   BHZ-03
AC   CVCL_WG38
DR   IBRC; C10714
DR   Wikidata; Q93426344
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   BHZ-04
AC   CVCL_WG39
DR   IBRC; C10715
DR   Wikidata; Q93426348
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   BHZ-05
AC   CVCL_WG40
DR   IBRC; C10716
DR   Wikidata; Q93426351
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   BHZ-06
AC   CVCL_WG41
DR   IBRC; C10717
DR   Wikidata; Q93426353
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   BHZ-07
AC   CVCL_WG42
DR   IBRC; C10718
DR   Wikidata; Q93426355
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   BI
AC   CVCL_LI17
DR   cancercelllines; CVCL_LI17
DR   Cosmic; 710852
DR   IARC_TP53; 16736
DR   Wikidata; Q54796513
RX   PubMed=11787853;
CC   From: Andren-Sandberg, Ake; Karolinska Institutet; Stockholm; Sweden.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val197Leu (c.589G>T); ClinVar=VCV000216468; Zygosity=Unspecified (PubMed=11787853).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   Bi Fin
AC   CVCL_3651
DR   CLO; CLO_0001976
DR   ATCC; CRL-1219
DR   Wikidata; Q54796515
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   BI.B12
AC   CVCL_XH89
SY   B1.B12
DR   Wikidata; Q93426367
RX   PubMed=9759867;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   BIC-1
AC   CVCL_8092
SY   Bic-1; BIC1; Bic1; BIC
DR   BTO; BTO_0003429
DR   BioSample; SAMN03151929
DR   cancercelllines; CVCL_8092
DR   Wikidata; Q54796516
RX   PubMed=9407969;
RX   PubMed=10078940;
RX   PubMed=16364037;
RX   PubMed=20075370;
RX   PubMed=23795680;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=20075370). Originally thought to originate from a esophageal Barrett adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00365.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 13
ST   D21S11: 30,30.2
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,15
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   BICR 10
AC   CVCL_2307
SY   BICR-10; BICR10; BICR-10 R; Beatson Institute for Cancer Research 10
DR   CLO; CLO_0009941
DR   EFO; EFO_0006540
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 835
DR   BioSample; SAMN03473143
DR   cancercelllines; CVCL_2307
DR   CancerTools; 152841
DR   Cell_Model_Passport; SIDM00077
DR   Cosmic-CLP; 1290724
DR   DepMap; ACH-001331
DR   ECACC; 04072103
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290724
DR   GEO; GSM827321
DR   GEO; GSM1669621
DR   LINCS_LDP; LCL-1203
DR   PharmacoDB; BICR10_93_2019
DR   Progenetix; CVCL_2307
DR   Wikidata; Q54796517
DR   Ximbio; 152841
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=9307265;
RX   PubMed=10523844;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31321735;
RX   PubMed=32990596;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*14:01,44:02; C*01:02,07:06 (PubMed=26589293).
CC   Karyotypic information: Near diploid karyotype (PubMed=31321735).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0%; East Asian, North=0.01%; East Asian, South=0%; South Asian=0.82%; European, North=71.25%; European, South=27.87% (PubMed=30894373).
CC   Discontinued: ECACC; 04072103; true.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): Cosmic-CLP=1290724; ECACC=04072103; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8,14
ST   D16S539: 9,13
ST   D18S51: 14,19
ST   D21S11: 30.2,32.2
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 7,18
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   BICR 16
AC   CVCL_2308
SY   BICR-16; BICR16; BICR-16 R; Beatson Institute for Cancer Research 16
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987687
DR   cancercelllines; CVCL_2308
DR   CancerTools; 152842
DR   Cell_Model_Passport; SIDM01520
DR   DepMap; ACH-000503
DR   ECACC; 06031001
DR   GEO; GSM886883
DR   GEO; GSM887948
DR   IARC_TP53; 28381
DR   LiGeA; CCLE_402
DR   PharmacoDB; BICR16_94_2019
DR   Progenetix; CVCL_2308
DR   Wikidata; Q54796521
DR   Ximbio; 152842
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=10523844;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,11:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Unspecified (PubMed=8390283).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.43%; Native American=0%; East Asian, North=3.56%; East Asian, South=0%; South Asian=0%; European, North=60.13%; European, South=35.88% (PubMed=30894373).
CC   Discontinued: ECACC; 06031001; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ECACC=06031001
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   BICR 18
AC   CVCL_2309
SY   BICR-18; BICR_18; BICR18; BICR-18 R; Beatson Institute for Cancer Research 18
DR   CLDB; cl7215
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987721
DR   cancercelllines; CVCL_2309
DR   CancerTools; 152843
DR   Cell_Model_Passport; SIDM01519
DR   Cosmic; 2588351
DR   DepMap; ACH-000992
DR   ECACC; 06051601
DR   GEO; GSM886884
DR   GEO; GSM887949
DR   IARC_TP53; 30020
DR   ICLC; HTL10003
DR   LiGeA; CCLE_387
DR   PharmacoDB; BICR18_95_2019
DR   Progenetix; CVCL_2309
DR   Wikidata; Q54796524
DR   Ximbio; 152843
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=9150362;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Partially contaminated. The ICLC stock (now discontinued) was found to be contaminated, probably by U-251MG (Cellosaurus=CVCL_0021).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=6.55%; Native American=0%; East Asian, North=7.21%; East Asian, South=0%; South Asian=0%; European, North=48.15%; European, South=38.08% (PubMed=30894373).
CC   Discontinued: ECACC; 06051601; true.
CC   Discontinued: ICLC; HTL10003; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=06051601
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 12,14
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 17,20
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   BICR 22
AC   CVCL_2310
SY   BICR-22; BICR22; BICR-22 M; Beatson Institute for Cancer Research 22
DR   CLO; CLO_0009942
DR   EFO; EFO_0006541
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 509
DR   BioSample; SAMN03473144
DR   BioSample; SAMN10987716
DR   cancercelllines; CVCL_2310
DR   CancerTools; 152844
DR   Cell_Model_Passport; SIDM00485
DR   Cosmic; 1995345
DR   Cosmic; 2296291
DR   Cosmic-CLP; 1240121
DR   DepMap; ACH-000794
DR   ECACC; 04072106
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240121
DR   GEO; GSM827154
DR   GEO; GSM886885
DR   GEO; GSM887950
DR   GEO; GSM1669622
DR   IARC_TP53; 30021
DR   LiGeA; CCLE_493
DR   LINCS_LDP; LCL-1213
DR   PharmacoDB; BICR22_96_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2310
DR   Wikidata; Q54796527
DR   Ximbio; 152844
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=9150362;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25275298;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.920-1G>T (IVS8-1G>T); ClinVar=VCV000480765; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25275298; DepMap=ACH-000794).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=9.32%; Native American=0%; East Asian, North=10.18%; East Asian, South=0%; South Asian=0%; European, North=36.79%; European, South=43.71% (PubMed=30894373).
CC   Discontinued: ECACC; 04072106; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1240121; ECACC=04072106; PubMed=25275298; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 28,31
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 23,24 (PubMed=25877200)
ST   FGA: 24 (PubMed=25275298)
ST   Penta D: 9,13
ST   Penta E: 12,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   BICR 3
AC   CVCL_2311
SY   BICR-3; BICR3; Beatson Institute for Cancer Research 3
DR   cancercelllines; CVCL_2311
DR   CancerTools; 152845
DR   Cosmic; 848752
DR   ECACC; 06032203
DR   Wikidata; Q54796529
DR   Ximbio; 152845
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=9150362;
RX   PubMed=10523844;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Pro (c.845G>C); ClinVar=VCV000376659; Zygosity=Unspecified (PubMed=8390283).
CC   Discontinued: ECACC; 06032203; true.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): ECACC=06032203
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   BICR 31
AC   CVCL_2312
SY   BICR-31; BICR31; Beatson Institute for Cancer Research 31
DR   CLO; CLO_0009943
DR   EFO; EFO_0006542
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473145
DR   BioSample; SAMN10987970
DR   cancercelllines; CVCL_2312
DR   CancerTools; 152846
DR   Cell_Model_Passport; SIDM00078
DR   Cosmic; 848754
DR   Cosmic-CLP; 1290725
DR   DepMap; ACH-000228
DR   ECACC; 04072107
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290725
DR   GEO; GSM827311
DR   GEO; GSM886886
DR   GEO; GSM887951
DR   GEO; GSM1669623
DR   IARC_TP53; 28360
DR   LiGeA; CCLE_691
DR   LINCS_LDP; LCL-1214
DR   PharmacoDB; BICR31_97_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2312
DR   Wikidata; Q54796530
DR   Ximbio; 152846
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=9150362;
RX   PubMed=10523844;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*32:01,32:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173_Arg174InsGly (c.518_520delTGA); Zygosity=Homozygous (PubMed=8390283; Cosmic-CLP=1290725; DepMap=ACH-000228).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.67%; Native American=0%; East Asian, North=1.96%; East Asian, South=0%; South Asian=0%; European, North=61.56%; European, South=34.81% (PubMed=30894373).
CC   Discontinued: ECACC; 04072107; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Cosmic-CLP=1290725; ECACC=04072107; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 16
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 10
ST   vWA: 18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   BICR 56
AC   CVCL_2313
SY   BICR-56; BICR56; Beatson Institute for Cancer Research 56
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987686
DR   cancercelllines; CVCL_2313
DR   CancerTools; 152847
DR   Cell_Model_Passport; SIDM01518
DR   DepMap; ACH-000771
DR   ECACC; 06031002
DR   GEO; GSM886887
DR   GEO; GSM887952
DR   IARC_TP53; 28393
DR   LiGeA; CCLE_893
DR   PharmacoDB; BICR56_98_2019
DR   Progenetix; CVCL_2313
DR   Wikidata; Q54796532
DR   Ximbio; 152847
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=9150362;
RX   PubMed=9307265;
RX   PubMed=10523844;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*07:02,50:01; C*06:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=8390283; DepMap=ACH-000771).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.75%; Native American=1.04%; East Asian, North=1.39%; East Asian, South=0%; South Asian=0.51%; European, North=67.74%; European, South=28.56% (PubMed=30894373).
CC   Discontinued: ECACC; 06031002; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ECACC=06031002
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   BICR 6
AC   CVCL_2314
SY   BICR-6; BICR6; Beatson Institute for Cancer Research 6
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 712
DR   BioSample; SAMN10987690
DR   cancercelllines; CVCL_2314
DR   CancerTools; 152848
DR   Cell_Model_Passport; SIDM01517
DR   Cosmic; 848753
DR   DepMap; ACH-000415
DR   ECACC; 05070501
DR   GEO; GSM886888
DR   GEO; GSM887953
DR   IARC_TP53; 1908
DR   LiGeA; CCLE_750
DR   PharmacoDB; BICR6_99_2019
DR   Progenetix; CVCL_2314
DR   Wikidata; Q54796533
DR   Ximbio; 152848
RX   PubMed=7646764;
RX   PubMed=8390283;
RX   PubMed=9150362;
RX   PubMed=10523844;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*01:02,30:02; B*07:02,18:01; C*05:01,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (PubMed=8390283; DepMap=ACH-000415).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.56%; Native American=0%; East Asian, North=5.39%; East Asian, South=0%; South Asian=0%; European, North=53.16%; European, South=36.88% (PubMed=30894373).
CC   Discontinued: ECACC; 05070501; true.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
ST   Source(s): ECACC=05070501
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   BICR 63
AC   CVCL_S694
SY   BICR-63; BICR63; Beatson Institute for Cancer Research 63
DR   Wikidata; Q54796536
RX   PubMed=7646764;
RX   PubMed=9150362;
RX   PubMed=10523844;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Phe (c.763A>T); ClinVar=VCV000376621; Zygosity=Unspecified (PubMed=9150362).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   BICR 68
AC   CVCL_S695
SY   BICR-68; BICR68; Beatson Institute for Cancer Research 68
DR   Wikidata; Q54796538
RX   PubMed=7646764;
RX   PubMed=9150362;
RX   PubMed=9307265;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   BICR 78
AC   CVCL_2315
SY   BICR-78; BICR78; Beatson Institute for Cancer Research 78
DR   CLO; CLO_0009944
DR   EFO; EFO_0006543
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 837
DR   BioSample; SAMN03473146
DR   cancercelllines; CVCL_2315
DR   CancerTools; 152849
DR   Cell_Model_Passport; SIDM00501
DR   Cosmic; 848755
DR   Cosmic; 1995346
DR   Cosmic-CLP; 1240122
DR   DepMap; ACH-001332
DR   ECACC; 04072111
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240122
DR   GEO; GSM827457
DR   GEO; GSM1669624
DR   LINCS_LDP; LCL-1205
DR   PharmacoDB; BICR78_100_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2315
DR   Wikidata; Q54796540
DR   Ximbio; 152849
RX   PubMed=7646764;
RX   PubMed=9150362;
RX   PubMed=10523844;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,29:02; B*44:03,44:03; C*05:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-7del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln38Ter (c.112C>T); Zygosity=Heterozygous (Cosmic-CLP=1240122; DepMap=ACH-001332).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Heterozygous (PubMed=9150362; Cosmic-CLP=1240122; DepMap=ACH-001332).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro177Leu (c.530C>T); ClinVar=VCV000406583; Zygosity=Heterozygous (Cosmic-CLP=1240122; DepMap=ACH-001332).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.26%; Native American=1.14%; East Asian, North=2.29%; East Asian, South=0%; South Asian=0.91%; European, North=63.51%; European, South=28.89% (PubMed=30894373).
CC   Discontinued: ECACC; 04072111; true.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): Cosmic-CLP=1240122; DepMap=ACH-001332; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13,19
ST   D21S11: 33.2
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 19
ST   Penta D: 10
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 15,16
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   BICR 82
AC   CVCL_2316
SY   BICR-82; BICR82; Beatson Institute for Cancer Research 82
DR   CancerTools; 152850
DR   Cosmic; 848756
DR   ECACC; 04072112
DR   Wikidata; Q54796543
DR   Ximbio; 152850
RX   PubMed=7646764;
RX   PubMed=10523844;
CC   Population: Caucasian.
CC   Discontinued: ECACC; 04072112; true.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   BICR/M1Rk
AC   CVCL_4128
SY   BICR/M1RK; BICR-M1Rk
DR   CLO; CLO_0001978
DR   ECACC; 96112021
DR   Wikidata; Q54796545
RX   PubMed=2303323;
RX   PubMed=2303324;
CC   Characteristics: Established from the spontaneous, transplantable mammary tumour BICR/M1 (ECACC=96112021).
CC   Doubling time: 10.5 hours (PubMed=2303324).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Marshall.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   Bid KO SV40 MEF
AC   CVCL_U629
DR   ATCC; CRL-2911
DR   Wikidata; Q54796547
CC   Knockout cell: Method=KO mouse; MGI; MGI:108093; Bid.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   BID007
AC   CVCL_W890
SY   Beth Israel Deaconess 007
DR   cancercelllines; CVCL_W890
DR   Cosmic; 2093906
DR   Wikidata; Q54796550
RX   PubMed=24353160;
RX   PubMed=31467113;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ala763_Tyr764insPheGlnGluAla (c.2284-5_2290dup); ClinVar=VCV000045248; Zygosity=Unspecified (PubMed=24353160).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   BID019
AC   CVCL_E6DY
SY   Beth Israel Deaconess 019
RX   PubMed=31467113;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771_His772insHis; Zygosity=Unspecified (PubMed=31467113).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BID7
AC   CVCL_1Q40
SY   BID 7
DR   Wikidata; Q54796552
RX   PubMed=2722195;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   BIE
AC   CVCL_HC67
SY   Bovine Intestinal Epithelial cell line
DR   Wikidata; Q54796554
RX   PubMed=19830445;
RX   PubMed=22047818;
RX   PubMed=23497067;
CC   Doubling time: 36.7 hours (PubMed=19830445).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   202FD
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 8
//
ID   BIE11
AC   CVCL_E4RA
RX   PubMed=2351695;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on choriocarcinoma cell line JAR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   BIE5
AC   CVCL_E4R8
RX   PubMed=2351695;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08648; Human ITGA5/CD49e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BIEC-c4
AC   CVCL_UZ22
SY   Bovine Intestinal Epithelial Cells-colony 4
DR   Wikidata; Q93426447
RX   PubMed=30600465;
CC   Doubling time: 14.16 hours (PubMed=30600465).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 7
//
ID   BIECs-21
AC   CVCL_F0KY
SY   Bovine Intestinal Epithelial Cells-21
DR   CCTCC; 45029
RX   PubMed=37351870;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1D
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BIHi001-A
AC   CVCL_IT54
SY   BCRT-3; BCRT#1
DR   BioSamples; SAMEA103885931
DR   hPSCreg; BIHi001-A
DR   SKIP; SKIP002500
DR   Wikidata; Q54796557
RX   PubMed=27138223;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
ID   BIHi001-A-1
AC   CVCL_TZ91
SY   iBCRT Cas9v1-3G-Kl.16
DR   BioSamples; SAMEA14074555
DR   hPSCreg; BIHi001-A-1
DR   Wikidata; Q54796560
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a construct containing Cas9 was introduced in the AAVS1 safe harbor locus (hPSCreg=BIHi001-A-1).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT54 ! BIHi001-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 9
//
ID   BIHi001-A-2
AC   CVCL_C0NJ
SY   AAVS1-Puro-CAG-eGFP targeted hiPSC
DR   hPSCreg; BIHi001-A-2
DR   Wikidata; Q112929326
RX   PubMed=32384610;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a PuroR-CAG-eGFP construct was introduced in the AAVS1 safe harbor locus (PubMed=32384610).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT54 ! BIHi001-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   BIHi001-B
AC   CVCL_YN70
DR   BioSamples; SAMEA6654883
DR   hPSCreg; BIHi001-B
DR   Wikidata; Q93426457
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   BIHi001-B-1
AC   CVCL_D6KX
DR   BioSamples; SAMEA114633136
DR   hPSCreg; BIHi001-B-1
DR   Wikidata; Q127380333
RX   PubMed=38006677;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10923; SLC16A2; Simple_edited; p.Gly327Arg (c.979G>A) (p.Gly401Arg, c.1201G>A); ClinVar=VCV000159901; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=38006677).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN70 ! BIHi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BIHi001-B-2
AC   CVCL_D6L0
SY   1B-THRB-GS-1
DR   hPSCreg; BIHi001-B-2
DR   Wikidata; Q127380334
RX   PubMed=38100912;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Simple_edited; p.Glu125_Gly126delinsGlySer (c.372_376delinsCGGCA); Zygosity=Homozygous; Note=By CRISPR/Cas9. Abolishes recognition of thyroid hormone response elements and regulation of gene expression (PubMed=38100912).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN70 ! BIHi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BIHi001-B-3
AC   CVCL_D6L1
SY   1B-THRB-GS-2
DR   hPSCreg; BIHi001-B-3
DR   Wikidata; Q127380335
RX   PubMed=38100912;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Simple_edited; p.Glu125_Gly126delinsGlySer (c.372_376delinsCGGCA); Zygosity=Homozygous; Note=By CRISPR/Cas9. Abolishes recognition of thyroid hormone response elements and regulation of gene expression (PubMed=38100912).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN70 ! BIHi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BIHi001-B-6
AC   CVCL_D6L2
SY   1B-THRB-KO
DR   hPSCreg; BIHi001-B-6
DR   Wikidata; Q127380336
RX   PubMed=38100912;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11799; THRB.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN70 ! BIHi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BIHi001-B-7
AC   CVCL_D6KY
DR   BioSamples; SAMEA114633138
DR   hPSCreg; BIHi001-B-7
DR   Wikidata; Q127380337
RX   PubMed=38006677;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10923; SLC16A2.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN70 ! BIHi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BIHi001-B-8
AC   CVCL_D6KZ
DR   BioSamples; SAMEA114633139
DR   hPSCreg; BIHi001-B-8
DR   Wikidata; Q127380338
RX   PubMed=38006677;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10923; SLC16A2.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN70 ! BIHi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BIHi002-A
AC   CVCL_UM44
DR   BioSamples; SAMEA5573666
DR   hPSCreg; BIHi002-A
DR   Wikidata; Q93426459
RX   PubMed=30763735;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2025; CLCN7; Simple; p.Gly292Glu (c.875G>A); Zygosity=Heterozygous (PubMed=30763735).
CC   Sequence variation: Mutation; HGNC; HGNC:2025; CLCN7; Simple; p.Arg403Gln (c.1208G>A); ClinVar=VCV001687236; Zygosity=Heterozygous (PubMed=30763735).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129733; Autosomal recessive osteopetrosis
DI   ORDO; Orphanet_667; Autosomal recessive malignant osteopetrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM45 ! BIHi002-B
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   BIHi002-B
AC   CVCL_UM45
DR   hPSCreg; BIHi002-B
DR   Wikidata; Q93426461
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2025; CLCN7; Simple; p.Gly292Glu (c.875G>A); Zygosity=Heterozygous (from autologous cell line BIHi002-A).
CC   Sequence variation: Mutation; HGNC; HGNC:2025; CLCN7; Simple; p.Arg403Gln (c.1208G>A); ClinVar=VCV001687236; Zygosity=Heterozygous (from autologous cell line BIHi002-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129733; Autosomal recessive osteopetrosis
DI   ORDO; Orphanet_667; Autosomal recessive malignant osteopetrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM44 ! BIHi002-A
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   BIHi004-A
AC   CVCL_IT55
SY   NHDF Epi5 Cl5 iPSC; EpiCl5 iPSC
DR   BioSamples; SAMEA103992834
DR   hPSCreg; BIHi004-A
DR   SKIP; SKIP002682
DR   Wikidata; Q54796561
RX   PubMed=27138223;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU81 ! BIHi004-B
OI   CVCL_WU82 ! BIHi004-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
ID   BIHi004-B
AC   CVCL_WU81
SY   NHDF Epi5 Cl2 iPSC
DR   BioSamples; SAMEA6654880
DR   hPSCreg; BIHi004-B
DR   Wikidata; Q93426467
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT55 ! BIHi004-A
OI   CVCL_WU82 ! BIHi004-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   BIHi004-C
AC   CVCL_WU82
SY   NHDF Epi5 Cl3 iPSC
DR   hPSCreg; BIHi004-C
DR   Wikidata; Q93426469
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT55 ! BIHi004-A
OI   CVCL_WU81 ! BIHi004-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   BIHi005-A
AC   CVCL_IT56
DR   BioSamples; SAMEA104012190
DR   hPSCreg; BIHi005-A
DR   SKIP; SKIP002907
DR   Wikidata; Q54796565
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UW21 ! BIHi005-B
OI   CVCL_UW22 ! BIHi005-C
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 8
//
ID   BIHi005-A-15
AC   CVCL_D6PN
DR   hPSCreg; BIHi005-A-15
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT56 ! BIHi005-A
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIHi005-A-17
AC   CVCL_D6TW
DR   hPSCreg; BIHi005-A-17
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6PJ ! BIHi005-A-20
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIHi005-A-20
AC   CVCL_D6PJ
DR   hPSCreg; BIHi005-A-20
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT56 ! BIHi005-A
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIHi005-A-39
AC   CVCL_E3RN
SY   hiPSC M368A; M368A hiPSC; BIHi005-A-M2 (ATG>GCT) M2 Cholinergic Receptor
DR   hPSCreg; BIHi005-A-39
RX   PubMed=38683874;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:1951; CHRM2; Simple_edited; p.Met368Ala (c.1102_1104ATG>GCT); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38683874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT56 ! BIHi005-A
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BIHi005-A-5
AC   CVCL_UW20
SY   hiPSC clone 17
DR   BioSamples; SAMEA1009819
DR   hPSCreg; BIHi005-A-5
DR   Wikidata; Q93426476
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:11185; SORL1.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT56 ! BIHi005-A
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   BIHi005-B
AC   CVCL_UW21
DR   hPSCreg; BIHi005-B
DR   Wikidata; Q93426478
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT56 ! BIHi005-A
OI   CVCL_UW22 ! BIHi005-C
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BIHi005-C
AC   CVCL_UW22
DR   hPSCreg; BIHi005-C
DR   Wikidata; Q93426480
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Asian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT56 ! BIHi005-A
OI   CVCL_UW21 ! BIHi005-B
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BIHi006-A
AC   CVCL_TZ93
DR   hPSCreg; BIHi006-A
DR   Wikidata; Q54796566
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ94 ! BIHi006-B
OI   CVCL_TZ95 ! BIHi006-C
OI   CVCL_TZ96 ! BIHi006-D
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 6
//
ID   BIHi006-B
AC   CVCL_TZ94
DR   hPSCreg; BIHi006-B
DR   Wikidata; Q54796568
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ93 ! BIHi006-A
OI   CVCL_TZ95 ! BIHi006-C
OI   CVCL_TZ96 ! BIHi006-D
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 6
//
ID   BIHi006-C
AC   CVCL_TZ95
DR   hPSCreg; BIHi006-C
DR   Wikidata; Q54796570
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ93 ! BIHi006-A
OI   CVCL_TZ94 ! BIHi006-B
OI   CVCL_TZ96 ! BIHi006-D
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 6
//
ID   BIHi006-D
AC   CVCL_TZ96
DR   BioSamples; SAMEA104493310
DR   EBiSC; BIHi006-D
DR   ECACC; 66540645
DR   hPSCreg; BIHi006-D
DR   Wikidata; Q54796572
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540645; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ93 ! BIHi006-A
OI   CVCL_TZ94 ! BIHi006-B
OI   CVCL_TZ95 ! BIHi006-C
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi007-A
AC   CVCL_TZ97
DR   BioSamples; SAMEA104387974
DR   EBiSC; BIHi007-A
DR   ECACC; 66540633
DR   hPSCreg; BIHi007-A
DR   Wikidata; Q54796574
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540633; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ98 ! BIHi007-B
OI   CVCL_TZ99 ! BIHi007-C
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi007-B
AC   CVCL_TZ98
DR   hPSCreg; BIHi007-B
DR   Wikidata; Q54796624
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ97 ! BIHi007-A
OI   CVCL_TZ99 ! BIHi007-C
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi007-C
AC   CVCL_TZ99
DR   hPSCreg; BIHi007-C
DR   Wikidata; Q54796627
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ97 ! BIHi007-A
OI   CVCL_TZ98 ! BIHi007-B
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi008-A
AC   CVCL_RH81
DR   BioSamples; SAMEA104387976
DR   EBiSC; BIHi008-A
DR   ECACC; 66540634
DR   hPSCreg; BIHi008-A
DR   Wikidata; Q54796630
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540634; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH82 ! BIHi008-B
OI   CVCL_RH83 ! BIHi008-C
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 10
//
ID   BIHi008-B
AC   CVCL_RH82
DR   hPSCreg; BIHi008-B
DR   Wikidata; Q54796631
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH81 ! BIHi008-A
OI   CVCL_RH83 ! BIHi008-C
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi008-C
AC   CVCL_RH83
DR   hPSCreg; BIHi008-C
DR   Wikidata; Q54796633
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH81 ! BIHi008-A
OI   CVCL_RH82 ! BIHi008-B
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi009-A
AC   CVCL_VA00
DR   BioSamples; SAMEA104130510
DR   EBiSC; BIHi009-A
DR   ECACC; 66540585
DR   hPSCreg; BIHi009-A
DR   Wikidata; Q54796634
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540585; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA01 ! BIHi009-B
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi009-B
AC   CVCL_VA01
DR   hPSCreg; BIHi009-B
DR   Wikidata; Q54796636
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA00 ! BIHi009-A
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi010-A
AC   CVCL_VA02
DR   BioSamples; SAMEA104130512
DR   EBiSC; BIHi010-A
DR   ECACC; 66540586
DR   hPSCreg; BIHi010-A
DR   Wikidata; Q54796639
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540586; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi011-A
AC   CVCL_VA03
DR   BioSamples; SAMEA104130514
DR   EBiSC; BIHi011-A
DR   ECACC; 66540587
DR   hPSCreg; BIHi011-A
DR   Wikidata; Q54796640
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540587; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi012-A
AC   CVCL_VA04
DR   BioSamples; SAMEA104387970
DR   EBiSC; BIHi012-A
DR   ECACC; 66540635
DR   hPSCreg; BIHi012-A
DR   Wikidata; Q54796642
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540635; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi014-A
AC   CVCL_WU83
DR   hPSCreg; BIHi014-A
DR   Wikidata; Q93426555
CC   From: Berlin Institute of Health; Berlin; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   BIHi015-A
AC   CVCL_VA05
DR   BioSamples; SAMEA104130516
DR   EBiSC; BIHi015-A
DR   ECACC; 66540588
DR   hPSCreg; BIHi015-A
DR   Wikidata; Q54796644
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540588; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi016-A
AC   CVCL_VA06
DR   BioSamples; SAMEA104130518
DR   EBiSC; BIHi016-A
DR   ECACC; 66540589
DR   hPSCreg; BIHi016-A
DR   Wikidata; Q54796645
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540589; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi017-A
AC   CVCL_VA07
DR   BioSamples; SAMEA104130520
DR   EBiSC; BIHi017-A
DR   ECACC; 66540590
DR   hPSCreg; BIHi017-A
DR   Wikidata; Q54796647
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540590; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi018-A
AC   CVCL_VA08
DR   BioSamples; SAMEA104130522
DR   EBiSC; BIHi018-A
DR   ECACC; 66540591
DR   hPSCreg; BIHi018-A
DR   Wikidata; Q54796649
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540591; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi019-A
AC   CVCL_VA09
DR   BioSamples; SAMEA104130524
DR   EBiSC; BIHi019-A
DR   ECACC; 66540592
DR   hPSCreg; BIHi019-A
DR   Wikidata; Q54796651
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540592; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi024-A
AC   CVCL_VA10
DR   BioSamples; SAMEA104384830
DR   EBiSC; BIHi024-A
DR   ECACC; 66540629
DR   hPSCreg; BIHi024-A
DR   Wikidata; Q54796653
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540629; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi025-A
AC   CVCL_VA11
DR   BioSamples; SAMEA104384832
DR   EBiSC; BIHi025-A
DR   ECACC; 66540630
DR   hPSCreg; BIHi025-A
DR   Wikidata; Q54796654
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540630; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi026-A
AC   CVCL_WU84
DR   hPSCreg; BIHi026-A
DR   Wikidata; Q93426579
CC   From: Berlin Institute of Health; Berlin; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   BIHi027-A
AC   CVCL_WU85
DR   hPSCreg; BIHi027-A
DR   Wikidata; Q93426580
CC   From: Berlin Institute of Health; Berlin; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   BIHi028-A
AC   CVCL_VA12
DR   BioSamples; SAMEA104493312
DR   EBiSC; BIHi028-A
DR   ECACC; 66540646
DR   hPSCreg; BIHi028-A
DR   Wikidata; Q54796658
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: EBiSC; BIHi028-A; true.
CC   Discontinued: ECACC; 66540646; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA13 ! BIHi028-B
OI   CVCL_VA14 ! BIHi028-C
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   BIHi028-B
AC   CVCL_VA13
DR   BioSamples; SAMEA104493314
DR   EBiSC; BIHi028-B
DR   ECACC; 66540647
DR   hPSCreg; BIHi028-B
DR   Wikidata; Q54796659
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540647; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA12 ! BIHi028-A
OI   CVCL_VA14 ! BIHi028-C
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi028-C
AC   CVCL_VA14
DR   hPSCreg; BIHi028-C
DR   Wikidata; Q54796660
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA12 ! BIHi028-A
OI   CVCL_VA13 ! BIHi028-B
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi029-A
AC   CVCL_VA15
DR   BioSamples; SAMEA104387972
DR   EBiSC; BIHi029-A
DR   ECACC; 66540636
DR   hPSCreg; BIHi029-A
DR   Wikidata; Q54796664
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540636; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA16 ! BIHi029-B
OI   CVCL_VA17 ! BIHi029-C
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi029-B
AC   CVCL_VA16
DR   hPSCreg; BIHi029-B
DR   Wikidata; Q54796666
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA15 ! BIHi029-A
OI   CVCL_VA17 ! BIHi029-C
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi029-C
AC   CVCL_VA17
DR   hPSCreg; BIHi029-C
DR   Wikidata; Q54796668
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA15 ! BIHi029-A
OI   CVCL_VA16 ! BIHi029-B
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi030-A
AC   CVCL_VA18
DR   hPSCreg; BIHi030-A
DR   Wikidata; Q54796669
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA19 ! BIHi030-B
OI   CVCL_TZ92 ! BIHi030-C
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi030-B
AC   CVCL_VA19
DR   hPSCreg; BIHi030-B
DR   Wikidata; Q54796670
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA18 ! BIHi030-A
OI   CVCL_TZ92 ! BIHi030-C
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi030-C
AC   CVCL_TZ92
DR   BioSamples; SAMEA104493315
DR   EBiSC; BIHi030-C
DR   ECACC; 66540648
DR   hPSCreg; BIHi030-C
DR   Wikidata; Q54796673
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540648; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VA18 ! BIHi030-A
OI   CVCL_VA19 ! BIHi030-B
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi031-A
AC   CVCL_VC49
DR   hPSCreg; BIHi031-A
DR   Wikidata; Q54796676
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC50 ! BIHi031-B
OI   CVCL_VC51 ! BIHi031-C
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi031-B
AC   CVCL_VC50
DR   BioSamples; SAMEA104493010
DR   EBiSC; BIHi031-B
DR   ECACC; 66540642
DR   hPSCreg; BIHi031-B
DR   Wikidata; Q54796677
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540642; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC49 ! BIHi031-A
OI   CVCL_VC51 ! BIHi031-C
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi031-C
AC   CVCL_VC51
DR   hPSCreg; BIHi031-C
DR   Wikidata; Q54796678
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC49 ! BIHi031-A
OI   CVCL_VC50 ! BIHi031-B
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi032-A
AC   CVCL_VC52
DR   BioSamples; SAMEA104493012
DR   EBiSC; BIHi032-A
DR   ECACC; 66540643
DR   hPSCreg; BIHi032-A
DR   Wikidata; Q54796681
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540643; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC53 ! BIHi032-B
OI   CVCL_VC54 ! BIHi032-C
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi032-B
AC   CVCL_VC53
DR   hPSCreg; BIHi032-B
DR   Wikidata; Q54796682
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC52 ! BIHi032-A
OI   CVCL_VC54 ! BIHi032-C
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   BIHi032-C
AC   CVCL_VC54
DR   hPSCreg; BIHi032-C
DR   Wikidata; Q54796684
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC52 ! BIHi032-A
OI   CVCL_VC53 ! BIHi032-B
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   BIHi033-A
AC   CVCL_C6TZ
SY   Chorea Huntington 3; CH3
DR   hPSCreg; BIHi033-A
DR   Wikidata; Q117704214
RX   PubMed=36434993;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=36434993).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-45Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi034-A
AC   CVCL_C6U0
SY   Chorea Huntington 4; CH4
DR   hPSCreg; BIHi034-A
DR   Wikidata; Q117704215
RX   PubMed=36434993;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=36434993).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-45Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi035-A
AC   CVCL_D0QS
SY   HD180
DR   BioSamples; SAMEA13371752
DR   hPSCreg; BIHi035-A
DR   Wikidata; Q123030790
RX   PubMed=36863131;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=36863131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi037-A
AC   CVCL_ZI05
AS   CVCL_ZI01
SY   GM27896; GM27896*C
DR   Coriell; GM27896
DR   hPSCreg; BIHi037-A
DR   Wikidata; Q98125562
RX   PubMed=30197081;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Pro485Leu (c.1454C>T); ClinVar=VCV000871442; Zygosity=Heterozygous (PubMed=30197081).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI02 ! GM27897
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   BIHi037-B
AC   CVCL_ZI06
DR   hPSCreg; BIHi037-B
DR   Wikidata; Q98125565
RX   PubMed=30197081;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Pro485Leu (c.1454C>T); ClinVar=VCV000871442; Zygosity=Heterozygous (PubMed=30197081).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI02 ! GM27897
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   BIHi037-C
AC   CVCL_ZI07
DR   hPSCreg; BIHi037-C
DR   Wikidata; Q98125566
RX   PubMed=30197081;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Pro485Leu (c.1454C>T); ClinVar=VCV000871442; Zygosity=Heterozygous (PubMed=30197081).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI02 ! GM27897
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   BIHi037-D
AC   CVCL_ZI08
DR   hPSCreg; BIHi037-D
DR   Wikidata; Q98125567
RX   PubMed=30197081;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Pro485Leu (c.1454C>T); ClinVar=VCV000871442; Zygosity=Heterozygous (PubMed=30197081).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI02 ! GM27897
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   BIHi037-E
AC   CVCL_ZI09
DR   hPSCreg; BIHi037-E
DR   Wikidata; Q98125571
RX   PubMed=30197081;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Pro485Leu (c.1454C>T); ClinVar=VCV000871442; Zygosity=Heterozygous (PubMed=30197081).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI02 ! GM27897
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   BIHi038-A
AC   CVCL_VC55
DR   hPSCreg; BIHi038-A
DR   Wikidata; Q54796685
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC56 ! BIHi038-B
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   BIHi038-B
AC   CVCL_VC56
DR   BioSamples; SAMEA104493014
DR   EBiSC; BIHi038-B
DR   ECACC; 66540644
DR   hPSCreg; BIHi038-B
DR   Wikidata; Q54796688
RX   PubMed=34062331;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Discontinued: ECACC; 66540644; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC55 ! BIHi038-A
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   BIHi250-A
AC   CVCL_YN69
DR   BioSamples; SAMEA6654881
DR   hPSCreg; BIHi250-A
DR   Wikidata; Q93426659
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1NR ! BIHi250-B
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 7
//
ID   BIHi250-A-1
AC   CVCL_D6PM
DR   hPSCreg; BIHi250-A-1
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6PK ! BIHi250-A-4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIHi250-A-2
AC   CVCL_D6PL
DR   hPSCreg; BIHi250-A-2
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN69 ! BIHi250-A
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIHi250-A-4
AC   CVCL_D6PK
DR   hPSCreg; BIHi250-A-4
RX   PubMed=38460306;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN69 ! BIHi250-A
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIHi250-B
AC   CVCL_C1NR
DR   hPSCreg; BIHi250-B
DR   Wikidata; Q114310749
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN69 ! BIHi250-A
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BIHi266-A
AC   CVCL_D0QW
DR   BioSamples; SAMEA11951418
DR   hPSCreg; BIHi266-A
DR   Wikidata; Q123030791
RX   PubMed=36669241;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Heteroplasmic (PubMed=36669241).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0QX ! BIHi266-B
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi266-B
AC   CVCL_D0QX
DR   hPSCreg; BIHi266-B
DR   Wikidata; Q123030792
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Heteroplasmic (from autologous cell line BIHi266-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0QW ! BIHi266-A
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi267-A
AC   CVCL_D0QY
DR   hPSCreg; BIHi267-A
DR   Wikidata; Q123030793
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu217Arg (m.9176T>G); ClinVar=VCV000009650; Zygosity=Homoplasmic (from autologous cell line BIHi267-B).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0QZ ! BIHi267-B
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi267-B
AC   CVCL_D0QZ
DR   BioSamples; SAMEA11951375
DR   hPSCreg; BIHi267-B
DR   Wikidata; Q123030794
RX   PubMed=36669241;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu217Arg (m.9176T>G); ClinVar=VCV000009650; Zygosity=Homoplasmic (PubMed=36669241).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0QY ! BIHi267-A
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi269-A
AC   CVCL_D0R0
DR   hPSCreg; BIHi269-A
DR   Wikidata; Q123030795
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu217Arg (m.9176T>G); ClinVar=VCV000009650; Zygosity=Heteroplasmic (from autologous cell line BIHi269-B).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R1 ! BIHi269-B
OI   CVCL_D0R2 ! BIHi269-C
OI   CVCL_D0R3 ! BIHi269-D
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi269-B
AC   CVCL_D0R1
DR   BioSamples; SAMEA11951596
DR   hPSCreg; BIHi269-B
DR   Wikidata; Q123030796
RX   PubMed=36669241;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu217Arg (m.9176T>G); ClinVar=VCV000009650; Zygosity=Heteroplasmic (PubMed=36669241).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R0 ! BIHi269-A
OI   CVCL_D0R2 ! BIHi269-C
OI   CVCL_D0R3 ! BIHi269-D
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi269-C
AC   CVCL_D0R2
DR   hPSCreg; BIHi269-C
DR   Wikidata; Q123030797
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu217Arg (m.9176T>G); ClinVar=VCV000009650; Zygosity=Heteroplasmic (from autologous cell line BIHi269-B).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R0 ! BIHi269-A
OI   CVCL_D0R1 ! BIHi269-B
OI   CVCL_D0R3 ! BIHi269-D
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi269-D
AC   CVCL_D0R3
DR   hPSCreg; BIHi269-D
DR   Wikidata; Q123030798
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu217Arg (m.9176T>G); ClinVar=VCV000009650; Zygosity=Heteroplasmic (from autologous cell line BIHi269-B).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R0 ! BIHi269-A
OI   CVCL_D0R1 ! BIHi269-B
OI   CVCL_D0R2 ! BIHi269-C
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi276-A
AC   CVCL_D0R4
DR   BioSamples; SAMEA11951393
DR   hPSCreg; BIHi276-A
DR   Wikidata; Q123030799
RX   PubMed=36669241;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Homoplasmic (PubMed=36669241).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R5 ! BIHi276-C
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi276-C
AC   CVCL_D0R5
DR   hPSCreg; BIHi276-C
DR   Wikidata; Q123030801
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Homoplasmic (from autologous cell line BIHi276-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R4 ! BIHi276-A
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIHi288-A
AC   CVCL_C6TY
SY   Chorea Huntington 1; CH1
DR   hPSCreg; BIHi288-A
DR   Wikidata; Q117704216
RX   PubMed=36434993;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[58] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=36434993).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-45Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   BIIG2
AC   CVCL_E4R9
DR   DSHB; BIIG2
RX   PubMed=2351695;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08648; Human ITGA5/CD49e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BIN-14
AC   CVCL_QX91
DR   Wikidata; Q54796690
RX   PubMed=6186388;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   BIN-16
AC   CVCL_S984
DR   Wikidata; Q54796692
RX   PubMed=2845729;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   BIN-22
AC   CVCL_S985
DR   Wikidata; Q54796695
RX   PubMed=2845729;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   BIN-36
AC   CVCL_QX92
DR   Wikidata; Q54796697
RX   PubMed=6186388;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   BIN-53
AC   CVCL_S986
DR   Wikidata; Q54796700
RX   PubMed=2845729;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   BIN-67
AC   CVCL_S987
SY   Bin-67; BIN67
DR   BTO; BTO_0005818
DR   ArrayExpress; E-MEXP-3872
DR   ArrayExpress; E-MTAB-1584
DR   cancercelllines; CVCL_S987
DR   Cell_Model_Passport; SIDM01516
DR   Cosmic; 1948264
DR   Cosmic; 2141841
DR   Cosmic; 2161693
DR   DepMap; ACH-001278
DR   GEO; GSM1622407
DR   Wikidata; Q54796702
RX   PubMed=1331173;
RX   PubMed=2845729;
RX   PubMed=23433318;
RX   PubMed=24658002;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; c.2438+1G>A; ClinVar=VCV000537781; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24658002; DepMap=ACH-001278).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; c.2439-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=24658002; DepMap=ACH-001278).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Garson, Kenneth.
CC   Derived from site: Metastatic; Pelvis; UBERON=UBERON_0002355.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13,19
ST   D19S433: 14,15.2
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 15,19
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 14
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
DI   ORDO; Orphanet_370396; Small cell carcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 22
//
ID   BIN-S1
AC   CVCL_A9GX
DR   CCRID; 5301BOV-KCB95002ZJ
DR   KCB; KCB 95002ZJ
DR   Wikidata; Q108819949
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BIN40
AC   CVCL_E482
DR   dbMHC; 48498
DR   ECACC; 86112010
DR   IHW; IHW09296
DR   IPD-IMGT/HLA; 10316
DR   Wikidata; Q54796738
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01:01,31:01:02; B*14:01,40:01:01; C*03:04:01/03:01,08:02; DPA1*01:03; DPB1*03:01:01,06:01; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:04 (IPD-IMGT/HLA=10316).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Bine4.8
AC   CVCL_GR74
SY   BINE4.8
DR   TOKU-E; 4010
DR   Wikidata; Q54796739
RX   PubMed=7499835;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR73 ! 18-81
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   Bing
AC   CVCL_3652
SY   CAK 8; CAK8
DR   CLO; CLO_0001979
DR   ATCC; CRL-11554
DR   BioSample; SAMN03471341
DR   TOKU-E; 671
DR   Wikidata; Q54796741
RX   Patent=WO1994019478A1;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11554.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: ATCC; CRL-11554; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-11554
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12,15
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3645 ! Anjou 65
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   BIntMEC
AC   CVCL_A1BF
SY   Bovine Intestine Microvascular Endothelial Cells
DR   ABM; T0830
DR   Wikidata; Q102113623
RX   PubMed=32722052;
CC   Doubling time: 30 hours (PubMed=32722052).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal intestine, microvascular endothelium; UBERON=UBERON_0000160+UBERON_0008339.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
CC   Breed/subspecies: Montbeliarde; VBO=VBO_0000306.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A1BE ! BBrMEC
OI   CVCL_A1BG ! BLuMEC
OI   CVCL_A1BH ! BMLNMEC
OI   CVCL_A1BI ! BOvMEC
OI   CVCL_A1BJ ! BSkMEC
OI   CVCL_A1BK ! BUcEC
SX   Female
AG   6FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   BIOi001-A
AC   CVCL_VG55
SY   PCGiPS-ZFX-1
DR   hPSCreg; BIOi001-A
DR   Wikidata; Q54796742
RX   PubMed=29677590;
CC   From: Beijing Institute of Ophthalmology; Beijing; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=29677590
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D12S391: 18,20.3
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 23,25
ST   D2S441: 11,12
ST   D3S1358: 17,18
ST   D5S818: 10,13
ST   D6S1043: 12,18
ST   D7S820: 8,13
ST   D8S1179: 15,16
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 17,19
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C150251; Primary congenital glaucoma
DI   ORDO; Orphanet_98976; Congenital glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BIOi002-A
AC   CVCL_A2YJ
SY   JWQ-C3-P6
DR   BioSamples; SAMEA7851595
DR   hPSCreg; BIOi002-A
DR   Wikidata; Q105506485
RX   PubMed=33752025;
CC   From: Beijing Institute of Ophthalmology; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Val903Glyfs*3 (c.2708_2711delTTAG); ClinVar=VCV000005082; Zygosity=Heterozygous (PubMed=33752025).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33752025
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 19,22
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 14.2,15.2
ST   D1S1656: 14
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D2S441: 10,11
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D6S1043: 13,14
ST   D7S820: 10,10.3
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 11,12
ST   Penta E: 9,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C169000; Optic atrophy 1
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   BIOi003-A
AC   CVCL_C1NS
SY   LYN-C1-P6
DR   BioSamples; SAMEA14374207
DR   hPSCreg; BIOi003-A
DR   Wikidata; Q114310750
RX   PubMed=35973334;
CC   From: Beijing Institute of Ophthalmology; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg408Ter (c.1222C>T); ClinVar=VCV000099035; Zygosity=Heterozygous (PubMed=35973334).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Phe973Leufs*3 (c.2919-884G>T); Zygosity=Heterozygous (PubMed=35973334).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   BIOMEDi001-A
AC   CVCL_UL80
SY   BIOMEDi001-A C1; 8379 C1
DR   hPSCreg; BIOMEDi001-A
DR   Wikidata; Q93426708
RX   PubMed=30611016;
CC   From: BioMedX Innovation Center; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K53 ! AG08379
SX   Female
AG   60Y5M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   BIOMEDi002-A
AC   CVCL_UL81
SY   BIOMEDi002-A C2; 8525 C2
DR   hPSCreg; BIOMEDi002-A
DR   Wikidata; Q93426710
RX   PubMed=30611016;
CC   From: BioMedX Innovation Center; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K74 ! AG08525
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   BIOMEDi003-A
AC   CVCL_UL82
SY   BIOMEDi003-A C3; 8543 C3
DR   hPSCreg; BIOMEDi003-A
DR   Wikidata; Q93426712
CC   From: BioMedX Innovation Center; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K90 ! AG08543
SX   Male
AG   61Y8M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   BIOMEDi004-A
AC   CVCL_UL83
SY   BIOMEDi004-A C4; 8125 C4
DR   hPSCreg; BIOMEDi004-A
DR   Wikidata; Q93426714
RX   PubMed=30611016;
CC   From: BioMedX Innovation Center; Heidelberg; Germany.
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K24 ! AG08125
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   BIOMEDi005-A
AC   CVCL_UL84
SY   BIOMEDi005-A sAD1; 6869 sAD1
DR   hPSCreg; BIOMEDi005-A
DR   Wikidata; Q93426716
RX   PubMed=30611016;
CC   From: BioMedX Innovation Center; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0J93 ! AG06869
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   BIOMEDi006-A
AC   CVCL_UL85
SY   BIOMEDi006-A sAD2; 8245 sAD2
DR   hPSCreg; BIOMEDi006-A
DR   Wikidata; Q93426718
RX   PubMed=30611016;
CC   From: BioMedX Innovation Center; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K38 ! AG08245
SX   Male
AG   74Y8M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   BIONi010-A
AC   CVCL_1E66
SY   K1_shp53; K1P53
DR   BioSamples; SAMEA3105765
DR   EBiSC; BIONi010-A
DR   ECACC; 66540022
DR   EGA; EGAS00001002755
DR   GEO; GSM1183105
DR   hPSCreg; BIONi010-A
DR   SKIP; SKIP002534
DR   Wikidata; Q54796746
RX   PubMed=25241739;
RX   PubMed=27596958;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540022; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E67 ! BIONi010-B
OI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   BIONi010-B
AC   CVCL_1E67
SY   K2_shp53; K2P53
DR   BioSamples; SAMEA3158000
DR   EBiSC; BIONi010-B
DR   ECACC; 66540030
DR   EGA; EGAS00001002755
DR   GEO; GSM1183106
DR   hPSCreg; BIONi010-B
DR   SKIP; SKIP002535
DR   Wikidata; Q54796747
RX   PubMed=25241739;
RX   PubMed=27596958;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540030; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E66 ! BIONi010-A
OI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   BIONi010-C
AC   CVCL_1E68
SY   K3_shp53; K3P53
DR   BioSamples; SAMEA3158050
DR   EBiSC; BIONi010-C
DR   ECACC; 66540023
DR   EGA; EGAS00001002755
DR   GEO; GSM1183107
DR   hPSCreg; BIONi010-C
DR   SKIP; SKIP002536
DR   Wikidata; Q54796750
RX   PubMed=25241739;
RX   PubMed=27596958;
RX   PubMed=30660866;
RX   PubMed=33660062;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540023; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): Bioneer
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 13,14.2
ST   D21S11: 28,32.2
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E66 ! BIONi010-A
OI   CVCL_1E67 ! BIONi010-B
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 18
//
ID   BIONi010-C-10
AC   CVCL_RM84
SY   HNF1AP291fsinsC +/- 54-5
DR   BioSamples; SAMEA104619380
DR   EBiSC; BIONi010-C-10
DR   ECACC; 66541074
DR   hPSCreg; BIONi010-C-10
DR   Wikidata; Q54796752
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple_edited; p.Gly292Argfs*25 (c.872dupC) (p.Pro291fs); ClinVar=VCV000014927; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (EBiSC=BIONi010-C-10).
CC   Discontinued: ECACC; 66541074; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129742; Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   BIONi010-C-11
AC   CVCL_RM85
SY   HNF1AP291fsinsC -/- 66-1
DR   BioSamples; SAMEA104619382
DR   EBiSC; BIONi010-C-11
DR   ECACC; 66541075
DR   hPSCreg; BIONi010-C-11
DR   Wikidata; Q54796754
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple_edited; p.Gly292Argfs*25 (c.872dupC) (p.Pro291fs); ClinVar=VCV000014927; Zygosity=Homozygous; Note=By CRISPR/Cas9 (EBiSC=BIONi010-C-11).
CC   Discontinued: ECACC; 66541075; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129742; Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   BIONi010-C-12
AC   CVCL_RM86
SY   HNF4ApR309C -/- 2-4
DR   BioSamples; SAMEA104619383
DR   EBiSC; BIONi010-C-12
DR   ECACC; 66541076
DR   hPSCreg; BIONi010-C-12
DR   Wikidata; Q54796756
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple_edited; p.Arg331Cys (c.991C>T) (R309C); ClinVar=VCV000036364; Zygosity=Homozygous; Note=By CRISPR/Cas9 (EBiSC=BIONi010-C-12).
CC   Discontinued: ECACC; 66541076; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   BIONi010-C-13
AC   CVCL_RF90
SY   BIONi010-C + NGN2 #I7-26
DR   BioSamples; SAMEA103988285
DR   EBiSC; BIONi010-C-13
DR   ECACC; 66540561
DR   hPSCreg; BIONi010-C-13
DR   SKIP; SKIP002903
DR   Wikidata; Q54796758
RX   PubMed=33610017;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Characteristics: Expression of NEUROG2/NGN2 is doxycycline-inducible. Using TALEN NEUROG2 under the control of a tetracycline response element and a 2A-PuroR was inserted into one allele of AAVS1 safe harbor locus. At the second locus a 2A-Neo-CAG-rtTA construct was inserted (PubMed=33610017).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: ECACC; 66540561; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   BIONi010-C-15
AC   CVCL_RM87
SY   BIONi010-C + dox inducible NGN2-GFP
DR   BioSamples; SAMEA104008229
DR   EBiSC; BIONi010-C-15
DR   ECACC; 66540570
DR   hPSCreg; BIONi010-C-15
DR   Wikidata; Q54796759
RX   PubMed=33610017;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Characteristics: Expression of NEUROG2/NGN2-eGFP is doxycycline-inducible. Using TALEN NEUROG2-T2A-eGFP under the control of a tetracycline response element and a 2A-PuroR was inserted into one allele of the AAVS1 safe harbor locus. At the second locus a 2A-Neo-CAG-rtTA construct was inserted (PubMed=33610017).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: ECACC; 66540570; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   BIONi010-C-17
AC   CVCL_RM88
SY   BIONi010-C TREM2 KO
DR   BioSamples; SAMEA104386270
DR   EBiSC; BIONi010-C-17
DR   ECACC; 66540632
DR   hPSCreg; BIONi010-C-17
DR   Wikidata; Q54796761
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2.
CC   Discontinued: ECACC; 66540632; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   BIONi010-C-18
AC   CVCL_RM89
SY   BIONi010-C TBK1 KO
DR   BioSamples; SAMEA104491010
DR   EBiSC; BIONi010-C-18
DR   ECACC; 66540637
DR   hPSCreg; BIONi010-C-18
DR   Wikidata; Q54796763
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Discontinued: ECACC; 66540637; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   BIONi010-C-19
AC   CVCL_VC57
SY   BIONi010-C IKBKE KO
DR   BioSamples; SAMEA104491011
DR   EBiSC; BIONi010-C-19
DR   ECACC; 66540638
DR   hPSCreg; BIONi010-C-19
DR   Wikidata; Q54796764
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Discontinued: ECACC; 66540638; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   BIONi010-C-2
AC   CVCL_II81
SY   BIONi010-C ApoE E3/E3 #H8 P32
DR   BioSamples; SAMEA4342705
DR   EBiSC; BIONi010-C-2
DR   ECACC; 66540268
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-2
DR   SKIP; SKIP002820
DR   Wikidata; Q54796765
RX   PubMed=30660866;
RX   PubMed=32971461;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg130Cys (c.388C>T); Zygosity=Hemizygous; Note=By CRISPR/Cas9. ApoE3 allele. The second allele is disrupted by a 3.4 kb insertion from the selection plasmid (PubMed=30660866; PubMed=32971461).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540268; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   BIONi010-C-24
AC   CVCL_VC58
SY   BIONi010-C Dox a-syn
DR   BioSamples; SAMEA104615912
DR   EBiSC; BIONi010-C-24
DR   ECACC; 66540904
DR   hPSCreg; BIONi010-C-24
DR   Wikidata; Q54796768
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Characteristics: Using TALEN SNCA under the control of a doxycycline inducible promoter has been inserted at the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:11138; SNCA.
CC   Discontinued: ECACC; 66540904; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 15
//
ID   BIONi010-C-25
AC   CVCL_VC59
SY   BIONi010-C heterozygous TREM2 KO
DR   BioSamples; SAMEA104623616
DR   EBiSC; BIONi010-C-25
DR   ECACC; 66541146
DR   hPSCreg; BIONi010-C-25
DR   Wikidata; Q54796770
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2 (Note=1 of 2 alleles).
CC   Discontinued: ECACC; 66541146; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   BIONi010-C-29
AC   CVCL_VR96
SY   BIONi010-C-E280A +/+; BIONi010-C + Psen1 E280A +/+
DR   hPSCreg; BIONi010-C-29
DR   Wikidata; Q93426783
RX   PubMed=30769329;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Glu280Ala (c.839A>C); ClinVar=VCV000018131; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=30769329).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   BIONi010-C-3
AC   CVCL_II82
SY   BIONi010-C ApoE KO #KO30 P30
DR   BioSamples; SAMEA4342740
DR   EBiSC; BIONi010-C-3
DR   ECACC; 66540269
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-3
DR   SKIP; SKIP002821
DR   Wikidata; Q54796773
RX   PubMed=30660866;
RX   PubMed=32971461;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540269; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 15
//
ID   BIONi010-C-30
AC   CVCL_VR97
SY   BIONi010-C-E280A +/-; BIONi010-C + Psen1 E280A +/-
DR   hPSCreg; BIONi010-C-30
DR   Wikidata; Q93426791
RX   PubMed=30769329;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Glu280Ala (c.839A>C); ClinVar=VCV000018131; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=30769329).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   BIONi010-C-37
AC   CVCL_UR26
SY   BIONi010-C London (V717I); APP V717I
DR   hPSCreg; BIONi010-C-37
DR   Wikidata; Q93426793
RX   PubMed=30634129;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=30634129).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   BIONi010-C-38
AC   CVCL_UR27
SY   BIONi010-C Swedish (KM670/671NL); APP KM670/671NL
DR   hPSCreg; BIONi010-C-38
DR   Wikidata; Q93426795
RX   PubMed=30634129;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Lys670_Met671delinsAsnLeu (c.2010_2011inv) (c.2010_2011delGAinsTC); ClinVar=VCV000018093; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=30634129).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   BIONi010-C-4
AC   CVCL_II83
SY   BIONi010-C ApoE E4/E4 #B44 P27
DR   BioSamples; SAMEA4452060
DR   EBiSC; BIONi010-C-4
DR   ECACC; 66540366
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-4
DR   SKIP; SKIP002853
DR   Wikidata; Q54796774
RX   PubMed=30660866;
RX   PubMed=32971461;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Hemizygous; Note=By CRISPR/Cas9. ApoE4 allele. The second allele is disrupted by a 5.4 kb insertion from the selection plasmid (PubMed=30660866; PubMed=32971461).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540366; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   BIONi010C-48
AC   CVCL_D6PB
SY   BIONi010-C hMDR1; BIONi010-C CAG_hMDR1 in AAVS1 cl. #B31-75
DR   BioSamples; SAMEA115286272
DR   hPSCreg; BIONi010-C-48
RX   PubMed=38364505;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Characteristics: Using TALEN a ABCB1/MDR1-neo construct was introduced in both alleles of the AAVS1 safe harbor locus (PubMed=38364505).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   BIONi010-C-5
AC   CVCL_II84
SY   BIONi010-C CD33 E2del #N14 P26
DR   BioSamples; SAMEA4452061
DR   EBiSC; BIONi010-C-5
DR   ECACC; 66540367
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-5
DR   SKIP; SKIP002854
DR   Wikidata; Q54796776
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1659; CD33.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540367; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   BIONi010-C-51
AC   CVCL_C9MD
SY   BIONi010-C TNNI3-mCherry reporter; BIONi010-C TNNI3-IRES-mCherry reporter cl. 84-4
DR   BioSamples; SAMEA9716844
DR   EBiSC; BIONi010-C-51
DR   ECACC; 66770028
DR   hPSCreg; BIONi010-C-51
DR   Wikidata; Q123030802
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Characteristics: Using CRISP/Cas9 a IRES-H2B-mCherry was integrated at the C-terminus of TNNI3 (Bioneer).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Discontinued: ECACC; 66770028; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): Bioneer
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 13,14.2
ST   D21S11: 28,32.2
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   BIONi010-C-52
AC   CVCL_C9MC
DR   BioSamples; SAMEA8093245
DR   EBiSC; BIONi010-C-52
DR   ECACC; 66770013
DR   hPSCreg; BIONi010-C-52
DR   Wikidata; Q123030803
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Homozygous; Note=By CRISPR/Cas9. ApoE2 allele (hPSCreg=BIONi010-C-52).
CC   Discontinued: ECACC; 66770013; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-53
AC   CVCL_C9MB
DR   BioSamples; SAMEA8093246
DR   EBiSC; BIONi010-C-53
DR   ECACC; 66770014
DR   hPSCreg; BIONi010-C-53
DR   Wikidata; Q123030804
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=By CRISPR/Cas9. ApoE3 allele (hPSCreg=BIONi010-C-53).
CC   Discontinued: ECACC; 66770014; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-54
AC   CVCL_C9MA
DR   BioSamples; SAMEA8093247
DR   EBiSC; BIONi010-C-54
DR   ECACC; 66770015
DR   hPSCreg; BIONi010-C-54
DR   Wikidata; Q123030805
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=By CRISPR/Cas9. ApoE4 allele (hPSCreg=BIONi010-C-54).
CC   Discontinued: ECACC; 66770015; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-55
AC   CVCL_C9M9
SY   BIONi010-C TNNI3-mCherry/TNNI1-EGFP dual reporter cl. 74
DR   BioSamples; SAMEA8837436
DR   EBiSC; BIONi010-C-55
DR   ECACC; 66770020
DR   hPSCreg; BIONi010-C-55
DR   Wikidata; Q123030806
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Characteristics: Using CRISP/Cas9 a IRES-H2B-mCherry was integrated at the C-terminus of TNNI3 and a IRES-d2EGFP at the C-terminus of TNNI1 (Bioneer).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Discontinued: ECACC; 66770020; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): Bioneer
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 13,14.2
ST   D21S11: 28,32.2
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9MD ! BIONi010-C-51
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   BIONi010-C-56
AC   CVCL_C9H1
SY   BIONi010-C-A713T-C25; Clone 25+/+; KUi011-A-56
DR   BioSamples; SAMEA112445949
DR   hPSCreg; BIONi010-C-56
DR   Wikidata; Q123030807
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Ala712Thr (c.2134G>A) (p.Ala713Thr, c.2137G>A); ClinVar=VCV000254268; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-57
AC   CVCL_C9H2
SY   BIONi010-C-A713T-C42; Clone 42+/+; KUi011-A-57
DR   BioSamples; SAMEA112445976
DR   hPSCreg; BIONi010-C-57
DR   Wikidata; Q123030808
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Ala712Thr (c.2134G>A) (p.Ala713Thr, c.2137G>A); ClinVar=VCV000254268; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-58
AC   CVCL_C9H3
SY   BIONi010-C-A713T-C1; Clone 1+/-; KUi011-A-58
DR   BioSamples; SAMEA112464094
DR   hPSCreg; BIONi010-C-58
DR   Wikidata; Q123030809
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Ala712Thr (c.2134G>A) (p.Ala713Thr, c.2137G>A); ClinVar=VCV000254268; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-59
AC   CVCL_C9H4
SY   BIONi010-C-A713T-C33; Clone 33+/-; KUi011-A-59
DR   BioSamples; SAMEA112464095
DR   hPSCreg; BIONi010-C-59
DR   Wikidata; Q123030810
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Ala712Thr (c.2134G>A) (p.Ala713Thr, c.2137G>A); ClinVar=VCV000254268; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-6
AC   CVCL_II85
SY   BIONi010-C ApoE E2/E2
DR   BioSamples; SAMEA4454009
DR   EBiSC; BIONi010-C-6
DR   ECACC; 66540368
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-6
DR   SKIP; SKIP002861
DR   Wikidata; Q54796778
RX   PubMed=30660866;
RX   PubMed=32971461;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Hemizygous; Note=By CRISPR/Cas9. ApoE2 allele. The second allele is disrupted by a 3.4 kb insertion from the selection plasmid (PubMed=30660866; PubMed=32971461).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540368; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 18
//
ID   BIONi010-C-60
AC   CVCL_C9H5
SY   BIONi010-C-R589C-C7; Clone 7+/+; KUi011-A-60
DR   BioSamples; SAMEA112484118
DR   hPSCreg; BIONi010-C-60
DR   Wikidata; Q123030811
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Arg588Cys (c.1762C>T) (p.Arg589Cys, c.1765C>T); ClinVar=VCV001691641; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-61
AC   CVCL_C9H6
SY   BIONi010-C-R589C-C16; Clone 16+/+; KUi011-A-61
DR   BioSamples; SAMEA112622036
DR   hPSCreg; BIONi010-C-61
DR   Wikidata; Q123030812
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Arg588Cys (c.1762C>T) (p.Arg589Cys, c.1765C>T); ClinVar=VCV001691641; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-62
AC   CVCL_C9H7
SY   BIONi010-C-R589C-C5; Clone 5+/-; KUi011-A-62
DR   BioSamples; SAMEA112622441
DR   hPSCreg; BIONi010-C-62
DR   Wikidata; Q123030813
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Arg588Cys (c.1762C>T) (p.Arg589Cys, c.1765C>T); ClinVar=VCV001691641; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-63
AC   CVCL_C9H8
SY   BIONi010-C-R589C-C9; Clone 9+/-; KUi011-A-63
DR   BioSamples; SAMEA112622448
DR   hPSCreg; BIONi010-C-63
DR   Wikidata; Q123030814
RX   PubMed=37651830;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Arg588Cys (c.1762C>T) (p.Arg589Cys, c.1765C>T); ClinVar=VCV001691641; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37651830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BIONi010-C-64
AC   CVCL_C1NT
SY   BIONi010-C-CYP3A4-2TA-Nluc; BIONi010-C-T2A-Nanoluciferase reporter cl. 29
DR   BioSamples; SAMEA10534760
DR   hPSCreg; BIONi010-C-64
DR   Wikidata; Q114310751
RX   PubMed=35598806;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Characteristics: Using CRISPR/Cas9 a T2A-Nluc construct was inserted at the C-terminus of one of the alleles of CYP3A4 (PubMed=35598806).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   BIONi010-C-7
AC   CVCL_II86
SY   BIONi010-C Trem2 R47H
DR   BioSamples; SAMEA4454010
DR   EBiSC; BIONi010-C-7
DR   ECACC; 66540369
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-7
DR   SKIP; SKIP002862
DR   Wikidata; Q54796779
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Homozygous; Note=By CRISPR/Cas9 (EBiSC=BIONi010-C-7).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540369; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 17
//
ID   BIONi010-C-70
AC   CVCL_D6RS
SY   APOE2Ch
DR   BioSamples; SAMEA115162592
DR   EBiSC; BIONi010-C-70
DR   hPSCreg; BIONi010-C-70
RX   PubMed=38703665;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg154Ser (c.460C>A) (R136S); ClinVar=VCV000017850; Zygosity=Homozygous; Note=By CRISPR/Ca9. Christchurch allele (PubMed=38703665).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIONi010-C-71
AC   CVCL_D6RT
SY   APOE3Ch
DR   BioSamples; SAMEA115162593
DR   EBiSC; BIONi010-C-71
DR   hPSCreg; BIONi010-C-71
RX   PubMed=38703665;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=By CRISPR/Cas9. ApoE3 allele (PubMed=38703665).
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg154Ser (c.460C>A) (R136S); ClinVar=VCV000017850; Zygosity=Homozygous; Note=By CRISPR/Ca9. Christchurch allele (PubMed=38703665).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIONi010-C-72
AC   CVCL_D6RU
SY   APOE4Ch
DR   BioSamples; SAMEA115162597
DR   EBiSC; BIONi010-C-72
DR   hPSCreg; BIONi010-C-72
RX   PubMed=38703665;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=By CRISPR/Cas9. ApoE4 allele (PubMed=38703665).
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg154Ser (c.460C>A) (R136S); ClinVar=VCV000017850; Zygosity=Homozygous; Note=By CRISPR/Ca9. Christchurch allele (PubMed=38703665).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BIONi010-C-8
AC   CVCL_LE09
SY   BIONi010-C Trem2 T66M; #Y5-80
DR   BioSamples; SAMEA4454011
DR   EBiSC; BIONi010-C-8
DR   ECACC; 66540370
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-8
DR   SKIP; SKIP002863
DR   Wikidata; Q54796782
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Thr66Met (c.197C>T); ClinVar=VCV000192242; Zygosity=Homozygous; Note=By CRISPR/Cas9 (EBiSC=BIONi010-C-8).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540370; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   BIONi010-C-9
AC   CVCL_LL40
SY   BIONi010-C CD33 KO
DR   BioSamples; SAMEA4454012
DR   EBiSC; BIONi010-C-9
DR   ECACC; 66540371
DR   EGA; EGAS00001002755
DR   hPSCreg; BIONi010-C-9
DR   Wikidata; Q54796783
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1659; CD33.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540371; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   BIONi010-C-NKX2.5-T2A-Nluc-44.37
AC   CVCL_C0VT
SY   #44.37
DR   Wikidata; Q114310752
RX   PubMed=33660062;
CC   Population: African.
CC   Biotechnology: Part of the PluriLum assay which is used for predicting developmental toxicity which relies on the formation of embryoid bodies (EBs) and the differentiation of these into cardiomyocytes (PubMed=33660062).
CC   Characteristics: Using CRISPR/Cas9 a T2A-Nluc construct was inserted at the C-terminus of both alleles of NKX2-5 (PubMed=33660062).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   BIONi010-C-NKX2.5-T2A-Nluc-73.59
AC   CVCL_C0VU
SY   #73.59
DR   Wikidata; Q114310753
RX   PubMed=33660062;
CC   Population: African.
CC   Biotechnology: Part of the PluriLum assay which is used for predicting developmental toxicity which relies on the formation of embryoid bodies (EBs) and the differentiation of these into cardiomyocytes (PubMed=33660062).
CC   Characteristics: Using CRISPR/Cas9 a T2A-Nluc construct was inserted at the C-terminus of both alleles of NKX2-5 (PubMed=33660062).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   BIONi011-B
AC   CVCL_VC60
SY   H170615 C1
DR   BioSamples; SAMEA104619384
DR   EBiSC; BIONi011-B
DR   ECACC; 66541077
DR   hPSCreg; BIONi011-B
DR   Wikidata; Q54796785
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: EBiSC; BIONi011-B; true.
CC   Discontinued: ECACC; 66541077; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC61 ! BIONi011-C
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 6
//
ID   BIONi011-C
AC   CVCL_VC61
SY   H170615 C4
DR   BioSamples; SAMEA104619385
DR   EBiSC; BIONi011-C
DR   ECACC; 66541078
DR   hPSCreg; BIONi011-C
DR   Wikidata; Q54796786
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: EBiSC; BIONi011-C; true.
CC   Discontinued: ECACC; 66541078; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC60 ! BIONi011-B
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 6
//
ID   BIONi012-A
AC   CVCL_LE10
SY   H230715 47-1
DR   BioSamples; SAMEA4342434
DR   EBiSC; BIONi012-A
DR   ECACC; 66540263
DR   hPSCreg; BIONi012-A
DR   Wikidata; Q54796788
CC   Problematic cell line: Misidentified/contaminated. The STR profile matches the wrong donor (EBiSC=BIONi012-A).
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: EBiSC; BIONi012-A; true.
CC   Discontinued: ECACC; 66540263; true.
CC   Discontinued: hPSCreg; BIONi012-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 7
//
ID   BIONi013-A
AC   CVCL_LE11
SY   H240715 47-1
DR   BioSamples; SAMEA4342502
DR   EBiSC; BIONi013-A
DR   ECACC; 66540264
DR   hPSCreg; BIONi013-A
DR   Wikidata; Q54796790
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540264; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi014-A
AC   CVCL_LE12
SY   H270715 47-1
DR   BioSamples; SAMEA4342566
DR   EBiSC; BIONi014-A
DR   ECACC; 66540265
DR   hPSCreg; BIONi014-A
DR   Wikidata; Q54796793
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540265; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi015-A
AC   CVCL_LE13
SY   H280715 47-1
DR   BioSamples; SAMEA4342649
DR   EBiSC; BIONi015-A
DR   ECACC; 66540266
DR   hPSCreg; BIONi015-A
DR   Wikidata; Q54796794
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540266; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi016-A
AC   CVCL_LE14
SY   H310715 47-1
DR   BioSamples; SAMEA4342607
DR   EBiSC; BIONi016-A
DR   ECACC; 66540267
DR   hPSCreg; BIONi016-A
DR   Wikidata; Q54796795
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540267; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi017-A
AC   CVCL_LE15
SY   H030815 47-1
DR   BioSamples; SAMEA4451663
DR   EBiSC; BIONi017-A
DR   ECACC; 66540360
DR   hPSCreg; BIONi017-A
DR   Wikidata; Q54796797
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540360; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi018-A
AC   CVCL_LE16
SY   H050815 48-4
DR   BioSamples; SAMEA4451665
DR   EBiSC; BIONi018-A
DR   ECACC; 66540361
DR   hPSCreg; BIONi018-A
DR   Wikidata; Q54796799
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540361; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi019-A
AC   CVCL_LE17
SY   H060815 48-3
DR   BioSamples; SAMEA4451667
DR   EBiSC; BIONi019-A
DR   ECACC; 66540362
DR   hPSCreg; BIONi019-A
DR   Wikidata; Q54796800
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540362; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi020-A
AC   CVCL_LE18
SY   H070815 47-2
DR   BioSamples; SAMEA4451669
DR   EBiSC; BIONi020-A
DR   ECACC; 66540363
DR   hPSCreg; BIONi020-A
DR   Wikidata; Q54796802
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540363; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi021-A
AC   CVCL_LE19
SY   H100815 48-2
DR   BioSamples; SAMEA4451671
DR   EBiSC; BIONi021-A
DR   ECACC; 66540364
DR   hPSCreg; BIONi021-A
DR   Wikidata; Q54796804
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540364; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi022-A
AC   CVCL_LE20
SY   H110815 47-2
DR   BioSamples; SAMEA4451673
DR   EBiSC; BIONi022-A
DR   ECACC; 66540365
DR   hPSCreg; BIONi022-A
DR   Wikidata; Q54796805
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540365; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi023-A
AC   CVCL_LE21
SY   H130815 47-4
DR   BioSamples; SAMEA4454014
DR   EBiSC; BIONi023-A
DR   ECACC; 66540372
DR   hPSCreg; BIONi023-A
DR   SKIP; SKIP002858
DR   Wikidata; Q54796806
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540372; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi024-A
AC   CVCL_LE22
SY   H170815 47-2
DR   BioSamples; SAMEA4454016
DR   EBiSC; BIONi024-A
DR   ECACC; 66540373
DR   hPSCreg; BIONi024-A
DR   SKIP; SKIP002859
DR   Wikidata; Q54796807
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540373; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi025-A
AC   CVCL_LE23
SY   H210815 48-3
DR   BioSamples; SAMEA4454018
DR   EBiSC; BIONi025-A
DR   ECACC; 66540374
DR   hPSCreg; BIONi025-A
DR   SKIP; SKIP002860
DR   Wikidata; Q54796852
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540374; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi026-A
AC   CVCL_LE24
SY   H300715 48-3
DR   BioSamples; SAMEA4455497
DR   EBiSC; BIONi026-A
DR   ECACC; 66540399
DR   hPSCreg; BIONi026-A
DR   SKIP; SKIP002873
DR   Wikidata; Q54796854
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540399; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi027-A
AC   CVCL_LE25
SY   H040815 48-1
DR   BioSamples; SAMEA4455499
DR   EBiSC; BIONi027-A
DR   ECACC; 66540400
DR   hPSCreg; BIONi027-A
DR   SKIP; SKIP002874
DR   Wikidata; Q54796857
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540400; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi028-A
AC   CVCL_LE26
SY   H120815 48-1
DR   BioSamples; SAMEA4455501
DR   EBiSC; BIONi028-A
DR   ECACC; 66540401
DR   hPSCreg; BIONi028-A
DR   SKIP; SKIP002875
DR   Wikidata; Q54796859
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540401; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi029-A
AC   CVCL_LE27
SY   H190815 47-1
DR   BioSamples; SAMEA4455503
DR   EBiSC; BIONi029-A
DR   ECACC; 66540402
DR   hPSCreg; BIONi029-A
DR   SKIP; SKIP002876
DR   Wikidata; Q54796861
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540402; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi030-A
AC   CVCL_LE28
SY   H200815 47-1
DR   BioSamples; SAMEA4455505
DR   EBiSC; BIONi030-A
DR   ECACC; 66540403
DR   hPSCreg; BIONi030-A
DR   Wikidata; Q54796863
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540403; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi031-A
AC   CVCL_LE29
SY   H240815 48-2
DR   BioSamples; SAMEA4455507
DR   EBiSC; BIONi031-A
DR   ECACC; 66540404
DR   hPSCreg; BIONi031-A
DR   SKIP; SKIP002877
DR   Wikidata; Q54796865
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540404; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi032-A
AC   CVCL_LE30
SY   H250815 48-1
DR   BioSamples; SAMEA4455509
DR   EBiSC; BIONi032-A
DR   ECACC; 66540405
DR   hPSCreg; BIONi032-A
DR   SKIP; SKIP002878
DR   Wikidata; Q54796866
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540405; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi033-A
AC   CVCL_LE31
SY   H180615
DR   BioSamples; SAMEA4563389
DR   EBiSC; BIONi033-A
DR   ECACC; 66540423
DR   hPSCreg; BIONi033-A
DR   SKIP; SKIP002891
DR   Wikidata; Q54796869
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540423; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi034-A
AC   CVCL_LE32
SY   H290715
DR   BioSamples; SAMEA4563391
DR   EBiSC; BIONi034-A
DR   ECACC; 66540424
DR   hPSCreg; BIONi034-A
DR   Wikidata; Q54796870
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540424; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi035-A
AC   CVCL_LE33
SY   H180815
DR   BioSamples; SAMEA4563393
DR   EBiSC; BIONi035-A
DR   ECACC; 66540425
DR   hPSCreg; BIONi035-A
DR   SKIP; SKIP002892
DR   Wikidata; Q54796872
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540425; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   BIONi036-A
AC   CVCL_UL90
SY   11599
DR   hPSCreg; BIONi036-A
DR   Wikidata; Q93426929
CC   From: Bioneer A/S; Horsholm; Denmark.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   BIONi037-A
AC   CVCL_II80
SY   16423 ApoE3/3; hiPSC-16423 #6
DR   BioSamples; SAMEA104026330
DR   EBiSC; BIONi037-A
DR   ECACC; 66540580
DR   hPSCreg; BIONi037-A
DR   Wikidata; Q54796873
RX   PubMed=27789407;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540580; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 9
//
ID   BIONi037-A-1
AC   CVCL_RF91
SY   16423 ApoE KO
DR   BioSamples; SAMEA104026332
DR   EBiSC; BIONi037-A-1
DR   ECACC; 66540581
DR   hPSCreg; BIONi037-A-1
DR   Wikidata; Q54796877
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Discontinued: ECACC; 66540581; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_II80 ! BIONi037-A
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   BIONi037-A-2
AC   CVCL_RF92
SY   BIONi037-A ApoE2/2 #M10-7
DR   BioSamples; SAMEA104235612
DR   EBiSC; BIONi037-A-2
DR   ECACC; 66540604
DR   hPSCreg; BIONi037-A-2
DR   Wikidata; Q54796878
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540604; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_II80 ! BIONi037-A
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   BIONi037-A-3
AC   CVCL_RF93
SY   BIONi037-A ApoE3/4 #P10-22
DR   BioSamples; SAMEA104235613
DR   EBiSC; BIONi037-A-3
DR   ECACC; 66540605
DR   hPSCreg; BIONi037-A-3
DR   Wikidata; Q54796879
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540605; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_II80 ! BIONi037-A
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   BIONi037-A-4
AC   CVCL_RF94
SY   BIONi037-A ApoE4/4 #I10-53
DR   BioSamples; SAMEA104235614
DR   EBiSC; BIONi037-A-4
DR   ECACC; 66540606
DR   hPSCreg; BIONi037-A-4
DR   Wikidata; Q54796882
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540606; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_II80 ! BIONi037-A
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   BIORTCi001-A
AC   CVCL_E3RP
SY   BAiPSC 000; OSTiFGM2
DR   BioSamples; SAMEA115628871
DR   hPSCreg; BIORTCi001-A
RX   PubMed=39067409;
CC   From: Biomedical Science Research and Training Centre (BIORTC); Damaturu; Nigeria.
CC   Population: African; Nigerian Babur/Bura.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BIOT-0630-LOAD
AC   CVCL_GP72
DR   Wikidata; Q54796884
RX   PubMed=27558606;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   BIOT-0708-EHMT1
AC   CVCL_IJ19
DR   Wikidata; Q54796887
RX   PubMed=27789404;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Sequence variation: Mutation; HGNC; HGNC:24650; EHMT1; Simple; p.Trp1138Ter (c.3413G>A); ClinVar=VCV000221980; Zygosity=Heterozygous (PubMed=27789404).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129976; Kleefstra syndrome
DI   ORDO; Orphanet_261494; Kleefstra syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   BIOT-0726-LOAD
AC   CVCL_GP73
DR   Wikidata; Q54796889
RX   PubMed=27558607;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   BIOT-0904-LOAD
AC   CVCL_GP74
DR   Wikidata; Q54796890
RX   PubMed=27558608;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   BIOT-4828-LOAD
AC   CVCL_GP75
DR   Wikidata; Q54796891
RX   PubMed=27558605;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   BIOTi001-A
AC   CVCL_GP76
SY   BIOT-7183-PSEN1
DR   BioSamples; SAMEA4999067
DR   hPSCreg; BIOTi001-A
DR   Wikidata; Q54796894
RX   PubMed=27558604;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Val89Leu (c.265G>T); ClinVar=VCV000021027; Zygosity=Heterozygous (PubMed=27558604).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   BIOTi002-A
AC   CVCL_E3RQ
SY   BIOT-2014-CTRL
DR   hPSCreg; BIOTi002-A
CC   From: BioTalentum, Ltd; Godollo; Hungary.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BIOTi628-A
AC   CVCL_QX61
DR   Wikidata; Q54796896
RX   PubMed=28677532;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   biPS-160-2
AC   CVCL_B5FG
SY   160-2
DR   GEO; GSM5027863
DR   GEO; GSM5027864
DR   GEO; GSM5027865
DR   GEO; GSM5027866
DR   GEO; GSM5027899
DR   GEO; GSM5027900
DR   GEO; GSM5027901
DR   GEO; GSM5027905
DR   GEO; GSM5027906
DR   GEO; GSM5027907
DR   GEO; GSM5027911
DR   GEO; GSM5027912
DR   GEO; GSM5027913
DR   GEO; GSM5027917
DR   GEO; GSM5027918
DR   GEO; GSM5027919
DR   GEO; GSM5027929
DR   GEO; GSM5027930
DR   GEO; GSM5027931
DR   GEO; GSM5027951
DR   GEO; GSM5027952
DR   GEO; GSM5027953
DR   GEO; GSM5027954
DR   GEO; GSM5027955
DR   GEO; GSM5027956
DR   Wikidata; Q110432634
RX   PubMed=24182315;
RX   PubMed=34864219;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_B5FH ! biPS-160-5
SX   Male
AG   160FD
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   biPS-160-5
AC   CVCL_B5FH
DR   Wikidata; Q110432635
RX   PubMed=24182315;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_B5FG ! biPS-160-2
SX   Male
AG   160FD
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   biPS-90-11
AC   CVCL_B5FE
DR   Wikidata; Q110432636
RX   PubMed=24182315;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_B5FF ! biPS-90-25
SX   Male
AG   90FD
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   biPS-90-25
AC   CVCL_B5FF
DR   Wikidata; Q110432637
RX   PubMed=24182315;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_B5FE ! biPS-90-11
SX   Male
AG   90FD
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   biPSC
AC   CVCL_A4PR
SY   baboon iPSC
DR   SKIP; SKIP003156
DR   Wikidata; Q105506488
RX   PubMed=29494646;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   BIPTi001-A
AC   CVCL_A9ZM
SY   hASC-iPSC-1A
DR   hPSCreg; BIPTi001-A
DR   Wikidata; Q102113624
RX   PubMed=32896746;
CC   From: Beijing Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   BIPTi002-A
AC   CVCL_A9ZN
SY   hASC-iPSC-2A
DR   hPSCreg; BIPTi002-A
DR   Wikidata; Q102113625
RX   PubMed=32896746;
CC   From: Beijing Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   BIU-87
AC   CVCL_6881
SY   BIU87
DR   CCTCC; GDC0120
DR   KCB; KCB 2006103YJ
DR   Wikidata; Q28658473
RX   PubMed=9594332;
RX   PubMed=23618585;
RX   PubMed=26116706;
RX   PubMed=30967374;
CC   Problematic cell line: Misidentified/contaminated. Seems to be contaminated by non-human cells (PubMed=26116706). Originally thought to originate from a 58 year old male patient with an urinary bladder carcinoma.
CC   Doubling time: 36 hours (PubMed=9594332); 25.30 +- 0.04 hours (PubMed=30967374).
OX   NCBI_TaxID=32644; ! Unidentified organism (Unknown organism)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   BIU-87/ADMR
AC   CVCL_6882
SY   BIU-87/ADM; BIU-87/DOX
DR   Wikidata; Q54796898
RX   PubMed=9594332;
RX   PubMed=23618585;
RX   PubMed=30967374;
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (BIU-87) seems to be contaminated by non-human cells.
CC   Doubling time: 48 hours (PubMed=9594332); 31.58 +- 0.37 hours (PubMed=30967374).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
OX   NCBI_TaxID=32644; ! Unidentified organism (Unknown organism)
HI   CVCL_6881 ! BIU-87
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   BIUi001-A
AC   CVCL_A0SV
SY   BIUi-001-A; T1A1i-001
DR   BioSamples; SAMEA9462481
DR   hPSCreg; BIUi001-A
DR   Wikidata; Q108819950
RX   PubMed=34560421;
CC   From: Bar Ilan University; Ramat Gan; Israel.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:29456; TOR1AIP1; Simple; p.Arg321Ter (c.961C>T); ClinVar=VCV000804380; Zygosity=Homozygous (PubMed=34560421).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C181000; Autosomal recessive limb-girdle muscular dystrophy type 2Y
DI   ORDO; Orphanet_424261; TOR1AIP1-related limb-girdle muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   BIUi002-A
AC   CVCL_A0SW
SY   BIUi-002-A; T1A1i-002
DR   BioSamples; SAMEA9486399
DR   hPSCreg; BIUi002-A
DR   Wikidata; Q108819951
RX   PubMed=34560421;
CC   From: Bar Ilan University; Ramat Gan; Israel.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:29456; TOR1AIP1; Simple; p.Arg321Ter (c.961C>T); ClinVar=VCV000804380; Zygosity=Homozygous (PubMed=34560421).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C181000; Autosomal recessive limb-girdle muscular dystrophy type 2Y
DI   ORDO; Orphanet_424261; TOR1AIP1-related limb-girdle muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   BJ [Human B-cell IHW]
AC   CVCL_E483
DR   dbMHC; 48499
DR   ECACC; 94022524
DR   IHW; IHW09254
DR   IPD-IMGT/HLA; 10317
DR   Wikidata; Q54796902
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*69:01,30:01; B*42:01,35:08; C*17:01,12:03; DPB1*01:01:01,02:01:02 (IPD-IMGT/HLA=10317).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   BJ [Human fibroblast]
AC   CVCL_3653
SY   FF-WT-BJ; BJ1
DR   BTO; BTO_0003807
DR   CLO; CLO_0001980
DR   EFO; EFO_0002779
DR   AddexBio; P0012005/4972
DR   ATCC; CRL-2522
DR   BioGRID_ORCS_Cell_line; 1125
DR   Cell_Model_Passport; SIDM01891
DR   ChEMBL-Cells; CHEMBL3307781
DR   ChEMBL-Targets; CHEMBL614358
DR   CLS; 305222
DR   ENCODE; ENCBS070WLP
DR   ENCODE; ENCBS074ENC
DR   ENCODE; ENCBS137RRI
DR   ENCODE; ENCBS170GUW
DR   ENCODE; ENCBS198NMJ
DR   ENCODE; ENCBS335XLL
DR   ENCODE; ENCBS339MSO
DR   ENCODE; ENCBS488ZLU
DR   ENCODE; ENCBS610AAA
DR   ENCODE; ENCBS611AAA
DR   ENCODE; ENCBS612AAA
DR   ENCODE; ENCBS613AAA
DR   ENCODE; ENCBS614AAA
DR   ENCODE; ENCBS615AAA
DR   ENCODE; ENCBS616AAA
DR   ENCODE; ENCBS628EGC
DR   ENCODE; ENCBS683XYV
DR   ENCODE; ENCBS693PNC
DR   ENCODE; ENCBS753AAA
DR   ENCODE; ENCBS754AAA
DR   ENCODE; ENCBS772THG
DR   ENCODE; ENCBS815JWZ
DR   ENCODE; ENCBS911DVL
DR   ENCODE; ENCBS935PZD
DR   GEO; GSM248213
DR   GEO; GSM248214
DR   GEO; GSM472898
DR   GEO; GSM472924
DR   GEO; GSM472925
DR   GEO; GSM579886
DR   GEO; GSM579887
DR   GEO; GSM736518
DR   GEO; GSM736596
DR   GEO; GSM749677
DR   GEO; GSM749752
DR   GEO; GSM749770
DR   GEO; GSM923444
DR   GEO; GSM945178
DR   GEO; GSM945204
DR   GEO; GSM945207
DR   GEO; GSM945235
DR   GEO; GSM2988896
DR   GEO; GSM7701416
DR   GEO; GSM7701417
DR   Lonza; 723
DR   PubChem_Cell_line; CVCL_3653
DR   SKIP; SKIP001154
DR   TOKU-E; 672
DR   Ubigene; YC-C080
DR   Wikidata; Q54796903
RX   PubMed=12554677;
RX   PubMed=23325432;
RX   PubMed=29444910;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/BJ_Stam_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=67
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Senescence: Senesces at 72 PDL. Has a long lifespan in comparison with other normal human fibroblast cell lines (ATCC=CRL-2522).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2522; CLS=305222; PubMed=29444910
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D18S51: 17,19
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 16,20
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 7,17
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   BJ [Human pancreatic adenocarcinoma]
AC   CVCL_LI18
DR   cancercelllines; CVCL_LI18
DR   Cosmic; 710853
DR   IARC_TP53; 16737
DR   Wikidata; Q54796906
RX   PubMed=11787853;
CC   From: Andren-Sandberg, Ake; Karolinska Institutet; Stockholm; Sweden.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Unspecified (PubMed=11787853).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   BJ epi iPS-C
AC   CVCL_X732
DR   SKIP; SKIP003267
DR   Wikidata; Q54796907
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   BJ hiPSC #11
AC   CVCL_6D12
SY   BJ hiPSC 5 factor #11
DR   SKIP; SKIP000622
DR   Wikidata; Q54796908
RX   PubMed=18786420;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BJ hiPSC #12
AC   CVCL_6D13
SY   BJ hiPSC 5 factor #12
DR   Wikidata; Q54796909
RX   PubMed=18786420;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BJ hiPSC #5
AC   CVCL_6D14
SY   BJ hiPSC 4 factor #5
DR   SKIP; SKIP000623
DR   Wikidata; Q54796910
RX   PubMed=18786420;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BJ hiPSC #8
AC   CVCL_6D15
SY   BJ hiPSC 4 factor #8
DR   Wikidata; Q54796911
RX   PubMed=18786420;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BJ iPSC clone 1
AC   CVCL_A4QM
SY   BJ1
DR   SKIP; SKIP000984
DR   Wikidata; Q105506491
RX   PubMed=27008180;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   BJ iPSC clone 2
AC   CVCL_A4QN
SY   BJ2
DR   SKIP; SKIP000988
DR   Wikidata; Q105506494
RX   PubMed=27008180;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   BJ iPSC clone 3
AC   CVCL_A4QP
SY   BJ3
DR   SKIP; SKIP000989
DR   Wikidata; Q105506499
RX   PubMed=27008180;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   BJ RiPS-A
AC   CVCL_X737
DR   SKIP; SKIP003263
DR   Wikidata; Q54796913
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   BJ RiPS-D
AC   CVCL_X738
DR   SKIP; SKIP003269
DR   Wikidata; Q54796917
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   BJ RiPS-E
AC   CVCL_X739
DR   SKIP; SKIP003261
DR   Wikidata; Q54796918
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   BJ SiPS-C
AC   CVCL_X740
DR   SKIP; SKIP003265
DR   Wikidata; Q54796921
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   BJ SiPS-D
AC   CVCL_X741
SY   HVRDi005-A
DR   BioSamples; SAMEA8325233
DR   hPSCreg; HVRDi005-A
DR   SKIP; SKIP003264
DR   Wikidata; Q54796923
RX   PubMed=28178525;
CC   From: Harvard University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 12
//
ID   BJ SiPS-D TH-TdTomato
AC   CVCL_C8FN
SY   TH-TdTomato BJ SiPS Reporter line; BJ-SIPS WT TH
DR   Wikidata; Q123030815
RX   PubMed=31902706;
CC   Population: Caucasian.
CC   Characteristics: Fluorescent (tdTomato) reporter cell line for TH expression. Using CRISPR/Cas9 a P2A-tdTomato construct was introduced in the C-terminal end of TH (PubMed=31902706).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X741 ! BJ SiPS-D
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 3
//
ID   BJ SiPS-D TH-TdTomato ATP10B KO clone #1
AC   CVCL_E3SX
SY   TH-TdTomato BJ SiPS ATP10B KO clone #1
RX   DOI=10.1101/2024.07.09.602700;
CC   Population: Caucasian.
CC   Characteristics: Fluorescent (tdTomato) reporter cell line for TH expression. Using CRISPR/Cas9 a P2A-tdTomato construct was introduced in the C-terminal end of TH (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13543; ATP10B.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8FN ! BJ SiPS-D TH-TdTomato
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BJ SiPS-D TH-TdTomato ATP10B KO clone #4
AC   CVCL_E3SY
SY   TH-TdTomato BJ SiPS ATP10B KO clone #4
RX   DOI=10.1101/2024.07.09.602700;
CC   Population: Caucasian.
CC   Characteristics: Fluorescent (tdTomato) reporter cell line for TH expression. Using CRISPR/Cas9 a P2A-tdTomato construct was introduced in the C-terminal end of TH (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13543; ATP10B.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8FN ! BJ SiPS-D TH-TdTomato
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BJ SiPS-D TH-TdTomato DJ1 HET KO
AC   CVCL_D5YD
DR   Wikidata; Q127380339
RX   PubMed=38200091;
CC   Population: Caucasian.
CC   Characteristics: Fluorescent (tdTomato) reporter cell line for TH expression. Using CRISPR/Cas9 a P2A-tdTomato construct was introduced in the C-terminal end of TH (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7 (Note=1 of 2 alleles).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8FN ! BJ SiPS-D TH-TdTomato
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BJ SiPS-D TH-TdTomato DJ1 HOM KO
AC   CVCL_D5YE
DR   Wikidata; Q127380340
RX   PubMed=38200091;
CC   Population: Caucasian.
CC   Characteristics: Fluorescent (tdTomato) reporter cell line for TH expression. Using CRISPR/Cas9 a P2A-tdTomato construct was introduced in the C-terminal end of TH (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8FN ! BJ SiPS-D TH-TdTomato
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   BJ-610
AC   CVCL_6F02
SY   BJ/610
DR   Wikidata; Q54796926
RX   PubMed=1328042;
CC   Transformant: NCBI_TaxID; 35252; Alcelaphine herpesvirus 1.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   BJ-RiPS-1.1
AC   CVCL_C922
SY   BJ_RiPS_1.1; BJ-RiPS1.1
DR   GEO; GSM579907
DR   SKIP; SKIP000674
DR   SKIP; SKIP003270
DR   Wikidata; Q54796927
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   BJ-RiPS-1.2
AC   CVCL_C923
SY   BJ_RiPS_1.2; BJ-RiPS1.2
DR   GEO; GSM579908
DR   SKIP; SKIP000675
DR   SKIP; SKIP003262
DR   Wikidata; Q54796928
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   BJ-TERT
AC   CVCL_C8QN
SY   BJ-EL; BJ EL; EL
DR   EFO; EFO_0007749
DR   Wikidata; Q123030816
RX   PubMed=18355723;
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=18355723).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   BJ-TERT/LT/ST
AC   CVCL_C8QP
SY   BJeH; BJ-EH; BJ EH; EH
DR   CLO; CLO_0037213
DR   EFO; EFO_0007748
DR   GEO; GSM7701461
DR   GEO; GSM7701463
DR   Wikidata; Q123030818
RX   PubMed=18355723;
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=18355723).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03081; Simian virus 40 (SV40) small T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QN ! BJ-TERT
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   BJ-TERT/LT/ST/RASV12
AC   CVCL_C8QQ
SY   BJeLR; BJ-ELR; BJ ELR; ELR
DR   CLO; CLO_0037212
DR   EFO; EFO_0007750
DR   GEO; GSM7701462
DR   GEO; GSM7701465
DR   Wikidata; Q123030819
RX   PubMed=18355723;
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Characteristics: Tumorigenic in nude mice (PubMed=18355723).
CC   Doubling time: 15 hours (PubMed=18355723).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03081; Simian virus 40 (SV40) small T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QP ! BJ-TERT/LT/ST
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   BJ-RiPS-1.3
AC   CVCL_C924
SY   BJ_RiPS_1.3; BJ-RiPS1.3
DR   GEO; GSM579909
DR   SKIP; SKIP000676
DR   SKIP; SKIP003258
DR   Wikidata; Q54796964
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   BJ0003
AC   CVCL_8S87
DR   ECACC; 91090501
DR   Wikidata; Q54796966
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BJ1-hTERT
AC   CVCL_6573
AS   CVCL_3654
SY   hTERT-BJ1; HTERT-BJ1; hTERT-BJ; hTERT BJ; BJ hTERT; BJ1; BJ-1; BJ-5ta; BJ-tert; BJhTERT; BJHTERT
DR   CLO; CLO_0001981
DR   ATCC; CRL-4001
DR   BioSample; SAMN03472773
DR   cancercelllines; CVCL_6573
DR   Cell_Model_Passport; SIDM01927
DR   ChEMBL-Cells; CHEMBL4295443
DR   ChEMBL-Targets; CHEMBL4296512
DR   DepMap; ACH-001018
DR   GEO; GSM7701460
DR   GEO; GSM7701464
DR   PharmacoDB; BJhTERT_101_2019
DR   Progenetix; CVCL_6573
DR   PubChem_Cell_line; CVCL_6573
DR   Wikidata; Q54796970
RX   PubMed=9454332;
RX   PubMed=10655550;
RX   PubMed=24119401;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/number-of-population-doublings-pdl-for-atcc-crl-4001
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/BJ-5ta_Struhl_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 36 hours (PubMed=25984343).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0.29%; Native American=0.6%; East Asian, North=1.01%; East Asian, South=0%; South Asian=0.05%; European, North=73.33%; European, South=24.72% (PubMed=30894373).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-4001; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,17
ST   D12S391: 15,23
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D18S51: 17,19
ST   D19S433: 14
ST   D1S1656: 12,16
ST   D21S11: 29
ST   D22S1045: 11,15
ST   D2S1338: 16,20
ST   D2S441: 11
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   DYS391: 10
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 7,17
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   BJ1-iPS1
AC   CVCL_C921
SY   BJ1-IPS1
DR   GEO; GSM248215
DR   Wikidata; Q54796971
RX   PubMed=18157115;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   BJ1-iPS3
AC   CVCL_V235
DR   Wikidata; Q54796973
RX   PubMed=18157115;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   BJAB
AC   CVCL_5711
SY   BJAb; BJA-B; BJAB-1; BJA-B1; BJA-B-1
DR   BTO; BTO_0001931
DR   EFO; EFO_0002815
DR   AddexBio; C0003016/4884
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 741
DR   BioSample; SAMN03470800
DR   cancercelllines; CVCL_5711
DR   CGH-DB; 9192-4
DR   ChEMBL-Cells; CHEMBL3308492
DR   ChEMBL-Targets; CHEMBL613536
DR   CLS; 302006
DR   Cosmic; 998715
DR   Cosmic; 1019312
DR   Cosmic; 1037700
DR   Cosmic; 1086323
DR   Cosmic; 1127265
DR   Cosmic; 1517659
DR   Cosmic; 1588562
DR   Cosmic; 1945179
DR   DSMZ; ACC-757
DR   DSMZCellDive; ACC-757
DR   EGA; EGAS00001000610
DR   GEO; GSM33155
DR   GEO; GSM710427
DR   GEO; GSM710443
DR   GEO; GSM1059805
DR   GEO; GSM3150240
DR   IARC_TP53; 699
DR   Lonza; 107
DR   PharmacoDB; BJAB_102_2019
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_5711
DR   PubChem_Cell_line; CVCL_5711
DR   TOKU-E; 3575
DR   Wikidata; Q50348210
RX   PubMed=62724;
RX   PubMed=171663;
RX   PubMed=175026;
RX   PubMed=179629;
RX   PubMed=1915267;
RX   PubMed=3495441;
RX   PubMed=3518877;
RX   PubMed=4369887;
RX   PubMed=6231253;
RX   PubMed=6245632;
RX   PubMed=6286763;
RX   PubMed=6600440;
RX   PubMed=7316467;
RX   PubMed=8344493;
RX   PubMed=8515068;
RX   PubMed=8558920;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=20054396;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26787899;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30165192;
RX   PubMed=31160637;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-73.html
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: African; Kenyan.
CC   Virology: EBV-negative. Even so that the original tumor tissue was infected with the B95-8 strain of EBV.
CC   Doubling time: ~22 hours (PubMed=179629); ~40-60 hours (DSMZ=ACC-757).
CC   HLA typing: A*01:01,02:01; B*13:02,35:01; C*04:01,06:02 (PubMed=26589293).
CC   HLA typing: A*01:02:83,02:01:01; B*13:02:01,35:01:01; C*04:01:01,06:02:01; DPB1*04:02:01G; DQA1*01:02:01,05:05:01; DQB1*03:01,06:04:01; DRB1*12:01:01,13:02:01 (CLS=302006).
CC   HLA typing: A*02:01:01,02:01:01; B*13:02:01,35:01:01; C*04:01:01,06:02:01; DPA1*01:03:01,01:03:01; DPB1*105:01,105:01; DQB1*03:01:01,06:09:01; DRA*01:01:01,01:02:02; DRB1*12:01:01,13:02:01 (DSMZCellDive=ACC-757).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-CLTC (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=1915267; PubMed=8344493).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302006; DSMZ=ACC-757; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 9,11
ST   D16S539: 9,11 (DSMZ=ACC-757; PubMed=25877200; Technion Genomics Center)
ST   D16S539: 9,12 (CLS=302006)
ST   D18S51: 16,21.2 (DSMZ=ACC-757)
ST   D18S51: 16,22 (PubMed=25877200; Technion Genomics Center)
ST   D19S433: 12,14
ST   D21S11: 27,28
ST   D2S1338: 21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 14,15 (CLS=302006; DSMZ=ACC-757; Technion Genomics Center)
ST   D8S1179: 15 (PubMed=25877200)
ST   FGA: 27 (DSMZ=ACC-757)
ST   FGA: 27,28 (PubMed=25877200; Technion Genomics Center)
ST   Penta D: 10,11
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 6,9
ST   vWA: 14,15 (CLS=302006; DSMZ=ACC-757; Technion Genomics Center)
ST   vWA: 14,16 (PubMed=25877200)
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   BJAB GFP-CD20
AC   CVCL_VD92
DR   cancercelllines; CVCL_VD92
DR   Kerafast; EUC018
DR   Wikidata; Q54796978
RX   PubMed=14976189;
RX   PubMed=23874341;
CC   Population: African; Kenyan.
CC   Characteristics: Expresses GFP fused to the N-terminus of MS4A1/CD20.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7315; MS4A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   BJAB GFP-MS4A4A
AC   CVCL_VD93
SY   BJAB MS4A4A-GFP
DR   cancercelllines; CVCL_VD93
DR   Wikidata; Q54796979
RX   PubMed=23874341;
RX   PubMed=28303902;
CC   Population: African; Kenyan.
CC   Characteristics: Expresses GFP fused to the N-terminus of MS4A4A/CD20L1 (PubMed=23874341).
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13371; MS4A4A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   BJAB GFP-MS4A6A
AC   CVCL_VD94
DR   cancercelllines; CVCL_VD94
DR   Wikidata; Q54796981
RX   PubMed=23874341;
CC   Population: African; Kenyan.
CC   Characteristics: Expresses GFP fused to the N-terminus of MS4A6A/CD20L3 (PubMed=23874341).
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13375; MS4A6A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   BJAB GFP-MS4A7
AC   CVCL_VD95
DR   cancercelllines; CVCL_VD95
DR   Wikidata; Q54796983
RX   PubMed=23874341;
CC   Population: African; Kenyan.
CC   Characteristics: Expresses GFP fused to the N-terminus of MS4A7/CD20L4 (PubMed=23874341).
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13378; MS4A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   BJAB GFP-MS4A8B
AC   CVCL_VD96
DR   cancercelllines; CVCL_VD96
DR   Kerafast; EUC016
DR   Wikidata; Q54796984
RX   PubMed=23874341;
CC   Population: African; Kenyan.
CC   Characteristics: Expresses GFP fused to the N-terminus of MS4A8 (PubMed=23874341).
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13380; MS4A8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   BJAB HA-MS4A4A
AC   CVCL_VE00
DR   cancercelllines; CVCL_VE00
DR   Kerafast; EUC014
DR   Wikidata; Q54796986
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13371; MS4A4A (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   BJAB HA-MS4A8B
AC   CVCL_VE01
DR   cancercelllines; CVCL_VE01
DR   Kerafast; EUC017
DR   Wikidata; Q54796989
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13380; MS4A8 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   BJAB K5 Cys23
AC   CVCL_F1JT
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Cys30Ala, p.Cys32Ala, p.His40Ala and p.Cys43Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 DE1
AC   CVCL_F1JU
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Glu178Ala, p.Asp179Ala and p.Glu182Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 DE12
AC   CVCL_F1JV
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Glu178Ala, p.Asp179Ala and p.Glu182Ala, p.Asp194Ala, p.Glu195Val, p.Glu196Ala and p.Asp199Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 DE2
AC   CVCL_F1JW
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Asp194Ala, p.Glu195Val, p.Glu196Ala and p.Asp199Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 N/A
AC   CVCL_F1JX
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Asn160Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 P/A
AC   CVCL_F1JY
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Pro167Ala, p.Arg169Ala, p.Pro171Ala and p.Pro174Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 R/A
AC   CVCL_F1JZ
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Arg162Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 T/A
AC   CVCL_F1K0
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Thr161Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 V/A
AC   CVCL_F1K1
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Val163Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 WT
AC   CVCL_F1K2
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 Y/A
AC   CVCL_F1K3
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Tyr156Ala and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB K5 Y/F
AC   CVCL_F1K4
RX   PubMed=17409151;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Tyr156Phe and a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BJAB-B95.8.6
AC   CVCL_B6UM
DR   cancercelllines; CVCL_B6UM
DR   Wikidata; Q111732959
RX   PubMed=2995242;
RX   PubMed=3872842;
RX   PubMed=8449221;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8.
CC   Karyotypic information: 45,XX,-8,3q+,7p+,8q+,10p+,11p+,inv(13) (PubMed=2995242).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   BJAB-K20
AC   CVCL_IZ94
SY   BJAB K20; BJA-B K20; K20
DR   cancercelllines; CVCL_IZ94
DR   Wikidata; Q54796991
RX   PubMed=10334995;
RX   PubMed=10336988;
RX   PubMed=22944676;
CC   Population: African; Kenyan.
CC   Characteristics: Lacks UDP-GlcNAc 2-epimerase activity.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Omics: Glycomics; N-glycan profiling.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   BJAB-K3
AC   CVCL_9876
SY   BJAB/K3; BJABK3
DR   EFO; EFO_0001090
DR   cancercelllines; CVCL_9876
DR   Wikidata; Q54796993
RX   PubMed=8627226;
RX   PubMed=17166914;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   BJAB-K43
AC   CVCL_IZ95
SY   BJAB K43; BJA-B K43; K43
DR   cancercelllines; CVCL_IZ95
DR   Wikidata; Q54796994
RX   PubMed=10334995;
RX   PubMed=10336988;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   BJAB-K5
AC   CVCL_9666
SY   BJAB/K5
DR   cancercelllines; CVCL_9666
DR   Wikidata; Q54796996
RX   PubMed=17166914;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   BJAB-K6
AC   CVCL_IZ96
SY   BJAB K6; BJA-B K6; K6
DR   cancercelllines; CVCL_IZ96
DR   Wikidata; Q54796997
RX   PubMed=10334995;
RX   PubMed=10336988;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   BJAB-K88
AC   CVCL_IZ97
SY   BJAB K88; BJA-B K88; K88
DR   cancercelllines; CVCL_IZ97
DR   Wikidata; Q54797000
RX   PubMed=10334995;
RX   PubMed=10336988;
RX   PubMed=22944676;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Omics: Glycomics; N-glycan profiling.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   BJAB-L-YFP
AC   CVCL_YY30
SY   B-L-YFP; BJAB-YFP-LANA-Flag
DR   cancercelllines; CVCL_YY30
DR   Kerafast; ENR001
DR   Wikidata; Q98125572
RX   PubMed=29416688;
CC   Population: African; Kenyan.
CC   Characteristics: Transduced with a pLVx-AcYFP-C1-LANA-FLAG construct.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QR71; Human herpesvirus 8 type P (isolate GK18) LANA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 13
//
ID   BJAB-YFP
AC   CVCL_YY31
SY   B-YFP; BJAB-YFP-Flag
DR   cancercelllines; CVCL_YY31
DR   Kerafast; ENR002
DR   Wikidata; Q98125574
RX   PubMed=29416688;
CC   Population: African; Kenyan.
CC   Characteristics: Transduced with a pLVx-AcYFP-C1-FLAG construct.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   BJAB/ADR
AC   CVCL_VC38
DR   cancercelllines; CVCL_VC38
DR   Wikidata; Q54797001
RX   DOI=10.3760/cma.j.issn.1009-9921.2014.03.005;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   BJAB-HR1K
AC   CVCL_B6UK
SY   BJAB/HR1K
DR   cancercelllines; CVCL_B6UK
DR   Wikidata; Q111732960
RX   PubMed=62724;
RX   PubMed=175026;
RX   PubMed=191406;
RX   PubMed=196397;
RX   PubMed=8449221;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (PubMed=175026).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   BJAB-HR1K-A5
AC   CVCL_E4B1
SY   BJAB-HR1K clone A5; A5
RX   PubMed=191406;
RX   PubMed=196397;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UK ! BJAB-HR1K
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BJAB-HR1K-A7
AC   CVCL_E4B2
SY   BJAB-HR1K clone A7; A7
RX   PubMed=191406;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UK ! BJAB-HR1K
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BJAB-HR1K-B1
AC   CVCL_E4AZ
SY   BJAB-HR1K clone B1; B1
RX   PubMed=191406;
RX   PubMed=196397;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UK ! BJAB-HR1K
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BJAB-HR1K-B1-19
AC   CVCL_E4B0
SY   BJAB-HR1K clone B1 subclone 19; B1-19
RX   PubMed=191406;
RX   PubMed=196397;
RX   PubMed=6245632;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4AZ ! BJAB-HR1K-B1
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BJAB-HR1K-B1-28
AC   CVCL_E4B3
SY   BJAB-HR1K clone B1 subclone 28; B1-28
RX   PubMed=191406;
RX   PubMed=196397;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676).
CC   Virology: EBNA-negative (PubMed=191406; PubMed=196397).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4AZ ! BJAB-HR1K-B1
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BJC
AC   CVCL_0G92
DR   SKIP; SKIP000561
DR   Wikidata; Q54797003
RX   PubMed=23283491;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BJD
AC   CVCL_0G93
DR   SKIP; SKIP000562
DR   Wikidata; Q54797005
RX   PubMed=23283491;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BJFF.6
AC   CVCL_VU02
SY   BJFF6
DR   Wikidata; Q93427174
RX   PubMed=30099335;
RX   PubMed=37712227;
WW   Info; -; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Parental_Cell_Line/RID=Q-2D6W
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=37712227
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D18S51: 17,19
ST   D19S433: 16
ST   D21S11: 29
ST   D2S1338: 16,20
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 9,11
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 7,17
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   BJMC338
AC   CVCL_6574
DR   Wikidata; Q54797006
RX   PubMed=22295235;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6575 ! BJMC3879
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 7
//
ID   BJMC3879
AC   CVCL_6575
DR   Lonza; 108
DR   Wikidata; Q54797009
RX   PubMed=22295235;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6574 ! BJMC338
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   BJMUe003-A
AC   CVCL_C795
SY   B4
DR   hPSCreg; BJMUe003-A
DR   SKIP; SKIP002292
DR   Wikidata; Q54797010
RX   PubMed=16143641;
CC   From: Peking University Third Hospital; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   BJMUe004-A
AC   CVCL_C796
SY   B7
DR   hPSCreg; BJMUe004-A
DR   SKIP; SKIP002293
DR   Wikidata; Q54797014
RX   PubMed=16143641;
CC   From: Peking University Third Hospital; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   BJNhem19
AC   CVCL_B842
SY   BJNhem 19; BJN hem19; JNCASRe001-A; JNCSRe001-A
DR   hPSCreg; JNCSRe001-A
DR   NIHhESC; NIHhESC-10-0083
DR   SKIP; SKIP001963
DR   Wikidata; Q54797016
RX   PubMed=18616385;
RX   PubMed=20178003;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/bjnhem19.aspx
CC   From: Jawaharlal Nehru Centre for Advanced Scientific Research; Jakkur; India.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0083.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-022, Steering comm. appl. SCSC07-43(1).
CC   Population: Indian.
CC   Donor information: Embryo is sibling to that giving rise to BJNhem20 (Cellosaurus=CVCL_B843).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   BJNhem20
AC   CVCL_B843
SY   BJNhem 20; BJN hem20; JNCASRe002-A; JNCSRe002-A
DR   BioSamples; SAMEA110751861
DR   hPSCreg; JNCSRe002-A
DR   NIHhESC; NIHhESC-10-0084
DR   SKIP; SKIP001964
DR   Wikidata; Q54797017
RX   PubMed=18616385;
RX   PubMed=20178003;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/bjnhem20.aspx
CC   From: Jawaharlal Nehru Centre for Advanced Scientific Research; Jakkur; India.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0084.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-021, Steering comm. appl. SCSC07-43(2).
CC   Population: Indian.
CC   Donor information: Embryo is sibling to that giving rise to BJNhem19 (Cellosaurus=CVCL_B842).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   BJNhem20-Asrij
AC   CVCL_DQ71
DR   Wikidata; Q54797019
RX   PubMed=27345997;
CC   Population: Indian.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1915345; Ociad1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 6
//
ID   BJNhem20-OCIAD1-CRISPR-20
AC   CVCL_9S74
DR   Wikidata; Q54797020
RX   PubMed=27345969;
CC   Population: Indian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16074; OCIAD1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   BJNhem20-OCIAD1-CRISPR-39
AC   CVCL_DQ69
DR   Wikidata; Q54797021
RX   PubMed=27345991;
CC   Population: Indian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16074; OCIAD1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   BJNhem20-OCIAD1-OV
AC   CVCL_AB54
DR   Wikidata; Q54797023
RX   PubMed=27345812;
CC   Population: Indian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16074; OCIAD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BJNhem20-OCIAD1-Tet-On
AC   CVCL_DQ66
DR   Wikidata; Q54797024
RX   PubMed=27345976;
CC   Population: Indian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16074; OCIAD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   BJNhem20-OCIAD2-CRISPR-33
AC   CVCL_C6Q6
SY   JNCSRe002-A-1
DR   BioSamples; SAMEA110751570
DR   hPSCreg; JNCSRe002-A-1
DR   Wikidata; Q117704217
RX   PubMed=36642056;
CC   Population: Indian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28685; OCIAD2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   BJNhem20-OCIAD2-CRISPR-40
AC   CVCL_C6Q7
SY   JNCSRe002-A-2
DR   BioSamples; SAMEA110751863
DR   hPSCreg; JNCSRe002-A-2
DR   Wikidata; Q117704218
RX   PubMed=36642056;
CC   Population: Indian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28685; OCIAD2 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   BJNhem20-OCIAD2-OV
AC   CVCL_C6Q8
SY   BJNhem20 OCIAD2-OV; JNCSRe002-A-3
DR   BioSamples; SAMEA111441033
DR   hPSCreg; JNCSRe002-A-3
DR   Wikidata; Q117704219
RX   PubMed=36640474;
CC   Population: Indian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28685; OCIAD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   BJNhem20-pCAG-EGFP
AC   CVCL_DQ70
SY   BJNhem20 pCAG-EGFP
DR   Wikidata; Q54797027
RX   PubMed=27345992;
CC   Population: Indian.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   BJNhem20-pCAG-tdTomato
AC   CVCL_DQ68
DR   Wikidata; Q54797029
RX   PubMed=27345986;
CC   Population: Indian.
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   BJNhem20-TetR
AC   CVCL_DQ67
DR   Wikidata; Q54797030
RX   PubMed=27345981;
CC   Population: Indian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   BJO,PA
AC   CVCL_E484
SY   BJO, PA
DR   dbMHC; 48500
DR   IHW; IHW09116
DR   IPD-IMGT/HLA; 11661
DR   Wikidata; Q54797032
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02; B*35,60; C*04:01; DPB1*03:01; DQA1*03,04:01; DQB1*03:01,04:02; DRB1*04:07,08:01; DRB4*01:01 (IPD-IMGT/HLA=11661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BJTTHi001-A-1
AC   CVCL_A8HB
DR   BioSamples; SAMEA8359795
DR   hPSCreg; BJTTHi001-A-1
DR   Wikidata; Q107113466
RX   PubMed=34247112;
CC   From: Beijing Tiantan Hospital; Beijing; China.
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10585; SCN1A.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HA ! RC01001-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BJTTHi001-A-2
AC   CVCL_A8HC
DR   BioSamples; SAMEA8359796
DR   hPSCreg; BJTTHi001-A-2
DR   Wikidata; Q107113467
RX   PubMed=34583279;
CC   From: Beijing Tiantan Hospital; Beijing; China.
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10586; SCN1B.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HA ! RC01001-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   BJTTHi001-A-3
AC   CVCL_C1SQ
DR   BioSamples; SAMEA14449092
DR   hPSCreg; BJTTHi001-A-3
DR   Wikidata; Q114310754
CC   From: Beijing Tiantan Hospital; Beijing; China.
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6220; KCNA2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HA ! RC01001-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   BJTTHi001-A-4
AC   CVCL_C1SR
DR   BioSamples; SAMEA14449443
DR   hPSCreg; BJTTHi001-A-4
DR   Wikidata; Q114310755
RX   PubMed=38547667;
CC   From: Beijing Tiantan Hospital; Beijing; China.
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6251; KCNH2 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HA ! RC01001-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   BJTTHi001-A-5
AC   CVCL_C1SS
DR   BioSamples; SAMEA14449444
DR   hPSCreg; BJTTHi001-A-5
DR   Wikidata; Q114310756
RX   PubMed=35961105;
CC   From: Beijing Tiantan Hospital; Beijing; China.
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HA ! RC01001-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   BJTTHi003-A
AC   CVCL_C9ME
SY   CARASIL WHN1C2
DR   BioSamples; SAMEA113557091
DR   hPSCreg; BJTTHi003-A
DR   Wikidata; Q123030820
CC   From: Beijing Tiantan Hospital; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:9476; HTRA1; Simple; p.Pro285Leu (c.854C>T); ClinVar=VCV000156100; Zygosity=Heterozygous (hPSCreg=BJTTHi003-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202018; Autosomal recessive cerebral arteriopathy with subcortical infarcts and leukoencephalopathy
DI   ORDO; Orphanet_199354; Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   BJTTHi004-A
AC   CVCL_E4FP
DR   hPSCreg; BJTTHi004-A
CC   From: Beijing Tiantan Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BK-10
AC   CVCL_S718
SY   BK 10; BK10
DR   SKY/M-FISH/CGH; 1465
DR   Wikidata; Q54797034
RX   PubMed=9719413;
RX   PubMed=10221340;
CC   Doubling time: 44.9 hours (Note=In PEC medium), 30.48 hours (Note=In F medium) (PubMed=9719413).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   BK-T
AC   CVCL_0C07
DR   Cosmic; 2239083
DR   Wikidata; Q54797037
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Doubling time: 51.2 hours (PubMed=1311980).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   BK0013
AC   CVCL_GZ15
DR   ECACC; 98100924
DR   Wikidata; Q54797039
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98100924; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3407; Essential thrombocythemia
DI   ORDO; Orphanet_3318; Essential thrombocythemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   BK0015
AC   CVCL_8S88
DR   ECACC; 99092421
DR   Wikidata; Q54797041
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99092421; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3407; Essential thrombocythemia
DI   ORDO; Orphanet_3318; Essential thrombocythemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BKD
AC   CVCL_M571
DR   Wikidata; Q54797086
RX   PubMed=2423498;
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
CC   Derived from site: In situ; Thoracic cavity; UBERON=UBERON_0002224.
CC   Breed/subspecies: Mixed breed.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 7
//
ID   bKEC
AC   CVCL_A2SZ
SY   bat Kidney Epithelial Cells; PKDCL; Pipistrellus nathusii Kidney Diploid Cell Line
DR   Wikidata; Q105506502
RX   PubMed=33105852;
RX   PubMed=33683063;
CC   Group: Bat cell line.
CC   Characteristics: Susceptible to infection by Listeria monocytogenes strain EGDe (PubMed=33105852).
CC   Virology: Susceptible to infection by bluetongue virus (BTV); Rift Valley fever virus (RVFV) and lumpy skin disease (LSDV) (PubMed=33683063).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=59473; ! Pipistrellus nathusii (Nathusius' pipistrelle)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 7
//
ID   BKO84
AC   CVCL_K035
DR   Wikidata; Q54797088
RX   PubMed=16794253;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96878; Blnk.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   BKP1
AC   CVCL_1K06
DR   Wikidata; Q54797089
RX   PubMed=25314094;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 7
//
ID   BKT1
AC   CVCL_YZ67
SY   Bat Kidney Transformed 1
DR   Wikidata; Q98125575
RX   DOI=10.14943/doctoral.k12177;
RX   PubMed=18258142;
RX   PubMed=24131711;
RX   PubMed=26605499;
RX   PubMed=30718752;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=59479; ! Rhinolophus ferrumequinum (Greater horseshoe bat)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   BKZ-1
AC   CVCL_A2WM
SY   BKZ1; Bethel Kaltschmidt Zelllinie-1
DR   DSMZCellDive; ACC-877
DR   Wikidata; Q105506506
RX   PubMed=31804333;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 28,32.2
ST   D2S1338: 18,23
ST   D3S1358: 16,19
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 11,13
ST   Penta E: 12,17
ST   TH01: 6,10
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C45550; Lung typical carcinoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 7
//
ID   BKZ-2
AC   CVCL_A2FV
SY   Bethel Kaltschmidt Zelllinie-2
DR   Wikidata; Q105506509
RX   PubMed=32927768;
CC   Population: Caucasian.
CC   Characteristics: Contains subpopulations with potential stem-like properties. Forms spheres under serum-free conditions and supplementation with heparin (PubMed=32927768).
CC   Doubling time: 40.12 +- 1.56 hours (PubMed=32927768).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C135213; Rectal neuroendocrine tumor
DI   ORDO; Orphanet_100081; Neuroendocrine tumor of the rectum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   BKZ-3
AC   CVCL_A2FW
SY   Bethel Kaltschmidt Zelllinie-3
DR   Wikidata; Q105506511
RX   PubMed=32927768;
CC   Population: Caucasian.
CC   Characteristics: Contains subpopulations with potential stem-like properties. Forms spheres under serum-free conditions and supplementation with heparin (PubMed=32927768).
CC   Doubling time: 21.88 +- 1.19 hours (PubMed=32927768).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   BL
AC   CVCL_U802
SY   BLmel; BL mel
DR   cancercelllines; CVCL_U802
DR   Cosmic; 888987
DR   Cosmic; 897737
DR   Cosmic; 928724
DR   GEO; GSM170823
DR   Wikidata; Q54797091
RX   PubMed=1697409;
RX   PubMed=9331097;
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=15688405;
RX   PubMed=17516929;
RX   PubMed=19383913;
RX   PubMed=22383533;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu88Lys (c.262G>A); ClinVar=VCV000821566; Zygosity=Unspecified (PubMed=9354451).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   BL-10
AC   CVCL_C131
SY   BL10; BL 10; IARC/BL10; IARC/BL 10; IARC-BL10; IARC BL10; IARC BL 10
DR   Cosmic; 931116
DR   Wikidata; Q54797092
RX   PubMed=3934070;
RX   PubMed=6286514;
RX   PubMed=6825067;
RX   PubMed=9473234;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C143 ! BL-31
OI   CVCL_VQ18 ! IARC-113
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   BL-100
AC   CVCL_1965
DR   BioSample; SAMN03473437
DR   DSMZ; ACC-684
DR   DSMZCellDive; ACC-684
DR   Wikidata; Q54797093
CC   Virology: EBV-negative.
CC   Doubling time: ~50 hours (DSMZ=ACC-684).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-684
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 9,13
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 9,13
ST   FGA: 19,22
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   BL-103
AC   CVCL_ZJ22
SY   BL103; BL 103; IARC/BL103; IARC-BL103; IARC BL103; IARC BL 103
DR   Wikidata; Q98125576
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ27 ! IARC-594
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
ID   BL-104
AC   CVCL_IU51
SY   BL104; BL 104; IARC/BL104; IARC-BL104; IARC BL104; IARC BL 104
DR   Wikidata; Q54797096
RX   PubMed=2052620;
RX   PubMed=3035497;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV18 ! IARC-629
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   BL-106
AC   CVCL_D4A7
SY   BL106; BL 106; IARC/BL106; IARC-BL106; IARC BL106; IARC BL 106
DR   Wikidata; Q127380341
RX   PubMed=7519050;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=7519050).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   BL-108
AC   CVCL_IV12
SY   BL108; BL 108; IARC/BL108; IARC-BL108; IARC BL108; IARC BL 108
DR   Wikidata; Q54797098
RX   PubMed=1356511;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU64 ! IARC-602
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   BL-113
AC   CVCL_C132
SY   BL113; BL 113; IARC/BL113; IARC-BL113; IARC BL113; IARC BL 113
DR   cancercelllines; CVCL_C132
DR   Cosmic; 1517662
DR   IARC_TP53; 135
DR   Wikidata; Q54797099
RX   PubMed=1356511;
RX   PubMed=2052620;
RX   PubMed=10997876;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=2052620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV07 ! IARC-632
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   BL-116
AC   CVCL_C133
SY   BL116; BL 116; IARC/BL116; IARC-BL116; IARC BL116; IARC BL 116
DR   Wikidata; Q54797100
RX   PubMed=1356511;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ28 ! IARC-661
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 10
//
ID   BL-12
AC   CVCL_M640
SY   BL12; BL 12; IARC/BL12; IARC/BL 12; CIARC-BL12; IARC BL12; IARC BL 12
DR   cancercelllines; CVCL_M640
DR   Cosmic; 2804858
DR   Wikidata; Q54797102
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6825067;
RX   PubMed=8108117;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Thr73Ile (c.218C>T); ClinVar=VCV000376300; Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Indicated as originating from a male patient in PubMed=3027441 and PubMed=3934070 and from a female patient in PubMed=6825067.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   BL-121
AC   CVCL_C160
SY   BL121; BL 121; IARC/BL121; IARC-BL121; IARC BL121; IARC BL 121
DR   Wikidata; Q54797103
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   BL-123
AC   CVCL_ZJ23
SY   BL123; BL 123; IARC/BL123; IARC-BL123; IARC BL123; IARC BL 123
DR   Wikidata; Q98125578
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ26 ! IARC-693
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   BL-125
AC   CVCL_C161
SY   BL125; BL 125; IARC/BL125; IARC-BL125; IARC BL125; IARC BL 125
DR   Wikidata; Q54797105
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   BL-126
AC   CVCL_C134
SY   BL126; BL 126; IARC/BL126; IARC-BL126; IARC BL126; IARC BL 126
DR   Wikidata; Q54797106
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 9
//
ID   BL-13
AC   CVCL_C135
SY   BL13; BL 13; IARC/BL13; IARC-BL13; IARC BL13; IARC BL 13
DR   Wikidata; Q54797109
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 9
//
ID   BL-135
AC   CVCL_IV13
SY   BL135; BL 135; IARC/BL135; IARC-BL135; IARC BL135; IARC BL 135
DR   Wikidata; Q54797110
RX   PubMed=1356511;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU65 ! IARC-822
OI   CVCL_ZJ29 ! IARC-837
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   BL-136
AC   CVCL_C136
SY   BL136; BL 136; IARC/BL136; IARC-BL136; IARC BL136; IARC BL 136
DR   Wikidata; Q54797112
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 9
//
ID   BL-137
AC   CVCL_ZU69
SY   BL137; BL 137; IARC/BL137; IARC-BL137; IARC BL137; IARC BL 137
DR   Wikidata; Q98125579
RX   PubMed=8382295;
RX   PubMed=14982850;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Virology: Contains an integrated EBV genome and also from 5 to 10 episomal copies of EBV (PubMed=8382295).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
ID   BL-14
AC   CVCL_M558
SY   BL14; BL 14; IARC/BL14; IARC/BL 14; IARC-BL14; IARC BL14; IARC BL 14
DR   Wikidata; Q54797113
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6806672;
RX   PubMed=6825067;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Turkish.
CC   Virology: EBV-negative.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6806672).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ50 ! IARC-070
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   BL-14B
AC   CVCL_ZI23
SY   BL14B; BL 14B; BL 014B; IARC/BL14B; IARC/BL 14B; IARC-BL14B; IARC BL14B; IARC BL 14B
DR   Wikidata; Q98125584
RX   PubMed=3026973;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Turkish.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M558 ! BL-14
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 6
//
ID   BL-16
AC   CVCL_C137
SY   BL16; BL 16; BL 016; IARC/BL16; IARC/BL 16; IARC-BL16; IARC BL16; IARC-BL-16; IARC BL 16; GM08686; GM17348
DR   CLO; CLO_0010619
DR   CLO; CLO_0013749
DR   BioSample; SAMN00798132
DR   Coriell; GM08686
DR   Coriell; GM17348
DR   Cosmic; 931117
DR   Wikidata; Q54797116
RX   CelloPub=CLPUB00447;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6231253;
RX   PubMed=6592381;
RX   PubMed=6825067;
RX   PubMed=9473234;
RX   PubMed=11793449;
RX   PubMed=24590883;
CC   Part of: Human variation panel.
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Africans south of the Sahara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW33 ! IARC-100
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 19
//
ID   BL-17
AC   CVCL_C138
SY   BL17; BL 17; IARC/BL17; IARC/BL 17; IARC-BL17; IARC BL17; IARC BL 17
DR   Wikidata; Q54797118
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6592381;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M555 ! BL-7
OI   CVCL_M639 ! BL-21
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
ID   BL-18
AC   CVCL_C139
SY   BL18; BL 18; IARC/BL18; IARC/BL 18; IARC-BL18; IARC BL18; IARC-BL-18; IARC BL 18; GM08687; GM17384
DR   CLO; CLO_0010612
DR   CLO; CLO_0012171
DR   BioSample; SAMN00798134
DR   Coriell; GM08687
DR   Coriell; GM17384
DR   Cosmic; 931096
DR   Cosmic; 2804859
DR   Wikidata; Q54797119
RX   CelloPub=CLPUB00447;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3004968;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6231253;
RX   PubMed=6825067;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=24590883;
CC   Part of: Human variation panel.
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Thr73Ala (c.217A>G); Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ19 ! IARC-099
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   BL-2
AC   CVCL_1966
SY   BL2; BL 2; BL 02; BL02; BL 002; IARC/BL2; IARC/BL 02; IARC-BL2; IARC BL2; IARC-BL-2; IARC BL 2
DR   BTO; BTO_0002748
DR   EFO; EFO_0005475
DR   BioSample; SAMN03473506
DR   Cosmic; 931095
DR   Cosmic; 2814531
DR   DepMap; ACH-001449
DR   DSMZ; ACC-625
DR   DSMZCellDive; ACC-625
DR   Lonza; 110
DR   Wikidata; Q54797121
RX   PubMed=1356511;
RX   PubMed=1915267;
RX   PubMed=2052620;
RX   PubMed=2825176;
RX   PubMed=3004968;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6286514;
RX   PubMed=6592381;
RX   PubMed=6806672;
RX   PubMed=6825067;
RX   PubMed=8896424;
RX   PubMed=9473234;
RX   PubMed=11793449;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25960936;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Virology: EBV-negative.
CC   Doubling time: ~24 hours (DSMZ=ACC-625).
CC   HLA typing: A*24:02,24:02; B*08:01,39:06; C*07:02,07:02; DQA1*01:01,05:01; DQB1*02:01,06:02; DRB1*03:01,14:01 (PubMed=25960936).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=6806672).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-625
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,21
ST   D19S433: 12,15
ST   D21S11: 29,31
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 9,15
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV28 ! IARC-304
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   BL-21
AC   CVCL_M639
SY   BL21; BL 21; IARC/BL21; IARC/BL 21; IARC-BL21; IARC BL21; IARC BL 21
DR   Cosmic; 2804865
DR   Wikidata; Q54797123
RX   PubMed=2470097;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6441706;
RX   PubMed=6592381;
RX   PubMed=6806672;
RX   PubMed=8108117;
RX   PubMed=22120970;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5715; IGK + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGK (PubMed=6441706; PubMed=6806672; PubMed=22120970).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M555 ! BL-7
OI   CVCL_C138 ! BL-17
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   BL-22
AC   CVCL_C140
SY   BL22; BL 22; IARC/BL22; IARC/BL 22; IARC-BL22; IARC BL22; IARC BL 22
DR   Wikidata; Q54797126
RX   PubMed=3027441;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ20 ! IARC-373
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 12
//
ID   BL-28
AC   CVCL_M567
SY   BL28; BL 28; IARC/BL28; IARC/BL 28; IARC-BL28; IARC BL28; IARC BL 28
DR   Cosmic; 931097
DR   NCBI_Iran; C103
DR   Wikidata; Q54797128
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3037521;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6231253;
RX   PubMed=6286514;
RX   PubMed=6806672;
RX   PubMed=6825067;
RX   PubMed=9473234;
RX   PubMed=17254797;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   HLA typing: A*01; B*08,16 (PubMed=3037521).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6806672).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D21S11: 29,31
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 23,25
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C142 ! BL-30
OI   CVCL_C144 ! BL-32
OI   CVCL_IV21 ! IARC-139
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 22
//
ID   BL-29
AC   CVCL_C141
SY   BL29; BL 29; BL 029; IARC/BL29; IARC/BL 29; IARC-BL29; IARC BL29; IARC-BL-29; IARC BL 29
DR   Cosmic; 931118
DR   DSMZ; ACC-950
DR   Wikidata; Q54797130
RX   PubMed=1356511;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6231253;
RX   PubMed=6806672;
RX   PubMed=6825067;
RX   PubMed=9473234;
RX   PubMed=11793449;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Doubling time: ~24 hours (DSMZ=ACC-950).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6806672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-950
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,14
ST   D18S51: 15,16
ST   D19S433: 12,13
ST   D21S11: 30,32.2
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 7,11
ST   D7S820: 9,12
ST   D8S1179: 10,12
ST   FGA: 19,20
ST   Penta D: 11
ST   Penta E: 15,17
ST   TH01: 9,10
ST   TPOX: 11,12
ST   vWA: 15,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ21 ! IARC-167
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   BL-3 [Bovine leukemia]
AC   CVCL_3454
SY   BL3; BL-1
DR   BTO; BTO_0004404
DR   CLO; CLO_0001985
DR   EFO; EFO_0022727
DR   CLDB; cl458
DR   ATCC; CRL-8037
DR   ECACC; 86062401
DR   Lonza; 111
DR   Wikidata; Q54797132
RX   Patent=US4323555;
RX   PubMed=1461683;
RX   PubMed=4171552;
RX   PubMed=7989438;
RX   PubMed=16441438;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8037.
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   BL-3 [Human Burkitt lymphoma]
AC   CVCL_M562
SY   BL3; BL 3; BL03; IARC/BL3; IARC/BL 03; IARC-BL3; IARC BL3; IARC BL 3
DR   Wikidata; Q54797135
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6286514;
RX   PubMed=6806672;
RX   PubMed=6825067;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6806672).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   BL-30
AC   CVCL_C142
SY   BL30; BL 30; BL 030; IARC/BL30; IARC/BL 30; IARC-BL30; IARC BL30; IARC BL 30
DR   cancercelllines; CVCL_C142
DR   Cosmic; 2814532
DR   DSMZ; ACC-916
DR   DSMZCellDive; ACC-916
DR   IARC_TP53; 701
DR   Wikidata; Q54797136
RX   PubMed=1356511;
RX   PubMed=1915267;
RX   PubMed=2825176;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6231253;
RX   PubMed=8515068;
RX   PubMed=8896424;
RX   PubMed=9973220;
RX   PubMed=11793449;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25960936;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: 15-24 hours (Note=Depending on cell density) (DSMZ=ACC-916).
CC   HLA typing: A*01:01,11:01; B*08:01,39:01; C*02:02,07:01; DQA1*01:03,05:01; DQB1*02:01,06:03; DRB1*03:01,13:01 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Thr (c.737T>C); ClinVar=VCV000428886; Zygosity=Unspecified (PubMed=1915267).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-916
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 19,24
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 23,25
ST   Penta D: 8,9
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M567 ! BL-28
OI   CVCL_C144 ! BL-32
OI   CVCL_IV21 ! IARC-139
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   BL-31
AC   CVCL_C143
SY   BL31; BL 31; BL 031; IARC/BL31; IARC/BL 31; IARC-BL31; IARC BL31; IARC-BL-31; IARC BL 31
DR   DSMZ; ACC-951
DR   Wikidata; Q54797138
RX   PubMed=2825176;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6231253;
RX   PubMed=6806672;
RX   PubMed=11793449;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6806672).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-951
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11,14
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 7,9
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 15,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C131 ! BL-10
OI   CVCL_VQ18 ! IARC-113
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   BL-32
AC   CVCL_C144
SY   BL32; BL 32; IARC/BL32; IARC/BL 32; IARC-BL32; IARC BL32; IARC BL 32
DR   Wikidata; Q54797139
RX   PubMed=3934070;
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M567 ! BL-28
OI   CVCL_C142 ! BL-30
OI   CVCL_IV21 ! IARC-139
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   BL-33
AC   CVCL_M557
SY   BL33; BL 33; IARC/BL33; IARC/BL 33; IARC-BL33; IARC BL33; IARC BL 33
DR   DSMZ; ACC-952
DR   Wikidata; Q54797140
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6806672;
RX   PubMed=6825067;
RX   PubMed=7519050;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: ~24 hours (DSMZ=ACC-952).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=6806672; PubMed=7519050).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-952
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 15,16
ST   D5S818: 7,12
ST   D7S820: 9,11
ST   D8S1179: 13,16
ST   FGA: 19,21
ST   Penta D: 14,17
ST   Penta E: 7,10
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,18
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   BL-35
AC   CVCL_C145
SY   BL35; BL 35; IARC/BL35; IARC/BL 35; IARC-BL35; IARC BL35; IARC BL 35
DR   Wikidata; Q54797144
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6825067;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   BL-36
AC   CVCL_C146
SY   BL36; BL 36; BL 036; IARC/BL36; IARC/BL 36; IARC-BL36; IARC BL36; IARC BL 36
DR   Cosmic; 931098
DR   DSMZ; ACC-917
DR   DSMZCellDive; ACC-917
DR   Wikidata; Q54797147
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6231253;
RX   PubMed=6592381;
RX   PubMed=8382295;
RX   PubMed=9473234;
RX   PubMed=11793449;
RX   PubMed=11983026;
RX   PubMed=25787276;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Virology: Contains a complete EBV genome (strain BL36) which has been sequenced (PubMed=25787276). Contains from 5 to 10 episomal copies of EBV (PubMed=8382295).
CC   Doubling time: ~24 hours (DSMZ=ACC-917).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw; UBERON=UBERON_0001708.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-917
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29.2,33.2
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 3,11
ST   Penta E: 13,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M641 ! BL-42
OI   CVCL_M565 ! BL-43
OI   CVCL_M566 ! BL-44
OI   CVCL_IV23 ! IARC-174
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 19
//
ID   BL-37
AC   CVCL_C147
SY   BL37; BL 37; BL 037; IARC/BL37; IARC/BL 37; IARC-BL37; IARC BL37; IARC BL 37
DR   cancercelllines; CVCL_C147
DR   Cosmic; 931119
DR   Cosmic; 2804866
DR   DSMZ; ACC-918
DR   DSMZCellDive; ACC-918
DR   IARC_TP53; 136
DR   Wikidata; Q54797148
RX   PubMed=1915267;
RX   PubMed=2052620;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3934070;
RX   PubMed=6087353;
RX   PubMed=6090749;
RX   PubMed=6422306;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=11793449;
RX   PubMed=25787276;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Virology: Contains a complete EBV genome (strain BL37) which has been sequenced (PubMed=25787276).
CC   Doubling time: ~50-60 hours (DSMZ=ACC-918).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=6422306).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (PubMed=1915267; PubMed=2052620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-918
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 9,18
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 19,24
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 6,15
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ32 ! BL-39
OI   CVCL_IV05 ! IARC-176A
OI   CVCL_A2XI ! IARC-176B
OI   CVCL_VQ22 ! IARC-303A
OI   CVCL_A2XH ! IARC-303B
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   BL-38
AC   CVCL_C148
SY   BL38; BL 38; IARC/BL38; IARC/BL 38; IARC-BL38; IARC BL38; IARC BL 38
DR   Wikidata; Q54797150
RX   PubMed=1356511;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ23 ! IARC-431
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   BL-39
AC   CVCL_VQ32
SY   BL39; BL 39; IARC/BL39; IARC/BL 39; IARC-BL39; IARC BL39; IARC BL 39
DR   Wikidata; Q93427472
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C147 ! BL-37
OI   CVCL_IV05 ! IARC-176A
OI   CVCL_A2XI ! IARC-176B
OI   CVCL_VQ22 ! IARC-303A
OI   CVCL_A2XH ! IARC-303B
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 6
//
ID   BL-40
AC   CVCL_C149
SY   BL40; BL 40; BL 040; IARC/BL40; IARC/BL 40; IARC-BL40; IARC BL40; IARC BL 40
DR   NCBI_Iran; C104
DR   Wikidata; Q54797153
RX   PubMed=1915267;
RX   PubMed=2825176;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=11793449;
RX   PubMed=17254797;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 13,14
ST   D21S11: 29,32
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,17
ST   FGA: 20,22
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM48 ! IARC-211
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 17
//
ID   BL-41
AC   CVCL_1087
SY   BL41; BL 41; BL 041; IARC/BL41; IARC/BL 41; IARC-BL41; IARC BL41; IARC-BL-41; IARC BL 41
DR   BTO; BTO_0003854
DR   CLO; CLO_0001987
DR   EFO; EFO_0022580
DR   CLDB; cl459
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473420
DR   BioSample; SAMN10987706
DR   cancercelllines; CVCL_1087
DR   Cell_Model_Passport; SIDM00985
DR   ChEMBL-Cells; CHEMBL3308526
DR   ChEMBL-Targets; CHEMBL2366173
DR   Cosmic; 910706
DR   Cosmic; 931099
DR   Cosmic; 991550
DR   Cosmic; 1086324
DR   Cosmic; 1818339
DR   Cosmic; 2297031
DR   Cosmic; 2361383
DR   Cosmic; 2814533
DR   Cosmic-CLP; 910706
DR   DepMap; ACH-000245
DR   DSMZ; ACC-160
DR   DSMZCellDive; ACC-160
DR   EGA; EGAS00001000978
DR   GDSC; 910706
DR   GEO; GSM119535
DR   GEO; GSM862863
DR   GEO; GSM862864
DR   GEO; GSM862865
DR   GEO; GSM862866
DR   GEO; GSM886889
DR   GEO; GSM887954
DR   GEO; GSM1669625
DR   GEO; GSM3150241
DR   IARC_TP53; 700
DR   IARC_TP53; 21194
DR   LiGeA; CCLE_122
DR   LINCS_LDP; LCL-2028
DR   NCBI_Iran; C493
DR   PharmacoDB; BL41_103_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1087
DR   PubChem_Cell_line; CVCL_1087
DR   Wikidata; Q54797155
RX   PubMed=1915267;
RX   PubMed=2645221;
RX   PubMed=2825176;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3037521;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
RX   PubMed=8547074;
RX   PubMed=8558920;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9973220;
RX   PubMed=11793449;
RX   PubMed=16960149;
RX   PubMed=19358282;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25355872;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: ~30 hours (DSMZ=ACC-160).
CC   HLA typing: A*11:01,32:01; B*35:01,49:01; C*04:01,07:01; DQA1*01:01,01:01; DQB1*05:03,05:03; DRB1*01:01,14:01 (PubMed=25960936).
CC   HLA typing: A*32:01,32:01; B*35:01,49:01; C*04:01,07:06; DQA1*01:01,01:01; DQB1*05:03,05:03; DRB1*01:01,14:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=1915267).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0.06%; East Asian, North=0%; East Asian, South=0.52%; South Asian=1.34%; European, North=57.31%; European, South=40.71% (PubMed=30894373).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Cosmic-CLP=910706; DSMZ=ACC-160
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10,11,14 (DSMZ=ACC-160)
ST   CSF1PO: 10,11 (Cosmic-CLP=910706)
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 15,19
ST   D19S433: 14,16
ST   D21S11: 31.2
ST   D2S1338: 17,21
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 24
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 7,8
ST   vWA: 14,18
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV22 ! IARC-171
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   BL-41/95
AC   CVCL_C5V2
SY   BL41/95
DR   Wikidata; Q116048603
RX   PubMed=2645221;
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*11,32; B*35,49 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   BL-42
AC   CVCL_M641
SY   BL42; BL 42; IARC/BL42; IARC/BL 42; IARC-BL42; IARC BL42; IARC BL 42
DR   Wikidata; Q54797158
RX   PubMed=1395095;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6231253;
RX   PubMed=6592381;
RX   PubMed=9685479;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C146 ! BL-36
OI   CVCL_M565 ! BL-43
OI   CVCL_M566 ! BL-44
OI   CVCL_IV23 ! IARC-174
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
ID   BL-43
AC   CVCL_M565
SY   BL43; BL 43; IARC/BL43; IARC/BL 43; IARC-BL43; IARC BL43; IARC BL 43
DR   Wikidata; Q54797161
RX   PubMed=3934070;
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C146 ! BL-36
OI   CVCL_M641 ! BL-42
OI   CVCL_M566 ! BL-44
OI   CVCL_IV23 ! IARC-174
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   BL-44
AC   CVCL_M566
SY   BL44; BL 44; IARC/BL44; IARC/BL 44; IARC-BL44; IARC BL44; IARC BL 44
DR   Wikidata; Q54797198
RX   PubMed=1356511;
RX   PubMed=2985508;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6231253;
RX   PubMed=6592381;
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C146 ! BL-36
OI   CVCL_M641 ! BL-42
OI   CVCL_M565 ! BL-43
OI   CVCL_IV23 ! IARC-174
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 15
//
ID   BL-45
AC   CVCL_M642
SY   BL45; BL 45; IARC/BL45; IARC/BL 45; IARC-BL45; IARC BL45; IARC BL 45
DR   Wikidata; Q54797200
RX   PubMed=3027441;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C151 ! BL-53
OI   CVCL_VQ24 ! IARC-464
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   BL-46
AC   CVCL_M559
SY   BL46; BL 46; IARC/BL46; IARC/BL 46; IARC-BL46; IARC BL46; IARC BL 46
DR   Wikidata; Q54797201
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ25 ! IARC-207
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
ID   BL-47
AC   CVCL_M643
SY   BL47; BL 47; BL 047; IARC/BL47; IARC/BL 47; IARC-BL47; IARC BL47; IARC BL 47
DR   Wikidata; Q54797205
RX   PubMed=2052620;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3934070;
RX   PubMed=6231253;
RX   PubMed=10997876;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV09 ! IARC-151
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   BL-48
AC   CVCL_M644
SY   BL48; BL 48; IARC/BL48; IARC/BL 48; IARC-BL48; IARC BL48; IARC BL 48
DR   Wikidata; Q54797207
RX   PubMed=3027441;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   BL-49
AC   CVCL_C150
SY   BL49; BL 49; BL 049; IARC/BL49; IARC/BL 49; IARC-BL49; IARC BL49; IARC-BL-49; IARC BL 49
DR   cancercelllines; CVCL_C150
DR   Cosmic; 931120
DR   IARC_TP53; 139
DR   Wikidata; Q54797208
RX   PubMed=2052620;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6592381;
RX   PubMed=9473234;
RX   PubMed=11793449;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Unspecified (PubMed=2052620).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=2052620).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV15 ! BL-50
OI   CVCL_VQ26 ! IARC-208
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   BL-5
AC   CVCL_M563
SY   BL5; BL 5; BL05; IARC/BL5; IARC/BL 05; IARC-BL5; IARC BL5; IARC BL 5
DR   Wikidata; Q54797210
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6825067;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   BL-50
AC   CVCL_IV15
SY   BL50; BL 50; IARC/BL50; IARC/BL 50; IARC-BL50; IARC BL50; IARC BL 50
DR   Wikidata; Q54797213
RX   PubMed=3035497;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C150 ! BL-49
OI   CVCL_VQ26 ! IARC-208
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   BL-52
AC   CVCL_VQ33
SY   BL52; BL 52; IARC/BL52; IARC/BL 52; IARC-BL52; IARC BL52; IARC BL 52
DR   Wikidata; Q93427566
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 6
//
ID   BL-53
AC   CVCL_C151
SY   BL53; BL 53; IARC/BL53; IARC/BL 53; IARC-BL53; IARC BL53; IARC BL 53
DR   Wikidata; Q54797215
RX   PubMed=1356511;
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=19358282;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M642 ! BL-45
OI   CVCL_VQ24 ! IARC-464
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   BL-54
AC   CVCL_M645
SY   BL54; BL 54; BL 054; IARC/BL54; IARC/BL 54; IARC-BL54; IARC BL54; IARC BL 54
DR   Wikidata; Q54797217
RX   PubMed=2985508;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6087353;
RX   PubMed=6592381;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M568 ! BL-59
OI   CVCL_IV19 ! IARC-247
OI   CVCL_VQ48 ! IARC-293
OI   CVCL_VQ49 ! IARC-470
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
ID   BL-55
AC   CVCL_VQ30
SY   BL55; BL 55; BL 055/B95; IARC/BL55; IARC/BL 55; IARC-BL55; IARC BL55; IARC BL 55
DR   Wikidata; Q93427584
RX   PubMed=3934070;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C152 ! BL-57
OI   CVCL_VQ31 ! IARC-205A
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 7
//
ID   BL-56
AC   CVCL_VQ37
SY   BL56; BL 56; IARC/BL56; IARC/BL 56; IARC-BL56; IARC BL56; IARC BL 56
DR   Wikidata; Q93427587
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 6
//
ID   BL-57
AC   CVCL_C152
SY   BL57; BL 57; IARC/BL57; IARC/BL 57; IARC-BL57; IARC BL57; IARC BL 57
DR   Cosmic; 931121
DR   Wikidata; Q54797219
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=9473234;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ30 ! BL-55
OI   CVCL_VQ31 ! IARC-205A
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   BL-58
AC   CVCL_C153
SY   BL58; BL 58; IARC/BL58; IARC/BL 58; IARC-BL58; IARC BL58; IARC BL 58
DR   Cosmic; 2814534
DR   Wikidata; Q54797220
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=22885699;
RX   PubMed=25960936;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   HLA typing: A*03:01,03:01; B*15:10,15:10; C*04:01,04:01; DQA1*05:01,05:01; DQB1*02:01,02:01; DRB1*03:01,14:46 (PubMed=25960936).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   BL-59
AC   CVCL_M568
SY   BL59; BL 59; IARC/BL59; IARC/BL 59; IARC-BL59; IARC BL59; IARC-BL-59; IARC BL 59
DR   Wikidata; Q54797223
RX   PubMed=2985508;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6087353;
RX   PubMed=6592381;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M645 ! BL-54
OI   CVCL_IV19 ! IARC-247
OI   CVCL_VQ48 ! IARC-293
OI   CVCL_VQ49 ! IARC-470
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   BL-6
AC   CVCL_M564
SY   BL6; BL 6; BL06; IARC/BL6; IARC/BL 06; IARC-BL6; IARC BL6; IARC BL 6
DR   Wikidata; Q54797224
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6825067;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Africans north of the Sahara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   BL-60
AC   CVCL_7034
SY   BL60; BL 60; BL 060; IARC/BL60; IARC/BL 60; IARC-BL60; IARC BL60; IARC BL 60
DR   BTO; BTO_0001934
DR   EFO; EFO_0022349
DR   cancercelllines; CVCL_7034
DR   Cosmic; 931100
DR   DSMZ; ACC-953
DR   IARC_TP53; 137
DR   Wikidata; Q54797225
RX   PubMed=1356511;
RX   PubMed=1945409;
RX   PubMed=2052620;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3934070;
RX   PubMed=6087353;
RX   PubMed=7519050;
RX   PubMed=8382295;
RX   PubMed=9473234;
RX   PubMed=10997876;
RX   PubMed=11793449;
RX   PubMed=19358282;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Virology: Contains an integrated EBV genome (PubMed=8382295).
CC   Doubling time: ~48 hours (DSMZ=ACC-953).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=1945409; PubMed=7519050).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=2052620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw; UBERON=UBERON_0001708.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-953
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D18S51: 11,12
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 24,26
ST   Penta D: 11,13
ST   Penta E: 11,13
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV17 ! IARC-261
OI   CVCL_IV06 ! IARC-277
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   BL-61
AC   CVCL_M556
SY   BL61; BL 61; BL 061; IARC/BL61; IARC/BL 61; IARC-BL61; IARC BL61; IARC BL 61
DR   Wikidata; Q54797229
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Africans north of the Sahara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C155 ! BL-64
OI   CVCL_IV10 ! IARC-549
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   BL-62
AC   CVCL_C162
SY   BL62; BL 62; IARC/BL62; IARC/BL 62; IARC-BL62; IARC BL62; IARC BL 62
DR   Wikidata; Q54797230
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Africans north of the Sahara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   BL-63
AC   CVCL_C154
SY   BL63; BL 63; IARC/BL63; IARC/BL 63; IARC-BL63; IARC BL63; IARC BL 63
DR   Wikidata; Q54797232
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ34 ! BL-68
OI   CVCL_M560 ! BL-69
OI   CVCL_1088 ! BL-70
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   BL-64
AC   CVCL_C155
SY   BL64; BL 64; IARC/BL64; IARC/BL 64; IARC-BL64; IARC BL64; IARC BL 64
DR   Cosmic; 2361384
DR   DSMZ; ACC-919
DR   DSMZCellDive; ACC-919
DR   Wikidata; Q54797235
RX   PubMed=2470097;
RX   PubMed=3458667;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6592381;
RX   PubMed=8547074;
RX   PubMed=10997876;
RX   PubMed=22120970;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Africans north of the Sahara.
CC   Doubling time: ~30-50 hours (DSMZ=ACC-919).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5715; IGK + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGK (PubMed=3458667; PubMed=22120970).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-919
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 12,15
ST   D21S11: 29,32.2
ST   D2S1338: 18,24
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 24
ST   Penta D: 10,14
ST   Penta E: 10,11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M556 ! BL-61
OI   CVCL_IV10 ! IARC-549
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 24
//
ID   BL-65
AC   CVCL_C163
SY   BL65; BL 65; BL-065; IARC/BL65; IARC/BL 65; IARC-BL65; IARC BL65; IARC BL 65
DR   DSMZ; ACC-920
DR   DSMZCellDive; ACC-920
DR   Wikidata; Q54797236
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-920
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 29,32.2
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23,26
ST   Penta D: 13,14
ST   Penta E: 7,17
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ46 ! IARC-305
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   BL-66
AC   CVCL_VQ35
SY   BL66; BL 66; IARC/BL66; IARC/BL 66; IARC-BL66; IARC BL66; IARC BL 66
DR   Wikidata; Q93427714
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ47 ! IARC-308
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 7
//
ID   BL-67
AC   CVCL_C156
SY   BL67; BL 67; BL 067; IARC/BL67; IARC/BL 67; IARC-BL67; IARC BL67; IARC BL 67
DR   Cosmic; 931122
DR   Cosmic; 2804862
DR   DSMZ; ACC-921
DR   DSMZCellDive; ACC-921
DR   Wikidata; Q54797238
RX   PubMed=1620543;
RX   PubMed=3004968;
RX   PubMed=3934070;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=11793449;
RX   PubMed=18647998;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Doubling time: ~10-25 hours (DSMZ=ACC-921).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Pro75Ser (c.223C>T); Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-921
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 12,20
ST   D19S433: 12,16
ST   D21S11: 27,28
ST   D2S1338: 17,23
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DZ ! BL-78
OI   CVCL_IV27 ! IARC-309
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   BL-68
AC   CVCL_VQ34
SY   BL68; BL 68; IARC/BL68; IARC/BL 68; IARC-BL68; IARC BL68; IARC BL 68
DR   Wikidata; Q93427725
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C154 ! BL-63
OI   CVCL_M560 ! BL-69
OI   CVCL_1088 ! BL-70
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 8
//
ID   BL-69
AC   CVCL_M560
SY   BL69; BL 69; IARC/BL69; IARC/BL 69; IARC-BL69; IARC BL69; IARC BL 69
DR   Wikidata; Q54797240
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6592381;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C154 ! BL-63
OI   CVCL_VQ34 ! BL-68
OI   CVCL_1088 ! BL-70
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
ID   BL-7
AC   CVCL_M555
SY   BL7; BL 7; BL07; IARC/BL7; IARC/BL 07; IARC-BL7; IARC BL7; IARC BL 7
DR   Wikidata; Q54797241
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6286514;
RX   PubMed=6592381;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C138 ! BL-17
OI   CVCL_M639 ! BL-21
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   BL-70
AC   CVCL_1088
SY   BL70; BL 70; IARC/BL70; IARC/BL 70; IARC-BL70; IARC BL70; IARC BL 70
DR   BTO; BTO_0003855
DR   CLO; CLO_0001988
DR   CLDB; cl460
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473383
DR   BioSample; SAMN10988162
DR   cancercelllines; CVCL_1088
DR   Cell_Model_Passport; SIDM00074
DR   ChEMBL-Cells; CHEMBL3308185
DR   ChEMBL-Targets; CHEMBL2366317
DR   Cosmic; 910707
DR   Cosmic; 2814535
DR   Cosmic-CLP; 910707
DR   DepMap; ACH-000402
DR   DSMZ; ACC-233
DR   DSMZCellDive; ACC-233
DR   GDSC; 910707
DR   GEO; GSM886890
DR   GEO; GSM887955
DR   IARC_TP53; 21195
DR   LiGeA; CCLE_204
DR   LINCS_LDP; LCL-2016
DR   PharmacoDB; BL70_104_2019
DR   Progenetix; CVCL_1088
DR   PubChem_Cell_line; CVCL_1088
DR   Wikidata; Q54797245
RX   PubMed=2825176;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25355872;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: ~44 hours (DSMZ=ACC-233).
CC   HLA typing: A*26:01,32:01; B*49:01,51:01; C*07:01,14:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*13:01,15:01 (PubMed=25960936).
CC   HLA typing: A*26:01,32:01; B*49:01,51:01; C*07:01,14:02; DQA1*01:02,01:02; DQB1*06:11,06:11; DRB1*13:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (Cosmic-CLP=910707).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.11%; Native American=1.03%; East Asian, North=0.85%; East Asian, South=0%; South Asian=1.04%; European, North=52.49%; European, South=42.5% (PubMed=30894373).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Cosmic-CLP=910707; DSMZ=ACC-233
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 13,16
ST   D19S433: 16
ST   D21S11: 30,34.2
ST   D2S1338: 21,23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 21,24
ST   Penta D: 11
ST   Penta E: 14,15
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C154 ! BL-63
OI   CVCL_VQ34 ! BL-68
OI   CVCL_M560 ! BL-69
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   BL-71
AC   CVCL_VQ36
SY   BL71; BL 71; IARC/BL71; IARC/BL 71; IARC-BL71; IARC BL71; IARC BL 71
DR   Wikidata; Q93427750
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 6
//
ID   BL-72
AC   CVCL_C157
SY   BL72; BL 72; BL 072; IARC/BL72; IARC/BL 72; IARC-BL72; IARC BL72; IARC BL 72
DR   cancercelllines; CVCL_C157
DR   Cosmic; 931114
DR   Cosmic; 2804860
DR   Wikidata; Q54797246
RX   PubMed=2985508;
RX   PubMed=3037521;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   HLA typing: A*11,28; B*27,45 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Thr73Ile (c.218C>T); ClinVar=VCV000376300; Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV24 ! IARC-307
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   BL-73
AC   CVCL_C164
SY   BL73; BL 73; IARC/BL73; IARC/BL 73; IARC-BL73; IARC BL73; IARC BL 73
DR   Wikidata; Q54797249
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 10
//
ID   BL-74
AC   CVCL_C158
SY   BL74; BL 74; BL 074; IARC/BL74; IARC/BL 74; IARC-BL74; IARC BL74; IARC BL 74
DR   DSMZ; ACC-922
DR   DSMZCellDive; ACC-922
DR   Wikidata; Q54797250
RX   PubMed=1356511;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=10997876;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Doubling time: ~45 hours (DSMZ=ACC-922).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-922
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D16S539: 8,13
ST   D18S51: 12,15
ST   D19S433: 13,17
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 13,16
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 19,20
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9BR ! IARC-290A
OI   CVCL_IV08 ! IARC-290B
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   BL-75
AC   CVCL_C1JI
SY   BL75; BL 75; BL 075; IARC/BL75; IARC-BL75; IARC BL75; IARC BL 75
DR   Wikidata; Q114310757
RX   PubMed=3905596;
RX   PubMed=6592381;
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 4
//
ID   BL-76
AC   CVCL_C1JJ
SY   BL76; BL 76; BL 076; IARC/BL76; IARC-BL76; IARC BL76; IARC BL 76
DR   Wikidata; Q114310758
RX   PubMed=3905596;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   BL-78
AC   CVCL_A1DZ
SY   BL78; BL 78; BL 078; IARC/BL78; IARC-BL78; IARC BL78; IARC BL 78
DR   cancercelllines; CVCL_A1DZ
DR   Cosmic; 2804861
DR   Wikidata; Q102113626
RX   PubMed=6592381;
RX   PubMed=8108117;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Thr73Ile (c.218C>T); ClinVar=VCV000376300; Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C156 ! BL-67
OI   CVCL_IV27 ! IARC-309
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   BL-79
AC   CVCL_C165
SY   BL79; BL 79; BL 079; IARC/BL79; IARC-BL79; IARC BL79; IARC BL 79
DR   Wikidata; Q54797254
RX   PubMed=10997876;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV11 ! IARC-385
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 11
//
ID   BL-8
AC   CVCL_M561
SY   BL8; BL 8; BL08; IARC/BL8; IARC/BL 08; IARC-BL8; IARC BL8; IARC BL 8
DR   Wikidata; Q54797256
RX   PubMed=3027441;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6806672;
RX   PubMed=6825067;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   BL-81
AC   CVCL_ZJ24
SY   BL81; BL 81; BL 081; IARC/BL81; IARC-BL81; IARC BL81; IARC BL 81
DR   Wikidata; Q98125585
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ30 ! IARC-370
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   BL-84
AC   CVCL_IU52
SY   BL84; BL 84; BL 084; IARC/BL84; IARC-BL84; IARC BL84; IARC BL 84
DR   Wikidata; Q54797258
RX   PubMed=2052620;
RX   PubMed=3035497;
RX   PubMed=7519050;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=7519050).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ31 ! IARC-443B
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   BL-86
AC   CVCL_ZJ25
SY   BL86; BL 86; BL 086; IARC/BL86; IARC-BL86; IARC BL86; IARC BL 86
DR   Wikidata; Q98125586
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ32 ! IARC-435B
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
ID   BL-89
AC   CVCL_C166
SY   BL89; BL 89; IARC/BL89; IARC-BL89; IARC BL89; IARC BL 89
DR   DSMZ; ACC-954
DR   Wikidata; Q54797260
RX   PubMed=3035497;
RX   PubMed=7519050;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: North African.
CC   Doubling time: ~3 days (DSMZ=ACC-954).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=7519050).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-954
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 23,25
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 21,24
ST   Penta D: 3,11
ST   Penta E: 7,13
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   BL-9
AC   CVCL_N271
SY   BL9; BL 9; BL09; IARC/BL9; IARC/BL 09; IARC-BL9; IARC BL9; IARC BL 9
DR   cancercelllines; CVCL_N271
DR   Cosmic; 2804857
DR   Wikidata; Q54797261
RX   PubMed=3934070;
RX   PubMed=6286514;
RX   PubMed=6825067;
RX   PubMed=8108117;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Thr73Ile (c.218C>T); ClinVar=VCV000376300; Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   BL-90
AC   CVCL_IV16
SY   BL90; BL 90; IARC/BL90; IARC-BL90; IARC BL90; IARC BL 90
DR   Wikidata; Q54797263
RX   PubMed=3035497;
RX   PubMed=7519050;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: North African.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=7519050).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   BL-92
AC   CVCL_ZI24
SY   BL92; BL 92; BL 092; IARC/BL92; IARC-BL92; IARC BL92; IARC BL 92
DR   Wikidata; Q98125587
RX   PubMed=11793449;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ33 ! IARC-503
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
ID   BL-99
AC   CVCL_IU53
SY   BL99; BL 99; IARC/BL99; IARC-BL99; IARC BL99; IARC BL 99
DR   cancercelllines; CVCL_IU53
DR   IARC_TP53; 138
DR   Wikidata; Q54797264
RX   PubMed=2052620;
RX   PubMed=3035497;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=2052620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   BL/6-III
AC   CVCL_Y628
SY   BL/6#3
DR   Wikidata; Q54797266
RX   PubMed=1959560;
RX   PubMed=9353641;
RX   PubMed=17828574;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   BL/RL12-NP
AC   CVCL_XF84
SY   BL/RL 12-NP
DR   Wikidata; Q93427832
RX   PubMed=90660;
RX   PubMed=6290043;
CC   Doubling time: 16 hours (PubMed=6290043).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C57BL/6Ka.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 4
//
ID   BL/VL3
AC   CVCL_XF85
DR   Wikidata; Q93427837
RX   PubMed=90660;
RX   PubMed=1856699;
RX   PubMed=6255478;
RX   PubMed=7730608;
CC   Transformant: NCBI_TaxID; 11787; Radiation murine leukemia virus.
CC   Breed/subspecies: C57BL/6Ka.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 4
//
ID   BL1391
AC   CVCL_A9SX
DR   Wikidata; Q102113628
RX   PubMed=32856169;
CC   Population: Caucasian; Swedish.
CC   Doubling time: ~48 hours (PubMed=32856169).
CC   Karyotypic information: Contains a giant rod-shaped marker (RGM) chromosome composed of high copy number amplifications of regions from chromosomes 1 and 11, arrayed in a complex fashion, with additional 8q sequences at both ends (PubMed=32856169).
CC   Sequence variation: Gene fusion; HGNC; HGNC:29314; CACHD1 + HGNC; HGNC:16262; YAP1; Name(s)=YAP1-CACHD1; Note=In frame (PubMed=32856169).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6974; MDM4 + HGNC; HGNC:29945; TENM4; Name(s)=TENM4-MDM4; Note=In frame (PubMed=32856169).
CC   Omics: Genomics; ChIP-seq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Donor ethnicity from personal communication of Storlazzi, Clelia Tiziana.
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
ST   Source(s): PubMed=32856169
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,15
ST   D12S391: 21,22
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14
ST   D1S1656: 16.3
ST   D21S11: 29,30
ST   D22S1045: 11,15
ST   D2S1338: 17,23
ST   D2S441: 10,13
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 11,14
ST   Penta E: 7,14
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   BL2-5-8
AC   CVCL_A8X0
SY   BL2
DR   RCB; RCB4495
DR   Wikidata; Q102113629
RX   PubMed=15225556;
CC   Characteristics: Transfected with a LexA-hCD2 reporter that consists of 8 tandem copies of a LexA binding element, a minimal promoter from mouse Ifnb and human CD2 (PubMed=15225556).
CC   Doubling time: 12 hours (RCB=RCB4495).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1639; CD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   BL2-8G-E6
AC   CVCL_V067
DR   CLO; CLO_0001984
DR   CLDB; cl461
DR   IHW; 11w 8001
DR   Wikidata; Q54797267
RX   PubMed=1655684;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Misspelling: BL2-8G-E5; PubMed=1655684; Note=In last paragraph.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   BL20
AC   CVCL_L859
SY   BL-20
DR   CLO; CLO_0001983
DR   CLDB; cl457
DR   Wikidata; Q54797269
RX   CelloPub=CLPUB00263;
RX   PubMed=1461683;
RX   PubMed=2421227;
RX   PubMed=2650460;
RX   PubMed=16441438;
RX   PubMed=23840536;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bronchial lymph node; UBERON=UBERON_0016481.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   BL2M3
AC   CVCL_5116
DR   RCB; RCB0422
DR   Wikidata; Q54797271
RX   PubMed=1327182;
RX   PubMed=3033403;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Discontinued: RCB; RCB0422; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   BL3 BM
AC   CVCL_ZC67
SY   BL0003
DR   ATCC; CRL-6026
DR   Wikidata; Q98125588
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6026; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   BL3.1
AC   CVCL_3455
SY   BL-3.1
DR   CLO; CLO_0001986
DR   ATCC; CRL-2306
DR   BCRJ; 0277
DR   Wikidata; Q54797274
RX   PubMed=1345904;
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_3454 ! BL-3 [Bovine leukemia]
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   BL312
AC   CVCL_5117
SY   B312
DR   CLO; CLO_0050969
DR   RCB; RCB0423
DR   Wikidata; Q54797275
RX   PubMed=1327182;
RX   PubMed=3033403;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   BL3M7
AC   CVCL_5118
DR   Wikidata; Q54797311
RX   PubMed=3033403;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   BL407
AC   CVCL_5119
DR   Wikidata; Q54797313
RX   PubMed=3033403;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   BL41-K3
AC   CVCL_9667
SY   BL41/K3; BL41 K3; BL41K3
DR   EFO; EFO_0001091
DR   cancercelllines; CVCL_9667
DR   Wikidata; Q54797314
RX   PubMed=8553575;
RX   PubMed=8627226;
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   BL6T
AC   CVCL_Z859
SY   BL-6T
DR   BTO; BTO_0005611
DR   Wikidata; Q54797316
RX   PubMed=10803709;
CC   Genetic integration: Method=Transfection; Gene=RGD; 67383; Prkcd.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0157 ! B16-BL6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 10
//
ID   BL8
AC   CVCL_HA74
SY   BL8L
DR   Wikidata; Q54797318
RX   PubMed=834282;
RX   PubMed=2867825;
RX   PubMed=2887193;
RX   PubMed=3675628;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   BL8 TA1
AC   CVCL_E3KH
SY   TA1; A1
RX   PubMed=2085791;
RX   PubMed=2867825;
CC   Characteristics: Tumorigenic in mice (PubMed=2867825).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA74 ! BL8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   BL8 TA2
AC   CVCL_E3KI
SY   TA2
RX   PubMed=2867825;
CC   Characteristics: Tumorigenic in mice (PubMed=2867825).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA74 ! BL8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   BL8 TB1
AC   CVCL_E3KJ
SY   TB1
RX   PubMed=2867825;
CC   Characteristics: Tumorigenic in mice (PubMed=2867825).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA74 ! BL8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   BL8 TB2
AC   CVCL_E3KK
SY   TB2
RX   PubMed=2867825;
CC   Characteristics: Tumorigenic in mice (PubMed=2867825).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA74 ! BL8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   BL8 TB3
AC   CVCL_E3KL
SY   TB3
RX   PubMed=2867825;
CC   Characteristics: Tumorigenic in mice (PubMed=2867825).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA74 ! BL8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   BL8 TB4
AC   CVCL_E3KM
SY   TB4
RX   PubMed=2867825;
CC   Characteristics: Tumorigenic in mice (PubMed=2867825).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA74 ! BL8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   BL8 TB5
AC   CVCL_E3KN
SY   TB5
RX   PubMed=2867825;
CC   Characteristics: Tumorigenic in mice (PubMed=2867825).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA74 ! BL8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   BL9
AC   CVCL_E3KF
RX   DOI=10.2520/myco.52.1;
RX   PubMed=2085791;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   BL9AT
AC   CVCL_E3KG
RX   PubMed=2085791;
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3KF ! BL9
SX   Male
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   BLA.3.3B6.3D4
AC   CVCL_B7CS
SY   BLA8
DR   Wikidata; Q112929327
RX   Patent=US9574007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4218.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 4
//
ID   BLAC-20
AC   CVCL_B0F3
SY   BLAC 20; BLAC20; Bovine Leukocyte Adherent Cell line-20
DR   Wikidata; Q108819952
RX   PubMed=1318416;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Leukocyte; CL=CL_0000738.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   Black93
AC   CVCL_T741
SY   Black-93; Black 93; Black-93A; BLACK-93A
DR   CGH-DB; 9193-4
DR   JCRB; JCRB1780
DR   Wikidata; Q54797319
RX   PubMed=8704258;
RX   PubMed=8847894;
RX   PubMed=9454894;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 32.5 hours (PubMed=8847894).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1780
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 9,10
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 16
//
ID   BLaER1
AC   CVCL_VQ57
SY   B cell Leukemia C/EBPalphaER clone 1
DR   EFO; EFO_0030018
DR   Millipore; SCC165
DR   Wikidata; Q93427919
RX   PubMed=23545498;
RX   PubMed=28494875;
CC   Population: Caucasian.
CC   Characteristics: Can efficiently be convert into cells exhibiting increased adherent, phagocytic and quiescent properties with a transcriptome resembling normal macrophages.
CC   Characteristics: Transduced with the retrovirus vector C/EBPaER-GFP which consist of CEBPA fused with the estrogen receptor hormone binding domain and GFP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1833; CEBPA.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Caution: Was originally (PubMed=23545498) described as originating from the Seraphina cell line (Cellosaurus=CVCL_M646) but was later (PubMed=28494875) shown to derive from RCH-ACV.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Millipore=SCC165
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 11
ST   D18S51: 13,16
ST   D21S11: 29,31.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 23,26
ST   Penta D: 8.4,10
ST   Penta E: 7,11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1851 ! RCH-ACV
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 15
//
ID   Blau1-corrected-iPSC
AC   CVCL_A4IS
DR   SKIP; SKIP005531
DR   Wikidata; Q105506517
RX   PubMed=28587749;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple_corrected; p.Arg334Trp (c.1000C>T) (p.Arg307Trp, c.919C>T); ClinVar=VCV000004696; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28587749).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4IQ ! Blau1-R334W-iPSC
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Blau1-R334W-iPSC
AC   CVCL_A4IQ
SY   Blau1E
DR   SKIP; SKIP005530
DR   Wikidata; Q105506520
RX   PubMed=28587749;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple; p.Arg334Trp (c.1000C>T) (p.Arg307Trp, c.919C>T); ClinVar=VCV000004696; Zygosity=Heterozygous (PubMed=28587749).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Blau2-corrected-iPSC
AC   CVCL_A4IT
DR   Wikidata; Q105506524
RX   PubMed=28587749;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple_corrected; p.Arg334Trp (c.1000C>T) (p.Arg307Trp, c.919C>T); ClinVar=VCV000004696; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28587749).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4IR ! Blau2-R334W-iPSC
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Blau2-R334W-iPSC
AC   CVCL_A4IR
SY   Blau2B
DR   Wikidata; Q105506527
RX   PubMed=28587749;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple; p.Arg334Trp (c.1000C>T) (p.Arg307Trp, c.919C>T); ClinVar=VCV000004696; Zygosity=Heterozygous (PubMed=28587749).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   BLC-1
AC   CVCL_0C42
DR   Wikidata; Q54797320
RX   PubMed=18594539;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C52 ! HCC-1.1
OI   CVCL_0C53 ! HCC-1.2
OI   CVCL_0C47 ! MF-1 [Human]
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   BLC-2
AC   CVCL_0C43
DR   Wikidata; Q54797321
RX   PubMed=18594539;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C54 ! HCC-2
OI   CVCL_0C48 ! MF-2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   BLC-4
AC   CVCL_0C44
DR   Wikidata; Q54797324
RX   PubMed=18594539;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C96792; Liver undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   BLC-6
AC   CVCL_0C45
DR   Wikidata; Q54797326
RX   PubMed=18594539;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C51 ! MF-6
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   BLC-7
AC   CVCL_0C46
DR   Wikidata; Q54797327
RX   PubMed=18594539;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   BLCA-30
AC   CVCL_6G46
DR   Wikidata; Q54797330
RX   Patent=US5622836;
RX   PubMed=2685375;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11784.
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   BLCA-38
AC   CVCL_6G47
SY   BLCA38; MIL-38
DR   Wikidata; Q54797332
RX   Patent=US5622836;
RX   PubMed=2685375;
RX   PubMed=27313791;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11785.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35052; Human GPC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   BLCA-8
AC   CVCL_6G45
DR   Wikidata; Q54797329
RX   Patent=US5622836;
RX   PubMed=2685375;
RX   PubMed=8635192;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10406.
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   BLCL-C162
AC   CVCL_SA49
DR   Wikidata; Q54797335
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Discontinued: NHPRR; Catalog number 139.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   BLG-139-3
AC   CVCL_A6ZF
SY   BLG
DR   RCB; RCB4496
DR   Wikidata; Q107113469
RX   PubMed=15225556;
CC   Characteristics: Transfected with a LexA-d1EGFP reporter that consists of 8 tandem copies of a LexA binding element, a minimal promoter from mouse Ifnb and d1EGFP (destabilized EGFP) (PubMed=15225556).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   BlH1
AC   CVCL_B7RB
SY   Blastema Hindlimb 1; B1H1
DR   Wikidata; Q112929328
RX   PubMed=3183586;
RX   PubMed=9415422;
RX   PubMed=10194417;
RX   PubMed=25740486;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Hindlimb, blastema; UBERON=UBERON_0012438.
OX   NCBI_TaxID=8316; ! Notophthalmus viridescens (Eastern newt)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   BLi0001
AC   CVCL_VA58
DR   ECACC; 15102927
DR   Wikidata; Q54797337
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BLi0036
AC   CVCL_VA59
DR   ECACC; 15102928
DR   Wikidata; Q54797339
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BLi0083
AC   CVCL_VA60
DR   ECACC; 15092907
DR   Wikidata; Q54797340
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BLi0097
AC   CVCL_VA61
DR   ECACC; 15102929
DR   Wikidata; Q54797341
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BLi0204
AC   CVCL_VA62
DR   ECACC; 15092908
DR   Wikidata; Q54797344
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   BLi0236
AC   CVCL_VA63
DR   ECACC; 15042416
DR   Wikidata; Q54797345
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BLi0246
AC   CVCL_VA64
DR   ECACC; 15042401
DR   Wikidata; Q54797347
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BLi0249
AC   CVCL_VA65
DR   ECACC; 15042403
DR   Wikidata; Q54797349
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BLi0251
AC   CVCL_VA66
DR   ECACC; 15042404
DR   Wikidata; Q54797351
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BLi0254
AC   CVCL_VA67
DR   ECACC; 15042402
DR   Wikidata; Q54797352
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BLi0265
AC   CVCL_VA68
DR   ECACC; 15042405
DR   Wikidata; Q54797354
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   Bliley
AC   CVCL_DN27
SY   TCC-Bliley
DR   GEO; GSM1974776
DR   Wikidata; Q54797355
RX   PubMed=22849686;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=29732388;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 20 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Heterozygous (PubMed=27197945; PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Shetland Sheepdog; VBO=VBO_0201217.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 227,239
ST   Dog FHC2054: 151
ST   Dog FHC2079: 275
ST   Dog PEZ1: 115,127
ST   Dog PEZ3: 119,124
ST   Dog PEZ5: 103,115
ST   Dog PEZ6: 172,183
ST   Dog PEZ8: 240
ST   Dog PEZ12: 285
ST   Dog PEZ20: 176,180
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   BLIN-1
AC   CVCL_8173
SY   Blin-1; Blin1; B-lineage 1
DR   BioSample; SAMN03151850
DR   cancercelllines; CVCL_8173
DR   Cosmic; 1070705
DR   GEO; GSM3145571
DR   GEO; GSM3145692
DR   Wikidata; Q54797358
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2642502;
RX   PubMed=7919343;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NALM-6 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00170.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV002900866; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 34
//
ID   BLIN-2
AC   CVCL_QW48
SY   BLIN2; B-lineage 2
DR   Wikidata; Q54797359
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9808575;
CC   Characteristics: Requires bone marrow stromal cells or skin fibroblasts for optimal growth.
CC   Doubling time: ~2 days (PubMed=9808575).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   BLIN-3
AC   CVCL_QW47
SY   B-lineage 3
DR   Wikidata; Q54797363
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=11719380;
RX   PubMed=14671638;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   BLIN-4
AC   CVCL_QW50
SY   B-lineage 4
DR   Wikidata; Q54797364
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=11431369;
CC   Characteristics: Requires bone marrow stromal cells for optimal growth.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   BLIN-4E
AC   CVCL_QW51
SY   B-lineage 4 Early
DR   Wikidata; Q54797367
RX   PubMed=11431369;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QW50 ! BLIN-4
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   BLIN-4L
AC   CVCL_QW52
SY   B-lineage 4 Late
DR   Wikidata; Q54797368
RX   PubMed=11431369;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QW50 ! BLIN-4
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   BLK CL.4
AC   CVCL_6576
SY   BLKCL.4
DR   CLO; CLO_0001992
DR   ATCC; TIB-81
DR   GEO; GSM17228
DR   GEO; GSM17241
DR   GEO; GSM17242
DR   RCB; RCB2656
DR   TKG; TKG 0472
DR   Wikidata; Q54797370
RX   PubMed=723934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Omics: Transcriptomics; Massively parallel signature sequencing (MPSS).
CC   Discontinued: RCB; RCB2656; true.
CC   Discontinued: TKG; TKG 0472; probable.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   BLK SV HD.2 A.5R.1 A.3R.1
AC   CVCL_6577
DR   CLO; CLO_0001993
DR   ATCC; TIB-88
DR   Wikidata; Q54797372
RX   PubMed=723934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6576 ! BLK CL.4
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BLM
AC   CVCL_7035
SY   BRO Lung Metastasis
DR   BTO; BTO_0002803
DR   cancercelllines; CVCL_7035
DR   Cosmic; 808558
DR   Cosmic; 1132580
DR   Cosmic; 1181767
DR   Cosmic; 2036700
DR   GEO; GSM1507940
DR   Wikidata; Q54797375
RX   PubMed=1918136;
RX   PubMed=2060184;
RX   PubMed=25502142;
RX   PubMed=25728708;
RX   PubMed=26550137;
CC   Population: Caucasian.
CC   Characteristics: Obtained by injection of parent cell line in nude mice and selection of cells from lung metastases.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=25728708).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: BML; Cosmic=1132580.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7036 ! BRO
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BLM-01
AC   CVCL_WA41
SY   BLooM-01
DR   IBRC; C10652
DR   Wikidata; Q93428125
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BLMRL-HMFG-Mc1
AC   CVCL_C7H9
SY   Mc1; 3.14.A3
DR   Wikidata; Q117704220
RX   PubMed=2365381;
RX   PubMed=6353626;
RX   PubMed=7309278;
RX   PubMed=7493358;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   BLMRL-HMFG-Mc16
AC   CVCL_C7JS
SY   Mc16
DR   Wikidata; Q117704221
RX   PubMed=7493358;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08431; Human MFGE8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   BLMRL-HMFG-Mc3
AC   CVCL_C7HA
SY   Mc3
DR   ABCD; ABCD_AE980
DR   Wikidata; Q117704223
RX   PubMed=2365381;
RX   PubMed=6353626;
RX   PubMed=7712480;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized Angiolix therapeutic antibody used against breast tumors.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08431; Human MFGE8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   BLMRL-HMFG-Mc5
AC   CVCL_C7HB
SY   Mc5
DR   Wikidata; Q117704224
RX   PubMed=6353626;
RX   PubMed=7493358;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   BLMRL-HMFG-Mc8
AC   CVCL_C7HD
SY   Mc8
DR   Wikidata; Q117704225
RX   PubMed=2365381;
RX   PubMed=7493358;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08431; Human MFGE8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   BLMRL-HMFG-McR2
AC   CVCL_C7HC
SY   McR2
DR   Wikidata; Q117704226
RX   PubMed=2365381;
RX   PubMed=6353626;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   BLn
AC   CVCL_3655
SY   Bovine Lymph node
DR   CLO; CLO_0001994
DR   ATCC; CRL-6017
DR   Wikidata; Q54797379
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6017; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4399 ! BBm
OI   CVCL_R939 ! BPf
OI   CVCL_3657 ! BSp
OI   CVCL_5244 ! BThy
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   BLN-1
AC   CVCL_B7G1
DR   EGA; EGAS00001001167
DR   Wikidata; Q112929329
RX   PubMed=28148826;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BLN-2
AC   CVCL_B7G2
DR   EGA; EGAS00001001167
DR   Wikidata; Q112929330
RX   PubMed=28148826;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BLN-3
AC   CVCL_6G24
DR   DSMZ; ACC-787
DR   DSMZCellDive; ACC-787
DR   EGA; EGAS00001001167
DR   Wikidata; Q54797381
RX   PubMed=28148826;
CC   Doubling time: ~2-4 days (DSMZ=ACC-787).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): DSMZ=ACC-787
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 13,16
ST   D21S11: 27,29
ST   D2S1338: 20,23
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 23,26
ST   Penta D: 12,14
ST   Penta E: 7,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   BLN-4
AC   CVCL_B7G3
DR   EGA; EGAS00001001167
DR   Wikidata; Q112929331
RX   PubMed=28148826;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   BLN-5
AC   CVCL_B7G0
DR   EGA; EGAS00001001167
DR   Wikidata; Q112929332
RX   PubMed=28148826;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   BLN-6
AC   CVCL_B7G4
DR   EGA; EGAS00001001167
DR   Wikidata; Q112929333
RX   PubMed=28148826;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   BLN-7
AC   CVCL_6G25
DR   DSMZ; ACC-789
DR   DSMZCellDive; ACC-789
DR   EGA; EGAS00001001167
DR   Wikidata; Q54797382
RX   PubMed=28148826;
CC   Doubling time: ~3-5 days (DSMZ=ACC-789).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): DSMZ=ACC-789
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 27,28
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   BLN-8
AC   CVCL_B7G5
DR   EGA; EGAS00001001167
DR   Wikidata; Q112929334
RX   PubMed=28148826;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   BLN-9
AC   CVCL_B7G6
DR   EGA; EGAS00001001167
DR   Wikidata; Q112929335
RX   PubMed=28148826;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   BLO-11
AC   CVCL_4129
SY   BLO 11; BLO11; Blotchy fibroblast-11
DR   CLO; CLO_0001996
DR   CLDB; cl465
DR   ATCC; CCL-198
DR   ECACC; 90112702
DR   KCLB; 10198
DR   Wikidata; Q54797383
RX   PubMed=20889;
RX   PubMed=7065527;
CC   Sequence variation: Mutation; MGI; MGI:99400; Atp7a; Simple; c.2421+3A>C (IVS11+3A>C); Zygosity=Unspecified (from inference of Blotch mice mutation).
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
CC   Breed/subspecies: B6.Cg-Atp7aMo-blo/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   BLP
AC   CVCL_Y304
DR   Wikidata; Q54797416
RX   PubMed=190778;
CC   Karyotypic information: Near tetraploid karotype (PubMed=190778).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 7
//
ID   BLS-1
AC   CVCL_9W20
SY   BLS1
DR   Wikidata; Q54797418
RX   PubMed=1538137;
RX   PubMed=1852002;
RX   PubMed=2511169;
RX   PubMed=2785516;
RX   PubMed=7615790;
RX   PubMed=8195723;
RX   PubMed=9806546;
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Unexplicit; 58-bp deletion that removes the last 23-bp and the splice donor site of exon 6; ClinVar=VCV000006598; Zygosity=Homozygous (PubMed=9806546).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   BLS-1.DR4
AC   CVCL_9W22
SY   BLS-1.DR4w4
DR   Wikidata; Q54797421
RX   PubMed=7615790;
RX   PubMed=8195723;
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Unexplicit; 58-bp deletion that removes the last 23-bp and the splice donor site of exon 6; ClinVar=VCV000006598; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4947; HLA-DRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DRB1*04:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W20 ! BLS-1
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   BLS-1.DR5
AC   CVCL_9W23
DR   Wikidata; Q54797422
RX   PubMed=7615790;
RX   PubMed=8195723;
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Unexplicit; 58-bp deletion that removes the last 23-bp and the splice donor site of exon 6; ClinVar=VCV000006598; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4947; HLA-DRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DRB1*11:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W20 ! BLS-1
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   BLS-2
AC   CVCL_9W21
SY   BLS2
DR   Wikidata; Q54797425
RX   PubMed=1538137;
RX   PubMed=1852002;
RX   PubMed=2511169;
RX   PubMed=2785516;
RX   PubMed=7615790;
RX   PubMed=8402893;
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; c.2888+1G>A (c.72bpdel2932-3003) (IVS13DS,G-A,+1) (p.Thr940_Ala963del); ClinVar=VCV000501277; Zygosity=Homozygous (PubMed=8402893).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3-4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   BLSC-KU-1
AC   CVCL_4711
AS   CVCL_F545
SY   BLSC-KU1; KU-1
DR   CLO; CLO_0050470
DR   RCB; RCB0417
DR   Wikidata; Q54797426
RX   PubMed=3012214;
RX   PubMed=3026121;
RX   PubMed=35632737;
CC   Virology: Contains a single copy of a defective provirus with approximately 1.7 kbp deleted from the C-terminal of the pol gene to most of the env-gp51 gene. The provirus is integrated in a an intron of the RPTOR gene (PubMed=35632737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   BLSC-KU-11
AC   CVCL_VN05
SY   KU-11
DR   Wikidata; Q93428180
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   BLSC-KU-15
AC   CVCL_VN03
SY   KU-15
DR   Wikidata; Q93428182
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese Shorthorn; VBO=VBO_0004990.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   BLSC-KU-16
AC   CVCL_VN04
SY   KU-16
DR   Wikidata; Q93428183
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese Shorthorn; VBO=VBO_0004990.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   BLSC-KU-17
AC   CVCL_4713
SY   BLSC-KU17; KU-17
DR   CLO; CLO_0050469
DR   RCB; RCB0418
DR   Wikidata; Q54797429
RX   PubMed=1580106;
RX   PubMed=35632737;
CC   Virology: Contains a single copy of a complete provirus. The provirus is integrated in the intergenic region between the RTN4IPI and ATG5 genes (PubMed=35632737).
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese Shorthorn; VBO=VBO_0004990.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   BLSC-KU-18
AC   CVCL_VN02
SY   KU-18
DR   Wikidata; Q93428193
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese Shorthorn; VBO=VBO_0004990.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   BLSC-KU-19
AC   CVCL_VN09
SY   KU-19
DR   Wikidata; Q93428196
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   BLSC-KU-2
AC   CVCL_VN00
SY   KU-2
DR   Wikidata; Q93428199
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese Shorthorn; VBO=VBO_0004990.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   BLSC-KU-7
AC   CVCL_VN01
SY   KU-7
DR   Wikidata; Q93428201
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese Shorthorn; VBO=VBO_0004990.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   BLSC-KU-8
AC   CVCL_DF72
SY   KU-8
DR   Wikidata; Q54797430
RX   PubMed=1580106;
CC   Transformant: NCBI_TaxID; 11901; Bovine leukemia virus (BLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   BLT-1
AC   CVCL_U445
DR   Wikidata; Q54797433
RX   PubMed=8807633;
RX   PubMed=15541572;
CC   Doubling time: 36-48 hours (PubMed=8807633).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: Inha promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   BLUE-1
AC   CVCL_1967
SY   BLUE1; Blue1
DR   BioSample; SAMN03473493
DR   cancercelllines; CVCL_1967
DR   Cell_Model_Passport; SIDM01515
DR   DepMap; ACH-001450
DR   DSMZ; ACC-594
DR   DSMZCellDive; ACC-594
DR   Lonza; 1506
DR   Wikidata; Q54797435
RX   PubMed=16697040;
RX   PubMed=21412927;
RX   PubMed=24590883;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: ~36-48 hours (PubMed=16697040); ~50 hours (DSMZ=ACC-594).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14078; BACH2 + HGNC; HGNC:992; BCL2L1; Name(s)=BACH2-BCL2L1 (PubMed=21412927; DepMap=ACH-001450).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=16697040).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (DepMap=ACH-001450).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DepMap=ACH-001450; DSMZ=ACC-594
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 15,16
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 14,16
ST   D3S1358: 18
ST   D5S818: 9,10
ST   D7S820: 7,10
ST   D8S1179: 14,16
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   BLuMEC
AC   CVCL_A1BG
SY   Bovine Lung Microvascular Endothelial Cells
DR   ABM; T0831
DR   Wikidata; Q102113630
RX   PubMed=32722052;
CC   Doubling time: 36 hours (PubMed=32722052).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal lung, endothelium; UBERON=UBERON_0005597+UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
CC   Breed/subspecies: Montbeliarde; VBO=VBO_0000306.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A1BE ! BBrMEC
OI   CVCL_A1BF ! BIntMEC
OI   CVCL_A1BH ! BMLNMEC
OI   CVCL_A1BI ! BOvMEC
OI   CVCL_A1BJ ! BSkMEC
OI   CVCL_A1BK ! BUcEC
SX   Female
AG   6FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   BM [Human breast carcinoma]
AC   CVCL_E6XA
RX   PubMed=12836015;
CC   HLA typing: A*02,03; B*07,07; DQB1*03:02,05:01:01; DRB1*01:01,04:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BM [L.calcarifer]
AC   CVCL_S926
SY   Barramundi Muscle
DR   Wikidata; Q54797436
RX   PubMed=19238757;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
OI   CVCL_S927 ! BSB
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   BM 2.2.1
AC   CVCL_W999
SY   BM2.2.1; ASL 5; ASL-w17
DR   cancercelllines; CVCL_W999
DR   IARC_TP53; 4803
DR   IARC_TP53; 9738
DR   Wikidata; Q54797439
RX   PubMed=7658501;
RX   PubMed=10022320;
RX   PubMed=10952247;
CC   Population: Caucasian.
CC   Doubling time: 52.8-55.2 hours (Note=At 23th passage) (PubMed=10952247).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Leu (c.536A>T); ClinVar=VCV000376608; Zygosity=Homozygous (PubMed=7658501; PubMed=10022320; PubMed=10952247).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
DI   NCIt; C4438; Liver angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 14
//
ID   BM-1604
AC   CVCL_1968
SY   BM 1604; BM1604
DR   BTO; BTO_0002015
DR   CLO; CLO_0002001
DR   EFO; EFO_0002117
DR   ArrayExpress; E-MTAB-38
DR   BioSample; SAMN03151637
DR   BioSample; SAMN03470924
DR   cancercelllines; CVCL_1968
DR   DSMZ; ACC-298
DR   DSMZCellDive; ACC-298
DR   IGRhCellID; BM1604
DR   Progenetix; CVCL_1968
DR   Wikidata; Q54797440
RX   PubMed=8054265;
RX   PubMed=10508494;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=25877200;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200713/http://capcelllines.ca:80/details.asp?id=71
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a DU145 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 67 year old man with a primary prostatic adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00113.
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=8054265); ~60 hours (Note=Highly variable) (DSMZ=ACC-298).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: DSMZ; ACC-298; true.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): DSMZ=ACC-298; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D18S51: 12
ST   D19S433: 12,13
ST   D21S11: 30,33,34
ST   D2S1338: 16
ST   D3S1358: 15,16
ST   D5S818: 10,14
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 12,14
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   BM-21E-HNU5
AC   CVCL_Z569
SY   Bm-21E-HNU5; Bm-e-HNU5; Bm-21E
DR   ICLDB; bm-21e-hnu5
DR   Wikidata; Q54797441
RX   CelloPub=CLPUB00535;
RX   DOI=10.19603/j.cnki.1000-1190.1991.04.021;
RX   DOI=10.19603/j.cnki.1000-1190.1995.04.025;
RX   DOI=10.3923/jas.2007.4040.4043;
CC   Group: Insect cell line.
CC   Doubling time: 48 hours (CelloPub=CLPUB00535).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Huahe 671 Dongfei.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   BM-314
AC   CVCL_3895
SY   BM 314; BM314
DR   BTO; BTO_0004889
DR   Wikidata; Q54797444
RX   PubMed=2203882;
RX   PubMed=7874267;
CC   Population: Japanese.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   Bm-Em-1
AC   CVCL_Z999
DR   ICLDB; bm-em-1
DR   Wikidata; Q54797445
RX   DOI=10.16380/j.kcxb.2011.12.013;
CC   Group: Insect cell line.
CC   Doubling time: 82.2 hours (DOI=10.16380/j.kcxb.2011.12.013).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Dazao.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BM-MSC/TERT292
AC   CVCL_B5T0
DR   Evercyte; CHT-063-0292
DR   Wikidata; Q111732961
CC   Doubling time: 34-38 hours (Evercyte=CHT-063-0292).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile, sex and age of donor from personal communication of Evercyte.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): Evercyte=CHT-063-0292
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   BM-N
AC   CVCL_Z633
SY   Bm N; BmN; BMN; BmN(1)
DR   BTO; BTO_0001267
DR   CLO; CLO_0002008
DR   CLO; CLO_0051457
DR   CLDB; cl467
DR   ATCC; CRL-8910
DR   ICLDB; bmn
DR   NISES; SK0010
DR   RCB; RCB0457
DR   Wikidata; Q54797447
RX   CelloPub=CLPUB00498;
RX   DOI=10.11416/kontyushigen1930.53.547;
RX   PubMed=2989694;
RX   PubMed=8799737;
RX   PubMed=10777062;
RX   PubMed=16346059;
RX   PubMed=16409117;
RX   PubMed=19496755;
RX   PubMed=29133148;
WW   Info; EMA; -; https://www.ema.europa.eu/en/documents/scientific-discussion/virbagen-omega-epar-scientific-discussion_en.pdf
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8910.
CC   Biotechnology: Used for the production of the VirBac Virbagen Omega, a recombinant cat alpha-inteferon used in veterinary medicine to treat cats infected with feline leukemia virus (FeLV) and/or feline immunodeficiency virus (FIV) infections.
CC   Virology: Infected by Bombyx mori macula-like latent virus (BmMLV).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 19
//
ID   BM0067
AC   CVCL_8S89
SY   100BR
DR   ECACC; 90011882
DR   Wikidata; Q54797448
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 90011882; true.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   BM1.5
AC   CVCL_B6UN
SY   BM 1.5
DR   cancercelllines; CVCL_B6UN
DR   Wikidata; Q111732962
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM10.1
AC   CVCL_B6UX
SY   BM 10.1
DR   cancercelllines; CVCL_B6UX
DR   Wikidata; Q111732964
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM102
AC   CVCL_X340
SY   BM 102
DR   ATCC; CRL-6028
DR   Wikidata; Q54797449
RX   PubMed=5587551;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6028; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   BM109
AC   CVCL_RP19
DR   Wikidata; Q54797451
RX   PubMed=28577549;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   BM11.1
AC   CVCL_B6UY
SY   BM 11.1
DR   cancercelllines; CVCL_B6UY
DR   Wikidata; Q111732965
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM111
AC   CVCL_X341
SY   BM 111
DR   ATCC; CRL-6029
DR   Wikidata; Q54797452
RX   PubMed=5587551;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6029; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 5
//
ID   BM12.1
AC   CVCL_B6UZ
SY   BM 12.1
DR   cancercelllines; CVCL_B6UZ
DR   Wikidata; Q111732966
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM123
AC   CVCL_X342
SY   BM 123
DR   ATCC; CRL-6030
DR   Wikidata; Q54797453
RX   PubMed=5587551;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6030; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   BM13.1
AC   CVCL_B6V0
SY   BM 13.1
DR   cancercelllines; CVCL_B6V0
DR   Wikidata; Q111732967
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM14.1
AC   CVCL_B6V1
SY   BM 14.1
DR   cancercelllines; CVCL_B6V1
DR   Wikidata; Q111732968
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM14
AC   CVCL_E485
SY   BM 14
DR   dbMHC; 48501
DR   ECACC; 88052033
DR   IHW; IHW09033
DR   IPD-IMGT/HLA; 11620
DR   Wikidata; Q54797457
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01; DPB1*04:01:01; DQA1*03; DQB1*03:02:01; DRA*01:01; DRB1*04:01:01; DRB4*01:01 (IPD-IMGT/HLA=11620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   BM15
AC   CVCL_E486
SY   Bm15; BM 15
DR   dbMHC; 48502
DR   ECACC; 88052040
DR   IHW; IHW09040
DR   IPD-IMGT/HLA; 11621
DR   Wikidata; Q54797458
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*01:01:01:01; B*49:01:01:02; C*07:01:01:01; DPA1*01; DPB1*104:01; DQA1*05:05; DQB1*03:19:01; DRA*01:01; DRB1*11:02:01; DRB3*02:02:01 (IPD-IMGT/HLA=11621).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   BM15.3
AC   CVCL_B6V2
SY   BM 15.3
DR   cancercelllines; CVCL_B6V2
DR   Wikidata; Q111732971
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM16
AC   CVCL_E487
SY   BM 16
DR   dbMHC; 48503
DR   ECACC; 88052038
DR   IHW; IHW09038
DR   IPD-IMGT/HLA; 10321
DR   Wikidata; Q54797461
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*02:01:01:01; B*18:01:01:02; C*07:01:01:01; DPA1*01:03; DPB1*02:01:02/02:01:19; DQA1*05:05:01:01; DQB1*03:01:01; DRA*01:02; DRB1*12:01:01/12:10; DRB3*02:02 (IPD-IMGT/HLA=10321).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   BM163
AC   CVCL_RP20
DR   Wikidata; Q54797464
RX   PubMed=28577549;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=28577549).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   BM18
AC   CVCL_4832
DR   Wikidata; Q54797466
RX   PubMed=15800936;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200521/http://capcelllines.ca:80/details.asp?id=174
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   BM19
AC   CVCL_B6V3
DR   cancercelllines; CVCL_B6V3
DR   Wikidata; Q111732972
RX   PubMed=2995242;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=2995242).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM1R2
AC   CVCL_E9WB
RX   PubMed=10628353;
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=10628353).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1339 ! KP-N-RT-BM-1
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BM2
AC   CVCL_0174
SY   LSCC-BM2
DR   MCCL; MCC:0000065
DR   Wikidata; Q54797469
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11866; Avian myeloblastosis virus (AMV).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Bm2-10
AC   CVCL_F0GM
SY   BM10; Bm10
DR   ABCD; ABCD_BF027
RX   PubMed=2474505;
RX   PubMed=25263136;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59339; Brucella sp. O-PS M-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   Bm2-15
AC   CVCL_F0GN
RX   PubMed=2474505;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59339; Brucella sp. O-PS M-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Bm2-28
AC   CVCL_F0GP
SY   BM28; Bm28
DR   ABCD; ABCD_BF028
RX   PubMed=2474505;
RX   PubMed=25263136;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59339; Brucella sp. O-PS M-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   BM2.2
AC   CVCL_B6UP
SY   BM 2.2
DR   cancercelllines; CVCL_B6UP
DR   Wikidata; Q111732974
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM2.2.3
AC   CVCL_B6V4
DR   cancercelllines; CVCL_B6V4
DR   Wikidata; Q111732975
RX   PubMed=8449221;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the grand-parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UP ! BM2.2
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM2/C3A
AC   CVCL_T437
SY   BM2 C3A
DR   Wikidata; Q54797470
RX   Patent=US5338680;
RX   PubMed=8437856;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11866; Avian myeloblastosis virus (AMV).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0174 ! BM2
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   BM21
AC   CVCL_E488
SY   BM 21
DR   dbMHC; 48504
DR   ECACC; 88052043
DR   IHW; IHW09043
DR   IPD-IMGT/HLA; 10322
DR   Wikidata; Q54797472
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; German/Italian.
CC   HLA typing: A*01:01:01:01; B*41:01:01; C*17:01:01:05; DPA1*02:01; DPB1*10:01:01; DQA1*05:05; DQB1*03:01:01; DRA*01:01; DRB1*11:01:01; DRB3*02:02 (IPD-IMGT/HLA=10322).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   BM2L
AC   CVCL_T438
DR   Wikidata; Q54797474
RX   Patent=US5338680;
RX   PubMed=8437856;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10468.
CC   Transformant: NCBI_TaxID; 11866; Avian myeloblastosis virus (AMV).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_T437 ! BM2/C3A
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   BM2L/A1b6
AC   CVCL_T439
SY   GM1243/1
DR   Wikidata; Q54797476
RX   Patent=US5338680;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10465.
CC   Transformant: NCBI_TaxID; 11866; Avian myeloblastosis virus (AMV).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_T438 ! BM2L
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   BM2L/A2a2
AC   CVCL_T440
SY   GM1243/2
DR   Wikidata; Q54797478
RX   Patent=US5338680;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10466.
CC   Transformant: NCBI_TaxID; 11866; Avian myeloblastosis virus (AMV).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_T438 ! BM2L
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   BM2L/A2b5
AC   CVCL_T441
SY   BM2L/A2B5; GM1243/3
DR   Wikidata; Q54797481
RX   Patent=US5338680;
RX   PubMed=8437856;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10467.
CC   Transformant: NCBI_TaxID; 11866; Avian myeloblastosis virus (AMV).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_T438 ! BM2L
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   Bm3-2
AC   CVCL_F0GQ
RX   PubMed=2474505;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59339; Brucella sp. O-PS M-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Bm3-7
AC   CVCL_F0GR
RX   PubMed=2474505;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59339; Brucella sp. O-PS M-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Bm3-8
AC   CVCL_F0GS
RX   PubMed=2474505;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59339; Brucella sp. O-PS M-antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BM3.1
AC   CVCL_B6UQ
SY   BM 3.1
DR   cancercelllines; CVCL_B6UQ
DR   Wikidata; Q111732977
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM4.1
AC   CVCL_B6UR
SY   BM 4.1
DR   cancercelllines; CVCL_B6UR
DR   Wikidata; Q111732979
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   Bm5
AC   CVCL_0A00
AS   CVCL_Z305
SY   BM-5; Bm-5; Bm
DR   CLO; CLO_0001997
DR   CLDB; cl466
DR   ICLDB; bm5
DR   Wikidata; Q54797482
RX   CelloPub=CLPUB00164;
RX   DOI=10.1002/cjce.5450690209;
RX   PubMed=4868367;
RX   PubMed=10585188;
RX   PubMed=22714272;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-167.html
CC   Group: Insect cell line.
CC   Doubling time: 43 +- 1 hours (Note=In static culture), 38 +- 1 hours (Note=In suspension culture) (PubMed=10585188).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   BM5
AC   CVCL_X924
SY   Bonnet Monkey 5
DR   Wikidata; Q54797484
RX   PubMed=2579038;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9548; ! Macaca radiata (Bonnet macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   BM5.2
AC   CVCL_B6US
SY   BM 5.2
DR   cancercelllines; CVCL_B6US
DR   Wikidata; Q111732980
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM55
AC   CVCL_X343
SY   BM 55
DR   ATCC; CRL-6027
DR   Wikidata; Q54797487
RX   PubMed=5587551;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6027; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   BM6.3
AC   CVCL_B6UT
SY   BM 6.3
DR   cancercelllines; CVCL_B6UT
DR   Wikidata; Q111732982
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM64
AC   CVCL_X344
SY   BM 64
DR   Wikidata; Q54797488
RX   PubMed=5587551;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   Bm7
AC   CVCL_A5BS
SY   BM7
DR   BTO; BTO_0006333
DR   Wikidata; Q107113470
RX   PubMed=24705471;
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Metastatic to brain. Established from intracardiac injection of parent cell in SCID mice and cultured from brain tissue.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BR ! CL1-5-F4-Luc
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   BM7.4
AC   CVCL_B6UU
SY   BM 7.4
DR   cancercelllines; CVCL_B6UU
DR   Wikidata; Q111732983
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   Bm7brm
AC   CVCL_A5BT
DR   BTO; BTO_0006478
DR   Wikidata; Q107113471
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Metastatic to brain. Established from intracardiac injection of parent cell in SCID mice and cultured from brain tissue.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BS ! Bm7
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   BM8.5
AC   CVCL_B6UV
SY   BM 8.5
DR   cancercelllines; CVCL_B6UV
DR   Wikidata; Q111732985
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM9
AC   CVCL_E489
SY   BM 9; BM09
DR   EFO; EFO_0022641
DR   dbMHC; 48505
DR   ECACC; 88052086
DR   IHW; IHW09068
DR   IPD-IMGT/HLA; 11619
DR   Wikidata; Q54797489
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*02:01:01:01; B*35:01:01:06; C*04:01:01:01; DPA1*01:03:01:01; DPB1*02:01:04; DQA1*04:01:01; DQB1*04:02:01; DRA*01:02; DRB1*08:01:01/08:77 (IPD-IMGT/HLA=11619).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   BM9.1
AC   CVCL_B6UW
SY   BM 9.1
DR   cancercelllines; CVCL_B6UW
DR   Wikidata; Q111732987
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   BM92
AC   CVCL_E490
SY   BM 92
DR   dbMHC; 48506
DR   IHW; IHW09092
DR   IPD-IMGT/HLA; 10326
DR   Wikidata; Q54797490
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*25:01:01; B*51:01:01:01; C*01:02:01; DPA1*01:03; DPB1*04:02:01; DQA1*03:01; DQB1*03:02:01; DRA*01:01; DRB1*04:04:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=10326).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BM95760M
AC   CVCL_LM87
SY   BM95
DR   CLO; CLO_0002006
DR   CLDB; cl469
DR   Wikidata; Q54797530
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   BMA1
AC   CVCL_6A85
SY   BMA-1; Bone Marrow Adenovirus-transformed 1
DR   Wikidata; Q54797532
RX   PubMed=3872809;
RX   PubMed=6603995;
CC   Characteristics: Produces CSF2 (PubMed=6603995).
CC   Doubling time: 21 hours (Note=At 60th passage) (PubMed=6603995).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: ddY.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BMA19
AC   CVCL_ZE82
DR   Wikidata; Q98125589
RX   PubMed=32348592;
CC   Doubling time: 30-40 hours (PubMed=32348592).
CC   Sequence variation: Gene fusion; HGNC; HGNC:591; BIRC3 + HGNC; HGNC:6819; MALT1; Name(s)=BIRC3-MALT1, API2-MALT1 (PubMed=32348592).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Arg267Ser (c.801G>C); Zygosity=Unspecified (PubMed=32348592).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=32348592
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,12,13
ST   D16S539: 9,13
ST   D21S11: 30,31.2
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3898; Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
DI   ORDO; Orphanet_52417; MALT lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   BMA3.1A
AC   CVCL_IW57
SY   BM A3.1A
DR   Wikidata; Q54797534
RX   PubMed=8506338;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   BMA3.1A7
AC   CVCL_IW58
SY   BM A3.1A7; BMA; A3.1A7
DR   ABM; T0673
DR   Wikidata; Q54797535
RX   DOI=10.4172/2155-9899.1000318;
RX   PubMed=7809629;
RX   PubMed=7925570;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IW57 ! BMA3.1A
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 6
//
ID   BMAC-1
AC   CVCL_G162
DR   ECACC; 89062103
DR   NCBI_Iran; H114
DR   Wikidata; Q54797538
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
CC   Discontinued: ECACC; 89062103; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   BMAC-3
AC   CVCL_G163
DR   ECACC; 89062105
DR   NCBI_Iran; H115
DR   Wikidata; Q54797540
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   BMC-PDC-019
AC   CVCL_D1GF
DR   Wikidata; Q127380342
RX   PubMed=37707774;
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=37707774).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (PubMed=37707774).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=37707774
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11,12,13
ST   D18S51: 13,14
ST   D19S433: 13,13.2,14,15
ST   D21S11: 29,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 10,11,12
ST   D7S820: 8,10,12
ST   D8S1179: 10,13,14,15
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 15,18,19
ST   TH01: 6,7,8,9
ST   TPOX: 11
ST   vWA: 14,15,16
DI   NCIt; C202133; Transformed EGFR-positive lung adenocarcinoma to small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Bmc140
AC   CVCL_Z845
SY   BmX
DR   ICLDB; bmc140
DR   Wikidata; Q54797543
RX   PubMed=22714272;
CC   Group: Insect cell line.
CC   Breed/subspecies: C140.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   BMC2
AC   CVCL_2I36
SY   BM MPsi C2; BMC-2
DR   BTO; BTO_0005613
DR   Wikidata; Q54797545
RX   PubMed=7925570;
RX   PubMed=8506338;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   BMC2.3
AC   CVCL_IW59
SY   BM C2.3
DR   Wikidata; Q54797547
RX   PubMed=7809629;
RX   PubMed=7925570;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2I36 ! BMC2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   BMD-iPS1
AC   CVCL_C925
SY   BMD-IPS1
DR   Wikidata; Q54797549
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8520 ! GM04569
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   BMD-iPS4
AC   CVCL_C926
SY   BMD-IPS4
DR   Wikidata; Q54797552
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8520 ! GM04569
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   BMD2-iPS1
AC   CVCL_C927
DR   Wikidata; Q54797554
CC   From: Children's Hospital Boston; Boston; USA.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   BMD2-iPS5
AC   CVCL_C928
DR   Wikidata; Q54797556
CC   From: Children's Hospital Boston; Boston; USA.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   BmE-SWU1
AC   CVCL_Z085
DR   ICLDB; bme-swu1
DR   Wikidata; Q54797558
RX   PubMed=17570024;
CC   Group: Insect cell line.
CC   Doubling time: 58.7 hours (PubMed=17570024).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Xiafang x Qiubai.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryo 4D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BmE-SWU2
AC   CVCL_Z086
DR   ICLDB; bme-swu2
DR   Wikidata; Q54797559
RX   DOI=10.16380/j.kcxb.2006.05.001;
RX   PubMed=17570024;
CC   Group: Insect cell line.
CC   Doubling time: 51.8 hours (DOI=10.16380/j.kcxb.2006.05.001); 46.6 hours (PubMed=17570024).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: 12-010 x p98.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryo 4D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   BME-UV1
AC   CVCL_W716
SY   BMEUV1
DR   IZSLER; BS CL 146
DR   Wikidata; Q54797560
RX   PubMed=8925136;
RX   PubMed=19708121;
RX   PubMed=26659725;
CC   Characteristics: Shows enhanced proliferation in the presence of epidermal growth factor (EGF) and insulin-like growth factor 1 (IGF1) (PubMed=8925136).
CC   Doubling time: 22.8 hours (Note=In presence of serum and supplements) (PubMed=8925136).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_HG42 ! BME-UV2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 12
//
ID   BME-UV2
AC   CVCL_HG42
DR   Wikidata; Q54797562
RX   PubMed=8925136;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_W716 ! BME-UV1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 9
//
ID   BME/CTVM2
AC   CVCL_Z145
DR   Wikidata; Q54797564
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=20388200;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=23140894;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   BME/CTVM23
AC   CVCL_Z146
DR   Wikidata; Q54797566
RX   PubMed=22743047;
RX   PubMed=23140894;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   BME/CTVM30
AC   CVCL_Z147
DR   Wikidata; Q54797568
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   BME/CTVM4
AC   CVCL_Z148
SY   BME/CTVM 4
DR   CLDB; cl470
DR   ECACC; 94022804
DR   Wikidata; Q54797571
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022804; true.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   BME/CTVM5
AC   CVCL_Z149
DR   Wikidata; Q54797572
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   BME/CTVM6
AC   CVCL_Z150
SY   BME/CTVM 6
DR   ECACC; 94022803
DR   Wikidata; Q54797573
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=20388200;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022803; true.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   BME/PIBB36
AC   CVCL_UD43
DR   Wikidata; Q93428540
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   Bme21
AC   CVCL_Z087
DR   ICLDB; bme21
DR   Wikidata; Q54797576
RX   Patent=US7955793;
RX   PubMed=22714272;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20852.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: e21.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   BME26
AC   CVCL_Z179
SY   BME 26
DR   Wikidata; Q54797578
RX   PubMed=2766897;
RX   PubMed=3404544;
RX   PubMed=17662657;
RX   PubMed=18405834;
RX   PubMed=22743047;
RX   PubMed=32158404;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   BME26-IVM
AC   CVCL_Z180
DR   Wikidata; Q54797580
RX   PubMed=24956999;
CC   Group: Tick cell line.
CC   Selected for resistance to: ChEBI; CHEBI_6078; Ivermectin.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
HI   CVCL_Z179 ! BME26
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   BMEC-1
AC   CVCL_A4BA
SY   CDC/CU.BMEC-1; Bone marrow Microvascular Endothelial Cell line-1
DR   ATCC; CRL-3421
DR   Wikidata; Q105506530
RX   PubMed=8954864;
CC   Senescence: According to ATCC it senesces at ~27 PDL (ATCC=CRL-3421), but this is not what is described in PubMed=8954864.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVT).
CC   Derived from site: In situ; Bone marrow, blood microvessel; UBERON=UBERON_8480067.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
ST   Source(s): ATCC=CRL-3421
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   BMEC-CH
AC   CVCL_HG35
SY   Bovine Mammary Epithelial Cell line-Chinese Holstein
DR   Wikidata; Q38004176
RX   PubMed=19888476;
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Chinese Holstein; VBO=VBO_0003142.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   3Y
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 10
//
ID   BMES
AC   CVCL_A5YH
SY   Bovine Muscular Epithelial cells Spontaneously-immortalized
DR   Wikidata; Q107113472
RX   PubMed=16511344;
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   BMET
AC   CVCL_A5YI
SY   Bovine Muscular Epithelial cells TERT-immortalized
DR   Wikidata; Q107113473
RX   PubMed=16511344;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   BMEV
AC   CVCL_A5YJ
SY   Bovine Muscular Epithelial cells Virus-immortalized
DR   Wikidata; Q107113474
RX   PubMed=16511344;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   BMG-1
AC   CVCL_DF74
SY   BMG1
DR   Wikidata; Q54797583
RX   PubMed=2808036;
RX   PubMed=11966317;
RX   PubMed=16509995;
RX   PubMed=23881600;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   BMGB
AC   CVCL_YC95
SY   Brown-Marbled Grouper Brain
DR   Wikidata; Q93428577
RX   PubMed=27087415;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 30 Celsius (PubMed=27087415).
CC   Virology: Infected with redspotted grouper nervous necrosis virus (RGNNV) (PubMed=27087415).
CC   Virology: Susceptible to infection by chum salmon virus (CSV), grouper nervous necrosis virus (GNNV-K1), giant seaperch iridovirus (GSIV-K1) and red sea bream iridovirus (RSIV-Ku) (PubMed=27087415).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=293821; ! Epinephelus fuscoguttatus (Brown-marbled grouper)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   BMGE+H
AC   CVCL_HG37
DR   Wikidata; Q54797585
RX   PubMed=6186672;
RX   PubMed=8056759;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_HG36 ! BMGE-H
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   BMGE-H
AC   CVCL_HG36
DR   Wikidata; Q54797586
RX   PubMed=6186672;
RX   PubMed=8056759;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_HG37 ! BMGE+H
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   bmGF-1
AC   CVCL_Y565
SY   brown-marbled Grouper Fin-1
DR   Wikidata; Q54797587
RX   DOI=10.1111/j.1365-2109.2009.02253.x;
CC   Group: Fish cell line.
CC   Doubling time: 50.6 hours (DOI=10.1111/j.1365-2109.2009.02253.x).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=293821; ! Epinephelus fuscoguttatus (Brown-marbled grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 10
//
ID   bmGH
AC   CVCL_Y566
SY   brown-marbled Grouper Heart
DR   Wikidata; Q54797589
RX   PubMed=20409167;
CC   Group: Fish cell line.
CC   Doubling time: 40.3 hours (PubMed=20409167).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=293821; ! Epinephelus fuscoguttatus (Brown-marbled grouper)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 10
//
ID   BmIFV-4E12
AC   CVCL_YA21
SY   4E12
DR   CCRID; 4201PAT-CCTCC00201
DR   Wikidata; Q93428608
RX   Patent=CN100554416C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200630.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B5LPA0; Infectious flacherie virus (isolate Silkworm) polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   BmIX
AC   CVCL_Z201
SY   B. microplus IX; B microplus IX; IX
DR   Wikidata; Q54797590
RX   PubMed=7255899;
RX   PubMed=17662657;
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   BML01
AC   CVCL_QX73
DR   Wikidata; Q54797592
RX   DOI=10.1016/j.jcyt.2015.03.422;
CC   Doubling time: 16 hours (DOI=10.1016/j.jcyt.2015.03.422).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   BML895
AC   CVCL_IV45
DR   Wikidata; Q54797593
RX   PubMed=9192833;
RX   PubMed=9973220;
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 7
//
ID   BMLNMEC
AC   CVCL_A1BH
SY   Bovine Mesenteric Lymph Node Microvascular Endothelial Cells
DR   ABM; T0832
DR   Wikidata; Q102113631
RX   PubMed=32722052;
CC   Virology: Highly susceptible to infection by foot-and-mouth disease virus (PubMed=32722052).
CC   Doubling time: 24 hours (PubMed=32722052).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal mesenteric lymph node, microvascular endothelium; UBERON=UBERON_0002509+UBERON_0008339.
CC   Breed/subspecies: Montbeliarde; VBO=VBO_0000306.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A1BE ! BBrMEC
OI   CVCL_A1BF ! BIntMEC
OI   CVCL_A1BG ! BLuMEC
OI   CVCL_A1BI ! BOvMEC
OI   CVCL_A1BJ ! BSkMEC
OI   CVCL_A1BK ! BUcEC
SX   Female
AG   6FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   BmN-SFM
AC   CVCL_Z635
SY   BmN4-SFM; BmN-Serum Free Medium
DR   ICLDB; bmn4-sfm
DR   Wikidata; Q54797596
RX   PubMed=24934233;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 112.8 hours (PubMed=24934233).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z634 ! BmN4
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BmN-SWU1
AC   CVCL_Z088
DR   ICLDB; bmn-swu1
DR   Wikidata; Q54797598
RX   PubMed=19665160;
RX   PubMed=25221982;
CC   Group: Insect cell line.
CC   Doubling time: ~57.7 hours (Note=At 45th passage) (PubMed=19665160).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: 21-872nlw.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
OI   CVCL_Z632 ! BmN-SWU2
SX   Female
AG   Fourth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BmN-SWU2
AC   CVCL_Z632
DR   ICLDB; bmn-swu2
DR   Wikidata; Q54797600
RX   PubMed=25221982;
CC   Group: Insect cell line.
CC   Doubling time: ~96 hours (PubMed=25221982).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: 21-872nlw.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
OI   CVCL_Z088 ! BmN-SWU1
SX   Female
AG   Fourth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BmN4
AC   CVCL_Z634
SY   BmN-4; BM-N4
DR   BTO; BTO_0005690
DR   ICLDB; bmn4
DR   NISES; SK0023
DR   Wikidata; Q54797601
RX   PubMed=10358729;
RX   PubMed=10585188;
RX   PubMed=15827172;
RX   PubMed=16756546;
RX   PubMed=22714272;
RX   PubMed=24934233;
RX   PubMed=33023468;
CC   Group: Insect cell line.
CC   Virology: Infected by Bombyx mori macula-like latent virus (BmMLV).
CC   Doubling time: 73.3 hours (PubMed=24934233); 58 +- 6 hours (Note=In static culture), 72 +- 2 hours (Note=In suspension culture) (PubMed=10585188).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z633 ! BM-N
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   BmN4-DR
AC   CVCL_Z089
DR   BTO; BTO_0001717
DR   CLO; CLO_0051458
DR   ICLDB; bmn4-dr
DR   RCB; RCB2125
DR   Wikidata; Q54797604
RX   PubMed=14680819;
CC   Group: Insect cell line.
CC   Characteristics: Used in a transient luciferase assay system for measuring extrachromosomal homologous recombination (HR). Expresses a disrupted luciferase gene which can become enzymatically active through HR (PubMed=14680819).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z634 ! BmN4
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   BmN4-IR
AC   CVCL_Z090
DR   BTO; BTO_0001280
DR   CLO; CLO_0051459
DR   ICLDB; bmn4-ir
DR   RCB; RCB2126
DR   Wikidata; Q54797606
RX   PubMed=14680819;
CC   Group: Insect cell line.
CC   Characteristics: Used in a transient luciferase assay system for measuring extrachromosomal homologous recombination (HR). Expresses a disrupted luciferase gene which can become enzymatically active through HR (PubMed=14680819).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z634 ! BmN4
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   BmN4-SID1
AC   CVCL_Z091
DR   BTO; BTO_0005677
DR   ICLDB; bmn4-sid1
DR   Wikidata; Q54797639
RX   PubMed=22293577;
CC   Group: Insect cell line.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q0GZC8; Caenorhabditis elegans sid-1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z634 ! BmN4
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   BMPR2 LCL 172
AC   CVCL_IM96
DR   GEO; GSM271848
DR   Wikidata; Q54797640
RX   PubMed=18823550;
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=18823550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   BMPR2 LCL 176
AC   CVCL_IM97
DR   GEO; GSM271847
DR   Wikidata; Q54797642
RX   PubMed=18823550;
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=18823550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   BMPR2 LCL 180
AC   CVCL_IM98
DR   GEO; GSM271849
DR   Wikidata; Q54797643
RX   PubMed=18823550;
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=18823550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   BMPR2 LCL 186
AC   CVCL_IM99
DR   GEO; GSM271868
DR   Wikidata; Q54797644
RX   PubMed=18823550;
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=18823550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   BMPR2 LCL 264
AC   CVCL_IN00
DR   GEO; GSM271866
DR   Wikidata; Q54797645
RX   PubMed=18823550;
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=18823550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   BMPR2 LCL 266
AC   CVCL_IN01
DR   GEO; GSM271867
DR   Wikidata; Q54797646
RX   PubMed=18823550;
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=18823550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   BMPR2 LCL 723
AC   CVCL_IN02
DR   GEO; GSM271865
DR   Wikidata; Q54797648
RX   PubMed=18823550;
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=18823550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   BMR26
AC   CVCL_L743
DR   CLO; CLO_0050343
DR   RCB; RCB2046
DR   Wikidata; Q54797650
RX   PubMed=8161226;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61360; Globoside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 7
//
ID   BMS-2
AC   CVCL_A9C5
SY   BMS2
DR   Wikidata; Q102113634
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a mammary gland nodular sclerocystic dystrophy.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   BMS-4
AC   CVCL_A9C6
SY   BMS4
DR   Wikidata; Q102113636
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a mammary gland adenofibroma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   BMS-5
AC   CVCL_A9C7
SY   BMS5
DR   Wikidata; Q102113638
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient operated for a benign breast lesion who later developed breast carcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   BMS-6
AC   CVCL_A9C8
SY   BMS6
DR   Wikidata; Q102113639
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a mammary gland diffuse adenosis.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   BMS-7
AC   CVCL_A9C9
SY   BMS7
DR   Wikidata; Q102113640
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a mammary gland cystic papillary adenoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   BMS1
AC   CVCL_D133
DR   Wikidata; Q54797651
RX   PubMed=3260182;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   BMS2
AC   CVCL_0175
DR   MCCL; MCC:0000066
DR   BCRJ; 0054
DR   Wikidata; Q54797653
RX   PubMed=2178944;
RX   PubMed=3260182;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BmSG-SWU1
AC   CVCL_DF35
DR   ICLDB; bmsg-swu1
DR   Wikidata; Q54797654
RX   DOI=10.1603/AN13022;
CC   Group: Insect cell line.
CC   Doubling time: ~62.8 hours (DOI=10.1603/AN13022).
CC   Derived from site: In situ; Silk gland; UBERON=UBERON_0011146.
CC   Breed/subspecies: Xiafang x Qiubai.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Newly hatched
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   BMSGDDi-GM11272-J8
AC   CVCL_QX47
SY   GM11272-J8
DR   Wikidata; Q54797655
RX   PubMed=28395743;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Argfs*8 (c.1157_1188del32) (p.Leu398Argfs*8, c.1193_1224del32) (1155del32); ClinVar=VCV000143366; Zygosity=Unspecified (PubMed=28395743).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F14 ! GM11272
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   BMSSDUi001-A
AC   CVCL_YT15
DR   hPSCreg; BMSSDUi001-A
DR   Wikidata; Q93428765
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   BMT10
AC   CVCL_VS63
SY   BMT-10
DR   Wikidata; Q93428768
RX   PubMed=3018509;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Parent cell line (BS-C-1) was originally thought to be of Chlorocebus aethiops origin but originate from Chlorocebus pygerythrus.
CC   Sequence variation: Mutation; UniProtKB; A0A7D5U6M6; MT-ND6; Simple; p.Tyr50fs*25 (c.147insG) (m.13952dupC); Zygosity=Heteroplasmic (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pKMT11).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_0607 ! BS-C-1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 8
//
ID   BMU-S1
AC   CVCL_A9IV
DR   CCRID; 5301BOV-KCB04011ZJ
DR   KCB; KCB 200411ZJ
DR   Wikidata; Q108819953
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30521; ! Bos mutus grunniens (Wild yak)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BmVIII-SCC
AC   CVCL_Z202
SY   VIII-SCC
DR   Wikidata; Q54797657
RX   PubMed=7288834;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   BmVIII-SCC-OPr-C34
AC   CVCL_Z203
SY   C34
DR   Wikidata; Q54797658
RX   PubMed=11931027;
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
HI   CVCL_Z202 ! BmVIII-SCC
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   BmVIII-SCC-OPr-C44
AC   CVCL_Z204
SY   C44
DR   Wikidata; Q54797659
RX   PubMed=11931027;
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
HI   CVCL_Z202 ! BmVIII-SCC
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   BmVIII-SCC-OPr-C54
AC   CVCL_Z205
SY   C54
DR   Wikidata; Q54797660
RX   PubMed=11931027;
CC   Group: Tick cell line.
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
HI   CVCL_Z202 ! BmVIII-SCC
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   BMWi19851992
AC   CVCL_GZ74
DR   Wikidata; Q54797661
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   BN
AC   CVCL_Y432
DR   Wikidata; Q54797663
RX   PubMed=17760811;
CC   Characteristics: Produces IgG lambda.
CC   Doubling time: ~4-6 days (PubMed=17760811).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 10
//
ID   BN-175
AC   CVCL_JY77
SY   BN 175; BN175; LS 175
DR   Wikidata; Q54797664
RX   PubMed=6186616;
CC   Breed/subspecies: Brown Norway; RS=RS_0000113.
DI   NCIt; C60434; Rat liposarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   BN/MSV
AC   CVCL_AW01
DR   Wikidata; Q54797665
RX   PubMed=7664754;
CC   Transformant: MSV.
CC   Breed/subspecies: Brown Norway; RS=RS_0000113.
DI   NCIt; C60530; Rat yolk sac carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 5
//
ID   BN17
AC   CVCL_U151
SY   Clone beta-N17
DR   BTO; BTO_0003351
DR   Wikidata; Q54797667
RX   PubMed=7980449;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:286; ADRB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0464 ! 108CC15
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 9
//
ID   Bn3
AC   CVCL_C3SK
SY   B3
DR   Wikidata; Q116048604
RX   PubMed=2983000;
RX   PubMed=3004943;
CC   Transformant: NCBI_TaxID; 10315; Human herpesvirus 2 (HHV-2) (strain HG52).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Bn5
AC   CVCL_C3SL
SY   B5
DR   Wikidata; Q116048605
RX   PubMed=2983000;
RX   PubMed=3004943;
CC   Transformant: NCBI_TaxID; 10315; Human herpesvirus 2 (HHV-2) (strain HG52).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Bn5T
AC   CVCL_C3SM
SY   B5T
DR   Wikidata; Q116048606
RX   PubMed=2983000;
RX   PubMed=3004943;
CC   Characteristics: Produced from a tumor induced by the inoculation of the parent cell line.
CC   Transformant: NCBI_TaxID; 10315; Human herpesvirus 2 (HHV-2) (strain HG52).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C3SL ! Bn5
SX   Sex unspecified
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BNBH-1
AC   CVCL_M707
SY   BNBH-I
DR   Wikidata; Q54797668
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3391709;
CC   Population: Japanese.
CC   Doubling time: 51 hours (PubMed=3391709).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   BNC1
AC   CVCL_UE03
SY   BNC 1
DR   Wikidata; Q93428839
RX   PubMed=3013426;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   BNI-FNS-51
AC   CVCL_C0X2
DR   GEO; GSM5460964
DR   Wikidata; Q114310759
RX   PubMed=35394061;
CC   Population: Chinese.
CC   Characteristics: Established from the PDX-NF2-FNS-05 xenograft.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral nervous system, cranial nerve, facial nerve; UBERON=UBERON_0001647.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=35394061
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D12S391: 18,20
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D1S1656: 15
ST   D21S11: 29,30
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D6S1043: 11,14
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 19,23
ST   Penta D: 11,15
ST   Penta E: 12,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3274; Neurofibromatosis type 2
DI   NCIt; C188213; Facial nerve schwannoma
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   BNI-VS-50
AC   CVCL_C0X3
DR   cancercelllines; CVCL_C0X3
DR   GEO; GSM5460962
DR   Wikidata; Q114310760
RX   PubMed=35394061;
CC   Population: Chinese.
CC   Characteristics: Established from the PDX-NF2-VS-02 xenograft.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Unspecified (PubMed=35394061).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=35394061
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D12S391: 18,20
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 13,19
ST   D19S433: 13,14
ST   D1S1656: 15,16
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D6S1043: 18,19
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 11,19
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C3274; Neurofibromatosis type 2
DI   NCIt; C3276; Vestibular schwannoma
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
DI   ORDO; Orphanet_252175; Vestibular schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   BNI-VS-52
AC   CVCL_C0X4
DR   GEO; GSM5460963
DR   Wikidata; Q114310761
RX   PubMed=35394061;
CC   Population: Chinese.
CC   Characteristics: Established from the PDX-NF2-VS-04 xenograft.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; c.808_809ins; Zygosity=Unspecified (PubMed=35394061).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=35394061
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D12S391: 18,20
ST   D13S317: 9,10
ST   D16S539: 9,10
ST   D18S51: 14,15
ST   D19S433: 13,16.2
ST   D1S1656: 15,17
ST   D21S11: 30,31
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D6S1043: 11,18
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   Penta D: 12,13
ST   Penta E: 8,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3274; Neurofibromatosis type 2
DI   NCIt; C3276; Vestibular schwannoma
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
DI   ORDO; Orphanet_252175; Vestibular schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   BNIi001-A
AC   CVCL_A4CT
DR   hPSCreg; BNIi001-A
DR   Wikidata; Q105506533
RX   PubMed=33388707;
CC   From: Barrow Neurological Institute; Phoenix; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple; c.2993-14G>T; dbSNP=rs1356799960; Zygosity=Heterozygous (PubMed=33388707).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple; p.Phe115Cys (c.344T>G); ClinVar=VCV000126561; Zygosity=Heterozygous (PubMed=33388707).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4CU ! BNIi001-B
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   BNIi001-B
AC   CVCL_A4CU
DR   hPSCreg; BNIi001-B
DR   Wikidata; Q105506535
RX   PubMed=33388707;
CC   From: Barrow Neurological Institute; Phoenix; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple; c.2993-14G>T; Zygosity=Heterozygous (PubMed=33388707).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple; p.Phe115Cys (c.344T>G); ClinVar=VCV000126561; Zygosity=Heterozygous (PubMed=33388707).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4CT ! BNIi001-A
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   BNL 1ME A.7R.1
AC   CVCL_6371
SY   BNL.1ME A.7R.1; BNL 1MEA.7R.1; BNL-HCC
DR   BTO; BTO_0005675
DR   CLO; CLO_0002009
DR   ATCC; TIB-75
DR   BCRC; 60215
DR   CCRID; 1101MOU-PUMC000273
DR   CCRID; 1101MOU-PUMC000326
DR   Wikidata; Q54797670
RX   PubMed=723934;
RX   PubMed=9667749;
RX   PubMed=23796475;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: Tumorigenic; forms tumors in BALB/c mice and ATxFL mice (ATCC=TIB-75).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Misspelling: TIB75; Note=Based on the ATCC catalog number.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4383 ! BNL CL.2
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   BNL 1NG A.2
AC   CVCL_6372
DR   CLO; CLO_0002010
DR   ATCC; TIB-76
DR   BCRC; 60216
DR   Wikidata; Q54797672
RX   PubMed=723934;
RX   PubMed=9667749;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4383 ! BNL CL.2
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   BNL CL.2
AC   CVCL_4383
SY   BNL-CL.2; BNL CL2; BNL.CL2; BN-CL2; BNCL-2; BNCL2
DR   BTO; BTO_0002537
DR   CLO; CLO_0002011
DR   CLDB; cl5164
DR   ATCC; TIB-73
DR   BCRC; 60180
DR   CCRID; 3101MOUGNM22
DR   CLS; 305177
DR   GEO; GSE75335
DR   IZSLER; BS CL 132
DR   KCB; KCB 2012114YJ
DR   Wikidata; Q54797674
RX   PubMed=723934;
RX   PubMed=9667749;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-418.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   BNL CL.2 High Passage
AC   CVCL_JM59
SY   F4 Tib 73 G6PD; Tib73-G6PD WT
DR   ATCC; CRL-3308
DR   Wikidata; Q54797675
RX   PubMed=26576833;
CC   Doubling time: ~40 hours (ATCC=CRL-3308).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4383 ! BNL CL.2
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   BNL SV A.8
AC   CVCL_4508
SY   BNL-SV A.8; BNL-SVA.8
DR   CLO; CLO_0002012
DR   CLDB; cl5171
DR   ATCC; TIB-74
DR   IZSLER; BS TCL 139
DR   Wikidata; Q54797677
RX   PubMed=723934;
RX   PubMed=9667749;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4383 ! BNL CL.2
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   BNL/R
AC   CVCL_B7TH
DR   Wikidata; Q112929336
RX   PubMed=23796475;
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6371 ! BNL 1ME A.7R.1
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   BNTX12
AC   CVCL_C5G2
DR   Wikidata; Q116048607
RX   PubMed=7590787;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08815; Centruroides noxius potassium channel toxin alpha-KTx 2.1 (Noxiustoxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BNTX14
AC   CVCL_C5G3
DR   Wikidata; Q116048608
RX   PubMed=7590787;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08815; Centruroides noxius potassium channel toxin alpha-KTx 2.1 (Noxiustoxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BNTX16
AC   CVCL_C5G4
DR   Wikidata; Q116048609
RX   DOI=10.1089/hyb.1995.14.303;
RX   PubMed=7590787;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08815; Centruroides noxius potassium channel toxin alpha-KTx 2.1 (Noxiustoxin) (Note=Also reacts with other Centruroides species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BNTX18
AC   CVCL_C5G5
DR   Wikidata; Q116048610
RX   PubMed=7590787;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08815; Centruroides noxius potassium channel toxin alpha-KTx 2.1 (Noxiustoxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BNTX21
AC   CVCL_C5G6
DR   Wikidata; Q116048611
RX   PubMed=7590787;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08815; Centruroides noxius potassium channel toxin alpha-KTx 2.1 (Noxiustoxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BNTX4
AC   CVCL_C5G1
DR   Wikidata; Q116048612
RX   PubMed=7590787;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08815; Centruroides noxius potassium channel toxin alpha-KTx 2.1 (Noxiustoxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BO #2
AC   CVCL_1E39
SY   BO 2; BO-2
DR   Wikidata; Q54797678
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=3518877;
CC   Doubling time: 58 hours (Note=At 5th passage), 72 hours (Note=At 62th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   Bo Gin
AC   CVCL_0096
DR   CLO; CLO_0002013
DR   ATCC; CRL-1180
DR   Wikidata; Q54797681
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Bo Mat
AC   CVCL_0F50
DR   ATCC; CRL-1146
DR   Wikidata; Q54797683
RX   PubMed=1054840;
CC   Discontinued: ATCC; CRL-1146; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BO-1
AC   CVCL_F0F6
RX   CelloPub=CLPUB00807;
RX   PubMed=18358665;
RX   PubMed=20206147;
CC   Virology: Susceptible to infection by Theiler's murine encephalomyelitis virus (TMEV) (PubMed=20206147).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte precursor cell; CL=CL_0002453.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1-3D
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BO-101
AC   CVCL_M140
SY   Bo-101
DR   Wikidata; Q54797685
RX   DOI=10.1093/jnen/48.3.301;
RX   PubMed=1862545;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 21.5 hours (PubMed=1862545).
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 9
//
ID   Bo-786-O
AC   CVCL_IS21
DR   cancercelllines; CVCL_IS21
DR   Wikidata; Q54797688
RX   PubMed=24587095;
RX   PubMed=27993170;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 18
//
ID   Bo01
AC   CVCL_VZ53
DR   IBRC; C10003
DR   Wikidata; Q93428908
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   Bo02
AC   CVCL_VZ54
DR   IBRC; C10031
DR   Wikidata; Q93428911
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BO0283
AC   CVCL_GZ19
DR   ECACC; 91072912
DR   Wikidata; Q54797690
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072912; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   BO0292
AC   CVCL_GZ17
DR   ECACC; 91091002
DR   Wikidata; Q54797691
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   BO0295
AC   CVCL_8S90
DR   ECACC; 91092402
DR   Wikidata; Q54797692
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;9)(5pter->5q22::9p22->9pter::9qter->9p22::5q22->5qter) (ECACC=91092402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0306
AC   CVCL_GZ18
DR   ECACC; 91111305
DR   Wikidata; Q54797694
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91111305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   BO0307
AC   CVCL_8S91
DR   ECACC; 91111413
DR   Wikidata; Q54797695
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91111413; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0312
AC   CVCL_8S92
DR   ECACC; 91121001
DR   Wikidata; Q54797696
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XXq- (ECACC=91121001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BO0329
AC   CVCL_8S93
DR   ECACC; 92022002
DR   Wikidata; Q54797698
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9227; Hypogonadism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0337
AC   CVCL_8S94
DR   ECACC; 92032004
DR   Wikidata; Q54797723
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,Xq+ (ECACC=92032004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92032004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0338
AC   CVCL_8S95
DR   ECACC; 92032601
DR   Wikidata; Q54797725
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;4)(11;14) (ECACC=92032601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0362
AC   CVCL_8S96
DR   ECACC; 92052010
DR   Wikidata; Q54797727
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,?t(2;12)(q32;q15),inv(6)(p21.1;p23) (ECACC=92052010).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0382
AC   CVCL_8S97
DR   ECACC; 92061011
DR   Wikidata; Q54797728
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(13)?(q22) (ECACC=92061011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0383
AC   CVCL_8S98
DR   ECACC; 92061501
DR   Wikidata; Q54797730
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,r(22) (ECACC=92061501).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179702; Ring chromosome 22 syndrome
DI   ORDO; Orphanet_1446; Ring chromosome 22 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0387
AC   CVCL_8S99
DR   ECACC; 92061813
DR   Wikidata; Q54797731
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(3;7)(p25;q36) (ECACC=92061813).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0388
AC   CVCL_8T00
DR   ECACC; 92061814
DR   Wikidata; Q54797732
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar (ECACC=92061814).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75477; Cat-eye syndrome
DI   ORDO; Orphanet_195; Cat-eye syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0389
AC   CVCL_8T01
DR   ECACC; 92061815
DR   Wikidata; Q54797734
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(qter-cen) (ECACC=92061815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0392
AC   CVCL_8T02
DR   ECACC; 92062610
DR   Wikidata; Q54797736
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062610; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BO0396
AC   CVCL_8T03
DR   ECACC; 92070102
DR   Wikidata; Q54797737
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(3;9)(p26;q21)mat (ECACC=92070102).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0401
AC   CVCL_8T04
DR   ECACC; 92070702
DR   Wikidata; Q54797738
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0430
AC   CVCL_8T05
DR   ECACC; 92073005
DR   Wikidata; Q54797740
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0436
AC   CVCL_8T06
DR   ECACC; 92080401
DR   Wikidata; Q54797741
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;22)(p36;p12) (ECACC=92080401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0467
AC   CVCL_8T07
DR   ECACC; 92100847
DR   Wikidata; Q54797743
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;3)(q27.3;p25) (ECACC=92100847).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92100847; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0471
AC   CVCL_8T08
DR   ECACC; 92101202
DR   Wikidata; Q54797744
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(4;6)(q31.3;p21.3) (ECACC=92101202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0557
AC   CVCL_8T09
DR   ECACC; 93010722
DR   Wikidata; Q54797746
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY?,(4;11)(q22;q21) (ECACC=93010722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010722; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0563
AC   CVCL_8T10
DR   ECACC; 93011408
DR   Wikidata; Q54797749
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0566
AC   CVCL_8T11
DR   ECACC; 93011512
DR   Wikidata; Q54797750
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,-X,+derX,t(X;6)(q28;p12) (ECACC=93011512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0574
AC   CVCL_8T12
DR   ECACC; 93020207
DR   Wikidata; Q54797752
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BO0575
AC   CVCL_8T13
DR   ECACC; 93020208
DR   Wikidata; Q54797754
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BO0576
AC   CVCL_8T14
DR   ECACC; 93020209
DR   Wikidata; Q54797755
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;17) (ECACC=93020209).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0603
AC   CVCL_8T15
DR   ECACC; 93022607
DR   Wikidata; Q54797758
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;10)(q27;q25) (ECACC=93022607).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0613
AC   CVCL_8T16
DR   ECACC; 93030913
DR   Wikidata; Q54797759
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,-5,+der5t(5;11)(p15;p14) (ECACC=93030913).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BO0662
AC   CVCL_8T17
DR   ECACC; 93050612
DR   Wikidata; Q54797760
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BO0663
AC   CVCL_8T18
DR   ECACC; 93050613
DR   Wikidata; Q54797761
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93050613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BO0705
AC   CVCL_8T19
DR   ECACC; 93061011
DR   Wikidata; Q54797764
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,5p+ (ECACC=93061011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   BO0706
AC   CVCL_8T20
DR   ECACC; 93061107
DR   Wikidata; Q54797765
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,12q+ (ECACC=93061107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0707
AC   CVCL_8T21
DR   ECACC; 93061108
DR   Wikidata; Q54797766
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,12q+ (ECACC=93061108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0717
AC   CVCL_8T22
DR   ECACC; 93061803
DR   Wikidata; Q54797768
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0718
AC   CVCL_8T23
DR   ECACC; 93061804
DR   Wikidata; Q54797769
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(15)(pter->q11.2::q13->qter) (ECACC=93061804).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0719
AC   CVCL_8T24
DR   ECACC; 93061805
DR   Wikidata; Q54797771
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0720
AC   CVCL_8T25
DR   ECACC; 93061806
DR   Wikidata; Q54797772
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0723
AC   CVCL_8T26
DR   ECACC; 93062506
DR   Wikidata; Q54797774
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,5q+ (ECACC=93062506).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93062506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0737
AC   CVCL_8T27
DR   ECACC; 93071404
DR   Wikidata; Q54797776
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,-22,+der(22)(T) (ECACC=93071404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0740
AC   CVCL_8T28
DR   ECACC; 93072101
DR   Wikidata; Q54797778
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;10)(q42;q22) (ECACC=93072101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93072101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0763
AC   CVCL_8T29
DR   ECACC; 93081602
DR   Wikidata; Q54797781
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,-8+der(8),t(8;20)(20pter->20p12::8p23->8qter)pat (ECACC=93081602).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0769
AC   CVCL_8T30
DR   ECACC; 93081909
DR   Wikidata; Q54797782
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,13q+ (ECACC=93081909).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0770
AC   CVCL_8T31
DR   ECACC; 93081915
DR   Wikidata; Q54797784
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081915; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0772
AC   CVCL_8T32
DR   ECACC; 93082627
DR   Wikidata; Q54797785
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(22)(q11.2) (ECACC=93082627).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BO0789
AC   CVCL_8T33
DR   ECACC; 93100611
DR   Wikidata; Q54797787
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 15q-; de novo (ECACC=93100611).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 10
//
ID   BO0790
AC   CVCL_8T34
DR   ECACC; 93101104
DR   Wikidata; Q54797812
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+marker (ECACC=93101104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   BO0794
AC   CVCL_8T35
DR   ECACC; 93101506
DR   Wikidata; Q54797814
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(8;20)(p23;p12) (ECACC=93101506).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0795
AC   CVCL_8T36
DR   ECACC; 93101505
DR   Wikidata; Q54797816
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+mar; 48,XX,+mar+mar (ECACC=93101505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   BO0799
AC   CVCL_8T37
DR   ECACC; 93102004
DR   Wikidata; Q54797817
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,5p-,inv(9)(p11;q13) (ECACC=93102004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO0800
AC   CVCL_8T38
DR   ECACC; 93102005
DR   Wikidata; Q54797818
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO0812
AC   CVCL_8T39
DR   ECACC; 93102908
DR   Wikidata; Q54797819
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(7)(p15.1;q11.23),dup(15)(q11.2;q13) (ECACC=93102908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102908; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0813
AC   CVCL_8T40
DR   ECACC; 93102909
DR   Wikidata; Q54797821
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,dup(15)(q11.2;q13) (ECACC=93102909).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   BO0819
AC   CVCL_8T41
DR   ECACC; 93110404
DR   Wikidata; Q54797822
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0841
AC   CVCL_8T42
DR   ECACC; 93111705
DR   Wikidata; Q54797823
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BO0851
AC   CVCL_8T43
DR   ECACC; 93112512
DR   Wikidata; Q54797825
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,ringY; 46,X,marY; 47,X,ring,marY (ECACC=93112512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0852
AC   CVCL_8T44
DR   ECACC; 931130121
DR   Wikidata; Q54797827
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;3)(p25;q25) (ECACC=931130121).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 931130121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0877
AC   CVCL_8T45
DR   ECACC; 94011110
DR   Wikidata; Q54797829
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(3;7)(q29;q36.1) (ECACC=94011110).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94011110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0885
AC   CVCL_8T46
DR   ECACC; 94012010
DR   Wikidata; Q54797830
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(10;22)(q26.3;q13.31) (ECACC=94012010).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012010; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0913
AC   CVCL_8T47
DR   ECACC; 94040703
DR   Wikidata; Q54797831
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84562; Anhidrotic ectodermal dysplasia 1
DI   ORDO; Orphanet_238468; Hypohidrotic ectodermal dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0920
AC   CVCL_8T48
DR   ECACC; 94041502
DR   Wikidata; Q54797834
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(3;5)(q25.3;q33.3) (ECACC=94041502).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94041502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0939
AC   CVCL_8T49
DR   ECACC; 94042659
DR   Wikidata; Q54797835
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BO0954
AC   CVCL_8T50
DR   ECACC; 94051310
DR   Wikidata; Q54797836
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(8)(p21;q11.2) (ECACC=94051310).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO0955
AC   CVCL_8T51
DR   ECACC; 94051311
DR   Wikidata; Q54797839
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   3Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BO0960
AC   CVCL_8T52
DR   ECACC; 94052404
DR   Wikidata; Q54797841
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,psce dic(Y),t(Y;15)(Ypter->cen->Yq11.2::15q11.2->15pter) (ECACC=94052404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94052404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO0988
AC   CVCL_8T53
DR   ECACC; 94080201
DR   Wikidata; Q54797842
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84562; Anhidrotic ectodermal dysplasia 1
DI   ORDO; Orphanet_238468; Hypohidrotic ectodermal dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO1028
AC   CVCL_8T54
DR   ECACC; 94082622
DR   Wikidata; Q54797845
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,dup(15)(q11.2->q13) (ECACC=94082622).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082622; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO1029
AC   CVCL_8T55
DR   ECACC; 94082673
DR   Wikidata; Q54797846
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,dup(15)(q11.2->q13) (ECACC=94082673).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082673; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO1035
AC   CVCL_8T56
DR   ECACC; 94090607
DR   Wikidata; Q54797848
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,dup(15)(q11.2->q13) (ECACC=94090607).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO1038
AC   CVCL_8T57
DR   ECACC; 94091404
DR   Wikidata; Q54797850
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,dup(15)(q11.2->q13) (ECACC=94091404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94091404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BO1039
AC   CVCL_8T58
DR   ECACC; 94091405
DR   Wikidata; Q54797851
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94091405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO1040
AC   CVCL_8T59
DR   ECACC; 94092001
DR   Wikidata; Q54797853
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X),(qter->p22.31) (ECACC=94092001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO1060
AC   CVCL_8T60
DR   ECACC; 94102005
DR   Wikidata; Q54797854
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(4;14)(q21;q13) (ECACC=94102005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94102005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO1064
AC   CVCL_8T61
DR   ECACC; 94110208
DR   Wikidata; Q54797855
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(5) (ECACC=94110208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO1087
AC   CVCL_8T62
DR   ECACC; 94120851
DR   Wikidata; Q54797858
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 5p deletion (ECACC=94120851).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO1091
AC   CVCL_8T63
DR   ECACC; 94121914
DR   Wikidata; Q54797859
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX; 47,XX,+r(?) (ECACC=94121914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO1093
AC   CVCL_8T64
DR   ECACC; 95010615
DR   Wikidata; Q54797861
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95010615; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BO2017
AC   CVCL_8T65
DR   ECACC; 95022113
DR   Wikidata; Q54797863
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 48,XY+mar1,+mar2; 48,XY,+mar1,+mar3; 49,XY,+mar1,+mar2,+mar3 (ECACC=95022113).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2036
AC   CVCL_8T66
DR   ECACC; 95031725
DR   Wikidata; Q54797864
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,10p+ (ECACC=95031725).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2048
AC   CVCL_8T67
DR   ECACC; 95040515
DR   Wikidata; Q54797866
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,?del(1) (ECACC=95040515).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2108
AC   CVCL_8T68
DR   ECACC; 95111002
DR   Wikidata; Q54797867
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;2)(q42.3;q37.1) (ECACC=95111002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BO2110
AC   CVCL_8T69
DR   ECACC; 95111402
DR   Wikidata; Q54797869
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,18pt (ECACC=95111402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2115
AC   CVCL_8T70
DR   ECACC; 95120703
DR   Wikidata; Q54797870
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95120703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BO2128
AC   CVCL_8T71
DR   ECACC; 96060202
DR   Wikidata; Q54797873
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BO2135
AC   CVCL_8T72
DR   ECACC; 96072502
DR   Wikidata; Q54797874
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96072502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   BO2136
AC   CVCL_8T73
DR   ECACC; 96072503
DR   Wikidata; Q54797875
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   BO2169
AC   CVCL_8T74
DR   ECACC; 97031439
DR   Wikidata; Q54797905
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   13Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2170
AC   CVCL_8T75
DR   ECACC; 97031440
DR   Wikidata; Q54797907
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,-9,+der t(4;9)(q34.2;p22)pat (ECACC=97031440).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2173
AC   CVCL_GZ16
DR   ECACC; 97032603
DR   Wikidata; Q54797909
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97032603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   BO2199
AC   CVCL_8T76
DR   ECACC; 98012204
DR   Wikidata; Q54797910
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(4)(q25;q27) (ECACC=98012204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2216
AC   CVCL_8T77
DR   ECACC; 98061602
DR   Wikidata; Q54797911
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2217
AC   CVCL_8T78
DR   ECACC; 98070913
DR   Wikidata; Q54797913
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   BO2224
AC   CVCL_8T79
DR   ECACC; 98092501
DR   Wikidata; Q54797915
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+r(5); 46,XY(25)ish r(19)(wep19+) (ECACC=98092501).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BO2C11
AC   CVCL_LB95
SY   Bo2C11
DR   Wikidata; Q54797916
RX   PubMed=9657749;
CC   Characteristics: Produces a monoclonal antibody that completely inhibits the procoagulant activity of native and activated factor VIII.
CC   Monoclonal antibody isotype: IgG4, kappa.
CC   Monoclonal antibody target: UniProtKB; P00451; Human F8.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   Boar88
AC   CVCL_M958
SY   Boar-88; Boar 88
DR   Wikidata; Q54797917
RX   PubMed=7519826;
RX   PubMed=11572760;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=11572760).
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   Bob
AC   CVCL_2317
DR   ECACC; 10021102
DR   Wikidata; Q54797919
RX   PubMed=19544327;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/bob/
CC   Group: Serum/protein free medium cell line.
CC   Karyotypic information: Near tetraploid karyotype. Has lost chromosome Y (PubMed=19544327).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): ECACC=10021102
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   BOB
AC   CVCL_E491
DR   CLDB; cl7227
DR   dbMHC; 48507
DR   ECACC; 88052089
DR   ICLC; HTL14003
DR   IHW; IHW09089
DR   IPD-IMGT/HLA; 11622
DR   PRIDE; PXD001205
DR   Wikidata; Q54797921
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=25502872;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; German.
CC   HLA typing: A*24:03:01:01; B*51:01:01:01; C*15:02:01:01; DPA1*01; DPB1*04:02:01; DQA1*05:05; DQB1*03:01:01; DRA*01:01; DRB1*11:04:01; DRB3*02:02 (IPD-IMGT/HLA=11622).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   BoCEFi
AC   CVCL_B6MS
SY   Bone-derived CEF immortal
DR   Wikidata; Q111732988
RX   PubMed=11237869;
RX   PubMed=11513975;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BOD-DSRCT
AC   CVCL_B5EI
DR   Wikidata; Q110432638
RX   PubMed=23759995;
RX   PubMed=34841430;
CC   Doubling time: 46.6 hours (PubMed=34841430).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex7-WT1 Ex8 fusion (PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:14010; MGA; Simple; p.Leu2167Glyfs*27; Zygosity=Unspecified (PubMed=34841430).
DI   NCIt; C27373; Adult desmoplastic small round cell tumor
DI   ORDO; Orphanet_83469; Desmoplastic small round cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   BOJO
AC   CVCL_M784
DR   Cosmic; 1590840
DR   Wikidata; Q54797923
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=15126569;
RX   PubMed=17786610;
RX   PubMed=22038905;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   BOKU
AC   CVCL_1089
SY   Boku
DR   CLO; CLO_0009925
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470920
DR   cancercelllines; CVCL_1089
DR   Cell_Model_Passport; SIDM00073
DR   ChEMBL-Cells; CHEMBL3308160
DR   ChEMBL-Targets; CHEMBL2366109
DR   Cosmic; 753536
DR   DepMap; ACH-001451
DR   EGA; EGAS00001000978
DR   GDSC; 753536
DR   GEO; GSM1669626
DR   IARC_TP53; 27686
DR   JCRB; IFO50323
DR   LINCS_LDP; LCL-1545
DR   PharmacoDB; BOKU_105_2019
DR   PubChem_Cell_line; CVCL_1089
DR   Wikidata; Q54797924
RX   CelloPub=CLPUB00481;
RX   PubMed=20164919;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~3 days (Note=Lot 11122010) (JCRB=IFO50323).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DepMap=ACH-001451; JCRB=IFO50323; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 13.2,14
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 8,11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 21.2,24
ST   Penta D: 12,13
ST   Penta E: 10,18
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,21
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   BOL #1
AC   CVCL_C7SB
DR   Wikidata; Q117704227
RX   PubMed=994214;
RX   PubMed=4524119;
CC   Doubling time: 36 hours (Note=At 30th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   BOLETH
AC   CVCL_E492
SY   BO
DR   EFO; EFO_0022585
DR   dbMHC; 48508
DR   ECACC; 88052031
DR   IHW; IHW09031
DR   IPD-IMGT/HLA; 10329
DR   Wikidata; Q54797927
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Swedish.
CC   HLA typing: A*02:01:01:01; B*15:01:01:01; C*03:04:01:01; DPA1*01:03:01; DPB1*04:01:01; DQA1*03:01:01; DQB1*03:02:01; DRA*01:01; DRB1*04:01:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=10329).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   BOM1-hiPSC1
AC   CVCL_C438
SY   BOM.1.H.iPSC.1; B-hiPSC1; RIi002-A
DR   hPSCreg; RIi002-A
DR   RSCB; RSCB0043
DR   SKIP; SKIP002397
DR   SKIP; SKIP005834
DR   Wikidata; Q54797928
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C441 ! BOM1-hiPSC12
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   BOM1-hiPSC10
AC   CVCL_C439
SY   BOM.1.H.iPSC.10
DR   RSCB; RSCB0061
DR   Wikidata; Q54797931
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C441 ! BOM1-hiPSC12
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BOM1-hiPSC11
AC   CVCL_C440
SY   BOM.1.H.iPSC.11; B-hiPSC11
DR   RSCB; RSCB0062
DR   Wikidata; Q54797932
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C441 ! BOM1-hiPSC12
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   BOM1-hiPSC12
AC   CVCL_C441
SY   BOM.1.H.iPSC.12; B-hiPSC12
DR   RSCB; RSCB0063
DR   Wikidata; Q54797933
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   BOM1-hiPSC13
AC   CVCL_C442
SY   BOM.1.H.iPSC.13
DR   RSCB; RSCB0064
DR   Wikidata; Q54797935
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C441 ! BOM1-hiPSC12
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BOM1-hiPSC3
AC   CVCL_C443
SY   BOM.1.H.iPSC.3
DR   RSCB; RSCB0044
DR   Wikidata; Q54797936
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C441 ! BOM1-hiPSC12
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BOM1-hiPSC4
AC   CVCL_C444
SY   BOM.1.H.iPSC.4
DR   RSCB; RSCB0045
DR   Wikidata; Q54797938
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C441 ! BOM1-hiPSC12
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BOM1-hiPSC8
AC   CVCL_C445
SY   BOM.1.H.iPSC.8
DR   RSCB; RSCB0049
DR   Wikidata; Q54797939
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C446 ! BOM1-hiPSC9
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C441 ! BOM1-hiPSC12
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BOM1-hiPSC9
AC   CVCL_C446
SY   BOM.1.H.iPSC.9
DR   RSCB; RSCB0060
DR   Wikidata; Q54797942
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C438 ! BOM1-hiPSC1
OI   CVCL_C443 ! BOM1-hiPSC3
OI   CVCL_C444 ! BOM1-hiPSC4
OI   CVCL_C445 ! BOM1-hiPSC8
OI   CVCL_C439 ! BOM1-hiPSC10
OI   CVCL_C440 ! BOM1-hiPSC11
OI   CVCL_C441 ! BOM1-hiPSC12
OI   CVCL_C442 ! BOM1-hiPSC13
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   BoMac
AC   CVCL_B6PF
SY   BoMAC
DR   Wikidata; Q111732990
RX   PubMed=7676607;
RX   PubMed=15075278;
RX   PubMed=16441438;
RX   PubMed=29316971;
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=29316971).
CC   Doubling time: 24 hours (PubMed=7676607).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=776).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: Jersey; VBO=VBO_0000250.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm
AC   CVCL_A7WX
SY   Macrophage Cell Line Derived from Wild Type Mice
DR   BEI_Resources; NR-9456
DR   Wikidata; Q107113475
RX   PubMed=21880772;
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Casp1-/-
AC   CVCL_A7WY
SY   Macrophage Cell Line Derived from Caspase 1 Knockout Mice
DR   BEI_Resources; NR-44113
DR   Wikidata; Q107113477
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:96544; Casp1.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Cd14-/-
AC   CVCL_A7WZ
SY   Macrophage Cell Line Derived from CD14 Knockout Mice
DR   BEI_Resources; NR-9570
DR   Wikidata; Q107113478
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:88318; Cd14.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Irf3-/-
AC   CVCL_A7XA
SY   Macrophage Cell Line Derived from IRF3 Knockout Mice
DR   BEI_Resources; NR-15635
DR   Wikidata; Q107113479
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1859179; Irf3.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Irf3-/- Irf7-/-
AC   CVCL_A7XB
SY   Macrophage Cell Line Derived from IRF3/IRF7 Double Knockout Mice
DR   BEI_Resources; NR-15637
DR   Wikidata; Q107113480
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1859179; Irf3.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1859212; Irf7.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Irf7-/-
AC   CVCL_A7XC
SY   Macrophage Cell Line Derived from IRF7 Knockout Mice
DR   BEI_Resources; NR-15636
DR   Wikidata; Q107113481
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1859212; Irf7.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Myd88-/-
AC   CVCL_A7XD
SY   Macrophage Cell Line Derived from MyD88 Knockout Mice
DR   BEI_Resources; NR-15633
DR   Wikidata; Q107113482
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Myd88-/- Ticam1-/-
AC   CVCL_A7XE
SY   Macrophage Cell Line Derived from TRIF/MyD88 Double Knockout Mice
DR   BEI_Resources; NR-15632
DR   Wikidata; Q107113483
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   BoMaMa-J2imm Ticam1-/-
AC   CVCL_A7XF
SY   Macrophage Cell Line Derived from TRIF Knockout Mice
DR   BEI_Resources; NR-9566
DR   Wikidata; Q107113484
RX   PubMed=21880772;
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   BoMaMa-J2imm Ticam1-/- Ticam2-/-
AC   CVCL_A7XG
SY   Macrophage Cell Line Derived from TRIF/TRAM Double Knockout Mice
DR   BEI_Resources; NR-9568
DR   Wikidata; Q107113486
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   BoMaMa-J2imm Ticam2-/-
AC   CVCL_A7XH
SY   Macrophage Cell Line Derived from TRAM Knockout Mice
DR   BEI_Resources; NR-9567
DR   Wikidata; Q107113487
RX   PubMed=21880772;
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tirap-/-
AC   CVCL_A7XI
SY   Macrophage Cell Line Derived from MAL Knockout Mice
DR   BEI_Resources; NR-9459
DR   Wikidata; Q107113488
RX   PubMed=21880772;
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2152213; Tirap.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr1-/-
AC   CVCL_A7XJ
SY   Macrophage Cell Line Derived from TLR1 Knockout Mice
DR   BEI_Resources; NR-19977
DR   Wikidata; Q107113489
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1341295; Tlr1.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr2-/-
AC   CVCL_A7XK
SY   Macrophage Cell Line Derived from TLR2 Knockout Mice
DR   BEI_Resources; NR-9457
DR   Wikidata; Q107113490
RX   PubMed=21880772;
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr2-/- Tlr4-/-
AC   CVCL_A7XL
SY   Macrophage Cell Line Derived from TLR2/TLR4 Double Knockout Mice
DR   BEI_Resources; NR-19975
DR   Wikidata; Q107113491
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2.
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr2-/- Tlr9-/-
AC   CVCL_A7XM
SY   Macrophage Cell Line Derived from TLR2/TLR9 Double Knockout Mice
DR   BEI_Resources; NR-19976
DR   Wikidata; Q107113492
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr3-/-
AC   CVCL_A7XN
SY   Macrophage Cell Line Derived from TLR3 Knockout Mice
DR   BEI_Resources; NR-19974
DR   Wikidata; Q107113493
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2156367; Tlr3.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr4-/-
AC   CVCL_A7XP
SY   Macrophage Cell Line Derived from TLR4 Knockout Mice
DR   BEI_Resources; NR-9458
DR   Wikidata; Q107113494
RX   PubMed=21880772;
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr6-/-
AC   CVCL_A7XQ
SY   Macrophage Cell Line Derived from TLR6 Knockout Mice
DR   BEI_Resources; NR-19972
DR   Wikidata; Q107113495
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1341296; Tlr6.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr7-/-
AC   CVCL_A7XR
SY   Macrophage Cell Line Derived from TLR7 Knockout Mice
DR   BEI_Resources; NR-15634
DR   Wikidata; Q107113496
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2176882; Tlr7.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr9-/-
AC   CVCL_A7XS
SY   Macrophage Cell Line Derived from TLR9 Knockout Mice
DR   BEI_Resources; NR-9569
DR   Wikidata; Q107113497
RX   PubMed=21880772;
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BoMaMa-J2imm Tlr9-/- GFP
AC   CVCL_A7XT
SY   Macrophage Cell Line Derived from TLR9 Knockout GFP Mice
DR   BEI_Resources; NR-19979
DR   Wikidata; Q107113498
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BON
AC   CVCL_E493
SY   BON-CT
DR   dbMHC; 48509
DR   ECACC; 94071429
DR   IHW; IHW09290
DR   IPD-IMGT/HLA; 10330
DR   Wikidata; Q54797943
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*01,03; B*44:03:01,35; C*16:01,04; DQA1*01:01; DRB1*01:03 (IPD-IMGT/HLA=10330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BON-1
AC   CVCL_3985
AS   CVCL_B390
SY   Bon-1; BON1; BON
DR   BTO; BTO_0003856
DR   EFO; EFO_0022643
DR   cancercelllines; CVCL_3985
DR   Cosmic; 721017
DR   Cosmic; 1620107
DR   Cosmic; 1879411
DR   Cosmic; 2433550
DR   Cosmic; 2530675
DR   Wikidata; Q54797946
RX   CelloPub=CLPUB00598;
RX   PubMed=1712329;
RX   PubMed=7978888;
RX   PubMed=8108375;
RX   PubMed=19295186;
RX   PubMed=22538498;
RX   PubMed=22929519;
RX   PubMed=25612765;
RX   PubMed=26087898;
RX   PubMed=29330294;
RX   PubMed=29444910;
RX   PubMed=29895527;
RX   PubMed=32884006;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BON
CC   Doubling time: 1.5 +- 0.4 days (PubMed=29330294); 46 +- 0.72 hours (PubMed=32884006).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25612765; PubMed=29444910).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=25612765; PubMed=29444910).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Heterozygous (PubMed=29444910).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1960Tyr (c.5879G>A); ClinVar=VCV000038003; Zygosity=Heterozygous (PubMed=29444910).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=25612765; PubMed=29444910).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=25612765; PubMed=29444910).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg1329His (c.3986G>A); ClinVar=VCV000041738; Zygosity=Unspecified (PubMed=25612765).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=29444910
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D21S11: 28,33.2
ST   D5S818: 9,12
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 9
ST   vWA: 18,19
DI   NCIt; C4446; Pancreatic serotonin-producing neuroendocrine tumor
DI   ORDO; Orphanet_506090; Serotonin-producing neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   BON1 RR1
AC   CVCL_WV97
SY   RR1
DR   cancercelllines; CVCL_WV97
DR   Wikidata; Q93430380
RX   DOI=10.1530/endoabs.49.EP154;
RX   PubMed=29895527;
CC   Selected for resistance to: ChEBI; CHEBI_68478; Everolimus (RAD001).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1960Tyr (c.5879G>A); ClinVar=VCV000038003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4446; Pancreatic serotonin-producing neuroendocrine tumor
DI   ORDO; Orphanet_506090; Serotonin-producing neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3985 ! BON-1
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   BON1 RR2
AC   CVCL_WV98
SY   RR2
DR   cancercelllines; CVCL_WV98
DR   Wikidata; Q93430383
RX   DOI=10.1530/endoabs.49.EP154;
RX   PubMed=29895527;
CC   Selected for resistance to: ChEBI; CHEBI_68478; Everolimus (RAD001).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1960Tyr (c.5879G>A); ClinVar=VCV000038003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4446; Pancreatic serotonin-producing neuroendocrine tumor
DI   ORDO; Orphanet_506090; Serotonin-producing neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3985 ! BON-1
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   BON1-MEN1-KO
AC   CVCL_A1AU
SY   MEN1-KO-BON1
DR   cancercelllines; CVCL_A1AU
DR   Wikidata; Q102113642
RX   PubMed=32884006;
CC   Doubling time: 36 +- 0.48 hours (PubMed=32884006).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1960Tyr (c.5879G>A); ClinVar=VCV000038003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4446; Pancreatic serotonin-producing neuroendocrine tumor
DI   ORDO; Orphanet_506090; Serotonin-producing neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3985 ! BON-1
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   BONA
AC   CVCL_E494
DR   dbMHC; 48510
DR   ECACC; 94050304
DR   IHW; IHW09325
DR   IPD-IMGT/HLA; 10331
DR   Wikidata; Q54797947
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*02,03; B*51; DPB1*04:01,03:01; DQA1*05:01,01:02; DQB1*03:01,05:02; DRB1*11:01,16:04; DRB3*02; DRB5*02; DRB6*02:02 (IPD-IMGT/HLA=10331).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Bone marrow macrophage immortalized BALB/c
AC   CVCL_C0MS
SY   BALBC; BALBC Macrophage Cell Line
DR   Kerafast; ENH168-FP
DR   Wikidata; Q112929337
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Bone marrow macrophage immortalized C57BL/10SnJ
AC   CVCL_C0MT
SY   C57BL/10SnJ (B10); C57BL/10SnJ (B10) Macrophage Cell Line
DR   Kerafast; ENH165-FP
DR   Wikidata; Q112929338
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/10SnJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Bone marrow macrophage immortalized C57BL/6
AC   CVCL_C0MU
SY   C57BL/6; C57BL/6 Macrophage Cell Line
DR   Kerafast; ENH166-FP
DR   Wikidata; Q112929339
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Bone marrow macrophage immortalized C57BL/6 x 129P3
AC   CVCL_C0MV
SY   B6/129; B6129 Macrophage Cell Line
DR   Kerafast; ENH164-FP
DR   Wikidata; Q112929340
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6 x 129P3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Bone marrow macrophage immortalized C57BL/6J
AC   CVCL_C0MW
SY   C57BL/6J; C57BL/6J Macrophage Cell Line
DR   Kerafast; ENH167-FP
DR   Wikidata; Q112929341
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   Bone marrow macrophage immortalized FVB/N
AC   CVCL_C0MX
SY   FVB/N; FVBN Macrophage Cell Line
DR   Kerafast; ENH171-FP
DR   Wikidata; Q112929342
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   BONNA-12
AC   CVCL_1090
SY   Bonna-12; BONNA12; Bonna12
DR   CLO; CLO_0002014
DR   CLDB; cl473
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473418
DR   cancercelllines; CVCL_1090
DR   Cell_Model_Passport; SIDM00984
DR   Cosmic; 906695
DR   Cosmic; 2690006
DR   Cosmic; 2756295
DR   Cosmic-CLP; 906695
DR   DepMap; ACH-001452
DR   DSMZ; ACC-150
DR   DSMZCellDive; ACC-150
DR   EGA; EGAS00001000978
DR   GEO; GSM1669627
DR   IARC_TP53; 21196
DR   PharmacoDB; BONNA12_106_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54797948
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1313127;
RX   PubMed=20164919;
RX   PubMed=20454443;
RX   PubMed=22653958;
RX   PubMed=27397505;
RX   PubMed=27463354;
RX   PubMed=29989027;
RX   PubMed=30894373;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Problematic cell line: Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (PubMed=27463354); ~50-60 hours (DSMZ=ACC-150).
CC   HLA typing: A*11:01:01,68:01:02; B*35:01:01,40:01:02; C*03:04:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,02:01:02; DQA1*01:03:01,01:01:01; DQB1*05:01:01,06:03:01; DRA*01:01:01,01:02:02; DRB1*01:01:01,13:01:01 (DSMZCellDive=ACC-150).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Thr2466Met (c.7397C>T); ClinVar=VCV000241169; Zygosity=Heterozygous (PubMed=29989027; Cosmic-CLP=906695; DepMap=ACH-001452).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.35%; Native American=0%; East Asian, North=1.04%; East Asian, South=0%; South Asian=0%; European, North=71.7%; European, South=26.91% (PubMed=30894373).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
ST   Source(s): Cosmic-CLP=906695; DepMap=ACH-001452; DSMZ=ACC-150
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11,12 (DSMZ=ACC-150)
ST   D16S539: 12 (Cosmic-CLP=906695; DepMap=ACH-001452)
ST   D18S51: 13 (DSMZ=ACC-150)
ST   D18S51: 14 (DepMap=ACH-001452)
ST   D19S433: 14,17
ST   D21S11: 30,31.2
ST   D2S1338: 19
ST   D3S1358: 14,17
ST   D5S818: 9,14
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 18,22
ST   Penta D: 9,11 (DSMZ=ACC-150)
ST   Penta D: 9,12 (DepMap=ACH-001452)
ST   Penta E: 10,11 (DSMZ=ACC-150)
ST   Penta E: 11 (DepMap=ACH-001452)
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   Boo-HA
AC   CVCL_E3K6
RX   PubMed=37254642;
CC   Doubling time: ~48 hours (PubMed=37254642).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: Sex of donor from personal communication of Schrock, Morgan S.
CC   Miscellaneous: STR profile carried out by CLS and provided by Schrock, Morgan S. The STR profile has 3 additional loci not in standard set: PEZ2:128,136, PEZ15:220 and PEZ17:206,218.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Dog FHC2010: 225,229
ST   Dog FHC2054: 154,170
ST   Dog FHC2079: 274
ST   Dog PEZ1: 110,114
ST   Dog PEZ6: 176,185
ST   Dog PEZ8: 228,247
ST   Dog PEZ12: 266
DI   NCIt; C210824; Canine astrocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   BoPr-1
AC   CVCL_VW48
DR   IBRC; C10654
DR   Wikidata; Q93430396
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-10
AC   CVCL_VW49
DR   IBRC; C10663
DR   Wikidata; Q93430398
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-11
AC   CVCL_VW50
DR   IBRC; C10664
DR   Wikidata; Q93430400
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-12
AC   CVCL_VW51
DR   IBRC; C10665
DR   Wikidata; Q93430402
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-13
AC   CVCL_VW52
DR   IBRC; C10666
DR   Wikidata; Q93430405
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-14
AC   CVCL_VW53
DR   IBRC; C10667
DR   Wikidata; Q93430407
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-15
AC   CVCL_VW54
DR   IBRC; C10668
DR   Wikidata; Q93430409
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-16
AC   CVCL_VW55
DR   IBRC; C10669
DR   Wikidata; Q93430411
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-17
AC   CVCL_VW56
DR   IBRC; C10670
DR   Wikidata; Q93430414
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-18
AC   CVCL_VW57
DR   IBRC; C10671
DR   Wikidata; Q93430417
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-19
AC   CVCL_VW58
DR   IBRC; C10672
DR   Wikidata; Q93430420
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-2
AC   CVCL_VW59
DR   IBRC; C10655
DR   Wikidata; Q93430422
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-20
AC   CVCL_VW60
DR   IBRC; C10673
DR   Wikidata; Q93430424
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-21
AC   CVCL_VW61
DR   IBRC; C10674
DR   Wikidata; Q93430427
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-22
AC   CVCL_VW62
DR   IBRC; C10675
DR   Wikidata; Q93430430
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-23
AC   CVCL_VW63
DR   IBRC; C10676
DR   Wikidata; Q93430432
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-24
AC   CVCL_VW64
DR   IBRC; C10677
DR   Wikidata; Q93430435
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-25
AC   CVCL_VW65
DR   IBRC; C10678
DR   Wikidata; Q93430437
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-26
AC   CVCL_VW66
DR   IBRC; C10686
DR   Wikidata; Q93430441
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-27
AC   CVCL_VW67
DR   IBRC; C10687
DR   Wikidata; Q93430443
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-28
AC   CVCL_VW68
DR   IBRC; C10688
DR   Wikidata; Q93430445
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-29
AC   CVCL_VW69
DR   IBRC; C10689
DR   Wikidata; Q93430447
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-3
AC   CVCL_VW70
DR   IBRC; C10656
DR   Wikidata; Q93430449
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-30
AC   CVCL_VW71
DR   IBRC; C10690
DR   Wikidata; Q93430452
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-31
AC   CVCL_VW72
DR   IBRC; C10691
DR   Wikidata; Q93430454
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-32
AC   CVCL_VW73
DR   IBRC; C10692
DR   Wikidata; Q93430456
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-33
AC   CVCL_VW74
DR   IBRC; C10693
DR   Wikidata; Q93430459
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-34
AC   CVCL_VW75
DR   IBRC; C10694
DR   Wikidata; Q93430461
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-35
AC   CVCL_VW76
DR   IBRC; C10695
DR   Wikidata; Q93430463
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-36
AC   CVCL_VW77
DR   IBRC; C10743
DR   Wikidata; Q93430465
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-37
AC   CVCL_VW78
DR   IBRC; C10744
DR   Wikidata; Q93430467
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-38
AC   CVCL_VW79
DR   IBRC; C10745
DR   Wikidata; Q93430470
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-39
AC   CVCL_VW80
DR   IBRC; C10729
DR   Wikidata; Q93430472
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-4
AC   CVCL_VW81
DR   IBRC; C10657
DR   Wikidata; Q93430474
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-40
AC   CVCL_VW82
DR   IBRC; C10730
DR   Wikidata; Q93430476
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-41
AC   CVCL_VW83
DR   IBRC; C10731
DR   Wikidata; Q93430477
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-42
AC   CVCL_VW84
DR   IBRC; C10732
DR   Wikidata; Q93430479
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-43
AC   CVCL_VW85
DR   IBRC; C10733
DR   Wikidata; Q93430481
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-44
AC   CVCL_VW86
DR   IBRC; C10734
DR   Wikidata; Q93430483
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-45
AC   CVCL_VW87
DR   IBRC; C10735
DR   Wikidata; Q93430486
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-46
AC   CVCL_VW88
DR   IBRC; C10736
DR   Wikidata; Q93430488
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-47
AC   CVCL_VW89
DR   IBRC; C10737
DR   Wikidata; Q93430490
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-48
AC   CVCL_VW90
DR   IBRC; C10738
DR   Wikidata; Q93430492
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-49
AC   CVCL_VW91
DR   IBRC; C10742
DR   Wikidata; Q93430495
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-5
AC   CVCL_VW92
DR   IBRC; C10658
DR   Wikidata; Q93430497
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-50
AC   CVCL_VW93
DR   IBRC; C10740
DR   Wikidata; Q93430499
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-51
AC   CVCL_VW94
DR   IBRC; C10741
DR   Wikidata; Q93430501
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-6
AC   CVCL_VW95
DR   IBRC; C10659
DR   Wikidata; Q93430503
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-7
AC   CVCL_VW96
DR   IBRC; C10660
DR   Wikidata; Q93430505
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-8
AC   CVCL_VW97
DR   IBRC; C10661
DR   Wikidata; Q93430507
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   BoPr-9
AC   CVCL_VW98
DR   IBRC; C10662
DR   Wikidata; Q93430509
RX   DOI=10.1007/s12686-016-0640-x;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sistani; VBO=VBO_0004948.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   Bor II
AC   CVCL_T699
SY   Bombina orientalis II
DR   Wikidata; Q54797949
RX   PubMed=6862516;
CC   Group: Amphibian cell line.
CC   Doubling time: 71 hours (Note=At 20 Celsius), 68 hours (Note=At 25 Celsius), 64 hours (Note=At 30 Celsius) (PubMed=6862516).
OX   NCBI_TaxID=8346; ! Bombina orientalis (Oriental fire-bellied toad)
SX   Sex unspecified
AG   Stage 20 embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   BORRU
AC   CVCL_A1YK
DR   Wikidata; Q105506539
RX   PubMed=19276180;
RX   PubMed=22257080;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 53.9 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   BOS-1
AC   CVCL_XE00
SY   KCB201042
DR   CCRID; 5301BOV-KCB10042ZJ
DR   KCB; KCB 2010042ZJ
DR   Wikidata; Q94337334
RX   PubMed=29048483;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30520; ! Bos gaurus frontalis (Domestic gayal)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   BOS-2
AC   CVCL_A9IS
DR   CCRID; 5301BOV-KCB10045ZJ
DR   KCB; KCB 2010045ZJ
DR   Wikidata; Q108819954
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30520; ! Bos gaurus frontalis (Domestic gayal)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   BOS-3
AC   CVCL_A9IQ
DR   CCRID; 5301BOV-KCB10047ZJ
DR   KCB; KCB 2010047ZJ
DR   Wikidata; Q108819955
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Brahman; VBO=VBO_0000159.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   BOS-4
AC   CVCL_A9IR
DR   CCRID; 5301BOV-KCB10049ZJ
DR   KCB; KCB 2010049ZJ
DR   Wikidata; Q108819956
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Brahman; VBO=VBO_0000159.
OX   NCBI_TaxID=9915; ! Bos indicus (Zebu)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   BOS-5
AC   CVCL_A9IT
DR   CCRID; 5301BOV-KCB10041ZJ
DR   KCB; KCB 2010041ZJ
DR   Wikidata; Q108819957
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=870456; ! Bos frontalis x Bos indicus (Hybrid cattle)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BOS-6
AC   CVCL_A9IU
DR   CCRID; 5301BOV-KCB10046ZJ
DR   KCB; KCB 2010046ZJ
DR   Wikidata; Q108819958
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=870456; ! Bos frontalis x Bos indicus (Hybrid cattle)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   BOS4
AC   CVCL_VS64
DR   Wikidata; Q93430516
RX   PubMed=3018509;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Parent cell line (BS-C-1) was originally thought to be of Chlorocebus aethiops origin but originate from Chlorocebus pygerythrus.
CC   Sequence variation: Mutation; UniProtKB; A0A7D5U6M6; MT-ND6; Simple; p.Tyr50fs*25 (c.147insG) (m.13952dupC); Zygosity=Heteroplasmic (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pK1dl26).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_0607 ! BS-C-1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 8
//
ID   BOSC-23
AC   CVCL_4401
SY   Bosc-23; BOSC 23; Bosc 23; BOSC23; Bosc23; Lenti-X 293T; LentiX 293T
DR   BTO; BTO_0004573
DR   EFO; EFO_0022411
DR   IBRC; C10142
DR   TOKU-E; 3585
DR   Wikidata; Q4836226
RX   Patent=WO1994019478A1;
RX   PubMed=7690960;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-443.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/BOSC23
WW   Provider; Takara Bio; 632180; https://www.takarabio.com/products/gene-function/viral-transduction/lentivirus/packaging-systems-and-cells/lenti-x-293t-cells
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11270.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X852 ! Bartlett 96
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Bosondjo
AC   CVCL_6F55
DR   Wikidata; Q54797953
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BOT-2
AC   CVCL_T293
SY   Breast Original Tumor-2
DR   Wikidata; Q54797955
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=171063;
RX   PubMed=212193;
CC   Population: Caucasian.
CC   Doubling time: 16-18 hours (PubMed=171063).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   BOV-2A8
AC   CVCL_D4C6
DR   CCRID; 4201PAT-CCTCC02488
DR   Wikidata; Q127380343
RX   Patent=CN117230015A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023196.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3YPH4; Primate bocaparvovirus 1 (strain Human bocavirus 1 type 1) (HBoV1) minor capsid protein VP1 (Note=The patent does not indicate which genotype of bocavirus was used to elicit the monoclonal antibody, so we arbitrarily chose HBoV1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   BOV-4B7
AC   CVCL_D4C7
DR   CCRID; 4201PAT-CCTCC02489
DR   Wikidata; Q127380345
RX   Patent=CN117230015A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023197.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q3YPH4; Primate bocaparvovirus 1 (strain Human bocavirus 1 type 1) (HBoV1) minor capsid protein VP1 (Note=The patent does not indicate which genotype of bocavirus was used to elicit the monoclonal antibody, so we arbitrarily chose HBoV1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   BOvMEC
AC   CVCL_A1BI
SY   Bovine Ovary Microvascular Endothelial Cells
DR   Wikidata; Q102113643
RX   PubMed=32722052;
CC   Doubling time: 30 hours (PubMed=32722052).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal ovary, microvascular endothelium; UBERON=UBERON_0000992+UBERON_0008339.
CC   Breed/subspecies: Montbeliarde; VBO=VBO_0000306.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A1BE ! BBrMEC
OI   CVCL_A1BF ! BIntMEC
OI   CVCL_A1BG ! BLuMEC
OI   CVCL_A1BH ! BMLNMEC
OI   CVCL_A1BJ ! BSkMEC
OI   CVCL_A1BK ! BUcEC
SX   Female
AG   6FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   BOW,MF
AC   CVCL_E495
SY   BOW, MF
DR   dbMHC; 48511
DR   ECACC; 94082250
DR   IHW; IHW09150
DR   IPD-IMGT/HLA; 11693
DR   Wikidata; Q54797957
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02; B*44,50; C*05; DPB1*04:01,04:02; DQA1*02:01,03; DQB1*03:01,02:01; DRB1*04:01,07; DRB4*01:01 (IPD-IMGT/HLA=11693).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BOWES CXCR3 clone #1
AC   CVCL_E7UK
RX   PubMed=25798946;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3317 ! HMCB
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   BOWES CXCR3 clone #2
AC   CVCL_E7UL
RX   PubMed=25798946;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3317 ! HMCB
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   BOWES CXCR3 clone #3
AC   CVCL_E7UM
RX   PubMed=25798946;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3317 ! HMCB
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   BOWES pCMV6 clone #1
AC   CVCL_E7UN
SY   BOWES PCMV6
RX   PubMed=25798946;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for the BOWES CXCR3 cell lines (PubMed=25798946).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3317 ! HMCB
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Bowes/sf
AC   CVCL_A0LF
SY   Bowes/serum-free
DR   Wikidata; Q123030821
RX   CelloPub=CLPUB00745;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3317 ! HMCB
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   BOx0029
AC   CVCL_VA69
DR   ECACC; 15042414
DR   Wikidata; Q54797959
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BOY-12E
AC   CVCL_7948
SY   BOY
DR   CLO; CLO_0050847
DR   BioSample; SAMN03471926
DR   cancercelllines; CVCL_7948
DR   GEO; GSM492490
DR   Progenetix; CVCL_7948
DR   RCB; RCB2627
DR   TKG; TKG 0641
DR   Wikidata; Q54797961
RX   CelloPub=CLPUB00345;
RX   PubMed=9036862;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Doubling time: 14.4-25.6 hours (CelloPub=CLPUB00345).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): RCB=RCB2627; TKG=TKG 0641
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   BP
AC   CVCL_WN38
DR   Wikidata; Q93430545
RX   PubMed=8302588;
RX   PubMed=20135361;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   BP(p)Tu
AC   CVCL_WN39
DR   Wikidata; Q93430547
RX   PubMed=8302588;
RX   PubMed=20135361;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Simple; p.Lys130Arg (c.389A>G); Zygosity=Homozygous (PubMed=8302588).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WN38 ! BP
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   BP-8
AC   CVCL_F952
AS   CVCL_H609
SY   BP 8; Bp8; BP8; BP8/C3H
DR   ChEMBL-Cells; CHEMBL3308070
DR   ChEMBL-Targets; CHEMBL613843
DR   PubChem_Cell_line; CVCL_F952
DR   TKG; TKG 0145
DR   Wikidata; Q54797963
RX   PubMed=953994;
RX   PubMed=6293268;
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   BP1-7
AC   CVCL_XE01
DR   CCRID; 4201PAT-CCTCC01302
DR   Wikidata; Q93430555
RX   Patent=CN110003320A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018205.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A6NLP5; Human TTC36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BP102
AC   CVCL_A6LI
SY   BP 102
DR   DSHB; BP-102-anti-CNS-axons
DR   Wikidata; Q107113499
RX   PubMed=8461134;
RX   PubMed=9247329;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Drosophila melanogaster antigen on CNS axons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   BP107.2.2
AC   CVCL_G641
DR   CLO; CLO_0002015
DR   ATCC; TIB-154
DR   Wikidata; Q54797965
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   BP11(R100)
AC   CVCL_U190
DR   CLO; CLO_0051427
DR   RCB; RCB1799
DR   Wikidata; Q54797967
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U191 ! BP11(R2)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP11(R2)
AC   CVCL_U191
DR   CLO; CLO_0051429
DR   RCB; RCB1798
DR   Wikidata; Q54797968
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP13(R100)
AC   CVCL_U192
DR   CLO; CLO_0051431
DR   RCB; RCB1801
DR   Wikidata; Q54797970
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U193 ! BP13(R2)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP13(R2)
AC   CVCL_U193
DR   CLO; CLO_0051430
DR   RCB; RCB1800
DR   Wikidata; Q54797971
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP26(R2)
AC   CVCL_U194
DR   CLO; CLO_0051432
DR   RCB; RCB1802
DR   Wikidata; Q54797973
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP26(R80)
AC   CVCL_U195
DR   CLO; CLO_0051433
DR   RCB; RCB1803
DR   Wikidata; Q54798000
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U194 ! BP26(R2)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP30(R100)
AC   CVCL_U196
DR   CLO; CLO_0051435
DR   RCB; RCB1805
DR   Wikidata; Q54798002
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U197 ! BP30(R2)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP30(R2)
AC   CVCL_U197
DR   CLO; CLO_0051434
DR   RCB; RCB1804
DR   Wikidata; Q54798003
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP36B(R100)
AC   CVCL_U198
DR   CLO; CLO_0051437
DR   RCB; RCB1807
DR   Wikidata; Q54798005
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U199 ! BP36B(R2)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP36B(R2)
AC   CVCL_U199
DR   CLO; CLO_0051436
DR   RCB; RCB1806
DR   Wikidata; Q54798006
RX   PubMed=11169143;
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   BP455
AC   CVCL_B4UE
DR   PRIDE; PXD012308
DR   Wikidata; Q110432639
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*02:01,31:01; B*39:06,40:01; C*03:04,07:02 (Direct_author_submission).
CC   HLA typing: DPA1*01:03; DPB1*02:01; DQA1*01:05,01:10; DQB1*05:01,06:03; DRB1*10:01,13:01; DRB3*01:01 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class II peptidome.
CC   Miscellaneous: HLA class I typing from personal communication of Bassani-Sternberg, Michal.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   BP50
AC   CVCL_C0UF
SY   Bascom Palmer 50
DR   Wikidata; Q112929343
RX   PubMed=34043754;
CC   Doubling time: 52.3 hours (PubMed=34043754).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.264+2T>C; ClinVar=VCV003237116; Zygosity=Unspecified; Note=Splice donor mutation, germline mutation (PubMed=34043754).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Eye, ocular adnexa; UBERON=UBERON_0035639.
ST   Source(s): PubMed=34043754
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D21S11: 28,31.2
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 7,16
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 18,20
DI   NCIt; C43340; Eye sebaceous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-59Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   Bp53MT143
AC   CVCL_LJ71
DR   Wikidata; Q54798008
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11169.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   Bp53WT
AC   CVCL_LJ70
DR   Wikidata; Q54798010
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11168.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   BP6054
AC   CVCL_VA70
DR   ECACC; 15042410
DR   Wikidata; Q54798012
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6061
AC   CVCL_VA71
DR   ECACC; 15042408
DR   Wikidata; Q54798013
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6063
AC   CVCL_VA72
DR   ECACC; 15042707
DR   Wikidata; Q54798014
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6072
AC   CVCL_VA73
DR   ECACC; 15042411
DR   Wikidata; Q54798016
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6074
AC   CVCL_VA74
DR   ECACC; 15042412
DR   Wikidata; Q54798017
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6077
AC   CVCL_VA75
DR   ECACC; 15042413
DR   Wikidata; Q54798018
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6124
AC   CVCL_VA76
DR   ECACC; 15082801
DR   Wikidata; Q54798020
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6165
AC   CVCL_VA77
DR   ECACC; 15082802
DR   Wikidata; Q54798022
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6206
AC   CVCL_VA78
DR   ECACC; 15082803
DR   Wikidata; Q54798023
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6308
AC   CVCL_VA79
DR   ECACC; 15102930
DR   Wikidata; Q54798026
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6334
AC   CVCL_VA80
DR   ECACC; 15102931
DR   Wikidata; Q54798027
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6391
AC   CVCL_VA81
DR   ECACC; 15102932
DR   Wikidata; Q54798028
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6447
AC   CVCL_VA82
DR   ECACC; 15102933
DR   Wikidata; Q54798030
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6488
AC   CVCL_VA83
DR   ECACC; 15102934
DR   Wikidata; Q54798032
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6494
AC   CVCL_VA84
DR   ECACC; 15102935
DR   Wikidata; Q54798034
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6502
AC   CVCL_VA85
DR   ECACC; 15102936
DR   Wikidata; Q54798037
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6504
AC   CVCL_VA86
DR   ECACC; 15082804
DR   Wikidata; Q54798038
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6508
AC   CVCL_VA87
DR   ECACC; 15102937
DR   Wikidata; Q54798040
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6531
AC   CVCL_VA88
DR   ECACC; 15102938
DR   Wikidata; Q54798041
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6535
AC   CVCL_VA89
DR   ECACC; 15082805
DR   Wikidata; Q54798043
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6550
AC   CVCL_VA90
DR   ECACC; 15102939
DR   Wikidata; Q54798044
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP6551
AC   CVCL_VA91
DR   ECACC; 15102940
DR   Wikidata; Q54798046
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   BP7(R80)
AC   CVCL_U200
DR   CLO; CLO_0051428
DR   RCB; RCB1797
DR   Wikidata; Q54798048
RX   PubMed=11169143;
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 8
//
ID   BP8
AC   CVCL_0176
SY   BP-8; 5L-rBP-8
DR   EFO; EFO_0022783
DR   MCCL; MCC:0000067
DR   Wikidata; Q54798050
RX   PubMed=2176138;
CC   Selected for resistance to: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F951 ! 5L
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   BPA191
AC   CVCL_A7UC
SY   BPA 191; Bovine Pulmonary Artery 191
DR   Wikidata; Q107113502
RX   PubMed=8300237;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237).
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BPA291
AC   CVCL_A7UD
SY   BPA 291; Bovine Pulmonary Artery 291
DR   Wikidata; Q107113503
RX   PubMed=8300237;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237).
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BPA593/1
AC   CVCL_A7UE
SY   BPA 593/1; Bovine Pulmonary Artery 593/1
DR   Wikidata; Q107113504
RX   PubMed=8300237;
RX   PubMed=9577776;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237).
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BPA987
AC   CVCL_A7TX
SY   Bovine Pulmonary Artery 987
DR   Wikidata; Q107113506
RX   CelloPub=CLPUB00632;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632).
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A7TW ! BA987
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BPAEC
AC   CVCL_4130
SY   Bovine Pulmonary Artery Endothelial Cells; BPAE
DR   BTO; BTO_0004400
DR   CLO; CLO_0002020
DR   CLDB; cl477
DR   ECACC; 86123101
DR   Wikidata; Q54798052
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/bpae/bpaecells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/endothelialindex
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (ECACC=86123101).
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
CC   Cell type: Endothelial cell of artery; CL=CL_1000413.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   BPC4
AC   CVCL_RP67
DR   Wikidata; Q54798053
RX   PubMed=9419351;
RX   PubMed=25277546;
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: C57BL/6NJ.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   BPE-1
AC   CVCL_L860
SY   Bovine Parthenogenetic Endoderm-1
DR   Wikidata; Q54798055
RX   PubMed=16153145;
CC   Doubling time: ~96 hours (PubMed=16153145).
CC   Derived from site: In situ; Endoderm; UBERON=UBERON_0000925.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   BPEG1
AC   CVCL_VL20
DR   Wikidata; Q93430725
RX   PubMed=12862320;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   27FD
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   BPEG2
AC   CVCL_VL21
DR   Wikidata; Q93430727
RX   PubMed=12862320;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   28FD
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   BPEI-1
AC   CVCL_DF63
SY   Bascom Palmer Eye Institute-1
DR   ABM; T0731
DR   Kerafast; EMI013
DR   Wikidata; Q54798056
RX   PubMed=7679997;
CC   Doubling time: 18 hours (PubMed=7679997).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   BPf
AC   CVCL_R939
DR   ATCC; CRL-6018
DR   Wikidata; Q54798057
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6018; true.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4399 ! BBm
OI   CVCL_3655 ! BLn
OI   CVCL_3657 ! BSp
OI   CVCL_5244 ! BThy
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   BPH-1
AC   CVCL_1091
SY   BPH1; Benign Prostatic Hyperplasia-1
DR   BTO; BTO_0001323
DR   CLO; CLO_0002022
DR   EFO; EFO_0022691
DR   CLDB; cl7219
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473417
DR   cancercelllines; CVCL_1091
DR   Cell_Model_Passport; SIDM00964
DR   ChEMBL-Cells; CHEMBL3308186
DR   ChEMBL-Targets; CHEMBL2366131
DR   Cosmic; 924105
DR   Cosmic; 1995347
DR   Cosmic-CLP; 924105
DR   DepMap; ACH-001453
DR   DSMZ; ACC-143
DR   DSMZCellDive; ACC-143
DR   EGA; EGAS00001000978
DR   GDSC; 924105
DR   GEO; GSM827571
DR   GEO; GSM1374405
DR   GEO; GSM1669628
DR   IARC_TP53; 27687
DR   ICLC; HTL11006
DR   IGRhCellID; BPH1
DR   LINCS_HMS; 50005
DR   LINCS_LDP; LCL-2095
DR   Millipore; SCC256
DR   PharmacoDB; BPH1_107_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1091
DR   PubChem_Cell_line; CVCL_1091
DR   SKY/M-FISH/CGH; 1510
DR   Wikidata; Q54798059
RX   CelloPub=CLPUB00698;
RX   PubMed=7535634;
RX   PubMed=11304728;
RX   PubMed=11719443;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21248069;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153427/http://capcelllines.ca:80/details.asp?id=132
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-143).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.5%; East Asian, South=0.02%; South Asian=2.82%; European, North=66.48%; European, South=29.17% (PubMed=30894373).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): Cosmic-CLP=924105; DepMap=ACH-001453; DSMZ=ACC-143; Millipore=SCC256; PubMed=11304728
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 10,16
ST   D19S433: 12,15
ST   D21S11: 28,32.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 21,24 (DepMap=ACH-001453; DSMZ=ACC-143; PubMed=11304728)
ST   FGA: 24 (Millipore=SCC256)
ST   Penta D: 9,14
ST   Penta E: 7,10
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   BPH-1 TETD-A
AC   CVCL_4751
SY   BPH1-TETD A; BPH1-TETD-A; BPH1TETD-A; BPH1(TETD)-A; BPH-1 TE-A
DR   SKY/M-FISH/CGH; 1515
DR   Wikidata; Q54798096
RX   PubMed=11719442;
RX   PubMed=11719443;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153600/http://capcelllines.ca:80/details.asp?id=134
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1091 ! BPH-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1 TETD-B
AC   CVCL_4752
SY   BPH1-TETD B; BPH1-TETD-B; BPH1TETD-B; BPH1(TETD)-B; BPH-1 TE-B
DR   SKY/M-FISH/CGH; 1516
DR   Wikidata; Q54798099
RX   PubMed=11719442;
RX   PubMed=11719443;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153600/http://capcelllines.ca:80/details.asp?id=134
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1091 ! BPH-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-01
AC   CVCL_4753
SY   BPH1-CAFTD-01; BPH1CAFTD-1; BPH1CAFTD-01; BPH1(CAFTD)1; BPH1(CAFTD)-01
DR   SKY/M-FISH/CGH; 1511
DR   Wikidata; Q54798060
RX   PubMed=11719442;
RX   PubMed=11719443;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1091 ! BPH-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-02
AC   CVCL_4754
SY   BPH1-CAFTD-02; BPH1CAFTD-2; BPH1CAFTD-02; BPH1(CAFTD)2; BPH1(CAFTD)-02
DR   SKY/M-FISH/CGH; 1512
DR   Wikidata; Q54798063
RX   PubMed=11719442;
RX   PubMed=11719443;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4753 ! BPH-1-CAFTD-01
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-03
AC   CVCL_4755
SY   BPH1-CAFTD-03; BPH1CAFTD-3; BPH1CAFTD-03; BPH1(CAFTD)3; BPH1(CAFTD)-03
DR   SKY/M-FISH/CGH; 1513
DR   Wikidata; Q54798064
RX   PubMed=11719442;
RX   PubMed=11719443;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1091 ! BPH-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-04
AC   CVCL_4756
SY   BPH1-CAFTD-04; BPH1CAFTD-4; BPH1CAFTD-04; BPH1(CAFTD)4; BPH1(CAFTD)-04
DR   SKY/M-FISH/CGH; 1514
DR   Wikidata; Q54798087
RX   PubMed=11719442;
RX   PubMed=11719443;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4755 ! BPH-1-CAFTD-03
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-05
AC   CVCL_4757
SY   BPH1-CAFTD-05; BPH1CAFTD-5; BPH1CAFTD-05; BPH1(CAFTD)5; BPH1(CAFTD)-05
DR   SKY/M-FISH/CGH; 1519
DR   Wikidata; Q54798089
RX   PubMed=11719442;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1091 ! BPH-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-06
AC   CVCL_4758
SY   BPH1-CAFTD-06; BPH1CAFTD-6; BPH1CAFTD-06; BPH1(CAFTD)6; BPH1(CAFTD)-06
DR   SKY/M-FISH/CGH; 1520
DR   Wikidata; Q54798090
RX   PubMed=11719442;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4757 ! BPH-1-CAFTD-05
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-07
AC   CVCL_4759
SY   BPH1-CAFTD-07; BPH1CAFTD-7; BPH1CAFTD-07; BPH1(CAFTD)7; BPH1(CAFTD)-07
DR   SKY/M-FISH/CGH; 1521
DR   Wikidata; Q54798093
RX   PubMed=11719442;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1091 ! BPH-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH-1-CAFTD-08
AC   CVCL_4760
SY   BPH1-CAFTD-08; BPH1CAFTD-8; BPH1CAFTD-08; BPH1(CAFTD)8; BPH1(CAFTD)-08
DR   SKY/M-FISH/CGH; 1522
DR   Wikidata; Q54798095
RX   PubMed=11719442;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4759 ! BPH-1-CAFTD-07
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   BPH22
AC   CVCL_A2PR
DR   Wikidata; Q105506541
RX   PubMed=20927604;
CC   Group: Insect cell line.
CC   Characteristics: Optimal growth temperature is 24 Celsius (PubMed=20927604).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=648918; ! Poekilocerus pictus (Painted grasshopper)
SX   Sex unspecified
AG   Nymph
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   BPK
AC   CVCL_R968
SY   Black Porgy Kidney
DR   Wikidata; Q54798100
RX   DOI=10.3147/jsfp.26.109;
CC   Group: Fish cell line.
CC   Doubling time: 88 hours (DOI=10.3147/jsfp.26.109).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=72011; ! Acanthopagrus schlegelii (Black porgy)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   BPKU
AC   CVCL_VT57
DR   Wikidata; Q93430793
RX   Patent=CN104293735A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.7801.
CC   Characteristics: Transfected with a COL17A1-IgG1 Fc fusion construct.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2194; COL17A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   BPMNU-MyCo-1
AC   CVCL_AV10
DR   Wikidata; Q54798101
RX   CelloPub=CLPUB00442;
RX   PubMed=1818221;
CC   Group: Insect cell line.
CC   Characteristics: Can be used for propagation of the microsporidian fungal parasite Nosema locustae.
CC   Doubling time: 40 hours (CelloPub=CLPUB00442).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=1123341; ! Mythimna convecta (Australian armyworm moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   BPot
AC   CVCL_E496
SY   BPOT
DR   dbMHC; 48512
DR   IHW; IHW09394
DR   IPD-IMGT/HLA; 10338
DR   Wikidata; Q54798104
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01; B*07:03,15:01:01:01; C*03:03:01,03:04:01:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*01:02:01:01,01:03:01:02; DQB1*06:02:01,06:03:01; DRB1*13:01:01,15:01:01; DRB3*01:01:02; DRB5*01:01:01 (IPD-IMGT/HLA=10338).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   BpRc1
AC   CVCL_3492
SY   BPRc1; BPrc1; BpRcl
DR   CLO; CLO_0002023
DR   ATCC; CRL-2217
DR   Wikidata; Q54798105
RX   PubMed=6300048;
RX   PubMed=18959748;
CC   Characteristics: Defective in aryl hydrocarbon receptor nuclear translocator (Arnt) function.
CC   Doubling time: 12-24 hours (ATCC=CRL-2217).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   BPS Bioscience A-549 EGFR KO
AC   CVCL_E8DE
SY   EGFR knockout A549
WW   Provider; BPS Bioscience; 82658; https://bpsbioscience.com/egfr-knockout-a549-cell-line-82658
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience A-549 NF-kappaB-driven luciferase reporter
AC   CVCL_A9P0
SY   NF-KappaB reporter (Luc)-A549; NF-kappaB luciferase reporter A549
DR   cancercelllines; CVCL_A9P0
DR   Wikidata; Q102114592
WW   Provider; BPS Bioscience; 60625; https://bpsbioscience.com/nf-kb-reporter-luc-a549-recombinant-stable-cell-line-60625
CC   Population: Caucasian.
CC   Characteristics: Expression of the luciferase reporter gene is driven by four copies of the NF-kappaB response element located upstream of a minimal TATA promoter (BPS Bioscience=60625).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   BPS Bioscience CHO-K1 NF-kappaB-driven luciferase reporter
AC   CVCL_A9P1
SY   NF-KappaB reporter (Luc)-CHO-K1
DR   Wikidata; Q102114593
WW   Provider; BPS Bioscience; 60622; https://bpsbioscience.com/nf-kappa-b-reporter-luc-cho-k1-recombinant-cell-line
CC   Characteristics: Expression of the luciferase reporter gene is driven by four copies of the NF-kappaB response element located upstream of a minimal TATA promoter (BPS Bioscience=60622).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   BPS Bioscience HCT 116 NF-kappaB-driven luciferase reporter
AC   CVCL_A9P2
SY   NF-KappaB reporter (Luc)-HCT-116; NF-KappaB reporter (Luc)-HCT116
DR   cancercelllines; CVCL_A9P2
DR   Wikidata; Q102114595
WW   Provider; BPS Bioscience; 60623; https://bpsbioscience.com/nf-kappa-b-reporter-luc-hct116-recombinant-cell-line
CC   Population: Caucasian.
CC   Characteristics: Expression of the luciferase reporter gene is driven by four copies of the NF-kappaB response element located upstream of a minimal TATA promoter (BPS Bioscience=60623).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   BPS Bioscience HEK293 NF-kappaB-driven luciferase reporter
AC   CVCL_A9P3
SY   NF-KappaB reporter (Luc)-HEK293
DR   Wikidata; Q102114596
WW   Provider; BPS Bioscience; 60650; https://bpsbioscience.com/nf-kb-reporter-luc-hek293-recombinant-cell-line
CC   Characteristics: Expression of the luciferase reporter gene is driven by four copies of the NF-kappaB response element located upstream of a minimal TATA promoter (BPS Bioscience=60650).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   BPS Bioscience HEK293 OX40+NF-kappaB-driven luciferase reporter
AC   CVCL_E8DF
SY   OX40/NF-kappaB luciferase reporter HEK293
WW   Provider; BPS Bioscience; 60482; https://bpsbioscience.com/ox40-nf-kb-luciferase-reporter-hek293-cell-line-60482
CC   Characteristics: Expression the luciferase reporter is under the control of a NF-kappaB responsive element (BPS Bioscience=60482).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11918; TNFRSF4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   BPS Bioscience HeLa PARG KO
AC   CVCL_E8DG
SY   PARG knockout HeLa
WW   Provider; BPS Bioscience; 82171; https://bpsbioscience.com/parg-knockout-hela-cell-line-82171
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8605; PARG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience HeLa PARP1 KO
AC   CVCL_E8DH
SY   PARP1 knockout HeLa
WW   Provider; BPS Bioscience; 82169; https://bpsbioscience.com/parp1-knockout-hela-cell-line-82169
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience Jurkat E6-1 B2M KO
AC   CVCL_E8DI
SY   B2M knockout Jurkat
WW   Provider; BPS Bioscience; 78342; https://bpsbioscience.com/b2m-knockout-jurkat-cell-line-78342
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience Jurkat E6-1 FOXP3-driven luciferase reporter
AC   CVCL_A9P6
SY   Foxp3 luciferase reporter Jurkat; Foxp3 reporter (Luc)-Jurkat
DR   cancercelllines; CVCL_A9P6
DR   Wikidata; Q102113854
WW   Provider; BPS Bioscience; 60628; https://bpsbioscience.com/foxp3-reporter-cell-line-60628
CC   Population: Caucasian.
CC   Characteristics: Expression of the luciferase reporter gene is driven by a CPG-island enhancer followed by a FOXP3 promoter (BPS Bioscience=60628).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   BPS Bioscience Jurkat E6.1 NF-kappaB-driven luciferase reporter
AC   CVCL_A9P4
SY   NF-kappaB reporter (Luc)-Jurkat; NF-kappaB luciferase reporter Jurkat
DR   cancercelllines; CVCL_A9P4
DR   Wikidata; Q102114597
WW   Provider; BPS Bioscience; 60651; https://bpsbioscience.com/nf-kb-luciferase-reporter-luc-jurkat-recombinant-cell-line
CC   Population: Caucasian.
CC   Characteristics: Expression of the luciferase reporter gene is driven by four copies of the NF-kappaB response element located upstream of a minimal TATA promoter (BPS Bioscience=60651).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   BPS Bioscience MCF-7 NECTIN4 KO
AC   CVCL_E8DJ
SY   Nectin-4 knockout MCF7 Cell line
WW   Provider; BPS Bioscience; 82656; https://bpsbioscience.com/nectin-4-knockout-mcf7-cell-line-82656
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19688; NECTIN4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience MCF-7 PARP1 KO
AC   CVCL_E8DK
SY   PARP1 knockout MCF7
WW   Provider; BPS Bioscience; 82690; https://bpsbioscience.com/parp1-knockout-mcf7-cell-line-82690
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience MCF-7 TACSTD2 KO
AC   CVCL_E8DL
SY   TROP2 knockout MCF7
WW   Provider; BPS Bioscience; 82657; https://bpsbioscience.com/trop2-knockout-mcf7-cell-line-82657
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience MM.1S TNFRSF17 KO
AC   CVCL_E8DM
SY   BCMA knockout MM.1S
WW   Provider; BPS Bioscience; 82687; https://bpsbioscience.com/bcma-knockout-mm-1s-cell-line-82687
CC   Population: African American.
CC   Characteristics: Produces IgA lambda (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11913; TNFRSF17.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8792 ! MM1.S
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   BPS Bioscience NIH 3T3 Gli-driven luciferase reporter
AC   CVCL_C5QT
SY   Gli luciferase reporter NIH3T3; Gli reporter-NIH3T3; 3T3 Gli1-Luc; 3T3Gli1-Luc
DR   Wikidata; Q116049080
WW   Provider; BPS Bioscience; 60409; https://bpsbioscience.com/hedgehog-pathway-gli-reporter-60409
CC   Characteristics: Expression of the luciferase reporter gene is under the control of Gli responsive elements (BPS Bioscience=60409).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BPS Bioscience Raji CD19 KO
AC   CVCL_E8DN
SY   CD19 knockout Raji
WW   Provider; BPS Bioscience; 82166; https://bpsbioscience.com/cd19-knockout-raji-cell-line-82166
CC   Population: African; Nigerian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience RPMI-8226 TNFRSF17 KO
AC   CVCL_E8DP
SY   BCMA knockout RPMI-8226
WW   Provider; BPS Bioscience; 82659; https://bpsbioscience.com/bcma-knockout-rpmi-8226-cell-line-82659
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11913; TNFRSF17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   BPS Bioscience THP-1 B2M KO
AC   CVCL_E8DQ
SY   B2M knockout THP-1
WW   Provider; BPS Bioscience; 78389; https://bpsbioscience.com/b2m-knockout-thp-1-cell-line-78389
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience THP-1 B2M/CIITA dKO
AC   CVCL_E8DR
SY   B2M/CIITA double knockout THP-1
WW   Provider; BPS Bioscience; 78391; https://bpsbioscience.com/b2m-ciita-double-knockout-thp-1-cell-line-78391
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience THP-1 CD36 KO
AC   CVCL_E8DS
SY   CD36 knockout THP-1
WW   Provider; BPS Bioscience; 82190; https://bpsbioscience.com/cd36-knockout-thp-1-cell-line-82190
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1663; CD36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience THP-1 CIITA KO
AC   CVCL_E8DT
SY   CIITA knockout THP-1
WW   Provider; BPS Bioscience; 78390; https://bpsbioscience.com/ciita-knockout-thp-1-cell-line-78390
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience THP-1 FCGR1A KO
AC   CVCL_E8DU
SY   FcGR1a (CD64) knockout THP-1
WW   Provider; BPS Bioscience; 82191; https://bpsbioscience.com/fcgr1a-cd64-knockout-thp-1-cell-line-82191
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3613; FCGR1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPS Bioscience THP-1 ISRE-driven luciferase reporter
AC   CVCL_F0PJ
SY   IRF Reporter (Luc) - THP-1
WW   Provider; BPS Bioscience; 79858; https://bpsbioscience.com/irf-reporter-luc-thp-1-cell-line-79858
CC   Population: Japanese.
CC   Characteristics: Expression of the luciferase reporter gene is under the control of A multimerized ISRE (Interferon Stimulated Response Element) located upstream of a minimal TATA promoter (BPS Bioscience=79858).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BPS-1
AC   CVCL_R969
SY   Black Porgy Spleen-1
DR   Wikidata; Q54798106
RX   DOI=10.3147/jsfp.26.109;
CC   Group: Fish cell line.
CC   Doubling time: 47 hours (DOI=10.3147/jsfp.26.109).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=72011; ! Acanthopagrus schlegelii (Black porgy)
OI   CVCL_R970 ! BPS-4
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   BPS-4
AC   CVCL_R970
SY   Black Porgy Spleen-4
DR   Wikidata; Q54798108
RX   DOI=10.3147/jsfp.26.109;
CC   Group: Fish cell line.
CC   Doubling time: 30 hours (DOI=10.3147/jsfp.26.109).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=72011; ! Acanthopagrus schlegelii (Black porgy)
OI   CVCL_R969 ! BPS-1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   BPT-1
AC   CVCL_B3N6
SY   Bovine Parthenogenetic Trophectoderm-1
DR   Wikidata; Q110432640
RX   PubMed=15293218;
CC   Doubling time: ~96 hours (PubMed=15293218).
CC   Derived from site: In situ; Trophectoderm; UBERON=UBERON_0004345.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   BPV1-FR3T3-2
AC   CVCL_E5JY
RX   PubMed=6330980;
CC   Doubling time: 16 hours (PubMed=6330980).
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C691 ! FR3T3
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPV1-FR3T3-3
AC   CVCL_E5JZ
RX   PubMed=6330980;
CC   Doubling time: 20 hours (PubMed=6330980).
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C691 ! FR3T3
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPV1-FR3T3-5
AC   CVCL_E5K0
RX   PubMed=6330980;
CC   Doubling time: 20 hours (PubMed=6330980).
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C691 ! FR3T3
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPV1-FR3T3-6
AC   CVCL_E5K1
RX   PubMed=6330980;
CC   Doubling time: 20 hours (PubMed=6330980).
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C691 ! FR3T3
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPV1-FR3T3-7
AC   CVCL_E5K2
RX   PubMed=6330980;
CC   Doubling time: 14 hours (PubMed=6330980).
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C691 ! FR3T3
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BPV1-FR3T3-8
AC   CVCL_E5K3
SY   FRBPV8
RX   PubMed=6330980;
CC   Doubling time: 20 hours (PubMed=6330980).
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C691 ! FR3T3
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BQ0419
AC   CVCL_8T80
DR   ECACC; 94020701
DR   Wikidata; Q54798109
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94020701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BQ0430
AC   CVCL_8T81
DR   ECACC; 94071517
DR   Wikidata; Q54798111
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071517; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BQ0431
AC   CVCL_8T82
DR   ECACC; 94071518
DR   Wikidata; Q54798113
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071518; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BQ0432
AC   CVCL_8T83
DR   ECACC; 94071519
DR   Wikidata; Q54798114
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071519; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BQ0464
AC   CVCL_8T84
DR   ECACC; 97051603
DR   Wikidata; Q54798116
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97051603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   BQ1
AC   CVCL_B6F8
DR   Wikidata; Q111732991
RX   PubMed=10762059;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059).
CC   Doubling time: 59.3 hours (Note=At 15th passage), 23.7 hours (Note=At 50th passage) (PubMed=10762059).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Brown Norway; RS=RS_0000113.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   BR
AC   CVCL_GT42
SY   BRMCT
DR   Wikidata; Q54798117
RX   PubMed=1634619;
RX   PubMed=9646437;
RX   PubMed=10210327;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Doubling time: 36 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:42422; KIT; Simple; p.Leu575Pro (c.1724T>C); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:46054; SETD2; Simple; p.Arg526fs (c.1576delA); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Ala193Asp (c.578C>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Arg263Cys (c.787C>T); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 227,235
ST   Dog FHC2054: 180
ST   Dog FHC2079: 279
ST   Dog PEZ1: 111,119
ST   Dog PEZ3: 121,134
ST   Dog PEZ5: 103,109
ST   Dog PEZ6: 180,184
ST   Dog PEZ8: 228,242
ST   Dog PEZ12: 270,274
ST   Dog PEZ20: 176,180
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   BR-1
AC   CVCL_C062
SY   USPe001-A
DR   hPSCreg; USPe001-A
DR   SKIP; SKIP002364
DR   Wikidata; Q54798119
RX   PubMed=20719082;
CC   From: Instituto de Biociencias; Sao Paulo; Brazil.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   BR-2
AC   CVCL_AU04
DR   Wikidata; Q54798121
RX   CelloPub=CLPUB00318;
CC   From: Instituto de Biociencias; Sao Paulo; Brazil.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   BR-4
AC   CVCL_AU02
DR   Wikidata; Q54798122
RX   DOI=10.13140/RG.2.1.2559.9520;
RX   PubMed=24633531;
RX   PubMed=26602357;
CC   From: Instituto de Biociencias; Sao Paulo; Brazil.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   BR-5
AC   CVCL_AU03
DR   Wikidata; Q54798124
RX   DOI=10.13140/RG.2.1.2559.9520;
RX   PubMed=24633531;
RX   PubMed=26602357;
CC   From: Instituto de Biociencias; Sao Paulo; Brazil.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   BR-6
AC   CVCL_6D92
DR   Wikidata; Q54798125
RX   PubMed=26540511;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   Br-NHF-1
AC   CVCL_M382
DR   Wikidata; Q54798127
RX   PubMed=7327377;
CC   Population: Japanese.
CC   Doubling time: ~100 hours (Note=At 27th passage) (PubMed=7327377).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   BR-SP-31-2
AC   CVCL_D2WF
SY   BR-SP-31
DR   Wikidata; Q127380346
WW   Provider; CReM; 647; https://stemcellbank.bu.edu/Catalog/Item/Details/647
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY18 ! CREM053i-BR31-1
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   BR110
AC   CVCL_LG24
SY   BR110-3
DR   ATCC; HB-11698
DR   Wikidata; Q54798129
RX   Patent=US5840854;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11698.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   BR15
AC   CVCL_0J23
SY   BR 15
DR   Wikidata; Q54798130
RX   PubMed=6300147;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BR1H788.6
AC   CVCL_5A87
SY   BR1H-788.6
DR   Wikidata; Q54798133
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4301.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1H826.5
AC   CVCL_5A88
SY   BR1H-826.5
DR   ATCC; CRL-13020
DR   Wikidata; Q54798135
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4302.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13020; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1H945.2
AC   CVCL_5A89
SY   BR1H-945.2
DR   ATCC; CRL-13021
DR   Wikidata; Q54798136
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4303.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13021; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1N129.5
AC   CVCL_5A90
SY   BR1N-129.5
DR   ATCC; CRL-13022
DR   Wikidata; Q54798137
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4304.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13022; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1N411.4
AC   CVCL_5A91
SY   BR1N-411.4
DR   ATCC; CRL-13023
DR   Wikidata; Q54798139
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4305.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13023; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1S060.2
AC   CVCL_5A92
SY   BR1S-060.2
DR   ATCC; CRL-13024
DR   Wikidata; Q54798140
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4306.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13024; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1S218.1
AC   CVCL_5A93
SY   BR1S-218.1
DR   ATCC; CRL-13025
DR   Wikidata; Q54798142
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4307.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13025; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1S384.5
AC   CVCL_5A94
SY   BR1S-384.5
DR   ATCC; CRL-13026
DR   Wikidata; Q54798145
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4308.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13026; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR1S425.1
AC   CVCL_5A95
SY   BR1S-425.1
DR   ATCC; CRL-13027
DR   Wikidata; Q54798146
RX   Patent=US6514713;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4309.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
CC   Discontinued: ATCC; CRL-13027; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   BR29
AC   CVCL_RN61
SY   CMES40 ACTB+/EGFP clone 29
DR   SKIP; SKIP001449
DR   Wikidata; Q54798147
RX   PubMed=21126169;
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=Homologous recombination; UniProtKB; F7HJT1; ACTB (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_B946 ! CMES40
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   BR55-2
AC   CVCL_JY75
SY   BR55.2; Br55-2
DR   ATCC; HB-9324
DR   Wikidata; Q54798149
RX   Patent=US4971792;
RX   Patent=US5182192;
RX   PubMed=2432062;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9324.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 6
//
ID   BR55-2-S2a
AC   CVCL_JY76
SY   BR55.2S2A
DR   ATCC; HB-9347
DR   Wikidata; Q54798152
RX   Patent=US4971792;
RX   Patent=US5182192;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9347.
CC   Characteristics: Isotype switched derivative of BR55-2.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JY75 ! BR55-2
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 6
//
ID   BR64 [Mouse hybridoma against human BRCA1]
AC   CVCL_LG12
DR   Wikidata; Q54798153
WW   Info; Wistar; -; https://www.wistar.org/technology-transfer/monoclonal-antibody-br64-the-identification-brca1
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 5
//
ID   BR64 [Mouse hybridoma against Lewis Y]
AC   CVCL_LG13
DR   Wikidata; Q54798180
RX   Patent=US5242824;
RX   PubMed=1690595;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9895.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 5
//
ID   BR64.60
AC   CVCL_LG14
DR   Wikidata; Q54798181
RX   Patent=US5242824;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10292.
CC   Characteristics: Isotype switched derivative of BR64.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_LG13 ! BR64 [Mouse hybridoma against Lewis Y]
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 5
//
ID   BR96
AC   CVCL_LG15
SY   BR96 (NL2); BR 96
DR   Wikidata; Q54798183
RX   Patent=US5491088;
RX   PubMed=1690595;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10036.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 6
//
ID   BRAD-3
AC   CVCL_B6E6
SY   BRAD3; 1A3-3
DR   Wikidata; Q111732993
RX   PubMed=7655002;
RX   PubMed=11889904;
RX   PubMed=32001734;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02161; Human RHD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BRAD-5
AC   CVCL_B6E7
SY   BRAD5; 1A11
DR   Wikidata; Q111732994
RX   PubMed=7655002;
RX   PubMed=11889904;
RX   PubMed=32001734;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02161; Human RHD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BRC-01
AC   CVCL_WC40
SY   BReast Cancer-01
DR   IBRC; C10647
DR   Wikidata; Q93431072
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-02
AC   CVCL_WC41
SY   BReast Cancer-02
DR   IBRC; C10719
DR   Wikidata; Q93431075
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-03
AC   CVCL_WC42
SY   BReast Cancer-03
DR   IBRC; C10724
DR   Wikidata; Q93431077
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-04
AC   CVCL_WC43
SY   BReast Cancer-04
DR   IBRC; C10749
DR   Wikidata; Q93431080
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-05
AC   CVCL_WC44
SY   BReast Cancer-05
DR   IBRC; C10784
DR   Wikidata; Q93431082
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-06
AC   CVCL_WC45
SY   BReast Cancer-06
DR   IBRC; C10785
DR   Wikidata; Q93431084
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-07
AC   CVCL_WC46
SY   BReast Cancer-07
DR   IBRC; C10786
DR   Wikidata; Q93431087
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-08
AC   CVCL_WC47
SY   BReast Cancer-08
DR   IBRC; C10759
DR   Wikidata; Q93431089
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-09
AC   CVCL_WC48
SY   BReast Cancer-09
DR   IBRC; C10760
DR   Wikidata; Q93431092
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-10
AC   CVCL_WC49
SY   BReast Cancer-10
DR   IBRC; C10806
DR   Wikidata; Q93431094
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-11
AC   CVCL_WC50
SY   BReast Cancer-11
DR   IBRC; C10814
DR   Wikidata; Q93431096
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-12
AC   CVCL_WC51
SY   BReast Cancer-12
DR   IBRC; C10796
DR   Wikidata; Q93431098
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-13
AC   CVCL_WC52
SY   BReast Cancer-13
DR   IBRC; C10817
DR   Wikidata; Q93431101
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-14
AC   CVCL_WC53
SY   BReast Cancer-14
DR   IBRC; C10818
DR   Wikidata; Q93431102
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-15
AC   CVCL_WC54
SY   BReast Cancer-15
DR   IBRC; C10821
DR   Wikidata; Q93431104
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-16
AC   CVCL_WC55
SY   BReast Cancer-16
DR   IBRC; C10823
DR   Wikidata; Q93431106
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-17
AC   CVCL_WC56
SY   BReast Cancer-17
DR   IBRC; C10824
DR   Wikidata; Q93431109
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-18
AC   CVCL_WC57
SY   BReast Cancer-18
DR   IBRC; C10825
DR   Wikidata; Q93431111
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-19
AC   CVCL_WC58
SY   BReast Cancer-19
DR   IBRC; C10843
DR   Wikidata; Q93431114
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-20
AC   CVCL_WC59
SY   BReast Cancer-20
DR   IBRC; C10839
DR   Wikidata; Q93431116
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-21
AC   CVCL_WC60
SY   BReast Cancer-21
DR   IBRC; C10847
DR   Wikidata; Q93431118
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-22
AC   CVCL_WC61
SY   BReast Cancer-22
DR   IBRC; C10852
DR   Wikidata; Q93431121
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-23
AC   CVCL_WC62
SY   BReast Cancer-23
DR   IBRC; C10873
DR   Wikidata; Q93431123
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-230
AC   CVCL_M099
SY   BRC 230; BRC230
DR   cancercelllines; CVCL_M099
DR   IARC_TP53; 13986
DR   Wikidata; Q54798185
RX   PubMed=8018954;
RX   PubMed=10841287;
RX   PubMed=12661003;
CC   Doubling time: 30.5 hours (PubMed=8018954).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Ter (c.796G>T); ClinVar=VCV000954591; Zygosity=Unspecified (PubMed=10841287).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   BRC-24
AC   CVCL_WC63
SY   BReast Cancer-24
DR   IBRC; C10874
DR   Wikidata; Q93431130
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-25
AC   CVCL_WC64
SY   BReast Cancer-25
DR   IBRC; C10880
DR   Wikidata; Q93431132
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-26
AC   CVCL_WC65
SY   BReast Cancer-26
DR   IBRC; C10884
DR   Wikidata; Q93431134
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-27
AC   CVCL_WC66
SY   BReast Cancer-27
DR   IBRC; C10887
DR   Wikidata; Q93431137
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-28
AC   CVCL_WC67
SY   BReast Cancer-28
DR   IBRC; C10888
DR   Wikidata; Q93431139
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-29
AC   CVCL_WC68
SY   BReast Cancer-29
DR   IBRC; C10967
DR   Wikidata; Q93431140
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-30
AC   CVCL_WC69
SY   BReast Cancer-30
DR   IBRC; C10958
DR   Wikidata; Q93431143
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-31
AC   CVCL_WC70
SY   BReast Cancer-31
DR   IBRC; C10973
DR   Wikidata; Q93431145
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-32
AC   CVCL_WC71
SY   BReast Cancer-32
DR   IBRC; C10978
DR   Wikidata; Q93431147
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-33
AC   CVCL_WC72
SY   BReast Cancer-33
DR   IBRC; C10979
DR   Wikidata; Q93431149
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-34
AC   CVCL_WC73
SY   BReast Cancer-34
DR   IBRC; C10981
DR   Wikidata; Q93431151
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-35
AC   CVCL_WC74
SY   BReast Cancer-35
DR   IBRC; C11001
DR   Wikidata; Q93431153
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-36
AC   CVCL_WC75
SY   BReast Cancer-36
DR   IBRC; C11002
DR   Wikidata; Q93431156
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-37
AC   CVCL_WC76
SY   BReast Cancer-37
DR   IBRC; C11003
DR   Wikidata; Q93431158
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-38
AC   CVCL_WC77
SY   BReast Cancer-38
DR   IBRC; C11004
DR   Wikidata; Q93431160
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-39
AC   CVCL_WC78
SY   BReast Cancer-39
DR   IBRC; C11011
DR   Wikidata; Q93431163
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-40
AC   CVCL_WC79
SY   BReast Cancer-40
DR   IBRC; C11012
DR   Wikidata; Q93431166
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-41
AC   CVCL_WC80
SY   BReast Cancer-41
DR   IBRC; C11032
DR   Wikidata; Q93431168
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-42
AC   CVCL_WC81
SY   BReast Cancer-42
DR   IBRC; C11044
DR   Wikidata; Q93431170
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-43
AC   CVCL_WC82
SY   BReast Cancer-43
DR   IBRC; C11049
DR   Wikidata; Q93431172
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-44
AC   CVCL_WC83
SY   BReast Cancer-44
DR   IBRC; C11053
DR   Wikidata; Q93431175
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-45
AC   CVCL_WC84
SY   BReast Cancer-45
DR   IBRC; C11063
DR   Wikidata; Q93431177
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-46
AC   CVCL_WC85
SY   BReast Cancer-46
DR   IBRC; C11064
DR   Wikidata; Q93431179
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-47
AC   CVCL_WC86
SY   BReast Cancer-47
DR   IBRC; C11065
DR   Wikidata; Q93431182
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-48
AC   CVCL_WC87
SY   BReast Cancer-48
DR   IBRC; C11086
DR   Wikidata; Q93431184
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-49
AC   CVCL_WC88
SY   BReast Cancer-49
DR   IBRC; C11107
DR   Wikidata; Q93431186
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-50
AC   CVCL_WC89
SY   BReast Cancer-50
DR   IBRC; C11110
DR   Wikidata; Q93431189
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-51
AC   CVCL_WC90
SY   BReast Cancer-51
DR   IBRC; C11146
DR   Wikidata; Q93431191
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-52
AC   CVCL_WC91
SY   BReast Cancer-52
DR   IBRC; C11147
DR   Wikidata; Q93431193
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-53
AC   CVCL_WC92
SY   BReast Cancer-53
DR   IBRC; C11158
DR   Wikidata; Q93431196
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-54
AC   CVCL_WC93
SY   BReast Cancer-54
DR   IBRC; C11161
DR   Wikidata; Q93431197
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC-55
AC   CVCL_WC94
SY   BReast Cancer-55
DR   IBRC; C11177
DR   Wikidata; Q93431199
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient who received doxorubicin and experienced cardiotoxicity.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BRC1
AC   CVCL_B978
DR   RCB; AES0005
DR   RCB; RCB2004
DR   SKIP; SKIP001633
DR   Wikidata; Q54798186
CC   Discontinued: RCB; RCB2004; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: (C57BL/6 x DBA/2) x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC2
AC   CVCL_B979
DR   RCB; AES0006
DR   RCB; RCB2005
DR   SKIP; SKIP001632
DR   Wikidata; Q54798188
CC   Discontinued: RCB; RCB2005; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: (C57BL/6 x DBA/2) x (C57BL/6 x DBA/2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC3
AC   CVCL_B980
DR   RCB; AES0007
DR   RCB; RCB2006
DR   SKIP; SKIP001631
DR   Wikidata; Q54798190
CC   Discontinued: RCB; RCB2006; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: (C57BL/6 x DBA/2) x (C57BL/6 x DBA/2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC4
AC   CVCL_B981
DR   RCB; AES0008
DR   RCB; RCB2007
DR   SKIP; SKIP001630
DR   Wikidata; Q54798191
CC   Discontinued: RCB; RCB2007; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC5
AC   CVCL_B982
DR   RCB; AES0009
DR   RCB; RCB2008
DR   SKIP; SKIP001629
DR   Wikidata; Q54798193
CC   Discontinued: RCB; RCB2008; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC6
AC   CVCL_B983
DR   RCB; AES0010
DR   RCB; RCB2009
DR   SKIP; SKIP001628
DR   Wikidata; Q54798195
CC   Discontinued: RCB; RCB2009; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC6(feeder-free)
AC   CVCL_RH44
DR   RCB; AES0186
DR   SKIP; SKIP002929
DR   Wikidata; Q54798196
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Can be maintained in undifferentiated state on hydroxyapatite coated with gelatin.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B983 ! BRC6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   BRC7
AC   CVCL_B984
DR   RCB; AES0011
DR   RCB; RCB2010
DR   SKIP; SKIP001627
DR   Wikidata; Q54798197
CC   Discontinued: RCB; RCB2010; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC8
AC   CVCL_B985
DR   RCB; AES0012
DR   RCB; RCB2011
DR   SKIP; SKIP001626
DR   Wikidata; Q54798199
CC   Discontinued: RCB; RCB2011; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BRC9
AC   CVCL_B986
DR   RCB; AES0013
DR   RCB; RCB2012
DR   SKIP; SKIP001625
DR   Wikidata; Q54798200
CC   Discontinued: RCB; RCB2012; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BrCA 5
AC   CVCL_D280
SY   BrCa 5; BrCA5
DR   BioSample; SAMN03151667
DR   Wikidata; Q54798201
RX   PubMed=557237;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=557237; PubMed=6451928; PubMed=20143388). Originally thought to originate from a ductal breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00016.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   BrCa-MZ-01
AC   CVCL_5495
SY   BR-CA-MZ-01; Breast Carcinoma-MainZ-01
DR   Wikidata; Q54798203
RX   PubMed=9663605;
RX   PubMed=12800145;
CC   Doubling time: 36 hours (PubMed=9663605).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   BrCa-MZ-02
AC   CVCL_5496
SY   BR-CA-MZ-02; Breast Carcinoma-MainZ-02
DR   Wikidata; Q54798205
RX   PubMed=9663605;
RX   PubMed=12353263;
RX   PubMed=12800145;
CC   Doubling time: 40 hours (PubMed=9663605).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Brca1 delta11/delta11 53Bp1-/- MEF (S7)
AC   CVCL_UJ18
SY   Brac1 delta11/delta1153Bp1-/- (S7)
DR   ATCC; CRL-3264
DR   Wikidata; Q93431460
RX   PubMed=20362325;
CC   Characteristics: Established from mice homologous for Brca1 Ex11del.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1351320; Trp53bp1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   Brca1 delta11/delta11 MEF (S12)
AC   CVCL_UJ17
SY   Brac1 delta11/delta11(S12)
DR   ATCC; CRL-3263
DR   Wikidata; Q93431464
RX   PubMed=20362325;
CC   Characteristics: Established from mice homologous for Brca1 Ex11del.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   BRCA2-999del5-1N
AC   CVCL_M371
SY   BRCA2 cell line-999del5 mutation-patient 1 Normal tissue
DR   Wikidata; Q54798207
RX   PubMed=16448223;
RX   PubMed=22019625;
CC   Population: Caucasian; Icelandic.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn257Lysfs*17 (c.771_775delTCAAA) (999del5); ClinVar=VCV000009326; Zygosity=Heterozygous (PubMed=16448223).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   BRCA2-999del5-2N
AC   CVCL_M370
SY   BRCA2 cell line-999del5 mutation-patient 2 Normal tissue
DR   Wikidata; Q54798208
RX   PubMed=16448223;
RX   PubMed=22019625;
CC   Population: Caucasian; Icelandic.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn257Lysfs*17 (c.771_775delTCAAA) (999del5); ClinVar=VCV000009326; Zygosity=Heterozygous (PubMed=16448223).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M369 ! BRCA2-999del5-2T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   BRCA2-999del5-2T
AC   CVCL_M369
SY   BRCA2 cell line-999del5 mutation-patient 2 Tumor tissue
DR   Wikidata; Q54798210
RX   PubMed=16448223;
RX   PubMed=22019625;
CC   Population: Caucasian; Icelandic.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn257Lysfs*17 (c.771_775delTCAAA) (999del5); ClinVar=VCV000009326; Zygosity=Heterozygous (PubMed=16448223).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C4194; Invasive breast carcinoma of no special type
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M370 ! BRCA2-999del5-2N
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   BRCA68D
AC   CVCL_A0QE
DR   Wikidata; Q108819959
RX   Patent=US10683364;
RX   Patent=US10730945;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BRCA69D
AC   CVCL_A0QF
DR   Wikidata; Q108819960
RX   Patent=US10683364;
RX   Patent=US10730945;
RX   PubMed=22615450;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BRCA84D
AC   CVCL_A0QG
DR   Wikidata; Q108819961
RX   Patent=US10683364;
RX   Patent=US10730945;
RX   PubMed=22615450;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   BRCi014-A-1
AC   CVCL_A8KM
SY   HPS5037; ISL1-TEZ_1
DR   hPSCreg; BRCi014-A-1
DR   Wikidata; Q108819962
RX   PubMed=34087992;
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a 2A-tdTomato-EF1a-BleoR construct was knocked-in at the 3'end of one allele of the ISL1 gene (PubMed=34087992).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UP39 ! 1383D6
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   BRCi014-A-2
AC   CVCL_A8KN
SY   HPS5038; ISL1-TEZ_2
DR   hPSCreg; BRCi014-A-2
DR   Wikidata; Q108819963
RX   PubMed=34087992;
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a 2A-tdTomato-EF1a-BleoR construct was knocked-in at the 3'end of one allele of the ISL1 gene (PubMed=34087992).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UP39 ! 1383D6
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   BRCi014-A-3
AC   CVCL_E3Y8
SY   MBP-TEZ
DR   BioSamples; SAMEA115499868
DR   hPSCreg; BRCi014-A-3
RX   PubMed=39032428;
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a 2XLG3 linker peptide-tdTomato-EF1a-BleoR construct was knocked-in at the 3'end of one allele of the MBP gene (PubMed=39032428).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UP39 ! 1383D6
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BRCi017-A
AC   CVCL_C0HI
SY   HiPS-GM05876
DR   hPSCreg; BRCi017-A
DR   Wikidata; Q112929344
RX   PubMed=35292424;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2Y97 ! GM05876
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   BRCi018-A
AC   CVCL_C0HJ
SY   HiPS-GM13325
DR   hPSCreg; BRCi018-A
DR   Wikidata; Q112929345
RX   PubMed=35292424;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2Y99 ! GM13325
SX   Female
AG   9D
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   BRCi021-A
AC   CVCL_B7ES
SY   hiPSC-TUH001; TUH1
DR   BioSamples; SAMEA13409766
DR   hPSCreg; BRCi021-A
DR   Wikidata; Q112929346
RX   PubMed=35500377;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Tyr267Ter (c.801T>A); Zygosity=Heterozygous (PubMed=35500377).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   BRCi024-A
AC   CVCL_D6S1
SY   HiPS-RTT_CUH01
DR   BioSamples; SAMEA115396857
DR   hPSCreg; BRCi024-A
RX   PubMed=38703668;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous (PubMed=38703668).
CC   Caution: Mutation indicated as p.Gly143fs (c.471delG) in paper (PubMed=38703668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BRCi025-A
AC   CVCL_D6S2
SY   HiPS-RTT_CUH02
DR   BioSamples; SAMEA115410986
DR   hPSCreg; BRCi025-A
RX   PubMed=38703668;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg255Ter (c.763C>T) (p.Arg267Ter, c.799C>T); ClinVar=VCV000011829; Zygosity=Heterozygous (PubMed=38703668).
CC   Caution: Mutation indicated as p.Arg129Ter (c.428C>T) in paper (PubMed=38703668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BRCi026-A
AC   CVCL_D6S3
SY   HiPS-RTT_CUH05
DR   BioSamples; SAMEA115411044
DR   hPSCreg; BRCi026-A
RX   PubMed=38703668;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Heterozygous (PubMed=38703668).
CC   Caution: Mutation indicated as p.Arg180Cys (c.580C>T) in paper (PubMed=38703668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BRCi027-A
AC   CVCL_D6S4
SY   HiPS-RTT_CUH06
DR   BioSamples; SAMEA115411213
DR   hPSCreg; BRCi027-A
RX   PubMed=38703668;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg106Trp (c.316C>T) (p.Arg118Trp, c.352C>T); ClinVar=VCV000011814; Zygosity=Heterozygous (PubMed=38703668).
CC   Caution: Mutation indicated as p.Arg97Trp (c.304C>T) in paper (PubMed=38703668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BRCi028-A
AC   CVCL_E4BN
SY   HiPS-cBA1; HiPS-BA20201019_1
DR   hPSCreg; BRCi028-A
RX   PubMed=39532815;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BRCi029-A
AC   CVCL_E4BP
SY   HiPS-cBA2; HiPS-BA20201019_2
DR   hPSCreg; BRCi029-A
RX   PubMed=39532815;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BRCi032-A
AC   CVCL_E4BQ
SY   HiPS-cBA3; HiPS-BA20210308_1
DR   hPSCreg; BRCi032-A
RX   PubMed=39532815;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BRCi033-A
AC   CVCL_E4BR
SY   HiPS-cBA4; HiPS-BA20210308_2
DR   hPSCreg; BRCi033-A
RX   PubMed=39532815;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BRCi035-A
AC   CVCL_E4BS
SY   HiPS-cBA5; HiPS-BA20220509_2
DR   hPSCreg; BRCi035-A
RX   PubMed=39532815;
CC   From: RIKEN BioResource Research Center; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BRE
AC   CVCL_A5NF
DR   Wikidata; Q107113507
RX   PubMed=10074495;
CC   Sequence variation: Mutation; HGNC; HGNC:43; TAP1; Simple; p.Asp273fs (c.819delC); Zygosity=Homozygous (PubMed=10074495).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171267; Bare lymphocyte syndrome type 1
DI   ORDO; Orphanet_34592; Immunodeficiency by defective expression of MHC class I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16-20Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   BRE-169
AC   CVCL_A282
SY   BRE169
DR   BTO; BTO_0003754
DR   Wikidata; Q54798211
RX   PubMed=17977821;
CC   Sequence variation: Mutation; HGNC; HGNC:43; TAP1; Simple; p.Asp273fs (c.819delC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171267; Bare lymphocyte syndrome type 1
DI   ORDO; Orphanet_34592; Immunodeficiency by defective expression of MHC class I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5NF ! BRE
SX   Male
AG   16-20Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   Bre-40
AC   CVCL_DP13
DR   Wikidata; Q54798212
RX   PubMed=9721850;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   Bre-60
AC   CVCL_DP12
DR   GEO; GSM197768
DR   GEO; GSM197769
DR   GEO; GSM197770
DR   Wikidata; Q54798214
RX   PubMed=9721850;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   Bre-70
AC   CVCL_DP14
DR   Wikidata; Q54798216
RX   PubMed=9721850;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   Bre-80
AC   CVCL_A283
SY   BRE-80; BRE80; Bre80; B80
DR   BTO; BTO_0006015
DR   GEO; GSM197771
DR   GEO; GSM197772
DR   GEO; GSM197773
DR   Wikidata; Q54798217
RX   PubMed=9721850;
RX   PubMed=11281650;
RX   PubMed=11791183;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   BrE1
AC   CVCL_XB09
SY   BrE-1; HB BrE-1
DR   CCRID; 4201PAT-CCTCC00037
DR   Wikidata; Q93431537
RX   Patent=WO1989007268A1;
RX   PubMed=2365381;
RX   PubMed=7493358;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9738.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BrE2
AC   CVCL_XB10
SY   BrE-2; HB BrE-2
DR   CCRID; 4201PAT-CCTCC00054
DR   Wikidata; Q93431541
RX   Patent=US5077220;
RX   PubMed=2365381;
RX   PubMed=7493358;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9795.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   BrE3
AC   CVCL_XB11
SY   BrE-3
DR   Wikidata; Q93431543
RX   Patent=US5075219;
RX   PubMed=2365381;
RX   PubMed=7493358;
RX   PubMed=8454302;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10028.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   Bre80hTert
AC   CVCL_RY31
DR   Wikidata; Q54798219
RX   PubMed=28889351;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D21S11: 29,31.2
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A283 ! Bre-80
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 7
//
ID   BREC1
AC   CVCL_B5LA
SY   Bovine Rumen Epithelial Clone 1
DR   GEO; GSE181659
DR   Wikidata; Q111732995
RX   PubMed=34570883;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Rumen; UBERON=UBERON_0007365.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Angus; VBO=VBO_0000104.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   >3M
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   BREM
AC   CVCL_8660
DR   cancercelllines; CVCL_8660
DR   Wikidata; Q54798221
RX   PubMed=15956410;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   BREN
AC   CVCL_B6Q6
DR   Wikidata; Q111732996
RX   PubMed=603627;
RX   PubMed=5428190;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BRF-41T
AC   CVCL_4761
SY   BRF 41 T; BRF41T
DR   Wikidata; Q54798223
RX   PubMed=9458347;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153433/http://capcelllines.ca:80/details.asp?id=143
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   BRF-55T
AC   CVCL_4762
SY   BRF 55 T; BRF55T
DR   Wikidata; Q54798224
RX   PubMed=9458347;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153605/http://capcelllines.ca:80/details.asp?id=144
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   BRF-69T
AC   CVCL_WS37
DR   Wikidata; Q93431579
RX   PubMed=9618944;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   BRF-71T1
AC   CVCL_WS38
DR   Wikidata; Q93431583
RX   PubMed=9618944;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS39 ! BRF-71T2
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   BRF-71T2
AC   CVCL_WS39
DR   Wikidata; Q93431586
RX   PubMed=9618944;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS38 ! BRF-71T1
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   BRF-97T
AC   CVCL_WS40
DR   FCS-free; 19-2-19-3-6-4
DR   Wikidata; Q93431590
RX   PubMed=9618944;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Donor information: Established from the normal tissue of a breast cancer patient (PubMed=9618944).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   BRF41
AC   CVCL_4131
SY   Brachydanio Rerio Fin 41
DR   CLO; CLO_0050163
DR   RCB; RCB0804
DR   Wikidata; Q54798225
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   BRG-A
AC   CVCL_W881
SY   BRG A; BRG IgA; BRG-IgA; BRGIgA; BrgIgA; BRG-P.5
DR   cancercelllines; CVCL_W881
DR   Cosmic; 1515197
DR   IARC_TP53; 6587
DR   Wikidata; Q54798227
RX   PubMed=8207254;
RX   PubMed=9399658;
RX   PubMed=10702812;
CC   Population: Caucasian.
CC   Characteristics: IgA1 producing subclone of BRG-P.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln354Glu (c.1060C>G); ClinVar=VCV001061283; Zygosity=Hemizygous (PubMed=9399658).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W880 ! BRG-P
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 14
//
ID   BRG-H
AC   CVCL_UI47
DR   Wikidata; Q93431609
RX   PubMed=8695808;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen p45.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W882 ! BRG-M
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 5
//
ID   BRG-M
AC   CVCL_W882
SY   BRG M; BRG IgM; BRG-IgM; BRG-P.1
DR   cancercelllines; CVCL_W882
DR   Cosmic; 1515196
DR   IARC_TP53; 6585
DR   Wikidata; Q54798229
RX   PubMed=8207254;
RX   PubMed=8695808;
RX   PubMed=9399658;
RX   PubMed=10702812;
CC   Population: Caucasian.
CC   Characteristics: IgM producing subclone of BRG-P.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Heterozygous (PubMed=9399658).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Gly (c.857_858AA>GT); Zygosity=Heterozygous (PubMed=9399658).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W880 ! BRG-P
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 14
//
ID   BRG-P
AC   CVCL_W880
DR   Wikidata; Q54798230
RX   PubMed=8207254;
RX   PubMed=8695808;
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Donor information: Established from a HIV-1 infected patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 10
//
ID   BRH 17
AC   CVCL_A2XE
DR   Wikidata; Q105506543
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   BRI-JM01
AC   CVCL_H218
DR   Wikidata; Q54798233
RX   PubMed=15318933;
CC   Characteristics: Can be used to study TGFbeta-induced epithelial-to-mesenchymal transition (EMT). Did not maintain expression of the activated Neu oncogene and lost the Tgfbr2 sequence (PubMed=15318933).
CC   Doubling time: 14 hours (PubMed=15318933).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV/activated Neu, Tgfbr2-AS transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   BRI-JM04
AC   CVCL_H219
DR   Wikidata; Q54798234
RX   PubMed=15318933;
CC   Characteristics: Can be used to investigate Neu oncogene driven mammary tumorigenesis (PubMed=15318933).
CC   Doubling time: 22 hours (PubMed=15318933).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV/activated Neu.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   BRI-JM05
AC   CVCL_H220
DR   Wikidata; Q54798235
RX   PubMed=15318933;
CC   Characteristics: Can be used to investigate Neu oncogene driven mammary tumorigenesis (PubMed=15318933).
CC   Doubling time: 25 hours (PubMed=15318933).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV/activated Neu, Tgfbr2-AS transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   BRIC 107
AC   CVCL_B6SN
SY   BRIC107
DR   Wikidata; Q111732997
RX   PubMed=7690639;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   BRIC 110
AC   CVCL_D6UW
SY   NBTS/BRIC 110; BRIC110
RX   PubMed=3679286;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08174; Human CD55.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 128
AC   CVCL_D6UX
SY   NBTS/BRIC 128; BRIC128
RX   PubMed=3679286;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P08174; Human CD55.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 18
AC   CVCL_B6SP
SY   NBTS/BRIC 18; BRIC18
DR   Wikidata; Q111732999
RX   PubMed=7161507;
RX   PubMed=7690639;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BRIC 203
AC   CVCL_B6SQ
SY   BRIC203
DR   Wikidata; Q111733000
RX   PubMed=7690639;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   BRIC 205
AC   CVCL_D6UY
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 214
AC   CVCL_D6UZ
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 219
AC   CVCL_D6V0
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 222
AC   CVCL_D6V1
SY   BRIC222
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 223
AC   CVCL_D6V2
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 225
AC   CVCL_D6V3
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 227
AC   CVCL_D6V4
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 229
AC   CVCL_D6VC
RX   PubMed=1374058;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13987; Human CD59.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 235
AC   CVCL_D6V5
SY   BRIC235
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 241
AC   CVCL_D6V6
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 257
AC   CVCL_D6VD
RX   PubMed=1374058;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P13987; Human CD59.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 35
AC   CVCL_D6V7
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 5
AC   CVCL_D6V8
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   BRIC 68
AC   CVCL_B6SR
SY   BRIC68
DR   Wikidata; Q111733001
RX   PubMed=7690639;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   BRIE 139
AC   CVCL_GZ55
SY   Berkeley Rat Intestinal Epithelial clone 139
DR   Wikidata; Q54798237
RX   PubMed=1711225;
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   BRIE 291
AC   CVCL_GZ56
SY   BRIE 139HGPRT-/Hmr; Berkeley Rat Intestinal Epithelial clone 291
DR   Wikidata; Q54798239
RX   PubMed=1711225;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GZ55 ! BRIE 139
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   BRIN-BD11
AC   CVCL_6811
DR   BTO; BTO_0002142
DR   CancerTools; 161629
DR   ECACC; 10033003
DR   Lonza; 1453
DR   Wikidata; Q54798240
RX   PubMed=8690162;
CC   Doubling time: ~20 hours (ECACC=10033003).
CC   Breed/subspecies: NEDH; RS=RS_0000603.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   BRIN-BG5
AC   CVCL_W093
DR   CancerTools; 161630
DR   ECACC; 10033001
DR   Wikidata; Q54798241
RX   PubMed=8778219;
CC   Doubling time: ~28 hours (ECACC=10033001).
CC   Breed/subspecies: NEDH; RS=RS_0000603.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 8
//
ID   BRIN-BG7
AC   CVCL_W094
DR   CancerTools; 161631
DR   ECACC; 10020902
DR   Wikidata; Q54798270
RX   PubMed=8778219;
CC   Doubling time: ~20 hours (ECACC=10020902).
CC   Breed/subspecies: NEDH; RS=RS_0000603.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 8
//
ID   BRIP
AC   CVCL_E497
SY   BRI-P
DR   dbMHC; 48513
DR   ECACC; 88052044
DR   IHW; IHW09044
DR   IPD-IMGT/HLA; 11623
DR   Wikidata; Q54798272
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*24:02:01:01; B*51:01:01:01,15:17:01:01; C*07:01:02,15:04:01; DPB1*02:01:02/02:01:19,04:02:01; DQA1*05:01; DQB1*03:01:01; DRB1*11:01:01; DRB3*02:02 (IPD-IMGT/HLA=11623).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Bristol 8
AC   CVCL_2318
SY   BRISTOL 8; Bristol-8; BRISTOL-8; BRISTOL8; Bri-8; BRI-8; BRI 8; GM03357; GM3357; GM03357B
DR   CLO; CLO_0002028
DR   CLO; CLO_0016544
DR   CLDB; cl480
DR   ChEMBL-Cells; CHEMBL3308429
DR   ChEMBL-Targets; CHEMBL614950
DR   Coriell; GM03357
DR   ECACC; 85011436
DR   PubChem_Cell_line; CVCL_2318
DR   Wikidata; Q54798274
RX   CelloPub=CLPUB00447;
RX   PubMed=75508;
RX   PubMed=6200433;
RX   PubMed=11416159;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 15,19
ST   D21S11: 28,32.2,33.2
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 19
//
ID   BRITER
AC   CVCL_0P40
SY   BMP Responsive Immortalized reporTER cell line
DR   Kerafast; EBI001
DR   Wikidata; Q29957968
RX   PubMed=22611465;
CC   Characteristics: Responds robustly, promptly and specifically to exogenously added BMP2 protein.
CC   Characteristics: Transfected with a BRE-SV40minP-FFLuc-SV40P-HygR-IRES-RRLuc construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Bmp2/4 dKO x R26CreER.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   BRK-1
AC   CVCL_C3XC
DR   Wikidata; Q116048613
RX   PubMed=2820727;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P07550; Human ADRB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BRK-2
AC   CVCL_C3XD
DR   Wikidata; Q116048614
RX   PubMed=2820727;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08588; Human ADRB1.
CC   Monoclonal antibody target: UniProtKB; P07550; Human ADRB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BRK-3
AC   CVCL_C3XE
DR   Wikidata; Q116048615
RX   PubMed=2820727;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P08588; Human ADRB1.
CC   Monoclonal antibody target: UniProtKB; P07550; Human ADRB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   BRL
AC   CVCL_4565
SY   Buffalo Rat Liver
DR   BTO; BTO_0001933
DR   CLO; CLO_0050618
DR   CCRID; 3101RATGNR1
DR   CCRID; 3101RATSCSP5294
DR   CLS; 305193
DR   KCB; KCB 2021065YJ
DR   RCB; RCB0273
DR   Wikidata; Q54798276
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   BRL-1
AC   CVCL_4132
SY   BRL1; Buffalo Rat Liver-1
DR   CLO; CLO_0002030
DR   CLDB; cl483
DR   ECACC; 94121649
DR   Wikidata; Q54798277
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   BRL-3A
AC   CVCL_0606
SY   BRL3A; BRL 3A; Buffalo Rat Liver-3A
DR   BTO; BTO_0000154
DR   CLO; CLO_0002029
DR   CLO; CLO_0002031
DR   EFO; EFO_0022728
DR   CLDB; cl481
DR   CLDB; cl482
DR   CLDB; cl4989
DR   ATCC; CRL-1442
DR   BCRC; 60218
DR   CCRID; 3101RATGNR10
DR   CCRID; 3101RATSCSP5434
DR   CCRID; 5301RAT-KCB92013YJ
DR   CLS; 500129
DR   ECACC; 85111503
DR   ICLC; AL00002
DR   JCRB; JCRB0025
DR   JCRB; JCRB9114
DR   KCB; KCB 92013YJ
DR   TOKU-E; 688
DR   Wikidata; Q54798280
CC   Doubling time: 19.8 hours (Note=Lots 051388 and 052588), 48 hours (Note=Lot 072398) (JCRB=JCRB0025).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 21
//
ID   BRL-4
AC   CVCL_0177
SY   BRL4; BRL 4
DR   MCCL; MCC:0000068
DR   Wikidata; Q54798281
RX   PubMed=8232317;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2687; Ghr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4565 ! BRL
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   BRL-5
AC   CVCL_B4K0
SY   BRL5; BRL 5
DR   Wikidata; Q110432641
RX   PubMed=8232317;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2687; Ghr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4565 ! BRL
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   BRL-4143
AC   CVCL_LF98
SY   BRL 4143; BRL4143; Bionetics Research Laboratories-4143
DR   Wikidata; Q54798283
RX   CelloPub=CLPUB00672;
RX   PubMed=174085;
RX   PubMed=1260760;
CC   Misspelling: BRL-4130; PubMed=174085; PubMed=1260760; Note=In both cases, table 1 mentions BRL-4130 while the rest of the text mentions BRL-4143.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   BRL-6005
AC   CVCL_B4K3
SY   BRL 6005; BRL6005; Bionetics Research Laboratories-6005
DR   Wikidata; Q110432642
RX   CelloPub=CLPUB00672;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   BRL-6278
AC   CVCL_B4K4
SY   BRL 6278; BRL6278; Bionetics Research Laboratories-6278
DR   Wikidata; Q110432643
RX   CelloPub=CLPUB00672;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   BRL-AG-1
AC   CVCL_Z337
DR   ICLDB; brl-ag-1
DR   Wikidata; Q54798284
RX   DOI=10.1007/BF02877059;
RX   PubMed=8799737;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Doubling time: 20-22 hours (DOI=10.1007/BF02877059).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7044; ! Anthonomus grandis (Mexican cotton boll weevil)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BRL-AG-2
AC   CVCL_Z338
SY   BRL-AG2
DR   ICLDB; brl-ag-2
DR   Wikidata; Q54798286
RX   DOI=10.1007/BF02877059;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7044; ! Anthonomus grandis (Mexican cotton boll weevil)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BRL-AG-3A
AC   CVCL_Z339
SY   AG3A
DR   ICLDB; brl-ag-3a
DR   Wikidata; Q54798287
RX   DOI=10.1007/BF02877059;
CC   Group: Insect cell line.
CC   Doubling time: 20-22 hours (DOI=10.1007/BF02877059).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7044; ! Anthonomus grandis (Mexican cotton boll weevil)
OI   CVCL_Z340 ! BRL-AG-3C
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BRL-AG-3C
AC   CVCL_Z340
DR   ICLDB; brl-ag-3c
DR   Wikidata; Q54798288
RX   DOI=10.1007/BF02877059;
CC   Group: Insect cell line.
CC   Doubling time: 20-22 hours (DOI=10.1007/BF02877059).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7044; ! Anthonomus grandis (Mexican cotton boll weevil)
OI   CVCL_Z339 ! BRL-AG-3A
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BRL-AG-4
AC   CVCL_Z341
DR   ICLDB; brl-ag-4
DR   Wikidata; Q54798291
RX   DOI=10.1007/BF02877059;
CC   Group: Insect cell line.
CC   Doubling time: 20-22 hours (DOI=10.1007/BF02877059).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7044; ! Anthonomus grandis (Mexican cotton boll weevil)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BrMi-J2imm
AC   CVCL_A7WK
SY   Microglial Cell Line Derived from Wild Type Mice
DR   BEI_Resources; NR-9460
DR   Wikidata; Q107113508
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Myd88-/- Ticam1-/-
AC   CVCL_A7WL
SY   Microglial Cell Line Derived from TRIF/MyD88 Double Knockout Mice
DR   BEI_Resources; NR-15640
DR   Wikidata; Q107113509
CC   Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 7
//
ID   BrMi-J2imm Myd88-/- Tirap-/-
AC   CVCL_A7WM
SY   Microglial Cell Line Derived from MAL/MyD88 Double Knockout Mice
DR   BEI_Resources; NR-9904
DR   Wikidata; Q107113510
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2152213; Tirap.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Ticam1-/-
AC   CVCL_A7WN
SY   Microglial Cell Line Derived from TRIF Knockout Mice
DR   BEI_Resources; NR-15638
DR   Wikidata; Q107113511
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   BrMi-J2imm Ticam2-/-
AC   CVCL_A7WP
SY   Microglial Cell Line Derived from TRAM Knockout Mice
DR   BEI_Resources; NR-9903
DR   Wikidata; Q107113512
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Tlr1-/-
AC   CVCL_A7WQ
SY   Microglial Cell Line Derived from TLR1 Knockout Mice
DR   BEI_Resources; NR-19978
DR   Wikidata; Q107113513
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1341295; Tlr1.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Tlr2-/-
AC   CVCL_A7WR
SY   Microglial Cell Line Derived from TLR2 Knockout Mice
DR   BEI_Resources; NR-15641
DR   Wikidata; Q107113514
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Tlr3-/-
AC   CVCL_A7WS
SY   Microglial Cell Line Derived from TLR3 Knockout Mice
DR   BEI_Resources; NR-9900
DR   Wikidata; Q107113515
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2156367; Tlr3.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Tlr4-/-
AC   CVCL_A7WT
SY   Microglial Cell Line Derived from TLR4 Knockout Mice
DR   BEI_Resources; NR-9901
DR   Wikidata; Q107113517
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Tlr6-/-
AC   CVCL_A7WU
SY   Microglial Cell Line Derived from TLR6 Knockout Mice
DR   BEI_Resources; NR-19973
DR   Wikidata; Q107113518
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1341296; Tlr6.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Tlr7-/-
AC   CVCL_A7WV
SY   Microglial Cell Line Derived from TLR7 Knockout Mice
DR   BEI_Resources; NR-19980
DR   Wikidata; Q107113519
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2176882; Tlr7.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   BrMi-J2imm Tlr9-/-
AC   CVCL_A7WW
SY   Microglial Cell Line Derived from TLR9 Knockout Mice
DR   BEI_Resources; NR-9902
DR   Wikidata; Q107113520
CC   From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9.
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   BRN-1
AC   CVCL_0U15
DR   Wikidata; Q54798292
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   BRN-2
AC   CVCL_0U16
DR   Wikidata; Q54798295
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   BRN-3
AC   CVCL_0U17
DR   Wikidata; Q54798296
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 12
//
ID   BRN-4
AC   CVCL_0U18
DR   Wikidata; Q54798298
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   BRN-5
AC   CVCL_0U19
DR   Wikidata; Q54798299
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   BRN-6
AC   CVCL_0U20
DR   Wikidata; Q54798300
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 14
//
ID   BRN-7
AC   CVCL_0U21
DR   Wikidata; Q54798302
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   BRN-9
AC   CVCL_0U22
DR   Wikidata; Q54798303
RX   PubMed=21573385;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   BRO
AC   CVCL_7036
SY   Bro
DR   ChEMBL-Cells; CHEMBL3308611
DR   ChEMBL-Targets; CHEMBL614665
DR   PubChem_Cell_line; CVCL_7036
DR   Wikidata; Q54798305
RX   PubMed=1968359;
RX   PubMed=3965144;
CC   Population: Caucasian.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   BRO,LJ
AC   CVCL_E498
SY   BRO, LJ
DR   dbMHC; 48514
DR   ECACC; 94082269
DR   IHW; IHW09169
DR   IPD-IMGT/HLA; 11712
DR   Wikidata; Q54798311
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,29; B*44,50; C*06,16:01; DPB1*01:01:01,02:01:02; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*01:01 (IPD-IMGT/HLA=11712).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BRO,ML
AC   CVCL_E499
SY   BRO, ML
DR   dbMHC; 48515
DR   ECACC; 940822105
DR   IHW; IHW09201
DR   IPD-IMGT/HLA; 11742
DR   Wikidata; Q54798313
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,29; B*44,58:01; C*07,16:01; DPB1*01:01:01,04:01; DQA1*05:01; DQB1*02:01,03:01; DRB1*03:01,13:03; DRB3*01:01 (IPD-IMGT/HLA=11742).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 18
//
ID   BRO/pFRmdr1.6 clone 1.1
AC   CVCL_RL86
SY   BRO/mdr1.1
DR   Wikidata; Q54798306
RX   PubMed=1968359;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7036 ! BRO
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   BRO/pFRmdr1.6 clone 1.4
AC   CVCL_RL87
DR   Wikidata; Q54798309
RX   PubMed=1968359;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7036 ! BRO
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   BroLi
AC   CVCL_E997
DR   cancercelllines; CVCL_E997
DR   Cosmic; 1699818
DR   GEO; GSM1904845
DR   PRIDE; PXD008181
DR   Progenetix; CVCL_E997
DR   Wikidata; Q54798314
RX   PubMed=20444890;
RX   PubMed=22363598;
RX   PubMed=23563200;
RX   PubMed=27121059;
RX   PubMed=30873613;
RX   PubMed=31889939;
CC   Doubling time: 5 days (PubMed=20444890); 4-5 days (PubMed=30873613).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 16,19
ST   D21S11: 27.2,29.2
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 11,17
ST   FGA: 20,26
ST   Penta D: 13
ST   Penta E: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   BRSO
AC   CVCL_UZ37
DR   Wikidata; Q93431922
RX   PubMed=10341211;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 45-60 PDL (PubMed=10341211).
CC   Derived from site: In situ; Axilla, skin; UBERON=UBERON_0015474.
CC   Cell type: Myoepithelial cell; CL=CL_0000185.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   BRT
AC   CVCL_0A26
SY   Bovine Rectal Tumor
DR   Wikidata; Q54798317
RX   PubMed=25441618;
CC   Doubling time: ~20.64 hours (PubMed=25441618).
DI   NCIt; C134768; Bovine rectal myxoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   BRU
AC   CVCL_E500
DR   IHW; 9w 0901
DR   Wikidata; Q54798318
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   Bruce-4
AC   CVCL_K037
SY   BRUCE-4; Bruce 4; Bruce4; BRUCE4; ES-Bruce4; EmbryoMax C57/BL6; CMTI-2
DR   EFO; EFO_0005483
DR   ENCODE; ENCBS250IKX
DR   ENCODE; ENCBS359ENC
DR   ENCODE; ENCBS551ZCI
DR   ENCODE; ENCBS855UGJ
DR   GEO; GSM769008
DR   GEO; GSM769009
DR   GEO; GSM769010
DR   GEO; GSM918748
DR   GEO; GSM918749
DR   GEO; GSM918750
DR   GEO; GSM1000089
DR   GEO; GSM1000099
DR   GEO; GSM1000109
DR   GEO; GSM1000127
DR   GEO; GSM1000147
DR   Millipore; CMTI-2
DR   Wikidata; Q54798320
RX   PubMed=8398989;
RX   PubMed=17828574;
RX   PubMed=25277546;
WW   Provider; Michigan TCPS; -; https://medresearch.umich.edu/office-research/about-office-research/biomedical-research-core-facilities/transgenic-animal-model/transgenic-core-products-services
CC   Part of: ENCODE project mouse cell lines.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: CMT1-2; PubMed=25277546.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.Cg-Thy1<a>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   BRUG
AC   CVCL_E501
DR   dbMHC; 48516
DR   IHW; IHW09244
DR   IPD-IMGT/HLA; 10351
DR   Wikidata; Q54798321
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*03:01:01:01,11:01:01:01; B*27:02:01,27:05:02; C*01:02:01,02:02:02:03; DPB1*04:01,14:01 (IPD-IMGT/HLA=10351).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   BRZ-CD99-shRNA#1
AC   CVCL_QW75
DR   GEO; GSM278149
DR   GEO; GSM278150
DR   Wikidata; Q54798322
RX   PubMed=20197622;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7082; CD99.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H724 ! IOR/BRZ
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 6
//
ID   BRZ-CD99-shRNA#2
AC   CVCL_QW76
DR   GEO; GSM278151
DR   GEO; GSM278152
DR   Wikidata; Q54798323
RX   PubMed=20197622;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7082; CD99.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H724 ! IOR/BRZ
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 6
//
ID   BRZ-CTR-shRNA
AC   CVCL_QW74
DR   GEO; GSM278147
DR   GEO; GSM278148
DR   Wikidata; Q54798324
RX   PubMed=20197622;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H724 ! IOR/BRZ
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 5
//
ID   BS
AC   CVCL_QW64
DR   Wikidata; Q54798325
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=14671638;
RX   PubMed=27467674;
CC   Doubling time: 24-48 hours (PubMed=27467674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   BS 38
AC   CVCL_B6WI
DR   Wikidata; Q111733002
RX   PubMed=3609487;
RX   PubMed=6526151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24. Recognizes M blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 39
AC   CVCL_B6WJ
DR   Wikidata; Q111733003
RX   PubMed=3609487;
RX   PubMed=6526151;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=Recognizes both M and N blood group antigens).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   BS 40
AC   CVCL_B6WK
DR   Wikidata; Q111733004
RX   PubMed=3609487;
RX   PubMed=6526151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 41
AC   CVCL_B6WL
DR   Wikidata; Q111733005
RX   PubMed=3609487;
RX   PubMed=6526151;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 42
AC   CVCL_B6WM
DR   Wikidata; Q111733006
RX   PubMed=3609487;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 44
AC   CVCL_B6WN
DR   Wikidata; Q111733007
RX   PubMed=3609487;
RX   PubMed=6526151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24. Recognizes M blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 45
AC   CVCL_B6SM
SY   BS45
DR   Wikidata; Q111733008
RX   CelloPub=CLPUB00687;
RX   CelloPub=CLPUB00688;
RX   Patent=EP0115063B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-268.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   BS 50
AC   CVCL_B6SL
SY   BS50
DR   Wikidata; Q111733009
RX   Patent=US4751183;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-313.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60568; Human IL2 (Note=Also regognizes IgG lambda).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   BS 57
AC   CVCL_B6WP
DR   Wikidata; Q111733010
RX   PubMed=3609487;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24. Recognizes M blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 59
AC   CVCL_B6WQ
DR   Wikidata; Q111733011
RX   PubMed=3609487;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 61
AC   CVCL_B6WR
DR   Wikidata; Q111733013
RX   PubMed=3609487;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS 75
AC   CVCL_B6WS
DR   Wikidata; Q111733014
RX   PubMed=3609487;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   BS PBiPS46-Sv4F-10
AC   CVCL_E7SL
SY   RB12146
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_BS%2520PBiPS46-Sv4F-10-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+BS+PBiPS46-Sv4F-10+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BS-1
AC   CVCL_C8GB
DR   Wikidata; Q123030822
RX   PubMed=8396796;
RX   PubMed=8438590;
CC   Virology: Susceptible to infection by cytomegalovirus (CMV) (PubMed=8396796).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   BS-C-1
AC   CVCL_0607
SY   BSC-1; BSC1; GMK,BSC-1; Biologics Standards-Cercopithecus-1
DR   CLO; CLO_0002035
DR   CLO; CLO_0002036
DR   CLO; CLO_0002037
DR   CLDB; cl484
DR   CLDB; cl486
DR   CLDB; cl487
DR   ATCC; CCL-26
DR   BCRC; 60078
DR   CCRID; 1101MON-PUMC000098
DR   CCRID; 1102MON-NIFDC00094
DR   CCRID; 4201MON-CCTCC00033
DR   CCTCC; GDC0033
DR   ChEMBL-Cells; CHEMBL3307388
DR   ChEMBL-Targets; CHEMBL614528
DR   CLS; 305009
DR   ECACC; 85011422
DR   IZSLER; BS CL 9
DR   JCRB; IFO50413
DR   JCRB; JCRB9011
DR   JCRB; JCRB9126
DR   KCLB; 10026
DR   NCBI_Iran; C484
DR   PubChem_Cell_line; CVCL_0607
DR   Wikidata; Q38086318
RX   DOI=10.1007/BF02618370;
RX   PubMed=272650;
RX   PubMed=303774;
RX   PubMed=3024506;
RX   PubMed=4203458;
RX   PubMed=4339410;
RX   PubMed=6988327;
RX   PubMed=14071033;
RX   PubMed=14215895;
RX   PubMed=14473108;
RX   PubMed=28046048;
RX   PubMed=33458215;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-526.html
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Chlorocebus aethiops origin but found to be from Chlorocebus pygerythrus (PubMed=33458215).
CC   Characteristics: Suitable for transfection by SV40 and may be used for the detection of viruses (ATCC=CCL-26).
CC   Doubling time: 72 hours (Note=At 68th passage) (PubMed=14071033).
CC   Sequence variation: Mutation; UniProtKB; A0A7D5U6M6; MT-ND6; Simple; p.Tyr50fs*25 (c.147insG) (m.13952dupC); Zygosity=Heteroplasmic; Note=In a majority of mitochondria (PubMed=33458215).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Discontinued: JCRB; JCRB9011; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 24
//
ID   BS-SHI-4
AC   CVCL_6G17
DR   Wikidata; Q54798330
RX   PubMed=3186719;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Could be identical to EBV-BS4-1 (Cellosaurus=CVCL_WX65).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BS-SHI-4M
AC   CVCL_A798
DR   CLO; CLO_0051018
DR   BioSample; SAMN03472073
DR   RCB; RCB1752
DR   Wikidata; Q54798333
RX   PubMed=3186719;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1752
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 10,13
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G17 ! BS-SHI-4
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   BS-SY1
AC   CVCL_WY21
DR   Wikidata; Q93432027
RX   PubMed=3875094;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   BS-SY2
AC   CVCL_WY22
DR   Wikidata; Q93432030
RX   PubMed=3875094;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   BS/BEK
AC   CVCL_4509
SY   BreScia/Bovine Embryo Kidney
DR   CLO; CLO_0002032
DR   CLDB; cl488
DR   IZSLER; BS CL 94
DR   Wikidata; Q54798335
RX   PubMed=1857265;
RX   PubMed=18645818;
CC   Virology: Highly susceptible to infection by Newcastle disease virus (NDV) isolate La Sota (PubMed=18645818).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   8FM
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   BS/HG
AC   CVCL_W714
SY   Brescia/Human Gum
DR   IZSLER; BS CL 150
DR   Wikidata; Q54798336
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): IZSLER=BS CL 150
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 7,13
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 10
//
ID   BS1-B4
AC   CVCL_4133
DR   CLO; CLO_0002033
DR   CLDB; cl489
DR   ECACC; 85011410
DR   Wikidata; Q54798368
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BS100
AC   CVCL_XH76
SY   BS 100
DR   Wikidata; Q93432057
RX   Patent=EP0273333A2;
RX   PubMed=3141465;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-644.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacterium tuberculosis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BS101
AC   CVCL_XH77
SY   BS 101
DR   Wikidata; Q93432062
RX   PubMed=3141465;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacterium tuberculosis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BS102
AC   CVCL_XH78
SY   BS 102
DR   Wikidata; Q93432064
RX   Patent=EP0273333A2;
RX   PubMed=3141465;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-645.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacterium tuberculosis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BS104
AC   CVCL_XH79
SY   BS 104
DR   Wikidata; Q93432068
RX   Patent=EP0273333A2;
RX   PubMed=3141465;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-646.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacterium tuberculosis 71 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BS107
AC   CVCL_XH80
SY   BS 107
DR   Wikidata; Q93432072
RX   Patent=EP0273333A2;
RX   PubMed=3141465;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-647.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacterium tuberculosis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BS108
AC   CVCL_XH81
SY   BS 108
DR   Wikidata; Q93432075
RX   PubMed=3141465;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacterium tuberculosis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BS110
AC   CVCL_XH82
SY   BS 110
DR   Wikidata; Q93432079
RX   PubMed=3141465;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacteriaceae (Note=Reacts with many species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   BS111
AC   CVCL_XH83
SY   BS 111
DR   Wikidata; Q93432082
RX   PubMed=3141465;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycobacteriaceae (Note=Reacts with many species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   BS125
AC   CVCL_IW38
DR   Wikidata; Q54798369
RX   PubMed=21406405;
CC   From: University of Basel; Basel; Switzerland.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   BS149
AC   CVCL_IW39
DR   GEO; GSM397669
DR   GEO; GSM397670
DR   Wikidata; Q54798371
RX   PubMed=21406405;
CC   From: University of Basel; Basel; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   BS153
AC   CVCL_S444
SY   BS-153
DR   Wikidata; Q54798328
RX   PubMed=11431328;
RX   PubMed=22570425;
RX   PubMed=23877316;
CC   Characteristics: Highly overexpresses EGFR (~50 fold). Overexpress the EGFRvIII splice isoform.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11431328).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 12,17
ST   D21S11: 28,29
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 9,14
ST   Penta E: 7
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   BS153-ResE
AC   CVCL_B3PI
SY   BS153ResE
DR   Wikidata; Q110432644
RX   PubMed=23877316;
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S444 ! BS153
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   Bs1A
AC   CVCL_UY99
SY   Bs-1A
DR   Wikidata; Q93432101
RX   PubMed=10936089;
RX   PubMed=11877394;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03072; JC polyomavirus large T antigen.
CC   Transformant: NCBI_TaxID; 10632; JC polyomavirus (JCPyV).
CC   Breed/subspecies: JCV T-Ag transgenic.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UZ00 ! BsB7
OI   CVCL_UZ01 ! BsB8
OI   CVCL_UZ02 ! BsB13
OI   CVCL_UZ03 ! BsB14
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 4
//
ID   BS1CH
AC   CVCL_L451
DR   JCRB; KURB1848
DR   Wikidata; Q54798372
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   BS1CH(SVT)
AC   CVCL_L452
DR   JCRB; KURB1849
DR   Wikidata; Q54798373
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L451 ! BS1CH
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 15
//
ID   BS1KA
AC   CVCL_L951
SY   Bloom Syndrome 1 KAnazawa; 86NoKi; GM05289; GM5289; GM05289B; GM17054; HG1309
DR   CLO; CLO_0014662
DR   CLO; CLO_0024951
DR   Coriell; GM05289
DR   Coriell; GM17054
DR   GEO; GSM1316984
DR   GEO; GSM1317023
DR   JCRB; JCRB3072
DR   JCRB; KURB1861
DR   Wikidata; Q54798377
RX   CelloPub=CLPUB00447;
RX   PubMed=3180052;
RX   PubMed=3627143;
RX   PubMed=3821765;
RX   PubMed=6705251;
RX   PubMed=17407155;
CC   Part of: Human variation panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (PubMed=17407155; Coriell=GM05289).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM17054).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 86(NoKi) (BSR86).
CC   Discontinued: JCRB; KURB1861; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3072
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 9,10
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX76 ! HG1805
OI   CVCL_ZS84 ! EB-BS-NoKi-1
OI   CVCL_ZS85 ! EB-BS-NoKi-2
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 27
//
ID   BS1KY
AC   CVCL_IW40
SY   BS 1KY; Bloom Syndrome 1 KYoto
DR   JCRB; KURB1854
DR   Wikidata; Q54798378
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   BS2CH
AC   CVCL_2867
DR   BioSample; SAMN03471621
DR   JCRB; JCRB0317
DR   JCRB; KURB1850
DR   Wikidata; Q54798380
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0317
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   BS2CH(SVT)
AC   CVCL_L453
DR   JCRB; KURB1851
DR   Wikidata; Q54798381
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2867 ! BS2CH
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   BS2CHTERT
AC   CVCL_2868
DR   JCRB; JCRB1061
DR   JCRB; NIHS0311
DR   Wikidata; Q54798383
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; NIHS0311; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1061
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2867 ! BS2CH
SX   Female
AG   4Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   BS2KA
AC   CVCL_W042
SY   BS-2KA; Bloom Syndrome 1 KAnazawa; 93YoYa
DR   JCRB; JCRB3071
DR   JCRB; KURB1864
DR   Wikidata; Q54798385
RX   PubMed=3627143;
RX   PubMed=3821765;
RX   PubMed=6705251;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (from autologous cell line HG1626).
CC   Donor information: From Bloom Syndrome Registry patient 93(YoYa) (BSR93).
CC   Discontinued: JCRB; KURB1864; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3071
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2869 ! BSL2KA
OI   CVCL_WX55 ! HG1626
SX   Male
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   BS2KAF
AC   CVCL_WX56
DR   JCRB; KURB1865
DR   Wikidata; Q93432171
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   BSa2
AC   CVCL_YU24
DR   Wikidata; Q93432174
RX   PubMed=32080776;
CC   Group: Fish cell line.
CC   Characteristics: Can differentiate into osteoblastic, chondroblastic and osteoclastic lineages.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   BSB
AC   CVCL_S927
SY   Barramundi Swim Bladder
DR   Wikidata; Q54798386
RX   PubMed=19238757;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
OI   CVCL_S926 ! BM [L.calcarifer]
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   BsB13
AC   CVCL_UZ02
SY   Bs-1B13
DR   Wikidata; Q93432185
RX   PubMed=10936089;
RX   PubMed=11877394;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03072; JC polyomavirus large T antigen.
CC   Transformant: NCBI_TaxID; 10632; JC polyomavirus (JCPyV).
CC   Breed/subspecies: JCV T-Ag transgenic.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UY99 ! Bs1A
OI   CVCL_UZ00 ! BsB7
OI   CVCL_UZ01 ! BsB8
OI   CVCL_UZ03 ! BsB14
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 4
//
ID   BsB14
AC   CVCL_UZ03
SY   Bs-1B14
DR   Wikidata; Q93432189
RX   PubMed=10936089;
RX   PubMed=11877394;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03072; JC polyomavirus large T antigen.
CC   Transformant: NCBI_TaxID; 10632; JC polyomavirus (JCPyV).
CC   Breed/subspecies: JCV T-Ag transgenic.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UY99 ! Bs1A
OI   CVCL_UZ00 ! BsB7
OI   CVCL_UZ01 ! BsB8
OI   CVCL_UZ02 ! BsB13
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 4
//
ID   BsB7
AC   CVCL_UZ00
SY   Bs-1B7
DR   Wikidata; Q93432193
RX   PubMed=10936089;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03072; JC polyomavirus large T antigen.
CC   Transformant: NCBI_TaxID; 10632; JC polyomavirus (JCPyV).
CC   Breed/subspecies: JCV T-Ag transgenic.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UY99 ! Bs1A
OI   CVCL_UZ01 ! BsB8
OI   CVCL_UZ02 ! BsB13
OI   CVCL_UZ03 ! BsB14
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 4
//
ID   BsB8
AC   CVCL_UZ01
SY   Bs-1B8
DR   Wikidata; Q93432197
RX   PubMed=10936089;
RX   PubMed=11877394;
RX   PubMed=22207898;
RX   PubMed=30108683;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03072; JC polyomavirus large T antigen.
CC   Transformant: NCBI_TaxID; 10632; JC polyomavirus (JCPyV).
CC   Breed/subspecies: JCV T-Ag transgenic.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UY99 ! Bs1A
OI   CVCL_UZ00 ! BsB7
OI   CVCL_UZ02 ! BsB13
OI   CVCL_UZ03 ! BsB14
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 4
//
ID   BSBS
AC   CVCL_IN44
SY   Black SeaBream Spleen
DR   Wikidata; Q54798387
RX   CelloPub=CLPUB00365;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 20 Celsius (CelloPub=CLPUB00365).
CC   Virology: Susceptible to infection by marine birnavirus (MABV Y-6), chum salmon virus (CSV), spring viremia of carp virus (SVCV) and hirame rhabdovirus (HIRRV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=72011; ! Acanthopagrus schlegelii (Black porgy)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 9
//
ID   BSC
AC   CVCL_M116
DR   BTO; BTO_0003525
DR   Wikidata; Q54798389
RX   CelloPub=CLPUB00024;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   BSC-C10
AC   CVCL_M117
SY   BSC-c10
DR   Wikidata; Q54798390
RX   CelloPub=CLPUB00024;
RX   PubMed=14656714;
RX   PubMed=17760834;
CC   Doubling time: 40-48 hours (CelloPub=CLPUB00024).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M116 ! BSC
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 10
//
ID   BSC-OF
AC   CVCL_HF86
DR   Wikidata; Q54798393
RX   PubMed=9379426;
RX   PubMed=15596299;
CC   Doubling time: 18.2 +- 5.4 hours (PubMed=9379426).
DI   NCIt; C129873; Floor of mouth basaloid squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 5
//
ID   BSC-SV Cl 1.1
AC   CVCL_F0RT
SY   BSC/SV Cl.1.1
RX   PubMed=4339410;
RX   PubMed=4350222;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Parent cell line (BS-C-1) was originally thought to be of Chlorocebus aethiops origin but originate from Chlorocebus pygerythrus.
CC   Sequence variation: Mutation; UniProtKB; A0A7D5U6M6; MT-ND6; Simple; p.Tyr50fs*25 (c.147insG) (m.13952dupC); Zygosity=Heteroplasmic (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_0607 ! BS-C-1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BSC40
AC   CVCL_3656
SY   BSC-40
DR   BTO; BTO_0001529
DR   CLO; CLO_0002038
DR   EFO; EFO_0022771
DR   AddexBio; T0011003/4893
DR   ATCC; CRL-2761
DR   Wikidata; Q54798394
RX   PubMed=4362640;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-221.html
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Parent cell line (BS-C-1) was originally thought to be of Chlorocebus aethiops origin but originate from Chlorocebus pygerythrus.
CC   Characteristics: Adapted to growth at 40 Celsius.
CC   Sequence variation: Mutation; UniProtKB; A0A7D5U6M6; MT-ND6; Simple; p.Tyr50fs*25 (c.147insG) (m.13952dupC); Zygosity=Heteroplasmic (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_0607 ! BS-C-1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 22
//
ID   BSCC
AC   CVCL_JX46
DR   Cosmic; 932156
DR   Wikidata; Q54798395
RX   DOI=10.5843/jsot.13.Suppliment_301;
CC   Population: Japanese.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   BSCC-93
AC   CVCL_8157
SY   BSCC93; Burn-derived Squamous Cell Carcinoma-93
DR   BioSample; SAMN03151634
DR   cancercelllines; CVCL_8157
DR   IARC_TP53; 21197
DR   RCB; RCB1202
DR   Wikidata; Q54798397
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a DJM-1 derivative (PubMed=16643607; PubMed=20143388).
CC   From: Usui, Keitaro; Jichi Medical School; Tochigi; Japan.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00185.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser144Ter (c.431C>G); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: RCB; RCB1202; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1172 ! DJM-1
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   BSF
AC   CVCL_9T83
SY   Black Sea bream Fibroblast
DR   Wikidata; Q54798398
RX   DOI=10.1007/s10695-004-5262-7;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=72011; ! Acanthopagrus schlegelii (Black porgy)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   BSH012
AC   CVCL_E502
SY   BSH 012
DR   dbMHC; 48517
DR   ECACC; 94082279
DR   IHW; IHW09179
DR   IPD-IMGT/HLA; 11721
DR   Wikidata; Q54798399
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*01,26; B*08,38:01; C*07,12; DPB1*01:01:01,04:01; DQA1*05:01,03; DQB1*02:01,03:02; DRB1*03:01,04:02; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=11721).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BSH017
AC   CVCL_E503
SY   BSH 017
DR   dbMHC; 48518
DR   ECACC; 94082280
DR   IHW; IHW09180
DR   IPD-IMGT/HLA; 11722
DR   Wikidata; Q54798400
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*30; B*18; DPB1*02:01:02,02:02; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*02:02 (IPD-IMGT/HLA=11722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   BSkMEC
AC   CVCL_A1BJ
SY   Bovine Skin Microvascular Endothelial Cells
DR   ABM; T0833
DR   Wikidata; Q102113644
RX   PubMed=32722052;
CC   Doubling time: 24 hours (PubMed=32722052).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
CC   Breed/subspecies: Montbeliarde; VBO=VBO_0000306.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A1BE ! BBrMEC
OI   CVCL_A1BF ! BIntMEC
OI   CVCL_A1BG ! BLuMEC
OI   CVCL_A1BH ! BMLNMEC
OI   CVCL_A1BI ! BOvMEC
OI   CVCL_A1BK ! BUcEC
SX   Female
AG   6FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   BSL2KA
AC   CVCL_2869
SY   BSL-2KA; BSL 2KA
DR   JCRB; JCRB1042
DR   JCRB; KURB1863
DR   JCRB; NIHS0306
DR   Wikidata; Q54798402
RX   PubMed=1900268;
RX   PubMed=2805228;
RX   PubMed=6705251;
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=1900268).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (from autologous cell line HG1626).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 93(YoYa) (BSR93).
CC   Discontinued: JCRB; NIHS0306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1042
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W042 ! BS2KA
OI   CVCL_WX55 ! HG1626
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   BSM
AC   CVCL_E504
SY   GM06821; GM06821A
DR   CLO; CLO_0036525
DR   Coriell; GM06821
DR   dbMHC; 48519
DR   ECACC; 88052032
DR   IHW; IHW09032
DR   IPD-IMGT/HLA; 11624
DR   Wikidata; Q54798403
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6417008;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*02:01:01:01; B*15:01:01:01; C*03:04:01:01; DPA1*01; DPB1*02:01:02/02:01:19; DQA1*03:01; DQB1*03:02:01; DRA*01:01; DRB1*04:01:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=11624).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   BSMZ
AC   CVCL_M100
DR   Wikidata; Q54798405
RX   PubMed=1356615;
CC   Population: Japanese.
CC   Doubling time: 27 hours (Note=At 120th passage) (PubMed=1356615).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   BSN
AC   CVCL_6F39
DR   Wikidata; Q54798406
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
RX   PubMed=10466804;
CC   Group: Fish cell line.
CC   Virology: Infected by blotched snakehead virus (BSNV).
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=64146; ! Channa lucius (Forest snakehead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   BSp
AC   CVCL_3657
SY   Bovine Spleen
DR   CLO; CLO_0002039
DR   ATCC; CRL-6019
DR   Wikidata; Q54798407
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6019; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4399 ! BBm
OI   CVCL_3655 ! BLn
OI   CVCL_R939 ! BPf
OI   CVCL_5244 ! BThy
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BSR
AC   CVCL_C8A1
DR   Wikidata; Q123030823
RX   PubMed=193466;
RX   PubMed=9857182;
RX   PubMed=27497184;
CC   Virology: Susceptible to infection by human herpesvirus 2 (HHV-2) and Rubella virus (PubMed=193466).
CC   Virology: Susceptible to infection by rabies virus (PubMed=9857182).
CC   Virology: Susceptible to infection by African horse sickness virus 4 (AHSV-4) (PubMed=27497184).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_HB78 ! BHK-21/WI-2
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   BSR p75NTR clone R4
AC   CVCL_C8A2
DR   Wikidata; Q123030825
RX   PubMed=9857182;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97323; Ngfr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_C8A1 ! BSR
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 4
//
ID   BSR p75NTR clone R5
AC   CVCL_C8A3
DR   Wikidata; Q123030826
RX   PubMed=9857182;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97323; Ngfr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_C8A1 ! BSR
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 4
//
ID   BSR-T7/5
AC   CVCL_RW96
SY   BsR-T7/5; BSR T7/5; BHK-T7
DR   CCLV; CCLV-RIE 0583
DR   Wikidata; Q54798410
RX   PubMed=9847328;
CC   Characteristics: Expression of the T7 RNA polymerase gene is under control of the cytomegalovirus promoter (PubMed=9847328).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: This cell line is protected by IP rights of the inventors. The CCLV of the Friedrich-Loeffler-Institute, Federal Research Center for Virus Diseases of Animals is the sole approved distributor is CCLV (personal communication of Finke, Stefan).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   BSR-T7/5 CL21
AC   CVCL_E3AZ
RX   PubMed=29267287;
CC   Characteristics: Compared to the parent cell line has increased T7 RNA polymerase expression (PubMed=29267287).
CC   Characteristics: Expression of the T7 RNA polymerase gene is under control of the cytomegalovirus promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_RW96 ! BSR-T7/5
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   BSS1-PBMC-iPS4F4
AC   CVCL_DQ80
DR   Wikidata; Q54798412
RX   PubMed=27346198;
RX   PubMed=27596517;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4444; GP9; Simple; p.Trp87Arg (c.259T>C); ClinVar=VCV001691236; Zygosity=Homozygous (PubMed=27346198).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=27346198; PubMed=27596517
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 11,16
ST   FGA: 19,23
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C84595; Bernard-Soulier syndrome
DI   ORDO; Orphanet_274; Bernard-Soulier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   BSS2-PBMC-iPS4F24
AC   CVCL_QX25
DR   Wikidata; Q54798414
RX   PubMed=27934591;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4444; GP9; Simple; p.Asn61Ser (c.182A>G); ClinVar=VCV000013529; Zygosity=Homozygous (PubMed=27934591).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=27934591
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D21S11: 30,32
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C84595; Bernard-Soulier syndrome
DI   ORDO; Orphanet_274; Bernard-Soulier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   BSS3-PBMC-iPS4F8
AC   CVCL_QX24
DR   Wikidata; Q54798416
RX   PubMed=28395735;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4444; GP9; Simple; p.Phe71Ser (c.212T>C); ClinVar=VCV000013531; Zygosity=Homozygous (PubMed=28395735).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395735
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 29
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C84595; Bernard-Soulier syndrome
DI   ORDO; Orphanet_274; Bernard-Soulier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   BST-SY1
AC   CVCL_WX67
DR   Wikidata; Q93432493
RX   PubMed=6305496;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX60 ! EBV-BS1-1
OI   CVCL_WX61 ! EBV-BS1-2
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   BST-SY2
AC   CVCL_WX68
DR   Wikidata; Q93432497
RX   PubMed=6305496;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX62 ! EBV-BS2-1
OI   CVCL_WX63 ! EBV-BS2-2
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   BSV-793
AC   CVCL_A7UG
SY   Bovine Saphenous vein Endothelial-793
DR   Wikidata; Q107113521
RX   PubMed=8784483;
CC   Derived from site: In situ; Limb, saphenous vein; UBERON=UBERON_0007318.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   BSY-1
AC   CVCL_B499
SY   BSY1
DR   cancercelllines; CVCL_B499
DR   Cosmic; 1436029
DR   IARC_TP53; 21644
DR   Wikidata; Q54798417
RX   PubMed=8882729;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=22336246;
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=15900046).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B500 ! BSY-2
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   BSY-2
AC   CVCL_B500
DR   Wikidata; Q54798418
RX   PubMed=8882729;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B499 ! BSY-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   BSZ2
AC   CVCL_6252
DR   Wikidata; Q54798419
RX   PubMed=16881970;
CC   Knockout cell: Method=KO mouse; MGI; MGI:105373; Ptch1 (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Breed/subspecies: Ptch1tm1Mps/J, K14-CreER,p53flox/flox.
DI   NCIt; C134570; Mouse basal cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   BT
AC   CVCL_4134
SY   Bovine Turbinate
DR   CLO; CLO_0002040
DR   CLDB; cl491
DR   CLDB; cl492
DR   ATCC; CRL-1390
DR   BCRC; 60304
DR   CCRID; 1102BOV-NIFDC00077
DR   CCRID; 4201BOV-CCTCC00260
DR   CCTCC; GDC0260
DR   ECACC; 89031603
DR   IZSLER; BS CL 10
DR   TOKU-E; 692
DR   Wikidata; Q54798420
RX   PubMed=4472511;
RX   PubMed=6160900;
RX   PubMed=17900332;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-223.html
CC   Virology: Not susceptible to infection by wild-type and vaccinal strains of myxoma virus (MYXV) (PubMed=17900332).
CC   Derived from site: In situ; Nose, nasal cavity, nasal turbinate; UBERON=UBERON_0035612.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Newborn
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Bt Thd
AC   CVCL_Y440
DR   ATCC; CRL-6031
DR   Wikidata; Q54798427
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6031; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   BT-1
AC   CVCL_WK81
SY   Bovine Trophoblast-1
DR   Wikidata; Q93432653
RX   PubMed=11504534;
RX   PubMed=15613779;
RX   PubMed=16251743;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Doubling time: ~2.72 days (Note=In fibroblast-conditioned medium), ~2.97 days (Note=In 10% FBS) (PubMed=11504534).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   BT-12
AC   CVCL_M155
SY   BT 12; BT12
DR   BioSample; SAMN10989598
DR   cancercelllines; CVCL_M155
DR   Cell_Model_Passport; SIDM01514
DR   DepMap; ACH-000160
DR   GEO; GSM3145596
DR   GEO; GSM3145691
DR   PharmacoDB; BT12_113_2019
DR   Wikidata; Q54798448
RX   PubMed=17446062;
RX   PubMed=20922763;
RX   PubMed=22206574;
RX   PubMed=31068700;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Brain/BT-12.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Brain.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   From: Biegel, Jaclyn A.; Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=20922763).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 29,33.2
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 20
//
ID   BT-16
AC   CVCL_M156
SY   BT 16; BT16
DR   cancercelllines; CVCL_M156
DR   Cell_Model_Passport; SIDM01521
DR   DepMap; ACH-001020
DR   PharmacoDB; BT16_119_2019
DR   Wikidata; Q54798449
RX   PubMed=17446062;
RX   PubMed=22206574;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Biegel, Jaclyn A.; Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   BT-1S
AC   CVCL_D5HN
SY   Bovine Trophoblast-1S
DR   JCRB; JCRB1875
DR   Wikidata; Q127380347
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_WK81 ! BT-1
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   BT-20
AC   CVCL_0178
SY   BT 20; BT20
DR   BTO; BTO_0001466
DR   CLO; CLO_0002041
DR   EFO; EFO_0001092
DR   MCCL; MCC:0000069
DR   CLDB; cl493
DR   CLDB; cl494
DR   CLDB; cl495
DR   ABM; T8959
DR   AddexBio; C0006014/4910
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-7912
DR   ATCC; HTB-19
DR   BioSample; SAMN03471671
DR   BioSample; SAMN03472738
DR   BioSample; SAMN10987894
DR   cancercelllines; CVCL_0178
DR   CCRID; 1101HUM-PUMC000335
DR   Cell_Model_Passport; SIDM00893
DR   ChEMBL-Cells; CHEMBL3307766
DR   ChEMBL-Targets; CHEMBL613870
DR   CLS; 300130
DR   Cosmic; 687463
DR   Cosmic; 871137
DR   Cosmic; 904350
DR   Cosmic; 906801
DR   Cosmic; 934519
DR   Cosmic; 979719
DR   Cosmic; 991332
DR   Cosmic; 997914
DR   Cosmic; 1010923
DR   Cosmic; 1017159
DR   Cosmic; 1018465
DR   Cosmic; 1046932
DR   Cosmic; 1047701
DR   Cosmic; 1136370
DR   Cosmic; 1287931
DR   Cosmic; 1289382
DR   Cosmic; 1434946
DR   Cosmic; 1524352
DR   Cosmic; 1603190
DR   Cosmic; 1609471
DR   Cosmic; 1995348
DR   Cosmic; 2009507
DR   Cosmic; 2036672
DR   Cosmic; 2301232
DR   Cosmic; 2301522
DR   Cosmic; 2307195
DR   Cosmic; 2318378
DR   Cosmic; 2361352
DR   Cosmic-CLP; 906801
DR   DepMap; ACH-000536
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906801
DR   GEO; GSM184390
DR   GEO; GSM184391
DR   GEO; GSM350505
DR   GEO; GSM421860
DR   GEO; GSM459725
DR   GEO; GSM783945
DR   GEO; GSM827574
DR   GEO; GSM843445
DR   GEO; GSM843446
DR   GEO; GSM847197
DR   GEO; GSM847452
DR   GEO; GSM886891
DR   GEO; GSM887956
DR   GEO; GSM1053689
DR   GEO; GSM1172940
DR   GEO; GSM1238127
DR   GEO; GSM1374406
DR   GEO; GSM1374407
DR   GEO; GSM1401673
DR   GEO; GSM1669629
DR   IARC_TP53; 3
DR   IBRC; C10149
DR   IGRhCellID; BT20
DR   KCLB; 60061
DR   LiGeA; CCLE_451
DR   LINCS_HMS; 50105
DR   LINCS_LDP; LCL-1476
DR   Lonza; 114
DR   NCBI_Iran; C434
DR   PharmacoDB; BT20_108_2019
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0178
DR   PubChem_Cell_line; CVCL_0178
DR   SLKBase; 3481
DR   TOKU-E; 693
DR   Wikidata; Q52392673
RX   DOI=10.1007/978-1-4757-0019-0_7;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4831449;
RX   PubMed=6220172;
RX   PubMed=6582512;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=10969801;
RX   PubMed=11414198;
RX   PubMed=11789735;
RX   PubMed=12661003;
RX   PubMed=12800145;
RX   PubMed=13611537;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28889351;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=BT-20
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/BT20.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/BT-20_(cell_line)
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Population: Caucasian.
CC   Doubling time: 70 hours (PubMed=25984343); 66.15 hours (JWGray panel).
CC   HLA typing: A*02:01,24:02; B*15:01,38:01; C*03:03,12:03; DQB1*06:03,06:03; DRB1*04:05,13:06 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*15:01,67:02; C*03:03,12:03; DQA1*01:02,01:02; DQB1*06:11,06:11; DRB1*04:05,13:01 (PubMed=26589293).
CC   HLA typing: A*24:02:01,24:03:01; B*15:01:01,14:01:01; C*03:03:01,12:03:01; DPB1*04:01:01G,06:01:01G; DQA1*01:03:01,03:01:01; DQB1*03:02:01,06:03:01; DRB1*04:04:01,13:01:01 (CLS=300130).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-19).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro539Arg (c.1616C>G); ClinVar=VCV000376243; Zygosity=Heterozygous (PubMed=19593635; PubMed=28889351; ATCC=HTB-19).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=19593635; PubMed=28889351; ATCC=HTB-19).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ile388Ser (c.1163T>G); ClinVar=VCV000665312; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Pro515Leu (c.1544C>T); Zygosity=Heterozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Homozygous (PubMed=16541312; PubMed=28889351; ATCC=HTB-19).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.3%; Native American=0%; East Asian, North=9.54%; East Asian, South=0%; South Asian=0%; European, North=43.6%; European, South=41.56% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7912; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): AddexBio=C0006014/4910; ATCC=HTB-19; CCRID=1101HUM-PUMC000335; CLS=300130; Cosmic-CLP=906801; KCLB=60061; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11 (PubMed=25877200)
ST   D16S539: 11,14 (AddexBio=C0006014/4910; ATCC=HTB-19; CCRID=1101HUM-PUMC000335; CLS=300130; Cosmic-CLP=906801; PubMed=28889351)
ST   D18S51: 17
ST   D19S433: 15
ST   D21S11: 28,29
ST   D2S1338: 19
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 22,24
ST   Penta D: 10,11
ST   Penta E: 11,13
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   BT-20/CMV-Luc
AC   CVCL_J244
DR   cancercelllines; CVCL_J244
DR   JCRB; JCRB1438
DR   JCRB; NIHS0700
DR   Wikidata; Q54798451
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1438).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro539Arg (c.1616C>G); ClinVar=VCV000376243; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ile388Ser (c.1163T>G); ClinVar=VCV000665312; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Pro515Leu (c.1544C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0700; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB=JCRB1438
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,14
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0178 ! BT-20
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 25
//
ID   BT-20/nKR
AC   CVCL_M061
DR   cancercelllines; CVCL_M061
DR   KCLB; 60071
DR   Wikidata; Q54798454
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro539Arg (c.1616C>G); ClinVar=VCV000376243; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ile388Ser (c.1163T>G); ClinVar=VCV000665312; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Pro515Leu (c.1544C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0178 ! BT-20
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   BT-20N
AC   CVCL_F0XP
RX   PubMed=10545506;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro539Arg (c.1616C>G); ClinVar=VCV000376243; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ile388Ser (c.1163T>G); ClinVar=VCV000665312; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Pro515Leu (c.1544C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1759; CDH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0178 ! BT-20
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BT-325
AC   CVCL_5120
SY   BT 325; BT325
DR   BTO; BTO_0003232
DR   CCRID; 5301HUM-KCB92026YJ
DR   KCB; KCB 92026YJ
DR   Wikidata; Q54798455
RX   CelloPub=CLPUB00249;
CC   Doubling time: ~36.5 hours (CelloPub=CLPUB00249).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): CCRID=5301HUM-KCB92026YJ
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 9,11
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 12,13
ST   D8S1179: 13,15
ST   FGA: 19,23
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   BT-37
AC   CVCL_JL57
SY   BT37; BT37 AT/RT
DR   Wikidata; Q54798457
RX   PubMed=25638158;
CC   From: Biegel, Jaclyn A.; Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Characteristics: Established from a serially passaged xenograft.
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   BT-410
AC   CVCL_X209
DR   Wikidata; Q54798459
RX   PubMed=212193;
RX   PubMed=1013510;
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   BT-474
AC   CVCL_0179
SY   Bt-474; BT474
DR   BTO; BTO_0001932
DR   CLO; CLO_0002042
DR   EFO; EFO_0001093
DR   MCCL; MCC:0000070
DR   CLDB; cl497
DR   CLDB; cl498
DR   CLDB; cl4997
DR   AddexBio; C0006012/4902
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-7913
DR   ATCC; HTB-20
DR   BCRC; 60359
DR   BCRJ; 0353
DR   BioSample; SAMN01821539
DR   BioSample; SAMN01821618
DR   BioSample; SAMN03473029
DR   BioSample; SAMN10988308
DR   BioSamples; SAMEA3516847
DR   BioSamples; SAMEA3516848
DR   BioSamples; SAMEA3516849
DR   cancercelllines; CVCL_0179
DR   CCRID; 1101HUM-PUMC000129
DR   CCRID; 1102HUM-NIFDC00023
DR   CCRID; 3101HUMTCHu143
DR   CCRID; 4201HUM-CCTCC00636
DR   Cell_Model_Passport; SIDM00963
DR   ChEMBL-Cells; CHEMBL3307636
DR   ChEMBL-Targets; CHEMBL614529
DR   CLS; 300131
DR   Cosmic; 687464
DR   Cosmic; 871138
DR   Cosmic; 904351
DR   Cosmic; 923058
DR   Cosmic; 934520
DR   Cosmic; 946359
DR   Cosmic; 970088
DR   Cosmic; 979721
DR   Cosmic; 1000122
DR   Cosmic; 1017168
DR   Cosmic; 1018460
DR   Cosmic; 1046934
DR   Cosmic; 1047699
DR   Cosmic; 1071903
DR   Cosmic; 1129654
DR   Cosmic; 1136353
DR   Cosmic; 1176605
DR   Cosmic; 1287890
DR   Cosmic; 1289383
DR   Cosmic; 1308996
DR   Cosmic; 1434947
DR   Cosmic; 1523771
DR   Cosmic; 1603191
DR   Cosmic; 1609475
DR   Cosmic; 1945863
DR   Cosmic; 2165003
DR   Cosmic; 2301523
DR   Cosmic; 2318376
DR   Cosmic; 2361356
DR   Cosmic-CLP; 946359
DR   DepMap; ACH-000927
DR   DSMZ; ACC-64
DR   DSMZCellDive; ACC-64
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 946359
DR   GEO; GSM1716
DR   GEO; GSM1725
DR   GEO; GSM69198
DR   GEO; GSM73557
DR   GEO; GSM73702
DR   GEO; GSM115110
DR   GEO; GSM147888
DR   GEO; GSM147957
DR   GEO; GSM149981
DR   GEO; GSM149989
DR   GEO; GSM149997
DR   GEO; GSM155210
DR   GEO; GSM184392
DR   GEO; GSM184393
DR   GEO; GSM213707
DR   GEO; GSM213717
DR   GEO; GSM213718
DR   GEO; GSM213719
DR   GEO; GSM213737
DR   GEO; GSM213740
DR   GEO; GSM213743
DR   GEO; GSM213745
DR   GEO; GSM217615
DR   GEO; GSM274657
DR   GEO; GSM276780
DR   GEO; GSM320173
DR   GEO; GSM344341
DR   GEO; GSM344391
DR   GEO; GSM350504
DR   GEO; GSM388211
DR   GEO; GSM421861
DR   GEO; GSM533397
DR   GEO; GSM533412
DR   GEO; GSM590105
DR   GEO; GSM679677
DR   GEO; GSM679678
DR   GEO; GSM679679
DR   GEO; GSM679680
DR   GEO; GSM679681
DR   GEO; GSM679682
DR   GEO; GSM679683
DR   GEO; GSM679684
DR   GEO; GSM679685
DR   GEO; GSM679686
DR   GEO; GSM679687
DR   GEO; GSM679688
DR   GEO; GSM679689
DR   GEO; GSM679690
DR   GEO; GSM679691
DR   GEO; GSM783958
DR   GEO; GSM799168
DR   GEO; GSM799169
DR   GEO; GSM799170
DR   GEO; GSM799171
DR   GEO; GSM799172
DR   GEO; GSM799173
DR   GEO; GSM843476
DR   GEO; GSM847198
DR   GEO; GSM847453
DR   GEO; GSM886892
DR   GEO; GSM887957
DR   GEO; GSM903063
DR   GEO; GSM903064
DR   GEO; GSM903065
DR   GEO; GSM903066
DR   GEO; GSM903067
DR   GEO; GSM903068
DR   GEO; GSM903069
DR   GEO; GSM967821
DR   GEO; GSM1008891
DR   GEO; GSM1053692
DR   GEO; GSM1172853
DR   GEO; GSM1172941
DR   GEO; GSM1214587
DR   GEO; GSM1238128
DR   GEO; GSM1264068
DR   GEO; GSM1264073
DR   GEO; GSM1264110
DR   GEO; GSM1264115
DR   GEO; GSM1374408
DR   GEO; GSM1374409
DR   GEO; GSM1374410
DR   GEO; GSM1401649
DR   GEO; GSM1669630
DR   GEO; GSM2176271
DR   GEO; GSM2176272
DR   IARC_TP53; 4
DR   IBRC; C10140
DR   ICLC; HTL00008
DR   IGRhCellID; BT474
DR   KCB; KCB 2011115YJ
DR   KCLB; 60062
DR   LiGeA; CCLE_516
DR   LINCS_HMS; 50106
DR   LINCS_LDP; LCL-1308
DR   NCBI_Iran; C435
DR   PharmacoDB; BT474_109_2019
DR   PRIDE; PXD002281
DR   PRIDE; PXD002635
DR   PRIDE; PXD004357
DR   PRIDE; PXD005390
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0179
DR   PubChem_Cell_line; CVCL_0179
DR   TOKU-E; 694
DR   Wikidata; Q54798460
RX   DOI=10.1007/978-1-4757-0019-0_7;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=94035;
RX   PubMed=212572;
RX   PubMed=1961733;
RX   PubMed=6582512;
RX   PubMed=7842014;
RX   PubMed=9671407;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11343771;
RX   PubMed=11687795;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=16142302;
RX   PubMed=16195238;
RX   PubMed=16397213;
RX   PubMed=16417655;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=17334996;
RX   PubMed=18386134;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=19671800;
RX   PubMed=19727395;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21247443;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=23671654;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24389870;
RX   PubMed=24456987;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26218769;
RX   PubMed=26589293;
RX   PubMed=26865974;
RX   PubMed=27362937;
RX   PubMed=27378269;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32942617;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/bt474-xenograft-model/
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 3.5 days (PubMed=9671407); 78 hours (PubMed=25984343); 45.8 hours (PubMed=24389870); ~60-80 hours (CLS=300131); ~100 hours (DSMZ=ACC-64); 92.49 hours (JWGray panel).
CC   HLA typing: A*29:02; B*07:02; C*07:02,16:01; DQB1*03:04,06:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*02:46,29:02; B*07:02,35:08; C*07:02,16:01; DQB1*03:02,06:02; DRB1*04:05,15:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,05:02:01; B*07:02:01,20:03:01; C*07:02:01,16:01:01; DPB1*04:01:01G,05:01:01G; DQA1*01:02:01,03:03:01; DQB1*06:02:01; DRB1*04:01,15:01 (CLS=300131).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (PubMed=26865974).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (PubMed=21247443; PubMed=26865974).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (PubMed=21247443; PubMed=26865974).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (PubMed=26865974).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (PubMed=21247443; PubMed=26865974).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (PubMed=26865974; Cosmic-CLP=946359; DepMap=ACH-000927).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (PubMed=26865974; Cosmic-CLP=946359; DepMap=ACH-000927).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (PubMed=26865974; ATCC=HTB-20; Cosmic-CLP=946359; DepMap=ACH-000927).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (PubMed=19593635; PubMed=26865974; Cosmic-CLP=946359; DepMap=ACH-000927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (PubMed=1961733; PubMed=16541312; PubMed=26865974; PubMed=28889351; ATCC=HTB-20; Cosmic-CLP=946359; DepMap=ACH-000927).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.6%; Native American=0%; East Asian, North=2.47%; East Asian, South=0%; South Asian=0%; European, North=70.19%; European, South=26.74% (PubMed=30894373).
CC   Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870).
CC   Discontinued: ATCC; CRL-7913; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): AddexBio=C0006012/4902; ATCC=HTB-20; CCRID; CLS=300131; Cosmic-CLP=946359; DSMZ=ACC-64; KCLB=60062; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 15
ST   D12S391: 17,18
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D19S433: 14,17
ST   D1S1656: 13,15.3
ST   D21S11: 28,32.2
ST   D22S1045: 14
ST   D2S1338: 19
ST   D2S441: 10,14
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   D8S1179: 10,12
ST   FGA: 22,25
ST   Penta D: 9,14
ST   Penta E: 5
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   BT-474 Clone 5
AC   CVCL_AQ07
SY   BT474 clone 5
DR   ATCC; CRL-3247
DR   cancercelllines; CVCL_AQ07
DR   Wikidata; Q54798462
RX   PubMed=14750129;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00072; Trastuzumab (Herceptin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   BT-474 Ecadherin EmGFP
AC   CVCL_A4CL
SY   BT-474 ECAD-EmGFP
DR   ATCC; HTB-20EMT
DR   cancercelllines; CVCL_A4CL
DR   Wikidata; Q105506549
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 CDH1 has been tagged in one allele at the C-terminus with EmGFP. Allows to monitor the epithelial-to-mesenchymal transition (EMT) status of cells in vitro by monitoring EmGFP expression.
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=HTB-20EMT
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   BT-474 EEI
AC   CVCL_AR96
SY   BT474-EEI; BT474 EEI; BT-474 Exogenous Estrogen Independent
DR   cancercelllines; CVCL_AR96
DR   Wikidata; Q54798463
RX   PubMed=19010901;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   BT-474 Tam1
AC   CVCL_AR86
SY   BT474 Tam1
DR   ATCC; CRL-3433
DR   BioSample; SAMN03152357
DR   cancercelllines; CVCL_AR86
DR   Wikidata; Q54798464
RX   PubMed=27378269;
CC   Population: Caucasian.
CC   Doubling time: ~2 weeks (ATCC=CRL-3433).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   BT-474 Tam2
AC   CVCL_A4AK
DR   ATCC; CRL-3434
DR   cancercelllines; CVCL_A4AK
DR   Wikidata; Q105506552
RX   PubMed=27378269;
CC   Population: Caucasian.
CC   Doubling time: ~2 weeks (ATCC=CRL-3434).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   BT-474-Luc2
AC   CVCL_C9CU
DR   ATCC; HTB-20-LUC2
DR   Wikidata; Q123030827
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=HTB-20-LUC2).
CC   Doubling time: ~61 hours (ATCC=HTB-20-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=HTB-20-LUC2
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   BT-474/CMV-Luc
AC   CVCL_4Y08
DR   cancercelllines; CVCL_4Y08
DR   JCRB; JCRB1450
DR   JCRB; NIHS0701
DR   Wikidata; Q54798466
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1450).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0701; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB=JCRB1450
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 20
//
ID   BT-474c1
AC   CVCL_IP20
SY   BT474c1; BT474C1
DR   cancercelllines; CVCL_IP20
DR   GEO; GSM1374411
DR   Wikidata; Q54798467
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   BT-483
AC   CVCL_2319
SY   BT483
DR   BTO; BTO_0003470
DR   CLO; CLO_0002043
DR   EFO; EFO_0001095
DR   AddexBio; C0006013/4903
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-121
DR   BioSample; SAMN03471598
DR   BioSample; SAMN10988523
DR   cancercelllines; CVCL_2319
DR   Cell_Model_Passport; SIDM00892
DR   ChEMBL-Cells; CHEMBL4295434
DR   ChEMBL-Targets; CHEMBL4296404
DR   Cosmic; 687465
DR   Cosmic; 809238
DR   Cosmic; 871139
DR   Cosmic; 877445
DR   Cosmic; 894085
DR   Cosmic; 897415
DR   Cosmic; 904352
DR   Cosmic; 934521
DR   Cosmic; 949187
DR   Cosmic; 1018466
DR   Cosmic; 1044221
DR   Cosmic; 1046935
DR   Cosmic; 1047698
DR   Cosmic; 1136343
DR   Cosmic; 1152524
DR   Cosmic; 1287891
DR   Cosmic; 1289384
DR   Cosmic; 1603192
DR   Cosmic; 1995349
DR   Cosmic; 2165017
DR   Cosmic; 2750526
DR   Cosmic-CLP; 949093
DR   DepMap; ACH-000818
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 949093
DR   GEO; GSM344342
DR   GEO; GSM344392
DR   GEO; GSM350551
DR   GEO; GSM421862
DR   GEO; GSM783946
DR   GEO; GSM827462
DR   GEO; GSM886893
DR   GEO; GSM887958
DR   GEO; GSM1008892
DR   GEO; GSM1053737
DR   GEO; GSM1172854
DR   GEO; GSM1172942
DR   GEO; GSM1215263
DR   GEO; GSM1238129
DR   GEO; GSM1669631
DR   IARC_TP53; 18374
DR   IARC_TP53; 24359
DR   LiGeA; CCLE_071
DR   LINCS_HMS; 50107
DR   LINCS_LDP; LCL-1309
DR   PharmacoDB; BT483_110_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2319
DR   PubChem_Cell_line; CVCL_2319
DR   Wikidata; Q54798468
RX   DOI=10.1007/978-1-4757-0019-0_7;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=212572;
RX   PubMed=10969801;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28889351;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 140.00 hours (JWGray panel).
CC   HLA typing: A*24:02,24:02; B*08:01,15:01; C*03:03,07:01; DQB1*02:02,06:11; DRB1*03:05,03:05 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*08:01,15:01; C*03:03,07:01; DQA1*01:02,05:01; DQB1*02:01,06:11; DRB1*03:01,13:27 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-000818).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>A); ClinVar=VCV000480961; Zygosity=Heterozygous (PubMed=16541312; DepMap=ACH-000818).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.96%; Native American=0%; East Asian, North=5.8%; East Asian, South=0%; South Asian=0%; European, North=48.37%; European, South=41.87% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): AddexBio=C0006013/4903; ATCC=HTB-121; Cosmic-CLP=949093; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D10S1248: 15
ST   D12S391: 15,20
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D1S1656: 15,16.3
ST   D21S11: 30,30.2
ST   D22S1045: 15
ST   D2S1338: 17,23
ST   D2S441: 11,14
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 23,26
ST   Penta D: 9,11
ST   Penta E: 14,20
ST   TH01: 5,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   BT-549
AC   CVCL_1092
SY   BT 549; BT.549; BT549
DR   BTO; BTO_0002548
DR   CLO; CLO_0002044
DR   EFO; EFO_0001096
DR   CLDB; cl7128
DR   AddexBio; C0006017/4962
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-6647
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-122
DR   BioGRID_ORCS_Cell_line; 510
DR   BioSample; SAMN03471380
DR   BioSample; SAMN10988343
DR   cancercelllines; CVCL_1092
DR   CCRID; 1101HUM-PUMC000336
DR   CCRID; 3101HUMTCHu93
DR   Cell_Model_Passport; SIDM00122
DR   ChEMBL-Cells; CHEMBL3308490
DR   ChEMBL-Targets; CHEMBL614072
DR   CLS; 300132
DR   Cosmic; 687466
DR   Cosmic; 850826
DR   Cosmic; 871140
DR   Cosmic; 875881
DR   Cosmic; 877446
DR   Cosmic; 897414
DR   Cosmic; 904353
DR   Cosmic; 934522
DR   Cosmic; 949188
DR   Cosmic; 974237
DR   Cosmic; 1010925
DR   Cosmic; 1018476
DR   Cosmic; 1044204
DR   Cosmic; 1044234
DR   Cosmic; 1046924
DR   Cosmic; 1047700
DR   Cosmic; 1092593
DR   Cosmic; 1136371
DR   Cosmic; 1152525
DR   Cosmic; 1175830
DR   Cosmic; 1176638
DR   Cosmic; 1287920
DR   Cosmic; 1289385
DR   Cosmic; 1305386
DR   Cosmic; 1308998
DR   Cosmic; 1312372
DR   Cosmic; 1434948
DR   Cosmic; 1603193
DR   Cosmic; 1609466
DR   Cosmic; 1995350
DR   Cosmic; 1998435
DR   Cosmic; 2036671
DR   Cosmic; 2164983
DR   Cosmic; 2301524
DR   Cosmic; 2318374
DR   Cosmic; 2361359
DR   Cosmic-CLP; 905951
DR   DepMap; ACH-000288
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905951
DR   GEO; GSM2121
DR   GEO; GSM50181
DR   GEO; GSM50245
DR   GEO; GSM217614
DR   GEO; GSM274638
DR   GEO; GSM274662
DR   GEO; GSM320176
DR   GEO; GSM344343
DR   GEO; GSM344393
DR   GEO; GSM350517
DR   GEO; GSM378149
DR   GEO; GSM421863
DR   GEO; GSM750775
DR   GEO; GSM783947
DR   GEO; GSM799318
DR   GEO; GSM799381
DR   GEO; GSM827358
DR   GEO; GSM839031
DR   GEO; GSM843477
DR   GEO; GSM843478
DR   GEO; GSM843479
DR   GEO; GSM843480
DR   GEO; GSM846287
DR   GEO; GSM847199
DR   GEO; GSM847454
DR   GEO; GSM886894
DR   GEO; GSM887959
DR   GEO; GSM1008893
DR   GEO; GSM1053686
DR   GEO; GSM1153387
DR   GEO; GSM1172855
DR   GEO; GSM1172943
DR   GEO; GSM1181340
DR   GEO; GSM1181341
DR   GEO; GSM1214578
DR   GEO; GSM1238130
DR   GEO; GSM1374412
DR   GEO; GSM1374413
DR   GEO; GSM1401657
DR   GEO; GSM1669632
DR   GEO; GSM2124662
DR   IARC_TP53; 5
DR   IARC_TP53; 28243
DR   IBRC; C10151
DR   ICLC; HTL02006
DR   KCB; KCB 2011118YJ
DR   LiGeA; CCLE_360
DR   LINCS_HMS; 50108
DR   LINCS_LDP; LCL-1310
DR   Lonza; 116
DR   NCI-DTP; BT-549
DR   PharmacoDB; BT549_111_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005292
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1092
DR   PubChem_Cell_line; CVCL_1092
DR   SKY/M-FISH/CGH; 1458
DR   SLKBase; 3393
DR   TOKU-E; 696
DR   Wikidata; Q54798471
RX   DOI=10.1007/978-1-4757-0019-0_7;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=1961733;
RX   PubMed=6500159;
RX   PubMed=7902062;
RX   PubMed=9331090;
RX   PubMed=9561029;
RX   PubMed=9671407;
RX   PubMed=10700174;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11343771;
RX   PubMed=15153330;
RX   PubMed=15677628;
RX   PubMed=15748285;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17088437;
RX   PubMed=17157791;
RX   PubMed=18277095;
RX   PubMed=18516279;
RX   PubMed=19372543;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=19727395;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=21552935;
RX   PubMed=21778573;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=23637631;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=30613774;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/BT549.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=4
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-446.html
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 3.7 days (PubMed=9671407); 51 hours (PubMed=25984343); 53.9 hours (NCI-DTP=BT-549); 25.46 hours (JWGray panel).
CC   HLA typing: B*15:17:01,55:01; C*03:03:01,07; DPB1*02:01:02,04:01; DQB1*03:01:01,06:04:01; DRB1*11,13 (PubMed=15748285).
CC   HLA typing: A*01:01,02:01; B*15:17,56; C*03:03,07:01 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*15:17,56:01; C*03:03,07:01; DQA1*03:02,03:02; DRB1*11:01,11:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (PubMed=19593635; ATCC=HTB-122; DepMap=ACH-000288).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-122).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (PubMed=1961733; PubMed=16541312; PubMed=17088437; PubMed=18277095; PubMed=28889351; Cosmic-CLP=905951; DepMap=ACH-000288).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.21%; Native American=0%; East Asian, North=3.6%; East Asian, South=0%; South Asian=7.26%; European, North=26.05%; European, South=62.87% (PubMed=30894373).
CC   Misspelling: HTB-122; Note=Based on the ATCC catalog number.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): AddexBio=C0006017/4962; ATCC=HTB-122; CCRID; CLS=300132; Cosmic-CLP=905951; PubMed=19372543; PubMed=20679594; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10 (PubMed=19372543)
ST   CSF1PO: 10,12 (AddexBio=C0006017/4962; ATCC=HTB-122; CCRID; CLS=300132; Cosmic-CLP=905951; PubMed=20679594; PubMed=25877200; PubMed=28889351)
ST   D13S317: 11
ST   D16S539: 8
ST   D18S51: 15
ST   D19S433: 15.2
ST   D21S11: 28,32.2 (PubMed=28889351)
ST   D21S11: 32.2 (ATCC=HTB-122; CCRID; CLS=300132; PubMed=19372543; PubMed=25877200)
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 9 (PubMed=19372543)
ST   D7S820: 9,10 (AddexBio=C0006017/4962; ATCC=HTB-122; CCRID; CLS=300132; Cosmic-CLP=905951; PubMed=20679594; PubMed=25877200; PubMed=28889351)
ST   D8S1179: 14,16
ST   FGA: 19
ST   Penta D: 13
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   BT-549-Dox
AC   CVCL_UJ22
DR   cancercelllines; CVCL_UJ22
DR   Wikidata; Q93432704
RX   PubMed=7902062;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: HTB-122-Dox; Note=Based on the ATCC catalog number of the parent cell line.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   BT-549-Luc
AC   CVCL_J245
DR   cancercelllines; CVCL_J245
DR   JCRB; JCRB1373
DR   JCRB; NIHS0637
DR   Wikidata; Q54798474
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0637; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB=JCRB1373
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 8
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 25
//
ID   BT-549/RFP
AC   CVCL_JY91
DR   cancercelllines; CVCL_JY91
DR   Cell_Biolabs; AKR-255
DR   Wikidata; Q54798475
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Cell_Biolabs; AKR-255; probable.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   BT-A
AC   CVCL_WK82
SY   Bovine Trophoblast-A
DR   JCRB; JCRB1927
DR   Wikidata; Q93432714
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 7
//
ID   BT-B [Bovine trophoblast]
AC   CVCL_WK83
SY   Bovine Trophoblast-B
DR   JCRB; JCRB1935
DR   Wikidata; Q93432716
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 7
//
ID   BT-B [Human HeLa contaminated cell line]
AC   CVCL_1858
DR   CLO; CLO_0002045
DR   CLDB; cl500
DR   BioSample; SAMN03151668
DR   BioSample; SAMN03470925
DR   Cosmic; 905951
DR   DSMZ; ACC-227
DR   DSMZCellDive; ACC-227
DR   Wikidata; Q54798477
RX   PubMed=2108047;
RX   PubMed=8230540;
RX   PubMed=11668190;
RX   PubMed=25877200;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (DSMZ=ACC-227). Originally thought to originate from the a 66 year old Caucasian man with a malignant urinary bladder carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00394.
CC   Population: African American.
CC   Doubling time: ~43 hours (DSMZ=ACC-227).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: DSMZ; ACC-227; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   BT-C
AC   CVCL_WK84
SY   Bovine Trophoblast-C
DR   JCRB; JCRB1866
DR   Wikidata; Q93432722
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT-D
AC   CVCL_WK85
SY   Bovine Trophoblast-D
DR   JCRB; JCRB1936
DR   Wikidata; Q93432724
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 7
//
ID   BT-E
AC   CVCL_WK86
SY   Bovine Trophoblast-E
DR   Wikidata; Q93432726
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT-F
AC   CVCL_WK87
SY   Bovine Trophoblast-F
DR   JCRB; JCRB1955
DR   Wikidata; Q93432728
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 7
//
ID   BT-G
AC   CVCL_WK88
SY   Bovine Trophoblast-G
DR   Wikidata; Q93432731
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT-H
AC   CVCL_WK89
SY   Bovine Trophoblast-H
DR   Wikidata; Q93432733
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT-I
AC   CVCL_WK90
SY   Bovine Trophoblast-I
DR   Wikidata; Q93432735
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT-IMF
AC   CVCL_A0WB
SY   Bos Taurus-Intestinal MyoFibroblast
DR   Wikidata; Q108819964
RX   PubMed=33474688;
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Myofibroblast; CL=CL_0000186.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   3-4FM
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   BT-J
AC   CVCL_WK91
SY   Bovine Trophoblast-J
DR   Wikidata; Q93432737
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT-K
AC   CVCL_WK92
SY   Bovine Trophoblast-K
DR   Wikidata; Q93432739
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT-L
AC   CVCL_WK93
SY   Bovine Trophoblast-L
DR   Wikidata; Q93432742
RX   PubMed=21862694;
RX   PubMed=22632112;
RX   PubMed=24950590;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   BT0001
AC   CVCL_8T85
DR   ECACC; 92042901
DR   Wikidata; Q54798478
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(11)(p14.1) (ECACC=92042901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BT012
AC   CVCL_RU28
SY   BT12; BT-12
DR   GEO; GSM2155019
DR   GEO; GSM2155022
DR   Wikidata; Q54798479
RX   PubMed=19544433;
RX   PubMed=20388696;
RX   PubMed=20593219;
RX   PubMed=26095605;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   BT018
AC   CVCL_UK46
DR   Wikidata; Q93432752
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT019
AC   CVCL_UK47
DR   Wikidata; Q93432755
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT020
AC   CVCL_UK48
DR   Wikidata; Q93432757
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT023
AC   CVCL_UK49
DR   Wikidata; Q93432759
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT025
AC   CVCL_UK41
SY   BT25
DR   GEO; GSM2155020
DR   GEO; GSM2155023
DR   Wikidata; Q93432761
RX   PubMed=19544433;
RX   PubMed=20593219;
RX   PubMed=26095605;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   BT028
AC   CVCL_UK44
DR   Wikidata; Q93432763
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT030
AC   CVCL_UK45
SY   BT30
DR   Wikidata; Q93432765
RX   PubMed=19544433;
RX   PubMed=26095605;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT033
AC   CVCL_UK50
DR   Wikidata; Q93432767
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT034
AC   CVCL_UK51
DR   Wikidata; Q93432769
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT042
AC   CVCL_UK42
DR   Wikidata; Q93432771
RX   PubMed=20593219;
CC   Group: Cancer stem cell line.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   BT048
AC   CVCL_RU29
SY   BT48; BT-48
DR   GEO; GSM2155021
DR   GEO; GSM2155024
DR   Wikidata; Q54798481
RX   PubMed=19544433;
RX   PubMed=20388696;
RX   PubMed=20593219;
RX   PubMed=26095605;
RX   PubMed=26245525;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   BT050
AC   CVCL_UK38
SY   BT50; BT-50
DR   ATCC; CRL-3408
DR   Wikidata; Q93432779
RX   PubMed=26095605;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3408
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   BT053
AC   CVCL_RU30
SY   BT53; BT-53
DR   Wikidata; Q54798482
RX   PubMed=19544433;
RX   PubMed=26095605;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   BT054
AC   CVCL_N707
SY   BT54
DR   ATCC; CRL-3416
DR   cancercelllines; CVCL_N707
DR   Wikidata; Q54798483
RX   PubMed=20388696;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=20388696).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3416
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   BT060
AC   CVCL_UK43
DR   Wikidata; Q93432789
RX   PubMed=20593219;
CC   Group: Cancer stem cell line.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   BT067
AC   CVCL_UK39
SY   BT67; BT-67
DR   ATCC; CRL-3409
DR   Wikidata; Q93432791
RX   PubMed=19544433;
RX   PubMed=26095605;
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3409
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   BT068
AC   CVCL_UK52
DR   Wikidata; Q93432793
RX   PubMed=19544433;
RX   PubMed=26095605;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT069
AC   CVCL_UK37
SY   BT69
DR   ATCC; CRL-3410
DR   Wikidata; Q93432795
RX   PubMed=19544433;
RX   PubMed=20593219;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3410
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 7
//
ID   BT071
AC   CVCL_UK53
DR   Wikidata; Q93432799
RX   PubMed=19544433;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT073
AC   CVCL_UK54
SY   BT73; BT-73
DR   Wikidata; Q93432801
RX   PubMed=19544433;
RX   PubMed=26095605;
RX   PubMed=26245525;
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   BT074
AC   CVCL_UK55
DR   Wikidata; Q93432804
RX   PubMed=19544433;
RX   PubMed=26245525;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT075
AC   CVCL_UK56
SY   BT75; BT-75
DR   Wikidata; Q93432806
RX   PubMed=19544433;
RX   PubMed=26095605;
RX   PubMed=26245525;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   BT084
AC   CVCL_UK69
SY   BT84; BT-84
DR   Wikidata; Q93432808
RX   PubMed=26095605;
RX   PubMed=26245525;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   BT085
AC   CVCL_UK70
DR   Wikidata; Q93432810
RX   PubMed=26245525;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT088
AC   CVCL_N708
SY   BT88
DR   ATCC; CRL-3417
DR   Wikidata; Q54798485
RX   PubMed=20388696;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=20388696).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3417
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   BT089
AC   CVCL_UK40
SY   BT89; BT-89
DR   ATCC; CRL-3411
DR   Wikidata; Q93432813
RX   PubMed=26095605;
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   BT090
AC   CVCL_UK71
DR   Wikidata; Q93432814
RX   PubMed=26245525;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT092
AC   CVCL_UK57
DR   Wikidata; Q93432815
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT094
AC   CVCL_UK72
SY   BT94; BT-94
DR   ATCC; CRL-3412
DR   Wikidata; Q93432817
RX   PubMed=26245525;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3412
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 7
//
ID   BT100
AC   CVCL_UK58
DR   Wikidata; Q93432818
RX   PubMed=26095605;
RX   PubMed=26245525;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT1009
AC   CVCL_E6GX
SY   CPDM_0073X
WW   Provider; CPDM; CPDM_0073X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain, midline cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT1012
AC   CVCL_E6H0
SY   CPDM_0772X
WW   Provider; CPDM; CPDM_0772X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C167335; Astrocytoma, IDH-mutant, grade 4
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT1016
AC   CVCL_E6GU
SY   CPDM_1533X
WW   Provider; CPDM; CPDM_1533X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT1018
AC   CVCL_E6GV
SY   Ag1032; CPDM_0095X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0095X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT108
AC   CVCL_UK59
DR   Wikidata; Q93432819
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT111
AC   CVCL_E6GA
SY   H262-BT111; CPDM_1271X
RX   PubMed=25416950;
WW   Provider; CPDM; CPDM_1271X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT112
AC   CVCL_WW37
SY   BT 112; CPDM_1272X
DR   PharmacoDB; BT112_112_2019
DR   Wikidata; Q93432548
RX   PubMed=24440720;
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1272X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT1153
AC   CVCL_E6G5
SY   CCLF-KL1060; CCLF_KL1060; CPDM_0102X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0102X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT1160
AC   CVCL_E6G6
SY   CCLF-KL1066; CCLF_KL1066; CPDM_0103X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0103X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Leu (c.638G>T); ClinVar=VCV000376650; Zygosity=Unspecified (CPDM=CPDM_0103X).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C167335; Astrocytoma, IDH-mutant, grade 4
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT119
AC   CVCL_UK60
DR   Wikidata; Q93432821
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT121
AC   CVCL_UK73
DR   Wikidata; Q93432822
RX   PubMed=26245525;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT124
AC   CVCL_UK61
DR   Wikidata; Q93432823
RX   PubMed=26095605;
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT126
AC   CVCL_UK65
DR   Wikidata; Q93432824
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   BT127
AC   CVCL_UK66
SY   BT-127
DR   Wikidata; Q93432825
RX   PubMed=26095605;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   BT131
AC   CVCL_WW38
SY   BT 131; CPDM_1275X
DR   PharmacoDB; BT131_114_2019
DR   Wikidata; Q93432552
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1275X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT134
AC   CVCL_UK67
DR   GEO; GSM1975008
DR   GEO; GSM1975009
DR   GEO; GSM1975010
DR   Wikidata; Q93432826
RX   PubMed=26095605;
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   BT138
AC   CVCL_E6EX
SY   CPDM_0814X
RX   PubMed=22343896;
WW   Provider; CPDM; CPDM_0814X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=22343896).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT139
AC   CVCL_WW39
SY   BT 139; CPDM_1276X
DR   PharmacoDB; BT139_115_2019
DR   Wikidata; Q93432556
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1276X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT1398
AC   CVCL_E6HM
SY   CPDM_0894X
WW   Provider; CPDM; CPDM_0894X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C129290; Astrocytoma, IDH-mutant, grade 3
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT142
AC   CVCL_D718
DR   cancercelllines; CVCL_D718
DR   Cosmic; 1629581
DR   Cosmic; 2012330
DR   Wikidata; Q54798487
RX   PubMed=22166263;
RX   PubMed=33504762;
CC   Group: Cancer stem cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=22166263).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C4050; Oligoastrocytoma
DI   ORDO; Orphanet_251656; Oligoastrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   BT142 mut/-
AC   CVCL_X501
DR   ATCC; ACS-1018
DR   cancercelllines; CVCL_X501
DR   SKIP; SKIP001284
DR   Wikidata; Q54798489
RX   PubMed=23757293;
CC   Group: Cancer stem cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:5382; IDH1; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (PubMed=23757293).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=23757293).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): ATCC=ACS-1018
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 12,14
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4050; Oligoastrocytoma
DI   ORDO; Orphanet_251656; Oligoastrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D718 ! BT142
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   BT143
AC   CVCL_UK62
SY   BT-143
DR   Wikidata; Q93432833
RX   PubMed=26095605;
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   BT145
AC   CVCL_IP10
SY   BT-145; BT 145; CPDM_1279X
DR   BTO; BTO_0005950
DR   PharmacoDB; BT145_116_2019
DR   Wikidata; Q54798421
RX   PubMed=24440720;
RX   PubMed=25184684;
RX   PubMed=25366336;
RX   PubMed=27723727;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1279X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=27723727).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   BT147 [Boston]
AC   CVCL_WW40
SY   BT 147; CPDM_1280X
DR   PharmacoDB; BT147_117_2019
DR   Wikidata; Q93432571
RX   PubMed=24440720;
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1280X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT147 [Calgary]
AC   CVCL_UK63
SY   BT-147
DR   GEO; GSM1975011
DR   GEO; GSM1975012
DR   GEO; GSM1975013
DR   GEO; GSM1975014
DR   GEO; GSM1975015
DR   GEO; GSM1975016
DR   Wikidata; Q93432835
RX   PubMed=26095605;
RX   PubMed=26245525;
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   BT1497
AC   CVCL_E6GW
SY   CPDM_2151
WW   Provider; CPDM; CPDM_2151; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT159
AC   CVCL_IP11
SY   BT-159; BT 159; CPDM_1282X
DR   BTO; BTO_0005951
DR   PharmacoDB; BT159_118_2019
DR   Wikidata; Q54798422
RX   PubMed=25184684;
RX   PubMed=25366336;
RX   PubMed=27723727;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1282X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=27723727).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   BT164 [Boston]
AC   CVCL_WW41
SY   BT 164; CCLF-KL1429; CCLF_KL1429; CPDM_0885X
DR   PharmacoDB; BT164_120_2019
DR   Wikidata; Q93432578
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0885X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT164 [Calgary]
AC   CVCL_UK68
DR   Wikidata; Q93432837
RX   PubMed=27006494;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   BT168
AC   CVCL_WW42
SY   BT 168; CPDM_1283X
DR   Wikidata; Q93432580
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1283X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left occipital lobe; UBERON=UBERON_0002806.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT169
AC   CVCL_VV25
DR   ATCC; CRL-3413
DR   Wikidata; Q93432839
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3413
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 9
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 7
//
ID   BT1707
AC   CVCL_E6G7
SY   CPDM_1587X
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT1718
AC   CVCL_E6G8
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT1719
AC   CVCL_E6G9
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT172
AC   CVCL_IP12
SY   BT-172; BT 172; CPDM_1284X
DR   BTO; BTO_0005953
DR   PharmacoDB; BT172_121_2019
DR   Wikidata; Q54798424
RX   PubMed=25184684;
RX   PubMed=25366336;
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   BT179
AC   CVCL_WW43
SY   BT 179; CPDM_1285X
DR   cancercelllines; CVCL_WW43
DR   PharmacoDB; BT179_122_2019
DR   Wikidata; Q93432586
RX   PubMed=25184684;
RX   PubMed=27723727;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1285X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Thr (c.764T>C); ClinVar=VCV000376623; Zygosity=Unspecified (PubMed=27723727).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   BT181
AC   CVCL_WW44
SY   BT 181; CPDM_1286X
DR   Wikidata; Q93432589
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1286X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT182
AC   CVCL_WW45
SY   BT 182; CPDM_1287X
DR   Wikidata; Q93432591
RX   PubMed=25184684;
WW   Provider; CPDM; CPDM_1287X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT187
AC   CVCL_WW46
SY   BT 187; CPDM_1288X
DR   PharmacoDB; BT187_123_2019
DR   Wikidata; Q93432593
RX   PubMed=25184684;
WW   Provider; CPDM; CPDM_1288X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT188
AC   CVCL_WW47
SY   BT 188; CPDM_1459X
DR   Wikidata; Q93432595
RX   PubMed=25184684;
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT189 [Boston]
AC   CVCL_WW48
SY   BT 189; CPDM_0796X
DR   Wikidata; Q93432597
RX   PubMed=25184684;
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT189 [Calgary]
AC   CVCL_UK74
SY   BT-189
DR   Wikidata; Q93432841
RX   PubMed=26095605;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   BT206
AC   CVCL_UK64
SY   BT-206
DR   Wikidata; Q93432843
RX   PubMed=26095605;
RX   PubMed=27006494;
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26095605).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   BT216
AC   CVCL_WW49
SY   BT 216; CPDM_1289X
DR   PharmacoDB; BT216_124_2019
DR   Wikidata; Q93432599
RX   PubMed=25184684;
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT224
AC   CVCL_WW50
SY   BT 224; CPDM_1458X
DR   PharmacoDB; BT224_125_2019
DR   Wikidata; Q93432601
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1458X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT228
AC   CVCL_WW51
SY   BT 228; CPDM_0887X
DR   PharmacoDB; BT228_126_2019
DR   Wikidata; Q93432603
RX   PubMed=25184684;
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT231
AC   CVCL_WW52
SY   BT 231; CPDM_2087
DR   PharmacoDB; BT231_127_2019
DR   Wikidata; Q93432605
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_2087; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   82Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT232
AC   CVCL_WW53
SY   BT 232; CPDM_1270X
DR   PharmacoDB; BT232_128_2019
DR   Wikidata; Q93432607
RX   PubMed=25184684;
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT237
AC   CVCL_E6FF
RX   PubMed=22343896;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=22343896).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT238
AC   CVCL_A4AY
DR   ATCC; CRL-3414
DR   Wikidata; Q105506557
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3414
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11,14
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   BT239
AC   CVCL_WW54
SY   BT 239; CPDM_1290X
DR   PharmacoDB; BT239_129_2019
DR   Wikidata; Q93432609
RX   PubMed=25184684;
RX   PubMed=27723727;
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=27723727).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   BT240
AC   CVCL_WW73
SY   BT 240; CPDM_1291X
DR   Wikidata; Q93432611
RX   PubMed=27723727;
WW   Provider; CPDM; CPDM_1291X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=27723727).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser227Tyr (c.680C>A); Zygosity=Unspecified (PubMed=27723727).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   BT245
AC   CVCL_IP13
SY   BT-245; BT 245; BCH245; Boston Children's Hospital 245; CPDM_0797X
DR   BTO; BTO_0005952
DR   cancercelllines; CVCL_IP13
DR   Millipore; SCC219
DR   PharmacoDB; BT245_130_2019
DR   Wikidata; Q54798426
RX   Patent=US20200384022;
RX   PubMed=25366336;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0797X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Grows as neurospheres in suspension (PubMed=34610309; Millipore=SCC219).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (Patent=US20200384022).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Millipore=SCC219
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14
ST   D21S11: 31.2
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 19
ST   Penta D: 12
ST   Penta E: 14
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 14,15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y8M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   BT248
AC   CVCL_WW55
SY   BT 248; CPDM_1292X
DR   PharmacoDB; BT248_131_2019
DR   Wikidata; Q93432617
RX   PubMed=25184684;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1292X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT260
AC   CVCL_E6FG
SY   CPDM_1293X
RX   PubMed=22343896;
WW   Provider; CPDM; CPDM_1293X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT271
AC   CVCL_WW56
SY   BT 271; CPDM_1592X
DR   PharmacoDB; BT271_132_2019
DR   Wikidata; Q93432619
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1592X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT273
AC   CVCL_E6H8
SY   CPDM_1471X
WW   Provider; CPDM; CPDM_1471X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT286
AC   CVCL_WW57
SY   BT 286; CPDM_0812X
DR   PharmacoDB; BT286_133_2019
DR   Wikidata; Q93432621
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0812X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT290
AC   CVCL_E6H3
SY   CPDM_1460X
WW   Provider; CPDM; CPDM_1460X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Derived from site: In situ; Brain, temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT295
AC   CVCL_E6FH
SY   CPDM_1294X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1294X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT2C
AC   CVCL_S569
SY   BT2c
DR   Wikidata; Q54798491
RX   PubMed=198983;
RX   PubMed=3468291;
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   BT301
AC   CVCL_A4AZ
DR   ATCC; CRL-3415
DR   Wikidata; Q105506560
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3415
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   BT320
AC   CVCL_WW58
SY   BT 320; CPDM_1295X
DR   PharmacoDB; BT320_134_2019
DR   Wikidata; Q93432623
RX   PubMed=27723727;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1295X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=27723727).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=27723727).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly132Ala (c.395G>C); Zygosity=Unspecified (PubMed=27723727).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   BT328
AC   CVCL_WW59
SY   BT 328; CPDM_1297X
DR   PharmacoDB; BT328_135_2019
DR   Wikidata; Q93432625
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1297X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT329
AC   CVCL_E6FI
SY   CCLF-KL1252; CCLF_KL1252; CPDM_1478X
RX   PubMed=34610309;
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT330
AC   CVCL_WW60
SY   BT 330; CPDM_1298X
DR   PharmacoDB; BT330_136_2019
DR   Wikidata; Q93432628
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1298X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT333
AC   CVCL_WW61
SY   BT 333; CPDM_0886X
DR   cancercelllines; CVCL_WW61
DR   PharmacoDB; BT333_137_2019
DR   Wikidata; Q93432630
RX   PubMed=27723727;
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0886X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=27723727).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Met (c.517G>A); ClinVar=VCV000233951; Zygosity=Unspecified (PubMed=27723727).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   BT340
AC   CVCL_WW62
SY   BT 340; CCLF-KL1433; CCLF_KL1433; CPDM_1299X
DR   PharmacoDB; BT340_138_2019
DR   Wikidata; Q93432632
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1299X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT359
AC   CVCL_WW63
SY   BT 359; CPDM_1300X
DR   PharmacoDB; BT359_139_2019
DR   Wikidata; Q93432634
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1300X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT360
AC   CVCL_E6FJ
SY   CPDM_1301X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1301X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT394
AC   CVCL_E6FK
SY   CCLF-KL1250; CCLF_KL1250; CPDM_1304X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1304X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT397
AC   CVCL_E6GB
SY   CPDM_1305X
WW   Provider; CPDM; CPDM_1305X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT402
AC   CVCL_E6H9
SY   CPDM_1307X
WW   Provider; CPDM; CPDM_1307X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT403
AC   CVCL_E6GC
SY   CPDM_1308X
WW   Provider; CPDM; CPDM_1308X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT412
AC   CVCL_E6H5
SY   CPDM_1309X
WW   Provider; CPDM; CPDM_1309X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Derived from site: In situ; Brain, temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3788; Ganglioglioma
DI   ORDO; Orphanet_251949; Ganglioglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y7M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT416
AC   CVCL_WW64
SY   BT 416; CPDM_0809X
DR   PharmacoDB; BT416_140_2019
DR   Wikidata; Q93432636
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT419
AC   CVCL_E6HA
SY   CPDM_1461X
WW   Provider; CPDM; CPDM_1461X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
DI   NCIt; C7173; Diffuse astrocytoma
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT422
AC   CVCL_WW65
SY   BT 422; CCLF-KL1254; CCLF_KL1254; CPDM_0888X
DR   PharmacoDB; BT422_141_2019
DR   Wikidata; Q93432639
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0888X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C167335; Astrocytoma, IDH-mutant, grade 4
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT423
AC   CVCL_E6GD
SY   CPDM_1312X
WW   Provider; CPDM; CPDM_1312X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT428
AC   CVCL_WW66
SY   BT 428; CPDM_1313X
DR   PharmacoDB; BT428_142_2019
DR   Wikidata; Q93432641
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1313X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT440
AC   CVCL_WW67
SY   BT 440; CPDM_1316X
DR   PharmacoDB; BT440_143_2019
DR   Wikidata; Q93432643
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1316X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT444
AC   CVCL_WW68
SY   BT 444; CPDM_1317X
DR   PharmacoDB; BT444_144_2019
DR   Wikidata; Q93432645
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1317X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT458
AC   CVCL_E6FL
SY   CPDM_1320X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1320X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT474 A3
AC   CVCL_YX79
SY   BT474-A3
DR   cancercelllines; CVCL_YX79
DR   Wikidata; Q93432844
RX   PubMed=20386540;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   BT474-5FU[r]
AC   CVCL_4V65
DR   cancercelllines; CVCL_4V65
DR   Wikidata; Q54798492
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10021C.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   BT474-J4
AC   CVCL_ZL46
SY   BT-474-J4
DR   cancercelllines; CVCL_ZL46
DR   GEO; GSM799174
DR   GEO; GSM799175
DR   GEO; GSM799176
DR   GEO; GSM799177
DR   GEO; GSM799178
DR   GEO; GSM799179
DR   GEO; GSM799180
DR   GEO; GSM799181
DR   GEO; GSM799182
DR   GEO; GSM799183
DR   GEO; GSM799184
DR   GEO; GSM799185
DR   Wikidata; Q98125591
RX   PubMed=19671800;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (PubMed=19671800).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (PubMed=19671800).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   BT474-LAPRa
AC   CVCL_EI02
DR   cancercelllines; CVCL_EI02
DR   Wikidata; Q54798494
RX   PubMed=26883193;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   BT474-LAPRb
AC   CVCL_EI03
DR   cancercelllines; CVCL_EI03
DR   Wikidata; Q54798496
RX   PubMed=26883193;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   BT474-LR
AC   CVCL_VL01
SY   BT474/LR; BT474 LR
DR   BTO; BTO_0006065
DR   cancercelllines; CVCL_VL01
DR   Wikidata; Q93432846
RX   PubMed=25590338;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   BT477
AC   CVCL_E6HB
SY   CPDM_1322X
WW   Provider; CPDM; CPDM_1322X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3904; Papillary meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT482
AC   CVCL_WW69
SY   BT 482; CPDM_0884X
DR   PharmacoDB; BT482_145_2019
DR   Wikidata; Q93432647
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0884X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT484
AC   CVCL_WW70
SY   BT 484; CPDM_1323X
DR   cancercelllines; CVCL_WW70
DR   Wikidata; Q93432649
RX   PubMed=27723727;
WW   Provider; CPDM; CPDM_1323X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys136Tyr (c.407G>A); ClinVar=VCV000189406; Zygosity=Unspecified (PubMed=27723727).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   BT497
AC   CVCL_E6GE
SY   CPDM_1462X
WW   Provider; CPDM; CPDM_1462X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT498
AC   CVCL_WW71
SY   BT 498; CPDM_1325X
DR   PharmacoDB; BT498_146_2019
DR   Wikidata; Q93432651
WW   Provider; CPDM; CPDM_1325X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Low-passage-number culture.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT4A
AC   CVCL_X150
DR   Wikidata; Q54798498
RX   PubMed=6283799;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5712 ! BT4C
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   BT4C
AC   CVCL_5712
SY   BT4c
DR   Wikidata; Q54798499
RX   PubMed=198983;
RX   PubMed=1985868;
RX   PubMed=6263063;
RX   PubMed=19381449;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_X150 ! BT4A
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   BT4Cn
AC   CVCL_S568
DR   Wikidata; Q54798502
RX   PubMed=1985868;
RX   PubMed=3178168;
RX   PubMed=3468291;
RX   PubMed=3731074;
CC   Doubling time: 26.7 +- 1.4 hours (Note=In serum-supplemented media), 38.7 +- 4.0 hours (Note=In serum-free media) (PubMed=3178168).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5712 ! BT4C
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   BT504
AC   CVCL_WW72
SY   BT 504; CPDM_1327X
DR   PharmacoDB; BT504_147_2019
DR   Wikidata; Q93432652
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1327X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Low-passage-number culture.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   BT509
AC   CVCL_E6FM
SY   CPDM_1328X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1328X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT511
AC   CVCL_E6HC
SY   CPDM_1329X
WW   Provider; CPDM; CPDM_1329X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y11M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT519
AC   CVCL_E6FN
SY   CCLF-KL1256; CCLF_KL1256; CPDM_1331X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1331X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (CPDM=CPDM_1331X).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left occipital lobe; UBERON=UBERON_0002806.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT530
AC   CVCL_E6FP
SY   CPDM_1334X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1334X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (CPDM=CPDM_1334X).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT538
AC   CVCL_E6GY
SY   CPDM_1335X
WW   Provider; CPDM; CPDM_1335X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, pineal gland; UBERON=UBERON_0001905.
DI   NCIt; C114812; Childhood pineoblastoma
DI   ORDO; Orphanet_251909; Pineoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT559
AC   CVCL_E6FQ
SY   CCLF-KL1431; CCLF_KL1431; CPDM_1336X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1336X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT572
AC   CVCL_E6GF
SY   CPDM_1337X
WW   Provider; CPDM; CPDM_1337X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (CPDM=CPDM_1337X).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT574
AC   CVCL_E6FR
SY   CCLF-KL1249; CCLF_KL1249; CPDM_1338X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1336X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT584
AC   CVCL_E6H4
SY   CPDM_0099X
WW   Provider; CPDM; CPDM_0099X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT5C
AC   CVCL_5713
SY   BT5c
DR   Wikidata; Q54798504
RX   PubMed=198983;
RX   PubMed=3178168;
RX   PubMed=3468291;
RX   PubMed=3731074;
CC   Doubling time: 22.7 +- 1.2 hours (Note=In serum-supplemented media), 23.3 +- 1.9 hours (Note=In serum-free media) (PubMed=3178168).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   BT607
AC   CVCL_E6GG
SY   CPDM_0100X
WW   Provider; CPDM; CPDM_0100X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT611
AC   CVCL_E6GH
SY   CPDM_1469X
WW   Provider; CPDM; CPDM_1469X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT627
AC   CVCL_E6H1
SY   CPDM_0113X
WW   Provider; CPDM; CPDM_0113X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT628
AC   CVCL_E6HD
SY   CPDM_0843X
WW   Provider; CPDM; CPDM_0843X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Derived from site: In situ; Brain, frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C3904; Papillary meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT632
AC   CVCL_E6FS
SY   Ag1052; CPDM_0098X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0098X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.159G>A); ClinVar=VCV000420659; Zygosity=Unspecified (CPDM=CPDM_0098X).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (CPDM=CPDM_0098X).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT633
AC   CVCL_E6FU
SY   CCLF-KL1248; CCLF_KL1248; CPDM_1342X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1342X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT639
AC   CVCL_E6FV
SY   CPDM_1343X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1343X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT657
AC   CVCL_E6GI
SY   CPDM_0858X
WW   Provider; CPDM; CPDM_0858X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (CPDM=CPDM_0858X).
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT658
AC   CVCL_E6H2
SY   CPDM_1580X
WW   Provider; CPDM; CPDM_1580X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right posterior fossa; UBERON=UBERON_0008788.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT681
AC   CVCL_E6FW
SY   CPDM_1346X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1346X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278His (c.833C>A); ClinVar=VCV000376646; Zygosity=Unspecified (CPDM=CPDM_1346X).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT699
AC   CVCL_E6FT
SY   CCLF-KL1247; CCLF_KL1247; CPDM_1347X
RX   PubMed=34610309;
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT701
AC   CVCL_E6FX
SY   CPDM_1348X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1348X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Ser (c.667C>T); Zygosity=Unspecified (CPDM=CPDM_1348X).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT702
AC   CVCL_E6GJ
SY   CPDM_1349X
WW   Provider; CPDM; CPDM_1349X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Pro (c.770T>C); ClinVar=VCV000458562; Zygosity=Unspecified (CPDM=CPDM_1349X).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT715
AC   CVCL_E6FY
SY   CPDM_1351X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1351X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT723
AC   CVCL_E6GK
SY   CPDM_1472X
WW   Provider; CPDM; CPDM_1472X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT772
AC   CVCL_E6HE
SY   CPDM_1490X
WW   Provider; CPDM; CPDM_1490X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: African American.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C92552; Angiocentric glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT774
AC   CVCL_E6FZ
SY   CPDM_1353X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1353X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT779
AC   CVCL_E6G0
SY   CPDM_1354X
RX   PubMed=34610309;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT786
AC   CVCL_E6GL
SY   CPDM_1205X
WW   Provider; CPDM; CPDM_1205X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: African American.
CC   Derived from site: In situ; Brain, right cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT790
AC   CVCL_E6G1
SY   CPDM_1355X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1355X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT793
AC   CVCL_E6HF
SY   CPDM_0838X
WW   Provider; CPDM; CPDM_0838X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C9505; Dysembryoplastic neuroepithelial tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT806
AC   CVCL_E6GZ
SY   CPDM_1590X
WW   Provider; CPDM; CPDM_1590X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, pineal gland; UBERON=UBERON_0001905.
DI   NCIt; C114812; Childhood pineoblastoma
DI   ORDO; Orphanet_251909; Pineoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT820
AC   CVCL_E6G2
SY   CPDM_1357X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_1357X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right posterior fossa; UBERON=UBERON_0008788.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT839
AC   CVCL_E6HG
SY   CPDM_0891X
WW   Provider; CPDM; CPDM_0891X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C129271; Astrocytoma, IDH-mutant, grade 2
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT843
AC   CVCL_E6HH
SY   CPDM_1530X
WW   Provider; CPDM; CPDM_1530X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain, midline suprasellar region.
DI   NCIt; C3329; Pituitary gland adenoma
DI   ORDO; Orphanet_99408; Pituitary adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT869
AC   CVCL_E6HI
SY   CPDM_0802X
WW   Provider; CPDM; CPDM_0802X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem; UBERON=UBERON_0002298.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y10M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT883
AC   CVCL_E6GM
SY   CPDM_2076
WW   Provider; CPDM; CPDM_2076; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT905
AC   CVCL_E6HJ
SY   CPDM_0893X
WW   Provider; CPDM; CPDM_0893X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C129290; Astrocytoma, IDH-mutant, grade 3
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT907
AC   CVCL_E6HK
SY   CPDM_1534X
WW   Provider; CPDM; CPDM_1534X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left suprasellar region.
DI   NCIt; C3904; Papillary meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT921
AC   CVCL_E6GN
SY   CPDM_0096X
WW   Provider; CPDM; CPDM_0096X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT923
AC   CVCL_E6GP
SY   CPDM_0097X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0097X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT924
AC   CVCL_E6G3
SY   Ag1011; CPDM_0094X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0094X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT952
AC   CVCL_E6GQ
SY   CPDM_1531X
WW   Provider; CPDM; CPDM_1531X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left occipital lobe; UBERON=UBERON_0002806.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT953
AC   CVCL_E6HL
SY   CPDM_0125X
WW   Provider; CPDM; CPDM_0125X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left occipital lobe; UBERON=UBERON_0002806.
DI   NCIt; C27005; Spindle cell sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT954
AC   CVCL_E6G4
SY   Ag1033; CPDM_0093X
RX   PubMed=34610309;
WW   Provider; CPDM; CPDM_0093X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Can grow as a neurosphere (PubMed=34610309).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT961
AC   CVCL_E6GR
SY   CPDM_1532X
WW   Provider; CPDM; CPDM_1532X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT970
AC   CVCL_E6H6
SY   CPDM_0895X
WW   Provider; CPDM; CPDM_0895X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C129318; Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT987
AC   CVCL_E6GS
SY   CPDM_0610X
WW   Provider; CPDM; CPDM_0610X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (CPDM=CPDM_0610X).
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT99
AC   CVCL_E6H7
SY   CPDM_1574X
RX   PubMed=24440720;
WW   Provider; CPDM; CPDM_1574X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BT990
AC   CVCL_E6GT
SY   CPDM_0092X
WW   Provider; CPDM; CPDM_0092X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   BTA-S2
AC   CVCL_A9GA
DR   CCRID; 5301BOV-KCB04009ZJ
DR   KCB; KCB 200409ZJ
DR   Wikidata; Q108819965
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   bTAN20
AC   CVCL_WI22
SY   bTAN 20
DR   DSHB; bTAN-20
DR   Wikidata; Q93432864
RX   PubMed=7604005;
RX   PubMed=9244302;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P46531; Human NOTCH1 (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   BTB
AC   CVCL_E505
DR   dbMHC; 48520
DR   ECACC; 88052067
DR   IHW; IHW09067
DR   IPD-IMGT/HLA; 11625
DR   Wikidata; Q54798505
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Scandinavian.
CC   HLA typing: A*02:01:01:01; B*27:05:02; C*01:02:01; DPA1*01; DPB1*04:01:01; DQA1*04:01; DQB1*04:02:01; DRA*01:02; DRB1*08:01:01/08:77 (IPD-IMGT/HLA=11625).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Discontinued: ECACC; 88052067; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   Btb(Ba)97
AC   CVCL_C2RC
SY   Btb(Ba)97, Hunter-Polston
DR   ICLDB; atcc-btbba97
DR   Wikidata; Q114310762
RX   PubMed=11161991;
CC   Group: Insect cell line.
CC   Doubling time: ~3 days (PubMed=11161991).
CC   Caution: Indicated by PubMed=11161991 to have been deposited in ATCC as CRL-12420, but this is the ATCC number for GI-101A a patented cell line (Cellosaurus=CVCL_0278).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7038; ! Bemisia tabaci (Sweetpotato whitefly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   BTC-5
AC   CVCL_W947
DR   Wikidata; Q54798507
RX   PubMed=1654206;
RX   PubMed=2162628;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P68835; Murine polyomavirus (strain A2) (MPyV) small T antigen (PyST).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6J double transgenic RIP1Tag2/Rip2pyST1.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   BTF
AC   CVCL_R835
SY   Bluefin Trevally Fin
DR   Wikidata; Q54798508
RX   PubMed=16532601;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=181461; ! Caranx melampygus (Bluefin trevally)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   BTF22
AC   CVCL_6G02
SY   Bengal Tiger Fibroblast cell line 22
DR   Wikidata; Q54798511
RX   PubMed=20687455;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: ~28 hours (PubMed=20687455).
CC   Misspelling: BTS22; PubMed=20687455; Note=In figure 1 legend.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=74535; ! Panthera tigris tigris (Bengal tiger)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BTH-C
AC   CVCL_ZW16
SY   BTHC
DR   Wikidata; Q102113645
RX   PubMed=24813252;
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Ser110Pro (c.328T>C); ClinVar=VCV000042255; Zygosity=Hemizygous (PubMed=24813252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   BTH-H
AC   CVCL_ZW17
SY   BTHH
DR   Wikidata; Q102113647
RX   PubMed=24813252;
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Asp173Thrfs*11 (c.517delG); ClinVar=VCV001704478; Zygosity=Hemizygous (PubMed=24813252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   BTHBIOi001-A
AC   CVCL_F0RI
SY   BiPSC-HXL-CNGA1
DR   BioSamples; SAMEA117516861
DR   hPSCreg; BTHBIOi001-A
RX   PubMed=40795580;
CC   From: Beijing Institute of Ophthalmology, Beijing Tongren Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2148; CNGA1; Simple; p.Arg420Gln (c.1259G>A); ClinVar=VCV000225316; Zygosity=Homozygous (PubMed=40795580).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40795580
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19,20
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 13,16
ST   D19S433: 13,16
ST   D1S1656: 14,15.3
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 18,21
ST   Penta D: 9,13
ST   Penta E: 13,18
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BThy
AC   CVCL_5244
DR   CLO; CLO_0002046
DR   ATCC; CRL-6020
DR   Wikidata; Q54798513
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6020; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4399 ! BBm
OI   CVCL_3655 ! BLn
OI   CVCL_R939 ! BPf
OI   CVCL_3657 ! BSp
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   BTI-Ea-88
AC   CVCL_Z255
SY   BTI-EA-88; BTI-Ea 88; Ea 88
DR   Wikidata; Q54798515
RX   PubMed=1369220;
RX   PubMed=8314732;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=56594; ! Estigmene acrea (Salt marsh moth)
HI   CVCL_Z253 ! BTI-EAA
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-EAA
AC   CVCL_Z253
SY   BTI-EaA; BTI EAA; EAA.BTI; BTI-EA-1174-A; EA 1174 A; EA1174A; EaA
DR   CLO; CLO_0002047
DR   CLDB; cl502
DR   CCLV; CCLV-RIE 0351
DR   DSMZ; ACC-176
DR   DSMZCellDive; ACC-176
DR   ICLDB; bti-eaa
DR   Wikidata; Q54798549
RX   DOI=10.1016/B978-0-12-429740-1.50043-6;
RX   PubMed=1367489;
RX   PubMed=19941903;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=56594; ! Estigmene acrea (Salt marsh moth)
OI   CVCL_Z254 ! BTI-EAH
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   BTI-EAH
AC   CVCL_Z254
SY   BTI-EA-1174-H; EA 1174 H; EA1174H
DR   ICLDB; bti-eah
DR   Wikidata; Q54798551
RX   DOI=10.1016/B978-0-12-429740-1.50043-6;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=56594; ! Estigmene acrea (Salt marsh moth)
OI   CVCL_Z253 ! BTI-EAA
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Pr-10B
AC   CVCL_Z957
SY   BTI-PR10B
DR   ICLDB; bti-pr-10b
DR   Wikidata; Q54798552
RX   DOI=10.1016/0022-2011(88)90135-8;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Pr-8A1
AC   CVCL_Z958
SY   BTI-PR8A1
DR   ICLDB; bti-pr-8a1
DR   Wikidata; Q54798553
RX   DOI=10.1016/0022-2011(88)90135-8;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
OI   CVCL_Z959 ! BTI-Pr-8A2
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Pr-8A2
AC   CVCL_Z959
SY   BTI-PR8A2
DR   ICLDB; bti-pr-8a2
DR   Wikidata; Q54798556
RX   DOI=10.1016/0022-2011(88)90135-8;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
OI   CVCL_Z958 ! BTI-Pr-8A1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Pr-9A
AC   CVCL_Z960
SY   BTI-PR9A
DR   ICLDB; bti-pr-9a
DR   Wikidata; Q54798557
RX   DOI=10.1016/0022-2011(88)90135-8;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Pu-2
AC   CVCL_Z370
SY   BTI-Pu-7202
DR   Wikidata; Q54798559
RX   Patent=US5686305;
RX   PubMed=10476920;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=103831; ! Mythimna unipuncta (Armyworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BTI-Pu-A7
AC   CVCL_Z371
SY   BTI-Pu-527A7
DR   Wikidata; Q54798560
RX   Patent=US5686305;
RX   PubMed=10476920;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=103831; ! Mythimna unipuncta (Armyworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BTI-Pu-A7S
AC   CVCL_Z372
SY   BTI-Pu-527A7S; BTI-PuA7S; A7S
DR   Wikidata; Q54798562
RX   Patent=US5686305;
RX   PubMed=10476920;
RX   PubMed=12573024;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12285.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=103831; ! Mythimna unipuncta (Armyworm moth)
HI   CVCL_Z371 ! BTI-Pu-A7
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BTI-Pu-B9
AC   CVCL_Z373
SY   BTI-Pu-527B9
DR   Wikidata; Q54798564
RX   Patent=US5686305;
RX   PubMed=10476920;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=103831; ! Mythimna unipuncta (Armyworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BTI-Pu-M
AC   CVCL_Z374
SY   BTI-Pu-527m
DR   Wikidata; Q54798566
RX   Patent=US5686305;
RX   PubMed=10476920;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=103831; ! Mythimna unipuncta (Armyworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BTI-Pu-M1B
AC   CVCL_Z375
SY   BTI-Pu-527M1B
DR   Wikidata; Q54798567
RX   Patent=US5686305;
RX   PubMed=10476920;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=103831; ! Mythimna unipuncta (Armyworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   BTI-Tn-4A14
AC   CVCL_DD38
SY   Tn-4A14
DR   ICLDB; bti-tn-4a14
DR   Wikidata; Q54798569
RX   DOI=10.1006/jipa.1997.4701;
RX   Patent=US6403375;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 20 hours (DOI=10.1006/jipa.1997.4701).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-4A2
AC   CVCL_DD37
SY   Tn-4A2
DR   ICLDB; bti-tn-4a2
DR   Wikidata; Q54798571
RX   Patent=US6403375;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-4A22
AC   CVCL_DD39
SY   Tn-4A22
DR   ICLDB; bti-tn-4a22
DR   Wikidata; Q54798572
RX   Patent=US6403375;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-4B
AC   CVCL_DD33
SY   BTI-Tn4B; Tn-4B; Tn4B
DR   ICLDB; bti-tn-4b
DR   Wikidata; Q54798574
RX   DOI=10.1006/jipa.1997.4701;
RX   Patent=US6403375;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11970.
CC   Doubling time: 28 hours (DOI=10.1006/jipa.1997.4701).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   BTI-Tn-4B1
AC   CVCL_Z408
SY   BTI-TN4B1
DR   ICLDB; bti-tn-4b1
DR   Wikidata; Q54798576
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_DD33 ! BTI-Tn-4B
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   BTI-Tn-4B42
AC   CVCL_DD35
SY   Tn-4B42
DR   ICLDB; bti-tn-4b42
DR   Wikidata; Q54798580
RX   Patent=US6403375;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_DD33 ! BTI-Tn-4B
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-4B44
AC   CVCL_DD36
SY   Tn-4B44
DR   ICLDB; bti-tn-4b44
DR   Wikidata; Q54798581
RX   Patent=US6403375;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_DD33 ! BTI-Tn-4B
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5B1
AC   CVCL_Z409
SY   BTI-TN-5B1; BTI-TN5B1
DR   ICLDB; bti-tn-5b1
DR   Wikidata; Q54798583
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   BTI-Tn-5B1-28
AC   CVCL_Z410
SY   BTI-TN-5B1-28
DR   ICLDB; bti-tn-5b1-28
DR   Wikidata; Q54798586
RX   Patent=US5300435;
RX   Patent=US7179648;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z409 ! BTI-Tn-5B1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5B1-4
AC   CVCL_C190
SY   BTI-TN-5B1-4; BTI-TN5B1-4; BTI-Tn5B14; BTI-Tn 5B1-4; Tn-5B1-4; Tn 5B1-4; Tn5 B1-4; Tn5B1-4; TN5B14; TnH5; High Five; High 5; High-5; High5; Hi-five; Hi-5; Hi5; Tn-5
DR   BTO; BTO_0003619
DR   CLO; CLO_0009378
DR   EFO; EFO_0022724
DR   CLDB; cl4535
DR   CCLV; CCLV-RIE 0350
DR   CCRID; 4201INS-CCTCC00293
DR   CCTCC; GDC0293
DR   ChEMBL-Cells; CHEMBL3833782
DR   ECACC; 94020901
DR   ICLDB; bti-tn-5b1-4
DR   Lonza; 1180
DR   PubChem_Cell_line; CVCL_C190
DR   TOKU-E; 4051
DR   TOKU-E; 4129
DR   Wikidata; Q17126384
RX   DOI=10.1016/S0022-2011(94)90400-6;
RX   DOI=10.1111/j.1744-7917.2004.tb00236.x;
RX   Patent=US5300435;
RX   Patent=US7179648;
RX   PubMed=1369220;
RX   PubMed=8314732;
RX   PubMed=10358729;
RX   PubMed=10397817;
RX   PubMed=10585188;
RX   PubMed=17686877;
RX   PubMed=19941903;
RX   PubMed=20300881;
RX   PubMed=21667340;
RX   PubMed=23848607;
RX   PubMed=24375231;
RX   PubMed=29133148;
RX   PubMed=29376823;
RX   PubMed=30449074;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-175.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/High_Five_cells
WW   Provider; Thermo Fisher; B85502; https://www.thermofisher.com/order/catalog/product/B85502
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10859.
CC   Virology: Infected with alphanodavirus TnCLV.
CC   Doubling time: 26 hours (DOI=10.1111/j.1744-7917.2004.tb00236.x; PubMed=21667340); 34 +- 1 hours (Note=In static culture), 27 +- 2 hours (Note=In suspension culture) (PubMed=10585188).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 94020901; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z410 ! BTI-Tn-5B1-28
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 32
//
ID   BTI-Tn-5C1
AC   CVCL_Z411
SY   BTI-TN5C1
DR   ICLDB; bti-tn-5c1
DR   Wikidata; Q54798588
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5F2
AC   CVCL_Z412
SY   BTI-TN5F2
DR   ICLDB; bti-tn-5f2
DR   Wikidata; Q54798589
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5F2A
AC   CVCL_Z414
SY   BTI-TN5F2A
DR   ICLDB; bti-tn-5f2a
DR   Wikidata; Q54798590
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z412 ! BTI-Tn-5F2
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5F2P
AC   CVCL_Z413
SY   BTI-TN5F2P
DR   ICLDB; bti-tn-5f2p
DR   Wikidata; Q54798592
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z412 ! BTI-Tn-5F2
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5G2A1
AC   CVCL_Z415
SY   BTI-TN5G2A1
DR   ICLDB; bti-tn-5g2a1
DR   Wikidata; Q54798593
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5G2A1P
AC   CVCL_Z416
SY   BTI-TN5G2A1P
DR   ICLDB; bti-tn-5g2a1p
DR   Wikidata; Q54798594
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z415 ! BTI-Tn-5G2A1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5G3
AC   CVCL_Z417
SY   BTI-TN5G3
DR   ICLDB; bti-tn-5g3
DR   Wikidata; Q54798597
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-5G33
AC   CVCL_Z418
SY   BTI-TN5G33
DR   ICLDB; bti-tn-5g33
DR   Wikidata; Q54798598
RX   PubMed=18640644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   BTI-Tn-AP2
AC   CVCL_Z258
SY   BTI-TN-AP2; Tn Ap2
DR   ICLDB; bti-tn-ap2
DR   Wikidata; Q54798600
RX   PubMed=1369220;
RX   PubMed=8314732;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   BTI-Tn-MG1
AC   CVCL_Z093
SY   BTI-TN-MG1; BTI-TN-MG-1; Tn MG-1; MG1; BTI-Tn M; Tn M
DR   ICLDB; bti-tn-mg1
DR   Wikidata; Q54798602
RX   Patent=US5300435;
RX   PubMed=1369220;
RX   PubMed=8314732;
RX   PubMed=21667340;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10860.
CC   Doubling time: 20 hours (PubMed=21667340).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   BTI-Tn4-B31
AC   CVCL_DD34
SY   BTI-Tn4B31; Tn-4B31; Tn4B31
DR   ICLDB; bti-tn4-b31
DR   Wikidata; Q54798577
RX   DOI=10.1006/jipa.1997.4701;
RX   Patent=US6403375;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11969.
CC   Doubling time: 26 hours (DOI=10.1006/jipa.1997.4701).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_DD33 ! BTI-Tn-4B
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   BTI-Tnao38
AC   CVCL_Z252
SY   Tnao38; Ao38
DR   ABM; T0853
DR   BioSample; SAMN06481107
DR   ICLDB; bti-tnao38
DR   Wikidata; Q54798603
RX   PubMed=20602790;
RX   PubMed=22531032;
RX   PubMed=24375231;
RX   PubMed=29133148;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Problematic cell line: Contaminated. Originally thought to be from Ascalapha odorata. Shown to be a BTI-Tn-5B1-4 derivative (PubMed=22531032).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00510.
CC   Doubling time: 20.2 hours (PubMed=20602790).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   BTIC
AC   CVCL_M366
DR   Wikidata; Q54798604
RX   PubMed=17645728;
CC   Population: Japanese.
CC   Doubling time: ~44 hours (PubMed=17645728).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   BTISi001-A
AC   CVCL_A4HQ
SY   BR7
DR   SKIP; SKIP005579
DR   Wikidata; Q105506563
CC   From: Stem Cell Group, Bioprocessing Technology Institute, A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   BTISi002-A
AC   CVCL_A4HR
SY   D5
DR   SKIP; SKIP005580
DR   Wikidata; Q105506565
CC   From: Stem Cell Group, Bioprocessing Technology Institute, A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   BTISi003-A
AC   CVCL_A4HS
SY   D9
DR   SKIP; SKIP005581
DR   Wikidata; Q105506568
CC   From: Stem Cell Group, Bioprocessing Technology Institute, A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   BTISi004-A
AC   CVCL_A4HT
SY   X13
DR   SKIP; SKIP005582
DR   Wikidata; Q105506572
CC   From: Stem Cell Group, Bioprocessing Technology Institute, A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   BTL2013
AC   CVCL_A9KJ
SY   MDBK N14
DR   CCRID; 4201PAT-CCTCC00460
DR   Wikidata; Q108819966
RX   Patent=CN104357444A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014116.
CC   Knockout cell: Method=siRNA knockdown; VGNC; VGNC:-; TRIM5 (Note=Isoform alpha).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   btl>Ras attP-L3
AC   CVCL_B3N7
SY   Btl3
DR   DGRC; 332
DR   FlyBase_Cell_line; FBtc0000332
DR   Wikidata; Q110432645
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: btl-Gal4 driving UAS-RasV12 and UAS-p35 (baculovirus anti-apoptotic factor p35) with an attP flanked cassette for RMCE.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
ID   btl>Ras attP-L7
AC   CVCL_XF53
SY   Btl-7; Btl-7 attP; Btl7
DR   DGRC; 285
DR   FlyBase_Cell_line; FBtc0000285
DR   Wikidata; Q93433040
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: btl-Gal4 driving UAS-RasV12 and UAS-p35 (baculovirus anti-apoptotic factor p35) with an attP flanked cassette for RMCE.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 7
//
ID   btl>Ras attP-L8
AC   CVCL_XF54
SY   Btl-8; Btl-8 attP; Btl8
DR   DGRC; 286
DR   FlyBase_Cell_line; FBtc0000286
DR   Wikidata; Q93433042
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: btl-Gal4 driving UAS-RasV12 and UAS-p35 (baculovirus anti-apoptotic factor p35) with an attP flanked cassette for RMCE.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 7
//
ID   BTLA6.4
AC   CVCL_B7F1
DR   Wikidata; Q112929347
RX   Patent=US9896507;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   BTLA7.1
AC   CVCL_B7F2
DR   Wikidata; Q112929348
RX   Patent=US9896507;
RX   PubMed=20693422;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   BTLA8.2
AC   CVCL_B7F3
SY   BTLA 8.2
DR   Wikidata; Q112929349
RX   Patent=US9896507;
RX   Patent=US10005839;
RX   PubMed=20693422;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4123.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   BTM-1
AC   CVCL_5G43
SY   Breast tumor line M-1
DR   Wikidata; Q54798605
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=212193;
RX   PubMed=4305322;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   BTM-28T
AC   CVCL_5G35
SY   BTM28T; Bovine Trabecular Meshwork-28 Transformed
DR   ABM; T0844
DR   Wikidata; Q54798606
RX   PubMed=23116564;
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU551.
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 12
//
ID   BTMS
AC   CVCL_R836
SY   Bluefin Trevally Muscle
DR   Wikidata; Q54798608
RX   PubMed=16532601;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=181461; ! Caranx melampygus (Bluefin trevally)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   bTS11
AC   CVCL_A6JI
SY   TS^(blast)#1; TSblast #1
DR   RCB; RCB4941
DR   Wikidata; Q107113522
RX   PubMed=29249463;
CC   Characteristics: Trophoblast stem cell line.
CC   Senescence: Senesces at 150 PDL (RCB=RCB4941).
CC   Doubling time: 21.7 +- 3.0 hours (PubMed=29249463).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   bTS5
AC   CVCL_A6JH
SY   TS^(blast)#2; TSblast #2
DR   RCB; RCB4940
DR   Wikidata; Q107113523
RX   PubMed=29249463;
CC   Characteristics: Trophoblast stem cell line.
CC   Senescence: Senesces at 150 PDL (RCB=RCB4940).
CC   Doubling time: 22.6 +- 2.5 hours (PubMed=29249463).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   BTSN4
AC   CVCL_B6E4
DR   Wikidata; Q111733015
RX   PubMed=7765935;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02161; Human RHD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6E5 ! BTSN5
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BTSN5
AC   CVCL_B6E5
DR   Wikidata; Q111733017
RX   PubMed=7765935;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02161; Human RHD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6E4 ! BTSN4
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BTSN6
AC   CVCL_B6E8
DR   Wikidata; Q111733018
RX   DOI=10.1007/BF00153748;
RX   PubMed=22358662;
CC   Monoclonal antibody isotype: IgG1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   BTT-T739
AC   CVCL_M626
SY   BTT T739; T739
DR   Wikidata; Q54798609
RX   PubMed=23691487;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: T739.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 7
//
ID   BTV10XSp2/0-Ag-14-10A1.34
AC   CVCL_4U65
SY   10A1.34
DR   ATCC; HB-8219
DR   Wikidata; Q54798611
RX   Patent=US4873189;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8219.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P69361; Bluetongue virus 10 VP7 (Note=Also reacts with most other BPV serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   BTV10XSp2/0-Ag-14-10D4.90
AC   CVCL_G642
SY   10D4.90
DR   CLO; CLO_0002048
DR   ATCC; HB-8377
DR   Wikidata; Q54798612
RX   Patent=US4873189;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8377.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bluetongue virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   BTYH-1
AC   CVCL_WK67
DR   KCB; KCB 92006
DR   Wikidata; Q93433151
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
OX   NCBI_TaxID=54133; ! Pygathrix nemaeus (Red-shanked douc langur)
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   BTYH-2
AC   CVCL_WK68
DR   KCB; KCB 92030
DR   Wikidata; Q93433153
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
OX   NCBI_TaxID=54133; ! Pygathrix nemaeus (Red-shanked douc langur)
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   BTYH-3
AC   CVCL_WK69
DR   KCB; KCB 92035
DR   Wikidata; Q93433154
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
OX   NCBI_TaxID=54133; ! Pygathrix nemaeus (Red-shanked douc langur)
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   BU-11
AC   CVCL_0180
SY   BU11
DR   MCCL; MCC:0000071
DR   TOKU-E; 4110
DR   Wikidata; Q54798637
RX   PubMed=10558919;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   BU1
AC   CVCL_D3BN
SY   BU1-Cr3-1; BU1Cr3-1
DR   Wikidata; Q127380348
RX   PubMed=39332406;
WW   Provider; CReM; 503; https://stemcellbank.bu.edu/Catalog/Item/Details/503
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   BU2:N1
AC   CVCL_D2WH
SY   BU2 N1; BU2-TetOn:NICD
DR   Wikidata; Q127380349
RX   PubMed=36332629;
WW   Provider; CReM; 782; https://stemcellbank.bu.edu/Catalog/Item/Details/782
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Under the control of doxycycline expresses the intracellular domain of the NOTCH1 receptor (NICD1). Using ZFN a construct containing a reverse tetracycline-controlled transactivator (rtTA), NICD1 and puroR was inserted in the AAVS1 safe harbor locus (PubMed=36332629).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:7881; NOTCH1 (Note=With p.Met1_Arg1762del = NICD1).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW25 ! CREM002i-BU2C10
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   BU3 NKX2-1-GFP SFTPC-tdTomato
AC   CVCL_WN82
SY   BU3 NKX2-1GFP;SFTPCtdTomato; BU3-NGST; BU3 NGST; BU3NGST
DR   Wikidata; Q93433163
RX   PubMed=28965766;
RX   PubMed=31924806;
WW   Provider; CReM; 509; https://stemcellbank.bu.edu/Catalog/Item/Details/509
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a 2A-eGFP-pA was inserted after the NKX2-1 coding sequence and using TALENs a tdTomato-pA-loxP-PGKp-PuroR-pA-loxP was inserted at the SFTPC translational start site.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW26 ! CREM003i-BU3C2
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   BU3-10-Cr1
AC   CVCL_D2WD
DR   Wikidata; Q127380350
RX   PubMed=36332629;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW26 ! CREM003i-BU3C2
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   BU3:N1
AC   CVCL_D2WI
DR   Wikidata; Q127380351
RX   PubMed=36332629;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Under the control of doxycycline expresses the intracellular domain of the NOTCH1 receptor (NICD1). Using ZFN a construct containing a reverse tetracycline-controlled transactivator (rtTA), NICD1 and puroR was inserted in the AAVS1 safe harbor locus (PubMed=36332629).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:7881; NOTCH1 (Note=With p.Met1_Arg1762del = NICD1).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2WD ! BU3-10-Cr1
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   BU6-Cr8
AC   CVCL_D2WE
SY   BU6
DR   Wikidata; Q127380352
RX   PubMed=36332629;
WW   Provider; CReM; 737; https://stemcellbank.bu.edu/Catalog/Item/Details/737
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   BU7
AC   CVCL_D2YE
SY   BU7-1S
DR   Wikidata; Q127380353
WW   Provider; CReM; 512; https://stemcellbank.bu.edu/Catalog/Item/Details/512
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   BU8-1
AC   CVCL_D2WB
SY   BU8
DR   Wikidata; Q127380354
WW   Provider; CReM; 513; https://stemcellbank.bu.edu/Catalog/Item/Details/513
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2WG ! BU8-3
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   BU8-3
AC   CVCL_D2WG
SY   BU8.3
DR   Wikidata; Q127380355
RX   PubMed=36332629;
CC   From: Boston University; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2WB ! BU8-1
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   BU8:N1
AC   CVCL_D2YC
SY   BU8 N1; BU8-TetOn:NICD1
DR   Wikidata; Q127380356
RX   PubMed=36332629;
WW   Provider; CReM; 784; https://stemcellbank.bu.edu/Catalog/Item/Details/784
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Under the control of doxycycline expresses the intracellular domain of the NOTCH1 receptor (NICD1). Using ZFN a construct containing a reverse tetracycline-controlled transactivator (rtTA), NICD1 and puroR was inserted in the AAVS1 safe harbor locus (PubMed=36332629).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:7881; NOTCH1 (Note=With p.Met1_Arg1762del = NICD1).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2WG ! BU8-3
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   BUC
AC   CVCL_G691
DR   cancercelllines; CVCL_G691
DR   Wikidata; Q54798638
RX   PubMed=6231643;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   BUcEC
AC   CVCL_A1BK
SY   Bovine Umbilical Cord Endothelial Cells
DR   ABM; T0834
DR   Wikidata; Q102113649
RX   PubMed=32722052;
CC   Doubling time: 36 hours (PubMed=32722052).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
CC   Breed/subspecies: Montbeliarde; VBO=VBO_0000306.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_A1BE ! BBrMEC
OI   CVCL_A1BF ! BIntMEC
OI   CVCL_A1BG ! BLuMEC
OI   CVCL_A1BH ! BMLNMEC
OI   CVCL_A1BI ! BOvMEC
OI   CVCL_A1BJ ! BSkMEC
SX   Female
AG   6FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   BUCREMi001-A
AC   CVCL_YE45
SY   iPSC-S6D63H-1-hom; Fetus Hom #1
DR   BioSamples; SAMEA6324163
DR   hPSCreg; BUCREMi001-A
DR   Wikidata; Q93433171
RX   PubMed=29555651;
CC   From: Boston University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:14934; SIRT6; Simple; p.Asp63His (c.187G>C); Zygosity=Homozygous (PubMed=29555651).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C118676; Perinatal mortality
DI   ORDO; Orphanet_580933; Lethal brain and heart developmental defects
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   BUCREMi002-A
AC   CVCL_YE46
SY   iPSC-S6D63H-3-hom; iPSC-S6D63H-3hom; Fetus Hom #3
DR   BioSamples; SAMEA6324161
DR   hPSCreg; BUCREMi002-A
DR   Wikidata; Q93433173
RX   PubMed=29555651;
CC   From: Boston University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:14934; SIRT6; Simple; p.Asp63His (c.187G>C); Zygosity=Homozygous (PubMed=29555651).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C118676; Perinatal mortality
DI   ORDO; Orphanet_580933; Lethal brain and heart developmental defects
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27FW
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   BUD-8
AC   CVCL_2321
DR   CLO; CLO_0002051
DR   CLDB; cl507
DR   CLDB; cl508
DR   ATCC; CRL-1554
DR   BioSample; SAMN03471395
DR   ChEMBL-Cells; CHEMBL3307997
DR   ChEMBL-Targets; CHEMBL612591
DR   ECACC; 90031532
DR   IZSLER; BS CL 11
DR   PubChem_Cell_line; CVCL_2321
DR   Wikidata; Q54798639
CC   Population: Caucasian.
CC   Characteristics: Highly sensitive to interferon and can be used in assays of interferon activity (ATCC=CRL-1554).
CC   Senescence: Senesces at ~8 PDL (ATCC=CRL-1554).
CC   Discontinued: ECACC; 90031532; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1554; IZSLER=BS CL 11
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 30,31.2
ST   D2S1338: 24,26
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 20,27
ST   Penta D: 12,13
ST   Penta E: 5,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   Buffalo 595
AC   CVCL_A7TY
DR   Wikidata; Q107113524
RX   PubMed=9577776;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9970; ! Syncerus caffer (African buffalo)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   Buffalo TE
AC   CVCL_F0D8
RX   PubMed=39399971;
CC   Senescence: Senesces at 21 PDL (PubMed=39399971).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Trophectoderm; UBERON=UBERON_0004345.
OX   NCBI_TaxID=89462; ! Bubalus bubalis (Domestic water buffalo)
SX   Female
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BufoTad
AC   CVCL_F0Y4
RX   PubMed=30452932;
CC   Group: Amphibian cell line.
CC   Characteristics: Optimal growth temperature is 25 Celsius (PubMed=30452932).
CC   Derived from site: In situ; Whole tadpole; UBERON=UBERON_0002547.
OX   NCBI_TaxID=8389; ! Anaxyrus americanus (American toad)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BUG
AC   CVCL_LJ53
DR   Wikidata; Q54798641
RX   PubMed=1753108;
CC   Characteristics: Produces IgA lambda.
CC   Characteristics: IL6 dependent.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 7
//
ID   BuGR1
AC   CVCL_DC10
SY   BUGR1; BUGR-1
DR   Wikidata; Q54798643
RX   PubMed=6690272;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06536; Rat Nr3c1/Grl (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   BuGR2
AC   CVCL_DC11
SY   BUGR2
DR   Wikidata; Q54798645
RX   PubMed=1314696;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06536; Rat Nr3c1/Grl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   BULA1
AC   CVCL_A9KS
SY   BALB/c Urethane-induced Lung Adenocarcinoma 1
DR   Wikidata; Q108819967
RX   PubMed=30828726;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726).
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BULA2
AC   CVCL_A9KT
SY   BALB/c Urethane-induced Lung Adenocarcinoma 2
DR   Wikidata; Q108819968
RX   PubMed=30828726;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726).
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   BUMA 31
AC   CVCL_VP96
SY   BUMA31
DR   Wikidata; Q93433201
RX   PubMed=10837406;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   BUMC-40v
AC   CVCL_6G65
DR   IPD-IMGT/HLA; 12646
DR   Wikidata; Q54798646
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,03; B*07,40:39; C*07; DQB1*03:01,06:02; DRB1*12:01,15:01; DRB3*02:02; DRB5*01/02 (IPD-IMGT/HLA=12646).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BuMEC [Buffalo 2012]
AC   CVCL_M445
SY   Buffalo Mammary Epithelial Cells
DR   Wikidata; Q54798647
RX   PubMed=22792341;
RX   PubMed=32179766;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=89462; ! Bubalus bubalis (Domestic water buffalo)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   BuMEC [Buffalo 2013]
AC   CVCL_9T69
SY   Buffalo Mammary Epithelial Cells
DR   Wikidata; Q54798649
RX   PubMed=23180034;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=89462; ! Bubalus bubalis (Domestic water buffalo)
SX   Female
AG   2-3Y
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BUMPT-306
AC   CVCL_D3WF
SY   Boston University Mouse Proximal Tubular cell-clone 306
DR   Wikidata; Q127380357
RX   PubMed=12419774;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   BUPH:OVSC-2
AC   CVCL_JK55
DR   Wikidata; Q54798650
RX   PubMed=12479096;
CC   Doubling time: ~41 hours (PubMed=12479096).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   BUR,E
AC   CVCL_E506
SY   BUR, E
DR   dbMHC; 48521
DR   ECACC; 94082217
DR   IHW; IHW09118
DR   IPD-IMGT/HLA; 11663
DR   Wikidata; Q54798652
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*56:01:01:02; C*01:02:01; DPA1*02:02:02; DPB1*05:01:01:01; DQA1*03:03:01:02,05:05:01; DQB1*04:02:01; DRB1*04:12,14:09; DRB3*01:01:02; DRB4*01:03:01:01 (IPD-IMGT/HLA=11663).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   Bushpig 1194
AC   CVCL_A7TZ
DR   Wikidata; Q107113525
RX   PubMed=9577776;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=273791; ! Potamochoerus porcus (Red river hog)
SX   Male
AG   Young
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BUTE1A
AC   CVCL_B6XN
SY   Bovine UTerine Epithelial clone 1A
DR   Wikidata; Q111733019
RX   PubMed=35064470;
CC   Doubling time: 74.99 hours (PubMed=35064470).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BUTE1B
AC   CVCL_B6XP
SY   Bovine UTerine Epithelial clone 1B
DR   Wikidata; Q111733020
RX   PubMed=35064470;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BUTE1C
AC   CVCL_B6XQ
SY   Bovine UTerine Epithelial clone 1C
DR   Wikidata; Q111733021
RX   PubMed=35064470;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BUTE1D
AC   CVCL_B6XR
SY   Bovine UTerine Epithelial clone 1D
DR   Wikidata; Q111733022
RX   PubMed=35064470;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BUTE1E
AC   CVCL_B6XS
SY   Bovine UTerine Epithelial clone 1E
DR   Wikidata; Q111733023
RX   PubMed=35064470;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   BV-173
AC   CVCL_0181
SY   BV173
DR   BTO; BTO_0004950
DR   CLO; CLO_0002052
DR   EFO; EFO_0002118
DR   MCCL; MCC:0000072
DR   CLDB; cl510
DR   CLDB; cl4968
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473373
DR   BioSample; SAMN10988488
DR   cancercelllines; CVCL_0181
DR   CCTCC; GDC0607
DR   Cell_Model_Passport; SIDM00962
DR   ChEMBL-Cells; CHEMBL3308228
DR   ChEMBL-Targets; CHEMBL2366145
DR   CLS; 300133
DR   Cosmic; 798672
DR   Cosmic; 910710
DR   Cosmic; 922164
DR   Cosmic; 994184
DR   Cosmic; 996292
DR   Cosmic; 998702
DR   Cosmic; 999741
DR   Cosmic; 1019833
DR   Cosmic; 1026570
DR   Cosmic; 1037734
DR   Cosmic; 1070701
DR   Cosmic; 1071881
DR   Cosmic; 1127249
DR   Cosmic; 1176600
DR   Cosmic; 1191703
DR   Cosmic; 1524792
DR   Cosmic-CLP; 910710
DR   DepMap; ACH-000432
DR   DSMZ; ACC-20
DR   DSMZCellDive; ACC-20
DR   EGA; EGAS00001000978
DR   GDSC; 910710
DR   GEO; GSM236779
DR   GEO; GSM236815
DR   GEO; GSM886895
DR   GEO; GSM887960
DR   GEO; GSM1374414
DR   GEO; GSM1669633
DR   IARC_TP53; 21199
DR   ICLC; HTL99018
DR   IGRhCellID; BV173
DR   LiGeA; CCLE_631
DR   LINCS_LDP; LCL-1111
DR   Lonza; 117
DR   PharmacoDB; BV173_148_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0181
DR   PubChem_Cell_line; CVCL_0181
DR   Wikidata; Q54798653
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1720549;
RX   PubMed=3098690;
RX   PubMed=3332852;
RX   PubMed=3856862;
RX   PubMed=6572735;
RX   PubMed=9680106;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=14504097;
RX   PubMed=16523483;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20809971;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30-35 hours (PubMed=6572735); ~48 hours (DSMZ=ACC-20).
CC   HLA typing: A*02:01,30:01; B*15:10,18:01; C*03:04,12:03 (PubMed=26589293).
CC   HLA typing: A*02:01:01,30:01:01; B*15:10:01,18:01:01; C*03:04:02,12:03:01; DPA1*01:03:01,02:01:02; DPB1*02:01:02,01:01:01; DQA1*01:02:01,01:02:02; DQB1*05:02:01,06:03:01; DRA*01:01:01,01:02:02; DRB1*13:02:01,16:01:01 (DSMZCellDive=ACC-20).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=20809971; DepMap=ACH-000432).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln4045Ter (c.12133C>T); Zygosity=Heterozygous (Cosmic-CLP=910710; DepMap=ACH-000432).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.38%; Native American=0%; East Asian, North=2.14%; East Asian, South=0%; South Asian=2.51%; European, North=52.2%; European, South=41.77% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): CLS=300133; Cosmic-CLP=910710; DSMZ=ACC-20
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 30,32
ST   D2S1338: 24,25
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 11,12,13 (CLS=300133)
ST   D8S1179: 12,13 (DSMZ=ACC-20)
ST   FGA: 20,24
ST   Penta D: 11
ST   Penta E: 12,16
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   BV-173/E255K
AC   CVCL_5K95
SY   BV173/E255K
DR   cancercelllines; CVCL_5K95
DR   CancerTools; 154032
DR   Kerafast; EVC001
DR   Wikidata; Q54798655
RX   PubMed=21474579;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Glu255Lys (c.763G>A); ClinVar=VCV000376090; Zygosity=Unspecified (PubMed=21474579).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln4045Ter (c.12133C>T); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0181 ! BV-173
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   BV-2
AC   CVCL_0182
SY   BV2
DR   BTO; BTO_0003350
DR   EFO; EFO_0022792
DR   MCCL; MCC:0000073
DR   CLDB; cl7130
DR   BCRJ; 0356
DR   BioGRID_ORCS_Cell_line; 765
DR   CCRID; 1101MOU-PUMC000063
DR   CCRID; 4201MOU-CCTCC00311
DR   CCTCC; GDC0311
DR   ChEMBL-Cells; CHEMBL3307704
DR   ChEMBL-Targets; CHEMBL614781
DR   CLS; 305156
DR   GEO; GSM635468
DR   GEO; GSM635469
DR   GEO; GSM635470
DR   GEO; GSM635471
DR   ICLC; ATL03001
DR   KCB; KCB 200770YJ
DR   Lonza; 118
DR   PRIDE; PXD001597
DR   PRIDE; PXD004984
DR   PubChem_Cell_line; CVCL_0182
DR   Ubigene; YC-C035
DR   Wikidata; Q54798657
RX   CelloPub=CLPUB00788;
RX   DOI=10.1007/s13273-019-00057-6;
RX   PubMed=2110186;
RX   PubMed=19565166;
RX   PubMed=21214938;
RX   PubMed=21961028;
RX   PubMed=22651808;
RX   PubMed=26227174;
CC   Transformant: Recombinant retrovirus J2.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Ubigene=YC-C035
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 17.3
ST   Mouse STR 6-7: 15
ST   Mouse STR 12-1: 16
ST   Mouse STR 15-3: 22.3,23.3,24.3
ST   Mouse STR 18-3: 16,17
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   BV-2 PU.1 KO
AC   CVCL_ZJ35
SY   PU.1 KO BV-2
DR   GEO; GSE134701
DR   Wikidata; Q98125592
RX   DOI=10.1007/s13273-019-00057-6;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98282; Spi1.
CC   Transformant: Recombinant retrovirus J2.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   BV0416
AC   CVCL_8T86
DR   ECACC; 94101406
DR   Wikidata; Q54798659
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(14;18)(q13;q12) (ECACC=94101406).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BV0698
AC   CVCL_8T87
DR   ECACC; 96072601
DR   Wikidata; Q54798660
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96072601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BV0699
AC   CVCL_8T88
DR   ECACC; 96072602
DR   Wikidata; Q54798661
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96072602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BV0700
AC   CVCL_8T89
DR   ECACC; 96072603
DR   Wikidata; Q54798662
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BV0702
AC   CVCL_8T90
DR   ECACC; 96081303
DR   Wikidata; Q54798664
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96081303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BV0703
AC   CVCL_8T91
DR   ECACC; 96081304
DR   Wikidata; Q54798666
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96081304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BV0704
AC   CVCL_8T92
DR   ECACC; 96081305
DR   Wikidata; Q54798667
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   BV0763
AC   CVCL_8T93
DR   ECACC; 97022605
DR   Wikidata; Q54798669
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Karyotypic information: 46,XY,4p- (ECACC=97022605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35528; Wolf-Hirschhorn syndrome
DI   ORDO; Orphanet_280; Wolf-Hirschhorn syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BV0968
AC   CVCL_8T94
DR   ECACC; 98060904
DR   Wikidata; Q54798671
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98060904; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   BV1
AC   CVCL_B6F9
DR   Wikidata; Q111733024
RX   PubMed=10762059;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059).
CC   Doubling time: 33.4 hours (Note=At 15th passage), 17.8 hours (Note=At 50th passage) (PubMed=10762059).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Brown Norway; RS=RS_0000113.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   BV2-EGFP
AC   CVCL_XD67
DR   Wikidata; Q93433296
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000628). It was the sole source of information for this entry.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   BV2-Luc
AC   CVCL_C8UX
DR   Ubigene; YC-C035-Luc-P
DR   Wikidata; Q123030828
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   BV2-mCherry
AC   CVCL_WJ28
DR   CCRID; 1101MOU-PUMC000627
DR   Wikidata; Q93433297
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 8
//
ID   BV2-tDT
AC   CVCL_XD66
DR   CCRID; 1101MOU-PUMC000626
DR   Wikidata; Q93433299
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 9
//
ID   BV9
AC   CVCL_JE78
DR   Wikidata; Q54798673
RX   PubMed=498142;
RX   PubMed=510855;
RX   PubMed=12148591;
CC   Doubling time: ~28 hours (PubMed=498142; PubMed=510855).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C63868; Adenocarcinoma of the rat glandular stomach
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   BVD2-21C11.3
AC   CVCL_9166
SY   BVD2-21C11
DR   CLO; CLO_0002054
DR   ATCC; HB-9569
DR   Wikidata; Q54798674
RX   Patent=US5070013;
RX   PubMed=1387110;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9569.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 10
//
ID   BVD2-23B6.4
AC   CVCL_9167
SY   BVD2-23B6
DR   CLO; CLO_0002055
DR   ATCC; HB-9568
DR   Wikidata; Q54798675
RX   Patent=US5070013;
RX   PubMed=1387110;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9568.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 10
//
ID   BVD2-5A2.4
AC   CVCL_DQ78
DR   ATCC; HB-9567
DR   Wikidata; Q54798677
RX   Patent=US5070013;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9567.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   BVD4-1D11.2
AC   CVCL_D1F7
SY   BVD4.1D11.2; BVD4.1D11; 1D11.2
DR   Wikidata; Q123030831
RX   PubMed=1387110;
RX   PubMed=8393043;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07750; Mouse Il4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   BVD6-24G2.3
AC   CVCL_D1F8
SY   BVD6.24G2.3; BVD6.24G2; 24G2.3
DR   Wikidata; Q123030832
RX   PubMed=1387110;
RX   PubMed=8393043;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07750; Mouse Il4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   BVK-Tll
AC   CVCL_LJ60
SY   BVK Tll
DR   Wikidata; Q54798679
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9871.
CC   Characteristics: Tumorigenic derivative of BEAS-2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   BVK168
AC   CVCL_A014
SY   Bank Vole Kidney No. 168
DR   CCLV; CCLV-RIE 1313
DR   Wikidata; Q54798681
RX   PubMed=21729307;
RX   PubMed=31513859;
CC   Virology: Susceptible to infection by many bornaviruses, bunyaviruses, flaviviruses, poxviruses and togaviruses (PubMed=21729307).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Western lineage.
OX   NCBI_TaxID=447135; ! Myodes glareolus (Bank vole)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 10
//
ID   BVR
AC   CVCL_1M70
SY   GM06828; GM06828A
DR   CLO; CLO_0036522
DR   Coriell; GM06828
DR   Wikidata; Q54798683
RX   CelloPub=CLPUB00447;
RX   PubMed=6417008;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 11
//
ID   BW
AC   CVCL_E4AK
RX   PubMed=52568;
RX   PubMed=3431441;
CC   Characteristics: Established from a transplantable mouse hepatoma BW7756.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S550 ! Hepa-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   BW 250/183
AC   CVCL_IQ67
DR   ABCD; ABCD_AH416
DR   Wikidata; Q54798684
RX   Patent=US6294172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2412.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma is known as Besilesomab (Scintimun) and used to detect inflammatory lesions and metastases.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31997; Human CEACAM8/CD66b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 7
//
ID   BW 431/26
AC   CVCL_IQ68
DR   Wikidata; Q54798685
RX   Patent=US6294172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2414.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   BW 494/32
AC   CVCL_IQ69
DR   Wikidata; Q54798688
RX   Patent=US6294172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2410.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   BW 495/36
AC   CVCL_IQ70
DR   Wikidata; Q54798689
RX   Patent=US6294172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2415.
CC   Monoclonal antibody isotype: IgG3, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   BW-1
AC   CVCL_QW60
DR   Wikidata; Q54798691
RX   PubMed=8704258;
RX   PubMed=8847894;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 34.2 hours (PubMed=8847894).
CC   Caution: Indicated as originating from a 68 year old male patient in text of PubMed=8847894 and from a 52 year old in table 1 of same paper.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   BW-1100.129
AC   CVCL_RW61
SY   BWalpha-; alpha(-) BW5147
DR   Wikidata; Q54798693
RX   PubMed=2778316;
RX   PubMed=3500416;
RX   PubMed=32419056;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Does not express functional TCR alpha chain.
CC   Doubling time: ~12 hours (PubMed=2778316).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4137 ! BW5147.G.1.4.OUAR.1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   BW-1100.129.237
AC   CVCL_RW62
SY   BWalpha-beta-; alpha(-)beta(-) BW5147; TCRalpha-beta- BW5147
DR   Wikidata; Q54798694
RX   PubMed=2778316;
RX   PubMed=32419056;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Does not express functional TCR alpha and beta chains.
CC   Doubling time: ~18 hours (PubMed=2778316).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW61 ! BW-1100.129
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   BW-J-M
AC   CVCL_C5SL
DR   Wikidata; Q116048617
RX   PubMed=6337232;
RX   PubMed=7341770;
CC   Virology: Venezuelan equine encephalomyelitis virus isolate TC-63 can bind to this cell line (PubMed=6337232).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: NZB x NZW.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BW-L-M
AC   CVCL_C5SM
DR   Wikidata; Q116048618
RX   PubMed=7341770;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: NZB x NZW.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   BW01k-p
AC   CVCL_F1GE
WW   Provider; ARI-TOX MWCB; BW01k-p; https://aritox.com/mwcb/mwcb-bw01k-p/
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=48708; ! Mesoplodon densirostris (Blainville's beaked whale)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   BW1
AC   CVCL_X356
SY   BW 1
DR   Wikidata; Q54798696
RX   PubMed=52568;
RX   PubMed=3431441;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4AK ! BW
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   BW125.1C
AC   CVCL_XG61
DR   Wikidata; Q93433387
RX   PubMed=1382975;
RX   PubMed=8157674;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1674; CD3E (Note=With p.Met1_Ser152del; IL2RA-CD3E chimeric receptor).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6008; IL2RA (Note=With p.Thr260_Ile272del; IL2RA-CD3E chimeric receptor).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:99919; Vcp (Note=With a C-terminal human MYC epitope).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   BW1J
AC   CVCL_3865
SY   BW1-J
DR   CLO; CLO_0002056
DR   CLDB; cl511
DR   ECACC; 94101901
DR   Wikidata; Q54798697
RX   PubMed=545721;
RX   PubMed=6932027;
CC   Doubling time: 24 hours (PubMed=6932027).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X356 ! BW1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   BW2
AC   CVCL_X357
SY   BW 2
DR   Wikidata; Q54798698
RX   PubMed=52568;
RX   PubMed=3431441;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4AK ! BW
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   BW288
AC   CVCL_Y431
DR   Wikidata; Q54798721
RX   Patent=US20070027175;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 6
//
ID   BW5147
AC   CVCL_3896
SY   BW-5147; BW 5147
DR   BTO; BTO_0000791
DR   CLO; CLO_0002057
DR   CLDB; cl512
DR   Lonza; 326
DR   NCBI_Iran; C542
DR   TKG; TKG 0729
DR   Wikidata; Q54798723
RX   PubMed=2530588;
RX   PubMed=6970130;
RX   PubMed=32419056;
CC   Group: Hybridoma fusion partner cell line.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   BW5147(T200-a)5.1
AC   CVCL_B391
SY   BW5147 (T200-a)5.1; BW/T200-; BWT200-; BW T200-; BW(T200-); BW/CD45-
DR   BTO; BTO_0002223
DR   Wikidata; Q54798734
RX   PubMed=2530588;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4137 ! BW5147.G.1.4.OUAR.1
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   BW5147(T200-a)5.2
AC   CVCL_6313
DR   CLO; CLO_0002058
DR   ATCC; TIB-233
DR   Wikidata; Q54798736
RX   PubMed=7194313;
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4137 ! BW5147.G.1.4.OUAR.1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   BW5147-AZG(R),OU(R)
AC   CVCL_U120
SY   BW 5147-AZG(R),OU(R)
DR   Wikidata; Q54798728
RX   PubMed=6159416;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   BW5147.3
AC   CVCL_4135
SY   BW-5147.3
DR   BTO; BTO_0001935
DR   CLO; CLO_0002059
DR   ATCC; TIB-47
DR   Wikidata; Q54798725
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   BW5147.3(Thy-1-e).10
AC   CVCL_6314
SY   BW5147.3 (Thy-1-e).10
DR   CLO; CLO_0002060
DR   ATCC; TIB-234
DR   Wikidata; Q54798727
RX   PubMed=667934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4135 ! BW5147.3
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   BW5147.G.1.4
AC   CVCL_6315
DR   CLO; CLO_0002061
DR   ATCC; TIB-48
DR   Wikidata; Q54798731
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4135 ! BW5147.3
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   BW5147.G.1.4.OUAR.1
AC   CVCL_4137
AS   CVCL_4136
SY   BW5147.G.1.4.OUA-R.1; BW5147.G.1.4.OUA/R.1
DR   CLO; CLO_0002062
DR   CLO; CLO_0002063
DR   CLDB; cl513
DR   CLDB; cl514
DR   ATCC; CRL-1588
DR   BCRC; 60173
DR   ECACC; 85082302
DR   ECACC; 88100507
DR   JCRB; JCRB9002
DR   Wikidata; Q54798732
RX   PubMed=2365383;
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: ~23 hours (Note=Lot 06212000) (JCRB=JCRB9002).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6315 ! BW5147.G.1.4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   BW5147.PHAR2.1
AC   CVCL_A5JZ
SY   BW5147-PHAR2.1; PHAR2.1; PhaR2.1
DR   Wikidata; Q107113526
RX   PubMed=710496;
RX   PubMed=6216250;
CC   Characteristics: Deficient in alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase (Mgat5) (PubMed=6216250).
CC   Selected for resistance to: UniProtKB; P05087; Phaseolus vulgaris leucoagglutinating phytohemagglutinin (PHA-L).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   BW5147.PHAR2.7
AC   CVCL_VT60
SY   BW5147.PHAR 2.7; PHAR 2.7; PHAR2.7; PhaR 2.7; PHAr 2.7
DR   Wikidata; Q93433460
RX   PubMed=710496;
RX   PubMed=7050108;
RX   PubMed=11159920;
CC   Characteristics: Deficient in glucosidase II.
CC   Selected for resistance to: UniProtKB; P05087; Phaseolus vulgaris leucoagglutinating phytohemagglutinin (PHA-L).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   BW5147RicR.3
AC   CVCL_HA78
SY   BW5147 RicR.3
DR   Wikidata; Q54798737
RX   PubMed=567654;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6315 ! BW5147.G.1.4
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   BW6F2
AC   CVCL_C3P0
DR   Wikidata; Q116048619
RX   PubMed=12606403;
CC   Senescence: Senesces at 113 PDL (PubMed=12606403).
CC   Doubling time: 17-24 hours (PubMed=12606403).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   35FD
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   BW6F2 hTERT clone 1-1
AC   CVCL_C3P1
DR   Wikidata; Q116048620
RX   PubMed=12606403;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_C3P0 ! BW6F2
SX   Male
AG   35FD
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BW6F2 hTERT clone 2-1
AC   CVCL_C3P2
DR   Wikidata; Q116048621
RX   PubMed=12606403;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_C3P0 ! BW6F2
SX   Male
AG   35FD
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BW6F2 hTERT clone 2-12
AC   CVCL_C3P6
DR   Wikidata; Q116048622
RX   PubMed=12606403;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_C3P0 ! BW6F2
SX   Male
AG   35FD
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BW6F2 hTERT clone 2-13
AC   CVCL_C3P7
DR   Wikidata; Q116048623
RX   PubMed=12606403;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_C3P0 ! BW6F2
SX   Male
AG   35FD
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BW6F2 hTERT clone 2-5
AC   CVCL_C3P3
DR   Wikidata; Q116048624
RX   PubMed=12606403;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_C3P0 ! BW6F2
SX   Male
AG   35FD
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BW6F2 hTERT clone 2-7
AC   CVCL_C3P4
DR   Wikidata; Q116048625
RX   PubMed=12606403;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_C3P0 ! BW6F2
SX   Male
AG   35FD
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BW6F2 hTERT clone 2-8
AC   CVCL_C3P5
DR   Wikidata; Q116048626
RX   PubMed=12606403;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Black Welsh Mountain; VBO=VBO_0001335.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_C3P0 ! BW6F2
SX   Male
AG   35FD
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   BWHGLi001
AC   CVCL_VN59
SY   NMR-EF-iPSCs
DR   Wikidata; Q93433465
RX   PubMed=29107591;
RX   PubMed=30107334;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Sex unspecified
AG   45FD
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   BWK
AC   CVCL_6F67
SY   Beluga Whale Kidney
DR   Wikidata; Q54798738
RX   DOI=10.1139/f89-188;
CC   Group: Cetacean cell line.
CC   Senescence: Senesces at 20 PDL (DOI=10.1139/f89-188).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9749; ! Delphinapterus leucas (Beluga whale)
SX   Male
AG   Juvenile
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 7
//
ID   BWTG3
AC   CVCL_F747
SY   BW TG3
DR   CLO; CLO_0002064
DR   CLDB; cl515
DR   Wikidata; Q54798740
RX   PubMed=52568;
RX   PubMed=1860901;
RX   PubMed=3431441;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4AK ! BW
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   BWZ.36
AC   CVCL_RW63
DR   BTO; BTO_0006294
DR   Wikidata; Q54798741
RX   PubMed=8186188;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Transfected with the NFAT-lacZ construct containing the lacZ reporter gene under control of the NFAT response element.
CC   Characteristics: Does not express functional TCR alpha and beta chains (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW62 ! BW-1100.129.237
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   BWZ.36/CD8alpha
AC   CVCL_RW75
SY   BWZ.36 CD8 alpha; BWZ.36.CD8 alpha
DR   BTO; BTO_0006295
DR   Wikidata; Q54798743
RX   PubMed=8186188;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Transfected with the NFAT-lacZ construct containing the lacZ reporter gene under control of the NFAT response element.
CC   Characteristics: Does not express functional TCR alpha and beta chains (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88346; Cd8a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW63 ! BWZ.36
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   Bx-GEM100
AC   CVCL_E4NG
RX   PubMed=26828016;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NF ! Bx-GEM50
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Bx-GEM200
AC   CVCL_E4NH
SY   BxPc-3-GEM
RX   PubMed=26828016;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NG ! Bx-GEM100
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Bx-GEM50
AC   CVCL_E4NF
RX   PubMed=26828016;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BX0006
AC   CVCL_8T95
DR   ECACC; 98111901
DR   Wikidata; Q54798745
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98111901; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   BXD-1425EPN
AC   CVCL_Y105
SY   BXD1425EPN; Baylor Xenograft Derived-1425EPN
DR   Wikidata; Q54798747
RX   PubMed=20511191;
CC   Characteristics: Established from a second generation patient-derived xenograft established in the brain of RAG2/SCID mice.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 8
//
ID   BXM14
AC   CVCL_B987
DR   RCB; AES0132
DR   RCB; RCB2706
DR   SKIP; SKIP001675
DR   Wikidata; Q54798748
RX   PubMed=17290420;
CC   Discontinued: RCB; RCB2706; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x MSM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   BXM15
AC   CVCL_B988
DR   RCB; AES0133
DR   RCB; RCB2707
DR   SKIP; SKIP003037
DR   Wikidata; Q54798750
RX   PubMed=17290420;
CC   Discontinued: RCB; RCB2707; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x MSM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   BXM3
AC   CVCL_0J07
DR   RCB; AES0130
DR   RCB; RCB2704
DR   SKIP; SKIP001673
DR   Wikidata; Q54798752
RX   PubMed=17290420;
CC   Discontinued: RCB; RCB2704; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x MSM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   BXM7
AC   CVCL_B989
DR   RCB; AES0131
DR   RCB; RCB2705
DR   SKIP; SKIP001674
DR   Wikidata; Q54798753
RX   PubMed=17290420;
CC   Discontinued: RCB; RCB2705; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x MSM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   BXP-21
AC   CVCL_LB69
DR   Wikidata; Q54798754
RX   PubMed=11309308;
RX   PubMed=12116365;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UNQ0; Human ABCG2/CD338.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   BXP-34
AC   CVCL_LB70
DR   Wikidata; Q54798756
RX   PubMed=10825126;
RX   PubMed=11309308;
RX   PubMed=12116365;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UNQ0; Human ABCG2/CD338.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   BxPC-3
AC   CVCL_0186
SY   BxPc-3; BXPC-3; Bx-PC3; BXPC3; BxPC3; BxPc3; Biopsy xenograft of Pancreatic Carcinoma line-3
DR   BTO; BTO_0001861
DR   CLO; CLO_0002065
DR   EFO; EFO_0002709
DR   MCCL; MCC:0000077
DR   CLDB; cl516
DR   CLDB; cl517
DR   CLDB; cl518
DR   AddexBio; C0018003/27
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1687
DR   BCRC; 60283
DR   BCRJ; 0056
DR   BioGRID_ORCS_Cell_line; 162
DR   BioSample; SAMN03470942
DR   BioSample; SAMN10987955
DR   cancercelllines; CVCL_0186
DR   CCRID; 1101HUM-PUMC000274
DR   CCRID; 3101HUMTCHu012
DR   Cell_Model_Passport; SIDM00132
DR   CGH-DB; 161-1
DR   CGH-DB; 9272-4
DR   ChEMBL-Cells; CHEMBL3307637
DR   ChEMBL-Targets; CHEMBL614530
DR   CLS; 305031
DR   Cosmic; 707248
DR   Cosmic; 730531
DR   Cosmic; 736269
DR   Cosmic; 755301
DR   Cosmic; 808164
DR   Cosmic; 872995
DR   Cosmic; 906693
DR   Cosmic; 913310
DR   Cosmic; 918055
DR   Cosmic; 922251
DR   Cosmic; 923165
DR   Cosmic; 932515
DR   Cosmic; 933516
DR   Cosmic; 947403
DR   Cosmic; 948372
DR   Cosmic; 949321
DR   Cosmic; 968108
DR   Cosmic; 1006369
DR   Cosmic; 1198209
DR   Cosmic; 1299295
DR   Cosmic; 1366281
DR   Cosmic; 1477430
DR   Cosmic; 1518232
DR   Cosmic; 1534316
DR   Cosmic; 1571773
DR   Cosmic; 1644317
DR   Cosmic; 1768263
DR   Cosmic; 1945873
DR   Cosmic; 2434095
DR   Cosmic; 2820476
DR   Cosmic-CLP; 906693
DR   DepMap; ACH-000535
DR   DSMZ; ACC-760
DR   DSMZCellDive; ACC-760
DR   ECACC; 93120816
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906693
DR   GEO; GSM206447
DR   GEO; GSM621894
DR   GEO; GSM784699
DR   GEO; GSM886896
DR   GEO; GSM887961
DR   GEO; GSM1024397
DR   GEO; GSM1374415
DR   GEO; GSM1374416
DR   GEO; GSM1374417
DR   GEO; GSM1588608
DR   GEO; GSM1588620
DR   GEO; GSM1669634
DR   GEO; GSM1906991
DR   GEO; GSM1906992
DR   GEO; GSM1906993
DR   IARC_TP53; 312
DR   ICLC; HTL96011
DR   IZSLER; BS TCL 4
DR   KCB; KCB 200428YJ
DR   LiGeA; CCLE_491
DR   LINCS_LDP; LCL-1731
DR   Lonza; 1013
DR   PharmacoDB; BxPC3_149_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   PRIDE; PXD032263
DR   Progenetix; CVCL_0186
DR   PubChem_Cell_line; CVCL_0186
DR   SKY/M-FISH/CGH; 1995
DR   TOKU-E; 707
DR   Ubigene; YC-C015
DR   Wikidata; Q54798758
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=1630814;
RX   PubMed=1764370;
RX   PubMed=3754176;
RX   PubMed=7961102;
RX   PubMed=8026879;
RX   PubMed=8194712;
RX   PubMed=8286197;
RX   PubMed=8426738;
RX   PubMed=9788440;
RX   PubMed=10027410;
RX   PubMed=10408907;
RX   PubMed=11115575;
RX   PubMed=11169959;
RX   PubMed=12692724;
RX   PubMed=15126341;
RX   PubMed=15367885;
RX   PubMed=15688027;
RX   PubMed=16912165;
RX   PubMed=18298655;
RX   PubMed=18380791;
RX   PubMed=20037478;
RX   PubMed=20164919;
RX   PubMed=20418756;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27073551;
RX   PubMed=27229158;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=27910856;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32782605;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/BxPC-3.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=63
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/BxPC-3
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/pancreatic-xenograft-models/bxpc-3-xenograft-model/
WW   Provider; BRICS; BRICS0125; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3928
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (PubMed=3754176); 48 hours (PubMed=25984343); ~48 hours (DSMZ=ACC-760).
CC   HLA typing: A*01:01,01:01; B*37:01,37:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11169959).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=9788440; PubMed=10408907; PubMed=15367885; PubMed=18380791).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (Cosmic-CLP=906693; DepMap=ACH-000535).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (PubMed=8026879; PubMed=11115575; PubMed=15367885).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=1630814; PubMed=7961102; PubMed=8026879; PubMed=8194712; PubMed=8426738; PubMed=11115575; PubMed=15367885; PubMed=21607521; Cosmic-CLP=906693; DepMap=ACH-000535).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.55%; Native American=0%; East Asian, North=1.41%; East Asian, South=0%; South Asian=0%; European, North=69.25%; European, South=27.79% (PubMed=30894373).
CC   Caution: Additional TP53 mutation in c.793C>T indicated incorrectly in PubMed=1630814.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): AddexBio=C0018003/27; ATCC=CRL-1687; CCRID; Cosmic-CLP=906693; DSMZ=ACC-760; ECACC=93120816; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D12S391: 20
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 13 (DSMZ=ACC-760)
ST   D19S433: 13,16.2 (ATCC=CRL-1687; CCRID)
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D2S441: 12,14
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 14
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   BxPC-3 human CCR5
AC   CVCL_E8JC
SY   BXPC3-CCR5
DR   KYinno; KC-1712
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-1712).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BxPC-3 human CLDN18.2
AC   CVCL_XZ31
SY   BxPC3-CLDN18.2
DR   cancercelllines; CVCL_XZ31
DR   KYinno; KC-1272
DR   Wikidata; Q93433500
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-1272).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   BxPC-3 human GPRC5D
AC   CVCL_E8JD
SY   BxPC3-GPRC5D
DR   KYinno; KC-1717
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13310; GPRC5D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BxPC-3 human GPRC5D-HA
AC   CVCL_E8JB
SY   BxPC3-GPRC5D-HA
DR   KYinno; KC-1608
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13310; GPRC5D (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BxPC-3 human SLC39A6
AC   CVCL_E8JE
SY   BxPC3-SLC39A6
DR   KYinno; KC-2108
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-2108).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18607; SLC39A6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   BxPC-3 SMAD2 KO
AC   CVCL_E2X4
SY   S2-KO BxPC-3
RX   PubMed=36207615;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BxPC-3 SMAD2/SMAD3 DKO
AC   CVCL_E2X5
SY   S2/3-KO BxPC-3
RX   PubMed=36207615;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BxPC-3 SMAD3 KO
AC   CVCL_E2X6
SY   S3-KO BxPC-3
RX   PubMed=36207615;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   BxPC-3 XL-1
AC   CVCL_E4N8
SY   XL-1
RX   PubMed=23661005;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72317; Carbozantinib (Cometriq).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BxPC-3 XL-2
AC   CVCL_E4N9
SY   XL-2
RX   PubMed=23661005;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72317; Carbozantinib (Cometriq).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4N8 ! BxPC-3 XL-1
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BxPC-3 XL-3
AC   CVCL_E4NA
SY   XL-3
RX   PubMed=23661005;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72317; Carbozantinib (Cometriq).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4N9 ! BxPC-3 XL-2
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BxPC-3 XL-4
AC   CVCL_E4NB
SY   XL-4
RX   PubMed=23661005;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72317; Carbozantinib (Cometriq).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NA ! BxPC-3 XL-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BxPC-3 XL-5
AC   CVCL_E4NC
SY   XL-5
RX   PubMed=23661005;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72317; Carbozantinib (Cometriq).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NB ! BxPC-3 XL-4
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BxPC-3 XL-6
AC   CVCL_E4ND
SY   XL-6
RX   PubMed=23661005;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72317; Carbozantinib (Cometriq).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NC ! BxPC-3 XL-5
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BxPC-3 XL-7
AC   CVCL_E4NE
SY   XL-7
RX   PubMed=23661005;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72317; Carbozantinib (Cometriq).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4ND ! BxPC-3 XL-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   BxPC-3-EGFP
AC   CVCL_C8WD
DR   Ubigene; YC-C015-EGFP-P
DR   Wikidata; Q123030833
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   BxPC-3-Luc
AC   CVCL_C8WE
DR   Ubigene; YC-C015-Luc-P
DR   Wikidata; Q123030834
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   BxPC-3-Luc#2
AC   CVCL_J246
DR   cancercelllines; CVCL_J246
DR   JCRB; JCRB1448
DR   JCRB; NIHS0702
DR   Wikidata; Q54798760
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0702; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1448
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   BxPc-3-luc2
AC   CVCL_5J14
SY   BxPc3-luc2
DR   cancercelllines; CVCL_5J14
DR   Revvity/PerkinElmer; 125058
DR   Wikidata; Q54798762
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 125058; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   BxPC3-R
AC   CVCL_XX78
DR   cancercelllines; CVCL_XX78
DR   GEO; GSM1906994
DR   GEO; GSM1906995
DR   GEO; GSM1906996
DR   Wikidata; Q93433506
RX   PubMed=27229158;
RX   PubMed=27910856;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   BxPC3-Red-FLuc
AC   CVCL_5I88
SY   Bioware Brite BxPC3-Red-FLuc; IVISbrite BxPC3 Red F-luc
DR   cancercelllines; CVCL_5I88
DR   Revvity/PerkinElmer; BW125058
DR   Wikidata; Q54798763
CC   Population: Caucasian.
CC   Doubling time: 36 hours (Revvity/PerkinElmer=BW125058).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   BXPC-3/Cas9-hyg
AC   CVCL_C9DP
DR   GeneCopoeia; SL521
DR   Wikidata; Q123030835
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL521).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   BY-2
AC   CVCL_D5GM
SY   BY2; TBY-2; TBY2; Tobacco BY-2; NT-1; NT1; Nicotiana tabacum-1
DR   BTO; BTO_0001972
DR   EFO; EFO_0022754
DR   DSMZ; PC-1181
DR   GEO; GSE6948
DR   GEO; GSE6949
DR   GEO; GSE14250
DR   GEO; GSE37649
DR   GEO; GSE42562
DR   GEO; GSE111980
DR   GEO; GSE160438
DR   GEO; GSE193131
DR   RIKEN_BRC_EPD; rpc00001
DR   Wikidata; Q7811455
RX   CelloPub=CLPUB00765;
RX   DOI=10.1007/3-540-32674-X_8;
RX   DOI=10.1016/S0074-7696(08)62452-3;
RX   DOI=10.4067/S0718-07642010000200002;
RX   PubMed=7766897;
RX   PubMed=10728644;
RX   PubMed=12601177;
RX   PubMed=14680934;
RX   PubMed=14688094;
RX   PubMed=15638240;
RX   PubMed=15818563;
RX   PubMed=16187337;
RX   PubMed=16664453;
RX   PubMed=17406390;
RX   PubMed=17406517;
RX   PubMed=17947977;
RX   PubMed=18567891;
RX   PubMed=22055919;
RX   PubMed=22928883;
RX   PubMed=29982119;
RX   PubMed=37642778;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Tobacco_BY-2_cells
CC   Group: Plant cell line.
CC   Characteristics: Can be used to prepare protoplasts (PubMed=17947977).
CC   Characteristics: Produces low levels of nicotine (PubMed=18567891).
CC   Characteristics: Tested for the production of animal proteins (PubMed=7766897).
CC   Characteristics: Tested for the production of bacterial proteins (PubMed=14688094; PubMed=22928883).
CC   Characteristics: Tested for the production of synthetic proteins (PubMed=15818563).
CC   Characteristics: Tested for the production of viral proteins (PubMed=14680934; PubMed=12601177; PubMed=16187337).
CC   Characteristics: Used as model for the electrochemical sensing of beta-glucuronidase activity of transgenic cell lines (PubMed=29982119).
CC   Doubling time: 15.8 hours (DOI=10.1016/S0074-7696(08)62452-3).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Anecdotal: This cell line was generated at the Japan Tobacco and Salt Monopoly Public Corporation. In 1982 Toshiyuki Nagata brought it with him to the USA and left it there after renaming it to NT-1 in order to distribute it clandestinely because he was not allowed officially to give the BY-2 cell line to others. He called it NT-1 as it could both mean Nicotiana tabacum or Nagata, Toshiyuki (PubMed=37642778).
CC   Discontinued: DSMZ; PC-1181; true.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Bright Yellow 2.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 5
//
ID   BY-GF11
AC   CVCL_D5GN
SY   GF11
DR   RIKEN_BRC_EPD; rpc00040
DR   Wikidata; Q127380358
RX   PubMed=16262709;
RX   PubMed=16672254;
RX   PubMed=18637163;
CC   Group: Plant cell line.
CC   Characteristics: Used to study actin filament-based processes (PubMed=16262709; PubMed=16672254; PubMed=18637163).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q7G188; Arabidopsis thaliana FIM1 (Note=With p.Met1_Lys34del).
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Bright Yellow 2.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GM ! BY-2
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   BY-GV7
AC   CVCL_D5GP
SY   GV7; BY-2 cell line 7
DR   RIKEN_BRC_EPD; rpc00039
DR   Wikidata; Q127380359
RX   PubMed=14581629;
RX   PubMed=16315234;
CC   Group: Plant cell line.
CC   Characteristics: Used to visualize vacuolar membranes thanks to the integration of the fusion construct GFP-AtSYP22/VAM3 (PubMed=14581629; PubMed=16315234).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P93654; Arabidopsis thaliana SYP22.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Bright Yellow 2.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GM ! BY-2
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   BY00018
AC   CVCL_H119
DR   IPD-IMGT/HLA; 12664
DR   Wikidata; Q54798764
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02; B*40:40,27:04; DRB1*12:KN,14:DJJ; DRB3*01:MS,02:CAY (IPD-IMGT/HLA=12664).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY0002
AC   CVCL_8T96
DR   ECACC; 98040808
DR   Wikidata; Q54798766
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Karyotypic information: 46,Y,t(x;4)(q24;q21.3) (ECACC=98040808).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   BY00022
AC   CVCL_H120
DR   IPD-IMGT/HLA; 12689
DR   Wikidata; Q54798767
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11; B*27:04,40:40 (IPD-IMGT/HLA=12689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00023
AC   CVCL_H121
DR   IPD-IMGT/HLA; 12687
DR   Wikidata; Q54798769
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,33; B*40:02,53:09 (IPD-IMGT/HLA=12687).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00025
AC   CVCL_H122
DR   IPD-IMGT/HLA; 12688
DR   Wikidata; Q54798771
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,03; B*27:05:02/27:05:04/27:13,40:40 (IPD-IMGT/HLA=12688).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00027
AC   CVCL_H123
DR   IPD-IMGT/HLA; 12690
DR   Wikidata; Q54798772
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30,23; B*15:16,42:04 (IPD-IMGT/HLA=12690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00028
AC   CVCL_H124
DR   IPD-IMGT/HLA; 12694
DR   Wikidata; Q54798773
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24,26; B*55:10,40:02 (IPD-IMGT/HLA=12694).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00029
AC   CVCL_H125
DR   IPD-IMGT/HLA; 12728
DR   Wikidata; Q54798774
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30,03; B*57:03,07:29; DRB1*15:DEW,13:BMD; DRB3*02:CAN; DRB5*01:BMK (IPD-IMGT/HLA=12728).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00040
AC   CVCL_H126
DR   IPD-IMGT/HLA; 12971
DR   Wikidata; Q54798775
RX   PubMed=12956882;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,30:02; B*40:43,27:05:02/27:05:04/27:13 (IPD-IMGT/HLA=12971).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00053
AC   CVCL_H127
DR   IPD-IMGT/HLA; 13314
DR   Wikidata; Q54798776
RX   PubMed=18069934;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:10,02:01; B*07:05,13:02; C*06:02,15:05; DRB1*07:01:01 (IPD-IMGT/HLA=13314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00083
AC   CVCL_H106
DR   IPD-IMGT/HLA; 14350
DR   Wikidata; Q54798778
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*48:16,46:01 (IPD-IMGT/HLA=14350).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00086
AC   CVCL_H107
DR   IPD-IMGT/HLA; 14342
DR   Wikidata; Q54798779
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*58:12,48:01 (IPD-IMGT/HLA=14342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00087
AC   CVCL_H108
DR   IPD-IMGT/HLA; 14349
DR   Wikidata; Q54798781
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*13:16,40:02:01 (IPD-IMGT/HLA=14349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00088
AC   CVCL_H109
DR   IPD-IMGT/HLA; 14351
DR   Wikidata; Q54798783
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*13:02:01,55:21 (IPD-IMGT/HLA=14351).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00089
AC   CVCL_H110
DR   IPD-IMGT/HLA; 14346
DR   Wikidata; Q54798808
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*27:36,57:01:01 (IPD-IMGT/HLA=14346).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00091
AC   CVCL_H111
DR   IPD-IMGT/HLA; 14345
DR   Wikidata; Q54798809
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*27:36,51:01:01 (IPD-IMGT/HLA=14345).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00092
AC   CVCL_H112
DR   IPD-IMGT/HLA; 14343
DR   Wikidata; Q54798810
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*58:12,51:01:01 (IPD-IMGT/HLA=14343).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00094
AC   CVCL_H113
DR   IPD-IMGT/HLA; 14369
DR   Wikidata; Q54798812
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:05,02:99 (IPD-IMGT/HLA=14369).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00096
AC   CVCL_H114
DR   IPD-IMGT/HLA; 14366
DR   Wikidata; Q54798814
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CRY,03:23:01 (IPD-IMGT/HLA=14366).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00099
AC   CVCL_H115
DR   IPD-IMGT/HLA; 14370
DR   Wikidata; Q54798816
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:27 (IPD-IMGT/HLA=14370).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00101
AC   CVCL_H116
DR   IPD-IMGT/HLA; 14375
DR   Wikidata; Q54798817
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*09:01:02,04:58 (IPD-IMGT/HLA=14375).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00102
AC   CVCL_H117
DR   IPD-IMGT/HLA; 14376
DR   Wikidata; Q54798818
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*15:01:01,13:72 (IPD-IMGT/HLA=14376).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00103
AC   CVCL_H128
DR   IPD-IMGT/HLA; 14374
DR   Wikidata; Q54798820
RX   PubMed=18069934;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:BZBD,11:15:02; B*35:BJGU,44:RDU; C*02:AFB,04:APNR; DRB1*01:EW,11:03 (IPD-IMGT/HLA=14374).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00116
AC   CVCL_V367
DR   IPD-IMGT/HLA; 14472
DR   Wikidata; Q54798821
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:DDKG,33:08; C*04:01:01:01,07:01 (IPD-IMGT/HLA=14472).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   BY00117
AC   CVCL_V368
DR   IPD-IMGT/HLA; 14474
DR   Wikidata; Q54798822
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01:01,24:59 (IPD-IMGT/HLA=14474).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   BY00118
AC   CVCL_H118
DR   IPD-IMGT/HLA; 14475
DR   Wikidata; Q54798824
RX   PubMed=16948657;
RX   PubMed=18384485;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*15:01:01,14:62 (IPD-IMGT/HLA=14475).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00119
AC   CVCL_V369
DR   IPD-IMGT/HLA; 14476
DR   Wikidata; Q54798826
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*12:02,03:27 (IPD-IMGT/HLA=14476).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   BY00120
AC   CVCL_V370
DR   IPD-IMGT/HLA; 14477
DR   Wikidata; Q54798827
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:01:02,24:66; C*04:01:01:01/04:01:01:02/04:09N,07:02 (IPD-IMGT/HLA=14477).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   BY00121
AC   CVCL_V371
DR   IPD-IMGT/HLA; 14473
DR   Wikidata; Q54798829
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,03:ANPZ; B*08:AKUY,51:AFJY; C*01:02:01/01:02:02,07:01:07; DRB1*03:WHX,11:ARAP (IPD-IMGT/HLA=14473).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   BY00128
AC   CVCL_H129
DR   IPD-IMGT/HLA; 14511
DR   Wikidata; Q54798830
RX   PubMed=18069934;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:BUVE,32:13; B*14:02,40:JMM; C*03:GFW,08:BE (IPD-IMGT/HLA=14511).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00151
AC   CVCL_G793
DR   IPD-IMGT/HLA; 14833
DR   Wikidata; Q54798831
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,01:23; B*27:EKN,35:BEZX; DRB1*04:04,12:CVT (IPD-IMGT/HLA=14833).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00152
AC   CVCL_G794
DR   IPD-IMGT/HLA; 14834
DR   Wikidata; Q54798832
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:03:01,23:15; B*37:01,07:NTH; DRB1*15:03,13:02 (IPD-IMGT/HLA=14834).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00153
AC   CVCL_G795
DR   IPD-IMGT/HLA; 14836
DR   Wikidata; Q54798833
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:02:01:01,03:29; B*15:BYXW,35:BZBW; DRB1*03:BYBY,11:BBJ (IPD-IMGT/HLA=14836).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00154
AC   CVCL_G796
SY   HN-4805229
DR   IPD-IMGT/HLA; 14837
DR   Wikidata; Q54798834
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:24,24:02:01:01; B*51:BVND,57:AC; DRB1*01:01,04:11 (IPD-IMGT/HLA=14837).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00156
AC   CVCL_G797
DR   IPD-IMGT/HLA; 14839
DR   Wikidata; Q54798835
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01:01:01,24:72; B*07:ASKU,58:01; DRB1*15:AK,16:01 (IPD-IMGT/HLA=14839).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00157
AC   CVCL_G798
DR   IPD-IMGT/HLA; 14832
DR   Wikidata; Q54798836
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:05,01:23; B*44:AXGG,58:01; DRB1*13:02,15:03 (IPD-IMGT/HLA=14832).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00158
AC   CVCL_G799
SY   HN-6373184
DR   IPD-IMGT/HLA; 14840
DR   Wikidata; Q54798838
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01:01:01,02:114; B*27:EKN,38:01; DRB1*03:01:01,11:03 (IPD-IMGT/HLA=14840).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00159
AC   CVCL_G800
SY   HG00000864
DR   IPD-IMGT/HLA; 14841
DR   Wikidata; Q54798839
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:25,02:HHJS; B*27:EKN,57:01:01; DRB1*01:01:01,07:01:01 (IPD-IMGT/HLA=14841).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00160
AC   CVCL_G801
DR   IPD-IMGT/HLA; 14843
DR   Wikidata; Q54798840
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:02:01,02:115; B*35:WAZ,58:01; DRB1*08:04,15:03 (IPD-IMGT/HLA=14843).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00161
AC   CVCL_G802
DR   IPD-IMGT/HLA; 14842
DR   Wikidata; Q54798841
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:01:02,31:16; B*35:03,52:AH; DRB1*03:BYBY,11:BBJ (IPD-IMGT/HLA=14842).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00162
AC   CVCL_G803
SY   HN-6847062
DR   IPD-IMGT/HLA; 14867
DR   Wikidata; Q54798842
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:26,01:BMFN; B*14:02:01,35:02:01; DRB1*01:02:01,13:02:01 (IPD-IMGT/HLA=14867).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00163
AC   CVCL_G804
SY   HN-2356415
DR   IPD-IMGT/HLA; 14865
DR   Wikidata; Q54798844
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:03:01,33:11; B*53:01,58:01; C*03:XV,04:BEYC; DRB1*03:02:01,08:04 (IPD-IMGT/HLA=14865).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00164
AC   CVCL_G805
DR   IPD-IMGT/HLA; 14866
DR   Wikidata; Q54798845
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02/24:02L/24:03/24:09N/24:11N/24:33/24:40N/24:50,02:06:04; B*35:BEZX,48:AF; DRB1*15:01 (IPD-IMGT/HLA=14866).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00165
AC   CVCL_G806
DR   IPD-IMGT/HLA; 14897
DR   Wikidata; Q54798847
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*34:02,68:39; B*15:BHJ,35:BZDD; DRB1*03:AC,03:BE (IPD-IMGT/HLA=14897).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00166
AC   CVCL_G807
DR   IPD-IMGT/HLA; 14896
DR   Wikidata; Q54798849
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:06,26:35; B*15:25,51:WBA; DRB1*09:01,15:02 (IPD-IMGT/HLA=14896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00168
AC   CVCL_G808
DR   IPD-IMGT/HLA; 14894
DR   Wikidata; Q54798851
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:04,02:35:03; B*51:WBA,51:WBA; DRB1*03:01,04:11 (IPD-IMGT/HLA=14894).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00169
AC   CVCL_G809
DR   IPD-IMGT/HLA; 14893
DR   Wikidata; Q54798852
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:01:01,02:120; B*07:ASKU,27:PEN; DRB1*01:ASDH,04:AGCB (IPD-IMGT/HLA=14893).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00170
AC   CVCL_G810
DR   IPD-IMGT/HLA; 14892
DR   Wikidata; Q54798854
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,02:119; B*15:BYYC,44:SDC; DRB1*04:BWFJ,04:BWFK (IPD-IMGT/HLA=14892).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00171
AC   CVCL_G811
DR   IPD-IMGT/HLA; 14891
DR   Wikidata; Q54798855
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:CEKU,02:118; B*15:APJS,40:XPM (IPD-IMGT/HLA=14891).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00172
AC   CVCL_G812
DR   IPD-IMGT/HLA; 14890
DR   Wikidata; Q54798856
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*74:AB,31:18; B*15:BKNX,48:AF; DRB1*13:ATNW,14:SM (IPD-IMGT/HLA=14890).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00174
AC   CVCL_G813
DR   IPD-IMGT/HLA; 15290
DR   Wikidata; Q54798857
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,02:136; B*35:05,40:02; DRB1*14:02,09:01 (IPD-IMGT/HLA=15290).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00176
AC   CVCL_G814
DR   IPD-IMGT/HLA; 14992
DR   Wikidata; Q54798860
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:123,23:01; B*44:03,51:WBA; DRB1*13:02,07:01 (IPD-IMGT/HLA=14992).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00177
AC   CVCL_G815
DR   IPD-IMGT/HLA; 14993
DR   Wikidata; Q54798862
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:77,24:02:01:01; B*07:AECG,35:SUW; DRB1*14:04,15:GEP (IPD-IMGT/HLA=14993).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00178
AC   CVCL_G816
DR   IPD-IMGT/HLA; 14990
DR   Wikidata; Q54798863
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,02:122; B*15:10,45:AC; DRB1*01:02,01:02 (IPD-IMGT/HLA=14990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00180
AC   CVCL_G817
DR   IPD-IMGT/HLA; 14995
DR   Wikidata; Q54798890
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,33:12; B*44,58:01; DRB1*07:01,13:02 (IPD-IMGT/HLA=14995).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00182
AC   CVCL_G818
DR   IPD-IMGT/HLA; 15020
DR   Wikidata; Q54798892
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,30:22; B*18,44; DRB1*07:MT,03:JZW (IPD-IMGT/HLA=15020).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00183
AC   CVCL_G819
DR   IPD-IMGT/HLA; 15021
DR   Wikidata; Q54798893
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:01,02:122; B*15:BHK,18; DRB1*01:02,03:AEK (IPD-IMGT/HLA=15021).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00185
AC   CVCL_G820
DR   IPD-IMGT/HLA; 15023
DR   Wikidata; Q54798894
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:ATEA,33:13; B*35:03,44; DRB1*07:01,08:CST (IPD-IMGT/HLA=15023).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00186
AC   CVCL_G821
DR   IPD-IMGT/HLA; 15024
DR   Wikidata; Q54798896
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:01:01,01:25; B*15:GYF,58:02; DRB1*01:02,16:02 (IPD-IMGT/HLA=15024).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00188
AC   CVCL_G822
SY   HN-9599886
DR   IPD-IMGT/HLA; 15026
DR   Wikidata; Q54798898
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:02:01,68:40; B*15:10,57:03:01; C*03:02,18:AB; DRB1*07:01:01,11:02 (IPD-IMGT/HLA=15026).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00189
AC   CVCL_G823
DR   IPD-IMGT/HLA; 15120
DR   Wikidata; Q54798899
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,24:81; B*15:GYF,51:WBA; DRB1*03:01,04:04 (IPD-IMGT/HLA=15120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00190
AC   CVCL_G824
DR   IPD-IMGT/HLA; 15144
DR   Wikidata; Q54798901
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:01:03,32:01:01/32:01:02; B*40:06,51:07; DRB1*10:01,15:AK (IPD-IMGT/HLA=15144).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00193
AC   CVCL_G825
DR   IPD-IMGT/HLA; 15114
DR   Wikidata; Q54798903
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:01:02,02:06:05; B*39:09,40:TTM; DRB1*04:07,16:02 (IPD-IMGT/HLA=15114).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00196
AC   CVCL_G826
DR   IPD-IMGT/HLA; 15106
DR   Wikidata; Q54798905
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:32,24:CNSY; B*15:AKNE,55:ANXC; DRB1*13:ARCR,15:VYF (IPD-IMGT/HLA=15106).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00197
AC   CVCL_G827
DR   IPD-IMGT/HLA; 15122
DR   Wikidata; Q54798906
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:CRGR,24:82; B*07:EH,40:06; DRB1*15:02,15:ANVF (IPD-IMGT/HLA=15122).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00199
AC   CVCL_G828
SY   HN-2058441
DR   IPD-IMGT/HLA; 15105
DR   Wikidata; Q54798907
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:CTSA,02:128; B*07:02:01,27:EKN; C*02:02:02,07:02; DRB1*07:01:01,12:02:01 (IPD-IMGT/HLA=15105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00200
AC   CVCL_G829
DR   IPD-IMGT/HLA; 15119
DR   Wikidata; Q54798909
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,01:30; B*38:01,51:WBA; DRB1*15:AD,16:AE (IPD-IMGT/HLA=15119).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00201
AC   CVCL_G830
DR   IPD-IMGT/HLA; 15118
DR   Wikidata; Q54798910
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CAKM,01:29; B*08,40; DRB1*03:01,14:04 (IPD-IMGT/HLA=15118).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00202
AC   CVCL_G831
DR   IPD-IMGT/HLA; 15111
DR   Wikidata; Q54798912
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:15N,68:01:02; B*08:AKNJ,44:BNGF; DRB1*03:WHX,11:ARAP (IPD-IMGT/HLA=15111).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00204
AC   CVCL_G832
DR   IPD-IMGT/HLA; 15109
DR   Wikidata; Q54798914
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:CGAG,29:17; B*07:EH,27:02; DRB1*11:01,04:04 (IPD-IMGT/HLA=15109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00206
AC   CVCL_G833
DR   IPD-IMGT/HLA; 15139
DR   Wikidata; Q54798915
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24,33; B*35,44; DRB1*14:71,07:01 (IPD-IMGT/HLA=15139).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00207
AC   CVCL_G834
DR   IPD-IMGT/HLA; 15138
DR   Wikidata; Q54798917
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,23; B*07,49:01; DRB1*14:70,15:01 (IPD-IMGT/HLA=15138).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00208
AC   CVCL_G835
DR   IPD-IMGT/HLA; 15136
DR   Wikidata; Q54798919
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:TDF,31:AB; B*15:11,48:01; DRB1*01:19,04:07:01 (IPD-IMGT/HLA=15136).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00209
AC   CVCL_G836
DR   IPD-IMGT/HLA; 15135
DR   Wikidata; Q54798920
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:GNF,26:02; B*15:11,40:02; DRB1*01:19,09:01:02 (IPD-IMGT/HLA=15135).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00210
AC   CVCL_G837
DR   IPD-IMGT/HLA; 15134
DR   Wikidata; Q54798921
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:11; B*51:AFJR,57:GW; DRB1*14:69,07:01 (IPD-IMGT/HLA=15134).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00211
AC   CVCL_G838
DR   IPD-IMGT/HLA; 15143
DR   Wikidata; Q54798922
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29,31; B*39,44; DRB1*14:72,04:01 (IPD-IMGT/HLA=15143).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00212
AC   CVCL_G839
DR   IPD-IMGT/HLA; 15133
DR   Wikidata; Q54798924
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:HGV,34:BD; B*35:02,35:BJYD; DRB1*01:18,11:04 (IPD-IMGT/HLA=15133).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00214
AC   CVCL_G840
DR   IPD-IMGT/HLA; 15131
DR   Wikidata; Q54798925
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:WUS,29:ANJP; B*35:23,44:AXGG; DRB1*01:17,04:07 (IPD-IMGT/HLA=15131).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00215
AC   CVCL_G841
DR   IPD-IMGT/HLA; 15130
DR   Wikidata; Q54798927
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:XAP,02:ZKP; B*15:07,51:AFKG; DRB1*14:44:02,08:02 (IPD-IMGT/HLA=15130).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00216
AC   CVCL_G842
DR   IPD-IMGT/HLA; 15142
DR   Wikidata; Q54798928
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:BKS,11:YPP; B*40:YPJ,52:AE; DRB1*14:73,15:02 (IPD-IMGT/HLA=15142).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00218
AC   CVCL_G843
DR   IPD-IMGT/HLA; 15127
DR   Wikidata; Q54798929
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02; B*07,51; DRB1*15:24,07:APA (IPD-IMGT/HLA=15127).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00219
AC   CVCL_G844
DR   IPD-IMGT/HLA; 15141
DR   Wikidata; Q54798931
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24,80:01; B*35:43,39:SPC; DRB1*16:12,04:07 (IPD-IMGT/HLA=15141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00221
AC   CVCL_G845
DR   IPD-IMGT/HLA; 15125
DR   Wikidata; Q54798932
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,11; B*44,58; DRB1*13:80,04:BK (IPD-IMGT/HLA=15125).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00222
AC   CVCL_G846
DR   IPD-IMGT/HLA; 15124
DR   Wikidata; Q54798934
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:WWP,30:GSH; B*44:ABXK,57:CG; DRB1*07:APA,15:23 (IPD-IMGT/HLA=15124).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00224
AC   CVCL_G847
DR   IPD-IMGT/HLA; 15128
DR   Wikidata; Q54798935
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANDB; B*07:BMAB,35:BMAC; DRB1*15:24,01:01 (IPD-IMGT/HLA=15128).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00225
AC   CVCL_G848
DR   IPD-IMGT/HLA; 15153
DR   Wikidata; Q54798936
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDA,26:PEU; B*07:ASKP,39:AFBG; DRB1*15:25,09:01 (IPD-IMGT/HLA=15153).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00226
AC   CVCL_G849
DR   IPD-IMGT/HLA; 15140
DR   Wikidata; Q54798938
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,24; B*35; DRB1*16:12,14:06 (IPD-IMGT/HLA=15140).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00228
AC   CVCL_G850
DR   IPD-IMGT/HLA; 15155
DR   Wikidata; Q54798939
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:HGV,33:DWH; B*15:02,18:ADSC; DRB1*10:02,12:02 (IPD-IMGT/HLA=15155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00229
AC   CVCL_G851
DR   IPD-IMGT/HLA; 15158
DR   Wikidata; Q54798941
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:06,11:01; B*38:02,40:02; DRB1*15:26,04:03:01 (IPD-IMGT/HLA=15158).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00230
AC   CVCL_G852
DR   IPD-IMGT/HLA; 15159
DR   Wikidata; Q54798942
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:02,68:PNP; B*15:10,45:AC; DRB1*13:81,03:01 (IPD-IMGT/HLA=15159).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00232
AC   CVCL_G853
DR   IPD-IMGT/HLA; 15161
DR   Wikidata; Q54798944
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,11; B*18,44; DRB1*03:37,01:03 (IPD-IMGT/HLA=15161).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00233
AC   CVCL_G854
DR   IPD-IMGT/HLA; 15123
DR   Wikidata; Q54798946
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:TE,74:ZVV; B*55:ANXC,57:03; DRB1*15:23,01:01 (IPD-IMGT/HLA=15123).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00234
AC   CVCL_G855
DR   IPD-IMGT/HLA; 15283
DR   Wikidata; Q54798947
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:GSH,33:DWH; B*18:ADUA,53:AB; DRB1*11:65:01,01:RY (IPD-IMGT/HLA=15283).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00235
AC   CVCL_G856
DR   IPD-IMGT/HLA; 15184
DR   Wikidata; Q54798948
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:ZUA,31:KP; B*18:AETB,58:02; DRB1*11:65:01,12:CVT (IPD-IMGT/HLA=15184).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00236
AC   CVCL_G857
DR   IPD-IMGT/HLA; 15183
DR   Wikidata; Q54798978
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11,24; B*15:02,27; DRB1*04:05:05,12:02 (IPD-IMGT/HLA=15183).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00237
AC   CVCL_G858
DR   IPD-IMGT/HLA; 15182
DR   Wikidata; Q54798979
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30,68; B*42:01,58:02; DRB1*03:38,12:AG (IPD-IMGT/HLA=15182).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00238
AC   CVCL_G859
DR   IPD-IMGT/HLA; 15178
DR   Wikidata; Q54798980
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,03:ANPZ; B*07:AWBG,08:AMXJ; DRB1*04:01:03,03:XBD (IPD-IMGT/HLA=15178).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00240
AC   CVCL_G860
DR   IPD-IMGT/HLA; 15175
DR   Wikidata; Q54798981
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11; B*15:02,40:YFU; DRB1*08:34,15:01 (IPD-IMGT/HLA=15175).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00241
AC   CVCL_G861
DR   IPD-IMGT/HLA; 15198
DR   Wikidata; Q54798983
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:WUS,30:GSH; B*50:01,51:AFKG; DRB1*04:68,11:01 (IPD-IMGT/HLA=15198).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00242
AC   CVCL_G862
DR   IPD-IMGT/HLA; 15370
DR   Wikidata; Q54798984
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:GSH,68:AEAV; B*40:XCG,50:01; DRB1*04:68,07:01 (IPD-IMGT/HLA=15370).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00243
AC   CVCL_G863
DR   IPD-IMGT/HLA; 15281
DR   Wikidata; Q54798985
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30,36; B*18,42:01; DRB1*11:65:01,03:02 (IPD-IMGT/HLA=15281).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00244
AC   CVCL_G864
DR   IPD-IMGT/HLA; 15282
DR   Wikidata; Q54798987
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:GSH,68:AJCN; B*15:17,18:AERZ; DRB1*11:65:01,15 (IPD-IMGT/HLA=15282).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00245
AC   CVCL_G865
DR   IPD-IMGT/HLA; 15199
DR   Wikidata; Q54798988
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BMTS,24:BZBD; B*15:17,51:WBA; DRB1*04:69,13:02:01 (IPD-IMGT/HLA=15199).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00246
AC   CVCL_G866
DR   IPD-IMGT/HLA; 15200
DR   Wikidata; Q54798989
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AZGG,24:10; B*18:02,40:06; DRB1*11:66,12:02:01 (IPD-IMGT/HLA=15200).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00248
AC   CVCL_G867
DR   IPD-IMGT/HLA; 15203
DR   Wikidata; Q54798990
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BRHJ; B*15:BYYS,44:APGK; DRB1*04:70,01:01:01 (IPD-IMGT/HLA=15203).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00249
AC   CVCL_G868
DR   IPD-IMGT/HLA; 15369
DR   Wikidata; Q54798992
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:16,02:AZGG; B*40:06,44:03; DRB1*11:66,07:01 (IPD-IMGT/HLA=15369).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00250
AC   CVCL_G869
DR   IPD-IMGT/HLA; 15204
DR   Wikidata; Q54798993
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:BUVE,11:BDFZ; B*35:BEZX,49:01; DRB1*04:71,01:01:01 (IPD-IMGT/HLA=15204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00251
AC   CVCL_G870
DR   IPD-IMGT/HLA; 15284
DR   Wikidata; Q54798995
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,24:GMP; B*55:02,58:01; DRB1*04:05:05,03:01:01 (IPD-IMGT/HLA=15284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00253
AC   CVCL_G871
DR   IPD-IMGT/HLA; 15206
DR   Wikidata; Q54798996
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,24; B*08,49:01; DRB1*03:39,01:01 (IPD-IMGT/HLA=15206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00254
AC   CVCL_G872
DR   IPD-IMGT/HLA; 15285
DR   Wikidata; Q54798997
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02; B*18,44; DRB1*03:37,08:01 (IPD-IMGT/HLA=15285).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00256
AC   CVCL_G873
DR   IPD-IMGT/HLA; 15244
DR   Wikidata; Q54798998
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:FKZ; B*40:ANHP,44:BHHP; DRB1*15:01:01,15:27 (IPD-IMGT/HLA=15244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00260
AC   CVCL_G874
DR   IPD-IMGT/HLA; 15265
DR   Wikidata; Q54799000
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EXE,33:DWH; B*51:CMCY,58:16; DRB1*03:YMP,04:GEX (IPD-IMGT/HLA=15265).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00263
AC   CVCL_G875
DR   IPD-IMGT/HLA; 15267
DR   Wikidata; Q54799001
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANFV,33:DWH; B*51:CMCY,35:84; DRB1*03:WZD,11:APNV (IPD-IMGT/HLA=15267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00268
AC   CVCL_UW23
DR   IPD-IMGT/HLA; 15821
DR   Wikidata; Q93434195
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:ANGR; B*07:ARKU,37:JTB; C*06:02:01:01,07:64; DRB1*10:01,15:AK (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00271
AC   CVCL_G876
SY   HN-3043303
DR   IPD-IMGT/HLA; 15460
DR   Wikidata; Q54799003
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:XKS,23:RRF; B*44:03:01,40:87; DRB1*13:01,07:01 (IPD-IMGT/HLA=15460).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00272
AC   CVCL_G877
DR   IPD-IMGT/HLA; 15461
DR   Wikidata; Q54799004
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDC,11:XSH; B*46:01:01,56:23; DRB1*09:01,12:02 (IPD-IMGT/HLA=15461).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00273
AC   CVCL_G878
DR   IPD-IMGT/HLA; 15462
DR   Wikidata; Q54799005
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANGK,29:ANJP; B*55:01:01/55:01:03,45:08; DRB1*07:APA,08:FX (IPD-IMGT/HLA=15462).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00274
AC   CVCL_G879
DR   IPD-IMGT/HLA; 15463
DR   Wikidata; Q54799006
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:02,24:ANRD; B*15:17:01:01,44:60; DRB1*04:BDJV,07:APA (IPD-IMGT/HLA=15463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00278
AC   CVCL_G880
DR   IPD-IMGT/HLA; 15468
DR   Wikidata; Q54799008
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:SWY,03:BBSA; B*07:22:02,35:BEZX; DRB1*01:01,07:01 (IPD-IMGT/HLA=15468).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00279
AC   CVCL_G881
DR   IPD-IMGT/HLA; 15469
DR   Wikidata; Q54799009
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CRY,30:01; B*81:04N,35:BEZX; DRB1*11:01,13:02 (IPD-IMGT/HLA=15469).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00280
AC   CVCL_G882
DR   IPD-IMGT/HLA; 15471
DR   Wikidata; Q54799011
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BYVR,24:BYVG; B*35:68:02,35:12; DRB1*16:02,09:01 (IPD-IMGT/HLA=15471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00281
AC   CVCL_G883
DR   IPD-IMGT/HLA; 15472
DR   Wikidata; Q54799012
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BEJX; B*44:03:01/44:03:03,18:29; DRB1*07:APA,11:ARAP (IPD-IMGT/HLA=15472).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00282
AC   CVCL_G884
DR   IPD-IMGT/HLA; 15473
DR   Wikidata; Q54799014
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,03:ANPZ; B*07:64,07:CZZS; DRB1*01:EW,15:GEP (IPD-IMGT/HLA=15473).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00283
AC   CVCL_G885
DR   IPD-IMGT/HLA; 15474
DR   Wikidata; Q54799015
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:ANSM; B*53:01:01,08:36; DRB1*08:04,11:APWP (IPD-IMGT/HLA=15474).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00284
AC   CVCL_G886
DR   IPD-IMGT/HLA; 15475
DR   Wikidata; Q54799016
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,24:AZUP; B*56:22,40:06; DRB1*04:APPB,11:APWP (IPD-IMGT/HLA=15475).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00285
AC   CVCL_G887
DR   IPD-IMGT/HLA; 15476
DR   Wikidata; Q54799017
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:GNF,02:GNF; B*15:143,15:27:01; DRB1*14:12,15:01 (IPD-IMGT/HLA=15476).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00286
AC   CVCL_G888
DR   IPD-IMGT/HLA; 15496
DR   Wikidata; Q54799019
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDC,11:XSH; B*14:08,15:01:01:01/15:01:06/15:01:07/15:102/15:104; DRB1*01:EW,07:APA (IPD-IMGT/HLA=15496).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00287
AC   CVCL_G889
DR   IPD-IMGT/HLA; 15495
DR   Wikidata; Q54799020
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,11; B*51:55,15:01:01:01; DRB1*04:01,15:01 (IPD-IMGT/HLA=15495).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00288
AC   CVCL_G890
DR   IPD-IMGT/HLA; 15494
DR   Wikidata; Q54799021
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDC,11:XSH; B*15:145,08:XKT; DRB1*15:DWK,15:VYF (IPD-IMGT/HLA=15494).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00290
AC   CVCL_G891
DR   IPD-IMGT/HLA; 15564
DR   Wikidata; Q54799022
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDC,11:XSH; B*51:55,44:WRJ; DRB1*04:AFNC,15:GUX (IPD-IMGT/HLA=15564).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00291
AC   CVCL_G892
DR   IPD-IMGT/HLA; 15491
DR   Wikidata; Q54799024
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,24; B*51:54,14:02:01; DRB1*07:01,10:01 (IPD-IMGT/HLA=15491).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00292
AC   CVCL_G893
SY   HN-4123369
DR   IPD-IMGT/HLA; 15490
DR   Wikidata; Q54799025
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:GNF,11:01; B*27:42,55:02:01; DRB1*15:01,08:03 (IPD-IMGT/HLA=15490).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00295
AC   CVCL_G894
SY   HN-6050321
DR   IPD-IMGT/HLA; 15470
DR   Wikidata; Q54799026
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:GNF; B*35:68:02,13:02:01; C*04:ARHA,06:BG; DQB1*02:MN,03:CA; DRB1*07:01,09:01 (IPD-IMGT/HLA=15470).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00296
AC   CVCL_G895
DR   IPD-IMGT/HLA; 15563
DR   Wikidata; Q54799028
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BEJX; B*35:68:02,44:WRJ; DRB1*09:01,13:APWN (IPD-IMGT/HLA=15563).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00297
AC   CVCL_G896
DR   IPD-IMGT/HLA; 15487
DR   Wikidata; Q54799029
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:TE; B*51:53,27:05:02; DRB1*01:EW,08:02 (IPD-IMGT/HLA=15487).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00298
AC   CVCL_G897
DR   IPD-IMGT/HLA; 15486
DR   Wikidata; Q54799052
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:AZWC,68:AEAN; B*27:41,07:CZZS; DRB1*11:APWP,15:VYF (IPD-IMGT/HLA=15486).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00299
AC   CVCL_G898
SY   HN-1241139
DR   IPD-IMGT/HLA; 15485
DR   Wikidata; Q54799054
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:GMP; B*39:19:02,15:15; DRB1*14:02,08:02 (IPD-IMGT/HLA=15485).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00300
AC   CVCL_G899
DR   IPD-IMGT/HLA; 15484
DR   Wikidata; Q54799055
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BPNJ,02:ZJW; B*53:16,50:01; DRB1*07:SAF (IPD-IMGT/HLA=15484).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00303
AC   CVCL_G900
DR   IPD-IMGT/HLA; 15506
DR   Wikidata; Q54799056
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:APBA,33:FDX; B*44:03:01/44:03:03,58:17N; DRB1*07:APA,13:02 (IPD-IMGT/HLA=15506).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00304
AC   CVCL_G901
SY   HN-2057856
DR   IPD-IMGT/HLA; 15535
DR   Wikidata; Q54799057
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:01,68:01; B*58:02,40:90; DRB1*04:04,12:AG (IPD-IMGT/HLA=15535).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00305
AC   CVCL_G902
DR   IPD-IMGT/HLA; 15536
DR   Wikidata; Q54799059
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:ANGR; B*57:01:01,51:56; DRB1*07:NZC,11:APKF (IPD-IMGT/HLA=15536).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00306
AC   CVCL_G903
DR   IPD-IMGT/HLA; 15537
DR   Wikidata; Q54799060
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:06:01,68:FKZ; B*15:15,39:01:05; DRB1*08:02,14:06 (IPD-IMGT/HLA=15537).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00309
AC   CVCL_G904
SY   HN-s5746869
DR   IPD-IMGT/HLA; 15541
DR   Wikidata; Q54799061
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:BZAZ,26:BYVK; B*08:01:01/08:19N,13:22; DRB1*13:01,15:01 (IPD-IMGT/HLA=15541).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00310
AC   CVCL_G905
SY   HN-6543265
DR   IPD-IMGT/HLA; 15542
DR   Wikidata; Q54799062
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:APTB,33:03:01; B*40:06:01,58:18; DRB1*03:UKV,13:UKW (IPD-IMGT/HLA=15542).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00312
AC   CVCL_G906
DR   IPD-IMGT/HLA; 15543
DR   Wikidata; Q54799064
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AZGG,11:BDFZ; B*44:03:02,52:13; DRB1*04:03 (IPD-IMGT/HLA=15543).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00313
AC   CVCL_G907
SY   HN-7102160
DR   IPD-IMGT/HLA; 15545
DR   Wikidata; Q54799065
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:BZAE,24:BZBB; B*44:03:01/44:03:03,14:09; C*04:WGY,08:BE; DRB1*15:03,12:CVT (IPD-IMGT/HLA=15545).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00314
AC   CVCL_G908
DR   IPD-IMGT/HLA; 15546
DR   Wikidata; Q54799067
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CRY,02:BRHJ; B*08:01:01/08:19N,15:147; DRB1*03:01,04:01 (IPD-IMGT/HLA=15546).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00315
AC   CVCL_G909
SY   HN-6965989
DR   IPD-IMGT/HLA; 15547
DR   Wikidata; Q54799068
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BRHJ,30:02; B*07:CZZS,57:17; DRB1*15:03,13:02 (IPD-IMGT/HLA=15547).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00316
AC   CVCL_G910
DR   IPD-IMGT/HLA; 15548
DR   Wikidata; Q54799069
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANFV,31:AF; B*40:AVGG,35:90; DRB1*04:07,07:APA (IPD-IMGT/HLA=15548).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00317
AC   CVCL_G911
SY   HN-0036645
DR   IPD-IMGT/HLA; 15549
DR   Wikidata; Q54799070
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BDFZ,32:01; B*14:01,55:31; C*03:BPSK,08:02; DRB1*01:01,07:01 (IPD-IMGT/HLA=15549).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00318
AC   CVCL_G912
DR   IPD-IMGT/HLA; 15550
DR   Wikidata; Q54799072
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BMTS,24:BZBD; B*44:03:02,27:43; DRB1*07:01,09:01 (IPD-IMGT/HLA=15550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00319
AC   CVCL_G913
DR   IPD-IMGT/HLA; 15551
DR   Wikidata; Q54799073
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BYWE,11:BZAM; B*44:03:02,35:91; DRB1*13:01,13:02 (IPD-IMGT/HLA=15551).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00322
AC   CVCL_G934
DR   IPD-IMGT/HLA; 15605
DR   Wikidata; Q54799074
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:VE,33:DWH; B*44:03:02,44:64; DRB1*07:SAF (IPD-IMGT/HLA=15605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00323
AC   CVCL_G935
DR   IPD-IMGT/HLA; 15603
DR   Wikidata; Q54799075
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:TYW,32:AC; B*44:62,40:AZAY; DRB1*11:01,04:01 (IPD-IMGT/HLA=15603).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00324
AC   CVCL_G936
DR   IPD-IMGT/HLA; 15604
DR   Wikidata; Q54799077
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CRY,02:GNF; B*18:RRG,44:63; DRB1*03:CVT,14:JGS (IPD-IMGT/HLA=15604).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00325
AC   CVCL_G937
DR   IPD-IMGT/HLA; 15640
DR   Wikidata; Q54799078
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:CVAB,11:34; B*07:ARKU,40:JMM; DRB1*01:EW,13:APWN (IPD-IMGT/HLA=15640).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00326
AC   CVCL_G938
DR   IPD-IMGT/HLA; 15641
DR   Wikidata; Q54799079
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,33:19; B*35:BJGU,57:AG; DRB1*01:EW,07:APA (IPD-IMGT/HLA=15641).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00327
AC   CVCL_G939
DR   IPD-IMGT/HLA; 15642
DR   Wikidata; Q54799081
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDC,11:XSH; B*15:AKZB,56:MS; DRB1*11:69,04:01:01 (IPD-IMGT/HLA=15642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00328
AC   CVCL_G940
DR   IPD-IMGT/HLA; 15643
DR   Wikidata; Q54799082
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:APFZ,26:CYK; B*13:01,51:02; DRB1*03:01:01,15:31 (IPD-IMGT/HLA=15643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00330
AC   CVCL_G914
DR   IPD-IMGT/HLA; 15645
DR   Wikidata; Q54799083
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24,31; B*39:06,48; DRB1*04:04,14:72 (IPD-IMGT/HLA=15645).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00331
AC   CVCL_G941
DR   IPD-IMGT/HLA; 15646
DR   Wikidata; Q54799084
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:01:01,24:90N; B*15:03,55:01; DRB1*13:02,04:05 (IPD-IMGT/HLA=15646).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00332
AC   CVCL_G942
DR   IPD-IMGT/HLA; 15679
DR   Wikidata; Q54799086
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DRPX,02:148; B*40:AZAY,52:AH; DRB1*01:01,14:BCAD (IPD-IMGT/HLA=15679).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00334
AC   CVCL_G943
DR   IPD-IMGT/HLA; 15674
DR   Wikidata; Q54799087
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,24; B*35,52; DRB1*14:81,01:03; DRB3*01:MS (IPD-IMGT/HLA=15674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00337
AC   CVCL_G944
DR   IPD-IMGT/HLA; 15677
DR   Wikidata; Q54799088
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:AZSP,33:DWH; B*18:ADSC,41:02; DRB1*13:03:01,13:11:02 (IPD-IMGT/HLA=15677).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00338
AC   CVCL_G945
DR   IPD-IMGT/HLA; 15678
DR   Wikidata; Q54799089
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANGN,03:ANGP; B*35:AWZB,44:AGWY; DRB1*11:01:01,13:84 (IPD-IMGT/HLA=15678).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00339
AC   CVCL_G946
DR   IPD-IMGT/HLA; 15691
DR   Wikidata; Q54799091
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:01,32:AE; B*13:AFB,40:PJA; DRB1*07:01:01,13:86 (IPD-IMGT/HLA=15691).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00340
AC   CVCL_G947
DR   IPD-IMGT/HLA; 15690
DR   Wikidata; Q54799092
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AJPE,34:BD; B*27:PEN,81:AB; DRB1*04:04,13:85 (IPD-IMGT/HLA=15690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00341
AC   CVCL_G915
DR   IPD-IMGT/HLA; 15689
DR   Wikidata; Q54799094
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,11:ZPF; B*51:55,08:01:01; DRB1*03:WHX,15:VYF (IPD-IMGT/HLA=15689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00342
AC   CVCL_UW24
DR   IPD-IMGT/HLA; 15709
DR   Wikidata; Q93434514
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BZNT,24:CNEX; B*18:ADSC,35:HNH; C*07:58,12:03:01:01; DRB1*11:ASZR,14:PRK (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00343
AC   CVCL_UW25
DR   IPD-IMGT/HLA; 15775
DR   Wikidata; Q93434517
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:APAD,25:MN; B*07:CZZS,18:30; C*07:BJ,12:NP; DRB1*10:01,15:AK (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 8
//
ID   BY00344
AC   CVCL_G916
DR   IPD-IMGT/HLA; 15776
DR   Wikidata; Q54799095
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:122,23:DFKR; B*15:10,44:ANHY; DRB1*07:NZC,11:APKF (IPD-IMGT/HLA=15776).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00345
AC   CVCL_G948
DR   IPD-IMGT/HLA; 15777
DR   Wikidata; Q54799096
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BEJX; B*15:DKGD,18:31; DRB1*15:AK,16:01 (IPD-IMGT/HLA=15777).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00347
AC   CVCL_G949
DR   IPD-IMGT/HLA; 15774
DR   Wikidata; Q54799097
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BDCH,24:AZRT; B*39:AFCS,40:ABUC; DRB1*16:02:01,14:83 (IPD-IMGT/HLA=15774).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00348
AC   CVCL_G950
DR   IPD-IMGT/HLA; 15837
DR   Wikidata; Q54799099
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:01,02:152; B*15:03,39; DRB1*01:MV,07:MT (IPD-IMGT/HLA=15837).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00350
AC   CVCL_G951
DR   IPD-IMGT/HLA; 15836
DR   Wikidata; Q54799100
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26:GAX,24:94; B*35,56; DRB1*04:BK,04:YK (IPD-IMGT/HLA=15836).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00352
AC   CVCL_G952
DR   IPD-IMGT/HLA; 15843
DR   Wikidata; Q54799101
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*74:01,74:13; B*49,07; DRB1*15:03,07:MT (IPD-IMGT/HLA=15843).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00354
AC   CVCL_G953
DR   IPD-IMGT/HLA; 15842
DR   Wikidata; Q54799102
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:CTSA,33:21; B*52:01,58:01; DRB1*13:05,13:BMD (IPD-IMGT/HLA=15842).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00355
AC   CVCL_G917
DR   IPD-IMGT/HLA; 15859
DR   Wikidata; Q54799134
RX   PubMed=19317748;
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,30:26; B*07:EH,35:BJGT; DRB1*04:07,14:KNC (IPD-IMGT/HLA=15859).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00356
AC   CVCL_G918
DR   Wikidata; Q54799135
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   BY00357
AC   CVCL_G919
DR   Wikidata; Q54799137
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   BY00358
AC   CVCL_G920
DR   Wikidata; Q54799138
RX   PubMed=19317748;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   BY00359
AC   CVCL_G955
DR   IPD-IMGT/HLA; 15876
DR   Wikidata; Q54799139
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:39,26:GA; B*27,51; DRB1*15:STF; DRB5*01:BMK,01:KBJ (IPD-IMGT/HLA=15876).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00361
AC   CVCL_G956
SY   HG00000550
DR   IPD-IMGT/HLA; 15877
DR   Wikidata; Q54799141
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:01,68:44; B*42:01:01,53:01:01; C*04:FEAS,17:MN; DRB1*11:US,13:AEK (IPD-IMGT/HLA=15877).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   BY00362
AC   CVCL_G957
DR   IPD-IMGT/HLA; 15878
DR   Wikidata; Q54799142
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01:22,24:CWFP; B*15:BKVK,15; DRB1*04:01,13:01 (IPD-IMGT/HLA=15878).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00363
AC   CVCL_G958
DR   IPD-IMGT/HLA; 15939
DR   Wikidata; Q54799143
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,24:95; B*38:01,39:BMFM; DRB1*11:01,11:04 (IPD-IMGT/HLA=15939).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00364
AC   CVCL_G959
SY   HN-7393785
DR   IPD-IMGT/HLA; 15879
DR   Wikidata; Q54799144
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:CAKR,24:95; B*07:BVED,39:EM; C*07:02; DRB1*08:02:01,15:01:01 (IPD-IMGT/HLA=15879).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00367
AC   CVCL_G960
DR   IPD-IMGT/HLA; 15920
DR   Wikidata; Q54799146
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:CAKR,29:19; B*40:CBSU,44:APAP; DRB1*04:AFRF,15:FJH (IPD-IMGT/HLA=15920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00368
AC   CVCL_G961
DR   IPD-IMGT/HLA; 15921
DR   Wikidata; Q54799147
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:BEKE,68:45; B*15:18,52:01; DRB1*15:JST,13:BMD; DRB3*01:MS; DRB5*01:BMK (IPD-IMGT/HLA=15921).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00370
AC   CVCL_G962
DR   IPD-IMGT/HLA; 15936
DR   Wikidata; Q54799148
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:18,24:CWFP; B*08:XKT,27:02; DRB1*03:01,07:01 (IPD-IMGT/HLA=15936).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00371
AC   CVCL_G963
DR   IPD-IMGT/HLA; 15937
DR   Wikidata; Q54799149
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,32:18; B*35:BEZX,40:AZAY; DRB1*13:KNK,14:BZFM (IPD-IMGT/HLA=15937).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00372
AC   CVCL_G964
DR   IPD-IMGT/HLA; 15935
DR   Wikidata; Q54799150
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:24,24:CWFP; B*15:KSB,54; C*01:02,15:02; DRB1*04:05,09:01 (IPD-IMGT/HLA=15935).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00373
AC   CVCL_G965
DR   IPD-IMGT/HLA; 15934
DR   Wikidata; Q54799152
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,24:97; B*40:DG,52; DRB1*04:YK,04:DJX (IPD-IMGT/HLA=15934).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00374
AC   CVCL_G966
DR   IPD-IMGT/HLA; 15933
DR   Wikidata; Q54799153
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:46,02:DFKP; B*07:EH,58:VE; DRB1*07:01,13:02 (IPD-IMGT/HLA=15933).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00375
AC   CVCL_G967
DR   IPD-IMGT/HLA; 15932
DR   Wikidata; Q54799154
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,02:153; B*44:ANHY,51:AFJR; DRB1*07:NZC,11:APKF (IPD-IMGT/HLA=15932).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00377
AC   CVCL_G968
DR   IPD-IMGT/HLA; 15930
DR   Wikidata; Q54799155
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BDFZ,25:08; B*18:ADSC,35:HNH; DRB1*08:ASET,15:FJH (IPD-IMGT/HLA=15930).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00378
AC   CVCL_G969
DR   IPD-IMGT/HLA; 15929
DR   Wikidata; Q54799156
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*74:AB,30:28; B*50:01,58:02; DRB1*11:ASZR,14:PRK (IPD-IMGT/HLA=15929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00385
AC   CVCL_G970
DR   IPD-IMGT/HLA; 15944
DR   Wikidata; Q54799157
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:CWFP,11; B*35:HNH,40:06; DRB1*07:APA,13:APWN (IPD-IMGT/HLA=15944).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00386
AC   CVCL_G971
SY   HN-3282501
DR   IPD-IMGT/HLA; 15945
DR   Wikidata; Q54799158
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,01:33; B*51:BVND,57:AC; DRB1*03:UGN,13:FSN (IPD-IMGT/HLA=15945).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00387
AC   CVCL_G972
DR   IPD-IMGT/HLA; 15946
DR   Wikidata; Q54799159
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:02:01,03; B*15:BKVK,51:WBA; DRB1*08:01,11:01 (IPD-IMGT/HLA=15946).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00388
AC   CVCL_G973
DR   IPD-IMGT/HLA; 15947
DR   Wikidata; Q54799162
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:CAKR,02:154; B*27:PEN,50:01; DRB1*01:EW,07:APA (IPD-IMGT/HLA=15947).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00389
AC   CVCL_G974
DR   IPD-IMGT/HLA; 15948
DR   Wikidata; Q54799163
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:86,02:155; B*39:BMFM,44:03; DRB1*11:02,08:11 (IPD-IMGT/HLA=15948).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00390
AC   CVCL_G975
DR   IPD-IMGT/HLA; 15949
DR   Wikidata; Q54799165
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:06:05,68:46; B*40:ZBH,48:01; DRB1*04:AGCB,14:AMGJ (IPD-IMGT/HLA=15949).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00391
AC   CVCL_G976
DR   IPD-IMGT/HLA; 15951
DR   Wikidata; Q54799166
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26:GAX,02:156; B*38:AF,56:01; DRB1*01:EW,13:APWN (IPD-IMGT/HLA=15951).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00393
AC   CVCL_G977
DR   IPD-IMGT/HLA; 15983
DR   Wikidata; Q54799168
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:ANJU,30:01; B*51:64,15:BKNX; DRB1*03:WHX,15:03 (IPD-IMGT/HLA=15983).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00394
AC   CVCL_G978
SY   HN-2686538
DR   IPD-IMGT/HLA; 15984
DR   Wikidata; Q54799169
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BYWF,68:XV; B*53:18,15:10; DRB1*01:02,13:03 (IPD-IMGT/HLA=15984).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00395
AC   CVCL_G979
DR   IPD-IMGT/HLA; 15986
DR   Wikidata; Q54799170
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BZNT,24:BZKA; B*35:DNXN,07:71; DRB1*08:APPA,15:AK (IPD-IMGT/HLA=15986).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00396
AC   CVCL_G980
DR   IPD-IMGT/HLA; 15987
DR   Wikidata; Q54799172
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:AE,33:FDX; B*18:33,14:01; DRB1*07:APA,11:ARAP (IPD-IMGT/HLA=15987).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00397
AC   CVCL_G981
DR   IPD-IMGT/HLA; 15988
DR   Wikidata; Q54799173
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,24; B*46:13:02,35:DNXN; DRB1*04:EUK,08:KAV (IPD-IMGT/HLA=15988).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00398
AC   CVCL_G982
SY   HN-0042411
DR   IPD-IMGT/HLA; 15989
DR   Wikidata; Q54799175
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BMTS,24:BZBD; B*15:154,35:DNXN; DRB1*13:01,08:01 (IPD-IMGT/HLA=15989).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00399
AC   CVCL_G983
SY   HN-7715052
DR   IPD-IMGT/HLA; 16008
DR   Wikidata; Q54799176
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BRHJ,68:01; B*07:72,44:WRJ; DRB1*12:CVT,15:01:01 (IPD-IMGT/HLA=16008).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00400
AC   CVCL_G984
SY   HN-7712737
DR   IPD-IMGT/HLA; 15990
DR   Wikidata; Q54799178
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BYVR,24:BYVG; B*15:155,35:BEZX; DRB1*08:02,09:01 (IPD-IMGT/HLA=15990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00401
AC   CVCL_G985
SY   HN-5092736
DR   IPD-IMGT/HLA; 15991
DR   Wikidata; Q54799179
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BMTS,24:BZBD; B*27:46,39:06:02; C*02:02:02,07:02; DRB1*16:01,08:01 (IPD-IMGT/HLA=15991).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00402
AC   CVCL_G986
SY   HN-7648279
DR   IPD-IMGT/HLA; 15992
DR   Wikidata; Q54799180
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BYVR,24:BYVG; B*51:65,44:03; DRB1*15:01,11:01 (IPD-IMGT/HLA=15992).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00414
AC   CVCL_G987
DR   IPD-IMGT/HLA; 16004
DR   Wikidata; Q54799182
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24; B*44:62,07:CZZS; DRB1*15:DEW,11:DJZ; DRB3*02:BMP; DRB5*01:BMK (IPD-IMGT/HLA=16004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00416
AC   CVCL_G988
DR   IPD-IMGT/HLA; 16006
DR   Wikidata; Q54799183
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANFV,33:DWH; B*42:01,15:156; DRB1*03:02,07:APA (IPD-IMGT/HLA=16006).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00417
AC   CVCL_G989
DR   IPD-IMGT/HLA; 16007
DR   Wikidata; Q54799184
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11,33; B*39:47,15:DFRA; DRB1*08:BMT,15:DKN; DRB5*01:BRG (IPD-IMGT/HLA=16007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00418
AC   CVCL_G990
DR   IPD-IMGT/HLA; 16015
DR   Wikidata; Q54799185
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*34,24; B*40:95,15:35; DRB1*08:BMT,15:DKN; DRB5*01:BRG (IPD-IMGT/HLA=16015).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00419
AC   CVCL_G991
DR   IPD-IMGT/HLA; 16014
DR   Wikidata; Q54799221
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,68; B*35:95,40:AZAY; DRB1*11:04,14:BME; DRB3*02:KBP (IPD-IMGT/HLA=16014).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00420
AC   CVCL_G992
DR   IPD-IMGT/HLA; 16013
DR   Wikidata; Q54799222
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,11:ANXJ; B*44:67,08:XKT; C*05,07; DRB1*03:WHX,15:VYF (IPD-IMGT/HLA=16013).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00422
AC   CVCL_G993
DR   IPD-IMGT/HLA; 16039
DR   Wikidata; Q54799223
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,68; B*08,14; DRB1*03:01,13:88; DRB3*01:GM (IPD-IMGT/HLA=16039).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00423
AC   CVCL_G994
DR   IPD-IMGT/HLA; 16040
DR   Wikidata; Q54799225
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:ANXH,36:01; B*07:BMAB,35:BMAC; DRB1*03:41,09:01:02 (IPD-IMGT/HLA=16040).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00425
AC   CVCL_G995
DR   IPD-IMGT/HLA; 16041
DR   Wikidata; Q54799226
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33,36; B*53; DRB1*11:72,03:02:01 (IPD-IMGT/HLA=16041).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00426
AC   CVCL_G996
DR   IPD-IMGT/HLA; 16042
DR   Wikidata; Q54799227
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:BZAE,24:BZBB; B*07:CDMS,15:CDKN; DRB1*01:21,09:01:02 (IPD-IMGT/HLA=16042).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00430
AC   CVCL_G997
DR   IPD-IMGT/HLA; 16060
DR   Wikidata; Q54799228
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01; B*08:40,39:06:02; DRB1*03:JZS,08:KAV; DRB3*01:GM (IPD-IMGT/HLA=16060).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00431
AC   CVCL_G998
DR   IPD-IMGT/HLA; 16059
DR   Wikidata; Q54799229
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30,03; B*35:02:01,39:48; DRB1*07:MT,13:KAF; DRB3*02:KBM (IPD-IMGT/HLA=16059).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00432
AC   CVCL_G999
DR   IPD-IMGT/HLA; 16058
DR   Wikidata; Q54799230
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,11:ANXJ; B*15:157,27:EKN; DRB1*13:ARCM,04:AFMZ (IPD-IMGT/HLA=16058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00433
AC   CVCL_H000
SY   HN-6486010
DR   IPD-IMGT/HLA; 16057
DR   Wikidata; Q54799233
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:BMFN,31:01; B*42:10,35:DNXN; C*04:KBG,17:MN; DRB1*14:02,08:04 (IPD-IMGT/HLA=16057).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00434
AC   CVCL_H001
SY   HN-0361266
DR   IPD-IMGT/HLA; 16055
DR   Wikidata; Q54799234
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:07,24:APTB; B*35:97,48:AF; DRB1*11:01,15:01 (IPD-IMGT/HLA=16055).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00444
AC   CVCL_UW26
DR   IPD-IMGT/HLA; 16126
DR   Wikidata; Q93434936
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*02:CNDW,03:58; B*09:01,40:XCG; C*07:02:01:01,35:BJJC; DRB1*15:AK (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00445
AC   CVCL_UW27
DR   IPD-IMGT/HLA; 16127
DR   Wikidata; Q93434937
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:BEKE,68:47; B*04:07:01,51:CVAE; C*15:02:01/15:13; DRB1*09:01:02 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00446
AC   CVCL_UW28
DR   IPD-IMGT/HLA; 16129
DR   Wikidata; Q93434940
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: A*24:CWFP,25:01:01; B*18:RRG,35:99; C*03:05,12:03:01/12:03:06; DRB1*08:02:01,15:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00447
AC   CVCL_UW29
DR   IPD-IMGT/HLA; 16135
DR   Wikidata; Q93434942
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American.
CC   HLA typing: A*02:G1,08:03:02; B*03:01:01,48:AF; C*07:CVAG,41:01; DRB1*08:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00448
AC   CVCL_G921
DR   IPD-IMGT/HLA; 20707
DR   Wikidata; Q54799235
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:CWFP,31:DUKU; B*15:DKGD,35:102; C*01:02,01:02+; DRB1*16:02:01,04:07:01 (IPD-IMGT/HLA=20707).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00449
AC   CVCL_UW30
DR   IPD-IMGT/HLA; 16128
DR   Wikidata; Q93434954
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: A*02:22/02:104,24:CWFP; B*35:43,35:99; C*01:02:01,03:05; DRB1*04:07:01,08:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00450
AC   CVCL_UV34
DR   IPD-IMGT/HLA; 16096
DR   Wikidata; Q93434957
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: A*02:DFKP,02:CGAE; B*35:05,40:AVGG; C*03:57,04:CVAF; DRB1*08:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00453
AC   CVCL_UV35
DR   IPD-IMGT/HLA; 16163
DR   Wikidata; Q93434960
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Chinese.
CC   HLA typing: A*02:169,24:CWFP; B*44:03,52:01; DRB1*07:01,13:12 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00454
AC   CVCL_UV36
DR   IPD-IMGT/HLA; 16162
DR   Wikidata; Q93434963
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Chinese; Singaporian.
CC   HLA typing: A*11:ANXJ,11:APCT; B*27:15,40:AZAY; DRB1*09:01:05,14:CFNU (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00459
AC   CVCL_H002
DR   IPD-IMGT/HLA; 16169
DR   Wikidata; Q54799236
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:15,74:13; B*07:02/61/62/63/64,15:10; C*03:04/47,15:05; DQB1*04:02,05:01; DRB1*03:02,12:01/06/10/17; DRB3*01:01/12/13 (IPD-IMGT/HLA=16169).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00460
AC   CVCL_UV37
DR   IPD-IMGT/HLA; 16466
DR   Wikidata; Q93434974
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,03:01; B*27:05,44:02; C*02:02:08,05:AC; DRB1*04:01,12:CVT (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00461
AC   CVCL_UV38
DR   IPD-IMGT/HLA; 16467
DR   Wikidata; Q93434978
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,03:01; B*15:01,56:01; C*01:02,03:59; DRB1*04:01,07:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00462
AC   CVCL_UV39
DR   IPD-IMGT/HLA; 16460
DR   Wikidata; Q93434981
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:WUS,29:BKZA; B*07:EH,51:AFJY; C*14:12,15:05 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00463
AC   CVCL_UV40
DR   IPD-IMGT/HLA; 16461
DR   Wikidata; Q93434985
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*04:01,24:02; B*08:01:04,15:01; C*07:02,07:02; DRB1*04:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00464
AC   CVCL_UV41
DR   IPD-IMGT/HLA; 16462
DR   Wikidata; Q93434988
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*30:01,34:02; B*35:01,52:01; C*16:01; DPB1*01:01:01,122:01; DQB1*02:02,04:02; DRB1*03:02,07:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00465
AC   CVCL_UV42
DR   IPD-IMGT/HLA; 16463
DR   Wikidata; Q93434992
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:01,68:01; B*42:11,58:02; C*06:02,17:01; DRB1*03:02,12:CVT (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00466
AC   CVCL_UU14
DR   IPD-IMGT/HLA; 16465
DR   Wikidata; Q93434995
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,26:40; B*44:02,51:01; C*07:04,15:02; DQB1*03:01/16,03:03; DRB1*09:01,11:01 (IPD-IMGT/HLA=16465).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00467
AC   CVCL_H010
DR   IPD-IMGT/HLA; 16454
DR   Wikidata; Q54799238
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:ECAD,11:44; B*52:AE,57:AG; DRB1*15:HW (IPD-IMGT/HLA=16454).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00469
AC   CVCL_UV43
DR   IPD-IMGT/HLA; 16471
DR   Wikidata; Q93435007
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:37,02:DFKP; B*07:02,08:01; C*07:01,07:02; DRB1*03:01,13:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00470
AC   CVCL_UV44
DR   IPD-IMGT/HLA; 16472
DR   Wikidata; Q93435010
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:02,68:01; B*18:01,53:01; C*02:02:02,04:41; DRB1*10:01,11:04 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00471
AC   CVCL_UV45
DR   IPD-IMGT/HLA; 16473
DR   Wikidata; Q93435013
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:179,26:GAX; B*35:08,78:01; C*04:01,16:01; DRB1*11:04,13:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00472
AC   CVCL_UV46
DR   IPD-IMGT/HLA; 16492
DR   Wikidata; Q93435016
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,29:02; B*08:BYXK,44:03:04; C*07:01,16:01; DRB1*03:01,07:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00475
AC   CVCL_UV47
DR   IPD-IMGT/HLA; 16880
DR   Wikidata; Q93435020
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Chinese.
CC   HLA typing: A*02:03,24:CNEY; B*38:XV,46:AB; C*01:BG,07:02; DRB1*12:20,16:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00476
AC   CVCL_G711
DR   IPD-IMGT/HLA; 20724
DR   Wikidata; Q54799239
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24,36; B*35:135,53:01:01; DRB1*04:YK,11:MFF; DRB3*02:BMP (IPD-IMGT/HLA=20724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00477
AC   CVCL_H011
DR   IPD-IMGT/HLA; 16915
DR   Wikidata; Q54799240
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:ANRC,29:ANJP; B*35:DNXN,44:82; DRB1*03:BC,14:AFXK (IPD-IMGT/HLA=16915).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00478
AC   CVCL_H012
DR   IPD-IMGT/HLA; 16916
DR   Wikidata; Q54799241
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:APEC,24:CNFP; B*38:01:01,15:18:03; DRB1*13:ARCM,14:VUU (IPD-IMGT/HLA=16916).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00479
AC   CVCL_H013
SY   HN-0340062
DR   IPD-IMGT/HLA; 16917
DR   Wikidata; Q54799243
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BRHJ; B*35:DNXN,56:26; DRB1*01:01,15:01 (IPD-IMGT/HLA=16917).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00480
AC   CVCL_H014
SY   HN-0397427
DR   IPD-IMGT/HLA; 19274
DR   Wikidata; Q54799244
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AZGG,02:BRHJ; B*07:CZZS,40:99; DRB1*04:07,08:01 (IPD-IMGT/HLA=19274).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00482
AC   CVCL_H015
DR   IPD-IMGT/HLA; 16919
DR   Wikidata; Q54799245
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BRHJ,30:02; B*27,58:24; DRB1*11:01,13:03 (IPD-IMGT/HLA=16919).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00483
AC   CVCL_H016
DR   IPD-IMGT/HLA; 16920
DR   Wikidata; Q54799246
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:WUS,31:AF; B*08:XKT,44:76; DRB1*03:WHX,15:VYF (IPD-IMGT/HLA=16920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00484
AC   CVCL_G712
DR   IPD-IMGT/HLA; 20725
DR   Wikidata; Q54799247
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,68:AEBF; B*52:01:01,40:110; DRB1*07:NZC,11:APKF (IPD-IMGT/HLA=20725).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00485
AC   CVCL_G713
DR   IPD-IMGT/HLA; 20726
DR   Wikidata; Q54799248
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26:UUA,68:AVDJ; B*40:130,52:AH; DRB1*07:APA,15:AAXP (IPD-IMGT/HLA=20726).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00486
AC   CVCL_H017
DR   IPD-IMGT/HLA; 17395
DR   Wikidata; Q54799249
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:HGV,23:ANJU; B*44:ENWF,35:01:10; DRB1*01:EW,13:APWN (IPD-IMGT/HLA=17395).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00487
AC   CVCL_G714
SY   HN-2630114
DR   IPD-IMGT/HLA; 20727
DR   Wikidata; Q54799251
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BYWG,23:BZAP; B*35:113,44:03; DRB1*01:02,08:02 (IPD-IMGT/HLA=20727).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00488
AC   CVCL_H018
DR   IPD-IMGT/HLA; 17396
DR   Wikidata; Q54799252
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:HGV,33:DWH; B*52:01:05,58:VE; DRB1*13:02,15:AAXP (IPD-IMGT/HLA=17396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00489
AC   CVCL_H019
DR   IPD-IMGT/HLA; 16921
DR   Wikidata; Q54799253
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:YE,68:PNP; B*07:AWCA,14:12; DRB1*07:APA,13:02 (IPD-IMGT/HLA=16921).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00490
AC   CVCL_H020
DR   IPD-IMGT/HLA; 16922
DR   Wikidata; Q54799255
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:ANRC,24:CNFM; B*27:05:02,15:170; DRB1*04:08,12:02 (IPD-IMGT/HLA=16922).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00491
AC   CVCL_H021
DR   IPD-IMGT/HLA; 16923
DR   Wikidata; Q54799256
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26:08,32; B*40:BUAG,51; DRB1*13:93,11:04:01 (IPD-IMGT/HLA=16923).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00492
AC   CVCL_H022
DR   IPD-IMGT/HLA; 16924
DR   Wikidata; Q54799257
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:02,29:BCHD; B*18:AETB,49:01; DRB1*11:02:01,11:01:11 (IPD-IMGT/HLA=16924).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00493
AC   CVCL_H023
DR   IPD-IMGT/HLA; 16925
DR   Wikidata; Q54799258
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:FFF,66:AD; B*40:YZK,41:02; DRB1*13:01:01,13:94 (IPD-IMGT/HLA=16925).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00494
AC   CVCL_H024
DR   IPD-IMGT/HLA; 16926
DR   Wikidata; Q54799259
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,01:WCS; B*08:APTN,39:05; DRB1*11:83,04:07 (IPD-IMGT/HLA=16926).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00495
AC   CVCL_H025
DR   IPD-IMGT/HLA; 16927
DR   Wikidata; Q54799260
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11,31; B*07,35; DRB1*15:01:07,10:01:01 (IPD-IMGT/HLA=16927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00496
AC   CVCL_H026
DR   IPD-IMGT/HLA; 16928
DR   Wikidata; Q54799261
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03,29; B*35,44; DRB1*04:02,11:84 (IPD-IMGT/HLA=16928).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00497
AC   CVCL_H027
DR   IPD-IMGT/HLA; 16929
DR   Wikidata; Q54799263
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,11; B*40:BNBC,46; DRB1*11:01:01,04:05:08 (IPD-IMGT/HLA=16929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00498
AC   CVCL_H028
DR   IPD-IMGT/HLA; 16930
DR   Wikidata; Q54799264
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:AZSP,31:AF; B*07:EH,27:PEN; DRB1*04:83,11:01:01 (IPD-IMGT/HLA=16930).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00499
AC   CVCL_H029
DR   IPD-IMGT/HLA; 16931
DR   Wikidata; Q54799265
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,23; B*07,39:10; DRB1*11:02:01,01:23 (IPD-IMGT/HLA=16931).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00500
AC   CVCL_H030
DR   IPD-IMGT/HLA; 16932
DR   Wikidata; Q54799266
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:03,33; B*38:02,58; DRB1*13:02:01,04:06:03 (IPD-IMGT/HLA=16932).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00501
AC   CVCL_H031
DR   IPD-IMGT/HLA; 16933
DR   Wikidata; Q54799267
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:11; B*27:AETG,40:DG; DRB1*15:01,04:04:02 (IPD-IMGT/HLA=16933).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00502
AC   CVCL_H032
DR   IPD-IMGT/HLA; 16934
DR   Wikidata; Q54799269
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CNDW; B*13:01,35:AWZB; DRB1*11:01:01,04:84 (IPD-IMGT/HLA=16934).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00503
AC   CVCL_H003
DR   IPD-IMGT/HLA; 16908
DR   Wikidata; Q54799301
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANPZ,11:ANRC; B*40:XCG,50:01; DRB1*07:01:01:01/02,11:69 (IPD-IMGT/HLA=16908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00511
AC   CVCL_H004
SY   HN-5903965
DR   IPD-IMGT/HLA; 16936
DR   Wikidata; Q54799302
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:01,33:03; B*58:VE,18:33; DRB1*03:01,11:04 (IPD-IMGT/HLA=16936).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00512
AC   CVCL_H033
DR   IPD-IMGT/HLA; 17398
DR   Wikidata; Q54799304
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:ANRC,24:CNFM; B*27:AETG,51:AFHX; DRB1*15:02:01,13:03:03 (IPD-IMGT/HLA=17398).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00513
AC   CVCL_H034
DR   IPD-IMGT/HLA; 17399
DR   Wikidata; Q54799305
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CRFN,33:28; B*40:06,44:APAP; DRB1*09:01,13:02 (IPD-IMGT/HLA=17399).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00514
AC   CVCL_H035
DR   IPD-IMGT/HLA; 17402
DR   Wikidata; Q54799307
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:AUX,02:193; B*13:02,42:01; DRB1*03:02,07:APA (IPD-IMGT/HLA=17402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00515
AC   CVCL_H036
DR   IPD-IMGT/HLA; 17403
DR   Wikidata; Q54799309
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:BEKE,01:43; B*07:CUCC,44:ABYZ; DRB1*14:HEM,15:FJH (IPD-IMGT/HLA=17403).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00517
AC   CVCL_G715
DR   IPD-IMGT/HLA; 20729
DR   Wikidata; Q54799310
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BDFZ,24:131; B*35:05,40:XCG; DRB1*11:APWP,15:AAXP (IPD-IMGT/HLA=20729).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00518
AC   CVCL_H037
DR   IPD-IMGT/HLA; 17647
DR   Wikidata; Q54799312
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:02:01,11:52; B*44:APJW,55:XUB; DRB1*07:APA,08:FX (IPD-IMGT/HLA=17647).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00519
AC   CVCL_UV48
DR   IPD-IMGT/HLA; 17577
DR   Wikidata; Q93435314
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:50,03:ECAM (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00520
AC   CVCL_H038
DR   IPD-IMGT/HLA; 17646
DR   Wikidata; Q54799313
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:ENWD,30:30; B*13:AFB,57:GW; DRB1*07:APA,15:AK (IPD-IMGT/HLA=17646).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00521
AC   CVCL_H039
DR   IPD-IMGT/HLA; 17674
DR   Wikidata; Q54799314
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANFV,31:AF; B*07:CZZS,27:59N; DRB1*08:02,11:APWP (IPD-IMGT/HLA=17674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00522
AC   CVCL_H040
DR   IPD-IMGT/HLA; 17673
DR   Wikidata; Q54799315
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDC,11:XSH; B*51:CVAE,46:22; DRB1*09:01,16:02 (IPD-IMGT/HLA=17673).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00523
AC   CVCL_H041
DR   IPD-IMGT/HLA; 17672
DR   Wikidata; Q54799316
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:AZWY,32:MZ; B*40:06:01:01/02,52:16; DRB1*04:BDJV,07:APA (IPD-IMGT/HLA=17672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00524
AC   CVCL_H042
DR   IPD-IMGT/HLA; 17671
DR   Wikidata; Q54799318
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ARSC,02:ARDB; B*40:AVGG,39:54; DRB1*08:AP (IPD-IMGT/HLA=17671).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00525
AC   CVCL_H005
SY   HN-5817025
DR   IPD-IMGT/HLA; 17578
DR   Wikidata; Q54799319
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:90N,33:01; B*42:01,55:01; DRB1*08:04,13:02:01 (IPD-IMGT/HLA=17578).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00526
AC   CVCL_H043
DR   IPD-IMGT/HLA; 17670
DR   Wikidata; Q54799320
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANGN,03:ANGP; B*51:CVAE,37:19; DRB1*11:ARKC,13:ARCR (IPD-IMGT/HLA=17670).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00527
AC   CVCL_H006
DR   IPD-IMGT/HLA; 19325
DR   Wikidata; Q54799321
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ASAD,36:01; B*45:AC,53:01; DRB1*11:72,01:02:01 (IPD-IMGT/HLA=19325).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00530
AC   CVCL_H007
DR   IPD-IMGT/HLA; 19322
DR   Wikidata; Q54799322
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANFV,33:DWH; B*39:EDVK,18:33; DRB1*10:01,11:ARAP (IPD-IMGT/HLA=19322).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00531
AC   CVCL_H044
DR   IPD-IMGT/HLA; 19321
DR   Wikidata; Q54799324
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:ASZA,30:UCB; B*14:02:05,15:17:01:01/02; DRB1*01:02,11:APWP (IPD-IMGT/HLA=19321).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00533
AC   CVCL_H045
SY   HN-7628141
DR   IPD-IMGT/HLA; 19320
DR   Wikidata; Q54799325
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:01,02:ARDE; B*13:32,55:01:01/03; C*03:BPSK,06:02; DQB1*02:01,02:02; DRB1*03:VEW,07:FP; DRB3*02:UNW (IPD-IMGT/HLA=19320).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00534
AC   CVCL_H046
DR   IPD-IMGT/HLA; 19319
DR   Wikidata; Q54799326
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AZGG,03:BTSC; B*15:25:01,15:185; DRB1*04:03,15:02 (IPD-IMGT/HLA=19319).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00535
AC   CVCL_G716
DR   IPD-IMGT/HLA; 20734
DR   Wikidata; Q54799328
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:AZUR,26:PEU; B*07:CZZS,35:136; DRB1*04:NJV,11:APWP (IPD-IMGT/HLA=20734).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00536
AC   CVCL_H047
DR   IPD-IMGT/HLA; 19318
DR   Wikidata; Q54799329
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EK,34:BD; B*07:CZZS,53:21; DRB1*11:02,15:03 (IPD-IMGT/HLA=19318).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00538
AC   CVCL_H048
DR   IPD-IMGT/HLA; 19316
DR   Wikidata; Q54799330
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:AGNS,24:AREE; B*40:06,50:01; DRB1*03:51,15:02:01 (IPD-IMGT/HLA=19316).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00539
AC   CVCL_H049
DR   IPD-IMGT/HLA; 19315
DR   Wikidata; Q54799332
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:AZWY,32:MZ; B*40:PXF,51:02; DRB1*08:02:01,11:87 (IPD-IMGT/HLA=19315).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00540
AC   CVCL_H050
DR   IPD-IMGT/HLA; 19314
DR   Wikidata; Q54799333
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:DERS,31:FHK; B*15:BTMR,51:02; DRB1*04:01:01,14:94 (IPD-IMGT/HLA=19314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00541
AC   CVCL_H051
DR   IPD-IMGT/HLA; 19313
DR   Wikidata; Q54799334
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANGN,03:ANGP; B*18:AERV,39:11; DRB1*04:17:02,11:04:01 (IPD-IMGT/HLA=19313).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00542
AC   CVCL_H052
DR   IPD-IMGT/HLA; 19312
DR   Wikidata; Q54799336
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:APBA,32:AE; B*15:ARAW,45:AC; DRB1*13:01:06,15:01:01:01/02 (IPD-IMGT/HLA=19312).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00543
AC   CVCL_H053
DR   IPD-IMGT/HLA; 19311
DR   Wikidata; Q54799337
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANNR,03:BG; B*35:CUPD,51:CUPF; DRB1*04:03:01,03:11:02 (IPD-IMGT/HLA=19311).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00544
AC   CVCL_H054
DR   IPD-IMGT/HLA; 19310
DR   Wikidata; Q54799339
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:DEPW,02:DERE; B*13:JG,44:BURE; DRB1*15:01:01:01/02,04:72 (IPD-IMGT/HLA=19310).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00545
AC   CVCL_UV49
DR   IPD-IMGT/HLA; 19309
DR   Wikidata; Q93435497
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANNS,30:01; B*15:31,48:01; DRB1*04:79,11:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00546
AC   CVCL_H055
DR   IPD-IMGT/HLA; 19308
DR   Wikidata; Q54799340
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:ANGR; B*07:AWCA,18:04; DRB1*11:01:01/06/08,01:01:16 (IPD-IMGT/HLA=19308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00547
AC   CVCL_H056
DR   IPD-IMGT/HLA; 19307
DR   Wikidata; Q54799342
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:DWH,33:FDX; B*15:10,53:01; DRB1*08:04:01,11:86 (IPD-IMGT/HLA=19307).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00548
AC   CVCL_H057
DR   IPD-IMGT/HLA; 19305
DR   Wikidata; Q54799343
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BTSH; B*13:VE,46:PU; DRB1*12:02:01,09:09 (IPD-IMGT/HLA=19305).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00549
AC   CVCL_H058
DR   IPD-IMGT/HLA; 19304
DR   Wikidata; Q54799344
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:11,68:AEBA; B*07:CUDU,15:YJR; DRB1*14:04,14:93 (IPD-IMGT/HLA=19304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00550
AC   CVCL_H008
DR   IPD-IMGT/HLA; 19303
DR   Wikidata; Q54799345
RX   PubMed=20604891;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANPZ,11:ANRC; B*35:BJKC,56:01; DRB1*03:01:01:01/02,11:69 (IPD-IMGT/HLA=19303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00551
AC   CVCL_H059
DR   IPD-IMGT/HLA; 19301
DR   Wikidata; Q54799346
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:DEPX,BLANK; B*07:JNC,08:DFAU; DRB1*11:85,13:01:01 (IPD-IMGT/HLA=19301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00564
AC   CVCL_H060
DR   IPD-IMGT/HLA; 19583
DR   Wikidata; Q54799347
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,30:34; B*51:WBA,57:03; C*15:BJ,18:02; DQB1*05:01,06:04; DRB1*13:01,13:02; DRB3*03:01 (IPD-IMGT/HLA=19583).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00565
AC   CVCL_H061
DR   IPD-IMGT/HLA; 20027
DR   Wikidata; Q54799348
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01:43,24:CWFP; B*18:CNGW,52:AH; DRB1*11:ANTH,11:ARCT (IPD-IMGT/HLA=20027).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00566
AC   CVCL_H062
DR   IPD-IMGT/HLA; 19531
DR   Wikidata; Q54799350
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:70,23:ENWE; B*53:JV,53:JV; DRB1*01:02,11:APWP (IPD-IMGT/HLA=19531).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00573
AC   CVCL_UV50
DR   IPD-IMGT/HLA; 19559
DR   Wikidata; Q93435572
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:03,33:DWH; B*15:02,58:28; C*03:02,08:AJ; DRB1*08:APPA,15:AK (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00575
AC   CVCL_H063
DR   IPD-IMGT/HLA; 19567
DR   Wikidata; Q54799351
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:FDYW,03:74; B*08:DGPV,15:CYGP; C*03:FXP,07:AJB; DRB1*01:EW,15:AK (IPD-IMGT/HLA=19567).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00576
AC   CVCL_H064
DR   IPD-IMGT/HLA; 19566
DR   Wikidata; Q54799352
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:171:02,33:FEAM; B*13:CJT,58:CWUS; C*03:02,03:GFW; DRB1*03:VHY,16:02 (IPD-IMGT/HLA=19566).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00577
AC   CVCL_H065
DR   IPD-IMGT/HLA; 19565
DR   Wikidata; Q54799383
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:CWFP,25:11; B*18:DUUV,41:AE; DRB1*07:01,15:01 (IPD-IMGT/HLA=19565).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00578
AC   CVCL_H066
DR   IPD-IMGT/HLA; 19564
DR   Wikidata; Q54799384
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:73,24:17; B*15:CCFP,40:DHRY; DRB1*10:01,12:02 (IPD-IMGT/HLA=19564).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00580
AC   CVCL_H067
DR   IPD-IMGT/HLA; 19562
DR   Wikidata; Q54799385
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:02:05,36:01; B*07:AWCA,27:PEN; DRB1*07:NZC,11:APKF (IPD-IMGT/HLA=19562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00581
AC   CVCL_H068
DR   IPD-IMGT/HLA; 19561
DR   Wikidata; Q54799386
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:21,02:20:01; B*07:DUEE,35:08; DRB1*04:AAHZ,11:01 (IPD-IMGT/HLA=19561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00582
AC   CVCL_G717
DR   IPD-IMGT/HLA; 21155
DR   Wikidata; Q54799388
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BDFZ,31:01:08; B*46:JV,55:02; DRB1*04:05,09:01 (IPD-IMGT/HLA=21155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00583
AC   CVCL_H069
DR   IPD-IMGT/HLA; 20549
DR   Wikidata; Q54799389
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*25:01,29:ANTJ; B*57:30,18:RRG; C*06:AJB,12:FT; DRB1*04:AMCV,15:FJH (IPD-IMGT/HLA=20549).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00584
AC   CVCL_H070
DR   IPD-IMGT/HLA; 20550
DR   Wikidata; Q54799390
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:YE,68:AEAV; B*18:RRG,51:90; C*05:ANJN,15:BC; DRB1*03:XEV,13:ASGS (IPD-IMGT/HLA=20550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00587
AC   CVCL_G718
DR   IPD-IMGT/HLA; 21156
DR   Wikidata; Q54799392
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,32:GC; B*51:01:02,35:117; DRB1*04:07,15:AAXP (IPD-IMGT/HLA=21156).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00588
AC   CVCL_H071
DR   IPD-IMGT/HLA; 20553
DR   Wikidata; Q54799394
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANGK,29:ANJP; B*44:03,51:91; C*07:BJ,16:01; DRB1*07:APA,08:APPA (IPD-IMGT/HLA=20553).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00589
AC   CVCL_H072
DR   IPD-IMGT/HLA; 20554
DR   Wikidata; Q54799395
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:HGV,23:ANJU; B*18:RRG,49:10; C*07:ANHC,07:ET; DRB1*11:APWP,12:02 (IPD-IMGT/HLA=20554).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00590
AC   CVCL_H073
DR   IPD-IMGT/HLA; 20555
DR   Wikidata; Q54799396
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,24:CNFN; B*37:01:01,51:01:17; C*01:BG,12:NP; DRB1*01:EW,04:07 (IPD-IMGT/HLA=20555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00591
AC   CVCL_G719
DR   IPD-IMGT/HLA; 21157
DR   Wikidata; Q54799397
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANPZ,11:ANRC; B*35:08:01,35:115; C*04:ANJM,04:TSR; DRB1*07:APA,13:02 (IPD-IMGT/HLA=21157).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00592
AC   CVCL_H074
DR   IPD-IMGT/HLA; 20556
DR   Wikidata; Q54799399
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:DUDE,29:DHVF; B*53:01:01,08:55; DRB1*11:01,15:03 (IPD-IMGT/HLA=20556).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00596
AC   CVCL_H075
DR   IPD-IMGT/HLA; 20101
DR   Wikidata; Q54799400
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANKG,24:AZSA; B*47:06,15:DFRA; DRB1*13:AFWJ,13:APVH (IPD-IMGT/HLA=20101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00597
AC   CVCL_G720
DR   IPD-IMGT/HLA; 21158
DR   Wikidata; Q54799402
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:WUS,23:ANXH; B*08:XKT,44:108N; C*04:TSR,07:ANHC; DRB1*03:VHY,07:APA (IPD-IMGT/HLA=21158).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00598
AC   CVCL_H076
DR   IPD-IMGT/HLA; 20104
DR   Wikidata; Q54799403
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DUEK,26:GAX; B*37:01:01,51:92; DRB1*04:AAHZ,10:01 (IPD-IMGT/HLA=20104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00599
AC   CVCL_G721
DR   IPD-IMGT/HLA; 21159
DR   Wikidata; Q54799404
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANJ,11:DHVB; B*46:DNXM,40:134; DRB1*09:AB (IPD-IMGT/HLA=21159).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00600
AC   CVCL_H077
DR   IPD-IMGT/HLA; 20105
DR   Wikidata; Q54799406
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:01,74:DWF; B*15:BKNX,78:07; C*02:TF,16:01; DRB1*13:AFWH,13:AFWK (IPD-IMGT/HLA=20105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00601
AC   CVCL_G722
DR   IPD-IMGT/HLA; 21160
DR   Wikidata; Q54799407
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DUEK,03:DUDJ; B*08:XKT,07:114; DRB1*01:01,03:01 (IPD-IMGT/HLA=21160).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00602
AC   CVCL_G723
DR   IPD-IMGT/HLA; 21161
DR   Wikidata; Q54799408
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:ANGR; B*13:02,07:115; C*06AJB,07:BJ; DRB1*04:APPB,11:ARAP (IPD-IMGT/HLA=21161).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00603
AC   CVCL_H078
DR   IPD-IMGT/HLA; 20106
DR   Wikidata; Q54799409
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:14,68:AEBA; B*27:EKN,53:22; C*02:AFB,04:APNR; DRB1*13:02,15:03 (IPD-IMGT/HLA=20106).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00604
AC   CVCL_H079
DR   IPD-IMGT/HLA; 20107
DR   Wikidata; Q54799410
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:APCS,68:APEB; B*07:CZZS,44:02:13; DRB1*01:EW,15:AK (IPD-IMGT/HLA=20107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00605
AC   CVCL_UV51
DR   IPD-IMGT/HLA; 20108
DR   Wikidata; Q93435723
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,24:CNFN; B*57:01:01,57:24; C*06:AJB,06:REV; DRB1*01:02,07:APA (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00606
AC   CVCL_G724
DR   IPD-IMGT/HLA; 21162
DR   Wikidata; Q54799411
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANGK,31:KP; B*40:135,07:CZZS; DRB1*04:AFRF,15:JH (IPD-IMGT/HLA=21162).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00607
AC   CVCL_H080
DR   IPD-IMGT/HLA; 20109
DR   Wikidata; Q54799412
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANJ,34:01; B*18:RRG,27:63; DRB1*12:02,15:02 (IPD-IMGT/HLA=20109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00608
AC   CVCL_H081
DR   IPD-IMGT/HLA; 20110
DR   Wikidata; Q54799413
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANJ,74:AB; B*46:DNXM,51:93; DRB1*04:05,14:04 (IPD-IMGT/HLA=20110).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00610
AC   CVCL_H082
DR   IPD-IMGT/HLA; 20114
DR   Wikidata; Q54799415
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BDDA,02:CNDW; B*15:DFRA,54:20; DRB1*12:GW,15:VYF (IPD-IMGT/HLA=20114).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00611
AC   CVCL_H083
DR   IPD-IMGT/HLA; 20115
DR   Wikidata; Q54799416
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,25:01; B*18:RRG,08:56; DRB1*03:WHX,15:VYF (IPD-IMGT/HLA=20115).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00612
AC   CVCL_G725
DR   IPD-IMGT/HLA; 21163
DR   Wikidata; Q54799417
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DUEK,03:DUDJ; B*44:ENWF,41:136; DRB1*01:02,11:01 (IPD-IMGT/HLA=21163).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00614
AC   CVCL_H084
DR   IPD-IMGT/HLA; 20089
DR   Wikidata; Q54799418
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:ANRC,24:CNFM; B*07:DGXD,40:DBEV; C*03:04,03:80; DRB1*03:WZB,04:ADTZ (IPD-IMGT/HLA=20089).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00615
AC   CVCL_H085
DR   IPD-IMGT/HLA; 20088
DR   Wikidata; Q54799419
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ASAD,36:01; B*15:CVZU,44:DGPW; C*05:36,12:03; DRB1*03:WHX,11:ARAP (IPD-IMGT/HLA=20088).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00616
AC   CVCL_H086
DR   IPD-IMGT/HLA; 20087
DR   Wikidata; Q54799421
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANGN,03:ANGP; B*44:DHNG,57:PXJ; C*05:AC,06:31; DRB1*07:APA,08:FX (IPD-IMGT/HLA=20087).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00617
AC   CVCL_H087
DR   IPD-IMGT/HLA; 20086
DR   Wikidata; Q54799422
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANKG,24:AZSA; B*08:CTZR,44:DGWR; C*07:CVAG,05:35; DRB1*03:WKH,04:AFMT (IPD-IMGT/HLA=20086).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00618
AC   CVCL_H088
DR   IPD-IMGT/HLA; 20085
DR   Wikidata; Q54799423
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:AF,68:AEBG; B*27:AETG,51:DREF; C*08:DJRU,02:26:02; DRB1*08:BJ,16:AB (IPD-IMGT/HLA=20085).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00619
AC   CVCL_G726
DR   IPD-IMGT/HLA; 21154
DR   Wikidata; Q54799425
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BANP,23:ANJU; B*08:DGUB,14:BPYK; C*08:02,07:141; DRB1*07:NZC,11:APKF (IPD-IMGT/HLA=21154).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00620
AC   CVCL_UV52
DR   IPD-IMGT/HLA; 20084
DR   Wikidata; Q93435786
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*34:BD,68:PNP; B*07:DHRB,78:01; C*15:22,16:01; DRB1*11:AET,13:ASGP (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   BY00623
AC   CVCL_H089
DR   IPD-IMGT/HLA; 20080
DR   Wikidata; Q54799426
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BANP,23:ANJU; B*35:08,52:01; C*04:FEAS,16:20; DRB1*04:BDJV,13:BMD (IPD-IMGT/HLA=20080).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00624
AC   CVCL_G727
DR   IPD-IMGT/HLA; 21153
DR   Wikidata; Q54799427
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,01:WCS; B*08:DGXF,08:DRFR; C*07:CVAG,07:140; DRB1*01:EW,03:XBD (IPD-IMGT/HLA=21153).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00625
AC   CVCL_G728
DR   IPD-IMGT/HLA; 21152
DR   Wikidata; Q54799428
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:WUS,33:DWH; B*08:CEMC,51:DFXA; C*02:02,07:140; DRB1*03:XEV,13:ASGS (IPD-IMGT/HLA=21152).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00626
AC   CVCL_H090
DR   IPD-IMGT/HLA; 20079
DR   Wikidata; Q54799429
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANXF,32:YH; B*37:JTB,50:01; C*06:02,06:30; DRB1*03:WKH,04:AFMT (IPD-IMGT/HLA=20079).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00628
AC   CVCL_H091
DR   IPD-IMGT/HLA; 20073
DR   Wikidata; Q54799430
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,01:WCS; B*35:DFWB,51:DFWU; C*14:02:01,04:55; DRB1*01:ANWV,04:AGCN (IPD-IMGT/HLA=20073).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00629
AC   CVCL_H092
DR   IPD-IMGT/HLA; 20072
DR   Wikidata; Q54799431
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BANP,23:ANJU; B*18:DHPD,35:CWAD; C*07:CVAG,04:54; DRB1*07:APA,11:ARAP (IPD-IMGT/HLA=20072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00630
AC   CVCL_H093
DR   IPD-IMGT/HLA; 20071
DR   Wikidata; Q54799461
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:ANGR; B*07:DGTG,51:DGTH; C*07:02/50/66/74,14:16; DRB1*03:WHX,15:VYF (IPD-IMGT/HLA=20071).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00631
AC   CVCL_H094
DR   IPD-IMGT/HLA; 20070
DR   Wikidata; Q54799462
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BZNT,24:CNEX; B*35:DDPF,48:KG; C*15:27; DRB1*04:AFRE,08:02 (IPD-IMGT/HLA=20070).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00632
AC   CVCL_H095
DR   IPD-IMGT/HLA; 20069
DR   Wikidata; Q54799464
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:11; B*40:06:01:01/02,37:22; C*06:AJB,12:02; DRB1*10:01,15:AK (IPD-IMGT/HLA=20069).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00635
AC   CVCL_H096
DR   IPD-IMGT/HLA; 20062
DR   Wikidata; Q54799465
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:ANGR; B*08:DHRE,55:DFXF; DRB1*09:01:02,03:01:09 (IPD-IMGT/HLA=20062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00637
AC   CVCL_H097
DR   IPD-IMGT/HLA; 20059
DR   Wikidata; Q54799466
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,68:PNP; B*08:DGUB,14:02; DRB1*03:01:01:01/02,13:66:02 (IPD-IMGT/HLA=20059).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00638
AC   CVCL_H098
DR   IPD-IMGT/HLA; 20058
DR   Wikidata; Q54799467
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:BTPY,68:ADHW; B*35:AAJB,37:AUCE; DRB1*13:01:01,11:92 (IPD-IMGT/HLA=20058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00639
AC   CVCL_H099
DR   IPD-IMGT/HLA; 20057
DR   Wikidata; Q54799468
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CNDW,02:CNDW; B*40:DGRY,49:01; DRB1*14:97,04:05:01 (IPD-IMGT/HLA=20057).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00641
AC   CVCL_H100
DR   IPD-IMGT/HLA; 20056
DR   Wikidata; Q54799469
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:AJVG,33:FDX; B*15:17,44:ANNB; DRB1*13:98,15:02:01 (IPD-IMGT/HLA=20056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00642
AC   CVCL_H101
DR   IPD-IMGT/HLA; 20055
DR   Wikidata; Q54799471
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:DEPW,02:DERE; B*08:BMNN,44:BTNY; DRB1*08:04:05,04:01:01 (IPD-IMGT/HLA=20055).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00645
AC   CVCL_H102
DR   IPD-IMGT/HLA; 20049
DR   Wikidata; Q54799472
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,03:ANPZ; B*40:PXF,57:AG; DRB1*11:91,11:03 (IPD-IMGT/HLA=20049).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00646
AC   CVCL_H103
DR   IPD-IMGT/HLA; 20048
DR   Wikidata; Q54799473
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDC,11:XSH; B*27:BFJA,55:CUDG; DRB1*15:01:01:01/02,01:01:18 (IPD-IMGT/HLA=20048).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00647
AC   CVCL_H104
DR   IPD-IMGT/HLA; 20116
DR   Wikidata; Q54799476
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:BTPU,33:DWH; B*14:BF,58:DFFP; DRB1*07:01:01:01/02,11:93 (IPD-IMGT/HLA=20116).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00653
AC   CVCL_G922
DR   IPD-IMGT/HLA; 21463
DR   Wikidata; Q54799477
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,26:01:14; B*40:AZAY,52:AH; C*03:04,12:02; DRB1*14:07:01,14:04 (IPD-IMGT/HLA=21463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00654
AC   CVCL_G923
DR   IPD-IMGT/HLA; 21188
DR   Wikidata; Q54799478
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:140,31:DUKU; B*15:25,51:CVAE; C*07:26,14:02:01; DRB1*10:01:01,15:02:01 (IPD-IMGT/HLA=21188).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00656
AC   CVCL_G924
DR   IPD-IMGT/HLA; 20667
DR   Wikidata; Q54799479
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:76,24:07; B*07:EH,08:XKT; C*07:WCP,15:05; DRB1*03:01:01,15:01:01 (IPD-IMGT/HLA=20667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00657
AC   CVCL_G925
DR   IPD-IMGT/HLA; 21465
DR   Wikidata; Q54799481
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02:35,31:DUKU; B*07:CVAG,52:AH; C*07:WCP,12:02; DRB1*13:01:01,04:03:01 (IPD-IMGT/HLA=21465).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00659
AC   CVCL_G926
DR   IPD-IMGT/HLA; 20665
DR   Wikidata; Q54799482
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:CWFP,68:CAKR; B*51:CVAE,52:AH; C*12:02:05,16:02; DRB1*01:01:01,04:03:01 (IPD-IMGT/HLA=20665).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00660
AC   CVCL_G927
DR   IPD-IMGT/HLA; 21464
DR   Wikidata; Q54799483
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ECAM,68:CAKR; B*13:02,15:18; C*07:04:04,06:02; DRB1*07:01,08:03:02 (IPD-IMGT/HLA=21464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00661
AC   CVCL_G928
DR   IPD-IMGT/HLA; 20663
DR   Wikidata; Q54799484
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ECAM,68:CAKR; B*40:06,51:CVAE; C*15:BJ; DRB1*04:05:10,04:07:01 (IPD-IMGT/HLA=20663).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00663
AC   CVCL_H105
DR   IPD-IMGT/HLA; 20668
DR   Wikidata; Q54799486
RX   PubMed=21568944;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:DHUY,29:DHVF; B*44:ENWF,08:61; DRB1*03:01,13:01 (IPD-IMGT/HLA=20668).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00668
AC   CVCL_G929
DR   IPD-IMGT/HLA; 21215
DR   Wikidata; Q54799487
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:03,24:DZRG; B*18:01:01,18:50; C*07:EMCY,12:DPG; DRB1*09:MV,15:DFZE (IPD-IMGT/HLA=21215).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00669
AC   CVCL_G930
DR   IPD-IMGT/HLA; 21208
DR   Wikidata; Q54799488
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CNDW,02:BDDA; B*15:DAFZ,35:DHXM; C*03:86,04:FEAS; DRB1*09:01,11:01 (IPD-IMGT/HLA=21208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00674
AC   CVCL_G931
DR   IPD-IMGT/HLA; 21213
DR   Wikidata; Q54799490
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:50,02:DFKP; B*15:17,73:01; DRB1*04:05,13:02 (IPD-IMGT/HLA=21213).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00676
AC   CVCL_G932
DR   IPD-IMGT/HLA; 21377
DR   Wikidata; Q54799491
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CMXA,24:CPDZ; B*15:20,18:50; DRB1*03:ATHX,04:11 (IPD-IMGT/HLA=21377).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00682
AC   CVCL_G729
DR   IPD-IMGT/HLA; 21536
DR   Wikidata; Q54799492
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:CWFP,02:263; B*18:RRG,51:01; C*12:03,15:02; DRB1*11:03,07:01 (IPD-IMGT/HLA=21536).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00683
AC   CVCL_G730
DR   IPD-IMGT/HLA; 21534
DR   Wikidata; Q54799493
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:EMRP,03:AUW; B*37:JTB,44:EBEA; C*05:AC,06:44; DRB1*11:04,13:01 (IPD-IMGT/HLA=21534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00684
AC   CVCL_G731
DR   IPD-IMGT/HLA; 21533
DR   Wikidata; Q54799495
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDA,26:PEU; B*40:DBET,56:BD; C*03:94,07:02; DRB1*12:BJ,14:04 (IPD-IMGT/HLA=21533).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00685
AC   CVCL_G732
DR   IPD-IMGT/HLA; 21532
DR   Wikidata; Q54799496
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EKGH,68:EKGW; B*48:CKTN; C*08:01:01,08:35; DRB1*08:02,09:01 (IPD-IMGT/HLA=21532).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00686
AC   CVCL_G733
DR   IPD-IMGT/HLA; 21531
DR   Wikidata; Q54799497
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EJUS,24:EPMH; B*39:EVKD,52:FJH; C*07:02,12:44; DRB1*08:03,15:02 (IPD-IMGT/HLA=21531).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00688
AC   CVCL_G734
DR   IPD-IMGT/HLA; 21529
DR   Wikidata; Q54799498
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:BSXK,68:54; B*15:BJXJ,18:DNWR; DRB1*01:02,14:01 (IPD-IMGT/HLA=21529).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00690
AC   CVCL_G735
DR   IPD-IMGT/HLA; 21535
DR   Wikidata; Q54799500
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:66,02:DFKP; B*35:EAZA,44:EAPK; C*04:EJUE,07:EMCY; DRB1*11:04,15:01 (IPD-IMGT/HLA=21535).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00695
AC   CVCL_G736
DR   IPD-IMGT/HLA; 21819
DR   Wikidata; Q54799502
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:EPZE,74;CWPF; B*37:EJPY,50;01; C*15:05:01,06:47; DRB1*11:02,15:03 (IPD-IMGT/HLA=21819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00697
AC   CVCL_G737
DR   IPD-IMGT/HLA; 21817
DR   Wikidata; Q54799503
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EKAE,29:DFUS; B*07:EH,44:AXJM; C*16:02:01,15:36; DRB1*04:02,10:01 (IPD-IMGT/HLA=21817).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00698
AC   CVCL_G738
DR   IPD-IMGT/HLA; 21816
DR   Wikidata; Q54799504
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:02:01,23:30; B*13:CYFZ,50:02; DRB1*07:01 (IPD-IMGT/HLA=21816).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00699
AC   CVCL_G739
DR   IPD-IMGT/HLA; 21815
DR   Wikidata; Q54799505
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:FJUK,68:03:03; B*52:EWD,78:01; C*12:CWNM,16:DBJV; DRB1*13:02,15:02 (IPD-IMGT/HLA=21815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00701
AC   CVCL_G740
DR   IPD-IMGT/HLA; 21813
DR   Wikidata; Q54799507
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:FJUK,02:271; B*08:DZFC,50:01; DRB1*03:01,07:FX (IPD-IMGT/HLA=21813).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00702
AC   CVCL_G741
DR   IPD-IMGT/HLA; 21812
DR   Wikidata; Q54799508
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*74:AB,23:31; B*35:EAZA,44:CUBJ; C*04:EKDN; DRB1*03:02,13:01 (IPD-IMGT/HLA=21812).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00704
AC   CVCL_G742
DR   IPD-IMGT/HLA; 21810
DR   Wikidata; Q54799510
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:DEJK,31:EPMN; B*27:ADDM,44:DKBZ; C*02:ATZ,16:27; DRB1*04:01,11:01 (IPD-IMGT/HLA=21810).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00705
AC   CVCL_G743
DR   IPD-IMGT/HLA; 21809
DR   Wikidata; Q54799511
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:EJUP; B*08:DZZC,08:EABG; C*07:151,07:CVAG; DRB1*03:01,08:04 (IPD-IMGT/HLA=21809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00706
AC   CVCL_G744
DR   IPD-IMGT/HLA; 21808
DR   Wikidata; Q54799512
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:FJUK,23:01:04; B*53:JV,57:EJRM; C*04:EJUD,06:EJUH; DRB1*03:DFXV,07:EJVX (IPD-IMGT/HLA=21808).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00708
AC   CVCL_G745
DR   IPD-IMGT/HLA; 21807
DR   Wikidata; Q54799551
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:02,31:40; B*35:11,40:EGNX; DRB1*04:07,15:01 (IPD-IMGT/HLA=21807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00709
AC   CVCL_G746
DR   IPD-IMGT/HLA; 21806
DR   Wikidata; Q54799552
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANJ,02:267; B*39:09,46:DNXM; DRB1*04:05,14:BCAD (IPD-IMGT/HLA=21806).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00711
AC   CVCL_G747
DR   IPD-IMGT/HLA; 21804
DR   Wikidata; Q54799553
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:02,03:89; B*08:DYSE,18:EKCS; DRB1*08:04,13:04 (IPD-IMGT/HLA=21804).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00712
AC   CVCL_G748
DR   IPD-IMGT/HLA; 21803
DR   Wikidata; Q54799554
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ECAM,30:44; B*15:10,44:EAPH; C*03:EAJZ,05:EKRG; DRB1*04:01,13:02 (IPD-IMGT/HLA=21803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00713
AC   CVCL_G749
DR   IPD-IMGT/HLA; 21799
DR   Wikidata; Q54799556
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:88,01:FJUK; B*07:EJZK,08:EAAY; C*07:EJZY,07:EKAA; DRB1*04:DZTN,13:CVMG (IPD-IMGT/HLA=21799).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00714
AC   CVCL_G750
DR   IPD-IMGT/HLA; 21798
DR   Wikidata; Q54799557
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ECAM,01:01:20; B*08:EANF,35:CWPY; C*07:EMBN,12:AUCW; DRB1*04:ZX,15:01 (IPD-IMGT/HLA=21798).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00715
AC   CVCL_G751
DR   IPD-IMGT/HLA; 21797
DR   Wikidata; Q54799558
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ECAM,11:70; B*35:EKCX,55:EKCY; C*01:EARV,04:EJZV; DRB1*09:EU,14:DGWD (IPD-IMGT/HLA=21797).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00716
AC   CVCL_G752
DR   IPD-IMGT/HLA; 21796
DR   Wikidata; Q54799559
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AKEF,32:EKAP; B*08:CTZR,44:EPAF; C*05:AC,07:150Q; DRB1*03:01,15:01 (IPD-IMGT/HLA=21796).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00718
AC   CVCL_G754
DR   IPD-IMGT/HLA; 21789
DR   Wikidata; Q54799561
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:DHUY,68:01; B*53:01:01,41:14; DRB1*07:01,13:02 (IPD-IMGT/HLA=21789).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00720
AC   CVCL_G755
DR   IPD-IMGT/HLA; 21787
DR   Wikidata; Q54799562
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:AUW,24:ERZA; B*35:CGAH,40:148; C*04:EJUB,15:DCJC; DRB1*07:FX,15:02 (IPD-IMGT/HLA=21787).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00721
AC   CVCL_G756
DR   IPD-IMGT/HLA; 21786
DR   Wikidata; Q54799563
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:EJUY,68:CVZG; B*44:ENWF,51:101; C*05:EKRG,15;DCJC; DRB1*04:09,14:02 (IPD-IMGT/HLA=21786).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00722
AC   CVCL_G757
DR   IPD-IMGT/HLA; 21785
DR   Wikidata; Q54799565
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:EPMP,33:EKYT; B*35:03:06,13:02; C*06:EJZW,12:AUGY; DRB1*07:FX,14:BCAD (IPD-IMGT/HLA=21785).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00723
AC   CVCL_G758
DR   IPD-IMGT/HLA; 21784
DR   Wikidata; Q54799566
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EJUS,24:EPMH; B*44:111,51:CVAE; C*04:ENPE,14:EKVH; DRB1*04:02,13:01 (IPD-IMGT/HLA=21784).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00725
AC   CVCL_G759
DR   IPD-IMGT/HLA; 21782
DR   Wikidata; Q54799568
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:EKGJ,32:EKGV; B*14:02:01,41:15; C*08:DPG,17:RV; DRB1*01:02,13:03 (IPD-IMGT/HLA=21782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00726
AC   CVCL_G760
DR   IPD-IMGT/HLA; 22289
DR   Wikidata; Q54799569
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EGBK,02:ECWK; B*15:CCWG,15:25; C*07:FEU,08:42; DRB1*12:02,12:UF (IPD-IMGT/HLA=22289).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00729
AC   CVCL_G761
DR   IPD-IMGT/HLA; 22287
DR   Wikidata; Q54799570
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:EJTF,02:EJTK; B*49:01:01,53:24; C*04:EKHJ,07:EKHM; DRB1*04:05,11:01 (IPD-IMGT/HLA=22287).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00730
AC   CVCL_G763
DR   IPD-IMGT/HLA; 22286
DR   Wikidata; Q54799571
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:EJTF,02:EJTK; B*08:66,15:DFRA; C*03:EMHG,07:EMHF; DRB1*03:01,04:01 (IPD-IMGT/HLA=22286).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00731
AC   CVCL_G764
DR   IPD-IMGT/HLA; 22260
DR   Wikidata; Q54799573
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EAGM,11:DHVB; B*27:EKN,35:148; DRB1*01:01,01:03 (IPD-IMGT/HLA=22260).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00732
AC   CVCL_G765
DR   IPD-IMGT/HLA; 22285
DR   Wikidata; Q54799574
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EKXW,02:EBGK; B*07:EKXK,44:43:02; C*07:EJZY,07:EKAA; DRB1*07:01,13:01 (IPD-IMGT/HLA=22285).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00733
AC   CVCL_G766
DR   IPD-IMGT/HLA; 22284
DR   Wikidata; Q54799575
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:EPMK; B*40:157,07:EH; C*07:EYCV,15:AJUE; DRB1*14:04,15:02 (IPD-IMGT/HLA=22284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00734
AC   CVCL_G767
DR   IPD-IMGT/HLA; 22283
DR   Wikidata; Q54799576
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CVYA,32:EKCH; B*44:114,51:ENFB; C*15:CUYF,16:EKPE; DRB1*07:FX,12:DUKV (IPD-IMGT/HLA=22283).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00735
AC   CVCL_G768
DR   IPD-IMGT/HLA; 22271
DR   Wikidata; Q54799577
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AF,02:GNF; B*51:CVAE,49:01:01; C*07:AG,15:02; DRB1*04:05,11:01 (IPD-IMGT/HLA=22271).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00736
AC   CVCL_G769
DR   IPD-IMGT/HLA; 22270
DR   Wikidata; Q54799578
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EK,03:EKGN; B*27:02,41:16; C*02:EKDE,07:EKHN; DRB1*13:05,16:01 (IPD-IMGT/HLA=22270).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00737
AC   CVCL_G770
DR   IPD-IMGT/HLA; 22267
DR   Wikidata; Q54799579
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:EKMV,24:EPMF; B*40:06,40:110; C*07:EPDC,12:CGCW; DRB1*07:FX,15;01 (IPD-IMGT/HLA=22267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00738
AC   CVCL_G771
DR   IPD-IMGT/HLA; 22266
DR   Wikidata; Q54799580
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:EKFM,03:EKFM; B*35:150,07:FAPG; C*04:EJUE,07:EPWA; DRB1*07:FX,11:01 (IPD-IMGT/HLA=22266).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00739
AC   CVCL_G772
DR   IPD-IMGT/HLA; 22264
DR   Wikidata; Q54799581
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:CNFR,68:PNP; B*14:02:01,35:149; C*04:ZFD,08:BE; DRB1*01:DGMG,04:DSJ (IPD-IMGT/HLA=22264).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00741
AC   CVCL_G933
DR   IPD-IMGT/HLA; 22261
DR   Wikidata; Q54799583
RX   PubMed=21729010;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:APEC,24:CNFP; B*40:JMM,54:AB; DRB1*15:01:01:01/02,14:100 (IPD-IMGT/HLA=22261).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00749
AC   CVCL_G773
DR   IPD-IMGT/HLA; 22647
DR   Wikidata; Q54799584
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EJZF,03:EJZG; B*18:54,51:CVAE; C*01:EBNM,07:EJNH; DRB1*01:01,15:01 (IPD-IMGT/HLA=22647).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00750
AC   CVCL_G774
DR   IPD-IMGT/HLA; 22646
DR   Wikidata; Q54799586
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:EKYG,26:DYRT; B*35:156,08:XKT; DRB1*13:02,13:04 (IPD-IMGT/HLA=22646).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00751
AC   CVCL_G775
DR   IPD-IMGT/HLA; 22645
DR   Wikidata; Q54799587
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:EJRU,24:EPWF; B*52:DZXA,54:EPUA; C*01:CYS,12:44; DRB1*04:05,15:02 (IPD-IMGT/HLA=22645).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00752
AC   CVCL_G776
DR   IPD-IMGT/HLA; 23040
DR   Wikidata; Q54799588
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:06,2402; B*35:17,39:06; C*03:04,07:02; DRB1*16:02:01,14:108 (IPD-IMGT/HLA=23040).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00759
AC   CVCL_G777
DR   IPD-IMGT/HLA; 23031
DR   Wikidata; Q54799590
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:CNFU,68:ARGF; B*07:EH,51:DNXY; C*15:02:01,15:36; DRB1*08:02,10:AC (IPD-IMGT/HLA=23031).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00763
AC   CVCL_G778
DR   IPD-IMGT/HLA; 23027
DR   Wikidata; Q54799591
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:ANRC,24:CNFM; B*27:AETG,52:01; DRB1*12:DUKV,14:107 (IPD-IMGT/HLA=23027).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00765
AC   CVCL_G779
DR   IPD-IMGT/HLA; 23025
DR   Wikidata; Q54799592
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24ENPX; B*07:EJRA,39:06; C*07:EMBK,07:EKXY; DRB1*14:106,15:01 (IPD-IMGT/HLA=23025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00766
AC   CVCL_G780
DR   IPD-IMGT/HLA; 23024
DR   Wikidata; Q54799594
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:EKJJ,68:EKJK; B*13:UUB,15:EATR; C*03:ECYV,06:EMRN; DRB1*08:01,07:21 (IPD-IMGT/HLA=23024).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00769
AC   CVCL_G781
DR   IPD-IMGT/HLA; 23022
DR   Wikidata; Q54799595
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:ERPK,68:ERYU; B*35:BHH,40:CMFM; DRB1*04:05:01,08:42 (IPD-IMGT/HLA=23022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00770
AC   CVCL_G782
DR   IPD-IMGT/HLA; 23021
DR   Wikidata; Q54799596
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:EPMK,24:EPMK; B*15:21,40:EGCH; C*04:EKVK,04:03; DRB1*09:01:02,04:95 (IPD-IMGT/HLA=23021).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00771
AC   CVCL_G783
DR   IPD-IMGT/HLA; 23020
DR   Wikidata; Q54799598
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:ERNP,24:ERNW; B*15:CRSD,35:EVNK; DRB1*12:02:01,16:18 (IPD-IMGT/HLA=23020).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00772
AC   CVCL_G784
DR   IPD-IMGT/HLA; 23039
DR   Wikidata; Q54799599
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:EJTF,02:EJTK; B*08:EANG,40:EABM; C*03:EBCY,07:EJWS; DRB1*13:02,03:60 (IPD-IMGT/HLA=23039).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00773
AC   CVCL_G785
DR   IPD-IMGT/HLA; 23018
DR   Wikidata; Q54799600
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:FDNV,32:ENRH; B*14:BPYK,38:BPSA; DRB1*15:01,07:20 (IPD-IMGT/HLA=23018).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00779
AC   CVCL_G786
DR   IPD-IMGT/HLA; 23046
DR   Wikidata; Q54799638
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EAGM,03:EKPR; B*07:EKFP,35:EKFW; C*04:EJUE,07:EPWA; DRB1*13:11,11:102 (IPD-IMGT/HLA=23046).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00782
AC   CVCL_G787
DR   IPD-IMGT/HLA; 23045
DR   Wikidata; Q54799640
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:EKFM; B*44:03,57:BZCF; C*04:EKHJ,07:EKHM; DRB1*08:04:06,15:03 (IPD-IMGT/HLA=23045).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00786
AC   CVCL_G788
DR   IPD-IMGT/HLA; 23043
DR   Wikidata; Q54799641
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:EPWM,68:DGJC; B*39:09,51:EKNW; C*07:EYCV,15:AJUE; DRB1*14:02,14:109 (IPD-IMGT/HLA=23043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00829
AC   CVCL_G789
DR   IPD-IMGT/HLA; 24698
DR   Wikidata; Q54799642
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:31,68:01; B*44:DNBV,58:BG; DRB1*12:DUKV,13:31 (IPD-IMGT/HLA=24698).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00831
AC   CVCL_G790
DR   Wikidata; Q54799644
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   BY00832
AC   CVCL_G791
DR   Wikidata; Q54799645
RX   PubMed=21995494;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   BY00846
AC   CVCL_9T36
DR   IPD-IMGT/HLA; 25460
DR   Wikidata; Q54799646
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:JGMS,68:84; B*35:16,51:GDWH; C*04:FEAS,15:AHR; DRB1*04:02,14:06 (IPD-IMGT/HLA=25460).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00847
AC   CVCL_9T37
DR   IPD-IMGT/HLA; 25461
DR   Wikidata; Q54799647
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:JGMT,02:331; B*39:06,48:AF; C*07:FEAU,08:DJRU; DRB1*14:02,14:EFMC (IPD-IMGT/HLA=25461).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00848
AC   CVCL_9T38
DR   IPD-IMGT/HLA; 25463
DR   Wikidata; Q54799648
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:JGMS,02:332; B*15:GTUV,27:GRGU; DRB1*04:01,01:AH (IPD-IMGT/HLA=25463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00849
AC   CVCL_9T39
DR   IPD-IMGT/HLA; 25464
DR   Wikidata; Q54799649
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:JDXY,33:52; B*35:GPPZ,35:GNFZ; DRB1*07:01,11:01 (IPD-IMGT/HLA=25464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00850
AC   CVCL_9T40
DR   IPD-IMGT/HLA; 25465
DR   Wikidata; Q54799651
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:JGMS,11:109N; B*07:DUHX,44DUJX; DRB1*1301,1501 (IPD-IMGT/HLA=25465).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00851
AC   CVCL_9T41
DR   IPD-IMGT/HLA; 25466
DR   Wikidata; Q54799652
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AZGG,11:01:35; B*13:VS,52:MX; DRB1*10:MN,15:02 (IPD-IMGT/HLA=25466).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00852
AC   CVCL_9T42
DR   IPD-IMGT/HLA; 25468
DR   Wikidata; Q54799654
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:JGMT,33:53; B*51:DVJA,57:AC; DRB1*07:01,13:01 (IPD-IMGT/HLA=25468).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00854
AC   CVCL_9T43
DR   IPD-IMGT/HLA; 25469
DR   Wikidata; Q54799655
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*34:02:01,03:133; B*07:FPJG,53:FMAA; C*04:FEAS; DRB1*12:02,15:03 (IPD-IMGT/HLA=25469).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00857
AC   CVCL_9T44
DR   IPD-IMGT/HLA; 25485
DR   Wikidata; Q54799657
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:JGMS,03:108; B*35:EGUP,57:GWR; DRB1*01:01,07:FX (IPD-IMGT/HLA=25485).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00858
AC   CVCL_9T45
DR   IPD-IMGT/HLA; 25484
DR   Wikidata; Q54799658
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:113,24:17; B*15:AUCX,51:EKEN; DRB1*04:ZX,07:FX (IPD-IMGT/HLA=25484).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00861
AC   CVCL_9T46
DR   IPD-IMGT/HLA; 25462
DR   Wikidata; Q54799659
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:66,02:JGMS; B*08:GPCM,51:GPRY; C*01:CYS,07:GSTH; DRB1*03:01,14:BCAD (IPD-IMGT/HLA=25462).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00862
AC   CVCL_9T47
DR   IPD-IMGT/HLA; 25459
DR   Wikidata; Q54799660
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01:51,03:JCRF; B*08:GMHM,15:GJNJ; C*07:GSTH; DRB1*03:01,13:01 (IPD-IMGT/HLA=25459).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00863
AC   CVCL_9T48
DR   IPD-IMGT/HLA; 25482
DR   Wikidata; Q54799661
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:WHG,02:05; B*14:02:01,18:68; DRB1*07:FX,07:FX (IPD-IMGT/HLA=25482).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00864
AC   CVCL_9T49
DR   IPD-IMGT/HLA; 25483
DR   Wikidata; Q54799662
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:FUMX,33:FTHW; B*58:JCKC,40:177; C*03:02,12:EGG; DRB1*07:01,12:DUKV (IPD-IMGT/HLA=25483).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00867
AC   CVCL_9T50
DR   IPD-IMGT/HLA; 25491
DR   Wikidata; Q54799663
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:FDYX,26ENKW; B*50:01:01,38:01:01; DRB1*04:02,07:01 (IPD-IMGT/HLA=25491).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00868
AC   CVCL_9T51
DR   IPD-IMGT/HLA; 25490
DR   Wikidata; Q54799664
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:GJKA,33:GJMC; B*15:11,58:36; DRB1*09:01,11:01 (IPD-IMGT/HLA=25490).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00869
AC   CVCL_9T52
DR   IPD-IMGT/HLA; 25489
DR   Wikidata; Q54799665
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BDFZ,31:DUKU; B*15:HHJY,51:126; DRB1*14:03,15:02 (IPD-IMGT/HLA=25489).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00870
AC   CVCL_9T53
DR   IPD-IMGT/HLA; 25488
DR   Wikidata; Q54799668
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*25:GC,32:ENRE; B*27:EKN,39:68; DRB1*07:01,14:BCAD (IPD-IMGT/HLA=25488).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00871
AC   CVCL_9T54
DR   IPD-IMGT/HLA; 25486
DR   Wikidata; Q54799669
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:GKEH,02:GKEH; B*44:03,07:143; DRB1*03:01,04:05 (IPD-IMGT/HLA=25486).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00872
AC   CVCL_9T55
DR   IPD-IMGT/HLA; 25487
DR   Wikidata; Q54799670
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:GJJY,29:GJKP; B*46:30,07:EH; DRB1*09:01,10:AC (IPD-IMGT/HLA=25487).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00873
AC   CVCL_9T56
DR   IPD-IMGT/HLA; 25479
DR   Wikidata; Q54799671
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:HDA,68:FUYG; B*15:10,53:22; C*04:FVTM,08:EUAV; DRB1*11:04,13:02 (IPD-IMGT/HLA=25479).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00874
AC   CVCL_9T57
DR   IPD-IMGT/HLA; 25478
DR   Wikidata; Q54799672
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:EPUR,33:EMGN; B*35:HHKD,40:76; DRB1*12:02,09:01 (IPD-IMGT/HLA=25478).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00875
AC   CVCL_9T58
DR   IPD-IMGT/HLA; 25476
DR   Wikidata; Q54799674
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:FUMX,24:FUMX; B*07:EH,15:204; C*07:26,15:DF; DRB1*10:01,15:02 (IPD-IMGT/HLA=25476).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00876
AC   CVCL_9T59
DR   IPD-IMGT/HLA; 25475
DR   Wikidata; Q54799675
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:FUMX,26:ERTN; B*18:37,35:HHKD; C*04:FEAS,12:03; DRB1*04:AAHZ,11:04 (IPD-IMGT/HLA=25475).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00877
AC   CVCL_G792
DR   IPD-IMGT/HLA; 25477
DR   Wikidata; Q54799676
RX   PubMed=21995494;
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:FTZP,11:FEXH; B*35:08:01,41:14; DRB1*11:04,07:01 (IPD-IMGT/HLA=25477).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   BY00878
AC   CVCL_9T61
DR   IPD-IMGT/HLA; 25480
DR   Wikidata; Q54799678
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:FMRP,32:EKYR; B*49:01:01,58:08:02; C*07:GSTG,12:AFB; DRB1*13:02,14:04 (IPD-IMGT/HLA=25480).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00879
AC   CVCL_9T62
DR   IPD-IMGT/HLA; 25471
DR   Wikidata; Q54799679
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:FNCN,30:02; B*14:BPYK,18:EMBS; C*05:FNTM,08:FRPM; DRB1*03:01,07:22 (IPD-IMGT/HLA=25471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00880
AC   CVCL_9T63
DR   IPD-IMGT/HLA; 25472
DR   Wikidata; Q54799681
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*34:01,34:01; B*40:FXAR,40:FXAP; C*15:BJ,15:WCY; DRB1*15:02,04:05:13 (IPD-IMGT/HLA=25472).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00886
AC   CVCL_9T64
DR   IPD-IMGT/HLA; 25470
DR   Wikidata; Q54799682
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:AZGG,03:FVHY; B*35:CWAD,50:01; C*04:FEAS,06:02; DRB1*08:02:01,14:120 (IPD-IMGT/HLA=25470).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00889
AC   CVCL_9T65
DR   IPD-IMGT/HLA; 25492
DR   Wikidata; Q54799683
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:FVBG,02:ERMU; B*07:EREN,08:EREX; DRB1*03:75,08:01 (IPD-IMGT/HLA=25492).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00891
AC   CVCL_9T66
DR   IPD-IMGT/HLA; 25493
DR   Wikidata; Q54799685
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DZKN,02:DZKN; B*44:EAHB,51:EJYW; DRB1*04:98:02,13:03:01 (IPD-IMGT/HLA=25493).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00892
AC   CVCL_9T67
DR   IPD-IMGT/HLA; 25473
DR   Wikidata; Q54799686
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ERMW,24:FVCT; B*40:EVUJ,46:EVSP; DRB1*14:BUYP,13:134 (IPD-IMGT/HLA=25473).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY00895
AC   CVCL_9T68
DR   IPD-IMGT/HLA; 25481
DR   Wikidata; Q54799688
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:FVCV,32:FVDK; B*27:EKN,35:184; DRB1*13:01,11:01 (IPD-IMGT/HLA=25481).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   BY40
AC   CVCL_XH58
DR   Wikidata; Q93436314
RX   Patent=US20130273062;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3889.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P49961; Human ENTPD1/CD39.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   BYD,A
AC   CVCL_E507
SY   BYD, A
DR   dbMHC; 48522
DR   ECACC; 940822106
DR   IHW; IHW09202
DR   IPD-IMGT/HLA; 11743
DR   Wikidata; Q54799689
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,03; B*35,50; C*04,06; DPB1*02:01:02,03:01; DQA1*05:01; DQB1*02:01,03:01; DRB1*03:01,11:04; DRB3*01:01,02:02 (IPD-IMGT/HLA=11743).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   BYH
AC   CVCL_A1FJ
DR   KCB; KCB 92008
DR   Wikidata; Q102113650
RX   DOI=10.16288/j.yczz.1999.01.001;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=54180; ! Trachypithecus francoisi (Francois' leaf monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 6
//
ID   BZ-L2C
AC   CVCL_JX19
DR   Wikidata; Q54799724
RX   PubMed=62799;
RX   PubMed=864758;
RX   PubMed=1034020;
RX   PubMed=1262783;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
DI   NCIt; C134564; Guinea pig leukemia
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
HI   CVCL_2547 ! L2C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 7
//
ID   BZR
AC   CVCL_3658
DR   CLO; CLO_0002067
DR   ATCC; CRL-9483
DR   Wikidata; Q54799725
RX   DOI=10.1007/978-1-4612-0411-4_25;
RX   Patent=US4885238;
RX   Patent=US5443954;
RX   PubMed=2539488;
RX   PubMed=2855021;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9483.
CC   Characteristics: Highly tumorigenic derivative of BEAS-2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-9483
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 13
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   BZR-T33
AC   CVCL_1G00
SY   BZRT33
DR   Wikidata; Q54799727
RX   DOI=10.1007/978-1-4612-0411-4_25;
RX   PubMed=2539488;
RX   PubMed=2855021;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3658 ! BZR
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   C-1300
AC   CVCL_4343
SY   C 1300; C1300; C-1300 MNB; C1300-NB; NA-C1300
DR   BTO; BTO_0000228
DR   CLO; CLO_0050186
DR   RCB; RCB0283
DR   Wikidata; Q54799728
RX   CelloPub=CLPUB00754;
RX   PubMed=3651891;
RX   PubMed=3756898;
RX   PubMed=4063972;
RX   PubMed=4343804;
RX   PubMed=7105037;
CC   Characteristics: Derived from the MNB transplantable tumor.
CC   Virology: Used in the rabies tissue-culture infection test (RTCIT) developed for the isolation of rabies virus from field cases submitted for rabies diagnosis (CelloPub=CLPUB00754; PubMed=3651891).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E9XF ! MNB-T1
OI   CVCL_E9XG ! MNB-T2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   C-1300 clone 7
AC   CVCL_UJ42
DR   Wikidata; Q93436318
RX   PubMed=164463;
RX   PubMed=173535;
RX   PubMed=233769;
RX   PubMed=4343804;
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 5
//
ID   C-1300 clone C46
AC   CVCL_VU15
SY   C46; C-46
DR   Wikidata; Q93436319
RX   PubMed=2759161;
RX   PubMed=3756898;
RX   PubMed=4063972;
CC   Characteristics: Non-producer of neurotransmitters clone of C-1300.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   C-1300 clone CR1
AC   CVCL_UJ43
DR   Wikidata; Q93436320
RX   PubMed=164463;
RX   PubMed=233769;
CC   Selected for resistance to: ChEBI; CHEBI_50095; Bucladesine (dibutyryl 3',5'-cyclic AMP).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UJ42 ! C-1300 clone 7
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   C-1300 clone N18
AC   CVCL_4724
AS   CVCL_8661
SY   N-18; N18; N18 (Hamprecht); C-1300N18
DR   CLO; CLO_0007920
DR   CLO; CLO_0050185
DR   CLDB; cl3614
DR   ECACC; 08062527
DR   GEO; GSM635472
DR   GEO; GSM635473
DR   GEO; GSM635474
DR   GEO; GSM635475
DR   RCB; RCB2620
DR   TKG; TKG 0307
DR   Wikidata; Q54907320
RX   PubMed=2759161;
RX   PubMed=4400294;
RX   PubMed=5283932;
RX   PubMed=21214938;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   C-1300 clone S20
AC   CVCL_VU14
SY   S20; S-20
DR   Wikidata; Q93436321
RX   PubMed=2759161;
RX   PubMed=3756898;
RX   PubMed=4063972;
CC   Characteristics: Cholinergic clone of C-1300.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   C-1300 clone TR1
AC   CVCL_UJ44
DR   Wikidata; Q93436322
RX   PubMed=173535;
CC   Characteristics: Temperature resistant, grows at 40 Celsius (PubMed=173535).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UJ42 ! C-1300 clone 7
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   C-1300/HHT
AC   CVCL_IM27
SY   C1300/HHT
DR   Wikidata; Q54799729
RX   PubMed=1680870;
CC   Selected for resistance to: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 6
//
ID   C-1509
AC   CVCL_5U42
SY   C1509
DR   Wikidata; Q54799731
RX   DOI=10.5795/jjscc.29.509;
CC   Population: Japanese.
CC   Doubling time: 25-38 hours (Note=At 25th passage) (DOI=10.5795/jjscc.29.509).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   C-2
AC   CVCL_N289
DR   ATCC; HB-8478
DR   Wikidata; Q54799732
RX   Patent=US4683196;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8478.
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   C-20/A4
AC   CVCL_6821
SY   C-20\A4; C20/A4; C-20a4; C20A4
DR   BTO; BTO_0005670
DR   ChEMBL-Cells; CHEMBL3308083
DR   ChEMBL-Targets; CHEMBL613871
DR   Millipore; SCC041
DR   PubChem_Cell_line; CVCL_6821
DR   Wikidata; Q54799734
RX   PubMed=7989586;
RX   PubMed=15604530;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Rib, costal cartilage; UBERON=UBERON_0002236.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): Millipore=SCC041
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 12,21
ST   D21S11: 29,30
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 11,12
ST   Penta E: 7,16
ST   TH01: 6,9.3
ST   TPOX: 10,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   C-26
AC   CVCL_XC68
SY   C26
DR   Wikidata; Q93436332
RX   Patent=US8586042;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-21875.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P38646; Human HSPA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   C-28/I2
AC   CVCL_0187
SY   C28/I2; C-28I2; C28I2; T/C-28I2
DR   BTO; BTO_0003859
DR   EFO; EFO_0022647
DR   MCCL; MCC:0000078
DR   Millipore; SCC043
DR   NCBI_Iran; C620
DR   Wikidata; Q54799736
RX   PubMed=7989586;
RX   PubMed=14673991;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Rib, costal cartilage; UBERON=UBERON_0002236.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): Millipore=SCC043
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 16,19
ST   D21S11: 27,29
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 14
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6850 ! T/C28a2
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   C-3-2
AC   CVCL_F0WX
RX   PubMed=6177865;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Epstein-Barr virus (strain B95-8) 212/236 kDa membrane antigen complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   C-33 A
AC   CVCL_1094
SY   C33A; C33a; C33-A; C-33-A; C-33A; C33
DR   BTO; BTO_0001968
DR   CLO; CLO_0002115
DR   EFO; EFO_0002120
DR   CLDB; cl7126
DR   AddexBio; C0008003/382
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRM-HTB-31
DR   ATCC; HTB-31
DR   BCRC; 60554
DR   BCRJ; 0348
DR   BioSample; SAMN03473073
DR   cancercelllines; CVCL_1094
DR   CCRID; 1101HUM-PUMC000172
DR   CCRID; 1102HUM-NIFDC00091
DR   CCRID; 3101HUMTCHu176
DR   CCRID; 4201HUM-CCTCC00144
DR   CCTCC; GDC0144
DR   Cell_Model_Passport; SIDM00889
DR   ChEMBL-Cells; CHEMBL3308230
DR   ChEMBL-Targets; CHEMBL2366313
DR   ChEMBL-Targets; CHEMBL614370
DR   CLS; 305072
DR   Cosmic; 687505
DR   Cosmic; 760217
DR   Cosmic; 809226
DR   Cosmic; 846180
DR   Cosmic; 877470
DR   Cosmic; 925355
DR   Cosmic; 928905
DR   Cosmic; 1071910
DR   Cosmic; 1131520
DR   Cosmic; 1176610
DR   Cosmic; 1193030
DR   Cosmic; 1201776
DR   Cosmic; 1324210
DR   Cosmic; 1995353
DR   Cosmic; 2301537
DR   Cosmic; 2602729
DR   Cosmic; 2660188
DR   Cosmic; 2791020
DR   Cosmic; 2816218
DR   Cosmic-CLP; 687505
DR   DepMap; ACH-001333
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687505
DR   GEO; GSM253296
DR   GEO; GSM675730
DR   GEO; GSM685441
DR   GEO; GSM1669637
DR   IARC_TP53; 324
DR   ICLC; HTL02004
DR   IGRhCellID; C33A
DR   LINCS_LDP; LCL-1300
DR   PharmacoDB; C33A_150_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1094
DR   PubChem_Cell_line; CVCL_1094
DR   Wikidata; Q54799738
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1648218;
RX   PubMed=2990217;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=14114965;
RX   PubMed=15531914;
RX   PubMed=20215515;
RX   PubMed=24134916;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28261610;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35692560;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-23.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Population: Caucasian.
CC   Doubling time: 1.36 days (PubMed=29156801).
CC   HLA typing: A*02:01,03:01; B*07:02,44:02; C*05:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=1648218).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=0.33%; East Asian, North=0.48%; East Asian, South=0.19%; South Asian=0.82%; European, North=66.58%; European, South=31.19% (PubMed=30894373).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): AddexBio=C0008003/382; ATCC=HTB-31; CCRID; Cosmic-CLP=687505; DepMap=ACH-001333; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 13,14
ST   D18S51: 15,17,18 (DepMap=ACH-001333)
ST   D18S51: 15,18 (ATCC=HTB-31; PubMed=25877200)
ST   D19S433: 11,13,14
ST   D21S11: 29,30,31
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 21,25,26 (ATCC=HTB-31)
ST   FGA: 21,26 (CCRID; PubMed=25877200)
ST   Penta D: 10
ST   Penta E: 6,8
ST   TH01: 7,8
ST   TPOX: 9
ST   vWA: 18,20
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E27 ! C-33 B
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   C-33 B
AC   CVCL_1E27
SY   C33B
DR   ATCC; CRL-7716
DR   Wikidata; Q54799739
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6935474;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7716; true.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1094 ! C-33 A
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 10
//
ID   C-378
AC   CVCL_4J79
SY   C378
DR   ATCC; CRL-2083
DR   cancercelllines; CVCL_4J79
DR   Wikidata; Q54799741
CC   Problematic cell line: Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 33 year old female patient.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: ATCC; CRL-2083; true.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): ATCC=CRL-2083
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2169 ! RD-ES
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 18
//
ID   C-386
AC   CVCL_U332
SY   C386
DR   ATCC; CRL-2074
DR   cancercelllines; CVCL_U332
DR   Wikidata; Q54799743
CC   Problematic cell line: Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 41 year old female patient.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: ATCC; CRL-2074; true.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): ATCC=CRL-2074
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2169 ! RD-ES
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   C-4-I
AC   CVCL_2253
SY   C-4I; C-4 I; C-4-i; C4-I; C4-1; C4 I; C4I; C41; Hs 636.T; Hs 636 T
DR   BTO; BTO_0006016
DR   CLO; CLO_0002125
DR   CLO; CLO_0002129
DR   EFO; EFO_0002122
DR   CLDB; cl521
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1594
DR   ATCC; CRL-7396
DR   BioSample; SAMN03471401
DR   cancercelllines; CVCL_2253
DR   Cell_Model_Passport; SIDM00905
DR   Cosmic; 687506
DR   Cosmic; 877471
DR   Cosmic; 925358
DR   Cosmic; 928906
DR   Cosmic; 1019308
DR   Cosmic; 1131518
DR   Cosmic; 1193035
DR   Cosmic; 1201771
DR   Cosmic; 2646656
DR   Cosmic; 2660189
DR   Cosmic; 2816213
DR   Cosmic-CLP; 687506
DR   DepMap; ACH-001334
DR   ECACC; 89051702
DR   EGA; EGAS00001000978
DR   GDSC; 687506
DR   GEO; GSM113860
DR   GEO; GSM253295
DR   GEO; GSM675731
DR   GEO; GSM685438
DR   GEO; GSM1669639
DR   IGRhCellID; C4I
DR   LINCS_LDP; LCL-1301
DR   PharmacoDB; C4I_151_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2253
DR   Wikidata; Q54799744
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=560251;
RX   PubMed=833871;
RX   PubMed=2983228;
RX   PubMed=2990217;
RX   PubMed=3029760;
RX   PubMed=3518877;
RX   PubMed=5796380;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=12661003;
RX   PubMed=13863218;
RX   PubMed=14114965;
RX   PubMed=15531914;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=35692560;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Virology: Contains a complete HPV18 genome.
CC   Doubling time: 2 days (PubMed=29156801).
CC   HLA typing: A*01,03; B*07,w40 (PubMed=77569).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.73%; East Asian, North=0%; East Asian, South=0%; South Asian=1.02%; European, North=72.49%; European, South=25.76% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7396; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-1594; Cosmic-CLP=687506; DepMap=ACH-001334; PubMed=29156801
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 25
ST   Penta D: 9,13
ST   Penta E: 19
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 14
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1095 ! C-4-II
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   C-4-II
AC   CVCL_1095
SY   C-4 II; C-4II; C4 II; C4II
DR   CLO; CLO_0002126
DR   EFO; EFO_0002123
DR   CLDB; cl571
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-1595
DR   ATCC; CRL-7914
DR   BioSample; SAMN03471403
DR   cancercelllines; CVCL_1095
DR   Cell_Model_Passport; SIDM00906
DR   ChEMBL-Cells; CHEMBL3308712
DR   ChEMBL-Targets; CHEMBL1075400
DR   Cosmic; 760218
DR   Cosmic; 809230
DR   Cosmic; 910553
DR   DepMap; ACH-001335
DR   ECACC; 88102701
DR   GEO; GSM675732
DR   GEO; GSM685437
DR   IARC_TP53; 21202
DR   IGRhCellID; C4II
DR   LINCS_LDP; LCL-1302
DR   Progenetix; CVCL_1095
DR   PubChem_Cell_line; CVCL_1095
DR   Wikidata; Q54799745
RX   PubMed=833871;
RX   PubMed=2990217;
RX   PubMed=3518877;
RX   PubMed=5796380;
RX   PubMed=6935474;
RX   PubMed=13863218;
RX   PubMed=14114965;
RX   PubMed=15531914;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=24134916;
RX   PubMed=29156801;
RX   PubMed=35692560;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Virology: Contains a complete HPV18 genome.
CC   Doubling time: 2.4 days (PubMed=29156801).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7914; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-1595; DepMap=ACH-001335; ECACC=88102701; PubMed=29156801
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 25
ST   Penta D: 9,13
ST   Penta E: 19
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 14
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2253 ! C-4-I
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   C-430
AC   CVCL_4J80
SY   C430
DR   ATCC; CRL-2084
DR   cancercelllines; CVCL_4J80
DR   Wikidata; Q54799748
CC   Problematic cell line: Probably contaminated. The STR profile is identical to that of the RD-ES cell line. Originally thought to originate from a giant cell tumor excised in 1986 from tumor tissue of a 42 year old female patient.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: ATCC; CRL-2084; true.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): ATCC=CRL-2084
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2169 ! RD-ES
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 18
//
ID   C-433
AC   CVCL_1969
SY   C433
DR   CLO; CLO_0002127
DR   CLDB; cl520
DR   ATCC; CRL-2085
DR   BioSample; SAMN03151903
DR   BioSample; SAMN03471441
DR   cancercelllines; CVCL_1969
DR   DSMZ; ACC-268
DR   DSMZCellDive; ACC-268
DR   Wikidata; Q54799749
RX   PubMed=8222432;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RD-ES derivative (DSMZ=ACC-268). Originally thought to originate from a 35 year old female patient with a benign giant cell tumor of the right distal tibia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00395.
CC   Population: Caucasian.
CC   Doubling time: ~25-30 hours (DSMZ=ACC-268).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: ATCC; CRL-2085; true.
CC   Discontinued: DSMZ; ACC-268; true.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): ATCC=CRL-2085; DSMZ=ACC-268
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,17.3
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 9,12
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2169 ! RD-ES
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   C-566
AC   CVCL_LL61
SY   C 566; C566
DR   Wikidata; Q54799750
RX   PubMed=4894370;
RX   PubMed=5235446;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   C-643
AC   CVCL_5969
SY   C 643; C643; c643
DR   BTO; BTO_0005149
DR   cancercelllines; CVCL_5969
DR   CCRID; 3101HUMSCSP545
DR   CLS; 300298
DR   Cosmic; 888095
DR   Cosmic; 888279
DR   Cosmic; 889491
DR   Cosmic; 913251
DR   Cosmic; 1068625
DR   Cosmic; 1084282
DR   Cosmic; 1152117
DR   Cosmic; 1155331
DR   Cosmic; 1239971
DR   Cosmic; 1280042
DR   Cosmic; 1507379
DR   Cosmic; 1533557
DR   Cosmic; 1536132
DR   Cosmic; 1889012
DR   Cosmic; 2036693
DR   Cosmic; 2054091
DR   Cosmic; 2186783
DR   Cosmic; 2319850
DR   Cosmic; 2786688
DR   Cosmic; 2791079
DR   IARC_TP53; 21626
DR   IBRC; C10312
DR   Wikidata; Q54799751
RX   PubMed=2848260;
RX   PubMed=14522906;
RX   PubMed=17465858;
RX   PubMed=17725429;
RX   PubMed=18713817;
RX   PubMed=19087340;
RX   PubMed=21868764;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=26680454;
RX   PubMed=30737244;
RX   PubMed=31368081;
CC   Doubling time: 23 hours (PubMed=31368081).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Unspecified (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Phe341Leu (c.1023T>G); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=14522906; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:28873; VTCN1; Simple; p.Tyr215Ter (c.645C>G); Zygosity=Unspecified (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): CLS=300298; PubMed=17465858; PubMed=18713817; PubMed=21868764; PubMed=25365311; PubMed=30737244; PubMed=31368081
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D18S51: 14 (PubMed=31368081)
ST   D18S51: 14,17 (PubMed=17465858)
ST   D18S51: 14,18 (CLS=300298; PubMed=18713817; PubMed=30737244)
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 11,13
ST   FGA: 18,21
ST   Penta D: 9
ST   Penta E: 5,15
ST   TH01: 9.3,10
ST   TPOX: 11,12
ST   vWA: 15,17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   C-69
AC   CVCL_XC69
SY   C69
DR   Wikidata; Q93436343
RX   Patent=US8586042;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-21876.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P38646; Human HSPA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   C-8049
AC   CVCL_6578
DR   CLO; CLO_0050775
DR   RCB; RCB1849
DR   Wikidata; Q54799753
RX   PubMed=1946997;
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 8
//
ID   C-8052
AC   CVCL_6579
DR   CLO; CLO_0050776
DR   RCB; RCB1850
DR   Wikidata; Q54799755
RX   PubMed=1946997;
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 8
//
ID   C-B9538F
AC   CVCL_LM94
SY   C-B95; TNGB-65823; 65823
DR   CLO; CLO_0002212
DR   CLDB; cl523
DR   TNGB; 65823
DR   Wikidata; Q54799756
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18-22FW
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   C-HAlb
AC   CVCL_B6JC
DR   Wikidata; Q111733025
RX   Patent=RU2719152;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-179.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:399; ALB.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   C-HC-20
AC   CVCL_W518
SY   cHc20; CHC20; HC-20; Hc-1
DR   Wikidata; Q54799757
RX   PubMed=2543326;
RX   PubMed=6300668;
RX   PubMed=7874267;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
ID   C-HC-32
AC   CVCL_RJ64
SY   cHc32; CHC32
DR   Wikidata; Q54799758
RX   PubMed=7874267;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
//
ID   C-HC-4
AC   CVCL_W519
SY   c-Hc-4; C-Hc4; cHc4; CHC4; HC-4; Hc-4
DR   CGH-DB; 9073-4
DR   ChEMBL-Cells; CHEMBL4523518
DR   ChEMBL-Targets; CHEMBL4523549
DR   PubChem_Cell_line; CVCL_W519
DR   TKG; TKG 0733
DR   Wikidata; Q54799760
RX   PubMed=2543326;
RX   PubMed=2856442;
RX   PubMed=6300668;
RX   PubMed=7874267;
RX   PubMed=12029633;
CC   Population: Japanese.
CC   Doubling time: ~20 hours (PubMed=2856442).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0733
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 14,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 13
//
ID   c-SST-2
AC   CVCL_6B37
DR   Wikidata; Q54799761
RX   PubMed=3409239;
RX   PubMed=9652751;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   c-SST-2 clone 2
AC   CVCL_6B47
SY   c-SST-2 cl-2
DR   Wikidata; Q54799762
RX   PubMed=3121552;
RX   PubMed=3409239;
CC   Characteristics: Tumorigenic and highly metastatic to lung (PubMed=3121552).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6B37 ! c-SST-2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   c-SST-2 clone 2r
AC   CVCL_6B50
SY   c-SST-2 cl-2r
DR   Wikidata; Q54799764
RX   PubMed=3121552;
RX   PubMed=3409239;
CC   Characteristics: Tumorigenic and weakly metastatic to lung (PubMed=3121552).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6B47 ! c-SST-2 clone 2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   c-SST-2 clone 3
AC   CVCL_6B48
SY   c-SST-2 cl-3
DR   Wikidata; Q54799765
RX   PubMed=3121552;
RX   PubMed=3409239;
CC   Characteristics: Tumorigenic and highly metastatic to lung (PubMed=3121552).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6B37 ! c-SST-2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   c-SST-2 clone 4
AC   CVCL_6B46
SY   c-SST-2 cl-4; Cl-4
DR   Wikidata; Q54799767
RX   PubMed=1618698;
RX   PubMed=3121552;
RX   PubMed=3409239;
CC   Characteristics: Tumorigenic and weakly metastatic to lung (PubMed=3121552).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6B37 ! c-SST-2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   c-SST-2 clone 6
AC   CVCL_6B49
SY   c-SST-2 cl-6
DR   Wikidata; Q54799768
RX   PubMed=3121552;
RX   PubMed=3409239;
CC   Characteristics: Tumorigenic and highly metastatic to lung (PubMed=3121552).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6B37 ! c-SST-2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   C-SU-iPS-1
AC   CVCL_E4G9
RX   PubMed=31495903;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple_corrected; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31495903).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31495903
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 11,14
ST   D19S433: 12,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4G8 ! SU-iPS-1
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   C-UPIC
AC   CVCL_C3G6
SY   Control-Urine Podocyte Immortalized Cell line
DR   GEO; GSM3933303
DR   GEO; GSM3933304
DR   GEO; GSM3933305
DR   Wikidata; Q114310763
RX   PubMed=32652570;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte; CL=CL_0000653.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Conditionally immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   c-WRT-7
AC   CVCL_J366
DR   Wikidata; Q54799770
RX   PubMed=3469020;
RX   PubMed=6572557;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   c-WRT-7-LR
AC   CVCL_J367
SY   LR
DR   JCRB; FDSC0004
DR   JCRB; JCRB0168
DR   Wikidata; Q54799771
RX   PubMed=3469020;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Discontinued: JCRB; FDSC0004; true.
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_J366 ! c-WRT-7
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   C.M.L.
AC   CVCL_E508
SY   CML
DR   dbMHC; 48523
DR   ECACC; 94050307
DR   IHW; IHW09315
DR   IPD-IMGT/HLA; 10364
DR   Wikidata; Q54799772
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Belgian.
CC   HLA typing: DPB1*14:01,04:01; DQA1*05:01,03; DQB1*02:01,03:01; DRB1*03:01,04:01; DRB3*01:01; DRB4*01:02 (IPD-IMGT/HLA=10364).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   C/wStr
AC   CVCL_4Z43
SY   C/wStr1
DR   Wikidata; Q54799773
RX   PubMed=23271364;
RX   PubMed=25155417;
CC   Group: Insect cell line.
CC   Characteristics: In vitro infected by the intracellular symbiont Wolbachia pipientis strain wStr.
CC   Doubling time: ~24 hours (PubMed=23271364).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z619 ! C7-10
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 10
//
ID   C_UF
AC   CVCL_E6E3
DR   GEO; GSM2794416
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C_UM
AC   CVCL_E6E4
DR   GEO; GSM2794417
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C0001
AC   CVCL_5G96
DR   ECACC; 09071302
DR   Wikidata; Q54799774
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   C0002
AC   CVCL_K286
DR   ECACC; 90090712
DR   Wikidata; Q54799775
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0003
AC   CVCL_K287
DR   ECACC; 90090713
DR   Wikidata; Q54799776
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0004
AC   CVCL_K288
DR   ECACC; 91081914
DR   Wikidata; Q54799777
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0005
AC   CVCL_K289
DR   ECACC; 90121704
DR   Wikidata; Q54799778
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0006
AC   CVCL_K290
DR   ECACC; 91070935
DR   Wikidata; Q54799781
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0007
AC   CVCL_K291
DR   ECACC; 91081915
DR   Wikidata; Q54799782
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0008
AC   CVCL_K292
DR   ECACC; 93010701
DR   Wikidata; Q54799783
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0009
AC   CVCL_K293
DR   ECACC; 93010702
DR   Wikidata; Q54799784
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C001
AC   CVCL_B4K8
SY   C001M
DR   cancercelllines; CVCL_B4K8
DR   GEO; GSM4178054
DR   Wikidata; Q110432646
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   C0010
AC   CVCL_K294
DR   ECACC; 93010703
DR   Wikidata; Q54799785
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0011
AC   CVCL_K295
DR   ECACC; 93010704
DR   Wikidata; Q54799786
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0012
AC   CVCL_K296
DR   ECACC; 91090414
DR   Wikidata; Q54799787
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0013
AC   CVCL_K297
DR   ECACC; 92031001
DR   Wikidata; Q54799789
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0015
AC   CVCL_K298
DR   ECACC; 93010705
DR   Wikidata; Q54799790
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0016
AC   CVCL_K299
DR   ECACC; 92030510
DR   Wikidata; Q54799791
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0018
AC   CVCL_K300
DR   ECACC; 91070931
DR   Wikidata; Q54799792
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0019
AC   CVCL_K301
DR   ECACC; 93010706
DR   Wikidata; Q54799793
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C002
AC   CVCL_EI31
SY   C002M
DR   cancercelllines; CVCL_EI31
DR   GEO; GSM4178055
DR   Wikidata; Q54799794
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Homozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0020
AC   CVCL_K302
DR   ECACC; 92030511
DR   Wikidata; Q54799795
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0022
AC   CVCL_K303
DR   ECACC; 91081902
DR   Wikidata; Q54799796
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0024
AC   CVCL_K304
DR   ECACC; 92031002
DR   Wikidata; Q54799797
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0025
AC   CVCL_K305
DR   ECACC; 92031003
DR   Wikidata; Q54799798
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0027
AC   CVCL_K306
DR   ECACC; 92031004
DR   Wikidata; Q54799799
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0028
AC   CVCL_K307
DR   ECACC; 91081905
DR   Wikidata; Q54799800
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0029
AC   CVCL_K308
DR   ECACC; 92031005
DR   Wikidata; Q54799802
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C003
AC   CVCL_B4KF
DR   cancercelllines; CVCL_B4KF
DR   Wikidata; Q110432647
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   C0030
AC   CVCL_K309
DR   ECACC; 91070934
DR   Wikidata; Q54799803
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0032
AC   CVCL_K310
DR   ECACC; 93010707
DR   Wikidata; Q54799804
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0034
AC   CVCL_K311
DR   ECACC; 91070933
DR   Wikidata; Q54799805
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0035
AC   CVCL_K312
DR   ECACC; 91081912
DR   Wikidata; Q54799806
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0036
AC   CVCL_K313
DR   ECACC; 91090411
DR   Wikidata; Q54799807
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0037
AC   CVCL_K314
DR   ECACC; 93010710
DR   Wikidata; Q54799808
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0038
AC   CVCL_K315
DR   ECACC; 92030512
DR   Wikidata; Q54799809
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0039
AC   CVCL_K316
DR   ECACC; 91081908
DR   Wikidata; Q54799811
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C004
AC   CVCL_EI32
DR   cancercelllines; CVCL_EI32
DR   Cosmic; 2465272
DR   Wikidata; Q54799812
RX   PubMed=22250051;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4KI ! C004-2
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   C004-2
AC   CVCL_B4KI
DR   cancercelllines; CVCL_B4KI
DR   Wikidata; Q110432648
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EI32 ! C004
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   C0040
AC   CVCL_K317
DR   ECACC; 91070932
DR   Wikidata; Q54799813
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0041
AC   CVCL_K318
DR   ECACC; 91070914
DR   Wikidata; Q54799814
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0042
AC   CVCL_K319
DR   ECACC; 91081909
DR   Wikidata; Q54799815
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0043
AC   CVCL_5G97
DR   ECACC; 11033101
DR   Wikidata; Q54799816
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   C0044
AC   CVCL_K320
DR   ECACC; 93010708
DR   Wikidata; Q54799817
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010708; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0045
AC   CVCL_K321
DR   ECACC; 91090410
DR   Wikidata; Q54799818
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0046
AC   CVCL_K322
DR   ECACC; 91081916
DR   Wikidata; Q54799819
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0047
AC   CVCL_K323
DR   ECACC; 94060801
DR   Wikidata; Q54799820
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0048
AC   CVCL_K324
DR   ECACC; 92031006
DR   Wikidata; Q54799821
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C0049
AC   CVCL_K325
DR   ECACC; 91090413
DR   Wikidata; Q54799822
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0050
AC   CVCL_K326
DR   ECACC; 92031007
DR   Wikidata; Q54799823
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0052
AC   CVCL_K327
DR   ECACC; 93010709
DR   Wikidata; Q54799827
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0053
AC   CVCL_K328
DR   ECACC; 93011303
DR   Wikidata; Q54799828
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0054
AC   CVCL_K329
DR   ECACC; 91070915
DR   Wikidata; Q54799829
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0055
AC   CVCL_K330
DR   ECACC; 94060802
DR   Wikidata; Q54799830
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0056
AC   CVCL_K331
DR   ECACC; 91081910
DR   Wikidata; Q54799831
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91081910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0057
AC   CVCL_K332
DR   ECACC; 93011304
DR   Wikidata; Q54799832
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93011304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0058
AC   CVCL_K333
DR   ECACC; 92031008
DR   Wikidata; Q54799833
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0059
AC   CVCL_K334
DR   ECACC; 91081904
DR   Wikidata; Q54799834
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C006
AC   CVCL_B4K9
SY   C006M
DR   cancercelllines; CVCL_B4K9
DR   GEO; GSM4178056
DR   Wikidata; Q110432649
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   C0060
AC   CVCL_K335
DR   ECACC; 92031009
DR   Wikidata; Q54799835
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0061
AC   CVCL_K336
DR   ECACC; 93011305
DR   Wikidata; Q54799836
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0063
AC   CVCL_K337
DR   ECACC; 94060803
DR   Wikidata; Q54799837
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0065
AC   CVCL_K338
DR   ECACC; 91081911
DR   Wikidata; Q54799838
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0066
AC   CVCL_K339
DR   ECACC; 93011306
DR   Wikidata; Q54799839
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0068
AC   CVCL_K340
DR   ECACC; 91081906
DR   Wikidata; Q54799840
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0069
AC   CVCL_K341
DR   ECACC; 92031010
DR   Wikidata; Q54799841
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0070
AC   CVCL_K342
DR   ECACC; 91090412
DR   Wikidata; Q54799842
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0071
AC   CVCL_K343
DR   ECACC; 93011307
DR   Wikidata; Q54799843
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93011307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0072
AC   CVCL_K344
DR   ECACC; 93011308
DR   Wikidata; Q54799844
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93011308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0073
AC   CVCL_K345
DR   ECACC; 91081913
DR   Wikidata; Q54799845
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0074
AC   CVCL_K346
DR   ECACC; 91081907
DR   Wikidata; Q54799846
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0075
AC   CVCL_K347
DR   ECACC; 93011309
DR   Wikidata; Q54799847
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0076
AC   CVCL_K348
DR   ECACC; 93011310
DR   Wikidata; Q54799848
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93011310; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0077
AC   CVCL_K349
DR   ECACC; 92031011
DR   Wikidata; Q54799849
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031011; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C008
AC   CVCL_EI33
DR   Cosmic; 2465273
DR   Wikidata; Q54799850
RX   PubMed=23890154;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Leu349Phe (c.1045C>T); Zygosity=Unspecified (PubMed=23890154).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0080
AC   CVCL_K350
DR   ECACC; 93011311
DR   Wikidata; Q54799851
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0081
AC   CVCL_K351
DR   ECACC; 93011312
DR   Wikidata; Q54799852
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0082
AC   CVCL_K352
DR   ECACC; 93012115
DR   Wikidata; Q54799853
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0083
AC   CVCL_K353
DR   ECACC; 91070937
DR   Wikidata; Q54799854
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070937; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0084
AC   CVCL_K354
DR   ECACC; 91081917
DR   Wikidata; Q54799855
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0085
AC   CVCL_K355
DR   ECACC; 94060804
DR   Wikidata; Q54799856
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0086
AC   CVCL_K356
DR   ECACC; 90081923
DR   Wikidata; Q54799857
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90081923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0087
AC   CVCL_K357
DR   ECACC; 93012116
DR   Wikidata; Q54799858
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0088
AC   CVCL_K358
DR   ECACC; 93012117
DR   Wikidata; Q54799859
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0089
AC   CVCL_K359
DR   ECACC; 93012118
DR   Wikidata; Q54799860
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0090
AC   CVCL_K360
DR   ECACC; 91081922
DR   Wikidata; Q54799861
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0091
AC   CVCL_K361
DR   ECACC; 94060805
DR   Wikidata; Q54799862
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0092
AC   CVCL_K362
SY   CO092
DR   ECACC; 93012119
DR   Wikidata; Q54799864
RX   PubMed=27995740;
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:3620; FCGR3B; Zygosity=Homozygous (PubMed=27995740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   C0093
AC   CVCL_K363
DR   ECACC; 91070938
DR   Wikidata; Q54799865
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0094
AC   CVCL_K364
DR   ECACC; 94060806
DR   Wikidata; Q54799866
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0095
AC   CVCL_K365
DR   ECACC; 93012120
DR   Wikidata; Q54799867
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0096
AC   CVCL_K366
DR   ECACC; 91090406
DR   Wikidata; Q54799870
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0097
AC   CVCL_K367
DR   ECACC; 94060807
DR   Wikidata; Q54799871
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0098
AC   CVCL_K368
DR   ECACC; 93012121
DR   Wikidata; Q54799872
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0099
AC   CVCL_K369
DR   ECACC; 94060808
DR   Wikidata; Q54799873
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0100
AC   CVCL_K370
DR   ECACC; 94060809
DR   Wikidata; Q54799874
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0101
AC   CVCL_K371
DR   ECACC; 94060810
DR   Wikidata; Q54799875
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060810; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0102
AC   CVCL_K372
DR   ECACC; 94060811
DR   Wikidata; Q54799876
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060811; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0103
AC   CVCL_K373
DR   ECACC; 91071215
DR   Wikidata; Q54799877
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071215; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0104
AC   CVCL_K374
DR   ECACC; 91070939
DR   Wikidata; Q54799878
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0105
AC   CVCL_K375
DR   ECACC; 94060812(2)
DR   Wikidata; Q54799879
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060812(2); true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0106
AC   CVCL_K376
DR   ECACC; 91071212
DR   Wikidata; Q54799880
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0107
AC   CVCL_AR49
DR   ECACC; 07080101
DR   Wikidata; Q54799881
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   C0108
AC   CVCL_K377
DR   ECACC; 93012122
DR   Wikidata; Q54799882
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0109
AC   CVCL_K378
DR   ECACC; 94060814
DR   Wikidata; Q54799883
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C011
AC   CVCL_EI34
SY   C011M
DR   cancercelllines; CVCL_EI34
DR   GEO; GSM4178057
DR   Wikidata; Q54799884
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0110
AC   CVCL_K379
DR   ECACC; 94060815
DR   Wikidata; Q54799885
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0111
AC   CVCL_K380
DR   ECACC; 93012123
DR   Wikidata; Q54799886
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0112
AC   CVCL_K381
DR   ECACC; 93012124
DR   Wikidata; Q54799887
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0113
AC   CVCL_K382
DR   ECACC; 93020402
DR   Wikidata; Q54799888
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0114
AC   CVCL_K383
DR   ECACC; 91081921
DR   Wikidata; Q54799889
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91081921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0115
AC   CVCL_K384
DR   ECACC; 93020403
DR   Wikidata; Q54799890
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0116
AC   CVCL_K385
DR   ECACC; 91071213
DR   Wikidata; Q54799891
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0117
AC   CVCL_K386
DR   ECACC; 93020404
DR   Wikidata; Q54799892
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0118
AC   CVCL_K387
DR   ECACC; 93020405
DR   Wikidata; Q54799893
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0119
AC   CVCL_K388
DR   ECACC; 93020406
DR   Wikidata; Q54799894
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0120
AC   CVCL_K389
DR   ECACC; 93020407
DR   Wikidata; Q54799895
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0121
AC   CVCL_K390
DR   ECACC; 91081918
DR   Wikidata; Q54799896
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0122
AC   CVCL_K391
DR   ECACC; 94060816
DR   Wikidata; Q54799897
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060816; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0123
AC   CVCL_K392
DR   ECACC; 93020408
DR   Wikidata; Q54799898
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0124
AC   CVCL_K393
DR   ECACC; 93020409
DR   Wikidata; Q54799899
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0125
AC   CVCL_K394
DR   ECACC; 93020410
DR   Wikidata; Q54799900
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0126
AC   CVCL_K395
DR   ECACC; 93020411
DR   Wikidata; Q54799901
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0127
AC   CVCL_K396
DR   ECACC; 93021101
DR   Wikidata; Q54799902
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0128
AC   CVCL_K397
DR   ECACC; 93021102
DR   Wikidata; Q54799903
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0129
AC   CVCL_K398
DR   ECACC; 94060817
DR   Wikidata; Q54799904
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C013
AC   CVCL_EI35
SY   C013M
DR   cancercelllines; CVCL_EI35
DR   GEO; GSM4178058
DR   Wikidata; Q54799905
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0130
AC   CVCL_K399
DR   ECACC; 93021103
DR   Wikidata; Q54799906
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0131
AC   CVCL_K400
DR   ECACC; 93021104
DR   Wikidata; Q54799907
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0132
AC   CVCL_K401
DR   ECACC; 93021105
DR   Wikidata; Q54799908
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0133
AC   CVCL_K402
DR   ECACC; 91100312
DR   Wikidata; Q54799909
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0134
AC   CVCL_K403
DR   ECACC; 93021106
DR   Wikidata; Q54799954
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0135
AC   CVCL_K404
DR   ECACC; 93021107
DR   Wikidata; Q54799955
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0136
AC   CVCL_K405
DR   ECACC; 93021108
DR   Wikidata; Q54799956
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0137
AC   CVCL_K406
DR   ECACC; 94060818
DR   Wikidata; Q54799957
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0138
AC   CVCL_K407
DR   ECACC; 93021109
DR   Wikidata; Q54799958
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0139
AC   CVCL_K408
DR   ECACC; 93012801
DR   Wikidata; Q54799959
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0140
AC   CVCL_K409
DR   ECACC; 93021110
DR   Wikidata; Q54799960
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0141
AC   CVCL_K410
DR   ECACC; 93021836
DR   Wikidata; Q54799961
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021836; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0142
AC   CVCL_K411
DR   ECACC; 93021837
DR   Wikidata; Q54799962
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0143
AC   CVCL_K412
DR   ECACC; 93021838
DR   Wikidata; Q54799963
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0144
AC   CVCL_K413
DR   ECACC; 91081919
DR   Wikidata; Q54799964
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0145
AC   CVCL_K414
DR   ECACC; 93012802
DR   Wikidata; Q54799965
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0146
AC   CVCL_K415
DR   ECACC; 93021839
DR   Wikidata; Q54799966
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0147
AC   CVCL_K416
DR   ECACC; 91081920
DR   Wikidata; Q54799967
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0148
AC   CVCL_K417
DR   ECACC; 93012803
DR   Wikidata; Q54799968
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0149
AC   CVCL_K418
DR   ECACC; 93021840
DR   Wikidata; Q54799969
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0150
AC   CVCL_K419
DR   ECACC; 93021841
DR   Wikidata; Q54799970
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0151
AC   CVCL_K420
DR   ECACC; 93012804
DR   Wikidata; Q54799971
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0152
AC   CVCL_K421
DR   ECACC; 93021842
DR   Wikidata; Q54799972
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0153
AC   CVCL_K422
DR   ECACC; 93021843
DR   Wikidata; Q54799973
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0154
AC   CVCL_K423
DR   ECACC; 93012805
DR   Wikidata; Q54799974
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0155
AC   CVCL_K424
DR   ECACC; 93021844
DR   Wikidata; Q54799975
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0156
AC   CVCL_K425
DR   ECACC; 93021845
DR   Wikidata; Q54799976
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0157
AC   CVCL_K426
DR   ECACC; 91071214
DR   Wikidata; Q54799977
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0158
AC   CVCL_K427
DR   ECACC; 93022508
DR   Wikidata; Q54799978
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0159
AC   CVCL_K428
DR   ECACC; 93022509
DR   Wikidata; Q54799979
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C016
AC   CVCL_B4KA
SY   C016M
DR   GEO; GSM4178059
DR   Wikidata; Q110432650
CC   Characteristics: Early passage culture.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   C0160
AC   CVCL_K429
DR   ECACC; 93022510
DR   Wikidata; Q54799980
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0161
AC   CVCL_K430
DR   ECACC; 93022511
DR   Wikidata; Q54799981
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022511; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0163
AC   CVCL_5G98
DR   ECACC; 09071303
DR   Wikidata; Q54799982
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   C0164
AC   CVCL_K431
DR   ECACC; 94060819
DR   Wikidata; Q54799983
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0165
AC   CVCL_K432
DR   ECACC; 94060820
DR   Wikidata; Q54799984
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060820; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0166
AC   CVCL_K433
DR   ECACC; 94060821
DR   Wikidata; Q54799986
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0167
AC   CVCL_K434
DR   ECACC; 94060822
DR   Wikidata; Q54799987
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0168
AC   CVCL_K435
DR   ECACC; 94060823
DR   Wikidata; Q54799988
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0169
AC   CVCL_K436
DR   ECACC; 94060824
DR   Wikidata; Q54799989
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C017
AC   CVCL_EI36
SY   C017M
DR   cancercelllines; CVCL_EI36
DR   GEO; GSM4178060
DR   Wikidata; Q54799990
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Gly414Val (c.1241G>T); Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0170
AC   CVCL_K437
DR   ECACC; 91090407
DR   Wikidata; Q54799991
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0172
AC   CVCL_K438
DR   ECACC; 93022514
DR   Wikidata; Q54799992
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0173
AC   CVCL_K439
DR   ECACC; 93022515
DR   Wikidata; Q54799993
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022515; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0174
AC   CVCL_K440
DR   ECACC; 93012806
DR   Wikidata; Q54799994
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0175
AC   CVCL_K441
DR   ECACC; 93022517
DR   Wikidata; Q54800001
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0176
AC   CVCL_K442
DR   ECACC; 94060825
DR   Wikidata; Q54800002
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0178
AC   CVCL_K443
DR   ECACC; 93012808
DR   Wikidata; Q54800003
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0179
AC   CVCL_K444
DR   ECACC; 94060826
DR   Wikidata; Q54800004
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0180
AC   CVCL_K445
DR   ECACC; 93012809
DR   Wikidata; Q54800005
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0181
AC   CVCL_K446
DR   ECACC; 91090409
DR   Wikidata; Q54800006
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0182
AC   CVCL_K447
DR   ECACC; 94060827
DR   Wikidata; Q54800007
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0183
AC   CVCL_K448
DR   ECACC; 93012810
DR   Wikidata; Q54800008
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0184
AC   CVCL_K449
DR   ECACC; 94060828
DR   Wikidata; Q54800009
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0185
AC   CVCL_K450
DR   ECACC; 94060829
DR   Wikidata; Q54800010
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0186
AC   CVCL_K451
DR   ECACC; 94060830
DR   Wikidata; Q54800012
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0187
AC   CVCL_K452
DR   ECACC; 94060831
DR   Wikidata; Q54800013
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0188
AC   CVCL_K453
DR   ECACC; 94060832
DR   Wikidata; Q54800014
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0189
AC   CVCL_K454
DR   ECACC; 91090408
DR   Wikidata; Q54800016
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0190
AC   CVCL_K455
DR   ECACC; 94060833
DR   Wikidata; Q54800017
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0191
AC   CVCL_K456
DR   ECACC; 94060834
DR   Wikidata; Q54800018
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0192
AC   CVCL_K457
DR   ECACC; 94060835
DR   Wikidata; Q54800019
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0193
AC   CVCL_K458
DR   ECACC; 94060836
DR   Wikidata; Q54800020
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0194
AC   CVCL_K459
DR   ECACC; 94060837
DR   Wikidata; Q54800021
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0195
AC   CVCL_K460
DR   ECACC; 94060838
DR   Wikidata; Q54800022
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0196
AC   CVCL_K461
DR   ECACC; 94060839
DR   Wikidata; Q54800024
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0197
AC   CVCL_K462
DR   ECACC; 94060840
DR   Wikidata; Q54800025
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0198
AC   CVCL_K463
DR   ECACC; 94060841
DR   Wikidata; Q54800026
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060841; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   C0199
AC   CVCL_K464
DR   ECACC; 94060842
DR   Wikidata; Q54800027
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0200
AC   CVCL_K465
DR   ECACC; 94060843
DR   Wikidata; Q54800028
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0201
AC   CVCL_K466
DR   ECACC; 94060844
DR   Wikidata; Q54800029
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0202
AC   CVCL_K467
DR   EFO; EFO_0007072
DR   ECACC; 94060845
DR   ENCODE; ENCBS213HMN
DR   GEO; GSM931321
DR   GEO; GSM931322
DR   Wikidata; Q54800030
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   C0203
AC   CVCL_K468
DR   ECACC; 91101006
DR   Wikidata; Q54800031
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0204
AC   CVCL_K469
DR   ECACC; 91101007
DR   Wikidata; Q54800032
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0205
AC   CVCL_K470
DR   ECACC; 94060846
DR   Wikidata; Q54800033
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0206
AC   CVCL_K471
DR   ECACC; 91101008
DR   Wikidata; Q54800035
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0207
AC   CVCL_K472
DR   ECACC; 94060847
DR   Wikidata; Q54800036
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0208
AC   CVCL_K473
DR   ECACC; 91101009
DR   Wikidata; Q54800037
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0209
AC   CVCL_K474
DR   ECACC; 91101010
DR   Wikidata; Q54800038
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C021
AC   CVCL_EI37
SY   C021M
DR   Cosmic; 1665190
DR   Cosmic; 2013932
DR   GEO; GSM4178061
DR   Wikidata; Q54800039
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C0210
AC   CVCL_K475
DR   ECACC; 94060848
DR   Wikidata; Q54800040
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0211
AC   CVCL_K476
DR   ECACC; 94060849
DR   Wikidata; Q54800041
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0212
AC   CVCL_K477
DR   ECACC; 94060850
DR   Wikidata; Q54800042
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060850; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0213
AC   CVCL_K478
DR   ECACC; 94060851
DR   Wikidata; Q54800043
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0214
AC   CVCL_K479
DR   ECACC; 94060852
DR   Wikidata; Q54800044
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0215
AC   CVCL_K480
DR   ECACC; 94060853
DR   Wikidata; Q54800051
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C022
AC   CVCL_EI38
SY   C022M1
DR   Cosmic; 1665193
DR   GEO; GSM4178062
DR   Wikidata; Q54800052
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C025
AC   CVCL_EI39
SY   C025M1
DR   Cosmic; 1665192
DR   GEO; GSM4178063
DR   Wikidata; Q54800053
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:18592; NEK10; Simple; p.Glu379Lys (c.1135G>A); Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C027
AC   CVCL_EI40
SY   C027M
DR   cancercelllines; CVCL_EI40
DR   GEO; GSM4178064
DR   Wikidata; Q54800054
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C028
AC   CVCL_EI41
DR   cancercelllines; CVCL_EI41
DR   Cosmic; 1665191
DR   Wikidata; Q54800055
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22250051; PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4KH ! C028-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   C028-2
AC   CVCL_B4KH
DR   cancercelllines; CVCL_B4KH
DR   Wikidata; Q110432651
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EI41 ! C028
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   C037
AC   CVCL_EI42
SY   C037M
DR   Cosmic; 2465274
DR   GEO; GSM4178065
DR   Wikidata; Q54800056
RX   PubMed=22250051;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C038
AC   CVCL_EI43
DR   cancercelllines; CVCL_EI43
DR   Wikidata; Q54800057
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C042
AC   CVCL_EI44
DR   cancercelllines; CVCL_EI44
DR   Cosmic; 1665188
DR   Wikidata; Q54800058
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22250051; PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4KJ ! C042-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   C042-2
AC   CVCL_B4KJ
DR   cancercelllines; CVCL_B4KJ
DR   Wikidata; Q110432652
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EI44 ! C042
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   C044
AC   CVCL_EI45
SY   C044M
DR   cancercelllines; CVCL_EI45
DR   GEO; GSM4178066
DR   Wikidata; Q54800059
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C045
AC   CVCL_B4KK
DR   cancercelllines; CVCL_B4KK
DR   Wikidata; Q110432653
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   C047
AC   CVCL_E509
DR   dbMHC; 48524
DR   ECACC; 94050312
DR   IHW; IHW09265
DR   IPD-IMGT/HLA; 10369
DR   Wikidata; Q54800060
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Spanish.
CC   HLA typing: A*01:01:01:01,24:02:01:01; B*51:01:01,15:01:01:01; C*15:04,07:04:01; DPA1*01:03:01:05,01:03:01:04; DPB1*04:01:01:01,04:02:01:01; DQA1*03:05:01:02; DQB1*03:01:01:03; DRB1*11:01:01,11:04:01; DRB3*02:02:01:02 (IPD-IMGT/HLA=10369).
CC   HLA typing: A*01:01:01:01,24:02:01:01; B*51:01:01:01,15:01:01:01; C*15:04:01,07:04:01:01; DPA1*01:03:01:04,01:03:01:05; DPB1*04:01:01:01(126:01),04:02:01:01(105:01); DQA1*05:05:01; DQB1*03:01:01:03; DRB1*11:01:01:01,11:04:01; DRB3*02:02:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   C052
AC   CVCL_EI46
DR   Wikidata; Q54800061
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C054
AC   CVCL_EI47
SY   C054M
DR   cancercelllines; CVCL_EI47
DR   GEO; GSM4178067
DR   Wikidata; Q54800062
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C055
AC   CVCL_VK09
SY   CO55-M1; C055M
DR   Cosmic; 2651887
DR   GEO; GSM4178068
DR   Wikidata; Q93437405
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 6
//
ID   C057
AC   CVCL_EI48
SY   C057M
DR   cancercelllines; CVCL_EI48
DR   GEO; GSM4178069
DR   Wikidata; Q54800063
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C058
AC   CVCL_EI49
SY   C058M
DR   cancercelllines; CVCL_EI49
DR   Cosmic; 2465275
DR   GEO; GSM4178070
DR   Wikidata; Q54800064
RX   PubMed=22250051;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Ser (c.1789_1790delCTinsTC); ClinVar=VCV000375942; Zygosity=Heterozygous (PubMed=22383533; PubMed=23890154).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   C060
AC   CVCL_EI50
SY   C060M
DR   cancercelllines; CVCL_EI50
DR   GEO; GSM4178071
DR   Wikidata; Q54800065
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C062
AC   CVCL_EI51
SY   C062M2
DR   cancercelllines; CVCL_EI51
DR   Cosmic; 1665186
DR   GEO; GSM4178072
DR   Wikidata; Q54800066
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22250051; PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   C065
AC   CVCL_EI52
SY   C065M
DR   cancercelllines; CVCL_EI52
DR   GEO; GSM4178073
DR   Wikidata; Q54800067
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C067
AC   CVCL_EI53
SY   C067M
DR   GEO; GSM4178074
DR   Wikidata; Q54800068
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C071
AC   CVCL_EI54
SY   C071M
DR   cancercelllines; CVCL_EI54
DR   GEO; GSM4178075
DR   Wikidata; Q54800069
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0722
AC   CVCL_K481
DR   ECACC; 93081916
DR   Wikidata; Q54800070
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0723
AC   CVCL_K482
DR   ECACC; 93081917
DR   Wikidata; Q54800071
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0724
AC   CVCL_K483
DR   ECACC; 93081918
DR   Wikidata; Q54800072
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0725
AC   CVCL_K484
DR   ECACC; 93081919
DR   Wikidata; Q54800073
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0726
AC   CVCL_K485
DR   ECACC; 93081920
DR   Wikidata; Q54800074
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081920; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0727
AC   CVCL_K486
DR   ECACC; 93081921
DR   Wikidata; Q54800075
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0728
AC   CVCL_K487
DR   ECACC; 93081922
DR   Wikidata; Q54800076
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0729
AC   CVCL_K488
DR   ECACC; 93081923
DR   Wikidata; Q54800077
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C073
AC   CVCL_E510
DR   dbMHC; 48525
DR   ECACC; 94050338
DR   IHW; IHW09261
DR   IPD-IMGT/HLA; 10370
DR   Wikidata; Q54800078
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01,29:02; B*44:03:01,51:01; C*02:02,16:02; DPB1*02:01:02,04:01 (IPD-IMGT/HLA=10370).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   C0730
AC   CVCL_K489
DR   ECACC; 93082615
DR   Wikidata; Q54800079
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0731
AC   CVCL_K490
DR   ECACC; 93082616
DR   Wikidata; Q54807494
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0732
AC   CVCL_K491
DR   ECACC; 93082617
DR   Wikidata; Q54807495
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082617; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0733
AC   CVCL_K492
DR   ECACC; 930826921
DR   Wikidata; Q54807496
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 930826921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0734
AC   CVCL_K493
DR   ECACC; 93082618
DR   Wikidata; Q54807497
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082618; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0735
AC   CVCL_K494
DR   ECACC; 93082619
DR   Wikidata; Q54807498
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0736
AC   CVCL_K495
DR   ECACC; 93082620
DR   Wikidata; Q54807499
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082620; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0737
AC   CVCL_K496
DR   ECACC; 94060854
DR   Wikidata; Q54807500
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060854; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0738
AC   CVCL_K497
DR   ECACC; 94060855
DR   Wikidata; Q54807501
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0739
AC   CVCL_K498
DR   ECACC; 94060856
DR   Wikidata; Q54807502
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C074
AC   CVCL_B4KB
SY   C074M
DR   cancercelllines; CVCL_B4KB
DR   GEO; GSM4178076
DR   Wikidata; Q110432656
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   C0740
AC   CVCL_K499
DR   ECACC; 94060857
DR   Wikidata; Q54807503
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0741
AC   CVCL_K500
DR   ECACC; 94060858
DR   Wikidata; Q54807504
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0742
AC   CVCL_K501
DR   ECACC; 94060859
DR   Wikidata; Q54807505
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0743
AC   CVCL_K502
DR   ECACC; 94060860
DR   Wikidata; Q54807506
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0744
AC   CVCL_K503
DR   ECACC; 94060861
DR   Wikidata; Q54807507
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0745
AC   CVCL_K504
DR   ECACC; 94060862
DR   Wikidata; Q54807508
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C0746
AC   CVCL_K505
DR   ECACC; 94060863
DR   Wikidata; Q54807509
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060863; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0747
AC   CVCL_K506
DR   ECACC; 94060864
DR   Wikidata; Q54807510
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0748
AC   CVCL_K507
DR   ECACC; 94060865
DR   Wikidata; Q54807512
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0749
AC   CVCL_K508
DR   ECACC; 94060866
DR   Wikidata; Q54807513
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0750
AC   CVCL_K509
DR   ECACC; 94060867
DR   Wikidata; Q54807514
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0751
AC   CVCL_K510
DR   ECACC; 94060868
DR   Wikidata; Q54807515
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060868; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0752
AC   CVCL_K511
DR   ECACC; 94060869
DR   Wikidata; Q54807516
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060869; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0753
AC   CVCL_K512
DR   ECACC; 94060870
DR   Wikidata; Q54807517
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0754
AC   CVCL_K513
DR   ECACC; 94060871
DR   Wikidata; Q54807518
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060871; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0755
AC   CVCL_K514
DR   ECACC; 94060872
DR   Wikidata; Q54807519
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0756
AC   CVCL_K515
DR   ECACC; 94060873
DR   Wikidata; Q54807520
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0757
AC   CVCL_K516
DR   ECACC; 94060874
DR   Wikidata; Q54807521
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060874; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0758
AC   CVCL_K517
DR   ECACC; 94060875
DR   Wikidata; Q54807522
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060875; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0759
AC   CVCL_K518
DR   ECACC; 94060876
DR   Wikidata; Q54807523
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060876; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C076
AC   CVCL_B4KC
SY   C076M
DR   GEO; GSM4178077
DR   Wikidata; Q110432657
CC   Characteristics: Early passage culture.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   C0760
AC   CVCL_K519
DR   ECACC; 94060877
DR   Wikidata; Q54807524
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060877; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0761
AC   CVCL_K520
DR   ECACC; 94060878
DR   Wikidata; Q54807525
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060878; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0762
AC   CVCL_K521
DR   ECACC; 94060879
DR   Wikidata; Q54807526
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060879; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0763
AC   CVCL_K522
DR   ECACC; 94060880
DR   Wikidata; Q54807527
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060880; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0764
AC   CVCL_K523
DR   ECACC; 94060881
DR   Wikidata; Q54807528
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060881; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0765
AC   CVCL_K524
DR   ECACC; 94060882
DR   Wikidata; Q54807529
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060882; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0766
AC   CVCL_K525
DR   ECACC; 94060883
DR   Wikidata; Q54807530
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060883; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0767
AC   CVCL_K526
DR   ECACC; 94060884
DR   Wikidata; Q54807531
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060884; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0768
AC   CVCL_K527
DR   ECACC; 94060885
DR   Wikidata; Q54807533
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060885; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0769
AC   CVCL_K528
DR   ECACC; 94060886
DR   Wikidata; Q54807534
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060886; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C077
AC   CVCL_EI55
SY   C077M1
DR   GEO; GSM4178078
DR   Wikidata; Q54807535
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:3432; ERBB4; Simple; p.Glu452Lys (c.1354G>A); ClinVar=VCV000091898; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C0770
AC   CVCL_K529
DR   ECACC; 94060887
DR   Wikidata; Q54807542
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060887; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0771
AC   CVCL_K530
DR   ECACC; 94060888
DR   Wikidata; Q54807543
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060888; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0772
AC   CVCL_K531
DR   ECACC; 94060889
DR   Wikidata; Q54807544
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060889; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0773
AC   CVCL_K532
DR   ECACC; 94060890
DR   Wikidata; Q54807545
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060890; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0774
AC   CVCL_K533
DR   ECACC; 94060891
DR   Wikidata; Q54807546
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060891; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0775
AC   CVCL_K534
DR   ECACC; 94060892
DR   Wikidata; Q54807547
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060892; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0777
AC   CVCL_K535
DR   ECACC; 94060893
DR   Wikidata; Q54807548
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060893; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0778
AC   CVCL_K536
DR   ECACC; 94090101
DR   Wikidata; Q54807549
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0779
AC   CVCL_K537
DR   ECACC; 94090102
DR   Wikidata; Q54807550
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C078
AC   CVCL_EI56
DR   cancercelllines; CVCL_EI56
DR   Cosmic; 1665189
DR   Wikidata; Q54807551
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1076; BMPR1A; Simple; p.Tyr245Ser (c.734A>C); Zygosity=Heterozygous (PubMed=22250051).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22250051; PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   C0780
AC   CVCL_K538
DR   ECACC; 94090103
DR   Wikidata; Q54807552
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0781
AC   CVCL_K539
DR   ECACC; 94090104
DR   Wikidata; Q54807553
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0782
AC   CVCL_K540
DR   ECACC; 94090105
DR   Wikidata; Q54807554
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0783
AC   CVCL_K541
DR   ECACC; 94090106
DR   Wikidata; Q54807555
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0784
AC   CVCL_K542
DR   ECACC; 94090107
DR   Wikidata; Q54807556
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0785
AC   CVCL_K543
DR   ECACC; 94090108
DR   Wikidata; Q54807557
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0786
AC   CVCL_K544
DR   ECACC; 94090109
DR   Wikidata; Q54807558
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0787
AC   CVCL_K545
DR   ECACC; 94090110
DR   Wikidata; Q54807559
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0788
AC   CVCL_K546
DR   ECACC; 94090111
DR   Wikidata; Q54807560
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0789
AC   CVCL_K547
DR   ECACC; 94090112
DR   Wikidata; Q54807561
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0790
AC   CVCL_K548
DR   ECACC; 94090113
DR   Wikidata; Q54807562
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0791
AC   CVCL_K549
DR   ECACC; 94090114
DR   Wikidata; Q54807563
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0792
AC   CVCL_K550
DR   ECACC; 94090115
DR   Wikidata; Q54807564
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0793
AC   CVCL_K551
DR   ECACC; 94090116
DR   Wikidata; Q54807565
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0794
AC   CVCL_K552
DR   ECACC; 94090117
DR   Wikidata; Q54807566
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0795
AC   CVCL_K553
DR   ECACC; 94090118
DR   Wikidata; Q54807567
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0796
AC   CVCL_K554
DR   ECACC; 94090119
DR   Wikidata; Q54807568
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090119; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0797
AC   CVCL_K555
DR   ECACC; 94090120
DR   Wikidata; Q54807570
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090120; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0798
AC   CVCL_K556
DR   ECACC; 94090121
DR   Wikidata; Q54807571
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0799
AC   CVCL_K557
DR   ECACC; 94090122
DR   Wikidata; Q54807572
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0800
AC   CVCL_K558
DR   ECACC; 94090123
DR   Wikidata; Q54807573
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090123; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0801
AC   CVCL_K559
DR   ECACC; 94090124
DR   Wikidata; Q54807574
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090124; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0802
AC   CVCL_K560
DR   ECACC; 94090125
DR   Wikidata; Q54807575
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090125; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0803
AC   CVCL_K561
DR   ECACC; 94090126
DR   Wikidata; Q54807577
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0804
AC   CVCL_K562
DR   ECACC; 94090127
DR   Wikidata; Q54807578
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090127; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0805
AC   CVCL_K563
DR   ECACC; 94090128
DR   Wikidata; Q54807579
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0806
AC   CVCL_K564
DR   ECACC; 94090129
DR   Wikidata; Q54807580
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090129; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C0806(2)
AC   CVCL_K565
DR   ECACC; 94060894
DR   Wikidata; Q54807581
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060894; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C0807
AC   CVCL_K566
DR   ECACC; 94090130
DR   Wikidata; Q54807582
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090130; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0808
AC   CVCL_K567
DR   ECACC; 94090131
DR   Wikidata; Q54807583
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090131; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0809
AC   CVCL_K568
DR   ECACC; 94090132
DR   Wikidata; Q54807591
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C081
AC   CVCL_EI57
DR   cancercelllines; CVCL_EI57
DR   Wikidata; Q54807592
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0810
AC   CVCL_K569
DR   ECACC; 94090133
DR   Wikidata; Q54807593
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0811
AC   CVCL_K570
DR   ECACC; 94090134
DR   Wikidata; Q54807594
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090134; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0812
AC   CVCL_K571
DR   ECACC; 94090135
DR   Wikidata; Q54807595
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090135; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0813
AC   CVCL_K572
DR   ECACC; 94090136
DR   Wikidata; Q54807596
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090136; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0814
AC   CVCL_K573
DR   ECACC; 94090137
DR   Wikidata; Q54807597
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090137; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0815
AC   CVCL_K574
DR   ECACC; 94090138
DR   Wikidata; Q54807598
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090138; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0816
AC   CVCL_K575
DR   ECACC; 94090139
DR   Wikidata; Q54807599
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090139; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0817
AC   CVCL_K576
DR   ECACC; 94090140
DR   Wikidata; Q54807600
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0818
AC   CVCL_K577
DR   ECACC; 94090141
DR   Wikidata; Q54807601
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090141; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0819
AC   CVCL_K578
DR   ECACC; 94090142
DR   Wikidata; Q54807602
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090142; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0820
AC   CVCL_K579
DR   ECACC; 94090143
DR   Wikidata; Q54807603
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090143; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0821
AC   CVCL_K580
DR   ECACC; 94090144
DR   Wikidata; Q54807604
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0822
AC   CVCL_K581
DR   ECACC; 94090145
DR   Wikidata; Q54807605
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090145; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0823
AC   CVCL_K582
DR   ECACC; 94090146
DR   Wikidata; Q54807606
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090146; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0824
AC   CVCL_K583
DR   ECACC; 94090147
DR   Wikidata; Q54807607
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090147; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0825
AC   CVCL_K584
DR   ECACC; 94090148
DR   Wikidata; Q54807608
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090148; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0826
AC   CVCL_K585
DR   ECACC; 94090149
DR   Wikidata; Q54807609
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0827
AC   CVCL_K586
DR   ECACC; 94090150
DR   Wikidata; Q54807610
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090150; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0828
AC   CVCL_K587
DR   ECACC; 94090151
DR   Wikidata; Q54807611
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090151; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0829
AC   CVCL_K588
DR   ECACC; 94090152
DR   Wikidata; Q54807612
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C083
AC   CVCL_EI58
DR   cancercelllines; CVCL_EI58
DR   Cosmic; 2013933
DR   Wikidata; Q54807613
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   C0830
AC   CVCL_K589
DR   ECACC; 94090153
DR   Wikidata; Q54807614
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090153; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0831
AC   CVCL_K590
DR   ECACC; 94090154
DR   Wikidata; Q54807615
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090154; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0832
AC   CVCL_K591
DR   ECACC; 94090155
DR   Wikidata; Q54807616
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0833
AC   CVCL_K593
DR   ECACC; 94090156
DR   Wikidata; Q54807617
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090156; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0834
AC   CVCL_L108
DR   ECACC; 94090157
DR   Wikidata; Q54807618
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090157; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0835
AC   CVCL_K594
DR   ECACC; 94090158
DR   Wikidata; Q54807619
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0836
AC   CVCL_K595
DR   ECACC; 94090159
DR   Wikidata; Q54807620
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090159; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0837
AC   CVCL_K596
DR   ECACC; 94090160
DR   Wikidata; Q54807621
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090160; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0839
AC   CVCL_K597
DR   ECACC; 94090162
DR   Wikidata; Q54807622
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C084
AC   CVCL_EI59
SY   C084M
DR   Cosmic; 1665187
DR   GEO; GSM4178079
DR   Wikidata; Q54807623
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C0840
AC   CVCL_K598
DR   ECACC; 94090163
DR   Wikidata; Q54807624
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090163; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0843
AC   CVCL_K599
DR   ECACC; 94090166
DR   Wikidata; Q54807625
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090166; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0844
AC   CVCL_K600
DR   ECACC; 94090167
DR   Wikidata; Q54807626
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0845
AC   CVCL_K601
DR   ECACC; 94090168
DR   Wikidata; Q54807627
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0846
AC   CVCL_K602
DR   ECACC; 94090169
DR   Wikidata; Q54807628
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090169; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0847
AC   CVCL_K603
DR   ECACC; 94060895
DR   Wikidata; Q54807629
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0848
AC   CVCL_K604
DR   ECACC; 94060896
DR   Wikidata; Q54807630
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0849
AC   CVCL_K605
DR   ECACC; 94060897
DR   Wikidata; Q54807634
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0850
AC   CVCL_K606
DR   ECACC; 94060898
DR   Wikidata; Q54807635
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0851
AC   CVCL_K607
DR   ECACC; 94060899
DR   Wikidata; Q54807636
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0852
AC   CVCL_K608
DR   ECACC; 940608100
DR   Wikidata; Q54807637
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0853
AC   CVCL_K609
DR   ECACC; 940608101
DR   Wikidata; Q54807638
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0854
AC   CVCL_K610
DR   ECACC; 940608102
DR   Wikidata; Q54807639
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0855
AC   CVCL_K611
DR   ECACC; 940608103
DR   Wikidata; Q54807640
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0856
AC   CVCL_K612
DR   ECACC; 940608104
DR   Wikidata; Q54807641
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0857
AC   CVCL_K613
DR   ECACC; 940608105
DR   Wikidata; Q54807642
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0858
AC   CVCL_K614
DR   ECACC; 940608106
DR   Wikidata; Q54807643
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0859
AC   CVCL_K615
DR   ECACC; 940608107
DR   Wikidata; Q54807644
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C086
AC   CVCL_EI60
SY   C086M
DR   Cosmic; 1665194
DR   Cosmic; 2465276
DR   GEO; GSM4178080
DR   Wikidata; Q54807645
RX   PubMed=22250051;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C0860
AC   CVCL_K616
DR   ECACC; 940608108
DR   Wikidata; Q54807646
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0861
AC   CVCL_K617
DR   ECACC; 940608109
DR   Wikidata; Q54807647
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0862
AC   CVCL_K618
DR   ECACC; 940608110
DR   Wikidata; Q54807648
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0863
AC   CVCL_K619
DR   ECACC; 940608111
DR   Wikidata; Q54807649
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0864
AC   CVCL_K620
DR   ECACC; 940608112
DR   Wikidata; Q54807650
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0865
AC   CVCL_K621
DR   ECACC; 940608113
DR   Wikidata; Q54807651
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0866
AC   CVCL_K622
DR   ECACC; 940608114
DR   Wikidata; Q54807652
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0867
AC   CVCL_K623
DR   ECACC; 940608115
DR   Wikidata; Q54807653
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0868
AC   CVCL_K624
DR   ECACC; 940608116
DR   Wikidata; Q54807654
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0869
AC   CVCL_K625
DR   ECACC; 940608117
DR   Wikidata; Q54807655
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0870
AC   CVCL_K626
DR   ECACC; 940608118
DR   Wikidata; Q54807656
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0871
AC   CVCL_K627
DR   ECACC; 940608119
DR   Wikidata; Q54807657
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0872
AC   CVCL_K628
DR   ECACC; 940608120
DR   Wikidata; Q54807658
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0873
AC   CVCL_K629
DR   ECACC; 940608121
DR   Wikidata; Q54807659
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0874
AC   CVCL_K630
DR   ECACC; 940608122
DR   Wikidata; Q54807660
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0875
AC   CVCL_K631
DR   ECACC; 940608123
DR   Wikidata; Q54807661
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0877
AC   CVCL_K632
DR   ECACC; 940608124
DR   Wikidata; Q54807662
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0878
AC   CVCL_K633
DR   ECACC; 94060911
DR   Wikidata; Q54807663
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0879
AC   CVCL_K634
DR   ECACC; 94060912
DR   Wikidata; Q54807664
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94060912; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C088
AC   CVCL_B4KD
SY   C088M1
DR   cancercelllines; CVCL_B4KD
DR   GEO; GSM4178081
DR   Wikidata; Q110432658
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4KL ! C088-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   C088-2
AC   CVCL_B4KL
DR   cancercelllines; CVCL_B4KL
DR   Wikidata; Q110432659
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4KD ! C088
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   C0880
AC   CVCL_K635
DR   ECACC; 94060913
DR   Wikidata; Q54807665
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0881
AC   CVCL_K636
DR   ECACC; 94060914
DR   Wikidata; Q54807666
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0882
AC   CVCL_K637
DR   ECACC; 94060915
DR   Wikidata; Q54807667
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0883
AC   CVCL_K638
DR   ECACC; 94060916
DR   Wikidata; Q54807668
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0884
AC   CVCL_K639
DR   ECACC; 94060917
DR   Wikidata; Q54807669
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0885
AC   CVCL_K640
DR   ECACC; 94060918
DR   Wikidata; Q54807670
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0886
AC   CVCL_K641
DR   ECACC; 94070401
DR   Wikidata; Q54807671
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0887
AC   CVCL_K642
DR   ECACC; 94070402
DR   Wikidata; Q54807672
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0888
AC   CVCL_K643
DR   ECACC; 94070403
DR   Wikidata; Q54807673
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0889
AC   CVCL_K644
DR   ECACC; 94070404
DR   Wikidata; Q54807681
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C089
AC   CVCL_EI61
SY   C089M
DR   cancercelllines; CVCL_EI61
DR   Cosmic; 2465277
DR   GEO; GSM4178082
DR   Wikidata; Q54807683
RX   PubMed=22250051;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533; PubMed=23890154).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Thr992Ile (c.2975C>T) (p.Thr1010Ile, c.3029C>T); ClinVar=VCV000041624; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   C0890
AC   CVCL_K645
DR   ECACC; 94070405
DR   Wikidata; Q54807684
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0891
AC   CVCL_K646
DR   ECACC; 94070406
DR   Wikidata; Q54807685
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0892
AC   CVCL_K647
DR   ECACC; 94070407
DR   Wikidata; Q54807686
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0893
AC   CVCL_K648
DR   ECACC; 94070408
DR   Wikidata; Q54807687
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0894
AC   CVCL_K649
DR   ECACC; 94070409
DR   Wikidata; Q54807688
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0895
AC   CVCL_K650
DR   ECACC; 94070410
DR   Wikidata; Q54807689
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0896
AC   CVCL_K651
DR   ECACC; 94070411
DR   Wikidata; Q54807690
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0897
AC   CVCL_K652
DR   ECACC; 94070412
DR   Wikidata; Q54807691
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0898
AC   CVCL_K653
DR   ECACC; 94070413
DR   Wikidata; Q54807692
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0899
AC   CVCL_K654
DR   ECACC; 94070414
DR   Wikidata; Q54807693
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0900
AC   CVCL_K655
DR   ECACC; 94070415
DR   Wikidata; Q54807694
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070415; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0901
AC   CVCL_K656
DR   ECACC; 94070416
DR   Wikidata; Q54807695
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0902
AC   CVCL_K657
DR   ECACC; 94081517
DR   Wikidata; Q54807696
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0903
AC   CVCL_K658
DR   ECACC; 94081518
DR   Wikidata; Q54807697
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081518; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0904
AC   CVCL_K659
DR   ECACC; 94081519
DR   Wikidata; Q54807698
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0905
AC   CVCL_K660
DR   ECACC; 94081520
DR   Wikidata; Q54807699
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081520; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0906
AC   CVCL_K661
DR   ECACC; 94081521
DR   Wikidata; Q54807700
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0907
AC   CVCL_K662
DR   ECACC; 94081522
DR   Wikidata; Q54807701
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0908
AC   CVCL_K663
DR   ECACC; 94081523
DR   Wikidata; Q54807702
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0909
AC   CVCL_K664
DR   ECACC; 94081524
DR   Wikidata; Q54807703
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C091
AC   CVCL_EI62
SY   C091M
DR   cancercelllines; CVCL_EI62
DR   GEO; GSM4178083
DR   Wikidata; Q54807704
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   C0910
AC   CVCL_K665
DR   ECACC; 94081525
DR   Wikidata; Q54807705
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0911
AC   CVCL_K666
DR   ECACC; 94081526
DR   Wikidata; Q54807706
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0912
AC   CVCL_K667
DR   ECACC; 94081527
DR   Wikidata; Q54807707
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081527; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0913
AC   CVCL_K668
DR   ECACC; 94081528
DR   Wikidata; Q54807708
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0914
AC   CVCL_K669
DR   ECACC; 94081529
DR   Wikidata; Q54807709
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081529; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0915
AC   CVCL_K670
DR   ECACC; 94081530
DR   Wikidata; Q54807710
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0916
AC   CVCL_K671
DR   ECACC; 94081531
DR   Wikidata; Q54807711
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081531; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0917
AC   CVCL_K672
DR   ECACC; 94081532
DR   Wikidata; Q54807712
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0918
AC   CVCL_K673
DR   ECACC; 94082601
DR   Wikidata; Q54807713
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0919
AC   CVCL_K674
DR   ECACC; 94082602
DR   Wikidata; Q54807714
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C092
AC   CVCL_EI63
SY   C092M
DR   Cosmic; 2465278
DR   GEO; GSM4178084
DR   Wikidata; Q54807715
RX   PubMed=23890154;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   C0920
AC   CVCL_K675
DR   ECACC; 94082603
DR   Wikidata; Q54807716
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0921
AC   CVCL_K676
DR   ECACC; 94082604
DR   Wikidata; Q54807717
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0922
AC   CVCL_K677
DR   ECACC; 94082605
DR   Wikidata; Q54807718
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0924
AC   CVCL_K678
DR   ECACC; 94082606
DR   Wikidata; Q54807719
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082606; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0925
AC   CVCL_K679
DR   ECACC; 94082607
DR   Wikidata; Q54807720
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0926
AC   CVCL_K680
DR   ECACC; 94082608
DR   Wikidata; Q54807721
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0927
AC   CVCL_K681
DR   ECACC; 94082609
DR   Wikidata; Q54807724
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0928
AC   CVCL_K682
DR   ECACC; 94082610
DR   Wikidata; Q54807725
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0929
AC   CVCL_K683
DR   ECACC; 94082611
DR   Wikidata; Q54807726
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0930
AC   CVCL_K684
DR   ECACC; 94082612
DR   Wikidata; Q54807727
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082612; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0931
AC   CVCL_K685
DR   ECACC; 94082613
DR   Wikidata; Q54807728
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0932
AC   CVCL_K686
DR   ECACC; 94082614
DR   Wikidata; Q54807729
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0933
AC   CVCL_K687
DR   ECACC; 93052001
DR   Wikidata; Q54807730
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0935
AC   CVCL_K688
DR   ECACC; 93052002
DR   Wikidata; Q54807731
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0936
AC   CVCL_K689
DR   ECACC; 93052003
DR   Wikidata; Q54807732
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0937
AC   CVCL_K690
DR   ECACC; 93052004
DR   Wikidata; Q54807733
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0938
AC   CVCL_K691
DR   ECACC; 93052005
DR   Wikidata; Q54807734
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0939
AC   CVCL_K693
DR   ECACC; 93052006
DR   Wikidata; Q54807735
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C094
AC   CVCL_B4KE
SY   C094M
DR   cancercelllines; CVCL_B4KE
DR   GEO; GSM4178085
DR   Wikidata; Q110432660
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   C0940
AC   CVCL_L109
DR   ECACC; 93052007
DR   Wikidata; Q54807736
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0941
AC   CVCL_K694
DR   ECACC; 93052008
DR   Wikidata; Q54807737
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0942
AC   CVCL_K695
DR   ECACC; 93052009
DR   Wikidata; Q54807738
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0943
AC   CVCL_K696
DR   ECACC; 93052010
DR   Wikidata; Q54807739
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0944
AC   CVCL_K697
DR   ECACC; 93052711
DR   Wikidata; Q54807740
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0945
AC   CVCL_K698
DR   ECACC; 93052712
DR   Wikidata; Q54807741
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0946
AC   CVCL_K699
DR   ECACC; 93052713
DR   Wikidata; Q54807742
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0947
AC   CVCL_K700
DR   ECACC; 93052714
DR   Wikidata; Q54807743
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052714; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0948
AC   CVCL_K701
DR   ECACC; 93052715
DR   Wikidata; Q54807744
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0949
AC   CVCL_K702
DR   ECACC; 93052716
DR   Wikidata; Q54807745
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052716; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0950
AC   CVCL_K703
DR   ECACC; 93052717
DR   Wikidata; Q54807746
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052717; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0951
AC   CVCL_K704
DR   ECACC; 93052718
DR   Wikidata; Q54807747
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0952
AC   CVCL_K705
DR   ECACC; 93052719
DR   Wikidata; Q54807748
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052719; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0953
AC   CVCL_K706
DR   ECACC; 93052720
DR   Wikidata; Q54807749
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0954
AC   CVCL_K707
DR   ECACC; 93060307
DR   Wikidata; Q54807750
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93060307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0955
AC   CVCL_K708
DR   ECACC; 93060308
DR   Wikidata; Q54807751
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93060308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0956
AC   CVCL_K709
DR   ECACC; 93060309
DR   Wikidata; Q54807752
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0957
AC   CVCL_K710
DR   ECACC; 93060310
DR   Wikidata; Q54807753
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0958
AC   CVCL_K711
DR   ECACC; 93060311
DR   Wikidata; Q54807754
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0959
AC   CVCL_K712
DR   ECACC; 93060312
DR   Wikidata; Q54807755
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C096
AC   CVCL_EI64
DR   cancercelllines; CVCL_EI64
DR   Wikidata; Q54807756
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   C0960
AC   CVCL_K713
DR   ECACC; 93060313
DR   Wikidata; Q54807757
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0961
AC   CVCL_K714
DR   ECACC; 93060314
DR   Wikidata; Q54807758
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0962
AC   CVCL_K715
DR   ECACC; 93060315
DR   Wikidata; Q54807759
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0963
AC   CVCL_K716
DR   ECACC; 93060316
DR   Wikidata; Q54807760
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0964
AC   CVCL_K717
DR   ECACC; 93060317
DR   Wikidata; Q54807761
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0965
AC   CVCL_K718
DR   ECACC; 93060318
DR   Wikidata; Q54807762
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0966
AC   CVCL_K719
DR   ECACC; 93061012
DR   Wikidata; Q54807763
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0967
AC   CVCL_K720
DR   ECACC; 93061013
DR   Wikidata; Q54807766
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0968
AC   CVCL_K721
DR   ECACC; 93061014
DR   Wikidata; Q54807767
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0969
AC   CVCL_K722
DR   ECACC; 93061015
DR   Wikidata; Q54807769
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C097
AC   CVCL_EI65
DR   cancercelllines; CVCL_EI65
DR   Wikidata; Q54807770
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   C0970
AC   CVCL_K723
DR   ECACC; 93061016
DR   Wikidata; Q54807771
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0971
AC   CVCL_K724
DR   ECACC; 93061017
DR   Wikidata; Q54807772
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0972
AC   CVCL_K725
DR   ECACC; 93061018
DR   Wikidata; Q54807773
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061018; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0973
AC   CVCL_K726
DR   ECACC; 93061019
DR   Wikidata; Q54807774
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061019; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0974
AC   CVCL_K727
DR   ECACC; 93061020
DR   Wikidata; Q54807775
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061020; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0975
AC   CVCL_K728
DR   ECACC; 93061021
DR   Wikidata; Q54807776
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061021; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0976
AC   CVCL_K729
DR   ECACC; 93061022
DR   Wikidata; Q54807777
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0977
AC   CVCL_K730
DR   ECACC; 93061023
DR   Wikidata; Q54807778
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0978
AC   CVCL_K731
DR   ECACC; 93061024
DR   Wikidata; Q54807779
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0979
AC   CVCL_K732
DR   ECACC; 93061701
DR   Wikidata; Q54807780
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0980
AC   CVCL_K733
DR   ECACC; 93061702
DR   Wikidata; Q54807781
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0981
AC   CVCL_K734
DR   ECACC; 93061703
DR   Wikidata; Q54807782
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0982
AC   CVCL_K735
DR   ECACC; 93061704
DR   Wikidata; Q54807783
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0983
AC   CVCL_K736
DR   ECACC; 93061705
DR   Wikidata; Q54807784
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0984
AC   CVCL_K737
DR   ECACC; 93080501
DR   Wikidata; Q54807785
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0985
AC   CVCL_K738
DR   ECACC; 93080502
DR   Wikidata; Q54807786
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0986
AC   CVCL_K739
DR   ECACC; 93080503
DR   Wikidata; Q54807787
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0987
AC   CVCL_K740
DR   ECACC; 93080504
DR   Wikidata; Q54807788
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0988
AC   CVCL_K741
DR   ECACC; 93080505
DR   Wikidata; Q54807789
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0989
AC   CVCL_K742
DR   ECACC; 93080506
DR   Wikidata; Q54807790
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0990
AC   CVCL_K743
DR   ECACC; 93080507
DR   Wikidata; Q54807792
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0991
AC   CVCL_K744
DR   ECACC; 93080508
DR   Wikidata; Q54807793
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080508; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0992
AC   CVCL_K745
DR   ECACC; 93080509
DR   Wikidata; Q54807794
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080509; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0993
AC   CVCL_K746
DR   ECACC; 93080510
DR   Wikidata; Q54807795
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080510; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0994
AC   CVCL_K747
DR   ECACC; 93081204
DR   Wikidata; Q54807796
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0995
AC   CVCL_K748
DR   ECACC; 93081205
DR   Wikidata; Q54807797
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0996
AC   CVCL_K749
DR   ECACC; 93081206
DR   Wikidata; Q54807798
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0997
AC   CVCL_K750
DR   ECACC; 93081207
DR   Wikidata; Q54807799
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C0998
AC   CVCL_K751
DR   ECACC; 93081208
DR   Wikidata; Q54807800
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C0999
AC   CVCL_K752
DR   ECACC; 93081209
DR   Wikidata; Q54807801
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1 [Dog mastocytoma]
AC   CVCL_1R43
DR   Wikidata; Q54807802
RX   PubMed=1634619;
RX   PubMed=2121170;
CC   Doubling time: 37.4 +- 18.7 hours (PubMed=2121170).
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   C1 [Mouse hybridoma]
AC   CVCL_U064
SY   COX IA2
DR   ECACC; 99061825
DR   Wikidata; Q54807803
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   C1 [Mouse hybridoma against human TNF]
AC   CVCL_E8PV
SY   Clone 1
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C1 [Mouse teratocarcinoma]
AC   CVCL_B5N4
DR   Wikidata; Q111733026
RX   PubMed=2153146;
RX   PubMed=8405769;
CC   Characteristics: Established from a tumor obtained by injection of parent cell line into irradiated syngeneic mice (PubMed=2153146).
CC   Characteristics: After injection into syngeneic mice, produce typical osteosarcomas.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5N3 ! 1003-pK4 clone 8129
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   c1 (B6NLxv1c2)
AC   CVCL_9103
SY   c1; B6NLxv1c2; B6NL
DR   CLO; CLO_0002075
DR   ATCC; CRL-2716
DR   Wikidata; Q54807804
RX   PubMed=3308449;
RX   PubMed=6623311;
RX   PubMed=6896205;
CC   Selected for resistance to: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Sequence variation: Mutation; MGI; MGI:88588; Cyp1a1; Simple; p.Gln415Ter (c.1243C>T); Zygosity=Homozygous (PubMed=3308449).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   C1 100 08 0002
AC   CVCL_WJ19
SY   C1 100080002; C802
DR   EFO; EFO_0009494
DR   ArrayExpress; E-TABM-1180
DR   ENCODE; ENCBS141AAA
DR   Wikidata; Q93438928
RX   PubMed=23264559;
WW   Info; ENCODE; -; https://www.encodeproject.org/documents/ca3a16d0-3a6b-4b1c-8bf2-fc470ae0f9d8/@@download/attachment/Olfneurosphere_Crawford_protocol.pdf
CC   Characteristics: Olfactory neurosphere derived cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 4
//
ID   C1 100 08 0003
AC   CVCL_WJ20
SY   C1 100080003; C803
DR   EFO; EFO_0009495
DR   ArrayExpress; E-TABM-1180
DR   ENCODE; ENCBS354AAA
DR   Wikidata; Q93438931
RX   PubMed=23264559;
WW   Info; ENCODE; -; https://www.encodeproject.org/documents/ca3a16d0-3a6b-4b1c-8bf2-fc470ae0f9d8/@@download/attachment/Olfneurosphere_Crawford_protocol.pdf
CC   Characteristics: Olfactory neurosphere derived cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   C1 100 08 0013
AC   CVCL_WJ21
SY   C1 100080013; C813
DR   EFO; EFO_0009496
DR   ArrayExpress; E-TABM-1180
DR   ENCODE; ENCBS142AAA
DR   Wikidata; Q93438933
RX   PubMed=23264559;
WW   Info; ENCODE; -; https://www.encodeproject.org/documents/ca3a16d0-3a6b-4b1c-8bf2-fc470ae0f9d8/@@download/attachment/Olfneurosphere_Crawford_protocol.pdf
CC   Characteristics: Olfactory neurosphere derived cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   C1-iPSC-1
AC   CVCL_C189
DR   Wikidata; Q54807806
RX   PubMed=21339753;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   C1-iPSC-2
AC   CVCL_VL27
DR   Wikidata; Q93438939
RX   PubMed=21339753;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   C1.02
AC   CVCL_E7V8
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C1.03
AC   CVCL_E7V9
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C1.18.4
AC   CVCL_3493
SY   C1-18
DR   CLO; CLO_0002076
DR   ATCC; TIB-11
DR   Wikidata; Q54807807
RX   PubMed=5439579;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C3H.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   C10
AC   CVCL_5245
DR   cancercelllines; CVCL_5245
DR   CancerTools; 151755
DR   Cell_Model_Passport; SIDM01532
DR   ColonAtlas; C10
DR   Cosmic; 948825
DR   Cosmic; 986001
DR   Cosmic; 995377
DR   Cosmic; 1043798
DR   Cosmic; 2301955
DR   Cosmic; 2760092
DR   DepMap; ACH-001454
DR   ECACC; 12022901
DR   GEO; GSM1346827
DR   GEO; GSM1374418
DR   GEO; GSM1448196
DR   IARC_TP53; 21732
DR   MetaboLights; MTBLS227
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54807810
DR   Ximbio; 151755
RX   PubMed=8464898;
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=26537799;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022901; true.
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
ST   Source(s): DepMap=ACH-001454; ECACC=12022901; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 18
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 13,16
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 14
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   C10 [Mouse hybridoma against human TNF]
AC   CVCL_E8Q4
SY   Clone 10
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C10/MJ-2
AC   CVCL_6822
AS   CVCL_0193
SY   C10/MJ2; C10-MJ2; C10MJ2; C10-MJ; C10/MJ
DR   MCCL; MCC:0000084
DR   BEI_Resources; ARP-4407
DR   Lonza; 388
DR   Wikidata; Q54807811
RX   PubMed=3003193;
RX   PubMed=6600519;
RX   PubMed=11021758;
RX   PubMed=12920029;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Misspelling: C5MJ2; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 19
//
ID   C100
AC   CVCL_EI66
SY   C100M
DR   GEO; GSM4178086
DR   Wikidata; Q54807812
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Arg (c.1405G>A); ClinVar=VCV000177775; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg88Gln (c.263G>A); ClinVar=VCV000376049; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   C1005
AC   CVCL_K753
DR   ECACC; 940606175
DR   Wikidata; Q54807813
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606175; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1006
AC   CVCL_K754
DR   ECACC; 940606184
DR   Wikidata; Q54807814
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C1008
AC   CVCL_K755
DR   ECACC; 940606176
DR   Wikidata; Q54807815
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C1009
AC   CVCL_K756
DR   ECACC; 940606185
DR   Wikidata; Q54807816
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606185; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C101
AC   CVCL_C6NM
DR   Wikidata; Q117704228
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   C1010
AC   CVCL_K757
DR   ECACC; 940606248
DR   Wikidata; Q54807817
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C1011
AC   CVCL_K758
DR   ECACC; 940606177
DR   Wikidata; Q54807818
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C1012
AC   CVCL_K759
DR   ECACC; 940606186
DR   Wikidata; Q54807819
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606186; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1013
AC   CVCL_K760
DR   ECACC; 940606195
DR   Wikidata; Q54807820
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606195; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1014
AC   CVCL_K761
DR   ECACC; 940606315
DR   Wikidata; Q54807821
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606315; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1015
AC   CVCL_K762
DR   ECACC; 940606316
DR   Wikidata; Q54807822
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606316; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1016
AC   CVCL_K763
DR   ECACC; 940606317
DR   Wikidata; Q54807823
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606317; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1017
AC   CVCL_K764
DR   ECACC; 940606318
DR   Wikidata; Q54807824
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606318; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1018
AC   CVCL_K765
DR   ECACC; 940606321
DR   Wikidata; Q54807825
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1019
AC   CVCL_K766
DR   ECACC; 940606319
DR   Wikidata; Q54807826
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1020
AC   CVCL_K767
DR   ECACC; 940606285
DR   Wikidata; Q54807827
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940606285; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C1026L
AC   CVCL_U099
DR   Wikidata; Q54807828
RX   PubMed=12114371;
RX   PubMed=17511773;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*35:01,44:031; C*08:01,14:03 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   C106 [Human melanoma]
AC   CVCL_EI67
SY   C106M
DR   cancercelllines; CVCL_EI67
DR   GEO; GSM4178087
DR   Wikidata; Q54807829
RX   PubMed=22250051;
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   C106 [Human rectal adenocarcinoma]
AC   CVCL_M011
DR   cancercelllines; CVCL_M011
DR   CancerTools; 151762
DR   ColonAtlas; C106
DR   Cosmic; 948836
DR   Cosmic; 986002
DR   Cosmic; 995375
DR   Cosmic; 1312289
DR   Cosmic; 2301956
DR   Cosmic; 2800588
DR   ECACC; 12022906
DR   GEO; GSM1346861
DR   GEO; GSM1374419
DR   GEO; GSM1448197
DR   IARC_TP53; 21733
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54807830
DR   Ximbio; 151762
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1237Glufs*2 (c.3709_3710delCA); ClinVar=VCV000433651; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.His1490fs*17 (c.4469delA); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Met (c.374C>T); ClinVar=VCV000183748; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022906; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ECACC=12022906; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 12,13
ST   D21S11: 32.2
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 29
//
ID   C108 [Human melanoma]
AC   CVCL_C6NN
DR   Wikidata; Q117704229
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   C108 [Mouse lung carcinoma]
AC   CVCL_3986
SY   C 108
DR   BTO; BTO_0000587
DR   CLO; CLO_0002068
DR   CLDB; cl519
DR   Wikidata; Q54807831
RX   PubMed=543011;
RX   PubMed=6085723;
RX   PubMed=6203864;
RX   PubMed=6480290;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   C10ABR
AC   CVCL_RN97
SY   Control 10 Australia BRisbane
DR   Wikidata; Q54807832
RX   PubMed=6197197;
RX   PubMed=6504056;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C11
AC   CVCL_E8Q5
SY   Clone 11
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C11.2
AC   CVCL_F710
DR   Wikidata; Q54807833
RX   PubMed=17049468;
CC   Doubling time: ~24 hours (PubMed=17049468).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_F711 ! C9 [Bovine fetal brain]
SX   Sex unspecified
AG   12FW
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   C11011
AC   CVCL_VG28
DR   SKIP; SKIP001328
DR   Wikidata; Q54807834
RX   PubMed=26740656;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012602; Zygosity=Unspecified (PubMed=26740656).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84652; Costello syndrome
DI   ORDO; Orphanet_3071; Costello syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   C11ABR
AC   CVCL_RN98
SY   Control 11 Australia BRisbane
DR   Wikidata; Q54807835
RX   PubMed=1944384;
RX   PubMed=6197197;
RX   PubMed=6228733;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C11C1
AC   CVCL_J449
DR   CLO; CLO_0002081
DR   Wikidata; Q54807836
RX   Patent=US4908431;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8964.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01042; Human KNG1 (Note=AA 390-644 = Kininogen light chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   C11STH
AC   CVCL_4U32
SY   C11 STH; C11-STH
DR   Wikidata; Q54807837
RX   PubMed=7526034;
CC   Doubling time: ~48 hours (PubMed=7526034).
CC   Karyotypic information: Trisomy of 8 and 11 (PubMed=7526034).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   C12
AC   CVCL_E8Q6
SY   Clone 12
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   c12 (B15ECiii2)
AC   CVCL_9104
SY   c12; B15ECiii2
DR   CLO; CLO_0002082
DR   ATCC; CRL-2710
DR   Wikidata; Q54807838
RX   PubMed=6623311;
CC   Selected for resistance to: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   C1218-39
AC   CVCL_DC72
DR   Wikidata; Q54807839
RX   PubMed=2470715;
CC   Doubling time: 18 hours (PubMed=2470715).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a gastric cancer.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   C125-PM
AC   CVCL_8175
AS   CVCL_8174
SY   C125PM; C125
DR   cancercelllines; CVCL_8175
DR   CancerTools; 151763
DR   Cell_Model_Passport; SIDM01541
DR   ColonAtlas; C125
DR   Cosmic; 948842
DR   Cosmic; 995376
DR   Cosmic; 1043799
DR   Cosmic; 1223130
DR   Cosmic; 1312290
DR   Cosmic; 1479601
DR   Cosmic; 2301957
DR   Cosmic; 2800565
DR   DepMap; ACH-001456
DR   ECACC; 12022909
DR   GEO; GSM1346862
DR   GEO; GSM1374420
DR   GEO; GSM1448181
DR   IARC_TP53; 21746
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54807840
DR   Ximbio; 151763
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Unspecified (DepMap=ACH-001456).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Lys117Asn (c.351A>C); ClinVar=VCV000375965; Zygosity=Unspecified (PubMed=20570890; DepMap=ACH-001456).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022909; true.
ST   Source(s): ECACC=12022909; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 28
ST   D5S818: 9
ST   D7S820: 8,10 (PubMed=25926053)
ST   D7S820: 8.2,10 (ECACC=12022909)
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   C127
AC   CVCL_6550
SY   C-127
DR   BTO; BTO_0001193
DR   CLO; CLO_0002083
DR   CLO; CLO_0050955
DR   EFO; EFO_0022823
DR   CLDB; cl546
DR   AddexBio; S0006001/28
DR   CCRID; 3101MOUTCM26
DR   CLS; 305169
DR   KCB; KCB 92023YJ
DR   RCB; RCB0036
DR   Wikidata; Q54807841
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-226.html
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   C127 clone 64
AC   CVCL_U341
SY   Clone 64
DR   CLO; CLO_0050953
DR   RCB; RCB1509
DR   Wikidata; Q54807842
RX   PubMed=1663110;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   C127 clone 76
AC   CVCL_U342
SY   Clone 76
DR   CLO; CLO_0050952
DR   RCB; RCB1508
DR   Wikidata; Q54807843
RX   PubMed=1663110;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   C127 clone YP1N25
AC   CVCL_U349
SY   Clone YP1N25
DR   CLO; CLO_0050959
DR   RCB; RCB1506
DR   Wikidata; Q54807845
RX   PubMed=8709268;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   C127 clone YP1N27
AC   CVCL_U348
SY   Clone YP1N27
DR   CLO; CLO_0050954
DR   RCB; RCB1507
DR   Wikidata; Q54807844
RX   PubMed=8709268;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   C127 ts
AC   CVCL_9W56
DR   CLO; CLO_0002084
DR   CLDB; cl547
DR   Wikidata; Q54807846
RX   PubMed=225570;
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   C127:LT
AC   CVCL_6580
DR   CLO; CLO_0002085
DR   ATCC; CRL-1804
DR   Wikidata; Q54807847
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   C127I
AC   CVCL_3882
SY   C127i; C 1271; C-127I; C-127 I; CNC 127I
DR   BTO; BTO_0000820
DR   CLO; CLO_0002069
DR   CLO; CLO_0002086
DR   CLO; CLO_0002537
DR   CLDB; cl548
DR   CLDB; cl549
DR   CLDB; cl822
DR   ATCC; CRL-1616
DR   CLS; 400134
DR   ECACC; 87091701
DR   ECACC; 90060504
DR   IZSLER; BS TCL 6
DR   Wikidata; Q54807848
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   C129
AC   CVCL_K126
SY   Clone 129
DR   CLO; CLO_0002087
DR   ATCC; HB-9516
DR   Wikidata; Q54807849
RX   Patent=US4959310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9516.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   C12ABR
AC   CVCL_IW80
SY   Control 12 Australia BRisbane
DR   Wikidata; Q54807851
RX   PubMed=2825700;
RX   PubMed=2836804;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   C12B9
AC   CVCL_ZC49
DR   Wikidata; Q98125593
RX   PubMed=1717839;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   C13
AC   CVCL_E8Q7
SY   Clone 13
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C1300 CLONE NA
AC   CVCL_4510
SY   C1300Clone NA; NA C 1300 clone
DR   CLO; CLO_0002091
DR   CLO; CLO_0007932
DR   CLDB; cl554
DR   CLDB; cl3626
DR   ECACC; 93120817
DR   IZSLER; BS TCL 46
DR   NCBI_Iran; C549
DR   Wikidata; Q54807852
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   C135
AC   CVCL_DG70
DR   ColonAtlas; C135
DR   Cosmic; 2301958
DR   GEO; GSM1346828
DR   Wikidata; Q54807853
RX   PubMed=24755471;
CC   Microsatellite instability: Instable (MSI) (PubMed=24755471).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   C13589
AC   CVCL_3659
DR   CLO; CLO_0002092
DR   ATCC; CRL-2704
DR   BioSample; SAMN03471769
DR   Wikidata; Q54807854
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[31]; Zygosity=Heterozygous (ATCC=CRL-2704).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[59]; Zygosity=Heterozygous (ATCC=CRL-2704).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2704
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 14,21
ST   D19S433: 12,15
ST   D21S11: 28,30
ST   D2S1338: 16,23
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 12,15
ST   FGA: 19,22
ST   Penta D: 11,13
ST   Penta E: 10,20
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   C13ABR
AC   CVCL_RN99
SY   Control 13 Australia BRisbane
DR   Wikidata; Q54807855
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C14
AC   CVCL_HE29
DR   ColonAtlas; C14
DR   Cosmic; 986003
DR   Wikidata; Q54807856
RX   PubMed=9482574;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1335Lysfs*9 (c.3997_4003dup); Zygosity=Unspecified (PubMed=9482574).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 6
//
ID   C146
AC   CVCL_S958
DR   GEO; GSM1448198
DR   Wikidata; Q54807857
RX   PubMed=1846553;
RX   PubMed=3435698;
RX   PubMed=3947514;
RX   PubMed=25926053;
CC   Doubling time: 16 +- 1 hours (PubMed=3947514).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D21S11: 29,32.2
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,18,19
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   C1498
AC   CVCL_3494
DR   CLO; CLO_0002093
DR   ATCC; TIB-49
DR   BCRJ; 0306
DR   Wikidata; Q54807858
RX   PubMed=4541304;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   C1498-eGFP-Puro
AC   CVCL_QZ96
DR   Imanis; CL136
DR   Wikidata; Q54807859
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL136).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3494 ! C1498
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   C1498-Fluc-Neo/eGFP-Puro
AC   CVCL_QZ97
DR   Imanis; CL145
DR   Wikidata; Q54807860
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL145).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3494 ! C1498
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   C1498-Fluc-Puro
AC   CVCL_QZ98
DR   Imanis; CL144
DR   Wikidata; Q54807861
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL144).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3494 ! C1498
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   C14ABR
AC   CVCL_RP00
SY   Control 14 Australia BRisbane
DR   Wikidata; Q54807862
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C15ABR
AC   CVCL_RP01
SY   Control 15 Australia BRisbane
DR   Wikidata; Q54807863
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C16
AC   CVCL_2322
DR   CLO; CLO_0002096
DR   CLDB; cl557
DR   BioSample; SAMN03151669
DR   ECACC; 84121902
DR   Wikidata; Q54807864
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a clone of MRC-5.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00296.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   C166
AC   CVCL_6581
SY   Clone 166
DR   CLO; CLO_0002097
DR   ATCC; CRL-2581
DR   TOKU-E; 719
DR   Wikidata; Q54807865
RX   PubMed=8792159;
RX   PubMed=25277546;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3657; FES (Note=With p.Gly2_Phe3insSerSerLysSerLys to produce an activated myristoylated kinase).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Yolk sac; UBERON=UBERON_0001040.
CC   Breed/subspecies: NMRI/GSF x CD-1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   C166-GFP
AC   CVCL_6582
DR   CLO; CLO_0002098
DR   ATCC; CRL-2583
DR   Wikidata; Q54807866
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3657; FES (Note=With p.Gly2_Phe3insSerSerLysSerLys to produce an activated myristoylated kinase).
CC   Derived from site: In situ; Yolk sac; UBERON=UBERON_0001040.
CC   Breed/subspecies: NMRI/GSF x CD-1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6581 ! C166
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   C166-lacZ
AC   CVCL_0F01
DR   ATCC; CRL-2582
DR   Wikidata; Q54807867
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3657; FES (Note=With p.Gly2_Phe3insSerSerLysSerLys to produce an activated myristoylated kinase).
CC   Derived from site: In situ; Yolk sac; UBERON=UBERON_0001040.
CC   Breed/subspecies: NMRI/GSF x CD-1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6581 ! C166
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   C168
AC   CVCL_IY90
DR   Wikidata; Q54807868
RX   PubMed=1846553;
RX   PubMed=3435698;
RX   PubMed=3947514;
CC   Doubling time: 25 +- 2 hours (PubMed=3947514).
DI   NCIt; C43584; Rectosigmoid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   C17 [Human nasopharyngeal carcinoma]
AC   CVCL_VT47
DR   Cell_Model_Passport; SIDM01989
DR   Wikidata; Q93439148
RX   PubMed=29769697;
CC   Characteristics: Established from a xenograft maintained in athymic nude mice.
CC   Doubling time: ~4.5 days (PubMed=29769697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=29769697
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 20
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11,14
ST   D7S820: 11
ST   D8S1179: 11,14,15
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 15,22
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14,15
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   C17 [Mouse teratocarcinoma]
AC   CVCL_B5MV
DR   Wikidata; Q111733027
RX   PubMed=988033;
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   C17 NKX2-1-GFP
AC   CVCL_D3D6
SY   C17 NG; C17 NKX2.1-GFP; iPS17 NKX2.1-GFP
DR   Wikidata; Q127380360
WW   Provider; CReM; 824; https://stemcellbank.bu.edu/Catalog/Item/Details/824
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Using TALEN a eGFP-pA-loxP-PGKp-PuroR-pA-loxP was inserted at the NKX2-1 translational start site.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN85 ! CF iPSC clone 17
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   C17 NKX2-1-GFP SFTPC-tdTomato
AC   CVCL_WN83
SY   C17 NKX2-1GFP;SFTPCtdTomato; C17-NGST; C17 NGST; iPS17-ST
DR   Wikidata; Q93439149
RX   PubMed=28965766;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Characteristics: Using TALEN a eGFP-pA-loxP-PGKp-PuroR-pA-loxP was inserted at the NKX2-1 translational start site and a tdTomato-pA-loxP-PGKp-PuroR-pA-loxP was inserted at the SFTPC translational start site.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3D6 ! C17 NKX2-1-GFP
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 14
//
ID   C17-S1
AC   CVCL_B5MW
SY   C17 S1; C17S1
DR   Wikidata; Q111733028
RX   PubMed=679992;
RX   PubMed=988033;
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5MV ! C17 [Mouse teratocarcinoma]
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   C17-S1 clone 1003
AC   CVCL_B5MX
SY   C 17-S1 1003; C17S1 clone 1003; 1003; 1003 EC; EC 1003; Embryonal carcinoma 1003
DR   Wikidata; Q111733030
RX   PubMed=276874;
RX   PubMed=2153146;
RX   PubMed=7021269;
RX   PubMed=7166333;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5MW ! C17-S1
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   C17-S1-D-T984
AC   CVCL_B5MY
SY   C17S1 T984; 984 C1 10; T984
DR   Wikidata; Q111733032
RX   PubMed=276874;
RX   PubMed=679992;
RX   PubMed=7029000;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5MW ! C17-S1
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   C17-S1-D-T984-15
AC   CVCL_B5MZ
SY   T984-15; 984 C1 10-15
DR   Wikidata; Q111733033
RX   PubMed=6199248;
RX   PubMed=7029000;
CC   Characteristics: No longer differentiates in vitro into myogenic tissue (PubMed=7029000).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5MY ! C17-S1-D-T984
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   C17.2
AC   CVCL_4511
SY   C17
DR   CLO; CLO_0037251
DR   ECACC; 07062902
DR   Lonza; 356
DR   Wikidata; Q54807869
RX   PubMed=2139634;
RX   PubMed=2307979;
RX   PubMed=22542584;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   C17.9C6
AC   CVCL_KR90
DR   DSHB; C17-9C6
DR   Wikidata; Q54807870
RX   PubMed=2185893;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07207; Drosophila melanogaster Notch (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   C170
AC   CVCL_S959
DR   CLO; CLO_0009954
DR   EFO; EFO_0006363
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473189
DR   cancercelllines; CVCL_S959
DR   ChEMBL-Cells; CHEMBL3308628
DR   ChEMBL-Targets; CHEMBL614705
DR   ColonAtlas; C170
DR   EGA; EGAS00001000610
DR   GEO; GSM206448
DR   GEO; GSM274834
DR   GEO; GSM513927
DR   GEO; GSM514181
DR   GEO; GSM827320
DR   GEO; GSM1448107
DR   LINCS_LDP; LCL-1156
DR   PharmacoDB; C170_152_2019
DR   Progenetix; CVCL_S959
DR   PubChem_Cell_line; CVCL_S959
DR   Wikidata; Q54807871
RX   PubMed=3435698;
RX   PubMed=3947514;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
CC   Doubling time: 26 +- 0.5 hours (PubMed=3947514).
CC   HLA typing: A*02:01,24:02; B*08:01,35:01; C*04:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=25877200; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D21S11: 29,32.2
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 9,14
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 23
//
ID   C171
AC   CVCL_K127
SY   Clone 171
DR   CLO; CLO_0002099
DR   ATCC; HB-9515
DR   Wikidata; Q54807872
RX   Patent=US4959310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9515.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01070; Glycine max Kunitz-type trypsin inhibitor.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   C17ABR
AC   CVCL_IW81
SY   Control 17 Australia BRisbane
DR   Wikidata; Q54807873
RX   PubMed=2825700;
RX   PubMed=2836804;
RX   PubMed=6197197;
RX   PubMed=6228733;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   C17B10
AC   CVCL_A0TP
DR   Wikidata; Q108819969
RX   Patent=WO2020103691A1;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03971; Human AMH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   C18/3
AC   CVCL_A0PZ
DR   Wikidata; Q108819970
RX   PubMed=2146321;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08603; Human CFH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   C180
AC   CVCL_K128
SY   Clone 180
DR   CLO; CLO_0002100
DR   ATCC; HB-9517
DR   Wikidata; Q54807874
RX   Patent=US4959310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9517.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01070; Glycine max Kunitz-type trypsin inhibitor.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   C180-13S
AC   CVCL_1B28
SY   C18013S
DR   ChEMBL-Cells; CHEMBL3308038
DR   ChEMBL-Targets; CHEMBL613540
DR   PubChem_Cell_line; CVCL_1B28
DR   Wikidata; Q54807875
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   C18ABR
AC   CVCL_RP07
SY   Control 18 Australia BRisbane
DR   Wikidata; Q54807876
RX   PubMed=6228733;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C19 MEL
AC   CVCL_VL17
SY   C19; MEL-C19
DR   BTO; BTO_0006114
DR   Wikidata; Q93439159
RX   PubMed=2405253;
RX   PubMed=11896618;
CC   Characteristics: Thymidine kinase negative.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 4
//
ID   C19Mab-1
AC   CVCL_D2TJ
DR   Wikidata; Q127380361
RX   PubMed=32271687;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15391; Human CD19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C19Mab-3
AC   CVCL_D2TK
DR   Wikidata; Q127380362
RX   PubMed=32271687;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15391; Human CD19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C1ABR
AC   CVCL_ZV73
SY   Control 1 Australia BRisbane
DR   Wikidata; Q98125595
RX   PubMed=7433105;
RX   PubMed=15044383;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   C1G6B8
AC   CVCL_XK36
DR   Wikidata; Q93439160
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_100241; Ciprofloxacin (CIP) (Note=Also recognizes enrofloxacin, norfloxacin and ofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   C1I
AC   CVCL_2402
SY   CII
DR   CLO; CLO_0002478
DR   CLDB; cl781
DR   ECACC; 86072801
DR   Wikidata; Q54807877
RX   PubMed=3763403;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0439 ! MNNG/HOS Cl #5
HI   CVCL_0594 ! NIH 3T3
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   C1PV
AC   CVCL_5928
SY   Control 1 PaVia
DR   CLO; CLO_0002101
DR   CLDB; cl558
DR   Wikidata; Q54807878
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C1R-A11
AC   CVCL_C0R9
DR   Wikidata; Q112929350
RX   PubMed=14871991;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*11:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   C1R-A2
AC   CVCL_9U98
SY   C1R.A2; CIR-A2
DR   NCBI_Iran; C507
DR   Wikidata; Q54807879
RX   PubMed=9331097;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 12
//
ID   C1R-A24
AC   CVCL_S990
SY   C1RA24
DR   Cosmic; 1995351
DR   Wikidata; Q54807880
RX   PubMed=17982631;
RX   PubMed=19123955;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*24:02).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 15
//
ID   C1R-A31
AC   CVCL_S991
DR   Wikidata; Q54807881
RX   PubMed=19123955;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*31).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 14
//
ID   C1R-A33
AC   CVCL_C0RA
DR   Wikidata; Q112929351
RX   PubMed=14871991;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*33:03).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   C1R-B27
AC   CVCL_J349
DR   BTO; BTO_0003700
DR   PRIDE; PXD004964
DR   Wikidata; Q54807882
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*27).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   C1R-B*27:02
AC   CVCL_C5VD
DR   Wikidata; Q116048627
RX   PubMed=1692072;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*27:02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 8
//
ID   C1R-B*27:05
AC   CVCL_C5VE
SY   C1R05
DR   PRIDE; PXD008500
DR   Wikidata; Q116048628
RX   PubMed=1692072;
RX   PubMed=25469497;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*27:05).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 8
//
ID   C1R-B7
AC   CVCL_6373
DR   CLO; CLO_0002102
DR   ATCC; CRL-2371
DR   BioSample; SAMN03471834
DR   Wikidata; Q54807883
RX   PubMed=7960968;
CC   Population: Caucasian.
CC   Characteristics: Expresses but does not secrete HLA-B allele B*07 (ATCC=CRL-2371).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2371
ST   Amelogenin: X
ST   CSF1PO: 6,10
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,12
ST   D8S1179: 15
ST   FGA: 20,21
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 20
//
ID   C1R-neo
AC   CVCL_6374
DR   CLO; CLO_0002103
DR   ATCC; CRL-2369
DR   Wikidata; Q54807884
RX   PubMed=7960968;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2369
ST   Amelogenin: X
ST   CSF1PO: 6,10
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,12
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 18
//
ID   C1R-sB7
AC   CVCL_6375
DR   CLO; CLO_0002104
DR   ATCC; CRL-2370
DR   NCBI_Iran; C525
DR   Wikidata; Q54807885
RX   PubMed=7960968;
CC   Population: Caucasian.
CC   Characteristics: Secrete HLA-B allele B*07 but does not express surface B*07 (ATCC=CRL-2370).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07. Soluble form without TM and cytoplasmic domains).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2370
ST   Amelogenin: X
ST   CSF1PO: 6,10
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,12
ST   D8S1179: 15
ST   FGA: 20,21
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   C2 [Dog mastocytoma]
AC   CVCL_1R44
SY   C2-S
DR   GEO; GSM1974778
DR   Wikidata; Q54807886
RX   PubMed=1634619;
RX   PubMed=2121170;
RX   PubMed=2431625;
RX   PubMed=10210327;
RX   PubMed=19185923;
RX   PubMed=25190452;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 49.3 +- 12.5 hours (PubMed=2121170); 21 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:54284; CCND3; Simple; p.Ala66_Ser67del (c.194_199delGCGCCA); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:42422; KIT; Unexplicit; Tandem duplication of a 48bp sequence; Zygosity=Unspecified (PubMed=10210327).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Val162Ala (c.485T>C); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231
ST   Dog FHC2054: 147,156
ST   Dog FHC2079: 271
ST   Dog PEZ1: 107,123
ST   Dog PEZ3: 115,119
ST   Dog PEZ5: 111
ST   Dog PEZ6: 183,187
ST   Dog PEZ8: 228,232
ST   Dog PEZ12: 270
ST   Dog PEZ20: 176,184
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   C2 [Human iPSC]
AC   CVCL_Y544
DR   SKIP; SKIP000296
DR   Wikidata; Q54807887
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80-82Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   C2 [Mouse ESC]
AC   CVCL_Y629
DR   Wikidata; Q54807888
RX   PubMed=17828574;
RX   PubMed=20582321;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6NTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   C2 [Mouse hybridoma against human TNF]
AC   CVCL_E8PW
SY   Clone 2
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C2 [Mouse myoblast]
AC   CVCL_6812
DR   Wikidata; Q54807889
RX   PubMed=563524;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   C2 [Mouse Sertoli]
AC   CVCL_E3B8
RX   PubMed=23509371;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C2-Rev 7
AC   CVCL_3361
SY   C2-Rev7; C2-rev7; Faof1C2-Rev7; FaoflC2-Rev7
DR   CLO; CLO_0002110
DR   CLDB; cl560
DR   CLDB; cl561
DR   ECACC; 94101907
DR   ICLC; ATL96007
DR   Wikidata; Q54807890
RX   PubMed=2956094;
RX   PubMed=6247070;
RX   PubMed=6932027;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4722 ! Faof1C2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   C2.04
AC   CVCL_E7VA
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: African American.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C2.06
AC   CVCL_E7VB
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: African American.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C2.7
AC   CVCL_DD46
SY   C2C7
DR   Wikidata; Q54807892
RX   PubMed=3053306;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6812 ! C2 [Mouse myoblast]
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   C2007
AC   CVCL_K768
DR   ECACC; 941208106
DR   Wikidata; Q54807893
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941208106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2008
AC   CVCL_K769
DR   ECACC; 941208105
DR   Wikidata; Q54807894
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941208105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2009
AC   CVCL_K770
DR   ECACC; 941208107
DR   Wikidata; Q54807895
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941208107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2010
AC   CVCL_K771
DR   ECACC; 941208108
DR   Wikidata; Q54807896
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941208108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2011
AC   CVCL_K772
DR   ECACC; 941208104
DR   Wikidata; Q54807897
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941208104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2012
AC   CVCL_K773
DR   ECACC; 941208136
DR   Wikidata; Q54807898
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2013
AC   CVCL_K774
DR   ECACC; 941208137
DR   Wikidata; Q54807899
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2014 [1st copy]
AC   CVCL_K775
DR   ECACC; 941208138
DR   Wikidata; Q54807900
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941208138; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2014 [2nd copy]
AC   CVCL_K776
DR   ECACC; 95051587
DR   Wikidata; Q54807901
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95051587; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2015
AC   CVCL_K777
DR   ECACC; 950220149
DR   Wikidata; Q54807902
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950220149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2016
AC   CVCL_K778
DR   ECACC; 950220150
DR   Wikidata; Q54807903
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950220150; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2017
AC   CVCL_K779
DR   ECACC; 950220151
DR   Wikidata; Q54807904
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950220151; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2018
AC   CVCL_K780
DR   ECACC; 950220152
DR   Wikidata; Q54807905
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2019
AC   CVCL_K781
DR   ECACC; 941208131
DR   Wikidata; Q54807906
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941208131; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2020
AC   CVCL_K782
DR   ECACC; 941208132
DR   Wikidata; Q54807907
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2021
AC   CVCL_K783
DR   ECACC; 941208133
DR   Wikidata; Q54807908
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2022
AC   CVCL_K784
DR   ECACC; 950220153
DR   Wikidata; Q54807909
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2023
AC   CVCL_K785
DR   ECACC; 950220156
DR   Wikidata; Q54807910
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2024
AC   CVCL_K786
DR   ECACC; 950220159
DR   Wikidata; Q54807911
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950220159; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2025
AC   CVCL_K787
DR   ECACC; 950220154
DR   Wikidata; Q54807912
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2026
AC   CVCL_K788
DR   ECACC; 950220155
DR   Wikidata; Q54807913
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2027
AC   CVCL_K789
DR   ECACC; 950220157
DR   Wikidata; Q54807914
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2028
AC   CVCL_K790
DR   ECACC; 950220158
DR   Wikidata; Q54807915
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950220158; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2029
AC   CVCL_K791
DR   ECACC; 95022087
DR   Wikidata; Q54807916
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022087; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2030
AC   CVCL_K792
DR   ECACC; 95022088
DR   Wikidata; Q54807917
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022088; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2031
AC   CVCL_K793
DR   ECACC; 95022089
DR   Wikidata; Q54807918
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022089; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2032
AC   CVCL_K794
DR   ECACC; 95022090
DR   Wikidata; Q54807919
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022090; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2033
AC   CVCL_K795
DR   ECACC; 95022091
DR   Wikidata; Q54807920
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022091; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2034
AC   CVCL_K796
DR   ECACC; 95022092
DR   Wikidata; Q54807921
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022092; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2035
AC   CVCL_K797
DR   ECACC; 95022093
DR   Wikidata; Q54807922
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022093; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2036
AC   CVCL_K798
DR   ECACC; 95022094
DR   Wikidata; Q54807923
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022094; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2037
AC   CVCL_K799
DR   ECACC; 95022095
DR   Wikidata; Q54807924
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022095; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2038
AC   CVCL_K800
DR   ECACC; 95022096
DR   Wikidata; Q54807925
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95022096; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2039
AC   CVCL_K801
DR   ECACC; 950405109
DR   Wikidata; Q54807926
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2040
AC   CVCL_K802
DR   ECACC; 950405107
DR   Wikidata; Q54807927
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2041
AC   CVCL_K803
DR   ECACC; 950405108
DR   Wikidata; Q54807928
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2042
AC   CVCL_K804
DR   ECACC; 950405106
DR   Wikidata; Q54807929
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2043
AC   CVCL_K805
DR   ECACC; 95040599
DR   Wikidata; Q54807930
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040599; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2044
AC   CVCL_K806
DR   ECACC; 950405100
DR   Wikidata; Q54807931
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2045
AC   CVCL_K807
DR   ECACC; 950405101
DR   Wikidata; Q54807934
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2046
AC   CVCL_K808
DR   ECACC; 950405102
DR   Wikidata; Q54807935
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2047
AC   CVCL_K809
DR   ECACC; 950405103
DR   Wikidata; Q54807936
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2048
AC   CVCL_K810
DR   ECACC; 950405104
DR   Wikidata; Q54807937
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2049
AC   CVCL_K811
DR   ECACC; 950405140
DR   Wikidata; Q54807938
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2050
AC   CVCL_K812
DR   ECACC; 950405141
DR   Wikidata; Q54807939
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405141; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2051
AC   CVCL_K813
DR   ECACC; 950405143
DR   Wikidata; Q54807940
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405143; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2052
AC   CVCL_K814
DR   ECACC; 950405144
DR   Wikidata; Q54807941
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2053
AC   CVCL_K815
DR   ECACC; 950405145
DR   Wikidata; Q54807942
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405145; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2054
AC   CVCL_K816
DR   ECACC; 950405146
DR   Wikidata; Q54807943
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405146; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2055
AC   CVCL_K817
DR   ECACC; 950405147
DR   Wikidata; Q54807944
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405147; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2056
AC   CVCL_K818
DR   ECACC; 950405148
DR   Wikidata; Q54807945
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405148; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2057
AC   CVCL_K819
DR   ECACC; 950405149
DR   Wikidata; Q54807946
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2058
AC   CVCL_K820
DR   ECACC; 950405150
DR   Wikidata; Q54807947
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405150; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2059
AC   CVCL_K821
DR   ECACC; 950405151
DR   Wikidata; Q54807948
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405151; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2060
AC   CVCL_K822
DR   ECACC; 950405152
DR   Wikidata; Q54807949
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405152; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2061
AC   CVCL_K823
DR   ECACC; 950405153
DR   Wikidata; Q54807950
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405153; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2062
AC   CVCL_K824
DR   ECACC; 950405154
DR   Wikidata; Q54807951
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405154; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2063
AC   CVCL_K825
DR   ECACC; 950405155
DR   Wikidata; Q54807952
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405155; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2064
AC   CVCL_K826
DR   ECACC; 950405156
DR   Wikidata; Q54807953
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405156; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2065
AC   CVCL_K827
DR   ECACC; 950405157
DR   Wikidata; Q54807954
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405157; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2066
AC   CVCL_K828
DR   ECACC; 950405158
DR   Wikidata; Q54807955
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405158; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2067
AC   CVCL_K829
DR   ECACC; 950405159
DR   Wikidata; Q54807956
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405159; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2068
AC   CVCL_K830
DR   ECACC; 950405160
DR   Wikidata; Q54807957
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405160; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2069
AC   CVCL_K831
DR   ECACC; 950405161
DR   Wikidata; Q54807958
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405161; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2070
AC   CVCL_K832
DR   ECACC; 950405162
DR   Wikidata; Q54807959
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2071
AC   CVCL_K833
DR   ECACC; 950405163
DR   Wikidata; Q54807960
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2072
AC   CVCL_K834
DR   ECACC; 950405164
DR   Wikidata; Q54807961
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2073
AC   CVCL_K835
DR   ECACC; 95040528
DR   Wikidata; Q54807962
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040528; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2074
AC   CVCL_K836
DR   ECACC; 95040529
DR   Wikidata; Q54807963
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2075
AC   CVCL_K837
DR   ECACC; 95040530
DR   Wikidata; Q54807964
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040530; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2076
AC   CVCL_K838
DR   ECACC; 95040531
DR   Wikidata; Q54807965
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040531; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2077
AC   CVCL_K839
DR   ECACC; 95040532
DR   Wikidata; Q54807966
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040532; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2078
AC   CVCL_K840
DR   ECACC; 95040533
DR   Wikidata; Q54807967
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2079
AC   CVCL_K841
DR   ECACC; 95040534
DR   Wikidata; Q54807968
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040534; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2080
AC   CVCL_K842
DR   ECACC; 95040524
DR   Wikidata; Q54807969
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040524; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2081
AC   CVCL_K843
DR   ECACC; 10080303
DR   Wikidata; Q54807970
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2082
AC   CVCL_K844
DR   ECACC; 95040519
DR   Wikidata; Q54807971
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040519; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2083
AC   CVCL_K845
DR   ECACC; 95040520
DR   Wikidata; Q54807972
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040520; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2084
AC   CVCL_K846
DR   ECACC; 95040521
DR   Wikidata; Q54807973
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040521; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2085
AC   CVCL_K847
DR   ECACC; 95040522
DR   Wikidata; Q54807975
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2086
AC   CVCL_K848
DR   ECACC; 95040523
DR   Wikidata; Q54807976
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95040523; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2087
AC   CVCL_K849
DR   ECACC; 950405172
DR   Wikidata; Q54807977
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405172; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2088
AC   CVCL_K850
DR   ECACC; 950405171
DR   Wikidata; Q54807978
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405171; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2089
AC   CVCL_K851
DR   ECACC; 950405170
DR   Wikidata; Q54807979
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2090
AC   CVCL_K852
DR   ECACC; 950405169
DR   Wikidata; Q54807980
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2091
AC   CVCL_K853
DR   ECACC; 950405168
DR   Wikidata; Q54807981
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2092
AC   CVCL_K854
DR   ECACC; 950405167
DR   Wikidata; Q54807982
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2093
AC   CVCL_K855
DR   ECACC; 950405166
DR   Wikidata; Q54807983
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2094
AC   CVCL_K856
DR   ECACC; 950405165
DR   Wikidata; Q54807984
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405165; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2095
AC   CVCL_K857
DR   ECACC; 950405175
DR   Wikidata; Q54807985
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405175; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2096
AC   CVCL_K858
DR   ECACC; 950405176
DR   Wikidata; Q54807986
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405176; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2097
AC   CVCL_K859
DR   ECACC; 950405177
DR   Wikidata; Q54807987
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950405177; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2098
AC   CVCL_K860
DR   ECACC; 95051593
DR   Wikidata; Q54807988
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2099
AC   CVCL_K861
DR   ECACC; 95051592
DR   Wikidata; Q54807989
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95051592; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C20D
AC   CVCL_E2WC
DR   BTO; BTO_0003348
RX   PubMed=15952070;
CC   Group: Plant cell line.
CC   From: Petiard, Vincent; Centre de Recherche Nestle-Tours; Tours; France.
CC   Characteristics: Synthesizes monoterpenoid indole alkaloids in response to auxin depletion from the culture medium (PubMed=15952070).
CC   Derived from site: In situ; Vascular leaf; PO=PO_0009025.
OX   NCBI_TaxID=4058; ! Catharanthus roseus (Madagascar periwinkle)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   C20Mab-11
AC   CVCL_A8V2
DR   Wikidata; Q102113651
RX   PubMed=32724441;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   C20Mab-60
AC   CVCL_A8V3
DR   Wikidata; Q102113652
RX   PubMed=32667234;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   C2100
AC   CVCL_K862
DR   ECACC; 95051591
DR   Wikidata; Q54807990
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95051591; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2101
AC   CVCL_K863
DR   ECACC; 95051590
DR   Wikidata; Q54807991
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2102
AC   CVCL_K864
DR   ECACC; 95051589
DR   Wikidata; Q54807992
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2103
AC   CVCL_K865
DR   ECACC; 95051588
DR   Wikidata; Q54807993
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2105
AC   CVCL_K866
DR   ECACC; 95051586
DR   Wikidata; Q54807994
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95051586; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2106
AC   CVCL_K867
DR   ECACC; 95051585
DR   Wikidata; Q54807995
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95051585; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2107
AC   CVCL_K868
DR   ECACC; 95051596
DR   Wikidata; Q54807996
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95051596; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2108
AC   CVCL_K869
DR   ECACC; 950515156
DR   Wikidata; Q54807997
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2109
AC   CVCL_K870
DR   ECACC; 950515175
DR   Wikidata; Q54807998
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C211
AC   CVCL_2323
SY   C 211
DR   CLO; CLO_0002070
DR   CLO; CLO_0002106
DR   CLDB; cl562
DR   ATCC; CCL-123
DR   BioSample; SAMN03472703
DR   ECACC; 90112604
DR   KCLB; 10123
DR   Wikidata; Q54807999
CC   Population: Caucasian.
CC   Senescence: Senesces at ~21 PDL (ATCC=CCL-123).
CC   Discontinued: ECACC; 90112604; true.
CC   Discontinued: KCLB; 10123; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-123
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12,18
ST   D19S433: 14
ST   D21S11: 31.2,33.2
ST   D2S1338: 18,23
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 20,24
ST   Penta D: 12,13
ST   Penta E: 8,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   C2110
AC   CVCL_K871
DR   ECACC; 950515141
DR   Wikidata; Q54808000
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2111
AC   CVCL_K872
DR   ECACC; 950515142
DR   Wikidata; Q54808001
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2112
AC   CVCL_K873
DR   ECACC; 950515144
DR   Wikidata; Q54808002
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2113
AC   CVCL_K874
DR   ECACC; 950515145
DR   Wikidata; Q54808003
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2114
AC   CVCL_K875
DR   ECACC; 950515146
DR   Wikidata; Q54808004
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2115
AC   CVCL_K876
DR   ECACC; 950515140
DR   Wikidata; Q54808005
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2116
AC   CVCL_K877
DR   ECACC; 950515143
DR   Wikidata; Q54808006
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2117
AC   CVCL_K878
DR   ECACC; 950515139
DR   Wikidata; Q54808007
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515139; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2118
AC   CVCL_K879
DR   ECACC; 950515138
DR   Wikidata; Q54808008
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2119
AC   CVCL_K880
DR   ECACC; 950515137
DR   Wikidata; Q54808009
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C212
AC   CVCL_E512
DR   dbMHC; 48527
DR   ECACC; 94071424
DR   IHW; IHW09348
DR   IPD-IMGT/HLA; 10374
DR   Wikidata; Q54808010
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*01,03; B*07,15; DPA1*01,02:01:01; DPB1*04:01,45:01; DQA1*01:03,01:01; DQB1*05:01,06:03; DRB1*01:01,13:01; DRB3*02:02 (IPD-IMGT/HLA=10374).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071424; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   C2120
AC   CVCL_K881
DR   ECACC; 950515136
DR   Wikidata; Q54808011
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2121
AC   CVCL_K882
DR   ECACC; 950515135
DR   Wikidata; Q54808012
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2122
AC   CVCL_K883
DR   ECACC; 950515134
DR   Wikidata; Q54808013
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2123
AC   CVCL_K884
DR   ECACC; 950515133
DR   Wikidata; Q54808014
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2124
AC   CVCL_K885
DR   ECACC; 950515132
DR   Wikidata; Q54808019
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2125
AC   CVCL_K886
DR   ECACC; 950515176
DR   Wikidata; Q54808020
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2126 [1st copy]
AC   CVCL_K887
DR   ECACC; 950515177
DR   Wikidata; Q54808021
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515177; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   C2126 [2nd copy]
AC   CVCL_K888
DR   ECACC; 95061968
DR   Wikidata; Q54808022
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061968; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2127
AC   CVCL_K889
DR   ECACC; 950515178
DR   Wikidata; Q54808023
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2128
AC   CVCL_K890
DR   ECACC; 950515179
DR   Wikidata; Q54808024
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2129
AC   CVCL_K891
DR   ECACC; 950515180
DR   Wikidata; Q54808025
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515180; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2130
AC   CVCL_K892
DR   ECACC; 950515181
DR   Wikidata; Q54808026
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2131
AC   CVCL_K893
DR   ECACC; 950515182
DR   Wikidata; Q54808027
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515182; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2132
AC   CVCL_K894
DR   ECACC; 950515183
DR   Wikidata; Q54808028
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2133
AC   CVCL_K895
DR   ECACC; 950515169
DR   Wikidata; Q54808029
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515169; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2134
AC   CVCL_K896
DR   ECACC; 950515157
DR   Wikidata; Q54808030
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515157; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2135
AC   CVCL_K897
DR   ECACC; 950515158
DR   Wikidata; Q54808031
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2136
AC   CVCL_K898
DR   ECACC; 950515159
DR   Wikidata; Q54808032
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515159; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2137
AC   CVCL_K899
DR   ECACC; 950515160
DR   Wikidata; Q54808033
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515160; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2138
AC   CVCL_K900
DR   ECACC; 950515161
DR   Wikidata; Q54808034
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515161; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2139
AC   CVCL_K901
DR   ECACC; 950515170
DR   Wikidata; Q54808035
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2140
AC   CVCL_K902
DR   ECACC; 950515171
DR   Wikidata; Q54808036
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515171; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2141
AC   CVCL_K903
DR   ECACC; 950515172
DR   Wikidata; Q54808037
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2142
AC   CVCL_K904
DR   ECACC; 950515190
DR   Wikidata; Q54808038
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2143
AC   CVCL_K905
DR   ECACC; 950515191
DR   Wikidata; Q54808039
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2144
AC   CVCL_K906
DR   ECACC; 950515192
DR   Wikidata; Q54808040
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2145
AC   CVCL_K907
DR   ECACC; 950515193
DR   Wikidata; Q54808041
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2146
AC   CVCL_K908
DR   ECACC; 950515194
DR   Wikidata; Q54808042
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2147
AC   CVCL_K909
DR   ECACC; 950515195
DR   Wikidata; Q54808043
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515195; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2148
AC   CVCL_K910
DR   ECACC; 950515196
DR   Wikidata; Q54808044
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2149
AC   CVCL_K911
DR   ECACC; 950515197
DR   Wikidata; Q54808045
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515197; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2150
AC   CVCL_K912
DR   ECACC; 950515198
DR   Wikidata; Q54808046
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2151
AC   CVCL_K913
DR   ECACC; 950515201
DR   Wikidata; Q54808047
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2152
AC   CVCL_K914
DR   ECACC; 950515225
DR   Wikidata; Q54808048
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2153
AC   CVCL_K915
DR   ECACC; 950515226
DR   Wikidata; Q54808049
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2154
AC   CVCL_K916
DR   ECACC; 950515227
DR   Wikidata; Q54808050
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515227; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2155
AC   CVCL_K917
DR   ECACC; 950515234
DR   Wikidata; Q54808051
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2156
AC   CVCL_K918
DR   ECACC; 950515235
DR   Wikidata; Q54808052
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2157
AC   CVCL_K919
DR   ECACC; 950515236
DR   Wikidata; Q54808053
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950515236; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2158
AC   CVCL_K920
DR   ECACC; 950515237
DR   Wikidata; Q54808054
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2159
AC   CVCL_K921
DR   ECACC; 950515238
DR   Wikidata; Q54808055
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   C2160
AC   CVCL_K922
DR   ECACC; 950515239
DR   Wikidata; Q54808056
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2161
AC   CVCL_K923
DR   ECACC; 950515240
DR   Wikidata; Q54808057
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2163
AC   CVCL_K924
DR   ECACC; 95061969
DR   Wikidata; Q54808058
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061969; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2164
AC   CVCL_K925
DR   ECACC; 95061970
DR   Wikidata; Q54808062
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061970; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2165
AC   CVCL_K926
DR   ECACC; 95061971
DR   Wikidata; Q54808063
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061971; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2166
AC   CVCL_K927
DR   ECACC; 95061972
DR   Wikidata; Q54808064
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061972; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2167
AC   CVCL_K928
DR   ECACC; 95061973
DR   Wikidata; Q54808065
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061973; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2168
AC   CVCL_K929
DR   ECACC; 95061974
DR   Wikidata; Q54808066
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061974; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2169
AC   CVCL_K930
DR   ECACC; 95061975
DR   Wikidata; Q54808067
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061975; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2170
AC   CVCL_K931
DR   ECACC; 95061976
DR   Wikidata; Q54808068
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061976; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2171
AC   CVCL_K932
DR   ECACC; 95061977
DR   Wikidata; Q54808069
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061977; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2172
AC   CVCL_K933
DR   ECACC; 95061993
DR   Wikidata; Q54808070
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2173
AC   CVCL_K934
DR   ECACC; 95061994
DR   Wikidata; Q54808071
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2174
AC   CVCL_K935
DR   ECACC; 95061995
DR   Wikidata; Q54808072
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2175
AC   CVCL_K936
DR   ECACC; 95061996
DR   Wikidata; Q54808073
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2176
AC   CVCL_K937
DR   ECACC; 95061997
DR   Wikidata; Q54808074
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2177
AC   CVCL_K938
DR   ECACC; 95061998
DR   Wikidata; Q54808075
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061998; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2178
AC   CVCL_K939
DR   ECACC; 95061999
DR   Wikidata; Q54808076
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061999; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2179
AC   CVCL_K940
DR   ECACC; 950619100
DR   Wikidata; Q54808077
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2180
AC   CVCL_K941
DR   ECACC; 950619101
DR   Wikidata; Q54808078
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2181
AC   CVCL_K942
DR   ECACC; 95061986
DR   Wikidata; Q54808079
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061986; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2182
AC   CVCL_K943
DR   ECACC; 960425318
DR   Wikidata; Q54808080
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2183
AC   CVCL_K944
DR   ECACC; 960425319
DR   Wikidata; Q54808081
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2184
AC   CVCL_K945
DR   ECACC; 960425320
DR   Wikidata; Q54808082
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2185
AC   CVCL_K946
DR   ECACC; 960425321
DR   Wikidata; Q54808083
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2186
AC   CVCL_K947
DR   ECACC; 960425322
DR   Wikidata; Q54808084
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2187
AC   CVCL_K948
DR   ECACC; 960425323
DR   Wikidata; Q54808085
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2188
AC   CVCL_K949
DR   ECACC; 960425324
DR   Wikidata; Q54808086
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C219
AC   CVCL_B0FJ
DR   Wikidata; Q108819971
RX   Patent=US4837306;
RX   PubMed=2412130;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
CC   Miscellaneous: The patent US4837306 claims a mAB against ABCB1 but does not seem to specifically claim hybridoma C219.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   C2190
AC   CVCL_K950
DR   ECACC; 960425326
DR   Wikidata; Q54808087
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   C2191
AC   CVCL_K951
DR   ECACC; 960425327
DR   Wikidata; Q54808088
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   C2192
AC   CVCL_K952
DR   ECACC; 960425332
DR   Wikidata; Q54808089
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425332; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2193
AC   CVCL_K953
DR   ECACC; 960425333
DR   Wikidata; Q54808090
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425333; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2194
AC   CVCL_K954
DR   ECACC; 960425334
DR   Wikidata; Q54808092
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425334; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2195
AC   CVCL_K955
DR   ECACC; 960425335
DR   Wikidata; Q54808093
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425335; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2196
AC   CVCL_K956
DR   ECACC; 960425336
DR   Wikidata; Q54808094
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425336; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2197
AC   CVCL_K957
DR   ECACC; 960425337
DR   Wikidata; Q54808095
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425337; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2198
AC   CVCL_K958
DR   ECACC; 960425338
DR   Wikidata; Q54808096
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425338; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C2199
AC   CVCL_K959
DR   ECACC; 960425339
DR   Wikidata; Q54808097
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 960425339; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   C21ABR
AC   CVCL_RP02
SY   Control 21 Australia BRisbane
DR   Wikidata; Q54808098
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C21C3
AC   CVCL_E3B9
RX   PubMed=23509371;
CC   Doubling time: 18 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B8 ! C2 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C21C4
AC   CVCL_E3BA
RX   PubMed=23509371;
CC   Doubling time: 18 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B8 ! C2 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C22 (Clara)
AC   CVCL_F277
SY   C22
DR   ABM; T0092
DR   ECACC; 07021401
DR   Wikidata; Q54808099
RX   PubMed=12026164;
WW   Provider; SLU; 98-008; https://www.slu.edu/research/faculty-resources/research-innovation-group/browse-ip/research-tools/98-008-c22-a-conditionally-immortalized-mouse-clara-cell-line.php
CC   Characteristics: Proliferates at permissive temperature (33 Celsius) in the presence of IFNG, terminally differentiates at restrictive temperature (39 Celsius) in the absence of IFNG.
CC   Doubling time: 48 hours (ECACC=07021401).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   C22A3
AC   CVCL_E3BB
RX   PubMed=23509371;
CC   Doubling time: 21 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B8 ! C2 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C22A4
AC   CVCL_E3BC
RX   PubMed=23509371;
CC   Doubling time: 21 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B8 ! C2 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C22ABR
AC   CVCL_RP03
SY   Control 22 Australia BRisbane
DR   Wikidata; Q54808100
RX   PubMed=1944384;
RX   PubMed=6504056;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C22B4
AC   CVCL_E3BD
RX   PubMed=23509371;
CC   Doubling time: 20 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B8 ! C2 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C23
AC   CVCL_HE30
DR   cancercelllines; CVCL_HE30
DR   ColonAtlas; C23
DR   Cosmic; 986004
DR   Wikidata; Q54808101
RX   PubMed=9482574;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1408Ter (c.4222G>T); ClinVar=VCV002502366; Zygosity=Unspecified (PubMed=9482574).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   C23/11
AC   CVCL_A5YN
SY   C-23/11
DR   Wikidata; Q107113527
RX   CelloPub=CLPUB00607;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2628077;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (CelloPub=CLPUB00607).
CC   Doubling time: 16-18 hours (Note=At passage <10), 20-23 hours (Note=At 42th passage) (CelloPub=CLPUB00607).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   C23ABR
AC   CVCL_RP04
SY   Control 23 Australia BRisbane
DR   Wikidata; Q54808102
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C243-3
AC   CVCL_KA73
SY   C-243-3; C 243 3; C243; C 243
DR   Wikidata; Q54808107
RX   PubMed=4343525;
RX   PubMed=4858239;
RX   PubMed=6182837;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   C24A4
AC   CVCL_E3BE
RX   PubMed=23509371;
CC   Doubling time: 25 hours (PubMed=23509371).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3B8 ! C2 [Mouse Sertoli]
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C26-10
AC   CVCL_3926
DR   BTO; BTO_0004067
DR   Wikidata; Q54808109
RX   PubMed=10956384;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0240 ! MC-26
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   C26-A
AC   CVCL_3927
DR   BTO; BTO_0004068
DR   Wikidata; Q54808110
RX   PubMed=10956384;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0240 ! MC-26
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   C26-G
AC   CVCL_3928
DR   BTO; BTO_0004069
DR   Wikidata; Q54808112
RX   PubMed=10956384;
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3925 ! Colon C26-G
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   C26C
AC   CVCL_C7T8
DR   Wikidata; Q117704230
RX   PubMed=15153338;
CC   Senescence: Senesces at ~30 PDL (PubMed=15153338).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1157Aspfs*7 (c.3471_3474delGAGA); ClinVar=VCV000186532; Zygosity=Heterozygous (PubMed=15153338).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   C26Ci
AC   CVCL_C7T9
SY   C26C immortal
DR   Wikidata; Q117704231
RX   PubMed=15153338;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1157Aspfs*7 (c.3471_3474delGAGA); ClinVar=VCV000186532; Zygosity=Heterozygous (PubMed=15153338).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T8 ! C26C
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   C273
AC   CVCL_K129
DR   CLO; CLO_0002107
DR   ATCC; HB-9303
DR   BCRC; 60426
DR   NCBI_Iran; H162
DR   Wikidata; Q54808113
RX   Patent=US5500362;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9303.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   C28-3.7.1
AC   CVCL_J966
SY   C28-3-7-1; C28371
DR   Wikidata; Q54808114
RX   Patent=WO1996040041A2;
CC   Group: Patented cell line.
CC   Registration: Chiron Master Culture Collection; CMCC 11266 (CMCC #11266).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   C28ABR
AC   CVCL_IW76
SY   Control 28 Australia BRisbane
DR   Wikidata; Q54808115
RX   PubMed=11080496;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   C2ABR
AC   CVCL_IW75
SY   Control 2 Australia BRisbane
DR   Wikidata; Q54808116
RX   PubMed=1944384;
RX   PubMed=2836804;
RX   PubMed=6504056;
RX   PubMed=7433105;
RX   PubMed=9150358;
RX   PubMed=11080496;
RX   PubMed=17347666;
RX   PubMed=17562789;
RX   PubMed=19643912;
RX   PubMed=25868131;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   C2BBe1
AC   CVCL_1096
AS   CVCL_0198
SY   C2BBE1; C2BBe 1; Caco-2/BBe 1; Caco-2/BBe; Caco-2BBe; Caco-2BBE; Caco-2 BBe; Caco2-BBE; Caco2BBe; Caco2BBE; CACO2BBE; BBE; Caco-2 Brush Border expressing 1
DR   BTO; BTO_0005156
DR   CLO; CLO_0002108
DR   EFO; EFO_0006546
DR   MCCL; MCC:0000089
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2102
DR   BCRC; 60182
DR   BCRJ; 0270
DR   BioGRID_ORCS_Cell_line; 580
DR   BioSample; SAMN03472296
DR   BioSample; SAMN10987952
DR   cancercelllines; CVCL_1096
DR   Cell_Model_Passport; SIDM01233
DR   ChEMBL-Cells; CHEMBL3308231
DR   ChEMBL-Targets; CHEMBL2366283
DR   ColonAtlas; C2BBE1
DR   Cosmic; 687516
DR   Cosmic; 910700
DR   Cosmic; 1479619
DR   Cosmic-CLP; 910700
DR   DepMap; ACH-000009
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910700
DR   GEO; GSM886897
DR   GEO; GSM887962
DR   GEO; GSM1669635
DR   IARC_TP53; 21203
DR   LiGeA; CCLE_083
DR   LINCS_LDP; LCL-1296
DR   PharmacoDB; C2BBe1_153_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1096
DR   PubChem_Cell_line; CVCL_1096
DR   Sigma-Aldrich; MTOX1000CC
DR   Wikidata; Q54808117
RX   PubMed=1506435;
RX   PubMed=15868485;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=25388687;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 44 hours (PubMed=25984343).
CC   HLA typing: A*02:01,02:01; B*15:34,15:34; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (ATCC=CRL-2102; Cosmic-CLP=910700; DepMap=ACH-000009).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (Cosmic-CLP=910700; DepMap=ACH-000009).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (Cosmic-CLP=910700; DepMap=ACH-000009).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (Cosmic-CLP=910700; DepMap=ACH-000009).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.84%; East Asian, South=0.11%; South Asian=0%; European, North=57.43%; European, South=40.62% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2102; Cosmic-CLP=910700; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11,13,14 (PubMed=25877200)
ST   D13S317: 11,13,14 (ATCC=CRL-2102; Cosmic-CLP=910700)
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 15
ST   D21S11: 30 (PubMed=25877200)
ST   D21S11: 30,32 (ATCC=CRL-2102)
ST   D2S1338: 17,25
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 19
ST   Penta D: 9,11
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   C2BBe1 BCRP KO
AC   CVCL_B5ZS
SY   Caco-2 BCRP Knockout Cell Line; C2BBe1 Cells BCRP -/-/-/-
DR   cancercelllines; CVCL_B5ZS
DR   Sigma-Aldrich; MTOX1002
DR   Sigma-Aldrich; MTOX1002P24
DR   Wikidata; Q111733034
RX   PubMed=25388687;
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   C2BBe1 MDR1 KO
AC   CVCL_B5ZT
SY   Caco-2 MDR1 Knockout Cell Line; C2BBe1 Cells MDR1 -/-/-/-
DR   cancercelllines; CVCL_B5ZT
DR   Sigma-Aldrich; MTOX1001
DR   Sigma-Aldrich; MTOX1001P24
DR   Wikidata; Q111733036
RX   PubMed=25388687;
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   C2BBe1 MDR1/BCRP KO
AC   CVCL_B5ZU
SY   Caco-2 MDR1/BCRP Double Knockout Cell Line; C2BBe1 Cells MDR1/BCRP -/-/-/-,-/-/-/-
DR   cancercelllines; CVCL_B5ZU
DR   Sigma-Aldrich; MTOX1004
DR   Sigma-Aldrich; MTOX1004P24
DR   Wikidata; Q111733037
RX   PubMed=25388687;
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   C2BBe1 MDR1/MRP2 KO
AC   CVCL_B5ZW
SY   Caco-2 MDR1/MRP2 Double Knockout Cell Line; C2BBe1 Cells MDR1/MRP2 -/-/-/-,-/-/-/-
DR   cancercelllines; CVCL_B5ZW
DR   Sigma-Aldrich; MTOX1005
DR   Sigma-Aldrich; MTOX1005P24
DR   Wikidata; Q111733038
RX   PubMed=25388687;
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZV ! C2BBe1 MRP2 KO
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   C2BBe1 MRP1 KO
AC   CVCL_B5ZY
SY   C2BBe1 MRP1 Knockout Cell Line
DR   cancercelllines; CVCL_B5ZY
DR   Sigma-Aldrich; MTOX1092
DR   Sigma-Aldrich; MTOX1092P24
DR   Wikidata; Q111733039
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:51; ABCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   C2BBe1 MRP2 KO
AC   CVCL_B5ZV
SY   Caco-2 MRP2 Knockout Cell Line; C2BBe1 Cells MRP2 -/-/-/-
DR   cancercelllines; CVCL_B5ZV
DR   Sigma-Aldrich; MTOX1003
DR   Sigma-Aldrich; MTOX1003P24
DR   Wikidata; Q111733041
RX   PubMed=25388687;
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   C2BBe1 MRP2/BCRP KO
AC   CVCL_B5ZX
SY   Caco-2 BCRP/MRP2 Double Knockout Cell Line; C2BBe1 Cells MRP2/BCRP -/-/-/-,-/-/-/-
DR   cancercelllines; CVCL_B5ZX
DR   Sigma-Aldrich; MTOX1006
DR   Sigma-Aldrich; MTOX1006P24
DR   Wikidata; Q111733042
RX   PubMed=25388687;
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZV ! C2BBe1 MRP2 KO
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   C2BBe1 MRP3 KO
AC   CVCL_B6A2
SY   Caco-2 MRP3 Knockout Cell Line; C2BBe1 MRP3 Knockout Cell Line
DR   cancercelllines; CVCL_B6A2
DR   Sigma-Aldrich; MTOX1093
DR   Sigma-Aldrich; MTOX1093P24
DR   Wikidata; Q111733043
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:54; ABCC3.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   C2BBe1 MRP3/MRP4 KO
AC   CVCL_B6A4
SY   C2BBe1 MRP3/MRP4 Knockout Cell Line
DR   cancercelllines; CVCL_B6A4
DR   Sigma-Aldrich; MTOX1098
DR   Wikidata; Q111733044
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:54; ABCC3.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Sigma-Aldrich; MTOX1098; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   C2BBe1 MRP4 KO
AC   CVCL_B6A1
SY   Caco-2 MRP4 Knockout Cell Line; C2BBe1 MRP4 Knockout Cell Line
DR   cancercelllines; CVCL_B6A1
DR   Sigma-Aldrich; MTOX1094
DR   Sigma-Aldrich; MTOX1094P24
DR   Wikidata; Q111733045
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   C2BBe1 MRP5 KO
AC   CVCL_B5ZZ
SY   Caco-2 MRP5 Knockout Cell Line; C2BBe1 MRP5 Knockout Cell Line
DR   cancercelllines; CVCL_B5ZZ
DR   Sigma-Aldrich; MTOX1095
DR   Sigma-Aldrich; MTOX1095P24
DR   Wikidata; Q111733046
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:56; ABCC5.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   C2BBe1 MRP6 KO
AC   CVCL_B6A3
SY   Caco-2 MRP6 Knockout Cell Line; C2BBe1 MRP6 Knockout Cell Line
DR   cancercelllines; CVCL_B6A3
DR   Sigma-Aldrich; MTOX1096
DR   Wikidata; Q111733047
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:57; ABCC6.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Sigma-Aldrich; MTOX1096; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   C2BBe1 MRP7 KO
AC   CVCL_B6A0
SY   Caco-2 MRP7 Knockout Cell Line; C2BBe1 MRP7 Knockout Cell Line
DR   cancercelllines; CVCL_B6A0
DR   Sigma-Aldrich; MTOX1097
DR   Sigma-Aldrich; MTOX1097P24
DR   Wikidata; Q111733049
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:52; ABCC10.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1096 ! C2BBe1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   C2BBe2
AC   CVCL_Z582
SY   C2BBe 2; Caco-2/BBe 2; Caco-2 Brush Border expressing 2
DR   cancercelllines; CVCL_Z582
DR   Wikidata; Q54808118
RX   PubMed=1506435;
RX   PubMed=15868485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   C2C12
AC   CVCL_0188
SY   C2c12; C2-C12; C12
DR   BTO; BTO_0000165
DR   CLO; CLO_0002071
DR   CLO; CLO_0050871
DR   EFO; EFO_0001098
DR   MCCL; MCC:0000079
DR   CLDB; cl563
DR   CLDB; cl564
DR   CLDB; cl5172
DR   Abcam; ab279976
DR   AddexBio; P0028001/4665
DR   ATCC; CRL-1772
DR   BCRC; 60083
DR   BCRJ; 0058
DR   BioGRID_ORCS_Cell_line; 1564
DR   CCRID; 1101MOU-PUMC000099
DR   CCRID; 3101MOUGNM26
DR   CCRID; 3101MOUSCSP505
DR   CCRID; 4201MOU-CCTCC00175
DR   CCTCC; GDC0175
DR   ChEMBL-Cells; CHEMBL3308003
DR   ChEMBL-Targets; CHEMBL612655
DR   CLS; 400476
DR   DSMZ; ACC-565
DR   DSMZCellDive; ACC-565
DR   ECACC; 91031101
DR   ENCODE; ENCBS124ENC
DR   ENCODE; ENCBS299ZOZ
DR   ENCODE; ENCBS981MXJ
DR   FCS-free; 221-17-457-3-4-3
DR   FCS-free; 221-17-505-3-4-12
DR   FCS-free; 221-21-488-3-4-12
DR   FCS-free; 221-5-486-3-3
DR   FCS-free; 221-5-527-1-3-3
DR   GEO; GSE30192
DR   GEO; GSM915162
DR   GEO; GSM915166
DR   GEO; GSM915174
DR   GEO; GSM915179
DR   GEO; GSM915182
DR   GEO; GSM915186
DR   GEO; GSM915188
DR   GEO; GSM918408
DR   GEO; GSM918410
DR   GEO; GSM918411
DR   GEO; GSM918415
DR   GEO; GSM918417
DR   GEO; GSM918422
DR   GEO; GSM1354755
DR   IZSLER; BS CL 148
DR   KCB; KCB 2012115YJ
DR   Lonza; 692
DR   MetaboLights; MTBLS127
DR   NCBI_Iran; C521
DR   PRIDE; PXD000022
DR   PRIDE; PXD000288
DR   PRIDE; PXD000328
DR   PRIDE; PXD000589
DR   PRIDE; PXD003211
DR   PRIDE; PXD004151
DR   PRIDE; PXD004960
DR   PRIDE; PXD012986
DR   PRIDE; PXD017465
DR   PRIDE; PXD050867
DR   PRIDE; PXD050903
DR   PubChem_Cell_line; CVCL_0188
DR   RCB; RCB0987
DR   TOKU-E; 728
DR   Ubigene; YC-A010
DR   Wikidata; Q5008075
RX   PubMed=563524;
RX   PubMed=8023908;
RX   PubMed=15596414;
RX   PubMed=19298647;
RX   PubMed=19350625;
RX   PubMed=19656770;
RX   PubMed=20635352;
RX   PubMed=22020321;
RX   PubMed=24735950;
RX   PubMed=25277546;
RX   PubMed=25894527;
WW   Info; -; -; https://web.archive.org/web/20130502024425/http://www.stanford.edu/group/blau/protocols/c2lineprotocol.html
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/c2c12/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-123.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/C2C12
WW   Provider; BRICS; BRICS0089; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3902
CC   Part of: ENCODE project mouse cell lines.
CC   Characteristics: Capable, upon starvation, of differentiating into contractile myotubes that express muscle-specific proteins.
CC   Doubling time: 19.6 +- 0.4 hours (Note=At 22th passage), 18.4 +- 0.2 hours (Note=At 38th passage) (PubMed=22020321); ~20 hours (DSMZ=ACC-565).
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K79me3.
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: C1C12; Note=Occasionally.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
ST   Source(s): Ubigene=YC-A010
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 16
ST   Mouse STR 15-3: 25.3
ST   Mouse STR 18-3: 16
ST   Mouse STR X-1: 25,26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6812 ! C2 [Mouse myoblast]
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   C2C12 Clone 5 DYSF shRNA
AC   CVCL_AS32
DR   ATCC; CRL-3418
DR   Wikidata; Q54808119
RX   PubMed=24967968;
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Doubling time: 48-72 hours (ATCC=CRL-3418).
CC   Knockout cell: Method=shRNA knockdown; MGI; MGI:1349385; Dysf.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   C2C12 Scrambled
AC   CVCL_UR38
DR   ATCC; CRL-3419
DR   Wikidata; Q93439914
RX   PubMed=24967968;
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Characteristics: Control cell line for C2C12 Clone 5 DYS shRNA. Transfected with a scrambled DYS shRNA.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   C2C12-Bmpr1b
AC   CVCL_RQ02
DR   Wikidata; Q54808120
RX   PubMed=16957682;
RX   PubMed=19956691;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1077; BMPR1B.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   C2C12-BRE
AC   CVCL_B0JA
SY   C2C12BRE; Clone 22
DR   Wikidata; Q108819972
RX   PubMed=19298647;
CC   Characteristics: Allows a sensitive, rapid and specific cell based assay for the simultaneous quantification of total and isoform specific BMP activity from biological samples (PubMed=19298647).
CC   Characteristics: Transfected with a construct in which the luciferase reporter gene is under the control of the BMP responsive element (BRE) of the Id1 promoter region.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   C2C12-EGFP
AC   CVCL_C8WR
DR   Ubigene; YC-A010-EGFP-P
DR   Wikidata; Q123030837
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   C2C12-hITGA11
AC   CVCL_A0NQ
SY   C2C12-hualpha11; C2C12-alpha11+; C2C12-alpha11
DR   Wikidata; Q108819973
RX   Patent=US20210079099;
RX   PubMed=11518510;
RX   PubMed=31159419;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6136; ITGA11.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   C2C12-Luc
AC   CVCL_C8UW
DR   Ubigene; YC-A010-Luc-P
DR   Wikidata; Q123030838
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   C2C12-R486Q-Bmpr1b
AC   CVCL_RQ03
DR   Wikidata; Q54808121
RX   PubMed=16957682;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1077; BMPR1B (Note=With p.Arg486Gln).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   C2C12-R486W-Bmpr1b
AC   CVCL_RQ04
DR   Wikidata; Q54808122
RX   PubMed=16957682;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1077; BMPR1B (Note=With p.Arg486Trp).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   C2C12/Cas9-hyg
AC   CVCL_C9FH
SY   C2C12-Cas9-hyg
DR   GeneCopoeia; SL564
DR   Wikidata; Q123030839
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL564).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   C2C12/NFkB-luc
AC   CVCL_KS37
DR   Wikidata; Q54808123
RX   PubMed=16834536;
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NF-kappaB response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0016.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 15
//
ID   C2C12(Cas9)
AC   CVCL_E7J0
WW   Provider; BRICS; ECC3048; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3982
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C2C12i
AC   CVCL_VR09
DR   Wikidata; Q93439920
RX   CelloPub=CLPUB00444;
RX   PubMed=14627628;
CC   Characteristics: Transfected with the replication-defective retroviral vector containing Escherichia coli lacZ.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 9
//
ID   C2C12N
AC   CVCL_0189
DR   MCCL; MCC:0000080
DR   Wikidata; Q54808124
RX   PubMed=6839359;
RX   PubMed=7499310;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   C2C7
AC   CVCL_J025
DR   ATCC; HB-8398
DR   Wikidata; Q54808125
RX   Patent=US4670382;
RX   Patent=US4806465;
RX   PubMed=6365778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8398.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Candida albicans antigen(s).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   C2E7
AC   CVCL_E4IJ
RX   CelloPub=CLPUB00800;
RX   DOI=10.1002/jctb.2228;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on breast cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   C2F3
AC   CVCL_6823
DR   Wikidata; Q54808126
WW   Info; -; -; https://web.archive.org/web/20130502024425/http://www.stanford.edu/group/blau/protocols/c2lineprotocol.html
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6812 ! C2 [Mouse myoblast]
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   C2M12
AC   CVCL_W166
SY   C2 M12
DR   Wikidata; Q54808127
RX   PubMed=8770979;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W167 ! C2M15
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   C2M15
AC   CVCL_W167
SY   C2 M15
DR   Wikidata; Q54808128
RX   PubMed=8770979;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W166 ! C2M12
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   C2Mab-6
AC   CVCL_D2VA
DR   Wikidata; Q127380363
RX   PubMed=35377242;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51683; Mouse Ccr2/Cd192.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   C2Mab-9
AC   CVCL_D2T0
DR   Wikidata; Q127380364
RX   PubMed=35917563;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P41597; Human CCR2/CD192.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C2PV
AC   CVCL_5929
SY   Control 2 PaVia
DR   CLO; CLO_0002109
DR   CLDB; cl565
DR   Wikidata; Q54808129
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C3 [Mouse HPV16 transformed]
AC   CVCL_DC63
DR   Wikidata; Q54808130
RX   PubMed=7690326;
RX   PubMed=21439369;
RX   PubMed=26900913;
CC   Virology: Tumorigenic. Probably contains a complete HPV16 genome (PubMed=7690326).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 11
//
ID   C3 [Mouse hybridoma against human TNF]
AC   CVCL_E8PX
SY   Clone 3
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3-124
AC   CVCL_K131
DR   CLO; CLO_0002112
DR   ATCC; HB-60
DR   Wikidata; Q54808131
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: Human IgG heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   C3-44
AC   CVCL_G700
SY   C3-44/MO; C-344; C344
DR   ChEMBL-Cells; CHEMBL3307921
DR   ChEMBL-Targets; CHEMBL614371
DR   PubChem_Cell_line; CVCL_G700
DR   Wikidata; Q54808141
RX   PubMed=6095307;
RX   PubMed=9516127;
CC   Virology: Persistently infected with HTLV-2 isolate Mo (PubMed=6095307).
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   C3-II-B-2-3
AC   CVCL_B6EC
DR   Wikidata; Q111733050
RX   PubMed=22358532;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   C3-luc
AC   CVCL_A7FZ
DR   Wikidata; Q107113528
RX   PubMed=26900913;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC63 ! C3 [Mouse HPV16 transformed]
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 9
//
ID   C3.05
AC   CVCL_E7VC
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C3.08
AC   CVCL_E7VD
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   C3.6
AC   CVCL_J983
SY   HB4a-C3.6
DR   PRIDE; PXD004195
DR   Wikidata; Q54808132
RX   PubMed=9935193;
RX   PubMed=16685446;
CC   Characteristics: Moderate expression of ERBB2 (PubMed=9935193).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J982 ! HB4a
SX   Female
AG   18Y
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   C30.1
AC   CVCL_K250
SY   C30-1
DR   Wikidata; Q54808133
RX   PubMed=2011131;
RX   PubMed=2258612;
RX   PubMed=2523424;
RX   PubMed=3100639;
CC   Characteristics: IL2 dependent.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   C30.1 line 1
AC   CVCL_5T94
SY   Line 1
DR   Wikidata; Q54808134
RX   PubMed=2011131;
RX   PubMed=2523424;
CC   Characteristics: IL2 or IL4 dependent.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K250 ! C30.1
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   C305
AC   CVCL_K130
DR   CLO; CLO_0002111
DR   ATCC; CRL-2424
DR   Wikidata; Q54808135
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   C30ABR
AC   CVCL_IW77
SY   Control 30 Australia BRisbane
DR   Wikidata; Q54808136
RX   PubMed=9150358;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   C311L
AC   CVCL_U100
DR   Wikidata; Q54808137
RX   PubMed=12114371;
RX   PubMed=17511773;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:012; B*51:01,52:01; C*12:02,14:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   C31ABR
AC   CVCL_IW78
SY   Control 31 Australia BRisbane
DR   Wikidata; Q54808138
RX   PubMed=11080496;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   C32 [Human colon adenocarcinoma]
AC   CVCL_5246
SY   C32COLON
DR   cancercelllines; CVCL_5246
DR   CancerTools; 151756
DR   ColonAtlas; C32
DR   Cosmic; 948845
DR   Cosmic; 986005
DR   Cosmic; 995374
DR   Cosmic; 1043555
DR   Cosmic; 1223131
DR   Cosmic; 1312291
DR   Cosmic; 1479621
DR   Cosmic; 2301959
DR   Cosmic; 2760093
DR   Cosmic; 2800567
DR   ECACC; 12022908
DR   GEO; GSM274682
DR   GEO; GSM1346829
DR   GEO; GSM1374421
DR   GEO; GSM1448199
DR   GEO; GSM3145606
DR   GEO; GSM3145693
DR   IARC_TP53; 21764
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q27902825
DR   Ximbio; 151756
RX   PubMed=8464898;
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asp777Leufs*2 (c.2329_2332delGACA); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser42Ile (c.125G>T); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022908; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=12022908; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9
ST   D21S11: 28,30
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 8,9 (ECACC=12022908)
ST   TPOX: 9 (PubMed=25926053)
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   C32 [Human melanoma]
AC   CVCL_1097
SY   C-32; C32-mel; C32 mel; C32r
DR   CLO; CLO_0002113
DR   EFO; EFO_0006364
DR   CLDB; cl566
DR   CLDB; cl5173
DR   AddexBio; C0020002/443
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1585
DR   BCRC; 60081
DR   BioGRID_ORCS_Cell_line; 581
DR   BioSample; SAMN03472821
DR   BioSample; SAMN10988316
DR   cancercelllines; CVCL_1097
DR   Cell_Model_Passport; SIDM00890
DR   CGH-DB; 9321-4
DR   ChEMBL-Cells; CHEMBL3308713
DR   ChEMBL-Targets; CHEMBL1075401
DR   Cosmic; 687432
DR   Cosmic; 888988
DR   Cosmic; 905234
DR   Cosmic; 906830
DR   Cosmic; 928725
DR   Cosmic; 933006
DR   Cosmic; 1022272
DR   Cosmic; 1155267
DR   Cosmic; 1458960
DR   Cosmic; 1995352
DR   Cosmic-CLP; 906830
DR   DepMap; ACH-000580
DR   ECACC; 87090201
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906830
DR   GEO; GSM162931
DR   GEO; GSM206449
DR   GEO; GSM215721
DR   GEO; GSM827471
DR   GEO; GSM886898
DR   GEO; GSM887963
DR   GEO; GSM1138788
DR   GEO; GSM1669636
DR   IARC_TP53; 21204
DR   IZSLER; BS TCL 150
DR   LiGeA; CCLE_275
DR   LINCS_HMS; 50112
DR   LINCS_LDP; LCL-1238
DR   PharmacoDB; C32_154_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1097
DR   PubChem_Cell_line; CVCL_1097
DR   Wikidata; Q27902869
RX   PubMed=3182330;
RX   PubMed=3900210;
RX   PubMed=9354451;
RX   PubMed=12068308;
RX   PubMed=15048078;
RX   PubMed=15467732;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22383533;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-and-morphology-of-atcc-crl-1585
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MET genetic alteration cell panel (ATCC TCP-1036).
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Population: Caucasian.
CC   Doubling time: 53 hours (PubMed=25984343).
CC   HLA typing: A*02:01,25:01; B*18:01,44:02; C*05:01,12:03; DQA1*01:02,03:02; DQB1*06:02,06:02; DRB1*04:01,15:01 (PubMed=25960936).
CC   HLA typing: A*02:01,25:01; B*18:01,44:02; C*05:01,12:03; DQA1*01:02,03:02; DQB1*06:02,06:02; DRB1*04:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=15048078; PubMed=15467732; PubMed=17363583; PubMed=22383533; Cosmic-CLP=906830; DepMap=ACH-000580).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ter157Serext*13 (c.470G>C); Zygosity=Homozygous (PubMed=9354451; DepMap=ACH-000580).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.03%; East Asian, North=2.04%; East Asian, South=0%; South Asian=0%; European, North=63.48%; European, South=33.45% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): AddexBio=C0020002/443; ATCC=CRL-1585; Cosmic-CLP=906830; ECACC=87090201; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 29 (PubMed=25877200)
ST   D21S11: 29,34.2 (ATCC=CRL-1585)
ST   D2S1338: 17,20
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 14,19
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   C32TG
AC   CVCL_2324
SY   C32-TG; C32-r16TG; C32r16TG
DR   BTO; BTO_0005451
DR   CLO; CLO_0002114
DR   EFO; EFO_0002119
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-1579
DR   BCRC; 60269
DR   BioSample; SAMN03472091
DR   cancercelllines; CVCL_2324
DR   CGH-DB; 9287-4
DR   Cosmic; 874386
DR   Cosmic; 905201
DR   Cosmic; 1007158
DR   ECACC; 96020925
DR   EGA; EGAS00001000610
DR   IGRhCellID; C32TG
DR   JCRB; JCRB0227
DR   PharmacoDB; C32TG_155_2019
DR   Progenetix; CVCL_2324
DR   RCB; RCB1929
DR   TKG; TKG 0190
DR   Wikidata; Q54808139
RX   PubMed=9290701;
RX   PubMed=15467732;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=26589293;
CC   Population: Caucasian.
CC   Doubling time: 37 hours (Note=Lot 09262006), ~43 hours (Note=Lot 10302018) (JCRB=JCRB0227).
CC   HLA typing: A*02:01,25:01; B*18:01,44:02; C*05:01,12:03 (PubMed=26589293).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ter157Serext*13 (c.470G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: RCB; RCB1929; true.
CC   Discontinued: TKG; TKG 0190; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-1579; JCRB=JCRB0227; RCB=RCB1929
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,10,11 (RCB=RCB1929)
ST   D7S820: 9,11 (ATCC=CRL-1579; JCRB=JCRB0227)
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 14,19
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1097 ! C32 [Human melanoma]
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   C33-1.6.1
AC   CVCL_J964
SY   C33-1-6-1; C33161
DR   Wikidata; Q54808140
RX   Patent=WO1996040041A2;
CC   Group: Patented cell line.
CC   Registration: Chiron Master Culture Collection; CMCC 11263 (CMCC #11263).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   c35 (B16GBi1c3)
AC   CVCL_9105
SY   c35; B16GBi1c3
DR   CLO; CLO_0002116
DR   ATCC; CRL-2715
DR   Wikidata; Q54808142
CC   Selected for resistance to: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Discontinued: ATCC; CRL-2715; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   C35ABR
AC   CVCL_IW79
SY   Control 35 Australia BRisbane
DR   Wikidata; Q54808143
RX   PubMed=11080496;
RX   PubMed=15510216;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   C3647
AC   CVCL_1G30
SY   C1.iPSC; C1; C3647_iPSC
DR   GEO; GSM1495393
DR   GEO; GSM1502695
DR   Wikidata; Q54808144
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_V847 ! S003647
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   C3649
AC   CVCL_1G31
SY   C2.iPSC; C2; C3649_iPSC
DR   GEO; GSM1495394
DR   GEO; GSM1502696
DR   GEO; GSM1712810
DR   GEO; GSM1712811
DR   GEO; GSM1712812
DR   Wikidata; Q54808146
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_V849 ! S003649
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   C3651
AC   CVCL_1G32
SY   C3.iPSC; C3; C3651_iPSC
DR   GEO; GSM1495395
DR   GEO; GSM1502697
DR   Wikidata; Q54808147
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_V851 ! S003651
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   c37 (B7IFi1)
AC   CVCL_9106
SY   c37; B7IFi1
DR   CLO; CLO_0002117
DR   ATCC; CRL-2711
DR   Wikidata; Q54808148
RX   PubMed=3308449;
CC   Selected for resistance to: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Sequence variation: Mutation; MGI; MGI:88588; Cyp1a1; Simple; p.Leu118Arg (c.353T>G); Zygosity=Homozygous (PubMed=3308449).
CC   Sequence variation: Mutation; MGI; MGI:88588; Cyp1a1; Simple; p.Arg245Pro (c.734G>C); Zygosity=Homozygous (PubMed=3308449).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   C3842
AC   CVCL_B042
SY   C-3842
DR   BTO; BTO_0003567
DR   Cosmic; 1602480
DR   Wikidata; Q54808151
RX   PubMed=15731924;
RX   PubMed=22057234;
CC   Doubling time: ~10 days (PubMed=15731924).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15731924).
CC   Derived from site: In situ; Bone, right proximal tibia; UBERON=UBERON_0008772.
DI   NCIt; C27482; Secondary chondrosarcoma
DI   NCIt; C3008; Enchondromatosis
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   C3948
AC   CVCL_XY60
DR   cancercelllines; CVCL_XY60
DR   Wikidata; Q93439974
RX   PubMed=31368081;
CC   Doubling time: 30 hours (PubMed=31368081).
CC   Sequence variation: Mutation; HGNC; HGNC:28648; DIS3L2; Simple; p.Trp361Leu (c.1082G>T); Zygosity=Unspecified (PubMed=31368081).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Ser216Phe (c.647C>T); ClinVar=VCV000376708; Zygosity=Unspecified (PubMed=31368081).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu346Ter (c.1036G>T); ClinVar=VCV000634697; Zygosity=Hemizygous (PubMed=31368081).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=31368081
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 12
ST   D21S11: 31
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 26
ST   Penta D: 9
ST   Penta E: 13,14
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   C396
AC   CVCL_A1UX
DR   cancercelllines; CVCL_A1UX
DR   DepMap; ACH-001818
DR   Wikidata; Q105506575
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): DepMap=ACH-001818
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 14,17
ST   D21S11: 31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 9,10
ST   FGA: 19,24
ST   Penta D: 9,13
ST   Penta E: 10,14
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 7
//
ID   C39Mab-1
AC   CVCL_D2RK
DR   Wikidata; Q127380365
RX   PubMed=38197855;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P55772; Mouse Entpd1/Cd39.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   C39Mab-2
AC   CVCL_D2RL
DR   Wikidata; Q127380366
RX   PubMed=38126892;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P55772; Mouse Entpd1/Cd39.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 5
//
ID   C3A/Cas9-hyg
AC   CVCL_C9DH
DR   GeneCopoeia; SL543
DR   Wikidata; Q123030840
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL543).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1098 ! Hep-G2/C3A
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   C3ABR
AC   CVCL_M914
SY   Control 3 Australia BRisbane
DR   BTO; BTO_0006124
DR   EFO; EFO_0022652
DR   Wikidata; Q54808154
RX   PubMed=1944384;
RX   PubMed=7433105;
RX   PubMed=9150358;
RX   PubMed=11080496;
RX   PubMed=12195425;
RX   PubMed=12645530;
RX   PubMed=15044383;
RX   PubMed=16540636;
RX   PubMed=17347666;
RX   PubMed=17562789;
RX   PubMed=19643912;
RX   PubMed=21149446;
RX   PubMed=25868131;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   C3B9
AC   CVCL_T979
DR   ECACC; 00020913
DR   Wikidata; Q54808155
RX   PubMed=2606940;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q4GYY5; Trypanosoma brucei brucei tubulin alpha-chain (Note=With acetylated p.Lys40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   C3Fe.SWV-Mbpshi/J Het PRX-#16
AC   CVCL_2H85
DR   Wikidata; Q54808156
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001428P10-2productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3Fe.SWV-Mbpshi/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   C3Fe.SWV-Mbpshi/J Hom PRX-#1003
AC   CVCL_2H86
DR   Wikidata; Q54808157
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001428P10productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3Fe.SWV-Mbpshi/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   C3Fe.SWV-Mbpshi/J WT PRX-#1
AC   CVCL_2H87
DR   Wikidata; Q54808158
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001428P10-3productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3Fe.SWV-Mbpshi/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   C3H/10T1/2 clone 8
AC   CVCL_0190
SY   C3H/10T1/2-clone8; C3H/10T1/2 CL8; C3H10T1/2 clone8; C3H10T1/2CL8; 10T1/2(clone8); 10T1/2; C3H10T1-2; C3H10T1/2; C3H-10T1/2; C3H 10T1/2; C3H/10T1/2
DR   BTO; BTO_0004058
DR   BTO; BTO_0005930
DR   CLO; CLO_0002120
DR   CLO; CLO_0050546
DR   EFO; EFO_0002816
DR   MCCL; MCC:0000081
DR   CLDB; cl567
DR   CLDB; cl568
DR   AddexBio; P0011003/4921
DR   ATCC; CCL-226
DR   CCRID; 1101MOU-PUMC000665
DR   CCRID; 3101MOUGNM19
DR   CCRID; 3101MOUSCSP506
DR   ChEMBL-Cells; CHEMBL3307493
DR   ChEMBL-Targets; CHEMBL614531
DR   CLS; 305164
DR   ECACC; 99072801
DR   ENCODE; ENCBS034ENC
DR   ENCODE; ENCBS035ENC
DR   JCRB; IFO50415
DR   JCRB; JCRB0003
DR   JCRB; JCRB0602
DR   JCRB; JCRB9080
DR   KCB; KCB 2010243YJ
DR   KCLB; 10226
DR   Lonza; 1346
DR   NCI-DTP; C3HIOT 1/2
DR   PubChem_Cell_line; CVCL_0190
DR   RCB; RCB0247
DR   TOKU-E; 3959
DR   Wikidata; Q54808159
RX   PubMed=2594967;
RX   PubMed=3152871;
RX   PubMed=4357355;
RX   PubMed=4796800;
RX   PubMed=25277546;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-279.html
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: ENCODE project mouse cell lines.
CC   Doubling time: 15.5 hours (Note=At 9th passage) (PubMed=4357355).
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: C3HIOT 1/2; NCI-DTP=C3HIOT 1/2.
CC   Misspelling: C3HT101/2; Note=Occasionally.
CC   Discontinued: JCRB; JCRB0602; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   C3H10T1/2 clone 82A
AC   CVCL_E9X8
SY   C3H10T1/2 CL 82A
RX   PubMed=2594967;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 Con clone A1
AC   CVCL_E9D4
RX   PubMed=3475570;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 Con clone H6
AC   CVCL_E9D5
RX   PubMed=3475570;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 MRF4-#7
AC   CVCL_C4L8
SY   MRF4#7
DR   Wikidata; Q116048629
RX   PubMed=2560751;
CC   Genetic integration: Method=Transfection; Gene=RGD; 3134; Myf6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   C3H10T1/2 MyoD1-#8
AC   CVCL_C4L9
DR   Wikidata; Q116048630
RX   PubMed=2560751;
CC   Genetic integration: Method=Transfection; Gene=RGD; 631429; Myod1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   C3H10T1/2 myogenin-#1
AC   CVCL_C4LA
DR   Wikidata; Q116048631
RX   PubMed=2560751;
CC   Genetic integration: Method=Transfection; Gene=RGD; 620432; Myog.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   C3H10T1/2 Myc clone A7
AC   CVCL_E9D6
RX   PubMed=3475570;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 Myc clone C2
AC   CVCL_E9D7
RX   PubMed=3475570;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 R+M clone E5
AC   CVCL_E9DA
SY   C3H10T1/2 Ras+Myc clone E5
RX   PubMed=3475570;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 R+M clone E6
AC   CVCL_E9DB
SY   C3H10T1/2 Ras+Myc clone E6
RX   PubMed=3475570;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 Ras clone C4
AC   CVCL_E9D8
SY   RasC4
RX   PubMed=3475570;
RX   PubMed=8564977;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H10T1/2 Ras clone C10
AC   CVCL_E9D9
RX   PubMed=3475570;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C3H/10T1/2-mRuby clone 2
AC   CVCL_5I32
DR   ATCC; CRL-3268
DR   Wikidata; Q54808160
RX   PubMed=26407291;
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8MJ78; mRuby2 (Note=Bright red fluorescent protein derived from eqFP61).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   C3H/HeN-emb
AC   CVCL_5U83
DR   RCB; RCB1311
DR   Wikidata; Q54808161
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/HeN Jcl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   C3H/MCA clone 15
AC   CVCL_4720
AS   CVCL_U204
SY   MCA-TCL15; MCA-TCL15/P3; MCA-TCL-15; TCL-15
DR   CLO; CLO_0002121
DR   ATCC; CRL-1411
DR   JCRB; IFO50042
DR   Wikidata; Q54808162
RX   PubMed=4796800;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   C3H/MCA clone 16
AC   CVCL_4721
AS   CVCL_U205
SY   MCA-TCL16; MCA-TCL16/P3
DR   CLO; CLO_0002122
DR   CLDB; cl569
DR   ATCC; CRL-1412
DR   ECACC; 90110523
DR   JCRB; JCRB0712
DR   Wikidata; Q54808163
RX   PubMed=4796800;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   C3H/MCA-58
AC   CVCL_Y467
DR   Wikidata; Q54808164
RX   PubMed=679187;
RX   PubMed=6265069;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
ID   C3H/TLR4mut MEF
AC   CVCL_X606
DR   InvivoGen; mef-c3h4m
DR   Wikidata; Q54808165
WW   Provider; InvivoGen; mef-c3h4m; https://www.invivogen.com/sites/default/files/invivogen/products/files/c3h_tlr4mut_tds.pdf
CC   Characteristics: Stably express a NF-kappaB-inducible SEAP reporter construct that allows to monitor in a simple and convenient manner the activation of NF-kappaB. As C3H/HeJ mice are defective in LPS signaling due to a TLR4 p.Pro712His mutation these cells are not activated by TLR4 agonists (InvivoGen=mef-c3h4m).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Discontinued: InvivoGen; mef-c3h4m; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 11
//
ID   C3H/WT MEF
AC   CVCL_X607
DR   InvivoGen; mef-c3hwt
DR   Wikidata; Q54808166
WW   Provider; InvivoGen; mef-c3hwt; https://www.invivogen.com/sites/default/files/invivogen/products/files/c3h_wt_tds.pdf
CC   Characteristics: Stably express a NF-kappaB-inducible SEAP reporter construct that allows to monitor in a simple and convenient manner the activation of NF-kappa-B (InvivoGen=mef-c3hw).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Discontinued: InvivoGen; mef-c3hwt; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 11
//
ID   C3H2K
AC   CVCL_6E65
DR   Wikidata; Q54808167
RX   PubMed=4168505;
RX   PubMed=4307755;
RX   PubMed=5693245;
CC   Doubling time: ~70 hours (PubMed=4168505).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 6
//
ID   C3H2K-C4
AC   CVCL_6E66
DR   Wikidata; Q54808168
RX   PubMed=195084;
RX   PubMed=6262522;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6E65 ! C3H2K
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 6
//
ID   C3Hfc-1
AC   CVCL_F033
DR   RCB; AES0032
DR   RCB; RCB2181
DR   SKIP; SKIP001686
DR   Wikidata; Q54808169
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2181; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   C3Hft-1
AC   CVCL_F031
DR   RCB; AES0030
DR   RCB; RCB2179
DR   SKIP; SKIP001684
DR   Wikidata; Q54808170
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2179; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   C3Hft-2
AC   CVCL_F032
DR   RCB; AES0031
DR   RCB; RCB2180
DR   SKIP; SKIP001685
DR   Wikidata; Q54808171
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2180; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   C3Hmt-1
AC   CVCL_F030
DR   RCB; AES0029
DR   RCB; RCB2178
DR   SKIP; SKIP001683
DR   Wikidata; Q54808173
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2178; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   C3Mab-2
AC   CVCL_D2R6
DR   Wikidata; Q127380367
RX   PubMed=33877898;
RX   PubMed=35225661;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P51678; Mouse Ccr3/Cd193.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C3Mab-3
AC   CVCL_D2R7
DR   Wikidata; Q127380368
RX   PubMed=35471049;
RX   PubMed=36546900;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P51678; Mouse Ccr3/Cd193.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C3Mab-4
AC   CVCL_D2RR
DR   Wikidata; Q127380369
RX   PubMed=36546900;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P51678; Mouse Ccr3/Cd193.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C3Mab-6
AC   CVCL_D2R3
DR   Wikidata; Q127380370
RX   PubMed=35471054;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51678; Mouse Ccr3/Cd193.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C3Mab-7
AC   CVCL_D2R4
DR   Wikidata; Q127380371
RX   PubMed=35471054;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51678; Mouse Ccr3/Cd193.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C3PV
AC   CVCL_5930
SY   Control 3 PaVia
DR   CLO; CLO_0002123
DR   CLDB; cl570
DR   Wikidata; Q54808174
RX   PubMed=8823375;
RX   PubMed=9584159;
RX   PubMed=10766188;
RX   PubMed=19329487;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C3RL4
AC   CVCL_C5IW
SY   C3H10T1/2, RARE-Luc, clone #4
DR   Wikidata; Q116048632
RX   PubMed=26820057;
CC   Biotechnology: Used in a bioassay to assess chemicals for the ability to interfere with retinol signaling.
CC   Characteristics: Expresses luciferase under the control of the retinoic acid response element (RARE) (PubMed=26820057).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   C4 [Human iPSC]
AC   CVCL_W593
DR   SKIP; SKIP000291
DR   Wikidata; Q54808175
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W594 ! C4+G2019S
SX   Female
AG   80-85Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   C4 [Mouse hybridoma against human TNF]
AC   CVCL_E8PY
SY   Clone 4
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   c4 (B13NBii1)
AC   CVCL_9085
SY   c4; B13NBii1
DR   CLO; CLO_0002124
DR   ATCC; CRL-2717
DR   Wikidata; Q54808176
RX   PubMed=6623311;
RX   PubMed=6896205;
CC   Selected for resistance to: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   C4-1-B-2
AC   CVCL_B6ED
DR   Wikidata; Q111733051
RX   PubMed=22358532;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=p6-1).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   C4+G2019S
AC   CVCL_W594
DR   SKIP; SKIP000295
DR   Wikidata; Q54808177
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W593 ! C4 [Human iPSC]
SX   Female
AG   80-85Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   C40-1.3.3
AC   CVCL_J965
SY   C401.3.3
DR   Wikidata; Q54808178
RX   Patent=WO1996040041A2;
CC   Group: Patented cell line.
CC   Registration: Chiron Master Culture Collection; CMCC 11264 (CMCC #11264).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   C40210
AC   CVCL_1G35
SY   C6.iPSC; C6; C40210_iPSC
DR   GEO; GSM1495398
DR   GEO; GSM1502700
DR   Wikidata; Q54808179
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   C40280
AC   CVCL_1G36
SY   C7.iPSC; C7; C40280_iPSC
DR   GEO; GSM1495399
DR   GEO; GSM1502701
DR   GEO; GSM1712813
DR   GEO; GSM1712814
DR   GEO; GSM1712815
DR   Wikidata; Q54808180
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   C418-59
AC   CVCL_DC73
SY   418-59
DR   Wikidata; Q54808181
RX   Patent=US5024946;
RX   PubMed=2470715;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85071031.
CC   Doubling time: 20 hours (PubMed=2470715).
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a gastric cancer.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   C42-7.4.5
AC   CVCL_J967
SY   C42-7-4-5; C42745
DR   Wikidata; Q54808182
RX   Patent=WO1996040041A2;
CC   Group: Patented cell line.
CC   Registration: Chiron Master Culture Collection; CMCC 11267 (CMCC #11267).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   C422L
AC   CVCL_U101
DR   Wikidata; Q54808183
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   HLA typing: A*26:01; B*46:01; C*01:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   C44
AC   CVCL_K132
DR   CLO; CLO_0002128
DR   ATCC; CRL-1943
DR   Wikidata; Q54808184
RX   PubMed=2777275;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_23359; Colchicine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   C44Mab-1
AC   CVCL_D2RC
DR   Wikidata; Q127380372
RX   PubMed=37185762;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44v9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-108
AC   CVCL_D2RD
DR   Wikidata; Q127380373
RX   PubMed=36975491;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44v4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-18
AC   CVCL_D2S9
DR   Wikidata; Q127380374
RX   PubMed=37504249;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44v10).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-3
AC   CVCL_D2RE
DR   Wikidata; Q127380375
RX   PubMed=37218897;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44v5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-34
AC   CVCL_D2RF
DR   Wikidata; Q127380376
RX   PubMed=37189717;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoforms CD44v7, CD44v8 and CD44v10).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-46
AC   CVCL_D2RG
DR   Wikidata; Q127380377
RX   PubMed=34283655;
RX   PubMed=35628345;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44s).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   C44Mab-5
AC   CVCL_D2RH
DR   Wikidata; Q127380378
RX   PubMed=29872736;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoforms CD44s and CD44v3-10).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-6
AC   CVCL_D2RI
DR   Wikidata; Q127380379
RX   PubMed=37176118;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44v3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-9
AC   CVCL_D2RJ
DR   Wikidata; Q127380380
RX   PubMed=36835416;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44v6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C44Mab-94
AC   CVCL_D2VB
DR   Wikidata; Q127380381
RX   PubMed=37489367;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44 (Note=Isoform CD44v8).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C463A
AC   CVCL_M527
DR   Wikidata; Q54808185
RX   Patent=US20030166146;
CC   Group: Patented cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   C4955
AC   CVCL_1G33
SY   C4.iPSC; C4; C4955_iPSC
DR   GEO; GSM1495396
DR   GEO; GSM1502698
DR   Wikidata; Q54808186
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_V864 ! S004955
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   C4A9H1
AC   CVCL_XK37
DR   Wikidata; Q93440183
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_100241; Ciprofloxacin (CIP) (Note=Also recognizes enrofloxacin, norfloxacin and ofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   C4ABR
AC   CVCL_RN92
SY   Control 4 Australia BRisbane
DR   Wikidata; Q54808187
RX   PubMed=1944384;
RX   PubMed=6504056;
RX   PubMed=7433105;
RX   PubMed=17347666;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   C4Mab-1
AC   CVCL_D2SU
DR   Wikidata; Q127380382
RX   PubMed=35471046;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51680; Mouse Ccr4/Cd194.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C4PV
AC   CVCL_5931
SY   Control 4 PaVia
DR   CLO; CLO_0002130
DR   CLDB; cl573
DR   Wikidata; Q54808188
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C4RO
AC   CVCL_ZP48
SY   Control 4 ROtterdam
DR   Wikidata; Q98125596
RX   PubMed=31374204;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   C5 [Mouse hybridoma against human TNF]
AC   CVCL_E8PZ
SY   Clone 5
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C5 [Human hybridoma against lipid A]
AC   CVCL_9089
SY   1F10
DR   CLO; CLO_0002131
DR   Wikidata; Q54808189
RX   Patent=US5426046;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8669.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_47040; Lipid A.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9088 ! SHM-A6
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 9
//
ID   C5 [Mouse hybridoma against human SERPINC1]
AC   CVCL_C4ZF
DR   Wikidata; Q116048634
RX   PubMed=1804774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01008; Human SERPINC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   C5 [Mouse hybridoma against V.anguillarum]
AC   CVCL_B6XE
DR   Wikidata; Q111733052
RX   PubMed=9404077;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Vibrio anguillarum.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   C5-1X
AC   CVCL_C0EA
SY   C5-1X/8
DR   Wikidata; Q112929352
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13688; Human CEACAM1/CD66a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 4
//
ID   C5.2
AC   CVCL_J984
SY   HB4a-C5.2
DR   Wikidata; Q54808190
RX   CelloPub=CLPUB00734;
RX   PubMed=9935193;
RX   PubMed=16685446;
CC   Characteristics: High expression of ERBB2 (PubMed=9935193).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Omics: Transcriptomics; Massively parallel signature sequencing (MPSS).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J982 ! HB4a
SX   Female
AG   18Y
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   C5/MJ
AC   CVCL_6376
AS   CVCL_9086
SY   C5-MJ; C5MJ
DR   CLO; CLO_0002132
DR   CLO; CLO_0002138
DR   CLDB; cl577
DR   ATCC; CRL-8293
DR   BioSample; SAMN03471199
DR   Wikidata; Q54808191
RX   Patent=US4743678;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3814825;
RX   PubMed=3874327;
RX   PubMed=6600519;
RX   PubMed=6601065;
RX   PubMed=6604130;
RX   PubMed=6604273;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8293.
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8293
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 8,11
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   C50
AC   CVCL_0191
SY   C-50
DR   MCCL; MCC:0000082
DR   Wikidata; Q54808192
RX   PubMed=2043251;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5797 ! MCa3D
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   C5065
AC   CVCL_LB79
SY   DFT1.C5065
DR   Wikidata; Q54808194
RX   PubMed=23479617;
RX   PubMed=25708088;
RX   PubMed=27936237;
RX   PubMed=32937435;
CC   Group: Marsupial cell line.
CC   Characteristics: Originates from DFT1 strain 3.
DI   NCIt; C176223; Devil facial tumor disease 1
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_LB75 ! 1/2Pea
OI   CVCL_LB76 ! 1426
OI   CVCL_LB77 ! 2112
OI   CVCL_LB78 ! 4906
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   C54
AC   CVCL_J386
DR   Wikidata; Q54808195
RX   PubMed=2579446;
RX   PubMed=7068654;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 9
//
ID   C55.7
AC   CVCL_J387
SY   CHO C55.7
DR   Wikidata; Q54808196
RX   PubMed=1692838;
RX   PubMed=2579446;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   C55.7Res
AC   CVCL_J388
DR   Wikidata; Q54808197
RX   PubMed=10887189;
CC   Selected for resistance to: ChEBI; CHEBI_90282; N(1),N(12)-diethylspermine (N1,N12-bis(ethyl)spermine).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_J387 ! C55.7
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   C57/B1
AC   CVCL_0192
SY   C57Bl melanoma clone mel 2C
DR   CLO; CLO_0002133
DR   MCCL; MCC:0000083
DR   CLDB; cl574
DR   ECACC; 85011438
DR   Wikidata; Q54808198
RX   PubMed=893544;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S409 ! PG19
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   C57/B6-L
AC   CVCL_A9HH
DR   CCRID; 5301MOU-KCB1365LZJ
DR   KCB; KCB 2013065LZJ
DR   Wikidata; Q108819974
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9HI ! C57/B6-S
OI   CVCL_A9HJ ! C57/B6-SPL
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   C57/B6-S
AC   CVCL_A9HI
DR   CCRID; 5301MOU-KCB1365SZJ
DR   KCB; KCB 2013065SZJ
DR   Wikidata; Q108819975
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9HH ! C57/B6-L
OI   CVCL_A9HJ ! C57/B6-SPL
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   C57/B6-SPL
AC   CVCL_A9HJ
DR   CCRID; 5301MOU-KCB1365SPL
DR   KCB; KCB 2013065SPL
DR   Wikidata; Q108819976
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9HH ! C57/B6-L
OI   CVCL_A9HI ! C57/B6-S
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   C57/MV7
AC   CVCL_B4F8
DR   Wikidata; Q110432661
RX   PubMed=10197631;
RX   PubMed=12702582;
CC   Characteristics: Control cell line for C57/Wnt-1 (Cellosaurus=CVCL_B4F9).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6824 ! C57MG
SX   Female
AG   23W
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   C57/Wnt-1
AC   CVCL_B4F9
DR   Wikidata; Q110432662
RX   PubMed=10197631;
RX   PubMed=12702582;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6824 ! C57MG
SX   Female
AG   23W
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   C57BL/6J-emb
AC   CVCL_5U84
DR   RCB; RCB1312
DR   Wikidata; Q54808199
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   C57iPS-C12
AC   CVCL_XG87
SY   iPS-C12
DR   Wikidata; Q93440320
RX   Patent=CN101492676B;
RX   PubMed=18826945;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XG84 ! GIBH001
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   C57iPS-C5
AC   CVCL_XG85
SY   iPS-C5
DR   Wikidata; Q93440326
RX   Patent=CN101492676B;
RX   PubMed=18826945;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XG84 ! GIBH001
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   C57iPS-C6
AC   CVCL_XG86
SY   iPS-C6
DR   Wikidata; Q93440329
RX   Patent=CN101492676B;
RX   PubMed=18826945;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XG84 ! GIBH001
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   C57L/J.Li
AC   CVCL_S354
DR   ATCC; CRL-6335
DR   Wikidata; Q54808200
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6335; true.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6377 ! C57L/J.We
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   C57L/J.We
AC   CVCL_6377
DR   CLO; CLO_0002134
DR   ATCC; CRL-6336
DR   Wikidata; Q54808201
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6336; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: C57L/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S354 ! C57L/J.Li
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   C57M10
AC   CVCL_B3T8
SY   C57BL/6 Muller cells postnatal day 10
DR   Wikidata; Q110432663
RX   CelloPub=CLPUB00658;
RX   PubMed=20505190;
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   C57MG
AC   CVCL_6824
SY   C57mg
DR   BTO; BTO_0003569
DR   GEO; GSE32096
DR   Lonza; 122
DR   Millipore; SCC273
DR   Wikidata; Q54808202
RX   PubMed=213889;
RX   PubMed=8065359;
RX   PubMed=8180133;
RX   PubMed=9488439;
RX   PubMed=11358845;
RX   PubMed=11832495;
RX   PubMed=22238613;
CC   Characteristics: Used to study Wnt signalling.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC273
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15.3
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 18
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   23W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   C57MG-A5
AC   CVCL_G295
DR   Wikidata; Q54808203
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/6BD35B4BDF214D8899F1FD2249E1D5C1
CC   Characteristics: Clone of C57BL/6 which is more reliable for Wnt assays than the parent cell line (Cornell TTO).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6824 ! C57MG
SX   Female
AG   23W
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   C57MG/2-69-23
AC   CVCL_LF86
SY   2-69-23
DR   Wikidata; Q54808204
RX   Patent=WO1999043804A1;
RX   PubMed=9488439;
RX   PubMed=11358845;
RX   PubMed=11832495;
CC   Group: Patented cell line.
CC   Characteristics: The expression of the Wnt1 gene is under the control of a tetracycline-repressible promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6824 ! C57MG
SX   Female
AG   23W
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 8
//
ID   C57MG/Wnt-1
AC   CVCL_LF85
DR   GEO; GSM32829
DR   Wikidata; Q54808205
RX   PubMed=11358845;
RX   PubMed=11832495;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6824 ! C57MG
SX   Female
AG   23W
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   C57SV
AC   CVCL_L861
DR   CLO; CLO_0002135
DR   CLDB; cl576
DR   Wikidata; Q54808206
RX   PubMed=87443;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   C58(NT)D
AC   CVCL_WI56
SY   (C58NT)D; W/Fu(C58NT)D; W/Fu C58(NT)D
DR   Wikidata; Q93440417
RX   PubMed=591098;
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   C58(NT)D.1.G.OUAR.1
AC   CVCL_8948
SY   C58(NT)D.1.G.OVAR.1
DR   CLO; CLO_0002136
DR   ATCC; TIB-236
DR   Wikidata; Q54808207
RX   PubMed=2965188;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI56 ! C58(NT)D
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   C595
AC   CVCL_C8BX
DR   Wikidata; Q123030841
RX   PubMed=1692469;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   C5ABR
AC   CVCL_RN93
SY   Control 5 Australia BRisbane
DR   Wikidata; Q54808208
RX   PubMed=1944384;
RX   PubMed=6197197;
RX   PubMed=6228733;
RX   PubMed=7433105;
RX   PubMed=17347666;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   C5B7
AC   CVCL_6316
DR   CLO; CLO_0002137
DR   ATCC; CRL-8753
DR   BioSample; SAMN03471207
DR   Wikidata; Q54808209
RX   Patent=US5662905;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8753.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8753
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 12
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB43 ! C5D5
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   C5D5
AC   CVCL_DB43
DR   Wikidata; Q54808210
RX   Patent=US4834975;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8754.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 4.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6316 ! C5B7
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 10
//
ID   C5Mab-1
AC   CVCL_D3EP
DR   Wikidata; Q127380383
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P51682; Mouse Ccr5/Cd195.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C5PV
AC   CVCL_5932
SY   Control 5 PaVia
DR   CLO; CLO_0002139
DR   CLDB; cl578
DR   Wikidata; Q54808211
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C5RO
AC   CVCL_ZP35
SY   Control 5 ROtterdam
DR   Wikidata; Q98125597
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   PubMed=3337113;
RX   PubMed=3803387;
RX   PubMed=7671243;
RX   PubMed=8317483;
RX   PubMed=8823375;
RX   PubMed=9012405;
RX   PubMed=9579555;
RX   PubMed=12060391;
RX   PubMed=14688028;
RX   PubMed=15220921;
RX   PubMed=17273966;
RX   PubMed=20221251;
RX   PubMed=31374204;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   C5ROLas
AC   CVCL_ZP36
DR   Wikidata; Q98125598
RX   PubMed=7671243;
RX   PubMed=9012405;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP35 ! C5RO
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 7
//
ID   C5RO-hTERT
AC   CVCL_ZP37
SY   C5RO(tert)
DR   Wikidata; Q98125599
RX   PubMed=14690602;
RX   PubMed=17273966;
RX   PubMed=30165384;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP35 ! C5RO
SX   Female
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   C6
AC   CVCL_0194
AS   CVCL_4060
SY   C-6; C 6; RGC-6; RGC6; RGc6
DR   BTO; BTO_0000529
DR   CLO; CLO_0002072
DR   CLO; CLO_0002140
DR   CLO; CLO_0051387
DR   CLO; CLO_0051388
DR   EFO; EFO_0022779
DR   MCCL; MCC:0000085
DR   CLDB; cl579
DR   CLDB; cl580
DR   CLDB; cl581
DR   CLDB; cl583
DR   CLDB; cl5165
DR   ABM; T8961
DR   ATCC; CCL-107
DR   BCRC; 60046
DR   BCRJ; 0057
DR   CCRID; 1101RAT-PUMC000131
DR   CCRID; 1102RAT-NIFDC00048
DR   CCRID; 3101RATTCR1
DR   ChEMBL-Cells; CHEMBL3308345
DR   ChEMBL-Targets; CHEMBL614657
DR   CLS; 500142
DR   DSMZ; ACC-550
DR   DSMZCellDive; ACC-550
DR   ECACC; 92090409
DR   ICLC; ATL95007
DR   IZSLER; BS TCL 5
DR   JCRB; IFO50110
DR   JCRB; JCRB9096
DR   KCB; KCB 93026YJ
DR   KCLB; 10107
DR   Lonza; 27
DR   NCBI_Iran; C575
DR   PRIDE; PXD026776
DR   PubChem_Cell_line; CVCL_0194
DR   RCB; RCB2783
DR   RCB; RCB2854
DR   TKG; TKG 0242
DR   TKG; TKG 0589
DR   TOKU-E; 750
DR   Wikidata; Q54808212
RX   CelloPub=CLPUB00233;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.5005/jp-journals-10082-02230;
RX   PubMed=2303323;
RX   PubMed=2303324;
RX   PubMed=3468959;
RX   PubMed=4873531;
RX   PubMed=19381449;
RX   PubMed=25492533;
RX   PubMed=34917708;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-129.html
CC   Doubling time: 14.75 hours (PubMed=2303324); 24-28 hours (DOI=10.5005/jp-journals-10082-02230); ~24 hours (CLS=500142); ~25-30 hours (DSMZ=ACC-550).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   C6 [Human colon adenocarcinoma]
AC   CVCL_HE31
DR   ColonAtlas; C6
DR   Cosmic; 986006
DR   Wikidata; Q54808213
RX   PubMed=9482574;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1309Aspfs*4 (c.3927_3931delAAAGA); ClinVar=VCV000000816; Zygosity=Unspecified (PubMed=9482574).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   C6 [Mouse hybridoma against human TNF]
AC   CVCL_E8Q0
SY   Clone 6
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C6 rho-0#14
AC   CVCL_ZB60
DR   Kerafast; ESA107
DR   Wikidata; Q98125601
RX   PubMed=27136098;
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Produced by transient transfection with plasmid pMA4008 encoding HSV-1 UL12.5M185 protein, which damages mtDNA by an unknown mechanism.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   C6-2-3
AC   CVCL_4138
DR   ECACC; 08062528
DR   Wikidata; Q54808214
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1970 ! C6-BU-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   C6-3
AC   CVCL_X905
SY   C6
DR   CGH-DB; 9336-4
DR   Wikidata; Q54808215
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 6
//
ID   C6-4-2
AC   CVCL_4139
DR   ECACC; 08062524
DR   Wikidata; Q54808216
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   C6-BU-1
AC   CVCL_1970
SY   C6-Bu-1; C6BU-1; C6BU1; C6Bu1; C6Bu
DR   CLO; CLO_0002144
DR   CLDB; cl584
DR   ChEMBL-Cells; CHEMBL3307389
DR   ChEMBL-Targets; CHEMBL614532
DR   DSMZ; ACC-108
DR   DSMZCellDive; ACC-108
DR   ECACC; 08062563
DR   PubChem_Cell_line; CVCL_1970
DR   TKG; TKG 0811
DR   Wikidata; Q54808217
RX   PubMed=598387;
RX   PubMed=4857160;
CC   Doubling time: ~30 hours (DSMZ=ACC-108).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   C6-C5
AC   CVCL_C5NF
DR   Wikidata; Q116048637
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   C6-Russian
AC   CVCL_9255
DR   CLO; CLO_0002146
DR   CLDB; cl585
DR   Wikidata; Q54808218
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   C6-SF2
AC   CVCL_6336
DR   JCRB; IFO50425
DR   Wikidata; Q54808219
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   C6-TK
AC   CVCL_E9CD
RX   PubMed=11916247;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C6/36
AC   CVCL_Z230
SY   Clone C6/36; Aedes albopictus clone C6/36; ATC-15(C6/36); AAL-C6/36; C6-36; SAAR-C6/36
DR   BTO; BTO_0005452
DR   CLO; CLO_0001672
DR   CLO; CLO_0002506
DR   CLDB; cl799
DR   ATCC; CRL-1660
DR   BCRC; 60114
DR   BCRJ; 0343
DR   CCRID; 4201INC-CCTCC00125
DR   CCRID; 5301INS-KCB82002YJ
DR   CCTCC; GDC0125
DR   ECACC; 89051705
DR   IZSLER; BS CL 219
DR   JCRB; IFO50010
DR   KCB; KCB 82002YJ
DR   NCBI_Iran; C612
DR   PRIDE; PXD004727
DR   Wikidata; Q54808220
RX   CelloPub=CLPUB00466;
RX   PubMed=690610;
RX   PubMed=2563994;
RX   PubMed=2861916;
RX   PubMed=3392770;
RX   PubMed=3611315;
RX   PubMed=3951024;
RX   PubMed=6126429;
RX   PubMed=6137452;
RX   PubMed=19951376;
RX   PubMed=20976219;
RX   PubMed=28404849;
RX   PubMed=29329394;
RX   PubMed=29973702;
RX   PubMed=33389257;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_4c091fefa9
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_b3bdc3fa97
WW   Info; Wikipedia; -; https://pt.wikipedia.org/wiki/C6/36
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Virology: Used for detection, propagation and analysis of mosquito-borne viruses.
CC   Virology: Supports replication of Sindbis virus (PubMed=3392770; PubMed=3951024).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Quantitative.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z223 ! ATC-15
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 24
//
ID   C6/36-HE8
AC   CVCL_B3N5
DR   DGRC; 336
DR   Wikidata; Q110432664
RX   PubMed=34819517;
CC   Group: Insect cell line.
CC   Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase.
CC   Doubling time: ~24 hours (DGRC=336).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z230 ! C6/36
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   C6/36-HT
AC   CVCL_VH42
SY   C6/36 HT
DR   Wikidata; Q54808221
RX   PubMed=10970418;
RX   PubMed=18571214;
CC   Group: Insect cell line.
CC   Characteristics: Capable of growing at 34-35 Celsius.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z230 ! C6/36
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   C6/ACNU
AC   CVCL_4V35
SY   C 6/ACNU
DR   Wikidata; Q54808222
RX   PubMed=3468959;
RX   PubMed=3479534;
CC   Selected for resistance to: ChEBI; CHEBI_75270; Nimustine (ACNU).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   C6/Cas9-hyg
AC   CVCL_C9FG
DR   GeneCopoeia; SL534
DR   Wikidata; Q123030842
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL534).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   C6/CH
AC   CVCL_8839
DR   CLO; CLO_0002141
DR   CLDB; cl586
DR   ECACC; 94031010
DR   Wikidata; Q54808223
CC   Discontinued: ECACC; 94031010; true.
CC   Breed/subspecies: AKR.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 7
//
ID   C6/lacZ
AC   CVCL_5657
SY   C6/LacZ
DR   CLO; CLO_0002142
DR   ATCC; CRL-2199
DR   Wikidata; Q54808224
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   C6/lacZ7
AC   CVCL_5658
SY   C6/LacZ7
DR   CLO; CLO_0002143
DR   ATCC; CRL-2303
DR   Wikidata; Q54808225
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5657 ! C6/lacZ
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   C611B
AC   CVCL_E899
DR   Wikidata; Q54808226
RX   PubMed=10590229;
CC   Doubling time: ~24 hours (PubMed=10590229).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   C651.6DbHN
AC   CVCL_WI15
SY   bhN6D
DR   DSHB; C651-6DbHN
DR   Wikidata; Q93440584
RX   PubMed=7604005;
RX   PubMed=9244302;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04721; Human NOTCH2 (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   C65B5
AC   CVCL_C3XV
SY   C6-5B5
DR   Wikidata; Q116048638
RX   PubMed=3125254;
RX   PubMed=3701062;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_51211; Alprenolol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   C666
AC   CVCL_M597
SY   C-666; cell-666; NPC-C666
DR   EFO; EFO_0022626
DR   cancercelllines; CVCL_M597
DR   Cosmic; 1322949
DR   GEO; GSM850538
DR   GEO; GSM850539
DR   GEO; GSM850587
DR   GEO; GSM850588
DR   Progenetix; CVCL_M597
DR   TOKU-E; 3579
DR   Wikidata; Q54808228
RX   PubMed=9494607;
CC   Population: Chinese.
CC   Characteristics: Established from the athymic nude mouse xenograft xeno-666.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 15
//
ID   C666-1
AC   CVCL_7949
SY   c666-1; C6661
DR   BTO; BTO_0004805
DR   Cell_Model_Passport; SIDM01988
DR   ChEMBL-Cells; CHEMBL4482988
DR   ChEMBL-Targets; CHEMBL4483231
DR   Cosmic; 1017617
DR   Cosmic; 1301000
DR   PubChem_Cell_line; CVCL_7949
DR   Wikidata; Q54808229
RX   PubMed=10449618;
RX   PubMed=12645650;
RX   PubMed=18196576;
RX   PubMed=23915735;
RX   PubMed=24991015;
RX   PubMed=25787276;
RX   PubMed=26116706;
RX   PubMed=30405107;
CC   Population: Chinese.
CC   Virology: Contains a complete EBV genome (strain C666-1) which has been sequenced (PubMed=23915735; PubMed=25787276).
CC   Doubling time: 3.5 days (PubMed=10449618).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=18196576; PubMed=26116706; PubMed=30405107
ST   Amelogenin: X,Y
ST   CSF1PO: 11,15 (PubMed=26116706)
ST   CSF1PO: 11,15,16 (PubMed=18196576; PubMed=30405107)
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 16 (PubMed=18196576; PubMed=30405107)
ST   D18S51: 16,17 (PubMed=26116706)
ST   D19S433: 13,15.2
ST   D21S11: 28,29,30.2,31.2 (PubMed=18196576; PubMed=30405107)
ST   D21S11: 29,31.2 (PubMed=26116706)
ST   D2S1338: 16,23
ST   D3S1358: 16,17 (PubMed=18196576; PubMed=30405107)
ST   D3S1358: 17 (PubMed=26116706)
ST   D5S818: 11,12
ST   D7S820: 10,11,12 (PubMed=26116706)
ST   D7S820: 11,12 (PubMed=18196576; PubMed=30405107)
ST   D8S1179: 11,13,14,15 (PubMed=18196576; PubMed=30405107)
ST   D8S1179: 13,15 (PubMed=26116706)
ST   FGA: 21,24 (PubMed=26116706)
ST   FGA: 23,24 (PubMed=18196576; PubMed=30405107)
ST   Penta D: 9,10
ST   Penta E: 11,15
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M597 ! C666
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   C6ABR
AC   CVCL_RN94
SY   Control 6 Australia BRisbane
DR   Wikidata; Q54808230
RX   PubMed=1944384;
RX   PubMed=7433105;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   C6Mab-13
AC   CVCL_D2SW
DR   Wikidata; Q127380384
RX   PubMed=36383115;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O54689; Mouse Ccr6/Cd196.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C6Mab-19
AC   CVCL_D2VC
DR   Wikidata; Q127380385
RX   PubMed=37428612;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51684; Human CCR6/CD196.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C6PV
AC   CVCL_5933
SY   Control 6 PaVia
DR   CLO; CLO_0002145
DR   CLDB; cl587
DR   Wikidata; Q54808231
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85019; Porokeratosis
DI   ORDO; Orphanet_79358; Porokeratosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C6rho0
AC   CVCL_B7TS
DR   Wikidata; Q112929353
RX   PubMed=33576438;
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Obtained by growth of parental cell line with ethidium bromide and 2',3'dideoxycytidine.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   C6TK-
AC   CVCL_5H90
DR   Wikidata; Q54808232
RX   PubMed=4842353;
RX   PubMed=6165598;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   C7
AC   CVCL_C118
DR   CLO; CLO_0051562
DR   DSMZ; ACC-416
DR   DSMZCellDive; ACC-416
DR   RCB; RCB1449
DR   Wikidata; Q54808233
RX   PubMed=9464281;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Characteristics: Can be induced to differentiate into osteoclasts (PubMed=9464281).
CC   Doubling time: ~80-100 hours (DSMZ=ACC-416).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: 129/Sv-Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   C7 [Mouse hybridoma against human TNF]
AC   CVCL_E8Q1
SY   Clone 7
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   c7
AC   CVCL_A7WF
SY   mAb-c7
DR   BEI_Resources; MRA-663
DR   Wikidata; Q107113529
RX   PubMed=3315732;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium berghei 52 kDa phosphoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   C7-10
AC   CVCL_Z619
SY   C7/10; C710
DR   Wikidata; Q54808234
RX   PubMed=2267971;
RX   PubMed=3392770;
RX   PubMed=3951024;
RX   PubMed=10475266;
RX   PubMed=20303973;
RX   PubMed=23271364;
WW   Info; -; -; https://web.archive.org/web/20100703114100/http://research.biology.arizona.edu/mosquito/willott/proj/labpro/Cell/MosCell.html
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_4c091fefa9
CC   Group: Insect cell line.
CC   Virology: Supports replication of Sindbis virus (PubMed=3392770; PubMed=3951024).
CC   Doubling time: 15 hours (PubMed=23271364).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z618 ! LT C-7
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 11
//
ID   C7-10B
AC   CVCL_Z818
DR   Wikidata; Q54808237
RX   PubMed=21214605;
RX   PubMed=23113940;
CC   Group: Insect cell line.
CC   Characteristics: In vitro infected by the intracellular symbiont Wolbachia pipientis strain wAlbB.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z619 ! C7-10
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   C7-10R
AC   CVCL_Z819
DR   Wikidata; Q54808238
RX   PubMed=21214605;
RX   PubMed=23113940;
CC   Group: Insect cell line.
CC   Characteristics: In vitro infected by the intracellular symbiont Wolbachia pipientis strain wRi.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z619 ! C7-10
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   C70
AC   CVCL_5247
DR   cancercelllines; CVCL_5247
DR   CancerTools; 151757
DR   ColonAtlas; C70
DR   Cosmic; 948847
DR   Cosmic; 986007
DR   Cosmic; 995382
DR   Cosmic; 1043800
DR   Cosmic; 1312292
DR   Cosmic; 2301960
DR   Cosmic; 2760094
DR   Cosmic; 2800574
DR   ECACC; 12022903
DR   GEO; GSM1346830
DR   GEO; GSM1448200
DR   IARC_TP53; 21754
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54808239
DR   Ximbio; 151757
RX   PubMed=8464898;
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/C70.html
CC   HLA typing: A*28,30 (PubMed=8464898).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1309Ter (c.3925G>T); ClinVar=VCV000824390; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+2T>G (IVS8+2T>G); ClinVar=VCV000428877; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=16418264).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022903; true.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): ECACC=12022903; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D21S11: 29,31.2
ST   D5S818: 10
ST   D7S820: 9
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   C75
AC   CVCL_5248
DR   cancercelllines; CVCL_5248
DR   CancerTools; 151758
DR   Cell_Model_Passport; SIDM01533
DR   ColonAtlas; C75
DR   Cosmic; 986008
DR   Cosmic; 995387
DR   Cosmic; 1043801
DR   Cosmic; 1312293
DR   Cosmic; 2760095
DR   DepMap; ACH-001458
DR   ECACC; 12022907
DR   GEO; GSM1374422
DR   GEO; GSM1448201
DR   IARC_TP53; 21734
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54808240
DR   Ximbio; 151758
RX   PubMed=8464898;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=23272949;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   HLA typing: A*01,11 (PubMed=8464898).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=16418264; DepMap=ACH-001458).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 12022907; true.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): DepMap=ACH-001458; ECACC=12022907; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 8,11
ST   D18S51: 12,14
ST   D21S11: 27,31 (DepMap=ACH-001458)
ST   D21S11: 31 (PubMed=25926053)
ST   D3S1358: 15,16
ST   D5S818: 8,12 (DepMap=ACH-001458; PubMed=25926053)
ST   D5S818: 12 (ECACC=12022907)
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 23
ST   Penta D: 12,15
ST   Penta E: 12
ST   TH01: 8,9.3
ST   TPOX: 10
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   C7786
AC   CVCL_B3W2
DR   Wikidata; Q110432665
RX   PubMed=9295267;
CC   From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   C7787
AC   CVCL_B3W3
DR   Wikidata; Q110432667
RX   PubMed=9295267;
CC   From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C; ClinVar=VCV000002644; Zygosity=Heterozygous (PubMed=9295267).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   C7788
AC   CVCL_B3W4
DR   Wikidata; Q110432668
RX   PubMed=9295267;
CC   From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C; ClinVar=VCV000002644; Zygosity=Heterozygous (PubMed=9295267).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   C7789
AC   CVCL_B3W5
DR   Wikidata; Q110432669
RX   PubMed=9295267;
CC   From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   C7790
AC   CVCL_B3W6
DR   Wikidata; Q110432670
RX   PubMed=9295267;
CC   From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C; ClinVar=VCV000002644; Zygosity=Heterozygous (PubMed=9295267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   C7ABR
AC   CVCL_RN95
SY   Control 7 Australia BRisbane
DR   Wikidata; Q54808241
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C7G25
AC   CVCL_XC14
DR   Wikidata; Q93440659
RX   PubMed=16248536;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_7719; Ochratoxin A (OTA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   C7PV
AC   CVCL_5934
SY   Control 7 PaVia
DR   CLO; CLO_0002148
DR   CLDB; cl588
DR   Wikidata; Q54808242
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C8 [Human colon adenocarcinoma]
AC   CVCL_B4N3
DR   cancercelllines; CVCL_B4N3
DR   Cosmic; 986009
DR   Wikidata; Q110432671
RX   PubMed=9482574;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1307Lysfs*7 (c.3920_3921delTA); ClinVar=VCV001736195; Zygosity=Unspecified (PubMed=9482574).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   C8 [Human HEK293 derivative]
AC   CVCL_ZZ37
DR   Wikidata; Q102113654
RX   PubMed=12235169;
RX   PubMed=15456755;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1347098; Slc27a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   C8 [Mouse hybridoma against human TNF]
AC   CVCL_E8Q2
SY   Clone 8
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C8-B
AC   CVCL_B6F4
DR   Wikidata; Q111733054
RX   PubMed=11097476;
CC   Characteristics: Transduced with the retroviral vector SSR#69 (MoMLV/LTR-LoxP-HygroR-HSV/TK-IRES-SV40T-LoxP-Neo-MoMLV/LTR) expressing HygroR, HSV-1 TK and SV40 T-antigen flanked by two loxP sites (PubMed=11097476).
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype (PubMed=11097476).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   C8-B/Ras
AC   CVCL_B6F5
DR   Wikidata; Q111733055
RX   PubMed=11097476;
CC   Characteristics: Tumorigenic.
CC   Characteristics: Transduced with the retroviral vector SSR#69 (MoMLV/LTR-LoxP-HygroR-HSV/TK-IRES-SV40T-LoxP-Neo-MoMLV/LTR) expressing HygroR, HSV-1 TK and SV40 T-antigen flanked by two loxP sites (from parent cell line).
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B6F4 ! C8-B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   C8-B4
AC   CVCL_6378
SY   C8B4
DR   CLO; CLO_0002154
DR   ATCC; CRL-2540
DR   Wikidata; Q54808243
RX   PubMed=8873987;
RX   PubMed=21961028;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/c8b4/c8b4cells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   C8-D1A
AC   CVCL_6379
SY   C8D1A; Astrocyte type I clone
DR   CLO; CLO_0002155
DR   ATCC; CRL-2541
DR   CCRID; 4201MOU-CCTCC00177
DR   CCTCC; GDC0177
DR   CLS; 300316
DR   PRIDE; PXD000501
DR   PRIDE; PXD001597
DR   Wikidata; Q54808244
RX   PubMed=6466977;
RX   PubMed=24753479;
RX   PubMed=26227174;
RX   PubMed=32561641;
CC   Characteristics: Susceptible to infection by mouse scrapie prion (PrPSc) strains 22L and RML (PubMed=32561641).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Astrocyte of cerebellum; CL=CL_0002603.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   C8-D30
AC   CVCL_6380
SY   C8D30; Astrocyte type III clone
DR   CLO; CLO_0002156
DR   ATCC; CRL-2534
DR   Wikidata; Q54808245
RX   PubMed=6466977;
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Astrocyte of cerebellum; CL=CL_0002603.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   C8-IV
AC   CVCL_B6EE
DR   Wikidata; Q111733056
RX   PubMed=22358532;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVE).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   C8-MEF
AC   CVCL_Z847
SY   C8 MEF; C8
DR   BTO; BTO_0005560
DR   Wikidata; Q54808246
RX   PubMed=8134344;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   C8-S
AC   CVCL_6381
SY   C8S; Astrocyte type II clone
DR   CLO; CLO_0002158
DR   ATCC; CRL-2535
DR   Wikidata; Q54808247
RX   PubMed=6466977;
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Astrocyte of cerebellum; CL=CL_0002603.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C80
AC   CVCL_5249
DR   cancercelllines; CVCL_5249
DR   CancerTools; 151759
DR   Cell_Model_Passport; SIDM01549
DR   ColonAtlas; C80
DR   Cosmic; 948830
DR   Cosmic; 986010
DR   Cosmic; 995390
DR   Cosmic; 1043802
DR   Cosmic; 1223132
DR   Cosmic; 1312294
DR   Cosmic; 1479604
DR   Cosmic; 2301961
DR   Cosmic; 2760096
DR   DepMap; ACH-001459
DR   ECACC; 12022904
DR   GEO; GSM1346863
DR   GEO; GSM1374423
DR   GEO; GSM1448202
DR   GEO; GSM3145607
DR   GEO; GSM3145696
DR   IARC_TP53; 21747
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54808248
DR   Ximbio; 151759
RX   PubMed=8464898;
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   HLA typing: A*03 (PubMed=8464898).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu629Ter (c.1886T>G); ClinVar=VCV000429049; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Val (c.437C>T); ClinVar=VCV000375962; Zygosity=Unspecified (PubMed=20570890; DepMap=ACH-001459).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln52Ter (c.154C>T); ClinVar=VCV001455400; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022904; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): DepMap=ACH-001459; ECACC=12022904; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 18
ST   D21S11: 28,29
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 12,16
ST   Penta E: 18
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   C8054
AC   CVCL_4Z02
DR   Wikidata; Q54808249
RX   PubMed=6572555;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   C8130
AC   CVCL_4Z03
DR   Wikidata; Q54808250
RX   PubMed=6572555;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 7
//
ID   C8146A
AC   CVCL_4Z04
SY   C81-46A
DR   Wikidata; Q54808251
RX   PubMed=2731157;
RX   PubMed=3667379;
RX   PubMed=3698005;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z05 ! C8146C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 9
//
ID   C8146C
AC   CVCL_4Z05
SY   C8146c; C81-46C
DR   Wikidata; Q54808252
RX   PubMed=2731157;
RX   PubMed=3079741;
RX   PubMed=3348949;
RX   PubMed=3667379;
RX   PubMed=3698005;
RX   PubMed=6572555;
RX   PubMed=6581509;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z04 ! C8146A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 9
//
ID   C8157
AC   CVCL_4Z06
DR   Wikidata; Q54808253
RX   PubMed=3864528;
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   C8161
AC   CVCL_6813
SY   C81-61; C-8161
DR   BTO; BTO_0002016
DR   cancercelllines; CVCL_6813
DR   Cosmic; 905862
DR   Cosmic; 1238116
DR   Cosmic; 1247859
DR   Cosmic; 1247864
DR   Cosmic; 1247865
DR   Cosmic; 1303034
DR   GEO; GSM952602
DR   Lonza; 899
DR   Progenetix; CVCL_6813
DR   Wikidata; Q54808254
RX   PubMed=1671030;
RX   PubMed=3079741;
RX   PubMed=3348949;
RX   PubMed=3667379;
RX   PubMed=3698005;
RX   PubMed=3864528;
RX   PubMed=15299072;
RX   PubMed=19767774;
CC   Doubling time: 5.8 +- 1.9 days (PubMed=1671030).
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   C8161-GFP
AC   CVCL_WS19
SY   C8161 GFP
DR   Wikidata; Q93440734
RX   PubMed=19767774;
RX   PubMed=21673604;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6813 ! C8161
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   C8161-PEDF
AC   CVCL_WS20
SY   C8161 PEDF
DR   Wikidata; Q93440737
RX   PubMed=19767774;
RX   PubMed=21673604;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8824; SERPINF1.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6813 ! C8161
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   C8161.9
AC   CVCL_0196
SY   C8161 cl.9; C8161cl.9; C8161 subclone 9
DR   BTO; BTO_0005751
DR   EFO; EFO_0022433
DR   MCCL; MCC:0000087
DR   Wikidata; Q54808255
RX   PubMed=8302587;
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6813 ! C8161
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   C8161.9KFM
AC   CVCL_6814
SY   C8161.9(KFM); C8161.9 KFM; C8161.9-KFM
DR   Wikidata; Q54808256
RX   PubMed=17312308;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6341; KISS1.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0196 ! C8161.9
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   C8166
AC   CVCL_1099
SY   C8166-CD4
DR   CLO; CLO_0002149
DR   CLDB; cl589
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10989599
DR   cancercelllines; CVCL_1099
DR   Cell_Model_Passport; SIDM00072
DR   ChEMBL-Cells; CHEMBL3307638
DR   ChEMBL-Targets; CHEMBL614533
DR   Cosmic; 906829
DR   DepMap; ACH-000206
DR   ECACC; 88051601
DR   EGA; EGAS00001000978
DR   GEO; GSM827337
DR   GEO; GSM1669640
DR   IARC_TP53; 21206
DR   KCB; KCB 94019YJ
DR   LINCS_LDP; LCL-1011
DR   PharmacoDB; C8166_157_2019
DR   Progenetix; CVCL_1099
DR   PubChem_Cell_line; CVCL_1099
DR   Wikidata; Q54808257
RX   PubMed=6412453;
RX   PubMed=12920029;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Provider; NIBSC; 0013; https://nibsc.org/Default.aspx?pageid=597&id=0013&theme=default
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000206).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.3%; Native American=0.05%; East Asian, North=1.72%; East Asian, South=0%; South Asian=0%; European, North=64.43%; European, South=33.5% (PubMed=30894373).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   C8166/45
AC   CVCL_0195
SY   C81-66/45; C8166-45; C63/CRII-2
DR   MCCL; MCC:0000086
DR   BEI_Resources; ARP-404
DR   Wikidata; Q54808258
RX   PubMed=6412453;
RX   PubMed=28357668;
RX   PubMed=32938764;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=28357668; PubMed=32938764
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (PubMed=32938764)
ST   CSF1PO: 10,11 (PubMed=28357668)
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D21S11: 27,30
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 11,14
ST   FGA: 21,22
ST   Penta D: 11,15
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1099 ! C8166
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   C8166/CCR5
AC   CVCL_A6UT
DR   Wikidata; Q107113531
RX   PubMed=11112502;
RX   PubMed=18577234;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1099 ! C8166
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   C82/TK
AC   CVCL_1H24
SY   C82/Tk
DR   Wikidata; Q54808259
RX   PubMed=6604273;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   C821
AC   CVCL_C6MA
SY   C 821
DR   Wikidata; Q116048639
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   C822
AC   CVCL_4Z07
DR   Wikidata; Q54808260
RX   PubMed=3864528;
RX   PubMed=6572555;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   C822A
AC   CVCL_C6MB
SY   C 822 A
DR   Wikidata; Q116048640
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6MC ! C822B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   C822B
AC   CVCL_C6MC
SY   C 822 B
DR   Wikidata; Q116048641
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6MB ! C822A
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   C827A
AC   CVCL_4Z08
SY   C82-7A; C82-7A1
DR   Wikidata; Q54808261
RX   PubMed=3079741;
RX   PubMed=3667379;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 4
//
ID   C831EBV-B
AC   CVCL_TZ84
SY   C831 EBV-B
DR   Wikidata; Q54808262
RX   PubMed=17725806;
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8662 ! C831L
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 6
//
ID   C831L
AC   CVCL_8662
DR   CLO; CLO_0050058
DR   BioSample; SAMN03471930
DR   RCB; RCB2819
DR   Wikidata; Q54808263
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=38639832;
CC   Population: Korean.
CC   HLA typing: A*02:06,26:01; B*07:02,35:01; C*07:02,08:01 (PubMed=12114371).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Gln22Ter (c.64C>T); Zygosity=Unspecified (PubMed=17725806).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2819
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ84 ! C831EBV-B
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   C832C
AC   CVCL_4Z09
SY   C83-2CY; C83-2C
DR   Wikidata; Q54808264
RX   PubMed=2731157;
RX   PubMed=3079741;
RX   PubMed=3667379;
RX   PubMed=3864528;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   C84
AC   CVCL_5250
DR   cancercelllines; CVCL_5250
DR   CancerTools; 151760
DR   Cell_Model_Passport; SIDM01548
DR   ColonAtlas; C84
DR   Cosmic; 948841
DR   Cosmic; 986011
DR   Cosmic; 995388
DR   Cosmic; 1043803
DR   Cosmic; 1223133
DR   Cosmic; 1312295
DR   Cosmic; 1479568
DR   Cosmic; 2301962
DR   Cosmic; 2760065
DR   Cosmic; 2800572
DR   DepMap; ACH-001460
DR   ECACC; 12022902
DR   GEO; GSM1346864
DR   GEO; GSM1374424
DR   GEO; GSM1448203
DR   IARC_TP53; 21748
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54808265
DR   Ximbio; 151760
RX   PubMed=8197130;
RX   PubMed=8464898;
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   HLA typing: A*02,03 (PubMed=8464898).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg283Ter (c.847C>T); ClinVar=VCV000184999; Zygosity=Unspecified (PubMed=24755471; DepMap=ACH-001460).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg640Trp (c.1918C>T); ClinVar=VCV000428132; Zygosity=Unspecified (PubMed=24755471; DepMap=ACH-001460).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=24755471; DepMap=ACH-001460).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Asp54Asn (c.160G>A); ClinVar=VCV001479725; Zygosity=Heterozygous (PubMed=8197130; DepMap=ACH-001460).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471; DepMap=ACH-001460).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=16418264; PubMed=24755471; DepMap=ACH-001460).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022902; true.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): DepMap=ACH-001460; ECACC=12022902; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13 (DepMap=ACH-001460)
ST   D16S539: 13 (ECACC=12022902; PubMed=25926053)
ST   D18S51: 17
ST   D21S11: 33.2
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 14
ST   Penta E: 7,8
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   C8442
AC   CVCL_4Z10
DR   Wikidata; Q54808266
RX   PubMed=3667379;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 4
//
ID   C8861
AC   CVCL_1G34
SY   C5.iPSC; C5; C8861_iPSC
DR   GEO; GSM1495397
DR   GEO; GSM1502699
DR   GEO; GSM1712816
DR   GEO; GSM1712817
DR   GEO; GSM1712818
DR   Wikidata; Q54808267
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_V946 ! S008861
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   C8ABR
AC   CVCL_RN96
SY   Control 8 Australia BRisbane
DR   Wikidata; Q54808268
RX   PubMed=1944384;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   C8C37
AC   CVCL_YM08
DR   CCRID; 4201PAT-CCTCC01307
DR   Wikidata; Q93440836
RX   Patent=CN110305844B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018204.
CC   Derived from site: In situ; Spinal cord; UBERON=UBERON_0002240.
OX   NCBI_TaxID=217509; ! Carassius carassius (Crucian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   C8H3-2
AC   CVCL_A0TQ
DR   Wikidata; Q108819977
RX   Patent=WO2020103691A1;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03971; Human AMH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   C8ID
AC   CVCL_B7P0
SY   C8
DR   Wikidata; Q112929354
RX   PubMed=1472476;
RX   PubMed=1719236;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   C8Mab-1
AC   CVCL_D2RT
DR   Wikidata; Q127380386
RX   PubMed=35483056;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56484; Mouse Ccr8/Cd198.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C8Mab-2
AC   CVCL_D2RU
DR   Wikidata; Q127380387
RX   PubMed=33900818;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P56484; Mouse Ccr8/Cd198.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C8Mab-3
AC   CVCL_D2SB
DR   Wikidata; Q127380388
RX   PubMed=35377236;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P56484; Mouse Ccr8/Cd198.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C8PA
AC   CVCL_9787
DR   BTO; BTO_0003451
DR   Wikidata; Q54808269
RX   PubMed=15456755;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1890505; Plin1.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1347098; Slc27a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZZ37 ! C8 [Human HEK293 derivative]
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   C8PV
AC   CVCL_5935
SY   Control 8 PaVia
DR   CLO; CLO_0002157
DR   CLDB; cl594
DR   Wikidata; Q54808270
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   C9 [Bovine fetal brain]
AC   CVCL_F711
DR   Wikidata; Q54808271
RX   PubMed=17049468;
CC   Doubling time: ~24 hours (PubMed=17049468).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_F710 ! C11.2
SX   Sex unspecified
AG   12FW
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   C9 [Mouse hybridoma against human TNF]
AC   CVCL_E8Q3
SY   Clone 9
RX   PubMed=31305212;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   C9-1B
AC   CVCL_ZJ40
DR   Wikidata; Q98125603
RX   PubMed=33837088;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous; Note=Has 185, 540 or 770 repeats due to instability of the expanded allele during iPSC reprogramming (PubMed=33837088).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   C9-2B
AC   CVCL_ZJ41
DR   Wikidata; Q98125604
RX   PubMed=33837088;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous; Note=Has 770 repeats (PubMed=33837088).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   C9-3B
AC   CVCL_ZJ42
DR   Wikidata; Q98125605
RX   PubMed=33837088;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous; Note=Has 215 repeats (PubMed=33837088).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   C9-4B
AC   CVCL_ZJ43
DR   Wikidata; Q98125606
RX   PubMed=33837088;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=33837088).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   C9-MEF
AC   CVCL_Z848
SY   C9
DR   BTO; BTO_0005561
DR   Wikidata; Q54808272
RX   PubMed=8134344;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   C91/PL
AC   CVCL_0197
AS   CVCL_8342
SY   C91-PL; C91PL
DR   CLO; CLO_0002160
DR   MCCL; MCC:0000088
DR   CLDB; cl596
DR   Wikidata; Q54808273
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6600519;
RX   PubMed=6604130;
RX   PubMed=6604273;
RX   PubMed=11021758;
RX   PubMed=11737246;
RX   PubMed=28357668;
WW   Provider; NIBSC; 0018; https://nibsc.org/Default.aspx?pageid=597&id=0018&theme=default
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Misspelling: C19PL; PubMed=11737246.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=28357668
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D21S11: 29,31.2
ST   D3S1358: 15,19
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   Penta D: 10,13
ST   Penta E: 16,20
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   C918
AC   CVCL_8471
DR   cancercelllines; CVCL_8471
DR   CancerTools; 160513
DR   CLS; 305109
DR   Cosmic; 1320367
DR   Cosmic; 1669120
DR   Wikidata; Q54808274
RX   PubMed=8683940;
RX   PubMed=10952317;
RX   PubMed=18689700;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=22383533).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000216). It was one of the sources for the STR profile of this entry.
ST   Source(s): CCRID; PubMed=18689700
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8472 ! M619
OI   CVCL_3447 ! MuM-2B
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   C93AB
AC   CVCL_E2WL
RX   DOI=10.1007/BF00039691;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Plant embryo; PO=PO_0009009.
OX   NCBI_TaxID=88032; ! Taxus canadensis (Canadian yew)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C93AD
AC   CVCL_E2WM
RX   DOI=10.1007/BF00039691;
RX   PubMed=16586507;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Plant embryo; PO=PO_0009009.
OX   NCBI_TaxID=88032; ! Taxus canadensis (Canadian yew)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   C99
AC   CVCL_8176
DR   cancercelllines; CVCL_8176
DR   CancerTools; 151761
DR   Cell_Model_Passport; SIDM01547
DR   ColonAtlas; C99
DR   Cosmic; 948840
DR   Cosmic; 986012
DR   Cosmic; 995381
DR   Cosmic; 1043804
DR   Cosmic; 1312296
DR   Cosmic; 2301963
DR   Cosmic; 2800566
DR   DepMap; ACH-001461
DR   ECACC; 12022905
DR   GEO; GSM1346865
DR   GEO; GSM1374425
DR   GEO; GSM1448204
DR   GEO; GSM3145608
DR   GEO; GSM3145697
DR   IARC_TP53; 21765
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54808275
DR   Ximbio; 151761
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022905; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): DepMap=ACH-001461; ECACC=12022905; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 11,13
ST   D18S51: 12
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 27
ST   Penta D: 13
ST   Penta E: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   C9F2-2
AC   CVCL_A0TM
DR   CCRID; 4201PAT-CCTCC01294
DR   Wikidata; Q108819978
RX   Patent=WO2020103691A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018183.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03971; Human AMH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   C9Mab-1
AC   CVCL_D2SE
DR   Wikidata; Q127380389
RX   PubMed=34161159;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51686; Human CCR9/CD199.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C9Mab-11
AC   CVCL_D2SG
DR   Wikidata; Q127380390
RX   PubMed=36383113;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P51686; Human CCR9/CD199.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C9Mab-24
AC   CVCL_D2SY
DR   Wikidata; Q127380391
RX   PubMed=36516144;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9WUT7; Mouse CCr9/Cd199.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   C9PV
AC   CVCL_5936
SY   Control 9 PaVia
DR   CLO; CLO_0002164
DR   CLDB; cl601
DR   Wikidata; Q54808276
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Ca
AC   CVCL_Z839
DR   FlyBase_Cell_line; FBtc9000030
DR   Wikidata; Q54808279
RX   PubMed=99294;
RX   PubMed=811480;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z861 ! Line C
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   CA
AC   CVCL_E319
DR   IARC_TP53; 21040
DR   TKG; TKG 0692
DR   Wikidata; Q54808280
RX   PubMed=14751132;
RX   PubMed=35692560;
CC   Population: Japanese.
CC   Doubling time: 14.3 hours (PubMed=14751132).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): TKG=TKG 0692
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 11,15
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 17
//
ID   CA #12
AC   CVCL_1E40
SY   CA 12; CA-12
DR   Wikidata; Q54808281
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=3518877;
CC   Doubling time: 17 hours (Note=At 18th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   Ca 18/3
AC   CVCL_RP29
SY   CA 18/3; Ca18/3
DR   Wikidata; Q54808282
RX   PubMed=11439348;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Ca 286
AC   CVCL_RP30
DR   Wikidata; Q54808283
RX   PubMed=11439348;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Ca 298
AC   CVCL_RP31
DR   Wikidata; Q54808284
RX   PubMed=11439348;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Ca 300
AC   CVCL_RP32
SY   CA 300
DR   Wikidata; Q54808285
RX   PubMed=11439348;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Ca 301
AC   CVCL_RP33
SY   CA 301
DR   Wikidata; Q54808286
RX   PubMed=11439348;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Ca Ski
AC   CVCL_1100
SY   Ca-Ski; CaSki; Caski; CASKI
DR   BTO; BTO_0003109
DR   CLO; CLO_0002165
DR   CLO; CLO_0002201
DR   CLO; CLO_0050930
DR   EFO; EFO_0006549
DR   CLDB; cl603
DR   CLDB; cl604
DR   CLDB; cl605
DR   CLDB; cl4940
DR   AddexBio; C0008004/375
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1550
DR   ATCC; CRL-7915
DR   ATCC; CRM-CRL-1550
DR   BCRC; 60251
DR   BioSample; SAMN01821540
DR   BioSample; SAMN01821672
DR   BioSample; SAMN01821725
DR   BioSample; SAMN03473214
DR   cancercelllines; CVCL_1100
DR   CCRID; 1101HUM-PUMC000101
DR   CCRID; 1102HUM-NIFDC00093
DR   CCRID; 3101HUMTCHu137
DR   CCRID; 4201HUM-CCTCC00111
DR   CCTCC; GDC0111
DR   Cell_Model_Passport; SIDM00923
DR   ChEMBL-Cells; CHEMBL3308097
DR   ChEMBL-Targets; CHEMBL1075403
DR   CLS; 300145
DR   Cosmic; 687507
DR   Cosmic; 760221
DR   Cosmic; 809232
DR   Cosmic; 846182
DR   Cosmic; 877469
DR   Cosmic; 906824
DR   Cosmic; 925357
DR   Cosmic; 928904
DR   Cosmic; 1019307
DR   Cosmic; 1131519
DR   Cosmic; 1193033
DR   Cosmic; 1201775
DR   Cosmic; 1324211
DR   Cosmic; 1995364
DR   Cosmic; 2060797
DR   Cosmic; 2301538
DR   Cosmic; 2646655
DR   Cosmic; 2660195
DR   Cosmic; 2668297
DR   Cosmic; 2791017
DR   Cosmic; 2816212
DR   Cosmic-CLP; 906824
DR   DepMap; ACH-001336
DR   ECACC; 87020501
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10431-106D8
DR   GDSC; 906824
DR   GEO; GSM29720
DR   GEO; GSM113861
DR   GEO; GSM226732
DR   GEO; GSM226867
DR   GEO; GSM253297
DR   GEO; GSM675733
DR   GEO; GSM685445
DR   GEO; GSM722572
DR   GEO; GSM722573
DR   GEO; GSM723053
DR   GEO; GSM723054
DR   GEO; GSM827309
DR   GEO; GSM1669667
DR   IARC_TP53; 21261
DR   IBRC; C10345
DR   ICLC; HTL98018
DR   IGRhCellID; CaSki%20GEO
DR   IZSLER; BS TCL 201
DR   JCRB; IFO50007
DR   KCB; KCB 2013034YJ
DR   KCLB; 21550
DR   LINCS_HMS; 50006
DR   LINCS_LDP; LCL-1541
DR   Lonza; 1669
DR   PharmacoDB; CaSki_158_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1100
DR   PubChem_Cell_line; CVCL_1100
DR   RCB; RCB1947
DR   TKG; TKG 0366
DR   Wikidata; Q54808287
RX   CelloPub=CLPUB00481;
RX   PubMed=867042;
RX   PubMed=2990217;
RX   PubMed=3029430;
RX   PubMed=3371749;
RX   PubMed=7751322;
RX   PubMed=9887230;
RX   PubMed=10423141;
RX   PubMed=15531914;
RX   PubMed=17311676;
RX   PubMed=17611311;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21439369;
RX   PubMed=22412903;
RX   PubMed=24134916;
RX   PubMed=24201445;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-21.html
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Virology: Contains from 100 to 800 copies of the HPV16 genome; some complete and others truncated.
CC   Doubling time: 3.2 days (PubMed=29156801).
CC   HLA typing: A*02:01,03:01; B*07:02,37:01; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln4079Ter (c.12235C>T); Zygosity=Heterozygous (Cosmic-CLP=906824; DepMap=ACH-001336).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=906824; DepMap=ACH-001336).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.02%; Native American=0%; East Asian, North=1.86%; East Asian, South=0%; South Asian=0%; European, North=68.36%; European, South=28.76% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7915; true.
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
ST   Source(s): AddexBio=C0008004/375; ATCC=CRL-1550; CCRID; CLS=300145; Cosmic-CLP=906824; DepMap=ACH-001336; ECACC=87020501; JCRB=IFO50007; KCLB=21550; PubMed=25877200; PubMed=29156801; RCB=RCB1947; TKG=TKG 0366
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 15,16
ST   D21S11: 30
ST   D2S1338: 21
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 15
ST   FGA: 21
ST   Penta D: 10
ST   Penta E: 5
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Ca Vel
AC   CVCL_U770
DR   ATCC; CRL-1331
DR   Wikidata; Q54808288
CC   Discontinued: ATCC; CRL-1331; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C67383; Epidermolysis bullosa
DI   ORDO; Orphanet_79361; Inherited epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   CA-2E
AC   CVCL_8840
SY   CA-2-E
DR   Wikidata; Q54808289
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2529221;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CA-77
AC   CVCL_8177
SY   CA77
DR   BTO; BTO_0002890
DR   ATCC; CRL-3234
DR   Wikidata; Q54808290
RX   PubMed=1761166;
RX   PubMed=6311819;
RX   PubMed=7736432;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-155.html
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Parafollicular cell; CL=CL_0000570.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C60369; Rat C-cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   CA-7T2
AC   CVCL_4768
SY   CA7T2CL
DR   Wikidata; Q54808291
RX   PubMed=10980119;
RX   PubMed=15643173;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153509/http://capcelllines.ca:80/details.asp?id=89
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   CA-CD437R
AC   CVCL_4Y66
DR   Wikidata; Q54808292
RX   PubMed=12237293;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88334; AHPN (6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid; CD437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0201 ! Caov-3
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   CA-HPV-10
AC   CVCL_3495
SY   Ca-HPV-10; CA-HPV10; CaHPV10; HPV10
DR   BTO; BTO_0003464
DR   CLO; CLO_0002174
DR   EFO; EFO_0002147
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2220
DR   BCRC; 60135
DR   BioSample; SAMN03472568
DR   cancercelllines; CVCL_3495
DR   Cosmic; 1071479
DR   GEO; GSM648817
DR   IGRhCellID; CaHPV10
DR   Progenetix; CVCL_3495
DR   Wikidata; Q54808293
RX   PubMed=7923200;
RX   PubMed=11135431;
RX   PubMed=12725112;
RX   PubMed=20215515;
RX   PubMed=21544329;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153453/http://capcelllines.ca:80/details.asp?id=83
CC   Population: Caucasian.
CC   Doubling time: 38.44 hours (JWGray panel).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2220
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 13
ST   D21S11: 28,31
ST   D2S1338: 16,19
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 8,16
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Ca1
AC   CVCL_A5TQ
SY   CA1
DR   Wikidata; Q107113532
RX   PubMed=17944752;
RX   PubMed=20426848;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CA1
AC   CVCL_B0E5
DR   Wikidata; Q108819979
RX   Patent=US6099839;
RX   PubMed=11878767;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11311.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 2C7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CA12
AC   CVCL_F0J1
RX   PubMed=2606940;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q4GYY6; Trypanosoma brucei brucei tubulin beta-chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CA130.1.4C3.1H4
AC   CVCL_B7CR
SY   LUCA1
DR   Wikidata; Q112929355
RX   Patent=US9574007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4217.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 4
//
ID   CA130.14H2.1A5
AC   CVCL_RQ31
DR   ATCC; PTA-5068
DR   Wikidata; Q54808294
RX   Patent=US7847070;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5068.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: N-linked carbohydrate epitope (LUCA2) found on a variety of human cells and proteins.
CC   Misspelling: CA130.1.4H2.1A5; ATCC=PTA-5068.
CC   Discontinued: ATCC; PTA-5068; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 6
//
ID   CA1L33e1
AC   CVCL_F0A8
SY   CA1L clone 33e1
RX   PubMed=33121367;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01592; Human immunoglobulin J chain (Note=Also reacts with Macaca malatta).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CA1LL23h8
AC   CVCL_F0A9
SY   CA1LL clone 23h8
RX   PubMed=33121367;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01592; Human immunoglobulin J chain (Note=Also reacts with Macaca malatta).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CA2
AC   CVCL_E5RM
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ca2-83
AC   CVCL_WS76
DR   Wikidata; Q93440991
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2410103;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   CA3-F4
AC   CVCL_K133
DR   CLO; CLO_0002167
DR   ATCC; CRL-1667
DR   Wikidata; Q54808295
RX   PubMed=6833281;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   CA3/7
AC   CVCL_JW73
SY   Ca3/7
DR   Wikidata; Q54808296
RX   PubMed=2463079;
RX   PubMed=19575421;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 5
//
ID   CA4
AC   CVCL_F1EA
DR   ABCD; ABCD_BF053
RX   PubMed=8063404;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_143719; Haemophilus influenzae type B capsular polysaccharide.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JK05 ! GLI-H7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CA46
AC   CVCL_1101
SY   CA-46; CA 46
DR   BTO; BTO_0000789
DR   CLO; CLO_0002168
DR   EFO; EFO_0002124
DR   CLDB; cl608
DR   CLDB; cl609
DR   CLDB; cl610
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1648
DR   BCRC; 60511
DR   BioSample; SAMN03473116
DR   BioSample; SAMN10987878
DR   cancercelllines; CVCL_1101
DR   CCRID; 1101HUM-PUMC000366
DR   CCRID; 4201HUM-CCTCC00098
DR   CCTCC; GDC0098
DR   Cell_Model_Passport; SIDM00907
DR   ChEMBL-Cells; CHEMBL3308488
DR   ChEMBL-Targets; CHEMBL612566
DR   CLS; 305082
DR   Cosmic; 687837
DR   Cosmic; 850210
DR   Cosmic; 910703
DR   Cosmic; 931101
DR   Cosmic; 1086325
DR   Cosmic; 1818340
DR   Cosmic; 2297029
DR   Cosmic; 2808223
DR   Cosmic; 2814536
DR   Cosmic-CLP; 910703
DR   DepMap; ACH-000440
DR   DSMZ; ACC-73
DR   DSMZCellDive; ACC-73
DR   ECACC; 95010509
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910703
DR   GEO; GSM119505
DR   GEO; GSM886900
DR   GEO; GSM887965
DR   GEO; GSM1177977
DR   GEO; GSM1177978
DR   GEO; GSM1669641
DR   IARC_TP53; 7395
DR   ICLC; HTL97007
DR   IGRhCellID; CA46
DR   IZSLER; BS TCL 159
DR   LiGeA; CCLE_534
DR   LINCS_LDP; LCL-2017
DR   Lonza; 439
DR   NCBI_Iran; C106
DR   PharmacoDB; CA46_159_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1101
DR   PubChem_Cell_line; CVCL_1101
DR   Wikidata; Q54808297
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=3026973;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=3921823;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=6286763;
RX   PubMed=7757991;
RX   PubMed=8176200;
RX   PubMed=8220424;
RX   PubMed=8316623;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8558920;
RX   PubMed=8568269;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9563901;
RX   PubMed=9643977;
RX   PubMed=9787181;
RX   PubMed=9973220;
RX   PubMed=10567774;
RX   PubMed=11587216;
RX   PubMed=12145705;
RX   PubMed=16960149;
RX   PubMed=17254797;
RX   PubMed=19220422;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Characteristics: Produces IgM kappa (ATCC=CRL-1648).
CC   Virology: EBV-negative.
CC   Doubling time: 21 hours (PubMed=8402660); ~16 hours (ATCC=CRL-1648); ~35 hours (DSMZ=ACC-73).
CC   HLA typing: A*26:03,26:03; B*27:04,27:04; C*12:02,12:02; DQA1*01:03,01:03; DQB1*06:01,06:01; DRB1*08:03,08:03 (PubMed=25960936).
CC   HLA typing: A*02:01,24:02; B*27:04,27:04; C*12:02,12:02; DQA1*01:03,01:03; DQB1*05:03,06:01; DRB1*08:03,08:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=3921823; PubMed=9643977; PubMed=11587216).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=8344493; PubMed=8402660; PubMed=19220422; Cosmic-CLP=910703; DepMap=ACH-000440).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=33.18%; Native American=0.85%; East Asian, North=7.55%; East Asian, South=35.68%; South Asian=0%; European, North=9.41%; European, South=13.32% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1648; CCRID; Cosmic-CLP=910703; DSMZ=ACC-73; PubMed=17254797; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11 (PubMed=17254797)
ST   CSF1PO: 10,12 (ATCC=CRL-1648; CCRID; Cosmic-CLP=910703; DSMZ=ACC-73; PubMed=25877200)
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 15.2 (ATCC=CRL-1648; CCRID)
ST   D19S433: 16 (DSMZ=ACC-73)
ST   D21S11: 27,28 (PubMed=17254797)
ST   D21S11: 28,29 (ATCC=CRL-1648; CCRID; DSMZ=ACC-73; PubMed=25877200)
ST   D2S1338: 20,22
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 15 (ATCC=CRL-1648; CCRID; DSMZ=ACC-73; PubMed=25877200)
ST   D8S1179: 16 (PubMed=17254797)
ST   FGA: 19,23
ST   Penta D: 12,13
ST   Penta E: 5,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   CA4AF5
AC   CVCL_B0KK
SY   CA4-AF5
DR   ATCC; HB-10439
DR   Wikidata; Q108819980
RX   Patent=US5248594;
RX   PubMed=1890189;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10439.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZXP3; Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) groEL (Note=Also reacts with many other Legionella species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   CA5
AC   CVCL_E3ZI
SY   CA5.5
RX   PubMed=9004048;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q61738; Mouse Itga7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CA5171
AC   CVCL_4U23
DR   cancercelllines; CVCL_4U23
DR   Wikidata; Q54808298
RX   PubMed=25394645;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~24 hours (PubMed=25394645).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=25394645).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr27Cys (c.80A>G); ClinVar=VCV000404160; Zygosity=Unspecified (PubMed=25394645).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Unspecified (PubMed=25394645).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   Ca759
AC   CVCL_8841
DR   CCRID; 1101MOU-PUMC000301
DR   Wikidata; Q54808299
CC   Breed/subspecies: 615.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   Ca761
AC   CVCL_8842
DR   CCRID; 1101MOU-PUMC000302
DR   Wikidata; Q54808300
CC   Breed/subspecies: 615.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   Ca761-03
AC   CVCL_L289
DR   Wikidata; Q54808301
RX   DOI=10.3969/j.issn.1000-8179.2006.20.010;
CC   Breed/subspecies: 615.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8842 ! Ca761
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   Ca761-86
AC   CVCL_5U29
SY   Ca 761-86
DR   Wikidata; Q54808302
RX   PubMed=3250824;
CC   Breed/subspecies: 615.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8842 ! Ca761
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   Ca761-P93
AC   CVCL_5U30
DR   Wikidata; Q54808303
RX   CelloPub=CLPUB00280;
CC   Breed/subspecies: 615.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U29 ! Ca761-86
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   Ca763
AC   CVCL_8843
DR   CCRID; 1101MOU-PUMC000303
DR   Wikidata; Q54808304
CC   Breed/subspecies: 615.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   Ca9-22
AC   CVCL_1102
SY   CA9-22; Ca 9-22; CA922; Ca922
DR   BTO; BTO_0005204
DR   CLO; CLO_0051380
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 840
DR   BioSample; SAMN01821673
DR   cancercelllines; CVCL_1102
DR   Cell_Model_Passport; SIDM00489
DR   CGH-DB; 355-2
DR   ChEMBL-Cells; CHEMBL3308714
DR   ChEMBL-Targets; CHEMBL1075404
DR   Cosmic; 753538
DR   Cosmic; 930339
DR   Cosmic; 932155
DR   Cosmic; 1042302
DR   Cosmic; 1046026
DR   Cosmic; 1118791
DR   Cosmic; 1120700
DR   Cosmic; 1123036
DR   Cosmic; 1140783
DR   Cosmic; 1219867
DR   Cosmic; 1317411
DR   Cosmic; 2266786
DR   Cosmic; 2546832
DR   Cosmic-CLP; 753538
DR   DepMap; ACH-002043
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10434-106E2
DR   GDSC; 753538
DR   GEO; GSM301576
DR   GEO; GSM827235
DR   GEO; GSM850380
DR   GEO; GSM1669642
DR   IARC_TP53; 1095
DR   JCRB; JCRB0625
DR   LINCS_HMS; 50007
DR   LINCS_LDP; LCL-2033
DR   PharmacoDB; Ca922_160_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1102
DR   PubChem_Cell_line; CVCL_1102
DR   RCB; RCB1976
DR   TKG; TKG 0485
DR   Wikidata; Q54808305
RX   DOI=10.5794/jjoms.23.619;
RX   PubMed=275414;
RX   PubMed=1570156;
RX   PubMed=2228902;
RX   PubMed=4549822;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9247707;
RX   PubMed=9290701;
RX   PubMed=10069537;
RX   PubMed=10741724;
RX   PubMed=12738951;
RX   PubMed=15800904;
RX   PubMed=17052259;
RX   PubMed=17325662;
RX   PubMed=17599052;
RX   PubMed=18097548;
RX   PubMed=18973137;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks of Ca9-22 are contaminated with MSK-922 (PubMed=21868764).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00437.
CC   Population: Japanese.
CC   HLA typing: A*02:07,24:02; B*35,46:01; C*01:02,14:02 (PubMed=9023415).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=1570156; PubMed=10741724; Cosmic-CLP=753538; DepMap=ACH-002043).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.96%; Native American=0%; East Asian, North=79.73%; East Asian, South=18.82%; South Asian=0%; European, North=0%; European, South=0.49% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): Cosmic-CLP=753538; JCRB=JCRB0625; RCB=RCB1976; TKG=TKG 0485
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   Ca9-22PF
AC   CVCL_HM42
SY   Ca 9-22 PF; Ca9-22 Protein Free
DR   cancercelllines; CVCL_HM42
DR   Wikidata; Q54808306
RX   PubMed=2228902;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1102 ! Ca9-22
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   Ca9-22SF
AC   CVCL_HM41
SY   Ca9-22 SF; Ca 9-22 SF; Ca9-22 Serum Free
DR   cancercelllines; CVCL_HM41
DR   Wikidata; Q54808307
RX   DOI=10.5794/jjoms.31.264;
RX   DOI=10.5794/jjoms.31.273;
RX   PubMed=2228902;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 18 hours (DOI=10.5794/jjoms.31.264).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1102 ! Ca9-22
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   CAB
AC   CVCL_B7JY
SY   Cromileptes Altivelis Brain
DR   Wikidata; Q112929356
RX   PubMed=34448109;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 26 Celsius (PubMed=34448109).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=304459; ! Cromileptes altivelis (Humpback grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   CAB 117-12D10
AC   CVCL_K160
SY   12D10
DR   CLO; CLO_0002171
DR   ATCC; HB-10558
DR   Wikidata; Q54808308
RX   Patent=US5506134;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10558.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08709; Human F7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CAB-80
AC   CVCL_B5DI
SY   Carassius Auratus Blastula-80
DR   Wikidata; Q110432672
RX   CelloPub=CLPUB00673;
RX   CelloPub=CLPUB00676;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 22 to 28 Celsius (CelloPub=CLPUB00673).
CC   Doubling time: 21-45 hours (CelloPub=CLPUB00673).
CC   Karyotypic information: Heteroploid karyotype (CelloPub=CLPUB00673).
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Blastula stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CaB34
AC   CVCL_E9XT
DR   GEO; GSE277693
RX   DOI=10.3390/cells14110819;
CC   Population: Caribbean.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): DOI=10.3390/cells14110819
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 10,12
ST   D5S818: 8,12
ST   D7S820: 8,10
ST   TH01: 5,7
ST   TPOX: 6,11
ST   vWA: 16,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CaB34-CF
AC   CVCL_E9XU
DR   GEO; GSE277693
RX   DOI=10.3390/cells14110819;
CC   Population: Caribbean.
CC   Characteristics: Shows significant radioresistance compared with the parent cell line. Established from parent cell line following exposure to fractionated radiotherapy mimicking a clinical schedule (total of f 78 Gy) (DOI=10.3390/cells14110819).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E9XT ! CaB34
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CABA I
AC   CVCL_4769
DR   BTO; BTO_0004406
DR   Wikidata; Q54808309
RX   CelloPub=CLPUB00451;
RX   PubMed=9220498;
RX   PubMed=11953869;
RX   PubMed=26934856;
CC   Problematic cell line: Authors of PubMed=26934856 have only been able to detect 3 out of 16 STR loci. Either there was a problem with the STR detection or this cell line is contaminated by non-human DNA (CelloPub=CLPUB00451).
CC   Doubling time: ~18 hours (PubMed=9220498).
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma. The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26934856
ST   Amelogenin: X
ST   D7S820: 10
ST   FGA: 28
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   CaBa002
AC   CVCL_VZ78
DR   IBRC; C10065
DR   Wikidata; Q93441114
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa01
AC   CVCL_VZ79
DR   IBRC; C10048
DR   Wikidata; Q93441116
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa02
AC   CVCL_VZ80
DR   IBRC; C10060
DR   Wikidata; Q93441118
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa03
AC   CVCL_VZ81
DR   IBRC; C10063
DR   Wikidata; Q93441121
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa04
AC   CVCL_VZ82
DR   IBRC; C10062
DR   Wikidata; Q93441123
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa05
AC   CVCL_VZ83
DR   IBRC; C10064
DR   Wikidata; Q93441126
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa06
AC   CVCL_VZ84
DR   IBRC; C10277
DR   Wikidata; Q93441128
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa07
AC   CVCL_VZ85
DR   IBRC; C10278
DR   Wikidata; Q93441130
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa08
AC   CVCL_VZ86
DR   IBRC; C10279
DR   Wikidata; Q93441134
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa09
AC   CVCL_VZ87
DR   IBRC; C10280
DR   Wikidata; Q93441136
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa10
AC   CVCL_VZ88
DR   IBRC; C10281
DR   Wikidata; Q93441139
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa11
AC   CVCL_VZ89
DR   IBRC; C10282
DR   Wikidata; Q93441141
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa12
AC   CVCL_VZ90
DR   IBRC; C10283
DR   Wikidata; Q93441145
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa13
AC   CVCL_VZ91
DR   IBRC; C10284
DR   Wikidata; Q93441147
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa17
AC   CVCL_VZ92
DR   IBRC; C10288
DR   Wikidata; Q93441149
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa23
AC   CVCL_VZ93
DR   IBRC; C10297
DR   Wikidata; Q93441152
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa24
AC   CVCL_VZ94
DR   IBRC; C10298
DR   Wikidata; Q93441154
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa25
AC   CVCL_VZ95
DR   IBRC; C10317
DR   Wikidata; Q93441157
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa26
AC   CVCL_VZ96
DR   IBRC; C10318
DR   Wikidata; Q93441159
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa27
AC   CVCL_VZ97
DR   IBRC; C10319
DR   Wikidata; Q93441162
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa28
AC   CVCL_VZ98
DR   IBRC; C10320
DR   Wikidata; Q93441164
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa29
AC   CVCL_VZ99
DR   IBRC; C10326
DR   Wikidata; Q93441166
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa30
AC   CVCL_WA00
DR   IBRC; C10327
DR   Wikidata; Q93441170
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa31
AC   CVCL_WA01
DR   IBRC; C10328
DR   Wikidata; Q93441172
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa32
AC   CVCL_WA02
DR   IBRC; C10329
DR   Wikidata; Q93441175
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa33
AC   CVCL_WA03
DR   IBRC; C10330
DR   Wikidata; Q93441178
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa34
AC   CVCL_WA04
DR   IBRC; C10331
DR   Wikidata; Q93441181
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa35
AC   CVCL_WA05
DR   IBRC; C10332
DR   Wikidata; Q93441183
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa36
AC   CVCL_WA06
DR   IBRC; C10333
DR   Wikidata; Q93441185
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa37
AC   CVCL_WA07
DR   IBRC; C10334
DR   Wikidata; Q93441188
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa38
AC   CVCL_WA08
DR   IBRC; C10335
DR   Wikidata; Q93441190
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa39
AC   CVCL_WA09
DR   IBRC; C10336
DR   Wikidata; Q93441193
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa40
AC   CVCL_WA10
DR   IBRC; C10337
DR   Wikidata; Q93441196
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa41
AC   CVCL_WA11
DR   IBRC; C10338
DR   Wikidata; Q93441198
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa42
AC   CVCL_WA12
DR   IBRC; C10339
DR   Wikidata; Q93441200
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa43
AC   CVCL_WA13
DR   IBRC; C10340
DR   Wikidata; Q93441202
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa44
AC   CVCL_WA14
DR   IBRC; C10341
DR   Wikidata; Q93441203
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa45
AC   CVCL_WA15
DR   IBRC; C10342
DR   Wikidata; Q93441204
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa46
AC   CVCL_WA16
DR   IBRC; C10343
DR   Wikidata; Q93441206
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa47
AC   CVCL_WA17
DR   IBRC; C10344
DR   Wikidata; Q93441208
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa49
AC   CVCL_WA18
DR   IBRC; C10347
DR   Wikidata; Q93441210
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa50
AC   CVCL_WA19
DR   IBRC; C10348
DR   Wikidata; Q93441211
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa51
AC   CVCL_WA20
DR   IBRC; C10349
DR   Wikidata; Q93441213
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa52
AC   CVCL_WA21
DR   IBRC; C10350
DR   Wikidata; Q93441214
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa53
AC   CVCL_WA22
DR   IBRC; C10351
DR   Wikidata; Q93441215
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa54
AC   CVCL_WA23
DR   IBRC; C10352
DR   Wikidata; Q93441217
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa55
AC   CVCL_WA24
DR   IBRC; C10353
DR   Wikidata; Q93441218
RX   PubMed=29497968;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa56
AC   CVCL_WA25
DR   IBRC; C10399
DR   Wikidata; Q93441221
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa57
AC   CVCL_WA26
DR   IBRC; C10400
DR   Wikidata; Q93441222
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa58
AC   CVCL_WA27
DR   IBRC; C10401
DR   Wikidata; Q93441223
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa59
AC   CVCL_WA28
DR   IBRC; C10402
DR   Wikidata; Q93441225
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa60
AC   CVCL_WA29
DR   IBRC; C10403
DR   Wikidata; Q93441227
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa61
AC   CVCL_WA30
DR   IBRC; C10404
DR   Wikidata; Q93441230
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a camel named Ghare Boghor.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa62
AC   CVCL_WA31
DR   IBRC; C10405
DR   Wikidata; Q93441231
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a camel named Maryam.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa63
AC   CVCL_WA32
DR   IBRC; C10406
DR   Wikidata; Q93441233
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a camel named Sari Boghor.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa64
AC   CVCL_WA33
DR   IBRC; C10416
DR   Wikidata; Q93441234
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a camel named Maya Chai.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CaBa65
AC   CVCL_WA34
DR   IBRC; C10417
DR   Wikidata; Q93441236
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a camel named Elizabet.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9837; ! Camelus bactrianus (Bactrian camel)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CABi002-A
AC   CVCL_UJ72
SY   OF0176-EYS02-C7; EYS02-MiPS4F7
DR   BioSamples; SAMEA8268542
DR   hPSCreg; CABi002-A
DR   Wikidata; Q93441237
RX   PubMed=30471616;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+EYS02-MiPS4F7+Solicitud+de+dep%C3%B3sito-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/EYS02-MiPS4F7%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21555; EYS; Simple; p.Gly1190Aspfs*39 (c.3567delA); ClinVar=VCV001065732; Zygosity=Heterozygous (PubMed=30471616).
CC   Sequence variation: Mutation; HGNC; HGNC:21555; EYS; Simple; p.Ser1610Phefs*7 (c.4829_4832delCATT); ClinVar=VCV000289905; Zygosity=Heterozygous (PubMed=30471616).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 30.2,31.2
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 13,15
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   CABi003-A
AC   CVCL_WP93
SY   DH05; OF_163/DH05-C16; DH05-C16; AMDdh05-MiPS4F16
DR   BioSamples; SAMEA8172008
DR   hPSCreg; CABi003-A
DR   Wikidata; Q93441239
RX   PubMed=31176916;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+AMDdh05-MiPS4F16+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/AMDdh05-MiPS4F16%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Heterozygous (PubMed=31176916).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8
ST   D16S539: 12
ST   D21S11: 28,30
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   CAC-1 [Human cervical carcinoma]
AC   CVCL_JX14
SY   Cervical AdenoCarcinoma-1
DR   Cosmic; 877473
DR   Cosmic; 1152548
DR   Wikidata; Q54808310
RX   CelloPub=CLPUB00398;
RX   DOI=10.15114/smj.57.603;
RX   PubMed=8380785;
RX   PubMed=9500206;
CC   Population: Japanese.
CC   Doubling time: 31 hours (CelloPub=CLPUB00398; DOI=10.15114/smj.57.603).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   CAC-1 [Human endometrial adenocarcinoma]
AC   CVCL_A421
DR   Wikidata; Q54808311
RX   PubMed=11115359;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   CAC2
AC   CVCL_6883
SY   CAC-2; Carcinoma Adenoide Cistico 2
DR   BioSample; SAMN03152001
DR   Wikidata; Q54808312
RX   CelloPub=CLPUB00355;
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=19557180;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=19557180; PubMed=20143388). Originally thought to originate from salivary gland adenoid cystic carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00362.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   CaCL 73-36
AC   CVCL_T324
AS   CVCL_D033
SY   CaCL73-36; CM73-36; M-6; M6
DR   cancercelllines; CVCL_T324
DR   ESTDAB; ESTDAB-132
DR   GEO; GSM202137
DR   IGRhCellID; M6%20GEO
DR   Progenetix; CVCL_T324
DR   Wikidata; Q54808313
RX   PubMed=944091;
RX   PubMed=1010531;
RX   PubMed=1127734;
RX   PubMed=3558490;
RX   PubMed=3800326;
RX   PubMed=7262181;
RX   PubMed=9268730;
RX   PubMed=10851482;
CC   Doubling time: 34 hours (PubMed=1127734).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ESTDAB=ESTDAB-132
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   FGA: 23,23.2
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 14
//
ID   CaCL 74-36
AC   CVCL_T325
DR   Wikidata; Q54808315
RX   CelloPub=CLPUB00489;
RX   PubMed=1010531;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   CaCL 78-1
AC   CVCL_T326
DR   Wikidata; Q54808316
RX   PubMed=7262181;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 6
//
ID   CaCL 78-4
AC   CVCL_T327
DR   Cosmic; 1113275
DR   Wikidata; Q54808317
RX   PubMed=7262181;
RX   PubMed=17824790;
CC   Misspelling: CaCo 78-4; Cosmic=1113275; PubMed=17824790.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 8
//
ID   CaCL 79-3
AC   CVCL_T328
DR   Wikidata; Q54808318
RX   PubMed=7262181;
RX   PubMed=17824790;
CC   Misspelling: CaCo 79-3; PubMed=17824790.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 8
//
ID   Caco-2
AC   CVCL_0025
SY   CaCo-2; CACO-2; Caco 2; CACO 2; CACO2; CaCo2; CaCO2; Caco2; Caco-2/ATCC; Caco-II
DR   BTO; BTO_0000195
DR   CLO; CLO_0002172
DR   CLO; CLO_0050627
DR   EFO; EFO_0001099
DR   MCCL; MCC:0000120
DR   CLDB; cl614
DR   CLDB; cl615
DR   CLDB; cl616
DR   CLDB; cl617
DR   CLDB; cl618
DR   CLDB; cl619
DR   CLDB; cl621
DR   CLDB; cl5174
DR   Abcam; ab275464
DR   AddexBio; C0009009/29
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; HTB-37
DR   BCRJ; 0059
DR   BioSample; SAMN03473140
DR   BioSample; SAMN05292461
DR   BioSample; SAMN10989600
DR   cancercelllines; CVCL_0025
DR   CCRID; 1101HUM-PUMC000100
DR   CCRID; 1102HUM-NIFDC00087
DR   CCRID; 3101HUMSCSP5027
DR   CCRID; 3101HUMTCHu146
DR   CCRID; 4201HUM-CCTCC00153
DR   CCRID; 5301HUM-KCB07010YJ
DR   CCTCC; GDC0153
DR   Cell_Model_Passport; SIDM00891
DR   ChEMBL-Cells; CHEMBL3307519
DR   ChEMBL-Targets; CHEMBL614058
DR   CLS; 300137
DR   ColonAtlas; CACO2
DR   Cosmic; 720340
DR   Cosmic; 873696
DR   Cosmic; 875297
DR   Cosmic; 876709
DR   Cosmic; 887244
DR   Cosmic; 889531
DR   Cosmic; 948127
DR   Cosmic; 948829
DR   Cosmic; 983736
DR   Cosmic; 995392
DR   Cosmic; 1043805
DR   Cosmic; 1122320
DR   Cosmic; 1132564
DR   Cosmic; 1132694
DR   Cosmic; 1184081
DR   Cosmic; 1187299
DR   Cosmic; 1310931
DR   Cosmic; 1466811
DR   Cosmic; 1479620
DR   Cosmic; 1524334
DR   Cosmic; 1552180
DR   Cosmic; 1676742
DR   Cosmic; 1708415
DR   Cosmic; 1803940
DR   Cosmic; 1933015
DR   Cosmic; 2036652
DR   Cosmic; 2145574
DR   Cosmic; 2156940
DR   Cosmic; 2301543
DR   Cosmic; 2301964
DR   Cosmic; 2667879
DR   Cosmic; 2800568
DR   DepMap; ACH-000003
DR   DSMZ; ACC-169
DR   DSMZCellDive; ACC-169
DR   ECACC; 09042001
DR   ECACC; 86010202
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS311PHE
DR   ENCODE; ENCBS390JMI
DR   ENCODE; ENCBS391ENC
DR   ENCODE; ENCBS530YXL
DR   ENCODE; ENCBS700RKG
DR   ENCODE; ENCBS890JZY
DR   FANTOM5_SSTAR; 10513-107D9
DR   FCS-free; 192-2-378-1-3-3
DR   GEO; GSM206450
DR   GEO; GSM274711
DR   GEO; GSM274712
DR   GEO; GSM274725
DR   GEO; GSM383861
DR   GEO; GSM472900
DR   GEO; GSM472933
DR   GEO; GSM513908
DR   GEO; GSM514182
DR   GEO; GSM741244
DR   GEO; GSM749689
DR   GEO; GSM749691
DR   GEO; GSM749748
DR   GEO; GSM784006
DR   GEO; GSM843481
DR   GEO; GSM843482
DR   GEO; GSM845394
DR   GEO; GSM945162
DR   GEO; GSM945203
DR   GEO; GSM945206
DR   GEO; GSM945236
DR   GEO; GSM1006210
DR   GEO; GSM1006211
DR   GEO; GSM1006212
DR   GEO; GSM1346866
DR   GEO; GSM1374426
DR   GEO; GSM1448160
DR   GEO; GSM2549989
DR   GEO; GSM7701359
DR   GEO; GSM7701360
DR   IARC_TP53; 21749
DR   IBRC; C10094
DR   ICLC; HTL97023
DR   IZSLER; BS TCL 87
DR   KCB; KCB 200710YJ
DR   KCLB; 30037.1
DR   LINCS_LDP; LCL-1170
DR   Lonza; 36
DR   MeSH; D018938
DR   MetaboLights; MTBLS227
DR   MetaboLights; MTBLS328
DR   NCBI_Iran; C139
DR   PharmacoDB; Caco2_161_2019
DR   PRIDE; PXD001550
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD018357
DR   PRIDE; PXD019645
DR   PRIDE; PXD023760
DR   Progenetix; CVCL_0025
DR   PubChem_Cell_line; CVCL_0025
DR   RCB; RCB0988
DR   TOKU-E; 762
DR   Ubigene; YC-D003
DR   Wikidata; Q5016050
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2914637;
RX   PubMed=3349466;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=7764660;
RX   PubMed=8253353;
RX   PubMed=8508948;
RX   PubMed=9294210;
RX   PubMed=10092214;
RX   PubMed=10612807;
RX   PubMed=10737795;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=12584437;
RX   PubMed=14599474;
RX   PubMed=15316659;
RX   PubMed=15731278;
RX   PubMed=15868485;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=16957166;
RX   PubMed=18258742;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=20831567;
RX   PubMed=21607810;
RX   PubMed=23272949;
RX   PubMed=23932154;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25841592;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25960936;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=26869432;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=29101300;
RX   PubMed=29787057;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31981602;
RX   PubMed=33389257;
RX   PubMed=34339474;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-rate-of-atcc-htb-37
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-htb-37
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/caco-2/
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544480
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-37.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Caco-2
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659; PubMed=15731278).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257; PubMed=34339474).
CC   Doubling time: 51.41 hours (PubMed=25944804); 3-4 days (ATCC=HTB-37); ~60-70 hours (CLS=300137); ~80 hours (DSMZ=ACC-169); ~32 hours (PBCF).
CC   HLA typing: A*02:01,02:01; B*15:05,56/39; C*04:01,04:01 (PubMed=25960936).
CC   HLA typing: A*02:01,02:01; B*15:01,15:01; C*04:01,04:01 (PubMed=26589293).
CC   HLA typing: A*02:01:01; B*15:01:01; C*04:01:01; DPB1*04:01:01; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:04:01 (CLS=300137).
CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (PubMed=24755471; DepMap=ACH-000003).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (PubMed=9294210).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (PubMed=24755471; DepMap=ACH-000003).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (PubMed=16418264; PubMed=24755471; PubMed=28683746; DepMap=ACH-000003).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.33%; Native American=0%; East Asian, North=4.59%; East Asian, South=0%; South Asian=0%; European, North=47.35%; European, South=44.73% (PubMed=30894373).
CC   Discontinued: Abcam; ab275464; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009009/29; ATCC=HTB-37; CCRID; CLS=300137; DSMZ=ACC-169; ECACC=09042001; ECACC=86010202; PubMed=11416159; PubMed=25877200; PubMed=25926053; RCB=RCB0988
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,15
ST   D12S391: 17,23
ST   D13S317: 11,13,14
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 15
ST   D1S1656: 15,16
ST   D21S11: 30 (DSMZ=ACC-169; PubMed=11416159; PubMed=25877200)
ST   D21S11: 30,32 (ATCC=HTB-37; CCRID; CLS=300137; PubMed=25926053)
ST   D22S1045: 15,16
ST   D2S1338: 17,25
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 11,12 (ATCC=HTB-37; CCRID; CLS=300137; DSMZ=ACC-169; ECACC=09042001; ECACC=86010202; PubMed=25877200; PubMed=25926053; RCB=RCB0988)
ST   D7S820: 12 (AddexBio=C0009009/29)
ST   D8S1179: 12 (DSMZ=ACC-169; PubMed=11416159)
ST   D8S1179: 12,14 (ATCC=HTB-37; CCRID; CLS=300137; PubMed=25877200)
ST   FGA: 19
ST   Penta D: 9 (DSMZ=ACC-169)
ST   Penta D: 9,11 (ATCC=HTB-37; PubMed=25877200)
ST   Penta E: 7
ST   SE33: 21
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 52
//
ID   Caco-2 Cu Pro-R
AC   CVCL_YP11
SY   Cu Pro-R Caco-2; Cu Pro-R
DR   cancercelllines; CVCL_YP11
DR   Wikidata; Q93441262
RX   PubMed=31981602;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_29036; Copper(2+).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   Caco-2 CuSO4-R
AC   CVCL_YP12
SY   CuSO4-R Caco-2; CuSO4-R
DR   cancercelllines; CVCL_YP12
DR   Wikidata; Q93441263
RX   PubMed=31981602;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_23414; Copper(II) sulfate.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   Caco-2 DUSP6 KO
AC   CVCL_C0R8
SY   DUSP6 KO Caco-2
DR   cancercelllines; CVCL_C0R8
DR   PRIDE; PXD029014
DR   Wikidata; Q112929357
RX   PubMed=27892926;
RX   PubMed=34818535;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3072; DUSP6.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Caco-2 EJ6
AC   CVCL_C8A0
DR   Wikidata; Q123030843
RX   PubMed=8508948;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   Caco-2 UNC45A KO
AC   CVCL_D0R6
SY   UNC45AKO Caco-2
DR   Wikidata; Q123030844
RX   PubMed=35575086;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30594; UNC45A.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Caco-2-ACE2
AC   CVCL_C9AR
DR   BioGRID_ORCS_Cell_line; 1691
DR   Wikidata; Q123030845
RX   PubMed=35879413;
CC   Group: SARS-CoV-2 research cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13557; ACE2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   Caco-2-Luc
AC   CVCL_C8Y3
DR   Ubigene; YC-D003-Luc-P
DR   Wikidata; Q123030846
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Caco-2-RCAr clone 2
AC   CVCL_HA82
DR   cancercelllines; CVCL_HA82
DR   Wikidata; Q54808319
RX   PubMed=10393089;
CC   Population: Caucasian.
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   Caco-2-SF
AC   CVCL_B6E1
SY   Caco-2-Serum Free
DR   cancercelllines; CVCL_B6E1
DR   Wikidata; Q111733058
RX   PubMed=7764660;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   Caco-2/15
AC   CVCL_0232
SY   Caco2/15
DR   BTO; BTO_0005279
DR   MCCL; MCC:0000121
DR   cancercelllines; CVCL_0232
DR   Wikidata; Q54808322
RX   PubMed=1764023;
RX   PubMed=9827699;
RX   PubMed=14599474;
RX   PubMed=15868485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   Caco-2/3
AC   CVCL_Z578
DR   cancercelllines; CVCL_Z578
DR   Wikidata; Q54808323
RX   PubMed=1764023;
RX   PubMed=15868485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   Caco-2/AQ
AC   CVCL_Z585
SY   Caco2/AQ
DR   BTO; BTO_0005666
DR   cancercelllines; CVCL_Z585
DR   Wikidata; Q54808324
RX   PubMed=9486194;
RX   PubMed=14599474;
RX   PubMed=15868485;
RX   PubMed=18205904;
RX   PubMed=22940288;
RX   PubMed=24176760;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0232 ! Caco-2/15
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   Caco-2/PD-10
AC   CVCL_Z579
SY   Caco-2/PD10; Caco2/PD10; PD-10; PD10
DR   cancercelllines; CVCL_Z579
DR   Wikidata; Q54808325
RX   PubMed=8175910;
RX   PubMed=15868485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   Caco-2/PD-7
AC   CVCL_Z580
SY   Caco-2/PD7; Caco2/PD7; PD-7; PD7
DR   cancercelllines; CVCL_Z580
DR   Wikidata; Q54808326
RX   DOI=10.1016/0378-5173(94)00280-I;
RX   PubMed=8175910;
RX   PubMed=15868485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   Caco-2/PF-11
AC   CVCL_Z581
SY   Caco-2/PF11; Caco2/PF11; PF-11; PF11
DR   cancercelllines; CVCL_Z581
DR   Wikidata; Q54808327
RX   DOI=10.1016/0378-5173(94)00280-I;
RX   PubMed=8175910;
RX   PubMed=15868485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   Caco-2/TC-7
AC   CVCL_0233
SY   Caco-2/TC7; Caco2/TC7; TC-7; TC7
DR   BTO; BTO_0002571
DR   EFO; EFO_0002817
DR   MCCL; MCC:0000122
DR   cancercelllines; CVCL_0233
DR   ChEMBL-Cells; CHEMBL4483155
DR   ChEMBL-Targets; CHEMBL4483233
DR   ColonAtlas; TC7
DR   Lonza; 1105
DR   Millipore; SCC209
DR   PubChem_Cell_line; CVCL_0233
DR   Wikidata; Q54808328
RX   DOI=10.1016/0378-5173(94)00280-I;
RX   PubMed=8175910;
RX   PubMed=14599474;
RX   PubMed=15868485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Millipore=SCC209
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13,14
ST   D16S539: 12,13
ST   D18S51: 12
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   Caco-2(Cas9)
AC   CVCL_E7J1
WW   Provider; BRICS; ECC3016; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3950
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Caco-2H
AC   CVCL_C8JI
DR   Wikidata; Q123030847
RX   PubMed=8253353;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for Caco-2MT (Cellosaurus=CVCL_C8JJ) and Caco-2T (Cellosaurus=CVCL_C8JK).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   Caco-2MT
AC   CVCL_C8JJ
DR   Wikidata; Q123030848
RX   PubMed=8253353;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   Caco-2T
AC   CVCL_C8JK
DR   Wikidata; Q123030849
RX   PubMed=8253353;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   Caco-3
AC   CVCL_QW78
DR   Wikidata; Q54808329
RX   PubMed=3518877;
RX   PubMed=6220172;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   CACT108A
AC   CVCL_D3UA
DR   Wikidata; Q127380392
RX   PubMed=1634253;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P12342; Bovine IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CACT116A
AC   CVCL_D3UB
DR   Wikidata; Q127380393
RX   PubMed=1634253;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12342; Bovine IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CAD
AC   CVCL_0199
SY   Cath-A-Differentiated
DR   BTO; BTO_0003695
DR   MCCL; MCC:0000090
DR   ECACC; 08100805
DR   Wikidata; Q54808330
RX   PubMed=9006967;
CC   Characteristics: Will differentiate to form neuronal processes in serum free conditions.
CC   Characteristics: Seems to have lost the expression of the parental cell SV40 T antigen.
CC   Doubling time: 18-22 hours (PubMed=9006967).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: C57BL/6 x DBA/2 rTH promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0204 ! CATH.a
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   CAD,KR
AC   CVCL_E513
SY   CAD, KR
DR   dbMHC; 48528
DR   ECACC; 94092209
DR   IHW; IHW09110
DR   IPD-IMGT/HLA; 11655
DR   Wikidata; Q54808331
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02; B*07,41; C*07; DPB1*04:01,06:01; DQA1*03,01:02; DQB1*03:02,06:02; DRB1*04:05,15:01; DRB4*01:01; DRB5*01:01 (IPD-IMGT/HLA=11655).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   CaD2
AC   CVCL_5714
DR   CLS; 400138
DR   Wikidata; Q54808332
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   CADO-ES1
AC   CVCL_1103
SY   CADO-ES-1; Cado-ES-1; CADO ES1; CADOES1; CADO-ES; Cado-ES; ESCADO1; Center for Adult Diseases Osaka-Ewing Sarcoma 1
DR   CLO; CLO_0002173
DR   EFO; EFO_0002818
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-6067
DR   ArrayExpress; E-MTAB-6111
DR   BioGRID_ORCS_Cell_line; 164
DR   BioSample; SAMN03473333
DR   BioSample; SAMN10988559
DR   cancercelllines; CVCL_1103
DR   Cell_Model_Passport; SIDM00961
DR   CLS; 300127
DR   Cosmic; 753539
DR   Cosmic; 1718434
DR   Cosmic; 2294581
DR   Cosmic-CLP; 753539
DR   DepMap; ACH-000210
DR   DSMZ; ACC-255
DR   DSMZCellDive; ACC-255
DR   EGA; EGAS00001000978
DR   GDSC; 753539
DR   GEO; GSM510004
DR   GEO; GSM886901
DR   GEO; GSM887966
DR   GEO; GSM1669643
DR   IARC_TP53; 21207
DR   LiGeA; CCLE_114
DR   PharmacoDB; CADOES1_162_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1103
DR   Wikidata; Q54808333
RX   PubMed=1756482;
RX   PubMed=11668190;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=21822310;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=23637631;
RX   PubMed=25984343;
RX   PubMed=26428435;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29464090;
RX   PubMed=30563222;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=33460449;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=25984343); ~40 hours (CLS=300127); ~35 hours (DSMZ=ACC-255).
CC   HLA typing: A*11:01,24:02; B*15:01,40:01; C*04:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=26428435; PubMed=33460449).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.63%; Native American=0.72%; East Asian, North=75.38%; East Asian, South=21.78%; South Asian=0%; European, North=0%; European, South=0.48% (PubMed=30894373).
CC   Caution: Was incorrectly indicated to have an EWSR1-FLI1 (EWS-FLI1) gene fusion in PubMed=23637631.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300127; Cosmic-CLP=753539; DSMZ=ACC-255; PubMed=19787792; PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 9,11
ST   D18S51: 15,20
ST   D19S433: 13.2,15.2 (PubMed=19787792)
ST   D19S433: 14,16 (DSMZ=ACC-255)
ST   D21S11: 31,32.2
ST   D2S1338: 22,25
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 12,15 (CLS=300127; PubMed=19787792)
ST   D8S1179: 15 (DSMZ=ACC-255)
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 12,19
ST   SE33: 19,28.2
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   CADO-LC1
AC   CVCL_Z047
SY   CADO LC1; Center for Adult Diseases Osaka-Lung Carcinoma 1
DR   Wikidata; Q54808334
RX   PubMed=7690355;
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 29 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CADO-LC10
AC   CVCL_Z054
SY   CADO LC10; Center for Adult Diseases Osaka-Lung Carcinoma 10
DR   Wikidata; Q54808335
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC11
AC   CVCL_Z055
SY   CADO LC11; Center for Adult Diseases Osaka-Lung Carcinoma 11
DR   Wikidata; Q54808336
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC15
AC   CVCL_Z056
SY   CADO LC15; Center for Adult Diseases Osaka-Lung Carcinoma 15
DR   Wikidata; Q54808337
RX   PubMed=7690355;
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CADO-LC16
AC   CVCL_RQ33
SY   CADO LC16; Center for Adult Diseases Osaka-Lung Carcinoma 16
DR   Wikidata; Q54808338
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CADO-LC17
AC   CVCL_Z057
SY   CADO LC17; Center for Adult Diseases Osaka-Lung Carcinoma 17
DR   Wikidata; Q54808339
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Caution: Erroneously indicated in Table 1 of PubMed=7690355 as being a SCLC cell line.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   CADO-LC19
AC   CVCL_RQ34
SY   CADO LC19; Center for Adult Diseases Osaka-Lung Carcinoma 19
DR   Wikidata; Q54808340
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 101 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CADO-LC2
AC   CVCL_RQ35
SY   CADO LC2; Center for Adult Diseases Osaka-Lung Carcinoma 2
DR   Wikidata; Q54808341
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 53 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CADO-LC20
AC   CVCL_Z058
SY   CADO LC20; Center for Adult Diseases Osaka-Lung Carcinoma 20
DR   Wikidata; Q54808342
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC21
AC   CVCL_Z059
SY   CADO LC21; Center for Adult Diseases Osaka-Lung Carcinoma 21
DR   Wikidata; Q54808343
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC22
AC   CVCL_Z060
SY   CADO LC22; Center for Adult Diseases Osaka-Lung Carcinoma 22
DR   Wikidata; Q54808344
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CADO-LC24
AC   CVCL_Z061
SY   CADO LC24; Center for Adult Diseases Osaka-Lung Carcinoma 24
DR   Wikidata; Q54808345
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CADO-LC26
AC   CVCL_Z062
SY   CADO LC26; Center for Adult Diseases Osaka-Lung Carcinoma 26
DR   Wikidata; Q54808346
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC27
AC   CVCL_RQ36
SY   CADO LC27; Center for Adult Diseases Osaka-Lung Carcinoma 27
DR   Wikidata; Q54808347
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 199 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CADO-LC28
AC   CVCL_RQ37
SY   CADO LC28; Center for Adult Diseases Osaka-Lung Carcinoma 28
DR   Wikidata; Q54808348
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 94 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CADO-LC29
AC   CVCL_RQ38
SY   CADO LC29; Center for Adult Diseases Osaka-Lung Carcinoma 29
DR   Wikidata; Q54808349
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 73 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CADO-LC3
AC   CVCL_Z048
SY   CADO LC3; Center for Adult Diseases Osaka-Lung Carcinoma 3
DR   Wikidata; Q54808350
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   CADO-LC4
AC   CVCL_RQ39
SY   CADO LC4; Center for Adult Diseases Osaka-Lung Carcinoma 4
DR   Wikidata; Q54808351
RX   PubMed=7934063;
CC   Population: Japanese.
CC   Doubling time: 41 hours (PubMed=7934063).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CADO-LC41
AC   CVCL_Z063
SY   CADO LC41; Center for Adult Diseases Osaka-Lung Carcinoma 41
DR   Wikidata; Q54808352
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC5
AC   CVCL_Z049
SY   CADO LC5; Center for Adult Diseases Osaka-Lung Carcinoma 5
DR   Wikidata; Q54808353
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC6
AC   CVCL_Z050
SY   CADO LC6; Center for Adult Diseases Osaka-Lung Carcinoma 6
DR   Wikidata; Q54808354
RX   PubMed=7690355;
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   CADO-LC7
AC   CVCL_Z051
SY   CADO LC7; Center for Adult Diseases Osaka-Lung Carcinoma 7
DR   Wikidata; Q54808355
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CADO-LC8
AC   CVCL_Z052
SY   CADO LC8; Center for Adult Diseases Osaka-Lung Carcinoma 8
DR   Wikidata; Q54808356
RX   PubMed=7690355;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   CADO-LC9
AC   CVCL_Z053
SY   CADO LC9; Center for Adult Diseases Osaka-Lung Carcinoma 9
DR   Wikidata; Q54808357
RX   PubMed=7690355;
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CAE606
AC   CVCL_B7GW
DR   cancercelllines; CVCL_B7GW
DR   Wikidata; Q112929358
RX   PubMed=35349366;
CC   Doubling time: 25.8 hours (PubMed=35349366).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.329G>A); ClinVar=VCV000376304; Zygosity=Homozygous (PubMed=35349366).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu28Lysfs*16 (c.81delT); Zygosity=Homozygous (PubMed=35349366).
CC   Derived from site: In situ; Ear, auditory canal; UBERON=UBERON_0001352.
ST   Source(s): PubMed=35349366
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D18S51: 14
ST   D21S11: 30,33.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C202594; External auditory canal squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   CAEP [Carassius]
AC   CVCL_4670
SY   Carassius Auratus ErythroPhoroma
DR   CLO; CLO_0051591
DR   RCB; RCB0185
DR   Wikidata; Q54808358
RX   PubMed=6572741;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   CAEP [Human lung carcinoma]
AC   CVCL_WH08
DR   IARC_TP53; 13988
DR   Wikidata; Q93441396
RX   PubMed=9809028;
RX   PubMed=10574245;
RX   PubMed=10841287;
RX   PubMed=26919099;
CC   Doubling time: ~50 hours (PubMed=9809028).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Ter (c.625A>T); Zygosity=Unspecified (PubMed=10841287).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   CaES-17
AC   CVCL_UY83
SY   CaEs17; CAES17
DR   Wikidata; Q93441397
RX   CelloPub=CLPUB00471;
RX   PubMed=26116706;
RX   PubMed=27113178;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from an esophageal squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00604.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   CAF
AC   CVCL_R883
SY   Carassius Auratus Fin
DR   CLO; CLO_0051593
DR   RCB; RCB0186
DR   Wikidata; Q54808359
RX   CelloPub=CLPUB00025;
CC   Group: Fish cell line.
CC   Doubling time: 0.8 day (Note=At 33 Celsius), 1.2 days (Note=At 26 Celsius), 1.6 days (Note=At 20 Celsius) (CelloPub=CLPUB00025).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   Caf 10
AC   CVCL_1H12
SY   caf 10; Caf10; CAF10
DR   Wikidata; Q54808360
RX   Patent=US6358511;
RX   PubMed=11192295;
RX   PubMed=11752148;
CC   Doubling time: 3 days (Patent=US6358511).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Donor information: Established from a HIV-1 infected child with rapid disease progression.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   CaF-2
AC   CVCL_W100
SY   Ca F-2; Carp Fin-2
DR   Wikidata; Q54808361
RX   CelloPub=CLPUB00303;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
ID   CAF-Clan I
AC   CVCL_AV11
DR   Wikidata; Q54808365
RX   PubMed=19343458;
CC   Group: Insect cell line.
CC   Doubling time: 68.5 hours (Note=At 22th passage) (PubMed=19343458).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=499538; ! Clostera anachoreta (Scarce chocolate-tip moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 8
//
ID   CAF-Clan II
AC   CVCL_AV12
DR   Wikidata; Q54808366
RX   PubMed=19343458;
CC   Group: Insect cell line.
CC   Doubling time: 38.2 hours (Note=At 24th passage) (PubMed=19343458).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=499538; ! Clostera anachoreta (Scarce chocolate-tip moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 8
//
ID   CAF-MM1
AC   CVCL_R884
DR   Wikidata; Q54808367
RX   PubMed=6408467;
RX   PubMed=7063616;
CC   Group: Fish cell line.
CC   Doubling time: 18 hours (Note=At 33 Celsius), 31 hours (Note=At 26 Celsius), 60 hours (Note=At 20 Celsius) (PubMed=7063616).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
HI   CVCL_R883 ! CAF
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CAF-SA
AC   CVCL_VR41
SY   Carcinoma-Associated Fibroblast-Salivary gland Adenoid cystic carcinoma
DR   CCRID; 4201PAT-CCTCC01041
DR   Wikidata; Q93441426
RX   Patent=CN108795851B;
RX   PubMed=29734861;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201745.
CC   Population: Chinese.
ST   Source(s): PubMed=29734861
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 22,25
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 14,19
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D6S1043: 13,19
ST   D7S820: 11,12
ST   D8S1179: 14,15,16
ST   FGA: 22
ST   Penta D: 9,15
ST   Penta E: 10,13
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   CAF19-LA
AC   CVCL_D4YH
SY   CAF19; DT19
DR   Wikidata; Q127380394
RX   PubMed=24567196;
RX   PubMed=34216317;
CC   Characteristics: This is a cancer-associated fibroblast (CAF) from a tumor belonging to the luminal subtype A (ER-, PR- and ErbB2+) (PubMed=24567196).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CAF21-Her2
AC   CVCL_D4YI
SY   CAF21; CAF21-H2N; DT21
DR   Wikidata; Q127380395
RX   PubMed=24567196;
RX   PubMed=34216317;
CC   Characteristics: This is a cancer-associated fibroblast (CAF) from a tumor belonging to the ER-, PR- and ErbB2+ type (PubMed=24567196).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CAF23-TN
AC   CVCL_D4YJ
SY   CAF23; CAF23-BAS; DT23
DR   Wikidata; Q127380396
RX   PubMed=24567196;
RX   PubMed=34216317;
CC   Characteristics: This is a cancer-associated fibroblast (CAF) from a tumor belonging to the triple negative type (PubMed=24567196).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CAG
AC   CVCL_D569
DR   BTO; BTO_0005277
DR   Wikidata; Q54808368
RX   CelloPub=CLPUB00604;
RX   PubMed=11001907;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (CelloPub=CLPUB00604).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14
ST   D12S391: 18.3,22
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D1S1656: 12,14
ST   D21S11: 28,31.2
ST   D22S1045: 15
ST   D2S1338: 20
ST   D2S441: 9,13
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 19,24
ST   Penta D: 13
ST   Penta E: 7,15
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XD83 ! ARD
OI   CVCL_D523 ! ARP-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   CaHo-01
AC   CVCL_VV87
DR   IBRC; C10158
DR   Wikidata; Q93441431
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Kamyar.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-02
AC   CVCL_VV88
DR   IBRC; C10159
DR   Wikidata; Q93441432
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Sohah.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-03
AC   CVCL_VV89
DR   IBRC; C10160
DR   Wikidata; Q93441471
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Roger.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-04
AC   CVCL_VV90
DR   IBRC; C10161
DR   Wikidata; Q93441475
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Logan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-05
AC   CVCL_VV91
DR   IBRC; C10196
DR   Wikidata; Q93441478
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Aigol.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-06
AC   CVCL_VV92
DR   IBRC; C10197
DR   Wikidata; Q93441481
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Jangal.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-07
AC   CVCL_VV93
DR   IBRC; C10200
DR   Wikidata; Q93441484
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Shahram.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-08
AC   CVCL_VV94
DR   IBRC; C10201
DR   Wikidata; Q93441487
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Shahryar.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-09
AC   CVCL_VV95
DR   IBRC; C10202
DR   Wikidata; Q93441489
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Bahman.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-10
AC   CVCL_VV96
DR   IBRC; C10203
DR   Wikidata; Q93441492
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Gharaz.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-11
AC   CVCL_VV97
DR   IBRC; C10204
DR   Wikidata; Q93441494
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Atefe.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-12
AC   CVCL_VV98
DR   IBRC; C10205
DR   Wikidata; Q93441496
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Sabbagh.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-13
AC   CVCL_VV99
SY   CaHo13
DR   IBRC; C10206
DR   Wikidata; Q93441499
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Gharghavo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-14
AC   CVCL_VW00
SY   CaHo14
DR   IBRC; C10207
DR   Wikidata; Q93441501
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Vishgah.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-15
AC   CVCL_VW01
DR   IBRC; C10208
DR   Wikidata; Q93441503
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Nima.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-16
AC   CVCL_VW02
DR   IBRC; C10209
DR   Wikidata; Q93441506
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Farhad.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-17
AC   CVCL_VW03
DR   IBRC; C10210
DR   Wikidata; Q93441509
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Amer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-18
AC   CVCL_VW04
DR   IBRC; C10211
DR   Wikidata; Q93441511
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Vakil.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-19
AC   CVCL_VW05
DR   IBRC; C10212
DR   Wikidata; Q93441513
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Fozad.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-20
AC   CVCL_VW06
DR   IBRC; C10193
DR   Wikidata; Q93441516
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Limozin.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-21
AC   CVCL_VW07
DR   IBRC; C10214
DR   Wikidata; Q93441518
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Fariba.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-22
AC   CVCL_VW08
DR   IBRC; C10215
DR   Wikidata; Q93441521
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Nastaran.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-23
AC   CVCL_VW09
DR   IBRC; C10216
DR   Wikidata; Q93441525
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Forozan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-24
AC   CVCL_VW10
SY   CaHo24
DR   IBRC; C10217
DR   Wikidata; Q93441527
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Rezvan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-25
AC   CVCL_VW11
SY   CaHo25
DR   IBRC; C10218
DR   Wikidata; Q93441529
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Lalin.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-26
AC   CVCL_VW12
SY   CaHo26
DR   IBRC; C10219
DR   Wikidata; Q93441532
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Ghazale.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-28
AC   CVCL_VW13
SY   CaHo28
DR   IBRC; C10232
DR   Wikidata; Q93441534
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Loraz.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-29
AC   CVCL_VW14
SY   CaHo29
DR   IBRC; C10233
DR   Wikidata; Q93441536
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Simin.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-30
AC   CVCL_VW15
SY   CaHo30
DR   IBRC; C10234
DR   Wikidata; Q93441540
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Darya.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-31
AC   CVCL_VW16
SY   CaHo31
DR   IBRC; C10257
DR   Wikidata; Q93441542
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Shervin.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-32
AC   CVCL_VW17
SY   CaHo32
DR   IBRC; C10258
DR   Wikidata; Q93441545
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Hormoz.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-33
AC   CVCL_VW18
SY   CaHo33
DR   IBRC; C10259
DR   Wikidata; Q93441548
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Gharan Saboor.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-34
AC   CVCL_VW19
SY   CaHo34
DR   IBRC; C10260
DR   Wikidata; Q93441551
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Kiana.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-35
AC   CVCL_VW20
SY   CaHo35
DR   IBRC; C10261
DR   Wikidata; Q93441553
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Mehri.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-36
AC   CVCL_VW21
SY   CaHo36
DR   IBRC; C10262
DR   Wikidata; Q93441556
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Gharan Ghrob.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-37
AC   CVCL_VW22
SY   CaHo37
DR   IBRC; C10263
DR   Wikidata; Q93441559
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Nasrin.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-38
AC   CVCL_VW23
SY   CaHo38
DR   IBRC; C10264
DR   Wikidata; Q93441561
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Ghror.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-39
AC   CVCL_VW24
SY   CaHo39
DR   IBRC; C10273
DR   Wikidata; Q93441564
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Kokab.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-41
AC   CVCL_VW25
SY   CaHo41
DR   IBRC; C10275
DR   Wikidata; Q93441566
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Samaneh.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-42
AC   CVCL_VW26
SY   CaHo42
DR   IBRC; C10276
DR   Wikidata; Q93441568
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Ghotame.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-43
AC   CVCL_VW27
SY   CaHo43
DR   IBRC; C10294
DR   Wikidata; Q93441571
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Siyah banou.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-44
AC   CVCL_VW28
SY   CaHo44
DR   IBRC; C10295
DR   Wikidata; Q93441575
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Kati.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-45
AC   CVCL_VW29
SY   CaHo45
DR   IBRC; C10296
DR   Wikidata; Q93441577
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Atiyeh.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-47
AC   CVCL_VW30
SY   CaHo47
DR   IBRC; C10300
DR   Wikidata; Q93441580
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Sanam.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-48
AC   CVCL_VW31
SY   CaHo48
DR   IBRC; C10301
DR   Wikidata; Q93441582
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Ozra.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-49
AC   CVCL_VW32
SY   CaHo49
DR   IBRC; C10302
DR   Wikidata; Q93441584
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Barfi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-50
AC   CVCL_VW33
SY   CaHo50
DR   IBRC; C10303
DR   Wikidata; Q93441586
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Shabnam.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-51
AC   CVCL_VW34
SY   CaHo51
DR   IBRC; C10304
DR   Wikidata; Q93441589
RX   PubMed=28039621;
CC   Donor information: Established from a horse named Amitis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-52
AC   CVCL_VW35
SY   CaHo52
DR   IBRC; C10305
DR   Wikidata; Q93441591
CC   Donor information: Established from a horse named Ghezel.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-53
AC   CVCL_VW36
SY   CaHo53
DR   IBRC; C10306
DR   Wikidata; Q93441595
CC   Donor information: Established from a horse named Babak.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CaHo-55
AC   CVCL_VW37
SY   CaHo55
DR   IBRC; C10308
DR   Wikidata; Q93441598
CC   Donor information: Established from a horse named Irangol.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Caspian; VBO=VBO_0000930.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CAISMOV24
AC   CVCL_A5TC
DR   cancercelllines; CVCL_A5TC
DR   Wikidata; Q107113533
RX   PubMed=29132324;
CC   Population: Brazilian.
CC   Doubling time: 71.2 hours (PubMed=29132324).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=29132324).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=29132324
ST   CSF1PO: 12
ST   D10S1248: 19,21
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,19
ST   D19S433: 13,14
ST   D1S1656: 15.3,16
ST   D21S11: 30,32.2
ST   D22S1045: 16
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   F13B: 9,10
ST   FGA: 23,25
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CAK [Cromileptes]
AC   CVCL_B7IV
SY   Cromileptes Altivelis Kidney
DR   Wikidata; Q112929359
RX   PubMed=35391635;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 26 Celsius.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=304459; ! Cromileptes altivelis (Humpback grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   CAK [Mouse]
AC   CVCL_HE49
DR   Wikidata; Q54808369
RX   PubMed=4138999;
CC   Doubling time: ~18 hours (PubMed=4138999).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: AKR/J x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   CAK-A32-G11
AC   CVCL_HE50
DR   Wikidata; Q54808370
RX   PubMed=4138999;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: AKR/J x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE49 ! CAK [Mouse]
SX   Female
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   CAK-B3
AC   CVCL_HE51
SY   CAK-A32-G11-D9-B3
DR   Wikidata; Q54808371
RX   PubMed=6581543;
RX   PubMed=6940188;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: AKR/J x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE50 ! CAK-A32-G11
SX   Female
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   CAK-B3-Toyr13
AC   CVCL_HE52
DR   Wikidata; Q54808372
RX   PubMed=6581543;
RX   PubMed=6940188;
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: AKR/J x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE51 ! CAK-B3
SX   Female
AG   15FD
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   CAK-TK-
AC   CVCL_HE53
DR   Wikidata; Q54808373
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: AKR/J x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE49 ! CAK [Mouse]
SX   Female
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   Caki-1
AC   CVCL_0234
SY   CAKI-1; CaKi-1; caki-1; CAKI.1; CAKI 1; CAKI1; Caki1
DR   BTO; BTO_0003204
DR   CLO; CLO_0002175
DR   CLO; CLO_0002176
DR   EFO; EFO_0002149
DR   MCCL; MCC:0000123
DR   CLDB; cl623
DR   CLDB; cl5175
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-46
DR   BioGRID_ORCS_Cell_line; 582
DR   BioSample; SAMN01821541
DR   BioSample; SAMN01821674
DR   BioSample; SAMN03473223
DR   BioSample; SAMN10987640
DR   cancercelllines; CVCL_0234
DR   CancerTools; 161903
DR   CCRID; 1101HUM-PUMC000244
DR   CCRID; 3101HUMSCSP5064
DR   CCRID; 3101HUMTCHu135
DR   Cell_Model_Passport; SIDM00941
DR   ChEMBL-Cells; CHEMBL3307522
DR   ChEMBL-Targets; CHEMBL614067
DR   CLS; 300149
DR   Cosmic; 687940
DR   Cosmic; 801356
DR   Cosmic; 849379
DR   Cosmic; 874611
DR   Cosmic; 875871
DR   Cosmic; 897463
DR   Cosmic; 905963
DR   Cosmic; 974303
DR   Cosmic; 979705
DR   Cosmic; 1044261
DR   Cosmic; 1092594
DR   Cosmic; 1305375
DR   Cosmic; 1312363
DR   Cosmic; 1998436
DR   Cosmic; 2036675
DR   Cosmic; 2301558
DR   Cosmic; 2520632
DR   Cosmic-CLP; 905963
DR   DepMap; ACH-000433
DR   DSMZ; ACC-142
DR   DSMZ; ACC-731
DR   DSMZCellDive; ACC-731
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905963
DR   GEO; GSM2147
DR   GEO; GSM50229
DR   GEO; GSM50293
DR   GEO; GSM743483
DR   GEO; GSM750816
DR   GEO; GSM799374
DR   GEO; GSM799437
DR   GEO; GSM846288
DR   GEO; GSM886902
DR   GEO; GSM887967
DR   GEO; GSM1153447
DR   GEO; GSM1177994
DR   GEO; GSM1177995
DR   GEO; GSM1181288
DR   GEO; GSM1181368
DR   GEO; GSM1669644
DR   GEO; GSM2124663
DR   IARC_TP53; 21041
DR   IGRhCellID; Caki1
DR   IPD-IMGT/HLA; 13865
DR   IZSLER; BS TCL 108
DR   JCRB; JCRB0801
DR   KCB; KCB 200850YJ
DR   KCLB; 30046
DR   LiGeA; CCLE_484
DR   LINCS_LDP; LCL-1774
DR   MetaboLights; MTBLS737
DR   NCI-DTP; CAKI-1
DR   PharmacoDB; CAKI1_163_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0234
DR   PubChem_Cell_line; CVCL_0234
DR   RCB; RCB1985
DR   SKY/M-FISH/CGH; 2790
DR   TKG; TKG 0436
DR   Wikidata; Q54808374
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=7591954;
RX   PubMed=9290701;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=10723130;
RX   PubMed=10929426;
RX   PubMed=11146448;
RX   PubMed=15604581;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17212712;
RX   PubMed=17804913;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22949125;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24477694;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=27993170;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30260228;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=37668370;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=38
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/caki-1-xenograft-model/
WW   Provider; BRICS; BRICS0117; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3921
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/caki-1-human-renal-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-534.
CC   Population: Caucasian.
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=37668370).
CC   Virology: Susceptible to infection by human coronavirus 229E (HCoV-229E), Middle East respiratory syndrome-related coronavirus (MERS-CoV), influenza A virus and respiratory syncytial virus (RSV) (PubMed=37668370).
CC   Doubling time: 36 hours (PubMed=25984343); ~40-60 hours (DSMZ=ACC-731); 39 hours (NCI-DTP=CAKI-1).
CC   HLA typing: A*23:01,24:02:01; B*35:02,44:03:01; C*04:01:01:01; DPB1*02:01:02,10:01; DQB1*02:02,03; DRB1*07:01,11:04:01 (PubMed=15748285).
CC   HLA typing: A*23:01,24:02; B*35:02,44:03; C*04:01,04:01; DRB1*11:118,11:118 (PubMed=26589293).
CC   HLA typing: A*23:01,24:02:01; B*35:02,44:03:01; C*04:01:01:01; DPB1*02:01:02,10:01; DQB1*02:02,03:AF; DRB1*07:01,11:04:01 (IPD-IMGT/HLA=13865).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (Cosmic-CLP=905963; DepMap=ACH-000433).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.09%; Native American=0.91%; East Asian, North=2.59%; East Asian, South=0.47%; South Asian=7.88%; European, North=28.81%; European, South=58.26% (PubMed=30894373).
CC   Discontinued: DSMZ; ACC-142; true.
CC   Discontinued: RCB; RCB1985; true.
CC   Discontinued: TKG; TKG 0436; probable.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=HTB-46; CCRID; CLS=300149; Cosmic-CLP=905963; DSMZ=ACC-731; JCRB=JCRB0801; KCLB=30046; PubMed=19372543; PubMed=25877200; RCB=RCB1985
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11 (DSMZ=ACC-731)
ST   D13S317: 11,12 (ATCC=HTB-46; CCRID; CLS=300149; Cosmic-CLP=905963; JCRB=JCRB0801; KCLB=30046; PubMed=19372543; PubMed=25877200; RCB=RCB1985)
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 17 (PubMed=19372543)
ST   D2S1338: 17,19 (ATCC=HTB-46; CCRID; DSMZ=ACC-731)
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,12 (ATCC=HTB-46; CCRID; CLS=300149; Cosmic-CLP=905963; DSMZ=ACC-731; JCRB=JCRB0801; KCLB=30046; PubMed=25877200; RCB=RCB1985)
ST   D7S820: 12 (PubMed=19372543)
ST   D8S1179: 12,14
ST   FGA: 26
ST   Penta D: 11,12
ST   Penta E: 11,22,23 (ATCC=HTB-46)
ST   Penta E: 22,23 (CLS=300149; DSMZ=ACC-731; PubMed=25877200)
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   Caki-1-Cas9-593
AC   CVCL_WZ60
DR   CCRID; 1101HUM-PUMC000593
DR   Wikidata; Q93442582
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): CCRID=1101HUM-PUMC000593
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 15,17
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D6S1043: 12
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 26
ST   Penta E: 22,23
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0234 ! Caki-1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Caki-1-Luc
AC   CVCL_J247
DR   JCRB; JCRB1400
DR   JCRB; NIHS0653
DR   Wikidata; Q54808375
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0653; true.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): JCRB=JCRB1400
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0234 ! Caki-1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   Caki-2
AC   CVCL_0235
SY   CAKI-2; CaKi-2; caki-2; CAKI 2; Caki 2; Caki2; CAKI2
DR   BTO; BTO_0006204
DR   CLO; CLO_0002177
DR   EFO; EFO_0002150
DR   MCCL; MCC:0000124
DR   CLDB; cl625
DR   CLDB; cl626
DR   CLDB; cl627
DR   CLDB; cl629
DR   4DN; 4DNSRDD5W2FZ
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-47
DR   BCRJ; 0408
DR   BioGRID_ORCS_Cell_line; 583
DR   BioSample; SAMN01821542
DR   BioSample; SAMN01821619
DR   BioSample; SAMN03471873
DR   BioSample; SAMN10988361
DR   cancercelllines; CVCL_0235
DR   CancerTools; 161904
DR   CCRID; 1101HUM-PUMC000337
DR   Cell_Model_Passport; SIDM01546
DR   ChEMBL-Cells; CHEMBL3308071
DR   ChEMBL-Targets; CHEMBL613852
DR   CLS; 300140
DR   Cosmic; 687941
DR   Cosmic; 874612
DR   Cosmic; 877458
DR   Cosmic; 979706
DR   Cosmic; 982278
DR   Cosmic; 1152536
DR   Cosmic; 2520633
DR   DepMap; ACH-000234
DR   DSMZ; ACC-54
DR   DSMZCellDive; ACC-54
DR   ECACC; 93120819
DR   EGA; EGAS00001000610
DR   ENCODE; ENCBS074UKQ
DR   ENCODE; ENCBS461KDA
DR   ENCODE; ENCBS611WID
DR   ENCODE; ENCBS768KGZ
DR   ENCODE; ENCBS787YGO
DR   GEO; GSM374478
DR   GEO; GSM886903
DR   GEO; GSM887968
DR   IARC_TP53; 30022
DR   ICLC; HTL95029
DR   IGRhCellID; Caki2
DR   IZSLER; BS TCL 8
DR   KCLB; 30047
DR   LiGeA; CCLE_157
DR   PharmacoDB; Caki2_164_2019
DR   PRIDE; PXD000335
DR   PRIDE; PXD003105
DR   Progenetix; CVCL_0235
DR   PubChem_Cell_line; CVCL_0235
DR   Wikidata; Q54808377
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=7591954;
RX   PubMed=10723130;
RX   PubMed=10929426;
RX   PubMed=15585611;
RX   PubMed=17409424;
RX   PubMed=20215515;
RX   PubMed=22185343;
RX   PubMed=22460905;
RX   PubMed=22949125;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27993170;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/caki-2-human-renal-cell-line
CC   Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2010-068.
CC   Population: Caucasian.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-54).
CC   HLA typing: A*01,11; B*08,51; C*07,12 (PubMed=15585611).
CC   HLA typing: A*01:01,11:01; B*08:01,52:01; C*07:01,12:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.61%; East Asian, North=1.28%; East Asian, South=0%; South Asian=0%; European, North=64.34%; European, South=33.76% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=HTB-47; CCRID=1101HUM-PUMC000337; CLS=300140; COG; DSMZ=ACC-54; ECACC=93120819; KCLB=30047; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 14,16
ST   D12S391: 19,23
ST   D13S317: 10
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 13,14
ST   D1S1656: 12,14
ST   D21S11: 27,31
ST   D22S1045: 15
ST   D2S1338: 17,20
ST   D2S441: 14
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 7,17
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   Caki-2 DNMT3A KO
AC   CVCL_E3VW
DR   CancerTools; 160723
RX   PubMed=30897760;
CC   Problematic cell line: Misclassified. Parent cell line originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2978; DNMT3A.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0235 ! Caki-2
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Caki-2 SETD2 KO
AC   CVCL_E3VX
DR   CancerTools; 160724
RX   PubMed=30897760;
CC   Problematic cell line: Misclassified. Parent cell line originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170).
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Caki-3
AC   CVCL_RX38
DR   CCLV; CCLV-RIE 1176
DR   Wikidata; Q54808378
OX   NCBI_TaxID=9838; ! Camelus dromedarius (Dromedary)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   Caki-3-R
AC   CVCL_RX39
DR   CCLV; CCLV-RIE 1284
DR   Wikidata; Q54808379
OX   NCBI_TaxID=9838; ! Camelus dromedarius (Dromedary)
HI   CVCL_RX38 ! Caki-3
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   Caki-dTub
AC   CVCL_0B30
DR   BTO; BTO_0005559
DR   Wikidata; Q54808380
RX   CelloPub=CLPUB00226;
RX   PubMed=17009030;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88246; 2'-deoxytubercidin.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0234 ! Caki-1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   CAL
AC   CVCL_E514
SY   TER249; TER-249; Ter 249; Extract 101; Extract 309; Extract 391
DR   IPD-IMGT/HLA; 10376
DR   Wikidata; Q54808381
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/326cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01,68:02; B*47:02,53:01; C*04:01,06:02; DPB1*04:01; DQA1*01:02,02:01; DQB1*06:04,02:02; DRB1*13:02,07:01; DRB3*03:01; DRB4*01:01 (IPD-IMGT/HLA=10376).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   CAL-1 [Human melanoma]
AC   CVCL_G085
SY   CAL 1; Centre Antoine Lacassagne-1
DR   Wikidata; Q54808382
RX   PubMed=2145926;
RX   PubMed=2440566;
RX   PubMed=6873970;
CC   Doubling time: 60 hours (PubMed=2145926).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   CAL-1 [Human plasmacytoid dendritic]
AC   CVCL_5G46
SY   Cal-1
DR   DSMZ; ACC-923
DR   DSMZCellDive; ACC-923
DR   Lonza; 1599
DR   Wikidata; Q54808383
RX   Patent=JP5011520;
RX   PubMed=15765784;
WW   Info; -; -; https://web.archive.org/web/20160706131224/http://www.clg.niigata-u.ac.jp:80/~matak/eng/resmat12.pdf
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20595.
CC   Population: Japanese.
CC   Doubling time: ~25-35 hours (DSMZ=ACC-923).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
ST   Source(s): DSMZ=ACC-923
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 8,9
ST   D18S51: 13,23
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19,23
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 15,18
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   CAL-1 TLR9 mCherry
AC   CVCL_XI46
DR   Wikidata; Q93442627
RX   CelloPub=CLPUB00539;
CC   Population: Japanese.
CC   Characteristics: Transfected with a Tet-on system so as to induce the expression of a TLR9-mCherry fusion protein with the addition of doxycycline to the culture medium.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G46 ! CAL-1 [Human plasmacytoid dendritic]
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   CAL-11
AC   CVCL_C4FU
DR   Wikidata; Q116048642
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-120
AC   CVCL_1104
SY   CAL 120; CAL120
DR   CLO; CLO_0002179
DR   EFO; EFO_0005356
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-6647
DR   BioGRID_ORCS_Cell_line; 166
DR   BioSample; SAMN03472991
DR   BioSample; SAMN03473555
DR   BioSample; SAMN10989564
DR   cancercelllines; CVCL_1104
DR   Cell_Model_Passport; SIDM00940
DR   ChEMBL-Cells; CHEMBL3308577
DR   ChEMBL-Targets; CHEMBL1075405
DR   Cosmic; 906826
DR   Cosmic; 1995355
DR   Cosmic; 2164984
DR   Cosmic-CLP; 906826
DR   DepMap; ACH-000212
DR   DSMZ; ACC-459
DR   DSMZCellDive; ACC-459
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906826
DR   GEO; GSM274647
DR   GEO; GSM274665
DR   GEO; GSM344361
DR   GEO; GSM344411
DR   GEO; GSM783963
DR   GEO; GSM827160
DR   GEO; GSM843483
DR   GEO; GSM847210
DR   GEO; GSM847455
DR   GEO; GSM886904
DR   GEO; GSM887969
DR   GEO; GSM1172944
DR   GEO; GSM1669645
DR   IARC_TP53; 21208
DR   LiGeA; CCLE_802
DR   LINCS_HMS; 51110
DR   LINCS_LDP; LCL-1463
DR   PharmacoDB; CAL120_165_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1104
DR   PubChem_Cell_line; CVCL_1104
DR   SLKBase; 3487
DR   Wikidata; Q54808384
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30613774;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 45 hours (PubMed=25984343); ~50-60 hours (DSMZ=ACC-459); 34.01 hours (JWGray panel).
CC   HLA typing: A*03:01,03:01; B*44:02,56:01; C*01:02,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+2T>G; ClinVar=VCV000635389; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=906826).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.62%; Native American=0%; East Asian, North=3.74%; East Asian, South=0%; South Asian=0.57%; European, North=51.79%; European, South=42.29% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906826; DSMZ=ACC-459; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 20,26
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 13
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8,9 (Cosmic-CLP=906826; DSMZ=ACC-459)
ST   TPOX: 9 (PubMed=25877200)
ST   vWA: 18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   CAL-12T
AC   CVCL_1105
SY   Cal-12T; Cal.12T; CAL 12T; CAL12T; Cal12T; CAL 12; Centre Antoine Lacassagne-12T
DR   CLO; CLO_0002180
DR   EFO; EFO_0006547
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473097
DR   BioSample; SAMN10987846
DR   cancercelllines; CVCL_1105
DR   Cell_Model_Passport; SIDM00939
DR   ChEMBL-Cells; CHEMBL3308132
DR   ChEMBL-Targets; CHEMBL1075406
DR   Cosmic; 753540
DR   Cosmic; 1995356
DR   Cosmic-CLP; 753540
DR   DepMap; ACH-000826
DR   DSMZ; ACC-443
DR   DSMZCellDive; ACC-443
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753540
DR   GEO; GSM784241
DR   GEO; GSM827248
DR   GEO; GSM886905
DR   GEO; GSM887970
DR   GEO; GSM1669646
DR   IARC_TP53; 21209
DR   LiGeA; CCLE_097
DR   LINCS_LDP; LCL-1603
DR   PharmacoDB; CAL12T_166_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1105
DR   PubChem_Cell_line; CVCL_1105
DR   Wikidata; Q54808385
RX   PubMed=1657424;
RX   PubMed=2145926;
RX   PubMed=2440566;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=1657424; PubMed=2145926); ~50 hours (DSMZ=ACC-443).
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Gly1291Glufs*4 (c.3872del) (p.Val1290fs, c.3870delG); Zygosity=Heterozygous (Cosmic-CLP=753540; DepMap=ACH-000826).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly466Val (c.1397G>T); ClinVar=VCV000013967; Zygosity=Heterozygous (Cosmic-CLP=753540; DepMap=ACH-000826).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (Cosmic-CLP=753540; DepMap=ACH-000826).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.12%; Native American=0.91%; East Asian, North=2.34%; East Asian, South=0.23%; South Asian=0%; European, North=56.03%; European, South=40.37% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=753540; DSMZ=ACC-443; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   CAL-12T KRAS (G12C/+)
AC   CVCL_A4II
SY   KRAS (G12C/+) Cal12T
DR   cancercelllines; CVCL_A4II
DR   Horizon_Discovery; HD+113-001
DR   Wikidata; Q105506577
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Gly1291Glufs*4 (c.3872del) (p.Val1290fs, c.3870delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly466Val (c.1397G>T); ClinVar=VCV000013967; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+113-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1105 ! CAL-12T
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   CAL-13
AC   CVCL_C4FV
DR   ABCD; ABCD_AF021
DR   Wikidata; Q116048643
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-148
AC   CVCL_1106
SY   CAL 148; CAL148; Centre Antoine Lacassagne-148
DR   CLO; CLO_0002181
DR   EFO; EFO_0005357
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471761
DR   BioSample; SAMN10988460
DR   cancercelllines; CVCL_1106
DR   Cell_Model_Passport; SIDM00938
DR   ChEMBL-Cells; CHEMBL3308794
DR   ChEMBL-Targets; CHEMBL1075407
DR   Cosmic; 924106
DR   Cosmic; 1603194
DR   Cosmic; 2164985
DR   Cosmic-CLP; 924106
DR   DepMap; ACH-000902
DR   DSMZ; ACC-460
DR   DSMZCellDive; ACC-460
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 924106
DR   GEO; GSM274695
DR   GEO; GSM344383
DR   GEO; GSM344433
DR   GEO; GSM783978
DR   GEO; GSM827186
DR   GEO; GSM886906
DR   GEO; GSM887971
DR   GEO; GSM1172945
DR   GEO; GSM1669647
DR   IARC_TP53; 27145
DR   LiGeA; CCLE_805
DR   LINCS_HMS; 51111
DR   LINCS_LDP; LCL-1464
DR   PharmacoDB; CAL148_167_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1106
DR   PubChem_Cell_line; CVCL_1106
DR   Wikidata; Q54808386
RX   PubMed=7531416;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-460); 42.78 hours (JWGray panel).
CC   HLA typing: A*11:01,24:18; B*15:78,45:01; C*06:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Lys (c.670G>A); ClinVar=VCV000480767; Zygosity=Heterozygous (Cosmic-CLP=924106).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.17%; Native American=0.26%; East Asian, North=2.18%; East Asian, South=0%; South Asian=0.58%; European, North=44.85%; European, South=48.96% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=924106; DSMZ=ACC-460; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13,14
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13,14
ST   D21S11: 28,31.2
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 18,23
ST   Penta D: 11,14
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   CAL-15
AC   CVCL_C4FW
DR   ABCD; ABCD_AF024
DR   Wikidata; Q116048644
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-16
AC   CVCL_C4FX
DR   ABCD; ABCD_AF026
DR   Wikidata; Q116048645
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-17
AC   CVCL_C4FY
DR   ABCD; ABCD_AF025
DR   Wikidata; Q116048646
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-18
AC   CVCL_C4FZ
DR   ABCD; ABCD_AF027
DR   Wikidata; Q116048647
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-185
AC   CVCL_G081
SY   CAL 185; Centre Antoine Lacassagne-185
DR   Wikidata; Q54808387
RX   PubMed=11720483;
CC   Doubling time: 72 hours (Note=At 26th passage) (PubMed=11720483).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   CAL-18A
AC   CVCL_G083
SY   CAL 18A; CAL 18 A; Centre Antoine Lacassagne-18A
DR   Wikidata; Q54808388
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2440566;
RX   PubMed=2982486;
CC   Doubling time: 15 hours (PubMed=2982486).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G084 ! CAL-18B
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   CAL-18B
AC   CVCL_G084
SY   CAL 18B; CAL 18 B; Centre Antoine Lacassagne-18B
DR   Wikidata; Q54808389
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2440566;
RX   PubMed=2982486;
CC   Doubling time: 26 hours (PubMed=2982486).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G083 ! CAL-18A
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   CAL-19
AC   CVCL_C4G0
DR   ABCD; ABCD_AF023
DR   Wikidata; Q116048648
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-2
AC   CVCL_5V17
SY   CAL 2; Centre Antoine Lacassagne-2
DR   Wikidata; Q54808390
RX   PubMed=2145926;
RX   PubMed=2440566;
CC   Doubling time: 48 hours (PubMed=2145926).
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   CAL-21
AC   CVCL_C4G1
DR   Wikidata; Q116048650
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-22
AC   CVCL_C4G2
DR   ABCD; ABCD_AF020
DR   Wikidata; Q116048652
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-23 [Human melanoma]
AC   CVCL_5V13
SY   CAL 23; Cal 23; Centre Antoine Lacassagne-23
DR   Wikidata; Q54808391
RX   PubMed=2145926;
RX   PubMed=2440566;
CC   Doubling time: 53 hours (PubMed=2145926).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   CAL-23 [Mouse hybridoma against cardiolipin]
AC   CVCL_C4G3
DR   ABCD; ABCD_AF022
DR   Wikidata; Q116048653
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-24
AC   CVCL_5V14
SY   CAL 24; Cal 24; Centre Antoine Lacassagne-24
DR   Wikidata; Q54808392
RX   PubMed=2145926;
RX   PubMed=2440566;
CC   Doubling time: 61 hours (PubMed=2145926).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   CAL-26
AC   CVCL_X042
SY   CAL 26; Cal 26; Centre Antoine Lacassagne-26
DR   Wikidata; Q54808393
RX   PubMed=2440566;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 5
//
ID   CAL-27
AC   CVCL_1107
SY   Cal-27; CAL 27; Cal 27; CAL27; Cal27; CAL-SCC-27; Centre Antoine Lacassagne-27
DR   BTO; BTO_0000921
DR   CLO; CLO_0002178
DR   CLO; CLO_0002182
DR   EFO; EFO_0006366
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2095
DR   BCRJ; 0326
DR   BioGRID_ORCS_Cell_line; 336
DR   BioSample; SAMN03471886
DR   BioSample; SAMN10987905
DR   cancercelllines; CVCL_1107
DR   CCRID; 1101HUM-PUMC000338
DR   CCRID; 4201HUM-CCTCC00248
DR   CCTCC; GDC0248
DR   Cell_Model_Passport; SIDM00937
DR   ChEMBL-Cells; CHEMBL3308098
DR   ChEMBL-Targets; CHEMBL1075408
DR   CLS; 305029
DR   Cosmic; 686972
DR   Cosmic; 910916
DR   Cosmic; 1006469
DR   Cosmic; 1017793
DR   Cosmic; 1041674
DR   Cosmic; 1339913
DR   Cosmic; 1466800
DR   Cosmic; 1530734
DR   Cosmic; 1752762
DR   Cosmic; 2043896
DR   Cosmic; 2131842
DR   Cosmic; 2296292
DR   Cosmic-CLP; 910916
DR   DepMap; ACH-000832
DR   DSMZ; ACC-446
DR   DSMZCellDive; ACC-446
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910916
DR   GEO; GSM422868
DR   GEO; GSM423671
DR   GEO; GSM886907
DR   GEO; GSM887972
DR   GEO; GSM1374427
DR   GEO; GSM1374428
DR   GEO; GSM1519074
DR   GEO; GSM1519075
DR   GEO; GSM1519076
DR   GEO; GSM1669648
DR   IARC_TP53; 17482
DR   IGRhCellID; CAL27%20GSE9585
DR   LiGeA; CCLE_698
DR   LINCS_LDP; LCL-1215
DR   PharmacoDB; CAL27_168_2019
DR   PRIDE; PXD002132
DR   PRIDE; PXD028810
DR   PRIDE; PXD029420
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1107
DR   PubChem_Cell_line; CVCL_1107
DR   Wikidata; Q54808394
RX   PubMed=2145926;
RX   PubMed=2440566;
RX   PubMed=3181269;
RX   PubMed=19631575;
RX   PubMed=20014447;
RX   PubMed=20164919;
RX   PubMed=21868764;
RX   PubMed=22460905;
RX   PubMed=24201445;
RX   PubMed=25275298;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25888065;
RX   PubMed=26589293;
RX   PubMed=27108184;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28476783;
RX   PubMed=29156801;
RX   PubMed=29770536;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34977030;
RX   PubMed=35839778;
RX   PubMed=36912284;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (Note=At 50th passage) (PubMed=3181269); 45 hours (PubMed=2145926); ~35 hours (ATCC=CRL-2095); ~20-40 hours (DSMZ=ACC-446).
CC   HLA typing: A*26:08,26:08; B*44:03,51:01; C*07:02,16:01; DQA1*01:02,02:01; DQB1*05:01,05:01; DRB1*01:03,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (PubMed=25275298).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.22%; Native American=0%; East Asian, North=2.6%; East Asian, South=0%; South Asian=0%; European, North=54.66%; European, South=40.51% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-2095; CCRID; Cosmic-CLP=910916; DSMZ=ACC-446; PubMed=19631575; PubMed=21868764; PubMed=25275298; PubMed=25877200; PubMed=36912284; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 12,16
ST   D12S391: 18.3,20
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 14,15.2 (ATCC=CRL-2095; CCRID; Technion Genomics Center)
ST   D19S433: 14,16 (DSMZ=ACC-446)
ST   D1S1656: 13,16
ST   D21S11: 28,29
ST   D22S1045: 13,16
ST   D2S1338: 23,24
ST   D2S441: 10,11.3
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 12
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 21,25 (CCRID)
ST   FGA: 25 (ATCC=CRL-2095; DSMZ=ACC-446; PubMed=19631575; PubMed=25275298; PubMed=25877200; Technion Genomics Center)
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C173807; Tongue adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   CAL-27 [Mouse hybridoma against cardiolipin]
AC   CVCL_C4G4
DR   ABCD; ABCD_AF028
DR   Wikidata; Q116048654
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-27 2B1
AC   CVCL_C0RK
SY   Cal27 2B1; 2B1
DR   PRIDE; PXD028810
DR   Wikidata; Q112929360
RX   PubMed=27108184;
RX   PubMed=34977030;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6156; ITGB3.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C173807; Tongue adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1107 ! CAL-27
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   CAL-27 2B3
AC   CVCL_C0RL
SY   Cal27 2B3; 2B3
DR   Wikidata; Q112929361
RX   PubMed=27108184;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6156; ITGB3.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C173807; Tongue adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1107 ! CAL-27
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   CAL-27 TPFR
AC   CVCL_GY99
DR   Wikidata; Q54808395
RX   PubMed=25962396;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C173807; Tongue adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1107 ! CAL-27
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   CAL-29
AC   CVCL_1808
SY   CAL 29; CAL29; Centre Antoine Lacassagne-29
DR   CLO; CLO_0037157
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 584
DR   BioSample; SAMN03473515
DR   BioSample; SAMN10988514
DR   cancercelllines; CVCL_1808
DR   Cell_Model_Passport; SIDM00936
DR   Cosmic; 1285115
DR   Cosmic; 1995357
DR   Cosmic; 2050440
DR   Cosmic; 2057444
DR   Cosmic; 2444248
DR   Cosmic; 2685941
DR   Cosmic-CLP; 1290730
DR   DepMap; ACH-000142
DR   DSMZ; ACC-515
DR   DSMZCellDive; ACC-515
DR   EGA; EGAS00001000978
DR   GDSC; 1290730
DR   GEO; GSM827161
DR   GEO; GSM886908
DR   GEO; GSM887973
DR   GEO; GSM1669649
DR   IARC_TP53; 28275
DR   LiGeA; CCLE_765
DR   LINCS_LDP; LCL-1711
DR   PharmacoDB; CAL29_169_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1808
DR   Wikidata; Q54808396
RX   PubMed=2440566;
RX   PubMed=11720483;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (Note=At 18th passage) (PubMed=11720483); ~50-60 hours (DSMZ=ACC-515).
CC   HLA typing: A*03:01,23:01; B*49:01,49:01; C*07:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (Cosmic-CLP=1290730; DepMap=ACH-000142).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (Cosmic-CLP=1290730; DepMap=ACH-000142).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.1%; East Asian, North=2.83%; East Asian, South=0%; South Asian=0%; European, North=51.89%; European, South=45.18% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Cosmic-CLP=1290730; DSMZ=ACC-515
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,18
ST   D19S433: 12,14
ST   D21S11: 31,33.2
ST   D2S1338: 20,25
ST   D3S1358: 18,19
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 5,13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   CAL-3
AC   CVCL_C4G5
DR   Wikidata; Q116048655
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-32
AC   CVCL_X043
SY   CAL 32; Cal 32; Centre Antoine Lacassagne-32
DR   Wikidata; Q54808397
RX   PubMed=2145926;
RX   PubMed=2440566;
CC   Doubling time: 124 hours (PubMed=2145926).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   CAL-33
AC   CVCL_1108
SY   Cal-33; CAL 33; CAL33; CAL-SCC-33; Centre Antoine Lacassagne-33
DR   BTO; BTO_0000941
DR   CLO; CLO_0002183
DR   EFO; EFO_0022592
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 841
DR   BioSample; SAMN03473547
DR   BioSample; SAMN10988048
DR   cancercelllines; CVCL_1108
DR   Cell_Model_Passport; SIDM00942
DR   ChEMBL-Cells; CHEMBL3308715
DR   ChEMBL-Targets; CHEMBL1075409
DR   Cosmic; 753541
DR   Cosmic; 2296293
DR   Cosmic-CLP; 753541
DR   DepMap; ACH-000518
DR   DSMZ; ACC-447
DR   DSMZCellDive; ACC-447
DR   EGA; EGAS00001000978
DR   GDSC; 753541
DR   GEO; GSM887974
DR   GEO; GSM1669650
DR   IARC_TP53; 21210
DR   LiGeA; CCLE_328
DR   LINCS_LDP; LCL-1216
DR   PharmacoDB; CAL33_170_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1108
DR   PubChem_Cell_line; CVCL_1108
DR   Wikidata; Q54808398
RX   PubMed=2145926;
RX   PubMed=2440566;
RX   PubMed=3181269;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24710094;
RX   PubMed=25275298;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34339474;
RX   PubMed=35839778;
RX   PubMed=36912284;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 43 hours (Note=At 50th passage) (PubMed=3181269); 78 hours (PubMed=2145926); ~30-40 hours (DSMZ=ACC-447).
CC   HLA typing: A*01:01,30:02; B*08:01,08:01; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11876; TMPRSS2; Simple; p.Gly8Val (c.23G>T) (c.-57+99G>T); ClinVar=VCV001273671; Zygosity=Homozygous (PubMed=34339474).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25275298).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.92%; Native American=0%; East Asian, North=2.32%; East Asian, South=0.33%; South Asian=0%; European, North=46.86%; European, South=49.56% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Cosmic-CLP=753541; DSMZ=ACC-447; PubMed=25275298; PubMed=36912284; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13,16
ST   D12S391: 15,18
ST   D13S317: 8,13
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14,15.2 (Technion Genomics Center)
ST   D19S433: 14,16 (DSMZ=ACC-447)
ST   D1S1656: 16,16.3
ST   D21S11: 29,30
ST   D22S1045: 16
ST   D2S1338: 20,25
ST   D2S441: 14
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   DYS391: 11
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 7,15
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 45
//
ID   CAL-39
AC   CVCL_1109
SY   CAL 39; CAL39; Centre Antoine Lacassagne-39
DR   CLO; CLO_0002184
DR   CLDB; cl630
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473368
DR   cancercelllines; CVCL_1109
DR   Cell_Model_Passport; SIDM00935
DR   ChEMBL-Cells; CHEMBL3308716
DR   ChEMBL-Targets; CHEMBL1075410
DR   Cosmic; 924107
DR   Cosmic; 1995358
DR   Cosmic-CLP; 924107
DR   DepMap; ACH-002091
DR   DSMZ; ACC-187
DR   DSMZCellDive; ACC-187
DR   EGA; EGAS00001000978
DR   GDSC; 924107
DR   GEO; GSM1669651
DR   IARC_TP53; 27146
DR   LINCS_LDP; LCL-1294
DR   PharmacoDB; CAL39_171_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1109
DR   Wikidata; Q54808399
RX   PubMed=20164919;
RX   PubMed=21573363;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (Note=At 34th passage) (PubMed=21573363); ~50-70 hours (DSMZ=ACC-187).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Arg2597Ter (c.7789C>T); ClinVar=VCV001937208; Zygosity=Homozygous (Cosmic-CLP=924107; DepMap=ACH-002091).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Homozygous (Cosmic-CLP=924107; DepMap=ACH-002091).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.88%; Native American=0.78%; East Asian, North=0%; East Asian, South=1.64%; South Asian=9.08%; European, North=26.43%; European, South=59.19% (PubMed=30894373).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
ST   Source(s): Cosmic-CLP=924107; DSMZ=ACC-187
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 21
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 16
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   CAL-4
AC   CVCL_G086
SY   CAL 4; Cal 4; Centre Antoine Lacassagne-4
DR   Wikidata; Q54808400
RX   PubMed=2145926;
RX   PubMed=2440566;
RX   PubMed=6873970;
CC   Doubling time: 130 hours (PubMed=2145926).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   CAL-41
AC   CVCL_5V16
SY   CAL 41; Centre Antoine Lacassagne-41
DR   Wikidata; Q54808401
RX   PubMed=2145926;
RX   PubMed=2440566;
CC   Doubling time: 96 hours (PubMed=2145926).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   CAL-43
AC   CVCL_X044
SY   CAL 43; CAL43; Centre Antoine Lacassagne-43
DR   Wikidata; Q54808402
RX   PubMed=2440566;
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   CAL-44
AC   CVCL_G082
SY   CAL 44; CAL44; Centre Antoine Lacassagne-44
DR   Wikidata; Q54808403
RX   PubMed=2440566;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CAL-48A
AC   CVCL_RL40
SY   CAL 48A; CAL 48 A; Centre Antoine Lacassagne-48A
DR   Wikidata; Q54808405
RX   PubMed=2145926;
CC   Doubling time: 58 hours (PubMed=2145926).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   CAL-51
AC   CVCL_1110
SY   CAL 51; CAL51; Cal51; Centre Antoine Lacassagne-51
DR   BTO; BTO_0000945
DR   CLO; CLO_0002185
DR   EFO; EFO_0005358
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 585
DR   BioSample; SAMN03473159
DR   BioSample; SAMN10988576
DR   cancercelllines; CVCL_1110
DR   Cell_Model_Passport; SIDM00933
DR   ChEMBL-Cells; CHEMBL3308717
DR   ChEMBL-Targets; CHEMBL1075411
DR   Cosmic; 687467
DR   Cosmic; 910927
DR   Cosmic; 1057761
DR   Cosmic; 2164986
DR   Cosmic-CLP; 910927
DR   DepMap; ACH-000856
DR   DSMZ; ACC-302
DR   DSMZCellDive; ACC-302
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910927
DR   GEO; GSM115099
DR   GEO; GSM217567
DR   GEO; GSM274645
DR   GEO; GSM274646
DR   GEO; GSM344362
DR   GEO; GSM344412
DR   GEO; GSM350521
DR   GEO; GSM459702
DR   GEO; GSM783973
DR   GEO; GSM827162
DR   GEO; GSM847246
DR   GEO; GSM847456
DR   GEO; GSM886909
DR   GEO; GSM887975
DR   GEO; GSM1172946
DR   GEO; GSM1374429
DR   GEO; GSM1664565
DR   GEO; GSM1669652
DR   IARC_TP53; 21211
DR   IGRhCellID; CAL51
DR   LiGeA; CCLE_143
DR   LINCS_HMS; 50008
DR   LINCS_LDP; LCL-1472
DR   Lonza; 1002
DR   PharmacoDB; CAL51_172_2019
DR   PRIDE; PXD000953
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1110
DR   PubChem_Cell_line; CVCL_1110
DR   SLKBase; 3399
DR   Wikidata; Q54808406
RX   PubMed=2390488;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=12661003;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23122841;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34339474;
RX   PubMed=35839778;
RX   PubMed=36476833;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/CAL51.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474).
CC   Doubling time: 24 hours (PubMed=25984343); ~30 hours (PubMed=34339474); ~50-60 hours (DSMZ=ACC-302).
CC   HLA typing: A*24:02,29:02; B*44:26,51:01; C*16:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=12661003; PubMed=15677628; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (DepMap=ACH-000856).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (DepMap=ACH-000856).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.75%; East Asian, North=0.86%; East Asian, South=0%; South Asian=2.28%; European, North=55.8%; European, South=40.31% (PubMed=30894373).
CC   Misspelling: Ca151; Cosmic=1057761.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=910927; DSMZ=ACC-302; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 15,16,17 (DSMZ=ACC-302)
ST   D18S51: 15,17 (PubMed=25877200)
ST   D19S433: 12,14
ST   D21S11: 31,32
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 7,12
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 10,14
ST   Penta E: 7,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   CAL-51 RRAS2 KO#11
AC   CVCL_E5L3
RX   PubMed=36476833;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1110 ! CAL-51
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CAL-54
AC   CVCL_1111
SY   CAL 54; CAL54; Centre Antoine Lacassagne-54
DR   CLO; CLO_0002186
DR   EFO; EFO_0002125
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473166
DR   BioSample; SAMN10988487
DR   cancercelllines; CVCL_1111
DR   Cell_Model_Passport; SIDM00932
DR   ChEMBL-Cells; CHEMBL3308346
DR   ChEMBL-Targets; CHEMBL1075412
DR   Cosmic; 910952
DR   Cosmic-CLP; 910952
DR   DepMap; ACH-000457
DR   DSMZ; ACC-365
DR   DSMZCellDive; ACC-365
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910952
DR   GEO; GSM886910
DR   GEO; GSM887976
DR   GEO; GSM1669653
DR   IARC_TP53; 21212
DR   IGRhCellID; CAL54
DR   LiGeA; CCLE_129
DR   LINCS_LDP; LCL-1757
DR   PharmacoDB; CAL54_173_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1111
DR   PubChem_Cell_line; CVCL_1111
DR   Wikidata; Q54808409
RX   PubMed=8868943;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 35 +- 2 hours (Note=At 14th passage) (PubMed=8868943); ~72 hours (DSMZ=ACC-365).
CC   HLA typing: A*01:01,01:01; B*57:01,57:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.26%; Native American=0%; East Asian, North=0%; East Asian, South=0.56%; South Asian=2.72%; European, North=51.11%; European, South=45.35% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=910952; DSMZ=ACC-365; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13,14
ST   D16S539: 13
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 30.2
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 9,12
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 7,19
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   CAL-6
AC   CVCL_C4G6
DR   ABCD; ABCD_AF029
DR   Wikidata; Q116048656
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CAL-62
AC   CVCL_1112
SY   Cal-62; CAL 62; Cal 62; CAL62; Centre Antoine Lacassagne-62
DR   BTO; BTO_0002146
DR   CLO; CLO_0002187
DR   EFO; EFO_0002126
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473548
DR   BioSample; SAMN10988563
DR   cancercelllines; CVCL_1112
DR   CCRID; 3101HUMSCSP546
DR   Cell_Model_Passport; SIDM00931
DR   ChEMBL-Cells; CHEMBL3308099
DR   ChEMBL-Targets; CHEMBL1075413
DR   CLS; 305114
DR   Cosmic; 891257
DR   Cosmic; 906828
DR   Cosmic; 1152118
DR   Cosmic; 1162838
DR   Cosmic; 1239974
DR   Cosmic; 2054116
DR   Cosmic; 2613252
DR   Cosmic-CLP; 906828
DR   DepMap; ACH-000174
DR   DSMZ; ACC-448
DR   DSMZCellDive; ACC-448
DR   EGA; EGAS00001000978
DR   GDSC; 906828
DR   GEO; GSM886911
DR   GEO; GSM887977
DR   GEO; GSM1669654
DR   IARC_TP53; 21213
DR   IGRhCellID; CAL62
DR   LiGeA; CCLE_550
DR   LINCS_LDP; LCL-1683
DR   PharmacoDB; CAL62_174_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1112
DR   PubChem_Cell_line; CVCL_1112
DR   Wikidata; Q54808410
RX   PubMed=1369551;
RX   PubMed=18713817;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (DSMZ=ACC-448).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Glu1541Ter (c.4621G>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asp1485fs (c.4454delA); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Homozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Glu215Ter (c.643G>T); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Asp (c.482C>A); ClinVar=VCV000422295; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.55%; Native American=0.27%; East Asian, North=1.91%; East Asian, South=0%; South Asian=1.04%; European, North=46.22%; European, South=50.02% (PubMed=30894373).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=906828; DSMZ=ACC-448; PubMed=18713817; PubMed=25365311; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 19,23
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 13
ST   Penta E: 5,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   CAL-7
AC   CVCL_G087
SY   CAL 7; Centre Antoine Lacassagne-7
DR   Wikidata; Q54808411
RX   PubMed=2145926;
RX   PubMed=6873970;
CC   Doubling time: 160 hours (PubMed=2145926).
CC   Derived from site: In situ; Left temple, skin; UBERON=UBERON_8480028.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   CAL-72
AC   CVCL_1113
SY   CAL 72; CAL72; Cal72; Centre Antoine Lacassagne-72
DR   BTO; BTO_0002089
DR   CLO; CLO_0002188
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 842
DR   BioSample; SAMN03473545
DR   cancercelllines; CVCL_1113
DR   Cell_Model_Passport; SIDM00930
DR   ChEMBL-Cells; CHEMBL3308718
DR   ChEMBL-Targets; CHEMBL1075414
DR   Cosmic; 906827
DR   Cosmic; 1074399
DR   Cosmic-CLP; 906827
DR   DepMap; ACH-001715
DR   DSMZ; ACC-439
DR   DSMZCellDive; ACC-439
DR   EGA; EGAS00001000978
DR   GDSC; 906827
DR   GEO; GSM320825
DR   GEO; GSM1669655
DR   IARC_TP53; 21214
DR   LINCS_LDP; LCL-1419
DR   PharmacoDB; CAL72_175_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1113
DR   Wikidata; Q54808412
RX   PubMed=10389764;
RX   PubMed=11668190;
RX   PubMed=12631258;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African.
CC   Doubling time: 66 hours (Note=At 17th passage) (PubMed=10389764); ~40-50 hours (DSMZ=ACC-439).
CC   Karyotypic information: Has lost chromosome Y (PubMed=10389764).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=67.94%; Native American=0.09%; East Asian, North=1.27%; East Asian, South=0%; South Asian=24.79%; European, North=0%; European, South=5.91% (PubMed=30894373).
CC   Derived from site: In situ; Bone, patella; UBERON=UBERON_0002446.
ST   Source(s): Cosmic-CLP=906827; DepMap=ACH-001715; DSMZ=ACC-439
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 10
ST   D18S51: 19
ST   D19S433: 13
ST   D21S11: 28
ST   D2S1338: 21
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 19,22
ST   Penta D: 8
ST   Penta E: 15,19
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   CAL-78
AC   CVCL_1809
SY   CAL 78; CAL78; Centre Antoine Lacassagne-78
DR   CLO; CLO_0002189
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 586
DR   BioSample; SAMN03473549
DR   BioSample; SAMN10988508
DR   cancercelllines; CVCL_1809
DR   Cell_Model_Passport; SIDM00929
DR   Cosmic; 1995359
DR   Cosmic-CLP; 1290765
DR   DepMap; ACH-000516
DR   DSMZ; ACC-449
DR   DSMZCellDive; ACC-449
DR   EGA; EGAS00001000978
DR   GDSC; 1290765
DR   GEO; GSM886912
DR   GEO; GSM887978
DR   GEO; GSM1669656
DR   IARC_TP53; 28271
DR   LiGeA; CCLE_364
DR   LINCS_LDP; LCL-1457
DR   PharmacoDB; CAL78_176_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1809
DR   Wikidata; Q54808413
RX   PubMed=21590123;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 60 hours (Note=At 15th passage) (PubMed=21590123); ~240 hours (DSMZ=ACC-449).
CC   HLA typing: A*29:01,32:01; B*18:01,55:01; C*03:03,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286_Glu287del (c.856_861delCTCTTC); Zygosity=Unspecified (DepMap=ACH-000516).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=7.03%; Native American=0%; East Asian, North=6.11%; East Asian, South=0%; South Asian=3.86%; European, North=15.05%; European, South=67.96% (PubMed=30894373).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
ST   Source(s): Cosmic-CLP=1290765; DSMZ=ACC-449
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D18S51: 11,15
ST   D19S433: 13,15
ST   D21S11: 30,32.2
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 11,12
ST   Penta E: 11,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   CAL-85-1
AC   CVCL_1114
SY   Cal-85-1; CAL 85-1; CAL85-1; CAL851; Centre Antoine Lacassagne-85-1
DR   CLO; CLO_0002190
DR   EFO; EFO_0005359
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473094
DR   BioSample; SAMN10988345
DR   cancercelllines; CVCL_1114
DR   Cell_Model_Passport; SIDM00928
DR   ChEMBL-Cells; CHEMBL3308700
DR   ChEMBL-Targets; CHEMBL1075415
DR   Cosmic; 910852
DR   Cosmic; 2164987
DR   Cosmic-CLP; 910852
DR   DepMap; ACH-000857
DR   DSMZ; ACC-440
DR   DSMZCellDive; ACC-440
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910852
DR   GEO; GSM274639
DR   GEO; GSM344363
DR   GEO; GSM344413
DR   GEO; GSM827163
DR   GEO; GSM843484
DR   GEO; GSM843485
DR   GEO; GSM847247
DR   GEO; GSM847457
DR   GEO; GSM886913
DR   GEO; GSM887979
DR   GEO; GSM1172947
DR   GEO; GSM1669657
DR   IARC_TP53; 21215
DR   LiGeA; CCLE_496
DR   LINCS_HMS; 51112
DR   LINCS_LDP; LCL-1465
DR   Lonza; 1212
DR   PharmacoDB; CAL851_177_2019
DR   Progenetix; CVCL_1114
DR   PubChem_Cell_line; CVCL_1114
DR   Wikidata; Q54808414
RX   CelloPub=CLPUB00701;
RX   PubMed=7531416;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Asian.
CC   Doubling time: ~70 hours (DSMZ=ACC-440); 99.85 hours (JWGray panel).
CC   HLA typing: A*03:01,03:01; B*50:01,67:02; C*06:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1461Profs*2 (c.4381delT); Zygosity=Heterozygous (Cosmic-CLP=910852; DepMap=ACH-000857).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Heterozygous (Cosmic-CLP=910852; DepMap=ACH-000857).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.83%; Native American=0%; East Asian, North=4.79%; East Asian, South=0%; South Asian=87.38%; European, North=0%; European, South=7% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): Cosmic-CLP=910852; DSMZ=ACC-440; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 15
ST   D21S11: 30.2,32.2
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7MJ ! CAL-85-2
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   CAL-85-2
AC   CVCL_B7MJ
SY   CAL 85-2
DR   Wikidata; Q112929362
RX   CelloPub=CLPUB00701;
CC   Population: Asian.
CC   Derived from site: Metastatic; Thorax; UBERON=UBERON_0000915.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1114 ! CAL-85-1
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   CAL-9 [Human ovarian carcinoma]
AC   CVCL_5V15
SY   CAL 9; Centre Antoine Lacassagne-9
DR   Wikidata; Q54808415
RX   PubMed=2145926;
RX   PubMed=2440566;
CC   Doubling time: 54 hours (PubMed=2145926).
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   CAL-9 [Mouse hybridoma against cardiolipin]
AC   CVCL_C4G7
DR   ABCD; ABCD_AF030
DR   Wikidata; Q116048657
RX   PubMed=8335914;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28494; Cardiolipin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CALDOX
AC   CVCL_RR30
DR   Wikidata; Q54808416
RX   PubMed=23122841;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1110 ! CAL-51
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   Calg-ARLC
AC   CVCL_6F05
SY   Calgary-Adult Rabbit Lung Cell line
DR   Wikidata; Q54808417
RX   PubMed=4817948;
CC   Doubling time: 12 hours (PubMed=4817948).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   CalH2
AC   CVCL_A5TR
DR   Wikidata; Q107113534
RX   PubMed=17944752;
RX   PubMed=20426848;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CalH3
AC   CVCL_A5TS
DR   Wikidata; Q107113535
RX   PubMed=17944752;
RX   PubMed=20426848;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Cali-1
AC   CVCL_RP61
DR   ATCC; HTB-51
DR   Wikidata; Q54808418
RX   PubMed=833871;
CC   Discontinued: ATCC; HTB-51; true.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   CalJa ESC 1
AC   CVCL_A7HN
DR   Wikidata; Q107113536
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: 46,XX,-20,+mar (PubMed=33711687).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 10
AC   CVCL_A7HX
DR   Wikidata; Q107113537
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 11
AC   CVCL_A7HY
DR   Wikidata; Q107113538
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 12
AC   CVCL_A7HZ
DR   Wikidata; Q107113539
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: 46,XY [2/7]; 46,XY,del(13p) [4/7]; 46,XY,del(3q),del(13p) [1/7] (PubMed=33711687).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 13
AC   CVCL_A7IA
DR   Wikidata; Q107113540
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 14
AC   CVCL_A7IB
DR   Wikidata; Q107113541
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 15
AC   CVCL_A7IC
DR   Wikidata; Q107113542
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 16
AC   CVCL_A7ID
DR   Wikidata; Q107113544
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: 46,XY [4/9]; 46,X,+19 [2/9]; 47,XY,+19 [3/9] (PubMed=33711687).
CC   Donor information: Embryo is sibling to that giving rise to CalJa ESC 17 (Cellosaurus=CVCL_A7IE).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   CalJa ESC 17
AC   CVCL_A7IE
DR   Wikidata; Q107113545
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Donor information: Embryo is sibling to that giving rise to CalJa ESC 16 (Cellosaurus=CVCL_A7ID).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   CalJa ESC 2
AC   CVCL_A7HP
DR   Wikidata; Q107113546
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 3
AC   CVCL_A7HQ
DR   Wikidata; Q107113547
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: 46,XX,del(13p) (PubMed=33711687).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 4
AC   CVCL_A7HR
DR   Wikidata; Q107113548
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: 46,XX [2/6]; 46,XX,-20,+mar [1/6]; 47,XX,+5 [2/6]; 47,XX,+5,del(5p),del(13p) [1/6] (PubMed=33711687).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 5
AC   CVCL_A7HS
DR   Wikidata; Q107113549
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 6
AC   CVCL_A7HT
DR   Wikidata; Q107113551
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 7
AC   CVCL_A7HU
DR   Wikidata; Q107113552
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: 46,XY [2/5]; 46,XY,del(1p) [2/5]; 45,X,del(1p) [1/5] (PubMed=33711687).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 8
AC   CVCL_A7HV
DR   Wikidata; Q107113553
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: 46,XX,del(13p) [5/8]; 46,XX,-1,+4,del(4q),del(13p) [1/8]; 46,XX,+4,-5,del(4q) [1/8]; 47,XX,+15,del(13p) [1/8] (PubMed=33711687).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CalJa ESC 9
AC   CVCL_A7HW
DR   Wikidata; Q107113554
RX   PubMed=33711687;
CC   Group: Non-human primate cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CALM KO MEF
AC   CVCL_6D16
DR   RCB; RCB4594
DR   Wikidata; Q54808419
RX   PubMed=22363754;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   CALM WT MEF
AC   CVCL_6D17
DR   RCB; RCB4593
DR   Wikidata; Q54808420
RX   PubMed=22363754;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   CALM/AF10 Cas9
AC   CVCL_C8ZE
SY   Line #171
DR   BioGRID_ORCS_Cell_line; 815
DR   Wikidata; Q123030850
RX   PubMed=29478914;
CC   Characteristics: The CALM/AF10 oncogene was transduced into bone marrow hematopoietic stem cells and then transferred cells to sub-lethally irradiated recipients. Primary acute myeloid leukemia cells were harvested 3-6 months later, serially transplanted three times and then cultured in the presence of cytokines (PubMed=29478914).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   CALM1-F142L iPSC c1
AC   CVCL_A4TV
SY   iPSC F142L c1
DR   SKIP; SKIP003214
DR   Wikidata; Q107113555
RX   PubMed=28158429;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1442; CALM1; Simple; p.Phe142Leu (c.426C>G) (c.9406C>G); ClinVar=VCV000183231; Zygosity=Heterozygous (PubMed=28158429).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177534; Long QT syndrome 14
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TW ! CALM1-F142L iPSC c2
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CALM1-F142L iPSC c2
AC   CVCL_A4TW
SY   iPSC F142L c2
DR   SKIP; SKIP003215
DR   Wikidata; Q107113556
RX   PubMed=28158429;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1442; CALM1; Simple; p.Phe142Leu (c.426C>G) (c.9406C>G); ClinVar=VCV000183231; Zygosity=Heterozygous (PubMed=28158429).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177534; Long QT syndrome 14
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TV ! CALM1-F142L iPSC c1
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CaLo
AC   CVCL_5121
SY   CALO
DR   BTO; BTO_0003110
DR   cancercelllines; CVCL_5121
DR   GEO; GSM722570
DR   GEO; GSM722571
DR   GEO; GSM723051
DR   GEO; GSM723052
DR   Progenetix; CVCL_5121
DR   SKY/M-FISH/CGH; 2648
DR   Wikidata; Q54808421
RX   CelloPub=CLPUB00348;
RX   CelloPub=CLPUB00743;
RX   PubMed=12659655;
RX   PubMed=22412903;
RX   PubMed=35692560;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell of uterus; CL=CL_0002149.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   CALOGERO
AC   CVCL_E515
DR   CLDB; cl7224
DR   dbMHC; 48529
DR   ECACC; 94070703
DR   ICLC; HTL14001
DR   IHW; IHW09084
DR   IPD-IMGT/HLA; 10377
DR   Wikidata; Q54808422
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*02:01:01:01; B*40:02:01:01; C*02:02:02:01; DPB1*04:01:01; DQA1*01:02:02; DQB1*05:02:01; DRB1*16:01:01 (IPD-IMGT/HLA=10377).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Misspelling: CALEGORO; PubMed=28360230.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   Calu-1
AC   CVCL_0608
SY   CaLu-1; CALU-1; Calu.1; CALU 1; Calu 1; CALU1; Calu1
DR   BTO; BTO_0002940
DR   CLO; CLO_0002191
DR   EFO; EFO_0002151
DR   CLDB; cl631
DR   CLDB; cl632
DR   CLDB; cl633
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-54
DR   BioGRID_ORCS_Cell_line; 233
DR   BioSample; SAMN03471732
DR   BioSample; SAMN10988371
DR   cancercelllines; CVCL_0608
DR   CancerTools; 161905
DR   CCRID; 3101HUMTCHu192
DR   Cell_Model_Passport; SIDM01545
DR   ChEMBL-Cells; CHEMBL3308031
DR   ChEMBL-Targets; CHEMBL613505
DR   CLS; 300141
DR   Cosmic; 724858
DR   Cosmic; 755615
DR   Cosmic; 929968
DR   Cosmic; 933574
DR   Cosmic; 934465
DR   Cosmic; 934541
DR   Cosmic; 1089224
DR   Cosmic; 1146872
DR   Cosmic; 1188586
DR   Cosmic; 1434968
DR   Cosmic; 2060525
DR   Cosmic; 2125218
DR   Cosmic; 2645023
DR   Cosmic; 2646653
DR   Cosmic; 2668264
DR   Cosmic; 2772160
DR   DepMap; ACH-000511
DR   ECACC; 93120818
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724858
DR   GEO; GSM108801
DR   GEO; GSM108802
DR   GEO; GSM206451
DR   GEO; GSM253387
DR   GEO; GSM274735
DR   GEO; GSM274736
DR   GEO; GSM434324
DR   GEO; GSM784250
DR   GEO; GSM794261
DR   GEO; GSM817063
DR   GEO; GSM843486
DR   GEO; GSM886914
DR   GEO; GSM887980
DR   GEO; GSM1374430
DR   GEO; GSM1374431
DR   GEO; GSM1374432
DR   IARC_TP53; 8200
DR   IARC_TP53; 21263
DR   ICLC; HTL95002
DR   IGRhCellID; Calu1
DR   IZSLER; BS TCL 76
DR   LiGeA; CCLE_612
DR   LINCS_HMS; 50009
DR   LINCS_LDP; LCL-1580
DR   PharmacoDB; Calu1_178_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_0608
DR   PubChem_Cell_line; CVCL_0608
DR   Wikidata; Q54808423
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=7736387;
RX   PubMed=7972006;
RX   PubMed=8385084;
RX   PubMed=11583962;
RX   PubMed=12068308;
RX   PubMed=12794755;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/calu-1-human-lung-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 784.
CC   Population: Caucasian.
CC   Doubling time: 37 hours (PubMed=25984343); 49.8 hours (PubMed=29681454).
CC   HLA typing: A*10,11; B*15,w35 (CLS=300141).
CC   HLA typing: A*26:01,29:02; B*15:01,44:03; C*03:04,16:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (MSKCC).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=12068308; PubMed=12794755; DepMap=ACH-000511).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.74%; East Asian, North=0.11%; East Asian, South=0%; South Asian=9.94%; European, North=31.4%; European, South=57.8% (PubMed=30894373).
CC   Misspelling: CALV1; Cosmic=1434968.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-54; CLS=300141; ECACC=93120818; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,17
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 16,17
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 10
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 9,9.3 (ATCC=HTB-54; CLS=300141; PubMed=25877200)
ST   TH01: 9.3 (ECACC=93120818)
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   Calu-1 W5-6
AC   CVCL_0U29
SY   W5-6
DR   ATCC; CRL-9267
DR   BioSample; SAMN03471214
DR   cancercelllines; CVCL_0U29
DR   Wikidata; Q54993476
RX   Patent=US6004761;
RX   PubMed=2430697;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9267.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-9267
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS71 ! Calu-1 W5S2
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   Calu-1 W5S2
AC   CVCL_WS71
SY   W5S2
DR   cancercelllines; CVCL_WS71
DR   Wikidata; Q93442856
RX   Patent=US6004761;
RX   PubMed=2430697;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0608 ! Calu-1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   Calu-2
AC   CVCL_1E46
DR   Wikidata; Q54808424
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6935474;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 6
//
ID   Calu-3
AC   CVCL_0609
SY   CaLu-3; CALU-3; Calu 3; Calu3; CALU3
DR   BTO; BTO_0002750
DR   CLO; CLO_0002192
DR   EFO; EFO_0002819
DR   CLDB; cl634
DR   CLDB; cl635
DR   CLDB; cl5176
DR   Abcam; ab275465
DR   AddexBio; C0016001/30
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-55
DR   BCRJ; 0264
DR   BioGRID_ORCS_Cell_line; 1375
DR   BioSample; SAMN03471552
DR   BioSample; SAMN10988517
DR   cancercelllines; CVCL_0609
DR   CancerTools; 161906
DR   CCRID; 1101HUM-PUMC000032
DR   CCRID; 1101HUM-PUMC000329
DR   CCRID; 3101HUMTCHu157
DR   CCRID; 4201HUM-CCTCC00647
DR   Cell_Model_Passport; SIDM00922
DR   ChEMBL-Cells; CHEMBL3307390
DR   ChEMBL-Targets; CHEMBL614534
DR   CLS; 305032
DR   Cosmic; 687777
DR   Cosmic; 910562
DR   Cosmic; 933578
DR   Cosmic; 945227
DR   Cosmic; 961842
DR   Cosmic; 1006532
DR   Cosmic; 1028940
DR   Cosmic; 1146873
DR   Cosmic; 1219068
DR   Cosmic; 1239869
DR   Cosmic; 1434969
DR   Cosmic; 1802295
DR   Cosmic; 2125219
DR   Cosmic; 2664117
DR   Cosmic; 2772161
DR   Cosmic-CLP; 687777
DR   DepMap; ACH-000392
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GDSC; 687777
DR   GEO; GSM108803
DR   GEO; GSM108804
DR   GEO; GSM159355
DR   GEO; GSM159356
DR   GEO; GSM159357
DR   GEO; GSM159358
DR   GEO; GSM253347
DR   GEO; GSM353233
DR   GEO; GSM434276
DR   GEO; GSM513948
DR   GEO; GSM514318
DR   GEO; GSM784249
DR   GEO; GSM794262
DR   GEO; GSM817064
DR   GEO; GSM827549
DR   GEO; GSM886915
DR   GEO; GSM887981
DR   GEO; GSM1374433
DR   GEO; GSM1374434
DR   GEO; GSM1669658
DR   IARC_TP53; 21264
DR   IGRhCellID; Calu3
DR   IZSLER; BS TCL 103
DR   KCB; KCB 202003YJ
DR   KCLB; 30055
DR   LiGeA; CCLE_462
DR   LINCS_HMS; 50010
DR   LINCS_LDP; LCL-1631
DR   Lonza; 342
DR   MetaboLights; MTBLS762
DR   MetaboLights; MTBLS2352
DR   MetaboLights; MTBLS2840
DR   Millipore; SCC438
DR   PharmacoDB; Calu3_179_2019
DR   PRIDE; PRD000594
DR   PRIDE; PXD000589
DR   PRIDE; PXD019645
DR   PRIDE; PXD023418
DR   PRIDE; PXD023422
DR   PRIDE; PXD023760
DR   PRIDE; PXD024242
DR   PRIDE; PXD024375
DR   PRIDE; PXD024883
DR   PRIDE; PXD025499
DR   PRIDE; PXD026302
DR   PRIDE; PXD030304
DR   PRIDE; PXD034135
DR   Progenetix; CVCL_0609
DR   PubChem_Cell_line; CVCL_0609
DR   TOKU-E; 768
DR   Wikidata; Q52392355
RX   PubMed=327080;
RX   PubMed=3129183;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=3940644;
RX   PubMed=6220172;
RX   PubMed=7459858;
RX   PubMed=7515578;
RX   PubMed=9636188;
RX   PubMed=10523844;
RX   PubMed=11064206;
RX   PubMed=15463957;
RX   PubMed=17483357;
RX   PubMed=18083107;
RX   PubMed=19153074;
RX   PubMed=19472407;
RX   PubMed=20090954;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24207061;
RX   PubMed=25485619;
RX   PubMed=25555374;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=34339474;
RX   PubMed=35839778;
RX   PubMed=35879413;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-604.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Calu-3
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/calu-3-xenograft-model/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/calu-3-human-lung-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-533.
CC   Population: Caucasian.
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474).
CC   Doubling time: 35 hours (Note=In RPMI 1640 + 10% FBS), 45 hours (Note=In ACL-3), 37 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 40.1 hours (PubMed=29681454); ~84 hours (PubMed=34339474).
CC   HLA typing: A*24:02,68:01; B*07:02,51:01; C*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (PubMed=20557307; ATCC=HTB-55).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.63%; Native American=0%; East Asian, North=2.09%; East Asian, South=0%; South Asian=0%; European, North=67.76%; European, South=29.51% (PubMed=30894373).
CC   Misspelling: CALV3; Cosmic=1434969.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0016001/30; ATCC=HTB-55; CCRID; Cosmic-CLP=687777; KCLB=30055; Millipore=SCC438; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,14
ST   D18S51: 14,17
ST   D19S433: 12,13
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 25
ST   Penta D: 9,16
ST   Penta E: 5,21
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 49
//
ID   Calu-3 2B4
AC   CVCL_YZ47
SY   2B4
DR   cancercelllines; CVCL_YZ47
DR   GEO; GSE17400
DR   Wikidata; Q98125608
RX   PubMed=20090954;
CC   Population: Caucasian.
CC   Characteristics: Increased expression of ACE2.
CC   Virology: Highly susceptible to SARS coronavirus (SARS-CoV) infection (PubMed=20090954).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0609 ! Calu-3
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   Calu-4
AC   CVCL_LK95
DR   Wikidata; Q54808425
RX   PubMed=3518877;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   Calu-5
AC   CVCL_U901
SY   CALU-5; CaLu-05
DR   Wikidata; Q54808426
RX   PubMed=3518877;
RX   PubMed=9636188;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/calu-05-01
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   Calu-6
AC   CVCL_0236
SY   CaLu-6; CALU-6; Calu.6; Calu 6; Calu6; CALU6; CaLu-06
DR   BTO; BTO_0002235
DR   CLO; CLO_0002193
DR   EFO; EFO_0002152
DR   MCCL; MCC:0000125
DR   CLDB; cl636
DR   CLDB; cl638
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-56
DR   BioGRID_ORCS_Cell_line; 587
DR   BioSample; SAMN03473148
DR   BioSample; SAMN10987791
DR   cancercelllines; CVCL_0236
DR   CancerTools; 161924
DR   CCRID; 1101HUM-PUMC000813
DR   CCRID; 3101HUMTCHu144
DR   Cell_Model_Passport; SIDM00921
DR   ChEMBL-Cells; CHEMBL3307639
DR   ChEMBL-Targets; CHEMBL614535
DR   CLS; 300135
DR   Cosmic; 724859
DR   Cosmic; 929969
DR   Cosmic; 933575
DR   Cosmic; 934466
DR   Cosmic; 934542
DR   Cosmic; 1071885
DR   Cosmic; 1089230
DR   Cosmic; 1146874
DR   Cosmic; 1176611
DR   Cosmic; 1434959
DR   Cosmic; 1995360
DR   Cosmic; 2668262
DR   Cosmic-CLP; 724859
DR   DepMap; ACH-000264
DR   DSMZ; ACC-734
DR   DSMZCellDive; ACC-734
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724859
DR   GEO; GSM108805
DR   GEO; GSM108806
DR   GEO; GSM253341
DR   GEO; GSM434325
DR   GEO; GSM513938
DR   GEO; GSM514319
DR   GEO; GSM794263
DR   GEO; GSM817065
DR   GEO; GSM843487
DR   GEO; GSM886916
DR   GEO; GSM887982
DR   GEO; GSM1374435
DR   GEO; GSM1374436
DR   GEO; GSM1669659
DR   IARC_TP53; 119
DR   IARC_TP53; 21265
DR   ICLC; HTL97003
DR   IGRhCellID; Calu6
DR   KCLB; 30056
DR   LiGeA; CCLE_215
DR   LINCS_LDP; LCL-1626
DR   Lonza; 1139
DR   NCBI_Iran; C431
DR   PharmacoDB; Calu6_180_2019
DR   PRIDE; PXD025499
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0236
DR   PubChem_Cell_line; CVCL_0236
DR   Wikidata; Q54808427
RX   PubMed=1855224;
RX   PubMed=2388294;
RX   PubMed=3129183;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=3940644;
RX   PubMed=6148444;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=7834619;
RX   PubMed=7972006;
RX   PubMed=8385084;
RX   PubMed=12068308;
RX   PubMed=12794755;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28273808;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-473.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/calu-6-xenograft-model/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/calu-06
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (Note=In RPMI 1640 + 10% FBS), 32 hours (Note=In ACL-3), 41 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 31.9 hours (PubMed=29681454); ~2 days (CLS=300135); ~72 hours (DSMZ=ACC-734).
CC   HLA typing: A*01:01,01:01; B*08:01,35:08; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (PubMed=1855224; PubMed=12068308; PubMed=12794755; ATCC=HTB-56; Cosmic-CLP=724859; DepMap=ACH-000264).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (PubMed=1855224; PubMed=12794755; ATCC=HTB-56; Cosmic-CLP=724859; DepMap=ACH-000264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.17%; Native American=0.95%; East Asian, North=0.74%; East Asian, South=0%; South Asian=0%; European, North=66.06%; European, South=32.08% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=HTB-56; CLS=300135; Cosmic-CLP=724859; DSMZ=ACC-734; KCLB=30056; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 17,26
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 5,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   Calu3-GemR
AC   CVCL_EQ19
DR   cancercelllines; CVCL_EQ19
DR   GEO; GSM159359
DR   GEO; GSM159360
DR   GEO; GSM159361
DR   GEO; GSM159362
DR   GEO; GSM159363
DR   GEO; GSM159364
DR   GEO; GSM159365
DR   GEO; GSM159366
DR   GEO; GSM159367
DR   GEO; GSM159368
DR   GEO; GSM159369
DR   GEO; GSM159370
DR   GEO; GSM159371
DR   GEO; GSM159372
DR   GEO; GSM159373
DR   GEO; GSM159374
DR   Wikidata; Q54808428
RX   PubMed=17483357;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0609 ! Calu-3
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   Calu6 Krev-2
AC   CVCL_D4Y3
DR   Wikidata; Q127380397
RX   PubMed=1485916;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9855; RAP1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Calu6 Krev-4
AC   CVCL_D4Y4
DR   Wikidata; Q127380398
RX   PubMed=1485916;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9855; RAP1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Calu6 Krev-7
AC   CVCL_D4Y5
DR   Wikidata; Q127380399
RX   PubMed=1485916;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9855; RAP1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Calu6 Krev-8
AC   CVCL_D4Y6
DR   Wikidata; Q127380400
RX   PubMed=1485916;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9855; RAP1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Calu6 Krev-9
AC   CVCL_D4Y7
DR   Wikidata; Q127380401
RX   PubMed=1485916;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9855; RAP1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Calu6/Beta2
AC   CVCL_C8GA
DR   Wikidata; Q123030851
RX   PubMed=19582164;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a IL12RB2/pEGFP-N1 construct (PubMed=19582164).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5972; IL12RB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   CAM
AC   CVCL_ZV35
SY   Cromileptes Altivelis Muscle
DR   Wikidata; Q98125611
RX   PubMed=32588157;
CC   Group: Fish cell line.
CC   Characteristics: Maximum growth rate at 28 Celsius (PubMed=32588157).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=304459; ! Cromileptes altivelis (Humpback grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   CaM-11D9B4B9
AC   CVCL_E5I3
DR   CCRID; 4201PAT-CCTCC02522
DR   CCRID; 4201PAT-CCTCC02661
RX   Patent=CN118979017A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023234.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Channa argus (Northern snakehead).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CAM-44A
AC   CVCL_B5E8
SY   Carassius Auratus Muscle-44A
DR   Wikidata; Q110432673
RX   PubMed=34725799;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
OI   CVCL_B5E9 ! CAM-44B
OI   CVCL_B5EA ! CAM-45A
OI   CVCL_B5EB ! CAM-45B
OI   CVCL_B5EC ! CAM-47A
SX   Sex unspecified
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CAM-44B
AC   CVCL_B5E9
SY   Carassius Auratus Muscle-44B
DR   Wikidata; Q110432674
RX   PubMed=34725799;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
OI   CVCL_B5E8 ! CAM-44A
OI   CVCL_B5EA ! CAM-45A
OI   CVCL_B5EB ! CAM-45B
OI   CVCL_B5EC ! CAM-47A
SX   Sex unspecified
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CAM-45A
AC   CVCL_B5EA
SY   Carassius Auratus Muscle-45A
DR   Wikidata; Q110432675
RX   PubMed=34725799;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
OI   CVCL_B5E8 ! CAM-44A
OI   CVCL_B5E9 ! CAM-44B
OI   CVCL_B5EB ! CAM-45B
OI   CVCL_B5EC ! CAM-47A
SX   Sex unspecified
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CAM-45B
AC   CVCL_B5EB
SY   Carassius Auratus Muscle-45B
DR   Wikidata; Q110432676
RX   PubMed=34725799;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
OI   CVCL_B5E8 ! CAM-44A
OI   CVCL_B5E9 ! CAM-44B
OI   CVCL_B5EA ! CAM-45A
OI   CVCL_B5EC ! CAM-47A
SX   Sex unspecified
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CAM-47A
AC   CVCL_B5EC
SY   Carassius Auratus Muscle-47A
DR   Wikidata; Q110432677
RX   PubMed=34725799;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
OI   CVCL_B5E8 ! CAM-44A
OI   CVCL_B5E9 ! CAM-44B
OI   CVCL_B5EA ! CAM-45A
OI   CVCL_B5EB ! CAM-45B
SX   Sex unspecified
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CAM-M
AC   CVCL_A9FY
DR   CCRID; 5301BIR-KCB1564MZJ
DR   KCB; KCB 2015064MZJ
DR   Wikidata; Q108819981
CC   Group: Bird cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9089; ! Chrysolophus pictus (Golden pheasant)
OI   CVCL_A9FZ ! CAM-S
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CAM-S
AC   CVCL_A9FZ
DR   CCRID; 5301BIR-KCB1564SZJ
DR   KCB; KCB 2015064SZJ
DR   Wikidata; Q108819982
CC   Group: Bird cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9089; ! Chrysolophus pictus (Golden pheasant)
OI   CVCL_A9FY ! CAM-M
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CAM020
AC   CVCL_E516
SY   Extract 384
DR   dbMHC; 48530
DR   ECACC; 94050334
DR   IHW; IHW09256
DR   IPD-IMGT/HLA; 10378
DR   Wikidata; Q54808429
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/324cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*24:02; B*48,15:13; C*08; DPB1*05:01,14:01 (IPD-IMGT/HLA=10378).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   CAM191
AC   CVCL_BS93
DR   KCB; KCB 200539YJ
DR   Wikidata; Q54808430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   CaMa clone 15
AC   CVCL_1T14
SY   CaMa (clone 15); CaMa 15; Cancer Mammae clone 15
DR   BioSample; SAMN03152002
DR   Wikidata; Q54808431
RX   PubMed=6451928;
RX   PubMed=14071827;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of human origin but found to be from both mouse and hamster (PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00034.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   CAMA-1
AC   CVCL_1115
SY   Cama-1; CAMA1; CAMA
DR   BTO; BTO_0005022
DR   CLO; CLO_0002194
DR   EFO; EFO_0001100
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-21
DR   BioGRID_ORCS_Cell_line; 588
DR   BioSample; SAMN03472698
DR   BioSample; SAMN10987851
DR   cancercelllines; CVCL_1115
DR   CancerTools; 161925
DR   Cell_Model_Passport; SIDM00920
DR   ChEMBL-Cells; CHEMBL3308719
DR   ChEMBL-Targets; CHEMBL1075416
DR   Cosmic; 687468
DR   Cosmic; 871153
DR   Cosmic; 904354
DR   Cosmic; 946382
DR   Cosmic; 997930
DR   Cosmic; 1000130
DR   Cosmic; 1046925
DR   Cosmic; 1047717
DR   Cosmic; 1136349
DR   Cosmic; 1287905
DR   Cosmic; 1289386
DR   Cosmic; 1603195
DR   Cosmic; 1995361
DR   Cosmic; 2165018
DR   Cosmic; 2750520
DR   Cosmic-CLP; 946382
DR   DepMap; ACH-000783
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 946382
DR   GEO; GSM344344
DR   GEO; GSM344394
DR   GEO; GSM378143
DR   GEO; GSM421864
DR   GEO; GSM783930
DR   GEO; GSM827295
DR   GEO; GSM843488
DR   GEO; GSM843489
DR   GEO; GSM847248
DR   GEO; GSM847458
DR   GEO; GSM886917
DR   GEO; GSM887983
DR   GEO; GSM984230
DR   GEO; GSM1008894
DR   GEO; GSM1053694
DR   GEO; GSM1172856
DR   GEO; GSM1172948
DR   GEO; GSM1215264
DR   GEO; GSM1238119
DR   GEO; GSM1374437
DR   GEO; GSM1661977
DR   GEO; GSM1669660
DR   IARC_TP53; 18372
DR   LiGeA; CCLE_527
DR   LINCS_HMS; 50131
DR   LINCS_LDP; LCL-1466
DR   Lonza; 1251
DR   PharmacoDB; CAMA1_181_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1115
DR   PubChem_Cell_line; CVCL_1115
DR   SLKBase; 3405
DR   Wikidata; Q54808432
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=10862037;
RX   PubMed=11343771;
RX   PubMed=12353263;
RX   PubMed=12661003;
RX   PubMed=12800145;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19593635;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-breast-cell-line-cama-1
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 926.
CC   Population: Caucasian.
CC   Doubling time: 72.94 hours (JWGray panel).
CC   HLA typing: A*02:01,32:01; B*15:01,40:02; C*02:02,03:03; DQB1*03:01,03:01; DRB1*11:01,11:01 (PubMed=25960936).
CC   HLA typing: A*02:01,32:01; B*15:01,40:02; C*02:02,03:03; DQA1*05:02,03:02; DQB1*03:04,03:04; DRB1*11:30,13:07 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; c.1712-1G>A; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp92His (c.274G>C); Zygosity=Heterozygous (PubMed=19593635; ATCC=HTB-21).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (PubMed=16541312; ATCC=HTB-21; Cosmic-CLP=946382; DepMap=ACH-000783).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=1.38%; East Asian, South=0%; South Asian=0%; European, North=66.52%; European, South=31.74% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-21; Cosmic-CLP=946382; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14,17
ST   D12S391: 15
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13
ST   D1S1656: 11,15
ST   D21S11: 32.2
ST   D22S1045: 11,17
ST   D2S1338: 17,21
ST   D2S441: 11
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 19,25
ST   Penta D: 10,11
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   CAMA-1/Cas9-hyg
AC   CVCL_C9DC
DR   GeneCopoeia; SL562
DR   Wikidata; Q123030852
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL562).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; c.1712-1G>A; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp92His (c.274G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1115 ! CAMA-1
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   Cama-2
AC   CVCL_LK71
DR   Wikidata; Q54808433
RX   PubMed=3518877;
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   CAMB
AC   CVCL_YD89
SY   Channa Argus Maculata Brain
DR   Wikidata; Q93442941
RX   PubMed=31654776;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 22 to 32 Celsius, the optimal growth temperature is 27 Celsius (PubMed=31654776).
CC   Virology: Susceptible to infection by Tilapia lake virus (TiLV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=413233; ! Channa argus x Channa maculata (Hybrid snakehead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 7
//
ID   CAMe001-A
AC   CVCL_9R98
SY   HNES-1; HNES1; hNES1; Human Naive Embryonic Stem cells 1
DR   ArrayExpress; E-MTAB-4461
DR   ArrayExpress; E-MTAB-4462
DR   ArrayExpress; E-MTAB-4463
DR   BioSamples; SAMEA6032113
DR   hPSCreg; CAMe001-A
DR   SKIP; SKIP002674
DR   Wikidata; Q54808434
RX   PubMed=26947977;
RX   PubMed=33831366;
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0063.
CC   Registration: UK Stem Cell Bank (UKSCB); R-19-001, Steering comm. appl. SCSC11-58-(c).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   CAMe002-A
AC   CVCL_9R99
SY   HNES-3; HNES3; hNES3; Human Naive Embryonic Stem cells 3
DR   ArrayExpress; E-MTAB-4461
DR   ArrayExpress; E-MTAB-4462
DR   BioSamples; SAMEA6032115
DR   hPSCreg; CAMe002-A
DR   SKIP; SKIP002675
DR   Wikidata; Q54808435
RX   PubMed=26947977;
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0064.
CC   Registration: UK Stem Cell Bank (UKSCB); R-19-002, Steering comm. appl. SCSC14-03.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   CAMi001-A
AC   CVCL_2Z89
SY   KiPS C1
DR   hPSCreg; CAMi001-A
DR   SKIP; SKIP002570
DR   Wikidata; Q54808436
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   CAMi002-A
AC   CVCL_2Z90
SY   FiPS 2a
DR   hPSCreg; CAMi002-A
DR   SKIP; SKIP002572
DR   Wikidata; Q54808437
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z91 ! CAMi002-B
OI   CVCL_2Z92 ! CAMi002-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   CAMi002-B
AC   CVCL_2Z91
SY   FiPS 2b
DR   hPSCreg; CAMi002-B
DR   SKIP; SKIP002571
DR   Wikidata; Q54808438
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z90 ! CAMi002-A
OI   CVCL_2Z92 ! CAMi002-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   CAMi002-C
AC   CVCL_2Z92
SY   FiPS 2C
DR   hPSCreg; CAMi002-C
DR   SKIP; SKIP002573
DR   Wikidata; Q54808439
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z90 ! CAMi002-A
OI   CVCL_2Z91 ! CAMi002-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   CAMi004-A
AC   CVCL_2Z93
SY   AdiPS 1
DR   hPSCreg; CAMi004-A
DR   SKIP; SKIP002574
DR   Wikidata; Q54808440
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   CAMi005-A
AC   CVCL_9S01
SY   hIPS-O27-Tat; O27Tat
DR   hPSCreg; CAMi005-A
DR   SKIP; SKIP002628
DR   Wikidata; Q54808441
CC   From: University of Cambridge; Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S02 ! CAMi005-B
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   CAMi005-B
AC   CVCL_9S02
SY   2F8
DR   hPSCreg; CAMi005-B
DR   SKIP; SKIP002629
DR   Wikidata; Q54808442
CC   From: University of Cambridge; Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S01 ! CAMi005-A
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   CAMi014-A
AC   CVCL_A1NY
SY   A1ATD1
DR   BioSamples; SAMEA7211861
DR   hPSCreg; CAMi014-A
DR   Wikidata; Q102113655
RX   PubMed=21993621;
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=21993621).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CAMK
AC   CVCL_YD04
SY   Channa Argus Maculata Kidney
DR   CCRID; 4201PAT-CCTCC01384
DR   Wikidata; Q93443006
RX   Patent=CN110295137B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201994.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=413233; ! Channa argus x Channa maculata (Hybrid snakehead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 8
//
ID   cAMP Hunter 1321N1 CALCR-RAMP3 Gs
AC   CVCL_KU71
DR   cancercelllines; CVCL_KU71
DR   DiscoverX; 95-0166C6
DR   Wikidata; Q54808443
CC   Problematic cell line: Contaminated. Ancestral cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9845; RAMP3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0110 ! 1321N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   cAMP Hunter CHO-K1 ADCYAP1R1 Gs/Gq
AC   CVCL_KU72
SY   cAMP Hunter CHO-K1 ADCYAP1R1 Gs
DR   DiscoverX; 95-0064C2
DR   Wikidata; Q54808444
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 ADORA1 Gi
AC   CVCL_KU73
DR   DiscoverX; 95-0061C2
DR   Wikidata; Q54808445
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:262; ADORA1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 ADORA2B Gs
AC   CVCL_KU74
DR   DiscoverX; 95-0041C2
DR   Wikidata; Q54808446
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:264; ADORA2B.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 ADORA3 Gi
AC   CVCL_KU75
DR   DiscoverX; 95-0101C2
DR   Wikidata; Q54808447
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:268; ADORA3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 ADRA2A Gi
AC   CVCL_KU76
DR   DiscoverX; 95-0126C2
DR   Wikidata; Q54808448
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:281; ADRA2A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 ADRA2C Gi
AC   CVCL_KU77
DR   DiscoverX; 95-0053C2
DR   Wikidata; Q54808450
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:283; ADRA2C.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 ADRB1 Gs
AC   CVCL_KU78
DR   DiscoverX; 95-0113C2
DR   Wikidata; Q54808451
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:285; ADRB1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 ADRB2 Gs
AC   CVCL_KU79
DR   DiscoverX; 95-0121C2
DR   Wikidata; Q54808452
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 AGTRL1 Gi
AC   CVCL_KU80
DR   DiscoverX; 95-0147C2
DR   Wikidata; Q54808453
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:339; APLNR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   cAMP Hunter CHO-K1 AVPR2 Gs
AC   CVCL_KU81
DR   DiscoverX; 95-0150C2
DR   Wikidata; Q54808454
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:897; AVPR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 C3AR1 Gi
AC   CVCL_KU82
DR   DiscoverX; 95-0155C2
DR   Wikidata; Q54808455
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1319; C3AR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 C5AR1 Gi
AC   CVCL_KU83
SY   cAMP Hunter CHO-K1 C5R1 Gi
DR   DiscoverX; 95-0079C2
DR   Wikidata; Q54808456
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1338; C5AR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CALCR Gs
AC   CVCL_KU84
DR   DiscoverX; 95-0161C2
DR   Wikidata; Q54808457
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CALCRL-RAMP1 Gs
AC   CVCL_KU85
DR   DiscoverX; 95-0164C2
DR   Wikidata; Q54808458
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CALCRL-RAMP3 Gs
AC   CVCL_KU86
DR   DiscoverX; 95-0169C2
DR   Wikidata; Q54808459
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9845; RAMP3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CCR1 Gi
AC   CVCL_KU87
DR   DiscoverX; 95-0066C2
DR   Wikidata; Q54808460
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1602; CCR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CCR10 Gi
AC   CVCL_KU88
DR   DiscoverX; 95-0175C2
DR   Wikidata; Q54808461
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4474; CCR10.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CCR5 Gi
AC   CVCL_KU89
DR   DiscoverX; 95-0068C2
DR   Wikidata; Q54808462
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CCR6 Gi
AC   CVCL_KU90
DR   DiscoverX; 95-0069C2
DR   Wikidata; Q54808463
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1607; CCR6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CCR7 Gi
AC   CVCL_KU91
DR   DiscoverX; 95-0070C2
DR   Wikidata; Q54808464
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1608; CCR7.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CHRM2 Gs
AC   CVCL_KU92
DR   DiscoverX; 95-0078C2
DR   Wikidata; Q54808465
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1951; CHRM2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CHRM4 Gs
AC   CVCL_KU93
DR   DiscoverX; 95-0145C2
DR   Wikidata; Q54808466
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1953; CHRM4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CMKLR1 Gi
AC   CVCL_KU94
DR   DiscoverX; 95-0080C2
DR   Wikidata; Q54808467
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2121; CMKLR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CNR1 Gi
AC   CVCL_KU95
DR   DiscoverX; 95-0071C2
DR   Wikidata; Q54808468
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2159; CNR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CNR2 Gi
AC   CVCL_KU96
DR   DiscoverX; 95-0060C2
DR   Wikidata; Q54808469
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2160; CNR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CRHR1 Gs
AC   CVCL_KU97
DR   DiscoverX; 95-0047C2
DR   Wikidata; Q54808470
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2357; CRHR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CRHR2 Gs
AC   CVCL_KU98
DR   DiscoverX; 95-0048C2
DR   Wikidata; Q54808471
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2358; CRHR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CRTH2 Gi
AC   CVCL_KU99
SY   cAMP Hunter CHO-K1 CRTh2 Gi
DR   DiscoverX; 95-0072C2
DR   Wikidata; Q54808472
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4502; PTGDR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CXCR1 Gi
AC   CVCL_KV00
DR   DiscoverX; 95-0073C2
DR   Wikidata; Q54808473
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6026; CXCR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CXCR2 Gi
AC   CVCL_KV01
DR   DiscoverX; 95-0074C2
DR   Wikidata; Q54808474
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6027; CXCR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CXCR3 Gi
AC   CVCL_KV02
DR   DiscoverX; 95-0054C2
DR   Wikidata; Q54808475
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CXCR4 Gi
AC   CVCL_KV03
DR   DiscoverX; 95-0081C2
DR   Wikidata; Q54808476
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CXCR5 Gi
AC   CVCL_KV04
DR   DiscoverX; 95-0082C2
DR   Wikidata; Q54808477
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1060; CXCR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 CXCR6 Gi
AC   CVCL_KV05
DR   DiscoverX; 95-0138C2
DR   Wikidata; Q54808478
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16647; CXCR6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 DRD1 Gs
AC   CVCL_KV06
DR   DiscoverX; 95-0083C2
DR   Wikidata; Q54808479
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3020; DRD1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 DRD2L Gi
AC   CVCL_KV07
DR   DiscoverX; 95-0125C2
DR   Wikidata; Q54808480
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3023; DRD2 (Note=Isoform long).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 DRD2S Gi
AC   CVCL_KV08
DR   DiscoverX; 95-0084C2
DR   Wikidata; Q54808481
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3023; DRD2 (Note=Isoform short).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 DRD4 Gi
AC   CVCL_KV09
DR   DiscoverX; 95-0123C2
DR   Wikidata; Q54808482
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3025; DRD4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 DRD5 Gs
AC   CVCL_KV10
DR   DiscoverX; 95-0094C2
DR   Wikidata; Q54808483
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3026; DRD5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 EBI2 Gi
AC   CVCL_KV11
DR   DiscoverX; 95-0172C2
DR   Wikidata; Q54808484
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3128; GPR183.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 EDG1 Gi
AC   CVCL_KV12
DR   DiscoverX; 95-0142C2
DR   Wikidata; Q54808485
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3165; S1PR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 EDG2 Gi
AC   CVCL_KV13
DR   DiscoverX; 95-0135C2
DR   Wikidata; Q54808486
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3166; LPAR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 FFAR3 Gi
AC   CVCL_KV14
DR   DiscoverX; 95-0136C2
DR   Wikidata; Q54808487
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4499; FFAR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 FPR1 Gi
AC   CVCL_KV15
DR   DiscoverX; 95-0139C2
DR   Wikidata; Q54808488
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3826; FPR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 FPR3 Gi
AC   CVCL_KV16
DR   DiscoverX; 95-0171C2
DR   Wikidata; Q54808489
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3828; FPR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 FPRL1 Gi
AC   CVCL_KV17
DR   DiscoverX; 95-0044C2
DR   Wikidata; Q54808496
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3827; FPR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 FSHR Gs
AC   CVCL_KV18
DR   DiscoverX; 95-0119C2
DR   Wikidata; Q54808497
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3969; FSHR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GABBR1-GABBR2 Gi
AC   CVCL_KV19
DR   DiscoverX; 95-0165C2
DR   Wikidata; Q54808498
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4070; GABBR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GALR1 Gi
AC   CVCL_KV20
DR   DiscoverX; 95-0058C2
DR   Wikidata; Q54808499
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4132; GALR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GCGR Gs
AC   CVCL_KV21
DR   DiscoverX; 95-0042C2
DR   Wikidata; Q54808500
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GHRHR Gs
AC   CVCL_KV22
DR   DiscoverX; 95-0076C2
DR   Wikidata; Q54808501
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4266; GHRHR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GIPR Gs
AC   CVCL_KV23
DR   DiscoverX; 95-0146C2
DR   Wikidata; Q54808502
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4271; GIPR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GLP1R Gs
AC   CVCL_KV24
DR   DiscoverX; 95-0062C2
DR   Wikidata; Q54808503
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GLP2R Gs
AC   CVCL_KV25
SY   cAMP Hunter CHO-K1 GLp2R
DR   DiscoverX; 95-0112C2
DR   Wikidata; Q54808504
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4325; GLP2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GPBAR1 Gs
AC   CVCL_KV26
DR   DiscoverX; 95-0049C2
DR   Wikidata; Q54808505
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19680; GPBAR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GPR109A Gi
AC   CVCL_KV27
DR   DiscoverX; 95-0122C2
DR   Wikidata; Q54808506
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24827; HCAR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GPR109B Gi
AC   CVCL_KV28
DR   DiscoverX; 95-0141C2
DR   Wikidata; Q54808507
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16824; HCAR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GPR35 Gi
AC   CVCL_KV29
DR   DiscoverX; 95-0152C2
DR   Wikidata; Q54808508
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4492; GPR35.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GPR81 Gi
AC   CVCL_KV30
DR   DiscoverX; 95-0149C2
DR   Wikidata; Q54808509
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4532; HCAR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GPR84 Gi
AC   CVCL_KV31
DR   DiscoverX; 95-0158C2
DR   Wikidata; Q54808510
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4535; GPR84.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GRM2 Gi
AC   CVCL_KV32
DR   DiscoverX; 95-0148C2
DR   Wikidata; Q54808511
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4594; GRM2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GRM3 Gi
AC   CVCL_KV33
DR   DiscoverX; 95-0137C2
DR   Wikidata; Q54808512
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4595; GRM3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GRM4 Gi
AC   CVCL_KV34
DR   DiscoverX; 95-0117C2
DR   Wikidata; Q54808513
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4596; GRM4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 GRM6 Gi
AC   CVCL_KV35
DR   DiscoverX; 95-0105C2
DR   Wikidata; Q54808514
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4598; GRM6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 HRH2 Gs/Gq
AC   CVCL_KV36
SY   cAMP Hunter CHO-K1 HRH2 Gs
DR   DiscoverX; 95-0043C2
DR   Wikidata; Q54808515
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5183; HRH2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 HRH3 Gi
AC   CVCL_KV37
DR   DiscoverX; 95-0103C2
DR   Wikidata; Q54808516
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5184; HRH3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 HTR1A Gi
AC   CVCL_KV38
DR   DiscoverX; 95-0132C2
DR   Wikidata; Q54808517
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5286; HTR1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 HTR1B Gi
AC   CVCL_KV39
DR   DiscoverX; 95-0162C2
DR   Wikidata; Q54808518
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5287; HTR1B.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 HTR1F Gi
AC   CVCL_KV40
DR   DiscoverX; 95-0143C2
DR   Wikidata; Q54808519
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5292; HTR1F.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 HTR5A Gi
AC   CVCL_KV41
DR   DiscoverX; 95-0160C2
DR   Wikidata; Q54808520
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5300; HTR5A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 HTR7A Gs
AC   CVCL_KV42
DR   DiscoverX; 95-0151C2
DR   Wikidata; Q54808521
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5302; HTR7 (Note=Isoform A).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 LHCGR Gs
AC   CVCL_KV43
DR   DiscoverX; 95-0106C2
DR   Wikidata; Q54808522
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6585; LHCGR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 LTB4R Gi
AC   CVCL_KV44
DR   DiscoverX; 95-0085C2
DR   Wikidata; Q54808523
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6713; LTB4R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 MC1R Gs
AC   CVCL_KV45
DR   DiscoverX; 95-0111C2
DR   Wikidata; Q54808524
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6929; MC1R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 MC3R Gs
AC   CVCL_KV46
DR   DiscoverX; 95-0045C2
DR   Wikidata; Q54808525
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6931; MC3R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 MC4R Gs
AC   CVCL_KV47
DR   DiscoverX; 95-0050C2
DR   Wikidata; Q54808526
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6932; MC4R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 MC5R Gs
AC   CVCL_KV48
DR   DiscoverX; 95-0046C2
DR   Wikidata; Q54808527
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6933; MC5R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 MCHR1 Gi
AC   CVCL_KV49
DR   DiscoverX; 95-0055C2
DR   Wikidata; Q54808528
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4479; MCHR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 mGIPR Gs
AC   CVCL_KV50
DR   DiscoverX; 95-0154C2
DR   Wikidata; Q54808529
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1352753; Gipr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   cAMP Hunter CHO-K1 mRXFP1 Gs
AC   CVCL_KV51
DR   DiscoverX; 95-0180C2
DR   Wikidata; Q54808530
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2682211; Rxfp1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   cAMP Hunter CHO-K1 mTAAR1 Gs
AC   CVCL_KV52
DR   DiscoverX; 95-0177C2
DR   Wikidata; Q54808531
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2148258; Taar1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   cAMP Hunter CHO-K1 MTNR1A Gi
AC   CVCL_KV53
DR   DiscoverX; 95-0086C2
DR   Wikidata; Q54808532
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7463; MTNR1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 MTNR1B Gi
AC   CVCL_KV54
DR   DiscoverX; 95-0056C2
DR   Wikidata; Q54808533
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7464; MTNR1B.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 NPBWR1 Gi
AC   CVCL_KV55
DR   DiscoverX; 95-0099C2
DR   Wikidata; Q54808534
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4522; NPBWR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 NPBWR2 Gi
AC   CVCL_KV56
DR   DiscoverX; 95-0100C2
DR   Wikidata; Q54808535
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4530; NPBWR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 NPFFR1 Gi
AC   CVCL_KV57
DR   DiscoverX; 95-0097C2
DR   Wikidata; Q54808538
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17425; NPFFR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 NPY2R Gi
AC   CVCL_KV58
DR   DiscoverX; 95-0077C2
DR   Wikidata; Q54808539
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7957; NPY2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 OPRD1 Gi
AC   CVCL_KV59
DR   DiscoverX; 95-0108C2
DR   Wikidata; Q54808541
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8153; OPRD1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 OPRK1 Gi
AC   CVCL_KV60
DR   DiscoverX; 95-0088C2
DR   Wikidata; Q54808542
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8154; OPRK1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 OPRL1 Gi
AC   CVCL_KV61
DR   DiscoverX; 95-0115C2
DR   Wikidata; Q54808543
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8155; OPRL1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 OPRM1 Gi
AC   CVCL_KV62
DR   DiscoverX; 95-0107C2
DR   Wikidata; Q54808544
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8156; OPRM1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 OXER1 Gi
AC   CVCL_KV63
DR   DiscoverX; 95-0089C2
DR   Wikidata; Q54808545
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24884; OXER1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PPYR1 Gi
AC   CVCL_KV64
DR   DiscoverX; 95-0087C2
DR   Wikidata; Q54808546
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9329; NPY4R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PROKR1 Gs
AC   CVCL_KV65
DR   DiscoverX; 95-0090C2
DR   Wikidata; Q54808547
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4524; PROKR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PTAFR Gi
AC   CVCL_KV66
DR   DiscoverX; 95-0091C2
DR   Wikidata; Q54808548
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9582; PTAFR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PTGDR Gs
AC   CVCL_KV67
DR   DiscoverX; 95-0110C2
DR   Wikidata; Q54808549
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9591; PTGDR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PTGER3 Gi
AC   CVCL_KV68
DR   DiscoverX; 95-0159C2
DR   Wikidata; Q54808550
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9595; PTGER3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PTGIR Gs
AC   CVCL_KV69
DR   DiscoverX; 95-0051C2
DR   Wikidata; Q54808551
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9602; PTGIR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PTHR1 Gs/Gq
AC   CVCL_KV70
SY   cAMP Hunter CHO-K1 PTHR1 Gs
DR   DiscoverX; 95-0118C2
DR   Wikidata; Q54808552
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9608; PTH1R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 PTHR2 Gs/Gq
AC   CVCL_KV71
SY   cAMP Hunter CHO-K1 PTHR2 Gs
DR   DiscoverX; 95-0057C2
DR   Wikidata; Q54808553
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9609; PTH2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 rDRD1 Gs
AC   CVCL_KV72
DR   DiscoverX; 95-0128C2
DR   Wikidata; Q54808554
CC   Genetic integration: Method=Transfection; Gene=RGD; 2518; Drd1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   cAMP Hunter CHO-K1 rDRD2L Gi
AC   CVCL_KV73
DR   DiscoverX; 95-0130C2
DR   Wikidata; Q54808555
CC   Genetic integration: Method=Transfection; Gene=RGD; 2520; Drd2 (Note=Isoform long).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   cAMP Hunter CHO-K1 rDRD2S Gi
AC   CVCL_KV74
DR   DiscoverX; 95-0129C2
DR   Wikidata; Q54808556
CC   Genetic integration: Method=Transfection; Gene=RGD; 2520; Drd2 (Note=Isoform short).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   cAMP Hunter CHO-K1 rTAAR1 Gs
AC   CVCL_KV75
DR   DiscoverX; 95-0178C2
DR   Wikidata; Q54808557
CC   Genetic integration: Method=Transfection; Gene=RGD; 621621; Taar1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   cAMP Hunter CHO-K1 RXFP1 Gs
AC   CVCL_KV76
DR   DiscoverX; 95-0127C2
DR   Wikidata; Q54808558
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19718; RXFP1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 RXFP2 Gs
AC   CVCL_KV77
DR   DiscoverX; 95-0140C2
DR   Wikidata; Q54808559
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17318; RXFP2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 RXFP3 Gi
AC   CVCL_KV78
DR   DiscoverX; 95-0102C2
DR   Wikidata; Q54808560
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24883; RXFP3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 RXFP4 Gi
AC   CVCL_KV79
DR   DiscoverX; 95-0134C2
DR   Wikidata; Q54808561
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14666; RXFP4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 SCTR Gs
AC   CVCL_KV80
DR   DiscoverX; 95-0075C2
DR   Wikidata; Q54808562
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10608; SCTR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 SSTR2 Gi
AC   CVCL_KV81
DR   DiscoverX; 95-0095C2
DR   Wikidata; Q54808563
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11331; SSTR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 SSTR3 Gi
AC   CVCL_KV82
DR   DiscoverX; 95-0131C2
DR   Wikidata; Q54808564
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11332; SSTR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 SSTR4 Gi
AC   CVCL_KV83
DR   DiscoverX; 95-0059C2
DR   Wikidata; Q54808565
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11333; SSTR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 SSTR5 Gi
AC   CVCL_KV84
DR   DiscoverX; 95-0133C2
DR   Wikidata; Q54808566
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11334; SSTR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 TAAR1 Gs
AC   CVCL_KV85
DR   DiscoverX; 95-0173C2
DR   Wikidata; Q54808567
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17734; TAAR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 TACR3 Gs/Gq
AC   CVCL_KV86
SY   cAMP Hunter CHO-K1 TACR3 Gs
DR   DiscoverX; 95-0092C2
DR   Wikidata; Q54808568
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11528; TACR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 TSHR(L) Gs
AC   CVCL_KV87
DR   DiscoverX; 95-0153C2
DR   Wikidata; Q54808569
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR (Note=Isoform long).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 VIPR1 Gs/Gq
AC   CVCL_KV88
SY   cAMP Hunter CHO-K1 VIPR1 Gs
DR   DiscoverX; 95-0093C2
DR   Wikidata; Q54808570
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12694; VIPR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 VIPR2 Gs
AC   CVCL_KV89
DR   DiscoverX; 95-0052C2
DR   Wikidata; Q54808571
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12695; VIPR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter CHO-K1 XCR1 Gi
AC   CVCL_KV90
DR   DiscoverX; 95-0096C2
DR   Wikidata; Q54808572
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1625; XCR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   cAMP Hunter DLD1 ADRB3 Gs
AC   CVCL_KV91
DR   DiscoverX; 95-0182C13
DR   Wikidata; Q54808573
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:288; ADRB3.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   cAMP Hunter DLD1 HTR7D Gs
AC   CVCL_KV92
DR   DiscoverX; 95-0163C13
DR   Wikidata; Q54808574
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5302; HTR7 (Note=Isoform D).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   cAMP Hunter DLD1 PTGER2 Gs
AC   CVCL_KV93
DR   DiscoverX; 95-0176C13
DR   Wikidata; Q54808575
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9594; PTGER2.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   cAMP Hunter U2OS HTR7B Gs
AC   CVCL_KV94
DR   DiscoverX; 95-0156C3
DR   Wikidata; Q54808576
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5302; HTR7 (Note=Isoform B).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   cAMP Hunter U2OS mGLP1R Gs
AC   CVCL_KV95
DR   DiscoverX; 95-0179C3
DR   Wikidata; Q54808577
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99571; Glp1r.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   CAN 19
AC   CVCL_A2XF
DR   Wikidata; Q105506581
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgG, lambda.
CC   Monoclonal antibody target: Human antigen on neurons and glia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   CaOs-1
AC   CVCL_H746
SY   CaOs1
DR   ChEMBL-Cells; CHEMBL3307926
DR   ChEMBL-Targets; CHEMBL614378
DR   PubChem_Cell_line; CVCL_H746
DR   Wikidata; Q54808578
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   CaOV
AC   CVCL_M091
DR   BioSample; SAMN03151670
DR   Wikidata; Q54808581
RX   PubMed=1246601;
RX   PubMed=4472134;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00035.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   Caov-1
AC   CVCL_0200
SY   CaOV-1; CAOV-1; CaOv1; CAOV1
DR   MCCL; MCC:0000091
DR   cancercelllines; CVCL_0200
DR   GEO; GSM784570
DR   Progenetix; CVCL_0200
DR   Wikidata; Q54808582
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 16
//
ID   Caov-2
AC   CVCL_6861
SY   CaOV-2; CAOV-2; CAOV2
DR   ATCC; HTB-74
DR   BioSample; SAMN03151863
DR   GEO; GSM711701
DR   GEO; GSM851912
DR   Wikidata; Q54808583
RX   PubMed=3518877;
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of its STR profile it seems to be a Calu-6 derivative. Originally thought to originate from an ovarian carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00458.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Was thought to be an OVCAR-2 derivative because its STR profile was identical to that originally reported for that cell line (PubMed=22710073). But this was shown (September 2025) not to be the correct STR profile for OVCAR-2. Meanwhile it was also noticed that the Caov-2 STR profile is identical to that of Calu-6.
CC   Discontinued: ATCC; HTB-74; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 17,26
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 23
//
ID   Caov-3
AC   CVCL_0201
AS   CVCL_0231
SY   CaOv-3; CaOV-3; CAOV-3; CAOV3; CaOV3; CaOv3; Caov3; CA-OV-3; CaOV3 (S)
DR   BTO; BTO_0000814
DR   CLO; CLO_0002195
DR   EFO; EFO_0002148
DR   MCCL; MCC:0000119
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-75
DR   BioGRID_ORCS_Cell_line; 338
DR   BioSample; SAMN03472624
DR   BioSample; SAMN05292465
DR   BioSample; SAMN10988200
DR   cancercelllines; CVCL_0201
DR   CancerTools; 161926
DR   CCRID; 1101HUM-PUMC000339
DR   CCRID; 3101HUMSCSP570
DR   CCRID; 4201HUM-CCTCC00118
DR   CCTCC; GDC0118
DR   Cell_Model_Passport; SIDM00919
DR   ChEMBL-Cells; CHEMBL3307927
DR   ChEMBL-Targets; CHEMBL614379
DR   CLS; 300319
DR   Cosmic; 687927
DR   Cosmic; 688092
DR   Cosmic; 809114
DR   Cosmic; 844349
DR   Cosmic; 906579
DR   Cosmic; 906825
DR   Cosmic; 924149
DR   Cosmic; 949225
DR   Cosmic; 1102821
DR   Cosmic; 1139227
DR   Cosmic; 1305310
DR   Cosmic; 1312190
DR   Cosmic; 1707569
DR   Cosmic; 1709259
DR   Cosmic; 2186585
DR   Cosmic; 2301585
DR   Cosmic-CLP; 906825
DR   DepMap; ACH-000713
DR   EGA; EGAS00001000610
DR   GDSC; 906825
DR   GEO; GSM184398
DR   GEO; GSM184399
DR   GEO; GSM274705
DR   GEO; GSM313711
DR   GEO; GSM459740
DR   GEO; GSM659371
DR   GEO; GSM711712
DR   GEO; GSM784569
DR   GEO; GSM851913
DR   GEO; GSM886918
DR   GEO; GSM887984
DR   GEO; GSM1001485
DR   GEO; GSM1291130
DR   GEO; GSM1669661
DR   GEO; GSM3161712
DR   GEO; GSM3161713
DR   IARC_TP53; 1416
DR   IARC_TP53; 28485
DR   IARC_TP53; 30197
DR   IGRhCellID; CaOv3
DR   IZSLER; BS TCL 165
DR   KCB; KCB 2013041YJ
DR   LiGeA; CCLE_499
DR   LINCS_LDP; LCL-1519
DR   PharmacoDB; Caov3_182_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0201
DR   PubChem_Cell_line; CVCL_0201
DR   Ubigene; YC-C031
DR   Wikidata; Q54808585
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=4016745;
RX   PubMed=9698466;
RX   PubMed=10318951;
RX   PubMed=12080474;
RX   PubMed=18560578;
RX   PubMed=19926575;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=22328975;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=33519462;
RX   PubMed=35681748;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544457
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/caov-3-human-ovarian-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2010-069.
CC   Population: Caucasian.
CC   Doubling time: 78 hours (PubMed=4016745); 68 hours (PubMed=25984343); ~44 hours (PBCF); 65.81 hours (JWGray panel).
CC   HLA typing: A*26:01,69:01; B*49:01,49:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Homozygous (PubMed=24023729; PubMed=25230021; ATCC=HTB-75).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.29%; Native American=0.12%; East Asian, North=2.22%; East Asian, South=0%; South Asian=15.22%; European, North=11.3%; European, South=68.85% (PubMed=30894373).
CC   Misspelling: CACOV-3; Note=Occasionally.
CC   Misspelling: CaCOV3; Note=Occasionally.
CC   Misspelling: CAVO3; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=HTB-75; CCRID; CLS=300319; Cosmic-CLP=906825; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 15,23
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 18
ST   D19S433: 14,17
ST   D21S11: 30
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 12
ST   D7S820: 10
ST   D8S1179: 9,14
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 11,15
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 51
//
ID   Caov-3-Luc
AC   CVCL_C8XM
DR   Ubigene; YC-C031-Luc-P
DR   Wikidata; Q123030853
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0201 ! Caov-3
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   CaOV3 CBPR
AC   CVCL_E3AS
RX   PubMed=35681748;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Homozygous (from parent cell line).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0201 ! Caov-3
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   CAOV3 (R)
AC   CVCL_C8XN
DR   Wikidata; Q123030855
RX   PubMed=33519462;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0201 ! Caov-3
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Caov-4
AC   CVCL_0202
SY   CaOv-4; CaOV-4; CAOV-4; CAOV4; Caov4
DR   CLO; CLO_0002196
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-76
DR   BioGRID_ORCS_Cell_line; 843
DR   BioSample; SAMN03472755
DR   BioSample; SAMN03472784
DR   BioSample; SAMN10987815
DR   cancercelllines; CVCL_0202
DR   CancerTools; 161927
DR   CCRID; 1101HUM-PUMC000367
DR   Cell_Model_Passport; SIDM00918
DR   ChEMBL-Cells; CHEMBL3308232
DR   ChEMBL-Targets; CHEMBL2366249
DR   Cosmic; 688093
DR   Cosmic; 809112
DR   Cosmic; 844350
DR   Cosmic; 849610
DR   Cosmic; 948287
DR   Cosmic; 949090
DR   Cosmic; 949226
DR   Cosmic; 1305321
DR   Cosmic-CLP; 949090
DR   DepMap; ACH-000103
DR   EGA; EGAS00001000978
DR   GDSC; 949090
DR   GEO; GSM784562
DR   GEO; GSM886919
DR   GEO; GSM887985
DR   GEO; GSM1001487
DR   GEO; GSM1291131
DR   GEO; GSM1669662
DR   IARC_TP53; 1414
DR   IARC_TP53; 28484
DR   IARC_TP53; 30198
DR   IGRhCellID; Caov4
DR   IZSLER; BS TCL 183
DR   KCLB; 30076
DR   LiGeA; CCLE_173
DR   LINCS_LDP; LCL-1520
DR   NCBI_Iran; C595
DR   PharmacoDB; Caov4_183_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0202
DR   PubChem_Cell_line; CVCL_0202
DR   Wikidata; Q54808586
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=9698466;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27235858;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/caov-4-human-ovarian-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2010-070.
CC   Population: Caucasian.
CC   Doubling time: >120 hours (PubMed=25984343).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val147Asp (c.440T>A); ClinVar=VCV001351017; Zygosity=Homozygous (PubMed=25230021; ATCC=HTB-76).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.23%; Native American=0%; East Asian, North=4.8%; East Asian, South=0%; South Asian=0%; European, North=67.03%; European, South=27.94% (PubMed=30894373).
CC   Derived from site: Metastatic; Fallopian tube, subserosa; UBERON=UBERON_8480037.
ST   Source(s): ATCC=HTB-76; CCRID=1101HUM-PUMC000367; Cosmic-CLP=949090; KCLB=30076; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10 (CCRID=1101HUM-PUMC000367; Cosmic-CLP=949090; KCLB=30076; PubMed=25230021; PubMed=25877200)
ST   CSF1PO: 10,11 (ATCC=HTB-76)
ST   D13S317: 12,14
ST   D16S539: 9,11
ST   D18S51: 21
ST   D19S433: 11,12
ST   D21S11: 28,33.2
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 11 (CCRID=1101HUM-PUMC000367; Cosmic-CLP=949090; KCLB=30076; PubMed=25230021; PubMed=25877200)
ST   D5S818: 11,13 (ATCC=HTB-76)
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   CAP
AC   CVCL_IQ88
SY   CEVEC's Amniocyte Production; N52.E6
DR   Lonza; 1310
DR   Wikidata; Q54907345
RX   Patent=US6558948;
RX   PubMed=11044912;
RX   PubMed=22373410;
RX   PubMed=22373426;
RX   PubMed=22821436;
WW   Provider; CEVEC; -; https://web.archive.org/web/20190713045907/https://cevec.com/technology/
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2416.
CC   Characteristics: Used for stable production of recombinant proteins.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IQ89 ! N52.F4
AG   Fetus
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 12
//
ID   CAP-CD63-tGFP
AC   CVCL_A8RY
DR   Wikidata; Q108819983
RX   PubMed=31461486;
CC   Characteristics: Overexpresses CD63-turboGFP. Transduced with a pStbl-CMV-bsd-CD63-tGFP vector.
CC   Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ88 ! CAP
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   CAP-CD63-tGFP-miRNA-493
AC   CVCL_A8SC
DR   Wikidata; Q108819984
RX   PubMed=31461486;
CC   Characteristics: Overexpresses CD63-turboGFP and MIR493. Transduced with a pStbl-CMV-bsd-CD63-tGFP vector and a pEGP-CMV-hsa-miRNA-493 vector.
CC   Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:32082; MIR493.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8RY ! CAP-CD63-tGFP
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   CAP-CD63-tGFP-miRNA-744
AC   CVCL_A8SD
DR   Wikidata; Q108819986
RX   PubMed=31461486;
CC   Characteristics: Overexpresses CD63-turboGFP and MIR744. Transduced with a pStbl-CMV-bsd-CD63-tGFP vector and a pEGP-CMV-hsa-miRNA-744 vector.
CC   Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:33658; MIR744.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8RY ! CAP-CD63-tGFP
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   CAP-CD63-tGFP-Null
AC   CVCL_A8SA
DR   Wikidata; Q108819987
RX   PubMed=31461486;
CC   Characteristics: Overexpresses CD63-turboGFP. Transduced with a pStbl-CMV-bsd-CD63-tGFP vector and a pEGP-CMV-Null vector.
CC   Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ88 ! CAP
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   CAP-pStbl-empty
AC   CVCL_A8RZ
DR   Wikidata; Q108819988
RX   PubMed=31461486;
CC   Characteristics: Transduced with a pStbl-CMV-bsd-Null vector.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ88 ! CAP
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   CAP-pStbl-empty-Null
AC   CVCL_A8SB
DR   Wikidata; Q108819989
RX   PubMed=31461486;
CC   Characteristics: Transduced with a pStbl-CMV-bsd-Null vector and a pEGP-CMV-Null vector.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8RZ ! CAP-pStbl-empty
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   CAP-T
AC   CVCL_WI61
DR   Wikidata; Q93443890
RX   PubMed=22373426;
CC   Characteristics: Used for stable production of recombinant proteins.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ88 ! CAP
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   CaPa
AC   CVCL_1U09
DR   Wikidata; Q54808587
RX   PubMed=14071827;
CC   Derived from site: Metastatic; Abdominal cavity; UBERON=UBERON_0003684.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   CaPA-4
AC   CVCL_V028
DR   Wikidata; Q54808588
RX   PubMed=8760589;
DI   NCIt; C5977; Submandibular gland carcinoma ex pleomorphic adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   Capan-1
AC   CVCL_0237
SY   CaPan-1; CAPAN-1; Capan 1; CAPAN 1; Capan1; CAPAN1
DR   BTO; BTO_0002744
DR   CLO; CLO_0002197
DR   EFO; EFO_0002153
DR   MCCL; MCC:0000126
DR   CLDB; cl639
DR   CLDB; cl640
DR   AddexBio; C0018001/31
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-79
DR   BCRJ; 0265
DR   BioGRID_ORCS_Cell_line; 844
DR   BioSample; SAMN01821543
DR   BioSample; SAMN01821620
DR   BioSample; SAMN03471999
DR   BioSample; SAMN05292467
DR   BioSample; SAMN10987884
DR   cancercelllines; CVCL_0237
DR   CancerTools; 161907
DR   Cell_Model_Passport; SIDM00934
DR   CGH-DB; 162-1
DR   CGH-DB; 9269-4
DR   ChEMBL-Cells; CHEMBL3307640
DR   ChEMBL-Targets; CHEMBL614536
DR   CLS; 300143
DR   Cosmic; 724646
DR   Cosmic; 736270
DR   Cosmic; 753624
DR   Cosmic; 755302
DR   Cosmic; 808173
DR   Cosmic; 872997
DR   Cosmic; 913302
DR   Cosmic; 922252
DR   Cosmic; 923166
DR   Cosmic; 932516
DR   Cosmic; 933521
DR   Cosmic; 947395
DR   Cosmic; 948374
DR   Cosmic; 948726
DR   Cosmic; 949231
DR   Cosmic; 1006365
DR   Cosmic; 1090399
DR   Cosmic; 1108338
DR   Cosmic; 1122342
DR   Cosmic; 1198205
DR   Cosmic; 1299296
DR   Cosmic; 1320462
DR   Cosmic; 1534317
DR   Cosmic; 1571774
DR   Cosmic; 1761694
DR   Cosmic; 1995362
DR   Cosmic; 2434105
DR   Cosmic-CLP; 753624
DR   DepMap; ACH-000354
DR   DSMZ; ACC-244
DR   DSMZCellDive; ACC-244
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753624
DR   GEO; GSM206452
DR   GEO; GSM383933
DR   GEO; GSM621902
DR   GEO; GSM784706
DR   GEO; GSM886920
DR   GEO; GSM887986
DR   GEO; GSM1024398
DR   GEO; GSM1374438
DR   GEO; GSM1374439
DR   GEO; GSM1669663
DR   IARC_TP53; 1560
DR   IGRhCellID; Capan1
DR   IZSLER; BS TCL 9
DR   KCLB; 30079
DR   LiGeA; CCLE_751
DR   LINCS_LDP; LCL-1732
DR   Lonza; 1011
DR   PharmacoDB; CAPAN1_184_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0237
DR   PubChem_Cell_line; CVCL_0237
DR   SKY/M-FISH/CGH; 1999
DR   TOKU-E; 773
DR   Wikidata; Q54808589
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/2324-9293.1000104;
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1764370;
RX   PubMed=3518877;
RX   PubMed=6278935;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=8026879;
RX   PubMed=8286197;
RX   PubMed=8426738;
RX   PubMed=8968085;
RX   PubMed=9331070;
RX   PubMed=10027410;
RX   PubMed=10408907;
RX   PubMed=11169957;
RX   PubMed=11668190;
RX   PubMed=12692724;
RX   PubMed=14695172;
RX   PubMed=15162061;
RX   PubMed=15367885;
RX   PubMed=16912165;
RX   PubMed=18264088;
RX   PubMed=18298655;
RX   PubMed=18380791;
RX   PubMed=20037478;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20418756;
RX   PubMed=21750719;
RX   PubMed=22109279;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-79-growth-conditions
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/capan-1.html
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544445
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/pancreatic-xenograft-models/capan1-xenograft-model/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/capan-1-human-pancreatic-adenocarcinoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 923.
CC   Population: Caucasian.
CC   Doubling time: 60-80 hours (CLS=300143); ~50-100 hours (DSMZ=ACC-244); ~49 hours (PBCF).
CC   HLA typing: A*02,09; B*13,17 (CLS=300143).
CC   HLA typing: A*01:01,30:01; B*13:02,57:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Hemizygous (PubMed=8968085; PubMed=15162061; PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:4039; FZD10; Simple; p.Asn54Lys (c.162C>A); Zygosity=Homozygous (PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:23671; GLT6D1; Simple; p.Trp198Ter (c.593G>A); Zygosity=Heterozygous (PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:4593; GRM1; Simple; p.Tyr486Ter (c.1458C>A); Zygosity=Homozygous (PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=8026879; PubMed=8426738; PubMed=15367885; PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Glu221Ter (c.661G>T); Zygosity=Homozygous (PubMed=9331070; PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser343Ter (c.1028C>G); ClinVar=VCV000822036; Zygosity=Homozygous (PubMed=10408907; PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:25082; SMAP2; Simple; p.Ser255Ter (c.764C>G); Zygosity=Heterozygous (PubMed=21750719; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (PubMed=8026879; PubMed=8426738; PubMed=15367885; Cosmic-CLP=753624; DepMap=ACH-000354).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.95%; Native American=0.56%; East Asian, North=4.79%; East Asian, South=0.11%; South Asian=7.09%; European, North=19.06%; European, South=66.44% (PubMed=30894373).
CC   Misspelling: CANPAN-1; Cosmic=2434105.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): AddexBio=C0018001/31; ATCC=HTB-79; CLS=300143; Cosmic-CLP=753624; DSMZ=ACC-244; KCLB=30079; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 15
ST   D12S391: 23
ST   D13S317: 9
ST   D16S539: 13,14
ST   D18S51: 12
ST   D19S433: 14,15
ST   D1S1656: 11,16
ST   D21S11: 28,30
ST   D22S1045: 18,19
ST   D2S1338: 20,24 (ATCC=HTB-79; DSMZ=ACC-244; PubMed=25877200)
ST   D2S1338: 24 (Technion Genomics Center)
ST   D2S441: 10,14
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 10,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   Capan-1 SimpleCell O-GalNAc
AC   CVCL_S022
SY   Capan-1 SimpleCell; Capan-1 SC
DR   cancercelllines; CVCL_S022
DR   Wikidata; Q54808590
RX   PubMed=21983924;
RX   PubMed=23399548;
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4039; FZD10; Simple; p.Asn54Lys (c.162C>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23671; GLT6D1; Simple; p.Trp198Ter (c.593G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4593; GRM1; Simple; p.Tyr486Ter (c.1458C>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Glu221Ter (c.661G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser343Ter (c.1028C>G); ClinVar=VCV000822036; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:25082; SMAP2; Simple; p.Ser255Ter (c.764C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0237 ! Capan-1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 23
//
ID   Capan-2
AC   CVCL_0026
SY   CaPan-2; CAPAN-2; Capan 2; CAPAN 2; Capan2; CAPAN2
DR   BTO; BTO_0002745
DR   CLO; CLO_0002198
DR   EFO; EFO_0002154
DR   MCCL; MCC:0000127
DR   CLDB; cl642
DR   CLDB; cl643
DR   CLDB; cl644
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-80
DR   BCRJ; 0060
DR   BioSample; SAMN03472025
DR   BioSample; SAMN03473387
DR   BioSample; SAMN10988212
DR   cancercelllines; CVCL_0026
DR   CancerTools; 161908
DR   Cell_Model_Passport; SIDM00943
DR   CGH-DB; 163-1
DR   CGH-DB; 9270-4
DR   ChEMBL-Cells; CHEMBL3308720
DR   ChEMBL-Targets; CHEMBL1075417
DR   CLS; 300144
DR   Cosmic; 730527
DR   Cosmic; 736271
DR   Cosmic; 755303
DR   Cosmic; 808163
DR   Cosmic; 868246
DR   Cosmic; 910915
DR   Cosmic; 913303
DR   Cosmic; 922256
DR   Cosmic; 923167
DR   Cosmic; 932517
DR   Cosmic; 932987
DR   Cosmic; 933522
DR   Cosmic; 934554
DR   Cosmic; 947396
DR   Cosmic; 948727
DR   Cosmic; 949232
DR   Cosmic; 1006366
DR   Cosmic; 1108339
DR   Cosmic; 1299297
DR   Cosmic; 1320463
DR   Cosmic; 1366277
DR   Cosmic; 1571775
DR   Cosmic; 1995363
DR   Cosmic; 2009527
DR   Cosmic; 2046535
DR   Cosmic; 2434087
DR   Cosmic; 2668288
DR   Cosmic-CLP; 910915
DR   DepMap; ACH-000107
DR   DSMZ; ACC-245
DR   DSMZCellDive; ACC-245
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910915
DR   GEO; GSM206453
DR   GEO; GSM621896
DR   GEO; GSM784710
DR   GEO; GSM886921
DR   GEO; GSM887987
DR   GEO; GSM1024399
DR   GEO; GSM1374440
DR   GEO; GSM1669664
DR   GEO; GSM7701427
DR   GEO; GSM7701428
DR   IARC_TP53; 313
DR   IARC_TP53; 21042
DR   IARC_TP53; 30199
DR   IGRhCellID; Capan2
DR   IZSLER; BS TCL 10
DR   KCLB; 30080
DR   LiGeA; CCLE_178
DR   LINCS_LDP; LCL-1733
DR   Lonza; 1464
DR   MetaboLights; MTBLS812
DR   PharmacoDB; Capan2_185_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0026
DR   PubChem_Cell_line; CVCL_0026
DR   SKY/M-FISH/CGH; 1993
DR   Wikidata; Q54808591
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=1630814;
RX   PubMed=1764370;
RX   PubMed=3019537;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=7809022;
RX   PubMed=7961102;
RX   PubMed=7972006;
RX   PubMed=8026879;
RX   PubMed=8194712;
RX   PubMed=8286197;
RX   PubMed=8426738;
RX   PubMed=10027410;
RX   PubMed=11169957;
RX   PubMed=11169959;
RX   PubMed=11668190;
RX   PubMed=12692724;
RX   PubMed=12800145;
RX   PubMed=14695172;
RX   PubMed=15126341;
RX   PubMed=15367885;
RX   PubMed=15688027;
RX   PubMed=15770730;
RX   PubMed=16957166;
RX   PubMed=18298655;
RX   PubMed=18380791;
RX   PubMed=20037478;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20418756;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=24700732;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31037374;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/capan-2.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-178.html
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/capan-2-human-pancreatic-adenocarcinoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2000-049.
CC   Population: Caucasian.
CC   Doubling time: 96 hours (PubMed=3019537); 45-60 hours (CLS=300144); ~50-70 hours (DSMZ=ACC-245).
CC   HLA typing: A*29:02,29:02; B*44:03,44:03; C*16:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Thr18_Ala19dup (c.52_57dupACGGCC); ClinVar=VCV000579466; Zygosity=Homozygous (PubMed=7972006; DepMap=ACH-000107).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=7961102; PubMed=8026879; PubMed=8426738; PubMed=11169959; PubMed=15367885; Cosmic-CLP=910915; DepMap=ACH-000107).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>T); ClinVar=VCV000237948; Zygosity=Homozygous; Note=Impairs TP53 splicing dramatically (PubMed=7961102; PubMed=8026879; PubMed=24700732; DepMap=ACH-000107).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.28%; Native American=0.63%; East Asian, North=0.28%; East Asian, South=0%; South Asian=0.34%; European, North=62.52%; European, South=35.95% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at c.818G>A in PubMed=1630814.
CC   Misspelling: CANPAN-2; Cosmic=2434087.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=HTB-80; CLS=300144; Cosmic-CLP=910915; DSMZ=ACC-245; KCLB=30080; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 13
ST   D19S433: 13,15
ST   D21S11: 31
ST   D2S1338: 19,25
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21,24
ST   Penta D: 13,15
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17 (DSMZ=ACC-245)
ST   vWA: 17 (ATCC=HTB-80; CLS=300144; Cosmic-CLP=910915; PubMed=25877200)
ST   vWA: 17,19 (KCLB=30080)
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   Capan-26
AC   CVCL_C0VB
DR   cancercelllines; CVCL_C0VB
DR   Wikidata; Q112929363
RX   PubMed=33788731;
CC   Population: Caucasian; Lithuanian.
CC   Doubling time: 74 hours (PubMed=33788731).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Glu37_Asn86del; Zygosity=Heterozygous (PubMed=33788731).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Phe (c.514G>T); ClinVar=VCV000428909; Zygosity=Unspecified (PubMed=33788731).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Capan1M9
AC   CVCL_0A59
DR   cancercelllines; CVCL_0A59
DR   Wikidata; Q54808592
RX   PubMed=22109279;
CC   Population: Caucasian.
CC   Characteristics: Highly migratory cell subclone of Capan-1.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4039; FZD10; Simple; p.Asn54Lys (c.162C>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23671; GLT6D1; Simple; p.Trp198Ter (c.593G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4593; GRM1; Simple; p.Tyr486Ter (c.1458C>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Glu221Ter (c.661G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser343Ter (c.1028C>G); ClinVar=VCV000822036; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:25082; SMAP2; Simple; p.Ser255Ter (c.764C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0237 ! Capan-1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   CAPE 1
AC   CVCL_0203
SY   CAPE; CAnine Prostate Epithelium 1
DR   MCCL; MCC:0000092
DR   Wikidata; Q54808593
RX   PubMed=6285321;
RX   PubMed=7145774;
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   1-4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   CAPF 1
AC   CVCL_B7DQ
SY   CAnine Prostate Fibroblast 1
DR   Wikidata; Q112929364
RX   PubMed=6285321;
RX   PubMed=7145774;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   1-4Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   CAPF 3
AC   CVCL_B7DR
SY   CAnine Prostate Fibroblast 3
DR   Wikidata; Q112929365
RX   PubMed=6285321;
RX   PubMed=7145774;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   1-4Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   CaPi
AC   CVCL_0I81
SY   Ca-Pi; Carp Pituitary
DR   Wikidata; Q54808594
RX   PubMed=6675352;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 15 to 35 Celsius, the optimal temperature is 30 Celsius (PubMed=6675352).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   3Y
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   CAR
AC   CVCL_4140
SY   Car
DR   CLO; CLO_0002199
DR   CLDB; cl646
DR   CLDB; cl647
DR   ATCC; CCL-71
DR   ECACC; 89072611
DR   IZSLER; BS CL 12
DR   Wikidata; Q54808595
RX   DOI=10.1007/BF02618370;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   CAR #1
AC   CVCL_IV96
DR   Wikidata; Q54808596
RX   PubMed=994214;
CC   Doubling time: 43 hours (Note=At 16th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   Car Bur
AC   CVCL_U771
DR   ATCC; CRL-1142
DR   Wikidata; Q54808597
CC   Discontinued: ATCC; CRL-1142; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   CAR,ML
AC   CVCL_E517
SY   CAR, ML
DR   dbMHC; 48531
DR   ECACC; 94082207
DR   IHW; IHW09108
DR   IPD-IMGT/HLA; 11653
DR   Wikidata; Q54808601
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02:01:01:01; B*35:01:01,55:01; C*03:03,04:01; DPB1*04:01,04:02; DQA1*01:01; DQB1*05:01; DRB1*01:01,14:01; DRB3*02:02 (IPD-IMGT/HLA=11653).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   CaR-1
AC   CVCL_1116
SY   CaR1; CAR1
DR   BTO; BTO_0003131
DR   CLO; CLO_0009955
DR   EFO; EFO_0006548
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472863
DR   cancercelllines; CVCL_1116
DR   Cell_Model_Passport; SIDM00488
DR   ChEMBL-Cells; CHEMBL3308100
DR   ChEMBL-Targets; CHEMBL1075418
DR   ColonAtlas; CAR1
DR   Cosmic; 873697
DR   Cosmic; 924108
DR   Cosmic; 1122321
DR   Cosmic; 1184086
DR   Cosmic; 1187300
DR   Cosmic-CLP; 924108
DR   DepMap; ACH-002345
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 924108
DR   GEO; GSM827225
DR   GEO; GSM1374441
DR   GEO; GSM1448170
DR   GEO; GSM1669665
DR   IARC_TP53; 21665
DR   IARC_TP53; 21735
DR   JCRB; JCRB0207
DR   LINCS_LDP; LCL-1288
DR   PharmacoDB; CaR1_186_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1116
DR   PubChem_Cell_line; CVCL_1116
DR   Wikidata; Q54808598
RX   CelloPub=CLPUB00026;
RX   PubMed=9290701;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 46 hours (CelloPub=CLPUB00026); ~55 hours (Note=Lot 110598), ~32 hours (Note=Lot 01232012) (JCRB=JCRB0207).
CC   HLA typing: A*02:06,11:01; B*15:01,54:01; C*01:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Homozygous (PubMed=16418264; Cosmic-CLP=924108; DepMap=ACH-002345).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.73%; East Asian, South=21.34%; South Asian=0.92%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at c.701A>G in PubMed=9290701.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Cosmic-CLP=924108; JCRB=JCRB0207; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 14,20
ST   D19S433: 13
ST   D21S11: 32.2
ST   D2S1338: 19,20
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 23,25
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   CAR-2/3F4
AC   CVCL_L833
SY   2/3 F4; 2/3F4
DR   ECACC; 97011602
DR   Wikidata; Q54808599
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10599; Human TXN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   CAR-XP10
AC   CVCL_L834
SY   XP10
DR   ECACC; 97011601
DR   Wikidata; Q54808600
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10599; Human TXN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   CAR47
AC   CVCL_S899
DR   ATCC; CRL-3235
DR   Wikidata; Q54808602
RX   PubMed=18056771;
RX   PubMed=21924324;
RX   PubMed=22266826;
CC   Sequence variation: Mutation; HGNC; HGNC:9388; PRKAR1A; Simple; c.177+1G>A (IVS2+1G>A); ClinVar=VCV000536896; Zygosity=Heterozygous (PubMed=18056771).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): ATCC=CRL-3235
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4705; Carney complex
DI   ORDO; Orphanet_1359; Carney complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   CarB
AC   CVCL_5715
SY   Carcinoma B; carB
DR   BTO; BTO_0003896
DR   Wikidata; Q54808603
RX   PubMed=1855225;
RX   PubMed=1918152;
RX   PubMed=12807763;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   CarC
AC   CVCL_5716
SY   Carcinoma C; carC
DR   Wikidata; Q54808604
RX   PubMed=1855225;
RX   PubMed=1918152;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C21810; Spindle-cell squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   CARIMi001-A
AC   CVCL_E9DG
DR   hPSCreg; CARIMi001-A
RX   DOI=10.26481/dis.20211105rr;
CC   From: Cardiovascular Research Institute; Maastricht; Netherlands.
CC   Population: Caucasian; Southern European.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Carl
AC   CVCL_0E92
SY   CARL
DR   ATCC; CRL-1857
DR   Wikidata; Q54808605
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-1857; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   CARM-L1 TG3
AC   CVCL_G349
SY   CARM-line 1
DR   ECACC; 11120835
DR   Wikidata; Q54808606
RX   PubMed=2981541;
CC   Doubling time: 34.1 +- 2.0 hours (Note=At 8th passage), 40.8 +- 2.6 hours (Note=At 21th passage) (PubMed=2981541).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: PVG/c (PVG/Arc); RS=RS_0003762.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G354 ! Me9-TG3
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   CARM-L11 TG3
AC   CVCL_G355
SY   CARM-line 11
DR   Wikidata; Q54808607
RX   PubMed=2981541;
CC   Doubling time: 47.4 +- 7.6 hours (Note=At 9th passage), 41.5 +- 3.3 hours (Note=At 21th passage) (PubMed=2981541).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: PVG/c (PVG/Arc); RS=RS_0003762.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G354 ! Me9-TG3
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   CARM-L12 TG3
AC   CVCL_G350
SY   CARM-line 12
DR   ECACC; 11120833
DR   Wikidata; Q54808608
RX   PubMed=2981541;
CC   Doubling time: 43.2 +- 1.4 hours (Note=At 8th passage), 40.8 +- 4.0 hours (Note=At 20th passage) (PubMed=2981541).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: PVG/c (PVG/Arc); RS=RS_0003762.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G354 ! Me9-TG3
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   CARNAVAL
AC   CVCL_D330
DR   DSMZ; ACC-724
DR   DSMZCellDive; ACC-724
DR   Wikidata; Q54808609
CC   Doubling time: ~40-50 hours (DSMZ=ACC-724).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-724
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 13,15
ST   D19S433: 13,15
ST   D21S11: 28,31
ST   D2S1338: 17,23
ST   D3S1358: 14,15
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
ID   CarNi/1
AC   CVCL_RX10
DR   Wikidata; Q54808610
RX   PubMed=23232719;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=40233; ! Carollia perspicillata (Seba's short-tailed bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   Carousel
AC   CVCL_B6PR
DR   Rockland; CB-0101
DR   Wikidata; Q111733059
WW   Info; Cellaria; -; https://web.archive.org/web/20230529014610/https://cellariainc.com/product/carousel-cell-model/
CC   Population: Caucasian.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cellaria
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 14,15
ST   D21S11: 30,31.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 19,26
ST   Penta D: 8,12
ST   Penta E: 7,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CarperAEC.B-1
AC   CVCL_QW39
SY   Carollia perspicillata Airway Epithelial Cells B subclone 1
DR   Wikidata; Q54808611
RX   PubMed=24454736;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Age/sex of donor from personal communication of Eckerle, Isabella.
OX   NCBI_TaxID=40233; ! Carollia perspicillata (Seba's short-tailed bat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 6
//
ID   CAS-1
AC   CVCL_1117
SY   CAS1
DR   CLO; CLO_0002200
DR   CLDB; cl4963
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 589
DR   BioSample; SAMN10987869
DR   cancercelllines; CVCL_1117
DR   Cell_Model_Passport; SIDM00212
DR   ChEMBL-Cells; CHEMBL3308187
DR   ChEMBL-Targets; CHEMBL2366100
DR   Cosmic; 910943
DR   Cosmic; 2367510
DR   Cosmic; 2516014
DR   Cosmic-CLP; 910943
DR   DepMap; ACH-000464
DR   EGA; EGAS00001000978
DR   GDSC; 910943
DR   GEO; GSM886922
DR   GEO; GSM887988
DR   GEO; GSM1669666
DR   IARC_TP53; 21216
DR   ICLC; HTL97009
DR   LiGeA; CCLE_412
DR   LINCS_LDP; LCL-1369
DR   PharmacoDB; CAS1_187_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1117
DR   PubChem_Cell_line; CVCL_1117
DR   Wikidata; Q54808612
RX   PubMed=12635657;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 60 hours (PubMed=25984343).
CC   HLA typing: A*02:01,02:01; B*50:01,51:01; C*01:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (Cosmic-CLP=910943).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.58%; East Asian, North=0%; East Asian, South=0.08%; South Asian=3.36%; European, North=46.51%; European, South=49.46% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=910943
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,14
ST   D5S818: 13
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   CAS-9
AC   CVCL_8537
DR   JCRB; JCRB1385
DR   Wikidata; Q54808613
RX   PubMed=8660794;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Casa-1
AC   CVCL_1E91
SY   CASA-1
DR   ATCC; HTB-42
DR   Wikidata; Q54808614
RX   DOI=10.1007/978-1-4757-1647-4_5;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: ATCC; HTB-42; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5977; Submandibular gland carcinoma ex pleomorphic adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   CAT(Wil)
AC   CVCL_W772
SY   CAT; Wil
DR   Wikidata; Q54808621
RX   PubMed=1828972;
RX   PubMed=8512807;
RX   PubMed=10948322;
RX   PubMed=12127398;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   CAT-13.0B10
AC   CVCL_1972
DR   CLO; CLO_0002202
DR   DSMZ; ACC-472
DR   DSMZCellDive; ACC-472
DR   Wikidata; Q54808615
CC   Doubling time: ~25 hours (DSMZ=ACC-472).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49961; Human ENTPD1/CD39.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   CAT-13.1E10
AC   CVCL_1973
DR   CLO; CLO_0002203
DR   DSMZ; ACC-473
DR   DSMZCellDive; ACC-473
DR   Wikidata; Q54808616
CC   Doubling time: ~30-40 hours (DSMZ=ACC-473).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   CAT-13.6E12
AC   CVCL_U079
SY   CAT 13.6E12
DR   CLO; CLO_0002204
DR   DSMZ; ACC-474
DR   DSMZCellDive; ACC-474
DR   Wikidata; Q54808618
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
CC   Discontinued: DSMZ; ACC-474; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CAT-13.9C1
AC   CVCL_1974
DR   CLO; CLO_0002205
DR   DSMZ; ACC-475
DR   DSMZCellDive; ACC-475
DR   Wikidata; Q54808619
CC   Doubling time: ~48 hours (DSMZ=ACC-475).
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06734; Human FCER2/CD23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   CAT-MT
AC   CVCL_T987
SY   JM
DR   ECACC; 12122001
DR   Wikidata; Q54808620
RX   PubMed=3906801;
RX   PubMed=19891692;
CC   Characteristics: Tumorigenic in athymic mice.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   Cates-1B
AC   CVCL_3296
SY   CATES-1B; Cates 1B
DR   CLO; CLO_0002206
DR   ATCC; HTB-104
DR   BioSample; SAMN03471090
DR   Wikidata; Q54808622
RX   PubMed=833871;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-104
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 7,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   CATH.a
AC   CVCL_0204
SY   Cath.a; CATH-a; CATHa; Central Adrenergic TH-expressing a
DR   BTO; BTO_0005820
DR   CLO; CLO_0002207
DR   MCCL; MCC:0000093
DR   ATCC; CRL-3595
DR   ATCC; CRL-11179
DR   KCB; KCB 2014010YJ
DR   Wikidata; Q54808629
RX   Patent=US5591626;
RX   PubMed=7665571;
RX   PubMed=7680068;
RX   PubMed=9006967;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-118.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11179.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-11179; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: C57BL/6 x DBA/2 rTH promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E3FK ! CATH.b
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   CATH.b
AC   CVCL_E3FK
SY   Central Adrenergic TH-expressing b
RX   PubMed=7665571;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: C57BL/6 x DBA/2 rTH promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0204 ! CATH.a
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CATL-2
AC   CVCL_A6TR
SY   CATL-2(+)
DR   RCB; RCB3573
DR   Wikidata; Q107113557
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CATL-3
AC   CVCL_A6TS
SY   CATL-3(+)
DR   RCB; RCB3574
DR   Wikidata; Q107113560
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CAgill1PFR
AC   CVCL_E8BW
SY   Chrysophrys Auratus, gill 1, Plant and Food Research
RX   PubMed=38987436;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at 30 Celsius but perishes at 4 Celsius (PubMed=38987436).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=75562; ! Chrysophrys auratus (Silver seabream)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CAtmus1PFR
AC   CVCL_C6MK
SY   Chrysophrys Auratus, tail muscle 1, Plant and Food Research
DR   Wikidata; Q116048658
RX   PubMed=36378268;
CC   Group: Fish cell line.
CC   Characteristics: Can grow well between 18 and 30 Celsius (PubMed=36378268).
CC   Derived from site: In situ; Tail, skeletal muscle; UBERON=UBERON_0003665.
CC   Cell type: Myofibroblast; CL=CL_0000186.
OX   NCBI_TaxID=75562; ! Chrysophrys auratus (Silver seabream)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   CAV
AC   CVCL_LM72
DR   Wikidata; Q54808630
RX   PubMed=2893555;
RX   PubMed=7809022;
CC   Characteristics: Established from a xenograft.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   CaVa
AC   CVCL_UA03
DR   Wikidata; Q93444151
RX   PubMed=113895;
RX   PubMed=1056018;
CC   Karyotypic information: 46,X,t(X;22)(q22;q13) (PubMed=1056018).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   CaVe
AC   CVCL_8444
SY   Cancer Ventriculi
DR   BioSample; SAMN03151671
DR   Wikidata; Q54808631
RX   PubMed=58478;
RX   PubMed=6451928;
RX   PubMed=11942358;
RX   PubMed=14071827;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Space-flown cell line (cellonaut).
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=58478; PubMed=6451928; PubMed=20143388). Originally thought to originate from a gastric carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00036.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Anecdotal: Have been flown in space on Zond-5 to study growth in microgravity (PubMed=11942358).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   CaVe K-10V
AC   CVCL_WN72
DR   Wikidata; Q93444159
RX   PubMed=11942358;
CC   Group: Space-flown cell line (cellonaut).
CC   Problematic cell line: Contaminated. Parent cell line (CaVe) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Anecdotal: Have been flown in space on Zond-5 to study growth in microgravity (PubMed=11942358).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8444 ! CaVe
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   CAVEOC-2
AC   CVCL_D308
DR   Wikidata; Q54808632
RX   PubMed=8615606;
RX   PubMed=8913435;
CC   Doubling time: 33 hours (PubMed=8615606).
CC   Miscellaneous: Cell line no longer available (personal communication of Merlin, Jean-Louis).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   CB [Catla]
AC   CVCL_U262
SY   Catla Brain
DR   NRFC; NRFC020
DR   Wikidata; Q54808633
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=19236559;
RX   PubMed=25052522;
WW   Provider; AAHL; -; https://aahl.res.in/catla-catla-catla-heart-sich-brain-cb-gill-icg-and-eye-sice-cell-lines/
WW   Provider; NRFC; NRFC020; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC020.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   CB [Cobia]
AC   CVCL_6F69
SY   Cobia Brain
DR   Wikidata; Q54808634
RX   PubMed=19925591;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=141264; ! Rachycentron canadum (Cobia)
OI   CVCL_6F70 ! CF [Cobia]
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   CB [Human B-cell IHW]
AC   CVCL_E518
DR   dbMHC; 48532
DR   ECACC; 94050344
DR   IHW; IHW09311
DR   IPD-IMGT/HLA; 10394
DR   Wikidata; Q54808635
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*02:01:01:01,03:01:01:01; B*07:02:01:01,39:08; C*07:02:01:03,07:02:01:01; DPA1*02:02:01; DPB1*04:01:01; DQB1*04:02:01,03:01:01; DRB1*04:10:01/04:10:03,13:03:01 (IPD-IMGT/HLA=10394).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   CB 15
AC   CVCL_B0MX
DR   Wikidata; Q108819990
RX   PubMed=3343518;
CC   Doubling time: 16 hours (PubMed=3343518).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CB 63
AC   CVCL_B0MY
DR   Wikidata; Q108819991
RX   PubMed=3343518;
CC   Doubling time: 14 hours (PubMed=3343518).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CB 79
AC   CVCL_B0N2
DR   Wikidata; Q108819992
RX   PubMed=3343518;
CC   Doubling time: 28 hours (PubMed=3343518).
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CB 84
AC   CVCL_B0MZ
DR   Wikidata; Q108819993
RX   PubMed=3343518;
CC   Doubling time: 26 hours (PubMed=3343518).
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CB 86
AC   CVCL_B0N0
DR   Wikidata; Q108819994
RX   PubMed=3343518;
CC   Doubling time: 24 hours (PubMed=3343518).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CB 87
AC   CVCL_B0N1
DR   Wikidata; Q108819995
RX   PubMed=3343518;
CC   Doubling time: 36 hours (PubMed=3343518).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CB-16
AC   CVCL_CW56
SY   CB16
DR   NCBI_Iran; H171
DR   Wikidata; Q54808636
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08637; Human FCGR3A/CD16a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 5
//
ID   CB-3512
AC   CVCL_7175
DR   CLO; CLO_0050474
DR   BioSample; SAMN03471919
DR   RCB; RCB2531
DR   TKG; TKG 0305
DR   Wikidata; Q54808637
RX   PubMed=6175525;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): RCB=RCB2531; TKG=TKG 0305
ST   Amelogenin: X (RCB=RCB2531)
ST   Amelogenin: X,Y (TKG=TKG 0305)
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,14
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17 (RCB=RCB2531)
ST   vWA: 16,17,18 (TKG=TKG 0305)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Cb-E1A
AC   CVCL_HB81
DR   Kerafast; EUR037
DR   Wikidata; Q54808638
RX   PubMed=8865201;
CC   Characteristics: Can be used as a model system for differentiated cerebellar granule neurons.
CC   Doubling time: 24 hours (Kerafast=EUR037).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A; rv12S).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Cerebellar granule cell; CL=CL_0001031.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   CB-F7
AC   CVCL_9V08
SY   CBF-7; CBF7
DR   Wikidata; Q54808639
RX   PubMed=2828478;
RX   PubMed=7492749;
RX   PubMed=9708833;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   CB-HIV1
AC   CVCL_9V09
SY   CB HIV1
DR   Wikidata; Q54808640
RX   PubMed=2828478;
CC   Doubling time: 24-28 hours (PubMed=2828478).
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   CB-HIV2
AC   CVCL_9V10
DR   Wikidata; Q54808641
RX   PubMed=2828478;
CC   Doubling time: 24-28 hours (PubMed=2828478).
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   CB-JMN
AC   CVCL_WH62
DR   Wikidata; Q93444250
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   From: Reynolds, Charles Patrick; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   Cb-neu
AC   CVCL_IZ80
DR   Wikidata; Q54808642
RX   PubMed=7582098;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Activated EGFR-neu.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   6D
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   CB-NJR
AC   CVCL_Y580
DR   Wikidata; Q54808643
RX   PubMed=2302710;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   From: Reynolds, Charles Patrick; Children's Hospital of Los Angeles; Los Angeles; USA.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   CB0001
AC   CVCL_8T97
DR   ECACC; 93012701
DR   Wikidata; Q54808644
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CB0051
AC   CVCL_8T98
DR   ECACC; 93111608
DR   Wikidata; Q54808645
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93111608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   CB0054
AC   CVCL_8T99
DR   ECACC; 93111919
DR   Wikidata; Q54808646
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93111919; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   CB01s-p
AC   CVCL_F1GF
WW   Provider; ARI-TOX MWCB; CB01s-p; https://aritox.com/mwcb/mwcb-cb01s-p/
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CB02
AC   CVCL_VQ54
DR   Wikidata; Q93444304
RX   PubMed=3412357;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08637; Human FCGR3A/CD16a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 4
//
ID   CB02s-p
AC   CVCL_F1GG
WW   Provider; ARI-TOX MWCB; CB02s-p; https://aritox.com/mwcb/mwcb-cb02s-p/
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CB1
AC   CVCL_U652
DR   Wikidata; Q54808647
RX   Patent=US6156307;
RX   PubMed=8083532;
RX   PubMed=8245771;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0C0N9; Avian retrovirus MH2 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   CB10
AC   CVCL_E3ZP
RX   PubMed=3943922;
CC   Monoclonal antibody isotype: IgG2, lambda.
CC   Monoclonal antibody target: Human cell surface glycoprotein of 180 kDa found in some neuroblastoma and melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CB109
AC   CVCL_E3RE
SY   CB 109
RX   PubMed=1378293;
RX   PubMed=7684596;
RX   PubMed=19373935;
CC   Doubling time: 50 hours (Note=At 6th passage), 30 hours (Note=At 101th passage) (PubMed=1378293).
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CB11
AC   CVCL_E2V0
RX   PubMed=2715875;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on embryonic fibroblasts.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CB191
AC   CVCL_E3RL
RX   PubMed=7684596;
RX   PubMed=19373935;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CB23
AC   CVCL_E421
SY   CB 23
DR   Wikidata; Q54808648
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=3491677;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   CB3.E4
AC   CVCL_F0W5
RX   PubMed=2312130;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: Mouse B cell surface complex of 67 kDa associated with MHC class II.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CB33
AC   CVCL_E422
SY   CB-33; CB 33; LCL-CB33
DR   BTO; BTO_0004407
DR   Wikidata; Q54808649
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   CB34
AC   CVCL_0I94
SY   CB 34
DR   Wikidata; Q54808650
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=3491677;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   CB43
AC   CVCL_E2V1
RX   PubMed=2465900;
RX   PubMed=2715875;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q01650; Human SLC7A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CB57/C91PL
AC   CVCL_0I93
DR   CLO; CLO_0002208
DR   Wikidata; Q54808651
RX   PubMed=3020320;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0197 ! C91/PL
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   CB58/MT2
AC   CVCL_0D79
DR   CLO; CLO_0002209
DR   Wikidata; Q54808652
RX   PubMed=1696163;
RX   PubMed=3020320;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Regulatory T-cell; CL=CL_0000815.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2631 ! MT-2
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   CB59/MT2
AC   CVCL_0D80
DR   CLO; CLO_0002210
DR   Wikidata; Q54808653
RX   PubMed=1696163;
RX   PubMed=3020320;
CC   Population: Japanese.
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Regulatory T-cell; CL=CL_0000815.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2631 ! MT-2
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   CB660
AC   CVCL_L184
DR   PRIDE; PXD002322
DR   Wikidata; Q54808654
RX   PubMed=18450476;
RX   PubMed=23884946;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/cb660.aspx
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-035, Steering comm. appl. SCSC08-25.
CC   Derived from site: In situ; Fetal brain, forebrain; UBERON=UBERON_0006240.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5DV ! CB660SP
SX   Female
AG   50-55FD
CA   Somatic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   CB660SP
AC   CVCL_A5DV
DR   Wikidata; Q107114609
RX   PubMed=18450476;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Derived from site: In situ; Fetal spinal cord; UBERON=UBERON_0006241.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L184 ! CB660
SX   Female
AG   50-55FD
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CB6B
AC   CVCL_E519
SY   CBG-IB
DR   dbMHC; 48533
DR   ECACC; 88052060
DR   IHW; IHW09060
DR   IPD-IMGT/HLA; 10397
DR   Wikidata; Q54808655
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=1363422;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01:01; B*15:01:01:01; C*03:03:01:01; DPA1*02:02:01; DPB1*19:01; DQA1*01:03; DQB1*06:03:01; DRA*01:01; DRB1*13:01:01; DRB3*02:02 (IPD-IMGT/HLA=10397).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   CB74
AC   CVCL_E3RM
RX   PubMed=7684596;
RX   PubMed=19373935;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CB9
AC   CVCL_E5RG
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   cBAL111
AC   CVCL_S904
DR   ABM; T0789
DR   Wikidata; Q54808656
RX   CelloPub=CLPUB00752;
RX   PubMed=18093687;
RX   PubMed=19845959;
CC   Characteristics: Has liver progenitor characteristics in vitro and can differentiate into mature hepatocytes in vivo (PubMed=18093687).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   14-18FW
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   cBB
AC   CVCL_C8X7
DR   Wikidata; Q123030856
RX   PubMed=16698284;
CC   Group: Fish cell line.
CC   Virology: Cured of nervous necrosis virus (NNV) infection using NNV-specific rabbit antiserum (PubMed=16698284).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
HI   CVCL_HG34 ! BB [Lates]
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBC.37
AC   CVCL_D7DN
RX   PubMed=11759053;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CBC2T-2
AC   CVCL_E7BV
DR   CCRID; 4201PAT-CCTCC02244
RX   Patent=CN117004571B;
RX   PubMed=38077157;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2022273.
CC   Population: Chinese.
CC   Doubling time: 47.11 hours (PubMed=38077157).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): Patent=CN117004571B; PubMed=38077157
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 19,20
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 19,22
ST   D2S441: 11,12
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 23,23.2
ST   Penta D: 9,11
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C208025; Extrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CBC3T-1
AC   CVCL_C1YT
DR   CCRID; 4201PAT-CCTCC02152
DR   Wikidata; Q123030857
RX   Patent=CN115786262B;
RX   PubMed=37966669;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2022169.
CC   Population: Chinese.
CC   Doubling time: 52 hours (Patent=CN115786262B; PubMed=37966669).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=37966669).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): Patent=CN115786262B; PubMed=37966669
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 22
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 13,22
ST   D19S433: 13,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 19,25
ST   D2S441: 12
ST   D3S1358: 16
ST   D5S818: 9,10
ST   D6S1043: 11
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CBC3T-6
AC   CVCL_E5HL
RX   PubMed=39613883;
CC   Population: Chinese.
CC   Characteristics: Highly tumorigenic (PubMed=39613883).
CC   Doubling time: ~50 hours (PubMed=39613883).
CC   Karyotypic information: Nearly triploid (PubMed=39613883).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=39613883).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Unspecified (PubMed=39613883).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=39613883
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 20,22
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13.3,14.3
ST   D19S433: 14,14.2
ST   D21S11: 30,31
ST   D2S1338: 22,23
ST   D2S441: 11,15
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D6S1043: 19
ST   D7S820: 11,13
ST   D8S1179: 12
ST   FGA: 21,25
ST   Penta D: 11,15
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C7976; Distal cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CBCHi001-A
AC   CVCL_C1ST
DR   hPSCreg; CBCHi001-A
DR   Wikidata; Q114310764
CC   From: Beijing Chest Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CBCHi001-A-1
AC   CVCL_C1SU
DR   BioSamples; SAMEA13855333
DR   hPSCreg; CBCHi001-A-1
DR   Wikidata; Q114310765
CC   From: Beijing Chest Hospital; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:143; ACTC1; Simple_edited; p.Glu239Gln (c.715G>C); ClinVar=VCV000520471; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=CBCHi001-A-1).
DI   NCIt; C188990; Familial hypertrophic cardiomyopathy type 11
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1ST ! CBCHi001-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CBDTi001-A
AC   CVCL_C6P0
DR   BioSamples; SAMEA111500307
DR   hPSCreg; CBDTi001-A
DR   Wikidata; Q117704232
RX   PubMed=36403549;
CC   From: Institute for Stem Cell Science and Regenerative Medicine; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.3628-41_3628-17del25 (delta25); ClinVar=VCV000177677; Zygosity=Heterozygous (PubMed=36403549).
CC   Donor information: At sampling donor was asymptomatic for cardiomyopathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CBF245
AC   CVCL_XB13
DR   Wikidata; Q93444407
RX   PubMed=18177616;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28845; Human HSD11B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   CBIAi001-A
AC   CVCL_VC62
DR   BioSamples; SAMEA104132030
DR   hPSCreg; CBIAi001-A
DR   Wikidata; Q54808657
CC   From: Centre for Biomedical Image Analysis; Brno; Czech Republic.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   CBIGi001-A
AC   CVCL_C0JY
SY   AIW002-02; AIW-002-02
DR   BioSamples; SAMEA12565538
DR   hPSCreg; CBIGi001-A
DR   Wikidata; Q112929366
RX   PubMed=34287353;
RX   PubMed=34500068;
RX   PubMed=35561458;
WW   Info; -; -; https://www.mcgill.ca/neuro/files/neuro/aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34500068
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 12,16
ST   D21S11: 29,32.2
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0KM ! AJC001-5
OI   CVCL_C0KN ! AJG001-C4
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   CBIGi001-A-1
AC   CVCL_C0JZ
SY   PRKN-KO; AIW002-02/PRKN-KO; PRKN-KO/AIW002-02; Parkin-KO/AIW002-02; AIW002-02-Parkin-KO
DR   BioSamples; SAMEA12565661
DR   hPSCreg; CBIGi001-A-1
DR   Wikidata; Q112929367
RX   PubMed=35561458;
WW   Info; -; -; https://www.mcgill.ca/neuro/files/neuro/parkin-ko-aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   CBIGi001-A-2
AC   CVCL_C0K0
SY   PINK1-KO; AIW002-02/PINK1-KO; PINK1-KO/AIW002-02
DR   BioSamples; SAMEA12866579
DR   hPSCreg; CBIGi001-A-2
DR   Wikidata; Q112929368
RX   PubMed=35561458;
WW   Info; McGill; -; https://www.mcgill.ca/neuro/files/neuro/pink1-ko-aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   CBIGi001-A-3
AC   CVCL_C0K1
SY   PINK1-KO/PRKN-KO; AIW002-02/PINK1-KO/PRKN-KO; PINK1-KO/PRKN-KO/AIW002-02; Parkin_PINK1-KO/AIW002-02
DR   BioSamples; SAMEA12866580
DR   hPSCreg; CBIGi001-A-3
DR   Wikidata; Q112929369
RX   PubMed=35561458;
WW   Info; McGill; -; https://www.mcgill.ca/neuro/files/neuro/pink1-ko-parkin-ko-aiw002-02-datasheet.pdf
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JZ ! CBIGi001-A-1
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   CBIGi002-A
AC   CVCL_C0K6
SY   2890; GBA W378G, heterozygous
DR   BioSamples; SAMEA13200837
DR   hPSCreg; CBIGi002-A
DR   Wikidata; Q112929370
RX   PubMed=36130446;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Trp417Gly (c.1249T>G) (W378G); ClinVar=VCV001211295; Zygosity=Heterozygous (PubMed=36130446).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   CBIGi002-A-1
AC   CVCL_C0K7
SY   2890-iso; GBA W378G-correction/2890; 2890 (isogenic correction)
DR   BioSamples; SAMEA13204586
DR   hPSCreg; CBIGi002-A-1
DR   Wikidata; Q112929371
RX   PubMed=36130446;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Trp417Gly (c.1249T>G) (W378G); ClinVar=VCV001211295; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36130446).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0K6 ! CBIGi002-A
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   CBIGi003-A
AC   CVCL_C0K8
SY   3026; GBA N370S, heterozygous
DR   BioSamples; SAMEA13204587
DR   hPSCreg; CBIGi003-A
DR   Wikidata; Q112929372
RX   PubMed=36130446;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36130446).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   CBIGi003-A-1
AC   CVCL_C0K9
SY   3026-iso; GBA N370S-correction/3026; 3026 (isogenic correction)
DR   BioSamples; SAMEA13204589
DR   hPSCreg; CBIGi003-A-1
DR   Wikidata; Q112929373
RX   PubMed=36130446;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36130446).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0K8 ! CBIGi003-A
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   CBiPS 2F-1c
AC   CVCL_9S23
SY   CBiPS c; ESi041-A
DR   hPSCreg; ESi041-A
DR   SKIP; SKIP002602
DR   Wikidata; Q54808658
RX   PubMed=24311783;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_Linea-CBiPS-2F-1c.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Linea_CBiPS_2F-1c.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_CBiPS_2F1c1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 28,32.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S25 ! CBiPS 4F-3a
OI   CVCL_9S24 ! CBiPS 4F-10b
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   CBiPS 4F-10b
AC   CVCL_9S24
SY   CBiPS 4F 10b; CBiPS 4F-10; CBiPS c; ESi041-C
DR   hPSCreg; ESi041-C
DR   SKIP; SKIP002604
DR   Wikidata; Q54808659
RX   PubMed=24311783;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_linea-CBiPS-4F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_CBiPS_4F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_Deposito_CBiPS_4F10.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 28,32.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S23 ! CBiPS 2F-1c
OI   CVCL_9S25 ! CBiPS 4F-3a
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   CBiPS 4F-3a
AC   CVCL_9S25
SY   CBiPS a; ESi041-B
DR   hPSCreg; ESi041-B
DR   SKIP; SKIP002603
DR   Wikidata; Q54808660
RX   PubMed=24311783;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_linea-CBiPS-4F-3a-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_CBiPS_4F-3a.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_CBiPS_4F3a.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 28,32.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S23 ! CBiPS 2F-1c
OI   CVCL_9S24 ! CBiPS 4F-10b
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   CBiPS-E12C1
AC   CVCL_B5QW
SY   E12C1; PCBC03hsi2011080405; SC11-012
DR   Wikidata; Q111733060
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E17C1
AC   CVCL_B5QX
SY   E17C1; PCBC03hsi2013090604; SC13-061
DR   GEO; GSM1084979
DR   GEO; GSM1085017
DR   Wikidata; Q111733061
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E17C6
AC   CVCL_B5QY
SY   E17C6; PCBC03hsi2011080406; SC11-013
DR   GEO; GSM1084984
DR   GEO; GSM1085022
DR   GEO; GSM1589806
DR   GEO; GSM1589818
DR   GEO; GSM1589938
DR   GEO; GSM1589950
DR   Wikidata; Q111733063
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E20C2
AC   CVCL_B5QZ
SY   E20C2; PCBC03hsi2013090602 SC13-059
DR   GEO; GSM1084980
DR   GEO; GSM1085018
DR   Wikidata; Q111733064
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E24C2
AC   CVCL_B5R0
SY   E24C2; PCBC03hsi2013090603; SC13-060
DR   Wikidata; Q111733066
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E32C9
AC   CVCL_B5R2
SY   E32C9; PCBC03hsi2013090605; SC13-062
DR   Wikidata; Q111733068
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E5C3
AC   CVCL_B5R1
SY   E5C3; PCBC03hsi2011080404; SC11-011
DR   GEO; GSM1084822
DR   GEO; GSM1084915
DR   GEO; GSM1084982
DR   GEO; GSM1085020
DR   GEO; GSM1589804
DR   GEO; GSM1589816
DR   GEO; GSM1589936
DR   GEO; GSM1589948
DR   Wikidata; Q111733070
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E7C1
AC   CVCL_B5R3
SY   E7C1; PCBC03hsi2013090606; SC13-063
DR   Wikidata; Q111733071
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E7C12
AC   CVCL_B5R4
SY   E7C12; PCBC03hsi2013090608; SC13-065
DR   Wikidata; Q111733074
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS-E7C9
AC   CVCL_B5R5
SY   E7C9; PCBC03hsi2013090607; SC13-064
DR   Wikidata; Q111733075
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CBiPS1sv-4F-40
AC   CVCL_V189
SY   ESi007-A; PRYDi-CB40; CBiPS40
DR   BioSamples; SAMEA3303231
DR   EBiSC; ESi007-A
DR   ECACC; 66540070
DR   hPSCreg; ESi007-A
DR   SKIP; SKIP002424
DR   Wikidata; Q54808661
RX   PubMed=30878013;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/CBiPS1sv-4F-40.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-CBiPS1sv-4F-40.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Misspelling: CBiPSsv-4F-40; Note=Occasionally.
CC   Discontinued: ECACC; 66540070; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V190 ! CBiPS1sv-4F-5
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   CBiPS1sv-4F-5
AC   CVCL_V190
SY   PRYDi-CB5; CBiPS5
DR   Wikidata; Q54808662
RX   PubMed=30878013;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520deposito%2520CBiPS1sv-4F-5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo%2520CBiPS1sv-4F-5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V189 ! CBiPS1sv-4F-40
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   CBiPS6-2F-1
AC   CVCL_V179
SY   CBiPS 2F-1; CBiPS2F-1
DR   Wikidata; Q54808663
RX   PubMed=19796614;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C746 ! CBiPS6-2F-4
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   CBiPS6-2F-4
AC   CVCL_C746
SY   CBiPS 2F-4; ESi033-A
DR   BioSamples; SAMEA104009426
DR   hPSCreg; ESi033-A
DR   SKIP; SKIP002416
DR   Wikidata; Q54808664
RX   PubMed=19796614;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_CBiPS6-2F-4_vfinal.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/CBiPS6-2F-4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_CBiPS6-2F-4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V179 ! CBiPS6-2F-1
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   CBiPSC19.11
AC   CVCL_RM95
SY   CBiPS-19.11; CB19.11; Cord Blood iPSC clone 19.11; PCBC03hsi2011080402; SC11-009
DR   GEO; GSM861001
DR   GEO; GSM1084905
DR   GEO; GSM1084990
DR   GEO; GSM1085028
DR   Wikidata; Q54808668
RX   PubMed=21494607;
RX   PubMed=22905176;
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Age/sex of donor from personal communication of Zambidis, Elias Thomas.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM92 ! CBiPSC6.2
OI   CVCL_RM93 ! CBiPSC6.11
OI   CVCL_RM94 ! CBiPSC6.13
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   CBiPSC6.11
AC   CVCL_RM93
SY   CBiPS-6.11; Cord Blood iPSC clone 6.11
DR   GEO; GSM860999
DR   GEO; GSM1084837
DR   GEO; GSM1084906
DR   Wikidata; Q54808666
RX   PubMed=21494607;
RX   PubMed=22905176;
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor from personal communication of Zambidis, Elias Thomas.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM92 ! CBiPSC6.2
OI   CVCL_RM94 ! CBiPSC6.13
OI   CVCL_RM95 ! CBiPSC19.11
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   CBiPSC6.13
AC   CVCL_RM94
SY   CBiPS-6.13; CB6.13; CBiPS-6.13-PCBC; Cord Blood iPSC clone 6.13; PCBC03hsi2011080403; SC11-010
DR   GEO; GSM861000
DR   GEO; GSM1084838
DR   GEO; GSM1084907
DR   GEO; GSM1084989
DR   GEO; GSM1085027
DR   WiCell; cbips-6-13-pcbc
DR   Wikidata; Q54808667
RX   PubMed=21494607;
RX   PubMed=22905176;
RX   PubMed=27293150;
RX   PubMed=27688775;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Age/sex of donor from personal communication of Zambidis, Elias Thomas.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM92 ! CBiPSC6.2
OI   CVCL_RM93 ! CBiPSC6.11
OI   CVCL_RM95 ! CBiPSC19.11
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   CBiPSC6.2
AC   CVCL_RM92
SY   CBiPS-6.2; CB6.2; CBiPS-6.2-PCBC; Cord Blood iPSC clone 6.2; CCRIi001-A; TMOi001-A; Gibco Human Episomal iPSC; A18945; PCBC03hsi2011080401; SC11-008
DR   BioSamples; SAMEA2253216
DR   GEO; GSM860998
DR   GEO; GSM1084836
DR   GEO; GSM1084908
DR   GEO; GSM1084909
DR   GEO; GSM1084988
DR   GEO; GSM1085026
DR   GEO; GSM1589803
DR   GEO; GSM1589815
DR   GEO; GSM1589935
DR   GEO; GSM1589947
DR   hPSCreg; TMOi001-A
DR   WiCell; cbips-6-2-pcbc
DR   Wikidata; Q54808665
RX   PubMed=21494607;
RX   PubMed=22905176;
RX   PubMed=27293150;
RX   PubMed=27688775;
RX   PubMed=34419745;
RX   PubMed=34479069;
WW   Provider; Thermo Fisher; A18945; https://www.thermofisher.com/order/catalog/product/A18945
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Age/sex of donor and identity of CBiPSC6.2 with Gibco cell line from personal communication of Zambidis, Elias Thomas.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=34479069
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 9,15
ST   FGA: 22,25
ST   Penta D: 2.2,11
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM93 ! CBiPSC6.11
OI   CVCL_RM94 ! CBiPSC6.13
OI   CVCL_RM95 ! CBiPSC19.11
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   CBL-1
AC   CVCL_K136
SY   CBL1
DR   CLO; CLO_0002213
DR   ABCD; ABCD_AR015
DR   ATCC; HB-8214
DR   Wikidata; Q54808674
RX   Patent=US5330896;
RX   Patent=US20070048305;
RX   PubMed=6208131;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8214.
CC   Biotechnology: Was used to produce the monoclonal antibody gavilimomab (ABX-CBL) which was intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease (Patent=US20070048305).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 7
//
ID   CBL166.10.28
AC   CVCL_C5XS
DR   Wikidata; Q116048659
RX   PubMed=1602134;
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa+lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBL175.1
AC   CVCL_C5XT
DR   Wikidata; Q116048660
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBL255.3
AC   CVCL_C5XU
DR   Wikidata; Q116048661
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBL52.2
AC   CVCL_C5XV
DR   Wikidata; Q116048662
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBL62.1
AC   CVCL_C5XW
DR   Wikidata; Q116048663
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBL63
AC   CVCL_GS35
DR   Wikidata; Q54808675
RX   PubMed=3143916;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   CBLC212.5
AC   CVCL_C5XX
DR   Wikidata; Q116048664
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC213.7
AC   CVCL_C5XY
DR   ABCD; ABCD_AE622
DR   Wikidata; Q116048665
RX   PubMed=1602134;
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC214.1
AC   CVCL_C5XZ
DR   Wikidata; Q116048666
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC221.4
AC   CVCL_C5Y0
DR   Wikidata; Q116048667
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC229.14
AC   CVCL_C5Y1
DR   Wikidata; Q116048669
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC235.7
AC   CVCL_C5Y2
DR   Wikidata; Q116048670
RX   PubMed=1602134;
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC237.2
AC   CVCL_C5Y3
DR   Wikidata; Q116048671
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC240.8
AC   CVCL_C5Y4
DR   Wikidata; Q116048672
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC262.7
AC   CVCL_C5Y5
DR   Wikidata; Q116048673
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC263.3
AC   CVCL_C5Y6
DR   Wikidata; Q116048674
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC264.7
AC   CVCL_C5Y7
DR   Wikidata; Q116048675
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC270.1
AC   CVCL_C5Y8
DR   Wikidata; Q116048676
RX   PubMed=1602134;
RX   PubMed=8757320;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC276.3
AC   CVCL_C5Y9
DR   Wikidata; Q116048677
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC302.2
AC   CVCL_C5YA
DR   Wikidata; Q116048678
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC308.7
AC   CVCL_C5YB
DR   Wikidata; Q116048679
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC312.8
AC   CVCL_C5YC
DR   Wikidata; Q116048680
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC323.5
AC   CVCL_C5YD
DR   Wikidata; Q116048682
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC333.4
AC   CVCL_C5YE
DR   Wikidata; Q116048683
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC334.4
AC   CVCL_C5YF
DR   Wikidata; Q116048684
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC482.4
AC   CVCL_C5YG
DR   Wikidata; Q116048685
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC490.2
AC   CVCL_C5YH
DR   Wikidata; Q116048686
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC551.8
AC   CVCL_C5YI
DR   Wikidata; Q116048687
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC650
AC   CVCL_C5YJ
DR   Wikidata; Q116048688
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBLC687
AC   CVCL_C5YK
DR   Wikidata; Q116048689
RX   PubMed=1602134;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16703; (2->6)-beta-D-fructan (Levan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CBM1-Ral-Sto
AC   CVCL_IS07
SY   CB-M1-Ral-Sto; CBM1
DR   Wikidata; Q54808676
RX   PubMed=2479717;
RX   PubMed=9685479;
CC   Virology: Transformed by the EBV strain from the Rael-BL (Cellosaurus=CVCL_7208) cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   CBMC iPSC #1
AC   CVCL_WR38
DR   Wikidata; Q93444531
RX   PubMed=27579041;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CBMC iPSC #2
AC   CVCL_WR39
DR   Wikidata; Q93444533
RX   PubMed=27579041;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CBMC iPSC #3
AC   CVCL_WR40
DR   Wikidata; Q93444536
RX   PubMed=27579041;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   cbMSC-hTERT
AC   CVCL_GT25
SY   hTERT-cbMSC
DR   BCRC; 60604
DR   Wikidata; Q54808677
RX   PubMed=20230225;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   cbMSC-hTERT-RFP
AC   CVCL_GT26
SY   hTERT/RFP-cbMSC
DR   BCRC; 60605
DR   Wikidata; Q54808679
RX   PubMed=20230225;
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GT25 ! cbMSC-hTERT
SX   Female
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   CBRA59109884011
AC   CVCL_9T60
DR   IPD-IMGT/HLA; 25497
DR   Wikidata; Q54808680
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:BMMP,02:ANGA; B*44:AMUT,49:01; C*05:01,07:219; DRB1*11:JECW,13JECK (IPD-IMGT/HLA=25497).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   CBRCULi001-A
AC   CVCL_C9IP
SY   13-6545-1; 13-6545 clone 1
DR   BioSamples; SAMEA112365009
DR   hPSCreg; CBRCULi001-A
DR   Wikidata; Q123030858
RX   PubMed=36739767;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBRCULi002-A
AC   CVCL_C9IQ
SY   19-1035-10; 19-1035 clone 10
DR   BioSamples; SAMEA112366214
DR   hPSCreg; CBRCULi002-A
DR   Wikidata; Q123030860
RX   PubMed=36739767;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1300] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=36739767).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi003-A
AC   CVCL_C9IR
SY   59-0944-2; 59-0944 clone 2
DR   BioSamples; SAMEA112366222
DR   hPSCreg; CBRCULi003-A
DR   Wikidata; Q123030861
RX   PubMed=36739767;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=36739767).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi004-A
AC   CVCL_C9IS
SY   79-1660-2; 79-1660 clone 2
DR   BioSamples; SAMEA112366224
DR   hPSCreg; CBRCULi004-A
DR   Wikidata; Q123030862
RX   PubMed=36739767;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1600] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=36739767).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi005-A
AC   CVCL_C9IT
SY   91-3158-1; 91-3158 clone 1
DR   BioSamples; SAMEA112366226
DR   hPSCreg; CBRCULi005-A
DR   Wikidata; Q123030863
RX   PubMed=36739767;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1600] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=36739767).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi006-A
AC   CVCL_C9IU
SY   59-0116-24; 59-0116 clone 24
DR   BioSamples; SAMEA112946754
DR   hPSCreg; CBRCULi006-A
DR   Wikidata; Q123030864
RX   PubMed=37352653;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBRCULi007-A
AC   CVCL_C9IV
SY   14-0730-1; 14-0730 clone 1
DR   BioSamples; SAMEA112946755
DR   hPSCreg; CBRCULi007-A
DR   Wikidata; Q123030865
RX   PubMed=37352653;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=37352653).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi008-A
AC   CVCL_C9IW
SY   522-0617-1; 522-0617 clone 1
DR   BioSamples; SAMEA112965612
DR   hPSCreg; CBRCULi008-A
DR   Wikidata; Q123030866
RX   PubMed=37473461;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBRCULi009-A
AC   CVCL_C9IX
SY   522-1839-4; 522-1839 clone 4
DR   BioSamples; SAMEA112965613
DR   hPSCreg; CBRCULi009-A
DR   Wikidata; Q123030867
RX   PubMed=37473461;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBRCULi010-A
AC   CVCL_C9IY
SY   GM00498E-1; GM00498E clone 1
DR   BioSamples; SAMEA113602411
DR   hPSCreg; CBRCULi010-A
DR   Wikidata; Q123030868
RX   PubMed=37871474;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7290 ! GM00498
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBRCULi011-A
AC   CVCL_C9IZ
SY   GM00969F-2; GM00969F clone 2
DR   BioSamples; SAMEA114243954
DR   hPSCreg; CBRCULi011-A
DR   Wikidata; Q123030869
RX   PubMed=37871474;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7311 ! GM00969
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBRCULi012-A
AC   CVCL_C9J0
SY   GM04601-21; GM04601 clone 21
DR   BioSamples; SAMEA114243996
DR   hPSCreg; CBRCULi012-A
DR   Wikidata; Q123030870
RX   PubMed=37871474;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y793 ! GM04601
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CBRCULi013-A
AC   CVCL_C9J1
SY   GM04602-2; GM04602 clone 2
DR   BioSamples; SAMEA114243997
DR   hPSCreg; CBRCULi013-A
DR   Wikidata; Q123030871
RX   PubMed=37871474;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y794 ! GM04602
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi014-A
AC   CVCL_C9J2
SY   AG09393A-3; AG09393A clone 3
DR   BioSamples; SAMEA114857239
DR   hPSCreg; CBRCULi014-A
DR   Wikidata; Q123030872
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2I82 ! AG09393
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   CBRCULi015-A
AC   CVCL_C9J3
SY   GM23375-1; GM23375 clone 1
DR   BioSamples; SAMEA114860034
DR   hPSCreg; CBRCULi015-A
DR   Wikidata; Q123030873
RX   PubMed=38704930;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Iraqi.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700-1800] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=38704930).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BV56 ! GM23375
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   CBRCULi016-A
AC   CVCL_D1FY
SY   SCN5A p.R219H-14C; SCN5A p.R219H clone 14C
DR   BioSamples; SAMEA114425089
DR   hPSCreg; CBRCULi016-A
DR   Wikidata; Q127380402
RX   PubMed=38232626;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Arg219His (c.656G>A); ClinVar=VCV000242206; Zygosity=Heterozygous (PubMed=38232626).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   CBRCULi016-A-1
AC   CVCL_D1FZ
SY   SCN5A p.R219H-14C-ISO; SCN5A p.R219H clone 14C isogenic
DR   hPSCreg; CBRCULi016-A-1
DR   Wikidata; Q127380403
RX   PubMed=38232626;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple_corrected; p.Arg219His (c.656G>A); ClinVar=VCV000242206; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38232626).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1FY ! CBRCULi016-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   CBRCULi017-A
AC   CVCL_D6FV
SY   SCN5A p.R219-22B; SCN5A p.R219 clone 22B
DR   BioSamples; SAMEA114531813
DR   hPSCreg; CBRCULi017-A
DR   Wikidata; Q127380404
RX   PubMed=38232626;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CBRCULi018-A
AC   CVCL_D6FW
SY   91-2032-7; 91-2032 clone 7
DR   BioSamples; SAMEA115098117
DR   hPSCreg; CBRCULi018-A
DR   Wikidata; Q127380405
RX   PubMed=38490135;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~2000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=38232626).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi019-A
AC   CVCL_D6FX
SY   19-1741-2; 19-1741 clone 2
DR   BioSamples; SAMEA115098171
DR   hPSCreg; CBRCULi019-A
DR   Wikidata; Q127380406
RX   PubMed=38490135;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~900] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=38232626).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CBRCULi020-A
AC   CVCL_D6FY
SY   79-1761-15; 79-1761 clone 15
DR   BioSamples; SAMEA115098172
DR   hPSCreg; CBRCULi020-A
DR   Wikidata; Q127380407
RX   PubMed=38490135;
CC   From: CERVO Brain Research Centre, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1200] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=38232626).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CBRH-7919
AC   CVCL_7176
SY   CBRH7919
DR   BTO; BTO_0005317
DR   CCRID; 3101RATTCR2
DR   CCRID; 6101MOU-CERC000117
DR   Wikidata; Q54808688
RX   CelloPub=CLPUB00284;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   CBRM1/1
AC   CVCL_0F21
DR   ATCC; CRL-2859
DR   Wikidata; Q54808681
RX   PubMed=7679388;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   CBRM1/10
AC   CVCL_0F23
DR   ATCC; CRL-2861
DR   Wikidata; Q54808682
RX   PubMed=7679388;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   CBRM1/23
AC   CVCL_0F24
DR   ATCC; CRL-2862
DR   Wikidata; Q54808683
RX   PubMed=7679388;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   CBRM1/30
AC   CVCL_0F25
DR   ATCC; CRL-2863
DR   Wikidata; Q54808685
RX   PubMed=7679388;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
CC   Discontinued: ATCC; CRL-2863; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   CBRM1/32
AC   CVCL_0F26
DR   ATCC; CRL-2864
DR   Wikidata; Q54808686
RX   PubMed=7679388;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
CC   Discontinued: ATCC; CRL-2864; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   CBRN1/6
AC   CVCL_0F22
DR   ATCC; CRL-2860
DR   Wikidata; Q54808687
RX   PubMed=9614126;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   CBS [Human colon carcinoma]
AC   CVCL_D298
SY   HCT-CBS; HCT CBS
DR   cancercelllines; CVCL_D298
DR   Cosmic; 887231
DR   Cosmic; 1131686
DR   IARC_TP53; 6474
DR   Wikidata; Q54808689
RX   PubMed=2835152;
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=7329817;
RX   PubMed=7761852;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=17363507;
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=9000147).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   CBS [Piaractus]
AC   CVCL_B5DL
DR   Wikidata; Q110432679
RX   PubMed=11330178;
CC   Group: Fish cell line.
CC   Doubling time: 27.00 +- 12.60 hours (PubMed=11330178).
CC   Derived from site: In situ; Anal fin; UBERON=UBERON_4000163.
OX   NCBI_TaxID=42529; ! Piaractus brachypomus (Pirapitinga)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   CBS-R
AC   CVCL_0I68
SY   CBS
DR   CCLV; CCLV-RIE 0266
DR   Wikidata; Q54808690
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal brain, cerebellum; UBERON=UBERON_0006238+UBERON_0002037.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   CBT
AC   CVCL_B5DM
DR   Wikidata; Q110432680
RX   PubMed=11330178;
CC   Group: Fish cell line.
CC   Doubling time: 33.40 +- 20.08 hours (PubMed=11330178).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=42529; ! Piaractus brachypomus (Pirapitinga)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   CBT026T
AC   CVCL_UH62
SY   CBT026T-HES
DR   Wikidata; Q93444601
RX   Patent=US8168586;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7742.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 5
//
ID   CBTCi001-A
AC   CVCL_UL91
SY   EA1c2-MS
DR   hPSCreg; CBTCi001-A
DR   Wikidata; Q93444602
RX   PubMed=31706097;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   CBTCi002-A
AC   CVCL_UL92
SY   EB3; EB3c9
DR   hPSCreg; CBTCi002-A
DR   Wikidata; Q93444603
RX   PubMed=31078962;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   CBTCi003-A
AC   CVCL_WJ46
SY   EB4; EB4c22
DR   hPSCreg; CBTCi003-A
DR   Wikidata; Q93444606
RX   PubMed=31078962;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CBTCi003-A-1
AC   CVCL_YM67
SY   EB4c22 CRISPR
DR   hPSCreg; CBTCi003-A-1
DR   Wikidata; Q93444607
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ46 ! CBTCi003-A
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   CBTCi004-A
AC   CVCL_WJ47
SY   EB14
DR   hPSCreg; CBTCi004-A
DR   Wikidata; Q93444608
RX   PubMed=31078962;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CBTCi005-A
AC   CVCL_UD84
SY   EB5
DR   hPSCreg; CBTCi005-A
DR   Wikidata; Q93444611
RX   PubMed=30296668;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=30296668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   CBTCi006-A
AC   CVCL_UD85
SY   EB8
DR   hPSCreg; CBTCi006-A
DR   Wikidata; Q93444612
RX   PubMed=30296668;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=30296668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   CBTCi007-A
AC   CVCL_UD86
SY   EB13
DR   hPSCreg; CBTCi007-A
DR   Wikidata; Q93444613
RX   PubMed=30296668;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Population: Afro-Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=30296668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   CBTCi008-A
AC   CVCL_WN05
SY   iM5
DR   hPSCreg; CBTCi008-A
DR   Wikidata; Q93444616
RX   PubMed=31272037;
CC   From: Centro de Biotecnologia e Terapia Celular, Hospital Sao Rafael; Salvador; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:10588; SCN2A; Simple; p.Arg856Ter (c.2566C>T); ClinVar=VCV000436662; Zygosity=Heterozygous (PubMed=31272037).
CC   Caution: Incorrectly called CBTCi007-A in PubMed=31272037.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   CBW
AC   CVCL_B5DN
DR   Wikidata; Q110432681
RX   PubMed=11330178;
CC   Group: Fish cell line.
CC   Doubling time: 28.05 +- 3.73 hours (PubMed=11330178).
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=42529; ! Piaractus brachypomus (Pirapitinga)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   CBZ1
AC   CVCL_D2WL
SY   CBZ1-1-Cr3
DR   Wikidata; Q127380408
RX   PubMed=32619491;
WW   Provider; CReM; 546; https://stemcellbank.bu.edu/Catalog/Item/Details/546
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ12
AC   CVCL_D2WU
DR   Wikidata; Q127380409
RX   PubMed=32619491;
WW   Provider; CReM; 554; https://stemcellbank.bu.edu/Catalog/Item/Details/554
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ13
AC   CVCL_D2WV
DR   Wikidata; Q127380410
RX   PubMed=32619491;
WW   Provider; CReM; 555; https://stemcellbank.bu.edu/Catalog/Item/Details/555
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ14
AC   CVCL_D2WW
DR   Wikidata; Q127380411
RX   PubMed=32619491;
WW   Provider; CReM; 556; https://stemcellbank.bu.edu/Catalog/Item/Details/556
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ3
AC   CVCL_D2WM
SY   CBZ3-13-Cr4
DR   Wikidata; Q127380412
RX   PubMed=32619491;
WW   Provider; CReM; 547; https://stemcellbank.bu.edu/Catalog/Item/Details/547
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ4
AC   CVCL_D2WN
SY   CBZ4S-2
DR   Wikidata; Q127380413
RX   PubMed=32619491;
WW   Provider; CReM; 548; https://stemcellbank.bu.edu/Catalog/Item/Details/548
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Caution: Indicated wrongly as originating from a mael donor in the Boston University iPSC catalog.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ5
AC   CVCL_D2WP
DR   Wikidata; Q127380414
RX   PubMed=32619491;
WW   Provider; CReM; 549; https://stemcellbank.bu.edu/Catalog/Item/Details/549
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ6
AC   CVCL_D2WQ
DR   Wikidata; Q127380415
RX   PubMed=32619491;
WW   Provider; CReM; 550; https://stemcellbank.bu.edu/Catalog/Item/Details/550
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ7
AC   CVCL_D2WR
SY   CBZ7-S3
DR   Wikidata; Q127380416
RX   PubMed=32619491;
WW   Provider; CReM; 551; https://stemcellbank.bu.edu/Catalog/Item/Details/551
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ8
AC   CVCL_D2WS
DR   Wikidata; Q127380417
RX   PubMed=32619491;
WW   Provider; CReM; 552; https://stemcellbank.bu.edu/Catalog/Item/Details/552
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CBZ9
AC   CVCL_D2WT
SY   CBZ9S-1
DR   Wikidata; Q127380418
RX   PubMed=32619491;
WW   Provider; CReM; 553; https://stemcellbank.bu.edu/Catalog/Item/Details/553
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CC
AC   CVCL_E520
DR   dbMHC; 48534
DR   ECACC; 94050336
DR   IHW; IHW09259
DR   IPD-IMGT/HLA; 10399
DR   Wikidata; Q54808691
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*43:01,74:01; B*44:03:01,15:03; C*02,08; DPB1*02:01:02,80:01; DRB1*15:03:01,13:02:01 (IPD-IMGT/HLA=10399).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   CC 11
AC   CVCL_K137
SY   CC-11; CC11
DR   ATCC; HB-9455
DR   Wikidata; Q54808692
RX   Patent=US5512443;
RX   PubMed=3396010;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9455.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CC 15
AC   CVCL_K138
SY   CC-15; CC15
DR   ATCC; HB-9460
DR   Wikidata; Q54808693
RX   Patent=US5512443;
RX   PubMed=3396010;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9460.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CC 29
AC   CVCL_C3TW
SY   CC-29; CC29
DR   Wikidata; Q116048690
RX   Patent=US5512443;
RX   PubMed=3396010;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CC 30
AC   CVCL_K139
SY   CC-30; CC30
DR   ATCC; HB-9457
DR   Wikidata; Q54808694
RX   Patent=US5512443;
RX   PubMed=3396010;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9457.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CC 46
AC   CVCL_K140
SY   CC-46; CC46
DR   Wikidata; Q54808695
RX   Patent=US5512443;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9458.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CC 49
AC   CVCL_K141
SY   CC-49; CC49
DR   CLO; CLO_0002214
DR   ABCD; ABCD_AJ342
DR   ATCC; HB-9459
DR   Wikidata; Q54808696
RX   DOI=10.1089/hyb.1997.16.207;
RX   Patent=US5512443;
RX   PubMed=3396010;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9459.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma is known as minretumomab and has been used in phase 1 clinical trials for the treatment of various cancers.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
CC   Discontinued: ATCC; HB-9459; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   CC 83
AC   CVCL_K142
SY   CC-83; CC83
DR   ABCD; ABCD_AJ344
DR   ATCC; HB-9453
DR   Wikidata; Q54808697
RX   Patent=US5512443;
RX   PubMed=3396010;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9453.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CC 92
AC   CVCL_K143
SY   CC-92; CC92
DR   ABCD; ABCD_AJ343
DR   ATCC; HB-9454
DR   Wikidata; Q54808698
RX   Patent=US5512443;
RX   PubMed=3396010;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9454.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   cc-006cpm8
AC   CVCL_WP72
DR   cancercelllines; CVCL_WP72
DR   Wikidata; Q93444666
RX   PubMed=31115570;
CC   Population: Chinese.
CC   Doubling time: 27 hours (PubMed=31115570).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=31115570).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   CC-1
AC   CVCL_4141
DR   CLO; CLO_0002215
DR   CLDB; cl651
DR   ChEMBL-Cells; CHEMBL3307391
DR   ChEMBL-Targets; CHEMBL614537
DR   ECACC; 93070901
DR   PubChem_Cell_line; CVCL_4141
DR   Wikidata; Q54808699
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C4MB ! RLC [Rat liver]
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   CC-10A
AC   CVCL_DF79
SY   CC10A
DR   cancercelllines; CVCL_DF79
DR   GEO; GSM226733
DR   GEO; GSM226869
DR   Progenetix; CVCL_DF79
DR   Wikidata; Q54808700
RX   PubMed=10554043;
RX   PubMed=17311676;
CC   Population: Surinamese.
CC   Doubling time: 58 +- 1 hours (PubMed=10554043).
CC   Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
DI   ORDO; Orphanet_213833; Glassy cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DF80 ! CC-10B
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CC-10B
AC   CVCL_DF80
SY   CC10B
DR   cancercelllines; CVCL_DF80
DR   GEO; GSM226741
DR   GEO; GSM226870
DR   Progenetix; CVCL_DF80
DR   Wikidata; Q54808702
RX   PubMed=10554043;
RX   PubMed=17311676;
CC   Population: Surinamese.
CC   Doubling time: 31 +- 2 hours (PubMed=10554043).
CC   Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
DI   ORDO; Orphanet_213833; Glassy cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DF79 ! CC-10A
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CC-11
AC   CVCL_DF81
SY   CC11
DR   Wikidata; Q54808703
RX   PubMed=10554043;
CC   Population: Surinamese.
CC   Doubling time: 62 +- 10 hours (PubMed=10554043).
CC   Transformant: NCBI_TaxID; 37120; Human papillomavirus type 67 (HPV67).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4519; Cervical adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CC-11+
AC   CVCL_DF82
SY   CC11+
DR   cancercelllines; CVCL_DF82
DR   GEO; GSM226736
DR   GEO; GSM226872
DR   Progenetix; CVCL_DF82
DR   Wikidata; Q54808704
RX   PubMed=17311676;
CC   Population: Surinamese.
CC   Transformant: NCBI_TaxID; 37120; Human papillomavirus type 67 (HPV67).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4519; Cervical adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DF81 ! CC-11
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   CC-11-
AC   CVCL_DF83
SY   CC11-
DR   cancercelllines; CVCL_DF83
DR   GEO; GSM226735
DR   GEO; GSM226871
DR   Progenetix; CVCL_DF83
DR   Wikidata; Q54808705
RX   PubMed=17311676;
CC   Population: Surinamese.
CC   Transformant: NCBI_TaxID; 37120; Human papillomavirus type 67 (HPV67).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4519; Cervical adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DF81 ! CC-11
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   CC-135-VGH
AC   CVCL_GT23
DR   BCRC; 60597
DR   Wikidata; Q54808706
RX   CelloPub=CLPUB00353;
CC   Population: Chinese.
CC   Doubling time: ~44 hours (CelloPub=CLPUB00353).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   CC-62
AC   CVCL_M274
DR   Wikidata; Q54808707
RX   PubMed=11249201;
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 7
//
ID   CC-8
AC   CVCL_DF78
SY   CC8
DR   cancercelllines; CVCL_DF78
DR   GEO; GSM226734
DR   GEO; GSM226868
DR   Progenetix; CVCL_DF78
DR   Wikidata; Q54808708
RX   PubMed=10554043;
RX   PubMed=17311676;
CC   Population: Surinamese.
CC   Doubling time: 55 +- 7 hours (PubMed=10554043).
CC   Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4519; Cervical adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CC-B1
AC   CVCL_B7J7
DR   Wikidata; Q112929374
RX   PubMed=9892213;
CC   HLA typing: DRB1*03,06 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   CC-CL-1
AC   CVCL_M733
DR   Cosmic; 927190
DR   Wikidata; Q54808709
RX   PubMed=11802210;
CC   Miscellaneous: Only mentioned as a cholangiocarcinoma cell line in PubMed=11802210.
CC   Misspelling: CC-LC-1; Cosmic=927190.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   CC-LP-1
AC   CVCL_0205
SY   CC-LP-I; CCLP-1; CCLP1
DR   BTO; BTO_0002933
DR   MCCL; MCC:0000094
DR   cancercelllines; CVCL_0205
DR   Cell_Model_Passport; SIDM01889
DR   Cosmic; 927189
DR   DepMap; ACH-001959
DR   TOKU-E; 4041
DR   Wikidata; Q54808710
RX   CelloPub=CLPUB00275;
RX   PubMed=1355757;
RX   PubMed=27231123;
RX   PubMed=31109923;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 180 hours (PubMed=1355757).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Unspecified (DepMap=ACH-001959).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (DepMap=ACH-001959).
CC   Caution: Indicated to derive from a female patient in PubMed=1355757, but has a X,Y amelogenin STR marker.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001959
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 9,13
ST   D18S51: 13,14
ST   D21S11: 29,33
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   CC-M1
AC   CVCL_Y096
DR   BCRC; 60448
DR   Wikidata; Q54808711
CC   Population: Chinese.
CC   Doubling time: 16-20 hours (BCRC=60448).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): BCRC=60448
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12,13
ST   D16S539: 10,11,12,13
ST   D5S818: 10,11,12
ST   D7S820: 11,12,13
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 16,22
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 8
//
ID   CC-M2
AC   CVCL_Y097
DR   BCRC; 60449
DR   cancercelllines; CVCL_Y097
DR   Wikidata; Q54808712
RX   PubMed=1696674;
RX   PubMed=15144569;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (BCRC=60449). Originally thought to originate from a 58 year old male patient with a sigmoid colorectal carcinoma.
CC   Population: Caucasian.
CC   Doubling time: 20.0 hours (Note=At 25th passage), 18.5 hours (Note=At 50th passage) (PubMed=1696674).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser227Phe (c.680C>T); Zygosity=Unspecified (PubMed=15144569).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: BCRC; 60449; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 15
//
ID   CC-M2MN
AC   CVCL_Y098
DR   Wikidata; Q54808713
RX   PubMed=1696674;
CC   Population: Chinese.
CC   Characteristics: Established by subcutaneous injection of the tumor cells into nude mice.
CC   Doubling time: 64.5 hours (Note=At 25th passage), 57.4 hours (Note=At 50th passage) (PubMed=1696674).
CC   Caution: Supposed to be established from the same patient as CC-M2 which was shown to be a SW480/SW620 derivative.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CC-M3
AC   CVCL_Y099
DR   BCRC; 60450
DR   cancercelllines; CVCL_Y099
DR   Wikidata; Q54808714
RX   PubMed=1696674;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (BCRC=60450). Originally thought to originate from a 80 year old female patient with a transverse colorectal carcinoma.
CC   Population: Caucasian.
CC   Doubling time: 16.6 hours (Note=At 25th passage), 16.1 hours (Note=At 50th passage) (PubMed=1696674).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: BCRC; 60450; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 15
//
ID   CC-M4
AC   CVCL_Y100
DR   Wikidata; Q54808715
RX   PubMed=1696674;
CC   Population: Chinese.
CC   Doubling time: 17.2 hours (Note=At 25th passage), 16.8 hours (Note=At 50th passage) (PubMed=1696674).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 7
//
ID   CC-ML3
AC   CVCL_F654
DR   cancercelllines; CVCL_F654
DR   Wikidata; Q54808716
RX   PubMed=2036925;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   CC-SW-1
AC   CVCL_A429
SY   CC-SW-I; CCSW-1; CCSW1
DR   cancercelllines; CVCL_A429
DR   Cell_Model_Passport; SIDM01888
DR   Cosmic; 927188
DR   DepMap; ACH-001960
DR   Wikidata; Q54808718
RX   CelloPub=CLPUB00275;
RX   PubMed=1355757;
RX   PubMed=27231123;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=1355757).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001960
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 14
ST   D5S818: 11,14
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 12,16
ST   TH01: 9,9.3
ST   TPOX: 6,8
ST   vWA: 13,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   CC0066
AC   CVCL_A5YD
DR   ECACC; 92063005
DR   Wikidata; Q107114611
RX   PubMed=16152642;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,r(14) (PubMed=16152642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92063005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185638; Ring chromosome 14 syndrome
DI   ORDO; Orphanet_1440; Ring chromosome 14 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   CC1 [Human ESC]
AC   CVCL_C638
DR   Wikidata; Q54808719
RX   PubMed=20555390;
CC   From: University of Calgary; Calgary; Canada.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-01.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   CC1 [Mouse hybridoma against bovine PTPRC]
AC   CVCL_M062
SY   AFRC IAH-CC1
DR   ECACC; 95072101
DR   Wikidata; Q54808720
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; F1MJS9; Bovine PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   CC1-IIA4
AC   CVCL_C4R5
SY   CC1; KLH-GD-CC1-IIA4
DR   ABCD; ABCD_AH957
DR   Wikidata; Q116048691
RX   PubMed=4021995;
RX   PubMed=15585315;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CC1-PI 19
AC   CVCL_9V76
DR   NCBI_Iran; C216
DR   Wikidata; Q54808721
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   CC101
AC   CVCL_U062
SY   AFRC IAH-CC101
DR   ECACC; 99011338
DR   Wikidata; Q54808722
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   CC104
AC   CVCL_M047
SY   AFRC IAH-CC104
DR   ECACC; 95072105
DR   Wikidata; Q54808723
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q24LN2; Bovine ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   CC13
AC   CVCL_G098
SY   AFRC IAH-CC13
DR   ECACC; 88022403
DR   Wikidata; Q54808724
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   CC14
AC   CVCL_G099
SY   AFRC IAH-CC14
DR   ECACC; 88022404
DR   Wikidata; Q54808725
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   CC15
AC   CVCL_G100
SY   AFRC IAH-CC15
DR   CLO; CLO_0002216
DR   ATCC; HB-265
DR   ECACC; 88022410
DR   Wikidata; Q54808726
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30205; Bovine WC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CC17
AC   CVCL_G101
SY   AFRC IAH-CC17
DR   CLO; CLO_0002217
DR   ATCC; HB-281
DR   ECACC; 88022406
DR   Wikidata; Q54808727
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19238; Bovine CD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC171
AC   CVCL_U063
SY   AFRC IAH-CC171
DR   ECACC; 99011340
DR   Wikidata; Q54808728
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; F1MJS9; Bovine PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   CC20 [Human colon adenocarcinoma]
AC   CVCL_2H54
DR   cancercelllines; CVCL_2H54
DR   Cosmic; 2760076
DR   GEO; GSM1374442
DR   IARC_TP53; 21750
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54808730
RX   PubMed=2994902;
RX   PubMed=8464898;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2H55 ! CC21 [Human colon adenocarcinoma]
OI   CVCL_2H56 ! CC22
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 16
//
ID   CC20 [Mouse hybridoma]
AC   CVCL_G102
SY   AFRC IAH-CC20
DR   CLO; CLO_0002218
DR   ATCC; HB-267
DR   ECACC; 91080605
DR   Wikidata; Q54808731
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC21 [Human colon adenocarcinoma]
AC   CVCL_2H55
DR   Wikidata; Q54808732
RX   PubMed=2994902;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2H54 ! CC20 [Human colon adenocarcinoma]
OI   CVCL_2H56 ! CC22
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   CC21 [Mouse hybridoma against bovine CR2]
AC   CVCL_G103
SY   AFRC IAH-CC21
DR   CLO; CLO_0002219
DR   ATCC; HB-288
DR   ECACC; 88022411
DR   Wikidata; Q54808733
RX   PubMed=2021068;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; C9EGT0; Bovine CR2/CD21 (BoWC3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CC22
AC   CVCL_2H56
DR   Wikidata; Q54808734
RX   PubMed=2994902;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2H54 ! CC20 [Human colon adenocarcinoma]
OI   CVCL_2H55 ! CC21 [Human colon adenocarcinoma]
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   CC29
AC   CVCL_G104
SY   AFRC IAH-CC29
DR   CLO; CLO_0002220
DR   ATCC; HB-269
DR   ECACC; 88022407
DR   Wikidata; Q54808735
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19238; Bovine CD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC3
AC   CVCL_C639
DR   Wikidata; Q54808736
RX   PubMed=20555390;
CC   From: University of Calgary; Calgary; Canada.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-01.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   CC3/CUHK3
AC   CVCL_S964
SY   cc3/CUHK3; CC3/CUHK; Cervical Carcinoma 3/Chinese University of Hong Kong 3
DR   Wikidata; Q54808737
RX   PubMed=2166463;
RX   PubMed=2334130;
CC   Population: Chinese.
CC   Doubling time: ~42 hours (PubMed=2334130).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 10
//
ID   CC30
AC   CVCL_G105
SY   AFRC IAH-CC30
DR   CLO; CLO_0002221
DR   ATCC; HB-270
DR   ECACC; 88022412
DR   Wikidata; Q54808738
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; I0J0K0; Bovine CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC32
AC   CVCL_M048
SY   AFRC IAH-CC32
DR   ECACC; 95072102
DR   Wikidata; Q54808741
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P98131; Bovine SELL/CD62L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   CC34
AC   CVCL_E6BH
RX   PubMed=31926174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Ictalurus punctatus leukocyte immune-type receptors (LITRs).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CC37
AC   CVCL_G106
SY   AFRC IAH-CC37
DR   ECACC; 92021415
DR   Wikidata; Q54808742
RX   PubMed=2021068;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; C9EGT0; Bovine CR2/CD21 (BoWC3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CC38
AC   CVCL_G107
SY   AFRC IAH-CC38
DR   CLO; CLO_0002222
DR   ATCC; HB-266
DR   ECACC; 88022413
DR   Wikidata; Q54808743
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; F1MU15; Bovine CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC39
AC   CVCL_G108
SY   AFRC IAH-CC39
DR   CLO; CLO_0002223
DR   ATCC; HB-274
DR   ECACC; 91080607
DR   Wikidata; Q54808744
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30205; Bovine WC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC41
AC   CVCL_E6BI
RX   PubMed=26856701;
RX   PubMed=31926174;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Ictalurus punctatus leukocyte immune-type receptors (LITRs).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CC42
AC   CVCL_G109
SY   AFRC IAH-CC42
DR   CLO; CLO_0002224
DR   ATCC; HB-272
DR   ECACC; 88022408
DR   Wikidata; Q54808746
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q148M9; Bovine CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC51
AC   CVCL_G110
SY   AFRC IAH-CC51
DR   CLO; CLO_0002225
DR   ATCC; HB-271
DR   ECACC; 88022414
DR   Wikidata; Q54808747
RX   PubMed=2021068;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; C9EGT0; Bovine CR2/CD21 (BoWC3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC531
AC   CVCL_0206
SY   CC-531
DR   EFO; EFO_0001101
DR   MCCL; MCC:0000095
DR   CLS; 500387
DR   Wikidata; Q54808748
RX   PubMed=7903965;
RX   PubMed=8225852;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   CC531mdr+
AC   CVCL_C5RJ
DR   ChEMBL-Cells; CHEMBL3833761
DR   Wikidata; Q116048692
RX   PubMed=7903965;
RX   PubMed=14727116;
CC   Characteristics: Multidrug resistant, in addition to colchicine it also is resistant against actinomycin D, daunorubicin, doxorubicin and vinblastine (PubMed=7903965).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0206 ! CC531
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   CC531rev
AC   CVCL_C5RK
DR   Wikidata; Q116048693
RX   PubMed=7903965;
CC   Characteristics: Revertant of parent cell line, no longer multidrug resistant.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: WAG/Rij; RS=RS_0000969.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C5RJ ! CC531mdr+
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   CC55
AC   CVCL_G111
SY   AFRC IAH-CC55
DR   CLO; CLO_0002226
DR   ATCC; HB-282
DR   ECACC; 91080604
DR   Wikidata; Q54808749
RX   PubMed=2021068;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine WC4 antigen (BoWC4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC56
AC   CVCL_G112
SY   AFRC IAH-CC56
DR   CLO; CLO_0002227
DR   ATCC; HB-273
DR   ECACC; 91080609
DR   Wikidata; Q54808750
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CC57
AC   CVCL_G113
SY   AFRC IAH-CC57
DR   CLO; CLO_0002228
DR   ATCC; HB-268
DR   ECACC; 91080608
DR   Wikidata; Q54808752
RX   PubMed=2021068;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine WC4 antigen (BoWC4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CC58
AC   CVCL_G114
SY   AFRC IAH-CC58
DR   CLO; CLO_0002229
DR   ATCC; HB-275
DR   ECACC; 91080606
DR   Wikidata; Q54808753
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   CC62
AC   CVCL_U061
SY   AFRC IAH-CC62
DR   ECACC; 99011334
DR   Wikidata; Q54808754
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P81425; Bovine DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CC63
AC   CVCL_G115
SY   AFRC IAH-CC63
DR   CLO; CLO_0002230
DR   ABCD; ABCD_AJ846
DR   ATCC; HB-264
DR   ECACC; 91080603
DR   Wikidata; Q54808755
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CC7
AC   CVCL_E5QE
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CC76A
AC   CVCL_M050
SY   AFRC IAH-CC76A
DR   ECACC; 95072103
DR   Wikidata; Q54808756
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   CC7T/VGH
AC   CVCL_K269
SY   CC-VGH-7-T; CC7T; CC-7T
DR   BCRC; 60195
DR   Wikidata; Q54808757
RX   CelloPub=CLPUB00027;
RX   PubMed=2536104;
CC   Population: Chinese.
CC   Doubling time: 34 hours (CelloPub=CLPUB00027).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): BCRC=60195
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   CC8
AC   CVCL_G116
SY   AFRC IAH-CC8
DR   CLO; CLO_0002231
DR   ATCC; HB-280
DR   ECACC; 88022405
DR   Wikidata; Q54808758
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; I0J0K0; Bovine CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CC94
AC   CVCL_M049
SY   AFRC IAH-CC94
DR   ECACC; 95072104
DR   Wikidata; Q54808759
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q24LN2; Bovine ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   CC98
AC   CVCL_U060
SY   AFRC IAH-CC98
DR   ECACC; 99011337
DR   Wikidata; Q54808760
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6WY07; Bovine LY75/CD205 (BoWC6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   CC9C10
AC   CVCL_G643
DR   CLO; CLO_0002239
DR   ABCD; ABCD_AE803
DR   ATCC; HB-123
DR   Wikidata; Q54808761
RX   PubMed=6193965;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01317; Bovine INS (Note=Also reacts with other species including human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CCa
AC   CVCL_Z821
DR   DGRC; 175
DR   FlyBase_Cell_line; FBtc0000175
DR   Wikidata; Q54808762
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 1 week (DGRC=175).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   CCA
AC   CVCL_N717
DR   Cosmic; 687947
DR   Cosmic; 1082512
DR   Wikidata; Q54808763
RX   CelloPub=CLPUB00569;
RX   PubMed=2065319;
RX   PubMed=2516717;
RX   PubMed=8617485;
RX   PubMed=23882450;
WW   Provider; Metalab; -; https://web.archive.org/web/20170423101416/http://lollini.it/cca.htm
CC   Doubling time: ~90 hours (PubMed=2516717).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   CCA-OF
AC   CVCL_A7MF
DR   Wikidata; Q107114612
RX   PubMed=33862109;
CC   Characteristics: Obtained by both Opisthorchis felineus infection and N-nitrosodimethylamine treatment (PubMed=33862109).
CC   Doubling time: 23.2 +- 2.7 hours (PubMed=33862109).
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Transformant: NCBI_TaxID; 147828; Opisthorchis felineus.
DI   NCIt; C134566; Hamster cholangiocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCAbrain
AC   CVCL_C4AN
SY   CCAbre; Cyprinus CArpio brain
DR   Wikidata; Q116048694
RX   PubMed=35934930;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by common carp paramyxovirus (CCPV) (PubMed=35934930).
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 3 (CyHV-3) Taiwan isolate (KHV-T) (PubMed=35934930).
CC   Virology: Not susceptible to infection by carp edema virus (CEV) (PubMed=35934930).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CCAcar
AC   CVCL_C4AP
SY   Cyprinus CArpio cardiac
DR   Wikidata; Q116048695
RX   PubMed=35934930;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by common carp paramyxovirus (CCPV) (PubMed=35934930).
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 3 (CyHV-3) Taiwan isolate (KHV-T) (PubMed=35934930).
CC   Virology: Not susceptible to infection by carp edema virus (CEV) (PubMed=35934930).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CCAgill
AC   CVCL_C4AQ
SY   Cyprinus CArpio gill
DR   Wikidata; Q116048696
RX   PubMed=35934930;
CC   Group: Fish cell line.
CC   Virology: Moderately susceptible to infection by common carp paramyxovirus (CCPV) (PubMed=35934930).
CC   Virology: Moderately susceptible to infection by cyprinid herpesvirus 3 (CyHV-3) Taiwan isolate (KHV-T) (PubMed=35934930).
CC   Virology: Not susceptible to infection by carp edema virus (CEV) (PubMed=35934930).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CCALD iPSC-10
AC   CVCL_B939
DR   Wikidata; Q54808764
RX   PubMed=21721033;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21721033
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 16,19
ST   D19S433: 13,15
ST   D21S11: 30,31.2
ST   D2S1338: 16,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 19,21
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9R20 ! GM04496
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CCALD iPSC-2
AC   CVCL_B940
DR   Wikidata; Q54808765
RX   PubMed=21721033;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21721033
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 16,19
ST   D19S433: 13,15
ST   D21S11: 30,31.2
ST   D2S1338: 16,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 19,21
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9R20 ! GM04496
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CCApin
AC   CVCL_VL39
SY   CCApin2l2k; Cyprinus CArpio pinnae
DR   Wikidata; Q93444966
RX   PubMed=29960082;
RX   PubMed=35934930;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by common carp paramyxovirus (CCPV) (PubMed=35934930).
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 3 (CyHV-3) Taiwan isolate (KHV-T) (PubMed=29960082; PubMed=35934930).
CC   Virology: Not susceptible to infection by carp edema virus (CEV) (PubMed=35934930).
CC   Doubling time: ~44 hours (PubMed=29960082).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   CCArly CAF
AC   CVCL_D4A6
DR   Wikidata; Q127380419
RX   PubMed=36980644;
CC   Population: Caucasian.
CC   Characteristics: This is a TERT-immortalized cancer-associated fibroblast cell line which is used for the growth of a 3D co-culture tumor model (CCTM) that requires co-culture of this cell line with cancer cell line MUG-CCArly (Cellosaurus=CVCL_D4A5) (PubMed=36980644).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D4A5 ! MUG-CCArly
SX   Female
AG   72Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CCB
AC   CVCL_W096
SY   Common Carp Brain; Cyprinid Carp Brain; Cyprinus Carpio Brain
DR   CCLV; CCLV-RIE 0816
DR   ECACC; 10072802
DR   Wikidata; Q54808766
RX   CelloPub=CLPUB00374;
RX   PubMed=19941903;
RX   PubMed=35934930;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by common carp paramyxovirus (CCPV) (PubMed=35934930).
CC   Virology: Susceptible to infection by cyprinid herpesvirus 3 (CyHV-3) Taiwan isolate (KHV-T) (PubMed=35934930).
CC   Virology: Not susceptible to infection by carp edema virus (CEV) (PubMed=35934930).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   CCB-J
AC   CVCL_XE02
SY   Cyprinus Carpio Brain-Jian
DR   CCRID; 4201PAT-CCTCC01342
DR   Wikidata; Q93444969
RX   Patent=CN109971710B;
RX   PubMed=33409805;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201933.
CC   Virology: Susceptible to infection by koi herpesvirus (KHV) (PubMed=33409805).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=749192; ! Cyprinus carpio var. jian (Jian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 11
//
ID   CCB63
AC   CVCL_C0X8
DR   CCRID; 4201PAT-CCTCC02047
DR   Wikidata; Q123030874
RX   Patent=CN115044556B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202256.
CC   Virology: Susceptible to infection by koi herpesvirus (KHV) (Patent=CN115044556B).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   CCC-5
AC   CVCL_LM83
SY   CCC5
DR   cancercelllines; CVCL_LM83
DR   DepMap; ACH-002647
DR   DSMZ; ACC-810
DR   DSMZCellDive; ACC-810
DR   Wikidata; Q54808767
RX   CelloPub=CLPUB00408;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 60.5 hours (CelloPub=CLPUB00408); 2-3 days (DSMZ=ACC-810).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (DepMap=ACH-002647).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (CelloPub=CLPUB00408).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-810
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 20,25
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 13,14
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   CCC-Ca761-03
AC   CVCL_L290
DR   CCRID; 1101MOU-PUMC000165
DR   Wikidata; Q54808768
CC   Breed/subspecies: 615.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L289 ! Ca761-03
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   CCC-ESF-1
AC   CVCL_6884
DR   CCRID; 1101HUM-PUMC000108
DR   Wikidata; Q54808769
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): CCRID=1101HUM-PUMC000108
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,20
ST   D19S433: 14.2,16.2
ST   D21S11: 29,32.2
ST   D2S1338: 19,20
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 9,10
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU30 ! CCC-HEK-1
OI   CVCL_VU31 ! CCC-HEL-1
OI   CVCL_6885 ! CCC-HPF-1
OI   CVCL_6886 ! CCC-HSF-1
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   CCC-HB-2
AC   CVCL_VU27
DR   CCRID; 1101HUM-PUMC000173
DR   Wikidata; Q93444977
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): CCRID=1101HUM-PUMC000173
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU28 ! CCC-HBE-2
OI   CVCL_VU29 ! CCC-HEH-2
OI   CVCL_VU32 ! CCC-HIE-2
OI   CVCL_VU33 ! CCC-HPE-2
OI   CVCL_VU34 ! CCC-HSM-2
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 8
//
ID   CCC-HBE-2
AC   CVCL_VU28
DR   CCRID; 1101HUM-PUMC000174
DR   Wikidata; Q93444980
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU27 ! CCC-HB-2
OI   CVCL_VU29 ! CCC-HEH-2
OI   CVCL_VU32 ! CCC-HIE-2
OI   CVCL_VU33 ! CCC-HPE-2
OI   CVCL_VU34 ! CCC-HSM-2
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   CCC-HEH-2
AC   CVCL_VU29
DR   CCRID; 1101HUM-PUMC000177
DR   Wikidata; Q93444983
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU27 ! CCC-HB-2
OI   CVCL_VU28 ! CCC-HBE-2
OI   CVCL_VU32 ! CCC-HIE-2
OI   CVCL_VU33 ! CCC-HPE-2
OI   CVCL_VU34 ! CCC-HSM-2
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   CCC-HEK-1
AC   CVCL_VU30
DR   CCRID; 1101HUM-PUMC000175
DR   Wikidata; Q93444985
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6884 ! CCC-ESF-1
OI   CVCL_VU31 ! CCC-HEL-1
OI   CVCL_6885 ! CCC-HPF-1
OI   CVCL_6886 ! CCC-HSF-1
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   CCC-HEL-1
AC   CVCL_VU31
DR   CCRID; 1101HUM-PUMC000176
DR   Wikidata; Q93444987
RX   PubMed=32380833;
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): CCRID=1101HUM-PUMC000176
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,20
ST   D21S11: 29,32.2
ST   D2S1338: 19,20
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D6S1043: 12,18
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta E: 14,16
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6884 ! CCC-ESF-1
OI   CVCL_VU30 ! CCC-HEK-1
OI   CVCL_6885 ! CCC-HPF-1
OI   CVCL_6886 ! CCC-HSF-1
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 10
//
ID   CCC-HIE-2
AC   CVCL_VU32
DR   CCRID; 1101HUM-PUMC000178
DR   Wikidata; Q93444990
CC   Derived from site: In situ; Fetal colon, mucosa; UBERON=UBERON_0000317.
ST   Source(s): CCRID=1101HUM-PUMC000178
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU27 ! CCC-HB-2
OI   CVCL_VU28 ! CCC-HBE-2
OI   CVCL_VU29 ! CCC-HEH-2
OI   CVCL_VU33 ! CCC-HPE-2
OI   CVCL_VU34 ! CCC-HSM-2
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 8
//
ID   CCC-HPE-2
AC   CVCL_VU33
DR   CCRID; 1101HUM-PUMC000179
DR   Wikidata; Q93444993
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
ST   Source(s): CCRID=1101HUM-PUMC000179
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU27 ! CCC-HB-2
OI   CVCL_VU28 ! CCC-HBE-2
OI   CVCL_VU29 ! CCC-HEH-2
OI   CVCL_VU32 ! CCC-HIE-2
OI   CVCL_VU34 ! CCC-HSM-2
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 8
//
ID   CCC-HPF-1
AC   CVCL_6885
DR   CCRID; 1101HUM-PUMC000107
DR   Wikidata; Q54808770
RX   PubMed=32380833;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): CCRID=1101HUM-PUMC000107
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,20
ST   D19S433: 14.2,16.2
ST   D21S11: 29,32.2
ST   D2S1338: 19,20
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 9,10
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6884 ! CCC-ESF-1
OI   CVCL_VU30 ! CCC-HEK-1
OI   CVCL_VU31 ! CCC-HEL-1
OI   CVCL_6886 ! CCC-HSF-1
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCC-HSF-1
AC   CVCL_6886
DR   Wikidata; Q54808771
RX   PubMed=32380833;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6884 ! CCC-ESF-1
OI   CVCL_VU30 ! CCC-HEK-1
OI   CVCL_VU31 ! CCC-HEL-1
OI   CVCL_6885 ! CCC-HPF-1
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   CCC-HSM-2
AC   CVCL_VU34
DR   CCRID; 1101HUM-PUMC000180
DR   Wikidata; Q93445004
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
ST   Source(s): CCRID=1101HUM-PUMC000180
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU27 ! CCC-HB-2
OI   CVCL_VU28 ! CCC-HBE-2
OI   CVCL_VU29 ! CCC-HEH-2
OI   CVCL_VU32 ! CCC-HIE-2
OI   CVCL_VU33 ! CCC-HPE-2
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 8
//
ID   CCC-REPF-1
AC   CVCL_A9CT
DR   CCRID; 1101RAT-PUMC000688
DR   Wikidata; Q108819996
RX   PubMed=33530899;
CC   Derived from site: In situ; Embryonic lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CCC3a subline 8C
AC   CVCL_W183
SY   8C
DR   Wikidata; Q54808772
RX   PubMed=4123287;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_2426 ! CRFK
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   CCCL-1
AC   CVCL_J320
SY   C85
DR   Wikidata; Q54808773
RX   PubMed=10428757;
RX   PubMed=11589301;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 26 hours (PubMed=10428757); 24 hours (PubMed=11589301).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 9
//
ID   CCCL-10
AC   CVCL_J321
DR   cancercelllines; CVCL_J321
DR   Cosmic; 1479616
DR   Wikidata; Q54808774
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=20570890).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   CCCL-11
AC   CVCL_J322
SY   CCCL11
DR   cancercelllines; CVCL_J322
DR   ColonAtlas; CCCL11
DR   Cosmic; 1479577
DR   Wikidata; Q54808775
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20570890).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   CCCL-13
AC   CVCL_J341
AS   CVCL_J323
SY   CCCL13
DR   cancercelllines; CVCL_J341
DR   ColonAtlas; CCCL13
DR   Cosmic; 1479578
DR   Wikidata; Q54808777
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20570890).
CC   Misspelling: CCCL-12; Cosmic=1479578; Note=Prior to 2020.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   CCCL-14
AC   CVCL_J324
DR   Cosmic; 1479622
DR   Wikidata; Q54808778
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CCCL-15
AC   CVCL_J342
DR   Wikidata; Q54808779
RX   DOI=10.1007/BF02715859;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-16
AC   CVCL_J343
DR   Wikidata; Q54808780
RX   DOI=10.1007/BF02715859;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-18
AC   CVCL_J325
SY   CCCL18
DR   cancercelllines; CVCL_J325
DR   ColonAtlas; CCCL18
DR   Cosmic; 1479563
DR   Wikidata; Q54808781
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Unspecified (PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=20570890).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   CCCL-19
AC   CVCL_J326
SY   CCCL19
DR   cancercelllines; CVCL_J326
DR   ColonAtlas; CCCL19
DR   Cosmic; 1479595
DR   Wikidata; Q54808782
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=20570890).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   CCCL-2
AC   CVCL_J327
SY   C86
DR   cancercelllines; CVCL_J327
DR   Cosmic; 1479576
DR   Wikidata; Q54808783
RX   DOI=10.1007/BF02715859;
RX   PubMed=10428757;
RX   PubMed=11589301;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 24 hours (PubMed=10428757); 27 hours (PubMed=11589301).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20570890).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 15
//
ID   CCCL-20
AC   CVCL_J328
DR   Cosmic; 1479623
DR   Wikidata; Q54808784
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-21
AC   CVCL_J329
DR   Cosmic; 1479624
DR   Wikidata; Q54808785
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-22
AC   CVCL_J344
DR   Wikidata; Q54808786
RX   DOI=10.1007/BF02715859;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-23
AC   CVCL_J330
SY   CCCL23
DR   cancercelllines; CVCL_J330
DR   ColonAtlas; CCCL23
DR   Cosmic; 1479565
DR   Wikidata; Q54808787
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Homozygous (PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=20570890).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   CCCL-26
AC   CVCL_J331
DR   Cosmic; 1479625
DR   Wikidata; Q54808788
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CCCL-28
AC   CVCL_J332
SY   CCCL28
DR   cancercelllines; CVCL_J332
DR   ColonAtlas; CCCL28
DR   Cosmic; 1479596
DR   Wikidata; Q54808789
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=20570890).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   CCCL-3
AC   CVCL_J333
SY   CCCL3
DR   cancercelllines; CVCL_J333
DR   ColonAtlas; CCCL3
DR   Cosmic; 1479585
DR   Wikidata; Q54808790
RX   DOI=10.1007/BF02715859;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=20570890).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   CCCL-30
AC   CVCL_J334
DR   Cosmic; 1479626
DR   Wikidata; Q54808791
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CCCL-4
AC   CVCL_J335
SY   C18
DR   Wikidata; Q54808792
RX   DOI=10.1007/BF02715859;
RX   PubMed=10428757;
RX   PubMed=11589301;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 44 hours (PubMed=10428757); 40 hours (PubMed=11589301).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 10
//
ID   CCCL-5
AC   CVCL_J337
DR   Wikidata; Q54808793
RX   DOI=10.1007/BF02715859;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-6
AC   CVCL_J336
SY   C29
DR   cancercelllines; CVCL_J336
DR   Cosmic; 1479617
DR   Wikidata; Q54808794
RX   DOI=10.1007/BF02715859;
RX   PubMed=10428757;
RX   PubMed=11589301;
RX   PubMed=20570890;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 48 hours (PubMed=10428757); 46 hours (PubMed=11589301).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=20570890).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   CCCL-7
AC   CVCL_J338
DR   Wikidata; Q54808795
RX   DOI=10.1007/BF02715859;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-8
AC   CVCL_J339
DR   Wikidata; Q54808796
RX   DOI=10.1007/BF02715859;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCCL-9
AC   CVCL_J340
DR   Wikidata; Q54808797
RX   DOI=10.1007/BF02715859;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   CCD-1001Sk
AC   CVCL_0F51
SY   CCD-1001sk
DR   ATCC; CRL-1987
DR   BioSample; SAMN03471269
DR   Wikidata; Q54808798
CC   Senescence: Senesces at ~35 PDL (ATCC=CRL-1987).
CC   Discontinued: ATCC; CRL-1987; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1987
ST   Amelogenin: X,Y
ST   CSF1PO: 11,15
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 12
//
ID   CCD-1037Sk
AC   CVCL_2325
DR   CLO; CLO_0002253
DR   ATCC; CRL-2054
DR   BioSample; SAMN03471422
DR   GEO; GSM426278
DR   Wikidata; Q54808799
RX   PubMed=19727395;
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-2054; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2054
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 8,9.3
ST   TPOX: 9,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   CCD-1043Sk
AC   CVCL_U268
SY   CCD-1043SK; CCD 1043SK
DR   ATCC; CRL-2056
DR   BioSample; SAMN03471423
DR   Wikidata; Q54808800
CC   Senescence: Senesces after 70 PDL (ATCC=CRL-2056).
CC   Discontinued: ATCC; CRL-2056; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2056
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y7M
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 12
//
ID   CCD-1056Sk
AC   CVCL_U270
SY   CCD-1056SK; CCD1056SK
DR   ATCC; CRL-2068
DR   BioSample; SAMN03471430
DR   Wikidata; Q54808801
CC   Senescence: Senesces at 37 PDL (ATCC=CRL-2068).
CC   Discontinued: ATCC; CRL-2068; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2068
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 11
//
ID   CCD-1058Sk
AC   CVCL_2326
SY   CCD 1058 SK
DR   CLO; CLO_0002254
DR   ATCC; CRL-2071
DR   BioSample; SAMN03471431
DR   Wikidata; Q54808802
CC   Senescence: Senesces at ~34 PDL (ATCC=CRL-2071).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2071
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,18
ST   D19S433: 15,16.2
ST   D21S11: 29,31.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 7,11
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 9,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   CCD-1059Sk
AC   CVCL_2327
SY   CCD-1059 Sk; CCD-1059SK; CCD1059Sk
DR   CLO; CLO_0002255
DR   ATCC; CRL-2072
DR   BCRJ; 0061
DR   BioSample; SAMN03471432
DR   Wikidata; Q54808803
CC   Population: Caucasian.
CC   Senescence: Senesces at ~35 PDL (ATCC=CRL-2072).
CC   Discontinued: BCRJ; 0061; probable.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2072
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 20,23
ST   Penta D: 13,14
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   CCD-1064Sk
AC   CVCL_2328
SY   CCD-1064SK; CCD1064Sk; 1064SK
DR   CLO; CLO_0002256
DR   ATCC; CRL-2076
DR   BioSample; SAMN03471434
DR   Wikidata; Q54808804
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-2076
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/1/cell-lines-detail-572.html
CC   Senescence: Senesces at ~54 PDL (ATCC=CRL-2076).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 14,21
ST   D19S433: 13,14
ST   D21S11: 30.2,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   CCD-1065Sk
AC   CVCL_2329
DR   CLO; CLO_0002257
DR   ATCC; CRL-2077
DR   BioSample; SAMN03471435
DR   Wikidata; Q54808805
CC   Population: African American.
CC   Senescence: Senesces at ~33 PDL (ATCC=CRL-2077).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2077
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,20
ST   D19S433: 12,15.2
ST   D21S11: 27,31.2
ST   D2S1338: 22,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 21,24
ST   Penta D: 5,8
ST   Penta E: 8,16
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1066Sk
AC   CVCL_0F52
DR   ATCC; CRL-2080
DR   Wikidata; Q54808806
CC   Discontinued: ATCC; CRL-2080; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CCD-1068Sk
AC   CVCL_2330
SY   CCD-1068SK; CCD1068SK
DR   CLO; CLO_0002258
DR   ATCC; CRL-2086
DR   BioSample; SAMN03471442
DR   Wikidata; Q54808807
CC   Senescence: Senesces at ~33 PDL (ATCC=CRL-2086).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2086
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,18
ST   D19S433: 14,16
ST   D21S11: 28,29
ST   D2S1338: 24,25
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   CCD-1069Sk
AC   CVCL_2331
SY   CCD 1069SK; CCD1069Sk
DR   CLO; CLO_0002259
DR   ATCC; CRL-2089
DR   BioSample; SAMN03471444
DR   Wikidata; Q54808808
CC   Senescence: Senesces at ~23 PDL (ATCC=CRL-2089).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2089
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 15
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 19,21
ST   Penta D: 11,12
ST   Penta E: 5,15
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1070Sk
AC   CVCL_2332
SY   CCD-1070sk; CCD-1070SK; CCD1070Sk; CCD1070SK
DR   CLO; CLO_0002260
DR   EFO; EFO_0022511
DR   ATCC; CRL-2091
DR   BioSample; SAMN03471446
DR   Wikidata; Q54808809
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/origin-of-atcc-crl-2091
CC   Senescence: Senesces at ~36 PDL (ATCC=CRL-2091).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2091
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,14
ST   D18S51: 14,19
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 20,23
ST   Penta D: 12,15
ST   Penta E: 5,7
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   CCD-1072Sk
AC   CVCL_2333
SY   CCD-1072sk; CCD 1072SK; CCD1072SK
DR   CLO; CLO_0002261
DR   ATCC; CRL-2088
DR   BCRJ; 0062
DR   BioSample; SAMN03471443
DR   Wikidata; Q54808810
CC   Senescence: Senesces at ~35 PDL (ATCC=CRL-2088).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2088
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 17,21
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 21,22
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 8,11
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 6,10
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1074Sk
AC   CVCL_2334
DR   CLO; CLO_0002262
DR   ATCC; CRL-2090
DR   BioSample; SAMN03471445
DR   Wikidata; Q54808812
CC   Senescence: Senesces at ~26 PDL (ATCC=CRL-2090).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2090
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 19,21
ST   Penta D: 11,14
ST   Penta E: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1076Sk
AC   CVCL_2335
SY   CCD-1076SK; CCD 1076Sk; CCD1076SK
DR   CLO; CLO_0002263
DR   ATCC; CRL-2096
DR   BioSample; SAMN03471447
DR   Wikidata; Q54808813
CC   Population: African American.
CC   Senescence: Senesces at ~46 PDL (ATCC=CRL-2096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2096
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 15,17
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,16
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 10,17
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   CCD-1077Sk
AC   CVCL_2336
SY   CCD-1077sk
DR   CLO; CLO_0002264
DR   ATCC; CRL-2094
DR   BioSample; SAMN03471448
DR   Wikidata; Q54808814
CC   Senescence: Senesces at ~40 PDL (ATCC=CRL-2094).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2094
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13,15
ST   D21S11: 31.2,32.2
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22,26
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1079Sk
AC   CVCL_2337
SY   CCD1079SK; CCD1079sk
DR   CLO; CLO_0002265
DR   ATCC; CRL-2097
DR   BioSample; SAMN03471450
DR   GEO; GSM909334
DR   GEO; GSM909335
DR   Wikidata; Q54808815
CC   Senescence: Senesces at ~56 PDL (ATCC=CRL-2097).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2097
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D19S433: 13,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 24,26
ST   Penta D: 9,15
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   CCD-1086Sk
AC   CVCL_2338
DR   CLO; CLO_0002266
DR   ATCC; CRL-2103
DR   BioSample; SAMN03472541
DR   Wikidata; Q54808816
CC   Senescence: Senesces at ~57 PDL (ATCC=CRL-2103).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2103
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 13,15
ST   D21S11: 32.2,34.2
ST   D2S1338: 20,25
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   FGA: 20,23
ST   Penta D: 12,14
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1087Sk
AC   CVCL_2339
SY   1087sk
DR   CLO; CLO_0002267
DR   ATCC; CRL-2104
DR   BioSample; SAMN03472542
DR   Wikidata; Q54808817
RX   PubMed=18511599;
CC   Senescence: Senesces at ~43 PDL (ATCC=CRL-2104).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2104
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 18,19
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 14,16
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 10,13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1090Sk
AC   CVCL_2340
DR   CLO; CLO_0002268
DR   ATCC; CRL-2106
DR   BioSample; SAMN03472544
DR   Wikidata; Q54808818
CC   Population: Caucasian.
CC   Senescence: Senesces at ~37 PDL (ATCC=CRL-2106).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2106
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1092Sk
AC   CVCL_2341
SY   CCD-1092SK; CCD-1092sk
DR   CLO; CLO_0002269
DR   ATCC; CRL-2114
DR   BioSample; SAMN03472545
DR   Wikidata; Q54808819
CC   Population: African American.
CC   Senescence: Senesces at ~38 PDL (ATCC=CRL-2114).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2114
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 28,30.2
ST   D2S1338: 21,24
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,13
ST   D8S1179: 15
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   CCD-1093Sk
AC   CVCL_2342
DR   CLO; CLO_0002270
DR   ATCC; CRL-2115
DR   BioSample; SAMN03472546
DR   Wikidata; Q54808820
CC   Population: Caucasian.
CC   Senescence: Senesces at ~42 PDL (ATCC=CRL-2115).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2115
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 30,32.2
ST   D2S1338: 18,23
ST   D3S1358: 14,15
ST   D5S818: 9,13
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 5,6
ST   TPOX: 8,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   CCD-1094Sk
AC   CVCL_2343
DR   CLO; CLO_0002271
DR   ATCC; CRL-2120
DR   BioSample; SAMN03472547
DR   Wikidata; Q54808821
CC   Population: Caucasian.
CC   Senescence: Senesces at ~41 PDL (ATCC=CRL-2120).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2120
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12.3,15.3
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 20,24
ST   Penta D: 12,14
ST   Penta E: 5,13
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1095Sk
AC   CVCL_2344
SY   CCD1095Sk
DR   BTO; BTO_0006446
DR   CLO; CLO_0002272
DR   ATCC; CRL-2122
DR   BioSample; SAMN03472548
DR   CCRID; 3101HUMGNHu15
DR   CLS; 300642
DR   Wikidata; Q54808822
CC   Population: Caucasian.
CC   Senescence: Senesces at ~36 PDL (ATCC=CRL-2122).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2122
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 13,19
ST   D19S433: 12,13
ST   D21S11: 30,31
ST   D2S1338: 19,20
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23,25
ST   Penta D: 9
ST   Penta E: 11,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   CCD-1096Sk
AC   CVCL_2345
SY   CCD1096sk
DR   CLO; CLO_0002273
DR   ATCC; CRL-2129
DR   BioSample; SAMN03472553
DR   Wikidata; Q54808823
CC   Population: Caucasian.
CC   Senescence: Senesces at ~43 PDL (ATCC=CRL-2129).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2129
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 15,22
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 18,25
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 21.2,24
ST   Penta D: 9,12
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C75464; Polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1097Sk
AC   CVCL_2346
SY   CCD1097SK
DR   CLO; CLO_0002274
DR   ATCC; CRL-2124
DR   BioSample; SAMN03472550
DR   Wikidata; Q54808824
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2124
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,22
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1098Sk
AC   CVCL_2347
DR   CLO; CLO_0002275
DR   ATCC; CRL-2127
DR   BioSample; SAMN03472552
DR   Wikidata; Q54808825
CC   Population: African American.
CC   Senescence: Senesces at ~23 PDL (ATCC=CRL-2127).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2127
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 13,15
ST   D19S433: 12,14.2
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 19,29
ST   Penta D: 2.2,11
ST   Penta E: 11,15
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1099Sk
AC   CVCL_2348
DR   CLO; CLO_0002276
DR   ATCC; CRL-2201
DR   BioSample; SAMN03472564
DR   Wikidata; Q54808826
CC   Population: Caucasian.
CC   Senescence: Senesces at ~60 PDL (ATCC=CRL-2201).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2201
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 10,14
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 20,24
ST   Penta D: 9,11
ST   Penta E: 12,15
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1100Sk
AC   CVCL_2350
DR   CLO; CLO_0002277
DR   ATCC; CRL-2211
DR   BioSample; SAMN03472566
DR   Wikidata; Q54808827
CC   Population: Caucasian.
CC   Senescence: Senesces at ~26 PDL (ATCC=CRL-2211).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2211
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 16,17
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 7,9
ST   D8S1179: 13
ST   FGA: 19,22.2
ST   Penta D: 9,13
ST   Penta E: 10,14
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1101Sk
AC   CVCL_2351
DR   CLO; CLO_0002278
DR   ATCC; CRL-2281
DR   BioSample; SAMN03471859
DR   Wikidata; Q54808828
CC   Population: Caucasian.
CC   Senescence: Senesces at ~10 PDL (ATCC=CRL-2281).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2281
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 20,23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 22,23
ST   Penta D: 11
ST   Penta E: 12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1102 KERTr
AC   CVCL_3297
SY   CCD 1102 KERTr; CCD-1102KerTr
DR   CLO; CLO_0002240
DR   ATCC; CRL-2310
DR   BioSample; SAMN03471867
DR   Wikidata; Q54808829
RX   CelloPub=CLPUB00528;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): ATCC=CRL-2310
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 16,17
ST   D19S433: 12.2,13
ST   D21S11: 30,32.2
ST   D2S1338: 18,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15,16
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 8,15
ST   TH01: 7,9.3
ST   TPOX: 6,8,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   CCD-1103 KIDTr
AC   CVCL_3298
SY   CCD 1103 KIDTr; CCD-1103KidTr; CCD1103KIDTR
DR   CLO; CLO_0002241
DR   ATCC; CRL-2304
DR   BioSample; SAMN03471863
DR   cancercelllines; CVCL_3298
DR   GEO; GSM827246
DR   Progenetix; CVCL_3298
DR   Wikidata; Q54808830
RX   CelloPub=CLPUB00347;
RX   PubMed=20215515;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Virology: Susceptible to infection by coxsackievirus A9, coxsackievirus B5, measles virus, poliovirus type 1 and human respiratory syncytial virus (ATCC=CRL-2304).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2304
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 12.2,14
ST   D21S11: 28,29
ST   D2S1338: 17,20
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 8,12
ST   Penta E: 8
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   CCD-1105 KIDTr
AC   CVCL_3299
SY   CCD 1105 KIDTr; CCD 1105 KIDTR; CCD-1105KidTr; CCD1105KIDTR
DR   CLO; CLO_0002242
DR   ATCC; CRL-2305
DR   BioSample; SAMN03471864
DR   cancercelllines; CVCL_3299
DR   GEO; GSM827247
DR   Progenetix; CVCL_3299
DR   Wikidata; Q54808831
RX   CelloPub=CLPUB00347;
RX   PubMed=20215515;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2305
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 17,23
ST   D3S1358: 14,17
ST   D5S818: 10,11
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 20,20.1
ST   Penta D: 9
ST   Penta E: 5,7
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   CCD-1106 KERTr
AC   CVCL_3300
SY   CCD 1106 KERTr; CCD-1106KerTr; KerTr
DR   CLO; CLO_0002243
DR   ATCC; CRL-2309
DR   BioSample; SAMN03471866
DR   Wikidata; Q54808832
RX   CelloPub=CLPUB00528;
RX   PubMed=20100199;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): ATCC=CRL-2309
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 8,12
ST   D18S51: 14,21
ST   D19S433: 12,16.2
ST   D21S11: 29,32.2
ST   D2S1338: 21,22
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 11
ST   Penta E: 11,15
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   CCD-1108Sk
AC   CVCL_2352
SY   CCD 1108Sk; CCD1108Sk; CCD1108SK
DR   CLO; CLO_0002244
DR   ATCC; CRL-2352
DR   BioSample; SAMN03471827
DR   GEO; GSM426279
DR   Wikidata; Q54808833
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~32 PDL (ATCC=CRL-2352).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2352
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 24,26
ST   Penta D: 10
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   CCD-1109Sk
AC   CVCL_2353
SY   CCD 1109SK
DR   CLO; CLO_0002279
DR   ATCC; CRL-2361
DR   BioSample; SAMN03471828
DR   Wikidata; Q54808834
CC   Population: Caucasian.
CC   Senescence: Senesces at ~20 PDL (ATCC=CRL-2361).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2361
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 31.2,32
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   CCD-1110Sk
AC   CVCL_0E06
DR   ATCC; CRL-2412
DR   BioSample; SAMN03471838
DR   Wikidata; Q54808835
CC   Senescence: Senesces at ~28 PDL (ATCC=CRL-2412).
CC   Misspelling: CCD-110Sk; BioSample=SAMN03471838.
CC   Discontinued: ATCC; CRL-2412; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2412
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12,13
ST   D16S539: 8,10,11
ST   D5S818: 12,13
ST   D7S820: 10,11,12
ST   TH01: 7,8,9.3
ST   TPOX: 8,11
ST   vWA: 15,16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 13
//
ID   CCD-1112Sk
AC   CVCL_2769
SY   CCD 1112SK; CCD1112Sk; WT-Fibr1
DR   CLO; CLO_0002280
DR   ATCC; CRL-2429
DR   BioSample; SAMN03472834
DR   GEO; GSM1053955
DR   GEO; GSM1053956
DR   GEO; GSM1053957
DR   GEO; GSM1053961
DR   GEO; GSM1053962
DR   GEO; GSM1053963
DR   GEO; GSM1053976
DR   GEO; GSM1053977
DR   GEO; GSM1053978
DR   Wikidata; Q54808836
RX   PubMed=18415935;
RX   PubMed=23225669;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~44 PDL (ATCC=CRL-2429).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: CCD 112SK; BioSample=SAMN03472834.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2429
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 17,21
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 25,26
ST   Penta D: 2.2,9
ST   Penta E: 8,11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   CCD-1113Sk
AC   CVCL_2354
SY   CCD 1113SK
DR   BTO; BTO_0006089
DR   CLO; CLO_0002281
DR   ATCC; CRL-2439
DR   BioSample; SAMN03471842
DR   Wikidata; Q54808837
CC   Population: African American.
CC   Senescence: Senesces at ~31 PDL (ATCC=CRL-2439).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2439
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   D8S1179: 14,17
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 9,15
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 13,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   CCD-1114Sk
AC   CVCL_2355
SY   CCD 1114SK; CCD1114sk
DR   CLO; CLO_0002282
DR   ATCC; CRL-2450
DR   BioSample; SAMN03471580
DR   Wikidata; Q54808838
CC   Population: Caucasian.
CC   Senescence: Senesces at ~30 PDL (ATCC=CRL-2450).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2450
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1117Sk
AC   CVCL_2356
SY   CCD-1117SK
DR   CLO; CLO_0002283
DR   ATCC; CRL-2465
DR   BioSample; SAMN03471583
DR   Wikidata; Q54808839
CC   Population: Caucasian.
CC   Senescence: Senesces at ~17 PDL (ATCC=CRL-2465).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2465
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D18S51: 12,13
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 20,25
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 10,11
ST   FGA: 21,24
ST   Penta D: 10,12
ST   Penta E: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   CCD-1118Sk
AC   CVCL_2357
DR   CLO; CLO_0002284
DR   ATCC; CRL-2466
DR   BioSample; SAMN03471584
DR   Wikidata; Q54808840
CC   Population: Caucasian.
CC   Senescence: Senesces at ~20 PDL (ATCC=CRL-2466).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2466
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 22,23
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1120Sk
AC   CVCL_2358
DR   CLO; CLO_0002286
DR   ATCC; CRL-2510
DR   BioSample; SAMN03471602
DR   Wikidata; Q54808841
CC   Population: Caucasian.
CC   Senescence: Senesces at ~36 PDL (ATCC=CRL-2510).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2510
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 13,15
ST   D19S433: 14
ST   D21S11: 27,30
ST   D2S1338: 21,22
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 21,24
ST   Penta D: 2.2,13
ST   Penta E: 8,16
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1121Sk
AC   CVCL_2359
DR   CLO; CLO_0002287
DR   ATCC; CRL-2511
DR   BioSample; SAMN03471603
DR   Wikidata; Q54808842
CC   Population: Caucasian.
CC   Senescence: Senesces at ~24 PDL (ATCC=CRL-2511).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2511
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D21S11: 32.2,33.2
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1122Sk
AC   CVCL_2360
SY   CCD 1122Sk; CCD1122Sk
DR   CLO; CLO_0002288
DR   ATCC; CRL-2513
DR   BioSample; SAMN03471604
DR   Wikidata; Q54808846
CC   Discontinued: ATCC; CRL-2513; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2513
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   CCD-1123Sk
AC   CVCL_2361
DR   CLO; CLO_0002289
DR   ATCC; CRL-2524
DR   BioSample; SAMN03471606
DR   Wikidata; Q54808847
CC   Senescence: Senesces at ~54 PDL (ATCC=CRL-2524).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2524
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 19,23
ST   Penta D: 9,13
ST   Penta E: 12,17
ST   TH01: 8,9.3
ST   TPOX: 9,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1124Sk
AC   CVCL_2362
SY   CCD 1124Sk
DR   CLO; CLO_0002290
DR   ATCC; CRL-2529
DR   BioSample; SAMN03471607
DR   Wikidata; Q54808848
CC   Senescence: Senesces at ~29 PDL (ATCC=CRL-2529).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2529
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 16,19
ST   D19S433: 13,17.2
ST   D21S11: 32.2,33.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 19,22
ST   Penta D: 12,14
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1126Sk
AC   CVCL_2363
DR   CLO; CLO_0002291
DR   ATCC; CRL-2564
DR   BioSample; SAMN03471672
DR   Wikidata; Q54808849
CC   Senescence: Senesces at ~46 PDL (ATCC=CRL-2564).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2564
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 12,17
ST   D19S433: 13,15.2
ST   D21S11: 28,29
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 22
ST   Penta D: 10,11
ST   Penta E: 7,11
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   CCD-1127Sk
AC   CVCL_2364
SY   CCD1127Sk
DR   CLO; CLO_0002292
DR   ATCC; CRL-2565
DR   BioSample; SAMN03471673
DR   Wikidata; Q54808850
CC   Population: Caucasian.
CC   Senescence: Senesces at ~40 PDL (ATCC=CRL-2565).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2565
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 13,15
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 11,12
ST   Penta E: 13,15
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1128Sk
AC   CVCL_2365
DR   CLO; CLO_0002293
DR   ATCC; CRL-2566
DR   BioSample; SAMN03471674
DR   Wikidata; Q54808851
CC   Population: Caucasian.
CC   Senescence: Senesces at ~30 PDL (ATCC=CRL-2566).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2566
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 12,15
ST   D21S11: 31,31.2
ST   D2S1338: 17,18
ST   D3S1358: 13,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 22,23
ST   Penta D: 8,13
ST   Penta E: 10,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   CCD-1129Sk
AC   CVCL_2366
SY   CCD-1129SK
DR   CLO; CLO_0002294
DR   ATCC; CRL-2575
DR   BioSample; SAMN03471681
DR   PRIDE; PXD000691
DR   Wikidata; Q54808852
RX   PubMed=26055192;
CC   Senescence: Senesces at ~36 PDL (ATCC=CRL-2575).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2575
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 13,14
ST   Penta E: 12,17
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   CCD-112CoN
AC   CVCL_6382
SY   CCD-112 CoN
DR   ATCC; CRL-1541
DR   BioSample; SAMN03471392
DR   Wikidata; Q54808853
RX   DOI=10.1016/B978-012361946-4/50009-0;
CC   Senescence: Senesces at ~76 PDL (ATCC=CRL-1541).
CC   Derived from site: In situ; Fetal colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-1541
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 8,10
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1131Sk
AC   CVCL_2367
DR   CLO; CLO_0002295
DR   ATCC; CRL-2617
DR   BioSample; SAMN03471677
DR   Wikidata; Q54808854
CC   Population: African American.
CC   Senescence: Senesces at ~60 PDL (ATCC=CRL-2617).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2617
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,10
ST   D18S51: 16,18
ST   D19S433: 13,14.2
ST   D21S11: 28,31.2
ST   D2S1338: 18,22
ST   D3S1358: 16,18
ST   D5S818: 8,12
ST   D7S820: 8,13
ST   D8S1179: 13,15
ST   FGA: 19.2,23
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1132Sk
AC   CVCL_2368
DR   CLO; CLO_0002296
DR   ATCC; CRL-2622
DR   BioSample; SAMN03471676
DR   Wikidata; Q54808855
CC   Population: African American.
CC   Senescence: Senesces at ~56 PDL (ATCC=CRL-2622).
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2622
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 16,19
ST   D5S818: 8,11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 10,12
ST   Penta E: 8,17
ST   TH01: 6,8
ST   TPOX: 9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   CCD-1134Sk
AC   CVCL_2369
DR   CLO; CLO_0002297
DR   ATCC; CRL-2673
DR   BioSample; SAMN03471759
DR   Wikidata; Q54808856
CC   Population: African American.
CC   Senescence: Senesces at ~35 PDL (ATCC=CRL-2673).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2673
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 8,11
ST   D18S51: 14,19
ST   D19S433: 11,13
ST   D21S11: 29.2,30
ST   D2S1338: 19,21
ST   D3S1358: 15,18
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 8,12
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   CCD-1135Sk
AC   CVCL_2370
DR   CLO; CLO_0002298
DR   ATCC; CRL-2691
DR   BioSample; SAMN03471765
DR   Wikidata; Q54808857
CC   Population: Caucasian.
CC   Senescence: Senesces at ~46 PDL (ATCC=CRL-2691).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2691
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 11,15
ST   D19S433: 14,15
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 11,14
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1136Sk
AC   CVCL_2371
DR   CLO; CLO_0002299
DR   ATCC; CRL-2697
DR   BioSample; SAMN03471767
DR   Wikidata; Q54808858
CC   Population: Caucasian.
CC   Senescence: Senesces at ~42 PDL (ATCC=CRL-2697).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2697
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 16,19
ST   D19S433: 14,15.2
ST   D21S11: 28,33.2
ST   D2S1338: 17,19
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 7,11
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1137Sk
AC   CVCL_2372
DR   CLO; CLO_0002300
DR   ATCC; CRL-2703
DR   BioSample; SAMN03471768
DR   Wikidata; Q54808859
CC   Senescence: Senesces at ~60 PDL (ATCC=CRL-2703).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-2703
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 15,19
ST   D19S433: 12,13
ST   D21S11: 28,32.2
ST   D2S1338: 19,25
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 11,14
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1138Sk
AC   CVCL_2373
SY   CCD1138sk
DR   CLO; CLO_0002301
DR   ATCC; CRL-2707
DR   BioSample; SAMN03471770
DR   Wikidata; Q54808860
CC   Population: Caucasian.
CC   Senescence: Senesces at ~25 PDL (ATCC=CRL-2707).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2707
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 22,25
ST   Penta D: 12
ST   Penta E: 10,15
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1139Sk
AC   CVCL_2374
SY   CCD-1139SK; CCD1139Sk
DR   CLO; CLO_0002302
DR   ATCC; CRL-2708
DR   BioSample; SAMN03471771
DR   Wikidata; Q54808861
CC   Population: Caucasian.
CC   Senescence: Senesces at ~52 PDL (ATCC=CRL-2708).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2708
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 14.2,15.2
ST   D21S11: 27,32.2
ST   D2S1338: 24
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 13,14
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1140Sk
AC   CVCL_2375
SY   CCD-1140sk; CCD1140Sk; CCD1140sk
DR   CLO; CLO_0002303
DR   ATCC; CRL-2714
DR   BioSample; SAMN03471773
DR   Wikidata; Q54808863
CC   Senescence: Senesces at ~55 PDL (ATCC=CRL-2714).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2714
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 12,13
ST   D19S433: 12,14
ST   D21S11: 29,33.2
ST   D2S1338: 17
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 7,13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-1141Sk
AC   CVCL_2376
DR   CLO; CLO_0002304
DR   ATCC; CRL-2796
DR   BioSample; SAMN03471790
DR   Wikidata; Q54808864
CC   Population: Caucasian.
CC   Senescence: Senesces at ~50 PDL (ATCC=CRL-2796).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-2796
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 20,21
ST   Penta D: 13,15
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-1142 FeAE (E6/E7)
AC   CVCL_B043
SY   CCD-1142 FeAE
DR   ATCC; CRL-2997
DR   BioSample; SAMN03471704
DR   Wikidata; Q54808865
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-2997; true.
CC   Derived from site: In situ; Fetal lung, bronchus, epithelium; UBERON=UBERON_0002031.
ST   Source(s): ATCC=CRL-2997
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   CCD-118Sk
AC   CVCL_Y116
SY   CCD118SK
DR   ATCC; CRL-1537
DR   Wikidata; Q54808866
CC   Discontinued: ATCC; CRL-1537; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   CCD-11Lu
AC   CVCL_2349
SY   CCD 11Lu; CCD11Lu
DR   CLO; CLO_0002305
DR   EFO; EFO_0005360
DR   CLDB; cl668
DR   ATCC; CCL-202
DR   BioSample; SAMN03471467
DR   ECACC; 94060302
DR   GEO; GSM426284
DR   Wikidata; Q54808867
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: Asian.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 94060302; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-202
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,14
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,14.2
ST   D21S11: 29,32.2
ST   D2S1338: 19,22
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   CCD-13Lu
AC   CVCL_2377
SY   CCD 13Lu; CCD-13 Lu; CCD13Lu
DR   BTO; BTO_0002644
DR   CLO; CLO_0002245
DR   CLO; CLO_0002306
DR   EFO; EFO_0005361
DR   CLDB; cl654
DR   ATCC; CCL-200
DR   BioSample; SAMN03471464
DR   ECACC; 90112704
DR   GEO; GSM426285
DR   Wikidata; Q54808868
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: African American.
CC   Senescence: Senesces at ~20 PDL (ATCC=CCL-200).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-200; ECACC=90112704
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 15
ST   D21S11: 30,36
ST   D2S1338: 24,25
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 18.2,22
ST   Penta D: 2.2,8
ST   Penta E: 13
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   CCD-14Br
AC   CVCL_2870
SY   CCD-14BR; CCD-14 Br
DR   ATCC; CCL-203
DR   BioSample; SAMN03471466
DR   BioSample; SAMN03472363
DR   cancercelllines; CVCL_2870
DR   GEO; GSM784279
DR   JCRB; JCRB9101
DR   Progenetix; CVCL_2870
DR   Wikidata; Q54808869
RX   PubMed=7065527;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ccd-14br-atcc-ccl-203
CC   Population: Caucasian.
CC   Senescence: Has been discontinued from ATCC because the cells senesced.
CC   Doubling time: ~1.6 days (Note=Lot 10172003), ~39 hours (Note=Lot 04052019) (JCRB=JCRB9101).
CC   Misspelling: CDD14BR; GEO=GSM784279.
CC   Discontinued: ATCC; CCL-203; true.
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CCL-203
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U329 ! CCD-14Sk
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   CCD-14Sk
AC   CVCL_U329
DR   ATCC; CRL-1454
DR   Wikidata; Q54808870
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-1454; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2870 ! CCD-14Br
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 9
//
ID   CCD-15Sk
AC   CVCL_Y305
SY   CCD-15sk
DR   ATCC; CRL-1457
DR   Wikidata; Q54808871
CC   Discontinued: ATCC; CRL-1457; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   CCD-16Lu
AC   CVCL_2378
SY   CCD 16Lu; CCD-16 Lu; CCD16Lu
DR   CLO; CLO_0002246
DR   CLO; CLO_0002307
DR   EFO; EFO_0005362
DR   CLDB; cl655
DR   ATCC; CCL-204
DR   BioSample; SAMN03471468
DR   ECACC; 86090301
DR   GEO; GSM426286
DR   Wikidata; Q54808872
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~11 PDL (ATCC=CCL-204).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from normal tissue from a patient who died of an astrocytoma (ATCC=CCL-204).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-204; ECACC=86090301
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 13
ST   D18S51: 14,15
ST   D19S433: 14,15.2
ST   D21S11: 30
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 7,11
ST   D8S1179: 12
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 7,9
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   CCD-186Sk
AC   CVCL_2381
SY   CCD-186SK
DR   CLO; CLO_0002308
DR   ATCC; CRL-1563
DR   BioSample; SAMN03471396
DR   Wikidata; Q54808873
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ATCC=CRL-1563).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1563
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 20,24
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 7,10
ST   D8S1179: 8,15
ST   FGA: 19,27
ST   Penta D: 9,13
ST   Penta E: 12,14
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   CCD-187Sk
AC   CVCL_Y117
SY   CCD-187sk; CCD 187 Sk; CCD187SK
DR   ATCC; CRL-1564
DR   Wikidata; Q54808874
RX   PubMed=2851922;
CC   Discontinued: ATCC; CRL-1564; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   CCD-18Co
AC   CVCL_2379
SY   CCD18Co; CCD18
DR   BTO; BTO_0004059
DR   CLO; CLO_0002309
DR   ATCC; CRL-1459
DR   BCRJ; 0400
DR   ChEMBL-Cells; CHEMBL4295453
DR   ChEMBL-Targets; CHEMBL4296405
DR   ECACC; 90070503
DR   GEO; GSM987744
DR   GEO; GSM987745
DR   GEO; GSM987746
DR   IZSLER; BS CL 204
DR   KCLB; 21459
DR   Lonza; 1019
DR   PRIDE; PXD000449
DR   PubChem_Cell_line; CVCL_2379
DR   Wikidata; Q54808875
RX   PubMed=16854228;
RX   PubMed=23234512;
CC   Population: African American.
CC   Senescence: Senesces at ~42 PDL (ATCC=CRL-1459).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Misspelling: CDC18Co; PubMed=16854228.
CC   Discontinued: ECACC; 90070503; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-1459; IZSLER=BS CL 204; KCLB=21459
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 17,19
ST   D19S433: 12.2,13
ST   D21S11: 29,30
ST   D2S1338: 19,22
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 18,24 (ATCC=CRL-1459)
ST   FGA: 18,24.2 (KCLB=21459)
ST   Penta D: 8,9
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2380 ! CCD-18Lu
SX   Female
AG   2M17D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   CCD-18Lu
AC   CVCL_2380
SY   CCD 18Lu; CCD-18 Lu
DR   CLO; CLO_0002247
DR   CLDB; cl656
DR   ATCC; CCL-205
DR   BioSample; SAMN03471469
DR   CLS; 305248
DR   ECACC; 90112706
DR   KCLB; 10205
DR   Wikidata; Q54808876
RX   PubMed=7065527;
CC   Population: African American.
CC   Senescence: Senesces at 60-70 PDL (ATCC=CCL-205).
CC   Discontinued: KCLB; 10205; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-205; ECACC=90112706
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 17,19
ST   D19S433: 12.2,13
ST   D21S11: 29,30
ST   D2S1338: 19,22
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 18,24
ST   Penta D: 8,9
ST   Penta E: 7,24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2379 ! CCD-18Co
SX   Female
AG   2M17D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   CCD-19Lu
AC   CVCL_2382
SY   CCD 19Lu; CCD-19LU; CCD19-Lu; CCD19Lu
DR   BTO; BTO_0003862
DR   CLO; CLO_0002248
DR   CLO; CLO_0002310
DR   EFO; EFO_0005363
DR   CLDB; cl657
DR   ATCC; CCL-210
DR   BioSample; SAMN03471471
DR   ChEMBL-Cells; CHEMBL3308347
DR   ChEMBL-Targets; CHEMBL614538
DR   ECACC; 90112708
DR   GEO; GSM426287
DR   KCLB; 10210
DR   PubChem_Cell_line; CVCL_2382
DR   Wikidata; Q54808877
RX   PubMed=3335022;
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~8-9 PDL (ATCC=CCL-210).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 90112708; true.
CC   Discontinued: KCLB; 10210; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-210
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13,16
ST   D21S11: 31,32.2
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U306 ! CCD-19Sk
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   CCD-19Sk
AC   CVCL_U306
SY   CCD-19SK
DR   ATCC; CRL-1471
DR   Wikidata; Q54808878
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-1471; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2382 ! CCD-19Lu
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 9
//
ID   CCD-1Sk
AC   CVCL_Y307
DR   ATCC; CRL-1445
DR   Wikidata; Q54808879
CC   Discontinued: ATCC; CRL-1445; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 7
//
ID   CCD-21Sk
AC   CVCL_Y118
DR   ATCC; CRL-1467
DR   Wikidata; Q54808880
CC   Discontinued: ATCC; CRL-1467; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   CCD-25Lu
AC   CVCL_2383
SY   CCD 25Lu; CCD25Lu
DR   BTO; BTO_0002646
DR   CLO; CLO_0002249
DR   CLO; CLO_0002311
DR   EFO; EFO_0005364
DR   CLDB; cl658
DR   ATCC; CCL-215
DR   BioSample; SAMN03471474
DR   ECACC; 90112710
DR   GEO; GSM426288
DR   KCLB; 10215
DR   Wikidata; Q54808881
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~9 PDL (ATCC=CCL-215).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from normal tissue from a child who died of a glioma of the brain stem (ATCC=CCL-215).
CC   Discontinued: KCLB; 10215; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-215
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,14
ST   D16S539: 9,11
ST   D18S51: 15,19
ST   D19S433: 12.2,14
ST   D21S11: 29,30
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 12,13
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2384 ! CCD-25Sk
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   CCD-25Sk
AC   CVCL_2384
SY   CCD-25sk; CCD25SK; CCD25Sk
DR   CLO; CLO_0002312
DR   ATCC; CRL-1474
DR   Wikidata; Q54808882
RX   PubMed=10741968;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~8 PDL (ATCC=CRL-1474).
CC   Donor information: Established from normal tissue from a child who died of a glioma of the brain stem (ATCC=CRL-1474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1474
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,14
ST   D16S539: 9,11
ST   D18S51: 15,19
ST   D19S433: 12.2,14
ST   D21S11: 29,30
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 12,13
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2383 ! CCD-25Lu
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-27Sk
AC   CVCL_2385
SY   CCD-27SK; CCD 27sk; CCD27SK; CCD27Sk
DR   BTO; BTO_0002647
DR   CLO; CLO_0002313
DR   ATCC; CRL-1475
DR   BioSample; SAMN03471361
DR   Wikidata; Q54808884
RX   DOI=10.1016/B978-012361946-4/50009-0;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1475
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 15.2,16
ST   D19S433: 10,12
ST   D21S11: 28,30
ST   D2S1338: 21,22
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 11,13
ST   Penta E: 9,14
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   CCD-28Sk
AC   CVCL_U307
SY   CCD-28SK; CCD28Sk
DR   ATCC; CRL-1477
DR   BioSample; SAMN03471363
DR   Wikidata; Q54808885
CC   Discontinued: ATCC; CRL-1477; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1477
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 10
//
ID   CCD-29Lu
AC   CVCL_2386
SY   CCD29Lu
DR   CLO; CLO_0002314
DR   EFO; EFO_0005365
DR   CLDB; cl661
DR   ATCC; CRL-1478
DR   BioSample; SAMN03471364
DR   ECACC; 90110516
DR   GEO; GSM426289
DR   Wikidata; Q54808886
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: African American.
CC   Senescence: Senesces at ~24 PDL (ATCC=CRL-1478).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-1478
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   CCD-32Lu
AC   CVCL_2387
SY   CCD32Lu
DR   CLO; CLO_0002315
DR   CLDB; cl662
DR   ATCC; CRL-1485
DR   ECACC; 90110517
DR   Wikidata; Q54808887
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=7065527;
CC   Donor information: Established from a child that died of congenital heart disease (ATCC=CRL-1485).
CC   Discontinued: ATCC; CRL-1485; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2388 ! CCD-32Sk
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-32Sk
AC   CVCL_2388
SY   CCD-32SK; CCD-32sk; CCD32SK; CCD32Sk
DR   CLO; CLO_0002316
DR   ATCC; CRL-1489
DR   BioSample; SAMN03471367
DR   Wikidata; Q54808891
CC   Donor information: Established from a child that died of congenital heart disease (ATCC=CRL-1489).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1489
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 19,25
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,16
ST   FGA: 21,22
ST   Penta D: 12,14
ST   Penta E: 5
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2387 ! CCD-32Lu
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-33Co
AC   CVCL_2389
SY   CCD33Co
DR   CLO; CLO_0002317
DR   ATCC; CRL-1539
DR   JCRB; IFO50483
DR   Wikidata; Q54808892
RX   PubMed=15900046;
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (ATCC=CRL-1539).
CC   Karyotypic information: 47,XY,+7 [62%] (ATCC=CRL-1539).
CC   Donor information: Established from normal tissue from a child who died of a brain tumor (from autologous cell line CCD-33Lu).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-1539; JCRB=IFO50483
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 14,22
ST   D19S433: 15,16.2
ST   D21S11: 31,31.2
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 8,11
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2390 ! CCD-33Lu
OI   CVCL_U328 ! CCD-33Sk
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-33Lu
AC   CVCL_2390
SY   CCD33Lu
DR   CLO; CLO_0002318
DR   EFO; EFO_0005366
DR   CLDB; cl664
DR   ATCC; CRL-1490
DR   BioSample; SAMN03471368
DR   ECACC; 90110515
DR   GEO; GSM426290
DR   Wikidata; Q54808893
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from normal tissue from a child who died of a brain tumor (ATCC=CRL-1490).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-1490
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 14,22
ST   D19S433: 15,16.2
ST   D21S11: 31,31.2
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 8,11
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2389 ! CCD-33Co
OI   CVCL_U328 ! CCD-33Sk
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   CCD-33Sk
AC   CVCL_U328
SY   CCD-33SK; CCD33SK
DR   ATCC; CRL-1493
DR   Wikidata; Q54808894
CC   Population: Caucasian.
CC   Donor information: Established from normal tissue from a child who died of a brain tumor (from autologous cell line CCD-33Lu).
CC   Discontinued: ATCC; CRL-1493; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2389 ! CCD-33Co
OI   CVCL_2390 ! CCD-33Lu
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 8
//
ID   CCD-34Lu
AC   CVCL_2391
DR   CLO; CLO_0002319
DR   CLDB; cl665
DR   ATCC; CRL-1491
DR   BioSample; SAMN03471369
DR   ECACC; 90110514
DR   Wikidata; Q54808895
RX   PubMed=7065527;
CC   Population: African American.
CC   Donor information: Established from a child who died of erythroblastosis (Rh incompatibility) (ATCC=CRL-1491).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-1491
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,13
ST   D16S539: 8,13
ST   D18S51: 10,14
ST   D19S433: 11,15
ST   D21S11: 29,30.2
ST   D2S1338: 19,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 20,23
ST   Penta D: 13
ST   Penta E: 14,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2392 ! CCD-34Sk
SX   Female
AG   2-3W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   CCD-34Sk
AC   CVCL_2392
SY   CCD-34SK; CCD34SK; CCD34Sk
DR   CLO; CLO_0002320
DR   ATCC; CRL-1497
DR   Wikidata; Q54808896
CC   Population: African American.
CC   Donor information: Established from a child who died of erythroblastosis (Rh incompatibility) (ATCC=CRL-1497).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1497
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,13
ST   D16S539: 8,13
ST   D18S51: 10,14
ST   D19S433: 11,15
ST   D21S11: 29,30.2
ST   D2S1338: 19,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 20,23
ST   Penta D: 13
ST   Penta E: 14,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2391 ! CCD-34Lu
SX   Female
AG   2-3W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-37Lu
AC   CVCL_2393
SY   CCD-37LU
DR   CLO; CLO_0002321
DR   CLDB; cl666
DR   ATCC; CRL-1496
DR   ECACC; 90110513
DR   Wikidata; Q54808897
RX   PubMed=7065527;
CC   Discontinued: ATCC; CRL-1496; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   CCD-39Lu
AC   CVCL_2394
DR   CLO; CLO_0002322
DR   CLDB; cl667
DR   ATCC; CRL-1498
DR   BioSample; SAMN03471370
DR   ECACC; 90110512
DR   Wikidata; Q54808898
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=7065527;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-1498; ECACC=90110512
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 15,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2395 ! CCD-39Sk
SX   Female
AG   8D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   CCD-39Sk
AC   CVCL_2395
SY   CCD-39SK; CCD 39SK; CCD39SK
DR   CLO; CLO_0002323
DR   ATCC; CRL-1501
DR   Wikidata; Q54808900
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1501
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 15,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2394 ! CCD-39Lu
SX   Female
AG   8D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   CCD-41Sk
AC   CVCL_U330
SY   CCD-41SK
DR   ATCC; CRL-1505
DR   Wikidata; Q54808901
CC   Discontinued: ATCC; CRL-1505; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   CCD-42Sk
AC   CVCL_2396
SY   CCD-42SK; CCD42SK
DR   CLO; CLO_0002324
DR   ATCC; CRL-1513
DR   BioSample; SAMN03471373
DR   Wikidata; Q54808902
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1513
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D18S51: 15,19
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 16,23
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-43Sk
AC   CVCL_2397
SY   CCD-43SK
DR   BTO; BTO_0003442
DR   CLO; CLO_0002325
DR   ATCC; CRL-1509
DR   BioSample; SAMN03471372
DR   Wikidata; Q54808903
CC   Population: Caucasian.
CC   Donor information: Established from normal skin of a child that died of necrotizing enterocolitis (ATCC=CRL-1509).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1509
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 11,13
ST   D16S539: 9,15
ST   D18S51: 13,16,21
ST   D19S433: 12,13
ST   D21S11: 30,31.2
ST   D2S1338: 16,18
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   D8S1179: 12,16
ST   FGA: 20,20.2
ST   Penta D: 9,12
ST   Penta E: 7,11,14
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   CCD-45Sk
AC   CVCL_U296
SY   CCD-45SK; CCD45SK
DR   ATCC; CRL-1506
DR   Wikidata; Q54808904
CC   Discontinued: ATCC; CRL-1506; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   CCD-48Sk
AC   CVCL_U297
SY   CCD-48 SK; CCD48Sk
DR   ATCC; CRL-1507
DR   Wikidata; Q54808905
CC   Discontinued: ATCC; CRL-1507; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   CCD-50Sk
AC   CVCL_U298
SY   CCD-50SK
DR   ATCC; CRL-1508
DR   Wikidata; Q54808906
CC   Discontinued: ATCC; CRL-1508; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   CCD-55Sk
AC   CVCL_U331
SY   CCD55SK
DR   ATCC; CRL-1510
DR   Wikidata; Q54808907
CC   Discontinued: ATCC; CRL-1510; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23FW
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   CCD-57Sk
AC   CVCL_Y119
DR   ATCC; CRL-1517
DR   Wikidata; Q54808909
CC   Discontinued: ATCC; CRL-1517; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   CCD-76Sk
AC   CVCL_Y120
DR   ATCC; CRL-1521
DR   Wikidata; Q54808910
CC   Discontinued: ATCC; CRL-1521; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   CCD-82Sk
AC   CVCL_Y121
SY   CCD-82 Sk
DR   ATCC; CRL-1527
DR   Wikidata; Q54808911
CC   Discontinued: ATCC; CRL-1527; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   CCD-841CoN
AC   CVCL_2871
SY   CCD 841 CoN; CCD841CoN; CCD-841-CoN
DR   BTO; BTO_0003171
DR   CLO; CLO_0002250
DR   AddexBio; P0009023/4981
DR   ATCC; CRL-1790
DR   BioSample; SAMN01821544
DR   BioSample; SAMN01821726
DR   BioSample; SAMN03471420
DR   ChEMBL-Cells; CHEMBL4295446
DR   ChEMBL-Targets; CHEMBL4296406
DR   Cosmic; 1609509
DR   JCRB; IFO50482
DR   PubChem_Cell_line; CVCL_2871
DR   Wikidata; Q54808912
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   DOI=10.1016/B978-012361946-4/50009-0;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/lifetime-of-atcc-crl-1790
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-and-growth-of-crl-1790-cells
CC   Senescence: Senesces at ~58 PDL (ATCC=CRL-1790).
CC   Discontinued: JCRB; IFO50482; true.
CC   Derived from site: In situ; Fetal colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=P0009023/4981; ATCC=CRL-1790; JCRB=IFO50482
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 14,18
ST   D19S433: 11,16.2
ST   D21S11: 29,31
ST   D2S1338: 23,25
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,26
ST   Penta D: 9,10
ST   Penta E: 9,13
ST   TH01: 7,8
ST   TPOX: 9,10
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2872 ! CCD-841CoTr
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   CCD-841CoTr
AC   CVCL_2872
SY   CCD 841 CoTr; CCD841CoTr; CCD-841-CoTr
DR   CLO; CLO_0002251
DR   ATCC; CRL-1807
DR   Wikidata; Q54808913
CC   Characteristics: Exhibits the transformed phenotype at the permissive temperature (33 Celsius) (ATCC=CRL-1807).
CC   Karyotypic information: Pentaploid. The karyology is very different from that of the parental cell line (ATCC=CRL-1807).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ts).
CC   Derived from site: In situ; Fetal colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-1807
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 14,18
ST   D19S433: 11,16.2
ST   D21S11: 29,31
ST   D2S1338: 23,25
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,26
ST   Penta D: 9,10
ST   Penta E: 9,13
ST   TH01: 7,8
ST   TPOX: 9,10
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2871 ! CCD-841CoN
SX   Female
AG   21FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   CCD-860Sk
AC   CVCL_0E39
SY   CCD-860SK
DR   ATCC; CRL-1782
DR   Wikidata; Q54808914
CC   Discontinued: ATCC; CRL-1782; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CCD-862Sk
AC   CVCL_0E40
SY   CCD-862SK
DR   ATCC; CRL-1784
DR   Wikidata; Q54808916
CC   Discontinued: ATCC; CRL-1784; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CCD-864Sk
AC   CVCL_0E41
DR   ATCC; CRL-1791
DR   Wikidata; Q54808917
CC   Discontinued: ATCC; CRL-1791; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CCD-866Sk
AC   CVCL_0E42
SY   CCD-866SK; CCD-866sk
DR   ATCC; CRL-1792
DR   Wikidata; Q54808918
CC   Discontinued: ATCC; CRL-1792; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CCD-8Lu
AC   CVCL_2398
SY   CCD 8Lu; CCD8Lu
DR   BTO; BTO_0002645
DR   CLO; CLO_0002252
DR   CLO; CLO_0002326
DR   EFO; EFO_0005367
DR   CLDB; cl659
DR   ATCC; CCL-201
DR   BioSample; SAMN03471465
DR   ECACC; 90112705
DR   GEO; GSM426283
DR   Wikidata; Q54808919
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~40-42 PDL (ATCC=CCL-201).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 90112705; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-201
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 12,14
ST   D21S11: 29.2,30
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 19,23
ST   Penta D: 9,13
ST   Penta E: 13
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   CCD-919Sk
AC   CVCL_U266
SY   CCD-919SK; CCD-919 Sk
DR   ATCC; CRL-1826
DR   BioSample; SAMN03471251
DR   Wikidata; Q54808920
CC   Discontinued: ATCC; CRL-1826; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1826
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 7,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 11
//
ID   CCD-922Sk
AC   CVCL_0E43
SY   CCD-922SK; CCD 922SK; CCD922SK
DR   ATCC; CRL-1828
DR   Wikidata; Q54808921
CC   Discontinued: ATCC; CRL-1828; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CCD-944Sk
AC   CVCL_2399
SY   CCD-944SK; CCD 944SK
DR   CLO; CLO_0002327
DR   ATCC; CRL-1836
DR   BioSample; SAMN03471254
DR   Wikidata; Q54808922
CC   Population: Caucasian.
CC   Senescence: Senesces at ~14 PDL (ATCC=CRL-1836).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1836
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 7,10
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 11,12
ST   Penta E: 7,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   CCD-965Sk
AC   CVCL_0F53
SY   CCD-965SK; CCD 965 SK; CCD965Sk
DR   ATCC; CRL-1876
DR   Wikidata; Q54808923
RX   PubMed=9804340;
RX   PubMed=12060391;
CC   Senescence: Senesces at ~25 PDL (ATCC=CRL-1876).
CC   Discontinued: ATCC; CRL-1876; true.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CCD-966Sk
AC   CVCL_U267
SY   CCD-966SK; CCD 966SK; CCD 966 SK; CCD966SK
DR   ATCC; CRL-1881
DR   BCRC; 60153
DR   BioSample; SAMN03471257
DR   Wikidata; Q54808924
CC   Discontinued: ATCC; CRL-1881; true.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1881
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 13
//
ID   CCD-967Sk
AC   CVCL_0F54
DR   ATCC; CRL-1884
DR   BioSample; SAMN03471258
DR   Wikidata; Q54808926
CC   Discontinued: ATCC; CRL-1884; true.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1884
ST   Amelogenin: X
ST   CSF1PO: 7,8
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D5S818: 9,12
ST   D7S820: 10,13
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 11
//
ID   CCD-969Sk
AC   CVCL_0F55
SY   CCD-969sk; CCD969SK
DR   ATCC; CRL-1885
DR   BioSample; SAMN03471259
DR   Wikidata; Q54808927
CC   Discontinued: ATCC; CRL-1885; true.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1885
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 6,8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 11
//
ID   CCD-973Sk
AC   CVCL_0F60
DR   ATCC; CRL-1892
DR   BioSample; SAMN03471260
DR   Wikidata; Q54808928
CC   Discontinued: ATCC; CRL-1892; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1892
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 11
//
ID   CCD-974Sk
AC   CVCL_U295
SY   CCD-974SK; CCD 974 SK
DR   ATCC; CRL-1906
DR   Wikidata; Q54808929
CC   Senescence: Senesces at ~13 PDL (ATCC=CRL-1906).
CC   Discontinued: ATCC; CRL-1906; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   CCD-976Sk
AC   CVCL_0F61
SY   CCD-976SK; CCD 976Sk
DR   ATCC; CRL-1904
DR   Wikidata; Q54808930
CC   Discontinued: ATCC; CRL-1904; true.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CCD-977Sk
AC   CVCL_0E73
DR   ATCC; CRL-1900
DR   BioSample; SAMN03471262
DR   Wikidata; Q54808931
CC   Discontinued: ATCC; CRL-1900; true.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1900
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 7,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 11
//
ID   CCD-978Sk
AC   CVCL_0E74
DR   ATCC; CRL-1905
DR   BioSample; SAMN03471263
DR   Wikidata; Q54808932
CC   Discontinued: ATCC; CRL-1905; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1905
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 8,11
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 11,12
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   CCD-986Sk
AC   CVCL_2400
SY   CCD-986SK; CCD 986 SK; CCD986SK
DR   BTO; BTO_0005133
DR   CLO; CLO_0002328
DR   ATCC; CRL-1947
DR   BioSample; SAMN03472815
DR   KCLB; 21947
DR   Wikidata; Q54808933
CC   Population: African American.
CC   Senescence: Senesces at ~36 PDL (ATCC=CRL-1947).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1947; KCLB=21947
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 8
ST   D18S51: 12,14
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   FGA: 21,26
ST   Penta D: 8,13
ST   Penta E: 10,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   CCD-IC
AC   CVCL_4676
SY   Cortical Collecting Ducts-Immortalized Cells; CCDC
DR   CLO; CLO_0050252
DR   RCB; RCB1911
DR   Wikidata; Q54808935
RX   PubMed=7966244;
RX   PubMed=7991021;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   CCD-SeV-iPS1
AC   CVCL_YT62
DR   Wikidata; Q93445295
RX   PubMed=26559068;
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Arg225Gln (c.674G>A); ClinVar=VCV000009302; Zygosity=Heterozygous (PubMed=26559068).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   CCD1-iPS 2
AC   CVCL_A4TH
DR   SKIP; SKIP003020
DR   Wikidata; Q107114613
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TI ! CCD1-iPS 4
OI   CVCL_A4TJ ! CCD1-iPS 6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCD1-iPS 4
AC   CVCL_A4TI
DR   SKIP; SKIP003020
DR   Wikidata; Q107114614
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TH ! CCD1-iPS 2
OI   CVCL_A4TJ ! CCD1-iPS 6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCD1-iPS 6
AC   CVCL_A4TJ
DR   SKIP; SKIP003020
DR   Wikidata; Q107114615
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TH ! CCD1-iPS 2
OI   CVCL_A4TI ! CCD1-iPS 4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCD2-iPS 12
AC   CVCL_A4TP
DR   SKIP; SKIP003021
DR   Wikidata; Q107114616
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TK ! CCD2-iPS 4
OI   CVCL_A4TL ! CCD2-iPS 7
OI   CVCL_A4TM ! CCD2-iPS 8
OI   CVCL_A4TN ! CCD2-iPS 9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCD2-iPS 4
AC   CVCL_A4TK
DR   SKIP; SKIP003021
DR   Wikidata; Q107114617
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TL ! CCD2-iPS 7
OI   CVCL_A4TM ! CCD2-iPS 8
OI   CVCL_A4TN ! CCD2-iPS 9
OI   CVCL_A4TP ! CCD2-iPS 12
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCD2-iPS 7
AC   CVCL_A4TL
DR   SKIP; SKIP003021
DR   Wikidata; Q107114618
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TK ! CCD2-iPS 4
OI   CVCL_A4TM ! CCD2-iPS 8
OI   CVCL_A4TN ! CCD2-iPS 9
OI   CVCL_A4TP ! CCD2-iPS 12
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCD2-iPS 8
AC   CVCL_A4TM
DR   SKIP; SKIP003021
DR   Wikidata; Q107114619
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TK ! CCD2-iPS 4
OI   CVCL_A4TL ! CCD2-iPS 7
OI   CVCL_A4TN ! CCD2-iPS 9
OI   CVCL_A4TP ! CCD2-iPS 12
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCD2-iPS 9
AC   CVCL_A4TN
DR   SKIP; SKIP003021
DR   Wikidata; Q107114620
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4TK ! CCD2-iPS 4
OI   CVCL_A4TL ! CCD2-iPS 7
OI   CVCL_A4TM ! CCD2-iPS 8
OI   CVCL_A4TP ! CCD2-iPS 12
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CCE
AC   CVCL_C313
SY   EK; EK.CCE
DR   BTO; BTO_0003560
DR   Wikidata; Q29017576
RX   PubMed=7242681;
CC   Anecdotal: CCE and ESC-ICR (Cellosaurus=CVCL_JA30) from Gail Roberta Martin are the first embryonic stem cell lines to have been established, in 1981.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 10
//
ID   CCE1
AC   CVCL_Z191
DR   Wikidata; Q54808943
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=176285; ! Carios capensis (Seabird soft tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   CCE1.1
AC   CVCL_HL96
SY   ConCordant Epilepsy 1.1
DR   GEO; GSM181381
DR   Wikidata; Q54808944
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE1.2 (Cellosaurus=CVCL_HL97).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   CCE1.2
AC   CVCL_HL97
SY   ConCordant Epilepsy 1.2
DR   GEO; GSM181382
DR   Wikidata; Q54808945
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE1.1 (Cellosaurus=CVCL_HL96).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   CCE2
AC   CVCL_Z192
SY   Carios Capensis Embryonic 2
DR   Wikidata; Q54808946
RX   PubMed=17662657;
RX   PubMed=18047211;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Doubling time: 5 days (PubMed=18047211).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=176285; ! Carios capensis (Seabird soft tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 10
//
ID   CCE2.1
AC   CVCL_HL98
SY   ConCordant Epilepsy 2.1
DR   GEO; GSM181384
DR   Wikidata; Q54808947
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE2.2 (Cellosaurus=CVCL_HL99).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   CCE2.2
AC   CVCL_HL99
SY   ConCordant Epilepsy 2.2
DR   GEO; GSM181385
DR   Wikidata; Q54808948
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE2.1 (Cellosaurus=CVCL_HL98).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   CCE3
AC   CVCL_Z193
SY   Carios Capensis Embryonic 3
DR   Wikidata; Q54808950
RX   PubMed=17662657;
RX   PubMed=18047211;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC   Group: Tick cell line.
CC   Doubling time: 5 days (PubMed=18047211).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=176285; ! Carios capensis (Seabird soft tick)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 7
//
ID   CCE3.1
AC   CVCL_HM00
SY   ConCordant Epilepsy 3.1
DR   GEO; GSM181389
DR   Wikidata; Q54808951
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE3.2 (Cellosaurus=CVCL_HM01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   CCE3.2
AC   CVCL_HM01
SY   ConCordant Epilepsy 3.2
DR   GEO; GSM181390
DR   Wikidata; Q54808952
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE3.1 (Cellosaurus=CVCL_HM00).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   CCE4.1
AC   CVCL_HM02
SY   ConCordant Epilepsy 4.1
DR   GEO; GSM181391
DR   Wikidata; Q54808953
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE4.2 (Cellosaurus=CVCL_HM03).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   CCE4.2
AC   CVCL_HM03
SY   ConCordant Epilepsy 4.2
DR   GEO; GSM181392
DR   Wikidata; Q54808954
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCE4.1 (Cellosaurus=CVCL_HM02).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   CCE5
AC   CVCL_Z194
DR   Wikidata; Q54808955
RX   PubMed=17662657;
CC   Group: Tick cell line.
OX   NCBI_TaxID=176285; ! Carios capensis (Seabird soft tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   CCEC-SV40T
AC   CVCL_C1GN
SY   Canine Corneal Epithelial Cells-SV40T immortalized
DR   Wikidata; Q114310766
RX   PubMed=35578336;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   cCEpi
AC   CVCL_VF63
SY   canine Corneal Epithelial
DR   Wikidata; Q54808957
RX   PubMed=29522723;
CC   Doubling time: 24.82 hours (Note=At 30th passage), 18.41 hours (Note=At 60th passage), 16.82 hours (Note=At 100th passage) (PubMed=29522723).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   CCES
AC   CVCL_Z509
DR   Wikidata; Q54808958
RX   PubMed=21039493;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CCf
AC   CVCL_T716
SY   Channel Catfish fin
DR   Wikidata; Q54808959
RX   PubMed=22358545;
CC   Group: Fish cell line.
CC   Doubling time: 48-72 hours (PubMed=22358545).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   CCF [Cyprinus fin China]
AC   CVCL_R837
SY   Cyprinus Carpio Fin
DR   Wikidata; Q54808960
RX   DOI=10.1007/BF01404746;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   CCF [Cyprinus fin India]
AC   CVCL_1H03
SY   Cyprinus Carpio Fin
DR   NRFC; NRFC004
DR   Wikidata; Q54808961
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=21526264;
WW   Provider; NRFC; NRFC004; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC004.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   CCF-K104
AC   CVCL_X184
SY   Carp Caudal Fin-Kochi 104
DR   Wikidata; Q54808962
RX   PubMed=24820532;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 25 to 30 Celsius.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 8
//
ID   CCF-RC1
AC   CVCL_9703
SY   CCF-RC-1
DR   Wikidata; Q54808963
RX   PubMed=2582448;
RX   PubMed=7591954;
CC   Population: Caucasian.
CC   Doubling time: 34 hours (PubMed=2582448).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9704 ! CCF-RC2
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 11
//
ID   CCF-RC2
AC   CVCL_9704
DR   Wikidata; Q54808965
RX   PubMed=2582448;
CC   Population: Caucasian.
CC   Doubling time: 36 hours (PubMed=2582448).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9703 ! CCF-RC1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   CCF-STTG1
AC   CVCL_1118
SY   CCFSTTG1; STTG1
DR   BTO; BTO_0003863
DR   CLO; CLO_0002329
DR   EFO; EFO_0002127
DR   CLDB; cl669
DR   CLDB; cl5177
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1718
DR   BioGRID_ORCS_Cell_line; 591
DR   BioSample; SAMN01821545
DR   BioSample; SAMN03470976
DR   BioSample; SAMN10988114
DR   cancercelllines; CVCL_1118
DR   Cell_Model_Passport; SIDM00131
DR   ChEMBL-Cells; CHEMBL3308795
DR   ChEMBL-Targets; CHEMBL1075419
DR   CLS; 300388
DR   Cosmic; 687565
DR   Cosmic; 849857
DR   Cosmic; 897441
DR   Cosmic; 906823
DR   Cosmic; 920820
DR   Cosmic; 1175808
DR   Cosmic; 1610750
DR   Cosmic; 1746959
DR   Cosmic; 2302324
DR   Cosmic; 2367511
DR   Cosmic-CLP; 906823
DR   DepMap; ACH-000329
DR   ECACC; 90021502
DR   EGA; EGAS00001000978
DR   GDSC; 906823
DR   GEO; GSM326233
DR   GEO; GSM886923
DR   GEO; GSM887989
DR   GEO; GSM1374443
DR   GEO; GSM1669668
DR   IARC_TP53; 21217
DR   IGRhCellID; CCFSTTG1
DR   IZSLER; BS TCL 125
DR   LiGeA; CCLE_127
DR   LINCS_LDP; LCL-1394
DR   PharmacoDB; CCFSTTG1_188_2019
DR   PRIDE; PXD003914
DR   Progenetix; CVCL_1118
DR   PubChem_Cell_line; CVCL_1118
DR   RCB; RCB1977
DR   TKG; TKG 0581
DR   Wikidata; Q54808966
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=1404494;
RX   PubMed=3877740;
RX   PubMed=19435942;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*08:01,37:01; C*06:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.55%; Native American=0%; East Asian, North=1.13%; East Asian, South=0%; South Asian=0.6%; European, North=60.84%; European, South=36.87% (PubMed=30894373).
CC   Discontinued: RCB; RCB1977; true.
CC   Discontinued: TKG; TKG 0581; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-1718; CLS=300388; Cosmic-CLP=906823; PubMed=25877200; RCB=RCB1977
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 15.2,16
ST   D21S11: 28,29
ST   D2S1338: 20,26
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   CCG [Carassius]
AC   CVCL_E7GQ
SY   Carassius Carassius Gill
RX   DOI=10.1016/j.aqrep.2022.101382;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 25 Celsius (DOI=10.1016/j.aqrep.2022.101382).
CC   Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (DOI=10.1016/j.aqrep.2022.101382).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=217509; ! Carassius carassius (Crucian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCG [Cyprinus]
AC   CVCL_R838
SY   Cyprinus Carpio Gill
DR   Wikidata; Q54808967
RX   DOI=10.1007/BF01404746;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   CCH
AC   CVCL_RL59
SY   Cyprinus Carpio Heart
DR   Wikidata; Q54808968
RX   CelloPub=CLPUB00463;
RX   PubMed=21526264;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   CCH-FAHNSCC-1
AC   CVCL_D7CS
SY   CCH-SCC-FA1; FA1
RX   PubMed=36912284;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=36912284
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   CCH-FAHNSCC-2
AC   CVCL_XX31
SY   CCH-SCC-FA2; FA2
DR   Wikidata; Q93445399
RX   PubMed=31541927;
RX   PubMed=36912284;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
ST   Source(s): PubMed=36912284
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   CCH-OS-C
AC   CVCL_XG73
DR   Wikidata; Q93445402
RX   PubMed=22186140;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   CCH-OS-D
AC   CVCL_XG67
SY   CCH.OS.D
DR   Wikidata; Q93445405
RX   CelloPub=CLPUB00529;
RX   PubMed=22075555;
RX   PubMed=22186140;
RX   PubMed=24136885;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   CCH-OS-G
AC   CVCL_XG74
DR   Wikidata; Q93445408
RX   PubMed=22186140;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   CCH-OS-K
AC   CVCL_XG71
DR   Wikidata; Q93445410
RX   CelloPub=CLPUB00529;
RX   PubMed=22186140;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   CCH-OS-M
AC   CVCL_XG75
DR   Wikidata; Q93445414
RX   PubMed=22186140;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   CCH-OS-O
AC   CVCL_XG72
DR   Wikidata; Q93445417
RX   CelloPub=CLPUB00529;
RX   PubMed=22186140;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   CCH-OS-R
AC   CVCL_XG76
DR   Wikidata; Q93445419
RX   PubMed=22186140;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   CCHMCi001-A
AC   CVCL_A1BW
SY   iPSC 72.3; IPSC72.3; iPSC72_3; iPSC 72_3; 72.3; 72_3; CuSTOM1
DR   hPSCreg; CCHMCi001-A
DR   hPSCreg; CUSTOMi001-A
DR   Wikidata; Q102114242
RX   PubMed=25363776;
RX   PubMed=28648364;
RX   PubMed=35905739;
CC   From: Cincinnati Children's Hospital Medical Center; Cincinnati; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=35905739
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D21S11: 30,30.2
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 12,13
ST   Penta E: 13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 8
//
ID   CCHMCi002-A
AC   CVCL_C1U9
SY   iPSC 115.1; iPSC115_1; 115_1
DR   hPSCreg; CCHMCi002-A
DR   Wikidata; Q114311755
RX   PubMed=35905739;
CC   From: Cincinnati Children's Hospital Medical Center; Cincinnati; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=35905739
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 17,18
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 8,12
ST   D8S1179: 11,13
ST   FGA: 21,24
ST   Penta D: 9,12
ST   Penta E: 5,16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   CCH-OS-T
AC   CVCL_XG77
DR   Wikidata; Q93445421
RX   PubMed=22186140;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   CCK-81
AC   CVCL_2873
SY   CCK81
DR   CLO; CLO_0009956
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 593
DR   BioSample; SAMN03471656
DR   BioSample; SAMN10987776
DR   cancercelllines; CVCL_2873
DR   Cell_Model_Passport; SIDM00487
DR   ColonAtlas; CCK81
DR   Cosmic; 1187301
DR   Cosmic; 2301965
DR   Cosmic; 2841356
DR   Cosmic-CLP; 1240123
DR   DepMap; ACH-000963
DR   EGA; EGAS00001000978
DR   GDSC; 1240123
DR   GEO; GSM827260
DR   GEO; GSM886924
DR   GEO; GSM887990
DR   GEO; GSM1346831
DR   GEO; GSM1374444
DR   GEO; GSM1448097
DR   GEO; GSM1669669
DR   GEO; GSM2983077
DR   GEO; GSM2983078
DR   GEO; GSM2983079
DR   GEO; GSM2983080
DR   IARC_TP53; 21737
DR   JCRB; JCRB0208
DR   LiGeA; CCLE_532
DR   LINCS_LDP; LCL-1171
DR   PharmacoDB; CCK81_189_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2873
DR   Wikidata; Q54808969
RX   PubMed=7418977;
RX   PubMed=9290701;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25623215;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34466148;
RX   PubMed=35839778;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=7418977); ~40 hours (Note=Lot 03182016) (JCRB=JCRB0208).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=24755471; PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (DepMap=ACH-000963).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (DepMap=ACH-000963).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Gln (c.14G>A); ClinVar=VCV000376520; Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000679).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Tyr42Cys (c.125A>G); Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000679).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278His (c.833C>A); ClinVar=VCV000376646; Zygosity=Heterozygous (PubMed=16418264; DepMap=ACH-000963).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.38%; East Asian, North=77.93%; East Asian, South=20.68%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1240123; JCRB=JCRB0208; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,12,13
ST   D16S539: 9,10
ST   D21S11: 28,31
ST   D5S818: 11,12,13
ST   D7S820: 8,8.1,10.3,12
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   CCK-81 R1 Cetux
AC   CVCL_A2BT
SY   CCK81 R1 Cetux
DR   cancercelllines; CVCL_A2BT
DR   Cosmic; 2841357
DR   Wikidata; Q105506584
RX   PubMed=25623215;
CC   Population: Japanese.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser464Leu (c.1391C>T); Zygosity=Heterozygous; Note=Acquired during resistance selection process (PubMed=25623215).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Gln (c.14G>A); ClinVar=VCV000376520; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Tyr42Cys (c.125A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278His (c.833C>A); ClinVar=VCV000376646; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2873 ! CCK-81
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   CCK-81 R2 Cetux
AC   CVCL_A2BU
SY   CCK81 R2 Cetux
DR   cancercelllines; CVCL_A2BU
DR   Cosmic; 2841358
DR   Wikidata; Q105506588
RX   PubMed=25623215;
CC   Population: Japanese.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Gln (c.14G>A); ClinVar=VCV000376520; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Tyr42Cys (c.125A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278His (c.833C>A); ClinVar=VCV000376646; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2873 ! CCK-81
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   CCK-81 R3 Cetux
AC   CVCL_A2BV
SY   CCK81 R3 Cetux
DR   cancercelllines; CVCL_A2BV
DR   Cosmic; 2841359
DR   Wikidata; Q105506591
RX   PubMed=25623215;
CC   Population: Japanese.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Gln (c.14G>A); ClinVar=VCV000376520; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Tyr42Cys (c.125A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278His (c.833C>A); ClinVar=VCV000376646; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2873 ! CCK-81
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   CCK061
AC   CVCL_J949
SY   CCK-061; CCK 061
DR   CLO; CLO_0002330
DR   ATCC; HB-8786
DR   Wikidata; Q54808970
RX   Patent=EP0200464B1;
RX   PubMed=3171697;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8786.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CCKF
AC   CVCL_1G73
SY   KCF; Cyprinus Carpio Koi Fin
DR   NRFC; NRFC007
DR   Wikidata; Q54808971
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=25990269;
WW   Provider; NRFC; NRFC007; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC007.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   CCL16-B1
AC   CVCL_U437
SY   B1
DR   Wikidata; Q54808973
RX   PubMed=9298714;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3472 ! Don
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   CCL16-B10
AC   CVCL_U438
DR   Wikidata; Q54808974
RX   PubMed=1027147;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3472 ! Don
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   CCL16-B11
AC   CVCL_U439
DR   Wikidata; Q54808975
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U438 ! CCL16-B10
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   CCL16-B2
AC   CVCL_U440
SY   B2
DR   Wikidata; Q54808976
RX   PubMed=483122;
RX   PubMed=947896;
RX   PubMed=1027147;
RX   PubMed=9298714;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U437 ! CCL16-B1
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   CCL16-B9
AC   CVCL_U441
SY   CCL-16-B9; B9
DR   Wikidata; Q54808977
RX   PubMed=483122;
RX   PubMed=558831;
RX   PubMed=1027147;
RX   PubMed=7592812;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-181.html
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U440 ! CCL16-B2
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   CCL3
AC   CVCL_M023
DR   BioSample; SAMN03152003
DR   Wikidata; Q54808978
RX   PubMed=19050584;
RX   PubMed=21253487;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be a human chordoma cell line but found to originate from mouse (PubMed=21253487).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00381.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   CCL4
AC   CVCL_M024
DR   Wikidata; Q54808979
RX   PubMed=18091487;
RX   PubMed=21253487;
CC   Problematic cell line: Misclassified. Originally thought to be a chordoma cell line but is either contaminated or established from nonchordoma cells (PubMed=21253487).
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 10
//
ID   CCLF-CORE-0002-T
AC   CVCL_D4BU
SY   CCLF_CORE_0002_T
DR   DepMap; ACH-002839
DR   Wikidata; Q127380420
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Grows as an organoid (CCLF).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CCLF-HEME-0002-T
AC   CVCL_E2QC
SY   CCLF_HEME_0002_T
DR   DSMZ; ACC-974
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
ST   Source(s): DSMZ=ACC-974
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 11,16
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 19,22
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 21
ST   Penta D: 11,12
ST   Penta E: 18,19
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CCLF-HNSC-0004-T
AC   CVCL_D3YX
SY   CCLF_HNSC_0004_T
DR   DSMZ; ACC-938
DR   Wikidata; Q127380421
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 20-30 hours (DSMZ=ACC-938).
ST   Source(s): DSMZ=ACC-938
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17,24
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 14,15
ST   TH01: 7,10
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CCLF-KL1017T
AC   CVCL_E6EQ
SY   CCLF_KL1017T; CPDM_0627X
WW   Provider; CPDM; CPDM_0627X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: Metastatic; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C27005; Spindle cell sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1023T
AC   CVCL_E6ER
SY   CCLF_KL1023T; CPDM_0607X
WW   Provider; CPDM; CPDM_0607X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Pro (c.581T>C); ClinVar=VCV000376635; Zygosity=Unspecified (CPDM=CPDM_0607X).
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1073T
AC   CVCL_E6ES
SY   CCLF_KL1073T; CPDM_0630X
WW   Provider; CPDM; CPDM_0630X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1081T
AC   CVCL_E6ET
SY   CCLF_KL1081T; CPDM_0735X
WW   Provider; CPDM; CPDM_0735X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1089T
AC   CVCL_E6EU
SY   CCLF_KL1089T; CPDM_0731X
WW   Provider; CPDM; CPDM_0731X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1092T
AC   CVCL_E6EV
SY   CCLF_KL1092T; CPDM_0632X
WW   Provider; CPDM; CPDM_0632X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1094T
AC   CVCL_E6EW
SY   CCLF_KL1094T; CPDM_0618X
WW   Provider; CPDM; CPDM_0618X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (CPDM=CPDM_0618X).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C167335; Astrocytoma, IDH-mutant, grade 4
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1105T
AC   CVCL_E6EY
SY   CCLF_KL1105T; CPDM_0603X
WW   Provider; CPDM; CPDM_0603X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1115T
AC   CVCL_E6EZ
SY   CCLF_KL1115T; CPDM_0766X
WW   Provider; CPDM; CPDM_0766X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1116T
AC   CVCL_E6F0
SY   CCLF_KL1116T; CPDM_0104X
WW   Provider; CPDM; CPDM_0104X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1118T
AC   CVCL_E6F1
SY   CCLF_KL1118T; CPDM_0601X
WW   Provider; CPDM; CPDM_0601X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1129T
AC   CVCL_E6F2
SY   CCLF_KL1129T; CPDM_0611X
WW   Provider; CPDM; CPDM_0611X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1149T
AC   CVCL_E6F3
SY   CCLF_KL1149T; CPDM_0619X
WW   Provider; CPDM; CPDM_0619X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: Metastatic; Brain, left cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3513; Esophageal carcinoma
DI   ORDO; Orphanet_70482; Carcinoma of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1173T
AC   CVCL_E6F4
SY   CCLF_KL1173T; CPDM_0653X
WW   Provider; CPDM; CPDM_0653X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain, right frontal cortex; UBERON=UBERON_0001870.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1182T
AC   CVCL_E6F5
SY   CCLF_KL1182T; CPDM_0589X
WW   Provider; CPDM; CPDM_0589X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain, right temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1187T
AC   CVCL_E6F6
SY   CCLF_KL1187T; CPDM_0762X
WW   Provider; CPDM; CPDM_0762X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: Metastatic; Brain, left temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1331T
AC   CVCL_E6F7
SY   CCLF_KL1331T; CPDM_1584X
WW   Provider; CPDM; CPDM_1584X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Asian.
CC   Derived from site: In situ; Brain, temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCLF-KL1434T
AC   CVCL_E6F8
SY   CCLF_KL1434T; CPDM_1935X
WW   Provider; CPDM; CPDM_1935X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, temporal cortex; UBERON=UBERON_0016538.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CCLF-MELM_0026-T-A
AC   CVCL_D3YZ
SY   CCLF_MELM_0026_T_A
DR   Wikidata; Q127380422
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3Z0 ! CCLF-MELM_0026-T-B
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CCLF-MELM_0026-T-B
AC   CVCL_D3Z0
SY   CCLF_MELM_0026_T_B
DR   DSMZ; ACC-935
DR   Wikidata; Q127380423
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Doubling time: ~3 days (DSMZ=ACC-935).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): DSMZ=ACC-935
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,13
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 13,15,16
ST   D21S11: 27,33
ST   D2S1338: 17,24
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3YZ ! CCLF-MELM_0026-T-A
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CCLF-NEURO-0048-T
AC   CVCL_D3YV
SY   CCLF_NEURO_0048_T
DR   DSMZ; ACC-939
DR   Wikidata; Q127380425
CC   Group: Serum/protein free medium cell line.
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Characteristics: Grows in neurospheres, single or fused to larger aggregates (spheroids) (DSMZ=ACC-939).
CC   Doubling time: 8-10 days (DSMZ=ACC-939).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg440Ter (c.1318C>T); ClinVar=VCV000230673; Zygosity=Heterozygous (DSMZ=ACC-939).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Lys567Glu (c.1699A>G); ClinVar=VCV000996075; Zygosity=Heterozygous (DSMZ=ACC-939).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): DSMZ=ACC-939
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 9,14
ST   Penta E: 12,15
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CCLF-NEURO-0107-T
AC   CVCL_D3YW
SY   CCLF_NEURO_0107_T
DR   DSMZ; ACC-940
DR   Wikidata; Q127380426
CC   Group: Serum/protein free medium cell line.
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Doubling time: 4 days (DSMZ=ACC-940).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu389Ter (c.1166T>A); ClinVar=VCV000126831; Zygosity=Homozygous (DSMZ=ACC-940).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (DSMZ=ACC-940).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): DSMZ=ACC-970
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 15
ST   D21S11: 29,31
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 15
ST   FGA: 21,24
ST   Penta D: 12
ST   Penta E: 14,15
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CCLF-NEURO-0108-T
AC   CVCL_D3YY
SY   CCLF_NEURO_0108_T; CCLF-KL1100T; CCLF_KL1100T; CPDM_0727X
DR   DSMZ; ACC-937
DR   Wikidata; Q127380427
WW   Provider; CPDM; CPDM_0727X; https://docs.google.com/spreadsheets/d/1sxAPF3p6xK2h01zaiQ1ExCWwzhxeZ-oDLN3s3LeJq98/edit?usp=sharing
CC   Group: Serum/protein free medium cell line.
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~4-5 days (DSMZ=ACC-937).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile33Asn (c.98T>A); Zygosity=Homozygous (DSMZ=ACC-937).
CC   Sequence variation: Mutation; HGNC; HGNC:11098; SMARCA2; Simple; p.Asp1546Glu (c.4638C>G); ClinVar=VCV000126349; Zygosity=Homozygous (DSMZ=ACC-937).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DSMZ=ACC-937).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, base of skull; UBERON=UBERON_0002517.
ST   Source(s): DSMZ=ACC-937
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 25
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 20,26
ST   Penta D: 12,13
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 14,15
DI   NCIt; C3904; Papillary meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CCLF-PEDS-0001-T
AC   CVCL_B3PK
SY   CCLF_PEDS_0001_T; Peds005T Susp
DR   Cell_Model_Passport; SIDM01968
DR   DepMap; ACH-001163
DR   Wikidata; Q110432682
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr107_Phe113del (c.320_340delACGGTTTCCGTCTGGGCTTCT); Zygosity=Heterozygous (DepMap=ACH-001163).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   CCLF-PEDS-0003-T
AC   CVCL_B3PL
SY   CCLF_PEDS_0003_T; CCLFPEDS0003T
DR   Cell_Model_Passport; SIDM01983
DR   DepMap; ACH-001164
DR   Wikidata; Q110432683
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
ID   CCLF-PEDS-0008-T
AC   CVCL_B3PM
SY   CCLF_PEDS_0008_T; CCLFPEDS0008T
DR   Cell_Model_Passport; SIDM01982
DR   DepMap; ACH-001433
DR   DSMZ; ACC-969
DR   Wikidata; Q110432684
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~2-3 days (DSMZ=ACC-969).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala148Thr (c.442G>A); ClinVar=VCV000041580; Zygosity=Heterozygous (DSMZ=ACC-969).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): DSMZ=ACC-969
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 12,18
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   CCLF-PEDS-0009-T
AC   CVCL_B3PN
SY   CCLF_PEDS_0009_T; CCLFPEDS0009T
DR   DepMap; ACH-001429
DR   Wikidata; Q110432685
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001429
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 7,18
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 16
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
ID   CCLF-PEDS-0018-T
AC   CVCL_B3PP
SY   CCLF_PEDS_0018_T; CCLFPEDS0018T
DR   DepMap; ACH-001767
DR   Wikidata; Q110432686
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): DepMap=ACH-001767
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,17
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 15,16
ST   FGA: 20,22
ST   Penta D: 10,11
ST   Penta E: 5,12
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Undefined cell line type
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
ID   CCLF-PEDS-0019-T
AC   CVCL_E1HD
DR   DSMZ; ACC-970
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Doubling time: ~3-4 days (DSMZ=ACC-970).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Pro937Leu; Zygosity=Heterozygous (DSMZ=ACC-970).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): DSMZ=ACC-970
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 29,31.2
ST   D2S1338: 25
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 8,13
ST   FGA: 20,23
ST   Penta D: 12,13
ST   Penta E: 8,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   CCLF-UPGI-0005-T
AC   CVCL_B4KV
SY   CCLF_UPGI_0005_T; CCLFUPGI0005T
DR   cancercelllines; CVCL_B4KV
DR   DepMap; ACH-002446
DR   Wikidata; Q110432687
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Pro (c.379T>C); ClinVar=VCV000934410; Zygosity=Homozygous (DepMap=ACH-002446).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   CCLF-UPGI-0061-T
AC   CVCL_B4KW
SY   CCLF_UPGI_0061_T; CCLFUPGI0061T
DR   DepMap; ACH-002777
DR   Wikidata; Q110432688
CC   Part of: Cancer Cell Line Factory (CCLF) cell models.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   CCLV-RIE270
AC   CVCL_A3AM
DR   CCLV; CCLV-RIE 0270
DR   Wikidata; Q105506595
RX   PubMed=28231273;
CC   Derived from site: In situ; Oviduct epithelium; UBERON=UBERON_0004804.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CCM [Catla]
AC   CVCL_R825
SY   CTB; Catla Catla Macrophage
DR   NRFC; NRFC034
DR   Wikidata; Q54808981
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=22678754;
WW   Provider; NRFC; NRFC034; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC034.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   CCM [Cyprinus]
AC   CVCL_E7BK
SY   Cyprinus Carpio Muscle
RX   PubMed=37277052;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 20 to 37 Celsius, the optimal temperature is 28 Celsius (PubMed=37277052).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=1045269; ! Cyprinus carpio haematopterus (Amur carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCM-52
AC   CVCL_B5N0
DR   Wikidata; Q111733076
RX   PubMed=7068600;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P29616; Chicken MYH6 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   CCMB-Me-14-CM1
AC   CVCL_XD96
SY   TCMC
DR   SKIP; SKIP005550
DR   Wikidata; Q93445502
RX   PubMed=31400702;
CC   Characteristics: Using CRISPR/Cas9 a T2A-mCherry construct was integrated in front of the stop codon of Cdx2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   CCMB-Me-14-STGG-A1
AC   CVCL_C4SE
SY   STGG
DR   Wikidata; Q116048697
RX   PubMed=36063726;
CC   Characteristics: Using CRISPR/Cas9 a T2A-H2B-tdTomato construct was inserted at the C-terminus of one allele of Sox2 and a H2B-GFP-SV40-Bsd cassette was inserted at the C-terminus of one allele of Gata6 (PubMed=36063726).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   CCMBi001-A
AC   CVCL_YT16
SY   M1
DR   hPSCreg; CCMBi001-A
DR   Wikidata; Q93445506
RX   PubMed=32916634;
CC   From: Centre for Cellular and Molecular Biology; Hyderabad; India.
CC   Population: Indian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   CCMCL1
AC   CVCL_RU10
SY   Cleveland Clinic Mantle Cell Lymphoma 1
DR   Millipore; SCC132
DR   Wikidata; Q54808982
RX   PubMed=25907904;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Millipore=SCC132
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D21S11: 31,32.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 19,22.2
ST   Penta D: 12,13
ST   Penta E: 5,7
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   CCMi001-A
AC   CVCL_VE07
SY   CCMi001DMD-A-3; CCMi001DMD-A-3 delta49 delta50; DMD1c3; DMD1
DR   BioSamples; SAMEA113987027
DR   hPSCreg; CCMi001-A
DR   Wikidata; Q54808983
RX   PubMed=29127875;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (PubMed=29127875).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29127875
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,14
ST   D16S539: 10,12
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 21,23
ST   Penta D: 11
ST   Penta E: 11,13
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CCMi002-A
AC   CVCL_RV17
SY   CCMi002BMD-A-9; CCMi002BMD-A-9 delta45-55; BMD1 c.9; BMD1
DR   hPSCreg; CCMi002-A
DR   Wikidata; Q54808984
RX   PubMed=29414413;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-55del; Zygosity=Hemizygous (PubMed=29414413).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29414413
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 15,15.2
ST   D21S11: 30.2,31.2
ST   D2S1338: 23,25
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 8,9
ST   D8S1179: 14
ST   FGA: 24,26
ST   Penta D: 8,10
ST   Penta E: 5,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   CCMi003-A
AC   CVCL_XI81
SY   DMD3 C2; DMD3
DR   hPSCreg; CCMi003-A
DR   Wikidata; Q93445530
RX   PubMed=31465894;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex51-53del; Zygosity=Hemizygous (PubMed=31465894).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   CCMi004-A
AC   CVCL_YB96
SY   BMD3 c.13; BMD3 C13
DR   hPSCreg; CCMi004-A
DR   Wikidata; Q93445533
RX   PubMed=32348941;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.1705-8T>C; Zygosity=Hemizygous; Note=Splicing mutation (PubMed=32348941).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   CCMi005-A
AC   CVCL_B3NP
SY   DMD4 C3
DR   hPSCreg; CCMi005-A
DR   Wikidata; Q110432689
RX   PubMed=35961103;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (PubMed=35961103).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   CCMi007-A
AC   CVCL_C3QU
SY   SAS1 C5
DR   BioSamples; SAMEA111382644
DR   hPSCreg; CCMi007-A
DR   Wikidata; Q116048698
RX   PubMed=36630840;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Donor information: Established from a COVID-19 patient who displayed increased levels of high-sensitivity Troponin (hsTnI) during the acute phase of infection. Also developed severe myocarditis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CCMi008-A
AC   CVCL_C3QV
SY   SAS2 C1
DR   BioSamples; SAMEA112286913
DR   hPSCreg; CCMi008-A
DR   Wikidata; Q116048700
RX   PubMed=36630840;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Donor information: Established from a COVID-19 patient who displayed increased levels of high-sensitivity Troponin (hsTnI) during the acute phase of infection. Also developed severe myocarditis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CCMi009-A
AC   CVCL_C3QW
SY   SAS3 C10
DR   BioSamples; SAMEA112286914
DR   hPSCreg; CCMi009-A
DR   Wikidata; Q116048701
RX   PubMed=36630840;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Donor information: Established from a COVID-19 patient who displayed increased levels of high-sensitivity Troponin (hsTnI) during the acute phase of infection.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CCMi010-A
AC   CVCL_C3QX
SY   SAS4 C1
DR   hPSCreg; CCMi010-A
DR   Wikidata; Q116048702
CC   From: Centro Cardiologico Monzino; Milan; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CCMi011-A
AC   CVCL_C7FH
SY   SAS7 C6
DR   BioSamples; SAMEA112286915
DR   hPSCreg; CCMi011-A
DR   Wikidata; Q117704233
RX   PubMed=36630840;
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Population: Caucasian.
CC   Donor information: Established from a COVID-19 patient who displayed increased levels of high-sensitivity Troponin (hsTnI) during the acute phase of infection (PubMed=36630840).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 02-05-24; Version: 3
//
ID   CCMi012-A
AC   CVCL_D6FZ
SY   LMNA_SP_C3
DR   BioSamples; SAMEA115436890
DR   hPSCreg; CCMi012-A
DR   Wikidata; Q127380428
CC   From: Centro Cardiologico Monzino; Milan; Italy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CCN1.1
AC   CVCL_HM14
DR   GEO; GSM181395
DR   GEO; GSM181399
DR   Wikidata; Q54808985
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN1.2 (Cellosaurus=CVCL_HM15).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN1.2
AC   CVCL_HM15
DR   GEO; GSM181396
DR   GEO; GSM181400
DR   Wikidata; Q54808986
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN1.1 (Cellosaurus=CVCL_HM14).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN2.1
AC   CVCL_HM16
DR   GEO; GSM181405
DR   Wikidata; Q54808987
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN2.2 (Cellosaurus=CVCL_HM17).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN2.2
AC   CVCL_HM17
DR   GEO; GSM181406
DR   Wikidata; Q54808995
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN2.1 (Cellosaurus=CVCL_HM16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN3.1
AC   CVCL_HM18
DR   GEO; GSM181409
DR   Wikidata; Q54808996
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN3.2 (Cellosaurus=CVCL_HM19).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN3.2
AC   CVCL_HM19
DR   GEO; GSM181410
DR   Wikidata; Q54808997
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN3.1 (Cellosaurus=CVCL_HM18).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN4.1
AC   CVCL_HM20
DR   GEO; GSM181412
DR   Wikidata; Q54808998
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN4.2 (Cellosaurus=CVCL_HM21).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN4.2
AC   CVCL_HM21
DR   GEO; GSM181413
DR   Wikidata; Q54808999
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN4.1 (Cellosaurus=CVCL_HM20).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN5.1
AC   CVCL_HM22
DR   GEO; GSM181416
DR   Wikidata; Q54809000
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN5.2 (Cellosaurus=CVCL_HM23).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCN5.2
AC   CVCL_HM23
DR   GEO; GSM181417
DR   Wikidata; Q54809002
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of CCN5.1 (Cellosaurus=CVCL_HM22).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   CCO
AC   CVCL_4142
SY   CCO/BB; Channel Catfish Ovary
DR   CLO; CLO_0002332
DR   CLDB; cl671
DR   ATCC; CRL-2748
DR   ATCC; CRL-2772
DR   ECACC; 95060212
DR   FCS-free; 28-10-30-2-4-4
DR   Wikidata; Q54809003
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=7390534;
RX   PubMed=33068031;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to originate from the ovary of a juvenile channel catfish (Ictalurus punctatus) but shown to be from brown bullhead (Ameiurus nebulosus) (PubMed=33068031).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00618.
CC   Characteristics: Grows at temperatures from 10 Celsius to 35 Celsius with the optimum at 30 Celsius (ECACC=95060212).
CC   Doubling time: 12 hours (ECACC=95060212).
CC   Discontinued: ATCC; CRL-2748; true.
CC   Discontinued: ATCC; CRL-2772; true.
OX   NCBI_TaxID=27778; ! Ameiurus nebulosus (Brown bullhead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   CCO-SFM
AC   CVCL_JX47
SY   CCO-Serum Free Medium
DR   FCS-free; 28-10-30-2-4-4
DR   Wikidata; Q54809004
RX   PubMed=24993608;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Serum/protein free medium cell line.
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (CCO) has been shown not to be from channel catfish (Ictalurus punctatus) but from brown bullhead (Ameiurus nebulosus).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00619.
OX   NCBI_TaxID=27778; ! Ameiurus nebulosus (Brown bullhead)
HI   CVCL_4142 ! CCO
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CCO7
AC   CVCL_D879
SY   CC07; Cco-7
DR   cancercelllines; CVCL_D879
DR   ColonAtlas; CC07
DR   Cosmic; 1312297
DR   Cosmic; 2760080
DR   IARC_TP53; 21736
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54809005
RX   PubMed=8464898;
RX   PubMed=9294210;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=29101300;
CC   From: Bodmer, Walter Fred; International Cancer Research Fund; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Proteomics.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   CCOC-T
AC   CVCL_JE72
DR   ABM; T8241
DR   GEO; GSM2231212
DR   Wikidata; Q54809006
RX   PubMed=28559020;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=28559020).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C54300; Clear cell odontogenic carcinoma
DI   ORDO; Orphanet_314425; Rare odontogenic tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   CCP-2
AC   CVCL_4566
DR   BTO; BTO_0002000
DR   CLO; CLO_0050274
DR   RCB; RCB1528
DR   Wikidata; Q54809007
RX   PubMed=11456411;
RX   PubMed=12172786;
CC   Transformant: Coculture with X-ray irradiated hamster chondrocytes.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_4567 ! CCP-7
OI   CVCL_4568 ! CCP-8
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   CCP-7
AC   CVCL_4567
DR   BTO; BTO_0002002
DR   CLO; CLO_0050273
DR   RCB; RCB1530
DR   Wikidata; Q54809008
RX   PubMed=11456411;
RX   PubMed=12172786;
CC   Transformant: Coculture with X-ray irradiated hamster chondrocytes.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_4566 ! CCP-2
OI   CVCL_4568 ! CCP-8
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   CCP-8
AC   CVCL_4568
DR   BTO; BTO_0002001
DR   CLO; CLO_0050275
DR   RCB; RCB1531
DR   Wikidata; Q54809010
RX   PubMed=11456411;
RX   PubMed=12172786;
CC   Transformant: Coculture with X-ray irradiated hamster chondrocytes.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_4566 ! CCP-2
OI   CVCL_4567 ! CCP-7
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   CCR4aN(Y6206)
AC   CVCL_A6XU
SY   Y6206
DR   RCB; RCB4193
DR   Wikidata; Q107114621
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9ULM6; Human CNOT6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CCR5
AC   CVCL_V322
DR   Wikidata; Q54809011
RX   PubMed=2073461;
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_9126 ! DM87
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   CCRC-1
AC   CVCL_LK64
SY   Cell Collection and Research Center-1
DR   Wikidata; Q54809012
RX   PubMed=28970485;
CC   Group: Vaccine production cell line.
CC   Virology: Susceptible to infection by a wide spectrum of viruses (PubMed=28970485).
CC   Doubling time: 30.8 +- 6.2 hours (Note=At 10th passage), 36.5 +- 4.0 hours (Note=At 15th passage), 42.8 +- 2.3 hours (Note=At 20th passage), 41.8 +- 4.3 hours (Note=At 25th passage), 42.4 +- 3.4 hours (Note=At 30th passage) (PubMed=28970485).
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
CC   Cell type: Mesenchymal stem cell of Wharton's jelly; CL=CL_0002568.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CCRC-M1
AC   CVCL_C2X8
DR   Wikidata; Q114310767
RX   PubMed=7512736;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Alpha-Fuc-(1,2)-beta-Gal glycan group.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M100
AC   CVCL_C2X9
DR   Wikidata; Q114310768
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M101
AC   CVCL_C2XA
DR   Wikidata; Q114310769
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M102
AC   CVCL_C2XB
DR   Wikidata; Q114310770
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M103
AC   CVCL_C2XC
DR   Wikidata; Q114310771
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M104
AC   CVCL_C2XD
DR   Wikidata; Q114310772
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M105
AC   CVCL_C2XE
DR   Wikidata; Q114310773
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M106
AC   CVCL_C2XF
DR   Wikidata; Q114310774
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M107
AC   CVCL_C2XG
DR   Wikidata; Q114310775
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type II.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M108
AC   CVCL_C2XH
DR   Wikidata; Q114310776
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Xylan-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M109
AC   CVCL_C2XI
DR   Wikidata; Q114310777
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Xylan-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M110
AC   CVCL_C2XJ
DR   Wikidata; Q114310778
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M111
AC   CVCL_C2XK
DR   Wikidata; Q114310779
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Xylan-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M112
AC   CVCL_C2XL
DR   Wikidata; Q114310780
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M113
AC   CVCL_C2XM
DR   Wikidata; Q114310781
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M114
AC   CVCL_C2XN
DR   Wikidata; Q114310782
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M115
AC   CVCL_C2XP
DR   Wikidata; Q114310783
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M116
AC   CVCL_C2XQ
DR   Wikidata; Q114310784
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M117
AC   CVCL_C2XR
DR   Wikidata; Q114310785
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M118
AC   CVCL_C2XS
DR   Wikidata; Q114310786
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M119
AC   CVCL_C2XT
DR   Wikidata; Q114310787
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M12
AC   CVCL_C2XU
SY   12C7.A2.F3.A3
DR   Wikidata; Q114310788
RX   PubMed=7512736;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M120
AC   CVCL_C2XV
DR   Wikidata; Q114310790
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M121
AC   CVCL_C2XW
DR   Wikidata; Q114310791
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M122
AC   CVCL_C2XX
DR   Wikidata; Q114310792
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M123
AC   CVCL_C2XY
DR   Wikidata; Q114310793
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M124
AC   CVCL_C2XZ
DR   Wikidata; Q114310794
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Arabinogalactan type IV.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M125
AC   CVCL_C2Y0
DR   Wikidata; Q114310795
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M126
AC   CVCL_C2Y1
DR   Wikidata; Q114310796
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M128
AC   CVCL_C2Y2
DR   Wikidata; Q114310797
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M129
AC   CVCL_C2Y3
DR   Wikidata; Q114310798
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M13
AC   CVCL_C2Y4
DR   Wikidata; Q114310799
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M130
AC   CVCL_C2Y5
DR   Wikidata; Q114310800
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M131
AC   CVCL_C2Y6
DR   Wikidata; Q114310801
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M132
AC   CVCL_C2Y7
DR   Wikidata; Q114310802
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M133
AC   CVCL_C2Y8
DR   Wikidata; Q114310803
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type II.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M134
AC   CVCL_C2Y9
DR   Wikidata; Q114310804
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M135
AC   CVCL_C2YA
DR   Wikidata; Q114310806
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M136
AC   CVCL_C2YB
DR   Wikidata; Q114310807
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Undefined glycan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M137
AC   CVCL_C2YC
DR   Wikidata; Q114310808
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M138
AC   CVCL_C2YD
DR   Wikidata; Q114310809
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M139
AC   CVCL_C2YE
DR   Wikidata; Q114310810
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M14
AC   CVCL_C2YF
DR   Wikidata; Q114310811
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M140
AC   CVCL_C2YG
DR   Wikidata; Q114310812
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M141
AC   CVCL_C2YH
DR   Wikidata; Q114310814
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Linseed mucilage rhamnogalacturonan I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M142
AC   CVCL_C2YI
DR   Wikidata; Q114310815
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Linseed mucilage rhamnogalacturonan I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M143
AC   CVCL_C2YJ
DR   Wikidata; Q114310816
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M144
AC   CVCL_C2YK
DR   Wikidata; Q114310818
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M145
AC   CVCL_C2YL
DR   Wikidata; Q114310819
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M146
AC   CVCL_C2YM
DR   Wikidata; Q114310820
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M147
AC   CVCL_C2YN
DR   Wikidata; Q114310821
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M148
AC   CVCL_C2YP
DR   Wikidata; Q114310822
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M149
AC   CVCL_C2YQ
DR   Wikidata; Q114310823
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M15
AC   CVCL_C2YR
DR   Wikidata; Q114310824
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M150
AC   CVCL_C2YS
DR   Wikidata; Q114310825
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M151
AC   CVCL_C2YT
DR   Wikidata; Q114310829
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M152
AC   CVCL_C2YU
DR   Wikidata; Q114310833
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M153
AC   CVCL_C2YV
DR   Wikidata; Q114310837
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M154
AC   CVCL_C2YW
DR   Wikidata; Q114310842
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M155
AC   CVCL_C2YX
DR   Wikidata; Q114310845
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M156
AC   CVCL_C2YY
DR   Wikidata; Q114310849
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M157
AC   CVCL_C2YZ
DR   Wikidata; Q114310853
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M158
AC   CVCL_C2Z0
DR   Wikidata; Q114310854
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M159
AC   CVCL_C2Z1
DR   Wikidata; Q114310855
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M16
AC   CVCL_C2Z2
DR   Wikidata; Q114310856
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ib.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M160
AC   CVCL_C2Z3
DR   Wikidata; Q114310857
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Xylan-3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M17
AC   CVCL_C2Z4
DR   Wikidata; Q114310858
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ib.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M18
AC   CVCL_C2Z5
DR   Wikidata; Q114310859
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ib.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M19
AC   CVCL_C2Z6
DR   Wikidata; Q114310860
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ib.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M2
AC   CVCL_C2Z7
DR   Wikidata; Q114310861
RX   PubMed=7512736;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ia.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M21
AC   CVCL_C2Z8
DR   Wikidata; Q114310862
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M22
AC   CVCL_C2Z9
DR   Wikidata; Q114310863
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M23
AC   CVCL_C2ZA
DR   Wikidata; Q114310864
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ib.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M24
AC   CVCL_C2ZB
DR   Wikidata; Q114310865
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M25
AC   CVCL_C2ZC
DR   Wikidata; Q114310866
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M26
AC   CVCL_C2ZD
DR   Wikidata; Q114310867
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M30
AC   CVCL_C2ZE
DR   Wikidata; Q114310868
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M31
AC   CVCL_C2ZF
DR   Wikidata; Q114310869
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M32
AC   CVCL_C2ZG
DR   Wikidata; Q114310870
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M33
AC   CVCL_C2ZH
DR   Wikidata; Q114310871
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M34
AC   CVCL_C2ZI
DR   Wikidata; Q114310872
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M35
AC   CVCL_C2ZJ
DR   Wikidata; Q114310873
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M36
AC   CVCL_C2ZK
DR   Wikidata; Q114310874
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M38
AC   CVCL_C2ZL
DR   Wikidata; Q114310877
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M39
AC   CVCL_C2ZM
DR   Wikidata; Q114310878
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M40
AC   CVCL_C2ZN
DR   Wikidata; Q114310879
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Linseed mucilage rhamnogalacturonan I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M41
AC   CVCL_C2ZP
DR   Wikidata; Q114310880
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M42
AC   CVCL_C2ZQ
DR   Wikidata; Q114310881
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M44
AC   CVCL_C2ZR
DR   Wikidata; Q114310882
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M47
AC   CVCL_C2ZS
DR   Wikidata; Q114310883
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M48
AC   CVCL_C2ZT
DR   Wikidata; Q114310884
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M49
AC   CVCL_C2ZU
DR   Wikidata; Q114310885
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M5
AC   CVCL_C2ZV
DR   Wikidata; Q114310886
RX   PubMed=7512736;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ia.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M50
AC   CVCL_C2ZW
DR   Wikidata; Q114310887
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M51
AC   CVCL_C2ZX
DR   Wikidata; Q114310888
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M52
AC   CVCL_C2ZY
DR   Wikidata; Q114310889
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M53
AC   CVCL_C2ZZ
DR   Wikidata; Q114310890
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M54
AC   CVCL_C3A0
DR   Wikidata; Q114310891
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M55
AC   CVCL_C3A1
DR   Wikidata; Q114310892
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M56
AC   CVCL_C3A2
DR   Wikidata; Q114310893
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ib.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M57
AC   CVCL_C3A3
DR   Wikidata; Q114310894
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M58
AC   CVCL_C3A4
DR   Wikidata; Q114310896
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M60
AC   CVCL_C3A5
DR   Wikidata; Q114310899
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M61
AC   CVCL_C3A6
DR   Wikidata; Q114310902
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan-Ic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M69
AC   CVCL_C3A7
DR   Wikidata; Q114310903
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M7
AC   CVCL_C3A8
DR   Wikidata; Q114310904
RX   PubMed=7512736;
RX   PubMed=8529225;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Arabinogalactan type II.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M70
AC   CVCL_C3A9
DR   Wikidata; Q114310905
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   CCRC-M72
AC   CVCL_C3AA
DR   Wikidata; Q114310906
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M74
AC   CVCL_C3AB
DR   Wikidata; Q114310907
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   CCRC-M75
AC   CVCL_C3AC
DR   Wikidata; Q114310908
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   CCRC-M76
AC   CVCL_C3AD
DR   Wikidata; Q114310909
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Undefined glycan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M77
AC   CVCL_C3AE
DR   Wikidata; Q114310910
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M78
AC   CVCL_C3AF
DR   Wikidata; Q114310911
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type IV.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M79
AC   CVCL_C3AG
DR   Wikidata; Q114310912
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M8
AC   CVCL_C3AH
SY   2E10.G1
DR   Wikidata; Q114310913
RX   PubMed=7512736;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M80
AC   CVCL_C3AI
DR   Wikidata; Q114310917
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M81
AC   CVCL_C3AJ
DR   Wikidata; Q114310921
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M82
AC   CVCL_C3AK
DR   Wikidata; Q114310923
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Linseed mucilage rhamnogalacturonan I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M83
AC   CVCL_C3AL
DR   Wikidata; Q114310924
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Linseed mucilage rhamnogalacturonan I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M84
AC   CVCL_C3AM
DR   Wikidata; Q114310925
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M85
AC   CVCL_C3AN
DR   Wikidata; Q114310927
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M86
AC   CVCL_C3AP
DR   Wikidata; Q114310929
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M87
AC   CVCL_C3AQ
DR   Wikidata; Q114310930
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M88
AC   CVCL_C3AR
DR   Wikidata; Q114310931
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M89
AC   CVCL_C3AS
DR   Wikidata; Q114310932
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M9
AC   CVCL_C3AT
SY   12H4.F8.C8.G2
DR   Wikidata; Q114310933
RX   PubMed=7512736;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M90
AC   CVCL_C3AU
DR   Wikidata; Q114310934
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M91
AC   CVCL_C3AV
DR   Wikidata; Q114310935
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type IV.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M92
AC   CVCL_C3AW
DR   Wikidata; Q114310936
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type IV.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M93
AC   CVCL_C3AX
DR   Wikidata; Q114310937
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M94
AC   CVCL_C3AY
DR   Wikidata; Q114310938
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Physcomitrella pectin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M95
AC   CVCL_C3AZ
DR   Wikidata; Q114310939
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M96
AC   CVCL_C3B0
DR   Wikidata; Q114310940
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M98
AC   CVCL_C3B1
DR   Wikidata; Q114310941
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Physcomitrella pectin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRC-M99
AC   CVCL_C3B2
DR   Wikidata; Q114310942
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Non-fucosylated xyloglucans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   CCRF S-180 II
AC   CVCL_2874
SY   CCRF S 180 II; S-180 II; CCRF S-180; S-180; S180; Sarcoma-180; Sarcoma 180; CCRF-180II
DR   BTO; BTO_0001197
DR   CLO; CLO_0002333
DR   EFO; EFO_0022776
DR   CLDB; cl672
DR   CLDB; cl673
DR   ATCC; CCL-8
DR   BCRC; 60337
DR   BCRJ; 0314
DR   BCRJ; 0320
DR   CCRID; 1101MOU-PUMC000319
DR   CCRID; 1101MOU-PUMC000416
DR   CCRID; 3101MOUTCM15
DR   CCRID; 4201MOU-CCTCC00056
DR   CCRID; 5301MOU-KCB93029YJ
DR   CCTCC; GDC0056
DR   ChEMBL-Cells; CHEMBL3307278
DR   ChEMBL-Targets; CHEMBL612567
DR   ChEMBL-Targets; CHEMBL614027
DR   CLS; 305165
DR   ECACC; 90011901
DR   IZSLER; BS TCL 13
DR   JCRB; JCRB9089
DR   KCB; KCB 93029YJ
DR   KCLB; 10008
DR   PubChem_Cell_line; CVCL_2874
DR   TKG; TKG 0173
DR   Wikidata; Q7388195
RX   DOI=10.1007/BF02618370;
RX   PubMed=366289;
RX   PubMed=1546443;
RX   PubMed=13035452;
RX   PubMed=13823721;
RX   PubMed=14185313;
RX   PubMed=14221803;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/S180
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/sarcoma-xenograft/s180-xenograft-model/
CC   Discontinued: BCRJ; 0314; probable.
CC   Discontinued: CLS; 305165; true.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9AY ! LLC-MS180
OI   CVCL_3598 ! Sarcoma 180
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   CCRF-6
AC   CVCL_6G39
SY   Wilms'-6; Children Cancer Research Fundation-6
DR   Wikidata; Q54809014
RX   PubMed=6244232;
RX   PubMed=13431913;
RX   PubMed=13823721;
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   CCRF-CEM
AC   CVCL_0207
SY   CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C
DR   BTO; BTO_0000736
DR   CLO; CLO_0002334
DR   CLO; CLO_0015478
DR   CLO; CLO_0050143
DR   EFO; EFO_0002128
DR   MCCL; MCC:0000096
DR   MCCL; MCC:0000097
DR   CLDB; cl675
DR   CLDB; cl676
DR   CLDB; cl677
DR   AddexBio; C0003001/32
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CCL-119
DR   ATCC; CRL-7916
DR   ATCC; CRL-8436
DR   ATCC; CRM-CCL-119
DR   BCRC; 60137
DR   BCRJ; 0063
DR   BioGRID_ORCS_Cell_line; 1318
DR   BioSample; SAMN00808493
DR   BioSample; SAMN01821675
DR   BioSample; SAMN03471121
DR   BioSample; SAMN03471203
DR   BioSample; SAMN03472050
DR   BioSample; SAMN03472700
DR   BioSample; SAMN03472808
DR   BioSample; SAMN03473385
DR   cancercelllines; CVCL_0207
DR   CCRID; 3101HUMTCHu147
DR   CCRID; 4201HUM-CCTCC00219
DR   CCTCC; GDC0219
DR   Cell_Model_Passport; SIDM00121
DR   ChEMBL-Cells; CHEMBL3307641
DR   ChEMBL-Targets; CHEMBL382
DR   ChEMBL-Targets; CHEMBL393
DR   CLS; 300147
DR   Coriell; GM03671
DR   Cosmic; 683716
DR   Cosmic; 721708
DR   Cosmic; 801728
DR   Cosmic; 846384
DR   Cosmic; 850198
DR   Cosmic; 875863
DR   Cosmic; 897449
DR   Cosmic; 905952
DR   Cosmic; 913411
DR   Cosmic; 919157
DR   Cosmic; 922674
DR   Cosmic; 932765
DR   Cosmic; 933544
DR   Cosmic; 974251
DR   Cosmic; 1012060
DR   Cosmic; 1037690
DR   Cosmic; 1044252
DR   Cosmic; 1070703
DR   Cosmic; 1071876
DR   Cosmic; 1092595
DR   Cosmic; 1115588
DR   Cosmic; 1118462
DR   Cosmic; 1127261
DR   Cosmic; 1151774
DR   Cosmic; 1175854
DR   Cosmic; 1176599
DR   Cosmic; 1191691
DR   Cosmic; 1224367
DR   Cosmic; 1226857
DR   Cosmic; 1247870
DR   Cosmic; 1281365
DR   Cosmic; 1305336
DR   Cosmic; 1330503
DR   Cosmic; 1375587
DR   Cosmic; 1483363
DR   Cosmic; 1509201
DR   Cosmic; 1523831
DR   Cosmic; 1524793
DR   Cosmic; 1639635
DR   Cosmic; 1664520
DR   Cosmic; 1760519
DR   Cosmic; 1998437
DR   Cosmic; 2165706
DR   Cosmic; 2301560
DR   Cosmic; 2361364
DR   Cosmic; 2433754
DR   Cosmic; 2458763
DR   Cosmic; 2462863
DR   Cosmic; 2602911
DR   Cosmic; 2649235
DR   Cosmic; 2649237
DR   Cosmic; 2668294
DR   Cosmic-CLP; 905952
DR   DepMap; ACH-001738
DR   DSMZ; ACC-240
DR   DSMZCellDive; ACC-240
DR   ECACC; 85112105
DR   EGA; EGAS00001000978
DR   GDSC; 905952
DR   GEO; GSM2116
DR   GEO; GSM50193
DR   GEO; GSM50257
DR   GEO; GSM236780
DR   GEO; GSM236816
DR   GEO; GSM743457
DR   GEO; GSM750806
DR   GEO; GSM799345
DR   GEO; GSM799408
DR   GEO; GSM1153416
DR   GEO; GSM1178011
DR   GEO; GSM1178012
DR   GEO; GSM1178013
DR   GEO; GSM1181330
DR   GEO; GSM1181347
DR   GEO; GSM1374445
DR   GEO; GSM1669670
DR   GEO; GSM2124653
DR   GEO; GSM5137708
DR   IARC_TP53; 13197
DR   IARC_TP53; 21218
DR   IGRhCellID; CCRFCEM
DR   IPD-IMGT/HLA; 10403
DR   IZSLER; BS TCL 11
DR   JCRB; IFO50412
DR   JCRB; JCRB0033
DR   JCRB; JCRB9023
DR   KCLB; 10119
DR   LINCS_LDP; LCL-1012
DR   Lonza; 647
DR   NCBI_Iran; C105
DR   NCI-DTP; CCRF-CEM
DR   PharmacoDB; CCRFCEM_190_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0207
DR   PubChem_Cell_line; CVCL_0207
DR   RCB; RCB1980
DR   SKY/M-FISH/CGH; 2784
DR   TKG; TKG 0563
DR   Wikidata; Q54809015
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1086134;
RX   PubMed=2041050;
RX   PubMed=2140233;
RX   PubMed=2144611;
RX   PubMed=2255914;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3335022;
RX   PubMed=3495441;
RX   PubMed=3874327;
RX   PubMed=4363409;
RX   PubMed=5224274;
RX   PubMed=6198871;
RX   PubMed=6582512;
RX   PubMed=6600440;
RX   PubMed=6954533;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8127147;
RX   PubMed=8547074;
RX   PubMed=8641406;
RX   PubMed=9108419;
RX   PubMed=9290701;
RX   PubMed=9331090;
RX   PubMed=9510473;
RX   PubMed=9557624;
RX   PubMed=9685479;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=9823951;
RX   PubMed=9933131;
RX   PubMed=10071127;
RX   PubMed=10700174;
RX   PubMed=10739008;
RX   PubMed=10769646;
RX   PubMed=11226526;
RX   PubMed=11565033;
RX   PubMed=14278051;
RX   PubMed=14500364;
RX   PubMed=15472075;
RX   PubMed=15748285;
RX   PubMed=16408098;
RX   PubMed=17088437;
RX   PubMed=17117183;
RX   PubMed=17170727;
RX   PubMed=17308084;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20922763;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=22675565;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25070259;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29718670;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31394625;
RX   PubMed=31733513;
RX   PubMed=35354797;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-of-atcc-ccl-119
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=29
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/ccrf-cem/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-12.html
WW   Provider; BRICS; BRICS0126; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3929
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
WW   Provider; NIBSC; 0005; https://nibsc.org/Default.aspx?pageid=597&id=0005&theme=default
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: NCI-7 clinical proteomics reference material cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8436.
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=17117183); 24 hours (PubMed=20922763); 22.0 hours (PubMed=25070259); ~24 hours (CLS=300147); ~24-30 hours (DSMZ=ACC-240); 26.7 hours (NCI-DTP=CCRF-CEM).
CC   HLA typing: B*08,40; C*03:04:01,07; DPB1*04:01,13:01; DQB1*02:01,02:02; DRB1*03:01:01,07:01 (PubMed=15748285).
CC   HLA typing: DPB1*04:01,13:01 (IPD-IMGT/HLA=10403).
CC   HLA typing: A*01:01:01,07:01:02; B*08:01:01,16:01:02; C*03:04:01,07:01:01; DPB1*04:01:01,13:XX; DQA1*02:01:01,05:01:01; DQB1*02:01:01,02:02:01; DRB1*03:01:01,07:01:01 (CLS=300147).
CC   HLA typing: A*01:01:01,31:01:02; B*08:01:01,40:01:02; C*03:04:01,07:01:01 (DSMZCellDive=ACC-240).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=10739008; PubMed=11226526; PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (PubMed=14500364; PubMed=17308084).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (PubMed=11565033; Cosmic-CLP=905952; DepMap=ACH-001738).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905952; DepMap=ACH-001738).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905952; DepMap=ACH-001738).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (PubMed=2144611; PubMed=10071127; PubMed=17088437; Cosmic-CLP=905952; DepMap=ACH-001738).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=2144611; PubMed=9331090; PubMed=10071127; PubMed=17088437; Cosmic-CLP=905952; DepMap=ACH-001738).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.2%; Native American=0.21%; East Asian, North=0.43%; East Asian, South=0.09%; South Asian=0.81%; European, North=69.4%; European, South=28.85% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7916; true.
CC   Discontinued: ATCC; CRL-8436; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): AddexBio=C0003001/32; ATCC=CCL-119; ATCC=CRL-8436; CLS=300147; Cosmic-CLP=905952; DSMZ=ACC-240; ECACC=85112105; JCRB=IFO50412; JCRB=JCRB0033; JCRB=JCRB9023; KCLB=10119; PubMed=19372543; PubMed=20922763; RCB=RCB1980
ST   Amelogenin: X
ST   CSF1PO: 9,10,11 (RCB=RCB1980)
ST   CSF1PO: 10,11 (AddexBio=C0003001/32; ATCC=CCL-119; Cosmic-CLP=905952; KCLB=10119; PubMed=20922763)
ST   CSF1PO: 10,11,12 (JCRB=IFO50412; JCRB=JCRB9023)
ST   CSF1PO: 10,13 (ATCC=CRL-8436; CLS=300147; DSMZ=ACC-240)
ST   CSF1PO: 11 (ECACC=85112105; JCRB=JCRB0033; PubMed=19372543)
ST   D13S317: 10,11,12 (RCB=RCB1980)
ST   D13S317: 11 (ATCC=CRL-8436; CLS=300147; DSMZ=ACC-240)
ST   D13S317: 11,12 (AddexBio=C0003001/32; ATCC=CCL-119; Cosmic-CLP=905952; ECACC=85112105; JCRB=IFO50412; JCRB=JCRB0033; JCRB=JCRB9023; KCLB=10119; PubMed=19372543; PubMed=20922763)
ST   D16S539: 10,13 (AddexBio=C0003001/32; ATCC=CCL-119; ATCC=CRL-8436; CLS=300147; Cosmic-CLP=905952; DSMZ=ACC-240; ECACC=85112105; JCRB=IFO50412; JCRB=JCRB0033; JCRB=JCRB9023; PubMed=19372543; PubMed=20922763)
ST   D16S539: 10,13,14 (RCB=RCB1980)
ST   D18S51: 13 (DSMZ=ACC-240)
ST   D18S51: 13,18 (ATCC=CCL-119; CLS=300147)
ST   D19S433: 14,15
ST   D21S11: 30,33.2 (ATCC=CCL-119; PubMed=19372543; PubMed=20922763)
ST   D21S11: 30,34.2 (CLS=300147; DSMZ=ACC-240)
ST   D2S1338: 23,24 (DSMZ=ACC-240)
ST   D2S1338: 24 (ATCC=CCL-119; PubMed=19372543; PubMed=20922763)
ST   D3S1358: 14,15 (CLS=300147; DSMZ=ACC-240; KCLB=10119)
ST   D3S1358: 15 (ATCC=CCL-119; PubMed=19372543)
ST   D3S1358: 15,16 (PubMed=20922763)
ST   D5S818: 12,13 (AddexBio=C0003001/32; ATCC=CCL-119; ATCC=CRL-8436; CLS=300147; DSMZ=ACC-240; ECACC=85112105; JCRB=IFO50412; JCRB=JCRB0033; JCRB=JCRB9023; KCLB=10119; PubMed=19372543; PubMed=20922763; RCB=RCB1980)
ST   D5S818: 12,13,14 (Cosmic-CLP=905952)
ST   D7S820: 9,12 (JCRB=JCRB0033)
ST   D7S820: 9,13 (AddexBio=C0003001/32; ATCC=CCL-119; ATCC=CRL-8436; CLS=300147; Cosmic-CLP=905952; DSMZ=ACC-240; ECACC=85112105; JCRB=IFO50412; JCRB=JCRB9023; KCLB=10119; PubMed=19372543; PubMed=20922763; RCB=RCB1980)
ST   D8S1179: 12,13 (CLS=300147; DSMZ=ACC-240; PubMed=20922763)
ST   D8S1179: 13 (ATCC=CCL-119; PubMed=19372543)
ST   FGA: 22,23,24,25 (DSMZ=ACC-240)
ST   FGA: 23,24 (ATCC=CCL-119; CLS=300147; PubMed=20922763)
ST   FGA: 24 (PubMed=19372543)
ST   Penta D: 10,11 (CLS=300147; DSMZ=ACC-240)
ST   Penta D: 11 (ATCC=CCL-119)
ST   Penta E: 5 (DSMZ=ACC-240)
ST   Penta E: 5,14 (ATCC=CCL-119; CLS=300147)
ST   TH01: 6,7
ST   TPOX: 7,8 (DSMZ=ACC-240)
ST   TPOX: 8 (AddexBio=C0003001/32; ATCC=CCL-119; ATCC=CRL-8436; CLS=300147; Cosmic-CLP=905952; ECACC=85112105; JCRB=IFO50412; JCRB=JCRB0033; JCRB=JCRB9023; KCLB=10119; PubMed=19372543; PubMed=20922763; RCB=RCB1980)
ST   vWA: 17,18,19 (DSMZ=ACC-240)
ST   vWA: 17,19 (AddexBio=C0003001/32; ATCC=CCL-119; ATCC=CRL-8436; CLS=300147; Cosmic-CLP=905952; ECACC=85112105; JCRB=IFO50412; JCRB=JCRB0033; JCRB=JCRB9023; KCLB=10119; PubMed=19372543; PubMed=20922763)
ST   vWA: 18,19 (RCB=RCB1980)
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   CCRF-CEM C1
AC   CVCL_B7A8
SY   CCRF/CEM-C1; CEM-C1; CEM C1; CEMC1; CEM clone 1
DR   cancercelllines; CVCL_B7A8
DR   Wikidata; Q111733077
RX   PubMed=269011;
RX   PubMed=6134583;
CC   Population: Caucasian.
CC   Characteristics: Resistant to glucocorticoid-mediated lysis.
CC   Doubling time: 25 +- 3 hours (PubMed=6134583).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C1-15
AC   CVCL_B7A9
SY   CEM-C1-15
DR   cancercelllines; CVCL_B7A9
DR   Wikidata; Q111733078
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Resistant to glucocorticoid-mediated lysis.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=31221196
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,16
ST   D12S391: 17,21
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 12,18
ST   D19S433: 14,16
ST   D21S11: 30,33.2
ST   D2S1338: 23,24
ST   D2S441: 10,14
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D6S1043: 11,14
ST   D7S820: 9,13
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7A8 ! CCRF-CEM C1
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7
AC   CVCL_6825
SY   CCRF-CEM-C7; CCRF/CEM-C7; CEM-C7; CEM C7; CEMC7; C7; CEM clone 7
DR   cancercelllines; CVCL_6825
DR   CLS; 300398
DR   Lonza; 240
DR   Wikidata; Q54809016
RX   PubMed=269011;
RX   PubMed=1972702;
RX   PubMed=3871171;
RX   PubMed=6134583;
RX   PubMed=6965106;
RX   PubMed=7812967;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to glucocorticoid-mediated lysis.
CC   Doubling time: 24 +- 3 hours (PubMed=6134583); 24.5 +- 2.8 hours (Note=In RPMI 1640+10% FBS), 25.0 +- 3.8 hours (Note=In RPMI 1640+BSA+Insulin+Transferrin+Se), 25.2 +- 3.8 hours (Note=In RPMI 1640+Insulin+Transferrin+Se) (PubMed=1972702).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 26
//
ID   CCRF-CEM C7 3R43
AC   CVCL_F1W6
SY   CEM-3R43; 3R43
RX   PubMed=1972702;
RX   PubMed=6965106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6825 ! CCRF-CEM C7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CCRF-CEM C7 3R7
AC   CVCL_F1W7
SY   CEM-3R7; 3R7
RX   PubMed=6965106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6825 ! CCRF-CEM C7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CCRF-CEM C7 4R4
AC   CVCL_F1W8
SY   CEM-4R4; 4R4
RX   PubMed=1972702;
RX   PubMed=6965106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6825 ! CCRF-CEM C7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CCRF-CEM C7 ICR 27
AC   CVCL_F1W5
SY   CEM-ICR 27; ICR 27
RX   PubMed=1972702;
RX   PubMed=6965106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6825 ! CCRF-CEM C7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CCRF-CEM C7-14
AC   CVCL_B7AA
SY   CEM-C7-14
DR   cancercelllines; CVCL_B7AA
DR   Wikidata; Q111733079
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to glucocorticoid-mediated lysis.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=31221196
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,14,15
ST   D12S391: 18,19,20
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 24,25
ST   D2S441: 11,14
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D6S1043: 11,14
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6825 ! CCRF-CEM C7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7-SC14
AC   CVCL_B7AG
SY   CEM-C7-SC14
DR   cancercelllines; CVCL_B7AG
DR   Wikidata; Q111733080
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to glucocorticoid-mediated lysis.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AA ! CCRF-CEM C7-14
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7-SC14/H
AC   CVCL_B7AH
SY   CEM-C7-SC14/H
DR   cancercelllines; CVCL_B7AH
DR   Wikidata; Q111733081
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to glucocorticoid-mediated lysis.
CC   Characteristics: Cultured under hypoxia for 5 weeks (PubMed=31221196).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AG ! CCRF-CEM C7-SC14
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7-SC14/HDR
AC   CVCL_B7AI
SY   CEM-C7-SC14/HDR
DR   cancercelllines; CVCL_B7AI
DR   Wikidata; Q111733082
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AG ! CCRF-CEM C7-SC14
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7-SC2
AC   CVCL_B7AJ
SY   CEM-C7-SC2
DR   cancercelllines; CVCL_B7AJ
DR   Wikidata; Q111733083
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to glucocorticoid-mediated lysis.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AA ! CCRF-CEM C7-14
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   CCRF-CEM C7-SC2/H
AC   CVCL_B7AK
SY   CEM-C7-SC2/H
DR   cancercelllines; CVCL_B7AK
DR   Wikidata; Q111733084
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to glucocorticoid-mediated lysis.
CC   Characteristics: Cultured under hypoxia for 5 weeks (PubMed=31221196).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AJ ! CCRF-CEM C7-SC2
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   CCRF-CEM C7-SC2/HDR
AC   CVCL_B7AL
SY   CEM-C7-SC2/HDR
DR   cancercelllines; CVCL_B7AL
DR   Wikidata; Q111733085
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AJ ! CCRF-CEM C7-SC2
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   CCRF-CEM C7/H
AC   CVCL_B7AB
SY   CEM-C7/H
DR   cancercelllines; CVCL_B7AB
DR   Wikidata; Q111733086
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to glucocorticoid-mediated lysis.
CC   Characteristics: Cultured under hypoxia for 5 weeks (PubMed=31221196).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=31221196
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,14,15
ST   D12S391: 18,19,20
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 24,25
ST   D2S441: 11,14
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D6S1043: 11,14
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AA ! CCRF-CEM C7-14
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7/HDR
AC   CVCL_B7AC
SY   CEM-C7/HDR
DR   cancercelllines; CVCL_B7AC
DR   Wikidata; Q111733087
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=31221196
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 13,16
ST   D12S391: 18,20
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 24,25
ST   D2S441: 11,14
ST   D3S1358: 15
ST   D5S818: 12,14
ST   D6S1043: 11,14
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AA ! CCRF-CEM C7-14
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7/HDR-C2
AC   CVCL_B7AD
SY   CEM-C7/HDR-C2
DR   cancercelllines; CVCL_B7AD
DR   Wikidata; Q111733088
RX   PubMed=31221196;
CC   Population: Caucasian.
CC   Characteristics: Made glucocorticoid resistant by culturing the grand-parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AC ! CCRF-CEM C7/HDR
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CCRF-CEM C7A
AC   CVCL_6826
SY   CEM-C7A; CEMC7A
DR   cancercelllines; CVCL_6826
DR   Lonza; 1047
DR   Wikidata; Q54809017
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6825 ! CCRF-CEM C7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   CCRF-CEM C7H2
AC   CVCL_EP75
SY   CCRF-CEM-C7H2; CEM-C7H2; CEM-C7.H2; CEM-C7-H2; CEMC7H2; C7H2
DR   cancercelllines; CVCL_EP75
DR   GEO; GSM286229
DR   GEO; GSM286230
DR   GEO; GSM286231
DR   GEO; GSM286232
DR   GEO; GSM286233
DR   GEO; GSM286234
DR   GEO; GSM286235
DR   GEO; GSM286236
DR   GEO; GSM286237
DR   GEO; GSM286238
DR   GEO; GSM286239
DR   GEO; GSM286240
DR   Wikidata; Q54809019
RX   PubMed=7812967;
RX   PubMed=8895760;
RX   PubMed=10467407;
RX   PubMed=15637111;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=15637111
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 13,17
ST   D21S11: 30,33.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6825 ! CCRF-CEM C7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 18
//
ID   CCRF-CEM C7H2-2C8
AC   CVCL_EP76
SY   CCRF-CEM-C7H2-2C8; CEM-C7H2-2C8; C7H2-2C8; CEMC7H2pEFrtTA-2C8
DR   cancercelllines; CVCL_EP76
DR   Wikidata; Q54809020
RX   PubMed=10467407;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EP75 ! CCRF-CEM C7H2
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM R3/7
AC   CVCL_V324
DR   cancercelllines; CVCL_V324
DR   Wikidata; Q54809021
RX   PubMed=2450647;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   CCRF-CEM R30/6
AC   CVCL_V323
DR   cancercelllines; CVCL_V323
DR   Wikidata; Q54809022
RX   PubMed=2450647;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   CCRF-CEM R30dm
AC   CVCL_V325
SY   R30dm-CCRF-CEM; R30dm
DR   cancercelllines; CVCL_V325
DR   ChEMBL-Cells; CHEMBL3307546
DR   ChEMBL-Targets; CHEMBL614143
DR   PubChem_Cell_line; CVCL_V325
DR   Wikidata; Q54809023
RX   PubMed=2007575;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V323 ! CCRF-CEM R30/6
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 21
//
ID   CCRF-CEM/HU-R
AC   CVCL_5H79
SY   CEM/HUR90; HU-R
DR   cancercelllines; CVCL_5H79
DR   Wikidata; Q54809024
RX   PubMed=10037195;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/MTX R1
AC   CVCL_5H80
SY   CEM/MTX R1; CEM/MTXR1
DR   cancercelllines; CVCL_5H80
DR   Wikidata; Q54809025
RX   PubMed=2754745;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/MTX R2
AC   CVCL_5H81
SY   CEM/MTX R2; CEM/MTXR2
DR   cancercelllines; CVCL_5H81
DR   Wikidata; Q54809027
RX   PubMed=2754745;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/MTX R3
AC   CVCL_5H82
SY   CEM/MTX R3; CEM/MTXR3
DR   cancercelllines; CVCL_5H82
DR   Wikidata; Q54809028
RX   PubMed=2754745;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/MTX140-LV
AC   CVCL_5H83
SY   CEM/MTX140LV
DR   cancercelllines; CVCL_5H83
DR   Wikidata; Q54809029
RX   PubMed=9369939;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/MTX1500-LV
AC   CVCL_5H84
SY   CEM/MTX1500LV
DR   cancercelllines; CVCL_5H84
DR   Wikidata; Q54809030
RX   PubMed=9369939;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/MTX5000-PGA
AC   CVCL_5H85
SY   CEM/MTX5000PGA
DR   cancercelllines; CVCL_5H85
DR   Wikidata; Q54809031
RX   PubMed=9369939;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/MTX60-PGA
AC   CVCL_5H86
SY   CEM/MTX60PGA
DR   cancercelllines; CVCL_5H86
DR   Wikidata; Q54809032
RX   PubMed=9369939;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CCRF-CEM/R1
AC   CVCL_S649
SY   CEM/R1; R1-CCRF-CEM
DR   cancercelllines; CVCL_S649
DR   ChEMBL-Cells; CHEMBL3307611
DR   ChEMBL-Targets; CHEMBL614384
DR   PubChem_Cell_line; CVCL_S649
DR   Wikidata; Q54809034
RX   CelloPub=CLPUB00028;
RX   PubMed=3855284;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 23
//
ID   CCRF-CEM/R2
AC   CVCL_S650
SY   CEM/R2; R2-CCRF-CEM
DR   cancercelllines; CVCL_S650
DR   ChEMBL-Cells; CHEMBL3307764
DR   ChEMBL-Targets; CHEMBL613523
DR   PubChem_Cell_line; CVCL_S650
DR   Wikidata; Q54809035
RX   PubMed=3855284;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S649 ! CCRF-CEM/R1
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 23
//
ID   CCRF-CEM/R3
AC   CVCL_S651
SY   CEM/R3; CEM/MTX
DR   cancercelllines; CVCL_S651
DR   Wikidata; Q54809036
RX   CelloPub=CLPUB00028;
RX   PubMed=3855284;
RX   PubMed=6929188;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   CCRF-CEM(Cas9)
AC   CVCL_E7J2
WW   Provider; BRICS; ECC3041; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3975
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CCRF-HSB-2
AC   CVCL_1859
AS   CVCL_5938
SY   CCRF HSB-2; CCRF-HSB2; HSB-2; HSB.2; HSB2; H-SB2; SB-2; HSB; H.S.B.; GM04155
DR   BTO; BTO_0005370
DR   CLO; CLO_0002335
DR   CLO; CLO_0004258
DR   CLO; CLO_0016177
DR   CLO; CLO_0050971
DR   EFO; EFO_0022508
DR   CLDB; cl678
DR   ATCC; CCL-120.1
DR   BEI_Resources; ARP-497
DR   BioSample; SAMN03472334
DR   BioSample; SAMN03472701
DR   BioSample; SAMN03473542
DR   cancercelllines; CVCL_1859
DR   Cell_Model_Passport; SIDM01558
DR   ChEMBL-Cells; CHEMBL3307642
DR   ChEMBL-Targets; CHEMBL614541
DR   CLS; 300214
DR   Coriell; GM04155
DR   Cosmic; 683532
DR   Cosmic; 801729
DR   Cosmic; 850195
DR   Cosmic; 913416
DR   Cosmic; 922679
DR   Cosmic; 932768
DR   Cosmic; 996307
DR   Cosmic; 998723
DR   Cosmic; 1037688
DR   Cosmic; 1115591
DR   Cosmic; 1175128
DR   Cosmic; 1226856
DR   Cosmic; 1281369
DR   Cosmic; 1330497
DR   Cosmic; 1524797
DR   Cosmic; 1641390
DR   Cosmic; 1760523
DR   Cosmic; 2165712
DR   Cosmic; 2361365
DR   Cosmic; 2458762
DR   Cosmic; 2462861
DR   Cosmic; 2602915
DR   Cosmic; 2649236
DR   DSMZ; ACC-435
DR   DSMZCellDive; ACC-435
DR   ECACC; 85112801
DR   GEO; GSM5137752
DR   IARC_TP53; 21649
DR   IZSLER; BS TCL 185
DR   JCRB; JCRB0031
DR   KCLB; 10120.1
DR   LINCS_LDP; LCL-1914
DR   NCBI_Iran; C530
DR   PRIDE; PXD023662
DR   PubChem_Cell_line; CVCL_1859
DR   RCB; RCB0016
DR   Wikidata; Q54809037
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=62390;
RX   PubMed=168255;
RX   PubMed=1086134;
RX   PubMed=2140233;
RX   PubMed=2144611;
RX   PubMed=2255914;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3495441;
RX   PubMed=3874327;
RX   PubMed=4363409;
RX   PubMed=4523807;
RX   PubMed=4991454;
RX   PubMed=6582512;
RX   PubMed=6600440;
RX   PubMed=7630190;
RX   PubMed=8316623;
RX   PubMed=8547074;
RX   PubMed=8558913;
RX   PubMed=8957066;
RX   PubMed=9787181;
RX   PubMed=9933131;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=15472075;
RX   PubMed=15901131;
RX   PubMed=17117183;
RX   PubMed=17170727;
RX   PubMed=22675565;
RX   PubMed=35354797;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/hsb-2/
WW   Provider; HHV-6 Foundation; -; https://hhv-6foundation.org/wp-content/uploads/2016/11/HSB-2-Cells-data-sheet.pdf
CC   Problematic cell line: Partially contaminated. The stock formerly distributed by CLS under catalog number 300214 was contaminated. Compared to the STR values obtained by other distributors it differed from having: Amelogenin: X; CSF1PO: 8,12; D16S539: 9,13,14; D18S51: 9,13,14; D21S11: 28,29; D7S820: 10,14; D8S1179: 9,15; FGA: 22,23,24; Penta D: 9; Penta E: 6,13 and TH01: 8,10.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Established by serial transplantation into newborn Syrian hamsters.
CC   Doubling time: 40 hours (PubMed=17117183); ~25 hours (DSMZ=ACC-435); 24 hours (Note=Lot 042091) (JCRB=JCRB0031).
CC   Microsatellite instability: Instable (MSI) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (PubMed=2255914).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=2144611).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: CCRF-HBS-2; NCBI_Iran=C530.
CC   Discontinued: CLS; 300214; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CCL-120.1; DSMZ=ACC-435; ECACC=85112801; JCRB=JCRB0031; KCLB=10120.1; RCB=RCB0016
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11 (DSMZ=ACC-435)
ST   CSF1PO: 10,12 (ATCC=CCL-120.1; ECACC=85112801; JCRB=JCRB0031; KCLB=10120.1; RCB=RCB0016)
ST   D13S317: 10,12
ST   D16S539: 9,12 (DSMZ=ACC-435)
ST   D16S539: 9,13 (ATCC=CCL-120.1; ECACC=85112801; JCRB=JCRB0031; RCB=RCB0016)
ST   D18S51: 9,14
ST   D19S433: 14,20
ST   D21S11: 27,28
ST   D2S1338: 17,18
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 24,25
ST   Penta D: 9,12
ST   Penta E: 8,13
ST   TH01: 9,9.3 (KCLB=10120.1)
ST   TH01: 9,10 (ATCC=CCL-120.1; DSMZ=ACC-435; ECACC=85112801; JCRB=JCRB0031; RCB=RCB0016)
ST   TPOX: 8
ST   vWA: 18,19 (ATCC=CCL-120.1; DSMZ=ACC-435; ECACC=85112801; JCRB=JCRB0031; KCLB=10120.1)
ST   vWA: 18,19,20 (RCB=RCB0016)
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1860 ! CCRF-SB
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   CCRF-RKB
AC   CVCL_IQ35
DR   Wikidata; Q54809038
RX   PubMed=4927348;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   CCRF-SB
AC   CVCL_1860
SY   CCRF SB; CCRFSB; SB; S.B.; GM04154; GM04154B
DR   CLO; CLO_0002336
DR   CLO; CLO_0016198
DR   EFO; EFO_0006550
DR   CLDB; cl679
DR   CLDB; cl680
DR   CLDB; cl681
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CCL-120
DR   BioSample; SAMN03471043
DR   BioSample; SAMN03472769
DR   cancercelllines; CVCL_1860
DR   CCRID; 4201HUM-CCTCC00304
DR   CCTCC; GDC0304
DR   ChEMBL-Cells; CHEMBL3307643
DR   ChEMBL-Targets; CHEMBL614542
DR   Coriell; GM04154
DR   Cosmic; 683533
DR   Cosmic; 2301562
DR   Cosmic; 2649231
DR   ECACC; 89090405
DR   EGA; EGAS00001000610
DR   GEO; GSM5137709
DR   IARC_TP53; 21219
DR   IGRhCellID; CCRFSB
DR   IZSLER; BS TCL 12
DR   JCRB; IFO50026
DR   JCRB; JCRB0032
DR   LINCS_LDP; LCL-1006
DR   NCI-DTP; CCRF-SB
DR   PharmacoDB; CCRFSB_191_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_1860
DR   PubChem_Cell_line; CVCL_1860
DR   Wikidata; Q54809040
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=62390;
RX   PubMed=1086134;
RX   PubMed=3335022;
RX   PubMed=4363409;
RX   PubMed=4523807;
RX   PubMed=4991454;
RX   PubMed=8316623;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29892436;
RX   PubMed=35124168;
RX   PubMed=35354797;
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*44:05,57:01; C*02:02,06:02 (PubMed=26589293).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-120; JCRB=IFO50026; JCRB=JCRB0032; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13 (ATCC=CCL-120; PubMed=25877200)
ST   D16S539: 13 (JCRB=IFO50026; JCRB=JCRB0032)
ST   D18S51: 9,14
ST   D19S433: 14,16
ST   D21S11: 27,28
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 9,15
ST   FGA: 25
ST   Penta D: 9,12
ST   Penta E: 6,13
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1859 ! CCRF-HSB-2
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   CCRF/ACTD400
AC   CVCL_D545
SY   CCRF ACTD400; CCRF-ACTD400; ACTD400
DR   cancercelllines; CVCL_D545
DR   Wikidata; Q54809041
RX   PubMed=1698543;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   CCRF/ADR5000
AC   CVCL_D544
SY   CCRF ADR5000; CCRF-ADR5000; CEM/ADR5000; CEM/ADR 5000; CEM-ADR5000; CEM ADR5000; ADR5000
DR   BTO; BTO_0005199
DR   cancercelllines; CVCL_D544
DR   ChEMBL-Cells; CHEMBL3307900
DR   ChEMBL-Targets; CHEMBL614266
DR   PubChem_Cell_line; CVCL_D544
DR   Wikidata; Q54809049
RX   PubMed=1698543;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   CCRF/CEM/ara-C/3A
AC   CVCL_4V17
DR   cancercelllines; CVCL_4V17
DR   Wikidata; Q54809050
RX   PubMed=7805176;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   CCRF/CEM/ara-C/7A
AC   CVCL_4V18
SY   CEM/ara-C/7A
DR   cancercelllines; CVCL_4V18
DR   Wikidata; Q54809051
RX   PubMed=7805176;
RX   PubMed=10769646;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   CCRF/CEM/ara-C/B
AC   CVCL_A5TY
SY   CEM/ara-C/B
DR   cancercelllines; CVCL_A5TY
DR   Wikidata; Q107114622
RX   PubMed=10769646;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CCRF/CEM/ara-C/C
AC   CVCL_A5UY
SY   CEM/ara-C/C
DR   cancercelllines; CVCL_A5UY
DR   Wikidata; Q107114623
RX   PubMed=10769646;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CCRF/CEM/ara-C/D
AC   CVCL_A5TZ
SY   CEM/ara-C/D
DR   cancercelllines; CVCL_A5TZ
DR   Wikidata; Q107114624
RX   PubMed=10769646;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CCRF/CEM/ara-C/G
AC   CVCL_A5UA
SY   CEM/ara-C/G
DR   cancercelllines; CVCL_A5UA
DR   Wikidata; Q107114625
RX   PubMed=10769646;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CCRF/CEM/ara-C/I
AC   CVCL_A5UB
SY   CEM/ara-C/I
DR   cancercelllines; CVCL_A5UB
DR   Wikidata; Q107114626
RX   PubMed=10769646;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CCRF/CEM/ara-C/J
AC   CVCL_A5UC
SY   CEM/ara-C/J
DR   cancercelllines; CVCL_A5UC
DR   Wikidata; Q107114628
RX   PubMed=10769646;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CCRF/VCR1000
AC   CVCL_D546
SY   CCRF VCR1000; CCRF-VCR 1000; CCRF VCR 1000; CCRF-CEM/VCR-1000; CEM-VCR 1000; CEM/VCR1000; VCR1000
DR   cancercelllines; CVCL_D546
DR   ChEMBL-Cells; CHEMBL3307393
DR   ChEMBL-Targets; CHEMBL614540
DR   PubChem_Cell_line; CVCL_D546
DR   Wikidata; Q54809052
RX   PubMed=1698543;
RX   PubMed=12482398;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 25
//
ID   CCRM-hESC-22
AC   CVCL_9T84
DR   Wikidata; Q54809053
RX   PubMed=23564289;
CC   From: Center of Clinical Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University; Nanjing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   CCRM-hESC-23
AC   CVCL_9T85
DR   Wikidata; Q54809054
RX   PubMed=23564289;
CC   From: Center of Clinical Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University; Nanjing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   CCRM8
AC   CVCL_9T86
SY   Center of Clinical Reproductive Medicine 8
DR   Wikidata; Q54809055
RX   PubMed=26522100;
CC   From: Center of Clinical Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University; Nanjing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   CCS292
AC   CVCL_0J30
DR   EGA; EGAD00001008611
DR   Wikidata; Q54809057
RX   PubMed=16766266;
RX   PubMed=36959380;
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=16766266).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=36959380
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 29,30.2
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 13,16
ST   Penta D: 12
ST   Penta E: 11,16
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   CCSP C1
AC   CVCL_C8EY
SY   Cancer Cell SubPopulation C1
DR   CancerTools; 157956
DR   Wikidata; Q123030875
DR   Ximbio; 157956
RX   PubMed=19118034;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8EZ ! CCSP C2
OI   CVCL_C8F0 ! CCSP C5
OI   CVCL_C8F1 ! CCSP C12
OI   CVCL_C8F2 ! CCSP C13
OI   CVCL_C8F3 ! CCSP C16
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   CCSP C2
AC   CVCL_C8EZ
SY   Cancer Cell SubPopulation C2
DR   CancerTools; 157957
DR   Wikidata; Q123030876
DR   Ximbio; 157957
RX   PubMed=19118034;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8EY ! CCSP C1
OI   CVCL_C8F0 ! CCSP C5
OI   CVCL_C8F1 ! CCSP C12
OI   CVCL_C8F2 ! CCSP C13
OI   CVCL_C8F3 ! CCSP C16
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   CCSP C5
AC   CVCL_C8F0
SY   Cancer Cell SubPopulation C5
DR   CancerTools; 157958
DR   Wikidata; Q123030877
DR   Ximbio; 157958
RX   PubMed=19118034;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8EY ! CCSP C1
OI   CVCL_C8EZ ! CCSP C2
OI   CVCL_C8F1 ! CCSP C12
OI   CVCL_C8F2 ! CCSP C13
OI   CVCL_C8F3 ! CCSP C16
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   CCSP C12
AC   CVCL_C8F1
SY   Cancer Cell SubPopulation C12
DR   CancerTools; 157959
DR   Wikidata; Q123030878
DR   Ximbio; 157959
RX   PubMed=19118034;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8EY ! CCSP C1
OI   CVCL_C8EZ ! CCSP C2
OI   CVCL_C8F0 ! CCSP C5
OI   CVCL_C8F2 ! CCSP C13
OI   CVCL_C8F3 ! CCSP C16
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   CCSP C13
AC   CVCL_C8F2
SY   Cancer Cell SubPopulation C13
DR   CancerTools; 157960
DR   Wikidata; Q123030879
DR   Ximbio; 157960
RX   PubMed=19118034;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8EY ! CCSP C1
OI   CVCL_C8EZ ! CCSP C2
OI   CVCL_C8F0 ! CCSP C5
OI   CVCL_C8F1 ! CCSP C12
OI   CVCL_C8F3 ! CCSP C16
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   CCSP C16
AC   CVCL_C8F3
SY   Cancer Cell SubPopulation C16
DR   CancerTools; 157961
DR   Wikidata; Q123030881
DR   Ximbio; 157961
RX   PubMed=19118034;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8EY ! CCSP C1
OI   CVCL_C8EZ ! CCSP C2
OI   CVCL_C8F0 ! CCSP C5
OI   CVCL_C8F1 ! CCSP C12
OI   CVCL_C8F2 ! CCSP C13
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   CCSN
AC   CVCL_YB60
DR   Wikidata; Q93445895
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
CC   Group: Fish cell line.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 4
//
ID   CCT [Cyprinus]
AC   CVCL_R839
SY   Cyprinus Carpio Testis
DR   Wikidata; Q54809058
RX   DOI=10.1007/BF01404746;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   CCT [Dog]
AC   CVCL_L312
DR   Wikidata; Q54809059
RX   PubMed=12867736;
RX   PubMed=15750320;
CC   Doubling time: ~30 hours (PubMed=12867736).
CC   Breed/subspecies: Borzoi; VBO=VBO_0200197.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   CCTCC-C201126
AC   CVCL_C4BF
DR   ABCD; ABCD_AS280
DR   Wikidata; Q116048703
RX   Patent=CN108893449B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201126.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62937; Human PPIA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CCX.2C4
AC   CVCL_E4IH
WW   Provider; Nuvonis; -; https://nuvonis.com/ccx-cell-line/
CC   Group: Bird cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Nuvonis Technologies GmbH; Vienna; Austria.
CC   Characteristics: Grows as an anchorage-dependent cell line (Nuvonis).
CC   Doubling time: 0.8-1 day (Nuvonis).
CC   Miscellaneous: Age at sampling from personal communication of Seipelt, Joachim.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
OI   CVCL_E4II ! CCX.E10
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CCX.E10
AC   CVCL_E4II
RX   CelloPub=CLPUB00780;
RX   PubMed=37584190;
WW   Provider; Nuvonis; -; https://nuvonis.com/ccx-cell-line/
CC   Group: Bird cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Nuvonis Technologies GmbH; Vienna; Austria.
CC   Biotechnology: Can be used for the manufacturing of the fusogenic oncolytic virus, rVSV-NDV, a recombinant vesicular stomatitis virus (VSV) backbone with fusogenic mutant glycoproteins of Newcastle disease virus (NDV) (PubMed=37584190).
CC   Characteristics: Grows in suspension (Nuvonis).
CC   Virology: When infected with Newcastle disease virus (NDV) produces high viral titers (CelloPub=CLPUB00780).
CC   Doubling time: 0.8-1 day (Nuvonis).
CC   Miscellaneous: Age at sampling from personal communication of Seipelt, Joachim.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
OI   CVCL_E4IH ! CCX.2C4
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CD
AC   CVCL_W955
SY   Cancer research institute Developed
DR   Wikidata; Q54809060
RX   DOI=10.1155/2014/286013;
CC   Population: Indian.
CC   Characteristics: Established from a gutka chewer.
CC   Doubling time: 31 +- 1 hours (DOI=10.1155/2014/286013).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (DOI=10.1155/2014/286013).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DOI=10.1155/2014/286013
ST   Amelogenin: X,Y
ST   CSF1PO: 9.3,12
ST   D13S317: 8,13
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,19.2
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   Cd R200
AC   CVCL_Z899
SY   CdR200
DR   FlyBase_Cell_line; FBtc9000031
DR   Wikidata; Q54809079
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=3919723;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z897 ! 1182-6
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   CD-2F8
AC   CVCL_F0CW
RX   PubMed=36096853;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Canine distemper virus (isolate CDV/Dog/Bly/Ind/2018) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CD-3D8
AC   CVCL_F0CX
RX   PubMed=36096853;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Canine distemper virus (isolate CDV/Dog/Bly/Ind/2018) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CD-4D6
AC   CVCL_F0CY
RX   PubMed=36096853;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Canine distemper virus (isolate CDV/Dog/Bly/Ind/2018).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CD-5D10
AC   CVCL_F0CZ
RX   PubMed=36096853;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Canine distemper virus (isolate CDV/Dog/Bly/Ind/2018).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CD-6E5
AC   CVCL_F0D0
RX   PubMed=36096853;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Canine distemper virus (isolate CDV/Dog/Bly/Ind/2018).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CD-AB3
AC   CVCL_F0D1
RX   PubMed=36096853;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Canine distemper virus (isolate CDV/Dog/Bly/Ind/2018).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Cd-K4D 1
AC   CVCL_E3SQ
SY   Common dog-K4D 1
RX   PubMed=35185293;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Breed/subspecies: Miniature Dachshund; VBO=VBO_0200408.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_E3SR ! Cd-K4DT 1
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Cd-K4DT 1
AC   CVCL_E3SR
SY   Common dog-K4DT 1
RX   PubMed=35185293;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Breed/subspecies: Miniature Dachshund; VBO=VBO_0200408.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_E3SQ ! Cd-K4D 1
SX   Male
AG   9Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Cd-K4D 2
AC   CVCL_E3SS
SY   Common dog-K4D 2
RX   PubMed=35185293;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Breed/subspecies: Miniature Dachshund; VBO=VBO_0200408.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_E3ST ! Cd-K4DT 2
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Cd-K4DT 2
AC   CVCL_E3ST
SY   Common dog-K4DT 2
RX   PubMed=35185293;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Breed/subspecies: Miniature Dachshund; VBO=VBO_0200408.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_E3SS ! Cd-K4D 2
SX   Male
AG   6Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CD-rA7
AC   CVCL_6E53
DR   Wikidata; Q54809061
RX   PubMed=10530804;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97171; Mt1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97172; Mt2.
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6E52 ! Mt1/Mt2 DKO SV40
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   CD-rB5
AC   CVCL_6E54
DR   Wikidata; Q54809062
RX   PubMed=10530804;
RX   PubMed=10688626;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97171; Mt1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97172; Mt2.
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6E52 ! Mt1/Mt2 DKO SV40
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   CD#00 iPSC
AC   CVCL_A5RR
DR   Wikidata; Q107114629
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.His244Arg (c.731A>G); ClinVar=VCV000371086; Zygosity=Homozygous (PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5RQ ! FFF0282000
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CD#01 iPSC
AC   CVCL_A5RT
DR   Wikidata; Q107114630
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu129Argfs*8 (c.382delC); ClinVar=VCV000551932; Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Arg168Cys (c.502C>T); ClinVar=VCV000813438; Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D21S11: 30,31
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5RS ! FFF0082001
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CD#59 ipsC
AC   CVCL_A5RK
DR   Wikidata; Q107114631
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000126510; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P14 ! GM00059
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CD#60 ipsC
AC   CVCL_A5RL
DR   Wikidata; Q107114632
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=33304759).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P15 ! GM00060
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CD#68 iPSC
AC   CVCL_A5RM
DR   Wikidata; Q107114634
RX   PubMed=33304759;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Homozygous (PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D21S11: 29,31.2
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P45 ! GM04268
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CD#68T-13 iPSC
AC   CVCL_A5RU
SY   CD68T-13 iPSC
DR   Wikidata; Q107114635
RX   PubMed=33304759;
CC   Population: Jewish.
CC   Characteristics: Using TALEN a EF1a promoter-ASPA-T2A-CD19t construct was introduced in the AAVS1 safe harbor locus (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Homozygous (PubMed=33304759).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:756; ASPA.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:1633; CD19 (Note=With p.Lys324_Arg556del = CD19t).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5RM ! CD#68 iPSC
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CD#92 iPSC
AC   CVCL_A5RP
DR   Wikidata; Q107114636
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Met82Asnfs*7 (c.244dupA); Zygosity=Homozygous (PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 29,30
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5RN ! FF08711992
SX   Female
AG   9M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CD114
AC   CVCL_DR66
DR   PRIDE; PXD001205
DR   Wikidata; Q54809063
RX   PubMed=25502872;
CC   HLA typing: DPB1*01:01,04:01; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*01:01 (PubMed=25502872).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class II peptidome.
DI   NCIt; C26714; Celiac disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   CD126
AC   CVCL_A8QK
DR   Wikidata; Q108819997
RX   PubMed=2246335;
RX   PubMed=2543678;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr1085_Ala1210del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CD165
AC   CVCL_B4UF
DR   PRIDE; PXD006939
DR   PRIDE; PXD012308
DR   Wikidata; Q110432690
RX   PubMed=28832583;
RX   PubMed=29242379;
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*02:05,24:02; B*15:01,50:01; C*03:03,06:02 (PubMed=28832583).
CC   HLA typing: DPA1*01:03; DPB1*04:01(105:01),04:02(126:01); DQA1*05:05; DQB1*03:01; DRB1*11:01; DRB3*02:02 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   CD34 FL-iPS-17
AC   CVCL_E7SS
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CD34+FL-iPS-17+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+CD34+FL-iPS-17+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Karyotypic information: 47,XX,+20 [17]; 47,XX,+mar [8] (BNLC).
CC   Donor information: Established from a pool of female fetal liver.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pro-B cell; CL=CL_0000826.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D21S11: 27,30
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CD34 iPS1
AC   CVCL_C946
DR   Wikidata; Q54809064
RX   PubMed=19299331;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C947 ! CD34 iPS2
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   CD34 iPS2
AC   CVCL_C947
DR   Wikidata; Q54809066
RX   PubMed=19299331;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C946 ! CD34 iPS1
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   CD36E
AC   CVCL_ZD82
DR   ABM; T0136
DR   Kerafast; ENH035-FP
DR   Wikidata; Q98125613
RX   PubMed=20696208;
WW   Provider; NIH OTT; E-151-2010-0; https://web.archive.org/web/20201016235957/https://www.ott.nih.gov/technology/e-151-2010-0
CC   Group: Malaria research cell line.
CC   Characteristics: Potentially useful for culturing Plasmodium vivax and other species of malaria; useful for hematological disease applications involving red blood cells or red blood cell precursors (Kerafast=ENH035-FP).
CC   Doubling time: 3-4 days (PubMed=20696208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: ABM wrongly indicates that this cell line originates from mouse (ABM=T0136).
CC   Discontinued: ABM; T0136; true.
CC   Discontinued: Kerafast; ENH035-FP; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   CD4+ N#2 500
AC   CVCL_2G94
DR   BEI_Resources; ARP-12533
DR   Wikidata; Q54809067
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   CD9-/- ES K2
AC   CVCL_E5ZX
RX   PubMed=19716222;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88348; Cd9.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CD9-/- ES K3
AC   CVCL_E5ZY
RX   PubMed=19716222;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88348; Cd9.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CD9-/- ES K4
AC   CVCL_E5ZZ
RX   PubMed=19716222;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88348; Cd9.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CDC 1C42H11
AC   CVCL_K221
DR   CLO; CLO_0002342
DR   ATCC; HB-216
DR   Wikidata; Q54809068
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Canine distemper virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CDDP-R B16F10
AC   CVCL_XH27
DR   Wikidata; Q93445909
RX   PubMed=31919315;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 7
//
ID   CDE6
AC   CVCL_E9YQ
RX   PubMed=10816384;
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic oval stem cell; CL=CL_0002196.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Cdelta2+
AC   CVCL_CW65
DR   Wikidata; Q54809069
RX   PubMed=23610747;
RX   PubMed=28871180;
CC   Characteristics: Bactericidal against Gram- (E.coli) and Gram+ (S.aureus) organisms.
CC   Miscellaneous: The '+' in the cell line name denotes the inclusion of LM929 supernatant in the culture medium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: USMARC mixed breed; VBO=VBO_0017519.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   10M
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   Cdelta2-
AC   CVCL_CW66
DR   Wikidata; Q54809070
RX   PubMed=23610747;
CC   Characteristics: Bactericidal against Gram- (E.coli) and Gram+ (S.aureus) organisms.
CC   Miscellaneous: The '-' in the cell line name denotes the absence of LM929 supernatant in the culture medium.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: USMARC mixed breed; VBO=VBO_0017519.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_CW65 ! Cdelta2+
SX   Female
AG   10M
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   CDH5-2C11
AC   CVCL_XJ49
DR   CCRID; 4201PAT-CCTCC00704
DR   Wikidata; Q93445911
RX   Patent=CN105669837B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201581.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P33151; Human CDH5/CD144.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   CDIB4
AC   CVCL_A8P3
SY   CD1B4
DR   ECACC; 19072502
DR   Wikidata; Q102113656
RX   PubMed=7642707;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; W5PK89; Sheep ODF2 (Note=Also reacts with human, mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   CDIi001-A
AC   CVCL_IT57
SY   01279
DR   BioSamples; SAMEA104012950
DR   hPSCreg; CDIi001-A
DR   SKIP; SKIP002920
DR   Wikidata; Q54809071
RX   PubMed=33268331;
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   CDIi001-A-1
AC   CVCL_C9YU
SY   CDIi001-A-TREM2-HZ
DR   BioSamples; SAMEA112655516
DR   hPSCreg; CDIi001-A-1
DR   Wikidata; Q123030882
WW   Provider; Fujifilm CDI; -; https://www.fujifilmcdi.com/icell-microglia-ad-trem2-01279-gmgltrem01279
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT57 ! CDIi001-A
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CDIi001-A-2
AC   CVCL_C9YV
SY   CDIi001-A-TREM2-HO
DR   Wikidata; Q123030883
WW   Provider; Fujifilm CDI; -; https://www.fujifilmcdi.com/icell-microglia-ad-trem2-01279-gmgltrem01279
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT57 ! CDIi001-A
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CDIi002-A
AC   CVCL_VC63
SY   01434
DR   BioSamples; SAMEA104012990
DR   hPSCreg; CDIi002-A
DR   Wikidata; Q54809072
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   CDIi003-A
AC   CVCL_UL93
SY   01501
DR   hPSCreg; CDIi003-A
DR   Wikidata; Q93445913
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CDIi004-A
AC   CVCL_VE12
SY   11713
DR   BioSamples; SAMEA104626278
DR   hPSCreg; CDIi004-A
DR   Wikidata; Q54809073
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   CDIi005-A
AC   CVCL_VL42
SY   01178
DR   BioSamples; SAMEA12616339
DR   hPSCreg; CDIi005-A
DR   Wikidata; Q93445918
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 5
//
ID   CDIi006-A
AC   CVCL_WU55
SY   01503
DR   BioSamples; SAMEA5892782
DR   hPSCreg; CDIi006-A
DR   Wikidata; Q93445920
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   CDIi007-A
AC   CVCL_A1VX
SY   01173
DR   hPSCreg; CDIi007-A
DR   Wikidata; Q105506598
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Discontinued: hPSCreg; CDIi007-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   CDIi009-A
AC   CVCL_C6NT
SY   11344
DR   hPSCreg; CDIi009-A
DR   Wikidata; Q117704234
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CDIi010-A
AC   CVCL_C6NU
SY   11299
DR   hPSCreg; CDIi010-A
DR   Wikidata; Q117704235
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CDIi011-A
AC   CVCL_C6NV
SY   21527
DR   BioSamples; SAMEA114494128
DR   hPSCreg; CDIi011-A
DR   Wikidata; Q117704236
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   CDIi012-A
AC   CVCL_C6NW
SY   21535
DR   hPSCreg; CDIi012-A
DR   Wikidata; Q117704238
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CDina26
AC   CVCL_A0IM
SY   BT 5/9; BT5/9; 5/9
DR   ABCD; ABCD_AA723
DR   Wikidata; Q108820000
RX   Patent=US9376498;
RX   Patent=US10208126;
RX   PubMed=6459366;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 12002.
CC   Biotechnology: Was used to produce the monoclonal antibody begelomab (Begedina) which was evaluated as a therapeutic agent against steroid-resistant acute graft-versus-host disease.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   cdLEC
AC   CVCL_F701
DR   Wikidata; Q54809075
RX   PubMed=22293671;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Wire Fox Terrier; VBO=VBO_0201424.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 15
//
ID   CDMLe012-A-1
AC   CVCL_XI83
SY   NMR-1(45,XO)
DR   hPSCreg; CDMLe012-A-1
DR   Wikidata; Q93445928
RX   PubMed=31357114;
CC   From: Cancer Disease Modeling Laboratory, University of Texas Health Center at Houston; Houston; USA.
CC   Karyotypic information: 45,X0. Spontaneously lost an X-chromosome during cell culture (PubMed=31357114).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B912 ! NMR-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   CDMLi002-A
AC   CVCL_UG21
SY   FCP351G
DR   hPSCreg; CDMLi002-A
DR   Wikidata; Q93445930
RX   PubMed=30312871;
CC   From: Cancer Disease Modeling Laboratory, University of Texas Health Center at Houston; Houston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; c.1878+32_1878+55del24; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=30312871).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   CDN01
AC   CVCL_C3UL
SY   CDN1
DR   Wikidata; Q116048705
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN02
AC   CVCL_C3UM
SY   CDN2
DR   Wikidata; Q116048706
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN03
AC   CVCL_C3UN
SY   CDN3
DR   Wikidata; Q116048707
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN04
AC   CVCL_C3UP
SY   CDN4
DR   ABCD; ABCD_AI943
DR   Wikidata; Q116048708
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN05
AC   CVCL_C3UQ
SY   CDN5
DR   Wikidata; Q116048709
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN07
AC   CVCL_C3UR
SY   CDN7
DR   Wikidata; Q116048710
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN08
AC   CVCL_C3US
SY   CDN8
DR   Wikidata; Q116048711
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN16
AC   CVCL_C3UT
DR   ABCD; ABCD_AI944
DR   Wikidata; Q116048712
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN17
AC   CVCL_C3UU
DR   Wikidata; Q116048713
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN24
AC   CVCL_C3UV
DR   Wikidata; Q116048714
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN27
AC   CVCL_C3UW
DR   ABCD; ABCD_AI945
DR   Wikidata; Q116048715
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN28
AC   CVCL_C3UX
DR   ABCD; ABCD_AI946
DR   Wikidata; Q116048716
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN29
AC   CVCL_C3UY
DR   Wikidata; Q116048717
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN30
AC   CVCL_C3UZ
DR   Wikidata; Q116048718
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN31
AC   CVCL_C3V0
DR   Wikidata; Q116048719
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN32
AC   CVCL_C3V1
DR   Wikidata; Q116048720
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN33
AC   CVCL_C3V2
DR   Wikidata; Q116048721
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN35
AC   CVCL_C3V3
DR   ABCD; ABCD_AI947
DR   Wikidata; Q116048722
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN36
AC   CVCL_C3V4
DR   Wikidata; Q116048723
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN37
AC   CVCL_C3V5
DR   Wikidata; Q116048724
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDN38
AC   CVCL_C3V6
DR   ABCD; ABCD_AI948
DR   Wikidata; Q116048725
RX   Patent=US20140377781;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CDNR1
AC   CVCL_5717
DR   Wikidata; Q54809076
RX   PubMed=2544547;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   CDNR2
AC   CVCL_5718
DR   Wikidata; Q54809077
RX   PubMed=2544547;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   CDNR4
AC   CVCL_5719
DR   CLS; 400391
DR   Wikidata; Q54809078
RX   PubMed=2544547;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   CDR1
AC   CVCL_9168
DR   CLO; CLO_0002344
DR   ATCC; HB-213
DR   Wikidata; Q54809080
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   CDR2
AC   CVCL_H172
DR   CLO; CLO_0002345
DR   ATCC; HB-214
DR   Wikidata; Q54809081
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   CDS06
AC   CVCL_WJ29
DR   Wikidata; Q93445956
RX   PubMed=30987403;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; None_reported; -; Zygosity=- (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=30987403).
ST   Source(s): PubMed=30987403
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 16,18
DI   NCIt; C27482; Secondary chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   CDS11
AC   CVCL_WJ30
DR   ABM; T8286
DR   cancercelllines; CVCL_WJ30
DR   Wikidata; Q93445958
RX   PubMed=30987403;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Leu (c.395G>T); ClinVar=VCV000375889; Zygosity=Heterozygous (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=30987403).
CC   Derived from site: In situ; Cartilage; UBERON=UBERON_0002418.
ST   Source(s): PubMed=30987403
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15
DI   NCIt; C27482; Secondary chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   CDS17
AC   CVCL_WJ31
SY   CDS-17
DR   cancercelllines; CVCL_WJ31
DR   Wikidata; Q93445960
RX   PubMed=30987403;
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple; p.Arg172Gly (c.514A>G); ClinVar=VCV000376439; Zygosity=Heterozygous (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.645T>G); ClinVar=VCV000376661; Zygosity=Homozygous (PubMed=30987403).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Cartilage; UBERON=UBERON_0002418.
ST   Source(s): PubMed=30987403
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 14,16
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   CE
AC   CVCL_6D96
SY   CE-1; Celebensis Embryo
DR   Wikidata; Q54809082
RX   PubMed=7881826;
RX   PubMed=16341864;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=126373; ! Oryzias celebensis (Celebes medaka)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   Ce Ar
AC   CVCL_3660
SY   CeAr
DR   CLO; CLO_0002347
DR   ATCC; CRL-1165
DR   Wikidata; Q54809083
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Heterozygous (from familial inference of XP8BE; XP9BE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Ce Geg
AC   CVCL_3661
SY   Culture 345
DR   CLO; CLO_0002348
DR   ATCC; CRL-1173
DR   Wikidata; Q54809085
RX   PubMed=4582519;
CC   Discontinued: ATCC; CRL-1173; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Ce Rel
AC   CVCL_U772
DR   ATCC; CRL-1196
DR   Wikidata; Q54809086
CC   Discontinued: ATCC; CRL-1196; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Ce Wal
AC   CVCL_3662
DR   CLO; CLO_0002349
DR   ATCC; CRL-1351
DR   BioSample; SAMN03471355
DR   Wikidata; Q54809087
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1351
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 10,14
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C53975; Poikiloderma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Ce Wo
AC   CVCL_U773
DR   ATCC; CRL-1340
DR   Wikidata; Q54809088
CC   Discontinued: ATCC; CRL-1340; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   CE-1
AC   CVCL_8949
SY   CE1; Cassette Exchange-1
DR   CLO; CLO_0002350
DR   ATCC; SCRC-1038
DR   Wikidata; Q54809089
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   CE-25
AC   CVCL_Y989
SY   CE 25; CE25
DR   Wikidata; Q54809090
RX   Patent=US5047507;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-719.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   CE-3
AC   CVCL_8950
SY   CE3; Cassette Exchange-3
DR   CLO; CLO_0002351
DR   ATCC; SCRC-1039
DR   CCRID; 3101MOUSCSP203
DR   Wikidata; Q54809092
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CE/F11
AC   CVCL_B0KE
SY   CE/F 11
DR   Wikidata; Q108820001
RX   PubMed=6205971;
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-26
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-98
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8043.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P01574; Human IFNB1.
CC   Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   CE/F12
AC   CVCL_B0KF
SY   CE/F 12
DR   Wikidata; Q108820002
RX   PubMed=6205971;
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-26
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-98
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8044.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P01574; Human IFNB1.
CC   Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   CE/F13
AC   CVCL_B0KG
SY   CE/F 13
DR   Wikidata; Q108820003
RX   PubMed=6205971;
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-26
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-98
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8045.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P01574; Human IFNB1.
CC   Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   CE/F14
AC   CVCL_B0KH
SY   CE/F 14
DR   Wikidata; Q108820004
RX   PubMed=6205971;
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-26
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-98
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8046.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P01574; Human IFNB1.
CC   Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   CE/F15
AC   CVCL_B0KI
SY   CE/F 15
DR   Wikidata; Q108820005
RX   PubMed=6205971;
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-26
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-98
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8047.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P01574; Human IFNB1.
CC   Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   CE/F16
AC   CVCL_B0KJ
SY   CE/F 16
DR   Wikidata; Q108820006
RX   PubMed=6205971;
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-26
WW   Info; -; -; https://www.ipmall.info/content/bpai-board-patent-appeals-and-interferences-patent-and-trademark-office-pto-1-ex-parte-98
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8048.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P01574; Human IFNB1.
CC   Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   CE0001
AC   CVCL_8U00
DR   ECACC; 92121301
DR   Wikidata; Q54809093
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Iranian.
CC   Karyotypic information: 46,XY,del(2)(q23->q24.5) (ECACC=92121301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   cE1
AC   CVCL_S005
SY   ADI-Ca cE1
DR   Wikidata; Q54809107
RX   PubMed=20631921;
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S006 ! cE2
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   CE11
AC   CVCL_E5R7
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CE146T/VGH
AC   CVCL_Y008
SY   CE 146T/VGH; CE 146T; CE146T; 146T
DR   BCRC; 60167
DR   Wikidata; Q54809108
RX   PubMed=20392990;
CC   Population: Chinese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): BCRC=60167
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 9
//
ID   cE2
AC   CVCL_S006
SY   ADI-Ca cE2
DR   Wikidata; Q54809109
RX   PubMed=20631921;
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S005 ! cE1
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   CE2
AC   CVCL_C4DK
DR   ABCD; ABCD_AG202
DR   Wikidata; Q116048726
RX   PubMed=23295252;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53218; Diphenylmethane-4,4'-diisocyanate (Methylene diphenyl diisocyanate; MDI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CE3
AC   CVCL_B5B2
DR   Wikidata; Q110432692
RX   DOI=10.1021/jf00066a055;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27827; Paraoxon.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   CE48T/VGH
AC   CVCL_Y009
SY   CE-48T/VGH; CE 48T/VGH; CE-48; CE48T; 48T
DR   BCRC; 60165
DR   Cosmic; 2646652
DR   Wikidata; Q54809110
RX   PubMed=3943066;
RX   PubMed=6583441;
RX   PubMed=12432233;
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~55 hours (PubMed=6583441).
CC   Discontinued: BCRC; 60165; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 10
//
ID   CE69T/VGH
AC   CVCL_Y010
SY   CE-69T/VGH
DR   Wikidata; Q54809111
RX   PubMed=2827967;
RX   PubMed=6583441;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~48 hours (PubMed=6583441).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE7 [Mouse hybridoma against human L1CAM]
AC   CVCL_E3ZM
DR   ABCD; ABCD_AN179
RX   PubMed=3943922;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P32004; Human L1CAM/CD171.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CE7 [Mouse hybridoma against vaccinia F13L]
AC   CVCL_E5S7
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04021; Vaccinia virus envelope phospholipase OPG057 (F13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CE81T/VGH
AC   CVCL_Y011
SY   CE-81T/VGH; CE 81T/VGH; CE 81T; CE81T; 81-T; 81T
DR   BCRC; 60166
DR   Wikidata; Q54809112
RX   PubMed=6583441;
RX   PubMed=12432233;
RX   PubMed=15885884;
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~72 hours (PubMed=6583441).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
ST   Source(s): BCRC=60166
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 11
//
ID   CE81T1
AC   CVCL_Y184
DR   Wikidata; Q54809114
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y011 ! CE81T/VGH
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T1-0
AC   CVCL_Y186
DR   Wikidata; Q54809115
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y184 ! CE81T1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T1-1
AC   CVCL_Y187
DR   Wikidata; Q54809116
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y184 ! CE81T1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T1-2
AC   CVCL_Y188
DR   Wikidata; Q54809117
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y184 ! CE81T1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T1-3
AC   CVCL_Y189
DR   Wikidata; Q54809118
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y184 ! CE81T1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T1-4
AC   CVCL_Y190
DR   Wikidata; Q54809119
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y184 ! CE81T1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T2
AC   CVCL_Y185
DR   Wikidata; Q54809120
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y011 ! CE81T/VGH
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T2-1
AC   CVCL_Y191
DR   Wikidata; Q54809121
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y185 ! CE81T2
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE81T2-4
AC   CVCL_Y192
DR   Wikidata; Q54809123
RX   PubMed=20392990;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y185 ! CE81T2
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 8
//
ID   CE9H9
AC   CVCL_G644
DR   CLO; CLO_0002352
DR   ABCD; ABCD_AE805
DR   ATCC; HB-127
DR   Wikidata; Q54809124
RX   PubMed=6193965;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CeAPA2
AC   CVCL_KR35
SY   APA2; 11B11
DR   DSHB; APA2
DR   Wikidata; Q54809125
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q22601; Caenorhabditis elegans apa-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CEB001
AC   CVCL_VL83
DR   Wikidata; Q93446100
RX   PubMed=22282976;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CEBe012-A-1
AC   CVCL_E3SZ
SY   HLAE0101cl.2A; NOVOe013-A-1
DR   BioSamples; SAMEA115287329
DR   hPSCreg; CEBe012-A-1
CC   Knockout cell: Method=TALEN; HGNC; HGNC:914; B2M.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:7067; CIITA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B296 ! SA121
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CEBe033-A-1
AC   CVCL_QX50
SY   GBA1_hESC_GBA#1-/-_10.18.11; GBA#1-/- hESC
DR   BioSamples; SAMEA104132790
DR   hPSCreg; CEBe033-A-1
DR   Wikidata; Q54809126
RX   PubMed=28925361;
CC   From: Hoffmann-La Roche, Ltd; Basel; Switzerland.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:4177; GBA1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=28925361
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 24,26
ST   Penta D: 9,13
ST   Penta E: 9,14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   CEBe033-A-10
AC   CVCL_C9Z4
SY   SA001_WT_HGPRT_1; ISTEMe034-A-10
DR   BioSamples; SAMEA112966277
DR   hPSCreg; CEBe033-A-10
DR   Wikidata; Q123030884
RX   PubMed=37331109;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Characteristics: Control cell line for the two HPRT1 KO cell lines, CEBe033-A-8 (Cellosaurus=CVCL_C9YW) and CEBe033-A-9 (Cellosaurus=CVCL_C9YX).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CEBe033-A-11
AC   CVCL_C9Z5
SY   SA001_WT_HGPRT_2; ISTEMe034-A-11
DR   BioSamples; SAMEA112966293
DR   hPSCreg; CEBe033-A-11
DR   Wikidata; Q123030885
RX   PubMed=37331109;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Characteristics: Control cell line for the two HPRT1 KO cell lines, CEBe033-A-8 (Cellosaurus=CVCL_C9YW) and CEBe033-A-9 (Cellosaurus=CVCL_C9YX).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CEBe033-A-2
AC   CVCL_C9YY
SY   SA001 Shank3 Hetero1; ISTEMe034-A-2
DR   BioSamples; SAMEA112902661
DR   hPSCreg; CEBe033-A-2
DR   Wikidata; Q123030886
RX   PubMed=37769384;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEBe033-A-3
AC   CVCL_C9YZ
SY   SA001 Shank3 Hetero2; ISTEMe034-A-3
DR   BioSamples; SAMEA112903631
DR   hPSCreg; CEBe033-A-3
DR   Wikidata; Q123030887
RX   PubMed=37769384;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEBe033-A-4
AC   CVCL_C9Z0
SY   SA001 Shank3 Hetero3; ISTEMe034-A-4
DR   BioSamples; SAMEA112910961
DR   hPSCreg; CEBe033-A-4
DR   Wikidata; Q123030888
RX   PubMed=37769384;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEBe033-A-5
AC   CVCL_C9Z1
SY   SA001 Shank3 Homo1; ISTEMe034-A-5
DR   BioSamples; SAMEA112927564
DR   hPSCreg; CEBe033-A-5
DR   Wikidata; Q123030889
RX   PubMed=37769384;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEBe033-A-6
AC   CVCL_C9Z2
SY   SA001 Shank3 Homo2; ISTEMe034-A-6
DR   BioSamples; SAMEA112937299
DR   hPSCreg; CEBe033-A-6
DR   Wikidata; Q123030891
RX   PubMed=37769384;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEBe033-A-7
AC   CVCL_C9Z3
SY   SA001 Shank3 Homo3; ISTEMe034-A-7
DR   BioSamples; SAMEA112938464
DR   hPSCreg; CEBe033-A-7
DR   Wikidata; Q123030892
RX   PubMed=37769384;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEBe033-A-8
AC   CVCL_C9YW
SY   SA001_KO_HGPRT_1; ISTEMe034-A-8
DR   BioSamples; SAMEA112964584
DR   hPSCreg; CEBe033-A-8
DR   Wikidata; Q123030893
RX   PubMed=37331109;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5157; HPRT1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEBe033-A-9
AC   CVCL_C9YX
SY   SA001_KO_HGPRT_2; ISTEMe034-A-9
DR   BioSamples; SAMEA112966052
DR   hPSCreg; CEBe033-A-9
DR   Wikidata; Q123030894
RX   PubMed=37331109;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5157; HPRT1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CEC CC 128
AC   CVCL_Z883
SY   CEC-CC-128; CCE/CC128; C. capitata line 128
DR   ICLDB; cec-cc-128
DR   Wikidata; Q54809127
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/S0769-2617(81)80057-3;
RX   PubMed=7280302;
RX   PubMed=19003376;
CC   Group: Insect cell line.
CC   Doubling time: 22 hours (PubMed=7280302).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J.R.C. Ispra.
OX   NCBI_TaxID=7213; ! Ceratitis capitata (Mediterranean fruit fly)
SX   Sex unspecified
AG   Blastokinesis embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   CEC CC 130
AC   CVCL_Z884
SY   CEC-CC-130; C. capitata line 130
DR   ICLDB; cec-cc-130
DR   Wikidata; Q54809128
RX   CelloPub=CLPUB00494;
RX   CelloPub=CLPUB00495;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/S0769-2617(81)80057-3;
RX   PubMed=7280302;
CC   Group: Insect cell line.
CC   Virology: Infected by Drosophila X virus (DXV) (DOI=10.1016/S0769-2617(81)80057-3).
CC   Doubling time: 22 hours (PubMed=7280302).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J.R.C. Ispra.
OX   NCBI_TaxID=7213; ! Ceratitis capitata (Mediterranean fruit fly)
SX   Sex unspecified
AG   Blastokinesis embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   CEC CC 228
AC   CVCL_WK39
SY   CEC-CC-228; C. capitata line 228
DR   ICLDB; cec-cc-228
DR   Wikidata; Q93446113
RX   DOI=10.1016/S0769-2617(81)80057-3;
CC   Group: Insect cell line.
CC   Virology: Infected by Drosophila X virus (DXV) (DOI=10.1016/S0769-2617(81)80057-3).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J.R.C. Ispra.
OX   NCBI_TaxID=7213; ! Ceratitis capitata (Mediterranean fruit fly)
SX   Sex unspecified
AG   Blastokinesis embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   CEC-32
AC   CVCL_D160
SY   SPCC-CEC32
DR   BCRJ; 0064
DR   CCLV; CCLV-RIE 0155
DR   Wikidata; Q54809129
RX   PubMed=6293961;
RX   PubMed=10954914;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of chicken origin but found to be from quail (PubMed=10954914).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 13
//
ID   CEC-32/chMx-Luc
AC   CVCL_D5YC
DR   Wikidata; Q127380429
RX   PubMed=7518167;
RX   PubMed=15035851;
CC   Group: Bird cell line.
CC   Problematic cell line: Misidentified. Parent cell line (CEC-32) was originally thought to be of chicken origin but found to be from quail.
CC   Characteristics: Used in a bioassay for the sensitive detection of chicken IFN (ChIFN) (PubMed=15035851).
CC   Characteristics: Expresses luciferase under the control of the IFN-inducible chicken gene Mx promoter (PubMed=7518167).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_D160 ! CEC-32
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   CeCAV1
AC   CVCL_KR36
SY   CAV1; 1F6
DR   DSHB; CAV1
DR   Wikidata; Q54809131
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q94051; Caenorhabditis elegans cav-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeCYP33E1
AC   CVCL_KR37
SY   CYP33E1; 1G3
DR   DSHB; CYP33E1
DR   Wikidata; Q54809132
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q27482; Caenorhabditis elegans cyp-33e1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeDAO5
AC   CVCL_KR38
SY   DAO5; 5E9
DR   DSHB; DAO5
DR   Wikidata; Q54809133
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9XVS4; Caenorhabditis elegans dao-5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeDLG1
AC   CVCL_KR39
SY   DLG1; 5E2
DR   DSHB; DLG1
DR   Wikidata; Q54809134
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; G5ECY0; Caenorhabditis elegans dlg-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeDYN1
AC   CVCL_KR40
SY   DYN1; 5B1
DR   DSHB; DYN1
DR   Wikidata; Q54809135
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P39055; Caenorhabditis elegans dyn-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeERM1
AC   CVCL_KR41
SY   ERM1; 5G2
DR   DSHB; ERM1
DR   Wikidata; Q54809136
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; G5EES2; Caenorhabditis elegans erm-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CEF ST-1
AC   CVCL_JY41
SY   Chicken Embryo Fibroblast + SV40 T Ag + cTERT-nr.1
DR   Wikidata; Q54809137
RX   Patent=US10428316;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transfection; Gene=CGNC; 9953; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CEF ST-2
AC   CVCL_JY42
SY   Chicken Embryo Fibroblast + SV40 T Ag + cTERT-nr.2
DR   Wikidata; Q54809138
RX   Patent=US10428316;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transfection; Gene=CGNC; 9953; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CEGHUi001-A
AC   CVCL_C9Z6
SY   iPSC_CEGH_C2
DR   BioSamples; SAMEA112648671
DR   hPSCreg; CEGHUi001-A
DR   Wikidata; Q123030895
RX   PubMed=37054903;
CC   From: Human Genome and Stem Cell Research Center, University of Sao Paulo; Sao Paulo; Brazil.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CeHCP4
AC   CVCL_KR42
SY   HCP4; 2E2
DR   DSHB; HCP4
DR   Wikidata; Q54809139
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; G5EDA3; Caenorhabditis elegans hcp-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeHMR1
AC   CVCL_KR43
SY   HMR1; 8H10
DR   DSHB; HMR1
DR   Wikidata; Q54809141
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q967F4; Caenorhabditis elegans hmr-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeHSP60
AC   CVCL_KR44
SY   HSP60; 1H12
DR   DSHB; HSP60
DR   Wikidata; Q54809142
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50140; Caenorhabditis elegans hsp-60.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CEIi001-A
AC   CVCL_A5QR
SY   CEP290Ex9-4
DR   hPSCreg; CEIi001-A
DR   Wikidata; Q107114638
RX   PubMed=33626495;
CC   From: Cole Eye Institute, Cleveland Clinic; Cleveland; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29021; CEP290.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5QQ ! Ep-1
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CEINGE clone 3
AC   CVCL_3362
SY   CEINGE CLONE 3; Ceinge clone 3; CEINGE CL3; CEINGE Cl3
DR   CLO; CLO_0002354
DR   CLDB; cl690
DR   CLDB; cl4979
DR   ICLC; ATL99012
DR   Wikidata; Q54809143
RX   PubMed=8264960;
CC   Doubling time: ~24 hours (PubMed=8264960).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   CEL-im
AC   CVCL_T063
SY   Chicken Embryo Liver-immortalized
DR   Wikidata; Q54809144
RX   PubMed=23687157;
CC   Group: Bird cell line.
CC   Virology: Highly susceptible to infection by avian metapneumovirus (AMPV). Weakly susceptible to infection by Marek's disease virus serotype 1 (MDV-1) and infectious laryngotracheitis virus (ILTV).
CC   Doubling time: 21.8-30 hours (PubMed=23687157).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   CeLET413
AC   CVCL_KR45
SY   LET413; 5C12
DR   DSHB; LET413
DR   Wikidata; Q54809145
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O61967; Caenorhabditis elegans let-413.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CellSensor AP1-bla A375
AC   CVCL_KS59
SY   CellSensor AP-1-bla A375; AP1-bla A375; AP-1-bla A375
DR   cancercelllines; CVCL_KS59
DR   Wikidata; Q54809148
WW   Provider; Thermo Fisher; K1660; https://www.thermofisher.com/order/catalog/product/K1660
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under the control of the AP1 response element.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   CellSensor AP1-bla HEK 293T
AC   CVCL_KS65
SY   CellSensor AP-1-bla HEK293T; AP1-bla HEK 293T; AP-1-bla HEK 293T
DR   Wikidata; Q54809149
WW   Provider; Thermo Fisher; K1658; https://www.thermofisher.com/order/catalog/product/K1658
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under the control of the AP1 response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CellSensor AP1-bla ME-180
AC   CVCL_KS60
SY   CellSensor AP-1-bla ME-180; AP1-bla ME-180; AP-1-bla ME-180
DR   cancercelllines; CVCL_KS60
DR   Wikidata; Q54809151
WW   Provider; Thermo Fisher; K1661; https://www.thermofisher.com/order/catalog/product/K1661
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under the control of the AP1 response element.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor ARE-bla Hep G2
AC   CVCL_KS12
SY   ARE-bla Hep G2; ARE-bla HepG2
DR   cancercelllines; CVCL_KS12
DR   Wikidata; Q54809167
WW   Provider; Thermo Fisher; K1633; https://www.thermofisher.com/order/catalog/product/K1633
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the antioxidant response element (ARE).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   CellSensor c-fos-bla HEK 293T
AC   CVCL_KS67
SY   c-fos-bla HEK 293T; c-fos-bla HEK293T
DR   Wikidata; Q54809168
WW   Provider; Thermo Fisher; K1659B; https://www.thermofisher.com/order/catalog/product/K1659B
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the FOS promoter.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CellSensor c-fos-bla ME-180
AC   CVCL_KS68
SY   c-fos-bla ME-180
DR   cancercelllines; CVCL_KS68
DR   Wikidata; Q54809169
WW   Provider; Thermo Fisher; K1650; https://www.thermofisher.com/order/catalog/product/K1650
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the FOS promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   CellSensor C/EBP-bla FreeStyle 293F
AC   CVCL_KS66
SY   C/EBP-bla FreeStyle 293F; C/EBP-bla FreeStyle HEK293F
DR   Wikidata; Q54809170
WW   Provider; Thermo Fisher; K1634; https://www.thermofisher.com/order/catalog/product/K1634
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the C/EBP response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D603 ! FreeStyle 293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CellSensor CRE-bla CHO-K1
AC   CVCL_KR97
SY   CRE-bla CHO-K1
DR   Wikidata; Q54809171
WW   Provider; Thermo Fisher; K1535; https://www.thermofisher.com/order/catalog/product/K1535
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor CRE-bla FreeStyle 293F
AC   CVCL_KS56
SY   CRE-bla FreeStyle 293F; CRE-bla FreeStyle HEK293F
DR   Wikidata; Q54809172
WW   Provider; Thermo Fisher; K1636; https://www.thermofisher.com/order/catalog/product/K1636
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1130.
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1492.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D603 ! FreeStyle 293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CellSensor CRE-bla HEK 293T
AC   CVCL_KS57
SY   CRE-bla HEK 293T; CRE-bla HEK293T
DR   Wikidata; Q54809173
WW   Provider; Thermo Fisher; K1540; https://www.thermofisher.com/order/catalog/product/K1540
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor CRE-bla Jurkat
AC   CVCL_KS58
SY   CRE-bla Jurkat
DR   cancercelllines; CVCL_KS58
DR   Wikidata; Q54809174
WW   Provider; Thermo Fisher; K1635; https://www.thermofisher.com/order/catalog/product/K1635
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   CellSensor CYP1A1-bla LS-180
AC   CVCL_KS51
SY   CYP1A1-bla LS-180
DR   cancercelllines; CVCL_KS51
DR   Wikidata; Q54809176
WW   Provider; Thermo Fisher; K1678; https://www.thermofisher.com/order/catalog/product/K1678
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CYP1A1 promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor DBE-bla MDA-MB-468
AC   CVCL_KS13
SY   DBE-bla MDA-MB-468
DR   cancercelllines; CVCL_KS13
DR   Wikidata; Q54809177
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of a FOXO-responsive DBE response element (DBE).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1814.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 20
//
ID   CellSensor dhfr(E2F)-bla NIH3T3
AC   CVCL_KS69
SY   CellSensor DHFR/E2F-bla NIH3T3; dhfr(E2F)-bla NIH3T3
DR   Wikidata; Q54809178
WW   Provider; Thermo Fisher; K1639B; https://www.thermofisher.com/order/catalog/product/K1639B
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the E2F/DP1 binding sequence from the DHFR gene promoter.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor ESRE-bla HeLa
AC   CVCL_KS05
SY   ESRE-bla HeLa
DR   Wikidata; Q54809179
WW   Provider; Thermo Fisher; K1817; https://www.thermofisher.com/order/catalog/product/K1817
CC   Population: African American.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of ER stress response element (ESRE).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor GAS-bla ME-180
AC   CVCL_KS52
SY   GAS-bla ME-180
DR   cancercelllines; CVCL_KS52
DR   Wikidata; Q54809180
WW   Provider; Thermo Fisher; K1651B; https://www.thermofisher.com/order/catalog/product/K1651B
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the gamma activated sequence (GAS) response element.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor Gli-bla 22Rv1
AC   CVCL_KS53
SY   CellSensor Gli-bla 22Rv.1; Gli-bla 22Rv1; Gli-bla 22Rv.1
DR   cancercelllines; CVCL_KS53
DR   Wikidata; Q54809181
WW   Provider; Thermo Fisher; K1838; https://www.thermofisher.com/order/catalog/product/K1838
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the Gli response element.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor Gli-bla NIH3T3
AC   CVCL_KS54
SY   Gli-bla NIH3T3
DR   Wikidata; Q54809182
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the Gli response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1642B.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CellSensor HRE-bla HCT-116
AC   CVCL_KS06
SY   HRE-bla HCT-116; HRE-bla HCT116
DR   cancercelllines; CVCL_KS06
DR   Wikidata; Q54809183
WW   Provider; Thermo Fisher; K1643; https://www.thermofisher.com/order/catalog/product/K1643
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the hypoxia response element (HRE).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor HRE-bla ME-180
AC   CVCL_KS07
SY   HRE-bla ME-180
DR   cancercelllines; CVCL_KS07
DR   Wikidata; Q54809184
WW   Provider; Thermo Fisher; K1644; https://www.thermofisher.com/order/catalog/product/K1644
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the hypoxia response element (HRE).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor HSE-bla HeLa
AC   CVCL_KS08
SY   HSE-bla HeLa
DR   Wikidata; Q54809186
WW   Provider; Thermo Fisher; K1813; https://www.thermofisher.com/order/catalog/product/K1813
CC   Population: African American.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of a heat shock element (HSE).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor IL-1-bla ECV304
AC   CVCL_KS70
SY   IL-1-bla ECV304
DR   cancercelllines; CVCL_KS70
DR   Wikidata; Q54809187
WW   Provider; Thermo Fisher; K1645; https://www.thermofisher.com/order/catalog/product/K1645
CC   Problematic cell line: Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene which has been randomly integrated in the genome of ECV-304 and which has been selected for IL1-responsiveness.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2029 ! ECV-304
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor irf1-bla Ba/F3
AC   CVCL_KS73
SY   irf1-bla Ba/F3
DR   Wikidata; Q54809188
WW   Provider; Thermo Fisher; K1654; https://www.thermofisher.com/order/catalog/product/K1654
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the irf-1 response element.
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CellSensor irf1-bla CTLL-2
AC   CVCL_KS71
SY   irf1-bla CTLL-2
DR   Wikidata; Q54809189
WW   Provider; Thermo Fisher; K1653; https://www.thermofisher.com/order/catalog/product/K1653
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the irf-1 response element.
CC   Characteristics: IL2 dependent.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0227 ! CTLL-2
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   CellSensor irf1-bla HEL
AC   CVCL_KS72
SY   irf1-bla HEL; IRF1-BLA HEL
DR   cancercelllines; CVCL_KS72
DR   Wikidata; Q54809190
WW   Provider; Thermo Fisher; K1647; https://www.thermofisher.com/order/catalog/product/K1647
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the irf-1 response element.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0001 ! HEL
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor irf1-bla TF1
AC   CVCL_KS74
SY   irf1-bla TF1; irf1-bla TF-1
DR   cancercelllines; CVCL_KS74
DR   Wikidata; Q54809191
WW   Provider; Thermo Fisher; K1657; https://www.thermofisher.com/order/catalog/product/K1657
CC   Population: Japanese.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the irf-1 response element.
CC   Characteristics: IL3 or CSF2 dependent.
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   CellSensor ISRE-bla HEK 293T
AC   CVCL_KS62
SY   ISRE-bla HEK 293T; ISRE-bla HEK293T
DR   Wikidata; Q54809192
WW   Provider; Thermo Fisher; K1655; https://www.thermofisher.com/order/catalog/product/K1655
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the interferon-stimulated response element (ISRE).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor ISRE-bla Jurkat
AC   CVCL_KS63
SY   ISRE-bla Jurkat
DR   cancercelllines; CVCL_KS63
DR   Wikidata; Q54809193
WW   Provider; Thermo Fisher; K1656; https://www.thermofisher.com/order/catalog/product/K1656
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the interferon-stimulated response element (ISRE).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   CellSensor ISRE-bla RA-1
AC   CVCL_KS64
SY   ISRE-bla RA-1; ISRE-bla RA1
DR   Wikidata; Q54809195
WW   Provider; Thermo Fisher; K1674; https://www.thermofisher.com/order/catalog/product/K1674
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the interferon-stimulated response element (ISRE).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor LEF/TCF-bla FreeStyle 293F
AC   CVCL_KS02
SY   LEF/TCF-bla FreeStyle 293F; LEF/TCF-bla FreeStyle HEK293F
DR   Wikidata; Q54809197
WW   Provider; Thermo Fisher; K1677; https://www.thermofisher.com/order/catalog/product/K1677
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of beta-catenin/LEF/TCF binding elements.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D603 ! FreeStyle 293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CellSensor LEF/TCF-bla HCT-116
AC   CVCL_KS04
SY   LEF/TCF-bla HCT-116
DR   cancercelllines; CVCL_KS04
DR   Wikidata; Q54809198
WW   Provider; Thermo Fisher; K1676; https://www.thermofisher.com/order/catalog/product/K1676
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of beta-catenin/LEF/TCF binding elements.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor LEF/TCF-bla SW480
AC   CVCL_KS03
SY   LEF/TCF-bla SW480; LEF/TCF-bla SW 480
DR   cancercelllines; CVCL_KS03
DR   Wikidata; Q54809199
WW   Provider; Thermo Fisher; K1675; https://www.thermofisher.com/order/catalog/product/K1675
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of beta-catenin/LEF/TCF binding elements.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   CellSensor MMTV-bla HeLa
AC   CVCL_KS75
SY   MMTV-bla HeLa
DR   Wikidata; Q54809200
CC   Population: African American.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the MMTV response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1279.
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1641B.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor Myc-bla HCT-116
AC   CVCL_KS14
SY   Myc-bla HCT-116; Myc-bla HCT116
DR   cancercelllines; CVCL_KS14
DR   Wikidata; Q54809201
WW   Provider; Thermo Fisher; K1467; https://www.thermofisher.com/order/catalog/product/K1467
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of Myc binding sequences.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor NFAT-bla CHO-K1
AC   CVCL_KB29
SY   NFAT-bla CHO-K1
DR   Wikidata; Q54809202
WW   Provider; Thermo Fisher; K1534; https://www.thermofisher.com/order/catalog/product/K1534
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   CellSensor NFAT-bla Freestyle 293F
AC   CVCL_XA24
SY   CellSensor NFAT-bla Freestyle HEK 293F
DR   Wikidata; Q93446320
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D603 ! FreeStyle 293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   CellSensor NFAT-bla HEK 293T
AC   CVCL_KB26
SY   NFAT-bla HEK 293T; NFAT bla HEK 293T; NFAT bla HEK293T
DR   Wikidata; Q54809203
WW   Provider; Thermo Fisher; K1538; https://www.thermofisher.com/order/catalog/product/K1538
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor NFAT-bla Jurkat
AC   CVCL_KB42
SY   NFAT-bla Jurkat
DR   cancercelllines; CVCL_KB42
DR   Wikidata; Q54809205
WW   Provider; Thermo Fisher; K1671B; https://www.thermofisher.com/order/catalog/product/K1671B
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   CellSensor NFAT-bla RA-1
AC   CVCL_KS46
SY   NFAT-bla RA-1
DR   Wikidata; Q54809206
WW   Provider; Thermo Fisher; K1490; https://www.thermofisher.com/order/catalog/product/K1490
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor NFkB-bla Freestyle 293F
AC   CVCL_KB48
SY   NFkB-bla Freestyle 293F; NFkB-bla Freestyle HEK293F
DR   Wikidata; Q54809207
WW   Provider; Thermo Fisher; K1663; https://www.thermofisher.com/order/catalog/product/K1663
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D603 ! FreeStyle 293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor NFkB-bla HEK 293T
AC   CVCL_KS61
SY   NFkB-bla HEK 293T; NFkB-bla HEK293T
DR   Wikidata; Q54809208
WW   Provider; Thermo Fisher; K1664; https://www.thermofisher.com/order/catalog/product/K1664
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CellSensor NFkB-bla Jurkat
AC   CVCL_KB43
SY   NFkB-bla Jurkat
DR   cancercelllines; CVCL_KB43
DR   Wikidata; Q54809209
WW   Provider; Thermo Fisher; K1666; https://www.thermofisher.com/order/catalog/product/K1666
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NF-kappaB response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   CellSensor NFkB-bla ME-180
AC   CVCL_KB44
SY   NFkB-bla ME-180
DR   cancercelllines; CVCL_KB44
DR   Wikidata; Q54809210
WW   Provider; Thermo Fisher; K1667; https://www.thermofisher.com/order/catalog/product/K1667
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NF-kappaB response element.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   CellSensor NFkB-bla RA-1
AC   CVCL_KB47
SY   NFkB-bla RA-1
DR   Wikidata; Q54809211
WW   Provider; Thermo Fisher; K1665; https://www.thermofisher.com/order/catalog/product/K1665
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NF-kappaB response element.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   CellSensor NFkB-bla RAW 264.7
AC   CVCL_KB45
SY   NFkB-bla RAW 264.7
DR   Wikidata; Q54809226
WW   Provider; Thermo Fisher; K1673; https://www.thermofisher.com/order/catalog/product/K1673
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor NFkB-bla THP-1
AC   CVCL_KB46
SY   NFkB-bla THP-1
DR   cancercelllines; CVCL_KB46
DR   Wikidata; Q54809227
WW   Provider; Thermo Fisher; K1662; https://www.thermofisher.com/order/catalog/product/K1662
CC   Population: Japanese.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NF-kappaB response element.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor p53RE-bla HCT-116
AC   CVCL_KS15
SY   p53RE-bla HCT-116
DR   cancercelllines; CVCL_KS15
DR   Wikidata; Q54809229
WW   Provider; Thermo Fisher; K1640; https://www.thermofisher.com/order/catalog/product/K1640
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the p53 response element (p53RE).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor SBE-bla A375
AC   CVCL_KS16
SY   SBE-bla A375
DR   cancercelllines; CVCL_KS16
DR   Wikidata; Q54809230
WW   Provider; Thermo Fisher; K1514; https://www.thermofisher.com/order/catalog/product/K1514
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of a Smad binding element (SBE).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   CellSensor SBE-bla HEK 293T
AC   CVCL_KS17
SY   SBE-bla HEK 293T; SBE-bla HEK293T
DR   Wikidata; Q54809231
WW   Provider; Thermo Fisher; K1550; https://www.thermofisher.com/order/catalog/product/K1550
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of a Smad binding element (SBE).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor SIE-bla HEK 293T
AC   CVCL_KS27
SY   SIE-bla HEK 293T; SIE-bla HEK293T
DR   Wikidata; Q54809232
WW   Provider; Thermo Fisher; K1649B; https://www.thermofisher.com/order/catalog/product/K1649B
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under the control of the Sis inducible element (SIE).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor SIE-bla ME-180
AC   CVCL_KS28
SY   SIE-bla ME-180
DR   cancercelllines; CVCL_KS28
DR   Wikidata; Q54809233
WW   Provider; Thermo Fisher; K1648; https://www.thermofisher.com/order/catalog/product/K1648
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under the control of the Sis inducible element (SIE).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor SIE-bla THP-1
AC   CVCL_KS29
SY   SIE-bla THP-1
DR   cancercelllines; CVCL_KS29
DR   Wikidata; Q54809234
WW   Provider; Thermo Fisher; K1652B; https://www.thermofisher.com/order/catalog/product/K1652B
CC   Population: Japanese.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under the control of the Sis inducible element (SIE).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor STAT6-bla RA-1
AC   CVCL_KS55
SY   STAT6-bla RA-1
DR   Wikidata; Q54809235
WW   Provider; Thermo Fisher; K1646; https://www.thermofisher.com/order/catalog/product/K1646
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the STAT6 response element.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor T-REx FOXO3-DBE-bla HeLa
AC   CVCL_KS77
SY   T-REx FOXO3-DBE-bla HeLa; TREx FOXO3-DBE-bla HeLa
DR   Wikidata; Q54809237
WW   Provider; Thermo Fisher; K1468; https://www.thermofisher.com/order/catalog/product/K1468
CC   Population: African American.
CC   Characteristics: Transfected with a FOXO3 response element driving beta-lactamase reporter gene expression (DBE-bla) along with tetracycline repressor and tetracycline/doxycycline-inducible FOXO3 constructs.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor T-REx NICD-CSL-bla HeLa
AC   CVCL_KS76
SY   T-REx NICD-CSL-bla HeLa
DR   Wikidata; Q54809239
WW   Provider; Thermo Fisher; K1487; https://www.thermofisher.com/order/catalog/product/K1487
CC   Population: African American.
CC   Characteristics: Transfected with a Notch response element driving beta-lactamase reporter gene expression (CSL-bla) along with tetracycline repressor and tetracycline/doxycycline-inducible NICD (notch intracellular domain) constructs. This cell line is a clonal population isolated by flow cytometry.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor TNFalpha-bla THP-1
AC   CVCL_KS30
SY   TNFalpha-bla THP-1
DR   cancercelllines; CVCL_KS30
DR   Wikidata; Q54809240
WW   Provider; Thermo Fisher; K1672B; https://www.thermofisher.com/order/catalog/product/K1672B
CC   Population: Japanese.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene which has been randomly integrated in the genome of THP-1 and which has been selected for TNFalpha-responsiveness.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   CellSensor TrkA-NFAT-bla CHO-K1
AC   CVCL_KB39
SY   TrkA-NFAT-bla CHO-K1
DR   Wikidata; Q54809241
RX   PubMed=20161825;
WW   Provider; Thermo Fisher; K1516; https://www.thermofisher.com/order/catalog/product/K1516
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8031; NTRK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor TrkB-NFAT-bla CHO-K1
AC   CVCL_KB40
SY   TrkB-NFAT-bla CHO-K1
DR   Wikidata; Q54809242
RX   PubMed=20161825;
WW   Provider; Thermo Fisher; K1491; https://www.thermofisher.com/order/catalog/product/K1491
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8032; NTRK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CellSensor TrkC-NFAT-bla CHO-K1
AC   CVCL_KB41
SY   TrkC-NFAT-bla CHO-K1
DR   Wikidata; Q54809243
RX   PubMed=20161825;
WW   Provider; Thermo Fisher; K1515; https://www.thermofisher.com/order/catalog/product/K1515
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8033; NTRK3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CeLMN1
AC   CVCL_KR46
SY   LMN1; 2G1
DR   DSHB; LMN1
DR   Wikidata; Q54809146
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q21443; Caenorhabditis elegans lmn-1.
CC   Caution: Indicated as producing an IgG1 mAb in PubMed=20405020 and an IgM mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeLMP1
AC   CVCL_KR47
SY   LMP1; 2E2
DR   DSHB; LMP1
DR   Wikidata; Q54809147
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q11117; Caenorhabditis elegans lmp-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CEM A2.01
AC   CVCL_X698
DR   BEI_Resources; ARP-2059
DR   cancercelllines; CVCL_X698
DR   Wikidata; Q54606417
CC   Population: Caucasian.
CC   Virology: Not susceptible to infection by HIV-1 (BEI_Resources=ARP-2059).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6244 ! CEM A3.01
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   CEM A3.01
AC   CVCL_6244
SY   A3.01
DR   BEI_Resources; ARP-166
DR   cancercelllines; CVCL_6244
DR   Lonza; 362
DR   Wikidata; Q54606728
RX   PubMed=2989831;
RX   PubMed=24312168;
CC   Population: Caucasian.
CC   Characteristics: CD4+/CXCR4+.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   CEM 2cl
AC   CVCL_Y484
DR   Wikidata; Q54809244
RX   PubMed=12747969;
RX   PubMed=14720195;
DI   NCIt; C35701; Salivary gland epithelial-myoepithelial carcinoma
DI   ORDO; Orphanet_276145; Malignant epithelial tumor of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   CEM cl13
AC   CVCL_V186
SY   CEM-CL13; CEM clone 13; CEM-C113; CEM-c113; CEM c113
DR   cancercelllines; CVCL_V186
DR   ChEMBL-Cells; CHEMBL3307394
DR   ChEMBL-Targets; CHEMBL614545
DR   PubChem_Cell_line; CVCL_V186
DR   Wikidata; Q54809246
RX   PubMed=2464361;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   CEM-AGR
AC   CVCL_J396
SY   CEM-AGR.RTM
DR   cancercelllines; CVCL_J396
DR   Wikidata; Q54809247
RX   Patent=US4544632;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8081.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 24
//
ID   CEM-CL10
AC   CVCL_X635
SY   CEM-CL 10; CEM-A
DR   BEI_Resources; ARP-588
DR   cancercelllines; CVCL_X635
DR   Wikidata; Q54809248
RX   PubMed=2570823;
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (BEI_Resources=ARP-588).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 20
//
ID   CEM-CM3
AC   CVCL_3930
SY   CCRF-CEM C3; CEM-C3; CEM/C3; CEMC3
DR   CLO; CLO_0002357
DR   CLDB; cl692
DR   ATCC; TIB-195
DR   BioSample; SAMN03471943
DR   cancercelllines; CVCL_3930
DR   Cosmic; 683536
DR   KCLB; 40195
DR   Wikidata; Q54809249
RX   PubMed=12068308;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=TIB-195; KCLB=40195
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 13,18
ST   D19S433: 13,15
ST   D21S11: 30,33.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 28
//
ID   CEM-GFP
AC   CVCL_1G53
DR   BEI_Resources; ARP-3655
DR   cancercelllines; CVCL_1G53
DR   Wikidata; Q54809250
RX   PubMed=9114046;
CC   Population: Caucasian.
CC   Virology: HIV-1 infection reporter cell line, the gene for GFP is under the control of a HIV-1 long terminal repeat.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 21
//
ID   CEM-GXR25
AC   CVCL_C8ZB
SY   GXR; CEM-GFP, CXCR4, CCR5, clone 25
DR   Wikidata; Q123030896
RX   PubMed=16182382;
CC   Population: Caucasian.
CC   Virology: HIV-1 infection reporter cell line, the gene for GFP is under the control of a HIV-1 long terminal repeat. Thansk to the increased expression of CCR5 can be used for both CXCR4-tropic and CCR5-tropic HIV-1 strains (PubMed=16182382).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1G53 ! CEM-GFP
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   CEM-LAV-2
AC   CVCL_3931
SY   CEM/LAV-2
DR   CLO; CLO_0002358
DR   cancercelllines; CVCL_3931
DR   Wikidata; Q54809251
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   CEM-ON
AC   CVCL_J395
SY   AGR-ON
DR   CLO; CLO_0009832
DR   ATCC; CRL-8199
DR   BioSample; SAMN03471198
DR   cancercelllines; CVCL_J395
DR   Cell_Model_Passport; SIDM01249
DR   LINCS_LDP; LCL-1033
DR   Wikidata; Q54809252
RX   Patent=US4675291;
RX   PubMed=3259875;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8199.
CC   Population: Caucasian.
CC   Characteristics: Constitutively secretes CSF1 (PubMed=3259875).
CC   Characteristics: Can be used as a fusion partner for constructing T-cell hybridomas (ATCC=CRL-8199).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-8199; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8199
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J396 ! CEM-AGR
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 29
//
ID   CEM-R6
AC   CVCL_HF38
DR   cancercelllines; CVCL_HF38
DR   Wikidata; Q54809253
RX   PubMed=7812967;
CC   Population: Caucasian.
CC   Characteristics: Glucocorticoids resistant.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Leu753Phe (c.2259A>T); ClinVar=VCV000016149; Zygosity=Heterozygous (PubMed=7812967).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Unexplicit; A>G mutation in the 3'-splice junction of intron G; Zygosity=Heterozygous (PubMed=7812967).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 18
//
ID   CEM-SS
AC   CVCL_J318
SY   CEM-ss; CEM SS; CEM_SS; CEMss; CEM-Syncitial Sensitive
DR   BEI_Resources; ARP-776
DR   cancercelllines; CVCL_J318
DR   ChEMBL-Cells; CHEMBL3307644
DR   ChEMBL-Targets; CHEMBL614548
DR   Cosmic; 1247869
DR   PubChem_Cell_line; CVCL_J318
DR   TOKU-E; 4084
DR   Wikidata; Q54809255
RX   PubMed=3481271;
RX   PubMed=25253335;
WW   Provider; NIBSC; 0048; http://www.nibsc.org/Default.aspx?pageid=597&id=0048&theme=default
CC   Population: Caucasian.
CC   Virology: Used for a quantitative syncytium-forming assay for the detection of human immunodeficiency virus-1 and -2 isolates.
CC   Doubling time: ~1-2 days (BEI_Resources=ARP-776).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 27
//
ID   CEM-T4
AC   CVCL_8178
SY   CEM T4; CemT4; CEMT4; CEM CD4+
DR   BEI_Resources; ARP-117
DR   cancercelllines; CVCL_8178
DR   Wikidata; Q54809256
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   CEM-TART
AC   CVCL_X697
SY   CEM/TART; CEMTART
DR   BEI_Resources; ARP-1944
DR   cancercelllines; CVCL_X697
DR   Wikidata; Q54809257
RX   PubMed=1502183;
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (BEI_Resources=ARP-1944).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 20
//
ID   CEM-TART clone 1A2
AC   CVCL_0R18
SY   Clone 1A2
DR   BEI_Resources; ARP-2884
DR   cancercelllines; CVCL_0R18
DR   Wikidata; Q54809258
RX   PubMed=1502183;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X697 ! CEM-TART
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   CEM-VBL16
AC   CVCL_D598
DR   BTO; BTO_0005154
DR   cancercelllines; CVCL_D598
DR   Wikidata; Q54809259
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   CEM-VCR R
AC   CVCL_3933
SY   CEM/VCR R
DR   BTO; BTO_0002143
DR   cancercelllines; CVCL_3933
DR   Wikidata; Q54809260
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   CEM-VLB
AC   CVCL_4V08
DR   cancercelllines; CVCL_4V08
DR   ChEMBL-Cells; CHEMBL3307645
DR   ChEMBL-Targets; CHEMBL614554
DR   PubChem_Cell_line; CVCL_4V08
DR   Wikidata; Q54809261
RX   PubMed=11801309;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   CEM.NKR
AC   CVCL_X622
SY   CEM.NKr; CEM-NKR
DR   BEI_Resources; ARP-458
DR   cancercelllines; CVCL_X622
DR   Wikidata; Q54809262
RX   PubMed=3871222;
CC   Population: Caucasian.
CC   Characteristics: Resistant to NK cell-mediated cell lysis.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 20
//
ID   CEM.NKR-CCR5
AC   CVCL_X623
SY   CEM.NKR CCR5+
DR   CLO; CLO_0037252
DR   BEI_Resources; ARP-4376
DR   cancercelllines; CVCL_X623
DR   Wikidata; Q54809263
RX   PubMed=10516002;
WW   Info; Quora; -; https://www.quora.com/What-are-features-of-the-CEM-NKR-CCR5-cell-line
CC   Population: Caucasian.
CC   Characteristics: Resistant to NK cell-mediated cell lysis (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X622 ! CEM.NKR
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 20
//
ID   CEM.NKR-CCR5-Luc
AC   CVCL_X624
SY   CEM-NKR-CCR5-Luc; CEM-NKr-CCR5-Luc; CEM.NKR CCR5+Luc+; CEM-R5
DR   BEI_Resources; ARP-5198
DR   cancercelllines; CVCL_X624
DR   Wikidata; Q54809265
RX   PubMed=11162843;
CC   Population: Caucasian.
CC   Characteristics: Resistant to NK cell-mediated cell lysis (from parent cell line).
CC   Characteristics: The luciferase reporter gene is under the transcriptional control of the HIV-2 LTR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X623 ! CEM.NKR-CCR5
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 23
//
ID   CEM/A5
AC   CVCL_U260
DR   cancercelllines; CVCL_U260
DR   Wikidata; Q54809266
RX   PubMed=7514153;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   CEM/A7
AC   CVCL_U261
SY   CEM-A7
DR   cancercelllines; CVCL_U261
DR   Wikidata; Q54809267
RX   PubMed=7514153;
RX   PubMed=7903222;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   CEM/ara-C
AC   CVCL_4V21
SY   CCRF-CEM/ara-C
DR   cancercelllines; CVCL_4V21
DR   ChEMBL-Cells; CHEMBL3307392
DR   ChEMBL-Targets; CHEMBL614539
DR   PubChem_Cell_line; CVCL_4V21
DR   Wikidata; Q54809268
RX   PubMed=21290089;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 19
//
ID   CEM/ara-G
AC   CVCL_A5TX
DR   cancercelllines; CVCL_A5TX
DR   Wikidata; Q107114639
RX   PubMed=25070259;
CC   Population: Caucasian.
CC   Doubling time: 21.4 hours (PubMed=25070259).
CC   Selected for resistance to: ChEBI; CHEBI_73141; 9-beta-D-arabinofuranosylguanine (ara-G).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CEM/C1
AC   CVCL_3496
SY   CCRF-CEM C1; CEM-C1; CEM.C1; CEMC1
DR   BTO; BTO_0000225
DR   CLO; CLO_0002355
DR   EFO; EFO_0001667
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2265
DR   BioSample; SAMN03471854
DR   cancercelllines; CVCL_3496
DR   CCRID; 3101HUMTCHu212
DR   Cell_Model_Passport; SIDM01256
DR   CLS; 305103
DR   Cosmic; 724837
DR   IGRhCellID; CEMC1
DR   IZSLER; BS TCL 160
DR   LINCS_LDP; LCL-1034
DR   Lonza; 241
DR   Progenetix; CVCL_3496
DR   Wikidata; Q54809269
RX   PubMed=7579731;
RX   PubMed=8895760;
RX   PubMed=12068308;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Doubling time: ~26 hours (ATCC=CRL-2265).
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2265; IZSLER=BS TCL 160
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,10,12 (ATCC=CRL-2265)
ST   D13S317: 10,12 (IZSLER=BS TCL 160)
ST   D16S539: 10,13
ST   D21S11: 30,33.2,34.2
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   CEM/C2
AC   CVCL_3497
SY   CCRF-CEM C2; CEM-C2; CEMC2
DR   BTO; BTO_0005931
DR   CLO; CLO_0002356
DR   CLDB; cl5178
DR   ATCC; CRL-2264
DR   BioSample; SAMN03471853
DR   cancercelllines; CVCL_3497
DR   Cell_Model_Passport; SIDM01250
DR   ChEMBL-Cells; CHEMBL3307952
DR   ChEMBL-Targets; CHEMBL612406
DR   Cosmic; 683535
DR   IZSLER; BS TCL 153
DR   LINCS_LDP; LCL-1035
DR   PubChem_Cell_line; CVCL_3497
DR   Wikidata; Q54809270
RX   PubMed=7579731;
RX   PubMed=12068308;
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (ATCC=CRL-2264).
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2264; IZSLER=BS TCL 153
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D21S11: 31,34.2
ST   D5S818: 13
ST   D7S820: 8.3,9 (ATCC=CRL-2264)
ST   D7S820: 9 (IZSLER=BS TCL 153)
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 33
//
ID   CEM/DNR
AC   CVCL_S256
SY   CEM-DNR
DR   cancercelllines; CVCL_S256
DR   ChEMBL-Cells; CHEMBL3307396
DR   ChEMBL-Targets; CHEMBL614547
DR   PubChem_Cell_line; CVCL_S256
DR   Wikidata; Q54809271
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   CEM/GN150
AC   CVCL_C3S3
DR   Wikidata; Q116048727
RX   PubMed=7632161;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28088; Genistein.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3S2 ! CEM/GN50
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CEM/GN50
AC   CVCL_C3S2
DR   Wikidata; Q116048728
RX   PubMed=7632161;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28088; Genistein.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CEM/MX1
AC   CVCL_0U11
DR   ATCC; CRL-2259
DR   BioSample; SAMN03471852
DR   cancercelllines; CVCL_0U11
DR   Wikidata; Q54809279
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2259; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2259
ST   Amelogenin: X
ST   CSF1PO: 10,11,13,14
ST   D13S317: 8,11,12
ST   D16S539: 10,11,13
ST   D5S818: 11,12
ST   D7S820: 9,11,12,13
ST   TH01: 6,7,8
ST   TPOX: 8,11
ST   vWA: 16,18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   CEM/P
AC   CVCL_A1BA
DR   cancercelllines; CVCL_A1BA
DR   Wikidata; Q102113657
RX   PubMed=34332580;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_71223; Pralatrexate (Folotyn).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CEM/VBL600
AC   CVCL_C5RY
SY   VBL600
DR   ChEMBL-Cells; CHEMBL3988481
DR   Wikidata; Q116048729
RX   PubMed=10087141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CEM/VLB10
AC   CVCL_D597
SY   CEM-VBL10
DR   BTO; BTO_0005153
DR   cancercelllines; CVCL_D597
DR   Wikidata; Q54809280
RX   PubMed=571759;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   CEM/VLB10-2
AC   CVCL_4V10
SY   CEM/VLB(10-2)
DR   cancercelllines; CVCL_4V10
DR   Wikidata; Q54809281
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D597 ! CEM/VLB10
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CEM/VLB100
AC   CVCL_3932
SY   CEM-VLB100; CEM/VLB 100; CEM/VBL 100; CEM-VBL100
DR   BTO; BTO_0005155
DR   cancercelllines; CVCL_3932
DR   ChEMBL-Cells; CHEMBL3988441
DR   Cosmic; 922676
DR   PubChem_Cell_line; CVCL_3932
DR   Wikidata; Q54809282
RX   PubMed=571759;
RX   PubMed=2888532;
RX   PubMed=3469013;
RX   PubMed=9557624;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Caution: Seems to be interchangeably called VLB100 or VBL100.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 28
//
ID   CEM/VLB500
AC   CVCL_4V12
SY   CEM/VBL500
DR   cancercelllines; CVCL_4V12
DR   Wikidata; Q54809283
RX   PubMed=571759;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Caution: Seems to be interchangeably called VLB500 or VBL500.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   CEM/VLB55
AC   CVCL_4V09
DR   cancercelllines; CVCL_4V09
DR   Wikidata; Q54809284
RX   PubMed=571759;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CEM/VLB55-8
AC   CVCL_4V11
SY   CEM/VLB55 8; CEM/VLB(55-8)
DR   cancercelllines; CVCL_4V11
DR   Wikidata; Q54809285
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V09 ! CEM/VLB55
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   CEM/VM-1
AC   CVCL_1B35
SY   CEM/VM1; CEM-VM1
DR   cancercelllines; CVCL_1B35
DR   ChEMBL-Cells; CHEMBL3307511
DR   ChEMBL-Targets; CHEMBL614030
DR   PubChem_Cell_line; CVCL_1B35
DR   Wikidata; Q54809287
RX   PubMed=2888532;
RX   PubMed=3469013;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   CEM231.6.7
AC   CVCL_B0VB
SY   CEM 231.6.7; 231.6.7; CEM231
DR   Wikidata; Q108820007
RX   Patent=EP0332424A2;
RX   PubMed=3141512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9620.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   CEMO-1
AC   CVCL_9489
DR   Cosmic; 1130243
DR   Wikidata; Q54809288
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8642878;
RX   PubMed=9490669;
CC   Doubling time: 48 hours (PubMed=8642878).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1008; BCL9 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL9 (PubMed=9490669).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   CEMR.3
AC   CVCL_7905
DR   cancercelllines; CVCL_7905
DR   Wikidata; Q54809289
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   CEMss/CCR5
AC   CVCL_WU90
DR   cancercelllines; CVCL_WU90
DR   Wikidata; Q93446628
RX   PubMed=9718374;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J318 ! CEM-SS
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   CEMx174/HIV-2ST
AC   CVCL_X615
SY   CEMx174 HIV-2 ST-Infected
DR   BEI_Resources; ARP-234
DR   Wikidata; Q54809290
CC   Virology: Infected with HIV-2 isolate ST (BEI_Resources=ARP-234).
CC   Doubling time: ~18 hours (BEI_Resources=ARP-234).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7904 ! T1
CA   Hybrid cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   CEMx174/SIVmac316 clone 3D8
AC   CVCL_A0CL
SY   CEMx174 SIV SIVmac316-Infected clone 3D8
DR   BEI_Resources; ARP-13239
DR   Wikidata; Q108820008
CC   Virology: Infected with simian immunodeficiency virus isolate SIVmac316 (BEI_Resources=ARP-13239).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7904 ! T1
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   cen1
AC   CVCL_B5SQ
SY   Cen1
DR   Wikidata; Q111733090
RX   PubMed=10094830;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   cen2
AC   CVCL_B5SN
DR   Wikidata; Q111733091
RX   PubMed=10094830;
RX   PubMed=12927806;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   cen2tel
AC   CVCL_S895
DR   Wikidata; Q54809291
RX   PubMed=12927806;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SN ! cen2
SX   Female
AG   102Y
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   cen3
AC   CVCL_B5SM
SY   Cen3
DR   Wikidata; Q111733092
RX   PubMed=10094830;
RX   PubMed=10530795;
RX   PubMed=12927806;
CC   Karyotypic information: Gains an extra copy of chromosome 7, X and 18 during progression towards senescence (PubMed=10530795).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   102Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   cen3tel
AC   CVCL_S896
SY   Cen3tel; Cen3 tel
DR   GEO; GSE15742
DR   Wikidata; Q54809292
RX   PubMed=12927806;
RX   PubMed=16357149;
RX   PubMed=21209796;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SM ! cen3
SX   Female
AG   102Y
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   cen4
AC   CVCL_B5SP
SY   Cen4
DR   Wikidata; Q111733093
RX   PubMed=10094830;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   103Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   cEND
AC   CVCL_E7H9
DR   ABM; T0290
RX   PubMed=22951995;
CC   Characteristics: Provides a useful model for studies involving the differentiation and regulation of blood brain barrier as it shares principal features of the BBB in vivo (ABM=T0290).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3-5D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CENSOi001-A
AC   CVCL_VT12
SY   FB78c13
DR   hPSCreg; CENSOi001-A
DR   Wikidata; Q93446652
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (from autologous cell line CENSOi001-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE86 ! CENSOi001-B
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   CENSOi001-B
AC   CVCL_LE86
SY   FB78R2c2; CENSOi249
DR   BioSamples; SAMEA104133950
DR   EBiSC; CENSOi001-B
DR   ECACC; 66540599
DR   hPSCreg; CENSOi001-B
DR   Wikidata; Q54809293
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (EBiSC=CENSOi001-B).
CC   Discontinued: ECACC; 66540599; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT12 ! CENSOi001-A
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 14
//
ID   CENSOi002-A
AC   CVCL_VT13
SY   FB74c7
DR   hPSCreg; CENSOi002-a
DR   Wikidata; Q93446662
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gln3231Ter (c.9691C>T); ClinVar=VCV000523784; Zygosity=Hemizygous (from autologous cell line CENSOi002-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE87 ! CENSOi002-B
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   CENSOi002-B
AC   CVCL_LE87
SY   FB74R2c4; CENSOi261
DR   BioSamples; SAMEA104133811
DR   EBiSC; CENSOi002-B
DR   ECACC; 66540597
DR   hPSCreg; CENSOi002-B
DR   Wikidata; Q54809294
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gln3231Ter (c.9691C>T); ClinVar=VCV000523784; Zygosity=Hemizygous (EBiSC=CENSOi002-B).
CC   Discontinued: ECACC; 66540597; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT13 ! CENSOi002-A
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 14
//
ID   CENSOi003-A
AC   CVCL_VC64
SY   FB79c6
DR   BioSamples; SAMEA104010849
DR   EBiSC; CENSOi003-A
DR   ECACC; 66540571
DR   hPSCreg; CENSOi003-A
DR   Wikidata; Q54809296
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex46-52del; Zygosity=Hemizygous (from autologous cell line CENSOi003-B).
CC   Discontinued: EBiSC; CENSOi003-A; true.
CC   Discontinued: ECACC; 66540571; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE88 ! CENSOi003-B
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   CENSOi003-B
AC   CVCL_LE88
SY   FB79R2c6; CENSOi258
DR   BioSamples; SAMEA104133810
DR   EBiSC; CENSOi003-B
DR   ECACC; 66540600
DR   hPSCreg; CENSOi003-B
DR   Wikidata; Q54809297
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex46-52del; Zygosity=Hemizygous (EBiSC=CENSOi003-B).
CC   Discontinued: ECACC; 66540600; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC64 ! CENSOi003-A
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   CENSOi004-D
AC   CVCL_VC65
SY   F191c2
DR   BioSamples; SAMEA1087268
DR   hPSCreg; CENSOi004-D
DR   Wikidata; Q54809298
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4FV ! CENSOi004-E
SX   Male
AG   40-50Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   CENSOi004-E
AC   CVCL_E4FV
DR   hPSCreg; CENSOi004-E
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/control/control-censoi004-e/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC65 ! CENSOi004-D
SX   Male
AG   40-50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi005-A
AC   CVCL_LE89
SY   FB76R2c5; CENSOi245
DR   BioSamples; SAMEA104133812
DR   EBiSC; CENSOi005-A
DR   ECACC; 66540601
DR   hPSCreg; CENSOi005-A
DR   Wikidata; Q54809299
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-41dup; Zygosity=Hemizygous (EBiSC=CENSOi005-A).
CC   Discontinued: ECACC; 66540601; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   CENSOi007-A
AC   CVCL_LE90
SY   FB75R2c5; CENSOi255
DR   BioSamples; SAMEA104133814
DR   EBiSC; CENSOi007-A
DR   ECACC; 66540602
DR   hPSCreg; CENSOi007-A
DR   Wikidata; Q54809300
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex52del; Zygosity=Hemizygous (EBiSC=CENSOi007-A).
CC   Discontinued: ECACC; 66540602; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   CENSOi008-A
AC   CVCL_LE91
SY   FB77R2c3; CENSOi260
DR   BioSamples; SAMEA104133816
DR   EBiSC; CENSOi008-A
DR   ECACC; 66540603
DR   hPSCreg; CENSOi008-A
DR   Wikidata; Q54809301
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Discontinued: ECACC; 66540603; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CENSOi010-A
AC   CVCL_LE92
DR   BioSamples; SAMEA104387510
DR   hPSCreg; CENSOi010-A
DR   Wikidata; Q54809302
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Miscellaneous: Cell line has been discarded (hPSCreg=CENSOi010-A).
CC   Discontinued: hPSCreg; CENSOi010-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   CENSOi011-A
AC   CVCL_E3T0
SY   hFB143c5; Censoi231
DR   hPSCreg; CENSOi011-A
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[39] (c.52CAG(39)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line CENSOi011-D).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VC66 ! CENSOi011-B
OI   CVCL_E4FQ ! CENSOi011-D
SX   Female
AG   40-50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi011-B
AC   CVCL_VC66
SY   F192c5
DR   BioSamples; SAMEA994015
DR   hPSCreg; CENSOi011-B
DR   Wikidata; Q54809303
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[39] (c.52CAG(39)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line CENSOi011-D).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3T0 ! CENSOi011-A
OI   CVCL_E4FQ ! CENSOi011-D
SX   Female
AG   40-50Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   CENSOi011-D
AC   CVCL_E4FQ
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/huntingtons-disease/huntingtons-disease-censoi011-d/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[39] (c.52CAG(39)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3T0 ! CENSOi011-A
OI   CVCL_VC66 ! CENSOi011-B
SX   Female
AG   40-50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi012-A
AC   CVCL_WP13
SY   B224c2
DR   hPSCreg; CENSOi012-A
DR   Wikidata; Q93446695
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP14 ! CENSOi012-B
OI   CVCL_WP15 ! CENSOi012-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi012-B
AC   CVCL_WP14
SY   B224c3
DR   hPSCreg; CENSOi012-B
DR   Wikidata; Q93446696
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP13 ! CENSOi012-A
OI   CVCL_WP15 ! CENSOi012-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi012-C
AC   CVCL_WP15
SY   B224c5
DR   hPSCreg; CENSOi012-C
DR   Wikidata; Q93446697
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP13 ! CENSOi012-A
OI   CVCL_WP14 ! CENSOi012-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi013-A
AC   CVCL_VC67
SY   F186c2
DR   BioSamples; SAMEA994024
DR   hPSCreg; CENSOi013-A
DR   Wikidata; Q54809304
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   CENSOi014-A
AC   CVCL_VC68
SY   F187c10
DR   BioSamples; SAMEA994022
DR   hPSCreg; CENSOi014-A
DR   Wikidata; Q54809306
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   CENSOi015-A
AC   CVCL_VC69
SY   F188c10
DR   BioSamples; SAMEA994020
DR   hPSCreg; CENSOi015-A
DR   Wikidata; Q54809307
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   CENSOi016-A
AC   CVCL_VC70
SY   F189c9
DR   BioSamples; SAMEA994018
DR   hPSCreg; CENSOi016-A
DR   Wikidata; Q54809308
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   CENSOi017-A
AC   CVCL_VC71
SY   F190c12b
DR   BioSamples; SAMEA994016
DR   hPSCreg; CENSOi017-A
DR   Wikidata; Q54809309
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/huntingtons-disease/huntingtons-disease-censoi017-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[~42] (c.52CAG(~42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   CENSOi018-A
AC   CVCL_WP16
SY   F197c3
DR   hPSCreg; CENSOi018-A
DR   Wikidata; Q93446709
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-als-censoi018-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Unspecified (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi019-A
AC   CVCL_WP17
SY   B226c5
DR   hPSCreg; CENSOi019-A
DR   Wikidata; Q93446711
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[127] (c.52CAG(127)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line CENSOi019-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4FR ! CENSOi019-B
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi019-B
AC   CVCL_E4FR
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/huntingtons-disease-censoi019-b/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[127] (c.52CAG(127)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP17 ! CENSOi019-A
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi020-A
AC   CVCL_WP18
SY   F215c6
DR   hPSCreg; CENSOi020-A
DR   Wikidata; Q93446712
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/spinocerebellar-ataxia-type-2-sca2-censoi020-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[38] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi021-A
AC   CVCL_WP19
SY   F220c7
DR   hPSCreg; CENSOi021-A
DR   Wikidata; Q93446713
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsonism-machado-joseph-disease-sca3-censoi021-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[69]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi022-A
AC   CVCL_WP20
SY   F221c2
DR   hPSCreg; CENSOi022-A
DR   Wikidata; Q93446717
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsonism-machado-joseph-disease-sca3-censoi022-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[70]; Zygosity=Heterozygous; Note=The other allele has 26 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi023-A
AC   CVCL_WP21
SY   F204c4
DR   hPSCreg; CENSOi023-A
DR   Wikidata; Q93446718
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi023-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Trp90Leufs*12 (c.268_283del); ClinVar=VCV003242199; Zygosity=Heterozygous (Axol).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi024-A
AC   CVCL_WP22
SY   F213c1
DR   hPSCreg; CENSOi024-A
DR   Wikidata; Q93446720
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi024-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Trp90Leufs*12 (c.268_283del); ClinVar=VCV003242199; Zygosity=Heterozygous (Axol).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi025-A
AC   CVCL_WP23
SY   F212c9
DR   hPSCreg; CENSOi025-A
DR   Wikidata; Q93446721
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-censoi025-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi026-A
AC   CVCL_WP24
SY   F199c5
DR   hPSCreg; CENSOi026-A
DR   Wikidata; Q93446723
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Arg246Ter (c.736C>T); ClinVar=VCV000002407; Zygosity=Heterozygous (from autologous cell line CENSOi026-C).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4-6 del; Zygosity=Heterozygous (from autologous cell line CENSOi026-C).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP25 ! CENSOi026-B
OI   CVCL_WP26 ! CENSOi026-C
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi026-B
AC   CVCL_WP25
SY   F199c2
DR   hPSCreg; CENSOi026-B
DR   Wikidata; Q93446724
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Arg246Ter (c.736C>T); ClinVar=VCV000002407; Zygosity=Heterozygous (from autologous cell line CENSOi026-C).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4-6 del; Zygosity=Heterozygous (from autologous cell line CENSOi026-C).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP24 ! CENSOi026-A
OI   CVCL_WP26 ! CENSOi026-C
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi026-C
AC   CVCL_WP26
SY   F199c3
DR   hPSCreg; CENSOi026-C
DR   Wikidata; Q93446725
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi026-c/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Arg246Ter (c.736C>T); ClinVar=VCV000002407; Zygosity=Heterozygous (Axol).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4-6 del; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP24 ! CENSOi026-A
OI   CVCL_WP25 ! CENSOi026-B
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi027-A
AC   CVCL_WP27
SY   F233c1
DR   hPSCreg; CENSOi027-A
DR   Wikidata; Q93446727
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (from autologous cell line CENSOi027-D).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP28 ! CENSOi027-B
OI   CVCL_WP29 ! CENSOi027-C
OI   CVCL_WP30 ! CENSOi027-D
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi027-B
AC   CVCL_WP28
SY   F233c7
DR   hPSCreg; CENSOi027-B
DR   Wikidata; Q93446728
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (from autologous cell line CENSOi027-D).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP27 ! CENSOi027-A
OI   CVCL_WP29 ! CENSOi027-C
OI   CVCL_WP30 ! CENSOi027-D
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi027-C
AC   CVCL_WP29
SY   F233 c9
DR   hPSCreg; CENSOi027-C
DR   Wikidata; Q93446730
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (from autologous cell line CENSOi027-D).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP27 ! CENSOi027-A
OI   CVCL_WP28 ! CENSOi027-B
OI   CVCL_WP30 ! CENSOi027-D
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi027-D
AC   CVCL_WP30
SY   F233 c4
DR   hPSCreg; CENSOi027-D
DR   Wikidata; Q93446731
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/amyotrophic-lateral-sclerosis-als-unaffected-censoi027-d/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Axol).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP27 ! CENSOi027-A
OI   CVCL_WP28 ! CENSOi027-B
OI   CVCL_WP29 ! CENSOi027-C
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi028-A
AC   CVCL_WP31
SY   F203c1
DR   hPSCreg; CENSOi028-A
DR   Wikidata; Q93446732
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi028-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Trp90Leufs*12 (c.268_283del); ClinVar=VCV003242199; Zygosity=Homozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi029-A
AC   CVCL_WP32
SY   F207R2c6
DR   hPSCreg; CENSOi029-A
DR   Wikidata; Q93446734
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP33 ! CENSOi029-B
OI   CVCL_WP34 ! CENSOi029-C
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi029-B
AC   CVCL_WP33
SY   F207R2c9
DR   hPSCreg; CENSOi029-B
DR   Wikidata; Q93446737
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP32 ! CENSOi029-A
OI   CVCL_WP34 ! CENSOi029-C
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi029-C
AC   CVCL_WP34
SY   F207R2c4
DR   hPSCreg; CENSOi029-C
DR   Wikidata; Q93446738
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP32 ! CENSOi029-A
OI   CVCL_WP33 ! CENSOi029-B
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi030-A
AC   CVCL_WP35
SY   F194c4
DR   BioSamples; SAMEA4760843
DR   hPSCreg; CENSOi030-A
DR   Wikidata; Q93446739
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi030-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Unspecified (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi031-A
AC   CVCL_WP36
SY   F195c2
DR   hPSCreg; CENSOi031-A
DR   Wikidata; Q93446740
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi031-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Unspecified (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi032-A
AC   CVCL_WP37
SY   F227c9
DR   hPSCreg; CENSOi032-A
DR   Wikidata; Q93446741
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-censoi032-a-copy/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Cys31Leufs*35 (c.87_90dup); ClinVar=VCV000098122; Zygosity=Unspecified (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi033-A
AC   CVCL_WP38
SY   F239c9
DR   hPSCreg; CENSOi033-A
DR   Wikidata; Q93446744
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsonism-machado-joseph-disease-sca3-censoi033-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[69]; Zygosity=Heterozygous; Note=The other allele has 25 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi034-A
AC   CVCL_WP39
SY   F240c5
DR   hPSCreg; CENSOi034-A
DR   Wikidata; Q93446746
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsonism-machado-joseph-disease-sca3-censoi034-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[66]; Zygosity=Heterozygous; Note=The other allele has 29 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi035-A
AC   CVCL_WP40
SY   F198R2c6
DR   hPSCreg; CENSOi035-A
DR   Wikidata; Q93446748
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp110Tyr (c.328G>T) (D109Y); ClinVar=VCV000899185; Zygosity=Heterozygous (from autologous cell line CENSOi035-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP41 ! CENSOi035-B
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi035-B
AC   CVCL_WP41
SY   F198R2c5
DR   hPSCreg; CENSOi035-B
DR   Wikidata; Q93446751
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/amyotrophic-lateral-sclerosis-als-censoi035-b/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp110Tyr (c.328G>T) (D109Y); ClinVar=VCV000899185; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP40 ! CENSOi035-A
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi036-A
AC   CVCL_WP42
SY   F216c15
DR   hPSCreg; CENSOi036-A
DR   Wikidata; Q93446754
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/spinocerebellar-ataxia-type-7-sca7-censoi036-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[39] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous; Note=The other allele has 10 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi037-A
AC   CVCL_WP43
SY   F224c7
DR   hPSCreg; CENSOi037-A
DR   Wikidata; Q93446756
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/friedreichs-ataxia-censoi037-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[>75]; ClinVar=VCV000561195; Zygosity=Homozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi038-A
AC   CVCL_WP44
SY   F225c7
DR   hPSCreg; CENSOi038-A
DR   Wikidata; Q93446759
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/friedreichs-ataxia-familial-control-censoi038-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[>75]; ClinVar=VCV000561195; Zygosity=Heterozygous (Axol).
CC   Donor information: At sampling donor was not affected with Friedreich ataxia but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi039-A
AC   CVCL_WP45
SY   F234c5
DR   hPSCreg; CENSOi039-A
DR   Wikidata; Q93446763
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/friedreichs-ataxia-control-censoi039-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi040-A
AC   CVCL_WP46
SY   F236c10
DR   hPSCreg; CENSOi040-A
DR   Wikidata; Q93446765
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/spinal-and-bulbar-muscular-atrophy-sbma-censoi040-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)47+-1 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi041-A
AC   CVCL_WP47
SY   F237c8
DR   hPSCreg; CENSOi041-A
DR   Wikidata; Q93446767
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP48 ! CENSOi041-B
OI   CVCL_YC20 ! CENSOi041-C
OI   CVCL_YC21 ! CENSOi041-D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   CENSOi041-B
AC   CVCL_WP48
SY   F237c7
DR   hPSCreg; CENSOi041-B
DR   Wikidata; Q93446770
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP47 ! CENSOi041-A
OI   CVCL_YC20 ! CENSOi041-C
OI   CVCL_YC21 ! CENSOi041-D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   CENSOi041-C
AC   CVCL_YC20
SY   F237c1
DR   hPSCreg; CENSOi041-C
DR   Wikidata; Q93446772
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP47 ! CENSOi041-A
OI   CVCL_WP48 ! CENSOi041-B
OI   CVCL_YC21 ! CENSOi041-D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi041-D
AC   CVCL_YC21
SY   F237c9
DR   hPSCreg; CENSOi041-D
DR   Wikidata; Q93446775
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP47 ! CENSOi041-A
OI   CVCL_WP48 ! CENSOi041-B
OI   CVCL_YC20 ! CENSOi041-C
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi042-A
AC   CVCL_WP49
SY   F241Sc4
DR   hPSCreg; CENSOi042-A
DR   Wikidata; Q93446777
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-pagets-disease-censoi042-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi043-A
AC   CVCL_WP50
SY   F242Sc2
DR   hPSCreg; CENSOi043-A
DR   Wikidata; Q93446780
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-pagets-disease-censoi043-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi044-A
AC   CVCL_WP51
SY   F223R2c2
DR   hPSCreg; CENSOi044-A
DR   Wikidata; Q93446783
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/friedreichs-ataxia-censoi044-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[>75]; ClinVar=VCV000561195; Zygosity=Homozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi045-A
AC   CVCL_WP52
SY   F202c6
DR   hPSCreg; CENSOi045-A
DR   Wikidata; Q93446785
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi045-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Gly51Asp (c.152G>A); ClinVar=VCV000097000; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi046-A
AC   CVCL_WP53
SY   F222c4
DR   hPSCreg; CENSOi046-A
DR   Wikidata; Q93446790
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi046-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi047-A
AC   CVCL_WP54
SY   F226c6
DR   hPSCreg; CENSOi047-A
DR   Wikidata; Q93446792
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/parkinsons-disease-censoi047-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP55 ! CENSOi047-B
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi047-B
AC   CVCL_WP55
SY   F226c5
DR   hPSCreg; CENSOi047-B
DR   Wikidata; Q93446796
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (from autologous cell line CENSOi047-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP54 ! CENSOi047-A
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi048-A
AC   CVCL_WP56
SY   F219c1
DR   hPSCreg; CENSOi048-A
DR   Wikidata; Q93446799
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/friedreichs-ataxia-censoi048-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[>66]; ClinVar=VCV000561195; Zygosity=Homozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi049-A
AC   CVCL_WP57
SY   F218c7
DR   hPSCreg; CENSOi049-A
DR   Wikidata; Q93446801
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP58 ! CENSOi049-B
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi049-B
AC   CVCL_WP58
SY   F218c4
DR   hPSCreg; CENSOi049-B
DR   Wikidata; Q93446805
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP57 ! CENSOi049-A
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi050-A
AC   CVCL_WP59
SY   F217c7
DR   hPSCreg; CENSOi050-A
DR   Wikidata; Q93446807
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/friedreichs-ataxia-censoi050-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[>75]; ClinVar=VCV000561195; Zygosity=Homozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi051-A
AC   CVCL_WP60
SY   F246c1
DR   hPSCreg; CENSOi051-A
DR   Wikidata; Q93446812
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[~36] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has ~22 repeats (from autologous cell line CENSOi051-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC22 ! CENSOi051-B
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   CENSOi051-B
AC   CVCL_YC22
SY   F246c6
DR   hPSCreg; CENSOi051-B
DR   Wikidata; Q93446815
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/spinocerebellar-ataxia-type-2-sca2-censoi051-b/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[~36] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has ~22 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP60 ! CENSOi051-A
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi052-A
AC   CVCL_WP61
SY   F243c6
DR   hPSCreg; CENSOi052-A
DR   Wikidata; Q93446819
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/huntingtons-disease-censoi052-a-copy/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi053-A
AC   CVCL_WP62
SY   F245R2c2
DR   hPSCreg; CENSOi053-A
DR   Wikidata; Q93446823
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/huntingtons-disease-censoi053-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[38] (c.52CAG(38)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Axol).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi054-A
AC   CVCL_WP63
SY   F274c5
DR   hPSCreg; CENSOi054-A
DR   Wikidata; Q93446825
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3033; ATN1; Repeat_expansion; CAG[~66] (g.17267CAG[(54-68)]); ClinVar=VCV000590267; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[~13] (from autologous cell line CENSOi054-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC23 ! CENSOi054-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   CENSOi054-B
AC   CVCL_YC23
SY   F274c2
DR   hPSCreg; CENSOi054-B
DR   Wikidata; Q93446828
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/dentatorubral-pallidoluysian-atrophy-drpla-censoi054-b-2/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3033; ATN1; Repeat_expansion; CAG[~66] (g.17267CAG[(54-68)]); ClinVar=VCV000590267; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[~13] (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP63 ! CENSOi054-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi055-A
AC   CVCL_WP64
SY   F275c6
DR   hPSCreg; CENSOi055-A
DR   Wikidata; Q93446831
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/dentatorubral-pallidoluysian-atrophy-drpla-censoi055-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:3033; ATN1; Repeat_expansion; CAG[57+-2] (g.17267CAG[(54-68)]); ClinVar=VCV000590267; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[17+-1] (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi056-A
AC   CVCL_WP65
SY   F277c6
DR   hPSCreg; CENSOi056-A
DR   Wikidata; Q93446833
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/spinocerebellar-ataxia-type-6-sca6-censoi056-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[23] (c.6937CAG[23]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi057-A
AC   CVCL_WP66
SY   F278c1
DR   hPSCreg; CENSOi057-A
DR   Wikidata; Q93446837
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[~39] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has ~22 repeats (from autologous cell line CENSOi057-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC24 ! CENSOi057-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   CENSOi057-B
AC   CVCL_YC24
SY   F278c6
DR   hPSCreg; CENSOi057-B
DR   Wikidata; Q93446840
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/spinocerebellar-ataxia-type-2-sca2-censoi057-b/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[~39] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has ~22 repeats (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP66 ! CENSOi057-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi058-A
AC   CVCL_WP67
SY   F279c3
DR   hPSCreg; CENSOi058-A
DR   Wikidata; Q93446842
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/dentatorubral-pallidoluysian-atrophy-drpla-censoi058-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi059-A
AC   CVCL_WP68
SY   F229c2
DR   hPSCreg; CENSOi059-A
DR   Wikidata; Q93446845
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/behavioural-variant-frontotemporal-dementia-bvftd-censoi059-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi060-A
AC   CVCL_WP69
SY   F230c4
DR   hPSCreg; CENSOi060-A
DR   Wikidata; Q93446847
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (from autologous cell line CENSOi060-B).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB92 ! CENSOi060-B
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   CENSOi060-B
AC   CVCL_YB92
SY   F230R2c1
DR   hPSCreg; CENSOi060-B
DR   Wikidata; Q93446852
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/behavioural-variant-frontotemporal-dementia-bvftd-censoi060-b/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP69 ! CENSOi060-A
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi061-A
AC   CVCL_WP70
SY   F231c6
DR   hPSCreg; CENSOi061-A
DR   Wikidata; Q93446855
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/behavioural-variant-frontotemporal-dementia-bvftd-censoi061-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi062-A
AC   CVCL_WP71
SY   F232c3
DR   hPSCreg; CENSOi062-A
DR   Wikidata; Q93446858
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-censoi062-a-copy/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (Axol).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   CENSOi063-A
AC   CVCL_D0MF
SY   B243c2
DR   hPSCreg; CENSOi063-A
DR   Wikidata; Q123030897
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/mucolipidosis-iv-ml4-censoi063-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; p.Phe262Ser (c.785T>C); ClinVar=VCV001028660; Zygosity=Heterozygous (Axol).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CENSOi064-A
AC   CVCL_D0MG
SY   B244c5
DR   hPSCreg; CENSOi064-A
DR   Wikidata; Q123030898
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/mucolipidosis-iv-ml4-censoi064-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Homozygous; Note=Splice acceptor mutation (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CENSOi065-A
AC   CVCL_D0MH
SY   B245c3
DR   hPSCreg; CENSOi065-A
DR   Wikidata; Q123030899
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (from autologous cell line CENSOi065-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0MI ! CENSOi065-B
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CENSOi065-B
AC   CVCL_D0MI
SY   B245c2
DR   hPSCreg; CENSOi065-B
DR   Wikidata; Q123030900
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/mucolipidosis-iv-ml4-censoi065-b/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0MH ! CENSOi065-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CENSOi066-A
AC   CVCL_D0MJ
SY   B242c7
DR   hPSCreg; CENSOi066-A
DR   Wikidata; Q123030901
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/mucolipidosis-iv-ml4-censoi066-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; p.Thr232Pro (c.694A>C); ClinVar=VCV000208021; Zygosity=Heterozygous (Axol).
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; p.Phe262Ser (c.785T>C); ClinVar=VCV001028660; Zygosity=Heterozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CENSOi067-A
AC   CVCL_D0MK
SY   F211R3c1
DR   hPSCreg; CENSOi067-A
DR   Wikidata; Q123030902
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CENSOi068-A
AC   CVCL_E4FU
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/charcot-marie-tooth-disease-type-4j-cmt4j-censoi068-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:16873; FIG4; Simple; p.Ile41Thr (c.122T>C); ClinVar=VCV000001721; Zygosity=Heterozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C134954; Charcot-Marie-Tooth disease type 4J
DI   ORDO; Orphanet_139515; Charcot-Marie-Tooth disease type 4J
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi069-B
AC   CVCL_E4FX
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-censoi069-b/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi070-A
AC   CVCL_E4FW
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi071-A
AC   CVCL_E4G3
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/spinocerebellar-ataxia-type-3-sca3-censoi071-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[75]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi072-A
AC   CVCL_E4FZ
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-censoi072-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi073-A
AC   CVCL_E4G0
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/nasu-hakola-disease-censoi073-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Trp50Cys (c.150G>T); Zygosity=Homozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212884; Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2
DI   ORDO; Orphanet_2770; Nasu-Hakola disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi074-A
AC   CVCL_E4FS
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/alzheimers-disease-censoi074-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi075-B
AC   CVCL_E4G2
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Trp50Cys (c.150G>T); Zygosity=Homozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212884; Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2
DI   ORDO; Orphanet_2770; Nasu-Hakola disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi076-A
AC   CVCL_E4FY
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/frontotemporal-dementia-ftd-censoi076-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Heterozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi077-C
AC   CVCL_E4FT
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/alzheimers-disease-censoi077-c/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CENSOi078-A
AC   CVCL_E4G1
WW   Provider; Axol; -; https://axolbio.com/shop/disease-models/nasu-hakola-disease-familial-control-censoi078-a/
CC   From: Axol Bioscience, Ltd (Censo Biotechnologies); Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Trp50Cys (c.150G>T); Zygosity=Homozygous (Axol).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212884; Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2
DI   ORDO; Orphanet_2770; Nasu-Hakola disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CeORC2
AC   CVCL_KR48
SY   ORC2; 4D4
DR   DSHB; ORC2
DR   Wikidata; Q54809310
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q21037; Caenorhabditis elegans orc-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CePAS7
AC   CVCL_KR49
SY   PAS7; 1A1
DR   DSHB; CePAS7
DR   Wikidata; Q54809311
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09583; Caenorhabditis elegans pas-7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CEPH-1332-NA00000
AC   CVCL_G393
SY   1332-8251
DR   dbMHC; 48552
DR   IHW; IHW01020
DR   IPD-IMGT/HLA; 25821
DR   Wikidata; Q54809312
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01,03:01; B*27:05,35:01; C*02:02:02,04:01; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:01,03:01; DQB1*03:02:01,05:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25821).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   CEPH-1344-NA00000
AC   CVCL_G436
SY   1344-8323
DR   dbMHC; 48595
DR   IHW; IHW01066
DR   IPD-IMGT/HLA; 25864
DR   Wikidata; Q54809313
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01; B*51:01; C*01:02; DPA1*01:03; DPB1*03:01:01; DQA1*01:01; DQB1*05:01:01; DRB1*01:01; DRB4*01 (IPD-IMGT/HLA=25864).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   CEPI17-CL4
AC   CVCL_C3M7
SY   Corneal EPIthelial 17-clone 4; CNCM I-1777
DR   Wikidata; Q116048730
RX   Patent=US6284537;
RX   PubMed=10235542;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1777.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIPSVU19).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   CERAi001-A-6
AC   CVCL_QW42
DR   Wikidata; Q54809314
RX   PubMed=28952926;
CC   From: Centre for Eye Research Australia, University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   CerCAF
AC   CVCL_A9BG
DR   Wikidata; Q108820009
RX   PubMed=31659294;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   cerebEND
AC   CVCL_E7HA
DR   ABM; T0291
RX   PubMed=22951995;
CC   Characteristics: Provides a useful model for studies involving the differentiation and regulation of blood brain barrier as it shares principal features of the BBB in vivo (ABM=T0291).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3-5D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CeRIM
AC   CVCL_KR50
SY   RIM; 4A5
DR   DSHB; RIM
DR   Wikidata; Q54809316
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q22366; Caenorhabditis elegans unc-10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeRIM2
AC   CVCL_KR51
SY   RIM2; 4E11
DR   DSHB; RIM2
DR   Wikidata; Q54809317
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q22366; Caenorhabditis elegans unc-10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeRME1
AC   CVCL_KR52
SY   RME1; 5G11
DR   DSHB; RME1
DR   Wikidata; Q54809319
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; G5EFP1; Caenorhabditis elegans rme-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CERV-186
AC   CVCL_5720
SY   Cerv-186; MRI-H-186; MRI-H186
DR   CLS; 300290
DR   Wikidata; Q54809320
RX   PubMed=15531914;
RX   PubMed=21439369;
CC   Virology: Contains around 26 copies of the HPV16 genome; some complete and others truncated.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CLS=300290
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 19,20
ST   Penta D: 10,12
ST   Penta E: 5,7
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   CERV-196
AC   CVCL_5721
SY   Cerv-196; MRI-H-196; MRI-H196
DR   CLS; 300291
DR   Wikidata; Q54809321
RX   PubMed=15531914;
RX   PubMed=21439369;
CC   Virology: Contains 4 to 6 copies of the HPV16 genome.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CLS=300291
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   CERV-215
AC   CVCL_5722
SY   Cerv-215; MRI-H-215; MRI-H215
DR   CLS; 300292
DR   Wikidata; Q54809322
RX   PubMed=15531914;
CC   Virology: Contains a HPV45 genome.
CC   HLA typing: A*02:01,03:01; B*11:08,40:01:00; C*03:04,04:01 (CLS=300292).
CC   Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CLS=300292
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 12
ST   D21S11: 33.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 19,21
ST   Penta D: 10
ST   Penta E: 12,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   CES-1
AC   CVCL_E8H3
RX   PubMed=26119236;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CES-3-12
AC   CVCL_E8H2
SY   3-12
RX   PubMed=26119236;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   cES1
AC   CVCL_JK97
DR   Wikidata; Q54809323
RX   PubMed=16292778;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 6
//
ID   cES2
AC   CVCL_JK98
DR   Wikidata; Q54809338
RX   PubMed=16292778;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 6
//
ID   CeSAX7
AC   CVCL_KR53
SY   SAX7; 11.2.1
DR   DSHB; CeSAX7
DR   Wikidata; Q54809339
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q53U87; Caenorhabditis elegans sax-7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeSNB1
AC   CVCL_KR54
SY   SB1; 5D1
DR   DSHB; SB1
DR   Wikidata; Q54809341
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O02495; Caenorhabditis elegans snb-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CeSQV8
AC   CVCL_KR55
SY   SQV8; 5B3
DR   DSHB; SQV8
DR   Wikidata; Q54809342
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q09363; Caenorhabditis elegans sqv-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CESS
AC   CVCL_0209
SY   Cess
DR   BTO; BTO_0004327
DR   CLO; CLO_0002360
DR   EFO; EFO_0002130
DR   MCCL; MCC:0000098
DR   CLDB; cl695
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; TIB-190
DR   BioSample; SAMN03471942
DR   cancercelllines; CVCL_0209
DR   Cell_Model_Passport; SIDM00917
DR   ChEMBL-Cells; CHEMBL3308863
DR   ChEMBL-Targets; CHEMBL2366361
DR   CLS; 300262
DR   Cosmic; 683658
DR   Cosmic; 910688
DR   Cosmic; 2131534
DR   Cosmic; 2306201
DR   Cosmic-CLP; 910688
DR   DepMap; ACH-002218
DR   ECACC; 92110206
DR   EGA; EGAS00001000978
DR   GDSC; 910688
DR   GEO; GSM1669671
DR   IARC_TP53; 21221
DR   IGRhCellID; CESS
DR   LINCS_LDP; LCL-1050
DR   PharmacoDB; CESS_192_2019
DR   Progenetix; CVCL_0209
DR   PubChem_Cell_line; CVCL_0209
DR   Wikidata; Q54809343
RX   PubMed=3106068;
RX   PubMed=6972960;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CESS
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=6.92%; Native American=0.8%; East Asian, North=5.8%; East Asian, South=0%; South Asian=5.27%; European, North=21.66%; European, South=59.54% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=TIB-190; CLS=300262; Cosmic-CLP=910688; ECACC=92110206
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11 (ATCC=TIB-190; CLS=300262; ECACC=92110206)
ST   CSF1PO: 10,11,12 (Cosmic-CLP=910688)
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,16
ST   D19S433: 12,14.2
ST   D21S11: 27,30
ST   D2S1338: 18
ST   D3S1358: 15,18
ST   D5S818: 10,11,12,13 (Cosmic-CLP=910688)
ST   D5S818: 11,12 (ATCC=TIB-190; CLS=300262; ECACC=92110206)
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10,12
ST   Penta E: 7,13
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16,17,18 (Cosmic-CLP=910688)
ST   vWA: 16,17 (ATCC=TIB-190; CLS=300262; ECACC=92110206)
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   CET.IPS ALZ-500
AC   CVCL_5I57
DR   Wikidata; Q54809344
WW   Provider; CET; -; https://web.archive.org/web/20231204033641/https://www.celleng-tech.com/ips-cell-line-derived-from-ap-1-mutation
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T877 ! AG07768
SX   Female
AG   30Y6M
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   CET.IPS HFF-500
AC   CVCL_5I61
DR   Wikidata; Q54809345
WW   Provider; CET; CET.IPS HFF-500; https://web.archive.org/web/20230930102650/https://www.celleng-tech.com/ips-cell-line-derived-from-hff
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   Discontinued: CET; Catalog number CET.IPS HFF-500.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   CET.IPS MULT-500
AC   CVCL_5I62
DR   Wikidata; Q54809346
WW   Provider; CET; CR1002-500; https://cet.bio/product/human-multipotent-induced-pluripotent-stem-cells-ipscs/
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 6
//
ID   CET.IPS.FFAD-500
AC   CVCL_5I58
SY   CET.IPS FFAD-500; CET-IPS-FFAD-500; iPSC FFAD
DR   CLS; 300612
DR   Wikidata; Q54809347
WW   Provider; CET; CET.IPS.FFAD-500; https://web.archive.org/web/20230605230606/https://www.celleng-tech.com/footprint-free-ips-cell-line-adipose-msc
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   Discontinued: CET; Catalog number CET.IPS.FFAD-500.
CC   Discontinued: CLS; 300612; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   CET.IPS.FFALP1-500
AC   CVCL_B5V8
DR   Wikidata; Q111733094
RX   PubMed=30488785;
WW   Provider; CET; CR1014-500; https://cet.bio/product/human-alpha-1-anti-trypsin-deficiency-ips-cells/
WW   Provider; JP2MRI; -; https://www.jp2mri.org/alpha1-antitrypsin-deficiency-57
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (JP2MRI).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   CET.IPS.FFALZ-500
AC   CVCL_RM10
SY   iPSC FFALZ
DR   CLS; 300616
DR   Wikidata; Q54809349
WW   Provider; JP2MRI; -; https://www.jp2mri.org/alzheimers-disease-type-3
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: CLS; 300616; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T877 ! AG07768
SX   Female
AG   30Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   CET.IPS.FFAM-500
AC   CVCL_RM11
SY   iPSC FFAM
DR   CLS; 300614
DR   Wikidata; Q54809350
WW   Provider; CET; CR1018-500; https://cet.bio/product/human-amniotic-membrane-induced-pluripotent-stem-cells-ipscs/
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   Discontinued: CLS; 300614; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   CET.IPS.FFCD34-500
AC   CVCL_RM12
SY   iPSC CD34+
DR   CLS; 300615
DR   Wikidata; Q54809351
WW   Provider; CET; CR1003-500; https://cet.bio/product/human-cd34-induced-pluripotent-stem-cells-ipscs/
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   Discontinued: CLS; 300615; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   CET.IPS.FFCYST-500
AC   CVCL_RM14
SY   iPSC FFCYST
DR   CLS; 300619
DR   Wikidata; Q54809353
WW   Provider; CET; CR1011-500; https://cet.bio/product/human-cystinosis-ipscs/
WW   Provider; JP2MRI; -; https://www.jp2mri.org/cystinosis
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Thr7Phefs*7 (c.18_21delGACT); ClinVar=VCV000188834; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: CLS; 300619; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W237 ! GM17886
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   CET.IPS.FFCYSTFIB-500
AC   CVCL_RM13
SY   iPSC FFCYSTFIB
DR   CLS; 300618
DR   Wikidata; Q54809352
WW   Provider; CET; CR1010-500; https://cet.bio/product/human-cystic-fibrosis-ipsc/
WW   Provider; JP2MRI; -; https://www.jp2mri.org/cystic-fibrosis-male-19-fibroblast
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: CLS; 300618; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V205 ! GM00770
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   CET-IPF-FFCYSTFIB2-500
AC   CVCL_B5V9
DR   Wikidata; Q111733095
RX   PubMed=30488785;
WW   Provider; JP2MRI; -; https://www.jp2mri.org/cystic-fibrosis-male-7-cd34
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (JP2MRI).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   CET.IPS.FFGAU-500
AC   CVCL_RM15
SY   iPSC FFGAU
DR   CLS; 300617
DR   Wikidata; Q54809354
WW   Provider; CET; CR1009-500; https://cet.bio/product/human-gauchers-type-1-ipsc/
WW   Provider; JP2MRI; -; https://www.jp2mri.org/gaucher-disease-type-i
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: CLS; 300617; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0R33 ! GM04394
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 17
//
ID   CET.IPS.FFHFF-500
AC   CVCL_5I59
SY   CET.IPS FFHFF-500; iPSC FFHFF
DR   CLS; 300611
DR   Wikidata; Q54809355
RX   PubMed=28884008;
WW   Provider; CET; CR1001-500; https://cet.bio/product/human-foreskin-fibroblast-derived-induced-pluripotent-stem-cells-ipscs/
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   Discontinued: CLS; 300611; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   CET.IPS.FFMP-500
AC   CVCL_5I60
SY   CET.IPS FFMP-500; iPSC FFMP
DR   CLS; 300613
DR   Wikidata; Q54809356
WW   Provider; CET; CET.IPS.FFMP-500; https://web.archive.org/web/20231204031903/https://www.celleng-tech.com/footprint-free-ips-multipotent
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   Discontinued: CET; Catalog number CET.IPS.FFMP-500.
CC   Discontinued: CLS; 300613; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   CET.IPS.FFNPC-01
AC   CVCL_RM16
SY   iPSC FFNPC-01; JP2MRI-NPC-01
DR   CLS; 300620
DR   Wikidata; Q54809357
WW   Provider; CET; CR1012-500; https://cet.bio/product/human-niemann-pick-type-c-male-ips-cells/
WW   Provider; JP2MRI; -; https://www.jp2mri.org/niemann-pick-c-sibling-npc-01
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: Caucasian.
CC   Discontinued: CLS; 300620; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   CET.IPS.FFNPC-02
AC   CVCL_RM17
SY   iPSC FFNPC-02; JP2MRI-NPC-02
DR   CLS; 300620-02
DR   Wikidata; Q54809359
WW   Provider; CET; CR1013-500; https://cet.bio/product/human-niemann-pick-type-c-female-ips-cells/
WW   Provider; JP2MRI; -; https://www.jp2mri.org/niemann-pick-c-sibling-npc-02
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: Caucasian.
CC   Discontinued: CLS; 300620-02; true.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   CeTAC1
AC   CVCL_KR56
SY   TAC1; 4.5.6
DR   DSHB; CeTAC1
DR   Wikidata; Q54809360
RX   PubMed=20405020;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; G5ECG0; Caenorhabditis elegans tac-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   CF [Chitala]
AC   CVCL_9T87
SY   Chitala Fin
DR   Wikidata; Q54809361
RX   CelloPub=CLPUB00463;
RX   PubMed=23877365;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 15 to 35 Celsius, the optimal temperature is 28 Celsius (PubMed=23877365).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=112163; ! Chitala chitala (Clown knifefish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   CF [Cobia]
AC   CVCL_6F70
SY   Cobia Fin
DR   Wikidata; Q54809362
RX   PubMed=19925591;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=141264; ! Rachycentron canadum (Cobia)
OI   CVCL_6F69 ! CB [Cobia]
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   CF [Cyprinus]
AC   CVCL_WY79
SY   Carp Fin
DR   Wikidata; Q93447038
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   CF [Human plasma cell myeloma]
AC   CVCL_Y433
DR   Wikidata; Q54809363
RX   PubMed=17760811;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~4-6 days (PubMed=17760811).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 11
//
ID   CF [Rat heart fibroblast]
AC   CVCL_HA34
DR   BCRJ; 0065
DR   Wikidata; Q54809364
CC   Discontinued: BCRJ; 0065; probable.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   CF iPSC clone 17
AC   CVCL_WN85
SY   C17
DR   Wikidata; Q93447053
RX   PubMed=25772471;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous (PubMed=25772471).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=25772471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0M23 ! GM04320
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   CF-1 MEF
AC   CVCL_5251
SY   MEF (CF-1)
DR   CLO; CLO_0002361
DR   CLO; CLO_0007666
DR   ATCC; SCRC-1040
DR   CCRID; 3101MOUSCSP105
DR   Wikidata; Q54811347
CC   Discontinued: ATCC; SCRC-1040; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   CF-1 MEF IRR
AC   CVCL_K232
SY   MEF (CF-1) IRR
DR   ATCC; SCRC-1040.1
DR   CCRID; 3101MOUSCSP105R
DR   Wikidata; Q54811348
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 10000 rads.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5251 ! CF-1 MEF
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   CF-1 MEF MITC
AC   CVCL_K233
SY   MEF (CF-1) MITC
DR   ATCC; SCRC-1040.2a
DR   Wikidata; Q54811349
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5251 ! CF-1 MEF
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   CF-10H5
AC   CVCL_1975
DR   CLO; CLO_0002362
DR   DSMZ; ACC-477
DR   DSMZCellDive; ACC-477
DR   Wikidata; Q54811350
CC   Doubling time: ~30-45 hours (DSMZ=ACC-477).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   CF-1D12
AC   CVCL_1976
DR   CLO; CLO_0002365
DR   ABCD; ABCD_AD320
DR   DSMZ; ACC-476
DR   DSMZCellDive; ACC-476
DR   Wikidata; Q54811351
CC   Doubling time: ~30-35 hours (DSMZ=ACC-476).
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P31358; Human CD52.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   CF-KM4
AC   CVCL_IN80
DR   Wikidata; Q54811352
RX   PubMed=10101000;
RX   PubMed=15463957;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=10101000).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trachea gland; UBERON=UBERON_0005203.
CC   Cell type: Serous cell of epithelium of trachea; CL=CL_1000330.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   CF-RiPS-1.2
AC   CVCL_C194
SY   CF_RiPS_1.2; CF-RiPS1.2
DR   GEO; GSM579910
DR   SKIP; SKIP000690
DR   SKIP; SKIP005165
DR   Wikidata; Q54811353
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C195 ! CF-RiPS-1.3
OI   CVCL_C196 ! CF-RiPS-1.4
SX   Sex unspecified
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   CF-RiPS-1.3
AC   CVCL_C195
SY   CF_RiPS_1.3; CF-RiPS1.3
DR   GEO; GSM579911
DR   SKIP; SKIP000691
DR   SKIP; SKIP005166
DR   Wikidata; Q54811354
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C194 ! CF-RiPS-1.2
OI   CVCL_C196 ! CF-RiPS-1.4
SX   Sex unspecified
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   CF-RiPS-1.4
AC   CVCL_C196
SY   CF_RiPS_1.4; CF-RiPS1.4
DR   GEO; GSM579912
DR   SKIP; SKIP000692
DR   SKIP; SKIP005167
DR   Wikidata; Q54811355
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C194 ! CF-RiPS-1.2
OI   CVCL_C195 ! CF-RiPS-1.3
SX   Sex unspecified
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   CF.2C7
AC   CVCL_D5YN
DR   DSHB; CF-2C7
DR   Wikidata; Q127380430
RX   PubMed=6390440;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12080; Drosophila melanogaster if.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CF.5E5
AC   CVCL_D5YP
DR   Wikidata; Q127380431
RX   PubMed=6390440;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q24247; Drosophila melanogaster mew.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CF.6G11
AC   CVCL_D5YM
DR   DSHB; CF-6G11
DR   Wikidata; Q127380432
RX   PubMed=6390440;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P11584; Drosophila melanogaster mys.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CF/T43
AC   CVCL_HA79
SY   CF-T43; CFT43
DR   Wikidata; Q54811356
RX   PubMed=2472008;
RX   PubMed=8755664;
RX   PubMed=9277448;
RX   PubMed=15463957;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=15463957).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIPneoSV(X)1/SV40T).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   CF10
AC   CVCL_E5QT
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CF10.Br
AC   CVCL_S245
DR   ATCC; CRL-6212
DR   Wikidata; Q54811357
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6212; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S244 ! CF10.Ht
OI   CVCL_S243 ! CF10.Int
OI   CVCL_S369 ! CF10.Li
OI   CVCL_S242 ! CF10.Res
OI   CVCL_S241 ! CF10.Sm
OI   CVCL_S370 ! CF10.Sp
SX   Sex unspecified
AG   >40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF10.Ht
AC   CVCL_S244
DR   ATCC; CRL-6213
DR   Wikidata; Q54811358
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6213; true.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S245 ! CF10.Br
OI   CVCL_S243 ! CF10.Int
OI   CVCL_S369 ! CF10.Li
OI   CVCL_S242 ! CF10.Res
OI   CVCL_S241 ! CF10.Sm
OI   CVCL_S370 ! CF10.Sp
SX   Sex unspecified
AG   >40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF10.Int
AC   CVCL_S243
DR   ATCC; CRL-6214
DR   Wikidata; Q54811359
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6214; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S245 ! CF10.Br
OI   CVCL_S244 ! CF10.Ht
OI   CVCL_S369 ! CF10.Li
OI   CVCL_S242 ! CF10.Res
OI   CVCL_S241 ! CF10.Sm
OI   CVCL_S370 ! CF10.Sp
SX   Sex unspecified
AG   >40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF10.Li
AC   CVCL_S369
DR   ATCC; CRL-6578
DR   Wikidata; Q54811360
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6578; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S245 ! CF10.Br
OI   CVCL_S244 ! CF10.Ht
OI   CVCL_S243 ! CF10.Int
OI   CVCL_S242 ! CF10.Res
OI   CVCL_S241 ! CF10.Sm
OI   CVCL_S370 ! CF10.Sp
SX   Sex unspecified
AG   >40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF10.Res
AC   CVCL_S242
DR   ATCC; CRL-6215
DR   Wikidata; Q54811361
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6215; true.
CC   Derived from site: In situ; Fetal lung, bronchus; UBERON=UBERON_0002185.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S245 ! CF10.Br
OI   CVCL_S244 ! CF10.Ht
OI   CVCL_S243 ! CF10.Int
OI   CVCL_S369 ! CF10.Li
OI   CVCL_S241 ! CF10.Sm
OI   CVCL_S370 ! CF10.Sp
SX   Sex unspecified
AG   >40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   CF10.Sm
AC   CVCL_S241
DR   ATCC; CRL-6216
DR   Wikidata; Q54811362
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6216; true.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S245 ! CF10.Br
OI   CVCL_S244 ! CF10.Ht
OI   CVCL_S243 ! CF10.Int
OI   CVCL_S369 ! CF10.Li
OI   CVCL_S242 ! CF10.Res
OI   CVCL_S370 ! CF10.Sp
SX   Sex unspecified
AG   >40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   CF10.Sp
AC   CVCL_S370
DR   ATCC; CRL-6579
DR   Wikidata; Q54811363
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6579; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S245 ! CF10.Br
OI   CVCL_S244 ! CF10.Ht
OI   CVCL_S243 ! CF10.Int
OI   CVCL_S369 ! CF10.Li
OI   CVCL_S242 ! CF10.Res
OI   CVCL_S241 ! CF10.Sm
SX   Sex unspecified
AG   >40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF11.T
AC   CVCL_5252
DR   CLO; CLO_0002363
DR   ATCC; CRL-6217
DR   Wikidata; Q54811364
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6217; true.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   CF15.T
AC   CVCL_S240
DR   ATCC; CRL-6218
DR   Wikidata; Q54811365
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6218; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   CF17.T
AC   CVCL_5253
DR   CLO; CLO_0002364
DR   ATCC; CRL-6219
DR   Wikidata; Q54811366
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6219; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   CF1TKB
AC   CVCL_J695
DR   CLO; CLO_0050703
DR   BioSample; SAMN03472132
DR   RCB; RCB1382
DR   Wikidata; Q54811367
RX   PubMed=40485979;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Val470Glufs*54 (c.1409_1418del); ClinVar=VCV000053250; Zygosity=Homozygous (PubMed=40485979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB1382
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   CF2.Ln
AC   CVCL_S237
DR   ATCC; CRL-6199
DR   Wikidata; Q54811368
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6199; true.
CC   Derived from site: In situ; Mesenteric lymph node; UBERON=UBERON_0002509.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S234 ! CF2.Sk
OI   CVCL_S238 ! CF2.Sp
OI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF2.Sk
AC   CVCL_S234
DR   ATCC; CRL-6198
DR   Wikidata; Q54811369
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6198; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S237 ! CF2.Ln
OI   CVCL_S238 ! CF2.Sp
OI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   CF2.Sp
AC   CVCL_S238
DR   ATCC; CRL-6200
DR   Wikidata; Q54811370
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6200; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S234 ! CF2.Sk
OI   CVCL_S237 ! CF2.Ln
OI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF2.Th
AC   CVCL_3363
SY   Cf2Th; CF2Th; CF2TH; Cf2TH; FCf2Th
DR   CLO; CLO_0002369
DR   CLO; CLO_0002370
DR   EFO; EFO_0022825
DR   CLDB; cl696
DR   CLDB; cl697
DR   CLDB; cl698
DR   CLDB; cl699
DR   ATCC; CRL-1430
DR   ATCC; CRL-6574
DR   CCRID; 1102CAN-NIFDC00103
DR   ECACC; 90110521
DR   ICLC; AL97003
DR   IZSLER; BS CL 13
DR   Wikidata; Q54811371
RX   PubMed=190163;
RX   PubMed=6500159;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-439.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6574; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S234 ! CF2.Sk
OI   CVCL_S237 ! CF2.Ln
OI   CVCL_S238 ! CF2.Sp
SX   Female
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   CF21.T
AC   CVCL_5254
DR   CLO; CLO_0002366
DR   ATCC; CRL-6220
DR   Wikidata; Q54811372
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   16D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   CF24.T
AC   CVCL_5255
DR   CLO; CLO_0002367
DR   ATCC; CRL-6221
DR   Wikidata; Q54811373
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6221; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   CF27
AC   CVCL_S235
DR   ATCC; CRL-6222
DR   Wikidata; Q54811374
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Donor information: Obtained from a pool of fetuses.
CC   Discontinued: ATCC; CRL-6222; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Mixed sex
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   CF28
AC   CVCL_5256
DR   CLO; CLO_0002368
DR   ATCC; CRL-6223
DR   Wikidata; Q54811375
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6223; true.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   CF29.Mg
AC   CVCL_S236
DR   ATCC; CRL-6224
DR   Wikidata; Q54811376
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6224; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_N776 ! CF51.Mg/L1
OI   CVCL_N777 ! CF51.Mg/L3
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   CF2A.Thy
AC   CVCL_Y442
DR   ATCC; CRL-6197
DR   Wikidata; Q54811377
CC   Discontinued: ATCC; CRL-6197; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 9
//
ID   Cf2Th-CCR5
AC   CVCL_1G50
SY   Cf2Th/syn CCR5; Cf2Th/PACH/synCCR5; Cf2Th synCCR5+
DR   BEI_Resources; ARP-4662
DR   Wikidata; Q54811378
RX   PubMed=11489906;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   Cf2Th-CXCR4
AC   CVCL_1G51
SY   CXCR4+ Cf2Th; Cf2Th/PACH/synCXCR4
DR   BEI_Resources; ARP-9398
DR   Wikidata; Q54811379
RX   PubMed=11489906;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_3363 ! CF2.Th
SX   Female
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   CF3
AC   CVCL_E5RP
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CF3.Ln
AC   CVCL_S263
DR   ATCC; CRL-6202
DR   Wikidata; Q54811380
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6202; true.
CC   Derived from site: In situ; Mesenteric lymph node; UBERON=UBERON_0002509.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S239 ! CF3.Sk
OI   CVCL_S264 ! CF3.Sp
OI   CVCL_5257 ! CF3.Th
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   CF3.Sk
AC   CVCL_S239
DR   ATCC; CRL-6201
DR   Wikidata; Q54811381
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6201; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S263 ! CF3.Ln
OI   CVCL_S264 ! CF3.Sp
OI   CVCL_5257 ! CF3.Th
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF3.Sp
AC   CVCL_S264
DR   ATCC; CRL-6203
DR   Wikidata; Q54811382
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6203; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S263 ! CF3.Ln
OI   CVCL_S239 ! CF3.Sk
OI   CVCL_5257 ! CF3.Th
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   CF3.Th
AC   CVCL_5257
DR   CLO; CLO_0002371
DR   ATCC; CRL-6575
DR   Wikidata; Q54811383
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6575; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S263 ! CF3.Ln
OI   CVCL_S264 ! CF3.Sp
OI   CVCL_S239 ! CF3.Sk
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   CF30.Mg
AC   CVCL_5258
DR   CLO; CLO_0002372
DR   ATCC; CRL-6225
DR   Wikidata; Q54811384
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6225; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   CF31A
AC   CVCL_N773
DR   ATCC; CRL-6226
DR   Wikidata; Q54811385
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6226; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CF33.MT
AC   CVCL_5259
SY   CF33; CF33.Mg
DR   CLO; CLO_0002373
DR   ATCC; CRL-6227
DR   IZSLER; BS TCL 225
DR   Wikidata; Q54811386
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6227; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CF34.Mg
AC   CVCL_5260
DR   CLO; CLO_0002374
DR   ATCC; CRL-6228
DR   Wikidata; Q54811391
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6228; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   CF35.Mg
AC   CVCL_5261
SY   CF35
DR   CLO; CLO_0002375
DR   ATCC; CRL-6229
DR   Wikidata; Q54811392
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6229; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   CF37.Mg
AC   CVCL_5262
DR   CLO; CLO_0002376
DR   ATCC; CRL-6230
DR   Wikidata; Q54811393
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   CF38.Mg
AC   CVCL_5263
DR   CLO; CLO_0002377
DR   ATCC; CRL-6231
DR   Wikidata; Q54811394
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   CF4
AC   CVCL_R840
SY   CF-4
DR   Wikidata; Q54811395
RX   DOI=10.1016/j.cbpa.2007.01.072;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   CF4-C4
AC   CVCL_5272
DR   CLO; CLO_0002386
DR   ATCC; CRL-1716
DR   Wikidata; Q54811396
RX   PubMed=6833281;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   CF41.Mg
AC   CVCL_5264
SY   CF41
DR   CLO; CLO_0002378
DR   ATCC; CRL-6232
DR   NCBI_Iran; C627
DR   Wikidata; Q54811397
RX   PubMed=28123715;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   CF42.Mg
AC   CVCL_N774
DR   ATCC; CRL-6233
DR   Wikidata; Q54811398
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6233; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   CF43.Mg
AC   CVCL_5265
DR   CLO; CLO_0002379
DR   ATCC; CRL-6234
DR   Wikidata; Q54811399
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6234; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   CF44.Mg
AC   CVCL_5266
DR   CLO; CLO_0002380
DR   ATCC; CRL-6235
DR   Wikidata; Q54811400
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6235; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   CF45A.Mg
AC   CVCL_N775
DR   ATCC; CRL-6236
DR   Wikidata; Q54811401
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6236; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_5267 ! CF45B.Mg
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   CF45B.Mg
AC   CVCL_5267
DR   CLO; CLO_0002381
DR   ATCC; CRL-6237
DR   Wikidata; Q54811402
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6237; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_N775 ! CF45A.Mg
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   CF46.Tr
AC   CVCL_5268
DR   CLO; CLO_0002382
DR   ATCC; CRL-6238
DR   Wikidata; Q54811403
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6238; true.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   CF47.Mg
AC   CVCL_5269
DR   CLO; CLO_0002383
DR   ATCC; CRL-6239
DR   Wikidata; Q54811404
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6239; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   CF48.Mg
AC   CVCL_5270
DR   CLO; CLO_0002384
DR   ATCC; CRL-6240
DR   Wikidata; Q54811405
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6240; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   CF49.Mg
AC   CVCL_5271
DR   CLO; CLO_0002385
DR   ATCC; CRL-6241
DR   Wikidata; Q54811406
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6241; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   CF5.Thy
AC   CVCL_S265
DR   ATCC; CRL-6204
DR   Wikidata; Q54811407
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6204; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Mixed sex
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   CF51.Mg/L1
AC   CVCL_N776
SY   CF51L1.Mg
DR   ATCC; CRL-6242
DR   Wikidata; Q54811408
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6242; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S236 ! CF29.Mg
OI   CVCL_N777 ! CF51.Mg/L3
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CF51.Mg/L3
AC   CVCL_N777
SY   CF51L3.Mg
DR   ATCC; CRL-6243
DR   Wikidata; Q54811409
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6243; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S236 ! CF29.Mg
OI   CVCL_N776 ! CF51.Mg/L1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CF52.Tr
AC   CVCL_5273
DR   CLO; CLO_0002387
DR   ATCC; CRL-6244
DR   Wikidata; Q54811410
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6244; true.
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   CF7.Bm
AC   CVCL_S266
DR   ATCC; CRL-6205
DR   Wikidata; Q54811411
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6205; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S267 ! CF7.Ln
OI   CVCL_0F43 ! CF7.Lu
OI   CVCL_S229 ! CF7.Thy
OI   CVCL_S368 ! CF7.Sp
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF7.Ln
AC   CVCL_S267
DR   ATCC; CRL-6206
DR   Wikidata; Q54811412
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6206; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S266 ! CF7.Bm
OI   CVCL_0F43 ! CF7.Lu
OI   CVCL_S368 ! CF7.Sp
OI   CVCL_S229 ! CF7.Thy
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF7.Lu
AC   CVCL_0F43
DR   ATCC; CRL-6209
DR   Wikidata; Q54811413
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6209; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S266 ! CF7.Bm
OI   CVCL_S267 ! CF7.Ln
OI   CVCL_S368 ! CF7.Sp
OI   CVCL_S229 ! CF7.Thy
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   CF7.Sp
AC   CVCL_S368
DR   ATCC; CRL-6576
DR   Wikidata; Q54811414
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6576; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S266 ! CF7.Bm
OI   CVCL_S267 ! CF7.Ln
OI   CVCL_0F43 ! CF7.Lu
OI   CVCL_S229 ! CF7.Thy
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF7.Thy
AC   CVCL_S229
SY   CF7.Th
DR   ATCC; CRL-6207
DR   Wikidata; Q54811415
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6207; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S266 ! CF7.Bm
OI   CVCL_S267 ! CF7.Ln
OI   CVCL_0F43 ! CF7.Lu
OI   CVCL_S368 ! CF7.Sp
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   CF8.Ln
AC   CVCL_S268
DR   ATCC; CRL-6208
DR   Wikidata; Q54811416
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6208; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S270 ! CF8.Lu
OI   CVCL_S269 ! CF8.Sp
OI   CVCL_5274 ! CF8.Thy
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   CF8.Lu
AC   CVCL_S270
DR   ATCC; CRL-6577
DR   Wikidata; Q54811417
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6577; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S268 ! CF8.Ln
OI   CVCL_S269 ! CF8.Sp
OI   CVCL_5274 ! CF8.Thy
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   CF8.Sp
AC   CVCL_S269
DR   ATCC; CRL-6210
DR   Wikidata; Q54811418
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6210; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S268 ! CF8.Ln
OI   CVCL_S270 ! CF8.Lu
OI   CVCL_5274 ! CF8.Thy
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   CF8.Thy
AC   CVCL_5274
DR   CLO; CLO_0002388
DR   ATCC; CRL-6211
DR   Wikidata; Q54811419
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6211; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S268 ! CF8.Ln
OI   CVCL_S270 ! CF8.Lu
OI   CVCL_S269 ! CF8.Sp
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   CF8Flp
AC   CVCL_WZ18
DR   Wikidata; Q93447351
RX   PubMed=26694805;
WW   Provider; JHTV; C12966; https://jhu.technologypublisher.com/technology/23388
CC   Characteristics: Contains a single recombination Flp-in target site for the stable integration and expression of a single cDNA, mini-gene, or complete gene.
CC   Characteristics: Transfected with the pFRT/lacZeo plasmid. A single Flp recombination target (FRT) was integrated into chromosome 8.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HL93 ! CFBE41o-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 12
//
ID   CF927
AC   CVCL_UG19
SY   CF-927; CF 927
DR   Wikidata; Q93447353
RX   CelloPub=CLPUB00450;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   CF996
AC   CVCL_E521
DR   dbMHC; 48719
DR   ECACC; 88052094
DR   IHW; IHW09094
DR   IPD-IMGT/HLA; 11626
DR   Wikidata; Q54811420
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*02:01:01:01,03:01:01:01; B*14:01:01; C*08:02:01:02; DPA1*01; DPB1*04:01:01,04:02:01; DQA1*02:01; DQB1*02:02:01; DRA*01:01; DRB1*07:01:01; DRB4*01:01 (IPD-IMGT/HLA=11626).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   cFA404-KiPS4F-1
AC   CVCL_C192
SY   cFA404-KiPS4F1; KiPS4F1; ESi005-A
DR   BioSamples; SAMEA3303130
DR   EBiSC; ESi005-A
DR   ECACC; 66540065
DR   hPSCreg; ESi005-A
DR   SKIP; SKIP002384
DR   Wikidata; Q54811421
RX   PubMed=19483674;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_cFA404-KiPS4F-1_DEF.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Linea_cFA404-KiPS4F-1_DEF.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_cFA404-KiPS4F1_def.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*02,24; B*35,51; C*02,04; DQB1*02,03; DRB1*03,04 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3582; FANCA.
CC   Discontinued: EBiSC; ESi005-A; true.
CC   Discontinued: ECACC; 66540065; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=19483674
ST   Amelogenin: X,Y
ST   D13S317: 12,13
ST   D18S51: 14,15
ST   D21S11: 27,29
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   vWA: 14,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C193 ! cFA404-KiPS4F-3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   cFA404-KiPS4F-3
AC   CVCL_C193
SY   cFA404-KiPS4F3; KiPS4F3; ESi005-B; ESi029-A
DR   hPSCreg; ESi005-B
DR   SKIP; SKIP002385
DR   Wikidata; Q54811422
RX   PubMed=19483674;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_cFA404-KiPS4F-3_DEF.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Linea_cFA404-KiPS4F-3_DEF.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_cFA404-KiPS4F3_def.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*02,24; B*35,51; C*02,04; DQB1*02,03; DRB1*03,04 (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3582; FANCA.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=19483674
ST   Amelogenin: X,Y
ST   D13S317: 12,13
ST   D18S51: 14,15
ST   D21S11: 27,29
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   vWA: 14,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C192 ! cFA404-KiPS4F-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   cFA90-44-01
AC   CVCL_W356
SY   cFA90-44-1
DR   Wikidata; Q54811423
RX   PubMed=19483674;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W357 ! cFA90-44-11
OI   CVCL_W358 ! cFA90-44-14
OI   CVCL_W359 ! cFA90-44-20
OI   CVCL_W360 ! cFA90-44-21
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   cFA90-44-11
AC   CVCL_W357
DR   Wikidata; Q54811424
RX   PubMed=19483674;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=19483674
ST   Amelogenin: X
ST   D13S317: 11,12
ST   D18S51: 15
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   vWA: 14,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W356 ! cFA90-44-01
OI   CVCL_W358 ! cFA90-44-14
OI   CVCL_W359 ! cFA90-44-20
OI   CVCL_W360 ! cFA90-44-21
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   cFA90-44-14
AC   CVCL_W358
DR   Wikidata; Q54811425
RX   PubMed=19483674;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=19483674
ST   Amelogenin: X
ST   D13S317: 11,12
ST   D18S51: 15
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   vWA: 14,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W356 ! cFA90-44-01
OI   CVCL_W357 ! cFA90-44-11
OI   CVCL_W359 ! cFA90-44-20
OI   CVCL_W360 ! cFA90-44-21
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   cFA90-44-20
AC   CVCL_W359
DR   Wikidata; Q54811426
RX   PubMed=19483674;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W356 ! cFA90-44-01
OI   CVCL_W357 ! cFA90-44-11
OI   CVCL_W358 ! cFA90-44-14
OI   CVCL_W360 ! cFA90-44-21
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   cFA90-44-21
AC   CVCL_W360
DR   Wikidata; Q54811427
RX   PubMed=19483674;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W356 ! cFA90-44-01
OI   CVCL_W357 ! cFA90-44-11
OI   CVCL_W358 ! cFA90-44-14
OI   CVCL_W359 ! cFA90-44-20
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   CFBE41o-
AC   CVCL_HL93
SY   CFBE41o(-); CF41o; CFBE
DR   EFO; EFO_0022620
DR   GEO; GSM2126999
DR   GEO; GSM2127001
DR   GEO; GSM2127003
DR   Lonza; 1158
DR   Millipore; SCC151
DR   PRIDE; PXD006933
DR   Wikidata; Q54811428
RX   PubMed=9614386;
RX   PubMed=12032687;
RX   PubMed=15463957;
RX   PubMed=16249874;
RX   PubMed=28970102;
WW   Info; Dartmouth; -; https://web.archive.org/web/20190126194809/http://www.dartmouth.edu/~cysfib/cell-lines.html
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=15463957).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC151
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 29,31.2
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 18
//
ID   CFBE41o- 4.7 DeltaF508-CFTR
AC   CVCL_VP35
SY   CFBE41oc4-4.7deltaF
DR   Millipore; SCC159
DR   Wikidata; Q93447380
RX   PubMed=18769032;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Unspecified; Note=In the 2 genomic alleles while the transfected copies are p.Phe508del (c.1522-1524delTTT) (PubMed=18769032).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1884; CFTR (Note=With p.Phe508del (c.1522_1524delTTT)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC159
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 29,31.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HL93 ! CFBE41o-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 16
//
ID   CFBE41o- 4.7 WT-CFTR
AC   CVCL_VP34
DR   Millipore; SCC158
DR   Wikidata; Q93447382
RX   PubMed=18769032;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Unspecified; Note=In the 2 genomic alleles while the transfected copies are wild type (PubMed=18769032).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1884; CFTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Caution: While not directly described in PubMed=18769032, that paper describes the process and constructs used to derive this cell line.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC158
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 31.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HL93 ! CFBE41o-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 15
//
ID   CFBE41o- 6.2 DeltaF508-CFTR
AC   CVCL_VP37
DR   Millipore; SCC161
DR   Wikidata; Q93447384
RX   PubMed=18769032;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Unspecified; Note=In the 2 genomic alleles while the transfected copies are p.Phe508del (c.1522-1524delTTT) (PubMed=18769032).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1884; CFTR (Note=With p.Phe508del (c.1522_1524delTTT)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Caution: While not directly described in PubMed=18769032, that paper describes the process and constructs used to derive this cell line.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC161
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 31.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HL93 ! CFBE41o-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 16
//
ID   CFBE41o- 6.2 WT-CFTR
AC   CVCL_VP36
DR   Millipore; SCC160
DR   Wikidata; Q93447387
RX   PubMed=18769032;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Unspecified; Note=In the 2 genomic alleles while the transfected copies are wild type (PubMed=18769032).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1884; CFTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Caution: PubMed=18769032 describes two clones, CFBE41o- c7-6.2wt and CFBE41o- c10-6.2wt, but it is not possible to trace back which of the 2 clones is the one distributed as SCC160 (personal communication of Millipore).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC160
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 31.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HL93 ! CFBE41o-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 16
//
ID   CFBE45o-
AC   CVCL_IN63
SY   CF45o-
DR   Wikidata; Q54811429
RX   PubMed=15463957;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg117His (c.350G>A); ClinVar=VCV000007109; Zygosity=Heterozygous (PubMed=15463957).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=15463957).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   CFBE46o-
AC   CVCL_IN64
DR   Wikidata; Q54811430
RX   PubMed=15463957;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg117His (c.350G>A); ClinVar=VCV000007109; Zygosity=Unspecified (PubMed=15463957).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   CFBR
AC   CVCL_1G74
SY   ClownFish BRain
DR   NRFC; NRFC011
DR   Wikidata; Q54811434
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC011.
CC   Miscellaneous: Cell line is no longer available (NRFC=NRFC011).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=229075; ! Amphiprion sebae (Sebae anemonefish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   CFC004
AC   CVCL_9U86
DR   Wikidata; Q54811435
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CFC008
AC   CVCL_9U87
DR   Wikidata; Q54811436
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CFC032
AC   CVCL_9U88
DR   Wikidata; Q54811437
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CFC034
AC   CVCL_9U89
DR   Wikidata; Q54811438
RX   PubMed=8639765;
RX   PubMed=9108096;
RX   PubMed=9192756;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CFCP1
AC   CVCL_1G75
SY   ClownFish Caudal Peduncle 1
DR   NRFC; NRFC013
DR   Wikidata; Q54811439
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC013; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC013.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=229075; ! Amphiprion sebae (Sebae anemonefish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   CFF
AC   CVCL_R805
SY   Catopra Fasciata Fin
DR   NRFC; NRFC039
DR   Wikidata; Q54811440
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=23933168;
WW   Provider; NRFC; NRFC039; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC039.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=302777; ! Pristolepis fasciata (Malayan leaffish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   CFFN2
AC   CVCL_1G76
SY   ClownFish FiN 2
DR   NRFC; NRFC010
DR   Wikidata; Q54811441
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC010; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC010.
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=229075; ! Amphiprion sebae (Sebae anemonefish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   CFG
AC   CVCL_6F71
SY   CatFish Gonad
DR   Wikidata; Q54811442
RX   CelloPub=CLPUB00305;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CFH
AC   CVCL_6F72
SY   CatFish Heart
DR   Wikidata; Q54811443
RX   CelloPub=CLPUB00305;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CFI-3
AC   CVCL_IN79
DR   Wikidata; Q54811444
RX   PubMed=1718974;
RX   PubMed=15463957;
CC   Population: North African.
CC   Doubling time: 24 hours (PubMed=1718974).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser549Asn (c.1646G>A); ClinVar=VCV000007116; Zygosity=Heterozygous (PubMed=1718974).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asn1303Lys (c.3909C>G); ClinVar=VCV000007136; Zygosity=Heterozygous (PubMed=1718974).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9640 ! CFT-1
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 14
//
ID   CFiS-S01
AC   CVCL_E7S1
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_CFiS-S01_1211.pdf
CC   Population: Japanese.
CC   Karyotypic information: 46,XY [19]; 47,XY,+12 [1] (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7S2 ! CFiS-S02
OI   CVCL_E7S3 ! CFiS-S03
OI   CVCL_E7S4 ! CFiS-S04
OI   CVCL_E7S5 ! CFiS-S06
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CFiS-S02
AC   CVCL_E7S2
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_CFiS-S02.pdf
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7S1 ! CFiS-S01
OI   CVCL_E7S3 ! CFiS-S03
OI   CVCL_E7S4 ! CFiS-S04
OI   CVCL_E7S5 ! CFiS-S06
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CFiS-S03
AC   CVCL_E7S3
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_CFiS-S03.pdf
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7S1 ! CFiS-S01
OI   CVCL_E7S2 ! CFiS-S02
OI   CVCL_E7S4 ! CFiS-S04
OI   CVCL_E7S5 ! CFiS-S06
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CFiS-S04
AC   CVCL_E7S4
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_CFiS-S04.pdf
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7S1 ! CFiS-S01
OI   CVCL_E7S2 ! CFiS-S02
OI   CVCL_E7S3 ! CFiS-S03
OI   CVCL_E7S5 ! CFiS-S06
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CFiS-S06
AC   CVCL_E7S5
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_CFiS-S06.pdf
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7S1 ! CFiS-S01
OI   CVCL_E7S2 ! CFiS-S02
OI   CVCL_E7S3 ! CFiS-S03
OI   CVCL_E7S4 ! CFiS-S04
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CFK
AC   CVCL_6F73
SY   CatFish Kidney
DR   Wikidata; Q54811445
RX   CelloPub=CLPUB00305;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CFK1
AC   CVCL_U887
DR   Wikidata; Q54811446
RX   PubMed=2246327;
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U886 ! OBCK6
SX   Sex unspecified
AG   19-20FD
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   CFK2
AC   CVCL_U888
DR   Wikidata; Q54811447
RX   PubMed=2246327;
RX   PubMed=8475797;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-185.html
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U886 ! OBCK6
SX   Sex unspecified
AG   19-20FD
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   CFL
AC   CVCL_C0VV
SY   Cave Fish Livers
DR   GEO; GSM5856815
DR   GEO; GSM5856816
DR   GEO; GSM5856817
DR   Wikidata; Q114310944
RX   PubMed=35710938;
CC   Group: Fish cell line.
CC   Doubling time: 1.7 days (PubMed=35710938).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Pachon cave morph.
OX   NCBI_TaxID=7994; ! Astyanax mexicanus (Blind cave fish)
SX   Sex unspecified
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CFNPE14o-
AC   CVCL_IN66
DR   Wikidata; Q54811448
RX   PubMed=1375758;
RX   PubMed=15463957;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=15463957).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   CFNPE9o-
AC   CVCL_IN65
SY   CFNPE9o(-); CFNPE9o; 2CFNPE9o-
DR   Wikidata; Q54811449
RX   PubMed=1375758;
RX   PubMed=15463957;
WW   Info; Dartmouth; -; https://web.archive.org/web/20190126194809/http://www.dartmouth.edu/~cysfib/cell-lines.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Caution: According to PubMed=1375758 it does not have a p.Phe508del mutation but this is in contradiction with the former web page on the Dartmouth Medical School (see the link to the Internet Archive) that indicates it is homozygous for that mutation.
CC   Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C3256; Nasal cavity polyp
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   CFPAC-1
AC   CVCL_1119
SY   CFPac-1; CF PAC-1; CF-PAC1; CF-Pac1; CF Pac1; CFPAC1; CFPac1; CFPAC
DR   BTO; BTO_0004738
DR   CLO; CLO_0002395
DR   EFO; EFO_0006551
DR   CLDB; cl705
DR   CLDB; cl7121
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1918
DR   BioGRID_ORCS_Cell_line; 439
DR   BioSample; SAMN03471976
DR   BioSample; SAMN10987887
DR   cancercelllines; CVCL_1119
DR   CCRID; 1101HUM-PUMC000245
DR   CCRID; 3101HUMTCHu112
DR   CCRID; 4201HUM-CCTCC00249
DR   CCTCC; GDC0249
DR   Cell_Model_Passport; SIDM00130
DR   CGH-DB; 164-1
DR   CGH-DB; 9273-4
DR   ChEMBL-Cells; CHEMBL3308032
DR   ChEMBL-Targets; CHEMBL613506
DR   CLS; 305066
DR   Cosmic; 710854
DR   Cosmic; 868245
DR   Cosmic; 872998
DR   Cosmic; 906821
DR   Cosmic; 913305
DR   Cosmic; 922259
DR   Cosmic; 923168
DR   Cosmic; 932518
DR   Cosmic; 948375
DR   Cosmic; 948741
DR   Cosmic; 949322
DR   Cosmic; 1006363
DR   Cosmic; 1122343
DR   Cosmic; 1198207
DR   Cosmic; 1299298
DR   Cosmic; 1358477
DR   Cosmic; 1518233
DR   Cosmic; 1571776
DR   Cosmic; 2434110
DR   Cosmic-CLP; 906821
DR   DepMap; ACH-000138
DR   ECACC; 91112501
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906821
DR   GEO; GSM206454
DR   GEO; GSM244428
DR   GEO; GSM621903
DR   GEO; GSM784694
DR   GEO; GSM886925
DR   GEO; GSM887991
DR   GEO; GSM1024400
DR   GEO; GSM1374446
DR   GEO; GSM1374447
DR   GEO; GSM1374448
DR   GEO; GSM1669672
DR   IARC_TP53; 2839
DR   ICLC; HTL01019
DR   IZSLER; BS TCL 166
DR   KCB; KCB 200730YJ
DR   LiGeA; CCLE_601
DR   LINCS_LDP; LCL-1748
DR   PharmacoDB; CFPAC1_193_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   PRIDE; PXD032263
DR   Progenetix; CVCL_1119
DR   PubChem_Cell_line; CVCL_1119
DR   SKY/M-FISH/CGH; 1998
DR   Wikidata; Q28199352
RX   DOI=10.4172/2324-9293.1000104;
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=1692630;
RX   PubMed=10027410;
RX   PubMed=10408907;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12800145;
RX   PubMed=14695172;
RX   PubMed=15126341;
RX   PubMed=15367885;
RX   PubMed=15463957;
RX   PubMed=15688027;
RX   PubMed=16912165;
RX   PubMed=18380791;
RX   PubMed=19077451;
RX   PubMed=20164919;
RX   PubMed=20418756;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/CF%20PAC-1.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (Note=At 17th passage), 32 hours (Note=At 74th passage) (PubMed=1692630); 45 hours (PubMed=25984343); ~32 hours (ATCC=CRL-1918).
CC   HLA typing: A*02:01,03:01; B*35:08,73:01; C*04:01,15:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=10408907; PubMed=11169959; PubMed=11787853; PubMed=15367885; PubMed=18380791).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=15463957; ATCC=CRL-1918).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=11169959; PubMed=11787853; PubMed=15367885; Cosmic-CLP=906821).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Arg (c.724T>C); ClinVar=VCV000449512; Zygosity=Homozygous (PubMed=11169959; PubMed=11787853; PubMed=15367885; Cosmic-CLP=906821).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.95%; Native American=0%; East Asian, North=5.48%; East Asian, South=0%; South Asian=0%; European, North=45.39%; European, South=45.18% (PubMed=30894373).
CC   Misspelling: CFPANC1; CGH-DB=164-1.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-1918; CCRID; Cosmic-CLP=906821; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 13,15
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D6S1043: 20
ST   D7S820: 8,10
ST   D8S1179: 11,15
ST   FGA: 21,22
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   CFPAC-1/Cas9-hyg
AC   CVCL_C9DR
DR   GeneCopoeia; SL540
DR   Wikidata; Q123030903
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL540).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Arg (c.724T>C); ClinVar=VCV000449512; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1119 ! CFPAC-1
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   CFS [Carassius]
AC   CVCL_6F75
SY   Carassius Fin from lake Suwa
DR   Wikidata; Q54811450
RX   PubMed=9156334;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=138676; ! Carassius langsdorfii (Japanese silver crucian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   CFS [Clarias]
AC   CVCL_6F74
SY   CatFish Spleen
DR   Wikidata; Q54811451
RX   CelloPub=CLPUB00305;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   CFS414
AC   CVCL_A7AT
DR   Wikidata; Q107114641
RX   PubMed=35288582;
CC   Group: Bird cell line.
CC   Doubling time: ~23.9 hours (PubMed=35288582).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Continental Chestnut Flanked White; VBO=VBO_0017485.
OX   NCBI_TaxID=59729; ! Taeniopygia guttata (Zebra finch)
SX   Male
AG   Hamburger-Hamilton stage 28 embryo
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CFS414_1G10
AC   CVCL_A7PF
SY   CFS414-pMB952 clone 1G10; CFS414_1G10-952; CFS414_FLEx-SaCas9-P2A-mCherry
DR   Wikidata; Q107114643
RX   PubMed=35288582;
CC   Group: Bird cell line.
CC   Characteristics: Constitutively expresses nuclear GFP (nGFP) and pac and conditionally expresses S.aureus Cas9 and mCherry in the presence of Cre recombinase.
CC   Characteristics: A FLEx-SaCas9-P2A-mCherry construct was transferred using a PiggyBac transposon vector.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; J7RUA5; Staphylococcus aureus Cas9.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Continental Chestnut Flanked White; VBO=VBO_0017485.
OX   NCBI_TaxID=59729; ! Taeniopygia guttata (Zebra finch)
HI   CVCL_A7AT ! CFS414
SX   Male
AG   Hamburger-Hamilton stage 28 embryo
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CFS414_F6
AC   CVCL_A7PE
SY   CFS414 clone F6
DR   Wikidata; Q107114644
RX   PubMed=35288582;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Continental Chestnut Flanked White; VBO=VBO_0017485.
OX   NCBI_TaxID=59729; ! Taeniopygia guttata (Zebra finch)
HI   CVCL_A7AT ! CFS414
SX   Male
AG   Hamburger-Hamilton stage 28 embryo
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   CFSa1
AC   CVCL_6F76
SY   Caudal fin Sparus aurata 1
DR   Wikidata; Q54811452
RX   PubMed=15820747;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   CFSC
AC   CVCL_M104
SY   CCl4-treated Fat Storing Cells
DR   BTO; BTO_0003522
DR   Wikidata; Q54811453
RX   PubMed=1753710;
RX   PubMed=8394478;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   CFSC-2G
AC   CVCL_4U34
DR   Wikidata; Q54811454
RX   PubMed=7635427;
RX   PubMed=8394478;
RX   PubMed=17760834;
RX   PubMed=20594261;
RX   PubMed=36139474;
CC   Karyotypic information: Hyperdiploid karyotype (PubMed=36139474).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M104 ! CFSC
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   CFSC-3H
AC   CVCL_4U35
DR   Wikidata; Q54811455
RX   PubMed=8394478;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M104 ! CFSC
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   CFSC-5H
AC   CVCL_4U36
DR   Wikidata; Q54811456
RX   PubMed=7635427;
RX   PubMed=8394478;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M104 ! CFSC
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   CFSC-8B
AC   CVCL_4U37
DR   Wikidata; Q54811457
RX   PubMed=8394478;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M104 ! CFSC
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   CFSMEo-
AC   CVCL_VP33
DR   Millipore; SCC155
DR   Wikidata; Q93447512
RX   PubMed=16037690;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln2Ter (c.4C>T); ClinVar=VCV000053980; Zygosity=Heterozygous (PubMed=16037690).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=16037690).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, submucosal gland; UBERON=UBERON_8410043.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): Millipore=SCC155
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,14
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 8,13
ST   FGA: 19
ST   Penta D: 9,10
ST   Penta E: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN60 ! 2CFSMEo-
OI   CVCL_IN58 ! 3ACFSMEo-
OI   CVCL_IN62 ! 6CFSMEo-
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 12
//
ID   CFSP
AC   CVCL_1G77
SY   ClownFish SPleen
DR   NRFC; NRFC012
DR   Wikidata; Q54811458
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC012.
CC   Miscellaneous: Cell line is no longer available (NRFC=NRFC012).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=229075; ! Amphiprion sebae (Sebae anemonefish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   CfT
AC   CVCL_E7GP
SY   Chlamys farreri Trochophore
RX   DOI=10.1016/j.aqrep.2025.102626;
CC   Group: Mollusk cell line.
OX   NCBI_TaxID=106299; ! Azumapecten farreri (Farrer's scallop)
AG   Trochophore larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CFT-1
AC   CVCL_9640
DR   Wikidata; Q54811459
RX   PubMed=7682954;
RX   PubMed=7689916;
RX   PubMed=12000003;
RX   PubMed=15463957;
CC   Population: North African.
CC   Doubling time: 24 hours (PubMed=7682954).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser549Asn (c.1646G>A); ClinVar=VCV000007116; Zygosity=Heterozygous (PubMed=15463957).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asn1303Lys (c.3909C>G); ClinVar=VCV000007136; Zygosity=Heterozygous (PubMed=15463957).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN79 ! CFI-3
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 19
//
ID   CFT-2
AC   CVCL_9641
DR   EFO; EFO_0001102
DR   Wikidata; Q54811460
RX   PubMed=7682954;
RX   PubMed=7689916;
RX   PubMed=12000003;
RX   PubMed=15463957;
CC   Doubling time: 24 hours (PubMed=7682954).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=15463957).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: CFT-3; PubMed=15463957.
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   4FM
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 20
//
ID   CFT012
AC   CVCL_9U90
DR   Wikidata; Q54811461
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CFT1
AC   CVCL_G214
DR   Kerafast; ENC001
DR   Wikidata; Q54811462
RX   DOI=10.1007/978-1-4612-0411-4_17;
RX   Patent=US5576206;
RX   PubMed=7684560;
RX   PubMed=15463957;
CC   Group: Patented cell line.
CC   Doubling time: 36.3 hours (Note=At 14th passage) (PubMed=7684560).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=15463957).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=pUC19).
CC   Discontinued: Kerafast; ENC001; true.
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   CFTE29o-
AC   CVCL_IN57
SY   CFTE29o(-); CFTE-29o-; EpsilonCFTE29o-; ECFTE29o-
DR   Millipore; SCC162
DR   Wikidata; Q54811463
RX   PubMed=7683197;
RX   PubMed=15463957;
WW   Info; Dartmouth; -; https://web.archive.org/web/20190126194809/http://www.dartmouth.edu/~cysfib/cell-lines.html
CC   Characteristics: Useful model for cystic fibrosis and for studying chloride ion transport and ion transport in human airways. The cells are useful for testing candidate chemotherapeutic drugs for their potential as treatments for ameliorating CF pathologies (Millipore=SCC162).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=7683197; PubMed=15463957).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
ST   Source(s): Millipore=SCC162
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D18S51: 14
ST   D21S11: 28,31.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 24,26
ST   Penta D: 10,12
ST   Penta E: 7,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 15
//
ID   CFZT(A)
AC   CVCL_3498
DR   CLO; CLO_0002396
DR   ATCC; CRL-6338
DR   Wikidata; Q54811464
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6338; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   CFZT(B)
AC   CVCL_3499
DR   CLO; CLO_0002397
DR   ATCC; CRL-6339
DR   Wikidata; Q54811465
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6339; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   CG-1
AC   CVCL_4J65
DR   Wikidata; Q54811466
RX   PubMed=8358942;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, fibula; UBERON=UBERON_0001446.
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   CG-4
AC   CVCL_0210
SY   CG4
DR   BTO; BTO_0005724
DR   MCCL; MCC:0000099
DR   Wikidata; Q54811467
RX   PubMed=1613821;
RX   PubMed=7751054;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-187.html
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte precursor cell; CL=CL_0002453.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1-3D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   CG-91
AC   CVCL_M729
SY   KG-91
DR   Wikidata; Q54811468
RX   Patent=RU2061753;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 45 5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   CG-SH
AC   CVCL_1K03
DR   Cosmic; 1246920
DR   Wikidata; Q54811469
RX   PubMed=19414191;
RX   PubMed=25934047;
CC   Doubling time: 48-52 hours (PubMed=19414191).
CC   Karyotypic information: Has a normal karyotype.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   CG0006
AC   CVCL_LG36
DR   BCRC; 08C0063
DR   Wikidata; Q54811470
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0008
AC   CVCL_LG37
DR   BCRC; 08C0072
DR   Wikidata; Q54811471
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   CG0020
AC   CVCL_LG38
SY   CG20
DR   BCRC; 60457
DR   Wikidata; Q54811472
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Asn52Ser (c.155A>G); ClinVar=VCV000000479; Zygosity=Heterozygous (BCRC=60457).
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Pro87Ser (c.259C>T); ClinVar=VCV000000480; Zygosity=Heterozygous (BCRC=60457).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C138171; Hyperphenylalaninemia, BH4-deficient A
DI   ORDO; Orphanet_13; 6-pyruvoyl-tetrahydropterin synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   CG0028
AC   CVCL_LG39
SY   CG28
DR   BCRC; 60388
DR   Wikidata; Q54811473
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=60388
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG0035
AC   CVCL_LG40
SY   CG35
DR   BCRC; 60458
DR   Wikidata; Q54811478
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0097
AC   CVCL_LG41
DR   BCRC; 08C0074
DR   Wikidata; Q54811479
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0074
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG0099
AC   CVCL_LG42
DR   BCRC; 08C0073
DR   Wikidata; Q54811480
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0100
AC   CVCL_LG43
DR   BCRC; 08C0052
DR   Wikidata; Q54811481
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0101
AC   CVCL_LG44
DR   BCRC; 08C0053
DR   Wikidata; Q54811482
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0103
AC   CVCL_LG45
DR   BCRC; 08C0054
DR   Wikidata; Q54811483
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0106
AC   CVCL_LG46
DR   BCRC; 08C0055
DR   Wikidata; Q54811484
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0107
AC   CVCL_LG47
DR   BCRC; 08C0051
DR   Wikidata; Q54811485
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0051
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D5S818: 7,12
ST   D7S820: 12,14
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG0108
AC   CVCL_LG48
DR   BCRC; 08C0056
DR   Wikidata; Q54811486
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0110
AC   CVCL_LG49
DR   BCRC; 08C0050
DR   Wikidata; Q54811487
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0113
AC   CVCL_LG50
SY   CG00113
DR   BCRC; 08C0049
DR   Wikidata; Q54811488
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0161
AC   CVCL_LG51
SY   CG161
DR   BCRC; 60401
DR   Wikidata; Q54811489
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=60401
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG0176
AC   CVCL_LG52
DR   BCRC; 08C0048
DR   Wikidata; Q54811491
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   CG0284
AC   CVCL_LG53
SY   CG284
DR   BCRC; 08C0017
DR   BCRC; 60389
DR   Wikidata; Q54811492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 7
//
ID   CG0289
AC   CVCL_LG54
DR   BCRC; 08C0018
DR   Wikidata; Q54811493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG0290
AC   CVCL_LG55
DR   BCRC; 08C0019
DR   Wikidata; Q54811494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG0319
AC   CVCL_LG56
DR   BCRC; 08C0020
DR   Wikidata; Q54811495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG0330
AC   CVCL_LG57
DR   BCRC; 08C0021
DR   Wikidata; Q54811496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG0396
AC   CVCL_LG58
DR   BCRC; 60459
DR   Wikidata; Q54811497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG0446
AC   CVCL_LG59
SY   CG446
DR   BCRC; 08C0032
DR   Wikidata; Q54811498
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
ST   Source(s): BCRC=08C0032
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG0467
AC   CVCL_LG60
SY   CG467
DR   BCRC; 08C0022
DR   Wikidata; Q54811499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG0468
AC   CVCL_LH36
DR   BCRC; 08C0031
DR   Wikidata; Q54811500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0031
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 8,10
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG0999
AC   CVCL_LG61
SY   CG999
DR   BCRC; 08C0067
DR   Wikidata; Q54811501
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   CG1 [Human nasopharyngeal carcinoma]
AC   CVCL_J445
DR   Wikidata; Q54811502
RX   PubMed=2479472;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~20 hours (Note=In a medium with 10% FBS), ~29 hours (Note=In a medium with 2.5% FBS) (PubMed=2479472).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   CG1 [Mouse mammary carcinoma]
AC   CVCL_0A62
DR   Wikidata; Q54811503
RX   PubMed=6087454;
RX   PubMed=6415065;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03522; Vesicular stomatitis Indiana virus (strain San Juan) glycoprotein (G).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   CG1/1
AC   CVCL_B6D6
DR   Wikidata; Q111733096
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47) 41 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG1000
AC   CVCL_LG62
SY   CG 1000
DR   BCRC; 60402
DR   Wikidata; Q54811504
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_28; Vitamin B12-responsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1001
AC   CVCL_WU74
DR   BCRC; 60403
DR   Wikidata; Q93447683
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Misidentified/contaminated. Shown to be 100% identical to CG1000 (BCRC=60403).
CC   Discontinued: BCRC; 60403; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_28; Vitamin B12-responsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LG62 ! CG1000
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   CG1006
AC   CVCL_LG63
DR   BCRC; 08C0068
DR   Wikidata; Q54811505
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0068
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 8,12
ST   D5S818: 10,14
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 9
//
ID   CG1070
AC   CVCL_LG64
DR   BCRC; 08C0023
DR   Wikidata; Q54811506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0023
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 7,8
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1149
AC   CVCL_LG65
SY   CG 1149
DR   BCRC; 08C0024
DR   Wikidata; Q54811507
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Asn52Ser (c.155A>G); ClinVar=VCV000000479; Zygosity=Heterozygous (BCRC=08C0024).
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Pro87Ser (c.259C>T); ClinVar=VCV000000480; Zygosity=Heterozygous (BCRC=08C0024).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0024
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   TH01: 7,10
ST   TPOX: 9
ST   vWA: 19
DI   NCIt; C138171; Hyperphenylalaninemia, BH4-deficient A
DI   ORDO; Orphanet_13; 6-pyruvoyl-tetrahydropterin synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   CG1150
AC   CVCL_LG66
DR   BCRC; 60461
DR   Wikidata; Q54811508
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Asn52Ser (c.155A>G); ClinVar=VCV000000479; Zygosity=Heterozygous (BCRC=60461).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   CG1151
AC   CVCL_LG67
DR   BCRC; 60462
DR   Wikidata; Q54811509
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Pro87Ser (c.259C>T); ClinVar=VCV000000480; Zygosity=Heterozygous (BCRC=60462).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   CG1152
AC   CVCL_LG68
DR   BCRC; 08C0069
DR   Wikidata; Q54811510
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0069
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 9
//
ID   CG1164
AC   CVCL_LG69
DR   BCRC; 60463
DR   Wikidata; Q54811511
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Asn52Ser (c.155A>G); ClinVar=VCV000000479; Zygosity=Heterozygous (BCRC=60463).
CC   Sequence variation: Mutation; HGNC; HGNC:9689; PTS; Simple; p.Pro87Ser (c.259C>T); ClinVar=VCV000000480; Zygosity=Heterozygous (BCRC=60463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C138171; Hyperphenylalaninemia, BH4-deficient A
DI   ORDO; Orphanet_13; 6-pyruvoyl-tetrahydropterin synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   CG12
AC   CVCL_B6D8
DR   Wikidata; Q111733099
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG1251
AC   CVCL_LG70
DR   BCRC; 08C0038
DR   Wikidata; Q54811512
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   CG1252
AC   CVCL_LG71
DR   BCRC; 60465
DR   Wikidata; Q54811513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1253
AC   CVCL_LG72
DR   BCRC; 60466
DR   Wikidata; Q54811514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1254
AC   CVCL_LG73
DR   BCRC; 60467
DR   Wikidata; Q54811515
CC   Sequence variation: Mutation; HGNC; HGNC:9752; QDPR; Simple; p.Thr233Pro (c.697A>C); Zygosity=Unspecified (BCRC=60467).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C138173; Hyperphenylalaninemia, BH4-deficient C
DI   ORDO; Orphanet_226; Dihydropteridine reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   CG1265
AC   CVCL_LG74
DR   BCRC; 08C0039
DR   Wikidata; Q54811516
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   CG1266
AC   CVCL_LG75
DR   BCRC; 08C0037
DR   Wikidata; Q54811517
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CG1297
AC   CVCL_LG76
DR   BCRC; 08C0060
DR   Wikidata; Q54811518
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG13/14/2
AC   CVCL_B6DA
DR   Wikidata; Q111733100
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG1332
AC   CVCL_LG77
DR   BCRC; 08C0042
DR   Wikidata; Q54811525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0042
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1357
AC   CVCL_LG78
DR   BCRC; 08C0075
DR   Wikidata; Q54811526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0075
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   TH01: 8,10
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1358
AC   CVCL_LG79
DR   BCRC; 08C0065
DR   Wikidata; Q54811527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1359
AC   CVCL_LG80
DR   BCRC; 08C0070
DR   Wikidata; Q54811528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0070
ST   Amelogenin: X,Y
ST   CSF1PO: 12,15
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1360
AC   CVCL_LG81
DR   BCRC; 08C0064
DR   Wikidata; Q54811529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG14/3/1
AC   CVCL_B6DG
DR   Wikidata; Q111733102
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG1427
AC   CVCL_LG82
DR   BCRC; 08C0076
DR   Wikidata; Q54811530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1428
AC   CVCL_LG83
DR   BCRC; 08C0077
DR   Wikidata; Q54811531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1429
AC   CVCL_LG84
DR   BCRC; 08C0080
DR   Wikidata; Q54811532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0080
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1449
AC   CVCL_LG85
DR   BCRC; 08C0046
DR   Wikidata; Q54811533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1469
AC   CVCL_LG86
DR   BCRC; 08C0066
DR   Wikidata; Q54811534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1472
AC   CVCL_LG87
DR   BCRC; 08C0078
DR   Wikidata; Q54811535
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0078
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 10,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C98674; Methylcrotonyl-CoA carboxylase deficiency
DI   ORDO; Orphanet_6; 3-methylcrotonyl-CoA carboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 9
//
ID   CG1474
AC   CVCL_LG88
DR   BCRC; 08C0079
DR   Wikidata; Q54811536
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0079
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 9
//
ID   CG1475
AC   CVCL_LG89
DR   BCRC; 08C0061
DR   Wikidata; Q54811537
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1476
AC   CVCL_GT20
DR   BCRC; 08C0057
DR   Wikidata; Q54811538
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GT21 ! CG1485
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   CG1480
AC   CVCL_LG90
DR   BCRC; 08C0043
DR   Wikidata; Q54811539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0043
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,9
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1483
AC   CVCL_LG91
DR   BCRC; 08C0040
DR   Wikidata; Q54811540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0040
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1484
AC   CVCL_LG92
DR   BCRC; 08C0058
DR   Wikidata; Q54811541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0058
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1485
AC   CVCL_GT21
DR   BCRC; 08C0044
DR   Wikidata; Q54811542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0044
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GT20 ! CG1476
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 02-05-24; Version: 8
//
ID   CG1486
AC   CVCL_LG93
DR   BCRC; 08C0045
DR   Wikidata; Q54811543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0045
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 9,13
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1519
AC   CVCL_LG94
DR   BCRC; 08C0059
DR   Wikidata; Q54811544
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1533
AC   CVCL_LG96
DR   BCRC; 08C0062
DR   Wikidata; Q54811546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1538
AC   CVCL_LG95
DR   BCRC; 08C0041
DR   Wikidata; Q54811545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0041
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1539
AC   CVCL_LG97
DR   BCRC; 08C0002
DR   Wikidata; Q54811547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1541
AC   CVCL_LG98
DR   BCRC; 08C0010
DR   Wikidata; Q54811548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1549
AC   CVCL_LG99
DR   BCRC; 08C0082
DR   Wikidata; Q54811549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1550
AC   CVCL_LH00
DR   BCRC; 08C0087
DR   Wikidata; Q54811550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1576
AC   CVCL_LH01
DR   BCRC; 08C0001
DR   Wikidata; Q54811551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1599
AC   CVCL_LH02
DR   BCRC; 08C0006
DR   Wikidata; Q54811552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1609
AC   CVCL_LH03
DR   BCRC; 08C0007
DR   Wikidata; Q54811553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0007
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 7,10
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG1610
AC   CVCL_LH04
DR   BCRC; 08C0008
DR   Wikidata; Q54811554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1629
AC   CVCL_LH05
DR   BCRC; 08C0011
DR   Wikidata; Q54811555
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1630
AC   CVCL_LH06
DR   BCRC; 08C0014
DR   Wikidata; Q54811556
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0014
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1631
AC   CVCL_LH07
DR   BCRC; 08C0012
DR   Wikidata; Q54811557
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0012
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1632
AC   CVCL_LH08
DR   BCRC; 08C0015
DR   Wikidata; Q54811558
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0015
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1633
AC   CVCL_LH09
DR   BCRC; 08C0013
DR   Wikidata; Q54811559
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0013
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1634
AC   CVCL_LH10
DR   BCRC; 08C0016
DR   Wikidata; Q54811560
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0016
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1635
AC   CVCL_LH11
DR   BCRC; 08C0025
DR   Wikidata; Q54811561
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0025
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 7,10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1637
AC   CVCL_LH12
DR   BCRC; 08C0026
DR   Wikidata; Q54811562
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0026
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1638
AC   CVCL_LH13
DR   BCRC; 08C0027
DR   Wikidata; Q54811563
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0027
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1639
AC   CVCL_LH14
DR   BCRC; 08C0029
DR   Wikidata; Q54811564
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0029
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1640
AC   CVCL_LH15
DR   BCRC; 08C0028
DR   Wikidata; Q54811567
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BCRC=08C0028
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1645
AC   CVCL_LH16
DR   BCRC; 08C0083
DR   Wikidata; Q54811568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1646
AC   CVCL_LH17
DR   BCRC; 08C0084
DR   Wikidata; Q54811569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1647
AC   CVCL_LH18
DR   BCRC; 08C0086
DR   Wikidata; Q54811570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   CG1669
AC   CVCL_LH19
DR   BCRC; 08C0009
DR   Wikidata; Q54811571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   CG1672
AC   CVCL_LH20
DR   BCRC; 08C0081
DR   Wikidata; Q54811572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0081
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 9,10
ST   D16S539: 9,11
ST   D5S818: 7,10
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 8
//
ID   CG1680
AC   CVCL_LH21
DR   BCRC; 08C0005
DR   Wikidata; Q54811573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BCRC=08C0005
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   CG2
AC   CVCL_A9AL
SY   Ch-CG2
DR   cancercelllines; CVCL_A9AL
DR   IARC_TP53; 1900
DR   Wikidata; Q108820010
RX   PubMed=1336431;
RX   PubMed=2159089;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236His (c.706T>C); ClinVar=VCV000216469; Zygosity=Unspecified (PubMed=1336431).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Val (c.709A>G); ClinVar=VCV000182934; Zygosity=Unspecified (PubMed=1336431).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=1336431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3178; Chronic myelomonocytic leukemia
DI   ORDO; Orphanet_98823; Chronic myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   57Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   CG2/2D
AC   CVCL_B6D7
DR   Wikidata; Q111733103
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG3 [Human leukemia]
AC   CVCL_A9AM
SY   Ch-CG3
DR   IARC_TP53; 1901
DR   Wikidata; Q108820011
RX   PubMed=1336431;
RX   PubMed=2159089;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu289His (c.866T>A); Zygosity=Unspecified (PubMed=1336431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3519; Atypical chronic myeloid leukemia, BCR-ABL1 negative
DI   ORDO; Orphanet_98824; Atypical chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   CG3 [Mouse hybridoma against vaccinia A25]
AC   CVCL_E5S8
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CG3/12/26
AC   CVCL_B6DF
DR   Wikidata; Q111733104
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG31
AC   CVCL_B6DB
DR   Wikidata; Q111733105
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG41/44/11
AC   CVCL_B6DC
DR   Wikidata; Q111733106
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG49
AC   CVCL_B6DD
DR   Wikidata; Q111733107
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2a, kappa+lambda.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG53/2/4
AC   CVCL_B6DE
DR   Wikidata; Q111733109
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47) 100 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG6
AC   CVCL_E5RL
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CG7
AC   CVCL_B6D9
DR   Wikidata; Q111733110
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CG7C7
AC   CVCL_G645
DR   CLO; CLO_0002399
DR   ABCD; ABCD_AE804
DR   ATCC; HB-126
DR   Wikidata; Q54811575
RX   PubMed=6193965;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CGBC 01
AC   CVCL_VG71
SY   CGBC01; Chang-Gung Breast Cancer 01
DR   BCRC; 60610
DR   Wikidata; Q54811576
RX   PubMed=29484537;
CC   Population: Chinese; Han in Taiwan.
CC   Characteristics: ER/PR-positive and ERBB2-negative.
CC   Doubling time: 30.68 hours (PubMed=29484537).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=29484537
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 23,24
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   CGBC 02
AC   CVCL_VG72
SY   CGBC02; Chang-Gung Breast Cancer 02
DR   Wikidata; Q54811577
RX   PubMed=29484537;
CC   Population: Chinese; Han in Taiwan.
CC   Characteristics: ER/PR-positive and ERBB2-negative.
CC   Doubling time: 52.34 hours (PubMed=29484537).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=29484537
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 13.2,15.2
ST   D21S11: 29,31
ST   D2S1338: 17,22
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   CGBQ
AC   CVCL_6383
SY   CG-BQ; SPGC-CCL169
DR   CLO; CLO_0002404
DR   ATCC; CCL-169
DR   Wikidata; Q54811578
RX   CelloPub=CLPUB00029;
RX   PubMed=18766641;
RX   PubMed=34737324;
CC   Group: Bird cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Anser anser anser origin but found to be from Anser cygnoides (PubMed=34737324).
CC   Misspelling: CBGQ; Note=Occasionally.
CC   Derived from site: In situ; Embryonic sternum; UBERON=UBERON_0000975.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8845; ! Anser cygnoides (Swan goose)
SX   Sex unspecified
AG   15-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   CGCCA
AC   CVCL_5U54
SY   Chang Gung CCA
DR   Wikidata; Q54811579
RX   PubMed=21734803;
CC   Doubling time: 32 hours (PubMed=21734803).
CC   Transformant: ChEBI; CHEBI_32497; Thiocetamide.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 7
//
ID   CGD-01
AC   CVCL_WA42
SY   CGD-1
DR   IBRC; C10378
DR   Wikidata; Q93447980
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-02
AC   CVCL_WA43
SY   CGD-2
DR   IBRC; C10397
DR   Wikidata; Q93447983
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-03
AC   CVCL_WA44
SY   CGD-3
DR   IBRC; C10398
DR   Wikidata; Q93447985
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-04
AC   CVCL_WA45
SY   CGD-4
DR   IBRC; C10408
DR   Wikidata; Q93447987
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-05
AC   CVCL_WA46
SY   CGD-5
DR   IBRC; C10573
DR   Wikidata; Q93447989
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-06
AC   CVCL_WA47
DR   IBRC; C10696
DR   Wikidata; Q93447991
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-07
AC   CVCL_WA48
DR   IBRC; C10697
DR   Wikidata; Q93447994
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-08
AC   CVCL_WA49
DR   IBRC; C10704
DR   Wikidata; Q93447996
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-09
AC   CVCL_WA50
DR   IBRC; C10709
DR   Wikidata; Q93447998
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-10
AC   CVCL_WA51
DR   IBRC; C10770
DR   Wikidata; Q93448001
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-11
AC   CVCL_WA52
DR   IBRC; C10830
DR   Wikidata; Q93448004
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-12
AC   CVCL_WA53
DR   IBRC; C10849
DR   Wikidata; Q93448006
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-13
AC   CVCL_WA54
DR   IBRC; C10850
DR   Wikidata; Q93448008
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-14
AC   CVCL_WA55
DR   IBRC; C10851
DR   Wikidata; Q93448010
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-17
AC   CVCL_WA56
DR   IBRC; C10878
DR   Wikidata; Q93448012
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-19
AC   CVCL_WA57
DR   IBRC; C10970
DR   Wikidata; Q93448014
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGD-20
AC   CVCL_WA58
DR   IBRC; C11042
DR   Wikidata; Q93448017
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CGF
AC   CVCL_E7BM
SY   Coreius Guichenoti Fin
RX   DOI=10.1016/j.aquaculture.2024.740749;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 20 to 28 Celsius, the optimal temperature is 28 Celsius (DOI=10.1016/j.aquaculture.2024.740749).
CC   Virology: Susceptible to infection by spring viremia of carp virus (SVCV) (DOI=10.1016/j.aquaculture.2024.740749).
CC   Doubling time: 68.28 hours (Note=With 20% FBS at 24 Celsius), 88.19 hours (Note=With 15% FBS at 24 Celsius), 80.45 hours (Note=With 15% FBS at 28 Celsius) (DOI=10.1016/j.aquaculture.2024.740749).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Myofibroblast; CL=CL_0000186.
OX   NCBI_TaxID=328532; ! Coreius guichenoti (Largemouth bronze gudgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CGFR-BO-1
AC   CVCL_1E25
SY   Cell Growth and Function Regulation-BOvine-1
DR   Wikidata; Q54811585
RX   PubMed=15529005;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   CGFR-BO-2
AC   CVCL_1E26
SY   Cell Growth and Function Regulation-BOvine-2
DR   Wikidata; Q54811586
RX   PubMed=15529005;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   CGFR-Ca-1
AC   CVCL_A5YE
SY   Cell Growth and Function Regulation-Canine-1
DR   Wikidata; Q107114646
RX   PubMed=15365251;
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   CGFR-Ca-1-H-Ras
AC   CVCL_E3E1
RX   PubMed=15365251;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A5YE ! CGFR-Ca-1
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CGFR-Ca-1-Puro
AC   CVCL_E3E2
RX   PubMed=15365251;
CC   Characteristics: Control cell line for CGFR-Ca-1-H-Ras (Cellosaurus=CVCL_E3E1) (PubMed=15365251).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A5YE ! CGFR-Ca-1
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   CGFR-Ca-2
AC   CVCL_A5YF
SY   Cell Growth and Function Regulation-Canine-2
DR   Wikidata; Q107114647
RX   PubMed=15365251;
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Unexplicit; Not described; Zygosity=Unspecified (PubMed=15365251).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CGFR-Ca-2-H-Ras
AC   CVCL_E3E3
RX   PubMed=15365251;
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Unexplicit; Not described; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A5YF ! CGFR-Ca-2
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CGFR-Ca-2-Puro
AC   CVCL_E3E4
RX   PubMed=15365251;
CC   Characteristics: Control cell line for CGFR-Ca-2-H-Ras (Cellosaurus=CVCL_E3E3) (PubMed=15365251).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Unexplicit; Not described; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A5YF ! CGFR-Ca-2
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CGFR-Ca-3
AC   CVCL_A5YG
SY   Cell Growth and Function Regulation-Canine-3
DR   Wikidata; Q107114648
RX   PubMed=15365251;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CGFR-Ca-3-H-Ras
AC   CVCL_E3E5
RX   PubMed=15365251;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A5YG ! CGFR-Ca-3
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CGFR-Ca-3-Puro
AC   CVCL_E3E6
RX   PubMed=15365251;
CC   Characteristics: Control cell line for CGFR-Ca-3-H-Ras (Cellosaurus=CVCL_E3E5) (PubMed=15365251).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A5YG ! CGFR-Ca-3
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CGL1
AC   CVCL_C8P0
SY   CGL 1
DR   Wikidata; Q123030904
RX   PubMed=7323948;
RX   PubMed=20927602;
ST   Source(s): PubMed=20927602
ST   Amelogenin: X,Y
ST   CSF1PO: 8,9,10
ST   D13S317: 9,12,13.3
ST   D16S539: 9,10,11,13
ST   D5S818: 11,12
ST   D7S820: 8,12,14
ST   TH01: 6,7,9.3
ST   TPOX: 8,10,12
ST   vWA: 16,17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8NZ ! ESH5
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 3
//
ID   CGL2
AC   CVCL_C8P1
SY   CGL-2; CGL 2
DR   BTO; BTO_0006503
DR   Wikidata; Q123030905
RX   PubMed=7323948;
RX   PubMed=15471901;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8NZ ! ESH5
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CGL3
AC   CVCL_C8P2
SY   CGL 3
DR   Wikidata; Q123030907
RX   PubMed=7323948;
CC   Characteristics: Tumorigenic (PubMed=7323948).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8NZ ! ESH5
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CGL4
AC   CVCL_C8P3
SY   CGL 4
DR   Wikidata; Q123030908
RX   PubMed=7323948;
CC   Characteristics: Tumorigenic (PubMed=7323948).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8NZ ! ESH5
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CGLK-1
AC   CVCL_HF49
DR   Wikidata; Q54811580
RX   PubMed=23460275;
CC   From: Chang Gung Memorial Hospital, Lin-Kou Medical Centre, Chang Gung University; Tao-Yuan; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   CGLK-2
AC   CVCL_HF50
DR   Wikidata; Q54811581
RX   PubMed=23460275;
CC   From: Chang Gung Memorial Hospital, Lin-Kou Medical Centre, Chang Gung University; Tao-Yuan; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   CGM1
AC   CVCL_7251
DR   CLO; CLO_0050078
DR   BioSample; SAMN03472291
DR   dbMHC; 48720
DR   ECACC; 94050319
DR   IHW; IHW09207
DR   IPD-IMGT/HLA; 10407
DR   RCB; RCB0566
DR   Wikidata; Q54811582
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*03:01:01:01,29:02; B*08:01:01,14:02:01; C*08:02,07:01:01; DPB1*04:01 (IPD-IMGT/HLA=10407).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): RCB=RCB0566
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 8,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
ID   CGMCC-10417
AC   CVCL_A0NV
DR   Wikidata; Q108820012
RX   Patent=US10882900;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10417.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CGMCC-13827
AC   CVCL_B0F4
DR   Wikidata; Q108820013
RX   Patent=US10428139;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.13827.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Aspergillus fumigatus (strain ATCC-1022) galactomannan antigen (GM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CGMCC-14696
AC   CVCL_WV96
DR   Wikidata; Q93448043
RX   Patent=US10696748;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.14696.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_3732; Clarithromycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 5
//
ID   CGMCC-14697
AC   CVCL_XY46
DR   Wikidata; Q93448045
RX   Patent=US11603414;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.14697.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_4046; Cyproheptadine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   CGMCC-14700
AC   CVCL_YU28
DR   Wikidata; Q95988751
RX   Patent=US10562979;
RX   PubMed=33455779;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.14700.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_6741; Meloxicam.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   CGMCC-18525
AC   CVCL_A0QP
DR   Wikidata; Q108820014
RX   Patent=US10882896;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18525.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_189548; 3,5-dinitrosalicylic acid hydrazide (DNSH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   CGMCC-3240
AC   CVCL_C4AV
DR   ABCD; ABCD_AF631
DR   Wikidata; Q116048731
RX   Patent=CN101659702B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.3240.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P27824; Human CANX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CGMHi001-A
AC   CVCL_WG66
SY   CGMH.SLC26A4919-2
DR   hPSCreg; CGMHi001-A
DR   SKIP; SKIP005552
DR   Wikidata; Q93448047
RX   PubMed=31415960;
CC   From: Chang Gung Memorial Hospital, Lin-Kou Medical Centre, Chang Gung University; Tao-Yuan; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; c.919-2A>G (IVS7AS,A-G,-2); ClinVar=VCV000004840; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=31415960).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158787; Deafness, autosomal recessive 4, with enlarged vestibular aqueduct
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   CGMHi002-A
AC   CVCL_WP73
SY   CGMH-iPSCs-PARK14-1
DR   hPSCreg; CGMHi002-A
DR   SKIP; SKIP005563
DR   Wikidata; Q93448049
RX   PubMed=31493761;
CC   From: Chang Gung Memorial Hospital, Lin-Kou Medical Centre, Chang Gung University; Tao-Yuan; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Asp331Tyr (c.991G>T); ClinVar=VCV000030371; Zygosity=Heterozygous (PubMed=31493761).
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Met358Ilefs*7 (c.1077G>A) (p.Ser359Ser); ClinVar=VCV000279875; Zygosity=Heterozygous; Note=Cryptic splice site mutation (PubMed=31493761).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201519; Parkinson disease 14, autosomal recessive
DI   ORDO; Orphanet_199351; Adult-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   CGP04
AC   CVCL_E522
DR   dbMHC; 48721
DR   IHW; IHW09425
DR   IPD-IMGT/HLA; 26028
DR   Wikidata; Q54811583
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01,29:02; B*35:01:01,44:03:01; C*04:01,16:01; DPB1*02:01:02,04:02; DQB1*05:01:01; DRB1*01:01:01 (IPD-IMGT/HLA=26028).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   CGR8
AC   CVCL_3987
SY   CGR-8
DR   BTO; BTO_0004308
DR   CLO; CLO_0002405
DR   EFO; EFO_0006273
DR   CLDB; cl713
DR   ECACC; 07032901
DR   ECACC; 95011018
DR   GEO; GSM428967
DR   TOKU-E; 4123
DR   Wikidata; Q54811584
RX   PubMed=8183905;
RX   PubMed=16086633;
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 95011018; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   CGR8-NS
AC   CVCL_A5EL
DR   Wikidata; Q107114650
RX   PubMed=16086633;
RX   PubMed=16766697;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3987 ! CGR8
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   CGRM03C3TT
AC   CVCL_B7NC
SY   C3
DR   Wikidata; Q112929375
RX   PubMed=34999422;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   CGRM03SB3CC
AC   CVCL_B7ND
SY   SB3
DR   Wikidata; Q112929376
RX   PubMed=34999422;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5293; HTR2A; Simple; p.Ser34Ser (c.102T>C) (T102C) (rs6313); ClinVar=VCV000515935; Zygosity=Homozygous (PubMed=34999422).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C73511; Bruxism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   CGSK
AC   CVCL_E7BN
SY   Coreius Guichenoti SKin
RX   DOI=10.1016/j.aquaculture.2024.740749;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 20 to 28 Celsius, the optimal temperature is 28 Celsius (DOI=10.1016/j.aquaculture.2024.740749).
CC   Virology: Susceptible to infection by spring viremia of carp virus (SVCV) (DOI=10.1016/j.aquaculture.2024.740749).
CC   Doubling time: 91.15 hours (Note=With 20% FBS at 24 Celsius), 102.01 hours (Note=With 15% FBS at 24 Celsius), 81.91 hours (Note=With 15% FBS at 28 Celsius) (DOI=10.1016/j.aquaculture.2024.740749).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=328532; ! Coreius guichenoti (Largemouth bronze gudgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CGT-5
AC   CVCL_F0KQ
RX   PubMed=1309953;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1G40 ! AtT-20ins
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CGT-6
AC   CVCL_6566
SY   AtT-20ins (CGT-6); CGT6
DR   CLO; CLO_0001768
DR   ATCC; CRL-11285
DR   Wikidata; Q54811587
RX   Patent=US5427940;
RX   PubMed=1309953;
RX   PubMed=8325893;
RX   PubMed=8433987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11285.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: ATCC; CRL-11285; true.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: LAF1.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1G40 ! AtT-20ins
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   CGTH-W-1
AC   CVCL_1120
SY   CGTH-W1; CGTH W-1; CGTHW1
DR   BTO; BTO_0004740
DR   CLO; CLO_0002406
DR   EFO; EFO_0002131
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470999
DR   BioSample; SAMN03473318
DR   BioSample; SAMN10987694
DR   cancercelllines; CVCL_1120
DR   Cell_Model_Passport; SIDM01248
DR   ChEMBL-Cells; CHEMBL3308849
DR   ChEMBL-Targets; CHEMBL2366300
DR   Cosmic; 910568
DR   Cosmic; 1995365
DR   Cosmic; 2054098
DR   Cosmic-CLP; 910568
DR   DepMap; ACH-001023
DR   DSMZ; ACC-360
DR   DSMZCellDive; ACC-360
DR   EGA; EGAS00001000978
DR   GDSC; 910568
DR   GEO; GSM886926
DR   GEO; GSM887992
DR   GEO; GSM1669673
DR   IARC_TP53; 21223
DR   IGRhCellID; CGTHW1
DR   LINCS_LDP; LCL-1691
DR   PharmacoDB; CGTHW1_194_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1120
DR   PubChem_Cell_line; CVCL_1120
DR   Wikidata; Q54811588
RX   PubMed=8826082;
RX   PubMed=8888804;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23833040;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW579 derivative (PubMed=25877200; DSMZ). Originally thought to originate from a thyroid gland follicular carcinoma metastasizing to the sternum of a 70 year old Chinese female patient.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00536.
CC   Population: Caucasian.
CC   Doubling time: ~18 hours (PubMed=8888804); ~20-25 hours (DSMZ=ACC-360).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Ser (c.764T>G); ClinVar=VCV000376622; Zygosity=Homozygous (Cosmic-CLP=910568; DepMap=ACH-001023).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=2.04%; East Asian, North=0.24%; East Asian, South=0%; South Asian=1.16%; European, North=64.53%; European, South=32.03% (PubMed=30894373).
CC   Discontinued: DSMZ; ACC-360; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=910568; DSMZ=ACC-360; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 15,17
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 9,11 (DSMZ=ACC-360)
ST   D5S818: 11 (Cosmic-CLP=910568; PubMed=25877200)
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 21,24 (PubMed=25877200)
ST   FGA: 21,24,25 (DSMZ=ACC-360)
ST   Penta D: 9 (PubMed=25877200)
ST   Penta D: 9,11,12 (DSMZ=ACC-360)
ST   Penta E: 11 (PubMed=25877200)
ST   Penta E: 11,12 (DSMZ=ACC-360)
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C46008; Thyroid gland squamous cell carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3603 ! SW579
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   CGTH-W-2
AC   CVCL_3897
SY   CGTH-W2; CGTH W-2
DR   BTO; BTO_0004741
DR   Wikidata; Q54811589
RX   PubMed=8888804;
CC   Population: Chinese.
CC   Doubling time: ~20 hours (PubMed=8888804).
CC   Derived from site: Metastatic; Skull; UBERON=UBERON_0003129.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   CGTH-W-3
AC   CVCL_3898
SY   CGTH-W3; CGTH W-3
DR   BTO; BTO_0004739
DR   Wikidata; Q54811590
RX   PubMed=8888804;
CC   Population: Chinese.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   CH
AC   CVCL_D7CL
RX   PubMed=1849869;
RX   PubMed=7987813;
RX   PubMed=8340107;
CC   Doubling time: ~30 hours (PubMed=8340107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ch 1 Es
AC   CVCL_2401
SY   Ch1.Es; Ch1Es; Ch 1 Es (NBL-8); NBL-8
DR   CLO; CLO_0002407
DR   CLO; CLO_0002409
DR   ATCC; CCL-73
DR   ATCC; CRL-6581
DR   BCRJ; 0066
DR   JCRB; JCRB9037
DR   KCLB; 10073
DR   Wikidata; Q54811591
RX   DOI=10.1007/BF02618370;
RX   PubMed=5587551;
RX   PubMed=6988327;
RX   PubMed=7989438;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Discontinued: ATCC; CRL-6581; true.
CC   Discontinued: KCLB; 10073; probable.
CC   Derived from site: In situ; Fetal esophagus; UBERON=UBERON_0001043.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   CH 8
AC   CVCL_M020
SY   CH8
DR   Wikidata; Q54811592
RX   PubMed=20461036;
CC   Derived from site: In situ; Bone, lumbar spine; UBERON=UBERON_0006074.
DI   NCIt; C5156; Spinal chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   CH-01
AC   CVCL_C7NF
SY   Clone 3; anti-CHRNB2 mAb-3
DR   Wikidata; Q117704239
RX   Patent=US12098205;
RX   PubMed=34331011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02857.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P17787; Human CHRNB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   Ch-1
AC   CVCL_M602
DR   Wikidata; Q54811593
RX   PubMed=9820274;
CC   Doubling time: 2 days (PubMed=9820274).
CC   Derived from site: In situ; Bone, thoracic vertebra; UBERON=UBERON_0002347.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   CH-157MN
AC   CVCL_5723
SY   CH157-MN; CH-157-MN; CH-157 MN; CH157MN
DR   BioSample; SAMN10988423
DR   cancercelllines; CVCL_5723
DR   Cell_Model_Passport; SIDM01543
DR   Cosmic; 2516046
DR   DepMap; ACH-000025
DR   PharmacoDB; CH157MN_195_2019
DR   Wikidata; Q54811594
RX   PubMed=7714613;
RX   PubMed=10083766;
RX   PubMed=18261772;
RX   PubMed=25984343;
RX   PubMed=28552950;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=34850056;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=25984343); 1 day (PubMed=34850056).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (DepMap=ACH-000025).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28552950).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0.5%; Native American=0%; East Asian, North=2.54%; East Asian, South=0%; South Asian=0.15%; European, North=57.82%; European, South=38.99% (PubMed=30894373).
CC   Caution: Indicated as originating from a 41 year old female patient in PubMed=7714613, from a 59 year old in PubMed=10083766 and from a 55 year old in PubMed=18261772.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   CH-157MN-LucNeo
AC   CVCL_HA68
SY   CH-157-MN-LucNeo
DR   cancercelllines; CVCL_HA68
DR   Wikidata; Q54811595
RX   PubMed=18240927;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5723 ! CH-157MN
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   CH-235MG
AC   CVCL_5724
DR   Wikidata; Q54811596
RX   PubMed=1639861;
RX   PubMed=1732280;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   ch-2879
AC   CVCL_9921
SY   CH-2879; CH2879
DR   Cosmic; 1602477
DR   Cosmic; 1992324
DR   IARC_TP53; 27034
DR   Wikidata; Q54811597
RX   PubMed=12808123;
RX   PubMed=19787792;
RX   PubMed=22057234;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 8,9
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D8S1179: 12
ST   FGA: 22
ST   SE33: 32.2
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 16
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   CH-3573
AC   CVCL_A013
SY   ch-3573
DR   cancercelllines; CVCL_A013
DR   Wikidata; Q54811598
RX   PubMed=22350793;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu201Cysfs*46 (c.602delT); ClinVar=VCV000924862; Zygosity=Homozygous (PubMed=22350793).
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   Ch-4
AC   CVCL_A1IY
DR   Wikidata; Q102113658
RX   PubMed=11562770;
CC   Population: Japanese.
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   Ch-8-OA
AC   CVCL_F763
DR   Wikidata; Q54811599
RX   PubMed=11562770;
CC   Population: Japanese.
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   CH-EB6
AC   CVCL_K203
DR   CLO; CLO_0002416
DR   ATCC; HB-200
DR   Wikidata; Q54811600
RX   PubMed=3495581;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human IgA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   CH-F42
AC   CVCL_D6TZ
RX   PubMed=1698478;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: CD7- subset of normal T lymphocytes and circulating malignant cells in adult T-cell lymphoma-leukemia.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ch-Huang-1
AC   CVCL_B392
DR   Wikidata; Q54811601
RX   PubMed=22613331;
CC   Population: Chinese.
CC   Doubling time: 36 hours (PubMed=22613331).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CH-K1W1.P17
AC   CVCL_D3X3
SY   K1W1.P17
DR   Wikidata; Q127380433
RX   PubMed=7559470;
CC   Characteristics: This is a class II Pseudomonas toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by the Pseudomonas toxin.
CC   Selected for resistance to: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
CC   Sequence variation: Mutation; UniProtKB; P09445; EEF2; Simple; p.Gly719Asp (c.2156G>A); Zygosity=Heterozygous (PubMed=7559470).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-MSC-01
AC   CVCL_WG58
SY   CHorionic-Mesenchymal Stem Cells-01
DR   IBRC; C10892
DR   Wikidata; Q93448070
CC   Derived from site: In situ; Placenta, chorion; UBERON=UBERON_0003124.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CH-MSC-02
AC   CVCL_WG59
SY   CHorionic-Mesenchymal Stem Cells-02
DR   IBRC; C10992
DR   Wikidata; Q93448072
CC   Derived from site: In situ; Placenta, chorion; UBERON=UBERON_0003124.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   Ch-N
AC   CVCL_E5VG
RX   PubMed=11562770;
CC   Population: Japanese.
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CH-N-1
AC   CVCL_W520
DR   Wikidata; Q54811602
RX   PubMed=2486614;
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft produced by subcutaneous infection of tumor cells into nude mice.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   CH-P1R2
AC   CVCL_D3WJ
SY   P1R2
DR   Wikidata; Q127380434
RX   PubMed=291128;
RX   PubMed=494060;
RX   PubMed=6717439;
RX   PubMed=6928655;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-P1R2.D11
AC   CVCL_D3X0
SY   P1R2.D11
DR   Wikidata; Q127380435
RX   PubMed=7559470;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3WJ ! CH-P1R2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-P1R2.D17
AC   CVCL_D3WK
SY   P1R2.D17
DR   Wikidata; Q127380436
RX   PubMed=6717439;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3WJ ! CH-P1R2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-P1R2.D20
AC   CVCL_D3WZ
SY   P1R2.D20
DR   Wikidata; Q127380437
RX   PubMed=7559470;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3WJ ! CH-P1R2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-P1R2.D8
AC   CVCL_D3WY
SY   P1R2.D8
DR   Wikidata; Q127380438
RX   PubMed=7559470;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3WJ ! CH-P1R2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-P1R2.DS
AC   CVCL_D3WL
SY   P1R2.DS
DR   Wikidata; Q127380439
RX   PubMed=6717439;
RX   PubMed=6928655;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (PubMed=6928655).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3WJ ! CH-P1R2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-R1.41
AC   CVCL_D3X4
SY   R1.41
DR   Wikidata; Q127380440
RX   PubMed=7559470;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin.
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; P09445; EEF2; Simple; p.Ile714Asn (c.2141T>A); Zygosity=Heterozygous (PubMed=7559470).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-R48.3
AC   CVCL_D3WM
DR   Wikidata; Q127380441
RX   PubMed=494060;
CC   Characteristics: This is a class I diphtheria toxin resistant cell line. The resistance of class I mutants can be overcome by increased concentration of the toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CH-RE.31
AC   CVCL_D3WN
DR   Wikidata; Q127380442
RX   PubMed=494060;
CC   Characteristics: This is a class I diphtheria toxin resistant cell line. The resistance of class I mutants can be overcome by increased concentration of the toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE.5
AC   CVCL_D3WP
DR   Wikidata; Q127380443
RX   PubMed=494060;
CC   Characteristics: This is a class I diphtheria toxin resistant cell line. The resistance of class I mutants can be overcome by increased concentration of the toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE1.11
AC   CVCL_D3WQ
DR   Wikidata; Q127380444
RX   PubMed=494060;
CC   Characteristics: This is a class I diphtheria toxin resistant cell line. The resistance of class I mutants can be overcome by increased concentration of the toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE1.22
AC   CVCL_D3X1
SY   RE1.22
DR   Wikidata; Q127380445
RX   PubMed=1353910;
RX   PubMed=7559470;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; P09445; EEF2; Simple; p.Gly717Arg (c.2149G>A); Zygosity=Heterozygous (PubMed=1353910).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE1.22c
AC   CVCL_D3WG
SY   RE1.22c
DR   Wikidata; Q127380446
RX   PubMed=291128;
RX   PubMed=494060;
RX   PubMed=1353910;
RX   PubMed=6928655;
RX   PubMed=7559470;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; P09445; EEF2; Simple; p.Gly717Arg (c.2149G>A); Zygosity=Homozygous (PubMed=1353910).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3X1 ! CH-RE1.22
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE1.22c-A3P2
AC   CVCL_D3WH
SY   CH-RE1.22cA3P2
DR   Wikidata; Q127380447
RX   PubMed=6928655;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (from parent cell line).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; P09445; EEF2; Simple; p.Gly717Arg (c.2149G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3WG ! CH-RE1.22c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE1.22c-A4P2
AC   CVCL_D3WI
SY   CH-RE1.22cA4P2
DR   Wikidata; Q127380449
RX   PubMed=291128;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (from parent cell line).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; P09445; EEF2; Simple; p.Gly717Arg (c.2149G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3WG ! CH-RE1.22c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE1.32
AC   CVCL_D3WR
SY   RE1.32
DR   Wikidata; Q127380450
RX   PubMed=291128;
RX   PubMed=494060;
RX   PubMed=7559470;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE10.21
AC   CVCL_D3WS
DR   Wikidata; Q127380451
RX   PubMed=494060;
CC   Characteristics: This is a class I diphtheria toxin resistant cell line. The resistance of class I mutants can be overcome by increased concentration of the toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE3.7
AC   CVCL_D3WT
DR   Wikidata; Q127380452
RX   PubMed=494060;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE5a.13
AC   CVCL_D3WU
DR   Wikidata; Q127380454
RX   PubMed=494060;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RE5b.2
AC   CVCL_D3WV
SY   RE5b.2
DR   Wikidata; Q127380455
RX   PubMed=494060;
RX   PubMed=7559470;
CC   Characteristics: This is a class II diphtheria toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by diphtheria toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RPE.10
AC   CVCL_D3X2
SY   RPE.10
DR   Wikidata; Q127380456
RX   PubMed=7559470;
CC   Characteristics: This is a class II Pseudomonas toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by the Pseudomonas toxin.
CC   Selected for resistance to: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH-RPE.11a
AC   CVCL_D3WW
SY   RPE.11a
DR   Wikidata; Q127380458
RX   PubMed=494060;
RX   PubMed=7559470;
CC   Characteristics: This is a class II Pseudomonas toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by the Pseudomonas toxin (PubMed=494060).
CC   Selected for resistance to: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
CC   Sequence variation: Mutation; UniProtKB; P09445; EEF2; Simple; p.Ser584Gly (c.1750A>G); Zygosity=Heterozygous (PubMed=7559470).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CGH-RPE.3b
AC   CVCL_D3WX
SY   RPE.3b
DR   Wikidata; Q127380459
RX   PubMed=6717439;
RX   PubMed=6928655;
CC   Characteristics: This is a class II Pseudomonas toxin resistant cell line. The resistance of class II mutants cannot be overcome by increased concentration of the toxin. They possess a mutationally altered EF-2 which does not serve as a substrate for ADP-ribosylation by the Pseudomonas toxin (PubMed=6928655).
CC   Selected for resistance to: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3VX ! CHO-K1c
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CH03
AC   CVCL_V562
SY   BCSCH03
DR   Cosmic; 2076359
DR   Wikidata; Q54811603
RX   PubMed=23958880;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr107Thrfs*15 (c.318delC); Zygosity=Unspecified (PubMed=23958880).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=23958880
ST   Amelogenin: X
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D8S1179: 11,14
ST   FGA: 23
ST   TH01: 8,9
ST   vWA: 17
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   CH1 [Human ESC]
AC   CVCL_D177
DR   Wikidata; Q54811604
RX   PubMed=21542965;
CC   From: Peking University; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   CH1 [Human ovarian carcinoma]
AC   CVCL_4992
DR   BioSample; SAMN03151886
DR   cancercelllines; CVCL_4992
DR   ChEMBL-Cells; CHEMBL3307620
DR   ChEMBL-Targets; CHEMBL614455
DR   GEO; GSM459735
DR   GEO; GSM711723
DR   GEO; GSM851914
DR   IGRhCellID; CH1
DR   Progenetix; CVCL_4992
DR   PubChem_Cell_line; CVCL_4992
DR   Wikidata; Q54811605
RX   PubMed=1423261;
RX   PubMed=1617660;
RX   PubMed=1892748;
RX   PubMed=2653399;
RX   PubMed=11416159;
RX   PubMed=15677628;
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PA-1 derivative (PubMed=22710073).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00459.
CC   Doubling time: 17 hours (PubMed=2653399).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro316Pro (c.948C>T); ClinVar=VCV000750727; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D21S11: 29,31.2
ST   D8S1179: 14,15
ST   FGA: 24
ST   TH01: 7,9
ST   vWA: 15,17
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0479 ! PA-1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   CH1 [Mouse lymphoma]
AC   CVCL_5424
DR   CLO; CLO_0002408
DR   ATCC; TIB-221
DR   Lonza; 374
DR   Wikidata; Q54811606
RX   PubMed=2582425;
RX   PubMed=6983495;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   CH1-cisR
AC   CVCL_X012
SY   CH1/cisR; CH1cisR; CH1Cis
DR   cancercelllines; CVCL_X012
DR   GEO; GSM851915
DR   Wikidata; Q54811611
RX   PubMed=1617660;
RX   PubMed=11416159;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (CH1) has been shown to be a PA-1 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00559.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 15,18
ST   D21S11: 29,31.2
ST   D8S1179: 14,15
ST   FGA: 24
ST   TH01: 7,9
ST   vWA: 15,17
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4992 ! CH1 [Human ovarian carcinoma]
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 23
//
ID   CH1:RD1694
AC   CVCL_Y426
DR   cancercelllines; CVCL_Y426
DR   Wikidata; Q54811612
RX   PubMed=7537518;
CC   Problematic cell line: Contaminated. Parent cell line (CH1) has been shown to be a PA-1 derivative.
CC   Selected for resistance to: ChEBI; CHEBI_5847; ICI D1694 (Tomudex; ZD1694).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4992 ! CH1 [Human ovarian carcinoma]
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 16
//
ID   CH12
AC   CVCL_6818
DR   Lonza; 243
DR   Wikidata; Q54811613
RX   PubMed=2582425;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   CH12.LX
AC   CVCL_0211
SY   CH12-LX; CH12LX
DR   BTO; BTO_0002493
DR   EFO; EFO_0005233
DR   MCCL; MCC:0000100
DR   4DN; 4DNSRNHF7J2Z
DR   ENCODE; ENCBS042ZWV
DR   ENCODE; ENCBS044ENC
DR   ENCODE; ENCBS045ENC
DR   ENCODE; ENCBS076QIH
DR   ENCODE; ENCBS088WDO
DR   ENCODE; ENCBS091RNA
DR   ENCODE; ENCBS092RNA
DR   ENCODE; ENCBS443MXB
DR   ENCODE; ENCBS455TUM
DR   ENCODE; ENCBS708XQN
DR   ENCODE; ENCBS777FXN
DR   ENCODE; ENCBS782ENP
DR   ENCODE; ENCBS789HDO
DR   ENCODE; ENCBS824VDB
DR   ENCODE; ENCBS912CAS
DR   ENCODE; ENCBS940UDN
DR   ENCODE; ENCBS948OTG
DR   GEO; GSM798327
DR   GEO; GSM912891
DR   GEO; GSM912898
DR   GEO; GSM912900
DR   GEO; GSM912901
DR   GEO; GSM912902
DR   GEO; GSM912906
DR   GEO; GSM912908
DR   GEO; GSM912909
DR   GEO; GSM912910
DR   GEO; GSM912911
DR   GEO; GSM912912
DR   GEO; GSM912920
DR   GEO; GSM912922
DR   GEO; GSM912924
DR   GEO; GSM912925
DR   GEO; GSM912926
DR   GEO; GSM912930
DR   GEO; GSM912931
DR   GEO; GSM923568
DR   GEO; GSM923584
DR   GEO; GSM946528
DR   GEO; GSM946530
DR   GEO; GSM946532
DR   GEO; GSM946546
DR   GEO; GSM946548
DR   GEO; GSM1000091
DR   GEO; GSM1000114
DR   GEO; GSM1000115
DR   GEO; GSM1000116
DR   GEO; GSM1000117
DR   GEO; GSM1000118
DR   GEO; GSM1000119
DR   GEO; GSM1000122
DR   GEO; GSM1003774
DR   GEO; GSM1003781
DR   GEO; GSM1003782
DR   GEO; GSM1003783
DR   GEO; GSM1003786
DR   GEO; GSM1003792
DR   GEO; GSM1003793
DR   GEO; GSM1003795
DR   GEO; GSM1003796
DR   GEO; GSM1003800
DR   GEO; GSM1003801
DR   GEO; GSM1003802
DR   GEO; GSM1003803
DR   GEO; GSM1014153
DR   GEO; GSM1113245
DR   GEO; GSM1113246
DR   Millipore; SCC252
DR   Wikidata; Q54811614
RX   PubMed=2945204;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/CH12_Weissman_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
ST   Source(s): Millipore=SCC252
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15,16
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15.3
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 29
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6818 ! CH12
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   CH12F3
AC   CVCL_E067
DR   BTO; BTO_0006297
DR   BioGRID_ORCS_Cell_line; 1496
DR   Lonza; 1416
DR   Wikidata; Q54811615
RX   PubMed=8671604;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0211 ! CH12.LX
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   CH12F3 (AID+/-)
AC   CVCL_GZ20
DR   Kerafast; ESP012
DR   Wikidata; Q54811616
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1342279; Aicda (Note=1 of 2 alleles).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   CH12F3 (AID-/-)
AC   CVCL_GZ21
DR   Kerafast; ESP013
DR   Wikidata; Q54811617
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1342279; Aicda.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CH12F3 (APE1+/+/-)
AC   CVCL_ZB63
DR   Kerafast; ESP022
DR   Wikidata; Q98125614
RX   PubMed=23382073;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:88042; Apex1 (Note=1 of 3 alleles).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   CH12F3 (APE1+/-/-)
AC   CVCL_ZB64
DR   Kerafast; ESP023
DR   Wikidata; Q98125615
RX   PubMed=23382073;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:88042; Apex1 (Note=2 of 3 alleles).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   CH12F3 (APE1-/-/-)
AC   CVCL_ZB65
DR   Kerafast; ESP024
DR   Wikidata; Q98125616
RX   PubMed=23382073;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:88042; Apex1.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   CH12F3 (APE1-/-/-APE2-)
AC   CVCL_GZ22
DR   Kerafast; ESP010
DR   Wikidata; Q54811618
RX   PubMed=23382073;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:88042; Apex1.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1924872; Apex2.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CH12F3 (APE2-)
AC   CVCL_GZ23
DR   Kerafast; ESP011
DR   Wikidata; Q54811619
RX   PubMed=23382073;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1924872; Apex2.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CH12F3 (CTNNBL1+/-)
AC   CVCL_GZ24
DR   Kerafast; ESP020
DR   Wikidata; Q54811620
RX   PubMed=20585033;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1913892; Ctnnbl1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   CH12F3 (CTNNBL1-/-)
AC   CVCL_GZ25
DR   Kerafast; ESP021
DR   Wikidata; Q54811621
RX   PubMed=20585033;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1913892; Ctnnbl1.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CH12F3 (Lig1+/-)
AC   CVCL_GZ26
DR   Kerafast; ESP016
DR   Wikidata; Q54811622
RX   PubMed=24726358;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:101789; Lig1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CH12F3 (Lig1+/-Lig4-/-)
AC   CVCL_GZ27
DR   Kerafast; ESP018
DR   Wikidata; Q54811623
RX   PubMed=26787901;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:101789; Lig1 (Note=1 of 2 alleles).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1335098; Lig4.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CH12F3 (Lig1-/-)
AC   CVCL_GZ28
DR   Kerafast; ESP017
DR   Wikidata; Q54811624
RX   PubMed=24726358;
RX   PubMed=26787901;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:101789; Lig1.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CH12F3 (Lig1-/-Lig4-/-)
AC   CVCL_GZ29
DR   Kerafast; ESP019
DR   Wikidata; Q54811625
RX   PubMed=26787901;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:101789; Lig1.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1335098; Lig4.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CH12F3 (Lig4+/-)
AC   CVCL_GZ30
DR   Kerafast; ESP014
DR   Wikidata; Q54811626
RX   PubMed=19001141;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1335098; Lig4 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CH12F3 (Lig4-/-)
AC   CVCL_GZ31
SY   Lig4-null CH12F3
DR   Kerafast; ESP015
DR   Wikidata; Q54811627
RX   PubMed=19001141;
RX   PubMed=26787901;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1335098; Lig4.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CH12F3-2
AC   CVCL_A5CM
DR   BTO; BTO_0003990
DR   Wikidata; Q107114651
RX   PubMed=10373455;
RX   PubMed=19196959;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E067 ! CH12F3
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CH12F3-2A
AC   CVCL_E068
SY   CH12F3.2A
DR   BTO; BTO_0006382
DR   CLO; CLO_0051570
DR   RCB; RCB2809
DR   Wikidata; Q54811628
RX   PubMed=11606740;
RX   PubMed=19196959;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-460.html
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A5CM ! CH12F3-2
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   Ch13
AC   CVCL_8951
SY   Ch-13
DR   CLO; CLO_0002410
DR   ATCC; HB-8573
DR   Wikidata; Q54811629
RX   Patent=US4695538;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8573.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   Ch2.D
AC   CVCL_5275
SY   Ch2D
DR   CLO; CLO_0002411
DR   ATCC; CRL-6270
DR   Wikidata; Q54811630
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6270; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   CH22
AC   CVCL_C159
SY   CH-22
DR   Wikidata; Q54811631
RX   PubMed=22504929;
RX   PubMed=28606919;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/ch22/
CC   Doubling time: 33 hours (PubMed=22504929); 2.3 days (Chordoma Foundation).
CC   Miscellaneous: STR profile from personal communication of Duan, Zhen-Feng.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,14
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   CH26-1352
AC   CVCL_K222
DR   CLO; CLO_0002412
DR   ATCC; HB-8329
DR   Wikidata; Q54811632
RX   Patent=US4623627;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8329.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   CH27 [Human lung carcinoma]
AC   CVCL_7177
SY   Ch27; CH-27
DR   BTO; BTO_0004891
DR   IARC_TP53; 25575
DR   Wikidata; Q54811633
RX   PubMed=11730720;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   CH27 [Mouse lymphoma]
AC   CVCL_7178
DR   Lonza; 251
DR   Millipore; SCC115
DR   Wikidata; Q54811634
RX   PubMed=2582425;
RX   PubMed=3491037;
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
ST   Source(s): Millipore=SCC115
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15.3
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16,17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 29
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   CH31
AC   CVCL_S465
DR   Wikidata; Q54811635
RX   PubMed=2582425;
RX   PubMed=3491037;
CC   Breed/subspecies: B10.H-2aH-4bp/Wts.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   CH34
AC   CVCL_W889
SY   BCSCH34
DR   cancercelllines; CVCL_W889
DR   Cosmic; 2076360
DR   Wikidata; Q54811636
RX   PubMed=23958880;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Unspecified (PubMed=23958880).
CC   Caution: Cell line not maintained.
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
ID   CH3A4A7
AC   CVCL_IQ36
DR   Wikidata; Q54811637
RX   Patent=US7659116;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2667.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9ULV1; Human FZD4/CD344.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   Ch5
AC   CVCL_DD89
SY   CH5; Ch-5
DR   Wikidata; Q54811638
RX   Patent=US4695538;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8572.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   CH56
AC   CVCL_V563
SY   BCSCH56
DR   cancercelllines; CVCL_V563
DR   Cosmic; 2076361
DR   Wikidata; Q54811639
RX   PubMed=23958880;
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple; p.Arg172Ser (c.516G>C); ClinVar=VCV000375985; Zygosity=Unspecified (PubMed=23958880).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): PubMed=23958880
ST   Amelogenin: X
ST   D16S539: 12
ST   D18S51: 15,26
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D8S1179: 11,14
ST   FGA: 24
ST   TH01: 6,9
ST   vWA: 14,18
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   CH7C17
AC   CVCL_GX97
SY   CH7-C17
DR   EFO; EFO_0022518
DR   cancercelllines; CVCL_GX97
DR   TOKU-E; 4175
DR   Wikidata; Q54811640
RX   PubMed=1588277;
RX   PubMed=7614994;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12155; TRB (Note=From HA1.7).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1316 ! J.RT3-T3.5
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   CHA,AJ
AC   CVCL_E523
SY   CHA, AJ
DR   dbMHC; 48722
DR   ECACC; 94082211
DR   IHW; IHW09112
DR   IPD-IMGT/HLA; 11657
DR   Wikidata; Q54811714
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01:01,24:03:01; B*39:06:02,50:01; C*02; DPB1*04:01; DQA1*05:01,01:02; DQB1*05:02,02:01; DRB1*03:01,16:01; DRB3*02:02; DRB5*02 (IPD-IMGT/HLA=11657).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   CHA-FT-NT17
AC   CVCL_B3VG
DR   Wikidata; Q110432693
RX   PubMed=32502464;
CC   From: CHA University; Seongnam; South Korea.
CC   Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 42-year-old female patient with central areolar choroidal dystrophy.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=32502464
ST   Amelogenin: X
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D8S1179: 11,13
ST   FGA: 19,25
ST   TH01: 6,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-FT-NT18
AC   CVCL_B3VH
SY   CHA-hES NT 18
DR   Wikidata; Q110432694
RX   PubMed=32502464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12019001.
CC   Characteristics: Produced by somatic cell nuclear transfer from mononucleated cells from cord blood.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=32502464
ST   Amelogenin: X,Y
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D8S1179: 10,15
ST   FGA: 20,24
ST   TH01: 9,9.3
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3VI ! CHA-FT-NT19
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-FT-NT19
AC   CVCL_B3VI
SY   CHA-hES NT 19
DR   Wikidata; Q110432695
RX   PubMed=32502464;
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12019002.
CC   Characteristics: Produced by somatic cell nuclear transfer from mononucleated cells from cord blood.
CC   Karyotypic information: 47,XYY (PubMed=32502464).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=32502464
ST   Amelogenin: X,Y
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D8S1179: 10,15
ST   FGA: 20,24
ST   TH01: 9,9.3
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3VH ! CHA-FT-NT18
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES1
AC   CVCL_IU46
SY   CHA hES-1; CHA-hES-1; CH01
DR   Wikidata; Q54811641
RX   PubMed=17356540;
CC   From: CHA University; Seongnam; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES10
AC   CVCL_9736
SY   CHA-hES 10; Kor-hES13
DR   Wikidata; Q54811642
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010022.
CC   HLA typing: A*11:01,30:04:01; B*14:01:01:01,54:01:01; C*01:02,08:02; DRB1*04:04,14:05 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 16,17
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 11,15
ST   TH01: 7,8
ST   TPOX: 10
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES11
AC   CVCL_9737
SY   CHA-hES 11; Kor-hES14
DR   Wikidata; Q54811643
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010023.
CC   HLA typing: A*02:01,31:01; B*15:18,54:01:01; C*01:02,07:04; DRB1*04:01,14:05 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 28,32.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 23,26
ST   Penta D: 11,12
ST   Penta E: 15,16
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES12
AC   CVCL_9738
SY   CHA-hES 12; Kor-hES15
DR   Wikidata; Q54811644
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010024.
CC   HLA typing: A*02:03,30:04:01; B*14:01:01:01,38:02; C*07:02,08:02; DRB1*08:02,11:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 12,14
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 12,17
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 12,20
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES13
AC   CVCL_9739
SY   CHA-hES 13; Kor-hES28
DR   Wikidata; Q54811645
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010026.
CC   HLA typing: A*24:02,30:01; B*07:02,13:02; C*06:02,07:02; DRB1*01:01,04:05 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 9
ST   D18S51: 13,16
ST   D21S11: 30,31.2
ST   D3S1358: 15,17
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 23,23.2
ST   Penta D: 8,13
ST   Penta E: 11,17
ST   TH01: 7,10
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES14
AC   CVCL_9740
SY   CHA-hES 14; Kor-hES29
DR   Wikidata; Q54811646
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010027.
CC   HLA typing: A*11:01,33:03; B*44:03,51:01; C*14:02,14:03; DRB1*09:01,13:02 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 30,31
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,21
ST   Penta D: 9
ST   Penta E: 15,16
ST   TH01: 9
ST   TPOX: 9,13
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES15
AC   CVCL_9741
SY   CHA-hES 15; Kor-hES30
DR   GEO; GSM4972447
DR   Wikidata; Q54811647
RX   PubMed=20587141;
RX   PubMed=24159464;
RX   PubMed=33714852;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010028.
CC   HLA typing: A*31:01,33:03; B*44:03,46:01; C*01:02,14:03; DRB1*04:03,13:02 (PubMed=20587141).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 18
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   CHA-hES16
AC   CVCL_9742
SY   CHA-hES 16; Kor-hES47
DR   Wikidata; Q54811648
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010029.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 9,11,12
ST   D18S51: 19,21
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 11,12,13
ST   D7S820: 10,12
ST   D8S1179: 15,16
ST   FGA: 22,23
ST   Penta D: 8,9,12
ST   Penta E: 11,14
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES17
AC   CVCL_9743
SY   CHA-hES 17; Kor-hES31
DR   Wikidata; Q54811649
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010030.
CC   HLA typing: A*33:03,68:01; B*51:01,58:01; C*03:02,15:02; DRB1*13:02,14:07 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 10,11
ST   Penta E: 5,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES18
AC   CVCL_9744
SY   CHA-hES 18; Kor-hES32
DR   Wikidata; Q54811650
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010038.
CC   HLA typing: A*24:02,26:03:01; B*15:01,55:02; C*01:02,03:03; DRB1*09:01,15:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 14,17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 5,16
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES19
AC   CVCL_9745
SY   CHA-hES 19; Kor-hES48
DR   Wikidata; Q54811654
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010031.
CC   HLA typing: A*02:03,24:02; B*38:02,51:01; C*07:02,14:02; DRB1*08:03,15:02 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D21S11: 30,31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   Penta D: 9,14
ST   Penta E: 11,15
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES2
AC   CVCL_IU47
SY   CHA hES-2; CHA-hES-2; CH02
DR   Wikidata; Q54811655
RX   PubMed=17356540;
CC   From: CHA University; Seongnam; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES20
AC   CVCL_9746
SY   CHA-hES 20; Kor-hES33
DR   Wikidata; Q54811656
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010032.
CC   HLA typing: A*02:01,02:07:01; B*15:01,46:01; C*01:03,04:01; DRB1*09:01,14:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 12,16
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 16,17
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES21
AC   CVCL_9747
SY   CHA-hES 21; Kor-hES34
DR   Wikidata; Q54811657
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010033.
CC   HLA typing: A*01:01,33:03; B*37:01,44:03; C*06:02,07:01; DRB1*03:01,07:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 13
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 11,15
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES22
AC   CVCL_9748
SY   CHA-hES 22; Kor-hES35
DR   Wikidata; Q54811658
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010039.
CC   HLA typing: A*02:06,02:06; B*40:01,55:02; C*01:02,07:02; DRB1*12:02,15:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,10
ST   D18S51: 13
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 11,19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES23
AC   CVCL_9749
SY   CHA-hES 23; Kor-hES36
DR   Wikidata; Q54811659
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010034.
CC   HLA typing: A*24:02,33:03; B*44:03,46:01; C*01:03,14:03; DRB1*09:01,15:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 15,17
ST   FGA: 19,21
ST   Penta D: 9,10
ST   Penta E: 5,11
ST   TH01: 6,10
ST   TPOX: 8,9
ST   vWA: 19,21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES24
AC   CVCL_9750
SY   CHA-hES 24; Kor-hES37
DR   Wikidata; Q54811660
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010035.
CC   HLA typing: A*02:06,30:04:01; B*14:01:01:01,35:01; C*08:01,08:02; DRB1*04:04,12:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 20
ST   D21S11: 29,32.2
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 20,25
ST   Penta D: 8,9
ST   Penta E: 17,18
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES25
AC   CVCL_9751
SY   CHA-hES 25; Kor-hES38
DR   Wikidata; Q54811661
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010040.
CC   HLA typing: A*01:01,02:06; B*35:01,37:01; C*03:03,06:02; DRB1*04:05,10:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15,20
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 14,22
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES26
AC   CVCL_9752
SY   CHA-hES 26; Kor-hES49
DR   Wikidata; Q54811662
RX   PubMed=20587141;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010036.
CC   HLA typing: A*02:01,02:06; C*01:02,03:04; DRB1*04:05,14:05 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 14,17
ST   D21S11: 31.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 8,10
ST   Penta E: 12,14
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES27
AC   CVCL_Y993
SY   CHA-hES 27
DR   Wikidata; Q54811663
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES28
AC   CVCL_Y994
SY   CHA-hES 28
DR   Wikidata; Q54811664
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011007.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES29
AC   CVCL_Y995
SY   CHA-hES 29
DR   Wikidata; Q54811665
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011008.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES3
AC   CVCL_9753
SY   CHA-HES3; CHA-hES 3; Kor-hES5; CHAe001-A
DR   hPSCreg; CHAe001-A
DR   SKIP; SKIP002084
DR   Wikidata; Q54811666
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010001.
CC   HLA typing: A*24:02,31:01; B*15:07:01:01,46:01; C*01:02,03:03; DRB1*04:03,08:03 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 11,14
ST   D18S51: 13,16
ST   D21S11: 33,34
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 23
ST   Penta D: 8,9
ST   Penta E: 18,19
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   CHA-hES3-eGFP
AC   CVCL_X167
DR   Wikidata; Q54811667
CC   From: CHA University; Seongnam; South Korea.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9753 ! CHA-hES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   CHA-hES3-RFP
AC   CVCL_X168
DR   Wikidata; Q54811668
CC   From: CHA University; Seongnam; South Korea.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9753 ! CHA-hES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   CHA-hES30
AC   CVCL_Y996
SY   CHA-hES 30
DR   Wikidata; Q54811669
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES31
AC   CVCL_Y997
SY   CHA-hES 31
DR   Wikidata; Q54811670
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES32
AC   CVCL_Y998
SY   CHA-hES 32
DR   Wikidata; Q54811671
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES33
AC   CVCL_Y999
SY   CHA-hES 33
DR   Wikidata; Q54811672
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES34
AC   CVCL_Z000
SY   CHA-hES 34
DR   Wikidata; Q54811673
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES35
AC   CVCL_Z001
SY   CHA-hES 35
DR   Wikidata; Q54811674
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES36
AC   CVCL_Z002
SY   CHA-hES 36
DR   Wikidata; Q54811675
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012007.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES37
AC   CVCL_Z003
SY   CHA-hES 37
DR   Wikidata; Q54811676
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012008.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES38
AC   CVCL_Z004
SY   CHA-hES 38
DR   Wikidata; Q54811677
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012010.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES39
AC   CVCL_Z005
SY   CHA-hES 39
DR   Wikidata; Q54811678
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012011.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES4
AC   CVCL_9754
SY   CHA-HES4; CHA-hES 4; Kor-hES6; CHAe002-A
DR   hPSCreg; CHAe002-A
DR   SKIP; SKIP002289
DR   Wikidata; Q54811679
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010002.
CC   HLA typing: A*02:07:01,11:01; B*18:01,46:01; C*01:02,12:03; DRB1*04:05,11:04 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 31,32.2
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 24
ST   Penta D: 10,13
ST   Penta E: 10,14
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   CHA-hES4-eGFP
AC   CVCL_X169
DR   Wikidata; Q54811680
CC   From: CHA University; Seongnam; South Korea.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9754 ! CHA-hES4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   CHA-hES4-RFP
AC   CVCL_X170
DR   Wikidata; Q54811681
CC   From: CHA University; Seongnam; South Korea.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9754 ! CHA-hES4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   CHA-hES40
AC   CVCL_Z006
SY   CHA-hES 40
DR   Wikidata; Q54811682
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012012.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES41
AC   CVCL_Z007
SY   CHA-hES 41
DR   Wikidata; Q54811683
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012013.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES42
AC   CVCL_Z008
SY   CHA-hES 42
DR   Wikidata; Q54811684
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012014.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES43
AC   CVCL_Z009
SY   CHA-hES 43
DR   Wikidata; Q54811685
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES44
AC   CVCL_Z010
SY   CHA-hES 44
DR   Wikidata; Q54811686
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES45
AC   CVCL_Z011
SY   CHA-hES 45
DR   Wikidata; Q54811687
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES46
AC   CVCL_Z012
SY   CHA-hES 46
DR   Wikidata; Q54811688
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES47
AC   CVCL_Z013
SY   CHA-hES 47
DR   Wikidata; Q54811689
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES48
AC   CVCL_Z014
SY   CHA-hES 48
DR   Wikidata; Q54811690
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12013006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHA-hES49
AC   CVCL_IS19
SY   CHA-hES 49
DR   Wikidata; Q54811691
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES5
AC   CVCL_9755
SY   CHA-hES 5; Kor-hES7
DR   Wikidata; Q54811692
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010017.
CC   HLA typing: A*24:02,33:03; B*07:02,44:03; C*07:02,14:03; DRB1*01:01,07:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D21S11: 30
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 5,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES50
AC   CVCL_IS17
SY   CHA-hES 50
DR   Wikidata; Q54811693
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES51
AC   CVCL_IS18
SY   CHA-hES 51
DR   Wikidata; Q54811697
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES52
AC   CVCL_IS13
SY   CHA-hES 52
DR   Wikidata; Q54811698
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES53
AC   CVCL_IS14
SY   CHA-hES 53
DR   Wikidata; Q54811699
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES54
AC   CVCL_IS15
SY   CHA-hES 54
DR   Wikidata; Q54811700
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES55
AC   CVCL_IS16
SY   CHA-hES 55
DR   Wikidata; Q54811701
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   CHA-hES56
AC   CVCL_B3VD
SY   CHA-hES 56
DR   Wikidata; Q110432697
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES57
AC   CVCL_B3VE
SY   CHA-hES 57
DR   Wikidata; Q110432698
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES58
AC   CVCL_B3VF
SY   CHA-hES 58
DR   Wikidata; Q110432699
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES59
AC   CVCL_B3V5
SY   CHA-hES 59
DR   Wikidata; Q110432700
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12018001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES6
AC   CVCL_9756
SY   CHA-hES 6; Kor-hES8
DR   Wikidata; Q54811702
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010018.
CC   HLA typing: A*02:01,02:03; B*38:02,40:01; C*03:04,07:02; DRB1*09:01,11:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 14,17
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 12,17
ST   FGA: 21,22
ST   Penta D: 11
ST   Penta E: 5,20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES60
AC   CVCL_B3V6
SY   CHA-hES 60
DR   Wikidata; Q110432701
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12018002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES61
AC   CVCL_B3V7
SY   CHA-hES 61
DR   Wikidata; Q110432702
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12018003.
CC   Karyotypic information: 70,XXX,+12.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES62
AC   CVCL_B3V2
SY   CHA-hES 62
DR   Wikidata; Q110432703
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12021001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES63
AC   CVCL_B3V3
SY   CHA-hES 63
DR   Wikidata; Q110432704
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12021002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES64
AC   CVCL_B3V4
SY   CHA-hES 64
DR   Wikidata; Q110432705
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12021003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHA-hES7
AC   CVCL_9757
SY   CHA-hES 7; Kor-hES9
DR   Wikidata; Q54811703
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010019.
CC   HLA typing: A*02:01,11:01; B*15:11,54:01:01; C*01:02,03:03; DRB1*04:05,12:02 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,13
ST   D18S51: 15,16
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 11,15
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES8
AC   CVCL_9758
SY   CHA-hES 8; Kor-hES10
DR   Wikidata; Q54811704
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010020.
CC   HLA typing: A*11:01,24:02; B*15:27,48:01; C*04:01,08:01; DRB1*04:06,14:05 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D18S51: 14
ST   D21S11: 31,32
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 11,17
ST   FGA: 19,21
ST   Penta D: 9,13
ST   Penta E: 5,20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hES9
AC   CVCL_9759
SY   CHA-hES 9; Kor-hES11
DR   Wikidata; Q54811705
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010021.
CC   HLA typing: A*02:01,11:01; B*13:01,40:01; C*03:04,07:02; DRB1*12:02,14:05 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19,24
ST   Penta D: 9,10
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hESB1
AC   CVCL_L124
SY   CHA-hES B1; Kor-hES44
DR   Wikidata; Q54811706
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010046.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   CHA-hESB2
AC   CVCL_L125
SY   CHA-hES B2; Kor-hES45
DR   Wikidata; Q54811707
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010047.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   CHA-hESB3
AC   CVCL_L126
SY   CHA-hES B3; Kor-hES46
DR   Wikidata; Q54811708
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010048.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   CHA-hESM1
AC   CVCL_9760
SY   CHA-hES M1; CHA-hESC M1; Kor-hES39
DR   Wikidata; Q54811709
RX   DOI=10.1016/j.fertnstert.2008.07.435;
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010041.
CC   HLA typing: A*11:01,31:01; B*15:01,40:02; C*03:04,04:01; DRB1*04:06,14:07 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,10
ST   D18S51: 14,17
ST   D21S11: 29,32.2
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 10,16
ST   FGA: 23,25
ST   Penta D: 9
ST   Penta E: 11,14
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CHA-hESR1
AC   CVCL_9761
SY   CHA-hES R1; Kor-hES40
DR   Wikidata; Q54811710
RX   DOI=10.1016/j.fertnstert.2008.07.435;
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010042.
CC   HLA typing: A*02:06,24:02; B*07:02,59:01:01:01; C*01:02,07:02; DRB1*01:01,04:05 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 14,15
ST   D21S11: 29,31.2
ST   D3S1358: 16,18
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 8,17
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CHA-hESR2
AC   CVCL_9762
SY   CHA-hES R2; Kor-hES41
DR   Wikidata; Q54811711
RX   DOI=10.1016/j.fertnstert.2008.07.435;
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010043.
CC   HLA typing: A*02:01,33:03; B*27:05,58:01; C*01:02,03:02; DRB1*01:01,13:02 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 9,13
ST   Penta E: 18
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CHA-hESR3
AC   CVCL_9763
SY   CHA-hES R3; Kor-hES42
DR   Wikidata; Q54811712
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010044.
CC   HLA typing: A*02:06,02:07:01; B*46:01,51:01; C*01:02,14:02; DRB1*08:03,12:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 23,25
ST   Penta D: 11
ST   Penta E: 11,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-hESR4
AC   CVCL_9764
SY   CHA-hES R4; Kor-hES43
DR   Wikidata; Q54811713
RX   PubMed=20587141;
RX   PubMed=24159464;
CC   From: CHA University; Seongnam; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010045.
CC   HLA typing: A*03:01,24:02; B*07:02,27:05; C*02:02,07:02; DRB1*01:01,01:01 (PubMed=20587141).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20587141
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 31,31.2
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 21,24
ST   Penta D: 8,9
ST   Penta E: 11,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CHA-NTK6
AC   CVCL_B5RM
SY   NTK-ESC #6; NT assisted by KDM4A-ESC #6; CHA-NT #6; CHA-hES NT6; CHAHESe001-A
DR   BioSamples; SAMEA11039557
DR   GEO; GSM1891813
DR   GEO; GSM1891814
DR   hPSCreg; CHAHESe001-A
DR   Wikidata; Q111733112
RX   PubMed=26526725;
RX   PubMed=34971932;
CC   From: CHA University; Seongnam; South Korea.
CC   Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 52-year-old female patient with age-related macular degeneration.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=26526725
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D19S433: 13,14.2
ST   D21S11: 29
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CHA-NTK7
AC   CVCL_B5RN
SY   NTK-ESC #7; NT assisted by KDM4A-ESC #7; CHA-NT #7
DR   GEO; GSM1891815
DR   GEO; GSM1891816
DR   Wikidata; Q111733114
RX   PubMed=26526725;
CC   From: CHA University; Seongnam; South Korea.
CC   Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 52-year-old female patient with age-related macular degeneration.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CHA-NTK8
AC   CVCL_B5RP
SY   NTK-ESC #8; NT assisted by KDM4A-ESC #8; CHA-NT #8
DR   GEO; GSM1891817
DR   GEO; GSM1891818
DR   Wikidata; Q111733115
RX   PubMed=26526725;
CC   From: CHA University; Seongnam; South Korea.
CC   Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 59-year-old male patient with age-related macular degeneration.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RR ! CHA-NTK9
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   CHA-NTK9
AC   CVCL_B5RR
SY   NTK-ESC #9; NT assisted by KDM4A-ESC #9; CHA-NT #9
DR   Wikidata; Q111733118
RX   PubMed=26526725;
CC   From: CHA University; Seongnam; South Korea.
CC   Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 59-year-old male patient with age-related macular degeneration.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RP ! CHA-NTK8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CHA08-023
AC   CVCL_9T34
DR   IPD-IMGT/HLA; 25439
DR   Wikidata; Q54811715
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,02:328; B*37:01,44:03; DRB1*07:01,10:01 (IPD-IMGT/HLA=25439).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   CHA255
AC   CVCL_B0V9
DR   Wikidata; Q108820015
RX   Patent=US4722892;
RX   PubMed=3927170;
RX   PubMed=8218161;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA (Note=The antibody binds to the chelated In+++ metal ion).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   CHA59
AC   CVCL_GZ61
SY   CHA-59
DR   GEO; GSM1676352
DR   GEO; GSM1701682
DR   NCI-DTP; CHA-59
DR   Wikidata; Q54811716
RX   PubMed=22870217;
RX   PubMed=26351324;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   CHA89
AC   CVCL_C7GP
DR   Wikidata; Q117704240
RX   PubMed=8330265;
RX   PubMed=11203250;
CC   Derived from site: In situ; Urinary bladder, trigone; UBERON=UBERON_0001257.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Chab1KMM
AC   CVCL_K104
DR   CLO; CLO_0050702
DR   BioSample; SAMN03472187
DR   RCB; RCB0875
DR   Wikidata; Q54811717
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,+(11;12)(q23.3;q15) (RCB=RCB0875).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0875
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   CHAD-B7
AC   CVCL_0C88
SY   CHAD-B7.4
DR   Wikidata; Q54811718
RX   PubMed=15064773;
RX   PubMed=16797414;
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Breed/subspecies: Border Collie; VBO=VBO_0200193.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   CHAD-G4
AC   CVCL_0C89
SY   CHAD-G4.1; CHAD G4; ChadG4
DR   GEO; GSM377398
DR   Wikidata; Q54811719
RX   PubMed=15064773;
RX   PubMed=16797414;
RX   PubMed=19461996;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   CHAD-G6
AC   CVCL_0C90
SY   CHAD-G6.4; CHAD G6; ChadG6
DR   GEO; GSM377399
DR   Wikidata; Q54811720
RX   PubMed=15064773;
RX   PubMed=19461996;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   CHAD-G8
AC   CVCL_0C91
SY   CHAD-G8.2; CHAD G8; ChadG8
DR   GEO; GSM377400
DR   Wikidata; Q54811721
RX   PubMed=15064773;
RX   PubMed=19461996;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   CHAD-P9
AC   CVCL_0C92
SY   CHAD-P9.5; CHAD P9; ChadP9
DR   GEO; GSM377404
DR   Wikidata; Q54811722
RX   PubMed=15064773;
RX   PubMed=19461996;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Portuguese water dog; VBO=VBO_0201077.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   ChaGo
AC   CVCL_DG43
DR   Wikidata; Q54811723
RX   PubMed=4708151;
RX   PubMed=4834404;
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (PubMed=4708151).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C35875; Bronchogenic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   ChaGo-C-5
AC   CVCL_DG44
SY   ChaGo-C5
DR   Wikidata; Q54811724
RX   PubMed=62839;
RX   PubMed=4514312;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C35875; Bronchogenic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DG43 ! ChaGo
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   ChaGo-K-1
AC   CVCL_1121
SY   CHAGO-K-1; ChaGo K-1; ChaGo-K1; CHAGOK1; ChaGoK1
DR   BTO; BTO_0003108
DR   CLO; CLO_0002413
DR   EFO; EFO_0002155
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-168
DR   BioGRID_ORCS_Cell_line; 594
DR   BioSample; SAMN03473197
DR   BioSample; SAMN10987978
DR   cancercelllines; CVCL_1121
DR   Cell_Model_Passport; SIDM00924
DR   ChEMBL-Cells; CHEMBL3308489
DR   ChEMBL-Targets; CHEMBL1075421
DR   Cosmic; 687596
DR   Cosmic; 1995366
DR   Cosmic-CLP; 687596
DR   DepMap; ACH-000867
DR   ECACC; 96020948
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10710-109H8
DR   GDSC; 687596
DR   GEO; GSM784215
DR   GEO; GSM827465
DR   GEO; GSM886927
DR   GEO; GSM887993
DR   GEO; GSM1669674
DR   IARC_TP53; 21266
DR   IZSLER; BS TCL 186
DR   LiGeA; CCLE_416
DR   LINCS_LDP; LCL-1579
DR   PharmacoDB; ChaGoK1_196_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1121
DR   PubChem_Cell_line; CVCL_1121
DR   Wikidata; Q54811725
RX   PubMed=62839;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; c.1921-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=687596; DepMap=ACH-000867).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.His684Asp (c.2050C>G); Zygosity=Heterozygous (Cosmic-CLP=687596; DepMap=ACH-000867).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu837Lys (c.2509G>A); Zygosity=Homozygous (Cosmic-CLP=687596; DepMap=ACH-000867).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Phe (c.824G>T); ClinVar=VCV000376582; Zygosity=Heterozygous (Cosmic-CLP=687596; DepMap=ACH-000867).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.18%; Native American=0%; East Asian, North=3.52%; East Asian, South=0%; South Asian=0.39%; European, North=59.93%; European, South=34.97% (PubMed=30894373).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ATCC=HTB-168; Cosmic-CLP=687596; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13,20
ST   D19S433: 14,14.2
ST   D21S11: 31.2,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 11,12
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C35875; Bronchogenic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DG43 ! ChaGo
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   CHAHESe001-A-1
AC   CVCL_B5RQ
SY   CHA-hES NT6 B2M KO#67; KUSCRBe002-A-1
DR   BioSamples; SAMEA11285969
DR   hPSCreg; CHAHESe001-A-1
DR   Wikidata; Q111733119
RX   PubMed=34971932;
CC   From: Konkuk University; Seoul; South Korea.
CC   Characteristics: The parent cell line was produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 59-year-old male patient with age-related macular degeneration.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5RM ! CHA-NTK6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CHAi001-A
AC   CVCL_A1NZ
SY   CHA-HLA-iPSC#1-Epi
DR   hPSCreg; CHAi001-A
DR   Wikidata; Q102113660
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03; DPB1*02:02,04:02; DQB1*06:04,06:04; DRB1*13:02,13:02 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi002-A
AC   CVCL_A1PA
SY   CHA-HLA-iPSC#2-Epi
DR   hPSCreg; CHAi002-A
DR   Wikidata; Q102113661
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03,33:03; B*58:01,58:01; C*03:02,03:02; DPB1*02:01,02:01; DQB1*06:09,06:09; DRB1*13:02,13:02 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi003-A
AC   CVCL_A1PB
SY   CHA-HLA-iPSC#3-Epi
DR   hPSCreg; CHAi003-A
DR   Wikidata; Q102113663
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*07:01,07:01; DPB1*13:01,13:01; DQB1*02:02,02:02; DRB1*07:01,07:01 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi004-A
AC   CVCL_A1PC
SY   CHA-HLA-iPSC#4-Epi
DR   hPSCreg; CHAi004-A
DR   Wikidata; Q102113664
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*24:02,24:02; B*07:02,07:02; C*07:02,07:02; DPB1*04:02,04:02; DQB1*05:01,05:01; DRB1*01:01,01:01 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi005-A
AC   CVCL_A1PD
SY   CHA-HLA-iPSC#5-Epi
DR   hPSCreg; CHAi005-A
DR   Wikidata; Q102113665
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02; DPB1*09:01,09:01; DQB1*06:01,06:01; DRB1*15:02,15:02 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi006-A
AC   CVCL_A1PE
SY   CHA-HLA-iPSC#6-Epi
DR   hPSCreg; CHAi006-A
DR   Wikidata; Q102113668
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*30:01,30:01; B*13:02,13:02; C*06:02,06:02; DPB1*17:01,17:01; DQB1*02:02,02:02; DRB1*07:01,07:01 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi007-A
AC   CVCL_A1PF
SY   CHA-HLA-iPSC#7-Epi
DR   hPSCreg; CHAi007-A
DR   Wikidata; Q102113669
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*11:01,11:01; B*15:01,15:01; C*04:01,04:01; DPB1*02:01,05:01; DQB1*03:02,03:02; DRB1*04:06,04:06 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi008-A
AC   CVCL_A1PG
SY   CHA-HLA-iPSC#8-Epi
DR   hPSCreg; CHAi008-A
DR   Wikidata; Q102113670
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03,33:03; B*58:01,58:01; C*03:02,03:02; DPB1*02:01,04:01; DQB1*02:01,02:01; DRB1*03:01,03:01 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi009-A
AC   CVCL_A1PH
SY   CHA-HLA-iPSC#9-Epi
DR   hPSCreg; CHAi009-A
DR   Wikidata; Q102113671
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*02:07,02:07; B*46:01,46:01; C*01:02,01:02; DPB1*02:02,04:01; DQB1*06:01,06:01; DRB1*08:03,08:03 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   CHAi010-A
AC   CVCL_A1PI
SY   CHA-HLA-iPSC#10-Epi
DR   hPSCreg; CHAi010-A
DR   Wikidata; Q102113672
RX   PubMed=30004605;
CC   From: CHA University; Seongnam; South Korea.
CC   Population: Korean.
CC   HLA typing: A*24:02,24:02; B*54:01,54:01; C*01:02,01:02; DPB1*05:01,05:01; DQB1*04:01,04:01; DRB1*04:05,04:05 (PubMed=30004605).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   Chang Liver
AC   CVCL_0238
SY   Chang liver; Chang Liver (HeLa derivative); Chang Cells; Chang; CHL
DR   BTO; BTO_0002049
DR   CLO; CLO_0002414
DR   CLO; CLO_0002415
DR   MCCL; MCC:0000128
DR   CLDB; cl715
DR   CLDB; cl716
DR   CLDB; cl717
DR   CLDB; cl718
DR   ATCC; CCL-13
DR   BCRC; 60024
DR   BioSample; SAMN03151672
DR   BioSample; SAMN03472417
DR   BioSample; SAMN03472705
DR   CLS; 300139
DR   ECACC; 88021102
DR   IZSLER; BS CL 14
DR   JCRB; IFO50016
DR   JCRB; JCRB9066
DR   RCB; RCB0491
DR   TOKU-E; 937
DR   Wikidata; Q54811726
RX   CelloPub=CLPUB00262;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=468301;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=6988327;
RX   PubMed=11416159;
RX   PubMed=13472685;
RX   PubMed=13531635;
RX   PubMed=14185313;
RX   PubMed=18655026;
RX   PubMed=20143388;
RX   PubMed=21656536;
RX   PubMed=23925245;
WW   Info; ICLAC; -; https://iclac.org/education/chang-liver/
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=1246601; PubMed=20143388; PubMed=21656536). Originally thought to originate from normal hepatic cells obtained from a liver biopsy of an adult.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00002.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; PTM; Ubiquitination.
CC   Discontinued: BCRC; 60024; true.
CC   Discontinued: RCB; RCB0491; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-13; CLS=300139; ECACC=88021102; JCRB=IFO50016; JCRB=JCRB9066; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 9,10 (JCRB=IFO50016; JCRB=JCRB9066)
ST   CSF1PO: 10 (ATCC=CCL-13; CLS=300139; ECACC=88021102)
ST   D13S317: 12,13.3 (ATCC=CCL-13; CLS=300139; JCRB=JCRB9066)
ST   D13S317: 12,14 (ECACC=88021102; JCRB=IFO50016)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 11,12 (JCRB=IFO50016; JCRB=JCRB9066)
ST   D5S818: 12 (ATCC=CCL-13; CLS=300139; ECACC=88021102)
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   CHARGE1-11
AC   CVCL_LJ31
SY   CH1#11
DR   Wikidata; Q54811727
RX   PubMed=29179815;
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Gln1391fs*13 (c.4171delC); Zygosity=Heterozygous (PubMed=29179815).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ32 ! CHARGE1-7
OI   CVCL_Y954 ! CHARGE1-13
OI   CVCL_Y955 ! CHARGE1-20
OI   CVCL_Y956 ! CHARGE1-25
SX   Male
AG   10-11Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   CHARGE1-13
AC   CVCL_Y954
SY   CH1#13; HPS0093
DR   Wikidata; Q54811728
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Gln1391fs*13 (c.4171delC); Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Okuno, Hironobu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ32 ! CHARGE1-7
OI   CVCL_LJ31 ! CHARGE1-11
OI   CVCL_Y955 ! CHARGE1-20
OI   CVCL_Y956 ! CHARGE1-25
SX   Male
AG   10-11Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   CHARGE1-20
AC   CVCL_Y955
SY   CH1#20; HPS0094
DR   Wikidata; Q54811729
RX   PubMed=29179815;
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Gln1391fs*13 (c.4171delC); Zygosity=Heterozygous (PubMed=29179815).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ32 ! CHARGE1-7
OI   CVCL_LJ31 ! CHARGE1-11
OI   CVCL_Y954 ! CHARGE1-13
OI   CVCL_Y956 ! CHARGE1-25
SX   Male
AG   10-11Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   CHARGE1-25
AC   CVCL_Y956
SY   CH1#25; HPS0095
DR   Wikidata; Q54811730
RX   PubMed=29179815;
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Gln1391fs*13 (c.4171delC); Zygosity=Heterozygous (PubMed=29179815).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ32 ! CHARGE1-7
OI   CVCL_LJ31 ! CHARGE1-11
OI   CVCL_Y954 ! CHARGE1-13
OI   CVCL_Y955 ! CHARGE1-20
SX   Male
AG   10-11Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   CHARGE1-7
AC   CVCL_LJ32
SY   CH1#7
DR   Wikidata; Q54811731
RX   PubMed=29179815;
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Gln1391fs*13 (c.4171delC); Zygosity=Heterozygous (PubMed=29179815).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ31 ! CHARGE1-11
OI   CVCL_Y954 ! CHARGE1-13
OI   CVCL_Y955 ! CHARGE1-20
OI   CVCL_Y956 ! CHARGE1-25
SX   Male
AG   10-11Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   CHARGE2-1
AC   CVCL_LJ33
SY   CH2#1
DR   Wikidata; Q54811732
RX   PubMed=29179815;
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Arg1494Ter (c.4480C>T); ClinVar=VCV000158296; Zygosity=Heterozygous (PubMed=29179815).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ34 ! CHARGE2-16
OI   CVCL_LJ35 ! CHARGE2-19
SX   Female
AG   >10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   CHARGE2-16
AC   CVCL_LJ34
SY   CH2#16
DR   Wikidata; Q54811733
RX   PubMed=29179815;
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Arg1494Ter (c.4480C>T); ClinVar=VCV000158296; Zygosity=Heterozygous (PubMed=29179815).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ33 ! CHARGE2-1
OI   CVCL_LJ35 ! CHARGE2-19
SX   Female
AG   >10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   CHARGE2-19
AC   CVCL_LJ35
SY   CH2#19
DR   Wikidata; Q54811734
RX   PubMed=29179815;
CC   From: Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Arg1494Ter (c.4480C>T); ClinVar=VCV000158296; Zygosity=Heterozygous (PubMed=29179815).
CC   Miscellaneous: Cell line information from personal communication of Okuno, Hironobu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LJ33 ! CHARGE2-1
OI   CVCL_LJ34 ! CHARGE2-16
SX   Female
AG   >10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   CHAUT-C
AC   CVCL_F588
DR   Wikidata; Q54811735
RX   PubMed=7850752;
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C134568; Hamster uterine leiomyosarcoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_5958 ! CHAUT-G
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   CHAUT-G
AC   CVCL_5958
DR   CLO; CLO_0051583
DR   RCB; RCB0715
DR   Wikidata; Q54811736
RX   PubMed=7850752;
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C134568; Hamster uterine leiomyosarcoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_F588 ! CHAUT-C
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   CHB
AC   CVCL_1R45
DR   BioSample; SAMN03151996
DR   Wikidata; Q54811740
RX   PubMed=5535723;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin (astrocytoma) but found to be from rat (PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00017.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   CHB-1
AC   CVCL_A812
DR   NIHhESC; NIHhESC-10-0001
DR   Wikidata; Q54811741
RX   PubMed=18223642;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CHB-10
AC   CVCL_A821
SY   CHB10; BCHe004-A
DR   hPSCreg; BCHe004-A
DR   NIHhESC; NIHhESC-10-0009
DR   SKIP; SKIP001987
DR   Wikidata; Q54811742
RX   PubMed=18223642;
RX   PubMed=28445466;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0009.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CHB-11
AC   CVCL_A822
SY   CHB11; BCHe005-A
DR   hPSCreg; BCHe005-A
DR   NIHhESC; NIHhESC-10-0010
DR   SKIP; SKIP001988
DR   Wikidata; Q54811743
RX   PubMed=18223642;
RX   PubMed=28445466;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0010.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   CHB-12
AC   CVCL_A823
SY   CHB12; BCHe006-A
DR   hPSCreg; BCHe006-A
DR   NIHhESC; NIHhESC-10-0011
DR   SKIP; SKIP001989
DR   Wikidata; Q54811744
RX   PubMed=18223642;
RX   PubMed=28445466;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0011.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CHB-13
AC   CVCL_A824
DR   Wikidata; Q54811745
RX   PubMed=22284529;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:5961; IKBKG; Simple; p.Leu153Arg (c.458T>G) (T458G); ClinVar=VCV000011460; Zygosity=Hemizygous (PubMed=22284529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118844; Ectodermal dysplasia and immunodeficiency
DI   ORDO; Orphanet_98813; Hypohidrotic ectodermal dysplasia with immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   CHB-14
AC   CVCL_A825
DR   Wikidata; Q54811746
RX   PubMed=22284529;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:5961; IKBKG; Simple; p.Leu153Arg (c.458T>G) (T458G); ClinVar=VCV000011460; Zygosity=Unspecified (PubMed=22284529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118844; Ectodermal dysplasia and immunodeficiency
DI   ORDO; Orphanet_98813; Hypohidrotic ectodermal dysplasia with immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   CHB-15
AC   CVCL_A826
DR   Wikidata; Q54811747
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CHB-2
AC   CVCL_A813
DR   NIHhESC; NIHhESC-10-0002
DR   Wikidata; Q54811748
RX   PubMed=18223642;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CHB-3
AC   CVCL_A814
DR   NIHhESC; NIHhESC-10-0003
DR   Wikidata; Q54811749
RX   PubMed=18223642;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CHB-4
AC   CVCL_A815
SY   CHB04; CHB4; PCBC08hse2012100901; SC12-038
DR   NIHhESC; NIHhESC-10-0004
DR   Wikidata; Q54811750
RX   PubMed=18223642;
RX   PubMed=27293150;
RX   PubMed=28445466;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0004.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CHB-5
AC   CVCL_A816
SY   CHB05
DR   NIHhESC; NIHhESC-10-0005
DR   Wikidata; Q54811751
RX   PubMed=18223642;
RX   PubMed=28445466;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0005.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   CHB-6
AC   CVCL_A817
SY   CHB06
DR   NIHhESC; NIHhESC-10-0006
DR   Wikidata; Q54811752
RX   PubMed=18223642;
RX   PubMed=28445466;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0006.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   CHB-7
AC   CVCL_A818
SY   BCHe001-A
DR   hPSCreg; BCHe001-A
DR   SKIP; SKIP001984
DR   Wikidata; Q54811753
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   CHB-8
AC   CVCL_A819
SY   CHB08; CHB8; BCHe002-A; PCBC08hse2012100902; SC12-039
DR   hPSCreg; BCHe002-A
DR   NIHhESC; NIHhESC-10-0007
DR   SKIP; SKIP001985
DR   Wikidata; Q54811754
RX   PubMed=18223642;
RX   PubMed=27293150;
RX   PubMed=28445466;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0007.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   CHB-9
AC   CVCL_A820
SY   CHB09; BCHe003-A
DR   hPSCreg; BCHe003-A
DR   NIHhESC; NIHhESC-10-0008
DR   SKIP; SKIP001986
DR   Wikidata; Q54811755
RX   PubMed=18223642;
RX   PubMed=28445466;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0008.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CHB-S2
AC   CVCL_A9HN
SY   CHBS2
DR   CCRID; 5301MAM-KCB05024ZJ
DR   KCB; KCB 200524ZJ
DR   Wikidata; Q108820016
CC   Group: Bat cell line.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89399; ! Rhinolophus sinicus (Chinese rufous horseshoe bat)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CHB235
AC   CVCL_B0VA
DR   Wikidata; Q108820017
RX   Patent=US4722892;
RX   PubMed=3927170;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   cHCC
AC   CVCL_L313
DR   Wikidata; Q28872907
RX   PubMed=15566568;
CC   Sequence variation: Mutation; VGNC; VGNC:43166; MET; Simple; p.Thr1344Ser (c.4030A>T); Zygosity=Unspecified (PubMed=15566568).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Cairn Terrier; VBO=VBO_0200267.
DI   NCIt; C129298; Canine hepatocellular carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   CHCC-NYU1
AC   CVCL_9Y74
SY   CHCC-NYU5
DR   Wikidata; Q54811756
RX   PubMed=6186403;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134557; Chicken fibrosarcoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   CHCC-OU1
AC   CVCL_T599
DR   Wikidata; Q54811757
RX   PubMed=6204901;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   CHCC-OU2
AC   CVCL_Y589
SY   CHCC-OU-2
DR   Wikidata; Q54811758
RX   Patent=US5866117;
RX   PubMed=3115063;
RX   PubMed=34737324;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12302.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   CHCMUi001-A
AC   CVCL_C0C4
DR   BioSamples; SAMEA14409935
DR   hPSCreg; CHCMUi001-A
DR   Wikidata; Q112929377
RX   PubMed=35660815;
CC   From: Children's hospital of Chongqing Medical University; Chongqing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8977; PIK3CD; Simple; p.Glu1021Lys (c.3061G>A); ClinVar=VCV000088675; Zygosity=Heterozygous (PubMed=35660815).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220694; Activated phosphatidylinositol-3-OH kinase delta syndrome, type 1
DI   ORDO; Orphanet_397596; Activated PI3K-delta syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 6
//
ID   CHCMUi002-A
AC   CVCL_C9Z7
DR   BioSamples; SAMEA113595353
DR   hPSCreg; CHCMUi002-A
DR   Wikidata; Q123030909
RX   PubMed=38134578;
CC   From: Children's hospital of Chongqing Medical University; Chongqing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2578; CYBB; Simple; c.785_786delTT; Zygosity=Hemizygous (PubMed=38134578).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   CHCY-1
AC   CVCL_3899
SY   CHCY 1; CHCY1
DR   BTO; BTO_0004890
DR   Wikidata; Q54811759
RX   PubMed=7874267;
RX   PubMed=11173916;
CC   Population: Japanese.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   CHD-1
AC   CVCL_EP71
SY   CHD1
DR   cancercelllines; CVCL_EP71
DR   ColonAtlas; CHD1
DR   Cosmic; 1849336
DR   Wikidata; Q54811760
RX   PubMed=8168998;
RX   PubMed=22808230;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=22808230).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   CHD-19
AC   CVCL_ZW19
SY   iPSC.2
DR   Wikidata; Q102113673
RX   PubMed=32619719;
CC   From: National Human Genome Research Institute; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Arg1104Ter (c.3310C>T); ClinVar=VCV000003809; Zygosity=Heterozygous (PubMed=32619719).
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Gly3408Arg (c.10222G>A); Zygosity=Heterozygous (PubMed=32619719).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   CHD-26
AC   CVCL_ZW18
SY   iPSC.1
DR   Wikidata; Q102113674
RX   PubMed=32619719;
CC   From: National Human Genome Research Institute; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Arg503Ter (c.1507C>T); ClinVar=VCV000620096; Zygosity=Heterozygous (PubMed=32619719).
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Gly3309Ser (c.9925G>A); Zygosity=Heterozygous (PubMed=32619719).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   CHD-39
AC   CVCL_ZW20
SY   iPSC.3
DR   Wikidata; Q102113675
RX   PubMed=32619719;
CC   From: National Human Genome Research Institute; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Val1564_Arg1621del (c.4862+1G>A) (c.4689_4862del); Zygosity=Heterozygous (PubMed=32619719).
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.His3236Tyr (c.9706C>T); Zygosity=Heterozygous (PubMed=32619719).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   CHD-5
AC   CVCL_ZW21
SY   iPSC.4
DR   Wikidata; Q102113676
RX   PubMed=32619719;
CC   From: National Human Genome Research Institute; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Val2651Phe (c.7951G>T); Zygosity=Heterozygous (PubMed=32619719).
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Ala3680Glyfs*8 (c.11039_11195del); Zygosity=Heterozygous (PubMed=32619719).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   CHDC
AC   CVCL_IU83
SY   Duck 3
DR   Wikidata; Q54811761
RX   PubMed=563848;
RX   PubMed=18770475;
CC   Group: Bird cell line.
CC   Doubling time: ~19 hours (PubMed=563848).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Breed/subspecies: White Pekin; VBO=VBO_0000713.
DI   NCIt; C134769; Duck neoplasm
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   CHDIi001-A
AC   CVCL_VC72
SY   #1C8; #1c8; CHDI-90002149
DR   BioSamples; SAMEA1088030
DR   EBiSC; CHDIi001-A
DR   ECACC; 66541147
DR   hPSCreg; CHDIi001-A
DR   Wikidata; Q54811762
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi001-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541147; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi002-A
AC   CVCL_VC73
SY   #2c3; CHDI-90002150
DR   BioSamples; SAMEA1088031
DR   EBiSC; CHDIi002-A
DR   ECACC; 66541148
DR   hPSCreg; CHDIi002-A
DR   Wikidata; Q54811763
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi002-A).
CC   Discontinued: ECACC; 66541148; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi003-A
AC   CVCL_VC74
SY   #3c1; CHDI-90002151
DR   BioSamples; SAMEA1088033
DR   EBiSC; CHDIi003-A
DR   ECACC; 66541149
DR   hPSCreg; CHDIi003-A
DR   Wikidata; Q54811764
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi003-A).
CC   Discontinued: ECACC; 66541149; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi004-A
AC   CVCL_VC75
SY   #4C2; #4c2; CHDI-90002152
DR   BioSamples; SAMEA1088035
DR   EBiSC; CHDIi004-A
DR   ECACC; 66541150
DR   hPSCreg; CHDIi004-A
DR   Wikidata; Q54811765
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541150; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi005-A
AC   CVCL_VC76
SY   #5C4; #5c4; CHDI-90002153
DR   BioSamples; SAMEA1088037
DR   EBiSC; CHDIi005-A
DR   ECACC; 66541151
DR   hPSCreg; CHDIi005-A
DR   Wikidata; Q54811766
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi005-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541151; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi006-A
AC   CVCL_VC77
SY   #6c7; CHDI-90002154
DR   BioSamples; SAMEA1088039
DR   EBiSC; CHDIi006-A
DR   ECACC; 66541152
DR   hPSCreg; CHDIi006-A
DR   Wikidata; Q54811767
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi006-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541152; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi007-A
AC   CVCL_VC78
SY   CHDI-90002155
DR   BioSamples; SAMEA4675631
DR   EBiSC; CHDIi007-A
DR   ECACC; 66541165
DR   hPSCreg; CHDIi007-A
DR   Wikidata; Q54811768
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi007-A; true.
CC   Discontinued: ECACC; 66541165; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi008-A
AC   CVCL_VC79
SY   #8c3; CHDI-90002156
DR   BioSamples; SAMEA4675633
DR   EBiSC; CHDIi008-A
DR   ECACC; 66541166
DR   hPSCreg; CHDIi008-A
DR   Wikidata; Q54811769
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi008-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541166; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi009-A
AC   CVCL_VC80
SY   CHDI-90002157
DR   BioSamples; SAMEA4675635
DR   EBiSC; CHDIi009-A
DR   ECACC; 66541167
DR   hPSCreg; CHDIi009-A
DR   Wikidata; Q54811770
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi009-A; true.
CC   Discontinued: ECACC; 66541167; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi010-A
AC   CVCL_VC81
SY   #10c2; HD2158; CHDI-90002158
DR   BioSamples; SAMEA4675637
DR   EBiSC; CHDIi010-A
DR   ECACC; 66541168
DR   hPSCreg; CHDIi010-A
DR   Wikidata; Q54811771
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi010-A).
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 66541168; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   CHDIi011-A
AC   CVCL_VC82
SY   #11c2; CHDI-90002159
DR   BioSamples; SAMEA4675639
DR   EBiSC; CHDIi011-A
DR   ECACC; 66541169
DR   hPSCreg; CHDIi011-A
DR   Wikidata; Q54811772
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi011-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541169; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi012-A
AC   CVCL_VC83
SY   #12C4; CHDI-90002160
DR   BioSamples; SAMEA1088042
DR   EBiSC; CHDIi012-A
DR   ECACC; 66541153
DR   hPSCreg; CHDIi012-A
DR   Wikidata; Q54811774
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi012-A; true.
CC   Discontinued: ECACC; 66541153; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi013-A
AC   CVCL_VC84
SY   #13c5; CTR2161; CHDI-90002161
DR   BioSamples; SAMEA4675323
DR   EBiSC; CHDIi013-A
DR   ECACC; 66541161
DR   hPSCreg; CHDIi013-A
DR   Wikidata; Q54811775
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 66541161; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   CHDIi014-A
AC   CVCL_VC85
SY   #14C1; #14c1; CTR2162; CHDI-90002162
DR   BioSamples; SAMEA1088051
DR   EBiSC; CHDIi014-A
DR   ECACC; 66541154
DR   hPSCreg; CHDIi014-A
DR   Wikidata; Q54811776
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 66541154; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   CHDIi015-A
AC   CVCL_VC86
SY   CHDI-90002163
DR   BioSamples; SAMEA4675641
DR   EBiSC; CHDIi015-A
DR   ECACC; 66541170
DR   hPSCreg; CHDIi015-A
DR   Wikidata; Q54811777
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi015-A; true.
CC   Discontinued: ECACC; 66541170; true.
CC   Discontinued: hPSCreg; CHDIi015-A; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   CHDIi016-A
AC   CVCL_VC87
SY   #16c6; CTR2164; CHDI-90002164
DR   BioSamples; SAMEA4675643
DR   EBiSC; CHDIi016-A
DR   ECACC; 66541171
DR   hPSCreg; CHDIi016-A
DR   Wikidata; Q54811778
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 66541171; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   CHDIi017-A
AC   CVCL_VC88
SY   #17c1; CHDI-90002165
DR   BioSamples; SAMEA4675645
DR   EBiSC; CHDIi017-A
DR   ECACC; 66541172
DR   hPSCreg; CHDIi017-A
DR   Wikidata; Q54811779
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi017-A).
CC   Discontinued: ECACC; 66541172; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi018-A
AC   CVCL_VC89
SY   #18c1; CHDI-90002166
DR   BioSamples; SAMEA4675647
DR   EBiSC; CHDIi018-A
DR   ECACC; 66541173
DR   hPSCreg; CHDIi018-A
DR   Wikidata; Q54811780
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi018-A).
CC   Discontinued: ECACC; 66541173; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi019-A
AC   CVCL_VC90
SY   #19C9; #19c9; CHDI-90002167
DR   BioSamples; SAMEA1088043
DR   EBiSC; CHDIi019-A
DR   ECACC; 66541155
DR   hPSCreg; CHDIi019-A
DR   Wikidata; Q54811785
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi019-A).
CC   Discontinued: ECACC; 66541155; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi020-A
AC   CVCL_VC91
SY   #20c2; CHDI-90002168
DR   BioSamples; SAMEA4675649
DR   EBiSC; CHDIi020-A
DR   ECACC; 66541174
DR   hPSCreg; CHDIi020-A
DR   Wikidata; Q54811786
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi020-A).
CC   Discontinued: ECACC; 66541174; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   CHDIi021-A
AC   CVCL_VC92
SY   #21C5; #21c5; CHDI-90002169
DR   BioSamples; SAMEA1088053
DR   EBiSC; CHDIi021-A
DR   ECACC; 66541156
DR   hPSCreg; CHDIi021-A
DR   Wikidata; Q54811787
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi021-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541156; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi022-A
AC   CVCL_VC93
SY   #22c1; HD2170; CHDI-90002170
DR   BioSamples; SAMEA4675651
DR   EBiSC; CHDIi022-A
DR   ECACC; 66541175
DR   hPSCreg; CHDIi022-A
DR   Wikidata; Q54811788
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi022-A).
CC   Omics: Variations; Array-based CGH.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541175; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   CHDIi023-A
AC   CVCL_VC94
SY   #23c8; CHDI-90002171
DR   BioSamples; SAMEA4675653
DR   EBiSC; CHDIi023-A
DR   ECACC; 66541176
DR   hPSCreg; CHDIi023-A
DR   Wikidata; Q54811790
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541176; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi024-A
AC   CVCL_VC95
SY   #24c7; CHDI-90002172
DR   BioSamples; SAMEA4675655
DR   EBiSC; CHDIi024-A
DR   ECACC; 66541177
DR   hPSCreg; CHDIi024-A
DR   Wikidata; Q54811791
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541177; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi025-A
AC   CVCL_VC96
SY   #25C7; CHDI-90002173
DR   BioSamples; SAMEA1088045
DR   EBiSC; CHDIi025-A
DR   ECACC; 66541157
DR   hPSCreg; CHDIi025-A
DR   Wikidata; Q54811792
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi025-A; true.
CC   Discontinued: ECACC; 66541157; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi026-A
AC   CVCL_VC97
SY   #26C3; #26c3; HD2174; CHDI-90002174
DR   BioSamples; SAMEA1088047
DR   EBiSC; CHDIi026-A
DR   ECACC; 66541158
DR   hPSCreg; CHDIi026-A
DR   Wikidata; Q54811793
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[47] (c.52CAG(47)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi026-A).
CC   Omics: Variations; Array-based CGH.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541158; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   CHDIi027-A
AC   CVCL_VC98
SY   #27c4; CTR2175; CHDI-90002175
DR   BioSamples; SAMEA4675657
DR   EBiSC; CHDIi027-A
DR   ECACC; 66541178
DR   hPSCreg; CHDIi027-A
DR   Wikidata; Q54811794
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 66541178; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   CHDIi028-A
AC   CVCL_VC99
SY   #28c3; CHDI-90002176
DR   BioSamples; SAMEA4675324
DR   EBiSC; CHDIi028-A
DR   ECACC; 66541162
DR   hPSCreg; CHDIi028-A
DR   Wikidata; Q54811795
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi028-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541162; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi029-A
AC   CVCL_VD00
SY   #29c4; CHDI-90002177
DR   BioSamples; SAMEA4675326
DR   EBiSC; CHDIi029-A
DR   ECACC; 66541163
DR   hPSCreg; CHDIi029-A
DR   Wikidata; Q54811796
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi029-A).
CC   Discontinued: ECACC; 66541163; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi030-A
AC   CVCL_VD01
SY   #30C5; CHDI-90002178
DR   BioSamples; SAMEA1088049
DR   EBiSC; CHDIi030-A
DR   ECACC; 66541159
DR   hPSCreg; CHDIi030-A
DR   Wikidata; Q54811797
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi030-A; true.
CC   Discontinued: ECACC; 66541159; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 8
//
ID   CHDIi031-A
AC   CVCL_VD02
SY   #31c1; CHDI-90002179
DR   BioSamples; SAMEA4675659
DR   EBiSC; CHDIi031-A
DR   ECACC; 66541179
DR   hPSCreg; CHDIi031-A
DR   Wikidata; Q54811798
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi031-A).
CC   Discontinued: ECACC; 66541179; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi032-A
AC   CVCL_VD03
SY   #103C6; CHDI-90002180
DR   BioSamples; SAMEA1088055
DR   EBiSC; CHDIi032-A
DR   ECACC; 66541160
DR   hPSCreg; CHDIi032-A
DR   Wikidata; Q54811799
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi032-A; true.
CC   Discontinued: ECACC; 66541160; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi033-A
AC   CVCL_VD04
SY   #104c2; CHDI-90002181
DR   BioSamples; SAMEA4675661
DR   EBiSC; CHDIi033-A
DR   ECACC; 66541180
DR   hPSCreg; CHDIi033-A
DR   Wikidata; Q54811800
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi033-A).
CC   Discontinued: ECACC; 66541180; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi034-A
AC   CVCL_VD05
SY   #105c1; CHDI-90002182
DR   BioSamples; SAMEA4675663
DR   EBiSC; CHDIi034-A
DR   ECACC; 66541181
DR   hPSCreg; CHDIi034-A
DR   Wikidata; Q54811801
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi034-A).
CC   Discontinued: ECACC; 66541181; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi035-A
AC   CVCL_VD06
SY   #108c5; CHDI-90002183
DR   BioSamples; SAMEA4675665
DR   EBiSC; CHDIi035-A
DR   ECACC; 66541182
DR   hPSCreg; CHDIi035-A
DR   Wikidata; Q54811802
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi035-A).
CC   Discontinued: ECACC; 66541182; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi036-A
AC   CVCL_VD07
SY   #110c5; CHDI-90002184
DR   BioSamples; SAMEA4675667
DR   EBiSC; CHDIi036-A
DR   ECACC; 66541183
DR   hPSCreg; CHDIi036-A
DR   Wikidata; Q54811803
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi036-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541183; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi037-A
AC   CVCL_VD08
SY   CHDI-90002185
DR   BioSamples; SAMEA4675669
DR   EBiSC; CHDIi037-A
DR   ECACC; 66541184
DR   hPSCreg; CHDIi037-A
DR   Wikidata; Q54811804
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi037-A; true.
CC   Discontinued: ECACC; 66541184; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 5
//
ID   CHDIi038-A
AC   CVCL_VD09
SY   #112c7; CHDI-90002186
DR   BioSamples; SAMEA4675329
DR   EBiSC; CHDIi038-A
DR   ECACC; 66541164
DR   hPSCreg; CHDIi038-A
DR   Wikidata; Q54811805
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi038-A).
CC   Discontinued: ECACC; 66541164; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi039-A
AC   CVCL_VD10
SY   CHDI-90002187
DR   BioSamples; SAMEA4675671
DR   EBiSC; CHDIi039-A
DR   ECACC; 66541185
DR   hPSCreg; CHDIi039-A
DR   Wikidata; Q54811806
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi039-A; true.
CC   Discontinued: ECACC; 66541185; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi040-A
AC   CVCL_VD11
SY   #115c6; CHDI-90002188
DR   BioSamples; SAMEA4675673
DR   EBiSC; CHDIi040-A
DR   ECACC; 66541186
DR   hPSCreg; CHDIi040-A
DR   Wikidata; Q54811807
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi040-A).
CC   Discontinued: ECACC; 66541186; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi041-A
AC   CVCL_VD12
SY   #116c2; CHDI-90002189
DR   BioSamples; SAMEA4675675
DR   EBiSC; CHDIi041-A
DR   ECACC; 66541187
DR   hPSCreg; CHDIi041-A
DR   Wikidata; Q54811808
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi041-A).
CC   Discontinued: ECACC; 66541187; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi042-A
AC   CVCL_VD13
SY   #117c5; CTR2190; CHDI-90002190
DR   BioSamples; SAMEA4675677
DR   EBiSC; CHDIi042-A
DR   ECACC; 66541188
DR   hPSCreg; CHDIi042-A
DR   Wikidata; Q54811809
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 66541188; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   CHDIi043-A
AC   CVCL_VD14
SY   #118c6; CHDI-90002191
DR   BioSamples; SAMEA4675679
DR   EBiSC; CHDIi043-A
DR   ECACC; 66541189
DR   hPSCreg; CHDIi043-A
DR   Wikidata; Q54811810
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541189; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi044-A
AC   CVCL_VD15
SY   #120c3; CHDI-90002192
DR   BioSamples; SAMEA4675681
DR   EBiSC; CHDIi044-A
DR   ECACC; 66541190
DR   hPSCreg; CHDIi044-A
DR   Wikidata; Q54811811
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541190; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi045-A
AC   CVCL_VD16
SY   #121c6; CHDI-90002193
DR   BioSamples; SAMEA4675683
DR   EBiSC; CHDIi045-A
DR   ECACC; 66541191
DR   hPSCreg; CHDIi045-A
DR   Wikidata; Q54811812
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi045-A).
CC   Discontinued: ECACC; 66541191; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CHDIi046-A
AC   CVCL_VD17
SY   #122c1; CHDI-90002194
DR   BioSamples; SAMEA4675685
DR   EBiSC; CHDIi046-A
DR   ECACC; 66541192
DR   hPSCreg; CHDIi046-A
DR   Wikidata; Q54811813
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi046-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541192; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi047-A
AC   CVCL_VD18
SY   #123c6; CHDI-90002195
DR   BioSamples; SAMEA4675687
DR   EBiSC; CHDIi047-A
DR   ECACC; 66541193
DR   hPSCreg; CHDIi047-A
DR   Wikidata; Q54811815
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541193; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi048-A
AC   CVCL_VD19
SY   #125c2; CHDI-90002196
DR   BioSamples; SAMEA4675689
DR   EBiSC; CHDIi048-A
DR   ECACC; 66541194
DR   hPSCreg; CHDIi048-A
DR   Wikidata; Q54811816
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[48] (c.52CAG(48)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi048-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541194; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi049-A
AC   CVCL_VD20
SY   #127c2; HD2197; CHDI-90002197
DR   BioSamples; SAMEA4675691
DR   EBiSC; CHDIi049-A
DR   ECACC; 66541195
DR   hPSCreg; CHDIi049-A
DR   Wikidata; Q54811817
RX   PubMed=35805069;
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi049-A).
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 66541195; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   CHDIi050-A
AC   CVCL_VD21
SY   #128c3; CHDI-90002198
DR   BioSamples; SAMEA4675693
DR   EBiSC; CHDIi050-A
DR   ECACC; 66541196
DR   hPSCreg; CHDIi050-A
DR   Wikidata; Q54811818
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541196; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 10
//
ID   CHDIi051-A
AC   CVCL_VD22
SY   #129c1; CHDI-90002199
DR   BioSamples; SAMEA4675911
DR   EBiSC; CHDIi051-A
DR   ECACC; 66541197
DR   hPSCreg; CHDIi051-A
DR   Wikidata; Q54811819
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541197; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi052-A
AC   CVCL_VD23
SY   CHDI-90002200
DR   BioSamples; SAMEA4675912
DR   EBiSC; CHDIi052-A
DR   ECACC; 66541198
DR   hPSCreg; CHDIi052-A
DR   Wikidata; Q54811820
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi052-A; true.
CC   Discontinued: ECACC; 66541198; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi053-A
AC   CVCL_VD24
SY   CHDI-90002201
DR   BioSamples; SAMEA4675914
DR   EBiSC; CHDIi053-A
DR   ECACC; 66541199
DR   hPSCreg; CHDIi053-A
DR   Wikidata; Q54811821
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi053-A; true.
CC   Discontinued: ECACC; 66541199; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDIi054-A
AC   CVCL_VD25
SY   #132c3; CHDI-90002202
DR   BioSamples; SAMEA4675916
DR   EBiSC; CHDIi054-A
DR   ECACC; 66541200
DR   hPSCreg; CHDIi054-A
DR   Wikidata; Q54811822
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541200; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi055-A
AC   CVCL_VD26
SY   #133c5; CHDI-90002203
DR   BioSamples; SAMEA4675919
DR   EBiSC; CHDIi055-A
DR   ECACC; 66541201
DR   hPSCreg; CHDIi055-A
DR   Wikidata; Q54811823
CC   From: CHDI Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=CHDIi055-A).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: ECACC; 66541201; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   CHDIi056-A
AC   CVCL_VD27
SY   #134c3; CHDI-90002204
DR   BioSamples; SAMEA4675921
DR   EBiSC; CHDIi056-A
DR   ECACC; 66541202
DR   hPSCreg; CHDIi056-A
DR   Wikidata; Q54811824
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: ECACC; 66541202; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 9
//
ID   CHDIi057-A
AC   CVCL_VD28
SY   CHDI-90002205
DR   BioSamples; SAMEA4675923
DR   EBiSC; CHDIi057-A
DR   ECACC; 66541203
DR   hPSCreg; CHDIi057-A
DR   Wikidata; Q54811825
CC   From: CHDI Foundation; New York; USA.
CC   Discontinued: EBiSC; CHDIi057-A; true.
CC   Discontinued: ECACC; 66541203; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   CHDTRi001-B
AC   CVCL_E3T1
SY   HT953B; iSP1.2.2B
DR   BioSamples; SAMEA115989791
DR   hPSCreg; CHDTRi001-B
RX   PubMed=39317061;
CC   From: Division of Translational Research, NICHD, NIH; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (PubMed=39317061).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.1056+3A>C; ClinVar=VCV000056247; Zygosity=Heterozygous (PubMed=39317061).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHDTRi002-B
AC   CVCL_E3T2
SY   HT954B; iSP5.2.1B
DR   BioSamples; SAMEA115989793
DR   hPSCreg; CHDTRi002-B
RX   PubMed=39317061;
CC   From: Division of Translational Research, NICHD, NIH; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Arg334His (c.1001G>A); ClinVar=VCV000056244; Zygosity=Heterozygous (PubMed=39317061).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Arg405Trp (c.1213C>T); ClinVar=VCV000418137; Zygosity=Heterozygous (PubMed=39317061).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHDTRi003-A
AC   CVCL_E3T3
SY   HT955A; iSP5.2.2A
DR   BioSamples; SAMEA115991768
DR   hPSCreg; CHDTRi003-A
RX   PubMed=39317061;
CC   From: Division of Translational Research, NICHD, NIH; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Arg334His (c.1001G>A); ClinVar=VCV000056244; Zygosity=Heterozygous (PubMed=39317061).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Arg405Trp (c.1213C>T); ClinVar=VCV000418137; Zygosity=Heterozygous (PubMed=39317061).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHDTRi004-B
AC   CVCL_E3T4
SY   HT956B; iSP8.2.1B
DR   BioSamples; SAMEA115991784
DR   hPSCreg; CHDTRi004-B
RX   PubMed=39317061;
CC   From: Division of Translational Research, NICHD, NIH; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Homozygous (PubMed=39317061).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHDTRi005-A
AC   CVCL_E3T5
SY   HT957A; iSP10.2.1A
DR   BioSamples; SAMEA115991787
DR   hPSCreg; CHDTRi005-A
RX   PubMed=39317061;
CC   From: Division of Translational Research, NICHD, NIH; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Arg334His (c.1001G>A); ClinVar=VCV000056244; Zygosity=Heterozygous (PubMed=39317061).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Unexplicit; Ex15 partial deletion; Zygosity=Heterozygous (PubMed=39317061).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHDTRi006-E
AC   CVCL_E3T6
SY   HT958E; iSP29.2.2E
DR   BioSamples; SAMEA115988712
DR   hPSCreg; CHDTRi006-E
RX   PubMed=39317061;
CC   From: Division of Translational Research, NICHD, NIH; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (PubMed=39317061).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-3C>G; ClinVar=VCV000422288; Zygosity=Heterozygous (PubMed=39317061).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHEF/16
AC   CVCL_J501
SY   CHEF16; CHEF 16; CHEF 16-2; Chinese Hamster Embryo Fibroblast 16
DR   Wikidata; Q54811826
RX   PubMed=694725;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_J502 ! CHEF/18
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   CHEF/18
AC   CVCL_J502
SY   CHEF18; CHEF 18; CHEF 18-1; Chinese Hamster Embryo Fibroblast 18
DR   Wikidata; Q54811831
RX   PubMed=694725;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_J501 ! CHEF/16
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Chem 7
AC   CVCL_8179
SY   Chem-7
DR   Wikidata; Q54811832
RX   PubMed=230517;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Chem-1
AC   CVCL_L474
SY   ChemiSCREEN Chem-1; Wild-type control Chem-1 cell line; ChemiSCREEN Chem-1 parental cell line
DR   DiscoverX; HTSCHEM-1RTA
DR   Millipore; HTSCHEM-1RTA
DR   Wikidata; Q54811833
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 7
//
ID   Chem-1 GCGR
AC   CVCL_E7IW
SY   ChemiSCREEN glucagon receptor stable cell line
DR   DiscoverX; HTS112C
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L474 ! Chem-1
CA   Undefined cell line type
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Chem-10
AC   CVCL_GS46
SY   ChemiSCREEN Chem-10; Wild-type control Chem-10 cell line; ChemiSCREEN Chem-10 parental cell line
DR   Millipore; HTSCHEM-10
DR   Wikidata; Q54811834
CC   Discontinued: Millipore; HTSCHEM-10; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Undefined cell line type
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   Chem-2
AC   CVCL_L475
SY   ChemiSCREEN Chem-2; Wild-type control Chem-2 cell line; ChemiSCREEN Chem-2 parental cell line
DR   Millipore; HTSCHEM-2
DR   Wikidata; Q54811835
CC   Discontinued: Eurofin; Catalog number HTSCHEM-2.
CC   Discontinued: Millipore; HTSCHEM-2; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 7
//
ID   Chem-2 HRH2
AC   CVCL_RU12
SY   ChemiScreen H2 histamine receptor stable cell line
DR   Wikidata; Q54811836
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5183; HRH2.
CC   Discontinued: Eurofin; Catalog number HTS086C.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L475 ! Chem-2
CA   Undefined cell line type
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   Chem-3
AC   CVCL_L476
SY   ChemiSCREEN Chem-3; Wild-type control Chem-3 cell line; ChemiSCREEN Chem-3 parental cell line
DR   Millipore; HTSCHEM-3RTA
DR   Wikidata; Q54811837
CC   Discontinued: Eurofin; Catalog number HTSCHEM-3.
CC   Discontinued: Eurofin; Catalog number HTSCHEM-3RTA.
CC   Discontinued: Millipore; HTSCHEM-3RTA; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 7
//
ID   Chem-3 HRH1
AC   CVCL_RU13
SY   ChemiScreen H1 histamine receptor stable cell line
DR   Millipore; HTS050RTA
DR   Wikidata; Q54811838
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5182; HRH1.
CC   Discontinued: Eurofin; Catalog number HTS050C.
CC   Discontinued: Millipore; HTS050RTA; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L476 ! Chem-3
CA   Undefined cell line type
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 6
//
ID   Chem-4
AC   CVCL_GS44
SY   ChemiSCREEN Chem-4; Wild-type control Chem-4 cell line; ChemiSCREEN Chem-4 parental cell line; Chem4
DR   Millipore; HTSCHEM-4
DR   Wikidata; Q54811839
CC   Discontinued: Millipore; HTSCHEM-4; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Undefined cell line type
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   Chem-4 CHRM4
AC   CVCL_C4TT
SY   ChemiScreen M4 muscarinic acetylcholine receptor stable cell line
DR   DiscoverX; HTS117C
DR   Wikidata; Q116048732
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1953; CHRM4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GS44 ! Chem-4
CA   Undefined cell line type
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   Chem-4 CX3CR1
AC   CVCL_KS82
SY   ChemiScreen CX3CR1 stable cell line
DR   Wikidata; Q54811840
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2558; CX3CR1.
CC   Discontinued: Eurofin; Catalog number HTS015C.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GS44 ! Chem-4
CA   Undefined cell line type
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 5
//
ID   Chem-5
AC   CVCL_GS45
SY   ChemiSCREEN Chem-5; Wild-type control Chem-5 cell line; ChemiSCREEN Chem-5 parental cell line
DR   Millipore; HTSCHEM-5
DR   Wikidata; Q54811841
CC   Discontinued: Millipore; HTSCHEM-5; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Undefined cell line type
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   Chem-5 CXCR6
AC   CVCL_C4TU
SY   ChemiScreen CXCR6 chemokine receptor stable cell line
DR   DiscoverX; HTS054C
DR   Wikidata; Q116048733
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16647; CXCR6.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GS45 ! Chem-5
CA   Undefined cell line type
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   Chem-5 DRD4
AC   CVCL_KS83
SY   ChemiScreen D4 dopamine receptor stable cell line
DR   DiscoverX; HTS223C
DR   Wikidata; Q54811842
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3025; DRD4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GS45 ! Chem-5
CA   Undefined cell line type
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   Chem-9
AC   CVCL_KS84
DR   Wikidata; Q54811843
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Undefined cell line type
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   Chem-9 GLP1R
AC   CVCL_KS85
SY   ChemiScreen human recombinant GLP-1 glucagon-like peptide receptor calcium-optimized stable cell line
DR   Wikidata; Q54811844
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4324; GLP1R.
CC   Discontinued: Eurofin; Catalog number HTS163C.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_KS84 ! Chem-9
CA   Undefined cell line type
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   Cheptage
AC   CVCL_M652
SY   Chep-BL; CHEP-BL; CHEP BL; Chep BL; CHEP; Chep
DR   Wikidata; Q54811845
RX   PubMed=2824665;
RX   PubMed=2898508;
RX   PubMed=2943927;
RX   PubMed=2985508;
RX   PubMed=25787276;
RX   PubMed=28960205;
CC   Population: African; Kenyan.
CC   Virology: Contains a complete EBV genome (strain Cheptage) which has been sequenced (PubMed=25787276).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 14
//
ID   CHES1
AC   CVCL_9732
SY   CH-ES1; UNIGEe001-A
DR   hPSCreg; UNIGEe001-A
DR   SKIP; SKIP001957
DR   Wikidata; Q54811846
RX   PubMed=18803035;
RX   PubMed=20428235;
WW   Info; BAG; B-FP-GV-6-0001-0001; https://www.bag.admin.ch/dam/bag/de/dokumente/biomed/stammzellenforschung/forschungsprojekte-gewinnungsverfahren/hes-6-0001.pdf.download.pdf/hes-6-0001.pdf
CC   From: University of Geneva; Geneva; Switzerland.
CC   Registration: Swiss research registry; BAG-hES-GEW-0001.
CC   Characteristics: Forms invasive tumors when injected into SCID mice (PubMed=18803035).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   CHES2
AC   CVCL_9733
SY   ChES2; CH-ES2; CHES-2; UNIBASe001-A; UBASe001-A
DR   hPSCreg; UBASe001-A
DR   SKIP; SKIP002342
DR   Wikidata; Q54811847
RX   PubMed=19950064;
RX   PubMed=24811852;
WW   Info; BAG; B-FP-GV-6-0001-0001; https://www.bag.admin.ch/dam/bag/de/dokumente/biomed/stammzellenforschung/forschungsprojekte-gewinnungsverfahren/hes-6-0001.pdf.download.pdf/hes-6-0001.pdf
CC   From: University Hospital of Basel; Basel; Switzerland.
CC   Registration: Swiss research registry; BAG-hES-GEW-0002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   CHES3
AC   CVCL_9734
SY   ChES3; CH-ES3; CHES-3; UNIBASe002-A; UBASe002-A
DR   hPSCreg; UBASe002-A
DR   SKIP; SKIP002348
DR   Wikidata; Q54811848
RX   PubMed=24811852;
WW   Info; BAG; B-FP-GV-6-0001-0001; https://www.bag.admin.ch/dam/bag/de/dokumente/biomed/stammzellenforschung/forschungsprojekte-gewinnungsverfahren/hes-6-0001.pdf.download.pdf/hes-6-0001.pdf
CC   From: University Hospital of Basel; Basel; Switzerland.
CC   Registration: Swiss research registry; BAG-hES-GEW-0003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   CHES5
AC   CVCL_9735
SY   ChES5; CH-ES5; CHES-5; UNIBASe003-A; UBASe003-A
DR   hPSCreg; UBASe003-A
DR   SKIP; SKIP002349
DR   Wikidata; Q54811849
RX   PubMed=24811852;
WW   Info; BAG; B-FP-GV-6-0001-0001; https://www.bag.admin.ch/dam/bag/de/dokumente/biomed/stammzellenforschung/forschungsprojekte-gewinnungsverfahren/hes-6-0001.pdf.download.pdf/hes-6-0001.pdf
CC   From: University Hospital of Basel; Basel; Switzerland.
CC   Registration: Swiss research registry; BAG-hES-GEW-0004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   CHES6
AC   CVCL_W089
SY   ChES6; CH-ES6; CHES-6
DR   Wikidata; Q54811850
RX   PubMed=24811852;
WW   Info; BAG; B-FP-GV-6-0001-0001; https://www.bag.admin.ch/dam/bag/de/dokumente/biomed/stammzellenforschung/forschungsprojekte-gewinnungsverfahren/hes-6-0001.pdf.download.pdf/hes-6-0001.pdf
CC   From: University Hospital of Basel; Basel; Switzerland.
CC   Registration: Swiss research registry; BAG-hES-GEW-0005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   CHES7
AC   CVCL_W090
SY   CH-ES7; CHES-7
DR   Wikidata; Q54811851
CC   From: University Hospital of Basel; Basel; Switzerland.
CC   Registration: Swiss research registry; BAG-hES-GEW-0006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   chESC-3
AC   CVCL_C063
SY   ChESC-3; chESC3; H3; CSUe001-A
DR   hPSCreg; CSUe001-A
DR   SKIP; SKIP002054
DR   Wikidata; Q54811852
RX   PubMed=19403374;
CC   From: Central South University; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   Chessie 13-39.1
AC   CVCL_A9NP
SY   C13
DR   BEI_Resources; ARP-990
DR   Wikidata; Q108820018
RX   PubMed=8068416;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03377; HIV-1 isolate BRU/LAI env (Note=AA 33-516 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   Chessie 6
AC   CVCL_A9NM
SY   C6
DR   Wikidata; Q108820019
RX   PubMed=8068416;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03377; HIV-1 isolate BRU/LAI env (Note=AA 33-516 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   Chessie 8
AC   CVCL_A9NN
SY   C8
DR   BEI_Resources; ARP-526
DR   Wikidata; Q108820020
RX   PubMed=8068416;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03377; HIV-1 isolate BRU/LAI env (Note=AA 517-861 = gp41).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   CHEULL1F
AC   CVCL_Y271
DR   CGH-DB; 9194-4
DR   Wikidata; Q54811853
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 6
//
ID   CHEV
AC   CVCL_ZU70
SY   CHEV.
DR   Wikidata; Q98125617
RX   PubMed=6289490;
RX   PubMed=6806672;
CC   Population: Caucasian; French.
CC   Virology: EBV-negative.
CC   Doubling time: 27-28 hours (PubMed=6289490).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6806672).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   CHG-5
AC   CVCL_B267
SY   CHG5
DR   Wikidata; Q54811854
RX   DOI=10.3321/j.issn:1000-5404.1999.12.004;
RX   DOI=10.3321/j.issn:1000-5404.2001.03.006;
RX   PubMed=19781350;
CC   Population: Chinese.
CC   Omics: Proteomics; 2DE.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   CHGS
AC   CVCL_M272
DR   Wikidata; Q54811855
RX   CelloPub=CLPUB00275;
RX   PubMed=2856440;
CC   Population: Japanese.
CC   Doubling time: 6.2 days (PubMed=2856440).
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   CHH-1
AC   CVCL_4143
SY   CHum salmon Heart-1
DR   CLO; CLO_0002417
DR   CLDB; cl719
DR   ATCC; CRL-1680
DR   ECACC; 92110412
DR   Wikidata; Q54811856
RX   CelloPub=CLPUB00103;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=6542066;
CC   Group: Fish cell line.
CC   Discontinued: ATCC; CRL-1680; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8018; ! Oncorhynchus keta (Chum salmon)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   chHES-10
AC   CVCL_A827
SY   chHES10
DR   Wikidata; Q54811857
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*11,33; B*13,44; DRB1*07,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 15
ST   FGA: 23,24
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-100
AC   CVCL_A828
SY   chHES100
DR   Wikidata; Q54811858
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,11; B*13,46; DRB1*14,15 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-101 (Cellosaurus=CVCL_A829).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 28,29
ST   D3S1358: 14,15
ST   D5S818: 9,10
ST   D7S820: 11
ST   D8S1179: 11
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 5,19
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-101
AC   CVCL_A829
SY   chHES101
DR   Wikidata; Q54811859
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,24; B*38,46; DRB1*14,16 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-100 (Cellosaurus=CVCL_A828).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 31,33.2
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 11
ST   D8S1179: 11,16
ST   FGA: 23,26
ST   Penta D: 12
ST   Penta E: 5,15
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-102
AC   CVCL_A830
SY   chHES102
DR   Wikidata; Q54811860
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*11,30; B*13,51; DRB1*07,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D21S11: 28,31.2
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 12,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-103
AC   CVCL_A831
SY   chHES103
DR   Wikidata; Q54811861
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*24,33; B*35,58; DRB1*04,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 21,22
ST   Penta D: 11,12
ST   Penta E: 13,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-104
AC   CVCL_A832
SY   chHES104
DR   Wikidata; Q54811862
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02; B*40(60),46; DRB1*09,16 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-105 (Cellosaurus=CVCL_A833).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 13,17
ST   D21S11: 29,32.2
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 17,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-105
AC   CVCL_A833
SY   chHES105
DR   Wikidata; Q54811863
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   Donor information: Embryo is sibling to that giving rise to chHES-104 (Cellosaurus=CVCL_A832).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 9,10,12
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D21S11: 31,33.2
ST   D3S1358: 15,16,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,12,15
ST   FGA: 25,26
ST   Penta D: 9,13
ST   Penta E: 14,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-106
AC   CVCL_A834
SY   chHES106
DR   Wikidata; Q54811864
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02; B*40(60),67; DRB1*01,08 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 14
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 18,25
ST   Penta D: 9
ST   Penta E: 13,20
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-107
AC   CVCL_A835
SY   chHES107
DR   Wikidata; Q54811865
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,11; B*15(75),46; DRB1*08,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 10,15
ST   FGA: 21,22
ST   Penta D: 8,11
ST   Penta E: 16,20
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-108
AC   CVCL_A836
SY   chHES108
DR   Wikidata; Q54811866
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*01,02; B*37,48; DRB1*10,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 18
ST   Penta D: 8,13
ST   Penta E: 11,16
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-109
AC   CVCL_A837
SY   chHES109
DR   Wikidata; Q54811867
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D18S51: 14,15
ST   D21S11: 29,30,32.2
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 8,12
ST   Penta E: 12,15
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-11
AC   CVCL_A838
SY   chHES11
DR   Wikidata; Q54811868
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,11; B*13,51; DRB1*10,11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 15,18
ST   D21S11: 28,31
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 10,13
ST   D8S1179: 15,16
ST   FGA: 25,27
ST   Penta D: 10,13
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-110
AC   CVCL_A839
SY   chHES110
DR   Wikidata; Q54811869
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*11,24; B*40(60); DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 14,18
ST   D21S11: 31,32
ST   D3S1358: 15,17
ST   D5S818: 11,14
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 8,11
ST   Penta E: 5,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-111
AC   CVCL_A840
SY   chHES111
DR   Wikidata; Q54811870
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*24,30; B*35,40(60); DRB1*04,08 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 16
ST   D21S11: 29,32.2
ST   D3S1358: 16
ST   D5S818: 7,11
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 9,11
ST   Penta E: 10,13
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-112
AC   CVCL_A841
SY   chHES112
DR   Wikidata; Q54811874
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,24; B*46,54; DRB1*09,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23,26
ST   Penta D: 9,10
ST   Penta E: 11,14
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-113
AC   CVCL_A842
SY   chHES113
DR   Wikidata; Q54811875
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*24; B*46,51; DRB1*09,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 14,16
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 13,14
ST   D7S820: 9,10
ST   D8S1179: 13,16
ST   FGA: 24,26
ST   Penta D: 11,12
ST   Penta E: 11,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-114
AC   CVCL_A843
SY   chHES114
DR   Wikidata; Q54811876
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,33; B*55,58; DRB1*13,16 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-115 (Cellosaurus=CVCL_A844).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D21S11: 32.2,33.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22.2,26.2
ST   Penta D: 10,12
ST   Penta E: 19,20
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-115
AC   CVCL_A844
SY   chHES115
DR   Wikidata; Q54811877
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,11; B*40(60),55; DRB1*04,12 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-114 (Cellosaurus=CVCL_A843).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D21S11: 31,33.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 24,25
ST   Penta D: 10,13
ST   Penta E: 17,18
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-116
AC   CVCL_A845
SY   chHES116
DR   Wikidata; Q54811878
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*11,24; B*07,55; DRB1*01,16 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-119 (Cellosaurus=CVCL_A848).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 8,10
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-117
AC   CVCL_A846
SY   chHES117
DR   Wikidata; Q54811879
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,03; B*38,52; DRB1*08,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13,19
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 18,24
ST   Penta D: 9
ST   Penta E: 11,15
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-118
AC   CVCL_A847
SY   chHES118
DR   Wikidata; Q54811880
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,11; B*15(75),46; DRB1*08,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 7,10
ST   D7S820: 9,12
ST   D8S1179: 11,16
ST   FGA: 21,22
ST   Penta D: 11,12
ST   Penta E: 14,18
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-119
AC   CVCL_A848
SY   chHES119
DR   Wikidata; Q54811881
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,24; B*40(61),48; DRB1*04,12 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-116 (Cellosaurus=CVCL_A845).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22,24
ST   Penta D: 10
ST   Penta E: 15,19
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-12
AC   CVCL_A849
SY   chHES12
DR   Wikidata; Q54811882
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*11; B*07,40(60); DRB1*01,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 13,14
ST   D21S11: 29,31
ST   D3S1358: 15,17
ST   D5S818: 7
ST   D7S820: 8,11
ST   D8S1179: 12
ST   FGA: 21,24
ST   Penta D: 12,13
ST   Penta E: 5,21
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-120
AC   CVCL_A850
SY   chHES120
DR   Wikidata; Q54811883
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,24; B*51,55; DRB1*04,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 30,32.2
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 11,14
ST   Penta E: 13
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-121
AC   CVCL_A851
SY   chHES121
DR   Wikidata; Q54811884
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,23; B*27,50; DRB1*11,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D21S11: 28.2,30
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   Penta D: 10,14
ST   Penta E: 12,19
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-122
AC   CVCL_A852
SY   chHES122
DR   Wikidata; Q54811886
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D13S317: 8,9,11
ST   D16S539: 9,14
ST   D18S51: 14,15
ST   D21S11: 29
ST   D3S1358: 16,17,18
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 10,11,13
ST   FGA: 23,24,25.2
ST   Penta D: 9
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-123
AC   CVCL_A853
SY   chHES123
DR   Wikidata; Q54811887
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02; B*13,46; DRB1*13,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 9,12
ST   D16S539: 9,10,12
ST   D18S51: 16,17
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 11,13,17
ST   FGA: 19,23
ST   Penta D: 11,13
ST   Penta E: 15,16
ST   TH01: 7,9
ST   TPOX: 8,9,11
ST   vWA: 14,16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-124
AC   CVCL_A854
SY   chHES124
DR   Wikidata; Q54811888
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,11; B*15(75),46; DRB1*12,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 11
ST   Penta E: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-125
AC   CVCL_A855
SY   chHES125
DR   Wikidata; Q54811889
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   HLA typing: A*02,11; B*38,67; DRB1*08,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 14,16
ST   D21S11: 28,29
ST   D3S1358: 16,19
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-126
AC   CVCL_A856
SY   chHES126
DR   Wikidata; Q54811890
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*46,48; DRB1*14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D21S11: 31.2
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 19,20
ST   Penta D: 8,9
ST   Penta E: 11,21
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-127
AC   CVCL_A857
SY   chHES127
DR   Wikidata; Q54811891
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*44,46; DRB1*03,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 15,16
ST   D21S11: 29,31
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23,27
ST   Penta D: 9,12
ST   Penta E: 5,9
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-128
AC   CVCL_A858
SY   chHES128
DR   Wikidata; Q54811892
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*15(75),40(60); DRB1*09,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 15,17
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 23,24
ST   Penta D: 12
ST   Penta E: 14,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-129
AC   CVCL_A859
SY   chHES129
DR   Wikidata; Q54811893
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*15(75),46; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 18,25
ST   Penta D: 13
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-13
AC   CVCL_A860
SY   chHES13
DR   Wikidata; Q54811894
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*40(60),48; DRB1*14,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 14,20
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 22,25.2
ST   Penta D: 9
ST   Penta E: 10,14
ST   TH01: 8,10
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-130
AC   CVCL_A861
SY   chHES130
DR   Wikidata; Q54811895
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*13,52; DRB1*15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 23,26
ST   Penta D: 9,12
ST   Penta E: 18
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-131
AC   CVCL_A862
SY   chHES131
DR   Wikidata; Q54811896
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*15(75),39; DRB1*11,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 29
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 5,22
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-132
AC   CVCL_A863
SY   chHES132
DR   Wikidata; Q54811897
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*38,46; DRB1*09,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 17,24
ST   D21S11: 29,31
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 19,25
ST   Penta D: 9,10
ST   Penta E: 5,14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-133
AC   CVCL_A864
SY   chHES133
DR   Wikidata; Q54811898
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*13,15(75); DRB1*03,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D21S11: 29,31.2
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 22,25
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-134
AC   CVCL_A865
SY   chHES134
DR   Wikidata; Q54811899
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*07,40(60); DRB1*11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 11,15
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 16,19
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-135
AC   CVCL_A866
SY   chHES135
DR   Wikidata; Q54811900
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 19,22
ST   D21S11: 28,29,31
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,13,14
ST   FGA: 21,24
ST   Penta D: 9,10,11
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-136
AC   CVCL_A867
SY   chHES136
DR   Wikidata; Q54811901
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11,12
ST   D16S539: 9,10,13
ST   D18S51: 13,16
ST   D21S11: 30,31.2,32.2
ST   D3S1358: 15,17,19
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 22,23,26
ST   Penta D: 12,13,16
ST   Penta E: 12,15,17
ST   TH01: 7,8,9
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-137
AC   CVCL_A868
SY   chHES137
DR   Wikidata; Q54811902
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*13,46; DRB1*09,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,22
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 10,18
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-138
AC   CVCL_A869
SY   chHES138
DR   Wikidata; Q54811903
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*46,54; DRB1*11,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D18S51: 14,18
ST   D21S11: 31,31.2
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 14,18
ST   FGA: 22,23
ST   Penta D: 12,14
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-139
AC   CVCL_A870
SY   chHES139
DR   Wikidata; Q54811904
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*03,11; B*07,40(60); DRB1*13,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 15,22
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 19,24
ST   Penta D: 9,12
ST   Penta E: 12,15
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-14
AC   CVCL_A871
SY   chHES14
DR   Wikidata; Q54811905
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*15(62),15(75); DRB1*13,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D18S51: 10,19
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D7S820: 12
ST   D8S1179: 15,16
ST   FGA: 23,25
ST   Penta D: 12,13
ST   Penta E: 16,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-140
AC   CVCL_A872
SY   chHES140
DR   Wikidata; Q54811906
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24,30; B*13,40(60); DRB1*07,08 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 16
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   D8S1179: 10,14
ST   FGA: 22,22.2
ST   Penta D: 9,14
ST   Penta E: 14,16
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-141
AC   CVCL_A873
SY   chHES141
DR   Wikidata; Q54811907
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46,51; DRB1*09,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D21S11: 29,32
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 24
ST   Penta D: 10
ST   Penta E: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-142
AC   CVCL_A874
SY   chHES142
DR   Wikidata; Q54811908
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 20,23
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 7,9
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-143
AC   CVCL_A875
SY   chHES143
DR   Wikidata; Q54811909
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24,31; B*40(60),46; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 12,13
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 7,12
ST   D7S820: 8,11
ST   D8S1179: 11,15
ST   FGA: 19,24
ST   Penta D: 10,14
ST   Penta E: 13,17
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-144
AC   CVCL_A876
SY   chHES144
DR   Wikidata; Q54811910
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10
ST   D18S51: 13,15,22
ST   D21S11: 29,30
ST   D3S1358: 15,16,18
ST   D5S818: 9,11,13
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 10,11,18
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-145
AC   CVCL_A877
SY   chHES145
DR   Wikidata; Q54811911
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D21S11: 29,31.2
ST   D3S1358: 15,16,18
ST   D5S818: 11,12
ST   D7S820: 8,11,12
ST   D8S1179: 11,14
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 9,11
ST   TH01: 7,9,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-146
AC   CVCL_A878
SY   chHES146
DR   Wikidata; Q54811912
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46,55; DRB1*09,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 29,31.2
ST   D3S1358: 14,16
ST   D5S818: 7,9,11
ST   D7S820: 11
ST   D8S1179: 10,15,18
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 5,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-147
AC   CVCL_A879
SY   chHES147
DR   Wikidata; Q54811913
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*15(62),51; DRB1*09,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D18S51: 15,19
ST   D21S11: 30,31
ST   D3S1358: 14,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 25,26
ST   Penta D: 9,13
ST   Penta E: 5,17
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-148
AC   CVCL_A880
SY   chHES148
DR   Wikidata; Q54811914
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*39,40(60); DRB1*11,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 10,13
ST   D18S51: 17
ST   D21S11: 30.2,31
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   Penta D: 8,10
ST   Penta E: 14,21
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-149
AC   CVCL_A881
SY   chHES149
DR   Wikidata; Q54811920
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*40(60),46; DRB1*09,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 16,18
ST   D21S11: 28,31
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13,16
ST   FGA: 22,25
ST   Penta D: 10,11
ST   Penta E: 11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-15
AC   CVCL_A882
SY   chHES15
DR   Wikidata; Q54811921
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*40(61),55; DRB1*04,07 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 16,18
ST   D21S11: 30,34.2
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 18,23
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-150
AC   CVCL_A883
SY   chHES150
DR   Wikidata; Q54811922
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*35,51; DRB1*12,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9,14
ST   D16S539: 8,11
ST   D18S51: 14,15
ST   D21S11: 28,31
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 9,13
ST   D8S1179: 10,14
ST   FGA: 20,24
ST   Penta D: 9,12
ST   Penta E: 16,21
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-151
AC   CVCL_A884
SY   chHES151
DR   Wikidata; Q54811923
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12,13
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 13,15,20
ST   D21S11: 28,30
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 20,21,22
ST   Penta D: 9,12
ST   Penta E: 12,13,15
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14,17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-152
AC   CVCL_A885
SY   chHES152
DR   Wikidata; Q54811924
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*33; B*58; DRB1*03 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,14
ST   D18S51: 14,16
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 10,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-153
AC   CVCL_A886
SY   chHES153
DR   Wikidata; Q54811925
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*46; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 28,29
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21,22.2
ST   Penta D: 7,10
ST   Penta E: 12,15
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-154
AC   CVCL_A887
SY   chHES154
DR   Wikidata; Q54811926
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   chHES-155
AC   CVCL_A888
SY   chHES155
DR   Wikidata; Q54811927
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   chHES-156
AC   CVCL_A889
SY   chHES156
DR   Wikidata; Q54811928
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*13,40(60); DRB1*14,15 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-157 (Cellosaurus=CVCL_A890).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 12
ST   D18S51: 13,16
ST   D21S11: 31.2,32.2
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 11,15
ST   FGA: 23,25
ST   Penta D: 9,14
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-157
AC   CVCL_A890
SY   chHES157
DR   Wikidata; Q54811929
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*40(60); DRB1*04,15 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-156 (Cellosaurus=CVCL_A889).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 31.2,32.2
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8
ST   D8S1179: 10,15
ST   FGA: 23,24
ST   Penta D: 8,9
ST   Penta E: 12
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-158
AC   CVCL_A891
SY   chHES158
DR   Wikidata; Q54811930
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,9,11
ST   D16S539: 9,10,11
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 15,16,17
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 12,13,14
ST   FGA: 19,22,24
ST   Penta D: 9,11,12
ST   Penta E: 15,23
ST   TH01: 7,8,9
ST   TPOX: 8,11
ST   vWA: 14,16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-159
AC   CVCL_A892
SY   chHES159
DR   Wikidata; Q54811931
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*15(71),40(60); DRB1*04,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 16,22
ST   D21S11: 30,31
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 14,17
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 5
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-16
AC   CVCL_A893
SY   chHES16
DR   Wikidata; Q54811932
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*15(62),40(60); DRB1*11,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 18,21
ST   D21S11: 29,30
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 21,26
ST   Penta D: 9,13
ST   Penta E: 11,18
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-160
AC   CVCL_A894
SY   chHES160
DR   Wikidata; Q54811933
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*15(62),15(75); DRB1*04,09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-161 (Cellosaurus=CVCL_A895).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 29,32.2
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 20,23
ST   Penta D: 12,14
ST   Penta E: 12,18
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-161
AC   CVCL_A895
SY   chHES161
DR   Wikidata; Q54811934
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24,30; B*13,15(62); DRB1*07,09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-160 (Cellosaurus=CVCL_A894).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 14,15
ST   D21S11: 31,32.2
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 20,23
ST   Penta D: 12,13
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-162
AC   CVCL_A896
SY   chHES162
DR   Wikidata; Q54811935
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,46; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D21S11: 29,31.2
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 11,13
ST   D8S1179: 10
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 15,16
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-163
AC   CVCL_A897
SY   chHES163
DR   Wikidata; Q54811936
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,31; B*46,51; DRB1*11,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 13
ST   D21S11: 32.2,33.2
ST   D3S1358: 14,15
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 16,21
ST   Penta D: 9
ST   Penta E: 11,19
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-164
AC   CVCL_A898
SY   chHES164
DR   Wikidata; Q54811937
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*40(60),46; DRB1*08,09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-165 (Cellosaurus=CVCL_A899).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 10,11
ST   D18S51: 14,18
ST   D21S11: 30,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 14,16
ST   TH01: 8,9
ST   TPOX: 11,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-165
AC   CVCL_A899
SY   chHES165
DR   Wikidata; Q54811938
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*40(60),46; DRB1*08,09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-164 (Cellosaurus=CVCL_A898).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 14,18
ST   D21S11: 30,32.2
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 11,14
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 16,19
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-166
AC   CVCL_A900
SY   chHES166
DR   Wikidata; Q54811939
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*46,55; DRB1*12,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 11,14
ST   D18S51: 17,19
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 8,11
ST   Penta E: 5,21
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-167
AC   CVCL_A901
SY   chHES167
DR   Wikidata; Q54811940
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*38,40(60); DRB1*08 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D21S11: 29,33
ST   D3S1358: 14,15
ST   D5S818: 7
ST   D7S820: 8,11
ST   D8S1179: 11,15
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 14,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-168
AC   CVCL_A902
SY   chHES168
DR   Wikidata; Q54811941
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*39,46; DRB1*08,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D21S11: 29,30
ST   D3S1358: 14,16
ST   D5S818: 11,14
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 12,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-169
AC   CVCL_A903
SY   chHES169
DR   Wikidata; Q54811942
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24,33; B*54,58; DRB1*03,08 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 19,24
ST   Penta D: 11,12
ST   Penta E: 12,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-17
AC   CVCL_A904
SY   chHES17
DR   Wikidata; Q54811943
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(75),35; DRB1*10,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 13,19
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 19,21
ST   Penta D: 9,13
ST   Penta E: 10,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 13,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-170
AC   CVCL_A905
SY   chHES170
DR   Wikidata; Q54811944
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(75); DRB1*12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D21S11: 28,29
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   Penta D: 9,10
ST   Penta E: 16,18
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-171
AC   CVCL_A906
SY   chHES171
DR   Wikidata; Q54811945
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*40(60),46; DRB1*08,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,17
ST   D21S11: 31,32
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 15
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-172
AC   CVCL_A907
SY   chHES172
DR   Wikidata; Q54811946
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(75); DRB1*09,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 12,13
ST   D8S1179: 12
ST   FGA: 22,24
ST   Penta D: 9,14
ST   Penta E: 11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-173
AC   CVCL_A908
SY   chHES173
DR   Wikidata; Q54811948
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,30; B*13,46; DRB1*07,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D18S51: 16
ST   D21S11: 30,32.2
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 12,13
ST   D8S1179: 13
ST   FGA: 18,24
ST   Penta D: 9,10
ST   Penta E: 12,17
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-174
AC   CVCL_A909
SY   chHES174
DR   Wikidata; Q54811949
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 13,17
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 10,18
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-175
AC   CVCL_A910
SY   chHES175
DR   Wikidata; Q54811950
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*46; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 16,17
ST   D5S818: 7,11
ST   D7S820: 9,10
ST   D8S1179: 11,15
ST   FGA: 25.2,26
ST   Penta D: 10,12
ST   Penta E: 11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-176
AC   CVCL_A911
SY   chHES176
DR   Wikidata; Q54811951
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,46; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 12,14
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 9,12
ST   Penta E: 10,17
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-177
AC   CVCL_A912
SY   chHES177
DR   Wikidata; Q54811952
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*07; DRB1*01 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 13
ST   D18S51: 13,15
ST   D21S11: 33
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,16
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-178
AC   CVCL_A913
SY   chHES178
DR   Wikidata; Q54811953
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*40(60),46; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   Penta D: 6,9
ST   Penta E: 15,17
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-179
AC   CVCL_A914
SY   chHES179
DR   Wikidata; Q54811954
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*40(60),46; DRB1*08,11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 14,16
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 19,25.2
ST   Penta D: 9,13
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-18
AC   CVCL_A915
SY   chHES18
DR   Wikidata; Q54811956
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*15(62),56; DRB1*11,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,19
ST   D21S11: 31,33.2
ST   D3S1358: 12,16
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 5,20
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-180
AC   CVCL_A916
SY   chHES180
DR   Wikidata; Q54811957
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*40(60),46; DRB1*04,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,16
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,18
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-181
AC   CVCL_A917
SY   chHES181
DR   Wikidata; Q54811958
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*15(71),40(61); DRB1*09,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 23,26
ST   Penta D: 9,10
ST   Penta E: 12,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-182
AC   CVCL_A918
SY   chHES182
DR   Wikidata; Q54811959
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,11; B*40(60),52; DRB1*08,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 29,30.2
ST   D3S1358: 14,17
ST   D5S818: 9,11
ST   D7S820: 9,13
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 8,11
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-183
AC   CVCL_A919
SY   chHES183
DR   Wikidata; Q54811960
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*08,15(75); DRB1*03,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 16
ST   D21S11: 28,29
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 12,16
ST   FGA: 16,22
ST   Penta D: 10,11
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-184
AC   CVCL_A920
SY   chHES184
DR   Wikidata; Q54811961
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*33; B*58,67; DRB1*13,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 13,18
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-185
AC   CVCL_A921
SY   chHES185
DR   Wikidata; Q54811964
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*15(75),46; DRB1*09,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 14,16
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23.2,26
ST   Penta D: 9,12
ST   Penta E: 11,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-186
AC   CVCL_A922
SY   chHES186
DR   Wikidata; Q54811965
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(75),51; DRB1*14,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D21S11: 31.2,32
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-187
AC   CVCL_A923
SY   chHES187
DR   Wikidata; Q54811966
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,02; B*13,37; DRB1*10,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D21S11: 29,32.2
ST   D3S1358: 17
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   Penta D: 7,12
ST   Penta E: 12,16
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-188
AC   CVCL_A924
SY   chHES188
DR   Wikidata; Q54811967
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D21S11: 32.2
ST   D3S1358: 14,18
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   Penta D: 12,13
ST   Penta E: 12,20
ST   TH01: 9,10
ST   TPOX: 9,10
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-189
AC   CVCL_A925
SY   chHES189
DR   Wikidata; Q54811968
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,30; B*13; DRB1*07,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 13,14
ST   D21S11: 30,32.2
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 17
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-19
AC   CVCL_A926
SY   chHES19
DR   Wikidata; Q54811969
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*40(60),48; DRB1*12,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 16,21
ST   D21S11: 30,31.2
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   D8S1179: 10,15
ST   FGA: 16,22
ST   Penta D: 9,10
ST   Penta E: 12,18
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-190
AC   CVCL_A927
SY   chHES190
DR   Wikidata; Q54811970
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(62),54; DRB1*04 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 12,16
ST   D21S11: 30
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,15
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 12,15
ST   TH01: 9
ST   TPOX: 9,12
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-191
AC   CVCL_A928
SY   chHES191
DR   Wikidata; Q54811971
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12,13
ST   D18S51: 12,14
ST   D21S11: 31,31.2
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   D8S1179: 11,14,16
ST   FGA: 21.2,22,23
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-192
AC   CVCL_A929
SY   chHES192
DR   Wikidata; Q54811972
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,55; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D21S11: 31,32
ST   D3S1358: 15,16
ST   D5S818: 7,10
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 24,26
ST   Penta D: 10,12
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-193
AC   CVCL_A930
SY   chHES193
DR   Wikidata; Q54811973
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*46,58; DRB1*03,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 15,20
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 23,24
ST   Penta D: 10,12
ST   Penta E: 14,17
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-194
AC   CVCL_A931
SY   chHES194
DR   Wikidata; Q54811974
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*46,54; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 8,13
ST   D18S51: 13,14
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 10,11,13
ST   D7S820: 8,11,12
ST   D8S1179: 12,13
ST   FGA: 19,22
ST   Penta D: 9
ST   Penta E: 5,12,15
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 14,15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-195
AC   CVCL_A932
SY   chHES195
DR   Wikidata; Q54811975
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,15(62); DRB1*04,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 14,21
ST   D21S11: 29,32.2
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 18,21.2
ST   Penta D: 10,13
ST   Penta E: 12,18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-20
AC   CVCL_A933
SY   ChHES-20; chHES20; CSUe004-A
DR   hPSCreg; CSUe004-A
DR   SKIP; SKIP002271
DR   Wikidata; Q54811976
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*40(60),55; DRB1*04,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 15
ST   D21S11: 29,34.2
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   Penta D: 8,9
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   chHES-21
AC   CVCL_A934
SY   chHES21
DR   Wikidata; Q54811977
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*46; DRB1*04,11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 17,22
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 9,13
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   chHES-22
AC   CVCL_A935
SY   ChHES-22; chHES22; CSUe005-A
DR   hPSCreg; CSUe005-A
DR   SKIP; SKIP002272
DR   Wikidata; Q54811978
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*35,40(60); DRB1*03,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 8,12
ST   Penta E: 18
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   chHES-23
AC   CVCL_A936
SY   chHES23
DR   Wikidata; Q54811979
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*55,56; DRB1*11,15 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-24 (Cellosaurus=CVCL_A937).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D18S51: 13,14
ST   D21S11: 31,31.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 22,26
ST   Penta D: 11,13
ST   Penta E: 5,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-24
AC   CVCL_A937
SY   chHES24
DR   Wikidata; Q54811980
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*38,56; DRB1*11,15 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-23 (Cellosaurus=CVCL_A936).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 10
ST   D18S51: 13,14,17
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 11,13,16
ST   FGA: 22,23,26
ST   Penta D: 9,11,14
ST   Penta E: 12,21
ST   TH01: 7,9
ST   TPOX: 9,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-25
AC   CVCL_A938
SY   chHES25
DR   Wikidata; Q54811981
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*40(61),46; DRB1*11,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 21,26
ST   Penta D: 10,14
ST   Penta E: 12,19
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-26
AC   CVCL_A939
SY   chHES26
DR   Wikidata; Q54811982
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*40(60),54; DRB1*12,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D21S11: 30,31
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 12,15
ST   FGA: 21,22
ST   Penta D: 8,9
ST   Penta E: 11,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-27
AC   CVCL_A940
SY   chHES27
DR   Wikidata; Q54811983
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*46,51; DRB1*09,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 24,25
ST   Penta D: 11
ST   Penta E: 11,13
ST   TH01: 7
ST   TPOX: 11,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-28
AC   CVCL_A941
SY   chHES28
DR   Wikidata; Q54811984
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,26; B*37,40(60); DRB1*10,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   Penta D: 10,13
ST   Penta E: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-29
AC   CVCL_A942
SY   chHES29
DR   Wikidata; Q54811985
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,15(75); DRB1*09,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D21S11: 30,32.2
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 24,25
ST   Penta D: 9
ST   Penta E: 5,16
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-3
AC   CVCL_A943
SY   chHES3
DR   Wikidata; Q54811986
RX   PubMed=20224969;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,13 (PubMed=20224969).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20224969
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 9,13
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 12,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-30
AC   CVCL_A944
SY   chHES30
DR   Wikidata; Q54811987
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,33; B*46,58; DRB1*09,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 14,17
ST   D21S11: 30,31
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 18,24
ST   Penta D: 10
ST   Penta E: 11,19
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-31
AC   CVCL_A945
SY   chHES31
DR   Wikidata; Q54811988
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*13,35; DRB1*11,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 28,29
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-32
AC   CVCL_A946
SY   chHES32
DR   Wikidata; Q54811989
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01; B*35; DRB1*13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 22
ST   D21S11: 31
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 17
ST   TH01: 9
ST   TPOX: 14
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-33
AC   CVCL_A947
SY   chHES33
DR   Wikidata; Q54811990
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,33; B*27,44; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 12,16
ST   FGA: 20,24
ST   Penta D: 9,12
ST   Penta E: 15,19
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-34
AC   CVCL_A948
SY   chHES34
DR   Wikidata; Q54811991
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 29,31
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,25
ST   Penta D: 9,13
ST   Penta E: 11,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-35
AC   CVCL_A949
SY   chHES35
DR   Wikidata; Q54811992
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*13,51; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13,21
ST   D21S11: 31,31.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   D8S1179: 13,16
ST   FGA: 20,26
ST   Penta D: 9,12
ST   Penta E: 5,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-355
AC   CVCL_A4GT
DR   Wikidata; Q105506601
RX   PubMed=28765174;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 5
//
ID   chHES-36
AC   CVCL_A950
SY   chHES36
DR   Wikidata; Q54811993
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,11; B*37,40(61); DRB1*11,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 10,14
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   D8S1179: 10,15
ST   FGA: 19,23
ST   Penta D: 11,13
ST   Penta E: 13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-37
AC   CVCL_A951
SY   chHES37
DR   Wikidata; Q54811994
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,31; B*37,51; DRB1*10,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,10
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 11
ST   D8S1179: 15,16
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 11,20
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-38
AC   CVCL_A952
SY   chHES38
DR   Wikidata; Q54811995
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,46; DRB1*15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D21S11: 29,33.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,12
ST   FGA: 19,24
ST   Penta D: 12,13
ST   Penta E: 10,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-39
AC   CVCL_A953
SY   chHES39
DR   Wikidata; Q54811996
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(62),38; DRB1*04,08 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 12,18
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-3XISTa
AC   CVCL_A4GU
DR   Wikidata; Q105506604
RX   PubMed=27934601;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Characteristics: Constitutively expresses XIST (PubMed=27934601).
CC   Karyotypic information: Has 8 derivatives chromosomes.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A943 ! chHES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 5
//
ID   chHES-4
AC   CVCL_A954
SY   chHES4
DR   Wikidata; Q54811997
RX   PubMed=20224969;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*15,38 (PubMed=20224969).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20224969
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 13,19
ST   D21S11: 29
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 19,24
ST   Penta D: 9,12
ST   Penta E: 11,18
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-40
AC   CVCL_A955
SY   chHES40
DR   Wikidata; Q54812000
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*15(75),46; DRB1*12,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 8,12
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D18S51: 14
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 11,15
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 5,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-41
AC   CVCL_A956
SY   chHES41
DR   Wikidata; Q54812001
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,31; B*48; DRB1*09,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 13,19
ST   D21S11: 28,32.2
ST   D3S1358: 15,17
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 23,24
ST   Penta D: 12
ST   Penta E: 10,16
ST   TH01: 8,9
ST   TPOX: 12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-415
AC   CVCL_AB80
DR   Wikidata; Q54811998
RX   PubMed=27345785;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Arg459Leu (c.1376G>T); ClinVar=VCV000100058; Zygosity=Heterozygous (PubMed=27345785).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   chHES-419
AC   CVCL_9T88
DR   Wikidata; Q54811999
RX   PubMed=26987927;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Gln1179Argfs*25 (c.3536delA); Zygosity=Heterozygous (PubMed=26987927).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   chHES-42
AC   CVCL_A957
SY   chHES42
DR   Wikidata; Q54812002
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,26; B*40(60),54; DRB1*08,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 30,32.2
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 21,26
ST   Penta D: 12,13
ST   Penta E: 15,24
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-427
AC   CVCL_AD57
DR   Wikidata; Q54812003
RX   PubMed=27345972;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7del; Zygosity=Homozygous (PubMed=27345972).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   chHES-43
AC   CVCL_A958
SY   chHES43
DR   Wikidata; Q54812007
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*40(60),51; DRB1*08,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 17,18
ST   D21S11: 32,32.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 11,15
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-44
AC   CVCL_A959
SY   chHES44
DR   Wikidata; Q54812008
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,31; B*40(60),58; DRB1*03,11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 12,17
ST   D21S11: 31,32.2
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 12,16
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 11,14
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-442
AC   CVCL_VE64
SY   NERCe004-A
DR   hPSCreg; NERCe004-A
DR   Wikidata; Q54812009
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 7
//
ID   chHES-45
AC   CVCL_A960
SY   chHES45
DR   Wikidata; Q54812010
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*40(60),51; DRB1*08,14 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-46 (Cellosaurus=CVCL_A961).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 31,31.2
ST   D3S1358: 16,18
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 9,12
ST   Penta E: 11,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-458
AC   CVCL_A4GE
DR   Wikidata; Q105506607
RX   PubMed=27934595;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[52] (c.52CAG(52)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=27934595).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   chHES-46
AC   CVCL_A961
SY   chHES46
DR   Wikidata; Q54812011
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*40(60),46; DRB1*08,09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-45 (Cellosaurus=CVCL_A960).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 15,18
ST   D21S11: 31
ST   D3S1358: 16,18
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 21,24
ST   Penta D: 8,13
ST   Penta E: 13,18
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-468
AC   CVCL_A4GQ
DR   Wikidata; Q105506611
RX   PubMed=27934598;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Glu3509Aspfs*117 (c.10526_10527delAG); Zygosity=Heterozygous (PubMed=27934598).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   chHES-47
AC   CVCL_A962
SY   chHES47
DR   Wikidata; Q54812012
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*39,54; DRB1*04,11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D18S51: 13,21
ST   D21S11: 30,31.2
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 15,16
ST   FGA: 23,27
ST   Penta D: 10,12
ST   Penta E: 11,19
ST   TH01: 6,9
ST   TPOX: 9,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-472
AC   CVCL_XA13
DR   Wikidata; Q93449754
RX   PubMed=27934588;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[~74]; Zygosity=Heterozygous (PubMed=27934588).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   chHES-478
AC   CVCL_A4GS
DR   Wikidata; Q105506615
RX   PubMed=27934600;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Arg299His (c.896G>A); ClinVar=VCV000003796; Zygosity=Heterozygous (PubMed=27934600).
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Arg311Leufs*7 (c.929dupC) (c.929_930insC) (p.Pro310Glnfs*9); ClinVar=VCV000003771; Zygosity=Heterozygous (PubMed=27934600).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   chHES-48
AC   CVCL_A963
SY   chHES48
DR   Wikidata; Q54812013
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,31; B*46,67; DRB1*07,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 13,18
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 21,24
ST   Penta D: 8,9
ST   Penta E: 17,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-480
AC   CVCL_A4GL
DR   Wikidata; Q105506617
RX   PubMed=27934597;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Glu609Lys (c.1825G>A); ClinVar=VCV000166626; Zygosity=Hemizygous (PubMed=27934597).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   chHES-49
AC   CVCL_A964
SY   chHES49
DR   Wikidata; Q54812014
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*40(60),54; DRB1*08,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 14,15
ST   D21S11: 30,32.2
ST   D3S1358: 15,16
ST   D5S818: 9
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 8,9
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-50
AC   CVCL_A965
SY   chHES50
DR   Wikidata; Q54812015
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,51; DRB1*04,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 13,20
ST   D21S11: 29,31
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 19,24
ST   Penta D: 11,14
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-51
AC   CVCL_A966
SY   chHES51
DR   Wikidata; Q54812016
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*40(60),40(61); DRB1*04,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 20,26
ST   Penta D: 10,13
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-52
AC   CVCL_A967
SY   chHES52
DR   Wikidata; Q54812017
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46,50; DRB1*03,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 23,24
ST   Penta D: 11,12
ST   Penta E: 12,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-53
AC   CVCL_A968
SY   chHES53
DR   Wikidata; Q54812018
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,30; B*13,46; DRB1*07 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 13,16
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 12,15
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-54
AC   CVCL_A969
SY   chHES54
DR   Wikidata; Q54812019
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,31; B*46,51; DRB1*04,08 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 13,17
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 10,14
ST   D8S1179: 14,17
ST   FGA: 21,24
ST   Penta D: 11,13
ST   Penta E: 5,14
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-55
AC   CVCL_A970
SY   chHES55
DR   Wikidata; Q54812020
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,33; B*38,58; DRB1*01,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D21S11: 32,32.2
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 8,13
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 15,17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-56
AC   CVCL_A971
SY   chHES56
DR   Wikidata; Q54812021
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*15(75),46; DRB1*08,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 28,31.2
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 24,25
ST   Penta D: 9,13
ST   Penta E: 13,17
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-57
AC   CVCL_A972
SY   chHES57
DR   Wikidata; Q54812022
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,11; B*39,52; DRB1*08,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 16,18
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 14,17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-58
AC   CVCL_A973
SY   chHES58
DR   Wikidata; Q54812023
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*40(60),51; DRB1*08,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 12,19
ST   D21S11: 29
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 12,19
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-59
AC   CVCL_A974
SY   chHES59
DR   Wikidata; Q54812024
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,35; DRB1*15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 14
ST   D21S11: 30,31
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 13,16
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-60
AC   CVCL_A975
SY   chHES60
DR   Wikidata; Q54812025
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,26; B*40(60),56; DRB1*14,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D21S11: 29,31
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 13,16
ST   FGA: 20,24
ST   Penta D: 12,13
ST   Penta E: 14,16
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-61
AC   CVCL_A976
SY   chHES61
DR   Wikidata; Q54812026
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*13,40(60); DRB1*08,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 7,13
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 19,20
ST   Penta D: 9,13
ST   Penta E: 12,21
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-62
AC   CVCL_A977
SY   chHES62
DR   Wikidata; Q54812027
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*15(62),46; DRB1*04,09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to those giving rise to chHES-63 (Cellosaurus=CVCL_A978) and chHES-64 (Cellosaurus=CVCL_A979).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D21S11: 32.2,33.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22,24
ST   Penta D: 12,14
ST   Penta E: 5,14
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-63
AC   CVCL_A978
SY   chHES63
DR   Wikidata; Q54812028
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,26; B*46,48; DRB1*09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to those giving rise to chHES-62 (Cellosaurus=CVCL_A977) and chHES-64 (Cellosaurus=CVCL_A979).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 13,14
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 10
ST   D7S820: 11,13
ST   D8S1179: 12,15
ST   FGA: 22,24
ST   Penta D: 12,14
ST   Penta E: 5
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-64
AC   CVCL_A979
SY   chHES64
DR   Wikidata; Q54812029
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*15(62),46; DRB1*04,14 (PubMed=19896436).
CC   Donor information: Embryo is sibling to those giving rise to chHES-62 (Cellosaurus=CVCL_A977) and chHES-63 (Cellosaurus=CVCL_A978).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   D8S1179: 13,15
ST   FGA: 22,24
ST   Penta D: 9,12
ST   Penta E: 5
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-65
AC   CVCL_A980
SY   chHES65
DR   Wikidata; Q54812030
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*48,51; DRB1*09,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 8,10
ST   D18S51: 15
ST   D21S11: 29,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,14
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 19,24
ST   Penta D: 9,13
ST   Penta E: 15,17
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-66
AC   CVCL_A981
SY   chHES66
DR   Wikidata; Q54812031
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*15(62),46; DRB1*04,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 18
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 7,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 16,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-67
AC   CVCL_A982
SY   chHES67
DR   Wikidata; Q54812032
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*40(60),46; DRB1*08,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 15,19
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 19,23
ST   Penta D: 8,11
ST   Penta E: 11,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-68
AC   CVCL_A983
SY   chHES68
DR   Wikidata; Q54812033
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*38,56; DRB1*13,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 14,18
ST   D21S11: 31,32.2
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 9,10
ST   Penta E: 11,21
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-69
AC   CVCL_A984
SY   chHES69
DR   Wikidata; Q54812034
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*27,40(61); DRB1*11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 19
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 9,13
ST   Penta E: 5,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-7
AC   CVCL_A985
SY   chHES7
DR   Wikidata; Q54812035
RX   PubMed=20224969;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*38,40 (PubMed=20224969).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20224969
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 17,19
ST   D21S11: 31,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,14
ST   D8S1179: 14,15
ST   FGA: 20,25
ST   Penta D: 9,13
ST   Penta E: 5,14
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-70
AC   CVCL_A986
SY   chHES70
DR   Wikidata; Q54812036
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,31; B*08,40(60); DRB1*03,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 10,20
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-71
AC   CVCL_A987
SY   chHES71
DR   Wikidata; Q54812037
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(75),39; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 12,17
ST   D21S11: 30,31
ST   D3S1358: 15,18
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21,22.2
ST   Penta D: 12,14
ST   Penta E: 13,17
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-72
AC   CVCL_A988
SY   chHES72
DR   Wikidata; Q54812038
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46; DRB1*08,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 19,23
ST   Penta D: 11,13
ST   Penta E: 11,15
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-73
AC   CVCL_A989
SY   chHES73
DR   Wikidata; Q54812039
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,15(62); DRB1*08,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10
ST   D18S51: 14,20
ST   D21S11: 30,31.2
ST   D3S1358: 17,18
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   D8S1179: 10,11
ST   FGA: 22,25
ST   Penta D: 9,10
ST   Penta E: 5,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-74
AC   CVCL_A990
SY   chHES74
DR   Wikidata; Q54812040
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*27,51; DRB1*11,15 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-75 (Cellosaurus=CVCL_A991).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 14,16
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 20,25
ST   Penta D: 8,10
ST   Penta E: 11,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-75
AC   CVCL_A991
SY   chHES75
DR   Wikidata; Q54812041
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*13,46; DRB1*08,15 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-74 (Cellosaurus=CVCL_A990).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 12,15
ST   FGA: 25
ST   Penta D: 10,12
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-76
AC   CVCL_A992
SY   chHES76
DR   Wikidata; Q54812042
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,26; B*15(62),46; DRB1*04,09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-77 (Cellosaurus=CVCL_A993).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 14,15
ST   D21S11: 31,32.2
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 20,26
ST   Penta D: 9,10
ST   Penta E: 14,16
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-77
AC   CVCL_A993
SY   chHES77
DR   Wikidata; Q54812043
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*46; DRB1*09 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-76 (Cellosaurus=CVCL_A992).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 13,15
ST   D21S11: 32.2
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 21,23
ST   Penta D: 9,10
ST   Penta E: 14,20
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-78
AC   CVCL_A994
SY   chHES78
DR   Wikidata; Q54812044
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,33; B*40(60),58; DRB1*03,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13,15
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 8,10
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-79
AC   CVCL_A995
SY   chHES79
DR   Wikidata; Q54812045
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,33; B*13,58; DRB1*03,12 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-80 (Cellosaurus=CVCL_A996).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,11,12
ST   D18S51: 15,16,19
ST   D21S11: 29,32.2
ST   D3S1358: 16
ST   D5S818: 9,10,12
ST   D7S820: 11,12
ST   D8S1179: 11,12,15
ST   FGA: 22,24
ST   Penta D: 8,10,12
ST   Penta E: 11,13,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-8
AC   CVCL_A996
SY   ChHES-8; chHES8; CSUe003-A; NERCe003-A
DR   BioSamples; SAMEA104132950
DR   hPSCreg; NERCe003-A
DR   SKIP; SKIP002270
DR   Wikidata; Q54812047
RX   PubMed=19896436;
RX   PubMed=28765174;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*31,33; B*40(61),58; DRB1*11,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 13,14
ST   D18S51: 15,18
ST   D21S11: 28,32.2
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 19,21
ST   Penta D: 9,13
ST   Penta E: 11,18
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   chHES-80
AC   CVCL_A997
SY   chHES80
DR   Wikidata; Q54812053
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*33; B*58; DRB1*03 (PubMed=19896436).
CC   Donor information: Embryo is sibling to that giving rise to chHES-79 (Cellosaurus=CVCL_A996).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 15,19
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 12,14
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 10,11
ST   Penta E: 11,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-81
AC   CVCL_A998
SY   chHES81
DR   Wikidata; Q54812054
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*38,40(60); DRB1*11,14 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13,17
ST   D21S11: 30,32
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20,26
ST   Penta D: 9,10
ST   Penta E: 19
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-82
AC   CVCL_A999
SY   chHES82
DR   Wikidata; Q54812055
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24,30; B*27,46; DRB1*09,11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14,20
ST   D21S11: 29,31.2
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 9,16
ST   Penta E: 5,15
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-83
AC   CVCL_B000
SY   chHES83
DR   Wikidata; Q54812056
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*13,15(62); DRB1*15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 31,32.2
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 15
ST   FGA: 20,22
ST   Penta D: 8,11
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-84
AC   CVCL_B001
SY   chHES84
DR   Wikidata; Q54812057
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*40(60),46; DRB1*08,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 13,14
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-85
AC   CVCL_B002
SY   chHES85
DR   Wikidata; Q54812058
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,33; B*40(60),58; DRB1*11,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 14
ST   D21S11: 29,30.2
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 23,24
ST   Penta D: 8,15
ST   Penta E: 17,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-86
AC   CVCL_B003
SY   chHES86
DR   Wikidata; Q54812059
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24; B*40(60); DRB1*04,11 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14,19
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   Penta D: 9,11
ST   Penta E: 12,21
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-87
AC   CVCL_B004
SY   chHES87
DR   Wikidata; Q54812060
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,33; B*51,58; DRB1*04,13 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 22,23.2
ST   Penta D: 8,12
ST   Penta E: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-88
AC   CVCL_B005
SY   chHES88
DR   Wikidata; Q54812061
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02; B*48,67; DRB1*12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,18
ST   D21S11: 29,33.2
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-89
AC   CVCL_B006
SY   chHES89
DR   Wikidata; Q54812062
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*13,46; DRB1*07,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,15
ST   D21S11: 30,32.2
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 8,11
ST   D8S1179: 7,14
ST   FGA: 23,26
ST   Penta D: 11,15
ST   Penta E: 17,19
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-9
AC   CVCL_B007
SY   chHES9
DR   Wikidata; Q54812064
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*38,40(61); DRB1*11,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 8,9
ST   Penta E: 13,16
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-90
AC   CVCL_B008
SY   chHES90; NERCe002-A
DR   BioSamples; SAMEA104132871
DR   hPSCreg; NERCe002-A
DR   Wikidata; Q54812065
RX   PubMed=19896436;
RX   PubMed=29414411;
RX   PubMed=29414419;
RX   PubMed=29501955;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,33; B*13,58; DRB1*03,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29414411; PubMed=29414419; PubMed=29501955
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 20,21
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 13,17
ST   D19S433: 12.2,14
ST   D1S1656: 16,17
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D6S1043: 11,18
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 17,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   chHES-91
AC   CVCL_B009
SY   chHES91
DR   Wikidata; Q54812066
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,10,12
ST   D18S51: 13,14,16
ST   D21S11: 29,31.2
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 21,23,24
ST   Penta D: 9
ST   Penta E: 10,14,17
ST   TH01: 7,9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-92
AC   CVCL_B010
SY   chHES92
DR   Wikidata; Q54812067
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,31; B*51,55; DRB1*08,09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 14,24
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 25,26
ST   Penta D: 10,11
ST   Penta E: 11,19
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-93
AC   CVCL_B011
SY   chHES93
DR   Wikidata; Q54812068
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   chHES-94
AC   CVCL_B012
SY   chHES94
DR   Wikidata; Q54812069
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*24,33; B*46,58; DRB1*09 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 11
ST   FGA: 19,23
ST   Penta D: 11,13
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-95
AC   CVCL_B013
SY   chHES95
DR   Wikidata; Q54812070
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*01,33; B*37,58; DRB1*03,10 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,14
ST   D16S539: 10,11
ST   D18S51: 14,17
ST   D21S11: 29,31
ST   D3S1358: 17
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 22,23.2
ST   Penta D: 9,11
ST   Penta E: 13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-96
AC   CVCL_B014
SY   chHES96
DR   Wikidata; Q54812071
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11,24; B*40(60); DRB1*08,12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 14,17,18
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   TH01: 7,8,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-97
AC   CVCL_B015
SY   chHES97
DR   Wikidata; Q54812072
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*11; B*15(62),15(75); DRB1*12 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,10
ST   D16S539: 10,13
ST   D18S51: 13,14
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 10,14
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 8,10
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-98
AC   CVCL_B016
SY   chHES98
DR   Wikidata; Q54812073
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,24; B*40(60),46; DRB1*09,16 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 14,15
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 18,22
ST   Penta D: 9,10
ST   Penta E: 13,16
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   chHES-99
AC   CVCL_B017
SY   chHES99
DR   Wikidata; Q54812074
RX   PubMed=19896436;
WW   Info; -; -; https://web.archive.org/web/20111114212412/http://www.hescbank.cn/news-conn.asp?id=25
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   HLA typing: A*02,11; B*15(75),46; DRB1*09,15 (PubMed=19896436).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19896436
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 30
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 8,12
ST   Penta E: 19,21
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   CHI007
AC   CVCL_E524
SY   CHI 007
DR   dbMHC; 48723
DR   ECACC; 94082291
DR   IHW; IHW09191
DR   IPD-IMGT/HLA; 11733
DR   Wikidata; Q54812075
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*29:01:01:01,24:10:01; B*07:05:01:01,51:01:01:01; C*07:04:01,15:29; DPA1*01:03:01,04:01; DPB1*03:01:01,13:01; DQA1*01:05:01,03:03:01; DQB1*04:01:01,05:01:01; DRB1*04:05:01,10:01:01; DRB4*01:03:01 (IPD-IMGT/HLA=11733).
CC   HLA typing: A*29:01:01:01,24:10:01; B*07:05:01:01,51:01:01:01; C*15:29,07:04:01:01; DPA1*01:03:01:02,04:01; DPB1*13:01:01,104:01; DQA1*01:05:01,03:03:01:03; DQB1*04:01:01,05:01:01:02,04:05:01; DRB1*10:01:01:01; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   CHI013
AC   CVCL_E525
SY   CHI 013
DR   dbMHC; 48724
DR   ECACC; 94082220
DR   IHW; IHW09121
DR   IPD-IMGT/HLA; 11665
DR   Wikidata; Q54812076
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*02,11; B*07,27; C*03; DPB1*04:01; DQA1*06:01; DQB1*03:01; DRB1*12:02; DRB3*03:01 (IPD-IMGT/HLA=11665).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   CHI034
AC   CVCL_E526
SY   CHI 034
DR   dbMHC; 48725
DR   ECACC; 940822104
DR   IHW; IHW09200
DR   IPD-IMGT/HLA; 11741
DR   Wikidata; Q54812077
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,19; B*07,40; DPA1*01:03:01; DPB1*02:01:02,32:01; DQA1*05:01,01:04; DQB1*05:01,03:01; DRB1*10:01,11; DRB3*02:02 (IPD-IMGT/HLA=11741).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   CHI037
AC   CVCL_F347
DR   CLO; CLO_0051129
DR   RCB; HSC0085
DR   Wikidata; Q54812078
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI05
AC   CVCL_F348
DR   CLO; CLO_0051150
DR   RCB; HSC0114
DR   Wikidata; Q54812079
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI059
AC   CVCL_F349
DR   CLO; CLO_0051082
DR   RCB; HSC0051
DR   Wikidata; Q54812080
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI08
AC   CVCL_F350
DR   CLO; CLO_0051078
DR   RCB; HSC0047
DR   Wikidata; Q54812081
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI101
AC   CVCL_F351
DR   CLO; CLO_0051183
DR   RCB; HSC0146
DR   Wikidata; Q54812082
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI139
AC   CVCL_F352
DR   CLO; CLO_0051088
DR   RCB; HSC0058
DR   Wikidata; Q54812083
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI142
AC   CVCL_F353
DR   CLO; CLO_0051200
DR   RCB; HSC0153
DR   Wikidata; Q54812084
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI144
AC   CVCL_F354
DR   CLO; CLO_0051201
DR   RCB; HSC0154
DR   Wikidata; Q54812085
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI146
AC   CVCL_F355
DR   CLO; CLO_0051182
DR   RCB; HSC0144
DR   Wikidata; Q54812086
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI147
AC   CVCL_F356
DR   CLO; CLO_0051202
DR   RCB; HSC0157
DR   Wikidata; Q54812087
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI212
AC   CVCL_F357
DR   CLO; CLO_0051098
DR   RCB; HSC0071
DR   Wikidata; Q54812088
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI214
AC   CVCL_F358
DR   CLO; CLO_0051092
DR   RCB; HSC0064
DR   Wikidata; Q54812089
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   CHI215
AC   CVCL_F359
DR   CLO; CLO_0051189
DR   RCB; HSC0158
DR   Wikidata; Q54812090
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI217
AC   CVCL_F360
DR   CLO; CLO_0051187
DR   RCB; HSC0155
DR   Wikidata; Q54812091
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI220
AC   CVCL_F361
DR   CLO; CLO_0051188
DR   RCB; HSC0156
DR   Wikidata; Q54812092
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI232
AC   CVCL_F362
DR   CLO; CLO_0051077
DR   RCB; HSC0045
DR   Wikidata; Q54812093
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI233
AC   CVCL_F363
DR   CLO; CLO_0051171
DR   RCB; HSC0135
DR   Wikidata; Q54812098
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI236
AC   CVCL_F364
DR   CLO; CLO_0051163
DR   RCB; HSC0127
DR   Wikidata; Q54812099
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI244
AC   CVCL_F365
DR   CLO; CLO_0051151
DR   RCB; HSC0115
DR   Wikidata; Q54812100
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI3
AC   CVCL_F366
DR   CLO; CLO_0051177
DR   RCB; HSC0145
DR   Wikidata; Q54812101
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI52
AC   CVCL_A061
SY   CHI-52
DR   Cosmic; 688094
DR   Cosmic; 1609541
DR   Wikidata; Q54812102
RX   PubMed=12068308;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   CHI60
AC   CVCL_F367
DR   CLO; CLO_0051081
DR   RCB; HSC0050
DR   Wikidata; Q54812103
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI76
AC   CVCL_F368
DR   CLO; CLO_0051185
DR   RCB; HSC0151
DR   Wikidata; Q54812104
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI84
AC   CVCL_F369
DR   CLO; CLO_0051172
DR   RCB; HSC0137
DR   Wikidata; Q54812105
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI85
AC   CVCL_F370
DR   CLO; CLO_0051178
DR   RCB; HSC0143
DR   Wikidata; Q54812107
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI88
AC   CVCL_F371
DR   CLO; CLO_0051184
DR   RCB; HSC0148
DR   Wikidata; Q54812108
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI89
AC   CVCL_F372
DR   CLO; CLO_0051203
DR   RCB; HSC0159
DR   Wikidata; Q54812109
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI90
AC   CVCL_F373
DR   CLO; CLO_0051176
DR   RCB; HSC0142
DR   Wikidata; Q54812110
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI91
AC   CVCL_F374
DR   CLO; CLO_0051162
DR   RCB; HSC0126
DR   Wikidata; Q54812111
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI94
AC   CVCL_F375
DR   CLO; CLO_0051181
DR   RCB; HSC0149
DR   Wikidata; Q54812112
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHI99
AC   CVCL_F376
DR   CLO; CLO_0051186
DR   RCB; HSC0152
DR   Wikidata; Q54812113
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHIC
AC   CVCL_E2T5
RX   PubMed=20955410;
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=20955410).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   CHIC-8E11
AC   CVCL_E7BU
SY   CHIC Clone-8E11; CHIC-Clone 8E11; CHIC 8E11; 8E11
RX   PubMed=38674783;
WW   Provider; Tentamus; -; https://www.tentamus-pharma.de/en/cell-line-products/
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic intestine; UBERON=UBERON_0000160.
CC   Cell type: Enterocyte; CL=CL_0000584.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHIE
AC   CVCL_R885
SY   Cloned HIrame Embryo; Clone HIrame Embryo
DR   Wikidata; Q54812114
RX   CelloPub=CLPUB00030;
CC   Group: Fish cell line.
CC   Doubling time: 12 days (CelloPub=CLPUB00030).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   CHINTAi001-A
AC   CVCL_F1KS
SY   iCON-001
DR   BioSamples; SAMEA120434799
DR   hPSCreg; CHINTAi001-A
CC   From: Centre for High Impact Neuroscience and Translational Applications (CHINTA); Kolkata; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CHINTAi002-A
AC   CVCL_F1KT
SY   iCON-002
DR   BioSamples; SAMEA120435233
DR   hPSCreg; CHINTAi002-A
CC   From: Centre for High Impact Neuroscience and Translational Applications (CHINTA); Kolkata; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CHIpMSC1
AC   CVCL_B3MQ
SY   F-CHI
DR   Wikidata; Q110432706
RX   CelloPub=CLPUB00652;
RX   PubMed=31525223;
CC   Sequence variation: Mutation; HGNC; HGNC:59; ABCC8; Simple; p.Gly316Arg (c.946G>A); ClinVar=VCV001687413; Zygosity=Heterozygous (PubMed=31525223).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): CelloPub=CLPUB00652
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 12
ST   D21S11: 27,29
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 19,21
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 14
DI   NCIt; C122923; Persistent hyperinsulinemic hypoglycemia of infancy
DI   ORDO; Orphanet_276575; Autosomal dominant hyperinsulinism due to SUR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Somatic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   CHIpMSC2
AC   CVCL_B3MP
SY   A-CHI; Nes160
DR   Wikidata; Q110432707
RX   CelloPub=CLPUB00651;
RX   CelloPub=CLPUB00652;
RX   PubMed=31525223;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): CelloPub=CLPUB00651; CelloPub=CLPUB00652
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 16,17
ST   D21S11: 29,31
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 19,20
ST   Penta D: 13,14
ST   Penta E: 10,14
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y5M
CA   Somatic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CHIpMSC3
AC   CVCL_B3MR
SY   D-CHI
DR   Wikidata; Q110432708
RX   CelloPub=CLPUB00652;
RX   PubMed=31525223;
CC   Sequence variation: Mutation; HGNC; HGNC:59; ABCC8; Simple; p.Arg1493Gln (c.4478G>A) (R1494Q); ClinVar=VCV000370910; Zygosity=Homozygous (PubMed=31525223).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): CelloPub=CLPUB00652
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 15,16
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 23,25
ST   Penta D: 8,10
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C122923; Persistent hyperinsulinemic hypoglycemia of infancy
DI   ORDO; Orphanet_276575; Autosomal dominant hyperinsulinism due to SUR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11W
CA   Somatic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   CHiPSC-B
AC   CVCL_QW43
DR   Wikidata; Q54812115
RX   PubMed=28677528;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Male
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ChiPSC10
AC   CVCL_UK26
SY   Cellartis Human iPS Cell Line 10
DR   Wikidata; Q93450296
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC11
AC   CVCL_UK27
SY   Cellartis Human iPS Cell Line 11
DR   Wikidata; Q93450299
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC12
AC   CVCL_RM99
SY   Cellartis Human iPS Cell Line 12
DR   SKIP; SKIP001004
DR   Wikidata; Q54812116
WW   Provider; Takara Bio; Y00285; https://www.takarabio.com/products/stem-cell-research/stem-cells-and-stem-cell-derived-cells/human-induced-pluripotent-stem-cells
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   HLA typing: A*01:01; B*08:01,37:01; C*06:02,07:01; DPB1*01:01,04:01; DQB1*02:01,03:01; DRB1*03:01,11:04 (Takara Bio).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   ChiPSC13
AC   CVCL_UK28
SY   Cellartis Human iPS Cell Line 13
DR   Wikidata; Q93450308
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC15
AC   CVCL_UK25
SY   Cellartis Human iPS Cell Line 15
DR   Wikidata; Q93450311
RX   PubMed=26385115;
RX   PubMed=29026098;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   HLA typing: A*02,29; B*44,49; C*07,16; DQA1*02,03; DQB1*02,03; DRB1*04,07 (PubMed=29026098).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC17
AC   CVCL_UK29
SY   Cellartis Human iPS Cell Line 17
DR   Wikidata; Q93450313
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC18
AC   CVCL_RN00
SY   Cellartis Human iPS Cell Line 18
DR   SKIP; SKIP001005
DR   Wikidata; Q54812117
RX   PubMed=26385115;
WW   Provider; Takara Bio; Y00305; https://www.takarabio.com/products/stem-cell-research/stem-cells-and-stem-cell-derived-cells/human-induced-pluripotent-stem-cells
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   HLA typing: A*23:01; B*07:02,49:01; C*07:01,07:02; DPB1*03:01,04:01; DQB1*02:02,04:02; DRB1*04:06,07:01 (Takara Bio).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   ChiPSC19
AC   CVCL_UK30
SY   Cellartis Human iPS Cell Line 19
DR   Wikidata; Q93450322
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC20
AC   CVCL_UK31
SY   Cellartis Human iPS Cell Line 20
DR   Wikidata; Q93450326
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC21
AC   CVCL_RN01
SY   Cellartis Human iPS Cell Line 21
DR   SKIP; SKIP001006
DR   Wikidata; Q54812118
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   HLA typing: A*02:01,30:02; B*18:01,51:01; C*02:02,05:01; DPB1*02:02,04:01; DQB1*02:01,03:01; DRB1*03:01,11:01 (Takara Bio).
CC   Discontinued: Takara/Clontech; Catalog number Y00310.
CC   Discontinued: Takara/Clontech; Catalog number Y00315.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   ChiPSC22
AC   CVCL_RN02
SY   Cellartis Human iPS Cell Line 22; CEBi001-A
DR   BioSamples; SAMEA7462432
DR   hPSCreg; CEBi001-A
DR   SKIP; SKIP001007
DR   Wikidata; Q54812119
RX   PubMed=26385115;
RX   PubMed=29026098;
WW   Provider; Takara Bio; Y00325; https://www.takarabio.com/products/stem-cell-research/stem-cells-and-stem-cell-derived-cells/human-induced-pluripotent-stem-cells
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   HLA typing: A*02,02; B*07,40; C*03,07; DQA1*01,01; DQB1*05,06; DRB1*13,14 (PubMed=29026098).
CC   HLA typing: A*02:01; B*07:02,40:01; C*03:04,07:02; DPB1*03:01,04:01; DQB1*05:03,06:04; DRB1*13:02,14:01 (Takara Bio).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   ChiPSC23
AC   CVCL_UK32
SY   Cellartis Human iPS Cell Line 23
DR   Wikidata; Q93450340
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC24
AC   CVCL_UK33
SY   Cellartis Human iPS Cell Line 24
DR   Wikidata; Q93450342
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC4
AC   CVCL_RM97
SY   Cellartis Human iPS Cell Line 4; ChiPS4; UODi001-A
DR   BioSamples; SAMEA4305459
DR   hPSCreg; UODi001-A
DR   SKIP; SKIP001002
DR   Wikidata; Q54812120
RX   PubMed=23856292;
RX   PubMed=26385115;
RX   PubMed=29026098;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Population: Caucasian.
CC   HLA typing: A*23,30; B*53,58; C*04,07; DQA1*01,01; DQB1*05,06; DRB1*15,16 (PubMed=29026098).
CC   Discontinued: Takara/Clontech; Catalog number Y00260.
CC   Discontinued: Takara/Clontech; Catalog number Y00265.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 11
//
ID   ChiPSC6b
AC   CVCL_UK34
SY   Cellartis Human iPS Cell Line 6b
DR   ArrayExpress; E-MTAB-5367
DR   Wikidata; Q93450353
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Takara/Clontech; Catalog number Y11032.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   ChiPSC7
AC   CVCL_RM98
SY   Cellartis Human iPS Cell Line 7
DR   SKIP; SKIP001003
DR   Wikidata; Q54812121
RX   PubMed=26385115;
WW   Provider; Takara Bio; Y00275; https://www.takarabio.com/products/stem-cell-research/stem-cells-and-stem-cell-derived-cells/human-induced-pluripotent-stem-cells
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   HLA typing: A*03:01; B*07:02,35:01; C*04:01,07:02; DPB1*04:01,04:02; DQB1*05:01,06:02; DRB1*01:01,15:01 (Takara Bio).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   ChiPSC8
AC   CVCL_UK35
SY   Cellartis Human iPS Cell Line 8
DR   Wikidata; Q93450361
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   ChiPSC9
AC   CVCL_UK36
SY   Cellartis Human iPS Cell Line 9
DR   Wikidata; Q93450363
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   Chironomus tentans epithelial cell line
AC   CVCL_0A36
SY   Epithelial cell line from Chironomus tentans; C. tentans epithelial cell line; C. tentans embryonic epithelial cell line
DR   Wikidata; Q54812122
RX   PubMed=7044809;
RX   PubMed=16313569;
RX   PubMed=25261295;
CC   Group: Insect cell line.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   CHK-Q
AC   CVCL_YS94
SY   Chinese Hamster Kidney-Q
DR   ArrayExpress; E-MTAB-11298
DR   RCB; RCB5676
DR   Wikidata; Q93450373
RX   CelloPub=CLPUB00554;
RX   PubMed=35358245;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   CHK-Q_SF
AC   CVCL_B7GJ
SY   Chinese Hamster Kidney-Q_Serum Free
DR   ArrayExpress; E-MTAB-11298
DR   Wikidata; Q112929378
RX   PubMed=35358245;
CC   Group: Serum/protein free medium cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_YS94 ! CHK-Q
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   CHK-Q_SS
AC   CVCL_B7GK
SY   Chinese Hamster Kidney-Q_Serum free and Suspension
DR   ArrayExpress; E-MTAB-11298
DR   Wikidata; Q112929379
RX   PubMed=35358245;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to both serum-free and suspension condition.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B7GJ ! CHK-Q_SF
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   CHK1
AC   CVCL_E7DV
RX   PubMed=27556910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Chicken 90 kDa protein in bone marrow stromal cells and 130 kDa in umbilical cord mesenchymal stem cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHK2
AC   CVCL_E7DW
RX   PubMed=27556910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Chicken 90 kDa protein in bone marrow stromal cells and 130 kDa in umbilical cord mesenchymal stem cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHKS-rL
AC   CVCL_C7UJ
DR   JCRB; JCRB1874
DR   Wikidata; Q123030910
RX   PubMed=16678911;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Pomeranian; VBO=VBO_0201043.
DI   NCIt; C129298; Canine hepatocellular carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 3
//
ID   CHKS-1
AC   CVCL_FA17
DR   JCRB; JCRB1890
DR   Wikidata; Q54812123
RX   PubMed=16678911;
CC   Doubling time: 21 hours (PubMed=16678911).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Pomeranian; VBO=VBO_0201043.
DI   NCIt; C129298; Canine hepatocellular carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C7UJ ! CHKS-rL
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CHKS-2
AC   CVCL_FA18
DR   JCRB; JCRB1905
DR   Wikidata; Q54812124
RX   PubMed=16678911;
CC   Doubling time: 45 hours (PubMed=16678911).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Pomeranian; VBO=VBO_0201043.
DI   NCIt; C129298; Canine hepatocellular carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C7UJ ! CHKS-rL
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CHKS-3
AC   CVCL_FA19
DR   JCRB; JCRB1926
DR   Wikidata; Q54812125
RX   PubMed=16678911;
CC   Doubling time: 36 hours (PubMed=16678911).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Pomeranian; VBO=VBO_0201043.
DI   NCIt; C129298; Canine hepatocellular carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C7UJ ! CHKS-rL
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CHKS-4
AC   CVCL_FA20
DR   JCRB; JCRB1920
DR   Wikidata; Q54812126
RX   PubMed=16678911;
CC   Doubling time: 35 hours (PubMed=16678911).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Pomeranian; VBO=VBO_0201043.
DI   NCIt; C129298; Canine hepatocellular carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C7UJ ! CHKS-rL
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CHL
AC   CVCL_0212
SY   Chinese Hamster Lung
DR   CLO; CLO_0002418
DR   CLO; CLO_0051575
DR   MCCL; MCC:0000101
DR   CLDB; cl720
DR   CCRID; 3101HAMGNHa2
DR   CCRID; 5301HAM-KCB08011YJ
DR   CLS; 305013
DR   ECACC; 87111906
DR   KCB; KCB 200811YJ
DR   KCB; KCB 93014YJ
DR   RCB; RCB0097
DR   Wikidata; Q54812127
RX   PubMed=688393;
RX   PubMed=1170023;
RX   PubMed=1370240;
RX   PubMed=3558490;
RX   PubMed=5452405;
RX   PubMed=7512690;
CC   Characteristics: Used in chemical substance-induced chromosomal aberration detection.
CC   Doubling time: ~30 hours (PubMed=5452405); ~14 hours (PubMed=1370240).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   CHL 4-10
AC   CVCL_UU96
SY   4-10
DR   Wikidata; Q93450411
RX   PubMed=7850790;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 4-3
AC   CVCL_UU94
SY   4-3
DR   Wikidata; Q93450413
RX   PubMed=7850790;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 4-9
AC   CVCL_UU95
SY   4-9
DR   Wikidata; Q93450416
RX   PubMed=7850790;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7-20
AC   CVCL_UU97
SY   7-20
DR   Wikidata; Q93450418
RX   PubMed=7850790;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7-33
AC   CVCL_UU98
SY   7-33
DR   Wikidata; Q93450422
RX   PubMed=7850790;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7-38
AC   CVCL_UU99
SY   7-38
DR   Wikidata; Q93450425
RX   PubMed=7850790;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7-40
AC   CVCL_UV00
SY   7-40
DR   Wikidata; Q93450428
RX   PubMed=7850790;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7M-102
AC   CVCL_UV07
SY   7M-102
DR   Wikidata; Q93450431
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU76 ! CHL CNM-4
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7M-116
AC   CVCL_UV08
SY   7M-116
DR   Wikidata; Q93450433
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU76 ! CHL CNM-4
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7M-124
AC   CVCL_UV09
SY   7M-124
DR   Wikidata; Q93450436
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU76 ! CHL CNM-4
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7M-126
AC   CVCL_UV10
SY   7M-126
DR   Wikidata; Q93450439
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU76 ! CHL CNM-4
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7M-41
AC   CVCL_UV06
SY   7M-41
DR   Wikidata; Q93450441
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU76 ! CHL CNM-4
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7P-101
AC   CVCL_UV01
SY   7P-101
DR   Wikidata; Q93450445
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU86 ! CHL CNP-40
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7P-142
AC   CVCL_UV02
SY   7P-142
DR   Wikidata; Q93450448
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU86 ! CHL CNP-40
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7P-145
AC   CVCL_UV03
SY   7P-145
DR   Wikidata; Q93450450
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU86 ! CHL CNP-40
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7P-217
AC   CVCL_UV04
SY   7P-217
DR   Wikidata; Q93450453
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU86 ! CHL CNP-40
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7P-219
AC   CVCL_UV05
SY   7P-219
DR   Wikidata; Q93450455
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU86 ! CHL CNP-40
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7R-10
AC   CVCL_UV11
SY   7R-10
DR   Wikidata; Q93450458
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL 7R-54
AC   CVCL_UV12
SY   7R-54
DR   Wikidata; Q93450460
RX   PubMed=7625840;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL A-15
AC   CVCL_UU65
SY   A-15
DR   Wikidata; Q93450461
RX   PubMed=1370240;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33616; Macaca fascicularis CYP1A1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   CHL A2R-36
AC   CVCL_UU74
SY   A2R-36
DR   Wikidata; Q93450464
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL A2R-39
AC   CVCL_UU75
SY   A2R-39
DR   Wikidata; Q93450465
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL A2R-5
AC   CVCL_UU73
SY   A2R-5
DR   Wikidata; Q93450467
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL AIG
AC   CVCL_8483
SY   AIG; Anchorage-Independent Growth
DR   JCRB; JCRB1105
DR   JCRB; NIHS0387
DR   Wikidata; Q54812128
RX   PubMed=1170023;
CC   Discontinued: JCRB; NIHS0387; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   CHL ANM-13
AC   CVCL_UU79
SY   ANM-15
DR   Wikidata; Q93450472
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU73 ! CHL A2R-5
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ANM-35
AC   CVCL_UU80
SY   ANM-35
DR   Wikidata; Q93450473
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU73 ! CHL A2R-5
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ANP-19
AC   CVCL_UU81
SY   ANP-19
DR   Wikidata; Q93450475
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU73 ! CHL A2R-5
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ANP-25
AC   CVCL_UU82
SY   ANP-25
DR   Wikidata; Q93450477
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU73 ! CHL A2R-5
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ANP-38
AC   CVCL_UU83
SY   ANP-38
DR   Wikidata; Q93450478
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU73 ! CHL A2R-5
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL AR-10
AC   CVCL_UU66
SY   AR-10
DR   Wikidata; Q93450480
RX   DOI=10.1006/abbi.1994.1169;
RX   PubMed=8424648;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33616; Macaca fascicularis CYP1A1.
CC   Caution: Originally thought to be transfected with mouse Por but later shown to be transfected with guinea pig por (DOI=10.1006/abbi.1994.1169).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU65 ! CHL A-15
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 11
//
ID   CHL AR-13
AC   CVCL_UU67
SY   AR-13
DR   Wikidata; Q93450482
RX   DOI=10.1006/abbi.1994.1169;
RX   PubMed=8424648;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33616; Macaca fascicularis CYP1A1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU65 ! CHL A-15
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL AR-16
AC   CVCL_UU68
SY   AR-16
DR   Wikidata; Q93450483
RX   DOI=10.1006/abbi.1994.1169;
RX   PubMed=8424648;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33616; Macaca fascicularis CYP1A1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU65 ! CHL A-15
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL AR-18
AC   CVCL_UU69
SY   AR-18
DR   Wikidata; Q93450485
RX   DOI=10.1006/abbi.1994.1169;
RX   PubMed=8424648;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33616; Macaca fascicularis CYP1A1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU65 ! CHL A-15
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL CNM-27
AC   CVCL_UU77
SY   CNM-27
DR   Wikidata; Q93450488
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL CNM-31
AC   CVCL_UU78
SY   CNM-31
DR   Wikidata; Q93450492
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL CNM-4
AC   CVCL_UU76
SY   CNM-4
DR   Wikidata; Q93450494
RX   PubMed=7625840;
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL CNP-16
AC   CVCL_UU84
SY   CNP-16
DR   Wikidata; Q93450495
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL CNP-26
AC   CVCL_UU85
SY   CNP-26
DR   Wikidata; Q93450497
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL CNP-40
AC   CVCL_UU86
SY   CNP-40
DR   Wikidata; Q93450498
RX   PubMed=7625840;
RX   PubMed=8012961;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU72 ! CHL CR-68
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL CR-119
AC   CVCL_UU90
SY   CR-119; CR119
DR   Wikidata; Q93450501
RX   PubMed=7803471;
RX   PubMed=7850790;
RX   PubMed=8692217;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHL CR-50
AC   CVCL_UU70
SY   CR-50
DR   Wikidata; Q93450503
RX   DOI=10.1006/abbi.1994.1169;
RX   PubMed=8424648;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHL CR-52
AC   CVCL_UU71
SY   CR-52
DR   Wikidata; Q93450504
RX   DOI=10.1006/abbi.1994.1169;
RX   PubMed=8424648;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHL CR-68
AC   CVCL_UU72
SY   CR-68
DR   Wikidata; Q93450506
RX   DOI=10.1006/abbi.1994.1169;
RX   PubMed=7625840;
RX   PubMed=8012961;
RX   PubMed=8424648;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHL CRM2-18
AC   CVCL_UU91
SY   CRM2-18
DR   Wikidata; Q93450509
RX   PubMed=7803471;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88610; Cyp3a13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHL CRM2-28
AC   CVCL_UU92
SY   CRM2-28
DR   Wikidata; Q93450510
RX   PubMed=7803471;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88610; Cyp3a13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHL CRM2-63
AC   CVCL_UU93
SY   CRM2-63
DR   Wikidata; Q93450512
RX   PubMed=7803471;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88610; Cyp3a13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHL ER-133
AC   CVCL_UV13
SY   ER-133
DR   Wikidata; Q93450553
RX   PubMed=8692217;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ER-181
AC   CVCL_UV14
SY   ER-181
DR   Wikidata; Q93450554
RX   PubMed=8692217;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ER-235
AC   CVCL_UV15
SY   ER-235
DR   Wikidata; Q93450555
RX   PubMed=8692217;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ER-238
AC   CVCL_UV16
SY   ER-238
DR   Wikidata; Q93450556
RX   PubMed=8692217;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL ER-269
AC   CVCL_UV17
SY   ER-269
DR   Wikidata; Q93450557
RX   PubMed=8692217;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P37039; Cavia porcellus Por.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UU90 ! CHL CR-119
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHL V-79 RJK
AC   CVCL_F0SV
SY   V-79 RJK
RX   DOI=10.1134/S1990519X15050028;
RX   DOI=10.1134/S1990519X21010041;
RX   PubMed=8754132;
RX   PubMed=38338745;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CHL-1
AC   CVCL_1122
SY   CHL1
DR   BTO; BTO_0004061
DR   CLO; CLO_0002420
DR   EFO; EFO_0002132
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3619
DR   ATCC; CRL-9446
DR   BioSample; SAMN03470897
DR   BioSample; SAMN10988230
DR   cancercelllines; CVCL_1122
DR   Cell_Model_Passport; SIDM01228
DR   ChEMBL-Cells; CHEMBL3308722
DR   ChEMBL-Targets; CHEMBL1075422
DR   Cosmic; 706115
DR   Cosmic; 897494
DR   Cosmic; 910853
DR   Cosmic; 1459665
DR   Cosmic; 1477418
DR   Cosmic; 1995367
DR   Cosmic-CLP; 910853
DR   DepMap; ACH-001024
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910853
DR   GEO; GSM886928
DR   GEO; GSM887994
DR   GEO; GSM1669675
DR   IARC_TP53; 21224
DR   IGRhCellID; CHL1
DR   PharmacoDB; CHL1_197_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1122
DR   PubChem_Cell_line; CVCL_1122
DR   Wikidata; Q54812129
RX   Patent=US5017478;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22178978;
RX   PubMed=22460905;
RX   PubMed=23637631;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9446.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07:13,57:01; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2352; CREM + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-CREM (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (Cosmic-CLP=910853; DepMap=ACH-001024).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Ile228Val (c.682A>G); Zygosity=Homozygous (ATCC=CRL-3619; Cosmic-CLP=910853; DepMap=ACH-001024).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (Cosmic-CLP=910853; DepMap=ACH-001024).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.39%; East Asian, South=0%; South Asian=0%; European, North=68.4%; European, South=31.21% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-9446; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3619; Cosmic-CLP=910853; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 11,12
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 10,13
ST   FGA: 23,25
ST   Penta D: 12,14
ST   Penta E: 10,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2713 ! RPMI-7932
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   CHL-2
AC   CVCL_V643
DR   ATCC; CRL-9451
DR   cancercelllines; CVCL_V643
DR   Wikidata; Q54812130
RX   Patent=US5017478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9451.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2352; CREM + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-CREM (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Ile228Val (c.682A>G); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9051; PLAT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-9451; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-9451
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1122 ! CHL-1
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 22
//
ID   CHL-3A4
AC   CVCL_J390
DR   Wikidata; Q54812131
RX   PubMed=10322772;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHL-CYP2C18
AC   CVCL_0U07
DR   Wikidata; Q54812132
RX   PubMed=12378636;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2620; CYP2C18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   CHL-YN
AC   CVCL_YS93
SY   YN; Chinese Hamster Lung-YN
DR   RCB; RCB5004
DR   Wikidata; Q93450572
RX   CelloPub=CLPUB00554;
RX   PubMed=33077772;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 8.1 hours (PubMed=33077772).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   CHL/IU
AC   CVCL_4585
SY   CHL-IU; CHL-CL-11; CHL-11
DR   CLO; CLO_0002419
DR   ATCC; CRL-1935
DR   Wikidata; Q54812133
RX   PubMed=9118971;
RX   PubMed=9393622;
RX   PubMed=10320750;
RX   PubMed=27692294;
CC   Characteristics: Useful for screening chemical for ability to induce chromosomal aberrations (ATCC=CRL-1935).
CC   Doubling time: 15 hours (ATCC=CRL-1935).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   CHL/IU (IVGT)
AC   CVCL_GP67
SY   CHL/IU(IVGT)
DR   ECACC; 14100201
DR   JCRB; JCRB0030
DR   Wikidata; Q54812134
RX   PubMed=27692294;
CC   Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4585 ! CHL/IU
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   CHL/IU KN63
AC   CVCL_UV18
SY   KN63
DR   Wikidata; Q93450577
RX   PubMed=9393622;
RX   PubMed=11080658;
CC   Characteristics: Designed to detect mutational events. The target gene is E.coli gpt that is present in a shuttle vector that can be rescued from the host cells (PubMed=9393622).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4585 ! CHL/IU
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHLA-01-MED
AC   CVCL_B044
DR   ATCC; CRL-3021
DR   BioSample; SAMN03471712
DR   cancercelllines; CVCL_B044
DR   Cosmic; 2772986
DR   Wikidata; Q54812135
RX   PubMed=24300787;
RX   PubMed=25211508;
RX   PubMed=26380221;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Heterozygous (PubMed=26380221).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
ST   Source(s): ATCC=CRL-3021
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 15
ST   D21S11: 27,29
ST   D2S1338: 18,24
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 11,14
ST   Penta E: 14,19,20
ST   TH01: 6,9.3
ST   TPOX: 9,12
ST   vWA: 16,17
DI   NCIt; C129446; Medulloblastoma, non-WNT/non-SHH, group 4
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N534 ! CHLA-01R-MED
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   CHLA-01R-MED
AC   CVCL_N534
SY   CHLA-01R
DR   ATCC; CRL-3034
DR   cancercelllines; CVCL_N534
DR   Lonza; 1680
DR   Wikidata; Q54812137
RX   PubMed=24300787;
RX   PubMed=25211508;
RX   PubMed=26380221;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Karyotypic information: 46,XY,del(11)(q13.3) (ATCC=CRL-3034).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Heterozygous (PubMed=26380221).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3034
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 15
ST   D21S11: 27,29
ST   D2S1338: 18,24
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 11,14
ST   Penta E: 14,20
ST   TH01: 6,9.3
ST   TPOX: 9,12
ST   vWA: 16
DI   NCIt; C129446; Medulloblastoma, non-WNT/non-SHH, group 4
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B044 ! CHLA-01-MED
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   CHLA-02-ATRT
AC   CVCL_B045
SY   CHLA-02
DR   ATCC; CRL-3020
DR   BioSample; SAMN03471711
DR   Wikidata; Q54812138
RX   PubMed=25211508;
RX   PubMed=25638158;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3020
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 17,21
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 10,12
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 10,12
ST   vWA: 16,18
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   CHLA-03-AA
AC   CVCL_U616
DR   ATCC; CRL-3035
DR   Wikidata; Q54812139
RX   PubMed=25211508;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): ATCC=CRL-3035
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 14,20
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 18,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 22
ST   Penta D: 9,15
ST   Penta E: 10,20
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 9
//
ID   CHLA-04-ATRT
AC   CVCL_0F38
SY   CHLA-04
DR   ATCC; CRL-3036
DR   Wikidata; Q54812144
RX   PubMed=25211508;
RX   PubMed=25246426;
RX   PubMed=25638158;
CC   Derived from site: In situ; Brain, lateral ventricle, third ventricle; UBERON=UBERON_0002286.
ST   Source(s): ATCC=CRL-3036
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 9,11
ST   FGA: 21,25
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   CHLA-05-ATRT
AC   CVCL_AQ41
DR   ATCC; CRL-3037
DR   Wikidata; Q54812145
RX   PubMed=24300787;
RX   PubMed=25211508;
RX   PubMed=25246426;
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): ATCC=CRL-3037
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,10
ST   TPOX: 11,12
ST   vWA: 15,16
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 7
//
ID   CHLA-06-ATRT
AC   CVCL_AQ42
SY   CHLA06ATRT; CHLA-06
DR   ATCC; CRL-3038
DR   cancercelllines; CVCL_AQ42
DR   Cell_Model_Passport; SIDM01550
DR   DepMap; ACH-001028
DR   Wikidata; Q54812146
RX   PubMed=24300787;
RX   PubMed=25211508;
RX   PubMed=25246426;
RX   PubMed=25638158;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His178Asp (c.532C>G); ClinVar=VCV000482223; Zygosity=Unspecified (DepMap=ACH-001028).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
ST   Source(s): ATCC=CRL-3038
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11,13
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   CHLA-07-BSGBM
AC   CVCL_AQ43
DR   Wikidata; Q54812147
RX   PubMed=24300787;
RX   PubMed=25211508;
CC   Derived from site: In situ; Brainstem; UBERON=UBERON_0002298.
DI   NCIt; C5097; Brain stem glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y7M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   CHLA-10
AC   CVCL_6583
SY   CHLA10
DR   cancercelllines; CVCL_6583
DR   Cell_Model_Passport; SIDM01542
DR   Cosmic; 930038
DR   DepMap; ACH-001029
DR   GEO; GSM1676328
DR   GEO; GSM1701625
DR   GEO; GSM4368463
DR   GEO; GSM5359634
DR   GEO; GSM5359635
DR   GEO; GSM5359636
DR   GEO; GSM5359637
DR   GEO; GSM5359638
DR   GEO; GSM5359639
DR   GEO; GSM5362864
DR   GEO; GSM5362865
DR   GEO; GSM5362866
DR   GEO; GSM5362867
DR   GEO; GSM5362868
DR   GEO; GSM5362869
DR   GEO; GSM5363941
DR   GEO; GSM5363942
DR   GEO; GSM5363943
DR   GEO; GSM5363944
DR   GEO; GSM5363945
DR   Wikidata; Q54812148
RX   DOI=10.5282/edoc.27750;
RX   PubMed=11212268;
RX   PubMed=15289350;
RX   PubMed=20922763;
RX   PubMed=24312454;
RX   PubMed=26351324;
RX   PubMed=28196595;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Brain/CHLA-10%20Cell%20Line%20Data%20Sheet.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 24 hours (PubMed=20922763); 32 hours (PubMed=24312454).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=36476851).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
ST   Source(s): COG; PubMed=20922763; PubMed=24312454
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 23
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M150 ! CHLA-9
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   CHLA-101
AC   CVCL_6584
DR   Cosmic; 930032
DR   Wikidata; Q54812149
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-103
AC   CVCL_6585
DR   Cosmic; 930048
DR   Wikidata; Q54812150
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-108
AC   CVCL_6586
DR   Cosmic; 930049
DR   Wikidata; Q54812151
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-11
AC   CVCL_AQ10
DR   Wikidata; Q54812152
RX   PubMed=24792489;
CC   Doubling time: 53 hours (COG).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   CHLA-119
AC   CVCL_A055
DR   cancercelllines; CVCL_A055
DR   Cosmic; 1161984
DR   IARC_TP53; 16197
DR   Wikidata; Q54812153
RX   PubMed=11507071;
RX   PubMed=18724359;
RX   PubMed=20922763;
RX   PubMed=28340497;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Leu (c.1025G>T); ClinVar=VCV001055894; Zygosity=Unspecified (PubMed=11507071).
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,24
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 11
ST   FGA: 23,25
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   CHLA-12
AC   CVCL_AQ11
DR   Wikidata; Q54812154
RX   PubMed=24792489;
CC   Doubling time: 65 hours (COG).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   CHLA-122
AC   CVCL_A054
DR   Wikidata; Q54812155
RX   PubMed=11507071;
RX   PubMed=20922763;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-122_Cell_Line_Data_Sheet_COGcell_org.pdf
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 23,25
ST   D3S1358: 15,18
ST   D5S818: 9,12
ST   D7S820: 8
ST   D8S1179: 10,13
ST   FGA: 23,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6590 ! CHLA-136
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   CHLA-123
AC   CVCL_A060
DR   Cosmic; 930050
DR   Cosmic; 1019952
DR   Cosmic; 1109361
DR   Wikidata; Q54812156
RX   PubMed=11212268;
RX   PubMed=16822308;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 12,19
ST   D19S433: 13,15
ST   D21S11: 32.2
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 24,25
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 9
//
ID   CHLA-124
AC   CVCL_6587
DR   Cosmic; 930051
DR   Wikidata; Q54812157
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-132
AC   CVCL_6588
DR   Cosmic; 930052
DR   Wikidata; Q54812158
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-134
AC   CVCL_6589
DR   IARC_TP53; 23828
DR   Wikidata; Q54812159
RX   PubMed=9850071;
RX   PubMed=11507071;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11507071).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 12.2,14
ST   D21S11: 31.2,33.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   CHLA-136
AC   CVCL_6590
SY   CHLA_136
DR   Cosmic; 930053
DR   Cosmic; 1890103
DR   IARC_TP53; 23825
DR   Wikidata; Q54812160
RX   PubMed=11212268;
RX   PubMed=11507071;
RX   PubMed=20922763;
RX   PubMed=23202128;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/NB_Cell_Lines/CHLA-136%20Cell%20Line%20Data%20Sheet.pdf
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 53 hours (PubMed=20922763); 44 hours (COG).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11507071).
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 23,25
ST   D3S1358: 15,18
ST   D5S818: 9,12
ST   D7S820: 8
ST   D8S1179: 10,13
ST   FGA: 23,25
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A054 ! CHLA-122
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   CHLA-138
AC   CVCL_6591
DR   Cosmic; 930054
DR   Wikidata; Q54812161
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-140
AC   CVCL_6592
DR   Cosmic; 930055
DR   Wikidata; Q54812162
RX   PubMed=11212268;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-140_Cell_Line_Data_Sheet_COGcell_org.pdf
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13.2,15
ST   D21S11: 30,32
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 25,26
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   CHLA-143
AC   CVCL_6593
DR   Cosmic; 930056
DR   Wikidata; Q54812163
RX   PubMed=11212268;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   CHLA-144
AC   CVCL_AQ12
DR   Wikidata; Q54812164
RX   PubMed=24792489;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 17,20
ST   D19S433: 12,14.2
ST   D21S11: 28,31
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 19
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ13 ! CHLA-145
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-145
AC   CVCL_AQ13
DR   Wikidata; Q54812165
RX   PubMed=24792489;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 17,20
ST   D19S433: 12,14.2
ST   D21S11: 28,31
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 19
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ12 ! CHLA-144
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-15
AC   CVCL_6594
SY   CHLA_15; CHLA15
DR   cancercelllines; CVCL_6594
DR   Cell_Model_Passport; SIDM01540
DR   Cosmic; 1890116
DR   DepMap; ACH-001300
DR   Wikidata; Q54812166
RX   PubMed=9850071;
RX   PubMed=23202128;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-15_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 21 hours (COG).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,26
ST   D3S1358: 16
ST   D5S818: 12,15
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6602 ! CHLA-20
SX   Female
AG   1Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   CHLA-150
AC   CVCL_A059
DR   cancercelllines; CVCL_A059
DR   Cosmic; 930057
DR   Cosmic; 1019936
DR   Cosmic; 1161985
DR   Wikidata; Q54812167
RX   PubMed=11212268;
RX   PubMed=16822308;
RX   PubMed=18724359;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (PubMed=18724359).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,13
ST   D16S539: 9
ST   D18S51: 13,14
ST   D19S433: 15
ST   D21S11: 30.2,31
ST   D2S1338: 23,25
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 20,23
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   CHLA-151
AC   CVCL_AX41
SY   CHLA_151
DR   Cosmic; 1890124
DR   Wikidata; Q54812168
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 14,14.2
ST   D21S11: 32.2,33.2
ST   D2S1338: 19,22
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,13
ST   D8S1179: 12,15
ST   FGA: 23
ST   TH01: 8
ST   TPOX: 8,10,11
ST   vWA: 16,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-152
AC   CVCL_6595
DR   Cosmic; 930058
DR   Wikidata; Q54812169
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-153
AC   CVCL_6596
DR   Cosmic; 930059
DR   Wikidata; Q54812170
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-171
AC   CVCL_6597
SY   CHLA171
DR   Cosmic; 930060
DR   Cosmic; 1019949
DR   IARC_TP53; 23826
DR   Wikidata; Q54812171
RX   PubMed=11212268;
RX   PubMed=11507071;
RX   PubMed=16822308;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-171_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11507071).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 17,19
ST   D19S433: 14
ST   D21S11: 29,34.2
ST   D2S1338: 21,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 10,14
ST   FGA: 20,26
ST   TH01: 7,8.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   CHLA-172
AC   CVCL_A056
DR   cancercelllines; CVCL_A056
DR   IARC_TP53; 16200
DR   Wikidata; Q54812172
RX   PubMed=11507071;
RX   PubMed=24792489;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Leu (c.646G>C); ClinVar=VCV000406596; Zygosity=Unspecified (PubMed=11507071).
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 9
ST   D18S51: 14,17
ST   D19S433: 14.2,15
ST   D21S11: 30,31
ST   D2S1338: 18,28
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 18,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   CHLA-174
AC   CVCL_6598
DR   Cosmic; 930034
DR   Wikidata; Q54812173
RX   PubMed=11212268;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,23
ST   D3S1358: 14,15
ST   D5S818: 9,13
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   TH01: 9.3,10
ST   TPOX: 11,12
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   CHLA-178
AC   CVCL_6599
DR   Cosmic; 930061
DR   Wikidata; Q54812174
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-179
AC   CVCL_6600
DR   Cosmic; 930036
DR   Wikidata; Q54812175
RX   PubMed=11212268;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,22
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23,25
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   CHLA-185
AC   CVCL_6601
DR   Cosmic; 930062
DR   Wikidata; Q54812176
RX   PubMed=11212268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   CHLA-192
AC   CVCL_AQ34
DR   Wikidata; Q54812177
RX   CelloPub=CLPUB00315;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13,17
ST   D19S433: 14,18
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 11
ST   FGA: 23,25
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-194
AC   CVCL_AQ35
DR   Wikidata; Q54812178
RX   CelloPub=CLPUB00315;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 19,23
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-20
AC   CVCL_6602
SY   CHLA20
DR   Cell_Model_Passport; SIDM01539
DR   Cosmic; 1890108
DR   Wikidata; Q54812179
RX   PubMed=9850071;
RX   PubMed=23202128;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-20_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Doubling time: 28 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12,15
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6594 ! CHLA-15
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   CHLA-200
AC   CVCL_M147
DR   Cosmic; 1875114
DR   Lonza; 1682
DR   Wikidata; Q54812180
RX   PubMed=22120608;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Brain/CHLA-200.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Brain.php
CC   Doubling time: 54 hours (PubMed=22120608).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): COG; PubMed=22120608
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 15,17
ST   D19S433: 15
ST   D21S11: 29,32.2
ST   D2S1338: 18,22
ST   D3S1358: 14,16
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   D8S1179: 10,15
ST   FGA: 21,26
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   CHLA-215
AC   CVCL_AQ36
SY   CHLA215
DR   Wikidata; Q54812181
RX   CelloPub=CLPUB00315;
RX   PubMed=27050416;
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 12
ST   D18S51: 18,19
ST   D19S433: 13,13.2
ST   D21S11: 29,31
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   CHLA-215-Luc
AC   CVCL_ZF05
DR   Wikidata; Q98125619
RX   PubMed=27050416;
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ36 ! CHLA-215
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   CHLA-218
AC   CVCL_0B48
SY   CHLA218
DR   cancercelllines; CVCL_0B48
DR   Cell_Model_Passport; SIDM01538
DR   Cosmic; 2228215
DR   DepMap; ACH-001030
DR   Wikidata; Q54812182
RX   PubMed=25010205;
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): COG; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11 (PubMed=25010205)
ST   D13S317: 11 (COG)
ST   D16S539: 12
ST   D18S51: 11,13
ST   D19S433: 13,16
ST   D21S11: 29,31
ST   D2S1338: 23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 8,13
ST   FGA: 21,24
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   CHLA-221
AC   CVCL_B3TF
DR   Wikidata; Q110432709
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/CHLA-221%20Cell%20Line%20Data%20Sheet.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 13,21
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 22,25
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   CHLA-222
AC   CVCL_AQ37
DR   Wikidata; Q54812183
RX   CelloPub=CLPUB00315;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 12,15
ST   D21S11: 28,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 9,14
ST   FGA: 23,25
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-223
AC   CVCL_AQ38
DR   Wikidata; Q54812187
RX   CelloPub=CLPUB00315;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-224
AC   CVCL_AQ39
DR   Wikidata; Q54812188
RX   CelloPub=CLPUB00315;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 12,17
ST   D19S433: 13.2,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,23
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 22,26
ST   TH01: 6,9
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-225
AC   CVCL_A057
DR   IARC_TP53; 23827
DR   Wikidata; Q54812189
RX   PubMed=11507071;
RX   PubMed=24792489;
CC   Doubling time: 62 hours (COG).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11507071).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 13,16.2
ST   D21S11: 28,31.2
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,26
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   CHLA-233
AC   CVCL_B3TG
DR   Wikidata; Q110432710
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   CHLA-237
AC   CVCL_A6BJ
DR   Wikidata; Q123030911
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 14,16
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   CHLA-246
AC   CVCL_AQ40
DR   Wikidata; Q54812190
RX   CelloPub=CLPUB00315;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 21,23
ST   D3S1358: 15,17
ST   D5S818: 7,12
ST   D7S820: 8
ST   D8S1179: 10,11
ST   FGA: 20,26
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-247
AC   CVCL_AQ14
DR   Wikidata; Q54812191
RX   PubMed=24792489;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,15
ST   D16S539: 11,12
ST   D18S51: 10,12
ST   D19S433: 14,14.2
ST   D21S11: 28,33.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,25
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ15 ! CHLA-253
OI   CVCL_AX48 ! CHLA-253h
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   CHLA-25
AC   CVCL_M152
SY   CHLA25
DR   cancercelllines; CVCL_M152
DR   Cosmic; 2228216
DR   GEO; GSM1676353
DR   GEO; GSM1701683
DR   GEO; GSM5359640
DR   GEO; GSM5359641
DR   GEO; GSM5359642
DR   GEO; GSM5359643
DR   GEO; GSM5359644
DR   GEO; GSM5359645
DR   GEO; GSM5362884
DR   GEO; GSM5362885
DR   GEO; GSM5362886
DR   GEO; GSM5362887
DR   GEO; GSM5362888
DR   GEO; GSM5362889
DR   GEO; GSM5363946
DR   GEO; GSM5363947
DR   GEO; GSM5363948
DR   GEO; GSM5363949
DR   GEO; GSM5363950
DR   Wikidata; Q54812489
RX   DOI=10.5282/edoc.27750;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Ewings/CHLA-25%20Cell%20Line%20Data%20Sheet.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Doubling time: 99 hours (PubMed=24312454).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG; Note=EWSR1 exon 7 with ERG exon 6 (PubMed=25010205; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Genomics; ChIP-seq; ERG.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): COG; PubMed=24312454; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 19,22
ST   D3S1358: 17,18
ST   D5S818: 10
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 24,25
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A444 ! TTC-466
SX   Female
AG   2Y7M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   CHLA-253
AC   CVCL_AQ15
DR   Wikidata; Q54812490
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,15
ST   D16S539: 11,12
ST   D18S51: 10,12
ST   D19S433: 14,14.2
ST   D21S11: 28,33.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,26
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ14 ! CHLA-247
OI   CVCL_AX48 ! CHLA-253h
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-253h
AC   CVCL_AX48
SY   CHLA253h
DR   Cosmic; 1890109
DR   Wikidata; Q54812491
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,15
ST   D16S539: 11,12
ST   D18S51: 10,12
ST   D19S433: 14,14.2
ST   D21S11: 28,33.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,26
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ14 ! CHLA-247
OI   CVCL_AQ15 ! CHLA-253
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   CHLA-255
AC   CVCL_AQ27
SY   CHLA 255; CHLA255; Childrens Hospital Los Angeles-255
DR   Wikidata; Q54812492
RX   PubMed=12810621;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12,15
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 9
//
ID   CHLA-255/MYCN
AC   CVCL_LI08
SY   CHLA-255-MYCN; CHLA255-MYCN
DR   Wikidata; Q54812493
RX   PubMed=17710228;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7559; MYCN.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ27 ! CHLA-255
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   CHLA-258
AC   CVCL_A058
SY   CHLA258
DR   cancercelllines; CVCL_A058
DR   Cell_Model_Passport; SIDM01720
DR   Cosmic; 1112131
DR   Cosmic; 2228217
DR   Cosmic; 2294582
DR   DepMap; ACH-001282
DR   GEO; GSM1676354
DR   GEO; GSM1701684
DR   Wikidata; Q54812494
RX   PubMed=15289350;
RX   PubMed=20922763;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Brain/CHLA-258%20Cell%20Line%20Data%20Sheet.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 71 hours (PubMed=20922763); 89 hours (PubMed=24312454).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 3 fusion (Ex10/Ex6) (PubMed=25010205).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): COG; PubMed=20922763; PubMed=24312454; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 10 (PubMed=20922763; PubMed=25010205)
ST   D16S539: 10,12 (COG; PubMed=24312454)
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 31.2
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 7,11
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   CHLA-259
AC   CVCL_M148
DR   Wikidata; Q54812495
RX   PubMed=22120608;
RX   PubMed=24300787;
RX   PubMed=27498314;
RX   PubMed=27812533;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Brain/CHLA-259.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Brain.php
CC   Population: Latino or Hispanic.
CC   Doubling time: 76 hours (PubMed=22120608).
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
ST   Source(s): COG; PubMed=22120608
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 16
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,26
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   CHLA-266
AC   CVCL_M149
SY   CHLA266
DR   cancercelllines; CVCL_M149
DR   Cell_Model_Passport; SIDM01537
DR   DepMap; ACH-001031
DR   Wikidata; Q54812496
RX   CelloPub=CLPUB00418;
RX   PubMed=20922763;
RX   PubMed=22120608;
WW   Provider; CCR; -; https://www.cccells.org/tables/Brain_N.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 40 hours (CelloPub=CLPUB00418); 45 hours (PubMed=22120608); 50 hours (PubMed=20922763).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
ST   Source(s): COG; PubMed=20922763; PubMed=22120608
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 10,12
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 20
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   CHLA-32
AC   CVCL_M151
SY   CHLA32
DR   cancercelllines; CVCL_M151
DR   Cell_Model_Passport; SIDM01536
DR   Cosmic; 2228218
DR   DepMap; ACH-001032
DR   GEO; GSM1676355
DR   GEO; GSM1701685
DR   Wikidata; Q54812497
RX   PubMed=15289350;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=26351324;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Ewings/CHLA-32%20Cell%20Line%20Data%20Sheet.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 26 hours (PubMed=24312454).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=25010205; DepMap=ACH-001032).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): COG; PubMed=24312454; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10,11 (PubMed=24312454)
ST   CSF1PO: 11 (COG; PubMed=25010205)
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 18,19 (PubMed=24312454)
ST   D18S51: 19 (COG; PubMed=25010205)
ST   D19S433: 13,15
ST   D21S11: 28,31
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 22
//
ID   CHLA-42
AC   CVCL_6603
SY   CHLA_42
DR   Cosmic; 930039
DR   Cosmic; 1890123
DR   Wikidata; Q54812498
RX   PubMed=9850071;
RX   PubMed=11212268;
RX   PubMed=23202128;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-42_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 8,13
ST   FGA: 23,25
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   CHLA-51
AC   CVCL_6604
DR   Cosmic; 930040
DR   Cosmic; 1161982
DR   Wikidata; Q54812499
RX   PubMed=9850071;
RX   PubMed=11212268;
RX   PubMed=11507071;
RX   PubMed=18724359;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D19S433: 14,14.2
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 19,22
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   CHLA-52
AC   CVCL_6605
DR   Cosmic; 930041
DR   Wikidata; Q54812500
RX   PubMed=11212268;
RX   PubMed=24792489;
CC   Doubling time: 88 hours (COG).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ16 ! CHLA-53
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   CHLA-53
AC   CVCL_AQ16
DR   Wikidata; Q54812501
RX   PubMed=24792489;
CC   Doubling time: 92 hours (COG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6605 ! CHLA-52
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 8
//
ID   CHLA-54
AC   CVCL_6606
DR   Cosmic; 930042
DR   Wikidata; Q54812502
RX   PubMed=11212268;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12,16
ST   D21S11: 28,30
ST   D2S1338: 18,20
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,16
ST   FGA: 21,26
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   CHLA-56
AC   CVCL_A5GH
DR   Wikidata; Q123030912
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 8,9
ST   D16S539: 8,11
ST   D18S51: 12,15
ST   D19S433: 14,15.2
ST   D21S11: 30,34.2
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 20,22
ST   TH01: 6,8
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   CHLA-57
AC   CVCL_0B49
SY   CHLA57
DR   cancercelllines; CVCL_0B49
DR   Cell_Model_Passport; SIDM01535
DR   DepMap; ACH-001033
DR   Wikidata; Q54812503
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 17
ST   D19S433: 15,17
ST   D21S11: 28,29
ST   D2S1338: 22,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 12,13
ST   D8S1179: 11,12
ST   FGA: 20,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CHLA-60
AC   CVCL_6607
DR   Cosmic; 930043
DR   Wikidata; Q54812504
RX   PubMed=11212268;
RX   PubMed=24792489;
CC   Doubling time: 96 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 28,30
ST   D2S1338: 23
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 23,26
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ17 ! CHLA-61
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   CHLA-61
AC   CVCL_AQ17
DR   Wikidata; Q54812505
RX   PubMed=24792489;
CC   Doubling time: 102 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 28,30
ST   D2S1338: 23
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 7,10
ST   D8S1179: 13
ST   FGA: 23,26
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6607 ! CHLA-60
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   CHLA-79
AC   CVCL_6608
SY   CHLA_79
DR   Cosmic; 930044
DR   Cosmic; 1019943
DR   Cosmic; 1161983
DR   IARC_TP53; 23824
DR   Wikidata; Q54812506
RX   PubMed=9850071;
RX   PubMed=11212268;
RX   PubMed=11507071;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=23202128;
RX   PubMed=24792489;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11507071).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 30,30.2
ST   D2S1338: 17,23
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 12
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   CHLA-8
AC   CVCL_6609
DR   Wikidata; Q54812508
RX   PubMed=9850071;
RX   PubMed=11507071;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 13,15
ST   D21S11: 30,30.2
ST   D2S1338: 18,19
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 19,20
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   CHLA-9
AC   CVCL_M150
SY   CHLA9
DR   cancercelllines; CVCL_M150
DR   Cell_Model_Passport; SIDM01534
DR   Cosmic; 2228220
DR   DepMap; ACH-001034
DR   GEO; GSM1676339
DR   GEO; GSM1701626
DR   GEO; GSM4368462
DR   Wikidata; Q54812509
RX   PubMed=15289350;
RX   PubMed=20922763;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Brain/CHLA-9%20Cell%20Line%20Data%20Sheet.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 20 hours (PubMed=20922763); 51 hours (PubMed=24312454).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Val628insThrAspIle; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Thorax; UBERON=UBERON_0000915.
ST   Source(s): COG; PubMed=20922763; PubMed=24312454; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6583 ! CHLA-10
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 23
//
ID   CHLA-90
AC   CVCL_6610
SY   CH-LA-90; CHLA90
DR   BTO; BTO_0006383
DR   cancercelllines; CVCL_6610
DR   Cosmic; 930045
DR   Cosmic; 1167412
DR   DepMap; ACH-001481
DR   IARC_TP53; 16199
DR   Wikidata; Q54812511
RX   PubMed=9850071;
RX   PubMed=11212268;
RX   PubMed=11507071;
RX   PubMed=15150091;
RX   PubMed=20922763;
RX   PubMed=24792489;
RX   PubMed=31631027;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/NB_Cell_Lines/CHLA-90%20Cell%20Line%20Data%20Sheet.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 52 hours (PubMed=20922763); 59 hours (COG).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Unexplicit; Ex2-10del; Zygosity=Hemizygous (PubMed=31631027).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Homozygous (PubMed=11507071; DepMap=ACH-001481).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 28,30.2
ST   D2S1338: 18,24
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 11
ST   FGA: 20,22
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   CHLA-95
AC   CVCL_6611
DR   Cosmic; 930046
DR   Wikidata; Q54812512
RX   PubMed=11212268;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-95_Cell_Line_Data_Sheet_COGcell_org.pdf
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,14
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   CHLA-98
AC   CVCL_6612
DR   Cosmic; 930047
DR   Wikidata; Q54812513
RX   PubMed=11212268;
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   CHLA-99
AC   CVCL_0B50
SY   CHLA99
DR   cancercelllines; CVCL_0B50
DR   Cell_Model_Passport; SIDM01513
DR   DepMap; ACH-001035
DR   Wikidata; Q54812514
RX   DOI=10.5282/edoc.27750;
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 12
ST   D21S11: 30,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 12,13
ST   D8S1179: 10,14
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   CHM 2100
AC   CVCL_7179
SY   CHM2100
DR   Lonza; 1379
DR   Wikidata; Q54812515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   CHM1-HuIg1
AC   CVCL_C5H6
DR   Wikidata; Q116048734
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgM+IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   CHM1-HuIg2
AC   CVCL_C5H7
DR   Wikidata; Q116048735
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgM+IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   CHM1-HuIg3
AC   CVCL_C5H8
DR   Wikidata; Q116048736
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CHM1-HuIg4
AC   CVCL_C5H9
DR   Wikidata; Q116048737
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgM+IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   ChM114-1
AC   CVCL_X917
DR   Wikidata; Q54812516
RX   PubMed=2579038;
RX   PubMed=6093374;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_X918 ! ChM114-2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   ChM114-2
AC   CVCL_X918
DR   Wikidata; Q54812517
RX   PubMed=2579038;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_X917 ! ChM114-1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   CHM13hTERT
AC   CVCL_VU12
SY   CHM13htert; CHM13
DR   BioSample; SAMN03255769
DR   Wikidata; Q93450973
RX   PubMed=27895111;
RX   PubMed=28396521;
RX   PubMed=30013044;
RX   PubMed=32663838;
WW   Info; -; -; https://sites.google.com/ucsc.edu/t2tworkinggroup/chm13-cell-line
WW   Info; diArk; -; https://www.diark.org/diark/species_list/Homo_sapiens_CHM13htert
CC   Characteristics: Has a completely homozygous genome, thus representing a functionally haploid genome.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Genomics; Whole genome sequencing.
CC   Anecdotal: Because of its homozygous genome it is being used to build/correct new generation of human genome assemblies.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3110; Hydatidiform mole
DI   ORDO; Orphanet_99927; Hydatidiform mole
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   CHM1hTERT
AC   CVCL_VU11
SY   CHM1htert; CHM1
DR   BioSample; SAMN02205338
DR   BioSample; SAMN02743421
DR   BioSample; SAMN02744161
DR   Wikidata; Q93450976
RX   PubMed=25373144;
RX   PubMed=27895111;
RX   PubMed=28396521;
RX   PubMed=30013044;
WW   Info; -; -; https://www.bio-itworld.com/news/2014/06/30/the-hunt-for-a-new-human-reference-genome
WW   Info; diArk; -; https://www.diark.org/diark/species_list/Homo_sapiens_CHM1htert
CC   Characteristics: Has a completely homozygous genome, thus representing a functionally haploid genome.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Genomics; Whole genome sequencing.
CC   Anecdotal: Because of its homozygous genome it is being used to build/correct new generation of human genome assemblies.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3110; Hydatidiform mole
DI   ORDO; Orphanet_99927; Hydatidiform mole
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   CHM4-HuIg1
AC   CVCL_C5HA
DR   Wikidata; Q116048738
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgM+IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H5 ! MuH4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   CHM4-HuIg2
AC   CVCL_C5HB
DR   Wikidata; Q116048739
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgM+IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H5 ! MuH4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   CHM4-HuIg3
AC   CVCL_C5HC
DR   Wikidata; Q116048740
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgM+IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H5 ! MuH4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   CHM4-HuIg4
AC   CVCL_C5HD
DR   Wikidata; Q116048741
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgM+IgY.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H5 ! MuH4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   ChMC
AC   CVCL_WH49
DR   Wikidata; Q93450979
RX   PubMed=24035468;
RX   PubMed=27292541;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   CHME-5
AC   CVCL_5J53
SY   CHME5
DR   Wikidata; Q54812518
RX   PubMed=7478261;
RX   PubMed=8845742;
RX   PubMed=10074188;
RX   PubMed=17157319;
RX   PubMed=30200996;
CC   Virology: Supports the replication of M-tropic HIV-1 strain YU-2 (PubMed=17157319).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: The cell line name was not assigned in the original paper (PubMed=7478261).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   8-10FW
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   CHMm
AC   CVCL_L146
DR   Wikidata; Q54812519
RX   PubMed=19754820;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L147 ! CHMp
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 15
//
ID   CHMp
AC   CVCL_L147
DR   Wikidata; Q54812520
RX   PubMed=19754820;
RX   PubMed=31308293;
CC   Characteristics: Can grow as a sphere (PubMed=31308293).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L146 ! CHMm
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   CHMp-13a
AC   CVCL_L144
DR   Wikidata; Q54812521
RX   PubMed=21714977;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L147 ! CHMp
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   CHMp-5b
AC   CVCL_L145
DR   Wikidata; Q54812522
RX   PubMed=21714977;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L147 ! CHMp
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   CHO
AC   CVCL_0213
SY   Chinese Hamster Ovary; CHO-ori
DR   BTO; BTO_0000246
DR   CLO; CLO_0002421
DR   EFO; EFO_0022760
DR   MCCL; MCC:0000102
DR   CLDB; cl721
DR   CLDB; cl722
DR   CLDB; cl724
DR   CCRID; 1101HAM-PUMC000116
DR   CCRID; 5301HAM-KCB83004YJ
DR   ChEMBL-Cells; CHEMBL3308072
DR   ChEMBL-Targets; CHEMBL613853
DR   CLS; 603479
DR   ECACC; 85050302
DR   IBRC; C10028
DR   ICLC; ATL95003
DR   KCB; KCB 82012YJ
DR   KCB; KCB 83004YJ
DR   Lonza; 755
DR   MeSH; D016466
DR   NCBI_Iran; C111
DR   PubChem_Cell_line; CVCL_0213
DR   Wikidata; Q56646
RX   DOI=10.3390/pr1030296;
RX   DOI=10.3390/pr5020020;
RX   PubMed=4120885;
RX   PubMed=13598821;
RX   PubMed=34050613;
WW   Info; -; -; https://cho-cell-transfection.com/
WW   Info; -; -; https://web.archive.org/web/20160506232703/https://www.biotechhistory.org/magazine-article/vital-tools-brief-history-cho-cells/
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CHO
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
CC   Discontinued: CLS; 603479; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   CHO (protein free)
AC   CVCL_JX40
SY   CHO (PROTEIN FREE)
DR   ECACC; 00102307
DR   Wikidata; Q54812610
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 7
//
ID   CHO 1-15 500
AC   CVCL_6339
SY   CHO 1-15
DR   CLO; CLO_0002422
DR   ATCC; CRL-9606
DR   BCRJ; 0067
DR   NCBI_Iran; C527
DR   Wikidata; Q54812525
RX   Patent=US4766075;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9606.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9051; PLAT.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C527.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   CHO 100DACT
AC   CVCL_4V30
DR   Wikidata; Q54812526
RX   PubMed=2445701;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V31 ! CHO 15DACT
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO 106.3 AM1
AC   CVCL_B0CX
SY   BNP106.3sc128am1CHO1162-236; 106.3 L1 B24/H2288
DR   Wikidata; Q108820022
RX   Patent=US7939069;
RX   Patent=US7998480;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6987.
CC   Characteristics: Produces the heavy and light chains of monoclonal antibody 106.3.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   CHO 13-5-1
AC   CVCL_AZ68
SY   CHO-13-5-1; 13-5-1
DR   BTO; BTO_0005752
DR   TOKU-E; 4000
DR   Wikidata; Q54812527
RX   PubMed=7790352;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   CHO 14-2-1
AC   CVCL_AZ69
SY   CHO-14-2-1; 14-2-1
DR   Wikidata; Q54812528
RX   PubMed=7790352;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 7
//
ID   CHO 15B
AC   CVCL_VU04
SY   15B; Clone 15B
DR   Wikidata; Q93451019
RX   PubMed=681360;
RX   PubMed=1168193;
RX   PubMed=4524616;
CC   Characteristics: Deficient in alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase activity.
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   CHO 15DACT
AC   CVCL_4V31
DR   Wikidata; Q54812529
RX   PubMed=2445701;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO 1beta9, 12.5, clone 36
AC   CVCL_DC99
SY   CHO 1beta9,12.5 Clone 36; CHO-1 beta 9, 12.5, CL 36
DR   CCRID; 4201PAT-CCTCC00031
DR   Wikidata; Q54812531
RX   Patent=US5221620;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9800.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11768; TGFB2.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   CHO 1C T6
AC   CVCL_JL49
DR   NCI-DTP; CHO 1C T6
DR   Wikidata; Q54812532
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 7
//
ID   CHO 22H11
AC   CVCL_GX98
SY   CHO 22h11; 22H11
DR   TOKU-E; 4001
DR   Wikidata; Q54812533
RX   PubMed=10699869;
CC   Characteristics: Transfected with glutamine synthetase expression system carrying a gene for a human-mouse chimeric antibody (cB72.3) (PubMed=10699869).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Glutamine synthetase (GS) expression system carrying a gene for human-mouse chimeric antibody cB72.3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 10
//
ID   CHO 25-RA
AC   CVCL_U429
SY   25-RA; 25RA; Clone 25-RA; 25 RA CHO
DR   Wikidata; Q54812550
RX   PubMed=2404988;
RX   PubMed=3335499;
RX   PubMed=6105157;
RX   PubMed=8898195;
CC   Sequence variation: Mutation; UniProtKB; P97260; Scap; Simple; p.Asp443Asn (c.1327G>A); Zygosity=Heterozygous (PubMed=8898195).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 10
//
ID   CHO 3-631-436 AM5
AC   CVCL_B0CV
SY   BNP3-631-436AM5CHO893-214
DR   Wikidata; Q108820023
RX   Patent=US7939069;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8369.
CC   Characteristics: Produces the heavy and light chains of monoclonal antibody 3-631-436.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   CHO 3-631-436 AM8
AC   CVCL_B0CW
SY   BNP3-631-436AM8CHO974-211
DR   Wikidata; Q108820024
RX   Patent=US7939069;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8368.
CC   Characteristics: Produces the heavy and light chains of monoclonal antibody 3-631-436.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   CHO 4364
AC   CVCL_K254
SY   CHO clone 4364; CHOK1 4364; 4364
DR   Wikidata; Q54812551
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 7
//
ID   CHO 4Tx
AC   CVCL_E8I9
SY   CHO4Tx
WW   Provider; ExcellGene; -; https://excellgene.com/technologies/cho
WW   Provider; Magellan Biologics; -; https://magellanbiologics.com/products/
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Useful for transient gene expression (>1g/L) in high-throughput (Magellan Biologics).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VN06 ! CHOExpress
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO 51D1
AC   CVCL_5A48
SY   51D1
DR   Wikidata; Q54812552
RX   PubMed=16522646;
RX   PubMed=20434408;
RX   PubMed=22923057;
CC   Doubling time: ~16 hours (PubMed=16522646).
CC   Knockout cell: Method=Homologous recombination; UniProtKB; G3GTU6; Rad51d.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 11
//
ID   CHO 51D1.3
AC   CVCL_5A49
SY   51D1.3
DR   Wikidata; Q54812554
RX   PubMed=16522646;
RX   PubMed=20434408;
CC   Doubling time: ~12 hours (PubMed=20434408).
CC   Knockout cell: Method=Homologous recombination; UniProtKB; G3GTU6; Rad51d.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G3GTU6; Cricetulus griseus Rad51d.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A48 ! CHO 51D1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 13
//
ID   CHO 7PA2
AC   CVCL_HC66
SY   CHO-7PA2; CHO7PA2; 7PA2
DR   Wikidata; Q54812555
RX   PubMed=7721886;
RX   PubMed=23948918;
RX   PubMed=24840308;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP751; with p.Val717Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   CHO 7WD10
AC   CVCL_HC65
SY   CHO7WD10; 7WD10; 7W
DR   Wikidata; Q54812557
RX   PubMed=7721886;
RX   PubMed=8021238;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP751).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   CHO 92UG21-9 gp120 (Clade D)
AC   CVCL_1Y13
SY   HIV-1 secreting 92UG21-9 gp120 CHO cells
DR   BEI_Resources; ARP-4699
DR   Wikidata; Q54812558
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q6BBX2; HIV-1 isolate 92UG021 env (gp120).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   CHO AC29
AC   CVCL_U430
SY   AC29; AC29 CHO; CHO (AC29); AC-29
DR   Wikidata; Q54812562
RX   PubMed=3335499;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U429 ! CHO 25-RA
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 8
//
ID   CHO Ade-A
AC   CVCL_1N32
SY   Ade-A; Ade A; AdeA; ade A
DR   Wikidata; Q54608776
RX   PubMed=1235902;
RX   PubMed=4525316;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 9
//
ID   CHO Ade-B
AC   CVCL_1N33
SY   Ade-B; AdeB; ade B
DR   Wikidata; Q54608777
RX   PubMed=1235902;
RX   PubMed=4525316;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 9
//
ID   CHO Ade-C
AC   CVCL_1N34
SY   Ade-C; Ade C; AdeC; CHO-K1 ade-C; ade C
DR   Wikidata; Q54608778
RX   PubMed=1235902;
RX   PubMed=4525316;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 9
//
ID   CHO Ade-D
AC   CVCL_1N35
SY   Ade-D; Ade D; AdeD; CHO Ade D; ade D
DR   Wikidata; Q54608779
RX   PubMed=1235902;
RX   PubMed=2004782;
RX   PubMed=4525316;
RX   PubMed=23394948;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 9
//
ID   CHO Ade-E
AC   CVCL_1N36
SY   Ade-E; Ade E; AdeE; CHO Ade E; ade E
DR   Wikidata; Q54608782
RX   PubMed=1235902;
RX   PubMed=1887335;
RX   PubMed=4525316;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 9
//
ID   CHO Ade-F
AC   CVCL_1N37
SY   Ade-F; AdeF; ade F
DR   Wikidata; Q54608786
RX   PubMed=1235902;
RX   PubMed=4525316;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 9
//
ID   CHO Ade-G
AC   CVCL_1N38
SY   Ade-G; AdeG; CHO-K1 ade-G
DR   Wikidata; Q54608787
RX   PubMed=483121;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 8
//
ID   CHO Ade-H
AC   CVCL_1N39
SY   Ade-H; AdeH; ade-H
DR   Wikidata; Q54608791
RX   PubMed=849250;
RX   PubMed=2004783;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 8
//
ID   CHO Ade-I
AC   CVCL_1N40
SY   Ade-I; Ade I; ade-I; AdeI; Ade-1; CHO-Ade I
DR   Wikidata; Q54608841
RX   PubMed=849250;
RX   PubMed=20884265;
RX   PubMed=23394948;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 8
//
ID   CHO Ade-PAB
AC   CVCL_1N41
SY   Ade-PAB
DR   Wikidata; Q54608842
RX   PubMed=7418008;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   CHO Ade-PcG
AC   CVCL_UZ04
SY   CHO J405; Clone 405; Ade-PCG
DR   Wikidata; Q93451095
RX   PubMed=6941256;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CHO AL
AC   CVCL_CX61
SY   AL
DR   Wikidata; Q54812564
RX   PubMed=286318;
RX   PubMed=1475708;
RX   PubMed=8946021;
RX   PubMed=9357544;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U406 ! CHO-glyA
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   CHO AL-AND6
AC   CVCL_CX63
SY   AL-AND6; AND6; GM15827
DR   CLO; CLO_0027760
DR   Coriell; GM15827
DR   Wikidata; Q54812565
RX   PubMed=1475708;
RX   PubMed=8946021;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX61 ! CHO AL
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   CHO ALC
AC   CVCL_CX62
SY   ALC
DR   Wikidata; Q54812566
RX   PubMed=9357544;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX61 ! CHO AL
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   CHO AM-1
AC   CVCL_D3W1
SY   AM-1 CHO; AM-1
DR   Wikidata; Q127380460
RX   Patent=US6210924;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO AM-1/D
AC   CVCL_D3W2
SY   AM-1/D CHO; AM-1/D; AM-1/cyclin D CHO
DR   Wikidata; Q127380462
RX   Patent=US6210924;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3W1 ! CHO AM-1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO B2/10
AC   CVCL_E7XG
RX   PubMed=1320210;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO B8-300
AC   CVCL_VU03
SY   B8-300
DR   Wikidata; Q93451114
RX   PubMed=2813359;
RX   PubMed=3865178;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   CHO beta2(414)cl.32
AC   CVCL_DD00
SY   CHO-beta2(414) CL.32; beta2(414)cl.32; CHO-beta2(414) CL.32 pTGF-beta2(414)
DR   CCRID; 4201PAT-CCTCC00071
DR   Wikidata; Q54812567
RX   Patent=US5221620;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10300.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11768; TGFB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   CHO BLMR-1
AC   CVCL_UZ89
SY   BLMR-1
DR   Wikidata; Q93451125
RX   PubMed=6163788;
RX   PubMed=6169344;
CC   Selected for resistance to: ChEBI; CHEBI_3139; Bleomycin A2.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   CHO BLMR-2
AC   CVCL_UZ90
SY   BLMR-2
DR   Wikidata; Q93451129
RX   PubMed=6163788;
CC   Selected for resistance to: ChEBI; CHEBI_3139; Bleomycin A2.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   CHO BLMR-3
AC   CVCL_UZ91
SY   BLMR-3
DR   Wikidata; Q93451131
RX   PubMed=6163788;
RX   PubMed=6169344;
CC   Selected for resistance to: ChEBI; CHEBI_3139; Bleomycin A2.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   CHO BLMR-4
AC   CVCL_UZ92
SY   BLMR-4
DR   Wikidata; Q93451133
RX   PubMed=6163788;
RX   PubMed=6169344;
CC   Selected for resistance to: ChEBI; CHEBI_3139; Bleomycin A2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   CHO C1s-/-
AC   CVCL_A9NY
SY   CHO.K1.Prot-
DR   BEI_Resources; ARP-13575
DR   Wikidata; Q108820025
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GUR0; C1s.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   CHO C1s-/- MGAT1-
AC   CVCL_A9NX
SY   C1s-/- MGAT1- CHO; CHO.K1.MGAT1-Prot-; CHO-s-MGAT1-Protease-
DR   BEI_Resources; ARP-13574
DR   Wikidata; Q108820026
RX   PubMed=31087560;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: This cell line minimizes proteolysis of clade B HIV-1 envelope proteins commonly observed in the production of monomeric gp120 and gp140 as well as gp140 trimers.
CC   Characteristics: This cell line can only produce N-linked carbohydrates with early oligomannose glycans (Man5-9).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GUR0; C1s.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VP59 ! CHO MGAT1-
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   CHO C1s-/- MGAT1- BaL-rgp120
AC   CVCL_A9NZ
SY   BaL-rgp120 C1s-/- MGAT1- CHO
DR   BEI_Resources; ARP-13573
DR   Wikidata; Q108820027
RX   PubMed=31087560;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Produces an unclipped gp120 from a clade B isolate (BaL-rgp120) and enriched for mannose-5 glycans. The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD) (PubMed=31087560).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GUR0; C1s.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q78225; HIV-1 isolate Ba-1 env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VP59 ! CHO MGAT1-
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CHO CAT-S
AC   CVCL_DR98
SY   CAT-S
DR   PRIDE; PXD003462
DR   Wikidata; Q54812568
RX   Patent=US9068198;
RX   PubMed=27070921;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 10090201.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CHO CD28
AC   CVCL_9V75
DR   NCBI_Iran; C504
DR   Wikidata; Q54812569
RX   PubMed=2164219;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1653; CD28.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   CHO CERT
AC   CVCL_GP77
DR   Wikidata; Q54812570
RX   PubMed=27547109;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2205; CERT1 (Note=With p.Ser132Ala).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   CHO clone 13
AC   CVCL_9244
DR   CLO; CLO_0002423
DR   CLDB; cl725
DR   Wikidata; Q54812571
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_9243 ! CHO MT+
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 8
//
ID   CHO clone B
AC   CVCL_9245
DR   CLO; CLO_0002424
DR   CLDB; cl726
DR   Wikidata; Q54812572
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_9243 ! CHO MT+
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 8
//
ID   CHO CT43
AC   CVCL_U431
SY   CT43
DR   Wikidata; Q54812573
RX   PubMed=10660558;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U429 ! CHO 25-RA
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 8
//
ID   CHO CT52
AC   CVCL_U432
SY   CT52
DR   Wikidata; Q54812574
RX   PubMed=2404988;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U429 ! CHO 25-RA
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 8
//
ID   CHO CT60
AC   CVCL_U433
SY   CT60
DR   Wikidata; Q54812576
RX   PubMed=2404988;
RX   PubMed=10660558;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-282.html
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U429 ! CHO 25-RA
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   CHO dhfr- Clone 20/1
AC   CVCL_A0GD
DR   BEI_Resources; ARP-1946
DR   Wikidata; Q108820028
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   CHO dhfr(-) Bcl2
AC   CVCL_JZ93
DR   Wikidata; Q54812577
RX   Patent=US20040014218;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 10142BP.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO dhfr(-) E1B-19K
AC   CVCL_JZ94
DR   Wikidata; Q54812578
RX   Patent=US20040014218;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 10143BP.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03246; Human adenovirus C serotype 5 E1B 19 kDa protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO DP-12
AC   CVCL_8844
SY   CHO-DP12
DR   Wikidata; Q54812579
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   CHO DP-12 clone#1933
AC   CVCL_8846
SY   CHO DP-12, clone#1993 alL8.92 NB 28605/12
DR   CLO; CLO_0002426
DR   ATCC; CRL-12444
DR   Wikidata; Q54812580
RX   Patent=US6025158;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12444.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Discontinued: ATCC; CRL-12444; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8844 ! CHO DP-12
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   CHO DP-12 clone#1934
AC   CVCL_8845
SY   CHO DP-12, clone#1934 aIL8.92 NB 28605/14
DR   CLO; CLO_0002425
DR   ATCC; CRL-3614
DR   ATCC; CRL-12445
DR   Wikidata; Q54812581
RX   Patent=US6025158;
RX   PubMed=22373341;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12445.
CC   Characteristics: Expresses the variable light and heavy chains of the mAB 6G4.2.5 produced by the hybridoma of the same name (Cellosaurus=CVCL_J003).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Discontinued: ATCC; CRL-12445; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8844 ! CHO DP-12
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   CHO DRA10
AC   CVCL_RW58
SY   CHO-K1 DRA10; DRA10
DR   Wikidata; Q54812582
RX   PubMed=8799130;
CC   Characteristics: Transfected with the DRneo construct which contains a hygromycin resistance gene and two non-functional copies of the neomycin resistance gene. This cell line is sensitive to G418 but recombination recreates a functional Neo gene and recombinants become G418 resistant.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   CHO E-10B
AC   CVCL_E4HM
SY   E-10B
RX   Patent=EP0088540A2;
RX   Patent=US5004689;
RX   PubMed=6308636;
CC   Group: Patented cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO E-10B3
AC   CVCL_E4HR
SY   E-10B3
RX   Patent=EP0088540A2;
RX   Patent=US5004689;
CC   Group: Patented cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HM ! CHO E-10B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO E-10B8
AC   CVCL_E4HP
SY   E-10B8
RX   PubMed=6308636;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HM ! CHO E-10B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO E-10C
AC   CVCL_E4HN
SY   E-10C
RX   Patent=EP0088540A2;
RX   Patent=US5004689;
RX   PubMed=6308636;
CC   Group: Patented cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO E-10C10m
AC   CVCL_E4HS
SY   E-10C10m; E-10C101
RX   Patent=EP0088540A2;
RX   Patent=US5004689;
RX   PubMed=6308636;
CC   Group: Patented cell line.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HN ! CHO E-10C
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO E-10C101-250
AC   CVCL_3711
SY   E-10C101-250; HIIF-D; R10C101-250nM; R10C101-250 nM
DR   CLO; CLO_0003754
DR   ATCC; CRL-8200
DR   Wikidata; Q54889543
RX   Patent=EP0088540A2;
RX   Patent=US5004689;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8200.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HN ! CHO E-10C
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   CHO E-10C6
AC   CVCL_E4HQ
SY   E-10C6
RX   Patent=EP0088540A2;
RX   Patent=US5004689;
RX   PubMed=6308636;
RX   PubMed=14705000;
RX   PubMed=16003777;
CC   Group: Patented cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Caution: It is uncertain whether the cell line used in PubMed=14705000 and PubMed=16003777 is CHO E-10C6 or another cell line derived from CHO EC-10B (Cellosaurus=CVCL_E4HM) or CHO EC-10C (Cellosaurus=CVCL_E4HN).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HN ! CHO E-10C
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO E1a
AC   CVCL_VU65
SY   CHO E1A; CHO-E1a; CHO-E1A; CHOE1a; CHOE1A
DR   Wikidata; Q93451206
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Misspelling: CHO EIA; Note=Occasionally.
CC   Misspelling: CHOEA1; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   CHO EOT-3
AC   CVCL_RG45
SY   EOT-3; EOT; PEOT; Pro-Emt(rI)Emt(rII)Oua(R)Thg(r); Emetine Ouabain Thioguanine resistant-3
DR   Wikidata; Q54832347
RX   PubMed=217113;
RX   PubMed=688393;
RX   PubMed=3003929;
RX   PubMed=6312294;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   CHO EOT-Toyr-2
AC   CVCL_F0DK
SY   EOT-Toyr-2; EOT-Toyr2
RX   PubMed=6312294;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG45 ! CHO EOT-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO EOT-Toyr-6
AC   CVCL_F0F1
SY   EOT-Toyr-6; EOT-Toyr6
RX   PubMed=6178748;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG45 ! CHO EOT-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO EOTMA
AC   CVCL_F0F2
SY   EOTMA; Pro-Emt(rI)Emt(rII)Oua(R)Thg(r)Mbg(r)Aza(r); PEOTMA-1
RX   PubMed=6178748;
RX   PubMed=6929113;
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Misspelling: PETOMA-1; PubMed=6929113.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG45 ! CHO EOT-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO EOTMAD
AC   CVCL_F0F4
SY   EOTMAD; Pro-Emt(rI)Emt(rII)Oua(R)Thg(r)Mbg(r)Aza(r)Dip(R); PEOTMA-DipR8; PEOTMAD
RX   PubMed=6929113;
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0F2 ! CHO EOTMA
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO EOTMADT
AC   CVCL_F0F5
SY   EOTMADT; Pro-Emt(rI)Emt(rII)Oua(R)Thg(r)Mbg(r)Aza(r)Dip(r)Toy(r); PEOTMAD-Toyr4; PEOTMADT
RX   PubMed=6929113;
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0F4 ! CHO EOTMAD
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO EOTMAP
AC   CVCL_F0F3
SY   EOTMAP; Pro-Emt(rI)Emt(rII)Oua(R)Thg(r)Mbg(r)Aza(r)Pha(r); PEOTMA-Phar5; PEOTMAP
RX   PubMed=6929113;
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: UniProtKB; P05087; Phaseolus vulgaris leucoagglutinating phytohemagglutinin (PHA-L).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0F2 ! CHO EOTMA
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO EOTMAPA
AC   CVCL_F0DA
SY   EOTMAPA; Pro-Emt(rI)Emt(rII)Oua(R)Thg(r)Mbg(r)Aza(r)Pha(r)Amn(r); PEOTMAP-Amnr3; PEOTMAPA
RX   PubMed=217113;
RX   PubMed=6929113;
CC   Selected for resistance to: ChEBI; CHEBI_22526; 4-aminofolic acid (Aminopterin).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: UniProtKB; P05087; Phaseolus vulgaris leucoagglutinating phytohemagglutinin (PHA-L).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0F3 ! CHO EOTMAP
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO EOTMAPAT
AC   CVCL_F0DB
SY   EOTMAPAT; Pro-Emt(rI)Emt(rII)Oua(R)Thg(r)Mbg(r)Aza(r)Pha(r)Amn(r)Toy(r); PEOTMAPA-Toyr5; PEOTMAPAT
RX   PubMed=217113;
RX   PubMed=6929113;
CC   Selected for resistance to: ChEBI; CHEBI_22526; 4-aminofolic acid (Aminopterin).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Selected for resistance to: UniProtKB; P05087; Phaseolus vulgaris leucoagglutinating phytohemagglutinin (PHA-L).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0DA ! CHO EOTMAPA
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO FIX.1F
AC   CVCL_E4JT
SY   FIX.1F
RX   DOI=10.1007/978-94-017-0926-2_3;
RX   PubMed=9565160;
CC   Biotechnology: Produces recombinant human factor IX sold under the brand name of BeneFIX.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3551; F9.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8568; FURIN (Note=Soluble version).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO Fomr-10
AC   CVCL_F0DL
SY   Fomr-10; Fomr10
RX   PubMed=3003929;
RX   PubMed=3020927;
CC   Selected for resistance to: ChEBI; CHEBI_42654; Formycin B.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO Fomr-12
AC   CVCL_F0DM
SY   Fomr-12; Fomr12
RX   PubMed=3003929;
RX   PubMed=3020927;
CC   Selected for resistance to: ChEBI; CHEBI_42654; Formycin B.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO FomR-2
AC   CVCL_F0DI
SY   FomR-2; FomR2
RX   PubMed=3020927;
RX   PubMed=4075228;
RX   PubMed=6312294;
RX   PubMed=8917457;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Selected for resistance to: ChEBI; CHEBI_42654; Formycin B.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO FomR-4
AC   CVCL_F0DJ
SY   FomR-4; FomR4
RX   PubMed=3003929;
RX   PubMed=3020927;
RX   PubMed=4075228;
RX   PubMed=6312294;
RX   PubMed=8917457;
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Selected for resistance to: ChEBI; CHEBI_42654; Formycin B.
CC   Sequence variation: Mutation; UniProtKB; P55262; Adk; Simple; p.Ser191Phe; Zygosity=Unspecified (PubMed=21586167).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO hAQP4-M1
AC   CVCL_A6YR
DR   Wikidata; Q107114652
RX   PubMed=26398585;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M1).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CHO hAQP4-M1/M23
AC   CVCL_A6YS
DR   Wikidata; Q107114654
RX   PubMed=26398585;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M1).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M23).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CHO hAQP4-M23
AC   CVCL_A6YT
DR   Wikidata; Q107114655
RX   PubMed=23746426;
RX   PubMed=26398585;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M23).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CHO HcD6
AC   CVCL_9Y69
SY   CHO HcD6-SF
DR   Wikidata; Q54812584
RX   PubMed=25548123;
RX   PubMed=26803706;
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   CHO hPCLP1 clone 12C
AC   CVCL_C6JC
DR   Wikidata; Q116048742
RX   PubMed=19293534;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9171; PODXL.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 8
//
ID   CHO Hu 164 SCF 17
AC   CVCL_A9KZ
SY   Hu164SCF17
DR   CCRID; 4201PAT-CCTCC00079
DR   Wikidata; Q108820029
RX   Patent=US6207417;
RX   Patent=US20080305074;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10557.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6343; KITLG (Note=With p.Ser191_Val273del).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   CHO IM4
AC   CVCL_VT63
SY   IM4
DR   Wikidata; Q94315931
RX   PubMed=10764830;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3711 ! CHO E-10C101-250
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   CHO IM4/IV
AC   CVCL_VT64
SY   IM4/IV
DR   Wikidata; Q94315934
RX   PubMed=10764830;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT63 ! CHO IM4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   CHO IM4/V/IV
AC   CVCL_VT67
SY   IM4/V/IV
DR   Wikidata; Q94315937
RX   PubMed=10764830;
RX   PubMed=11469797;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT65 ! CHO IM4/Vh
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   CHO IM4/V/IV-G1
AC   CVCL_VT68
SY   IM4/V/IV-G1
DR   Wikidata; Q94315941
RX   PubMed=11469797;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:924; B4GALT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT67 ! CHO IM4/V/IV
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   CHO IM4/V/IV-G2
AC   CVCL_VT69
SY   IM4/V/IV-G2
DR   Wikidata; Q94315943
RX   PubMed=11469797;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:924; B4GALT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT67 ! CHO IM4/V/IV
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   CHO IM4/V/IV-G3
AC   CVCL_VT70
SY   IM4/V/IV-G3
DR   Wikidata; Q94315945
RX   PubMed=11469797;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:924; B4GALT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT67 ! CHO IM4/V/IV
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   CHO IM4/V/IV-G4
AC   CVCL_VT71
SY   IM4/V/IV-G4
DR   Wikidata; Q94315949
RX   PubMed=11469797;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:924; B4GALT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT67 ! CHO IM4/V/IV
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   CHO IM4/V/IV-G5
AC   CVCL_VT72
SY   IM4/V/IV-G5
DR   Wikidata; Q94315952
RX   PubMed=11469797;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:924; B4GALT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT67 ! CHO IM4/V/IV
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   CHO IM4/Vh
AC   CVCL_VT65
SY   IM4/Vh
DR   Wikidata; Q94315954
RX   PubMed=10764830;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT63 ! CHO IM4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   CHO IM4/Vm
AC   CVCL_VT66
SY   IM4/Vm
DR   Wikidata; Q94315956
RX   PubMed=10764830;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7049; MGAT5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VT63 ! CHO IM4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   CHO INSR 1284
AC   CVCL_UE11
SY   CHO-INSR-1284
DR   ATCC; CRL-3307
DR   DSMZ; ACC-858
DR   DSMZCellDive; ACC-858
DR   Wikidata; Q93451213
RX   PubMed=20209060;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-858).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=Isoform Long).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U424 ! Flp-In-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   CHO irs-20
AC   CVCL_S167
SY   CHO irs 20; irs-20; Irs-20; IRS-20; irs20
DR   Wikidata; Q54812585
RX   PubMed=7504309;
RX   PubMed=7910196;
RX   PubMed=8248482;
RX   PubMed=9008208;
RX   PubMed=9518490;
CC   Sequence variation: Mutation; UniProtKB; A0A061I8A6; Prkdc; Simple; p.Glu4090Lys (c.11268G>A); Zygosity=Heterozygous (PubMed=9518490).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_S165 ! CHO-10B2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 11
//
ID   CHO irs1SF
AC   CVCL_K038
SY   irs1SF
DR   CLO; CLO_0050425
DR   RCB; RCB2328
DR   Wikidata; Q54812586
RX   PubMed=3347204;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 11
//
ID   CHO IS1
AC   CVCL_S166
DR   Wikidata; Q54812587
RX   PubMed=7528122;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_S165 ! CHO-10B2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 9
//
ID   CHO JR-FL gp160 (Clone A19)
AC   CVCL_1Y10
SY   HIV-1 JR-FL gp160 Secreting CHO Cells (Clone A19)
DR   BEI_Resources; ARP-4022
DR   Wikidata; Q54812589
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HIV-1 isolate JRFL env (gp160).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   CHO LA 3-5
AC   CVCL_4587
SY   LA 3-5; LA3-5
DR   CLO; CLO_0007224
DR   ATCC; CRL-10101
DR   Wikidata; Q54901860
RX   Patent=WO1987004187A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10101.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   CHO LH1 275
AC   CVCL_B0UZ
SY   LH1275
DR   Wikidata; Q108820030
RX   Patent=US9163091;
RX   PubMed=19509417;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8422.
CC   Characteristics: Transfected with plasmid pATH1009 encoding the Ig heavy and light chains of humanized version (LT1009) of mAB (LT1002) produced by hybridoma 306D326.26 (Cellosaurus=CVCL_B0UY).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DR95 ! CHOK1SV
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 6
//
ID   CHO MGAT1-
AC   CVCL_VP59
SY   MGAT1- CHO; MGAT1- CHO 3.4F10; 3.4F10; 3.4F10 MGAT1- CHO; CHO.K1.MGAT1-
DR   BEI_Resources; ARP-13576
DR   Wikidata; Q93451231
RX   PubMed=30071025;
RX   PubMed=30157178;
RX   PubMed=31087560;
CC   Characteristics: This cell line can only produce N-linked carbohydrates with early oligomannose glycans (Man5-9).
CC   Doubling time: 20.7 hours (PubMed=30157178).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 10
//
ID   CHO MGAT1- A244_N332-rgp120 5F
AC   CVCL_A0BY
SY   6.4D
DR   BEI_Resources; ARP-13577
DR   Wikidata; Q108820031
RX   PubMed=30071025;
CC   Characteristics: Produces a gp120 from a modified A244 isolate (A244_N332-rgp120) where a glycosylation was moved from Asn-334 to Asn-332. It is enriched for mannose-5 glycans. The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD) (PubMed=30071025).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VP59 ! CHO MGAT1-
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CHO MGAT1- TZ97008-rgp120 2D7
AC   CVCL_A0BT
SY   2D7
DR   BEI_Resources; ARP-13581
DR   Wikidata; Q108820032
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Produces a gp120 from a clade C isolate (TZ97008-rgp120) and enriched for mannose-5 glycans. The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HIV-1 isolate TZ97008 env (gp120).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VP59 ! CHO MGAT1-
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CHO MGAT1- TZ97008-rgp120 3E5
AC   CVCL_A0BU
SY   3E5 MGAT1- CHO TZ97008
DR   Wikidata; Q108820033
RX   PubMed=30344523;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Produces a gp120 from a clade C isolate (TZ97008-rgp120) and enriched for mannose-5 glycans. The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HIV-1 isolate TZ97008 env (gp120).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_VP59 ! CHO MGAT1-
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CHO MT+
AC   CVCL_9243
DR   CLO; CLO_0002428
DR   CLDB; cl727
DR   Wikidata; Q54812590
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 9
//
ID   CHO MW959 gp140 (Clade A)
AC   CVCL_1Y09
SY   HIV-1 MW959 gp140 secreting CHO Cells
DR   BEI_Resources; ARP-4698
DR   Wikidata; Q54812591
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q6BBZ9; HIV-1 isolate 93MW959 env (gp140).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   CHO NA4-4
AC   CVCL_E4I6
SY   NA4-4; NA
RX   PubMed=2157974;
RX   PubMed=2243084;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95824; Nr3c1 (Note=With p.Glu555Gly).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CHO Nav1.7
AC   CVCL_E5E2
CC   From: Anaxon AG; Bern; Switzerland.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10597; SCN9A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO NB1-5
AC   CVCL_E4I7
SY   NB1-5; NB
RX   PubMed=2157974;
RX   PubMed=2243084;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95824; Nr3c1 (Note=With p.Arg493His).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CHO NGAL rAg 662
AC   CVCL_C1J5
SY   NGAL rAg CHO 662
DR   Wikidata; Q114310945
RX   Patent=US8394606;
RX   Patent=WO2009052400A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8020.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6526; LCN2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   CHO NGAL rAg C87S
AC   CVCL_C1J6
SY   NGAL rAg CHO C87S; C87S NGAL rAg CHO 734; CHO cell clone #734
DR   Wikidata; Q114310947
RX   Patent=US8394606;
RX   Patent=WO2009052400A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8168.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6526; LCN2 (Note=With p.Cys107Ser).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   CHO NL4-3 gp120
AC   CVCL_1H27
SY   HIV-1 NL4-3 gp120 secreting CHO Cells
DR   BEI_Resources; ARP-4125
DR   Wikidata; Q54812592
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q72502; HIV-1 isolate NL4-3 env (Note=gp120).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   CHO NL4-3 gp160
AC   CVCL_1G49
SY   HIV-1 NL4-3 gp160 Secreting CHO Cells
DR   BEI_Resources; ARP-3972
DR   Wikidata; Q54812593
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q72502; HIV-1 isolate NL4-3 env (Note=gp160).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   CHO P192
AC   CVCL_C8IZ
SY   P192
DR   Wikidata; Q123030913
RX   PubMed=6885929;
CC   Characteristics: Accumulates UDP glucuronic acid (UDPglcUA) (PubMed=6885929).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CHO PBj gp130
AC   CVCL_1Y08
SY   2-8-2; SIV PBj 2-8-2 gp130 Secreting CHO Cells
DR   BEI_Resources; ARP-4126
DR   Wikidata; Q54812594
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P19503; Simian immunodeficiency virus (isolate PBj14/BCL-3) (SIV-sm) env (gp130).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 10
//
ID   CHO Pro-3
AC   CVCL_7182
SY   CHO-pro3-; CHO pro3-; CHP PRO-3; Pro-3 CHO; CHO Toronto; CHO-Toronto; CHO WTB; WTB; Pro- (CHO); pro-; Pro-3
DR   Wikidata; Q54813099
RX   DOI=10.3390/pr1030296;
RX   PubMed=688393;
RX   PubMed=730780;
RX   PubMed=1028172;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
CC   Characteristics: Defective in purine biosynthesis.
CC   Doubling time: 14 hours (PubMed=1028172).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   CHO Pro-3 MtxRI OuaR-3-6
AC   CVCL_C5S2
SY   Pro-3 MtxRI OuaR 3-6
DR   Wikidata; Q116048743
RX   PubMed=1035580;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRI-2-6
AC   CVCL_C5S3
SY   Pro-3 MtxRI-2-6; Pro-3 MtxRI2-6
DR   Wikidata; Q116048745
RX   PubMed=1028172;
RX   PubMed=7003776;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRI-3-3
AC   CVCL_C5S4
SY   Pro-3 MtxRI-3-3; Pro-3 MtxRI 3-3
DR   Wikidata; Q116048746
RX   PubMed=1028172;
RX   PubMed=1035580;
CC   Doubling time: 14 hours (PubMed=1028172).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRI-4-3
AC   CVCL_C5S5
SY   Pro-3 MtxRI-4-3
DR   Wikidata; Q116048747
RX   PubMed=1028172;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRI-6-3
AC   CVCL_C5S6
SY   Pro-3 MtxRI-6-3
DR   Wikidata; Q116048748
RX   PubMed=1028172;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRII OuaR-5-3
AC   CVCL_C5S7
SY   Pro-3 MtxRII OuaR 5-3
DR   Wikidata; Q116048749
RX   PubMed=1035580;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRII-5-3
AC   CVCL_C5S8
SY   Pro-3 MtxRII-5-3; Pro-3 MtxRII 5-3; MtxRII 5-3
DR   Wikidata; Q116048750
RX   PubMed=1028172;
RX   PubMed=1035580;
CC   Doubling time: 15 hours (PubMed=1028172).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRII-7-5
AC   CVCL_C5S9
SY   Pro-3 MtxRII-7-5
DR   Wikidata; Q116048751
RX   PubMed=1028172;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRIII OuaR-3-5
AC   CVCL_C5SA
SY   Pro-3 MtxRIII OuaR 3-5
DR   Wikidata; Q116048752
RX   PubMed=1035580;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 MtxRIII-1-2
AC   CVCL_C5SB
SY   Pro-3 MtxRIII-1-2; Pro-3 MtxRIII 1-2
DR   Wikidata; Q116048753
RX   PubMed=1028172;
RX   PubMed=1035580;
CC   Doubling time: 15 hours (PubMed=1028172).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-3 OuaR-1-2
AC   CVCL_C5SC
SY   Pro-3 OuaR 1-2
DR   Wikidata; Q116048754
RX   PubMed=1035580;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4
AC   CVCL_C5RR
SY   CHO-pro4-; Pro-4
DR   Wikidata; Q116048755
RX   PubMed=1028172;
CC   Characteristics: Defective in purine biosynthesis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 4
//
ID   CHO Pro-4 MtxRI OuaR-6-3
AC   CVCL_C5SD
SY   Pro-4 MtxRI OuaR 6-3; Pro-4 MtxRIOuaR6-3
DR   Wikidata; Q116048756
RX   PubMed=1035580;
RX   PubMed=7003776;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4 MtxRI-1-2
AC   CVCL_C5SE
SY   Pro-4 MtxRI-1-2
DR   Wikidata; Q116048757
RX   PubMed=1028172;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4 MtxRI-3-4
AC   CVCL_C5SF
SY   Pro-4 MtxRI-3-4
DR   Wikidata; Q116048758
RX   PubMed=1028172;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4 MtxRII OuaR-2-4
AC   CVCL_C5SG
SY   Pro-4 MtxRII OuaR 2-4; MTXRIIOuaR2-4; R2
DR   ChEMBL-Cells; CHEMBL3886001
DR   ChEMBL-Targets; CHEMBL614385
DR   Wikidata; Q116048759
RX   PubMed=1035580;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4 MtxRII-2-1
AC   CVCL_C5SH
SY   Pro-4 MtxRII-2-1
DR   Wikidata; Q116048760
RX   PubMed=1028172;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4 MtxRII-4-5
AC   CVCL_C5SI
SY   Pro-4 MtxRII-4-5; MtxRII 4-5
DR   Wikidata; Q116048761
RX   PubMed=1028172;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4 MtxRIII OuaR-1-6
AC   CVCL_C5SJ
SY   Pro-4 MtxRIII OuaR 1-6
DR   Wikidata; Q116048762
RX   PubMed=1035580;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-4 OuaR-2-4
AC   CVCL_C5SK
SY   Pro-4 OuaR 2-4
DR   Wikidata; Q116048763
RX   PubMed=1035580;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C5RR ! CHO Pro-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CHO Pro-5
AC   CVCL_4382
SY   CHOpro-5; CHO-Pro5; CHO clone Pro-5; CHO, clone Pro5; Pro-5
DR   BTO; BTO_0002176
DR   CLO; CLO_0008486
DR   ATCC; CRL-1781
DR   Wikidata; Q54812595
RX   DOI=10.3390/pr1030296;
RX   PubMed=1182798;
RX   PubMed=6623313;
RX   PubMed=8900435;
CC   Characteristics: Defective in purine biosynthesis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   CHO Pro-5-Esel
AC   CVCL_A1BC
SY   CHO-Pro5-Esel
DR   Wikidata; Q102113678
RX   PubMed=8900435;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10718; SELE.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   CHO Pyrr-1
AC   CVCL_F0DR
SY   Pyrr-1; Pyrr1
RX   PubMed=8917457;
CC   Selected for resistance to: ChEBI; CHEBI_90284; Pyrazofurin (Pirazofurin; PF).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   CHO Q131-91A
AC   CVCL_1N58
DR   Wikidata; Q54812596
RX   PubMed=2286371;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1N56 ! Urd-C
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   CHO SH-87
AC   CVCL_UZ06
SY   SH-87; SH87
DR   MetaboLights; MTBLS493
DR   Wikidata; Q93451260
RX   PubMed=22024589;
RX   PubMed=28544881;
CC   Characteristics: Transfected with a tricistronic vector utilizing internal ribosome entry site (IRES) elements to express the light chain (LC), heavy chain (HC) and a neo selection marker from one transcript.
CC   Characteristics: Produces an anti-ERBB2 monoclonal antibody.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   CHO SSF3
AC   CVCL_E4HJ
SY   CHOSSF3; SSF3
RX   DOI=10.3929/ethz-a-000888370;
RX   PubMed=8549740;
RX   PubMed=9634782;
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO SSF3/pMOZ uPA clone 1
AC   CVCL_E4HK
SY   CHO SSF3 C1
RX   PubMed=9634782;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9052; PLAU.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HJ ! CHO SSF3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO SSF3/pMOZ uPA clone 8
AC   CVCL_E4HL
SY   CHO SSF3 C8
RX   PubMed=9634782;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9052; PLAU.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HJ ! CHO SSF3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO SSF3GR
AC   CVCL_E4HT
SY   SSF3GR
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HJ ! CHO SSF3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO SSF3KVN1
AC   CVCL_E4HU
SY   SSF3KVN1
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The expression of VTN is under transcriptional control of a DEX-inducible MMTV promoter. Displays constitutively adherent growth (PubMed=10516577).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12724; VTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HT ! CHO SSF3GR
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO SSF3KVN7
AC   CVCL_E4HV
SY   SSF3KVN7
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The expression of VTN is under transcriptional control of a DEX-inducible MMTV promoter. Displays constitutively adherent growth (PubMed=10516577).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12724; VTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HT ! CHO SSF3GR
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO SSF3VN17
AC   CVCL_E4HY
SY   SSF3VN17
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The expression of VTN is under transcriptional control of a DEX-inducible MMTV promoter (PubMed=10516577).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12724; VTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HT ! CHO SSF3GR
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO SSF3VN8
AC   CVCL_E4HW
SY   SSF3VN8
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The expression of VTN is under transcriptional control of a DEX-inducible MMTV promoter (PubMed=10516577).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12724; VTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HT ! CHO SSF3GR
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO SSF3VN9
AC   CVCL_E4HX
SY   SSF3VN9
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The expression of VTN is under transcriptional control of a DEX-inducible MMTV promoter (PubMed=10516577).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12724; VTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HT ! CHO SSF3GR
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO SSF3VN9hmGluR1b
AC   CVCL_E4I0
SY   SSF3VN9hmGluR1b; CHO SSF3VN-hGluR1b
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The expression of VTN is under transcriptional control of a DEX-inducible MMTV promoter (PubMed=10516577).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4593; GRM1 (Note=Isoform beta).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12724; VTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HX ! CHO SSF3VN9
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO SSF3VN9Luc
AC   CVCL_E4HZ
SY   SSF3VN9Luc
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The expression of VTN is under transcriptional control of a DEX-inducible MMTV promoter (PubMed=10516577).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12724; VTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HX ! CHO SSF3VN9
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   CHO ST4.2
AC   CVCL_W649
SY   CHO-ST4.2
DR   BEI_Resources; ARP-501
DR   Wikidata; Q54812597
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   CHO Tet-On 3G
AC   CVCL_V348
DR   Wikidata; Q54812598
WW   Provider; Takara Bio; 631195; https://www.takarabio.com/products/gene-function/tet-inducible-expression-systems/tet-on-3g-systems/tet-on-3g-cell-lines
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   CHO Toyr-15
AC   CVCL_F0DD
SY   Toyr-15; Toyr15
RX   PubMed=217113;
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO Toyr-16
AC   CVCL_F0DE
SY   Toyr-16; Toyr16; ToyrI-16
RX   PubMed=217113;
RX   PubMed=6712702;
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO Toyr-21
AC   CVCL_F0DQ
SY   Toyr-21; Toyr21
RX   PubMed=8917457;
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO Toyr-3
AC   CVCL_F0G1
SY   Toyr-3; Toyr3
RX   PubMed=8917457;
RX   PubMed=11242543;
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Sequence variation: Mutation; UniProtKB; P55262; Adk; Unexplicit; Partial deletion; Zygosity=Unspecified (PubMed=11242543).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO Toyr-4
AC   CVCL_F0DC
SY   Toyr-4; Toyr4
RX   PubMed=217113;
RX   PubMed=3003929;
RX   PubMed=3020927;
RX   PubMed=4075228;
RX   PubMed=6178748;
RX   PubMed=6312294;
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO Toyr-5
AC   CVCL_F0DP
SY   Toyr-5; Toyr5
RX   PubMed=3020927;
RX   PubMed=4075228;
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO ToyrII-1
AC   CVCL_F0DG
SY   ToyrII-1
RX   PubMed=6712702;
CC   Characteristics: Second step toyocamycin mutant obtained from the parent cell line after selection in presence of higher concentrations of toyocamycin (PubMed=6712702).
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0DE ! CHO Toyr-16
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO ToyrII-2
AC   CVCL_F0DH
SY   ToyrII-2
RX   PubMed=6712702;
CC   Characteristics: Second step toyocamycin mutant obtained from the parent cell line after selection in presence of higher concentrations of toyocamycin (PubMed=6712702).
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0DE ! CHO Toyr-16
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO TSHR-0
AC   CVCL_E3EJ
SY   TSHR-0
RX   PubMed=8895321;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR (Note=With deleted untranslated regions).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO TSHR-10,000
AC   CVCL_E3EM
SY   TSHR-10,0000
RX   PubMed=8895321;
CC   Characteristics: Adapted to growth in 10000 nM methotrexate (PubMed=8895321).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR (Note=With deleted untranslated regions).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3EL ! CHO TSHR-800
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO TSHR-289
AC   CVCL_E3EN
SY   TSHR-289
RX   PubMed=10022441;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR (Note=With p.Lys290-Leu764 del).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO TSHR-800
AC   CVCL_E3EL
SY   TSHR-800
RX   PubMed=8895321;
CC   Characteristics: Adapted to growth in 800 nM methotrexate (PubMed=8895321).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR (Note=With deleted untranslated regions).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3EJ ! CHO TSHR-0
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO TSHR-WT
AC   CVCL_E3EK
SY   TSHR-WT
RX   PubMed=8895321;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO Tubr-1
AC   CVCL_F0DN
SY   Tubr-1; Tubr1
RX   PubMed=8917457;
RX   PubMed=11242543;
CC   Selected for resistance to: ChEBI; CHEBI_48267; Tubercidin (7-deazaadenosine).
CC   Sequence variation: Mutation; UniProtKB; P55262; Adk; Unexplicit; Partial deletion; Zygosity=Unspecified (PubMed=11242543).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO Tubr-7
AC   CVCL_F0DF
SY   Tubr-7; Tubr7
RX   PubMed=217113;
CC   Selected for resistance to: ChEBI; CHEBI_48267; Tubercidin (7-deazaadenosine).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO VpmR-1
AC   CVCL_F0E7
SY   VpmR-1
RX   PubMed=6831403;
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO VpmR-3
AC   CVCL_F0E8
SY   VpmR-3
RX   PubMed=6831403;
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO VpmR-5
AC   CVCL_F0E9
SY   VpmR-5
RX   PubMed=6831403;
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO VpmR-6
AC   CVCL_F0EA
SY   VpmR-6
RX   PubMed=6831403;
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO W3-7
AC   CVCL_E4I8
SY   W3-7; W3
RX   PubMed=2157974;
RX   PubMed=2243084;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95824; Nr3c1.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CHO W9-7
AC   CVCL_E4I9
SY   W9-7; W9
RX   PubMed=2157974;
RX   PubMed=2243084;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95824; Nr3c1.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CHO WCL2
AC   CVCL_DC12
SY   WCL2; WCL-2
DR   Wikidata; Q54993621
RX   PubMed=2019585;
RX   PubMed=2243084;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95824; Nr3c1.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CHO XBP1s
AC   CVCL_GP78
DR   Wikidata; Q54812609
RX   PubMed=27547109;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12801; XBP1 (Note=Isoform XBP1s).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   CHO(His9)
AC   CVCL_2875
DR   JCRB; JCRB2209
DR   Wikidata; Q54813168
RX   PubMed=10919723;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains human chromosome 9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06988; Escherichia coli hisD.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0213 ! CHO
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   CHO(I-mfa)
AC   CVCL_E9DH
SY   CHOI-mfa
RX   PubMed=14530267;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28870; MDFIC (Note=With a N-terminal FLAG tag = F-I-mfa).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO(pMAM-HSluc)
AC   CVCL_U217
SY   pMAM-HSluc
DR   JCRB; JCRB0136.2
DR   JCRB; NIHS0212.2
DR   Wikidata; Q54813169
RX   PubMed=9113384;
CC   Characteristics: The expression of the luciferase gene is under the control of a Hsp70 promoter (PubMed=9113384).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0212.2; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO(pMAM-luc)
AC   CVCL_U218
SY   pMAM-luc
DR   JCRB; JCRB0136.1
DR   JCRB; NIHS0212.1
DR   Wikidata; Q54813170
RX   PubMed=9113384;
CC   Doubling time: ~24 hours (Note=Lot 092999) (JCRB=JCRB0136.1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0212.1; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-10B2
AC   CVCL_S165
SY   CHO 10B2; CHO10B2; 10B2
DR   Wikidata; Q54812611
RX   PubMed=9518490;
RX   PubMed=22923057;
CC   Misspelling: CHO 10B12; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 12
//
ID   CHO-13D-35D
AC   CVCL_IR13
SY   CHO 13D-35D; 13D-35D
DR   Wikidata; Q54812612
RX   PubMed=18078289;
RX   PubMed=19134553;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:775; SERPINC1.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-1C6
AC   CVCL_8847
DR   CLO; CLO_0002435
DR   ATCC; CRL-1793
DR   Wikidata; Q54812614
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 8
//
ID   CHO-22
AC   CVCL_V326
DR   BTO; BTO_0004810
DR   Wikidata; Q54812615
RX   PubMed=16895900;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2577; CYBA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-27-1
AC   CVCL_VU10
SY   CHO 27-1; 27-1
DR   Wikidata; Q93451304
RX   PubMed=2308597;
RX   PubMed=6889678;
RX   PubMed=16143348;
CC   Sequence variation: Mutation; UniProtKB; A0MQ57; Ercc3; Simple; p.Lys359Glu (c.1075C>G); Zygosity=Unspecified (PubMed=16143348).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D898 ! CHO-9
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 7
//
ID   CHO-3E7
AC   CVCL_JY74
SY   CHO 3E7; CHO-EBNA1c clone 3E7; CHO EBNA1c-3E7
DR   Wikidata; Q54812616
RX   Patent=US9353382;
WW   Provider; NRC Canada; 11992; https://nrc.canada.ca/en/research-development/intellectual-property-licensing/cho-expression-platform-l-11266-11992-12273-12671
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1 (Note=With p.Met1_Gly335del = EBNA1c).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   CHO-43-3B
AC   CVCL_5A47
SY   CHO 43-3B; 43-3B
DR   Wikidata; Q54812617
RX   PubMed=2499773;
RX   PubMed=2499774;
RX   PubMed=3982442;
RX   PubMed=6889678;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D898 ! CHO-9
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 7
//
ID   CHO-5-HT1B
AC   CVCL_XD05
DR   CCRID; 4201PAT-CCTCC00960
DR   Wikidata; Q93451328
RX   Patent=CN108570450A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016175.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5287; HTR1B.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   CHO-6
AC   CVCL_4700
SY   CHO6; CHO 6
DR   BTO; BTO_0003450
DR   Wikidata; Q54812618
RX   PubMed=12379725;
RX   PubMed=16925789;
CC   Characteristics: Resistant to infection by Chlamydia pneumoniae, Chlamydia psittaci and Chlamydia trachomatis.
CC   Characteristics: Has a defect in the processing of the signal sequence of P4HB/PDIA1 which lead to impaired chlamydial attachment and infectivity.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   CHO-7
AC   CVCL_D893
SY   CHO7
DR   BTO; BTO_0002988
DR   Wikidata; Q54812620
RX   PubMed=2570073;
RX   PubMed=17038318;
CC   Characteristics: Were derived from parent cell line by adaptation to continuous growth in lipoprotein-deficient serum.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   CHO-9
AC   CVCL_D898
SY   CHO9; GM16132
DR   CLO; CLO_0018833
DR   EFO; EFO_0022826
DR   Coriell; GM16132
DR   Wikidata; Q54812621
RX   PubMed=1518409;
RX   PubMed=2499774;
RX   PubMed=6889678;
RX   PubMed=8187089;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_V245 ! CHO-KK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   CHO-91
AC   CVCL_V327
DR   BTO; BTO_0004809
DR   Wikidata; Q54812622
RX   PubMed=16895900;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2578; CYBB.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-91-22
AC   CVCL_V328
DR   BTO; BTO_0004808
DR   Wikidata; Q54812623
RX   PubMed=16895900;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2577; CYBA.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2578; CYBB.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-91-22-47-67
AC   CVCL_V329
SY   CHOphox
DR   BTO; BTO_0004807
DR   Wikidata; Q54812624
RX   PubMed=16895900;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2577; CYBA.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2578; CYBB.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7660; NCF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7661; NCF2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-91-47-67
AC   CVCL_V330
SY   CHO-91/47/67
DR   BTO; BTO_0004806
DR   Wikidata; Q54812625
RX   PubMed=16895900;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2578; CYBB.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7660; NCF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7661; NCF2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-A7
AC   CVCL_H340
SY   CHO A7; A7
DR   BTO; BTO_0005753
DR   Wikidata; Q54812627
RX   PubMed=3924915;
RX   PubMed=4033657;
RX   PubMed=6727873;
RX   PubMed=7159597;
RX   PubMed=7198184;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   CHO-AA8
AC   CVCL_4386
SY   CHO AA8; CHO (AA8); AA8
DR   BTO; BTO_0002641
DR   CLO; CLO_0001630
DR   CLO; CLO_0050419
DR   EFO; EFO_0022798
DR   ATCC; CRL-1859
DR   BCRC; 60162
DR   CCRID; 3101HAMSCSP5041
DR   ChEMBL-Cells; CHEMBL3307400
DR   ChEMBL-Targets; CHEMBL614555
DR   PubChem_Cell_line; CVCL_4386
DR   RCB; RCB2326
DR   TOKU-E; 498
DR   Wikidata; Q54812630
RX   DOI=10.3390/pr1030296;
RX   PubMed=2218721;
RX   PubMed=2687628;
RX   PubMed=3347204;
RX   PubMed=7360155;
RX   PubMed=7404270;
RX   PubMed=8765433;
RX   PubMed=16522646;
CC   Doubling time: ~13 hours (PubMed=16522646).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 20
//
ID   CHO-AA8 Tet-Off
AC   CVCL_V347
SY   CHO AA8 Tet-Off
DR   Wikidata; Q54812631
WW   Provider; Takara Bio; 630904; https://www.takarabio.com/documents/Certificate%20of%20Analysis/630904/630904-PA033650.pdf
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   CHO-AA8-Luc Tet-Off
AC   CVCL_KT00
SY   CHO AA8-Luc Tet-Off
DR   Wikidata; Q54812632
WW   Provider; Takara Bio; 631122; https://www.takarabio.com/documents/Certificate%20of%20Analysis/631122/631122.pdf
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Characteristics: The firefly luciferase reporter gene is under the control of a tetracycline-responsive promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 15
//
ID   CHO-ADLE
AC   CVCL_JZ95
DR   Wikidata; Q54812633
RX   Patent=WO2008056961A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 11014BP.
CC   Characteristics: Transfected with a albumin-EPO fusion protein ADLE (Albumin-Domain-Linker-EPO) (Patent=WO2008056961A1).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:399; ALB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   CHO-ADRB2
AC   CVCL_U013
SY   CHO-Beta-2; T26J-1/09
DR   ECACC; 10031601
DR   Wikidata; Q54971480
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-AFLE
AC   CVCL_JZ96
DR   Wikidata; Q54812634
RX   Patent=WO2008056961A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 11015BP.
CC   Characteristics: Transfected with a albumin-EPO fusion protein AFLE (Albumin-Full-Linker-EPO) (Patent=WO2008056961A1).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:399; ALB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   CHO-AR1
AC   CVCL_5A24
SY   AR1
DR   Wikidata; Q54812636
RX   PubMed=162911;
CC   Selected for resistance to: ChEBI; CHEBI_16335; Adenosine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO-AR7
AC   CVCL_5A25
SY   AR7
DR   Wikidata; Q54812637
RX   PubMed=162911;
CC   Selected for resistance to: ChEBI; CHEBI_16335; Adenosine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO-AS52
AC   CVCL_Y504
SY   CHO AS52; AS52
DR   Wikidata; Q54812638
RX   PubMed=2432598;
RX   PubMed=3005850;
RX   PubMed=6095070;
RX   PubMed=29289706;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-152.html
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_Y503 ! CHO-X3/5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   CHO-AS52 Ogg1(-/-)-Mutyh(-/-)
AC   CVCL_RM50
SY   AS52 Ogg1-/-Mutyh-/-; OGG1-/-MUTYH-/- AS52
DR   Wikidata; Q54812640
RX   PubMed=29289706;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GX91; Ogg1.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GYQ5; Mutyh.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_Y504 ! CHO-AS52
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   CHO-AT3-2
AC   CVCL_DE19
SY   AT3-2
DR   Wikidata; Q54812641
RX   PubMed=3129654;
RX   PubMed=6449663;
RX   PubMed=7491132;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   CHO-AUXB1
AC   CVCL_D264
SY   CHO AUXB1; AuxB1; AUXB1; AUX B1; Aux-B1; AuX B1; Gat-(CHO); gat-CHO
DR   TOKU-E; 4114
DR   Wikidata; Q54812642
RX   PubMed=583488;
RX   PubMed=688393;
RX   PubMed=3365701;
RX   PubMed=3839900;
RX   PubMed=4472030;
RX   PubMed=4547236;
RX   PubMed=35381425;
CC   Characteristics: Auxotrophic for glycine, adenosine, and thymidine (GAT-) (PubMed=4547236).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   CHO-AUXB1 HuR-12
AC   CVCL_D5AR
SY   HuR-12
DR   Wikidata; Q127380463
RX   PubMed=432759;
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-AUXB1 HuR-12 SC13
AC   CVCL_D5AS
SY   SC13
DR   Wikidata; Q127380464
RX   PubMed=432759;
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D5AR ! CHO-AUXB1 HuR-12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-AUXB1 HuR-12 SC17
AC   CVCL_D5AT
SY   SC17
DR   Wikidata; Q127380465
RX   PubMed=432759;
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D5AR ! CHO-AUXB1 HuR-12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-AUXB1 HuR-12 SC8
AC   CVCL_D5AU
SY   SC8
DR   Wikidata; Q127380467
RX   PubMed=432759;
RX   PubMed=3622008;
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D5AR ! CHO-AUXB1 HuR-12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-AUXB3
AC   CVCL_5A30
SY   CHO AUXB3; AUXB3; AUX B3
DR   Wikidata; Q54812643
RX   PubMed=583488;
RX   PubMed=4547236;
CC   Characteristics: Auxotrophic for glycine and adenosine (GA-) (PubMed=4547236).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 7
//
ID   CHO-AUXE29
AC   CVCL_M722
SY   AUXE29; AuxE29
DR   Wikidata; Q54812644
RX   PubMed=4585080;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 8
//
ID   CHO-B7H3
AC   CVCL_E6AU
DR   CLS; 305417
WW   Provider; InSCREENeX; INS-SF-1019; https://www.inscreenex.de/product/cho-b7h3/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:19137; CD276.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-betaGal
AC   CVCL_Y102
DR   BCRC; 60377
DR   Wikidata; Q54812648
RX   PubMed=11776965;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Discontinued: BCRC; 60377; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   CHO-betaGal-SF
AC   CVCL_Y103
SY   CHO-betaGal-Serum Free
DR   BCRC; 60378
DR   Wikidata; Q54812650
RX   PubMed=11776965;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_Y102 ! CHO-betaGal
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   CHO-CCR8
AC   CVCL_E6A2
DR   CLS; 305418
WW   Provider; InSCREENeX; INS-SF-1023; https://www.inscreenex.de/product/cho-ccr8/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-CD36
AC   CVCL_8848
DR   CLO; CLO_0002459
DR   ATCC; CRL-2092
DR   Wikidata; Q54812651
RX   PubMed=7682381;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1663; CD36.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   CHO-CD81/SR-B1
AC   CVCL_E8TN
RX   PubMed=12913001;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1701; CD81.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1664; SCARB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E8TM ! CHO-SR-B1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-CH3S
AC   CVCL_VR93
SY   CH3S
DR   Wikidata; Q93451465
RX   PubMed=2165233;
RX   PubMed=10407672;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   CHO-CHRB30
AC   CVCL_4703
SY   CHRB30; CHrB30
DR   BTO; BTO_0000860
DR   Wikidata; Q54812652
RX   PubMed=2412130;
RX   PubMed=2863759;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D266 ! CHO-CHRC5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   CHO-CHRC4
AC   CVCL_D265
SY   CHRC4; CHrC4
DR   Wikidata; Q54812653
RX   PubMed=4855907;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   CHO-CHRC5
AC   CVCL_D266
SY   CHO/CHRC5; CHO CHRC5; CHRC/5; CHRC5; CHrC5; CHORC5
DR   ChEMBL-Cells; CHEMBL3307930
DR   ChEMBL-Targets; CHEMBL614457
DR   PubChem_Cell_line; CVCL_D266
DR   Wikidata; Q54812654
RX   PubMed=2158805;
RX   PubMed=2412130;
RX   PubMed=2458323;
RX   PubMed=3365701;
RX   PubMed=3567908;
RX   PubMed=4855907;
RX   PubMed=35381425;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   CHO-CHRM1
AC   CVCL_U002
DR   ECACC; 10110203
DR   Wikidata; Q54812655
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-CHRM2
AC   CVCL_U003
DR   ECACC; 10110204
DR   Wikidata; Q54812657
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:1951; CHRM2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-CHRM3
AC   CVCL_U011
SY   CHO-M3; T02J-7/10
DR   ECACC; 10031603
DR   Wikidata; Q54971390
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:1952; CHRM3.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-CHRM5
AC   CVCL_U004
DR   ECACC; 11041302
DR   Wikidata; Q54812658
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:1954; CHRM5.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   Cho-CK
AC   CVCL_M268
DR   Wikidata; Q54812667
RX   CelloPub=CLPUB00275;
RX   PubMed=11107175;
RX   PubMed=35640676;
CC   Population: Korean.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   CHO-CNR1
AC   CVCL_U000
DR   ECACC; 12110601
DR   Wikidata; Q54812668
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-CPR C10
AC   CVCL_D1GK
SY   CHO-CPR 10
DR   Wikidata; Q127380468
RX   PubMed=37681872;
CC   Doubling time: 25.2 hours (PubMed=37681872).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9208; POR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO-CPR C12
AC   CVCL_D1GL
SY   CHO-CPR 12
DR   Wikidata; Q127380469
RX   PubMed=37681872;
CC   Doubling time: 19.9 hours (PubMed=37681872).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO-CPR C13
AC   CVCL_D1GM
SY   CHO-CPR 13
DR   Wikidata; Q127380470
RX   PubMed=37681872;
CC   Doubling time: 31.9 hours (PubMed=37681872).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO-CPR/CYP1A2 C9
AC   CVCL_D1GN
DR   Wikidata; Q127380471
RX   PubMed=37681872;
CC   Doubling time: 22.5 hours (PubMed=37681872).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D1GL ! CHO-CPR C12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO-CPR/CYP2B6 C8
AC   CVCL_D1GP
DR   Wikidata; Q127380472
RX   PubMed=37681872;
CC   Doubling time: 20.1 hours (PubMed=37681872).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D1GL ! CHO-CPR C12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO-CPR/CYP3A4 C1
AC   CVCL_D1GQ
DR   Wikidata; Q127380473
RX   PubMed=37681872;
CC   Doubling time: 20.9 hours (PubMed=37681872).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D1GL ! CHO-CPR C12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO-CTLA4
AC   CVCL_E6AS
DR   CLS; 305414
WW   Provider; InSCREENeX; INS-SF-1013; https://www.inscreenex.de/product/cho-ctla4/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-CUR2
AC   CVCL_5A37
SY   CUR2
DR   Wikidata; Q54812669
RX   PubMed=8589689;
RX   PubMed=9762903;
CC   Selected for resistance to: ChEBI; CHEBI_29036; Copper(2+).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO-CUR3
AC   CVCL_D583
SY   CUR3
DR   BTO; BTO_0005225
DR   Wikidata; Q54812670
RX   PubMed=8589689;
RX   PubMed=9762903;
CC   Selected for resistance to: ChEBI; CHEBI_29036; Copper(2+).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   CHO-CXCR4-Low
AC   CVCL_E6AP
DR   CLS; 305411L
WW   Provider; InSCREENeX; INS-SF-1004-L; https://www.inscreenex.de/product/cho-cxcr4/
CC   Characteristics: Expresses CXCR4 at a low range (ca. 400 molecules/cell) (InSCREENeX=INS-SF-1004-L).
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-CXCR4-Medium-High
AC   CVCL_E6AQ
DR   CLS; 305411MH
WW   Provider; InSCREENeX; INS-SF-1004-MH; https://www.inscreenex.de/product/cho-cxcr4/
CC   Characteristics: Expresses CXCR4 at a medium-high range (ca. 9500 molecules/cell) (InSCREENeX=INS-SF-1004-MH).
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-CXCR7-Low
AC   CVCL_E6AL
DR   CLS; 305412L
WW   Provider; InSCREENeX; INS-SF-1007-L; https://www.inscreenex.de/product/cho-cxcr7/
CC   Characteristics: Expresses CXCR7 at a low range (InSCREENeX=INS-SF-1007-L).
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:23692; ACKR3.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-CXCR7-Medium-High
AC   CVCL_E6AM
DR   CLS; 305412MH
WW   Provider; InSCREENeX; INS-SF-1007-MH; https://www.inscreenex.de/product/cho-cxcr7/
CC   Characteristics: Expresses CXCR7 at a medium-high range (InSCREENeX=INS-SF-1007-MH).
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:23692; ACKR3.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-CYP1A2 C2
AC   CVCL_D1GR
DR   Wikidata; Q127380474
RX   PubMed=37681872;
CC   Doubling time: 22.3 hours (PubMed=37681872).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-CYP2B6 C1
AC   CVCL_D1GS
DR   Wikidata; Q127380475
RX   PubMed=37681872;
CC   Doubling time: 18.4 hours (PubMed=37681872).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-CYP3A4 C1
AC   CVCL_D1GT
DR   Wikidata; Q127380476
RX   PubMed=37681872;
CC   Doubling time: 24.4 hours (PubMed=37681872).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-DG44
AC   CVCL_7180
SY   CHO DG44; CHO-DG44 (DHFR-); CHO DG-44; DG-44; DG44
DR   Lonza; 467
DR   Lonza; 468
DR   NCBI_Iran; C576
DR   TOKU-E; 3678
DR   Wikidata; Q54812671
RX   DOI=10.1007/978-1-4020-5476-1_59;
RX   DOI=10.3390/pr1030296;
RX   DOI=10.3390/pr5020020;
RX   PubMed=6305508;
RX   PubMed=16403443;
RX   PubMed=21345355;
RX   PubMed=23873082;
RX   PubMed=28876938;
RX   PubMed=29987698;
RX   PubMed=32619503;
RX   PubMed=32985598;
RX   PubMed=34050613;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-404.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
CC   Doubling time: 24.4 +- 0.68 hours (PubMed=21345355).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (PubMed=6305508).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   CHO-DG44 (cGMP banked)
AC   CVCL_KA66
DR   Wikidata; Q54812672
WW   Provider; Thermo Fisher; A1097101; https://www.thermofisher.com/order/catalog/product/A1097101
WW   Provider; Thermo Fisher; A1100001; https://www.thermofisher.com/order/catalog/product/A1100001
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Pre-adapted to CD DG44 medium and selected for superior cell growth and transfection efficiency.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   CHO-DXB11
AC   CVCL_1977
AS   CVCL_9246
SY   CHO DXB-11; CHO DXB11; DXB11-CHO; DXB 11 CHO; CHO-DUX-B11; CHO (Dux B11); CHO-DUK-XB11; DUK-XB11; CHO-DUKX B11; CHO-DUKXB11; DUKX-B11; DUX B11; DUXB11; DXB-11; DXB11; CHO-DUKX; DUKX-CHO; DUKX; CHO DHFR-; CHO-DHFR -; CHO/dhFr-; CHO/dhfr-; CHO(dhfr-); CHO duk-; CHOd-; CHO B11; B11
DR   CLO; CLO_0002429
DR   CLO; CLO_0002460
DR   CLO; CLO_0002849
DR   CLDB; cl728
DR   CLDB; cl729
DR   CLDB; cl1114
DR   ATCC; CRL-3618
DR   ATCC; CRL-9096
DR   BCRC; 60133
DR   BCRJ; 0068
DR   CCRID; 1101HAM-PUMC000003
DR   CCRID; 1102HAM-NIFDC00096
DR   CCRID; 3101HAMGNHa4
DR   CCRID; 4201HAM-CCTCC00117
DR   CCRID; 6101MOU-CERC000112
DR   CCTCC; GDC0117
DR   DSMZ; ACC-126
DR   DSMZCellDive; ACC-126
DR   ECACC; 94060607
DR   GEO; GSM1968573
DR   GEO; GSM1968574
DR   GEO; GSM1968577
DR   GEO; GSM1968578
DR   GEO; GSM1968579
DR   GEO; GSM1968580
DR   GEO; GSM1968581
DR   GEO; GSM1968582
DR   GEO; GSM1968583
DR   GEO; GSM1968584
DR   GEO; GSM1968585
DR   GEO; GSM1968586
DR   GEO; GSM1968587
DR   GEO; GSM1968588
DR   GEO; GSM1968590
DR   GEO; GSM1968592
DR   KCB; KCB 200712YJ
DR   NCBI_Iran; C590
DR   TOKU-E; 945
DR   Wikidata; Q54812674
RX   DOI=10.3390/pr1030296;
RX   DOI=10.3390/pr5020020;
RX   PubMed=6287224;
RX   PubMed=6933469;
RX   PubMed=16003777;
RX   PubMed=19003404;
RX   PubMed=21945585;
RX   PubMed=25887056;
RX   PubMed=26993211;
RX   PubMed=32619503;
RX   PubMed=33596973;
RX   PubMed=34050613;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9096.
CC   Doubling time: ~20-24 hours (DSMZ=ACC-126).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (PubMed=25887056).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (PubMed=25887056).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-9096; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A23 ! CHO-UKB25
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   CHO-DXB11 35.6
AC   CVCL_6356
SY   35.6
DR   CLO; CLO_0001311
DR   ATCC; CRL-10052
DR   Wikidata; Q54585006
RX   Patent=US5856297;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10052.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2334; CR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   CHO-DXB11 5E27
AC   CVCL_E4IB
SY   5E27
RX   PubMed=2292596;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6019; IL6R (Note=With p.Phe345_Arg468del = sIL-6R).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO-DXB11 6E6
AC   CVCL_4582
SY   6E6
DR   CLO; CLO_0001459
DR   ATCC; CRL-11398
DR   Wikidata; Q54604541
RX   Patent=US5854070;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11398.
CC   Characteristics: Transfected with Ig heavy and light chains of humanized version of mAB produced by hybridoma 23F2g (Cellosaurus=CVCL_4W87).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   CHO-DXB11 B13-24
AC   CVCL_4583
SY   B13-24
DR   CLO; CLO_0001787
DR   ATCC; CRL-11397
DR   Wikidata; Q54752337
RX   Patent=US5854070;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11397.
CC   Characteristics: Transfected with Ig heavy and light chain of humanized version of mAB produced by hybridoma 23F2g (Cellosaurus=CVCL_4W87).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   CHO-DXB11 CTLA4 Ig-24
AC   CVCL_6384
SY   CTLA4 Ig-24; CTLA4Ig-24
DR   CLO; CLO_0002634
DR   ATCC; CRL-10762
DR   CCRID; 3101HAMGNHa9
DR   CLS; 305014
DR   Wikidata; Q54814741
RX   Patent=US5434131;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10762.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2505; CTLA4 (Note=Extracellular domain fused to the hinge, CH2 and CH3 regions of IgC.gamma.1 domain).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   CHO-DXB11 F435
AC   CVCL_5A31
SY   F435
DR   Wikidata; Q54833139
RX   PubMed=19906157;
RX   PubMed=25887056;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3546; F8 (Note=Construct called N8 with 20-769 and 1657-2351).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   CHO-DXB11 FLT-3L
AC   CVCL_E4IA
SY   DXB-11:FLT-3L; DXB11:FLT-3L
RX   PubMed=19003404;
CC   Doubling time: 42.1 +- 11.8 hours (PubMed=19003404).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3766; FLT3LG.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO-DXB11 hGCR SC 12.9
AC   CVCL_C1CN
SY   Subclone 12.9
DR   Wikidata; Q114310948
RX   PubMed=23091360;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4177; GBA1 (Note=With p.Arg534His).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   CHO-EE
AC   CVCL_S542
DR   BEI_Resources; ARP-2238
DR   Wikidata; Q54812675
RX   PubMed=8230430;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   CHO-EM9
AC   CVCL_3683
SY   CHO EM9; EM9; EM-9; EM9-1
DR   BTO; BTO_0002640
DR   CLO; CLO_0002924
DR   CLO; CLO_0050424
DR   ATCC; CRL-1861
DR   BCRC; 60500
DR   RCB; RCB2327
DR   Wikidata; Q54812678
RX   PubMed=2218721;
RX   PubMed=2687628;
RX   PubMed=3919945;
RX   PubMed=6889677;
RX   PubMed=7404270;
RX   PubMed=7404271;
RX   PubMed=8765433;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   CHO-EU-1
AC   CVCL_CX58
SY   EU-1; EU1
DR   Wikidata; Q54812679
RX   PubMed=2687628;
RX   PubMed=7404271;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3683 ! CHO-EM9
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   CHO-EU-2
AC   CVCL_CX59
SY   EU-2; EU2
DR   Wikidata; Q54812680
RX   PubMed=2687628;
RX   PubMed=7404271;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3683 ! CHO-EM9
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   CHO-FFAR2
AC   CVCL_U005
DR   ECACC; 10110202
DR   Wikidata; Q54812681
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:4501; FFAR2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-FFAR3
AC   CVCL_U014
SY   T35J-5/09
DR   ECACC; 10031602
DR   Wikidata; Q54971525
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:4499; FFAR3.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   CHO-FLAG-hBLT1
AC   CVCL_T763
SY   CHO-hBLT1; CHO-LTBR
DR   CLO; CLO_0050412
DR   RCB; RCB1821
DR   Wikidata; Q54812682
RX   PubMed=9177352;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6713; LTB4R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-Flt-3
AC   CVCL_B6NH
DR   Wikidata; Q111733120
RX   PubMed=9890713;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3765; FLT3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   CHO-FOLR1
AC   CVCL_E6AJ
DR   CLS; 305416
WW   Provider; InSCREENeX; INS-SF-1017; https://www.inscreenex.de/product/cho-folr1/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:3791; FOLR1.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-GAT
AC   CVCL_1N80
SY   CHO GAT; CHO(GAT); GAT-; Gat-; GAT
DR   Wikidata; Q54812683
RX   PubMed=1235902;
RX   PubMed=4525316;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 8
//
ID   CHO-GCGR
AC   CVCL_U010
SY   T02J-10/10
DR   ECACC; 10031605
DR   Wikidata; Q54971389
RX   PubMed=21335600;
CC   Characteristics: The target gene was transfected using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:4192; GCGR.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-GFP-clone 6
AC   CVCL_C8Z6
SY   CHO-GFP-cl6
DR   Wikidata; Q123030914
RX   PubMed=15033998;
CC   Characteristics: Transfected with a TAT-GFP construct that contains the sequence "YGRKKRRQRRR" from the basic domain of HIV-1 Tat (PubMed=15033998).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   CHO-GLUT4myc29
AC   CVCL_E6Z1
RX   PubMed=7686158;
CC   Characteristics: Stably expresses Slc2a4/Glut4 containing a 14 amino-acid epitope of human MYC within its first exofacial loop (PubMed=7686158).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2711; Slc2a4 (Note=With a Myc tag in the 1st ectodomain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-GLUT4myc33
AC   CVCL_E6YU
RX   PubMed=7686158;
CC   Characteristics: Stably expresses Slc2a4/Glut4 containing a 14 amino-acid epitope of human MYC within its first exofacial loop (PubMed=7686158).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2711; Slc2a4 (Note=With a Myc tag in the 1st ectodomain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-GLUT4mycIR
AC   CVCL_E6YV
RX   PubMed=7686158;
CC   Characteristics: Stably expresses Slc2a4/Glut4 containing a 14 amino-acid epitope of human MYC within its first exofacial loop (PubMed=7686158).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2711; Slc2a4 (Note=With a Myc tag in the 1st ectodomain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E6YU ! CHO-GLUT4myc33
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-GLUT4mycIRMet
AC   CVCL_E6Z0
RX   PubMed=7686158;
CC   Characteristics: Stably expresses Slc2a4/Glut4 containing a 14 amino-acid epitope of human MYC within its first exofacial loop (PubMed=7686158).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Lys1057Met).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2711; Slc2a4 (Note=With a Myc tag in the 1st ectodomain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E6YU ! CHO-GLUT4myc33
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-glyA
AC   CVCL_U406
SY   CHO-K1 glyA; glyA; Gly-A; Gly A; gly-A; CHO-K1 772-56; CHO-77256; 772-56; 77256
DR   Wikidata; Q54812684
RX   PubMed=341370;
RX   PubMed=2218721;
RX   PubMed=5271752;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-137.html
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-glyB
AC   CVCL_U407
SY   glyB; Gly-B
DR   Wikidata; Q54812686
RX   PubMed=10978331;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 9
//
ID   CHO-gmt4
AC   CVCL_W354
SY   JW152
DR   Wikidata; Q54899194
RX   CelloPub=CLPUB00638;
RX   Patent=US9243235;
RX   PubMed=20346410;
RX   PubMed=24166780;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9657.
CC   Characteristics: Lacks N-acetylglucosaminyltransferase I activity.
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Ter (c.1015C>T); Zygosity=Unspecified (PubMed=20346410).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 11
//
ID   CHO-gmt4D
AC   CVCL_A8SP
DR   Wikidata; Q108820034
RX   CelloPub=CLPUB00638;
RX   PubMed=24166780;
CC   Characteristics: Lacks N-acetylglucosaminyltransferase I activity.
CC   Knockout cell: Method=ZFN; UniProtKB; Q2MH30; Dhfr.
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Ter (c.1015C>T); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_W354 ! CHO-gmt4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 6
//
ID   CHO-gmt4D-EPO-GnT I
AC   CVCL_A8SQ
SY   CHO-gmt4D-GnT I EPO; CHO-gmt4D-GnT I; Clone 13-4-1; 13-4-1
DR   Wikidata; Q108820035
RX   CelloPub=CLPUB00638;
RX   PubMed=24166780;
CC   Characteristics: Transfected with the pEGD vector containing CMV-EPO-IRES-GnTI-IRES-DHFR.
CC   Knockout cell: Method=ZFN; UniProtKB; Q2MH30; Dhfr.
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q2MH30; Cricetulus griseus Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q924C0; Cricetulus griseus Mgat1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A8SP ! CHO-gmt4D
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   CHO-GPR120
AC   CVCL_U007
DR   ECACC; 10110205
DR   Wikidata; Q54812688
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:19061; FFAR4.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-GPR81
AC   CVCL_C3MM
DR   Wikidata; Q116048764
RX   PubMed=16755919;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4532; HCAR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   CHO-GS
AC   CVCL_H215
SY   GS-CHO
DR   Wikidata; Q54812691
RX   DOI=10.1016/j.enzmictec.2004.08.027;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   CHO-HA-hBLT2
AC   CVCL_T764
SY   CHO-hBLT2
DR   CLO; CLO_0050413
DR   RCB; RCB1822
DR   Wikidata; Q54812692
RX   PubMed=10934230;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19260; LTB4R2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   CHO-hAANAT
AC   CVCL_LH55
SY   CHO-hAANAT-8
DR   Wikidata; Q54812694
RX   PubMed=12363042;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19; AANAT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-hD3
AC   CVCL_1B31
SY   CHO.hD3
DR   ChEMBL-Cells; CHEMBL3307496
DR   ChEMBL-Targets; CHEMBL614557
DR   PubChem_Cell_line; CVCL_1B31
DR   Wikidata; Q54812695
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3024; DRD3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   CHO-HER2-High
AC   CVCL_E6AG
DR   CLS; 305413H
WW   Provider; InSCREENeX; INS-SF-1010-H; https://www.inscreenex.de/product/cho-her2/
CC   Characteristics: Expresses ERBB2 at a high range (ca. 85000 molecules/cell) (InSCREENeX=INS-SF-1010-H).
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-HER2-Medium-High
AC   CVCL_E6AH
DR   CLS; 305413MH
WW   Provider; InSCREENeX; INS-SF-1010-MH; https://www.inscreenex.de/product/cho-her2/
CC   Characteristics: Expresses ERBB2 at a medium-high range (ca. 13000 molecules/cell) (InSCREENeX=INS-SF-1010-MH).
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-hGluN1-hGluN2A
AC   CVCL_B3TY
DR   Wikidata; Q110432711
WW   Provider; Evotec; -; https://web.archive.org/web/20240415055633/https://www.evotec.com/f/cc7a9da5a460d976142c3bc6b006f36b.pdf
CC   From: Evotec, Aptuit; Verona; Italy.
CC   Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2A (Evotec).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4584; GRIN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4585; GRIN2A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D586 ! T-REx-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 11
//
ID   CHO-hGluN1-hGluN2B
AC   CVCL_B3TZ
DR   Wikidata; Q110432712
WW   Provider; Evotec; -; https://web.archive.org/web/20240415055633/https://www.evotec.com/f/cc7a9da5a460d976142c3bc6b006f36b.pdf
CC   From: Evotec, Aptuit; Verona; Italy.
CC   Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2b (Evotec).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4584; GRIN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4586; GRIN2B.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D586 ! T-REx-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 11
//
ID   CHO-hGluN1-hGluN2C
AC   CVCL_B3U0
DR   Wikidata; Q110432714
WW   Provider; Evotec; -; https://web.archive.org/web/20240415055633/https://www.evotec.com/f/cc7a9da5a460d976142c3bc6b006f36b.pdf
CC   From: Evotec, Aptuit; Verona; Italy.
CC   Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2C (Evotec).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4584; GRIN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4587; GRIN2C.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D586 ! T-REx-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 11
//
ID   CHO-hGluN1-hGluN2D
AC   CVCL_B3U1
DR   Wikidata; Q110432715
WW   Provider; Evotec; -; https://web.archive.org/web/20240415055633/https://www.evotec.com/f/cc7a9da5a460d976142c3bc6b006f36b.pdf
CC   From: Evotec, Aptuit; Verona; Italy.
CC   Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2D (Evotec).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4587; GRIN2C.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4588; GRIN2D.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D586 ! T-REx-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 11
//
ID   CHO-hL1
AC   CVCL_X975
SY   hL1-CHO
DR   Wikidata; Q54812697
RX   PubMed=11706054;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6470; L1CAM.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 9
//
ID   CHO-hNCX1
AC   CVCL_1F91
DR   AddexBio; S0017001/85
DR   Wikidata; Q54812698
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11068; SLC8A1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   CHO-HPX
AC   CVCL_UW80
DR   Wikidata; Q93451593
RX   DOI=10.5812/gct.13360;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5171; HPX.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-HRH1
AC   CVCL_XD06
DR   CCRID; 4201PAT-CCTCC00961
DR   Wikidata; Q93451598
RX   Patent=CN108570451A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016176.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5182; HRH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   CHO-HRH2
AC   CVCL_U012
SY   CHO-H2; T02J-9/10
DR   ECACC; 10031604
DR   Wikidata; Q54971391
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:5183; HRH2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-HTPO12
AC   CVCL_E3ED
RX   PubMed=2474568;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12015; TPO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO-HTPO12b
AC   CVCL_E3EE
RX   PubMed=2474568;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12015; TPO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3ED ! CHO-HTPO12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO-HTPO12g
AC   CVCL_E3EF
SY   CHO-HTPO-12g
RX   PubMed=2274058;
RX   PubMed=2474568;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12015; TPO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3ED ! CHO-HTPO12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO-hTRPV1
AC   CVCL_1F92
DR   AddexBio; S0017002/86
DR   Wikidata; Q54812699
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12716; TRPV1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   CHO-ICAM-1
AC   CVCL_8849
DR   CLO; CLO_0002461
DR   ATCC; CRL-2093
DR   Wikidata; Q54812702
RX   PubMed=7682381;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5344; ICAM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   CHO-ICAM-1Fc
AC   CVCL_AS85
SY   CHO ICAM-1Fc
DR   CancerTools; 152756
DR   Wikidata; Q54812703
DR   Ximbio; 152756
RX   PubMed=9452454;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5344; ICAM1 (Note=Five extracellular domains joined to the hinge, CH2 and CH3 domains of IgG1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   CHO-IRAla
AC   CVCL_E6YW
RX   PubMed=3101064;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Lys1057Ala).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-IRArg
AC   CVCL_E6YX
RX   PubMed=3101064;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Lys1057Arg).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-IRLys
AC   CVCL_E6YY
RX   PubMed=3101064;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-IRMet
AC   CVCL_E6YZ
RX   PubMed=3101064;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Lys1057Met).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-JP09
AC   CVCL_VL73
SY   CHO-JPO9; CHO/JP09; CHO/JPO9; JP09; JPO9
DR   Wikidata; Q94331701
RX   PubMed=2171505;
RX   PubMed=7836899;
RX   PubMed=7912172;
RX   PubMed=9691974;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   CHO-JP14
AC   CVCL_F0HP
SY   CHO/JP14; JP14
RX   PubMed=2171505;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-JP26
AC   CVCL_F0HQ
SY   CHO/JP26; JP26
RX   PubMed=2171505;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-JP28
AC   CVCL_F0HR
SY   CHO/JP28; JP28
RX   PubMed=2171505;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1
AC   CVCL_0214
SY   CHO K1; CHOK1; CHO cell clone K1; GM15452
DR   BTO; BTO_0000457
DR   CLO; CLO_0002427
DR   CLO; CLO_0002462
DR   CLO; CLO_0002463
DR   CLO; CLO_0026669
DR   CLO; CLO_0050409
DR   CLO; CLO_0050420
DR   CLO; CLO_0050423
DR   EFO; EFO_0022782
DR   MCCL; MCC:0000103
DR   CLDB; cl730
DR   CLDB; cl731
DR   CLDB; cl732
DR   CLDB; cl734
DR   CLDB; cl735
DR   CLDB; cl738
DR   CLDB; cl739
DR   CLDB; cl740
DR   CLDB; cl741
DR   CLDB; cl4897
DR   AddexBio; P0017001/33
DR   ATCC; CCL-61
DR   ATCC; CRL-9618
DR   BCRC; 60006
DR   BCRJ; 0069
DR   CCLV; CCLV-RIE 0134
DR   CCLV; CCLV-RIE 0315
DR   CCRID; 1101HAM-PUMC000004
DR   CCRID; 1102HAM-NIFDC00006
DR   CCRID; 3101HAMGNHa7
DR   CCRID; 3101HAMSCSP507
DR   CCRID; 4201HAM-CCTCC00018
DR   CCRID; 4201PAT-CCTCC00006
DR   CCRID; 5301HAM-KCB88028YJ
DR   CCRID; 6101MOU-CERC000111
DR   CCTCC; GDC0018
DR   ChEMBL-Cells; CHEMBL3307512
DR   ChEMBL-Targets; CHEMBL614031
DR   CLS; 603480
DR   Coriell; GM15452
DR   DSMZ; ACC-110
DR   DSMZCellDive; ACC-110
DR   ECACC; 85051005
DR   GEO; GSE92885
DR   GEO; GSM1968555
DR   GEO; GSM1968556
DR   GEO; GSM1968557
DR   GEO; GSM1968558
DR   GEO; GSM1968559
DR   GEO; GSM1968560
DR   GEO; GSM1968561
DR   GEO; GSM1968562
DR   GEO; GSM1968563
DR   GEO; GSM1968564
DR   GEO; GSM1968565
DR   GEO; GSM1968566
DR   GEO; GSM1968567
DR   GEO; GSM1968568
DR   GEO; GSM1968569
DR   GEO; GSM1968570
DR   GEO; GSM1968571
DR   GEO; GSM1968572
DR   GEO; GSM1968589
DR   GEO; GSM1968591
DR   GEO; GSM1968593
DR   GEO; GSM1968594
DR   GEO; GSM1968595
DR   GEO; GSM1968596
DR   GEO; GSM1968597
DR   GEO; GSM1968598
DR   GEO; GSM1968599
DR   GEO; GSM1968600
DR   IBRC; C10136
DR   ICLC; ATL98003
DR   IZSLER; BS CL 15
DR   JCRB; IFO50414
DR   JCRB; JCRB9018
DR   KCB; KCB 88028YJ
DR   KCLB; 10061
DR   Lonza; 44
DR   MetaboLights; MTBLS493
DR   NCBI_Iran; C645
DR   PubChem_Cell_line; CVCL_0214
DR   RCB; RCB0285
DR   RCB; RCB2330
DR   RCB; RCB2869
DR   TKG; TKG 0328
DR   TOKU-E; 949
DR   TOKU-E; 950
DR   Ubigene; YC-C066
DR   Wikidata; Q54812705
RX   DOI=10.3390/pr1030296;
RX   DOI=10.3390/pr5020020;
RX   PubMed=10320750;
RX   PubMed=21804562;
RX   PubMed=21945585;
RX   PubMed=22971049;
RX   PubMed=23873082;
RX   PubMed=26993211;
RX   PubMed=28544881;
RX   PubMed=32078082;
RX   PubMed=32619503;
RX   PubMed=34050613;
RX   PubMed=34737324;
RX   PubMed=36610518;
WW   Info; -; -; http://genome.ucsc.edu/cgi-bin/hgGateway?db=criGriChoV2&redirect=manual&source=genome.ucsc.edu
WW   Info; -; -; https://web.archive.org/web/20160506232703/https://www.biotechhistory.org/magazine-article/vital-tools-brief-history-cho-cells/
WW   Info; -; -; https://www.chogenome.org/
WW   Info; diArk; -; https://www.diark.org/diark/species_list/Cricetulus_griseus__CHO__K1
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/cho-k1/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-30.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Chinese_hamster_ovary_cell
WW   Provider; BRICS; BRICS0072; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3887
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9618.
CC   Doubling time: ~24 hours (DSMZ=ACC-110).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-9618; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   CHO-K1 (+Galpha16) AequoScreen
AC   CVCL_5I89
SY   CHO-K1 + Ga16 parental aequorin cell line
DR   Revvity/PerkinElmer; ES-000-A24
DR   Wikidata; Q54812709
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1 (+Galpha16) AequoScreen CX3CR1
AC   CVCL_RQ21
DR   Revvity/PerkinElmer; ES-137-A
DR   Wikidata; Q54812711
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2558; CX3CR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5I89 ! CHO-K1 (+Galpha16) AequoScreen
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 (+Galpha16) AequoScreen CXCR2
AC   CVCL_KT03
DR   Revvity/PerkinElmer; ES-145-A
DR   Wikidata; Q54812715
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6027; CXCR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5I89 ! CHO-K1 (+Galpha16) AequoScreen
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1 (+Galpha16) AequoScreen HTR2C (ne)
AC   CVCL_RQ11
SY   Serotonin 5-HT2C (non-edited) receptor AequoScreen
DR   Revvity/PerkinElmer; ES-318-A
DR   Wikidata; Q54812717
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5I89 ! CHO-K1 (+Galpha16) AequoScreen
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1 (+Gqi5) AequoScreen
AC   CVCL_5I90
SY   CHO-K1 + Gqi/5 parental aequorin cell line
DR   Revvity/PerkinElmer; ES-000-A21
DR   Wikidata; Q54812718
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1 (+Gqi5) AequoScreen S1P5
AC   CVCL_RQ10
SY   Sphingosine 1-phosphate receptor 5 AequoScreen; Lysophospholipid S1P5 (EDG8) AequoScreen
DR   Revvity/PerkinElmer; ES-593-A
DR   Wikidata; Q54812719
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14299; S1PR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5I90 ! CHO-K1 (+Gqi5) AequoScreen
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1 (GS Null) HD-BIOP3
AC   CVCL_LF20
SY   HD-BIOP3 GS null CHOK1; HD-BIOP3; CHO K1 (GS Null)
DR   Horizon_Discovery; HD+BIOP3
DR   Wikidata; Q54812720
WW   Info; Ensembl; -; https://www.ensembl.org/Cricetulus_griseus_chok1gshd/Info/Index
WW   Info; Horizon_Discovery; -; https://horizondiscovery.com/en/news/2017/Horizon-Discovery-announces-release-of-high-quality-well-annotated-CHO-genome-sequence
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; UniProtKB; P04773; Glul.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   CHO-K1 (SC)
AC   CVCL_U864
DR   CLO; CLO_0050422
DR   RCB; RCB0403
DR   Wikidata; Q54812722
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 7
//
ID   CHO-K1 43-17
AC   CVCL_F0DS
SY   43-17
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 43-19
AC   CVCL_F0DT
SY   43-19
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 43-37
AC   CVCL_F0DU
SY   43-37
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 43-64
AC   CVCL_F0DV
SY   43-64; 4364
RX   PubMed=4508395;
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 43-86
AC   CVCL_F0DW
SY   43-86
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 4B21
AC   CVCL_F0E5
SY   4B21
RX   PubMed=4508395;
CC   Characteristics: Auxotrophic for glycine (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0DV ! CHO-K1 43-64
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 51-11
AC   CVCL_F0DX
SY   51-11; 5111
RX   PubMed=4508395;
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 51-50
AC   CVCL_F0DY
SY   51-50
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 56-18
AC   CVCL_F0DZ
SY   56-18
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 56-65
AC   CVCL_F0E0
SY   56-65
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 765-10
AC   CVCL_F0E2
SY   765-10
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 765-36
AC   CVCL_F0E3
SY   765-36
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 765-4
AC   CVCL_F0E1
SY   765-4
RX   PubMed=5271752;
CC   Characteristics: Auxotrophic for glycine (PubMed=5271752).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 A563
AC   CVCL_F0E4
SY   A563
RX   PubMed=4508395;
CC   Characteristics: Auxotrophic for glycine (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0DX ! CHO-K1 51-11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 ADRA1A Gq
AC   CVCL_KU49
DR   DiscoverX; 95-1023C2
DR   Wikidata; Q54812724
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:277; ADRA1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 AequoScreen
AC   CVCL_5I91
SY   CHO-K1 parental aequorin cell line
DR   Revvity/PerkinElmer; ES-000-A12
DR   Wikidata; Q54812706
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 AequoScreen ADORA1
AC   CVCL_RU27
SY   Adenosine A1 AequoScreen
DR   Revvity/PerkinElmer; ES-010-A
DR   Wikidata; Q54812707
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:262; ADORA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5I91 ! CHO-K1 AequoScreen
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 AequoScreen FFAR1
AC   CVCL_RQ12
SY   Free fatty acid receptor 1 AequoScreen
DR   Revvity/PerkinElmer; ES-652-A
DR   Wikidata; Q54812708
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4498; FFAR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5I91 ! CHO-K1 AequoScreen
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 BDKRB1 Gq
AC   CVCL_KU50
DR   DiscoverX; 95-1011C2
DR   Wikidata; Q54812725
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1029; BDKRB1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 BDKRB2 clone #14
AC   CVCL_E3KZ
SY   clone #14
RX   PubMed=1329734;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 BRS3 Gq
AC   CVCL_KU51
DR   DiscoverX; 95-1001C2
DR   Wikidata; Q54812736
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1113; BRS3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 cat FFAR4
AC   CVCL_VG09
DR   Wikidata; Q54812738
RX   CelloPub=CLPUB00428;
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:62236; Cat FFAR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 cyno ICOS
AC   CVCL_XZ32
SY   CHOK1-cyno-ICOS
DR   KYinno; KC-1274
DR   Wikidata; Q93451704
CC   Doubling time: ~24 hours (KYinno=KC-1274).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TQU4; Macaca fascicularis ICOS.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 cyno MSLN
AC   CVCL_XZ33
SY   CHOK1-cyno-MSLN
DR   KYinno; KC-1174
DR   Wikidata; Q93451706
CC   Doubling time: ~24 hours (KYinno=KC-1174).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TW94; Macaca fascicularis MSLN.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 cyno TNFRSF1B
AC   CVCL_XZ34
SY   CHOK1-cyno-TNFRSF1B
DR   KYinno; KC-1189
DR   Wikidata; Q93451708
CC   Doubling time: ~24 hours (KYinno=KC-1189).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VET2; Macaca fascicularis TNFRSF1B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 cyno TPBG
AC   CVCL_XZ35
SY   CHOK1-cyno-TPBG
DR   KYinno; KC-1231
DR   Wikidata; Q93451710
CC   Doubling time: ~24 hours (KYinno=KC-1231).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UEN3; Macaca fascicularis TPBG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 CYSLTR2 Gq
AC   CVCL_KU52
DR   DiscoverX; 95-1013C2
DR   Wikidata; Q54812739
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18274; CYSLTR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 Dd-B6
AC   CVCL_YD16
SY   Dd-B6
DR   Wikidata; Q93451717
RX   PubMed=8782489;
CC   Characteristics: Lacks Na+-dependent glutamate transport activity.
CC   Characteristics: Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-aspartate and stored so as to allow time for cells that had taken up the D-aspartate to be killed by radiation damage.
CC   Selected for resistance to: NCIt; C165595; Tritium beta radiation.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   CHO-K1 Dd-B7
AC   CVCL_YD17
SY   Dd-B7
DR   Wikidata; Q93451720
RX   PubMed=8782489;
RX   PubMed=9498811;
RX   PubMed=9822723;
CC   Characteristics: Lacks Na+-dependent glutamate transport activity.
CC   Characteristics: Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-aspartate and stored so as to allow time for cells that had taken up the D-aspartate to be killed by radiation damage.
CC   Selected for resistance to: NCIt; C165595; Tritium beta radiation.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   CHO-K1 Dd-B7/GLT-1
AC   CVCL_YD20
SY   GLT-1/Dd-B7
DR   Wikidata; Q93451722
RX   PubMed=9498811;
RX   PubMed=9822723;
CC   Selected for resistance to: NCIt; C165595; Tritium beta radiation.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3697; Slc1a2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_YD17 ! CHO-K1 Dd-B7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 DeltaGMD
AC   CVCL_B7A4
DR   Wikidata; Q111733122
RX   PubMed=35185292;
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q8K3X3; Gmds.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   CHO-K1 DeltaGMDDeltaGFT
AC   CVCL_B7A5
DR   Wikidata; Q111733123
RX   PubMed=35185292;
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3HCE4; Fut8.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q8K3X3; Gmds.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B7A4 ! CHO-K1 DeltaGMD
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   CHO-K1 dog CD47-Flag
AC   CVCL_XZ36
SY   CHOK1-Dog-CD47-Flag; CHOK1-Dog-CD47
DR   KYinno; KC-1310
DR   Wikidata; Q93451724
CC   Doubling time: ~24 hours (KYinno=KC-1310).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:38960; Dog CD47 (Note=With a FLAG tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1 DR31
AC   CVCL_F0E6
SY   DR31 (CHO-K1); DR31; Dr-31
RX   PubMed=217113;
RX   PubMed=4508395;
CC   Characteristics: Auxotrophic for glycine (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0E5 ! CHO-K1 4B21
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 DrToyR-18
AC   CVCL_F0EB
SY   DrToyR-18
RX   PubMed=21586167;
CC   Characteristics: Auxotrophic for glycine (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: ChEBI; CHEBI_134606; Toyocamycin (Vengicide).
CC   Sequence variation: Mutation; UniProtKB; P55262; Adk; Simple; p.Glu242Lys (c.724G>A); Zygosity=Unspecified (PubMed=21586167).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0E6 ! CHO-K1 DR31
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1 Ed-A1
AC   CVCL_YD18
SY   Ed-A1
DR   Wikidata; Q93451727
RX   PubMed=8101392;
RX   PubMed=8782489;
RX   PubMed=9075644;
CC   Characteristics: Has reduced Na+-dependent glutamate transport activity. Have an increased permeability to small neutral molecules.
CC   Characteristics: Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-aspartate and stored so as to allow time for cells that had taken up the D-aspartate to be killed by radiation damage.
CC   Selected for resistance to: NCIt; C165595; Tritium beta radiation.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   CHO-K1 Ed-B8
AC   CVCL_YD19
SY   Ed-B8
DR   Wikidata; Q93451729
RX   PubMed=8101392;
RX   PubMed=8782489;
CC   Characteristics: Has reduced Na+-dependent glutamate transport activity. Have an increased permeability to small neutral molecules.
CC   Characteristics: Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-aspartate and stored so as to allow time for cells that had taken up the D-aspartate to be killed by radiation damage.
CC   Selected for resistance to: NCIt; C165595; Tritium beta radiation.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   CHO-K1 EDG3 Gq
AC   CVCL_KU53
DR   DiscoverX; 95-1007C2
DR   Wikidata; Q54812740
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3167; S1PR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 EDG4 Gq
AC   CVCL_KU54
DR   DiscoverX; 95-1012C2
DR   Wikidata; Q54812741
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3168; LPAR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 F2RL1 Gq
AC   CVCL_KU55
DR   DiscoverX; 95-1006C2
DR   Wikidata; Q54812742
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3538; F2RL1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 FFAR1 Gq
AC   CVCL_KU56
DR   DiscoverX; 95-1005C2
DR   Wikidata; Q54812744
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4498; FFAR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 FFAR2 Gq
AC   CVCL_KU57
DR   DiscoverX; 95-1002C2
DR   Wikidata; Q54812745
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4501; FFAR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 GABA(A)R alpha1beta2gamma2L
AC   CVCL_C0YP
SY   alpha1beta2gamma2L GABAAR-CHO
DR   Wikidata; Q114310949
RX   DOI=10.13523/j.cb.2108063;
CC   Characteristics: The expression of GABRA1 is induced by tetracycline while the expression of GABRB2 and GABRG2 is constitutive.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4075; GABRA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4082; GABRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2 (Note=Isoform 3).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 GALR2 Gq
AC   CVCL_KU58
DR   DiscoverX; 95-1010C2
DR   Wikidata; Q54812747
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4133; GALR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 GFP-Pygm
AC   CVCL_C1YQ
DR   Wikidata; Q114310951
RX   PubMed=22818872;
CC   Characteristics: Transfected with a CMV-EGFP-Pygm construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97830; Pygm.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   CHO-K1 GFP-Pygm-G205S
AC   CVCL_C1YR
SY   CHO-K1 GFP-G205S
DR   Wikidata; Q114310952
RX   PubMed=22818872;
CC   Characteristics: Transfected with a CMV-EGFP-Pygm construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97830; Pygm (Note=With p.Gly205Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   CHO-K1 GFP-Pygm-R50X
AC   CVCL_C1YS
SY   CHO-K1 GFP-R50X
DR   Wikidata; Q114310953
RX   PubMed=22818872;
CC   Characteristics: Transfected with a CMV-EGFP-Pygm construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97830; Pygm (Note=With p.Arg50Ter).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   CHO-K1 GNRHR Gq
AC   CVCL_KU59
DR   DiscoverX; 95-1004C2
DR   Wikidata; Q54812748
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4421; GNRHR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 GPR17 Gq
AC   CVCL_KU60
DR   DiscoverX; 95-1022C2
DR   Wikidata; Q54812749
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4471; GPR17.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 h-GABA-b R1a/R2
AC   CVCL_LC01
DR   Wikidata; Q54812751
RX   Patent=US20060216749;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 6046CB.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4070; GABBR1 (Note=Isoform 1A).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4507; GABBR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   CHO-K1 HAY1-H
AC   CVCL_C1KW
SY   HAY1-H
DR   Wikidata; Q114310954
RX   PubMed=12788810;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r (Note=With a HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   CHO-K1 HAY1-L
AC   CVCL_C1KX
SY   HAY1-L
DR   Wikidata; Q114310955
RX   PubMed=12788810;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r (Note=With a HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   CHO-K1 HAY1C-H
AC   CVCL_C1KY
SY   HAY1C-H
DR   Wikidata; Q114310956
RX   PubMed=12788810;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r (Note=With p.Cys337Ala and a HA tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   CHO-K1 HAY1C-L
AC   CVCL_C1KZ
SY   HAY1C-L
DR   Wikidata; Q114310957
RX   PubMed=12788810;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r (Note=With p.Cys337Ala and a HA tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   CHO-K1 hMCHR1
AC   CVCL_B0GU
SY   MCHR1-CHO
DR   Wikidata; Q108820036
RX   PubMed=16524757;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4479; MCHR1.
CC   Discontinued: Euroscreen; Catalog number ES-370-C.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   CHO-K1 human CD154(CD40L)
AC   CVCL_XZ37
SY   CHOK1-CD40L (CD154)
DR   KYinno; KC-1316
DR   Wikidata; Q93451777
CC   Doubling time: ~24 hours (KYinno=KC-1316).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 human CD16a-F158
AC   CVCL_XZ38
SY   CHO-K1 CD16a-F158; CHOK1-CD16a-F158
DR   KYinno; KC-1264
DR   Wikidata; Q93451779
CC   Doubling time: ~24 hours (KYinno=KC-1264).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 human CD16a-V158
AC   CVCL_XZ39
SY   CHOK1 CD16a-V158; CHOK1-CD16a-V158(FCGR3A)
DR   KYinno; KC-1153
DR   Wikidata; Q93451781
CC   Doubling time: ~24 hours (KYinno=KC-1153).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 human CD47
AC   CVCL_UE26
SY   CHOK1 human CD47; CHOK1-CD47
DR   KYinno; KC-1149
DR   Wikidata; Q93451784
CC   Doubling time: ~24 hours (KYinno=KC-1149).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1 human CD70
AC   CVCL_XZ40
SY   CHOK1-CD70
DR   KYinno; KC-1267
DR   Wikidata; Q93451786
CC   Doubling time: ~24 hours (KYinno=KC-1267).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11937; CD70.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 human CLDN18.1
AC   CVCL_XZ41
SY   CHOK1 human CLDN18.1; CHOK1-CLDN18.1
DR   KYinno; KC-1181
DR   Wikidata; Q93451789
CC   Doubling time: ~24 hours (KYinno=KC-1181).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 human CLDN18.2
AC   CVCL_XZ42
SY   CHOK1 human CLDN18.2; CHOK1-CLDN18.2
DR   KYinno; KC-1180
DR   Wikidata; Q93451792
CC   Doubling time: ~24 hours (KYinno=KC-1180).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 human INSR
AC   CVCL_UE27
SY   CHOK1 human INSR; CHOK1-INSR
DR   KYinno; KC-1031
DR   Wikidata; Q93451794
CC   Doubling time: ~24 hours (KYinno=KC-1031).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1 human MSLN
AC   CVCL_UE28
SY   CHOK1 human MSLN
DR   KYinno; KC-1152
DR   Wikidata; Q93451796
CC   Doubling time: ~24 hours (KYinno=KC-1152).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7371; MSLN.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: KYinno; KC-1152; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1 human NTRK1
AC   CVCL_XZ43
SY   CHO-K1 human TRKA; CHOK1-TRKA
DR   KYinno; KC-0903
DR   Wikidata; Q93451798
CC   Doubling time: ~24 hours (KYinno=KC-0903).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8031; NTRK1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 human TNFRSF1B
AC   CVCL_XZ44
SY   CHOK1-TNFRSF1B
DR   KYinno; KC-1186
DR   Wikidata; Q93451801
CC   Doubling time: ~24 hours (KYinno=KC-1186).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 Mev-1
AC   CVCL_A5KD
SY   Mev-1
DR   Wikidata; Q107114656
RX   PubMed=4019518;
RX   PubMed=6118375;
RX   PubMed=7961793;
CC   Characteristics: Deficient for mevalonate biosynthesis. Lacks hydroxymethylglutaryl-CoA synthase activity (PubMed=4019518).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CHO-K1 Mev-SM
AC   CVCL_A5KE
SY   Mev-SM
DR   Wikidata; Q107114657
RX   PubMed=7961793;
CC   Characteristics: Repairs the deficiency in mevalonate biosynthesis of the parent cell line (PubMed=7961793).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2804; Hmgcs2.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5KD ! CHO-K1 Mev-1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CHO-K1 MMC-1
AC   CVCL_VU05
SY   MMC-1
DR   Wikidata; Q93451803
RX   PubMed=2413991;
RX   PubMed=3093856;
CC   Characteristics: Sensitive to mitomycin C.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   CHO-K1 MMC-2
AC   CVCL_VU06
SY   MMC-2; CHO-MMC-2
DR   Wikidata; Q93451806
RX   PubMed=2110815;
RX   PubMed=2413991;
RX   PubMed=3093856;
RX   PubMed=16143348;
CC   Characteristics: Sensitive to mitomycin C.
CC   Sequence variation: Mutation; UniProtKB; A0MQ57; Ercc3; Simple; p.Gln739Ter (c.2215C>T); Zygosity=Unspecified (PubMed=16143348).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 7
//
ID   CHO-K1 MMC-3
AC   CVCL_VU07
SY   MMC-3
DR   Wikidata; Q93451808
RX   PubMed=2110815;
RX   PubMed=2413991;
RX   PubMed=3093856;
CC   Characteristics: Sensitive to mitomycin C.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   CHO-K1 MMC-4
AC   CVCL_VU08
SY   MMC-4
DR   Wikidata; Q93451810
RX   PubMed=2413991;
RX   PubMed=3093856;
CC   Characteristics: Sensitive to mitomycin C.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   CHO-K1 MMC-5
AC   CVCL_VU09
SY   MMC-5
DR   Wikidata; Q93451812
RX   PubMed=2413991;
RX   PubMed=3093856;
CC   Characteristics: Sensitive to mitomycin C.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   CHO-K1 mouse ICOS
AC   CVCL_XZ45
SY   CHOK1-mouse-ICOS
DR   KYinno; KC-1273
DR   Wikidata; Q93451815
CC   Doubling time: ~24 hours (KYinno=KC-1273).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1858745; Icos.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 MRP1/ABCC1 Arg1058Gln
AC   CVCL_E5ZH
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Arg1058Gln (c.3173G>A)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 MRP1/ABCC1 Arg723Gln
AC   CVCL_E5ZI
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Arg723Gln (c.2168G>A)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 MRP1/ABCC1 Cys43Ser
AC   CVCL_E5ZJ
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Cys43Ser (c.128G>C)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 MRP1/ABCC1 Thr73Ile
AC   CVCL_E5ZK
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Thr73lle (c.218C>T)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 MRP1/ABCC1 WT
AC   CVCL_E5ZG
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 MUC1-IgG
AC   CVCL_E3IX
SY   CHO MUC1
RX   PubMed=12950230;
RX   PubMed=16319059;
CC   Characteristics: The transfected MUC1 construct contains the first 16 tandem repeats of the extracellular domain of MUC1 followed by an enterokinase cleavage site (DDDDK) fusef to exon 1-3 of mouse IgG2a Fc (PubMed=16319059).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1 (Note=With p.Ala381_Leu1255del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 MUC1-IgG ST6GALNAC1
AC   CVCL_E3IY
SY   CHO MUC1 ST6GalNAc-I
RX   PubMed=16319059;
CC   Characteristics: The transfected MUC1 construct contains the first 16 tandem repeats of the extracellular domain of MUC1 followed by an enterokinase cleavage site (DDDDK) fusef to exon 1-3 of mouse IgG2a Fc (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1 (Note=With p.Ala381_Leu1255del).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23614; ST6GALNAC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3IX ! CHO-K1 MUC1-IgG
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1 mutant 29
AC   CVCL_A5KM
SY   Mutant 29
DR   Wikidata; Q107114658
RX   PubMed=2684962;
CC   Characteristics: Defective in the incorporation of ethanolamine into phosphatidylethanolamine (PubMed=2684962).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-K1 OS8
AC   CVCL_XZ46
SY   CHOK1-OS8; CHOK1 OS8
DR   KYinno; KC-1146
DR   Wikidata; Q93451818
CC   Characteristics: Transfected with the ScFV sequence of anti-human CD3 mAb OKT3 and a C-terminal domain of mouse CD8a which consists of the transmembrane and cytoplasmic domains.
CC   Doubling time: ~24 hours (KYinno=KC-1146).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88346; Cd8a (Note=With p.Met1_Tyr196del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1 OS8-SIGLEC15
AC   CVCL_XZ47
SY   CHO-K1 OS8-Siglec15; CHOK1-OS8-SIGLEC15
DR   KYinno; KC-1283
DR   Wikidata; Q93451820
CC   Characteristics: Transfected with the ScFV sequence of anti-human CD3 mAb OKT3 and a C-terminal domain of mouse CD8a which consists of the transmembrane and cytoplasmic domains.
CC   Doubling time: ~24 hours (KYinno=KC-1283).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:27596; SIGLEC15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88346; Cd8a (Note=With p.Met1_Tyr196del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1 PSA-1
AC   CVCL_A5KN
SY   PSA-1
DR   Wikidata; Q107114659
RX   PubMed=3084470;
CC   Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-K1 PSA-2
AC   CVCL_A5KP
SY   PSA-2
DR   Wikidata; Q107114660
RX   PubMed=3084470;
CC   Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-K1 PSA-3
AC   CVCL_A5KQ
SY   PSA-3
DR   Wikidata; Q107114661
RX   PubMed=1748687;
RX   PubMed=3084470;
CC   Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470). Defective for phosphatidylserine synthase 1 (Ptdss1) (PubMed=1748687).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-K1 PTGER1 Gq
AC   CVCL_KU61
DR   DiscoverX; 95-1003C2
DR   Wikidata; Q54812753
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9593; PTGER1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 PTGFR Gq
AC   CVCL_KU62
DR   DiscoverX; 95-1009C2
DR   Wikidata; Q54812754
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9600; PTGFR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 rabbit CD47
AC   CVCL_XZ48
SY   CHOK1-Rabbit-CD47
DR   KYinno; KC-1230
DR   Wikidata; Q93451830
CC   Doubling time: ~24 hours (KYinno=KC-1230).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G1TS80; Rabbit CD47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 rat CD47
AC   CVCL_XZ49
SY   CHOK1-Rat-CD47
DR   KYinno; KC-1223
DR   Wikidata; Q93451832
CC   Doubling time: ~24 hours (KYinno=KC-1223).
CC   Genetic integration: Method=Transduction; Gene=RGD; 2308; Cd47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1 Tet-On
AC   CVCL_KU42
SY   CHO K1 Tet-On
DR   Wikidata; Q54812755
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630917.
CC   Discontinued: Takara/Clontech; Catalog number 631142.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1 tsTM13
AC   CVCL_LH73
SY   tsTM13
DR   Wikidata; Q54973161
RX   PubMed=1309502;
RX   PubMed=2237640;
RX   PubMed=8944784;
CC   Characteristics: Temperature sensitive. Exhibits a delayed cell cycle progression from metaphase to telophase at a non-permissive temperature of 39 Celsius and is finally arrested from anaphase to telophase.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 tsTM18
AC   CVCL_J507
SY   tsTM18
DR   Wikidata; Q54973163
RX   PubMed=2237640;
RX   PubMed=15878348;
CC   Characteristics: Temperature sensitive. Exhibits chromosomal instability and cell-cycle arrest at S and G2 phases with decreased DNA synthesis at the non-permissive temperature of 39 Celsius (PubMed=15878348).
CC   Doubling time: 31 hours (PubMed=2237640).
CC   Sequence variation: Mutation; UniProtKB; Q76B40; Smu1; Simple; p.Gly489Arg (c.1465G>A); Zygosity=Homozygous (PubMed=15878348).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   CHO-K1 tsTM3
AC   CVCL_LH72
SY   tsTM3
DR   Wikidata; Q54973165
RX   PubMed=2237640;
RX   PubMed=24805847;
RX   PubMed=26059705;
CC   Characteristics: Temperature sensitive. Exhibits chromosomal instability and cell-cycle arrest at S and G2 phases with decreased DNA synthesis at the non-permissive temperature of 39 Celsius.
CC   Sequence variation: Mutation; UniProtKB; G3IBG3; Uba1; Simple; p.Met256Ile (c.768G>A); Zygosity=Unspecified (PubMed=24805847).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1 tsTM4
AC   CVCL_J617
SY   tsTM4
DR   Wikidata; Q54973166
RX   PubMed=2237640;
RX   PubMed=9272869;
CC   Characteristics: Temperature sensitive. Exhibits abnormal induction of sister chromatid exchanges along with a decrease of DNA synthesis in the cells arrested in S phase at the non-permissive temperature of 39 Celsius (PubMed=9272869).
CC   Doubling time: 34 hours (PubMed=2237640).
CC   Sequence variation: Mutation; UniProtKB; P11414; Polr2a; Simple; p.Pro1006Ser (c.3016C>T); Zygosity=Homozygous (PubMed=9272869).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   CHO-K1 UA10
AC   CVCL_ZE99
SY   UA10
DR   Wikidata; Q98125620
RX   PubMed=32346859;
CC   Characteristics: Doubly auxotrophic; deficient in 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) and uridine monophosphate synthetase (UMPS), respectively disrupting the purine and pyrimidine de novo synthesis pathways.
CC   Characteristics: Useful for the production of recombinant monoclonal antibodies as it rovides a rapid and efficient selection method for the serial or simultaneous transfer of genes for multiple polypeptides of choice into the cells using readily available purine- and pyrimidine-free commercial media.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3I1V4; Atic.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GSP0; Umps.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 5
//
ID   CHO-K1 Y1
AC   CVCL_C1KU
SY   Y1
DR   Wikidata; Q114310958
RX   PubMed=12788810;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   CHO-K1 Y1C
AC   CVCL_C1KV
SY   Y1C
DR   Wikidata; Q114310959
RX   PubMed=12788810;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r (Note=With p.Cys337Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   CHO-K1-AC-free
AC   CVCL_AR65
DR   ECACC; 13080801
DR   Wikidata; Q54812757
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 8
//
ID   CHO-K1-BH4
AC   CVCL_Y502
SY   CHO K1-BH4; K1-BH4; K1BH4
DR   ChEMBL-Cells; CHEMBL3307354
DR   ChEMBL-Targets; CHEMBL614256
DR   PubChem_Cell_line; CVCL_Y502
DR   Wikidata; Q54812758
RX   PubMed=194347;
RX   PubMed=1235913;
RX   PubMed=2432598;
RX   PubMed=3005850;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 30-01-24; Version: 10
//
ID   CHO-K1-C5
AC   CVCL_E9XE
RX   PubMed=12573016;
CC   Characteristics: Established from serial dilution of the parent cell line which has been obtained after four rounds of infection of CHO-K1 with GFP-tagged recombinant human adenovirus (rhAd-GFP) (PubMed=12573016).
CC   Virology: Particularly permissive torRecombinant human adenovirus (rhAd) infection (PubMed=12573016).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E9XD ! CHO-K1-S4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1-CNG-Gs
AC   CVCL_C0RV
SY   CHO-K1-CNG
DR   Wikidata; Q112929380
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR. Serves as a parent cell line for various ACTOne PDE cell lines.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: Has Dexorgen catalog number CB-81300-100, but not distributed separately from children cell lines.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   CHO-K1-cPD-1
AC   CVCL_F0GT
RX   Patent=US10973915;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; B0LAJ3; Macaca fascicularis PDCD1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1-ESM
AC   CVCL_XI04
SY   CHO-K1-MSB
DR   Wikidata; Q93451849
RX   Patent=WO1999045028A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1970.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3466; ESM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1-Gln(-)
AC   CVCL_1F96
DR   Wikidata; Q54812759
RX   Patent=US20100221781;
CC   Group: Patented cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 8
//
ID   CHO-K1-hPD-1
AC   CVCL_F0GU
SY   CHOK1-hPD-1
RX   Patent=US10973915;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8760; PDCD1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1-Luc
AC   CVCL_C8WX
DR   Ubigene; YC-C066-Luc-P
DR   Wikidata; Q123030915
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   CHO-K1-S4
AC   CVCL_E9XD
RX   PubMed=12573016;
CC   Characteristics: Established after four rounds of infection of CHO-K1 with GFP-tagged recombinant human adenovirus (rhAd-GFP) (PubMed=12573016).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-K1-SFM
AC   CVCL_9U94
DR   TKG; TKG 0587
DR   Wikidata; Q54812760
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 8
//
ID   CHO-K1-UCSC
AC   CVCL_A9NT
SY   CHO.K1.UCSC
DR   BEI_Resources; ARP-13589
DR   Wikidata; Q108820037
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   CHO-K1-XIAP
AC   CVCL_UW12
SY   CHO-K1-XIAP-5; CHO-K1-XIAP clone 5
DR   Wikidata; Q93451858
RX   CelloPub=CLPUB00467;
RX   PubMed=20547346;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:592; XIAP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-K1-XIAP-GFP
AC   CVCL_UW13
DR   Wikidata; Q93451861
RX   CelloPub=CLPUB00467;
CC   Genetic integration: Method=Transfection; Gene=FPbase; B28N7; Cycle3 (Note=AlphaGFP, long stokes shift fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:592; XIAP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UW12 ! CHO-K1-XIAP
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CHO-K1.Cl-0204
AC   CVCL_DE93
DR   ECACC; 15042903
DR   Wikidata; Q54813058
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3616; FCGR2A (Note=With p.His167Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   CHO-K1.Cl-0205
AC   CVCL_DE94
DR   ECACC; 15042905
DR   Wikidata; Q54813059
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3616; FCGR2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   CHO-K1.Cl-0206
AC   CVCL_DE95
DR   ECACC; 15042907
DR   Wikidata; Q54813060
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3618; FCGR2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   CHO-K1.Cl-0235
AC   CVCL_DE96
DR   ECACC; 15042908
DR   Wikidata; Q54813061
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; H2RAL6; Pan troglodytes FCGR3A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHO-K1.Cl-0236
AC   CVCL_DE97
DR   ECACC; 15042909
DR   Wikidata; Q54813062
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=Cercocebus torquatus FCGR3A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHO-K1.Cl-0237
AC   CVCL_DE98
DR   ECACC; 15042910
DR   Wikidata; Q54813063
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A140HDP8; Macaca fascicularis FCGR3A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHO-K1.Cl-0238
AC   CVCL_DE99
DR   ECACC; 15042911
DR   Wikidata; Q54813064
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A3RFZ7; Macaca mulatta FCGR3A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHO-K1.Cl-0239
AC   CVCL_DF00
DR   Wikidata; Q54813065
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A096MT85; Papio anubis FCGR3A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHO-K1.Cl-0270
AC   CVCL_DF01
DR   ECACC; 15042912
DR   Wikidata; Q54813066
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G7MEA7; Macaca mulatta FCGR2B.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHO-K1.Cl6
AC   CVCL_DF02
DR   ECACC; 15042901
DR   Wikidata; Q54813067
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   CHO-K1.Cl7
AC   CVCL_DF03
DR   ECACC; 15042902
DR   Wikidata; Q54813068
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   CHO-K1/4-1BB
AC   CVCL_KA46
DR   GenScript; M00538
DR   Wikidata; Q54812761
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/5-HT1A/Galpha15
AC   CVCL_H378
DR   GenScript; M00330
DR   Wikidata; Q54812763
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5286; HTR1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/5-HT2A
AC   CVCL_H379
DR   GenScript; M00251
DR   Wikidata; Q54812765
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5293; HTR2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/5-HT2B
AC   CVCL_H380
DR   GenScript; M00249
DR   Wikidata; Q54812766
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5294; HTR2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/5-HT2C
AC   CVCL_H381
DR   GenScript; M00253
DR   Wikidata; Q54812767
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/5-HT4/Galpha15
AC   CVCL_H382
DR   GenScript; M00444
DR   Wikidata; Q54812768
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5299; HTR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: GenScript; M00444; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   CHO-K1/ACE2
AC   CVCL_E5IY
DR   GenScript; M00771
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-K1/ADORA1/Galpha15
AC   CVCL_H383
DR   GenScript; M00324
DR   Wikidata; Q54812769
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:262; ADORA1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/ADORA2A/Galpha15
AC   CVCL_H384
DR   GenScript; M00246
DR   Wikidata; Q54812771
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:263; ADORA2A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/ADORA2B/Galpha15
AC   CVCL_H385
DR   GenScript; M00329
DR   Wikidata; Q54812772
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:264; ADORA2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/ADORA3/Galpha15
AC   CVCL_H386
DR   GenScript; M00464
DR   Wikidata; Q54812773
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:268; ADORA3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Misspelling: CHO-K1/ADORA3/Gqi5; Note=In some obsolete GenScript technical documents and in Cellosaurus releases 5 to 22.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/ADRA1A
AC   CVCL_H387
DR   GenScript; M00225
DR   Wikidata; Q54812774
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:277; ADRA1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/ADRA1B
AC   CVCL_H388
DR   GenScript; M00260
DR   Wikidata; Q54812775
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:278; ADRA1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/ADRA1D
AC   CVCL_H389
DR   GenScript; M00340
DR   Wikidata; Q54812777
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:280; ADRA1D.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/ADRA2A/Galpha15
AC   CVCL_H390
DR   GenScript; M00281
DR   Wikidata; Q54812778
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:281; ADRA2A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/ADRA2B/Gqi5
AC   CVCL_H391
DR   GenScript; M00454
DR   Wikidata; Q54812779
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:282; ADRA2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H447 ! CHO-K1/Gqi5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/ADRA2C/Galpha15
AC   CVCL_H392
DR   GenScript; M00252
DR   Wikidata; Q54812780
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:283; ADRA2C.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/ADRB1/Galpha15
AC   CVCL_H393
DR   GenScript; M00269
DR   Wikidata; Q54812781
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:285; ADRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/ADRB2/Galpha15
AC   CVCL_H394
DR   GenScript; M00308
DR   Wikidata; Q54812782
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00308; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/AGTRL1/Galpha15
AC   CVCL_H395
DR   GenScript; M00245
DR   Wikidata; Q54812783
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/AM1
AC   CVCL_H396
DR   GenScript; M00450
DR   Wikidata; Q54812784
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9844; RAMP2.
CC   Discontinued: GenScript; M00450; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/AM2/Galpha15
AC   CVCL_H397
DR   GenScript; M00479
DR   Wikidata; Q54812785
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9845; RAMP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00479; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/AMY1/CRE-Luc
AC   CVCL_H398
DR   GenScript; M00350
DR   Wikidata; Q54812801
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00350; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H414 ! CHO-K1/CRE-Luc
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/AMY1/Galpha15
AC   CVCL_H399
DR   GenScript; M00475
DR   Wikidata; Q54812802
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00475; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/AMY2/Galpha15
AC   CVCL_H400
DR   GenScript; M00490
DR   Wikidata; Q54812803
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9844; RAMP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00490; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/AMY3/Galpha15
AC   CVCL_H401
DR   GenScript; M00481
DR   Wikidata; Q54812804
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9845; RAMP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00481; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/AT2/Gqi5
AC   CVCL_E5JT
DR   GenScript; M00445
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:338; AGTR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00445; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/B1/Galpha15
AC   CVCL_H402
DR   GenScript; M00482
DR   Wikidata; Q54812805
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1029; BDKRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00482; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/B2/Galpha15
AC   CVCL_H403
DR   GenScript; M00184
DR   Wikidata; Q54812806
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/B7-H2
AC   CVCL_E5IT
DR   GenScript; M00671
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17087; ICOSLG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/B7-H3
AC   CVCL_KA47
DR   GenScript; M00536
DR   Wikidata; Q54812807
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19137; CD276.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/B7-H4
AC   CVCL_KA48
DR   GenScript; M00537
DR   Wikidata; Q54812808
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28873; VTCN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/BB1
AC   CVCL_H404
DR   GenScript; M00254
DR   Wikidata; Q54812810
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7843; NMBR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/BB2
AC   CVCL_H405
DR   GenScript; M00182
DR   Wikidata; Q54812811
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4609; GRPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/BB3
AC   CVCL_H406
DR   GenScript; M00183
DR   Wikidata; Q54812812
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1113; BRS3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/BDCA2
AC   CVCL_E5IE
DR   GenScript; M00595
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13258; CLEC4C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/BDCA2 and FcER1G
AC   CVCL_E5IG
DR   GenScript; M00593
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13258; CLEC4C.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/BTLA
AC   CVCL_KA49
DR   GenScript; M00534
DR   Wikidata; Q54812814
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:21087; BTLA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/C5a/Galpha15
AC   CVCL_H407
DR   GenScript; M00327
DR   Wikidata; Q54812815
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1338; C5AR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/CASR
AC   CVCL_H408
DR   GenScript; M00434
DR   Wikidata; Q54812817
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1514; CASR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/CB1/Galpha15
AC   CVCL_H409
DR   GenScript; M00299
DR   Wikidata; Q54812818
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/CB2
AC   CVCL_H410
DR   GenScript; M00433
DR   Wikidata; Q54812819
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2160; CNR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/CCKA/Galpha15
AC   CVCL_H411
DR   GenScript; M00271
DR   Wikidata; Q54812820
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1570; CCKAR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/CCKB
AC   CVCL_H412
DR   GenScript; M00154
DR   Wikidata; Q54812821
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1571; CCKBR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/CD112
AC   CVCL_E5IN
DR   GenScript; M00590
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9707; NECTIN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/CD155
AC   CVCL_E5IP
DR   GenScript; M00591
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9705; PVR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/CD160
AC   CVCL_KA24
DR   GenScript; M00535
DR   Wikidata; Q54812823
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17013; CD160.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: GenScript; M00535; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD16A 158F
AC   CVCL_KA22
SY   CHO-K1/CD16a 158F
DR   GenScript; M00586
DR   Wikidata; Q54812824
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD16A 158V
AC   CVCL_E5I6
DR   GenScript; M00597
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/CD16B
AC   CVCL_KA23
SY   CHO-K1/CD16B NA1; CHO-K1/human CD16B NA1
DR   GenScript; M00602
DR   Wikidata; Q54812825
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3620; FCGR3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD200 R1
AC   CVCL_KA25
DR   GenScript; M00541
DR   Wikidata; Q54812826
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24235; CD200R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD27
AC   CVCL_KA26
DR   GenScript; M00564
DR   Wikidata; Q54812827
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11922; CD27.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00564; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD32A 131Arg
AC   CVCL_KA28
SY   CHO-K1/CD32A 131R; CHO-K1/human CD32A 131Arg
DR   GenScript; M00599
DR   GenScript; M00887
DR   Wikidata; Q54812828
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3616; FCGR2A (Note=With p.His167Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00599; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD32A 131His
AC   CVCL_KA27
SY   CHO-K1/CD32A 131H
DR   GenScript; M00598
DR   Wikidata; Q54812829
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3616; FCGR2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD32B 232Ile
AC   CVCL_KA29
SY   CHO-K1/CD32B 232I; CHO-K1/CD32b Ile232
DR   GenScript; M00587
DR   Wikidata; Q54812830
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3618; FCGR2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD32B 232Thr
AC   CVCL_KA30
SY   CHO-K1/CD32B 232T; CHO-K1/human CD32B 232Thr
DR   GenScript; M00600
DR   Wikidata; Q54812831
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3618; FCGR2B (Note=With p.Ile232Thr).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD32C 13Gln
AC   CVCL_KA31
SY   CHO-K1/human CD32C 13Gln
DR   GenScript; M00601
DR   Wikidata; Q54812832
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15626; FCGR2C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD38
AC   CVCL_KA32
SY   CHO-K1/human CD38
DR   GenScript; M00553
DR   Wikidata; Q54812834
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1667; CD38.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD40
AC   CVCL_KA33
DR   GenScript; M00540
DR   Wikidata; Q54812835
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11919; CD40.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00540; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CHO-K1/CD47
AC   CVCL_KA34
SY   CHO-K1/human CD47
DR   GenScript; M00581
DR   Wikidata; Q54812836
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD64
AC   CVCL_E5I7
DR   GenScript; M00588
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3613; FCGR1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/CD80
AC   CVCL_KA35
DR   GenScript; M00545
DR   Wikidata; Q54812837
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CD86
AC   CVCL_KA36
DR   GenScript; M00546
DR   Wikidata; Q54812838
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1705; CD86.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00546; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CLDN18.2
AC   CVCL_E5J1
DR   GenScript; M00916
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/CMKLR1/Galpha15
AC   CVCL_H413
DR   GenScript; M00301
DR   Wikidata; Q54812839
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2121; CMKLR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/CRE-Luc
AC   CVCL_H414
SY   CHO-K1/CRE-Luciferase
DR   GenScript; M00187
DR   Wikidata; Q54812840
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (GenScript=M00187).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: GenScript; M00187; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/CRE-Luc/VPAC2
AC   CVCL_KA21
SY   CHO-K1/CRE-luciferase/VPAC2; CHO-K1/CRE/Luciferase/VIPR2
DR   GenScript; M00547
DR   Wikidata; Q54812842
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12695; VIPR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00547; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H414 ! CHO-K1/CRE-Luc
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/CRE/Luc
AC   CVCL_KA77
SY   CHO-K1/CRE/Luciferase
DR   GenScript; M00145
DR   Wikidata; Q54812841
CC   Characteristics: Expresses firefly luciferase under the control of a 4xCRE element (GenScript=M00145).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: GenScript; M00145; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/CRF1/Galpha15
AC   CVCL_H415
DR   GenScript; M00343
DR   Wikidata; Q54812843
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2357; CRHR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/CRF2/Galpha15
AC   CVCL_H416
DR   GenScript; M00208
DR   Wikidata; Q54812844
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2358; CRHR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/CT
AC   CVCL_KA67
DR   GenScript; M00153
DR   Wikidata; Q54812846
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Discontinued: GenScript; M00153; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CHO-K1/CT/Galpha15
AC   CVCL_H417
DR   GenScript; M00320
DR   Wikidata; Q54812871
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/CTLA4
AC   CVCL_KA37
DR   GenScript; M00530
DR   Wikidata; Q54812872
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/cyno 4-1BB
AC   CVCL_KA50
DR   GenScript; M00569
DR   Wikidata; Q54812873
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A9YYE7; Macaca fascicularis TNFRSF9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/cyno BDCA2
AC   CVCL_E5IF
DR   GenScript; M00596
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A2K5UWP4; Macaca fascicularis CLEC4C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/cyno BDCA2 and FcER1G
AC   CVCL_E5IH
DR   GenScript; M00594
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A2K5UWP4; Macaca fascicularis CLEC4C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q8SPW1; Macaca fascicularis FCER1G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/cyno CD155
AC   CVCL_E5IQ
DR   GenScript; M00643
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A7N9D908; Macaca fascicularis PVR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/cyno CD47
AC   CVCL_E5IL
DR   GenScript; M00632
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A2K5X4I2; Macaca fascicularis CD47.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/cyno CTLA4
AC   CVCL_KA51
DR   GenScript; M00571
DR   Wikidata; Q54812874
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G7PL88; Macaca fascicularis CTLA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/cyno FLT3
AC   CVCL_KA52
DR   GenScript; M00578
DR   Wikidata; Q54812876
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G7PVX3; Macaca fascicularis FLT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00578; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/cyno HVEM
AC   CVCL_E5IW
DR   GenScript; M00648
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A7N9CGR4; Macaca fascicularis TNFRSF14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/cyno PD-1
AC   CVCL_KA53
DR   GenScript; M00572
DR   Wikidata; Q54812877
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; B0LAJ3; Macaca fascicularis PDCD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/cyno PD-L1
AC   CVCL_KA54
DR   GenScript; M00573
DR   Wikidata; Q54812878
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G7PSE7; Macaca fascicularis CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/cyno PD-L2
AC   CVCL_E5IB
DR   GenScript; M00629
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A7N9CYI9; Macaca fascicularis PDCD1LG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/cyno VISTA
AC   CVCL_E5ID
DR   GenScript; M00634
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A7N9CK37; Macaca fascicularis VSIR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/CysLT1/Galpha15
AC   CVCL_H418
DR   GenScript; M00462
DR   Wikidata; Q54812879
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17451; CYSLTR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/CysLT2
AC   CVCL_H419
DR   GenScript; M00449
DR   Wikidata; Q54812880
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18274; CYSLTR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: GenScript; M00449; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   CHO-K1/D1
AC   CVCL_H420
DR   GenScript; M00247
DR   Wikidata; Q54812881
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3020; DRD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/D2/Galpha15
AC   CVCL_H421
DR   GenScript; M00152
DR   Wikidata; Q54812882
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3023; DRD2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/D2s/Galpha15
AC   CVCL_H422
SY   CHO-K1/D2S/Galpha15
DR   GenScript; M00274
DR   Wikidata; Q54812883
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3023; DRD2 (Note=Isoform short).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/D5/Galpha15
AC   CVCL_H423
DR   GenScript; M00322
DR   Wikidata; Q54812886
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3026; DRD5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/DP1/Galpha15
AC   CVCL_H424
DR   GenScript; M00453
DR   Wikidata; Q54812887
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9591; PTGDR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/DP2/Galpha15
AC   CVCL_H425
DR   GenScript; M00436
DR   Wikidata; Q54812888
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4502; PTGDR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/EDG5/Galpha15
AC   CVCL_KA68
DR   GenScript; M00197
DR   Wikidata; Q54812889
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3169; S1PR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: GenScript; M00197; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CHO-K1/EDNRA
AC   CVCL_H426
DR   GenScript; M00149
DR   Wikidata; Q54812890
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3179; EDNRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/EDNRB
AC   CVCL_H427
DR   GenScript; M00150
DR   Wikidata; Q54812891
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3180; EDNRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/EP2/Galpha15
AC   CVCL_H428
DR   GenScript; M00311
DR   Wikidata; Q54812892
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9594; PTGER2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/FcRn
AC   CVCL_E5I8
DR   GenScript; M00603
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3621; FCGRT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/FFA1/Galpha15
AC   CVCL_H429
DR   GenScript; M00273
DR   Wikidata; Q54812893
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4498; FFAR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/FFA2/Galpha15
AC   CVCL_H430
DR   GenScript; M00437
DR   Wikidata; Q54812895
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4501; FFAR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/FLT3
AC   CVCL_KA38
SY   CHO-K1/human FLT3
DR   GenScript; M00576
DR   Wikidata; Q54812896
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3765; FLT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00576; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/FPR1/Galpha15
AC   CVCL_H431
DR   GenScript; M00429
DR   Wikidata; Q54812898
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3826; FPR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/FPRL1/Galpha15
AC   CVCL_H432
DR   GenScript; M00305
DR   Wikidata; Q54812899
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3827; FPR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00305; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GAL1/Galpha15
AC   CVCL_H433
DR   GenScript; M00277
DR   Wikidata; Q54812901
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4132; GALR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GAL2
AC   CVCL_H434
DR   GenScript; M00209
DR   Wikidata; Q54812902
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4133; GALR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/Galpha15
AC   CVCL_H446
DR   GenScript; M00257
DR   Wikidata; Q54812903
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/Galpha15/AMY1
AC   CVCL_KA08
DR   GenScript; M00557
DR   Wikidata; Q54812904
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CHO-K1/Galpha15/AMY2
AC   CVCL_KA09
DR   GenScript; M00558
DR   Wikidata; Q54812905
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9844; RAMP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CHO-K1/Galpha15/AMY3
AC   CVCL_KA10
DR   GenScript; M00559
DR   Wikidata; Q54812906
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9845; RAMP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/Galpha15/CCR1
AC   CVCL_KA12
SY   CHO-K1/Galpha15/human CCR1
DR   GenScript; M00522
DR   Wikidata; Q54812907
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1602; CCR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/Galpha15/CCR5
AC   CVCL_KA13
SY   CHO-K1/Galpha15/human CCR5
DR   GenScript; M00523
DR   Wikidata; Q54812908
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/Galpha15/CXCR1
AC   CVCL_KA14
SY   CHO-K1/Galpha15/human CXCR1
DR   GenScript; M00524
DR   Wikidata; Q54812909
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6026; CXCR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/Galpha15/CXCR3
AC   CVCL_KA15
SY   CHO-K1/Galpha15/human CXCR3
DR   GenScript; M00525
DR   Wikidata; Q54812911
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CHO-K1/Galpha15/CXCR4
AC   CVCL_KA16
SY   CHO-K1/Galpha15/human CXCR4; CHO-K1/Ga1pha15/hCXCR4
DR   GenScript; M00556
DR   Wikidata; Q54812912
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CHO-K1/Galpha15/CXCR5
AC   CVCL_KA17
SY   CHO-K1/Galpha15/human CXCR5
DR   GenScript; M00526
DR   Wikidata; Q54812914
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1060; CXCR5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   CHO-K1/Galpha15/MRGPRX1
AC   CVCL_E5JS
DR   GenScript; M00484
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17962; MRGPRX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00484; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-K1/Galpha15/OXER1
AC   CVCL_H489
SY   CHO-K1/OXE-Flag/Galpha15
DR   GenScript; M00488
DR   Wikidata; Q54812915
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24884; OXER1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00488; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GCGR/Galpha15
AC   CVCL_H435
DR   GenScript; M00345
DR   Wikidata; Q54812916
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   CHO-K1/GHSR
AC   CVCL_H436
DR   GenScript; M00189
DR   Wikidata; Q54812917
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4267; GHSR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/GIP/Galpha15
AC   CVCL_H437
DR   GenScript; M00486
DR   Wikidata; Q54812919
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4271; GIPR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GITR
AC   CVCL_KA39
DR   GenScript; M00539
DR   Wikidata; Q54812939
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11914; TNFRSF18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/GLP1/Galpha15
AC   CVCL_H438
DR   GenScript; M00451
DR   Wikidata; Q54812940
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GLP2/Galpha15
AC   CVCL_H439
DR   GenScript; M00307
DR   Wikidata; Q54812941
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4325; GLP2R.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GNRHR/Galpha15
AC   CVCL_H440
DR   GenScript; M00426
DR   Wikidata; Q54812942
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4421; GNRHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/GPBAR1
AC   CVCL_H441
DR   GenScript; M00432
DR   Wikidata; Q54812944
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19680; GPBAR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/GPR103/Galpha15
AC   CVCL_H442
DR   GenScript; M00321
DR   Wikidata; Q54812945
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15565; QRFPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/GPR120/Galpha15
AC   CVCL_H443
DR   GenScript; M00440
DR   Wikidata; Q54812946
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19061; FFAR4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00440; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GPR68/Galpha15
AC   CVCL_H444
DR   GenScript; M00439
DR   Wikidata; Q54812948
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4519; GPR68.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/Gqi5
AC   CVCL_H447
DR   GenScript; M00455
DR   Wikidata; Q54812949
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   CHO-K1/GRM2/Galpha15
AC   CVCL_H445
DR   GenScript; M00427
DR   Wikidata; Q54812950
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4594; GRM2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/GRM3/Gqi5
AC   CVCL_KA80
DR   GenScript; M00466
DR   Wikidata; Q54812951
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4595; GRM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00466; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H447 ! CHO-K1/Gqi5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CHO-K1/H2/Galpha15
AC   CVCL_H448
DR   GenScript; M00306
DR   Wikidata; Q54812952
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5183; HRH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/H3/Galpha15
AC   CVCL_H449
DR   GenScript; M00331
DR   Wikidata; Q54812953
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5184; HRH3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/H4/Galpha15
AC   CVCL_H450
DR   GenScript; M00289
DR   Wikidata; Q54812955
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17383; HRH4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/hERG
AC   CVCL_H512
DR   GenScript; M00283
DR   Wikidata; Q54812956
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6251; KCNH2.
CC   Discontinued: GenScript; M00283; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/HVEM
AC   CVCL_E5IU
DR   GenScript; M00646
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11912; TNFRSF14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/ICOS
AC   CVCL_E5IS
DR   GenScript; M00649
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5351; ICOS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/IP1/Galpha15
AC   CVCL_H451
DR   GenScript; M00310
DR   Wikidata; Q54812958
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9602; PTGIR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/ITGAE
AC   CVCL_E5IM
DR   GenScript; M00592
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6147; ITGAE.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/KIR
AC   CVCL_E5II
DR   GenScript; M00650
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6329; KIR2DL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/KiSS1
AC   CVCL_H452
DR   GenScript; M00190
DR   Wikidata; Q54812959
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4510; KISS1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/Lag3
AC   CVCL_KA40
DR   GenScript; M00532
DR   Wikidata; Q54812960
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6476; LAG3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/LTB4/Galpha15
AC   CVCL_H453
DR   GenScript; M00435
DR   Wikidata; Q54812961
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6713; LTB4R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/M1
AC   CVCL_H454
DR   GenScript; M00185
DR   Wikidata; Q54812963
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/M2/Galpha15
AC   CVCL_H455
DR   GenScript; M00258
DR   Wikidata; Q54812964
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1951; CHRM2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/M3
AC   CVCL_H456
DR   GenScript; M00259
DR   Wikidata; Q54812965
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1952; CHRM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/M4/Galpha15
AC   CVCL_H457
DR   GenScript; M00238
DR   Wikidata; Q54812966
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1953; CHRM4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/M5
AC   CVCL_H458
DR   GenScript; M00186
DR   Wikidata; Q54812967
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1954; CHRM5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/MC2/Galpha15
AC   CVCL_H459
DR   GenScript; M00336
DR   Wikidata; Q54812969
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6930; MC2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/MC3/Galpha15
AC   CVCL_H460
DR   GenScript; M00242
DR   Wikidata; Q54812970
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6931; MC3R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/MC4/Galpha15
AC   CVCL_H461
DR   GenScript; M00272
DR   Wikidata; Q54812972
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6932; MC4R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/MC5/Galpha15
AC   CVCL_H462
DR   GenScript; M00243
DR   Wikidata; Q54812973
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6933; MC5R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/MCH2
AC   CVCL_H463
DR   GenScript; M00280
DR   Wikidata; Q54812974
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20867; MCHR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/mouse 4-1BB
AC   CVCL_KA55
DR   GenScript; M00568
DR   Wikidata; Q54812975
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1101059; Tnfrsf9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/mouse ADORA2A
AC   CVCL_KA19
DR   GenScript; M00575
DR   Wikidata; Q54812976
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99402; Adora2a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   CHO-K1/mouse CD155
AC   CVCL_E5IR
DR   GenScript; M00642
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107741; Pvr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/mouse CD38
AC   CVCL_E5IJ
DR   GenScript; M00636
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107474; Cd38.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/mouse CD47
AC   CVCL_E5IK
DR   GenScript; M00631
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96617; Cd47.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/mouse CTLA4
AC   CVCL_KA56
DR   GenScript; M00570
DR   Wikidata; Q54812977
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88556; Ctla4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/mouse FLT3
AC   CVCL_KA57
DR   GenScript; M00577
DR   Wikidata; Q54812978
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95559; Flt3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00577; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/mouse HVEM
AC   CVCL_E5IV
DR   GenScript; M00647
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2675303; Tnfrsf14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/mouse PD-1
AC   CVCL_KA58
SY   CHO-K1/mPD-1
DR   GenScript; M00552
DR   Wikidata; Q54812979
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104879; Pdcd1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/mouse PD-L1
AC   CVCL_KA59
DR   GenScript; M00567
DR   Wikidata; Q54812980
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1926446; Cd274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/mouse PD-L2
AC   CVCL_E5JR
DR   GenScript; M00628
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1930125; Pdcd1lg2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00628; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/mouse TIGIT
AC   CVCL_KA06
DR   GenScript; M00585
DR   Wikidata; Q54812981
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:3642260; Tigit.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CHO-K1/mouse VISTA
AC   CVCL_E5IC
DR   GenScript; M00633
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1921298; Vsir.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/MRGPRD/Galpha15
AC   CVCL_H464
DR   GenScript; M00467
DR   Wikidata; Q54812983
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29626; MRGPRD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00467; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/MRGPRX2
AC   CVCL_H465
DR   GenScript; M00425
DR   Wikidata; Q54812984
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17983; MRGPRX2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   CHO-K1/MT1/Galpha15
AC   CVCL_H466
DR   GenScript; M00424
DR   Wikidata; Q54812985
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7463; MTNR1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/MT2/Galpha15
AC   CVCL_H467
DR   GenScript; M00312
DR   Wikidata; Q54812986
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7464; MTNR1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/MTLR/Galpha15
AC   CVCL_H468
DR   GenScript; M00347
DR   Wikidata; Q54812993
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4495; MLNR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/NIACR1/Galpha15
AC   CVCL_H469
DR   GenScript; M00428
DR   Wikidata; Q54812994
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24827; HCAR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NK1
AC   CVCL_H470
DR   GenScript; M00199
DR   Wikidata; Q54812995
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11526; TACR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/NK2
AC   CVCL_H471
DR   GenScript; M00200
DR   Wikidata; Q54812996
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11527; TACR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/NK3
AC   CVCL_H472
DR   GenScript; M00201
DR   Wikidata; Q54812997
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11528; TACR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/NMU1
AC   CVCL_H473
DR   GenScript; M00191
DR   Wikidata; Q54812998
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4518; NMUR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/NPBW1/Galpha15
AC   CVCL_H474
DR   GenScript; M00452
DR   Wikidata; Q54812999
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4522; NPBWR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NPFF1/Galpha15
AC   CVCL_H475
DR   GenScript; M00431
DR   Wikidata; Q54813000
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17425; NPFFR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00431; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NPFF2/Galpha15
AC   CVCL_H476
DR   GenScript; M00474
DR   Wikidata; Q54813001
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4525; NPFFR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00474; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NPS1a/Galpha15
AC   CVCL_H477
DR   GenScript; M00338
DR   Wikidata; Q54813002
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23631; NPSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NPS1b/Galpha15
AC   CVCL_H478
DR   GenScript; M00344
DR   Wikidata; Q54813003
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23631; NPSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NPY1/Galpha15
AC   CVCL_H479
DR   GenScript; M00192
DR   Wikidata; Q54813004
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7956; NPY1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00192; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NPY2/Gqi5
AC   CVCL_H480
DR   GenScript; M00460
DR   Wikidata; Q54813005
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7957; NPY2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H447 ! CHO-K1/Gqi5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/NPY4/Galpha15
AC   CVCL_H481
DR   GenScript; M00237
DR   Wikidata; Q54813006
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9329; NPY4R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   CHO-K1/NTS1
AC   CVCL_H482
DR   GenScript; M00194
DR   Wikidata; Q54813007
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8039; NTSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/OPRD1/Galpha15
AC   CVCL_H483
DR   GenScript; M00323
DR   Wikidata; Q54813008
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8153; OPRD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/OPRK1/Galpha15
AC   CVCL_H484
DR   GenScript; M00290
DR   Wikidata; Q54813009
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8154; OPRK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/OPRL1/Galpha15
AC   CVCL_H485
DR   GenScript; M00447
DR   Wikidata; Q54813010
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8155; OPRL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/OPRM1/Galpha15
AC   CVCL_H486
DR   GenScript; M00304
DR   Wikidata; Q54813011
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8156; OPRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/OX-40
AC   CVCL_KA41
DR   GenScript; M00561
DR   Wikidata; Q54813014
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11918; TNFRSF4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CHO-K1/OX-40L
AC   CVCL_KA42
DR   GenScript; M00563
DR   Wikidata; Q54813015
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11934; TNFSF4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/OX1
AC   CVCL_H487
DR   GenScript; M00224
DR   Wikidata; Q54813012
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4848; HCRTR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/OX2
AC   CVCL_H488
DR   GenScript; M00316
DR   Wikidata; Q54813013
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4849; HCRTR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/OXGR1/Galpha15
AC   CVCL_H490
DR   GenScript; M00483
DR   Wikidata; Q54813016
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4531; OXGR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: GenScript; M00483; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/OXTR
AC   CVCL_H491
DR   GenScript; M00195
DR   Wikidata; Q54813017
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8529; OXTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/P2Y9/Galpha15
AC   CVCL_KA78
DR   GenScript; M00438
DR   Wikidata; Q54813018
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4478; LPAR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: GenScript; M00438; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CHO-K1/PAC1/Galpha15
AC   CVCL_H492
DR   GenScript; M00203
DR   Wikidata; Q54813019
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12695; VIPR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/PAR2/Galpha15
AC   CVCL_H493
DR   GenScript; M00446
DR   Wikidata; Q54813020
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3538; F2RL1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/PAR4
AC   CVCL_H494
DR   GenScript; M00206
DR   Wikidata; Q54813021
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3540; F2RL3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/PD-L1
AC   CVCL_KA44
DR   GenScript; M00543
DR   Wikidata; Q54813023
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/PD-L2
AC   CVCL_E5IA
DR   GenScript; M00627
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18731; PDCD1LG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/PD1
AC   CVCL_KA43
DR   GenScript; M00529
DR   Wikidata; Q54813022
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/PODXL
AC   CVCL_D2TW
DR   Wikidata; Q127380477
RX   PubMed=28384052;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9171; PODXL.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CHO-K1/PRLHR
AC   CVCL_H495
DR   GenScript; M00341
DR   Wikidata; Q54813024
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4464; PRLHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/PTAFR
AC   CVCL_H496
DR   GenScript; M00262
DR   Wikidata; Q54813025
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9582; PTAFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/PTH1/Galpha15
AC   CVCL_H497
DR   GenScript; M00315
DR   Wikidata; Q54813026
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9608; PTH1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/SCTR/Galpha15
AC   CVCL_H498
DR   GenScript; M00326
DR   Wikidata; Q54813027
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10608; SCTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/SF
AC   CVCL_8850
DR   CLO; CLO_0002464
DR   CLDB; cl742
DR   ECACC; 93061607
DR   Wikidata; Q54813028
RX   PubMed=23873082;
CC   Group: Serum/protein free medium cell line.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   CHO-K1/SIRP alpha
AC   CVCL_KA60
SY   CHO-K1/human SIRP alpha
DR   GenScript; M00582
DR   Wikidata; Q54813029
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9662; SIRPA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00582; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/SIRP gamma
AC   CVCL_KA61
SY   CHO-K1/human SIRP gamma
DR   GenScript; M00584
DR   Wikidata; Q54813030
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15757; SIRPG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: GenScript; M00584; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/Spike
AC   CVCL_E5IZ
DR   GenScript; M00803
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-K1/SST1/Gqi5
AC   CVCL_H499
DR   GenScript; M00473
DR   Wikidata; Q54813031
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11330; SSTR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H447 ! CHO-K1/Gqi5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/SST2/Galpha15
AC   CVCL_H500
DR   GenScript; M00325
DR   Wikidata; Q54813032
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11331; SSTR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/SST3/Galpha15
AC   CVCL_H501
DR   GenScript; M00285
DR   Wikidata; Q54813042
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11332; SSTR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/SST4/Galpha15
AC   CVCL_H502
DR   GenScript; M00334
DR   Wikidata; Q54813044
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11333; SSTR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/SST5/Galpha15
AC   CVCL_H503
DR   GenScript; M00286
DR   Wikidata; Q54813045
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11334; SSTR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/SUCNR1/Galpha15
AC   CVCL_H504
DR   GenScript; M00471
DR   Wikidata; Q54813046
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4542; SUCNR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: GenScript; M00471; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/TIGIT
AC   CVCL_KA05
DR   GenScript; M00542
DR   Wikidata; Q54813047
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26838; TIGIT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/Tim3
AC   CVCL_KA45
DR   GenScript; M00531
DR   Wikidata; Q54813048
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18437; HAVCR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/TRH1
AC   CVCL_H505
DR   GenScript; M00202
DR   Wikidata; Q54813049
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12299; TRHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/UT2/Galpha15
AC   CVCL_H506
DR   GenScript; M00339
DR   Wikidata; Q54813050
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4468; UTS2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   CHO-K1/V1A
AC   CVCL_H507
DR   GenScript; M00181
DR   Wikidata; Q54813051
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:895; AVPR1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: GenScript; M00181; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   CHO-K1/V1B
AC   CVCL_H508
DR   GenScript; M00205
DR   Wikidata; Q54813052
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:896; AVPR1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   CHO-K1/V2/Galpha15
AC   CVCL_H509
DR   GenScript; M00170
DR   Wikidata; Q54813053
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:897; AVPR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/VISTA
AC   CVCL_KA62
DR   GenScript; M00533
DR   Wikidata; Q54813054
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30085; VSIR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CHO-K1/VPAC1/Galpha15
AC   CVCL_H510
DR   GenScript; M00342
DR   Wikidata; Q54813056
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12694; VIPR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1/VPAC2/Galpha15
AC   CVCL_H511
DR   GenScript; M00226
DR   Wikidata; Q54813057
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12695; VIPR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H446 ! CHO-K1/Galpha15
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CHO-K1c
AC   CVCL_D3VX
DR   Wikidata; Q127380478
RX   PubMed=494060;
RX   PubMed=6717439;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO-K1v
AC   CVCL_6F16
SY   CHO K1v
DR   Wikidata; Q54813069
WW   Provider; RCCC-V; -; https://web.archive.org/web/20200220021323/http://www.sevin.ru/collections/cellcolls/rcccm/lines_list.html
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   CHO-KK
AC   CVCL_V245
SY   CHO-kk
DR   Wikidata; Q54813070
RX   PubMed=730050;
RX   PubMed=7360150;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 8
//
ID   CHO-LY-A
AC   CVCL_J422
SY   LY-A
DR   CLO; CLO_0050417
DR   RCB; RCB1869
DR   Wikidata; Q54813072
RX   PubMed=9837968;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   CHO-LY-B
AC   CVCL_4701
SY   LY-B
DR   BTO; BTO_0004897
DR   CLO; CLO_0050415
DR   RCB; RCB1698
DR   Wikidata; Q54813073
RX   PubMed=9837968;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   CHO-LY-B/cLCB1
AC   CVCL_U862
SY   LY-B/cLCB1
DR   CLO; CLO_0050411
DR   RCB; RCB1699
DR   Wikidata; Q54813074
RX   PubMed=9837968;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; O54695; Cricetulus griseus Sptlc1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4701 ! CHO-LY-B
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   CHO-M1
AC   CVCL_T062
DR   Wikidata; Q54813075
RX   PubMed=23660994;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8845 ! CHO DP-12 clone#1934
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 8
//
ID   CHO-M19
AC   CVCL_H628
SY   CHO M19; M19
DR   ChEMBL-Cells; CHEMBL3307785
DR   ChEMBL-Targets; CHEMBL1909242
DR   PubChem_Cell_line; CVCL_H628
DR   Wikidata; Q54813076
RX   PubMed=7940020;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 10
//
ID   CHO-mB7
AC   CVCL_CW95
DR   Wikidata; Q54813077
RX   PubMed=1373896;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   CHO-MCHR2
AC   CVCL_U366
DR   Wikidata; Q54813078
RX   PubMed=20099459;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:20867; MCHR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   CHO-MG
AC   CVCL_7181
SY   CHOMG; CHO MG; Pro-3 MG(R) 2-2
DR   BTO; BTO_0004065
DR   ChEMBL-Cells; CHEMBL3307646
DR   ChEMBL-Targets; CHEMBL614558
DR   PubChem_Cell_line; CVCL_7181
DR   Wikidata; Q54813079
RX   PubMed=730773;
RX   PubMed=2766456;
RX   PubMed=2782395;
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Caution: Four MGBG-resistant cell lines (Pro-3 MG(R) 1-23, Pro-3 MG(R) 2-2, Pro-3 MG(R) 3-1 and Pro-6 MG(R) 4-8) were created (PubMed=730773). As it is not clear which cell line has been distributed under the name CHO-MG, we have selected Pro-3 MG(R) 2-2 as it is used extensively in the original paper.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   CHO-MK
AC   CVCL_YS95
SY   Chinese Hamster Ovary-MK
DR   Wikidata; Q93452576
RX   CelloPub=CLPUB00554;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   CHO-MK42
AC   CVCL_S408
SY   CHO MK42; MK42
DR   Wikidata; Q54813080
RX   PubMed=281704;
RX   PubMed=6287224;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   CHO-mL1
AC   CVCL_X976
SY   mL1-CHO
DR   Wikidata; Q54813081
RX   PubMed=11706054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96721; L1cam.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   CHO-MOG
AC   CVCL_DG55
DR   Wikidata; Q54813083
RX   PubMed=16461459;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7197; MOG.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   CHO-NPY1R
AC   CVCL_U001
DR   ECACC; 12110602
DR   Wikidata; Q54813084
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:7956; NPY1R.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-OPRL1
AC   CVCL_U008
DR   ECACC; 10110201
DR   Wikidata; Q54813085
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:8155; OPRL1.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-P22
AC   CVCL_4267
SY   CHO P22; P22
DR   CLO; CLO_0008311
DR   CLDB; cl3821
DR   ECACC; 89030317
DR   Wikidata; Q54813097
RX   PubMed=4033657;
RX   PubMed=7988294;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_H340 ! CHO-A7
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 10
//
ID   CHO-p658-hPRL
AC   CVCL_WS56
DR   Wikidata; Q93452605
RX   PubMed=11001873;
CC   Characteristics: The sequence of PRL was inserted in the p658 (p7047 derivative) construct (PubMed=11001873).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9445; PRL.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P69714; Hepatitis B virus genotype A2 subtype adw (isolate Japan/Nishioka/1983) protein X.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   CHO-pEDdc-hPRL
AC   CVCL_WS57
DR   FCS-free; 24-8-406-3-4-12
DR   Wikidata; Q93452607
RX   PubMed=11001873;
RX   PubMed=22692846;
CC   Characteristics: The sequence of PRL was inserted in the pEDdc construct (PubMed=11001873).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9445; PRL.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   CHO-PI
AC   CVCL_S541
SY   HIV-1 HXB2 gp120 GPI-anchored CHO Cells
DR   BEI_Resources; ARP-2284
DR   Wikidata; Q54813098
RX   PubMed=8230430;
CC   Characteristics: Expresses GPI-anchored gp120.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   CHO-R5
AC   CVCL_VA36
DR   Wikidata; Q54813100
CC   Discontinued: New England Biolabs; Catalog number C2005.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 6
//
ID   CHO-RD
AC   CVCL_4669
DR   CLO; CLO_0050421
DR   RCB; RCB1477
DR   Wikidata; Q54813101
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 10
//
ID   CHO-RED-clone 15
AC   CVCL_C8Z7
SY   CHO-RED clone15; CHO-RED-cl15
DR   Wikidata; Q123030917
RX   PubMed=15033998;
CC   Characteristics: Transfected with a pCMV-DsRed-Express plasmid (PubMed=15033998).
CC   Genetic integration: Method=Transfection; Gene=FPbase; DCYCK; DsRed-Express (Note=Orange fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   CHO-S
AC   CVCL_7183
SY   CHO-s; CHOS
DR   CLO; CLO_0037216
DR   GEO; GSM1968575
DR   GEO; GSM1968576
DR   Lonza; 842
DR   Wikidata; Q54813102
RX   DOI=10.3390/pr1030296;
RX   DOI=10.3390/pr5020020;
RX   PubMed=837451;
RX   PubMed=4585080;
RX   PubMed=23873082;
RX   PubMed=26993211;
RX   PubMed=28876938;
RX   PubMed=32985598;
RX   PubMed=34050613;
RX   PubMed=36610518;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-207.html
WW   Provider; Thermo Fisher; A1155701; https://www.thermofisher.com/order/catalog/product/A1155701
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   CHO-S Cmah KO clone 1
AC   CVCL_E5SM
SY   CMAH-1
RX   DOI=10.1016/j.bej.2020.107663;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q9WV23; Cmah.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Misspelling: CAMH-1; DOI=10.1016/j.bej.2020.107663; Note=Three times in text.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-S Cmah KO clone 25
AC   CVCL_E5SN
SY   CMAH-25
RX   DOI=10.1016/j.bej.2020.107663;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q9WV23; Cmah.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Misspelling: CAMH-25; DOI=10.1016/j.bej.2020.107663; Note=Once in text.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-S Cmah KO clone 62
AC   CVCL_E5SP
SY   CMAH-62
RX   DOI=10.1016/j.bej.2020.107663;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q9WV23; Cmah.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Misspelling: CAMH-62; DOI=10.1016/j.bej.2020.107663; Note=Three times in text.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO-S FUT8-/-
AC   CVCL_WJ93
SY   FUT8-/- CHO-S
DR   Wikidata; Q93452631
RX   PubMed=30982137;
RX   PubMed=32624826;
CC   Characteristics: Useful for the production of fucose-negative antibodies.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3HCE4; Fut8.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 7
//
ID   CHO-S r34.1 (clone D8)
AC   CVCL_A0AT
SY   D8; 8ED
DR   BEI_Resources; ARP-13578
DR   Wikidata; Q108820038
RX   PubMed=30502324;
CC   Characteristics: Expresses the murine 34.1 monoclonal antibody against the N-terminus of HSV-1 glycoprotein D (gD) (BEI_Resources=ARP-13578).
CC   Doubling time: ~24 hours (PubMed=30502324).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CHO-S TIMP-2-EK-6XHis
AC   CVCL_E8D7
RX   PubMed=29140689;
CC   Characteristics: Transfected with a construct that contains an enterokinase cleavage site (EK) inserted between the C-terminus of TIMP2 and a six-histidine tag (6XHis) (PubMed=29140689).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11821; TIMP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D604 ! FreeStyle CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-S/C0101
AC   CVCL_5A26
SY   C0101
DR   Wikidata; Q54813103
RX   PubMed=23873082;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   CHO-S/H9C2
AC   CVCL_A0TS
DR   CCRID; 4201PAT-CCTCC00523
DR   Wikidata; Q108820039
RX   Patent=CN104630131B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014191.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3546; F8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CHO-S/K70E10-1D6
AC   CVCL_XF07
DR   CCRID; 4201PAT-CCTCC00520
DR   Wikidata; Q93452635
RX   Patent=CN104593333B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014189.
CC   Characteristics: Expresses the anti-AGR2 humanized monoclonal antibody K70E10-1D6.
CC   Misspelling: CHO-S/K7OE10-1D6; CCRID=4201PAT-CCTCC00520.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 8
//
ID   CHO-SEC
AC   CVCL_S543
SY   HIV-1 HXB2 gp120-secreting CHO Cells
DR   BEI_Resources; ARP-2237
DR   Wikidata; Q54813104
RX   PubMed=8230430;
CC   Characteristics: Expresses secreted gp120.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   CHO-SIINFEKL/H-2Kb
AC   CVCL_E7G0
SY   CHO.SIINFEKL/H-2Kb
RX   Patent=US20210380661;
RX   PubMed=30347189;
WW   Provider; TTU; -; https://ttu.flintbox.com/technologies/48eb7349-649b-475b-85b9-759856124d72
CC   Characteristics: Enables the large-scale and continuous batch production of soluble, fully folded and epitope-defined MHC class I molecules. Engineered to secrete peptide/MHC complexes that can be selectively purified in bulk using affinity chromatography, biotinylated, multimerized (via streptavidin) and the resulting reagent incorporated into immunologically relevant assays for detection of antigen-specific T-cells (PubMed=30347189).
CC   Characteristics: Using a sleeping beauty transposon system a SIINFEKL-linker-B2m-linker-H2K(b)-AviTag construct was integrated in the parent cell line (PubMed=30347189).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:88127; B2m.
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-SIVmac239 gp130 Clone 3
AC   CVCL_X696
SY   CHO-1A-130
DR   BEI_Resources; ARP-1822
DR   Wikidata; Q54813105
RX   PubMed=1760229;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   CHO-SIVsmH4 gp130 Clone AD5
AC   CVCL_X695
DR   BEI_Resources; ARP-1821
DR   Wikidata; Q54813106
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   CHO-SNS22
AC   CVCL_EP77
DR   Wikidata; Q54813107
RX   PubMed=12050667;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3629; Scn10a.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CHO-SPB-1
AC   CVCL_T760
SY   SPB-1
DR   CLO; CLO_0050414
DR   RCB; RCB1696
DR   Wikidata; Q54813108
RX   PubMed=1429697;
RX   PubMed=2125045;
RX   PubMed=9837968;
CC   Characteristics: Has a thermolabile serine palmitoyltransferase 1 (Sptlc1) (PubMed=2125045).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-SPB-1/cLCB1
AC   CVCL_T761
SY   SPB-1/cLCB1
DR   CLO; CLO_0050410
DR   RCB; RCB1697
DR   Wikidata; Q54813109
RX   PubMed=9405408;
CC   Characteristics: Corrects the deficient parental thermolabile serine palmitoyltransferase 1 (Sptlc1) (PubMed=9405408).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; O54695; Cricetulus griseus Sptlc1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_T760 ! CHO-SPB-1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-SR-B1
AC   CVCL_E8TM
SY   CHO-SR-BI
RX   PubMed=12356718;
RX   PubMed=12913001;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1664; SCARB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHO-SSR1
AC   CVCL_3364
SY   CHO-SSTR1
DR   CLO; CLO_0002465
DR   CLDB; cl4905
DR   ICLC; ATL98001
DR   Wikidata; Q54813111
RX   PubMed=7907016;
CC   Genetic integration: Method=Transfection; Gene=RGD; 3762; Sstr1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   CHO-SSR2
AC   CVCL_3365
SY   CHO-SSTR2
DR   CLO; CLO_0002466
DR   CLDB; cl4906
DR   ICLC; ATL98002
DR   Wikidata; Q54813112
RX   PubMed=7907016;
CC   Genetic integration: Method=Transfection; Gene=RGD; 3763; Sstr2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   CHO-SSTR1
AC   CVCL_U009
DR   ECACC; 10110206
DR   Wikidata; Q54813113
RX   PubMed=21335600;
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:11330; SSTR1.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   CHO-TACD2
AC   CVCL_E6AE
DR   CLS; 305415
WW   Provider; InSCREENeX; INS-SF-1015; https://www.inscreenex.de/product/cho-tacd2/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:11530; TACSTD2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO-Tax 11-3
AC   CVCL_U352
SY   CHO-TAX 11-3; Tax 11-3
DR   Wikidata; Q54813115
RX   PubMed=2870070;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-Tax 11-6
AC   CVCL_U353
SY   CHO-TAX 11-6; Tax 11-6
DR   Wikidata; Q54813116
RX   PubMed=2870070;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-Tax 2-3
AC   CVCL_U350
SY   CHO-TAX 2-3; Tax 2-3
DR   Wikidata; Q54813117
RX   PubMed=2870070;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-Tax 2-4
AC   CVCL_U351
SY   CHO-TAX 2-4; Tax 2-4
DR   Wikidata; Q54813118
RX   PubMed=2870070;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   CHO-Tax 5-6
AC   CVCL_U346
SY   CHO-TAX 5-6; Tax 5-6
DR   ChEMBL-Cells; CHEMBL3307401
DR   ChEMBL-Targets; CHEMBL614559
DR   PubChem_Cell_line; CVCL_U346
DR   Wikidata; Q54813119
RX   PubMed=2870070;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   CHO-TPO-2B
AC   CVCL_E3EH
RX   PubMed=1936519;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12015; TPO.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO-TPO-C4C,
AC   CVCL_E3EI
RX   PubMed=1936519;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12015; TPO.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO-TPO-M1-K1
AC   CVCL_E3EG
RX   PubMed=1936519;
RX   PubMed=2274058;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12015; TPO (Note=With p.Trp849_Leu933del, secreted = TPO-M1).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO-TRVb
AC   CVCL_U420
SY   TRVb-CHO; TRVb; TRVb-1; TRVb1
DR   Wikidata; Q54813120
RX   PubMed=3611186;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-200.html
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11763; TFRC.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   CHO-tsH1
AC   CVCL_0F81
SY   tsH1
DR   Wikidata; Q54813121
RX   PubMed=2777768;
RX   PubMed=4361675;
RX   PubMed=4585080;
RX   PubMed=6863284;
RX   PubMed=6965094;
RX   PubMed=7444715;
CC   Characteristics: Temperature-sensitive leucyl-tRNA synthetase mutant (PubMed=4361675).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   CHO-tsH1-C11
AC   CVCL_A5KF
SY   tsH1-C11
DR   Wikidata; Q107114662
RX   PubMed=2777768;
RX   PubMed=6863284;
CC   Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0F81 ! CHO-tsH1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-tsH1-C11B6
AC   CVCL_A5KI
SY   tsH1-C11B6; C11B6
DR   Wikidata; Q107114663
RX   PubMed=2777768;
CC   Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=2777768).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5KF ! CHO-tsH1-C11
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-tsH1-C4B4
AC   CVCL_A5KJ
SY   tsH1-C4B4; C4B4
DR   Wikidata; Q107114665
RX   PubMed=2777768;
CC   Characteristics: Compared to the parent cell line, it has reduced system L transport activity. Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5KI ! CHO-tsH1-C11B6
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CHO-tsH1-C5D9
AC   CVCL_A5KK
SY   tsH1-C5D9; C5D9
DR   Wikidata; Q107114667
RX   PubMed=2777768;
CC   Characteristics: Compared to the parent cell line, it has reduced system L transport activity. Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5KI ! CHO-tsH1-C11B6
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CHO-tsH1-C9D9
AC   CVCL_A5KL
SY   tsH1-C9D9; C9D9
DR   Wikidata; Q107114668
RX   PubMed=2777768;
CC   Characteristics: Compared to the parent cell line, it has reduced system L transport activity. Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5KI ! CHO-tsH1-C11B6
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CHO-tsH1-D10
AC   CVCL_A5KG
SY   tsH1-D10
DR   Wikidata; Q107114670
RX   PubMed=6863284;
CC   Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0F81 ! CHO-tsH1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-tsH1-F10
AC   CVCL_A5KH
SY   tsH1-F10
DR   Wikidata; Q107114671
RX   PubMed=6863284;
CC   Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0F81 ! CHO-tsH1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CHO-UKB25
AC   CVCL_5A23
SY   CHO UKB25; UKB25
DR   Wikidata; Q54813122
RX   PubMed=6287224;
RX   PubMed=6933469;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO-UV-1
AC   CVCL_CX60
SY   CHO UV-1; UV-1
DR   Wikidata; Q54813123
RX   PubMed=341370;
RX   PubMed=2218721;
RX   PubMed=2317821;
RX   PubMed=3023994;
RX   PubMed=7197403;
RX   PubMed=7404271;
CC   Characteristics: Hypersensitive to UV radiation (PubMed=341370).
CC   Characteristics: Auxotrophic for glycine (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_U406 ! CHO-glyA
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   CHO-VV 3-2
AC   CVCL_Y287
SY   VLB 3-2
DR   ChEMBL-Cells; CHEMBL3307402
DR   ChEMBL-Targets; CHEMBL614560
DR   PubChem_Cell_line; CVCL_Y287
DR   Wikidata; Q54813124
RX   PubMed=2563346;
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
ID   CHO-WBL
AC   CVCL_GP66
DR   ChEMBL-Cells; CHEMBL4802055
DR   PubChem_Cell_line; CVCL_GP66
DR   Wikidata; Q54813125
RX   PubMed=9118971;
RX   PubMed=10320750;
RX   PubMed=27692294;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 9
//
ID   CHO-WBL (IVGT)
AC   CVCL_AR56
SY   CHO-WBL(IVGT)
DR   ECACC; 14043001
DR   JCRB; JCRB1702
DR   Wikidata; Q54813126
RX   PubMed=27692294;
CC   Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GP66 ! CHO-WBL
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   CHO-WT
AC   CVCL_S544
DR   BEI_Resources; ARP-2239
DR   Wikidata; Q54813127
RX   PubMed=8230430;
CC   Characteristics: Expresses wild-type Env proteins.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   CHO-X3/5
AC   CVCL_Y503
SY   X3/5
DR   Wikidata; Q54813128
RX   PubMed=2432598;
RX   PubMed=3005850;
RX   PubMed=6095070;
CC   Characteristics: Established from parent cell line following X-irradiation with 500 rads and selection in 10 muM Tioguanine (PubMed=6095070).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_Y502 ! CHO-K1-BH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 9
//
ID   CHO-xrs-1
AC   CVCL_5A38
SY   CHO xrs-1; CHO-XRS1; xrs-1; xrs1
DR   Wikidata; Q54813129
RX   PubMed=6197643;
RX   PubMed=6513971;
RX   PubMed=9032253;
CC   Characteristics: Sensitive to X-ray. Has a defect in double-strand break rejoining (PubMed=6513971).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO-xrs-2
AC   CVCL_E4AE
SY   xrs-2
RX   PubMed=6197643;
RX   PubMed=6513971;
CC   Characteristics: Sensitive to X-ray. Has a defect in double-strand break rejoining (PubMed=6513971).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO-xrs-3
AC   CVCL_E4AF
SY   xrs-3
RX   PubMed=6197643;
CC   Characteristics: Slightly sensitive to X-rays (PubMed=6197643).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHO-xrs-4
AC   CVCL_5A39
SY   xrs-4; xrs4
DR   Wikidata; Q54813130
RX   PubMed=2564870;
RX   PubMed=6197643;
RX   PubMed=6513971;
RX   PubMed=9032253;
CC   Characteristics: Sensitive to X-ray. Has a defect in double-strand break rejoining (PubMed=6513971).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO-xrs-5
AC   CVCL_4601
SY   CHO-XRS5; CHO-xrs5; CHO Xrs5; XRS-5; Xrs-5; xrs-5; xrs 5; XrS5; xrs5
DR   CLO; CLO_0009691
DR   ATCC; CRL-2348
DR   Wikidata; Q54813131
RX   PubMed=2218721;
RX   PubMed=2564870;
RX   PubMed=6197643;
RX   PubMed=6513971;
RX   PubMed=7603335;
RX   PubMed=9032253;
RX   PubMed=22923057;
CC   Characteristics: Sensitive to X-ray. Has a defect in double-strand break rejoining (PubMed=6513971).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   CHO-xrs-6
AC   CVCL_4340
SY   CHO-XrS6; CHO-XRS6; CHO XrS6; xrs-6; xrs 6; XrS6; XRS6; xrs6
DR   BTO; BTO_0004066
DR   CLO; CLO_0009692
DR   CLDB; cl4784
DR   ChEMBL-Cells; CHEMBL3307295
DR   ChEMBL-Targets; CHEMBL614060
DR   ECACC; 92052128
DR   PubChem_Cell_line; CVCL_4340
DR   Wikidata; Q54813132
RX   PubMed=2564870;
RX   PubMed=3785270;
RX   PubMed=6197643;
RX   PubMed=6513971;
RX   PubMed=8799130;
RX   PubMed=9032253;
CC   Characteristics: Sensitive to X-ray. Has a defect in double-strand break rejoining (PubMed=6513971).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   CHO-xrs-6-hamKu80
AC   CVCL_4341
SY   XrS6-hamKu80; xrs6-hamKu80
DR   CLO; CLO_0009693
DR   ECACC; 96012301
DR   Wikidata; Q54813133
RX   PubMed=9032253;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q60449; Cricetulus griseus Xrcc5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4340 ! CHO-xrs-6
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   CHO-xrs-6C
AC   CVCL_5A41
SY   xrs-6c; XRS-6C; XRS6C; xrs6c
DR   Wikidata; Q54813135
RX   PubMed=2034785;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4340 ! CHO-xrs-6
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO-xrs-7
AC   CVCL_5A40
SY   xrs-7; xrs7
DR   Wikidata; Q54813136
RX   PubMed=2564870;
RX   PubMed=3785270;
RX   PubMed=6197643;
RX   PubMed=6513971;
RX   PubMed=9032253;
CC   Characteristics: Sensitive to X-ray. Has a defect in double-strand break rejoining (PubMed=6513971).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHO.1F8
AC   CVCL_T032
SY   CHO-1F8
DR   CLO; CLO_0050427
DR   RCB; RCB1823
DR   Wikidata; Q54813167
RX   PubMed=7594622;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9582; PTAFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   CHO.B95aSLAMtag
AC   CVCL_A8GL
DR   Wikidata; Q107114672
RX   PubMed=11390585;
RX   PubMed=12941904;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9GJT3; Saguinus oedipus SLAMF1 (Note=With a N-terminal HA tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   CHO.CowSLAMtag
AC   CVCL_A8GM
DR   Wikidata; Q107114673
RX   PubMed=11390585;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:34653; Bovine SLAMF1 (Note=With a N-terminal HA tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CHO.DogSLAMtag
AC   CVCL_A8GN
DR   Wikidata; Q107114674
RX   PubMed=11390585;
RX   PubMed=12941904;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:46206; Dog SLAMF1 (Note=With a N-terminal HA tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CHO.IAR-4
AC   CVCL_E4I5
SY   CHO.IAR
RX   PubMed=3022282;
CC   Characteristics: Transfected with a hybrid human insulin receptor (INSR), bacterial aspartate receptor (tar) construct (PubMed=3022282).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Asp949_Ser1382del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P02941; Salmonella typhimurium methyl-accepting chemotaxis protein II (tar) (Note=With p.Met1_Arg170del).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO.T
AC   CVCL_9701
SY   CHO-T
DR   Wikidata; Q54813114
RX   PubMed=3022282;
RX   PubMed=3518947;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   CHO.T-t
AC   CVCL_E4I4
RX   PubMed=3518947;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Met1271_Ser1382del and an added p.GlyIleArgAlaLeuAspLys = Truncated hIR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO.YF1
AC   CVCL_E4I2
RX   PubMed=3518947;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Tyr1189Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO.YF3
AC   CVCL_E4I3
RX   PubMed=3518947;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR (Note=With p.Tyr1189Phe and p.Tyr1190Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CHO/159-1
AC   CVCL_E7EP
RX   CelloPub=CLPUB00790;
RX   CelloPub=CLPUB00791;
RX   PubMed=9537249;
CC   Selected for resistance to: ChEBI; CHEBI_50225; Razoxane (ICRF-159).
CC   Sequence variation: Mutation; UniProtKB; P41515; Top2a; Simple; p.Tyr49Phe (c.146A>T); Zygosity=Heterozygous (PubMed=9537249).
CC   Sequence variation: Mutation; UniProtKB; P41515; Top2a; Simple; p.Gln308_Ser312del (c.922_936del); Zygosity=Heterozygous (PubMed=9537249).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHO/2 x RIEDL-ChamPDPN
AC   CVCL_D3CS
DR   Wikidata; Q127380479
RX   PubMed=35483059;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q401Z9; Cricetulus griseus Pdpn (Note=With 2 N-terminal RIEDL tags).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/2 x RIEDL-ferPDPN
AC   CVCL_D3CQ
DR   Wikidata; Q127380480
RX   PubMed=35471053;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G9KFV5; Mustela putorius furo PDPN (Note=With 2 N-terminal RIEDL tags).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/2 x RIEDL-GhamPDPN
AC   CVCL_D3CT
DR   Wikidata; Q127380481
RX   PubMed=35483059;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A3Q0D4D1; Mesocricetus auratus Pdpn (Note=With 2 N-terminal RIEDL tags).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/2 x RIEDL-seaPDPN
AC   CVCL_D2S3
DR   Wikidata; Q127380482
RX   PubMed=34042540;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A6J2BQN3; Zalophus californianus PDPN (Note=With 2 N-terminal RIEDL tags).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CHO/AA4
AC   CVCL_C8BM
DR   Wikidata; Q123030918
RX   PubMed=10934210;
CC   Genetic integration: Method=Transfection; Gene=RGD; 621251; Cd93.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 4
//
ID   CHO/aPDPN
AC   CVCL_D2V7
DR   Wikidata; Q127380484
RX   PubMed=30997422;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A6J0AGQ3; Vicugna pacos PDPN (Note=With a N-terminal GPGDDMVNPGLEDRIE = RAP16-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/ASCT2
AC   CVCL_D3PI
SY   ASCT2/CHO
DR   Wikidata; Q127380485
RX   PubMed=27865832;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10943; SLC1A5 (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/bovPDPN
AC   CVCL_D2UQ
SY   CHO/bovPDPN-FLAG
DR   Wikidata; Q127380486
RX   PubMed=27267652;
RX   PubMed=27380308;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:50142; Bovine PDPN (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CHO/bPDPN
AC   CVCL_D3CD
DR   Wikidata; Q127380487
RX   PubMed=31061899;
RX   PubMed=31721640;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A384CET4; Ursus maritimus PDPN (Note=With a N-terminal BAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/catPDPN
AC   CVCL_D2RP
DR   Wikidata; Q127380488
RX   PubMed=28737447;
RX   PubMed=31009336;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:64095; Cat PDPN (Note=With a N-terminal GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CHO/CD133
AC   CVCL_D2RV
DR   Wikidata; Q127380489
RX   PubMed=28910211;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9454; PROM1 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/CD19
AC   CVCL_D2TG
DR   Wikidata; Q127380490
RX   PubMed=32271687;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1633; CD19 (Note=With a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/CD20
AC   CVCL_A8V4
DR   Wikidata; Q102113679
RX   PubMed=32667234;
RX   PubMed=32724441;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7315; MS4A1 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   CHO/CD44s
AC   CVCL_D2R9
DR   Wikidata; Q127380491
RX   PubMed=35628345;
RX   PubMed=36835416;
RX   PubMed=36975491;
RX   PubMed=37176118;
RX   PubMed=37185762;
RX   PubMed=37218897;
RX   PubMed=37504249;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1681; CD44 (Note=Isoform s; with a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/CD44v3-10
AC   CVCL_D2RA
DR   Wikidata; Q127380492
RX   PubMed=36835416;
RX   PubMed=36975491;
RX   PubMed=37176118;
RX   PubMed=37185762;
RX   PubMed=37189717;
RX   PubMed=37218897;
RX   PubMed=37489367;
RX   PubMed=37504249;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1681; CD44 (Note=Isoform v3-10; with a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/CERT 2.20
AC   CVCL_B0VY
DR   Wikidata; Q108820040
RX   Patent=US9340592;
RX   PubMed=19428735;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2989.
CC   Characteristics: Has improved secretion characteristics in comparison to non-transgenic cell lines.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2205; CERT1 (Note=With p.Ser132Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CHO/CERT 2.41
AC   CVCL_B0VZ
DR   Wikidata; Q108820041
RX   Patent=US9340592;
RX   PubMed=19428735;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2990.
CC   Characteristics: Has improved secretion characteristics in comparison to non-transgenic cell lines.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2205; CERT1 (Note=With p.Ser132Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CHO/CLDN3
AC   CVCL_D3PM
SY   CLDN3/CHO
DR   Wikidata; Q127380493
RX   Patent=US8076458;
RX   PubMed=19555390;
RX   PubMed=21115905;
RX   PubMed=25744656;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2045; CLDN3 (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/CLDN4
AC   CVCL_D3PN
SY   CLDN4/CHO
DR   Wikidata; Q127380494
RX   Patent=US8076458;
RX   PubMed=19555390;
RX   PubMed=21115905;
RX   PubMed=25744656;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2046; CLDN4 (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/CLDN5
AC   CVCL_D3PP
SY   CLDN5/CHO
DR   Wikidata; Q127380495
RX   Patent=US8076458;
RX   PubMed=19555390;
RX   PubMed=25744656;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2047; CLDN5 (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/CLDN6
AC   CVCL_D3PQ
SY   CLDN6/CHO
DR   Wikidata; Q127380496
RX   Patent=US8076458;
RX   PubMed=19555390;
RX   PubMed=25744656;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2048; CLDN6 (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/CLDN9
AC   CVCL_D3PR
SY   CLDN9/CHO
DR   Wikidata; Q127380497
RX   Patent=US8076458;
RX   PubMed=19555390;
RX   PubMed=25744656;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2051; CLDN9 (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/CREB-luc
AC   CVCL_KS38
DR   Wikidata; Q54813137
RX   PubMed=16834536;
CC   Characteristics: The luciferase reporter gene is under the control of the CREB response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0008.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   CHO/dhFr-AC-free
AC   CVCL_JX39
DR   ECACC; 05011002
DR   Wikidata; Q54813139
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   CHO/EpCAM
AC   CVCL_D2TL
DR   Wikidata; Q127380498
RX   PubMed=33125138;
RX   PubMed=35735360;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11529; EPCAM (Note=With a C-terminal GVAMPGAEDDVV = PA-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/Galpha16
AC   CVCL_IY41
SY   CHO/Ga16; RD-HGA16; CHO-RD-HGA16
DR   CLO; CLO_0037221
DR   Wikidata; Q54813148
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: Molecular Devices; Catalog number RD-HGA16.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   CHO/gpCXCR1
AC   CVCL_E7DA
RX   PubMed=28430080;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q0QLG2; Guinea pig Cxcr1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO/gpCXCR2
AC   CVCL_E7DB
RX   PubMed=28430080;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q810T4; Guinea pig Cxcr2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO/gPDPN
AC   CVCL_D2V5
DR   Wikidata; Q127380499
RX   PubMed=31338471;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A452F5L0; Capra hircus PDPN (Note=With a N-terminal PGTGDGMVPPGIEDKI = MAP16 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CHO/Gqi5 G418-resistant
AC   CVCL_IY42
DR   Wikidata; Q54813149
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Molecular Devices; Catalog number RD-HGQI5 (G418).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   CHO/Gqi5 hygromycin-resistant
AC   CVCL_IY43
DR   Wikidata; Q54813150
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: Molecular Devices; Catalog number RD-HGQI5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   CHO/Gqo5
AC   CVCL_IY44
DR   Wikidata; Q54813151
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: Molecular Devices; Catalog number RD-HGQO5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   CHO/Gqs5 G418-resistant
AC   CVCL_IY45
SY   RD-HGQS5 (G148)
DR   Wikidata; Q54813152
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqs5, with 355-QYELL-359 from GNAS).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Molecular Devices; Catalog number RD-HGQS5 (G418).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   CHO/Gqs5 hygromycin-resistant
AC   CVCL_IY46
DR   Wikidata; Q54813153
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqs5, with 355-QYELL-359 from GNAS).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: Molecular Devices; Catalog number RD-HGQS5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   CHO/Gqz5 G418-resistant
AC   CVCL_IY47
DR   Wikidata; Q54813154
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqz5, with 355-YIGLC-359 from GNAZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Molecular Devices; Catalog number RD-HGQZ5 (G418).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   CHO/Gqz5 hygromycin-resistant
AC   CVCL_IY48
DR   Wikidata; Q54813155
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqz5, with 355-YIGLC-359 from GNAZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: Molecular Devices; Catalog number RD-HGQZ5 (HYG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   CHO/hCCR6
AC   CVCL_D2T1
DR   Wikidata; Q127380500
RX   PubMed=37428612;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1607; CCR6 (Note=With a C-terminal Myc-DDK tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/hCCR9
AC   CVCL_D2SF
DR   Wikidata; Q127380501
RX   PubMed=34161159;
RX   PubMed=36383113;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1610; CCR9 (Note=With a C-terminal Myc-DDK tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/HER2 [Iran]
AC   CVCL_E8FW
DR   ABM; T3193
RX   DOI=10.7508/rmm.2015.03.002;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CHO/HER2 [Japan]
AC   CVCL_D2T4
DR   Wikidata; Q127380502
RX   PubMed=28700270;
RX   PubMed=38563783;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CHO/HER2 W614A
AC   CVCL_D3EI
DR   Wikidata; Q127380503
RX   PubMed=38563783;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Trp614Ala and with a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/HER3-PA
AC   CVCL_D2TC
DR   Wikidata; Q127380504
RX   PubMed=34184091;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3431; ERBB3 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/HGPRT
AC   CVCL_8545
DR   JCRB; JCRB0218
DR   Wikidata; Q54813156
CC   Characteristics: HGPRT-deficient.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 9
//
ID   CHO/horPDPN
AC   CVCL_D2UY
DR   Wikidata; Q127380505
RX   PubMed=30362932;
RX   PubMed=30766925;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112763; Horse PDPN (Note=With a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CHO/hPD-L1
AC   CVCL_D2S6
DR   Wikidata; Q127380506
RX   PubMed=29608408;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/hPDPN
AC   CVCL_D2U5
SY   CHO-K1/hPDPN; CHO/hPDPN-FLAG
DR   Wikidata; Q127380507
RX   Patent=US10227407;
RX   PubMed=25080943;
RX   PubMed=26492619;
RX   PubMed=26683179;
RX   PubMed=26788987;
RX   PubMed=26937552;
RX   PubMed=27267652;
RX   PubMed=27328060;
RX   PubMed=27380308;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29602; PDPN (Note=With a C-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/hTIGIT
AC   CVCL_D2TE
DR   Wikidata; Q127380508
RX   PubMed=33900817;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26838; TIGIT (Note=With a N-terminal PGTGDGMVPPGIEDKI = MAP16-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/IDH1-R132C
AC   CVCL_D3DS
DR   Wikidata; Q127380509
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Cys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH1-R132G
AC   CVCL_D3DT
DR   Wikidata; Q127380511
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Gly).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH1-R132H
AC   CVCL_D3DU
DR   Wikidata; Q127380512
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CHO/IDH1-R132L
AC   CVCL_D3DV
DR   Wikidata; Q127380513
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Leu).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH1-R132S
AC   CVCL_D3DW
DR   Wikidata; Q127380514
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH1-R132V
AC   CVCL_D3DX
DR   Wikidata; Q127380515
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH1-WT
AC   CVCL_D3DY
DR   Wikidata; Q127380516
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5382; IDH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH2-R172G
AC   CVCL_D3DQ
DR   Wikidata; Q127380517
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Gly).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH2-R172K
AC   CVCL_D3D8
DR   Wikidata; Q127380518
RX   PubMed=23524262;
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH2-R172M
AC   CVCL_D3D9
DR   Wikidata; Q127380519
RX   PubMed=23524262;
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Met).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH2-R172S
AC   CVCL_D3DR
DR   Wikidata; Q127380520
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH2-R172W
AC   CVCL_D3DA
DR   Wikidata; Q127380522
RX   PubMed=23524262;
RX   PubMed=23782684;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Trp).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IDH2-WT
AC   CVCL_D3DB
SY   CHO/IDH2-Wild Type
DR   Wikidata; Q127380523
RX   PubMed=23524262;
RX   PubMed=24328739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5383; IDH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/IR
AC   CVCL_R864
SY   CHO-IR
DR   EFO; EFO_0022827
DR   Wikidata; Q54813157
RX   PubMed=1385403;
RX   PubMed=10389839;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   CHO/IR/IRS-1
AC   CVCL_R865
SY   CHO-IR/IRS-1; CHO IR/IRS-1; CHO-IR/IRS1
DR   Wikidata; Q54813158
RX   PubMed=1385403;
RX   PubMed=10389839;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2922; Irs1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_R864 ! CHO/IR
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   CHO/IR/IRS-2
AC   CVCL_R867
DR   Wikidata; Q54813160
RX   PubMed=10389839;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109334; Irs2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_R864 ! CHO/IR
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   CHO/IRS-1
AC   CVCL_R866
DR   Wikidata; Q54813159
RX   PubMed=1385403;
RX   PubMed=10389839;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2922; Irs1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   CHO/Kcnk3
AC   CVCL_HC54
SY   CHO/Task-1
DR   Kerafast; EG0003-FP
DR   Wikidata; Q54813161
CC   From: Bayliss, Douglas A.; University of Virginia; Cleveland; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61997; Kcnk3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 10
//
ID   CHO/Kcnk3/Kcnk9
AC   CVCL_HC55
SY   CHO/Task-1/Task-3
DR   Kerafast; EG0005-FP
DR   Wikidata; Q54813162
CC   From: Bayliss, Douglas A.; University of Virginia; Cleveland; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61997; Kcnk3.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 621451; Kcnk9.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 10
//
ID   CHO/Kcnk9
AC   CVCL_HC56
SY   CHO/Task-3
DR   Kerafast; EG0004-FP
DR   Wikidata; Q54813163
CC   From: Bayliss, Douglas A.; University of Virginia; Cleveland; USA.
CC   Genetic integration: Method=Transfection; Gene=RGD; 621451; Kcnk9.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 10
//
ID   CHO/MAP-ChamPDPN
AC   CVCL_D3CR
SY   CHO/ChamPDPN
DR   Wikidata; Q127380524
RX   PubMed=35483059;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q401Z9; Cricetulus griseus Pdpn (Note=With a N-terminal GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/MAP-ferPDPN
AC   CVCL_D3CN
SY   CHO/ferPDPN
DR   Wikidata; Q127380525
RX   PubMed=34161160;
RX   PubMed=35471053;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G9KFV5; Mustela putorius furo PDPN (Note=With a N-terminal GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/MAP-seaPDPN
AC   CVCL_D2S2
DR   Wikidata; Q127380526
RX   PubMed=34042540;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A6J2BQN3; Zalophus californianus PDPN (Note=With a N-terminal GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CHO/MAP16-elePDPN
AC   CVCL_D3CJ
DR   Wikidata; Q127380527
RX   PubMed=34042502;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G3T5I4; Loxodonta africana PDPN (Note=With a N-terminal PGTGDGMVPPGIEDKI = MAP16 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/MAP16-girPDPN
AC   CVCL_D3CW
DR   Wikidata; Q127380528
RX   PubMed=38150189;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Giraffa camelopardalis PDPN (Note=With a N-terminal PGTGDGMVPPGIEDKI = MAP16 tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/mCCR2
AC   CVCL_D2ST
DR   Wikidata; Q127380529
RX   PubMed=35377242;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:106185; Ccr2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/mCCR3
AC   CVCL_D2R5
DR   Wikidata; Q127380530
RX   PubMed=33877898;
RX   PubMed=35225661;
RX   PubMed=35471049;
RX   PubMed=35471054;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104616; Ccr3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CHO/mCCR4
AC   CVCL_D2SV
DR   Wikidata; Q127380531
RX   PubMed=35471046;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107824; Ccr4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/mCCR6
AC   CVCL_D2SX
DR   Wikidata; Q127380532
RX   PubMed=36383115;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1333797; Ccr6 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a with a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/mCCR8
AC   CVCL_D2RS
DR   Wikidata; Q127380533
RX   PubMed=33900818;
RX   PubMed=35377236;
RX   PubMed=35483056;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1201402; Ccr8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/mCCR9
AC   CVCL_D2SZ
DR   Wikidata; Q127380534
RX   PubMed=36516144;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341902; Ccr9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CHO/mCD39
AC   CVCL_D2RN
DR   Wikidata; Q127380536
RX   PubMed=38126892;
RX   PubMed=38197855;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:102805; Entpd1 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a with a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/mCXCR6
AC   CVCL_D2SC
DR   Wikidata; Q127380539
RX   PubMed=35736626;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1934582; Cxcr6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/mEGFR
AC   CVCL_D2SI
DR   Wikidata; Q127380540
RX   PubMed=37489364;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95294; Egfr (Note=With a N-terminal GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/mHER2
AC   CVCL_D2SQ
DR   Wikidata; Q127380541
RX   DOI=10.3390/ijtm3030022;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95410; Erbb2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CHO/mo AA4
AC   CVCL_C8BP
DR   Wikidata; Q123030919
RX   PubMed=11465094;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:106664; Cd93.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 4
//
ID   CHO/mPDPN
AC   CVCL_YA13
SY   CHO/mPDPN-FLAG
DR   Wikidata; Q93452590
RX   PubMed=23012488;
RX   PubMed=26683179;
RX   PubMed=26788987;
RX   PubMed=27267652;
RX   PubMed=27380308;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:103098; Pdpn (Note=With a C-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   CHO/OAR2-3
AC   CVCL_F973
DR   TKG; TKG 0407
DR   Wikidata; Q54813164
RX   PubMed=7916570;
CC   Selected for resistance to: ChEBI; CHEBI_44658; Okadaic acid.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   CHO/OAR6-6
AC   CVCL_F974
DR   TKG; TKG 0408
DR   Wikidata; Q54813165
RX   PubMed=7916570;
CC   Selected for resistance to: ChEBI; CHEBI_44658; Okadaic acid.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   CHO/PA-bovPDPN-RAP-MAP
AC   CVCL_D2UR
DR   Wikidata; Q127380542
RX   PubMed=27267652;
RX   PubMed=27380308;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:50142; Bovine PDPN (Note=With a N-terminal GVAMPGAEDDVV = PA-tag, C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CHO/PA-dPDPN-RAP-MAP
AC   CVCL_D2UW
DR   Wikidata; Q127380543
RX   PubMed=27380308;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:52226; Dog PDPN (Note=With a N-terminal GVAMPGAEDDVV = PA-tag, C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CHO/PA-hKLRG1
AC   CVCL_C5D7
SY   CHO/hKLRG1
DR   Wikidata; Q116048765
RX   PubMed=33900816;
RX   PubMed=36306514;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6380; KLRG1 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   CHO/PA16-girPDPN
AC   CVCL_D3CX
DR   Wikidata; Q127380544
RX   PubMed=38150189;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Giraffa camelopardalis PDPN (Note=With a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   CHO/PA16-HER3
AC   CVCL_D2TD
DR   Wikidata; Q127380545
RX   PubMed=34184091;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3431; ERBB3 (Note=With a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CHO/PA16-TROP2-RAP-MAP
AC   CVCL_B7JS
DR   Wikidata; Q112929381
RX   PubMed=33300065;
RX   PubMed=33490649;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a N-terminal GLEGGVAMPGAEDDVV = PA16-tag, C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   CHO/pPDPN
AC   CVCL_D2V1
DR   Wikidata; Q127380547
RX   PubMed=30681406;
RX   PubMed=30802179;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:91288; Pig PDPN (Note=With a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CHO/pS2P
AC   CVCL_2H49
DR   Wikidata; Q54813166
RX   PubMed=9774448;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15455; MBTPS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   CHO/rabPDPN
AC   CVCL_D2UN
SY   CHO/PA-rabPDPN
DR   Wikidata; Q127380548
RX   PubMed=26788987;
RX   PubMed=27267652;
RX   PubMed=27380308;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G1SPW9; Rabbit PDPN (Note=With a N-terminal GVAMPGAEDDVV = PA-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/RIEDL-elePDPN
AC   CVCL_D3CK
SY   CHO/elePDPN
DR   Wikidata; Q127380549
RX   PubMed=34042502;
RX   PubMed=35917562;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G3T5I4; Loxodonta africana PDPN (Note=With a N-terminal RIEDL tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/rPDPN
AC   CVCL_D2UL
SY   CHO/rPDPN-His
DR   Wikidata; Q127380550
RX   PubMed=26683179;
RX   PubMed=26788987;
RX   PubMed=27267652;
RX   PubMed=27380308;
CC   Genetic integration: Method=Transfection; Gene=RGD; 61819; Pdpn (Note=With a C-terminal V5-His tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CHO/sPDPN
AC   CVCL_D2RY
DR   Wikidata; Q127380551
RX   PubMed=32349619;
RX   PubMed=32679010;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; W5PMJ8; Sheep PDPN (Note=With a N-terminal DMVNPGLEDRIEDL = RAP14-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CHO/tasPDPN
AC   CVCL_D2V8
DR   Wikidata; Q127380552
RX   PubMed=30984883;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G3WRM2; Sarcophilus harrisii PDPN (Note=With a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CHO/tigPDPN
AC   CVCL_D2V0
DR   Wikidata; Q127380553
RX   PubMed=31009336;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A8C9K7D8; Panthera tigris altaica PDPN (Note=With a N-terminal NSVTGIRIEDLPTSES = LP-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CHO/TROP2-PA
AC   CVCL_B7JT
DR   Wikidata; Q112929382
RX   PubMed=33300065;
RX   PubMed=33490649;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   CHO/wPDPN
AC   CVCL_D3CG
DR   Wikidata; Q127380554
RX   PubMed=31161965;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A2Y9EM55; Physeter macrocephalus PDPN (Note=With a N-terminal RIEDL tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CHO10PV
AC   CVCL_RU92
DR   CLO; CLO_0002430
DR   CLDB; cl743
DR   Wikidata; Q54813171
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO12RO
AC   CVCL_IM59
DR   CLO; CLO_0002431
DR   CLDB; cl744
DR   Wikidata; Q54813172
RX   PubMed=7135166;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   CHO181PV
AC   CVCL_RU93
DR   CLO; CLO_0002432
DR   CLDB; cl745
DR   Wikidata; Q54813173
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO191PV
AC   CVCL_RU94
DR   CLO; CLO_0002433
DR   CLDB; cl746
DR   Wikidata; Q54813174
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO192PV
AC   CVCL_RU95
DR   CLO; CLO_0002434
DR   CLDB; cl747
DR   Wikidata; Q54813175
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO201PV
AC   CVCL_RU96
DR   CLO; CLO_0002436
DR   CLDB; cl748
DR   Wikidata; Q54813176
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO202PV
AC   CVCL_RU97
DR   CLO; CLO_0002437
DR   CLDB; cl749
DR   Wikidata; Q54813177
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO203PV
AC   CVCL_RU98
DR   CLO; CLO_0002438
DR   CLDB; cl750
DR   Wikidata; Q54813178
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO204PV
AC   CVCL_RU99
DR   CLO; CLO_0002439
DR   CLDB; cl751
DR   Wikidata; Q54813179
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO205PV
AC   CVCL_RV00
DR   CLO; CLO_0002440
DR   CLDB; cl752
DR   Wikidata; Q54813180
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO211PV
AC   CVCL_RV01
DR   CLO; CLO_0002441
DR   CLDB; cl753
DR   Wikidata; Q54813181
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO23PV
AC   CVCL_RV02
DR   CLO; CLO_0002442
DR   CLDB; cl754
DR   Wikidata; Q54813182
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO2PV
AC   CVCL_RV03
DR   CLO; CLO_0002443
DR   CLDB; cl755
DR   Wikidata; Q54813183
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO302PV
AC   CVCL_RV04
DR   CLO; CLO_0002444
DR   CLDB; cl756
DR   Wikidata; Q54813184
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO30PV
AC   CVCL_RV05
DR   CLO; CLO_0002445
DR   CLDB; cl757
DR   Wikidata; Q54813185
RX   PubMed=22358449;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO33RO
AC   CVCL_IM60
DR   CLO; CLO_0002446
DR   CLDB; cl758
DR   Wikidata; Q54813186
RX   PubMed=7135166;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   CHO3PV
AC   CVCL_RV06
DR   CLO; CLO_0002447
DR   CLDB; cl759
DR   Wikidata; Q54813187
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO40PV
AC   CVCL_RV07
DR   CLO; CLO_0002448
DR   CLDB; cl760
DR   Wikidata; Q54813196
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO421PV
AC   CVCL_RV08
DR   CLO; CLO_0002449
DR   CLDB; cl761
DR   Wikidata; Q54813197
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO423PV
AC   CVCL_RV09
DR   CLO; CLO_0002450
DR   CLDB; cl762
DR   Wikidata; Q54813198
RX   PubMed=22358449;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO43RO
AC   CVCL_IM61
DR   CLO; CLO_0002451
DR   CLDB; cl763
DR   Wikidata; Q54813199
RX   PubMed=7135166;
RX   PubMed=22358449;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   CHO4PV
AC   CVCL_RV10
DR   CLO; CLO_0002452
DR   CLDB; cl764
DR   Wikidata; Q54813200
RX   PubMed=1855213;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO50PV
AC   CVCL_RV11
DR   CLO; CLO_0002453
DR   CLDB; cl765
DR   Wikidata; Q54813201
RX   PubMed=1855213;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO51PV
AC   CVCL_RV12
DR   CLO; CLO_0002454
DR   CLDB; cl766
DR   Wikidata; Q54813202
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO5PV
AC   CVCL_RV13
DR   CLO; CLO_0002455
DR   CLDB; cl767
DR   Wikidata; Q54813203
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO60PV
AC   CVCL_RV14
DR   CLO; CLO_0002456
DR   CLDB; cl768
DR   Wikidata; Q54813204
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO7PV
AC   CVCL_RV15
DR   CLO; CLO_0002457
DR   CLDB; cl769
DR   Wikidata; Q54813205
RX   PubMed=1855213;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHO9PV
AC   CVCL_RV16
DR   CLO; CLO_0002458
DR   CLDB; cl770
DR   Wikidata; Q54813206
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   CHOCi002-A
AC   CVCL_C9Z8
DR   hPSCreg; CHOCi002-A
DR   Wikidata; Q123030920
RX   PubMed=37167752;
CC   From: Children's Hospital of Orange County; Orange; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (PubMed=37167752).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Tyr609Ter (c.1826dupA); ClinVar=VCV000189144; Zygosity=Heterozygous (PubMed=37167752).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CHOCi003-A
AC   CVCL_C9Z9
DR   hPSCreg; CHOCi003-A
DR   Wikidata; Q123030921
RX   PubMed=37167752;
CC   From: Children's Hospital of Orange County; Orange; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asn87Glnfs*9 (c.258dupC) (c.251insC); ClinVar=VCV000282842; Zygosity=Heterozygous (PubMed=37167752).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gln743Ter (c.2227C>T); ClinVar=VCV000370157; Zygosity=Heterozygous (PubMed=37167752).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CHOCi004-A
AC   CVCL_C9ZA
DR   hPSCreg; CHOCi004-A
DR   Wikidata; Q123030922
CC   From: Children's Hospital of Orange County; Orange; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CHOCi005-A
AC   CVCL_C9ZB
DR   BioSamples; SAMEA115493702
DR   hPSCreg; CHOCi005-A
DR   Wikidata; Q123030923
CC   From: Children's Hospital of Orange County; Orange; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Cys127Tyr (c.380G>A); ClinVar=VCV000918041; Zygosity=Heterozygous (hPSCreg=CHOCi005-A).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Trp161Gly (c.481T>G); ClinVar=VCV000092910; Zygosity=Heterozygous (hPSCreg=CHOCi005-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W024 ! GM03589
SX   Female
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   CHOCi006-A
AC   CVCL_C9ZC
DR   hPSCreg; CHOCi006-A
DR   Wikidata; Q123030924
CC   From: Children's Hospital of Orange County; Orange; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CHOC 400
AC   CVCL_4Y55
SY   CHOC400; CHO C400
DR   Wikidata; Q54813207
RX   PubMed=2841578;
RX   PubMed=6273843;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   CHOEBNALT85
AC   CVCL_E3JG
RX   PubMed=23357356;
WW   Provider; Icosagen; -; https://www.icosagen.com/science/qmcf-technology-licensing/
CC   Biotechnology: Used in an expression system called QMCF Technology which allows transient mammalian expression system for recombinant protein production with high yields of up to 1g/L (Icosagen).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOJ5; Murine polyomavirus (strain A3) (MPyV) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 157703; Murine polyomavirus (strain A3) (MPyV).
CC   Miscellaneous: Information on transfected genes from personal communication of Mannik, Andres.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   CHOEBNALT85-furin
AC   CVCL_E3KX
WW   Provider; Icosagen; -; https://www.icosagen.com/news/cho-based-furin-expression-cell-line-for-production-of-difficult-to-express-proteins/
CC   Biotechnology: Used in an expression system called QMCF Technology which allows transient mammalian expression system for recombinant protein production with high yields of up to 1g/L (Icosagen).
CC   Biotechnology: Allows better processing of pro-proteins expressed using this cell line (Icosagen).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8568; FURIN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOJ5; Murine polyomavirus (strain A3) (MPyV) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 157703; Murine polyomavirus (strain A3) (MPyV).
CC   Miscellaneous: Information on transfected genes from personal communication of Mannik, Andres.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3JG ! CHOEBNALT85
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   CHOExpress
AC   CVCL_VN06
SY   CHO-Express
DR   Wikidata; Q93453004
WW   Provider; ExcellGene; -; https://excellgene.com/technologies/cho
CC   Group: Serum/protein free medium cell line.
CC   Biotechnology: Used for high yield production of therapeutic proteins and antibodies (ExcellGene).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   Choi-CK
AC   CVCL_M269
DR   Wikidata; Q54813208
RX   CelloPub=CLPUB00275;
RX   PubMed=11107175;
RX   PubMed=35640676;
CC   Population: Korean.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   CHOK1-E
AC   CVCL_E8IB
RX   PubMed=23335490;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13280; ERO1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHOK1SV
AC   CVCL_DR95
SY   CHO-K1SV; CHO K1SV
DR   FCS-free; 72-8-221-1-4-3
DR   PRIDE; PXD003462
DR   Wikidata; Q54813209
RX   Patent=US8241870;
RX   PubMed=17172663;
RX   PubMed=27070921;
WW   Provider; Lonza; -; https://web.archive.org/web/20190323073441/http://www.lonza.com/custom-manufacturing/development-technologies/gs-gene-expression-system.aspx
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Compared to CHO-K1, this cell line is adapted to growth in suspension and protein-free medium.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   CHOK1SV GS KO
AC   CVCL_DR97
SY   CHOK1SV GS-KO; CHO K1SV GS KO; CHOK1SV GS Knockout
DR   Wikidata; Q54813210
RX   PubMed=22068567;
RX   PubMed=25502369;
WW   Provider; Lonza; -; https://www.lonza.com/knowledge-center/biologics/w/chok1sv-gs-ko-cell-line
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=ZFN; UniProtKB; P04773; Glul.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DR95 ! CHOK1SV
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHOL761h
AC   CVCL_C8H6
SY   CHO-L761h; CHOL76-1h
DR   Wikidata; Q123030925
RX   Patent=US6653101;
RX   PubMed=1707522;
CC   Characteristics: Expresses a mutant form of the Ad5 E1A gene product under the control of a SV40 promoter. Allows maximal transactivation of constructs that are under the control of a hCMV-MIE promoter (Patent=US6653101; PubMed=1707522).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein (Note=With p.Glu126Gly = R1176E1A).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   CHOmt17-0
AC   CVCL_YY02
DR   Wikidata; Q98125622
RX   PubMed=29439861;
RX   PubMed=32125558;
CC   Characteristics: Can produce a considerably large amount of sialyled glycoproteins.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10860; ST6GAL1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1354951; Gne.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   CHOmt17-100
AC   CVCL_YY03
DR   Wikidata; Q98125623
RX   PubMed=32125558;
CC   Characteristics: Can produce a considerably large amount of sialyled glycoproteins.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10860; ST6GAL1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1354951; Gne.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_YY02 ! CHOmt17-0
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   CHOmt17-200
AC   CVCL_YY04
DR   Wikidata; Q98125624
RX   PubMed=32125558;
CC   Characteristics: Can produce a considerably large amount of sialyled glycoproteins.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10860; ST6GAL1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1354951; Gne.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_YY02 ! CHOmt17-0
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   CHOmt17-300
AC   CVCL_YY05
DR   Wikidata; Q98125625
RX   PubMed=32125558;
CC   Characteristics: Can produce a considerably large amount of sialyled glycoproteins.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10860; ST6GAL1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1354951; Gne.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_YY02 ! CHOmt17-0
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   CHON-001
AC   CVCL_C462
DR   ATCC; CRL-2846
DR   BioSample; SAMN03471801
DR   Wikidata; Q54813211
CC   HLA typing: B*58,81; C*06,08 (ATCC=CRL-2846).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal bone, long bone, cartilage; UBERON=UBERON_8480044.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): ATCC=CRL-2846
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D18S51: 12,15
ST   D19S433: 10,13
ST   D21S11: 30.2,36
ST   D2S1338: 19,25
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 20,25
ST   Penta D: 8,12
ST   Penta E: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C463 ! CHON-002
OI   CVCL_0F16 ! CHON-003
OI   CVCL_0F18 ! CHON-004
OI   CVCL_0F19 ! CHON-005
OI   CVCL_0F20 ! CHON-006
SX   Female
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   CHON-002
AC   CVCL_C463
DR   ATCC; CRL-2847
DR   Wikidata; Q54813212
CC   HLA typing: B*58,81; C*06,08 (ATCC=CRL-2847).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal bone, long bone, cartilage; UBERON=UBERON_8480044.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): ATCC=CRL-2847
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D18S51: 12,15
ST   D19S433: 10,13
ST   D21S11: 30.2,36
ST   D2S1338: 19,25
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 20,25
ST   Penta D: 8,12
ST   Penta E: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C462 ! CHON-001
OI   CVCL_0F16 ! CHON-003
OI   CVCL_0F18 ! CHON-004
OI   CVCL_0F19 ! CHON-005
OI   CVCL_0F20 ! CHON-006
SX   Female
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   CHON-003
AC   CVCL_0F16
DR   ATCC; CRL-2848
DR   Wikidata; Q54813213
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-2848; true.
CC   Derived from site: In situ; Fetal bone, long bone, cartilage; UBERON=UBERON_8480044.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): ATCC=CRL-2848
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C462 ! CHON-001
OI   CVCL_C463 ! CHON-002
OI   CVCL_0F18 ! CHON-004
OI   CVCL_0F19 ! CHON-005
OI   CVCL_0F20 ! CHON-006
SX   Female
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   CHON-004
AC   CVCL_0F18
DR   ATCC; CRL-2856
DR   Wikidata; Q54813214
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-2856; true.
CC   Derived from site: In situ; Fetal bone, long bone, cartilage; UBERON=UBERON_8480044.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): ATCC=CRL-2856
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C462 ! CHON-001
OI   CVCL_C463 ! CHON-002
OI   CVCL_0F16 ! CHON-003
OI   CVCL_0F19 ! CHON-005
OI   CVCL_0F20 ! CHON-006
SX   Female
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   CHON-005
AC   CVCL_0F19
DR   ATCC; CRL-2857
DR   Wikidata; Q54813215
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-2857; true.
CC   Derived from site: In situ; Fetal bone, long bone, cartilage; UBERON=UBERON_8480044.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): ATCC=CRL-2857
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C462 ! CHON-001
OI   CVCL_C463 ! CHON-002
OI   CVCL_0F16 ! CHON-003
OI   CVCL_0F18 ! CHON-004
OI   CVCL_0F20 ! CHON-006
SX   Female
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   CHON-006
AC   CVCL_0F20
DR   ATCC; CRL-2858
DR   Wikidata; Q54813216
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-2858; true.
CC   Derived from site: In situ; Fetal bone, long bone, cartilage; UBERON=UBERON_8480044.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C462 ! CHON-001
OI   CVCL_C463 ! CHON-002
OI   CVCL_0F16 ! CHON-003
OI   CVCL_0F18 ! CHON-004
OI   CVCL_0F19 ! CHON-005
SX   Female
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   CHOP
AC   CVCL_4702
DR   BTO; BTO_0002426
DR   EFO; EFO_0022828
DR   Wikidata; Q54813217
RX   PubMed=2011514;
RX   PubMed=16140251;
CC   Characteristics: Supports the extrachromosomal replication of eukaryotic expression vector carrying a polyoma origin of replication.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   CHOP-KO-DR
AC   CVCL_B046
DR   ATCC; CRL-2979
DR   Wikidata; Q54813218
CC   Knockout cell: Method=KO mouse; MGI; MGI:109247; Ddit3.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CHOP-TU
AC   CVCL_RJ71
DR   Wikidata; Q54813219
RX   PubMed=8800685;
CC   Characteristics: Supports the extrachromosomal replication of eukaryotic expression vector carrying a polyoma origin of replication.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   CHOPe003-A
AC   CVCL_C9EC
SY   H9-ACTG2-R257C; R257C #54 H9-hESC
DR   BioSamples; SAMEA114268384
DR   hPSCreg; CHOPe003-A
DR   Wikidata; Q123030926
RX   PubMed=37643495;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:145; ACTG2; Simple_edited; p.Arg257Cys (c.769C>T); ClinVar=VCV000132803; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37643495).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C201588; Visceral myopathy 1
DI   ORDO; Orphanet_2604; Familial visceral myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CHOPHPS1
AC   CVCL_DQ88
DR   Wikidata; Q54813221
RX   PubMed=27345974;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.His497Glnfs*90 (c.1472_1487dup16); ClinVar=VCV000005277; Zygosity=Homozygous (PubMed=27345974).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0R45 ! GM14609
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   CHOPHPS2
AC   CVCL_DQ89
DR   Wikidata; Q54813222
RX   PubMed=27345985;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; p.Arg509Ter (c.1525C>T); ClinVar=VCV000006377; Zygosity=Heterozygous (PubMed=27345985).
CC   Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; p.Glu659Ter (c.1975G>T); ClinVar=VCV000006378; Zygosity=Heterozygous (PubMed=27345985).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150368; Hermansky-Pudlak syndrome 2
DI   ORDO; Orphanet_183678; Hermansky-Pudlak syndrome with neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0R47 ! GM17890
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   CHOPi001-A
AC   CVCL_VN17
SY   CHOPJMML1854
DR   BioSamples; SAMEA5291610
DR   hPSCreg; CHOPi001-A
DR   Wikidata; Q93453044
RX   PubMed=30096712;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1541; CBL; Simple; p.Tyr371His (c.1111T>C); ClinVar=VCV000013811; Zygosity=Hemizygous (PubMed=30096712).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9233; Juvenile myelomonocytic leukemia
DI   ORDO; Orphanet_86834; Juvenile myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   CHOPi002-A
AC   CVCL_UL69
SY   CHOPSCA2-1
DR   hPSCreg; CHOPi002-A
DR   Wikidata; Q93453045
RX   PubMed=30611021;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian; French/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[33] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous (PubMed=30611021).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CHOPi003-A
AC   CVCL_UL70
SY   CHOPSCA2-2
DR   hPSCreg; CHOPi003-A
DR   Wikidata; Q93453046
RX   PubMed=30611021;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[43] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous (PubMed=30611021).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CHOPi004-A
AC   CVCL_A1VY
SY   CHOPWT4
DR   hPSCreg; CHOPi004-A
DR   Wikidata; Q105506620
RX   PubMed=33202304;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0N66 ! AG07095
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   CHOPi005-A
AC   CVCL_B3NQ
SY   LD0638.0A
DR   BioSamples; SAMEA9693917
DR   hPSCreg; CHOPi005-A
DR   Wikidata; Q110432716
RX   PubMed=37003180;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:20774; TUBB4A; Simple; p.Asp249Asn (c.745G>A); ClinVar=VCV000050985; Zygosity=Heterozygous (PubMed=37003180).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183310; Hypomyelinating leukodystrophy-6
DI   ORDO; Orphanet_139441; Hypomyelination with atrophy of basal ganglia and cerebellum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   CHOPi006-A
AC   CVCL_B3NR
SY   LD0313.0
DR   BioSamples; SAMEA9693915
DR   hPSCreg; CHOPi006-A
DR   Wikidata; Q110432717
RX   PubMed=37003180;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20774; TUBB4A; Simple; p.Asp249Asn (c.745G>A); ClinVar=VCV000050985; Zygosity=Heterozygous (PubMed=37003180).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183310; Hypomyelinating leukodystrophy-6
DI   ORDO; Orphanet_139441; Hypomyelination with atrophy of basal ganglia and cerebellum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   CHOPi007-A
AC   CVCL_B3NS
SY   LD_0853.0
DR   BioSamples; SAMEA9693342
DR   hPSCreg; CHOPi007-A
DR   Wikidata; Q110432720
RX   PubMed=37003180;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20774; TUBB4A; Simple; p.Asp249Asn (c.745G>A); ClinVar=VCV000050985; Zygosity=Heterozygous (PubMed=37003180).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183310; Hypomyelinating leukodystrophy-6
DI   ORDO; Orphanet_139441; Hypomyelination with atrophy of basal ganglia and cerebellum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   CHOPi008-A
AC   CVCL_C1NU
SY   TMD145.T21.G1S
DR   BioSamples; SAMEA111510065
DR   hPSCreg; CHOPi008-A
DR   Wikidata; Q114310960
RX   PubMed=37084616;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+21 (PubMed=37084616).
CC   Sequence variation: Mutation; HGNC; HGNC:4170; GATA1; Simple; p.Glu2Glyfs*37 (c.4dupG) (c.3_4insG); ClinVar=VCV000998065; Zygosity=Unspecified (PubMed=37084616).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C82339; Transient abnormal myelopoiesis associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1NV ! CHOPi008-B
OI   CVCL_C1NW ! CHOPi008-C
SX   Male
AG   8D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   CHOPi008-B
AC   CVCL_C1NV
SY   TMD145.E46.G1S; CHOPi-008-B
DR   BioSamples; SAMEA111510100
DR   hPSCreg; CHOPi008-B
DR   Wikidata; Q114310961
RX   PubMed=37677872;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Characteristics: While originating from a Down syndrome patient, this cell line has lost the extra copy of chromosome 21 (PubMed=37677872).
CC   Karyotypic information: 46,XY (PubMed=37677872).
CC   Sequence variation: Mutation; HGNC; HGNC:4170; GATA1; Simple; p.Glu2Glyfs*37 (c.4dupG) (c.3_4insG); ClinVar=VCV000998065; Zygosity=Unspecified (PubMed=37677872).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C82339; Transient abnormal myelopoiesis associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1NU ! CHOPi008-A
OI   CVCL_C1NW ! CHOPi008-C
SX   Male
AG   8D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   CHOPi008-C
AC   CVCL_C1NW
SY   DS145.T21.G1
DR   BioSamples; SAMEA111510099
DR   hPSCreg; CHOPi008-C
DR   Wikidata; Q114310962
RX   PubMed=37084616;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+21 (PubMed=37084616).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C82339; Transient abnormal myelopoiesis associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1NU ! CHOPi008-A
OI   CVCL_C1NV ! CHOPi008-B
SX   Male
AG   8D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   CHOPi009-A
AC   CVCL_C1NX
SY   LD_0324.0
DR   BioSamples; SAMEA110587394
DR   hPSCreg; CHOPi009-A
DR   Wikidata; Q114310963
RX   PubMed=38181636;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:225; ADAR; Simple; p.Gly1007Arg (c.3019G>A); ClinVar=VCV000039458; Zygosity=Heterozygous (PubMed=38181636).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206070; Aicardi-Goutieres syndrome 6
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   CHOPi010-A
AC   CVCL_C1NY
SY   LD_1163.0
DR   BioSamples; SAMEA110587398
DR   hPSCreg; CHOPi010-A
DR   Wikidata; Q114310964
RX   PubMed=38181636;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:225; ADAR; Simple; p.Gly1007Arg (c.3019G>A); ClinVar=VCV000039458; Zygosity=Heterozygous (PubMed=38181636).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206070; Aicardi-Goutieres syndrome 6
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   CHOPi011-A
AC   CVCL_C1NZ
SY   LD_1669.0
DR   BioSamples; SAMEA110587400
DR   hPSCreg; CHOPi011-A
DR   Wikidata; Q114310965
RX   PubMed=38181636;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:225; ADAR; Simple; p.Gly1007Arg (c.3019G>A); ClinVar=VCV000039458; Zygosity=Heterozygous (PubMed=38181636).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206070; Aicardi-Goutieres syndrome 6
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   CHOPi012-A
AC   CVCL_C6SS
SY   CHOPACTG2-R257C
DR   BioSamples; SAMEA114192292
DR   hPSCreg; CHOPi012-A
DR   Wikidata; Q117704241
RX   PubMed=37572398;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:145; ACTG2; Simple; p.Arg257Cys (c.769C>T); ClinVar=VCV000132803; Zygosity=Heterozygous (PubMed=37572398).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201588; Visceral myopathy 1
DI   ORDO; Orphanet_2604; Familial visceral myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   CHOPi013-A
AC   CVCL_C9JE
SY   CHOPWT17_TPM1KOc28
DR   BioSamples; SAMEA113376662
DR   hPSCreg; CHOPi013-A
DR   Wikidata; Q123030927
RX   PubMed=37422949;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12010; TPM1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37422949
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 14,15
ST   D12S391: 17,24
ST   D13S317: 8,13
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D1S1656: 12,16
ST   D21S11: 29,31
ST   D22S1045: 14,15
ST   D2S1338: 17,20
ST   D2S441: 10,14
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   DYS391: 12
ST   FGA: 22,25
ST   Penta D: 10,11
ST   Penta E: 7,21
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JD ! CHOPWT17
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CHOPi014-A
AC   CVCL_F1KU
SY   CHOPWT15
DR   hPSCreg; CHOPi014-A
RX   PubMed=40865209;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40865209
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D10S1248: 13,15
ST   D12S391: 20,22
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 18,19
ST   D19S433: 12,14.2
ST   D1S1656: 10,14
ST   D21S11: 28,30
ST   D22S1045: 11,16
ST   D2S1338: 19,25
ST   D2S441: 12,13
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 15,16
ST   DYS391: 10
ST   FGA: 21
ST   Penta D: 2.2,11
ST   Penta E: 7,11
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CHOpper Discovery
AC   CVCL_WB19
DR   Wikidata; Q93453047
RX   Patent=US8962312;
RX   PubMed=21345355;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2909.
CC   Doubling time: ~17 hours (Patent=US8962312).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q2MH30; Cricetulus griseus Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   CHOpper Standard
AC   CVCL_WB20
DR   Wikidata; Q93453048
RX   Patent=US8962312;
RX   PubMed=21345355;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2910.
CC   Doubling time: ~22 hours (Patent=US8962312).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q2MH30; Cricetulus griseus Dhfr.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   CHOPS1a
AC   CVCL_E3DU
RX   PubMed=10771091;
RX   PubMed=11330054;
CC   Characteristics: Transfected with a GFP C-terminally tagged with peroxisomal PTS1 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CHOPS12a
AC   CVCL_E3DV
RX   PubMed=10771091;
CC   Characteristics: Transfected with a GFP N-terminally tagged with peroxisomal PTS2 signal and C-terminally tagged with a PTS1 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CHOPS2a
AC   CVCL_E3DW
RX   PubMed=10771091;
RX   PubMed=11330054;
CC   Characteristics: Transfected with a GFP N-terminally tagged with peroxisomal PTS2 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CHOPWT1.1
AC   CVCL_DR05
SY   CHOP_WT1.1; WT1.1; PCBC01hsi2011070101; SC11-002
DR   GEO; GSM1195654
DR   GEO; GSM1195655
DR   GEO; GSM1195656
DR   Wikidata; Q54813224
RX   PubMed=23940280;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [18]; 47,XX,+12 [2] (PubMed=27293150).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7311 ! GM00969
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CHOPWT1.2
AC   CVCL_DR06
SY   CHOP_WT1.2; WT1.2; PCBC01hsi2011070102; SC11-003
DR   GEO; GSM1195657
DR   GEO; GSM1195658
DR   GEO; GSM1195659
DR   Wikidata; Q54813225
RX   PubMed=23940280;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7311 ! GM00969
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHOPWT1.3
AC   CVCL_DR07
SY   CHOP_WT1.3; WT1.3; PCBC01hsi2011070103; SC11-004
DR   GEO; GSM1195660
DR   GEO; GSM1195661
DR   GEO; GSM1195662
DR   Wikidata; Q54813226
RX   PubMed=23940280;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7311 ! GM00969
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CHOPWT10
AC   CVCL_DQ90
DR   Wikidata; Q54813227
RX   PubMed=27345999;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CHOPWT17
AC   CVCL_C9JD
DR   Wikidata; Q123030928
RX   PubMed=37422949;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CHOPWT2.1
AC   CVCL_DR08
SY   CHOP_WT2.1; WT2.1; PCBC01hsi2011070104; SC11-005
DR   GEO; GSM1195663
DR   GEO; GSM1195664
DR   GEO; GSM1195665
DR   Wikidata; Q54813228
RX   PubMed=23940280;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Latino or Hispanic.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7432 ! GM05565
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CHOPWT2.2
AC   CVCL_DR09
SY   CHOP_WT2.2; WT2.2; PCBC01hsi2011070105; SC11-006
DR   GEO; GSM1195666
DR   GEO; GSM1195667
DR   GEO; GSM1195668
DR   Wikidata; Q54813229
RX   PubMed=23940280;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Latino or Hispanic.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7432 ! GM05565
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CHOPWT2.3
AC   CVCL_DR10
SY   CHOP_WT2.3; WT2.3; PCBC01hsi2011070106; SC11-007
DR   GEO; GSM1195669
DR   GEO; GSM1195670
DR   GEO; GSM1195671
DR   Wikidata; Q54813230
RX   PubMed=23940280;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Population: Latino or Hispanic.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7432 ! GM05565
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CHOPWT9
AC   CVCL_9U75
DR   Wikidata; Q54813231
RX   PubMed=27345777;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   CHOR 3-4
AC   CVCL_HA81
DR   Wikidata; Q54813232
RX   PubMed=9049097;
CC   Selected for resistance to: UniProtKB; P11140; Abrus precatorius abrin-A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   Chor-IN-1
AC   CVCL_AV04
DR   Wikidata; Q54813233
RX   DOI=10.1158/1538-7445.AM2015-74;
RX   PubMed=28835717;
CC   Doubling time: ~7 days (PubMed=28835717).
CC   Sequence variation: Mutation; HGNC; HGNC:6308; KEL; Simple; p.Ser726fs (c.2176delA); Zygosity=Unspecified; Note=Somatic (PubMed=28835717).
CC   Sequence variation: Mutation; HGNC; HGNC:7508; MUC1; Simple; p.Pro24Thr (c.70C>A); Zygosity=Unspecified; Note=Somatic (PubMed=28835717).
CC   Sequence variation: Mutation; HGNC; HGNC:16860; SART3; Simple; p.Glu556Lys (c.1666G>A); Zygosity=Unspecified; Note=Somatic (PubMed=28835717).
CC   Sequence variation: Mutation; HGNC; HGNC:11720; TECTA; Simple; p.Arg1450His (c.4349G>A); Zygosity=Unspecified; Note=Somatic (PubMed=28835717).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): PubMed=28835717
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15,17
ST   D21S11: 31,31.2
ST   D3S1358: 17,18
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   D8S1179: 12,15
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 12,21
ST   TH01: 9.3
ST   TPOX: 7,8
ST   vWA: 18
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   CHOR16
AC   CVCL_UG11
DR   Wikidata; Q93453073
RX   PubMed=10196349;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10943; SLC1A5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   CHORC5 DeltaP-gp A1
AC   CVCL_C7GL
DR   Wikidata; Q117704242
RX   PubMed=35381425;
CC   Characteristics: Shows complete reversal of the resistance to both colchicine and doxorubicin which exist in the parental cell line (PubMed=35381425).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; P21448; Abcb1.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D266 ! CHO-CHRC5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   CHORC5 DeltaP-gp A2
AC   CVCL_C7GM
DR   Wikidata; Q117704243
RX   PubMed=35381425;
CC   Characteristics: Shows complete reversal of the resistance to both colchicine and doxorubicin which exist in the parental cell line (PubMed=35381425).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; P21448; Abcb1.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D266 ! CHO-CHRC5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   CHORC5 DeltaP-gp A3
AC   CVCL_C7GN
DR   Wikidata; Q117704244
RX   PubMed=35381425;
CC   Characteristics: Shows complete reversal of the resistance to both colchicine and doxorubicin which exist in the parental cell line (PubMed=35381425).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; P21448; Abcb1.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D266 ! CHO-CHRC5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   CHOS
AC   CVCL_CW30
DR   Wikidata; Q54813234
RX   PubMed=27017908;
CC   Population: Chinese.
CC   Doubling time: 36 hours (PubMed=27017908).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Bone, scapula; UBERON=UBERON_0006849.
DI   NCIt; C4021; Chondroblastic osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   CHOS-X
AC   CVCL_E8IA
SY   CHOS-XBP-1S
RX   PubMed=23335490;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12801; XBP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHOS-XE
AC   CVCL_Y012
SY   CHOS-XBP-1S/ERO1-Lalpha; CHOS-XE clone 18
DR   Wikidata; Q54813235
RX   PubMed=23335490;
CC   Characteristics: Used in transient gene expression (TGE) systems (PubMed=23335490).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13280; ERO1A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12801; XBP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E8IA ! CHOS-X
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   CHOTKa
AC   CVCL_HB34
SY   CHO-TKa; CHO-K1, TKa; Tka
DR   Wikidata; Q54813236
RX   PubMed=9016792;
CC   Genetic integration: Method=Transfection; Gene=RGD; 61814; Pex2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   CHOTKaEG1
AC   CVCL_HB36
SY   TKaEG1
DR   Wikidata; Q54813237
RX   PubMed=23009329;
CC   Characteristics: Contains a PTS1-fused EGFP.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=RGD; 61814; Pex2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   CHOTKaEG2
AC   CVCL_HB37
SY   TKaEG2; TKa/EG2
DR   Wikidata; Q54813252
RX   PubMed=12054588;
CC   Characteristics: Contains a PTS2-fused EGFP.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=RGD; 61814; Pex2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   CHOTKaG1
AC   CVCL_HB62
SY   TKaG1
DR   Wikidata; Q54813253
RX   PubMed=10222140;
CC   Characteristics: Contains a GFP-PTS1 (AKL) fusion protein (PubMed=10222140).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=RGD; 61814; Pex2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   CHOTKaG2
AC   CVCL_HB63
SY   TKaG2
DR   Wikidata; Q54813254
RX   PubMed=10222140;
CC   Characteristics: Contains a PTS2-GFP fusion protein (PubMed=10222140).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=RGD; 61814; Pex2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   CHOTKb
AC   CVCL_E8IC
SY   CHO-TKb; CHO-K1, TKb; Tkb
RX   PubMed=9016792;
CC   Genetic integration: Method=Transfection; Gene=RGD; 61814; Pex2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHOTKc
AC   CVCL_E8ID
SY   CHO-TKc; CHO-K1, TKc; Tkc
RX   PubMed=9016792;
CC   Genetic integration: Method=Transfection; Gene=RGD; 61814; Pex2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CHOZN GS-/-
AC   CVCL_RN03
DR   Sigma-Aldrich; CHOGS
DR   Wikidata; Q54813255
RX   PubMed=32619503;
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=ZFN; UniProtKB; P04773; Glul.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   CHOZN GS-/- Slc35a1-/-
AC   CVCL_RN11
SY   SLC35A1 KO CHO
DR   Wikidata; Q54813256
RX   Patent=US10377990;
RX   PubMed=27642072;
CC   Group: Serum/protein free medium cell line.
CC   Virology: Resistant to infection/contamination by minute virus of mice (MVM).
CC   Knockout cell: Method=ZFN; UniProtKB; P04773; Glul.
CC   Knockout cell: Method=ZFN; UniProtKB; O08520; Slc35a1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RN03 ! CHOZN GS-/-
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   CHP 3 (M.W.)
AC   CVCL_2778
SY   CHP 3; CHP #3; CHP3; GM-53; GM00053; GM0053
DR   CLO; CLO_0002468
DR   CLO; CLO_0002469
DR   CLO; CLO_0025176
DR   CLDB; cl772
DR   CLDB; cl777
DR   ATCC; CCL-132
DR   BioSample; SAMN03472706
DR   Coriell; GM00053
DR   ECACC; 90102536
DR   IZSLER; BS CL 16
DR   Wikidata; Q54813257
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1192846;
RX   PubMed=6988327;
CC   Population: African American.
CC   Discontinued: ECACC; 90102536; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-132; IZSLER=BS CL 16
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 16,23
ST   D19S433: 13.2,14.2
ST   D21S11: 28,31
ST   D2S1338: 19,24
ST   D3S1358: 14,14.3
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 8,14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 11,16
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   CHP 4 (W.W.)
AC   CVCL_2779
AS   CVCL_F482
SY   CHP 4; CHP #4; CHP4; GM00052; GM0052; GM052; GM-52; GM52
DR   CLO; CLO_0002470
DR   CLO; CLO_0002471
DR   CLDB; cl774
DR   CLDB; cl778
DR   ATCC; CCL-133
DR   BioSample; SAMN03470908
DR   Coriell; GM00052
DR   ECACC; 90102537
DR   IZSLER; BS CL 17
DR   Wikidata; Q54813258
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1192846;
RX   PubMed=6988327;
RX   PubMed=11416159;
RX   PubMed=25877200;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Ser135Leu (c.404C>T); ClinVar=VCV000003618; Zygosity=Heterozygous (from autologous cell line GM02796).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Phe171Ser (c.512T>C); ClinVar=VCV000003616; Zygosity=Heterozygous (from autologous cell line GM02796).
CC   Discontinued: Coriell; GM00052; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-133; ECACC=90102537; IZSLER=BS CL 17; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 11,14
ST   D21S11: 30,31
ST   D2S1338: 19,24
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 7,15
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F483 ! GM01908
OI   CVCL_F484 ! GM02796
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   CHP-1
AC   CVCL_6E27
DR   Wikidata; Q54813259
RX   PubMed=26762899;
RX   PubMed=30268330;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Jack Russell Terrier; VBO=VBO_0200724.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   CHP-100
AC   CVCL_7166
SY   CHP 100; CHP100; Children's Hospital of Philadelphia-100; NB-100
DR   BTO; BTO_0005253
DR   CLO; CLO_0007944
DR   CLDB; cl3642
DR   BioSample; SAMN03151800
DR   cancercelllines; CVCL_7166
DR   Cosmic; 1167419
DR   DSMZ; ACC-830
DR   DSMZCellDive; ACC-830
DR   ECACC; 06122001
DR   GEO; GSM510003
DR   GEO; GSM1676329
DR   GEO; GSM1701661
DR   IARC_TP53; 27037
DR   Progenetix; CVCL_7166
DR   Wikidata; Q54813260
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=10079;
RX   PubMed=1992541;
RX   PubMed=2777647;
RX   PubMed=19787792;
RX   PubMed=21822310;
RX   PubMed=26351324;
RX   PubMed=26428435;
RX   PubMed=33460449;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misclassified. Originally thought to originate from a neuroblastoma but shown to be from an Ewing sarcoma (PubMed=33460449). Was also partially contaminated as some stocks where shown to be IMR-32 derivatives.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00382.
CC   Doubling time: 45.8 hours (PubMed=10079); ~36 hours (DSMZ=ACC-830).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Hemizygous (PubMed=19787792).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=26428435; PubMed=33460449).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 06122001; true.
CC   Derived from site: In situ; Bone, spine, epidural space; UBERON=UBERON_0003691.
ST   Source(s): DSMZ=ACC-830; PubMed=19787792; PubMed=33460449
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 10
ST   D18S51: 12,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 18,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 22,25
ST   Penta D: 11,14
ST   Penta E: 11,12
ST   SE33: 17,19
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18,19 (DSMZ=ACC-830)
ST   vWA: 17,19 (PubMed=19787792; PubMed=33460449)
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   CHP-100L
AC   CVCL_IV94
SY   CHP-100-L; CHP100L; CHP-100 Large
DR   Cosmic; 2228221
DR   Wikidata; Q54813261
RX   PubMed=6825097;
RX   PubMed=25010205;
RX   PubMed=28196595;
RX   PubMed=33460449;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Misclassified. Parent cell line (CHP-100) was originally thought to originate from a neuroblastoma but was later shown to be from an Ewing sarcoma.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00610.
CC   Doubling time: 21 hours (PubMed=6825097).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His233fs (c.696_697ins4); Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Bone, spine, epidural space; UBERON=UBERON_0003691.
ST   Source(s): PubMed=25010205; PubMed=33460449
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,13
ST   D16S539: 10
ST   D18S51: 12,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 18,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7166 ! CHP-100
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 13
//
ID   CHP-100S
AC   CVCL_IV95
SY   CHP-100-S; CHP100S; CHP-100 Small
DR   Wikidata; Q54813262
RX   PubMed=6825097;
CC   Problematic cell line: Misclassified. Parent cell line (CHP-100) was originally thought to originate from a neuroblastoma but was later shown to be from an Ewing sarcoma.
CC   Doubling time: 26 hours (PubMed=6825097).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (from parent cell line).
CC   Derived from site: In situ; Bone, spine, epidural space; UBERON=UBERON_0003691.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7166 ! CHP-100
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   CHP-126
AC   CVCL_1123
SY   CHP 126; CHP126; Children's Hospital of Philadelphia-126
DR   BTO; BTO_0005254
DR   CLO; CLO_0002472
DR   CLO; CLO_0050266
DR   CLDB; cl776
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821621
DR   BioSample; SAMN03473117
DR   BioSample; SAMN10988481
DR   cancercelllines; CVCL_1123
DR   Cell_Model_Passport; SIDM00286
DR   ChEMBL-Cells; CHEMBL3308252
DR   ChEMBL-Targets; CHEMBL2366137
DR   CLS; 300432
DR   Cosmic; 688062
DR   Cosmic; 910567
DR   Cosmic; 1019935
DR   Cosmic; 2485942
DR   Cosmic-CLP; 910567
DR   DepMap; ACH-000136
DR   DSMZ; ACC-304
DR   DSMZCellDive; ACC-304
DR   EGA; EGAS00001000978
DR   GDSC; 910567
DR   GEO; GSM563360
DR   GEO; GSM886929
DR   GEO; GSM887995
DR   GEO; GSM1366403
DR   GEO; GSM1669676
DR   GEO; GSM3145586
DR   GEO; GSM3145698
DR   IARC_TP53; 21225
DR   LiGeA; CCLE_141
DR   LINCS_LDP; LCL-1973
DR   PharmacoDB; CHP126_198_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1123
DR   PubChem_Cell_line; CVCL_1123
DR   RCB; RCB0486
DR   Wikidata; Q54813263
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=10079;
RX   PubMed=17466;
RX   PubMed=71759;
RX   PubMed=1374683;
RX   PubMed=6113887;
RX   PubMed=6888561;
RX   PubMed=7139592;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 44.5 hours (PubMed=10079); 24.0 hours (PubMed=1374683).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.41%; East Asian, North=1.27%; East Asian, South=0%; South Asian=0.75%; European, North=65.66%; European, South=31.9% (PubMed=30894373).
CC   Discontinued: CLS; 300432; true.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): Cosmic-CLP=910567; DSMZ=ACC-304; PubMed=11416159; PubMed=25877200; RCB=RCB0486
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D18S51: 13,16.1
ST   D19S433: 13.2,14 (PubMed=25877200)
ST   D19S433: 14 (DSMZ=ACC-304)
ST   D21S11: 30
ST   D2S1338: 17,24
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 11,14
ST   D8S1179: 12,15
ST   FGA: 19,20
ST   Penta D: 10 (DSMZ=ACC-304)
ST   Penta D: 10,12 (PubMed=25877200)
ST   Penta E: 12,15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9506 ! CHP-126BL
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   CHP-126BL
AC   CVCL_9506
SY   Children's Hospital of Philadelphia-126BL
DR   Wikidata; Q54813264
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=17466;
CC   Population: Caucasian.
CC   Misspelling: CHP-126B1; DOI=10.1007/0-306-46872-7_2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1123 ! CHP-126
SX   Female
AG   1Y7M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 12
//
ID   CHP-134
AC   CVCL_1124
SY   CHP 134; CHP_134; CHP134; Children's Hospital of Philadelphia-134
DR   BTO; BTO_0002989
DR   CLO; CLO_0051417
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472330
DR   BioSample; SAMN03473466
DR   cancercelllines; CVCL_1124
DR   Cell_Model_Passport; SIDM00285
DR   CGH-DB; 75-1
DR   CGH-DB; 9099-4
DR   ChEMBL-Cells; CHEMBL3308253
DR   ChEMBL-Targets; CHEMBL2366128
DR   Cosmic; 688063
DR   Cosmic; 801744
DR   Cosmic; 848934
DR   Cosmic; 910941
DR   Cosmic; 920253
DR   Cosmic; 930063
DR   Cosmic; 947707
DR   Cosmic; 1019934
DR   Cosmic; 1037353
DR   Cosmic; 1099150
DR   Cosmic; 1109362
DR   Cosmic; 1153779
DR   Cosmic; 1161986
DR   Cosmic; 1526620
DR   Cosmic; 2131592
DR   Cosmic; 2393629
DR   Cosmic; 2485943
DR   Cosmic-CLP; 910941
DR   DepMap; ACH-001338
DR   DSMZ; ACC-653
DR   DSMZCellDive; ACC-653
DR   ECACC; 06122002
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10508-107D4
DR   GDSC; 910941
DR   GEO; GSM313800
DR   GEO; GSM333795
DR   GEO; GSM563356
DR   GEO; GSM692863
DR   GEO; GSM1366404
DR   GEO; GSM1669677
DR   GEO; GSM2371222
DR   GEO; GSM2394376
DR   GEO; GSM3145587
DR   GEO; GSM3145699
DR   IARC_TP53; 21226
DR   PharmacoDB; CHP134_199_2019
DR   Progenetix; CVCL_1124
DR   PubChem_Cell_line; CVCL_1124
DR   RCB; RCB0487
DR   Wikidata; Q54813265
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=10079;
RX   PubMed=71759;
RX   PubMed=6113887;
RX   PubMed=6888561;
RX   PubMed=7139592;
RX   PubMed=12702577;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=22213050;
RX   PubMed=23202128;
RX   PubMed=24466371;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 57.6 hours (PubMed=10079); ~30 hours (DSMZ=ACC-653).
CC   Karyotypic information: Pseudodiploid (PubMed=71759).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.04%; Native American=0%; East Asian, North=0.15%; East Asian, South=0%; South Asian=0.93%; European, North=70.26%; European, South=28.62% (PubMed=30894373).
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Cosmic-CLP=910941; DepMap=ACH-001338; DSMZ=ACC-653; ECACC=06122002; RCB=RCB0487
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12 (Cosmic-CLP=910941; RCB=RCB0487)
ST   CSF1PO: 9,13 (DepMap=ACH-001338; DSMZ=ACC-653; ECACC=06122002)
ST   D13S317: 8,10,11 (DepMap=ACH-001338)
ST   D13S317: 8,11 (Cosmic-CLP=910941; DSMZ=ACC-653; ECACC=06122002; RCB=RCB0487)
ST   D16S539: 11 (RCB=RCB0487)
ST   D16S539: 11,13 (Cosmic-CLP=910941; DepMap=ACH-001338; DSMZ=ACC-653; ECACC=06122002)
ST   D18S51: 15,18
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 20,27
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 8,14 (DepMap=ACH-001338)
ST   D8S1179: 14 (DSMZ=ACC-653)
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 5,7
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   CHP-166
AC   CVCL_9507
SY   CHP166; Children's Hospital of Philadelphia-166
DR   Wikidata; Q54813266
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=6488196;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   CHP-212
AC   CVCL_1125
AS   CVCL_A797
SY   CHP 212; CHP212; NB9; NB-9; Children's Hospital of Philadelphia-212
DR   CLO; CLO_0002467
DR   CLO; CLO_0002473
DR   CLO; CLO_0050261
DR   EFO; EFO_0002133
DR   CLDB; cl771
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2273
DR   BioGRID_ORCS_Cell_line; 595
DR   BioSample; SAMN03472322
DR   BioSample; SAMN03473208
DR   BioSample; SAMN10988326
DR   cancercelllines; CVCL_1125
DR   Cell_Model_Passport; SIDM00910
DR   ChEMBL-Cells; CHEMBL3308101
DR   ChEMBL-Targets; CHEMBL1075423
DR   Cosmic; 724826
DR   Cosmic; 906820
DR   Cosmic; 920244
DR   Cosmic; 1161987
DR   Cosmic; 2131574
DR   Cosmic-CLP; 906820
DR   DepMap; ACH-000120
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906820
DR   GEO; GSM563361
DR   GEO; GSM886930
DR   GEO; GSM887996
DR   GEO; GSM1366405
DR   GEO; GSM1669678
DR   GEO; GSM2371223
DR   GEO; GSM2394381
DR   IARC_TP53; 21227
DR   IGRhCellID; CHP212
DR   LiGeA; CCLE_207
DR   LINCS_LDP; LCL-1964
DR   PharmacoDB; CHP212_200_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1125
DR   PubChem_Cell_line; CVCL_1125
DR   RCB; RCB0477
DR   Wikidata; Q54813267
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=6113887;
RX   PubMed=7139592;
RX   PubMed=12068308;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=18724359;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=39255063;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
CC   HLA typing: A*02:01,24:02; B*07:07,58:05; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; ATCC=CRL-2273; Cosmic-CLP=906820; DepMap=ACH-000120).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Extrachromosomal circular DNA (scEC); Single cell.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.16%; Native American=0%; East Asian, North=1.09%; East Asian, South=0.43%; South Asian=0.86%; European, North=70.26%; European, South=25.19% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-2273; Cosmic-CLP=906820; PubMed=25877200; RCB=RCB0477
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8 (RCB=RCB0477)
ST   D13S317: 8,13 (ATCC=CRL-2273; Cosmic-CLP=906820; PubMed=25877200)
ST   D16S539: 13
ST   D18S51: 14,16
ST   D19S433: 12,15
ST   D21S11: 27,29
ST   D2S1338: 22,25
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 9,10
ST   Penta E: 5,15
ST   TH01: 6 (ATCC=CRL-2273; Cosmic-CLP=906820; PubMed=25877200)
ST   TH01: 6,7 (RCB=RCB0477)
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   CHP-234
AC   CVCL_4359
SY   CHP 234; CHP234; Children's Hospital of Philadelphia-234
DR   ATCC; CRL-2272
DR   BioSample; SAMN03152004
DR   BioSample; SAMN03471857
DR   Wikidata; Q54813268
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=6113887;
RX   PubMed=15720811;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00297.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Discontinued: ATCC; CRL-2272; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2272
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   CHP-382
AC   CVCL_5G77
SY   Children's Hospital of Philadelphia-382
DR   Wikidata; Q54813269
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2582423;
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   CHP-382/JK
AC   CVCL_5G78
SY   Children's Hospital of Philadelphia-382/JK
DR   Wikidata; Q54813270
RX   PubMed=2582423;
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G77 ! CHP-382
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   CHP-404
AC   CVCL_5G79
SY   CHP 404; CHP404; Children's Hospital of Philadelphia-404
DR   Wikidata; Q54813271
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   CHP-901
AC   CVCL_6613
SY   CHP 901; CHP901; Children's Hospital of Philadelphia-901
DR   Cosmic; 930064
DR   Cosmic; 1019948
DR   Cosmic; 1109363
DR   Cosmic; 1161988
DR   Cosmic; 1526621
DR   Wikidata; Q54813272
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=11212268;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
CC   From: Ikegaki, Naohiko; Department of Anatomy and Cell Biology, College of Medicine, University of Illinois at Chicago; Chicago; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   CHP-902
AC   CVCL_6614
SY   CHP902; Children's Hospital of Philadelphia-902
DR   Wikidata; Q54813273
CC   From: Kuroda, Hiro; Children's Hospital of Philadelphia; Philadelphia; USA.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   CHP-902R
AC   CVCL_6615
SY   CHP902R; Children's Hospital of Philadelphia-902R
DR   Cosmic; 930065
DR   Cosmic; 1526622
DR   IARC_TP53; 23835
DR   Wikidata; Q54813274
RX   PubMed=11212268;
RX   PubMed=15892104;
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6614 ! CHP-902
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   CHP-903
AC   CVCL_6616
SY   CHP 903; CHP903; Children's Hospital of Philadelphia-903
DR   Wikidata; Q54813275
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=15892104;
CC   From: Ikegaki, Naohiko; Department of Anatomy and Cell Biology, College of Medicine, University of Illinois at Chicago; Chicago; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   CHP-K3
AC   CVCL_A9HR
SY   CHPK3
DR   CCRID; 5301MAM-KCB0689KZJ
DR   KCB; KCB 200689KZJ
DR   Wikidata; Q108820042
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64680; ! Tamias sibiricus (Siberian chipmunk)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CHP-M1
AC   CVCL_A9HP
SY   CHPM1
DR   CCRID; 5301MAM-KCB0307RZJ
DR   KCB; KCB 200307RZJ
DR   Wikidata; Q108820043
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=64680; ! Tamias sibiricus (Siberian chipmunk)
OI   CVCL_A9HQ ! CHP-S1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CHP-S1
AC   CVCL_A9HQ
SY   CHPS1
DR   CCRID; 5301MAM-KCB0307SZJ
DR   KCB; KCB 200307SZJ
DR   Wikidata; Q108820044
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=64680; ! Tamias sibiricus (Siberian chipmunk)
OI   CVCL_A9HP ! CHP-M1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CHP01
AC   CVCL_F377
DR   CLO; CLO_0051137
DR   RCB; HSC0002
DR   Wikidata; Q54813276
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Bolivian; native South American; Chipayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHP02
AC   CVCL_F378
DR   CLO; CLO_0051138
DR   RCB; HSC0003
DR   Wikidata; Q54813277
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Bolivian; native South American; Chipayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHP04
AC   CVCL_F379
DR   CLO; CLO_0051140
DR   RCB; HSC0007
DR   Wikidata; Q54813278
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Bolivian; native South American; Chipayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHP06
AC   CVCL_F380
DR   CLO; CLO_0051141
DR   RCB; HSC0009
DR   Wikidata; Q54813279
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Bolivian; native South American; Chipayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHP07
AC   CVCL_F381
DR   CLO; CLO_0051146
DR   RCB; HSC0028
DR   Wikidata; Q54813280
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Bolivian; native South American; Chipayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHP08
AC   CVCL_F382
DR   CLO; CLO_0051133
DR   RCB; HSC0004
DR   Wikidata; Q54813282
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Bolivian; native South American; Chipayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHP09
AC   CVCL_F383
DR   CLO; CLO_0051143
DR   RCB; HSC0017
DR   Wikidata; Q54813283
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Bolivian; native South American; Chipayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CHQC-MCQ1-4
AC   CVCL_9W50
SY   MCQ 1-4
DR   Wikidata; Q54813284
RX   PubMed=72738;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   9-10W
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CHQC-MCQ3-5
AC   CVCL_9W51
SY   MCQ 3-5
DR   Wikidata; Q54813285
RX   PubMed=72738;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   9-10W
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CHQC-QMC
AC   CVCL_T597
SY   QMC
DR   Wikidata; Q54813286
RX   PubMed=74792;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   CHR,KJ
AC   CVCL_E527
SY   CHR, KJ
DR   dbMHC; 48726
DR   IHW; IHW09203
DR   IPD-IMGT/HLA; 11744
DR   Wikidata; Q54813287
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*08,57; DPB1*04:01,04:02; DQA1*05:01,02:01; DQB1*03:03,02:01; DRB1*03:01,07; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=11744).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   ChR2-C2C12
AC   CVCL_A6JR
DR   RCB; RCB4693
DR   Wikidata; Q107114675
RX   PubMed=21809334;
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8RUT8; Chlamydomonas reinhardtii channelrhodopsin-2 (cop4).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   CHRF-288-11
AC   CVCL_A280
SY   CHRF288-11; CHRF-288
DR   EFO; EFO_0022520
DR   Cosmic; 787422
DR   Cosmic; 975240
DR   Cosmic; 1050595
DR   GEO; GSE3838
DR   Wikidata; Q54813288
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2310825;
RX   PubMed=3719517;
RX   PubMed=17309828;
RX   PubMed=27277069;
CC   Population: Caucasian.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: ~33 hours (PubMed=2310825).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: CHRF-28-11; Note=Occasionally.
CC   Derived from site: Metastatic; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   Chromphi-1
AC   CVCL_X544
SY   chromphi-1
DR   Wikidata; Q54813289
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=8932342;
RX   PubMed=11139287;
CC   Doubling time: 24 hours (PubMed=8932342).
CC   Misspelling: chromhpi-1; Note=In Cellosaurus releases 10 to 23.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   Chromphi-2
AC   CVCL_X545
SY   chromphi-2
DR   Wikidata; Q54813290
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=8932342;
RX   PubMed=11139287;
CC   Doubling time: 40 hours (PubMed=8932342).
CC   Misspelling: chromhpi-2; Note=In Cellosaurus releases 10 to 23.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   Chromphi-3
AC   CVCL_X546
SY   chromphi-3
DR   IARC_TP53; 23266
DR   Wikidata; Q54813291
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=8932342;
RX   PubMed=11139287;
CC   Doubling time: 40 hours (PubMed=8932342).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11139287).
CC   Misspelling: chromhpi-3; Note=In Cellosaurus releases 10 to 23.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   Chromphi-4
AC   CVCL_X547
SY   chromphi-4
DR   Wikidata; Q54813292
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=8932342;
RX   PubMed=11139287;
CC   Doubling time: 51 hours (PubMed=8932342).
CC   Misspelling: chromhpi-4; Note=In Cellosaurus releases 10 to 23.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   Chrompho-A
AC   CVCL_X536
SY   chrompho-A
DR   Wikidata; Q54813301
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=7717462;
RX   PubMed=11139287;
CC   Doubling time: 51 hours (PubMed=7717462).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4146; Chromophobe renal cell carcinoma
DI   ORDO; Orphanet_319303; Chromophobe renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X537 ! Chrompho-B
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   Chrompho-B
AC   CVCL_X537
SY   chrompho-B
DR   Wikidata; Q54813302
RX   CelloPub=CLPUB00411;
RX   PubMed=7717462;
CC   Doubling time: 43 hours (PubMed=7717462).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4146; Chromophobe renal cell carcinoma
DI   ORDO; Orphanet_319303; Chromophobe renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X536 ! Chrompho-A
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   CHS-01
AC   CVCL_WA59
DR   IBRC; C10829
DR   Wikidata; Q93453293
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CHS-03
AC   CVCL_WA60
DR   IBRC; C10968
DR   Wikidata; Q93453296
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CHS-1
AC   CVCL_L314
SY   Canine Histiocytic Sarcoma-1
DR   Wikidata; Q54813303
RX   PubMed=17213706;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   CHS-2
AC   CVCL_L315
SY   Canine Histiocytic Sarcoma-2
DR   Wikidata; Q54813304
RX   PubMed=17213706;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Shetland Sheepdog; VBO=VBO_0201217.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 16
//
ID   CHS-20
AC   CVCL_E8BL
RX   PubMed=21371505;
CC   Group: Non-human primate cell line.
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (from parent cell line).
CC   Virology: Susceptible to infection by peste des petits ruminants virus (PPRV). Infection of this cell by PPRV resulted in the development of syncytia (PubMed=21371505).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q283L5; Capra hircus SLAMF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_U425 ! Flp-In-CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CHS-3
AC   CVCL_L316
SY   Canine Histiocytic Sarcoma-3
DR   Wikidata; Q54813305
RX   PubMed=17213706;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Bernese mountain dog; VBO=VBO_0200161.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 15
//
ID   CHS-4
AC   CVCL_L317
SY   Canine Histiocytic Sarcoma-4
DR   Wikidata; Q54813306
RX   PubMed=17213706;
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Breed/subspecies: Flat-coated Retriever; VBO=VBO_0200528.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   CHS-5
AC   CVCL_L318
SY   Canine Histiocytic Sarcoma-5
DR   Wikidata; Q54813307
RX   PubMed=17213706;
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   CHS-6
AC   CVCL_L319
SY   Canine Histiocytic Sarcoma-6
DR   Wikidata; Q54813308
RX   PubMed=17213706;
RX   PubMed=30268330;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Bernese mountain dog; VBO=VBO_0200161.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 16
//
ID   CHS-7
AC   CVCL_L320
SY   Canine Histiocytic Sarcoma-7
DR   Wikidata; Q54813309
RX   PubMed=17213706;
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Breed/subspecies: Flat-coated Retriever; VBO=VBO_0200528.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   CHSA0011
AC   CVCL_X483
SY   CHSA 0011
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X483
DR   Cell_Model_Passport; SIDM00051
DR   Cosmic-CLP; 1290767
DR   DepMap; ACH-002092
DR   EGA; EGAS00001000978
DR   GDSC; 1290767
DR   PharmacoDB; CHSA0011_201_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54813310
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=1.37%; Native American=0.01%; East Asian, North=3.14%; East Asian, South=0%; South Asian=0%; European, North=66.06%; European, South=29.42% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1290767
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 20
//
ID   CHSA0108
AC   CVCL_X484
SY   CHSA 0108
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X484
DR   Cell_Model_Passport; SIDM00050
DR   Cosmic-CLP; 1290768
DR   DepMap; ACH-002093
DR   EGA; EGAS00001000978
DR   GDSC; 1290768
DR   PharmacoDB; CHSA0108_202_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54813311
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=2.14%; Native American=0.79%; East Asian, North=1.29%; East Asian, South=0%; South Asian=0%; European, North=63.46%; European, South=32.32% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1290768
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 20
//
ID   CHSA8926
AC   CVCL_X485
SY   CHSA 8926
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X485
DR   Cell_Model_Passport; SIDM00176
DR   Cosmic-CLP; 1303912
DR   DepMap; ACH-002094
DR   EGA; EGAS00001000978
DR   GDSC; 1303912
DR   GEO; GSM1669679
DR   PharmacoDB; CHSA8926_203_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54813312
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0.93%; East Asian, North=0%; East Asian, South=0.11%; South Asian=4.08%; European, North=68.86%; European, South=26.02% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1303912
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,15
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 20
//
ID   CHSE-114
AC   CVCL_R822
SY   CHSE 114; CHinook Salmon Embryo-114
DR   Wikidata; Q54813314
RX   CelloPub=CLPUB00703;
RX   PubMed=6542066;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV) (CelloPub=CLPUB00703).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   CHSE-214
AC   CVCL_2780
SY   CHSE 214; CHSE214; CHinook Salmon Embryo-214
DR   CLO; CLO_0002474
DR   CLO; CLO_0002475
DR   CLDB; cl779
DR   CLDB; cl780
DR   ATCC; CRL-1681
DR   CCLV; CCLV-RIE 1104
DR   CCTCC; GDC0168
DR   ECACC; 91041114
DR   IZSLER; BS CL 18
DR   NCBI_Iran; C202
DR   Wikidata; Q54813315
RX   CelloPub=CLPUB00103;
RX   CelloPub=CLPUB00703;
RX   CelloPub=CLPUB00808;
RX   DOI=10.1016/B978-0-444-82033-4.50019-2;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1139/f78-164;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=1368400;
RX   PubMed=6542066;
RX   PubMed=7766144;
RX   PubMed=15825496;
RX   PubMed=19002917;
RX   PubMed=19941903;
RX   PubMed=32576161;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV) (CelloPub=CLPUB00703).
CC   Discontinued: ATCC; CRL-1681; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 27
//
ID   CHSE-E
AC   CVCL_DG45
DR   Wikidata; Q54813317
RX   PubMed=27236514;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_2780 ! CHSE-214
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   CHSE-EC
AC   CVCL_DG46
SY   EC
DR   Wikidata; Q54813318
RX   PubMed=27236514;
RX   PubMed=32576161;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_DG45 ! CHSE-E
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 13
//
ID   CHSE-EC-PKR-C19
AC   CVCL_E3AE
SY   EC-PKR-C19
RX   PubMed=39058317;
CC   Group: Fish cell line.
CC   Characteristics: The parent cell line was transiently transfected with a mix of sgRNAs designed against eif2ak2/pkr and against mEGFP. mEGFP-deficient cells were isolated (PubMed=39058317).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A8C7HVT8; eif2ak2.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_DG46 ! CHSE-EC
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CHSE-EC-PKR-C28
AC   CVCL_E3AF
SY   EC-PKR-C28
RX   PubMed=39058317;
CC   Group: Fish cell line.
CC   Characteristics: The parent cell line was transiently transfected with a mix of sgRNAs designed against eif2ak2/pkr and against mEGFP. mEGFP-deficient cells were isolated. As this particular clone is not KO for eif2ak2 it is used as a control cell line (PubMed=39058317).
CC   Sequence variation: Mutation; UniProtKB; A0A8C7HVT8; eif2ak2; Simple_edited; p.Cys11_Glu12del (c.30_35delGTGCGA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=39058317).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_DG46 ! CHSE-EC
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CHSE-EC-PKR-C3
AC   CVCL_E3AC
SY   EC-PKR-C3
RX   PubMed=39058317;
CC   Group: Fish cell line.
CC   Characteristics: The parent cell line was transiently transfected with a mix of sgRNAs designed against eif2ak2/pkr and against mEGFP. mEGFP-deficient cells were isolated (PubMed=39058317).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A8C7HVT8; eif2ak2.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_DG46 ! CHSE-EC
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CHSE-EC-PKR-C5
AC   CVCL_E3AD
SY   EC-PKR-C5
RX   PubMed=39058317;
CC   Group: Fish cell line.
CC   Characteristics: The parent cell line was transiently transfected with a mix of sgRNAs designed against eif2ak2/pkr and against mEGFP. mEGFP-deficient cells were isolated (PubMed=39058317).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A8C7HVT8; eif2ak2.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_DG46 ! CHSE-EC
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CHSE-GS2
AC   CVCL_YI85
SY   GS2
DR   Wikidata; Q93453361
RX   PubMed=31142600;
CC   Group: Fish cell line.
CC   Characteristics: The parent cell line was transiently transfected with a mix of sgRNAs designed against stat2 and against mEGFP. mEGFP-deficient cells were isolated (PubMed=31142600).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A8C8HVT5; stat2.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_DG46 ! CHSE-EC
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CHSE-sp
AC   CVCL_L017
DR   Wikidata; Q54813319
RX   CelloPub=CLPUB00808;
RX   DOI=10.1007/BF02631437;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=8320177;
CC   Group: Fish cell line.
CC   Characteristics: Adapted to grow in suspension-stirred culture (CelloPub=CLPUB00808).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_2780 ! CHSE-214
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 12
//
ID   CHSE-TOF-MX10
AC   CVCL_E3AL
RX   PubMed=22405879;
CC   Group: Fish cell line.
CC   Characteristics: Transfected with the pTet-Off plasmid from the Tet On/Off Clontech system and with rainbow trout Mx1 (PubMed=22405879).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q91192; Oncorhynchus mykiss Mx1.
CC   Miscellaneous: Cell line has been lost (personal communication of Collet, Bertrand).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_R886 ! CHSE-TOF5
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CHSE-TOF-MX8
AC   CVCL_E3AM
RX   PubMed=22405879;
CC   Group: Fish cell line.
CC   Characteristics: Transfected with the pTet-Off plasmid from the Tet On/Off Clontech system and with rainbow trout Mx1 (PubMed=22405879).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q91192; Oncorhynchus mykiss Mx1.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_R886 ! CHSE-TOF5
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   CHSE-TOF5
AC   CVCL_R886
SY   CHSE-TOF
DR   Wikidata; Q54813320
RX   PubMed=22089998;
RX   PubMed=22405879;
CC   Group: Fish cell line.
CC   Characteristics: Transfected with the pTet-Off plasmid from the Tet On/Off Clontech system (PubMed=22089998).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Cell line has been lost (personal communication of Collet, Bertrand).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_2780 ! CHSE-214
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   CHSE/F
AC   CVCL_G347
SY   CHSE-214
DR   ECACC; 00021714
DR   Wikidata; Q54813322
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Oncorhynchus tschawytscha origin and to be CHSE-214 but found to be from Lepomis macrochirus.
OX   NCBI_TaxID=13106; ! Lepomis macrochirus (Bluegill)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 9
//
ID   CHU-2
AC   CVCL_U416
DR   Wikidata; Q54813323
RX   PubMed=1714402;
RX   PubMed=3487449;
RX   PubMed=7691144;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-427.html
CC   Population: Japanese.
CC   Characteristics: Secretes large amount of CSF3 (PubMed=3487449).
CC   Characteristics: Established after the 9th passage of the original tumor cell in nude mice (PubMed=3487449).
CC   Doubling time: ~20 hours (PubMed=3487449).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   Chub-S7
AC   CVCL_0239
SY   CHUB-S7; CHUB S7; ChubS7
DR   MCCL; MCC:0000129
DR   Wikidata; Q54813324
RX   PubMed=12934077;
CC   Doubling time: 45.6 +- 0.8 hours (PubMed=12934077).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Abdomen, adipose tissue; UBERON=UBERON_0014455.
CC   Cell type: Preadipocyte; CL=CL_0002334.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Chula2.hES
AC   CVCL_B031
SY   CHULAe001-A
DR   hPSCreg; CHULAe001-A
DR   SKIP; SKIP002365
DR   Wikidata; Q54813325
RX   PubMed=23514952;
RX   PubMed=26821869;
CC   From: Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   Chula3.hES
AC   CVCL_AV08
DR   Wikidata; Q54813326
RX   PubMed=26821869;
CC   From: Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Karyotypic information: Triploid karyotype.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   Chula4.hES
AC   CVCL_Y611
DR   Wikidata; Q54813327
RX   PubMed=23514952;
CC   From: Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Chula5.hES
AC   CVCL_Y612
DR   Wikidata; Q54813328
RX   PubMed=23514952;
CC   From: Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CHULAi001-A
AC   CVCL_C6P1
SY   GPDi001-A
DR   BioSamples; SAMEA111477548
DR   hPSCreg; CHULAi001-A
DR   Wikidata; Q117704245
RX   PubMed=36334578;
CC   From: Faculty of Allied Health Sciences, Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Val321Met (c.871G>A); ClinVar=VCV000010386; Zygosity=Hemizygous; Note=G6PD Viangchan (PubMed=36334578).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CHUQi001-A
AC   CVCL_RL75
SY   522-2666-2
DR   BioSamples; SAMEA104271492
DR   hPSCreg; CHUQi001-A
DR   SKIP; SKIP003062
DR   Wikidata; Q54813330
RX   PubMed=29274549;
CC   From: CHU de Quebec Research Center, Universite Laval; Quebec; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~200] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=29274549).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL74 ! 522-2666
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   CHUQi002-A
AC   CVCL_E3RD
SY   ARSM44081223
DR   BioSamples; SAMEA115975574
DR   hPSCreg; CHUQi002-A
CC   From: CHU de Quebec Research Center, Universite Laval; Quebec; Canada.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CHUSJi001-A
AC   CVCL_C0FW
SY   EA1C5
DR   BioSamples; SAMEA10370051
DR   hPSCreg; CHUSJi001-A
DR   Wikidata; Q112929383
RX   PubMed=35193008;
CC   From: CHU de Sainte Justine; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Val432Glufs*41 (c.1295_1296del); Zygosity=Heterozygous (PubMed=35193008).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187703; Esophageal atresia/tracheoesophageal fistula type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   CHUSJi002-A
AC   CVCL_C0FX
SY   EA2C5
DR   hPSCreg; CHUSJi002-A
DR   Wikidata; Q112929384
RX   PubMed=35193008;
CC   From: CHU de Sainte Justine; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187703; Esophageal atresia/tracheoesophageal fistula type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 5
//
ID   CHUSJi003-A
AC   CVCL_C0FY
SY   EA3C6
DR   BioSamples; SAMEA11294534
DR   hPSCreg; CHUSJi003-A
DR   Wikidata; Q112929385
RX   PubMed=35193008;
CC   From: CHU de Sainte Justine; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24238; CEP350; Simple; p.Ser1571Phefs*3 (c.4711_4712del); Zygosity=Heterozygous (PubMed=35193008).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187703; Esophageal atresia/tracheoesophageal fistula type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   CHUVi001-A
AC   CVCL_A8KP
SY   HC2
DR   BioSamples; SAMEA8394196
DR   hPSCreg; CHUVi001-A
DR   Wikidata; Q108820045
RX   PubMed=30409508;
CC   From: Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CHW
AC   CVCL_C575
SY   GM00458; GM-458; GM0458
DR   CLO; CLO_0025978
DR   Coriell; GM00458
DR   Wikidata; Q54813331
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=217113;
RX   PubMed=527380;
RX   PubMed=688393;
RX   PubMed=730780;
RX   PubMed=4462979;
RX   PubMed=5563334;
CC   Doubling time: 12 hours (PubMed=4462979).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   CHW-1102
AC   CVCL_C574
SY   CHW 1102; CHW1102; 1102; GM00459; GM-459; GM0459; GM459; GM00459A
DR   CLO; CLO_0025977
DR   Coriell; GM00459
DR   Wikidata; Q54813332
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00736;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=509993;
RX   PubMed=4462979;
CC   Characteristics: HPRT deficient.
CC   Doubling time: 13 hours (PubMed=4462979).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C575 ! CHW
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   CHW-1103
AC   CVCL_1K14
SY   CHW 1103; CHW1103
DR   Wikidata; Q54813333
RX   CelloPub=CLPUB00736;
RX   PubMed=509993;
CC   Characteristics: HPRT deficient.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C574 ! CHW-1102
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   CHWi001-A
AC   CVCL_YN68
SY   iPSC31-2; IPS31-2
DR   BioSamples; SAMEA6611121
DR   hPSCreg; CHWi001-A
DR   SKIP; SKIP005795
DR   Wikidata; Q93453419
RX   PubMed=32388443;
CC   From: Center of Prenatal Diagnosis, The Central Hospital of Wenzhou; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 7
//
ID   CHZJUi001-A
AC   CVCL_E3T7
SY   CSJHFiPSC
DR   BioSamples; SAMEA116044106
DR   hPSCreg; CHZJUi001-A
RX   PubMed=39577308;
CC   From: Children's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6742; LZTR1; Simple; p.Arg362Ter (c.1084C>T); ClinVar=VCV000289969; Zygosity=Heterozygous (PubMed=39577308).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CI
AC   CVCL_Y548
DR   Cell_Model_Passport; SIDM01631
DR   DepMap; ACH-001484
DR   DSMZ; ACC-770
DR   DSMZCellDive; ACC-770
DR   Wikidata; Q54813334
RX   PubMed=6263808;
RX   PubMed=7239716;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~30-60 hours (DSMZ=ACC-770).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-770
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 10.2,16
ST   D19S433: 11,14
ST   D21S11: 29,33
ST   D2S1338: 19,23
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 21,26
ST   Penta D: 5,10
ST   Penta E: 7,8
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0D73 ! CII
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 16
//
ID   Ci-1
AC   CVCL_1861
SY   CI-1; CI1; Ci1
DR   CLO; CLO_0037048
DR   EFO; EFO_0006367
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472964
DR   BioSample; SAMN10988163
DR   cancercelllines; CVCL_1861
DR   Cell_Model_Passport; SIDM01531
DR   Cosmic; 1086331
DR   DepMap; ACH-000687
DR   DSMZ; ACC-570
DR   DSMZCellDive; ACC-570
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM886931
DR   GEO; GSM887997
DR   IARC_TP53; 30023
DR   LiGeA; CCLE_633
DR   LINCS_LDP; LCL-1130
DR   PharmacoDB; CI1_204_2019
DR   Progenetix; CVCL_1861
DR   Wikidata; Q54813336
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3098690;
RX   PubMed=8558920;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-570).
CC   HLA typing: A*30:01,30:01; B*13:02,44:06; C*05:01,06:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr211Ala (c.631A>G); ClinVar=VCV000406581; Zygosity=Heterozygous (DepMap=ACH-000687).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.56%; Native American=0%; East Asian, North=0.29%; East Asian, South=1.5%; South Asian=8.65%; European, North=34.89%; European, South=54.11% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-570; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 8,12
ST   D18S51: 13,17
ST   D19S433: 15,16
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 14,16 (PubMed=25877200)
ST   D8S1179: 16 (DSMZ=ACC-570)
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   CI-hAELVi
AC   CVCL_C1M0
SY   hAELVi.A; human Alveolar Epithelial Lentivirus immortalized clone A
DR   Wikidata; Q114311559
RX   PubMed=26985677;
RX   PubMed=36748276;
WW   Provider; InSCREENeX; INS-CI-1015; https://www.inscreenex.de/product/ci-haelvi/
CC   Characteristics: Suitable to model the air-blood barrier of the peripheral lung. Forms tight intercellular junctions, with high trans-epithelial electrical resistance (PubMed=26985677).
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=26985677).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 1 pneumocyte; CL=CL_0002062.
ST   Source(s): InSCREENeX=INS-CI-1015
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 13,13.2
ST   D21S11: 30.2,33.2
ST   D2S1338: 17
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1M1 ! hAELVi.B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   CI-huArlo
AC   CVCL_E6BF
SY   Arlo
RX   PubMed=36748276;
WW   Provider; InSCREENeX; INS-CI-1031; https://www.inscreenex.de/product/ci-huarlo/
CC   Characteristics: Derived from parent cell line by single-cell printing and shows an overall improved alveolar phenotype, most notably a tighter barrier formation (InSCREENeX=INS-CI-1031).
CC   Characteristics: While identified as a type 1 pneumocyte (AT-1) under long-term Air-Liquid Interface (ALI) culture conditions, might exhibit type 2 (AT-2) characteristics, including lamellar body formation and surfactant protein secretion (InSCREENeX=INS-CI-1031).
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 1 pneumocyte; CL=CL_0002062.
ST   Source(s): InSCREENeX=INS-CI-1031
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 13,13.2
ST   D21S11: 30.2,33.2
ST   D2S1338: 17
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1M0 ! CI-hAELVi
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CI-huBroBEC
AC   CVCL_E6EG
WW   Provider; InSCREENeX; INS-CI-1025; https://www.inscreenex.de/product/ci-hubrobec/
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (InSCREENeX=INS-CI-1025).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CI-huEGC
AC   CVCL_E6BG
SY   CIK
RX   PubMed=37153631;
WW   Provider; InSCREENeX; INS-CI-1030; https://www.inscreenex.de/product/ci-huegc/
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=37153631).
CC   HLA typing: A*01:01,30:01; B*07:02,08:01; C*07:01,12:03; DQA1*01:02,01:03; DQB1*06:02,06:03; DRB1*13:01,15:01 (PubMed=37153631).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Colon, myenteric nerve plexus; UBERON=UBERON_8410058.
CC   Cell type: Enteric glial cell; CL=CL_4040002.
ST   Source(s): InSCREENeX=INS-CI-1030
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D19S433: 15
ST   D21S11: 30,32.2
ST   D2S1338: 17,19
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CI-huFIB
AC   CVCL_B7TY
SY   e-hDFib1; MHC12
DR   Wikidata; Q112929470
RX   PubMed=29520052;
WW   Provider; InSCREENeX; INS-CI-1010; https://www.inscreenex.de/product/ci-hufib/
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7TZ ! e-hDFib2
OI   CVCL_B7U0 ! e-hDFib3
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   CI-huMEC
AC   CVCL_E6EF
WW   Provider; InSCREENeX; INS-CI-1008; https://www.inscreenex.de/product/ci-humec/
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (InSCREENeX=INS-CI-1008).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
ST   Source(s): InSCREENeX=INS-CI-1008
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 12,17
ST   D19S433: 13,16
ST   D21S11: 30,31
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 13,16
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CI-huOB
AC   CVCL_E6EE
WW   Provider; InSCREENeX; INS-CI-1005; https://www.inscreenex.de/product/huob/
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (InSCREENeX=INS-CI-1005).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
ST   Source(s): InSCREENeX=INS-CI-1005
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 12,15
ST   D19S433: 14,16
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CI-huThyrEC-1
AC   CVCL_D3FP
SY   huThyrEC-1; A5-1
DR   Wikidata; Q127380555
RX   PubMed=35663474;
WW   Provider; InSCREENeX; INS-CI-1017; https://www.inscreenex.de/product/huthyrec/
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=35663474).
CC   Doubling time: 32.6 hours (PubMed=35663474).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Although only one catalog number exists (INS-CI-1017), InSCREENeX distributes the 4 different CI-huThyrEC cell lines.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
ST   Source(s): InSCREENeX=INS-CI-1017
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D19S433: 16.2
ST   D21S11: 27,29
ST   D2S1338: Not_detected
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   D8S1179: 10,11
ST   FGA: 19,23
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3FQ ! CI-huThyrEC-2
OI   CVCL_D3FR ! CI-huThyrEC-3
OI   CVCL_D3FS ! CI-huThyrEC-4
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CI-huThyrEC-2
AC   CVCL_D3FQ
SY   huThyrEC-2; A1
DR   Wikidata; Q127380556
RX   PubMed=35663474;
WW   Provider; InSCREENeX; INS-CI-1017; https://www.inscreenex.de/product/huthyrec/
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=35663474).
CC   Doubling time: 28.7 hours (PubMed=35663474).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Although only one catalog number exists (INS-CI-1017), InSCREENeX distributes the 4 different CI-huThyrEC cell lines.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3FP ! CI-huThyrEC-1
OI   CVCL_D3FR ! CI-huThyrEC-3
OI   CVCL_D3FS ! CI-huThyrEC-4
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CI-huThyrEC-3
AC   CVCL_D3FR
SY   huThyrEC-3; AA3
DR   Wikidata; Q127380557
RX   PubMed=35663474;
WW   Provider; InSCREENeX; INS-CI-1017; https://www.inscreenex.de/product/huthyrec/
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=35663474).
CC   Doubling time: 30.3 hours (PubMed=35663474).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Miscellaneous: Although only one catalog number exists (INS-CI-1017), InSCREENeX distributes the 4 different CI-huThyrEC cell lines.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3FP ! CI-huThyrEC-1
OI   CVCL_D3FQ ! CI-huThyrEC-2
OI   CVCL_D3FS ! CI-huThyrEC-4
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CI-huThyrEC-4
AC   CVCL_D3FS
SY   huThyrEC-4; AA2
DR   Wikidata; Q127380558
RX   PubMed=35663474;
WW   Provider; InSCREENeX; INS-CI-1017; https://www.inscreenex.de/product/huthyrec/
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=35663474).
CC   Doubling time: 30.6 hours (PubMed=35663474).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Although only one catalog number exists (INS-CI-1017), InSCREENeX distributes the 4 different CI-huThyrEC cell lines.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3FP ! CI-huThyrEC-1
OI   CVCL_D3FQ ! CI-huThyrEC-2
OI   CVCL_D3FR ! CI-huThyrEC-3
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CI-huVEC
AC   CVCL_B7UJ
SY   e-hUVEC-2
DR   Wikidata; Q112929504
RX   PubMed=29520052;
WW   Provider; InSCREENeX; INS-CI-1002; https://www.inscreenex.de/product/huvec/
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 46XY,+5,-13 (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   CI-muADINTESTI
AC   CVCL_E6EN
WW   Provider; InSCREENeX; INS-CI-1018; https://www.inscreenex.de/product/muadintesti/
CC   Characteristics: Established from primary cells that were cultured as intestinal organoids before immortalization to maintain optimal functionality (InSCREENeX=INS-CI-1018).
CC   Characteristics: Expresses typical epithelial markers and grow polarized (InSCREENeX=INS-CI-1018).
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (InSCREENeX=INS-CI-1018).
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CI-muHepa
AC   CVCL_B7UU
SY   e-mHepB
DR   Wikidata; Q112929519
RX   PubMed=29520052;
WW   Provider; InSCREENeX; INS-CI-1012; https://www.inscreenex.de/product/muhepa/
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Characteristics: Tumorigenic (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   CI-muINTEPI
AC   CVCL_E6EI
SY   IEC-1; Intestinal Epithelial Cell line-1
RX   PubMed=23940817;
WW   Provider; InSCREENeX; INS-CI-1007; https://www.inscreenex.de/product/muintepi/
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   19-20FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CI-muMEC
AC   CVCL_E6EH
WW   Provider; InSCREENeX; INS-CI-1004; https://www.inscreenex.de/product/mumec/
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (InSCREENeX=INS-CI-1004).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CI-pNaEC
AC   CVCL_E6B4
SY   P1
RX   PubMed=37765214;
RX   PubMed=37896199;
WW   Provider; InSCREENeX; INS-CI-1029; https://www.inscreenex.de/product/pnaec/
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=37765214).
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CI0001
AC   CVCL_8U01
DR   ECACC; 94012016
DR   Wikidata; Q54813337
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+mar; de novo (ECACC=94012016).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   CI0004
AC   CVCL_8U02
DR   ECACC; 97052218
DR   Wikidata; Q54813339
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY; 47,XY,+mar (ECACC=97052218).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   CI78-1
AC   CVCL_V526
SY   CI 78-1
DR   Wikidata; Q54813340
RX   PubMed=3899078;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   CI79-36
AC   CVCL_D286
SY   CI 79-36
DR   Wikidata; Q54813341
RX   PubMed=3899078;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63-64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   CI80-13A
AC   CVCL_D287
SY   CI 80-13A; 80-13A
DR   Cosmic; 1524362
DR   Wikidata; Q54813342
RX   PubMed=3899078;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D285 ! CI80-13S
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   CI80-13S
AC   CVCL_D285
SY   CI-80-13S; CI 80-13S
DR   ChEMBL-Cells; CHEMBL3307931
DR   ChEMBL-Targets; CHEMBL614458
DR   PubChem_Cell_line; CVCL_D285
DR   Wikidata; Q54813344
RX   PubMed=3899078;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D287 ! CI80-13A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   CI81-1
AC   CVCL_D288
SY   CI 81-1
DR   Wikidata; Q54813345
RX   PubMed=3899078;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   CIA-E-4.15
AC   CVCL_H155
DR   CLO; CLO_0002476
DR   ATCC; HB-235
DR   Wikidata; Q54813346
RX   PubMed=6233363;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01854; Human immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CIA-E-7.12
AC   CVCL_H156
DR   CLO; CLO_0002477
DR   ATCC; HB-236
DR   Wikidata; Q54813347
RX   PubMed=6233363;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01854; Human immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CIAUi001-A
AC   CVCL_C9LW
SY   AOY7
DR   hPSCreg; CIAUi001-A
DR   Wikidata; Q123030930
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CIAUi002-A
AC   CVCL_C9LT
SY   UBC3-A2
DR   hPSCreg; CIAUi002-A
DR   Wikidata; Q123030931
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; c.392+3A>G; ClinVar=VCV000918002; Zygosity=Heterozygous (from autologous cell line CIAUi002-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126651; Progressive familial heart block, type Ia
DI   ORDO; Orphanet_871; Familial progressive cardiac conduction defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9LU ! CIAUi002-B
OI   CVCL_C9LV ! CIAUi002-C
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CIAUi002-B
AC   CVCL_C9LU
SY   UBC3-U
DR   hPSCreg; CIAUi002-B
DR   Wikidata; Q123030932
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; c.392+3A>G; ClinVar=VCV000918002; Zygosity=Heterozygous (from autologous cell line CIAUi002-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126651; Progressive familial heart block, type Ia
DI   ORDO; Orphanet_871; Familial progressive cardiac conduction defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9LT ! CIAUi002-A
OI   CVCL_C9LV ! CIAUi002-C
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CIAUi002-C
AC   CVCL_C9LV
SY   UBC3 M1
DR   BioSamples; SAMEA112941291
DR   hPSCreg; CIAUi002-C
DR   Wikidata; Q123030933
RX   PubMed=37385135;
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; c.392+3A>G; ClinVar=VCV000918002; Zygosity=Heterozygous (PubMed=37385135).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126651; Progressive familial heart block, type Ia
DI   ORDO; Orphanet_871; Familial progressive cardiac conduction defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9LT ! CIAUi002-A
OI   CVCL_C9LU ! CIAUi002-B
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CIAUi003-A
AC   CVCL_WM06
SY   BFC4; MCCIi005-A-1
DR   BioSamples; SAMEA112186036
DR   hPSCreg; CIAUi003-A
DR   Wikidata; Q95985819
RX   PubMed=31039485;
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1513; CASQ2; Simple; p.Lys180Arg (c.539A>G); ClinVar=VCV000265850; Zygosity=Heterozygous (PubMed=31039485).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148368; Catecholaminergic polymorphic ventricular tachycardia type 2
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   CIAUi003-A-1
AC   CVCL_C6P2
SY   BFC4-C; BFC4-CRISPR-corrected
DR   BioSamples; SAMEA112186035
DR   hPSCreg; CIAUi003-A-1
DR   Wikidata; Q117704246
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1513; CASQ2; Simple_corrected; p.Lys180Arg (c.539A>G); ClinVar=VCV000265850; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=CIAUi003-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148368; Catecholaminergic polymorphic ventricular tachycardia type 2
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM06 ! CIAUi003-A
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CIBCgp185
AC   CVCL_C7GZ
DR   Wikidata; Q117704247
RX   PubMed=11847421;
RX   PubMed=15156100;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CIBCHTB1
AC   CVCL_C7H0
DR   Wikidata; Q117704248
RX   PubMed=11341176;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CIBCNSH3
AC   CVCL_C7H1
DR   Wikidata; Q117704249
RX   PubMed=10690627;
RX   PubMed=11847425;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CIBCRGC1
AC   CVCL_C7H2
DR   Wikidata; Q117704250
RX   PubMed=11847425;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CIBi003-A
AC   CVCL_YB93
SY   iPSD0023
DR   hPSCreg; CIBi003-A
DR   Wikidata; Q93453488
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   CIBi004-A
AC   CVCL_YB94
SY   iPSD0029
DR   hPSCreg; CIBi004-A
DR   Wikidata; Q93453490
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   CIBi005-A
AC   CVCL_YB95
SY   iPSD0030
DR   hPSCreg; CIBi005-A
DR   Wikidata; Q93453492
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   CIBi007-A
AC   CVCL_YT00
SY   PARK2/HTRA2 iPSC; YOPD iPSC-C28; iPSD0036
DR   BioSamples; SAMEA6649654
DR   hPSCreg; CIBi007-A
DR   SKIP; SKIP005866
DR   Wikidata; Q93453494
RX   PubMed=32688332;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14348; HTRA2; Simple; p.Pro143Ala (c.427C>G); ClinVar=VCV000030583; Zygosity=Heterozygous (PubMed=32688332).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Cys154Phe (c.461G>T); Zygosity=Heterozygous (PubMed=32688332).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Cys337Tyr (c.1010G>A); Zygosity=Heterozygous (PubMed=32688332).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   CIBi008-A
AC   CVCL_ZX44
SY   Beta-thala iPSC
DR   BioSamples; SAMEA8152170
DR   hPSCreg; CIBi008-A
DR   Wikidata; Q102113680
RX   PubMed=33157391;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.-78A>G (-28A>G); ClinVar=VCV000015471; Zygosity=Heterozygous (PubMed=33157391).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-197C>T (IVS2-654C>T); ClinVar=VCV000015458; Zygosity=Heterozygous (PubMed=33157391).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   CIBi009-A
AC   CVCL_A7JG
SY   iPSD0050; PBMC20191212-01 SeV C4
DR   hPSCreg; CIBi009-A
DR   Wikidata; Q107114676
RX   PubMed=33892292;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:603; APOB; Simple; p.Asp540Tyr (c.1618G>T); ClinVar=VCV000925431; Zygosity=Heterozygous (PubMed=33892292).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Leu414Arg (c.1241T>G); ClinVar=VCV000251747; Zygosity=Heterozygous (PubMed=33892292).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176014; Hypercholesterolemia, familial, 2
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CIBi010-A
AC   CVCL_B3NT
SY   iPSM0059
DR   BioSamples; SAMEA13603589
DR   hPSCreg; CIBi010-A
DR   Wikidata; Q110432721
RX   PubMed=35561459;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a T2A-mCherry construct was integrated in front of the stop codon of both alleles of ASGR1 (PubMed=35561459).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   CIBi011-A
AC   CVCL_B7DL
SY   iPSN0058; AF191113-01 SeV C1
DR   BioSamples; SAMEA13409962
DR   hPSCreg; CIBi011-A
DR   Wikidata; Q112929386
RX   PubMed=35609349;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   CIBi012-A
AC   CVCL_C6TM
SY   FAP iPSC
DR   hPSCreg; CIBi012-A
DR   Wikidata; Q117704251
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CIBi013-A
AC   CVCL_C6TL
SY   DJ-1_c.334C>G
DR   hPSCreg; CIBi013-A
DR   Wikidata; Q117704252
RX   PubMed=36469984;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple; p.Leu122Val (c.334C>G); Zygosity=Homozygous (PubMed=36469984).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CIBi014-A
AC   CVCL_C6TK
SY   LRRK2_c.5136A>T
DR   hPSCreg; CIBi014-A
DR   Wikidata; Q117704253
RX   PubMed=36528012;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Leu1712Phe (c.5136A>T); Zygosity=Heterozygous (PubMed=36528012).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CIBIOi001-A
AC   CVCL_UF38
SY   Q66K#44DRM
DR   hPSCreg; CIBIOi001-A
DR   Wikidata; Q93453497
RX   PubMed=30366341;
CC   From: CIBIO, University of Trento; Trento; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple; p.Gln66Lys (c.196C>A); ClinVar=VCV002734791; Zygosity=Heterozygous (PubMed=30366341).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 10
//
ID   CIBIOi002-A
AC   CVCL_UF39
SY   sALS#24DRM
DR   hPSCreg; CIBIOi002-A
DR   Wikidata; Q93453499
CC   From: CIBIO, University of Trento; Trento; Italy.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   CIBIOi004-A
AC   CVCL_E3AN
DR   hPSCreg; CIBIOi004-A
CC   From: CIBIO, University of Trento; Trento; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CIBIOi005-A
AC   CVCL_E3AP
DR   hPSCreg; CIBIOi005-A
CC   From: CIBIO, University of Trento; Trento; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CIBIOi006-A
AC   CVCL_E3AQ
DR   hPSCreg; CIBIOi006-A
CC   From: CIBIO, University of Trento; Trento; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ciChEnC
AC   CVCL_B4IC
SY   conditionally immortalized Choroidal Endothelial Cell
DR   Wikidata; Q110432722
RX   PubMed=29392318;
CC   Characteristics: Can be maintained in culture at the permissive temperature of 33 Celsius for up to 27 passages without signs of senescence.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Conditionally immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 10
//
ID   CID 9
AC   CVCL_E1I1
SY   CID-9
RX   CelloPub=CLPUB00773;
RX   PubMed=1498370;
RX   PubMed=2251252;
CC   Characteristics: Expresses high level of beta-casein and secretes it into a lumen (PubMed=2251252).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CIEB
AC   CVCL_6A77
SY   Calf small Intestinal Epithelial cells B
DR   Wikidata; Q54813352
RX   CelloPub=CLPUB00287;
RX   PubMed=20444515;
RX   PubMed=22193509;
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Limousin; VBO=VBO_0000274.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   cIEC
AC   CVCL_A4DU
SY   canine Intestinal Epithelial Cell
DR   Wikidata; Q105506622
RX   PubMed=30022673;
WW   Info; -; -; https://www.slideshare.net/WalthamCPN/modelling-the-canine-intestinal-epithelium-characterisation-and-assay-development
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   cIEC-H2
AC   CVCL_E7BT
SY   chicken Intestinal Epithelial Cells-H2
RX   PubMed=37517361;
WW   Provider; Vetagro; -; https://www.vetagro.com/press-room/establishment-and-characterization-of-an-sv40-immortalized-chicken-intestinal-epithelial-cell-line/
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic intestine; UBERON=UBERON_0000160.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   CiGEnC
AC   CVCL_W185
SY   Conditionally immortalized Glomerular Endothelial Cells
DR   Wikidata; Q54813353
DR   Ximbio; 152137
RX   PubMed=16557232;
WW   Provider; University of Bristol; -; https://express-licences.bristol.ac.uk/product/conditionally-immortalised-glomerular-endothelial-cell-line
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Glomerular endothelial cell; CL=CL_0002188.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   Ciha-1
AC   CVCL_Z281
DR   ICLDB; ciha-1
DR   Wikidata; Q54813354
RX   PubMed=20019079;
CC   Group: Insect cell line.
CC   Doubling time: ~2 days (PubMed=20019079).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=643112; ! Neoaliturus haematoceps (Leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CIHGM-1
AC   CVCL_W168
SY   Conditionally Immortalized Human Glomerular Mesangial cells-1
DR   Wikidata; Q54813355
DR   Ximbio; 152138
RX   PubMed=21653636;
WW   Provider; University of Bristol; -; https://express-licences.bristol.ac.uk/product/conditionally-immortalised-mesangial-cell-line
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line name and sex of donor from author direct submission.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   CIHP-1
AC   CVCL_W186
SY   Conditionally Immortalized Human Podocytes-1; AB8/13; AB 8/13; hiPOD; ciPOD
DR   GEO; GSM1199237
DR   GEO; GSM1199238
DR   GEO; GSM1199239
DR   GEO; GSM1199240
DR   GEO; GSM1199241
DR   GEO; GSM1199242
DR   Wikidata; Q54813356
DR   Ximbio; 152135
RX   PubMed=11856766;
RX   PubMed=24349133;
WW   Provider; University of Bristol; -; https://express-licences.bristol.ac.uk/product/podocyte-cell-line
CC   Doubling time: ~52 hours (PubMed=24349133).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3Y
CA   Conditionally immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   CII
AC   CVCL_0D73
SY   CLL-CII
DR   Cell_Model_Passport; SIDM01429
DR   DepMap; ACH-001485
DR   DSMZ; ACC-773
DR   DSMZCellDive; ACC-773
DR   NCBI_Iran; C582
DR   Wikidata; Q54813357
RX   PubMed=6263808;
RX   PubMed=7239716;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~40-60 hours (DSMZ=ACC-773).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DepMap=ACH-001485; DSMZ=ACC-773
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 10.2,16
ST   D19S433: 11,14
ST   D21S11: 29,33
ST   D2S1338: 19,23
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 21,26
ST   Penta D: 3.2,10
ST   Penta E: 7,8
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   CII3
AC   CVCL_V068
DR   CLO; CLO_0002479
DR   CLDB; cl782
DR   IHW; 11w 8002
DR   Wikidata; Q54813358
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   CIIC1
AC   CVCL_L835
SY   C1
DR   ABCD; ABCD_AH052
DR   DSHB; CIIC1
DR   ECACC; 89083001
DR   Wikidata; Q54813359
RX   PubMed=2421741;
RX   PubMed=16125192;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1 (Note=Also reacts with mammalian, fish and Xenopus. Recognizes the C1 epitope N-GARGLTGRPGDA-C).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 30-01-24; Version: 6
//
ID   CIIC2
AC   CVCL_C3TV
SY   C2
DR   Wikidata; Q116048766
RX   PubMed=2421741;
RX   PubMed=16125192;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CIK
AC   CVCL_CV32
SY   Ctenopharyngodon Idellus Kidney
DR   CCRID; 4201FIS-CCTCC00086
DR   CCTCC; GDC0086
DR   Wikidata; Q54813360
RX   CelloPub=CLPUB00329;
RX   PubMed=26911257;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 10
//
ID   CIM
AC   CVCL_F0XU
SY   Ctenopharyngodon Idellus Muscle
RX   PubMed=37782384;
CC   Group: Fish cell line.
CC   Doubling time: 29.24 hours (Note=At 29th passage) (PubMed=37782384).
CC   Miscellaneous: Age of donor from personal communication of Tan, Qing-Song.
CC   Derived from site: In situ; Muscle, epaxial muscle; UBERON=UBERON_0008778.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CIMA 62
AC   CVCL_VP97
SY   CIMA62
DR   Wikidata; Q93453547
RX   PubMed=10837406;
RX   PubMed=12488552;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP98 ! CIMA 73
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   CIMA 73
AC   CVCL_VP98
SY   CIMA73
DR   Wikidata; Q93453550
RX   PubMed=10837406;
RX   PubMed=12488552;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP97 ! CIMA 62
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   CIMAi001-A
AC   CVCL_YC91
SY   PH1-iPSC-G170R
DR   hPSCreg; CIMAi001-A
DR   Wikidata; Q93453553
RX   PubMed=31715429;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigacion Medica Aplicada (CIMA); Pamplona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Arg122Ter (c.364C>T); ClinVar=VCV000204097; Zygosity=Heterozygous (PubMed=31715429).
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Gly170Arg (c.508G>A); ClinVar=VCV000040166; Zygosity=Heterozygous (PubMed=31715429).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123212; Primary hyperoxaluria type I
DI   ORDO; Orphanet_93598; Primary hyperoxaluria type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   CIMHi001-A
AC   CVCL_UL94
SY   CIMHi44f028#4
DR   BioSamples; SAMEA5230377
DR   hPSCreg; CIMHi001-A
DR   Wikidata; Q93453555
RX   PubMed=36473250;
CC   From: Central Institute of Mental Health; Mannheim; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   CIMHi002-A
AC   CVCL_UL95
SY   CIMHi29m067#3
DR   BioSamples; SAMEA5248241
DR   hPSCreg; CIMHi002-A
DR   Wikidata; Q93453558
CC   From: Central Institute of Mental Health; Mannheim; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skeletal muscle; UBERON=UBERON_0001499.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   CIMHi003-A
AC   CVCL_UL96
SY   CIMHi23m035#2
DR   BioSamples; SAMEA5248243
DR   hPSCreg; CIMHi003-A
DR   Wikidata; Q93453561
CC   From: Central Institute of Mental Health; Mannheim; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skeletal muscle; UBERON=UBERON_0001499.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   CIMHi004-A
AC   CVCL_WP74
SY   CIMHi24f007#4
DR   BioSamples; SAMEA5697080
DR   hPSCreg; CIMHi004-A
DR   Wikidata; Q93453563
RX   PubMed=36473250;
CC   From: Central Institute of Mental Health; Mannheim; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1033; BDNF; Simple; p.Val66Met (c.196G>A); ClinVar=VCV000017697; Zygosity=Heterozygous (PubMed=36473250).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 6
//
ID   CIMHi005-A
AC   CVCL_WP75
SY   CIMHi25f100#5
DR   BioSamples; SAMEA13190977
DR   hPSCreg; CIMHi005-A
DR   Wikidata; Q93453567
RX   PubMed=36473250;
CC   From: Central Institute of Mental Health; Mannheim; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1033; BDNF; Simple; p.Val66Met (c.196G>A); ClinVar=VCV000017697; Zygosity=Homozygous (PubMed=36473250).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 7
//
ID   CIMP
AC   CVCL_E9DV
SY   Conditionally Immortalized Mouse Podocytes
RX   PubMed=25720381;
WW   Provider; University of Bristol; -; https://express-licences.bristol.ac.uk/product/murine-podocyte-cell-line
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CIN-612
AC   CVCL_ER24
SY   CIN 612; CIN612
DR   Wikidata; Q54813361
RX   PubMed=1323879;
RX   PubMed=1326657;
RX   PubMed=1850010;
RX   PubMed=7835777;
RX   PubMed=8390960;
CC   Virology: Contains about 50 HPV31b episomes per cell.
CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
DI   NCIt; C3782; Cervical intraepithelial neoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   CIN-612 3E
AC   CVCL_ER25
SY   CIN-612-3E; CIN 612-3E
DR   Wikidata; Q54813362
RX   PubMed=7835777;
RX   PubMed=8390960;
CC   Virology: Contains about 50 HPV31b episomes per cell.
CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
DI   NCIt; C3782; Cervical intraepithelial neoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ER24 ! CIN-612
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   CIN-612 6E
AC   CVCL_ER26
SY   CIN-612-6E; CIN 612-6E
DR   Wikidata; Q54813363
RX   PubMed=7835777;
RX   PubMed=8390960;
RX   PubMed=8764055;
CC   Virology: Contains 2 to 5 copies of integrated HPV31b genomes.
CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
DI   NCIt; C3782; Cervical intraepithelial neoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ER24 ! CIN-612
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   CIN-612 9E
AC   CVCL_ER27
SY   CIN 612-9E; CIN612-9E; CIN-612 clone 9E; CIN612 clone 9E; CIN612 subclone 9E
DR   GEO; GSM1435014
DR   GEO; GSM1435015
DR   GEO; GSM1435016
DR   GEO; GSM1435017
DR   Wikidata; Q54813364
RX   PubMed=1326657;
RX   PubMed=7835777;
RX   PubMed=8764055;
RX   PubMed=12388689;
CC   Virology: Contains about 50 HPV31b episomes per cell.
CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3782; Cervical intraepithelial neoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ER24 ! CIN-612
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   CIN-680
AC   CVCL_ER28
DR   Wikidata; Q54813365
RX   PubMed=7835777;
RX   PubMed=8764055;
CC   Virology: Contains integrated HPV16 genome(s).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C3782; Cervical intraepithelial neoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   Cindy
AC   CVCL_WS63
SY   HSA-1
DR   Wikidata; Q93453600
RX   PubMed=22849686;
RX   PubMed=30601866;
RX   PubMed=31175136;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Breed, age of donor and equivalence of Cyndy with HSA-1 from personal communication of MacNeill, Amy L.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 231,239
ST   Dog FHC2054: 147,181
ST   Dog FHC2079: 272,279
ST   Dog PEZ1: 119,123
ST   Dog PEZ3: 124,134
ST   Dog PEZ5: 103,111
ST   Dog PEZ6: 171,179
ST   Dog PEZ8: 236,244
ST   Dog PEZ12: 281,284
ST   Dog PEZ20: 180,184
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 6
//
ID   CIOV1
AC   CVCL_A8Q1
DR   ECACC; 17100534
DR   Wikidata; Q102113681
CC   Discontinued: ECACC; 17100534; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ECACC=17100534
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 8,13
ST   FGA: 20
ST   Penta D: 10,12
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   CIOV2
AC   CVCL_A8Q2
DR   ECACC; 17100535
DR   Wikidata; Q102113682
CC   Discontinued: ECACC; 17100535; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   CIOV3
AC   CVCL_A8Q3
DR   ECACC; 17100536
DR   Wikidata; Q102113683
CC   Discontinued: ECACC; 17100536; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ECACC=17100536
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 10,17
ST   D21S11: 30,31
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   ciPEC
AC   CVCL_B7JX
SY   conditionally immortalized Parietal Epithelial Cells
DR   Wikidata; Q112929387
RX   PubMed=34181939;
CC   Doubling time: 35 hours (PubMed=34181939).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Parietal epithelial cell; CL=CL_1000452.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   9M
CA   Conditionally immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   CIPGC
AC   CVCL_YJ30
SY   Conditional Immortal Porcine Granulosa Cells
DR   Wikidata; Q93453606
RX   PubMed=31936362;
CC   Characteristics: Transduced with a P-TR3G-SV40largeT-T2A-mCherry-PhPGKp-PuroR-T2A-rTer-VP16 construct. The expression of the SV40 largeT antigen is under the control of the Tet-On system and induced by doxycycline.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   CIPi001-A
AC   CVCL_B3S5
SY   iPSC-16p11.2 deletion
DR   BioSamples; SAMEA10271033
DR   hPSCreg; CIPi001-A
DR   Wikidata; Q110432723
RX   PubMed=34995844;
CC   From: Children's Hospital of Capital Institute of Pediatrics; Beijing; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183308; Benign familial infantile seizures
DI   NCIt; C120408; Chromosome 16p11.2 deletion syndrome
DI   ORDO; Orphanet_306; Benign familial infantile epilepsy
DI   ORDO; Orphanet_261197; Proximal 16p11.2 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y3M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CIPi002-A
AC   CVCL_C0II
DR   BioSamples; SAMEA14436310
DR   hPSCreg; CIPi002-A
DR   Wikidata; Q112929388
RX   PubMed=35853415;
CC   From: Children's Hospital of Capital Institute of Pediatrics; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:10596; SCN8A; Simple; p.Met367Val (c.1099A>G); ClinVar=VCV000207105; Zygosity=Heterozygous (PubMed=35853415).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188139; Developmental and epileptic encephalopathy 13
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y5M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   CIPi003-A
AC   CVCL_C1SV
DR   hPSCreg; CIPi003-A
DR   Wikidata; Q114310967
RX   PubMed=37722146;
CC   From: Children's Hospital of Capital Institute of Pediatrics; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:18423; DEPDC5; Simple; p.Gln83Ter (c.247C>T); ClinVar=VCV001073664; Zygosity=Heterozygous (PubMed=37722146).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C161005; Familial focal epilepsy with variable foci 1
DI   ORDO; Orphanet_98820; Familial focal epilepsy with variable foci
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CIPi004-A
AC   CVCL_E3TM
DR   BioSamples; SAMEA115525688
DR   hPSCreg; CIPi004-A
RX   PubMed=38761686;
CC   From: Children's Hospital of Capital Institute of Pediatrics; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.1527+1G>C; ClinVar=VCV000431589; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=38761686).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CIPi005-A
AC   CVCL_E3TN
DR   BioSamples; SAMEA115908488
DR   hPSCreg; CIPi005-A
CC   From: Children's Hospital of Capital Institute of Pediatrics; Beijing; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CIPm
AC   CVCL_L148
DR   Wikidata; Q54813366
RX   PubMed=19754820;
RX   PubMed=28283079;
RX   PubMed=33461558;
CC   Doubling time: 20.29 hours (PubMed=33461558).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Shih Tzu; VBO=VBO_0201223.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L149 ! CIPp
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 16
//
ID   CIPp
AC   CVCL_L149
DR   Wikidata; Q54813367
RX   PubMed=19754820;
RX   PubMed=28283079;
RX   PubMed=33461558;
CC   Doubling time: 23.17 hours (PubMed=33461558).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Shih Tzu; VBO=VBO_0201223.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L148 ! CIPm
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   ciPS
AC   CVCL_YE48
SY   chick induced Pluripotent Stem
DR   Wikidata; Q93453622
RX   PubMed=31673064;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Taiwan black silkie; VBO=VBO_0017530.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   9FD
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   ciPS5
AC   CVCL_A4IE
DR   GEO; GSM748376
DR   GEO; GSM748377
DR   GEO; GSM748378
DR   Wikidata; Q105506625
RX   PubMed=22310243;
CC   From: National Institute of Biological Sciences; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple_corrected; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous; Note=By homologous recombination (PubMed=22310243).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4IB ! piPS7
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   ciPS9
AC   CVCL_A4IF
DR   Wikidata; Q105506629
RX   PubMed=22310243;
CC   From: National Institute of Biological Sciences; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple_corrected; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous; Note=By homologous recombination (PubMed=22310243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4IB ! piPS7
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ciPSC line 3
AC   CVCL_A5QC
DR   Wikidata; Q107114677
RX   PubMed=30215317;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5QD ! ciPSC line 6
SX   Male
AG   30FD
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   ciPSC line 6
AC   CVCL_A5QD
DR   Wikidata; Q107114678
RX   PubMed=30215317;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5QC ! ciPSC line 3
SX   Male
AG   30FD
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   ciPSC P9
AC   CVCL_A5QE
DR   Wikidata; Q107114680
RX   PubMed=32424848;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   ciPTEC
AC   CVCL_W184
SY   conditionally immortalized Proximal Tubule Epithelial Cells
DR   Wikidata; Q54813368
DR   Ximbio; 152139
RX   PubMed=19902259;
WW   Provider; University of Bristol; -; https://express-licences.bristol.ac.uk/product/conditionally-immortalised-proximal-tubular-cell-line
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Conditionally immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   ciPTEC-OAT1
AC   CVCL_LI01
DR   Wikidata; Q54813369
RX   PubMed=26821801;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10970; SLC22A6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W184 ! ciPTEC
SX   Female
AG   12Y
CA   Conditionally immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 12
//
ID   ciPTEC-OAT3
AC   CVCL_LI02
DR   Wikidata; Q54813370
RX   PubMed=26821801;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10972; SLC22A8.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W184 ! ciPTEC
SX   Female
AG   12Y
CA   Conditionally immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 12
//
ID   CIPULLO
AC   CVCL_M711
DR   cancercelllines; CVCL_M711
DR   Cosmic; 2297021
DR   GEO; GSM119490
DR   Progenetix; CVCL_M711
DR   Wikidata; Q54813371
RX   PubMed=16960149;
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   CIR 229
AC   CVCL_VP99
SY   CIR229
DR   Wikidata; Q93453645
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   CiRA-PD22
AC   CVCL_DQ42
SY   Cira22
DR   GEO; GSM936056
DR   GEO; GSM1489203
DR   GEO; GSM1489226
DR   GEO; GSM1489438
DR   Wikidata; Q54813372
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ43 ! CiRA-PD23
OI   CVCL_DQ44 ! CiRA-PD24
OI   CVCL_DQ45 ! CiRA-PD25
OI   CVCL_DR16 ! CiRA-PD82
OI   CVCL_DR17 ! CiRA-PD83
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CiRA-PD23
AC   CVCL_DQ43
SY   Cira23
DR   GEO; GSM936057
DR   GEO; GSM1489204
DR   GEO; GSM1489227
DR   GEO; GSM1489439
DR   Wikidata; Q54813373
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ42 ! CiRA-PD22
OI   CVCL_DQ44 ! CiRA-PD24
OI   CVCL_DQ45 ! CiRA-PD25
OI   CVCL_DR16 ! CiRA-PD82
OI   CVCL_DR17 ! CiRA-PD83
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CiRA-PD24
AC   CVCL_DQ44
SY   Cira24; PD01 #24
DR   GEO; GSM936058
DR   GEO; GSM1489205
DR   GEO; GSM1489237
DR   GEO; GSM1489440
DR   Wikidata; Q54813374
RX   PubMed=22802639;
RX   PubMed=23364790;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ42 ! CiRA-PD22
OI   CVCL_DQ43 ! CiRA-PD23
OI   CVCL_DQ45 ! CiRA-PD25
OI   CVCL_DR16 ! CiRA-PD82
OI   CVCL_DR17 ! CiRA-PD83
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   CiRA-PD25
AC   CVCL_DQ45
SY   Cira25; PD01-25
DR   GEO; GSM701543
DR   GEO; GSM936059
DR   GEO; GSM1489291
DR   Wikidata; Q54813375
RX   PubMed=22802639;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ42 ! CiRA-PD22
OI   CVCL_DQ43 ! CiRA-PD23
OI   CVCL_DQ44 ! CiRA-PD24
OI   CVCL_DR16 ! CiRA-PD82
OI   CVCL_DR17 ! CiRA-PD83
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   CiRA-PD26
AC   CVCL_DQ46
SY   Cira26; PD01-26; PD01 #26
DR   GEO; GSM936060
DR   GEO; GSM1489292
DR   Wikidata; Q54813376
RX   PubMed=22802639;
RX   PubMed=23364790;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ47 ! CiRA-PD27
OI   CVCL_DQ48 ! CiRA-PD28
OI   CVCL_DQ49 ! CiRA-PD29
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CiRA-PD27
AC   CVCL_DQ47
SY   Cira27
DR   GEO; GSM936061
DR   GEO; GSM1489200
DR   GEO; GSM1489435
DR   Wikidata; Q54813378
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ46 ! CiRA-PD26
OI   CVCL_DQ48 ! CiRA-PD28
OI   CVCL_DQ49 ! CiRA-PD29
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CiRA-PD28
AC   CVCL_DQ48
SY   Cira28
DR   GEO; GSM936062
DR   GEO; GSM1489293
DR   Wikidata; Q54813379
RX   PubMed=22802639;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ46 ! CiRA-PD26
OI   CVCL_DQ47 ! CiRA-PD27
OI   CVCL_DQ49 ! CiRA-PD29
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   CiRA-PD29
AC   CVCL_DQ49
SY   Cira29
DR   GEO; GSM936063
DR   GEO; GSM1489201
DR   GEO; GSM1489436
DR   Wikidata; Q54813380
RX   PubMed=22802639;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ46 ! CiRA-PD26
OI   CVCL_DQ47 ! CiRA-PD27
OI   CVCL_DQ48 ! CiRA-PD28
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   CiRA-PD82
AC   CVCL_DR16
SY   Cira82
DR   GEO; GSM1489202
DR   GEO; GSM1489437
DR   GEO; GSM1942575
DR   Wikidata; Q54813381
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ42 ! CiRA-PD22
OI   CVCL_DQ43 ! CiRA-PD23
OI   CVCL_DQ44 ! CiRA-PD24
OI   CVCL_DQ45 ! CiRA-PD25
OI   CVCL_DR17 ! CiRA-PD83
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   CiRA-PD83
AC   CVCL_DR17
SY   Cira83
DR   GEO; GSM1489206
DR   GEO; GSM1489441
DR   Wikidata; Q54813382
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ42 ! CiRA-PD22
OI   CVCL_DQ43 ! CiRA-PD23
OI   CVCL_DQ44 ! CiRA-PD24
OI   CVCL_DQ45 ! CiRA-PD25
OI   CVCL_DR16 ! CiRA-PD82
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   CiRA00002
AC   CVCL_UP54
SY   HPS1747
DR   RCB; HPS1747
DR   Wikidata; Q93453704
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP55 ! CiRA00003
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   CiRA00003
AC   CVCL_UP55
SY   HPS1745
DR   RCB; HPS1745
DR   Wikidata; Q93453706
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP54 ! CiRA00002
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   CiRA00004
AC   CVCL_RL44
SY   ADPKD_P1-iPSCs
DR   SKIP; SKIP001423
DR   Wikidata; Q54813383
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; c.2986-15C>T; ClinVar=VCV000256939; Zygosity=Unspecified (PubMed=27418197).
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; c.8161+38G>A; ClinVar=VCV000440080; Zygosity=Unspecified (PubMed=27418197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27418197
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 13,22
ST   D21S11: 29,33.2
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 19,21
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 14
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   CiRA00005
AC   CVCL_RL45
SY   ADPKD_P2-iPSCs
DR   SKIP; SKIP001459
DR   Wikidata; Q54813384
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Trp429Ser (c.1286G>C); Zygosity=Unspecified (PubMed=27418197).
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Ser2235Leu (c.6704C>T); Zygosity=Unspecified (PubMed=27418197).
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Val3008Met (c.9022G>A); ClinVar=VCV000811571; Zygosity=Unspecified (PubMed=27418197).
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Ser3405Tyr (c.10214C>A) (p.Ser3404Tyr, c.10211C>A); Zygosity=Unspecified (PubMed=27418197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27418197
ST   Amelogenin: X
ST   CSF1PO: 7,9
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,16
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   CiRA00006
AC   CVCL_RL46
SY   ADPKD_P3-iPSCs
DR   SKIP; SKIP001458
DR   Wikidata; Q54813385
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple; p.Ala190Thr (c.568G>A); ClinVar=VCV000092796; Zygosity=Unspecified (PubMed=27418197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27418197
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 12,14
ST   D18S51: 18,19
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 9,13
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   Penta D: 9,14
ST   Penta E: 19,20
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   CiRA00007
AC   CVCL_RL47
SY   ADPKD_P4-iPSCs
DR   SKIP; SKIP001460
DR   Wikidata; Q54813386
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Gly3818Arg (c.11452G>C); Zygosity=Unspecified (PubMed=27418197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27418197
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D21S11: 29
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 8
ST   D8S1179: 14,17
ST   FGA: 23,24
ST   Penta D: 9,11
ST   Penta E: 9,19
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   CiRA00008
AC   CVCL_RL48
SY   ADPKD_P5-iPSCs
DR   SKIP; SKIP001461
DR   Wikidata; Q54813387
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Glu2111Lys (c.6331G>A); ClinVar=VCV001194414; Zygosity=Unspecified (PubMed=27418197).
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Arg2327Trp (c.6979C>T); ClinVar=VCV000618812; Zygosity=Unspecified (PubMed=27418197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27418197
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 17,21
ST   D21S11: 31,31.2
ST   D3S1358: 15,16
ST   D5S818: 7,12
ST   D7S820: 8,14
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 15,21
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   CiRA00009
AC   CVCL_RL49
SY   ADPKD_P6-iPSCs
DR   SKIP; SKIP001462
DR   Wikidata; Q54813388
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Gln3955Ter (c.11863C>T) (p.Gln3895Ter) (12069C>T); ClinVar=VCV000974399; Zygosity=Unspecified (PubMed=27418197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27418197
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 15,17
ST   D21S11: 30,30.2
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 5,15
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   CiRA00010
AC   CVCL_RL50
SY   ADPKD_P7-iPSCs
DR   SKIP; SKIP001463
DR   Wikidata; Q54813389
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Asp2273Alafs*145 (c.6818_6819delAC) (7024delAC); Zygosity=Unspecified (PubMed=27418197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27418197
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D21S11: 30,32.2
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 20,25
ST   Penta D: 9,12
ST   Penta E: 11,15
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   CiRA00021
AC   CVCL_Y961
SY   A21412; HPS0289; HPS0327
DR   RCB; HPS0289
DR   RCB; HPS0327
DR   SKIP; SKIP000626
DR   Wikidata; Q54813390
RX   PubMed=22855461;
RX   PubMed=30127392;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gln343Arg (c.1028A>G); ClinVar=VCV000005235; Zygosity=Heterozygous (PubMed=22855461).
CC   Discontinued: RCB; HPS0289; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T779 ! CiRA00022
OI   CVCL_T780 ! CiRA00023
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   CiRA00022
AC   CVCL_T779
SY   Cira22; A21421; HPS0290
DR   RCB; HPS0290
DR   SKIP; SKIP000228
DR   Wikidata; Q54813392
RX   PubMed=22855461;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gln343Arg (c.1028A>G); ClinVar=VCV000005235; Zygosity=Heterozygous (PubMed=22855461).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y961 ! CiRA00021
OI   CVCL_T780 ! CiRA00023
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   CiRA00023
AC   CVCL_T780
SY   A21428; HPS0291
DR   RCB; HPS0291
DR   SKIP; SKIP000229
DR   Wikidata; Q54813393
RX   PubMed=22855461;
RX   PubMed=30127392;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gln343Arg (c.1028A>G); ClinVar=VCV000005235; Zygosity=Heterozygous (PubMed=22855461).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y961 ! CiRA00021
OI   CVCL_T779 ! CiRA00022
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   CiRA00024
AC   CVCL_T781
SY   A3411; HPS0292
DR   RCB; HPS0292
DR   SKIP; SKIP000230
DR   Wikidata; Q54813405
RX   PubMed=22855461;
RX   PubMed=30127392;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Met337Val (c.1009A>G); ClinVar=VCV000005228; Zygosity=Heterozygous (PubMed=22855461).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T782 ! CiRA00025
OI   CVCL_T783 ! CiRA00026
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   CiRA00025
AC   CVCL_T782
SY   A3415; HPS0293
DR   RCB; HPS0293
DR   SKIP; SKIP000231
DR   Wikidata; Q54813406
RX   PubMed=22855461;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Met337Val (c.1009A>G); ClinVar=VCV000005228; Zygosity=Heterozygous (PubMed=22855461).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T781 ! CiRA00024
OI   CVCL_T783 ! CiRA00026
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   CiRA00026
AC   CVCL_T783
SY   A3416; HPS0294
DR   RCB; HPS0294
DR   SKIP; SKIP000232
DR   Wikidata; Q54813407
RX   PubMed=22855461;
RX   PubMed=30127392;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Met337Val (c.1009A>G); ClinVar=VCV000005228; Zygosity=Heterozygous (PubMed=22855461).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T781 ! CiRA00024
OI   CVCL_T782 ! CiRA00025
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   CiRA00111
AC   CVCL_VM71
SY   DMD-iPSC #1; DMD-iPSC clone #1; HPS0383
DR   RCB; HPS0383
DR   Wikidata; Q93453759
RX   PubMed=25434822;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex44del; Zygosity=Hemizygous (PubMed=25434822).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   CiRA00111-CKI-C2
AC   CVCL_VM72
SY   DMD-iPSC #1 CKIC2; HPS0387
DR   RCB; HPS0387
DR   Wikidata; Q93453761
RX   PubMed=25434822;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 DMD exon 44 was knocked-in thus restoring the reading frame.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM71 ! CiRA00111
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   CiRA00111-ES-H19
AC   CVCL_VM73
SY   DMD-iPSC #1 ESH19; HPS0385
DR   RCB; HPS0385
DR   Wikidata; Q93453762
RX   PubMed=25434822;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Characteristics: Using TALEN a 18 bp deletion was introduced spanning the splicing acceptor site of DMD exon 45 thus restoring the reading frame.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM71 ! CiRA00111
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   CiRA00111-IF-D28
AC   CVCL_VM74
SY   DMD-iPSC #1 IFD28; HPS0384
DR   RCB; HPS0384
DR   Wikidata; Q93453764
RX   PubMed=25434822;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Characteristics: Using TALEN a 1 bp deletion was introduced in DMD exon 45 thus restoring the reading frame.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM71 ! CiRA00111
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   CiRA00111-TKI-I15
AC   CVCL_VM75
SY   DMD-iPSC #1 TKII15; HPS0386
DR   RCB; HPS0386
DR   Wikidata; Q93453766
RX   PubMed=25434822;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Characteristics: Using TALEN DMD exon 44 was knocked-in thus restoring the reading frame.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM71 ! CiRA00111
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   CiRA00139
AC   CVCL_IP54
SY   HPS0426
DR   RCB; HPS0426
DR   SKIP; SKIP001191
DR   Wikidata; Q54813410
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   CiRA00142
AC   CVCL_IP55
SY   HPS0429
DR   RCB; HPS0429
DR   SKIP; SKIP001192
DR   Wikidata; Q54813411
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   CIRA00150-19
AC   CVCL_C4NX
DR   Wikidata; Q116048767
RX   PubMed=36259166;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Val1316fs (c.3944dupC) (p.Thr1315fs*17) (c.3944_3945insC); ClinVar=VCV000180624; Zygosity=Heterozygous (PubMed=36259166).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4NY ! CIRA00150-22
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CIRA00150-22
AC   CVCL_C4NY
DR   Wikidata; Q116048768
RX   PubMed=36259166;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Val1316fs (c.3944dupC) (p.Thr1315fs*17) (c.3944_3945insC); ClinVar=VCV000180624; Zygosity=Heterozygous (PubMed=36259166).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4NX ! CIRA00150-19
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CIRA00153-18
AC   CVCL_C4NZ
DR   Wikidata; Q116048769
RX   PubMed=36259166;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Ala40Glyfs*24 (c.118dupG) (c.118_119insG); ClinVar=VCV000003810; Zygosity=Heterozygous (PubMed=36259166).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW70 ! GM02075
SX   Female
AG   1Y6M
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CIRA00153-9
AC   CVCL_C4P0
DR   Wikidata; Q116048770
RX   PubMed=36259166;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Ala40Glyfs*24 (c.118dupG) (c.118_119insG); ClinVar=VCV000003810; Zygosity=Heterozygous (PubMed=36259166).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW70 ! GM02075
SX   Female
AG   1Y6M
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CiRA00160
AC   CVCL_IP56
SY   HPS0507
DR   RCB; HPS0507
DR   SKIP; SKIP001193
DR   Wikidata; Q54813412
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   CiRA00161
AC   CVCL_IP57
SY   HPS0508
DR   RCB; HPS0508
DR   SKIP; SKIP001194
DR   Wikidata; Q54813413
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   CiRA00169
AC   CVCL_UR06
SY   HPS0522
DR   RCB; HPS0522
DR   SKIP; SKIP003027
DR   Wikidata; Q93453774
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR07 ! CiRA00170
OI   CVCL_UR08 ! CiRA00171
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   CiRA00170
AC   CVCL_UR07
SY   HPS0523
DR   RCB; HPS0523
DR   Wikidata; Q93453775
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR06 ! CiRA00169
OI   CVCL_UR08 ! CiRA00171
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   CiRA00171
AC   CVCL_UR08
SY   HPS0524
DR   RCB; HPS0524
DR   Wikidata; Q93453776
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR06 ! CiRA00169
OI   CVCL_UR07 ! CiRA00170
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   CiRA00455
AC   CVCL_VM55
SY   HPS1746
DR   RCB; HPS1746
DR   Wikidata; Q93453777
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C81 ! HPS0254
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   CiRA086Ai-m1
AC   CVCL_T776
SY   HPS0117
DR   RCB; HPS0117
DR   SKIP; SKIP000171
DR   Wikidata; Q54813408
RX   PubMed=22723549;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:16400; NLRP3; Simple; p.Gly309Ser (c.925G>A) (p.Gly307Ser, c.919G>A); Zygosity=Heterozygous; Note=Somatic mosaicism (PubMed=22723549).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
DI   ORDO; Orphanet_1451; CINCA syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y542 ! CiRA086Ai-w1
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   CiRA086Ai-w1
AC   CVCL_Y542
SY   HPS0118
DR   SKIP; SKIP000172
DR   Wikidata; Q54813409
RX   PubMed=22723549;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Misspelling: HSP0118; SKIP=SKIP000172.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
DI   ORDO; Orphanet_1451; CINCA syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T776 ! CiRA086Ai-m1
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   CiRA188Ai-M1
AC   CVCL_T777
SY   HPS0119
DR   RCB; HPS0119
DR   SKIP; SKIP000173
DR   Wikidata; Q54813414
RX   PubMed=22723549;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:16400; NLRP3; Simple; p.Tyr572Cys (c.1715G>A) (p.Tyr570Cys, c.1709A>G); ClinVar=VCV000097946; Zygosity=Heterozygous; Note=Somatic mosaicism (PubMed=22723549).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
DI   ORDO; Orphanet_1451; CINCA syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T778 ! CiRA188Ai-W1
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   CiRA188Ai-W1
AC   CVCL_T778
SY   HPS0120
DR   RCB; HPS0120
DR   SKIP; SKIP000174
DR   Wikidata; Q54813415
RX   PubMed=22723549;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116380; Chronic infantile neurological cutaneous and articular syndrome
DI   ORDO; Orphanet_1451; CINCA syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T777 ! CiRA188Ai-M1
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   CIRAi001-A
AC   CVCL_QX84
SY   HPS1816
DR   hPSCreg; CIRAi001-A
DR   RCB; HPS1816
DR   Wikidata; Q54813416
RX   PubMed=29034893;
CC   Sequence variation: Mutation; HGNC; HGNC:4193; GCH1; Simple; c.626+1G>C; ClinVar=VCV000529415; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29034893).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034893
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 28,31.2
ST   D3S1358: 18,20
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 17,18
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C116719; Dopa-responsive dystonia
DI   ORDO; Orphanet_255; Dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   CIRAi002-A
AC   CVCL_QX85
SY   HPS1732
DR   hPSCreg; CIRAi002-A
DR   RCB; HPS1732
DR   Wikidata; Q54813417
RX   PubMed=29034879;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6572; LGI1; Simple; p.Ser473Leu (c.1418C>T); ClinVar=VCV000208480; Zygosity=Heterozygous (PubMed=29034879).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034879
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 13,23
ST   D19S433: 14,15.2
ST   D21S11: 29,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C141441; Autosomal dominant lateral temporal lobe epilepsy
DI   ORDO; Orphanet_101046; Autosomal dominant epilepsy with auditory features
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   CIRAi003-A
AC   CVCL_QX86
SY   HPS1036
DR   hPSCreg; CIRAi003-A
DR   RCB; HPS1036
DR   Wikidata; Q54813419
RX   PubMed=29034894;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10947; SLC20A2; Simple; p.Trp616Ter (c.1848G>A); ClinVar=VCV003704396; Zygosity=Heterozygous (PubMed=29034894).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034894
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 15,19
ST   D19S433: 13,14
ST   D21S11: 31,34.2
ST   D2S1338: 20,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1SX ! HPS1705
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 12
//
ID   CIRAi004-A
AC   CVCL_UL56
SY   HPS3660
DR   hPSCreg; CIRAi004-A
DR   RCB; HPS3660
DR   SKIP; SKIP005532
DR   Wikidata; Q93453810
RX   PubMed=30605843;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30605843
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,19
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 19,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   CIRAi005-A
AC   CVCL_ZA41
SY   F2KU1#4; F2KU1
DR   BioSamples; SAMEA6983572
DR   hPSCreg; CIRAi005-A
DR   Wikidata; Q98125626
RX   PubMed=30107443;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29090; SMCHD1; Simple; p.Val1373_Lys1377del (c.4118_4132del); Zygosity=Heterozygous (hPSCreg=CIRAi005-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172705; Facioscapulohumeral muscular dystrophy 2
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   CIRAi005-A-1
AC   CVCL_ZA42
SY   IsC2-F2KU1#4; IsC-F2KU1; CIRAi005-B
DR   BioSamples; SAMEA7001537
DR   EBiSC; CIRAi005-A-1
DR   ECACC; 66770001
DR   hPSCreg; CIRAi005-A-1
DR   Wikidata; Q98125627
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29090; SMCHD1; Simple_corrected; p.Val1373_Lys1377del (c.4118_4132del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=CIRAi005-A-1).
CC   Discontinued: ECACC; 66770001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172705; Facioscapulohumeral muscular dystrophy 2
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA41 ! CIRAi005-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CIRAi006-A
AC   CVCL_ZA43
SY   F2KU2#17; F2KU2
DR   BioSamples; SAMEA7001538
DR   hPSCreg; CIRAi006-A
DR   Wikidata; Q98125628
RX   PubMed=32711388;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29090; SMCHD1; Simple; p.Lys607Ter (c.1819A>T); Zygosity=Heterozygous (PubMed=32711388).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172705; Facioscapulohumeral muscular dystrophy 2
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CIRAi006-A-1
AC   CVCL_ZA44
SY   IsC41-F2KU2#17; IsC-F2KU2; CIRAi006-B
DR   BioSamples; SAMEA7001540
DR   hPSCreg; CIRAi006-A-1
DR   Wikidata; Q98125630
RX   PubMed=32711388;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29090; SMCHD1; Simple_corrected; p.Lys607Ter (c.1819A>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32711388).
CC   Sequence variation: Mutation; HGNC; HGNC:29090; SMCHD1; Simple_edited; p.Gly612Gly (c.1835A>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9. Silent mutation (PubMed=32711388).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172705; Facioscapulohumeral muscular dystrophy 2
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA43 ! CIRAi006-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CIRC-HLF
AC   CVCL_CW31
DR   NCBI_Iran; C580
DR   Wikidata; Q54813420
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CIRC-HLF-CI
AC   CVCL_CW32
DR   NCBI_Iran; C581
DR   Wikidata; Q54813421
CC   Donor information: Established from the lung biopsy of a victim of chemical weapons who sustained injury 23 years before the cell line was established.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   CiSB
AC   CVCL_A8ZF
SY   Ctenopharyngodon idellus Swim Bladder
DR   Wikidata; Q108820046
RX   PubMed=33460745;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by grass carp reovirus (GCRV) genotype 2 (PubMed=33460745).
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   Citrullinemia
AC   CVCL_3301
AS   CVCL_U513
SY   citrullinemia; GM00063; GM0063; GM-63; GM63
DR   CLO; CLO_0002480
DR   CLO; CLO_0002481
DR   CLDB; cl783
DR   ATCC; CCL-76
DR   BioSample; SAMN03471287
DR   Coriell; GM00063
DR   ECACC; 90102532
DR   Wikidata; Q54813422
RX   CelloPub=CLPUB00387;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7174798;
RX   PubMed=16591537;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00063; probable.
CC   Discontinued: ECACC; 90102532; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-76
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 14,14.2
ST   D21S11: 28,30
ST   D2S1338: 17,19
ST   D3S1358: 14,17
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 15
ST   FGA: 21,23
ST   Penta D: 9,11
ST   Penta E: 5,7
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   CJ
AC   CVCL_UI83
DR   Wikidata; Q93453826
RX   PubMed=2155676;
RX   PubMed=20664054;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CJ.F4
AC   CVCL_XH91
DR   Wikidata; Q93453828
RX   PubMed=9759867;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   Cj11
AC   CVCL_2Z80
SY   cj11
DR   SKIP; SKIP001439
DR   Wikidata; Q54813423
RX   Patent=US5843780;
RX   PubMed=8828827;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   Cj11.2
AC   CVCL_2U74
DR   Wikidata; Q54813424
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_2Z80 ! Cj11
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   CJ179
AC   CVCL_WY31
DR   Wikidata; Q93453838
RX   PubMed=15574327;
RX   PubMed=16874298;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C162694; Severe combined immunodeficiency, Athabascan type
DI   ORDO; Orphanet_275; Severe combined immunodeficiency due to DCLRE1C deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   CJ179-hTERT
AC   CVCL_WY32
SY   CJ179 hTERT; CJ179 hTert; CJ179hTERT; CJ179hTert
DR   Wikidata; Q93453840
RX   PubMed=15574327;
RX   PubMed=16540517;
RX   PubMed=16874298;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C162694; Severe combined immunodeficiency, Athabascan type
DI   ORDO; Orphanet_275; Severe combined immunodeficiency due to DCLRE1C deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WY31 ! CJ179
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   CJ18
AC   CVCL_M708
DR   Wikidata; Q54813425
RX   PubMed=4081642;
CC   Doubling time: 3-4 days (PubMed=4081642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Cj25.1
AC   CVCL_2U75
DR   Wikidata; Q54813426
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   Cj28
AC   CVCL_2U76
DR   Wikidata; Q54813427
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   Cj33
AC   CVCL_2U77
DR   Wikidata; Q54813428
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   Cj35
AC   CVCL_2U78
DR   Wikidata; Q54813429
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   Cj36
AC   CVCL_2U79
DR   Wikidata; Q54813430
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   Cj39
AC   CVCL_2U80
DR   Wikidata; Q54813431
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   CJ4.1A
AC   CVCL_UZ29
DR   ABM; T0368
DR   Wikidata; Q93453872
RX   PubMed=17123516;
WW   Provider; WSU OTC; 14-1256; https://wayne.technologypublisher.com/technology/23894
CC   Doubling time: 22 +- 7 hours (PubMed=17123516).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   15W
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CJ4.3C
AC   CVCL_UZ30
DR   ABM; T0369
DR   Wikidata; Q93453875
RX   PubMed=17123516;
WW   Provider; WSU OTC; 14-1256; https://wayne.technologypublisher.com/technology/23894
CC   Doubling time: 23 +- 9 hours (PubMed=17123516).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   15W
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   Cj62
AC   CVCL_2U81
SY   cj62
DR   SKIP; SKIP001440
DR   Wikidata; Q54813432
RX   PubMed=8828827;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   CJ7
AC   CVCL_C316
SY   ES-CJ7; CJ7-mESC; CJ-7
DR   BTO; BTO_0004413
DR   EFO; EFO_0005916
DR   ENCODE; ENCBS028ENC
DR   ENCODE; ENCBS816RMP
DR   GEO; GSM1014187
DR   Wikidata; Q54813433
RX   PubMed=8224839;
RX   PubMed=17828574;
RX   PubMed=25277546;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/ES-CJ7_Stam_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-149.html
WW   Provider; Michigan TCPS; -; https://medresearch.umich.edu/office-research/about-office-research/biomedical-research-core-facilities/transgenic-animal-model/transgenic-core-products-services
CC   Part of: ENCODE project mouse cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S1/SvImJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   CJA00369IN
AC   CVCL_E152
DR   Wikidata; Q54813434
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00370IN
AC   CVCL_E153
DR   Wikidata; Q54813435
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00371IN
AC   CVCL_E154
DR   Wikidata; Q54813436
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00372IN
AC   CVCL_E155
DR   Wikidata; Q54813437
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00373IN
AC   CVCL_E156
DR   Wikidata; Q54813438
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00374IN
AC   CVCL_E157
DR   Wikidata; Q54813439
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00375IN
AC   CVCL_E158
DR   Wikidata; Q54813440
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00376IN
AC   CVCL_E159
DR   Wikidata; Q54813441
RX   PubMed=18477388;
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJA00377IN
AC   CVCL_E160
DR   Wikidata; Q54813442
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CJD13
AC   CVCL_D3BL
DR   Wikidata; Q127380559
RX   PubMed=39332406;
WW   Provider; CReM; 702; https://stemcellbank.bu.edu/Catalog/Item/Details/702
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CJD13CR
AC   CVCL_D3BM
DR   Wikidata; Q127380560
WW   Provider; CReM; 826; https://stemcellbank.bu.edu/Catalog/Item/Details/826
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple_corrected; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Boston University).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3BL ! CJD13
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CJD2
AC   CVCL_D2WC
DR   Wikidata; Q127380561
RX   PubMed=39332406;
WW   Provider; CReM; 681; https://stemcellbank.bu.edu/Catalog/Item/Details/681
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CJD29
AC   CVCL_D3BP
DR   Wikidata; Q127380562
RX   PubMed=39332406;
WW   Provider; CReM; 686; https://stemcellbank.bu.edu/Catalog/Item/Details/686
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Pro84_Gln91del (c.204_227del24); ClinVar=VCV000065494; Zygosity=Heterozygous (PubMed=39332406).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CJD2CR
AC   CVCL_D3BK
DR   Wikidata; Q127380564
WW   Provider; CReM; 825; https://stemcellbank.bu.edu/Catalog/Item/Details/825
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple_corrected; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Boston University).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2WC ! CJD2
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   CJD3
AC   CVCL_D3BQ
DR   Wikidata; Q127380565
RX   PubMed=39332406;
WW   Provider; CReM; 682; https://stemcellbank.bu.edu/Catalog/Item/Details/682
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CJD4
AC   CVCL_D3BR
DR   Wikidata; Q127380566
RX   PubMed=39332406;
WW   Provider; CReM; 683; https://stemcellbank.bu.edu/Catalog/Item/Details/683
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CJD40
AC   CVCL_D3BS
DR   Wikidata; Q127380567
RX   PubMed=39332406;
WW   Provider; CReM; 687; https://stemcellbank.bu.edu/Catalog/Item/Details/687
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CJD5
AC   CVCL_D3BT
DR   Wikidata; Q127380569
RX   PubMed=39332406;
WW   Provider; CReM; 684; https://stemcellbank.bu.edu/Catalog/Item/Details/684
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   CJD6
AC   CVCL_D3BU
DR   Wikidata; Q127380570
RX   PubMed=39332406;
WW   Provider; CReM; 685; https://stemcellbank.bu.edu/Catalog/Item/Details/685
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Glu200Lys (c.598G>A); ClinVar=VCV000013398; Zygosity=Heterozygous (PubMed=39332406).
CC   Donor information: Asymptomatic for Creutzfeldt-Jakob disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26802; Creutzfeldt-Jakob disease
DI   ORDO; Orphanet_282166; Inherited Creutzfeldt-Jakob disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   cjes001
AC   CVCL_RH32
DR   GEO; GSM1585274
DR   GEO; GSM1585275
DR   GEO; GSM1585276
DR   GEO; GSM1585277
DR   SKIP; SKIP001422
DR   Wikidata; Q54813443
RX   PubMed=19251728;
RX   PubMed=25785453;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   CJF
AC   CVCL_XE61
DR   CCRID; 4201PAT-CCTCC00321
DR   Wikidata; Q93453928
RX   Patent=CN101993854B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200956.
CC   Population: Chinese.
CC   Doubling time: 48 hours (Patent=CN101993854B).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   CJM [Human melanoma]
AC   CVCL_U797
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 713
DR   BioSample; SAMN10987715
DR   cancercelllines; CVCL_U797
DR   Cell_Model_Passport; SIDM01512
DR   Cosmic; 888989
DR   Cosmic; 928720
DR   DepMap; ACH-000458
DR   GEO; GSM170865
DR   GEO; GSM215722
DR   GEO; GSM886932
DR   GEO; GSM887998
DR   IARC_TP53; 28281
DR   LiGeA; CCLE_507
DR   PharmacoDB; CJM_205_2019
DR   Progenetix; CVCL_U797
DR   Wikidata; Q54813444
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Asian.
CC   HLA typing: A*02:01,02:01; B*40:02,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Gly (c.838A>G); ClinVar=VCV000376658; Zygosity=Homozygous (DepMap=ACH-000458).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.43%; Native American=0.61%; East Asian, North=76.74%; East Asian, South=21.81%; South Asian=0%; European, North=0%; European, South=0.4% (PubMed=30894373).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 24
//
ID   CJM [Human OCSCC]
AC   CVCL_8663
SY   CJM-108
DR   CLO; CLO_0050092
DR   BioSample; SAMN03472153
DR   RCB; RCB1034
DR   Wikidata; Q54813445
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224.
ST   Source(s): RCB=RCB1034
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8289 ! T3M-1
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   CJM Cl4
AC   CVCL_8664
SY   CJM-15 cl4-3
DR   CLO; CLO_0050093
DR   RCB; RCB1035
DR   Wikidata; Q54813456
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8663 ! CJM [Human OCSCC]
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CJM Cl5
AC   CVCL_8665
SY   CJM-15 cl5-3
DR   CLO; CLO_0050094
DR   RCB; RCB1036
DR   Wikidata; Q54813457
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8663 ! CJM [Human OCSCC]
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CJM Cl6
AC   CVCL_8666
SY   CJM-15 cl6-3
DR   CLO; CLO_0050095
DR   RCB; RCB1037
DR   Wikidata; Q54813458
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8663 ! CJM [Human OCSCC]
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CJM Cl7
AC   CVCL_8667
SY   CJM-15 cl7-3
DR   CLO; CLO_0050096
DR   RCB; RCB1038
DR   Wikidata; Q54813459
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8663 ! CJM [Human OCSCC]
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CJM Cl8
AC   CVCL_8668
SY   CJM-15 cl8-3
DR   CLO; CLO_0050097
DR   RCB; RCB1039
DR   Wikidata; Q54813460
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8663 ! CJM [Human OCSCC]
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CJO-A
AC   CVCL_E528
SY   CJO
DR   dbMHC; 48727
DR   ECACC; 85022808
DR   IHW; IHW09243
DR   IPD-IMGT/HLA; 10418
DR   Wikidata; Q54813461
RX   PubMed=6417008;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*11:01:01; B*35; C*04:01:01:01 (IPD-IMGT/HLA=10418).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   CJUHi001-A
AC   CVCL_C6TW
DR   hPSCreg; CJUHi001-A
DR   Wikidata; Q117704254
RX   PubMed=36459834;
CC   From: China-Japan Union Hospital; Changchun City; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[44]; Zygosity=Heterozygous (PubMed=36459834).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CK
AC   CVCL_W462
SY   Calf Kidney
DR   Wikidata; Q54813462
RX   PubMed=4280232;
CC   Virology: Susceptible to infection by bovine adenovirus B serotype 3 (PubMed=4280232).
CC   Doubling time: 31.4 hours (PubMed=4280232).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   CK-1B7
AC   CVCL_A6QM
DR   Wikidata; Q107114681
RX   PubMed=2481696;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   CK-1F7
AC   CVCL_A6QN
DR   DSHB; CK-1F7
DR   Wikidata; Q107114682
RX   PubMed=2240609;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12277; Human CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   CK-2A7
AC   CVCL_A6QQ
DR   DSHB; CK-2A7
DR   Wikidata; Q107114683
RX   PubMed=1696130;
RX   PubMed=2240609;
RX   PubMed=3435448;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05122; Chicken CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   CK-5D11
AC   CVCL_A6QP
DR   DSHB; CK-5D11
DR   Wikidata; Q107114684
RX   PubMed=2481696;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   CK-5H5
AC   CVCL_A6QR
DR   DSHB; CK-5H5
DR   Wikidata; Q107114685
RX   PubMed=1696130;
RX   PubMed=3435448;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P05122; Chicken CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   CK-ART
AC   CVCL_A6QI
DR   DSHB; CK-ART
DR   Wikidata; Q107114686
RX   PubMed=1696130;
RX   PubMed=2467657;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00565; Chicken CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   CK-JAC
AC   CVCL_A6QJ
SY   CK-JAC(6F11); 6F11; CK-JAC-6F11
DR   DSHB; CK-JAC-6F11
DR   Wikidata; Q107114687
RX   PubMed=1696130;
RX   PubMed=2240609;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05122; Chicken CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   CK-JIL
AC   CVCL_A6QK
SY   CK-JIL(5G11); 5G11
DR   Wikidata; Q107114688
RX   PubMed=1696130;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05122; Chicken CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   CK-JOE
AC   CVCL_A6QL
DR   Wikidata; Q107114689
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Creatine.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05122; Chicken CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   CK1
AC   CVCL_E9YV
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK10
AC   CVCL_E9Z4
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK2
AC   CVCL_E9YW
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK3
AC   CVCL_E9YX
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK4
AC   CVCL_E9YY
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK5
AC   CVCL_E9YZ
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK6
AC   CVCL_E9Z0
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK7
AC   CVCL_E9Z1
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK8
AC   CVCL_E9Z2
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CK9
AC   CVCL_E9Z3
RX   PubMed=8383632;
CC   Characteristics: Transfected with both the pCMV-CAT plasmid and pHPV33 which contains the HPV-33 genome interrupted within the E2 ORF (PubMed=8383632).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CKMM 14.15
AC   CVCL_8851
DR   CLO; CLO_0002482
DR   ATCC; HB-9419
DR   Wikidata; Q54813463
RX   Patent=US4950592;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9419.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   CKMM 14.5
AC   CVCL_8852
DR   CLO; CLO_0002483
DR   ATCC; HB-9420
DR   Wikidata; Q54813464
RX   Patent=US4950592;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9420.
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   CKMM 14.52
AC   CVCL_8853
DR   CLO; CLO_0002484
DR   ATCC; HB-9421
DR   Wikidata; Q54813465
RX   Patent=US4950592;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9421.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06732; Human CKM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   CKS
AC   CVCL_4826
DR   Wikidata; Q54813466
RX   PubMed=6268719;
RX   PubMed=7069245;
CC   Doubling time: 32-36 hours (PubMed=6268719).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   CKT-1
AC   CVCL_2403
SY   CKT; CKT clone 1; Calf Kidney Tokushima-1
DR   CLO; CLO_0050863
DR   JCRB; IFO50003
DR   JCRB; JCRB0008
DR   RCB; RCB0249
DR   Wikidata; Q54813467
RX   PubMed=4303468;
RX   PubMed=5169311;
CC   Doubling time: 6 days (Note=At 105th passage) (PubMed=4303468).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Calf
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CL 21
AC   CVCL_7252
SY   Cl 21; CL21; Clone 21
DR   ECACC; 86080602
DR   Wikidata; Q54813468
RX   PubMed=3763403;
RX   PubMed=4371646;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7908 ! GM00847
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   CL-01
AC   CVCL_0082
SY   CL01; BL16 sub-line CL-01
DR   Wikidata; Q54813469
RX   PubMed=9498752;
WW   Provider; Novus; NBP1-49595; https://www.novusbio.com/products/cl-01-cell-line_nbp1-49595
CC   Population: Africans south of the Sahara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Novus; Catalog number NBP1-49595.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C137 ! BL-16
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   CL-1
AC   CVCL_L321
SY   CL1
DR   Wikidata; Q54813470
RX   PubMed=9437822;
RX   PubMed=22236332;
RX   PubMed=23365669;
RX   PubMed=29674676;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: Japanese Terrier; VBO=VBO_0200741.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   CL-11
AC   CVCL_1978
SY   CL11
DR   CLO; CLO_0009957
DR   EFO; EFO_0006368
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 845
DR   BioSample; SAMN03471897
DR   BioSample; SAMN03473558
DR   BioSample; SAMN10989560
DR   cancercelllines; CVCL_1978
DR   Cell_Model_Passport; SIDM00944
DR   ColonAtlas; CL11
DR   Cosmic-CLP; 1290769
DR   DepMap; ACH-000249
DR   DSMZ; ACC-467
DR   DSMZCellDive; ACC-467
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1290769
DR   GEO; GSM206455
DR   GEO; GSM274838
DR   GEO; GSM513931
DR   GEO; GSM514183
DR   GEO; GSM886933
DR   GEO; GSM887999
DR   GEO; GSM1448148
DR   GEO; GSM1669680
DR   GEO; GSM2549990
DR   IARC_TP53; 28335
DR   LiGeA; CCLE_409
DR   LINCS_LDP; LCL-1167
DR   PharmacoDB; CL11_206_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1978
DR   Wikidata; Q54813471
RX   PubMed=19003396;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~3-4 days (DSMZ=ACC-467).
CC   HLA typing: A*02:01,02:01; B*51:01,51:01; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Heterozygous (Cosmic-CLP=1290769; DepMap=ACH-000249).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Val14Ile (c.40G>A); ClinVar=VCV000012589; Zygosity=Heterozygous (PubMed=28683746; Cosmic-CLP=1290769; DepMap=ACH-000249).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous (PubMed=28683746; Cosmic-CLP=1290769; DepMap=ACH-000249).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Asn (c.644G>A); ClinVar=VCV000376662; Zygosity=Homozygous (PubMed=28683746; Cosmic-CLP=1290769; DepMap=ACH-000249).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.97%; Native American=0%; East Asian, North=2.17%; East Asian, South=0%; South Asian=0%; European, North=62.27%; European, South=34.59% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=1290769; DSMZ=ACC-467; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9 (DSMZ=ACC-467)
ST   D7S820: 9,10 (Cosmic-CLP=1290769; PubMed=25877200; PubMed=25926053)
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 9,13
ST   Penta E: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D331 ! CL-11m
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   CL-11m
AC   CVCL_D331
SY   CL-11M; CL11m; CL-11mucoid
DR   Wikidata; Q54813472
RX   PubMed=19003396;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1978 ! CL-11
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   CL-14
AC   CVCL_1979
SY   CL14
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473569
DR   BioSample; SAMN10988457
DR   cancercelllines; CVCL_1979
DR   Cell_Model_Passport; SIDM01491
DR   ColonAtlas; CL14
DR   DepMap; ACH-000342
DR   DSMZ; ACC-504
DR   DSMZCellDive; ACC-504
DR   GEO; GSM513932
DR   GEO; GSM514184
DR   GEO; GSM886934
DR   GEO; GSM888000
DR   GEO; GSM1448171
DR   IARC_TP53; 28287
DR   LiGeA; CCLE_737
DR   PharmacoDB; CL14_207_2019
DR   Progenetix; CVCL_1979
DR   Wikidata; Q54813473
RX   PubMed=15316659;
RX   PubMed=19003396;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=34339474;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474).
CC   Doubling time: ~1 week (DSMZ=ACC-504).
CC   HLA typing: A*02:01,11:01; B*07:02,51:01; C*04:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (DepMap=ACH-000342).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.68%; Native American=0%; East Asian, North=5.8%; East Asian, South=0%; South Asian=0%; European, North=50.95%; European, South=39.58% (PubMed=30894373).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): DSMZ=ACC-504; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 13,17
ST   D21S11: 28,29
ST   D2S1338: 21,25
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 25
ST   Penta D: 10
ST   Penta E: 10,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   CL-19 [Human colon adenocarcinoma]
AC   CVCL_D332
SY   CL19
DR   Wikidata; Q54813474
RX   PubMed=19003396;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   CL-19 [Human cholangiocarcinoma]
AC   CVCL_C6N0
DR   Wikidata; Q116048771
RX   CelloPub=CLPUB00729;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CL-2
AC   CVCL_C6N1
DR   Wikidata; Q116048772
RX   CelloPub=CLPUB00729;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CL-21
AC   CVCL_D333
SY   CL21
DR   Wikidata; Q54813475
RX   PubMed=19003396;
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   CL-23
AC   CVCL_D334
SY   CL23
DR   Wikidata; Q54813476
RX   PubMed=19003396;
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   CL-30
AC   CVCL_D335
SY   CL30
DR   Wikidata; Q54813477
RX   PubMed=19003396;
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   CL-34
AC   CVCL_1980
SY   CL34
DR   CLO; CLO_0037282
DR   EFO; EFO_0006369
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471564
DR   BioSample; SAMN03473518
DR   BioSample; SAMN10989562
DR   cancercelllines; CVCL_1980
DR   Cell_Model_Passport; SIDM00945
DR   ColonAtlas; CL34
DR   Cosmic-CLP; 1290771
DR   DepMap; ACH-000895
DR   DSMZ; ACC-520
DR   DSMZCellDive; ACC-520
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1290771
DR   GEO; GSM206456
DR   GEO; GSM274835
DR   GEO; GSM513933
DR   GEO; GSM514185
DR   GEO; GSM886935
DR   GEO; GSM888001
DR   GEO; GSM1448119
DR   GEO; GSM2549991
DR   IARC_TP53; 28389
DR   LiGeA; CCLE_697
DR   PharmacoDB; CL34_208_2019
DR   Progenetix; CVCL_1980
DR   Wikidata; Q54813478
RX   PubMed=19003396;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~70 hours (DSMZ=ACC-520).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053; PubMed=28683746; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu418Ter (c.1252G>T); Zygosity=Heterozygous (DepMap=ACH-000895).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg856Cys (c.2566C>T); ClinVar=VCV000469755; Zygosity=Heterozygous (DepMap=ACH-000895).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556fs*3 (c.4660_4661insA) (E1554fs); Zygosity=Heterozygous (DepMap=ACH-000895).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=28683746; DepMap=ACH-000895).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Pro (c.379T>C); ClinVar=VCV000934410; Zygosity=Unspecified (PubMed=28683746; DepMap=ACH-000895).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys382Asnfs*40 (c.1146delA); ClinVar=VCV001408583; Zygosity=Unspecified (PubMed=28683746; DepMap=ACH-000895).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.8%; Native American=0.86%; East Asian, North=2.45%; East Asian, South=0%; South Asian=0.51%; European, North=74%; European, South=21.37% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=1290771; DSMZ=ACC-520; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11 (PubMed=25877200)
ST   CSF1PO: 11,16 (Cosmic-CLP=1290771; DSMZ=ACC-520; PubMed=25926053)
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 12,17,18 (PubMed=25877200)
ST   D18S51: 12,17,18,19 (DSMZ=ACC-520)
ST   D19S433: 12,16
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 12,17 (DSMZ=ACC-520)
ST   D3S1358: 12,17,18 (PubMed=25877200)
ST   D5S818: 9,11
ST   D7S820: 10 (PubMed=25877200)
ST   D7S820: 10,15 (Cosmic-CLP=1290771; DSMZ=ACC-520; PubMed=25926053)
ST   D8S1179: 10,11
ST   FGA: 22,24 (DSMZ=ACC-520)
ST   FGA: 22,24,25 (PubMed=25877200)
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   CL-36
AC   CVCL_D336
SY   CL36
DR   Wikidata; Q54813479
RX   PubMed=19003396;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   CL-38
AC   CVCL_1981
SY   CL 38; CL38
DR   DSMZ; ACC-621
DR   DSMZCellDive; ACC-621
DR   Wikidata; Q54813480
RX   CelloPub=CLPUB00363;
RX   PubMed=2684400;
RX   PubMed=2720663;
RX   PubMed=2895109;
RX   PubMed=9288899;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-621).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   CL-39
AC   CVCL_V481
SY   CL39
DR   Wikidata; Q54813482
RX   PubMed=19003396;
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   CL-40
AC   CVCL_1982
SY   CL40
DR   CLO; CLO_0009958
DR   EFO; EFO_0006370
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 596
DR   BioSample; SAMN03471322
DR   BioSample; SAMN10988464
DR   cancercelllines; CVCL_1982
DR   Cell_Model_Passport; SIDM00960
DR   ColonAtlas; CL40
DR   Cosmic-CLP; 1240124
DR   DepMap; ACH-000798
DR   DSMZ; ACC-535
DR   DSMZCellDive; ACC-535
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240124
DR   GEO; GSM206457
DR   GEO; GSM274775
DR   GEO; GSM274836
DR   GEO; GSM513934
DR   GEO; GSM514186
DR   GEO; GSM886936
DR   GEO; GSM888002
DR   GEO; GSM1448149
DR   GEO; GSM1669681
DR   GEO; GSM2549992
DR   IARC_TP53; 28302
DR   LiGeA; CCLE_875
DR   LINCS_LDP; LCL-1199
DR   PharmacoDB; CL40_209_2019
DR   PRIDE; PXD005235
DR   Progenetix; CVCL_1982
DR   PubChem_Cell_line; CVCL_1982
DR   Wikidata; Q54813483
RX   PubMed=19003396;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=34339474;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474).
CC   Doubling time: ~3-4 days (DSMZ=ACC-535).
CC   HLA typing: A*11:01,11:01; B*27:05,27:05; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=28683746; Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=28683746; DepMap=ACH-000798).
CC   Sequence variation: Mutation; HGNC; HGNC:11876; TMPRSS2; Simple; p.Gly8Val (c.23G>T) (c.-57+99G>T); ClinVar=VCV001273671; Zygosity=Heterozygous (PubMed=34339474).
CC   Sequence variation: Mutation; HGNC; HGNC:11876; TMPRSS2; Simple; p.Val197Met (c.589G>A) (p.Val160Met, c.478G>A); ClinVar=VCV001257425; Zygosity=Heterozygous (PubMed=34339474).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=28683746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.13%; East Asian, North=0%; East Asian, South=0.86%; South Asian=0%; European, North=71.2%; European, South=27.8% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=1240124; DSMZ=ACC-535; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 12,13
ST   D21S11: 30,32.2
ST   D2S1338: 19,25
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 14
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 38
//
ID   CL-44
AC   CVCL_1983
SY   CL 44; CL44
DR   DSMZ; ACC-622
DR   DSMZCellDive; ACC-622
DR   Wikidata; Q54813484
RX   CelloPub=CLPUB00363;
RX   PubMed=2720663;
RX   PubMed=2895109;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-622).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   CL-49
AC   CVCL_WU97
SY   CL 49; CL49
DR   Wikidata; Q93454125
RX   CelloPub=CLPUB00363;
RX   PubMed=2684400;
RX   PubMed=2895109;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 6
//
ID   CL-49IV
AC   CVCL_1984
SY   CL 49-IV; CL49IV
DR   DSMZ; ACC-628
DR   DSMZCellDive; ACC-628
DR   Wikidata; Q54813485
RX   CelloPub=CLPUB00363;
RX   PubMed=2895109;
CC   Doubling time: ~60-100 hours (DSMZ=ACC-628).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WU97 ! CL-49
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   CL-49VIII
AC   CVCL_A4FT
SY   CL 49-VIII
DR   Wikidata; Q105506632
RX   CelloPub=CLPUB00363;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WU97 ! CL-49
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CL-50
AC   CVCL_WU98
SY   CL 50; CL50
DR   Wikidata; Q93454133
RX   CelloPub=CLPUB00363;
RX   PubMed=2895109;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 6
//
ID   CL-50IIa
AC   CVCL_1985
SY   CL 50-IIa; CL50IIa
DR   DSMZ; ACC-623
DR   DSMZCellDive; ACC-623
DR   Wikidata; Q54813486
RX   CelloPub=CLPUB00363;
RX   PubMed=2684400;
RX   PubMed=2895109;
CC   Doubling time: ~50-60 hours (DSMZ=ACC-623).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WU98 ! CL-50
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   CL-52
AC   CVCL_HM43
SY   CL 52; CL52
DR   Wikidata; Q54813487
RX   CelloPub=CLPUB00363;
RX   PubMed=2895109;
RX   PubMed=8625260;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   CL-52a
AC   CVCL_WU99
SY   CL 52a; CL52a; CL-52VIa
DR   Wikidata; Q93454148
RX   CelloPub=CLPUB00363;
RX   PubMed=2895109;
RX   PubMed=8625260;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HM43 ! CL-52
SX   Male
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 6
//
ID   CL-52b
AC   CVCL_VR74
SY   CL 52b; CL52b; CL-52VIb
DR   DSMZ; ACC-843
DR   DSMZCellDive; ACC-843
DR   Wikidata; Q93454151
RX   CelloPub=CLPUB00363;
RX   PubMed=2895109;
RX   PubMed=8625260;
CC   Doubling time: ~50 hours (DSMZ=ACC-843).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HM43 ! CL-52
SX   Male
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CL-6
AC   CVCL_C6N2
DR   Wikidata; Q116048773
RX   CelloPub=CLPUB00729;
RX   PubMed=21517231;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Cl-66M1
AC   CVCL_B394
SY   Cl66M1
DR   Wikidata; Q54813488
RX   PubMed=10651311;
CC   Doubling time: 29.1 +- 1.4 hours (PubMed=10651311).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9722 ! 66 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   Cl-66M2
AC   CVCL_B395
SY   Cl66M2
DR   BTO; BTO_0004310
DR   Wikidata; Q54813489
RX   PubMed=10651311;
CC   Doubling time: 28.1 +- 2.2 hours (PubMed=10651311).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9722 ! 66 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   CL-9
AC   CVCL_D337
SY   CL9
DR   Wikidata; Q54813490
RX   PubMed=19003396;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   CL-S1
AC   CVCL_3500
DR   CLO; CLO_0002512
DR   CLDB; cl787
DR   ATCC; CRL-1615
DR   ECACC; 90110502
DR   Wikidata; Q54813491
RX   PubMed=232056;
RX   PubMed=1583006;
RX   PubMed=2606877;
RX   PubMed=7306960;
CC   Doubling time: ~24 hours (PubMed=232056).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4S4 ! WAZ-1
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Cl. Ly1+2-/9
AC   CVCL_6317
SY   Cl.Ly1+2-/9; T-cell clone Ly1+2(-)/9
DR   CLO; CLO_0002485
DR   ATCC; CRL-8179
DR   CCRID; 1101MOU-PUMC000217
DR   Wikidata; Q54813492
RX   Patent=US4613459;
RX   PubMed=6785749;
RX   PubMed=6971154;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8179.
CC   Characteristics: Produces IL3.
CC   Discontinued: ATCC; CRL-8179; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C57BL/6-TL+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   CL001
AC   CVCL_A9MN
DR   Wikidata; Q108820047
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9083.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200702.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL002
AC   CVCL_A9MP
DR   Wikidata; Q108820048
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9084.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200703.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL003
AC   CVCL_A9MQ
DR   Wikidata; Q108820049
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9085.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200704.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL004
AC   CVCL_A9MR
DR   Wikidata; Q108820050
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9086.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200705.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL005
AC   CVCL_A9MS
DR   Wikidata; Q108820051
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9087.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200706.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL006
AC   CVCL_A9MT
DR   Wikidata; Q108820052
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9088.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200707.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL007
AC   CVCL_A9MU
DR   Wikidata; Q108820053
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9089.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200708.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL008
AC   CVCL_A9MV
DR   Wikidata; Q108820054
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9090.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200709.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL009
AC   CVCL_A9MW
DR   Wikidata; Q108820056
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9091.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200710.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL01
AC   CVCL_C864
SY   UPS-FRe001-A; UPSFRe001-A
DR   hPSCreg; UPSFRe001-A
DR   SKIP; SKIP002019
DR   Wikidata; Q54813493
RX   PubMed=22514597;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_cl01.pdf
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE06-024-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CL010
AC   CVCL_A9MX
DR   Wikidata; Q108820057
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9092.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200711.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL011
AC   CVCL_A9MY
DR   Wikidata; Q108820058
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9093.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200712.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL015
AC   CVCL_A9MZ
DR   Wikidata; Q108820059
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9097.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200716.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL016
AC   CVCL_A9NA
DR   Wikidata; Q108820060
RX   Patent=US20090197945;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9098.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200717.
CC   Characteristics: Reference control cell line for pharmacogenomics testing.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   CL02
AC   CVCL_C797
SY   UPS-FRe002-A; UPSFRe002-A
DR   hPSCreg; UPSFRe002-A
DR   SKIP; SKIP002350
DR   Wikidata; Q54813494
RX   PubMed=22514597;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   CL03
AC   CVCL_C798
SY   UPS-FRe003-A; UPSFRe003-A
DR   hPSCreg; UPSFRe003-A
DR   SKIP; SKIP002351
DR   Wikidata; Q54813495
RX   PubMed=22514597;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_cl03.pdf
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE10-131-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CL04
AC   CVCL_Y594
DR   Wikidata; Q54813496
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_cl04.pdf
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE10-151-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   CL1 [Dog mastocytoma]
AC   CVCL_GT43
DR   Wikidata; Q54813504
RX   PubMed=19054577;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 6
//
ID   CL1 [Human ESC]
AC   CVCL_L883
DR   Wikidata; Q54813505
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   CL1-0
AC   CVCL_3871
AS   CVCL_D516
SY   CL 1-0; CL1.0; CL1
DR   BTO; BTO_0002875
DR   EFO; EFO_0022435
DR   ChEMBL-Cells; CHEMBL4482997
DR   ChEMBL-Targets; CHEMBL4483232
DR   GEO; GSM185873
DR   GEO; GSM997731
DR   GEO; GSM997732
DR   GEO; GSM997733
DR   GEO; GSM997734
DR   GEO; GSM997739
DR   GEO; GSM997740
DR   GEO; GSM997741
DR   GEO; GSM997742
DR   GEO; GSM997747
DR   GEO; GSM997748
DR   GEO; GSM997749
DR   GEO; GSM997750
DR   GEO; GSM1039261
DR   GEO; GSM1039262
DR   GEO; GSM1039263
DR   PubChem_Cell_line; CVCL_3871
DR   TOKU-E; 4035
DR   TOKU-E; 4044
DR   Wikidata; Q54813506
RX   PubMed=1497905;
RX   PubMed=9308922;
RX   PubMed=11431363;
RX   PubMed=16354588;
RX   PubMed=24705471;
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 24 hours (PubMed=1497905).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   CL1-1
AC   CVCL_D517
SY   CL 1-1
DR   BTO; BTO_0003341
DR   GEO; GSM185874
DR   Wikidata; Q54813507
RX   PubMed=9308922;
RX   PubMed=11431363;
CC   Population: Chinese; Taiwan.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3871 ! CL1-0
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CL1-2
AC   CVCL_D518
DR   BTO; BTO_0003342
DR   Wikidata; Q54813509
RX   PubMed=9308922;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3871 ! CL1-0
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   CL1-3
AC   CVCL_D519
DR   BTO; BTO_0003343
DR   Wikidata; Q54813510
RX   PubMed=9308922;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3871 ! CL1-0
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   CL1-4
AC   CVCL_D520
DR   BTO; BTO_0003344
DR   Wikidata; Q54813511
RX   PubMed=9308922;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3871 ! CL1-0
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   CL1-5
AC   CVCL_D521
SY   CL 1-5
DR   BTO; BTO_0002876
DR   EFO; EFO_0022436
DR   ChEMBL-Cells; CHEMBL4802056
DR   GEO; GSM185875
DR   GEO; GSM997735
DR   GEO; GSM997736
DR   GEO; GSM997737
DR   GEO; GSM997738
DR   GEO; GSM997743
DR   GEO; GSM997744
DR   GEO; GSM997745
DR   GEO; GSM997746
DR   GEO; GSM997751
DR   GEO; GSM997752
DR   GEO; GSM997753
DR   GEO; GSM997754
DR   GEO; GSM1039264
DR   GEO; GSM1039265
DR   GEO; GSM1039266
DR   PubChem_Cell_line; CVCL_D521
DR   TOKU-E; 3876
DR   Wikidata; Q54813512
RX   PubMed=9308922;
RX   PubMed=11431363;
RX   PubMed=16354588;
RX   PubMed=21998723;
RX   PubMed=23267084;
RX   PubMed=28678517;
CC   Population: Chinese; Taiwan.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3871 ! CL1-0
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   CL1-5 Fut8-KD
AC   CVCL_C8P6
SY   CL1-5 FUT8 KD; CL1-5/shFUT8
DR   BTO; BTO_0006506
DR   Wikidata; Q123030934
RX   PubMed=23267084;
RX   PubMed=28678517;
CC   Population: Chinese; Taiwan.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:4019; FUT8.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D521 ! CL1-5
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CL1-5-F4
AC   CVCL_IN56
SY   CL 1-5-F 4; CL1-5F4; F4
DR   BTO; BTO_0006343
DR   GEO; GSM185876
DR   Wikidata; Q54813514
RX   PubMed=11431363;
RX   PubMed=19597463;
RX   PubMed=24705471;
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D521 ! CL1-5
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   CL1-5-F4-Luc
AC   CVCL_A5BR
SY   F4-Luc
DR   Wikidata; Q107114690
RX   PubMed=19597463;
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IN56 ! CL1-5-F4
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   CL1-R2
AC   CVCL_XK34
DR   Wikidata; Q93454206
RX   Patent=US10208124;
RX   PubMed=12486241;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3204.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95971; Human CD160.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   CL100
AC   CVCL_Y428
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   Wikidata; Q54813515
RX   PubMed=26202522;
RX   PubMed=26554430;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=26202522).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141Ser (c.421T>A); ClinVar=VCV000376567; Zygosity=Unspecified (PubMed=26202522).
CC   Omics: Proteomics; Subcellular; Membrane.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   CL141
AC   CVCL_N822
DR   cancercelllines; CVCL_N822
DR   Cosmic; 1790393
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   Wikidata; Q54813516
RX   PubMed=23024022;
RX   PubMed=26202522;
RX   PubMed=26554430;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=23024022; PubMed=26202522).
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   CL152
AC   CVCL_N823
DR   cancercelllines; CVCL_N823
DR   Cosmic; 1790394
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   Wikidata; Q54813517
RX   PubMed=23024022;
RX   PubMed=26202522;
RX   PubMed=26554430;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=23024022; PubMed=26202522).
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   CL18/1D8
AC   CVCL_K204
SY   CL18/1
DR   ATCC; CRL-2517
DR   Wikidata; Q54813518
RX   PubMed=1680878;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33729; Dog ICAM1/CD54.
CC   Discontinued: ATCC; CRL-2517; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CL18/6
AC   CVCL_K205
DR   CLO; CLO_0002487
DR   ATCC; CRL-2518
DR   Wikidata; Q54813520
RX   PubMed=1680878;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33729; Dog ICAM1/CD54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CL1DNEO
AC   CVCL_E3EY
RX   PubMed=2128461;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CL2 [Human lung carcinoma]
AC   CVCL_W144
DR   Wikidata; Q54813521
RX   PubMed=1497905;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 30 hours (PubMed=1497905).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   CL2 [Mouse hybridoma against human SELE]
AC   CVCL_K206
DR   CLO; CLO_0002488
DR   ATCC; CRL-2514
DR   Wikidata; Q54813522
RX   PubMed=1713515;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CL25
AC   CVCL_N824
DR   cancercelllines; CVCL_N824
DR   Cosmic; 1790395
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   Wikidata; Q54813523
RX   PubMed=23024022;
RX   PubMed=26202522;
RX   PubMed=26554430;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=26202522).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Tyr (c.404G>A); ClinVar=VCV000141762; Zygosity=Unspecified (PubMed=23024022; PubMed=26202522).
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   CL2621
AC   CVCL_A0XU
SY   CL-2621; CL 2621
DR   Wikidata; Q108820061
RX   Patent=US8546124;
RX   PubMed=1616975;
RX   PubMed=1616976;
RX   PubMed=8507694;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   From: Boehringer Ingelheim Animal Health, Inc.; St. Joseph; USA.
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_3845 ! MA-104
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   CL3 [Human lung carcinoma]
AC   CVCL_W145
SY   CL-3
DR   BTO; BTO_0003340
DR   Wikidata; Q54813524
RX   PubMed=1497905;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 32 hours (PubMed=1497905).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   CL3 [Mouse hybridoma against human SELE]
AC   CVCL_K207
DR   CLO; CLO_0002489
DR   ATCC; CRL-2515
DR   Wikidata; Q54813525
RX   PubMed=1713515;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CL37
AC   CVCL_K208
DR   CLO; CLO_0002490
DR   ATCC; CRL-2516
DR   Wikidata; Q54813526
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CL83
AC   CVCL_N825
DR   Cosmic; 1790392
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   Wikidata; Q54813527
RX   PubMed=23024022;
RX   PubMed=26202522;
RX   PubMed=26554430;
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   CL89-12117
AC   CVCL_WY83
DR   Wikidata; Q93454286
RX   PubMed=8986805;
RX   PubMed=11717438;
CC   Sequence variation: Gene fusion; HGNC; HGNC:9343; PRCC + HGNC; HGNC:11752; TFE3; Name(s)=PRCC-TFE3 (PubMed=8986805).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   CL89-17872
AC   CVCL_WY84
DR   Wikidata; Q93454290
RX   PubMed=8986805;
RX   PubMed=11717438;
CC   Sequence variation: Gene fusion; HGNC; HGNC:9343; PRCC + HGNC; HGNC:11752; TFE3; Name(s)=PRCC-TFE3 (PubMed=8986805).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   CL97
AC   CVCL_N826
SY   CL97TM/GA
DR   cancercelllines; CVCL_N826
DR   ChEMBL-Cells; CHEMBL4513104
DR   ChEMBL-Targets; CHEMBL4513122
DR   Cosmic; 1790396
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   PubChem_Cell_line; CVCL_N826
DR   Wikidata; Q54813529
RX   PubMed=23024022;
RX   PubMed=26202522;
RX   PubMed=26554430;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gly719Ala (c.2156G>C); ClinVar=VCV000045225; Zygosity=Unspecified (PubMed=23024022).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=23024022).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=23024022; PubMed=26202522).
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   CL97-L2G
AC   CVCL_IQ77
DR   cancercelllines; CVCL_IQ77
DR   Wikidata; Q54813530
RX   PubMed=23024022;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gly719Ala (c.2156G>C); ClinVar=VCV000045225; Zygosity=Unspecified (PubMed=23024022).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=23024022).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N826 ! CL97
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 16
//
ID   CLA
AC   CVCL_E529
DR   dbMHC; 48728
DR   ECACC; 94022525
DR   IHW; IHW09209
DR   IPD-IMGT/HLA; 10422
DR   Wikidata; Q54813531
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:06:01,24:02; B*08:01,35; C*07; DPB1*13:01,20:01:01 (IPD-IMGT/HLA=10422).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   CLA-1
AC   CVCL_VH37
DR   Wikidata; Q54813532
RX   CelloPub=CLPUB00433;
RX   PubMed=9768212;
RX   PubMed=9813481;
CC   Group: Insect cell line.
OX   NCBI_TaxID=316597; ! Aedes pseudoscutellaris (Mosquito)
HI   CVCL_Z362 ! LSTM-AP-61
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   CLA-HT
AC   CVCL_VH38
DR   Wikidata; Q54813533
RX   CelloPub=CLPUB00433;
CC   Group: Insect cell line.
CC   Characteristics: Capable of growing at 33 Celsius.
OX   NCBI_TaxID=316597; ! Aedes pseudoscutellaris (Mosquito)
HI   CVCL_VH37 ! CLA-1
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   CLA1RGB
AC   CVCL_R887
DR   CLO; CLO_0050714
DR   BioSample; SAMN03472351
DR   RCB; RCB0266
DR   Wikidata; Q54813534
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0266
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C98969; Lactic acidosis
DI   ORDO; Orphanet_17; Fatal infantile lactic acidosis with methylmalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   CLA4
AC   CVCL_A601
SY   CLA-4
DR   Wikidata; Q54813535
RX   CelloPub=CLPUB00548;
RX   PubMed=468301;
RX   PubMed=1181076;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   CLAB
AC   CVCL_6A78
DR   Wikidata; Q54813536
RX   CelloPub=CLPUB00287;
RX   PubMed=20444515;
RX   PubMed=22193509;
RX   PubMed=28239090;
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   CLAC
AC   CVCL_J360
SY   Canine Lung Adenocarcinoma Cells
DR   JCRB; JCRB1453
DR   Wikidata; Q54813537
RX   PubMed=21245282;
CC   Doubling time: ~51 hours (PubMed=21245282).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Pointer; VBO=VBO_0201029.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   CLB-Ba
AC   CVCL_9517
SY   CLB-BA
DR   cancercelllines; CVCL_9517
DR   Cosmic; 1153808
DR   Wikidata; Q54813538
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=18534018;
RX   PubMed=18923523;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3520T>C); ClinVar=VCV000217849; Zygosity=Heterozygous (PubMed=18923523).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y3M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CLB-Bac
AC   CVCL_9518
SY   CLB-BAC
DR   Wikidata; Q54813539
RX   DOI=10.1007/0-306-46872-7_2;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y2M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   CLB-Bar
AC   CVCL_9519
SY   CLB-BAR
DR   ArrayExpress; E-MTAB-6654
DR   PRIDE; PXD011187
DR   Wikidata; Q54813540
RX   PubMed=20160348;
RX   PubMed=30459281;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Unexplicit; Ex4-11; Zygosity=Unspecified (PubMed=30459281).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sex of donor from personal communication of Combaret, Valerie.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GP62 ! CLB-BARrec
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   CLB-BARrec
AC   CVCL_GP62
SY   CLB-BARREC
DR   Wikidata; Q54813541
RX   PubMed=20160348;
CC   Miscellaneous: Sex of donor from personal communication of Combaret, Valerie.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9519 ! CLB-Bar
SX   Female
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 6
//
ID   CLB-Be
AC   CVCL_9520
SY   CLB-BE
DR   Wikidata; Q54813542
RX   DOI=10.1007/0-306-46872-7_2;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   CLB-Bel
AC   CVCL_9521
SY   CLB-BEL
DR   Wikidata; Q54813543
RX   PubMed=18534018;
RX   PubMed=20160348;
CC   Miscellaneous: Sex of donor from personal communication of Combaret, Valerie.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   CLB-BerLud1
AC   CVCL_9522
SY   CLB-Ber1
DR   Wikidata; Q54813544
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=20160348;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9523 ! CLB-BerLud2
SX   Male
AG   5Y5M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   CLB-BerLud2
AC   CVCL_9523
SY   CLB-Ber2
DR   Wikidata; Q54813545
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=20160348;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9522 ! CLB-BerLud1
SX   Male
AG   5Y5M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   CLB-Bou
AC   CVCL_9524
DR   Wikidata; Q54813546
RX   PubMed=18534018;
CC   Miscellaneous: Sex of donor from personal communication of Combaret, Valerie.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   CLB-Br
AC   CVCL_9525
DR   Wikidata; Q54813547
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y7M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   CLB-Ca
AC   CVCL_9526
SY   CLB-CA; CLB-CAR
DR   Wikidata; Q54813556
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=20160348;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y4M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CLB-Chas
AC   CVCL_9527
DR   Wikidata; Q54813557
RX   PubMed=18534018;
CC   Miscellaneous: Sex of donor from personal communication of Combaret, Valerie.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   CLB-Es
AC   CVCL_9528
SY   CLB-ES; CLB-ESP
DR   Wikidata; Q54813558
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=20160348;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   CLB-Ga
AC   CVCL_9529
SY   CLB-GA; CLB-GAR
DR   cancercelllines; CVCL_9529
DR   Cosmic; 1153805
DR   Cosmic; 1526623
DR   Wikidata; Q54813559
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=11550280;
RX   PubMed=18534018;
RX   PubMed=18923523;
RX   PubMed=20160348;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Heterozygous (PubMed=18923523).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   CLB-Ge1
AC   CVCL_9530
SY   CLB-Ge
DR   ArrayExpress; E-MTAB-6654
DR   cancercelllines; CVCL_9530
DR   PRIDE; PXD011187
DR   Wikidata; Q54813560
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=18923523;
RX   PubMed=20160348;
RX   PubMed=30459281;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Val (c.3520T>G); ClinVar=VCV000065670; Zygosity=Unspecified (PubMed=18923523; PubMed=30459281).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9531 ! CLB-Ge2
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   CLB-Ge2
AC   CVCL_9531
DR   Wikidata; Q54813561
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=19349462;
RX   PubMed=20160348;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9530 ! CLB-Ge1
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CLB-Hu-TT-1
AC   CVCL_EY25
SY   CLBHuTT1
DR   Wikidata; Q54813563
RX   PubMed=6327321;
RX   PubMed=7590790;
RX   PubMed=7756584;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   CLB-Hut
AC   CVCL_EY24
SY   CLB-HUT
DR   Wikidata; Q54813564
RX   PubMed=20160348;
CC   Miscellaneous: Sex of donor and metastatic site from personal communication of Combaret, Valerie.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   CLB-Ma1
AC   CVCL_9532
SY   CLB-MA PT
DR   cancercelllines; CVCL_9532
DR   Wikidata; Q54813565
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=18534018;
RX   PubMed=20160348;
RX   PubMed=31452835;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous; Note=Only detected in 5% of the cells in early passages but increase to 50% in late passages (PubMed=31452835).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Leu1196Met (c.3586C>A); ClinVar=VCV000376135; Zygosity=Heterozygous; Note=Only detected in 0.45% of the cells in early passages but increase to 32% in late passages (PubMed=31452835).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn235Ser (c.704A>G); ClinVar=VCV000127821; Zygosity=Unspecified (PubMed=18534018).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9533 ! CLB-Ma2
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   CLB-Ma2
AC   CVCL_9533
SY   CLB-Ma; CLB-MA BM
DR   cancercelllines; CVCL_9533
DR   Progenetix; CVCL_9533
DR   Wikidata; Q54813566
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=18923523;
RX   PubMed=20160348;
RX   PubMed=31452835;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=18923523; PubMed=31452835).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9532 ! CLB-Ma1
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CLB-Pe
AC   CVCL_9534
SY   CLB-PE; CLB-PEC
DR   cancercelllines; CVCL_9534
DR   Wikidata; Q54813567
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=18534018;
RX   PubMed=20160348;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=18534018).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   CLB-Re
AC   CVCL_9535
SY   CLB-RE; CLB-REM
DR   Wikidata; Q54813568
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=20160348;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CLB-SAV
AC   CVCL_D7EN
DR   EFO; EFO_0022573
RX   PubMed=18657504;
RX   PubMed=23065768;
CC   From: Caux, Christophe; Centre Leon Berard; Lyon; France.
CC   Characteristics: ER-positive.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CLB-Sedp
AC   CVCL_9536
SY   CLB Sedp; CLB-Sed; CLB-SED
DR   Wikidata; Q54813569
RX   PubMed=18534018;
RX   PubMed=20160348;
CC   Miscellaneous: Sex of donor from personal communication of Combaret, Valerie.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   CLB-Tr
AC   CVCL_9537
SY   CLB-TR; CLB-Tra; CLB-TRA
DR   cancercelllines; CVCL_9537
DR   Cosmic; 1153810
DR   Wikidata; Q54813570
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7705946;
RX   PubMed=18923523;
RX   PubMed=20160348;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3520T>C); ClinVar=VCV000217849; Zygosity=Heterozygous (PubMed=18923523).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CLB-VolMo
AC   CVCL_9538
SY   CLB-VOL
DR   Wikidata; Q54813571
RX   PubMed=19349462;
RX   PubMed=20160348;
CC   Miscellaneous: Sex of donor and metastatic site from personal communication of Combaret, Valerie.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   CLB70
AC   CVCL_FA11
DR   ChEMBL-Cells; CHEMBL4295488
DR   ChEMBL-Targets; CHEMBL4296407
DR   PubChem_Cell_line; CVCL_FA11
DR   Wikidata; Q54813572
RX   PubMed=27506920;
CC   Doubling time: ~28 hours (PubMed=27506920).
CC   Derived from site: In situ; Submandibular lymph node; UBERON=UBERON_0002520.
CC   Breed/subspecies: Shih Tzu; VBO=VBO_0201223.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   CLBL-1
AC   CVCL_L322
SY   CLBL1
DR   ChEMBL-Cells; CHEMBL4295489
DR   ChEMBL-Targets; CHEMBL4296408
DR   GEO; GSM1974779
DR   GEO; GSM2143059
DR   GEO; GSM2282267
DR   PubChem_Cell_line; CVCL_L322
DR   Wikidata; Q54813573
RX   PubMed=20153049;
RX   PubMed=22761949;
RX   PubMed=23365669;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=27639374;
RX   PubMed=29674676;
RX   PubMed=31175136;
RX   PubMed=32651429;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 19 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:54284; CCND3; Simple; p.Arg358fs (c.1071_1075delCAGAG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Ala127Val (c.380C>T); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Arg257His (c.770G>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Caution: This cell line is owned by the University of Veterinary Medicine, Vienna who is the sole authorized distributor for both commercial and non-commercial research use.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Bernese mountain dog; VBO=VBO_0200161.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231
ST   Dog FHC2054: 156,164
ST   Dog FHC2079: 271
ST   Dog PEZ1: 119
ST   Dog PEZ3: 119,124
ST   Dog PEZ5: 115
ST   Dog PEZ6: 183,187
ST   Dog PEZ8: 236,240
ST   Dog PEZ12: 274,277
ST   Dog PEZ20: 176
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 24
//
ID   CLBL-1/luc
AC   CVCL_A9PA
DR   Wikidata; Q102113684
RX   PubMed=32651429;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Bernese mountain dog; VBO=VBO_0200161.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L322 ! CLBL-1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   CLBL-1M
AC   CVCL_L323
DR   Wikidata; Q54813574
RX   PubMed=22761949;
RX   PubMed=29674676;
CC   Characteristics: Established from a tumor in Rag-/- Gamma-c-/- mice injected subcutaneously with the parent cell line (PubMed=22761949).
CC   Doubling time: 26.4 hours (PubMed=22761949).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Bernese mountain dog; VBO=VBO_0200161.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L322 ! CLBL-1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   CLC [Cyprinus]
AC   CVCL_4144
SY   Carp Leukocyte Culture
DR   CLO; CLO_0002494
DR   CLDB; cl791
DR   ATCC; CRL-2763
DR   ECACC; 95070628
DR   Wikidata; Q54813575
RX   PubMed=2369971;
CC   Group: Fish cell line.
CC   Discontinued: ATCC; CRL-2763; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Female
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   CLC [Dog lymphoma]
AC   CVCL_L324
DR   Wikidata; Q54813576
RX   PubMed=23196801;
CC   Doubling time: 14.5 hours (PubMed=23196801).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: French Bulldog; VBO=VBO_0201455.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   CLC-1
AC   CVCL_A0WN
DR   Wikidata; Q108820062
RX   PubMed=34248270;
CC   Doubling time: 48.8 +- 3.3 hours (PubMed=34248270).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CLC1
AC   CVCL_RH12
SY   Chinese Liver Cancer cell line 1
DR   cancercelllines; CVCL_RH12
DR   GEO; GSM2070032
DR   LIMORE; CLC1
DR   Wikidata; Q54813577
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0001; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3816
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 33.28 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Arg (c.100G>A); ClinVar=VCV000376232; Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Met (c.427G>A); ClinVar=VCV000142657; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   CLC10
AC   CVCL_ZF73
SY   Chinese Liver Cancer cell line 10
DR   cancercelllines; CVCL_ZF73
DR   GEO; GSM2551542
DR   LIMORE; CLC10
DR   Wikidata; Q98125631
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0041; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3856
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 52.18 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Gly381Ter (c.1141G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 9,14
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC11
AC   CVCL_RH18
SY   Chinese Liver Cancer cell line 11
DR   cancercelllines; CVCL_RH18
DR   EGA; EGAS00001001678
DR   GEO; GSM2070047
DR   LIMORE; CLC11
DR   Wikidata; Q54813579
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0007; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3822
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Phe (c.713G>T); ClinVar=VCV000376574; Zygosity=Unspecified (PubMed=27273737).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 9,10
ST   D16S539: 9
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   CLC12
AC   CVCL_ZF74
SY   Chinese Liver Cancer cell line 12
DR   GEO; GSM2551543
DR   LIMORE; CLC12
DR   Wikidata; Q98125634
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0042; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3857
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 26.97 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asp1850Glyfs*4 (c.5548dupG); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Glu245Ter (c.733G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CLC12N2
AC   CVCL_A8GH
DR   cancercelllines; CVCL_A8GH
DR   TKG; TKG 0802
DR   Wikidata; Q107114691
RX   PubMed=20500518;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16412; NLRC4 (Note=With p.Leu152_Ala1024del, CARD domain, C12N2 construct).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): TKG=TKG 0802
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   CLC13
AC   CVCL_RH19
SY   Chinese Liver Cancer cell line 13
DR   cancercelllines; CVCL_RH19
DR   EGA; EGAS00001001678
DR   GEO; GSM2070050
DR   LIMORE; CLC13
DR   Wikidata; Q54813580
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0008; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3823
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ile (c.122C>T); ClinVar=VCV000017587; Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly105Asp (c.314G>A); ClinVar=VCV000141114; Zygosity=Unspecified (PubMed=27273737; PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   CLC14
AC   CVCL_ZF75
SY   Chinese Liver Cancer cell line 14
DR   cancercelllines; CVCL_ZF75
DR   GEO; GSM2551544
DR   LIMORE; CLC14
DR   Wikidata; Q98125635
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0012; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3827
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 28.11 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC15
AC   CVCL_ZF76
SY   Chinese Liver Cancer cell line 15
DR   GEO; GSM2551545
DR   LIMORE; CLC15
DR   Wikidata; Q98125636
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0043; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3858
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 41.22 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Arg582Ter (c.1744A>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu843Glyfs*6 (c.2528delA); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CLC16
AC   CVCL_RH20
SY   Chinese Liver Cancer cell line 16
DR   cancercelllines; CVCL_RH20
DR   EGA; EGAS00001001678
DR   GEO; GSM2070053
DR   LIMORE; CLC16
DR   Wikidata; Q54813581
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0009; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3824
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; c.934-2A>T; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783-2A>T; ClinVar=VCV000635385; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   CLC17
AC   CVCL_ZF77
SY   Chinese Liver Cancer cell line 17
DR   cancercelllines; CVCL_ZF77
DR   GEO; GSM2551546
DR   LIMORE; CLC17
DR   Wikidata; Q98125637
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0044; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3859
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 41.36 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC18
AC   CVCL_ZF78
SY   Chinese Liver Cancer cell line 18
DR   GEO; GSM2551547
DR   LIMORE; CLC18
DR   Wikidata; Q98125638
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0045; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3860
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 25.7 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:1577; CCNA1; Simple; c.1098+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Tyr373Ter (c.1119C>G); ClinVar=VCV002910237; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC19
AC   CVCL_ZF79
SY   Chinese Liver Cancer cell line 19
DR   cancercelllines; CVCL_ZF79
DR   GEO; GSM2551548
DR   LIMORE; CLC19
DR   Wikidata; Q98125639
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0015; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3830
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly101Val (c.302G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 13,14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZF80 ! CLC20
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC2
AC   CVCL_RH13
SY   Chinese Liver Cancer cell line 2
DR   GEO; GSM2070035
DR   LIMORE; CLC2
DR   Wikidata; Q54813582
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0002; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3817
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 31.11 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Leu618Profs*39 (c.1852dupC); Zygosity=Unspecified (PubMed=31378681).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   CLC20
AC   CVCL_ZF80
SY   Chinese Liver Cancer cell line 20
DR   cancercelllines; CVCL_ZF80
DR   GEO; GSM2551549
DR   LIMORE; CLC20
DR   Wikidata; Q98125640
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0046; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3861
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 31.58 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly101Val (c.302G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZF79 ! CLC19
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC21
AC   CVCL_ZF81
SY   Chinese Liver Cancer cell line 21
DR   cancercelllines; CVCL_ZF81
DR   GEO; GSM2551550
DR   LIMORE; CLC21
DR   Wikidata; Q98125641
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0017; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3832
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 36.15 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 13,14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC22
AC   CVCL_ZF82
SY   Chinese Liver Cancer cell line 22
DR   cancercelllines; CVCL_ZF82
DR   GEO; GSM2551551
DR   LIMORE; CLC22
DR   Wikidata; Q98125643
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0047; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3862
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 25.39 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Arg368Ter (c.1102A>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Thr79Profs*5 (c.234delC); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   CLC23
AC   CVCL_ZF83
SY   Chinese Liver Cancer cell line 23
DR   cancercelllines; CVCL_ZF83
DR   GEO; GSM2551552
DR   LIMORE; CLC23
DR   Wikidata; Q98125644
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0016; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3831
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 31.57 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu14Serfs*15 (c.38dupC); ClinVar=VCV000487431; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 13,14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC24
AC   CVCL_ZF84
SY   Chinese Liver Cancer cell line 24
DR   GEO; GSM2551553
DR   LIMORE; CLC24
DR   Wikidata; Q98125645
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0040; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3855
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 37.57 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Gln176Leu (c.527A>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly334Val (c.1001G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 10,13
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CLC25
AC   CVCL_ZF85
SY   Chinese Liver Cancer cell line 25
DR   cancercelllines; CVCL_ZF85
DR   GEO; GSM2551554
DR   LIMORE; CLC25
DR   Wikidata; Q98125646
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0048; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3863
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 28.62 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 11,13
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC26
AC   CVCL_ZF86
SY   Chinese Liver Cancer cell line 26
DR   cancercelllines; CVCL_ZF86
DR   GEO; GSM2551555
DR   LIMORE; CLC26
DR   Wikidata; Q98125647
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0049; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3864
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 49.16 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:14085; RTN4; Simple; p.Glu299Ter (c.895G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC27
AC   CVCL_ZF87
SY   Chinese Liver Cancer cell line 27
DR   cancercelllines; CVCL_ZF87
DR   GEO; GSM2551556
DR   LIMORE; CLC27
DR   Wikidata; Q98125649
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0050; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3865
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 40.13 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Pro605Serfs*13 (c.1813_1835delCCACTTCCCATTCAGATGTACTA); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 9,13
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC28
AC   CVCL_ZF88
SY   Chinese Liver Cancer cell line 28
DR   GEO; GSM2551557
DR   LIMORE; CLC28
DR   Wikidata; Q98125650
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0051; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3866
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 35.3 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC29
AC   CVCL_ZF89
SY   Chinese Liver Cancer cell line 29
DR   cancercelllines; CVCL_ZF89
DR   GEO; GSM2551558
DR   LIMORE; CLC29
DR   Wikidata; Q98125651
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0022; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3837
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 27.78 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Ala (c.721T>G); ClinVar=VCV000376665; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC3
AC   CVCL_ZF90
SY   Chinese Liver Cancer cell line 3
DR   cancercelllines; CVCL_ZF90
DR   GEO; GSM2551559
DR   LIMORE; CLC3
DR   Wikidata; Q98125652
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0013; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3828
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 17.72 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Pro865Glnfs*50 (c.2594_2597delCAGC); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ile (c.839G>T); ClinVar=VCV000161517; Zygosity=Unspecified (PubMed=31378681).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   CLC30
AC   CVCL_ZF91
SY   Chinese Liver Cancer cell line 30
DR   GEO; GSM2551560
DR   LIMORE; CLC30
DR   Wikidata; Q98125653
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0018; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3833
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 34.06 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Glu158Lysfs*24 (c.472delG); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 7,11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC31
AC   CVCL_ZF92
SY   Chinese Liver Cancer cell line 31
DR   cancercelllines; CVCL_ZF92
DR   GEO; GSM2551561
DR   LIMORE; CLC31
DR   Wikidata; Q98125654
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0019; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3834
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 32.21 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Leu449Ter (c.1346T>A); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe270Cys (c.809T>G); ClinVar=VCV000376597; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC32
AC   CVCL_ZF93
SY   Chinese Liver Cancer cell line 32
DR   GEO; GSM2551596
DR   LIMORE; CLC32
DR   Wikidata; Q98125655
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0024; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3839
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 27.1 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC33
AC   CVCL_ZF94
SY   Chinese Liver Cancer cell line 33
DR   cancercelllines; CVCL_ZF94
DR   GEO; GSM2551597
DR   LIMORE; CLC33
DR   Wikidata; Q98125657
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0020; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3835
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 26.97 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn329Lysfs*14 (c.987_990delTAAA); ClinVar=VCV000189441; Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln165Ter (c.493C>T); ClinVar=VCV000182930; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC34
AC   CVCL_ZF95
SY   Chinese Liver Cancer cell line 34
DR   GEO; GSM2551598
DR   LIMORE; CLC34
DR   Wikidata; Q98125659
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0025; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3840
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 37.44 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro250His (c.749C>A); Zygosity=Unspecified (PubMed=31378681).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC35
AC   CVCL_ZF96
SY   Chinese Liver Cancer cell line 35
DR   GEO; GSM3394790
DR   LIMORE; CLC35
DR   Wikidata; Q98125660
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0021; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3836
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Serfs*5 (c.798_799insT); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CLC36
AC   CVCL_ZF97
SY   Chinese Liver Cancer cell line 36
DR   GEO; GSM3394791
DR   LIMORE; CLC36
DR   Wikidata; Q98125661
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0023; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3838
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,13
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   CLC37
AC   CVCL_ZF98
SY   Chinese Liver Cancer cell line 37
DR   GEO; GSM3394792
DR   LIMORE; CLC37
DR   Wikidata; Q98125662
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0026; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3841
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala276Phe (c.826_827GC>TT); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 11,13
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CLC38
AC   CVCL_ZF99
SY   Chinese Liver Cancer cell line 38
DR   GEO; GSM3394793
DR   LIMORE; CLC38
DR   Wikidata; Q98125664
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0027; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3842
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC39
AC   CVCL_ZG00
SY   Chinese Liver Cancer cell line 39
DR   GEO; GSM3394794
DR   LIMORE; CLC39
DR   Wikidata; Q98125665
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0028; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3843
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu17Lysfs*27 (c.49delG); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 13
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,15
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CLC4
AC   CVCL_RH14
SY   Chinese Liver Cancer cell line 4
DR   cancercelllines; CVCL_RH14
DR   GEO; GSM2070038
DR   LIMORE; CLC4
DR   Wikidata; Q54813583
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0003; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3818
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 42.81 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   CLC40
AC   CVCL_ZG01
SY   Chinese Liver Cancer cell line 40
DR   cancercelllines; CVCL_ZG01
DR   GEO; GSM3394795
DR   LIMORE; CLC40
DR   Wikidata; Q98125666
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0031; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3846
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Leu2258Hisfs*4 (c.6773_6788delTGTTGGACATCTCGGT); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC41
AC   CVCL_ZG02
SY   Chinese Liver Cancer cell line 41
DR   cancercelllines; CVCL_ZG02
DR   GEO; GSM3394796
DR   LIMORE; CLC41
DR   Wikidata; Q98125667
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0030; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3845
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,20
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC42
AC   CVCL_ZG03
SY   Chinese Liver Cancer cell line 42
DR   cancercelllines; CVCL_ZG03
DR   GEO; GSM3394797
DR   LIMORE; CLC42
DR   Wikidata; Q98125669
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0029; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3844
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1421+1G>T; ClinVar=VCV003045281; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Glu (c.843C>G); ClinVar=VCV000376587; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC43
AC   CVCL_ZG04
SY   Chinese Liver Cancer cell line 43
DR   GEO; GSM3394798
DR   LIMORE; CLC43
DR   Wikidata; Q98125671
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0036; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3851
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC44
AC   CVCL_ZG05
SY   Chinese Liver Cancer cell line 44
DR   cancercelllines; CVCL_ZG05
DR   GEO; GSM3394799
DR   LIMORE; CLC44
DR   Wikidata; Q98125672
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0039; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3854
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Ser579Ter (c.1736C>A); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Glu366Ter (c.1096G>T); ClinVar=VCV000012400; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,11
ST   D16S539: 9,10,11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC45
AC   CVCL_ZG06
SY   Chinese Liver Cancer cell line 45
DR   GEO; GSM3394800
DR   LIMORE; CLC45
DR   Wikidata; Q98125673
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0033; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3848
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   CLC46
AC   CVCL_ZG07
SY   Chinese Liver Cancer cell line 46
DR   GEO; GSM3394801
DR   LIMORE; CLC46
DR   Wikidata; Q98125675
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0034; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3849
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Ser1990Cysfs*5 (c.5968_5978delAGCCTGTCATT); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser315Leufs*30 (c.943delT); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 11,13
ST   D5S818: 9,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC47
AC   CVCL_ZG08
SY   Chinese Liver Cancer cell line 47
DR   GEO; GSM3394802
DR   LIMORE; CLC47
DR   Wikidata; Q98125676
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0035; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3850
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Glu188Ter (c.562G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CLC48
AC   CVCL_ZG09
SY   Chinese Liver Cancer cell line 48
DR   GEO; GSM3394803
DR   LIMORE; CLC48
DR   Wikidata; Q98125677
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0032; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3847
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:172; ACVR1B; Simple; p.Trp518Cysfs*9 (c.1554delG); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Gly508Valfs*197 (c.1523delG); Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 13
ST   D5S818: 7,10
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CLC49
AC   CVCL_ZG10
SY   Chinese Liver Cancer cell line 49
DR   cancercelllines; CVCL_ZG10
DR   GEO; GSM3394804
DR   LIMORE; CLC49
DR   Wikidata; Q98125678
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0038; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3853
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Gly944Ter (c.2830G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLC5
AC   CVCL_RH15
SY   Chinese Liver Cancer cell line 5
DR   cancercelllines; CVCL_RH15
DR   EGA; EGAS00001001678
DR   GEO; GSM2070040
DR   LIMORE; CLC5
DR   Wikidata; Q54813584
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0004; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3819
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Glu709Ter (c.2125G>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu68Ter (c.202G>T); ClinVar=VCV000224551; Zygosity=Unspecified (PubMed=27273737; PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 11,12
ST   vWA: 14,16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   CLC50
AC   CVCL_ZG11
SY   Chinese Liver Cancer cell line 50
DR   GEO; GSM3394805
DR   LIMORE; CLC50
DR   Wikidata; Q98125679
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0037; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3852
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,13
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   CLC6
AC   CVCL_RH16
SY   Chinese Liver Cancer cell line 6
DR   GEO; GSM2070042
DR   LIMORE; CLC6
DR   Wikidata; Q54813585
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0005; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3820
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 28.68 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys652Ter (c.1954A>T); ClinVar=VCV003237040; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D5S818: 7,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   CLC7
AC   CVCL_RH17
SY   Chinese Liver Cancer cell line 7
DR   GEO; GSM2070044
DR   LIMORE; CLC7
DR   Wikidata; Q54813586
RX   PubMed=27273737;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0006; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3821
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27273737; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   CLC8
AC   CVCL_ZG12
SY   Chinese Liver Cancer cell line 8
DR   cancercelllines; CVCL_ZG12
DR   GEO; GSM2551562
DR   LIMORE; CLC8
DR   Wikidata; Q98125680
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0011; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3826
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Doubling time: 21.96 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 13,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   CLC9
AC   CVCL_ZG13
SY   Chinese Liver Cancer cell line 9
DR   GEO; GSM2551563
DR   LIMORE; CLC9
DR   Wikidata; Q98125681
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0014; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3829
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1577; CCNA1; Simple; p.Leu276His (c.827T>A); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CLCL
AC   CVCL_Y302
DR   Wikidata; Q54813587
RX   Patent=US3871954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-99.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10-22FW
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   ClDuF
AC   CVCL_YU26
SY   Clarias Dussumieri Fin
DR   NRFC; NRFC059
DR   Wikidata; Q93454624
RX   PubMed=31989626;
WW   Provider; NRFC; NRFC059; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC059.
CC   Doubling time: ~24 hours (PubMed=31989626).
CC   Misspelling: CIDu; NRFC=NRFC059.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=685904; ! Clarias dussumieri (Dussumier's catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   Cle-H3
AC   CVCL_F498
SY   H-3
DR   CLO; CLO_0050551
DR   RCB; RCB0549
DR   Wikidata; Q54813588
RX   PubMed=1505125;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   Cle-H3^(neo+)
AC   CVCL_T378
SY   H-3neo
DR   CLO; CLO_0050552
DR   RCB; RCB0550
DR   Wikidata; Q54813589
RX   PubMed=1505125;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F498 ! Cle-H3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   ClearCa-1
AC   CVCL_X548
SY   clearCa-1
DR   Wikidata; Q54813590
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=9146668;
RX   PubMed=11139287;
CC   Doubling time: 34 hours (PubMed=9146668).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   ClearCa-10
AC   CVCL_X549
SY   clearCa-10
DR   Wikidata; Q54813591
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=9146668;
CC   Doubling time: 51 hours (PubMed=9146668).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-11
AC   CVCL_X550
SY   clearCa-11
DR   IARC_TP53; 23213
DR   Wikidata; Q54813592
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=11139287;
RX   PubMed=15863265;
CC   Doubling time: 27 hours (PubMed=9146668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15863265).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-12
AC   CVCL_X551
SY   clearCa-12
DR   IARC_TP53; 23214
DR   Wikidata; Q54813593
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=9146668;
RX   PubMed=15863265;
CC   Doubling time: 104 hours (PubMed=9146668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15863265).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-13
AC   CVCL_X552
SY   clearCa-13
DR   cancercelllines; CVCL_X552
DR   Cosmic; 972656
DR   Wikidata; Q54813594
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=10925357;
CC   Doubling time: 42 hours (PubMed=9146668).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Cys77Ter (c.231C>A); ClinVar=VCV002028206; Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-14
AC   CVCL_X553
SY   clearCa-14
DR   Wikidata; Q54813595
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-15
AC   CVCL_X554
SY   clearCa-15
DR   IARC_TP53; 23215
DR   Wikidata; Q54813596
RX   CelloPub=CLPUB00407;
RX   PubMed=11139287;
RX   PubMed=15863265;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11139287; PubMed=15863265).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-16
AC   CVCL_X555
SY   clearCa-16
DR   Wikidata; Q54813597
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-17
AC   CVCL_X556
SY   clearCa-17
DR   cancercelllines; CVCL_X556
DR   IARC_TP53; 23265
DR   Wikidata; Q54813601
RX   CelloPub=CLPUB00407;
RX   PubMed=11139287;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Leu (c.638G>T); ClinVar=VCV000376650; Zygosity=Unspecified (PubMed=11139287).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   ClearCa-18
AC   CVCL_X557
SY   clearCa-18
DR   Wikidata; Q54813602
RX   CelloPub=CLPUB00407;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-19
AC   CVCL_X558
SY   clearCa-19
DR   IARC_TP53; 23216
DR   Wikidata; Q54813603
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=10737390;
RX   PubMed=15863265;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15863265).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-2
AC   CVCL_X559
SY   clearCa-2
DR   Cosmic; 972663
DR   Wikidata; Q54813604
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=10925357;
CC   Doubling time: 37 hours (PubMed=9146668).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-20
AC   CVCL_X560
SY   clearCa-20
DR   Wikidata; Q54813605
RX   CelloPub=CLPUB00407;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-21
AC   CVCL_X561
SY   clearCa-21
DR   Wikidata; Q54813606
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-22
AC   CVCL_X562
SY   clearCa-22
DR   cancercelllines; CVCL_X562
DR   Cosmic; 972664
DR   Wikidata; Q54813607
RX   CelloPub=CLPUB00407;
RX   PubMed=10925357;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Tyr98Ter (c.294C>G); ClinVar=VCV000625235; Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-23
AC   CVCL_X563
SY   clearCa-23
DR   Cosmic; 972666
DR   Wikidata; Q54813608
RX   CelloPub=CLPUB00407;
RX   PubMed=10925357;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Pro172Leufs*30 (c.514delC); Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 8
//
ID   ClearCa-24
AC   CVCL_X564
SY   clearCa-24
DR   Wikidata; Q54813609
RX   CelloPub=CLPUB00407;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-25
AC   CVCL_X565
SY   clearCa-25
DR   Wikidata; Q54813610
RX   CelloPub=CLPUB00407;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-26
AC   CVCL_X566
SY   clearCa-26
DR   cancercelllines; CVCL_X566
DR   Cosmic; 972658
DR   Wikidata; Q54813611
RX   CelloPub=CLPUB00407;
RX   PubMed=10925357;
RX   PubMed=11139287;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asn78Ile (c.233A>T); ClinVar=VCV000223169; Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   ClearCa-27
AC   CVCL_X567
SY   clearCa-27
DR   Cosmic; 972660
DR   Cosmic; 972667
DR   Wikidata; Q54813612
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=10925357;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Val130Asp (c.389T>A); Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 8
//
ID   ClearCa-28
AC   CVCL_X579
SY   clearCa-28
DR   Wikidata; Q54813613
RX   CelloPub=CLPUB00411;
RX   PubMed=10737390;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-29
AC   CVCL_X581
SY   clearCa-29
DR   Wikidata; Q54813614
RX   CelloPub=CLPUB00411;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-3
AC   CVCL_X568
SY   clearCa-3
DR   IARC_TP53; 23209
DR   Wikidata; Q54813615
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=9146668;
RX   PubMed=11139287;
RX   PubMed=15863265;
CC   Doubling time: 31 hours (PubMed=9146668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15863265).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-31
AC   CVCL_X569
SY   clearCa-31
DR   cancercelllines; CVCL_X569
DR   Cosmic; 972659
DR   Wikidata; Q54813616
RX   CelloPub=CLPUB00411;
RX   PubMed=10925357;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Phe76Tyr (c.227T>A); ClinVar=VCV000625224; Zygosity=Unspecified (PubMed=10925357).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Cys77Ser (c.229T>A); Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 12
//
ID   ClearCa-32
AC   CVCL_X570
SY   clearCa-32
DR   Cosmic; 972665
DR   Wikidata; Q54813618
RX   CelloPub=CLPUB00411;
RX   PubMed=10925357;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Arg108Alafs*51 (c.322delC); Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 9
//
ID   ClearCa-33
AC   CVCL_RJ66
SY   clearCa-33
DR   Wikidata; Q54813619
RX   CelloPub=CLPUB00411;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   ClearCa-35
AC   CVCL_X571
SY   clearCa-35
DR   Cosmic; 972661
DR   Wikidata; Q54813620
RX   CelloPub=CLPUB00411;
RX   PubMed=10925357;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser68Ter (c.203_204CG>AA); Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 9
//
ID   ClearCa-36
AC   CVCL_X572
SY   clearCa-36
DR   cancercelllines; CVCL_X572
DR   Cosmic; 972657
DR   Wikidata; Q54813621
RX   CelloPub=CLPUB00411;
RX   PubMed=10925357;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asn78Thr (c.233A>C); ClinVar=VCV000223168; Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   ClearCa-39
AC   CVCL_X580
SY   clearCa-39
DR   Wikidata; Q54813622
RX   CelloPub=CLPUB00411;
RX   PubMed=10737390;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   ClearCa-4
AC   CVCL_X573
SY   clearCa-4
DR   Wikidata; Q54813623
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=11139287;
CC   Doubling time: 33 hours (PubMed=9146668).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   ClearCa-43
AC   CVCL_RJ67
SY   clearCa-43
DR   Wikidata; Q54813624
RX   CelloPub=CLPUB00411;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   ClearCa-5
AC   CVCL_X574
SY   clearCa-5
DR   IARC_TP53; 23210
DR   Wikidata; Q54813625
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=9146668;
RX   PubMed=10737390;
RX   PubMed=11139287;
RX   PubMed=15863265;
CC   Doubling time: 32 hours (PubMed=9146668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.952_966del15; Zygosity=Unspecified (PubMed=15863265).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 9
//
ID   ClearCa-6
AC   CVCL_X575
SY   clearCa-6
DR   cancercelllines; CVCL_X575
DR   Cosmic; 972662
DR   IARC_TP53; 23211
DR   Wikidata; Q54813626
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=10925357;
RX   PubMed=11139287;
RX   PubMed=15863265;
CC   Doubling time: 45 hours (PubMed=9146668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg290His (c.869G>A); ClinVar=VCV000127825; Zygosity=Unspecified (PubMed=11139287; PubMed=15863265).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu178Glnfs (c.532_533insC); Zygosity=Unspecified (PubMed=10925357).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 11
//
ID   ClearCa-7
AC   CVCL_X576
SY   clearCa-7
DR   IARC_TP53; 23212
DR   Wikidata; Q54813627
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=15863265;
CC   Doubling time: 60 hours (PubMed=9146668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15863265).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 10
//
ID   ClearCa-8
AC   CVCL_X577
SY   clearCa-8
DR   Wikidata; Q54813628
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=11139287;
CC   Doubling time: 112 hours (PubMed=9146668).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   ClearCa-9
AC   CVCL_X578
SY   clearCa-9
DR   Wikidata; Q54813629
RX   CelloPub=CLPUB00407;
RX   CelloPub=CLPUB00411;
RX   PubMed=9146668;
RX   PubMed=11139287;
CC   Doubling time: 64 hours (PubMed=9146668).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   CLEC213
AC   CVCL_JF73
SY   CLEC-213; Chicken Lung Epithelial Cells 213
DR   Wikidata; Q54813630
RX   PubMed=21557972;
RX   PubMed=28441462;
CC   Group: Bird cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: White Leghorn SPF PA12.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   5-7W
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   CLF
AC   CVCL_6F77
SY   Cyclopterus Lumpus Fin
DR   Wikidata; Q54813631
RX   DOI=10.1139/f77-017;
CC   Group: Fish cell line.
CC   Doubling time: 108 hours (DOI=10.1139/f77-017).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8103; ! Cyclopterus lumpus (Lumpsucker)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 11
//
ID   CLF-PED-015-T
AC   CVCL_RS38
SY   CLF_PEDS015T; Peds015T; PEDS015T; CPDM_0167X
DR   Wikidata; Q54813632
RX   PubMed=27329820;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Brain, left occipital lobe; UBERON=UBERON_0002806.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   CLF_PEDS0005_N
AC   CVCL_C9B2
DR   dbGAP; phs001800.v1.p1
DR   Wikidata; Q123030935
RX   PubMed=30860482;
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9B3 ! CLF_PEDS0005_T1
OI   CVCL_C9B4 ! CLF_PEDS0005_T2A
OI   CVCL_C9B5 ! CLF_PEDS0005_T2B
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   CLF_PEDS0005_T1
AC   CVCL_C9B3
DR   dbGAP; phs001800.v1.p1
DR   GEO; GSM3039703
DR   Wikidata; Q123030936
RX   PubMed=30860482;
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=30860482).
CC   Sequence variation: Gene fusion; HGNC; HGNC:28667; C1orf116 + HGNC; HGNC:11103; SMARCB1; Name(s)=SMARCB1-C1orf116; Note=SMARCB1 intron 1 fused to C1orf116 C-terminal (PubMed=30860482).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9B2 ! CLF_PEDS0005_N
OI   CVCL_C9B4 ! CLF_PEDS0005_T2A
OI   CVCL_C9B5 ! CLF_PEDS0005_T2B
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CLF_PEDS0005_T2A
AC   CVCL_C9B4
SY   CLF_PEDS0005_T2a
DR   BioGRID_ORCS_Cell_line; 1223
DR   dbGAP; phs001800.v1.p1
DR   GEO; GSM3039705
DR   Wikidata; Q123030937
RX   PubMed=30860482;
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (from autologous cell line CLF_PEDS0005_T1).
CC   Sequence variation: Gene fusion; HGNC; HGNC:28667; C1orf116 + HGNC; HGNC:11103; SMARCB1; Name(s)=SMARCB1-C1orf116; Note=SMARCB1 intron 1 fused to C1orf116 C-terminal (from autologous cell line CLF_PEDS0005_T1).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9B2 ! CLF_PEDS0005_N
OI   CVCL_C9B3 ! CLF_PEDS0005_T1
OI   CVCL_C9B5 ! CLF_PEDS0005_T2B
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CLF_PEDS0005_T2B
AC   CVCL_C9B5
SY   CLF_PEDS0005_T2b
DR   BioGRID_ORCS_Cell_line; 1224
DR   dbGAP; phs001800.v1.p1
DR   GEO; GSM3039704
DR   Wikidata; Q123030938
RX   PubMed=30860482;
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (from autologous cell line CLF_PEDS0005_T1).
CC   Sequence variation: Gene fusion; HGNC; HGNC:28667; C1orf116 + HGNC; HGNC:11103; SMARCB1; Name(s)=SMARCB1-C1orf116; Note=SMARCB1 intron 1 fused to C1orf116 C-terminal (from autologous cell line CLF_PEDS0005_T1).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9B2 ! CLF_PEDS0005_N
OI   CVCL_C9B3 ! CLF_PEDS0005_T1
OI   CVCL_C9B4 ! CLF_PEDS0005_T2A
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CLF_PEDS1012_T1
AC   CVCL_C9B7
DR   Wikidata; Q123030939
RX   PubMed=30860482;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CLF_PEDS9001_T1
AC   CVCL_C9B6
SY   CLF_PEDS9001_T
DR   dbGAP; phs001800.v1.p1
DR   GEO; GSM3687425
DR   Wikidata; Q123030940
RX   PubMed=30860482;
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=30860482).
CC   Sequence variation: Gene fusion; HGNC; HGNC:30036; PLEKHA5 + HGNC; HGNC:11103; SMARCB1; Name(s)=SMARCB1-PLEKHA5; Note=SMARCB1 intron 6 fused to PLEKHA5 intron 10 (PubMed=30860482).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CLF1
AC   CVCL_UE04
SY   CLF 1
DR   Wikidata; Q93454843
RX   PubMed=3013426;
RX   PubMed=8543165;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   CLGL-90
AC   CVCL_DI62
SY   CLGL90; Chronic Large Granular Lymphocytic-90
DR   Wikidata; Q54813633
RX   PubMed=15746063;
RX   PubMed=22236332;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 5
//
ID   CLH 6
AC   CVCL_J673
SY   CLH6
DR   ATCC; HB-8232
DR   Wikidata; Q54813634
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8232.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CLH 68
AC   CVCL_J674
SY   CLH68
DR   ATCC; HB-8243
DR   Wikidata; Q54813635
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8243.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CLH 70
AC   CVCL_J675
SY   CLH70
DR   Wikidata; Q54813636
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8245.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CLI
AC   CVCL_C8HL
SY   CL; Chimpanzee Liver Ivy
DR   Wikidata; Q123030941
RX   PubMed=4286950;
RX   PubMed=4842701;
CC   Group: Non-human primate cell line.
CC   Virology: Susceptible to infection by various adenoviruses, polioviruses, respiratory syncytial virus and various simian viruses (PubMed=4286950).
CC   Virology: Susceptible to infection by adenovirus types 5 (Ad5) and 12 (Ad12) (PubMed=4842701).
CC   Donor information: Established from a chimpanzee named Ivy.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CLK
AC   CVCL_L325
DR   Wikidata; Q54813637
RX   PubMed=23196801;
CC   Doubling time: 36.2 hours (PubMed=23196801).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Pyrenean mountain dog; VBO=VBO_0200629.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   CLL 36A/76
AC   CVCL_DC64
SY   36A/76
DR   Wikidata; Q54813638
RX   Patent=US4477567;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-1407.
CC   Characteristics: Secretes insulin.
CC   Doubling time: ~24 hours (Patent=US4477567).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0003921+UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   CLL-1390
AC   CVCL_DI61
SY   CLL1390
DR   GEO; GSM1974780
DR   Wikidata; Q54813639
RX   PubMed=15746063;
RX   PubMed=22236332;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 37 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:39069; CDKN1B; Simple; p.Ter199fs (c.596_597insCC); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple; p.Val1131fs (c.3390delCinsGGG); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47261; TET2; Simple; p.Gln965Ter (c.2893C>T); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Asp60fs (c.176_177insAAGGGAGCTTGAAGGTTTCT); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235,239
ST   Dog FHC2054: 151,172
ST   Dog FHC2079: 275
ST   Dog PEZ1: 111,119
ST   Dog PEZ3: 115,131
ST   Dog PEZ5: 107,115
ST   Dog PEZ6: 176,179
ST   Dog PEZ8: 240
ST   Dog PEZ12: 263,271
ST   Dog PEZ20: 176,180
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CLL-AAT
AC   CVCL_CY99
SY   CLL-MT
DR   Wikidata; Q54813640
RX   Patent=US8840885;
RX   PubMed=16418292;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3920.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   CLM-7
AC   CVCL_4W28
DR   Wikidata; Q54813641
RX   PubMed=3365701;
RX   PubMed=5533992;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
ID   CLM-7/AD XV
AC   CVCL_5A46
DR   Wikidata; Q54813649
RX   PubMed=3365701;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4W28 ! CLM-7
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 6
//
ID   CLN
AC   CVCL_3663
SY   Canine Lymph Node
DR   CLO; CLO_0002496
DR   ATCC; CRL-6245
DR   Wikidata; Q54813650
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_N778 ! CSN
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   CLN3-iPS 1A
AC   CVCL_VK57
DR   Wikidata; Q93454896
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Homozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK58 ! CLN3-iPS 1B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 1B
AC   CVCL_VK58
DR   Wikidata; Q93454899
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Homozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK57 ! CLN3-iPS 1A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 2A
AC   CVCL_VK59
DR   Wikidata; Q93454901
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.1056+3A>C; ClinVar=VCV000056247; Zygosity=Heterozygous (PubMed=24271013).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Asp416Gly (c.1247A>G); ClinVar=VCV000056252; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK60 ! CLN3-iPS 2B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 2B
AC   CVCL_VK60
DR   Wikidata; Q93454903
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.1056+3A>C; ClinVar=VCV000056247; Zygosity=Heterozygous (PubMed=24271013).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Asp416Gly (c.1247A>G); ClinVar=VCV000056252; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK59 ! CLN3-iPS 2A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 3A
AC   CVCL_VK61
DR   Wikidata; Q93454905
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Homozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK62 ! CLN3-iPS 3B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 3B
AC   CVCL_VK62
DR   Wikidata; Q93454908
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Homozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK61 ! CLN3-iPS 3A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 4A
AC   CVCL_VK63
DR   Wikidata; Q93454910
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Homozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK64 ! CLN3-iPS 4B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 4B
AC   CVCL_VK64
DR   Wikidata; Q93454912
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Homozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK63 ! CLN3-iPS 4A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   CLN3-iPS 5A
AC   CVCL_VK65
DR   Wikidata; Q93454915
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   CLNH11.4
AC   CVCL_3664
SY   CLN H11.4; CLNH11
DR   CLO; CLO_0002497
DR   ATCC; HB-8307
DR   BioSample; SAMN03471081
DR   Wikidata; Q54813651
RX   Patent=US6090924;
RX   PubMed=6604917;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8307.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): ATCC=HB-8307
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 11
ST   D16S539: 9,11,12
ST   D18S51: 11,16,22
ST   D19S433: 14,15.2,16
ST   D21S11: 29,31.2,32.2
ST   D2S1338: 17,18,19,25
ST   D3S1358: 15,16
ST   D5S818: 10,11,12,13
ST   D7S820: 9,11
ST   D8S1179: 10,13,14
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 5,7,15,20
ST   TH01: 6,7,8,9.3
ST   TPOX: 8,11
ST   vWA: 14,17,19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   CLNH5.5
AC   CVCL_3665
SY   CLNH5
DR   CLO; CLO_0002498
DR   ATCC; HB-8206
DR   BioSample; SAMN03471080
DR   Wikidata; Q54813652
RX   Patent=US6090924;
RX   PubMed=6604917;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8206.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human cervical squamous cell carcinoma (Note=Also reacts with lung, prostate, vulva and skin cancer cells).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): ATCC=HB-8206
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,11,12
ST   D18S51: 11,16,22
ST   D19S433: 14,15.2,16
ST   D21S11: 29,31.2,32.2
ST   D2S1338: 17,18,19,25
ST   D3S1358: 15,16
ST   D5S818: 10,11,13
ST   D7S820: 9,11
ST   D8S1179: 10,13,14
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 5,7,15,20
ST   TH01: 6,7,8,9
ST   TPOX: 8,11
ST   vWA: 14,17,19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Clo03
AC   CVCL_YZ53
SY   Clone 3
DR   Wikidata; Q98125683
RX   PubMed=10233862;
RX   PubMed=32106286;
CC   Doubling time: 29-32 hours (PubMed=10233862).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   Clom 15
AC   CVCL_1R52
DR   BioSample; SAMN03152005
DR   Wikidata; Q54813653
RX   PubMed=20951163;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00383.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   Clone 10
AC   CVCL_E2QS
RX   PubMed=26301929;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; G3GK26; Staphylococcus aureus (strain COL) mecA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Clone 104
AC   CVCL_E2S7
SY   104
RX   PubMed=26090599;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NP55; Human BPIFA1 (Note=Cross-reacts with IgG1 Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Clone 12.6
AC   CVCL_XH62
DR   Wikidata; Q93454932
RX   Patent=US6849720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2390.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01130; Human LDLR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   Clone 130
AC   CVCL_E2S8
SY   130
RX   PubMed=26090599;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NP55; Human BPIFA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   clone 16
AC   CVCL_C7NB
DR   Wikidata; Q117704255
RX   Patent=US9920135;
RX   PubMed=24502396;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-01644.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Clone 160
AC   CVCL_E2S9
SY   160
RX   PubMed=26090599;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NP55; Human BPIFA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   clone 18
AC   CVCL_C7NC
DR   Wikidata; Q117704256
RX   Patent=US9920135;
RX   PubMed=24502396;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-01643.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   clone 19
AC   CVCL_C7ND
DR   Wikidata; Q117704257
RX   Patent=US9920135;
RX   PubMed=24502396;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-01642.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Clone 197
AC   CVCL_M377
SY   197
DR   ECACC; 91060548
DR   Wikidata; Q54813654
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Sheep T19 antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   Clone 1A
AC   CVCL_1T03
DR   BioSample; SAMN03151624
DR   Wikidata; Q54813655
RX   PubMed=19002917;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Oncorhynchus mykiss origin but found to be a Oncorhynchus tshawytscha CHSE-214 derivative (PubMed=19002917).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00371.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_2780 ! CHSE-214
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   Clone 218
AC   CVCL_M393
DR   ECACC; 91060545
DR   Wikidata; Q54813656
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; W5Q5Y1; Sheep ITGA4/CD49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   Clone 28
AC   CVCL_XH63
DR   Wikidata; Q93454947
RX   Patent=US6849720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2391.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01130; Human LDLR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   Clone 29.8
AC   CVCL_XH64
DR   Wikidata; Q93454949
RX   Patent=US6849720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2392.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01130; Human LDLR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   Clone 30
AC   CVCL_XH65
DR   Wikidata; Q93454952
RX   Patent=US6849720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2393.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01130; Human LDLR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   Clone 38
AC   CVCL_E2QT
RX   PubMed=26301929;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; G3GK26; Staphylococcus aureus (strain COL) mecA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Clone 50.30
AC   CVCL_XH66
DR   Wikidata; Q93454955
RX   Patent=US6849720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2394.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01130; Human LDLR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   Clone 69T1RevEnv
AC   CVCL_1H05
SY   Env-expressing cell clone 69
DR   BEI_Resources; ARP-3336
DR   Wikidata; Q54813657
RX   PubMed=8676479;
CC   Population: African American.
CC   Characteristics: HIV-1 Rev and Env proteins are induced by removing tetracycline from the culture medium.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03377; HIV-1 isolate BRU/LAI env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04620; HIV-1 isolate BRU/LAI rev.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2523 ! HtTA-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   Clone 707
AC   CVCL_4145
SY   clone 707; Friend Leukemic Cells clone 707; FLC clone 707; FLC-707
DR   CLO; CLO_0002502
DR   CLDB; cl796
DR   CLDB; cl806
DR   ECACC; 86052101
DR   Wikidata; Q54813658
RX   PubMed=1986259;
RX   PubMed=3116422;
RX   PubMed=4527816;
RX   PubMed=5277089;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 10
//
ID   Clone 81
AC   CVCL_7216
AS   CVCL_9495
SY   CCC clone 81; CCC3a subline 8C clone 81; CC81; CC 81; 8C81
DR   CLO; CLO_0002232
DR   CLO; CLO_0002503
DR   CLDB; cl652
DR   CLDB; cl797
DR   ECACC; 90031403
DR   Wikidata; Q54813659
RX   PubMed=4365331;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_W183 ! CCC3a subline 8C
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   Clone 9
AC   CVCL_E2S6
SY   9
RX   PubMed=26090599;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NP55; Human BPIFA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Clone C
AC   CVCL_6483
SY   IC250 clone C; Clone C of IC250 cells
DR   CLO; CLO_0002505
DR   ATCC; CRL-2531
DR   Wikidata; Q54813660
RX   PubMed=1325122;
CC   Characteristics: May be used to study terminal differentiation of intercalated cells (ATCC=CRL-2531).
CC   Characteristics: Bicarbonate-secreting.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, distal tubule; UBERON=UBERON_0004135.
CC   Cell type: Renal intercalated cell; CL=CL_0005010.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   Clone HXBdeltaPdeltaEnv-T1RevEnv
AC   CVCL_1H06
DR   BEI_Resources; ARP-3337
DR   Wikidata; Q54813661
RX   PubMed=8676479;
CC   Group: Retrovirus packaging cell line.
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2523 ! HtTA-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   Clone M-3
AC   CVCL_4512
AS   CVCL_7682
SY   Cloudman S91 melanoma clone M-3; S91 clone M3; CLONE M3; M3 Clone M-3; Cloudman M3
DR   CLO; CLO_0002511
DR   CLO; CLO_0007474
DR   CLDB; cl804
DR   CLDB; cl805
DR   CLDB; cl3315
DR   ATCC; CCL-53.1
DR   BCRC; 60075
DR   ECACC; 87081806
DR   ECACC; 93120827
DR   IZSLER; BS TCL 37
DR   KCLB; 10053.1
DR   Lonza; 1404
DR   RCB; RCB2616
DR   TKG; TKG 0554
DR   Wikidata; Q54813662
RX   DOI=10.1007/BF02618370;
RX   PubMed=3348949;
RX   PubMed=3667379;
RX   PubMed=4364526;
RX   PubMed=6581509;
RX   PubMed=33596583;
CC   Characteristics: Highly pigmented (PubMed=4364526).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=33596583).
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: RCB; RCB2616; true.
CC   Discontinued: TKG; TKG 0554; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J817 ! S91
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   Clone-119
AC   CVCL_C7IJ
SY   clone-119; clone 119
DR   Wikidata; Q117704258
RX   PubMed=28746862;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; Q86UP6; Human CUZD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Clone-275
AC   CVCL_C7IK
SY   clone-275; clone 275
DR   Wikidata; Q117704259
RX   PubMed=28746862;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; Q86UP6; Human CUZD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CLS-103
AC   CVCL_5725
SY   CLS 103; CLS103
DR   CLS; 400176
DR   Wikidata; Q54813663
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: NMRI.
DI   NCIt; C24234; Mouse gastric squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   CLS-138
AC   CVCL_5726
DR   CLS; 400177
DR   Wikidata; Q54813665
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Breed/subspecies: NMRI.
DI   NCIt; C21613; Mouse spindle cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   CLS-145
AC   CVCL_5727
SY   CLS145
DR   CLS; 300180
DR   GEO; GSM552356
DR   Wikidata; Q54813666
CC   Population: Caucasian.
CC   Doubling time: 36 hours (CLS=300180).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): CLS=300180
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 30.2,32.2
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 12,13,14
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   CLS-354
AC   CVCL_5971
SY   XF354; XF 354
DR   BTO; BTO_0004443
DR   CLS; 300152
DR   Wikidata; Q54813667
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, mouth; UBERON=UBERON_0000165.
ST   Source(s): CLS=300152
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D18S51: 15
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 7,9
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 10,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   CLS-439
AC   CVCL_5982
SY   CLS439
DR   CLS; 300150
DR   Wikidata; Q54813668
RX   PubMed=28196595;
RX   PubMed=29732388;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): CLS=300150
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,13
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 7
ST   TPOX: 9,10
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   CLS-54
AC   CVCL_5728
DR   cancercelllines; CVCL_5728
DR   CLS; 300227
DR   GEO; GSM513974
DR   GEO; GSM514320
DR   Progenetix; CVCL_5728
DR   Wikidata; Q54813669
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=300227
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 11,17,18
ST   D21S11: 30,31.2
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 11
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 12,15
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   CLS-79
AC   CVCL_Z543
SY   CLS79
DR   ICLDB; cls-79
DR   Wikidata; Q54813670
RX   DOI=10.1007/BF02372123;
RX   Patent=US5266314;
RX   PubMed=10358729;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9373.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   CLS-79-C7
AC   CVCL_Z544
DR   ICLDB; cls-79-c7
DR   Wikidata; Q54813672
RX   Patent=US5145775;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2723.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
HI   CVCL_Z543 ! CLS-79
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   CLS-ACI-1
AC   CVCL_5729
SY   CLS-ACI-I
DR   CLS; 500459
DR   Wikidata; Q54813673
RX   PubMed=26536200;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   CLS-CD3575
AC   CVCL_5730
SY   CLS-CD-3575
DR   CLS; 400146
DR   Wikidata; Q54813674
CC   Characteristics: Tumorigenic in syngeneic mice (CLS=400146).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=400146
ST   Mouse STR 1-1: 14
ST   Mouse STR 1-2: 17,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 16,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 24
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   CLS1
AC   CVCL_C740
SY   AAUe001-A
DR   hPSCreg; AAUe001-A
DR   SKIP; SKIP001990
DR   Wikidata; Q54813675
RX   PubMed=16454946;
RX   PubMed=20177991;
CC   From: Aalborg University; Aalborg; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   CLS2
AC   CVCL_C741
SY   AAUe002-A
DR   hPSCreg; AAUe002-A
DR   SKIP; SKIP001991
DR   Wikidata; Q54813676
RX   PubMed=16454946;
RX   PubMed=20177991;
CC   From: Aalborg University; Aalborg; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   CLS3
AC   CVCL_C742
SY   AAUe003-A
DR   hPSCreg; AAUe003-A
DR   SKIP; SKIP001992
DR   Wikidata; Q54813677
RX   PubMed=16454946;
RX   PubMed=20177991;
CC   From: Aalborg University; Aalborg; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   CLS4
AC   CVCL_C743
SY   AAUe004-A
DR   hPSCreg; AAUe004-A
DR   SKIP; SKIP001993
DR   Wikidata; Q54813678
RX   PubMed=16454946;
RX   PubMed=20177991;
CC   From: Aalborg University; Aalborg; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   CLT 15
AC   CVCL_J676
SY   CLT15
DR   Wikidata; Q54813679
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8250.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CLT 152
AC   CVCL_J677
SY   CLT152; SKI 294/CLT 152; SKI294/CLT152
DR   CLO; CLO_0002513
DR   ATCC; HB-8244
DR   Wikidata; Q54813680
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8244.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CLT 174
AC   CVCL_J678
SY   CLT174; T 174; T174
DR   ATCC; HB-8242
DR   Wikidata; Q54813681
RX   Patent=US4579827;
RX   Patent=US5168043;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8242.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CLT 218
AC   CVCL_J679
SY   CLT218; T 218; T218
DR   ATCC; HB-8249
DR   Wikidata; Q54813682
RX   Patent=US4579827;
RX   Patent=US5168043;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8249.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   CLT 307
AC   CVCL_J680
SY   CLT307
DR   ATCC; HB-8251
DR   Wikidata; Q54813683
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8251.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CLT 479
AC   CVCL_J681
SY   CLT479
DR   ATCC; HB-8241
DR   Wikidata; Q54813684
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8241.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CLT 85
AC   CVCL_J682
SY   CLT85; SKI 294/CLT 85; SKI294/CLT85
DR   CLO; CLO_0002514
DR   ATCC; HB-8240
DR   Wikidata; Q54813685
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8240.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   CLT 86
AC   CVCL_J683
SY   CLT86
DR   ATCC; HB-8252
DR   Wikidata; Q54813686
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8252.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   CLVIII-3A6-E3
AC   CVCL_U030
DR   ECACC; 08041720
DR   Wikidata; Q54813687
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   CLXXVI-3C11-F14
AC   CVCL_U048
SY   V-1; V1
DR   Wikidata; Q54813688
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania mexicana venezuelensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   CLY
AC   CVCL_IQ58
DR   Wikidata; Q54813689
RX   PubMed=17342324;
CC   Population: Chinese.
CC   Doubling time: ~29.5 hours (PubMed=17342324).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   CM
AC   CVCL_H246
DR   Cosmic; 1620108
DR   Cosmic; 2530676
DR   Wikidata; Q54813694
RX   CelloPub=CLPUB00031;
RX   PubMed=10194529;
RX   PubMed=17492774;
RX   PubMed=18384119;
RX   PubMed=22538498;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C95598; Pancreatic insulinoma
DI   ORDO; Orphanet_97279; Insulinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   CM-1 [Human ESC]
AC   CVCL_Y613
SY   CM1; CM 1
DR   Wikidata; Q54813695
RX   PubMed=20038950;
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   CM-1 [Human/mouse hybridoma]
AC   CVCL_XI18
SY   CM-I
DR   Wikidata; Q93455192
RX   Patent=WO2009104100A2;
RX   PubMed=12775891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2584.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CM-10
AC   CVCL_Y614
SY   CM10; CM 10
DR   Wikidata; Q54813696
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-11
AC   CVCL_Y615
SY   CM11; CM 11
DR   Wikidata; Q54813697
RX   PubMed=20038950;
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-12
AC   CVCL_Y616
SY   CM12; CM 12
DR   Wikidata; Q54813698
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-13
AC   CVCL_Y617
SY   CM13; CM 13
DR   Wikidata; Q54813699
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-14
AC   CVCL_Y618
SY   CM14; CM 14
DR   Wikidata; Q54813700
RX   PubMed=20038950;
RX   PubMed=21861759;
RX   PubMed=23954875;
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-16
AC   CVCL_Y619
SY   CM16; CM 16
DR   Wikidata; Q54813701
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-2 [Human ESC]
AC   CVCL_C716
SY   CM2; CM 2
DR   Wikidata; Q54813703
RX   PubMed=20038950;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CM-2 [Human leukemia]
AC   CVCL_N718
DR   Wikidata; Q54813704
RX   PubMed=7613515;
CC   Doubling time: 20 hours (PubMed=7613515).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CM-2 [Human/mouse hybridoma]
AC   CVCL_XI19
DR   Wikidata; Q93455242
RX   Patent=US7772372;
RX   Patent=WO2009104100A2;
RX   PubMed=12775891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2598.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CM-3 [Human ESC]
AC   CVCL_Y620
SY   CM3; CM 3
DR   Wikidata; Q54813705
RX   PubMed=21861759;
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-3 [Human leukemia]
AC   CVCL_N719
DR   Wikidata; Q54813706
RX   PubMed=7613515;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N718 ! CM-2 [Human leukemia]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CM-319
AC   CVCL_M022
SY   CM319
DR   Wikidata; Q54813707
RX   PubMed=12839683;
RX   PubMed=21253487;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (on the basis of the STR profile of PubMed=21253487). Originally thought to originate from a 42 year old male patient with chordoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00626.
CC   Population: African American.
CC   Doubling time: ~33 hours (PubMed=12839683).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=21253487
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   CM-4 [Human ESC]
AC   CVCL_Y621
SY   CM4; CM 4
DR   Wikidata; Q54813708
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-4 [Human leukemia]
AC   CVCL_N720
DR   Wikidata; Q54813709
RX   PubMed=7613515;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N718 ! CM-2 [Human leukemia]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CM-5 [Human ESC]
AC   CVCL_Y622
SY   CM5; CM 5
DR   Wikidata; Q54813710
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-5 [Human leukemia]
AC   CVCL_N721
DR   Wikidata; Q54813711
RX   PubMed=7613515;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N718 ! CM-2 [Human leukemia]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CM-6
AC   CVCL_C717
SY   CM6; CM 6
DR   Wikidata; Q54813712
RX   PubMed=20038950;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CM-7
AC   CVCL_C718
SY   CM7; CM 7
DR   Wikidata; Q54813713
RX   PubMed=20038950;
RX   PubMed=21861759;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CM-8
AC   CVCL_Y623
SY   CM8; CM 8
DR   Wikidata; Q54813714
RX   PubMed=20038950;
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-9
AC   CVCL_Y624
SY   CM9; CM 9
DR   Wikidata; Q54813715
RX   PubMed=23954875;
WW   Provider; Lurie Children's; -; https://web.archive.org/web/20170701111726/https://www.luriechildrens.org/en-us/research/facilities/Pages/ips-human-stem-cell.aspx
CC   From: Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   CM-AS16
AC   CVCL_VE09
DR   cancercelllines; CVCL_VE09
DR   Wikidata; Q54813716
RX   PubMed=29653142;
CC   Population: Chinese; Han.
CC   Doubling time: ~72 hours (PubMed=29653142).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=29653142).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857.
ST   Source(s): PubMed=29653142
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 15,16
ST   D19S433: 15,16.2
ST   D1S1656: 16,18.3
ST   D21S11: 28,31
ST   D2S1338: 19,24
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D6S1043: 18
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4550; Conjunctival melanoma
DI   ORDO; Orphanet_617910; Conjunctival malignant melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   CM-MC
AC   CVCL_WH42
SY   Cutaneous Mastocytoma-Mast Cells
DR   Wikidata; Q93455319
RX   PubMed=11490155;
CC   Doubling time: 52.2 +- 6.8 hours (PubMed=11490155).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: Shiba; VBO=VBO_0201220.
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   CM-S
AC   CVCL_F327
DR   Wikidata; Q54813717
RX   PubMed=2543775;
RX   PubMed=2993032;
RX   PubMed=3465677;
RX   PubMed=3971383;
RX   PubMed=6707103;
RX   PubMed=7105012;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   CM-S/Tum
AC   CVCL_3367
DR   CLDB; cl7205
DR   ICLC; HTL08001
DR   Wikidata; Q54813719
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ICLC=HTL08001
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F327 ! CM-S
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   CM-S/un
AC   CVCL_3366
DR   CLDB; cl7179
DR   ICLC; HTL06005
DR   Wikidata; Q54813720
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ICLC=HTL06005
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F327 ! CM-S
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   CM-SM
AC   CVCL_DE05
DR   Wikidata; Q54813718
RX   PubMed=6688425;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F327 ! CM-S
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CM0007
AC   CVCL_8U03
DR   ECACC; 94050303
DR   Wikidata; Q54813721
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,22q+ (ECACC=94050303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CM0035
AC   CVCL_8U04
DR   ECACC; 95102502
DR   Wikidata; Q54813722
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95102502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   CM0036
AC   CVCL_8U05
DR   ECACC; 95111406
DR   Wikidata; Q54813724
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(18)(q22.1) (ECACC=95111406).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95111406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M2W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   CM05287
AC   CVCL_B4ZP
DR   GEO; GSE135500
DR   Wikidata; Q110432724
RX   PubMed=25694335;
RX   PubMed=31582743;
CC   Karyotypic information: 60% trisomy 21, 40% normal karyotype (PubMed=25694335).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   CM1-1
AC   CVCL_2Z40
SY   CM1-1.2; WC00009
DR   CLO; CLO_0013437
DR   BioSamples; SAME17777
DR   Coriell; WC00009
DR   Wikidata; Q54813725
RX   PubMed=9712021;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00009; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 8
//
ID   CM1/33
AC   CVCL_B6DH
DR   Wikidata; Q111733125
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47) 41 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CM10
AC   CVCL_A9D0
SY   CM-10
DR   Wikidata; Q102113685
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a breast atypic adenocarcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CM11
AC   CVCL_A9D1
SY   CM-11
DR   Wikidata; Q102113686
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a breast polymorphic adenocarcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CM11/33
AC   CVCL_B6DK
DR   Wikidata; Q111733126
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CM16
AC   CVCL_A9D2
SY   CM-16
DR   Wikidata; Q102113687
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a breast adenocarcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CM19
AC   CVCL_A9D3
SY   CM-19
DR   Wikidata; Q102113689
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a breast adenocarcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CM2005.1
AC   CVCL_M592
SY   CM2005_1
DR   cancercelllines; CVCL_M592
DR   Cosmic; 2639620
DR   Wikidata; Q54813726
RX   PubMed=17947278;
RX   PubMed=25722211;
RX   PubMed=28903377;
CC   Characteristics: Highly pigmented.
CC   Doubling time: ~35 hours (PubMed=17947278).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25722211).
ST   Source(s): PubMed=25722211
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 16.2
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 12,14
ST   D8S1179: 14,15
ST   FGA: 20,23
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4550; Conjunctival melanoma
DI   ORDO; Orphanet_617910; Conjunctival malignant melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   CM23/24
AC   CVCL_B6DL
DR   Wikidata; Q111733127
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CM3
AC   CVCL_A9D4
SY   CM-3
DR   Wikidata; Q102113690
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a breast intracanacular adenocarcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CM3.B6
AC   CVCL_2404
DR   ECACC; 11060101
DR   Wikidata; Q54813727
RX   PubMed=7518528;
CC   Monoclonal antibody isotype: IgG1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=11060101
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2301 ! B12.F8
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   CM3/5/3
AC   CVCL_B6DI
DR   Wikidata; Q111733128
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CM421F
AC   CVCL_A8YL
DR   GEO; GSM4617888
DR   Wikidata; Q108820063
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   4Y9M
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   CM421F B-0-12 iPSC
AC   CVCL_A8YM
SY   CM421F_B0_12_iPS
DR   GEO; GSM4617887
DR   Wikidata; Q108820064
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8YL ! CM421F
SX   Female
AG   4Y9M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   CM467
AC   CVCL_B4UG
DR   PRIDE; PXD006939
DR   PRIDE; PXD012308
DR   Wikidata; Q110432725
RX   PubMed=28832583;
RX   PubMed=29242379;
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*01:01,24:02; B*13:02,39:06; C*06:02,12:03 (PubMed=28832583).
CC   HLA typing: DPA1*01:03; DPB1*02:01,23:01; DQA1*01:02,02:01; DQB1*02:02,05:02; DRB1*07:01,16:01; DRB4*01:03; DRB5*02:02 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   CM5
AC   CVCL_A9D5
SY   CM-5
DR   Wikidata; Q102113691
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a breast polymorphic adenocarcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CM5/57
AC   CVCL_B6DJ
DR   Wikidata; Q111733129
RX   PubMed=1369335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Chuzan virus (isolate K-47).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   CM7/1
AC   CVCL_D045
SY   CM7-1; Clone CM 7/1
DR   EFO; EFO_0002820
DR   Wikidata; Q54813728
RX   PubMed=14578102;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6412 ! J1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   CM8
AC   CVCL_A9D6
SY   CM-8
DR   Wikidata; Q102113692
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
CC   Donor information: Established from a patient suffering from a breast atypic adenocarcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CMA-01
AC   CVCL_M484
DR   GEO; GSM143348
DR   GEO; GSM290286
DR   Wikidata; Q54813729
RX   PubMed=16266902;
RX   PubMed=17171682;
RX   PubMed=18700954;
CC   Characteristics: Produces IgD lambda.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 90 hours (PubMed=16266902).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   CMA-02
AC   CVCL_M485
DR   GEO; GSM143342
DR   GEO; GSM290287
DR   Wikidata; Q54813730
RX   PubMed=16266902;
RX   PubMed=17171682;
RX   PubMed=18700954;
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 110 hours (PubMed=16266902).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   CMA-03
AC   CVCL_M486
SY   CMA03
DR   EFO; EFO_0006552
DR   Cosmic; 2391808
DR   GEO; GSM143344
DR   GEO; GSM290288
DR   GEO; GSM977751
DR   GEO; GSM977752
DR   GEO; GSM977753
DR   GEO; GSM977754
DR   GEO; GSM977755
DR   GEO; GSM977756
DR   Wikidata; Q54813731
RX   PubMed=16266902;
RX   PubMed=17171682;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=24327544;
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 80 hours (PubMed=16266902).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   CMA-03/06
AC   CVCL_2G61
SY   CMA-03_06; CMA03/06
DR   EFO; EFO_0006553
DR   Cosmic; 2391809
DR   GEO; GSM977757
DR   GEO; GSM977758
DR   GEO; GSM977759
DR   Wikidata; Q54813732
RX   PubMed=24327544;
CC   Characteristics: Compared to the parent cell line, not IL6 dependent.
CC   Doubling time: ~80 hours (PubMed=24327544).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M486 ! CMA-03
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   CmA40
AC   CVCL_L096
SY   CmA 40
DR   Wikidata; Q54813733
RX   Patent=US8232048;
RX   PubMed=21467761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11304.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   CMA400
AC   CVCL_E4RD
SY   200a; 9C5
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMA405
AC   CVCL_E4RE
SY   200Nb; 4A7
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4 (Note=Acetylated on p.Lys5 (H4K5ac)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMA408
AC   CVCL_E4RF
SY   200Nd; 72A9
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4 (Note=Acetylated on p.Lys8 (H4K8ac)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMA412
AC   CVCL_E4RG
SY   200Nf; 50B3
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4 (Note=Acetylated on p.Lys12 (H4K12ac)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMA416
AC   CVCL_E4RH
SY   200f; 1B2
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4 (Note=Acetylated on p.Lys16 (H4K16ac)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMA421
AC   CVCL_E4RI
SY   200b; 15F11
DR   ABCD; ABCD_AW291
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4 (Note=Mono-methylated on p.Lys20 (H4K20me1)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMA422
AC   CVCL_E4RJ
SY   200c; 2E2
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4 (Note=Bi-methylated on p.Lys20 (H4K20me2)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMA423
AC   CVCL_E4RK
SY   200d; 27F10
RX   PubMed=26343042;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P62805; Human histone H4 (Note=Tri-methylated on p.Lys20 (H4K20me3)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CMab-43
AC   CVCL_D2RX
DR   Wikidata; Q127380571
RX   PubMed=28910211;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O43490; Human PROM1/CD133.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CMAfin1
AC   CVCL_B5E7
DR   Wikidata; Q110432727
RX   PubMed=34822677;
RX   PubMed=36349563;
CC   Group: Fish cell line.
CC   Doubling time: 11.8 +- 1.61 days (Note=In 5% FBS), 6.3 +- 0.27 days (Note=In 10% FBS), 4.6 +- 0.19 days (Note=In 15% FBS), 4.1 +- 0.15 days (Note=In 20% FBS) (PubMed=36349563).
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=674131; ! Coregonus maraena (Maraena whitefish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   CMBS-PB
AC   CVCL_S716
SY   Cell and Molecular Biology Section-PancreatoBlastoma
DR   SKY/M-FISH/CGH; 2750
DR   Wikidata; Q54813734
RX   PubMed=15721631;
CC   Population: African American.
CC   Misspelling: CMBS-BS; Note=In Cellosaurus releases 8 to 45.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C4265; Pancreatoblastoma
DI   ORDO; Orphanet_677; Pancreatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   CMC-hiPSC-001
AC   CVCL_WR24
DR   Wikidata; Q93455392
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*44:03; C*14:03; DPA1*01:03; DPB1*02:01,04:01; DQA1*01:01,01:02; DQB1*06:04; DRB1*13:02 (PubMed=28941241).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   CMC-hiPSC-002
AC   CVCL_WR25
DR   Wikidata; Q93455393
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*44:03; C*07:06; DPA1*02:01; DPB1*13:01; DQA1*02:01; DQB1*02:02; DRB1*07:01 (PubMed=28941241).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CMC-hiPSC-003
AC   CVCL_WR10
SY   KSCBi005-A
DR   BioSamples; SAMEA5713550
DR   GEO; GSM4972448
DR   hPSCreg; KSCBi005-A
DR   Wikidata; Q93455395
RX   PubMed=28941241;
RX   PubMed=33714852;
RX   PubMed=38636267;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*44:03; C*14:03; DPA1*01:03; DPB1*02:02,04:01; DQA1*01:01,01:02; DQB1*06:04; DRB1*13:02 (PubMed=28941241).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
ST   Source(s): PubMed=38636267
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9,14
ST   D18S51: 11,14
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 17,18
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   CMC-hiPSC-004
AC   CVCL_WR26
DR   Wikidata; Q93455397
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*44:03; C*07:06; DPA1*02:02; DPB1*02:01,13:01; DQA1*02:01; DQB1*02:02; DRB1*07:01 (PubMed=28941241).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CMC-hiPSC-005
AC   CVCL_WR27
SY   KSCBi0016-A; KSCBi021-A
DR   GEO; GSM4972449
DR   hPSCreg; KSCBi021-A
DR   Wikidata; Q93455399
RX   PubMed=28941241;
RX   PubMed=33714852;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*58:01; C*03:02; DPA1*01:03; DPB1*02:01,05:01; DQA1*02:01,01:02; DQB1*06:09; DRB1*13:02 (PubMed=28941241).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   CMC-hiPSC-006
AC   CVCL_WR28
DR   Wikidata; Q93455400
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*44:03; C*07:06; DPA1*01:03; DPB1*04:01,13:01; DQA1*01:01,01:02; DQB1*02:02; DRB1*13:02 (PubMed=28941241).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CMC-hiPSC-007
AC   CVCL_WR29
DR   Wikidata; Q93455402
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*02:01; B*48:01; C*14:54; DPA1*01:03; DPB1*02:01; DQA1*01:01,01:02; DQB1*05:02,05:03; DRB1*14:54 (PubMed=28941241).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CMC-hiPSC-008
AC   CVCL_WR30
DR   Wikidata; Q93455403
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*44:03; C*14:03; DPA1*01:03; DPB1*04:01,13:01; DQA1*01:01,01:02; DQB1*06:04; DRB1*13:02 (PubMed=28941241).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CMC-hiPSC-009
AC   CVCL_WR31
SY   KSCBi0017-A; KSCBi019-A
DR   GEO; GSM4972450
DR   hPSCreg; KSCBi019-A
DR   Wikidata; Q93455404
RX   PubMed=28941241;
RX   PubMed=33714852;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*24:02; B*07:02; C*07:02; DPA1*01:03; DPB1*04:02; DQA1*03:01; DQB1*05:01; DRB1*01:01 (PubMed=28941241).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   CMC-hiPSC-010
AC   CVCL_WR32
DR   Wikidata; Q93455405
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*02:01; B*51:01; C*14:02; DPA1*02:02; DPB1*03:01,04:02; DQA1*01:01,01:02; DQB1*03:02; DRB1*04:03 (PubMed=28941241).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   CMC-hiPSC-011
AC   CVCL_WR33
SY   KSCBi0018-A; KSCBi018-A
DR   GEO; GSM4972451
DR   hPSCreg; KSCBi018-A
DR   Wikidata; Q93455406
RX   PubMed=28941241;
RX   PubMed=33714852;
RX   PubMed=35917600;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*11:01; B*15:01; C*04:01; DPA1*01:03,02:01; DPB1*02:01; DQA1*01:01,01:02; DQB1*03:02; DRB1*04:06 (PubMed=28941241).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   CMC-hiPSC-012
AC   CVCL_WR34
DR   Wikidata; Q93455407
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*58:01; C*03:02; DPA1*01:03; DPB1*05:01; DQA1*03:01; DQB1*06:09; DRB1*13:02 (PubMed=28941241).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CMC-hiPSC-013
AC   CVCL_WR35
DR   Wikidata; Q93455408
RX   PubMed=28941241;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   HLA typing: A*33:03; B*58:01; C*03:02; DPA1*01:03; DPB1*02:01,04:02; DQA1*01:01,01:02; DQB1*06:09; DRB1*13:02 (PubMed=28941241).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   CMC-hiPSC-022
AC   CVCL_A7LB
SY   KSCBi0019-A; KSCBi020-A
DR   GEO; GSM4972457
DR   hPSCreg; KSCBi020-A
DR   Wikidata; Q107114692
RX   PubMed=33714852;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CMC-iPS-C1
AC   CVCL_UG73
SY   CMC-iPS-C1P20
DR   GEO; GSM807106
DR   Wikidata; Q93455410
RX   PubMed=20036631;
RX   PubMed=21949351;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta, chorion; UBERON=UBERON_0003124.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG75 ! CMC-iPS-C9
OI   CVCL_UG74 ! CMC-iPS-C28
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   CMC-iPS-C28
AC   CVCL_UG74
SY   CMC-iPS-C28P20
DR   GEO; GSM807105
DR   Wikidata; Q93455411
RX   PubMed=20036631;
RX   PubMed=21949351;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta, chorion; UBERON=UBERON_0003124.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG73 ! CMC-iPS-C1
OI   CVCL_UG75 ! CMC-iPS-C9
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   CMC-iPS-C9
AC   CVCL_UG75
DR   Wikidata; Q93455412
RX   PubMed=20036631;
CC   Derived from site: In situ; Placenta, chorion; UBERON=UBERON_0003124.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG73 ! CMC-iPS-C1
OI   CVCL_UG74 ! CMC-iPS-C28
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   CMCi001-A
AC   CVCL_ZX45
SY   CMC-KIN-hiPSCs; KMC-KIN-hiPSCs; KMC-KIN-hiPSC
DR   BioSamples; SAMEA7807652
DR   hPSCreg; CMCi001-A
DR   SKIP; SKIP005764
DR   Wikidata; Q102113693
RX   PubMed=32563974;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:29170; FAN1; Simple; p.Gly663Ilefs*54 (c.1985_1994del10); Zygosity=Homozygous (PubMed=32563974).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173626; Karyomegalic interstitial nephritis
DI   ORDO; Orphanet_401996; Karyomegalic interstitial nephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   CMCi002-A
AC   CVCL_A2GD
SY   CMC-GIT-001
DR   BioSamples; SAMEA7807653
DR   hPSCreg; CMCi002-A
DR   Wikidata; Q105506635
RX   PubMed=33370877;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:10912; SLC12A3; Simple; p.Cys16Glnfs*13 (c.46_47delTG); ClinVar=VCV001459093; Zygosity=Heterozygous (PubMed=33370877).
CC   Sequence variation: Mutation; HGNC; HGNC:10912; SLC12A3; Simple; p.Ile988Thr (c.2963T>C) (p.Ile979Thr, c.2936T>C); Zygosity=Heterozygous (PubMed=33370877).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84730; Gitelman syndrome
DI   ORDO; Orphanet_358; Gitelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMCi003-A
AC   CVCL_A4ER
SY   CMC-T1DM-i001; T1D-iPSC
DR   hPSCreg; CMCi003-A
DR   Wikidata; Q105506637
RX   PubMed=32882526;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   CMCi004-A
AC   CVCL_A4ES
SY   CMC-T2DM-i001; T2D-iPSC
DR   hPSCreg; CMCi004-A
DR   Wikidata; Q105506642
RX   PubMed=32882526;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   CMCi005-A
AC   CVCL_A4ET
SY   CMC-Normal-i001; ND-iPSC
DR   hPSCreg; CMCi005-A
DR   Wikidata; Q105506647
RX   PubMed=32882526;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   CMCi006-A
AC   CVCL_A4EQ
SY   CMC-Fb-001; CMC-Fb-001-hiPSCs; Fb1-hiPSC
DR   BioSamples; SAMEA7807666
DR   hPSCreg; CMCi006-A
DR   Wikidata; Q105506649
RX   PubMed=33545641;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Leu324Trpfs*24 (c.969delC); ClinVar=VCV001050825; Zygosity=Hemizygous (PubMed=33545641).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   CMCi006-A-1
AC   CVCL_C3QY
SY   CMC-Fb001(A4GALT-KO)
DR   BioSamples; SAMEA111327964
DR   hPSCreg; CMCi006-A-1
DR   Wikidata; Q116048774
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18149; A4GALT.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Leu324Trpfs*24 (c.969delC); ClinVar=VCV001050825; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4EQ ! CMCi006-A
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CMCi007-A
AC   CVCL_A4EP
SY   CMC-Fb-004; CMC-Fb-004-hiPSCs; Fb4-hiPSC
DR   BioSamples; SAMEA7807667
DR   hPSCreg; CMCi007-A
DR   Wikidata; Q105506651
RX   PubMed=33545641;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Leu324Trpfs*24 (c.969delC); ClinVar=VCV001050825; Zygosity=Heterozygous (PubMed=33545641).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   CMCi008-A
AC   CVCL_A4EU
DR   hPSCreg; CMCi008-A
DR   Wikidata; Q105506656
CC   From: The Catholic University of Korea; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   CMCi009-A
AC   CVCL_A4EN
SY   CMCi009; CMC-BHD-001
DR   BioSamples; SAMEA7807657
DR   hPSCreg; CMCi009-A
DR   Wikidata; Q105506659
RX   PubMed=33540282;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.His429Thrfs*39 (c.1285delC); ClinVar=VCV000003364; Zygosity=Heterozygous (PubMed=33540282).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C28244; Birt-Hogg-Dube syndrome
DI   ORDO; Orphanet_122; Birt-Hogg-Dube syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMCi010-A
AC   CVCL_A4EV
SY   CMC-Fb-002
DR   BioSamples; SAMEA7807674
DR   hPSCreg; CMCi010-A
DR   Wikidata; Q105506664
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   CMCi011-A
AC   CVCL_D0D4
SY   CMC-DENT-001
DR   BioSamples; SAMEA112370824
DR   hPSCreg; CMCi011-A
DR   Wikidata; Q123030942
RX   PubMed=37356184;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2023; CLCN5; Simple; c.1347+1G>A; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=37356184).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123260; Dent disease
DI   ORDO; Orphanet_93622; Dent disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CMCSCC-1
AC   CVCL_0I25
DR   Wikidata; Q54813735
RX   PubMed=25784373;
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=25784373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CMD004AN
AC   CVCL_G710
DR   IPD-IMGT/HLA; 10424
DR   Wikidata; Q54813745
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:03 (IPD-IMGT/HLA=10424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   CMDi001-A
AC   CVCL_D0DG
SY   01016
DR   BioSamples; SAMEA112655517
DR   hPSCreg; CMDi001-A
DR   Wikidata; Q123030943
RX   PubMed=30405424;
WW   Provider; Fujifilm CDI; -; https://www.fujifilmcdi.com/mycell-cardiomyocytes-dcm-lmna-l35p-01016-gcmcl35p01016
CC   From: CureCMD; Lakewood; USA.
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Leu35Pro (c.104T>C); ClinVar=VCV000066765; Zygosity=Unspecified (PubMed=30405424).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CMDi002-A
AC   CVCL_D0DH
SY   01173
DR   BioSamples; SAMEA112655519
DR   hPSCreg; CMDi002-A
DR   Wikidata; Q123030944
RX   PubMed=30405424;
CC   From: CureCMD; Lakewood; USA.
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Lys32del (c.94_96delAAG); ClinVar=VCV000066960; Zygosity=Unspecified (PubMed=30405424).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CMDi003-A
AC   CVCL_D0DI
SY   01174
DR   BioSamples; SAMEA112655521
DR   hPSCreg; CMDi003-A
DR   Wikidata; Q123030945
CC   From: CureCMD; Lakewood; USA.
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CMDi004-A
AC   CVCL_D0DJ
SY   01175
DR   BioSamples; SAMEA112655523
DR   hPSCreg; CMDi004-A
DR   Wikidata; Q123030946
CC   From: CureCMD; Lakewood; USA.
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CMDi005-A
AC   CVCL_D0DK
SY   01176
DR   BioSamples; SAMEA112655525
DR   hPSCreg; CMDi005-A
DR   Wikidata; Q123030947
CC   From: CureCMD; Lakewood; USA.
CC   From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CMDCl12
AC   CVCL_6B25
DR   Wikidata; Q54813746
RX   PubMed=22040608;
CC   Sequence variation: Mutation; HGNC; HGNC:17089; SYNE1; Simple; c.2345G>T; Zygosity=Unspecified (PubMed=22040608).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, paravertebral; UBERON=UBERON_0002462.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C84910; Muscular dystrophy
DI   ORDO; Orphanet_261; Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   16Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   CME L1
AC   CVCL_Z786
SY   CME-L1; L1
DR   EFO; EFO_0005650
DR   DGRC; 156
DR   ENCODE; ENCBS089KAQ
DR   FlyBase_Cell_line; FBtc0000156
DR   GEO; GSE16270
DR   Wikidata; Q54813747
RX   CelloPub=CLPUB00762;
RX   DOI=10.1242/dev.102.4.805;
RX   PubMed=1905427;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 47 hours (DGRC=156).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, prothoracic leg; UBERON=UBERON_6001781.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   CME L1A
AC   CVCL_Z787
SY   CME-L1A; L1A; L1 A; CME L1 clone Astrew
DR   DGRC; 158
DR   FlyBase_Cell_line; FBtc0000158
DR   Wikidata; Q54813748
RX   CelloPub=CLPUB00762;
RX   PubMed=28305676;
RX   PubMed=28306001;
CC   Group: Insect cell line.
CC   Doubling time: 38 hours (DGRC=158).
CC   Anecdotal: The clone was named after a field on David John Peel father's farm on the Isle of Wight (CelloPub=CLPUB00762).
CC   Derived from site: In situ; Imaginal disc, prothoracic leg; UBERON=UBERON_6001781.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z786 ! CME L1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 13
//
ID   CME L1P
AC   CVCL_D5CV
SY   CME-L1P; L1P; L1 P; CME L1 clone Prussacks
DR   Wikidata; Q127380572
RX   CelloPub=CLPUB00762;
RX   PubMed=28305676;
CC   Group: Insect cell line.
CC   Anecdotal: The clone was named after a field on David John Peel father's farm on the Isle of Wight (CelloPub=CLPUB00762).
CC   Derived from site: In situ; Imaginal disc, prothoracic leg; UBERON=UBERON_6001781.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z786 ! CME L1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 3
//
ID   CME L2
AC   CVCL_Z788
SY   CME-L2; L2
DR   DGRC; 157
DR   FlyBase_Cell_line; FBtc0000157
DR   Wikidata; Q54813749
RX   DOI=10.1242/dev.102.4.805;
RX   PubMed=1905427;
CC   Group: Insect cell line.
CC   Doubling time: 57 hours (DGRC=157).
CC   Derived from site: In situ; Imaginal disc, prothoracic leg; UBERON=UBERON_6001781.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 11
//
ID   CME W1
AC   CVCL_Z789
SY   CME-W1; W1
DR   DGRC; 180
DR   FlyBase_Cell_line; FBtc0000180
DR   Wikidata; Q54813750
RX   CelloPub=CLPUB00762;
RX   DOI=10.1242/dev.102.4.805;
RX   PubMed=1905427;
RX   PubMed=28305676;
RX   PubMed=28306001;
CC   Group: Insect cell line.
CC   Doubling time: 57 hours (DGRC=180).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   CME W1 cl.13
AC   CVCL_D5CR
SY   CME W1 clone 13
DR   Wikidata; Q127380573
RX   CelloPub=CLPUB00762;
RX   PubMed=28305676;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z789 ! CME W1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CME W1 cl.7
AC   CVCL_D5CS
SY   CME W1 clone 7
DR   Wikidata; Q127380574
RX   CelloPub=CLPUB00762;
RX   PubMed=28305676;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z789 ! CME W1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CME W1 cl.8+
AC   CVCL_Z790
SY   CME-W1-Cl.8+; CME W1 clone 8; CME Cl.8+; Cl8+; C1.8+; Clone 8
DR   EFO; EFO_0005743
DR   DGRC; 151
DR   ENCODE; ENCBS075HTX
DR   ENCODE; ENCBS115NHU
DR   ENCODE; ENCBS172BFS
DR   ENCODE; ENCBS244JXW
DR   ENCODE; ENCBS337HVD
DR   ENCODE; ENCBS371JYE
DR   ENCODE; ENCBS378YVD
DR   ENCODE; ENCBS554CPV
DR   ENCODE; ENCBS648NZI
DR   ENCODE; ENCBS668VWE
DR   ENCODE; ENCBS674BMY
DR   ENCODE; ENCBS945PPB
DR   FlyBase_Cell_line; FBtc0000151
DR   GEO; GSE28136
DR   Wikidata; Q54813751
RX   CelloPub=CLPUB00762;
RX   PubMed=9467932;
RX   PubMed=17890361;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
RX   PubMed=28305676;
RX   PubMed=28306001;
WW   Info; -; -; https://palivec.entu.cas.cz/zurovec/eng/research/cultures.html
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Characteristics: 20-hydroxyecdysone (20-HE) susceptible (CelloPub=CLPUB00762).
CC   Doubling time: 46 hours (DGRC=151).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z789 ! CME W1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   CME W1 Cl.8R
AC   CVCL_Z892
SY   CME-W1-Cl.8R; Cl.8R; C1.8R
DR   DGRC; 162
DR   FlyBase_Cell_line; FBtc0000162
DR   Wikidata; Q54813752
RX   CelloPub=CLPUB00762;
RX   PubMed=28306001;
CC   Group: Insect cell line.
CC   Characteristics: 20-hydroxyecdysone (20-HE) resistant (CelloPub=CLPUB00762; PubMed=28306001).
CC   Doubling time: 41 hours (DGRC=162).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z790 ! CME W1 cl.8+
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 11
//
ID   CME W1 cl.9
AC   CVCL_D5CT
SY   CME W1 clone 9
DR   Wikidata; Q127380575
RX   CelloPub=CLPUB00762;
RX   PubMed=28305676;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z789 ! CME W1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CME W1 cl.C9
AC   CVCL_D5CU
SY   CME W1 clone C9
DR   Wikidata; Q127380576
RX   CelloPub=CLPUB00762;
RX   PubMed=28305676;
RX   PubMed=28306001;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z789 ! CME W1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CME W2
AC   CVCL_Z791
SY   CME-W2; W2
DR   EFO; EFO_0005744
DR   DGRC; 155
DR   ENCODE; ENCBS996YBY
DR   FlyBase_Cell_line; FBtc0000155
DR   GEO; GSE37440
DR   Wikidata; Q54813753
RX   CelloPub=CLPUB00762;
RX   DOI=10.1242/dev.102.4.805;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
RX   PubMed=28306001;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 55 hours (DGRC=155).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   CME-1
AC   CVCL_N586
SY   CME1; CME
DR   BTO; BTO_0006385
DR   Cell_Model_Passport; SIDM01489
DR   Cosmic; 2307727
DR   DepMap; ACH-001322
DR   Wikidata; Q54813754
RX   PubMed=7736791;
RX   PubMed=24726063;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (PubMed=7736791; DepMap=ACH-001322).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   CMeC-1
AC   CVCL_L326
SY   CMeC1; C1
DR   Wikidata; Q54813755
RX   PubMed=15585963;
RX   PubMed=28283079;
CC   Doubling time: 37.7 +- 3.44 hours (PubMed=15585963).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Chow; VBO=VBO_0200361.
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   CMeC-2
AC   CVCL_L327
SY   CMeC2; C2
DR   Wikidata; Q54813756
RX   PubMed=15585963;
RX   PubMed=28283079;
CC   Characteristics: Established from lung metastatic lesion obtained after subcutaneous injection of the parent cell line in nude mice (PubMed=15585963).
CC   Doubling time: 57.9 +- 3.28 hours (PubMed=15585963).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Chow; VBO=VBO_0200361.
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L326 ! CMeC-1
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   CMEC-4
AC   CVCL_XH94
SY   Cow Mammary Epithelial Cell line-4
DR   Wikidata; Q93455440
RX   Patent=CN104928250B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.8707.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Chinese Holstein; VBO=VBO_0003142.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   CMEC-UCONN
AC   CVCL_HL94
SY   CMEC; Caprine Mammary Epithelial Cells-University of CONNecticut
DR   Wikidata; Q54813757
RX   PubMed=10451220;
RX   PubMed=10691038;
CC   Doubling time: 28 hours (PubMed=10691038).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Anglo-Nubian; VBO=VBO_0000722.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 8
//
ID   CMEE-1
AC   CVCL_D791
SY   Chinchilla Middle Ear Epithelial cell line-1
DR   Wikidata; Q54813759
RX   PubMed=10526847;
RX   PubMed=12382283;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10152; ! Chinchilla chinchilla (Short-tailed chinchilla)
SX   Male
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   CMel 136
AC   CVCL_U910
DR   Wikidata; Q54813760
RX   PubMed=3485457;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   CMES20
AC   CVCL_B948
SY   CMESC 20; No20_ES; Common Marmoset Embryonic Stem cell 20
DR   GEO; GSM4610406
DR   SKIP; SKIP001420
DR   Wikidata; Q54813761
RX   PubMed=16109758;
RX   PubMed=31178141;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   CMES30
AC   CVCL_B947
SY   CMESC 30; Common Marmoset Embryonic Stem cell 30
DR   SKIP; SKIP001421
DR   Wikidata; Q54813762
RX   PubMed=16109758;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   CMES40
AC   CVCL_B946
SY   CMESC 40; No40_ES; Common Marmoset Embryonic Stem cell 40
DR   GEO; GSM4610404
DR   RCB; AES0053
DR   RCB; AES0166
DR   RCB; RCB2294
DR   SKIP; SKIP001419
DR   Wikidata; Q54813763
RX   PubMed=16109758;
RX   PubMed=21126169;
RX   PubMed=31178141;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Incorrectly indicated as male in RCB=AES0166.
CC   Discontinued: RCB; AES0053; probable.
CC   Discontinued: RCB; RCB2294; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   CMES40-OC
AC   CVCL_A7IS
DR   Wikidata; Q107114693
RX   PubMed=33799281;
CC   Group: Non-human primate cell line.
CC   Characteristics: Using CRISPR/Cas9 a P2A-mCerulean3-T2A-PuroR construct was knocked in at the c-terminus of one allele of POU5F1/OCT4 (PubMed=33799281).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; TWJXO; mCerulean3 (Note=Bright cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_B946 ! CMES40
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   cmESF-iPS-C4
AC   CVCL_F0RR
RX   PubMed=40789250;
CC   Group: Non-human primate cell line.
CC   From: National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology; Cheongju; South Korea.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   cmESF-iPS-C5
AC   CVCL_C6U1
DR   Wikidata; Q117704260
RX   PubMed=36403550;
CC   Group: Non-human primate cell line.
CC   From: National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology; Cheongju; South Korea.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 3
//
ID   CMG-1
AC   CVCL_A2FX
DR   Wikidata; Q105506666
RX   PubMed=32921644;
CC   Doubling time: 11.8 +- 1.2 hours (PubMed=32921644).
CC   Derived from site: In situ; Eye lid, sebaceous gland; UBERON=UBERON_0013231.
DI   NCIt; C176701; Canine sebaceous gland epithelioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   CMG14-12
AC   CVCL_A9A2
SY   CMG 14-12
DR   RCB; RCB5036
DR   Wikidata; Q102113695
RX   PubMed=10934646;
WW   Info; RCB; -; https://cell.brc.riken.jp/en/wp-content/uploads/pdf/Prep._of_CMG_sup_Rev2%20_20200305.pdf
CC   Characteristics: Expression of the Csf1 gene is driven by the chicken beta-actin promoter and the human cytomegalovirus enhancer (PubMed=10934646).
CC   Doubling time: 20 hours (RCB=RCB5036).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1339753; Csf1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   CMGANTi002-A
AC   CVCL_D0QV
DR   BioSamples; SAMEA14291308
DR   hPSCreg; CMGANTi002-A
DR   Wikidata; Q123030948
CC   From: Center of Medical Genetics Antwerp; Antwerp; Belgium.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CMGANTi003-A
AC   CVCL_C1SW
SY   SEMD1
DR   BioSamples; SAMEA14369850
DR   hPSCreg; CMGANTi003-A
DR   Wikidata; Q114310968
RX   PubMed=36640472;
CC   From: Center of Medical Genetics Antwerp; Antwerp; Belgium.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1044; BGN; Simple; p.Gly259Val (c.776G>T); ClinVar=VCV000243091; Zygosity=Hemizygous (PubMed=36640472).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188996; X-linked spondyloepimetaphyseal dysplasia
DI   ORDO; Orphanet_93349; X-linked spondyloepimetaphyseal dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   CMGANTi004-A
AC   CVCL_C1SX
SY   SEMD2
DR   BioSamples; SAMEA14370027
DR   hPSCreg; CMGANTi004-A
DR   Wikidata; Q114310969
RX   PubMed=36640472;
CC   From: Center of Medical Genetics Antwerp; Antwerp; Belgium.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1044; BGN; Simple; p.Gly259Val (c.776G>T); ClinVar=VCV000243091; Zygosity=Hemizygous (PubMed=36640472).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188996; X-linked spondyloepimetaphyseal dysplasia
DI   ORDO; Orphanet_93349; X-linked spondyloepimetaphyseal dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   CMGANTi005-A
AC   CVCL_D0QU
SY   iPSC_MFS_FBN1_MCE-KB_C8
DR   BioSamples; SAMEA112328776
DR   hPSCreg; CMGANTi005-A
DR   Wikidata; Q123030949
RX   PubMed=36708686;
CC   From: Center of Medical Genetics Antwerp; Antwerp; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Ile2585Thr (c.7754T>C); ClinVar=VCV000163462; Zygosity=Heterozygous (PubMed=36708686).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CMGANTi006-A
AC   CVCL_D0D5
SY   SEDC1
DR   BioSamples; SAMEA112249023
DR   hPSCreg; CMGANTi006-A
DR   Wikidata; Q123030951
RX   PubMed=36966641;
CC   From: Center of Medical Genetics Antwerp; Antwerp; Belgium.
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly1107Arg (c.3319G>A); ClinVar=VCV001067590; Zygosity=Heterozygous (PubMed=36966641).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135088; Spondyloperipheral dysplasia
DI   ORDO; Orphanet_1856; Spondyloperipheral dysplasia-short ulna syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CMGANTi007-A
AC   CVCL_D0D6
SY   SEDC2
DR   BioSamples; SAMEA112320817
DR   hPSCreg; CMGANTi007-A
DR   Wikidata; Q123030952
RX   PubMed=36966641;
CC   From: Center of Medical Genetics Antwerp; Antwerp; Belgium.
CC   Population: Caucasian; Belgian.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly408Asp (c.1223G>A); Zygosity=Heterozygous (PubMed=36966641).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135088; Spondyloperipheral dysplasia
DI   ORDO; Orphanet_1856; Spondyloperipheral dysplasia-short ulna syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CMGANTi008-A
AC   CVCL_D0D7
SY   iPSC_MFS_FBN1_Fi930129_C8
DR   BioSamples; SAMEA112366464
DR   hPSCreg; CMGANTi008-A
DR   Wikidata; Q123030953
RX   PubMed=36801568;
CC   From: Center of Medical Genetics Antwerp; Antwerp; Belgium.
CC   Population: Caucasian; Belgian.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1791Tyr (c.5372G>A); ClinVar=VCV000263568; Zygosity=Heterozygous (PubMed=36801568).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CMGD-2
AC   CVCL_0D66
SY   CMGD2
DR   Kerafast; EMN006-FP
DR   Wikidata; Q54813764
RX   PubMed=12944992;
CC   Doubling time: ~24-48 hours (Kerafast=EMN006-FP).
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 14
//
ID   CMGD-3
AC   CVCL_0D67
SY   CMG3
DR   Wikidata; Q54813765
RX   PubMed=12944992;
WW   Provider; UMN; -; https://web.archive.org/web/20100613061254/http://www.cvm.umn.edu/accr/research/modianolab/scientificresources/reagentsandscientificresources/home.html
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   CMGD-4
AC   CVCL_0D68
SY   CMGD4
DR   Wikidata; Q54813766
RX   PubMed=12944992;
WW   Provider; UMN; -; https://web.archive.org/web/20100613061254/http://www.cvm.umn.edu/accr/research/modianolab/scientificresources/reagentsandscientificresources/home.html
CC   Derived from site: In situ; Oral cavity, palate; UBERON=UBERON_0001716.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   CMGD-5
AC   CVCL_0D69
SY   CMGD5
DR   Kerafast; EMN007-FP
DR   Wikidata; Q54813767
RX   PubMed=12944992;
CC   Doubling time: 24-48 hours (Kerafast=EMN007-FP).
CC   Derived from site: In situ; Oral cavity, palate; UBERON=UBERON_0001716.
CC   Breed/subspecies: Miniature Poodle; VBO=VBO_0201051.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   CMgB-1
AC   CVCL_A2ZT
SY   Clarias Magur Barbel-1
DR   NRFC; NRFC067
DR   Wikidata; Q105506669
WW   Provider; NRFC; NRFC067; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC067.
CC   Derived from site: In situ; Barbel; UBERON=UBERON_2000622.
OX   NCBI_TaxID=1594786; ! Clarias magur (Asian catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   CMgM-1
AC   CVCL_A2ZS
SY   Clarias Magur Muscle-1
DR   NRFC; NRFC066
DR   Wikidata; Q105506672
WW   Provider; NRFC; NRFC066; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC066.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=1594786; ! Clarias magur (Asian catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   CMgT-1
AC   CVCL_A2ZR
SY   Clarias Magur Testis-1
DR   NRFC; NRFC062
DR   Wikidata; Q105506674
RX   DOI=10.1007/s13237-020-00345-w;
WW   Provider; NRFC; NRFC062; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC062.
CC   Doubling time: 51 hours (DOI=10.1007/s13237-020-00345-w).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=1594786; ! Clarias magur (Asian catfish)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   CMH1a
AC   CVCL_3501
DR   CLO; CLO_0002525
DR   ATCC; CRL-8399
DR   Wikidata; Q54813768
RX   Patent=US4696898;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8399.
CC   Characteristics: Produces HBsAg under the control of a metallothionei promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03139; Hepatitis B virus genotype D subtype adw (isolate United Kingdom/adyw/1979) envelope protein (HBsAg).
CC   Discontinued: ATCC; CRL-8399; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3882 ! C127I
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   CMI00339IN
AC   CVCL_E161
DR   Wikidata; Q54813769
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CMiPS #1
AC   CVCL_D3UT
DR   Wikidata; Q127380578
RX   PubMed=29742964;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
OI   CVCL_D3UU ! CMiPS #2
OI   CVCL_D3UV ! CMiPS #3
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CMiPS #2
AC   CVCL_D3UU
SY   #2 CMiPS
DR   Wikidata; Q127380579
RX   PubMed=29742964;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
OI   CVCL_D3UT ! CMiPS #1
OI   CVCL_D3UV ! CMiPS #3
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CMiPS #3
AC   CVCL_D3UV
DR   Wikidata; Q127380580
RX   PubMed=29742964;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
OI   CVCL_D3UT ! CMiPS #1
OI   CVCL_D3UU ! CMiPS #2
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CMK
AC   CVCL_0216
DR   BTO; BTO_0000978
DR   CLO; CLO_0002526
DR   EFO; EFO_0003037
DR   MCCL; MCC:0000105
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473574
DR   BioSample; SAMN10988101
DR   cancercelllines; CVCL_0216
DR   CCRID; 5301HUM-KCB17032YJ
DR   Cell_Model_Passport; SIDM00959
DR   ChEMBL-Cells; CHEMBL3308149
DR   ChEMBL-Targets; CHEMBL2366177
DR   Cosmic; 787423
DR   Cosmic; 910566
DR   Cosmic; 919131
DR   Cosmic; 975241
DR   Cosmic; 1012061
DR   Cosmic; 1070695
DR   Cosmic; 1176598
DR   Cosmic; 1191081
DR   Cosmic; 1191702
DR   Cosmic; 1281307
DR   Cosmic; 1286955
DR   Cosmic; 1315742
DR   Cosmic; 1524829
DR   Cosmic; 1559970
DR   Cosmic; 2089668
DR   Cosmic; 2131535
DR   Cosmic; 2306202
DR   Cosmic-CLP; 910566
DR   DepMap; ACH-000641
DR   DSMZ; ACC-392
DR   DSMZCellDive; ACC-392
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS071ENC
DR   GDSC; 910566
DR   GEO; GSM236781
DR   GEO; GSM236817
DR   GEO; GSM510583
DR   GEO; GSM886938
DR   GEO; GSM888005
DR   GEO; GSM1374449
DR   IARC_TP53; 21228
DR   KCB; KCB 2017032YJ
DR   LiGeA; CCLE_184
DR   LINCS_LDP; LCL-1051
DR   PharmacoDB; CMK_210_2019
DR   Progenetix; CVCL_0216
DR   PubChem_Cell_line; CVCL_0216
DR   TOKU-E; 4113
DR   Wikidata; Q54813770
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1571549;
RX   PubMed=1991165;
RX   PubMed=2217443;
RX   PubMed=2527057;
RX   PubMed=2665839;
RX   PubMed=8784480;
RX   PubMed=9510473;
RX   PubMed=9738977;
RX   PubMed=10674912;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23325432;
RX   PubMed=23955599;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=36982453;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/CMK_Stam_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~40 hours (PubMed=2527057); ~40-50 hours (DSMZ=ACC-392).
CC   HLA typing: A*02:01,24:02; B*15:18,40:02; C*08:01,08:01 (PubMed=26589293).
CC   HLA typing: A*02:01:01,24:02:01; B*15:18:01,40:02:01; C*03:04:01,08:01:01; DRA*01:01:01,01:01:01; DRB1*11:01:01,11:01:01 (DSMZCellDive=ACC-392).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:4024; FXR2 + HGNC; HGNC:11998; TP53; Name(s)=TP53-FXR2 (from child cell line CMK-86).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (Cosmic-CLP=910566; DepMap=ACH-000641).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.58%; Native American=0%; East Asian, North=93.95%; East Asian, South=3.14%; South Asian=0%; European, North=0%; European, South=2.33% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=910566; DSMZ=ACC-392
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 20,23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   CMK-11-5
AC   CVCL_0217
SY   CMK 11-5; CMK11-5; CMK115
DR   MCCL; MCC:0000106
DR   BioSample; SAMN10987844
DR   cancercelllines; CVCL_0217
DR   Cell_Model_Passport; SIDM01235
DR   DepMap; ACH-001036
DR   GEO; GSM886937
DR   GEO; GSM888003
DR   IARC_TP53; 28399
DR   JCRB; IFO50430
DR   PharmacoDB; CMK115_211_2019
DR   Progenetix; CVCL_0217
DR   Wikidata; Q54813771
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1391807;
RX   PubMed=1991165;
RX   PubMed=16778363;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32180119;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~2 days (Note=Lot 12122008), ~34 hours (Note=Lot 12082016) (JCRB=IFO50430).
CC   Sequence variation: Gene fusion; HGNC; HGNC:4024; FXR2 + HGNC; HGNC:11998; TP53; Name(s)=TP53-FXR2 (PubMed=16778363).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (PubMed=16778363).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.58%; Native American=0%; East Asian, North=95.47%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=3.94% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=IFO50430
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2804 ! CMK-86
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   CMK-6
AC   CVCL_RM24
SY   CMK6
DR   cancercelllines; CVCL_RM24
DR   Wikidata; Q54813773
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1991165;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:4024; FXR2 + HGNC; HGNC:11998; TP53; Name(s)=TP53-FXR2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0216 ! CMK
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   CMK-86
AC   CVCL_2804
SY   CMK86
DR   BTO; BTO_0004960
DR   cancercelllines; CVCL_2804
DR   Cell_Model_Passport; SIDM01940
DR   Cosmic; 2089670
DR   DepMap; ACH-001037
DR   GEO; GSM888004
DR   JCRB; IFO50428
DR   PharmacoDB; CMK86_212_2019
DR   Progenetix; CVCL_2804
DR   Wikidata; Q54813774
RX   PubMed=16778363;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:4024; FXR2 + HGNC; HGNC:11998; TP53; Name(s)=TP53-FXR2 (PubMed=16778363).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.34%; East Asian, North=91.48%; East Asian, South=8.18%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=IFO50428
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0216 ! CMK
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   CMK5
AC   CVCL_2U82
DR   Wikidata; Q54813775
RX   PubMed=11668604;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   CMK6
AC   CVCL_2U83
SY   CMK-6; CMK 6
DR   Wikidata; Q54813776
RX   PubMed=11668604;
RX   PubMed=16728281;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   CMK6G
AC   CVCL_E9XJ
RX   PubMed=16456125;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
HI   CVCL_2U83 ! CMK6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CMK7
AC   CVCL_2U84
DR   Wikidata; Q54813777
RX   PubMed=11668604;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   CMK9
AC   CVCL_2U85
DR   Wikidata; Q54813779
RX   PubMed=11668604;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   cmKF-iPS-C5
AC   CVCL_C1Y1
DR   Wikidata; Q114310970
RX   PubMed=35944314;
CC   Group: Non-human primate cell line.
CC   From: National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology; Cheongju; South Korea.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CML-1
AC   CVCL_0D19
SY   CML1
DR   Wikidata; Q54813780
RX   PubMed=3434911;
RX   PubMed=15965647;
RX   PubMed=22901430;
RX   PubMed=23410087;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: Toy Poodle; VBO=VBO_0201061.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_RW90 ! CML-1R
SX   Sex unspecified
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   CML-10
AC   CVCL_IZ11
SY   CML10
DR   Wikidata; Q54813782
RX   CelloPub=CLPUB00708;
RX   PubMed=15965647;
RX   PubMed=35053440;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   CML-10C2
AC   CVCL_0D25
SY   CML-10c2; CML_10C2; CML10C2
DR   GEO; GSM1974781
DR   Wikidata; Q54813783
RX   PubMed=21908323;
RX   PubMed=22901430;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 21 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Gly12Val (c.35G>T); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231
ST   Dog FHC2054: 156
ST   Dog FHC2079: 271,291
ST   Dog PEZ1: 123
ST   Dog PEZ3: 119
ST   Dog PEZ5: 115
ST   Dog PEZ6: 179,183
ST   Dog PEZ8: 228,240
ST   Dog PEZ12: 270,274
ST   Dog PEZ20: 176
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_IZ11 ! CML-10
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 19
//
ID   CML-10C7
AC   CVCL_C1GA
SY   CML-10c7
DR   Wikidata; Q114310971
RX   PubMed=1539903;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_IZ11 ! CML-10
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   CML-115
AC   CVCL_D5EA
DR   Wikidata; Q127380581
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CML-13
AC   CVCL_0D22
DR   Wikidata; Q54813785
RX   PubMed=11467477;
RX   PubMed=12944992;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CML-150
AC   CVCL_D5EB
DR   Wikidata; Q127380582
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CML-1R
AC   CVCL_RW90
DR   Wikidata; Q54813781
RX   PubMed=3434911;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: Toy Poodle; VBO=VBO_0201061.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_0D19 ! CML-1
SX   Sex unspecified
AG   10Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   CML-2
AC   CVCL_0D23
SY   CML2
DR   Wikidata; Q54813786
RX   PubMed=3434911;
RX   PubMed=8239507;
RX   PubMed=11467477;
RX   PubMed=12944992;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: Scottish Terrier; VBO=VBO_0201198.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_RW91 ! CML-2M
SX   Sex unspecified
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   CML-2M
AC   CVCL_RW91
DR   Wikidata; Q54813788
RX   PubMed=3434911;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Scottish Terrier; VBO=VBO_0201198.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_0D23 ! CML-2
SX   Sex unspecified
AG   11Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   CML-3
AC   CVCL_RW92
SY   CML3
DR   Wikidata; Q54813789
RX   PubMed=3434911;
RX   PubMed=8239507;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   14Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   CML-4
AC   CVCL_RW93
SY   CML4
DR   Wikidata; Q54813797
RX   PubMed=3434911;
RX   PubMed=8239507;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   13Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   CML-5
AC   CVCL_RW94
SY   CML5
DR   Wikidata; Q54813798
RX   PubMed=3434911;
RX   PubMed=8239507;
CC   Derived from site: In situ; Oral cavity, palate; UBERON=UBERON_0001716.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   1Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   CML-6M
AC   CVCL_0D24
SY   CML_6M; CML6M
DR   GEO; GSM1974782
DR   Wikidata; Q54813799
RX   PubMed=3434911;
RX   PubMed=8239507;
RX   PubMed=15965647;
RX   PubMed=21908323;
RX   PubMed=22901430;
RX   PubMed=23410087;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Characteristics: Pigmented.
CC   Doubling time: 15 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:43761; NF1; Simple; p.Pro1599fs (c.4795delCinsTT); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235,239
ST   Dog FHC2054: 151
ST   Dog FHC2079: 275
ST   Dog PEZ1: 119,127
ST   Dog PEZ3: 127,134
ST   Dog PEZ5: 103
ST   Dog PEZ6: 179
ST   Dog PEZ8: 236,240
ST   Dog PEZ12: 277,297
ST   Dog PEZ20: 172,180
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   CML-6MC2
AC   CVCL_IZ10
SY   CML-6M-C2; CML6MC-2
DR   Wikidata; Q54813800
RX   PubMed=8239507;
RX   PubMed=11467477;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0D24 ! CML-6M
SX   Sex unspecified
AG   8Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 6
//
ID   CML-75
AC   CVCL_D5EC
DR   Wikidata; Q127380583
RX   PubMed=6948897;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on leukemic blast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CML-C-1
AC   CVCL_X930
DR   Wikidata; Q54813801
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7540608;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Characteristics: Dependent on mouse bone marrow stromal cells for growth.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=7540608; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   CML-iPSCs Pt1-No.10
AC   CVCL_A3ZV
DR   SKIP; SKIP003241
DR   Wikidata; Q105506675
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.11
AC   CVCL_A3ZW
DR   SKIP; SKIP003242
DR   Wikidata; Q105506677
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.12
AC   CVCL_A3ZX
DR   SKIP; SKIP003243
DR   Wikidata; Q105506680
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.13
AC   CVCL_A3ZY
DR   SKIP; SKIP003244
DR   Wikidata; Q105506681
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.14
AC   CVCL_A3ZZ
DR   SKIP; SKIP003245
DR   Wikidata; Q105506685
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.3
AC   CVCL_A3ZN
SY   CML Pt 1 iPSCs Clone No.3
DR   SKIP; SKIP003148
DR   Wikidata; Q105506686
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.4
AC   CVCL_A3ZP
DR   SKIP; SKIP003236
DR   Wikidata; Q105506688
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.5
AC   CVCL_A3ZQ
DR   SKIP; SKIP003149
DR   Wikidata; Q105506689
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.6
AC   CVCL_A3ZR
DR   SKIP; SKIP003238
DR   Wikidata; Q105506691
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.7
AC   CVCL_A3ZS
DR   SKIP; SKIP003239
DR   Wikidata; Q105506693
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.8
AC   CVCL_A3ZT
DR   SKIP; SKIP003246
DR   Wikidata; Q105506694
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZU ! CML-iPSCs Pt1-No.9
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt1-No.9
AC   CVCL_A3ZU
DR   SKIP; SKIP003240
DR   Wikidata; Q105506696
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ZN ! CML-iPSCs Pt1-No.3
OI   CVCL_A3ZP ! CML-iPSCs Pt1-No.4
OI   CVCL_A3ZQ ! CML-iPSCs Pt1-No.5
OI   CVCL_A3ZR ! CML-iPSCs Pt1-No.6
OI   CVCL_A3ZS ! CML-iPSCs Pt1-No.7
OI   CVCL_A3ZT ! CML-iPSCs Pt1-No.8
OI   CVCL_A3ZV ! CML-iPSCs Pt1-No.10
OI   CVCL_A3ZW ! CML-iPSCs Pt1-No.11
OI   CVCL_A3ZX ! CML-iPSCs Pt1-No.12
OI   CVCL_A3ZY ! CML-iPSCs Pt1-No.13
OI   CVCL_A3ZZ ! CML-iPSCs Pt1-No.14
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt2-No.1
AC   CVCL_A4AA
DR   SKIP; SKIP003250
DR   Wikidata; Q105506697
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4AB ! CML-iPSCs Pt2-No.2
OI   CVCL_A4AC ! CML-iPSCs Pt2-No.3
OI   CVCL_A4AD ! CML-iPSCs Pt2-No.4
OI   CVCL_A4AE ! CML-iPSCs Pt2-No.6
OI   CVCL_A4AF ! CML-iPSCs Pt2-No.8
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt2-No.2
AC   CVCL_A4AB
DR   SKIP; SKIP003248
DR   Wikidata; Q105506698
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4AA ! CML-iPSCs Pt2-No.1
OI   CVCL_A4AC ! CML-iPSCs Pt2-No.3
OI   CVCL_A4AD ! CML-iPSCs Pt2-No.4
OI   CVCL_A4AE ! CML-iPSCs Pt2-No.6
OI   CVCL_A4AF ! CML-iPSCs Pt2-No.8
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt2-No.3
AC   CVCL_A4AC
DR   SKIP; SKIP003249
DR   Wikidata; Q105506699
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4AA ! CML-iPSCs Pt2-No.1
OI   CVCL_A4AB ! CML-iPSCs Pt2-No.2
OI   CVCL_A4AD ! CML-iPSCs Pt2-No.4
OI   CVCL_A4AE ! CML-iPSCs Pt2-No.6
OI   CVCL_A4AF ! CML-iPSCs Pt2-No.8
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt2-No.4
AC   CVCL_A4AD
SY   CML Pt 2 iPSCs Clone No.4
DR   SKIP; SKIP003247
DR   Wikidata; Q105506701
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4AA ! CML-iPSCs Pt2-No.1
OI   CVCL_A4AB ! CML-iPSCs Pt2-No.2
OI   CVCL_A4AC ! CML-iPSCs Pt2-No.3
OI   CVCL_A4AE ! CML-iPSCs Pt2-No.6
OI   CVCL_A4AF ! CML-iPSCs Pt2-No.8
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt2-No.6
AC   CVCL_A4AE
DR   SKIP; SKIP003155
DR   Wikidata; Q105506702
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4AA ! CML-iPSCs Pt2-No.1
OI   CVCL_A4AB ! CML-iPSCs Pt2-No.2
OI   CVCL_A4AC ! CML-iPSCs Pt2-No.3
OI   CVCL_A4AD ! CML-iPSCs Pt2-No.4
OI   CVCL_A4AF ! CML-iPSCs Pt2-No.8
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-iPSCs Pt2-No.8
AC   CVCL_A4AF
DR   SKIP; SKIP003251
DR   Wikidata; Q105506703
RX   PubMed=29429960;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29429960).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4AA ! CML-iPSCs Pt2-No.1
OI   CVCL_A4AB ! CML-iPSCs Pt2-No.2
OI   CVCL_A4AC ! CML-iPSCs Pt2-No.3
OI   CVCL_A4AD ! CML-iPSCs Pt2-No.4
OI   CVCL_A4AE ! CML-iPSCs Pt2-No.6
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CML-T1
AC   CVCL_1126
SY   CML T1; CMLT-1; CMLT1
DR   CLO; CLO_0002527
DR   EFO; EFO_0002134
DR   CLDB; cl815
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473449
DR   BioSample; SAMN10988485
DR   cancercelllines; CVCL_1126
DR   Cell_Model_Passport; SIDM00958
DR   Cosmic; 910951
DR   Cosmic; 913424
DR   Cosmic; 1012062
DR   Cosmic; 1026574
DR   Cosmic; 1151775
DR   Cosmic-CLP; 910951
DR   DepMap; ACH-000920
DR   DSMZ; ACC-7
DR   DSMZCellDive; ACC-7
DR   EGA; EGAS00001000978
DR   GDSC; 910951
DR   GEO; GSM886939
DR   GEO; GSM888006
DR   GEO; GSM1669682
DR   IARC_TP53; 21229
DR   IARC_TP53; 30192
DR   IGRhCellID; CMLT1
DR   LiGeA; CCLE_639
DR   PharmacoDB; CMLT1_213_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1126
DR   Wikidata; Q54813803
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2788468;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=16408098;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20809971;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~48-60 hours (DSMZ=ACC-7).
CC   HLA typing: A*26:01,26:01; B*40:06,46:01; C*01:02,03:04 (PubMed=26589293).
CC   HLA typing: A*26:01:01,26:01:01; B*40:06:01,46:01:01; C*01:02:01,03:04:01; DQB1*04:01:01,05:02:01 (DSMZCellDive=ACC-7).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=20809971; DepMap=ACH-000920).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr321fs*23 (c.963delA); Zygosity=Heterozygous (Cosmic-CLP=910951; DepMap=ACH-000920).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (DepMap=ACH-000920).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg290Cys (c.868C>T); ClinVar=VCV000216472; Zygosity=Heterozygous (DepMap=ACH-000920).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=71.95%; East Asian, South=26.83%; South Asian=0.3%; European, North=0%; European, South=0.92% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=910951; DSMZ=ACC-7
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13 (Cosmic-CLP=910951)
ST   D13S317: 10,13,14 (DSMZ=ACC-7)
ST   D16S539: 10,11 (Cosmic-CLP=910951)
ST   D16S539: 10,11,12 (DSMZ=ACC-7)
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 14,15,16
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 12,13
ST   Penta E: 15,16,23,24
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   CMM1
AC   CVCL_0C75
SY   CMM-1; Pu; Canine Malignant Melanoma 1
DR   Wikidata; Q54813804
RX   PubMed=11217070;
RX   PubMed=24035468;
RX   PubMed=27292541;
RX   PubMed=28283079;
CC   Doubling time: 18.4 +- 1.96 hours (PubMed=11217070).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Toy Poodle; VBO=VBO_0201061.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   CMM10
AC   CVCL_WH17
SY   Canine Malignant Melanoma 10
DR   Wikidata; Q93455629
RX   PubMed=28283079;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   CMM11
AC   CVCL_WH18
SY   Canine Malignant Melanoma 11
DR   Wikidata; Q93455631
RX   PubMed=28283079;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   CMM12
AC   CVCL_WH19
SY   Canine Malignant Melanoma 12
DR   Wikidata; Q93455634
RX   PubMed=28283079;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   CMM2
AC   CVCL_0C76
SY   CMM-2; Mi; Canine Malignant Melanoma 2
DR   Wikidata; Q54813806
RX   PubMed=11217070;
RX   PubMed=24035468;
RX   PubMed=27292541;
RX   PubMed=28283079;
CC   Doubling time: 21.0 +- 0.73 hours (PubMed=11217070).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   13Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   CMM7
AC   CVCL_WH20
SY   Canine Malignant Melanoma 7
DR   Wikidata; Q93455641
RX   PubMed=28283079;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   CMM8
AC   CVCL_WH21
SY   Canine Malignant Melanoma 8
DR   Wikidata; Q93455643
RX   PubMed=28283079;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   CMM9
AC   CVCL_WH22
SY   Canine Malignant Melanoma 9
DR   Wikidata; Q93455646
RX   PubMed=28283079;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   CMMT
AC   CVCL_3456
SY   Cocultivated Monkey Mammary Tumor
DR   CLO; CLO_0002528
DR   ATCC; CRL-6299
DR   Wikidata; Q54813807
RX   PubMed=7491763;
RX   PubMed=7635923;
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C134784; Rhesus monkey mammary tumor
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   CMMT 110/C1
AC   CVCL_U241
DR   ATCC; CRL-6300
DR   Wikidata; Q54813808
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Discontinued: ATCC; CRL-6300; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C134784; Rhesus monkey mammary tumor
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_3456 ! CMMT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   CMMT-CD4
AC   CVCL_E8AJ
RX   PubMed=7491763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C134784; Rhesus monkey mammary tumor
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_3456 ! CMMT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CMMT-CD4-LTR-beta-Gal
AC   CVCL_1H34
SY   Simian MAGI; sMAGI; Simian Multinuclear Activation of a Galactosidase Indicator
DR   BEI_Resources; ARP-2955
DR   Wikidata; Q54813809
RX   PubMed=7491763;
CC   Group: Non-human primate cell line.
CC   Characteristics: Transfected with a construct pEQ447 containing the HIV-1 LTR fused to a lacZ reporter gene that contains a MPKKKRK N-terminal sequence directing it to the nucleus (PubMed=7491763).
CC   Virology: Indicator cell line that allows rapid quantification of infectious SIV (PubMed=7491763).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C134784; Rhesus monkey mammary tumor
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_E8AJ ! CMMT-CD4
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 18
//
ID   CMMT/CD4
AC   CVCL_JQ46
DR   Wikidata; Q54813810
RX   PubMed=7635923;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C134784; Rhesus monkey mammary tumor
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_3456 ! CMMT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   CmOv-1
AC   CVCL_WK37
SY   CmC1
DR   Wikidata; Q93455683
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1303/aez.13.170;
RX   PubMed=5458787;
CC   Group: Insect cell line.
CC   Doubling time: ~30 hours (PubMed=5458787).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=233155; ! Culex pipiens molestus (London underground mosquito)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CMP [Cirrhinus]
AC   CVCL_A2ZP
SY   Cirrhinus Mrigala Peritoneal
DR   NRFC; NRFC056
DR   Wikidata; Q105745588
WW   Provider; NRFC; NRFC056; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC056.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
OX   NCBI_TaxID=683832; ! Cirrhinus mrigala (Mrigala)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   CMP [Human contaminated rectal cancer]
AC   CVCL_D297
DR   BioSample; SAMN03151674
DR   Wikidata; Q54813811
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928: PubMed=20143388). Originally thought to originate from a rectal adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00003.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   CMPII C2
AC   CVCL_L115
DR   BioSample; SAMN03151675
DR   Wikidata; Q54813812
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00038.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   CMR-01
AC   CVCL_WA61
SY   Carrier Mental Retardation-01
DR   IBRC; C10841
DR   Wikidata; Q93455700
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CMR-02
AC   CVCL_WA62
SY   Carrier Mental Retardation-02
DR   IBRC; C10844
DR   Wikidata; Q93455703
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CMR-03
AC   CVCL_WA63
SY   Carrier Mental Retardation-03
DR   IBRC; C10826
DR   Wikidata; Q93455705
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CMR-04
AC   CVCL_WA64
SY   Carrier Mental Retardation-04
DR   IBRC; C11148
DR   Wikidata; Q93455707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CMR-05
AC   CVCL_WA65
SY   Carrier Mental Retardation-05
DR   IBRC; C11156
DR   Wikidata; Q93455709
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CMR-06
AC   CVCL_WA66
SY   Carrier Mental Retardation-06
DR   IBRC; C11159
DR   Wikidata; Q93455712
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CMS
AC   CVCL_H248
DR   Cosmic; 996322
DR   Cosmic; 1037674
DR   Cosmic; 2089660
DR   DSMZ; ACC-985
DR   Wikidata; Q54813813
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10674912;
RX   PubMed=14504097;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Doubling time: 42 hours (DOI=10.1016/B978-0-12-221970-2.50457-5); ~48 hours (DSMZ=ACC-985).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-985
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 18,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 11,14
ST   FGA: 21,23
ST   Penta D: 9,10
ST   Penta E: 13,18
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,15
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   CMS-5
AC   CVCL_H247
SY   CMS 5; CMS5
DR   Wikidata; Q54813814
RX   PubMed=197192;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   CMS-C
AC   CVCL_L328
DR   Wikidata; Q54813815
RX   PubMed=21519159;
CC   Doubling time: 23 hours (PubMed=21519159).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C129300; Canine rhabdomyosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   CMT-1 [Chihuahua]
AC   CVCL_C7GG
DR   Wikidata; Q117704261
RX   PubMed=36717813;
CC   Doubling time: 26.67 hours (PubMed=36717813).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
CC   Breed/subspecies: Chihuahua; VBO=VBO_0200338.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   CMT-1 [Poodle]
AC   CVCL_X218
SY   CMT1; CMT-1p; Canine Mammary Tumor-1
DR   Wikidata; Q54813816
RX   CelloPub=CLPUB00711;
RX   PubMed=3462415;
RX   PubMed=8476218;
CC   Doubling time: ~30 hours (PubMed=3462415).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 12
//
ID   CMT-1 c1
AC   CVCL_C1GY
DR   Wikidata; Q114310972
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_X218 ! CMT-1 [Poodle]
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-1 c2
AC   CVCL_C1GZ
DR   Wikidata; Q114310973
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_X218 ! CMT-1 [Poodle]
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-1 c3
AC   CVCL_C1H0
SY   CMT-1c3
DR   Wikidata; Q114310974
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_X218 ! CMT-1 [Poodle]
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-1 c4
AC   CVCL_C1H1
SY   CMT-1c4
DR   Wikidata; Q114310975
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_X218 ! CMT-1 [Poodle]
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-1 c5
AC   CVCL_C1H2
SY   CMT-1c5
DR   Wikidata; Q114310976
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_X218 ! CMT-1 [Poodle]
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-1026
AC   CVCL_B3SL
SY   Canine Mammary Tumor-1026
DR   Wikidata; Q110432728
RX   PubMed=34712723;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Doubling time: 23.95 hours (PubMed=34712723).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Teddy Bear.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CMT-12CnB7-1R25
AC   CVCL_C1IG
SY   R25
DR   Wikidata; Q114310977
RX   PubMed=12529965;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:38975; Dog CD80.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   CMT-12CnB7-1R26
AC   CVCL_C1IH
SY   R26
DR   Wikidata; Q114310978
RX   PubMed=12529965;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:38975; Dog CD80.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   CMT-12CnB7-2Q2
AC   CVCL_C1II
SY   Q2
DR   Wikidata; Q114310980
RX   PubMed=12529965;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:38979; Dog CD86.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   CMT-12HuB7-2C10
AC   CVCL_C1IJ
SY   C10
DR   Wikidata; Q114310981
RX   PubMed=12529965;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1705; CD86.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   CMT-2 c1
AC   CVCL_C1H3
DR   Wikidata; Q114310982
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-2 c2
AC   CVCL_C1H4
DR   Wikidata; Q114310983
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-2 c3
AC   CVCL_C1H5
DR   Wikidata; Q114310984
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-2 c4
AC   CVCL_C1H6
SY   CMT-2c4
DR   Wikidata; Q114310985
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-2 c5
AC   CVCL_C1H7
DR   Wikidata; Q114310986
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-3
AC   CVCL_U520
SY   CMT3; Canine Mammary Tumor-3
DR   Wikidata; Q54813818
RX   CelloPub=CLPUB00711;
RX   PubMed=3462415;
CC   Doubling time: ~40 hours (PubMed=3462415).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 15
//
ID   CMT-4
AC   CVCL_U521
SY   CMT4; Canine Mammary Tumor-4
DR   Wikidata; Q54813819
RX   CelloPub=CLPUB00711;
RX   PubMed=3462415;
CC   Doubling time: ~30 hours (PubMed=3462415).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 14
//
ID   CMT-5
AC   CVCL_X220
SY   CMT5; Canine Mammary Tumor-5
DR   Wikidata; Q54813820
RX   CelloPub=CLPUB00711;
RX   PubMed=3462415;
CC   Doubling time: ~30 hours (PubMed=3462415).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 12
//
ID   CMT-6
AC   CVCL_X221
SY   CMT6; Canine Mammary Tumor-6
DR   Wikidata; Q54813821
RX   CelloPub=CLPUB00711;
RX   PubMed=3462415;
CC   Doubling time: ~24 hours (PubMed=3462415).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 13
//
ID   CMT-7
AC   CVCL_C1H8
SY   Canine Mammary Tumor-7
DR   Wikidata; Q114310987
RX   CelloPub=CLPUB00711;
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-7 c1
AC   CVCL_C1H9
DR   Wikidata; Q114310988
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C1H8 ! CMT-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-7 c2
AC   CVCL_C1HA
DR   Wikidata; Q114310989
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C1H8 ! CMT-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-7 c3
AC   CVCL_C1HB
DR   Wikidata; Q114310991
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C1H8 ! CMT-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-7 c4
AC   CVCL_C1HC
DR   Wikidata; Q114310993
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C1H8 ! CMT-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-7 c5
AC   CVCL_C1HD
SY   CMT-7c5
DR   Wikidata; Q114310994
RX   PubMed=8476218;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_C1H8 ! CMT-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CMT-7364
AC   CVCL_A8JR
SY   Canine Mammary Tumor-7364
DR   Wikidata; Q108820065
RX   PubMed=30309498;
RX   PubMed=37077947;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: Tumorigenic in nude mice (PubMed=30309498).
CC   Doubling time: 21.12 hours (PubMed=30309498).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 5
//
ID   CMT-7364/R
AC   CVCL_D2PT
DR   Wikidata; Q127380584
RX   PubMed=37077947;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Doubling time: 40.17 +- 0.37 hours (PubMed=37077947).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A8JR ! CMT-7364
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   CMT-7364/S
AC   CVCL_D2PU
DR   Wikidata; Q127380585
RX   PubMed=37077947;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: Control cell line for CMT-7364/R (Cellosaurus=CVCL_D2PT). Was passaged without doxorubicin.
CC   Doubling time: 32.23 +- 0.2773 hours (PubMed=37077947).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A8JR ! CMT-7364
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CMT-Star
AC   CVCL_B7H9
DR   GEO; GSM3153065
DR   GEO; GSM3153066
DR   GEO; GSM3153069
DR   GEO; GSM3153070
DR   GEO; GSM3153071
DR   GEO; GSM3153072
DR   GEO; GSM3153073
DR   GEO; GSM3153074
DR   Wikidata; Q112929389
RX   DOI=10.1080/09712119.2022.2032719;
CC   Doubling time: 24.4 +- 0.028 hours (DOI=10.1080/09712119.2022.2032719).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_B7H8 ! CMT-Stylo
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   CMT-Stylo
AC   CVCL_B7H8
DR   GEO; GSM3153063
DR   GEO; GSM3153064
DR   GEO; GSM3153067
DR   GEO; GSM3153068
DR   GEO; GSM3153075
DR   GEO; GSM3153076
DR   GEO; GSM3153077
DR   GEO; GSM3153078
DR   Wikidata; Q112929390
RX   DOI=10.1080/09712119.2022.2032719;
CC   Doubling time: 23.55 +- 1.8 hours (DOI=10.1080/09712119.2022.2032719).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   CMT-U111
AC   CVCL_L331
SY   Cell line 111
DR   Wikidata; Q54813823
RX   PubMed=1375928;
CC   Doubling time: ~12 hours (PubMed=1375928).
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 11
//
ID   CMT-U131
AC   CVCL_L332
SY   Cell line 131
DR   Wikidata; Q54813824
RX   PubMed=1375928;
CC   Doubling time: ~24 hours (PubMed=1375928).
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 11
//
ID   CMT-U155
AC   CVCL_L333
SY   Cell line 155
DR   Wikidata; Q54813825
RX   PubMed=1375928;
CC   Doubling time: ~36 hours (PubMed=1375928).
CC   Breed/subspecies: Borzoi; VBO=VBO_0200197.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 11
//
ID   CMT-U229
AC   CVCL_L334
SY   Cell line 229; #229; CMT3
DR   Wikidata; Q54813827
RX   PubMed=1375928;
RX   PubMed=9042250;
CC   Doubling time: ~24 hours (PubMed=1375928).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Cys163Phe (c.488G>T); Zygosity=Hemizygous (PubMed=9042250).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   CMT-U27
AC   CVCL_L335
SY   Cell line 27; #27; CMT5
DR   ATCC; CRL-3456
DR   GEO; GSM724825
DR   GEO; GSM724826
DR   GEO; GSM724833
DR   GEO; GSM724834
DR   GEO; GSM1075089
DR   GEO; GSM1075093
DR   GEO; GSM1075097
DR   GEO; GSM1290250
DR   GEO; GSM1290251
DR   GEO; GSM1889009
DR   GEO; GSM1889010
DR   Wikidata; Q54813828
RX   PubMed=1375928;
RX   PubMed=9042250;
RX   PubMed=19609018;
RX   PubMed=20453304;
RX   PubMed=22235976;
CC   Doubling time: ~48 hours (PubMed=1375928); 54.7 hours (PubMed=20453304).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   CMT-U304
AC   CVCL_J400
DR   Wikidata; Q54813829
RX   PubMed=10965996;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jamthund; VBO=VBO_0200733.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_J403 ! CMT-U335
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   CMT-U309
AC   CVCL_J401
SY   CMTU309
DR   GEO; GSM724831
DR   GEO; GSM724832
DR   GEO; GSM724839
DR   GEO; GSM724840
DR   GEO; GSM1075088
DR   GEO; GSM1075092
DR   GEO; GSM1075098
DR   GEO; GSM1290252
DR   GEO; GSM1290253
DR   Wikidata; Q54813831
RX   PubMed=10965996;
RX   PubMed=19609018;
RX   PubMed=20453304;
CC   Doubling time: 103.8 hours (PubMed=20453304).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Newfoundland; VBO=VBO_0200938.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   CMT-U334
AC   CVCL_J402
DR   Wikidata; Q54813832
RX   PubMed=10965996;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   CMT-U335
AC   CVCL_J403
SY   CMTU335
DR   Wikidata; Q54813833
RX   PubMed=10965996;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jamthund; VBO=VBO_0200733.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_J400 ! CMT-U304
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   CMT-W1
AC   CVCL_L336
DR   GEO; GSM724835
DR   GEO; GSM724836
DR   GEO; GSM724843
DR   GEO; GSM724844
DR   GEO; GSM1075091
DR   GEO; GSM1075095
DR   GEO; GSM1075100
DR   Wikidata; Q54813834
RX   PubMed=20145299;
RX   PubMed=20453304;
RX   PubMed=24116159;
RX   PubMed=24724465;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L337 ! CMT-W1M
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   CMT-W1M
AC   CVCL_L337
DR   Wikidata; Q54813835
RX   PubMed=20145299;
RX   PubMed=24116159;
RX   PubMed=24724465;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L336 ! CMT-W1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   CMT-W2
AC   CVCL_L338
DR   GEO; GSM724829
DR   GEO; GSM724830
DR   GEO; GSM724837
DR   GEO; GSM724838
DR   GEO; GSM1075101
DR   GEO; GSM1075102
DR   GEO; GSM1075103
DR   Wikidata; Q54813836
RX   PubMed=20145299;
RX   PubMed=20453304;
RX   PubMed=24116159;
RX   PubMed=24724465;
CC   Doubling time: 88.5 hours (PubMed=20453304).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L339 ! CMT-W2M
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   CMT-W2M
AC   CVCL_L339
DR   Wikidata; Q54813838
RX   PubMed=20145299;
RX   PubMed=24116159;
RX   PubMed=24724465;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L338 ! CMT-W2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   CMT1
AC   CVCL_F0RU
RX   PubMed=3018509;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pKMT11).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CMT12
AC   CVCL_L329
AS   CVCL_X219
SY   CMT-12; Canine Mammary Tumor 12; CMT-2; CMT2; Canine Mammary Tumor-2
DR   GEO; GSM1974783
DR   Wikidata; Q54813839
RX   CelloPub=CLPUB00711;
RX   DOI=10.4236/ojvm.2012.24045;
RX   PubMed=3462415;
RX   PubMed=8476218;
RX   PubMed=11848473;
RX   PubMed=12529965;
RX   PubMed=19130492;
RX   PubMed=21801068;
RX   PubMed=21908323;
RX   PubMed=23238983;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: ~24 hours (PubMed=3462415); 19 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:42490; KMT2C; Simple; p.Arg1201fs (c.3600delGinsAA); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Val132Glu (c.395T>A); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: CMT-2 was renamed CMT-12 (PubMed=11848473).
CC   Caution: On the basis of the STR profile CMT12 and CMT27 seem to originate from the same donor (PubMed=21908323; PubMed=27197945).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235
ST   Dog FHC2054: 151,176
ST   Dog FHC2079: 271
ST   Dog PEZ1: 115
ST   Dog PEZ3: 113,119
ST   Dog PEZ5: 103
ST   Dog PEZ6: 176
ST   Dog PEZ8: 233,244
ST   Dog PEZ12: 277
ST   Dog PEZ20: 176
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_1R41 ! CMT27
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 22
//
ID   CMT167
AC   CVCL_2405
SY   CMT-167; CMT 167
DR   BTO; BTO_0005821
DR   CancerTools; 151448
DR   ECACC; 10032302
DR   Wikidata; Q54813840
DR   Ximbio; 151448
RX   PubMed=6324836;
RX   PubMed=9347924;
RX   PubMed=19003861;
CC   Omics: Proteomics; 2DE-MS.
CC   Discontinued: ECACC; 10032302; true.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2406 ! CMT64
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   CMT170
AC   CVCL_B492
SY   CMT-170; CMT 170
DR   CancerTools; 153332
DR   Wikidata; Q54813841
DR   Ximbio; 153332
RX   PubMed=6324836;
RX   PubMed=9347924;
RX   PubMed=19003861;
CC   Omics: Proteomics; 2DE-MS.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2405 ! CMT167
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   CMT175
AC   CVCL_B493
SY   CMT-175; CMT 175
DR   Wikidata; Q54813842
RX   PubMed=6324836;
RX   PubMed=9347924;
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B492 ! CMT170
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   CMT181
AC   CVCL_B494
SY   CMT-181; CMT 181
DR   Wikidata; Q54813850
RX   PubMed=6324836;
RX   PubMed=9347924;
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B493 ! CMT175
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   CMT1A-1-hiPSCs 1
AC   CVCL_A4EY
DR   SKIP; SKIP003055
DR   Wikidata; Q105506706
RX   PubMed=29276154;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (PubMed=29276154).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4EZ ! CMT1A-1-hiPSCs 2
OI   CVCL_A4FA ! CMT1A-1-hiPSCs 3
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMT1A-1-hiPSCs 2
AC   CVCL_A4EZ
DR   SKIP; SKIP003056
DR   Wikidata; Q105506708
RX   PubMed=29276154;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (PubMed=29276154).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4EY ! CMT1A-1-hiPSCs 1
OI   CVCL_A4FA ! CMT1A-1-hiPSCs 3
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMT1A-1-hiPSCs 3
AC   CVCL_A4FA
DR   SKIP; SKIP003057
DR   Wikidata; Q105506710
RX   PubMed=29276154;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (PubMed=29276154).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4EY ! CMT1A-1-hiPSCs 1
OI   CVCL_A4EZ ! CMT1A-1-hiPSCs 2
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMT1A-2-hiPSCs 1
AC   CVCL_A4FB
DR   SKIP; SKIP003058
DR   Wikidata; Q105506711
RX   PubMed=29276154;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (PubMed=29276154).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4FC ! CMT1A-2-hiPSCs 2
OI   CVCL_A4FD ! CMT1A-2-hiPSCs 3
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMT1A-2-hiPSCs 2
AC   CVCL_A4FC
DR   SKIP; SKIP003059
DR   Wikidata; Q105506712
RX   PubMed=29276154;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (PubMed=29276154).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4FB ! CMT1A-2-hiPSCs 1
OI   CVCL_A4FD ! CMT1A-2-hiPSCs 3
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMT1A-2-hiPSCs 3
AC   CVCL_A4FD
DR   SKIP; SKIP003060
DR   Wikidata; Q105506714
RX   PubMed=29276154;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (PubMed=29276154).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4FB ! CMT1A-2-hiPSCs 1
OI   CVCL_A4FC ! CMT1A-2-hiPSCs 2
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CMT2-FiPS4F1
AC   CVCL_JL72
DR   Wikidata; Q54813851
RX   PubMed=28395795;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Solicitud_Deposito_CMT2_FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Facultad de Biologia, Universidad de Valencia; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:15968; GDAP1; Simple; p.Gln163Ter (c.487C>T); ClinVar=VCV000004193; Zygosity=Heterozygous (PubMed=28395795).
CC   Sequence variation: Mutation; HGNC; HGNC:15968; GDAP1; Simple; p.Thr288Asnfs*3 (c.862dupA); ClinVar=VCV000004194; Zygosity=Heterozygous (PubMed=28395795).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133886; Charcot-Marie-Tooth disease type 2K
DI   ORDO; Orphanet_99944; Autosomal dominant Charcot-Marie-Tooth disease type 2K
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 15
//
ID   CMT25
AC   CVCL_L330
SY   CMT-25; Canine Mammary Tumor 25
DR   Wikidata; Q54813852
RX   DOI=10.4236/ojvm.2012.24045;
RX   PubMed=21801068;
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   CMT27
AC   CVCL_1R41
SY   CMT-27; Canine Mammary Tumor 27
DR   GEO; GSM1974784
DR   Wikidata; Q54813853
RX   PubMed=19130492;
RX   PubMed=21908323;
RX   PubMed=23238983;
RX   PubMed=27197945;
RX   PubMed=27257868;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 18 hours (PubMed=27257868).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: On the basis of STR profile (PubMed=21908323; PubMed=27197945) CMT12 and CMT27 seem to originate from the same donor.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
ST   Source(s): PubMed=27197945
ST   Dog FHC2010: 235
ST   Dog FHC2054: 151
ST   Dog FHC2079: 271
ST   Dog PEZ1: 115
ST   Dog PEZ3: 113,119
ST   Dog PEZ5: 103
ST   Dog PEZ6: 176
ST   Dog PEZ8: 244,249
ST   Dog PEZ12: 277
ST   Dog PEZ20: 176
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L329 ! CMT12
SX   Female
AG   >10Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   CMT28
AC   CVCL_1R42
SY   Canine Mammary Tumor 28
DR   Wikidata; Q54813854
RX   PubMed=19130492;
RX   PubMed=23238983;
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   CMT3
AC   CVCL_VS65
SY   COS-CMT3
DR   Wikidata; Q93455773
RX   PubMed=3018509;
RX   PubMed=8543166;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pKMT11).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 6
//
ID   CMT4
AC   CVCL_F0RV
RX   PubMed=3018509;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pKMT11).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CMT64
AC   CVCL_2406
SY   CMT-64; CMT.64; CMT 64; C57 Mouse Tumor 64
DR   CancerTools; 151447
DR   ECACC; 10032301
DR   Wikidata; Q54813855
DR   Ximbio; 151447
RX   PubMed=1253168;
RX   PubMed=9347924;
RX   PubMed=19003861;
CC   Omics: Proteomics; 2DE-MS.
CC   Discontinued: ECACC; 10032301; true.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   CMT64/61
AC   CVCL_4146
DR   CLO; CLO_0002531
DR   CLDB; cl819
DR   CancerTools; 152751
DR   ECACC; 86082105
DR   Wikidata; Q54813856
DR   Ximbio; 152751
CC   Discontinued: ECACC; 86082105; true.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2406 ! CMT64
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   CMT7
AC   CVCL_JX29
DR   Wikidata; Q54813857
RX   PubMed=9042250;
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Gly233Ala (c.698G>C); Zygosity=Hemizygous (PubMed=9042250).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   CMT7364
AC   CVCL_JQ48
DR   Wikidata; Q54813858
RX   PubMed=28525328;
CC   Doubling time: 31.6 +- 0.6 hours (PubMed=28525328).
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   CMT7364/5-FU
AC   CVCL_JQ49
DR   Wikidata; Q54813859
RX   PubMed=28525328;
CC   Doubling time: 48.6 +- 0.3 hours (PubMed=28525328).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_JQ48 ! CMT7364
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 5
//
ID   CMT8
AC   CVCL_JX30
DR   Wikidata; Q54813860
RX   PubMed=9042250;
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Tyr224Asn (c.670T>A); Zygosity=Hemizygous (PubMed=9042250).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   CMT9
AC   CVCL_U522
DR   Wikidata; Q54813861
RX   PubMed=9042250;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   CMT93
AC   CVCL_1986
SY   CMT-93; CMT 93; C57 Mouse Tumor 93
DR   BTO; BTO_0003864
DR   CLO; CLO_0002530
DR   CLO; CLO_0002532
DR   CLDB; cl817
DR   CLDB; cl818
DR   AddexBio; C0009020/4925
DR   ATCC; CCL-223
DR   BioSample; SAMN11397626
DR   CancerTools; 152752
DR   ECACC; 89111413
DR   IZSLER; BS TCL 14
DR   KCLB; 10223
DR   Wikidata; Q54813862
DR   Ximbio; 152752
RX   DOI=10.21926/obm.genet.1803037;
RX   PubMed=722371;
RX   PubMed=31220119;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-434.html
CC   Transformant: ChEBI; CHEBI_82341; Methylazoxymethanol acetate (MAM acetate).
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 89111413; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
CC   Breed/subspecies: C57BL/ICRF.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 19,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 14,16,17
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 27
DI   NCIt; C134779; Mouse rectum carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   CMT93/69
AC   CVCL_4147
DR   BTO; BTO_0001361
DR   CLO; CLO_0002533
DR   CLDB; cl820
DR   CancerTools; 152753
DR   ECACC; 86082106
DR   Wikidata; Q54813863
DR   Ximbio; 152753
CC   Transformant: ChEBI; CHEBI_82341; Methylazoxymethanol acetate (MAM acetate).
CC   Discontinued: ECACC; 86082106; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
CC   Breed/subspecies: C57BL/ICRF.
DI   NCIt; C134779; Mouse rectum carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1986 ! CMT93
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   CMT93tk
AC   CVCL_S837
SY   CMT93-tk
DR   Wikidata; Q54813864
RX   PubMed=9813657;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: ChEBI; CHEBI_82341; Methylazoxymethanol acetate (MAM acetate).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
CC   Breed/subspecies: C57BL/ICRF.
DI   NCIt; C134779; Mouse rectum carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1986 ! CMT93
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   CMTI-1
AC   CVCL_GS41
SY   CMTI1; EmbryoMax 129/SVEV
DR   Millipore; CMTI-1
DR   Wikidata; Q54813865
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   CMUi001-A
AC   CVCL_WG49
SY   FBN1-E2130K-iPSC
DR   hPSCreg; CMUi001-A
DR   Wikidata; Q93455820
RX   PubMed=30870686;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu2130Lys (c.6388G>A); ClinVar=VCV000200191; Zygosity=Heterozygous (PubMed=30870686).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   CMUi002-A
AC   CVCL_YT01
DR   BioSamples; SAMEA6907388
DR   hPSCreg; CMUi002-A
DR   Wikidata; Q93455822
RX   PubMed=32717574;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Population: Chinese; Han.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA45 ! CMUi002-B
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   CMUi002-A-1
AC   CVCL_ZX41
SY   NONO-KO-iPSC
DR   BioSamples; SAMEA7258634
DR   hPSCreg; CMUi002-A-1
DR   Wikidata; Q102113697
RX   PubMed=32717574;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7871; NONO; Simple_edited; p.Glu234Argfs*31 (c.966insA); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=32717574).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YT01 ! CMUi002-A
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   CMUi002-B
AC   CVCL_ZA45
DR   hPSCreg; CMUi002-B
DR   Wikidata; Q98125684
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Population: Chinese; Han.
CC   Discontinued: hPSCreg; CMUi002-B; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT01 ! CMUi002-A
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CMV
AC   CVCL_A9D7
DR   Wikidata; Q102113698
RX   PubMed=2822736;
RX   PubMed=3374507;
CC   Donor information: Established from a patient suffering from a breast carcinoma.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   CMY
AC   CVCL_A602
DR   Cosmic; 787424
DR   Cosmic; 975242
DR   Cosmic; 996323
DR   Cosmic; 1012063
DR   Cosmic; 1037675
DR   Cosmic; 1191082
DR   Cosmic; 1281308
DR   Cosmic; 2089669
DR   DSMZ; ACC-986
DR   Wikidata; Q54813866
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9852262;
RX   PubMed=10674912;
RX   PubMed=14504097;
RX   PubMed=16408098;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Doubling time: ~46 hours (PubMed=9852262); ~48 hours (DSMZ=ACC-986).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Tyr3Ter (c.9C>G); Zygosity=Unspecified (PubMed=23955599).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-986
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 22,23
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 10,13
ST   Penta E: 5,16
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   CN patient 1 line 1
AC   CVCL_WV70
DR   Wikidata; Q93455831
RX   PubMed=20739751;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Tyr293Metfs*69 (c.877_890delTACATTAATGCTTCinsA) (p.Tyr292Metfs, c.874_887delTACATTAATGCTTCinsA) (879 del 13); ClinVar=VCV000012266; Zygosity=Homozygous (PubMed=20739751).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM09551, the patient description and its mutation description are identical.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AA80 ! GM09551
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   CN patient 1 line 2
AC   CVCL_WV71
DR   Wikidata; Q93455835
RX   PubMed=20739751;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Tyr293Metfs*69 (c.877_890delTACATTAATGCTTCinsA) (p.Tyr292Metfs, c.874_887delTACATTAATGCTTCinsA) (879 del 13); ClinVar=VCV000012266; Zygosity=Homozygous (PubMed=20739751).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM09551, the patient description and its mutation description are identical.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AA80 ! GM09551
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   CN patient 1 line 3
AC   CVCL_WV72
DR   Wikidata; Q93455838
RX   PubMed=20739751;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Tyr293Metfs*69 (c.877_890delTACATTAATGCTTCinsA) (p.Tyr292Metfs, c.874_887delTACATTAATGCTTCinsA) (879 del 13); ClinVar=VCV000012266; Zygosity=Homozygous (PubMed=20739751).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM09551, the patient description and its mutation description are identical.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AA80 ! GM09551
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   CN-Mel
AC   CVCL_7037
SY   CNMel
DR   cancercelllines; CVCL_7037
DR   Cosmic; 1109804
DR   Cosmic; 1295332
DR   GEO; GSM276749
DR   Wikidata; Q54813867
RX   PubMed=11121133;
RX   PubMed=11851879;
RX   PubMed=18384130;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Microsatellite instability: Stable (MSS) (PubMed=11851879).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   CN1.4
AC   CVCL_B396
DR   BTO; BTO_0002514
DR   Wikidata; Q54813868
RX   PubMed=9819136;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Conditionally immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   CN46
AC   CVCL_JG58
DR   JCRB; JCRB1723
DR   Wikidata; Q54813869
RX   PubMed=6272292;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Unexplicit; Ex16-18del (nsv1067857); ClinVar=VCV000003711; Zygosity=Heterozygous (PubMed=6272292).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1723
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   CN96
AC   CVCL_5937
DR   CLO; CLO_0002536
DR   CLDB; cl821
DR   Wikidata; Q54813870
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   CNDT2
AC   CVCL_L293
DR   BioSample; SAMN03152007
DR   Wikidata; Q54813871
RX   PubMed=17699847;
RX   PubMed=20959409;
RX   PubMed=22538498;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Possibly misidentified: Not certain if this a midgut carcinoid cell line (PubMed=20959409).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00384.
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   CNDT2.5
AC   CVCL_L294
DR   GEO; GSM600366
DR   GEO; GSM600367
DR   GEO; GSM600368
DR   GEO; GSM600369
DR   GEO; GSM830109
DR   GEO; GSM830110
DR   Wikidata; Q54813872
RX   PubMed=17699847;
RX   PubMed=20959409;
RX   PubMed=23119007;
CC   Problematic cell line: Possibly misidentified: Not certain if this a midgut carcinoid cell line (PubMed=20959409).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L293 ! CNDT2
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   CNE 19
AC   CVCL_A2XG
DR   Wikidata; Q105506715
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   CNE-1
AC   CVCL_6888
AS   CVCL_6887
SY   CNE1; CNE
DR   BTO; BTO_0006074
DR   BioSample; SAMN06481108
DR   cancercelllines; CVCL_6888
DR   CCTCC; GDC0208
DR   ChEMBL-Cells; CHEMBL3308055
DR   ChEMBL-Targets; CHEMBL613824
DR   Cosmic; 755504
DR   Cosmic; 923773
DR   Cosmic; 944909
DR   Cosmic; 1193457
DR   Cosmic; 1322946
DR   Cosmic; 2366879
DR   GEO; GSM375845
DR   Progenetix; CVCL_6888
DR   PubChem_Cell_line; CVCL_6888
DR   TOKU-E; 3588
DR   Ubigene; YC-C062
DR   Wikidata; Q54813873
RX   PubMed=206962;
RX   PubMed=1813165;
RX   PubMed=7129938;
RX   PubMed=12645650;
RX   PubMed=18196576;
RX   PubMed=24991015;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-2 and seems to be a hybrid of HeLa and of cell line of unknown origin. This is also confirmed by RNASeq data from PubMed=24991015. Originally thought to originate from a 58 year old female patient with a nasopharyngeal carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00473.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=18196576
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,16
ST   FGA: 18,21
ST   TH01: 6,7,9
ST   TPOX: 8,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   CNE-2
AC   CVCL_6889
SY   CNE2
DR   BTO; BTO_0005250
DR   BioSample; SAMN06481109
DR   cancercelllines; CVCL_6889
DR   CCTCC; GDC0155
DR   ChEMBL-Cells; CHEMBL4295476
DR   ChEMBL-Targets; CHEMBL4296409
DR   Cosmic; 755505
DR   Cosmic; 923774
DR   Cosmic; 944910
DR   Cosmic; 1017619
DR   Cosmic; 1300999
DR   Cosmic; 1322947
DR   Cosmic; 2366880
DR   GEO; GSM375846
DR   Progenetix; CVCL_6889
DR   PubChem_Cell_line; CVCL_6889
DR   Wikidata; Q54813874
RX   CelloPub=CLPUB00143;
RX   CelloPub=CLPUB00484;
RX   PubMed=6852976;
RX   PubMed=17062557;
RX   PubMed=18196576;
RX   PubMed=20406978;
RX   PubMed=24991015;
RX   PubMed=25028967;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of the STR profile (PubMed=18196576) it is identical to CNE-1 and seems to be a hybrid of HeLa and of cell line of unknown origin. Originally thought to originate from a 68 year old male patient with a nasopharyngeal carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00474.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=18196576
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,17
ST   FGA: 18,21
ST   TH01: 6,7,9
ST   TPOX: 8,9,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   CNE-2Z
AC   CVCL_6890
SY   CNE-2z; CNE2Z
DR   ChEMBL-Cells; CHEMBL4632321
DR   ChEMBL-Targets; CHEMBL4632328
DR   PubChem_Cell_line; CVCL_6890
DR   Wikidata; Q54813875
RX   PubMed=1813165;
CC   Problematic cell line: Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000151). It was the sole source for the STR profile of this entry.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10,11
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,17
ST   FGA: 18,21
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6889 ! CNE-2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   CNE-3
AC   CVCL_M598
DR   Wikidata; Q54813876
RX   PubMed=1400565;
CC   Population: Chinese.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   CNE/LULS44
AC   CVCL_ZU87
DR   Wikidata; Q98125685
RX   PubMed=32486323;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=144565; ! Culicoides nubeculosus (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   CNE/LULS47
AC   CVCL_ZU88
DR   Wikidata; Q98125686
RX   PubMed=32486323;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=144565; ! Culicoides nubeculosus (Biting midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   CNE1 SRPK1 KO
AC   CVCL_YT53
SY   SRPK1 KO NPC
DR   Wikidata; Q93455913
RX   PubMed=32671994;
CC   Problematic cell line: Contaminated. The parent cell line (CNE-1) seems to be a hybrid of HeLa and of cell line of unknown origin.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6888 ! CNE-1
CA   Hybrid cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   CNE1 SRPK1/2 KO
AC   CVCL_YT55
SY   SRPK1/2 KO NPC
DR   Wikidata; Q93455916
RX   PubMed=32671994;
CC   Problematic cell line: Contaminated. The grand-parent cell line (CNE-1) seems to be a hybrid of HeLa and of cell line of unknown origin.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11306; SRPK2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YT54 ! CNE1 SRPK2 KO
CA   Hybrid cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   CNE1 SRPK2 KO
AC   CVCL_YT54
SY   SRPK2 KO NPC
DR   Wikidata; Q93455920
RX   PubMed=32671994;
CC   Problematic cell line: Contaminated. The parent cell line (CNE-1) seems to be a hybrid of HeLa and of cell line of unknown origin.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11306; SRPK2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6888 ! CNE-1
CA   Hybrid cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   CNE2-IR
AC   CVCL_C9B8
SY   CNE2IR
DR   BioGRID_ORCS_Cell_line; 1630
DR   Wikidata; Q123030954
RX   PubMed=20406978;
CC   Problematic cell line: Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.
CC   Characteristics: Radiaresistant (PubMed=20406978).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Omics: Phenotyping; CRISPR screening.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6889 ! CNE-2
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   cNF00.10a
AC   CVCL_B9UZ
DR   Wikidata; Q112929391
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   cNF04.9a
AC   CVCL_B9VB
DR   Wikidata; Q112929392
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   cNF97.2a
AC   CVCL_B9V1
DR   Wikidata; Q112929393
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B9V2 ! cNF97.2b
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   cNF97.2b
AC   CVCL_B9V2
DR   Wikidata; Q112929395
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B9V1 ! cNF97.2a
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   cNF98.4c
AC   CVCL_B9V5
DR   Wikidata; Q112929397
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B9V6 ! cNF98.4d
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   cNF98.4d
AC   CVCL_B9V6
DR   Wikidata; Q112929400
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B9V5 ! cNF98.4c
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   CNGBCCAC00007
AC   CVCL_YT61
DR   Wikidata; Q93455923
RX   PubMed=31898011;
CC   Doubling time: 21.28 hours (PubMed=31898011).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9886; ! Muntiacus reevesi (Reeves' muntjac)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   CnGSC
AC   CVCL_C5TS
SY   Coilia nasus Gonadal Somatic Cell line
DR   Wikidata; Q116048775
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=365059; ! Coilia nasus (Japanese grenadier anchovy)
SX   Sex unspecified
AG   1Y6M
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CNh
AC   CVCL_9W60
SY   CNH
DR   Wikidata; Q54813877
RX   Patent=US8337829;
RX   PubMed=10203336;
RX   PubMed=22203612;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-16D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   CNIO AA
AC   CVCL_UT97
SY   CNIO-AA
DR   cancercelllines; CVCL_UT97
DR   IARC_TP53; 24520
DR   Wikidata; Q93455932
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 36 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=16888811).
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO AB
AC   CVCL_UU15
DR   Wikidata; Q93455934
RX   CelloPub=CLPUB00464;
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AC
AC   CVCL_UU16
DR   Wikidata; Q93455937
RX   CelloPub=CLPUB00464;
DI   NCIt; C2929; Squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AD
AC   CVCL_UU17
DR   Wikidata; Q93455940
RX   CelloPub=CLPUB00464;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AE
AC   CVCL_UU18
DR   Wikidata; Q93455942
RX   CelloPub=CLPUB00464;
DI   NCIt; C156757; Parathyroid gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO AF
AC   CVCL_UU19
DR   Wikidata; Q93455946
RX   CelloPub=CLPUB00464;
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AG
AC   CVCL_UU20
DR   Wikidata; Q93455949
RX   CelloPub=CLPUB00464;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AH
AC   CVCL_UU21
DR   Wikidata; Q93455952
RX   CelloPub=CLPUB00464;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AI
AC   CVCL_UU22
DR   Wikidata; Q93455955
RX   CelloPub=CLPUB00464;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO AJ
AC   CVCL_UU23
DR   Wikidata; Q93455957
RX   CelloPub=CLPUB00464;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AK
AC   CVCL_UU24
DR   Wikidata; Q93455959
RX   CelloPub=CLPUB00464;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AL
AC   CVCL_UU25
DR   Wikidata; Q93455963
RX   CelloPub=CLPUB00464;
DI   NCIt; C2929; Squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AM
AC   CVCL_UU26
DR   Wikidata; Q93455965
RX   CelloPub=CLPUB00464;
DI   NCIt; C4815; Thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO AN
AC   CVCL_UU27
DR   Wikidata; Q93455968
RX   CelloPub=CLPUB00464;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AO
AC   CVCL_UU28
DR   Wikidata; Q93455970
RX   CelloPub=CLPUB00464;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AP
AC   CVCL_UU29
DR   Wikidata; Q93455973
RX   CelloPub=CLPUB00464;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AQ
AC   CVCL_UU30
DR   Wikidata; Q93455976
RX   CelloPub=CLPUB00464;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AR
AC   CVCL_UU31
DR   Wikidata; Q93455978
RX   CelloPub=CLPUB00464;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AS
AC   CVCL_UU32
DR   Wikidata; Q93455981
RX   CelloPub=CLPUB00464;
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AT
AC   CVCL_UU33
DR   Wikidata; Q93455983
RX   CelloPub=CLPUB00464;
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AU
AC   CVCL_UU34
DR   Wikidata; Q93455986
RX   CelloPub=CLPUB00464;
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AV
AC   CVCL_UU35
DR   Wikidata; Q93455989
RX   CelloPub=CLPUB00464;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO AW
AC   CVCL_UT98
DR   cancercelllines; CVCL_UT98
DR   IARC_TP53; 24515
DR   Wikidata; Q93455992
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 48 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=16888811).
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT99 ! CNIO AX
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO AX
AC   CVCL_UT99
DR   cancercelllines; CVCL_UT99
DR   IARC_TP53; 24516
DR   Wikidata; Q93455995
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 48 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=16888811).
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT98 ! CNIO AW
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO AY
AC   CVCL_UU00
DR   IARC_TP53; 24526
DR   Wikidata; Q93455997
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 48 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO AZ
AC   CVCL_UU01
DR   Wikidata; Q93456000
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 96 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C7075; Fibroblastic neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   CNIO BA
AC   CVCL_UU36
DR   Wikidata; Q93456003
RX   CelloPub=CLPUB00464;
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO BB
AC   CVCL_UU02
DR   IARC_TP53; 24528
DR   Wikidata; Q93456005
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 72 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO BC
AC   CVCL_UU03
DR   IARC_TP53; 24527
DR   Wikidata; Q93456008
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 96 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO BD
AC   CVCL_UU37
DR   Wikidata; Q93456011
RX   CelloPub=CLPUB00464;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO BE
AC   CVCL_UU38
DR   Wikidata; Q93456013
RX   CelloPub=CLPUB00464;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   CNIO BF
AC   CVCL_UU04
DR   cancercelllines; CVCL_UU04
DR   IARC_TP53; 24521
DR   Wikidata; Q93456016
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 24 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=16888811).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   CNIO BG
AC   CVCL_UU05
DR   IARC_TP53; 24523
DR   Wikidata; Q93456023
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 24 hours (PubMed=16888811).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=16888811).
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO BH
AC   CVCL_UU39
DR   Wikidata; Q93456026
RX   CelloPub=CLPUB00464;
DI   NCIt; C3088; Angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO BI
AC   CVCL_UU06
DR   cancercelllines; CVCL_UU06
DR   IARC_TP53; 24524
DR   Wikidata; Q93456029
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 24 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=16888811).
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO BJ
AC   CVCL_UU07
DR   IARC_TP53; 24529
DR   Wikidata; Q93456032
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 96 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   CNIO BK
AC   CVCL_UU08
DR   IARC_TP53; 24525
DR   Wikidata; Q93456035
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
CC   Doubling time: 96 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO BL
AC   CVCL_UU40
DR   Wikidata; Q93456037
RX   CelloPub=CLPUB00464;
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO BM
AC   CVCL_UU09
DR   IARC_TP53; 24530
DR   Wikidata; Q93456040
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 96 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C3702; Hibernoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   CNIO BN
AC   CVCL_UU10
DR   IARC_TP53; 24531
DR   Wikidata; Q93456042
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 72 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO BO
AC   CVCL_UU41
DR   Wikidata; Q93456045
RX   CelloPub=CLPUB00464;
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO BP
AC   CVCL_UU11
DR   cancercelllines; CVCL_UU11
DR   IARC_TP53; 24522
DR   Wikidata; Q93456048
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 48 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=16888811).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   CNIO BQ
AC   CVCL_UU42
DR   Wikidata; Q93456051
RX   CelloPub=CLPUB00464;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO BR
AC   CVCL_UU43
DR   Wikidata; Q93456054
RX   CelloPub=CLPUB00464;
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO BT
AC   CVCL_UU44
DR   Wikidata; Q93456057
RX   CelloPub=CLPUB00464;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO BU
AC   CVCL_UU45
DR   Wikidata; Q93456059
RX   CelloPub=CLPUB00464;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO BV
AC   CVCL_UU46
DR   Wikidata; Q93456062
RX   CelloPub=CLPUB00464;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO BW
AC   CVCL_UU47
DR   Wikidata; Q93456064
RX   CelloPub=CLPUB00464;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO BX
AC   CVCL_UU48
DR   Wikidata; Q93456067
RX   CelloPub=CLPUB00464;
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO BY
AC   CVCL_UU49
DR   Wikidata; Q93456070
RX   CelloPub=CLPUB00464;
DI   NCIt; C3085; Hemangioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO BZ
AC   CVCL_UU50
DR   Wikidata; Q93456072
RX   CelloPub=CLPUB00464;
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO CB
AC   CVCL_UU51
DR   Wikidata; Q93456076
RX   CelloPub=CLPUB00464;
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO CC
AC   CVCL_UU52
DR   Wikidata; Q93456078
RX   CelloPub=CLPUB00464;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO CD
AC   CVCL_UU53
DR   Wikidata; Q93456080
RX   CelloPub=CLPUB00464;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO CE
AC   CVCL_UU12
DR   IARC_TP53; 24544
DR   Wikidata; Q93456083
RX   CelloPub=CLPUB00464;
RX   PubMed=16888811;
RX   PubMed=17431109;
RX   PubMed=24758355;
CC   Doubling time: 48 hours (PubMed=16888811).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CNIO CF
AC   CVCL_UU54
DR   Wikidata; Q93456087
RX   CelloPub=CLPUB00464;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   CNIO CG
AC   CVCL_UU55
DR   Wikidata; Q93456089
RX   CelloPub=CLPUB00464;
DI   NCIt; C3246; Mycosis fungoides
DI   ORDO; Orphanet_2584; Classic mycosis fungoides
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNIO CJ
AC   CVCL_UU56
DR   Wikidata; Q93456092
RX   CelloPub=CLPUB00464;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   CNIO CL
AC   CVCL_UU57
DR   Wikidata; Q93456094
RX   CelloPub=CLPUB00464;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UU58 ! CNIO CM
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   CNIO CM
AC   CVCL_UU58
DR   Wikidata; Q93456097
RX   CelloPub=CLPUB00464;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UU57 ! CNIO CL
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   CNIO CP
AC   CVCL_UU59
DR   Wikidata; Q93456100
RX   CelloPub=CLPUB00464;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   CNIO CQ
AC   CVCL_UU60
DR   Wikidata; Q93456108
RX   CelloPub=CLPUB00464;
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   CNK-89
AC   CVCL_D4YL
DR   Wikidata; Q127380586
RX   CelloPub=CLPUB00760;
RX   PubMed=33774906;
CC   Doubling time: ~26 hours (PubMed=33774906).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: NK T-cell; CL=CL_0000814.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
DI   NCIt; C205646; Canine NK cell neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CNLBC1
AC   CVCL_V650
DR   Cosmic; 1465953
DR   Wikidata; Q54813878
RX   PubMed=14999297;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=14999297).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:25589; SEPTIN11; Name(s)=KMT2A-SEPTIN11, KMT2A-SEPT11, MLL-SEPT11 (PubMed=14999297).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3179; Chronic neutrophilic leukemia
DI   ORDO; Orphanet_86829; Chronic neutrophilic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2121 ! MOLM-20
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   CNLMG-B5537LC
AC   CVCL_J117
SY   B5537LC
DR   CCRID; 4201PAT-CCTCC00136
DR   Wikidata; Q54813879
RX   Patent=EP0838526A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C96001.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J118 ! CNLMG-B5537SKIN
SX   Male
AG   28-30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CNLMG-B5537SKIN
AC   CVCL_J118
SY   B5537SKIN
DR   CCRID; 4201PAT-CCTCC00137
DR   Wikidata; Q54813880
RX   Patent=EP0838526A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C96002.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J117 ! CNLMG-B5537LC
SX   Male
AG   28-30Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   CNLMG-B5538LC
AC   CVCL_J119
SY   B5538LC
DR   CCRID; 4201PAT-CCTCC00138
DR   Wikidata; Q54813881
RX   Patent=EP0838526A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C96003.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J120 ! CNLMG-B5538SKIN
SX   Male
AG   28-30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   CNLMG-B5538SKIN
AC   CVCL_J120
SY   B5538SKIN
DR   CCRID; 4201PAT-CCTCC00139
DR   Wikidata; Q54813882
RX   Patent=EP0838526A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C96004.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J119 ! CNLMG-B5538LC
SX   Male
AG   28-30Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   CNMm
AC   CVCL_L152
DR   Wikidata; Q54813883
RX   PubMed=19754820;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L153 ! CNMp
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 11
//
ID   CNMp
AC   CVCL_L153
DR   Wikidata; Q54813884
RX   PubMed=19754820;
RX   PubMed=31308293;
CC   Characteristics: Can grow as a sphere (PubMed=31308293).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L152 ! CNMm
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   CNNDi001-A-1
AC   CVCL_C6TN
SY   DYR0100-ABCA7 KO
DR   hPSCreg; CNNDi001-A-1
DR   Wikidata; Q117704262
RX   PubMed=36521383;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37; ABCA7.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C253 ! ATCC-DYR0100
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CNNDi001-A-2
AC   CVCL_D6MH
SY   SYSUTFi003-A-2
DR   hPSCreg; CNNDi001-A-2
DR   Wikidata; Q127380587
RX   PubMed=38217994;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10621; CCL22.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: There is a major issue with this cell line. It is indicated to be derived from ATCC-DYR0100 (Cellosaurus=CVCL_C253), a male cell line, but the karyotype of this cell line is female and the paper also indicates that it originate from a Chinese female newborn.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   CNS-1
AC   CVCL_5276
DR   Millipore; SCC487
DR   Wikidata; Q54813885
RX   PubMed=7760095;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CNS-1
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   CNS-1-TK
AC   CVCL_E9CE
RX   PubMed=11916247;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5276 ! CNS-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CNS1-hiPSC1
AC   CVCL_C004
SY   CNS.1.H.iPSC.1
DR   RSCB; RSCB0131
DR   Wikidata; Q54813886
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C012 ! CNS1-hiPSC9
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS1-hiPSC10
AC   CVCL_C005
SY   CNS.1.H.iPSC.10; RIi015-A
DR   hPSCreg; RIi015-A
DR   RSCB; RSCB0139
DR   SKIP; SKIP002410
DR   SKIP; SKIP005849
DR   Wikidata; Q54813887
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C012 ! CNS1-hiPSC9
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   CNS1-hiPSC2
AC   CVCL_C006
SY   CNS.1.H.iPSC.2
DR   RSCB; RSCB0132
DR   Wikidata; Q54813888
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C012 ! CNS1-hiPSC9
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS1-hiPSC4
AC   CVCL_C007
SY   CNS.1.H.iPSC.4
DR   RSCB; RSCB0133
DR   Wikidata; Q54813889
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C012 ! CNS1-hiPSC9
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS1-hiPSC5
AC   CVCL_C008
SY   CNS.1.H.iPSC.5
DR   RSCB; RSCB0134
DR   Wikidata; Q54813900
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C012 ! CNS1-hiPSC9
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS1-hiPSC6
AC   CVCL_C009
SY   CNS.1.H.iPSC.6
DR   RSCB; RSCB0135
DR   Wikidata; Q54813901
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C012 ! CNS1-hiPSC9
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS1-hiPSC7
AC   CVCL_C010
SY   CNS.1.H.iPSC.7
DR   RSCB; RSCB0136
DR   Wikidata; Q54813902
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C012 ! CNS1-hiPSC9
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS1-hiPSC8
AC   CVCL_C011
SY   CNS.1.H.iPSC.8
DR   RSCB; RSCB0137
DR   Wikidata; Q54813903
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C012 ! CNS1-hiPSC9
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS1-hiPSC9
AC   CVCL_C012
SY   CNS.1.H.iPSC.9
DR   RSCB; RSCB0138
DR   Wikidata; Q54813904
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C004 ! CNS1-hiPSC1
OI   CVCL_C006 ! CNS1-hiPSC2
OI   CVCL_C007 ! CNS1-hiPSC4
OI   CVCL_C008 ! CNS1-hiPSC5
OI   CVCL_C009 ! CNS1-hiPSC6
OI   CVCL_C010 ! CNS1-hiPSC7
OI   CVCL_C011 ! CNS1-hiPSC8
OI   CVCL_C005 ! CNS1-hiPSC10
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS2-hiPSC1
AC   CVCL_C013
SY   CNS.2.H.iPSC.1
DR   RSCB; RSCB0140
DR   Wikidata; Q54813906
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C014 ! CNS2-hiPSC2
OI   CVCL_C015 ! CNS2-hiPSC3
OI   CVCL_C016 ! CNS2-hiPSC4
OI   CVCL_C017 ! CNS2-hiPSC5
OI   CVCL_C018 ! CNS2-hiPSC6
OI   CVCL_C019 ! CNS2-hiPSC7
OI   CVCL_C020 ! CNS2-hiPSC8
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS2-hiPSC2
AC   CVCL_C014
SY   CNS.2.H.iPSC.2
DR   RSCB; RSCB0141
DR   Wikidata; Q54813907
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C013 ! CNS2-hiPSC1
OI   CVCL_C015 ! CNS2-hiPSC3
OI   CVCL_C016 ! CNS2-hiPSC4
OI   CVCL_C017 ! CNS2-hiPSC5
OI   CVCL_C018 ! CNS2-hiPSC6
OI   CVCL_C019 ! CNS2-hiPSC7
OI   CVCL_C020 ! CNS2-hiPSC8
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS2-hiPSC3
AC   CVCL_C015
SY   CNS.2.H.iPSC.3
DR   RSCB; RSCB0142
DR   Wikidata; Q54813908
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C013 ! CNS2-hiPSC1
OI   CVCL_C014 ! CNS2-hiPSC2
OI   CVCL_C016 ! CNS2-hiPSC4
OI   CVCL_C017 ! CNS2-hiPSC5
OI   CVCL_C018 ! CNS2-hiPSC6
OI   CVCL_C019 ! CNS2-hiPSC7
OI   CVCL_C020 ! CNS2-hiPSC8
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS2-hiPSC4
AC   CVCL_C016
SY   CNS.2.H.iPSC.4
DR   RSCB; RSCB0143
DR   Wikidata; Q54813909
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C013 ! CNS2-hiPSC1
OI   CVCL_C014 ! CNS2-hiPSC2
OI   CVCL_C015 ! CNS2-hiPSC3
OI   CVCL_C017 ! CNS2-hiPSC5
OI   CVCL_C018 ! CNS2-hiPSC6
OI   CVCL_C019 ! CNS2-hiPSC7
OI   CVCL_C020 ! CNS2-hiPSC8
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS2-hiPSC5
AC   CVCL_C017
SY   CNS.2.H.iPSC.5
DR   RSCB; RSCB0144
DR   Wikidata; Q54813910
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C013 ! CNS2-hiPSC1
OI   CVCL_C014 ! CNS2-hiPSC2
OI   CVCL_C015 ! CNS2-hiPSC3
OI   CVCL_C016 ! CNS2-hiPSC4
OI   CVCL_C018 ! CNS2-hiPSC6
OI   CVCL_C019 ! CNS2-hiPSC7
OI   CVCL_C020 ! CNS2-hiPSC8
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   CNS2-hiPSC6
AC   CVCL_C018
SY   CNS.2.H.iPSC.6
DR   RSCB; RSCB0145
DR   Wikidata; Q54813911
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C013 ! CNS2-hiPSC1
OI   CVCL_C014 ! CNS2-hiPSC2
OI   CVCL_C015 ! CNS2-hiPSC3
OI   CVCL_C016 ! CNS2-hiPSC4
OI   CVCL_C017 ! CNS2-hiPSC5
OI   CVCL_C019 ! CNS2-hiPSC7
OI   CVCL_C020 ! CNS2-hiPSC8
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNS2-hiPSC7
AC   CVCL_C019
SY   CNS.2.H.iPSC.7; CNS2hiPSC7; RIi016-A
DR   hPSCreg; RIi016-A
DR   RSCB; RSCB0146
DR   SKIP; SKIP002411
DR   SKIP; SKIP005848
DR   Wikidata; Q54813912
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C013 ! CNS2-hiPSC1
OI   CVCL_C014 ! CNS2-hiPSC2
OI   CVCL_C015 ! CNS2-hiPSC3
OI   CVCL_C016 ! CNS2-hiPSC4
OI   CVCL_C017 ! CNS2-hiPSC5
OI   CVCL_C018 ! CNS2-hiPSC6
OI   CVCL_C020 ! CNS2-hiPSC8
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   CNS2-hiPSC8
AC   CVCL_C020
SY   CNS.2.H.iPSC.8
DR   RSCB; RSCB0147
DR   Wikidata; Q54813913
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Leu413Pro; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C013 ! CNS2-hiPSC1
OI   CVCL_C014 ! CNS2-hiPSC2
OI   CVCL_C015 ! CNS2-hiPSC3
OI   CVCL_C016 ! CNS2-hiPSC4
OI   CVCL_C017 ! CNS2-hiPSC5
OI   CVCL_C018 ! CNS2-hiPSC6
OI   CVCL_C019 ! CNS2-hiPSC7
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   CNT
AC   CVCL_4677
DR   CLO; CLO_0050251
DR   RCB; RCB1912
DR   Wikidata; Q54813914
RX   PubMed=8022100;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Kidney, distal tubule; UBERON=UBERON_0004135.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   CNTL1
AC   CVCL_VF89
DR   SKIP; SKIP001731
DR   Wikidata; Q54813915
RX   PubMed=28082870;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   CNTL2
AC   CVCL_VF90
DR   SKIP; SKIP001732
DR   Wikidata; Q54813916
RX   PubMed=28082870;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   CNTL3
AC   CVCL_VF91
DR   SKIP; SKIP001733
DR   Wikidata; Q54813918
RX   PubMed=28082870;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   CNTO2549
AC   CVCL_A0GI
DR   Wikidata; Q108820066
RX   PubMed=21529288;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CNTO8195
AC   CVCL_A0GJ
DR   Wikidata; Q108820067
RX   PubMed=21529288;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CNTO9195
AC   CVCL_A0GK
DR   Wikidata; Q108820068
RX   PubMed=21529288;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CNTO9383
AC   CVCL_A0GL
DR   Wikidata; Q108820069
RX   PubMed=21529288;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CNUH-HNSCC-1
AC   CVCL_S890
SY   Chonnam National University Hospital-Head and Neck Squamous Cell Carcinoma-1
DR   Wikidata; Q54813919
RX   PubMed=22111066;
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=22111066).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   CO
AC   CVCL_J653
SY   COLE; Cole; Co
DR   BioSample; SAMN03151618
DR   cancercelllines; CVCL_J653
DR   Cosmic; 1086354
DR   Cosmic; 1486583
DR   Wikidata; Q54813920
RX   PubMed=2602651;
RX   PubMed=2690233;
RX   PubMed=4018743;
RX   PubMed=8558920;
RX   PubMed=12581897;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=29533902;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12581897; PubMed=12592342; PubMed=20143388). Originally thought to originate from the lymph node biopsy of a patient with Hodgkin lymphoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00186.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 29
//
ID   Co-115
AC   CVCL_D102
SY   CO-115; Co 115; CO115; Co115
DR   cancercelllines; CVCL_D102
DR   ColonAtlas; CO115
DR   Cosmic; 711254
DR   Cosmic; 887213
DR   Cosmic; 1057757
DR   Cosmic; 1132574
DR   Cosmic; 1303885
DR   Cosmic; 1479610
DR   Cosmic; 2036658
DR   GEO; GSM1448067
DR   GEO; GSM2549993
DR   MetaboLights; MTBLS227
DR   TOKU-E; 4097
DR   Wikidata; Q54813921
RX   PubMed=975046;
RX   PubMed=1389533;
RX   PubMed=3349466;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=20570890;
RX   PubMed=24042735;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=28683746;
CC   Population: Caucasian.
CC   Characteristics: Established from a tumor implanted into a nude mice.
CC   Doubling time: ~36 hours (Note=At 26th passage) (PubMed=975046); 27.66 hours (PubMed=25944804).
CC   Microsatellite instability: Instable (MSI) (PubMed=9000147; PubMed=24042735; PubMed=25926053; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20570890; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu157Glyfs*23 (c.469dupG) (c.469_470insG); ClinVar=VCV000655856; Zygosity=Unspecified (PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Unspecified (PubMed=24042735; PubMed=28683746).
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): PubMed=24042735; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12,13,14 (PubMed=25926053)
ST   CSF1PO: 11,13 (PubMed=24042735)
ST   D13S317: 12,16 (PubMed=25926053)
ST   D13S317: 13,16 (PubMed=24042735)
ST   D16S539: 10,11
ST   D18S51: 14,15
ST   D19S433: 10,14,15
ST   D21S11: 34.2,35 (PubMed=25926053)
ST   D21S11: 35,35.2 (PubMed=24042735)
ST   D2S1338: 22,25
ST   D3S1358: 13,15,16
ST   D5S818: 10,11 (PubMed=24042735)
ST   D5S818: 10,12 (PubMed=25926053)
ST   D7S820: 7 (PubMed=24042735)
ST   D7S820: 7,10.3 (PubMed=25926053)
ST   D8S1179: 11,12
ST   FGA: 19,21
ST   TH01: 9,9.3
ST   TPOX: 8,9 (PubMed=24042735)
ST   TPOX: 8,10 (PubMed=25926053)
ST   vWA: 15,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 32
//
ID   CO-13-7
AC   CVCL_5H91
DR   Wikidata; Q54813922
RX   PubMed=3456614;
RX   PubMed=6165598;
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5H90 ! C6TK-
CA   Hybrid cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 3
//
ID   CO-MZ-1
AC   CVCL_W157
SY   COlon carcinoma-MainZ-1
DR   Wikidata; Q54813923
RX   PubMed=7510115;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   CO-MZ-2
AC   CVCL_W158
SY   COlon carcinoma-MainZ-2
DR   Wikidata; Q54813924
RX   PubMed=7510115;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   CO-MZ-4
AC   CVCL_W159
SY   COlon carcinoma-MainZ-4
DR   Wikidata; Q54813925
RX   PubMed=7510115;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   CO-MZ-5
AC   CVCL_F745
SY   COlon carcinoma-MainZ-5
DR   Wikidata; Q54813926
RX   PubMed=7510115;
CC   Doubling time: 17 days (PubMed=7510115).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   CO-MZ-6
AC   CVCL_F746
SY   COlon carcinoma-MainZ-6
DR   Wikidata; Q54813927
RX   PubMed=7510115;
CC   Doubling time: 11 hours (PubMed=7510115).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Co108
AC   CVCL_D109
DR   ColonAtlas; Co108
DR   Cosmic; 1235041
DR   Cosmic; 1430352
DR   Cosmic; 1473131
DR   IARC_TP53; 23329
DR   Wikidata; Q54813929
RX   PubMed=16959974;
RX   PubMed=17932254;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CO2 [Dog osteosarcoma]
AC   CVCL_L340
DR   Wikidata; Q54813930
RX   PubMed=10643981;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   CO2 [Human iPSC]
AC   CVCL_XA14
DR   Wikidata; Q93456372
RX   PubMed=27934589;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   CO3
AC   CVCL_L341
DR   Wikidata; Q54813931
RX   PubMed=10643981;
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   5Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   Co403
AC   CVCL_6617
SY   Co-403
DR   BTO; BTO_0002569
DR   Wikidata; Q54813932
RX   PubMed=16446362;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Coronary artery; UBERON=UBERON_0001621.
CC   Cell type: Coronary artery smooth muscle cell; CL=CL_0002592.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   CO5
AC   CVCL_L342
DR   Wikidata; Q54813933
RX   PubMed=10643981;
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   Co53
AC   CVCL_VK05
DR   cancercelllines; CVCL_VK05
DR   Cosmic; 2667977
DR   Wikidata; Q93456392
RX   PubMed=12615714;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (PubMed=12615714).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   CO7
AC   CVCL_L343
DR   Wikidata; Q54813934
RX   PubMed=10643981;
CC   Derived from site: In situ; Bone, proximal humerus; UBERON=UBERON_0004411.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   Co74
AC   CVCL_D110
DR   ColonAtlas; Co74
DR   Cosmic; 1235039
DR   Cosmic; 1430353
DR   Cosmic; 1473132
DR   IARC_TP53; 23327
DR   Wikidata; Q54813935
RX   PubMed=16959974;
RX   PubMed=17932254;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe134Leu (c.402T>G); ClinVar=VCV001018290; Zygosity=Homozygous (PubMed=16959974).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   Co79
AC   CVCL_D111
DR   ColonAtlas; Co79
DR   Cosmic; 1235050
DR   Cosmic; 1473076
DR   IARC_TP53; 23330
DR   Wikidata; Q54813936
RX   PubMed=16959974;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   CO8
AC   CVCL_L344
DR   Wikidata; Q54813937
RX   PubMed=10643981;
CC   Derived from site: In situ; Bone, proximal femur; UBERON=UBERON_0004412.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   Co82
AC   CVCL_D112
DR   cancercelllines; CVCL_D112
DR   ColonAtlas; Co82
DR   Cosmic; 1235051
DR   Cosmic; 1430382
DR   IARC_TP53; 23331
DR   Wikidata; Q54813938
RX   PubMed=16959974;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (PubMed=16959974).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   Co84
AC   CVCL_D113
DR   cancercelllines; CVCL_D113
DR   ColonAtlas; Co84
DR   Cosmic; 1235052
DR   Cosmic; 1430383
DR   IARC_TP53; 23332
DR   Wikidata; Q54813939
RX   PubMed=16959974;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Homozygous (PubMed=16959974).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   Co88BV59-1
AC   CVCL_3666
SY   CO 88BV59-1
DR   CLO; CLO_0002538
DR   ATCC; CRL-10624
DR   BioSample; SAMN03471303
DR   Wikidata; Q54813940
RX   Patent=US5474755;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10624.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Human colon tumor associated antigen 16.88 (CTAA 16.88).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-10624; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-10624
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Co88BV59H21-2
AC   CVCL_3667
DR   CLO; CLO_0002539
DR   ATCC; CRL-11538
DR   Wikidata; Q54813941
RX   Patent=US5474755;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11538.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-11538; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-11538
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3666 ! Co88BV59-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   Co88BV59H21-2V67-66
AC   CVCL_3668
DR   CLO; CLO_0002540
DR   ATCC; CRL-11539
DR   Wikidata; Q54813942
RX   Patent=US5474755;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11539.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-11539; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-11539
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3667 ! Co88BV59H21-2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   Co92
AC   CVCL_D114
DR   cancercelllines; CVCL_D114
DR   ColonAtlas; Co92
DR   Cosmic; 1235040
DR   Cosmic; 1430354
DR   Cosmic; 1473015
DR   IARC_TP53; 23328
DR   Wikidata; Q54813955
RX   PubMed=16959974;
RX   PubMed=17932254;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=16959974).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   CO93D
AC   CVCL_E2WK
SY   C093D
RX   DOI=10.1007/BF00039691;
RX   PubMed=20552456;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Plant embryo; PO=PO_0009009.
OX   NCBI_TaxID=88032; ! Taxus canadensis (Canadian yew)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Co94
AC   CVCL_D115
DR   ColonAtlas; Co94
DR   Cosmic; 1235053
DR   IARC_TP53; 23333
DR   Wikidata; Q54813956
RX   PubMed=16959974;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   CO95
AC   CVCL_9T89
SY   Co95
DR   Wikidata; Q54813957
RX   PubMed=9515795;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 3
//
ID   COA1
AC   CVCL_YE00
DR   Wikidata; Q93456443
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE01 ! COA2
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   COA2
AC   CVCL_YE01
DR   Wikidata; Q93456445
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE00 ! COA1
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   Coala
AC   CVCL_F0RS
RX   PubMed=40758205;
CC   Characteristics: Can also be cultured as a 3D spheroid (PubMed=40758205).
CC   Doubling time: ~2.5 days (PubMed=40758205).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1309Aspfs*4 (c.3927_3931delAAAGA); ClinVar=VCV000000816; Zygosity=Heterozygous (PubMed=40758205).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1355Leufs*60 (c.4063delT); ClinVar=VCV002121014; Zygosity=Heterozygous (PubMed=40758205).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys1183Arg (c.3548A>G); ClinVar=VCV000041818; Zygosity=Heterozygous (PubMed=40758205).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1170Ala (c.3508C>G); ClinVar=VCV000134082; Zygosity=Heterozygous (PubMed=40758205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=40758205).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=40758205
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 14
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   COBL-a
AC   CVCL_E8BV
SY   COrd BLood-a
DR   FANTOM5_SSTAR; 10449-106F8
DR   FANTOM5_SSTAR; 10452-106G2
DR   FANTOM5_SSTAR; 10453-106G3
RX   PubMed=17412987;
RX   PubMed=18374960;
CC   Population: Japanese.
CC   Virology: Susceptible to infection by measles virus (PubMed=17412987).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CoC1
AC   CVCL_6891
SY   COC1
DR   CCRID; 4201HUM-CCTCC00003
DR   CCTCC; GDC0003
DR   Wikidata; Q54813958
RX   PubMed=9275551;
RX   PubMed=23464471;
RX   PubMed=25502083;
CC   Population: Chinese.
CC   Doubling time: 31 hours (PubMed=9275551).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): CCRID=4201HUM-CCTCC00003
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,12,13
ST   D18S51: 12,18
ST   D19S433: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 9,13,14
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17,20
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 18
//
ID   CoC1/DDP
AC   CVCL_6892
SY   COC1/DDP
DR   CCRID; 4201HUM-CCTCC00058
DR   CCTCC; GDC0058
DR   Wikidata; Q54813959
RX   PubMed=9275551;
RX   PubMed=23464471;
RX   PubMed=25502083;
CC   Population: Chinese.
CC   Doubling time: 27 hours (PubMed=9275551).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): CCRID=4201HUM-CCTCC00058
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,12,13
ST   D18S51: 12,18
ST   D19S433: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 24
ST   D3S1358: 15,20
ST   D5S818: 12,13
ST   D7S820: 9,13,14
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17,20
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6891 ! CoC1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 20
//
ID   COC1501
AC   CVCL_B0SM
DR   CCRID; 4201PAT-CCTCC00746
DR   Wikidata; Q108820070
RX   Patent=CN105738627A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015136.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   COCA
AC   CVCL_G362
DR   ECACC; 10112001
DR   Wikidata; Q54813960
RX   PubMed=21510892;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Cocca-6A
AC   CVCL_V013
SY   Cocca 6A
DR   Wikidata; Q29884601
RX   CelloPub=CLPUB00247;
RX   PubMed=22666387;
CC   Doubling time: ~27 hours (PubMed=22666387).
CC   Anecdotal: Cell line name is derived from the cat name 'Cocca'.
CC   Breed/subspecies: Domestic Calico.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 9
//
ID   CoCM-1
AC   CVCL_1127
SY   CoCM1; COCM1
DR   CLO; CLO_0009959
DR   BioSample; SAMN03470823
DR   cancercelllines; CVCL_1127
DR   ChEMBL-Cells; CHEMBL3308133
DR   ColonAtlas; CoCM1
DR   Cosmic; 910783
DR   Cosmic; 1479618
DR   Cosmic; 2301966
DR   EGA; EGAS00001002554
DR   GEO; GSM827287
DR   GEO; GSM1346832
DR   GEO; GSM1448167
DR   IARC_TP53; 21267
DR   JCRB; JCRB0257
DR   LINCS_LDP; LCL-1196
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Progenetix; CVCL_1127
DR   Wikidata; Q54813961
RX   PubMed=2570482;
RX   PubMed=8348978;
RX   PubMed=9290701;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=2570482); ~34 hours (Note=Lot 06302006), ~59 hours (Note=Lot 12222011) (JCRB=JCRB0257).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg1023Gln (c.3068G>A); Zygosity=Unspecified (PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
ST   Source(s): JCRB=JCRB0257; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 18,20
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   CODI
AC   CVCL_E530
SY   5192
DR   dbMHC; 48729
DR   ECACC; 94071404
DR   IHW; IHW09272
DR   IPD-IMGT/HLA; 10427
DR   Wikidata; Q54813962
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*80:01; B*58,70; C*02 (IPD-IMGT/HLA=10427).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   CoE 115
AC   CVCL_R888
SY   Coho Embryo 115
DR   Wikidata; Q54813963
RX   DOI=10.1577/1548-8667(1994)006<0260:SOFNSC>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8019; ! Oncorhynchus kisutch (Coho salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   CoE 345
AC   CVCL_R889
SY   Coho Embryo 345
DR   Wikidata; Q54813964
RX   DOI=10.1577/1548-8667(1994)006<0260:SOFNSC>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8019; ! Oncorhynchus kisutch (Coho salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   CoE 45
AC   CVCL_R890
SY   Coho Embryo 45
DR   Wikidata; Q54813965
RX   DOI=10.1577/1548-8667(1994)006<0260:SOFNSC>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8019; ! Oncorhynchus kisutch (Coho salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   COG-AR-359
AC   CVCL_RS25
SY   COGAR359
DR   cancercelllines; CVCL_RS25
DR   Cell_Model_Passport; SIDM01488
DR   DepMap; ACH-001289
DR   Wikidata; Q54813966
RX   CelloPub=CLPUB00418;
WW   Provider; CCR; -; https://www.cccells.org/tables/Brain.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 53 hours (CelloPub=CLPUB00418).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): COG; DepMap=ACH-001289
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 20,25
ST   D3S1358: 14,15
ST   D5S818: 9,10
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   Penta D: 12,15
ST   Penta E: 13,14
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RS26 ! COG-AR-382
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   COG-AR-382
AC   CVCL_RS26
DR   Cell_Model_Passport; SIDM01487
DR   Wikidata; Q54813967
RX   CelloPub=CLPUB00418;
CC   Doubling time: 82 hours (CelloPub=CLPUB00418).
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RS25 ! COG-AR-359
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   COG-E-352
AC   CVCL_M153
SY   CHLA-352; CHLA352; COGE352
DR   cancercelllines; CVCL_M153
DR   Cell_Model_Passport; SIDM01486
DR   Cosmic; 2228219
DR   DepMap; ACH-001038
DR   GEO; GSM1676350
DR   GEO; GSM1701627
DR   Wikidata; Q54813968
RX   DOI=10.5282/edoc.27750;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 28 hours (PubMed=24312454).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Leu791fs; Zygosity=Unspecified (PubMed=25010205; DepMap=ACH-001038).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=25010205; DepMap=ACH-001038).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=24312454; PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 12 (PubMed=25010205)
ST   D18S51: 12,14 (PubMed=24312454)
ST   D19S433: 14 (PubMed=25010205)
ST   D19S433: 14,14.2 (PubMed=24312454)
ST   D21S11: 29,30
ST   D2S1338: 19,24 (PubMed=24312454)
ST   D2S1338: 24 (PubMed=25010205)
ST   D3S1358: 17 (PubMed=25010205)
ST   D3S1358: 17,18 (PubMed=24312454)
ST   D5S818: 10,13 (PubMed=24312454)
ST   D5S818: 13 (PubMed=25010205)
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 19 (PubMed=25010205)
ST   FGA: 19,21 (PubMed=24312454)
ST   TH01: 6,7 (PubMed=24312454)
ST   TH01: 7 (PubMed=25010205)
ST   TPOX: 8,11 (PubMed=24312454)
ST   TPOX: 11 (PubMed=25010205)
ST   vWA: 18 (PubMed=25010205)
ST   vWA: 18,20 (PubMed=24312454)
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 23
//
ID   COG-G-407
AC   CVCL_A6TU
DR   Wikidata; Q123030955
WW   Provider; CCR; -; https://www.cccells.org/tables/Brain.php
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D19S433: 13
ST   D21S11: 29,30.2
ST   D2S1338: 19,23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 10,12
ST   FGA: 20,23
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   COG-LL-317
AC   CVCL_M159
DR   GEO; GSM5137710
DR   PRIDE; PXD023662
DR   Wikidata; Q54813969
RX   PubMed=19298590;
RX   PubMed=20922763;
RX   PubMed=35354797;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-317.pdf
WW   Provider; CCR; -; https://www.cccells.org/suppdata/dl/3karyotypes_2007-02-09.pdf
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 21 hours (PubMed=20922763); 30-40 hours (COG).
CC   Karyotypic information: 46,XY,t(8;14)(q24.1;q11.2) (COG).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   D8S1179: 15
ST   FGA: 20,23
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M160 ! COG-LL-317h
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   COG-LL-317h
AC   CVCL_M160
DR   Wikidata; Q54813970
RX   PubMed=22137317;
RX   PubMed=26080839;
RX   PubMed=28119491;
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymp_N.php
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Characteristics: Hypoxic cell line grown at 5% O2.
CC   Doubling time: 19-20 hours (COG).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   D8S1179: 15
ST   FGA: 20,23
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M159 ! COG-LL-317
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   COG-LL-319
AC   CVCL_B3TH
DR   Wikidata; Q110432729
RX   PubMed=19298590;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-319.pdf
WW   Provider; CCR; -; https://www.cccells.org/suppdata/dl/3karyotypes_2007-02-09.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Karyotypic information: 46,XX,der(7)t(1;7)(q32;q36),del(9)(p11.2),der(19)t(1;19)(q23;p13.3) (COG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,14
ST   D18S51: 12,14
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M161 ! COG-LL-319h
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   COG-LL-319h
AC   CVCL_M161
DR   GEO; GSM5137711
DR   GEO; GSM5137753
DR   PRIDE; PXD023662
DR   Wikidata; Q54813971
RX   PubMed=22137317;
RX   PubMed=26080839;
RX   PubMed=35354797;
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-leuk.php
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-319.pdf
CC   Characteristics: Hypoxic cell line grown at 5% O2.
CC   Doubling time: 50-62 hours (COG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,14
ST   D18S51: 12,14
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TH ! COG-LL-319
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   COG-LL-329
AC   CVCL_B3TI
DR   Wikidata; Q110432730
RX   PubMed=19298590;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-329.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13.2,15
ST   D21S11: 29,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 25,26
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M162 ! COG-LL-329h
OI   CVCL_B3TJ ! COG-LL-332
OI   CVCL_M163 ! COG-LL-332h
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   COG-LL-329h
AC   CVCL_M162
DR   Wikidata; Q54813972
RX   PubMed=22137317;
RX   PubMed=26080839;
RX   PubMed=28119491;
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-leuk.php
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-329.pdf
CC   Characteristics: Hypoxic cell line grown at 5% O2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13.2,15
ST   D21S11: 29,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 25,26
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TI ! COG-LL-329
OI   CVCL_B3TJ ! COG-LL-332
OI   CVCL_M163 ! COG-LL-332h
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   COG-LL-332
AC   CVCL_B3TJ
DR   Wikidata; Q110432731
RX   PubMed=19298590;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-332.pdf
WW   Provider; CCR; -; https://www.cccells.org/suppdata/dl/3karyotypes_2007-02-09.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Karyotypic information: 46,XY,t(1;9)(p34;q34) (COG).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13.2,15
ST   D21S11: 29,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 24,25
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TI ! COG-LL-329
OI   CVCL_M162 ! COG-LL-329h
OI   CVCL_M163 ! COG-LL-332h
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   COG-LL-332h
AC   CVCL_M163
DR   GEO; GSM5137712
DR   PRIDE; PXD023662
DR   Wikidata; Q54813973
RX   PubMed=22137317;
RX   PubMed=26080839;
RX   PubMed=28119491;
RX   PubMed=35354797;
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-leuk.php
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-332.pdf
CC   Characteristics: Hypoxic cell line grown at 5% O2.
CC   Doubling time: 30-34 hours (COG).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13.2,15
ST   D21S11: 29,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 24,25
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TI ! COG-LL-329
OI   CVCL_M162 ! COG-LL-329h
OI   CVCL_B3TJ ! COG-LL-332
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   COG-LL-355
AC   CVCL_B3TK
DR   Wikidata; Q110432733
RX   PubMed=19298590;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-355.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,16
ST   FGA: 19,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M164 ! COG-LL-355h
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   COG-LL-355h
AC   CVCL_M164
DR   GEO; GSM5137713
DR   GEO; GSM5137754
DR   PRIDE; PXD023662
DR   Wikidata; Q54813974
RX   PubMed=22137317;
RX   PubMed=26080839;
RX   PubMed=35354797;
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-leuk.php
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-355.pdf
CC   Characteristics: Hypoxic cell line grown at 5% O2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,16
ST   FGA: 19,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TK ! COG-LL-355
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   COG-LL-356
AC   CVCL_B3TL
DR   Wikidata; Q110432734
RX   PubMed=19298590;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D19S433: 14,14.2
ST   D21S11: 30,31
ST   D2S1338: 21,23
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M165 ! COG-LL-356h
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   COG-LL-356h
AC   CVCL_M165
DR   GEO; GSM5137714
DR   PRIDE; PXD023662
DR   Wikidata; Q54813975
RX   PubMed=35354797;
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Characteristics: Hypoxic cell line grown at 5% O2.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D19S433: 14,14.2
ST   D21S11: 30,31
ST   D2S1338: 21,23
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TL ! COG-LL-356
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   COG-LL-384h
AC   CVCL_M166
SY   COG-LL-384
DR   Wikidata; Q54813976
RX   PubMed=19298590;
RX   PubMed=22137317;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-384h.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Characteristics: Hypoxic cell line grown at 5% O2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 12,21
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5J5 ! COG-LY-357h
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   COG-LL-394h
AC   CVCL_C6NC
DR   GEO; GSM5137755
DR   PRIDE; PXD023662
DR   Wikidata; Q116048776
RX   PubMed=35354797;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:16493; ZMIZ1; Name(s)=ABL1-ZMIZ1, ZMIZ1-ABL1 (PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12,15
ST   D19S433: 12.2,13.2
ST   D21S11: 28,30.2
ST   D2S1338: 16,26
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 19
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   COG-LL-402h
AC   CVCL_AQ49
DR   GEO; GSM5137756
DR   PRIDE; PXD023662
DR   Wikidata; Q54813977
RX   PubMed=26080839;
RX   PubMed=35354797;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-402h.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 16,18
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 19,22
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 24
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   COG-LL-434h
AC   CVCL_B5AZ
DR   Wikidata; Q123030956
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-434h.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 13,15.2
ST   D21S11: 28,31.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 18.2,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 13,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   COG-LY-357h
AC   CVCL_D5J5
DR   Wikidata; Q127380588
RX   PubMed=28119491;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 12,21
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M166 ! COG-LL-384h
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   COG-LY-457
AC   CVCL_B3TE
DR   Wikidata; Q110432735
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LY-457.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12,13
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 17
ST   D3S1358: 15,16,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13,17
ST   FGA: 22,23,25
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TD ! COG-LY-458
OI   CVCL_B3TC ! COG-LY-459
OI   CVCL_B3TB ! COG-LY-460
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   COG-LY-458
AC   CVCL_B3TD
DR   Wikidata; Q110432736
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LY-458.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13,17
ST   FGA: 23,25
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TE ! COG-LY-457
OI   CVCL_B3TC ! COG-LY-459
OI   CVCL_B3TB ! COG-LY-460
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   COG-LY-459
AC   CVCL_B3TC
DR   Wikidata; Q110432737
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LY-459.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13,17
ST   FGA: 23,25
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TE ! COG-LY-457
OI   CVCL_B3TD ! COG-LY-458
OI   CVCL_B3TB ! COG-LY-460
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   COG-LY-460
AC   CVCL_B3TB
DR   Wikidata; Q110432738
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LY-460.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13,17
ST   FGA: 23,25
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TE ! COG-LY-457
OI   CVCL_B3TD ! COG-LY-458
OI   CVCL_B3TC ! COG-LY-459
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   COG-N-253
AC   CVCL_AX66
DR   Wikidata; Q54813978
RX   PubMed=24792489;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   COG-N-261h
AC   CVCL_AX54
SY   COG_N_261_H
DR   Wikidata; Q54813979
RX   PubMed=23202128;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-263
AC   CVCL_AX46
SY   COGN_263
DR   Cosmic; 1890111
DR   Wikidata; Q54813980
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 17,21
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-265
AC   CVCL_AX55
SY   COGN265
DR   Wikidata; Q54813981
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 16
ST   D19S433: 15.2,16.2
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4-5Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-276h
AC   CVCL_AX56
SY   COG_N_276_H
DR   Cosmic; 1890090
DR   Wikidata; Q54813982
RX   PubMed=23202128;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6-7Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-278
AC   CVCL_AX49
SY   COGN278; NB06C
DR   cancercelllines; CVCL_AX49
DR   Cell_Model_Passport; SIDM01485
DR   Cosmic; 1890076
DR   DepMap; ACH-001301
DR   GEO; GSM3145564
DR   GEO; GSM3145700
DR   Wikidata; Q54813983
RX   PubMed=23202128;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D19S433: 14,16
ST   D21S11: 29,30
ST   D2S1338: 22,25
ST   D3S1358: 16,18
ST   D5S818: 9,11
ST   D7S820: 9
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   4-5Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   COG-N-289
AC   CVCL_AX45
SY   COGN289
DR   Cosmic; 1890091
DR   Wikidata; Q54813984
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   FGA: 21,23
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4-5Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-291
AC   CVCL_AQ18
DR   Wikidata; Q54813985
RX   PubMed=24792489;
RX   PubMed=28636942;
CC   Characteristics: Has long and heterogeneous telomeres and no telomerase activity. Its telomeres shortens continuously at an average rate of 80 base pairs per population doubling (PubMed=28636942).
CC   Doubling time: 3.4 days (PubMed=28636942); 224 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 19,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   COG-N-294
AC   CVCL_AX67
DR   Wikidata; Q54813986
RX   PubMed=24792489;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 14,16.2
ST   D21S11: 28,33.2
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ20 ! COG-N-321
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 5
//
ID   COG-N-295
AC   CVCL_AX43
SY   COGN_295
DR   Cosmic; 1890125
DR   Wikidata; Q54813987
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 17,18
ST   D19S433: 14,15
ST   D21S11: 31
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-297
AC   CVCL_AX57
SY   COGN297
DR   Wikidata; Q54813989
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 31
ST   D2S1338: 18,24
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 10,12
ST   FGA: 22
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2-3Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-299
AC   CVCL_AX58
SY   COGN_299
DR   Wikidata; Q54813990
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 13,14
ST   D21S11: 28,30.2
ST   D2S1338: 16,19
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,21
ST   TH01: 7,8
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-305
AC   CVCL_AX42
SY   COGN305
DR   cancercelllines; CVCL_AX42
DR   Cell_Model_Passport; SIDM01484
DR   Cosmic; 1890106
DR   DepMap; ACH-001302
DR   GEO; GSM3145568
DR   GEO; GSM3145701
DR   Wikidata; Q54813991
RX   PubMed=23202128;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Tyr216Ter (c.648C>A); Zygosity=Unspecified (PubMed=23202128; DepMap=ACH-001302).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,14
ST   D16S539: 10,11
ST   D18S51: 17
ST   D19S433: 14,15.2
ST   D21S11: 28,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1-2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 16
//
ID   COG-N-316
AC   CVCL_AQ19
SY   COGN316
DR   Cosmic; 1890096
DR   Wikidata; Q54813992
RX   PubMed=23202128;
RX   PubMed=24792489;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,13
ST   D21S11: 31.2
ST   D2S1338: 18
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,22.2
ST   TH01: 6,8
ST   TPOX: 9,10
ST   vWA: 15,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y2M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-318
AC   CVCL_AX44
SY   COG_N_318
DR   Cosmic; 1890092
DR   Wikidata; Q54813993
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14,15
ST   D19S433: 13,14.2
ST   D21S11: 31.2,34
ST   D2S1338: 17,23
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,17
ST   FGA: 21,26
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-1Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-321
AC   CVCL_AQ20
DR   Wikidata; Q54813994
RX   PubMed=24792489;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 14,16.2
ST   D21S11: 28,33.2
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX67 ! COG-N-294
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-324
AC   CVCL_AX59
SY   COGN324
DR   Wikidata; Q54813996
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 11,15
ST   D19S433: 12,14
ST   D21S11: 29,31.2
ST   D2S1338: 18,21
ST   D3S1358: 14,19
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 10,12
ST   FGA: 22,23
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-327h
AC   CVCL_AX47
SY   COGN327h
DR   Cosmic; 1890094
DR   Wikidata; Q54814010
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 18,19
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,25
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 10
ST   FGA: 21,24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-328h
AC   CVCL_AX60
SY   COGN_328h
DR   Wikidata; Q54814011
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 23,24
ST   D3S1358: 18,19
ST   D5S818: 11
ST   D7S820: 7,10
ST   D8S1179: 11,14
ST   FGA: 18,25
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-6Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-331
AC   CVCL_AX61
SY   COGN331
DR   Wikidata; Q54814012
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D18S51: 12,16
ST   D19S433: 11,14
ST   D21S11: 28,30
ST   D2S1338: 16,25
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 26,28
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 15,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9-10Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-334
AC   CVCL_AX62
SY   COGN334
DR   Wikidata; Q54814013
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 20,26
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   TH01: 8,9
ST   TPOX: 6,8
ST   vWA: 15,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1-2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-346h
AC   CVCL_AX63
SY   COGN346h
DR   Wikidata; Q54814014
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-1Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   COG-N-347
AC   CVCL_AQ21
SY   COGN347
DR   Wikidata; Q54814015
RX   PubMed=23202128;
RX   PubMed=24792489;
CC   Doubling time: 126 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 14,19
ST   D19S433: 13,14
ST   D21S11: 31,33.2
ST   D2S1338: 17,19
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 24,26
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-349
AC   CVCL_AX50
SY   NB03C
DR   Cosmic; 1890073
DR   Wikidata; Q54814016
RX   PubMed=23202128;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,21
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 20,26
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 6
//
ID   COG-N-354
AC   CVCL_AX64
DR   Wikidata; Q54814017
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 28
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 15,16
ST   FGA: 21,25
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX65 ! COG-N-354h
SX   Sex unspecified
AG   1-2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-354h
AC   CVCL_AX65
SY   COGN354h
DR   Wikidata; Q54814018
RX   PubMed=23202128;
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 28
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 15,16
ST   FGA: 21,25
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX64 ! COG-N-354
SX   Sex unspecified
AG   1-2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-367h
AC   CVCL_AX51
SY   NB05C
DR   Cosmic; 1890075
DR   GEO; GSM3145566
DR   GEO; GSM3145702
DR   Wikidata; Q54814019
RX   PubMed=23202128;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,18
ST   D19S433: 14,14.2
ST   D21S11: 28,30
ST   D2S1338: 19,20
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   TH01: 8,9.3
ST   TPOX: 11,12
ST   vWA: 16,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   COG-N-386h
AC   CVCL_AX52
SY   NB04C
DR   Cosmic; 1890074
DR   Wikidata; Q54814020
RX   PubMed=23202128;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,13
ST   D16S539: 13,14
ST   D18S51: 14,18
ST   D19S433: 12,15
ST   D21S11: 28,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 21,25
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2-3Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 7
//
ID   COG-N-387h
AC   CVCL_AX53
SY   NB02C
DR   Cosmic; 1890072
DR   Wikidata; Q54814021
RX   PubMed=23202128;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 15,17
ST   D21S11: 27,31
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   D8S1179: 14,16
ST   FGA: 23.2,24
ST   TH01: 6,9.3
ST   TPOX: 9
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3-4Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 7
//
ID   COG-N-399
AC   CVCL_AQ22
DR   Wikidata; Q54814022
RX   PubMed=24792489;
CC   Doubling time: 40 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15,17
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 11,12
ST   FGA: 18,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   COG-N-415
AC   CVCL_AQ23
SY   COGN415
DR   cancercelllines; CVCL_AQ23
DR   GEO; GSM2371224
DR   GEO; GSM4104571
DR   GEO; GSM4104572
DR   GEO; GSM4104624
DR   GEO; GSM4104625
DR   GEO; GSM4105303
DR   GEO; GSM4105304
DR   GEO; GSM4105305
DR   GEO; GSM4105306
DR   GEO; GSM4105307
DR   Wikidata; Q54814023
RX   PubMed=24792489;
RX   PubMed=28340497;
RX   PubMed=28350380;
CC   Doubling time: 50 hours (COG).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (PubMed=28350380).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 19,21
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 11,13,14
ST   FGA: 19,22
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   COG-N-421
AC   CVCL_AQ24
DR   Wikidata; Q54814024
RX   PubMed=24792489;
CC   Doubling time: 65 hours (COG).
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   COG-N-426
AC   CVCL_LF58
SY   Felix
DR   cancercelllines; CVCL_LF58
DR   GEO; GSM2371235
DR   Wikidata; Q54814025
RX   PubMed=28350380;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1245Cys (c.3734T>G); ClinVar=VCV000217856; Zygosity=Unspecified (PubMed=28350380).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 10,12
ST   D18S51: 10,13
ST   D19S433: 14,15.2
ST   D21S11: 28
ST   D2S1338: 24,25
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 7,12
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 10,12
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   COG-N-440
AC   CVCL_AQ25
DR   GEO; GSM2371225
DR   GEO; GSM4104573
DR   GEO; GSM4104574
DR   Wikidata; Q54814026
RX   PubMed=24792489;
RX   PubMed=28350380;
CC   Doubling time: 65 hours (COG).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11
ST   FGA: 21,24
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   COG-N-452
AC   CVCL_VS96
DR   Wikidata; Q93456545
RX   PubMed=28340497;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 12
ST   D18S51: 15,17
ST   D19S433: 12,16
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 18,22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF59 ! COG-N-453
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   COG-N-453
AC   CVCL_LF59
DR   cancercelllines; CVCL_LF59
DR   GEO; GSM2371226
DR   GEO; GSM4104575
DR   GEO; GSM4104576
DR   Wikidata; Q54814027
RX   PubMed=28350380;
CC   Doubling time: 71 hours (COG).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (PubMed=28350380).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 15,17
ST   D19S433: 12
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 18,22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS96 ! COG-N-452
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   COG-N-471nb
AC   CVCL_LF60
DR   GEO; GSM2371227
DR   Wikidata; Q54814028
RX   PubMed=28350380;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   COG-N-496
AC   CVCL_LF61
DR   GEO; GSM2371228
DR   Wikidata; Q54814029
RX   PubMed=28350380;
CC   Doubling time: 85 hours (COG).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3Y2M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   COG-N-519
AC   CVCL_LF62
DR   GEO; GSM2371229
DR   Wikidata; Q54814030
RX   PubMed=28350380;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   COG-N-534
AC   CVCL_LF63
DR   GEO; GSM2371230
DR   Wikidata; Q54814031
RX   PubMed=28350380;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   COG-N-549
AC   CVCL_LF64
DR   GEO; GSM2371231
DR   Wikidata; Q54814032
RX   PubMed=28350380;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   COG-N-557nb
AC   CVCL_LF65
DR   GEO; GSM2371232
DR   Wikidata; Q54814033
RX   PubMed=28350380;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   COG-N-561
AC   CVCL_LF66
DR   GEO; GSM2371233
DR   Wikidata; Q54814034
RX   PubMed=28350380;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   COG-N-573
AC   CVCL_LF67
DR   GEO; GSM2371234
DR   Wikidata; Q54814035
RX   PubMed=28350380;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   COG203C
AC   CVCL_8U06
DR   ECACC; 03082236
DR   Wikidata; Q54814036
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   COG583
AC   CVCL_8U07
DR   ECACC; 05090602
DR   Wikidata; Q54814037
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   COGA-1
AC   CVCL_A071
SY   COGA1
DR   Cosmic; 877900
DR   Wikidata; Q54814038
RX   PubMed=12096341;
CC   Microsatellite instability: Instable (MSI) (PubMed=12096341).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
DI   NCIt; C4910; Colon carcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   COGA-10
AC   CVCL_A072
SY   COGA10
DR   Cosmic; 877902
DR   Wikidata; Q54814040
RX   PubMed=12096341;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   COGA-12
AC   CVCL_A073
SY   COGA12
DR   Cosmic; 877905
DR   GEO; GSM1448103
DR   Wikidata; Q54814041
RX   PubMed=12096341;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 14,15
ST   D16S539: 11,12
ST   D21S11: 30,30.2
ST   D5S818: 11,15
ST   D7S820: 12,13
ST   TH01: 9.3
ST   TPOX: 10,13
ST   vWA: 14,16
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   COGA-13
AC   CVCL_Z584
SY   Coga13
DR   BTO; BTO_0005665
DR   Wikidata; Q54814042
RX   PubMed=18205904;
RX   PubMed=22940288;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 5
//
ID   COGA-1A
AC   CVCL_Z583
SY   COGA1A; Coga1A
DR   BTO; BTO_0005664
DR   GEO; GSM1448099
DR   Wikidata; Q54814039
RX   PubMed=18205904;
RX   PubMed=22940288;
RX   PubMed=24176760;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D21S11: 27,34
ST   D5S818: 11,12
ST   D7S820: 7.3,10
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C4910; Colon carcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A071 ! COGA-1
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   COGA-2
AC   CVCL_A074
SY   COGA2
DR   cancercelllines; CVCL_A074
DR   Cosmic; 877906
DR   GEO; GSM1448100
DR   IARC_TP53; 17885
DR   Wikidata; Q54814043
RX   PubMed=12096341;
RX   PubMed=25926053;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=12096341).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12,13
ST   D21S11: 29,36.2
ST   D5S818: 12,16
ST   D7S820: 11,13
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 18,20,21
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   COGA-3
AC   CVCL_A075
SY   COGA3
DR   ColonAtlas; COGA3
DR   Cosmic; 877907
DR   GEO; GSM1448101
DR   Wikidata; Q54814044
RX   PubMed=12096341;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, right colic flexure; UBERON=UBERON_0022277.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,12,13
ST   D16S539: 10,11
ST   D21S11: 30.2,31.2
ST   D5S818: 12
ST   D7S820: 8,11,11.1
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   COGA-5
AC   CVCL_A076
SY   COGA5
DR   cancercelllines; CVCL_A076
DR   Cosmic; 877901
DR   GEO; GSM1448150
DR   IARC_TP53; 17884
DR   Wikidata; Q54814045
RX   PubMed=12096341;
RX   PubMed=25926053;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=12096341).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, right colic flexure; UBERON=UBERON_0022277.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A077 ! COGA-5L
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   COGA-5L
AC   CVCL_A077
SY   COGA5L
DR   cancercelllines; CVCL_A077
DR   Cosmic; 877903
DR   GEO; GSM1448151
DR   Wikidata; Q54814046
RX   PubMed=12096341;
RX   PubMed=25926053;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=12096341).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18,20
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A076 ! COGA-5
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   COGA-8
AC   CVCL_A078
SY   COGA8
DR   Cosmic; 877904
DR   GEO; GSM1448102
DR   Wikidata; Q54814047
RX   PubMed=12096341;
RX   PubMed=25926053;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D21S11: 29,31
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   COH [Human colon adenocarcinoma]
AC   CVCL_WV04
DR   Wikidata; Q93456580
RX   PubMed=15144569;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser227Phe (c.680C>T); Zygosity=Unspecified (PubMed=15144569).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 6
//
ID   COH [Human Ewing sarcoma]
AC   CVCL_U564
DR   Wikidata; Q54814048
RX   PubMed=26428435;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-575.html
CC   From: Delattre, Olivier; Institut Curie; Paris; France.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 3 fusion (Ex10/Ex6) (PubMed=26428435).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   COH-DHL1
AC   CVCL_C1GL
SY   City Of Hope-Double Hit Lymphoma 1
DR   Wikidata; Q114310995
RX   PubMed=35687491;
CC   Doubling time: 47.8 hours (PubMed=35687491).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=35687491).
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Gly12Asp (c.35G>A); Zygosity=Heterozygous (PubMed=35687491).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=35687491
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   COH-THL1
AC   CVCL_C1GM
SY   City Of Hope-Triple Hit Lymphoma 1
DR   Wikidata; Q114310996
RX   PubMed=35687491;
CC   Characteristics: Has chromosomal translocation of the MYC, BCL2 and BCL6 genes.
CC   Doubling time: 27 hours (PubMed=35687491).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=35687491).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=35687491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=35687491
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11
ST   D21S11: 28,32.2
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C131913; High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   COL [Human neuroblastoma]
AC   CVCL_FA09
DR   Wikidata; Q54814050
RX   PubMed=15026342;
RX   PubMed=22415601;
RX   PubMed=24046071;
CC   Problematic cell line: Misclassified. Originally thought to originate from an osteosarcoma and is now identified as a neuroblastoma cell line (PubMed=22415601; PubMed=24046071).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 9
//
ID   COL [Human plasma cell myeloma]
AC   CVCL_A6IS
SY   col
DR   Wikidata; Q107114694
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8051085;
RX   PubMed=8427968;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   Col 2
AC   CVCL_D645
SY   Col-2; Col2
DR   BTO; BTO_0005289
DR   ChEMBL-Cells; CHEMBL3307622
DR   ChEMBL-Targets; CHEMBL614462
DR   PubChem_Cell_line; CVCL_D645
DR   Wikidata; Q54814057
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   COL,E
AC   CVCL_E531
SY   COL, E
DR   dbMHC; 48730
DR   ECACC; 94082246
DR   IHW; IHW09146
DR   IPD-IMGT/HLA; 11689
DR   Wikidata; Q54814061
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02; B*15; C*03; DPB1*04:01,13:01; DQA1*03; DQB1*03:02; DRB1*04:01; DRB4*01:01 (IPD-IMGT/HLA=11689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   COL,S
AC   CVCL_E532
SY   COL, S
DR   dbMHC; 48731
DR   ECACC; 94082297
DR   IHW; IHW09197
DR   IPD-IMGT/HLA; 11738
DR   Wikidata; Q54814062
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*03,24; B*07,40; C*07; DPB1*04:01,05:01; DQA1*01:02,01:04; DQB1*05:03,06; DRB1*15:01,14:05; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=11738).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   Col-1
AC   CVCL_2A40
SY   COL-1
DR   Wikidata; Q54814058
RX   PubMed=3455746;
CC   Characteristics: The Col series of TS/A derived cell lines are obtained from repeated intravenous passage of lung colonies in BALB/c female mice (PubMed=3455746).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   Col-10
AC   CVCL_4604
SY   COL-10
DR   CLO; CLO_0002541
DR   CLDB; cl823
DR   Wikidata; Q54814059
RX   PubMed=3455746;
CC   Characteristics: The Col series of TS/A derived cell lines are obtained from repeated intravenous passage of lung colonies in BALB/c female mice (PubMed=3455746).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4605 ! Col-7
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Col-7
AC   CVCL_4605
SY   COL-7
DR   CLO; CLO_0002542
DR   CLDB; cl824
DR   Wikidata; Q54814060
RX   PubMed=3455746;
CC   Characteristics: The Col series of TS/A derived cell lines are obtained from repeated intravenous passage of lung colonies in BALB/c female mice (PubMed=3455746).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2A40 ! Col-1
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Col-GFP HSC
AC   CVCL_B7MI
SY   Col-GFP-HSC; HSC Col-GFP
DR   DSMZ; ACC-941
DR   Wikidata; Q112929403
RX   PubMed=23437087;
RX   PubMed=36067186;
CC   Doubling time: ~16 hours (DSMZ=ACC-941).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Age/sex of donor from personal communication of Weiskirchen, Ralf.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: pCol9GFP-HS4,5 transgenic.
ST   Source(s): PubMed=36067186
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   Colin
AC   CVCL_6F56
DR   Wikidata; Q54814064
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   COLM-6
AC   CVCL_W467
DR   Wikidata; Q54814065
RX   PubMed=16143030;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7973; Rectal mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 103
AC   CVCL_X381
SY   COLO #103; Colorado 103
DR   Wikidata; Q54814066
RX   DOI=10.1093/jnci/59.2.301;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 110
AC   CVCL_5450
SY   COLO #110; Colorado 110
DR   Wikidata; Q54814068
RX   PubMed=72600;
RX   PubMed=498076;
RX   PubMed=6277475;
CC   Population: Caucasian.
CC   Misspelling: COLO 109; PubMed=72600; Note=In table 1.
CC   Derived from site: Metastatic; Fallopian tube; UBERON=UBERON_0003889.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   COLO 16
AC   CVCL_D607
SY   COLO-16; Colo-16; Colo 16; COLO #16; Colo16; Colorado 16
DR   BTO; BTO_0005163
DR   Wikidata; Q54814069
RX   PubMed=924690;
RX   PubMed=1157043;
RX   PubMed=6277475;
RX   PubMed=21868764;
CC   Population: African American.
CC   Miscellaneous: STR profile from personal communication of Korch, Christopher T.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Direct_author_submission; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 14.2,16.2
ST   D21S11: 30,32.2
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 26
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   COLO 197
AC   CVCL_9976
SY   COLO-197; Colorado 197
DR   Cell_Model_Passport; SIDM00825
DR   Wikidata; Q54814071
RX   PubMed=565251;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9977 ! COLO 200
OI   CVCL_1987 ! COLO 201
OI   CVCL_0218 ! COLO 205
OI   CVCL_1988 ! COLO 206F
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   COLO 200
AC   CVCL_9977
SY   COLO-200; Colorado 200
DR   Cell_Model_Passport; SIDM00824
DR   Wikidata; Q54814072
RX   PubMed=565251;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9976 ! COLO 197
OI   CVCL_1987 ! COLO 201
OI   CVCL_0218 ! COLO 205
OI   CVCL_1988 ! COLO 206F
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   COLO 201
AC   CVCL_1987
SY   Colo 201; Colo-201; COLO-201; COLO201; Colo201; Colorado 201
DR   BTO; BTO_0002568
DR   CLO; CLO_0002543
DR   EFO; EFO_0002135
DR   CLDB; cl825
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-224
DR   BioSample; SAMN03471321
DR   BioSample; SAMN10987883
DR   cancercelllines; CVCL_1987
DR   CCRID; 1101HUM-PUMC000340
DR   Cell_Model_Passport; SIDM00823
DR   ChEMBL-Cells; CHEMBL4523536
DR   ChEMBL-Targets; CHEMBL4523567
DR   ColonAtlas; COLO201
DR   Cosmic; 738935
DR   Cosmic; 876710
DR   Cosmic; 948822
DR   Cosmic; 1001661
DR   Cosmic; 1154650
DR   Cosmic; 1184100
DR   Cosmic; 1187302
DR   Cosmic; 1223134
DR   Cosmic; 1479611
DR   Cosmic; 1609481
DR   Cosmic; 1676731
DR   Cosmic; 1805248
DR   Cosmic; 2301967
DR   Cosmic; 2760081
DR   DepMap; ACH-000253
DR   ECACC; 87091201
DR   EGA; EGAS00001000610
DR   GEO; GSM206458
DR   GEO; GSM274721
DR   GEO; GSM274722
DR   GEO; GSM274730
DR   GEO; GSM827324
DR   GEO; GSM1346833
DR   GEO; GSM1374450
DR   GEO; GSM1448068
DR   IGRhCellID; COLO201
DR   JCRB; JCRB0226
DR   KCLB; 10224
DR   LiGeA; CCLE_773
DR   LINCS_LDP; LCL-1172
DR   Lonza; 252
DR   PharmacoDB; COLO201_214_2019
DR   Progenetix; CVCL_1987
DR   PubChem_Cell_line; CVCL_1987
DR   SKY/M-FISH/CGH; 2837
DR   Wikidata; Q54814073
RX   PubMed=565251;
RX   PubMed=7874267;
RX   PubMed=8464898;
RX   PubMed=9023415;
RX   PubMed=9290701;
RX   PubMed=9294210;
RX   PubMed=10051639;
RX   PubMed=10612807;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=16418264;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 41.33 hours (PubMed=25944804).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02 (PubMed=9023415).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:06,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (PubMed=24755471; DepMap=ACH-000253).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20570890; PubMed=24755471; ATCC=CCL-224; DepMap=ACH-000253).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (PubMed=9294210).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=13.18%; Native American=0%; East Asian, North=12.19%; East Asian, South=0%; South Asian=0%; European, North=27.33%; European, South=47.3% (PubMed=30894373).
CC   Misspelling: Colo210; Cosmic=1184100.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CCL-224; CCRID=1101HUM-PUMC000340; ECACC=87091201; JCRB=JCRB0226; KCLB=10224; PubMed=11416159; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10 (ATCC=CCL-224; ECACC=87091201; JCRB=JCRB0226; PubMed=25877200)
ST   D13S317: 10,12 (CCRID=1101HUM-PUMC000340; KCLB=10224; PubMed=25926053)
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9976 ! COLO 197
OI   CVCL_9977 ! COLO 200
OI   CVCL_0218 ! COLO 205
OI   CVCL_1988 ! COLO 206F
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   COLO 201-EGFP
AC   CVCL_A9CV
DR   cancercelllines; CVCL_A9CV
DR   CCRID; 1101HUM-PUMC000841
DR   Wikidata; Q108820071
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000841
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1987 ! COLO 201
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   COLO 201-Luc2-tdT
AC   CVCL_A9CW
DR   cancercelllines; CVCL_A9CW
DR   CCRID; 1101HUM-PUMC000844
DR   Wikidata; Q108820072
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000844
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1987 ! COLO 201
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   COLO 201-mCherry
AC   CVCL_A9CX
DR   cancercelllines; CVCL_A9CX
DR   CCRID; 1101HUM-PUMC000842
DR   Wikidata; Q108820073
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000842
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1987 ! COLO 201
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   COLO 201-tdT
AC   CVCL_A9CY
DR   cancercelllines; CVCL_A9CY
DR   CCRID; 1101HUM-PUMC000843
DR   Wikidata; Q108820074
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000843
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1987 ! COLO 201
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   COLO 205
AC   CVCL_0218
SY   Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205
DR   BTO; BTO_0000179
DR   CLO; CLO_0002544
DR   CLO; CLO_0050630
DR   EFO; EFO_0003082
DR   MCCL; MCC:0000107
DR   CLDB; cl826
DR   CLDB; cl5096
DR   AddexBio; C0009018/4908
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-222
DR   BCRC; 60054
DR   BioGRID_ORCS_Cell_line; 846
DR   BioSample; SAMN03470991
DR   BioSample; SAMN10987610
DR   cancercelllines; CVCL_0218
DR   CCRID; 1101HUM-PUMC000132
DR   CCRID; 3101HUMTCHu102
DR   Cell_Model_Passport; SIDM00826
DR   ChEMBL-Cells; CHEMBL3308348
DR   ChEMBL-Targets; CHEMBL614561
DR   CLS; 300380
DR   ColonAtlas; COLO205
DR   Cosmic; 685865
DR   Cosmic; 720342
DR   Cosmic; 738936
DR   Cosmic; 875901
DR   Cosmic; 876711
DR   Cosmic; 887242
DR   Cosmic; 889524
DR   Cosmic; 897456
DR   Cosmic; 902796
DR   Cosmic; 905961
DR   Cosmic; 948130
DR   Cosmic; 948823
DR   Cosmic; 974244
DR   Cosmic; 995391
DR   Cosmic; 1043806
DR   Cosmic; 1044256
DR   Cosmic; 1045404
DR   Cosmic; 1066207
DR   Cosmic; 1067224
DR   Cosmic; 1092596
DR   Cosmic; 1132577
DR   Cosmic; 1154651
DR   Cosmic; 1175838
DR   Cosmic; 1184101
DR   Cosmic; 1187303
DR   Cosmic; 1223135
DR   Cosmic; 1305351
DR   Cosmic; 1310944
DR   Cosmic; 1312336
DR   Cosmic; 1374634
DR   Cosmic; 1479612
DR   Cosmic; 1609485
DR   Cosmic; 1676745
DR   Cosmic; 1708401
DR   Cosmic; 1945864
DR   Cosmic; 1995368
DR   Cosmic; 1998438
DR   Cosmic; 2036651
DR   Cosmic; 2301968
DR   Cosmic; 2560250
DR   Cosmic; 2651868
DR   Cosmic; 2800580
DR   Cosmic-CLP; 905961
DR   DepMap; ACH-001039
DR   ECACC; 87061208
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FCS-free; 180-2-342-3-16-3
DR   GDSC; 905961
DR   GEO; GSM2089
DR   GEO; GSM50186
DR   GEO; GSM50250
DR   GEO; GSM206459
DR   GEO; GSM274717
DR   GEO; GSM274718
DR   GEO; GSM274728
DR   GEO; GSM741249
DR   GEO; GSM743441
DR   GEO; GSM750794
DR   GEO; GSM799329
DR   GEO; GSM799392
DR   GEO; GSM827422
DR   GEO; GSM843490
DR   GEO; GSM846289
DR   GEO; GSM886940
DR   GEO; GSM888007
DR   GEO; GSM1153400
DR   GEO; GSM1178029
DR   GEO; GSM1178030
DR   GEO; GSM1178031
DR   GEO; GSM1181248
DR   GEO; GSM1181264
DR   GEO; GSM1346867
DR   GEO; GSM1374451
DR   GEO; GSM1374452
DR   GEO; GSM1448172
DR   GEO; GSM1669683
DR   GEO; GSM2124638
DR   GEO; GSM2549994
DR   IARC_TP53; 21116
DR   ICLC; HTL00010
DR   KCB; KCB 200719YJ
DR   KCLB; 10222
DR   LINCS_LDP; LCL-1173
DR   Lonza; 253
DR   MetaboLights; MTBLS227
DR   NCI-DTP; COLO 205
DR   PharmacoDB; COLO205_221_2019
DR   PRIDE; PXD001550
DR   PRIDE; PXD003539
DR   PRIDE; PXD005235
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0218
DR   PubChem_Cell_line; CVCL_0218
DR   RCB; RCB2127
DR   SKY/M-FISH/CGH; 2801
DR   TKG; TKG 0457
DR   Wikidata; Q54814074
RX   PubMed=565251;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=3629545;
RX   PubMed=6277475;
RX   PubMed=7651727;
RX   PubMed=9023415;
RX   PubMed=9294210;
RX   PubMed=9331090;
RX   PubMed=10051639;
RX   PubMed=10674020;
RX   PubMed=10700174;
RX   PubMed=10737795;
RX   PubMed=11414198;
RX   PubMed=12068308;
RX   PubMed=12584437;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23272949;
RX   PubMed=23631600;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25841592;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28192450;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29718670;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ccl-222-growth-and-morphology
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=19
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-194.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/colo-205-xenograft-model/
WW   Provider; BRICS; BRICS0103; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3909
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: NCI-7 clinical proteomics reference material cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 26.76 hours (PubMed=25944804); 25 hours (PubMed=25984343); 20-25 hours (CLS=300380); 23.8 hours (NCI-DTP=COLO 205).
CC   HLA typing: A*01,02; B*07,08; C*07:02:01,07; DPB1*04:01; DQB1*06:03; DRB1*04:01:01,13:01:01 (PubMed=15748285).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02 (PubMed=9023415).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:01; DQB1*06:11,06:11; DRB1*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (PubMed=17088437; PubMed=24755471; ATCC=CCL-222; Cosmic-CLP=905961; DepMap=ACH-001039).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905961; DepMap=ACH-001039).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (PubMed=9294210).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (PubMed=7651727; PubMed=17088437; PubMed=28683746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.08%; East Asian, South=0%; South Asian=0%; European, North=61.39%; European, South=36.53% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): AddexBio=C0009018/4908; ATCC=CCL-222; CCRID; CLS=300380; Cosmic-CLP=905961; ECACC=87061208; KCLB=10222; PubMed=19372543; PubMed=25877200; PubMed=25926053; RCB=RCB2127; Technion Genomics Center; TKG=TKG 0457
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14,15
ST   D12S391: 15
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D1S1656: 11,15
ST   D21S11: 30.2 (PubMed=19372543)
ST   D21S11: 30.2,33.2 (ATCC=CCL-222; CCRID; CLS=300380; PubMed=25877200; PubMed=25926053; Technion Genomics Center)
ST   D22S1045: 16
ST   D2S1338: 17,18
ST   D2S441: 10,11
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 9 (PubMed=19372543)
ST   D8S1179: 9,14 (ATCC=CCL-222; CCRID; CLS=300380; PubMed=25877200; Technion Genomics Center)
ST   DYS391: 10
ST   FGA: 21,23
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9976 ! COLO 197
OI   CVCL_9977 ! COLO 200
OI   CVCL_1987 ! COLO 201
OI   CVCL_1988 ! COLO 206F
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   COLO 205 SimpleCell O-GalNAc
AC   CVCL_S023
SY   Colo205 SimpleCell; Colo205 SC
DR   cancercelllines; CVCL_S023
DR   Wikidata; Q54814075
RX   PubMed=21983924;
RX   PubMed=23399548;
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   COLO 205-EGFP
AC   CVCL_A9DG
DR   cancercelllines; CVCL_A9DG
DR   CCRID; 1101HUM-PUMC000845
DR   Wikidata; Q108820075
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   COLO 205-Luc2-tdT
AC   CVCL_A9DH
DR   cancercelllines; CVCL_A9DH
DR   CCRID; 1101HUM-PUMC000848
DR   Wikidata; Q108820076
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   COLO 205-mCherry
AC   CVCL_A9DI
DR   cancercelllines; CVCL_A9DI
DR   CCRID; 1101HUM-PUMC000846
DR   Wikidata; Q108820077
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   COLO 205-tdT
AC   CVCL_A9DJ
DR   cancercelllines; CVCL_A9DJ
DR   CCRID; 1101HUM-PUMC000847
DR   Wikidata; Q108820078
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   COLO 205/Cas9-hyg
AC   CVCL_C9EV
DR   GeneCopoeia; SL542
DR   Wikidata; Q123030958
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL542).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   COLO 205/CMV-Luc
AC   CVCL_J248
DR   cancercelllines; CVCL_J248
DR   JCRB; JCRB1451
DR   JCRB; NIHS0703
DR   Wikidata; Q54814076
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1451).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0703; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1451
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   COLO 205(Cas9)
AC   CVCL_E7J3
WW   Provider; BRICS; ECC3017; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3951
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 205_6244R
AC   CVCL_C3GG
SY   C6244-R; C6244-R1
DR   cancercelllines; CVCL_C3GG
DR   Wikidata; Q114310997
RX   PubMed=21447798;
RX   PubMed=31048689;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   COLO 206F
AC   CVCL_1988
SY   Colo-206F; COLO-206F; Colo 206F; COLO206F; COLO 206; COLO206; Colorado 206F
DR   BTO; BTO_0002199
DR   CLO; CLO_0002570
DR   EFO; EFO_0006554
DR   CLDB; cl864
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_1988
DR   Cell_Model_Passport; SIDM00822
DR   ColonAtlas; COLO206F
DR   Cosmic; 2760082
DR   DSMZ; ACC-21
DR   DSMZCellDive; ACC-21
DR   ECACC; 93052620
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM206460
DR   GEO; GSM274776
DR   GEO; GSM513935
DR   GEO; GSM514188
DR   GEO; GSM784009
DR   GEO; GSM1374453
DR   LINCS_LDP; LCL-1159
DR   PharmacoDB; COLO206F_215_2019
DR   Progenetix; CVCL_1988
DR   Wikidata; Q54814077
RX   PubMed=6277475;
RX   PubMed=8464898;
RX   PubMed=10051639;
RX   PubMed=11668190;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~2-3 days (DSMZ=ACC-21).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-21
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9976 ! COLO 197
OI   CVCL_9977 ! COLO 200
OI   CVCL_1987 ! COLO 201
OI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   COLO 229
AC   CVCL_WH78
SY   COLO-229; COLO #229; Colorado 229
DR   Wikidata; Q93456667
RX   PubMed=208962;
RX   PubMed=924690;
CC   Population: Caucasian.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L279 ! COLO 232
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   COLO 232
AC   CVCL_L279
SY   COLO-232; Colo-232; Colo 232; COLO #232; COLO232; COLO 232F; Colorado 232
DR   Cosmic; 925823
DR   Wikidata; Q54814078
RX   PubMed=208962;
RX   PubMed=3708594;
RX   PubMed=6244232;
RX   PubMed=6277475;
RX   PubMed=11416159;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=208962).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 17
ST   D21S11: 28,32.2
ST   D8S1179: 15
ST   FGA: 20
ST   TH01: 9
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WH78 ! COLO 229
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 13
//
ID   COLO 239F
AC   CVCL_9975
SY   COLO 239; COLO #239; Colo 239F; COLO239F; Colo239F; COLOF; COLO-F; Colorado 239F
DR   cancercelllines; CVCL_9975
DR   Cosmic; 888990
DR   Cosmic; 928709
DR   GEO; GSM162934
DR   Wikidata; Q54814079
RX   PubMed=1697409;
RX   PubMed=6277475;
RX   PubMed=7379029;
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   COLO 251
AC   CVCL_A1BQ
SY   COLO #251; Colorado 251
DR   Wikidata; Q102113699
RX   PubMed=7379029;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   COLO 293
AC   CVCL_X397
SY   Colo 293; COLO #293; Colorado 293
DR   Wikidata; Q54814081
RX   PubMed=6277475;
CC   Miscellaneous: Age/sex of donor from archive documents of Moore G.E.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   COLO 296
AC   CVCL_E5HM
SY   COLO #296; Colorado 298
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X388 ! COLO 298
OI   CVCL_E5HN ! COLO 300
OI   CVCL_E5HP ! COLO 302
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 297F
AC   CVCL_X382
SY   COLO #297; Colorado 297
DR   Wikidata; Q54814082
RX   PubMed=6174766;
RX   PubMed=6349783;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 7
//
ID   COLO 298
AC   CVCL_X388
SY   COLO #298; Colorado 298
DR   Wikidata; Q54814083
RX   PubMed=6174766;
RX   PubMed=6277475;
RX   PubMed=6349783;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HM ! COLO 296
OI   CVCL_E5HN ! COLO 300
OI   CVCL_E5HP ! COLO 302
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   COLO 300
AC   CVCL_E5HN
SY   COLO #300; Colorado 300
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HM ! COLO 296
OI   CVCL_X388 ! COLO 298
OI   CVCL_E5HP ! COLO 302
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 302
AC   CVCL_E5HP
SY   COLO #302; Colorado 302
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HM ! COLO 296
OI   CVCL_X388 ! COLO 298
OI   CVCL_E5HN ! COLO 300
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 316
AC   CVCL_5451
SY   COLO-316; Colo 316; COLO #316; COLO316; Colo316; Colorado 316
DR   cancercelllines; CVCL_5451
DR   GEO; GSM784568
DR   Progenetix; CVCL_5451
DR   Wikidata; Q54814085
RX   PubMed=498076;
RX   PubMed=2714338;
RX   PubMed=3518877;
RX   PubMed=6277475;
RX   PubMed=6582512;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 18
//
ID   COLO 319
AC   CVCL_5452
SY   COLO #319; COLO 319F; Colorado 319
DR   Wikidata; Q54814086
RX   PubMed=498076;
RX   PubMed=6277475;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   COLO 320
AC   CVCL_1989
SY   COLO-320; Colo-320; Colo 320; COLO #320; COLO320; Colo320; CoLo320; Co320; COLO 320F; Colorado 320
DR   BTO; BTO_0002047
DR   CLO; CLO_0002571
DR   CLO; CLO_0050628
DR   EFO; EFO_0022664
DR   CLDB; cl828
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821622
DR   BioSample; SAMN03470903
DR   BioSample; SAMN10988542
DR   cancercelllines; CVCL_1989
DR   CCRID; 3101HUMTCHu14
DR   Cell_Model_Passport; SIDM00071
DR   ChEMBL-Cells; CHEMBL3307577
DR   ChEMBL-Targets; CHEMBL614257
DR   ColonAtlas; COLO%20320
DR   Cosmic; 687518
DR   Cosmic; 711268
DR   Cosmic; 738934
DR   Cosmic; 873698
DR   Cosmic; 876712
DR   Cosmic; 887238
DR   Cosmic; 905008
DR   Cosmic; 913888
DR   Cosmic; 948129
DR   Cosmic; 948848
DR   Cosmic; 973606
DR   Cosmic; 995400
DR   Cosmic; 1057763
DR   Cosmic; 1122322
DR   Cosmic; 1132572
DR   Cosmic; 1154642
DR   Cosmic; 1184085
DR   Cosmic; 1187304
DR   Cosmic; 1479627
DR   Cosmic; 1609493
DR   Cosmic; 1676752
DR   Cosmic; 1805249
DR   Cosmic; 2550351
DR   Cosmic; 2800592
DR   DepMap; ACH-000202
DR   DSMZ; ACC-144
DR   DSMZCellDive; ACC-144
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10420-106C6
DR   GEO; GSM794
DR   GEO; GSM741256
DR   GEO; GSM747237
DR   GEO; GSM886941
DR   GEO; GSM888008
DR   GEO; GSM1448152
DR   GEO; GSM1669684
DR   GEO; GSM2549995
DR   IARC_TP53; 30025
DR   LiGeA; CCLE_284
DR   LINCS_LDP; LCL-1174
DR   MetaboLights; MTBLS227
DR   PharmacoDB; COLO320_222_2019
DR   Progenetix; CVCL_1989
DR   PubChem_Cell_line; CVCL_1989
DR   RCB; RCB1193
DR   Wikidata; Q54814087
RX   PubMed=498117;
RX   PubMed=3629545;
RX   PubMed=6277475;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9023415;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=11526487;
RX   PubMed=11668190;
RX   PubMed=11687795;
RX   PubMed=16854228;
RX   PubMed=20570890;
RX   PubMed=22460905;
RX   PubMed=24042735;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 24.19 hours (PubMed=25944804); ~38 hours (DSMZ=ACC-144).
CC   HLA typing: A*24:02; B*14:02; C*08:02 (PubMed=9023415).
CC   HLA typing: A*24:02,24:02; B*14:02,14:02; C*07:01,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=25926053; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.51%; Native American=2.1%; East Asian, North=3.77%; East Asian, South=0.13%; South Asian=9.18%; European, North=3.59%; European, South=80.72% (PubMed=30894373).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): DSMZ=ACC-144; PubMed=25877200; PubMed=25926053; RCB=RCB1193
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 16.2 (PubMed=25877200)
ST   D19S433: 17 (DSMZ=ACC-144)
ST   D21S11: 33.2
ST   D2S1338: 18,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 11 (DSMZ=ACC-144)
ST   Penta E: 11,13 (PubMed=25877200)
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K030 ! COLO 321
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   COLO 320DM
AC   CVCL_0219
SY   COLO-320DM; COLO_320DM; COLO-320-DM; COLO #320DM; COLO320/DM; COLO320-DM; COLO320DM; Colo320DM; COLO320 DM; COLO 320 DM; COLO 320 (DM); Colorado 320 Double Minutes
DR   CLO; CLO_0002546
DR   EFO; EFO_0002136
DR   MCCL; MCC:0000108
DR   CLDB; cl827
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CCL-220
DR   BCRC; 60108
DR   BioSample; SAMN03471612
DR   cancercelllines; CVCL_0219
DR   CCRID; 1101HUM-PUMC000133
DR   CCRID; 3101HUMTCHu208
DR   CCTCC; GDC0042
DR   ChEMBL-Cells; CHEMBL3307647
DR   ChEMBL-Targets; CHEMBL614562
DR   CLS; 300153
DR   ColonAtlas; COLO320DM
DR   Cosmic; 808509
DR   Cosmic; 1043807
DR   Cosmic; 1223136
DR   Cosmic; 1310932
DR   Cosmic; 1312298
DR   Cosmic; 1374635
DR   Cosmic; 1466812
DR   Cosmic; 2301969
DR   Cosmic; 2664052
DR   Cosmic; 2668253
DR   Cosmic; 2760069
DR   Cosmic; 2811047
DR   ECACC; 87061205
DR   EGA; EGAS00001000610
DR   GEO; GSM206461
DR   GEO; GSM274777
DR   GEO; GSM513909
DR   GEO; GSM514187
DR   GEO; GSM739989
DR   GEO; GSM739990
DR   GEO; GSM739991
DR   GEO; GSM740012
DR   GEO; GSM784007
DR   GEO; GSM827245
DR   GEO; GSM1346834
DR   GEO; GSM1374454
DR   GEO; GSM1374455
DR   GEO; GSM1448173
DR   IARC_TP53; 4553
DR   JCRB; JCRB0225
DR   KCB; KCB 200694YJ
DR   KCLB; 10220
DR   LINCS_LDP; LCL-1197
DR   PharmacoDB; COLO320DM_216_2019
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Progenetix; CVCL_0219
DR   PubChem_Cell_line; CVCL_0219
DR   SKY/M-FISH/CGH; 5014
DR   TOKU-E; 985
DR   Wikidata; Q54814089
RX   PubMed=498117;
RX   PubMed=3164477;
RX   PubMed=7651727;
RX   PubMed=7874267;
RX   PubMed=9290701;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=22538498;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=28179481;
RX   PubMed=28196595;
RX   PubMed=29101300;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,24:02; B*14:02,39:10; C*08:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (PubMed=24755471; PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=7651727; PubMed=16418264; PubMed=24755471).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: COLD-320-DM; Cosmic=1466812.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): ATCC=CCL-220; CCRID; CLS=300153; ECACC=87061205; JCRB=JCRB0225; KCLB=10220; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11 (ATCC=CCL-220; CCRID; CLS=300153; JCRB=JCRB0225; KCLB=10220; PubMed=25877200; PubMed=25926053)
ST   CSF1PO: 11,12 (ECACC=87061205)
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 15,16.2 (ATCC=CCL-220)
ST   D19S433: 16.2 (CCRID)
ST   D21S11: 31,33.2 (ATCC=CCL-220; PubMed=25926053)
ST   D21S11: 33.2 (CCRID; CLS=300153; PubMed=25877200)
ST   D2S1338: 18,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 11 (CLS=300153; PubMed=25877200)
ST   Penta E: 11,13 (ATCC=CCL-220)
ST   TH01: 8,9 (ECACC=87061205)
ST   TH01: 9 (ATCC=CCL-220; CCRID; CLS=300153; JCRB=JCRB0225; KCLB=10220; PubMed=25877200; PubMed=25926053)
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1989 ! COLO 320
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   COLO 320DM-EGFP
AC   CVCL_XD07
DR   cancercelllines; CVCL_XD07
DR   CCRID; 1101HUM-PUMC000465
DR   Wikidata; Q93456707
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   COLO 320DM-RFP
AC   CVCL_XD08
DR   cancercelllines; CVCL_XD08
DR   CCRID; 1101HUM-PUMC000466
DR   Wikidata; Q93456710
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): CCRID=1101HUM-PUMC000466
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 16.2
ST   D21S11: 33.2
ST   D2S1338: 18,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 12,13
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 15,16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   COLO 320DM#3
AC   CVCL_A6UJ
SY   COLO 320DM #3; COLO 320 (DM) subclone 3
DR   cancercelllines; CVCL_A6UJ
DR   Wikidata; Q107114695
RX   PubMed=3164477;
RX   PubMed=31569279;
RX   PubMed=33539925;
CC   Population: Caucasian.
CC   Characteristics: Contains multiple DMs with amplified MYC (PubMed=3164477).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   COLO 320DM#3 SIRT1 KO cl.1
AC   CVCL_A6UK
SY   COLO 320DM#3 SIRT1 KO clone 1
DR   cancercelllines; CVCL_A6UK
DR   RCB; RCB5381
DR   Wikidata; Q107114696
RX   PubMed=33539925;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   COLO 320DM#3 SIRT1 KO cl.2
AC   CVCL_A6UL
SY   COLO 320DM#3 SIRT1 KO clone 2
DR   cancercelllines; CVCL_A6UL
DR   RCB; RCB5382
DR   Wikidata; Q107114697
RX   PubMed=33539925;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   COLO 320DM#3 SIRT1 KO cl.3
AC   CVCL_A6UM
SY   COLO 320DM#3 SIRT1 KO clone 3
DR   cancercelllines; CVCL_A6UM
DR   RCB; RCB5383
DR   Wikidata; Q107114698
RX   PubMed=33539925;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   COLO 320DM#3 SIRT1 KO cl.4
AC   CVCL_A6UN
SY   COLO 320DM#3 SIRT1 KO clone 4
DR   cancercelllines; CVCL_A6UN
DR   RCB; RCB5384
DR   Wikidata; Q107114699
RX   PubMed=33539925;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   COLO 320DM#3 SIRT1 KO cl.5
AC   CVCL_A6UP
SY   COLO 320DM#3 SIRT1 KO clone 5
DR   cancercelllines; CVCL_A6UP
DR   RCB; RCB5385
DR   Wikidata; Q107114700
RX   PubMed=33539925;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   COLO 320DM#3 SIRT1 KO cl.6
AC   CVCL_A6UQ
SY   COLO 320DM#3 SIRT1 KO clone 6
DR   cancercelllines; CVCL_A6UQ
DR   RCB; RCB5386
DR   Wikidata; Q107114701
RX   PubMed=33539925;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   COLO 320DMF
AC   CVCL_1990
SY   COLO-320DMF; COLO-320-DMF; COLO 320 DMF; COLO320DMF
DR   CLO; CLO_0002545
DR   CLDB; cl830
DR   CLDB; cl831
DR   cancercelllines; CVCL_1990
DR   Cosmic; 1609480
DR   ECACC; 93051118
DR   ICLC; HTL95027
DR   Wikidata; Q54814090
RX   PubMed=11416159;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 15
ST   D21S11: 31,33.2
ST   D8S1179: 13
ST   FGA: 20
ST   TH01: 8,9
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   COLO 320HSR
AC   CVCL_0220
SY   COLO-320HSR; COLO #320HSR COLO320HSR; COLO 320 HSR; COLO-320-HSR; COLO 320 (HSR); COLO-HSR; Colorado 320 Homogeneously Staining Regions
DR   CLO; CLO_0002547
DR   CLO; CLO_0009960
DR   EFO; EFO_0002137
DR   MCCL; MCC:0000109
DR   CLDB; cl832
DR   CLDB; cl833
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-220.1
DR   BCRC; 60109
DR   BioGRID_ORCS_Cell_line; 847
DR   BioSample; SAMN03473155
DR   cancercelllines; CVCL_0220
DR   Cell_Model_Passport; SIDM00842
DR   ChEMBL-Cells; CHEMBL3308337
DR   ChEMBL-Targets; CHEMBL2366265
DR   CLS; 305271
DR   ColonAtlas; COLO320HSR
DR   Cosmic; 720341
DR   Cosmic; 808508
DR   Cosmic; 910569
DR   Cosmic; 1609506
DR   Cosmic; 1995369
DR   Cosmic-CLP; 910569
DR   DepMap; ACH-002219
DR   ECACC; 87101501
DR   EGA; EGAS00001000978
DR   GDSC; 910569
DR   GEO; GSM206462
DR   GEO; GSM274778
DR   GEO; GSM784008
DR   GEO; GSM843491
DR   GEO; GSM1448182
DR   GEO; GSM1669685
DR   IARC_TP53; 21232
DR   IGRhCellID; COLO320HSR
DR   KCLB; 10220.1
DR   LINCS_LDP; LCL-1189
DR   PharmacoDB; COLO320HSR_223_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0220
DR   PubChem_Cell_line; CVCL_0220
DR   TOKU-E; 986
DR   Wikidata; Q54814091
RX   PubMed=498117;
RX   PubMed=3164477;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=2.14%; East Asian, North=0.47%; East Asian, South=2.14%; South Asian=10.52%; European, North=6.29%; European, South=78.44% (PubMed=30894373).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): ATCC=CCL-220.1; Cosmic-CLP=910569; KCLB=10220.1; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 15,16.2
ST   D21S11: 31,33.2
ST   D2S1338: 18,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 11,13
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   COLO 321
AC   CVCL_K030
SY   COLO #321; Colorado 321
DR   Wikidata; Q54814092
RX   PubMed=498117;
RX   PubMed=6277475;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1989 ! COLO 320
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   COLO 322
AC   CVCL_E5HQ
SY   COLO #322; Colorado 322
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X383 ! COLO 324
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 324
AC   CVCL_X383
SY   COLO #324; Colorado 324
DR   Wikidata; Q54814093
RX   PubMed=6174766;
RX   PubMed=6349783;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HQ ! COLO 322
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 7
//
ID   COLO 330
AC   CVCL_5453
SY   COLO #330; Colorado 330
DR   Wikidata; Q54814094
RX   PubMed=498076;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   COLO 338
AC   CVCL_X394
SY   Colo 338; COLO #338; Colorado 338
DR   Wikidata; Q54814095
RX   CelloPub=CLPUB00149;
RX   PubMed=6277475;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 342
AC   CVCL_E5HR
SY   COLO #342; Colorado 342
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HS ! COLO 343
OI   CVCL_X385 ! COLO 349
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 343
AC   CVCL_E5HS
SY   COLO #343; Colorado 343
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HR ! COLO 342
OI   CVCL_X385 ! COLO 349
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 346
AC   CVCL_X404
SY   COLO #346; COLO 346F; Colorado 346
DR   Wikidata; Q54814096
RX   PubMed=6277475;
RX   PubMed=7262900;
CC   Population: Hispanic.
CC   Doubling time: 36 hours (PubMed=7262900).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9166; Gallbladder adenocarcinoma
DI   ORDO; Orphanet_424991; Adenocarcinoma of the gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   COLO 349
AC   CVCL_X385
SY   COLO #349; Colorado 349
DR   Wikidata; Q54814097
RX   PubMed=6174766;
RX   PubMed=6277475;
RX   PubMed=6349783;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HR ! COLO 342
OI   CVCL_E5HS ! COLO 343
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   COLO 353
AC   CVCL_X392
SY   COLO #353; Colorado 353
DR   Wikidata; Q54814098
RX   PubMed=6277475;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 5
//
ID   COLO 357
AC   CVCL_0221
SY   COLO-357; Colo-357; Colo 357; COLO #357; COLO357; Colo357; Colorado 357
DR   BTO; BTO_0003440
DR   CLO; CLO_0002548
DR   EFO; EFO_0002710
DR   MCCL; MCC:0000506
DR   CLDB; cl5052
DR   cancercelllines; CVCL_0221
DR   Cell_Model_Passport; SIDM01654
DR   ChEMBL-Cells; CHEMBL3307702
DR   ChEMBL-Targets; CHEMBL614778
DR   Cosmic; 685615
DR   Cosmic; 724642
DR   Cosmic; 736272
DR   Cosmic; 808167
DR   Cosmic; 922258
DR   Cosmic; 933529
DR   Cosmic; 949233
DR   Cosmic; 1006371
DR   Cosmic; 1198206
DR   ECACC; 94072245
DR   GEO; GSM621898
DR   PubChem_Cell_line; CVCL_0221
DR   Wikidata; Q54814099
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=1764370;
RX   PubMed=3815343;
RX   PubMed=6277475;
RX   PubMed=6435863;
RX   PubMed=6989766;
RX   PubMed=8426738;
RX   PubMed=11169959;
RX   PubMed=12692724;
RX   PubMed=12800145;
RX   PubMed=14695172;
RX   PubMed=16912165;
RX   PubMed=18298655;
RX   PubMed=20037478;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/Colo%20357.html
CC   Population: African American.
CC   Doubling time: 21 hours (PubMed=6989766).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8426738; PubMed=11169959).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Discontinued: ECACC; 94072245; true.
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,15
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 11,13
ST   D1S1656: 15
ST   D21S11: 29,32.2
ST   D22S1045: 11
ST   D2S1338: 21,24
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 25
ST   Penta D: 5,9
ST   Penta E: 8,9
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   COLO 357-TRS4
AC   CVCL_RL60
SY   COLO-TRS4
DR   cancercelllines; CVCL_RL60
DR   Wikidata; Q54814100
RX   PubMed=16135802;
CC   Population: African American.
CC   Characteristics: Expresses tetracyclin-inducible SMAD4 siRNA.
CC   Knockout cell: Method=siRNA knockdown; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0221 ! COLO 357
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   COLO 357/FG
AC   CVCL_8196
SY   FG; Colo 357 FG; Colo 357/FG; Colo357FG; COLO357FG; FG/COLO357; COLO 357 Fast Growing
DR   cancercelllines; CVCL_8196
DR   Wikidata; Q54814102
RX   PubMed=1544114;
RX   PubMed=3815343;
RX   PubMed=15235133;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0221 ! COLO 357
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   COLO 357/FG-2
AC   CVCL_N514
SY   FG-2; FG2; FG-Met-2; FG-Met2
DR   cancercelllines; CVCL_N514
DR   ChEMBL-Cells; CHEMBL3307953
DR   ChEMBL-Targets; CHEMBL612407
DR   Cosmic; 922253
DR   PubChem_Cell_line; CVCL_N514
DR   Wikidata; Q54814103
RX   PubMed=3815343;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8196 ! COLO 357/FG
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   COLO 357/SG
AC   CVCL_IP74
SY   SG; Colo 357 SG; COLO 357 Slow Growing
DR   cancercelllines; CVCL_IP74
DR   Wikidata; Q54814106
RX   PubMed=1544114;
RX   PubMed=3815343;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0221 ! COLO 357
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   COLO 358
AC   CVCL_E5HT
SY   COLO #358; Colorado 358
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HU ! COLO 361
OI   CVCL_E5HV ! COLO 362
OI   CVCL_E5HW ! COLO 363
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 361
AC   CVCL_E5HU
SY   COLO #361; Colorado 361
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HT ! COLO 358
OI   CVCL_E5HV ! COLO 362
OI   CVCL_E5HW ! COLO 363
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 362
AC   CVCL_E5HV
SY   COLO #362; Colorado 362
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HT ! COLO 358
OI   CVCL_E5HU ! COLO 361
OI   CVCL_E5HW ! COLO 363
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 363
AC   CVCL_E5HW
SY   COLO #363; Colorado 363
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HT ! COLO 358
OI   CVCL_E5HU ! COLO 361
OI   CVCL_E5HV ! COLO 362
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 368
AC   CVCL_X389
SY   COLO #368; Colorado 368
DR   Wikidata; Q54814107
RX   PubMed=6174766;
RX   PubMed=6277475;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Flank, skin; UBERON=UBERON_8480023.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X384 ! COLO 381
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   COLO 38
AC   CVCL_3934
SY   Colo-38; Colo 38; COLO #38; Colo38; COLO38; Colorado 38
DR   BTO; BTO_0002941
DR   cancercelllines; CVCL_3934
DR   CLS; 300151
DR   Cosmic; 928682
DR   Cosmic; 1477405
DR   Cosmic; 2757118
DR   Wikidata; Q54814108
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=72600;
RX   PubMed=15661905;
RX   PubMed=24732172;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (ICLAC). Originally thought to originate from a 67 year old female patient with a melanoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00556.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24732172).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: CLS; 300151; true.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ICLAC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   COLO 381
AC   CVCL_X384
SY   COLO #381; Colorado 381
DR   Wikidata; Q54814109
RX   PubMed=6174766;
RX   PubMed=6349783;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Flank, skin; UBERON=UBERON_8480023.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X389 ! COLO 368
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   COLO 38R
AC   CVCL_A1FC
SY   Colo38-R; Colo38R
DR   cancercelllines; CVCL_A1FC
DR   Cosmic; 2757119
DR   Wikidata; Q102113700
RX   PubMed=24732172;
CC   Problematic cell line: Contaminated. Parent cell line (COLO 38) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24732172).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3934 ! COLO 38
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   COLO 383
AC   CVCL_E5HX
SY   COLO #383; Colorado 383
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X386 ! COLO 415
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 394
AC   CVCL_6976
SY   COLO-394; COLO #394; COLO394; Colorado 394
DR   CCRID; 4201PAT-CCTCC00074
DR   Wikidata; Q54814110
RX   PubMed=6277475;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X398 ! COLO 397
OI   CVCL_X399 ! COLO 463
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   COLO 397
AC   CVCL_X398
SY   Colo 397; COLO #397; Colorado 397
DR   Wikidata; Q54814111
RX   PubMed=3629545;
RX   PubMed=6277475;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6976 ! COLO 394
OI   CVCL_X399 ! COLO 463
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   COLO 415
AC   CVCL_X386
SY   COLO #415; Colorado 415
DR   Wikidata; Q54814112
RX   PubMed=6174766;
RX   PubMed=6277475;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HX ! COLO 383
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   COLO 417
AC   CVCL_X387
SY   COLO #417; Colorado 417
DR   Wikidata; Q54814113
RX   PubMed=6174766;
RX   PubMed=6349783;
CC   Population: Caucasian.
CC   Donor information: Established from a donor suffering from schizophrenia.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HY ! COLO 419
OI   CVCL_E5HZ ! COLO 437
OI   CVCL_E5I0 ! COLO 441v
OI   CVCL_E5I1 ! COLO 442v
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   COLO 419
AC   CVCL_E5HY
SY   COLO #419; Colorado 419
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Donor information: Established from a donor suffering from schizophrenia.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X387 ! COLO 417
OI   CVCL_E5HZ ! COLO 437
OI   CVCL_E5I0 ! COLO 441v
OI   CVCL_E5I1 ! COLO 442v
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 437
AC   CVCL_E5HZ
SY   COLO #437; Colorado 437
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Donor information: Established from a donor suffering from schizophrenia.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X387 ! COLO 417
OI   CVCL_E5HY ! COLO 419
OI   CVCL_E5I0 ! COLO 441v
OI   CVCL_E5I1 ! COLO 442v
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 441v
AC   CVCL_E5I0
SY   COLO #441v; Colorado 441v
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Donor information: Established from a donor suffering from schizophrenia.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X387 ! COLO 417
OI   CVCL_E5HY ! COLO 419
OI   CVCL_E5HZ ! COLO 437
OI   CVCL_E5I1 ! COLO 442v
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 442v
AC   CVCL_E5I1
SY   COLO #442v; Colorado 442v
RX   PubMed=6174766;
CC   Population: Caucasian.
CC   Donor information: Established from a donor suffering from schizophrenia.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X387 ! COLO 417
OI   CVCL_E5HY ! COLO 419
OI   CVCL_E5HZ ! COLO 437
OI   CVCL_E5I0 ! COLO 441v
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COLO 463
AC   CVCL_X399
SY   COLO #463; Colorado 463
DR   Wikidata; Q54814114
RX   PubMed=6277475;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6976 ! COLO 394
OI   CVCL_X398 ! COLO 397
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   COLO 508
AC   CVCL_X402
SY   COLO #508; Colorado 508
DR   Wikidata; Q54814115
RX   CelloPub=CLPUB00149;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X395 ! COLO 509
OI   CVCL_X401 ! COLO 510
OI   CVCL_X396 ! COLO 511
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 509
AC   CVCL_X395
SY   COLO #509; Colorado 509
DR   Wikidata; Q54814116
RX   CelloPub=CLPUB00149;
RX   PubMed=6277475;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X402 ! COLO 508
OI   CVCL_X401 ! COLO 510
OI   CVCL_X396 ! COLO 511
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 510
AC   CVCL_X401
SY   COLO #510; Colorado 510
DR   Wikidata; Q54814117
RX   CelloPub=CLPUB00149;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X402 ! COLO 508
OI   CVCL_X395 ! COLO 509
OI   CVCL_X396 ! COLO 511
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 511
AC   CVCL_X396
SY   COLO #511; Colorado 511
DR   Wikidata; Q54814118
RX   CelloPub=CLPUB00149;
RX   PubMed=6277475;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X402 ! COLO 508
OI   CVCL_X395 ! COLO 509
OI   CVCL_X401 ! COLO 510
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 52
AC   CVCL_X378
SY   COLO #52; Colorado 52
DR   Wikidata; Q54814119
RX   DOI=10.1093/jnci/59.2.301;
CC   Miscellaneous: Age of donor from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X379 ! COLO 53
OI   CVCL_X380 ! COLO 55
OI   CVCL_A1BR ! COLO 59
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 525
AC   CVCL_X390
SY   Colo 525; COLO #525; Colorado 525
DR   Wikidata; Q54814120
RX   PubMed=6277475;
CC   Miscellaneous: Age/sex of donor from archive documents of Moore G.E.
CC   Caution: From a melanoma according to PubMed=6277475 and from a lung carcinoma according to archive documents of Moore G.E.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X391 ! COLO 527
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   COLO 526
AC   CVCL_X400
SY   Colo 526; COLO #526; Colorado 526
DR   Wikidata; Q54814121
RX   PubMed=3629545;
RX   PubMed=6277475;
RX   PubMed=9213340;
CC   Miscellaneous: Age of donor from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   COLO 527
AC   CVCL_X391
SY   Colo 527; COLO #527; Colorado 527
DR   Wikidata; Q54814122
RX   PubMed=6277475;
CC   Miscellaneous: Age/sex of donor from archive documents of Moore G.E.
CC   Caution: From a melanoma according to PubMed=6277475 and from a lung carcinoma according to archive documents of Moore G.E.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X390 ! COLO 525
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   COLO 53
AC   CVCL_X379
SY   COLO #53; Colorado 53
DR   Wikidata; Q54814123
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=72600;
CC   Miscellaneous: Age of donor from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X378 ! COLO 52
OI   CVCL_X380 ! COLO 55
OI   CVCL_A1BR ! COLO 59
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 534
AC   CVCL_X393
SY   COLO #534; Colorado 534
DR   Wikidata; Q54814124
RX   PubMed=6277475;
CC   Miscellaneous: Age/sex of donor from archive documents of Moore G.E.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   COLO 55
AC   CVCL_X380
SY   COLO #55; Colorado 55
DR   Wikidata; Q54814125
RX   DOI=10.1093/jnci/59.2.301;
CC   Miscellaneous: Age of donor from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X378 ! COLO 52
OI   CVCL_X379 ! COLO 53
OI   CVCL_A1BR ! COLO 59
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   COLO 587
AC   CVCL_F641
SY   COLO-587; COLO #587; COLO587; Colorado 587
DR   ATCC; CRL-2000
DR   BioSample; SAMN03151627
DR   cancercelllines; CVCL_F641
DR   GEO; GSM784695
DR   IZSLER; BS TCL 167
DR   Progenetix; CVCL_F641
DR   Wikidata; Q54814126
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/colo-587-atcc-crl-2000
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a COLO 320DM derivative. Originally thought to originate from the ascites of a 56 year old female patient with a mesothelioma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00396.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: ATCC; CRL-2000; true.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): ATCC=CRL-2000; IZSLER=BS TCL 167
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 31,33.2
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0219 ! COLO 320DM
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 25
//
ID   COLO 59
AC   CVCL_A1BR
SY   COLO #59; Colorado 59
DR   Wikidata; Q102113701
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=72600;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Age of donor from archive documents of Moore G.E.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X378 ! COLO 52
OI   CVCL_X379 ! COLO 53
OI   CVCL_X380 ! COLO 55
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   COLO 591
AC   CVCL_A1CX
SY   COLO #591; Colorado 591
DR   Wikidata; Q102113702
RX   CelloPub=CLPUB00796;
CC   Miscellaneous: Cell line information from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   COLO 60H
AC   CVCL_4572
SY   COLO-60H; Colo-60H; COLO60H
DR   CLS; 300456
DR   GEO; GSM1448094
DR   Wikidata; Q54814127
RX   PubMed=25926053;
CC   HLA typing: A*02:01 (CLS=300456).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
ST   Source(s): CLS=300456; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,15
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 13,15
ST   D19S433: 12,13
ST   D21S11: 29,33.2
ST   D2S1338: 21,24
ST   D3S1358: 15,16,17
ST   D5S818: 9,16
ST   D7S820: 7.3,10
ST   D8S1179: 11
ST   FGA: 21,24
ST   Penta D: 14
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 7,10
ST   vWA: 15,16,17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   COLO 660
AC   CVCL_A1BS
SY   COLO #660; Colorado 660
DR   Wikidata; Q102113703
CC   Miscellaneous: Cell line information from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   COLO 667
AC   CVCL_A430
SY   Colo 667; Colo-667; COLO667; Colorado 667
DR   Cosmic; 1070715
DR   Cosmic; 1071884
DR   Wikidata; Q54814128
RX   PubMed=2823272;
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   COLO 668
AC   CVCL_1128
SY   Colo 668; COLO-668; COLO668; Colo668; Colorado 668
DR   CLO; CLO_0002549
DR   CLO; CLO_0009995
DR   EFO; EFO_0002138
DR   CLDB; cl835
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10987711
DR   cancercelllines; CVCL_1128
DR   Cell_Model_Passport; SIDM00143
DR   ChEMBL-Cells; CHEMBL3308864
DR   ChEMBL-Targets; CHEMBL2366215
DR   Cosmic; 877393
DR   Cosmic; 910692
DR   Cosmic; 1152488
DR   Cosmic; 1995370
DR   Cosmic-CLP; 910692
DR   DepMap; ACH-000803
DR   ECACC; 87061209
DR   EGA; EGAS00001000978
DR   GDSC; 910692
DR   GEO; GSM17195
DR   GEO; GSM886942
DR   GEO; GSM888009
DR   GEO; GSM1669686
DR   GEO; GSM1887952
DR   GEO; GSM1888029
DR   IARC_TP53; 21231
DR   LiGeA; CCLE_861
DR   LINCS_LDP; LCL-1867
DR   PharmacoDB; COLO668_224_2019
DR   PRIDE; PXD030304
DR   PRIDE; PXD033685
DR   Progenetix; CVCL_1128
DR   PubChem_Cell_line; CVCL_1128
DR   Wikidata; Q54814129
RX   PubMed=11668190;
RX   PubMed=15016488;
RX   PubMed=18397470;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=18397470).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=910692; DepMap=ACH-000803).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu337Trpfs*12 (c.1010delG); Zygosity=Heterozygous (Cosmic-CLP=910692; DepMap=ACH-000803).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln436Ter (c.1306C>T); ClinVar=VCV003236968; Zygosity=Heterozygous (Cosmic-CLP=910692; DepMap=ACH-000803).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Heterozygous (Cosmic-CLP=910692; DepMap=ACH-000803).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.4%; Native American=16.55%; East Asian, North=3.63%; East Asian, South=0%; South Asian=3.09%; European, North=28.55%; European, South=45.77% (PubMed=30894373).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=910692; ECACC=87061209
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,10 (Cosmic-CLP=910692)
ST   D7S820: 8.2,10 (ECACC=87061209)
ST   TH01: 9
ST   TPOX: 8 (ECACC=87061209)
ST   TPOX: 8,11 (Cosmic-CLP=910692)
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   COLO 677
AC   CVCL_1862
SY   COLO-677; COLO #677; COLO677; Colorado 677
DR   CLO; CLO_0002550
DR   CLDB; cl837
DR   CLDB; cl838
DR   BioSample; SAMN03151910
DR   cancercelllines; CVCL_1862
DR   Cosmic; 753542
DR   DSMZ; ACC-248
DR   DSMZCellDive; ACC-248
DR   ECACC; 93072109
DR   GEO; GSM784242
DR   IARC_TP53; 21233
DR   PharmacoDB; COLO677_225_2019
DR   Progenetix; CVCL_1862
DR   Wikidata; Q54814130
RX   CelloPub=CLPUB00604;
RX   PubMed=11668190;
RX   PubMed=20143388;
RX   PubMed=32123307;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Problematic cell line: Contaminated. Shown to be a RPMI-8226 derivative (PubMed=20143388). Originally thought to originate from the lymph nodes of a 50 year old male patient with a small cell lung carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00299.
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Doubling time: ~40 hours (DSMZ=ACC-248).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: DSMZ; ACC-248; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-248
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 15,19
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 3,11
ST   Penta E: 16,17
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   COLO 678
AC   CVCL_1129
SY   Colo-678; COLO-678; COLO #678; COLO678; Colorado 678
DR   BTO; BTO_0002200
DR   CLO; CLO_0002572
DR   EFO; EFO_0006371
DR   CLDB; cl865
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 607
DR   BioSample; SAMN03473135
DR   BioSample; SAMN10988483
DR   cancercelllines; CVCL_1129
DR   Cell_Model_Passport; SIDM00957
DR   ChEMBL-Cells; CHEMBL3308349
DR   ChEMBL-Targets; CHEMBL1075425
DR   ColonAtlas; COLO678
DR   Cosmic; 910689
DR   Cosmic; 948821
DR   Cosmic; 995379
DR   Cosmic; 1312299
DR   Cosmic; 1995371
DR   Cosmic; 2301970
DR   Cosmic; 2800586
DR   Cosmic-CLP; 910689
DR   DepMap; ACH-000350
DR   DSMZ; ACC-194
DR   DSMZCellDive; ACC-194
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910689
DR   GEO; GSM206463
DR   GEO; GSM274779
DR   GEO; GSM513929
DR   GEO; GSM514189
DR   GEO; GSM784010
DR   GEO; GSM886943
DR   GEO; GSM888010
DR   GEO; GSM1346868
DR   GEO; GSM1374456
DR   GEO; GSM1448174
DR   GEO; GSM1669687
DR   GEO; GSM2549996
DR   IARC_TP53; 21234
DR   LiGeA; CCLE_077
DR   LINCS_LDP; LCL-1160
DR   PharmacoDB; COLO678_226_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1129
DR   PubChem_Cell_line; CVCL_1129
DR   Wikidata; Q54814131
RX   PubMed=10737795;
RX   PubMed=11668190;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~60-70 hours (DSMZ=ACC-194).
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=910689; DepMap=ACH-000350).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=24755471; PubMed=28683746; Cosmic-CLP=910689; DepMap=ACH-000350).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.56%; Native American=0.29%; East Asian, North=3.34%; East Asian, South=0%; South Asian=0%; European, North=57.97%; European, South=35.83% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=910689; DSMZ=ACC-194; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 9
ST   D18S51: 11,14
ST   D19S433: 14
ST   D21S11: 27,29
ST   D2S1338: 24
ST   D3S1358: 15,18
ST   D5S818: 13,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 25,27
ST   Penta D: 11,14
ST   Penta E: 10,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   COLO 679
AC   CVCL_1130
SY   COLO-679; COLO #679; COLO679; Colorado 679
DR   CLO; CLO_0002551
DR   CLO; CLO_0037120
DR   CLO; CLO_0050697
DR   EFO; EFO_0006372
DR   CLDB; cl839
DR   CLDB; cl840
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 606
DR   BioSample; SAMN03473118
DR   BioSample; SAMN10988260
DR   cancercelllines; CVCL_1130
DR   Cell_Model_Passport; SIDM00284
DR   ChEMBL-Cells; CHEMBL3308723
DR   ChEMBL-Targets; CHEMBL1075426
DR   Cosmic; 687433
DR   Cosmic; 906818
DR   Cosmic; 1995372
DR   Cosmic-CLP; 906818
DR   DepMap; ACH-000805
DR   DSMZ; ACC-264
DR   DSMZCellDive; ACC-264
DR   ECACC; 87061210
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10514-107E1
DR   GDSC; 906818
DR   GEO; GSM886944
DR   GEO; GSM888011
DR   GEO; GSM1669688
DR   IARC_TP53; 21235
DR   LiGeA; CCLE_683
DR   LINCS_HMS; 50011
DR   LINCS_LDP; LCL-1232
DR   PharmacoDB; COLO679_227_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1130
DR   PubChem_Cell_line; CVCL_1130
DR   RCB; RCB0989
DR   Wikidata; Q54814132
RX   DOI=10.1111/j.1755-148X.2009.00641.x;
RX   PubMed=7780963;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=22170099;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~34 hours (DSMZ=ACC-264).
CC   HLA typing: A*01:01,24:02; B*08:01,51:01; C*07:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=906818; DepMap=ACH-000805).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.47%; East Asian, South=0.33%; South Asian=0.94%; European, North=65.46%; European, South=32.79% (PubMed=30894373).
CC   Misspelling: COLO 697; DOI=10.1111/j.1755-148X.2009.00641.x.
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
ST   Source(s): Cosmic-CLP=906818; DSMZ=ACC-264; ECACC=87061210; PubMed=11416159; PubMed=25877200; RCB=RCB0989
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 19,25
ST   Penta D: 7,11
ST   Penta E: 5,13
ST   TH01: 7,9
ST   TPOX: 9,12
ST   vWA: 15
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   COLO 679-Luc
AC   CVCL_J249
DR   cancercelllines; CVCL_J249
DR   JCRB; JCRB1377
DR   JCRB; NIHS0642
DR   Wikidata; Q54814134
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0642; true.
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
ST   Source(s): JCRB=JCRB1377
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9
ST   TPOX: 9,12
ST   vWA: 15
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1130 ! COLO 679
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   COLO 680N
AC   CVCL_1131
SY   COLO-680N; COLO #680N; COLO680N; Colorado 680N
DR   CLO; CLO_0002573
DR   EFO; EFO_0006373
DR   CLDB; cl866
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 848
DR   BioSample; SAMN03471044
DR   BioSample; SAMN03473366
DR   BioSample; SAMN10988482
DR   cancercelllines; CVCL_1131
DR   Cell_Model_Passport; SIDM00956
DR   ChEMBL-Cells; CHEMBL3308724
DR   ChEMBL-Targets; CHEMBL1075427
DR   CLS; 300464
DR   Cosmic; 906817
DR   Cosmic-CLP; 906817
DR   DepMap; ACH-000717
DR   DSMZ; ACC-182
DR   DSMZCellDive; ACC-182
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906817
DR   GEO; GSM827548
DR   GEO; GSM886945
DR   GEO; GSM888012
DR   GEO; GSM1669689
DR   IARC_TP53; 21236
DR   LiGeA; CCLE_092
DR   LINCS_LDP; LCL-1551
DR   PharmacoDB; COLO680N_228_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1131
DR   PubChem_Cell_line; CVCL_1131
DR   Wikidata; Q54814135
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Characteristics: Established from a nude mice xenograft.
CC   Doubling time: ~60 hours (CLS=300464); ~60-70 hours (DSMZ=ACC-182).
CC   HLA typing: A*02:01,30:02; B*15:16,57:01; C*06:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (Cosmic-CLP=906817; DepMap=ACH-000717).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=83.09%; Native American=0%; East Asian, North=4.36%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=12.54% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): CLS=300464; Cosmic-CLP=906817; DSMZ=ACC-182; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 19
ST   D21S11: 27
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 18.2
ST   Penta D: 12
ST   Penta E: 7,8
ST   TH01: 8
ST   TPOX: 6 (CLS=300464; PubMed=25877200)
ST   TPOX: 6,8 (Cosmic-CLP=906817; DSMZ=ACC-182)
ST   vWA: 17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   COLO 684
AC   CVCL_1132
SY   COLO-684; COLO #684; COLO684; Colo684; Colorado 684
DR   CLO; CLO_0002552
DR   CLDB; cl841
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 849
DR   BioSample; SAMN03470977
DR   BioSample; SAMN10988054
DR   cancercelllines; CVCL_1132
DR   Cell_Model_Passport; SIDM00142
DR   ChEMBL-Cells; CHEMBL3308284
DR   ChEMBL-Targets; CHEMBL2366176
DR   Cosmic; 910691
DR   Cosmic-CLP; 910691
DR   DepMap; ACH-000864
DR   ECACC; 87061203
DR   EGA; EGAS00001000978
DR   GDSC; 910691
DR   GEO; GSM827423
DR   GEO; GSM888013
DR   GEO; GSM1669690
DR   LiGeA; CCLE_897
DR   LINCS_LDP; LCL-1504
DR   PharmacoDB; COLO684_229_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1132
DR   PubChem_Cell_line; CVCL_1132
DR   Wikidata; Q54814136
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,11:01; B*07:02,45:01; C*04:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (Cosmic-CLP=910691; DepMap=ACH-000864).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.07%; East Asian, South=0%; South Asian=0%; European, North=67.5%; European, South=30.43% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Cosmic-CLP=910691; ECACC=87061203; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D21S11: 27,31.2
ST   D2S1338: 18,22
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   D8S1179: 11,12
ST   FGA: 19,20,23
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 7,8
ST   vWA: 14,15,16
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1991 ! COLO 685
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   COLO 685
AC   CVCL_1991
SY   COLO-685; COLO #685; COLO685; Colorado 685
DR   CLO; CLO_0002553
DR   CLDB; cl842
DR   BioSample; SAMN03470978
DR   cancercelllines; CVCL_1991
DR   Cell_Model_Passport; SIDM00141
DR   ECACC; 87061206
DR   GEO; GSM827424
DR   Progenetix; CVCL_1991
DR   Wikidata; Q54814137
RX   PubMed=20215515;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ECACC=87061206; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D21S11: 27,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   D8S1179: 11,12
ST   FGA: 20,23
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1132 ! COLO 684
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   COLO 699
AC   CVCL_1992
SY   COLO-699; Colo-699; COLO #699; Colo699; COLO699; Colorado 699; CHL1DM
DR   BTO; BTO_0003017
DR   CLO; CLO_0002574
DR   EFO; EFO_0006374
DR   CLDB; cl868
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473074
DR   BioSample; SAMN10989575
DR   cancercelllines; CVCL_1992
DR   Cell_Model_Passport; SIDM00911
DR   Cosmic; 844591
DR   Cosmic; 877394
DR   Cosmic; 1028946
DR   Cosmic; 1146950
DR   Cosmic; 1152489
DR   DepMap; ACH-001041
DR   DSMZ; ACC-196
DR   DSMZCellDive; ACC-196
DR   EGA; EGAS00001000610
DR   GEO; GSM434300
DR   GEO; GSM886946
DR   GEO; GSM888014
DR   IGRhCellID; COLO699GEO
DR   PharmacoDB; COLO699_230_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_1992
DR   Wikidata; Q54814138
RX   PubMed=10908148;
RX   PubMed=11668190;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=31068700;
CC   Problematic cell line: Contaminated. Shown to be a CHL-1 (or RPMI-7932) derivative (DSMZ=ACC-196; DepMap=ACH-001041). Originally thought to originate from the pleural effusion of a 57 year old female patient with lung adenocarcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~38 hours (DSMZ=ACC-196).
CC   HLA typing: A*02:01,02:01; B*07:02,37:04; C*06:02,07:02 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2352; CREM + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-CREM (DepMap=ACH-001041).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Ile228Val (c.682A>G); Zygosity=Heterozygous (DepMap=ACH-001041).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DepMap=ACH-001041).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: DSMZ; ACC-196; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-196; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 11,12
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 10,13
ST   FGA: 23
ST   Penta D: 12,14
ST   Penta E: 10,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1122 ! CHL-1
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   COLO 699N
AC   CVCL_1993
SY   COLO 699 N; COLO-699N; COLO #699N; Colorado 699N
DR   CLO; CLO_0002554
DR   CLO; CLO_0002555
DR   CLDB; cl843
DR   CLDB; cl844
DR   Cell_Model_Passport; SIDM00912
DR   Cosmic; 687779
DR   ECACC; 93052608
DR   ICLC; HTL95009
DR   Wikidata; Q54814139
CC   Problematic cell line: Contaminated. Shown to be a CHL-1 (or RPMI-7932) derivative (ECACC=93052608). Originally thought to originate from the pleural effusion of a 57 year old female patient with lung adenocarcinoma.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2352; CREM + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-CREM (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Ile228Val (c.682A>G); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=93052608
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1122 ! CHL-1
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   COLO 704
AC   CVCL_1994
SY   COLO-704; COLO #704; COLO704; Colorado 704
DR   CLO; CLO_0002575
DR   EFO; EFO_0002139
DR   CLDB; cl869
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473293
DR   BioSample; SAMN03473372
DR   BioSample; SAMN10988210
DR   cancercelllines; CVCL_1994
DR   Cell_Model_Passport; SIDM01719
DR   Cosmic; 688095
DR   Cosmic; 1707567
DR   DepMap; ACH-001042
DR   DSMZ; ACC-198
DR   DSMZCellDive; ACC-198
DR   EGA; EGAS00001000610
DR   GEO; GSM274700
DR   GEO; GSM659372
DR   GEO; GSM886947
DR   GEO; GSM888015
DR   GEO; GSM1001490
DR   IGRhCellID; COLO704
DR   LINCS_LDP; LCL-1531
DR   PharmacoDB; COLO704_231_2019
DR   Progenetix; CVCL_1994
DR   Wikidata; Q54814140
RX   PubMed=11668190;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=25984343); ~30-40 hours (DSMZ=ACC-198).
CC   HLA typing: A*02:01,11:01; B*07:02,45:01; C*04:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (DepMap=ACH-001042).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys382Asnfs*40 (c.1146delA); ClinVar=VCV001408583; Zygosity=Heterozygous (PubMed=24023729).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.08%; East Asian, North=1.33%; East Asian, South=0.27%; South Asian=0%; European, North=68.17%; European, South=30.15% (PubMed=30894373).
CC   Caution: According to DSMZ from a 46 year old female and from ascite fluids while archive documents of Moore G.E. indicate a 50 year old female and from a pleural effusion.
CC   Discontinued: DSMZ; ACC-198; true.
CC   Derived from site: Metastatic; Ascites; Note=From a colon metastasis; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-198; PubMed=22710073; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,11 (PubMed=22710073)
ST   CSF1PO: 11 (PubMed=25877200)
ST   CSF1PO: 11,12 (DSMZ=ACC-198; PubMed=30485824)
ST   D13S317: 12 (DSMZ=ACC-198; PubMed=25877200)
ST   D13S317: 12,13 (PubMed=22710073; PubMed=30485824)
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 13,14,15 (PubMed=22710073)
ST   D19S433: 14,15 (DSMZ=ACC-198)
ST   D21S11: 27,31.2
ST   D2S1338: 18,22
ST   D3S1358: 14,17
ST   D5S818: 11,12,13 (PubMed=30485824)
ST   D5S818: 12,13 (DSMZ=ACC-198; PubMed=22710073; PubMed=25877200)
ST   D7S820: 11,12,13 (PubMed=22710073)
ST   D7S820: 11,13 (DSMZ=ACC-198; PubMed=25877200; PubMed=30485824)
ST   D8S1179: 11,12
ST   FGA: 20,23
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 7,8
ST   vWA: 15,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   COLO 716
AC   CVCL_A1BU
SY   COLO #716; Colorado 716
DR   Wikidata; Q102113704
CC   Miscellaneous: Cell line information from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   COLO 719
AC   CVCL_A1CW
SY   COLO #719; Colorado 719
DR   Wikidata; Q102113705
CC   Miscellaneous: Cell line information from archive documents of Moore G.E.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   COLO 720E
AC   CVCL_1995
SY   COLO 720 E; COLO-720E; COLO720E; Colo720E; Colorado 720E
DR   CLO; CLO_0002556
DR   CLDB; cl845
DR   cancercelllines; CVCL_1995
DR   Cosmic; 688126
DR   Cosmic; 1707568
DR   GEO; GSM711727
DR   IARC_TP53; 21240
DR   Wikidata; Q54814141
RX   PubMed=20164919;
RX   PubMed=22710073;
RX   PubMed=24023729;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by COLO 704 (Cellosaurus=CVCL_AV69).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00438.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala138Val (c.413C>T); ClinVar=VCV000184863; Zygosity=Heterozygous (PubMed=24023729).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys373Argfs*49 (c.1118delA); ClinVar=VCV001052297; Zygosity=Heterozygous (PubMed=24023729).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 13,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 18,24
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1863 ! COLO 720L
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   COLO 720E contaminated
AC   CVCL_AV69
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03473075
DR   cancercelllines; CVCL_AV69
DR   ECACC; 93072111
DR   GEO; GSM1291132
DR   Wikidata; Q54814142
RX   PubMed=25230021;
RX   PubMed=25877200;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. The stock of COLO 720E distributed by ECACC was contaminated by COLO 704 (PubMed=25230021; PubMed=25877200).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00438.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys382Asnfs*40 (c.1146delA); ClinVar=VCV001408583; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 93072111; true.
CC   Derived from site: Metastatic; Ascites; Note=From a colon metastasis; UBERON=UBERON_0007795.
ST   Source(s): PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 12,13,14
ST   D18S51: 14
ST   D21S11: 27,31.2
ST   D3S1358: 17
ST   D5S818: 12,15
ST   D7S820: 11,13
ST   D8S1179: 11,12
ST   FGA: 20,23
ST   Penta D: 10.4,12 (PubMed=25230021)
ST   Penta D: 11,12 (PubMed=25877200)
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1994 ! COLO 704
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 21
//
ID   COLO 720L
AC   CVCL_1863
SY   COLO 720 L; COLO-720L; Colo-720L; Colorado 720L
DR   BTO; BTO_0002063
DR   CLO; CLO_0002557
DR   CLDB; cl846
DR   CLDB; cl847
DR   BioSample; SAMN03473376
DR   DSMZ; ACC-206
DR   DSMZCellDive; ACC-206
DR   ECACC; 93052623
DR   Wikidata; Q54814143
RX   PubMed=20454443;
RX   PubMed=22710073;
CC   Doubling time: ~20-30 hours (DSMZ=ACC-206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-206; ECACC=93052623; PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 13,15.2 (PubMed=22710073)
ST   D19S433: 13,16 (DSMZ=ACC-206)
ST   D21S11: 28,32.2
ST   D2S1338: 18,24
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 8,10 (DSMZ=ACC-206)
ST   D8S1179: 10,13 (PubMed=22710073)
ST   FGA: 21,25
ST   Penta D: 12,14
ST   Penta E: 10,20
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1995 ! COLO 720E
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   COLO 736
AC   CVCL_A1FU
SY   COLO #736; Colorado 736
DR   Wikidata; Q102113707
CC   Miscellaneous: Cell line information from archive documents of Moore G.E.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   COLO 738
AC   CVCL_2407
SY   Colo 738; COLO-738; MFHL-2; Colorado 738
DR   Cell_Model_Passport; SIDM00913
DR   ECACC; 94072238
DR   Wikidata; Q54814144
CC   Caution: Could be identical to RPMI-7932 (Cellosaurus=CVCL_2713).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   COLO 741
AC   CVCL_1133
SY   COLO-741; Colo741; COLO741; Colorado 741
DR   CLO; CLO_0002558
DR   EFO; EFO_0006375
DR   CLDB; cl848
DR   CLDB; cl849
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 168
DR   BioSample; SAMN03472285
DR   BioSample; SAMN10988282
DR   cancercelllines; CVCL_1133
DR   Cell_Model_Passport; SIDM01483
DR   ChEMBL-Cells; CHEMBL3308102
DR   ChEMBL-Targets; CHEMBL1075428
DR   ColonAtlas; COLO741
DR   Cosmic; 685866
DR   Cosmic; 906815
DR   Cosmic; 948864
DR   Cosmic; 995383
DR   Cosmic; 1043808
DR   Cosmic; 1609496
DR   Cosmic; 1805250
DR   Cosmic; 1995373
DR   Cosmic-CLP; 906815
DR   DepMap; ACH-000582
DR   ECACC; 93052621
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906815
DR   GEO; GSM206464
DR   GEO; GSM741250
DR   GEO; GSM827458
DR   GEO; GSM886948
DR   GEO; GSM888016
DR   GEO; GSM1374457
DR   GEO; GSM1448133
DR   GEO; GSM1669691
DR   IARC_TP53; 21241
DR   ICLC; HTL95008
DR   LiGeA; CCLE_895
DR   LINCS_LDP; LCL-1158
DR   PharmacoDB; COLO741_232_2019
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Progenetix; CVCL_1133
DR   PubChem_Cell_line; CVCL_1133
DR   Wikidata; Q54814145
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Misclassified. Originally thought to be a colon adenocarcinoma cell line but shown to be from a melanoma (PubMed=25926053).
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343).
CC   HLA typing: A*03:01,03:01; B*07:02,51:01; C*07:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=906815; DepMap=ACH-000582).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro322fs*24 (c.963_964insAA); Zygosity=Heterozygous (Cosmic-CLP=906815; DepMap=ACH-000582).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.14%; East Asian, North=1.84%; East Asian, South=0%; South Asian=2.44%; European, North=63.98%; European, South=31.59% (PubMed=30894373).
CC   Derived from site: Metastatic; Pelvic wall; UBERON=UBERON_8480043.
ST   Source(s): Cosmic-CLP=906815; ECACC=93052621; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 11,12 (Cosmic-CLP=906815; ECACC=93052621)
ST   D16S539: 12 (PubMed=25877200; PubMed=25926053)
ST   D18S51: 13
ST   D21S11: 29,32.2
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 16
ST   FGA: 21
ST   Penta D: 12,16
ST   Penta E: 13,16
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   COLO 742
AC   CVCL_A1BT
SY   COLO #742; Colorado 742
DR   Wikidata; Q102113708
CC   Miscellaneous: Cell line information from archive documents of Moore, George Eugene.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 5
//
ID   COLO 775
AC   CVCL_1996
SY   COLO-775; Colorado 775
DR   CLO; CLO_0002559
DR   CLDB; cl850
DR   BioSample; SAMN10988053
DR   cancercelllines; CVCL_1996
DR   Cell_Model_Passport; SIDM01718
DR   DepMap; ACH-001043
DR   ECACC; 94072236
DR   IARC_TP53; 21242
DR   PharmacoDB; COLO775_217_2019
DR   Progenetix; CVCL_1996
DR   Wikidata; Q54814146
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RPMI-8226 derivative (ECACC=94072236). Originally thought to originate from the peripheral blood of a 57 year old female patient with chronic myelogenous leukemia.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00537.
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (DepMap=ACH-001043).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (DepMap=ACH-001043).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Genome ancestry: African=73.36%; Native American=0%; East Asian, North=2.48%; East Asian, South=0%; South Asian=0%; European, North=7.83%; European, South=16.33% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   COLO 783
AC   CVCL_1997
SY   COLO-783; COLO #783; Colo783; COLO783; Colorado 783
DR   CLO; CLO_0002576
DR   EFO; EFO_0006376
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473278
DR   BioSample; SAMN03473334
DR   BioSample; SAMN10987968
DR   cancercelllines; CVCL_1997
DR   Cell_Model_Passport; SIDM00955
DR   Cosmic-CLP; 1240125
DR   DepMap; ACH-000812
DR   DSMZ; ACC-257
DR   DSMZCellDive; ACC-257
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240125
DR   GEO; GSM886949
DR   GEO; GSM888017
DR   IARC_TP53; 28401
DR   LiGeA; CCLE_908
DR   LINCS_LDP; LCL-1243
DR   PharmacoDB; COLO783_233_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1997
DR   Wikidata; Q54814151
RX   PubMed=11668190;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=25984343); ~5-7 days (DSMZ=ACC-257).
CC   HLA typing: A*24:02,24:02; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=1240125; DepMap=ACH-000812).
CC   Sequence variation: Mutation; HGNC; HGNC:1785; CDKN1B; Simple; p.Glu14fs*109 (c.39_43delGGAGC); Zygosity=Heterozygous (Cosmic-CLP=1240125; DepMap=ACH-000812).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro48Leu (c.143C>T); Zygosity=Homozygous (Cosmic-CLP=1240125; DepMap=ACH-000812).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro27Leu (c.80C>T); ClinVar=VCV000481176; Zygosity=Homozygous (Cosmic-CLP=1240125; DepMap=ACH-000812).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.51%; East Asian, North=1.36%; East Asian, South=0%; South Asian=0%; European, North=67.32%; European, South=30.81% (PubMed=30894373).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Cosmic-CLP=1240125; DSMZ=ACC-257; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 30,33.2
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8 (PubMed=25877200)
ST   D7S820: 8,11 (Cosmic-CLP=1240125; DSMZ=ACC-257)
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   Penta D: 13,15
ST   Penta E: 13
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   COLO 792
AC   CVCL_1134
SY   COLO-792; COLO #792; COLO792; Colorado 792
DR   CLO; CLO_0002560
DR   EFO; EFO_0006377
DR   CLDB; cl851
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 605
DR   BioSample; SAMN03472864
DR   BioSample; SAMN10987972
DR   cancercelllines; CVCL_1134
DR   Cell_Model_Passport; SIDM00140
DR   ChEMBL-Cells; CHEMBL3308796
DR   ChEMBL-Targets; CHEMBL1075429
DR   Cosmic; 906814
DR   Cosmic; 1995374
DR   Cosmic-CLP; 906814
DR   DepMap; ACH-000968
DR   ECACC; 93052616
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906814
DR   GEO; GSM827459
DR   GEO; GSM886950
DR   GEO; GSM888018
DR   GEO; GSM1669692
DR   IARC_TP53; 21243
DR   LiGeA; CCLE_807
DR   LINCS_LDP; LCL-1239
DR   PharmacoDB; COLO792_234_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1134
DR   PubChem_Cell_line; CVCL_1134
DR   Wikidata; Q54814152
RX   PubMed=7780963;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*03:02,11:01; B*08:01,52:01; C*07:01,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Arg274Ter (c.820C>T); ClinVar=VCV001031208; Zygosity=Heterozygous (Cosmic-CLP=906814; DepMap=ACH-000968).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.5%; Native American=0%; East Asian, North=5.22%; East Asian, South=0%; South Asian=6.48%; European, North=22.34%; European, South=62.45% (PubMed=30894373).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=906814; ECACC=93052616; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11 (ECACC=93052616; PubMed=25877200)
ST   CSF1PO: 11,12 (Cosmic-CLP=906814)
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,17
ST   D21S11: 28,32.2
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 18,21
ST   Penta D: 8,13
ST   Penta E: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   COLO 794
AC   CVCL_2408
SY   COLO-794; Colo 794; COLO #794; COLO794; Colorado 794
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472865
DR   cancercelllines; CVCL_2408
DR   Cell_Model_Passport; SIDM00514
DR   Cosmic; 972283
DR   DepMap; ACH-001339
DR   ECACC; 94072237
DR   EGA; EGAS00001000610
DR   ESTDAB; ESTDAB-001
DR   PharmacoDB; COLO794_218_2019
DR   Wikidata; Q54814153
RX   PubMed=15592718;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,29:02; B*44:02,44:03:01; C*05:01,16:01; DPB1*04:01,17:01; DQB1*03:01:01,02:01; DRB1*12:01,07:01 (PubMed=15592718).
CC   HLA typing: A*02:01,29:02; B*44:03,44:03; C*05:01,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-001339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Arg (c.403T>C); ClinVar=VCV000376560; Zygosity=Heterozygous (DepMap=ACH-001339).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): DepMap=ACH-001339; ECACC=94072237; ESTDAB=ESTDAB-001; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 29,30
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1135 ! COLO 800
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   COLO 800
AC   CVCL_1135
SY   COLO-800; COLO #800; COLO800; Colorado 800
DR   CLO; CLO_0002561
DR   CLO; CLO_0037121
DR   EFO; EFO_0006378
DR   CLDB; cl852
DR   CLDB; cl853
DR   CLDB; cl854
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 604
DR   BioSample; SAMN10987785
DR   cancercelllines; CVCL_1135
DR   Cell_Model_Passport; SIDM00515
DR   ChEMBL-Cells; CHEMBL3308285
DR   ChEMBL-Targets; CHEMBL2366224
DR   Cosmic; 687434
DR   Cosmic; 906813
DR   Cosmic; 1995375
DR   Cosmic; 2163765
DR   Cosmic-CLP; 906813
DR   DepMap; ACH-000401
DR   DSMZ; ACC-193
DR   DSMZCellDive; ACC-193
DR   ECACC; 93051123
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ESTDAB; ESTDAB-002
DR   GDSC; 906813
DR   GEO; GSM886951
DR   GEO; GSM888019
DR   GEO; GSM1669693
DR   IARC_TP53; 21244
DR   ICLC; HTL97005
DR   LiGeA; CCLE_856
DR   LINCS_HMS; 50012
DR   LINCS_LDP; LCL-1233
DR   PharmacoDB; COLO800_235_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1135
DR   PubChem_Cell_line; CVCL_1135
DR   Wikidata; Q54814154
RX   PubMed=7780963;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=15592718;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23851445;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (DSMZ=ACC-193).
CC   HLA typing: A*02:01,29:02; B*44:02,44:03:01; C*05:01,16:01; DPB1*04:01,17:01; DQB1*03:01:02,02:01; DRB1*12:01,07:01:01 (PubMed=15592718).
CC   HLA typing: A*29:02,29:02; B*44:02,44:02; C*05:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=23851445; Cosmic-CLP=906813; DepMap=ACH-000401).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.69_70CC>AT); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Arg (c.403T>C); ClinVar=VCV000376560; Zygosity=Heterozygous (PubMed=23851445; Cosmic-CLP=906813; DepMap=ACH-000401).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.05%; East Asian, South=0.97%; South Asian=2.89%; European, North=40.03%; European, South=56.06% (PubMed=30894373).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Cosmic-CLP=906813; DSMZ=ACC-193; ECACC=93051123; ESTDAB=ESTDAB-002; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2408 ! COLO 794
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   COLO 818
AC   CVCL_1998
SY   COLO-818; COLO #818; COLO818; Colorado 818
DR   CLO; CLO_0002562
DR   CLO; CLO_0037122
DR   CLDB; cl169
DR   CLDB; cl855
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03151628
DR   BioSample; SAMN03473279
DR   BioSample; SAMN10988106
DR   cancercelllines; CVCL_1998
DR   Cell_Model_Passport; SIDM01153
DR   Cosmic; 972257
DR   DepMap; ACH-001044
DR   DSMZ; ACC-81
DR   DSMZCellDive; ACC-81
DR   ECACC; 93052622
DR   EGA; EGAS00001000610
DR   ESTDAB; ESTDAB-003
DR   GEO; GSM886952
DR   GEO; GSM888020
DR   IARC_TP53; 28387
DR   LINCS_LDP; LCL-1244
DR   PharmacoDB; COLO818_236_2019
DR   Progenetix; CVCL_1998
DR   Wikidata; Q54814155
RX   PubMed=7780963;
RX   PubMed=10508494;
RX   PubMed=11668190;
RX   PubMed=15592718;
RX   PubMed=20143388;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a COLO 800 derivative (PubMed=10508494; PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00114.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-81).
CC   HLA typing: A*02:01,29:02; B*44:02,44:03:01; C*05:01,16:01; DPB1*04:01,17:01; DQB1*03:01:01,02:01; DRB1*12:01,07:01 (PubMed=15592718).
CC   HLA typing: A*02:01,29:02; B*44:03,44:03; C*05:01,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-001044).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Arg (c.403T>C); ClinVar=VCV000376560; Zygosity=Heterozygous (DepMap=ACH-001044).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=1.07%; South Asian=3.33%; European, North=39.88%; European, South=55.71% (PubMed=30894373).
CC   Discontinued: ECACC; 93052622; true.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): DSMZ=ACC-81; ESTDAB=ESTDAB-003; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1135 ! COLO 800
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   COLO 824
AC   CVCL_1136
SY   COLO-824; Colo-824; Colo 824; COLO #824; COLO824; Colo824; Colorado 824
DR   CLO; CLO_0002577
DR   CLDB; cl870
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 850
DR   BioSample; SAMN03471347
DR   BioSample; SAMN03473374
DR   cancercelllines; CVCL_1136
DR   Cell_Model_Passport; SIDM00954
DR   ChEMBL-Cells; CHEMBL3308725
DR   ChEMBL-Targets; CHEMBL1075430
DR   CLS; 300463
DR   Cosmic; 906812
DR   Cosmic-CLP; 906812
DR   DepMap; ACH-001820
DR   DSMZ; ACC-200
DR   DSMZCellDive; ACC-200
DR   EGA; EGAS00001000978
DR   GDSC; 906812
DR   GEO; GSM718287
DR   GEO; GSM783979
DR   GEO; GSM843492
DR   GEO; GSM843493
DR   GEO; GSM847249
DR   GEO; GSM847459
DR   GEO; GSM1669694
DR   IARC_TP53; 21245
DR   LINCS_LDP; LCL-1477
DR   PharmacoDB; COLO824_237_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1136
DR   PubChem_Cell_line; CVCL_1136
DR   Wikidata; Q54814156
RX   PubMed=9892114;
RX   PubMed=10969801;
RX   PubMed=20164919;
RX   PubMed=24176112;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: ~60-80 hours (DSMZ=ACC-200).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=85.4%; Native American=0.04%; East Asian, North=1.28%; East Asian, South=0%; South Asian=0%; European, North=5.62%; European, South=7.67% (PubMed=30894373).
CC   Caution: Previously erroneously indicated as originating from a male patient, correct sex assignment from Moore G.E. in a personal communication to the authors of PubMed=9892114.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300463; Cosmic-CLP=906812; DepMap=ACH-001820; DSMZ=ACC-200; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11,12 (DepMap=ACH-001820; DSMZ=ACC-200)
ST   CSF1PO: 10,12 (CLS=300463; Cosmic-CLP=906812; PubMed=25877200)
ST   D13S317: 11,12,13
ST   D16S539: 12,13 (DSMZ=ACC-200)
ST   D16S539: 13 (CLS=300463; Cosmic-CLP=906812; DepMap=ACH-001820; PubMed=25877200)
ST   D18S51: 15,18,19 (DSMZ=ACC-200)
ST   D18S51: 15,19 (CLS=300463; DepMap=ACH-001820; PubMed=25877200)
ST   D19S433: 15
ST   D21S11: 28
ST   D2S1338: 21
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 7,7.3,8,11 (DepMap=ACH-001820)
ST   D7S820: 7.3,8,11 (DSMZ=ACC-200)
ST   D7S820: 7.9,8,11 (PubMed=25877200)
ST   D7S820: 8,11 (CLS=300463; Cosmic-CLP=906812)
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 5,10
ST   Penta E: 7
ST   TH01: 7,9
ST   TPOX: 6,11
ST   vWA: 16
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   COLO 829
AC   CVCL_1137
SY   COLO-829; Colo-829; Colo 829; COLO #829; COLO829; Colo829; Colorado 829
DR   CLO; CLO_0002563
DR   CLO; CLO_0037123
DR   EFO; EFO_0002140
DR   CLDB; cl856
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1974
DR   BioSample; SAMN03470888
DR   BioSample; SAMN10988208
DR   cancercelllines; CVCL_1137
DR   Cell_Model_Passport; SIDM00909
DR   ChEMBL-Cells; CHEMBL3308286
DR   ChEMBL-Targets; CHEMBL2366275
DR   Cosmic; 687448
DR   Cosmic; 965553
DR   Cosmic; 1459644
DR   Cosmic; 1477404
DR   Cosmic; 1995376
DR   Cosmic; 2159430
DR   Cosmic-CLP; 687448
DR   dbGAP; phs001839.v1.p1
DR   DepMap; ACH-000644
DR   ECACC; 93052611
DR   EGA; EGAS00000000052
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS172AAA
DR   GDSC; 687448
DR   GEO; GSE151409
DR   GEO; GSM206465
DR   GEO; GSM274683
DR   GEO; GSM886953
DR   GEO; GSM888021
DR   GEO; GSM1008571
DR   GEO; GSM1178047
DR   GEO; GSM1178048
DR   GEO; GSM1669695
DR   IARC_TP53; 21246
DR   IGRhCellID; COLO829
DR   IZSLER; BS TCL 198
DR   LiGeA; CCLE_650
DR   LINCS_LDP; LCL-1269
DR   PharmacoDB; COLO829_238_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1137
DR   PubChem_Cell_line; CVCL_1137
DR   Wikidata; Q54814157
RX   PubMed=7780963;
RX   PubMed=12068308;
RX   PubMed=14762065;
RX   PubMed=18698037;
RX   PubMed=20016485;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23285177;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27094764;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32587328;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Colo829_Crawford_protocol.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/OtherCellLineDescriptions/COLO829.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Single cell sequencing has shown that it is composed of four major sub-clones (PubMed=32587328).
CC   HLA typing: A*01:01,01:01; B*08:01,40:02; C*03:04,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=27094764; ATCC=CRL-1974; Cosmic-CLP=687448; DepMap=ACH-000644).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68Glyfs*51 (c.203_204delCG); Zygosity=Homozygous (PubMed=27094764; ATCC=CRL-1974).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.493_634del142; Zygosity=Homozygous (ATCC=CRL-1974).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Single cell.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.12%; Native American=0%; East Asian, North=2.63%; East Asian, South=0%; South Asian=0%; European, North=71.18%; European, South=26.07% (PubMed=30894373).
CC   Discontinued: ECACC; 93052611; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-1974; Cosmic-CLP=687448; DepMap=ACH-000644; IZSLER=BS TCL 198; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14
ST   D12S391: 20,22
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D1S1656: 11
ST   D21S11: 27,29
ST   D22S1045: 16
ST   D2S1338: 18,26
ST   D2S441: 11,11.3
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 9,14
ST   Penta E: 7,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   COLO 829BL
AC   CVCL_1999
SY   COLO-829BL; COLO-829-BL; COLO 829 BL; COLO829-BL; COLO829BL; Colorado 829BL
DR   CLO; CLO_0002564
DR   ATCC; CRL-1980
DR   BioSample; SAMN03471268
DR   Cell_Model_Passport; SIDM00908
DR   dbGAP; phs001839.v1.p1
DR   DepMap; ACH-002380
DR   EGA; EGAS00000000052
DR   Wikidata; Q54814158
RX   PubMed=14762065;
RX   PubMed=20016485;
RX   PubMed=20164919;
RX   PubMed=27094764;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1980
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 27,29
ST   D2S1338: 18,26
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 9,14
ST   Penta E: 7,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   COLO 831
AC   CVCL_L503
SY   COLO-831; Colo 831; COLO #831; Colorado 831
DR   Wikidata; Q54814159
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Umbilicus; UBERON=UBERON_0007118.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   COLO 832
AC   CVCL_2000
SY   COLO-832; Colo 832; COLO832; Colorado 832
DR   CLO; CLO_0002565
DR   CLDB; cl857
DR   ECACC; 93051124
DR   Wikidata; Q54814160
RX   PubMed=7780963;
CC   Population: Caucasian.
CC   Discontinued: ECACC; 93051124; true.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   COLO 833
AC   CVCL_L504
SY   COLO-833; Colo 833; COLO #833; Colorado 833
DR   Wikidata; Q54814161
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   COLO 834
AC   CVCL_L505
SY   COLO-834; Colo 834; COLO #834; Colorado 834
DR   Wikidata; Q54814162
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   COLO 835
AC   CVCL_L506
SY   COLO-835; Colo 835; COLO #835; Colorado 835
DR   Wikidata; Q54814163
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   COLO 838
AC   CVCL_L507
SY   COLO-838; Colo 838; COLO #838; Colorado 838
DR   Wikidata; Q54814164
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   COLO 839
AC   CVCL_2001
SY   COLO-839; Colo 839; COLO #839; COLO839; Colorado 839
DR   CLO; CLO_0002566
DR   CLDB; cl858
DR   ECACC; 93051119
DR   Wikidata; Q54814165
RX   PubMed=7780963;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=93051119
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   COLO 845
AC   CVCL_L508
SY   COLO-845; Colo 845; COLO #845; COLO845; Colorado 845
DR   Wikidata; Q54814166
RX   PubMed=7780963;
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   COLO 848
AC   CVCL_L509
SY   COLO-848; Colo 848; COLO #848; Colorado 848
DR   Wikidata; Q54814167
RX   PubMed=8402545;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   COLO 849
AC   CVCL_2002
SY   COLO-849; Colo 849; COLO #849; COLO849; Colorado 849
DR   CLO; CLO_0002578
DR   EFO; EFO_0006379
DR   CLDB; cl872
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473234
DR   cancercelllines; CVCL_2002
DR   Cell_Model_Passport; SIDM01870
DR   Cosmic; 888062
DR   DepMap; ACH-001045
DR   DSMZ; ACC-216
DR   DSMZCellDive; ACC-216
DR   EGA; EGAS00001000610
DR   GEO; GSM886954
DR   GEO; GSM888022
DR   IARC_TP53; 21247
DR   LINCS_LDP; LCL-1245
DR   PharmacoDB; COLO849_239_2019
DR   Progenetix; CVCL_2002
DR   Wikidata; Q54814168
RX   PubMed=7780963;
RX   PubMed=8402545;
RX   PubMed=11668190;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-216).
CC   HLA typing: A*01:01,03:01; B*08:01,40:02; C*03:04,07:01 (PubMed=26589293).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.07%; East Asian, North=2.02%; East Asian, South=0%; South Asian=0%; European, North=73.1%; European, South=24.82% (PubMed=30894373).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): DSMZ=ACC-216; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 27,29
ST   D2S1338: 18,26
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14 (PubMed=25877200)
ST   D8S1179: 13,16 (DSMZ=ACC-216)
ST   FGA: 21,25
ST   Penta D: 9,14
ST   Penta E: 7,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   COLO 853
AC   CVCL_2003
SY   COLO-853; Colo 853; COLO853; Colorado 853
DR   CLO; CLO_0002567
DR   EFO; EFO_0006380
DR   CLDB; cl859
DR   CLDB; cl860
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_2003
DR   ECACC; 93052606
DR   EGA; EGAS00001000610
DR   GEO; GSM827310
DR   IARC_TP53; 21248
DR   ICLC; HTL96001
DR   LINCS_LDP; LCL-1240
DR   PharmacoDB; COLO853_219_2019
DR   Progenetix; CVCL_2003
DR   Wikidata; Q54814169
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=26589293;
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*40:02,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ECACC=93052606
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2004 ! COLO 857
OI   CVCL_2005 ! COLO 858
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   COLO 857
AC   CVCL_2004
SY   COLO-857; Colo 857; COLO857; Colorado 857
DR   CLO; CLO_0002568
DR   EFO; EFO_0006381
DR   CLDB; cl861
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472866
DR   cancercelllines; CVCL_2004
DR   Cosmic; 972258
DR   ECACC; 93051120
DR   EGA; EGAS00001000610
DR   GEO; GSM827425
DR   LINCS_LDP; LCL-1241
DR   PharmacoDB; COLO857_220_2019
DR   Progenetix; CVCL_2004
DR   Wikidata; Q54814170
RX   PubMed=7780963;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*40:02,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ECACC=93051120; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 17,18,19 (PubMed=25877200)
ST   vWA: 17,19 (ECACC=93051120)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2005 ! COLO 858
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   COLO 858
AC   CVCL_2005
SY   COLO-858; Colo 858; COLO858; Colorado 858
DR   CLO; CLO_0002569
DR   CLDB; cl862
DR   CLDB; cl863
DR   BioSample; SAMN03470979
DR   cancercelllines; CVCL_2005
DR   ECACC; 93052613
DR   GEO; GSM827426
DR   ICLC; HTL97017
DR   LINCS_HMS; 50149
DR   LINCS_LDP; LCL-1242
DR   Progenetix; CVCL_2005
DR   Wikidata; Q54814171
RX   PubMed=7780963;
RX   PubMed=20215515;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ECACC=93052613; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 18,26
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 17 (PubMed=25877200)
ST   vWA: 17,19 (ECACC=93052613)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2004 ! COLO 857
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   COLO 93
AC   CVCL_X377
SY   COLO #93; Colorado 93
DR   Wikidata; Q54814172
RX   DOI=10.1093/jnci/59.2.301;
CC   Miscellaneous: Age of donor from archive documents of Moore, George Eugene.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   COLO 94H
AC   CVCL_4573
SY   COLO-94H; Colo-94H; COLO94H
DR   cancercelllines; CVCL_4573
DR   CLS; 300161
DR   GEO; GSM1448153
DR   Wikidata; Q54814173
RX   PubMed=25926053;
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (CLS=300161).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300161; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 18
ST   D21S11: 27,28
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 17
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   COLO-679rNutlin20muM
AC   CVCL_RT15
SY   Colo-679rNutlin20muM
DR   cancercelllines; CVCL_RT15
DR   Wikidata; Q54814174
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Phe (c.713G>T); ClinVar=VCV000376574; Zygosity=Heterozygous (PubMed=22170099).
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1130 ! COLO 679
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   COLO-679rPLX4032_10muM
AC   CVCL_RT16
SY   Colo-679rPLX4032_10muM
DR   cancercelllines; CVCL_RT16
DR   Wikidata; Q54814175
RX   PubMed=22170099;
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1130 ! COLO 679
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   COLO-679rVCR20
AC   CVCL_RQ50
SY   Colo-679rVCR20
DR   cancercelllines; CVCL_RQ50
DR   Wikidata; Q54814176
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1130 ! COLO 679
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   COLO-704rCDDP1000
AC   CVCL_RS29
DR   cancercelllines; CVCL_RS29
DR   Wikidata; Q54814177
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys382Asnfs*40 (c.1146delA); ClinVar=VCV001408583; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; Note=From a colon metastasis; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1994 ! COLO 704
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   CoLo-TC
AC   CVCL_8290
SY   CoLoTC
DR   BioSample; SAMN03151626
DR   cancercelllines; CVCL_8290
DR   Cosmic; 1066208
DR   RCB; RCB1984
DR   TKG; TKG 0404
DR   Wikidata; Q54814178
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a COLO 205 derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00300.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: RCB; RCB1984; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): TKG=TKG 0404
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   COLO/B
AC   CVCL_U288
DR   Wikidata; Q54814179
RX   PubMed=2714338;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5451 ! COLO 316
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   COLO/C
AC   CVCL_U289
DR   Wikidata; Q54814180
RX   PubMed=2714338;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5451 ! COLO 316
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   COLO/D
AC   CVCL_U290
DR   Wikidata; Q54814181
RX   PubMed=2714338;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5451 ! COLO 316
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   COLO/DDP50
AC   CVCL_U291
DR   Wikidata; Q54814182
RX   PubMed=2714338;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5451 ! COLO 316
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   COLO119
AC   CVCL_F385
DR   CLO; CLO_0051083
DR   RCB; HSC0052
DR   Wikidata; Q54814183
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO129
AC   CVCL_F386
DR   CLO; CLO_0051084
DR   RCB; HSC0053
DR   Wikidata; Q54814185
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO131
AC   CVCL_F387
DR   CLO; CLO_0051156
DR   RCB; HSC0120
DR   Wikidata; Q54814186
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American and Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO133
AC   CVCL_F388
DR   CLO; CLO_0051174
DR   RCB; HSC0140
DR   Wikidata; Q54814187
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American and Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO134
AC   CVCL_F389
DR   CLO; CLO_0051153
DR   RCB; HSC0117
DR   Wikidata; Q54814188
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American and Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO142
AC   CVCL_F390
DR   CLO; CLO_0051155
DR   RCB; HSC0119
DR   Wikidata; Q54814189
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American and Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO157
AC   CVCL_F391
DR   CLO; CLO_0051124
DR   RCB; HSC0102
DR   Wikidata; Q54814190
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO158
AC   CVCL_F392
DR   CLO; CLO_0051148
DR   RCB; HSC0112
DR   Wikidata; Q54814191
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO164
AC   CVCL_F393
DR   CLO; CLO_0051127
DR   RCB; HSC0105
DR   Wikidata; Q54814201
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO165
AC   CVCL_F394
DR   CLO; CLO_0051161
DR   RCB; HSC0125
DR   Wikidata; Q54814203
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO166
AC   CVCL_F395
DR   CLO; CLO_0051157
DR   RCB; HSC0111
DR   Wikidata; Q54814204
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO167
AC   CVCL_F396
DR   CLO; CLO_0051072
DR   RCB; HSC0039
DR   Wikidata; Q54814205
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO198
AC   CVCL_F397
DR   CLO; CLO_0051149
DR   RCB; HSC0113
DR   Wikidata; Q54814206
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO200
AC   CVCL_F398
DR   CLO; CLO_0051135
DR   RCB; HSC0106
DR   Wikidata; Q54814207
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO201
AC   CVCL_F399
DR   CLO; CLO_0051130
DR   RCB; HSC0101
DR   Wikidata; Q54814208
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO201-AR
AC   CVCL_4V91
DR   cancercelllines; CVCL_4V91
DR   Wikidata; Q54814209
RX   PubMed=21098728;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1987 ! COLO 201
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   COLO202
AC   CVCL_F400
DR   CLO; CLO_0051334
DR   RCB; HSC0108
DR   Wikidata; Q54814210
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO204
AC   CVCL_F401
DR   CLO; CLO_0051173
DR   RCB; HSC0138
DR   Wikidata; Q54814211
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO205
AC   CVCL_F402
DR   CLO; CLO_0051333
DR   RCB; HSC0107
DR   Wikidata; Q54814212
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   Colo205-luc2
AC   CVCL_5J18
DR   cancercelllines; CVCL_5J18
DR   Revvity/PerkinElmer; 124317
DR   Wikidata; Q54814213
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124317; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   Colo205-Red-FLuc
AC   CVCL_5I92
SY   Colo205 Red-FLuc; Bioware Brite Colo205 Red-FLuc; IVISbrite Colo205 Red F-luc
DR   cancercelllines; CVCL_5I92
DR   Revvity/PerkinElmer; BW124317
DR   Wikidata; Q54814215
CC   Population: Caucasian.
CC   Doubling time: 28 hours (Revvity/PerkinElmer=BW124317).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   COLO206F-AR
AC   CVCL_4V92
DR   Wikidata; Q54814216
RX   PubMed=21098728;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1988 ! COLO 206F
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   COLO209
AC   CVCL_F403
DR   CLO; CLO_0051154
DR   RCB; HSC0118
DR   Wikidata; Q54814217
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   COLO383
AC   CVCL_F384
SY   COL383
DR   CLO; CLO_0051134
DR   RCB; HSC0109
DR   Wikidata; Q54814218
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   Colo829/R
AC   CVCL_IW11
DR   cancercelllines; CVCL_IW11
DR   Wikidata; Q54814220
RX   PubMed=26365896;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90295; PLX-4720 (PLX4720).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68Glyfs*51 (c.203_204delCG); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.493_634del142; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1137 ! COLO 829
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   Colon 26-L5
AC   CVCL_3924
SY   26-L5; Colon26 clone 5
DR   BTO; BTO_0000103
DR   Wikidata; Q54814221
RX   PubMed=19265263;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0240 ! MC-26
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   Colon C26-G
AC   CVCL_3925
DR   BTO; BTO_0003631
DR   Wikidata; Q54814222
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0240 ! MC-26
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   Colon26-Luc
AC   CVCL_M253
DR   JCRB; JCRB1496
DR   JCRB; NIHS0704
DR   Wikidata; Q54814223
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Discontinued: JCRB; NIHS0704; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0240 ! MC-26
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   COM-3
AC   CVCL_3900
SY   COM3
DR   BTO; BTO_0004263
DR   Wikidata; Q54814224
RX   PubMed=9227903;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   COMA
AC   CVCL_M813
DR   Wikidata; Q54814225
RX   PubMed=11063793;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   COMI
AC   CVCL_A1YL
DR   Wikidata; Q105506716
RX   PubMed=19276180;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 60 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   COMM-1
AC   CVCL_XI61
SY   Chinese Oral Mucosal Melanoma-1
DR   CCRID; 4201PAT-CCTCC00709
DR   Wikidata; Q93457067
RX   Patent=CN105462928B;
RX   PubMed=36004461;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201586.
CC   Population: Chinese.
CC   Doubling time: 104.43 hours (Patent=CN105462928B).
ST   Source(s): Patent=CN105462928B
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 21
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,14.2
ST   D21S11: 29,32.2
ST   D2S1338: 19,24
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D6S1043: 13
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 18,21
ST   Penta D: 9
ST   Penta E: 12,21
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   COMM-1 AD
AC   CVCL_E9WU
SY   COMM AD; Chinese Oral Mucosal Melanoma-1 ADhesive
RX   PubMed=36004461;
CC   Population: Chinese.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XI61 ! COMM-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   COMM-1 SUS
AC   CVCL_E9WV
SY   COMM-SUS; Chinese Oral Mucosal Melanoma-1 SUSpension
RX   PubMed=36004461;
CC   Population: Chinese.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XI61 ! COMM-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   COMM-2
AC   CVCL_E9WT
SY   Chinese Oral Mucosal Melanoma-2
RX   PubMed=36004461;
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   COMMA-1D/PDK1
AC   CVCL_JZ81
SY   Comma-1D-PDK1
DR   Wikidata; Q54814226
RX   PubMed=12068001;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8816; PDPK1.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   COMMA-D
AC   CVCL_5731
SY   Comma-D; COMMA D; Comma 1D; Comma-1D; COMMA-1D; COMMA1D; CD
DR   EFO; EFO_0022829
DR   GEO; GSE182589
DR   Wikidata; Q54814228
RX   PubMed=2423737;
RX   PubMed=3653254;
RX   PubMed=6587390;
RX   PubMed=24259225;
RX   PubMed=36630696;
CC   Characteristics: Can functionally differentiate to preneoplastic and neoplastic phenotypes (PubMed=36630696).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   COMMA-D beta
AC   CVCL_5732
SY   Comma-Dbeta; CD-beta
DR   Wikidata; Q54814229
RX   PubMed=16545360;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: Could be identical to COMMA-D beta-geo (Cellosaurus=CVCL_5733).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   COMMA-D beta-geo
AC   CVCL_5733
SY   COMMA-Dbeta-geo; CD-betageo; CDbetageo
DR   Wikidata; Q54814230
RX   PubMed=17227796;
RX   PubMed=19913532;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: Could be identical to COMMA-D beta (Cellosaurus=CVCL_5732).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5732 ! COMMA-D beta
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   COMMA-D clone DB-1
AC   CVCL_E1II
SY   DB-1
RX   PubMed=3653254;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   COMMA-D/MME
AC   CVCL_U227
SY   PS-BME-C1; Penn State Bovine Mammary Epithelial Clone-1
DR   Wikidata; Q54948402
RX   CelloPub=CLPUB00779;
RX   DOI=10.1007/BF02634376;
RX   PubMed=1890074;
RX   PubMed=7505235;
RX   PubMed=7525614;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of bovine origin but found to be a mouse COMMA-D derivative (DOI=10.1007/BF02634376).
CC   Doubling time: 6.3-7.9 hours (Note=Depending on the growth conditions) (PubMed=1890074).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   COMMA-F
AC   CVCL_5G82
SY   COMMA-D/F
DR   Wikidata; Q54814231
RX   PubMed=2423737;
RX   PubMed=3653254;
RX   PubMed=24259225;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 8
//
ID   COMMA-F clone FA-5
AC   CVCL_E1IG
SY   FA-5
RX   PubMed=3653254;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5G82 ! COMMA-F
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   COMMA-T
AC   CVCL_5G83
SY   COMMA-D/T
DR   Wikidata; Q54814232
RX   PubMed=2423737;
RX   PubMed=3653254;
RX   PubMed=24259225;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 8
//
ID   COMMA-T clone TA-1
AC   CVCL_E1IH
SY   TA-1
RX   PubMed=3653254;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5G83 ! COMMA-T
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CoMS
AC   CVCL_L345
DR   Wikidata; Q54814233
RX   PubMed=11642274;
CC   Doubling time: 27.0 +- 0.7 hours (PubMed=11642274).
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 8
//
ID   CON 242
AC   CVCL_VQ00
SY   CON242
DR   Wikidata; Q93457100
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   Con-005
AC   CVCL_RL15
DR   SKIP; SKIP001320
DR   Wikidata; Q54814234
RX   PubMed=24139042;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Con-006
AC   CVCL_RL16
DR   SKIP; SKIP001324
DR   Wikidata; Q54814235
RX   PubMed=24139042;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Con-010
AC   CVCL_RL17
DR   SKIP; SKIP001322
DR   Wikidata; Q54814236
RX   PubMed=24139042;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Con-018
AC   CVCL_RL18
DR   SKIP; SKIP001321
DR   Wikidata; Q54814237
RX   PubMed=24139042;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   Con-CiPS
AC   CVCL_RL19
DR   SKIP; SKIP001323
DR   Wikidata; Q54814238
RX   PubMed=24139042;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   CON.1
AC   CVCL_G646
DR   CLO; CLO_0002579
DR   ATCC; CRL-2229
DR   Wikidata; Q54814239
RX   PubMed=1547490;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04973; Bovine CLTA (Note=Also reacts with human).
CC   Monoclonal antibody target: UniProtKB; P04975; Bovine CLTB (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CON8
AC   CVCL_9U76
DR   Wikidata; Q54814240
RX   PubMed=27345781;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CON9
AC   CVCL_VE87
DR   Wikidata; Q54814241
RX   PubMed=29268155;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   ConA-B1-VICK
AC   CVCL_5497
SY   ConA-B1
DR   CLO; CLO_0002580
DR   ATCC; CRL-12357
DR   Wikidata; Q54814242
RX   Patent=US5691200;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12357.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Discontinued: ATCC; CRL-12357; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   42W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   ConA-C1-VICK
AC   CVCL_5498
SY   ConA-C1
DR   CLO; CLO_0002581
DR   ATCC; CRL-12135
DR   Wikidata; Q54814243
RX   Patent=US5691200;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12135.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Discontinued: ATCC; CRL-12135; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   42W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   CONACYT-CenVir-Brain
AC   CVCL_B7B5
DR   Wikidata; Q111733130
RX   PubMed=34814757;
CC   Group: Fish cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=56564; ! Centropomus viridis (White snook)
OI   CVCL_B7B6 ! CONACYT-CenVir-Heart
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CONACYT-CenVir-Heart
AC   CVCL_B7B6
DR   Wikidata; Q111733131
RX   PubMed=34814757;
CC   Group: Fish cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=56564; ! Centropomus viridis (White snook)
OI   CVCL_B7B5 ! CONACYT-CenVir-Brain
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ConjEp-1
AC   CVCL_UZ27
DR   Wikidata; Q93457141
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 18 PDL (PubMed=12077343).
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   Connor-HSA
AC   CVCL_0D03
DR   Wikidata; Q54814244
WW   Provider; UMN; -; https://web.archive.org/web/20100613061254/http://www.cvm.umn.edu/accr/research/modianolab/scientificresources/reagentsandscientificresources/home.html
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   Control-2#11
AC   CVCL_RM33
SY   WIBR-IPS-NPC11920delG/wt #11
DR   SKIP; SKIP000975
DR   Wikidata; Q54814260
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX75 ! GM23151
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   Control-2#13
AC   CVCL_RM34
SY   WIBR-IPS-NPC11920delG/wt #13
DR   SKIP; SKIP000976
DR   Wikidata; Q54814261
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX75 ! GM23151
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   Control-2Corr#7
AC   CVCL_RM35
SY   WIBR-IPSNPC11920delG/corr #7
DR   SKIP; SKIP000979
DR   Wikidata; Q54814262
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX75 ! GM23151
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   Control-2Corr#9
AC   CVCL_RM36
SY   WIBR-IPSNPC11920delG/corr #9
DR   SKIP; SKIP000980
DR   Wikidata; Q54814263
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX75 ! GM23151
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   Control-2Mut#11
AC   CVCL_RM37
DR   SKIP; SKIP000977
DR   Wikidata; Q54814264
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX75 ! GM23151
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   Control-2Mut#13
AC   CVCL_RM38
DR   SKIP; SKIP000978
DR   Wikidata; Q54814265
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CX75 ! GM23151
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   COP,AH
AC   CVCL_E533
SY   COP, AH
DR   dbMHC; 48732
DR   ECACC; 94082212
DR   IHW; IHW09113
DR   IPD-IMGT/HLA; 11658
DR   Wikidata; Q54814266
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02,03; B*44; C*05:01; DPB1*04:01,05:01; DQA1*01:02,03:01; DQB1*03:01,06:01; DRB1*04:01,13:02; DRB3*03:01; DRB4*01:01 (IPD-IMGT/HLA=11658).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   COPA 159
AC   CVCL_VP95
SY   COPA-159; COPA159; COPA
DR   cancercelllines; CVCL_VP95
DR   Wikidata; Q93457170
RX   CelloPub=CLPUB00440;
RX   PubMed=16638848;
RX   PubMed=21863025;
RX   PubMed=29492214;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29492214).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   COR CJ0780
AC   CVCL_B7FZ
SY   CORECB/SF08-06
DR   Wikidata; Q112929405
RX   Patent=US9388380;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08020604.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   Cor Per
AC   CVCL_4603
SY   Cor Per II
DR   CLO; CLO_0002582
DR   CLDB; cl875
DR   ATCC; CRL-1145
DR   ATCC; CRL-1243
DR   Wikidata; Q54814267
RX   PubMed=2722184;
RX   PubMed=3337712;
CC   Discontinued: ATCC; CRL-1145; true.
CC   Discontinued: ATCC; CRL-1243; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   COR-L103
AC   CVCL_D744
SY   COR L103; Cor L103; CORL103
DR   ECACC; 96020735
DR   Wikidata; Q54814268
RX   PubMed=1327513;
RX   PubMed=3034934;
RX   PubMed=8383976;
CC   Population: Caucasian.
CC   Discontinued: ECACC; 96020735; true.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2409 ! COR-L24
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   COR-L105
AC   CVCL_1138
SY   CORL105; COR-L 105
DR   CLO; CLO_0002584
DR   CLO; CLO_0009996
DR   EFO; EFO_0002141
DR   CLDB; cl876
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 170
DR   BioSample; SAMN10987708
DR   cancercelllines; CVCL_1138
DR   Cell_Model_Passport; SIDM00513
DR   ChEMBL-Cells; CHEMBL3308350
DR   ChEMBL-Targets; CHEMBL1075431
DR   Cosmic; 906805
DR   Cosmic; 1995377
DR   Cosmic-CLP; 906805
DR   DepMap; ACH-000161
DR   ECACC; 92031918
DR   EGA; EGAS00001000978
DR   GDSC; 906805
DR   GEO; GSM827563
DR   GEO; GSM886955
DR   GEO; GSM888023
DR   GEO; GSM1669696
DR   IARC_TP53; 21249
DR   IGRhCellID; CORL105
DR   LiGeA; CCLE_112
DR   LINCS_LDP; LCL-1635
DR   NCBI_Iran; C113
DR   PharmacoDB; CORL105_240_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1138
DR   PubChem_Cell_line; CVCL_1138
DR   Wikidata; Q54814269
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (DepMap=ACH-000161).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.7%; Native American=1.16%; East Asian, North=2.98%; East Asian, South=0%; South Asian=0.88%; European, North=66.49%; European, South=27.79% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906805; ECACC=92031918
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   COR-L23
AC   CVCL_1139
SY   CORL23; COR-L23P; COR-L23/P; L23/P
DR   CLO; CLO_0002585
DR   CLO; CLO_0037287
DR   EFO; EFO_0002142
DR   CLDB; cl877
DR   CLDB; cl878
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 851
DR   BioSample; SAMN10987871
DR   cancercelllines; CVCL_1139
DR   Cell_Model_Passport; SIDM00512
DR   ChEMBL-Cells; CHEMBL3308073
DR   ChEMBL-Targets; CHEMBL613854
DR   Cosmic; 687780
DR   Cosmic; 1995378
DR   Cosmic-CLP; 687780
DR   DepMap; ACH-000662
DR   DSMZ; ACC-882
DR   DSMZCellDive; ACC-882
DR   ECACC; 92031919
DR   EGA; EGAS00001000978
DR   GDSC; 687780
DR   GEO; GSM784278
DR   GEO; GSM827427
DR   GEO; GSM886956
DR   GEO; GSM888024
DR   GEO; GSM1669697
DR   ICLC; HTL95012
DR   IGRhCellID; CORL23
DR   LiGeA; CCLE_640
DR   LINCS_LDP; LCL-1780
DR   PharmacoDB; CORL23_241_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1139
DR   PubChem_Cell_line; CVCL_1139
DR   Wikidata; Q54814270
RX   PubMed=2998422;
RX   PubMed=3034934;
RX   PubMed=7903701;
RX   PubMed=12068308;
RX   PubMed=12606785;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=25984343); ~30 hours (DSMZ=ACC-882).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=687780; DepMap=ACH-000662).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.14%; East Asian, North=1.45%; East Asian, South=0%; South Asian=0.98%; European, North=69.11%; European, South=28.32% (PubMed=30894373).
CC   Misspelling: COR123; CLO=CLO_0037287.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=687780; DSMZ=ACC-882; ECACC=92031919
ST   Amelogenin: X (Cosmic-CLP=687780; DSMZ=ACC-882)
ST   Amelogenin: X,Y (ECACC=92031919)
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 31.2
ST   D2S1338: 23,26
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 12,20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   COR-L23/5010
AC   CVCL_2006
DR   CLO; CLO_0002586
DR   CLDB; cl5054
DR   cancercelllines; CVCL_2006
DR   ECACC; 96042338
DR   Wikidata; Q54814271
RX   PubMed=7903701;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=96042338
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 9
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1139 ! COR-L23
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   COR-L23/CPR
AC   CVCL_2007
SY   COR-L 23/CPR; L23/CPR
DR   CLO; CLO_0002583
DR   CLDB; cl5053
DR   cancercelllines; CVCL_2007
DR   ECACC; 96042336
DR   GEO; GSM827460
DR   LINCS_LDP; LCL-1779
DR   Progenetix; CVCL_2007
DR   Wikidata; Q54814272
RX   PubMed=1327513;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=96042336
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 9
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1139 ! COR-L23
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   COR-L23/R
AC   CVCL_2008
SY   COR-L23-R; COR-L23R
DR   CLO; CLO_0002587
DR   cancercelllines; CVCL_2008
DR   Cell_Model_Passport; SIDM01204
DR   DSMZ; ACC-883
DR   DSMZCellDive; ACC-883
DR   ECACC; 96042339
DR   Wikidata; Q54814273
RX   PubMed=3011054;
RX   PubMed=7903701;
RX   PubMed=12606785;
CC   Population: Caucasian.
CC   Doubling time: ~35-40 hours (DSMZ=ACC-883).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-883
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 31.2
ST   D2S1338: 23,26
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 12,20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1139 ! COR-L23
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   COR-L23/R23-
AC   CVCL_2009
SY   COR-L23/Rev
DR   cancercelllines; CVCL_2009
DR   ECACC; 96042337
DR   Wikidata; Q54814274
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=96042337
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 9
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2008 ! COR-L23/R
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   COR-L24
AC   CVCL_2409
SY   COR L24; Cor L24; CORL24
DR   CLO; CLO_0002588
DR   CLDB; cl879
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988002
DR   cancercelllines; CVCL_2409
DR   Cell_Model_Passport; SIDM01490
DR   DepMap; ACH-000382
DR   ECACC; 96020717
DR   GEO; GSM886957
DR   GEO; GSM888025
DR   IARC_TP53; 28322
DR   LiGeA; CCLE_722
DR   PharmacoDB; CORL24_242_2019
DR   Progenetix; CVCL_2409
DR   Wikidata; Q54814275
RX   PubMed=2998422;
RX   PubMed=3034934;
RX   PubMed=8383976;
RX   PubMed=12397641;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1554Ter (c.4660G>T); ClinVar=VCV000433664; Zygosity=Homozygous (DepMap=ACH-000382).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Heterozygous (DepMap=ACH-000382).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.16%; Native American=0%; East Asian, North=4.31%; East Asian, South=0%; South Asian=0%; European, North=57.22%; European, South=35.31% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=96020717
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D744 ! COR-L103
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   COR-L26
AC   CVCL_2410
SY   CORL26
DR   EFO; EFO_0006555
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473034
DR   ECACC; 96020740
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   PharmacoDB; CORL26_243_2019
DR   Wikidata; Q54814276
RX   PubMed=2998422;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 28,30
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 18,19
ST   Penta D: 9,10
ST   Penta E: 10,17
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   COR-L266
AC   CVCL_D745
DR   Wikidata; Q54814277
RX   PubMed=1327513;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   COR-L27
AC   CVCL_D733
SY   Cor L27
DR   Wikidata; Q54814278
RX   PubMed=2998422;
RX   PubMed=3034934;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   COR-L279
AC   CVCL_1140
SY   COR L279; CORL279; LuCL4
DR   CLO; CLO_0002589
DR   EFO; EFO_0002143
DR   CLDB; cl880
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 603
DR   BioSample; SAMN03473035
DR   BioSample; SAMN10988050
DR   cancercelllines; CVCL_1140
DR   Cell_Model_Passport; SIDM00511
DR   ChEMBL-Cells; CHEMBL3308549
DR   ChEMBL-Targets; CHEMBL2366352
DR   Cosmic; 910937
DR   Cosmic; 1524010
DR   Cosmic-CLP; 910937
DR   DepMap; ACH-000257
DR   ECACC; 96020724
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910937
DR   GEO; GSM827428
DR   GEO; GSM888026
DR   GEO; GSM1669698
DR   IARC_TP53; 21251
DR   IGRhCellID; CORL279
DR   LiGeA; CCLE_514
DR   LINCS_LDP; LCL-1825
DR   PharmacoDB; CORL279_244_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1140
DR   PubChem_Cell_line; CVCL_1140
DR   Wikidata; Q54814280
RX   PubMed=1327513;
RX   PubMed=10700188;
RX   PubMed=12397641;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*35:08,58:05; C*01:02,07:01; DRB1*09:01,15:01 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*35:08,58:05; C*01:02,07:01; DRB1*09:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.1623-45_1623-41 (c.2822-43del3); Zygosity=Heterozygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-4_384del13; Zygosity=Homozygous (Cosmic-CLP=910937; DepMap=ACH-000257).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.83%; Native American=0.3%; East Asian, North=2.65%; East Asian, South=0%; South Asian=0%; European, North=60.06%; European, South=34.17% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=910937; ECACC=96020724; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 13,16
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 14,15
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   COR-L283R
AC   CVCL_7215
SY   CORL283R
DR   CLO; CLO_0002590
DR   ECACC; 96020723
DR   Wikidata; Q54814281
CC   Discontinued: ECACC; 96020723; true.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   COR-L30
AC   CVCL_D734
DR   Wikidata; Q54814282
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   COR-L303
AC   CVCL_2411
SY   CORL303; COR L303
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_2411
DR   Cell_Model_Passport; SIDM00510
DR   Cosmic-CLP; 1297438
DR   DepMap; ACH-002095
DR   ECACC; 96020722
DR   EGA; EGAS00001000978
DR   GDSC; 1297438
DR   GEO; GSM1669699
DR   PharmacoDB; CORL303_245_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54814283
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~5 days (ECACC=96020722).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=1.07%; Native American=0.33%; East Asian, North=2.4%; East Asian, South=0%; South Asian=0%; European, North=68.04%; European, South=28.16% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1297438; ECACC=96020722
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   COR-L31
AC   CVCL_D735
SY   COR L31; Cor L31
DR   Wikidata; Q54814284
RX   PubMed=2998422;
RX   PubMed=8383976;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   COR-L311
AC   CVCL_2412
SY   CORL311
DR   CLO; CLO_0002591
DR   CLDB; cl881
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10987984
DR   cancercelllines; CVCL_2412
DR   Cell_Model_Passport; SIDM00509
DR   Cosmic; 687980
DR   Cosmic; 1609513
DR   Cosmic-CLP; 687980
DR   DepMap; ACH-000187
DR   ECACC; 96020721
DR   EGA; EGAS00001000978
DR   GDSC; 687980
DR   GEO; GSM886958
DR   GEO; GSM888027
DR   GEO; GSM1669700
DR   IARC_TP53; 30026
DR   LiGeA; CCLE_088
DR   PharmacoDB; CORL311_246_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2412
DR   Wikidata; Q54814285
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser82Ter (c.245C>A); ClinVar=VCV000837710; Zygosity=Homozygous (Cosmic-CLP=687980; DepMap=ACH-000187).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.920-1G>A (IVS8-1G>A); ClinVar=VCV000141377; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=687980; DepMap=ACH-000187).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.93%; Native American=0%; East Asian, North=2.41%; East Asian, South=0%; South Asian=0%; European, North=61.29%; European, South=34.37% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=687980; ECACC=96020721
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 14
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   COR-L32
AC   CVCL_2413
SY   Cor L32; CORL32
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473036
DR   cancercelllines; CVCL_2413
DR   Cell_Model_Passport; SIDM00508
DR   Cosmic-CLP; 1322212
DR   DepMap; ACH-001489
DR   ECACC; 96020744
DR   EGA; EGAS00001000978
DR   GDSC; 1322212
DR   GEO; GSM1669701
DR   GEO; GSM1887953
DR   GEO; GSM1888030
DR   PharmacoDB; CORL32_247_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54814286
RX   PubMed=2998422;
RX   PubMed=25877200;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Heterozygous (DepMap=ACH-001489).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.46%; East Asian, South=0%; South Asian=0%; European, North=70.96%; European, South=27.58% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=1322212; DepMap=ACH-001489; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8 (PubMed=25877200)
ST   D13S317: 8,11 (Cosmic-CLP=1322212; DepMap=ACH-001489)
ST   D16S539: 9,11
ST   D18S51: 13
ST   D21S11: 27,32.2
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 10
ST   vWA: 14
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   COR-L321
AC   CVCL_2414
SY   CORL321
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_2414
DR   Cell_Model_Passport; SIDM00507
DR   Cosmic-CLP; 1322213
DR   DepMap; ACH-001490
DR   ECACC; 96020756
DR   EGA; EGAS00001000978
DR   GDSC; 1322213
DR   GEO; GSM1669702
DR   PharmacoDB; CORL321_248_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54814287
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Heterozygous (DepMap=ACH-001490).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (DepMap=ACH-001490).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.7%; East Asian, South=0%; South Asian=0%; European, North=67.03%; European, South=32.26% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1322213; DepMap=ACH-001490
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 7
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   COR-L41
AC   CVCL_D736
DR   Wikidata; Q54814288
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   COR-L42
AC   CVCL_D737
SY   COR L42; Cor L42
DR   Wikidata; Q54814289
RX   PubMed=2998422;
RX   PubMed=3034934;
RX   PubMed=8383976;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   COR-L47
AC   CVCL_2415
SY   Cor L47; CORL47
DR   CLO; CLO_0002592
DR   EFO; EFO_0006556
DR   CLDB; cl882
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 602
DR   BioSample; SAMN03473037
DR   BioSample; SAMN10987980
DR   cancercelllines; CVCL_2415
DR   Cell_Model_Passport; SIDM01482
DR   ChEMBL-Cells; CHEMBL4523537
DR   ChEMBL-Targets; CHEMBL4523568
DR   Cosmic; 753544
DR   DepMap; ACH-000695
DR   ECACC; 92031915
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM886959
DR   GEO; GSM888028
DR   GEO; GSM1887954
DR   GEO; GSM1888031
DR   IARC_TP53; 28263
DR   LiGeA; CCLE_621
DR   PharmacoDB; CORL47_249_2019
DR   Progenetix; CVCL_2415
DR   PubChem_Cell_line; CVCL_2415
DR   SKY/M-FISH/CGH; 1627
DR   Wikidata; Q54814290
RX   PubMed=2998422;
RX   PubMed=3034934;
RX   PubMed=12397641;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32586373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*03:01,03:01; B*08:01,37:04; C*07:01,07:01 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*08:01,18:01; C*07:01,07:01; DRB1*13:07,13:07 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu18Ter (c.52G>T); Zygosity=Homozygous (DepMap=ACH-000695).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (DepMap=ACH-000695).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.67%; Native American=0.43%; East Asian, North=2.28%; East Asian, South=0%; South Asian=1.16%; European, North=59.47%; European, South=34.99% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ECACC=92031915; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D21S11: 30,31.2
ST   D3S1358: 14
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   COR-L51
AC   CVCL_2416
SY   Cor L51; CORL51
DR   CLO; CLO_0002593
DR   CLDB; cl883
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03473038
DR   BioSample; SAMN10988010
DR   cancercelllines; CVCL_2416
DR   Cell_Model_Passport; SIDM01717
DR   Cosmic; 687981
DR   Cosmic; 910555
DR   DepMap; ACH-001047
DR   ECACC; 92031916
DR   GEO; GSM17196
DR   IARC_TP53; 21252
DR   LINCS_LDP; LCL-1826
DR   PharmacoDB; CORL51_250_2019
DR   Progenetix; CVCL_2416
DR   Wikidata; Q54814291
RX   PubMed=2998422;
RX   PubMed=3034934;
RX   PubMed=12397641;
RX   PubMed=15016488;
RX   PubMed=20164919;
RX   PubMed=25877200;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe134Cys (c.401T>G); ClinVar=VCV000230477; Zygosity=Heterozygous (DepMap=ACH-001047).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.99%; Native American=0%; East Asian, North=3.95%; East Asian, South=0%; South Asian=0%; European, North=54.28%; European, South=37.79% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=92031916; PubMed=25877200
ST   Amelogenin: X (ECACC=92031916)
ST   Amelogenin: X,Y (PubMed=25877200)
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 13,20
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21,23.2
ST   Penta D: 10,11
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   COR-L54
AC   CVCL_D738
DR   Wikidata; Q54814293
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   COR-L59
AC   CVCL_D739
DR   Wikidata; Q54814294
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   COR-L64
AC   CVCL_2417
SY   CORL64
DR   BioSample; SAMN03472983
DR   ECACC; 96020749
DR   Wikidata; Q54814295
RX   PubMed=2998422;
RX   PubMed=25877200;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 12,19
ST   D21S11: 30
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 11,15
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 16
//
ID   COR-L65
AC   CVCL_D740
DR   Wikidata; Q54814296
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   COR-L71
AC   CVCL_D741
DR   Wikidata; Q54814297
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   COR-L80
AC   CVCL_D742
DR   Wikidata; Q54814298
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   COR-L84
AC   CVCL_D743
DR   Wikidata; Q54814299
RX   PubMed=2998422;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   COR-L88
AC   CVCL_1141
SY   Cor L88; CORL88; CorL88
DR   CLO; CLO_0002594
DR   EFO; EFO_0002144
DR   CLDB; cl884
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473039
DR   BioSample; SAMN10988006
DR   cancercelllines; CVCL_1141
DR   Cell_Model_Passport; SIDM00506
DR   ChEMBL-Cells; CHEMBL3308865
DR   ChEMBL-Targets; CHEMBL2366329
DR   Cosmic; 687982
DR   Cosmic; 906808
DR   Cosmic; 1609523
DR   Cosmic; 1995379
DR   Cosmic-CLP; 906808
DR   DepMap; ACH-000508
DR   ECACC; 92031917
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906808
DR   GEO; GSM17306
DR   GEO; GSM827452
DR   GEO; GSM886960
DR   GEO; GSM888029
DR   GEO; GSM1669703
DR   GEO; GSM1887924
DR   GEO; GSM1888005
DR   IARC_TP53; 21253
DR   IGRhCellID; CORL88
DR   LiGeA; CCLE_438
DR   LINCS_LDP; LCL-1827
DR   PharmacoDB; CORL88_251_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1141
DR   PubChem_Cell_line; CVCL_1141
DR   Wikidata; Q54814300
RX   PubMed=2998422;
RX   PubMed=3034934;
RX   PubMed=12397641;
RX   PubMed=15016488;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*37:04,58:05; C*07:06,07:06 (PubMed=25960936).
CC   HLA typing: A*01:01,01:01; B*37:04,58:05; C*07:06,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (Cosmic-CLP=906808; DepMap=ACH-000508).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.68%; Native American=0%; East Asian, North=2.39%; East Asian, South=0%; South Asian=0%; European, North=58.19%; European, South=36.74% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906808; ECACC=92031917; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 9,13
ST   FGA: 19,20
ST   Penta D: 9
ST   Penta E: 14
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   COR-L95
AC   CVCL_2418
SY   CORL95
DR   CLO; CLO_0002595
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988007
DR   cancercelllines; CVCL_2418
DR   Cell_Model_Passport; SIDM00521
DR   Cosmic; 1297439
DR   Cosmic; 2125174
DR   Cosmic-CLP; 1297439
DR   DepMap; ACH-000743
DR   ECACC; 96020733
DR   EGA; EGAS00001000978
DR   GDSC; 1297439
DR   GEO; GSM827338
DR   GEO; GSM886961
DR   GEO; GSM888030
DR   GEO; GSM1669704
DR   IARC_TP53; 28298
DR   LiGeA; CCLE_687
DR   LINCS_LDP; LCL-1828
DR   PharmacoDB; CORL95_252_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2418
DR   Wikidata; Q54814301
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,24:02; B*35:03,35:03; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265-1G>A; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=1297439; DepMap=ACH-000743).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Tyr (c.775G>T); ClinVar=VCV000634680; Zygosity=Homozygous (Cosmic-CLP=1297439; DepMap=ACH-000743).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.63%; Native American=0%; East Asian, North=1.84%; East Asian, South=0%; South Asian=0%; European, North=66.43%; European, South=31.09% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1297439; ECACC=96020733
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11 (ECACC=96020733)
ST   D13S317: 8,13 (Cosmic-CLP=1297439)
ST   D16S539: 11,13
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 16,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   COR-L96-CAR
AC   CVCL_1142
SY   COR-L96CAR; CORL96CAR
DR   ArrayExpress; E-MTAB-783
DR   Cosmic; 971776
DR   IARC_TP53; 27147
DR   Wikidata; Q54814305
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V485 ! COR-L96-LCL
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   COR-L96-LCL
AC   CVCL_V485
SY   COR-L96LCL
DR   Wikidata; Q54814306
RX   PubMed=14762065;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1142 ! COR-L96-CAR
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 8
//
ID   Cor.4U
AC   CVCL_Y550
SY   Cor4U
DR   Wikidata; Q54814307
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20170913005750/http://axiogenesis.com/products/cardiac-cells/cor-4u-hipsc-cardiomyocytes.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 8
//
ID   Cor.At
AC   CVCL_Y551
SY   Cor.At CL; Cor.At Colorless
DR   Lonza; 1372
DR   Wikidata; Q54814308
RX   PubMed=15659535;
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20150509040519/http://axiogenesis.com/products/murine-cardiomyocytes/cells/cor-at-cl-es.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 10
//
ID   Cor.At GFP
AC   CVCL_Y552
DR   Wikidata; Q54814309
RX   PubMed=15659535;
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20150509040529/http://axiogenesis.com/products/murine-cardiomyocytes/cells/cor-at-gfp-es.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 11
//
ID   Cor.At-iPS-CL
AC   CVCL_1E63
DR   Wikidata; Q54814310
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20150509040524/http://axiogenesis.com/products/murine-cardiomyocytes/cells/cor-at-cl-ips.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 7
//
ID   Cor1
AC   CVCL_A5EM
SY   COR1; Cor-1
DR   BTO; BTO_0006560
DR   Wikidata; Q107114702
RX   PubMed=16086633;
RX   PubMed=16766697;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/animal-stem-cells-catalogue-isenet.pdf
CC   Miscellaneous: Sex of donor from personal communication of BioKryo (ISENET Biobanking).
CC   Derived from site: In situ; Embryonic brain, neocortex; UBERON=UBERON_0006238+UBERON_0001950.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   16FD
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 11
//
ID   COS-1
AC   CVCL_0223
SY   Cos-1; COS 1; Cos 1; COS1; Cos1; CV-1 in Origin Simian-1
DR   BTO; BTO_0001538
DR   CLO; CLO_0002596
DR   CLO; CLO_0050514
DR   EFO; EFO_0022742
DR   MCCL; MCC:0000111
DR   CLDB; cl886
DR   CLDB; cl887
DR   CLDB; cl888
DR   CLDB; cl889
DR   CLDB; cl7122
DR   AddexBio; T0014001/34
DR   ATCC; CRL-1650
DR   BCRC; 60002
DR   BCRJ; 0070
DR   CCRID; 1101MON-PUMC000157
DR   CCRID; 3101MONGNO28
DR   CCRID; 5301MON-KCB93018YJ
DR   ChEMBL-Cells; CHEMBL3308351
DR   ChEMBL-Targets; CHEMBL614563
DR   CLS; 305005
DR   DSMZ; ACC-63
DR   DSMZCellDive; ACC-63
DR   ECACC; 88031701
DR   ICLC; ATL01002
DR   IZSLER; BS CL 95
DR   JCRB; JCRB9082
DR   KCB; KCB 93018YJ
DR   KCLB; 21650
DR   Lonza; 722
DR   MeSH; D019556
DR   NCBI_Iran; C518
DR   PubChem_Cell_line; CVCL_0223
DR   RCB; RCB0143
DR   TOKU-E; 992
DR   Ubigene; YC-A031
DR   Wikidata; Q27556079
RX   PubMed=6260373;
RX   PubMed=34737324;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cos1/cos1cells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells/agmindex
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-13.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/COS_cells
CC   Group: Non-human primate cell line.
CC   Doubling time: ~48 hours (DSMZ=ACC-63).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   COS-1-InVitrus
AC   CVCL_Z934
DR   ECACC; 04092902
DR   Wikidata; Q54814311
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   COS-1-pA104R
AC   CVCL_ZW94
DR   Wikidata; Q102113709
RX   PubMed=31323824;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P68742; African swine fever virus (strain Badajoz 1971 Vero-adapted) pA104R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   COS-1/B2T.cl.17
AC   CVCL_FA30
DR   Wikidata; Q54814312
RX   PubMed=24709903;
CC   Group: Non-human primate cell line.
CC   Characteristics: Transfected with a TNFRSF13C-TNFRSF1A (BAFFR-TNFR1) hybrid receptor containing the extracellular BAFF-binding portion of the TNFRSF13C and the intracellular signaling portion of TNFRSF1A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17755; TNFRSF13C (Note=AA 1-78).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11916; TNFRSF1A (Note=AA 204-443).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   COS-3
AC   CVCL_HE48
SY   Cos-3; COS3; Cos3; CV-1 in Origin Simian-3
DR   Wikidata; Q54814313
RX   PubMed=6260373;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/COS_cells
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   COS-33
AC   CVCL_A8S2
DR   Wikidata; Q102113711
RX   PubMed=32676162;
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft in its third passage (OS-33).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex8-9del; Zygosity=Homozygous (PubMed=32676162).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   COS-7
AC   CVCL_0224
SY   Cos-7; COS 7; Cos 7; COS7; Cos7; CV-1 in Origin Simian-7
DR   BTO; BTO_0000298
DR   CLO; CLO_0002597
DR   CLO; CLO_0050508
DR   EFO; EFO_0022725
DR   MCCL; MCC:0000112
DR   CLDB; cl890
DR   CLDB; cl891
DR   CLDB; cl892
DR   CLDB; cl893
DR   AddexBio; T0014002/35
DR   ATCC; CRL-1651
DR   BCRC; 60094
DR   BCRJ; 0071
DR   CCRID; 1101MON-PUMC000033
DR   CCRID; 3101MONGNO2
DR   CCRID; 3101MONSCSP508
DR   CCRID; 5301MON-KCB93019YJ
DR   CCTCC; GDC0609
DR   ChEMBL-Cells; CHEMBL3307648
DR   ChEMBL-Targets; CHEMBL614564
DR   CLS; 605470
DR   DSMZ; ACC-60
DR   DSMZCellDive; ACC-60
DR   ECACC; 87021302
DR   FCS-free; 47-11-47-1-8-9
DR   IBRC; C10146
DR   ICLC; ATL96005
DR   IZSLER; BS CL 103
DR   JCRB; IFO50068
DR   JCRB; JCRB9127
DR   KCB; KCB 93019YJ
DR   KCLB; 21651
DR   Lonza; 587
DR   MeSH; D019556
DR   NCBI_Iran; C143
DR   PubChem_Cell_line; CVCL_0224
DR   RCB; RCB0539
DR   TKG; TKG 0514
DR   TOKU-E; 993
DR   Wikidata; Q27556092
RX   PubMed=6260373;
RX   PubMed=22059503;
RX   PubMed=29468137;
WW   Info; -; -; https://cos-7.com/
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cos7/cos7cells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells/agmindex
WW   Info; Quora; -; https://www.quora.com/How-is-the-COS-7-cell-line-produced-and-what-is-its-application
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-5.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/COS_cells
CC   Group: Non-human primate cell line.
CC   Virology: Highly susceptible to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   Doubling time: ~35-48 hours (DSMZ=ACC-60); ~2 days (Note=Lot 03052018) (JCRB=IFO50068); ~34 hours (Note=Lot 02292000), ~30 hours (Note=Lots 11222004 and 10052007) (JCRB=JCRB9127).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Misspelling: COS-2; Note=Thanks to a personal communication of Galan, Jorge Enrique we were made aware that COS-2 was mistakenly used instead of COS-7 in 3 papers: PubMed 14662750, PubMed 17074883 and PubMed 19379694.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 36
//
ID   COS-7 1C7
AC   CVCL_A5PZ
SY   1C7
DR   Wikidata; Q107114703
RX   PubMed=7509982;
CC   Group: Non-human primate cell line.
CC   Characteristics: Useful to study endothelin analogues for agonist or antagonist activity (PubMed=7509982).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3180; EDNRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   COS-7 1E7
AC   CVCL_LH58
SY   1E7
DR   Wikidata; Q54814314
RX   PubMed=11313340;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19; AANAT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   COS-7-InVitrus
AC   CVCL_Z935
DR   ECACC; 05063001
DR   Wikidata; Q54814315
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   COS-7L
AC   CVCL_0J76
SY   COS7L
DR   Wikidata; Q54814316
WW   Provider; Thermo Fisher; 11622-016; https://tools.thermofisher.com/content/sfs/manuals/3915.pdf
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Discontinued: Thermo Fisher/Gibco; Catalog number 11622-016.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   COS-F2-130
AC   CVCL_A5QA
DR   Wikidata; Q107114704
RX   PubMed=11356706;
CC   Group: Non-human primate cell line.
CC   Characteristics: Useful system for studying steroidogenesis. Converts cholesterol to pregnenolone but lack downstream enzymes that catalyze other steroidogenic reactions (PubMed=11356706).
CC   Characteristics: Transfected with the F2 construct that consist of the fusion of P450scc-adrenodoxin reductase-adrenodoxin (PubMed=11356706).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2590; CYP11A1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3638; FDX1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3642; FDXR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   COS-M5
AC   CVCL_C760
SY   Cos-M5; COS M5; COS/M5; COSM5; CosM5
DR   Wikidata; Q54814318
RX   PubMed=6192195;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   COS-M6
AC   CVCL_8561
SY   COS-m6; COS M6; COSM6; CosM6; COSm6; COS-1 M6; Cos-1/M6
DR   Wikidata; Q54814319
RX   PubMed=6192195;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-196.html
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Misspelling: COS-7/M6; Note=Incorrect as not a COS-7 derivative.
CC   Misspelling: COS-7 subline M6; Note=Incorrect as not a COS-7 derivative.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   COS/Fucci
AC   CVCL_E071
SY   COS-Fucci
DR   CLO; CLO_0050516
DR   RCB; RCB2814
DR   Wikidata; Q54814317
RX   PubMed=18267078;
CC   Group: Non-human primate cell line.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct.
CC   Characteristics: Transfected with the Fucci probe which consist of the fusion of monomeric Kusabira-Orange2 (mKO2) to the ubiquitination domain of human CDT1 (AA 30-120) and monomeric AzamiGreen (mAG) to the ubiquitination domain of human geminin (AA 1-110).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; HC91W; AzamiGreen (Note=Green fluorescent protein from G.fascicularis).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 134NN; mKusabira-Orange2 (Note=mKO2, orange fluorescent protein derived from F.concinna Kusabira-Orange (KO)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   COS_1033
AC   CVCL_FA25
DR   Wikidata; Q54814320
RX   PubMed=29056719;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y1M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   COS_1186h
AC   CVCL_FA21
DR   Wikidata; Q54814321
RX   PubMed=29056719;
CC   Derived from site: In situ; Bone, scapula; UBERON=UBERON_0006849.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_FA22 ! COS_1186w
SX   Male
AG   11Y2M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   COS_1186w
AC   CVCL_FA22
DR   Wikidata; Q54814322
RX   PubMed=29056719;
CC   Derived from site: In situ; Bone, scapula; UBERON=UBERON_0006849.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_FA21 ! COS_1186h
SX   Male
AG   11Y2M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   COS_1189
AC   CVCL_FA23
DR   Wikidata; Q54814323
RX   PubMed=29056719;
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y3M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   COS_1220
AC   CVCL_FA24
DR   Wikidata; Q54814324
RX   PubMed=29056719;
CC   Derived from site: In situ; Bone, radius; UBERON=UBERON_0001423.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y3M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   COS1NR
AC   CVCL_M797
DR   Wikidata; Q54814325
RX   PubMed=9619880;
CC   Transformant: ChEBI; CHEBI_28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344/Ns1c.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_M798 ! COS2NR
OI   CVCL_M799 ! COS4NR
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   COS2NR
AC   CVCL_M798
DR   Wikidata; Q54814326
RX   PubMed=9619880;
CC   Transformant: ChEBI; CHEBI_28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344/Ns1c.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_M797 ! COS1NR
OI   CVCL_M799 ! COS4NR
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   COS31
AC   CVCL_L346
SY   COS 31; Canine osteosarcoma cells from passage 31
DR   BTO; BTO_0005363
DR   Wikidata; Q54814327
RX   PubMed=9827351;
RX   PubMed=9827352;
RX   PubMed=33446089;
CC   Doubling time: 28 hours (PubMed=9827352).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: Metastatic; Bone, left distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Saint Bernard; VBO=VBO_0201160.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   COS31/rCDDP
AC   CVCL_L347
DR   Wikidata; Q54814329
RX   PubMed=9827351;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone, left distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Saint Bernard; VBO=VBO_0201160.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L346 ! COS31
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   COS4NR
AC   CVCL_M799
DR   Wikidata; Q54814330
RX   PubMed=9619880;
CC   Transformant: ChEBI; CHEBI_28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344/Ns1c.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_M797 ! COS1NR
OI   CVCL_M798 ! COS2NR
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   COS7-moRIII
AC   CVCL_B7HB
SY   moRIII-COS7
DR   Wikidata; Q112929408
RX   DOI=10.1080/09712119.2011.558685;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95500; Fcgr3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   COS7 moRIII-gamma
AC   CVCL_B7HC
SY   moRIII-gamma-COS7
DR   Wikidata; Q112929409
RX   DOI=10.1080/09712119.2011.558685;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95496; Fcer1g.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95500; Fcgr3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   COS7-pc
AC   CVCL_B7HD
SY   pc-COS7
DR   Wikidata; Q112929410
RX   DOI=10.1080/09712119.2011.558685;
CC   Group: Non-human primate cell line.
CC   Characteristics: Control cell line for COS7-moRIII (Cellosaurus=CVCL_B7HB) and COS7 moRIII-gamma (Cellosaurus=CVCL_B7HC) (DOI=10.1080/09712119.2011.558685).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   COSB
AC   CVCL_5I33
DR   Wikidata; Q54814331
RX   PubMed=24582862;
CC   Sequence variation: Mutation; VGNC; VGNC:84862; EP300; Simple; p.Asn1570fs (c.4704dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:44555; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Ala150fs (c.447delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Leu184Phe (c.550C>T); Zygosity=Heterozygous (from parent cell line).
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0C95 ! SB-HSA
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   COSCA-Pr
AC   CVCL_L349
SY   COSCA-PR; COSCA-Princess
DR   Wikidata; Q54814332
RX   PubMed=9522958;
CC   Doubling time: 4 days (PubMed=9522958).
CC   Derived from site: Metastatic; Bone, right proximal humerus; UBERON=UBERON_0004411.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   COSCA-T
AC   CVCL_L348
SY   COSCA-Toby
DR   Wikidata; Q54814333
RX   PubMed=9522958;
CC   Doubling time: 14 days (PubMed=9522958).
CC   Derived from site: Metastatic; Bone, left distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   COST
AC   CVCL_9491
DR   Wikidata; Q54814334
RX   PubMed=15356658;
RX   PubMed=15356659;
RX   PubMed=16596703;
RX   PubMed=26657151;
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=15356659; PubMed=26657151).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   COT-62
AC   CVCL_D5JG
SY   COT-62-M
DR   Wikidata; Q127380589
RX   DOI=10.1007/BF02822702;
RX   PubMed=16667897;
CC   Group: Plant cell line.
CC   Characteristics: Selected from parent cell line for high chlorophyll (DOI=10.1007/BF02822702; PubMed=16667897).
CC   Characteristics: Photoautotrophic growth (DOI=10.1007/BF02822702; PubMed=16667897).
CC   Derived from site: In situ; Cotyledon; PO=PO_0020030.
CC   Derived from site: In situ; Hypocotyl; PO=PO_0020100.
CC   Breed/subspecies: Cultivar Stoneville 825.
OX   NCBI_TaxID=3635; ! Gossypium hirsutum (Upland cotton)
HI   CVCL_D5JB ! COT-P
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   COT-P
AC   CVCL_D5JB
DR   Wikidata; Q127380590
RX   DOI=10.1007/BF02822702;
RX   DOI=10.1016/S0074-7696(08)62455-9;
RX   PubMed=16666458;
RX   PubMed=16667210;
RX   PubMed=16667897;
RX   PubMed=24241763;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (PubMed=16666458; PubMed=16667210; PubMed=24241763).
CC   Characteristics: Capable of photorespiration (PubMed=16667210).
CC   Characteristics: Capable of growth in vitamin-free medium (PubMed=16667897).
CC   Doubling time: 8-14 days (PubMed=16666458).
CC   Derived from site: In situ; Cotyledon; PO=PO_0020030.
CC   Derived from site: In situ; Hypocotyl; PO=PO_0020100.
CC   Breed/subspecies: Cultivar Stoneville 825.
OX   NCBI_TaxID=3635; ! Gossypium hirsutum (Upland cotton)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   COT-PA
AC   CVCL_D5JC
DR   Wikidata; Q127380591
RX   DOI=10.1016/S0074-7696(08)62455-9;
RX   PubMed=16666458;
RX   PubMed=16667210;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (PubMed=16666458; PubMed=16667210).
CC   Characteristics: Capable of photorespiration (PubMed=16667210).
CC   Doubling time: ~14 days (PubMed=16666458).
CC   Derived from site: In situ; Cotyledon; PO=PO_0020030.
CC   Derived from site: In situ; Hypocotyl; PO=PO_0020100.
CC   Breed/subspecies: Cultivar Stoneville 825.
OX   NCBI_TaxID=3635; ! Gossypium hirsutum (Upland cotton)
HI   CVCL_D5JB ! COT-P
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Cou-L
AC   CVCL_1K09
SY   Cou-LB
DR   Wikidata; Q54814335
RX   PubMed=11564178;
RX   PubMed=14962098;
CC   Miscellaneous: Sampling site and synonym from personal communication of Bensussan, Armand.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K07 ! Cou-LS
OI   CVCL_1K08 ! Cou-L3
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 7
//
ID   Cou-L3
AC   CVCL_1K08
DR   Wikidata; Q54814337
RX   PubMed=12534590;
CC   Miscellaneous: Sampling site from personal communication of Bensussan, Armand.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K09 ! Cou-L
OI   CVCL_1K07 ! Cou-LS
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 7
//
ID   Cou-LS
AC   CVCL_1K07
DR   Wikidata; Q54814338
RX   PubMed=9596682;
CC   Miscellaneous: Sampling site from personal communication of Bensussan, Armand.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K09 ! Cou-L
OI   CVCL_1K08 ! Cou-L3
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 7
//
ID   COV318
AC   CVCL_2419
SY   Cov318; COV-318
DR   EFO; EFO_0006382
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 601
DR   BioSample; SAMN03473267
DR   BioSample; SAMN10987637
DR   cancercelllines; CVCL_2419
DR   Cell_Model_Passport; SIDM01480
DR   DepMap; ACH-000256
DR   ECACC; 07071903
DR   EGA; EGAS00001000610
DR   GEO; GSM313686
DR   GEO; GSM886962
DR   GEO; GSM888031
DR   GEO; GSM1291133
DR   GEO; GSM2474973
DR   IARC_TP53; 28345
DR   LiGeA; CCLE_904
DR   PharmacoDB; COV318_253_2019
DR   PRIDE; PXD003668
DR   Progenetix; CVCL_2419
DR   Wikidata; Q54814339
RX   PubMed=8436435;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32612269;
RX   PubMed=35918200;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 50 hours (PubMed=25984343).
CC   HLA typing: A*02:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Phe (c.583A>T); ClinVar=VCV000376617; Zygosity=Homozygous (PubMed=25230021; PubMed=28273451; DepMap=ACH-000256).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.46%; East Asian, South=0%; South Asian=0.55%; European, North=70.13%; European, South=27.85% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=07071903; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 14
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 13.2
ST   D21S11: 30
ST   D2S1338: 17,27
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   Penta D: 10
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   COV353
AC   CVCL_4Y49
SY   Cov353
DR   Wikidata; Q54814340
RX   PubMed=1958589;
RX   PubMed=8436435;
CC   Derived from site: Metastatic; Urinary bladder, bladder dome; UBERON=UBERON_0006082.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2423 ! COV413B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   COV362
AC   CVCL_2420
SY   Cov362; COV-362
DR   EFO; EFO_0006383
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 600
DR   BioSample; SAMN03473268
DR   BioSample; SAMN10987971
DR   cancercelllines; CVCL_2420
DR   Cell_Model_Passport; SIDM01479
DR   DepMap; ACH-000278
DR   ECACC; 07071910
DR   EGA; EGAS00001000610
DR   GEO; GSM886963
DR   GEO; GSM888032
DR   GEO; GSM1291135
DR   IARC_TP53; 28329
DR   LiGeA; CCLE_216
DR   PharmacoDB; COV362_254_2019
DR   Progenetix; CVCL_2420
DR   Wikidata; Q54814342
RX   PubMed=8436435;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=32612269;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 91 hours (PubMed=25984343).
CC   HLA typing: A*03:01,03:01; B*40:01,40:01; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871fs (c.2611_2612ins1); Zygosity=Homozygous (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.4095+1G>T; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=25230021; DepMap=ACH-000278).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=25230021; DepMap=ACH-000278).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.85%; Native American=0.2%; East Asian, North=3.12%; East Asian, South=0%; South Asian=0%; European, North=61.78%; European, South=33.05% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=07071910; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 10,14
ST   D8S1179: 11
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   COV362 RRAS2 KO#1
AC   CVCL_E5L4
RX   PubMed=36476833;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871fs (c.2611_2612ins1); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.4095+1G>T; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2420 ! COV362
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COV362 RRAS2 KO#41
AC   CVCL_E5L6
RX   PubMed=36476833;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871fs (c.2611_2612ins1); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.4095+1G>T; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2420 ! COV362
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COV362 RRAS2 KO#5
AC   CVCL_E5L5
RX   PubMed=36476833;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871fs (c.2611_2612ins1); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.4095+1G>T; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2420 ! COV362
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COV362.4
AC   CVCL_2421
SY   COV362-4; COV-362.4
DR   BioSample; SAMN03473272
DR   cancercelllines; CVCL_2421
DR   Cell_Model_Passport; SIDM01630
DR   ECACC; 07071904
DR   GEO; GSM313709
DR   GEO; GSM1291134
DR   Progenetix; CVCL_2421
DR   Wikidata; Q54814343
RX   PubMed=8436435;
RX   PubMed=25230021;
RX   PubMed=25877200;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871fs (c.2611_2612ins1); Zygosity=Homozygous (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.4095+1G>T; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=25230021).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=07071904; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 12,13 (PubMed=25877200)
ST   D5S818: 13 (PubMed=25230021)
ST   D7S820: 10,14
ST   D8S1179: 11
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2420 ! COV362
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   COV413A
AC   CVCL_2422
SY   COV 413A
DR   EFO; EFO_0006557
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472963
DR   cancercelllines; CVCL_2422
DR   Cell_Model_Passport; SIDM01478
DR   DepMap; ACH-001340
DR   ECACC; 07071905
DR   EGA; EGAS00001000610
DR   GEO; GSM1291136
DR   PharmacoDB; COV413A_255_2019
DR   Wikidata; Q54814344
RX   PubMed=8436435;
RX   PubMed=9413942;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=25230021; DepMap=ACH-001340).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): DepMap=ACH-001340; ECACC=07071905; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 9,12
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 19
ST   Penta D: 14
ST   Penta E: 12,14
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2423 ! COV413B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   COV413B
AC   CVCL_2423
DR   EFO; EFO_0006558
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472965
DR   cancercelllines; CVCL_2423
DR   Cell_Model_Passport; SIDM01477
DR   ECACC; 07071906
DR   EGA; EGAS00001000610
DR   GEO; GSM1291137
DR   PharmacoDB; COV413B_256_2019
DR   Wikidata; Q54814345
RX   PubMed=8436435;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=25230021).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Urinary bladder, bladder dome; UBERON=UBERON_0006082.
ST   Source(s): ECACC=07071906; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 9,12
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 19
ST   Penta D: 14
ST   Penta E: 12,14
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2422 ! COV413A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   COV434
AC   CVCL_2010
SY   COV-434; COV 434
DR   EFO; EFO_0006384
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 599
DR   BioSample; SAMN03473273
DR   BioSample; SAMN10987973
DR   cancercelllines; CVCL_2010
DR   Cell_Model_Passport; SIDM01476
DR   Cosmic; 1149408
DR   Cosmic; 1213590
DR   Cosmic; 1429992
DR   Cosmic; 2368539
DR   Cosmic; 2391829
DR   DepMap; ACH-000123
DR   ECACC; 07071909
DR   EGA; EGAS00001000610
DR   GEO; GSM313704
DR   GEO; GSM886964
DR   GEO; GSM888033
DR   IARC_TP53; 30027
DR   LiGeA; CCLE_469
DR   PharmacoDB; COV434_257_2019
DR   Progenetix; CVCL_2010
DR   Wikidata; Q54814346
RX   PubMed=8436435;
RX   PubMed=9413942;
RX   PubMed=15541573;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=33328126;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/cov434/
CC   Problematic cell line: Misclassified. Originally thought to be an ovarian granulosa cell tumor but seems to be a small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) (PubMed=33328126).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Because it conserved a number of properties of normal human granulosa cells, it is used in the investigation of such cell type.
CC   Doubling time: 24 hours (PubMed=25984343).
CC   HLA typing: A*02:05,31:01; B*44:02,50:01; C*06:02,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; c.3952-1G>C; ClinVar=VCV000635379; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=33328126; DepMap=ACH-000123).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.5%; Native American=0.68%; East Asian, North=0.76%; East Asian, South=0%; South Asian=0%; European, North=60.55%; European, South=36.51% (PubMed=30894373).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): ECACC=07071909; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 10,15
ST   D21S11: 28
ST   D3S1358: 15,19
ST   D5S818: 10,11
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
DI   ORDO; Orphanet_370396; Small cell carcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   COV504
AC   CVCL_2424
SY   Cov504; COV 504
DR   EFO; EFO_0006385
DR   ArrayExpress; E-MTAB-2706
DR   BioGRID_ORCS_Cell_line; 598
DR   BioSample; SAMN03473269
DR   BioSample; SAMN10987860
DR   cancercelllines; CVCL_2424
DR   Cell_Model_Passport; SIDM01475
DR   DepMap; ACH-001048
DR   ECACC; 07071902
DR   EGA; EGAS00001000610
DR   GEO; GSM886965
DR   GEO; GSM888034
DR   GEO; GSM1291138
DR   GEO; GSM2474974
DR   IARC_TP53; 28258
DR   PharmacoDB; COV504_258_2019
DR   Progenetix; CVCL_2424
DR   Wikidata; Q54814347
RX   PubMed=8436435;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28273451;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 50 hours (PubMed=25984343).
CC   HLA typing: A*11:01,11:01; B*35:01,35:01; C*04:01,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu323Glyfs*13 (c.966_967delAC); Zygosity=Homozygous (PubMed=25230021; PubMed=28273451; DepMap=ACH-001048).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.33%; East Asian, North=1.96%; East Asian, South=0%; South Asian=1.71%; European, North=68.77%; European, South=27.23% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=07071902; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 13
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 7,16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   COV504 RRAS2 KO#7
AC   CVCL_E5L7
RX   PubMed=36476833;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu323Glyfs*13 (c.966_967delAC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2424 ! COV504
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COV644
AC   CVCL_2425
SY   COV-644
DR   CLO; CLO_0037288
DR   EFO; EFO_0006386
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 597
DR   BioSample; SAMN03473270
DR   BioSample; SAMN10988003
DR   cancercelllines; CVCL_2425
DR   Cell_Model_Passport; SIDM01474
DR   DepMap; ACH-000608
DR   ECACC; 07071908
DR   EGA; EGAS00001000610
DR   GEO; GSM313681
DR   GEO; GSM886966
DR   GEO; GSM888035
DR   GEO; GSM1291139
DR   LiGeA; CCLE_477
DR   PharmacoDB; COV644_259_2019
DR   Progenetix; CVCL_2425
DR   Wikidata; Q54814357
RX   PubMed=8436435;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 188 hours (PubMed=25984343).
CC   HLA typing: A*02:01,02:01; B*35:03,35:03; C*04:01,04:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.23%; Native American=0%; East Asian, North=3.96%; East Asian, South=0%; South Asian=21.27%; European, North=16.37%; European, South=57.17% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ECACC=07071908; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,16.2
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 10
ST   Penta E: 18
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   CovCis
AC   CVCL_E5FS
DR   CancerTools; 161762
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Phe (c.583A>T); ClinVar=VCV000376617; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2419 ! COV318
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   COVID19-SRBD-8
AC   CVCL_B0EU
DR   CCRID; 4201PAT-CCTCC01935
DR   Wikidata; Q108820079
RX   Patent=CN113215107B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202167.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   COX
AC   CVCL_E534
DR   CLS; 302138
DR   dbMHC; 48733
DR   IHW; IHW09022
DR   IPD-IMGT/HLA; 10429
DR   PRIDE; PXD017682
DR   Wikidata; Q54814358
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=15140828;
RX   PubMed=16440057;
RX   PubMed=16702430;
RX   PubMed=18193213;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01:01; B*08:01:01:01; C*07:01:01:01; DPA1*01:03:01:03; DPB1*03:01:01; DQA1*05:01:01; DQB1*02:01:01; DRA*01:02; DRB1*03:01:01; DRB3*01:01:02:01 (IPD-IMGT/HLA=10429).
CC   HLA typing: A*01:01:01:01; B*08:01:01:01; C*07:01:01:01; DPA1*01:03:01:03; DPB1*03:01:01; DQA1*05:01:01:02; DQB1*02:01:01; DRB1*03:01:01; DRB3*01:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   COX10 KO clone K19
AC   CVCL_YM15
SY   COX10 KO clone KO#19
DR   Kerafast; EMI019
DR   Wikidata; Q93457338
RX   PubMed=16782876;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:1917633; Cox10.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: 129X1/SvJ x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 8
//
ID   CP
AC   CVCL_6F78
SY   Climbing perch caudal Peduncle
DR   Wikidata; Q54814359
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
RX   PubMed=1717644;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=64144; ! Anabas testudineus (Climbing perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   CP-1268
AC   CVCL_Z342
DR   ICLDB; cp-1268
DR   Wikidata; Q54814360
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=184032;
RX   PubMed=5142331;
CC   Group: Insect cell line.
CC   Doubling time: 24 hours (PubMed=5142331).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   CP-169
AC   CVCL_Z343
SY   Cp 169; CP 169; Cp169
DR   ICLDB; cp-169
DR   Wikidata; Q54814361
RX   DOI=10.1007/BF02620830;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=1017845;
RX   PubMed=5142331;
RX   PubMed=8799737;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Doubling time: 24 hours (PubMed=5142331).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   CP-18821
AC   CVCL_A8WD
DR   IARC_TP53; 9373
DR   Wikidata; Q108820080
RX   PubMed=9453489;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9453489).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser303Alafs*42 (c.906del); Zygosity=Unspecified (PubMed=9453489).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   CP-52731
AC   CVCL_A8WE
DR   IARC_TP53; 9374
DR   Wikidata; Q108820081
RX   PubMed=9453489;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu97Gln (c.290T>A); Zygosity=Unspecified (PubMed=9453489).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=9453489).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   cp-73
AC   CVCL_WM04
DR   Wikidata; Q93457353
RX   CelloPub=CLPUB00496;
RX   PubMed=4197135;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7175; ! Culex pipiens (House mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CP-81
AC   CVCL_S374
SY   CP81
DR   ATCC; CRL-6302
DR   Wikidata; Q28872842
RX   PubMed=198878;
RX   PubMed=208990;
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: ~20 hours (PubMed=198878).
CC   Transformant: NCBI_TaxID; 159603; Pongine herpesvirus 2 (Herpesvirus pongo).
CC   Discontinued: ATCC; CRL-6302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
OI   CVCL_S375 ! CP81.Sk
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CP-94251
AC   CVCL_A8WF
DR   IARC_TP53; 9372
DR   Wikidata; Q108820082
RX   PubMed=9453489;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=9453489).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   CP-A
AC   CVCL_C451
SY   CP-A hTRT; KR-42421 hTERT; QhTERT
DR   ATCC; CRL-4027
DR   BioSample; SAMN03471730
DR   Wikidata; Q54814362
RX   PubMed=12807723;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
ST   Source(s): ATCC=CRL-4027
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 12,15
ST   D21S11: 27,31.2
ST   D2S1338: 20,25
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 8,13
ST   FGA: 22,23
ST   Penta D: 13,14
ST   Penta E: 12,13
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8WG ! KR-42421
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   CP-B
AC   CVCL_C452
SY   CP-B hTRT; CP-52731 hTERT; ChTERT
DR   ATCC; CRL-4028
DR   BioSample; SAMN03471731
DR   Wikidata; Q54814363
RX   PubMed=12807723;
CC   Doubling time: ~34 hours (ATCC=CRL-4028).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu97Gln (c.290T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
ST   Source(s): ATCC=CRL-4028
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 12,21
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 23,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 17,19
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 18,20
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8WE ! CP-52731
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   CP-C
AC   CVCL_C453
SY   CP-C hTRT; CP-94251 hTERT
DR   ATCC; CRL-4029
DR   Wikidata; Q54814364
RX   PubMed=12807723;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
ST   Source(s): ATCC=CRL-4029
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 8,10
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 12,14
ST   D21S11: 31.2
ST   D2S1338: 17,21
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 10,12
ST   FGA: 19,21
ST   Penta D: 12
ST   Penta E: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8WF ! CP-94251
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   CP-D
AC   CVCL_C454
SY   CP-D hTRT; CP-18821 hTERT
DR   ATCC; CRL-4030
DR   BioSample; SAMN03471733
DR   Wikidata; Q54814365
RX   PubMed=12807723;
RX   PubMed=27594985;
CC   Doubling time: ~39 hours (ATCC=CRL-4030).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser303Alafs*42 (c.906del); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
ST   Source(s): ATCC=CRL-4030
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 13,16
ST   D19S433: 15,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 23,25
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 20,22
ST   Penta D: 12,13
ST   Penta E: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8WD ! CP-18821
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   CP-MSC/TERT308
AC   CVCL_B5T2
DR   Evercyte; CHT-064-0308
DR   Wikidata; Q111733132
CC   Doubling time: 28-34 hours (Evercyte=CHT-064-0308).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Placenta, chorionic plate; UBERON=UBERON_0004027.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): Evercyte=CHT-064-0308
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5SY ! P-MSC/TERT308
OI   CVCL_B5SX ! RA-MSC/TERT308
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   CP-R6
AC   CVCL_D5XQ
SY   CP190-KO
DR   DGRC; 338
DR   FlyBase_Cell_line; FBtc0000338
DR   Wikidata; Q127380592
RX   PubMed=36735780;
CC   Group: Insect cell line.
CC   Knockout cell: Method=P-element; FlyBase_Gene; FBgn0000283; Cp190 (Note=p.Gln61Ter mutation).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Discontinued: DGRC; 338; probable.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Cp190[3].
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   CP.B8
AC   CVCL_XH90
DR   Wikidata; Q93457376
RX   Patent=US6770745;
RX   PubMed=9759867;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12107.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   CP132
AC   CVCL_4148
DR   CLO; CLO_0002598
DR   CLDB; cl894
DR   ATCC; CRL-6304
DR   ECACC; 91012416
DR   Wikidata; Q54814366
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6304; true.
CC   Discontinued: ECACC; 91012416; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   CP18.Sk
AC   CVCL_S373
DR   ATCC; CRL-6301
DR   Wikidata; Q54814367
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6301; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   CP5
AC   CVCL_X511
SY   Carticular Progenitor 5
DR   ECACC; 08052101
DR   Wikidata; Q54814368
CC   Characteristics: Able to re-differentiate into articular chondrocytes after extensive population doublings (>30 PDL) (ECACC=08052101).
CC   Derived from site: In situ; Articular cartilage; UBERON=UBERON_0010996.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   CP50-EBV
AC   CVCL_UY79
SY   CP50EBV
DR   Cell_Model_Passport; SIDM01716
DR   DepMap; ACH-002346
DR   Wikidata; Q93457391
RX   PubMed=20164919;
RX   PubMed=20364150;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1143 ! CP50-MEL-B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   CP50-MEL-B
AC   CVCL_1143
SY   CP50MELB; CP50-MEL
DR   CLO; CLO_0037124
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1143
DR   Cell_Model_Passport; SIDM00175
DR   ChEMBL-Cells; CHEMBL3308325
DR   ChEMBL-Targets; CHEMBL2366076
DR   Cosmic; 753545
DR   Cosmic-CLP; 753545
DR   DepMap; ACH-002096
DR   EGA; EGAS00001000978
DR   GDSC; 753545
DR   GEO; GSM1669705
DR   IARC_TP53; 21254
DR   LINCS_LDP; LCL-1270
DR   PharmacoDB; CP50MELB_260_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1143
DR   Wikidata; Q54814369
RX   PubMed=20164919;
RX   PubMed=20364150;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-002096).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Tyr44fs*76 (c.128_129insT); Zygosity=Unspecified (DepMap=ACH-002096).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro246fs*11 (c.736_737insAA); Zygosity=Unspecified (DepMap=ACH-002096).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.34%; East Asian, North=0%; East Asian, South=2.1%; South Asian=3.16%; European, North=59.29%; European, South=35.11% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753545
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12,14
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UY79 ! CP50-EBV
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   CP66-EBV
AC   CVCL_VU67
SY   CP66EBV
DR   Cell_Model_Passport; SIDM01715
DR   DepMap; ACH-002347
DR   Wikidata; Q93457398
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1144 ! CP66-MEL
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   CP66-MEL
AC   CVCL_1144
SY   CP66MEL; CP66
DR   CLO; CLO_0037125
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1144
DR   Cell_Model_Passport; SIDM00190
DR   ChEMBL-Cells; CHEMBL3308287
DR   ChEMBL-Targets; CHEMBL2366363
DR   Cosmic; 753546
DR   Cosmic; 2230116
DR   Cosmic-CLP; 753546
DR   DepMap; ACH-002097
DR   EGA; EGAS00001000978
DR   GDSC; 753546
DR   GEO; GSM1669706
DR   IARC_TP53; 21255
DR   LINCS_LDP; LCL-1271
DR   PharmacoDB; CP66MEL_261_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1144
DR   Wikidata; Q54814370
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Homozygous (Cosmic-CLP=753546; DepMap=ACH-002097).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.27%; East Asian, North=0.56%; East Asian, South=0%; South Asian=2.13%; European, North=67.46%; European, South=29.58% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753546
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU67 ! CP66-EBV
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   CP67-MEL
AC   CVCL_1145
SY   CP67MEL
DR   ArrayExpress; E-MTAB-783
DR   cancercelllines; CVCL_1145
DR   Cell_Model_Passport; SIDM00189
DR   ChEMBL-Cells; CHEMBL3308288
DR   ChEMBL-Targets; CHEMBL2366095
DR   Cosmic; 949092
DR   Cosmic-CLP; 949092
DR   DepMap; ACH-002098
DR   GDSC; 949092
DR   GEO; GSM1669707
DR   IARC_TP53; 27551
DR   PharmacoDB; CP67MEL_262_2019
DR   PubChem_Cell_line; CVCL_1145
DR   Wikidata; Q54814371
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=949092; DepMap=ACH-002098).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.09%; Native American=0.46%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=64.17%; European, South=35.28% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949092
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   CP81.Sk
AC   CVCL_S375
DR   ATCC; CRL-6303
DR   Wikidata; Q54814372
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6303; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
OI   CVCL_S374 ! CP-81
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   CPA
AC   CVCL_2876
SY   Calf Pulmonary Artery
DR   CLO; CLO_0002599
DR   CLDB; cl895
DR   CLDB; cl896
DR   ATCC; CCL-207
DR   ECACC; 89050801
DR   IZSLER; BS CL 19
DR   JCRB; IFO50272
DR   JCRB; JCRB9025
DR   Wikidata; Q54814373
RX   PubMed=83028;
RX   PubMed=7065527;
RX   PubMed=7989438;
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Doubling time: 82 hours (Note=Lot 070298) (JCRB=JCRB9025).
CC   Caution: Could be identical to CPA 47 (Cellosaurus=CVCL_3669).
CC   Discontinued: ATCC; CCL-207; true.
CC   Discontinued: ECACC; 89050801; true.
CC   Discontinued: JCRB; IFO50272; true.
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
CC   Cell type: Endothelial cell of artery; CL=CL_1000413.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Calf
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   CPA 47
AC   CVCL_3669
SY   CPA47; Calf Pulmonary Artery 47
DR   CLO; CLO_0002600
DR   CLDB; cl897
DR   ATCC; CRL-1733
DR   IZSLER; BS CL 20
DR   Wikidata; Q54814374
RX   PubMed=83028;
RX   PubMed=7989438;
RX   PubMed=25565633;
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Caution: Could be identical to CPA (Cellosaurus=CVCL_2876).
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
CC   Cell type: Endothelial cell of artery; CL=CL_1000413.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   CPA-1
AC   CVCL_DN56
SY   CPA 1
DR   Wikidata; Q54814375
RX   PubMed=3368402;
CC   Doubling time: 40-45 hours (PubMed=3368402).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   CPA-Yang1
AC   CVCL_X015
DR   Wikidata; Q54814376
RX   PubMed=20719150;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   CPA-Yang1-BR
AC   CVCL_X016
DR   Wikidata; Q54814377
RX   PubMed=23945241;
CC   Population: Chinese.
CC   Characteristics: Brain metastatic phenotype. Obtained after passage of the parent cell line in the brain of nude mice.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X015 ! CPA-Yang1
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   CPA-Yang2
AC   CVCL_X017
DR   Wikidata; Q54814378
RX   PubMed=20723342;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 7
//
ID   CPA-Yang3
AC   CVCL_L787
DR   Wikidata; Q54814379
RX   Patent=CN101955911B;
RX   PubMed=21342638;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.3137.
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   CPA-Yang3BM
AC   CVCL_L788
DR   Wikidata; Q54814380
RX   PubMed=21342638;
CC   Population: Chinese.
CC   Characteristics: Bone metastatic phenotype. Obtained after 3 serial passages of the parent cell line in nude mice.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L787 ! CPA-Yang3
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   CPA-Yang5
AC   CVCL_ZX76
DR   Wikidata; Q102113712
RX   Patent=CN101955912B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.3139.
CC   Population: Chinese.
CC   Characteristics: Metastatic to bone.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   CPA-Yang6
AC   CVCL_ZX75
SY   Yang6
DR   Wikidata; Q102113713
RX   Patent=CN103131668B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.5404.
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   CPACd-AB4
AC   CVCL_F0BR
RX   PubMed=37798461;
CC   Doubling time: 35.2 +- 1.4 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACd-AC12
AC   CVCL_F0BS
RX   PubMed=37798461;
CC   Doubling time: 22.4 +- 1.2 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACd-AD4
AC   CVCL_F0BT
RX   PubMed=37798461;
CC   Doubling time: 21.8 +- 2.0 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACd-AE3
AC   CVCL_F0BU
RX   PubMed=37798461;
CC   Doubling time: 23.3 +- 2.0 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACd-BB4
AC   CVCL_F0BV
RX   PubMed=37798461;
CC   Doubling time: 19.1 +- 1.1 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACd-CG11
AC   CVCL_F0BW
RX   PubMed=37798461;
CC   Doubling time: 22.0 +- 1.2 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACd-DC10
AC   CVCL_F0BX
RX   PubMed=37798461;
CC   Doubling time: 20.4 +- 1.1 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACd-p
AC   CVCL_F0BQ
SY   Canine Pulmonary AdenoCarcinoma DMEM-parental
RX   PubMed=37798461;
CC   Doubling time: 23.3 +- 1.0 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-AD4
AC   CVCL_F0BZ
RX   PubMed=37798461;
CC   Doubling time: 18.9 +- 0.9 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-AH4
AC   CVCL_F0C0
RX   PubMed=37798461;
CC   Doubling time: 20.5 +- 2.2 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-BC9
AC   CVCL_F0C1
RX   PubMed=37798461;
CC   Doubling time: 17.8 +- 0.7 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-BH12
AC   CVCL_F0C2
RX   PubMed=37798461;
CC   Doubling time: 24.1 +- 1.8 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-CB2
AC   CVCL_F0C3
RX   PubMed=37798461;
CC   Doubling time: 20.7 +- 1.0 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-DC3
AC   CVCL_F0C4
RX   PubMed=37798461;
CC   Doubling time: 18.4 +- 2.3 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-DD10
AC   CVCL_F0C5
RX   PubMed=37798461;
CC   Doubling time: 23.9 +- 0.9 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_F0BY ! CPACr-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPACr-p
AC   CVCL_F0BY
SY   Canine Pulmonary AdenoCarcinoma RPMI-parental
RX   PubMed=37798461;
CC   Doubling time: 23.0 +- 0.1 hours (PubMed=37798461).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_F0BQ ! CPACd-p
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPAE
AC   CVCL_2877
SY   Calf Pulmonary Artery Endothelial
DR   CLO; CLO_0002601
DR   CLO; CLO_0050473
DR   CLDB; cl899
DR   CLDB; cl900
DR   CLDB; cl901
DR   ATCC; CCL-209
DR   ChEMBL-Cells; CHEMBL3307355
DR   ChEMBL-Targets; CHEMBL614258
DR   ECACC; 86111401
DR   IZSLER; BS CL 21
DR   JCRB; IFO50273
DR   JCRB; JCRB9022
DR   KCLB; 10209
DR   PubChem_Cell_line; CVCL_2877
DR   RCB; RCB0990
DR   Wikidata; Q54814381
RX   PubMed=6270164;
RX   PubMed=7065527;
RX   PubMed=7989438;
RX   PubMed=34737324;
CC   Senescence: Senesces at 24 PDL (JCRB=JCRB9022).
CC   Virology: Persistently infected by bovine viral diarrhea virus 2 (BVDV-2) (PubMed=7989438; PubMed=34737324).
CC   Doubling time: ~1.8 days (Note=Lot 12172003) (JCRB=JCRB9022).
CC   Discontinued: JCRB; IFO50273; true.
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Calf
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   CPB
AC   CVCL_Z515
SY   Chinese Perch Brain
DR   Wikidata; Q54814382
RX   PubMed=25376532;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   CPC-2
AC   CVCL_F922
DR   TKG; TKG 0702
DR   Wikidata; Q54814383
RX   PubMed=8869156;
RX   PubMed=18162136;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
ST   Source(s): TKG=TKG 0702
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 8,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4715; Choroid plexus carcinoma
DI   ORDO; Orphanet_251899; Choroid plexus carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   CPC-N
AC   CVCL_1146
SY   CPC.N; CPCN; CPN
DR   CLO; CLO_0002602
DR   EFO; EFO_0006559
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473098
DR   BioSample; SAMN10988109
DR   cancercelllines; CVCL_1146
DR   Cell_Model_Passport; SIDM00953
DR   ChEMBL-Cells; CHEMBL3308830
DR   ChEMBL-Targets; CHEMBL2366061
DR   Cosmic; 753547
DR   Cosmic; 1995380
DR   Cosmic-CLP; 753547
DR   DepMap; ACH-001049
DR   DSMZ; ACC-306
DR   DSMZCellDive; ACC-306
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753547
DR   GEO; GSM784202
DR   GEO; GSM886967
DR   GEO; GSM888036
DR   GEO; GSM1669708
DR   IARC_TP53; 21256
DR   LINCS_LDP; LCL-1829
DR   PharmacoDB; CPCN_263_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1146
DR   PubChem_Cell_line; CVCL_1146
DR   Wikidata; Q54814384
RX   CelloPub=CLPUB00547;
RX   PubMed=1318772;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~4 days (DSMZ=ACC-306).
CC   HLA typing: A*01:01,30:02; B*08:01,18:01; C*05:01,07:01 (PubMed=25960936).
CC   HLA typing: A*01:01,30:02; B*08:01,18:01; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Homozygous (Cosmic-CLP=753547; DepMap=ACH-001049).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=0%; East Asian, North=0.58%; East Asian, South=0.17%; South Asian=1.56%; European, North=55.27%; European, South=42% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=753547; DSMZ=ACC-306; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 18,22
ST   Penta D: 11,14
ST   Penta E: 12,15
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   CpDW1
AC   CVCL_AV13
DR   ICLDB; cpdw1
DR   Wikidata; Q54814385
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW10
AC   CVCL_AV20
DR   ICLDB; cpdw10
DR   Wikidata; Q54814386
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW11
AC   CVCL_AV21
DR   ICLDB; cpdw11
DR   Wikidata; Q54814387
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV19 ! CpDW9
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW12
AC   CVCL_AV22
DR   ICLDB; cpdw12
DR   Wikidata; Q54814388
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW13
AC   CVCL_AV23
DR   ICLDB; cpdw13
DR   Wikidata; Q54814389
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV19 ! CpDW9
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW14
AC   CVCL_AV24
DR   ICLDB; cpdw14
DR   Wikidata; Q54814390
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV19 ! CpDW9
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW15
AC   CVCL_AV25
DR   ICLDB; cpdw15
DR   Wikidata; Q54814391
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV20 ! CpDW10
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW2
AC   CVCL_AV14
DR   ICLDB; cpdw2
DR   Wikidata; Q54814393
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW3
AC   CVCL_AV15
DR   ICLDB; cpdw3
DR   Wikidata; Q54814394
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW4
AC   CVCL_AV16
DR   ICLDB; cpdw4
DR   Wikidata; Q54814395
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW5
AC   CVCL_AV17
DR   ICLDB; cpdw5
DR   Wikidata; Q54814396
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW6
AC   CVCL_AV18
DR   ICLDB; cpdw6
DR   Wikidata; Q54814397
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CpDW9
AC   CVCL_AV19
DR   ICLDB; cpdw9
DR   Wikidata; Q54814402
RX   PubMed=8345351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_AV13 ! CpDW1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CPE/LULS50
AC   CVCL_C1YI
DR   Wikidata; Q114310998
RX   PubMed=34680640;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Characteristics: Originally infected by the intracellular symbiont Wolbachia wPip but cured of infection by tetracycline.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Caldbeck line.
OX   NCBI_TaxID=1833972; ! Culex pipiens pipiens x Culex pipiens molestus (Hybrid mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   CPEK
AC   CVCL_WY80
SY   Canine Progenitor Epidermal Keratinocyte
DR   GEO; GSE77041
DR   Wikidata; Q93457518
RX   PubMed=18772565;
RX   PubMed=20837364;
RX   PubMed=20860556;
RX   PubMed=23067725;
RX   PubMed=25190452;
RX   PubMed=30268330;
WW   Provider; CELLnTEC; -; https://cellntec.com/products/cpek
CC   Characteristics: Useful for investigating the immunopathogenesis of inflammatory skin diseases.
CC   Doubling time: 14.8 +- 1.50 hours (PubMed=18772565).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Sex of donor from personal communication of Girling, Peter.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   CPG
AC   CVCL_1G78
SY   Channa Punctatus Gill
DR   NRFC; NRFC049
DR   Wikidata; Q54814403
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC049; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC049.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=304456; ! Channa punctata (Spotted snakehead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   CPG10
AC   CVCL_B3RS
DR   Wikidata; Q110432739
RX   PubMed=33426406;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CPG166
AC   CVCL_B3RT
DR   Wikidata; Q110432741
RX   PubMed=33426406;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CPG18
AC   CVCL_B3RU
DR   Wikidata; Q110432742
RX   PubMed=33426406;
RX   PubMed=34864218;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CPG7
AC   CVCL_B3RV
DR   Wikidata; Q110432743
RX   PubMed=33426406;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CPG8
AC   CVCL_B3RW
DR   Wikidata; Q110432744
RX   PubMed=33426406;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CPGHi001-A
AC   CVCL_A9XF
SY   TMC1-QRQ
DR   hPSCreg; CPGHi001-A
DR   Wikidata; Q102113715
RX   PubMed=33217648;
RX   PubMed=35247837;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16513; TMC1; Simple; p.Met418Lys (c.1253T>A); ClinVar=VCV000183668; Zygosity=Heterozygous (PubMed=33217648).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=35247837
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 18,23
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 14,17
ST   D19S433: 13.2,16.2
ST   D21S11: 30,30.3
ST   D2S1338: 20,21,24
ST   D2S441: 10,11
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 14,19
ST   D7S820: 9,12
ST   D8S1179: 10,11
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 14,18
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C174444; Deafness, autosomal dominant 36
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   CPGHi001-A-1
AC   CVCL_B7DM
DR   hPSCreg; CPGHi001-A-1
DR   Wikidata; Q112929412
RX   PubMed=35247837;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16513; TMC1; Simple_corrected; p.Met418Lys (c.1253T>A); ClinVar=VCV000183668; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35247837).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=35247837
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 18,23
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 14,17
ST   D19S433: 13.2,16.2
ST   D21S11: 30,30.3
ST   D2S1338: 20,21,24
ST   D2S441: 10,11
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 14,19
ST   D7S820: 9,12
ST   D8S1179: 10,11
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 14,18
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C174444; Deafness, autosomal dominant 36
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9XF ! CPGHi001-A
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   CPGHi002-A
AC   CVCL_A1AZ
SY   JYIPS0056
DR   BioSamples; SAMEA7340582
DR   hPSCreg; CPGHi002-A
DR   Wikidata; Q102113716
RX   PubMed=32961450;
RX   PubMed=33714068;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:854; ATP6V1B2; Simple; p.Arg506Ter (c.1516C>T); ClinVar=VCV000203442; Zygosity=Heterozygous (PubMed=32961450).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175240; Autosomal dominant congenital deafness with onychodystrophy
DI   ORDO; Orphanet_79499; Autosomal dominant deafness-onychodystrophy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   CPGHi002-A-1
AC   CVCL_A7IF
SY   JYIPS0056-R-3-1
DR   hPSCreg; CPGHi002-A-1
DR   Wikidata; Q107114708
RX   PubMed=33714068;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:854; ATP6V1B2; Simple_corrected; p.Arg506Ter (c.1516C>T); ClinVar=VCV000203442; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33714068).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175240; Autosomal dominant congenital deafness with onychodystrophy
DI   ORDO; Orphanet_79499; Autosomal dominant deafness-onychodystrophy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1AZ ! CPGHi002-A
SX   Female
AG   10M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   CPGHi003-A
AC   CVCL_A7IG
SY   AIFM1-MSW
DR   hPSCreg; CPGHi003-A
DR   Wikidata; Q107114710
RX   PubMed=34088005;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8768; AIFM1; Simple; p.Arg422Gln (c.1265G>A); ClinVar=VCV000162480; Zygosity=Hemizygous (PubMed=34088005).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C180843; X-linked deafness-5, with peripheral neuropathy
DI   ORDO; Orphanet_90625; X-linked non-syndromic sensorineural deafness type DFN
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CPGHi004-A
AC   CVCL_B3Q2
SY   DJH521
DR   BioSamples; SAMEA10331600
DR   hPSCreg; CPGHi004-A
DR   Wikidata; Q110432746
RX   PubMed=34995845;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CPGHi005-A
AC   CVCL_B5QQ
DR   BioSamples; SAMEA12097270
DR   hPSCreg; CPGHi005-A
DR   Wikidata; Q111733133
RX   PubMed=35691110;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11190; SOX10; Unexplicit; SVA-F retrotransposon insertion in intron 2; Zygosity=Heterozygous (PubMed=35691110).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CPGHi006-A
AC   CVCL_B5QR
AS   CVCL_B6XG
SY   PLAFMCi006-A
DR   BioSamples; SAMEA12123062
DR   hPSCreg; CPGHi006-A
DR   Wikidata; Q111733134
RX   PubMed=35091308;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Unexplicit; Ex3-15del; Zygosity=Heterozygous (PubMed=35091308).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   CPGHi007-A
AC   CVCL_B7DN
SY   PLAFMCi007-A
DR   BioSamples; SAMEA12279771
DR   hPSCreg; CPGHi007-A
DR   Wikidata; Q112929414
RX   PubMed=35339884;
CC   From: Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   CPGHi008-A
AC   CVCL_B7DP
DR   BioSamples; SAMEA12599200
DR   hPSCreg; CPGHi008-A
DR   Wikidata; Q112929416
RX   PubMed=35405383;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Leu2665Pro (c.7994T>C); ClinVar=VCV002152014; Zygosity=Homozygous (PubMed=35405383).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   CPH-54A
AC   CVCL_8180
SY   CPH 54A; CPH54A; CPH SCCL 54A; 054 A
DR   Cosmic; 2648020
DR   Wikidata; Q54814404
RX   PubMed=2995041;
RX   PubMed=3020867;
RX   PubMed=9212023;
RX   PubMed=9551745;
RX   PubMed=9744504;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8181 ! CPH-54B
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   CPH-54B
AC   CVCL_8181
SY   CPH 54B; CPH54B; CPH SCCL 54B
DR   Cosmic; 2648021
DR   Wikidata; Q54814405
RX   PubMed=2995041;
RX   PubMed=3020867;
RX   PubMed=9212023;
RX   PubMed=9744504;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8180 ! CPH-54A
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   CpHi01
AC   CVCL_VX42
DR   IBRC; C10420
DR   Wikidata; Q93457534
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi02
AC   CVCL_VX43
DR   IBRC; C10421
DR   Wikidata; Q93457536
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi03
AC   CVCL_VX44
DR   IBRC; C10422
DR   Wikidata; Q93457538
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi04
AC   CVCL_VX45
DR   IBRC; C10423
DR   Wikidata; Q93457540
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi05
AC   CVCL_VX46
DR   IBRC; C10424
DR   Wikidata; Q93457542
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi06
AC   CVCL_VX47
DR   IBRC; C10425
DR   Wikidata; Q93457545
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi07
AC   CVCL_VX48
DR   IBRC; C10426
DR   Wikidata; Q93457547
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi08
AC   CVCL_VX49
DR   IBRC; C10427
DR   Wikidata; Q93457549
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi09
AC   CVCL_VX50
DR   IBRC; C10428
DR   Wikidata; Q93457551
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi10
AC   CVCL_VX51
DR   IBRC; C10429
DR   Wikidata; Q93457553
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi11
AC   CVCL_VX52
DR   IBRC; C10430
DR   Wikidata; Q93457555
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi12
AC   CVCL_VX53
DR   IBRC; C10431
DR   Wikidata; Q93457557
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi13
AC   CVCL_VX54
DR   IBRC; C10432
DR   Wikidata; Q93457559
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi14
AC   CVCL_VX55
DR   IBRC; C10433
DR   Wikidata; Q93457561
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi15
AC   CVCL_VX56
DR   IBRC; C10434
DR   Wikidata; Q93457563
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi16
AC   CVCL_VX57
DR   IBRC; C10435
DR   Wikidata; Q93457565
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi17
AC   CVCL_VX58
DR   IBRC; C10436
DR   Wikidata; Q93457567
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi18
AC   CVCL_VX59
DR   IBRC; C10437
DR   Wikidata; Q93457570
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi19
AC   CVCL_VX60
DR   IBRC; C10438
DR   Wikidata; Q93457572
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi20
AC   CVCL_VX61
DR   IBRC; C10439
DR   Wikidata; Q93457574
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi21
AC   CVCL_VX62
DR   IBRC; C10440
DR   Wikidata; Q93457576
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi22
AC   CVCL_VX63
DR   IBRC; C10441
DR   Wikidata; Q93457578
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi23
AC   CVCL_VX64
DR   IBRC; C10442
DR   Wikidata; Q93457580
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi24
AC   CVCL_VX65
DR   IBRC; C10443
DR   Wikidata; Q93457584
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi25
AC   CVCL_VX66
DR   IBRC; C10444
DR   Wikidata; Q93457586
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi26
AC   CVCL_VX67
DR   IBRC; C10445
DR   Wikidata; Q93457588
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi27
AC   CVCL_VX68
DR   IBRC; C10446
DR   Wikidata; Q93457590
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi28
AC   CVCL_VX69
DR   IBRC; C10447
DR   Wikidata; Q93457592
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi29
AC   CVCL_VX70
DR   IBRC; C10448
DR   Wikidata; Q93457594
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi30
AC   CVCL_VX71
DR   IBRC; C10449
DR   Wikidata; Q93457596
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   1Y7M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi31
AC   CVCL_VX72
DR   IBRC; C10460
DR   Wikidata; Q93457598
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi32
AC   CVCL_VX73
DR   IBRC; C10461
DR   Wikidata; Q93457600
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi33
AC   CVCL_VX74
DR   IBRC; C10462
DR   Wikidata; Q93457603
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi34
AC   CVCL_VX75
DR   IBRC; C10463
DR   Wikidata; Q93457605
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi35
AC   CVCL_VX76
DR   IBRC; C10464
DR   Wikidata; Q93457607
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi36
AC   CVCL_VX77
DR   IBRC; C10465
DR   Wikidata; Q93457609
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi37
AC   CVCL_VX78
DR   IBRC; C10466
DR   Wikidata; Q93457611
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi38
AC   CVCL_VX79
DR   IBRC; C10467
DR   Wikidata; Q93457614
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi39
AC   CVCL_VX80
DR   IBRC; C10468
DR   Wikidata; Q93457616
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi40
AC   CVCL_VX81
DR   IBRC; C10469
DR   Wikidata; Q93457619
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi41
AC   CVCL_VX82
DR   IBRC; C10470
DR   Wikidata; Q93457621
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi42
AC   CVCL_VX83
DR   IBRC; C10471
DR   Wikidata; Q93457623
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi43
AC   CVCL_VX84
DR   IBRC; C10472
DR   Wikidata; Q93457626
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi44
AC   CVCL_VX85
DR   IBRC; C10473
DR   Wikidata; Q93457627
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi45
AC   CVCL_VX86
DR   IBRC; C10474
DR   Wikidata; Q93457628
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi46
AC   CVCL_VX87
DR   IBRC; C10475
DR   Wikidata; Q93457629
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi47
AC   CVCL_VX88
DR   IBRC; C10476
DR   Wikidata; Q93457630
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi48
AC   CVCL_VX89
DR   IBRC; C10477
DR   Wikidata; Q93457631
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi49
AC   CVCL_VX90
DR   IBRC; C10478
DR   Wikidata; Q93457632
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi50
AC   CVCL_VX91
DR   IBRC; C10479
DR   Wikidata; Q93457633
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi51
AC   CVCL_VX92
DR   IBRC; C10480
DR   Wikidata; Q93457634
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi52
AC   CVCL_VX93
DR   IBRC; C10481
DR   Wikidata; Q93457635
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi53
AC   CVCL_VX94
DR   IBRC; C10482
DR   Wikidata; Q93457636
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi54
AC   CVCL_VX95
DR   IBRC; C10483
DR   Wikidata; Q93457637
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi55
AC   CVCL_VX96
DR   IBRC; C10484
DR   Wikidata; Q93457638
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi56
AC   CVCL_VX97
DR   IBRC; C10485
DR   Wikidata; Q93457640
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi57
AC   CVCL_VX98
DR   IBRC; C10486
DR   Wikidata; Q93457641
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CpHi58
AC   CVCL_VX99
DR   IBRC; C10487
DR   Wikidata; Q93457642
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Markhoz; VBO=VBO_0009015.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   CPL/LULS56
AC   CVCL_E1IE
RX   PubMed=34680640;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Breed/subspecies: Caldbeck line.
OX   NCBI_TaxID=1833972; ! Culex pipiens pipiens x Culex pipiens molestus (Hybrid mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   CPL0903
AC   CVCL_V633
DR   Wikidata; Q54814406
RX   PubMed=24416385;
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 46.81 +- 1.10 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   CpLu
AC   CVCL_RX25
DR   Wikidata; Q54814407
RX   PubMed=24023659;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=40233; ! Carollia perspicillata (Seba's short-tailed bat)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CPN4B
AC   CVCL_7253
DR   RCB; RCB1690
DR   Wikidata; Q54814408
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8330; ! Cynops pyrrhogaster (Japanese fire-bellied newt)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Cpp-512
AC   CVCL_Z447
SY   CPP-512; Cpp512
DR   Wikidata; Q29582650
RX   CelloPub=CLPUB00190;
RX   CelloPub=CLPUB00192;
RX   DOI=10.3969/j.issn.1673-5234.2000.04.020;
CC   Group: Insect cell line.
CC   Doubling time: 21 hours (CelloPub=CLPUB00192).
OX   NCBI_TaxID=42434; ! Culex pipiens pallens (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   CPP19
AC   CVCL_YJ11
DR   Wikidata; Q93457645
RX   PubMed=27456153;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   CPP24
AC   CVCL_YJ12
DR   Wikidata; Q93457646
RX   PubMed=27456153;
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 4
//
ID   CPP25
AC   CVCL_YJ13
DR   Wikidata; Q93457647
RX   PubMed=27456153;
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 4
//
ID   CPP30
AC   CVCL_YJ14
DR   Wikidata; Q93457648
RX   PubMed=27456153;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   CPP44
AC   CVCL_YJ15
DR   cancercelllines; CVCL_YJ15
DR   Wikidata; Q93457649
RX   PubMed=27456153;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=27456153).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=27456153).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ18 ! CTC44
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   CPP45
AC   CVCL_YJ16
DR   Wikidata; Q93457650
RX   PubMed=27456153;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ19 ! CTC45
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   CPPU-a
AC   CVCL_C8LP
DR   Wikidata; Q123030960
RX   PubMed=35200339;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CPSF
AC   CVCL_C5YX
SY   Canara PearlSpot Fin
DR   Wikidata; Q116048777
RX   DOI=10.1016/j.aquaculture.2021.737589;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Virology: Not susceptible to infection by Tilapia lake virus (TiLV) (DOI=10.1016/j.aquaculture.2021.737589).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=302778; ! Etroplus canarensis (Canara pearlspot cichlid)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CPT-K5
AC   CVCL_2878
SY   CPT-K-5; CPTK5; RPMI 8402/CPTK5
DR   BioSample; SAMN03472497
DR   cancercelllines; CVCL_2878
DR   JCRB; JCRB1067
DR   Wikidata; Q54814409
RX   PubMed=1849260;
RX   PubMed=3039492;
RX   PubMed=14679002;
RX   PubMed=29496689;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (PubMed=29496689).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Glu1583_Gln1584insProValGluLeuMetProProGlu (c.4750_4751insCCGTGGAGCTGATGCCGCCGGAGC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg159Ser (c.477G>T); ClinVar=VCV000375959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Asp533Gly (c.1598A>G); ClinVar=VCV000016773; Zygosity=Unspecified (PubMed=1849260).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser121Ter (c.362C>A); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB1067; PubMed=29496689
ST   Amelogenin: X
ST   CSF1PO: 9,10,11,12
ST   D13S317: 10,12
ST   D16S539: 10,14
ST   D18S51: 14,17,18
ST   D19S433: 14,15
ST   D21S11: 28,30,33.2,34.2
ST   D2S1338: 23,24,26,27
ST   D3S1358: 14,15,16
ST   D5S818: 11,12,13
ST   D7S820: 9,12,14
ST   D8S1179: 13,14
ST   FGA: 21,22,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18,20,22
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1667 ! RPMI-8402
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   CPTC-ABCB1-2
AC   CVCL_YE83
DR   DSHB; CPTC-ABCB1-2
DR   Wikidata; Q93457651
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ABCB1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ADA-1
AC   CVCL_D3SM
DR   DSHB; CPTC-ADA-1
DR   Wikidata; Q127380593
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ADA-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00813; Human ADA.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-AKR1B1-1
AC   CVCL_YE84
DR   DSHB; CPTC-AKR1B1-1
DR   Wikidata; Q93457652
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKR1B1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15121; Human AKR1B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKR1B1-2
AC   CVCL_YE85
DR   DSHB; CPTC-AKR1B1-2
DR   Wikidata; Q93457653
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKR1B1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15121; Human AKR1B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKR1B1-3
AC   CVCL_YE86
DR   DSHB; CPTC-AKR1B1-3
DR   Wikidata; Q93457654
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKR1B1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15121; Human AKR1B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKR1C1-1
AC   CVCL_YE87
DR   DSHB; CPTC-AKR1C1-1
DR   Wikidata; Q93457655
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKR1C1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04828; Human AKR1C1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKR1C2-1
AC   CVCL_YE88
DR   DSHB; CPTC-AKR1C2-1
DR   Wikidata; Q93457656
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKR1C2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P52895; Human AKR1C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKR1C2-2
AC   CVCL_YE89
DR   DSHB; CPTC-AKR1C2-2
DR   Wikidata; Q93457657
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKR1C2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P52895; Human AKR1C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKR1C2-3
AC   CVCL_YE90
DR   DSHB; CPTC-AKR1C2-3
DR   Wikidata; Q93457658
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKR1C2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P52895; Human AKR1C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT1-1
AC   CVCL_YE91
DR   DSHB; CPTC-AKT1-1
DR   Wikidata; Q93457659
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P31749; Human AKT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT1-2
AC   CVCL_YE92
DR   DSHB; CPTC-AKT1-2
DR   Wikidata; Q93457660
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31749; Human AKT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT1-3
AC   CVCL_YE93
DR   DSHB; CPTC-AKT1-3
DR   Wikidata; Q93457661
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P31749; Human AKT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT1-4
AC   CVCL_C2K2
DR   DSHB; CPTC-AKT1-4
DR   Wikidata; Q114310999
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31749; Human AKT1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT1-5
AC   CVCL_C2K3
DR   DSHB; CPTC-AKT1-5
DR   Wikidata; Q114311001
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31749; Human AKT1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT1-6
AC   CVCL_C2K4
DR   DSHB; CPTC-AKT1-6
DR   Wikidata; Q114311002
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT1-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31749; Human AKT1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT2-1
AC   CVCL_YE94
DR   DSHB; CPTC-AKT2-1
DR   Wikidata; Q93457662
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P31751; Human AKT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT2-2
AC   CVCL_YE95
DR   DSHB; CPTC-AKT2-2
DR   Wikidata; Q93457663
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31751; Human AKT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT2-3
AC   CVCL_YE96
DR   DSHB; CPTC-AKT2-3
DR   Wikidata; Q93457664
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P31751; Human AKT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT2-4
AC   CVCL_YE97
DR   DSHB; CPTC-AKT2-4
DR   Wikidata; Q93457666
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT2-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P31751; Human AKT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT2-5
AC   CVCL_C2K5
DR   DSHB; CPTC-AKT2-5
DR   Wikidata; Q114311003
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT2-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31751; Human AKT2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT2-6
AC   CVCL_C2K1
DR   DSHB; CPTC-AKT2-6
DR   Wikidata; Q114311004
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT2-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31751; Human AKT2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT3-1
AC   CVCL_YE98
DR   DSHB; CPTC-AKT3-1
DR   Wikidata; Q93457667
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9Y243; Human AKT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT3-2
AC   CVCL_C2K7
DR   DSHB; CPTC-AKT3-2
DR   Wikidata; Q114311005
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y243; Human AKT3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT3-3
AC   CVCL_C2K6
DR   DSHB; CPTC-AKT3-3
DR   Wikidata; Q114311006
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT3-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y243; Human AKT3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT3-4
AC   CVCL_C2K8
DR   DSHB; CPTC-AKT3-4
DR   Wikidata; Q114311007
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT3-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y243; Human AKT3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT3-5
AC   CVCL_YE99
DR   DSHB; CPTC-AKT3-5
DR   Wikidata; Q93457669
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT3-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y243; Human AKT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT3-6
AC   CVCL_YF00
DR   DSHB; CPTC-AKT3-6
DR   Wikidata; Q93457670
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT3-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y243; Human AKT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AKT3-7
AC   CVCL_YF01
DR   DSHB; CPTC-AKT3-7
DR   Wikidata; Q93457671
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AKT3-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y243; Human AKT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ALCAM-1
AC   CVCL_D3SN
DR   DSHB; CPTC-ALCAM-1
DR   Wikidata; Q127380594
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ALCAM-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13740; Human ALCAM/CD166.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-ALCAM-2
AC   CVCL_D3SP
DR   DSHB; CPTC-ALCAM-2
DR   Wikidata; Q127380595
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ALCAM-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13740; Human ALCAM/CD166.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-ANXA1-1
AC   CVCL_YF02
DR   DSHB; CPTC-ANXA1-1
DR   Wikidata; Q93457672
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ANXA1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04083; Human ANXA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ANXA1-2
AC   CVCL_YF03
DR   DSHB; CPTC-ANXA1-2
DR   Wikidata; Q93457673
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ANXA1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04083; Human ANXA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ANXA1-3
AC   CVCL_YF04
DR   DSHB; CPTC-ANXA1-3
DR   Wikidata; Q93457674
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ANXA1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04083; Human ANXA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ANXA1-4
AC   CVCL_C2L2
DR   DSHB; CPTC-ANXA1-4
DR   Wikidata; Q114311009
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ANXA1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04083; Human ANXA1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ANXA1-5
AC   CVCL_D3SQ
DR   DSHB; CPTC-ANXA1-5
DR   Wikidata; Q127380596
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ANXA1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04083; Human ANXA1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-ANXA4-1
AC   CVCL_C2LU
DR   DSHB; CPTC-ANXA4-1
DR   Wikidata; Q114311011
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ANXA4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09525; Human ANXA4.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-APEX1-2
AC   CVCL_YF05
DR   DSHB; CPTC-APEX1-2
DR   Wikidata; Q93457675
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-APEX1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27695; Human APEX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ARAF-1
AC   CVCL_YF06
DR   DSHB; CPTC-ARAF-1
DR   Wikidata; Q93457676
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ARAF-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10398; Human ARAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ARAF-2
AC   CVCL_YF07
DR   DSHB; CPTC-ARAF-2
DR   Wikidata; Q93457677
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ARAF-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P10398; Human ARAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ARAF-3
AC   CVCL_YF08
DR   DSHB; CPTC-ARAF-3
DR   Wikidata; Q93457678
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ARAF-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10398; Human ARAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ARAF-4
AC   CVCL_YF09
DR   DSHB; CPTC-ARAF-4
DR   Wikidata; Q93457679
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ARAF-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10398; Human ARAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ARAF-5
AC   CVCL_C2K9
DR   DSHB; CPTC-ARAF-5
DR   Wikidata; Q114311012
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ARAF-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P10398; Human ARAF.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ARG1-1
AC   CVCL_D3SR
DR   DSHB; CPTC-ARG1-1
DR   Wikidata; Q127380597
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ARG1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P05089; Human ARG1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-ARG2-1
AC   CVCL_D3SS
DR   DSHB; CPTC-ARG2-1
DR   Wikidata; Q127380598
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ARG2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P78540; Human ARG2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-ASAP1-1
AC   CVCL_C2LV
DR   DSHB; CPTC-ASAP1-1
DR   Wikidata; Q114311013
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ASAP1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9ULH1; Human ASAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ASAP1-2
AC   CVCL_C2LW
DR   DSHB; CPTC-ASAP1-2
DR   Wikidata; Q114311014
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ASAP1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9ULH1; Human ASAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ASAP1-3
AC   CVCL_C2LX
DR   DSHB; CPTC-ASAP1-3
DR   Wikidata; Q114311016
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ASAP1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9ULH1; Human ASAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ATM-1
AC   CVCL_C2LY
DR   DSHB; CPTC-ATM-1
DR   Wikidata; Q114311017
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ATM-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13315; Human ATM.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ATM-3
AC   CVCL_C2LZ
DR   DSHB; CPTC-ATM-3
DR   Wikidata; Q114311018
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ATM-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13315; Human ATM.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ATM-4
AC   CVCL_C2M0
DR   DSHB; CPTC-ATM-4
DR   Wikidata; Q114311019
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ATM-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13315; Human ATM.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ATR-1
AC   CVCL_C2QJ
DR   DSHB; CPTC-ATR-1
DR   Wikidata; Q114311020
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ATR-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13535; Human ATR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ATRIP-1
AC   CVCL_C2M1
DR   DSHB; CPTC-ATRIP-1
DR   Wikidata; Q114311021
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ATRIP-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q8WXE1; Human ATRIP.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ATRIP-2
AC   CVCL_C2M2
DR   DSHB; CPTC-ATRIP-2
DR   Wikidata; Q114311022
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ATRIP-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q8WXE1; Human ATRIP.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-AVPR1A-1
AC   CVCL_D3ST
DR   DSHB; CPTC-AVPR1A-1
DR   Wikidata; Q127380599
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AVPR1A-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P37288; Human AVPR1A.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-AXL-1
AC   CVCL_D3SU
DR   DSHB; CPTC-AXL-1
DR   Wikidata; Q127380600
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AXL-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-AXL-2
AC   CVCL_D3SV
DR   DSHB; CPTC-AXL-2
DR   Wikidata; Q127380601
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-AXL-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P30530; Human AXL.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-B2M-1
AC   CVCL_D3SW
DR   DSHB; CPTC-B2M-1
DR   Wikidata; Q127380602
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-B2M-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-BAD-1
AC   CVCL_D3SX
DR   DSHB; CPTC-BAD-1
DR   Wikidata; Q127380603
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BAD-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q92934; Human BAD.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-BAI1-1
AC   CVCL_YF10
DR   DSHB; CPTC-BAI1-1
DR   Wikidata; Q93457680
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BAI1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; O14514; Human ADGRB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BAI1-2
AC   CVCL_YF11
DR   DSHB; CPTC-BAI1-2
DR   Wikidata; Q93457681
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BAI1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; O14514; Human ADGRB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BAI1-3
AC   CVCL_YF12
DR   DSHB; CPTC-BAI1-3
DR   Wikidata; Q93457682
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BAI1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14514; Human ADGRB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BCL2L1-1
AC   CVCL_YF13
DR   DSHB; CPTC-BCL2L1-1
DR   Wikidata; Q93457683
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BCL2L1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q07817; Human BCL2L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BCL2L1-2
AC   CVCL_YF14
DR   DSHB; CPTC-BCL2L1-2
DR   Wikidata; Q93457684
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BCL2L1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q07817; Human BCL2L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BCL2L1-3
AC   CVCL_YF15
DR   DSHB; CPTC-BCL2L1-3
DR   Wikidata; Q93457685
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BCL2L1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q07817; Human BCL2L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BCL2L2-1
AC   CVCL_YF16
DR   DSHB; CPTC-BCL2L2-1
DR   Wikidata; Q93457686
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BCL2L2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q92843; Human BCL2L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BCL2L2-2
AC   CVCL_YF17
DR   DSHB; CPTC-BCL2L2-2
DR   Wikidata; Q93457687
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BCL2L2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q92843; Human BCL2L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BCL2L2-3
AC   CVCL_YF18
DR   DSHB; CPTC-BCL2L2-3
DR   Wikidata; Q93457688
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BCL2L2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92843; Human BCL2L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRAF-1
AC   CVCL_YF19
DR   DSHB; CPTC-BRAF-1
DR   Wikidata; Q93457689
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRAF-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15056; Human BRAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRAF-2
AC   CVCL_YF20
DR   DSHB; CPTC-BRAF-2
DR   Wikidata; Q93457690
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRAF-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15056; Human BRAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRAF-3
AC   CVCL_YF21
DR   DSHB; CPTC-BRAF-3
DR   Wikidata; Q93457691
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRAF-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15056; Human BRAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRAF-4
AC   CVCL_YF22
DR   DSHB; CPTC-BRAF-4
DR   Wikidata; Q93457692
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRAF-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15056; Human BRAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRAF-5
AC   CVCL_YF23
DR   DSHB; CPTC-BRAF-5
DR   Wikidata; Q93457693
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRAF-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15056; Human BRAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRAF-6
AC   CVCL_YF24
DR   DSHB; CPTC-BRAF-6
DR   Wikidata; Q93457695
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRAF-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15056; Human BRAF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRAF-7
AC   CVCL_C2KA
DR   DSHB; CPTC-BRAF-7
DR   Wikidata; Q114311023
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRAF-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P15056; Human BRAF.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRCA1-1
AC   CVCL_YF25
DR   DSHB; CPTC-BRCA1-1
DR   Wikidata; Q93457696
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRCA1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRCA1-2
AC   CVCL_YF26
DR   DSHB; CPTC-BRCA1-2
DR   Wikidata; Q93457697
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRCA1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRCA1-4
AC   CVCL_C2L3
DR   DSHB; CPTC-BRCA1-4
DR   Wikidata; Q114311024
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRCA1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P38398; Human BRCA1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRIP1-1
AC   CVCL_YF27
DR   DSHB; CPTC-BRIP1-1
DR   Wikidata; Q93457698
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRIP1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BX63; Human BRIP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRIP1-2
AC   CVCL_YF28
DR   DSHB; CPTC-BRIP1-2
DR   Wikidata; Q93457699
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRIP1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BX63; Human BRIP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRIP1-3
AC   CVCL_D3T0
DR   DSHB; CPTC-BRIP1-3
DR   Wikidata; Q127380604
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRIP1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BX63; Human BRIP1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-BRIP1-4
AC   CVCL_C2L4
DR   DSHB; CPTC-BRIP1-4
DR   Wikidata; Q114311025
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRIP1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BX63; Human BRIP1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BRIP1-5
AC   CVCL_C2L5
DR   DSHB; CPTC-BRIP1-5
DR   Wikidata; Q114311026
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BRIP1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BX63; Human BRIP1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BTK-1
AC   CVCL_D3T1
DR   DSHB; CPTC-BTK-1
DR   Wikidata; Q127380605
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BTK-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q06187; Human BTK.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-BTLA-1
AC   CVCL_C2M3
DR   DSHB; CPTC-BTLA-1
DR   Wikidata; Q114311027
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BTLA-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BTLA-2
AC   CVCL_C2M4
DR   DSHB; CPTC-BTLA-2
DR   Wikidata; Q114311028
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BTLA-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-BTLA-3
AC   CVCL_C2M5
DR   DSHB; CPTC-BTLA-3
DR   Wikidata; Q114311029
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-BTLA-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CA8-1
AC   CVCL_YF29
DR   DSHB; CPTC-CA8-1
DR   Wikidata; Q93457700
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CA8-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P35219; Human CA8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CA8-2
AC   CVCL_YF30
DR   DSHB; CPTC-CA8-2
DR   Wikidata; Q93457701
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CA8-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35219; Human CA8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CADM1-1
AC   CVCL_C2M6
DR   DSHB; CPTC-CADM1-1
DR   Wikidata; Q114311030
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CADM1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9BY67; Human CADM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Calcyclin-1
AC   CVCL_YF31
DR   DSHB; CPTC-Calcyclin-1
DR   Wikidata; Q93457702
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Calcyclin-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06703; Human S100A6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Calcyclin-3
AC   CVCL_YF32
DR   DSHB; CPTC-Calcyclin-3
DR   Wikidata; Q93457703
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Calcyclin-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06703; Human S100A6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CALR-1
AC   CVCL_C2M7
DR   DSHB; CPTC-CALR-1
DR   Wikidata; Q114311031
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CALR-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P27797; Human CALR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CASP3-1
AC   CVCL_D3T2
DR   DSHB; CPTC-CASP3-1
DR   Wikidata; Q127380606
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CASP3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P42574; Human CASP3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CCL5-1
AC   CVCL_D3T3
DR   DSHB; CPTC-CCL5-1
DR   Wikidata; Q127380607
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCL5-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13501; Human CCL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CCND1-1
AC   CVCL_YF33
DR   DSHB; CPTC-CCND1-1
DR   Wikidata; Q93457704
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCND1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24385; Human CCND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CCND1-2
AC   CVCL_YF34
DR   DSHB; CPTC-CCND1-2
DR   Wikidata; Q93457705
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCND1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P24385; Human CCND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CCND1-3
AC   CVCL_YF35
DR   DSHB; CPTC-CCND1-3
DR   Wikidata; Q93457706
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCND1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P24385; Human CCND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CCND1-4
AC   CVCL_YF36
DR   DSHB; CPTC-CCND1-4
DR   Wikidata; Q93457707
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCND1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P24385; Human CCND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CCND1-5
AC   CVCL_YF37
DR   DSHB; CPTC-CCND1-5
DR   Wikidata; Q93457708
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCND1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24385; Human CCND1.
CC   Discontinued: DSHB; CPTC-CCND1-5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-CCND1-6
AC   CVCL_YF38
DR   DSHB; CPTC-CCND1-6
DR   Wikidata; Q93457709
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCND1-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24385; Human CCND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CCND1-7
AC   CVCL_C2L6
DR   DSHB; CPTC-CCND1-7
DR   Wikidata; Q114311032
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CCND1-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24385; Human CCND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD14-1
AC   CVCL_C2M8
DR   DSHB; CPTC-CD14-1
DR   Wikidata; Q114311033
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD14-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD27-3
AC   CVCL_D3T4
DR   DSHB; CPTC-CD27-3
DR   Wikidata; Q127380608
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD27-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P26842; Human CD27.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD274-1
AC   CVCL_C2M9
DR   DSHB; CPTC-CD274-1
DR   Wikidata; Q114311034
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD274-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD276-1
AC   CVCL_D3T5
DR   DSHB; CPTC-CD276-1
DR   Wikidata; Q127380609
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD276-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD33-1
AC   CVCL_C2MA
DR   DSHB; CPTC-CD33-1
DR   Wikidata; Q114311035
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD33-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P20138; Human CD33.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD33-3
AC   CVCL_D3RE
DR   DSHB; CPTC-CD33-3
DR   Wikidata; Q127380610
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD33-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P20138; Human CD33.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD33-4
AC   CVCL_D3RF
DR   DSHB; CPTC-CD33-4
DR   Wikidata; Q127380611
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD33-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20138; Human CD33.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD38-1
AC   CVCL_D3RG
DR   DSHB; CPTC-CD38-1
DR   Wikidata; Q127380612
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD38-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD4-1
AC   CVCL_D3T7
DR   DSHB; CPTC-CD4-1
DR   Wikidata; Q127380613
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD4-2
AC   CVCL_D3T8
DR   DSHB; CPTC-CD4-2
DR   Wikidata; Q127380614
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD4-3
AC   CVCL_D3T9
DR   DSHB; CPTC-CD4-3
DR   Wikidata; Q127380615
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD4-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD4-4
AC   CVCL_D3TB
DR   DSHB; CPTC-CD4-4
DR   Wikidata; Q127380616
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD4-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD40-1
AC   CVCL_C2MB
DR   DSHB; CPTC-CD40-1
DR   Wikidata; Q114311036
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD40-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD40-2
AC   CVCL_D3T6
DR   DSHB; CPTC-CD40-2
DR   Wikidata; Q127380617
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD40-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD44-1
AC   CVCL_C2MC
DR   DSHB; CPTC-CD44-1
DR   Wikidata; Q114311037
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD44-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD44-2
AC   CVCL_D3TA
DR   DSHB; CPTC-CD44-2
DR   Wikidata; Q127380618
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD44-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD47-1
AC   CVCL_YF39
DR   DSHB; CPTC-CD47-1
DR   Wikidata; Q93457710
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD47-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD47-2
AC   CVCL_YF40
DR   DSHB; CPTC-CD47-2
DR   Wikidata; Q93457711
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD47-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD47-3
AC   CVCL_YF41
DR   DSHB; CPTC-CD47-3
DR   Wikidata; Q93457712
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD47-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD48-1
AC   CVCL_D3RH
DR   DSHB; CPTC-CD48-1
DR   Wikidata; Q127380619
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD48-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09326; Human CD48.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD70-2
AC   CVCL_D3TC
DR   DSHB; CPTC-CD70-2
DR   Wikidata; Q127380620
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD70-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P32970; Human CD70.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD70-3
AC   CVCL_D3TD
DR   DSHB; CPTC-CD70-3
DR   Wikidata; Q127380621
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD70-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P32970; Human CD70.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CD74-1
AC   CVCL_C2MD
DR   DSHB; CPTC-CD74-1
DR   Wikidata; Q114311038
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD74-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04233; Human CD74.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CD8A-1
AC   CVCL_D3TE
DR   DSHB; CPTC-CD8A-1
DR   Wikidata; Q127380622
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CD8A-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01732; Human CD8A.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CDC25B-2
AC   CVCL_D3TF
DR   DSHB; CPTC-CDC25B-2
DR   Wikidata; Q127380623
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDC25B-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P30305; Human CDC25B (Note=With phospho p.Ser323).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CDC25C-1
AC   CVCL_D3TG
DR   DSHB; CPTC-CDC25C-1
DR   Wikidata; Q127380624
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDC25C-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P30307; Human CDC25C (Note=With phospho p.Ser216).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CDC34-1
AC   CVCL_YF42
DR   DSHB; CPTC-CDC34-1
DR   Wikidata; Q93457713
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDC34-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49427; Human CDC34.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDC34-2
AC   CVCL_YF43
DR   DSHB; CPTC-CDC34-2
DR   Wikidata; Q93457714
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDC34-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49427; Human CDC34.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDCA8-1
AC   CVCL_D3TH
DR   DSHB; CPTC-CDCA8-1
DR   Wikidata; Q127380625
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDCA8-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q53HL2; Human CDCA8.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CDH1-1
AC   CVCL_YF44
DR   DSHB; CPTC-CDH1-1
DR   Wikidata; Q93457715
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDH1-2
AC   CVCL_YF45
DR   DSHB; CPTC-CDH1-2
DR   Wikidata; Q93457716
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDH1-3
AC   CVCL_YF46
DR   DSHB; CPTC-CDH1-3
DR   Wikidata; Q93457717
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDH1-4
AC   CVCL_YF47
DR   DSHB; CPTC-CDH1-4
DR   Wikidata; Q93457718
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDH2-1
AC   CVCL_YF48
DR   DSHB; CPTC-CDH2-1
DR   Wikidata; Q93457719
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P19022; Human CDH2/CD325.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDH2-2
AC   CVCL_YF49
DR   DSHB; CPTC-CDH2-2
DR   Wikidata; Q93457720
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P19022; Human CDH2/CD325.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDH2-4
AC   CVCL_YF50
DR   DSHB; CPTC-CDH2-4
DR   Wikidata; Q93457721
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH2-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19022; Human CDH2/CD325.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CDH2-5
AC   CVCL_C2KY
DR   DSHB; CPTC-CDH2-5
DR   Wikidata; Q114311039
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CDH2-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19022; Human CDH2/CD325.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CGB-1
AC   CVCL_C2MG
DR   DSHB; CPTC-CGB-1
DR   Wikidata; Q114311040
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CGB-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01233; Human CGB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CGB-10
AC   CVCL_C2MJ
DR   DSHB; CPTC-CGB-10
DR   Wikidata; Q114311041
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CGB-10
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01233; Human CGB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CGB-2
AC   CVCL_C2MH
DR   DSHB; CPTC-CGB-2
DR   Wikidata; Q114311042
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CGB-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01233; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CGB-4
AC   CVCL_C2MI
DR   DSHB; CPTC-CGB-4
DR   Wikidata; Q114311043
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CGB-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01233; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHEK1-3
AC   CVCL_YF51
DR   DSHB; CPTC-CHEK1-3
DR   Wikidata; Q93457722
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHEK1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O14757; Human CHEK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHEK1-4
AC   CVCL_C2L7
DR   DSHB; CPTC-CHEK1-4
DR   Wikidata; Q114311044
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHEK1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O14757; Human CHEK1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHEK1-5
AC   CVCL_C2L8
DR   DSHB; CPTC-CHEK1-5
DR   Wikidata; Q114311045
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHEK1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O14757; Human CHEK1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHEK2-1
AC   CVCL_D3TI
DR   DSHB; CPTC-CHEK2-1
DR   Wikidata; Q127380626
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHEK2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O96017; Human CHEK2 (Note=With phospho p.Ser379).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CHGA-1
AC   CVCL_YF52
DR   DSHB; CPTC-CHGA-1
DR   Wikidata; Q93457723
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHGA-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10645; Human CHGA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHGA-2
AC   CVCL_YF53
DR   DSHB; CPTC-CHGA-2
DR   Wikidata; Q93457724
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHGA-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10645; Human CHGA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHGA-3
AC   CVCL_YF54
DR   DSHB; CPTC-CHGA-3
DR   Wikidata; Q93457725
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHGA-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10645; Human CHGA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHKA-1
AC   CVCL_C2L9
DR   DSHB; CPTC-CHKA-1
DR   Wikidata; Q114311046
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHKA-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHKA-2
AC   CVCL_YF55
DR   DSHB; CPTC-CHKA-2
DR   Wikidata; Q93457726
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHKA-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHKA-3
AC   CVCL_YF56
DR   DSHB; CPTC-CHKA-3
DR   Wikidata; Q93457727
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHKA-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35790; Human CHKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHP2-1
AC   CVCL_YF57
DR   DSHB; CPTC-CHP2-1
DR   Wikidata; Q93457728
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHP2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43745; Human CHP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHP2-2
AC   CVCL_YF58
DR   DSHB; CPTC-CHP2-2
DR   Wikidata; Q93457729
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHP2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43745; Human CHP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CHP2-3
AC   CVCL_YF59
DR   DSHB; CPTC-CHP2-3
DR   Wikidata; Q93457731
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CHP2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43745; Human CHP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CKB-1
AC   CVCL_YF60
DR   DSHB; CPTC-CKB-1
DR   Wikidata; Q93457733
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CKB-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12277; Human CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CKB-2
AC   CVCL_YF61
DR   DSHB; CPTC-CKB-2
DR   Wikidata; Q93457735
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CKB-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12277; Human CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CKB-3
AC   CVCL_YF62
DR   DSHB; CPTC-CKB-3
DR   Wikidata; Q93457737
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CKB-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12277; Human CKB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CLIC1-1
AC   CVCL_YF63
DR   DSHB; CPTC-CLIC1-1
DR   Wikidata; Q93457739
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CLIC1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O00299; Human CLIC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CLIC1-2
AC   CVCL_YF64
DR   DSHB; CPTC-CLIC1-2
DR   Wikidata; Q93457741
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CLIC1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O00299; Human CLIC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CLU-1
AC   CVCL_C2MK
DR   DSHB; CPTC-CLU-1
DR   Wikidata; Q114311047
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CLU-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P10909; Human CLU.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CPE-1
AC   CVCL_YF65
DR   DSHB; CPTC-CPE-1
DR   Wikidata; Q93457743
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CPE-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16870; Human CPE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CPE-2
AC   CVCL_YF66
DR   DSHB; CPTC-CPE-2
DR   Wikidata; Q93457745
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CPE-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P16870; Human CPE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CPE-3
AC   CVCL_YF67
DR   DSHB; CPTC-CPE-3
DR   Wikidata; Q93457748
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CPE-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16870; Human CPE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CRABP2-1
AC   CVCL_D3TJ
DR   DSHB; CPTC-CRABP2-1
DR   Wikidata; Q127380627
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CRABP2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P29373; Human CRABP2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CRABP2-2
AC   CVCL_D3TK
DR   DSHB; CPTC-CRABP2-2
DR   Wikidata; Q127380628
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CRABP2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P29373; Human CRABP2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CRYAB-1
AC   CVCL_YF68
DR   DSHB; CPTC-CRYAB-1
DR   Wikidata; Q93457750
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CRYAB-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02511; Human CRYAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CRYAB-2
AC   CVCL_YF69
DR   DSHB; CPTC-CRYAB-2
DR   Wikidata; Q93457752
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CRYAB-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02511; Human CRYAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CRYAB-3
AC   CVCL_YF70
DR   DSHB; CPTC-CRYAB-3
DR   Wikidata; Q93457754
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CRYAB-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02511; Human CRYAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CSF1-1
AC   CVCL_C2ML
DR   DSHB; CPTC-CSF1-1
DR   Wikidata; Q114311048
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSF1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09603; Human CSF1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CSF2RA-1
AC   CVCL_D3TL
DR   DSHB; CPTC-CSF2RA-1
DR   Wikidata; Q127380629
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSF2RA-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P15509; Human CSF2RA/CD116.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CSTA-1
AC   CVCL_YF71
DR   DSHB; CPTC-CSTA-1
DR   Wikidata; Q93457756
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSTA-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01040; Human CSTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CSTA-2
AC   CVCL_YF72
DR   DSHB; CPTC-CSTA-2
DR   Wikidata; Q93457758
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSTA-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01040; Human CSTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CSTA-3
AC   CVCL_YF73
DR   DSHB; CPTC-CSTA-3
DR   Wikidata; Q93457760
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSTA-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01040; Human CSTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CSTB-1
AC   CVCL_YF74
DR   DSHB; CPTC-CSTB-1
DR   Wikidata; Q93457762
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSTB-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04080; Human CSTB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CSTB-2
AC   CVCL_YF75
DR   DSHB; CPTC-CSTB-2
DR   Wikidata; Q93457765
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSTB-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04080; Human CSTB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CSTB-3
AC   CVCL_YF76
DR   DSHB; CPTC-CSTB-3
DR   Wikidata; Q93457767
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CSTB-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04080; Human CSTB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CTLA4-1
AC   CVCL_D3TM
DR   DSHB; CPTC-CTLA4-1
DR   Wikidata; Q127380630
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CTLA4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CTNNBL1-1
AC   CVCL_YF77
DR   DSHB; CPTC-CTNNBL1-1
DR   Wikidata; Q93457769
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CTNNBL1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WYA6; Human CTNNBL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CXCL10-1
AC   CVCL_D3TN
DR   DSHB; CPTC-CXCL10-1
DR   Wikidata; Q127380631
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CXCL10-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P02778; Human CXCL10.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CXCL13-1
AC   CVCL_D3TP
DR   DSHB; CPTC-CXCL13-1
DR   Wikidata; Q127380632
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CXCL13-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43927; Human CXCL13.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-CXCL9-1
AC   CVCL_YF78
DR   DSHB; CPTC-CXCL9-1
DR   Wikidata; Q93457771
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CXCL9-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q07325; Human CXCL9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-CXCL9-2
AC   CVCL_C2LA
DR   DSHB; CPTC-CXCL9-2
DR   Wikidata; Q114311049
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-CXCL9-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q07325; Human CXCL9.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-DDIT3-1
AC   CVCL_YF79
DR   DSHB; CPTC-DDIT3-1
DR   Wikidata; Q93457773
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-DDIT3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P35638; Human DDIT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-DDIT3-2
AC   CVCL_YF80
DR   DSHB; CPTC-DDIT3-2
DR   Wikidata; Q93457776
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-DDIT3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P35638; Human DDIT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-DLC1-1
AC   CVCL_YF81
DR   DSHB; CPTC-DLC1-1
DR   Wikidata; Q93457778
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-DLC1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96QB1; Human DLC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-DLC1-2
AC   CVCL_YF82
DR   DSHB; CPTC-DLC1-2
DR   Wikidata; Q93457780
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-DLC1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96QB1; Human DLC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-DLC1-3
AC   CVCL_YF83
DR   DSHB; CPTC-DLC1-3
DR   Wikidata; Q93457782
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-DLC1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96QB1; Human DLC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EBAG9-1
AC   CVCL_YF84
DR   DSHB; CPTC-EBAG9-1
DR   Wikidata; Q93457784
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EBAG9-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O00559; Human EBAG9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EBAG9-3
AC   CVCL_YF85
DR   DSHB; CPTC-EBAG9-3
DR   Wikidata; Q93457786
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EBAG9-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00559; Human EBAG9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-1
AC   CVCL_YF86
DR   DSHB; CPTC-EGFR-1
DR   Wikidata; Q93457788
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-10
AC   CVCL_C2KD
DR   DSHB; CPTC-EGFR-10
DR   Wikidata; Q114311050
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-10
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-11
AC   CVCL_C2KE
DR   DSHB; CPTC-EGFR-11
DR   Wikidata; Q114311052
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-11
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-12
AC   CVCL_C2KF
DR   DSHB; CPTC-EGFR-12
DR   Wikidata; Q114311053
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-12
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-13
AC   CVCL_C2KG
DR   DSHB; CPTC-EGFR-13
DR   Wikidata; Q114311054
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-13
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-2
AC   CVCL_YF87
DR   DSHB; CPTC-EGFR-2
DR   Wikidata; Q93457790
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-4
AC   CVCL_YF88
DR   DSHB; CPTC-EGFR-4
DR   Wikidata; Q93457792
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-5
AC   CVCL_YF89
DR   DSHB; CPTC-EGFR-5
DR   Wikidata; Q93457795
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-6
AC   CVCL_YF90
DR   DSHB; CPTC-EGFR-6
DR   Wikidata; Q93457797
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-7
AC   CVCL_YF91
DR   DSHB; CPTC-EGFR-7
DR   Wikidata; Q93457799
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-8
AC   CVCL_C2KB
DR   DSHB; CPTC-EGFR-8
DR   Wikidata; Q114311055
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-8
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EGFR-9
AC   CVCL_C2KC
DR   DSHB; CPTC-EGFR-9
DR   Wikidata; Q114311056
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EGFR-9
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ENTPD1-1
AC   CVCL_C2MM
DR   DSHB; CPTC-ENTPD1-1
DR   Wikidata; Q114311057
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ENTPD1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49961; Human ENTPD1/CD39.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EPHB4-1
AC   CVCL_YF92
DR   DSHB; CPTC-EPHB4-1
DR   Wikidata; Q93457801
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EPHB4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P54760; Human EPHB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-EPHB4-2
AC   CVCL_YF93
DR   DSHB; CPTC-EPHB4-2
DR   Wikidata; Q93457803
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-EPHB4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54760; Human EPHB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ERBB2-2
AC   CVCL_YF94
DR   DSHB; CPTC-ERBB2-2
DR   Wikidata; Q93457805
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERBB2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ERBB2-3
AC   CVCL_YF95
DR   DSHB; CPTC-ERBB2-3
DR   Wikidata; Q93457807
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERBB2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ERBB2-4
AC   CVCL_C2KH
DR   DSHB; CPTC-ERBB2-4
DR   Wikidata; Q114311058
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERBB2-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ERBB3-1
AC   CVCL_YF96
DR   DSHB; CPTC-ERBB3-1
DR   Wikidata; Q93457809
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERBB3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
CC   Discontinued: DSHB; CPTC-ERBB3-1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-ERBB3-2
AC   CVCL_YF97
DR   DSHB; CPTC-ERBB3-2
DR   Wikidata; Q93457811
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERBB3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ERBB3-3
AC   CVCL_YF98
DR   DSHB; CPTC-ERBB3-3
DR   Wikidata; Q93457813
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERBB3-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ERBB3-4
AC   CVCL_YF99
DR   DSHB; CPTC-ERBB3-4
DR   Wikidata; Q93457815
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERBB3-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ERCC2-1
AC   CVCL_D3TQ
DR   DSHB; CPTC-ERCC2-1
DR   Wikidata; Q127380633
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERCC2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P18074; Human ERCC2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-ERRFI1-1
AC   CVCL_D3TR
DR   DSHB; CPTC-ERRFI1-1
DR   Wikidata; Q127380634
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERRFI1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9UJM3; Human ERRFI1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-ERRFI1-2
AC   CVCL_D3TS
DR   DSHB; CPTC-ERRFI1-2
DR   Wikidata; Q127380635
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ERRFI1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9UJM3; Human ERRFI1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-Ezrin-1
AC   CVCL_YG00
DR   DSHB; CPTC-Ezrin-1
DR   Wikidata; Q93457818
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Ezrin-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P15311; Human EZR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Ezrin-2
AC   CVCL_C2LB
SY   CPTC-EZRIN-2
DR   DSHB; CPTC-EZRIN-2
DR   Wikidata; Q114311059
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Ezrin-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P15311; Human EZR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FAAP100-1
AC   CVCL_C2MN
DR   DSHB; CPTC-FAAP100-1
DR   Wikidata; Q114311061
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FAAP100-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q0VG06; Human FAAP100.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FAAP100-2
AC   CVCL_C2MP
DR   DSHB; CPTC-FAAP100-2
DR   Wikidata; Q114311062
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FAAP100-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q0VG06; Human FAAP100.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FABP2-1
AC   CVCL_YG01
DR   DSHB; CPTC-FABP2-1
DR   Wikidata; Q93457820
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FABP2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12104; Human FABP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FABP2-2
AC   CVCL_YG02
DR   DSHB; CPTC-FABP2-2
DR   Wikidata; Q93457822
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FABP2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12104; Human FABP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FABP4-1
AC   CVCL_C2MQ
DR   DSHB; CPTC-FABP4-1
DR   Wikidata; Q114311063
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FABP4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P15090; Human FABP4.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FABP5-1
AC   CVCL_YG03
DR   DSHB; CPTC-FABP5-1
DR   Wikidata; Q93457824
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FABP5-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01469; Human FABP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FABP5-2
AC   CVCL_YG04
DR   DSHB; CPTC-FABP5-2
DR   Wikidata; Q93457826
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FABP5-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01469; Human FABP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FABP5-3
AC   CVCL_YG05
DR   DSHB; CPTC-FABP5-3
DR   Wikidata; Q93457828
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FABP5-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01469; Human FABP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FAF1-1
AC   CVCL_YG06
DR   DSHB; CPTC-FAF1-1
DR   Wikidata; Q93457830
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FAF1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UNN5; Human FAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FAF1-2
AC   CVCL_YG07
DR   DSHB; CPTC-FAF1-2
DR   Wikidata; Q93457832
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FAF1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNN5; Human FAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FAF1-3
AC   CVCL_YG08
DR   DSHB; CPTC-FAF1-3
DR   Wikidata; Q93457834
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FAF1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UNN5; Human FAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FANCD2-1
AC   CVCL_C2MR
DR   DSHB; CPTC-FANCD2-1
DR   Wikidata; Q114311064
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FANCD2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BXW9; Human FANCD2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FANCD2-2
AC   CVCL_C2MS
DR   DSHB; CPTC-FANCD2-2
DR   Wikidata; Q114311065
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FANCD2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BXW9; Human FANCD2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Fascin1-1
AC   CVCL_YG09
DR   DSHB; CPTC-Fascin-1
DR   Wikidata; Q93457837
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Fascin1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q16658; Human FSCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Fascin1-2
AC   CVCL_YG10
DR   DSHB; CPTC-Fascin-2
DR   Wikidata; Q93457839
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Fascin1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q16658; Human FSCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Fascin1-3
AC   CVCL_YG11
DR   DSHB; CPTC-Fascin-3
DR   Wikidata; Q93457841
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Fascin1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16658; Human FSCN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FBN1-1
AC   CVCL_C2MT
DR   DSHB; CPTC-FBN1-1
DR   Wikidata; Q114311066
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FBN1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P35555; Human FBN1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FBN1-2
AC   CVCL_C2MU
DR   DSHB; CPTC-FBN1-2
DR   Wikidata; Q114311067
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FBN1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P35555; Human FBN1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FBN1-3
AC   CVCL_C2MV
DR   DSHB; CPTC-FBN1-3
DR   Wikidata; Q114311068
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FBN1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P35555; Human FBN1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FEN1-1
AC   CVCL_C2MW
DR   DSHB; CPTC-FEN1-1
DR   Wikidata; Q114311069
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FEN1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P39748; Human FEN1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FHL1-1
AC   CVCL_C2MX
DR   DSHB; CPTC-FHL1-1
DR   Wikidata; Q114311070
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FHL1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13642; Human FHL1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FOS-1
AC   CVCL_YG12
DR   DSHB; CPTC-FOS-1
DR   Wikidata; Q93457843
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOS-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FOS-2
AC   CVCL_YG13
DR   DSHB; CPTC-FOS-2
DR   Wikidata; Q93457845
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOS-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FOS-3
AC   CVCL_YG14
DR   DSHB; CPTC-FOS-3
DR   Wikidata; Q93457847
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOS-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FOS-4
AC   CVCL_YG15
DR   DSHB; CPTC-FOS-4
DR   Wikidata; Q93457849
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOS-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FOXC2-1
AC   CVCL_D3TT
DR   DSHB; CPTC-FOXC2-1
DR   Wikidata; Q127380636
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOXC2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q99958; Human FOXC2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-FOXO1-1
AC   CVCL_D3TU
DR   DSHB; CPTC-FOXO1-1
DR   Wikidata; Q127380638
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOXO1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q12778; Human FOXO1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-FOXO3-1
AC   CVCL_C2MY
DR   DSHB; CPTC-FOXO3-1
DR   Wikidata; Q114311071
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOXO3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43524; Human FOXO3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FOXO3-2
AC   CVCL_D3TV
DR   DSHB; CPTC-FOXO3-2
DR   Wikidata; Q127380639
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOXO3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43524; Human FOXO3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-FOXQ1-1
AC   CVCL_C2MZ
DR   DSHB; CPTC-FOXQ1-1
DR   Wikidata; Q114311073
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOXQ1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9C009; Human FOXQ1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FOXQ1-2
AC   CVCL_C2N0
DR   DSHB; CPTC-FOXQ1-2
DR   Wikidata; Q114311074
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FOXQ1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9C009; Human FOXQ1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-FSCN1-1
AC   CVCL_D3TW
DR   DSHB; CPTC-FSCN1-1
DR   Wikidata; Q127380640
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-FSCN1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q16658; Human FSCN1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-GCLM-1
AC   CVCL_YG16
DR   DSHB; CPTC-GCLM-1
DR   Wikidata; Q93457851
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GCLM-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P48507; Human GCLM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GCLM-2
AC   CVCL_YG17
DR   DSHB; CPTC-GCLM-2
DR   Wikidata; Q93457853
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GCLM-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P48507; Human GCLM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GCLM-3
AC   CVCL_YG18
DR   DSHB; CPTC-GCLM-3
DR   Wikidata; Q93457855
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GCLM-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P48507; Human GCLM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Gelsolin-1
AC   CVCL_YG19
DR   DSHB; CPTC-Gelsolin-1
DR   Wikidata; Q93457857
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Gelsolin-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06396; Human GSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Gelsolin-2
AC   CVCL_YG20
DR   DSHB; CPTC-Gelsolin-2
DR   Wikidata; Q93457860
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Gelsolin-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06396; Human GSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Gelsolin-3
AC   CVCL_YG21
DR   DSHB; CPTC-Gelsolin-3
DR   Wikidata; Q93457862
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Gelsolin-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06396; Human GSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-Gelsolin-4
AC   CVCL_YG22
DR   DSHB; CPTC-Gelsolin-4
DR   Wikidata; Q93457864
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-Gelsolin-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06396; Human GSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GI.1 Norovirus RDRP-1
AC   CVCL_YG23
SY   CPTC-RDRP-1
DR   DSHB; CPTC-RDRP-1
DR   Wikidata; Q93457865
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RDRP-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q83883; Norovirus GI.1 genome polyprotein (Note=AA 1282-1789 = RNA-dependent RNA polymerase).
CC   Discontinued: DSHB; CPTC-RDRP-1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   CPTC-GI.1 Norovirus RDRP-2
AC   CVCL_YG24
SY   CPTC-RDRP-2
DR   DSHB; CPTC-RDRP-2
DR   Wikidata; Q93457867
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RDRP-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q83883; Norovirus GI.1 genome polyprotein (Note=AA 1282-1789 = RNA-dependent RNA polymerase).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-GI.1 Norovirus RDRP-3
AC   CVCL_YG25
SY   CPTC-RDRP-3
DR   DSHB; CPTC-RDRP-3
DR   Wikidata; Q93457870
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RDRP-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q83883; Norovirus GI.1 genome polyprotein (Note=AA 1282-1789 = RNA-dependent RNA polymerase).
CC   Discontinued: DSHB; CPTC-RDRP-3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   CPTC-GIT2-1
AC   CVCL_D3TX
DR   DSHB; CPTC-GIT2-1
DR   Wikidata; Q127380642
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GIT2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q14161; Human GIT2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-GLO1-1
AC   CVCL_YG26
DR   DSHB; CPTC-GLO1-1
DR   Wikidata; Q93457872
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GLO1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04760; Human GLO1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GLO1-2
AC   CVCL_YG27
DR   DSHB; CPTC-GLO1-2
DR   Wikidata; Q93457874
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GLO1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04760; Human GLO1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GLO1-3
AC   CVCL_YG28
DR   DSHB; CPTC-GLO1-3
DR   Wikidata; Q93457876
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GLO1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04760; Human GLO1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GMNN-1
AC   CVCL_YG29
DR   DSHB; CPTC-GMNN-1
DR   Wikidata; Q93457878
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GMNN-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75496; Human GMNN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GMNN-2
AC   CVCL_YG30
DR   DSHB; CPTC-GMNN-2
DR   Wikidata; Q93457880
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GMNN-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75496; Human GMNN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GPI-1
AC   CVCL_YG31
DR   DSHB; CPTC-GPI-1
DR   Wikidata; Q93457882
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GPI-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06744; Human GPI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GPI-2
AC   CVCL_YG32
DR   DSHB; CPTC-GPI-2
DR   Wikidata; Q93457884
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GPI-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06744; Human GPI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GPI-3
AC   CVCL_YG33
DR   DSHB; CPTC-GPI-3
DR   Wikidata; Q93457886
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GPI-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06744; Human GPI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GRB2-1
AC   CVCL_C2N1
DR   DSHB; CPTC-GRB2-1
DR   Wikidata; Q114311075
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GRB2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P62993; Human GRB2.
CC   Caution: Erroneously indicated as produced from myeloma cell line P3x63Ag8.653 in DSHB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSC-1
AC   CVCL_C2N2
DR   DSHB; CPTC-GSC-1
DR   Wikidata; Q114311077
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSC-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P56915; Human GSC.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSC-2
AC   CVCL_C2N3
DR   DSHB; CPTC-GSC-2
DR   Wikidata; Q114311078
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSC-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P56915; Human GSC.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSC-4
AC   CVCL_C2N4
DR   DSHB; CPTC-GSC-4
DR   Wikidata; Q114311079
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSC-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P56915; Human GSC.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-1
AC   CVCL_YG34
DR   DSHB; CPTC-GSK3B-1
DR   Wikidata; Q93457888
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-2
AC   CVCL_YG35
DR   DSHB; CPTC-GSK3B-2
DR   Wikidata; Q93457891
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-3
AC   CVCL_YG36
DR   DSHB; CPTC-GSK3B-3
DR   Wikidata; Q93457893
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-4
AC   CVCL_YG37
DR   DSHB; CPTC-GSK3B-4
DR   Wikidata; Q93457895
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-5
AC   CVCL_YG38
DR   DSHB; CPTC-GSK3B-5
DR   Wikidata; Q93457897
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-6
AC   CVCL_YG39
DR   DSHB; CPTC-GSK3B-6
DR   Wikidata; Q93457899
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-7
AC   CVCL_YG40
DR   DSHB; CPTC-GSK3B-7
DR   Wikidata; Q93457902
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-8
AC   CVCL_YG41
DR   DSHB; CPTC-GSK3B-8
DR   Wikidata; Q93457904
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-8
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSK3B-9
AC   CVCL_C2KI
DR   DSHB; CPTC-GSK3B-9
DR   Wikidata; Q114311081
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSK3B-9
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P49841; Human GSK3B.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu1-1
AC   CVCL_YG42
DR   DSHB; CPTC-GSTMu1-1
DR   Wikidata; Q93457906
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09488; Human GSTM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu1-2
AC   CVCL_YG43
DR   DSHB; CPTC-GSTMu1-2
DR   Wikidata; Q93457908
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09488; Human GSTM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu1-3
AC   CVCL_YG44
DR   DSHB; CPTC-GSTMu1-3
DR   Wikidata; Q93457910
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09488; Human GSTM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu1-4
AC   CVCL_YG45
DR   DSHB; CPTC-GSTMu1-4
DR   Wikidata; Q93457912
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09488; Human GSTM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu1-5
AC   CVCL_YG46
DR   DSHB; CPTC-GSTMu1-5
DR   Wikidata; Q93457914
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09488; Human GSTM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu1-6
AC   CVCL_YG47
DR   DSHB; CPTC-GSTMu1-6
DR   Wikidata; Q93457917
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09488; Human GSTM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu1-7
AC   CVCL_YG48
DR   DSHB; CPTC-GSTMu1-7
DR   Wikidata; Q93457919
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09488; Human GSTM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu2-1
AC   CVCL_YG49
DR   DSHB; CPTC-GSTMu2-1
DR   Wikidata; Q93457921
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P28161; Human GSTM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu2-2
AC   CVCL_YG50
DR   DSHB; CPTC-GSTMu2-2
DR   Wikidata; Q93457923
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28161; Human GSTM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu2-3
AC   CVCL_YG51
DR   DSHB; CPTC-GSTMu2-3
DR   Wikidata; Q93457925
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28161; Human GSTM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu3-1
AC   CVCL_YG52
DR   DSHB; CPTC-GSTMu3-1
DR   Wikidata; Q93457927
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P21266; Human GSTM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu3-2
AC   CVCL_YG53
DR   DSHB; CPTC-GSTMu3-2
DR   Wikidata; Q93457929
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21266; Human GSTM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTMu3-3
AC   CVCL_YG54
DR   DSHB; CPTC-GSTMu3-3
DR   Wikidata; Q93457931
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GST+Mu3-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21266; Human GSTM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-GSTP1-1
AC   CVCL_C2N5
DR   DSHB; CPTC-GSTP1-1
DR   Wikidata; Q114311083
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-GSTP1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09211; Human GSTP1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPB1-1
AC   CVCL_YG55
DR   DSHB; CPTC-HSPB1-1
DR   Wikidata; Q93457934
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPB1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04792; Human HSPB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPB1-2
AC   CVCL_YG56
DR   DSHB; CPTC-HSPB1-2
DR   Wikidata; Q93457936
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPB1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04792; Human HSPB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPB1-3
AC   CVCL_YG57
DR   DSHB; CPTC-HSPB1-3
DR   Wikidata; Q93457938
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPB1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04792; Human HSPB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPB1-4
AC   CVCL_C2LC
DR   DSHB; CPTC-HSPB1-4
DR   Wikidata; Q114311086
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPB1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04792; Human HSPB1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPB1-6
AC   CVCL_C2LD
DR   DSHB; CPTC-HSPB1-6
DR   Wikidata; Q114311089
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPB1-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04792; Human HSPB1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPD1-1
AC   CVCL_YG58
DR   DSHB; CPTC-HSPD1-1
DR   Wikidata; Q93457940
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPD1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10809; Human HSPD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPD1-2
AC   CVCL_YG59
DR   DSHB; CPTC-HSPD1-2
DR   Wikidata; Q93457942
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPD1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10809; Human HSPD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-HSPD1-3
AC   CVCL_YG60
DR   DSHB; CPTC-HSPD1-3
DR   Wikidata; Q93457944
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-HSPD1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10809; Human HSPD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ICOSLG-1
AC   CVCL_C2N6
DR   DSHB; CPTC-ICOSLG-1
DR   Wikidata; Q114311092
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ICOSLG-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O75144; Human ICOSLG/CD275.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IDO1-1
AC   CVCL_YG61
DR   DSHB; CPTC-IDO1-1
DR   Wikidata; Q93457946
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IDO1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P14902; Human IDO1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IDO1-2
AC   CVCL_YG62
DR   DSHB; CPTC-IDO1-2
DR   Wikidata; Q93457948
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IDO1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P14902; Human IDO1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IFIT1-1
AC   CVCL_D3U1
DR   DSHB; CPTC-IFIT1-1
DR   Wikidata; Q127380643
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IFIT1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09914; Human IFIT1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-IFIT2-1
AC   CVCL_D3U2
DR   DSHB; CPTC-IFIT2-1
DR   Wikidata; Q127380644
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IFIT2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09913; Human IFIT2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-IFIT3-1
AC   CVCL_D3U0
DR   DSHB; CPTC-IFIT3-1
DR   Wikidata; Q127380645
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IFIT3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O14879; Human IFIT3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CPTC-IL18-1
AC   CVCL_YG63
DR   DSHB; CPTC-IL18-1
DR   Wikidata; Q93457950
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IL18-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14116; Human IL18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IL18-2
AC   CVCL_YG64
DR   DSHB; CPTC-IL18-2
DR   Wikidata; Q93457952
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IL18-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14116; Human IL18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IL18-3
AC   CVCL_YG65
DR   DSHB; CPTC-IL18-3
DR   Wikidata; Q93457954
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IL18-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14116; Human IL18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IL18-4
AC   CVCL_C2LE
DR   DSHB; CPTC-IL18-4
DR   Wikidata; Q114311095
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IL18-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q14116; Human IL18.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IL6-1
AC   CVCL_YG66
DR   DSHB; CPTC-IL6-1
DR   Wikidata; Q93457956
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IL6-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05231; Human IL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IL6-2
AC   CVCL_YG67
DR   DSHB; CPTC-IL6-2
DR   Wikidata; Q93457958
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IL6-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05231; Human IL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-IL6-3
AC   CVCL_YG68
DR   DSHB; CPTC-IL6-3
DR   Wikidata; Q93457960
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-IL6-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05231; Human IL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ITCH-1
AC   CVCL_YG69
DR   DSHB; CPTC-ITCH-1
DR   Wikidata; Q93457962
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ITCH-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96J02; Human ITCH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ITCH-2
AC   CVCL_YG70
DR   DSHB; CPTC-ITCH-2
DR   Wikidata; Q93457964
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ITCH-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96J02; Human ITCH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ITCH-3
AC   CVCL_YG71
DR   DSHB; CPTC-ITCH-3
DR   Wikidata; Q93457967
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ITCH-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96J02; Human ITCH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ITGAE-1
AC   CVCL_C2N7
DR   DSHB; CPTC-ITGAE-1
DR   Wikidata; Q114311098
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ITGAE-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-JAK1-1
AC   CVCL_C2N8
DR   DSHB; CPTC-JAK1-1
DR   Wikidata; Q114311102
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-JAK1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P23458; Human JAK1.
CC   Discontinued: DSHB; CPTC-JAK1-1; true.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   CPTC-JUN-1
AC   CVCL_YG72
DR   DSHB; CPTC-JUN-1
DR   Wikidata; Q93457969
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-JUN-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05412; Human JUN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-JUN-2
AC   CVCL_YG73
DR   DSHB; CPTC-JUN-2
DR   Wikidata; Q93457971
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-JUN-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05412; Human JUN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-JUN-3
AC   CVCL_YG74
DR   DSHB; CPTC-JUN-3
DR   Wikidata; Q93457973
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-JUN-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05412; Human JUN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-JUN-4
AC   CVCL_C2LF
DR   DSHB; CPTC-JUN-4
DR   Wikidata; Q114311103
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-JUN-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P05412; Human JUN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-JUN-5
AC   CVCL_C2LG
DR   DSHB; CPTC-JUN-5
DR   Wikidata; Q114311106
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-JUN-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P05412; Human JUN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-JUN-6
AC   CVCL_C2LH
DR   DSHB; CPTC-JUN-6
DR   Wikidata; Q114311109
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-JUN-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P05412; Human JUN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KIAA1967-1
AC   CVCL_YG75
DR   DSHB; CPTC-KIAA1967-1
DR   Wikidata; Q93457976
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KIAA1967-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N163; Human CCAR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KIAA1967-2
AC   CVCL_YG76
DR   DSHB; CPTC-KIAA1967-2
DR   Wikidata; Q93457978
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KIAA1967-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N163; Human CCAR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KIF2C-1
AC   CVCL_YG77
DR   DSHB; CPTC-KIF2C-1
DR   Wikidata; Q93457980
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KIF2C-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99661; Human KIF2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KIF2C-2
AC   CVCL_YG78
DR   DSHB; CPTC-KIF2C-2
DR   Wikidata; Q93457982
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KIF2C-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99661; Human KIF2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KIF2C-3
AC   CVCL_YG79
DR   DSHB; CPTC-KIF2C-3
DR   Wikidata; Q93457984
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KIF2C-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99661; Human KIF2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KLHDC8A-1
AC   CVCL_YG80
DR   DSHB; CPTC-KLHDC8A-1
DR   Wikidata; Q93457986
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KLHDC8A-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IYD2; Human KLHDC8A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KLHDC8A-2
AC   CVCL_YG81
DR   DSHB; CPTC-KLHDC8A-2
DR   Wikidata; Q93457988
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KLHDC8A-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8IYD2; Human KLHDC8A.
CC   Discontinued: DSHB; CPTC-KLHDC8A-2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-KRAS4B-1
AC   CVCL_YG82
DR   DSHB; CPTC-KRAS4B-1
DR   Wikidata; Q93457989
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRAS4B-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01116; Human KRAS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KRAS4B-2
AC   CVCL_YG83
DR   DSHB; CPTC-KRAS4B-2
DR   Wikidata; Q93457992
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRAS4B-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P01116; Human KRAS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KRAS4B-3
AC   CVCL_YG84
DR   DSHB; CPTC-KRAS4B-3
DR   Wikidata; Q93457994
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRAS4B-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01116; Human KRAS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KRAS4B-4
AC   CVCL_YG85
DR   DSHB; CPTC-KRAS4B-4
DR   Wikidata; Q93457996
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRAS4B-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01116; Human KRAS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KRT5-1
AC   CVCL_C2N9
DR   DSHB; CPTC-KRT5-1
DR   Wikidata; Q114311112
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRT5-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P13647; Human KRT5.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KRT5-2
AC   CVCL_C2NA
DR   DSHB; CPTC-KRT5-2
DR   Wikidata; Q114311114
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRT5-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P13647; Human KRT5.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KRT7-1
AC   CVCL_C2NB
DR   DSHB; CPTC-KRT7-1
DR   Wikidata; Q114311117
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRT7-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08729; Human KRT7.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-KRT7-2
AC   CVCL_C2NC
DR   DSHB; CPTC-KRT7-2
DR   Wikidata; Q114311120
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-KRT7-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08729; Human KRT7.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-LAP3-1
AC   CVCL_C2ND
DR   DSHB; CPTC-LAP3-1
DR   Wikidata; Q114311123
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-LAP3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P28838; Human LAP3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-LBX1-1
AC   CVCL_C2NE
DR   DSHB; CPTC-LBX1-1
DR   Wikidata; Q114311126
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-LBX1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P52954; Human LBX1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-LBX1-2
AC   CVCL_C2NF
DR   DSHB; CPTC-LBX1-2
DR   Wikidata; Q114311129
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-LBX1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P52954; Human LBX1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-LBX1-3
AC   CVCL_C2NG
DR   DSHB; CPTC-LBX1-3
DR   Wikidata; Q114311130
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-LBX1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P52954; Human LBX1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-LGALS1-1
AC   CVCL_C2NH
DR   DSHB; CPTC-LGALS1-1
DR   Wikidata; Q114311131
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-LGALS1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09382; Human LGALS1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-LIN28A-1
AC   CVCL_YG86
DR   DSHB; CPTC-LIN28A-1
DR   Wikidata; Q93457998
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-LIN28A-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H9Z2; Human LIN28A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAGEA4-1
AC   CVCL_YG87
DR   DSHB; CPTC-MAGEA4-1
DR   Wikidata; Q93458000
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAGEA4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P43358; Human MAGEA4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAGEA4-2
AC   CVCL_YG88
DR   DSHB; CPTC-MAGEA4-2
DR   Wikidata; Q93458002
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAGEA4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P43358; Human MAGEA4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAGEA4-3
AC   CVCL_YG89
DR   DSHB; CPTC-MAGEA4-3
DR   Wikidata; Q93458004
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAGEA4-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P43358; Human MAGEA4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAP2K1-1
AC   CVCL_YG90
DR   DSHB; CPTC-MAP2K1-1
DR   Wikidata; Q93458006
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAP2K1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02750; Human MAP2K1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAP2K1-2
AC   CVCL_YG91
DR   DSHB; CPTC-MAP2K1-2
DR   Wikidata; Q93458008
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAP2K1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02750; Human MAP2K1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK1-1
AC   CVCL_C2KJ
DR   DSHB; CPTC-MAPK1-1
DR   Wikidata; Q114311132
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P28482; Human MAPK1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK1-2
AC   CVCL_C2KK
DR   DSHB; CPTC-MAPK1-2
DR   Wikidata; Q114311133
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P28482; Human MAPK1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK1-3
AC   CVCL_C2KL
DR   DSHB; CPTC-MAPK1-3
DR   Wikidata; Q114311134
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P28482; Human MAPK1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK1-4
AC   CVCL_C2KM
DR   DSHB; CPTC-MAPK1-4
DR   Wikidata; Q114311135
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P28482; Human MAPK1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK14-1
AC   CVCL_YG92
DR   DSHB; CPTC-MAPK14-1
DR   Wikidata; Q93458010
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK14-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16539; Human MAPK14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK14-2
AC   CVCL_YG93
DR   DSHB; CPTC-MAPK14-2
DR   Wikidata; Q93458012
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK14-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16539; Human MAPK14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK14-3
AC   CVCL_YG94
DR   DSHB; CPTC-MAPK14-3
DR   Wikidata; Q93458014
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK14-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16539; Human MAPK14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK3-1
AC   CVCL_YG95
DR   DSHB; CPTC-MAPK3-1
DR   Wikidata; Q93458016
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27361; Human MAPK3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK3-2
AC   CVCL_YG96
DR   DSHB; CPTC-MAPK3-2
DR   Wikidata; Q93458018
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27361; Human MAPK3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK3-3
AC   CVCL_C2KN
DR   DSHB; CPTC-MAPK3-3
DR   Wikidata; Q114311136
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK3-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27361; Human MAPK3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK3-4
AC   CVCL_C2KP
DR   DSHB; CPTC-MAPK3-4
DR   Wikidata; Q114311137
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK3-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P27361; Human MAPK3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK3-5
AC   CVCL_C2KQ
DR   DSHB; CPTC-MAPK3-5
DR   Wikidata; Q114311139
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK3-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P27361; Human MAPK3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MAPK3-6
AC   CVCL_C2L1
DR   DSHB; CPTC-MAPK3-6
DR   Wikidata; Q114311140
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MAPK3-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P27361; Human MAPK3.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MBD1-1
AC   CVCL_YG97
DR   DSHB; CPTC-MBD1-1
DR   Wikidata; Q93458020
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MBD1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UIS9; Human MBD1.
CC   Discontinued: DSHB; CPTC-MBD1-1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-MBD1-2
AC   CVCL_YG98
DR   DSHB; CPTC-MBD1-2
DR   Wikidata; Q93458022
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MBD1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UIS9; Human MBD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MBD1-3
AC   CVCL_YG99
DR   DSHB; CPTC-MBD1-3
DR   Wikidata; Q93458025
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MBD1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UIS9; Human MBD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MDC1-1
AC   CVCL_YH00
DR   DSHB; CPTC-MDC1-1
DR   Wikidata; Q93458027
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MDC1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14676; Human MDC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MDC1-2
AC   CVCL_YH01
DR   DSHB; CPTC-MDC1-2
DR   Wikidata; Q93458029
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MDC1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14676; Human MDC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MDC1-3
AC   CVCL_YH02
DR   DSHB; CPTC-MDC1-3
DR   Wikidata; Q93458031
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MDC1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14676; Human MDC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MDC1-5
AC   CVCL_C2LI
DR   DSHB; CPTC-MDC1-5
DR   Wikidata; Q114311141
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MDC1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q14676; Human MDC1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MDH1-1
AC   CVCL_YH03
DR   DSHB; CPTC-MDH1-1
DR   Wikidata; Q93458033
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MDH1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P40925; Human MDH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MDH1-2
AC   CVCL_YH04
DR   DSHB; CPTC-MDH1-2
DR   Wikidata; Q93458036
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MDH1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P40925; Human MDH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MDH1-3
AC   CVCL_YH05
DR   DSHB; CPTC-MDH1-3
DR   Wikidata; Q93458038
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MDH1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P40925; Human MDH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MEN1-1
AC   CVCL_YH06
DR   DSHB; CPTC-MEN1-1
DR   Wikidata; Q93458040
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MEN1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00255; Human MEN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MET-1
AC   CVCL_C2NI
DR   DSHB; CPTC-MET-1
DR   Wikidata; Q114311142
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MET-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MKI67-1
AC   CVCL_C2NJ
DR   DSHB; CPTC-MKI67-1
DR   Wikidata; Q114311143
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MKI67-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MKI67-2
AC   CVCL_C2NK
DR   DSHB; CPTC-MKI67-2
DR   Wikidata; Q114311144
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MKI67-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MPO-1
AC   CVCL_YH07
DR   DSHB; CPTC-MPO-1
DR   Wikidata; Q93458042
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MPO-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MPO-2
AC   CVCL_YH08
DR   DSHB; CPTC-MPO-2
DR   Wikidata; Q93458044
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MPO-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MPO-3
AC   CVCL_YH09
DR   DSHB; CPTC-MPO-3
DR   Wikidata; Q93458046
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MPO-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05164; Human MPO.
CC   Discontinued: DSHB; CPTC-MPO-3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-MSN-1
AC   CVCL_YH10
DR   DSHB; CPTC-MSN-1
DR   Wikidata; Q93458048
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MSN-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26038; Human MSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MSN-2
AC   CVCL_YH11
DR   DSHB; CPTC-MSN-2
DR   Wikidata; Q93458050
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MSN-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26038; Human MSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MSN-3
AC   CVCL_YH12
DR   DSHB; CPTC-MSN-3
DR   Wikidata; Q93458052
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MSN-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26038; Human MSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-1
AC   CVCL_YH13
DR   DSHB; CPTC-MTOR-1
DR   Wikidata; Q93458054
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-2
AC   CVCL_YH14
DR   DSHB; CPTC-MTOR-2
DR   Wikidata; Q93458056
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-3
AC   CVCL_YH15
DR   DSHB; CPTC-mTOR-3
DR   Wikidata; Q93458058
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-4
AC   CVCL_YH16
DR   DSHB; CPTC-mTOR-4
DR   Wikidata; Q93458060
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-5
AC   CVCL_YH17
DR   DSHB; CPTC-mTOR-5
DR   Wikidata; Q93458063
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-6
AC   CVCL_YH18
DR   DSHB; CPTC-mTOR-6
DR   Wikidata; Q93458065
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-7
AC   CVCL_YH19
DR   DSHB; CPTC-mTOR-7
DR   Wikidata; Q93458067
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-MTOR-8
AC   CVCL_YH20
DR   DSHB; CPTC-mTOR-8
DR   Wikidata; Q93458069
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-8
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MTOR-9
AC   CVCL_C2KR
DR   DSHB; CPTC-MTOR-9
DR   Wikidata; Q114311145
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MTOR-9
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P42345; Human MTOR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MUC1-1
AC   CVCL_C2NL
DR   DSHB; CPTC-MUC1-1
DR   Wikidata; Q114311146
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MUC1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
CC   Caution: Erroneously indicated as produced from myeloma cell line P3x63Ag8.653 in DSHB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MUC1-2
AC   CVCL_C2NM
DR   DSHB; CPTC-MUC1-2
DR   Wikidata; Q114311147
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MUC1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-MUC17 CRD1 L CRD2-1
AC   CVCL_YH21
DR   DSHB; CPTC-MUC17-CRD1-L-CRD2-1
DR   Wikidata; Q93458072
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MUC17+CRD1+L+CRD2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q685J3; Human MUC17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-MUC17 CRD1 L CRD2-2
AC   CVCL_YH22
DR   DSHB; CPTC-MUC17-CRD1-L-CRD2-2
DR   Wikidata; Q93458074
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MUC17+CRD1+L+CRD2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q685J3; Human MUC17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-MUC17 CRD1 L CRD2-3
AC   CVCL_YH23
DR   DSHB; CPTC-MUC17-CRD1-L-CRD2-3
DR   Wikidata; Q93458076
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-MUC17+CRD1+L+CRD2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q685J3; Human MUC17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-NANOG-1
AC   CVCL_C2NN
DR   DSHB; CPTC-NANOG-1
DR   Wikidata; Q114311148
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NANOG-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9H9S0; Human NANOG.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NANOG-2
AC   CVCL_C2NP
DR   DSHB; CPTC-NANOG-2
DR   Wikidata; Q114311149
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NANOG-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9H9S0; Human NANOG.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NBN-1
AC   CVCL_C2NQ
DR   DSHB; CPTC-NBN-1
DR   Wikidata; Q114311150
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NBN-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O60934; Human NBN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NBN-3
AC   CVCL_C2NR
DR   DSHB; CPTC-NBN-3
DR   Wikidata; Q114311151
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NBN-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O60934; Human NBN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NBN-4
AC   CVCL_C2NS
DR   DSHB; CPTC-NBN-4
DR   Wikidata; Q114311152
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NBN-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O60934; Human NBN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NBN-5
AC   CVCL_C2NT
DR   DSHB; CPTC-NBN-5
DR   Wikidata; Q114311153
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NBN-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O60934; Human NBN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NCOR1-1
AC   CVCL_YH24
DR   DSHB; CPTC-NCOR1-1
DR   Wikidata; Q93458078
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NCOR1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75376; Human NCOR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NCOR1-2
AC   CVCL_YH25
DR   DSHB; CPTC-NCOR1-2
DR   Wikidata; Q93458080
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NCOR1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75376; Human NCOR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NEDD4-1
AC   CVCL_YH26
DR   DSHB; CPTC-NEDD4-1
DR   Wikidata; Q93458082
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NEDD4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P46934; Human NEDD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NEDD4-2
AC   CVCL_YH27
DR   DSHB; CPTC-NEDD4-2
DR   Wikidata; Q93458084
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NEDD4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P46934; Human NEDD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NEDD4-3
AC   CVCL_YH28
DR   DSHB; CPTC-NEDD4-3
DR   Wikidata; Q93458086
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NEDD4-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P46934; Human NEDD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NF1-1
AC   CVCL_C2NU
DR   DSHB; CPTC-NF1-1
DR   Wikidata; Q114311154
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NF1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P21359; Human NF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NF1-2
AC   CVCL_C2NV
DR   DSHB; CPTC-NF1-2
DR   Wikidata; Q114311155
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NF1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21359; Human NF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NF1-3
AC   CVCL_C2NW
DR   DSHB; CPTC-NF1-3
DR   Wikidata; Q114311156
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NF1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21359; Human NF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NFKB2-1
AC   CVCL_C2NX
DR   DSHB; CPTC-NFKB2-1
DR   Wikidata; Q114311157
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NFKB2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q00653; Human NFKB2.
CC   Caution: Erroneously indicated as produced from myeloma cell line P3x63Ag8.653 in DSHB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NME1-1
AC   CVCL_YH29
DR   DSHB; CPTC-NME1-1
DR   Wikidata; Q93458088
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15531; Human NME1.
CC   Discontinued: DSHB; CPTC-NME1-1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-NME1-2
AC   CVCL_YH30
DR   DSHB; CPTC-NME1-2
DR   Wikidata; Q93458090
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15531; Human NME1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NME1-3
AC   CVCL_YH31
DR   DSHB; CPTC-NME1-3
DR   Wikidata; Q93458092
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15531; Human NME1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NME1-4
AC   CVCL_YH32
DR   DSHB; CPTC-NME1-4
DR   Wikidata; Q93458095
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15531; Human NME1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NME1-5
AC   CVCL_YH33
DR   DSHB; CPTC-NME1-5
DR   Wikidata; Q93458097
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15531; Human NME1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NME2-1
AC   CVCL_YH34
DR   DSHB; CPTC-NME2-1
DR   Wikidata; Q93458099
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P22392; Human NME2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NME2-2
AC   CVCL_YH35
DR   DSHB; CPTC-NME2-2
DR   Wikidata; Q93458101
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P22392; Human NME2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-NME2-3
AC   CVCL_YH36
DR   DSHB; CPTC-NME2-3
DR   Wikidata; Q93458103
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-NME2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P22392; Human NME2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ODC1-1
AC   CVCL_YH37
DR   DSHB; CPTC-ODC1-1
DR   Wikidata; Q93458105
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ODC1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11926; Human ODC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ODC1-2
AC   CVCL_YH38
DR   DSHB; CPTC-ODC1-2
DR   Wikidata; Q93458107
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ODC1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11926; Human ODC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ODC1-3
AC   CVCL_YH39
DR   DSHB; CPTC-ODC1-3
DR   Wikidata; Q93458109
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ODC1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11926; Human ODC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-OGG1-1
AC   CVCL_YH40
DR   DSHB; CPTC-OGG1-1
DR   Wikidata; Q93458111
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-OGG1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O15527; Human OGG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-OTUB1-1
AC   CVCL_YH41
DR   DSHB; CPTC-OTUB1-1
DR   Wikidata; Q93458113
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-OTUB1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96FW1; Human OTUB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-OTUB1-2
AC   CVCL_YH42
DR   DSHB; CPTC-OTUB1-2
DR   Wikidata; Q93458115
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-OTUB1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96FW1; Human OTUB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-OTUB1-3
AC   CVCL_YH43
DR   DSHB; CPTC-OTUB1-3
DR   Wikidata; Q93458117
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-OTUB1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96FW1; Human OTUB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-OTUB2-1
AC   CVCL_YH44
DR   DSHB; CPTC-OTUB2-1
DR   Wikidata; Q93458119
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-OTUB2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96DC9; Human OTUB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-OTUB2-2
AC   CVCL_YH45
DR   DSHB; CPTC-OTUB2-2
DR   Wikidata; Q93458121
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-OTUB2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96DC9; Human OTUB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PALB2-1
AC   CVCL_C2NY
DR   DSHB; CPTC-PALB2-1
DR   Wikidata; Q114311158
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PALB2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q86YC2; Human PALB2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PCNA-1
AC   CVCL_C2NZ
DR   DSHB; CPTC-PCNA-1
DR   Wikidata; Q114311159
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PCNA-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P12004; Human PCNA.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PCNA-3
AC   CVCL_C2P0
DR   DSHB; CPTC-PCNA-3
DR   Wikidata; Q114311160
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PCNA-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P12004; Human PCNA.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PCNA-4
AC   CVCL_C2P1
DR   DSHB; CPTC-PCNA-4
DR   Wikidata; Q114311161
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PCNA-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P12004; Human PCNA.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PCNA-5
AC   CVCL_C2P2
DR   DSHB; CPTC-PCNA-5
DR   Wikidata; Q114311163
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PCNA-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P12004; Human PCNA.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PDCD1LG2-1
AC   CVCL_C2P3
DR   DSHB; CPTC-PDCD1LG2-1
DR   Wikidata; Q114311164
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PDCD1LG2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BQ51; Human PDCD1LG2/CD273.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PDLIM1-1
AC   CVCL_YH46
DR   DSHB; CPTC-PDLIM1-1
DR   Wikidata; Q93458123
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PDLIM1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00151; Human PDLIM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PDLIM1-2
AC   CVCL_YH47
DR   DSHB; CPTC-PDLIM1-2
DR   Wikidata; Q93458125
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PDLIM1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00151; Human PDLIM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PDLIM1-3
AC   CVCL_YH48
DR   DSHB; CPTC-PDLIM1-3
DR   Wikidata; Q93458127
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PDLIM1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00151; Human PDLIM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PEBP1-2
AC   CVCL_YH49
DR   DSHB; CPTC-PEBP1-2
DR   Wikidata; Q93458129
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PEBP1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P30086; Human PEBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PGR-1
AC   CVCL_C2P4
DR   DSHB; CPTC-PGR-1
DR   Wikidata; Q114311165
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PGR-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P06401; Human PGR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PGR-2
AC   CVCL_C2P5
DR   DSHB; CPTC-PGR-2
DR   Wikidata; Q114311166
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PGR-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P06401; Human PGR.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PLIN2-1
AC   CVCL_YH50
DR   DSHB; CPTC-PLIN2-1
DR   Wikidata; Q93458131
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PLIN2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99541; Human PLIN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PLIN2-2
AC   CVCL_YH51
DR   DSHB; CPTC-PLIN2-2
DR   Wikidata; Q93458133
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PLIN2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99541; Human PLIN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PLIN2-3
AC   CVCL_YH52
DR   DSHB; CPTC-PLIN2-3
DR   Wikidata; Q93458135
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PLIN2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99541; Human PLIN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PLIN4-1
AC   CVCL_C2P6
DR   DSHB; CPTC-PLIN4-1
DR   Wikidata; Q114311167
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PLIN4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q96Q06; Human PLIN4.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PLIN4-2
AC   CVCL_C2P7
DR   DSHB; CPTC-PLIN4-2
DR   Wikidata; Q114311168
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PLIN4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q96Q06; Human PLIN4.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PNMT-1
AC   CVCL_YH53
DR   DSHB; CPTC-PNMT-1
DR   Wikidata; Q93458137
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PNMT-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11086; Human PNMT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PNMT-2
AC   CVCL_YH54
DR   DSHB; CPTC-PNMT-2
DR   Wikidata; Q93458140
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PNMT-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11086; Human PNMT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PNMT-3
AC   CVCL_YH55
DR   DSHB; CPTC-PNMT-3
DR   Wikidata; Q93458142
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PNMT-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11086; Human PNMT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PP2A-1
AC   CVCL_YH56
DR   DSHB; CPTC-PP2A-1
DR   Wikidata; Q93458144
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PP2A-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15257; Human PTPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PP2A-2
AC   CVCL_YH57
DR   DSHB; CPTC-PP2A-2
DR   Wikidata; Q93458146
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PP2A-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15257; Human PTPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PP2A-3
AC   CVCL_YH58
DR   DSHB; CPTC-PP2A-3
DR   Wikidata; Q93458147
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PP2A-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15257; Human PTPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PP2A-4
AC   CVCL_YH59
DR   DSHB; CPTC-PP2A-4
DR   Wikidata; Q93458149
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PP2A-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15257; Human PTPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PRDX2-1
AC   CVCL_C2P8
DR   DSHB; CPTC-PRDX2-1
DR   Wikidata; Q114311169
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PRDX2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P32119; Human PRDX2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PRDX2-2
AC   CVCL_C2P9
DR   DSHB; CPTC-PRDX2-2
DR   Wikidata; Q114311172
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PRDX2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P32119; Human PRDX2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PRDX4-1
AC   CVCL_YH60
DR   DSHB; CPTC-PRDX4-1
DR   Wikidata; Q93458151
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PRDX4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13162; Human PRDX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PRDX4-2
AC   CVCL_YH61
DR   DSHB; CPTC-PRDX4-2
DR   Wikidata; Q93458153
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PRDX4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13162; Human PRDX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PRDX4-3
AC   CVCL_YH62
DR   DSHB; CPTC-PRDX4-3
DR   Wikidata; Q93458155
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PRDX4-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13162; Human PRDX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PRDX4-5
AC   CVCL_C2PA
DR   DSHB; CPTC-PRDX4-5
DR   Wikidata; Q114311173
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PRDX4-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q13162; Human PRDX4.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PROM1-1
AC   CVCL_C2PB
DR   DSHB; CPTC-PROM1-1
DR   Wikidata; Q114311176
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PROM1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43490; Human PROM1/CD133.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSAT1-1
AC   CVCL_YH63
DR   DSHB; CPTC-PSAT1-1
DR   Wikidata; Q93458157
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSAT1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y617; Human PSAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSAT1-2
AC   CVCL_YH64
DR   DSHB; CPTC-PSAT1-2
DR   Wikidata; Q93458160
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSAT1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y617; Human PSAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSAT1-3
AC   CVCL_YH65
DR   DSHB; CPTC-PSAT1-3
DR   Wikidata; Q93458162
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSAT1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y617; Human PSAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSAT1-4
AC   CVCL_YH66
DR   DSHB; CPTC-PSAT1-4
DR   Wikidata; Q93458164
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSAT1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y617; Human PSAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSMA1-1
AC   CVCL_C2PC
DR   DSHB; CPTC-PSMA1-1
DR   Wikidata; Q114311179
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSMA1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P25786; Human PSMA1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSMD4-1
AC   CVCL_YH67
DR   DSHB; CPTC-PSMD4-1
DR   Wikidata; Q93458167
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSMD4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55036; Human PSMD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSMD4-2
AC   CVCL_YH68
DR   DSHB; CPTC-PSMD4-2
DR   Wikidata; Q93458169
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSMD4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P55036; Human PSMD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSMD4-3
AC   CVCL_YH69
DR   DSHB; CPTC-PSMD4-3
DR   Wikidata; Q93458171
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSMD4-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55036; Human PSMD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSPHL-1
AC   CVCL_YH70
DR   DSHB; CPTC-PSPHL-1
DR   Wikidata; Q93458173
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSPHL-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15172; Human PSPHP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSPHL-2
AC   CVCL_YH71
DR   DSHB; CPTC-PSPHL-2
DR   Wikidata; Q93458175
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSPHL-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15172; Human PSPHP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PSPHL-3
AC   CVCL_YH72
DR   DSHB; CPTC-PSPHL-3
DR   Wikidata; Q93458178
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PSPHL-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15172; Human PSPHP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-1
AC   CVCL_YH73
DR   DSHB; CPTC-PTEN-1
DR   Wikidata; Q93458180
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-2
AC   CVCL_YH74
DR   DSHB; CPTC-PTEN-2
DR   Wikidata; Q93458182
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-3
AC   CVCL_YH75
DR   DSHB; CPTC-PTEN-3
DR   Wikidata; Q93458184
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-4
AC   CVCL_YH76
DR   DSHB; CPTC-PTEN-4
DR   Wikidata; Q93458186
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-5
AC   CVCL_YH77
DR   DSHB; CPTC-PTEN-5
DR   Wikidata; Q93458188
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-6
AC   CVCL_YH78
DR   DSHB; CPTC-PTEN-6
DR   Wikidata; Q93458190
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-7
AC   CVCL_YH79
DR   DSHB; CPTC-PTEN-7
DR   Wikidata; Q93458192
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-7
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTEN-8
AC   CVCL_YH80
DR   DSHB; CPTC-PTEN-8
DR   Wikidata; Q93458194
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTEN-8
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P60484; Human PTEN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTGS2-1
AC   CVCL_C2PD
DR   DSHB; CPTC-PTGS2-1
DR   Wikidata; Q114311182
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTGS2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P35354; Human PTGS2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTHrP-1
AC   CVCL_YH81
DR   DSHB; CPTC-PTHrP-1
DR   Wikidata; Q93458196
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTHrP-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTHrP-2
AC   CVCL_YH82
DR   DSHB; CPTC-PTHrP-2
DR   Wikidata; Q93458199
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTHrP-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12272; Human PTHLH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTPN6-1
AC   CVCL_YH83
DR   DSHB; CPTC-PTPN6-1
DR   Wikidata; Q93458201
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTPN6-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P29350; Human PTPN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTPN6-2
AC   CVCL_YH84
DR   DSHB; CPTC-PTPN6-2
DR   Wikidata; Q93458203
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTPN6-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P29350; Human PTPN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTPN6-3
AC   CVCL_YH85
DR   DSHB; CPTC-PTPN6-3
DR   Wikidata; Q93458205
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTPN6-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P29350; Human PTPN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTPRC-1
AC   CVCL_C2PE
DR   DSHB; CPTC-PTPRC-1
DR   Wikidata; Q114311185
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTPRC-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-PTPRC-2
AC   CVCL_C2PF
DR   DSHB; CPTC-PTPRC-2
DR   Wikidata; Q114311189
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-PTPRC-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAC1-1
AC   CVCL_YH86
DR   DSHB; CPTC-RAC1-1
DR   Wikidata; Q93458207
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAC1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P63000; Human RAC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAC1-2
AC   CVCL_YH87
DR   DSHB; CPTC-RAC1-2
DR   Wikidata; Q93458209
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAC1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P63000; Human RAC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD18-1
AC   CVCL_YH88
DR   DSHB; CPTC-RAD18-1
DR   Wikidata; Q93458211
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD18-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NS91; Human RAD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD18-2
AC   CVCL_YH89
DR   DSHB; CPTC-RAD18-2
DR   Wikidata; Q93458213
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD18-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NS91; Human RAD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD18-4
AC   CVCL_C2LJ
DR   DSHB; CPTC-RAD18-4
DR   Wikidata; Q114311193
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD18-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9NS91; Human RAD18.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD18-5
AC   CVCL_C2LK
DR   DSHB; CPTC-RAD18-5
DR   Wikidata; Q114311196
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD18-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9NS91; Human RAD18.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD23B-1
AC   CVCL_C2PG
DR   DSHB; CPTC-RAD23B-1
DR   Wikidata; Q114311198
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD23B-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P54727; Human RAD23B.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD23B-2
AC   CVCL_C2PH
DR   DSHB; CPTC-RAD23B-2
DR   Wikidata; Q114311201
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD23B-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P54727; Human RAD23B.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD50-1
AC   CVCL_C2PI
DR   DSHB; CPTC-RAD50-1
DR   Wikidata; Q114311204
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD50-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q92878; Human RAD50.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD50-2
AC   CVCL_C2PJ
DR   DSHB; CPTC-RAD50-2
DR   Wikidata; Q114311207
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD50-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q92878; Human RAD50.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD51C-1
AC   CVCL_C2PK
DR   DSHB; CPTC-RAD51C-1
DR   Wikidata; Q114311209
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD51C-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43502; Human RAD51C.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD51C-2
AC   CVCL_C2PL
DR   DSHB; CPTC-RAD51C-2
DR   Wikidata; Q114311210
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD51C-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43502; Human RAD51C.
CC   Discontinued: DSHB; CPTC-RAD51C-2; true.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   CPTC-RAD52-1
AC   CVCL_YH90
DR   DSHB; CPTC-RAD52-1
DR   Wikidata; Q93458215
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD52-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P43351; Human RAD52.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD52-2
AC   CVCL_YH91
DR   DSHB; CPTC-RAD52-2
DR   Wikidata; Q93458217
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD52-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P43351; Human RAD52.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAD52-3
AC   CVCL_YH92
DR   DSHB; CPTC-RAD52-3
DR   Wikidata; Q93458219
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAD52-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P43351; Human RAD52.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAF1-1
AC   CVCL_C2KS
DR   DSHB; CPTC-RAF1-1
DR   Wikidata; Q114311211
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAF1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P04049; Human RAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAF1-2
AC   CVCL_C2KT
DR   DSHB; CPTC-RAF1-2
DR   Wikidata; Q114311212
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAF1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P04049; Human RAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAF1-3
AC   CVCL_C2KU
DR   DSHB; CPTC-RAF1-3
DR   Wikidata; Q114311213
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAF1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04049; Human RAF1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAF1-4
AC   CVCL_C2KV
DR   DSHB; CPTC-RAF1-4
DR   Wikidata; Q114311214
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAF1-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04049; Human RAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAF1-5
AC   CVCL_C2KW
DR   DSHB; CPTC-RAF1-5
DR   Wikidata; Q114311215
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAF1-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04049; Human RAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RAF1-6
AC   CVCL_C2KX
DR   DSHB; CPTC-RAF1-6
DR   Wikidata; Q114311216
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RAF1-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04049; Human RAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RB1-1
AC   CVCL_YH93
DR   DSHB; CPTC-RB1-1
DR   Wikidata; Q93458221
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RB1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RB1-2
AC   CVCL_C2KZ
DR   DSHB; CPTC-RB1-2
DR   Wikidata; Q114311217
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RB1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RB1-3
AC   CVCL_C2L0
DR   DSHB; CPTC-RB1-3
DR   Wikidata; Q114311218
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RB1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RPTOR-1
AC   CVCL_YH94
DR   DSHB; CPTC-RPTOR-1
DR   Wikidata; Q93458223
RX   PubMed=31467290;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RPTOR-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8N122; Human RPTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RRM2-1
AC   CVCL_C2PM
DR   DSHB; CPTC-RRM2-1
DR   Wikidata; Q114311219
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RRM2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31350; Human RRM2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RRM2-2
AC   CVCL_C2PN
DR   DSHB; CPTC-RRM2-2
DR   Wikidata; Q114311220
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RRM2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31350; Human RRM2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-RTF1-2
AC   CVCL_C2PP
DR   DSHB; CPTC-RTF1-2
DR   Wikidata; Q114311221
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-RTF1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q92541; Human RTF1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-S100A2-1
AC   CVCL_YH95
DR   DSHB; CPTC-S100A2-1
DR   Wikidata; Q93458225
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-S100A2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P29034; Human S100A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-S100A2-2
AC   CVCL_YH96
DR   DSHB; CPTC-S100A2-2
DR   Wikidata; Q93458228
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-S100A2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P29034; Human S100A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-S100A2-3
AC   CVCL_YH97
DR   DSHB; CPTC-S100A2-3
DR   Wikidata; Q93458230
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-S100A2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P29034; Human S100A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-S100A4-1
AC   CVCL_YH98
DR   DSHB; CPTC-S100A4-1
DR   Wikidata; Q93458232
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-S100A4-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: UniProtKB; P26447; Human S100A4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-S100A4-2
AC   CVCL_YH99
DR   DSHB; CPTC-S100A4-2
DR   Wikidata; Q93458234
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-S100A4-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: UniProtKB; P26447; Human S100A4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-S100A4-3
AC   CVCL_YI00
DR   DSHB; CPTC-S100A4-3
DR   Wikidata; Q93458236
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-S100A4-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: UniProtKB; P26447; Human S100A4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SAAL1-1
AC   CVCL_C2PQ
DR   DSHB; CPTC-SAAL1-1
DR   Wikidata; Q114311222
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SAAL1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q96ER3; Human SAAL1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SAT1-1
AC   CVCL_YI01
DR   DSHB; CPTC-SAT1-1
DR   Wikidata; Q93458238
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SAT1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21673; Human SAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SAT1-2
AC   CVCL_YI02
DR   DSHB; CPTC-SAT1-2
DR   Wikidata; Q93458240
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SAT1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21673; Human SAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SAT1-3
AC   CVCL_YI03
DR   DSHB; CPTC-SAT1-3
DR   Wikidata; Q93458242
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SAT1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P21673; Human SAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SERPINA1-1
AC   CVCL_YI04
DR   DSHB; CPTC-SERPINA1-1
DR   Wikidata; Q93458244
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SERPINA1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01009; Human SERPINA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SERPINA6-1
AC   CVCL_C2PR
DR   DSHB; CPTC-SERPINA6-1
DR   Wikidata; Q114311223
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SERPINA6-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P08185; Human SERPINA6.
CC   Caution: Erroneously indicated as produced from myeloma cell line P3x63Ag8.653 in DSHB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SERPINB3-1
AC   CVCL_YI05
DR   DSHB; CPTC-SERPINB3-1
DR   Wikidata; Q93458246
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SERPINB3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29508; Human SERPINB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SERPINB3-2
AC   CVCL_YI06
DR   DSHB; CPTC-SERPINB3-2
DR   Wikidata; Q93458248
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SERPINB3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29508; Human SERPINB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SERPINB3-3
AC   CVCL_YI07
DR   DSHB; CPTC-SERPINB3-3
DR   Wikidata; Q93458249
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SERPINB3-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29508; Human SERPINB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SFN-1
AC   CVCL_YI08
DR   DSHB; CPTC-SFN-1
DR   Wikidata; Q93458250
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SFN-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31947; Human SFN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SFN-2
AC   CVCL_YI09
DR   DSHB; CPTC-SFN-2
DR   Wikidata; Q93458252
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SFN-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31947; Human SFN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SFN-3
AC   CVCL_YI10
DR   DSHB; CPTC-SFN-3
DR   Wikidata; Q93458253
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SFN-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31947; Human SFN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC27A3-1
AC   CVCL_C2PS
DR   DSHB; CPTC-SLC27A3-1
DR   Wikidata; Q114311224
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC27A3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5K4L6; Human SLC27A3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC27A3-2
AC   CVCL_C2PT
DR   DSHB; CPTC-SLC27A3-2
DR   Wikidata; Q114311225
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC27A3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5K4L6; Human SLC27A3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC27A3-3
AC   CVCL_C2PU
DR   DSHB; CPTC-SLC27A3-3
DR   Wikidata; Q114311226
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC27A3-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5K4L6; Human SLC27A3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC27A3-4
AC   CVCL_C2PV
DR   DSHB; CPTC-SLC27A3-4
DR   Wikidata; Q114311227
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC27A3-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5K4L6; Human SLC27A3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC31A1-1
AC   CVCL_YI11
DR   DSHB; CPTC-SLC31A1-1
DR   Wikidata; Q93458254
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC31A1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15431; Human SLC31A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC31A2-1
AC   CVCL_YI12
DR   DSHB; CPTC-SLC31A2-1
DR   Wikidata; Q93458255
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC31A2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15432; Human SLC31A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC31A2-2
AC   CVCL_C2LL
DR   DSHB; CPTC-SLC31A2-2
DR   Wikidata; Q114311228
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC31A2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15432; Human SLC31A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SLC31A2-3
AC   CVCL_YI13
DR   DSHB; CPTC-SLC31A2-3
DR   Wikidata; Q93458256
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SLC31A2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15432; Human SLC31A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SNAI1-1
AC   CVCL_C2PW
DR   DSHB; CPTC-SNAI1-1
DR   Wikidata; Q114311229
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SNAI1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95863; Human SNAI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SNAI2-1
AC   CVCL_C2PX
DR   DSHB; CPTC-SNAI2-1
DR   Wikidata; Q114311230
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SNAI2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43623; Human SNAI2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SNCG-1
AC   CVCL_YI14
DR   DSHB; CPTC-SNCG-1
DR   Wikidata; Q93458257
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SNCG-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O76070; Human SNCG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SNCG-2
AC   CVCL_YI15
DR   DSHB; CPTC-SNCG-2
DR   Wikidata; Q93458258
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SNCG-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O76070; Human SNCG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SNCG-3
AC   CVCL_C2LM
DR   DSHB; CPTC-SNCG-3
DR   Wikidata; Q114311231
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SNCG-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O76070; Human SNCG.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SOX9-1
AC   CVCL_C2PY
DR   DSHB; CPTC-SOX9-1
DR   Wikidata; Q114311232
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SOX9-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P48436; Human SOX9.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SOX9-2
AC   CVCL_C2PZ
DR   DSHB; CPTC-SOX9-2
DR   Wikidata; Q114311233
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SOX9-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P48436; Human SOX9.
CC   Discontinued: DSHB; CPTC-SOX9-2; true.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   CPTC-STAT1-1
AC   CVCL_C2Q0
DR   DSHB; CPTC-STAT1-1
DR   Wikidata; Q114311234
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-STAT1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P42224; Human STAT1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SULT1E1-1
AC   CVCL_YI16
DR   DSHB; CPTC-SULT1E1-1
DR   Wikidata; Q93458259
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SULT1E1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P49888; Human SULT1E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SULT1E1-2
AC   CVCL_YI17
DR   DSHB; CPTC-SULT1E1-2
DR   Wikidata; Q93458260
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SULT1E1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49888; Human SULT1E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SULT1E1-3
AC   CVCL_YI18
DR   DSHB; CPTC-SULT1E1-3
DR   Wikidata; Q93458261
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SULT1E1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49888; Human SULT1E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SVIL-1
AC   CVCL_C2LN
SY   1E2
DR   ABCD; ABCD_AJ230
DR   DSHB; CPTC-SVIL-1
DR   Wikidata; Q114311235
RX   PubMed=30332471;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SVIL-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O95425; Human SVIL.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SVIL-2
AC   CVCL_C2LP
SY   4A8
DR   ABCD; ABCD_AJ233
DR   DSHB; CPTC-SVIL-2
DR   Wikidata; Q114311236
RX   PubMed=30332471;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SVIL-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O95425; Human SVIL.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SVIL-3
AC   CVCL_YI19
SY   5A8
DR   DSHB; CPTC-SVIL-3
DR   Wikidata; Q93458262
RX   PubMed=30332471;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SVIL-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O95425; Human SVIL.
CC   Caution: Indicated as producing an IgG2a mAb in PubMed=30332471 and an IgG2c mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-SVIL-4
AC   CVCL_YI20
SY   5G3
DR   DSHB; CPTC-SVIL-4
DR   Wikidata; Q93458263
RX   PubMed=30332471;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-SVIL-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95425; Human SVIL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TACSTD2-1
AC   CVCL_YI21
DR   DSHB; CPTC-TACSTD2-1
DR   Wikidata; Q93458264
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TACSTD2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TACSTD2-2
AC   CVCL_YI22
DR   DSHB; CPTC-TACSTD2-2
DR   Wikidata; Q93458265
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TACSTD2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TACSTD2-3
AC   CVCL_YI23
DR   DSHB; CPTC-TACSTD2-3
DR   Wikidata; Q93458266
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TACSTD2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TAGLN-1
AC   CVCL_C2Q1
DR   DSHB; CPTC-TAGLN-1
DR   Wikidata; Q114311237
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TAGLN-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q01995; Human TAGLN.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TAPBP-1
AC   CVCL_YI24
DR   DSHB; CPTC-TAPBP-1
DR   Wikidata; Q93458267
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TAPBP-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: UniProtKB; O15533; Human TAPBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TAPBP-2
AC   CVCL_YI25
DR   DSHB; CPTC-TAPBP-2
DR   Wikidata; Q93458268
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TAPBP-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: UniProtKB; O15533; Human TAPBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TDP2-1
AC   CVCL_YI26
DR   DSHB; CPTC-TDP2-1
DR   Wikidata; Q93458269
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TDP2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95551; Human TDP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TDP2-2
AC   CVCL_YI27
DR   DSHB; CPTC-TDP2-2
DR   Wikidata; Q93458270
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TDP2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95551; Human TDP2.
CC   Discontinued: DSHB; CPTC-TDP2-2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-TDP2-3
AC   CVCL_YI28
DR   DSHB; CPTC-TDP2-3
DR   Wikidata; Q93458271
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TDP2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95551; Human TDP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TERF2-1
AC   CVCL_YI29
DR   DSHB; CPTC-TERF2-1
DR   Wikidata; Q93458272
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TERF2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15554; Human TERF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TERF2-2
AC   CVCL_C2LQ
DR   DSHB; CPTC-TERF2-2
DR   Wikidata; Q114311238
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TERF2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15554; Human TERF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TERF2-3
AC   CVCL_C2LR
DR   DSHB; CPTC-TERF2-3
DR   Wikidata; Q114311239
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TERF2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q15554; Human TERF2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TNFRSF17-1
AC   CVCL_C2Q2
DR   DSHB; CPTC-TNFRSF17-1
DR   Wikidata; Q114311240
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNFRSF17-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q02223; Human TNFRSF17/CD269.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TNFRSF9-1
AC   CVCL_YI30
DR   DSHB; CPTC-TNFRSF9-1
DR   Wikidata; Q93458273
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNFRSF9-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q07011; Human TNFRSF9/CD137.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TNFRSF9-2
AC   CVCL_YI31
DR   DSHB; CPTC-TNFRSF9-2
DR   Wikidata; Q93458276
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNFRSF9-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q07011; Human TNFRSF9/CD137.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TNFRSF9-3
AC   CVCL_YI32
DR   DSHB; CPTC-TNFRSF9-3
DR   Wikidata; Q93458277
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNFRSF9-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q07011; Human TNFRSF9/CD137.
CC   Discontinued: DSHB; CPTC-TNFRSF9-3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   CPTC-TNFRSF9-4
AC   CVCL_F0G4
DR   DSHB; CPTC-TNFRSF9-4
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNFRSF9-4
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q07011; Human TNFRSF9/CD137.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPTC-TNFRSF9-5
AC   CVCL_F0G2
DR   DSHB; CPTC-TNFRSF9-5
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNFRSF9-5
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q07011; Human TNFRSF9/CD137.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPTC-TNFRSF9-6
AC   CVCL_F0G3
DR   DSHB; CPTC-TNFRSF9-6
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNFRSF9-6
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q07011; Human TNFRSF9/CD137.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CPTC-TNK2-3
AC   CVCL_C2Q3
DR   DSHB; CPTC-TNK2-3
DR   Wikidata; Q114311241
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TNK2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q07912; Human TNK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TOP1-1
AC   CVCL_YI33
DR   DSHB; CPTC-TOP1-1
DR   Wikidata; Q93458278
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TOP1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11387; Human TOP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TOP1-2
AC   CVCL_YI34
DR   DSHB; CPTC-TOP1-2
DR   Wikidata; Q93458279
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TOP1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11387; Human TOP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TOP1MT-1
AC   CVCL_YI35
DR   DSHB; CPTC-TOP1-MT-1
DR   Wikidata; Q93458280
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TOP1MT-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q969P6; Human TOP1MT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TOP1MT-2
AC   CVCL_YI36
DR   DSHB; CPTC-TOP1-MT-2
DR   Wikidata; Q93458281
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TOP1MT-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q969P6; Human TOP1MT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TOP1MT-3
AC   CVCL_YI37
DR   DSHB; CPTC-TOP1-MT-3
DR   Wikidata; Q93458282
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TOP1MT-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q969P6; Human TOP1MT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TP53-1
AC   CVCL_C2Q4
DR   DSHB; CPTC-TP53-1
DR   Wikidata; Q114311243
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TP53-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TP53-2
AC   CVCL_C2Q5
DR   DSHB; CPTC-TP53-2
DR   Wikidata; Q114311244
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TP53-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TRAF3-1
AC   CVCL_C2Q6
DR   DSHB; CPTC-TRAF3-1
DR   Wikidata; Q114311245
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TRAF3-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13114; Human TRAF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TRAF3-2
AC   CVCL_C2Q7
DR   DSHB; CPTC-TRAF3-2
DR   Wikidata; Q114311246
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TRAF3-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13114; Human TRAF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TRAF3-3
AC   CVCL_C2Q8
DR   DSHB; CPTC-TRAF3-3
DR   Wikidata; Q114311247
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TRAF3-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13114; Human TRAF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TSHB-1
AC   CVCL_C2Q9
DR   DSHB; CPTC-TSHB-1
DR   Wikidata; Q114311248
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TSHB-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TSHB-2
AC   CVCL_C2QA
DR   DSHB; CPTC-TSHB-2
DR   Wikidata; Q114311249
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TSHB-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TTR-1
AC   CVCL_YI38
DR   DSHB; CPTC-TTR-1
DR   Wikidata; Q93458283
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TTR-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02766; Human TTR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-TUBB-1
AC   CVCL_C2QB
DR   DSHB; CPTC-TUBB-1
DR   Wikidata; Q114311250
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-TUBB-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P07437; Human TUBB.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBA1-2
AC   CVCL_YI42
DR   DSHB; CPTC-UBA1-2
DR   Wikidata; Q93458287
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBA1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P22314; Human UBA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBA1-3
AC   CVCL_YI43
DR   DSHB; CPTC-UBA1-3
DR   Wikidata; Q93458288
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBA1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22314; Human UBA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2C-1
AC   CVCL_YI44
DR   DSHB; CPTC-UBE2C-1
DR   Wikidata; Q93458289
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2C-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O00762; Human UBE2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2C-2
AC   CVCL_C2LS
DR   DSHB; CPTC-UBE2C-2
DR   Wikidata; Q114311251
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2C-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O00762; Human UBE2C.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2C-3
AC   CVCL_C2LT
DR   DSHB; CPTC-UBE2C-3
DR   Wikidata; Q114311252
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2C-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O00762; Human UBE2C.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2E1-1
AC   CVCL_YI45
DR   DSHB; CPTC-UBE2E1-1
DR   Wikidata; Q93458290
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2E1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51965; Human UBE2E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2E1-2
AC   CVCL_YI46
DR   DSHB; CPTC-UBE2E1-2
DR   Wikidata; Q93458291
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2E1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51965; Human UBE2E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2E1-3
AC   CVCL_YI47
DR   DSHB; CPTC-UBE2E1-3
DR   Wikidata; Q93458292
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2E1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51965; Human UBE2E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2E2-1
AC   CVCL_YI48
DR   DSHB; CPTC-UBE2E2-1
DR   Wikidata; Q93458293
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2E2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96LR5; Human UBE2E2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2E2-2
AC   CVCL_YI49
DR   DSHB; CPTC-UBE2E2-2
DR   Wikidata; Q93458294
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2E2-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96LR5; Human UBE2E2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2E2-3
AC   CVCL_YI50
DR   DSHB; CPTC-UBE2E2-3
DR   Wikidata; Q93458295
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2E2-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96LR5; Human UBE2E2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2I-1
AC   CVCL_C2QC
DR   DSHB; CPTC-UBE2I-1
DR   Wikidata; Q114311253
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2I-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P63279; Human UBE2I.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2J1-1
AC   CVCL_YI51
DR   DSHB; CPTC-UBE2J1-1
DR   Wikidata; Q93458296
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2J1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y385; Human UBE2J1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2J1-2
AC   CVCL_YI52
DR   DSHB; CPTC-UBE2J1-2
DR   Wikidata; Q93458297
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2J1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y385; Human UBE2J1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2J1-3
AC   CVCL_YI53
DR   DSHB; CPTC-UBE2J1-3
DR   Wikidata; Q93458298
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2J1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y385; Human UBE2J1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-UBE2L6-1
AC   CVCL_YI39
SY   CPTC-UB2L6-1
DR   DSHB; CPTC-UBE2L6-1
DR   Wikidata; Q93458284
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2L6-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14933; Human UBE2L6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-UBE2L6-2
AC   CVCL_YI40
SY   CPTC-UB2L6-2
DR   DSHB; CPTC-UBE2L6-2
DR   Wikidata; Q93458285
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2L6-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14933; Human UBE2L6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-UBE2L6-3
AC   CVCL_YI41
SY   CPTC-UB2L6-3
DR   DSHB; CPTC-UBE2L6-3
DR   Wikidata; Q93458286
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2L6-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14933; Human UBE2L6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-UBE2T-1
AC   CVCL_C2QD
DR   DSHB; CPTC-UBE2T-1
DR   Wikidata; Q114311255
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-UBE2T-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9NPD8; Human UBE2T.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-VCAM1-1
AC   CVCL_C2QE
DR   DSHB; CPTC-VCAM1-1
DR   Wikidata; Q114311256
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-VCAM1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P19320; Human VCAM1/CD106.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-XMRV P12-1
AC   CVCL_YI54
DR   DSHB; CPTC-XMRV-P12-1
DR   Wikidata; Q93458299
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-XMRV+P12-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2F7J3; Xenotropic MuLV-related virus GAG-POL (Note=AA 130-213 = RNA-binding phosphoprotein p12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-XMRV P12-2
AC   CVCL_YI55
DR   DSHB; CPTC-XMRV-P12-2
DR   Wikidata; Q93458300
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-XMRV+P12-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q2F7J3; Xenotropic MuLV-related virus GAG-POL (Note=AA 130-213 = RNA-binding phosphoprotein p12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-XMRV P12-3
AC   CVCL_YI56
DR   DSHB; CPTC-XMRV-P12-3
DR   Wikidata; Q93458301
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-XMRV+P12-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2F7J3; Xenotropic MuLV-related virus GAG-POL (Note=AA 130-213 = RNA-binding phosphoprotein p12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CPTC-XPNPEP1-1
AC   CVCL_C2QF
DR   DSHB; CPTC-XPNPEP1-1
DR   Wikidata; Q114311257
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-XPNPEP1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9NQW7; Human XPNPEP1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-XPNPEP1-2
AC   CVCL_C2QG
DR   DSHB; CPTC-XPNPEP1-2
DR   Wikidata; Q114311258
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-XPNPEP1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9NQW7; Human XPNPEP1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-YWHAB-1
AC   CVCL_YI57
DR   DSHB; CPTC-YWHAB-1
DR   Wikidata; Q93458302
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-YWHAB-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P31946; Human YWHAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-YWHAB-2
AC   CVCL_YI58
DR   DSHB; CPTC-YWHAB-2
DR   Wikidata; Q93458303
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-YWHAB-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31946; Human YWHAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-YWHAB-3
AC   CVCL_YI59
DR   DSHB; CPTC-YWHAB-3
DR   Wikidata; Q93458304
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-YWHAB-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P31946; Human YWHAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-YWHAE-1
AC   CVCL_YI60
DR   DSHB; CPTC-YWHAE-1
DR   Wikidata; Q93458305
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-YWHAE-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P62258; Human YWHAE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-YWHAE-2
AC   CVCL_YI61
DR   DSHB; CPTC-YWHAE-2
DR   Wikidata; Q93458306
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-YWHAE-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P62258; Human YWHAE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-YWHAE-3
AC   CVCL_YI62
DR   DSHB; CPTC-YWHAE-3
DR   Wikidata; Q93458307
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-YWHAE-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P62258; Human YWHAE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ZEB1-1
AC   CVCL_C2QH
DR   DSHB; CPTC-ZEB1-1
DR   Wikidata; Q114311260
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZEB1-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P37275; Human ZEB1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ZEB1-2
AC   CVCL_C2QI
DR   DSHB; CPTC-ZEB1-2
DR   Wikidata; Q114311262
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZEB1-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P37275; Human ZEB1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ZEB1-3
AC   CVCL_C2ME
DR   DSHB; CPTC-ZEB1-3
DR   Wikidata; Q114311263
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZEB1-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P37275; Human ZEB1.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ZEB2-1
AC   CVCL_C2MF
DR   DSHB; CPTC-ZEB2-1
DR   Wikidata; Q114311264
RX   PubMed=29928062;
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZEB2-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O60315; Human ZEB2.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z069 ! 240E-W2
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ZFAND6-1
AC   CVCL_YI63
DR   DSHB; CPTC-ZFAND6-1
DR   Wikidata; Q93458308
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZFAND6-1
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6FIF0; Human ZFAND6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ZFAND6-2
AC   CVCL_YI64
DR   DSHB; CPTC-ZFAND6-2
DR   Wikidata; Q93458309
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZFAND6-2
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q6FIF0; Human ZFAND6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CPTC-ZFAND6-3
AC   CVCL_YI65
DR   DSHB; CPTC-ZFAND6-3
DR   Wikidata; Q93458310
WW   Info; NCI; -; https://antibodies.cancer.gov/detail/CPTC-ZFAND6-3
CC   Part of: NCI Clinical Proteomics Technologies for Cancer (CPTC) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q6FIF0; Human ZFAND6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   CQ.C11
AC   CVCL_XH92
DR   Wikidata; Q93458311
RX   Patent=US6770745;
RX   PubMed=9759867;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12105.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31785; Human IL2RG/CD132.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   Cq4
AC   CVCL_D5YK
SY   MAbCq4
DR   DSHB; Cq4
DR   Wikidata; Q127380646
RX   PubMed=8365569;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10040; Drosophila melanogaster crb (Note=Also reacts with D.virilis).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CQ4-iPSC clone 14
AC   CVCL_QY04
SY   iPSC-CoQ4mut-clone 14; CQ4-C14
DR   Wikidata; Q54814410
RX   PubMed=28465093;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito-iPSC-CoQ4mut-clone-14.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO-Deposito-iPSC-CoQ4mut-clone-14.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:19693; COQ4; Simple; p.Glu161Asp (c.483G>C); ClinVar=VCV000380493; Zygosity=Heterozygous (PubMed=28465093).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28465093
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D19S433: 15.2,16
ST   D21S11: 26,28
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C142083; Coenzyme Q10 deficiency
DI   ORDO; Orphanet_457185; Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM97 ! CQ4-iPSC clone 34
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   CQ4-iPSC clone 34
AC   CVCL_UM97
SY   iPSC-CoQ4mut-clone 34; CQ4-C34
DR   Wikidata; Q93458312
RX   PubMed=28465093;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito-iPSC-CoQ4mut-clone-34.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO-Deposito-iPSC-CoQ4mut-clone-34.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:19693; COQ4; Simple; p.Glu161Asp (c.483G>C); ClinVar=VCV000380493; Zygosity=Heterozygous (PubMed=28465093).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28465093
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D19S433: 15.2,16
ST   D21S11: 26,28
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C142083; Coenzyme Q10 deficiency
DI   ORDO; Orphanet_457185; Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY04 ! CQ4-iPSC clone 14
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   CQ4ed-iPSC
AC   CVCL_A8HP
SY   iPSC-CoQ4mut-genetically corrected
DR   Wikidata; Q107114712
RX   PubMed=28465093;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Dep%C3%B3sito+de+iPSC+COQ4+corrected.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo%2520iPSC%2520COQ4%2520corrected.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:19693; COQ4; Simple_corrected; p.Glu161Asp (c.483G>C); ClinVar=VCV000380493; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28465093).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142083; Coenzyme Q10 deficiency
DI   ORDO; Orphanet_457185; Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QY04 ! CQ4-iPSC clone 14
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CQ8-A2D9
AC   CVCL_B3RK
DR   CCRID; 4201PAT-CCTCC01093
DR   Wikidata; Q110432747
RX   Patent=WO2019047921A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017108.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P30556; Human AGTR1 (Note=Immunized with the peptide 181-AFHYESQ-187 and recognizes it).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 5
//
ID   CR-30609
AC   CVCL_F550
SY   Extract 325
DR   IPD-IMGT/HLA; 11823
DR   Wikidata; Q54814411
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:01,68:02; B*51:01,58:02; C*06:02,16:01; DPA1*02:01,02:02; DPB1*01:01,11:01/74:01; DQA1*01,03; DQB1*02:02,05:01; DRB1*11:01,13:02; DRB3*02,03 (IPD-IMGT/HLA=11823).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   CR-M2
AC   CVCL_C3BX
DR   Wikidata; Q114311265
RX   PubMed=6412453;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3246; Mycosis fungoides
DI   ORDO; Orphanet_2584; Classic mycosis fungoides
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7GH ! CTCL-3
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CR-Mel
AC   CVCL_7038
SY   CRMel
DR   cancercelllines; CVCL_7038
DR   Cosmic; 1109805
DR   Cosmic; 1295333
DR   GEO; GSM276730
DR   Wikidata; Q54814412
RX   PubMed=11851879;
RX   PubMed=18384130;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Microsatellite instability: Stable (MSS) (PubMed=11851879).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   cR-NCRM2
AC   CVCL_C0VZ
SY   chemically Reset-NCRM2
DR   Wikidata; Q114311266
RX   PubMed=28765214;
CC   Characteristics: Epigenetically reset using a t2iLGo naive cell maintenance medium (PubMed=28765214).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E72 ! NCRM-2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CR0001
AC   CVCL_8U08
DR   ECACC; 93072808
DR   Wikidata; Q54814413
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93072808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   CR0002
AC   CVCL_8U09
DR   ECACC; 93072809
DR   Wikidata; Q54814414
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93072809; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0003
AC   CVCL_8U10
DR   ECACC; 93072810
DR   Wikidata; Q54814415
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93072810; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0004
AC   CVCL_8U11
DR   ECACC; 93092110
DR   Wikidata; Q54814416
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93092110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0005
AC   CVCL_8U12
DR   ECACC; 93092111
DR   Wikidata; Q54814417
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93092111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0006
AC   CVCL_8U13
DR   ECACC; 93092112
DR   Wikidata; Q54814418
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93092112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0007
AC   CVCL_8U14
DR   ECACC; 93092302
DR   Wikidata; Q54814419
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   CR0009
AC   CVCL_8U15
DR   ECACC; 93101209
DR   Wikidata; Q54814420
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0010
AC   CVCL_8U16
DR   ECACC; 93101210
DR   Wikidata; Q54814421
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0011
AC   CVCL_8U17
DR   ECACC; 93101211
DR   Wikidata; Q54814422
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR0012
AC   CVCL_8U18
DR   ECACC; 93103006
DR   Wikidata; Q54814423
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93103006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   CR1
AC   CVCL_C809
DR   Wikidata; Q54814424
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: University of Texas Health Science Center at Houston; Houston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   CR1-002
AC   CVCL_E7DC
SY   AbCR1
RX   PubMed=28430079;
RX   PubMed=28430080;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q0QLG2; Guinea pig Cxcr1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CR2-004
AC   CVCL_E7DD
SY   AbCR2
RX   PubMed=28430079;
RX   PubMed=28430080;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q810T4; Guinea pig Cxcr2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Cr24.1
AC   CVCL_A0AJ
SY   CR24.1
DR   Wikidata; Q108820083
RX   PubMed=15811952;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O95727; Human CRTAM/CD355.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   CR24.2.8
AC   CVCL_A0AK
DR   BEI_Resources; ARP-12850
DR   Wikidata; Q108820084
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O95727; Human CRTAM/CD355.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0AJ ! Cr24.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   CR2
AC   CVCL_C810
DR   Wikidata; Q54814425
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: University of Texas Health Science Center at Houston; Houston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   CR4 [Human colon carcinoma]
AC   CVCL_X142
DR   cancercelllines; CVCL_X142
DR   Millipore; SCC107
DR   Wikidata; Q54814426
RX   PubMed=24921652;
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (Millipore=SCC107).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Millipore=SCC107
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 19
ST   D21S11: 28,32.2
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 8,11
ST   Penta E: 13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   CR4 [Human ESC]
AC   CVCL_E083
SY   CR-4
DR   NIHhESC; NIHhESC-13-0210
DR   Wikidata; Q54814427
RX   PubMed=28395800;
CC   From: University of Texas Health Science Center at Houston; Houston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0210.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   CR4E8E10E10
AC   CVCL_B0JJ
DR   Wikidata; Q108820085
RX   Patent=US5434076;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10304.
CC   Monoclonal antibody isotype: IgM.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   CRAM-13H33
AC   CVCL_LC59
SY   13H33; H33
DR   Wikidata; Q54814428
RX   Patent=US7790863;
RX   PubMed=11053409;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2622.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9D8B7; Mouse Jam3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   CRAM-18F26
AC   CVCL_LC61
SY   18F26; F26
DR   Wikidata; Q54814429
RX   PubMed=11053409;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9D8B7; Mouse Jam3 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   CRAM-19H36
AC   CVCL_LC60
SY   19H36; H36
DR   Wikidata; Q54814430
RX   PubMed=11053409;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9D8B7; Mouse Jam3 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   CRB
AC   CVCL_E535
DR   dbMHC; 48734
DR   ECACC; 94022526
DR   IHW; IHW09234
DR   IPD-IMGT/HLA; 10432
DR   Wikidata; Q54814431
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African.
CC   HLA typing: A*66:02,30:02:01; B*18:01,58:01; C*07:01; DPB1*01:01:02,02:01:02 (IPD-IMGT/HLA=10432).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 16
//
ID   CRBL
AC   CVCL_E6DZ
DR   ABM; T0759
RX   PubMed=18395703;
CC   Characteristics: Expresses both neuronal and glial cell markers as well as a considerable level of cellular prion protein (PRNP). Susceptible to infections by strain SMB prions (PubMed=18395703).
CC   Doubling time: 15.6 +- 2.5 hours (Note=At 10th passage in 10% FBS), 11.6 hours (Note=At 60th passage in 10% FBS), 10.6 +- 0.7 hours (Note=At 80th passage in 10% FBS), 23.5 hours (Note=At 10th passage in 2.5% FBS) (PubMed=18395703).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CRBM-1990
AC   CVCL_6893
SY   CRBM 1990
DR   BTO; BTO_0003847
DR   Wikidata; Q54814432
RX   PubMed=15274344;
RX   PubMed=27993170;
CC   Derived from site: Metastatic; Bone, thoracic vertebra; UBERON=UBERON_0002347.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   CrCB
AC   CVCL_XX39
SY   Crucian Carp Brain
DR   Wikidata; Q93458357
RX   PubMed=31471871;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=31471871).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=217509; ! Carassius carassius (Crucian carp)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   CRCBT-02-001
AC   CVCL_C5R4
SY   P1G5-P2B3
DR   ABCD; ABCD_AY728
DR   Wikidata; Q116048778
RX   Patent=US9605079;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10685.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6UXB8; Human PI16/CD364.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CRCBT-06-001
AC   CVCL_C5R5
DR   ABCD; ABCD_AY729
DR   Wikidata; Q116048779
RX   Patent=US10287359;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CRCBT-06-002
AC   CVCL_C5R6
DR   ABCD; ABCD_AY730
DR   Wikidata; Q116048781
RX   Patent=US10287359;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CRCBT-06-003
AC   CVCL_C5R7
DR   ABCD; ABCD_AY731
DR   Wikidata; Q116048782
RX   Patent=US10287359;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CRCBT-06-004
AC   CVCL_C5R8
DR   ABCD; ABCD_AY732
DR   Wikidata; Q116048783
RX   Patent=US10287359;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CRCBT-06-005
AC   CVCL_C5R9
DR   ABCD; ABCD_AY733
DR   Wikidata; Q116048784
RX   Patent=US10287359;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CRCBT-06-006
AC   CVCL_C5RA
DR   ABCD; ABCD_AY734
DR   Wikidata; Q116048785
RX   Patent=US10287359;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CRCBT-06-007
AC   CVCL_C5RB
DR   Wikidata; Q116048786
RX   Patent=US10287359;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP84; Human TNFRSF12A/CD266.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   CRE BAG 2
AC   CVCL_4149
SY   CRE BAG2; CREBAG2
DR   CLO; CLO_0002607
DR   CLO; CLO_0002608
DR   CLDB; cl906
DR   ATCC; CRL-1858
DR   ECACC; 95082219
DR   Wikidata; Q54814433
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4278 ! Psi-CRE
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   Cre4
AC   CVCL_ZB94
DR   Kerafast; ESA109
DR   Wikidata; Q98125688
RX   PubMed=23884459;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J x Lig3LoxP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   Cre4 rho-0#11
AC   CVCL_ZB95
DR   Kerafast; ESA108
DR   Wikidata; Q98125689
RX   PubMed=23884459;
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Produced by propagation for 3 weeks of the parent cell line in a medium containing 5 ug/ml EtBr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J x Lig3LoxP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZB94 ! Cre4
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   Cre4/2941#6
AC   CVCL_ZC14
DR   Kerafast; ESA110
DR   Wikidata; Q98125690
RX   PubMed=23884459;
CC   Characteristics: The deletion of Lig3 is accompanied by the loss of mitochondrial DNA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109152; Lig3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Tg(CAG-cre/Esr1)5Amc/J x Lig3LoxP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZB94 ! Cre4
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   CRE8
AC   CVCL_9V15
SY   Cre8; Cre-8
DR   NCBI_Iran; C539
DR   Wikidata; Q54814434
RX   PubMed=9032314;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   CrEK
AC   CVCL_B5DP
DR   Wikidata; Q110432748
RX   PubMed=34843633;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 28 Celsius (PubMed=34843633).
CC   Virology: Highly susceptible to infection by Chinese rice-field eels rhabdovirus (CrERV) (PubMed=34843633).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=43700; ! Monopterus albus (Swamp eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 6
//
ID   CREM001i-bBU1C2
AC   CVCL_JW24
SY   bBU1C2
DR   SKIP; SKIP003554
DR   WiCell; crem001i-bbu1c2
DR   Wikidata; Q54814435
RX   PubMed=31924806;
RX   PubMed=36332629;
WW   Provider; CReM; 504; https://stemcellbank.bu.edu/Catalog/Item/Details/504
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3BN ! BU1
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CREM002i-BU2C10
AC   CVCL_JW25
SY   BU2-15-Cre10; BU2-15-Cr10; BU2
DR   SKIP; SKIP003555
DR   WiCell; crem002i-bu2c10
DR   Wikidata; Q54814436
RX   PubMed=36332629;
WW   Provider; CReM; 506; https://stemcellbank.bu.edu/Catalog/Item/Details/506
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   CREM003i-BU3C2
AC   CVCL_JW26
SY   BU3-10-Cre02; BU3-10-Cr2; BU3
DR   SKIP; SKIP003556
DR   WiCell; crem003i-bu3c2
DR   Wikidata; Q54814437
RX   PubMed=39332406;
WW   Provider; CReM; 507; https://stemcellbank.bu.edu/Catalog/Item/Details/507
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2WD ! BU3-10-Cr1
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   CREM004i-SS2-1
AC   CVCL_JW27
SY   SS2-1; SS2
DR   SKIP; SKIP003063
DR   SKIP; SKIP003557
DR   WiCell; crem004i-ss2-1
DR   Wikidata; Q54814438
RX   PubMed=28111279;
WW   Provider; CReM; 598; https://stemcellbank.bu.edu/Catalog/Item/Details/598
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   CREM005i-SS2-1GAG
AC   CVCL_YY12
SY   SCD iPSC SS.2-1-GAG; SS2-1GAG
DR   SKIP; SKIP003064
DR   WiCell; crem005i-ss2-1gag
DR   Wikidata; Q98125692
RX   PubMed=28111279;
WW   Provider; CReM; 599; https://stemcellbank.bu.edu/Catalog/Item/Details/599
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple_corrected; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=28111279).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW27 ! CREM004i-SS2-1
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM006i-SS4-1
AC   CVCL_JW28
SY   SS4-1; SS4
DR   SKIP; SKIP003065
DR   SKIP; SKIP003558
DR   WiCell; crem006i-ss4-1
DR   Wikidata; Q54814439
RX   PubMed=28111279;
WW   Provider; CReM; 600; https://stemcellbank.bu.edu/Catalog/Item/Details/600
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem006i-ss4-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM007i-SS5-1
AC   CVCL_JW29
SY   SS5-1; SS5
DR   SKIP; SKIP003066
DR   SKIP; SKIP003559
DR   WiCell; crem007i-ss5-1
DR   Wikidata; Q54814440
RX   PubMed=28111279;
WW   Provider; CReM; 601; https://stemcellbank.bu.edu/Catalog/Item/Details/601
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem007i-ss5-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM008i-SS6-1
AC   CVCL_JW30
SY   SS6-1; SS6
DR   SKIP; SKIP003560
DR   WiCell; crem008i-ss6-1
DR   Wikidata; Q54814441
RX   PubMed=28111279;
WW   Provider; CReM; 602; https://stemcellbank.bu.edu/Catalog/Item/Details/602
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem008i-ss6-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM009i-SS8-2
AC   CVCL_JW31
SY   SS8-2; SS8
DR   SKIP; SKIP003067
DR   SKIP; SKIP003561
DR   WiCell; crem009i-ss8-2
DR   Wikidata; Q54814447
RX   PubMed=28111279;
WW   Provider; CReM; 603; https://stemcellbank.bu.edu/Catalog/Item/Details/603
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem009i-ss8-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM010i-SS9-1
AC   CVCL_JW32
SY   SS9-1; SS9
DR   SKIP; SKIP003068
DR   SKIP; SKIP003562
DR   WiCell; crem010i-ss9-1
DR   Wikidata; Q54814449
RX   PubMed=28111279;
WW   Provider; CReM; 604; https://stemcellbank.bu.edu/Catalog/Item/Details/604
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem010i-ss9-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM011i-SS12-1
AC   CVCL_YY11
SY   SS12-1; SS12
DR   SKIP; SKIP003069
DR   WiCell; crem011i-ss12-1
DR   Wikidata; Q98125693
RX   PubMed=28111279;
WW   Provider; CReM; 605; https://stemcellbank.bu.edu/Catalog/Item/Details/605
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem011i-ss12-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   CREM012i-SS13-1
AC   CVCL_JW33
SY   SS13-1; SS13
DR   SKIP; SKIP003070
DR   SKIP; SKIP003563
DR   WiCell; crem012i-ss13-1
DR   Wikidata; Q54814450
RX   PubMed=28111279;
WW   Provider; CReM; 606; https://stemcellbank.bu.edu/Catalog/Item/Details/606
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem012i-ss13-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM013i-SS14-1
AC   CVCL_JW34
SY   SS14-1; SS14
DR   SKIP; SKIP003071
DR   SKIP; SKIP003564
DR   WiCell; crem013i-ss14-1
DR   Wikidata; Q54814451
RX   PubMed=28111279;
WW   Provider; CReM; 607; https://stemcellbank.bu.edu/Catalog/Item/Details/607
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem013i-ss14-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM014i-SS15-1
AC   CVCL_JW35
SY   SS15-1; SS15
DR   SKIP; SKIP003072
DR   SKIP; SKIP003565
DR   WiCell; crem014i-ss15-1
DR   Wikidata; Q54814452
RX   PubMed=28111279;
WW   Provider; CReM; 608; https://stemcellbank.bu.edu/Catalog/Item/Details/608
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem014i-ss15-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM015i-SS16-1
AC   CVCL_JW36
SY   SS16-1; SS16
DR   SKIP; SKIP003073
DR   SKIP; SKIP003566
DR   WiCell; crem015i-ss16-1
DR   Wikidata; Q54814453
RX   PubMed=28111279;
WW   Provider; CReM; 609; https://stemcellbank.bu.edu/Catalog/Item/Details/609
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem015i-ss16-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM016i-SS18-1
AC   CVCL_JW37
SY   SS18-1; SS18
DR   SKIP; SKIP003074
DR   SKIP; SKIP003567
DR   WiCell; crem016i-ss18-1
DR   Wikidata; Q54814454
RX   PubMed=28111279;
WW   Provider; CReM; 610; https://stemcellbank.bu.edu/Catalog/Item/Details/610
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem016i-ss18-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM017i-SS19-1
AC   CVCL_JW38
SY   SS19-1; SS19
DR   SKIP; SKIP003075
DR   SKIP; SKIP003568
DR   WiCell; crem017i-ss19-1
DR   Wikidata; Q54814455
RX   PubMed=28111279;
WW   Provider; CReM; 611; https://stemcellbank.bu.edu/Catalog/Item/Details/611
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem017i-ss19-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM018i-SS24-1
AC   CVCL_JW39
SY   SS24-1; SS24
DR   SKIP; SKIP003076
DR   SKIP; SKIP003569
DR   WiCell; crem018i-ss24-1
DR   Wikidata; Q54814456
RX   PubMed=28111279;
WW   Provider; CReM; 612; https://stemcellbank.bu.edu/Catalog/Item/Details/612
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem018i-ss24-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM019i-SS25-1
AC   CVCL_JW40
SY   SS25-1; SS25
DR   SKIP; SKIP003077
DR   SKIP; SKIP003570
DR   WiCell; crem019i-ss25-1
DR   Wikidata; Q54814457
RX   PubMed=28111279;
WW   Provider; CReM; 613; https://stemcellbank.bu.edu/Catalog/Item/Details/613
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem019i-ss25-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM020i-SS28-1
AC   CVCL_JW41
SY   SS28-1; SS28
DR   SKIP; SKIP003078
DR   SKIP; SKIP003571
DR   WiCell; crem020i-ss28-1
DR   Wikidata; Q54814458
RX   PubMed=28111279;
WW   Provider; CReM; 614; https://stemcellbank.bu.edu/Catalog/Item/Details/614
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem020i-ss28-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM021i-SS29-1
AC   CVCL_JW42
SY   SS29-1; SS29
DR   SKIP; SKIP003079
DR   SKIP; SKIP003572
DR   WiCell; crem021i-ss29-1
DR   Wikidata; Q54814459
RX   PubMed=28111279;
WW   Provider; CReM; 615; https://stemcellbank.bu.edu/Catalog/Item/Details/615
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem021i-ss29-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM022i-SS32-1
AC   CVCL_JW43
SY   SS32-1; SS32
DR   SKIP; SKIP003081
DR   SKIP; SKIP003573
DR   WiCell; crem022i-ss32-1
DR   Wikidata; Q54814460
RX   PubMed=28111279;
WW   Provider; CReM; 616; https://stemcellbank.bu.edu/Catalog/Item/Details/616
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem022i-ss32-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM023i-SS35-1
AC   CVCL_JW44
SY   SS35-1; SS35
DR   SKIP; SKIP003080
DR   SKIP; SKIP003574
DR   WiCell; crem023i-ss35-1
DR   Wikidata; Q54814461
RX   PubMed=28111279;
WW   Provider; CReM; 617; https://stemcellbank.bu.edu/Catalog/Item/Details/617
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem023i-ss35-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM024i-SS36-1
AC   CVCL_JW45
SY   SS36-1; SS36
DR   SKIP; SKIP003082
DR   SKIP; SKIP003575
DR   WiCell; crem024i-ss36-1
DR   Wikidata; Q54814462
RX   PubMed=28111279;
WW   Provider; CReM; 618; https://stemcellbank.bu.edu/Catalog/Item/Details/618
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem024i-ss36-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM025i-SS37-1
AC   CVCL_JW46
SY   SS37-1; SS37
DR   SKIP; SKIP003083
DR   SKIP; SKIP003576
DR   WiCell; crem025i-ss37-1
DR   Wikidata; Q54814463
RX   PubMed=28111279;
WW   Provider; CReM; 619; https://stemcellbank.bu.edu/Catalog/Item/Details/619
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem025i-ss37-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM026i-SS38-1
AC   CVCL_JW47
SY   SS38-1; SS38
DR   SKIP; SKIP003084
DR   SKIP; SKIP003577
DR   WiCell; crem026i-ss38-1
DR   Wikidata; Q54814464
RX   PubMed=28111279;
WW   Provider; CReM; 620; https://stemcellbank.bu.edu/Catalog/Item/Details/620
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem026i-ss38-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM027i-SS41-1
AC   CVCL_JW48
SY   SS41-1; SS41
DR   SKIP; SKIP003094
DR   SKIP; SKIP003578
DR   WiCell; crem027i-ss41-1
DR   Wikidata; Q54814465
RX   PubMed=28111279;
WW   Provider; CReM; 621; https://stemcellbank.bu.edu/Catalog/Item/Details/621
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem027i-ss41-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM028i-SS43-2
AC   CVCL_JW49
SY   SS43-2; SS43
DR   SKIP; SKIP003095
DR   SKIP; SKIP003579
DR   WiCell; crem028i-ss43-2
DR   Wikidata; Q54814466
RX   PubMed=28111279;
WW   Provider; CReM; 688; https://stemcellbank.bu.edu/Catalog/Item/Details/688
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem028i-ss43-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM029i-SS44-1
AC   CVCL_JW50
SY   SS44-1; SS44
DR   SKIP; SKIP003096
DR   SKIP; SKIP003580
DR   WiCell; crem029i-ss44-1
DR   Wikidata; Q54814467
RX   PubMed=28111279;
WW   Provider; CReM; 623; https://stemcellbank.bu.edu/Catalog/Item/Details/623
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem029i-ss44-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM030i-SS45-1
AC   CVCL_JW51
SY   SS45-1; SS45
DR   SKIP; SKIP003097
DR   SKIP; SKIP003581
DR   WiCell; crem030i-ss45-1
DR   Wikidata; Q54814468
RX   PubMed=28111279;
WW   Provider; CReM; 624; https://stemcellbank.bu.edu/Catalog/Item/Details/624
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem030i-ss45-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM031i-SS47-1
AC   CVCL_JW52
SY   SS47-1; SS47
DR   SKIP; SKIP003098
DR   SKIP; SKIP003582
DR   WiCell; crem031i-ss47-1
DR   Wikidata; Q54814469
RX   PubMed=28111279;
WW   Provider; CReM; 625; https://stemcellbank.bu.edu/Catalog/Item/Details/625
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem031i-ss47-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM032i-SS48-1
AC   CVCL_JW53
SY   SS48-1; SS48
DR   SKIP; SKIP003099
DR   SKIP; SKIP003583
DR   WiCell; crem032i-ss48-1
DR   Wikidata; Q54814470
RX   PubMed=28111279;
WW   Provider; CReM; 626; https://stemcellbank.bu.edu/Catalog/Item/Details/626
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem032i-ss48-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM033i-SS49-1
AC   CVCL_JW54
SY   SS49-1; SS49
DR   SKIP; SKIP003100
DR   SKIP; SKIP003584
DR   WiCell; crem033i-ss49-1
DR   Wikidata; Q54814471
RX   PubMed=28111279;
WW   Provider; CReM; 627; https://stemcellbank.bu.edu/Catalog/Item/Details/627
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem033i-ss49-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM034i-SA5-1
AC   CVCL_JW55
SY   SA5-1; SA5
DR   SKIP; SKIP003101
DR   SKIP; SKIP003585
DR   WiCell; crem034i-sa5-1
DR   Wikidata; Q54814472
RX   PubMed=28111279;
WW   Provider; CReM; 628; https://stemcellbank.bu.edu/Catalog/Item/Details/628
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem034i-sa5-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM035i-SA36-1
AC   CVCL_JW56
SY   SA36-1; SA36
DR   SKIP; SKIP003102
DR   SKIP; SKIP003586
DR   WiCell; crem035i-sa36-1
DR   Wikidata; Q54814473
RX   PubMed=28111279;
WW   Provider; CReM; 629; https://stemcellbank.bu.edu/Catalog/Item/Details/629
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem035i-sa36-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM036i-SA40-1
AC   CVCL_JW57
SY   SA40-1; SA40
DR   SKIP; SKIP003103
DR   SKIP; SKIP003587
DR   WiCell; crem036i-sa40-1
DR   Wikidata; Q54814474
RX   PubMed=28111279;
WW   Provider; CReM; 630; https://stemcellbank.bu.edu/Catalog/Item/Details/630
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem036i-sa40-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM037i-SA53-1
AC   CVCL_JW58
SY   SA53-1; SA53
DR   SKIP; SKIP003104
DR   SKIP; SKIP003588
DR   WiCell; crem037i-sa53-1
DR   Wikidata; Q54814475
RX   PubMed=28111279;
WW   Provider; CReM; 631; https://stemcellbank.bu.edu/Catalog/Item/Details/631
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem037i-sa53-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM038i-SA64-1
AC   CVCL_JW59
SY   SA64-1; SA64
DR   SKIP; SKIP003105
DR   SKIP; SKIP003589
DR   WiCell; crem038i-sa64-1
DR   Wikidata; Q54814476
RX   PubMed=28111279;
WW   Provider; CReM; 632; https://stemcellbank.bu.edu/Catalog/Item/Details/632
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem038i-sa64-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM039i-SA108
AC   CVCL_A4VD
SY   SA108; SA108-1
DR   SKIP; SKIP005457
DR   Wikidata; Q107114715
RX   PubMed=28111279;
WW   Provider; CReM; 634; https://stemcellbank.bu.edu/Catalog/Item/Details/634
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CREM040i-SA82-2
AC   CVCL_A4VE
SY   SA82-2; SA82
DR   SKIP; SKIP005458
DR   Wikidata; Q107114716
RX   PubMed=28111279;
WW   Provider; CReM; 633; https://stemcellbank.bu.edu/Catalog/Item/Details/633
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CREM041i-SA208-2
AC   CVCL_JW60
SY   SA208-2; SA208
DR   SKIP; SKIP003106
DR   SKIP; SKIP003590
DR   WiCell; crem041i-sa208-2
DR   Wikidata; Q54814477
RX   PubMed=28111279;
WW   Provider; CReM; 635; https://stemcellbank.bu.edu/Catalog/Item/Details/635
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem041i-sa208-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM042i-SA209-1
AC   CVCL_JW61
SY   SA209-1; SA209
DR   SKIP; SKIP003107
DR   SKIP; SKIP003591
DR   WiCell; crem042i-sa209-1
DR   Wikidata; Q54814478
RX   PubMed=28111279;
WW   Provider; CReM; 636; https://stemcellbank.bu.edu/Catalog/Item/Details/636
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem042i-sa209-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM043i-SA210-1
AC   CVCL_A4VF
SY   SA210-1; SA210
DR   SKIP; SKIP005459
DR   Wikidata; Q107114718
RX   PubMed=28111279;
WW   Provider; CReM; 637; https://stemcellbank.bu.edu/Catalog/Item/Details/637
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CREM044i-SA50-1
AC   CVCL_JW62
SY   SA50-1; SA50
DR   SKIP; SKIP003108
DR   SKIP; SKIP003592
DR   WiCell; crem044i-sa50-1
DR   Wikidata; Q54814479
RX   PubMed=28111279;
WW   Provider; CReM; 638; https://stemcellbank.bu.edu/Catalog/Item/Details/638
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem044i-sa50-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   CREM045i-SA106-1
AC   CVCL_JW63
SY   SA106-1; SA106
DR   SKIP; SKIP003109
DR   SKIP; SKIP003593
DR   WiCell; crem045i-sa106-1
DR   Wikidata; Q54814480
RX   PubMed=28111279;
WW   Provider; CReM; 639; https://stemcellbank.bu.edu/Catalog/Item/Details/639
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem045i-sa106-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   CREM046i-SA138-1
AC   CVCL_JW64
SY   SA138-1; SA138
DR   SKIP; SKIP003110
DR   SKIP; SKIP003594
DR   WiCell; crem046i-sa138-1
DR   Wikidata; Q54814481
RX   PubMed=28111279;
WW   Provider; CReM; 640; https://stemcellbank.bu.edu/Catalog/Item/Details/640
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem046i-sa138-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM047i-SA170-1
AC   CVCL_JW65
SY   SA170-1; SA170
DR   SKIP; SKIP003111
DR   SKIP; SKIP003595
DR   WiCell; crem047i-sa170-1
DR   Wikidata; Q54814482
RX   PubMed=28111279;
WW   Provider; CReM; 641; https://stemcellbank.bu.edu/Catalog/Item/Details/641
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem047i-sa170-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   CREM048i-BR3-1
AC   CVCL_YY13
SY   BR-SP-3-1; BR-SP-3
DR   WiCell; crem048i-br3-1
DR   Wikidata; Q98125694
RX   PubMed=28111279;
WW   Provider; CReM; 642; https://stemcellbank.bu.edu/Catalog/Item/Details/642
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem048i-br3-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM049i-BR21-1
AC   CVCL_YY14
SY   BR-SP-21-1; BR-SP-21
DR   SKIP; SKIP005460
DR   WiCell; crem049i-br21-1
DR   Wikidata; Q98125695
RX   PubMed=28111279;
WW   Provider; CReM; 643; https://stemcellbank.bu.edu/Catalog/Item/Details/643
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem049i-br21-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   CREM050i-BR23-1
AC   CVCL_YY15
SY   BR-SP-23-1; BR-SP-23
DR   WiCell; crem050i-br23-1
DR   Wikidata; Q98125698
RX   PubMed=28111279;
WW   Provider; CReM; 644; https://stemcellbank.bu.edu/Catalog/Item/Details/644
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem050i-br23-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM051i-BR25-1
AC   CVCL_YY16
SY   BR-SP-25-1; BR-SP-25
DR   WiCell; crem051i-br25-1
DR   Wikidata; Q98125699
RX   PubMed=28111279;
WW   Provider; CReM; 645; https://stemcellbank.bu.edu/Catalog/Item/Details/645
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem051i-br25-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM052i-BR29-1
AC   CVCL_YY17
SY   BR-SP-29-1; BR-SP-29
DR   WiCell; crem052i-br29-1
DR   Wikidata; Q98125700
RX   PubMed=28111279;
WW   Provider; CReM; 646; https://stemcellbank.bu.edu/Catalog/Item/Details/646
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem052i-br29-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM053i-BR31-1
AC   CVCL_YY18
SY   BR-SP-31-1
DR   WiCell; crem053i-br31-1
DR   Wikidata; Q98125702
RX   PubMed=28111279;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem053i-br31-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2WF ! BR-SP-31-2
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   CREM054i-BR33-1
AC   CVCL_YY19
SY   BR-SP-33-1; BR-SP-33
DR   WiCell; crem054i-br33-1
DR   Wikidata; Q98125703
RX   PubMed=28111279;
WW   Provider; CReM; 648; https://stemcellbank.bu.edu/Catalog/Item/Details/648
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem054i-br33-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM055i-BR37-1
AC   CVCL_YY20
SY   BR-SP-37-1; BR-SP-37
DR   WiCell; crem055i-br37-1
DR   Wikidata; Q98125704
RX   PubMed=28111279;
WW   Provider; CReM; 649; https://stemcellbank.bu.edu/Catalog/Item/Details/649
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem055i-br37-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM056i-BR39-1
AC   CVCL_YY21
SY   BR-SP-39-1; BR-SP-39
DR   WiCell; crem056i-br39-1
DR   Wikidata; Q98125705
RX   PubMed=28111279;
WW   Provider; CReM; 650; https://stemcellbank.bu.edu/Catalog/Item/Details/650
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem056i-br39-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM057i-BR41-1
AC   CVCL_YY22
SY   BR-SP-41-1; BR-SP-41
DR   WiCell; crem057i-br41-1
DR   Wikidata; Q98125706
RX   PubMed=28111279;
WW   Provider; CReM; 651; https://stemcellbank.bu.edu/Catalog/Item/Details/651
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem057i-br41-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM058i-BR43-1
AC   CVCL_YY23
SY   BR-SP-43-1; BR-SP-43
DR   WiCell; crem058i-br43-1
DR   Wikidata; Q98125707
RX   PubMed=28111279;
WW   Provider; CReM; 652; https://stemcellbank.bu.edu/Catalog/Item/Details/652
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem058i-br43-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM059i-BR45-1
AC   CVCL_YY24
SY   BR-SP-45-1; BR-SP-45
DR   WiCell; crem059i-br45-1
DR   Wikidata; Q98125708
RX   PubMed=28111279;
WW   Provider; CReM; 653; https://stemcellbank.bu.edu/Catalog/Item/Details/653
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem059i-br45-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM060i-BR51-1
AC   CVCL_YY25
SY   BR-SP-51-1; BR-SP-51
DR   WiCell; crem060i-br51-1
DR   Wikidata; Q98125710
RX   PubMed=28111279;
WW   Provider; CReM; 654; https://stemcellbank.bu.edu/Catalog/Item/Details/654
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (WiCell=crem060i-br51-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CREM061i-BT1-1
AC   CVCL_YY26
SY   BT1-1; BT1
DR   WiCell; crem061i-bt1-1
DR   Wikidata; Q98125711
WW   Provider; CReM; 655; https://stemcellbank.bu.edu/Catalog/Item/Details/655
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Southeast Asian; Cambodian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.92+1G>T (IVS1,G>T,+1); ClinVar=VCV000015437; Zygosity=Unspecified; Note=Splice donor mutation (WiCell=crem061i-bt1-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Boston University
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16,17
ST   D21S11: 28,29
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 11,14
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 12
//
ID   CREM062i-BT2
AC   CVCL_YY27
SY   BT2-1; BT2
DR   WiCell; crem062i-bt2
DR   Wikidata; Q98125712
WW   Provider; CReM; 656; https://stemcellbank.bu.edu/Catalog/Item/Details/656
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.92+6T>C (IVS1,T>C,+6) (IVS I-6 T>C); ClinVar=VCV000015450; Zygosity=Heterozygous (WiCell=crem062i-bt2).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Gln40Ter (c.118C>T) (Q39*); ClinVar=VCV000015402; Zygosity=Heterozygous (WiCell=crem062i-bt2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Boston University
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 15,18
ST   D21S11: 29
ST   D3S1358: 17,18
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 9,16
ST   Penta E: 11,14
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 15,17
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 12
//
ID   CrF
AC   CVCL_B7QC
SY   Croaker Fibroblast
DR   Wikidata; Q112929417
RX   PubMed=7422670;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is from 26 to 32 Celsius (PubMed=7422670).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=29154; ! Micropogonias undulatus (Atlantic croaker)
SX   Male
AG   Mature
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   CRF-1
AC   CVCL_8854
SY   Clonal Red sea bream Fin-1
DR   Wikidata; Q54814483
RX   PubMed=17335926;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by red sea bream iridovirus (RSIV).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=143350; ! Pagrus major (Red sea bream)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   CRFi001-A
AC   CVCL_A1VZ
SY   iPS GM25383
DR   hPSCreg; CRFi001-A
DR   Wikidata; Q105506718
CC   From: Choroideremia Research Foundation; Springfield; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW52 ! GM25383
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   CRFK
AC   CVCL_2426
SY   CrFK; Crfk; NBL-CrFK; Crandell Reese Feline Kidney; CFK; Crandell Feline Kidney; CCC; Crandell's Cat Cell
DR   CLO; CLO_0002609
DR   CLDB; cl907
DR   CLDB; cl908
DR   ATCC; CCL-94
DR   ATCC; CRL-6073
DR   BCRC; 60151
DR   BCRJ; 0072
DR   CCRID; 1102MAM-NIFDC00047
DR   CCRID; 3101MAMGNO16
DR   CCRID; 4201MAM-CCTCC00321
DR   CCTCC; GDC0321
DR   ECACC; 86093002
DR   IZSLER; BS CL 22
DR   JCRB; JCRB9035
DR   KCB; KCB 200974YJ
DR   KCLB; 10094
DR   Lonza; 801
DR   TOKU-E; 997
DR   Wikidata; Q54814484
RX   PubMed=75945;
RX   PubMed=1313703;
RX   PubMed=4130570;
RX   PubMed=6160900;
RX   PubMed=9696876;
RX   PubMed=20631117;
RX   PubMed=21029758;
RX   PubMed=23585909;
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-435.html
CC   Group: Vaccine production cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Biotechnology: Widely used to manufacture vaccines for parvoviruses such as feline panleukopenia virus (FPLV) and canine parvoviruses (CPVs).
CC   Virology: Persistently infected by feline endogenous virus RD-114.
CC   Discontinued: ATCC; CRL-6073; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_DB45 ! FCK
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   CRFK/FIV-AZR-1
AC   CVCL_X693
DR   BEI_Resources; ARP-1446
DR   Wikidata; Q54814485
RX   PubMed=1845891;
CC   Doubling time: 16-24 hours (BEI_Resources=ARP-1446).
CC   Selected for resistance to: ChEBI; CHEBI_10110; Zidovudine (3'-azido-3'-deoxythymidine).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_2426 ! CRFK
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 11
//
ID   Cri du Chat
AC   CVCL_4150
AS   CVCL_X223
SY   GM00071; GM-0071; GM-71; GM 71; GM71
DR   CLO; CLO_0002611
DR   CLO; CLO_0025165
DR   CLDB; cl910
DR   ATCC; CCL-90
DR   BioSample; SAMN03471291
DR   Coriell; GM00071
DR   ECACC; 90102533
DR   KCB; KCB 94023YJ
DR   Wikidata; Q54814486
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1001031;
RX   PubMed=6661932;
RX   PubMed=6988327;
CC   Population: Caucasian.
CC   Discontinued: ECACC; 90102533; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-90
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 7,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   CRI-10P
AC   CVCL_8855
SY   Cambridge Rat Islet-10P
DR   CLO; CLO_0002612
DR   CLDB; cl911
DR   ECACC; 88031606
DR   Wikidata; Q54814487
RX   PubMed=3011941;
CC   Discontinued: ECACC; 88031606; true.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4152 ! CRI-D2
OI   CVCL_4151 ! CRI-D11
OI   CVCL_0225 ! CRI-G1
OI   CVCL_4153 ! CRI-G5
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   CRI-D11
AC   CVCL_4151
SY   CRI D11; CRID11; Cambridge Rat Islet-D11
DR   CLO; CLO_0002613
DR   CLDB; cl912
DR   CLDB; cl5179
DR   ECACC; 88031604
DR   IZSLER; BS TCL 113
DR   Wikidata; Q54814494
RX   PubMed=3011941;
CC   Misspelling: CRI DII; Note=Occasionally.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8855 ! CRI-10P
OI   CVCL_4152 ! CRI-D2
OI   CVCL_0225 ! CRI-G1
OI   CVCL_4153 ! CRI-G5
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   CRI-D2
AC   CVCL_4152
SY   CRID2; Cambridge Rat Islet-D2
DR   CLO; CLO_0002614
DR   CLDB; cl913
DR   ECACC; 88031605
DR   NCBI_Iran; C187
DR   Wikidata; Q54814495
RX   PubMed=3011941;
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8855 ! CRI-10P
OI   CVCL_4151 ! CRI-D11
OI   CVCL_0225 ! CRI-G1
OI   CVCL_4153 ! CRI-G5
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   CRI-G1
AC   CVCL_0225
SY   CRIG1; CRIg1; Cambridge Rat Islet-G1; CRI-G1-RR; CRI-G1-Rotenone-Resistant
DR   CLO; CLO_0002615
DR   MCCL; MCC:0000113
DR   CLDB; cl914
DR   ECACC; 87052701
DR   GEO; GSM498426
DR   GEO; GSM498427
DR   GEO; GSM498428
DR   GEO; GSM498441
DR   GEO; GSM498442
DR   GEO; GSM498443
DR   Wikidata; Q54814496
RX   PubMed=3011941;
RX   PubMed=21249230;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8855 ! CRI-10P
OI   CVCL_4152 ! CRI-D2
OI   CVCL_4151 ! CRI-D11
OI   CVCL_4153 ! CRI-G5
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   CRI-G1-RS
AC   CVCL_GU04
SY   CRI-G1-Rotenone Sensitive
DR   GEO; GSM498444
DR   GEO; GSM498445
DR   GEO; GSM498446
DR   GEO; GSM498447
DR   GEO; GSM498448
DR   GEO; GSM498449
DR   Wikidata; Q54814497
RX   PubMed=21249230;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0225 ! CRI-G1
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   CRI-G5
AC   CVCL_4153
SY   CRIG5; Cambridge Rat Islet-G5
DR   CLO; CLO_0002616
DR   CLDB; cl915
DR   ECACC; 88031603
DR   Wikidata; Q54814499
RX   PubMed=3011941;
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8855 ! CRI-10P
OI   CVCL_4152 ! CRI-D2
OI   CVCL_4151 ! CRI-D11
OI   CVCL_0225 ! CRI-G1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   CRIB-1
AC   CVCL_DD19
SY   Cells Resistant to Infection with BVDV-1; CRIB; MDBK-CRIB
DR   ATCC; SD-1831
DR   CCLV; CCLV-RIE 0354
DR   Wikidata; Q54814501
RX   Patent=US5541102;
RX   PubMed=7747428;
RX   PubMed=24973239;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11883.
CC   Virology: Not susceptible to infection by bovine viral diarrhea virus (BVDV).
CC   Discontinued: ATCC; SD-1831; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CRICKi001-A
AC   CVCL_A5EU
SY   iFCI001
DR   BioSamples; SAMEA13299074
DR   hPSCreg; CRICKi001-A
DR   Wikidata; Q107114720
RX   PubMed=33799280;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Arg1203Cys (c.3607C>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33799280).
CC   Derived from site: In situ; Hair root; UBERON=UBERON_0000329.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   CRICKi002-A
AC   CVCL_A5EV
SY   iFCI027
DR   BioSamples; SAMEA13315508
DR   hPSCreg; CRICKi002-A
DR   Wikidata; Q107114722
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 7
//
ID   CRICKi003-A
AC   CVCL_C1P0
SY   iFCI002
DR   BioSamples; SAMEA112239993
DR   hPSCreg; CRICKi003-A
DR   Wikidata; Q114311267
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRICKi004-A
AC   CVCL_C3QZ
SY   iFCI008
DR   BioSamples; SAMEA111497816
DR   hPSCreg; CRICKi004-A
DR   Wikidata; Q116048787
RX   PubMed=36332468;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2961; DYNC1H1; Simple; p.Arg399Gly (c.1195A>G); ClinVar=VCV000637515; Zygosity=Homozygous (PubMed=36332468).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C191765; Autosomal dominant lower extremity-predominant spinal muscular atrophy-1
DI   ORDO; Orphanet_209341; DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CRICKi005-A
AC   CVCL_C3R0
SY   iFCI004
DR   BioSamples; SAMEA112226452
DR   hPSCreg; CRICKi005-A
DR   Wikidata; Q116048788
RX   PubMed=36332468;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2961; DYNC1H1; Simple; p.Arg399Gly (c.1195A>G); ClinVar=VCV000637515; Zygosity=Heterozygous (PubMed=36332468).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C191765; Autosomal dominant lower extremity-predominant spinal muscular atrophy-1
DI   ORDO; Orphanet_209341; DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CRICKi006-A
AC   CVCL_C3R1
SY   iFCI005
DR   BioSamples; SAMEA112226497
DR   hPSCreg; CRICKi006-A
DR   Wikidata; Q116048789
RX   PubMed=36332468;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2961; DYNC1H1; Simple; p.Asp338Asn (c.1012G>A); ClinVar=VCV000637514; Zygosity=Heterozygous (PubMed=36332468).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C191765; Autosomal dominant lower extremity-predominant spinal muscular atrophy-1
DI   ORDO; Orphanet_209341; DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CRICKi007-A
AC   CVCL_C3R2
SY   iFCI009
DR   BioSamples; SAMEA112227670
DR   hPSCreg; CRICKi007-A
DR   Wikidata; Q116048790
RX   PubMed=36332468;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:17208; BICD2; Simple; p.Ile189Phe (c.565A>T); ClinVar=VCV000637065; Zygosity=Heterozygous (PubMed=36332468).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C191766; Autosomal dominant childhood-onset lower extremity-predominant spinal muscular atrophy-2A
DI   ORDO; Orphanet_363454; BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   CRICKi008-A
AC   CVCL_C5T0
SY   iFCI006; NH13-0078
DR   BioSamples; SAMEA112229690
DR   hPSCreg; CRICKi008-A
DR   Wikidata; Q116048791
RX   PubMed=36989620;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Simple; p.Tyr198Ter (c.594C>G); Zygosity=Hemizygous (PubMed=36989620).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CRICKi009-A
AC   CVCL_C5T1
SY   iFCI012 Clone 4; iBK983
DR   BioSamples; SAMEA112239881
DR   hPSCreg; CRICKi009-A
DR   Wikidata; Q116048792
RX   PubMed=39549334;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Val137Cysfs*22 (c.409delG); Zygosity=Heterozygous (PubMed=39549334).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   CRICKi010-A
AC   CVCL_C5T2
SY   iFCI013 Clone 7; iBK985
DR   BioSamples; SAMEA112239931
DR   hPSCreg; CRICKi010-A
DR   Wikidata; Q116048793
RX   PubMed=39549334;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Phe136Ser (c.407T>C); ClinVar=VCV000496064; Zygosity=Heterozygous (PubMed=39549334).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   CRICKi011-A
AC   CVCL_C5T3
SY   iFCI016
DR   BioSamples; SAMEA112229924
DR   hPSCreg; CRICKi011-A
DR   Wikidata; Q116048794
RX   PubMed=37336145;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Gly51Asp (c.152G>A); ClinVar=VCV000097000; Zygosity=Heterozygous (PubMed=37336145).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CRICKi012-A
AC   CVCL_C5T4
SY   iFCI017
DR   BioSamples; SAMEA112233748
DR   hPSCreg; CRICKi012-A
DR   Wikidata; Q116048795
RX   PubMed=37336145;
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Gly51Asp (c.152G>A); ClinVar=VCV000097000; Zygosity=Heterozygous (PubMed=37336145).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CRICKi013-A
AC   CVCL_D0D8
SY   iFCI018 Clone 6
DR   BioSamples; SAMEA114237381
DR   hPSCreg; CRICKi013-A
DR   Wikidata; Q123030961
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CRICKi014-A
AC   CVCL_D0D9
SY   iFCI019 Clone 4
DR   BioSamples; SAMEA114237654
DR   hPSCreg; CRICKi014-A
DR   Wikidata; Q123030963
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CRICKi015-A
AC   CVCL_D0DA
SY   iFCI020 Clone 1
DR   BioSamples; SAMEA114237802
DR   hPSCreg; CRICKi015-A
DR   Wikidata; Q123030964
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CRICKi016-A
AC   CVCL_D0DB
SY   iFCI021 Clone 7
DR   BioSamples; SAMEA114237804
DR   hPSCreg; CRICKi016-A
DR   Wikidata; Q123030965
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CRICKi017-A
AC   CVCL_D0DC
SY   iFCI022 Clone 4
DR   BioSamples; SAMEA115470504
DR   hPSCreg; CRICKi017-A
DR   Wikidata; Q123030966
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CRICKi018-A
AC   CVCL_D0DD
SY   iFCI023; iKER 12
DR   BioSamples; SAMEA115489539
DR   hPSCreg; CRICKi018-A
DR   Wikidata; Q123030967
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CRICKi019-A
AC   CVCL_D0DE
SY   iFCI024; iKER 8
DR   BioSamples; SAMEA115529753
DR   hPSCreg; CRICKi019-A
DR   Wikidata; Q123030968
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CRICKi020-A
AC   CVCL_D0DF
SY   iFCI025; iKER 10
DR   BioSamples; SAMEA115529813
DR   hPSCreg; CRICKi020-A
DR   Wikidata; Q123030969
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CRICKi021-A
AC   CVCL_D1G0
SY   iFCI007
DR   BioSamples; SAMEA114466772
DR   hPSCreg; CRICKi021-A
DR   Wikidata; Q127380647
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CRICKi022-A
AC   CVCL_E3TP
SY   iFCI031
DR   BioSamples; SAMEA115470506
DR   hPSCreg; CRICKi022-A
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CRICKi023-A
AC   CVCL_E3TQ
SY   iFCI032
DR   BioSamples; SAMEA115470704
DR   hPSCreg; CRICKi023-A
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Donor information: Established from a patient suffering from a lung Squamous cell carcinoma (hPSCreg=CRICKi023-A).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CRICKi024-A
AC   CVCL_E3TR
SY   XXY-A4
DR   BioSamples; SAMEA115470704
DR   hPSCreg; CRICKi024-A
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CRICKi024-B
AC   CVCL_E3TS
SY   XXY-2A1
DR   BioSamples; SAMEA116060738
DR   hPSCreg; CRICKi024-B
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CRICKi024-C
AC   CVCL_E3TT
SY   XXY-3A9
DR   BioSamples; SAMEA116060739
DR   hPSCreg; CRICKi024-C
CC   From: The Francis Crick Institute Limited; London; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CRIS
AC   CVCL_E536
DR   IHW; 9w 1702
DR   Wikidata; Q54814502
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*02,31; B*51,63; C*w03 (IHW=9w 1702).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   CRISPRi Gen1B 1
AC   CVCL_VM35
SY   WTB CRISPRi Gen1 clone 1; 1B-1
DR   Wikidata; Q93458758
RX   PubMed=26971820;
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB-P2A-mCherry is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM30 ! WTB6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   CRISPRi Gen1B 3
AC   CVCL_VM36
SY   WTB CRISPRi Gen1 clone 3; 1B-3
DR   Wikidata; Q93458761
RX   PubMed=26971820;
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB-P2A-mCherry is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM30 ! WTB6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   CRISPRi Gen1C 5
AC   CVCL_VM38
SY   WTC CRISPRi Gen1 clone 5; CRISPRi (Gen1C 5); 1C-5
DR   Wikidata; Q93458763
RX   PubMed=26971820;
RX   PubMed=30290179;
CC   Population: Japanese.
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB-P2A-mCherry is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 13
//
ID   CRISPRi Gen1C 6
AC   CVCL_VM39
SY   WTC CRISPRi Gen1 clone 6; 1C-6
DR   Wikidata; Q93458765
RX   PubMed=26971820;
CC   Population: Japanese.
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB-P2A-mCherry is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   CRISPRi Gen2C 1
AC   CVCL_VM40
SY   WTC CRISPRi Gen2 clone 1; 2C-1
DR   Wikidata; Q93458768
RX   PubMed=26971820;
CC   Population: Japanese.
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   CRISPRi Gen2C 2
AC   CVCL_VM41
SY   WTC CRISPRi Gen2 clone 2; 2C-2
DR   Wikidata; Q93458770
RX   PubMed=26971820;
CC   Population: Japanese.
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   CRISPRi Gen3C A3
AC   CVCL_VM42
SY   WTC CRISPRi Gen3 clone A3; 3C-A3
DR   Wikidata; Q93458772
RX   PubMed=26971820;
CC   Population: Japanese.
CC   Characteristics: Cell line with constitutive CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a CAG promoter and dCas9-KRAB is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 9
//
ID   CRISPRi Gen3C A4
AC   CVCL_VM43
SY   WTC CRISPRi Gen3 clone A4; 3C-A4
DR   Wikidata; Q93458774
RX   PubMed=26971820;
CC   Population: Japanese.
CC   Characteristics: Cell line with constitutive CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a CAG promoter and dCas9-KRAB is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 9
//
ID   CRISPRn Gen1B 1
AC   CVCL_VM31
SY   WTB CRISPRn Gen1 clone 1; 1B-n1
DR   Wikidata; Q93458777
RX   PubMed=26971820;
CC   Characteristics: Cell line with Dox-inducible CRISPR nuclease (CRISPRn).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9 is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM30 ! WTB6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   CRISPRn Gen1B 3
AC   CVCL_VM32
SY   WTB CRISPRn Gen1 clone 3; 1B-n3
DR   Wikidata; Q93458779
RX   PubMed=26971820;
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9 is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM30 ! WTB6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   CRISPRn Gen1C 19
AC   CVCL_VM33
SY   WTC CRISPRn Gen1 clone 19; CRISPRi (Gen1C 19); 1C-n19
DR   Wikidata; Q93458781
RX   PubMed=26971820;
CC   Population: Japanese.
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9 is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   CRISPRn Gen1C 22
AC   CVCL_VM34
SY   WTC CRISPRn Gen1 clone 22; CRISPRi (Gen1C 22); 1C-n22
DR   Wikidata; Q93458783
RX   PubMed=26971820;
CC   Population: Japanese.
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9 is introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   CRL
AC   CVCL_YD58
SY   Cotton Rat Lung
DR   Wikidata; Q93458785
RX   Patent=US7906311;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3930.
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=42415; ! Sigmodon hispidus (Hispid cotton rat)
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   CRL-6440
AC   CVCL_ZE35
SY   Mouse
DR   ATCC; CRL-6440
DR   Wikidata; Q98125713
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6440; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   CRMi001-A-1
AC   CVCL_UG26
SY   CRMi001-A-1-CLTA-TQ2; NCRM-5-CLTA-TQ2; SANFi002-A-1
DR   hPSCreg; CRMi001-A-1
DR   Wikidata; Q93458788
RX   PubMed=30340091;
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Characteristics: Using CRISPR/Cas9 CTLA has been endogenously tagged in one allele at the C-terminus with a mTurquoise2-P2A-PuroR construct (PubMed=30340091).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 7AV5G; mTurquoise2 (Note=Tq2, cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E75 ! NCRM-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   CRMi003-A-2
AC   CVCL_B5S5
SY   LUMCi041-A-2; DOXiH2BmTurq2
DR   BioSamples; SAMEA10199970
DR   hPSCreg; CRMi003-A-2
DR   Wikidata; Q111733136
RX   PubMed=34775202;
CC   Characteristics: Expresses a doxycycline inducible H2B-mTurquoise2 reporter. Instrumental to track cells and to temporally assess cell divisions and apoptosis in iPSC-based differentiation and cell toxicity assays (PubMed=34775202).
CC   Characteristics: Using CRISPR/Cas9 a T2A-PuroR-CAG-rTA3G-H2B-mTurquoise2-TRE3G construct was introduced in the AAVS1 safe harbor locus (PubMed=34775202).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 7AV5G; mTurquoise2 (Note=Tq2, cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E71 ! NCRM-1
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   CRMi003-A-3
AC   CVCL_C1P1
SY   Proliving; GMNN-mScarletI Reporter; LUMCi041-A-3
DR   BioSamples; SAMEA110425584
DR   hPSCreg; CRMi003-A-3
DR   Wikidata; Q114311268
RX   PubMed=36702081;
CC   Characteristics: Expresses a doxycycline inducible H2B-mTurquoise2 reporter. Instrumental to track cells and to temporally assess cell divisions and apoptosis in iPSC-based differentiation and cell toxicity assays (PubMed=36702081).
CC   Characteristics: Using CRISPR/Cas9 a T2A-PuroR-CAG-rTA3G-H2B-mTurquoise2-TRE3G construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 a mScarletI-GMNN(1-110) construct was introduced in the AAVS1 safe harbor locus (PubMed=36702081).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 6VVTK; mScarlet-I (Note=Red fluorescent protein).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 7AV5G; mTurquoise2 (Note=Tq2, cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5S5 ! CRMi003-A-2
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   CRMM-1
AC   CVCL_M593
SY   CRMM1; Conjunctival Recurrent Malignant Melanoma-1
DR   cancercelllines; CVCL_M593
DR   Cosmic; 2639616
DR   Wikidata; Q54814503
RX   PubMed=15993408;
RX   PubMed=22275346;
RX   PubMed=25722211;
RX   PubMed=28903377;
RX   PubMed=32545782;
CC   Characteristics: Can form 3D spheroids (PubMed=32545782).
CC   Doubling time: ~60 hours (Note=At 20-40th passages) (PubMed=15993408).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25722211).
CC   Derived from site: In situ; Eye, bulbar conjunctiva; UBERON=UBERON_0010306.
ST   Source(s): PubMed=25722211
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 17,20
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 21,23
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C4550; Conjunctival melanoma
DI   ORDO; Orphanet_617910; Conjunctival malignant melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   CRMM-2
AC   CVCL_M594
SY   CRMM2; Conjunctival Recurrent Malignant Melanoma-2
DR   cancercelllines; CVCL_M594
DR   Cosmic; 2639618
DR   Wikidata; Q54814504
RX   PubMed=15993408;
RX   PubMed=22275346;
RX   PubMed=25722211;
RX   PubMed=28903377;
RX   PubMed=32545782;
CC   Characteristics: Can form 3D spheroids (PubMed=32545782).
CC   Doubling time: ~60 hours (Note=At 19-30th passages) (PubMed=15993408).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=25722211).
CC   Derived from site: In situ; Eye, bulbar conjunctiva; UBERON=UBERON_0010306.
ST   Source(s): PubMed=25722211
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D21S11: 28,31.2
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 24
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4550; Conjunctival melanoma
DI   ORDO; Orphanet_617910; Conjunctival malignant melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   CRO-AP1
AC   CVCL_C414
SY   CRO-AP/1
DR   Wikidata; Q54814505
RX   PubMed=9389573;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   CRO-AP2
AC   CVCL_1147
SY   CRO-AP/2; CROAP2; AP2
DR   BTO; BTO_0002724
DR   CLO; CLO_0002617
DR   EFO; EFO_0002145
DR   CLDB; cl3486
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473560
DR   cancercelllines; CVCL_1147
DR   Cell_Model_Passport; SIDM00952
DR   ChEMBL-Cells; CHEMBL3308254
DR   ChEMBL-Targets; CHEMBL2366080
DR   Cosmic; 906807
DR   Cosmic-CLP; 906807
DR   DepMap; ACH-002220
DR   DSMZ; ACC-48
DR   DSMZCellDive; ACC-48
DR   EGA; EGAS00001000978
DR   GDSC; 906807
DR   GEO; GSM634729
DR   GEO; GSM1669709
DR   IARC_TP53; 21257
DR   IGRhCellID; CROAP2
DR   PharmacoDB; CROAP2_264_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1147
DR   PubChem_Cell_line; CVCL_1147
DR   Wikidata; Q54814506
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9389573;
RX   PubMed=9766492;
RX   PubMed=10784388;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=21685375;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CRO-AP%2f2
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~20-40 hours (DSMZ=ACC-48).
CC   HLA typing: A*68:02:01,68:02:01; B*15:01:01,15:01:01; C*03:03:01,07:04:01; DPA1*01:03:01,02:01:01; DPB1*03:01:01,10:01:01; DQA1*03:01:01,03:01:01; DQB1*03:02:01,05:01:01; DRA*01:01:01,01:02:02; DRB1*04:02:01,14:54:01 (DSMZCellDive=ACC-48).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.25%; Native American=0.15%; East Asian, North=0.73%; East Asian, South=0.29%; South Asian=5.13%; European, North=44.53%; European, South=48.9% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906807; DSMZ=ACC-48
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 10,13
ST   Penta E: 12
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   CRO-AP3
AC   CVCL_1810
SY   CRO-AP/3; CROAP3; AP3
DR   BTO; BTO_0002725
DR   CLO; CLO_0002618
DR   BioSample; SAMN03473339
DR   cancercelllines; CVCL_1810
DR   Cell_Model_Passport; SIDM00070
DR   Cosmic-CLP; 1297440
DR   DepMap; ACH-002393
DR   DSMZ; ACC-275
DR   DSMZCellDive; ACC-275
DR   GDSC; 1297440
DR   PharmacoDB; CROAP3_265_2019
DR   Wikidata; Q54814507
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9734661;
RX   PubMed=9766492;
RX   PubMed=10784388;
RX   PubMed=30894373;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CRO-AP%2f3
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: Contains 10 to 30 copies of the human herpesvirus 8 (HHV-8/KSHV) genome per cell.
CC   Doubling time: ~50 hours (DSMZ=ACC-275).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Genome ancestry: African=2.63%; Native American=0%; East Asian, North=0.61%; East Asian, South=1.52%; South Asian=1.46%; European, North=42.74%; European, South=51.05% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-275
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 12,16
ST   D19S433: 14,16
ST   D21S11: 30.2,32.2
ST   D2S1338: 21,24
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 21,26
ST   Penta D: 9,13
ST   Penta E: 12,14
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   CRO-AP5
AC   CVCL_1148
SY   CRO-AP/5; CROAP5; AP5
DR   BTO; BTO_0002726
DR   CLO; CLO_0002619
DR   EFO; EFO_0002146
DR   CLDB; cl420
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473377
DR   cancercelllines; CVCL_1148
DR   Cosmic; 906806
DR   DSMZ; ACC-215
DR   DSMZCellDive; ACC-215
DR   GEO; GSM634730
DR   IARC_TP53; 21258
DR   IGRhCellID; CROAP5
DR   Progenetix; CVCL_1148
DR   Wikidata; Q54814509
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9734661;
RX   PubMed=9766492;
RX   PubMed=10784388;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=21685375;
RX   PubMed=31160637;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CRO-AP%2f5
CC   Part of: LL-100 blood cancer cell line panel.
CC   Virology: Contains 30 to 60 copies of the human herpesvirus 8 (HHV-8/KSHV) genome per cell.
CC   Doubling time: ~35-40 hours (DSMZ=ACC-215).
CC   HLA typing: A*24:02:01,30:01:01; B*13:02:01,15:18:01; C*06:02:01,07:04:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,16:01:01; DQA1*02:01:01,02:01:01; DQB1*02:02:01,03:01:01; DRA*01:01:01,01:01:01; DRB1*07:01:01,11:01:01 (DSMZCellDive=ACC-215).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-215
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 10,18
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 17,18
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 25
ST   Penta D: 11,12
ST   Penta E: 7,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   CRO-AP6
AC   CVCL_1811
SY   CRO-AP/6; AP6
DR   BioSample; SAMN03473463
DR   DSMZ; ACC-650
DR   DSMZCellDive; ACC-650
DR   Wikidata; Q54814510
RX   PubMed=10914556;
CC   Doubling time: 40-50 hours (PubMed=10914556); ~48 hours (DSMZ=ACC-650).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-650
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 19,21
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   Crocsu-Lu
AC   CVCL_RX46
DR   Wikidata; Q54814511
RX   PubMed=24457147;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=52631; ! Crocidura suaveolens (Lesser white-toothed shrew)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   CRP-1
AC   CVCL_L999
DR   Wikidata; Q54814512
RX   Patent=US5500345;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2873.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02741; Human CRP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   CRP-2
AC   CVCL_M000
DR   Wikidata; Q54814513
RX   Patent=US5500345;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2874.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02741; Human CRP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   CRP-3
AC   CVCL_M001
DR   Wikidata; Q54814514
RX   Patent=US5500345;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2875.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02741; Human CRP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   CRP-4
AC   CVCL_M002
DR   Wikidata; Q54814516
RX   Patent=US5500345;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2876.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02741; Human CRP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   CRP2
AC   CVCL_XV51
SY   CRP-2
DR   CCRID; 4201PAT-CCTCC00990
DR   Wikidata; Q93458845
RX   Patent=CN107022527B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016218.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02741; Human CRP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   CRTDi001-A
AC   CVCL_Y543
AS   CVCL_IT58
SY   C1-1; T12.9; T12; MPIi004-A
DR   BioSamples; SAMEA104011275
DR   BioSamples; SAMEA104382077
DR   hPSCreg; CRTDi001-A
DR   SKIP; SKIP000294
DR   SKIP; SKIP002913
DR   Wikidata; Q54814517
RX   PubMed=23472874;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54-56Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   CRTDi003-A
AC   CVCL_UL97
SY   CRTD2
DR   BioSamples; SAMEA6654877
DR   hPSCreg; CRTDi003-A
DR   Wikidata; Q93458853
RX   PubMed=32384610;
RX   PubMed=36261438;
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR22 ! CRTDi003-B
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   CRTDi003-B
AC   CVCL_YR22
SY   CRTD3
DR   BioSamples; SAMEA6663966
DR   hPSCreg; CRTDi003-B
DR   Wikidata; Q93458855
RX   PubMed=32384610;
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL97 ! CRTDi003-A
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   CRTDi004-A
AC   CVCL_YR23
SY   CRTD1
DR   BioSamples; SAMEA6689581
DR   hPSCreg; CRTDi004-A
DR   Wikidata; Q93458858
RX   PubMed=36261438;
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   CRTDi004-A-1
AC   CVCL_D0DL
SY   CRTD1sc-AAVS1-iCas9-BFP2
DR   BioSamples; SAMEA10157779
DR   hPSCreg; CRTDi004-A-1
DR   Wikidata; Q123030970
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YR23 ! CRTDi004-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CRTDi005-A
AC   CVCL_YR24
SY   CRTD4
DR   BioSamples; SAMEA6689580
DR   hPSCreg; CRTDi005-A
DR   Wikidata; Q93458861
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 7
//
ID   CRTDi005-B
AC   CVCL_YR25
SY   CRTD5
DR   BioSamples; SAMEA6654879
DR   hPSCreg; CRTDi005-B
DR   Wikidata; Q93458865
RX   PubMed=30292704;
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 7
//
ID   CRTDi006-A
AC   CVCL_C1P2
SY   AGS1V201D_1
DR   BioSamples; SAMEA12596512
DR   hPSCreg; CRTDi006-A
DR   Wikidata; Q114311269
RX   PubMed=36027857;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Val201Asp (c.602T>A); ClinVar=VCV000004182; Zygosity=Homozygous (PubMed=36027857).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36027857
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 14
ST   D18S51: 13
ST   D19S433: 16.2
ST   D21S11: 30
ST   D2S1338: 19,25
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 21,23
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1YD ! CRTDi006-B
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi006-B
AC   CVCL_C1YD
SY   AGS1V201D_2
DR   BioSamples; SAMEA13151271
DR   hPSCreg; CRTDi006-B
DR   Wikidata; Q114311270
RX   PubMed=36027857;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Val201Asp (c.602T>A); ClinVar=VCV000004182; Zygosity=Homozygous (PubMed=36027857).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36027857
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 14
ST   D18S51: 13
ST   D19S433: 16.2
ST   D21S11: 30
ST   D2S1338: 19,25
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 21,23
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P2 ! CRTDi006-A
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi007-A
AC   CVCL_C1P3
SY   AGS1R114H_1
DR   BioSamples; SAMEA12983670
DR   hPSCreg; CRTDi007-A
DR   Wikidata; Q114311271
RX   PubMed=36027857;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Arg114His (c.341G>A); ClinVar=VCV000004179; Zygosity=Homozygous (PubMed=36027857).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36027857
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,18
ST   D19S433: 14
ST   D21S11: 30,30.2
ST   D2S1338: 19,23
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 7,8
ST   D8S1179: 12,16
ST   FGA: 19,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1YE ! CRTDi007-B
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi007-B
AC   CVCL_C1YE
SY   AGS1R114H_2
DR   BioSamples; SAMEA12984492
DR   hPSCreg; CRTDi007-B
DR   Wikidata; Q114311272
RX   PubMed=36027857;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Arg114His (c.341G>A); ClinVar=VCV000004179; Zygosity=Homozygous (PubMed=36027857).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36027857
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,18
ST   D19S433: 14
ST   D21S11: 30,30.2
ST   D2S1338: 19,23
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 7,8
ST   D8S1179: 12,16
ST   FGA: 19,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P3 ! CRTDi007-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi008-A
AC   CVCL_C1P4
DR   BioSamples; SAMEA13127436
DR   hPSCreg; CRTDi008-A
DR   Wikidata; Q114311273
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.Arg290His (c.869G>A); ClinVar=VCV002501214; Zygosity=Heterozygous (from autologous cell line CRTDi008-B).
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.Gln548Ter (c.1642C>T); ClinVar=VCV000004071; Zygosity=Heterozygous (from autologous cell line CRTDi008-B).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4SC ! CRTDi008-B
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi008-B
AC   CVCL_C4SC
SY   AGS5_R290H/Q548X
DR   BioSamples; SAMEA13127475
DR   hPSCreg; CRTDi008-B
DR   Wikidata; Q116048796
RX   PubMed=36115319;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.Arg290His (c.869G>A); ClinVar=VCV002501214; Zygosity=Heterozygous (PubMed=36115319).
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.Gln548Ter (c.1642C>T); ClinVar=VCV000004071; Zygosity=Heterozygous (PubMed=36115319).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P4 ! CRTDi008-A
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CRTDi009-A
AC   CVCL_C1P5
SY   AGS5_H167Y
DR   BioSamples; SAMEA13152764
DR   hPSCreg; CRTDi009-A
DR   Wikidata; Q114311274
RX   PubMed=36115319;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.His167Tyr (c.499C>T); Zygosity=Homozygous (PubMed=36115319).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P6 ! CRTDi009-B
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi009-B
AC   CVCL_C1P6
DR   BioSamples; SAMEA13127435
DR   hPSCreg; CRTDi009-B
DR   Wikidata; Q114311275
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.His167Tyr (c.499C>T); Zygosity=Homozygous (from autologous cell line CRTDi009-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P5 ! CRTDi009-A
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi010-A
AC   CVCL_C1P7
DR   BioSamples; SAMEA13155327
DR   hPSCreg; CRTDi010-A
DR   Wikidata; Q114311276
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.Arg164Ter (c.490C>T); ClinVar=VCV000004069; Zygosity=Homozygous (from autologous cell line CRTDi010-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4SB ! CRTDi010-B
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CRTDi010-B
AC   CVCL_C4SB
SY   AGS5_R164X
DR   BioSamples; SAMEA13155326
DR   hPSCreg; CRTDi010-B
DR   Wikidata; Q116048797
RX   PubMed=36115319;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Simple; p.Arg164Ter (c.490C>T); ClinVar=VCV000004069; Zygosity=Homozygous (PubMed=36115319).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P7 ! CRTDi010-A
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CRTDi011-A
AC   CVCL_C1P8
SY   IDP52555 #9
DR   BioSamples; SAMEA110177238
DR   hPSCreg; CRTDi011-A
DR   Wikidata; Q114311277
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P9 ! CRTDi011-B
OI   CVCL_C1PA ! CRTDi011-C
OI   CVCL_C1PB ! CRTDi011-D
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CRTDi011-B
AC   CVCL_C1P9
SY   IDP52555 #13
DR   BioSamples; SAMEA110177239
DR   hPSCreg; CRTDi011-B
DR   Wikidata; Q114311279
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P8 ! CRTDi011-A
OI   CVCL_C1PA ! CRTDi011-C
OI   CVCL_C1PB ! CRTDi011-D
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CRTDi011-C
AC   CVCL_C1PA
SY   IDP52555 #36
DR   BioSamples; SAMEA110177240
DR   hPSCreg; CRTDi011-C
DR   Wikidata; Q114311280
WW   Provider; TU Dresden; -; https://tu-dresden.de/cmcb/technologie-plattform/facilities/stem-cell-engineering/serviceleistungen/facility-hipsc-lines
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P8 ! CRTDi011-A
OI   CVCL_C1P9 ! CRTDi011-B
OI   CVCL_C1PB ! CRTDi011-D
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CRTDi011-D
AC   CVCL_C1PB
SY   IDP52555 #44
DR   BioSamples; SAMEA110177241
DR   hPSCreg; CRTDi011-D
DR   Wikidata; Q114311281
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1P8 ! CRTDi011-A
OI   CVCL_C1P9 ! CRTDi011-B
OI   CVCL_C1PA ! CRTDi011-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   CS
AC   CVCL_C0PF
DR   Wikidata; Q112929418
RX   PubMed=6316162;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   CS-1 [Human chondrosarcoma]
AC   CVCL_T023
SY   Cs-1; CS1; CHSA cell line
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_T023
DR   Cell_Model_Passport; SIDM00199
DR   Cosmic; 1992322
DR   Cosmic-CLP; 1290795
DR   DepMap; ACH-002099
DR   EGA; EGAS00001000978
DR   GDSC; 1290795
DR   GEO; GSM419912
DR   GEO; GSM1669710
DR   PharmacoDB; CS1_266_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54814518
RX   PubMed=12631627;
RX   PubMed=14637196;
RX   PubMed=19528443;
RX   PubMed=19742314;
RX   PubMed=24866169;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0.36%; East Asian, North=1.25%; East Asian, South=0%; South Asian=0%; European, North=68.97%; European, South=29.41% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): Cosmic-CLP=1290795
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 13,14
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 25
//
ID   CS-1 [Human leukemia]
AC   CVCL_T022
DR   Wikidata; Q54814519
RX   PubMed=12673685;
CC   Population: Caucasian.
CC   Doubling time: 57.6 +- 10.8 hours (PubMed=12673685).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   CS-1/ER
AC   CVCL_F1B2
SY   CS-1/ET
DR   GEO; GSM419913
RX   PubMed=19742314;
CC   Population: Caucasian.
CC   Characteristics: Exhibits cross resistance to cisplatin and methotrexate but not to doxorubicin (PubMed=19742314).
CC   Selected for resistance to: ChEBI; CHEBI_84050; Trabectedin (Ecteinascidin-743; ET-743).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T023 ! CS-1 [Human chondrosarcoma]
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CS-1/PR
AC   CVCL_F1B3
SY   CS-1/Zal
DR   GEO; GSM419914
RX   PubMed=19742314;
CC   Population: Caucasian.
CC   Characteristics: Exhibits cross resistance to cisplatin and methotrexate but not to doxorubicin (PubMed=19742314).
CC   Selected for resistance to: ChEBI; CHEBI_235523; Zalypsis (PM00104).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T023 ! CS-1 [Human chondrosarcoma]
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CS-10
AC   CVCL_C7TC
DR   Wikidata; Q117704263
RX   PubMed=12354749;
DI   NCIt; C3295; Osteochondroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   32Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-11
AC   CVCL_C7TD
DR   Wikidata; Q117704264
RX   PubMed=12354749;
DI   NCIt; C3295; Osteochondroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   19Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-12
AC   CVCL_C7TE
DR   Wikidata; Q117704265
RX   PubMed=12354749;
DI   NCIt; C8780; Recurrent chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   35Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-13
AC   CVCL_C7TF
DR   Wikidata; Q117704266
RX   PubMed=12354749;
DI   NCIt; C121870; Chondrosarcoma, grade 2
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   77Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   cs-17-25
AC   CVCL_8546
DR   JCRB; JCRB1102
DR   JCRB; NIHS0384
DR   Wikidata; Q54814520
RX   PubMed=1170023;
RX   PubMed=2437133;
RX   PubMed=8168155;
CC   Characteristics: Cold-sensitive mutant of CHL. Unable to form colonies in soft agar at 34.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0384; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   cs-19-36
AC   CVCL_8547
DR   JCRB; JCRB1103
DR   JCRB; NIHS0385
DR   Wikidata; Q54814521
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Cold-sensitive mutant of CHL. Unable to form colonies in soft agar at 34.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0385; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   CS-2
AC   CVCL_C7TG
DR   Wikidata; Q117704267
RX   PubMed=12354749;
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   50Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   cs-20-5
AC   CVCL_8548
DR   JCRB; JCRB1104
DR   JCRB; NIHS0386
DR   Wikidata; Q54814522
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Cold-sensitive mutant of CHL. Unable to form colonies in soft agar at 34.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0386; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   CS-3
AC   CVCL_C7TH
DR   Wikidata; Q117704268
RX   PubMed=12354749;
DI   NCIt; C8780; Recurrent chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   35Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-4
AC   CVCL_C7TI
SY   UIIA0
DR   GEO; GSM383853
DR   Wikidata; Q117704269
RX   PubMed=12354749;
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Cartilage; UBERON=UBERON_0002418.
CC   Cell type: Chondrocyte; CL=CL_0000138.
DI   NCIt; C121871; Chondrosarcoma, grade 3
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 3
//
ID   CS-5
AC   CVCL_C7TJ
DR   Wikidata; Q117704270
RX   PubMed=12354749;
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   31Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-56
AC   CVCL_C3BV
DR   Wikidata; Q114311284
RX   PubMed=6435883;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_18250; Chondroitin 4'-sulfate (Chondroitin sulfate A).
CC   Monoclonal antibody target: ChEBI; CHEBI_18296; Chondroitin 6'-sulfate (Chondroitin sulfate C).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   CS-6
AC   CVCL_C7TK
DR   Wikidata; Q117704271
RX   PubMed=12354749;
DI   NCIt; C121871; Chondrosarcoma, grade 3
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   77Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-7
AC   CVCL_C7TL
DR   Wikidata; Q117704272
RX   PubMed=12354749;
RX   PubMed=16765318;
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   41Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-8
AC   CVCL_C7TM
SY   UIIC0
DR   GEO; GSM383849
DR   Wikidata; Q117704273
RX   PubMed=12354749;
RX   PubMed=16765318;
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Cartilage; UBERON=UBERON_0002418.
CC   Cell type: Chondrocyte; CL=CL_0000138.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 3
//
ID   CS-9
AC   CVCL_C7TN
DR   Wikidata; Q117704274
RX   PubMed=12354749;
RX   PubMed=16765318;
DI   NCIt; C121871; Chondrosarcoma, grade 3
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   61Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   CS-99
AC   CVCL_U142
DR   Wikidata; Q54814523
RX   PubMed=18334012;
CC   Doubling time: 27 hours (Note=At 26th passage), 23 hours (Note=At 66th passage) (PubMed=18334012).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   CS-A-3
AC   CVCL_D3BC
DR   Wikidata; Q127380649
RX   PubMed=3770774;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Clavibacter sepedonicus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CS-B-5
AC   CVCL_D3BD
DR   Wikidata; Q127380650
RX   PubMed=3770774;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Clavibacter sepedonicus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CS-C1
AC   CVCL_W808
DR   Wikidata; Q54814524
RX   PubMed=2445463;
CC   Characteristics: Established from the 12th passage in nude mice of the OvCa-1 xenograft.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W809 ! CS-S1
OI   CVCL_W810 ! CS-S2
OI   CVCL_W811 ! CS-S3
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   CS-e
AC   CVCL_WB17
DR   IBRC; C10191
DR   Wikidata; Q93458910
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=602068; ! Salmo caspius (Caspian trout)
SX   Sex unspecified
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CS-OKB
AC   CVCL_D043
DR   Wikidata; Q54814525
RX   PubMed=9672194;
CC   Population: Japanese.
CC   Doubling time: 5 days (PubMed=9672194).
CC   Derived from site: Metastatic; Muscle, left biceps femoris; UBERON=UBERON_0001374.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 12
//
ID   CS-R
AC   CVCL_A7NP
SY   CSR
DR   Cosmic; 998744
DR   Wikidata; Q107114723
RX   PubMed=10233379;
RX   PubMed=10739008;
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CS-S1
AC   CVCL_W809
DR   Wikidata; Q54814526
RX   PubMed=2445463;
CC   Characteristics: Established from the 12th passage in nude mice of the OvCa-1 xenograft.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W808 ! CS-C1
OI   CVCL_W810 ! CS-S2
OI   CVCL_W811 ! CS-S3
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   CS-S2
AC   CVCL_W810
DR   Wikidata; Q54814527
RX   PubMed=2445463;
CC   Characteristics: Established from the 12th passage in nude mice of the OvCa-1 xenograft.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W808 ! CS-C1
OI   CVCL_W809 ! CS-S1
OI   CVCL_W811 ! CS-S3
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   CS-S3
AC   CVCL_W811
DR   Wikidata; Q54814528
RX   PubMed=2445463;
CC   Characteristics: Established from the 12th passage in nude mice of the OvCa-1 xenograft.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W808 ! CS-C1
OI   CVCL_W809 ! CS-S1
OI   CVCL_W810 ! CS-S2
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   CS-THL1
AC   CVCL_C1GK
SY   Cedars Sinai-Triple-Hit Lymphoma 1
DR   Wikidata; Q114311286
RX   PubMed=25916698;
RX   PubMed=35687491;
CC   Characteristics: Has chromosomal translocation of the MYC, BCL2 and BCL6 genes.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C131913; High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   CS0002iCTR-nxx
AC   CVCL_E8CP
SY   CS0002iCTRnxx; CS002
RX   PubMed=34746695;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CS00iCTR21-n1
AC   CVCL_ZC86
SY   CS00iCTR21n1; CS00iCTR-n1; 00iCTR
DR   Wikidata; Q98125715
RX   PubMed=25740845;
RX   PubMed=34746695;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs00ictr-n7xx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: African American.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X,Y
ST   CSF1PO: 8,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 8,12
ST   D7S820: 8,9
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7426 ! GM05400
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   CS00iCTR21-n2
AC   CVCL_UK08
SY   CS00iCTR21n2; CS00iCTR-n2; CS00iCTR
DR   CLO; CLO_0037521
DR   LINCS_LDP; LSC-1024
DR   Wikidata; Q93458938
RX   PubMed=25740845;
RX   PubMed=28526555;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs00ictr-n7xx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: African American.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7426 ! GM05400
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   CS0179iCTR-n1
AC   CVCL_E8CQ
SY   CS0179iCTR; W14-C179; W14C179
RX   PubMed=34746695;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 10,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CS01iMCT8
AC   CVCL_YP62
SY   CS01iMCT8-nxx
DR   Wikidata; Q93458942
RX   PubMed=28526555;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs01imct8-nxx/
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:10923; SLC16A2; Simple; p.Pro247Leu (c.740C>T); Zygosity=Hemizygous (PubMed=28526555).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   CS01iMCT8cor
AC   CVCL_YP63
DR   Wikidata; Q93458945
RX   PubMed=28526555;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:10923; SLC16A2; Simple_corrected; p.Pro247Leu (c.740C>T); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=28526555).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP62 ! CS01iMCT8
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   CS0201iCTR-n1
AC   CVCL_E8CR
SY   CS0201iCTR; W15-C201; W15C201
RX   PubMed=34746695;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11,14
ST   D7S820: 8,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CS0206iCTR-n1
AC   CVCL_E8CS
SY   CS0206iCTR; W15-C206
RX   PubMed=34746695;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CS02iCTR
AC   CVCL_YR34
DR   Wikidata; Q93458951
RX   PubMed=28526555;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   CS03iCTR
AC   CVCL_YP64
SY   CS03iCTR-nxx
DR   Wikidata; Q93458954
RX   PubMed=28526555;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs03ictr-nxx/
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 7
//
ID   CS03iCTRmut
AC   CVCL_YP65
DR   Wikidata; Q93458958
RX   PubMed=28526555;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:10923; SLC16A2; Simple_edited; p.Pro247Leu (c.740C>T); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=28526555).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP64 ! CS03iCTR
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   CS03iHD-53nxx
AC   CVCL_YU34
DR   Wikidata; Q93458960
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs03ihd-53nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[53] (c.52CAG(53)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Cedars-Sinai).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 11
//
ID   CS04iALS-SOD1H44Rn3
AC   CVCL_UK09
SY   CS04iALS-SOD1H44Rnxx
DR   CLO; CLO_0037520
DR   LINCS_LDP; LSC-1023
DR   Wikidata; Q93458963
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs04ials-sod1h44rnxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His44Arg (c.131A>G) (H43R); ClinVar=VCV000014756; Zygosity=Heterozygous (Cedars-Sinai).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY49 ! ND50068
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   CS06iCTR
AC   CVCL_YU35
SY   CS06iCTR-nxx
DR   Wikidata; Q93458966
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs06ictr-nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7334 ! GM01706
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   CS08iFAD-nxx
AC   CVCL_YX93
DR   Wikidata; Q93458970
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs08ifad-nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (Cedars-Sinai).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T872 ! AG09908
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 12
//
ID   CS09iHD109-n1
AC   CVCL_ZC79
SY   CS09iHD109n1
DR   Wikidata; Q98125716
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC78 ! ND39258
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS09iHD109-n4
AC   CVCL_ZC80
SY   CS09iHD109n4
DR   Wikidata; Q98125717
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC78 ! ND39258
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS09iHD109-n5
AC   CVCL_ZC81
SY   CS09iHD109n5
DR   Wikidata; Q98125718
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC78 ! ND39258
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS10BR
AC   CVCL_ZN67
SY   Cockayne Syndrome 10 BRighton
DR   Wikidata; Q98125719
RX   PubMed=9443879;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys1203Argfs*33 (c.3607_3608insGGGCTGGCTGCTTAAGGTCCACCTTA) (3686ins26); ClinVar=VCV000190168; Zygosity=Homozygous (PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS10LO
AC   CVCL_ZN69
SY   Cockayne Syndrome 10 LOndon
DR   Wikidata; Q98125720
RX   PubMed=8834235;
RX   PubMed=9443879;
RX   PubMed=19179371;
RX   PubMed=22466610;
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Ser429Lysfs*7 (c.1280dupT); ClinVar=VCV000190146; Zygosity=Homozygous (PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS11iALS-SOD1I114Tn10
AC   CVCL_UK10
SY   CS11iALS-SOD1I113Tn10
DR   CLO; CLO_0037530
DR   LINCS_LDP; LSC-1033
DR   Wikidata; Q93458974
WW   Provider; Cedars-Sinai; -; https://www.cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/ALS-iPSC-Lines.aspx
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (Cedars-Sinai).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY50 ! ND50071
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   CS138isALS-Tn1
AC   CVCL_UK13
SY   CS138isALS-Tnxx
DR   CLO; CLO_0037526
DR   LINCS_LDP; LSC-1029
DR   Wikidata; Q93458977
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs138isals-tnxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA23 ! ND50077
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   CS14iCTR28-n5
AC   CVCL_ZC85
SY   CS14iCTR28n5
DR   Wikidata; Q98125721
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   CS14iCTR28-n6
AC   CVCL_JK54
SY   CS14iCTR28n6; CS14iCTR-n6; CS14iCTR
DR   CLO; CLO_0037500
DR   LINCS_LDP; LSC-1002
DR   Wikidata; Q54814529
RX   PubMed=25740845;
RX   PubMed=28526555;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   CS14isALS-Tn16
AC   CVCL_UK11
DR   CLO; CLO_0037519
DR   LINCS_LDP; LSC-1022
DR   Wikidata; Q93458984
WW   Provider; Cedars-Sinai; -; https://www.cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/ALS-iPSC-Lines.aspx
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA20 ! ND50073
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   CS152isALS-Tn2
AC   CVCL_UK14
SY   CS152isALS-Tnxx
DR   CLO; CLO_0037527
DR   LINCS_LDP; LSC-1030
DR   Wikidata; Q93458988
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs152isals-tnxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA30 ! ND50084
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   CS15PV
AC   CVCL_ZS00
SY   Cockayne Syndrome 15 PaVia
DR   Wikidata; Q98125722
RX   PubMed=29572252;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Homozygous (PubMed=29572252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS166isALS-Tn2
AC   CVCL_UK15
SY   CS166isALS-Tnxx
DR   CLO; CLO_0037524
DR   LINCS_LDP; LSC-1027
DR   Wikidata; Q93458990
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs166isals-tnxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA28 ! ND50082
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   CS1ABR
AC   CVCL_ZN68
SY   Cockayne Syndrome 1 Australia BRisbane
DR   Wikidata; Q98125723
RX   DOI=10.1086/302394;
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
RX   PubMed=9443879;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; c.2599-26A>G; ClinVar=VCV000190162; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e; DOI=10.1086/302394).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys1203Argfs*33 (c.3607_3608insGGGCTGGCTGCTTAAGGTCCACCTTA) (3686ins26); ClinVar=VCV000190168; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e; DOI=10.1086/302394).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CS1AN
AC   CVCL_L471
SY   Cockayne Syndrome 1 ANn Arbor; UM106; UM 106; GM00739; GM-739; GM 739; GM739; GM00739A
DR   CLO; CLO_0028821
DR   Coriell; GM00739
DR   GEO; GSM3738754
DR   GEO; GSM3738755
DR   JCRB; KURB1910
DR   Wikidata; Q54836433
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=157803;
RX   PubMed=431551;
RX   PubMed=1339317;
RX   PubMed=2973075;
RX   PubMed=6492896;
RX   PubMed=7264357;
RX   PubMed=7301938;
RX   PubMed=7360141;
RX   PubMed=8609460;
RX   PubMed=12665480;
RX   PubMed=18079351;
RX   PubMed=19329487;
RX   PubMed=34271225;
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (PubMed=6492896).
CC   Doubling time: 50 hours (PubMed=8609460).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys337Ter (c.1009A>T) (A1088T); ClinVar=VCV000550722; Zygosity=Heterozygous (PubMed=1339317).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg857Ter (c.2569C>T); ClinVar=VCV000553383; Zygosity=Heterozygous (PubMed=1339317).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34271225
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 18.3,20
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 14,19
ST   D19S433: 13,14
ST   D1S1656: 16
ST   D21S11: 30,30.2
ST   D2S1338: 18,24
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D6S1043: 17,19
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 19,23
ST   Penta D: 10,15
ST   Penta E: 7,11
ST   TH01: 6,7
ST   TPOX: 8,11
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 23
//
ID   CS1AN-S3-G2
AC   CVCL_L472
SY   CS1AN.S3.G2; CS1-AN.S3.G2; CS1ANps3g2; GM16095; GM739(SV); GM739SV
DR   Coriell; GM16095
DR   GEO; GSM3048742
DR   GEO; GSM3048743
DR   GEO; GSM3048744
DR   GEO; GSM3048745
DR   JCRB; JCRB3022
DR   JCRB; KURB1911
DR   Wikidata; Q54848319
RX   PubMed=1339317;
RX   PubMed=3002824;
RX   PubMed=7664335;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys337Ter (c.1009A>T) (A1088T); ClinVar=VCV000550722; Zygosity=Hemizygous (PubMed=1339317).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; KURB1911; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3022
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L471 ! CS1AN
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 22
//
ID   CS1ATM
AC   CVCL_B5LX
DR   JCRB; KURB1921
DR   Wikidata; Q111733137
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CS1AW
AC   CVCL_M677
DR   JCRB; KURB1895
DR   Wikidata; Q54814530
RX   DOI=10.11251/ojjscn1969.10.465;
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (from familial inference of CS2AW).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   CS1AW(SV)
AC   CVCL_ZY32
DR   JCRB; KURB1896
DR   Wikidata; Q102113718
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M677 ! CS1AW
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   CS1BE
AC   CVCL_L473
SY   Cockayne Syndrome 1 BEthesda; GM01629; GM-1629; GM 1629; GM1629
DR   CLO; CLO_0031492
DR   BioSample; SAMN00806991
DR   Coriell; GM01629
DR   JCRB; JCRB3040
DR   JCRB; KURB1918
DR   Wikidata; Q54836963
RX   CelloPub=CLPUB00447;
RX   DOI=10.21954/ou.ro.0000e27e;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7301938;
RX   PubMed=8317483;
RX   PubMed=9443879;
RX   PubMed=12665480;
RX   PubMed=27543334;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg670Trp (c.2008C>T) (C2087T); ClinVar=VCV000190158; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Tyr1179Leufs*22 (c.3536delA) (3615delA); ClinVar=VCV000190167; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Discontinued: JCRB; KURB1918; probable.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3040
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   CS1BI
AC   CVCL_ZQ18
SY   Cockayne Syndrome 1 BIrmingham
DR   Wikidata; Q98125725
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS1BO
AC   CVCL_ZQ19
SY   Cockayne Syndrome 1 BOston
DR   Wikidata; Q98125727
RX   PubMed=8834235;
RX   PubMed=9443879;
RX   PubMed=18079351;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys506Asnfs*37 (c.1518delG) (1597delG); ClinVar=VCV000190150; Zygosity=Heterozygous (PubMed=9443879).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Pro1095Arg (c.3284C4G) (G3363C); ClinVar=VCV000001707; Zygosity=Heterozygous (PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS1BR
AC   CVCL_ZN61
SY   Cockayne Syndrome 1 BRighton
DR   Wikidata; Q98125728
RX   PubMed=18079351;
RX   PubMed=29572252;
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Val161Ile (c.481G>A); ClinVar=VCV000645783; Zygosity=Homozygous (PubMed=29572252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS1FABE
AC   CVCL_C3Q6
SY   Cockayne Syndrome 1 FArgo BEthesda; GM05324; RB 5324
DR   Coriell; GM05324
DR   Wikidata; Q116048798
RX   PubMed=6096450;
CC   Discontinued: Coriell; GM05324; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3Q7 ! CS1FABE LCL
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CS1FABE LCL
AC   CVCL_C3Q7
SY   Cockayne Syndrome 1 FArgo BEthesda LCL; GM05325; RB 5325
DR   Coriell; GM05325
DR   Wikidata; Q116048799
RX   PubMed=6096450;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM05325; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3Q6 ! CS1FABE
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CS1IAF
AC   CVCL_ZN73
DR   Wikidata; Q98125729
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
RX   PubMed=9443879;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Val957Gly (c.2870T>G) (T2949G); ClinVar=VCV001704479; Zygosity=Homozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS1MA
AC   CVCL_ZN74
SY   Cockayne Syndrome 1 MAnchester
DR   Wikidata; Q98125730
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
RX   PubMed=9443879;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Phe665_Gln723del (c.1993_2169del177); Zygosity=Homozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS1MO
AC   CVCL_ZP14
SY   Cockayne Syndrome 1 MOriguchi
DR   JCRB; KURB1885
DR   JCRB; KURB1886
DR   Wikidata; Q98125731
RX   PubMed=9777763;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS1OS
AC   CVCL_M678
SY   Cockayne Syndrome 1 OSaka
DR   JCRB; KURB1906
DR   Wikidata; Q54814531
RX   PubMed=7151298;
RX   PubMed=9777763;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CS1PV
AC   CVCL_L862
SY   Cockayne Syndrome 1 PaVia
DR   CLO; CLO_0002621
DR   CLDB; cl917
DR   Wikidata; Q54814532
RX   PubMed=8823375;
RX   PubMed=8834235;
RX   PubMed=19329487;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   CS1TAN
AC   CVCL_ZN59
SY   Cockayne Syndrome 1 Turkey ANkara
DR   Wikidata; Q98125732
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
RX   PubMed=9443879;
RX   PubMed=10767341;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=10767341
ST   Amelogenin: X,Y
ST   D21S11: 29,31.2
ST   FGA: 20,24
ST   TH01: 8,9
ST   vWA: 17,18
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS1USAU
AC   CVCL_ZP65
DR   Wikidata; Q98125733
RX   PubMed=23623389;
RX   PubMed=30165384;
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Cys236Arg (c.706T>C); ClinVar=VCV000055827; Zygosity=Heterozygous (PubMed=23623389).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Tyr577Ter (c.1730dupA); ClinVar=VCV000055828; Zygosity=Heterozygous (PubMed=23623389).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS1YO
AC   CVCL_B5LS
SY   Cockayne Syndrome 1 YOkohama
DR   JCRB; KURB1955
DR   Wikidata; Q111733138
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CS1YOF
AC   CVCL_B5LT
SY   Cockayne Syndrome 1 YOkohama Father
DR   JCRB; KURB1957
DR   Wikidata; Q111733139
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CS1YOM
AC   CVCL_B5LU
SY   Cockayne Syndrome 1 YOkohama Mother
DR   JCRB; KURB1958
DR   Wikidata; Q111733140
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CS2-1
AC   CVCL_WB15
DR   IBRC; C10192
DR   Wikidata; Q93459019
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=602068; ! Salmo caspius (Caspian trout)
SX   Sex unspecified
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CS2-2
AC   CVCL_WB16
DR   IBRC; C10190
DR   Wikidata; Q93459022
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=602068; ! Salmo caspius (Caspian trout)
SX   Sex unspecified
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   CS2-Cl26
AC   CVCL_D3FJ
SY   CS2 clone 26
DR   Wikidata; Q127380651
RX   PubMed=36744062;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a Superfolder GFP (sfGFP) construct was inserted at the C-terminal end of PLP1 (PubMed=36744062).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36744062
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,14
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 16,24
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 8,9
ST   D8S1179: 15
ST   FGA: 20,22.2
ST   Penta D: 9,13
ST   Penta E: 13,18
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3FI ! CS2PFYiCTR-nxx
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   CS20LO
AC   CVCL_ZP67
SY   Cockayne Syndrome 20 LOndon
DR   Wikidata; Q98125734
RX   PubMed=23623389;
CC   Sequence variation: Mutation; HGNC; HGNC:3433; ERCC1; Simple; p.Phe231Leu (c.693C>G); ClinVar=VCV000016778; Zygosity=Homozygous (PubMed=23623389).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS210BE
AC   CVCL_EG51
SY   Cockayne Syndrome 210 BEthesda; GM17536
DR   CLO; CLO_0013056
DR   Coriell; GM17536
DR   Wikidata; Q54848961
RX   PubMed=27543334;
CC   Population: Pakistani.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   CS21iHD60-n5
AC   CVCL_ZC82
SY   CS21iHD60n5; HD60n5
DR   Wikidata; Q98125736
RX   PubMed=25740845;
RX   PubMed=35805069;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[60] (c.52CAG(60)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F063 ! GM03621
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   CS21iHD60-n8
AC   CVCL_ZC83
SY   CS21iHD60n8
DR   Wikidata; Q98125737
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[60] (c.52CAG(60)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F063 ! GM03621
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS22iALS-SOD1I114Tn2
AC   CVCL_UK12
SY   CS22iALS-SOD1I114Tnxx; CS22iALS-SOD1I113Tn2
DR   CLO; CLO_0037525
DR   LINCS_LDP; LSC-1028
DR   Wikidata; Q93459027
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs22ials-sod1i114tnxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (Cedars-Sinai).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA38 ! ND50096
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   CS24iALS-SOD1E50Kn9
AC   CVCL_A9SS
SY   CS24iALS-SOD1E49Knxx
DR   Wikidata; Q102113720
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs24ials-sod1e50knxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu50Lys (c.148G>A) (E49K); ClinVar=VCV000658902; Zygosity=Unspecified (Cedars-Sinai).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T862 ! ND39026
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 10
//
ID   CS25iCTR-18n2
AC   CVCL_IW29
SY   CS25iCTR-18nxx; 25iCTR; 25i
DR   CLO; CLO_0037502
DR   LINCS_LDP; LSC-1004
DR   Wikidata; Q54814533
RX   PubMed=26185257;
RX   PubMed=34746695;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs25ictr-18nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y895 ! ND30625
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   CS267BE
AC   CVCL_EG47
SY   Cockayne Syndrome 267 BEthesda; GM11551
DR   CLO; CLO_0021057
DR   Coriell; GM11551
DR   Wikidata; Q54845152
RX   PubMed=12060391;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG46 ! CS267BE LCL
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   CS267BE LCL
AC   CVCL_EG46
SY   Cockayne Syndrome 267 BEthesda LCL; GM11550
DR   CLO; CLO_0021058
DR   Coriell; GM11550
DR   Wikidata; Q54845151
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG47 ! CS267BE
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CS28iALS-C9n1
AC   CVCL_W558
SY   CS28iALS-n1; 28iALS-n1
DR   SKIP; SKIP000320
DR   Wikidata; Q54814534
RX   PubMed=24154603;
WW   Provider; Cedars-Sinai; -; https://www.cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/ALS-iPSC-Lines.aspx
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24154603).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9T5 ! F09128
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   CS28iALS-C9n2
AC   CVCL_JC26
SY   CS28iALS-n2A
DR   CLO; CLO_0037503
DR   CLO; CLO_0037528
DR   LINCS_LDP; LSC-1005
DR   LINCS_LDP; LSC-1031
DR   Wikidata; Q54814536
WW   Provider; Cedars-Sinai; -; https://www.cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/ALS-iPSC-Lines.aspx
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (Cedars-Sinai).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9T5 ! F09128
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 15
//
ID   CS29iALS-C9n1
AC   CVCL_W559
SY   CS29iALS-n1N; 29iALS-n1
DR   CLO; CLO_0037504
DR   CLO; CLO_0037522
DR   LINCS_LDP; LSC-1006
DR   LINCS_LDP; LSC-1025
DR   SKIP; SKIP000321
DR   Wikidata; Q54814537
RX   PubMed=24154603;
WW   Provider; Cedars-Sinai; -; https://www.cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/ALS-iPSC-Lines.aspx
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24154603).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9SR ! F09229
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   CS2AN
AC   CVCL_ZS03
SY   Cockayne Syndrome 2 ANn Arbor; UM102; UM 102
DR   Wikidata; Q98125738
RX   PubMed=431551;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS2AW
AC   CVCL_2879
DR   BioSample; SAMN03471618
DR   JCRB; JCRB0310
DR   JCRB; KURB1889
DR   Wikidata; Q54814538
RX   DOI=10.11251/ojjscn1969.10.465;
RX   PubMed=12655141;
RX   PubMed=22466610;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (PubMed=12655141).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0310
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   CS2AW(SVT)
AC   CVCL_YX95
DR   JCRB; KURB1890
DR   Wikidata; Q93459077
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2879 ! CS2AW
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   CS2AWTERT
AC   CVCL_2880
DR   JCRB; JCRB1059
DR   JCRB; NIHS0309
DR   Wikidata; Q54814545
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; NIHS0309; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1059
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2879 ! CS2AW
SX   Female
AG   4Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   CS2BE
AC   CVCL_7314
SY   Cockayne Syndrome 2 BEthesda; CS5HO; GM01098; GM-1098; GM 1098; GM1098; GM 1098B; GM01098B
DR   CLO; CLO_0030186
DR   BioSample; SAMN00803626
DR   Coriell; GM01098
DR   JCRB; KURB1916
DR   Wikidata; Q54836644
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=157803;
RX   PubMed=431551;
RX   PubMed=6096450;
RX   PubMed=6622549;
RX   PubMed=7301938;
RX   PubMed=7471106;
RX   PubMed=9443879;
RX   PubMed=9777763;
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Ser222Tyrfs*25 (c.665_723del59) (Ex10del); Zygosity=Heterozygous (PubMed=9443879).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Tyr1179Ilefs*22 (c.3535delT); Zygosity=Heterozygous (PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L458 ! CS2BE LCL
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   CS2BE LCL
AC   CVCL_L458
SY   Cockayne Syndrome 2 BEthesda LCL; GM01712; GM-1712; GM 1712; GM1712; GM01712A
DR   CLO; CLO_0030988
DR   BioSample; SAMN00807099
DR   Coriell; GM01712
DR   Wikidata; Q54837029
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2805228;
RX   PubMed=3180052;
RX   PubMed=6096450;
CC   Population: Caucasian.
CC   HLA typing: A*w32,10; B*w15,14 (Coriell=GM01712).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Ser222Tyrfs*25 (c.665_723del59) (Ex10del); Zygosity=Heterozygous (Coriell=GM01712).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Tyr1179Ilefs*22 (c.3535delT); Zygosity=Heterozygous (Coriell=GM01712).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7314 ! CS2BE
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 20
//
ID   CS2BI
AC   CVCL_ZN70
SY   Cockayne Syndrome 2 BIrmingham
DR   Wikidata; Q98125739
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
RX   PubMed=9443879;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg670Trp (c.2008C>T) (C2087T); ClinVar=VCV000190158; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Pro1042Leu (c.3125C>T) (C3204T); Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS2BR
AC   CVCL_ZN62
SY   Cockayne Syndrome 2 BRighton
DR   Wikidata; Q98125741
RX   PubMed=8834235;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS2IAF
AC   CVCL_ZT16
DR   Wikidata; Q98125742
RX   PubMed=8834235;
RX   PubMed=9338586;
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Tyr322Ter (c.966C>A); ClinVar=VCV000001715; Zygosity=Homozygous (PubMed=9338586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS2GO
AC   CVCL_ZT14
SY   Cockayne Syndrome 2 GOthenburg
DR   Wikidata; Q98125744
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Leu45Pro (c.134C>T) (C213T); Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Trp851Arg (c.2551T>A) (T2630A); ClinVar=VCV000522698; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg1213Gly (c.3637A>G) (A3716G); ClinVar=VCV000129017; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e).
CC   Caution: CS2GO (Cellosaurus=CVCL_ZT14) and CS3GO (Cellosaurus=CVCL_ZT15) originate from 2 siblings, however their mutation profile is different, different hypothesis are proposed about this issue (DOI=10.21954/ou.ro.0000e27e).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS2MO
AC   CVCL_ZP17
SY   Cockayne Syndrome 2 MOriguchi
DR   JCRB; KURB1887
DR   Wikidata; Q98125745
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS2OS
AC   CVCL_2881
SY   Cockayne Syndrome 2 OSaka
DR   BioSample; SAMN03471617
DR   JCRB; JCRB0309
DR   JCRB; KURB1900
DR   Wikidata; Q54814546
RX   PubMed=12655141;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (PubMed=12655141).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0309
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11,13
ST   vWA: 16
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   CS2OS hTERT-1
AC   CVCL_ZY33
DR   JCRB; JCRB3065
DR   JCRB; KURB1904
DR   Wikidata; Q102113721
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; JCRB3065; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2881 ! CS2OS
SX   Male
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CS2OS hTERT-2
AC   CVCL_ZY34
DR   JCRB; KURB1905
DR   Wikidata; Q102113722
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2881 ! CS2OS
SX   Male
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CS2OS(SVT)
AC   CVCL_2882
DR   JCRB; JCRB1056
DR   JCRB; KURB1902
DR   JCRB; NIHS0305
DR   Wikidata; Q54814547
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; NIHS0305; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1056
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11,13
ST   vWA: 16
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2881 ! CS2OS
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   CS2PFYiCTR-nxx
AC   CVCL_D3FI
SY   CS2PFYiCTR-nx.x
DR   Wikidata; Q127380652
RX   PubMed=36744062;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs2pfyictr-nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36744062
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,14
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 16,24
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 8,9
ST   D8S1179: 15
ST   FGA: 20,22.2
ST   Penta D: 9,13
ST   Penta E: 13,18
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CS2SE
AC   CVCL_ZN64
SY   Cockayne Syndrome 2 SEndai
DR   Wikidata; Q98125746
RX   PubMed=7513056;
RX   PubMed=12655141;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Gln106Pro (c.317A>C); Zygosity=Heterozygous (PubMed=12655141).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Heterozygous (PubMed=12655141).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   CS2TAN
AC   CVCL_ZN58
SY   Cockayne Syndrome 2 Turkey ANkara
DR   Wikidata; Q98125748
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
RX   PubMed=9443879;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Trp517Ter (c.1550G>A); ClinVar=VCV000001700; Zygosity=Homozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS30iALS-C9n1
AC   CVCL_W560
SY   CS30iALS-C9nxx; CS30iALS-n1N; CS30iALS-n1A; 30iALS-n1
DR   CLO; CLO_0037505
DR   CLO; CLO_0037523
DR   LINCS_LDP; LSC-1007
DR   LINCS_LDP; LSC-1026
DR   SKIP; SKIP000322
DR   Wikidata; Q54814548
RX   PubMed=24154603;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs30ials-c9nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24154603).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA21 ! ND50074
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   CS32iSMA-n3
AC   CVCL_IW30
SY   CS32iSMA-nxx
DR   CLO; CLO_0037507
DR   LINCS_LDP; LSC-1009
DR   Wikidata; Q54814549
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs32isma-nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (Cedars-Sinai).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y965 ! GM00232
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 17
//
ID   CS3AM
AC   CVCL_ZP09
DR   Wikidata; Q98125749
RX   PubMed=9777763;
RX   PubMed=21143350;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg77Ter (c.229C>T) (C308T); ClinVar=VCV000001708; Zygosity=Homozygous (PubMed=21143350).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173106; UV-sensitive syndrome 1
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS3AN
AC   CVCL_ZS04
SY   Cockayne Syndrome 3 ANn Arbor; UM110
DR   Wikidata; Q98125750
RX   PubMed=431551;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS3BE
AC   CVCL_F632
SY   Cockayne Syndrome 3 BEthesda; GM01856; GM-1856; GM 1856; GM1856; GM01856B; GM 1856B
DR   CLO; CLO_0031403
DR   BioSample; SAMN00807229
DR   Coriell; GM01856
DR   JCRB; KURB1908
DR   Wikidata; Q54837129
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2903889;
RX   PubMed=6096450;
RX   PubMed=7301938;
RX   PubMed=8317483;
RX   PubMed=9777763;
RX   PubMed=15744458;
RX   PubMed=17297471;
RX   PubMed=18079351;
RX   PubMed=19329487;
RX   PubMed=27543334;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Heterozygous (PubMed=15744458).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Ala160Val (c.479C>T); ClinVar=VCV000001717; Zygosity=Heterozygous (PubMed=15744458).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F633 ! CS3BE LCL
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   CS3BE LCL
AC   CVCL_F633
SY   Cockayne Syndrome 3 BEthesda LCL; GM01857; GM-1857; GM 1857; GM01857A
DR   CLO; CLO_0031392
DR   BioSample; SAMN00807231
DR   Coriell; GM01857
DR   Wikidata; Q54837130
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
CC   Population: Caucasian.
CC   HLA typing: A*09,11; B*07,w15 (Coriell=GM01857).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Heterozygous (from autologous cell line CS3BE).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Ala160Val (c.479C>T); ClinVar=VCV000001717; Zygosity=Heterozygous (from autologous cell line CS3BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F632 ! CS3BE
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   CS3BE-S3-G1
AC   CVCL_F631
SY   CS3BE.S3.G1; CS3BE.S3G1; CS3BEs3gl; CS3BESV; GM16094; GM1856(SV)
DR   CLO; CLO_0018853
DR   BioSample; SAMN00804326
DR   Coriell; GM16094
DR   JCRB; KURB1909
DR   Wikidata; Q54848318
RX   PubMed=1339317;
RX   PubMed=2903889;
RX   PubMed=3002824;
RX   PubMed=7664335;
RX   PubMed=7671243;
RX   PubMed=19329487;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Ala160Val (c.479C>T); ClinVar=VCV000001717; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F632 ! CS3BE
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   CS3BR
AC   CVCL_ZN63
SY   Cockayne Syndrome 3 BRighton
DR   Wikidata; Q98125751
RX   PubMed=7825573;
RX   PubMed=8834235;
RX   PubMed=29572252;
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Leu271Pro (c.812T>C); ClinVar=VCV000354015; Zygosity=Homozygous (PubMed=29572252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS3GO
AC   CVCL_ZT15
SY   Cockayne Syndrome 3 GOthenburg
DR   Wikidata; Q98125752
RX   DOI=10.21954/ou.ro.0000e27e;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg1213Gly (c.3637A>G) (A3716G); ClinVar=VCV000129017; Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; c.3779_4574del (3858-4653del); Zygosity=Heterozygous (DOI=10.21954/ou.ro.0000e27e).
CC   Caution: CS2GO (Cellosaurus=CVCL_ZT14) and CS3GO (Cellosaurus=CVCL_ZT15) originate from 2 siblings, however their mutation profile is different, different hypothesis are proposed about this issue (DOI=10.21954/ou.ro.0000e27e).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS3IAF
AC   CVCL_ZT17
DR   Wikidata; Q98125754
RX   PubMed=8834235;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   CS3LO
AC   CVCL_ZN60
SY   Cockayne Syndrome 3 LOndon
DR   Wikidata; Q98125755
RX   PubMed=8834235;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2-3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS3TAN
AC   CVCL_ZN71
SY   Cockayne Syndrome 3 Turkey ANkara
DR   Wikidata; Q98125756
RX   DOI=10.21954/ou.ro.0000e27e;
RX   PubMed=8834235;
RX   PubMed=9443879;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Trp851Arg (c.2551T>A) (T2630A); ClinVar=VCV000522698; Zygosity=Homozygous (DOI=10.21954/ou.ro.0000e27e; PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1-2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS40iFAD-nxx
AC   CVCL_YX94
DR   Wikidata; Q93459117
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs40ifad-nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (Cedars-Sinai).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H793 ! AG06840
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 11
//
ID   CS4AN
AC   CVCL_ZS05
SY   Cockayne Syndrome 4 ANn Arbor; UM111
DR   Wikidata; Q98125757
RX   PubMed=431551;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS4BR
AC   CVCL_W050
SY   Cockayne Syndrome 4 BRighton
DR   Wikidata; Q54814550
RX   PubMed=8823375;
RX   PubMed=8834235;
RX   PubMed=9443879;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Gln184Ter (c.550C>T) (C629T); ClinVar=VCV001459151; Zygosity=Heterozygous (PubMed=9443879).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg670Trp (c.2008C>T) (C2087T); ClinVar=VCV000190158; Zygosity=Heterozygous (PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2557 ! CS4BR LCL
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   CS4BR LCL
AC   CVCL_2557
SY   Cockayne Syndrome 4 BRighton LCL; LB242; 242
DR   ECACC; 98062324
DR   Wikidata; Q54902050
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Gln184Ter (c.550C>T) (C629T); ClinVar=VCV001459151; Zygosity=Heterozygous (from autologous cell line CS4BR).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg670Trp (c.2008C>T) (C2087T); ClinVar=VCV000190158; Zygosity=Heterozygous (from autologous cell line CS4BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W050 ! CS4BR
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   CS4IAF
AC   CVCL_ZT18
DR   Wikidata; Q98125759
RX   PubMed=8834235;
CC   Population: Arab.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS4MI
AC   CVCL_B5LW
SY   Cockayne Syndrome 4 MIe prefecture
DR   JCRB; KURB1932
DR   Wikidata; Q111733141
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CS4PV
AC   CVCL_YQ72
SY   Cockayne Syndrome 4 PaVia
DR   Wikidata; Q93459124
RX   PubMed=17297471;
RX   PubMed=29572252;
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asn75Glnfs*9 (c.223_227del5); ClinVar=VCV001455112; Zygosity=Homozygous (PubMed=29572252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   CS52iALS-C9n1
AC   CVCL_W561
SY   CS52iALS-n1; 52iALS-n1
DR   SKIP; SKIP000323
DR   Wikidata; Q54814551
RX   PubMed=24154603;
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs52ials-c9nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24154603).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZD02 ! F09152
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   CS52iALS-C9n6
AC   CVCL_JC27
SY   CS52iALS-n6A
DR   CLO; CLO_0037506
DR   CLO; CLO_0037529
DR   LINCS_LDP; LSC-1008
DR   LINCS_LDP; LSC-1032
DR   Wikidata; Q54814552
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs52ials-c9nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (Cedars-Sinai).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZD02 ! F09152
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 16
//
ID   CS58iMCT8
AC   CVCL_YP61
DR   Wikidata; Q93459137
RX   PubMed=28526555;
CC   Sequence variation: Mutation; HGNC; HGNC:10923; SLC16A2; Simple; p.Ala330fs*12; Zygosity=Hemizygous (PubMed=28526555).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   CS5BR
AC   CVCL_ZN78
SY   Cockayne Syndrome 5 BRighton
DR   Wikidata; Q98125760
RX   PubMed=7664335;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Unexplicit; Mutation in splice donor site of intron 9; Zygosity=Homozygous (PubMed=7664335).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS5IAF
AC   CVCL_ZT19
DR   Wikidata; Q98125761
RX   PubMed=8834235;
RX   PubMed=29572252;
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Tyr322Ter (c.966C>A); ClinVar=VCV000001715; Zygosity=Homozygous (PubMed=29572252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS5LO
AC   CVCL_ZT21
SY   Cockayne Syndrome 5 LOndon
DR   Wikidata; Q98125762
RX   PubMed=8834235;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS5MI
AC   CVCL_B5LV
SY   Cockayne Syndrome 5 MIe prefecture
DR   JCRB; KURB1933
DR   Wikidata; Q111733142
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   CS697CTO
AC   CVCL_ZS08
SY   Cockayne Syndrome 697 Canada TOronto
DR   Wikidata; Q98125763
RX   PubMed=157803;
RX   PubMed=7067035;
RX   PubMed=7360141;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   CS698CTO
AC   CVCL_ZS09
SY   Cockayne Syndrome Heterozygote 698 Canada TOronto
DR   Wikidata; Q98125765
RX   PubMed=157803;
RX   PubMed=7067035;
RX   PubMed=7360141;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   CS6BR
AC   CVCL_ZN79
SY   Cockayne Syndrome 6 BRighton
DR   Wikidata; Q98125767
RX   PubMed=7664335;
RX   PubMed=7825573;
RX   PubMed=8834235;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Unexplicit; Mutation in splice donor site of intron 9; Zygosity=Homozygous (PubMed=7664335).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS6MO
AC   CVCL_ZS06
SY   Cockayne Syndrome 6 MOntreal
DR   Wikidata; Q98125768
RX   PubMed=431551;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS6PV
AC   CVCL_YQ73
SY   Cockayne Syndrome 6 PaVia
DR   Wikidata; Q93459139
RX   PubMed=17297471;
RX   PubMed=19329487;
RX   PubMed=29572252;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   CS77iSMA-n5
AC   CVCL_IW31
DR   CLO; CLO_0037509
DR   LINCS_LDP; LSC-1012
DR   Wikidata; Q54814553
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, ocular lens; UBERON=UBERON_0000965.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W562 ! GM09677
SX   Male
AG   1Y11M
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   CS7LO
AC   CVCL_ZT22
SY   Cockayne Syndrome 7 LOndon
DR   Wikidata; Q98125769
RX   PubMed=8834235;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS7PV
AC   CVCL_YQ74
SY   Cockayne Syndrome 7 PaVia
DR   Wikidata; Q93459145
RX   PubMed=17297471;
RX   PubMed=19329487;
RX   PubMed=29572252;
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; c.719-1G>A; dbSNP=rs1239745117; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=29572252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   CS7SE
AC   CVCL_L469
SY   Cockayne Syndrome 7 SEattle; CSRDSE; 74.47; 7447; GM01428; GM-1428; GM 1428; GM1428
DR   CLO; CLO_0030774
DR   BioSample; SAMN00803882
DR   Coriell; GM01428
DR   JCRB; KURB1917
DR   Wikidata; Q54836824
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=157803;
RX   PubMed=431551;
RX   PubMed=7301938;
RX   PubMed=7360141;
RX   PubMed=7471106;
RX   PubMed=12665480;
RX   PubMed=27543334;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   CS7SE hTERT
AC   CVCL_ZU52
SY   GM01428T
DR   Wikidata; Q98125770
RX   PubMed=27543334;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L469 ! CS7SE
SX   Female
AG   8Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS7TAN
AC   CVCL_ZN72
SY   Cockayne Syndrome 7 Turkey ANkara
DR   Wikidata; Q98125772
RX   PubMed=9443879;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg1213Gly (c.3637A>G) (A3716G); ClinVar=VCV000129017; Zygosity=Homozygous (PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS83iCTR33-n1
AC   CVCL_IW28
SY   CS83iCTR-33n1; CS83iCTR33n1; 83iCTR; 83i
DR   CLO; CLO_0037501
DR   LINCS_LDP; LSC-1003
DR   Wikidata; Q54814555
RX   PubMed=25740845;
RX   PubMed=26185257;
RX   PubMed=34746695;
RX   PubMed=35805069;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 19
//
ID   CS83iCTR33-n2
AC   CVCL_ZC84
SY   CS83iCTR33n2
DR   Wikidata; Q98125773
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (from parent cell line).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   CS83iSMA-n5
AC   CVCL_JJ99
SY   CS83iSMA-nxx
DR   CLO; CLO_0037508
DR   LINCS_LDP; LSC-1011
DR   Wikidata; Q54814556
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs83isma-nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   CS84iSMA-n12B
AC   CVCL_A9T6
SY   CS84iSMA-nxx
DR   Wikidata; Q102113723
WW   Provider; Cedars-Sinai; -; https://biomanufacturing.cedars-sinai.org/product/cs84isma-nxx/
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (Cedars-Sinai).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W564 ! GM10684
SX   Female
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   CS8BR
AC   CVCL_ZN65
SY   Cockayne Syndrome 8 BRighton
DR   Wikidata; Q98125774
RX   PubMed=9443879;
CC   Population: Indo Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Gln854Ter (c.2560C>T) (C2639T); ClinVar=VCV000557733; Zygosity=Homozygous (PubMed=9443879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CS8LO
AC   CVCL_ZT23
SY   Cockayne Syndrome 8 LOndon
DR   Wikidata; Q98125775
RX   PubMed=8834235;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS8SE
AC   CVCL_ZS07
SY   Cockayne Syndrome 8 SEattle; 70-22
DR   Wikidata; Q98125776
RX   PubMed=431551;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CS97iHD180-n1
AC   CVCL_ZD64
SY   CS97iHD180n1
DR   Wikidata; Q98125778
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS97iHD180-n2
AC   CVCL_ZD65
SY   CS97iHD180n2
DR   Wikidata; Q98125779
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS97iHD180-n3
AC   CVCL_ZD66
SY   CS97iHD180n3
DR   Wikidata; Q98125780
RX   PubMed=25740845;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CS9IAF
AC   CVCL_ZT20
DR   Wikidata; Q98125781
RX   PubMed=29572252;
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Tyr322Ter (c.966C>A); ClinVar=VCV000001715; Zygosity=Homozygous (PubMed=29572252).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CSA-2G9
AC   CVCL_RT38
SY   CsA-2G9
DR   Wikidata; Q54814557
RX   Patent=US6686454;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4170.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   CSAC
AC   CVCL_BS81
SY   Cynoglossus Semilaevis Astroglial Cell line
DR   Wikidata; Q54814558
RX   PubMed=26452695;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   CSB-iPSC clone 1
AC   CVCL_L643
SY   CSB-iPSC cl1
DR   Wikidata; Q54814559
RX   PubMed=22661500;
CC   From: University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (PubMed=22661500).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84666; De Sanctis-Cacchione syndrome
DI   ORDO; Orphanet_1569; De Sanctis-Cacchione syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F146 ! GM10903
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   CSB-iPSC clone 2
AC   CVCL_L644
SY   CSB-iPSC cl2
DR   Wikidata; Q54814560
RX   PubMed=22661500;
CC   From: University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (PubMed=22661500).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84666; De Sanctis-Cacchione syndrome
DI   ORDO; Orphanet_1569; De Sanctis-Cacchione syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F146 ! GM10903
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   CSB-iPSC clone 3
AC   CVCL_L645
SY   CSB-iPSC cl3
DR   Wikidata; Q54814561
RX   PubMed=22661500;
CC   From: University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (PubMed=22661500).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84666; De Sanctis-Cacchione syndrome
DI   ORDO; Orphanet_1569; De Sanctis-Cacchione syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F146 ! GM10903
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   CSBZZUi001-A
AC   CVCL_E3TU
SY   CSBZZU_PS1_001
DR   BioSamples; SAMEA115444276
DR   hPSCreg; CSBZZUi001-A
RX   PubMed=38968760;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Phe237Leu (c.709T>C); ClinVar=VCV000098072; Zygosity=Heterozygous (PubMed=38968760).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CSBZZUi002-A
AC   CVCL_E3TV
DR   BioSamples; SAMEA115444277
DR   hPSCreg; CSBZZUi002-A
RX   PubMed=39442281;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   CSBZZUi003-A
AC   CVCL_E3TW
DR   BioSamples; SAMEA115437399
DR   hPSCreg; CSBZZUi003-A
RX   PubMed=41218450;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   CSBZZUi004-A
AC   CVCL_E3TX
DR   BioSamples; SAMEA115437461
DR   hPSCreg; CSBZZUi004-A
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   CSC-1-5
AC   CVCL_C3NY
SY   Chicken embryonic fibroblast Single Cloned cell line 1-5
DR   Wikidata; Q116048800
RX   PubMed=30076744;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Rugao Yellow; VBO=VBO_0006744.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   CSC14
AC   CVCL_B918
DR   NIHhESC; NIHhESC-14-0284
DR   Wikidata; Q54814562
WW   Info; NIHhESC; -; https://acd.od.nih.gov/documents/reports/09052014Botkin-hESC.pdf
CC   From: Caladrius Biosciences, Inc. (Neostem, Inc.); Basking Ridge; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0284.
CC   Miscellaneous: Was first disapproved for use in NIH-funded research due to issues in the original informed consent form. Later accepted because of a new consent form.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   CSCC-1
AC   CVCL_DF76
SY   CSCC1
DR   cancercelllines; CVCL_DF76
DR   GEO; GSM226737
DR   GEO; GSM226873
DR   Progenetix; CVCL_DF76
DR   Wikidata; Q54814563
RX   PubMed=10554043;
RX   PubMed=17311676;
CC   Population: Caucasian.
CC   Virology: Contains an episomal HPV16 genome.
CC   Doubling time: 74 +- 5 hours (PubMed=10554043).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   CSCC-7
AC   CVCL_DF77
SY   CSCC7
DR   cancercelllines; CVCL_DF77
DR   GEO; GSM226738
DR   GEO; GSM226874
DR   Progenetix; CVCL_DF77
DR   Wikidata; Q54814564
RX   PubMed=10554043;
RX   PubMed=17311676;
CC   Population: Surinamese.
CC   Doubling time: 50 +- 4 hours (PubMed=10554043).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   CSCC-R1
AC   CVCL_WH50
DR   Wikidata; Q93459200
RX   PubMed=30268330;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   CSCIi001-A
AC   CVCL_C2VK
SY   niPSC 16.2.b; niPSC-16.2b; niPSC HDF16
DR   BioSamples; SAMEA115462286
DR   hPSCreg; CSCIi001-A
DR   Wikidata; Q114312550
RX   PubMed=31708477;
CC   From: Wellcome Trust - MRC Stem Cell Institute, University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CSCIi002-A
AC   CVCL_E3TY
SY   niPSC 75.1.c2; niPSC-75.1c2; niPSC HDF75
DR   BioSamples; SAMEA115466178
DR   hPSCreg; CSCIi002-A
RX   PubMed=31708477;
CC   From: Wellcome Trust - MRC Stem Cell Institute, University of Cambridge; Cambridge; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CSCR19i-indCFANCA
AC   CVCL_QX43
DR   Wikidata; Q54814565
RX   PubMed=28395741;
CC   From: Centre for Stem Cell Research, Christian Medical College; Vellore; India.
CC   Characteristics: Expression of transduced FANCA is doxycycline-inducible.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3582; FANCA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   CSCRi005-A
AC   CVCL_VG02
SY   TJC8-iPSC
DR   hPSCreg; CSCRi005-A
DR   Wikidata; Q54814566
RX   PubMed=29665501;
CC   From: Centre for Stem Cell Research, Christian Medical College; Vellore; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   CSCRi006-A
AC   CVCL_C7XP
SY   DBA-fib-iPSC-R2C4
DR   BioSamples; SAMEA112879430
DR   hPSCreg; CSCRi006-A
DR   Wikidata; Q123030971
RX   PubMed=37603219;
CC   From: Centre for Stem Cell Research, Christian Medical College; Vellore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10402; RPS19; Simple; p.Asp8Argfs*42 (c.22_23delAG); Zygosity=Heterozygous (PubMed=37603219).
CC   Miscellaneous: Sex and age of donor from personal communication of Rani, Sonam.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=37603219
ST   Amelogenin: X,Y
ST   D10S1248: 14,16
ST   D12S391: 18,20
ST   D16S539: 8,12
ST   D18S51: 13,17
ST   D19S433: 14.2,15.2
ST   D1S1656: 11
ST   D21S11: 28,32.2
ST   D22S1045: 11
ST   D2S1338: 19,20
ST   D2S441: 11,14
ST   D3S1358: 16
ST   D8S1179: 12,13
ST   FGA: 23,26
ST   SE33: 30.2,33.2
ST   TH01: 6
ST   vWA: 16,17
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   CSCRMi001-A
AC   CVCL_QX93
SY   POGLUT1 c.699T > G (D233E)-II.5-3
DR   hPSCreg; CSCRMi001-A
DR   Wikidata; Q54814567
RX   PubMed=29034878;
CC   From: Center for Stem Cell and Regenerative Medicine (CSCRM), University of Texas Health Science Center; Houston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:22954; POGLUT1; Simple; p.Asp233Glu (c.699T>G); ClinVar=VCV000372263; Zygosity=Homozygous (PubMed=29034878).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142082; Limb-girdle muscular dystrophy type 2Z
DI   ORDO; Orphanet_480682; Autosomal recessive limb-girdle muscular dystrophy type 2Z
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   CSCVE
AC   CVCL_A8VS
SY   Channa Striatus CardioVascular Endothelial
DR   Wikidata; Q108820086
RX   PubMed=25194832;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 22 to 32 Celsius, the optimal temperature is 28 Celsius (PubMed=25194832).
CC   Doubling time: 68 hours (Note=At 7th passage), 57 hours (Note=At 15th passage), 47 hours (Note=At 23th passage), 41 hours (Note=At 37th passage), 39 hours (Note=At 45th passage), 33 hours (Note=At 64th passage) (PubMed=25194832).
CC   Derived from site: In situ; Heart, blood vessel; UBERON=UBERON_0003498.
CC   Cell type: Endothelial cell of blood vessel; CL=CL_0000071.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   CSE-119
AC   CVCL_4154
SY   CSE 119; Coho Salmon Embryo-119
DR   CLO; CLO_0002626
DR   CLO; CLO_0002627
DR   CLDB; cl920
DR   CLDB; cl5058
DR   ECACC; 95122019
DR   IZSLER; BS CL 126
DR   Wikidata; Q54814568
RX   CelloPub=CLPUB00703;
RX   PubMed=6542066;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8019; ! Oncorhynchus kisutch (Coho salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   CSEC [Cynoglossus]
AC   CVCL_R873
SY   Cynoglossus Semilaevis Embryonic Cell line
DR   Wikidata; Q54814569
RX   DOI=10.1007/s13131-010-0025-z;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gastrula; UBERON=UBERON_0004734.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   CSEC [Human]
AC   CVCL_E309
DR   Wikidata; Q54814570
RX   PubMed=18477252;
CC   Population: Chinese.
CC   Doubling time: 39.6 hours (Note=At 45th passage) (PubMed=18477252).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   CSEC216
AC   CVCL_ZL35
SY   ECST109
DR   Wikidata; Q98125783
RX   PubMed=32489320;
CC   Population: Chinese.
CC   Doubling time: 29.7 hours (PubMed=32489320).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): PubMed=32489320
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,14
ST   D18S51: 16
ST   D21S11: 29,32.2
ST   D3S1358: 14
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 17,23
ST   Penta D: 10,12
ST   Penta E: 14,15
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   CSES1
AC   CVCL_B812
SY   Cedars Sinai Embryonic Stem cell 1
DR   GEO; GSM540748
DR   Wikidata; Q54814571
RX   PubMed=18450823;
RX   PubMed=20224970;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   CSES10
AC   CVCL_B821
SY   Cedars Sinai Embryonic Stem cell 10
DR   Wikidata; Q54814572
RX   PubMed=20224970;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   CSES11
AC   CVCL_B822
SY   Cedars Sinai Embryonic Stem cell 11
DR   NIHhESC; NIHhESC-11-0110
DR   Wikidata; Q54814573
RX   PubMed=20224970;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0110.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   CSES12
AC   CVCL_B823
SY   Cedars Sinai Embryonic Stem cell 12
DR   GEO; GSM1576685
DR   NIHhESC; NIHhESC-11-0111
DR   Wikidata; Q54814574
RX   PubMed=20224970;
RX   PubMed=26070610;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0111.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   CSES13
AC   CVCL_B824
SY   Cedars Sinai Embryonic Stem cell 13
DR   GEO; GSM1576688
DR   NIHhESC; NIHhESC-11-0112
DR   Wikidata; Q54814575
RX   PubMed=20641042;
RX   PubMed=23045682;
RX   PubMed=26070610;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0112.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   CSES14
AC   CVCL_B825
SY   Cedars Sinai Embryonic Stem cell 14
DR   NIHhESC; NIHhESC-11-0113
DR   Wikidata; Q54814576
RX   PubMed=20224970;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0113.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   CSES15
AC   CVCL_B826
SY   Cedars Sinai Embryonic Stem cell 15
DR   GEO; GSM1246013
DR   NIHhESC; NIHhESC-11-0114
DR   Wikidata; Q54814577
RX   PubMed=26070610;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0114.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CSES16
AC   CVCL_B827
SY   Cedars Sinai Embryonic Stem cell 16
DR   Wikidata; Q54814578
RX   PubMed=20641042;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   CSES17
AC   CVCL_B828
SY   Cedars Sinai Embryonic Stem cell 17
DR   NIHhESC; NIHhESC-11-0115
DR   Wikidata; Q54814579
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0115.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CSES18
AC   CVCL_B829
SY   Cedars Sinai Embryonic Stem cell 18
DR   NIHhESC; NIHhESC-11-0135
DR   Wikidata; Q54814580
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0135.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CSES19
AC   CVCL_B830
SY   Cedars Sinai Embryonic Stem cell 19
DR   NIHhESC; NIHhESC-11-0116
DR   Wikidata; Q54814581
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0116.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   CSES2
AC   CVCL_B813
SY   CSES02; Cedars Sinai Embryonic Stem cell 2
DR   NIHhESC; NIHhESC-11-0106
DR   Wikidata; Q54814582
RX   PubMed=18450823;
RX   PubMed=20224970;
RX   PubMed=20641042;
RX   PubMed=23045682;
RX   PubMed=28445466;
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0106.
CC   Registration: Swiss research registry; BAG-hES-IMP-0049.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   CSES20
AC   CVCL_B831
SY   Cedars Sinai Embryonic Stem cell 20
DR   GEO; GSM1576689
DR   NIHhESC; NIHhESC-11-0117
DR   Wikidata; Q54814583
RX   PubMed=20641042;
RX   PubMed=26070610;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0117.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   CSES21
AC   CVCL_B832
SY   Cedars Sinai Embryonic Stem cell 21
DR   GEO; GSM1576690
DR   NIHhESC; NIHhESC-11-0118
DR   Wikidata; Q54814584
RX   PubMed=20641042;
RX   PubMed=26070610;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0118.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   CSES22
AC   CVCL_B833
SY   Cedars Sinai Embryonic Stem cell 22
DR   GEO; GSM1246010
DR   GEO; GSM1246017
DR   GEO; GSM1246020
DR   GEO; GSM1576686
DR   NIHhESC; NIHhESC-11-0119
DR   Wikidata; Q54814585
RX   PubMed=20641042;
RX   PubMed=26070610;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0119.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C37866; Trisomy 16
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   CSES23
AC   CVCL_B834
SY   Cedars Sinai Embryonic Stem cell 23
DR   NIHhESC; NIHhESC-11-0120
DR   Wikidata; Q54814602
RX   PubMed=20641042;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0120.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   CSES24
AC   CVCL_B835
SY   Cedars Sinai Embryonic Stem cell 24
DR   NIHhESC; NIHhESC-11-0121
DR   Wikidata; Q54814603
RX   PubMed=20641042;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0121.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   CSES25
AC   CVCL_B836
SY   Cedars Sinai Embryonic Stem cell 25
DR   GEO; GSM1246014
DR   NIHhESC; NIHhESC-11-0122
DR   Wikidata; Q54814604
RX   PubMed=26070610;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0122.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CSES26
AC   CVCL_EG75
SY   Cedars Sinai Embryonic Stem cell 26
DR   GEO; GSM1246015
DR   Wikidata; Q54814605
RX   PubMed=22892439;
RX   PubMed=26070610;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   CSES27
AC   CVCL_EG78
SY   Cedars Sinai Embryonic Stem cell 27
DR   Wikidata; Q54814606
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CSES28
AC   CVCL_EG79
SY   Cedars Sinai Embryonic Stem cell 28
DR   Wikidata; Q54814607
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES29
AC   CVCL_EG80
SY   Cedars Sinai Embryonic Stem cell 29
DR   Wikidata; Q54814608
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES3
AC   CVCL_B814
SY   Cedars Sinai Embryonic Stem cell 3
DR   Wikidata; Q54814609
RX   PubMed=18450823;
RX   PubMed=20224970;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   CSES30
AC   CVCL_EG81
SY   Cedars Sinai Embryonic Stem cell 30
DR   Wikidata; Q54814611
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES31
AC   CVCL_EG82
SY   Cedars Sinai Embryonic Stem cell 31
DR   Wikidata; Q54814612
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES32
AC   CVCL_EG76
SY   Cedars Sinai Embryonic Stem cell 32
DR   GEO; GSM1576691
DR   Wikidata; Q54814613
RX   PubMed=22892439;
RX   PubMed=26070610;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   CSES33
AC   CVCL_EG83
SY   Cedars Sinai Embryonic Stem cell 33
DR   Wikidata; Q54814614
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES34
AC   CVCL_EG84
SY   Cedars Sinai Embryonic Stem cell 34
DR   Wikidata; Q54814615
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES35
AC   CVCL_EG85
SY   Cedars Sinai Embryonic Stem cell 35
DR   Wikidata; Q54814616
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES36
AC   CVCL_EG86
SY   Cedars Sinai Embryonic Stem cell 36
DR   Wikidata; Q54814617
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36397; Trisomy 20
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CSES37
AC   CVCL_EG87
SY   Cedars Sinai Embryonic Stem cell 37
DR   Wikidata; Q54814619
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES4
AC   CVCL_B815
SY   CSES04; Cedars Sinai Embryonic Stem cell 4
DR   NIHhESC; NIHhESC-11-0107
DR   Wikidata; Q54814620
RX   PubMed=18450823;
RX   PubMed=20224970;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0107.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CSES40
AC   CVCL_EG88
SY   Cedars Sinai Embryonic Stem cell 40
DR   Wikidata; Q54814621
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36397; Trisomy 20
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CSES41
AC   CVCL_EG89
SY   Cedars Sinai Embryonic Stem cell 41
DR   Wikidata; Q54814623
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36397; Trisomy 20
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CSES42
AC   CVCL_EG90
SY   Cedars Sinai Embryonic Stem cell 42
DR   Wikidata; Q54814624
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES43
AC   CVCL_EG91
SY   Cedars Sinai Embryonic Stem cell 43
DR   Wikidata; Q54814625
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES44
AC   CVCL_EG92
SY   Cedars Sinai Embryonic Stem cell 44
DR   Wikidata; Q54814626
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES45
AC   CVCL_EG77
SY   Cedars Sinai Embryonic Stem cell 45
DR   GEO; GSM1246011
DR   GEO; GSM1246018
DR   GEO; GSM1576687
DR   Wikidata; Q54814627
RX   PubMed=22892439;
RX   PubMed=26070610;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36420; Trisomy 12
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   CSES46
AC   CVCL_EG93
SY   Cedars Sinai Embryonic Stem cell 46
DR   Wikidata; Q54814628
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES47
AC   CVCL_EG94
SY   Cedars Sinai Embryonic Stem cell 47
DR   Wikidata; Q54814629
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES48
AC   CVCL_EG95
SY   Cedars Sinai Embryonic Stem cell 48
DR   Wikidata; Q54814630
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES49
AC   CVCL_EG96
SY   Cedars Sinai Embryonic Stem cell 49
DR   Wikidata; Q54814631
RX   PubMed=22892439;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   CSES5
AC   CVCL_B816
SY   Cedars Sinai Embryonic Stem cell 5
DR   NIHhESC; NIHhESC-11-0133
DR   Wikidata; Q54814632
RX   PubMed=18450823;
RX   PubMed=20224970;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0133.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   CSES6
AC   CVCL_B817
SY   CSES06; Cedars Sinai Embryonic Stem cell 6
DR   NIHhESC; NIHhESC-11-0134
DR   Wikidata; Q54814634
RX   PubMed=18450823;
RX   PubMed=20224970;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0134.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CSES7
AC   CVCL_B818
SY   CSES07; Cedars Sinai Embryonic Stem cell 7
DR   GEO; GSM1246012
DR   NIHhESC; NIHhESC-11-0108
DR   Wikidata; Q54814636
RX   PubMed=18450823;
RX   PubMed=20224970;
RX   PubMed=20641042;
RX   PubMed=26070610;
RX   PubMed=28445466;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0108.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   CSES8
AC   CVCL_B819
SY   Cedars Sinai Embryonic Stem cell 8
DR   GEO; GSM540749
DR   NIHhESC; NIHhESC-11-0109
DR   Wikidata; Q54814637
RX   PubMed=20641042;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0109.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C37865; Trisomy 17
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   CSES9
AC   CVCL_B820
SY   Cedars Sinai Embryonic Stem cell 9
DR   Wikidata; Q54814639
RX   PubMed=20224970;
RX   PubMed=20641042;
CC   From: Cedars-Sinai Medical Center; Los Angeles; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   CSG
AC   CVCL_R821
SY   Channa Striatus Gill
DR   NRFC; NRFC046
DR   Wikidata; Q39292726
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=23972731;
RX   PubMed=25052522;
WW   Provider; NRFC; NRFC046; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC046.
CC   Doubling time: ~37 hours (PubMed=23972731).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   CSGC
AC   CVCL_L786
SY   Cynoglossus Semilaevis Gonad Cell line
DR   Wikidata; Q54814642
RX   PubMed=21547062;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 10
//
ID   CSH
AC   CVCL_R874
SY   Cynoglossus Semilaevis Heart
DR   Wikidata; Q54814643
RX   PubMed=20376698;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 12 to 30 Celsius, the optimal temperature is 24 Celsius (PubMed=20376698).
CC   Virology: Susceptible to infection by lymphocystis disease virus (LCDV) (PubMed=20376698).
CC   Doubling time: 73.39 hours (PubMed=20376698).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   CSH1AN
AC   CVCL_ZS01
SY   Cockayne Syndrome Heterozygote 1 ANn Arbor; UM114
DR   Wikidata; Q98125784
RX   PubMed=157803;
RX   PubMed=431551;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CSH2AN
AC   CVCL_ZS02
SY   Cockayne Syndrome Heterozygote 2 ANn Arbor; UM115
DR   Wikidata; Q98125785
RX   PubMed=157803;
RX   PubMed=431551;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CSH695CTO
AC   CVCL_ZS10
SY   Cockayne Syndrome Heterozygote 695 Canada TOronto
DR   Wikidata; Q98125786
RX   PubMed=157803;
RX   PubMed=7360141;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   CSH696CTO
AC   CVCL_ZS11
SY   Cockayne Syndrome Heterozygote 696 Canada TOronto
DR   Wikidata; Q98125787
RX   PubMed=157803;
RX   PubMed=7360141;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   CSHM1BE LCL
AC   CVCL_L477
SY   Cockayne Syndrome Heterozygote Male 1 BEthesda LCL; GM02474; GM 2474; GM02474A
DR   CLO; CLO_0033216
DR   Coriell; GM02474
DR   Wikidata; Q54837511
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   CSHM1FABE
AC   CVCL_C3Q8
SY   Cockayne Syndrome Heterozygous Male 1 FArgo BEthesda; GM05322; RB 5322
DR   Coriell; GM05322
DR   Wikidata; Q116048802
RX   PubMed=6096450;
CC   Discontinued: Coriell; GM05322; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3Q9 ! CSHM1FABE LCL
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CSHM1FABE LCL
AC   CVCL_C3Q9
SY   Cockayne Syndrome Heterozygous Male 1 FArgo BEthesda LCL; GM05323; RB 5323
DR   Coriell; GM05323
DR   Wikidata; Q116048803
RX   PubMed=6096450;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM05323; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3Q8 ! CSHM1FABE
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CSHM1MO
AC   CVCL_ZP18
DR   JCRB; KURB1888
DR   Wikidata; Q98125788
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   CSi001-A
AC   CVCL_UD87
DR   hPSCreg; CSi001-A
DR   SKIP; SKIP005542
DR   Wikidata; Q93459523
RX   PubMed=30292881;
CC   From: Changshu No.2 Hospital, Yangzhou University School of Medicine; Suchow; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   CSIRi001-A
AC   CVCL_E3TZ
SY   CSIR-SA-001-J4
DR   BioSamples; SAMEA115863934
DR   hPSCreg; CSIRi001-A
RX   PubMed=39146664;
CC   From: Council for Scientific and Industrial Research South Africa (CSIR); Pretoria; South Africa.
CC   Population: African; Zulu.
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3U0 ! CSIRi001-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CSIRi001-B
AC   CVCL_E3U0
SY   CSIR-SA-001-J3
DR   BioSamples; SAMEA115883344
DR   hPSCreg; CSIRi001-B
RX   PubMed=39146664;
CC   From: Council for Scientific and Industrial Research South Africa (CSIR); Pretoria; South Africa.
CC   Population: African; Zulu.
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3TZ ! CSIRi001-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CSIRi002-A
AC   CVCL_E3U1
SY   CSIR-SA-001-L2
DR   BioSamples; SAMEA115883343
DR   hPSCreg; CSIRi002-A
RX   PubMed=39146664;
CC   From: Council for Scientific and Industrial Research South Africa (CSIR); Pretoria; South Africa.
CC   Population: African American.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3U2 ! CSIRi002-B
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CSIRi002-B
AC   CVCL_E3U2
SY   CSIR-SA-001-L10
DR   BioSamples; SAMEA115889835
DR   hPSCreg; CSIRi002-B
RX   PubMed=39146664;
CC   From: Council for Scientific and Industrial Research South Africa (CSIR); Pretoria; South Africa.
CC   Population: African American.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3U1 ! CSIRi002-A
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CSIRO-BCIRL-HA1
AC   CVCL_Z978
SY   HA1
DR   ICLDB; csiro-bcirl-ha1
DR   Wikidata; Q54814645
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CSIRO-BCIRL-HA2
AC   CVCL_Z979
SY   HA2
DR   ICLDB; csiro-bcirl-ha2
DR   Wikidata; Q54814646
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CSIRO-BCIRL-HA3
AC   CVCL_Z980
SY   HA3
DR   ICLDB; csiro-bcirl-ha3
DR   Wikidata; Q54814647
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CSIRO-BCIRL-HP1
AC   CVCL_Z981
SY   HP1
DR   Wikidata; Q54814648
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=27545; ! Helicoverpa punctigera (Australian bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CSIRO-BCIRL-HP2
AC   CVCL_Z982
SY   HP2
DR   Wikidata; Q54814649
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=27545; ! Helicoverpa punctigera (Australian bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CSIRO-BCIRL-HP3
AC   CVCL_Z983
SY   HP3
DR   Wikidata; Q54814650
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=27545; ! Helicoverpa punctigera (Australian bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   CSIRO-BCIRL-HP4
AC   CVCL_Z984
SY   HP4
DR   Wikidata; Q54814653
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=27545; ! Helicoverpa punctigera (Australian bollworm)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CSIRO-BCIRL-HP5
AC   CVCL_Z985
SY   HP5
DR   Wikidata; Q54814654
RX   PubMed=10475263;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=27545; ! Helicoverpa punctigera (Australian bollworm)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   CSK [Channa]
AC   CVCL_1G79
SY   Channa Striatus Kidney
DR   NRFC; NRFC045
DR   Wikidata; Q54814656
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=23558109;
WW   Provider; NRFC; NRFC045; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC045.
CC   Doubling time: ~29 hours (PubMed=23558109).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   CSK [Cynoglossus]
AC   CVCL_YL77
SY   Cynoglossus Semilaevis Kidney
DR   Wikidata; Q93459560
RX   DOI=10.1007/s00343-019-9084-y;
CC   Group: Fish cell line.
CC   Characteristics: Grows at temperatures ranging from 16 to 30 Celsius. The highest growth rate is obtained at 25 Celsius (DOI=10.1007/s00343-019-9084-y).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 7
//
ID   CSL 224
AC   CVCL_JZ45
SY   Commonwealth Serum Laboratories 224
DR   Wikidata; Q54814658
RX   PubMed=559639;
CC   Group: Marsupial cell line.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
SX   Female
AG   Pouched young
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   CSL 225
AC   CVCL_JZ46
SY   Commonwealth Serum Laboratories 225
DR   Wikidata; Q54814659
RX   PubMed=559639;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
OI   CVCL_JZ47 ! CSL 226
OI   CVCL_JZ48 ! CSL 227
SX   Male
AG   Pouched young
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   CSL 226
AC   CVCL_JZ47
SY   Commonwealth Serum Laboratories 226
DR   Wikidata; Q54814660
RX   PubMed=559639;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
OI   CVCL_JZ46 ! CSL 225
OI   CVCL_JZ48 ! CSL 227
SX   Male
AG   Pouched young
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   CSL 227
AC   CVCL_JZ48
SY   Commonwealth Serum Laboratories 227
DR   Wikidata; Q54814661
RX   PubMed=521801;
RX   PubMed=559639;
CC   Group: Marsupial cell line.
CC   Virology: Seems to be infected by an oncovirus.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
OI   CVCL_JZ46 ! CSL 225
OI   CVCL_JZ47 ! CSL 226
SX   Male
AG   Pouched young
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   CSL 234
AC   CVCL_JZ49
SY   Commonwealth Serum Laboratories 234
DR   Wikidata; Q54814662
RX   PubMed=559639;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   CSL 235
AC   CVCL_JZ50
SY   CSL235; Commonwealth Serum Laboratories 235
DR   Wikidata; Q54814663
RX   DOI=10.1071/BI9770461;
RX   PubMed=521801;
RX   PubMed=559639;
CC   Group: Marsupial cell line.
CC   Virology: Seems to be infected by an oncovirus.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
SX   Female
AG   Pouched young
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   CSL 503
AC   CVCL_WJ15
SY   CSL503; Commonwealth Serum Laboratories 503
DR   Wikidata; Q93459609
RX   PubMed=2549933;
RX   PubMed=6298990;
RX   PubMed=12368331;
CC   Senescence: Senesces at 50-70 PDL (PubMed=2549933).
CC   Virology: Susceptible to infection by ovine adebonviruses.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   CSLEX1
AC   CVCL_JZ51
SY   CSLEX-1; CSLEX 1
DR   Wikidata; Q54814664
RX   Patent=US4752569;
RX   PubMed=6386148;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8580.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 6
//
ID   CSM14.1
AC   CVCL_8182
SY   CSM 14.1
DR   BTO; BTO_0004073
DR   TOKU-E; 4009
DR   Wikidata; Q54814665
RX   CelloPub=CLPUB00032;
RX   PubMed=12171477;
RX   PubMed=17203489;
RX   PubMed=22863662;
RX   PubMed=24592386;
CC   Characteristics: Proliferates at 33 Celsius and displays flat morphology. At 39 Celsius the cells stop dividing and some cells change from flat cells with broad processes to neuron-like morphology (CelloPub=CLPUB00032).
CC   Characteristics: Can be differentiated in vitro into tyrosine hydroxylase (TH) and aldehyde-dehydrogenase 2-containing neurons (PubMed=12171477).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Embryonic brain, mesencephalon; UBERON=UBERON_0009616.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   CSMalphabeta1h
AC   CVCL_6618
SY   CSMab1h
DR   CLO; CLO_0002628
DR   ATCC; CRL-8401
DR   Wikidata; Q54814666
RX   Patent=US5767251;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8401.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1885; CGA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1886; CGB3.
CC   Discontinued: ATCC; CRL-8401; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   CSMalphabeta6C
AC   CVCL_6619
SY   CSMab6C
DR   CLO; CLO_0002629
DR   ATCC; CRL-8400
DR   Wikidata; Q54814667
RX   Patent=US5767251;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8400.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1885; CGA.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1886; CGB3.
CC   Discontinued: ATCC; CRL-8400; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   CSMCi001-A
AC   CVCL_D0DM
SY   CS011iMEN1-n4
DR   BioSamples; SAMEA112648426
DR   hPSCreg; CSMCi001-A
DR   Wikidata; Q123030972
RX   PubMed=37209468;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg465Ter (c.1393C>T) (p.Arg460Ter, c.1378C>T; ClinVar=VCV000016692; Zygosity=Heterozygous (PubMed=37209468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CSMCi001-A-1
AC   CVCL_D0DN
SY   CS011iMEN1-n4.Homo5; CS011MEN1-n4.HomoMut5
DR   BioSamples; SAMEA112648669
DR   hPSCreg; CSMCi001-A-1
DR   Wikidata; Q123030973
RX   PubMed=37209468;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg465Ter (c.1393C>T) (p.Arg460Ter, c.1378C>T; ClinVar=VCV000016692; Zygosity=Heterozygous (PubMed=37209468).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple_edited; p.Arg465Ter (c.1393C>T) (p.Arg460Ter, c.1378C>T; ClinVar=VCV000016692; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37209468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0DM ! CSMCi001-A
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CSMCi001-A-2
AC   CVCL_D0DP
SY   CS011MEN1-n4.Corrected1
DR   BioSamples; SAMEA112648670
DR   hPSCreg; CSMCi001-A-2
DR   Wikidata; Q123030974
RX   PubMed=37209468;
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple_corrected; p.Arg465Ter (c.1393C>T) (p.Arg460Ter, c.1378C>T; ClinVar=VCV000016692; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37209468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0DM ! CSMCi001-A
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CSML-0
AC   CVCL_E114
SY   CSML-O; CSML0
DR   Wikidata; Q54814668
RX   CelloPub=CLPUB00033;
RX   PubMed=2550322;
RX   PubMed=11329088;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: A/Sn.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   CSML-100
AC   CVCL_0226
SY   CSML100
DR   MCCL; MCC:0000114
DR   Wikidata; Q54814669
RX   CelloPub=CLPUB00133;
RX   PubMed=2550322;
RX   PubMed=11329088;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: A/Sn.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E114 ! CSML-0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   CSN
AC   CVCL_N778
SY   Canine Stomach Normal
DR   ATCC; CRL-6246
DR   Wikidata; Q54814670
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6246; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_3663 ! CLN
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   CSO
AC   CVCL_Y562
SY   Cynoglossus Semilaevis Ovary
DR   Wikidata; Q54814671
RX   PubMed=25359438;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   CSOC 882
AC   CVCL_L039
SY   CSOC882
DR   Wikidata; Q54814672
RX   PubMed=16956650;
CC   Population: Southeast Asian; Filipino.
CC   Doubling time: 30.7 hours (PubMed=16956650).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   CSPMG
AC   CVCL_0I98
SY   Cynoglossus Semilaevis PseudoMale Gonad
DR   Wikidata; Q54814673
RX   PubMed=25724869;
CC   Group: Fish cell line.
CC   Doubling time: 45.03 hours (Note=At 20th passage) (PubMed=25724869).
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   CSQT-1
AC   CVCL_XE56
DR   CCRID; 4201PAT-CCTCC00241
DR   Wikidata; Q93459689
RX   DOI=10.3724/SP.J.1008.2009.00001;
RX   Patent=CN101597591B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200814.
CC   Population: Chinese.
CC   Doubling time: 48.2 hours (Patent=CN101597591B).
CC   Derived from site: Metastatic; Portal vein; UBERON=UBERON_0002017.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   CSQT-2
AC   CVCL_M183
DR   CCRID; 4201PAT-CCTCC00280
DR   Wikidata; Q54814674
RX   Patent=CN101955914B;
RX   PubMed=20461085;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200913.
CC   Population: Chinese.
CC   Doubling time: 36 hours (Patent=CN101955914B).
CC   Derived from site: Metastatic; Portal vein; UBERON=UBERON_0002017.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   CsR-1000
AC   CVCL_DD09
SY   CsR
DR   Wikidata; Q54814675
RX   Patent=US5272070;
RX   PubMed=2105319;
RX   PubMed=2267628;
RX   PubMed=2521484;
CC   Selected for resistance to: ChEBI; CHEBI_27860; Castanospermine (Cs).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   CSRCC01
AC   CVCL_XI62
SY   Colorectal Signet Ring Cell Carcinoma 01
DR   Wikidata; Q93459700
RX   Patent=CN107058227B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201722.
CC   Population: Chinese.
CC   Doubling time: ~48 hours (Patent=CN107058227B).
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   CSS
AC   CVCL_E7BJ
SY   Cynoglossus Semilaevis Skin
RX   PubMed=37774902;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Css-12
AC   CVCL_LH49
SY   Clone 12
DR   Wikidata; Q54814677
RX   Patent=US5053492;
RX   PubMed=3535169;
CC   Group: Animal toxin research hybridoma.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9165.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18998; Crotalus scutulatus scutulatus Mojave toxin acidic chain (Note=Also reacts with other Crotalus species).
CC   Monoclonal antibody target: UniProtKB; P62023; Crotalus scutulatus scutulatus Mojave toxin basic chain (Note=Also reacts with other Crotalus species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   CSSi001-A
AC   CVCL_VD29
SY   CSSi001-A (2850); 2850; Joub03cl2; Joub03 cl2; COR419
DR   BioSamples; SAMEA104620766
DR   hPSCreg; CSSi001-A
DR   SKIP; SKIP002980
DR   Wikidata; Q54814679
RX   PubMed=29334628;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:21575; AHI1; Simple; p.His896Arg (c.2687A>G); ClinVar=VCV000217532; Zygosity=Homozygous (PubMed=29334628).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148259; Joubert syndrome 3
DI   ORDO; Orphanet_220493; Joubert syndrome with ocular defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CSSi002-A
AC   CVCL_RV19
SY   CSSi002-A (2851); 2851; HD8yrs; HD 8 yrs
DR   BioSamples; SAMEA104620790
DR   hPSCreg; CSSi002-A
DR   SKIP; SKIP002977
DR   Wikidata; Q54814680
RX   PubMed=29342448;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[~84] (c.52CAG(~84)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=29342448).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147072; Juvenile Huntington disease
DI   ORDO; Orphanet_248111; Juvenile Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   CSSi003-A
AC   CVCL_VD30
SY   CSSi003-A (2961); 2961; COL04 clE2
DR   BioSamples; SAMEA104621351
DR   hPSCreg; CSSi003-A
DR   SKIP; SKIP003154
DR   Wikidata; Q54814681
RX   PubMed=29494847;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9834; RAI1; Simple; p.Ser399Profs*40 (c.1194delC); Zygosity=Heterozygous (PubMed=29494847).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CSSi004-A
AC   CVCL_VD31
SY   CSSi004-A (2962); 2962; HD256.05 cl1
DR   BioSamples; SAMEA104622926
DR   hPSCreg; CSSi004-A
DR   SKIP; SKIP003160
DR   Wikidata; Q54814682
RX   PubMed=29486399;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=29486399).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   CSSi005-A
AC   CVCL_VD32
SY   CSSi005-A (3544); 3544; COL03 cl.C3
DR   BioSamples; SAMEA994533
DR   hPSCreg; CSSi005-A
DR   Wikidata; Q54814683
RX   PubMed=30218896;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:1960; CHRNA7; Duplication; Zygosity=Unspecified; Note=15q13.3 interstitial duplication (PubMed=30218896).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   CSSi006-A
AC   CVCL_VD33
SY   CSSi006-A (3681); 3681
DR   BioSamples; SAMEA4675569
DR   hPSCreg; CSSi006-A
DR   Wikidata; Q54814684
RX   PubMed=29704769;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[65] (c.52CAG(65)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=29704769).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147072; Juvenile Huntington disease
DI   ORDO; Orphanet_248111; Juvenile Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   CSSi007-A
AC   CVCL_WK21
SY   CSSi007-A (4383); 4383; Joub07 cl1; COR11-NG708
DR   BioSamples; SAMEA5359104
DR   hPSCreg; CSSi007-A
DR   Wikidata; Q93459733
RX   PubMed=31202121;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:21575; AHI1; Simple; p.Arg723Gln (c.2168G>A); ClinVar=VCV000002015; Zygosity=Homozygous (PubMed=31202121).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C159653; Joubert syndrome 7
DI   ORDO; Orphanet_220497; Joubert syndrome with renal defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   CSSi008-A
AC   CVCL_WK22
SY   CSSi008-A (4698); 4698; AT214-01-02
DR   BioSamples; SAMEA5728485
DR   hPSCreg; CSSi008-A
DR   Wikidata; Q93459735
RX   PubMed=31493762;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3033; ATN1; Repeat_expansion; CAG[65] (g.17267CAG[(54-68)]); ClinVar=VCV000590267; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[13] (PubMed=31493762).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   CSSi009-A
AC   CVCL_XI71
SY   GDB1307_Z2#1
DR   BioSamples; SAMEA8325239
DR   hPSCreg; CSSi009-A
DR   Wikidata; Q93459738
RX   PubMed=31479876;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4401; GNB5; Simple; p.Glu88Argfs*8 (c.262delG) (p.Glu46Argfs*8, c.136delG); ClinVar=VCV001210290; Zygosity=Homozygous (PubMed=31479876).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164154; Intellectual developmental disorder with cardiac arrhythmia
DI   ORDO; Orphanet_542306; GNB5-related intellectual disability-cardiac arrhythmia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   CSSi010-A
AC   CVCL_XI72
SY   GNB5_KO#5A
DR   hPSCreg; CSSi010-A
DR   Wikidata; Q93459740
RX   PubMed=31479876;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4401; GNB5; Simple_edited; c.204_208delCATGG; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31479876).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164154; Intellectual developmental disorder with cardiac arrhythmia
DI   ORDO; Orphanet_542306; GNB5-related intellectual disability-cardiac arrhythmia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   CSSi011-A
AC   CVCL_ZA85
DR   BioSamples; SAMEA7044786
DR   hPSCreg; CSSi011-A
DR   Wikidata; Q98125791
RX   PubMed=32739880;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Albanian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (PubMed=32739880).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CSSi012-A
AC   CVCL_A8KQ
SY   CSSi012-A (7672); 7672; CSS012-A; GAFU cl.A
DR   BioSamples; SAMEA8427021
DR   hPSCreg; CSSi012-A
DR   Wikidata; Q108820087
RX   PubMed=34087986;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly376Asp (c.1127G>A); Zygosity=Heterozygous (PubMed=34087986).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   CSSi013-A
AC   CVCL_B7SG
SY   CSSi013-A (9360); 9360; CSSi013-A cl.D
DR   BioSamples; SAMEA14080160
DR   hPSCreg; CSSi013-A
DR   Wikidata; Q112929419
RX   PubMed=35714448;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly376Asp (c.1127G>A); Zygosity=Heterozygous (PubMed=35714448).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   CSSi014-A
AC   CVCL_B7SH
SY   CSSi014-A (9407); 9407; MPS II 9991 IPS cl H
DR   BioSamples; SAMEA14252991
DR   hPSCreg; CSSi014-A
DR   Wikidata; Q112929420
RX   PubMed=35759972;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.Pro160Leu (c.479C>T); Zygosity=Hemizygous (PubMed=35759972).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   CSSi015-A
AC   CVCL_C1PC
SY   CSSi015-A (9553); 9553; FC17; FC 17 cl D1
DR   BioSamples; SAMEA110061803
DR   hPSCreg; CSSi015-A
DR   Wikidata; Q114311287
RX   PubMed=36638628;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1514; CASR; Simple; p.Thr972Met (c.2915C>T); ClinVar=VCV000342802; Zygosity=Heterozygous (PubMed=36638628).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123262; Familial hypocalciuric hypercalcemia
DI   ORDO; Orphanet_405; Familial hypocalciuric hypercalcemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   CSSi016-A
AC   CVCL_C3RC
SY   CSSi016-A (9938); 9938; PORA cl C
DR   BioSamples; SAMEA111417866
DR   hPSCreg; CSSi016-A
DR   Wikidata; Q116048805
RX   PubMed=36272304;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:10542; SBF1; Simple; p.Arg763His (c.2288G>A); ClinVar=VCV001065826; Zygosity=Heterozygous (PubMed=36272304).
CC   Sequence variation: Mutation; HGNC; HGNC:10542; SBF1; Simple; p.Gly1064Glu (c.3191G>A); ClinVar=VCV001120019; Zygosity=Heterozygous (PubMed=36272304).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C190871; Charcot-Marie-Tooth disease type 4B3
DI   ORDO; Orphanet_363981; Charcot-Marie-Tooth disease type 4B3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CSSi017-A
AC   CVCL_D6R3
SY   CSSi017-A (12862); 12862; 1150 cl 4
DR   BioSamples; SAMEA114594441
DR   hPSCreg; CSSi017-A
RX   PubMed=38613988;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous; Note=Has 56 repeats (PubMed=38613988).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   CSSi018-A
AC   CVCL_D6R4
SY   CSSi018-A (14192); 14192
DR   BioSamples; SAMEA115577322
DR   hPSCreg; CSSi018-A
RX   PubMed=38852424;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Phe601Tyr (c.1802T>A); ClinVar=VCV001304432; Zygosity=Heterozygous (PubMed=38852424).
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Gly1358Arg (c.4072G>A); dbSNP=rs1404091496; Zygosity=Heterozygous (PubMed=38852424).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C210817; Hypomyelinating leukodystrophy-7
DI   ORDO; Orphanet_289494; 4H leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   CSSi019-A
AC   CVCL_E3CM
SY   CSSi019-A (14432); 14432; A1150 Asymptomatic cl 7
DR   BioSamples; SAMEA115741727
DR   hPSCreg; CSSi019-A
RX   PubMed=39191178;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous; Note=Has 36 repeats (PubMed=39191178).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   CSSi020-A
AC   CVCL_E3U3
SY   CSSi020-A (14437); 14437; SMSdel1 cl Q
DR   BioSamples; SAMEA115788086
DR   hPSCreg; CSSi020-A
RX   PubMed=39260069;
CC   From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9834; RAI1; Zygosity=Heterozygous (PubMed=39260069).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CSSTH1
AC   CVCL_A1EC
SY   Chinese SoftShell Turtle Heart 1
DR   KCB; KCB 200553H
DR   Wikidata; Q102113724
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=13735; ! Pelodiscus sinensis (Chinese softshell turtle)
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   CSSTL1
AC   CVCL_A1ED
SY   Chinese SoftShell Turtle Lung 1
DR   KCB; KCB 200553L
DR   Wikidata; Q102113725
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=13735; ! Pelodiscus sinensis (Chinese softshell turtle)
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   CSSTSP1
AC   CVCL_A1EE
SY   Chinese SoftShell Turtle Spleen 1
DR   KCB; KCB 200553SP
DR   Wikidata; Q102113726
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=13735; ! Pelodiscus sinensis (Chinese softshell turtle)
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   CST
AC   CVCL_A2ZQ
SY   OST; Channa Striatus Thymus
DR   NRFC; NRFC055
DR   Wikidata; Q105506720
RX   PubMed=25877070;
WW   Provider; NRFC; NRFC055; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC055.
CC   Characteristics: Grows well from 28 to 32 Celsius, the optimal growth temperature is 28 Celsius (PubMed=25877070).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   cST2146
AC   CVCL_IQ94
SY   ST2146
DR   ABCD; ABCD_AC985
DR   Wikidata; Q54814685
RX   Patent=US8048417;
RX   PubMed=12671694;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 02003.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P24821; Human TNC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   cST2485
AC   CVCL_E2SX
SY   cST2485/A3e/Al2f; ST2485
DR   ABCD; ABCD_BA638
RX   Patent=US7989171;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 03003.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24821; Human TNC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   cST3232/10
AC   CVCL_IR11
SY   ST3232/10
DR   Wikidata; Q54814686
RX   Patent=US8318911;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 06004.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   CSTF
AC   CVCL_R891
SY   Chinese Sturgeon Tail-Fin
DR   Wikidata; Q54814687
RX   DOI=10.1111/j.1095-8649.2008.02076.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=61970; ! Acipenser sinensis (Chinese sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   CSTO-1
AC   CVCL_A5XD
DR   Wikidata; Q107114725
RX   PubMed=6744310;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human stomach adenocarcinoma-associated antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CSUASOi001-A
AC   CVCL_WU16
SY   XLRS-UiPSC
DR   hPSCreg; CSUASOi001-A
DR   SKIP; SKIP005555
DR   Wikidata; Q93459756
RX   PubMed=31141763;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Arg102Trp (c.304C>T); ClinVar=VCV000009887; Zygosity=Hemizygous (PubMed=31141763).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   CSUASOi001-A-1
AC   CVCL_D6KP
SY   CSUi006-A-1
DR   hPSCreg; CSUASOi001-A-1
DR   Wikidata; Q127380653
RX   PubMed=38011758;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple_corrected; p.Arg102Trp (c.304C>T); ClinVar=VCV000009887; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=38011758).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU16 ! CSUASOi001-A
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   CSUASOi002-A
AC   CVCL_WU17
DR   hPSCreg; CSUASOi002-A
DR   Wikidata; Q93459759
RX   PubMed=31669782;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6938; CHST6; Simple; p.Leu21delinsArgfs (c.62_63delTinsGA); Zygosity=Heterozygous (PubMed=31669782).
CC   Sequence variation: Mutation; HGNC; HGNC:6938; CHST6; Simple; p.Gln298Ter (c.892C>T); ClinVar=VCV000320606; Zygosity=Heterozygous (PubMed=31669782).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34793; Macular corneal dystrophy
DI   ORDO; Orphanet_98969; Macular corneal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   CSUASOi003-A
AC   CVCL_YU32
SY   CRB1-BiPS
DR   hPSCreg; CSUASOi003-A
DR   SKIP; SKIP005694
DR   Wikidata; Q93459762
RX   PubMed=32244200;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Gly750Asp (c.2249G>A); Zygosity=Heterozygous (PubMed=32244200).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Ala937Thr (c.2809G>A); ClinVar=VCV000285879; Zygosity=Heterozygous (PubMed=32244200).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   CSUASOi004-A
AC   CVCL_YU18
SY   PRPF6-BiPS
DR   hPSCreg; CSUASOi004-A
DR   SKIP; SKIP005749
DR   Wikidata; Q93459764
RX   PubMed=32335390;
RX   PubMed=36103774;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:15860; PRPF6; Simple; p.Arg900His (c.2699G>A); ClinVar=VCV000842292; Zygosity=Heterozygous (PubMed=32335390).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   CSUASOi004-A-1
AC   CVCL_C4SD
DR   hPSCreg; CSUASOi004-A-1
DR   Wikidata; Q116048806
RX   PubMed=36103774;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:15860; PRPF6; Simple_corrected; p.Arg900His (c.2699G>A); ClinVar=VCV000842292; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36103774).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YU18 ! CSUASOi004-A
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CSUASOi005-A
AC   CVCL_YU19
SY   PJ-iPSC
DR   hPSCreg; CSUASOi005-A
DR   SKIP; SKIP005815
DR   Wikidata; Q93459766
RX   PubMed=32050117;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Phe176Tyr (c.527T>A); ClinVar=VCV000540204; ClinVar=VCV000540204; Zygosity=Hemizygous (PubMed=32050117).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   CSUASOi006-A
AC   CVCL_ZX46
SY   RP-PRPF8; PRPF8-UiPS
DR   hPSCreg; CSUASOi006-A
DR   Wikidata; Q102113728
RX   PubMed=33157387;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:17340; PRPF8; Simple; p.Thr1931Met (c.5792C>T); ClinVar=VCV000867014; Zygosity=Unspecified (PubMed=33157387).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   CSUASOi007-A
AC   CVCL_A7IP
SY   RP-CNGB1; RP-iPSCs
DR   hPSCreg; CSUASOi007-A
DR   Wikidata; Q107114727
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   CSUASOi008-A
AC   CVCL_B3NU
SY   55
DR   hPSCreg; CSUASOi008-A
DR   Wikidata; Q110432749
RX   PubMed=34959203;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   CSUASOi009-A
AC   CVCL_B5RT
DR   hPSCreg; CSUASOi009-A
DR   Wikidata; Q111733143
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   CSUASOi010-A
AC   CVCL_B5RU
SY   46
DR   hPSCreg; CSUASOi010-A
DR   Wikidata; Q111733144
RX   PubMed=35841806;
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   CSUASOi011-A
AC   CVCL_B5RV
SY   57
DR   hPSCreg; CSUASOi011-A
DR   Wikidata; Q111733145
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   CSUASOi012-A
AC   CVCL_D0DQ
SY   PRPF6-Mu
DR   hPSCreg; CSUASOi012-A
DR   Wikidata; Q123030976
CC   From: Central South University, Aier School of Ophthalmology; Changsha; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CSUe011-A
AC   CVCL_A1AT
SY   H9-ESRG pr-tdTom
DR   BioSamples; SAMEA6907391
DR   hPSCreg; CSUe011-A
DR   Wikidata; Q102113729
RX   PubMed=32919352;
CC   From: Central South University; Changsha; China.
CC   Characteristics: Using CRISPR/Cas9 a construct containing the ESRG promoter followed by tdTomato was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   CSUi002-A
AC   CVCL_A6XJ
SY   iPSC-DYT1-#17
DR   BioSamples; SAMEA7976393
DR   hPSCreg; CSUi002-A
DR   Wikidata; Q107114730
RX   PubMed=33706202;
RX   PubMed=34438319;
RX   PubMed=35533513;
CC   From: Central South University; Changsha; China.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (PubMed=33706202).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35533513
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D18S51: 13,16
ST   D19S433: 16,17.2
ST   D21S11: 30,32.5
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 13,16
ST   Penta D: 9,13
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   CSUi002-A-1
AC   CVCL_B0GP
DR   hPSCreg; CSUi002-A-1
DR   Wikidata; Q108820088
RX   PubMed=34438319;
CC   From: Central South University; Changsha; China.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 LMNB1 has been endogenously tagged in one allele at the N-terminus with EGFP (PubMed=34438319).
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6XJ ! CSUi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   CSUi002-A-2
AC   CVCL_C0JT
SY   LSUHSi003-A-2; DYT1-CR-4B2
DR   BioSamples; SAMEA12515777
DR   hPSCreg; CSUi002-A-2
DR   Wikidata; Q112929421
RX   PubMed=35533513;
CC   From: Louisiana State University Health Sciences Center in Shreveport; Shreveport; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_corrected; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35533513).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35533513
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D18S51: 13,16
ST   D19S433: 16,17.2
ST   D21S11: 30,32.5
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 13,16
ST   Penta D: 9,13
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6XJ ! CSUi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   CSUi002-A-3
AC   CVCL_C0JU
SY   LSUHSi003-A-3; DYT1-CR-A6
DR   BioSamples; SAMEA12515778
DR   hPSCreg; CSUi002-A-3
DR   Wikidata; Q112929422
RX   PubMed=35533513;
CC   From: Louisiana State University Health Sciences Center in Shreveport; Shreveport; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_corrected; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35533513).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35533513
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D18S51: 13,16
ST   D19S433: 16,17.2
ST   D21S11: 30,32.5
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 13,16
ST   Penta D: 9,13
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6XJ ! CSUi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   CSUi003-A
AC   CVCL_A6XK
DR   hPSCreg; CSUi003-A
DR   Wikidata; Q107114732
RX   PubMed=33845242;
CC   From: Central South University; Changsha; China.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   CSUi004-A
AC   CVCL_A6XL
DR   hPSCreg; CSUi004-A
DR   Wikidata; Q107114734
RX   PubMed=33865102;
CC   From: Central South University; Changsha; China.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   CSUi005-A
AC   CVCL_D0DR
DR   hPSCreg; CSUi005-A
DR   Wikidata; Q123030977
CC   From: Central South University; Changsha; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0DS ! CSUi005-B
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CSUi005-B
AC   CVCL_D0DS
DR   hPSCreg; CSUi005-B
DR   Wikidata; Q123030978
CC   From: Central South University; Changsha; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0DR ! CSUi005-A
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CSUi007-A
AC   CVCL_E3CK
DR   BioSamples; SAMEA114861658
DR   hPSCreg; CSUi007-A
RX   PubMed=39232357;
CC   From: Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple_edited; p.Arg102Trp (c.304C>T); ClinVar=VCV000009887; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=39232357).
CC   Caution: Indicated by PubMed=39232357 to be derived from a normal iPSC but the paper does not describe the parental cell line.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   CSUi008-A
AC   CVCL_E3CL
DR   hPSCreg; CSUi008-A
CC   From: Central South University; Changsha; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CSUXHEi001-A
AC   CVCL_C4S9
DR   BioSamples; SAMEA110640177
DR   hPSCreg; CSUXHEi001-A
DR   Wikidata; Q116048807
RX   PubMed=36126472;
CC   From: Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Ser517Phefs*10 (c.1547dupC) (c.1545_1546insC); ClinVar=VCV000188759; Zygosity=Heterozygous (PubMed=36126472).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CSUXHEi002-A
AC   CVCL_C4SA
DR   BioSamples; SAMEA110644481
DR   hPSCreg; CSUXHEi002-A
DR   Wikidata; Q116048808
RX   PubMed=36126472;
CC   From: Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Lys440Ter (c.1318A>T); ClinVar=VCV000627478; Zygosity=Heterozygous (PubMed=36126472).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   CSUXHi001-A
AC   CVCL_XI42
SY   XHCSUi001-A; UiPSC-SCA3-001
DR   BioSamples; SAMEA6114048
DR   hPSCreg; CSUXHi001-A
DR   SKIP; SKIP005566
DR   Wikidata; Q93459769
RX   PubMed=31491691;
CC   From: Department of Neurology, Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous (PubMed=31491691).
CC   Donor information: At sampling donor was not affected with Machado-Joseph disease but at significant risk for disease.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=31491691
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18,19
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 13,15.2
ST   D19S433: 14.2,15.2
ST   D1S1656: 12,16
ST   D21S11: 29,33.2
ST   D2S1338: 20,24
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D6S1043: 14,18
ST   D7S820: 11,13
ST   D8S1179: 12,15,16
ST   FGA: 24,25
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   CSUXHi002-A
AC   CVCL_ZA46
SY   SCA1-iPSCs
DR   BioSamples; SAMEA6762571
DR   hPSCreg; CSUXHi002-A
DR   SKIP; SKIP005742
DR   Wikidata; Q98125792
RX   PubMed=32335388;
CC   From: Department of Neurology, Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[65]; Zygosity=Heterozygous (PubMed=32335388).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   CSUXHi003-A
AC   CVCL_A1MU
DR   BioSamples; SAMEA7574345
DR   hPSCreg; CSUXHi003-A
DR   Wikidata; Q102113731
RX   PubMed=33454628;
CC   From: Department of Neurology, Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7105; MITF; Simple; p.His316Leu (c.947A>T) (p.His209Leu, c.626A>T); Zygosity=Heterozygous (PubMed=33454628).
CC   Derived from site: In situ; Scalp, skin, dermis; UBERON=UBERON_8300000+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75009; Waardenburg syndrome type 2
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   CSUXHi004-A
AC   CVCL_A2YC
DR   BioSamples; SAMEA7873284
DR   hPSCreg; CSUXHi004-A
DR   Wikidata; Q105506721
RX   PubMed=33774334;
CC   From: Department of Neurology, Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8617; PAX3; Simple; c.452-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33774334).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75008; Waardenburg syndrome type 1
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CSUXHi005-A
AC   CVCL_A4GP
SY   UiPSC-SCA3-002-C5
DR   BioSamples; SAMEA7996636
DR   hPSCreg; CSUXHi005-A
DR   Wikidata; Q105506723
RX   PubMed=33761381;
CC   From: Department of Neurology, Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[76]; Zygosity=Heterozygous; Note=The other allele has 26 repeats (PubMed=33761381).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   CSUXHi006-A
AC   CVCL_B3NV
DR   BioSamples; SAMEA9326348
DR   hPSCreg; CSUXHi006-A
DR   Wikidata; Q110432750
CC   From: Department of Neurology, Xiangya Hospital of Central South University; Changsha; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   CSZ1
AC   CVCL_6253
SY   CSZ-1
DR   Wikidata; Q54814688
RX   PubMed=16881970;
CC   Knockout cell: Method=KO mouse; MGI; MGI:105373; Ptch1 (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Breed/subspecies: Ptch1tm1Mps/J, K5-CrePR,p53flox/flox.
DI   NCIt; C134570; Mouse basal cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   CT 1
AC   CVCL_Z282
SY   CT-1; CT1; Circulifer Tenellus 1
DR   ICLDB; ct-1
DR   Wikidata; Q54814689
RX   PubMed=9709012;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=102981; ! Neoaliturus tenellus (Beet leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   CT ADF1-iPS3F6
AC   CVCL_E7T4
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CT+ADF1-iPS3F6+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+CT+ADF1-iPS3F6+Anexo+-+v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad de Malaga; Granada; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11,13
ST   D7S820: 9,13
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CT-1 [Human ESC]
AC   CVCL_B846
SY   CT1
DR   NIHhESC; NIHhESC-10-0068
DR   Wikidata; Q54814690
RX   PubMed=20336513;
RX   PubMed=28445466;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/services/distribution-of-human-pluripotent-stem-cell-lines/human-embryonic-stem-cell-lines/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0068.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   CT-1 [Mouse hybridoma against human TNF]
AC   CVCL_VK51
DR   Wikidata; Q93459784
RX   Patent=US6090923;
RX   PubMed=3889916;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-472.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   CT-1413-H
AC   CVCL_UG07
DR   Wikidata; Q93459785
RX   PubMed=6850643;
CC   Derived from site: Metastatic; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: American longhair; VBO=VBO_0100013.
DI   NCIt; C156362; Feline melanoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_UG08 ! CT-1413-L
OI   CVCL_UG09 ! CT-1413-T
SX   Sex unspecified
AG   9Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 6
//
ID   CT-1413-L
AC   CVCL_UG08
SY   CT1413
DR   Wikidata; Q93459786
RX   PubMed=6850643;
RX   PubMed=6961415;
RX   PubMed=15784142;
CC   Characteristics: Trans-differentiates into neuronal cells after in vitro infection with feline endogenous retrovirus RD-114 (PubMed=6961415).
CC   Doubling time: 19.5 hours (PubMed=6850643).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: American longhair; VBO=VBO_0100013.
DI   NCIt; C156362; Feline melanoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_UG07 ! CT-1413-H
OI   CVCL_UG09 ! CT-1413-T
SX   Sex unspecified
AG   9Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   CT-1413-T
AC   CVCL_UG09
DR   Wikidata; Q93459787
RX   PubMed=6850643;
CC   Breed/subspecies: American longhair; VBO=VBO_0100013.
DI   NCIt; C156362; Feline melanoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_UG07 ! CT-1413-H
OI   CVCL_UG08 ! CT-1413-L
SX   Sex unspecified
AG   9Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 5
//
ID   CT-2
AC   CVCL_B847
SY   CT2
DR   NIHhESC; NIHhESC-10-0069
DR   Wikidata; Q54814691
RX   PubMed=20336513;
RX   PubMed=28445466;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/services/distribution-of-human-pluripotent-stem-cell-lines/human-embryonic-stem-cell-lines/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0069.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   CT-2A
AC   CVCL_ZJ44
SY   CT2A
DR   Millipore; SCC194
DR   Wikidata; Q98125793
RX   PubMed=1418222;
RX   PubMed=16911584;
RX   PubMed=17701911;
RX   PubMed=22514559;
CC   Characteristics: Mouse model for therapeutic research on brain malignancies (Millipore=SCC194).
CC   Characteristics: Established from a tumor maintained through serial intracranial transplants.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2-3M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   CT-2A-Luc
AC   CVCL_ZJ60
SY   CT-2A Luciferase; CT2A Luciferase
DR   Millipore; SCC195
DR   Wikidata; Q98125794
CC   Characteristics: Transduced with a lentiviral vector containing a Fluc-IRES-GFP construct expressed under the control of the CMV promoter.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6J.
ST   Source(s): Millipore=SCC195
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZJ44 ! CT-2A
SX   Sex unspecified
AG   2-3M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   CT-3
AC   CVCL_B848
SY   CT3
DR   NIHhESC; NIHhESC-10-0070
DR   Wikidata; Q54814693
RX   PubMed=20336513;
RX   PubMed=28445466;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/services/distribution-of-human-pluripotent-stem-cell-lines/human-embryonic-stem-cell-lines/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0070.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CT-4
AC   CVCL_B849
SY   CT4
DR   NIHhESC; NIHhESC-10-0071
DR   Wikidata; Q54814694
RX   PubMed=20336513;
RX   PubMed=28445466;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/services/distribution-of-human-pluripotent-stem-cell-lines/human-embryonic-stem-cell-lines/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0071.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   CT-TC
AC   CVCL_N821
DR   cancercelllines; CVCL_N821
DR   Cosmic; 724813
DR   Cosmic; 2355911
DR   Wikidata; Q54814695
RX   PubMed=12068308;
RX   PubMed=23882450;
CC   From: Hosoi, Hajime; Kyoto Prefectural University of Medicine; Kyoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Unspecified (PubMed=12068308).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   CT.4R
AC   CVCL_6827
DR   Wikidata; Q54814696
RX   PubMed=2783601;
CC   Characteristics: IL2 and IL4 dependent.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6829 ! CT.EV
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   CT.4S
AC   CVCL_6828
SY   CT4S; CT-4S
DR   BCRJ; 0073
DR   Wikidata; Q54814697
RX   PubMed=2783601;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CT.4S
CC   Characteristics: IL4 dependent.
CC   Discontinued: BCRJ; 0073; probable.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6827 ! CT.4R
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   CT.EV
AC   CVCL_6829
SY   CTEV
DR   Wikidata; Q54814702
RX   PubMed=2783601;
CC   Characteristics: IL2 dependent.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0227 ! CTLL-2
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   CT/BCIRL-DvWL1-0619-KZ
AC   CVCL_A1LX
SY   DvWL1
DR   ICLDB; ctbcirl-dvwl1-0619-kz
DR   Wikidata; Q102113780
RX   PubMed=32409954;
CC   Group: Insect cell line.
CC   Doubling time: 102 hours (PubMed=32409954).
OX   NCBI_TaxID=50389; ! Diabrotica virgifera (Western corn root beetle)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   CT/BCIRL-DvWL2-0619-KZ
AC   CVCL_A1LY
SY   DvWL2
DR   ICLDB; ctbcirl-dvwl2-0619-kz
DR   Wikidata; Q102113782
RX   PubMed=32409954;
CC   Group: Insect cell line.
CC   Doubling time: 51 hours (PubMed=32409954).
OX   NCBI_TaxID=50389; ! Diabrotica virgifera (Western corn root beetle)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   CT/BCIRL-DvWL3-0619-KZ
AC   CVCL_A1LZ
SY   DvWL3
DR   ICLDB; ctbcirl-dvwl3-0619-kz
DR   Wikidata; Q102113783
RX   PubMed=32409954;
CC   Group: Insect cell line.
CC   Doubling time: 67 hours (PubMed=32409954).
OX   NCBI_TaxID=50389; ! Diabrotica virgifera (Western corn root beetle)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   CT/BCIRL-DvWL3-B4-0619-KZ
AC   CVCL_C2TQ
SY   DvWL3-B4
DR   ICLDB; ctbcirl-dvwl3-b4-0619-kz
DR   Wikidata; Q114311289
CC   Group: Insect cell line.
CC   From: Zhou, Kai-Le; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
OX   NCBI_TaxID=50389; ! Diabrotica virgifera (Western corn root beetle)
HI   CVCL_A1LZ ! CT/BCIRL-DvWL3-0619-KZ
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   CT/BCIRL-DvWL3-C5-0619-KZ
AC   CVCL_C2TR
SY   DvWL3-C5
DR   ICLDB; ctbcirl-dvwl3-c5-0619-kz
DR   Wikidata; Q114311290
CC   Group: Insect cell line.
CC   From: Zhou, Kai-Le; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
OX   NCBI_TaxID=50389; ! Diabrotica virgifera (Western corn root beetle)
HI   CVCL_A1LZ ! CT/BCIRL-DvWL3-0619-KZ
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   CT/BCIRL-DvWL3-C6-0619-KZ
AC   CVCL_C2TS
SY   DvWL3-C6
DR   ICLDB; ctbcirl-dvwl3-c6-0619-kz
DR   Wikidata; Q114311292
CC   Group: Insect cell line.
CC   From: Zhou, Kai-Le; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
OX   NCBI_TaxID=50389; ! Diabrotica virgifera (Western corn root beetle)
HI   CVCL_A1LZ ! CT/BCIRL-DvWL3-0619-KZ
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   CT/BCIRL-SfMG-0617-KZ
AC   CVCL_UZ18
AS   CVCL_YP20
SY   BCIRL-CAMTech-SfMG1-0617-KZ; SfMG1-0617
DR   ICLDB; ctbcirl-sfmg-0617-kz
DR   Wikidata; Q93459800
RX   CelloPub=CLPUB00473;
RX   PubMed=31792802;
CC   Group: Insect cell line.
CC   Doubling time: 50.4 hours (PubMed=31792802).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   CT/BCIRL-SfMG1-0611-E7-KZ
AC   CVCL_C2T6
SY   BCIRL-CAMTech-SfMG1-0611-E7-KZ
DR   ICLDB; ctbcirl-sfmg1-0611-e7-kz
DR   Wikidata; Q114311294
CC   Group: Insect cell line.
CC   From: Goodman, Cynthia Lenz; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_UZ19 ! CT/BCIRL-SfMG1-0611-KZ
SX   Sex unspecified
AG   Sixth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CT/BCIRL-SfMG1-0611-E8-KZ
AC   CVCL_C2T7
SY   BCIRL-CAMTech-SfMG1-0611-E8-KZ
DR   ICLDB; ctbcirl-sfmg1-0611-e8-kz
DR   Wikidata; Q114311295
CC   Group: Insect cell line.
CC   From: Goodman, Cynthia Lenz; Biological Control of Insects Research Laboratory, USDA/Agricultural Research Service; Columbia; USA.
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_UZ19 ! CT/BCIRL-SfMG1-0611-KZ
SX   Sex unspecified
AG   Sixth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   CT/BCIRL-SfMG1-0611-KZ
AC   CVCL_UZ19
AS   CVCL_YP19
SY   BCIRL-CAMTech-SfMG1-0611-KZ; SfMG1-0611
DR   ICLDB; ctbcirl-sfmg1-0611-kz
DR   Wikidata; Q93459802
RX   CelloPub=CLPUB00473;
RX   PubMed=31792802;
CC   Group: Insect cell line.
CC   Doubling time: 73.9 hours (PubMed=31792802).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Sixth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   CT1258-EGFP
AC   CVCL_DN57
DR   Wikidata; Q54814703
RX   PubMed=24324078;
RX   PubMed=24914948;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Briard; VBO=VBO_0200234.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W737 ! TihoDProAdcarc1258
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   CT1258-EGFP-HMGA2
AC   CVCL_DN58
DR   Wikidata; Q54814704
RX   PubMed=24324078;
RX   PubMed=24914948;
CC   Characteristics: Transfected with a EGFP-HMGA2 fusion protein (PubMed=24324078; PubMed=24914948).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112754; Dog HMGA2.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Briard; VBO=VBO_0200234.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W737 ! TihoDProAdcarc1258
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   CT1258-FusionRed
AC   CVCL_ZE83
DR   Wikidata; Q98125798
RX   PubMed=32368185;
CC   Doubling time: 28.6 hours (PubMed=32368185).
CC   Genetic integration: Method=Transfection; Gene=FPbase; S6A7A; FusionRed (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Briard; VBO=VBO_0200234.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W737 ! TihoDProAdcarc1258
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   CT1258-mKate2C
AC   CVCL_ZE84
DR   Wikidata; Q98125799
RX   PubMed=32368185;
CC   Doubling time: 29.5 hours (PubMed=32368185).
CC   Genetic integration: Method=Transfection; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Briard; VBO=VBO_0200234.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W737 ! TihoDProAdcarc1258
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   CT1258-TurboFP650
AC   CVCL_ZE85
DR   Wikidata; Q98125800
RX   PubMed=32368185;
CC   Doubling time: 27.2 hours (PubMed=32368185).
CC   Genetic integration: Method=Transfection; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Briard; VBO=VBO_0200234.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W737 ! TihoDProAdcarc1258
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   CT14-B2
AC   CVCL_L560
DR   ECACC; 85102205
DR   NCBI_Iran; H121
DR   Wikidata; Q54814705
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   CT14-G4
AC   CVCL_L561
DR   CLO; CLO_0050385
DR   RCB; RCB0212
DR   Wikidata; Q54814706
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   CT26
AC   CVCL_7254
SY   CT-26; CT 26; Colon Tumor 26
DR   BTO; BTO_0003630
DR   ABM; T8267
DR   BioGRID_ORCS_Cell_line; 1261
DR   ChEMBL-Cells; CHEMBL3308079
DR   ChEMBL-Targets; CHEMBL613866
DR   CLS; 305229
DR   KCB; KCB 2012007YJ
DR   KCLB; 80009
DR   Lonza; 1686
DR   NCBI_Iran; C532
DR   PubChem_Cell_line; CVCL_7254
DR   TOKU-E; 4093
DR   Wikidata; Q54814707
RX   PubMed=6992981;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-441.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/ct26-xenograft-model/
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from child cell line CT26.WT).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from child cell line CT26.WT).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   CT26-DsRed
AC   CVCL_9V16
SY   CT26dsRed
DR   NCBI_Iran; C533
DR   Wikidata; Q54814708
RX   PubMed=15900588;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; DCYCK; DsRed-Express (Note=Orange fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   CT26-hCD39-LZ
AC   CVCL_E8GY
SY   genO-CT26-hCD39-LZ
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/ct26-hcd39-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:102805; Entpd1 (Note=With a fully humanized extracellular domain).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CT26-hEpCam-LZ
AC   CVCL_E8GZ
SY   genO-CT26-hEpCAM-LZ
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/ct26-hepcam-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11529; EPCAM.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   CT26-hPD-L1
AC   CVCL_B7NP
SY   genO-CT26-hPD-L1
DR   Wikidata; Q112929425
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/ct26-hpd-l1
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7NN ! CT26-PD-L1 KO
SX   Female
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   CT26-PD-L1 KO
AC   CVCL_B7NN
SY   CT26-Pd-l1 Knockout; genO-CT26-Pd-l1KO
DR   Wikidata; Q112929428
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/ct26-pd-l1-ko
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   CT26/Cas9-hyg
AC   CVCL_C9FK
SY   CT26-Cas9-hyg
DR   GeneCopoeia; SL582
DR   Wikidata; Q123030979
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL582).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   CT26.CL25
AC   CVCL_7255
SY   CT26-clone 25
DR   BTO; BTO_0006019
DR   CLO; CLO_0002630
DR   ATCC; CRL-2639
DR   BCRC; 60443
DR   BioSample; SAMN11397650
DR   CLS; 305353
DR   Wikidata; Q54814709
RX   PubMed=7722321;
RX   PubMed=31220119;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 14,15
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 19
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25,26
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   CT26.WT
AC   CVCL_7256
SY   CT-26 WT; CT26.wt; CT26WT
DR   BTO; BTO_0006018
DR   CLO; CLO_0002631
DR   ATCC; CRL-2638
DR   BCRC; 60447
DR   BCRJ; 0402
DR   BioSample; SAMN11397649
DR   CCRID; 1101MOU-PUMC000275
DR   CCRID; 3101MOUTCM37
DR   ChEMBL-Cells; CHEMBL4513106
DR   ChEMBL-Targets; CHEMBL4513123
DR   CLS; 305178
DR   KCB; KCB 201207YJ
DR   PubChem_Cell_line; CVCL_7256
DR   Ubigene; YC-B003
DR   Wikidata; Q54814710
RX   DOI=10.21926/obm.genet.1803037;
RX   PubMed=7722321;
RX   PubMed=11089883;
RX   PubMed=24621249;
RX   PubMed=25277546;
RX   PubMed=31220119;
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (PubMed=24621249).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (PubMed=24621249).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119; Ubigene=YC-B003
ST   Mouse STR 1-1: 14,15
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2,17.2,18.2
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 15,16,17
ST   Mouse STR 18-3: 19,20
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25,26
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   CT26.WT human B7H4
AC   CVCL_UE29
SY   CT26-B7H4
DR   KYinno; KC-1002
DR   Wikidata; Q93459841
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:28873; VTCN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   CT26.WT human CLDN18.2
AC   CVCL_XZ50
SY   CT26-CLDN18.2
DR   KYinno; KC-1195
DR   Wikidata; Q93459843
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   CT26.WT-eGFP-Puro
AC   CVCL_QZ99
DR   Imanis; CL044
DR   Wikidata; Q54814711
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL044).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   CT26.WT-Fluc-Neo
AC   CVCL_RA00
DR   Imanis; CL043
DR   Wikidata; Q54814712
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Neo vector encoding for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL043).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   CT26.WT-Fluc-Neo/eGFP-Puro
AC   CVCL_RA01
DR   Imanis; CL046
DR   Wikidata; Q54814713
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL046).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   CT26.WT-Fluc-Neo/iRFP-Puro
AC   CVCL_RA02
DR   Imanis; CL092
DR   Wikidata; Q54814714
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-iRFP-P2A-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL092).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   CT26.WT-iRFP-Neo
AC   CVCL_RA03
DR   Imanis; CL091
DR   Wikidata; Q54814715
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Neo which encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL091).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   CT26.WT-iRFP-Neo/mNIS-Puro
AC   CVCL_RA04
DR   Imanis; CL093
DR   Wikidata; Q54814716
CC   Characteristics: Reporter cell line, transduced with both the LV-iRFP-P2A-Neo and LV-mNIS-PGKp-Puro vectors. LV-iRFP-P2A-Neo encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-mNIS-PGKp-Puro encodes for mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL093).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   CT26.WT-Luc
AC   CVCL_C8XR
DR   Ubigene; YC-B003-Luc-P
DR   Wikidata; Q123030980
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   CT26.WT-mNIS (monoclonal)
AC   CVCL_RA05
DR   Imanis; CL119
DR   Wikidata; Q54814717
CC   Characteristics: Transduced with the LV-mNIS vector encoding mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL119).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   CT26.WT-mNIS-Neo/eGFP-Puro
AC   CVCL_RA06
DR   Imanis; CL045
DR   Wikidata; Q54814718
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL045).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   CT26.WT-mNIS-Neo/Fluc-Puro
AC   CVCL_RA07
DR   Imanis; CL047
DR   Wikidata; Q54814720
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-Fluc-P2A-Puro vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene under control of the spleen focus-forming virus (SFFV) promoter. LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL047).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   CT26.WT-mNIS-Puro
AC   CVCL_RA08
DR   Imanis; CL061
DR   Wikidata; Q54814721
CC   Characteristics: Reporter cell line, transduced with the LV-mNIS-PGKp-Puro vector encoding for mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL061).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   CT27
AC   CVCL_A7AZ
SY   TS^(CT)#1
DR   RCB; RCB4936
DR   Wikidata; Q107114737
RX   PubMed=29249463;
RX   PubMed=32178868;
CC   Characteristics: Trophoblast stem cell line.
CC   Senescence: Senesces at 150 PDL (RCB=RCB4936).
CC   Doubling time: 24.0 +- 1.7 hours (PubMed=29249463).
CC   Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   CT29
AC   CVCL_A7BA
SY   TS^(CT)#2
DR   RCB; RCB4937
DR   Wikidata; Q107114738
RX   PubMed=29249463;
CC   Characteristics: Trophoblast stem cell line.
CC   Senescence: Senesces at 150 PDL (RCB=RCB4937).
CC   Doubling time: 22.6 +- 2.5 hours (PubMed=29249463).
CC   Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   CT3 [Mouse hybridoma against chicken CD3]
AC   CVCL_WI29
SY   CT-3
DR   Wikidata; Q93459788
RX   PubMed=2425031;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Chicken CD3 complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   CT3 [Mouse hybridoma against human GPC2]
AC   CVCL_E8D5
DR   ABCD; ABCD_BF001
RX   Patent=US12012463;
RX   PubMed=32623934;
WW   Provider; NCI TTC; TAB-4215/E-198-2018-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4215
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8N158; Human GPC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CT30
AC   CVCL_A7BB
SY   TS^(CT)#3
DR   RCB; RCB4938
DR   Wikidata; Q107114739
RX   PubMed=29249463;
CC   Characteristics: Trophoblast stem cell line.
CC   Senescence: Senesces at 150 PDL (RCB=RCB4938).
CC   Doubling time: 19.4 +- 1.6 hours (PubMed=29249463).
CC   Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   CT305X1
AC   CVCL_C1I4
DR   Wikidata; Q114311297
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT305, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT306X1
AC   CVCL_C1I5
DR   Wikidata; Q114311298
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT306, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT307X1
AC   CVCL_C1I6
DR   Wikidata; Q114311299
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT307, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT310X6
AC   CVCL_C1I7
DR   Wikidata; Q114311300
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT310, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT314X6
AC   CVCL_C1I8
DR   Wikidata; Q114311301
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT314, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT316X5
AC   CVCL_C1I9
DR   Wikidata; Q114311302
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT316, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT320
AC   CVCL_C1IA
DR   Wikidata; Q114311303
RX   PubMed=17210723;
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1IB ! CT320X6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT320X6
AC   CVCL_C1IB
DR   Wikidata; Q114311304
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT320, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1IA ! CT320
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT329
AC   CVCL_C1IC
DR   Wikidata; Q114311305
RX   PubMed=17210723;
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1ID ! CT329X12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT329X12
AC   CVCL_C1ID
DR   Wikidata; Q114311306
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT329, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1IC ! CT329
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT339X
AC   CVCL_C1IE
DR   Wikidata; Q114311307
RX   PubMed=17210723;
CC   Characteristics: Established from a xenograft, XenoCT339, obtained from subcutaneous grafting of the tumor in male Swiss nu/nu nude mice.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT343
AC   CVCL_C1IF
DR   Wikidata; Q114311308
RX   PubMed=17210723;
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   CT36
AC   CVCL_0A64
SY   CT 36
DR   Wikidata; Q54814722
RX   PubMed=6992981;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   CT4
AC   CVCL_E3Y9
RX   PubMed=3258329;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9W6V7; Chicken CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CT43
AC   CVCL_KR83
SY   CT 43; CT-43
DR   Wikidata; Q54814723
RX   Patent=US5459043;
RX   PubMed=8504532;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10217.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human mucin epitope of unknown structure.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   CT5
AC   CVCL_E8D6
DR   ABCD; ABCD_BF002
RX   Patent=US12012463;
WW   Provider; NCI TTC; TAB-4215/E-198-2018-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4215
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8N158; Human GPC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CT51
AC   CVCL_0A65
SY   CT 51
DR   Wikidata; Q54814724
RX   PubMed=6992981;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   CT6-1D7
AC   CVCL_J889
DR   CLO; CLO_0002632
DR   ATCC; CRL-2438
DR   Wikidata; Q54814725
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   CT66
AC   CVCL_KR84
SY   CT 66; CT-66
DR   Wikidata; Q54814726
RX   Patent=US5459043;
RX   PubMed=8504532;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10218.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_62265; Beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcpNAc (Lewis A).
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 5
//
ID   CT8
AC   CVCL_E3YA
RX   PubMed=3258329;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Chicken CD8 complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CT9-B7
AC   CVCL_L562
DR   ECACC; 85102206
DR   Wikidata; Q54814727
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   CTA60001
AC   CVCL_A9F1
DR   Wikidata; Q102113734
RX   PubMed=7822435;
CC   Population: Indian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   CTAC
AC   CVCL_4155
SY   C_TAC
DR   ECACC; 90071812
DR   GEO; GSM1974777
DR   Wikidata; Q54814728
RX   PubMed=14266865;
RX   PubMed=21908323;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=29991117;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 15 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:40436; ERBB2; Simple; p.Val659Glu (c.1976T>A); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Thr114Met (c.341C>T); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 227,231
ST   Dog FHC2054: 151,164
ST   Dog FHC2079: 275
ST   Dog PEZ1: 119
ST   Dog PEZ3: 113,119
ST   Dog PEZ5: 103,115
ST   Dog PEZ6: 179,183
ST   Dog PEZ8: 228,240
ST   Dog PEZ12: 263,277
ST   Dog PEZ20: 176
DI   NCIt; C132275; Canine thyroid adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   CTb
AC   CVCL_9W61
DR   Wikidata; Q54814729
RX   Patent=US8337829;
RX   PubMed=10203336;
RX   PubMed=16646156;
RX   PubMed=22203612;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
DI   NCIt; C125660; Mouse trisomy 16
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-16D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   CTB-1
AC   CVCL_1149
SY   CTB1
DR   CLO; CLO_0050077
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472128
DR   cancercelllines; CVCL_1149
DR   Cell_Model_Passport; SIDM00283
DR   ChEMBL-Cells; CHEMBL3308188
DR   ChEMBL-Targets; CHEMBL2366344
DR   Cosmic; 949088
DR   Cosmic; 2297019
DR   Cosmic; 2437311
DR   Cosmic-CLP; 949088
DR   DepMap; ACH-002221
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10631-108I1
DR   GDSC; 949088
DR   GEO; GSM119489
DR   GEO; GSM1669711
DR   IARC_TP53; 27552
DR   LINCS_LDP; LCL-1118
DR   PharmacoDB; CTB1_267_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1149
DR   PubChem_Cell_line; CVCL_1149
DR   RCB; RCB1316
DR   Wikidata; Q54814731
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=16960149;
RX   PubMed=20164919;
RX   PubMed=21533490;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=21533490).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Glu616del (c.1844AAG[1]) (c.1847_1849del); ClinVar=VCV003761042; Zygosity=Heterozygous (DepMap=ACH-002221).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Pro463Leufs*23 (c.1386delT) (p.Ser462fs); Zygosity=Heterozygous (Cosmic-CLP=949088; DepMap=ACH-002221).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.23%; East Asian, North=25.3%; East Asian, South=74.47%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
ST   Source(s): Cosmic-CLP=949088; RCB=RCB1316
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   CTBm
AC   CVCL_L150
DR   Wikidata; Q54814732
RX   PubMed=19754820;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L151 ! CTBp
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   CTBp
AC   CVCL_L151
DR   Wikidata; Q54814733
RX   PubMed=19754820;
RX   PubMed=28283079;
RX   PubMed=31308293;
CC   Characteristics: Can grow as a sphere (PubMed=31308293).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_L150 ! CTBm
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   CTC-3
AC   CVCL_YI80
SY   Circulating Tumor Cell-3
DR   CCRID; 4201PAT-CCTCC01209
DR   Wikidata; Q93459979
RX   Patent=CN108611322B;
RX   PubMed=31762819;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201892.
CC   Population: Chinese.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31762819
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 11
ST   D21S11: 30,33
ST   D5S818: 11,15
ST   D7S820: 7,10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   CTC-MCC-41
AC   CVCL_0I26
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41
DR   cancercelllines; CVCL_0I26
DR   Wikidata; Q54814734
RX   PubMed=25592149;
RX   PubMed=30374140;
CC   Doubling time: 20 hours (PubMed=25592149).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=25592149; PubMed=30374140).
CC   Omics: Variations; CNV analysis.
CC   Donor information: Established from a colon cancer patient that presented at diagnosis a widespread disease with numerous abdominal and mediastinal metastatic lymph nodes as well as metastatic lesions in the liver (PubMed=25592149).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 13
//
ID   CTC-MCC-41.4
AC   CVCL_F0X6
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.4
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the second relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC-MCC-41.5A
AC   CVCL_F0X7
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5A
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC-MCC-41.5B
AC   CVCL_F0X8
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5B
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC-MCC-41.5C
AC   CVCL_F0X9
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5C
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC-MCC-41.5D
AC   CVCL_F0XA
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5D
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC-MCC-41.5E
AC   CVCL_F0XB
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5E
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XC ! CTC-MCC-41.5F
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC-MCC-41.5F
AC   CVCL_F0XC
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5F
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XD ! CTC-MCC-41.5G
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC-MCC-41.5G
AC   CVCL_F0XD
SY   Circulating Tumor Cells-Metastatic Colon Cancer-41.5G
RX   PubMed=30374140;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30374140).
CC   Donor information: Established at the third relapse of the patient from which CTC-MCC-41 (Cellosaurus=CVCL_0I26) was established (PubMed=30374140).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I26 ! CTC-MCC-41
OI   CVCL_F0X6 ! CTC-MCC-41.4
OI   CVCL_F0X7 ! CTC-MCC-41.5A
OI   CVCL_F0X8 ! CTC-MCC-41.5B
OI   CVCL_F0X9 ! CTC-MCC-41.5C
OI   CVCL_F0XA ! CTC-MCC-41.5D
OI   CVCL_F0XB ! CTC-MCC-41.5E
OI   CVCL_F0XC ! CTC-MCC-41.5F
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CTC41
AC   CVCL_YJ17
SY   Circulatin Tumor Cells 41
DR   Wikidata; Q93459983
RX   PubMed=27456153;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 7
//
ID   CTC44
AC   CVCL_YJ18
SY   Circulatin Tumor Cells 44
DR   cancercelllines; CVCL_YJ18
DR   Wikidata; Q93459984
RX   PubMed=27456153;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=27456153).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=27456153).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ15 ! CPP44
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   CTC45
AC   CVCL_YJ19
SY   Circulatin Tumor Cells 45
DR   cancercelllines; CVCL_YJ19
DR   Wikidata; Q93459987
RX   PubMed=27456153;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=27456153).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ16 ! CPP45
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   CTCC-1
AC   CVCL_VT59
DR   cancercelllines; CVCL_VT59
DR   Wikidata; Q93459988
RX   CelloPub=CLPUB00475;
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (CelloPub=CLPUB00475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (CelloPub=CLPUB00475).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   CTCF19.7-1c
AC   CVCL_D5XP
SY   CTCF-KO
DR   DGRC; 345
DR   FlyBase_Cell_line; FBtc0000345
DR   Wikidata; Q127380654
RX   PubMed=36735780;
CC   Group: Insect cell line.
CC   Knockout cell: Method=P-element; FlyBase_Gene; FBgn0035769; Ctcf (Note=3.3-kb deletion).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: P{3'EPgy2}CTCFy+1.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CTCJ
AC   CVCL_WH51
DR   Wikidata; Q93459990
RX   PubMed=30268330;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   CTCL-2
AC   CVCL_B7GI
DR   Wikidata; Q112929432
RX   PubMed=6256763;
RX   PubMed=6272125;
RX   PubMed=6975346;
CC   Population: African American.
CC   Characteristics: IL2 independent.
CC   Caution: Indicated as originating from a 60 year old in PubMed=6256763 and 64 year old in PubMed=6272125.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   CTCL-3
AC   CVCL_B7GH
DR   Wikidata; Q112929435
RX   PubMed=6256763;
RX   PubMed=6261256;
RX   PubMed=6272125;
RX   PubMed=26696625;
CC   Population: African American.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3246; Mycosis fungoides
DI   ORDO; Orphanet_2584; Classic mycosis fungoides
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3526 ! HuT 102
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   CTD110.6
AC   CVCL_SA15
SY   CTD 110.6
DR   Wikidata; Q54814735
RX   PubMed=11399029;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28009; N-acetyl-beta-D-glucosamine (Note=In beta-O-glycosidic linkage to serine and threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 5
//
ID   CTE
AC   CVCL_R826
SY   Catla Thymus Epithelial
DR   NRFC; NRFC029
DR   Wikidata; Q54814736
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=23026220;
WW   Provider; NRFC; NRFC029; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC029.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   CTEFe001-A
AC   CVCL_C1PD
SY   MUCG01
DR   BioSamples; SAMEA110472599
DR   hPSCreg; CTEFe001-A
DR   Wikidata; Q114311309
RX   PubMed=37700192;
CC   From: Cell and Tissue Engineering Facility, St. Anne's University Hospital Brno; Brno; Czech Republic.
CC   Doubling time: 22.0 +- 2.5 hours (PubMed=37700192).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   CTEFe002-A
AC   CVCL_C1PE
SY   MUCG02
DR   BioSamples; SAMEA110472601
DR   hPSCreg; CTEFe002-A
DR   Wikidata; Q114311310
RX   PubMed=37700192;
CC   From: Cell and Tissue Engineering Facility, St. Anne's University Hospital Brno; Brno; Czech Republic.
CC   Doubling time: 24.1 +- 2.0 hours (PubMed=37700192).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   CTEFe003-A
AC   CVCL_C1PF
SY   MUCG03
DR   BioSamples; SAMEA110472603
DR   hPSCreg; CTEFe003-A
DR   Wikidata; Q114311311
RX   PubMed=37700192;
CC   From: Cell and Tissue Engineering Facility, St. Anne's University Hospital Brno; Brno; Czech Republic.
CC   Doubling time: 24.1 +- 3.3 hours (PubMed=37700192).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   CTEFi001-A
AC   CVCL_D0DT
SY   CTEF-hiPSC10; FNUSA-hiPSC10
DR   BioSamples; SAMEA113904283
DR   hPSCreg; CTEFi001-A
DR   Wikidata; Q123030981
CC   From: Cell and Tissue Engineering Facility, St. Anne's University Hospital Brno; Brno; Czech Republic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CTG1
AC   CVCL_0A63
DR   Wikidata; Q54814738
RX   PubMed=6087454;
RX   PubMed=6415065;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03522; VSV G protein (Note=Truncated).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6550 ! C127
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   CTGUi001-A
AC   CVCL_C6P3
SY   F01; FD01; FD-01
DR   BioSamples; SAMEA111265587
DR   hPSCreg; CTGUi001-A
DR   Wikidata; Q117704277
RX   PubMed=36917862;
CC   From: China Three Gorges University; Yichang; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Cys52Ter (c.156C>A); Zygosity=Hemizygous (PubMed=36917862).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   CTL156
AC   CVCL_ZC72
SY   Control156; 156
DR   Wikidata; Q98125802
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   CTL161
AC   CVCL_ZC73
SY   Control161; 161
DR   Wikidata; Q98125803
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   CTL44
AC   CVCL_D100
SY   CTLL-44
DR   Wikidata; Q54814740
RX   PubMed=8370927;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CTL44
CC   Characteristics: IL4 dependent.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0227 ! CTLL-2
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   CTLL-2
AC   CVCL_0227
SY   CTLL 2; CTLL2; CTLL(2)
DR   BTO; BTO_0001482
DR   CLO; CLO_0002636
DR   CLO; CLO_0050181
DR   EFO; EFO_0002821
DR   MCCL; MCC:0000115
DR   CLDB; cl925
DR   CLDB; cl4995
DR   ATCC; TIB-214
DR   BCRC; 60376
DR   BCRJ; 0281
DR   BioSample; SAMN11397659
DR   CCRID; 1102MOU-NIFDC00051
DR   CCRID; 3101MOUGNM4
DR   CLS; 400482
DR   DSMZ; ACC-27
DR   DSMZCellDive; ACC-27
DR   ECACC; 93042610
DR   ICLC; AL00003
DR   Lonza; 1012
DR   NCBI_Iran; C538
DR   RCB; RCB0637
DR   Wikidata; Q54814742
RX   PubMed=145543;
RX   PubMed=9619491;
RX   PubMed=9744750;
RX   PubMed=31220119;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CTLL-2
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-67.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: IL2 dependent.
CC   Doubling time: 24 hours (PubMed=145543).
CC   Discontinued: BCRJ; 0281; probable.
CC   Discontinued: DSMZ; ACC-27; true.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19,20
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17,18
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 17,20
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 14,15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13,14
ST   Mouse STR X-1: 28,29
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   CTLL-2 NF-kappaB
AC   CVCL_YU23
SY   CTLL-2_NF-kappaB
DR   Wikidata; Q93459998
RX   PubMed=32094407;
CC   Characteristics: Reporter cell line for the measurement of the biological activity of a wide variety of cytokines.
CC   Characteristics: Activated by NF-kappaB through a NF-kappaB response element fused to a secNanoLuc-T2A-mCherry construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0227 ! CTLL-2
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 9
//
ID   CTLL-20
AC   CVCL_9786
SY   CTLL-2 clone 20
DR   Wikidata; Q54814743
RX   PubMed=310861;
CC   Characteristics: IL2 dependent.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0227 ! CTLL-2
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   CTLL-4
AC   CVCL_0228
SY   CTLL4
DR   MCCL; MCC:0000116
DR   Wikidata; Q54814744
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 6
//
ID   CTLL-A1
AC   CVCL_DC85
DR   Wikidata; Q54814746
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC82 ! CTLL-AP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-A11
AC   CVCL_DC87
DR   Wikidata; Q54814747
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC82 ! CTLL-AP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-A2
AC   CVCL_DC86
DR   Wikidata; Q54814748
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC82 ! CTLL-AP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-AP
AC   CVCL_DC82
DR   Wikidata; Q54814749
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-D5
AC   CVCL_DC84
DR   Wikidata; Q54814750
RX   Patent=US4683199;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-FP
AC   CVCL_DC83
DR   Wikidata; Q54814751
RX   Patent=US4683199;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-R1
AC   CVCL_DC88
DR   Wikidata; Q54814752
RX   PubMed=6600215;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC81 ! CTLL-RP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-R11
AC   CVCL_DC92
DR   Wikidata; Q54814753
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8204.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC81 ! CTLL-RP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CTLL-R12
AC   CVCL_DC93
DR   Wikidata; Q54814754
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8205.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC81 ! CTLL-RP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CTLL-R5
AC   CVCL_DC89
DR   Wikidata; Q54814755
RX   PubMed=6600215;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC81 ! CTLL-RP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CTLL-R8
AC   CVCL_DC90
DR   Wikidata; Q54814756
RX   Patent=US4683199;
RX   PubMed=6600215;
RX   PubMed=8245705;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8202.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC81 ! CTLL-RP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CTLL-R9
AC   CVCL_DC91
DR   Wikidata; Q54814757
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8203.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC81 ! CTLL-RP
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CTLL-RP
AC   CVCL_DC81
DR   Wikidata; Q54814758
RX   Patent=US4683199;
RX   PubMed=6600215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8201.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   CTM
AC   CVCL_1G80
SY   Catla Thymus Macrophage
DR   NRFC; NRFC028
DR   Wikidata; Q54814759
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1111/j.1365-2109.2012.03227.x;
WW   Provider; NRFC; NRFC028; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC028.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Thymic macrophage; CL=CL_0000866.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   CTM1953541
AC   CVCL_E537
SY   CTM195354
DR   dbMHC; 48735
DR   ECACC; 94071420
DR   IHW; IHW09283
DR   IPD-IMGT/HLA; 10450
DR   Wikidata; Q54814760
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*80:01,30:02; B*08:01,27; C*02:02,07:01 (IPD-IMGT/HLA=10450).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   CTM3953540
AC   CVCL_E538
SY   CTM395354
DR   dbMHC; 48736
DR   ECACC; 94071421
DR   IHW; IHW09282
DR   IPD-IMGT/HLA; 10453
DR   Wikidata; Q54814761
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Spanish.
CC   HLA typing: A*80:01,03:01; B*08:01,55:01; C*03:03,07:01 (IPD-IMGT/HLA=10453).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   CTM4955926
AC   CVCL_E539
SY   CTM495592
DR   dbMHC; 48737
DR   ECACC; 94071419
DR   IHW; IHW09281
DR   IPD-IMGT/HLA; 10456
DR   Wikidata; Q54814762
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*33:03:01,11:01; B*35; C*04:01 (IPD-IMGT/HLA=10456).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   CTN-16A3-13
AC   CVCL_C4DC
DR   Wikidata; Q116048812
RX   PubMed=23202236;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_39178; Clothianidin.
CC   Monoclonal antibody target: ChEBI; CHEBI_39183; Dinotefuran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   CTN3
AC   CVCL_W952
DR   Wikidata; Q54814763
RX   PubMed=15705875;
RX   PubMed=17893233;
RX   PubMed=22538498;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97874; Rb1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:9884; RB1.
CC   Breed/subspecies: Rb+/- Tg(POMC-RB)109Ayn.
DI   NCIt; C24170; Mouse medullary thyroid carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 7
//
ID   CTNI-C4
AC   CVCL_XE89
DR   CCRID; 4201PAT-CCTCC00431
DR   Wikidata; Q93460106
RX   Patent=CN103694355B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013185.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   CTO11-NS
AC   CVCL_VJ59
SY   CTO11 NS
DR   Cosmic; 2568853
DR   Wikidata; Q93460108
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO12-NS
AC   CVCL_VJ60
SY   CTO12 NS
DR   Cosmic; 2568854
DR   Wikidata; Q93460111
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO15-AC
AC   CVCL_VJ61
SY   CTO15 AC
DR   Cosmic; 2568866
DR   Wikidata; Q93460114
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ62 ! CTO15-NS
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO15-NS
AC   CVCL_VJ62
SY   CTO15 NS
DR   Cosmic; 2568855
DR   Wikidata; Q93460116
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ61 ! CTO15-AC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO16-AC
AC   CVCL_VJ63
SY   CTO16 AC
DR   Cosmic; 2568867
DR   Wikidata; Q93460119
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO20-AC
AC   CVCL_VJ64
SY   CTO20 AC
DR   Cosmic; 2568868
DR   Wikidata; Q93460121
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO21-AC
AC   CVCL_VJ65
SY   CTO21 AC
DR   Cosmic; 2568869
DR   Wikidata; Q93460124
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO22-NS
AC   CVCL_VJ66
SY   CTO22 NS
DR   Cosmic; 2568856
DR   Wikidata; Q93460127
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO3-AC
AC   CVCL_VJ67
SY   CTO3 AC
DR   Cosmic; 2568865
DR   Wikidata; Q93460130
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ68 ! CTO3-NS
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTO3-NS
AC   CVCL_VJ68
SY   CTO3 NS
DR   Cosmic; 2568852
DR   Wikidata; Q93460134
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ67 ! CTO3-AC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CTOD1
AC   CVCL_VW45
DR   IBRC; C11088
DR   Wikidata; Q93460136
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_VW46 ! ADod-01
SX   Female
AG   1Y4M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   CTPE
AC   CVCL_4794
SY   Cadmium-Transformed Prostate Epithelial
DR   Wikidata; Q54814764
RX   PubMed=11212230;
RX   PubMed=15643173;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   CTPS
AC   CVCL_3457
DR   CLO; CLO_0002637
DR   ATCC; CRL-6496
DR   Wikidata; Q54814765
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 10623; Cottontail rabbit papillomavirus (Kappapapillomavirus 2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C134998; Rabbit papilloma
OX   NCBI_TaxID=9988; ! Sylvilagus floridanus (Cottontail rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   CTR2#6
AC   CVCL_A5DG
SY   HIPS CTR2#6
DR   Wikidata; Q107114740
RX   PubMed=32188154;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CTR4#5
AC   CVCL_A5DF
SY   clone #5
DR   Wikidata; Q107114742
RX   PubMed=30251567;
RX   PubMed=32188154;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5CV ! CTR4#9
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   CTR4#9
AC   CVCL_A5CV
SY   HIPS CTR4#9; HIPSCTR4#9; clone #9
DR   Wikidata; Q107114743
RX   PubMed=30251567;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5DF ! CTR4#5
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   CTR8#14
AC   CVCL_A5DH
DR   Wikidata; Q107114744
RX   PubMed=32188154;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Ctrl 154
AC   CVCL_XX76
SY   Control line 154
DR   Wikidata; Q93460152
CC   Miscellaneous: Cell line information from personal communication of Varcianna, Andre E.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   Ctrl 155
AC   CVCL_UF81
SY   Control line 155; 155
DR   Wikidata; Q93460154
RX   PubMed=24379375;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   Ctrl 170
AC   CVCL_UF82
SY   Control line 170; 170
DR   Wikidata; Q93460157
RX   PubMed=24379375;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   Ctrl 3050
AC   CVCL_UH66
SY   Control line 3050; 3050
DR   Wikidata; Q93460159
CC   Miscellaneous: Cell line information from personal communication of Varcianna, Andre E.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 6
//
ID   Ctrl. BS PBiPS37-Sv4F-1
AC   CVCL_A7HH
DR   Wikidata; Q107114745
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Ctrl.%2520BS%2520PBiPS37-Sv4F-1-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Ctrl.+BS+PBiPS37-Sv4F-1+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D21S11: 27,31
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5TB ! IDIBGIi001-A
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   CTRL7-II
AC   CVCL_IJ20
SY   CTL07-II
DR   Wikidata; Q54814739
RX   PubMed=27789397;
CC   From: Department of Neuroscience, Karolinska Institutet; Stockholm; Sweden.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=27789397
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,21
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 7,8
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   CTRL-9-II
AC   CVCL_JL74
SY   CTL09-II
DR   Wikidata; Q54814767
RX   PubMed=28395796;
CC   From: Department of Neuroscience, Karolinska Institutet; Stockholm; Sweden.
CC   Donor information: Established from monozygotic twin of KICRi002-A/CTRL-10-I (Cellosaurus=CVCL_JL73).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28395796
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 20,23
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D1S1656: 15.3,17.3
ST   D21S11: 28,29
ST   D2S1338: 20,22
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D6S1043: 12,18
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 9,12
ST   Penta E: 11,16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   CTRL-iPSC
AC   CVCL_ZI69
DR   Wikidata; Q98125804
RX   PubMed=25556567;
RX   PubMed=26455413;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Ctrl1-12
AC   CVCL_W566
SY   iLB-C1-30m-R12; iLB-C1-30 m-r12; LB-30-12; UKBi004-A
DR   BioSamples; SAMEA4583828
DR   EBiSC; UKBi004-A
DR   ECACC; 66540009
DR   hPSCreg; UKBi004-A
DR   SKIP; SKIP000305
DR   SKIP; SKIP002507
DR   Wikidata; Q54814768
RX   PubMed=22113611;
RX   PubMed=25392050;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Discontinued: ECACC; 66540009; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W567 ! Ctrl1-17
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 13
//
ID   Ctrl1-17
AC   CVCL_W567
DR   SKIP; SKIP000306
DR   Wikidata; Q54814769
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W566 ! Ctrl1-12
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   Ctrl2-2
AC   CVCL_W568
SY   iLB-C2-36m-R2; UKBi002-A
DR   BioSamples; SAMEA2590957
DR   EBiSC; UKBi002-A
DR   ECACC; 66540005
DR   hPSCreg; UKBi002-A
DR   SKIP; SKIP000307
DR   SKIP; SKIP002505
DR   Wikidata; Q54814770
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Discontinued: ECACC; 66540005; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W569 ! Ctrl2-8
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 14
//
ID   Ctrl2-8
AC   CVCL_W569
DR   SKIP; SKIP000308
DR   Wikidata; Q54814771
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W568 ! Ctrl2-2
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   CTS
AC   CVCL_A431
DR   Cosmic; 787425
DR   Cosmic; 975243
DR   Cosmic; 996317
DR   Cosmic; 998753
DR   Cosmic; 1037669
DR   Cosmic; 1281309
DR   Cosmic; 2089648
DR   DSMZ; ACC-987
DR   Wikidata; Q54814772
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8904886;
RX   PubMed=10674912;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=23955599;
RX   PubMed=36982453;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=8904886); ~48 hours (DSMZ=ACC-987).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (PubMed=8904886; PubMed=14671638).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-987
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 19,22
ST   D3S1358: 14,15
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 25,26
ST   Penta D: 12
ST   Penta E: 15
ST   TH01: 6,7
ST   TPOX: 12
ST   vWA: 16,19
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   CTSC-1
AC   CVCL_W664
DR   Wikidata; Q54814773
RX   Patent=CN103966169A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012176.
CC   Population: Chinese.
CC   Doubling time: 37.52 +- 1.34 hours (Note=At 10th passage), 30.85 +- 0.53 hours (Note=At 30th passage) (Patent=CN103966169A).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Patent=CN103966169A
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 20,21
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 14,15
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D6S1043: 11,14
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 15,16
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   CTSC-2
AC   CVCL_XB88
DR   Wikidata; Q93460214
RX   Patent=CN102911916A;
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Doubling time: 31.48 +- 0.79 hours (Note=At 10th passage), 32.72 +- 0.81 hours (Note=At 30th passage) (Patent=CN102911916A).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Patent=CN102911916A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18,19
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 15
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,16
ST   D5S818: 13,14
ST   D6S1043: 14,18
ST   D7S820: 11,13
ST   D8S1179: 12,15
ST   FGA: 20,25
ST   Penta D: 7,9
ST   Penta E: 19,20
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   CTSC-3
AC   CVCL_XB89
DR   CCRID; 4201PAT-CCTCC00465
DR   Wikidata; Q93460218
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   CTSC#1.1
AC   CVCL_A9WH
SY   CRC-SC#1.1
DR   cancercelllines; CVCL_A9WH
DR   Wikidata; Q102113736
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr182Ilefs*2 (c.543_546delACAA); ClinVar=VCV000470005; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg259Trp (c.775C>T); ClinVar=VCV000411556; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1284Ter (c.3850G>T); ClinVar=VCV000946474; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg361Cys (c.1081C>T); ClinVar=VCV000008543; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Leu200Profs*10 (c.593_594insC); Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WI ! CTSC#1.2
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#1.2
AC   CVCL_A9WI
SY   CRC-SC#1.2
DR   cancercelllines; CVCL_A9WI
DR   Wikidata; Q102113737
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr182Ilefs*2 (c.543_546delACAA); ClinVar=VCV000470005; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg259Trp (c.775C>T); ClinVar=VCV000411556; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1284Ter (c.3850G>T); ClinVar=VCV000946474; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Pro606Ala (c.1816C>G); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg361Cys (c.1081C>T); ClinVar=VCV000008543; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Leu200Profs*10 (c.593_594insC); Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WH ! CTSC#1.1
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#18
AC   CVCL_A9WJ
SY   CRC-SC#18
DR   cancercelllines; CVCL_A9WJ
DR   Wikidata; Q102113738
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:172; ACVR1B; Simple; p.Trp501Ter (c.1503G>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala199Val (c.596C>T); ClinVar=VCV000246301; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gly2250Asp (c.6749G>A); ClinVar=VCV001502413; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Lys647Glu (c.1939A>G); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323Metfs*21 (c.968delA); ClinVar=VCV000653412; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Ser569Profs*33 (c.1700delC); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp148Ter (c.441dupT); Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   CTSC#383
AC   CVCL_A9WM
SY   CRC-SC#383
DR   cancercelllines; CVCL_A9WM
DR   Wikidata; Q102113739
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg564Ter (c.1690C>T); ClinVar=VCV000000808; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala612Hisfs*18 (c.1834delG); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Trp690Arg (c.2068T>C); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Asp54Tyr (c.160G>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Glu326Lys (c.976G>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Asn (c.644G>A); ClinVar=VCV000376662; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 12,15
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#389
AC   CVCL_A9WN
SY   CRC-SC#389; CSC10
DR   cancercelllines; CVCL_A9WN
DR   Wikidata; Q102113740
RX   PubMed=26956206;
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Ala626Val (c.1877C>T); ClinVar=VCV001698991; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln366Ter (c.1096C>T); ClinVar=VCV000405490; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg497His (c.1490G>A); ClinVar=VCV000959550; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11204; SOX9; Simple; p.Gly461Cys (c.1381G>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 14,15
ST   D16S539: 9,14
ST   D5S818: 12,13,15
ST   D7S820: 8,11
ST   TH01: 9,9.3
ST   TPOX: 10,12
ST   vWA: 15,18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   CTSC#393
AC   CVCL_A9WP
SY   CRC-SC#393; CSC11
DR   cancercelllines; CVCL_A9WP
DR   Wikidata; Q102113741
RX   PubMed=26956206;
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala440Thr (c.1318G>A); ClinVar=VCV000418008; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala759Asnfs*2 (c.2273_2285delAAGCCCTAGAAGC); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Val325Ile (c.973G>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Glu110Lys (c.328G>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Gln277Ter (c.829C>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Val (c.2909A>T); Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9,12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#398
AC   CVCL_A9WQ
SY   CRC-SC#398
DR   cancercelllines; CVCL_A9WQ
DR   Wikidata; Q102113743
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met314Ile (c.942G>T); ClinVar=VCV000517186; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu991Ter (c.2971G>T); ClinVar=VCV000186494; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Lys (c.1571G>A); ClinVar=VCV000132954; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg361Cys (c.1081C>T); ClinVar=VCV000008543; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 9,14
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 10,12
ST   vWA: 14,15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   CTSC#416
AC   CVCL_A9WR
SY   CRC-SC#416; CSC13
DR   Wikidata; Q102113744
RX   PubMed=26956206;
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Arg462His (c.1385G>A); ClinVar=VCV001308032; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11204; SOX9; Simple; p.Ala481Val (c.1442C>T); Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,13
ST   D13S317: 7,12
ST   D16S539: 11,14
ST   D5S818: 11,14
ST   D7S820: 12,13
ST   TH01: 6,9.3
ST   TPOX: 7
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#417
AC   CVCL_A9WS
SY   CRC-SC#417
DR   cancercelllines; CVCL_A9WS
DR   Wikidata; Q102113745
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-low) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met438Thr (c.1313T>C); ClinVar=VCV000630112; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg876Ter (c.2626C>T); ClinVar=VCV000216014; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Lys (c.1571G>A); ClinVar=VCV000132954; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,8
ST   TPOX: 9
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#430
AC   CVCL_A9WT
SY   CRC-SC#430; CSC21
DR   cancercelllines; CVCL_A9WT
DR   Wikidata; Q102113747
RX   PubMed=26956206;
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gly97Arg (c.289G>A); ClinVar=VCV001697514; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1465Trpfs*3 (c.4385_4386AG[4]); ClinVar=VCV000000811; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.His104Tyr (c.310C>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg179Cys (c.535C>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly248Ser (c.742G>A); ClinVar=VCV000523491; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu563Lys (c.1687G>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu57Trpfs*42 (c.166delT); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Thr34Lys (c.101C>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.His287Gln (c.861T>G); Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 11,15
ST   D7S820: 8,14
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16,19,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   CTSC#432
AC   CVCL_A9WU
SY   CRC-SC#432; CSC22
DR   cancercelllines; CVCL_A9WU
DR   Wikidata; Q102113748
RX   PubMed=26956206;
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Arg486His (c.1457G>A); ClinVar=VCV000809472; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Pro300Leu (c.899C>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Leu (c.814G>T); ClinVar=VCV000012358; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, distal; UBERON=UBERON_0008971.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 13
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#438
AC   CVCL_A9WV
SY   CRC-SC#438
DR   cancercelllines; CVCL_A9WV
DR   Wikidata; Q102113751
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Leu443Ser (c.1328T>C); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Arg182Ter (c.544C>T); ClinVar=VCV001187876; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11204; SOX9; Simple; p.Thr243Profs*10 (c.723delC); ClinVar=VCV000817191; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   CTSC#446
AC   CVCL_A9WW
SY   CRC-SC#446
DR   cancercelllines; CVCL_A9WW
DR   Wikidata; Q102113753
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:172; ACVR1B; Simple; p.Met361Leu (c.1081A>C); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:172; ACVR1B; Simple; p.Glu482Gly (c.1445A>G); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp412Gly (c.1235A>G); ClinVar=VCV001498964; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Arg717His (c.2150G>A); ClinVar=VCV001208710; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Ser142Arg (c.424A>C); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Ser678Ter (c.2033C>G); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Asp105Val (c.314A>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Cys186Tyr (c.557G>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His93Arg (c.278A>G); ClinVar=VCV000007848; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu182Ser (c.545T>C); ClinVar=VCV000187827; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Asn34Asp (c.100A>G); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Leu254Phe (c.760C>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11204; SOX9; Simple; p.Pro108His (c.323C>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Gln263Arg (c.788A>G); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala189Profs*58 (c.565delG); ClinVar=VCV003148285; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe270Cys (c.809T>G); ClinVar=VCV000376597; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 10
//
ID   CTSC#482
AC   CVCL_A9WX
SY   CRC-SC#482
DR   cancercelllines; CVCL_A9WX
DR   Wikidata; Q102113754
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn436Ilefs*18 (c.1307delA); ClinVar=VCV000487058; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1465Trpfs*3 (c.4385_4386AG[4]); ClinVar=VCV000000811; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asp1636Metfs*14 (c.4906dupG); ClinVar=VCV000469982; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro3Thr (c.7C>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11204; SOX9; Simple; p.Gln368Lys (c.1102C>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11204; SOX9; Simple; p.Leu382Gln (c.1145T>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu201Ter (c.602T>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 10
ST   D5S818: 9,10
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,9,10
ST   vWA: 15,16,17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#510
AC   CVCL_A9WY
SY   CRC-SC#510
DR   cancercelllines; CVCL_A9WY
DR   Wikidata; Q102113755
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1752Ter (c.5254C>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ile (c.122C>T); ClinVar=VCV000017587; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000177777; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asn107Metfs*3 (c.320delA) (c.316delA); ClinVar=VCV001728912; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg361His (c.1082G>A); ClinVar=VCV000024832; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Asp91Val (c.272A>T); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; p.Met411Thr (c.1232T>C); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu388Lys (c.1162G>A); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser392Ter (c.1175C>A); dbSNP=rs769664911; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ter394Aspext*28 (c.1180_1182insGAC); Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 18,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#553
AC   CVCL_A9WZ
SY   CRC-SC#553
DR   Wikidata; Q102113757
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   CTSC#85
AC   CVCL_A9WL
SY   CRC-SC#85
DR   cancercelllines; CVCL_A9WL
DR   Wikidata; Q102113759
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg283Ter (c.847C>T); ClinVar=VCV000184999; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1415Argfs*4 (c.4245delT); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val54Ala (c.161T>C); Zygosity=Unspecified (PubMed=33128777).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg361Cys (c.1081C>T); ClinVar=VCV000008543; Zygosity=Unspecified (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D5S818: 9,12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   CTSC#CRO
AC   CVCL_A9WK
SY   CRC-SC#CRO
DR   Wikidata; Q102113760
RX   PubMed=27286453;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Sant Andrea Hospital; Rome; Italy.
CC   Microsatellite instability: Stable (MSS) (PubMed=33128777).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   CTUi001-A
AC   CVCL_D6SQ
SY   RS004-PPM1A-/-
DR   BioSamples; SAMEA115160200
DR   hPSCreg; CTUi001-A
RX   PubMed=38643711;
CC   From: Shandong Medicinal Biotechnology Center, Shandong First Medical University; Jinan; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9275; PPM1A.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6SP ! RS004
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   CTUi002-A
AC   CVCL_E3U4
DR   hPSCreg; CTUi002-A
CC   From: Shandong Medicinal Biotechnology Center, Shandong First Medical University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CTUi003-A
AC   CVCL_E3U5
DR   hPSCreg; CTUi003-A
CC   From: Shandong Medicinal Biotechnology Center, Shandong First Medical University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CTUi005-A
AC   CVCL_E3U6
SY   RD001
DR   BioSamples; SAMEA115676025
DR   hPSCreg; CTUi005-A
RX   PubMed=38972232;
CC   From: Shandong Medicinal Biotechnology Center, Shandong First Medical University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Arg500Argfs*30 (c.1498_1499insG); Zygosity=Heterozygous (PubMed=38972232).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176897; Neurodevelopmental disorder with spastic diplegia and visual defects
DI   ORDO; Orphanet_404473; Severe intellectual disability-progressive spastic diplegia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CTV-1
AC   CVCL_1150
SY   CTV1
DR   CLO; CLO_0002638
DR   CLDB; cl927
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473579
DR   cancercelllines; CVCL_1150
DR   Cell_Model_Passport; SIDM00951
DR   ChEMBL-Cells; CHEMBL3308189
DR   ChEMBL-Targets; CHEMBL2366360
DR   Cosmic; 717685
DR   Cosmic; 753548
DR   Cosmic; 787426
DR   Cosmic; 947372
DR   Cosmic; 975244
DR   Cosmic; 998755
DR   Cosmic; 1078737
DR   Cosmic; 1151776
DR   Cosmic; 1524794
DR   Cosmic; 1760520
DR   Cosmic; 2089657
DR   Cosmic; 2131536
DR   Cosmic; 2306203
DR   Cosmic-CLP; 753548
DR   DepMap; ACH-001737
DR   DepMap; ACH-002222
DR   DSMZ; ACC-40
DR   DSMZCellDive; ACC-40
DR   EGA; EGAS00001000978
DR   GDSC; 753548
DR   GEO; GSM1374458
DR   GEO; GSM1669712
DR   IARC_TP53; 21259
DR   LINCS_LDP; LCL-1013
DR   PharmacoDB; CTV1_268_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1150
DR   Wikidata; Q54814774
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3458274;
RX   PubMed=6593267;
RX   PubMed=9379676;
RX   PubMed=10739008;
RX   PubMed=15843827;
RX   PubMed=20164919;
RX   PubMed=22675565;
RX   PubMed=23955599;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Problematic cell line: Probably misidentified. Originally thought to be a acute monoblastic leukemia but seems to be a T-ALL cell line (PubMed=15843827). Was also said to originate from a 40 year old female patient (PubMed=6593267) but has a male STR profile.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=6593267); ~40 hours (DSMZ=ACC-40).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Gly477Ser (c.1429G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Gly831Glu (c.2492G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Ala353Val (c.1058C>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Pro447Leu (c.1340C>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Ala500Thr (c.1498G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gly1532Arg (c.4594G>A); ClinVar=VCV001462589; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Ser2523Ter (c.7568C>A); Zygosity=Heterozygous (Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:8804; PDGFRB; Simple; p.Met772Ile (c.2316G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys656Phe (c.1967G>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Arg75Met (c.224G>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys175Met (c.524A>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=753548; DepMap=ACH-002222).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.02%; Native American=1.28%; East Asian, North=0%; East Asian, South=0.34%; South Asian=5.64%; European, North=45.18%; European, South=46.55% (PubMed=30894373).
CC   Misspelling: CTY-1; Cosmic=717685; PubMed=9379676.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=753548; DSMZ=ACC-40
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 9,14
ST   D18S51: 8,14
ST   D19S433: 14,16
ST   D21S11: 27,28
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11,13
ST   D8S1179: 9,15
ST   FGA: 24,25
ST   Penta D: 9,11
ST   Penta E: 6,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18 (DSMZ=ACC-40)
ST   vWA: 18,19 (Cosmic-CLP=753548)
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RX77 ! CTV-2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   CTV-2
AC   CVCL_RX77
DR   Wikidata; Q54814775
RX   PubMed=3458274;
CC   Problematic cell line: Possibly misidentified. The sister cell line CTV-1 was originally thought to be a acute monoblastic leukemia but seems to be a T-ALL cell line. CTV-1 was also said to originate from a 40 year old female patient but has a male STR profile.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1150 ! CTV-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   CTVT cell line
AC   CVCL_WW14
SY   Canine Transmissible Venereal Tumour cell line
DR   Wikidata; Q93460234
RX   PubMed=31276062;
RX   PubMed=36061122;
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C162473; Canine transmissible venereal tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 7
//
ID   CTX TNA2
AC   CVCL_3670
DR   CLO; CLO_0002639
DR   AddexBio; P0005006/4887
DR   ATCC; CRL-2006
DR   BCRC; 60547
DR   ChEMBL-Cells; CHEMBL4802057
DR   CLS; 305358
DR   ECACC; 98102213
DR   PubChem_Cell_line; CVCL_3670
DR   Wikidata; Q54814776
RX   PubMed=1378628;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   CTX0E03
AC   CVCL_9T00
SY   CTXOE03; CTX-OE-03; CTX-OE03
DR   Wikidata; Q54814777
RX   Patent=US7666672;
RX   PubMed=16464451;
RX   PubMed=19343502;
RX   PubMed=19633272;
RX   PubMed=32374064;
WW   Info; LifeMap Discovery; -; https://web.archive.org/web/20241222163647/https://discovery.lifemapsc.com//stem-cell-differentiation/in-vitro-cells/brain-homo-sapiens-neural-stem-cell-line-ctx0e03-reneuron
CC   Group: Patented cell line.
CC   From: ReNeuron, Ltd; Pencoed; United Kingdom.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 04091601.
CC   Doubling time: 3-4 days (Patent=US7666672).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Transformant: Myc.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   CTXNS1 B-1 iPSC
AC   CVCL_A8YR
SY   CTXNS1_B1_iPS
DR   GEO; GSM4617889
DR   Wikidata; Q108820091
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   95FD
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   CTXNS2 B-1 iPSC
AC   CVCL_A8YS
SY   CTXNS2_B1_iPS
DR   GEO; GSM4617890
DR   Wikidata; Q108820092
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   95FD
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   CU-1
AC   CVCL_T546
SY   GACL-1; CU1; MDCC-CU1
DR   Wikidata; Q54814778
RX   PubMed=624595;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: N-line.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-10
AC   CVCL_T552
SY   TLT-1; TLT1; LSCC-TLT1; CU10; LSCC-CU10
DR   Wikidata; Q54814780
RX   PubMed=3273463;
RX   PubMed=6586288;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 17.0 hours (PubMed=3273463).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-11
AC   CVCL_T553
SY   CU11; MDCC-CU11
DR   Wikidata; Q54814781
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-12
AC   CVCL_T554
SY   CU12; MDCC-CU12
DR   Wikidata; Q54814782
RX   PubMed=6273319;
RX   PubMed=6586288;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-13
AC   CVCL_T555
SY   CU13; MDCC-CU13
DR   Wikidata; Q54814783
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: GB-1.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-14
AC   CVCL_T556
SY   CU14; MDCC-CU14
DR   Wikidata; Q54814784
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-15
AC   CVCL_T557
SY   CU15; MDCC-CU15
DR   Wikidata; Q54814785
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-16
AC   CVCL_T558
SY   CU16; MDCC-CU16
DR   Wikidata; Q54814786
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
CC   Breed/subspecies: S.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-17
AC   CVCL_T559
SY   CU17; MDCC-CU17
DR   Wikidata; Q54814797
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-18
AC   CVCL_T560
SY   CU18; MDCC-CU18
DR   Wikidata; Q54814798
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
CC   Breed/subspecies: S.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-19
AC   CVCL_T561
SY   CU19; MDCC-CU19
DR   Wikidata; Q54814799
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: GB-1.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-2
AC   CVCL_T547
SY   CUCL-1; CU2; MDCC-CU2
DR   Wikidata; Q54814800
RX   PubMed=624595;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: P-line.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-20
AC   CVCL_T562
SY   CU20; MDCC-CU20
DR   Wikidata; Q54814802
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: RPRL-7.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 7
//
ID   CU-21
AC   CVCL_T563
SY   CU21; MDCC-CU21
DR   Wikidata; Q54814803
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
CC   Breed/subspecies: N-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T564 ! CU-22
OI   CVCL_T566 ! CU-24
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-22
AC   CVCL_T564
SY   CU22; MDCC-CU22
DR   Wikidata; Q54814804
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
CC   Breed/subspecies: N-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T563 ! CU-21
OI   CVCL_T566 ! CU-24
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-23
AC   CVCL_T565
SY   CU23; MDCC-CU23
DR   Wikidata; Q54814805
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: N-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-24
AC   CVCL_T566
SY   CU24; MDCC-CU24
DR   Wikidata; Q54814806
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
CC   Breed/subspecies: N-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T563 ! CU-21
OI   CVCL_T564 ! CU-22
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-25
AC   CVCL_T567
SY   CU25; MDCC-CU25
DR   Wikidata; Q54814807
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-003.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-26
AC   CVCL_T568
SY   CU26; MDCC-CU26
DR   Wikidata; Q54814808
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-336.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-27
AC   CVCL_T569
SY   CU27; MDCC-CU27
DR   Wikidata; Q54814809
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-28
AC   CVCL_T570
SY   CU28; MDCC-CU28
DR   Wikidata; Q54814810
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: UCD-335.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-29
AC   CVCL_T571
SY   CU29; MDCC-CU29
DR   Wikidata; Q54814811
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-003.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T579 ! CU-38
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-3
AC   CVCL_T548
SY   JMCL-1; CU3; MDCC-CU3
DR   Wikidata; Q54814812
RX   PubMed=624595;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: PDR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-30
AC   CVCL_T572
SY   CU30; MDCC-CU30
DR   Wikidata; Q54814813
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-253.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-31
AC   CVCL_T573
SY   CU31; MDCC-CU31
DR   Wikidata; Q54814814
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-254.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-32
AC   CVCL_T574
SY   CU32; MDCC-CU32
DR   Wikidata; Q54814815
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-33
AC   CVCL_T575
SY   CU33; MDCC-CU33
DR   Wikidata; Q54814816
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-35
AC   CVCL_T576
SY   CU35; MDCC-CU35
DR   Wikidata; Q54814817
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-36
AC   CVCL_T577
SY   CU36; MDCC-CU36
DR   Wikidata; Q54814818
RX   PubMed=3496613;
RX   PubMed=6273319;
RX   PubMed=6586288;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-003.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T578 ! CU-37
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-37
AC   CVCL_T578
SY   CU37; MDCC-CU37
DR   Wikidata; Q54814819
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-003.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T577 ! CU-36
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-38
AC   CVCL_T579
SY   CU38; MDCC-CU38
DR   Wikidata; Q54814820
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: UCD-003.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T571 ! CU-29
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-39
AC   CVCL_T580
SY   CU39; MDCC-CU39
DR   Wikidata; Q54814821
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T583 ! CU-42
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-4
AC   CVCL_T549
SY   GACL-4; CU4; MDCC-CU4
DR   Wikidata; Q54814822
RX   PubMed=624595;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: N-line.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-40
AC   CVCL_T581
SY   CU40; MDCC-CU40
DR   Wikidata; Q54814823
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T582 ! CU-41
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-41
AC   CVCL_T582
SY   CU41; MDCC-CU41
DR   Wikidata; Q54814824
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T581 ! CU-40
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-42
AC   CVCL_T583
SY   CU42; MDCC-CU42
DR   Wikidata; Q54814825
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T580 ! CU-39
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-43
AC   CVCL_T584
SY   CU43; MDCC-CU43
DR   Wikidata; Q54814826
RX   PubMed=6273319;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Breed/subspecies: P-2.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   CU-47
AC   CVCL_T585
SY   CU47; MDCC-CU47
DR   Wikidata; Q54814828
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-48
AC   CVCL_T586
SY   CU48; MDCC-CU48
DR   Wikidata; Q54814829
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-49
AC   CVCL_T587
SY   CU49; MDCC-CU49
DR   Wikidata; Q54814830
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-5
AC   CVCL_T550
SY   GBCL-1; CU5; MDCC-CU5
DR   Wikidata; Q54814831
RX   PubMed=624595;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: GB-1.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-6
AC   CVCL_T551
SY   GACL-6; CU6; MDCC-CU6
DR   Wikidata; Q54814832
RX   PubMed=624595;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: P-line.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   CU-ACC1
AC   CVCL_RQ00
SY   Colorado University-AdrenoCortical cancer 1
DR   cancercelllines; CVCL_RQ00
DR   Wikidata; Q54814833
RX   PubMed=29371329;
RX   PubMed=35764904;
CC   Doubling time: 35 hours (Note=At 10th passage) (PubMed=29371329).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Arg (c.100G>A); ClinVar=VCV000376232; Zygosity=Unspecified (PubMed=29371329).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Perinephric space; UBERON=UBERON_8480016.
ST   Source(s): PubMed=29371329
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D18S51: 15,21
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 19,20
ST   Penta D: 12,13
ST   Penta E: 12,17
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   CU-ACC2
AC   CVCL_RQ01
SY   Colorado University-AdrenoCortical cancer 2
DR   cancercelllines; CVCL_RQ01
DR   Wikidata; Q54814834
RX   PubMed=29371329;
RX   PubMed=35764904;
CC   Doubling time: 29 hours (Note=At 10th passage) (PubMed=29371329).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Unexplicit; Ex1-6del; Zygosity=Unspecified (PubMed=29371329).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=29371329).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=29371329
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 19,20
ST   D21S11: 29
ST   D3S1358: 13,14
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 14
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18,20
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   CU0001
AC   CVCL_8U19
DR   ECACC; 93090201
DR   Wikidata; Q54814836
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;17)(q21.3;q23.3) (ECACC=93090201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U21 ! CU0003
SX   Female
AG   3Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CU0002
AC   CVCL_8U20
DR   ECACC; 93092205
DR   Wikidata; Q54814837
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(17)(q11.2;q24.3->q25.1) (ECACC=93092205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CU0003
AC   CVCL_8U21
DR   ECACC; 94080526
DR   Wikidata; Q54814838
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U19 ! CU0001
SX   Female
AG   4Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CU0004
AC   CVCL_8U22
DR   ECACC; 94120107
DR   Wikidata; Q54814839
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   CU1
AC   CVCL_B881
DR   Wikidata; Q54814848
RX   PubMed=21716665;
CC   From: Columbia University; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   Cu1.Ov
AC   CVCL_S386
SY   Cu1 Ov
DR   ATCC; CRL-6522
DR   Wikidata; Q54814849
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6522; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   CU2
AC   CVCL_B882
DR   Wikidata; Q54814850
RX   PubMed=21716665;
CC   From: Columbia University; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   Cu2.Tes
AC   CVCL_S387
SY   CU/TES
DR   ATCC; CRL-6523
DR   Wikidata; Q54814851
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6523; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   CUBi001-A
AC   CVCL_IT59
DR   BioSamples; SAMEA103992830
DR   hPSCreg; CUBi001-A
DR   SKIP; SKIP002894
DR   Wikidata; Q54814852
RX   PubMed=28346228;
RX   PubMed=34119956;
CC   From: Charite, Universitatsmedizin Berlin; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1348; SAMD9; Simple; p.Arg685Gln (c.2054G>A); ClinVar=VCV000421898; Zygosity=Heterozygous; Note=De novo mutation (PubMed=28346228).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147530; MIRAGE syndrome
DI   ORDO; Orphanet_494433; MIRAGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   CUBi002-A
AC   CVCL_XJ86
DR   hPSCreg; CUBi002-A
DR   Wikidata; Q93460512
CC   From: Charite, Universitatsmedizin Berlin; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1348; SAMD9; Simple; p.Ile983Ser (c.2948T>G); Zygosity=Heterozygous (from autologous cell line CUBi002-B).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147530; MIRAGE syndrome
DI   ORDO; Orphanet_494433; MIRAGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT60 ! CUBi002-B
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   CUBi002-B
AC   CVCL_IT60
DR   BioSamples; SAMEA103992832
DR   hPSCreg; CUBi002-B
DR   SKIP; SKIP002902
DR   Wikidata; Q54814853
RX   PubMed=28346228;
RX   PubMed=34119956;
CC   From: Charite, Universitatsmedizin Berlin; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1348; SAMD9; Simple; p.Ile983Ser (c.2948T>G); Zygosity=Heterozygous (PubMed=28346228).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147530; MIRAGE syndrome
DI   ORDO; Orphanet_494433; MIRAGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ86 ! CUBi002-A
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   CuFi-1
AC   CVCL_C457
SY   CuFi1; Cystic Fibrosis, University of Iowa-1
DR   ATCC; CRL-4013
DR   BioSample; SAMN03471722
DR   CancerTools; 154445
DR   ChEMBL-Cells; CHEMBL4513116
DR   ChEMBL-Targets; CHEMBL4513124
DR   PubChem_Cell_line; CVCL_C457
DR   Wikidata; Q54814854
RX   PubMed=12676769;
RX   PubMed=17191107;
CC   Karyotypic information: 47,XX,+20 [16]; 46,XX [4] (PubMed=12676769).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=12676769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4013
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,22
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 11
ST   FGA: 19,26
ST   Penta D: 12
ST   Penta E: 14,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 28
//
ID   CuFi-2
AC   CVCL_IN82
SY   Cystic Fibrosis, University of Iowa-2
DR   Wikidata; Q54814855
RX   PubMed=12676769;
CC   Karyotypic information: 47,XY,+20 [6]; 48,XY,+5,+20 [2]; 48,XY,i(7)(p10),+20 [2] (PubMed=12676769).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=12676769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 17
//
ID   CuFi-3
AC   CVCL_C458
SY   CuFi3; Cystic Fibrosis, University of Iowa-3
DR   ATCC; CRL-4014
DR   BioSample; SAMN03471723
DR   CancerTools; 154446
DR   Wikidata; Q54814856
RX   PubMed=12676769;
RX   PubMed=17191107;
CC   Karyotypic information: 48,XY,+5,+20 [10] (PubMed=12676769).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=12676769).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg553Ter (c.1657C>T); ClinVar=VCV000007122; Zygosity=Heterozygous (PubMed=12676769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-4014; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4014
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 16,19
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 28
//
ID   CuFi-4
AC   CVCL_C459
SY   Cystic Fibrosis, University of Iowa-4
DR   ATCC; CRL-4015
DR   BioSample; SAMN03471724
DR   CancerTools; 154447
DR   Wikidata; Q54814857
RX   PubMed=12676769;
CC   Karyotypic information: 48,XX,+5,+20 [10] (PubMed=12676769).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=12676769).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (PubMed=12676769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4015
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 20,23
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 21,24
ST   Penta D: 12
ST   Penta E: 12,17
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 27
//
ID   CuFi-5
AC   CVCL_C460
SY   Cystic Fibrosis, University of Iowa-5
DR   ATCC; CRL-4016
DR   BioSample; SAMN03471725
DR   CancerTools; 154464
DR   Wikidata; Q54814858
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ATCC=CRL-4016).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4016
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 11,20
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS95 ! CuFi-7
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 27
//
ID   CuFi-6
AC   CVCL_C461
SY   Cystic Fibrosis, University of Iowa-6
DR   ATCC; CRL-4017
DR   BioSample; SAMN03471726
DR   CancerTools; 154465
DR   Wikidata; Q54814859
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ATCC=CRL-4017).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4017
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 5,7
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 27
//
ID   CuFi-7
AC   CVCL_AS95
SY   Cystic Fibrosis, University of Iowa-7
DR   ATCC; CRL-4018
DR   Wikidata; Q54814860
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ATCC=CRL-4018).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-4018; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4018
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C460 ! CuFi-5
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 20
//
ID   CuFi-8
AC   CVCL_C0GK
SY   Cystic Fibrosis, University of Iowa-8
DR   CancerTools; 154454
DR   Wikidata; Q112929438
DR   Ximbio; 154454
RX   PubMed=22956907;
RX   PubMed=24825015;
RX   PubMed=32337159;
CC   Virology: Supports productive infection by human bocavirus 1 (HBoV1) (PubMed=22956907).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=32337159).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   CUi001-A
AC   CVCL_A8ZB
SY   WB1-10
DR   BioSamples; SAMEA8660439
DR   hPSCreg; CUi001-A
DR   Wikidata; Q108820093
RX   PubMed=34087989;
CC   From: Chiba University; Chiba; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=34087989).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34087989
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 12,13
ST   D12S391: 18,20
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D18S51: 19,20
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D22S1045: 11,17
ST   D2S1338: 19,22
ST   D2S441: 11,13
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 10
ST   D8S1179: 11,14
ST   DYS391: 10
ST   FGA: 19,26
ST   SE33: 17,21
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   CUi001-A-1
AC   CVCL_A8ZC
SY   WB1-10 WRNKI-Cre18
DR   hPSCreg; CUi001-A-1
DR   Wikidata; Q108820094
RX   PubMed=34087989;
CC   From: Chiba University; Chiba; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=34087989).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple_corrected; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Splice acceptor mutation (PubMed=34087989).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34087989
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 12,13
ST   D12S391: 18,20
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D18S51: 19,20
ST   D19S433: 14,15.2
ST   D1S1656: 17
ST   D21S11: 29
ST   D22S1045: 11,17
ST   D2S1338: 19,22
ST   D2S441: 11,13
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 10
ST   D8S1179: 11,14
ST   DYS391: 10
ST   FGA: 19,26
ST   SE33: 17,21
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8ZB ! CUi001-A
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   CUi002-A
AC   CVCL_D0DU
SY   CS1-6
DR   hPSCreg; CUi002-A
DR   Wikidata; Q123030982
CC   From: Chiba University; Chiba; Japan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CUIMCi003-A
AC   CVCL_A0KG
SY   THA20_1; THA20.1
DR   BioSamples; SAMEA113468498
DR   hPSCreg; CUIMCi003-A
DR   Wikidata; Q108820095
RX   PubMed=34214899;
RX   PubMed=35390757;
RX   PubMed=35950852;
CC   From: Columbia University Irving Medical Center; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16876; ARNT2; Simple; p.Pro130Ala (c.388C>G); Zygosity=Heterozygous; Note=De novo mutation (PubMed=34214899; PubMed=35390757).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178882; Class 3 obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   CUIMCi003-A-1
AC   CVCL_C1SY
SY   THA20-1 #6 cl11
DR   BioSamples; SAMEA113468435
DR   hPSCreg; CUIMCi003-A-1
DR   Wikidata; Q114311312
RX   PubMed=35950852;
CC   From: Columbia University Irving Medical Center; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16876; ARNT2; Simple_corrected; p.Pro130Ala (c.388C>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35950852).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178882; Class 3 obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0KG ! CUIMCi003-A
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   CUIMCi004-A
AC   CVCL_B5SL
SY   1514_1
DR   BioSamples; SAMEA10333981
DR   hPSCreg; CUIMCi004-A
DR   Wikidata; Q111733148
RX   PubMed=35074682;
CC   From: Columbia University Irving Medical Center; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple; p.Leu713Argfs*28 (c.2136_2139del+1insCT); Zygosity=Hemizygous (PubMed=35074682).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84940; Oculocerebrorenal syndrome
DI   ORDO; Orphanet_534; Oculocerebrorenal syndrome of Lowe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   CUIMCi004-A-1
AC   CVCL_D0DV
SY   1514_1 #1 CL25
DR   BioSamples; SAMEA114396364
DR   hPSCreg; CUIMCi004-A-1
DR   Wikidata; Q123030983
CC   From: Columbia University Irving Medical Center; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple_corrected; p.Leu713Argfs*28 (c.2136_2139del+1insCT); Zygosity=Hemizygous; Note=By method not specified (hPSCreg=CUIMCi004-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84940; Oculocerebrorenal syndrome
DI   ORDO; Orphanet_534; Oculocerebrorenal syndrome of Lowe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SL ! CUIMCi004-A
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   CUIMCi005-A
AC   CVCL_C1SZ
SY   BB#2; BB9068#2; 9068
DR   BioSamples; SAMEA110758814
DR   hPSCreg; CUIMCi005-A
DR   Wikidata; Q114311313
RX   PubMed=36455383;
CC   From: Columbia University Irving Medical Center; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Glu1650Argfs*12 (c.4947delC); ClinVar=VCV000289420; Zygosity=Heterozygous (PubMed=36455383).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Gly1961Glu (c.5882G>A); ClinVar=VCV000007888; Zygosity=Heterozygous (PubMed=36455383).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   CUIMCi006-A
AC   CVCL_D0DW
SY   CR9-S1 #4
DR   BioSamples; SAMEA114396365
DR   hPSCreg; CUIMCi006-A
DR   Wikidata; Q123030984
CC   From: Columbia University Irving Medical Center; New York; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CULA
AC   CVCL_A9KU
SY   C57BL/6 Urethane-induced Lung Adenocarcinoma
DR   GEO; GSM2492147
DR   Wikidata; Q108820096
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; None_reported; -; Zygosity=- (Direct_author_submission).
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age/sex of donor and Kras mutation status from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   Culb-TC
AC   CVCL_WI39
SY   Culb TC
DR   Wikidata; Q93460514
RX   PubMed=171466;
RX   PubMed=4338925;
RX   PubMed=8390914;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5U43 ! RLC-10
SX   Female
AG   11D
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 5
//
ID   CUMC-2
AC   CVCL_RV35
SY   Catholic University Medical College-2
DR   Wikidata; Q54814861
RX   CelloPub=CLPUB00419;
CC   Population: Korean.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   CUMC-3
AC   CVCL_7950
SY   Catholic University Medical College-3
DR   Cosmic; 944114
DR   Wikidata; Q54814862
RX   PubMed=7705700;
RX   PubMed=35692560;
CC   Population: Korean.
CC   Doubling time: ~48 hours (PubMed=7705700).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 13
//
ID   CUMC-6
AC   CVCL_7951
SY   Catholic University Medical College-6
DR   Cosmic; 944115
DR   Wikidata; Q54814863
RX   PubMed=8751555;
RX   PubMed=35692560;
CC   Population: Korean.
CC   Doubling time: ~36 hours (PubMed=8751555).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 13
//
ID   CUME-1
AC   CVCL_S913
DR   Wikidata; Q54814864
RX   PubMed=9352788;
CC   Population: Korean.
CC   Doubling time: ~56 hours (PubMed=9352788).
CC   HLA typing: DQA1*01:01,03; DQB1*03,06; DRB1*04,13 (PubMed=9352788).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Cuta/ChaoA
AC   CVCL_0F44
DR   ATCC; CRL-6585
DR   Wikidata; Q54814865
CC   Group: Insect cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6585; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7177; ! Culex tarsalis (Encephalitis mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   Cuta/ChaoB
AC   CVCL_0F45
DR   ATCC; CRL-6586
DR   Wikidata; Q54814866
CC   Group: Insect cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6586; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7177; ! Culex tarsalis (Encephalitis mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   CUTC48
AC   CVCL_W917
SY   PE121410
DR   Cosmic; 2054097
DR   Wikidata; Q54946888
RX   PubMed=23833040;
RX   PubMed=30733375;
RX   PubMed=30737244;
CC   Doubling time: 29 hours (PubMed=30733375).
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (PubMed=30733375; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30733375; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30733375; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,19
ST   D21S11: 30,32.2
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   CUTC5
AC   CVCL_W916
SY   PE030810
DR   cancercelllines; CVCL_W916
DR   Cosmic; 2054115
DR   Wikidata; Q54946886
RX   PubMed=23833040;
RX   PubMed=30733375;
RX   PubMed=30737244;
CC   Doubling time: 29 hours (PubMed=30733375).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Glu1108Ter (c.3322G>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30733375; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Leu (c.395G>T); ClinVar=VCV000375889; Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Trp (c.405C>G); ClinVar=VCV000376561; Zygosity=Homozygous (PubMed=30733375; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30733375; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D21S11: 27,31.2
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 22.2,26
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   CUTC60
AC   CVCL_VM61
DR   cancercelllines; CVCL_VM61
DR   Wikidata; Q93460551
RX   PubMed=30733375;
RX   PubMed=30737244;
CC   Doubling time: 22 hours (PubMed=30733375).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30733375; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=30733375; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (PubMed=30733375; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=30733375; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 15
ST   D21S11: 32.2
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 8
ST   D8S1179: 14,16
ST   FGA: 20
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   CUTC61
AC   CVCL_VM62
DR   cancercelllines; CVCL_VM62
DR   Wikidata; Q93460554
RX   PubMed=30733375;
RX   PubMed=30737244;
CC   Doubling time: 29 hours (PubMed=30733375).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000160364; Zygosity=Heterozygous (PubMed=30733375; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=30733375; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.375+1G>A; ClinVar=VCV000634702; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30733375; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=30733375; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,19
ST   D21S11: 28,30
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 24,25
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 14
//
ID   CUTLL1
AC   CVCL_4966
SY   CUTLL-1; Columbia University T-cell Lymphoblastic Lymphoma 1
DR   EFO; EFO_0022345
DR   ABM; T8008
DR   cancercelllines; CVCL_4966
DR   ChEMBL-Cells; CHEMBL4651374
DR   Cosmic; 1224376
DR   Cosmic; 1641388
DR   Millipore; SCC286
DR   PubChem_Cell_line; CVCL_4966
DR   Wikidata; Q54814867
RX   PubMed=16688224;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7881; NOTCH1 + HGNC; HGNC:12155; TRB; Name(s)=TRB-NOTCH1, TCRB-NOTCH1 (PubMed=16688224).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=16688224).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: CUTTL-1; Note=Occasionally.
CC   Misspelling: CUTTL1; Cosmic=1224376.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Millipore=SCC286
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,13
ST   D13S317: 8,10,11,12
ST   D16S539: 9,10,11
ST   D18S51: 13,14,16,20,21
ST   D21S11: 29,31.2,32.2,33.2,34.2
ST   D3S1358: 14,15,17
ST   D5S818: 9,10,12
ST   D7S820: 8,10
ST   D8S1179: 11,12,13
ST   FGA: 19,21,22,24
ST   Penta D: 10,11,12,12.4,14
ST   Penta E: 8,10,12
ST   TH01: 6,7,9.3
ST   TPOX: 8,10
ST   vWA: 16,18,19
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   CUTO-14
AC   CVCL_C8TF
SY   CUTO14; Colorado University Thoracic Oncology 14
DR   Wikidata; Q123030986
RX   PubMed=29686424;
RX   PubMed=33355298;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Val769_Asp770insAlaSerVal (c.2308_2309insCCAGCGTGG) (c.2300_2308dup) (M766_A767insASV) (p.Ala767_Val769dupAlaSerVal) (A767_V769dupASV); ClinVar=VCV000177678; Zygosity=Heterozygous (PubMed=33355298).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CUTO-17
AC   CVCL_C8TG
SY   CUTO17; Colorado University Thoracic Oncology 17
DR   Wikidata; Q123030987
RX   PubMed=33355298;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771_His773dupAsnProHis (c.2311_2319dup) (N771_H773dupNPH); ClinVar=VCV000177911; Zygosity=Heterozygous (PubMed=33355298).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CUTO-18
AC   CVCL_C8TH
SY   CUTO18; Colorado University Thoracic Oncology 18
DR   Wikidata; Q123030988
RX   PubMed=33355298;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser768_Asp770dupSerValAsp (c.2303_2311dup) (S768_D770dupSVD); ClinVar=VCV000045253; Zygosity=Heterozygous (PubMed=33355298).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CUTO-2
AC   CVCL_UJ34
SY   CUTO2; Colorado University Thoracic Oncology-2
DR   Wikidata; Q93460568
RX   PubMed=24349229;
RX   PubMed=30538120;
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:10661; SDC4; Name(s)=SDC4-ROS1 (PubMed=24349229).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   CUTO-22
AC   CVCL_C5VR
SY   CUTO22; Colorado University Thoracic Oncology 22
DR   Wikidata; Q116048813
RX   PubMed=33795352;
CC   Sequence variation: Gene fusion; HGNC; HGNC:6324; KIF5B + HGNC; HGNC:9967; RET; Name(s)=KIF5B-RET; Note=KIF5B exon 23 fused to RET exon 12 (PubMed=33795352).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   CUTO-23
AC   CVCL_C8SZ
SY   CUTO23; Colorado University Thoracic Oncology 23
DR   GEO; GSM7675355
DR   GEO; GSM7675356
DR   GEO; GSM7675357
DR   GEO; GSM7675358
DR   GEO; GSM7675359
DR   GEO; GSM7675360
DR   Wikidata; Q123030989
RX   PubMed=29636358;
RX   PubMed=30538120;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (PubMed=30538120).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   CUTO-27
AC   CVCL_C8T1
SY   CUTO27; Colorado University Thoracic Oncology 27
DR   GEO; GSM7675361
DR   GEO; GSM7675362
DR   GEO; GSM7675363
DR   GEO; GSM7675364
DR   GEO; GSM7675365
DR   GEO; GSM7675366
DR   Wikidata; Q123030990
RX   PubMed=29636358;
WW   Provider; UCSM; -; https://web.archive.org/web/20241201182000/https://cuamc.technologypublisher.com/technology/48354
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (UCSM).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   CUTO-28
AC   CVCL_C8T2
SY   CUTO28; Colorado University Thoracic Oncology 28
DR   GEO; GSM7675367
DR   GEO; GSM7675368
DR   GEO; GSM7675369
DR   GEO; GSM7675370
DR   GEO; GSM7675371
DR   GEO; GSM7675372
DR   Wikidata; Q123030991
RX   DOI=10.1158/1535-7163.TARG-21-P076;
RX   DOI=10.1158/1538-7445.AM2020-3003;
RX   DOI=10.63028/10067/2105480151162165141;
RX   PubMed=29636358;
RX   PubMed=36101520;
WW   Provider; UCSM; -; https://web.archive.org/web/20241201182000/https://cuamc.technologypublisher.com/technology/48353
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-ROS1 (DOI=10.1158/1538-7445.AM2020-3003; PubMed=36101520).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   CUTO-28 ROS1 p.G2032R
AC   CVCL_E6J7
RX   DOI=10.63028/10067/2105480151162165141;
CC   Characteristics: The ROS1 mutation introduced is most prevalent among patients presenting relapsed disease. Shows resistance to ceritinib, crizotinib, entrectinib and lorlatinib (DOI=10.63028/10067/2105480151162165141).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Gly2032Arg (c.6094G>A) (p.Gly2026Arg, c.6076G>A); ClinVar=VCV000376139; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (DOI=10.63028/10067/2105480151162165141).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T2 ! CUTO-28
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CUTO-28 ROS1 p.L2026M
AC   CVCL_E6J8
RX   DOI=10.63028/10067/2105480151162165141;
CC   Characteristics: Shows resistance to entrectinib (DOI=10.63028/10067/2105480151162165141).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Leu2026Met (c.6076C>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (DOI=10.63028/10067/2105480151162165141).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T2 ! CUTO-28
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CUTO-28 ROS1 p.S1986Y
AC   CVCL_E6J9
RX   DOI=10.63028/10067/2105480151162165141;
CC   Characteristics: Shows resistance to ceritinib, crizotinib, entrectinib, lorlatinib and repotrectinib (DOI=10.63028/10067/2105480151162165141).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Ser1986Tyr (c.5957C>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (DOI=10.63028/10067/2105480151162165141).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T2 ! CUTO-28
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CUTO-28-CR
AC   CVCL_C8T8
SY   CUTO28CR
DR   Wikidata; Q123030992
RX   DOI=10.1158/1535-7163.TARG-21-P076;
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-ROS1 (DOI=10.1158/1535-7163.TARG-21-P076).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T2 ! CUTO-28
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CUTO-29
AC   CVCL_C8TC
SY   CUTO29; Colorado University Thoracic Oncology 29
DR   ArrayExpress; E-MTAB-11342
DR   Wikidata; Q123030994
RX   PubMed=35933914;
CC   Doubling time: 37 +- 1.3 hours (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7325; MSH2; Zygosity=Homozygous (PubMed=35933914).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A19 v3 fusion (PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Cys1156Tyr (c.3467G>A); ClinVar=VCV000376340; Zygosity=Heterozygous (PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg680Ter (c.2038C>T); ClinVar=VCV000036572; Zygosity=Heterozygous (PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Tyr (c.830G>A); ClinVar=VCV000185722; Zygosity=Homozygous (PubMed=35933914).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CUTO-3
AC   CVCL_C8TE
SY   CUTO3; Colorado University Thoracic Oncology-3
DR   Wikidata; Q123030995
RX   PubMed=24162815;
CC   Sequence variation: Gene fusion; HGNC; HGNC:30321; MPRIP + HGNC; HGNC:8031; NTRK1; Name(s)=MPRIP-NTRK1; Note=MPRIP exon 21 fused to NTRK1 exon 14 (PubMed=24162815).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CUTO-3.29
AC   CVCL_UJ35
SY   CUTO3.29; Colorado University Thoracic Oncology-3.29
DR   Wikidata; Q93460571
RX   PubMed=26216294;
CC   Sequence variation: Gene fusion; HGNC; HGNC:30321; MPRIP + HGNC; HGNC:8031; NTRK1; Name(s)=MPRIP-NTRK1; Note=MPRIP exon 21 fused to NTRK1 exon 14 (PubMed=26216294).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TE ! CUTO-3
SX   Female
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   CUTO-32
AC   CVCL_C5VS
SY   CUTO32; Colorado University Thoracic Oncology 32
DR   Wikidata; Q116048814
RX   PubMed=33795352;
CC   Sequence variation: Gene fusion; HGNC; HGNC:6324; KIF5B + HGNC; HGNC:9967; RET; Name(s)=KIF5B-RET; Note=KIF5B exon 15 fused to RET exon 12 (PubMed=33795352).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   CUTO-33
AC   CVCL_C8T0
SY   CUTO33; Colorado University Thoracic Oncology 33
DR   GEO; GSM7675373
DR   GEO; GSM7675374
DR   GEO; GSM7675375
DR   GEO; GSM7675376
DR   GEO; GSM7675377
DR   GEO; GSM7675378
DR   Wikidata; Q123030996
RX   PubMed=30538120;
RX   PubMed=37727007;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (PubMed=30538120; PubMed=37727007).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.437G>A); ClinVar=VCV000634785; Zygosity=Unspecified (PubMed=37727007).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   CUTO-34
AC   CVCL_C8TA
SY   CUTO34; Colorado University Thoracic Oncology 34
DR   Wikidata; Q123030997
RX   DOI=10.1101/2022.06.08.495301;
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (DOI=10.1101/2022.06.08.495301).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CUTO-37
AC   CVCL_C8T3
SY   CUTO37; Colorado University Thoracic Oncology 37
DR   GEO; GSM7675379
DR   GEO; GSM7675380
DR   GEO; GSM7675381
DR   GEO; GSM7675382
DR   GEO; GSM7675383
DR   GEO; GSM7675384
DR   Wikidata; Q123030998
RX   DOI=10.1158/1535-7163.TARG-21-P076;
RX   DOI=10.63028/10067/2105480151162165141;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (DOI=10.1158/1535-7163.TARG-21-P076).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CUTO-37 ROS1 p.G2032R
AC   CVCL_E6JA
RX   DOI=10.63028/10067/2105480151162165141;
CC   Characteristics: The ROS1 mutation introduced is most prevalent among patients presenting relapsed disease. Sows significant resistance to ceritinib, crizotinib, entrectinib, lorlatinib and repotrectinib (DOI=10.63028/10067/2105480151162165141).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Gly2032Arg (c.6094G>A) (p.Gly2026Arg, c.6076G>A); ClinVar=VCV000376139; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (DOI=10.63028/10067/2105480151162165141).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T3 ! CUTO-37
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CUTO-37 ROS1 p.L2026M
AC   CVCL_E6JB
RX   DOI=10.63028/10067/2105480151162165141;
CC   Characteristics: Does not show resistance to the five compounds tested (ceritinib, crizotinib, entrectinib, lorlatinib and repotrectinib) (DOI=10.63028/10067/2105480151162165141).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Leu2026Met (c.6076C>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (DOI=10.63028/10067/2105480151162165141).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T3 ! CUTO-37
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CUTO-37 ROS1 p.S1986Y
AC   CVCL_E6JC
RX   DOI=10.63028/10067/2105480151162165141;
CC   Characteristics: Does not show resistance to the five compounds tested (ceritinib, crizotinib, entrectinib, lorlatinib and repotrectinib) (DOI=10.63028/10067/2105480151162165141).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Ser1986Tyr (c.5957C>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (DOI=10.63028/10067/2105480151162165141).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T3 ! CUTO-37
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   CUTO-37-CR
AC   CVCL_C8T7
SY   CUTO37CR
DR   Wikidata; Q123030999
RX   DOI=10.1158/1535-7163.TARG-21-P076;
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (DOI=10.1158/1535-7163.TARG-21-P076).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T3 ! CUTO-37
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CUTO-37-ER
AC   CVCL_C8T6
SY   CUTO37ER
DR   Wikidata; Q123031000
RX   DOI=10.1158/1535-7163.TARG-21-P076;
CC   Selected for resistance to: ChEBI; CHEBI_195558; Entrectinib (Rozlytrek).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (DOI=10.1158/1535-7163.TARG-21-P076).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T3 ! CUTO-37
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CUTO-38
AC   CVCL_C8T4
SY   CUTO38; Colorado University Thoracic Oncology 38
DR   GEO; GSM7675385
DR   GEO; GSM7675386
DR   GEO; GSM7675387
DR   GEO; GSM7675388
DR   GEO; GSM7675389
DR   GEO; GSM7675390
DR   Wikidata; Q123031001
RX   DOI=10.1158/1538-7445.AM2020-3003;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (DOI=10.1158/1538-7445.AM2020-3003).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CUTO-42
AC   CVCL_C5VT
SY   CUTO42; Colorado University Thoracic Oncology 42
DR   Wikidata; Q116048815
RX   PubMed=33795352;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1316; EML4 + HGNC; HGNC:9967; RET; Name(s)=EML4-RET; Note=EML4 exon 9 fused to RET exon 12 (PubMed=33795352).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   CUTO-8
AC   CVCL_C8T9
SY   CUTO8; Colorado University Thoracic Oncology 8
DR   ArrayExpress; E-MTAB-11342
DR   Wikidata; Q123031002
RX   DOI=10.1101/2022.06.08.495301;
RX   PubMed=35933914;
CC   Doubling time: 28 +- 3.1 hours (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=35933914).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (DOI=10.1101/2022.06.08.495301; PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly293fs*13 (c.876dupA); Zygosity=Homozygous (PubMed=35933914).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CUTO-9
AC   CVCL_C8TB
SY   CUTO9; Colorado University Thoracic Oncology 9
DR   ArrayExpress; E-MTAB-11342
DR   Wikidata; Q123031003
RX   PubMed=35933914;
CC   Doubling time: 26 +- 0.6 hours (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=35933914).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Pro1838fs*22 (c.5513delC) (p.Pro1851fs*22, c.5552delC); Zygosity=Heterozygous (PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln642Ter (c.1924C>T); ClinVar=VCV000952282; Zygosity=Heterozygous (PubMed=35933914).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   CV-062020-PPB
AC   CVCL_C3S4
DR   Wikidata; Q116048816
RX   PubMed=36164515;
CC   Group: Insect cell line.
CC   Doubling time: 37.7 hours (PubMed=36164515).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7373; ! Calliphora vicina (Blue blowfly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CV-1
AC   CVCL_0229
SY   Cv-1; CV 1; CV-1.K; CV1
DR   BTO; BTO_0000318
DR   CLO; CLO_0002640
DR   CLO; CLO_0050506
DR   EFO; EFO_0022733
DR   MCCL; MCC:0000117
DR   CLDB; cl928
DR   CLDB; cl929
DR   CLDB; cl931
DR   CLDB; cl932
DR   CLDB; cl933
DR   ATCC; CCL-70
DR   ATCC; CRL-6305
DR   BCRC; 60065
DR   CCLV; CCLV-RIE 0185
DR   CCRID; 1101MON-PUMC000064
DR   CCRID; 1102MON-NIFDC00020
DR   CCRID; 3101MONGNO11
DR   ChEMBL-Cells; CHEMBL3308033
DR   ChEMBL-Targets; CHEMBL613507
DR   CLS; 601470
DR   ECACC; 87032605
DR   IZSLER; BS CL 23
DR   JCRB; JCRB9049
DR   KCLB; 10070
DR   Lonza; 255
DR   PubChem_Cell_line; CVCL_0229
DR   RCB; RCB0160
DR   TKG; TKG 0327
DR   TOKU-E; 1008
DR   Wikidata; Q54814868
RX   DOI=10.1007/BF02618370;
RX   PubMed=14192657;
RX   PubMed=16494729;
RX   PubMed=22059503;
RX   PubMed=28046048;
RX   PubMed=28203643;
RX   PubMed=34737324;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cv1/cv1cells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells/agmindex
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-108.html
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=16494729).
CC   Doubling time: 20.1 hours (PubMed=28203643).
CC   Discontinued: ATCC; CRL-6305; true.
CC   Discontinued: TKG; TKG 0327; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 34
//
ID   CV-1 clone 3.9.2
AC   CVCL_WY42
SY   Clone 3.9.2
DR   Wikidata; Q93460578
RX   PubMed=1326316;
CC   Group: Non-human primate cell line.
CC   Characteristics: Transfected with the pMMTV-CAT plasmid.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2147; Ar.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   CV-1 Clone B5
AC   CVCL_4156
DR   CLO; CLO_0002641
DR   CLDB; cl935
DR   ECACC; 90032601
DR   Wikidata; Q54814869
CC   Group: Non-human primate cell line.
CC   Virology: Selected for sensitivity to SV40 (ECACC=90032601).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   CV-1 D 5.2
AC   CVCL_A5CG
DR   Wikidata; Q107114746
RX   PubMed=3039660;
CC   Group: Non-human primate cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CV-1 D 6.1
AC   CVCL_A5CH
DR   Wikidata; Q107114748
RX   PubMed=3039660;
CC   Group: Non-human primate cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CV-1 D 7.3
AC   CVCL_A5CI
DR   Wikidata; Q107114750
RX   PubMed=3039660;
CC   Group: Non-human primate cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CV-1 E 4.1
AC   CVCL_A5CJ
DR   Wikidata; Q107114752
RX   PubMed=3039660;
CC   Group: Non-human primate cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CV-1 E 5.5
AC   CVCL_A5CK
DR   Wikidata; Q107114756
RX   PubMed=3039660;
CC   Group: Non-human primate cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   CV-1/EBNA-1
AC   CVCL_6385
SY   CV-1/EBNA; CV1/EBNA
DR   CLO; CLO_0002642
DR   ATCC; CRL-10478
DR   Wikidata; Q54814870
RX   Patent=US5426048;
RX   PubMed=1833184;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10478.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-10478; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   CV-hIPS-B
AC   CVCL_1N86
SY   CVB; GM25430; GM25430*C
DR   Coriell; GM25430
DR   SKIP; SKIP000665
DR   Wikidata; Q54853956
RX   PubMed=21368825;
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Donor information: Established from Craig Venter fibroblasts.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI21 ! CV-hIPS-F
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   CV-hIPS-B-APP-E693A clone 2b2
AC   CVCL_VR52
SY   GM25430-APP-E693A clone 2b2; 2b2
DR   Wikidata; Q93460583
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Glu693Ala (c.2078_2079AA>CC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=30686764).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   CV-hIPS-B-APP-E693A clone 3d9
AC   CVCL_VR53
SY   GM25430-APP-E693A clone 3d9; 3d9
DR   Wikidata; Q93460584
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Glu693Ala (c.2078_2079AA>CC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=30686764).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   CV-hIPS-B-APP-F691A/E693A clone D12
AC   CVCL_VR54
SY   GM25430-APP-F691A/E693A clone D12; D12
DR   Wikidata; Q93460585
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Phe691Ala (c.2071_2072TT>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=30686764).
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Glu693Ala (c.2078_2079AA>CC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=30686764).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   CV-hIPS-B-APP-KO clone 1B6
AC   CVCL_UI22
SY   GM25430-APP-KO clone 1B6; 1B6; APPnull in CV background
DR   Wikidata; Q93460586
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   CV-hIPS-B-control APP edition clone B10
AC   CVCL_VR50
SY   GM25430-control APP edition clone B10; B10
DR   Wikidata; Q93460587
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for the APP-edited cell lines derived from CV-hIPS-B. Have been transfected with CAS9, guide RNA and APP repair oligo but have not been edited.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 30-01-24; Version: 8
//
ID   CV-hIPS-B-control APP edition clone B11
AC   CVCL_VR51
SY   GM25430-control APP edition clone B11; B11
DR   Wikidata; Q93460588
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for the APP-edited cell lines derived from CV-hIPS-B. Have been transfected with CAS9, guide RNA and APP repair oligo but have not been edited.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 30-01-24; Version: 8
//
ID   CV-hIPS-B-control APP KO clone 151
AC   CVCL_UI49
SY   GM25430-control APP KO clone 151; 151
DR   Wikidata; Q93460589
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for the APP KO cell line derived from CV-hIPS-B. Have been transfected with CAS9 and guide RNA but have not been edited.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 7
//
ID   CV-hIPS-F
AC   CVCL_UI21
SY   CVF
DR   Wikidata; Q93460590
RX   PubMed=21368825;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Donor information: Established from Craig Venter fibroblasts.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N86 ! CV-hIPS-B
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   CV-iPS1
AC   CVCL_AV06
DR   Wikidata; Q54814871
RX   PubMed=26987929;
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AV07 ! CV-iPS2
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   CV-iPS2
AC   CVCL_AV07
DR   Wikidata; Q54814872
RX   PubMed=26987929;
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AV06 ! CV-iPS1
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   CV-S
AC   CVCL_DE07
DR   Wikidata; Q54814873
RX   PubMed=2543775;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3820; Cyclic neutropenia
DI   ORDO; Orphanet_2686; Cyclic neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   CV0001
AC   CVCL_8U23
DR   ECACC; 93090202
DR   Wikidata; Q54814874
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,rec(21)dup q,inv(21)(p21;q22.1) (ECACC=93090202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   CV10-AC
AC   CVCL_VJ69
SY   CV10 AC
DR   Cosmic; 2568861
DR   Wikidata; Q93460603
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CV19
AC   CVCL_F1HE
RX   PubMed=2471746;
CC   Karyotypic information: 46,X,t(7;X)(p15;q22) (PubMed=2471746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   CV13-NS
AC   CVCL_VJ70
SY   CV13 NS
DR   Cosmic; 2568848
DR   Wikidata; Q93460605
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CV2-AC
AC   CVCL_VJ71
SY   CV2 AC
DR   Cosmic; 2568857
DR   Wikidata; Q93460606
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CV21-AC
AC   CVCL_VJ72
SY   CV21 AC
DR   Cosmic; 2568862
DR   Wikidata; Q93460609
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ73 ! CV21-NS
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CV21-NS
AC   CVCL_VJ73
SY   CV21 NS
DR   Cosmic; 2568849
DR   Wikidata; Q93460611
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ72 ! CV21-AC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CV6-AC
AC   CVCL_VJ74
SY   CV6 AC
DR   Cosmic; 2568858
DR   Wikidata; Q93460613
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CV8-AC
AC   CVCL_VJ75
SY   CV8 AC
DR   Cosmic; 2568859
DR   Wikidata; Q93460615
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CV9-AC
AC   CVCL_VJ76
SY   CV9 AC
DR   Cosmic; 2568860
DR   Wikidata; Q93460617
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   CVC.1
AC   CVCL_4513
SY   CVC 1
DR   CLO; CLO_0002645
DR   ATCC; TIB-135
DR   Wikidata; Q54814875
RX   PubMed=6189124;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04973; Bovine CLTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   CVC.4
AC   CVCL_4514
SY   CVC 4
DR   CLO; CLO_0002646
DR   ATCC; TIB-137
DR   Wikidata; Q54814876
RX   PubMed=6189124;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04973; Bovine CLTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   CVC.7
AC   CVCL_4515
SY   CVC 7
DR   CLO; CLO_0002647
DR   CLDB; cl5180
DR   ATCC; TIB-138
DR   IZSLER; BS Hy 6
DR   Wikidata; Q54814877
RX   PubMed=6189124;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04973; Bovine CLTA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   CVG-1
AC   CVCL_VL95
DR   Wikidata; Q93460630
RX   PubMed=29696010;
CC   Virology: Contains ~3.6 copies of the genome of MCPyV per haploid cell (PubMed=29696010).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   CvMab-6
AC   CVCL_D2SA
DR   Wikidata; Q127380655
RX   PubMed=36555473;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   CVP
AC   CVCL_C3HS
DR   Wikidata; Q114311314
RX   PubMed=1711532;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pX8 ori-).
CC   Derived from site: In situ; Fetal vas deferens, epithelium; UBERON=UBERON_0004806.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18-22FW
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   CVT-A
AC   CVCL_E1HG
RX   PubMed=6942961;
CC   Characteristics: Established from the parent cell line after subculture in the subcutis of newborn Syrian hamsters (PubMed=6942961).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
DI   NCIt; C162473; Canine transmissible venereal tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_E1HF ! CVT-I
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CVT-I
AC   CVCL_E1HF
SY   CVT I
RX   PubMed=5689737;
RX   PubMed=6942961;
CC   Characteristics: Established from the subcutis of a female mongrel dog inoculated with a tumor removed from the vulva of a Cocker spaniel (PubMed=5689737).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
DI   NCIt; C162473; Canine transmissible venereal tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CVT-III
AC   CVCL_E1HH
RX   PubMed=6942961;
CC   Characteristics: Established from the subcutis of a male German shepherd dog inoculated with a tumor removed from the vulva of a CTVT-suffering dog (PubMed=5689737).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C162473; Canine transmissible venereal tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CVT-MT
AC   CVCL_E1HJ
SY   MT
RX   PubMed=6942961;
CC   Characteristics: Established from the parent cell line after subculture in the subcutis of weanling C3H mice exposed to radiation (PubMed=6942961).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C162473; Canine transmissible venereal tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_E1HI ! CVT-V
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CVT-V
AC   CVCL_E1HI
RX   PubMed=6942961;
CC   Characteristics: Established from the subcutis of a male mongrel dog inoculated with a tumor removed from the vulva of a CTVT-suffering dog (PubMed=5689737).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C162473; Canine transmissible venereal tumor
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   CVTTHi001-A
AC   CVCL_A1QC
DR   BioSamples; SAMEA7274736
DR   hPSCreg; CVTTHi001-A
DR   Wikidata; Q102113762
RX   PubMed=33221676;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Formulario%2520registro%2520linea%2520iPS-CVTTHi001-A-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Annexes_4-9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Vasco de Transfusion y Tejidos Humanos; Galdakao; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1425+2delT; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33221676).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 17,22
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C220695; Activated phosphatidylinositol-3-OH kinase delta syndrome, type 2
DI   ORDO; Orphanet_397596; Activated PI3K-delta syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 10
//
ID   CVTTHi002-A
AC   CVCL_E3YB
DR   BioSamples; SAMEA115853746
DR   hPSCreg; CVTTHi002-A
RX   PubMed=39874650;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Vasco de Transfusion y Tejidos Humanos; Galdakao; Spain.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,26:01:01; B*27:05:02,38:01:01; C*02:02P;12:03:01; DPA1*02:01P,02:01P; DPB1*11:01P,13:01P; DQA1*03:01P,03:01P; DQB1*03:02P,03:02P; DRB1*04:02P,04:04P (PubMed=39874650).
CC   Karyotypic information: 47,XXY (PubMed=39874650).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CVTTHi003-A
AC   CVCL_E3YC
DR   BioSamples; SAMEA115888507
DR   hPSCreg; CVTTHi003-A
RX   PubMed=39874650;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Vasco de Transfusion y Tejidos Humanos; Galdakao; Spain.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,31:01:02; B*27:02:01,44:05:01; C*02:02:02;07:02:01; DPA1*01:03P,02:01P; DPB1*01:01:01,02:01P; DQA1*01:01P,05:01P; DQB1*03:01P,05:01:01; DRB1*01:03P,11:01:01 (PubMed=39874650).
CC   Karyotypic information: 47,XXY (PubMed=39874650).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CVTTHi004-A
AC   CVCL_E3YD
DR   BioSamples; SAMEA115888524
DR   hPSCreg; CVTTHi004-A
RX   PubMed=39874650;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Vasco de Transfusion y Tejidos Humanos; Galdakao; Spain.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,49:01:01; C*06:02:01;07:01:01; DPA1*02:01:01,02:01:01; DPB1*10:01:01,10:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01P,03:02:01; DRB1*04:01:01,11:01:01 (PubMed=39874650).
CC   Karyotypic information: 47,XXY (PubMed=39874650).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   CW-2
AC   CVCL_1151
SY   CW2
DR   BTO; BTO_0005032
DR   CLO; CLO_0050626
DR   EFO; EFO_0006560
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472230
DR   BioSample; SAMN03472867
DR   BioSample; SAMN10987729
DR   cancercelllines; CVCL_1151
DR   CCRID; 1101HUM-PUMC000672
DR   CCRID; 3101HUMTCHu15
DR   Cell_Model_Passport; SIDM00282
DR   ChEMBL-Cells; CHEMBL3308161
DR   ChEMBL-Targets; CHEMBL2366174
DR   CLS; 305134
DR   ColonAtlas; CW2
DR   Cosmic; 910554
DR   Cosmic; 2664056
DR   Cosmic-CLP; 910554
DR   DepMap; ACH-000998
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910554
DR   GEO; GSM886968
DR   GEO; GSM888037
DR   GEO; GSM1669713
DR   IARC_TP53; 21260
DR   LiGeA; CCLE_933
DR   LINCS_LDP; LCL-1190
DR   PharmacoDB; CW2_269_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1151
DR   PubChem_Cell_line; CVCL_1151
DR   RCB; RCB0778
DR   Wikidata; Q54814878
RX   PubMed=20164919;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   HLA typing: A*26:01,26:01; B*44:03,46:01; C*14:03,14:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro140His (c.419C>A); Zygosity=Heterozygous (Cosmic-CLP=910554; DepMap=ACH-000998).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro47Pro (c.141G>A); ClinVar=VCV000184839; Zygosity=Heterozygous (Cosmic-CLP=910554; DepMap=ACH-000998).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.46%; East Asian, South=24.54%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID; Cosmic-CLP=910554; PubMed=25877200; RCB=RCB0778
ST   Amelogenin: X
ST   CSF1PO: 10,11,14 (PubMed=25877200; RCB=RCB0778)
ST   CSF1PO: 11,14 (CCRID; Cosmic-CLP=910554)
ST   D12S391: 19,20
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 12,13
ST   D19S433: 12,14.2
ST   D21S11: 31
ST   D2S1338: 18 (PubMed=25877200)
ST   D2S1338: 18,19 (CCRID)
ST   D3S1358: 16,17
ST   D5S818: 11,12,13 (PubMed=25877200; RCB=RCB0778)
ST   D5S818: 11,13 (CCRID; Cosmic-CLP=910554)
ST   D7S820: 10,12,13 (RCB=RCB0778)
ST   D7S820: 10,13 (CCRID; Cosmic-CLP=910554; PubMed=25877200)
ST   D8S1179: 15,17
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 11,14
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 18,21
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   CW10001
AC   CVCL_4Q37
SY   CIRM-CW10001i-Ctl; CIRMi06C-A
DR   BioSamples; SAMEA114482519
DR   Coriell; CW10001
DR   FCDI; CW10001
DR   hPSCreg; CIRMi06C-A
DR   SKIP; SKIP003596
DR   Wikidata; Q54814879
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW10001; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW10002
AC   CVCL_JH36
SY   CIRMi06D-A
DR   BioSamples; SAMEA114482521
DR   Coriell; CW10002
DR   FCDI; CW10002
DR   hPSCreg; CIRMi06D-A
DR   Wikidata; Q54814880
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW10002; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 8
//
ID   CW10003
AC   CVCL_4Q38
SY   CIRM-CW10003i-Affected; CIRMi06E-A
DR   BioSamples; SAMEA114482523
DR   Coriell; CW10003
DR   FCDI; CW10003
DR   hPSCreg; CIRMi06E-A
DR   SKIP; SKIP003597
DR   Wikidata; Q54814881
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10003; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10004
AC   CVCL_AN15
SY   CIRM-CW10004i-Affected; CIRMi06F-A
DR   BioSamples; SAMEA114482525
DR   Coriell; CW10004
DR   FCDI; CW10004
DR   hPSCreg; CIRMi06F-A
DR   SKIP; SKIP003598
DR   Wikidata; Q54814882
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10004; true.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 11
//
ID   CW10005
AC   CVCL_AN16
SY   CIRM-CW10005i-Affected; CIRMi06G-A
DR   BioSamples; SAMEA114482527
DR   Coriell; CW10005
DR   FCDI; CW10005
DR   hPSCreg; CIRMi06G-A
DR   SKIP; SKIP003599
DR   Wikidata; Q54814883
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10005; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10007
AC   CVCL_4Q39
SY   CIRM-CW10007i-Affected; CIRMi06H-A
DR   BioSamples; SAMEA114482529
DR   Coriell; CW10007
DR   FCDI; CW10007
DR   hPSCreg; CIRMi06H-A
DR   SKIP; SKIP003600
DR   Wikidata; Q54814884
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10007; true.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW10009
AC   CVCL_4Q40
SY   CIRM-CW10009i-Ctl; CIRMi06I-A
DR   BioSamples; SAMEA114482531
DR   Coriell; CW10009
DR   FCDI; CW10009
DR   hPSCreg; CIRMi06I-A
DR   SKIP; SKIP003601
DR   Wikidata; Q54814885
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10009; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 10
//
ID   CW10010
AC   CVCL_4Q41
SY   CIRM-CW10010i-Affected; CIRMi06J-A
DR   BioSamples; SAMEA114482533
DR   Coriell; CW10010
DR   FCDI; CW10010
DR   hPSCreg; CIRMi06J-A
DR   SKIP; SKIP003602
DR   Wikidata; Q54814886
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Native North American.
CC   Discontinued: Coriell; CW10010; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10011
AC   CVCL_4Q42
SY   CIRM-CW10011i-Affected; CIRMi06K-A
DR   BioSamples; SAMEA114482535
DR   Coriell; CW10011
DR   FCDI; CW10011
DR   hPSCreg; CIRMi06K-A
DR   SKIP; SKIP003603
DR   Wikidata; Q54814887
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW10011; true.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW10012
AC   CVCL_4Q43
SY   CIRM-CW10012i-Affected; CIRMi06L-A
DR   BioSamples; SAMEA114482537
DR   Coriell; CW10012
DR   FCDI; CW10012
DR   hPSCreg; CIRMi06L-A
DR   SKIP; SKIP003604
DR   Wikidata; Q54814890
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10012; true.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW10013
AC   CVCL_HG43
SY   CIRMi06M-A
DR   BioSamples; SAMEA114482539
DR   Coriell; CW10013
DR   FCDI; CW10013
DR   hPSCreg; CIRMi06M-A
DR   Wikidata; Q54814891
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10013; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10014
AC   CVCL_4Q44
SY   CIRM-CW10014i-Affected; CIRMi06N-A
DR   BioSamples; SAMEA114482541
DR   Coriell; CW10014
DR   FCDI; CW10014
DR   hPSCreg; CIRMi06N-A
DR   SKIP; SKIP003605
DR   Wikidata; Q54814892
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10014; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10015
AC   CVCL_DI66
SY   CIRMi06O-A
DR   BioSamples; SAMEA114482543
DR   Coriell; CW10015
DR   FCDI; CW10015
DR   hPSCreg; CIRMi06O-A
DR   Wikidata; Q54814893
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10015; true.
DI   NCIt; C150596; Hepatic steatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 8
//
ID   CW10018
AC   CVCL_4Q45
SY   CIRM-CW10018i-Affected; CIRMi06P-A
DR   BioSamples; SAMEA114482545
DR   Coriell; CW10018
DR   FCDI; CW10018
DR   hPSCreg; CIRMi06P-A
DR   SKIP; SKIP003606
DR   Wikidata; Q54814894
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10018; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10019
AC   CVCL_4Q46
SY   CIRM-CW10019i-Affected
DR   Coriell; CW10019
DR   FCDI; CW10019
DR   SKIP; SKIP003607
DR   Wikidata; Q54814895
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10019; true.
CC   Discontinued: FCDI; CW10019; probable.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 12
//
ID   CW10020
AC   CVCL_4Q47
SY   CIRM-CW10020i-Affected; CIRMi06Q-A
DR   BioSamples; SAMEA114482547
DR   Coriell; CW10020
DR   FCDI; CW10020
DR   hPSCreg; CIRMi06Q-A
DR   SKIP; SKIP003608
DR   Wikidata; Q54814896
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10020; true.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW10021
AC   CVCL_AN17
SY   CIRM-CW10021i-Ctl; CIRMi06R-A
DR   BioSamples; SAMEA114482549
DR   Coriell; CW10021
DR   FCDI; CW10021
DR   hPSCreg; CIRMi06R-A
DR   SKIP; SKIP003609
DR   Wikidata; Q54814897
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10021; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   CW10022
AC   CVCL_4Q48
DR   Coriell; CW10022
DR   Wikidata; Q54814898
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10022; true.
DI   NCIt; C150596; Hepatic steatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 5
//
ID   CW10023
AC   CVCL_4Q49
SY   CIRM-CW10023i-Affected; CIRMi06S-A
DR   BioSamples; SAMEA114482551
DR   Coriell; CW10023
DR   FCDI; CW10023
DR   hPSCreg; CIRMi06S-A
DR   SKIP; SKIP003610
DR   Wikidata; Q54814899
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10023; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10024
AC   CVCL_4Q50
SY   CIRM-CW10024i-Ctl; CIRMi06T-A
DR   BioSamples; SAMEA114482553
DR   Coriell; CW10024
DR   FCDI; CW10024
DR   hPSCreg; CIRMi06T-A
DR   SKIP; SKIP003611
DR   Wikidata; Q54814900
RX   PubMed=33268331;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW10024; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10025
AC   CVCL_HG44
SY   CIRMi06U-A
DR   BioSamples; SAMEA114482555
DR   Coriell; CW10025
DR   FCDI; CW10025
DR   hPSCreg; CIRMi06U-A
DR   Wikidata; Q54814902
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10025; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10026
AC   CVCL_4Q51
SY   CIRM-CW10026i-Affected; CIRMi06V-A
DR   BioSamples; SAMEA114482557
DR   Coriell; CW10026
DR   FCDI; CW10026
DR   hPSCreg; CIRMi06V-A
DR   SKIP; SKIP003612
DR   Wikidata; Q54814903
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10026; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10027
AC   CVCL_DI67
SY   CIRMi06W-A
DR   BioSamples; SAMEA114482559
DR   Coriell; CW10027
DR   FCDI; CW10027
DR   hPSCreg; CIRMi06W-A
DR   Wikidata; Q54814904
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10027; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 8
//
ID   CW10028
AC   CVCL_4Q52
SY   CIRM-CW10028i-Ctl
DR   Coriell; CW10028
DR   FCDI; CW10028
DR   SKIP; SKIP003613
DR   Wikidata; Q54814905
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10028; true.
CC   Discontinued: FCDI; CW10028; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 12
//
ID   CW10030
AC   CVCL_4Q53
SY   CIRM-CW10030i-Ctl; CIRMi06X-A
DR   BioSamples; SAMEA114482561
DR   Coriell; CW10030
DR   FCDI; CW10030
DR   hPSCreg; CIRMi06X-A
DR   SKIP; SKIP003614
DR   Wikidata; Q54814906
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian and Native North American.
CC   Discontinued: Coriell; CW10030; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW10031
AC   CVCL_4Q54
SY   CIRM-CW10031i-Affected
DR   Coriell; CW10031
DR   FCDI; CW10031
DR   SKIP; SKIP003615
DR   Wikidata; Q54814908
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10031; true.
CC   Discontinued: FCDI; CW10031; probable.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW10033
AC   CVCL_HG45
SY   CIRMi06Y-A
DR   BioSamples; SAMEA114482563
DR   Coriell; CW10033
DR   FCDI; CW10033
DR   hPSCreg; CIRMi06Y-A
DR   Wikidata; Q54814909
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10033; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 8
//
ID   CW10034
AC   CVCL_JH37
SY   CIRMi06Z-A
DR   BioSamples; SAMEA114482565
DR   Coriell; CW10034
DR   FCDI; CW10034
DR   hPSCreg; CIRMi06Z-A
DR   Wikidata; Q54814910
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10034; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW10035
AC   CVCL_4Q55
SY   CIRM-CW10035i-Affected; CIRMi07A-A
DR   BioSamples; SAMEA114482567
DR   Coriell; CW10035
DR   FCDI; CW10035
DR   hPSCreg; CIRMi07A-A
DR   SKIP; SKIP003616
DR   Wikidata; Q54814911
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10035; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10036
AC   CVCL_4Q56
SY   CIRM-CW10036i-Affected; CIRMi07B-A
DR   BioSamples; SAMEA114482569
DR   Coriell; CW10036
DR   FCDI; CW10036
DR   hPSCreg; CIRMi07B-A
DR   SKIP; SKIP003617
DR   Wikidata; Q54814912
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American and Caucasian.
CC   Discontinued: Coriell; CW10036; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10037
AC   CVCL_4Q57
SY   CIRM-CW10037i-Ctl; CIRMi07C-A
DR   BioSamples; SAMEA114482571
DR   Coriell; CW10037
DR   FCDI; CW10037
DR   hPSCreg; CIRMi07C-A
DR   SKIP; SKIP003618
DR   Wikidata; Q54814913
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10037; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW10038
AC   CVCL_4Q58
SY   CIRM-CW10038i-Affected; CIRMi07D-A
DR   BioSamples; SAMEA114482573
DR   Coriell; CW10038
DR   FCDI; CW10038
DR   hPSCreg; CIRMi07D-A
DR   SKIP; SKIP003619
DR   Wikidata; Q54814915
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10038; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10039
AC   CVCL_4Q59
SY   CIRM-CW10039i-Affected; CIRMi07E-A
DR   BioSamples; SAMEA114482575
DR   Coriell; CW10039
DR   FCDI; CW10039
DR   hPSCreg; CIRMi07E-A
DR   SKIP; SKIP003620
DR   Wikidata; Q54814916
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10039; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10040
AC   CVCL_DI68
SY   CIRM-CW10040i-Ctl; CIRMi07F-A
DR   BioSamples; SAMEA114482577
DR   Coriell; CW10040
DR   FCDI; CW10040
DR   hPSCreg; CIRMi07F-A
DR   SKIP; SKIP003621
DR   Wikidata; Q54814917
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10040; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW10041
AC   CVCL_4Q60
SY   CIRM-CW10041i-Affected; CIRMi07G-A
DR   BioSamples; SAMEA114482579
DR   Coriell; CW10041
DR   FCDI; CW10041
DR   hPSCreg; CIRMi07G-A
DR   SKIP; SKIP003622
DR   Wikidata; Q54814918
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10041; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10042
AC   CVCL_DI69
SY   CIRM-CW10042i-Affected; CIRMi07H-A
DR   BioSamples; SAMEA114482581
DR   Coriell; CW10042
DR   FCDI; CW10042
DR   hPSCreg; CIRMi07H-A
DR   SKIP; SKIP003623
DR   Wikidata; Q54814919
RX   PubMed=33268331;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW10042; true.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW10044
AC   CVCL_4Q61
SY   CIRM-CW10044i-Affected; CIRMi07I-A
DR   BioSamples; SAMEA114482583
DR   Coriell; CW10044
DR   FCDI; CW10044
DR   hPSCreg; CIRMi07I-A
DR   SKIP; SKIP003624
DR   Wikidata; Q54814920
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10044; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10045
AC   CVCL_4Q62
SY   CIRM-CW10045i-Affected; CIRMi07J-A
DR   BioSamples; SAMEA114482585
DR   Coriell; CW10045
DR   FCDI; CW10045
DR   hPSCreg; CIRMi07J-A
DR   SKIP; SKIP003625
DR   Wikidata; Q54814921
RX   PubMed=33268331;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Mongolian.
CC   Discontinued: Coriell; CW10045; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10046
AC   CVCL_4Q63
SY   CIRM-CW10046i-Affected
DR   Coriell; CW10046
DR   FCDI; CW10046
DR   SKIP; SKIP003626
DR   Wikidata; Q54814922
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10046; true.
CC   Discontinued: FCDI; CW10046; probable.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW10048
AC   CVCL_AN18
SY   CIRM-CW10048i-Affected
DR   Coriell; CW10048
DR   FCDI; CW10048
DR   SKIP; SKIP003627
DR   Wikidata; Q54814923
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10048; true.
CC   Discontinued: FCDI; CW10048; probable.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW10049
AC   CVCL_4Q64
SY   CIRM-CW10049i-Affected
DR   Coriell; CW10049
DR   SKIP; SKIP003628
DR   Wikidata; Q54814924
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10049; true.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 8
//
ID   CW10050
AC   CVCL_4Q65
SY   CIRM-CW10050i-Affected; CIRMi07K-A
DR   BioSamples; SAMEA114482587
DR   Coriell; CW10050
DR   FCDI; CW10050
DR   hPSCreg; CIRMi07K-A
DR   SKIP; SKIP003629
DR   Wikidata; Q54814925
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10050; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10054
AC   CVCL_4Q66
SY   CIRM-CW10054i-Ctl; CIRMi07L-A
DR   BioSamples; SAMEA114482589
DR   Coriell; CW10054
DR   FCDI; CW10054
DR   hPSCreg; CIRMi07L-A
DR   SKIP; SKIP003630
DR   Wikidata; Q54814926
RX   PubMed=33268331;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10054; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10058
AC   CVCL_DI70
SY   CIRMi07M-A
DR   BioSamples; SAMEA114482591
DR   Coriell; CW10058
DR   FCDI; CW10058
DR   hPSCreg; CIRMi07M-A
DR   Wikidata; Q54814927
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10058; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW10060
AC   CVCL_4Q67
SY   CIRM-CW10060i-Affected; CIRMi07N-A
DR   BioSamples; SAMEA114482593
DR   Coriell; CW10060
DR   FCDI; CW10060
DR   hPSCreg; CIRMi07N-A
DR   SKIP; SKIP003631
DR   Wikidata; Q54814928
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10060; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10061
AC   CVCL_HG46
SY   CIRMi07O-A
DR   BioSamples; SAMEA114482595
DR   Coriell; CW10061
DR   FCDI; CW10061
DR   hPSCreg; CIRMi07O-A
DR   Wikidata; Q54814929
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10061; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10062
AC   CVCL_HG47
SY   CIRMi07P-A
DR   BioSamples; SAMEA114482597
DR   Coriell; CW10062
DR   FCDI; CW10062
DR   hPSCreg; CIRMi07P-A
DR   Wikidata; Q54814930
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10062; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10063
AC   CVCL_JH38
SY   CIRMi07Q-A
DR   BioSamples; SAMEA114482599
DR   Coriell; CW10063
DR   FCDI; CW10063
DR   hPSCreg; CIRMi07Q-A
DR   Wikidata; Q54814931
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10063; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10064
AC   CVCL_HG48
SY   CIRMi07R-A
DR   BioSamples; SAMEA114482601
DR   Coriell; CW10064
DR   FCDI; CW10064
DR   hPSCreg; CIRMi07R-A
DR   Wikidata; Q54814932
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10064; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10066
AC   CVCL_HG49
SY   CIRMi07S-A
DR   BioSamples; SAMEA114482603
DR   Coriell; CW10066
DR   FCDI; CW10066
DR   hPSCreg; CIRMi07S-A
DR   Wikidata; Q54814951
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10066; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10067
AC   CVCL_4Q68
SY   CIRM-CW10067i-Affected; CIRMi07T-A
DR   BioSamples; SAMEA114482605
DR   Coriell; CW10067
DR   FCDI; CW10067
DR   hPSCreg; CIRMi07T-A
DR   SKIP; SKIP003632
DR   Wikidata; Q54814952
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10067; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW10068
AC   CVCL_JH39
SY   CIRMi07U-A
DR   BioSamples; SAMEA114482607
DR   Coriell; CW10068
DR   FCDI; CW10068
DR   hPSCreg; CIRMi07U-A
DR   Wikidata; Q54814953
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10068; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10069
AC   CVCL_HG50
SY   CIRMi07V-A
DR   BioSamples; SAMEA114482609
DR   Coriell; CW10069
DR   FCDI; CW10069
DR   hPSCreg; CIRMi07V-A
DR   Wikidata; Q54814954
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10069; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10073
AC   CVCL_DI71
SY   CIRM-CW10073i-Affected; CIRMi07W-A
DR   BioSamples; SAMEA114482611
DR   Coriell; CW10073
DR   FCDI; CW10073
DR   hPSCreg; CIRMi07W-A
DR   SKIP; SKIP003634
DR   Wikidata; Q54814955
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10073; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW10074
AC   CVCL_AN19
SY   CIRM-CW10074i-Affected; CIRMi07X-A
DR   BioSamples; SAMEA114482614
DR   Coriell; CW10074
DR   FCDI; CW10074
DR   hPSCreg; CIRMi07X-A
DR   SKIP; SKIP003635
DR   Wikidata; Q54814956
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10074; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10075
AC   CVCL_DI72
SY   CIRM-CW10075i-Affected; CIRMi07Y-A
DR   BioSamples; SAMEA114482616
DR   Coriell; CW10075
DR   FCDI; CW10075
DR   hPSCreg; CIRMi07Y-A
DR   SKIP; SKIP003636
DR   Wikidata; Q54814957
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10075; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW10076
AC   CVCL_4Q69
SY   CIRM-CW10076i-Affected; CIRMi07Z-A
DR   BioSamples; SAMEA114482618
DR   Coriell; CW10076
DR   FCDI; CW10076
DR   hPSCreg; CIRMi07Z-A
DR   SKIP; SKIP003637
DR   Wikidata; Q54814958
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Burmese.
CC   Discontinued: Coriell; CW10076; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW10077
AC   CVCL_4Q70
SY   CIRM-CW10077i-Affected; CIRMi08A-A
DR   BioSamples; SAMEA114482620
DR   Coriell; CW10077
DR   FCDI; CW10077
DR   hPSCreg; CIRMi08A-A
DR   SKIP; SKIP003638
DR   Wikidata; Q54814959
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10077; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW10078
AC   CVCL_AN20
SY   CIRM-CW10078i-Affected; CIRMi08B-A
DR   BioSamples; SAMEA114482622
DR   Coriell; CW10078
DR   FCDI; CW10078
DR   hPSCreg; CIRMi08B-A
DR   SKIP; SKIP003639
DR   Wikidata; Q54814960
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10078; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW10079
AC   CVCL_HG51
SY   CIRMi08C-A
DR   BioSamples; SAMEA114482624
DR   Coriell; CW10079
DR   FCDI; CW10079
DR   hPSCreg; CIRMi08C-A
DR   Wikidata; Q54814962
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10079; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10081
AC   CVCL_JH40
SY   CIRMi08D-A
DR   BioSamples; SAMEA114482626
DR   Coriell; CW10081
DR   FCDI; CW10081
DR   hPSCreg; CIRMi08D-A
DR   Wikidata; Q54814963
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10081; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10083
AC   CVCL_AN21
SY   CIRM-CW10083i-Affected; CIRMi08E-A
DR   BioSamples; SAMEA114482628
DR   Coriell; CW10083
DR   FCDI; CW10083
DR   hPSCreg; CIRMi08E-A
DR   SKIP; SKIP003640
DR   Wikidata; Q54814964
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10083; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10084
AC   CVCL_HG52
SY   CIRMi08F-A
DR   BioSamples; SAMEA114482630
DR   Coriell; CW10084
DR   FCDI; CW10084
DR   hPSCreg; CIRMi08F-A
DR   Wikidata; Q54814965
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10084; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10085
AC   CVCL_HG53
SY   CIRMi08G-A
DR   BioSamples; SAMEA114482632
DR   Coriell; CW10085
DR   FCDI; CW10085
DR   hPSCreg; CIRMi08G-A
DR   Wikidata; Q54814967
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10085; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10086
AC   CVCL_JH41
SY   CIRMi08H-A
DR   BioSamples; SAMEA114482634
DR   Coriell; CW10086
DR   FCDI; CW10086
DR   hPSCreg; CIRMi08H-A
DR   Wikidata; Q54814968
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10086; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10087
AC   CVCL_HG54
SY   CIRMi08I-A
DR   BioSamples; SAMEA114482636
DR   Coriell; CW10087
DR   FCDI; CW10087
DR   hPSCreg; CIRMi08I-A
DR   Wikidata; Q54814969
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10087; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10088
AC   CVCL_HG55
SY   CIRMi08J-A
DR   BioSamples; SAMEA114482638
DR   Coriell; CW10088
DR   FCDI; CW10088
DR   hPSCreg; CIRMi08J-A
DR   Wikidata; Q54814970
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10088; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10089
AC   CVCL_DI73
SY   CIRMi08K-A
DR   BioSamples; SAMEA114482640
DR   Coriell; CW10089
DR   FCDI; CW10089
DR   hPSCreg; CIRMi08K-A
DR   Wikidata; Q54814971
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10089; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW10090
AC   CVCL_JH42
SY   CIRMi08L-A
DR   BioSamples; SAMEA114482642
DR   Coriell; CW10090
DR   FCDI; CW10090
DR   hPSCreg; CIRMi08L-A
DR   Wikidata; Q54814972
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10090; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10091
AC   CVCL_HG56
SY   CIRMi08M-A
DR   BioSamples; SAMEA114482644
DR   Coriell; CW10091
DR   FCDI; CW10091
DR   hPSCreg; CIRMi08M-A
DR   Wikidata; Q54814973
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10091; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10093
AC   CVCL_JH43
SY   CIRMi08N-A
DR   BioSamples; SAMEA114482649
DR   Coriell; CW10093
DR   FCDI; CW10093
DR   hPSCreg; CIRMi08N-A
DR   Wikidata; Q54814974
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10093; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10094
AC   CVCL_AN22
SY   CIRM-CW10094i-Affected; CIRMi08O-A
DR   BioSamples; SAMEA114482651
DR   Coriell; CW10094
DR   FCDI; CW10094
DR   hPSCreg; CIRMi08O-A
DR   SKIP; SKIP003641
DR   Wikidata; Q54814975
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10094; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10095
AC   CVCL_DI74
SY   CIRM-CW10095i-Affected; CIRMi08P-A
DR   BioSamples; SAMEA114482653
DR   Coriell; CW10095
DR   FCDI; CW10095
DR   hPSCreg; CIRMi08P-A
DR   SKIP; SKIP003642
DR   Wikidata; Q54814976
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10095; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW10096
AC   CVCL_DI75
SY   CIRM-CW10096i-Affected; CIRMi08Q-A
DR   BioSamples; SAMEA114482655
DR   Coriell; CW10096
DR   FCDI; CW10096
DR   hPSCreg; CIRMi08Q-A
DR   SKIP; SKIP003643
DR   Wikidata; Q54814977
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10096; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW10097
AC   CVCL_HG57
SY   CIRMi08R-A
DR   BioSamples; SAMEA114482657
DR   Coriell; CW10097
DR   FCDI; CW10097
DR   hPSCreg; CIRMi08R-A
DR   Wikidata; Q54814978
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10097; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10098
AC   CVCL_DI76
SY   CIRMi08S-A
DR   BioSamples; SAMEA114482659
DR   Coriell; CW10098
DR   FCDI; CW10098
DR   hPSCreg; CIRMi08S-A
DR   Wikidata; Q54814979
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10098; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW10100
AC   CVCL_DI77
SY   CIRM-CW10100i-Affected; CIRMi08T-A
DR   BioSamples; SAMEA114482661
DR   Coriell; CW10100
DR   FCDI; CW10100
DR   hPSCreg; CIRMi08T-A
DR   SKIP; SKIP003644
DR   Wikidata; Q54814980
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10100; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW10101
AC   CVCL_DI78
SY   CIRMi08U-A
DR   BioSamples; SAMEA114482663
DR   Coriell; CW10101
DR   FCDI; CW10101
DR   hPSCreg; CIRMi08U-A
DR   Wikidata; Q54814982
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10101; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW10102
AC   CVCL_AN23
SY   CIRM-CW10102i-Affected; CIRMi08V-A
DR   BioSamples; SAMEA114482665
DR   Coriell; CW10102
DR   FCDI; CW10102
DR   hPSCreg; CIRMi08V-A
DR   SKIP; SKIP003645
DR   Wikidata; Q54814983
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10102; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10103
AC   CVCL_HG58
SY   CIRMi08W-A
DR   BioSamples; SAMEA114482667
DR   Coriell; CW10103
DR   FCDI; CW10103
DR   hPSCreg; CIRMi08W-A
DR   Wikidata; Q54814984
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10103; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10104
AC   CVCL_HG59
SY   CIRMi08X-A
DR   BioSamples; SAMEA114482669
DR   Coriell; CW10104
DR   FCDI; CW10104
DR   hPSCreg; CIRMi08X-A
DR   Wikidata; Q54814985
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10104; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10107
AC   CVCL_AN24
SY   CIRM-CW10107i-Affected; CIRMi08Y-A
DR   BioSamples; SAMEA114482671
DR   Coriell; CW10107
DR   FCDI; CW10107
DR   hPSCreg; CIRMi08Y-A
DR   SKIP; SKIP003646
DR   Wikidata; Q54814986
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10107; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10109
AC   CVCL_HG60
SY   CIRMi08Z-A
DR   BioSamples; SAMEA114482673
DR   Coriell; CW10109
DR   FCDI; CW10109
DR   hPSCreg; CIRMi08Z-A
DR   Wikidata; Q54814987
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10109; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10110
AC   CVCL_DI79
SY   CIRMi09A-A
DR   BioSamples; SAMEA114482675
DR   Coriell; CW10110
DR   FCDI; CW10110
DR   hPSCreg; CIRMi09A-A
DR   Wikidata; Q54814988
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10110; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW10111
AC   CVCL_HG61
SY   CIRMi09B-A
DR   BioSamples; SAMEA114482677
DR   Coriell; CW10111
DR   FCDI; CW10111
DR   hPSCreg; CIRMi09B-A
DR   Wikidata; Q54814989
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10111; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10114
AC   CVCL_AN25
SY   CIRM-CW10114i-Affected; CIRMi09C-A
DR   BioSamples; SAMEA114482679
DR   Coriell; CW10114
DR   FCDI; CW10114
DR   hPSCreg; CIRMi09C-A
DR   SKIP; SKIP003647
DR   Wikidata; Q54814990
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10114; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10115
AC   CVCL_AN26
SY   CIRM-CW10115i-Affected; CIRMi09D-A
DR   BioSamples; SAMEA114482681
DR   Coriell; CW10115
DR   FCDI; CW10115
DR   hPSCreg; CIRMi09D-A
DR   SKIP; SKIP003648
DR   Wikidata; Q54814991
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10115; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10116
AC   CVCL_HG62
SY   CIRMi09E-A
DR   BioSamples; SAMEA114482683
DR   Coriell; CW10116
DR   FCDI; CW10116
DR   hPSCreg; CIRMi09E-A
DR   Wikidata; Q54814992
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10116; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10118
AC   CVCL_DI80
SY   CIRMi09F-A
DR   BioSamples; SAMEA114482685
DR   Coriell; CW10118
DR   FCDI; CW10118
DR   hPSCreg; CIRMi09F-A
DR   Wikidata; Q54814993
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10118; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW10120
AC   CVCL_HG63
SY   CIRMi09G-A
DR   BioSamples; SAMEA114482687
DR   Coriell; CW10120
DR   FCDI; CW10120
DR   hPSCreg; CIRMi09G-A
DR   Wikidata; Q54815002
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10120; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10121
AC   CVCL_JH44
SY   CIRMi09H-A
DR   BioSamples; SAMEA114482689
DR   Coriell; CW10121
DR   FCDI; CW10121
DR   hPSCreg; CIRMi09H-A
DR   Wikidata; Q54815003
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10121; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10122
AC   CVCL_AN27
SY   CIRM-CW10122i-Affected; CIRMi09I-A
DR   BioSamples; SAMEA114482691
DR   Coriell; CW10122
DR   FCDI; CW10122
DR   hPSCreg; CIRMi09I-A
DR   SKIP; SKIP003649
DR   Wikidata; Q54815004
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10122; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10126
AC   CVCL_JH45
SY   CIRMi09J-A
DR   BioSamples; SAMEA114482693
DR   Coriell; CW10126
DR   FCDI; CW10126
DR   hPSCreg; CIRMi09J-A
DR   Wikidata; Q54815005
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10126; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10127
AC   CVCL_HG64
SY   CIRMi09K-A
DR   BioSamples; SAMEA114482695
DR   Coriell; CW10127
DR   FCDI; CW10127
DR   hPSCreg; CIRMi09K-A
DR   Wikidata; Q54815006
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10127; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10128
AC   CVCL_DI81
SY   CIRM-CW10128i-Affected; CIRMi09L-A
DR   BioSamples; SAMEA114482697
DR   Coriell; CW10128
DR   FCDI; CW10128
DR   hPSCreg; CIRMi09L-A
DR   SKIP; SKIP003650
DR   Wikidata; Q54815007
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW10130
AC   CVCL_DI82
SY   CIRM-CW10130i-Affected; CIRMi09M-A
DR   BioSamples; SAMEA114482699
DR   Coriell; CW10130
DR   FCDI; CW10130
DR   hPSCreg; CIRMi09M-A
DR   SKIP; SKIP003651
DR   Wikidata; Q54815008
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Nepali.
CC   Discontinued: Coriell; CW10130; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW10131
AC   CVCL_HG65
SY   CIRMi09N-A
DR   BioSamples; SAMEA114482701
DR   Coriell; CW10131
DR   FCDI; CW10131
DR   hPSCreg; CIRMi09N-A
DR   Wikidata; Q54815009
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10131; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10133
AC   CVCL_JH46
SY   CIRMi09O-A
DR   BioSamples; SAMEA114482703
DR   Coriell; CW10133
DR   FCDI; CW10133
DR   hPSCreg; CIRMi09O-A
DR   Wikidata; Q54815011
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10133; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10135
AC   CVCL_HG66
SY   CIRMi09P-A
DR   BioSamples; SAMEA114482705
DR   Coriell; CW10135
DR   FCDI; CW10135
DR   hPSCreg; CIRMi09P-A
DR   Wikidata; Q54815012
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American and Caucasian.
CC   Discontinued: Coriell; CW10135; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10136
AC   CVCL_HG67
SY   CIRMi09Q-A
DR   BioSamples; SAMEA114482707
DR   Coriell; CW10136
DR   FCDI; CW10136
DR   hPSCreg; CIRMi09Q-A
DR   Wikidata; Q54815013
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10136; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10137
AC   CVCL_JH47
SY   CIRMi09R-A
DR   BioSamples; SAMEA114482709
DR   Coriell; CW10137
DR   FCDI; CW10137
DR   hPSCreg; CIRMi09R-A
DR   Wikidata; Q54815014
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10137; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10139
AC   CVCL_HG68
SY   CIRMi09S-A
DR   BioSamples; SAMEA114482711
DR   Coriell; CW10139
DR   FCDI; CW10139
DR   hPSCreg; CIRMi09S-A
DR   Wikidata; Q54815015
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10139; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10141
AC   CVCL_HG69
SY   CIRMi09T-A
DR   BioSamples; SAMEA114482713
DR   Coriell; CW10141
DR   FCDI; CW10141
DR   hPSCreg; CIRMi09T-A
DR   Wikidata; Q54815016
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10141; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10142
AC   CVCL_JH48
SY   CIRMi09U-A
DR   BioSamples; SAMEA114482715
DR   Coriell; CW10142
DR   FCDI; CW10142
DR   hPSCreg; CIRMi09U-A
DR   Wikidata; Q54815017
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10142; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10143
AC   CVCL_HG70
SY   CIRMi09V-A
DR   BioSamples; SAMEA114482717
DR   Coriell; CW10143
DR   FCDI; CW10143
DR   hPSCreg; CIRMi09V-A
DR   Wikidata; Q54815018
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10143; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10144
AC   CVCL_JH49
SY   CIRMi09W-A
DR   BioSamples; SAMEA114482719
DR   Coriell; CW10144
DR   FCDI; CW10144
DR   hPSCreg; CIRMi09W-A
DR   Wikidata; Q54815020
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10144; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10146
AC   CVCL_HG71
SY   CIRMi09X-A
DR   BioSamples; SAMEA114482721
DR   Coriell; CW10146
DR   FCDI; CW10146
DR   hPSCreg; CIRMi09X-A
DR   Wikidata; Q54815021
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10146; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10147
AC   CVCL_JH50
SY   CIRMi09Y-A
DR   BioSamples; SAMEA114482723
DR   Coriell; CW10147
DR   FCDI; CW10147
DR   hPSCreg; CIRMi09Y-A
DR   Wikidata; Q54815022
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10147; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10148
AC   CVCL_JH51
SY   CIRMi09Z-A
DR   BioSamples; SAMEA114482725
DR   Coriell; CW10148
DR   FCDI; CW10148
DR   hPSCreg; CIRMi09Z-A
DR   Wikidata; Q54815023
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10148; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10149
AC   CVCL_DI83
SY   CIRM-CW10149i-Ctl; CIRMi10A-A
DR   BioSamples; SAMEA114482727
DR   Coriell; CW10149
DR   FCDI; CW10149
DR   hPSCreg; CIRMi10A-A
DR   SKIP; SKIP003652
DR   Wikidata; Q54815024
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW10149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW10150
AC   CVCL_DI84
SY   CIRMi10B-A
DR   BioSamples; SAMEA114482729
DR   Coriell; CW10150
DR   FCDI; CW10150
DR   hPSCreg; CIRMi10B-A
DR   Wikidata; Q54815025
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10150; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW10151
AC   CVCL_DI85
SY   CIRM-CW10151i-Affected
DR   Coriell; CW10151
DR   SKIP; SKIP003653
DR   Wikidata; Q54815027
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10151; true.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW10152
AC   CVCL_DI86
SY   CIRM-CW10152i-Affected; CIRMi10C-A
DR   BioSamples; SAMEA114482731
DR   Coriell; CW10152
DR   FCDI; CW10152
DR   hPSCreg; CIRMi10C-A
DR   SKIP; SKIP003654
DR   Wikidata; Q54815028
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10152; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW10153
AC   CVCL_HG72
SY   CIRMi10D-A
DR   BioSamples; SAMEA114482793
DR   Coriell; CW10153
DR   FCDI; CW10153
DR   hPSCreg; CIRMi10D-A
DR   Wikidata; Q54815029
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10153; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10154
AC   CVCL_DI87
SY   CIRMi10E-A
DR   BioSamples; SAMEA114482795
DR   Coriell; CW10154
DR   FCDI; CW10154
DR   hPSCreg; CIRMi10E-A
DR   Wikidata; Q54815030
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10154; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW10155
AC   CVCL_HG73
SY   CIRMi10F-A
DR   BioSamples; SAMEA114482797
DR   Coriell; CW10155
DR   FCDI; CW10155
DR   hPSCreg; CIRMi10F-A
DR   Wikidata; Q54815031
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10155; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10156
AC   CVCL_AN28
SY   CIRM-CW10156i-Affected; CIRMi10G-A
DR   BioSamples; SAMEA114482799
DR   Coriell; CW10156
DR   FCDI; CW10156
DR   hPSCreg; CIRMi10G-A
DR   SKIP; SKIP003655
DR   Wikidata; Q54815032
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10156; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW10157
AC   CVCL_HG74
SY   CIRMi10H-A
DR   BioSamples; SAMEA114482801
DR   Coriell; CW10157
DR   FCDI; CW10157
DR   hPSCreg; CIRMi10H-A
DR   Wikidata; Q54815033
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10157; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10158
AC   CVCL_ER30
SY   CIRMi10I-A
DR   BioSamples; SAMEA114482803
DR   Coriell; CW10158
DR   FCDI; CW10158
DR   hPSCreg; CIRMi10I-A
DR   Wikidata; Q54815034
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10158; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW10159
AC   CVCL_AN29
SY   CIRM-CW10159i-Affected; CIRMi10J-A
DR   BioSamples; SAMEA114482805
DR   Coriell; CW10159
DR   FCDI; CW10159
DR   hPSCreg; CIRMi10J-A
DR   SKIP; SKIP003656
DR   Wikidata; Q54815035
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10159; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW10160
AC   CVCL_HG75
SY   CIRMi10K-A
DR   BioSamples; SAMEA114482807
DR   Coriell; CW10160
DR   FCDI; CW10160
DR   hPSCreg; CIRMi10K-A
DR   Wikidata; Q54815036
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10160; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10162
AC   CVCL_JH52
SY   CIRMi10L-A
DR   BioSamples; SAMEA114482809
DR   Coriell; CW10162
DR   FCDI; CW10162
DR   hPSCreg; CIRMi10L-A
DR   Wikidata; Q54815037
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10162; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW10163
AC   CVCL_HG76
SY   CIRMi10M-A
DR   BioSamples; SAMEA114482811
DR   Coriell; CW10163
DR   FCDI; CW10163
DR   hPSCreg; CIRMi10M-A
DR   Wikidata; Q54815038
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10163; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10165
AC   CVCL_ER31
SY   CIRMi10N-A
DR   BioSamples; SAMEA114482813
DR   Coriell; CW10165
DR   FCDI; CW10165
DR   hPSCreg; CIRMi10N-A
DR   Wikidata; Q54815039
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10165; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW10166
AC   CVCL_HG77
SY   CIRMi10O-A
DR   BioSamples; SAMEA114482815
DR   Coriell; CW10166
DR   FCDI; CW10166
DR   hPSCreg; CIRMi10O-A
DR   Wikidata; Q54815040
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10166; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10167
AC   CVCL_DI88
SY   CIRM-CW10167i-Affected; CIRMi10P-A
DR   BioSamples; SAMEA114482817
DR   Coriell; CW10167
DR   FCDI; CW10167
DR   hPSCreg; CIRMi10P-A
DR   SKIP; SKIP003633
DR   Wikidata; Q54815041
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW10168
AC   CVCL_HG78
SY   CIRMi10Q-A
DR   BioSamples; SAMEA114482819
DR   Coriell; CW10168
DR   FCDI; CW10168
DR   hPSCreg; CIRMi10Q-A
DR   Wikidata; Q54815042
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10168; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10169
AC   CVCL_HG79
SY   CIRMi10R-A
DR   BioSamples; SAMEA114482821
DR   Coriell; CW10169
DR   FCDI; CW10169
DR   hPSCreg; CIRMi10R-A
DR   Wikidata; Q54815044
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10169; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10171
AC   CVCL_DI89
SY   CIRM-CW10171i-Affected; CIRMi10S-A
DR   BioSamples; SAMEA114482823
DR   Coriell; CW10171
DR   FCDI; CW10171
DR   hPSCreg; CIRMi10S-A
DR   SKIP; SKIP003657
DR   Wikidata; Q54815045
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10171; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW10172
AC   CVCL_HG80
SY   CIRMi10T-A
DR   BioSamples; SAMEA114482825
DR   Coriell; CW10172
DR   FCDI; CW10172
DR   hPSCreg; CIRMi10T-A
DR   Wikidata; Q54815060
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10172; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10173
AC   CVCL_HG81
SY   CIRMi10U-A
DR   BioSamples; SAMEA114482827
DR   Coriell; CW10173
DR   FCDI; CW10173
DR   hPSCreg; CIRMi10U-A
DR   Wikidata; Q54815061
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10173; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10175
AC   CVCL_DI90
SY   CIRMi10V-A
DR   BioSamples; SAMEA114482829
DR   Coriell; CW10175
DR   FCDI; CW10175
DR   hPSCreg; CIRMi10V-A
DR   Wikidata; Q54815062
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW10175; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW10176
AC   CVCL_HG82
SY   CIRMi10W-A
DR   BioSamples; SAMEA114482831
DR   Coriell; CW10176
DR   FCDI; CW10176
DR   hPSCreg; CIRMi10W-A
DR   Wikidata; Q54815063
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10176; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10177
AC   CVCL_HG83
SY   CIRMi10X-A
DR   BioSamples; SAMEA114482833
DR   Coriell; CW10177
DR   FCDI; CW10177
DR   hPSCreg; CIRMi10X-A
DR   Wikidata; Q54815065
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10177; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10178
AC   CVCL_ER32
SY   CIRM-CW10178i-Ctl; CIRMi10Y-A
DR   BioSamples; SAMEA114482835
DR   Coriell; CW10178
DR   FCDI; CW10178
DR   hPSCreg; CIRMi10Y-A
DR   SKIP; SKIP003658
DR   Wikidata; Q54815066
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10178; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 13
//
ID   CW10181
AC   CVCL_JH53
SY   CIRMi10Z-A
DR   BioSamples; SAMEA114482837
DR   Coriell; CW10181
DR   FCDI; CW10181
DR   hPSCreg; CIRMi10Z-A
DR   Wikidata; Q54815067
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10181; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW10182
AC   CVCL_HG84
SY   CIRMi11A-A
DR   BioSamples; SAMEA114482839
DR   Coriell; CW10182
DR   FCDI; CW10182
DR   hPSCreg; CIRMi11A-A
DR   Wikidata; Q54815068
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW10182; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10183
AC   CVCL_HG85
SY   CIRMi11B-A
DR   BioSamples; SAMEA114482841
DR   Coriell; CW10183
DR   FCDI; CW10183
DR   hPSCreg; CIRMi11B-A
DR   Wikidata; Q54815069
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10183; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10184
AC   CVCL_HG86
SY   CIRMi11C-A
DR   BioSamples; SAMEA114482843
DR   Coriell; CW10184
DR   FCDI; CW10184
DR   hPSCreg; CIRMi11C-A
DR   Wikidata; Q54815071
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10184; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150596; Hepatic steatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10185
AC   CVCL_HG87
SY   CIRMi11D-A
DR   BioSamples; SAMEA114482845
DR   Coriell; CW10185
DR   FCDI; CW10185
DR   hPSCreg; CIRMi11D-A
DR   Wikidata; Q54815072
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10185; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10186
AC   CVCL_RV42
SY   CIRMi11E-A
DR   BioSamples; SAMEA114482847
DR   Coriell; CW10186
DR   FCDI; CW10186
DR   hPSCreg; CIRMi11E-A
DR   Wikidata; Q54815073
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Nepali.
CC   Discontinued: Coriell; CW10186; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   CW10187
AC   CVCL_HG88
SY   CIRMi11F-A
DR   BioSamples; SAMEA114482849
DR   Coriell; CW10187
DR   FCDI; CW10187
DR   hPSCreg; CIRMi11F-A
DR   Wikidata; Q54815074
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10187; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10188
AC   CVCL_HG89
SY   CIRMi11G-A
DR   BioSamples; SAMEA114482851
DR   Coriell; CW10188
DR   FCDI; CW10188
DR   hPSCreg; CIRMi11G-A
DR   Wikidata; Q54815075
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10188; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10189
AC   CVCL_HG90
SY   CIRMi11H-A
DR   BioSamples; SAMEA114482853
DR   Coriell; CW10189
DR   FCDI; CW10189
DR   hPSCreg; CIRMi11H-A
DR   Wikidata; Q54815076
RX   PubMed=33268331;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10189; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10190
AC   CVCL_RV43
SY   CIRMi11I-A
DR   BioSamples; SAMEA114482855
DR   Coriell; CW10190
DR   FCDI; CW10190
DR   hPSCreg; CIRMi11I-A
DR   Wikidata; Q54815078
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10190; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   CW10191
AC   CVCL_HG91
SY   CIRMi11J-A
DR   BioSamples; SAMEA114482857
DR   Coriell; CW10191
DR   FCDI; CW10191
DR   hPSCreg; CIRMi11J-A
DR   Wikidata; Q54815080
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10191; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10192
AC   CVCL_HG92
SY   CIRMi11K-A
DR   BioSamples; SAMEA114482859
DR   Coriell; CW10192
DR   FCDI; CW10192
DR   hPSCreg; CIRMi11K-A
DR   Wikidata; Q54815081
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10192; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10201
AC   CVCL_HG93
SY   CIRMi11L-A
DR   BioSamples; SAMEA114482861
DR   Coriell; CW10201
DR   FCDI; CW10201
DR   hPSCreg; CIRMi11L-A
DR   Wikidata; Q54815082
RX   PubMed=33268331;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10202
AC   CVCL_DI91
SY   CIRMi11M-A
DR   BioSamples; SAMEA114482863
DR   Coriell; CW10202
DR   FCDI; CW10202
DR   hPSCreg; CIRMi11M-A
DR   Wikidata; Q54815083
RX   PubMed=33268331;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW10203
AC   CVCL_HG94
SY   CIRMi11N-A
DR   BioSamples; SAMEA114482865
DR   Coriell; CW10203
DR   FCDI; CW10203
DR   hPSCreg; CIRMi11N-A
DR   Wikidata; Q54815084
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW10203; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW10205
AC   CVCL_HG95
SY   CIRMi11O-A
DR   BioSamples; SAMEA114482867
DR   Coriell; CW10205
DR   FCDI; CW10205
DR   hPSCreg; CIRMi11O-A
DR   Wikidata; Q54815086
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW10205; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3098; Hepatitis C infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW10206
AC   CVCL_ER33
SY   CIRM-CW10206i-Ctl; CIRMi11P-A
DR   BioSamples; SAMEA114482869
DR   Coriell; CW10206
DR   FCDI; CW10206
DR   hPSCreg; CIRMi11P-A
DR   SKIP; SKIP003659
DR   Wikidata; Q54815087
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW10206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 13
//
ID   CW10208
AC   CVCL_RV44
SY   CIRMi11Q-A
DR   BioSamples; SAMEA114482871
DR   Coriell; CW10208
DR   FCDI; CW10208
DR   hPSCreg; CIRMi11Q-A
DR   Wikidata; Q54815088
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW10208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   CW12
AC   CVCL_7952
SY   CW12-1E
DR   Cosmic; 1097742
DR   Cosmic; 1104555
DR   Wikidata; Q54815089
RX   PubMed=1680555;
RX   PubMed=7536457;
RX   PubMed=8275086;
RX   PubMed=23665679;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=7536457; PubMed=8275086).
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   CW12-XPC
AC   CVCL_M224
SY   CW-12
DR   Wikidata; Q54815090
RX   PubMed=3030788;
CC   Population: Egyptian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV7).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L774 ! XP7CA
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   CW12000
AC   CVCL_D0A9
SY   CIRMi231-A
DR   BioSamples; SAMEA113375186
DR   hPSCreg; CIRMi231-A
DR   Wikidata; Q123031004
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101268; Bilateral optic nerve hypoplasia
DI   ORDO; Orphanet_637061; Isolated optic nerve hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   CW12001
AC   CVCL_D0AA
SY   CIRMi232-A
DR   BioSamples; SAMEA113375216
DR   hPSCreg; CIRMi232-A
DR   Wikidata; Q123031005
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW12002
AC   CVCL_D0AB
SY   CIRMi233-A
DR   BioSamples; SAMEA113375242
DR   hPSCreg; CIRMi233-A
DR   Wikidata; Q123031007
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101268; Bilateral optic nerve hypoplasia
DI   ORDO; Orphanet_637061; Isolated optic nerve hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   CW12003
AC   CVCL_D0AC
SY   CIRMi234-A
DR   BioSamples; SAMEA113375267
DR   hPSCreg; CIRMi234-A
DR   Wikidata; Q123031008
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW12004
AC   CVCL_D0AD
SY   CIRMi235-A
DR   BioSamples; SAMEA113375290
DR   hPSCreg; CIRMi235-A
DR   Wikidata; Q123031009
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW11000
AC   CVCL_D6G0
SY   CIRMi11U-A
DR   BioSamples; SAMEA115399961
DR   hPSCreg; CIRMi11U-A
DR   Wikidata; Q127380656
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11001
AC   CVCL_D6G1
SY   CIRMi11V-A
DR   BioSamples; SAMEA115399962
DR   hPSCreg; CIRMi11V-A
DR   Wikidata; Q127380658
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   CW11004
AC   CVCL_D6G2
SY   CIRMi11W-A
DR   BioSamples; SAMEA115399964
DR   hPSCreg; CIRMi11W-A
DR   Wikidata; Q127380659
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11005
AC   CVCL_D6G3
SY   CIRMi11X-A
DR   BioSamples; SAMEA115399966
DR   hPSCreg; CIRMi11X-A
DR   Wikidata; Q127380660
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11006
AC   CVCL_D6G4
SY   CIRMi11Y-A
DR   BioSamples; SAMEA115399968
DR   hPSCreg; CIRMi11Y-A
DR   Wikidata; Q127380661
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11009
AC   CVCL_D6G5
SY   CIRMi11Z-A
DR   BioSamples; SAMEA115399970
DR   hPSCreg; CIRMi11Z-A
DR   Wikidata; Q127380662
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11012
AC   CVCL_D6G6
SY   CIRMi12A-A
DR   BioSamples; SAMEA115399972
DR   hPSCreg; CIRMi12A-A
DR   Wikidata; Q127380663
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11013
AC   CVCL_D6G7
SY   CIRMi12B-A
DR   BioSamples; SAMEA115399974
DR   hPSCreg; CIRMi12B-A
DR   Wikidata; Q127380664
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11015
AC   CVCL_D6G8
SY   CIRMi12C-A
DR   BioSamples; SAMEA115399976
DR   hPSCreg; CIRMi12C-A
DR   Wikidata; Q127380666
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11016
AC   CVCL_D6G9
SY   CIRMi12D-A
DR   BioSamples; SAMEA115399978
DR   hPSCreg; CIRMi12D-A
DR   Wikidata; Q127380667
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11018
AC   CVCL_D6GA
SY   CIRMi12E-A
DR   BioSamples; SAMEA115399980
DR   hPSCreg; CIRMi12E-A
DR   Wikidata; Q127380668
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11019
AC   CVCL_D6GB
SY   CIRMi12F-A
DR   BioSamples; SAMEA115399982
DR   hPSCreg; CIRMi12F-A
DR   Wikidata; Q127380669
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11030
AC   CVCL_D6GC
SY   CIRMi12G-A
DR   BioSamples; SAMEA115399984
DR   hPSCreg; CIRMi12G-A
DR   Wikidata; Q127380671
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11031
AC   CVCL_D6GD
SY   CIRMi12H-A
DR   BioSamples; SAMEA115399986
DR   hPSCreg; CIRMi12H-A
DR   Wikidata; Q127380672
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11032
AC   CVCL_D6GE
SY   CIRMi12I-A
DR   BioSamples; SAMEA115399988
DR   hPSCreg; CIRMi12I-A
DR   Wikidata; Q127380673
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11033
AC   CVCL_D6GF
SY   CIRMi12J-A
DR   BioSamples; SAMEA115399990
DR   hPSCreg; CIRMi12J-A
DR   Wikidata; Q127380674
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11034
AC   CVCL_D6GG
SY   CIRMi12K-A
DR   BioSamples; SAMEA115399992
DR   hPSCreg; CIRMi12K-A
DR   Wikidata; Q127380675
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11036
AC   CVCL_D6GH
SY   CIRMi12L-A
DR   BioSamples; SAMEA115399994
DR   hPSCreg; CIRMi12L-A
DR   Wikidata; Q127380676
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11040
AC   CVCL_D6GI
SY   CIRMi12M-A
DR   BioSamples; SAMEA115399996
DR   hPSCreg; CIRMi12M-A
DR   Wikidata; Q127380677
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11041
AC   CVCL_D6GJ
SY   CIRMi12N-A
DR   BioSamples; SAMEA115399998
DR   hPSCreg; CIRMi12N-A
DR   Wikidata; Q127380678
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11042
AC   CVCL_D6GK
SY   CIRMi12O-A
DR   BioSamples; SAMEA115400000
DR   hPSCreg; CIRMi12O-A
DR   Wikidata; Q127380679
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11043
AC   CVCL_D6GL
SY   CIRMi12P-A
DR   BioSamples; SAMEA115400002
DR   hPSCreg; CIRMi12P-A
DR   Wikidata; Q127380680
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11046
AC   CVCL_D6GM
SY   CIRMi12Q-A
DR   BioSamples; SAMEA115400004
DR   hPSCreg; CIRMi12Q-A
DR   Wikidata; Q127380681
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11072
AC   CVCL_D6GN
SY   CIRMi12R-A
DR   BioSamples; SAMEA115400006
DR   hPSCreg; CIRMi12R-A
DR   Wikidata; Q127380682
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11074
AC   CVCL_D6GP
SY   CIRMi12S-A
DR   BioSamples; SAMEA115400008
DR   hPSCreg; CIRMi12S-A
DR   Wikidata; Q127380683
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11075
AC   CVCL_D6GQ
SY   CIRMi12T-A
DR   BioSamples; SAMEA115400010
DR   hPSCreg; CIRMi12T-A
DR   Wikidata; Q127380684
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11077
AC   CVCL_D6GR
SY   CIRMi12U-A
DR   BioSamples; SAMEA115400012
DR   hPSCreg; CIRMi12U-A
DR   Wikidata; Q127380686
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11078
AC   CVCL_D6GS
SY   CIRMi12V-A
DR   BioSamples; SAMEA115400014
DR   hPSCreg; CIRMi12V-A
DR   Wikidata; Q127380687
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11079
AC   CVCL_D6GT
SY   CIRMi12W-A
DR   BioSamples; SAMEA115400016
DR   hPSCreg; CIRMi12W-A
DR   Wikidata; Q127380688
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11090
AC   CVCL_D6GU
SY   CIRMi12X-A
DR   BioSamples; SAMEA115400018
DR   hPSCreg; CIRMi12X-A
DR   Wikidata; Q127380689
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11091
AC   CVCL_D6GV
SY   CIRMi12Y-A
DR   BioSamples; SAMEA115400020
DR   hPSCreg; CIRMi12Y-A
DR   Wikidata; Q127380690
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11093
AC   CVCL_D6GW
SY   CIRMi12Z-A
DR   BioSamples; SAMEA115400022
DR   hPSCreg; CIRMi12Z-A
DR   Wikidata; Q127380691
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11094
AC   CVCL_D6GX
SY   CIRMi13A-A
DR   BioSamples; SAMEA115400024
DR   hPSCreg; CIRMi13A-A
DR   Wikidata; Q127380692
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11096
AC   CVCL_D6GY
SY   CIRMi13B-A
DR   BioSamples; SAMEA115400026
DR   hPSCreg; CIRMi13B-A
DR   Wikidata; Q127380694
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11098
AC   CVCL_D6GZ
SY   CIRMi13C-A
DR   BioSamples; SAMEA115400028
DR   hPSCreg; CIRMi13C-A
DR   Wikidata; Q127380695
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11100
AC   CVCL_D6H0
SY   CIRMi13D-A
DR   BioSamples; SAMEA115400030
DR   hPSCreg; CIRMi13D-A
DR   Wikidata; Q127380696
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11101
AC   CVCL_D6H1
SY   CIRMi13E-A
DR   BioSamples; SAMEA115400032
DR   hPSCreg; CIRMi13E-A
DR   Wikidata; Q127380697
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11110
AC   CVCL_D6H2
SY   CIRMi13F-A
DR   BioSamples; SAMEA115400034
DR   hPSCreg; CIRMi13F-A
DR   Wikidata; Q127380698
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11119
AC   CVCL_D6H3
SY   CIRMi13G-A
DR   BioSamples; SAMEA115400036
DR   hPSCreg; CIRMi13G-A
DR   Wikidata; Q127380699
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11120
AC   CVCL_D6H4
SY   CIRMi13H-A
DR   BioSamples; SAMEA115400038
DR   hPSCreg; CIRMi13H-A
DR   Wikidata; Q127380711
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11121
AC   CVCL_D6H5
SY   CIRMi13I-A
DR   BioSamples; SAMEA115400040
DR   hPSCreg; CIRMi13I-A
DR   Wikidata; Q127380712
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11122
AC   CVCL_D6H6
SY   CIRMi13J-A
DR   BioSamples; SAMEA115400042
DR   hPSCreg; CIRMi13J-A
DR   Wikidata; Q127380714
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11123
AC   CVCL_D6H7
SY   CIRMi13K-A
DR   BioSamples; SAMEA115400044
DR   hPSCreg; CIRMi13K-A
DR   Wikidata; Q127380715
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11124
AC   CVCL_D6H8
SY   CIRMi13L-A
DR   BioSamples; SAMEA115400046
DR   hPSCreg; CIRMi13L-A
DR   Wikidata; Q127380716
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11125
AC   CVCL_D6H9
SY   CIRMi13M-A
DR   BioSamples; SAMEA115400048
DR   hPSCreg; CIRMi13M-A
DR   Wikidata; Q127380717
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11126
AC   CVCL_D6HA
SY   CIRMi13N-A
DR   BioSamples; SAMEA115400050
DR   hPSCreg; CIRMi13N-A
DR   Wikidata; Q127380718
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11127
AC   CVCL_D6HB
SY   CIRMi13O-A
DR   BioSamples; SAMEA115400052
DR   hPSCreg; CIRMi13O-A
DR   Wikidata; Q127380719
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11132
AC   CVCL_D6HC
SY   CIRMi13P-A
DR   BioSamples; SAMEA115400054
DR   hPSCreg; CIRMi13P-A
DR   Wikidata; Q127380720
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11133
AC   CVCL_D6HD
SY   CIRMi13Q-A
DR   BioSamples; SAMEA115400056
DR   hPSCreg; CIRMi13Q-A
DR   Wikidata; Q127380721
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11140
AC   CVCL_D6HE
SY   CIRMi13R-A
DR   BioSamples; SAMEA115400058
DR   hPSCreg; CIRMi13R-A
DR   Wikidata; Q127380722
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11141
AC   CVCL_D6HF
SY   CIRMi13S-A
DR   BioSamples; SAMEA115400060
DR   hPSCreg; CIRMi13S-A
DR   Wikidata; Q127380723
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92622; Generalized anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11147
AC   CVCL_D6HG
SY   CIRMi13T-A
DR   BioSamples; SAMEA115400062
DR   hPSCreg; CIRMi13T-A
DR   Wikidata; Q127380724
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11148
AC   CVCL_D6HH
SY   CIRMi13U-A
DR   BioSamples; SAMEA115400064
DR   hPSCreg; CIRMi13U-A
DR   Wikidata; Q127380725
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW11150
AC   CVCL_D6HI
SY   CIRMi13V-A
DR   BioSamples; SAMEA115400066
DR   hPSCreg; CIRMi13V-A
DR   Wikidata; Q127380726
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   CW13000
AC   CVCL_D0AE
SY   CIRMi001-A
DR   BioSamples; SAMEA112654287
DR   hPSCreg; CIRMi001-A
DR   Wikidata; Q123031010
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13002
AC   CVCL_D0AF
SY   CIRMi002-A
DR   BioSamples; SAMEA112654289
DR   hPSCreg; CIRMi002-A
DR   Wikidata; Q123031011
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13003
AC   CVCL_D0AG
SY   CIRMi003-A
DR   BioSamples; SAMEA112654291
DR   hPSCreg; CIRMi003-A
DR   Wikidata; Q123031012
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13005
AC   CVCL_D0AH
SY   CIRMi004-A
DR   BioSamples; SAMEA112654293
DR   hPSCreg; CIRMi004-A
DR   Wikidata; Q123031013
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13006
AC   CVCL_D0AI
SY   CIRMi005-A
DR   BioSamples; SAMEA112654295
DR   hPSCreg; CIRMi005-A
DR   Wikidata; Q123031014
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13009
AC   CVCL_D0AJ
SY   CIRMi006-A
DR   BioSamples; SAMEA112654297
DR   hPSCreg; CIRMi006-A
DR   Wikidata; Q123031015
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13011
AC   CVCL_D0AK
SY   CIRMi007-A
DR   BioSamples; SAMEA112654299
DR   hPSCreg; CIRMi007-A
DR   Wikidata; Q123031016
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13016
AC   CVCL_D0AL
SY   CIRMi008-A
DR   BioSamples; SAMEA112654301
DR   hPSCreg; CIRMi008-A
DR   Wikidata; Q123031017
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13017
AC   CVCL_D0AM
SY   CIRMi009-A
DR   BioSamples; SAMEA112654303
DR   hPSCreg; CIRMi009-A
DR   Wikidata; Q123031018
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13018
AC   CVCL_D0AN
SY   CIRMi010-A
DR   BioSamples; SAMEA112654305
DR   hPSCreg; CIRMi010-A
DR   Wikidata; Q123031019
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13020
AC   CVCL_D0AP
SY   CIRMi011-A
DR   BioSamples; SAMEA112654307
DR   hPSCreg; CIRMi011-A
DR   Wikidata; Q123031020
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13021
AC   CVCL_D0AQ
SY   CIRMi012-A
DR   BioSamples; SAMEA112654309
DR   hPSCreg; CIRMi012-A
DR   Wikidata; Q123031021
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13023
AC   CVCL_D0AR
SY   CIRMi013-A
DR   BioSamples; SAMEA112654311
DR   hPSCreg; CIRMi013-A
DR   Wikidata; Q123031022
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13024
AC   CVCL_D0AS
SY   CIRMi014-A
DR   BioSamples; SAMEA112654313
DR   hPSCreg; CIRMi014-A
DR   Wikidata; Q123031023
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13025
AC   CVCL_D0AT
SY   CIRMi015-A
DR   BioSamples; SAMEA112654315
DR   hPSCreg; CIRMi015-A
DR   Wikidata; Q123031024
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13026
AC   CVCL_D0AU
SY   CIRMi016-A
DR   BioSamples; SAMEA112654317
DR   hPSCreg; CIRMi016-A
DR   Wikidata; Q123031025
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13028
AC   CVCL_D0AV
SY   CIRMi017-A
DR   BioSamples; SAMEA112654319
DR   hPSCreg; CIRMi017-A
DR   Wikidata; Q123031026
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13029
AC   CVCL_D0AW
SY   CIRMi018-A
DR   BioSamples; SAMEA112654321
DR   hPSCreg; CIRMi018-A
DR   Wikidata; Q123031027
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13030
AC   CVCL_D0AX
SY   CIRMi019-A
DR   BioSamples; SAMEA112654323
DR   hPSCreg; CIRMi019-A
DR   Wikidata; Q123031028
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13031
AC   CVCL_D0AY
SY   CIRMi020-A
DR   BioSamples; SAMEA112654325
DR   hPSCreg; CIRMi020-A
DR   Wikidata; Q123031029
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13032
AC   CVCL_D0AZ
SY   CIRMi021-A
DR   BioSamples; SAMEA112654327
DR   hPSCreg; CIRMi021-A
DR   Wikidata; Q123031030
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13033
AC   CVCL_D0B0
SY   CIRMi022-A
DR   BioSamples; SAMEA112654329
DR   hPSCreg; CIRMi022-A
DR   Wikidata; Q123031031
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13034
AC   CVCL_D0B1
SY   CIRMi023-A
DR   BioSamples; SAMEA112654331
DR   hPSCreg; CIRMi023-A
DR   Wikidata; Q123031032
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13037
AC   CVCL_D0B2
SY   CIRMi024-A
DR   BioSamples; SAMEA112654333
DR   hPSCreg; CIRMi024-A
DR   Wikidata; Q123031033
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13038
AC   CVCL_D0B3
SY   CIRMi025-A
DR   BioSamples; SAMEA112654335
DR   hPSCreg; CIRMi025-A
DR   Wikidata; Q123031034
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13041
AC   CVCL_D0B4
SY   CIRMi026-A
DR   BioSamples; SAMEA112654337
DR   hPSCreg; CIRMi026-A
DR   Wikidata; Q123031035
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13042
AC   CVCL_D0B5
SY   CIRMi027-A
DR   BioSamples; SAMEA112654339
DR   hPSCreg; CIRMi027-A
DR   Wikidata; Q123031037
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13044
AC   CVCL_D0B6
SY   CIRMi028-A
DR   BioSamples; SAMEA112654341
DR   hPSCreg; CIRMi028-A
DR   Wikidata; Q123031038
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13045
AC   CVCL_D0B7
SY   CIRMi029-A
DR   BioSamples; SAMEA112654343
DR   hPSCreg; CIRMi029-A
DR   Wikidata; Q123031039
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13047
AC   CVCL_D0B8
SY   CIRMi030-A
DR   BioSamples; SAMEA112654354
DR   hPSCreg; CIRMi030-A
DR   Wikidata; Q123031041
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13048
AC   CVCL_D0B9
SY   CIRMi031-A
DR   BioSamples; SAMEA112654369
DR   hPSCreg; CIRMi031-A
DR   Wikidata; Q123031043
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13049
AC   CVCL_D0BA
SY   CIRMi032-A
DR   BioSamples; SAMEA112654371
DR   hPSCreg; CIRMi032-A
DR   Wikidata; Q123031044
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13052
AC   CVCL_D0BB
SY   CIRMi033-A
DR   BioSamples; SAMEA112654610
DR   hPSCreg; CIRMi033-A
DR   Wikidata; Q123031045
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13053
AC   CVCL_D0BC
SY   CIRMi034-A
DR   BioSamples; SAMEA112654812
DR   hPSCreg; CIRMi034-A
DR   Wikidata; Q123031046
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13054
AC   CVCL_D0BD
SY   CIRMi065-A
DR   BioSamples; SAMEA112655538
DR   hPSCreg; CIRMi065-A
DR   Wikidata; Q123031047
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13055
AC   CVCL_D0BE
SY   CIRMi035-A
DR   BioSamples; SAMEA112654814
DR   hPSCreg; CIRMi035-A
DR   Wikidata; Q123031048
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13060
AC   CVCL_D0BF
SY   CIRMi036-A
DR   BioSamples; SAMEA112654816
DR   hPSCreg; CIRMi036-A
DR   Wikidata; Q123031050
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13061
AC   CVCL_D0BG
SY   CIRMi037-A
DR   BioSamples; SAMEA112654818
DR   hPSCreg; CIRMi037-A
DR   Wikidata; Q123031051
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13063
AC   CVCL_D0BH
SY   CIRMi038-A
DR   BioSamples; SAMEA112654820
DR   hPSCreg; CIRMi038-A
DR   Wikidata; Q123031053
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13064
AC   CVCL_D0BI
SY   CIRMi039-A
DR   BioSamples; SAMEA112654822
DR   hPSCreg; CIRMi039-A
DR   Wikidata; Q123031054
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic and Native North American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13065
AC   CVCL_D0BJ
SY   CIRMi040-A
DR   BioSamples; SAMEA112654824
DR   hPSCreg; CIRMi040-A
DR   Wikidata; Q123031056
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13066
AC   CVCL_D0BK
SY   CIRMi041-A
DR   BioSamples; SAMEA112654826
DR   hPSCreg; CIRMi041-A
DR   Wikidata; Q123031058
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13067
AC   CVCL_D0BL
SY   CIRMi042-A
DR   BioSamples; SAMEA112655470
DR   hPSCreg; CIRMi042-A
DR   Wikidata; Q123031059
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13069
AC   CVCL_D0BM
SY   CIRMi066-A
DR   BioSamples; SAMEA112655540
DR   hPSCreg; CIRMi066-A
DR   Wikidata; Q123031060
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13070
AC   CVCL_D0BN
SY   CIRMi043-A
DR   BioSamples; SAMEA112655472
DR   hPSCreg; CIRMi043-A
DR   Wikidata; Q123031061
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13072
AC   CVCL_D0BP
SY   CIRMi044-A
DR   BioSamples; SAMEA112655474
DR   hPSCreg; CIRMi044-A
DR   Wikidata; Q123031062
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13073
AC   CVCL_D0BQ
SY   CIRMi045-A
DR   BioSamples; SAMEA112655476
DR   hPSCreg; CIRMi045-A
DR   Wikidata; Q123031063
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic and Native North American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13074
AC   CVCL_D0BR
SY   CIRMi046-A
DR   BioSamples; SAMEA112655478
DR   hPSCreg; CIRMi046-A
DR   Wikidata; Q123031064
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13075
AC   CVCL_D0BS
SY   CIRMi047-A
DR   BioSamples; SAMEA112655480
DR   hPSCreg; CIRMi047-A
DR   Wikidata; Q123031065
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13076
AC   CVCL_D0BT
SY   CIRMi048-A
DR   BioSamples; SAMEA112655482
DR   hPSCreg; CIRMi048-A
DR   Wikidata; Q123031066
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13077
AC   CVCL_D0BU
SY   CIRMi049-A
DR   BioSamples; SAMEA112655484
DR   hPSCreg; CIRMi049-A
DR   Wikidata; Q123031067
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13079
AC   CVCL_D0BV
SY   CIRMi050-A
DR   BioSamples; SAMEA112655486
DR   hPSCreg; CIRMi050-A
DR   Wikidata; Q123031068
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13088
AC   CVCL_D0BW
SY   CIRMi051-A
DR   BioSamples; SAMEA112655488
DR   hPSCreg; CIRMi051-A
DR   Wikidata; Q123031069
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13092
AC   CVCL_D0BX
SY   CIRMi052-A
DR   BioSamples; SAMEA112655490
DR   hPSCreg; CIRMi052-A
DR   Wikidata; Q123031070
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13093
AC   CVCL_D0BY
SY   CIRMi053-A
DR   BioSamples; SAMEA112655492
DR   hPSCreg; CIRMi053-A
DR   Wikidata; Q123031071
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13094
AC   CVCL_D0BZ
SY   CIRMi054-A
DR   BioSamples; SAMEA112655494
DR   hPSCreg; CIRMi054-A
DR   Wikidata; Q123031073
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13095
AC   CVCL_D0C0
SY   CIRMi055-A
DR   BioSamples; SAMEA112655496
DR   hPSCreg; CIRMi055-A
DR   Wikidata; Q123031074
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13097
AC   CVCL_D0C1
SY   CIRMi056-A
DR   BioSamples; SAMEA112655498
DR   hPSCreg; CIRMi056-A
DR   Wikidata; Q123031075
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13098
AC   CVCL_D0C2
SY   CIRMi057-A
DR   BioSamples; SAMEA112655500
DR   hPSCreg; CIRMi057-A
DR   Wikidata; Q123031076
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13105
AC   CVCL_D0C3
SY   CIRMi058-A
DR   BioSamples; SAMEA112655502
DR   hPSCreg; CIRMi058-A
DR   Wikidata; Q123031077
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13107
AC   CVCL_D0C4
SY   CIRMi059-A
DR   BioSamples; SAMEA112655504
DR   hPSCreg; CIRMi059-A
DR   Wikidata; Q123031078
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13108
AC   CVCL_D0C5
SY   CIRMi060-A
DR   BioSamples; SAMEA112655506
DR   hPSCreg; CIRMi060-A
DR   Wikidata; Q123031079
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13109
AC   CVCL_D0C6
SY   CIRMi061-A
DR   BioSamples; SAMEA112655508
DR   hPSCreg; CIRMi061-A
DR   Wikidata; Q123031080
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13111
AC   CVCL_D0C7
SY   CIRMi062-A
DR   BioSamples; SAMEA112655510
DR   hPSCreg; CIRMi062-A
DR   Wikidata; Q123031081
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13112
AC   CVCL_D0C8
SY   CIRMi063-A
DR   BioSamples; SAMEA112655512
DR   hPSCreg; CIRMi063-A
DR   Wikidata; Q123031082
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW13113
AC   CVCL_D0C9
SY   CIRMi064-A
DR   BioSamples; SAMEA112655514
DR   hPSCreg; CIRMi064-A
DR   Wikidata; Q123031083
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW1474
AC   CVCL_D4Z7
DR   ATCC; CRL-3529
DR   Wikidata; Q127380727
RX   PubMed=35934060;
RX   PubMed=37182784;
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft (PubMed=35934060).
CC   Doubling time: 41 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly279_Thr284del; Zygosity=Homozygous (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Doubling time, TP53 mutation, age at sampling and ethnic origin of patient from personal communication of Blum, Andrew E.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   CW20001
AC   CVCL_DI92
SY   CIRM-CW20001i-Affected; CIRMi13W-A
DR   BioSamples; SAMEA115401902
DR   Coriell; CW20001
DR   FCDI; CW20001
DR   hPSCreg; CIRMi13W-A
DR   SKIP; SKIP003660
DR   Wikidata; Q54815091
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20002
AC   CVCL_4Q71
SY   CIRM-CW20002i-Affected; CIRMi13X-A
DR   BioSamples; SAMEA115401904
DR   Coriell; CW20002
DR   FCDI; CW20002
DR   hPSCreg; CIRMi13X-A
DR   SKIP; SKIP003661
DR   Wikidata; Q54815092
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of CW20042 (Cellosaurus=CVCL_4Q82).
CC   Discontinued: Coriell; CW20002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 15
//
ID   CW20004
AC   CVCL_HG96
SY   CIRMi13Y-A
DR   BioSamples; SAMEA115401906
DR   Coriell; CW20004
DR   FCDI; CW20004
DR   hPSCreg; CIRMi13Y-A
DR   Wikidata; Q54815093
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20006
AC   CVCL_4Q72
SY   CIRM-CW20006i-Affected; CIRMi13Z-A
DR   BioSamples; SAMEA115401908
DR   Coriell; CW20006
DR   FCDI; CW20006
DR   hPSCreg; CIRMi13Z-A
DR   SKIP; SKIP003662
DR   Wikidata; Q54815094
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20006; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 11
//
ID   CW20008
AC   CVCL_4Q73
SY   CIRM-CW20008i-Affected; CIRMi14A-A
DR   BioSamples; SAMEA115401910
DR   Coriell; CW20008
DR   FCDI; CW20008
DR   hPSCreg; CIRMi14A-A
DR   SKIP; SKIP003663
DR   Wikidata; Q54815095
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20008; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 11
//
ID   CW20009
AC   CVCL_HG97
SY   CIRMi14B-A
DR   BioSamples; SAMEA115401912
DR   Coriell; CW20009
DR   FCDI; CW20009
DR   hPSCreg; CIRMi14B-A
DR   Wikidata; Q54815096
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20012
AC   CVCL_AN30
SY   CIRMi14C-A
DR   BioSamples; SAMEA115401914
DR   Coriell; CW20012
DR   FCDI; CW20012
DR   hPSCreg; CIRMi14C-A
DR   Wikidata; Q54815097
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20012; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 10
//
ID   CW20013
AC   CVCL_4Q74
SY   CIRM-CW20013i-Affected
DR   Coriell; CW20013
DR   FCDI; CW20013
DR   SKIP; SKIP003664
DR   Wikidata; Q54815098
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW20013; true.
CC   Discontinued: FCDI; CW20013; probable.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW20015
AC   CVCL_HG98
SY   CIRMi14D-A
DR   BioSamples; SAMEA115401916
DR   Coriell; CW20015
DR   FCDI; CW20015
DR   hPSCreg; CIRMi14D-A
DR   Wikidata; Q54815099
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20015; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20016
AC   CVCL_DI93
SY   CIRM-CW20016i-Ctl; CIRMi14E-A
DR   BioSamples; SAMEA115401918
DR   Coriell; CW20016
DR   FCDI; CW20016
DR   hPSCreg; CIRMi14E-A
DR   SKIP; SKIP003665
DR   Wikidata; Q54815100
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20016; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 15
//
ID   CW20020
AC   CVCL_DI94
SY   CIRMi14F-A
DR   BioSamples; SAMEA115401920
DR   Coriell; CW20020
DR   FCDI; CW20020
DR   hPSCreg; CIRMi14F-A
DR   Wikidata; Q54815101
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20020; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20021
AC   CVCL_HG99
SY   CIRMi14G-A
DR   BioSamples; SAMEA115401922
DR   Coriell; CW20021
DR   FCDI; CW20021
DR   hPSCreg; CIRMi14G-A
DR   Wikidata; Q54815102
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20021; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 8
//
ID   CW20023
AC   CVCL_4Q75
SY   CIRM-CW20023i-Ctl; CIRMi14H-A
DR   BioSamples; SAMEA115401924
DR   Coriell; CW20023
DR   FCDI; CW20023
DR   hPSCreg; CIRMi14H-A
DR   SKIP; SKIP003666
DR   Wikidata; Q54815103
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20023; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20025
AC   CVCL_4Q76
SY   CIRM-CW20025i-Affected; CIRMi14I-A
DR   BioSamples; SAMEA115401926
DR   Coriell; CW20025
DR   FCDI; CW20025
DR   hPSCreg; CIRMi14I-A
DR   SKIP; SKIP003667
DR   Wikidata; Q54815104
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20025; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20026
AC   CVCL_DI95
SY   CIRM-CW20026i-Affected; CIRMi14J-A
DR   BioSamples; SAMEA115401928
DR   Coriell; CW20026
DR   FCDI; CW20026
DR   hPSCreg; CIRMi14J-A
DR   SKIP; SKIP003668
DR   Wikidata; Q54815109
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20026; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20027
AC   CVCL_4Q77
SY   CIRM-CW20027i-Ctl; CIRMi14K-A
DR   BioSamples; SAMEA115401930
DR   Coriell; CW20027
DR   FCDI; CW20027
DR   hPSCreg; CIRMi14K-A
DR   SKIP; SKIP003669
DR   Wikidata; Q54815110
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20027; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20029
AC   CVCL_HH00
SY   CIRMi14L-A
DR   BioSamples; SAMEA115401932
DR   Coriell; CW20029
DR   FCDI; CW20029
DR   hPSCreg; CIRMi14L-A
DR   Wikidata; Q54815111
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20029; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 8
//
ID   CW20030
AC   CVCL_DI96
SY   CIRM-CW20030i-Affected; CIRMi14M-A
DR   BioSamples; SAMEA115401934
DR   Coriell; CW20030
DR   FCDI; CW20030
DR   hPSCreg; CIRMi14M-A
DR   SKIP; SKIP003670
DR   Wikidata; Q54815112
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20030; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 11
//
ID   CW20031
AC   CVCL_4Q78
SY   CIRM-CW20031i-Affected; CIRMi14N-A
DR   BioSamples; SAMEA115401936
DR   Coriell; CW20031
DR   FCDI; CW20031
DR   hPSCreg; CIRMi14N-A
DR   SKIP; SKIP003671
DR   Wikidata; Q54815113
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20031; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 15
//
ID   CW20032
AC   CVCL_4Q79
SY   CIRM-CW20032i-Ctl; CIRMi14O-A
DR   BioSamples; SAMEA115401938
DR   Coriell; CW20032
DR   FCDI; CW20032
DR   hPSCreg; CIRMi14O-A
DR   SKIP; SKIP003672
DR   Wikidata; Q54815114
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20032; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 15
//
ID   CW20033
AC   CVCL_DI97
SY   CIRM-CW20033i-Ctl; CIRMi14P-A
DR   BioSamples; SAMEA115401940
DR   Coriell; CW20033
DR   FCDI; CW20033
DR   hPSCreg; CIRMi14P-A
DR   SKIP; SKIP003673
DR   Wikidata; Q54815115
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW20033; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 12
//
ID   CW20034
AC   CVCL_4Q80
SY   CIRM-CW20034i-Affected; CIRMi14Q-A
DR   BioSamples; SAMEA115401942
DR   Coriell; CW20034
DR   FCDI; CW20034
DR   hPSCreg; CIRMi14Q-A
DR   SKIP; SKIP003674
DR   Wikidata; Q54815116
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20034; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20035
AC   CVCL_4Q81
SY   CIRM-CW20035i-Affected; CIRMi14R-A
DR   BioSamples; SAMEA115401944
DR   Coriell; CW20035
DR   FCDI; CW20035
DR   hPSCreg; CIRMi14R-A
DR   SKIP; SKIP003675
DR   Wikidata; Q54815117
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20035; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20039
AC   CVCL_HH01
SY   CIRMi14S-A
DR   BioSamples; SAMEA115401946
DR   Coriell; CW20039
DR   FCDI; CW20039
DR   hPSCreg; CIRMi14S-A
DR   Wikidata; Q54815119
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20039; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20041
AC   CVCL_HH02
SY   CIRMi14T-A
DR   BioSamples; SAMEA115401948
DR   Coriell; CW20041
DR   FCDI; CW20041
DR   hPSCreg; CIRMi14T-A
DR   Wikidata; Q54815120
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20041; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20042
AC   CVCL_4Q82
SY   CIRM-CW20042i-Affected; CIRMi14U-A
DR   BioSamples; SAMEA115401950
DR   Coriell; CW20042
DR   FCDI; CW20042
DR   hPSCreg; CIRMi14U-A
DR   SKIP; SKIP003676
DR   Wikidata; Q54815121
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of CW20002 (Cellosaurus=CVCL_4Q71).
CC   Discontinued: Coriell; CW20042; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 15
//
ID   CW20043
AC   CVCL_DI98
SY   CIRM-CW20043i-Ctl; CIRMi14V-A
DR   BioSamples; SAMEA115401952
DR   Coriell; CW20043
DR   FCDI; CW20043
DR   hPSCreg; CIRMi14V-A
DR   SKIP; SKIP003677
DR   Wikidata; Q54815122
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20043; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20044
AC   CVCL_DI99
SY   CIRM-CW20044i-Affected; CIRMi14W-A
DR   BioSamples; SAMEA115401954
DR   Coriell; CW20044
DR   FCDI; CW20044
DR   hPSCreg; CIRMi14W-A
DR   SKIP; SKIP003678
DR   Wikidata; Q54815123
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20044; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20046
AC   CVCL_4Q83
SY   CIRM-CW20046i-Affected; CIRMi14X-A
DR   BioSamples; SAMEA115401956
DR   Coriell; CW20046
DR   FCDI; CW20046
DR   hPSCreg; CIRMi14X-A
DR   SKIP; SKIP003679
DR   Wikidata; Q54815124
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20046; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20047
AC   CVCL_4Q84
SY   CIRM-CW20047i-Ctl; CIRMi14Y-A
DR   BioSamples; SAMEA115401958
DR   Coriell; CW20047
DR   FCDI; CW20047
DR   hPSCreg; CIRMi14Y-A
DR   SKIP; SKIP003680
DR   Wikidata; Q54815125
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20047; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20048
AC   CVCL_DJ00
SY   CIRM-CW20048i-Ctl; CIRMi14Z-A
DR   BioSamples; SAMEA115401960
DR   Coriell; CW20048
DR   FCDI; CW20048
DR   hPSCreg; CIRMi14Z-A
DR   SKIP; SKIP003681
DR   Wikidata; Q54815127
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20048; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20049
AC   CVCL_DJ01
SY   CIRM-CW20049i-Ctl; CIRMi15A-A
DR   BioSamples; SAMEA115401962
DR   Coriell; CW20049
DR   FCDI; CW20049
DR   hPSCreg; CIRMi15A-A
DR   SKIP; SKIP003682
DR   Wikidata; Q54815128
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20049; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20050
AC   CVCL_4Q85
SY   CIRMi15B-A
DR   BioSamples; SAMEA115401964
DR   Coriell; CW20050
DR   FCDI; CW20050
DR   hPSCreg; CIRMi15B-A
DR   Wikidata; Q54815129
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20050; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 10
//
ID   CW20051
AC   CVCL_4Q86
SY   CIRM-CW20051i-Ctl; CIRMi15C-A
DR   BioSamples; SAMEA115401966
DR   Coriell; CW20051
DR   FCDI; CW20051
DR   hPSCreg; CIRMi15C-A
DR   SKIP; SKIP003683
DR   Wikidata; Q54815130
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20051; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20052
AC   CVCL_DJ02
SY   CIRM-CW20052i-Ctl; CIRMi15D-A
DR   BioSamples; SAMEA115401968
DR   Coriell; CW20052
DR   FCDI; CW20052
DR   hPSCreg; CIRMi15D-A
DR   SKIP; SKIP003684
DR   Wikidata; Q54815131
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20052; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   CW20053
AC   CVCL_HH03
SY   CIRMi15E-A
DR   BioSamples; SAMEA115401970
DR   Coriell; CW20053
DR   FCDI; CW20053
DR   hPSCreg; CIRMi15E-A
DR   Wikidata; Q54815132
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20053; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20054
AC   CVCL_HH04
SY   CIRMi15F-A
DR   BioSamples; SAMEA115401972
DR   Coriell; CW20054
DR   FCDI; CW20054
DR   hPSCreg; CIRMi15F-A
DR   Wikidata; Q54815133
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20054; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20055
AC   CVCL_DJ03
SY   CIRM-CW20055i-Affected; CIRMi15G-A
DR   BioSamples; SAMEA115401974
DR   Coriell; CW20055
DR   FCDI; CW20055
DR   hPSCreg; CIRMi15G-A
DR   SKIP; SKIP003685
DR   Wikidata; Q54815134
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20055; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20056
AC   CVCL_DJ04
SY   CIRM-CW20056i-Ctl; CIRMi15H-A
DR   BioSamples; SAMEA115401976
DR   Coriell; CW20056
DR   FCDI; CW20056
DR   hPSCreg; CIRMi15H-A
DR   SKIP; SKIP003686
DR   Wikidata; Q54815136
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20056; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20057
AC   CVCL_DJ05
SY   CIRM-CW20057i-Ctl; CIRMi15I-A
DR   BioSamples; SAMEA115401978
DR   Coriell; CW20057
DR   FCDI; CW20057
DR   hPSCreg; CIRMi15I-A
DR   SKIP; SKIP003687
DR   Wikidata; Q54815137
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20057; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20058
AC   CVCL_DJ06
SY   CIRM-CW20058i-Ctl; CIRMi15J-A
DR   BioSamples; SAMEA115401980
DR   Coriell; CW20058
DR   FCDI; CW20058
DR   hPSCreg; CIRMi15J-A
DR   SKIP; SKIP003688
DR   Wikidata; Q54815138
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20058; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20061
AC   CVCL_JH54
SY   CIRMi15K-A
DR   BioSamples; SAMEA115401982
DR   Coriell; CW20061
DR   FCDI; CW20061
DR   hPSCreg; CIRMi15K-A
DR   Wikidata; Q54815139
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20061; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20062
AC   CVCL_DJ07
SY   CIRMi15L-A
DR   BioSamples; SAMEA115401984
DR   Coriell; CW20062
DR   FCDI; CW20062
DR   hPSCreg; CIRMi15L-A
DR   Wikidata; Q54815140
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20062; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20063
AC   CVCL_JH55
SY   CIRMi15M-A
DR   BioSamples; SAMEA115401986
DR   Coriell; CW20063
DR   FCDI; CW20063
DR   hPSCreg; CIRMi15M-A
DR   Wikidata; Q54815142
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20063; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20065
AC   CVCL_DJ08
SY   CIRM-CW20065i-Affected; CIRMi15N-A
DR   BioSamples; SAMEA115401988
DR   Coriell; CW20065
DR   FCDI; CW20065
DR   hPSCreg; CIRMi15N-A
DR   SKIP; SKIP003689
DR   Wikidata; Q54815143
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20065; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20068
AC   CVCL_DJ09
SY   CIRM-CW20068i-Ctl; CIRMi15O-A
DR   BioSamples; SAMEA115401990
DR   Coriell; CW20068
DR   FCDI; CW20068
DR   hPSCreg; CIRMi15O-A
DR   SKIP; SKIP003690
DR   Wikidata; Q54815144
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20068; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20069
AC   CVCL_HH05
SY   CIRMi15P-A
DR   BioSamples; SAMEA115401992
DR   Coriell; CW20069
DR   FCDI; CW20069
DR   hPSCreg; CIRMi15P-A
DR   Wikidata; Q54815145
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20069; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20070
AC   CVCL_4Q87
SY   CIRM-CW20070i-Affected; CIRMi15Q-A
DR   BioSamples; SAMEA115401994
DR   Coriell; CW20070
DR   FCDI; CW20070
DR   hPSCreg; CIRMi15Q-A
DR   SKIP; SKIP003691
DR   Wikidata; Q54815146
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20070; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW20072
AC   CVCL_DJ10
SY   CIRM-CW20072i-Affected
DR   Coriell; CW20072
DR   SKIP; SKIP003692
DR   Wikidata; Q54815147
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW20072; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW20073
AC   CVCL_JH56
SY   CIRMi15R-A
DR   BioSamples; SAMEA115401996
DR   Coriell; CW20073
DR   FCDI; CW20073
DR   hPSCreg; CIRMi15R-A
DR   Wikidata; Q54815149
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20073; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20074
AC   CVCL_DJ11
SY   CIRM-CW20074i-Ctl; CIRMi15S-A
DR   BioSamples; SAMEA115402056
DR   Coriell; CW20074
DR   FCDI; CW20074
DR   hPSCreg; CIRMi15S-A
DR   SKIP; SKIP003693
DR   Wikidata; Q54815150
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20074; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20075
AC   CVCL_DJ12
SY   CIRM-CW20075i-Ctl; CIRMi15T-A
DR   BioSamples; SAMEA115402116
DR   Coriell; CW20075
DR   FCDI; CW20075
DR   hPSCreg; CIRMi15T-A
DR   SKIP; SKIP003694
DR   Wikidata; Q54815151
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20075; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20076
AC   CVCL_DJ13
SY   CIRMi15U-A
DR   BioSamples; SAMEA115402118
DR   Coriell; CW20076
DR   FCDI; CW20076
DR   hPSCreg; CIRMi15U-A
DR   Wikidata; Q54815152
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20076; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20077
AC   CVCL_DJ14
SY   CIRM-CW20077i-Ctl; CIRMi15V-A
DR   BioSamples; SAMEA115402120
DR   Coriell; CW20077
DR   FCDI; CW20077
DR   hPSCreg; CIRMi15V-A
DR   SKIP; SKIP003695
DR   Wikidata; Q54815153
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20077; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20078
AC   CVCL_DJ15
SY   CIRM-CW20078i-Ctl; CIRMi15W-A
DR   BioSamples; SAMEA115402122
DR   Coriell; CW20078
DR   FCDI; CW20078
DR   hPSCreg; CIRMi15W-A
DR   SKIP; SKIP003696
DR   Wikidata; Q54815174
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian and Chinese.
CC   Discontinued: Coriell; CW20078; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20079
AC   CVCL_JH57
SY   CIRMi15X-A
DR   BioSamples; SAMEA115402124
DR   Coriell; CW20079
DR   FCDI; CW20079
DR   hPSCreg; CIRMi15X-A
DR   Wikidata; Q54815175
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20079; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20080
AC   CVCL_DJ16
SY   CIRM-CW20080i-Ctl; CIRMi15Y-A
DR   BioSamples; SAMEA115402126
DR   Coriell; CW20080
DR   FCDI; CW20080
DR   hPSCreg; CIRMi15Y-A
DR   SKIP; SKIP003697
DR   Wikidata; Q54815176
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20080; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20081
AC   CVCL_DJ17
SY   CIRM-CW20081i-Affected; CIRMi15Z-A
DR   BioSamples; SAMEA115402128
DR   Coriell; CW20081
DR   FCDI; CW20081
DR   hPSCreg; CIRMi15Z-A
DR   SKIP; SKIP003698
DR   Wikidata; Q54815177
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20081; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20083
AC   CVCL_DJ18
SY   CIRM-CW20083i-Affected; CIRMi16A-A
DR   BioSamples; SAMEA115402130
DR   Coriell; CW20083
DR   FCDI; CW20083
DR   hPSCreg; CIRMi16A-A
DR   SKIP; SKIP003699
DR   Wikidata; Q54815178
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20083; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20084
AC   CVCL_DJ19
SY   CIRM-CW20084i-Ctl; CIRMi16B-A
DR   BioSamples; SAMEA115402132
DR   Coriell; CW20084
DR   FCDI; CW20084
DR   hPSCreg; CIRMi16B-A
DR   SKIP; SKIP003700
DR   Wikidata; Q54815179
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20084; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20085
AC   CVCL_DJ20
SY   CIRMi16C-A
DR   BioSamples; SAMEA115402134
DR   Coriell; CW20085
DR   FCDI; CW20085
DR   hPSCreg; CIRMi16C-A
DR   Wikidata; Q54815180
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20085; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20087
AC   CVCL_HH06
SY   CIRMi16D-A
DR   BioSamples; SAMEA115402136
DR   Coriell; CW20087
DR   FCDI; CW20087
DR   hPSCreg; CIRMi16D-A
DR   Wikidata; Q54815181
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20087; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20088
AC   CVCL_DJ21
SY   CIRM-CW20088i-Ctl; CIRMi16E-A
DR   BioSamples; SAMEA115402138
DR   Coriell; CW20088
DR   FCDI; CW20088
DR   hPSCreg; CIRMi16E-A
DR   SKIP; SKIP003701
DR   Wikidata; Q54815182
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20088; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20090
AC   CVCL_DJ22
SY   CIRM-CW20090i-Affected
DR   Coriell; CW20090
DR   FCDI; CW20090
DR   SKIP; SKIP003702
DR   Wikidata; Q54815183
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW20090; true.
CC   Discontinued: FCDI; CW20090; probable.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW20091
AC   CVCL_JH59
SY   CIRMi16F-A
DR   BioSamples; SAMEA115402140
DR   Coriell; CW20091
DR   FCDI; CW20091
DR   hPSCreg; CIRMi16F-A
DR   Wikidata; Q54815184
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20091; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20092
AC   CVCL_JH60
SY   CIRMi16G-A
DR   BioSamples; SAMEA115402142
DR   Coriell; CW20092
DR   FCDI; CW20092
DR   hPSCreg; CIRMi16G-A
DR   Wikidata; Q54815185
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20092; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20094
AC   CVCL_JH61
SY   CIRMi16H-A
DR   BioSamples; SAMEA115402144
DR   Coriell; CW20094
DR   FCDI; CW20094
DR   hPSCreg; CIRMi16H-A
DR   Wikidata; Q54815186
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20094; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20095
AC   CVCL_RV45
SY   CIRMi16I-A
DR   BioSamples; SAMEA115402146
DR   Coriell; CW20095
DR   FCDI; CW20095
DR   hPSCreg; CIRMi16I-A
DR   Wikidata; Q54815187
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20095; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20098
AC   CVCL_DJ23
SY   CIRM-CW20098i-Ctl; CIRMi16J-A
DR   BioSamples; SAMEA115402148
DR   Coriell; CW20098
DR   FCDI; CW20098
DR   hPSCreg; CIRMi16J-A
DR   SKIP; SKIP003703
DR   Wikidata; Q54815188
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20098; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20099
AC   CVCL_DJ24
SY   CIRM-CW20099i-Ctl; CIRMi16K-A
DR   BioSamples; SAMEA115402150
DR   Coriell; CW20099
DR   FCDI; CW20099
DR   hPSCreg; CIRMi16K-A
DR   SKIP; SKIP003704
DR   Wikidata; Q54815189
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20099; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20100
AC   CVCL_RV46
SY   CIRMi16L-A
DR   BioSamples; SAMEA115402152
DR   Coriell; CW20100
DR   FCDI; CW20100
DR   hPSCreg; CIRMi16L-A
DR   Wikidata; Q54815190
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20101
AC   CVCL_RV47
SY   CIRMi16M-A
DR   BioSamples; SAMEA115402154
DR   Coriell; CW20101
DR   FCDI; CW20101
DR   hPSCreg; CIRMi16M-A
DR   Wikidata; Q54815191
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20103
AC   CVCL_HH07
SY   CIRMi16N-A
DR   BioSamples; SAMEA115402156
DR   Coriell; CW20103
DR   FCDI; CW20103
DR   hPSCreg; CIRMi16N-A
DR   Wikidata; Q54815192
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20104
AC   CVCL_LI60
SY   CIRMi16O-A
DR   BioSamples; SAMEA115402158
DR   Coriell; CW20104
DR   FCDI; CW20104
DR   hPSCreg; CIRMi16O-A
DR   Wikidata; Q54815193
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 10
//
ID   CW20105
AC   CVCL_HH08
SY   CIRMi16P-A
DR   BioSamples; SAMEA115402160
DR   Coriell; CW20105
DR   FCDI; CW20105
DR   hPSCreg; CIRMi16P-A
DR   Wikidata; Q54815194
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20106
AC   CVCL_DJ25
SY   CIRMi16Q-A
DR   BioSamples; SAMEA115402162
DR   Coriell; CW20106
DR   FCDI; CW20106
DR   hPSCreg; CIRMi16Q-A
DR   Wikidata; Q54815195
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20107
AC   CVCL_JH62
SY   CIRMi16R-A
DR   BioSamples; SAMEA115402164
DR   Coriell; CW20107
DR   FCDI; CW20107
DR   hPSCreg; CIRMi16R-A
DR   Wikidata; Q54815196
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20108
AC   CVCL_JH63
SY   CIRMi16S-A
DR   BioSamples; SAMEA115402166
DR   Coriell; CW20108
DR   FCDI; CW20108
DR   hPSCreg; CIRMi16S-A
DR   Wikidata; Q54815197
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20109
AC   CVCL_DJ26
SY   CIRM-CW20109i-Ctl; CIRMi16T-A
DR   BioSamples; SAMEA115402168
DR   Coriell; CW20109
DR   FCDI; CW20109
DR   hPSCreg; CIRMi16T-A
DR   SKIP; SKIP003705
DR   Wikidata; Q54815198
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20110
AC   CVCL_DJ27
SY   CIRM-CW20110i-Ctl; CIRMi16U-A
DR   BioSamples; SAMEA115402170
DR   Coriell; CW20110
DR   FCDI; CW20110
DR   hPSCreg; CIRMi16U-A
DR   SKIP; SKIP003706
DR   Wikidata; Q54815199
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20111
AC   CVCL_HH09
SY   CIRMi16V-A
DR   BioSamples; SAMEA115402172
DR   Coriell; CW20111
DR   FCDI; CW20111
DR   hPSCreg; CIRMi16V-A
DR   Wikidata; Q54815200
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20112
AC   CVCL_RV48
SY   CIRMi16W-A
DR   BioSamples; SAMEA115402174
DR   Coriell; CW20112
DR   FCDI; CW20112
DR   hPSCreg; CIRMi16W-A
DR   Wikidata; Q54815201
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20115
AC   CVCL_DJ28
SY   CIRM-CW20115i-Ctl; CIRMi16X-A
DR   BioSamples; SAMEA115402176
DR   Coriell; CW20115
DR   FCDI; CW20115
DR   hPSCreg; CIRMi16X-A
DR   SKIP; SKIP003707
DR   Wikidata; Q54815202
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20116
AC   CVCL_JH64
SY   CIRMi16Y-A
DR   BioSamples; SAMEA115402178
DR   Coriell; CW20116
DR   FCDI; CW20116
DR   hPSCreg; CIRMi16Y-A
DR   Wikidata; Q54815203
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20118
AC   CVCL_DJ29
SY   CIRM-CW20118i-Ctl; CIRMi16Z-A
DR   BioSamples; SAMEA115402180
DR   Coriell; CW20118
DR   FCDI; CW20118
DR   hPSCreg; CIRMi16Z-A
DR   SKIP; SKIP003708
DR   Wikidata; Q54815204
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20121
AC   CVCL_RV49
SY   CIRMi17A-A
DR   BioSamples; SAMEA115402182
DR   Coriell; CW20121
DR   FCDI; CW20121
DR   hPSCreg; CIRMi17A-A
DR   Wikidata; Q54815205
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20122
AC   CVCL_DJ30
SY   CIRM-CW20122i-Ctl; CIRMi17B-A
DR   BioSamples; SAMEA115402184
DR   Coriell; CW20122
DR   FCDI; CW20122
DR   hPSCreg; CIRMi17B-A
DR   SKIP; SKIP003709
DR   Wikidata; Q54815206
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW20122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20123
AC   CVCL_JH65
SY   CIRMi17C-A
DR   BioSamples; SAMEA115402186
DR   Coriell; CW20123
DR   FCDI; CW20123
DR   hPSCreg; CIRMi17C-A
DR   Wikidata; Q54815207
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Nepali.
CC   Discontinued: Coriell; CW20123; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20124
AC   CVCL_HH10
SY   CIRMi17D-A
DR   BioSamples; SAMEA115402188
DR   Coriell; CW20124
DR   FCDI; CW20124
DR   hPSCreg; CIRMi17D-A
DR   Wikidata; Q54815208
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20124; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20125
AC   CVCL_RV50
SY   CIRMi17E-A
DR   BioSamples; SAMEA115402190
DR   Coriell; CW20125
DR   FCDI; CW20125
DR   hPSCreg; CIRMi17E-A
DR   Wikidata; Q54815209
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20125; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20126
AC   CVCL_HH11
SY   CIRMi17F-A
DR   BioSamples; SAMEA115402192
DR   Coriell; CW20126
DR   FCDI; CW20126
DR   hPSCreg; CIRMi17F-A
DR   Wikidata; Q54815210
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20128
AC   CVCL_DJ31
SY   CIRM-CW20128i-Ctl; CIRMi17G-A
DR   BioSamples; SAMEA115402194
DR   Coriell; CW20128
DR   FCDI; CW20128
DR   hPSCreg; CIRMi17G-A
DR   SKIP; SKIP003710
DR   Wikidata; Q54815211
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   CW20129
AC   CVCL_HH12
SY   CIRMi17H-A
DR   BioSamples; SAMEA115402196
DR   Coriell; CW20129
DR   FCDI; CW20129
DR   hPSCreg; CIRMi17H-A
DR   Wikidata; Q54815212
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20129; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20131
AC   CVCL_HH13
SY   CIRMi17I-A
DR   BioSamples; SAMEA115402198
DR   Coriell; CW20131
DR   FCDI; CW20131
DR   hPSCreg; CIRMi17I-A
DR   Wikidata; Q54815214
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20131; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 8
//
ID   CW20132
AC   CVCL_DJ32
SY   CIRM-CW20132i-Ctl; CIRMi17J-A
DR   BioSamples; SAMEA115402200
DR   Coriell; CW20132
DR   FCDI; CW20132
DR   hPSCreg; CIRMi17J-A
DR   SKIP; SKIP003711
DR   Wikidata; Q54815224
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20133
AC   CVCL_HH14
SY   CIRMi17K-A
DR   BioSamples; SAMEA115402202
DR   Coriell; CW20133
DR   FCDI; CW20133
DR   hPSCreg; CIRMi17K-A
DR   Wikidata; Q54815225
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20135
AC   CVCL_DJ33
SY   CIRM-CW20135i-Affected; CIRMi17L-A
DR   BioSamples; SAMEA115402204
DR   Coriell; CW20135
DR   FCDI; CW20135
DR   hPSCreg; CIRMi17L-A
DR   SKIP; SKIP003712
DR   Wikidata; Q54815226
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20135; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20136
AC   CVCL_HH15
SY   CIRMi17M-A
DR   BioSamples; SAMEA115402206
DR   Coriell; CW20136
DR   FCDI; CW20136
DR   hPSCreg; CIRMi17M-A
DR   Wikidata; Q54815227
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Nepali.
CC   Discontinued: Coriell; CW20136; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20137
AC   CVCL_DJ34
SY   CIRM-CW20137i-Ctl; CIRMi17N-A
DR   BioSamples; SAMEA115402208
DR   Coriell; CW20137
DR   FCDI; CW20137
DR   hPSCreg; CIRMi17N-A
DR   SKIP; SKIP003713
DR   Wikidata; Q54815228
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20137; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20139
AC   CVCL_JH66
SY   CIRMi17O-A
DR   BioSamples; SAMEA115402210
DR   Coriell; CW20139
DR   FCDI; CW20139
DR   hPSCreg; CIRMi17O-A
DR   Wikidata; Q54815229
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20139; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20140
AC   CVCL_HH16
SY   CIRMi17P-A
DR   BioSamples; SAMEA115402212
DR   Coriell; CW20140
DR   FCDI; CW20140
DR   hPSCreg; CIRMi17P-A
DR   Wikidata; Q54815230
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20141
AC   CVCL_HH17
SY   CIRMi17Q-A
DR   BioSamples; SAMEA115402214
DR   Coriell; CW20141
DR   FCDI; CW20141
DR   hPSCreg; CIRMi17Q-A
DR   Wikidata; Q54815231
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20141; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20142
AC   CVCL_DJ35
SY   CIRM-CW20142i-Affected; CIRMi17R-A
DR   BioSamples; SAMEA115402216
DR   Coriell; CW20142
DR   FCDI; CW20142
DR   hPSCreg; CIRMi17R-A
DR   SKIP; SKIP003714
DR   Wikidata; Q54815232
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20142; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20144
AC   CVCL_JH67
SY   CIRMi17S-A
DR   BioSamples; SAMEA115402218
DR   Coriell; CW20144
DR   FCDI; CW20144
DR   hPSCreg; CIRMi17S-A
DR   Wikidata; Q54815233
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20146
AC   CVCL_DJ36
SY   CIRM-CW20146i-Ctl; CIRMi17T-A
DR   BioSamples; SAMEA115402220
DR   Coriell; CW20146
DR   FCDI; CW20146
DR   hPSCreg; CIRMi17T-A
DR   SKIP; SKIP003715
DR   Wikidata; Q54815234
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20146; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW20149
AC   CVCL_DJ37
SY   CIRMi17U-A
DR   BioSamples; SAMEA115402222
DR   Coriell; CW20149
DR   FCDI; CW20149
DR   hPSCreg; CIRMi17U-A
DR   Wikidata; Q54815235
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20150
AC   CVCL_RV51
SY   CIRMi17V-A
DR   BioSamples; SAMEA115402224
DR   Coriell; CW20150
DR   FCDI; CW20150
DR   hPSCreg; CIRMi17V-A
DR   Wikidata; Q54815236
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20150; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20151
AC   CVCL_DJ38
SY   CIRMi17W-A
DR   BioSamples; SAMEA115402226
DR   Coriell; CW20151
DR   FCDI; CW20151
DR   hPSCreg; CIRMi17W-A
DR   Wikidata; Q54815237
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20151; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20152
AC   CVCL_HH18
SY   CIRMi17X-A
DR   BioSamples; SAMEA115402228
DR   Coriell; CW20152
DR   FCDI; CW20152
DR   hPSCreg; CIRMi17X-A
DR   Wikidata; Q54815238
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20152; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20153
AC   CVCL_HH19
SY   CIRMi17Y-A
DR   BioSamples; SAMEA115402230
DR   Coriell; CW20153
DR   FCDI; CW20153
DR   hPSCreg; CIRMi17Y-A
DR   Wikidata; Q54815239
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Japanese.
CC   Discontinued: Coriell; CW20153; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20156
AC   CVCL_RV52
SY   CIRMi17Z-A
DR   BioSamples; SAMEA115402232
DR   Coriell; CW20156
DR   FCDI; CW20156
DR   hPSCreg; CIRMi17Z-A
DR   Wikidata; Q54815240
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20156; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20158
AC   CVCL_RV53
SY   CIRMi18A-A
DR   BioSamples; SAMEA115402234
DR   Coriell; CW20158
DR   FCDI; CW20158
DR   hPSCreg; CIRMi18A-A
DR   Wikidata; Q54815241
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20158; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20164
AC   CVCL_JH68
SY   CIRMi18B-A
DR   BioSamples; SAMEA115402236
DR   Coriell; CW20164
DR   FCDI; CW20164
DR   hPSCreg; CIRMi18B-A
DR   Wikidata; Q54815242
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese; Taiwan.
CC   Discontinued: Coriell; CW20164; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20166
AC   CVCL_JH69
SY   CIRMi18C-A
DR   BioSamples; SAMEA115402238
DR   Coriell; CW20166
DR   FCDI; CW20166
DR   hPSCreg; CIRMi18C-A
DR   Wikidata; Q54815243
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20166; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20167
AC   CVCL_JH70
SY   CIRMi18D-A
DR   BioSamples; SAMEA115402241
DR   Coriell; CW20167
DR   FCDI; CW20167
DR   hPSCreg; CIRMi18D-A
DR   Wikidata; Q54815244
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20170
AC   CVCL_LI61
SY   CIRMi18E-A
DR   BioSamples; SAMEA115402243
DR   Coriell; CW20170
DR   FCDI; CW20170
DR   hPSCreg; CIRMi18E-A
DR   Wikidata; Q54815245
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW20170; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 10
//
ID   CW20178
AC   CVCL_JH71
SY   CIRMi18F-A
DR   BioSamples; SAMEA115402245
DR   Coriell; CW20178
DR   FCDI; CW20178
DR   hPSCreg; CIRMi18F-A
DR   Wikidata; Q54815246
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20178; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20179
AC   CVCL_RV54
SY   CIRMi18G-A
DR   BioSamples; SAMEA115402247
DR   Coriell; CW20179
DR   FCDI; CW20179
DR   hPSCreg; CIRMi18G-A
DR   Wikidata; Q54815247
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20179; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20181
AC   CVCL_RV55
SY   CIRMi18H-A
DR   BioSamples; SAMEA115402249
DR   Coriell; CW20181
DR   FCDI; CW20181
DR   hPSCreg; CIRMi18H-A
DR   Wikidata; Q54815248
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20181; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20183
AC   CVCL_HH20
SY   CIRMi18I-A
DR   BioSamples; SAMEA115402251
DR   Coriell; CW20183
DR   FCDI; CW20183
DR   hPSCreg; CIRMi18I-A
DR   Wikidata; Q54815249
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20183; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20184
AC   CVCL_HH21
SY   high_PRS_3; CIRMi18J-A
DR   BioSamples; SAMEA115402253
DR   Coriell; CW20184
DR   FCDI; CW20184
DR   hPSCreg; CIRMi18J-A
DR   Wikidata; Q54815250
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally high polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW20184; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20185
AC   CVCL_RV56
SY   CIRMi18K-A
DR   BioSamples; SAMEA115402255
DR   Coriell; CW20185
DR   FCDI; CW20185
DR   hPSCreg; CIRMi18K-A
DR   Wikidata; Q54815251
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20185; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20186
AC   CVCL_RV57
SY   CIRMi18L-A
DR   BioSamples; SAMEA115402257
DR   Coriell; CW20186
DR   FCDI; CW20186
DR   hPSCreg; CIRMi18L-A
DR   Wikidata; Q54815252
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20186; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20188
AC   CVCL_RV58
SY   CIRMi18M-A
DR   BioSamples; SAMEA115402259
DR   Coriell; CW20188
DR   FCDI; CW20188
DR   hPSCreg; CIRMi18M-A
DR   Wikidata; Q54815253
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20188; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20192
AC   CVCL_HH22
SY   CIRMi18N-A
DR   BioSamples; SAMEA115402261
DR   Coriell; CW20192
DR   FCDI; CW20192
DR   hPSCreg; CIRMi18N-A
DR   Wikidata; Q54815254
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20192; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20193
AC   CVCL_JH72
SY   CIRMi18O-A
DR   BioSamples; SAMEA115402263
DR   Coriell; CW20193
DR   FCDI; CW20193
DR   hPSCreg; CIRMi18O-A
DR   Wikidata; Q54815255
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20193; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20195
AC   CVCL_RV59
SY   CIRMi18P-A
DR   BioSamples; SAMEA115402265
DR   Coriell; CW20195
DR   FCDI; CW20195
DR   hPSCreg; CIRMi18P-A
DR   Wikidata; Q54815256
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20195; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20196
AC   CVCL_JH73
SY   CIRMi18Q-A
DR   BioSamples; SAMEA115402267
DR   Coriell; CW20196
DR   FCDI; CW20196
DR   hPSCreg; CIRMi18Q-A
DR   Wikidata; Q54815258
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20196; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20200
AC   CVCL_JH74
SY   CIRMi18R-A
DR   BioSamples; SAMEA115402269
DR   Coriell; CW20200
DR   FCDI; CW20200
DR   hPSCreg; CIRMi18R-A
DR   Wikidata; Q54815259
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20200; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20201
AC   CVCL_HH23
SY   CIRMi18S-A
DR   BioSamples; SAMEA115402271
DR   Coriell; CW20201
DR   FCDI; CW20201
DR   hPSCreg; CIRMi18S-A
DR   Wikidata; Q54815260
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20202
AC   CVCL_RV60
SY   CIRMi18T-A
DR   BioSamples; SAMEA115402273
DR   Coriell; CW20202
DR   FCDI; CW20202
DR   hPSCreg; CIRMi18T-A
DR   Wikidata; Q54815261
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20203
AC   CVCL_HH24
SY   CIRMi18U-A
DR   BioSamples; SAMEA115402275
DR   Coriell; CW20203
DR   FCDI; CW20203
DR   hPSCreg; CIRMi18U-A
DR   Wikidata; Q54815263
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20204
AC   CVCL_HH25
SY   CIRMi18V-A
DR   BioSamples; SAMEA115402277
DR   Coriell; CW20204
DR   FCDI; CW20204
DR   hPSCreg; CIRMi18V-A
DR   Wikidata; Q54815264
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian and Caucasian.
CC   Discontinued: Coriell; CW20204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20206
AC   CVCL_HH26
SY   CIRMi18W-A
DR   BioSamples; SAMEA115402279
DR   Coriell; CW20206
DR   FCDI; CW20206
DR   hPSCreg; CIRMi18W-A
DR   Wikidata; Q54815265
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20207
AC   CVCL_RV61
SY   CIRMi18X-A
DR   BioSamples; SAMEA115402281
DR   Coriell; CW20207
DR   FCDI; CW20207
DR   hPSCreg; CIRMi18X-A
DR   Wikidata; Q54815277
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20209
AC   CVCL_RV62
SY   CIRMi18Y-A
DR   BioSamples; SAMEA115402283
DR   Coriell; CW20209
DR   FCDI; CW20209
DR   hPSCreg; CIRMi18Y-A
DR   Wikidata; Q54815278
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20210
AC   CVCL_HH27
SY   CIRMi18Z-A
DR   BioSamples; SAMEA115402285
DR   Coriell; CW20210
DR   FCDI; CW20210
DR   hPSCreg; CIRMi18Z-A
DR   Wikidata; Q54815279
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20212
AC   CVCL_RV63
SY   CIRMi19A-A
DR   BioSamples; SAMEA115402287
DR   Coriell; CW20212
DR   FCDI; CW20212
DR   hPSCreg; CIRMi19A-A
DR   Wikidata; Q54815280
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: East Indian.
CC   Discontinued: Coriell; CW20212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20213
AC   CVCL_HH28
SY   CIRMi19B-A
DR   BioSamples; SAMEA115402289
DR   Coriell; CW20213
DR   FCDI; CW20213
DR   hPSCreg; CIRMi19B-A
DR   Wikidata; Q54815281
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20214
AC   CVCL_HH29
SY   CIRMi19C-A
DR   BioSamples; SAMEA115402291
DR   Coriell; CW20214
DR   FCDI; CW20214
DR   hPSCreg; CIRMi19C-A
DR   Wikidata; Q54815282
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW20214; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20222
AC   CVCL_HH30
SY   CIRMi19D-A
DR   BioSamples; SAMEA115402293
DR   Coriell; CW20222
DR   FCDI; CW20222
DR   hPSCreg; CIRMi19D-A
DR   Wikidata; Q54815283
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20222; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20225
AC   CVCL_HH31
SY   CIRMi19E-A
DR   BioSamples; SAMEA115402295
DR   Coriell; CW20225
DR   FCDI; CW20225
DR   hPSCreg; CIRMi19E-A
DR   Wikidata; Q54815284
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW20225; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20226
AC   CVCL_HH32
SY   CIRMi19F-A
DR   BioSamples; SAMEA115402297
DR   Coriell; CW20226
DR   FCDI; CW20226
DR   hPSCreg; CIRMi19F-A
DR   Wikidata; Q54815285
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20226; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20231
AC   CVCL_HH33
SY   CIRMi19G-A
DR   BioSamples; SAMEA115402299
DR   Coriell; CW20231
DR   FCDI; CW20231
DR   hPSCreg; CIRMi19G-A
DR   Wikidata; Q54815286
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20231; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20235
AC   CVCL_RV64
SY   CIRMi19H-A
DR   BioSamples; SAMEA115402301
DR   Coriell; CW20235
DR   FCDI; CW20235
DR   hPSCreg; CIRMi19H-A
DR   Wikidata; Q54815287
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20235; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20237
AC   CVCL_DJ39
SY   CIRMi19I-A
DR   BioSamples; SAMEA115402303
DR   Coriell; CW20237
DR   FCDI; CW20237
DR   hPSCreg; CIRMi19I-A
DR   Wikidata; Q54815288
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20237; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW20239
AC   CVCL_HH34
SY   CIRMi19J-A
DR   BioSamples; SAMEA115402305
DR   Coriell; CW20239
DR   FCDI; CW20239
DR   hPSCreg; CIRMi19J-A
DR   Wikidata; Q54815289
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20239; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20240
AC   CVCL_RV65
SY   CIRMi19K-A
DR   BioSamples; SAMEA115402307
DR   Coriell; CW20240
DR   FCDI; CW20240
DR   hPSCreg; CIRMi19K-A
DR   Wikidata; Q54815290
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20240; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20242
AC   CVCL_HH35
SY   CIRMi19L-A
DR   BioSamples; SAMEA115402309
DR   Coriell; CW20242
DR   FCDI; CW20242
DR   hPSCreg; CIRMi19L-A
DR   Wikidata; Q54815291
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Hispanic.
CC   Discontinued: Coriell; CW20242; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20243
AC   CVCL_JH75
SY   CIRMi19M-A
DR   BioSamples; SAMEA115402311
DR   Coriell; CW20243
DR   FCDI; CW20243
DR   hPSCreg; CIRMi19M-A
DR   Wikidata; Q54815292
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20243; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20245
AC   CVCL_RV66
SY   CIRMi19N-A
DR   BioSamples; SAMEA115402313
DR   Coriell; CW20245
DR   FCDI; CW20245
DR   hPSCreg; CIRMi19N-A
DR   Wikidata; Q54815293
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20245; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20249
AC   CVCL_HH36
SY   CIRMi19O-A
DR   BioSamples; SAMEA115402315
DR   Coriell; CW20249
DR   FCDI; CW20249
DR   hPSCreg; CIRMi19O-A
DR   Wikidata; Q54815294
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20249; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 10
//
ID   CW20252
AC   CVCL_JH77
SY   CIRMi19P-A
DR   BioSamples; SAMEA115402317
DR   Coriell; CW20252
DR   FCDI; CW20252
DR   hPSCreg; CIRMi19P-A
DR   Wikidata; Q54815295
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW20252; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20273
AC   CVCL_RV67
SY   CIRMi19Q-A
DR   BioSamples; SAMEA115402319
DR   Coriell; CW20273
DR   FCDI; CW20273
DR   hPSCreg; CIRMi19Q-A
DR   Wikidata; Q54815296
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian and Chinese.
CC   Discontinued: Coriell; CW20273; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20277
AC   CVCL_RV68
SY   CIRMi19R-A
DR   BioSamples; SAMEA115402321
DR   Coriell; CW20277
DR   FCDI; CW20277
DR   hPSCreg; CIRMi19R-A
DR   Wikidata; Q54815297
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian and Chinese.
CC   Discontinued: Coriell; CW20277; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20278
AC   CVCL_RV69
SY   CIRMi19S-A
DR   BioSamples; SAMEA115402323
DR   Coriell; CW20278
DR   FCDI; CW20278
DR   hPSCreg; CIRMi19S-A
DR   Wikidata; Q54815298
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20278; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20284
AC   CVCL_LI62
SY   CIRMi19T-A
DR   BioSamples; SAMEA115402325
DR   Coriell; CW20284
DR   FCDI; CW20284
DR   hPSCreg; CIRMi19T-A
DR   Wikidata; Q54815300
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American and Chinese.
CC   Discontinued: Coriell; CW20284; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 10
//
ID   CW20295
AC   CVCL_JH78
SY   CIRMi19U-A
DR   BioSamples; SAMEA115402327
DR   Coriell; CW20295
DR   FCDI; CW20295
DR   hPSCreg; CIRMi19U-A
DR   Wikidata; Q54815301
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20295; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20296
AC   CVCL_JH79
SY   CIRMi19V-A
DR   BioSamples; SAMEA115402329
DR   Coriell; CW20296
DR   FCDI; CW20296
DR   hPSCreg; CIRMi19V-A
DR   Wikidata; Q54815302
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20296; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20299
AC   CVCL_LJ96
SY   CIRMi19W-A
DR   BioSamples; SAMEA115402331
DR   Coriell; CW20299
DR   FCDI; CW20299
DR   hPSCreg; CIRMi19W-A
DR   Wikidata; Q54815303
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian and Caucasian.
CC   Discontinued: Coriell; CW20299; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 10
//
ID   CW20300
AC   CVCL_LJ97
SY   CIRMi19X-A
DR   BioSamples; SAMEA115402333
DR   Coriell; CW20300
DR   FCDI; CW20300
DR   hPSCreg; CIRMi19X-A
DR   Wikidata; Q54815305
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20300; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 10
//
ID   CW20303
AC   CVCL_RV70
SY   CIRMi19Y-A
DR   BioSamples; SAMEA115402335
DR   Coriell; CW20303
DR   FCDI; CW20303
DR   hPSCreg; CIRMi19Y-A
DR   Wikidata; Q54815306
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Korean.
CC   Discontinued: Coriell; CW20303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20311
AC   CVCL_RV71
SY   CIRMi19Z-A
DR   BioSamples; SAMEA115402337
DR   Coriell; CW20311
DR   FCDI; CW20311
DR   hPSCreg; CIRMi19Z-A
DR   Wikidata; Q54815307
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20311; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20320
AC   CVCL_RV72
SY   CIRMi20A-A
DR   BioSamples; SAMEA115402339
DR   Coriell; CW20320
DR   FCDI; CW20320
DR   hPSCreg; CIRMi20A-A
DR   Wikidata; Q54815308
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20320; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20321
AC   CVCL_JH80
SY   CIRMi20B-A
DR   BioSamples; SAMEA115402341
DR   Coriell; CW20321
DR   FCDI; CW20321
DR   hPSCreg; CIRMi20B-A
DR   Wikidata; Q54815310
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW20321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   CW20322
AC   CVCL_RV74
SY   CIRMi20C-A
DR   BioSamples; SAMEA115402343
DR   Coriell; CW20322
DR   FCDI; CW20322
DR   hPSCreg; CIRMi20C-A
DR   Wikidata; Q54815311
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW20322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20323
AC   CVCL_RV75
SY   CIRMi20D-A
DR   BioSamples; SAMEA115402345
DR   Coriell; CW20323
DR   FCDI; CW20323
DR   hPSCreg; CIRMi20D-A
DR   Wikidata; Q54815312
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW20323; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20324
AC   CVCL_RV76
SY   CIRMi20E-A
DR   BioSamples; SAMEA115402348
DR   Coriell; CW20324
DR   FCDI; CW20324
DR   hPSCreg; CIRMi20E-A
DR   Wikidata; Q54815313
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20324; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20325
AC   CVCL_RV77
SY   CIRMi20F-A
DR   BioSamples; SAMEA115402350
DR   Coriell; CW20325
DR   FCDI; CW20325
DR   hPSCreg; CIRMi20F-A
DR   Wikidata; Q54815315
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW20325; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW20326
AC   CVCL_RV78
SY   CIRMi20G-A
DR   BioSamples; SAMEA115402352
DR   Coriell; CW20326
DR   FCDI; CW20326
DR   hPSCreg; CIRMi20G-A
DR   Wikidata; Q54815316
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW20326; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   CW3-XPE
AC   CVCL_M225
DR   Wikidata; Q54815317
RX   PubMed=3030788;
CC   Doubling time: 15 hours (PubMed=3030788).
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000008788; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV7).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F496 ! XP2RO
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   CW30001
AC   CVCL_4Q88
SY   CIRM-CW30001i-Affected; CIRMi726-A
DR   BioSamples; SAMEA114426854
DR   Coriell; CW30001
DR   FCDI; CW30001
DR   hPSCreg; CIRMi726-A
DR   SKIP; SKIP003716
DR   Wikidata; Q54815318
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30001; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30002
AC   CVCL_4Q89
SY   CIRM-CW30002i-Affected; CIRMi727-A
DR   BioSamples; SAMEA114426856
DR   Coriell; CW30002
DR   FCDI; CW30002
DR   hPSCreg; CIRMi727-A
DR   SKIP; SKIP003717
DR   Wikidata; Q54815319
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30002; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30003
AC   CVCL_4Q90
SY   CIRM-CW30003i-Affected; CIRMi728-A
DR   BioSamples; SAMEA114426858
DR   Coriell; CW30003
DR   FCDI; CW30003
DR   hPSCreg; CIRMi728-A
DR   SKIP; SKIP003718
DR   Wikidata; Q54815320
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30003; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30004
AC   CVCL_HH37
SY   CIRMi729-A
DR   BioSamples; SAMEA114426860
DR   Coriell; CW30004
DR   FCDI; CW30004
DR   hPSCreg; CIRMi729-A
DR   Wikidata; Q54815325
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30004; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 9
//
ID   CW30005
AC   CVCL_JH81
SY   CIRMi730-A
DR   BioSamples; SAMEA114426862
DR   Coriell; CW30005
DR   FCDI; CW30005
DR   hPSCreg; CIRMi730-A
DR   Wikidata; Q54815326
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30005; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 8
//
ID   CW30006
AC   CVCL_DJ40
SY   CIRMi731-A
DR   BioSamples; SAMEA114426864
DR   Coriell; CW30006
DR   FCDI; CW30006
DR   hPSCreg; CIRMi731-A
DR   Wikidata; Q54815327
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30006; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 9
//
ID   CW30007
AC   CVCL_AN31
SY   CIRM-CW30007i-Affected; CIRMi732-A
DR   BioSamples; SAMEA114426866
DR   Coriell; CW30007
DR   FCDI; CW30007
DR   hPSCreg; CIRMi732-A
DR   SKIP; SKIP003719
DR   Wikidata; Q54815328
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30007; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 11
//
ID   CW30008
AC   CVCL_HH38
SY   CIRMi733-A
DR   BioSamples; SAMEA114426868
DR   Coriell; CW30008
DR   FCDI; CW30008
DR   hPSCreg; CIRMi733-A
DR   Wikidata; Q54815329
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30008; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 8
//
ID   CW30009
AC   CVCL_4Q91
SY   CIRM-CW30009i-Affected; CIRMi734-A
DR   BioSamples; SAMEA114426870
DR   Coriell; CW30009
DR   FCDI; CW30009
DR   hPSCreg; CIRMi734-A
DR   SKIP; SKIP003720
DR   Wikidata; Q54815330
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30009; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW30010
AC   CVCL_4Q92
SY   CIRM-CW30010i-Affected; CIRMi735-A
DR   BioSamples; SAMEA114426872
DR   Coriell; CW30010
DR   FCDI; CW30010
DR   hPSCreg; CIRMi735-A
DR   SKIP; SKIP003721
DR   Wikidata; Q54815331
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30010; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW30011
AC   CVCL_4Q93
SY   CIRM-CW30011i-Affected; CIRMi736-A
DR   BioSamples; SAMEA114426874
DR   Coriell; CW30011
DR   FCDI; CW30011
DR   hPSCreg; CIRMi736-A
DR   SKIP; SKIP003722
DR   Wikidata; Q54815332
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30011; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW30012
AC   CVCL_JH82
SY   CIRMi737-A
DR   BioSamples; SAMEA114426876
DR   Coriell; CW30012
DR   FCDI; CW30012
DR   hPSCreg; CIRMi737-A
DR   Wikidata; Q54815333
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30012; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 8
//
ID   CW30013
AC   CVCL_AN32
SY   CIRM-CW30013i-Affected
DR   Coriell; CW30013
DR   FCDI; CW30013
DR   SKIP; SKIP003723
DR   Wikidata; Q54815334
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30013; true.
CC   Discontinued: FCDI; CW30013; probable.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW30014
AC   CVCL_4Q94
SY   CIRM-CW30014i-Affected; CIRMi738-A
DR   BioSamples; SAMEA114426878
DR   Coriell; CW30014
DR   FCDI; CW30014
DR   hPSCreg; CIRMi738-A
DR   SKIP; SKIP003724
DR   Wikidata; Q54815335
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30014; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW30015
AC   CVCL_HH39
SY   CIRMi739-A
DR   BioSamples; SAMEA114426880
DR   Coriell; CW30015
DR   FCDI; CW30015
DR   hPSCreg; CIRMi739-A
DR   Wikidata; Q54815336
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30015; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 7
//
ID   CW30016
AC   CVCL_4Q95
SY   CIRM-CW30016i-Affected; CIRMi740-A
DR   BioSamples; SAMEA114426882
DR   Coriell; CW30016
DR   FCDI; CW30016
DR   hPSCreg; CIRMi740-A
DR   SKIP; SKIP003725
DR   Wikidata; Q54815337
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30016; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW30017
AC   CVCL_AN33
SY   CIRM-CW30017i-Affected; CIRMi741-A
DR   BioSamples; SAMEA114426884
DR   Coriell; CW30017
DR   FCDI; CW30017
DR   hPSCreg; CIRMi741-A
DR   SKIP; SKIP003726
DR   Wikidata; Q54815339
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30017; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 11
//
ID   CW30018
AC   CVCL_4Q96
SY   CIRM-CW30018i-Affected; CIRMi742-A
DR   BioSamples; SAMEA114426886
DR   Coriell; CW30018
DR   FCDI; CW30018
DR   hPSCreg; CIRMi742-A
DR   SKIP; SKIP003727
DR   Wikidata; Q54815340
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30018; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30019
AC   CVCL_JH83
SY   CIRMi743-A
DR   BioSamples; SAMEA114426888
DR   Coriell; CW30019
DR   FCDI; CW30019
DR   hPSCreg; CIRMi743-A
DR   Wikidata; Q54815341
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30019; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 9
//
ID   CW30020
AC   CVCL_DJ41
SY   CIRM-CW30020i-Affected; CIRMi744-A
DR   BioSamples; SAMEA114426890
DR   Coriell; CW30020
DR   FCDI; CW30020
DR   hPSCreg; CIRMi744-A
DR   SKIP; SKIP003728
DR   Wikidata; Q54815342
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30020; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW30022
AC   CVCL_DJ42
SY   CIRM-CW30022i-Affected; CIRMi745-A
DR   BioSamples; SAMEA114426892
DR   Coriell; CW30022
DR   FCDI; CW30022
DR   hPSCreg; CIRMi745-A
DR   SKIP; SKIP003729
DR   Wikidata; Q54815343
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30022; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW30024
AC   CVCL_JH84
SY   CIRMi746-A
DR   BioSamples; SAMEA114426894
DR   Coriell; CW30024
DR   FCDI; CW30024
DR   hPSCreg; CIRMi746-A
DR   Wikidata; Q54815344
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30024; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 9
//
ID   CW30027
AC   CVCL_AN34
SY   CIRM-CW30027i-Affected; CIRMi747-A
DR   BioSamples; SAMEA114426896
DR   Coriell; CW30027
DR   FCDI; CW30027
DR   hPSCreg; CIRMi747-A
DR   SKIP; SKIP003730
DR   Wikidata; Q54815345
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30027; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 11
//
ID   CW30028
AC   CVCL_4Q97
SY   CIRM-CW30028i-Affected; CIRMi748-A
DR   BioSamples; SAMEA114426898
DR   Coriell; CW30028
DR   FCDI; CW30028
DR   hPSCreg; CIRMi748-A
DR   SKIP; SKIP003731
DR   Wikidata; Q54815346
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30028; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW30029
AC   CVCL_4Q98
SY   CIRM-CW30029i-Affected; CIRMi749-A
DR   BioSamples; SAMEA114426900
DR   Coriell; CW30029
DR   FCDI; CW30029
DR   hPSCreg; CIRMi749-A
DR   SKIP; SKIP003732
DR   Wikidata; Q54815347
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30029; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30030
AC   CVCL_JH85
SY   CIRMi750-A
DR   BioSamples; SAMEA114426902
DR   Coriell; CW30030
DR   FCDI; CW30030
DR   hPSCreg; CIRMi750-A
DR   Wikidata; Q54815348
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30030; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 8
//
ID   CW30031
AC   CVCL_JH86
SY   CIRMi751-A
DR   BioSamples; SAMEA114426904
DR   Coriell; CW30031
DR   FCDI; CW30031
DR   hPSCreg; CIRMi751-A
DR   Wikidata; Q54815349
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30031; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 9
//
ID   CW30032
AC   CVCL_ER34
SY   CIRMi752-A
DR   BioSamples; SAMEA114426906
DR   Coriell; CW30032
DR   FCDI; CW30032
DR   hPSCreg; CIRMi752-A
DR   Wikidata; Q54815350
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30032; true.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 9
//
ID   CW30033
AC   CVCL_AN35
SY   CIRM-CW30033i-Affected; CIRMi753-A
DR   BioSamples; SAMEA114426908
DR   Coriell; CW30033
DR   FCDI; CW30033
DR   hPSCreg; CIRMi753-A
DR   SKIP; SKIP003733
DR   Wikidata; Q54815351
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30033; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   CW30035
AC   CVCL_JH87
SY   CIRMi754-A
DR   BioSamples; SAMEA114426910
DR   Coriell; CW30035
DR   FCDI; CW30035
DR   hPSCreg; CIRMi754-A
DR   Wikidata; Q54815352
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30035; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 9
//
ID   CW30036
AC   CVCL_HH40
SY   CIRMi755-A
DR   BioSamples; SAMEA114426912
DR   Coriell; CW30036
DR   FCDI; CW30036
DR   hPSCreg; CIRMi755-A
DR   Wikidata; Q54815353
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30036; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 9
//
ID   CW30037
AC   CVCL_HH41
SY   CIRMi756-A
DR   BioSamples; SAMEA114426914
DR   Coriell; CW30037
DR   FCDI; CW30037
DR   hPSCreg; CIRMi756-A
DR   Wikidata; Q54815354
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30037; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 9
//
ID   CW30038
AC   CVCL_AN36
SY   CIRM-CW30038i-Affected; CIRMi757-A
DR   BioSamples; SAMEA114426916
DR   Coriell; CW30038
DR   FCDI; CW30038
DR   hPSCreg; CIRMi757-A
DR   SKIP; SKIP003734
DR   Wikidata; Q54815355
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30038; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 12
//
ID   CW30040
AC   CVCL_JH88
SY   CIRMi758-A
DR   BioSamples; SAMEA114426918
DR   Coriell; CW30040
DR   FCDI; CW30040
DR   hPSCreg; CIRMi758-A
DR   Wikidata; Q54815356
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30040; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30042
AC   CVCL_AN37
SY   CIRMi759-A
DR   BioSamples; SAMEA114426920
DR   Coriell; CW30042
DR   FCDI; CW30042
DR   hPSCreg; CIRMi759-A
DR   Wikidata; Q54815357
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30042; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   CW30043
AC   CVCL_AN38
SY   CIRM-CW30043i-Affected; CIRMi760-A
DR   BioSamples; SAMEA114426922
DR   Coriell; CW30043
DR   FCDI; CW30043
DR   hPSCreg; CIRMi760-A
DR   SKIP; SKIP003735
DR   Wikidata; Q54815359
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30043; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30044
AC   CVCL_4Q99
SY   CIRM-CW30044i-Affected; CIRMi761-A
DR   BioSamples; SAMEA114426924
DR   Coriell; CW30044
DR   FCDI; CW30044
DR   hPSCreg; CIRMi761-A
DR   SKIP; SKIP003736
DR   Wikidata; Q54815360
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30044; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30045
AC   CVCL_HH42
SY   CIRMi762-A
DR   BioSamples; SAMEA114426926
DR   Coriell; CW30045
DR   FCDI; CW30045
DR   hPSCreg; CIRMi762-A
DR   Wikidata; Q54815361
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30045; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30046
AC   CVCL_4R00
SY   CIRM-CW30046i-Affected; CIRMi763-A
DR   BioSamples; SAMEA114426928
DR   Coriell; CW30046
DR   FCDI; CW30046
DR   hPSCreg; CIRMi763-A
DR   SKIP; SKIP003737
DR   Wikidata; Q54815362
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30046; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30048
AC   CVCL_HH43
SY   CIRMi764-A
DR   BioSamples; SAMEA114426930
DR   Coriell; CW30048
DR   FCDI; CW30048
DR   hPSCreg; CIRMi764-A
DR   Wikidata; Q54815363
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30048; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30049
AC   CVCL_HH44
SY   CIRMi765-A
DR   BioSamples; SAMEA114426932
DR   Coriell; CW30049
DR   FCDI; CW30049
DR   hPSCreg; CIRMi765-A
DR   Wikidata; Q54815364
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30049; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30050
AC   CVCL_HH45
SY   CIRMi766-A
DR   BioSamples; SAMEA114426934
DR   Coriell; CW30050
DR   FCDI; CW30050
DR   hPSCreg; CIRMi766-A
DR   Wikidata; Q54815365
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30050; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30051
AC   CVCL_4R01
SY   CIRMi767-A
DR   BioSamples; SAMEA114426936
DR   Coriell; CW30051
DR   FCDI; CW30051
DR   hPSCreg; CIRMi767-A
DR   Wikidata; Q54815366
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30051; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30052
AC   CVCL_4R02
SY   CIRM-CW30052i-Affected; CIRMi768-A
DR   BioSamples; SAMEA114426938
DR   Coriell; CW30052
DR   FCDI; CW30052
DR   hPSCreg; CIRMi768-A
DR   SKIP; SKIP003738
DR   Wikidata; Q54815374
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30052; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30053
AC   CVCL_HH46
SY   CIRMi769-A
DR   BioSamples; SAMEA114426940
DR   Coriell; CW30053
DR   FCDI; CW30053
DR   hPSCreg; CIRMi769-A
DR   Wikidata; Q54815375
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30053; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30054
AC   CVCL_ER35
SY   CIRMi770-A
DR   BioSamples; SAMEA114426942
DR   Coriell; CW30054
DR   FCDI; CW30054
DR   hPSCreg; CIRMi770-A
DR   Wikidata; Q54815376
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30054; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30055
AC   CVCL_HH47
SY   CIRMi771-A
DR   BioSamples; SAMEA114426944
DR   Coriell; CW30055
DR   FCDI; CW30055
DR   hPSCreg; CIRMi771-A
DR   Wikidata; Q54815377
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30055; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30056
AC   CVCL_DJ43
SY   CIRMi772-A
DR   BioSamples; SAMEA114426946
DR   Coriell; CW30056
DR   FCDI; CW30056
DR   hPSCreg; CIRMi772-A
DR   Wikidata; Q54815378
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30056; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30057
AC   CVCL_AN39
DR   Coriell; CW30057
DR   FCDI; CW30057
DR   Wikidata; Q54815379
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30057; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   CW30058
AC   CVCL_4R03
SY   CIRM-CW30058i-Affected; CIRMi773-A
DR   BioSamples; SAMEA114426948
DR   Coriell; CW30058
DR   FCDI; CW30058
DR   hPSCreg; CIRMi773-A
DR   SKIP; SKIP003739
DR   Wikidata; Q54815380
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30058; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30059
AC   CVCL_4R04
SY   CIRM-CW30059i-Affected; CIRMi774-A
DR   BioSamples; SAMEA114426950
DR   Coriell; CW30059
DR   FCDI; CW30059
DR   hPSCreg; CIRMi774-A
DR   SKIP; SKIP003740
DR   Wikidata; Q54815381
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30059; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW30060
AC   CVCL_4R05
SY   CIRM-CW30060i-Affected; CIRMi775-A
DR   BioSamples; SAMEA114426952
DR   Coriell; CW30060
DR   FCDI; CW30060
DR   hPSCreg; CIRMi775-A
DR   SKIP; SKIP003741
DR   Wikidata; Q54815382
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30060; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30061
AC   CVCL_4R06
SY   CIRM-CW30061i-Affected; CIRMi776-A
DR   BioSamples; SAMEA114426954
DR   Coriell; CW30061
DR   FCDI; CW30061
DR   hPSCreg; CIRMi776-A
DR   SKIP; SKIP003742
DR   Wikidata; Q54815383
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30061; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30062
AC   CVCL_4R07
SY   CIRM-CW30062i-Affected; CIRMi777-A
DR   BioSamples; SAMEA114426956
DR   Coriell; CW30062
DR   FCDI; CW30062
DR   hPSCreg; CIRMi777-A
DR   SKIP; SKIP003743
DR   Wikidata; Q54815384
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30062; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30063
AC   CVCL_4R08
SY   CIRM-CW30063i-Affected; CIRMi778-A
DR   BioSamples; SAMEA114426958
DR   Coriell; CW30063
DR   FCDI; CW30063
DR   hPSCreg; CIRMi778-A
DR   SKIP; SKIP003744
DR   Wikidata; Q54815385
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30063; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30064
AC   CVCL_4R09
SY   CIRM-CW30064i-Affected; CIRMi779-A
DR   BioSamples; SAMEA114426960
DR   Coriell; CW30064
DR   FCDI; CW30064
DR   hPSCreg; CIRMi779-A
DR   SKIP; SKIP003745
DR   Wikidata; Q54815387
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30064; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30065
AC   CVCL_4R10
SY   CIRM-CW30065i-Affected; CIRMi780-A
DR   BioSamples; SAMEA114426962
DR   Coriell; CW30065
DR   FCDI; CW30065
DR   hPSCreg; CIRMi780-A
DR   SKIP; SKIP003746
DR   Wikidata; Q54815388
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30065; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30066
AC   CVCL_4R11
SY   CIRM-CW30066i-Affected
DR   Coriell; CW30066
DR   SKIP; SKIP003747
DR   Wikidata; Q54815389
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30066; true.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 8
//
ID   CW30067
AC   CVCL_4R12
SY   CIRM-CW30067i-Affected; CIRMi781-A
DR   BioSamples; SAMEA114426964
DR   Coriell; CW30067
DR   FCDI; CW30067
DR   hPSCreg; CIRMi781-A
DR   SKIP; SKIP003748
DR   Wikidata; Q54815390
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30067; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30068
AC   CVCL_ER36
SY   CIRMi782-A
DR   BioSamples; SAMEA114426966
DR   Coriell; CW30068
DR   FCDI; CW30068
DR   hPSCreg; CIRMi782-A
DR   Wikidata; Q54815391
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30068; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30069
AC   CVCL_4R13
SY   CIRM-CW30069i-Affected; CIRMi783-A
DR   BioSamples; SAMEA114426968
DR   Coriell; CW30069
DR   FCDI; CW30069
DR   hPSCreg; CIRMi783-A
DR   SKIP; SKIP003749
DR   Wikidata; Q54815392
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30069; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30070
AC   CVCL_4R14
SY   CIRM-CW30070i-Affected; CIRMi784-A
DR   BioSamples; SAMEA114426970
DR   Coriell; CW30070
DR   FCDI; CW30070
DR   hPSCreg; CIRMi784-A
DR   SKIP; SKIP003750
DR   Wikidata; Q54815393
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30070; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30071
AC   CVCL_4R15
SY   CIRM-CW30071i-Affected; CIRMi785-A
DR   BioSamples; SAMEA114426972
DR   Coriell; CW30071
DR   FCDI; CW30071
DR   hPSCreg; CIRMi785-A
DR   SKIP; SKIP003751
DR   Wikidata; Q54815394
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30071; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30073
AC   CVCL_4R16
SY   CIRM-CW30073i-Affected; CIRMi786-A
DR   BioSamples; SAMEA114426974
DR   Coriell; CW30073
DR   FCDI; CW30073
DR   hPSCreg; CIRMi786-A
DR   SKIP; SKIP003752
DR   Wikidata; Q54815395
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30073; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30074
AC   CVCL_4R17
SY   CIRM-CW30074i-Affected; CIRMi787-A
DR   BioSamples; SAMEA114426976
DR   Coriell; CW30074
DR   FCDI; CW30074
DR   hPSCreg; CIRMi787-A
DR   SKIP; SKIP003753
DR   Wikidata; Q54815396
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30074; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30075
AC   CVCL_4R18
SY   CIRM-CW30075i-Affected; CIRMi788-A
DR   BioSamples; SAMEA114426978
DR   Coriell; CW30075
DR   FCDI; CW30075
DR   hPSCreg; CIRMi788-A
DR   SKIP; SKIP003754
DR   Wikidata; Q54815397
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30075; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30076
AC   CVCL_4R19
SY   CIRM-CW30076i-Affected; CIRMi789-A
DR   BioSamples; SAMEA114426980
DR   Coriell; CW30076
DR   FCDI; CW30076
DR   hPSCreg; CIRMi789-A
DR   SKIP; SKIP003755
DR   Wikidata; Q54815398
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30076; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30077
AC   CVCL_JH89
SY   CIRMi790-A
DR   BioSamples; SAMEA114426982
DR   Coriell; CW30077
DR   FCDI; CW30077
DR   hPSCreg; CIRMi790-A
DR   Wikidata; Q54815400
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30077; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 9
//
ID   CW30078
AC   CVCL_4R20
SY   CIRM-CW30078i-Affected; CIRMi791-A
DR   BioSamples; SAMEA114426984
DR   Coriell; CW30078
DR   FCDI; CW30078
DR   hPSCreg; CIRMi791-A
DR   SKIP; SKIP003756
DR   Wikidata; Q54815401
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30078; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30079
AC   CVCL_4R21
SY   CIRM-CW30079i-Affected; CIRMi792-A
DR   BioSamples; SAMEA114426986
DR   Coriell; CW30079
DR   FCDI; CW30079
DR   hPSCreg; CIRMi792-A
DR   SKIP; SKIP003757
DR   Wikidata; Q54815402
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30079; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30080
AC   CVCL_JH90
SY   CIRMi793-A
DR   BioSamples; SAMEA114426988
DR   Coriell; CW30080
DR   FCDI; CW30080
DR   hPSCreg; CIRMi793-A
DR   Wikidata; Q54815403
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30080; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30081
AC   CVCL_HH48
SY   CIRMi794-A
DR   BioSamples; SAMEA114426990
DR   Coriell; CW30081
DR   FCDI; CW30081
DR   hPSCreg; CIRMi794-A
DR   Wikidata; Q54815404
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30081; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30082
AC   CVCL_4R22
SY   CIRM-CW30082i-Affected; CIRMi795-A
DR   BioSamples; SAMEA114426992
DR   Coriell; CW30082
DR   FCDI; CW30082
DR   hPSCreg; CIRMi795-A
DR   SKIP; SKIP003758
DR   Wikidata; Q54815405
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30082; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30083
AC   CVCL_4R23
SY   CIRM-CW30083i-Affected; CIRMi796-A
DR   BioSamples; SAMEA114426994
DR   Coriell; CW30083
DR   FCDI; CW30083
DR   hPSCreg; CIRMi796-A
DR   SKIP; SKIP003759
DR   Wikidata; Q54815406
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30083; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30084
AC   CVCL_HH49
SY   CIRMi797-A
DR   BioSamples; SAMEA114426996
DR   Coriell; CW30084
DR   FCDI; CW30084
DR   hPSCreg; CIRMi797-A
DR   Wikidata; Q54815407
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30084; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 9
//
ID   CW30085
AC   CVCL_4R24
SY   CIRM-CW30085i-Affected; CIRMi798-A
DR   BioSamples; SAMEA114426998
DR   Coriell; CW30085
DR   FCDI; CW30085
DR   hPSCreg; CIRMi798-A
DR   SKIP; SKIP003760
DR   Wikidata; Q54815408
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30085; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW30086
AC   CVCL_4R25
SY   CIRM-CW30086i-Affected; CIRMi799-A
DR   BioSamples; SAMEA114427000
DR   Coriell; CW30086
DR   FCDI; CW30086
DR   hPSCreg; CIRMi799-A
DR   SKIP; SKIP003761
DR   Wikidata; Q54815409
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30086; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30089
AC   CVCL_4R26
SY   CIRMi800-A
DR   BioSamples; SAMEA114427002
DR   Coriell; CW30089
DR   FCDI; CW30089
DR   hPSCreg; CIRMi800-A
DR   Wikidata; Q54815410
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30089; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 10
//
ID   CW30090
AC   CVCL_DJ44
SY   CIRM-CW30090i-Affected; CIRMi801-A
DR   BioSamples; SAMEA114427004
DR   Coriell; CW30090
DR   FCDI; CW30090
DR   hPSCreg; CIRMi801-A
DR   SKIP; SKIP003762
DR   Wikidata; Q54815411
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30090; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30092
AC   CVCL_HH50
SY   CIRMi802-A
DR   BioSamples; SAMEA114427006
DR   Coriell; CW30092
DR   FCDI; CW30092
DR   hPSCreg; CIRMi802-A
DR   Wikidata; Q54815412
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30092; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30093
AC   CVCL_4R27
SY   CIRM-CW30093i-Affected; CIRMi803-A
DR   BioSamples; SAMEA114427008
DR   Coriell; CW30093
DR   FCDI; CW30093
DR   hPSCreg; CIRMi803-A
DR   SKIP; SKIP003763
DR   Wikidata; Q54815413
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30093; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW30094
AC   CVCL_DJ45
SY   CIRMi804-A
DR   BioSamples; SAMEA114427010
DR   Coriell; CW30094
DR   FCDI; CW30094
DR   hPSCreg; CIRMi804-A
DR   Wikidata; Q54815414
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30094; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30095
AC   CVCL_JH91
SY   CIRMi805-A
DR   BioSamples; SAMEA114427012
DR   Coriell; CW30095
DR   FCDI; CW30095
DR   hPSCreg; CIRMi805-A
DR   Wikidata; Q54815415
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30095; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30096
AC   CVCL_4R28
SY   CIRM-CW30096i-Affected; CIRMi806-A
DR   BioSamples; SAMEA114427014
DR   Coriell; CW30096
DR   FCDI; CW30096
DR   hPSCreg; CIRMi806-A
DR   SKIP; SKIP003764
DR   Wikidata; Q54815430
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30096; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30097
AC   CVCL_4R29
SY   CIRM-CW30097i-Affected; CIRMi807-A
DR   BioSamples; SAMEA114427016
DR   Coriell; CW30097
DR   FCDI; CW30097
DR   hPSCreg; CIRMi807-A
DR   SKIP; SKIP003765
DR   Wikidata; Q54815431
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30097; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30098
AC   CVCL_4R30
SY   CIRM-CW30098i-Affected; CIRMi808-A
DR   BioSamples; SAMEA114427018
DR   Coriell; CW30098
DR   FCDI; CW30098
DR   hPSCreg; CIRMi808-A
DR   SKIP; SKIP003766
DR   Wikidata; Q54815432
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30098; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30099
AC   CVCL_4R31
SY   CIRM-CW30099i-Affected; CIRMi809-A
DR   BioSamples; SAMEA114427020
DR   Coriell; CW30099
DR   FCDI; CW30099
DR   hPSCreg; CIRMi809-A
DR   SKIP; SKIP003767
DR   Wikidata; Q54815433
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30099; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30101
AC   CVCL_4R32
SY   CIRM-CW30101i-Affected; CIRMi810-A
DR   BioSamples; SAMEA114427022
DR   Coriell; CW30101
DR   FCDI; CW30101
DR   hPSCreg; CIRMi810-A
DR   SKIP; SKIP003768
DR   Wikidata; Q54815434
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30102
AC   CVCL_4R33
SY   CIRM-CW30102i-Affected; CIRMi811-A
DR   BioSamples; SAMEA114427024
DR   Coriell; CW30102
DR   FCDI; CW30102
DR   hPSCreg; CIRMi811-A
DR   SKIP; SKIP003769
DR   Wikidata; Q54815435
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30103
AC   CVCL_4R34
SY   CIRM-CW30103i-Affected; CIRMi812-A
DR   BioSamples; SAMEA114427026
DR   Coriell; CW30103
DR   FCDI; CW30103
DR   hPSCreg; CIRMi812-A
DR   SKIP; SKIP003770
DR   Wikidata; Q54815436
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30104
AC   CVCL_AN40
SY   CIRM-CW30104i-Affected; CIRMi813-A
DR   BioSamples; SAMEA114427028
DR   Coriell; CW30104
DR   FCDI; CW30104
DR   hPSCreg; CIRMi813-A
DR   SKIP; SKIP003771
DR   Wikidata; Q54815437
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30105
AC   CVCL_4R35
SY   CIRM-CW30105i-Affected; CIRMi814-A
DR   BioSamples; SAMEA114427030
DR   Coriell; CW30105
DR   FCDI; CW30105
DR   hPSCreg; CIRMi814-A
DR   SKIP; SKIP003772
DR   Wikidata; Q54815438
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30106
AC   CVCL_AN41
SY   CIRM-CW30106i-Affected; CIRMi815-A
DR   BioSamples; SAMEA114427032
DR   Coriell; CW30106
DR   FCDI; CW30106
DR   hPSCreg; CIRMi815-A
DR   SKIP; SKIP003773
DR   Wikidata; Q54815439
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30107
AC   CVCL_JH92
SY   CIRMi816-A
DR   BioSamples; SAMEA114427034
DR   Coriell; CW30107
DR   FCDI; CW30107
DR   hPSCreg; CIRMi816-A
DR   Wikidata; Q54815440
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30108
AC   CVCL_4R36
SY   CIRM-CW30108i-Affected; CIRMi817-A; low_PRS_1
DR   BioSamples; SAMEA114427036
DR   Coriell; CW30108
DR   FCDI; CW30108
DR   hPSCreg; CIRMi817-A
DR   SKIP; SKIP003774
DR   Wikidata; Q54815441
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally low polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW30108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 14
//
ID   CW30109
AC   CVCL_AN42
SY   CIRM-CW30109i-Affected; CIRMi818-A
DR   BioSamples; SAMEA114427038
DR   Coriell; CW30109
DR   FCDI; CW30109
DR   hPSCreg; CIRMi818-A
DR   SKIP; SKIP003775
DR   Wikidata; Q54815442
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30110
AC   CVCL_AN43
SY   CIRMi819-A
DR   BioSamples; SAMEA114427040
DR   Coriell; CW30110
DR   FCDI; CW30110
DR   hPSCreg; CIRMi819-A
DR   Wikidata; Q54815443
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   CW30111
AC   CVCL_4R37
SY   CIRM-CW30111i-Affected; CIRMi820-A
DR   BioSamples; SAMEA114427042
DR   Coriell; CW30111
DR   FCDI; CW30111
DR   hPSCreg; CIRMi820-A
DR   SKIP; SKIP003776
DR   Wikidata; Q54815445
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30112
AC   CVCL_4R38
SY   CIRM-CW30112i-Affected; CIRMi821-A
DR   BioSamples; SAMEA114427044
DR   Coriell; CW30112
DR   FCDI; CW30112
DR   hPSCreg; CIRMi821-A
DR   SKIP; SKIP003777
DR   Wikidata; Q54815446
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30113
AC   CVCL_4R39
SY   CIRM-CW30113i-Affected; CIRMi822-A
DR   BioSamples; SAMEA114427046
DR   Coriell; CW30113
DR   FCDI; CW30113
DR   hPSCreg; CIRMi822-A
DR   SKIP; SKIP003778
DR   Wikidata; Q54815447
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30115
AC   CVCL_HH51
SY   CIRMi823-A
DR   BioSamples; SAMEA114427048
DR   Coriell; CW30115
DR   FCDI; CW30115
DR   hPSCreg; CIRMi823-A
DR   Wikidata; Q54815448
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30116
AC   CVCL_AN44
SY   CIRM-CW30116i-Affected; CIRMi824-A
DR   BioSamples; SAMEA114427050
DR   Coriell; CW30116
DR   FCDI; CW30116
DR   hPSCreg; CIRMi824-A
DR   SKIP; SKIP003779
DR   Wikidata; Q54815449
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30117
AC   CVCL_4R40
SY   CIRM-CW30117i-Affected
DR   Coriell; CW30117
DR   FCDI; CW30117
DR   SKIP; SKIP003780
DR   Wikidata; Q54815450
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30117; true.
CC   Discontinued: FCDI; CW30117; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30118
AC   CVCL_4R41
SY   CIRM-CW30118i-Affected
DR   Coriell; CW30118
DR   FCDI; CW30118
DR   SKIP; SKIP003781
DR   Wikidata; Q54815451
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30118; true.
CC   Discontinued: FCDI; CW30118; probable.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 11
//
ID   CW30119
AC   CVCL_AN45
SY   CIRM-CW30119i-Affected; CIRMi825-A
DR   BioSamples; SAMEA114427052
DR   Coriell; CW30119
DR   FCDI; CW30119
DR   hPSCreg; CIRMi825-A
DR   SKIP; SKIP003782
DR   Wikidata; Q54815452
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30119; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30120
AC   CVCL_4R42
SY   CIRM-CW30120i-Affected; CIRMi826-A
DR   BioSamples; SAMEA114427054
DR   Coriell; CW30120
DR   FCDI; CW30120
DR   hPSCreg; CIRMi826-A
DR   SKIP; SKIP003783
DR   Wikidata; Q54815453
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30120; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30121
AC   CVCL_4R43
SY   CIRM-CW30121i-Affected; CIRMi827-A
DR   BioSamples; SAMEA114427056
DR   Coriell; CW30121
DR   FCDI; CW30121
DR   hPSCreg; CIRMi827-A
DR   SKIP; SKIP003784
DR   Wikidata; Q54815454
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30122
AC   CVCL_4R44
SY   CIRM-CW30122i-Affected; CIRMi828-A
DR   BioSamples; SAMEA114427058
DR   Coriell; CW30122
DR   FCDI; CW30122
DR   hPSCreg; CIRMi828-A
DR   SKIP; SKIP003785
DR   Wikidata; Q54815455
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30123
AC   CVCL_4R45
SY   CIRM-CW30123i-Affected
DR   Coriell; CW30123
DR   FCDI; CW30123
DR   SKIP; SKIP003786
DR   Wikidata; Q54815456
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30123; true.
CC   Discontinued: FCDI; CW30123; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30125
AC   CVCL_4R46
SY   CIRM-CW30125i-Affected; CIRMi829-A
DR   BioSamples; SAMEA114427060
DR   Coriell; CW30125
DR   FCDI; CW30125
DR   hPSCreg; CIRMi829-A
DR   SKIP; SKIP003787
DR   Wikidata; Q54815457
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30125; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30126
AC   CVCL_4R47
SY   CIRM-CW30126i-Affected; CIRMi830-A
DR   BioSamples; SAMEA114427062
DR   Coriell; CW30126
DR   FCDI; CW30126
DR   hPSCreg; CIRMi830-A
DR   SKIP; SKIP003788
DR   Wikidata; Q54815458
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30127
AC   CVCL_4R48
SY   CIRM-CW30127i-Affected
DR   Coriell; CW30127
DR   FCDI; CW30127
DR   SKIP; SKIP003789
DR   Wikidata; Q54815459
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30127; true.
CC   Discontinued: FCDI; CW30127; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30128
AC   CVCL_4R49
SY   CIRM-CW30128i-Affected; CIRMi831-A
DR   BioSamples; SAMEA114427064
DR   Coriell; CW30128
DR   FCDI; CW30128
DR   hPSCreg; CIRMi831-A
DR   SKIP; SKIP003790
DR   Wikidata; Q54815460
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30129
AC   CVCL_4R50
SY   CIRM-CW30129i-Affected
DR   Coriell; CW30129
DR   FCDI; CW30129
DR   SKIP; SKIP003791
DR   Wikidata; Q54815461
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30129; true.
CC   Discontinued: FCDI; CW30129; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30130
AC   CVCL_4R51
SY   CIRM-CW30130i-Affected; CIRMi832-A
DR   BioSamples; SAMEA114427066
DR   Coriell; CW30130
DR   FCDI; CW30130
DR   hPSCreg; CIRMi832-A
DR   SKIP; SKIP003792
DR   Wikidata; Q54815462
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30130; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30131
AC   CVCL_JH93
SY   CIRMi833-A
DR   BioSamples; SAMEA114427068
DR   Coriell; CW30131
DR   FCDI; CW30131
DR   hPSCreg; CIRMi833-A
DR   Wikidata; Q54815463
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30131; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30132
AC   CVCL_4R52
SY   CIRM-CW30132i-Affected; CIRMi834-A
DR   BioSamples; SAMEA114427070
DR   Coriell; CW30132
DR   FCDI; CW30132
DR   hPSCreg; CIRMi834-A
DR   SKIP; SKIP003793
DR   Wikidata; Q54815464
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30133
AC   CVCL_4R53
SY   CIRM-CW30133i-Affected; CIRMi835-A
DR   BioSamples; SAMEA114427072
DR   Coriell; CW30133
DR   FCDI; CW30133
DR   hPSCreg; CIRMi835-A
DR   SKIP; SKIP003794
DR   Wikidata; Q54815466
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30134
AC   CVCL_4R54
SY   CIRM-CW30134i-Affected
DR   Coriell; CW30134
DR   FCDI; CW30134
DR   SKIP; SKIP003795
DR   Wikidata; Q54815467
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30134; true.
CC   Discontinued: FCDI; CW30134; probable.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30136
AC   CVCL_4R55
SY   CIRM-CW30136i-Affected
DR   Coriell; CW30136
DR   FCDI; CW30136
DR   SKIP; SKIP003796
DR   Wikidata; Q54815468
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30136; true.
CC   Discontinued: FCDI; CW30136; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30137
AC   CVCL_4R56
SY   CIRM-CW30137i-Affected; CIRMi836-A
DR   BioSamples; SAMEA114427074
DR   Coriell; CW30137
DR   FCDI; CW30137
DR   hPSCreg; CIRMi836-A
DR   SKIP; SKIP003797
DR   Wikidata; Q54815469
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30137; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30138
AC   CVCL_4R57
SY   CIRM-CW30138i-Affected; CIRMi837-A
DR   BioSamples; SAMEA114427076
DR   Coriell; CW30138
DR   FCDI; CW30138
DR   hPSCreg; CIRMi837-A
DR   SKIP; SKIP003798
DR   Wikidata; Q54815470
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30138; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30139
AC   CVCL_4R58
SY   CIRM-CW30139i-Affected; CIRMi838-A
DR   BioSamples; SAMEA114427078
DR   Coriell; CW30139
DR   FCDI; CW30139
DR   hPSCreg; CIRMi838-A
DR   SKIP; SKIP003799
DR   Wikidata; Q54815471
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30139; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30140
AC   CVCL_4R59
SY   CIRM-CW30140i-Affected; CIRMi839-A
DR   BioSamples; SAMEA114427080
DR   Coriell; CW30140
DR   FCDI; CW30140
DR   hPSCreg; CIRMi839-A
DR   SKIP; SKIP003800
DR   Wikidata; Q54815480
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30141
AC   CVCL_4R60
SY   CIRM-CW30141i-Affected; CIRMi840-A
DR   BioSamples; SAMEA114427082
DR   Coriell; CW30141
DR   FCDI; CW30141
DR   hPSCreg; CIRMi840-A
DR   SKIP; SKIP003801
DR   Wikidata; Q54815481
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30141; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30142
AC   CVCL_4R61
SY   CIRM-CW30142i-Affected; CIRMi841-A
DR   BioSamples; SAMEA114427084
DR   Coriell; CW30142
DR   FCDI; CW30142
DR   hPSCreg; CIRMi841-A
DR   SKIP; SKIP003802
DR   Wikidata; Q54815482
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30142; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30143
AC   CVCL_JH94
SY   CIRMi842-A
DR   BioSamples; SAMEA114427086
DR   Coriell; CW30143
DR   FCDI; CW30143
DR   hPSCreg; CIRMi842-A
DR   Wikidata; Q54815484
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30143; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30144
AC   CVCL_4R62
SY   CIRM-CW30144i-Affected
DR   Coriell; CW30144
DR   FCDI; CW30144
DR   SKIP; SKIP003803
DR   Wikidata; Q54815485
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30144; true.
CC   Discontinued: FCDI; CW30144; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30145
AC   CVCL_AN46
SY   CIRM-CW30145i-Ctl; CIRMi843-A
DR   BioSamples; SAMEA114427088
DR   Coriell; CW30145
DR   FCDI; CW30145
DR   hPSCreg; CIRMi843-A
DR   SKIP; SKIP003804
DR   Wikidata; Q54815486
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30145; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30146
AC   CVCL_DJ46
SY   CIRM-CW30146i-Affected; CIRMi844-A
DR   BioSamples; SAMEA114427090
DR   Coriell; CW30146
DR   FCDI; CW30146
DR   hPSCreg; CIRMi844-A
DR   SKIP; SKIP003805
DR   Wikidata; Q54815487
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30146; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW30147
AC   CVCL_4R63
SY   CIRM-CW30147i-Affected
DR   Coriell; CW30147
DR   FCDI; CW30147
DR   SKIP; SKIP003806
DR   Wikidata; Q54815488
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30147; true.
CC   Discontinued: FCDI; CW30147; probable.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30148
AC   CVCL_AN47
SY   CIRM-CW30148i-Affected; CIRMi845-A
DR   BioSamples; SAMEA114427092
DR   Coriell; CW30148
DR   FCDI; CW30148
DR   hPSCreg; CIRMi845-A
DR   SKIP; SKIP003807
DR   Wikidata; Q54815489
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30148; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30149
AC   CVCL_AN48
SY   CIRM-CW30149i-Affected; CIRMi846-A
DR   BioSamples; SAMEA114427094
DR   Coriell; CW30149
DR   FCDI; CW30149
DR   hPSCreg; CIRMi846-A
DR   SKIP; SKIP003808
DR   Wikidata; Q54815490
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30150
AC   CVCL_4R64
SY   CIRM-CW30150i-Affected
DR   Coriell; CW30150
DR   FCDI; CW30150
DR   SKIP; SKIP003809
DR   Wikidata; Q54815491
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30150; true.
CC   Discontinued: FCDI; CW30150; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30151
AC   CVCL_HH52
SY   CIRMi847-A
DR   BioSamples; SAMEA114427096
DR   Coriell; CW30151
DR   FCDI; CW30151
DR   hPSCreg; CIRMi847-A
DR   Wikidata; Q54815492
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30151; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30152
AC   CVCL_4R65
SY   CIRM-CW30152i-Affected; CIRMi848-A
DR   BioSamples; SAMEA114427098
DR   Coriell; CW30152
DR   FCDI; CW30152
DR   hPSCreg; CIRMi848-A
DR   SKIP; SKIP003810
DR   Wikidata; Q54815493
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30152; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30154
AC   CVCL_4R66
SY   CIRM-CW30154i-Affected; CIRMi849-A; low_PRS_6
DR   BioSamples; SAMEA114427100
DR   Coriell; CW30154
DR   FCDI; CW30154
DR   hPSCreg; CIRMi849-A
DR   SKIP; SKIP003811
DR   Wikidata; Q54815494
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally low polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW30154; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 14
//
ID   CW30155
AC   CVCL_4R67
SY   CIRM-CW30155i-Affected; CIRMi850-A
DR   BioSamples; SAMEA114427102
DR   Coriell; CW30155
DR   FCDI; CW30155
DR   hPSCreg; CIRMi850-A
DR   SKIP; SKIP003812
DR   Wikidata; Q54815495
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30155; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30156
AC   CVCL_JH95
SY   CIRMi851-A
DR   BioSamples; SAMEA114427104
DR   Coriell; CW30156
DR   FCDI; CW30156
DR   hPSCreg; CIRMi851-A
DR   Wikidata; Q54815496
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30156; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30157
AC   CVCL_ER37
SY   CIRMi852-A
DR   BioSamples; SAMEA114427106
DR   Coriell; CW30157
DR   FCDI; CW30157
DR   hPSCreg; CIRMi852-A
DR   Wikidata; Q54815497
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30157; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30158
AC   CVCL_JH96
SY   CIRMi853-A
DR   BioSamples; SAMEA114427108
DR   Coriell; CW30158
DR   FCDI; CW30158
DR   hPSCreg; CIRMi853-A
DR   Wikidata; Q54815498
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30158; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30159
AC   CVCL_AN49
SY   CIRM-CW30159i-Affected; CIRMi854-A
DR   BioSamples; SAMEA114427110
DR   Coriell; CW30159
DR   FCDI; CW30159
DR   hPSCreg; CIRMi854-A
DR   SKIP; SKIP003813
DR   Wikidata; Q54815499
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30159; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30160
AC   CVCL_AN50
SY   CIRM-CW30160i-Affected
DR   Coriell; CW30160
DR   FCDI; CW30160
DR   SKIP; SKIP003814
DR   Wikidata; Q54815500
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30160; true.
CC   Discontinued: FCDI; CW30160; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW30161
AC   CVCL_AN51
SY   CIRM-CW30161i-Affected; CIRMi855-A
DR   BioSamples; SAMEA114427112
DR   Coriell; CW30161
DR   FCDI; CW30161
DR   hPSCreg; CIRMi855-A
DR   SKIP; SKIP003815
DR   Wikidata; Q54815501
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30161; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30162
AC   CVCL_AN52
SY   CIRM-CW30162i-Affected
DR   Coriell; CW30162
DR   FCDI; CW30162
DR   SKIP; SKIP003816
DR   Wikidata; Q54815502
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30162; true.
CC   Discontinued: FCDI; CW30162; probable.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW30163
AC   CVCL_JH97
SY   CIRMi856-A
DR   BioSamples; SAMEA114427114
DR   Coriell; CW30163
DR   FCDI; CW30163
DR   hPSCreg; CIRMi856-A
DR   Wikidata; Q54815503
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30163; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30164
AC   CVCL_DJ47
SY   CIRMi857-A
DR   BioSamples; SAMEA114427116
DR   Coriell; CW30164
DR   FCDI; CW30164
DR   hPSCreg; CIRMi857-A
DR   Wikidata; Q54815504
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30164; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30165
AC   CVCL_4R68
SY   CIRM-CW30165i-Affected; CIRMi858-A
DR   BioSamples; SAMEA114427118
DR   Coriell; CW30165
DR   FCDI; CW30165
DR   hPSCreg; CIRMi858-A
DR   SKIP; SKIP003817
DR   Wikidata; Q54815505
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30165; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30166
AC   CVCL_AN53
SY   CIRM-CW30166i-Affected; CIRMi859-A
DR   BioSamples; SAMEA114427120
DR   Coriell; CW30166
DR   FCDI; CW30166
DR   hPSCreg; CIRMi859-A
DR   SKIP; SKIP003818
DR   Wikidata; Q54815506
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30166; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30167
AC   CVCL_AN54
SY   CIRM-CW30167i-Affected; CIRMi860-A
DR   BioSamples; SAMEA114427122
DR   Coriell; CW30167
DR   FCDI; CW30167
DR   hPSCreg; CIRMi860-A
DR   SKIP; SKIP003819
DR   Wikidata; Q54815507
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30168
AC   CVCL_DJ48
SY   CIRM-CW30168i-Affected; CIRMi861-A
DR   BioSamples; SAMEA114427124
DR   Coriell; CW30168
DR   FCDI; CW30168
DR   hPSCreg; CIRMi861-A
DR   SKIP; SKIP003820
DR   Wikidata; Q54815508
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30168; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30169
AC   CVCL_4R69
SY   CIRM-CW30169i-Affected; CIRMi862-A
DR   BioSamples; SAMEA114427126
DR   Coriell; CW30169
DR   FCDI; CW30169
DR   hPSCreg; CIRMi862-A
DR   SKIP; SKIP003821
DR   Wikidata; Q54815509
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30169; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30170
AC   CVCL_AN55
SY   CIRM-CW30170i-Affected; CIRMi863-A
DR   BioSamples; SAMEA114427128
DR   Coriell; CW30170
DR   FCDI; CW30170
DR   hPSCreg; CIRMi863-A
DR   SKIP; SKIP003822
DR   Wikidata; Q54815510
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30170; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30171
AC   CVCL_AN56
SY   CIRM-CW30171i-Ctl; CIRMi864-A
DR   BioSamples; SAMEA114427130
DR   Coriell; CW30171
DR   FCDI; CW30171
DR   hPSCreg; CIRMi864-A
DR   SKIP; SKIP003823
DR   Wikidata; Q54815511
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30171; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30172
AC   CVCL_JH98
SY   CIRMi865-A
DR   BioSamples; SAMEA114427132
DR   Coriell; CW30172
DR   FCDI; CW30172
DR   hPSCreg; CIRMi865-A
DR   Wikidata; Q54815512
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30172; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30173
AC   CVCL_AN57
SY   CIRM-CW30173i-Affected
DR   Coriell; CW30173
DR   FCDI; CW30173
DR   SKIP; SKIP003824
DR   Wikidata; Q54815513
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30173; true.
CC   Discontinued: FCDI; CW30173; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW30174
AC   CVCL_LI63
SY   CIRMi866-A
DR   BioSamples; SAMEA114427134
DR   Coriell; CW30174
DR   FCDI; CW30174
DR   hPSCreg; CIRMi866-A
DR   Wikidata; Q54815514
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30174; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30175
AC   CVCL_DJ49
SY   CIRM-CW30175i-Affected; CIRMi867-A
DR   BioSamples; SAMEA114427136
DR   Coriell; CW30175
DR   FCDI; CW30175
DR   hPSCreg; CIRMi867-A
DR   SKIP; SKIP003825
DR   Wikidata; Q54815515
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30175; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30176
AC   CVCL_JH99
SY   CIRMi868-A
DR   BioSamples; SAMEA114427159
DR   Coriell; CW30176
DR   FCDI; CW30176
DR   hPSCreg; CIRMi868-A
DR   Wikidata; Q54815516
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30176; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30177
AC   CVCL_4R70
SY   CIRM-CW30177i-Affected; CIRMi869-A
DR   BioSamples; SAMEA114427161
DR   Coriell; CW30177
DR   FCDI; CW30177
DR   hPSCreg; CIRMi869-A
DR   SKIP; SKIP003826
DR   Wikidata; Q54815517
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30177; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30178
AC   CVCL_AN58
SY   CIRM-CW30178i-Affected; CIRMi870-A
DR   BioSamples; SAMEA114427163
DR   Coriell; CW30178
DR   FCDI; CW30178
DR   hPSCreg; CIRMi870-A
DR   SKIP; SKIP003827
DR   Wikidata; Q54815518
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30178; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30179
AC   CVCL_JI00
SY   CIRMi871-A
DR   BioSamples; SAMEA114427165
DR   Coriell; CW30179
DR   FCDI; CW30179
DR   hPSCreg; CIRMi871-A
DR   Wikidata; Q54815519
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30179; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30180
AC   CVCL_AN59
SY   CIRM-CW30180i-Affected; CIRMi872-A
DR   BioSamples; SAMEA114427167
DR   Coriell; CW30180
DR   FCDI; CW30180
DR   hPSCreg; CIRMi872-A
DR   SKIP; SKIP003828
DR   Wikidata; Q54815520
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30180; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30181
AC   CVCL_AN60
SY   CIRM-CW30181i-Affected; CIRMi873-A
DR   BioSamples; SAMEA114427169
DR   Coriell; CW30181
DR   FCDI; CW30181
DR   hPSCreg; CIRMi873-A
DR   SKIP; SKIP003829
DR   Wikidata; Q54815532
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30181; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30182
AC   CVCL_DJ50
SY   CIRMi874-A
DR   BioSamples; SAMEA114427171
DR   Coriell; CW30182
DR   FCDI; CW30182
DR   hPSCreg; CIRMi874-A
DR   Wikidata; Q54815533
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30182; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30184
AC   CVCL_4R71
SY   CIRM-CW30184i-Affected; CIRMi875-A
DR   BioSamples; SAMEA114427173
DR   Coriell; CW30184
DR   FCDI; CW30184
DR   hPSCreg; CIRMi875-A
DR   SKIP; SKIP003830
DR   Wikidata; Q54815534
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30184; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30185
AC   CVCL_4R72
SY   CIRM-CW30185i-Affected; CIRMi876-A
DR   BioSamples; SAMEA114427175
DR   Coriell; CW30185
DR   FCDI; CW30185
DR   hPSCreg; CIRMi876-A
DR   SKIP; SKIP003831
DR   Wikidata; Q54815535
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30185; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30186
AC   CVCL_4R73
SY   CIRM-CW30186i-Affected
DR   Coriell; CW30186
DR   FCDI; CW30186
DR   SKIP; SKIP003832
DR   Wikidata; Q54815536
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30186; true.
CC   Discontinued: FCDI; CW30186; probable.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30187
AC   CVCL_4R74
SY   CIRM-CW30187i-Affected
DR   Coriell; CW30187
DR   FCDI; CW30187
DR   SKIP; SKIP003833
DR   Wikidata; Q54815537
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30187; true.
CC   Discontinued: FCDI; CW30187; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW30188
AC   CVCL_4R75
SY   CIRM-CW30188i-Affected; CIRMi877-A
DR   BioSamples; SAMEA114427177
DR   Coriell; CW30188
DR   FCDI; CW30188
DR   hPSCreg; CIRMi877-A
DR   SKIP; SKIP003834
DR   Wikidata; Q54815538
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30188; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30189
AC   CVCL_4R76
SY   CIRM-CW30189i-Affected; CIRMi878-A
DR   BioSamples; SAMEA114427179
DR   Coriell; CW30189
DR   FCDI; CW30189
DR   hPSCreg; CIRMi878-A
DR   SKIP; SKIP003835
DR   Wikidata; Q54815539
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30189; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30190
AC   CVCL_JI01
SY   CIRMi879-A; low_PRS_4
DR   BioSamples; SAMEA114427181
DR   Coriell; CW30190
DR   FCDI; CW30190
DR   hPSCreg; CIRMi879-A
DR   Wikidata; Q54815540
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally low polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW30190; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   CW30191
AC   CVCL_JI02
SY   CIRMi880-A
DR   BioSamples; SAMEA114427183
DR   Coriell; CW30191
DR   FCDI; CW30191
DR   hPSCreg; CIRMi880-A
DR   Wikidata; Q54815541
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30191; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30192
AC   CVCL_4R77
SY   CIRM-CW30192i-Affected; CIRMi881-A
DR   BioSamples; SAMEA114427185
DR   Coriell; CW30192
DR   FCDI; CW30192
DR   hPSCreg; CIRMi881-A
DR   SKIP; SKIP003836
DR   Wikidata; Q54815542
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30192; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30193
AC   CVCL_JI03
SY   CIRMi882-A
DR   BioSamples; SAMEA114427187
DR   Coriell; CW30193
DR   FCDI; CW30193
DR   hPSCreg; CIRMi882-A
DR   Wikidata; Q54815543
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30193; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30194
AC   CVCL_AN61
SY   CIRMi883-A
DR   BioSamples; SAMEA114427189
DR   Coriell; CW30194
DR   FCDI; CW30194
DR   hPSCreg; CIRMi883-A
DR   Wikidata; Q54815544
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30194; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   CW30195
AC   CVCL_HH53
SY   CIRMi884-A
DR   BioSamples; SAMEA114427191
DR   Coriell; CW30195
DR   FCDI; CW30195
DR   hPSCreg; CIRMi884-A
DR   Wikidata; Q54815545
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30195; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30196
AC   CVCL_4R78
SY   CIRM-CW30196i-Affected; CIRMi885-A
DR   BioSamples; SAMEA114427193
DR   Coriell; CW30196
DR   FCDI; CW30196
DR   hPSCreg; CIRMi885-A
DR   SKIP; SKIP003837
DR   Wikidata; Q54815546
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30196; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30197
AC   CVCL_4R79
SY   CIRM-CW30197i-Affected; CIRMi886-A
DR   BioSamples; SAMEA114427195
DR   Coriell; CW30197
DR   FCDI; CW30197
DR   hPSCreg; CIRMi886-A
DR   SKIP; SKIP003838
DR   Wikidata; Q54815547
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30197; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30198
AC   CVCL_4R80
SY   CIRM-CW30198i-Affected; CIRMi887-A
DR   BioSamples; SAMEA114427197
DR   Coriell; CW30198
DR   FCDI; CW30198
DR   hPSCreg; CIRMi887-A
DR   SKIP; SKIP003839
DR   Wikidata; Q54815548
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30198; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30199
AC   CVCL_DJ51
SY   CIRMi888-A
DR   BioSamples; SAMEA114427199
DR   Coriell; CW30199
DR   FCDI; CW30199
DR   hPSCreg; CIRMi888-A
DR   Wikidata; Q54815549
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30199; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30200
AC   CVCL_LI64
SY   CIRMi889-A
DR   BioSamples; SAMEA114427201
DR   Coriell; CW30200
DR   FCDI; CW30200
DR   hPSCreg; CIRMi889-A
DR   Wikidata; Q54815550
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30200; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30202
AC   CVCL_HH54
SY   CIRMi890-A
DR   BioSamples; SAMEA114427203
DR   Coriell; CW30202
DR   FCDI; CW30202
DR   hPSCreg; CIRMi890-A
DR   Wikidata; Q54815551
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30203
AC   CVCL_AN62
SY   CIRM-CW30203i-Affected; CIRMi891-A
DR   BioSamples; SAMEA114427205
DR   Coriell; CW30203
DR   FCDI; CW30203
DR   hPSCreg; CIRMi891-A
DR   SKIP; SKIP003840
DR   Wikidata; Q54815552
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30204
AC   CVCL_JI04
SY   CIRMi892-A
DR   BioSamples; SAMEA114427207
DR   Coriell; CW30204
DR   FCDI; CW30204
DR   hPSCreg; CIRMi892-A
DR   Wikidata; Q54815553
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30204; true.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 9
//
ID   CW30205
AC   CVCL_AN63
SY   CIRM-CW30205i-Affected; CIRMi893-A
DR   BioSamples; SAMEA114427209
DR   Coriell; CW30205
DR   FCDI; CW30205
DR   hPSCreg; CIRMi893-A
DR   SKIP; SKIP003841
DR   Wikidata; Q54815554
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30207
AC   CVCL_AN64
SY   CIRM-CW30207i-Affected; CIRMi894-A
DR   BioSamples; SAMEA114427211
DR   Coriell; CW30207
DR   FCDI; CW30207
DR   hPSCreg; CIRMi894-A
DR   SKIP; SKIP003842
DR   Wikidata; Q54815555
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30208
AC   CVCL_JI05
SY   CIRMi895-A
DR   BioSamples; SAMEA114427213
DR   Coriell; CW30208
DR   FCDI; CW30208
DR   hPSCreg; CIRMi895-A
DR   Wikidata; Q54815556
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30209
AC   CVCL_HH55
SY   CIRMi896-A
DR   BioSamples; SAMEA114427215
DR   Coriell; CW30209
DR   FCDI; CW30209
DR   hPSCreg; CIRMi896-A
DR   Wikidata; Q54815557
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30210
AC   CVCL_JI06
SY   CIRMi897-A
DR   BioSamples; SAMEA114427217
DR   Coriell; CW30210
DR   FCDI; CW30210
DR   hPSCreg; CIRMi897-A
DR   Wikidata; Q54815558
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30211
AC   CVCL_AN65
SY   CIRM-CW30211i-Affected; CIRMi898-A
DR   BioSamples; SAMEA114427219
DR   Coriell; CW30211
DR   FCDI; CW30211
DR   hPSCreg; CIRMi898-A
DR   SKIP; SKIP003843
DR   Wikidata; Q54815559
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30212
AC   CVCL_AN66
SY   CIRM-CW30212i-Affected; CIRMi899-A
DR   BioSamples; SAMEA114427221
DR   Coriell; CW30212
DR   FCDI; CW30212
DR   hPSCreg; CIRMi899-A
DR   SKIP; SKIP003844
DR   Wikidata; Q54815560
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30213
AC   CVCL_JI07
SY   CIRMi900-A
DR   BioSamples; SAMEA114427223
DR   Coriell; CW30213
DR   FCDI; CW30213
DR   hPSCreg; CIRMi900-A
DR   Wikidata; Q54815561
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30214
AC   CVCL_AN67
SY   CIRM-CW30214i-Affected; CIRMi901-A
DR   BioSamples; SAMEA114427225
DR   Coriell; CW30214
DR   FCDI; CW30214
DR   hPSCreg; CIRMi901-A
DR   SKIP; SKIP003845
DR   Wikidata; Q54815562
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30214; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30215
AC   CVCL_AN68
SY   CIRM-CW30215i-Affected; CIRMi902-A
DR   BioSamples; SAMEA114427227
DR   Coriell; CW30215
DR   FCDI; CW30215
DR   hPSCreg; CIRMi902-A
DR   SKIP; SKIP003846
DR   Wikidata; Q54815563
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30215; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30216
AC   CVCL_JI08
SY   CIRMi903-A
DR   BioSamples; SAMEA114427229
DR   Coriell; CW30216
DR   FCDI; CW30216
DR   hPSCreg; CIRMi903-A
DR   Wikidata; Q54815564
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30216; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30217
AC   CVCL_AN69
SY   CIRM-CW30217i-Affected
DR   Coriell; CW30217
DR   FCDI; CW30217
DR   SKIP; SKIP003847
DR   Wikidata; Q54815565
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30217; true.
CC   Discontinued: FCDI; CW30217; probable.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW30219
AC   CVCL_AN70
SY   CIRM-CW30219i-Affected; CIRMi904-A
DR   BioSamples; SAMEA114427231
DR   Coriell; CW30219
DR   FCDI; CW30219
DR   hPSCreg; CIRMi904-A
DR   SKIP; SKIP003848
DR   Wikidata; Q54815566
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30219; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30220
AC   CVCL_JI09
SY   CIRMi905-A
DR   BioSamples; SAMEA114427233
DR   Coriell; CW30220
DR   FCDI; CW30220
DR   hPSCreg; CIRMi905-A
DR   Wikidata; Q54815567
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30220; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30221
AC   CVCL_JI10
SY   CIRMi906-A
DR   BioSamples; SAMEA114427235
DR   Coriell; CW30221
DR   FCDI; CW30221
DR   hPSCreg; CIRMi906-A
DR   Wikidata; Q54815568
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30221; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30222
AC   CVCL_AN71
SY   CIRM-CW30222i-Affected; CIRMi907-A
DR   BioSamples; SAMEA114427237
DR   Coriell; CW30222
DR   FCDI; CW30222
DR   hPSCreg; CIRMi907-A
DR   SKIP; SKIP003849
DR   Wikidata; Q54815569
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30222; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30223
AC   CVCL_DJ52
SY   CIRMi908-A
DR   BioSamples; SAMEA114427239
DR   Coriell; CW30223
DR   FCDI; CW30223
DR   hPSCreg; CIRMi908-A
DR   Wikidata; Q54815570
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30223; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30224
AC   CVCL_JI11
SY   CIRMi909-A
DR   BioSamples; SAMEA114427241
DR   Coriell; CW30224
DR   FCDI; CW30224
DR   hPSCreg; CIRMi909-A
DR   Wikidata; Q54815571
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30224; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30225
AC   CVCL_AN72
SY   CIRM-CW30225i-Affected; CIRMi910-A
DR   BioSamples; SAMEA114427243
DR   Coriell; CW30225
DR   FCDI; CW30225
DR   hPSCreg; CIRMi910-A
DR   SKIP; SKIP003850
DR   Wikidata; Q54815575
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30225; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30226
AC   CVCL_ER38
SY   CIRMi911-A
DR   BioSamples; SAMEA114427245
DR   Coriell; CW30226
DR   FCDI; CW30226
DR   hPSCreg; CIRMi911-A
DR   Wikidata; Q54815576
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30226; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30227
AC   CVCL_JI12
SY   CIRMi912-A
DR   BioSamples; SAMEA114427247
DR   Coriell; CW30227
DR   FCDI; CW30227
DR   hPSCreg; CIRMi912-A
DR   Wikidata; Q54815577
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30227; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30228
AC   CVCL_AN73
SY   CIRM-CW30228i-Affected; CIRMi913-A
DR   BioSamples; SAMEA114427249
DR   Coriell; CW30228
DR   FCDI; CW30228
DR   hPSCreg; CIRMi913-A
DR   SKIP; SKIP003851
DR   Wikidata; Q54815578
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30228; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30229
AC   CVCL_AN74
SY   CIRM-CW30229i-Affected; CIRMi914-A
DR   BioSamples; SAMEA114427251
DR   Coriell; CW30229
DR   FCDI; CW30229
DR   hPSCreg; CIRMi914-A
DR   SKIP; SKIP003852
DR   Wikidata; Q54815579
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30229; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30230
AC   CVCL_AN75
SY   CIRM-CW30230i-Affected; CIRMi915-A
DR   BioSamples; SAMEA114427253
DR   Coriell; CW30230
DR   FCDI; CW30230
DR   hPSCreg; CIRMi915-A
DR   SKIP; SKIP003853
DR   Wikidata; Q54815580
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30230; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30231
AC   CVCL_JI13
SY   CIRMi916-A
DR   BioSamples; SAMEA114427255
DR   Coriell; CW30231
DR   FCDI; CW30231
DR   hPSCreg; CIRMi916-A
DR   Wikidata; Q54815581
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30231; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 9
//
ID   CW30232
AC   CVCL_AN76
SY   CIRM-CW30232i-Affected; CIRMi917-A
DR   BioSamples; SAMEA114427257
DR   Coriell; CW30232
DR   FCDI; CW30232
DR   hPSCreg; CIRMi917-A
DR   SKIP; SKIP003854
DR   Wikidata; Q54815582
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30232; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30233
AC   CVCL_HH56
SY   CIRMi918-A
DR   BioSamples; SAMEA114427259
DR   Coriell; CW30233
DR   FCDI; CW30233
DR   hPSCreg; CIRMi918-A
DR   Wikidata; Q54815583
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30233; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30234
AC   CVCL_AN77
SY   CIRM-CW30234i-Affected; CIRMi919-A
DR   BioSamples; SAMEA114427261
DR   Coriell; CW30234
DR   FCDI; CW30234
DR   hPSCreg; CIRMi919-A
DR   SKIP; SKIP003855
DR   Wikidata; Q54815584
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30234; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30235
AC   CVCL_JI14
SY   CIRMi920-A
DR   BioSamples; SAMEA114427263
DR   Coriell; CW30235
DR   FCDI; CW30235
DR   hPSCreg; CIRMi920-A
DR   Wikidata; Q54815585
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30235; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30236
AC   CVCL_4R81
SY   CIRM-CW30236i-Affected; CIRMi921-A
DR   BioSamples; SAMEA114427265
DR   Coriell; CW30236
DR   FCDI; CW30236
DR   hPSCreg; CIRMi921-A
DR   SKIP; SKIP003856
DR   Wikidata; Q54815586
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30236; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30237
AC   CVCL_4R82
SY   CIRM-CW30237i-Affected; CIRMi922-A
DR   BioSamples; SAMEA114427267
DR   Coriell; CW30237
DR   FCDI; CW30237
DR   hPSCreg; CIRMi922-A
DR   SKIP; SKIP003857
DR   Wikidata; Q54815587
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30237; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30238
AC   CVCL_AN78
SY   CIRM-CW30238i-Affected; CIRMi923-A
DR   BioSamples; SAMEA114427269
DR   Coriell; CW30238
DR   FCDI; CW30238
DR   hPSCreg; CIRMi923-A
DR   SKIP; SKIP003858
DR   Wikidata; Q54815588
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30238; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30240
AC   CVCL_AN79
SY   CIRM-CW30240i-Affected; CIRMi924-A
DR   BioSamples; SAMEA114427271
DR   Coriell; CW30240
DR   FCDI; CW30240
DR   hPSCreg; CIRMi924-A
DR   SKIP; SKIP003859
DR   Wikidata; Q54815589
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30240; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30241
AC   CVCL_DJ53
SY   CIRMi925-A
DR   BioSamples; SAMEA114427273
DR   Coriell; CW30241
DR   FCDI; CW30241
DR   hPSCreg; CIRMi925-A
DR   Wikidata; Q54815590
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30241; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 9
//
ID   CW30242
AC   CVCL_AN80
SY   CIRM-CW30242i-Affected; CIRMi926-A
DR   BioSamples; SAMEA114427275
DR   Coriell; CW30242
DR   FCDI; CW30242
DR   hPSCreg; CIRMi926-A
DR   SKIP; SKIP003860
DR   Wikidata; Q54815591
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30242; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30243
AC   CVCL_AN81
SY   CIRM-CW30243i-Affected; CIRMi927-A
DR   BioSamples; SAMEA114427277
DR   Coriell; CW30243
DR   FCDI; CW30243
DR   hPSCreg; CIRMi927-A
DR   SKIP; SKIP003861
DR   Wikidata; Q54815592
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30243; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30244
AC   CVCL_ER39
SY   CIRMi928-A
DR   BioSamples; SAMEA114427279
DR   Coriell; CW30244
DR   FCDI; CW30244
DR   hPSCreg; CIRMi928-A
DR   Wikidata; Q54815593
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30244; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30245
AC   CVCL_AN82
SY   CIRM-CW30245i-Affected; CIRMi929-A
DR   BioSamples; SAMEA114427281
DR   Coriell; CW30245
DR   FCDI; CW30245
DR   hPSCreg; CIRMi929-A
DR   SKIP; SKIP003862
DR   Wikidata; Q54815594
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30245; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30246
AC   CVCL_4R83
SY   CIRM-CW30246i-Affected; CIRMi930-A
DR   BioSamples; SAMEA114427283
DR   Coriell; CW30246
DR   FCDI; CW30246
DR   hPSCreg; CIRMi930-A
DR   SKIP; SKIP003863
DR   Wikidata; Q54815595
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30246; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30247
AC   CVCL_AN83
SY   CIRM-CW30247i-Affected; CIRMi931-A
DR   BioSamples; SAMEA114427285
DR   Coriell; CW30247
DR   FCDI; CW30247
DR   hPSCreg; CIRMi931-A
DR   SKIP; SKIP003864
DR   Wikidata; Q54815596
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30247; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30248
AC   CVCL_AN84
SY   CIRM-CW30248i-Affected; CIRMi932-A
DR   BioSamples; SAMEA114427287
DR   Coriell; CW30248
DR   FCDI; CW30248
DR   hPSCreg; CIRMi932-A
DR   SKIP; SKIP003865
DR   Wikidata; Q54815597
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30248; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30249
AC   CVCL_4R84
SY   CIRM-CW30249i-Affected; CIRMi933-A
DR   BioSamples; SAMEA114427289
DR   Coriell; CW30249
DR   FCDI; CW30249
DR   hPSCreg; CIRMi933-A
DR   SKIP; SKIP003866
DR   Wikidata; Q54815598
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30249; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30251
AC   CVCL_4R85
SY   CIRM-CW30251i-Affected; CIRMi934-A
DR   BioSamples; SAMEA114427291
DR   Coriell; CW30251
DR   FCDI; CW30251
DR   hPSCreg; CIRMi934-A
DR   SKIP; SKIP003867
DR   Wikidata; Q54815599
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30251; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW30253
AC   CVCL_AN85
SY   CIRM-CW30253i-Affected; CIRMi935-A
DR   BioSamples; SAMEA114427293
DR   Coriell; CW30253
DR   FCDI; CW30253
DR   hPSCreg; CIRMi935-A
DR   SKIP; SKIP003868
DR   Wikidata; Q54815600
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30253; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30254
AC   CVCL_DJ54
SY   CIRMi936-A
DR   BioSamples; SAMEA114427295
DR   Coriell; CW30254
DR   FCDI; CW30254
DR   hPSCreg; CIRMi936-A
DR   Wikidata; Q54815601
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30254; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30255
AC   CVCL_AN86
SY   CIRM-CW30255i-Affected
DR   Coriell; CW30255
DR   FCDI; CW30255
DR   SKIP; SKIP003869
DR   Wikidata; Q54815602
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30255; true.
CC   Discontinued: FCDI; CW30255; probable.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW30256
AC   CVCL_DJ55
SY   CIRMi937-A
DR   BioSamples; SAMEA114427297
DR   Coriell; CW30256
DR   FCDI; CW30256
DR   hPSCreg; CIRMi937-A
DR   Wikidata; Q54815603
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30256; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30257
AC   CVCL_JI15
SY   CIRMi938-A
DR   BioSamples; SAMEA114427299
DR   Coriell; CW30257
DR   FCDI; CW30257
DR   hPSCreg; CIRMi938-A
DR   Wikidata; Q54815604
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30257; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30258
AC   CVCL_AN87
SY   CIRM-CW30258i-Affected; CIRMi939-A
DR   BioSamples; SAMEA114427301
DR   Coriell; CW30258
DR   FCDI; CW30258
DR   hPSCreg; CIRMi939-A
DR   SKIP; SKIP003870
DR   Wikidata; Q54815605
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30258; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30259
AC   CVCL_AN88
SY   CIRM-CW30259i-Affected; CIRMi940-A
DR   BioSamples; SAMEA114427303
DR   Coriell; CW30259
DR   FCDI; CW30259
DR   hPSCreg; CIRMi940-A
DR   SKIP; SKIP003871
DR   Wikidata; Q54815606
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30259; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30260
AC   CVCL_JI16
SY   CIRMi941-A
DR   BioSamples; SAMEA114427305
DR   Coriell; CW30260
DR   FCDI; CW30260
DR   hPSCreg; CIRMi941-A
DR   Wikidata; Q54815607
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30260; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30261
AC   CVCL_HH57
SY   CIRMi942-A
DR   BioSamples; SAMEA114427307
DR   Coriell; CW30261
DR   FCDI; CW30261
DR   hPSCreg; CIRMi942-A
DR   Wikidata; Q54815608
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30261; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30262
AC   CVCL_HH58
SY   CIRMi943-A
DR   BioSamples; SAMEA114427309
DR   Coriell; CW30262
DR   FCDI; CW30262
DR   hPSCreg; CIRMi943-A
DR   Wikidata; Q54815609
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30262; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30263
AC   CVCL_HH59
SY   CIRMi944-A
DR   BioSamples; SAMEA114427311
DR   Coriell; CW30263
DR   FCDI; CW30263
DR   hPSCreg; CIRMi944-A
DR   Wikidata; Q54815610
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30263; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30264
AC   CVCL_JI17
SY   CIRMi945-A
DR   BioSamples; SAMEA114427313
DR   Coriell; CW30264
DR   FCDI; CW30264
DR   hPSCreg; CIRMi945-A
DR   Wikidata; Q54815611
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30264; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30265
AC   CVCL_DN40
SY   CIRM-CW30265i-Affected; CIRMi946-A
DR   BioSamples; SAMEA114427579
DR   Coriell; CW30265
DR   FCDI; CW30265
DR   hPSCreg; CIRMi946-A
DR   SKIP; SKIP003872
DR   Wikidata; Q54815612
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30265; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 14
//
ID   CW30266
AC   CVCL_HH60
SY   CIRMi947-A
DR   BioSamples; SAMEA114427593
DR   Coriell; CW30266
DR   FCDI; CW30266
DR   hPSCreg; CIRMi947-A
DR   Wikidata; Q54815613
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30266; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30267
AC   CVCL_HH61
SY   CIRMi948-A
DR   BioSamples; SAMEA114427610
DR   Coriell; CW30267
DR   FCDI; CW30267
DR   hPSCreg; CIRMi948-A
DR   Wikidata; Q54815614
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30267; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30268
AC   CVCL_AN89
SY   CIRM-CW30268i-Affected; CIRMi949-A
DR   BioSamples; SAMEA114427633
DR   Coriell; CW30268
DR   FCDI; CW30268
DR   hPSCreg; CIRMi949-A
DR   SKIP; SKIP003873
DR   Wikidata; Q54815628
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30268; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30269
AC   CVCL_AN90
SY   CIRM-CW30269i-Affected; CIRMi950-A
DR   BioSamples; SAMEA114427735
DR   Coriell; CW30269
DR   FCDI; CW30269
DR   hPSCreg; CIRMi950-A
DR   SKIP; SKIP003874
DR   Wikidata; Q54815629
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30269; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30270
AC   CVCL_HH62
SY   CIRMi951-A
DR   BioSamples; SAMEA114427780
DR   Coriell; CW30270
DR   FCDI; CW30270
DR   hPSCreg; CIRMi951-A
DR   Wikidata; Q54815631
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30270; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30272
AC   CVCL_JI18
SY   CIRMi952-A
DR   BioSamples; SAMEA114427794
DR   Coriell; CW30272
DR   FCDI; CW30272
DR   hPSCreg; CIRMi952-A
DR   Wikidata; Q54815632
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30272; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30273
AC   CVCL_JI19
SY   CIRMi953-A
DR   BioSamples; SAMEA114427809
DR   Coriell; CW30273
DR   FCDI; CW30273
DR   hPSCreg; CIRMi953-A
DR   Wikidata; Q54815633
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30273; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30274
AC   CVCL_AN91
SY   CIRM-CW30274i-Affected; CIRMi954-A; high_PRS_1
DR   BioSamples; SAMEA114427823
DR   Coriell; CW30274
DR   FCDI; CW30274
DR   hPSCreg; CIRMi954-A
DR   SKIP; SKIP003875
DR   Wikidata; Q54815634
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally high polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW30274; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 14
//
ID   CW30275
AC   CVCL_LI65
SY   CIRMi955-A
DR   BioSamples; SAMEA114427838
DR   Coriell; CW30275
DR   FCDI; CW30275
DR   hPSCreg; CIRMi955-A
DR   Wikidata; Q54815635
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30275; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30276
AC   CVCL_DJ56
SY   CIRM-CW30276i-Affected; CIRMi956-A
DR   BioSamples; SAMEA114427852
DR   Coriell; CW30276
DR   FCDI; CW30276
DR   hPSCreg; CIRMi956-A
DR   SKIP; SKIP003876
DR   Wikidata; Q54815636
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30276; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30277
AC   CVCL_AN92
SY   CIRM-CW30277i-Affected
DR   Coriell; CW30277
DR   FCDI; CW30277
DR   SKIP; SKIP003877
DR   Wikidata; Q54815637
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30277; true.
CC   Discontinued: FCDI; CW30277; probable.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW30279
AC   CVCL_DJ57
SY   CIRMi957-A
DR   BioSamples; SAMEA114427867
DR   Coriell; CW30279
DR   FCDI; CW30279
DR   hPSCreg; CIRMi957-A
DR   Wikidata; Q54815638
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30279; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30280
AC   CVCL_AN93
SY   CIRM-CW30280i-Affected; CIRMi958-A
DR   BioSamples; SAMEA114427881
DR   Coriell; CW30280
DR   FCDI; CW30280
DR   hPSCreg; CIRMi958-A
DR   SKIP; SKIP003878
DR   Wikidata; Q54815639
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30280; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30282
AC   CVCL_AN94
SY   CIRM-CW30282i-Affected; CIRMi959-A
DR   BioSamples; SAMEA114427895
DR   Coriell; CW30282
DR   FCDI; CW30282
DR   hPSCreg; CIRMi959-A
DR   SKIP; SKIP003879
DR   Wikidata; Q54815640
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30282; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30283
AC   CVCL_AN95
SY   CIRM-CW30283i-Affected; CIRMi960-A
DR   BioSamples; SAMEA114427910
DR   Coriell; CW30283
DR   FCDI; CW30283
DR   hPSCreg; CIRMi960-A
DR   SKIP; SKIP003880
DR   Wikidata; Q54815641
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30283; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30284
AC   CVCL_DJ58
SY   CIRMi961-A
DR   BioSamples; SAMEA114427924
DR   Coriell; CW30284
DR   FCDI; CW30284
DR   hPSCreg; CIRMi961-A
DR   Wikidata; Q54815642
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30284; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30285
AC   CVCL_AN96
SY   CIRM-CW30285i-Affected; CIRMi962-A
DR   BioSamples; SAMEA114427938
DR   Coriell; CW30285
DR   FCDI; CW30285
DR   hPSCreg; CIRMi962-A
DR   SKIP; SKIP003881
DR   Wikidata; Q54815643
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30285; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30286
AC   CVCL_JI20
SY   CIRMi963-A
DR   BioSamples; SAMEA114427953
DR   Coriell; CW30286
DR   FCDI; CW30286
DR   hPSCreg; CIRMi963-A
DR   Wikidata; Q54815644
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30286; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30287
AC   CVCL_JI21
SY   CIRMi964-A
DR   BioSamples; SAMEA114427968
DR   Coriell; CW30287
DR   FCDI; CW30287
DR   hPSCreg; CIRMi964-A
DR   Wikidata; Q54815645
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30287; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30288
AC   CVCL_DJ59
SY   CIRM-CW30288i-Affected; CIRMi965-A
DR   BioSamples; SAMEA114427982
DR   Coriell; CW30288
DR   FCDI; CW30288
DR   hPSCreg; CIRMi965-A
DR   SKIP; SKIP003882
DR   Wikidata; Q54815646
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30288; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30289
AC   CVCL_DJ60
SY   CIRM-CW30289i-Affected; CIRMi966-A
DR   BioSamples; SAMEA114427996
DR   Coriell; CW30289
DR   FCDI; CW30289
DR   hPSCreg; CIRMi966-A
DR   SKIP; SKIP003883
DR   Wikidata; Q54815647
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30289; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30290
AC   CVCL_DJ61
SY   CIRM-CW30290i-Affected; CIRMi967-A
DR   BioSamples; SAMEA114428010
DR   Coriell; CW30290
DR   FCDI; CW30290
DR   hPSCreg; CIRMi967-A
DR   SKIP; SKIP003884
DR   Wikidata; Q54815648
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30290; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30291
AC   CVCL_DJ62
SY   CIRM-CW30291i-Ctl; CIRMi968-A
DR   BioSamples; SAMEA114428024
DR   Coriell; CW30291
DR   FCDI; CW30291
DR   hPSCreg; CIRMi968-A
DR   SKIP; SKIP003885
DR   Wikidata; Q54815649
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30291; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30292
AC   CVCL_AN97
SY   CIRM-CW30292i-Affected; CIRMi969-A
DR   BioSamples; SAMEA114428039
DR   Coriell; CW30292
DR   FCDI; CW30292
DR   hPSCreg; CIRMi969-A
DR   SKIP; SKIP003886
DR   Wikidata; Q54815650
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30292; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30293
AC   CVCL_HH63
SY   CIRMi970-A
DR   BioSamples; SAMEA114428054
DR   Coriell; CW30293
DR   FCDI; CW30293
DR   hPSCreg; CIRMi970-A
DR   Wikidata; Q54815651
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30293; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30295
AC   CVCL_DJ63
SY   CIRM-CW30295i-Affected; CIRMi971-A
DR   BioSamples; SAMEA114428069
DR   Coriell; CW30295
DR   FCDI; CW30295
DR   hPSCreg; CIRMi971-A
DR   SKIP; SKIP003887
DR   Wikidata; Q54815653
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30295; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30297
AC   CVCL_DJ64
SY   CIRM-CW30297i-Affected; CIRMi972-A
DR   BioSamples; SAMEA114428083
DR   Coriell; CW30297
DR   FCDI; CW30297
DR   hPSCreg; CIRMi972-A
DR   SKIP; SKIP003888
DR   Wikidata; Q54815654
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30297; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30298
AC   CVCL_HH64
SY   CIRMi973-A
DR   BioSamples; SAMEA114428098
DR   Coriell; CW30298
DR   FCDI; CW30298
DR   hPSCreg; CIRMi973-A
DR   Wikidata; Q54815655
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30298; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30299
AC   CVCL_AN98
SY   CIRM-CW30299i-Affected; CIRMi974-A
DR   BioSamples; SAMEA114428112
DR   Coriell; CW30299
DR   FCDI; CW30299
DR   hPSCreg; CIRMi974-A
DR   SKIP; SKIP003889
DR   Wikidata; Q54815656
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30299; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30300
AC   CVCL_DJ65
SY   CIRMi975-A
DR   BioSamples; SAMEA114428127
DR   Coriell; CW30300
DR   FCDI; CW30300
DR   hPSCreg; CIRMi975-A
DR   Wikidata; Q54815657
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30300; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30302
AC   CVCL_AN99
SY   CIRM-CW30302i-Affected; CIRMi976-A
DR   BioSamples; SAMEA114428141
DR   Coriell; CW30302
DR   FCDI; CW30302
DR   hPSCreg; CIRMi976-A
DR   SKIP; SKIP003890
DR   Wikidata; Q54815658
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30303
AC   CVCL_AP00
SY   CIRM-CW30303i-Affected; CIRMi977-A
DR   BioSamples; SAMEA114428157
DR   Coriell; CW30303
DR   FCDI; CW30303
DR   hPSCreg; CIRMi977-A
DR   SKIP; SKIP003891
DR   Wikidata; Q54815659
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30305
AC   CVCL_JI22
SY   CIRMi978-A
DR   BioSamples; SAMEA114428170
DR   Coriell; CW30305
DR   FCDI; CW30305
DR   hPSCreg; CIRMi978-A
DR   Wikidata; Q54815660
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30306
AC   CVCL_AP01
SY   CIRM-CW30306i-Affected; CIRMi979-A
DR   BioSamples; SAMEA114428186
DR   Coriell; CW30306
DR   FCDI; CW30306
DR   hPSCreg; CIRMi979-A
DR   SKIP; SKIP003892
DR   Wikidata; Q54815661
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30307
AC   CVCL_AP02
SY   CIRM-CW30307i-Affected; CIRMi980-A
DR   BioSamples; SAMEA114428198
DR   Coriell; CW30307
DR   FCDI; CW30307
DR   hPSCreg; CIRMi980-A
DR   SKIP; SKIP003893
DR   Wikidata; Q54815663
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30309
AC   CVCL_DJ66
SY   CIRM-CW30309i-Affected; CIRMi981-A
DR   BioSamples; SAMEA114428215
DR   Coriell; CW30309
DR   FCDI; CW30309
DR   hPSCreg; CIRMi981-A
DR   SKIP; SKIP003894
DR   Wikidata; Q54815664
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30309; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30310
AC   CVCL_AP03
SY   CIRM-CW30310i-Affected; CIRMi982-A
DR   BioSamples; SAMEA114428229
DR   Coriell; CW30310
DR   FCDI; CW30310
DR   hPSCreg; CIRMi982-A
DR   SKIP; SKIP003895
DR   Wikidata; Q54815666
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30310; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30311
AC   CVCL_AP04
SY   CIRM-CW30311i-Affected; CIRMi983-A
DR   BioSamples; SAMEA114428243
DR   Coriell; CW30311
DR   FCDI; CW30311
DR   hPSCreg; CIRMi983-A
DR   SKIP; SKIP003896
DR   Wikidata; Q54815667
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30311; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30312
AC   CVCL_AP05
SY   CIRM-CW30312i-Affected; CIRMi984-A
DR   BioSamples; SAMEA114428257
DR   Coriell; CW30312
DR   FCDI; CW30312
DR   hPSCreg; CIRMi984-A
DR   SKIP; SKIP003897
DR   Wikidata; Q54815668
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30314
AC   CVCL_AP06
SY   CIRM-CW30314i-Affected; CIRMi985-A
DR   BioSamples; SAMEA114428273
DR   Coriell; CW30314
DR   FCDI; CW30314
DR   hPSCreg; CIRMi985-A
DR   SKIP; SKIP003898
DR   Wikidata; Q54815669
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30316
AC   CVCL_DJ67
SY   CIRMi986-A
DR   BioSamples; SAMEA114428286
DR   Coriell; CW30316
DR   FCDI; CW30316
DR   hPSCreg; CIRMi986-A
DR   Wikidata; Q54815670
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30316; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30317
AC   CVCL_DJ68
SY   CIRMi987-A
DR   BioSamples; SAMEA114428301
DR   Coriell; CW30317
DR   FCDI; CW30317
DR   hPSCreg; CIRMi987-A
DR   Wikidata; Q54815672
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30317; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30318
AC   CVCL_DJ69
SY   CIRMi988-A
DR   BioSamples; SAMEA114428315
DR   Coriell; CW30318
DR   FCDI; CW30318
DR   hPSCreg; CIRMi988-A
DR   Wikidata; Q54815681
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30318; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30319
AC   CVCL_DJ70
SY   CIRM-CW30319i-Affected; CIRMi989-A
DR   BioSamples; SAMEA114428330
DR   Coriell; CW30319
DR   FCDI; CW30319
DR   hPSCreg; CIRMi989-A
DR   SKIP; SKIP003899
DR   Wikidata; Q54815682
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30320
AC   CVCL_JI23
SY   CIRMi990-A
DR   BioSamples; SAMEA114428344
DR   Coriell; CW30320
DR   FCDI; CW30320
DR   hPSCreg; CIRMi990-A
DR   Wikidata; Q54815683
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30320; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30321
AC   CVCL_HH65
SY   CIRMi991-A
DR   BioSamples; SAMEA114428360
DR   Coriell; CW30321
DR   FCDI; CW30321
DR   hPSCreg; CIRMi991-A
DR   Wikidata; Q54815684
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30322
AC   CVCL_DJ71
SY   CIRM-CW30322i-Affected; CIRMi992-A
DR   BioSamples; SAMEA114428374
DR   Coriell; CW30322
DR   FCDI; CW30322
DR   hPSCreg; CIRMi992-A
DR   SKIP; SKIP003900
DR   Wikidata; Q54815685
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30323
AC   CVCL_DJ72
SY   CIRMi993-A
DR   BioSamples; SAMEA114428389
DR   Coriell; CW30323
DR   FCDI; CW30323
DR   hPSCreg; CIRMi993-A
DR   Wikidata; Q54815686
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30323; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30324
AC   CVCL_HH66
SY   CIRMi994-A
DR   BioSamples; SAMEA114428406
DR   Coriell; CW30324
DR   FCDI; CW30324
DR   hPSCreg; CIRMi994-A
DR   Wikidata; Q54815687
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30324; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30325
AC   CVCL_DJ73
SY   CIRMi995-A
DR   BioSamples; SAMEA114428425
DR   Coriell; CW30325
DR   FCDI; CW30325
DR   hPSCreg; CIRMi995-A
DR   Wikidata; Q54815688
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30325; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30326
AC   CVCL_DJ74
SY   CIRMi996-A
DR   BioSamples; SAMEA114428443
DR   Coriell; CW30326
DR   FCDI; CW30326
DR   hPSCreg; CIRMi996-A
DR   Wikidata; Q54815689
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30326; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30327
AC   CVCL_DJ75
SY   CIRM-CW30327i-Affected; CIRMi997-A
DR   BioSamples; SAMEA114428463
DR   Coriell; CW30327
DR   FCDI; CW30327
DR   hPSCreg; CIRMi997-A
DR   SKIP; SKIP003901
DR   Wikidata; Q54815690
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30327; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30328
AC   CVCL_AP07
SY   CIRM-CW30328i-Affected; CIRMi998-A
DR   BioSamples; SAMEA114428482
DR   Coriell; CW30328
DR   FCDI; CW30328
DR   hPSCreg; CIRMi998-A
DR   SKIP; SKIP003902
DR   Wikidata; Q54815691
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30328; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30329
AC   CVCL_DJ76
SY   CIRM-CW30329i-Affected; CIRMi999-A
DR   BioSamples; SAMEA114428496
DR   Coriell; CW30329
DR   FCDI; CW30329
DR   hPSCreg; CIRMi999-A
DR   SKIP; SKIP003903
DR   Wikidata; Q54815692
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30329; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30331
AC   CVCL_AP08
SY   CIRM-CW30331i-Affected; CIRMi00A-A
DR   BioSamples; SAMEA114428511
DR   Coriell; CW30331
DR   FCDI; CW30331
DR   hPSCreg; CIRMi00A-A
DR   SKIP; SKIP003904
DR   Wikidata; Q54815693
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30331; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30332
AC   CVCL_HH67
SY   CIRMi00B-A
DR   BioSamples; SAMEA114428528
DR   Coriell; CW30332
DR   FCDI; CW30332
DR   hPSCreg; CIRMi00B-A
DR   Wikidata; Q54815694
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30332; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30333
AC   CVCL_ER40
SY   CIRMi00C-A
DR   BioSamples; SAMEA114428550
DR   Coriell; CW30333
DR   FCDI; CW30333
DR   hPSCreg; CIRMi00C-A
DR   Wikidata; Q54815695
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30333; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30334
AC   CVCL_DJ77
SY   CIRMi00D-A
DR   BioSamples; SAMEA114428572
DR   Coriell; CW30334
DR   FCDI; CW30334
DR   hPSCreg; CIRMi00D-A
DR   Wikidata; Q54815696
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30334; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30335
AC   CVCL_AP09
SY   CIRM-CW30335i-Affected; CIRMi00E-A
DR   BioSamples; SAMEA114428587
DR   Coriell; CW30335
DR   FCDI; CW30335
DR   hPSCreg; CIRMi00E-A
DR   SKIP; SKIP003905
DR   Wikidata; Q54815697
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30335; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30336
AC   CVCL_AP10
SY   CIRM-CW30336i-Affected; CIRMi00F-A
DR   BioSamples; SAMEA114428601
DR   Coriell; CW30336
DR   FCDI; CW30336
DR   hPSCreg; CIRMi00F-A
DR   SKIP; SKIP003906
DR   Wikidata; Q54815698
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30336; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30337
AC   CVCL_HH68
SY   CIRMi00G-A
DR   BioSamples; SAMEA114428616
DR   Coriell; CW30337
DR   FCDI; CW30337
DR   hPSCreg; CIRMi00G-A
DR   Wikidata; Q54815699
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30337; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30338
AC   CVCL_AP11
SY   CIRM-CW30338i-Affected; CIRMi00H-A
DR   BioSamples; SAMEA114428629
DR   Coriell; CW30338
DR   FCDI; CW30338
DR   hPSCreg; CIRMi00H-A
DR   SKIP; SKIP003907
DR   Wikidata; Q54815700
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30338; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30339
AC   CVCL_ER41
SY   CIRMi00I-A
DR   BioSamples; SAMEA114428644
DR   Coriell; CW30339
DR   FCDI; CW30339
DR   hPSCreg; CIRMi00I-A
DR   Wikidata; Q54815701
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30339; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30340
AC   CVCL_AP12
SY   CIRM-CW30340i-Affected; CIRMi00J-A
DR   BioSamples; SAMEA114428659
DR   Coriell; CW30340
DR   FCDI; CW30340
DR   hPSCreg; CIRMi00J-A
DR   SKIP; SKIP003908
DR   Wikidata; Q54815702
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30340; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW30342
AC   CVCL_ER42
SY   CIRMi00K-A
DR   BioSamples; SAMEA114428673
DR   Coriell; CW30342
DR   FCDI; CW30342
DR   hPSCreg; CIRMi00K-A
DR   Wikidata; Q54815703
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30342; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30343
AC   CVCL_HH69
SY   CIRMi00L-A
DR   BioSamples; SAMEA114428688
DR   Coriell; CW30343
DR   FCDI; CW30343
DR   hPSCreg; CIRMi00L-A
DR   Wikidata; Q54815704
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30343; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30344
AC   CVCL_ER43
SY   CIRMi00M-A
DR   BioSamples; SAMEA114428705
DR   Coriell; CW30344
DR   FCDI; CW30344
DR   hPSCreg; CIRMi00M-A
DR   Wikidata; Q54815705
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30344; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30345
AC   CVCL_ER44
SY   CIRMi00N-A
DR   BioSamples; SAMEA114428727
DR   Coriell; CW30345
DR   FCDI; CW30345
DR   hPSCreg; CIRMi00N-A
DR   Wikidata; Q54815706
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30345; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30346
AC   CVCL_HH70
SY   CIRMi00O-A
DR   BioSamples; SAMEA114428747
DR   Coriell; CW30346
DR   FCDI; CW30346
DR   hPSCreg; CIRMi00O-A
DR   Wikidata; Q54815707
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: East Indian.
CC   Discontinued: Coriell; CW30346; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30348
AC   CVCL_JI24
SY   CIRMi00P-A
DR   BioSamples; SAMEA114428765
DR   Coriell; CW30348
DR   FCDI; CW30348
DR   hPSCreg; CIRMi00P-A
DR   Wikidata; Q54815708
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30348; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30349
AC   CVCL_HH71
SY   CIRMi00Q-A
DR   BioSamples; SAMEA114428779
DR   Coriell; CW30349
DR   FCDI; CW30349
DR   hPSCreg; CIRMi00Q-A
DR   Wikidata; Q54815709
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30349; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30350
AC   CVCL_HH72
SY   CIRMi00R-A
DR   BioSamples; SAMEA114428797
DR   Coriell; CW30350
DR   FCDI; CW30350
DR   hPSCreg; CIRMi00R-A
DR   Wikidata; Q54815710
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30350; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 11
//
ID   CW30353
AC   CVCL_HH73
SY   CIRMi00S-A
DR   BioSamples; SAMEA114428814
DR   Coriell; CW30353
DR   FCDI; CW30353
DR   hPSCreg; CIRMi00S-A
DR   Wikidata; Q54815711
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30353; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30354
AC   CVCL_ER45
SY   CIRMi00T-A
DR   BioSamples; SAMEA114428833
DR   Coriell; CW30354
DR   FCDI; CW30354
DR   hPSCreg; CIRMi00T-A
DR   Wikidata; Q54815712
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30354; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30355
AC   CVCL_HH74
SY   CIRMi00U-A
DR   BioSamples; SAMEA114428852
DR   Coriell; CW30355
DR   FCDI; CW30355
DR   hPSCreg; CIRMi00U-A
DR   Wikidata; Q54815713
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30355; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30356
AC   CVCL_HH75
SY   CIRMi00V-A
DR   BioSamples; SAMEA114428866
DR   Coriell; CW30356
DR   FCDI; CW30356
DR   hPSCreg; CIRMi00V-A
DR   Wikidata; Q54815714
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30356; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30357
AC   CVCL_HH76
SY   CIRMi00W-A
DR   BioSamples; SAMEA114428885
DR   Coriell; CW30357
DR   FCDI; CW30357
DR   hPSCreg; CIRMi00W-A
DR   Wikidata; Q54815715
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30357; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30358
AC   CVCL_ER46
SY   CIRMi00X-A
DR   BioSamples; SAMEA114428900
DR   Coriell; CW30358
DR   FCDI; CW30358
DR   hPSCreg; CIRMi00X-A
DR   Wikidata; Q54815716
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30358; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30359
AC   CVCL_ER47
SY   CIRMi00Y-A
DR   BioSamples; SAMEA114428915
DR   Coriell; CW30359
DR   FCDI; CW30359
DR   hPSCreg; CIRMi00Y-A
DR   Wikidata; Q54815717
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30359; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30360
AC   CVCL_HH77
SY   CIRMi00Z-A
DR   BioSamples; SAMEA114428930
DR   Coriell; CW30360
DR   FCDI; CW30360
DR   hPSCreg; CIRMi00Z-A
DR   Wikidata; Q54815718
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30360; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30361
AC   CVCL_HH78
SY   CIRMi01A-A
DR   BioSamples; SAMEA114428944
DR   Coriell; CW30361
DR   FCDI; CW30361
DR   hPSCreg; CIRMi01A-A
DR   Wikidata; Q54815719
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30361; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30362
AC   CVCL_HH79
SY   CIRMi01B-A
DR   BioSamples; SAMEA114428995
DR   Coriell; CW30362
DR   FCDI; CW30362
DR   hPSCreg; CIRMi01B-A
DR   Wikidata; Q54815720
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30362; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30363
AC   CVCL_HH80
SY   CIRMi01C-A
DR   BioSamples; SAMEA114429084
DR   Coriell; CW30363
DR   FCDI; CW30363
DR   hPSCreg; CIRMi01C-A
DR   Wikidata; Q54815731
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30363; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30364
AC   CVCL_HH81
SY   CIRMi01D-A
DR   BioSamples; SAMEA114429188
DR   Coriell; CW30364
DR   FCDI; CW30364
DR   hPSCreg; CIRMi01D-A
DR   Wikidata; Q54815732
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30364; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30369
AC   CVCL_DJ78
SY   CIRM-CW30369i-Affected; CIRMi01E-A
DR   BioSamples; SAMEA114429289
DR   Coriell; CW30369
DR   FCDI; CW30369
DR   hPSCreg; CIRMi01E-A
DR   SKIP; SKIP003909
DR   Wikidata; Q54815733
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30369; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30370
AC   CVCL_DJ79
SY   CIRM-CW30370i-Affected; CIRMi01F-A
DR   BioSamples; SAMEA114429303
DR   Coriell; CW30370
DR   FCDI; CW30370
DR   hPSCreg; CIRMi01F-A
DR   SKIP; SKIP003910
DR   Wikidata; Q54815734
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30370; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30371
AC   CVCL_DJ80
SY   CIRM-CW30371i-Affected; CIRMi01G-A
DR   BioSamples; SAMEA114429316
DR   Coriell; CW30371
DR   FCDI; CW30371
DR   hPSCreg; CIRMi01G-A
DR   SKIP; SKIP003911
DR   Wikidata; Q54815735
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30371; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30374
AC   CVCL_LI66
SY   CIRMi01H-A
DR   BioSamples; SAMEA114429328
DR   Coriell; CW30374
DR   FCDI; CW30374
DR   hPSCreg; CIRMi01H-A
DR   Wikidata; Q54815737
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30374; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30376
AC   CVCL_HH82
SY   CIRMi01I-A
DR   BioSamples; SAMEA114429338
DR   Coriell; CW30376
DR   FCDI; CW30376
DR   hPSCreg; CIRMi01I-A
DR   Wikidata; Q54815738
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30376; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30380
AC   CVCL_DJ81
SY   CIRMi01J-A
DR   BioSamples; SAMEA114429353
DR   Coriell; CW30380
DR   FCDI; CW30380
DR   hPSCreg; CIRMi01J-A
DR   Wikidata; Q54815740
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30380; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30382
AC   CVCL_LI67
SY   CIRMi01K-A
DR   BioSamples; SAMEA114429366
DR   Coriell; CW30382
DR   FCDI; CW30382
DR   hPSCreg; CIRMi01K-A
DR   Wikidata; Q54815741
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30382; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30383
AC   CVCL_DJ82
SY   CIRM-CW30383i-Affected; CIRMi01L-A
DR   BioSamples; SAMEA114429385
DR   Coriell; CW30383
DR   FCDI; CW30383
DR   hPSCreg; CIRMi01L-A
DR   SKIP; SKIP003912
DR   Wikidata; Q54815742
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30383; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30386
AC   CVCL_HH83
SY   CIRMi01M-A
DR   BioSamples; SAMEA114429402
DR   Coriell; CW30386
DR   FCDI; CW30386
DR   hPSCreg; CIRMi01M-A
DR   Wikidata; Q54815744
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30386; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30387
AC   CVCL_LI68
SY   CIRMi01N-A
DR   BioSamples; SAMEA114429412
DR   Coriell; CW30387
DR   FCDI; CW30387
DR   hPSCreg; CIRMi01N-A
DR   Wikidata; Q54815745
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: East Indian.
CC   Discontinued: Coriell; CW30387; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30389
AC   CVCL_JI25
SY   CIRMi01O-A
DR   BioSamples; SAMEA114429423
DR   Coriell; CW30389
DR   FCDI; CW30389
DR   hPSCreg; CIRMi01O-A
DR   Wikidata; Q54815746
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30389; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30390
AC   CVCL_HH84
SY   CIRMi01P-A
DR   BioSamples; SAMEA114429433
DR   Coriell; CW30390
DR   FCDI; CW30390
DR   hPSCreg; CIRMi01P-A
DR   Wikidata; Q54815747
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW30390; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 9
//
ID   CW30391
AC   CVCL_HH85
SY   CIRMi01Q-A
DR   BioSamples; SAMEA114429448
DR   Coriell; CW30391
DR   FCDI; CW30391
DR   hPSCreg; CIRMi01Q-A
DR   Wikidata; Q54815748
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30391; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30392
AC   CVCL_DJ83
SY   CIRM-CW30392i-Affected; CIRMi01R-A
DR   BioSamples; SAMEA114429462
DR   Coriell; CW30392
DR   FCDI; CW30392
DR   hPSCreg; CIRMi01R-A
DR   SKIP; SKIP003913
DR   Wikidata; Q54815749
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30392; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30393
AC   CVCL_DJ84
SY   CIRM-CW30393i-Affected; CIRMi01S-A
DR   BioSamples; SAMEA114429476
DR   Coriell; CW30393
DR   FCDI; CW30393
DR   hPSCreg; CIRMi01S-A
DR   SKIP; SKIP003914
DR   Wikidata; Q54815750
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30393; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30394
AC   CVCL_HH86
SY   CIRMi01T-A
DR   BioSamples; SAMEA114429489
DR   Coriell; CW30394
DR   FCDI; CW30394
DR   hPSCreg; CIRMi01T-A
DR   Wikidata; Q54815752
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30394; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30395
AC   CVCL_HH87
SY   CIRMi01U-A
DR   BioSamples; SAMEA114429500
DR   Coriell; CW30395
DR   FCDI; CW30395
DR   hPSCreg; CIRMi01U-A
DR   Wikidata; Q54815753
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30395; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30397
AC   CVCL_JI26
SY   CIRMi01V-A
DR   BioSamples; SAMEA114429515
DR   Coriell; CW30397
DR   FCDI; CW30397
DR   hPSCreg; CIRMi01V-A
DR   Wikidata; Q54815754
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30397; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30398
AC   CVCL_HH88
SY   CIRMi01W-A
DR   BioSamples; SAMEA114429528
DR   Coriell; CW30398
DR   FCDI; CW30398
DR   hPSCreg; CIRMi01W-A
DR   Wikidata; Q54815755
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30398; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30399
AC   CVCL_HH89
SY   CIRMi01X-A
DR   BioSamples; SAMEA114429542
DR   Coriell; CW30399
DR   FCDI; CW30399
DR   hPSCreg; CIRMi01X-A
DR   Wikidata; Q54815756
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30399; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30400
AC   CVCL_HH90
SY   CIRMi01Y-A
DR   BioSamples; SAMEA114429556
DR   Coriell; CW30400
DR   FCDI; CW30400
DR   hPSCreg; CIRMi01Y-A
DR   Wikidata; Q54815757
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30400; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30401
AC   CVCL_DJ85
SY   CIRM-CW30401i-Affected; CIRMi01Z-A
DR   BioSamples; SAMEA114429567
DR   Coriell; CW30401
DR   FCDI; CW30401
DR   hPSCreg; CIRMi01Z-A
DR   SKIP; SKIP003915
DR   Wikidata; Q54815759
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30403
AC   CVCL_HH91
SY   CIRMi02A-A
DR   BioSamples; SAMEA114429580
DR   Coriell; CW30403
DR   FCDI; CW30403
DR   hPSCreg; CIRMi02A-A
DR   Wikidata; Q54815760
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30404
AC   CVCL_DJ86
SY   CIRMi02B-A
DR   BioSamples; SAMEA114429592
DR   Coriell; CW30404
DR   FCDI; CW30404
DR   hPSCreg; CIRMi02B-A
DR   Wikidata; Q54815761
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30406
AC   CVCL_ER48
SY   CIRMi02C-A
DR   BioSamples; SAMEA114429608
DR   Coriell; CW30406
DR   FCDI; CW30406
DR   hPSCreg; CIRMi02C-A
DR   Wikidata; Q54815762
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30408
AC   CVCL_DJ87
SY   CIRM-CW30408i-Affected; CIRMi02D-A
DR   BioSamples; SAMEA114429623
DR   Coriell; CW30408
DR   FCDI; CW30408
DR   hPSCreg; CIRMi02D-A
DR   SKIP; SKIP003916
DR   Wikidata; Q54815763
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30409
AC   CVCL_DJ88
SY   CIRM-CW30409i-Affected; CIRMi02E-A
DR   BioSamples; SAMEA114429638
DR   Coriell; CW30409
DR   FCDI; CW30409
DR   hPSCreg; CIRMi02E-A
DR   SKIP; SKIP003917
DR   Wikidata; Q54815764
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW30410
AC   CVCL_DJ89
SY   CIRM-CW30410i-Affected; CIRMi02F-A
DR   BioSamples; SAMEA114429652
DR   Coriell; CW30410
DR   FCDI; CW30410
DR   hPSCreg; CIRMi02F-A
DR   SKIP; SKIP003918
DR   Wikidata; Q54815766
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30412
AC   CVCL_DJ90
SY   CIRM-CW30412i-Affected; CIRMi02G-A
DR   BioSamples; SAMEA114429666
DR   Coriell; CW30412
DR   FCDI; CW30412
DR   hPSCreg; CIRMi02G-A
DR   SKIP; SKIP003919
DR   Wikidata; Q54815767
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30412; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30413
AC   CVCL_DJ91
SY   CIRM-CW30413i-Affected; CIRMi02H-A
DR   BioSamples; SAMEA114429687
DR   Coriell; CW30413
DR   FCDI; CW30413
DR   hPSCreg; CIRMi02H-A
DR   SKIP; SKIP003920
DR   Wikidata; Q54815768
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30413; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30414
AC   CVCL_DJ92
SY   CIRM-CW30414i-Affected; CIRMi02I-A
DR   BioSamples; SAMEA114429700
DR   Coriell; CW30414
DR   FCDI; CW30414
DR   hPSCreg; CIRMi02I-A
DR   SKIP; SKIP003921
DR   Wikidata; Q54815769
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30414; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30415
AC   CVCL_DJ93
SY   CIRM-CW30415i-Affected; CIRMi02J-A
DR   BioSamples; SAMEA114429717
DR   Coriell; CW30415
DR   FCDI; CW30415
DR   hPSCreg; CIRMi02J-A
DR   SKIP; SKIP003922
DR   Wikidata; Q54815770
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30415; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30417
AC   CVCL_HH92
SY   CIRMi02K-A
DR   BioSamples; SAMEA114429732
DR   Coriell; CW30417
DR   FCDI; CW30417
DR   hPSCreg; CIRMi02K-A
DR   Wikidata; Q54815771
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30417; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30418
AC   CVCL_HH93
SY   CIRMi02L-A
DR   BioSamples; SAMEA114429748
DR   Coriell; CW30418
DR   FCDI; CW30418
DR   hPSCreg; CIRMi02L-A
DR   Wikidata; Q54815773
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30418; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30419
AC   CVCL_DJ94
SY   CIRMi02M-A
DR   BioSamples; SAMEA114429764
DR   Coriell; CW30419
DR   FCDI; CW30419
DR   hPSCreg; CIRMi02M-A
DR   Wikidata; Q54815774
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30419; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30420
AC   CVCL_HH94
SY   CIRMi02N-A
DR   BioSamples; SAMEA114429781
DR   Coriell; CW30420
DR   FCDI; CW30420
DR   hPSCreg; CIRMi02N-A
DR   Wikidata; Q54815775
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30420; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30421
AC   CVCL_HH95
SY   CIRMi02O-A; high_PRS_4
DR   BioSamples; SAMEA114429797
DR   Coriell; CW30421
DR   FCDI; CW30421
DR   hPSCreg; CIRMi02O-A
DR   Wikidata; Q54815776
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally high polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW30421; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 11
//
ID   CW30422
AC   CVCL_DJ95
SY   CIRM-CW30422i-Affected; CIRMi02P-A
DR   BioSamples; SAMEA114429811
DR   Coriell; CW30422
DR   FCDI; CW30422
DR   hPSCreg; CIRMi02P-A
DR   SKIP; SKIP003923
DR   Wikidata; Q54815777
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30422; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW30423
AC   CVCL_DJ96
SY   CIRMi02Q-A
DR   BioSamples; SAMEA114429825
DR   Coriell; CW30423
DR   FCDI; CW30423
DR   hPSCreg; CIRMi02Q-A
DR   Wikidata; Q54815788
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30423; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30425
AC   CVCL_DJ97
SY   CIRMi02R-A
DR   BioSamples; SAMEA114429841
DR   Coriell; CW30425
DR   FCDI; CW30425
DR   hPSCreg; CIRMi02R-A
DR   Wikidata; Q54815789
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30425; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30426
AC   CVCL_DJ98
SY   CIRMi02S-A
DR   BioSamples; SAMEA114429855
DR   Coriell; CW30426
DR   FCDI; CW30426
DR   hPSCreg; CIRMi02S-A
DR   Wikidata; Q54815790
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30426; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30427
AC   CVCL_ER49
SY   CIRMi02T-A
DR   BioSamples; SAMEA114429870
DR   Coriell; CW30427
DR   FCDI; CW30427
DR   hPSCreg; CIRMi02T-A
DR   Wikidata; Q54815791
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30427; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30428
AC   CVCL_DJ99
SY   CIRMi02U-A
DR   BioSamples; SAMEA114429884
DR   Coriell; CW30428
DR   FCDI; CW30428
DR   hPSCreg; CIRMi02U-A
DR   Wikidata; Q54815792
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30428; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30429
AC   CVCL_DK00
SY   CIRMi02V-A
DR   BioSamples; SAMEA114429889
DR   Coriell; CW30429
DR   FCDI; CW30429
DR   hPSCreg; CIRMi02V-A
DR   Wikidata; Q54815793
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30429; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30430
AC   CVCL_DK01
SY   CIRMi02W-A
DR   BioSamples; SAMEA114429891
DR   Coriell; CW30430
DR   FCDI; CW30430
DR   hPSCreg; CIRMi02W-A
DR   Wikidata; Q54815794
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30430; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30431
AC   CVCL_ER50
SY   CIRMi02X-A
DR   BioSamples; SAMEA114429893
DR   Coriell; CW30431
DR   FCDI; CW30431
DR   hPSCreg; CIRMi02X-A
DR   Wikidata; Q54815795
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30431; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30432
AC   CVCL_ER51
SY   CIRMi02Y-A
DR   BioSamples; SAMEA114429895
DR   Coriell; CW30432
DR   FCDI; CW30432
DR   hPSCreg; CIRMi02Y-A
DR   Wikidata; Q54815796
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30432; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30433
AC   CVCL_DK02
SY   CIRMi02Z-A
DR   BioSamples; SAMEA114429897
DR   Coriell; CW30433
DR   FCDI; CW30433
DR   hPSCreg; CIRMi02Z-A
DR   Wikidata; Q54815797
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30433; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30434
AC   CVCL_ER52
SY   CIRMi03A-A
DR   BioSamples; SAMEA114429899
DR   Coriell; CW30434
DR   FCDI; CW30434
DR   hPSCreg; CIRMi03A-A
DR   Wikidata; Q54815798
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30434; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30435
AC   CVCL_DK03
SY   CIRMi03B-A
DR   BioSamples; SAMEA114429901
DR   Coriell; CW30435
DR   FCDI; CW30435
DR   hPSCreg; CIRMi03B-A
DR   Wikidata; Q54815799
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30435; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30436
AC   CVCL_DK04
SY   CIRMi03C-A
DR   BioSamples; SAMEA114429903
DR   Coriell; CW30436
DR   FCDI; CW30436
DR   hPSCreg; CIRMi03C-A
DR   Wikidata; Q54815800
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30436; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30437
AC   CVCL_JI27
SY   CIRMi03D-A
DR   BioSamples; SAMEA114429905
DR   Coriell; CW30437
DR   FCDI; CW30437
DR   hPSCreg; CIRMi03D-A
DR   Wikidata; Q54815801
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30437; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30438
AC   CVCL_HH96
SY   CIRMi03E-A
DR   BioSamples; SAMEA114429907
DR   Coriell; CW30438
DR   FCDI; CW30438
DR   hPSCreg; CIRMi03E-A
DR   Wikidata; Q54815802
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30438; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30439
AC   CVCL_HH97
SY   CIRMi03F-A
DR   BioSamples; SAMEA114429909
DR   Coriell; CW30439
DR   FCDI; CW30439
DR   hPSCreg; CIRMi03F-A
DR   Wikidata; Q54815803
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30439; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30440
AC   CVCL_JI28
SY   CIRMi03G-A
DR   BioSamples; SAMEA114429911
DR   Coriell; CW30440
DR   FCDI; CW30440
DR   hPSCreg; CIRMi03G-A
DR   Wikidata; Q54815804
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30440; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30441
AC   CVCL_JI29
SY   CIRMi03H-A
DR   BioSamples; SAMEA114429913
DR   Coriell; CW30441
DR   FCDI; CW30441
DR   hPSCreg; CIRMi03H-A
DR   Wikidata; Q54815805
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30441; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30442
AC   CVCL_DK05
SY   CIRMi03I-A
DR   BioSamples; SAMEA114429915
DR   Coriell; CW30442
DR   FCDI; CW30442
DR   hPSCreg; CIRMi03I-A
DR   Wikidata; Q54815806
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30442; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30443
AC   CVCL_HH98
SY   CIRMi03J-A
DR   BioSamples; SAMEA114429917
DR   Coriell; CW30443
DR   FCDI; CW30443
DR   hPSCreg; CIRMi03J-A
DR   Wikidata; Q54815807
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30443; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30444
AC   CVCL_JI30
SY   CIRMi03K-A
DR   BioSamples; SAMEA114429919
DR   Coriell; CW30444
DR   FCDI; CW30444
DR   hPSCreg; CIRMi03K-A
DR   Wikidata; Q54815809
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30444; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30445
AC   CVCL_HH99
SY   CIRMi03L-A
DR   BioSamples; SAMEA114429921
DR   Coriell; CW30445
DR   FCDI; CW30445
DR   hPSCreg; CIRMi03L-A
DR   Wikidata; Q54815810
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30445; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30446
AC   CVCL_DK06
SY   CIRMi03M-A
DR   BioSamples; SAMEA114429923
DR   Coriell; CW30446
DR   FCDI; CW30446
DR   hPSCreg; CIRMi03M-A
DR   Wikidata; Q54815811
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30446; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW30447
AC   CVCL_HI00
SY   CIRMi03N-A
DR   BioSamples; SAMEA114429925
DR   Coriell; CW30447
DR   FCDI; CW30447
DR   hPSCreg; CIRMi03N-A
DR   Wikidata; Q54815812
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30447; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30448
AC   CVCL_HI01
SY   CIRMi03O-A
DR   BioSamples; SAMEA114429927
DR   Coriell; CW30448
DR   FCDI; CW30448
DR   hPSCreg; CIRMi03O-A
DR   Wikidata; Q54815813
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30448; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30449
AC   CVCL_HI02
SY   CIRMi03P-A
DR   BioSamples; SAMEA114429929
DR   Coriell; CW30449
DR   FCDI; CW30449
DR   hPSCreg; CIRMi03P-A
DR   Wikidata; Q54815814
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30449; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30450
AC   CVCL_HI03
SY   CIRMi03Q-A
DR   BioSamples; SAMEA114429931
DR   Coriell; CW30450
DR   FCDI; CW30450
DR   hPSCreg; CIRMi03Q-A
DR   Wikidata; Q54815815
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30450; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30452
AC   CVCL_JI31
SY   CIRMi03R-A
DR   BioSamples; SAMEA114429933
DR   Coriell; CW30452
DR   FCDI; CW30452
DR   hPSCreg; CIRMi03R-A
DR   Wikidata; Q54815816
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30452; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30453
AC   CVCL_HI04
SY   CIRMi03S-A
DR   BioSamples; SAMEA114429935
DR   Coriell; CW30453
DR   FCDI; CW30453
DR   hPSCreg; CIRMi03S-A
DR   Wikidata; Q54815817
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30453; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30454
AC   CVCL_HI05
SY   CIRMi03T-A; high_PRS_6
DR   BioSamples; SAMEA114429937
DR   Coriell; CW30454
DR   FCDI; CW30454
DR   hPSCreg; CIRMi03T-A
DR   Wikidata; Q54815818
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally high polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW30454; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 11
//
ID   CW30455
AC   CVCL_HI06
SY   CIRMi03U-A
DR   BioSamples; SAMEA114429939
DR   Coriell; CW30455
DR   FCDI; CW30455
DR   hPSCreg; CIRMi03U-A
DR   Wikidata; Q54815819
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30455; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30456
AC   CVCL_HI07
SY   CIRMi03V-A
DR   BioSamples; SAMEA114429941
DR   Coriell; CW30456
DR   FCDI; CW30456
DR   hPSCreg; CIRMi03V-A
DR   Wikidata; Q54815821
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30456; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30457
AC   CVCL_HI08
SY   CIRMi03W-A
DR   BioSamples; SAMEA114429943
DR   Coriell; CW30457
DR   FCDI; CW30457
DR   hPSCreg; CIRMi03W-A
DR   Wikidata; Q54815822
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30457; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30459
AC   CVCL_HI09
SY   CIRMi03X-A
DR   BioSamples; SAMEA114429945
DR   Coriell; CW30459
DR   FCDI; CW30459
DR   hPSCreg; CIRMi03X-A
DR   Wikidata; Q54815823
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30459; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30460
AC   CVCL_HI10
SY   CIRMi03Y-A
DR   BioSamples; SAMEA114429947
DR   Coriell; CW30460
DR   FCDI; CW30460
DR   hPSCreg; CIRMi03Y-A
DR   Wikidata; Q54815824
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30460; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30461
AC   CVCL_HI11
SY   CIRMi03Z-A
DR   BioSamples; SAMEA114429949
DR   Coriell; CW30461
DR   FCDI; CW30461
DR   hPSCreg; CIRMi03Z-A
DR   Wikidata; Q54815825
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30461; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30462
AC   CVCL_ER53
SY   CIRMi04A-A
DR   BioSamples; SAMEA114429951
DR   Coriell; CW30462
DR   FCDI; CW30462
DR   hPSCreg; CIRMi04A-A
DR   Wikidata; Q54815826
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30462; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW30463
AC   CVCL_HI12
SY   CIRMi04B-A
DR   BioSamples; SAMEA114429953
DR   Coriell; CW30463
DR   FCDI; CW30463
DR   hPSCreg; CIRMi04B-A
DR   Wikidata; Q54815827
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30463; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30464
AC   CVCL_HI13
SY   CIRMi04C-A
DR   BioSamples; SAMEA114429955
DR   Coriell; CW30464
DR   FCDI; CW30464
DR   hPSCreg; CIRMi04C-A
DR   Wikidata; Q54815828
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30464; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30465
AC   CVCL_HI14
SY   CIRMi04D-A
DR   BioSamples; SAMEA114429957
DR   Coriell; CW30465
DR   FCDI; CW30465
DR   hPSCreg; CIRMi04D-A
DR   Wikidata; Q54815829
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30465; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30466
AC   CVCL_HI15
SY   CIRMi04E-A
DR   BioSamples; SAMEA114429959
DR   Coriell; CW30466
DR   FCDI; CW30466
DR   hPSCreg; CIRMi04E-A
DR   Wikidata; Q54815842
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30466; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30467
AC   CVCL_HI16
SY   CIRMi04F-A
DR   BioSamples; SAMEA114429961
DR   Coriell; CW30467
DR   FCDI; CW30467
DR   hPSCreg; CIRMi04F-A
DR   Wikidata; Q54815843
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30467; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30468
AC   CVCL_HI17
SY   CIRMi04G-A
DR   BioSamples; SAMEA114429963
DR   Coriell; CW30468
DR   FCDI; CW30468
DR   hPSCreg; CIRMi04G-A
DR   Wikidata; Q54815844
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30468; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30470
AC   CVCL_HI18
SY   CIRMi04H-A
DR   BioSamples; SAMEA114429965
DR   Coriell; CW30470
DR   FCDI; CW30470
DR   hPSCreg; CIRMi04H-A
DR   Wikidata; Q54815845
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30470; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30471
AC   CVCL_HI19
SY   CIRMi04I-A
DR   BioSamples; SAMEA114429967
DR   Coriell; CW30471
DR   FCDI; CW30471
DR   hPSCreg; CIRMi04I-A
DR   Wikidata; Q54815846
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30471; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30472
AC   CVCL_HI20
SY   CIRMi04J-A
DR   BioSamples; SAMEA114429969
DR   Coriell; CW30472
DR   FCDI; CW30472
DR   hPSCreg; CIRMi04J-A
DR   Wikidata; Q54815847
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30472; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30473
AC   CVCL_HI21
SY   CIRMi04K-A
DR   BioSamples; SAMEA114429971
DR   Coriell; CW30473
DR   FCDI; CW30473
DR   hPSCreg; CIRMi04K-A
DR   Wikidata; Q54815848
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30473; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30474
AC   CVCL_JI32
SY   CIRMi04L-A
DR   BioSamples; SAMEA114429973
DR   Coriell; CW30474
DR   FCDI; CW30474
DR   hPSCreg; CIRMi04L-A
DR   Wikidata; Q54815849
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30474; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30476
AC   CVCL_HI22
SY   CIRMi04M-A
DR   BioSamples; SAMEA114429975
DR   Coriell; CW30476
DR   FCDI; CW30476
DR   hPSCreg; CIRMi04M-A
DR   Wikidata; Q54815850
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30476; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30477
AC   CVCL_HI23
SY   CIRMi04N-A
DR   BioSamples; SAMEA114429977
DR   Coriell; CW30477
DR   FCDI; CW30477
DR   hPSCreg; CIRMi04N-A
DR   Wikidata; Q54815851
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW30477; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30478
AC   CVCL_HI24
SY   CIRMi04O-A
DR   BioSamples; SAMEA114429979
DR   Coriell; CW30478
DR   FCDI; CW30478
DR   hPSCreg; CIRMi04O-A
DR   Wikidata; Q54815852
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30478; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30479
AC   CVCL_HI25
SY   CIRMi04P-A
DR   BioSamples; SAMEA114429981
DR   Coriell; CW30479
DR   FCDI; CW30479
DR   hPSCreg; CIRMi04P-A
DR   Wikidata; Q54815853
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30479; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30480
AC   CVCL_HI26
SY   CIRMi04Q-A
DR   BioSamples; SAMEA114429983
DR   Coriell; CW30480
DR   FCDI; CW30480
DR   hPSCreg; CIRMi04Q-A
DR   Wikidata; Q54815854
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30480; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30481
AC   CVCL_HI27
SY   CIRMi04R-A
DR   BioSamples; SAMEA114429985
DR   Coriell; CW30481
DR   FCDI; CW30481
DR   hPSCreg; CIRMi04R-A
DR   Wikidata; Q54815855
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30481; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30482
AC   CVCL_JI33
SY   CIRMi04S-A
DR   BioSamples; SAMEA114429987
DR   Coriell; CW30482
DR   FCDI; CW30482
DR   hPSCreg; CIRMi04S-A
DR   Wikidata; Q54815856
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30482; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30483
AC   CVCL_JI34
SY   CIRMi04T-A
DR   BioSamples; SAMEA114429989
DR   Coriell; CW30483
DR   FCDI; CW30483
DR   hPSCreg; CIRMi04T-A
DR   Wikidata; Q54815857
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30483; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30484
AC   CVCL_HI28
SY   CIRMi04U-A
DR   BioSamples; SAMEA114429991
DR   Coriell; CW30484
DR   FCDI; CW30484
DR   hPSCreg; CIRMi04U-A
DR   Wikidata; Q54815858
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30484; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62798; Restrictive cardiomyopathy
DI   ORDO; Orphanet_217632; Restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 11
//
ID   CW30485
AC   CVCL_HI29
SY   CIRMi04V-A
DR   BioSamples; SAMEA114429993
DR   Coriell; CW30485
DR   FCDI; CW30485
DR   hPSCreg; CIRMi04V-A
DR   Wikidata; Q54815859
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30485; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30486
AC   CVCL_HI30
SY   CIRMi04W-A
DR   BioSamples; SAMEA114429995
DR   Coriell; CW30486
DR   FCDI; CW30486
DR   hPSCreg; CIRMi04W-A
DR   Wikidata; Q54815860
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30486; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30488
AC   CVCL_HI31
SY   CIRMi04X-A
DR   BioSamples; SAMEA114429997
DR   Coriell; CW30488
DR   FCDI; CW30488
DR   hPSCreg; CIRMi04X-A
DR   Wikidata; Q54815861
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30488; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30489
AC   CVCL_HI32
SY   CIRMi04Y-A
DR   BioSamples; SAMEA114429999
DR   Coriell; CW30489
DR   FCDI; CW30489
DR   hPSCreg; CIRMi04Y-A
DR   Wikidata; Q54815862
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30489; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30490
AC   CVCL_HI33
SY   CIRMi04Z-A
DR   BioSamples; SAMEA114430001
DR   Coriell; CW30490
DR   FCDI; CW30490
DR   hPSCreg; CIRMi04Z-A
DR   Wikidata; Q54815863
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30490; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30491
AC   CVCL_HI34
SY   CIRMi05A-A
DR   BioSamples; SAMEA114430003
DR   Coriell; CW30491
DR   FCDI; CW30491
DR   hPSCreg; CIRMi05A-A
DR   Wikidata; Q54815864
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30491; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30492
AC   CVCL_HI35
SY   CIRMi05B-A
DR   BioSamples; SAMEA114430005
DR   Coriell; CW30492
DR   FCDI; CW30492
DR   hPSCreg; CIRMi05B-A
DR   Wikidata; Q54815865
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30492; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30494
AC   CVCL_LI69
SY   CIRMi05C-A
DR   BioSamples; SAMEA114430007
DR   Coriell; CW30494
DR   FCDI; CW30494
DR   hPSCreg; CIRMi05C-A
DR   Wikidata; Q54815867
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW30494; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30495
AC   CVCL_HI36
SY   CIRMi05D-A
DR   BioSamples; SAMEA114430009
DR   Coriell; CW30495
DR   FCDI; CW30495
DR   hPSCreg; CIRMi05D-A
DR   Wikidata; Q54815868
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30495; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30496
AC   CVCL_HI37
SY   CIRMi05E-A
DR   BioSamples; SAMEA114430011
DR   Coriell; CW30496
DR   FCDI; CW30496
DR   hPSCreg; CIRMi05E-A
DR   Wikidata; Q54815870
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30496; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30497
AC   CVCL_HI38
SY   CIRMi05F-A
DR   BioSamples; SAMEA114430013
DR   Coriell; CW30497
DR   FCDI; CW30497
DR   hPSCreg; CIRMi05F-A
DR   Wikidata; Q54815871
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30497; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30499
AC   CVCL_HI39
SY   CIRMi05G-A
DR   BioSamples; SAMEA114430015
DR   Coriell; CW30499
DR   FCDI; CW30499
DR   hPSCreg; CIRMi05G-A
DR   Wikidata; Q54815872
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30499; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30500
AC   CVCL_HI40
SY   CIRMi05H-A
DR   BioSamples; SAMEA114430017
DR   Coriell; CW30500
DR   FCDI; CW30500
DR   hPSCreg; CIRMi05H-A
DR   Wikidata; Q54815873
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30500; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30501
AC   CVCL_HI41
SY   CIRMi05I-A
DR   BioSamples; SAMEA114430019
DR   Coriell; CW30501
DR   FCDI; CW30501
DR   hPSCreg; CIRMi05I-A
DR   Wikidata; Q54815874
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30503
AC   CVCL_JI35
SY   CIRMi05J-A
DR   BioSamples; SAMEA114430021
DR   Coriell; CW30503
DR   FCDI; CW30503
DR   hPSCreg; CIRMi05J-A
DR   Wikidata; Q54815875
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30505
AC   CVCL_HI42
SY   CIRMi05K-A
DR   BioSamples; SAMEA114430023
DR   Coriell; CW30505
DR   FCDI; CW30505
DR   hPSCreg; CIRMi05K-A
DR   Wikidata; Q54815876
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30505; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30506
AC   CVCL_HI43
SY   CIRMi05L-A
DR   BioSamples; SAMEA114430025
DR   Coriell; CW30506
DR   FCDI; CW30506
DR   hPSCreg; CIRMi05L-A
DR   Wikidata; Q54815877
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30508
AC   CVCL_HI44
SY   CIRMi05M-A
DR   BioSamples; SAMEA114430027
DR   Coriell; CW30508
DR   FCDI; CW30508
DR   hPSCreg; CIRMi05M-A
DR   Wikidata; Q54815878
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW30508; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30509
AC   CVCL_HI45
SY   CIRMi05N-A
DR   BioSamples; SAMEA114430029
DR   Coriell; CW30509
DR   FCDI; CW30509
DR   hPSCreg; CIRMi05N-A
DR   Wikidata; Q54815880
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pacific.
CC   Discontinued: Coriell; CW30509; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30510
AC   CVCL_HI46
SY   CIRMi05O-A
DR   BioSamples; SAMEA114430031
DR   Coriell; CW30510
DR   FCDI; CW30510
DR   hPSCreg; CIRMi05O-A
DR   Wikidata; Q54815881
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30510; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW30512
AC   CVCL_JI36
SY   CIRMi05P-A
DR   BioSamples; SAMEA114430033
DR   Coriell; CW30512
DR   FCDI; CW30512
DR   hPSCreg; CIRMi05P-A
DR   Wikidata; Q54815882
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30512; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30513
AC   CVCL_JI37
SY   CIRMi05Q-A
DR   BioSamples; SAMEA114430035
DR   Coriell; CW30513
DR   FCDI; CW30513
DR   hPSCreg; CIRMi05Q-A
DR   Wikidata; Q54815883
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30513; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30515
AC   CVCL_JI38
SY   CIRMi05R-A
DR   BioSamples; SAMEA114430037
DR   Coriell; CW30515
DR   FCDI; CW30515
DR   hPSCreg; CIRMi05R-A
DR   Wikidata; Q54815884
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30515; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30516
AC   CVCL_JI39
SY   CIRMi05S-A
DR   BioSamples; SAMEA114430039
DR   Coriell; CW30516
DR   FCDI; CW30516
DR   hPSCreg; CIRMi05S-A
DR   Wikidata; Q54815903
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30516; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30519
AC   CVCL_JI40
SY   CIRMi05T-A
DR   BioSamples; SAMEA114430041
DR   Coriell; CW30519
DR   FCDI; CW30519
DR   hPSCreg; CIRMi05T-A
DR   Wikidata; Q54815904
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30519; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30520
AC   CVCL_JI41
SY   CIRMi05U-A
DR   BioSamples; SAMEA114430043
DR   Coriell; CW30520
DR   FCDI; CW30520
DR   hPSCreg; CIRMi05U-A
DR   Wikidata; Q54815905
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30520; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30522
AC   CVCL_JI42
SY   CIRMi05V-A
DR   BioSamples; SAMEA114430045
DR   Coriell; CW30522
DR   FCDI; CW30522
DR   hPSCreg; CIRMi05V-A
DR   Wikidata; Q54815906
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30522; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30523
AC   CVCL_JI43
SY   CIRMi05W-A
DR   BioSamples; SAMEA114430047
DR   Coriell; CW30523
DR   FCDI; CW30523
DR   hPSCreg; CIRMi05W-A
DR   Wikidata; Q54815907
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30523; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW30525
AC   CVCL_JI44
SY   CIRMi05X-A; high_PRS_2
DR   BioSamples; SAMEA114430049
DR   Coriell; CW30525
DR   FCDI; CW30525
DR   hPSCreg; CIRMi05X-A
DR   Wikidata; Q54815908
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally high polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW30525; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   CW30526
AC   CVCL_LJ98
SY   CIRMi05Y-A
DR   BioSamples; SAMEA114430051
DR   Coriell; CW30526
DR   FCDI; CW30526
DR   hPSCreg; CIRMi05Y-A
DR   Wikidata; Q54815909
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30526; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30527
AC   CVCL_LJ99
SY   CIRMi05Z-A
DR   BioSamples; SAMEA114430053
DR   Coriell; CW30527
DR   FCDI; CW30527
DR   hPSCreg; CIRMi05Z-A
DR   Wikidata; Q54815911
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30527; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30528
AC   CVCL_LK00
SY   CIRMi06A-A
DR   BioSamples; SAMEA114430055
DR   Coriell; CW30528
DR   FCDI; CW30528
DR   hPSCreg; CIRMi06A-A
DR   Wikidata; Q54815912
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30528; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW30529
AC   CVCL_LK01
SY   CIRMi06B-A
DR   BioSamples; SAMEA114430057
DR   Coriell; CW30529
DR   FCDI; CW30529
DR   hPSCreg; CIRMi06B-A
DR   Wikidata; Q54815913
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW30529; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW39-1B10
AC   CVCL_A6IF
DR   Wikidata; Q107114758
RX   Patent=WO2002026831A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2511.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P56202; Human CTSW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CW39-2B6
AC   CVCL_A6IG
DR   Wikidata; Q107114759
RX   Patent=WO2002026831A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2512.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P56202; Human CTSW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CW40-1B1
AC   CVCL_A6IH
DR   Wikidata; Q107114762
RX   Patent=WO2002026831A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2513.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P56202; Human CTSW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   CW4-XPG
AC   CVCL_M226
DR   Wikidata; Q54815914
RX   PubMed=3030788;
CC   Doubling time: 60 hours (PubMed=3030788).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Arg372Thrfs*5 (c.1115_1118delGGAA); ClinVar=VCV000016574; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Leu858Pro (c.2573T>C); ClinVar=VCV000016573; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV7).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M223 ! XP2BI
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   CW40001
AC   CVCL_AP13
SY   CIRM-CW40001i-Affected
DR   Coriell; CW40001
DR   FCDI; CW40001
DR   SKIP; SKIP003924
DR   Wikidata; Q54815915
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40001; true.
CC   Discontinued: FCDI; CW40001; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW40002
AC   CVCL_4R86
SY   CIRM-CW40002i-Affected; CIRMi544-A
DR   BioSamples; SAMEA114397010
DR   Coriell; CW40002
DR   FCDI; CW40002
DR   hPSCreg; CIRMi544-A
DR   SKIP; SKIP003925
DR   Wikidata; Q54815916
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40002; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40003
AC   CVCL_AP14
SY   CIRM-CW40003i-Affected; CIRMi545-A
DR   BioSamples; SAMEA114397012
DR   Coriell; CW40003
DR   FCDI; CW40003
DR   hPSCreg; CIRMi545-A
DR   SKIP; SKIP003926
DR   Wikidata; Q54815917
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40003; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 12
//
ID   CW40004
AC   CVCL_4R87
SY   CIRM-CW40004i-Affected; CIRMi546-A
DR   BioSamples; SAMEA114397014
DR   Coriell; CW40004
DR   FCDI; CW40004
DR   hPSCreg; CIRMi546-A
DR   SKIP; SKIP003927
DR   Wikidata; Q54815918
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40004; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40005
AC   CVCL_DK07
SY   CIRMi547-A
DR   BioSamples; SAMEA114397016
DR   Coriell; CW40005
DR   FCDI; CW40005
DR   hPSCreg; CIRMi547-A
DR   Wikidata; Q54815919
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40005; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 9
//
ID   CW40006
AC   CVCL_4R88
SY   CIRM-CW40006i-Affected; CIRMi548-A
DR   BioSamples; SAMEA114397018
DR   Coriell; CW40006
DR   FCDI; CW40006
DR   hPSCreg; CIRMi548-A
DR   SKIP; SKIP003928
DR   Wikidata; Q54815920
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40006; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40007
AC   CVCL_4R89
SY   CIRM-CW40007i-Affected
DR   Coriell; CW40007
DR   FCDI; CW40007
DR   SKIP; SKIP003929
DR   Wikidata; Q54815921
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40007; true.
CC   Discontinued: FCDI; CW40007; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW40008
AC   CVCL_4R90
SY   CIRM-CW40008i-Affected
DR   Coriell; CW40008
DR   SKIP; SKIP003930
DR   Wikidata; Q54815922
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40008; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 9
//
ID   CW40009
AC   CVCL_4R91
SY   CIRM-CW40009i-Affected; CIRMi549-A
DR   BioSamples; SAMEA114397020
DR   Coriell; CW40009
DR   FCDI; CW40009
DR   hPSCreg; CIRMi549-A
DR   SKIP; SKIP003931
DR   Wikidata; Q54815923
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40009; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40010
AC   CVCL_JI45
SY   CIRMi550-A
DR   BioSamples; SAMEA114397022
DR   Coriell; CW40010
DR   FCDI; CW40010
DR   hPSCreg; CIRMi550-A
DR   Wikidata; Q54815924
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40010; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW40011
AC   CVCL_AP15
SY   CIRM-CW40011i-Affected; CIRMi551-A
DR   BioSamples; SAMEA114397024
DR   Coriell; CW40011
DR   FCDI; CW40011
DR   hPSCreg; CIRMi551-A
DR   SKIP; SKIP003932
DR   Wikidata; Q54815925
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40011; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40012
AC   CVCL_JI46
SY   CIRMi552-A
DR   BioSamples; SAMEA114397026
DR   Coriell; CW40012
DR   FCDI; CW40012
DR   hPSCreg; CIRMi552-A
DR   Wikidata; Q54815926
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40012; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40013
AC   CVCL_4R92
SY   CIRM-CW40013i-Affected; CIRMi553-A
DR   BioSamples; SAMEA114397028
DR   Coriell; CW40013
DR   FCDI; CW40013
DR   hPSCreg; CIRMi553-A
DR   SKIP; SKIP003933
DR   Wikidata; Q54815927
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40013; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW40014
AC   CVCL_4R93
SY   CIRM-CW40014i-Affected; CIRMi554-A
DR   BioSamples; SAMEA114397030
DR   Coriell; CW40014
DR   FCDI; CW40014
DR   hPSCreg; CIRMi554-A
DR   SKIP; SKIP003934
DR   Wikidata; Q54815928
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40014; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40015
AC   CVCL_4R94
SY   CIRM-CW40015i-Affected; CIRMi555-A
DR   BioSamples; SAMEA114397032
DR   Coriell; CW40015
DR   FCDI; CW40015
DR   hPSCreg; CIRMi555-A
DR   SKIP; SKIP003935
DR   Wikidata; Q54815929
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40015; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40017
AC   CVCL_HI47
SY   CIRMi556-A
DR   BioSamples; SAMEA114397034
DR   Coriell; CW40017
DR   FCDI; CW40017
DR   hPSCreg; CIRMi556-A
DR   Wikidata; Q54815930
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40017; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40018
AC   CVCL_HI48
SY   CIRMi557-A
DR   BioSamples; SAMEA114397036
DR   Coriell; CW40018
DR   FCDI; CW40018
DR   hPSCreg; CIRMi557-A
DR   Wikidata; Q54815931
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40018; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40020
AC   CVCL_HI49
SY   CIRMi558-A
DR   BioSamples; SAMEA114397038
DR   Coriell; CW40020
DR   FCDI; CW40020
DR   hPSCreg; CIRMi558-A
DR   Wikidata; Q54815932
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40020; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40021
AC   CVCL_DK08
SY   CIRMi559-A
DR   BioSamples; SAMEA114397040
DR   Coriell; CW40021
DR   FCDI; CW40021
DR   hPSCreg; CIRMi559-A
DR   Wikidata; Q54815933
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40021; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW40022
AC   CVCL_4R95
SY   CIRM-CW40022i-Affected; CIRMi560-A
DR   BioSamples; SAMEA114397063
DR   Coriell; CW40022
DR   FCDI; CW40022
DR   hPSCreg; CIRMi560-A
DR   SKIP; SKIP003936
DR   Wikidata; Q54815934
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40022; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40023
AC   CVCL_4R96
SY   CIRM-CW40023i-Affected; CIRMi561-A
DR   BioSamples; SAMEA114397154
DR   Coriell; CW40023
DR   FCDI; CW40023
DR   hPSCreg; CIRMi561-A
DR   SKIP; SKIP003937
DR   Wikidata; Q54815935
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40023; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40024
AC   CVCL_DK09
SY   CIRM-CW40024i-Affected; CIRMi562-A
DR   BioSamples; SAMEA114397238
DR   Coriell; CW40024
DR   FCDI; CW40024
DR   hPSCreg; CIRMi562-A
DR   SKIP; SKIP003938
DR   Wikidata; Q54815936
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40024; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW40025
AC   CVCL_4R97
SY   CIRM-CW40025i-Affected; CIRMi563-A
DR   BioSamples; SAMEA114397240
DR   Coriell; CW40025
DR   FCDI; CW40025
DR   hPSCreg; CIRMi563-A
DR   SKIP; SKIP003939
DR   Wikidata; Q54815937
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40025; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40026
AC   CVCL_4R98
SY   CIRM-CW40026i-Affected; CIRMi564-A
DR   BioSamples; SAMEA114397242
DR   Coriell; CW40026
DR   FCDI; CW40026
DR   hPSCreg; CIRMi564-A
DR   SKIP; SKIP003940
DR   Wikidata; Q54815938
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40026; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40027
AC   CVCL_4R99
SY   CIRM-CW40027i-Affected; CIRMi565-A
DR   BioSamples; SAMEA114397244
DR   Coriell; CW40027
DR   FCDI; CW40027
DR   hPSCreg; CIRMi565-A
DR   SKIP; SKIP003941
DR   Wikidata; Q54815939
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40027; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40028
AC   CVCL_4S00
SY   CIRM-CW40028i-Affected; CIRMi566-A
DR   BioSamples; SAMEA114397246
DR   Coriell; CW40028
DR   FCDI; CW40028
DR   hPSCreg; CIRMi566-A
DR   SKIP; SKIP003943
DR   Wikidata; Q54815940
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40028; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW40029
AC   CVCL_4S01
SY   CIRM-CW40029i-Affected; CIRMi567-A
DR   BioSamples; SAMEA114397248
DR   Coriell; CW40029
DR   FCDI; CW40029
DR   hPSCreg; CIRMi567-A
DR   SKIP; SKIP003944
DR   Wikidata; Q54815941
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40029; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40030
AC   CVCL_JI47
SY   CIRMi568-A
DR   BioSamples; SAMEA114397250
DR   Coriell; CW40030
DR   FCDI; CW40030
DR   hPSCreg; CIRMi568-A
DR   Wikidata; Q54815942
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40030; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40031
AC   CVCL_4S02
SY   CIRM-CW40031i-Affected; CIRMi569-A
DR   BioSamples; SAMEA114397252
DR   Coriell; CW40031
DR   FCDI; CW40031
DR   hPSCreg; CIRMi569-A
DR   SKIP; SKIP003945
DR   Wikidata; Q54815943
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40031; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40032
AC   CVCL_4S03
SY   CIRMi570-A
DR   BioSamples; SAMEA114397254
DR   Coriell; CW40032
DR   FCDI; CW40032
DR   hPSCreg; CIRMi570-A
DR   Wikidata; Q54815947
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40032; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40033
AC   CVCL_DK10
SY   CIRMi571-A
DR   BioSamples; SAMEA114397256
DR   Coriell; CW40033
DR   FCDI; CW40033
DR   hPSCreg; CIRMi571-A
DR   Wikidata; Q54815948
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40033; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW40034
AC   CVCL_AP16
SY   CIRM-CW40034i-Affected; CIRMi572-A
DR   BioSamples; SAMEA114397258
DR   Coriell; CW40034
DR   FCDI; CW40034
DR   hPSCreg; CIRMi572-A
DR   SKIP; SKIP003946
DR   Wikidata; Q54815949
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40034; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40035
AC   CVCL_4S04
SY   CIRM-CW40035i-Affected; CIRMi573-A
DR   BioSamples; SAMEA114397260
DR   Coriell; CW40035
DR   FCDI; CW40035
DR   hPSCreg; CIRMi573-A
DR   SKIP; SKIP003947
DR   Wikidata; Q54815950
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40035; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40036
AC   CVCL_4S05
SY   CIRM-CW40036i-Affected
DR   Coriell; CW40036
DR   SKIP; SKIP003948
DR   Wikidata; Q54815951
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40036; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 9
//
ID   CW40037
AC   CVCL_AP17
SY   CIRM-CW40037i-Affected; CIRMi574-A
DR   BioSamples; SAMEA114397262
DR   Coriell; CW40037
DR   FCDI; CW40037
DR   hPSCreg; CIRMi574-A
DR   SKIP; SKIP003949
DR   Wikidata; Q54815952
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40037; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40038
AC   CVCL_HI50
SY   CIRMi575-A
DR   BioSamples; SAMEA114397264
DR   Coriell; CW40038
DR   FCDI; CW40038
DR   hPSCreg; CIRMi575-A
DR   Wikidata; Q54815953
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40038; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40039
AC   CVCL_AP18
SY   CIRM-CW40039i-Affected; CIRMi576-A
DR   BioSamples; SAMEA114397266
DR   Coriell; CW40039
DR   FCDI; CW40039
DR   hPSCreg; CIRMi576-A
DR   SKIP; SKIP003950
DR   Wikidata; Q54815954
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40039; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40040
AC   CVCL_DK11
SY   CIRM-CW40040i-Affected; CIRMi577-A
DR   BioSamples; SAMEA114397268
DR   Coriell; CW40040
DR   FCDI; CW40040
DR   hPSCreg; CIRMi577-A
DR   SKIP; SKIP003951
DR   Wikidata; Q54815955
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40040; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW40042
AC   CVCL_HI51
SY   CIRMi578-A
DR   BioSamples; SAMEA114397270
DR   Coriell; CW40042
DR   FCDI; CW40042
DR   hPSCreg; CIRMi578-A
DR   Wikidata; Q54815956
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40042; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40043
AC   CVCL_AP19
SY   CIRM-CW40043i-Affected; CIRMi579-A
DR   BioSamples; SAMEA114397272
DR   Coriell; CW40043
DR   FCDI; CW40043
DR   hPSCreg; CIRMi579-A
DR   SKIP; SKIP003952
DR   Wikidata; Q54815957
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40043; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40044
AC   CVCL_ER54
SY   CIRMi580-A
DR   BioSamples; SAMEA114397274
DR   Coriell; CW40044
DR   FCDI; CW40044
DR   hPSCreg; CIRMi580-A
DR   Wikidata; Q54815958
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40044; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 10
//
ID   CW40045
AC   CVCL_AP20
SY   CIRM-CW40045i-Affected
DR   Coriell; CW40045
DR   FCDI; CW40045
DR   SKIP; SKIP003953
DR   Wikidata; Q54815959
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40045; true.
CC   Discontinued: FCDI; CW40045; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW40046
AC   CVCL_HI52
SY   CIRMi581-A
DR   BioSamples; SAMEA114397276
DR   Coriell; CW40046
DR   FCDI; CW40046
DR   hPSCreg; CIRMi581-A
DR   Wikidata; Q54815960
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40046; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40047
AC   CVCL_HI53
SY   CIRMi582-A
DR   BioSamples; SAMEA114397278
DR   Coriell; CW40047
DR   FCDI; CW40047
DR   hPSCreg; CIRMi582-A
DR   Wikidata; Q54815961
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40047; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40049
AC   CVCL_4S06
SY   CIRM-CW40049i-Affected; CIRMi583-A
DR   BioSamples; SAMEA114397280
DR   Coriell; CW40049
DR   FCDI; CW40049
DR   hPSCreg; CIRMi583-A
DR   SKIP; SKIP003954
DR   Wikidata; Q54815962
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40049; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40051
AC   CVCL_4S07
SY   CIRM-CW40051i-Affected; CIRMi584-A
DR   BioSamples; SAMEA114397282
DR   Coriell; CW40051
DR   FCDI; CW40051
DR   hPSCreg; CIRMi584-A
DR   SKIP; SKIP003955
DR   Wikidata; Q54815963
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40051; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40052
AC   CVCL_JI48
SY   CIRMi585-A
DR   BioSamples; SAMEA114397284
DR   Coriell; CW40052
DR   FCDI; CW40052
DR   hPSCreg; CIRMi585-A
DR   Wikidata; Q54815964
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40052; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40053
AC   CVCL_JI49
SY   CIRMi586-A
DR   BioSamples; SAMEA114397286
DR   Coriell; CW40053
DR   FCDI; CW40053
DR   hPSCreg; CIRMi586-A
DR   Wikidata; Q54815965
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40053; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40054
AC   CVCL_HI54
SY   CIRMi587-A
DR   BioSamples; SAMEA114397288
DR   Coriell; CW40054
DR   FCDI; CW40054
DR   hPSCreg; CIRMi587-A
DR   Wikidata; Q54815966
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40054; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40055
AC   CVCL_AP21
SY   CIRM-CW40055i-Affected; CIRMi588-A
DR   BioSamples; SAMEA114397290
DR   Coriell; CW40055
DR   FCDI; CW40055
DR   hPSCreg; CIRMi588-A
DR   SKIP; SKIP003956
DR   Wikidata; Q54815967
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40055; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40057
AC   CVCL_JI50
SY   CIRMi589-A
DR   BioSamples; SAMEA114397292
DR   Coriell; CW40057
DR   FCDI; CW40057
DR   hPSCreg; CIRMi589-A
DR   Wikidata; Q54815968
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40057; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40061
AC   CVCL_JI51
SY   CIRMi590-A
DR   BioSamples; SAMEA114397294
DR   Coriell; CW40061
DR   FCDI; CW40061
DR   hPSCreg; CIRMi590-A
DR   Wikidata; Q54815969
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40061; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40062
AC   CVCL_JI52
SY   CIRMi591-A
DR   BioSamples; SAMEA114397296
DR   Coriell; CW40062
DR   FCDI; CW40062
DR   hPSCreg; CIRMi591-A
DR   Wikidata; Q54815970
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40062; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40063
AC   CVCL_JI53
SY   CIRMi592-A
DR   BioSamples; SAMEA114397298
DR   Coriell; CW40063
DR   FCDI; CW40063
DR   hPSCreg; CIRMi592-A
DR   Wikidata; Q54815971
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40063; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40064
AC   CVCL_DK12
SY   CIRM-CW40064i-Affected; CIRMi593-A
DR   BioSamples; SAMEA114397300
DR   Coriell; CW40064
DR   FCDI; CW40064
DR   hPSCreg; CIRMi593-A
DR   SKIP; SKIP003957
DR   Wikidata; Q54815972
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40064; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW40065
AC   CVCL_AP22
SY   CIRM-CW40065i-Affected; CIRMi594-A
DR   BioSamples; SAMEA114397302
DR   Coriell; CW40065
DR   FCDI; CW40065
DR   hPSCreg; CIRMi594-A
DR   SKIP; SKIP003958
DR   Wikidata; Q54815973
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40065; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40066
AC   CVCL_JI54
SY   CIRMi595-A
DR   BioSamples; SAMEA114397304
DR   Coriell; CW40066
DR   FCDI; CW40066
DR   hPSCreg; CIRMi595-A
DR   Wikidata; Q54815974
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40066; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW40067
AC   CVCL_4S08
SY   CIRM-CW40067i-Affected; CIRMi596-A
DR   BioSamples; SAMEA114397306
DR   Coriell; CW40067
DR   FCDI; CW40067
DR   hPSCreg; CIRMi596-A
DR   SKIP; SKIP003959
DR   Wikidata; Q54815975
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40067; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 15
//
ID   CW40068
AC   CVCL_4S09
SY   CIRM-CW40068i-Affected; CIRMi597-A
DR   BioSamples; SAMEA114397308
DR   Coriell; CW40068
DR   FCDI; CW40068
DR   hPSCreg; CIRMi597-A
DR   SKIP; SKIP003960
DR   Wikidata; Q54815976
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40068; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40070
AC   CVCL_JI55
SY   CIRMi598-A
DR   BioSamples; SAMEA114397310
DR   Coriell; CW40070
DR   FCDI; CW40070
DR   hPSCreg; CIRMi598-A
DR   Wikidata; Q54815977
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40070; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40071
AC   CVCL_AP23
SY   CIRM-CW40071i-Affected; CIRMi599-A
DR   BioSamples; SAMEA114397312
DR   Coriell; CW40071
DR   FCDI; CW40071
DR   hPSCreg; CIRMi599-A
DR   SKIP; SKIP003961
DR   Wikidata; Q54815978
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40071; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40073
AC   CVCL_JI56
SY   CIRMi600-A
DR   BioSamples; SAMEA114397314
DR   Coriell; CW40073
DR   FCDI; CW40073
DR   hPSCreg; CIRMi600-A
DR   Wikidata; Q54815979
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40073; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40074
AC   CVCL_DK13
SY   CIRM-CW40074i-Affected; CIRMi601-A
DR   BioSamples; SAMEA114397316
DR   Coriell; CW40074
DR   FCDI; CW40074
DR   hPSCreg; CIRMi601-A
DR   SKIP; SKIP003962
DR   Wikidata; Q54815980
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40074; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40075
AC   CVCL_AP24
SY   CIRM-CW40075i-Affected; CIRMi602-A
DR   BioSamples; SAMEA114397318
DR   Coriell; CW40075
DR   FCDI; CW40075
DR   hPSCreg; CIRMi602-A
DR   SKIP; SKIP003963
DR   Wikidata; Q54815982
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40075; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 16
//
ID   CW40077
AC   CVCL_JI57
SY   CIRMi603-A
DR   BioSamples; SAMEA114397320
DR   Coriell; CW40077
DR   FCDI; CW40077
DR   hPSCreg; CIRMi603-A
DR   Wikidata; Q54815984
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40077; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40078
AC   CVCL_DK14
SY   CIRM-CW40078i-Affected; CIRMi604-A
DR   BioSamples; SAMEA114397322
DR   Coriell; CW40078
DR   FCDI; CW40078
DR   hPSCreg; CIRMi604-A
DR   SKIP; SKIP003964
DR   Wikidata; Q54815985
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40078; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW40079
AC   CVCL_HI55
SY   CIRMi605-A
DR   BioSamples; SAMEA114397324
DR   Coriell; CW40079
DR   FCDI; CW40079
DR   hPSCreg; CIRMi605-A
DR   Wikidata; Q54815986
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40079; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40080
AC   CVCL_AP25
SY   CIRM-CW40080i-Affected; CIRMi606-A
DR   BioSamples; SAMEA114397326
DR   Coriell; CW40080
DR   FCDI; CW40080
DR   hPSCreg; CIRMi606-A
DR   SKIP; SKIP003965
DR   Wikidata; Q54815987
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40080; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40081
AC   CVCL_HI56
SY   CIRMi607-A
DR   BioSamples; SAMEA114397328
DR   Coriell; CW40081
DR   FCDI; CW40081
DR   hPSCreg; CIRMi607-A
DR   Wikidata; Q54815988
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40081; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 9
//
ID   CW40083
AC   CVCL_AP26
SY   CIRM-CW40083i-Affected; CIRMi608-A
DR   BioSamples; SAMEA114397330
DR   Coriell; CW40083
DR   FCDI; CW40083
DR   hPSCreg; CIRMi608-A
DR   SKIP; SKIP003966
DR   Wikidata; Q54816001
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40083; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40084
AC   CVCL_4S10
SY   CIRM-CW40084i-Affected; CIRMi609-A
DR   BioSamples; SAMEA114397332
DR   Coriell; CW40084
DR   FCDI; CW40084
DR   hPSCreg; CIRMi609-A
DR   SKIP; SKIP003967
DR   Wikidata; Q54816002
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40084; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40085
AC   CVCL_4S11
SY   CIRM-CW40085i-Affected; CIRMi610-A
DR   BioSamples; SAMEA114397334
DR   Coriell; CW40085
DR   FCDI; CW40085
DR   hPSCreg; CIRMi610-A
DR   SKIP; SKIP003968
DR   Wikidata; Q54816003
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40085; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40086
AC   CVCL_4S12
SY   CIRMi611-A
DR   BioSamples; SAMEA114397336
DR   Coriell; CW40086
DR   FCDI; CW40086
DR   hPSCreg; CIRMi611-A
DR   Wikidata; Q54816004
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40086; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW40087
AC   CVCL_AP27
SY   CIRM-CW40087i-Affected; CIRMi612-A
DR   BioSamples; SAMEA114397338
DR   Coriell; CW40087
DR   FCDI; CW40087
DR   hPSCreg; CIRMi612-A
DR   SKIP; SKIP003969
DR   Wikidata; Q54816005
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40087; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40088
AC   CVCL_DK15
SY   CIRMi613-A
DR   BioSamples; SAMEA114397340
DR   Coriell; CW40088
DR   FCDI; CW40088
DR   hPSCreg; CIRMi613-A
DR   Wikidata; Q54816006
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40088; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW40089
AC   CVCL_AP28
SY   CIRM-CW40089i-Affected; CIRMi614-A
DR   BioSamples; SAMEA114397342
DR   Coriell; CW40089
DR   FCDI; CW40089
DR   hPSCreg; CIRMi614-A
DR   SKIP; SKIP003970
DR   Wikidata; Q54816007
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40089; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40090
AC   CVCL_AP29
SY   CIRM-CW40090i-Affected; CIRMi615-A
DR   BioSamples; SAMEA114397344
DR   Coriell; CW40090
DR   FCDI; CW40090
DR   hPSCreg; CIRMi615-A
DR   SKIP; SKIP003971
DR   Wikidata; Q54816008
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40090; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40091
AC   CVCL_4S13
SY   CIRM-CW40091i-Affected; CIRMi616-A
DR   BioSamples; SAMEA114397346
DR   Coriell; CW40091
DR   FCDI; CW40091
DR   hPSCreg; CIRMi616-A
DR   SKIP; SKIP003972
DR   Wikidata; Q54816009
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40091; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40092
AC   CVCL_HI57
SY   CIRMi617-A
DR   BioSamples; SAMEA114397348
DR   Coriell; CW40092
DR   FCDI; CW40092
DR   hPSCreg; CIRMi617-A
DR   Wikidata; Q54816010
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40092; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40094
AC   CVCL_JI58
SY   CIRMi618-A
DR   BioSamples; SAMEA114397350
DR   Coriell; CW40094
DR   FCDI; CW40094
DR   hPSCreg; CIRMi618-A
DR   Wikidata; Q54816011
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40094; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW40096
AC   CVCL_LI70
SY   CIRMi619-A
DR   BioSamples; SAMEA114397352
DR   Coriell; CW40096
DR   FCDI; CW40096
DR   hPSCreg; CIRMi619-A
DR   Wikidata; Q54816012
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40096; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW40097
AC   CVCL_AP30
SY   CIRM-CW40097i-Affected; CIRMi620-A
DR   BioSamples; SAMEA114397354
DR   Coriell; CW40097
DR   FCDI; CW40097
DR   hPSCreg; CIRMi620-A
DR   SKIP; SKIP003973
DR   Wikidata; Q54816013
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40097; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40100
AC   CVCL_HI58
SY   CIRMi621-A
DR   BioSamples; SAMEA114397356
DR   Coriell; CW40100
DR   FCDI; CW40100
DR   hPSCreg; CIRMi621-A
DR   Wikidata; Q54816014
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40101
AC   CVCL_JI59
SY   CIRMi622-A
DR   BioSamples; SAMEA114397358
DR   Coriell; CW40101
DR   FCDI; CW40101
DR   hPSCreg; CIRMi622-A
DR   Wikidata; Q54816015
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW40102
AC   CVCL_4S14
SY   CIRM-CW40102i-Affected
DR   Coriell; CW40102
DR   FCDI; CW40102
DR   SKIP; SKIP003974
DR   Wikidata; Q54816016
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40102; true.
CC   Discontinued: FCDI; CW40102; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW40105
AC   CVCL_4S15
SY   CIRM-CW40105i-Affected; CIRMi623-A
DR   BioSamples; SAMEA114397360
DR   Coriell; CW40105
DR   FCDI; CW40105
DR   hPSCreg; CIRMi623-A
DR   SKIP; SKIP003975
DR   Wikidata; Q54816017
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40106
AC   CVCL_4S16
SY   CIRM-CW40106i-Affected; CIRMi624-A
DR   BioSamples; SAMEA114397362
DR   Coriell; CW40106
DR   FCDI; CW40106
DR   hPSCreg; CIRMi624-A
DR   SKIP; SKIP003976
DR   Wikidata; Q54816018
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40107
AC   CVCL_DK16
SY   CIRM-CW40107i-Affected; CIRMi625-A
DR   BioSamples; SAMEA114397364
DR   Coriell; CW40107
DR   FCDI; CW40107
DR   hPSCreg; CIRMi625-A
DR   SKIP; SKIP003977
DR   Wikidata; Q54816019
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW40109
AC   CVCL_AP31
SY   CIRM-CW40109i-Affected; CIRMi626-A
DR   BioSamples; SAMEA114397366
DR   Coriell; CW40109
DR   FCDI; CW40109
DR   hPSCreg; CIRMi626-A
DR   SKIP; SKIP003978
DR   Wikidata; Q54816020
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40110
AC   CVCL_HJ46
SY   CIRMi627-A
DR   BioSamples; SAMEA114397368
DR   Coriell; CW40110
DR   FCDI; CW40110
DR   hPSCreg; CIRMi627-A
DR   Wikidata; Q54816021
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40111
AC   CVCL_4S17
SY   CIRM-CW40111i-Affected; CIRMi628-A
DR   BioSamples; SAMEA114397370
DR   Coriell; CW40111
DR   FCDI; CW40111
DR   hPSCreg; CIRMi628-A
DR   SKIP; SKIP003979
DR   Wikidata; Q54816022
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40112
AC   CVCL_4S18
SY   CIRM-CW40112i-Affected; CIRMi629-A
DR   BioSamples; SAMEA114397372
DR   Coriell; CW40112
DR   FCDI; CW40112
DR   hPSCreg; CIRMi629-A
DR   SKIP; SKIP003980
DR   Wikidata; Q54816023
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40113
AC   CVCL_4S19
SY   CIRM-CW40113i-Affected; CIRMi630-A
DR   BioSamples; SAMEA114397374
DR   Coriell; CW40113
DR   FCDI; CW40113
DR   hPSCreg; CIRMi630-A
DR   SKIP; SKIP003981
DR   Wikidata; Q54816024
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40114
AC   CVCL_4S20
SY   CIRM-CW40114i-Affected; CIRMi631-A
DR   BioSamples; SAMEA114397376
DR   Coriell; CW40114
DR   FCDI; CW40114
DR   hPSCreg; CIRMi631-A
DR   SKIP; SKIP003982
DR   Wikidata; Q54816025
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40115
AC   CVCL_4S21
SY   CIRM-CW40115i-Affected; CIRMi632-A
DR   BioSamples; SAMEA114397378
DR   Coriell; CW40115
DR   FCDI; CW40115
DR   hPSCreg; CIRMi632-A
DR   SKIP; SKIP003983
DR   Wikidata; Q54816026
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40116
AC   CVCL_4S22
SY   CIRM-CW40116i-Affected; CIRMi633-A
DR   BioSamples; SAMEA114397380
DR   Coriell; CW40116
DR   FCDI; CW40116
DR   hPSCreg; CIRMi633-A
DR   SKIP; SKIP003984
DR   Wikidata; Q54816027
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40118
AC   CVCL_4S23
SY   CIRM-CW40118i-Affected; CIRMi634-A
DR   BioSamples; SAMEA114397382
DR   Coriell; CW40118
DR   FCDI; CW40118
DR   hPSCreg; CIRMi634-A
DR   SKIP; SKIP003985
DR   Wikidata; Q54816028
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40119
AC   CVCL_4S24
SY   CIRM-CW40119i-Affected; CIRMi635-A
DR   BioSamples; SAMEA114397384
DR   Coriell; CW40119
DR   FCDI; CW40119
DR   hPSCreg; CIRMi635-A
DR   SKIP; SKIP003986
DR   Wikidata; Q54816029
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40119; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 16
//
ID   CW40120
AC   CVCL_4S25
SY   CIRM-CW40120i-Affected; CIRMi636-A
DR   BioSamples; SAMEA114397386
DR   Coriell; CW40120
DR   FCDI; CW40120
DR   hPSCreg; CIRMi636-A
DR   SKIP; SKIP003987
DR   Wikidata; Q54816030
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40120; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40121
AC   CVCL_4S26
SY   CIRMi637-A
DR   BioSamples; SAMEA114397388
DR   Coriell; CW40121
DR   FCDI; CW40121
DR   hPSCreg; CIRMi637-A
DR   Wikidata; Q54816031
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 11
//
ID   CW40122
AC   CVCL_LI71
SY   CIRMi638-A
DR   BioSamples; SAMEA114397390
DR   Coriell; CW40122
DR   FCDI; CW40122
DR   hPSCreg; CIRMi638-A
DR   Wikidata; Q54816032
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40123
AC   CVCL_4S27
SY   CIRM-CW40123i-Affected; CIRMi639-A
DR   BioSamples; SAMEA114397392
DR   Coriell; CW40123
DR   FCDI; CW40123
DR   hPSCreg; CIRMi639-A
DR   SKIP; SKIP003988
DR   Wikidata; Q54816033
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40123; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40124
AC   CVCL_4S28
SY   CIRM-CW40124i-Affected; CIRMi640-A
DR   BioSamples; SAMEA114397394
DR   Coriell; CW40124
DR   FCDI; CW40124
DR   hPSCreg; CIRMi640-A
DR   SKIP; SKIP003989
DR   Wikidata; Q54816034
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40124; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40125
AC   CVCL_LI72
SY   CIRMi641-A
DR   BioSamples; SAMEA114397396
DR   Coriell; CW40125
DR   FCDI; CW40125
DR   hPSCreg; CIRMi641-A
DR   Wikidata; Q54816035
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40125; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40126
AC   CVCL_4S29
SY   CIRM-CW40126i-Affected; CIRMi642-A
DR   BioSamples; SAMEA114397398
DR   Coriell; CW40126
DR   FCDI; CW40126
DR   hPSCreg; CIRMi642-A
DR   SKIP; SKIP003990
DR   Wikidata; Q54816036
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40127
AC   CVCL_HI59
SY   CIRMi643-A
DR   BioSamples; SAMEA114397400
DR   Coriell; CW40127
DR   FCDI; CW40127
DR   hPSCreg; CIRMi643-A
DR   Wikidata; Q54816037
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40127; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40128
AC   CVCL_4S30
SY   CIRM-CW40128i-Affected; CIRMi644-A
DR   BioSamples; SAMEA114397402
DR   Coriell; CW40128
DR   FCDI; CW40128
DR   hPSCreg; CIRMi644-A
DR   SKIP; SKIP003991
DR   Wikidata; Q54816038
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40129
AC   CVCL_4S31
SY   CIRM-CW40129i-Affected; CIRMi645-A
DR   BioSamples; SAMEA114397404
DR   Coriell; CW40129
DR   FCDI; CW40129
DR   hPSCreg; CIRMi645-A
DR   SKIP; SKIP003992
DR   Wikidata; Q54816039
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40129; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40130
AC   CVCL_DK17
SY   CIRM-CW40130i-Affected
DR   Coriell; CW40130
DR   FCDI; CW40130
DR   SKIP; SKIP003993
DR   Wikidata; Q54816040
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40130; true.
CC   Discontinued: FCDI; CW40130; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW40131
AC   CVCL_4S32
SY   CIRM-CW40131i-Affected; CIRMi646-A
DR   BioSamples; SAMEA114397406
DR   Coriell; CW40131
DR   FCDI; CW40131
DR   hPSCreg; CIRMi646-A
DR   SKIP; SKIP003994
DR   Wikidata; Q54816053
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40131; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40132
AC   CVCL_4S33
SY   CIRM-CW40132i-Affected; CIRMi647-A
DR   BioSamples; SAMEA114397408
DR   Coriell; CW40132
DR   FCDI; CW40132
DR   hPSCreg; CIRMi647-A
DR   SKIP; SKIP003995
DR   Wikidata; Q54816055
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40135
AC   CVCL_4S34
SY   CIRM-CW40135i-Affected; CIRMi648-A
DR   BioSamples; SAMEA114397410
DR   Coriell; CW40135
DR   FCDI; CW40135
DR   hPSCreg; CIRMi648-A
DR   SKIP; SKIP003996
DR   Wikidata; Q54816056
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40135; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW40136
AC   CVCL_4S35
SY   CIRM-CW40136i-Affected; CIRMi649-A
DR   BioSamples; SAMEA114397412
DR   Coriell; CW40136
DR   FCDI; CW40136
DR   hPSCreg; CIRMi649-A
DR   SKIP; SKIP003997
DR   Wikidata; Q54816057
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40136; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40137
AC   CVCL_4S36
SY   CIRM-CW40137i-Affected; CIRMi650-A
DR   BioSamples; SAMEA114397414
DR   Coriell; CW40137
DR   FCDI; CW40137
DR   hPSCreg; CIRMi650-A
DR   SKIP; SKIP003998
DR   Wikidata; Q54816058
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40137; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40139
AC   CVCL_4S37
SY   CIRM-CW40139i-Affected; CIRMi651-A
DR   BioSamples; SAMEA114397416
DR   Coriell; CW40139
DR   FCDI; CW40139
DR   hPSCreg; CIRMi651-A
DR   SKIP; SKIP003999
DR   Wikidata; Q54816059
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40139; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40142
AC   CVCL_4S38
SY   CIRM-CW40142i-Affected; CIRMi652-A
DR   BioSamples; SAMEA114397418
DR   Coriell; CW40142
DR   FCDI; CW40142
DR   hPSCreg; CIRMi652-A
DR   SKIP; SKIP004000
DR   Wikidata; Q54816060
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40142; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40144
AC   CVCL_HI60
SY   CIRMi653-A
DR   BioSamples; SAMEA114397420
DR   Coriell; CW40144
DR   FCDI; CW40144
DR   hPSCreg; CIRMi653-A
DR   Wikidata; Q54816061
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40145
AC   CVCL_AP32
SY   CIRM-CW40145i-Affected; CIRMi654-A
DR   BioSamples; SAMEA114397422
DR   Coriell; CW40145
DR   FCDI; CW40145
DR   hPSCreg; CIRMi654-A
DR   SKIP; SKIP004001
DR   Wikidata; Q54816062
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40145; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40147
AC   CVCL_4S39
SY   CIRM-CW40147i-Affected; CIRMi655-A
DR   BioSamples; SAMEA114397424
DR   Coriell; CW40147
DR   FCDI; CW40147
DR   hPSCreg; CIRMi655-A
DR   SKIP; SKIP004002
DR   Wikidata; Q54816063
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40147; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40148
AC   CVCL_AP33
SY   CIRM-CW40148i-Affected; CIRMi656-A
DR   BioSamples; SAMEA114397426
DR   Coriell; CW40148
DR   FCDI; CW40148
DR   hPSCreg; CIRMi656-A
DR   SKIP; SKIP004003
DR   Wikidata; Q54816064
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40148; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40149
AC   CVCL_4S40
SY   CIRM-CW40149i-Affected; CIRMi657-A
DR   BioSamples; SAMEA114397428
DR   Coriell; CW40149
DR   FCDI; CW40149
DR   hPSCreg; CIRMi657-A
DR   SKIP; SKIP004004
DR   Wikidata; Q54816065
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW40152
AC   CVCL_HI61
SY   CIRMi658-A
DR   BioSamples; SAMEA114397430
DR   Coriell; CW40152
DR   FCDI; CW40152
DR   hPSCreg; CIRMi658-A
DR   Wikidata; Q54816066
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40152; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40153
AC   CVCL_LI73
SY   CIRMi659-A
DR   BioSamples; SAMEA114397432
DR   Coriell; CW40153
DR   FCDI; CW40153
DR   hPSCreg; CIRMi659-A
DR   Wikidata; Q54816067
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40153; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40155
AC   CVCL_AP34
SY   CIRM-CW40155i-Affected
DR   Coriell; CW40155
DR   FCDI; CW40155
DR   SKIP; SKIP004005
DR   Wikidata; Q54816068
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40155; true.
CC   Discontinued: FCDI; CW40155; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW40157
AC   CVCL_AP35
SY   CIRM-CW40157i-Affected; CIRMi660-A
DR   BioSamples; SAMEA114397434
DR   Coriell; CW40157
DR   FCDI; CW40157
DR   hPSCreg; CIRMi660-A
DR   SKIP; SKIP004006
DR   Wikidata; Q54816069
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40157; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40158
AC   CVCL_AP36
SY   CIRM-CW40158i-Affected
DR   Coriell; CW40158
DR   SKIP; SKIP004007
DR   Wikidata; Q54816070
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40158; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 9
//
ID   CW40159
AC   CVCL_AP37
SY   CIRM-CW40159i-Affected; CIRMi661-A
DR   BioSamples; SAMEA114397436
DR   Coriell; CW40159
DR   FCDI; CW40159
DR   hPSCreg; CIRMi661-A
DR   SKIP; SKIP004008
DR   Wikidata; Q54816071
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40159; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40160
AC   CVCL_AP38
SY   CIRM-CW40160i-Affected; CIRMi662-A
DR   BioSamples; SAMEA114397438
DR   Coriell; CW40160
DR   FCDI; CW40160
DR   hPSCreg; CIRMi662-A
DR   SKIP; SKIP004009
DR   Wikidata; Q54816072
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40160; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40161
AC   CVCL_AP39
SY   CIRM-CW40161i-Affected; CIRMi663-A
DR   BioSamples; SAMEA114397440
DR   Coriell; CW40161
DR   FCDI; CW40161
DR   hPSCreg; CIRMi663-A
DR   SKIP; SKIP004010
DR   Wikidata; Q54816073
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40161; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40163
AC   CVCL_DK18
SY   CIRMi664-A
DR   BioSamples; SAMEA114397442
DR   Coriell; CW40163
DR   FCDI; CW40163
DR   hPSCreg; CIRMi664-A
DR   Wikidata; Q54816074
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40163; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40164
AC   CVCL_AP40
SY   CIRM-CW40164i-Affected; CIRMi665-A
DR   BioSamples; SAMEA114397444
DR   Coriell; CW40164
DR   FCDI; CW40164
DR   hPSCreg; CIRMi665-A
DR   SKIP; SKIP004011
DR   Wikidata; Q54816075
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40164; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40165
AC   CVCL_AP41
SY   CIRM-CW40165i-Affected; CIRMi666-A
DR   BioSamples; SAMEA114397446
DR   Coriell; CW40165
DR   FCDI; CW40165
DR   hPSCreg; CIRMi666-A
DR   SKIP; SKIP004012
DR   Wikidata; Q54816076
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40165; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40167
AC   CVCL_HI62
SY   CIRMi667-A
DR   BioSamples; SAMEA114397448
DR   Coriell; CW40167
DR   FCDI; CW40167
DR   hPSCreg; CIRMi667-A
DR   Wikidata; Q54816077
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40169
AC   CVCL_AP42
SY   CIRM-CW40169i-Affected; CIRMi668-A
DR   BioSamples; SAMEA114397450
DR   Coriell; CW40169
DR   FCDI; CW40169
DR   hPSCreg; CIRMi668-A
DR   SKIP; SKIP004013
DR   Wikidata; Q54816078
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40169; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40172
AC   CVCL_LI74
SY   CIRMi669-A
DR   BioSamples; SAMEA114397452
DR   Coriell; CW40172
DR   FCDI; CW40172
DR   hPSCreg; CIRMi669-A
DR   Wikidata; Q54816079
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40172; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40174
AC   CVCL_AP43
SY   CIRM-CW40174i-Affected; CIRMi670-A
DR   BioSamples; SAMEA114397454
DR   Coriell; CW40174
DR   FCDI; CW40174
DR   hPSCreg; CIRMi670-A
DR   SKIP; SKIP004014
DR   Wikidata; Q54816080
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40174; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40175
AC   CVCL_AP44
SY   CIRM-CW40175i-Affected
DR   Coriell; CW40175
DR   FCDI; CW40175
DR   SKIP; SKIP004015
DR   Wikidata; Q54816081
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40175; true.
CC   Discontinued: FCDI; CW40175; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW40176
AC   CVCL_AP45
SY   CIRM-CW40176i-Affected
DR   Coriell; CW40176
DR   FCDI; CW40176
DR   SKIP; SKIP004016
DR   Wikidata; Q54816082
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40176; true.
CC   Discontinued: FCDI; CW40176; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 10
//
ID   CW40178
AC   CVCL_AP46
SY   CIRM-CW40178i-Affected; CIRMi671-A
DR   BioSamples; SAMEA114397456
DR   Coriell; CW40178
DR   FCDI; CW40178
DR   hPSCreg; CIRMi671-A
DR   SKIP; SKIP004017
DR   Wikidata; Q54816083
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40178; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40179
AC   CVCL_DK19
DR   Coriell; CW40179
DR   FCDI; CW40179
DR   Wikidata; Q54816084
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40179; true.
CC   Discontinued: FCDI; CW40179; probable.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
ID   CW40181
AC   CVCL_LI75
SY   CIRMi672-A
DR   BioSamples; SAMEA114397458
DR   Coriell; CW40181
DR   FCDI; CW40181
DR   hPSCreg; CIRMi672-A
DR   Wikidata; Q54816085
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40181; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40182
AC   CVCL_AP47
SY   CIRM-CW40182i-Affected; CIRMi673-A
DR   BioSamples; SAMEA114397460
DR   Coriell; CW40182
DR   FCDI; CW40182
DR   hPSCreg; CIRMi673-A
DR   SKIP; SKIP004018
DR   Wikidata; Q54816086
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40182; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40183
AC   CVCL_AP48
SY   CIRM-CW40183i-Affected; CIRMi674-A
DR   BioSamples; SAMEA114397462
DR   Coriell; CW40183
DR   FCDI; CW40183
DR   hPSCreg; CIRMi674-A
DR   SKIP; SKIP004019
DR   Wikidata; Q54816087
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40183; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 14
//
ID   CW40185
AC   CVCL_HI63
SY   CIRMi675-A
DR   BioSamples; SAMEA114397464
DR   Coriell; CW40185
DR   FCDI; CW40185
DR   hPSCreg; CIRMi675-A
DR   Wikidata; Q54816089
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW40185; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40186
AC   CVCL_AP49
SY   CIRM-CW40186i-Affected
DR   Coriell; CW40186
DR   SKIP; SKIP004020
DR   Wikidata; Q54816090
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40186; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 9
//
ID   CW40187
AC   CVCL_DK20
SY   CIRMi676-A
DR   BioSamples; SAMEA114397466
DR   Coriell; CW40187
DR   FCDI; CW40187
DR   hPSCreg; CIRMi676-A
DR   Wikidata; Q54816091
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40187; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 12
//
ID   CW40190
AC   CVCL_AP50
SY   CIRM-CW40190i-Affected; CIRMi677-A
DR   BioSamples; SAMEA114397468
DR   Coriell; CW40190
DR   FCDI; CW40190
DR   hPSCreg; CIRMi677-A
DR   SKIP; SKIP004021
DR   Wikidata; Q54816092
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40190; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40191
AC   CVCL_LK02
SY   CIRMi678-A
DR   BioSamples; SAMEA114397470
DR   Coriell; CW40191
DR   FCDI; CW40191
DR   hPSCreg; CIRMi678-A
DR   Wikidata; Q54816093
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW40191; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40192
AC   CVCL_JI60
SY   CIRMi679-A
DR   BioSamples; SAMEA114397472
DR   Coriell; CW40192
DR   FCDI; CW40192
DR   hPSCreg; CIRMi679-A
DR   Wikidata; Q54816094
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40192; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW40193
AC   CVCL_ER55
SY   CIRMi680-A
DR   BioSamples; SAMEA114397474
DR   Coriell; CW40193
DR   FCDI; CW40193
DR   hPSCreg; CIRMi680-A
DR   Wikidata; Q54816105
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40193; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW40194
AC   CVCL_DK21
SY   CIRM-CW40194i-Affected; CIRMi681-A
DR   BioSamples; SAMEA114397476
DR   Coriell; CW40194
DR   FCDI; CW40194
DR   hPSCreg; CIRMi681-A
DR   SKIP; SKIP004022
DR   Wikidata; Q54816106
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40194; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40195
AC   CVCL_DK22
SY   CIRM-CW40195i-Affected; CIRMi682-A
DR   BioSamples; SAMEA114397478
DR   Coriell; CW40195
DR   FCDI; CW40195
DR   hPSCreg; CIRMi682-A
DR   SKIP; SKIP004023
DR   Wikidata; Q54816107
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40195; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40196
AC   CVCL_DK23
SY   CIRMi683-A
DR   BioSamples; SAMEA114397480
DR   Coriell; CW40196
DR   FCDI; CW40196
DR   hPSCreg; CIRMi683-A
DR   Wikidata; Q54816108
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40196; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40197
AC   CVCL_DK24
SY   CIRM-CW40197i-Affected; CIRMi684-A
DR   BioSamples; SAMEA114397482
DR   Coriell; CW40197
DR   FCDI; CW40197
DR   hPSCreg; CIRMi684-A
DR   SKIP; SKIP004024
DR   Wikidata; Q54816109
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40197; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40198
AC   CVCL_DK25
SY   CIRM-CW40198i-Affected; CIRMi685-A
DR   BioSamples; SAMEA114397484
DR   Coriell; CW40198
DR   FCDI; CW40198
DR   hPSCreg; CIRMi685-A
DR   SKIP; SKIP004025
DR   Wikidata; Q54816110
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40198; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40199
AC   CVCL_DK26
SY   CIRMi686-A
DR   BioSamples; SAMEA114397486
DR   Coriell; CW40199
DR   FCDI; CW40199
DR   hPSCreg; CIRMi686-A
DR   Wikidata; Q54816111
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40199; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40200
AC   CVCL_DK27
SY   CIRM-CW40200i-Affected; CIRMi687-A
DR   BioSamples; SAMEA114397488
DR   Coriell; CW40200
DR   FCDI; CW40200
DR   hPSCreg; CIRMi687-A
DR   SKIP; SKIP004026
DR   Wikidata; Q54816112
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW40200; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40201
AC   CVCL_AP51
SY   CIRM-CW40201i-Affected; CIRMi688-A; high_PRS_5
DR   BioSamples; SAMEA114397490
DR   Coriell; CW40201
DR   FCDI; CW40201
DR   hPSCreg; CIRMi688-A
DR   SKIP; SKIP004027
DR   Wikidata; Q54816113
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally high polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW40201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 15
//
ID   CW40206
AC   CVCL_HI64
SY   CIRMi689-A
DR   BioSamples; SAMEA114397492
DR   Coriell; CW40206
DR   FCDI; CW40206
DR   hPSCreg; CIRMi689-A
DR   Wikidata; Q54816114
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40207
AC   CVCL_DK28
SY   CIRM-CW40207i-Affected; CIRMi690-A
DR   BioSamples; SAMEA114397494
DR   Coriell; CW40207
DR   FCDI; CW40207
DR   hPSCreg; CIRMi690-A
DR   SKIP; SKIP004028
DR   Wikidata; Q54816115
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40208
AC   CVCL_AP52
SY   CIRM-CW40208i-Affected; CIRMi691-A
DR   BioSamples; SAMEA114397496
DR   Coriell; CW40208
DR   FCDI; CW40208
DR   hPSCreg; CIRMi691-A
DR   SKIP; SKIP004029
DR   Wikidata; Q54816116
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 13
//
ID   CW40209
AC   CVCL_HI65
SY   CIRMi692-A
DR   BioSamples; SAMEA114397498
DR   Coriell; CW40209
DR   FCDI; CW40209
DR   hPSCreg; CIRMi692-A
DR   Wikidata; Q54816117
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW40209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40210
AC   CVCL_DK29
SY   CIRM-CW40210i-Affected
DR   Coriell; CW40210
DR   SKIP; SKIP004030
DR   Wikidata; Q54816118
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40210; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 9
//
ID   CW40211
AC   CVCL_HI66
SY   CIRMi693-A
DR   BioSamples; SAMEA114397500
DR   Coriell; CW40211
DR   FCDI; CW40211
DR   hPSCreg; CIRMi693-A
DR   Wikidata; Q54816119
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40212
AC   CVCL_ER56
SY   CIRMi694-A
DR   BioSamples; SAMEA114397502
DR   Coriell; CW40212
DR   FCDI; CW40212
DR   hPSCreg; CIRMi694-A
DR   Wikidata; Q54816120
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Japanese.
CC   Discontinued: Coriell; CW40212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW40213
AC   CVCL_ER57
SY   CIRMi695-A
DR   BioSamples; SAMEA114397504
DR   Coriell; CW40213
DR   FCDI; CW40213
DR   hPSCreg; CIRMi695-A
DR   Wikidata; Q54816121
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW40214
AC   CVCL_HI67
SY   CIRMi696-A
DR   BioSamples; SAMEA114397506
DR   Coriell; CW40214
DR   FCDI; CW40214
DR   hPSCreg; CIRMi696-A
DR   Wikidata; Q54816122
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40214; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40217
AC   CVCL_JI61
SY   CIRMi697-A
DR   BioSamples; SAMEA114397508
DR   Coriell; CW40217
DR   FCDI; CW40217
DR   hPSCreg; CIRMi697-A
DR   Wikidata; Q54816123
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40217; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW40218
AC   CVCL_HI68
SY   CIRMi698-A
DR   BioSamples; SAMEA114397510
DR   Coriell; CW40218
DR   FCDI; CW40218
DR   hPSCreg; CIRMi698-A
DR   Wikidata; Q54816124
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40218; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40219
AC   CVCL_DK30
SY   CIRM-CW40219i-Affected; CIRMi699-A
DR   BioSamples; SAMEA114397512
DR   Coriell; CW40219
DR   FCDI; CW40219
DR   hPSCreg; CIRMi699-A
DR   SKIP; SKIP004031
DR   Wikidata; Q54816125
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40219; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40220
AC   CVCL_DK31
SY   CIRM-CW40220i-Affected; CIRMi700-A
DR   BioSamples; SAMEA114397514
DR   Coriell; CW40220
DR   FCDI; CW40220
DR   hPSCreg; CIRMi700-A
DR   SKIP; SKIP004032
DR   Wikidata; Q54816126
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW40220; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40221
AC   CVCL_DK32
SY   CIRM-CW40221i-Affected; CIRMi701-A
DR   BioSamples; SAMEA114397516
DR   Coriell; CW40221
DR   FCDI; CW40221
DR   hPSCreg; CIRMi701-A
DR   SKIP; SKIP004033
DR   Wikidata; Q54816127
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40221; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40222
AC   CVCL_DK33
SY   CIRM-CW40222i-Affected; CIRMi702-A
DR   BioSamples; SAMEA114397518
DR   Coriell; CW40222
DR   FCDI; CW40222
DR   hPSCreg; CIRMi702-A
DR   SKIP; SKIP004034
DR   Wikidata; Q54816129
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40222; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40224
AC   CVCL_LI76
SY   CIRMi703-A
DR   BioSamples; SAMEA114397520
DR   Coriell; CW40224
DR   FCDI; CW40224
DR   hPSCreg; CIRMi703-A
DR   Wikidata; Q54816131
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40224; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40225
AC   CVCL_LK03
SY   CIRMi704-A
DR   BioSamples; SAMEA114397522
DR   Coriell; CW40225
DR   FCDI; CW40225
DR   hPSCreg; CIRMi704-A
DR   Wikidata; Q54816132
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40225; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40226
AC   CVCL_DK34
SY   CIRMi705-A
DR   BioSamples; SAMEA114397524
DR   Coriell; CW40226
DR   FCDI; CW40226
DR   hPSCreg; CIRMi705-A
DR   Wikidata; Q54816133
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40226; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40227
AC   CVCL_DK35
SY   CIRM-CW40227i-Affected; CIRMi706-A
DR   BioSamples; SAMEA114397526
DR   Coriell; CW40227
DR   FCDI; CW40227
DR   hPSCreg; CIRMi706-A
DR   SKIP; SKIP003942
DR   Wikidata; Q54816134
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40227; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW40228
AC   CVCL_HI69
SY   CIRMi707-A
DR   BioSamples; SAMEA114397528
DR   Coriell; CW40228
DR   FCDI; CW40228
DR   hPSCreg; CIRMi707-A
DR   Wikidata; Q54816135
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40228; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40229
AC   CVCL_HI70
SY   CIRMi708-A
DR   BioSamples; SAMEA114397530
DR   Coriell; CW40229
DR   FCDI; CW40229
DR   hPSCreg; CIRMi708-A
DR   Wikidata; Q54816136
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40229; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40230
AC   CVCL_HI71
SY   CIRMi709-A
DR   BioSamples; SAMEA114397532
DR   Coriell; CW40230
DR   FCDI; CW40230
DR   hPSCreg; CIRMi709-A
DR   Wikidata; Q54816137
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40230; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   CW40231
AC   CVCL_DK36
SY   CIRM-CW40231i-Affected; CIRMi710-A
DR   BioSamples; SAMEA114397534
DR   Coriell; CW40231
DR   FCDI; CW40231
DR   hPSCreg; CIRMi710-A
DR   SKIP; SKIP004035
DR   Wikidata; Q54816138
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40231; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW40232
AC   CVCL_DK37
SY   CIRMi711-A
DR   BioSamples; SAMEA114397536
DR   Coriell; CW40232
DR   FCDI; CW40232
DR   hPSCreg; CIRMi711-A
DR   Wikidata; Q54816139
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40232; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40233
AC   CVCL_DK38
SY   CIRMi712-A
DR   BioSamples; SAMEA114397538
DR   Coriell; CW40233
DR   FCDI; CW40233
DR   hPSCreg; CIRMi712-A
DR   Wikidata; Q54816140
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40233; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40234
AC   CVCL_HI72
SY   CIRMi713-A
DR   BioSamples; SAMEA114397540
DR   Coriell; CW40234
DR   FCDI; CW40234
DR   hPSCreg; CIRMi713-A
DR   Wikidata; Q54816141
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40234; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40235
AC   CVCL_HI73
SY   CIRMi714-A
DR   BioSamples; SAMEA114397542
DR   Coriell; CW40235
DR   FCDI; CW40235
DR   hPSCreg; CIRMi714-A
DR   Wikidata; Q54816143
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW40235; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40236
AC   CVCL_DK39
SY   CIRMi715-A
DR   BioSamples; SAMEA114397544
DR   Coriell; CW40236
DR   FCDI; CW40236
DR   hPSCreg; CIRMi715-A
DR   Wikidata; Q54816144
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40236; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40237
AC   CVCL_DK40
SY   CIRMi716-A
DR   BioSamples; SAMEA114397546
DR   Coriell; CW40237
DR   FCDI; CW40237
DR   hPSCreg; CIRMi716-A
DR   Wikidata; Q54816145
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40237; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40239
AC   CVCL_DK41
SY   CIRMi717-A
DR   BioSamples; SAMEA114397548
DR   Coriell; CW40239
DR   FCDI; CW40239
DR   hPSCreg; CIRMi717-A
DR   Wikidata; Q54816146
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW40239; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40240
AC   CVCL_DK42
DR   Coriell; CW40240
DR   Wikidata; Q54816147
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW40240; true.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   CW40243
AC   CVCL_HI74
SY   CIRMi718-A
DR   BioSamples; SAMEA114397550
DR   Coriell; CW40243
DR   FCDI; CW40243
DR   hPSCreg; CIRMi718-A
DR   Wikidata; Q54816156
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW40243; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW40244
AC   CVCL_DK43
SY   CIRMi719-A
DR   BioSamples; SAMEA114397552
DR   Coriell; CW40244
DR   FCDI; CW40244
DR   hPSCreg; CIRMi719-A
DR   Wikidata; Q54816157
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40244; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40245
AC   CVCL_DK44
SY   CIRMi720-A
DR   BioSamples; SAMEA114397554
DR   Coriell; CW40245
DR   FCDI; CW40245
DR   hPSCreg; CIRMi720-A
DR   Wikidata; Q54816159
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW40245; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40246
AC   CVCL_DK45
SY   CIRMi721-A
DR   BioSamples; SAMEA114397556
DR   Coriell; CW40246
DR   FCDI; CW40246
DR   hPSCreg; CIRMi721-A
DR   Wikidata; Q54816160
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW40246; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40247
AC   CVCL_ER58
SY   CIRMi722-A
DR   BioSamples; SAMEA114397558
DR   Coriell; CW40247
DR   FCDI; CW40247
DR   hPSCreg; CIRMi722-A
DR   Wikidata; Q54816161
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40247; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW40249
AC   CVCL_DK46
SY   CIRMi723-A
DR   BioSamples; SAMEA114397560
DR   Coriell; CW40249
DR   FCDI; CW40249
DR   hPSCreg; CIRMi723-A
DR   Wikidata; Q54816162
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW40249; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW40250
AC   CVCL_LI77
SY   CIRMi724-A
DR   BioSamples; SAMEA114397562
DR   Coriell; CW40250
DR   FCDI; CW40250
DR   hPSCreg; CIRMi724-A
DR   Wikidata; Q54816163
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40250; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW40251
AC   CVCL_DK47
SY   CIRMi725-A
DR   BioSamples; SAMEA114397564
DR   Coriell; CW40251
DR   FCDI; CW40251
DR   hPSCreg; CIRMi725-A
DR   Wikidata; Q54816164
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW40251; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50001
AC   CVCL_4S41
SY   CIRM-CW50001i-Ctl; CIRMi068-A
DR   BioSamples; SAMEA112959163
DR   Coriell; CW50001
DR   FCDI; CW50001
DR   hPSCreg; CIRMi068-A
DR   SKIP; SKIP004036
DR   Wikidata; Q54816165
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW50001; true.
CC   Discontinued: FCDI; CW50001; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW50002
AC   CVCL_4S42
SY   CIRM-CW50002i-Ctl; CIRMi101-A
DR   BioSamples; SAMEA112959379
DR   Coriell; CW50002
DR   FCDI; CW50002
DR   hPSCreg; CIRMi101-A
DR   SKIP; SKIP004037
DR   Wikidata; Q54816166
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW50003
AC   CVCL_4S43
SY   CIRM-CW50003i-Ctl; CIRMi102-A
DR   BioSamples; SAMEA112959381
DR   Coriell; CW50003
DR   FCDI; CW50003
DR   hPSCreg; CIRMi102-A
DR   SKIP; SKIP004038
DR   Wikidata; Q54816167
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW50004
AC   CVCL_4S44
SY   CIRM-CW50004i-Affected; CIRMi103-A
DR   BioSamples; SAMEA112959383
DR   Coriell; CW50004
DR   FCDI; CW50004
DR   hPSCreg; CIRMi103-A
DR   SKIP; SKIP004039
DR   Wikidata; Q54816168
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW50005
AC   CVCL_4S45
SY   CIRM-CW50005i-Ctl; CIRMi069-A
DR   BioSamples; SAMEA112959165
DR   Coriell; CW50005
DR   FCDI; CW50005
DR   hPSCreg; CIRMi069-A
DR   SKIP; SKIP004040
DR   Wikidata; Q54816169
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW50005; true.
CC   Discontinued: FCDI; CW50005; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW50006
AC   CVCL_4S46
SY   CIRM-CW50006i-Ctl; CIRMi104-A
DR   BioSamples; SAMEA112959385
DR   Coriell; CW50006
DR   FCDI; CW50006
DR   hPSCreg; CIRMi104-A
DR   SKIP; SKIP004041
DR   Wikidata; Q54816170
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW50007
AC   CVCL_4S47
SY   CIRM-CW50007i-Ctl; CIRMi070-A
DR   BioSamples; SAMEA112959167
DR   Coriell; CW50007
DR   FCDI; CW50007
DR   hPSCreg; CIRMi070-A
DR   SKIP; SKIP004042
DR   Wikidata; Q54816171
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW50007; true.
CC   Discontinued: FCDI; CW50007; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW50008
AC   CVCL_4S48
SY   CIRM-CW50008i-Ctl; CIRMi105-A
DR   BioSamples; SAMEA112959387
DR   Coriell; CW50008
DR   FCDI; CW50008
DR   hPSCreg; CIRMi105-A
DR   SKIP; SKIP004043
DR   Wikidata; Q54816172
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50008; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW50009
AC   CVCL_DK48
SY   CIRMi106-A
DR   BioSamples; SAMEA112959389
DR   Coriell; CW50009
DR   FCDI; CW50009
DR   hPSCreg; CIRMi106-A
DR   Wikidata; Q54816173
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50010
AC   CVCL_D0CA
SY   CIRMi071-A
DR   BioSamples; SAMEA112959169
DR   hPSCreg; CIRMi071-A
DR   Wikidata; Q123031084
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50013
AC   CVCL_4S49
SY   CIRM-CW50013i-Ctl; CIRMi107-A
DR   BioSamples; SAMEA112959391
DR   Coriell; CW50013
DR   FCDI; CW50013
DR   hPSCreg; CIRMi107-A
DR   SKIP; SKIP004044
DR   Wikidata; Q54816175
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50013; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW50015
AC   CVCL_DK49
SY   CIRM-CW50015i-Ctl; CIRMi072-A
DR   BioSamples; SAMEA112959171
DR   Coriell; CW50015
DR   FCDI; CW50015
DR   hPSCreg; CIRMi072-A
DR   SKIP; SKIP004045
DR   Wikidata; Q54816176
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW50015; true.
CC   Discontinued: FCDI; CW50015; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW50016
AC   CVCL_DK50
SY   CIRM-CW50016i-CTL; CIRMi108-A
DR   BioSamples; SAMEA112959393
DR   Coriell; CW50016
DR   FCDI; CW50016
DR   hPSCreg; CIRMi108-A
DR   SKIP; SKIP004046
DR   Wikidata; Q54816177
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50016; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50017
AC   CVCL_D0CB
SY   CIRMi073-A
DR   BioSamples; SAMEA112959173
DR   hPSCreg; CIRMi073-A
DR   Wikidata; Q123031085
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50018
AC   CVCL_DK51
SY   CIRM-CW50018i-Affected; CIRMi109-A
DR   BioSamples; SAMEA112959395
DR   Coriell; CW50018
DR   FCDI; CW50018
DR   hPSCreg; CIRMi109-A
DR   SKIP; SKIP004047
DR   Wikidata; Q54816178
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50018; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50019
AC   CVCL_DK52
SY   CIRM-CW50019i-CTL; CIRMi110-A
DR   BioSamples; SAMEA112959397
DR   Coriell; CW50019
DR   FCDI; CW50019
DR   hPSCreg; CIRMi110-A
DR   SKIP; SKIP004048
DR   Wikidata; Q54816179
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50019; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50020
AC   CVCL_D0CC
SY   CIRMi074-A
DR   BioSamples; SAMEA112959175
DR   hPSCreg; CIRMi074-A
DR   Wikidata; Q123031086
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50021
AC   CVCL_HI75
SY   CIRMi111-A
DR   BioSamples; SAMEA112959399
DR   Coriell; CW50021
DR   FCDI; CW50021
DR   hPSCreg; CIRMi111-A
DR   Wikidata; Q54816180
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50021; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50022
AC   CVCL_DK53
SY   CIRM-CW50022i-CTL; CIRMi112-A
DR   BioSamples; SAMEA112959401
DR   Coriell; CW50022
DR   FCDI; CW50022
DR   hPSCreg; CIRMi112-A
DR   SKIP; SKIP004049
DR   Wikidata; Q54816181
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50022; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50023
AC   CVCL_LI78
SY   CIRMi113-A
DR   BioSamples; SAMEA112959409
DR   Coriell; CW50023
DR   FCDI; CW50023
DR   hPSCreg; CIRMi113-A
DR   Wikidata; Q54816183
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50023; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50024
AC   CVCL_DK54
SY   CIRM-CW50024i-Affected; CIRMi114-A
DR   BioSamples; SAMEA112959468
DR   Coriell; CW50024
DR   FCDI; CW50024
DR   hPSCreg; CIRMi114-A
DR   SKIP; SKIP004050
DR   Wikidata; Q54816184
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50024; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50025
AC   CVCL_DK55
SY   CIRMi115-A
DR   BioSamples; SAMEA112959470
DR   Coriell; CW50025
DR   FCDI; CW50025
DR   hPSCreg; CIRMi115-A
DR   Wikidata; Q54816185
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50025; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50026
AC   CVCL_DK56
SY   CIRM-CW50026i-Ctl; CIRMi116-A
DR   BioSamples; SAMEA112959472
DR   Coriell; CW50026
DR   FCDI; CW50026
DR   hPSCreg; CIRMi116-A
DR   SKIP; SKIP004051
DR   Wikidata; Q54816186
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50026; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50027
AC   CVCL_DK57
SY   CIRM-CW50027i-Ctl; CIRMi117-A
DR   BioSamples; SAMEA112959474
DR   Coriell; CW50027
DR   FCDI; CW50027
DR   hPSCreg; CIRMi117-A
DR   SKIP; SKIP004052
DR   Wikidata; Q54816187
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW50027; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   CW50028
AC   CVCL_DK58
SY   CIRM-CW50028i-Ctl; CIRMi118-A
DR   BioSamples; SAMEA112959476
DR   Coriell; CW50028
DR   FCDI; CW50028
DR   hPSCreg; CIRMi118-A
DR   SKIP; SKIP004053
DR   Wikidata; Q54816188
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50028; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50029
AC   CVCL_DK59
SY   CIRM-CW50029i-Ctl; CIRMi119-A
DR   BioSamples; SAMEA112959478
DR   Coriell; CW50029
DR   FCDI; CW50029
DR   hPSCreg; CIRMi119-A
DR   SKIP; SKIP004054
DR   Wikidata; Q54816189
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50029; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50030
AC   CVCL_D0CD
SY   CIRMi075-A
DR   BioSamples; SAMEA112959177
DR   hPSCreg; CIRMi075-A
DR   Wikidata; Q123031088
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50032
AC   CVCL_LI79
SY   CIRMi120-A
DR   BioSamples; SAMEA112959480
DR   Coriell; CW50032
DR   FCDI; CW50032
DR   hPSCreg; CIRMi120-A
DR   Wikidata; Q54816190
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50032; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50033
AC   CVCL_DK60
SY   CIRM-CW50033i-Ctl; CIRMi121-A
DR   BioSamples; SAMEA112959482
DR   Coriell; CW50033
DR   FCDI; CW50033
DR   hPSCreg; CIRMi121-A
DR   SKIP; SKIP004055
DR   Wikidata; Q54816191
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50033; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50034
AC   CVCL_DK61
SY   CIRM-CW50034i-CTL; CIRMi122-A
DR   BioSamples; SAMEA112959484
DR   Coriell; CW50034
DR   FCDI; CW50034
DR   hPSCreg; CIRMi122-A
DR   SKIP; SKIP004056
DR   Wikidata; Q54816192
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50034; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50035
AC   CVCL_DK62
SY   CIRM-CW50035i-CTL; CIRMi123-A
DR   BioSamples; SAMEA112959486
DR   Coriell; CW50035
DR   FCDI; CW50035
DR   hPSCreg; CIRMi123-A
DR   SKIP; SKIP004057
DR   Wikidata; Q54816193
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50035; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50036
AC   CVCL_DK63
SY   CIRM-CW50036i-CTL; CIRMi124-A
DR   BioSamples; SAMEA112959488
DR   Coriell; CW50036
DR   FCDI; CW50036
DR   hPSCreg; CIRMi124-A
DR   SKIP; SKIP004058
DR   Wikidata; Q54816194
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50036; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50037
AC   CVCL_DK64
SY   CIRM-CW50037i-CTL; CIRMi125-A
DR   BioSamples; SAMEA112959490
DR   Coriell; CW50037
DR   FCDI; CW50037
DR   hPSCreg; CIRMi125-A
DR   SKIP; SKIP004059
DR   Wikidata; Q54816195
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50037; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50038
AC   CVCL_DK65
SY   CIRM-CW50038i-CTL; CIRMi126-A
DR   BioSamples; SAMEA112959492
DR   Coriell; CW50038
DR   FCDI; CW50038
DR   hPSCreg; CIRMi126-A
DR   SKIP; SKIP004060
DR   Wikidata; Q54816196
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50038; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50039
AC   CVCL_LI80
SY   CIRMi127-A
DR   BioSamples; SAMEA112959494
DR   Coriell; CW50039
DR   FCDI; CW50039
DR   hPSCreg; CIRMi127-A
DR   Wikidata; Q54816197
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50039; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50040
AC   CVCL_HI76
SY   CIRMi128-A
DR   BioSamples; SAMEA112959496
DR   Coriell; CW50040
DR   FCDI; CW50040
DR   hPSCreg; CIRMi128-A
DR   Wikidata; Q54816199
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50040; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50041
AC   CVCL_LI81
SY   CIRMi129-A
DR   BioSamples; SAMEA112959498
DR   Coriell; CW50041
DR   FCDI; CW50041
DR   hPSCreg; CIRMi129-A
DR   Wikidata; Q54816213
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50041; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50042
AC   CVCL_DK66
SY   CIRM-CW50042i-Ctl; CIRMi130-A
DR   BioSamples; SAMEA112959500
DR   Coriell; CW50042
DR   FCDI; CW50042
DR   hPSCreg; CIRMi130-A
DR   SKIP; SKIP004061
DR   Wikidata; Q54816215
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50042; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50043
AC   CVCL_DK67
SY   CIRM-CW50043i-Affected; CIRMi131-A
DR   BioSamples; SAMEA112959502
DR   Coriell; CW50043
DR   FCDI; CW50043
DR   hPSCreg; CIRMi131-A
DR   SKIP; SKIP004062
DR   Wikidata; Q54816216
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50043; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50044
AC   CVCL_DK68
SY   CIRM-CW50044i-Ctl; CIRMi132-A
DR   BioSamples; SAMEA112959504
DR   Coriell; CW50044
DR   FCDI; CW50044
DR   hPSCreg; CIRMi132-A
DR   SKIP; SKIP004063
DR   Wikidata; Q54816217
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50044; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50045
AC   CVCL_DK69
SY   CIRM-CW50045i-Ctl; CIRMi133-A
DR   BioSamples; SAMEA112959506
DR   Coriell; CW50045
DR   FCDI; CW50045
DR   hPSCreg; CIRMi133-A
DR   SKIP; SKIP004064
DR   Wikidata; Q54816218
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50045; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50046
AC   CVCL_DK70
SY   CIRM-CW50046i-CTL; CIRMi134-A
DR   BioSamples; SAMEA112959508
DR   Coriell; CW50046
DR   FCDI; CW50046
DR   hPSCreg; CIRMi134-A
DR   SKIP; SKIP004065
DR   Wikidata; Q54816219
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50046; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50047
AC   CVCL_DK71
SY   CIRM-CW50047i-CTL; CIRMi135-A
DR   BioSamples; SAMEA112959510
DR   Coriell; CW50047
DR   FCDI; CW50047
DR   hPSCreg; CIRMi135-A
DR   SKIP; SKIP004066
DR   Wikidata; Q54816220
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50047; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50048
AC   CVCL_D0CE
SY   CIRMi076-A
DR   BioSamples; SAMEA112959179
DR   hPSCreg; CIRMi076-A
DR   Wikidata; Q123031089
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50049
AC   CVCL_D0CF
SY   CIRMi067-A
DR   BioSamples; SAMEA112957549
DR   hPSCreg; CIRMi067-A
DR   Wikidata; Q123031090
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50050
AC   CVCL_DK72
SY   CIRM-CW50050i-Ctl; CIRMi136-A
DR   BioSamples; SAMEA112959512
DR   Coriell; CW50050
DR   FCDI; CW50050
DR   hPSCreg; CIRMi136-A
DR   SKIP; SKIP004067
DR   Wikidata; Q54816222
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50050; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50051
AC   CVCL_DK73
SY   CIRM-CW50051i-CTL; CIRMi137-A
DR   BioSamples; SAMEA112959514
DR   Coriell; CW50051
DR   FCDI; CW50051
DR   hPSCreg; CIRMi137-A
DR   SKIP; SKIP004068
DR   Wikidata; Q54816224
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50051; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50052
AC   CVCL_DK74
SY   CIRM-CW50052i-Affected; CIRMi138-A
DR   BioSamples; SAMEA112959516
DR   Coriell; CW50052
DR   FCDI; CW50052
DR   hPSCreg; CIRMi138-A
DR   SKIP; SKIP004069
DR   Wikidata; Q54816225
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50052; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50054
AC   CVCL_DK75
SY   CIRM-CW50054i-Ctl; CIRMi139-A
DR   BioSamples; SAMEA112959518
DR   Coriell; CW50054
DR   FCDI; CW50054
DR   hPSCreg; CIRMi139-A
DR   SKIP; SKIP004070
DR   Wikidata; Q54816227
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50054; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50055
AC   CVCL_DK76
SY   CIRM-CW50055i-Ctl; CIRMi140-A
DR   BioSamples; SAMEA112959520
DR   Coriell; CW50055
DR   FCDI; CW50055
DR   hPSCreg; CIRMi140-A
DR   SKIP; SKIP004071
DR   Wikidata; Q54816228
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50055; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50056
AC   CVCL_DK77
SY   CIRM-CW50056i-Ctl; CIRMi141-A
DR   BioSamples; SAMEA112959522
DR   Coriell; CW50056
DR   FCDI; CW50056
DR   hPSCreg; CIRMi141-A
DR   SKIP; SKIP004072
DR   Wikidata; Q54816229
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50056; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50057
AC   CVCL_DK78
SY   CIRMi077-A
DR   BioSamples; SAMEA112959181
DR   Coriell; CW50057
DR   FCDI; CW50057
DR   hPSCreg; CIRMi077-A
DR   Wikidata; Q54816231
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW50057; true.
CC   Discontinued: FCDI; CW50057; probable.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 9
//
ID   CW50058
AC   CVCL_DK79
SY   CIRMi142-A
DR   BioSamples; SAMEA112959524
DR   Coriell; CW50058
DR   FCDI; CW50058
DR   hPSCreg; CIRMi142-A
DR   Wikidata; Q54816233
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50058; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50059
AC   CVCL_DK80
SY   CIRM-CW50059i-Ctl; CIRMi143-A
DR   BioSamples; SAMEA112959526
DR   Coriell; CW50059
DR   FCDI; CW50059
DR   hPSCreg; CIRMi143-A
DR   SKIP; SKIP004073
DR   Wikidata; Q54816234
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50059; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50060
AC   CVCL_DK81
SY   CIRMi144-A
DR   BioSamples; SAMEA112959528
DR   Coriell; CW50060
DR   FCDI; CW50060
DR   hPSCreg; CIRMi144-A
DR   Wikidata; Q54816235
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50060; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50061
AC   CVCL_DK82
SY   CIRMi145-A
DR   BioSamples; SAMEA112959530
DR   Coriell; CW50061
DR   FCDI; CW50061
DR   hPSCreg; CIRMi145-A
DR   Wikidata; Q54816236
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW50061; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 10
//
ID   CW50062
AC   CVCL_DK83
SY   CIRMi146-A
DR   BioSamples; SAMEA112959532
DR   Coriell; CW50062
DR   FCDI; CW50062
DR   hPSCreg; CIRMi146-A
DR   Wikidata; Q54816237
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50062; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50063
AC   CVCL_DK84
SY   CIRMi147-A
DR   BioSamples; SAMEA112959534
DR   Coriell; CW50063
DR   FCDI; CW50063
DR   hPSCreg; CIRMi147-A
DR   Wikidata; Q54816239
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50063; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50064
AC   CVCL_DK85
SY   CIRMi148-A
DR   BioSamples; SAMEA112959536
DR   Coriell; CW50064
DR   FCDI; CW50064
DR   hPSCreg; CIRMi148-A
DR   Wikidata; Q54816240
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50064; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50065
AC   CVCL_DK86
SY   CIRM-CW50065i-Ctl; CIRMi149-A
DR   BioSamples; SAMEA112959538
DR   Coriell; CW50065
DR   FCDI; CW50065
DR   hPSCreg; CIRMi149-A
DR   SKIP; SKIP004074
DR   Wikidata; Q54816241
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50065; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50066
AC   CVCL_DK87
SY   CIRM-CW50066i-Ctl; CIRMi150-A
DR   BioSamples; SAMEA112959540
DR   Coriell; CW50066
DR   FCDI; CW50066
DR   hPSCreg; CIRMi150-A
DR   SKIP; SKIP004075
DR   Wikidata; Q54816242
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50066; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50067
AC   CVCL_DK88
SY   CIRM-CW50067i-CTL; CIRMi151-A
DR   BioSamples; SAMEA112959542
DR   Coriell; CW50067
DR   FCDI; CW50067
DR   hPSCreg; CIRMi151-A
DR   SKIP; SKIP004076
DR   Wikidata; Q54816243
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50067; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50068
AC   CVCL_HI77
SY   CIRMi152-A
DR   BioSamples; SAMEA112959544
DR   Coriell; CW50068
DR   FCDI; CW50068
DR   hPSCreg; CIRMi152-A
DR   Wikidata; Q54816245
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50068; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50069
AC   CVCL_DK89
SY   CIRM-CW50069i-Affected; CIRMi153-A
DR   BioSamples; SAMEA112959546
DR   Coriell; CW50069
DR   FCDI; CW50069
DR   hPSCreg; CIRMi153-A
DR   SKIP; SKIP004077
DR   Wikidata; Q54816246
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50069; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50070
AC   CVCL_DK90
SY   CIRM-CW50070i-Ctl; CIRMi154-A
DR   BioSamples; SAMEA112959548
DR   Coriell; CW50070
DR   FCDI; CW50070
DR   hPSCreg; CIRMi154-A
DR   SKIP; SKIP004078
DR   Wikidata; Q54816247
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50070; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50071
AC   CVCL_DK91
SY   CIRM-CW50071i-CTL; CIRMi155-A
DR   BioSamples; SAMEA112959550
DR   Coriell; CW50071
DR   FCDI; CW50071
DR   hPSCreg; CIRMi155-A
DR   SKIP; SKIP004079
DR   Wikidata; Q54816248
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50071; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50072
AC   CVCL_ER59
SY   CIRMi156-A
DR   BioSamples; SAMEA112959552
DR   Coriell; CW50072
DR   FCDI; CW50072
DR   hPSCreg; CIRMi156-A
DR   Wikidata; Q54816249
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50072; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW50073
AC   CVCL_HI78
SY   CIRMi157-A
DR   BioSamples; SAMEA112959554
DR   Coriell; CW50073
DR   FCDI; CW50073
DR   hPSCreg; CIRMi157-A
DR   Wikidata; Q54816250
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50073; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50074
AC   CVCL_HI79
SY   CIRMi158-A
DR   BioSamples; SAMEA112959556
DR   Coriell; CW50074
DR   FCDI; CW50074
DR   hPSCreg; CIRMi158-A
DR   Wikidata; Q54816251
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50074; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50075
AC   CVCL_HI80
SY   CIRMi159-A
DR   BioSamples; SAMEA112959558
DR   Coriell; CW50075
DR   FCDI; CW50075
DR   hPSCreg; CIRMi159-A
DR   Wikidata; Q54816252
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50075; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50076
AC   CVCL_ER60
SY   CIRMi160-A
DR   BioSamples; SAMEA112959560
DR   Coriell; CW50076
DR   FCDI; CW50076
DR   hPSCreg; CIRMi160-A
DR   Wikidata; Q54816253
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50076; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW50077
AC   CVCL_D0CG
SY   CIRMi078-A
DR   BioSamples; SAMEA112959183
DR   hPSCreg; CIRMi078-A
DR   Wikidata; Q123031091
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50078
AC   CVCL_DK92
SY   CIRMi161-A
DR   BioSamples; SAMEA112959562
DR   Coriell; CW50078
DR   FCDI; CW50078
DR   hPSCreg; CIRMi161-A
DR   Wikidata; Q54816255
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50078; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50079
AC   CVCL_DK93
SY   CIRMi162-A
DR   BioSamples; SAMEA112959564
DR   Coriell; CW50079
DR   FCDI; CW50079
DR   hPSCreg; CIRMi162-A
DR   Wikidata; Q54816256
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50079; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50080
AC   CVCL_D0CH
SY   CIRMi079-A
DR   BioSamples; SAMEA112959185
DR   hPSCreg; CIRMi079-A
DR   Wikidata; Q123031092
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50081
AC   CVCL_D0CI
SY   CIRMi080-A
DR   BioSamples; SAMEA112959187
DR   hPSCreg; CIRMi080-A
DR   Wikidata; Q123031093
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50082
AC   CVCL_DK94
SY   CIRM-CW50082i-Affected; CIRMi163-A
DR   BioSamples; SAMEA112959566
DR   Coriell; CW50082
DR   FCDI; CW50082
DR   hPSCreg; CIRMi163-A
DR   SKIP; SKIP004080
DR   Wikidata; Q54816257
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW50082; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50083
AC   CVCL_D0CJ
SY   CIRMi081-A
DR   BioSamples; SAMEA112959189
DR   hPSCreg; CIRMi081-A
DR   Wikidata; Q123031094
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50084
AC   CVCL_D0CK
SY   CIRMi082-A
DR   BioSamples; SAMEA112959191
DR   hPSCreg; CIRMi082-A
DR   Wikidata; Q123031095
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50085
AC   CVCL_D0CL
SY   CIRMi083-A
DR   BioSamples; SAMEA112959193
DR   hPSCreg; CIRMi083-A
DR   Wikidata; Q123031096
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50086
AC   CVCL_DK95
SY   CIRM-CW50086i-CTL; CIRMi164-A
DR   BioSamples; SAMEA112959568
DR   Coriell; CW50086
DR   FCDI; CW50086
DR   hPSCreg; CIRMi164-A
DR   SKIP; SKIP004081
DR   Wikidata; Q54816258
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50086; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50087
AC   CVCL_D0CM
SY   CIRMi084-A
DR   BioSamples; SAMEA112959195
DR   hPSCreg; CIRMi084-A
DR   Wikidata; Q123031097
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50088
AC   CVCL_D0CN
SY   CIRMi085-A
DR   BioSamples; SAMEA112959197
DR   hPSCreg; CIRMi085-A
DR   Wikidata; Q123031098
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50089
AC   CVCL_D0CP
SY   CIRMi086-A
DR   BioSamples; SAMEA112959199
DR   hPSCreg; CIRMi086-A
DR   Wikidata; Q123031099
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50090
AC   CVCL_D0CQ
SY   CIRMi087-A
DR   BioSamples; SAMEA112959201
DR   hPSCreg; CIRMi087-A
DR   Wikidata; Q123031100
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50091
AC   CVCL_D0CR
SY   CIRMi088-A
DR   BioSamples; SAMEA112959203
DR   hPSCreg; CIRMi088-A
DR   Wikidata; Q123031101
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50092
AC   CVCL_D0CS
SY   CIRMi089-A
DR   BioSamples; SAMEA112959205
DR   hPSCreg; CIRMi089-A
DR   Wikidata; Q123031102
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50093
AC   CVCL_LI82
SY   CIRMi165-A
DR   BioSamples; SAMEA112959570
DR   Coriell; CW50093
DR   FCDI; CW50093
DR   hPSCreg; CIRMi165-A
DR   Wikidata; Q54816259
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50093; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50094
AC   CVCL_DK96
SY   CIRM-CW50094i-CTL; CIRMi166-A
DR   BioSamples; SAMEA112959572
DR   Coriell; CW50094
DR   FCDI; CW50094
DR   hPSCreg; CIRMi166-A
DR   SKIP; SKIP004082
DR   Wikidata; Q54816260
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50094; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 15
//
ID   CW50095
AC   CVCL_DK97
SY   CIRM-CW50095i-CTL; CIRMi167-A
DR   BioSamples; SAMEA112959574
DR   Coriell; CW50095
DR   FCDI; CW50095
DR   hPSCreg; CIRMi167-A
DR   SKIP; SKIP004083
DR   Wikidata; Q54816261
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50095; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50096
AC   CVCL_LI83
SY   CIRMi168-A
DR   BioSamples; SAMEA112959576
DR   Coriell; CW50096
DR   FCDI; CW50096
DR   hPSCreg; CIRMi168-A
DR   Wikidata; Q54816277
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50096; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50097
AC   CVCL_DK98
SY   CIRM-CW50097i-Ctl; CIRMi169-A
DR   BioSamples; SAMEA112959578
DR   Coriell; CW50097
DR   FCDI; CW50097
DR   hPSCreg; CIRMi169-A
DR   SKIP; SKIP004084
DR   Wikidata; Q54816278
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50097; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50099
AC   CVCL_DK99
SY   CIRM-CW50099i-CTL; CIRMi170-A
DR   BioSamples; SAMEA112959580
DR   Coriell; CW50099
DR   FCDI; CW50099
DR   hPSCreg; CIRMi170-A
DR   SKIP; SKIP004085
DR   Wikidata; Q54816279
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50099; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW50100
AC   CVCL_D0CT
SY   CIRMi090-A
DR   BioSamples; SAMEA112959207
DR   hPSCreg; CIRMi090-A
DR   Wikidata; Q123031103
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50101
AC   CVCL_HI81
SY   CIRMi171-A
DR   BioSamples; SAMEA112959582
DR   Coriell; CW50101
DR   FCDI; CW50101
DR   hPSCreg; CIRMi171-A
DR   Wikidata; Q54816280
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 12
//
ID   CW50102
AC   CVCL_D0CU
SY   CIRMi091-A
DR   BioSamples; SAMEA112959209
DR   hPSCreg; CIRMi091-A
DR   Wikidata; Q123031104
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50103
AC   CVCL_D0CV
SY   CIRMi092-A
DR   BioSamples; SAMEA112959211
DR   hPSCreg; CIRMi092-A
DR   Wikidata; Q123031105
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50104
AC   CVCL_DL00
SY   CIRMi172-A
DR   BioSamples; SAMEA112959584
DR   Coriell; CW50104
DR   FCDI; CW50104
DR   hPSCreg; CIRMi172-A
DR   Wikidata; Q54816281
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50105
AC   CVCL_D0CW
SY   CIRMi093-A
DR   BioSamples; SAMEA112959213
DR   hPSCreg; CIRMi093-A
DR   Wikidata; Q123031106
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50106
AC   CVCL_DL01
SY   CIRMi173-A
DR   BioSamples; SAMEA112959586
DR   Coriell; CW50106
DR   FCDI; CW50106
DR   hPSCreg; CIRMi173-A
DR   Wikidata; Q54816282
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 12
//
ID   CW50107
AC   CVCL_DL02
SY   CIRMi174-A
DR   BioSamples; SAMEA112959588
DR   Coriell; CW50107
DR   FCDI; CW50107
DR   hPSCreg; CIRMi174-A
DR   Wikidata; Q54816283
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50108
AC   CVCL_HI82
SY   CIRMi175-A
DR   BioSamples; SAMEA112959590
DR   Coriell; CW50108
DR   FCDI; CW50108
DR   hPSCreg; CIRMi175-A
DR   Wikidata; Q54816284
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50109
AC   CVCL_DL03
SY   CIRMi176-A
DR   BioSamples; SAMEA112959592
DR   Coriell; CW50109
DR   FCDI; CW50109
DR   hPSCreg; CIRMi176-A
DR   Wikidata; Q54816285
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50111
AC   CVCL_DL04
SY   CIRMi177-A
DR   BioSamples; SAMEA112959594
DR   Coriell; CW50111
DR   FCDI; CW50111
DR   hPSCreg; CIRMi177-A
DR   Wikidata; Q54816286
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50112
AC   CVCL_JI62
SY   CIRMi178-A
DR   BioSamples; SAMEA112959596
DR   Coriell; CW50112
DR   FCDI; CW50112
DR   hPSCreg; CIRMi178-A
DR   Wikidata; Q54816288
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW50113
AC   CVCL_HI83
SY   CIRMi179-A
DR   BioSamples; SAMEA112959598
DR   Coriell; CW50113
DR   FCDI; CW50113
DR   hPSCreg; CIRMi179-A
DR   Wikidata; Q54816289
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50114
AC   CVCL_DL05
SY   CIRMi180-A
DR   BioSamples; SAMEA112959600
DR   Coriell; CW50114
DR   FCDI; CW50114
DR   hPSCreg; CIRMi180-A
DR   Wikidata; Q54816290
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50115
AC   CVCL_HI84
SY   CIRMi181-A
DR   BioSamples; SAMEA112959602
DR   Coriell; CW50115
DR   FCDI; CW50115
DR   hPSCreg; CIRMi181-A
DR   Wikidata; Q54816291
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50117
AC   CVCL_HI85
SY   CIRMi182-A
DR   BioSamples; SAMEA112959604
DR   Coriell; CW50117
DR   FCDI; CW50117
DR   hPSCreg; CIRMi182-A
DR   Wikidata; Q54816292
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50118
AC   CVCL_DL06
SY   CIRMi183-A
DR   BioSamples; SAMEA112959606
DR   Coriell; CW50118
DR   FCDI; CW50118
DR   hPSCreg; CIRMi183-A
DR   Wikidata; Q54816293
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50119
AC   CVCL_LK04
SY   CIRMi184-A
DR   BioSamples; SAMEA112959608
DR   Coriell; CW50119
DR   FCDI; CW50119
DR   hPSCreg; CIRMi184-A
DR   Wikidata; Q54816294
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50119; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50120
AC   CVCL_DL07
SY   CIRMi185-A
DR   BioSamples; SAMEA112959610
DR   Coriell; CW50120
DR   FCDI; CW50120
DR   hPSCreg; CIRMi185-A
DR   Wikidata; Q54816295
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50120; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50121
AC   CVCL_DL08
SY   CIRMi186-A
DR   BioSamples; SAMEA112959612
DR   Coriell; CW50121
DR   FCDI; CW50121
DR   hPSCreg; CIRMi186-A
DR   Wikidata; Q54816297
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50122
AC   CVCL_DL09
SY   CIRMi187-A
DR   BioSamples; SAMEA112959614
DR   Coriell; CW50122
DR   FCDI; CW50122
DR   hPSCreg; CIRMi187-A
DR   Wikidata; Q54816298
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50123
AC   CVCL_LI84
SY   CIRMi188-A
DR   BioSamples; SAMEA112959616
DR   Coriell; CW50123
DR   FCDI; CW50123
DR   hPSCreg; CIRMi188-A
DR   Wikidata; Q54816299
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50123; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50124
AC   CVCL_D0CX
SY   CIRMi094-A
DR   BioSamples; SAMEA112959215
DR   hPSCreg; CIRMi094-A
DR   Wikidata; Q123031107
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50125
AC   CVCL_D0CY
SY   CIRMi095-A
DR   BioSamples; SAMEA112959217
DR   hPSCreg; CIRMi095-A
DR   Wikidata; Q123031108
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50126
AC   CVCL_DL10
SY   CIRMi189-A
DR   BioSamples; SAMEA112959618
DR   Coriell; CW50126
DR   FCDI; CW50126
DR   hPSCreg; CIRMi189-A
DR   Wikidata; Q54816300
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Native North American.
CC   Discontinued: Coriell; CW50126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50127
AC   CVCL_DL11
SY   CIRMi190-A
DR   BioSamples; SAMEA112959620
DR   Coriell; CW50127
DR   FCDI; CW50127
DR   hPSCreg; CIRMi190-A
DR   Wikidata; Q54816301
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50127; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW50128
AC   CVCL_HI86
SY   CIRMi191-A
DR   BioSamples; SAMEA112959622
DR   Coriell; CW50128
DR   FCDI; CW50128
DR   hPSCreg; CIRMi191-A
DR   Wikidata; Q54816302
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW50128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50129
AC   CVCL_HI87
SY   CIRMi192-A
DR   BioSamples; SAMEA112959624
DR   Coriell; CW50129
DR   FCDI; CW50129
DR   hPSCreg; CIRMi192-A
DR   Wikidata; Q54816303
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50129; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50130
AC   CVCL_JI63
SY   CIRMi193-A
DR   BioSamples; SAMEA112959626
DR   Coriell; CW50130
DR   FCDI; CW50130
DR   hPSCreg; CIRMi193-A
DR   Wikidata; Q54816304
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50130; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW50131
AC   CVCL_HI88
SY   CIRMi194-A
DR   BioSamples; SAMEA112959628
DR   Coriell; CW50131
DR   FCDI; CW50131
DR   hPSCreg; CIRMi194-A
DR   Wikidata; Q54816305
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50131; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50132
AC   CVCL_HI89
SY   CIRMi195-A
DR   BioSamples; SAMEA112959630
DR   Coriell; CW50132
DR   FCDI; CW50132
DR   hPSCreg; CIRMi195-A
DR   Wikidata; Q54816306
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50133
AC   CVCL_HI90
SY   CIRMi196-A
DR   BioSamples; SAMEA112959632
DR   Coriell; CW50133
DR   FCDI; CW50133
DR   hPSCreg; CIRMi196-A
DR   Wikidata; Q54816309
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50134
AC   CVCL_HI91
SY   CIRMi197-A
DR   BioSamples; SAMEA112959634
DR   Coriell; CW50134
DR   FCDI; CW50134
DR   hPSCreg; CIRMi197-A
DR   Wikidata; Q54816310
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50134; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50135
AC   CVCL_D0CZ
SY   CIRMi096-A
DR   BioSamples; SAMEA112959219
DR   hPSCreg; CIRMi096-A
DR   Wikidata; Q123031109
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50136
AC   CVCL_ER61
SY   CIRMi198-A
DR   BioSamples; SAMEA112959636
DR   Coriell; CW50136
DR   FCDI; CW50136
DR   hPSCreg; CIRMi198-A
DR   Wikidata; Q54816311
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50136; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW50137
AC   CVCL_ER62
SY   CIRMi199-A
DR   BioSamples; SAMEA112959638
DR   Coriell; CW50137
DR   FCDI; CW50137
DR   hPSCreg; CIRMi199-A
DR   Wikidata; Q54816312
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50137; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 11
//
ID   CW50138
AC   CVCL_HI92
SY   CIRMi200-A
DR   BioSamples; SAMEA112959640
DR   Coriell; CW50138
DR   FCDI; CW50138
DR   hPSCreg; CIRMi200-A
DR   Wikidata; Q54816313
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50138; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50139
AC   CVCL_HI93
SY   CIRMi201-A
DR   BioSamples; SAMEA112959642
DR   Coriell; CW50139
DR   FCDI; CW50139
DR   hPSCreg; CIRMi201-A
DR   Wikidata; Q54816314
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50139; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50140
AC   CVCL_D0D0
SY   CIRMi097-A
DR   BioSamples; SAMEA112959371
DR   hPSCreg; CIRMi097-A
DR   Wikidata; Q123031110
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50141
AC   CVCL_HI94
SY   CIRMi202-A
DR   BioSamples; SAMEA112959644
DR   Coriell; CW50141
DR   FCDI; CW50141
DR   hPSCreg; CIRMi202-A
DR   Wikidata; Q54816316
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50141; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50142
AC   CVCL_HI95
SY   CIRMi203-A
DR   BioSamples; SAMEA112959646
DR   Coriell; CW50142
DR   FCDI; CW50142
DR   hPSCreg; CIRMi203-A
DR   Wikidata; Q54816317
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50142; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50143
AC   CVCL_HI96
SY   CIRMi204-A
DR   BioSamples; SAMEA112959648
DR   Coriell; CW50143
DR   FCDI; CW50143
DR   hPSCreg; CIRMi204-A
DR   Wikidata; Q54816318
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50143; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50144
AC   CVCL_HI97
SY   CIRMi205-A
DR   BioSamples; SAMEA112959650
DR   Coriell; CW50144
DR   FCDI; CW50144
DR   hPSCreg; CIRMi205-A
DR   Wikidata; Q54816319
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50145
AC   CVCL_HI98
SY   CIRMi206-A
DR   BioSamples; SAMEA112959652
DR   Coriell; CW50145
DR   FCDI; CW50145
DR   hPSCreg; CIRMi206-A
DR   Wikidata; Q54816320
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50145; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50147
AC   CVCL_HI99
SY   CIRMi207-A
DR   BioSamples; SAMEA112959654
DR   Coriell; CW50147
DR   FCDI; CW50147
DR   hPSCreg; CIRMi207-A
DR   Wikidata; Q54816321
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50147; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50148
AC   CVCL_HJ00
SY   CIRMi208-A
DR   BioSamples; SAMEA112959656
DR   Coriell; CW50148
DR   FCDI; CW50148
DR   hPSCreg; CIRMi208-A
DR   Wikidata; Q54816334
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50148; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50149
AC   CVCL_HJ01
SY   CIRMi209-A
DR   BioSamples; SAMEA112959658
DR   Coriell; CW50149
DR   FCDI; CW50149
DR   hPSCreg; CIRMi209-A
DR   Wikidata; Q54816335
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50149; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50150
AC   CVCL_HJ02
SY   CIRMi210-A
DR   BioSamples; SAMEA112959660
DR   Coriell; CW50150
DR   FCDI; CW50150
DR   hPSCreg; CIRMi210-A
DR   Wikidata; Q54816337
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50150; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50151
AC   CVCL_D0D1
SY   CIRMi098-A
DR   BioSamples; SAMEA112959373
DR   hPSCreg; CIRMi098-A
DR   Wikidata; Q123031111
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50152
AC   CVCL_HJ03
SY   CIRMi211-A
DR   BioSamples; SAMEA112959662
DR   Coriell; CW50152
DR   FCDI; CW50152
DR   hPSCreg; CIRMi211-A
DR   Wikidata; Q54816339
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50152; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50153
AC   CVCL_HJ04
SY   CIRMi212-A
DR   BioSamples; SAMEA112959664
DR   Coriell; CW50153
DR   FCDI; CW50153
DR   hPSCreg; CIRMi212-A
DR   Wikidata; Q54816341
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50153; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50155
AC   CVCL_LK05
SY   CIRMi213-A
DR   BioSamples; SAMEA112959666
DR   Coriell; CW50155
DR   FCDI; CW50155
DR   hPSCreg; CIRMi213-A
DR   Wikidata; Q54816342
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50155; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50156
AC   CVCL_LK06
SY   CIRMi214-A
DR   BioSamples; SAMEA112959668
DR   Coriell; CW50156
DR   FCDI; CW50156
DR   hPSCreg; CIRMi214-A
DR   Wikidata; Q54816343
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50156; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50157
AC   CVCL_LK07
SY   CIRMi215-A
DR   BioSamples; SAMEA112959670
DR   Coriell; CW50157
DR   FCDI; CW50157
DR   hPSCreg; CIRMi215-A
DR   Wikidata; Q54816344
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50157; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50158
AC   CVCL_HJ05
SY   CIRMi216-A
DR   BioSamples; SAMEA112959672
DR   Coriell; CW50158
DR   FCDI; CW50158
DR   hPSCreg; CIRMi216-A
DR   Wikidata; Q54816345
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50158; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW50159
AC   CVCL_JI64
SY   CIRMi217-A
DR   BioSamples; SAMEA112959678
DR   Coriell; CW50159
DR   FCDI; CW50159
DR   hPSCreg; CIRMi217-A
DR   Wikidata; Q54816346
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW50159; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 10
//
ID   CW50161
AC   CVCL_JI65
SY   CIRMi218-A
DR   BioSamples; SAMEA112959680
DR   Coriell; CW50161
DR   FCDI; CW50161
DR   hPSCreg; CIRMi218-A
DR   Wikidata; Q54816349
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50161; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW50162
AC   CVCL_JI66
SY   CIRMi219-A
DR   BioSamples; SAMEA112959682
DR   Coriell; CW50162
DR   FCDI; CW50162
DR   hPSCreg; CIRMi219-A
DR   Wikidata; Q54816350
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50162; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW50163
AC   CVCL_D0D2
SY   CIRMi099-A
DR   BioSamples; SAMEA112959375
DR   hPSCreg; CIRMi099-A
DR   Wikidata; Q123031112
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50164
AC   CVCL_D0D3
SY   CIRMi100-A
DR   BioSamples; SAMEA112959377
DR   hPSCreg; CIRMi100-A
DR   Wikidata; Q123031114
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW50165
AC   CVCL_JI67
SY   CIRMi220-A
DR   BioSamples; SAMEA112959684
DR   Coriell; CW50165
DR   FCDI; CW50165
DR   hPSCreg; CIRMi220-A
DR   Wikidata; Q54816351
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50165; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW50166
AC   CVCL_LK08
SY   CIRMi221-A
DR   BioSamples; SAMEA112959686
DR   Coriell; CW50166
DR   FCDI; CW50166
DR   hPSCreg; CIRMi221-A
DR   Wikidata; Q54816352
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50166; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50167
AC   CVCL_JI68
SY   CIRMi222-A
DR   BioSamples; SAMEA112959688
DR   Coriell; CW50167
DR   FCDI; CW50167
DR   hPSCreg; CIRMi222-A
DR   Wikidata; Q54816353
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW50168
AC   CVCL_LK09
SY   CIRMi223-A
DR   BioSamples; SAMEA112959690
DR   Coriell; CW50168
DR   FCDI; CW50168
DR   hPSCreg; CIRMi223-A
DR   Wikidata; Q54816354
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50168; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50169
AC   CVCL_LK10
SY   CIRMi224-A
DR   BioSamples; SAMEA112959692
DR   Coriell; CW50169
DR   FCDI; CW50169
DR   hPSCreg; CIRMi224-A
DR   Wikidata; Q54816355
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50169; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50170
AC   CVCL_LK11
SY   CIRMi225-A
DR   BioSamples; SAMEA112959694
DR   Coriell; CW50170
DR   FCDI; CW50170
DR   hPSCreg; CIRMi225-A
DR   Wikidata; Q54816356
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50170; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50173
AC   CVCL_LK12
SY   CIRMi226-A
DR   BioSamples; SAMEA112959696
DR   Coriell; CW50173
DR   FCDI; CW50173
DR   hPSCreg; CIRMi226-A
DR   Wikidata; Q54816357
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50173; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50174
AC   CVCL_LK13
SY   CIRMi227-A
DR   BioSamples; SAMEA112959698
DR   Coriell; CW50174
DR   FCDI; CW50174
DR   hPSCreg; CIRMi227-A
DR   Wikidata; Q54816358
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50174; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50175
AC   CVCL_LK14
SY   CIRMi228-A
DR   BioSamples; SAMEA112959700
DR   Coriell; CW50175
DR   FCDI; CW50175
DR   hPSCreg; CIRMi228-A
DR   Wikidata; Q54816359
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50175; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50176
AC   CVCL_LK15
SY   CIRMi229-A
DR   BioSamples; SAMEA112959702
DR   Coriell; CW50176
DR   FCDI; CW50176
DR   hPSCreg; CIRMi229-A
DR   Wikidata; Q54816360
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50176; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW50177
AC   CVCL_LK16
SY   CIRMi230-A
DR   BioSamples; SAMEA112959704
DR   Coriell; CW50177
DR   FCDI; CW50177
DR   hPSCreg; CIRMi230-A
DR   Wikidata; Q54816361
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW50177; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW60001
AC   CVCL_DL12
DR   Coriell; CW60001
DR   FCDI; CW60001
DR   Wikidata; Q54816362
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60001; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   CW60002
AC   CVCL_DL13
DR   Coriell; CW60002
DR   Wikidata; Q54816363
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60002; true.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   CW60011
AC   CVCL_LI85
DR   Coriell; CW60011
DR   FCDI; CW60011
DR   Wikidata; Q54816364
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60011; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60013
AC   CVCL_DL14
SY   CIRM-CW60013i-Ctl
DR   Coriell; CW60013
DR   FCDI; CW60013
DR   SKIP; SKIP004086
DR   Wikidata; Q54816365
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60013; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60014
AC   CVCL_DL15
SY   CIRM-CW60014i-Ctl
DR   Coriell; CW60014
DR   FCDI; CW60014
DR   SKIP; SKIP004087
DR   Wikidata; Q54816366
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60014; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60015
AC   CVCL_HJ06
DR   Coriell; CW60015
DR   FCDI; CW60015
DR   Wikidata; Q54816367
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60015; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60017
AC   CVCL_LI86
DR   Coriell; CW60017
DR   FCDI; CW60017
DR   Wikidata; Q54816368
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60017; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60018
AC   CVCL_DL16
SY   CIRM-CW60018i-Affected
DR   Coriell; CW60018
DR   FCDI; CW60018
DR   SKIP; SKIP004088
DR   Wikidata; Q54816369
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60018; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60021
AC   CVCL_4S50
SY   CIRM-CW60021i-Affected
DR   Coriell; CW60021
DR   FCDI; CW60021
DR   SKIP; SKIP004090
DR   Wikidata; Q54816371
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Israeli.
CC   Discontinued: Coriell; CW60021; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   CW60024
AC   CVCL_DL17
SY   CIRM-CW60024i-Affected
DR   Coriell; CW60024
DR   FCDI; CW60024
DR   SKIP; SKIP004091
DR   Wikidata; Q54816372
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60024; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60026
AC   CVCL_4S51
SY   CIRM-CW60026i-Affected
DR   Coriell; CW60026
DR   FCDI; CW60026
DR   SKIP; SKIP004092
DR   Wikidata; Q54816373
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60026; true.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW60027
AC   CVCL_HJ07
DR   Coriell; CW60027
DR   FCDI; CW60027
DR   Wikidata; Q54816374
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60027; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60029
AC   CVCL_DL18
SY   CIRM-CW60029i-Affected
DR   Coriell; CW60029
DR   FCDI; CW60029
DR   SKIP; SKIP004093
DR   Wikidata; Q54816375
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60029; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 9
//
ID   CW60031
AC   CVCL_LI87
DR   Coriell; CW60031
DR   FCDI; CW60031
DR   Wikidata; Q54816376
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW60031; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60034
AC   CVCL_DL19
SY   CIRM-CW60034i-CTL
DR   Coriell; CW60034
DR   FCDI; CW60034
DR   SKIP; SKIP004094
DR   Wikidata; Q54816377
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60034; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW60037
AC   CVCL_RV79
DR   Coriell; CW60037
DR   FCDI; CW60037
DR   Wikidata; Q54816379
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60037; true.
CC   Discontinued: FCDI; CW60037; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   CW60039
AC   CVCL_4S52
DR   Coriell; CW60039
DR   FCDI; CW60039
DR   Wikidata; Q54816380
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of CW60040 (Cellosaurus=CVCL_DL20).
CC   Discontinued: Coriell; CW60039; true.
CC   Discontinued: FCDI; CW60039; probable.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW60040
AC   CVCL_DL20
SY   CIRM-CW60040i-Ctl
DR   Coriell; CW60040
DR   FCDI; CW60040
DR   SKIP; SKIP004096
DR   Wikidata; Q54816399
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of CW60039 (Cellosaurus=CVCL_4S52).
CC   Discontinued: Coriell; CW60040; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 11
//
ID   CW60045
AC   CVCL_DL21
SY   CIRM-CW60045i-Ctl
DR   Coriell; CW60045
DR   FCDI; CW60045
DR   SKIP; SKIP004097
DR   Wikidata; Q54816400
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60045; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60046
AC   CVCL_DL22
SY   CIRM-CW60046i-Affected
DR   Coriell; CW60046
DR   FCDI; CW60046
DR   SKIP; SKIP004098
DR   Wikidata; Q54816401
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60046; true.
CC   Discontinued: FCDI; CW60046; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60048
AC   CVCL_DL23
SY   CIRM-CW60048i-Affected
DR   Coriell; CW60048
DR   FCDI; CW60048
DR   SKIP; SKIP004099
DR   Wikidata; Q54816402
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60048; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 14
//
ID   CW60049
AC   CVCL_DL24
SY   CIRM-CW60049i-Affected
DR   Coriell; CW60049
DR   FCDI; CW60049
DR   SKIP; SKIP004100
DR   Wikidata; Q54816403
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60049; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 14
//
ID   CW60051
AC   CVCL_LI88
DR   Coriell; CW60051
DR   FCDI; CW60051
DR   Wikidata; Q54816404
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60051; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60053
AC   CVCL_LI89
DR   Coriell; CW60053
DR   FCDI; CW60053
DR   Wikidata; Q54816405
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60053; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60054
AC   CVCL_LI90
DR   Coriell; CW60054
DR   FCDI; CW60054
DR   Wikidata; Q54816406
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60054; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60055
AC   CVCL_DL25
DR   Coriell; CW60055
DR   FCDI; CW60055
DR   Wikidata; Q54816407
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60055; true.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
ID   CW60056
AC   CVCL_DL26
SY   CIRM-CW60056i-Affected
DR   Coriell; CW60056
DR   FCDI; CW60056
DR   SKIP; SKIP004101
DR   Wikidata; Q54816408
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60056; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 14
//
ID   CW60057
AC   CVCL_LI91
DR   Coriell; CW60057
DR   FCDI; CW60057
DR   Wikidata; Q54816409
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60057; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60058
AC   CVCL_LK17
DR   Coriell; CW60058
DR   FCDI; CW60058
DR   Wikidata; Q54816410
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60058; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60060
AC   CVCL_DL27
SY   CIRM-CW60060i-Ctl
DR   Coriell; CW60060
DR   FCDI; CW60060
DR   SKIP; SKIP004102
DR   Wikidata; Q54816411
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60060; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW60065
AC   CVCL_LI92
DR   Coriell; CW60065
DR   FCDI; CW60065
DR   Wikidata; Q54816412
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60065; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60066
AC   CVCL_LI93
DR   Coriell; CW60066
DR   FCDI; CW60066
DR   Wikidata; Q54816413
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60066; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60070
AC   CVCL_JI69
DR   Coriell; CW60070
DR   FCDI; CW60070
DR   Wikidata; Q54816414
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60070; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60076
AC   CVCL_LI94
DR   Coriell; CW60076
DR   FCDI; CW60076
DR   Wikidata; Q54816415
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60076; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60079
AC   CVCL_RV80
DR   Coriell; CW60079
DR   FCDI; CW60079
DR   Wikidata; Q54816416
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60079; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60083
AC   CVCL_DL28
SY   CIRM-CW60083i-Affected
DR   Coriell; CW60083
DR   FCDI; CW60083
DR   SKIP; SKIP004103
DR   Wikidata; Q54816417
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60083; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 14
//
ID   CW60084
AC   CVCL_JI70
DR   Coriell; CW60084
DR   FCDI; CW60084
DR   Wikidata; Q54816419
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60084; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60085
AC   CVCL_LI95
DR   Coriell; CW60085
DR   FCDI; CW60085
DR   Wikidata; Q54816420
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60085; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60086
AC   CVCL_LI96
DR   Coriell; CW60086
DR   FCDI; CW60086
DR   Wikidata; Q54816422
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60086; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60087
AC   CVCL_LI97
DR   Coriell; CW60087
DR   FCDI; CW60087
DR   Wikidata; Q54816423
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60087; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60088
AC   CVCL_JI71
DR   Coriell; CW60088
DR   FCDI; CW60088
DR   Wikidata; Q54816425
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60088; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60089
AC   CVCL_DL29
SY   CIRM-CW60089i-Affected
DR   Coriell; CW60089
DR   FCDI; CW60089
DR   SKIP; SKIP004104
DR   Wikidata; Q54816426
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60089; true.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW60092
AC   CVCL_JI72
DR   Coriell; CW60092
DR   FCDI; CW60092
DR   Wikidata; Q54816427
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60092; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60094
AC   CVCL_AP53
DR   Coriell; CW60094
DR   FCDI; CW60094
DR   Wikidata; Q54816428
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60094; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 12
//
ID   CW60095
AC   CVCL_AP54
DR   Coriell; CW60095
DR   FCDI; CW60095
DR   Wikidata; Q54816429
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60095; true.
CC   Discontinued: FCDI; CW60095; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   CW60097
AC   CVCL_DL30
SY   CIRM-CW60097i-Ctl
DR   Coriell; CW60097
DR   FCDI; CW60097
DR   SKIP; SKIP004095
DR   Wikidata; Q54816430
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60097; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW60098
AC   CVCL_DL31
SY   CIRM-CW60098i-Ctl
DR   Coriell; CW60098
DR   FCDI; CW60098
DR   SKIP; SKIP004105
DR   Wikidata; Q54816431
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60098; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60104
AC   CVCL_HJ08
DR   Coriell; CW60104
DR   FCDI; CW60104
DR   Wikidata; Q54816432
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60104; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60105
AC   CVCL_LI98
DR   Coriell; CW60105
DR   FCDI; CW60105
DR   Wikidata; Q54816433
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW60105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60106
AC   CVCL_LI99
DR   Coriell; CW60106
DR   FCDI; CW60106
DR   Wikidata; Q54816434
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW60106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60107
AC   CVCL_LJ00
DR   Coriell; CW60107
DR   FCDI; CW60107
DR   Wikidata; Q54816435
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60107; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60108
AC   CVCL_DL32
SY   CIRM-CW60108i-Affected
DR   Coriell; CW60108
DR   FCDI; CW60108
DR   SKIP; SKIP004106
DR   Wikidata; Q54816436
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60109
AC   CVCL_4S53
SY   CIRM-CW60109i-Ctl
DR   Coriell; CW60109
DR   FCDI; CW60109
DR   SKIP; SKIP004107
DR   Wikidata; Q54816437
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   CW60110
AC   CVCL_DL33
SY   CIRM-CW60110i-Affected
DR   Coriell; CW60110
DR   FCDI; CW60110
DR   SKIP; SKIP004108
DR   Wikidata; Q54816438
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   CW60111
AC   CVCL_DL34
SY   CIRM-CW60111i-Affected
DR   Coriell; CW60111
DR   FCDI; CW60111
DR   SKIP; SKIP004109
DR   Wikidata; Q54816439
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60115
AC   CVCL_4S54
SY   CIRM-CW60115i-Affected
DR   Coriell; CW60115
DR   FCDI; CW60115
DR   SKIP; SKIP004110
DR   Wikidata; Q54816440
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   CW60117
AC   CVCL_LJ01
DR   Coriell; CW60117
DR   FCDI; CW60117
DR   Wikidata; Q54816441
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian and Native North American.
CC   Discontinued: Coriell; CW60117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60118
AC   CVCL_DL35
SY   CIRM-CW60118i-Affected
DR   Coriell; CW60118
DR   FCDI; CW60118
DR   SKIP; SKIP004111
DR   Wikidata; Q54816448
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60119
AC   CVCL_DL36
DR   Coriell; CW60119
DR   FCDI; CW60119
DR   Wikidata; Q54816449
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60119; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   CW60122
AC   CVCL_DL37
DR   Coriell; CW60122
DR   FCDI; CW60122
DR   Wikidata; Q54816450
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60122; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   CW60123
AC   CVCL_DL38
DR   Coriell; CW60123
DR   FCDI; CW60123
DR   Wikidata; Q54816451
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60123; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   CW60124
AC   CVCL_LJ02
DR   Coriell; CW60124
DR   FCDI; CW60124
DR   Wikidata; Q54816452
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60124; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60125
AC   CVCL_HJ09
DR   Coriell; CW60125
DR   FCDI; CW60125
DR   Wikidata; Q54816454
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60125; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60130
AC   CVCL_DL39
DR   Coriell; CW60130
DR   FCDI; CW60130
DR   Wikidata; Q54816455
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60130; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW60131
AC   CVCL_HJ10
DR   Coriell; CW60131
DR   FCDI; CW60131
DR   Wikidata; Q54816456
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60131; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60132
AC   CVCL_DL40
SY   CIRM-CW60132i-Ctl
DR   Coriell; CW60132
DR   FCDI; CW60132
DR   SKIP; SKIP004112
DR   Wikidata; Q54816457
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60133
AC   CVCL_DL41
SY   CIRM-CW60133i-Affected
DR   Coriell; CW60133
DR   FCDI; CW60133
DR   SKIP; SKIP004113
DR   Wikidata; Q54816458
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34460; Cerebral palsy
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60134
AC   CVCL_DL42
SY   CIRM-CW60134i-Ctl
DR   Coriell; CW60134
DR   FCDI; CW60134
DR   SKIP; SKIP004114
DR   Wikidata; Q54816459
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60134; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60135
AC   CVCL_LJ03
DR   Coriell; CW60135
DR   FCDI; CW60135
DR   Wikidata; Q54816461
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60135; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60136
AC   CVCL_DL43
DR   Coriell; CW60136
DR   FCDI; CW60136
DR   Wikidata; Q54816462
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60136; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   CW60138
AC   CVCL_HJ11
DR   Coriell; CW60138
DR   FCDI; CW60138
DR   Wikidata; Q54816463
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60138; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60139
AC   CVCL_LJ04
DR   Coriell; CW60139
DR   FCDI; CW60139
DR   Wikidata; Q54816464
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60139; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60141
AC   CVCL_DL44
SY   CIRM-CW60141i-Ctl
DR   Coriell; CW60141
DR   FCDI; CW60141
DR   SKIP; SKIP004115
DR   Wikidata; Q54816466
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60141; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60142
AC   CVCL_DL45
SY   CIRM-CW60142i-Affected
DR   Coriell; CW60142
DR   FCDI; CW60142
DR   SKIP; SKIP004116
DR   Wikidata; Q54816467
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60142; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60143
AC   CVCL_JI73
DR   Coriell; CW60143
DR   FCDI; CW60143
DR   Wikidata; Q54816468
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60143; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60144
AC   CVCL_LJ05
DR   Coriell; CW60144
DR   FCDI; CW60144
DR   Wikidata; Q54816469
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60144; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60145
AC   CVCL_JI74
DR   Coriell; CW60145
DR   FCDI; CW60145
DR   Wikidata; Q54816470
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60145; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60146
AC   CVCL_LJ06
DR   Coriell; CW60146
DR   FCDI; CW60146
DR   Wikidata; Q54816471
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60146; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60155
AC   CVCL_HJ12
DR   Coriell; CW60155
DR   FCDI; CW60155
DR   Wikidata; Q54816473
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60155; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60157
AC   CVCL_LJ07
DR   Coriell; CW60157
DR   FCDI; CW60157
DR   Wikidata; Q54816474
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60157; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60159
AC   CVCL_HJ13
DR   Coriell; CW60159
DR   FCDI; CW60159
DR   Wikidata; Q54816475
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60159; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60161
AC   CVCL_DL46
SY   CIRM-CW60161i-Ctl
DR   Coriell; CW60161
DR   FCDI; CW60161
DR   SKIP; SKIP004117
DR   Wikidata; Q54816476
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60161; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60163
AC   CVCL_LJ08
DR   Coriell; CW60163
DR   FCDI; CW60163
DR   Wikidata; Q54816477
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60163; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60164
AC   CVCL_DL47
SY   CIRM-CW60164i-Affected
DR   Coriell; CW60164
DR   FCDI; CW60164
DR   SKIP; SKIP004118
DR   Wikidata; Q54816478
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60164; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 14
//
ID   CW60166
AC   CVCL_LJ09
DR   Coriell; CW60166
DR   FCDI; CW60166
DR   Wikidata; Q54816480
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60166; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60167
AC   CVCL_LJ10
DR   Coriell; CW60167
DR   FCDI; CW60167
DR   Wikidata; Q54816481
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60167; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60168
AC   CVCL_LJ11
DR   Coriell; CW60168
DR   FCDI; CW60168
DR   Wikidata; Q54816482
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60168; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60171
AC   CVCL_DL48
SY   CIRM-CW60171i-Affected
DR   Coriell; CW60171
DR   FCDI; CW60171
DR   SKIP; SKIP004119
DR   Wikidata; Q54816483
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60171; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60172
AC   CVCL_HJ14
DR   Coriell; CW60172
DR   FCDI; CW60172
DR   Wikidata; Q54816484
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60172; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   CW60174
AC   CVCL_JI75
DR   Coriell; CW60174
DR   FCDI; CW60174
DR   Wikidata; Q54816486
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60174; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60175
AC   CVCL_JI76
DR   Coriell; CW60175
DR   FCDI; CW60175
DR   Wikidata; Q54816488
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60175; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60181
AC   CVCL_LJ12
DR   Coriell; CW60181
DR   FCDI; CW60181
DR   Wikidata; Q54816489
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60181; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60182
AC   CVCL_JI77
DR   Coriell; CW60182
DR   FCDI; CW60182
DR   Wikidata; Q54816490
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60182; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60184
AC   CVCL_JI78
DR   Coriell; CW60184
DR   FCDI; CW60184
DR   Wikidata; Q54816491
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60184; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60186
AC   CVCL_LJ13
DR   Coriell; CW60186
DR   FCDI; CW60186
DR   Wikidata; Q54816492
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60186; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60187
AC   CVCL_DL49
SY   CIRM-CW60187i-Affected
DR   Coriell; CW60187
DR   FCDI; CW60187
DR   SKIP; SKIP004120
DR   Wikidata; Q54816494
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60187; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60188
AC   CVCL_JI79
DR   Coriell; CW60188
DR   FCDI; CW60188
DR   Wikidata; Q54816495
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60188; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60189
AC   CVCL_VK77
DR   Coriell; CW60189
DR   FCDI; CW60189
DR   Wikidata; Q93463820
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60189; true.
CC   Discontinued: FCDI; CW60189; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   CW60190
AC   CVCL_LJ14
DR   Coriell; CW60190
DR   FCDI; CW60190
DR   Wikidata; Q54816512
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60190; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60193
AC   CVCL_JI80
DR   Coriell; CW60193
DR   FCDI; CW60193
DR   Wikidata; Q54816513
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60193; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60195
AC   CVCL_LJ15
DR   Coriell; CW60195
DR   FCDI; CW60195
DR   Wikidata; Q54816514
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60195; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60200
AC   CVCL_LJ16
DR   Coriell; CW60200
DR   FCDI; CW60200
DR   Wikidata; Q54816515
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60200; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60201
AC   CVCL_HJ15
DR   Coriell; CW60201
DR   FCDI; CW60201
DR   Wikidata; Q54816516
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60201; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60205
AC   CVCL_JI81
DR   Coriell; CW60205
DR   FCDI; CW60205
DR   Wikidata; Q54816517
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60205; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60207
AC   CVCL_LJ17
DR   Coriell; CW60207
DR   FCDI; CW60207
DR   Wikidata; Q54816518
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60207; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60208
AC   CVCL_JI82
DR   Coriell; CW60208
DR   FCDI; CW60208
DR   Wikidata; Q54816520
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60208; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60209
AC   CVCL_JI83
DR   Coriell; CW60209
DR   FCDI; CW60209
DR   Wikidata; Q54816521
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60209; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60210
AC   CVCL_HJ16
DR   Coriell; CW60210
DR   FCDI; CW60210
DR   Wikidata; Q54816522
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Pakistani.
CC   Discontinued: Coriell; CW60210; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60213
AC   CVCL_LJ18
DR   Coriell; CW60213
DR   FCDI; CW60213
DR   Wikidata; Q54816523
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lybian.
CC   Discontinued: Coriell; CW60213; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60214
AC   CVCL_DL50
DR   Coriell; CW60214
DR   FCDI; CW60214
DR   Wikidata; Q54816524
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60214; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   CW60217
AC   CVCL_DL51
SY   CIRM-CW60217i-Affected
DR   Coriell; CW60217
DR   FCDI; CW60217
DR   SKIP; SKIP004121
DR   Wikidata; Q54816526
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60217; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60218
AC   CVCL_LJ19
DR   Coriell; CW60218
DR   FCDI; CW60218
DR   Wikidata; Q54816527
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60218; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60219
AC   CVCL_DL52
SY   CIRM-CW60219i-Affected
DR   Coriell; CW60219
DR   FCDI; CW60219
DR   SKIP; SKIP004122
DR   Wikidata; Q54816528
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60219; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60220
AC   CVCL_DL53
SY   CIRM-CW60220i-Ctl
DR   Coriell; CW60220
DR   FCDI; CW60220
DR   SKIP; SKIP004123
DR   Wikidata; Q54816529
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60220; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60221
AC   CVCL_DL54
SY   CIRM-CW60221i-Affected
DR   Coriell; CW60221
DR   FCDI; CW60221
DR   SKIP; SKIP004089
DR   Wikidata; Q54816530
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60221; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 13
//
ID   CW60222
AC   CVCL_DL55
DR   Coriell; CW60222
DR   FCDI; CW60222
DR   Wikidata; Q54816531
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60222; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   CW60223
AC   CVCL_HJ17
DR   Coriell; CW60223
DR   FCDI; CW60223
DR   Wikidata; Q54816532
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60223; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   CW60224
AC   CVCL_4S55
SY   CIRM-CW60224i-Affected
DR   Coriell; CW60224
DR   FCDI; CW60224
DR   SKIP; SKIP004124
DR   Wikidata; Q54816533
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60224; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34460; Cerebral palsy
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   CW60226
AC   CVCL_DL56
SY   CIRM-CW60226i-Affected
DR   Coriell; CW60226
DR   FCDI; CW60226
DR   SKIP; SKIP004125
DR   Wikidata; Q54816535
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60226; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60227
AC   CVCL_LJ20
DR   Coriell; CW60227
DR   FCDI; CW60227
DR   Wikidata; Q54816536
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60227; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60228
AC   CVCL_LK18
DR   Coriell; CW60228
DR   FCDI; CW60228
DR   Wikidata; Q54816537
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60228; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60230
AC   CVCL_DL57
SY   CIRM-CW60230i-Affected
DR   Coriell; CW60230
DR   FCDI; CW60230
DR   SKIP; SKIP004126
DR   Wikidata; Q54816539
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60230; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60231
AC   CVCL_LJ21
DR   Coriell; CW60231
DR   FCDI; CW60231
DR   Wikidata; Q54816540
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60231; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60232
AC   CVCL_DL58
SY   CIRM-CW60232i-Affected
DR   Coriell; CW60232
DR   FCDI; CW60232
DR   SKIP; SKIP004127
DR   Wikidata; Q54816541
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60232; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60234
AC   CVCL_DL59
SY   CIRM-CW60234i-Affected
DR   Coriell; CW60234
DR   FCDI; CW60234
DR   SKIP; SKIP004128
DR   Wikidata; Q54816542
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60234; true.
CC   Discontinued: FCDI; CW60234; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60236
AC   CVCL_DL60
SY   CIRM-CW60236i-Affected
DR   Coriell; CW60236
DR   FCDI; CW60236
DR   SKIP; SKIP004129
DR   Wikidata; Q54816543
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60236; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 14
//
ID   CW60237
AC   CVCL_DL61
SY   CIRM-CW60237i-Ctl
DR   Coriell; CW60237
DR   FCDI; CW60237
DR   SKIP; SKIP004130
DR   Wikidata; Q54816544
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60237; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   CW60239
AC   CVCL_DL62
SY   CIRM-CW60239i-Affected
DR   Coriell; CW60239
DR   FCDI; CW60239
DR   SKIP; SKIP004131
DR   Wikidata; Q54816545
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60239; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34460; Cerebral palsy
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60242
AC   CVCL_JI84
DR   Coriell; CW60242
DR   FCDI; CW60242
DR   Wikidata; Q54816546
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60242; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60243
AC   CVCL_JI85
DR   Coriell; CW60243
DR   FCDI; CW60243
DR   Wikidata; Q54816547
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Arab.
CC   Discontinued: Coriell; CW60243; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60245
AC   CVCL_JI86
DR   Coriell; CW60245
DR   FCDI; CW60245
DR   Wikidata; Q54816548
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60245; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60247
AC   CVCL_JI87
DR   Coriell; CW60247
DR   FCDI; CW60247
DR   Wikidata; Q54816549
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60247; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60252
AC   CVCL_JI88
DR   Coriell; CW60252
DR   FCDI; CW60252
DR   Wikidata; Q54816550
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60252; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60261
AC   CVCL_JI89
DR   Coriell; CW60261
DR   FCDI; CW60261
DR   Wikidata; Q54816551
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60261; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60263
AC   CVCL_LJ22
DR   Coriell; CW60263
DR   FCDI; CW60263
DR   Wikidata; Q54816553
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60263; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60264
AC   CVCL_DL63
SY   CIRM-CW60264i-Affected
DR   Coriell; CW60264
DR   FCDI; CW60264
DR   SKIP; SKIP004132
DR   Wikidata; Q54816554
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW60264; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60267
AC   CVCL_LJ23
DR   Coriell; CW60267
DR   FCDI; CW60267
DR   Wikidata; Q54816555
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60267; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60269
AC   CVCL_DL64
DR   Coriell; CW60269
DR   FCDI; CW60269
DR   Wikidata; Q54816557
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60269; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   CW60270
AC   CVCL_RV81
DR   Coriell; CW60270
DR   FCDI; CW60270
DR   Wikidata; Q54816571
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60270; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60272
AC   CVCL_DL65
SY   CIRM-CW60272i-Affected
DR   Coriell; CW60272
DR   FCDI; CW60272
DR   SKIP; SKIP004133
DR   Wikidata; Q54816572
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60272; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   CW60277
AC   CVCL_JI90
DR   Coriell; CW60277
DR   FCDI; CW60277
DR   Wikidata; Q54816573
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60277; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60278
AC   CVCL_JI91
DR   Coriell; CW60278
DR   FCDI; CW60278
DR   Wikidata; Q54816575
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60278; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60279
AC   CVCL_JI92
DR   Coriell; CW60279
DR   FCDI; CW60279
DR   Wikidata; Q54816576
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60279; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60280
AC   CVCL_JI93
DR   Coriell; CW60280
DR   FCDI; CW60280
DR   Wikidata; Q54816577
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60280; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60281
AC   CVCL_LJ24
DR   Coriell; CW60281
DR   FCDI; CW60281
DR   Wikidata; Q54816578
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60281; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60286
AC   CVCL_JI94
DR   Coriell; CW60286
DR   FCDI; CW60286
DR   Wikidata; Q54816579
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60286; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60288
AC   CVCL_LJ25
DR   Coriell; CW60288
DR   FCDI; CW60288
DR   Wikidata; Q54816581
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60288; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60289
AC   CVCL_JI95
DR   Coriell; CW60289
DR   FCDI; CW60289
DR   Wikidata; Q54816582
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60289; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60290
AC   CVCL_JI96
DR   Coriell; CW60290
DR   FCDI; CW60290
DR   Wikidata; Q54816583
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60290; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60291
AC   CVCL_LK19
DR   Coriell; CW60291
DR   FCDI; CW60291
DR   Wikidata; Q54816584
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60291; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60296
AC   CVCL_LJ26
DR   Coriell; CW60296
DR   FCDI; CW60296
DR   Wikidata; Q54816585
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60296; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60297
AC   CVCL_RV82
DR   Coriell; CW60297
DR   FCDI; CW60297
DR   Wikidata; Q54816586
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60297; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60298
AC   CVCL_JI97
DR   Coriell; CW60298
DR   FCDI; CW60298
DR   Wikidata; Q54816588
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60298; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60302
AC   CVCL_JI98
DR   Coriell; CW60302
DR   FCDI; CW60302
DR   Wikidata; Q54816589
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60302; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60303
AC   CVCL_JI99
DR   Coriell; CW60303
DR   FCDI; CW60303
DR   Wikidata; Q54816590
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60303; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60304
AC   CVCL_JJ00
DR   Coriell; CW60304
DR   FCDI; CW60304
DR   Wikidata; Q54816591
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60304; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60305
AC   CVCL_LK20
DR   Coriell; CW60305
DR   FCDI; CW60305
DR   Wikidata; Q54816592
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60305; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60308
AC   CVCL_RV83
DR   Coriell; CW60308
DR   FCDI; CW60308
DR   Wikidata; Q54816593
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60308; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60309
AC   CVCL_RV84
DR   Coriell; CW60309
DR   FCDI; CW60309
DR   Wikidata; Q54816594
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60309; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60310
AC   CVCL_RV85
DR   Coriell; CW60310
DR   FCDI; CW60310
DR   Wikidata; Q54816596
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60310; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60314
AC   CVCL_RV86
SY   CIRMi11R-A
DR   BioSamples; SAMEA115396990
DR   Coriell; CW60314
DR   FCDI; CW60314
DR   hPSCreg; CIRMi11R-A
DR   Wikidata; Q54816597
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60314; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 10
//
ID   CW60319
AC   CVCL_RV87
DR   Coriell; CW60319
DR   FCDI; CW60319
DR   Wikidata; Q54816599
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60320
AC   CVCL_HJ18
DR   Coriell; CW60320
DR   FCDI; CW60320
DR   Wikidata; Q54816600
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60320; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   CW60325
AC   CVCL_JJ01
DR   Coriell; CW60325
DR   FCDI; CW60325
DR   Wikidata; Q54816601
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60325; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60330
AC   CVCL_JJ02
DR   Coriell; CW60330
DR   FCDI; CW60330
DR   Wikidata; Q54816602
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60330; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60331
AC   CVCL_JJ03
DR   Coriell; CW60331
DR   FCDI; CW60331
DR   Wikidata; Q54816603
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60331; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60333
AC   CVCL_JJ04
DR   Coriell; CW60333
DR   FCDI; CW60333
DR   Wikidata; Q54816604
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60333; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60334
AC   CVCL_RV88
DR   Coriell; CW60334
DR   FCDI; CW60334
DR   Wikidata; Q54816605
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60334; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60335
AC   CVCL_JJ05
DR   Coriell; CW60335
DR   FCDI; CW60335
DR   Wikidata; Q54816606
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60335; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60336
AC   CVCL_RV89
DR   Coriell; CW60336
DR   FCDI; CW60336
DR   Wikidata; Q54816607
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60336; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60338
AC   CVCL_RV90
DR   Coriell; CW60338
DR   FCDI; CW60338
DR   Wikidata; Q54816608
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60338; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60342
AC   CVCL_JJ06
DR   Coriell; CW60342
DR   FCDI; CW60342
DR   Wikidata; Q54816609
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60342; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60350
AC   CVCL_LK21
DR   Coriell; CW60350
DR   FCDI; CW60350
DR   Wikidata; Q54816610
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60350; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60353
AC   CVCL_JJ07
DR   Coriell; CW60353
DR   FCDI; CW60353
DR   Wikidata; Q54816612
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60353; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60354
AC   CVCL_RV91
DR   Coriell; CW60354
DR   FCDI; CW60354
DR   Wikidata; Q54816613
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60354; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60355
AC   CVCL_JJ08
DR   Coriell; CW60355
DR   FCDI; CW60355
DR   Wikidata; Q54816614
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60355; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60359
AC   CVCL_RV92
DR   Coriell; CW60359
DR   FCDI; CW60359
DR   Wikidata; Q54816615
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60359; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60362
AC   CVCL_RV93
DR   Coriell; CW60362
DR   FCDI; CW60362
DR   Wikidata; Q54816617
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60362; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60365
AC   CVCL_RV94
DR   Coriell; CW60365
DR   FCDI; CW60365
DR   Wikidata; Q54816629
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60365; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60383
AC   CVCL_HJ19
DR   Coriell; CW60383
DR   FCDI; CW60383
DR   Wikidata; Q54816630
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60383; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   CW60384
AC   CVCL_HJ20
DR   Coriell; CW60384
DR   FCDI; CW60384
DR   Wikidata; Q54816631
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60384; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   CW60389
AC   CVCL_LK22
DR   Coriell; CW60389
DR   FCDI; CW60389
DR   Wikidata; Q54816632
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60389; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60390
AC   CVCL_JJ09
DR   Coriell; CW60390
DR   FCDI; CW60390
DR   Wikidata; Q54816633
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60390; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60391
AC   CVCL_LK23
DR   Coriell; CW60391
DR   FCDI; CW60391
DR   Wikidata; Q54816634
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60391; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60395
AC   CVCL_RV95
DR   Coriell; CW60395
DR   FCDI; CW60395
DR   Wikidata; Q54816635
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60395; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60403
AC   CVCL_JJ10
DR   Coriell; CW60403
DR   FCDI; CW60403
DR   Wikidata; Q54816636
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60403; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60404
AC   CVCL_JJ11
DR   Coriell; CW60404
DR   FCDI; CW60404
DR   Wikidata; Q54816638
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60404; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60405
AC   CVCL_LK24
DR   Coriell; CW60405
DR   FCDI; CW60405
DR   Wikidata; Q54816639
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60405; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60408
AC   CVCL_JJ12
DR   Coriell; CW60408
DR   FCDI; CW60408
DR   Wikidata; Q54816640
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60408; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60410
AC   CVCL_JJ13
DR   Coriell; CW60410
DR   FCDI; CW60410
DR   Wikidata; Q54816641
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60410; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60412
AC   CVCL_JJ14
DR   Coriell; CW60412
DR   FCDI; CW60412
DR   Wikidata; Q54816642
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60412; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60413
AC   CVCL_JJ15
DR   Coriell; CW60413
DR   FCDI; CW60413
DR   Wikidata; Q54816643
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60413; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60416
AC   CVCL_JJ16
DR   Coriell; CW60416
DR   FCDI; CW60416
DR   Wikidata; Q54816644
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60416; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60417
AC   CVCL_LK25
DR   Coriell; CW60417
DR   FCDI; CW60417
DR   Wikidata; Q54816645
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60417; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60418
AC   CVCL_RV96
DR   Coriell; CW60418
DR   FCDI; CW60418
DR   Wikidata; Q54816646
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60418; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60420
AC   CVCL_RV97
DR   Coriell; CW60420
DR   FCDI; CW60420
DR   Wikidata; Q54816647
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60420; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60421
AC   CVCL_LJ27
DR   Coriell; CW60421
DR   FCDI; CW60421
DR   Wikidata; Q54816648
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60421; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60427
AC   CVCL_LK26
DR   Coriell; CW60427
DR   FCDI; CW60427
DR   Wikidata; Q54816649
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60427; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60428
AC   CVCL_RV98
DR   Coriell; CW60428
DR   FCDI; CW60428
DR   Wikidata; Q54816650
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60428; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60436
AC   CVCL_RV99
DR   Coriell; CW60436
DR   FCDI; CW60436
DR   Wikidata; Q54816651
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60436; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60437
AC   CVCL_JJ17
DR   Coriell; CW60437
DR   FCDI; CW60437
DR   Wikidata; Q54816652
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60437; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60441
AC   CVCL_RW00
SY   CIRMi11S-A
DR   BioSamples; SAMEA115396992
DR   Coriell; CW60441
DR   FCDI; CW60441
DR   hPSCreg; CIRMi11S-A
DR   Wikidata; Q54816654
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60441; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 10
//
ID   CW60447
AC   CVCL_JJ18
DR   Coriell; CW60447
DR   FCDI; CW60447
DR   Wikidata; Q54816655
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60447; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60450
AC   CVCL_LK27
DR   Coriell; CW60450
DR   FCDI; CW60450
DR   Wikidata; Q54816656
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60450; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60453
AC   CVCL_LK28
DR   Coriell; CW60453
DR   FCDI; CW60453
DR   Wikidata; Q54816658
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60453; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60456
AC   CVCL_JJ19
DR   Coriell; CW60456
DR   FCDI; CW60456
DR   Wikidata; Q54816659
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60456; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60457
AC   CVCL_JJ20
DR   Coriell; CW60457
DR   FCDI; CW60457
DR   Wikidata; Q54816660
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60457; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60458
AC   CVCL_JJ21
DR   Coriell; CW60458
DR   FCDI; CW60458
DR   Wikidata; Q54816661
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60458; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60462
AC   CVCL_RW01
DR   Coriell; CW60462
DR   FCDI; CW60462
DR   Wikidata; Q54816662
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60462; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60465
AC   CVCL_JJ22
DR   Coriell; CW60465
DR   FCDI; CW60465
DR   Wikidata; Q54816663
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60465; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60469
AC   CVCL_RW02
DR   Coriell; CW60469
DR   FCDI; CW60469
DR   Wikidata; Q54816664
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60469; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60470
AC   CVCL_LK29
DR   Coriell; CW60470
DR   FCDI; CW60470
DR   Wikidata; Q54816665
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60470; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60473
AC   CVCL_JJ23
DR   Coriell; CW60473
DR   FCDI; CW60473
DR   Wikidata; Q54816667
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60473; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60474
AC   CVCL_JJ24
DR   Coriell; CW60474
DR   FCDI; CW60474
DR   Wikidata; Q54816669
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60474; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60477
AC   CVCL_RW03
DR   Coriell; CW60477
DR   FCDI; CW60477
DR   Wikidata; Q54816670
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60477; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60480
AC   CVCL_RW04
DR   Coriell; CW60480
DR   FCDI; CW60480
DR   Wikidata; Q54816671
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60480; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60481
AC   CVCL_RW05
DR   Coriell; CW60481
DR   FCDI; CW60481
DR   Wikidata; Q54816672
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60481; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60483
AC   CVCL_JJ25
DR   Coriell; CW60483
DR   FCDI; CW60483
DR   Wikidata; Q54816674
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60483; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60498
AC   CVCL_RW06
DR   Coriell; CW60498
DR   FCDI; CW60498
DR   Wikidata; Q54816686
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60498; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60499
AC   CVCL_RW07
DR   Coriell; CW60499
DR   FCDI; CW60499
DR   Wikidata; Q54816687
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60499; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW60503
AC   CVCL_LJ28
DR   Coriell; CW60503
DR   FCDI; CW60503
DR   Wikidata; Q54816689
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60503; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   CW60504
AC   CVCL_JJ26
DR   Coriell; CW60504
DR   FCDI; CW60504
DR   Wikidata; Q54816690
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60504; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60507
AC   CVCL_JJ27
DR   Coriell; CW60507
DR   FCDI; CW60507
DR   Wikidata; Q54816691
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60507; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   CW60509
AC   CVCL_RW08
DR   Coriell; CW60509
DR   FCDI; CW60509
DR   Wikidata; Q54816692
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60509; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60510
AC   CVCL_JJ28
DR   Coriell; CW60510
DR   FCDI; CW60510
DR   Wikidata; Q54816693
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60510; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60517
AC   CVCL_JJ29
DR   Coriell; CW60517
DR   FCDI; CW60517
DR   Wikidata; Q54816694
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60517; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60520
AC   CVCL_JJ30
SY   CIRMi11T-A
DR   BioSamples; SAMEA115396994
DR   Coriell; CW60520
DR   FCDI; CW60520
DR   hPSCreg; CIRMi11T-A
DR   Wikidata; Q54816695
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60520; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   CW60521
AC   CVCL_JJ31
DR   Coriell; CW60521
DR   FCDI; CW60521
DR   Wikidata; Q54816696
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60521; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   CW60548
AC   CVCL_LK30
DR   Coriell; CW60548
DR   FCDI; CW60548
DR   Wikidata; Q54816697
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60548; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34460; Cerebral palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   CW60569
AC   CVCL_RW09
DR   Coriell; CW60569
DR   FCDI; CW60569
DR   Wikidata; Q54816698
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW60569; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60576
AC   CVCL_RW10
DR   Coriell; CW60576
DR   FCDI; CW60576
DR   Wikidata; Q54816699
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW60576; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   CW60594
AC   CVCL_RW11
DR   Coriell; CW60594
DR   FCDI; CW60594
DR   Wikidata; Q54816700
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW60594; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   CW678
AC   CVCL_IU54
SY   CW 678
DR   cancercelllines; CVCL_IU54
DR   IARC_TP53; 142
DR   Wikidata; Q54816701
RX   PubMed=2052620;
RX   PubMed=2415623;
RX   PubMed=3026973;
RX   PubMed=6286763;
RX   PubMed=8515068;
RX   PubMed=24590883;
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=2052620).
CC   Misspelling: CW698; PubMed=3026973; PubMed=24590883.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   CW70001
AC   CVCL_4S56
SY   CIRM-CW70001i-Ctl; CIRMi267-A
DR   BioSamples; SAMEA113585320
DR   Coriell; CW70001
DR   FCDI; CW70001
DR   hPSCreg; CIRMi267-A
DR   SKIP; SKIP004134
DR   Wikidata; Q54816702
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70001; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70002
AC   CVCL_4S57
SY   CIRM-CW70002i-Affected; CIRMi268-A
DR   BioSamples; SAMEA113585322
DR   Coriell; CW70002
DR   FCDI; CW70002
DR   hPSCreg; CIRMi268-A
DR   SKIP; SKIP004135
DR   Wikidata; Q54816703
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70002; true.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70004
AC   CVCL_4S58
SY   CIRM-CW70004i-Affected; CIRMi269-A
DR   BioSamples; SAMEA113585324
DR   Coriell; CW70004
DR   FCDI; CW70004
DR   hPSCreg; CIRMi269-A
DR   SKIP; SKIP004136
DR   Wikidata; Q54816705
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70004; true.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   CW70005
AC   CVCL_4S59
SY   CIRM-CW70005i-Affected; CIRMi270-A
DR   BioSamples; SAMEA113585326
DR   Coriell; CW70005
DR   FCDI; CW70005
DR   hPSCreg; CIRMi270-A
DR   SKIP; SKIP004137
DR   Wikidata; Q54816706
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70005; true.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70006
AC   CVCL_4S60
SY   CIRM-CW70006i-Affected; CIRMi271-A
DR   BioSamples; SAMEA113585328
DR   Coriell; CW70006
DR   FCDI; CW70006
DR   hPSCreg; CIRMi271-A
DR   SKIP; SKIP004138
DR   Wikidata; Q54816707
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70006; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70007
AC   CVCL_4S61
SY   CIRM-CW70007i-Affected; CIRMi272-A
DR   BioSamples; SAMEA113585330
DR   Coriell; CW70007
DR   FCDI; CW70007
DR   hPSCreg; CIRMi272-A
DR   SKIP; SKIP004139
DR   Wikidata; Q54816708
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70007; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70008
AC   CVCL_4S62
SY   CIRM-CW70008i-Affected; CIRMi273-A
DR   BioSamples; SAMEA113585332
DR   Coriell; CW70008
DR   FCDI; CW70008
DR   hPSCreg; CIRMi273-A
DR   SKIP; SKIP004140
DR   Wikidata; Q54816709
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70008; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70009
AC   CVCL_DL66
SY   CIRM-CW70009i-Affected; CIRMi274-A
DR   BioSamples; SAMEA113585334
DR   Coriell; CW70009
DR   FCDI; CW70009
DR   hPSCreg; CIRMi274-A
DR   SKIP; SKIP004141
DR   Wikidata; Q54816710
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70009; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW70010
AC   CVCL_DL67
SY   CIRM-CW70010i-Affected; CIRMi397-A
DR   BioSamples; SAMEA113585581
DR   Coriell; CW70010
DR   FCDI; CW70010
DR   hPSCreg; CIRMi397-A
DR   SKIP; SKIP004142
DR   Wikidata; Q54816711
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70010; true.
CC   Discontinued: FCDI; CW70010; probable.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW70011
AC   CVCL_DL68
SY   CIRM-CW70011i-Affected; CIRMi275-A
DR   BioSamples; SAMEA113585336
DR   Coriell; CW70011
DR   FCDI; CW70011
DR   hPSCreg; CIRMi275-A
DR   SKIP; SKIP004143
DR   Wikidata; Q54816712
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70011; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW70012
AC   CVCL_4S63
SY   CIRM-CW70012i-Affected; CIRMi276-A
DR   BioSamples; SAMEA113585338
DR   Coriell; CW70012
DR   FCDI; CW70012
DR   hPSCreg; CIRMi276-A
DR   SKIP; SKIP004144
DR   Wikidata; Q54816713
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70012; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70013
AC   CVCL_4S64
SY   CIRM-CW70013i-Affected; CIRMi277-A
DR   BioSamples; SAMEA113585340
DR   Coriell; CW70013
DR   FCDI; CW70013
DR   hPSCreg; CIRMi277-A
DR   SKIP; SKIP004145
DR   Wikidata; Q54816714
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70013; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70014
AC   CVCL_4S65
SY   CIRM-CW70014i-Affected; CIRMi278-A
DR   BioSamples; SAMEA113585342
DR   Coriell; CW70014
DR   FCDI; CW70014
DR   hPSCreg; CIRMi278-A
DR   SKIP; SKIP004146
DR   Wikidata; Q54816715
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70014; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70015
AC   CVCL_4S66
SY   CIRM-CW70015i-Ctl; CIRMi279-A
DR   BioSamples; SAMEA113585344
DR   Coriell; CW70015
DR   FCDI; CW70015
DR   hPSCreg; CIRMi279-A
DR   SKIP; SKIP004147
DR   Wikidata; Q54816716
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70015; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70016
AC   CVCL_DL69
SY   CIRMi280-A
DR   BioSamples; SAMEA113585346
DR   Coriell; CW70016
DR   FCDI; CW70016
DR   hPSCreg; CIRMi280-A
DR   Wikidata; Q54816717
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70016; true.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   CW70017
AC   CVCL_4S67
SY   CIRM-CW70017i-Affected; CIRMi281-A
DR   BioSamples; SAMEA113585348
DR   Coriell; CW70017
DR   FCDI; CW70017
DR   hPSCreg; CIRMi281-A
DR   SKIP; SKIP004148
DR   Wikidata; Q54816718
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70017; true.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70018
AC   CVCL_4S68
SY   CIRM-CW70018i-Affected; CIRMi282-A
DR   BioSamples; SAMEA113585350
DR   Coriell; CW70018
DR   FCDI; CW70018
DR   hPSCreg; CIRMi282-A
DR   SKIP; SKIP004149
DR   Wikidata; Q54816719
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70018; true.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70019
AC   CVCL_4S69
SY   CIRM-CW70019i-Ctl; CIRMi283-A
DR   BioSamples; SAMEA113585352
DR   Coriell; CW70019
DR   FCDI; CW70019
DR   hPSCreg; CIRMi283-A
DR   SKIP; SKIP004150
DR   Wikidata; Q54816720
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70019; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70021
AC   CVCL_DL70
SY   CIRM-CW70021i-Affected; CIRMi284-A
DR   BioSamples; SAMEA113585354
DR   Coriell; CW70021
DR   FCDI; CW70021
DR   hPSCreg; CIRMi284-A
DR   SKIP; SKIP004151
DR   Wikidata; Q54816721
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70021; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW70022
AC   CVCL_DL71
SY   CIRM-CW70022i-Affected; CIRMi285-A
DR   BioSamples; SAMEA113585356
DR   Coriell; CW70022
DR   FCDI; CW70022
DR   hPSCreg; CIRMi285-A
DR   SKIP; SKIP004152
DR   Wikidata; Q54816722
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70022; true.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70028
AC   CVCL_DL72
SY   CIRM-CW70028i-Affected; CIRMi286-A
DR   BioSamples; SAMEA113585358
DR   Coriell; CW70028
DR   FCDI; CW70028
DR   hPSCreg; CIRMi286-A
DR   SKIP; SKIP004153
DR   Wikidata; Q54816723
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70028; true.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70029
AC   CVCL_DL73
SY   CIRM-CW70029i-Affected; CIRMi287-A
DR   BioSamples; SAMEA113585360
DR   Coriell; CW70029
DR   FCDI; CW70029
DR   hPSCreg; CIRMi287-A
DR   SKIP; SKIP004154
DR   Wikidata; Q54816724
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70029; true.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70030
AC   CVCL_DL74
SY   CIRM-CW70030i-CTL; CIRMi288-A
DR   BioSamples; SAMEA113585362
DR   Coriell; CW70030
DR   FCDI; CW70030
DR   hPSCreg; CIRMi288-A
DR   SKIP; SKIP004155
DR   Wikidata; Q54816725
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70030; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70031
AC   CVCL_DL75
SY   CIRM-CW70031i-Affected
DR   Coriell; CW70031
DR   FCDI; CW70031
DR   SKIP; SKIP004156
DR   Wikidata; Q54816726
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70031; true.
CC   Discontinued: FCDI; CW70031; probable.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW70032
AC   CVCL_DL76
SY   CIRM-CW70032i-Affected; CIRMi289-A
DR   BioSamples; SAMEA113585364
DR   Coriell; CW70032
DR   FCDI; CW70032
DR   hPSCreg; CIRMi289-A
DR   SKIP; SKIP004157
DR   Wikidata; Q54816727
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70032; true.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70033
AC   CVCL_JJ32
SY   CIRMi290-A
DR   BioSamples; SAMEA113585366
DR   Coriell; CW70033
DR   FCDI; CW70033
DR   hPSCreg; CIRMi290-A
DR   Wikidata; Q54816737
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70033; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70034
AC   CVCL_4S70
SY   CIRM-CW70034i-Affected; CIRMi291-A
DR   BioSamples; SAMEA113585368
DR   Coriell; CW70034
DR   FCDI; CW70034
DR   hPSCreg; CIRMi291-A
DR   SKIP; SKIP004158
DR   Wikidata; Q54816738
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70034; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70035
AC   CVCL_4S71
SY   CIRM-CW70035i-Affected; CIRMi292-A
DR   BioSamples; SAMEA113585370
DR   Coriell; CW70035
DR   FCDI; CW70035
DR   hPSCreg; CIRMi292-A
DR   SKIP; SKIP004159
DR   Wikidata; Q54816740
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70035; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70036
AC   CVCL_4S72
SY   CIRM-CW70036i-Affected; CIRMi293-A
DR   BioSamples; SAMEA113585372
DR   Coriell; CW70036
DR   FCDI; CW70036
DR   hPSCreg; CIRMi293-A
DR   SKIP; SKIP004160
DR   Wikidata; Q54816741
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70036; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   NCIt; C34538; Diabetic retinopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70037
AC   CVCL_4S73
SY   CIRM-CW70037i-Affected; CIRMi294-A
DR   BioSamples; SAMEA113585374
DR   Coriell; CW70037
DR   FCDI; CW70037
DR   hPSCreg; CIRMi294-A
DR   SKIP; SKIP004161
DR   Wikidata; Q54816742
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70037; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70038
AC   CVCL_4S74
SY   CIRM-CW70038i-Affected; CIRMi295-A
DR   BioSamples; SAMEA113585376
DR   Coriell; CW70038
DR   FCDI; CW70038
DR   hPSCreg; CIRMi295-A
DR   SKIP; SKIP004162
DR   Wikidata; Q54816743
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70038; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70039
AC   CVCL_4S75
SY   CIRM-CW70039i-Affected; CIRMi296-A
DR   BioSamples; SAMEA113585378
DR   Coriell; CW70039
DR   FCDI; CW70039
DR   hPSCreg; CIRMi296-A
DR   SKIP; SKIP004163
DR   Wikidata; Q54816744
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70039; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70040
AC   CVCL_4S76
SY   CIRM-CW70040i-Affected; CIRMi297-A
DR   BioSamples; SAMEA113585380
DR   Coriell; CW70040
DR   FCDI; CW70040
DR   hPSCreg; CIRMi297-A
DR   SKIP; SKIP004164
DR   Wikidata; Q54816745
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70040; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 16
//
ID   CW70041
AC   CVCL_DL77
SY   CIRM-CW70041i-Affected; CIRMi298-A
DR   BioSamples; SAMEA113585382
DR   Coriell; CW70041
DR   FCDI; CW70041
DR   hPSCreg; CIRMi298-A
DR   SKIP; SKIP004165
DR   Wikidata; Q54816746
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70041; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70042
AC   CVCL_4S77
SY   CIRM-CW70042i-Affected; CIRMi299-A
DR   BioSamples; SAMEA113585384
DR   Coriell; CW70042
DR   FCDI; CW70042
DR   hPSCreg; CIRMi299-A
DR   SKIP; SKIP004166
DR   Wikidata; Q54816747
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70042; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70043
AC   CVCL_4S78
SY   CIRM-CW70043i-Affected; CIRMi300-A
DR   BioSamples; SAMEA113585386
DR   Coriell; CW70043
DR   FCDI; CW70043
DR   hPSCreg; CIRMi300-A
DR   SKIP; SKIP004167
DR   Wikidata; Q54816748
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70043; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70044
AC   CVCL_4S79
SY   CIRM-CW70044i-Affected; CIRMi301-A
DR   BioSamples; SAMEA113585388
DR   Coriell; CW70044
DR   FCDI; CW70044
DR   hPSCreg; CIRMi301-A
DR   SKIP; SKIP004168
DR   Wikidata; Q54816749
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70044; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70045
AC   CVCL_4S80
SY   CIRM-CW70045i-Affected; CIRMi302-A
DR   BioSamples; SAMEA113585390
DR   Coriell; CW70045
DR   FCDI; CW70045
DR   hPSCreg; CIRMi302-A
DR   SKIP; SKIP004169
DR   Wikidata; Q54816750
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70045; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70047
AC   CVCL_DL78
SY   CIRM-CW70047i-Affected; CIRMi303-A
DR   BioSamples; SAMEA113585392
DR   Coriell; CW70047
DR   FCDI; CW70047
DR   hPSCreg; CIRMi303-A
DR   SKIP; SKIP004170
DR   Wikidata; Q54816751
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70047; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70048
AC   CVCL_4S81
SY   CIRM-CW70048i-Affected; CIRMi304-A
DR   BioSamples; SAMEA113585394
DR   Coriell; CW70048
DR   FCDI; CW70048
DR   hPSCreg; CIRMi304-A
DR   SKIP; SKIP004171
DR   Wikidata; Q54816752
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70048; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70049
AC   CVCL_4S82
SY   CIRM-CW70049i-Affected; CIRMi305-A
DR   BioSamples; SAMEA113585396
DR   Coriell; CW70049
DR   FCDI; CW70049
DR   hPSCreg; CIRMi305-A
DR   SKIP; SKIP004172
DR   Wikidata; Q54816753
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70049; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70050
AC   CVCL_4S83
SY   CIRM-CW70050i-Affected; CIRMi306-A
DR   BioSamples; SAMEA113585398
DR   Coriell; CW70050
DR   FCDI; CW70050
DR   hPSCreg; CIRMi306-A
DR   SKIP; SKIP004173
DR   Wikidata; Q54816754
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70050; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70051
AC   CVCL_4S84
SY   CIRM-CW70051i-Affected
DR   Coriell; CW70051
DR   FCDI; CW70051
DR   SKIP; SKIP004174
DR   Wikidata; Q54816755
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70051; true.
CC   Discontinued: FCDI; CW70051; probable.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW70052
AC   CVCL_4S85
SY   CIRM-CW70052i-Affected; CIRMi307-A
DR   BioSamples; SAMEA113585400
DR   Coriell; CW70052
DR   FCDI; CW70052
DR   hPSCreg; CIRMi307-A
DR   SKIP; SKIP004175
DR   Wikidata; Q54816756
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70052; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70054
AC   CVCL_4S86
SY   CIRM-CW70054i-Ctl; CIRMi398-A
DR   BioSamples; SAMEA113585583
DR   Coriell; CW70054
DR   FCDI; CW70054
DR   hPSCreg; CIRMi398-A
DR   SKIP; SKIP004176
DR   Wikidata; Q54816757
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70054; true.
CC   Discontinued: FCDI; CW70054; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70055
AC   CVCL_4S87
SY   CIRM-CW70055i-Affected; CIRMi399-A
DR   BioSamples; SAMEA113585585
DR   Coriell; CW70055
DR   FCDI; CW70055
DR   hPSCreg; CIRMi399-A
DR   SKIP; SKIP004177
DR   Wikidata; Q54816758
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70055; true.
CC   Discontinued: FCDI; CW70055; probable.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 13
//
ID   CW70056
AC   CVCL_4S88
SY   CIRM-CW70056i-Affected; CIRMi308-A
DR   BioSamples; SAMEA113585402
DR   Coriell; CW70056
DR   FCDI; CW70056
DR   hPSCreg; CIRMi308-A
DR   SKIP; SKIP004178
DR   Wikidata; Q54816760
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70056; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70057
AC   CVCL_DL79
SY   CIRMi309-A
DR   BioSamples; SAMEA113585404
DR   Coriell; CW70057
DR   FCDI; CW70057
DR   hPSCreg; CIRMi309-A
DR   Wikidata; Q54816761
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70057; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70059
AC   CVCL_DL80
SY   CIRM-CW70059i-Affected; CIRMi310-A
DR   BioSamples; SAMEA113585406
DR   Coriell; CW70059
DR   FCDI; CW70059
DR   hPSCreg; CIRMi310-A
DR   SKIP; SKIP004179
DR   Wikidata; Q54816762
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70059; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70060
AC   CVCL_JJ33
SY   CIRMi311-A
DR   BioSamples; SAMEA113585408
DR   Coriell; CW70060
DR   FCDI; CW70060
DR   hPSCreg; CIRMi311-A
DR   Wikidata; Q54816763
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70060; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70061
AC   CVCL_4S89
SY   CIRM-CW70061i-Affected; CIRMi312-A
DR   BioSamples; SAMEA113585410
DR   Coriell; CW70061
DR   FCDI; CW70061
DR   hPSCreg; CIRMi312-A
DR   SKIP; SKIP004180
DR   Wikidata; Q54816765
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70061; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 16
//
ID   CW70063
AC   CVCL_4S90
SY   CIRM-CW70063i-Affected; CIRMi313-A
DR   BioSamples; SAMEA113585412
DR   Coriell; CW70063
DR   FCDI; CW70063
DR   hPSCreg; CIRMi313-A
DR   SKIP; SKIP004181
DR   Wikidata; Q54816766
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70063; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70064
AC   CVCL_DL81
SY   CIRM-CW70064i-Affected; CIRMi314-A
DR   BioSamples; SAMEA113585414
DR   Coriell; CW70064
DR   FCDI; CW70064
DR   hPSCreg; CIRMi314-A
DR   SKIP; SKIP004182
DR   Wikidata; Q54816767
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70064; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70066
AC   CVCL_DL82
SY   CIRMi315-A
DR   BioSamples; SAMEA113585416
DR   Coriell; CW70066
DR   FCDI; CW70066
DR   hPSCreg; CIRMi315-A
DR   Wikidata; Q54816768
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70066; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70067
AC   CVCL_4S91
SY   CIRM-CW70067i-Ctl
DR   Coriell; CW70067
DR   FCDI; CW70067
DR   SKIP; SKIP004183
DR   Wikidata; Q54816770
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70067; true.
CC   Discontinued: FCDI; CW70067; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW70071
AC   CVCL_4S92
SY   CIRM-CW70071i-Affected; CIRMi316-A
DR   BioSamples; SAMEA113585418
DR   Coriell; CW70071
DR   FCDI; CW70071
DR   hPSCreg; CIRMi316-A
DR   SKIP; SKIP004184
DR   Wikidata; Q54816772
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70071; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70072
AC   CVCL_DL83
SY   CIRMi317-A
DR   BioSamples; SAMEA113585420
DR   Coriell; CW70072
DR   FCDI; CW70072
DR   hPSCreg; CIRMi317-A
DR   Wikidata; Q54816773
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70072; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70073
AC   CVCL_4S93
SY   CIRMi318-A
DR   BioSamples; SAMEA113585422
DR   Coriell; CW70073
DR   FCDI; CW70073
DR   hPSCreg; CIRMi318-A
DR   Wikidata; Q54816774
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70073; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70075
AC   CVCL_4S94
SY   CIRM-CW70075i-Affected; CIRMi319-A
DR   BioSamples; SAMEA113585424
DR   Coriell; CW70075
DR   FCDI; CW70075
DR   hPSCreg; CIRMi319-A
DR   SKIP; SKIP004185
DR   Wikidata; Q54816775
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70075; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70077
AC   CVCL_4S95
SY   CIRM-CW70077i-Affected; CIRMi320-A
DR   BioSamples; SAMEA113585426
DR   Coriell; CW70077
DR   FCDI; CW70077
DR   hPSCreg; CIRMi320-A
DR   SKIP; SKIP004186
DR   Wikidata; Q54816776
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW70077; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70078
AC   CVCL_4S96
DR   Coriell; CW70078
DR   Wikidata; Q54816777
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70078; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   CW70079
AC   CVCL_4S97
SY   CIRM-CW70079i-Ctl; CIRMi321-A
DR   BioSamples; SAMEA113585428
DR   Coriell; CW70079
DR   FCDI; CW70079
DR   hPSCreg; CIRMi321-A
DR   SKIP; SKIP004187
DR   Wikidata; Q54816778
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70079; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70080
AC   CVCL_4S98
SY   CIRM-CW70080i-Affected; CIRMi400-A
DR   BioSamples; SAMEA113585587
DR   Coriell; CW70080
DR   FCDI; CW70080
DR   hPSCreg; CIRMi400-A
DR   SKIP; SKIP004188
DR   Wikidata; Q54816779
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70080; true.
CC   Discontinued: FCDI; CW70080; probable.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   CW70081
AC   CVCL_4S99
SY   CIRM-CW70081i-Affected; CIRMi322-A
DR   BioSamples; SAMEA113585430
DR   Coriell; CW70081
DR   FCDI; CW70081
DR   hPSCreg; CIRMi322-A
DR   SKIP; SKIP004189
DR   Wikidata; Q54816780
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70081; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70082
AC   CVCL_4T00
SY   CIRM-CW70082i-Affected
DR   Coriell; CW70082
DR   FCDI; CW70082
DR   SKIP; SKIP004190
DR   Wikidata; Q54816781
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70082; true.
CC   Discontinued: FCDI; CW70082; probable.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW70083
AC   CVCL_DL84
SY   CIRM-CW70083i-Affected
DR   Coriell; CW70083
DR   SKIP; SKIP004191
DR   Wikidata; Q54816791
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70083; true.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW70084
AC   CVCL_DL85
DR   Coriell; CW70084
DR   FCDI; CW70084
DR   Wikidata; Q54816792
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70084; true.
CC   Discontinued: FCDI; CW70084; probable.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW70085
AC   CVCL_DL86
SY   CIRM-CW70085i-Affected; CIRMi323-A
DR   BioSamples; SAMEA113585432
DR   Coriell; CW70085
DR   FCDI; CW70085
DR   hPSCreg; CIRMi323-A
DR   SKIP; SKIP004192
DR   Wikidata; Q54816793
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70085; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70086
AC   CVCL_HJ47
SY   CIRMi324-A
DR   BioSamples; SAMEA113585434
DR   Coriell; CW70086
DR   FCDI; CW70086
DR   hPSCreg; CIRMi324-A
DR   Wikidata; Q54816794
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70086; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70087
AC   CVCL_4T01
SY   CIRM-CW70087i-Affected; CIRMi325-A
DR   BioSamples; SAMEA113585436
DR   Coriell; CW70087
DR   FCDI; CW70087
DR   hPSCreg; CIRMi325-A
DR   SKIP; SKIP004193
DR   Wikidata; Q54816795
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70087; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70088
AC   CVCL_4T02
SY   CIRM-CW70088i-Affected; CIRMi326-A
DR   BioSamples; SAMEA113585438
DR   Coriell; CW70088
DR   FCDI; CW70088
DR   hPSCreg; CIRMi326-A
DR   SKIP; SKIP004194
DR   Wikidata; Q54816796
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70088; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70089
AC   CVCL_4T03
SY   CIRM-CW70089i-Affected; CIRMi327-A
DR   BioSamples; SAMEA113585440
DR   Coriell; CW70089
DR   FCDI; CW70089
DR   hPSCreg; CIRMi327-A
DR   SKIP; SKIP004195
DR   Wikidata; Q54816797
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70089; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70090
AC   CVCL_JJ34
SY   CIRMi328-A
DR   BioSamples; SAMEA113585442
DR   Coriell; CW70090
DR   FCDI; CW70090
DR   hPSCreg; CIRMi328-A
DR   Wikidata; Q54816798
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70090; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70091
AC   CVCL_4T04
SY   CIRM-CW70091i-Affected; CIRMi329-A
DR   BioSamples; SAMEA113585444
DR   Coriell; CW70091
DR   FCDI; CW70091
DR   hPSCreg; CIRMi329-A
DR   SKIP; SKIP004196
DR   Wikidata; Q54816799
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70091; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 16
//
ID   CW70092
AC   CVCL_JJ35
SY   CIRMi330-A
DR   BioSamples; SAMEA113585446
DR   Coriell; CW70092
DR   FCDI; CW70092
DR   hPSCreg; CIRMi330-A
DR   Wikidata; Q54816800
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Israeli.
CC   Discontinued: Coriell; CW70092; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70093
AC   CVCL_4T05
SY   CIRM-CW70093i-Affected; CIRMi331-A
DR   BioSamples; SAMEA113585448
DR   Coriell; CW70093
DR   FCDI; CW70093
DR   hPSCreg; CIRMi331-A
DR   SKIP; SKIP004197
DR   Wikidata; Q54816801
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW70093; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70094
AC   CVCL_4T06
SY   CIRM-CW70094i-Affected; CIRMi332-A
DR   BioSamples; SAMEA113585450
DR   Coriell; CW70094
DR   FCDI; CW70094
DR   hPSCreg; CIRMi332-A
DR   SKIP; SKIP004198
DR   SKIP; SKIP004199
DR   Wikidata; Q54816802
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70094; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70095
AC   CVCL_4T07
SY   CIRM-CW70095i-Affected
DR   Coriell; CW70095
DR   FCDI; CW70095
DR   SKIP; SKIP004200
DR   Wikidata; Q54816803
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70095; true.
CC   Discontinued: FCDI; CW70095; probable.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 11
//
ID   CW70096
AC   CVCL_4T08
SY   CIRM-CW70096i-Affected; CIRMi333-A
DR   BioSamples; SAMEA113585452
DR   Coriell; CW70096
DR   FCDI; CW70096
DR   hPSCreg; CIRMi333-A
DR   SKIP; SKIP004201
DR   Wikidata; Q54816804
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70096; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70097
AC   CVCL_LK31
SY   CIRMi334-A
DR   BioSamples; SAMEA113585454
DR   Coriell; CW70097
DR   FCDI; CW70097
DR   hPSCreg; CIRMi334-A
DR   Wikidata; Q54816805
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70097; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 10
//
ID   CW70098
AC   CVCL_DL87
SY   CIRM-CW70098i-Affected; CIRMi335-A
DR   BioSamples; SAMEA113585456
DR   Coriell; CW70098
DR   FCDI; CW70098
DR   hPSCreg; CIRMi335-A
DR   SKIP; SKIP004202
DR   Wikidata; Q54816806
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70098; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70100
AC   CVCL_JJ36
SY   CIRMi336-A
DR   BioSamples; SAMEA113585458
DR   Coriell; CW70100
DR   FCDI; CW70100
DR   hPSCreg; CIRMi336-A
DR   Wikidata; Q54816807
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70101
AC   CVCL_HJ21
SY   CIRMi337-A
DR   BioSamples; SAMEA113585460
DR   Coriell; CW70101
DR   FCDI; CW70101
DR   hPSCreg; CIRMi337-A
DR   Wikidata; Q54816808
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70102
AC   CVCL_DL88
SY   CIRM-CW70102i-Affected; CIRMi338-A
DR   BioSamples; SAMEA113585462
DR   Coriell; CW70102
DR   FCDI; CW70102
DR   hPSCreg; CIRMi338-A
DR   SKIP; SKIP004203
DR   Wikidata; Q54816809
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70103
AC   CVCL_JJ37
SY   CIRMi339-A
DR   BioSamples; SAMEA113585464
DR   Coriell; CW70103
DR   FCDI; CW70103
DR   hPSCreg; CIRMi339-A
DR   Wikidata; Q54816810
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70104
AC   CVCL_JJ38
SY   CIRMi340-A
DR   BioSamples; SAMEA113585466
DR   Coriell; CW70104
DR   FCDI; CW70104
DR   hPSCreg; CIRMi340-A
DR   Wikidata; Q54816811
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70105
AC   CVCL_DL89
SY   CIRM-CW70105i-Affected; CIRMi341-A
DR   BioSamples; SAMEA113585468
DR   Coriell; CW70105
DR   FCDI; CW70105
DR   hPSCreg; CIRMi341-A
DR   SKIP; SKIP004204
DR   Wikidata; Q54816812
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70106
AC   CVCL_JJ39
SY   CIRMi342-A
DR   BioSamples; SAMEA113585470
DR   Coriell; CW70106
DR   FCDI; CW70106
DR   hPSCreg; CIRMi342-A
DR   Wikidata; Q54816813
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70107
AC   CVCL_DL90
SY   CIRM-CW70107i-Affected; CIRMi343-A
DR   BioSamples; SAMEA113585472
DR   Coriell; CW70107
DR   FCDI; CW70107
DR   hPSCreg; CIRMi343-A
DR   SKIP; SKIP004205
DR   Wikidata; Q54816814
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70108
AC   CVCL_DL91
SY   CIRM-CW70108i-Affected; CIRMi344-A
DR   BioSamples; SAMEA113585474
DR   Coriell; CW70108
DR   FCDI; CW70108
DR   hPSCreg; CIRMi344-A
DR   SKIP; SKIP004206
DR   Wikidata; Q54816815
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70109
AC   CVCL_DL92
SY   CIRM-CW70109i-Affected; CIRMi345-A
DR   BioSamples; SAMEA113585476
DR   Coriell; CW70109
DR   FCDI; CW70109
DR   hPSCreg; CIRMi345-A
DR   SKIP; SKIP004207
DR   Wikidata; Q54816816
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70110
AC   CVCL_DL93
SY   CIRM-CW70110i-Affected; CIRMi346-A
DR   BioSamples; SAMEA113585478
DR   Coriell; CW70110
DR   FCDI; CW70110
DR   hPSCreg; CIRMi346-A
DR   SKIP; SKIP004208
DR   Wikidata; Q54816817
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70111
AC   CVCL_DL94
SY   CIRM-CW70111i-Affected; CIRMi347-A
DR   BioSamples; SAMEA113585480
DR   Coriell; CW70111
DR   FCDI; CW70111
DR   hPSCreg; CIRMi347-A
DR   SKIP; SKIP004209
DR   Wikidata; Q54816818
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70112
AC   CVCL_DL95
SY   CIRM-CW70112i-Affected; CIRMi348-A
DR   BioSamples; SAMEA113585482
DR   Coriell; CW70112
DR   FCDI; CW70112
DR   hPSCreg; CIRMi348-A
DR   SKIP; SKIP004210
DR   Wikidata; Q54816819
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70114
AC   CVCL_DL96
SY   CIRM-CW70114i-Affected; CIRMi349-A
DR   BioSamples; SAMEA113585484
DR   Coriell; CW70114
DR   FCDI; CW70114
DR   hPSCreg; CIRMi349-A
DR   SKIP; SKIP004211
DR   Wikidata; Q54816820
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70115
AC   CVCL_LK32
SY   CIRMi350-A
DR   BioSamples; SAMEA113585486
DR   Coriell; CW70115
DR   FCDI; CW70115
DR   hPSCreg; CIRMi350-A
DR   Wikidata; Q54816822
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 12
//
ID   CW70116
AC   CVCL_4T09
SY   CIRM-CW70116i-Affected; CIRMi351-A
DR   BioSamples; SAMEA113585488
DR   Coriell; CW70116
DR   FCDI; CW70116
DR   hPSCreg; CIRMi351-A
DR   SKIP; SKIP004212
DR   Wikidata; Q54816824
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70117
AC   CVCL_4T10
SY   CIRM-CW70117i-Affected; CIRMi352-A
DR   BioSamples; SAMEA113585490
DR   Coriell; CW70117
DR   FCDI; CW70117
DR   hPSCreg; CIRMi352-A
DR   SKIP; SKIP004213
DR   Wikidata; Q54816825
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70118
AC   CVCL_DL97
SY   CIRMi353-A
DR   BioSamples; SAMEA113585492
DR   Coriell; CW70118
DR   FCDI; CW70118
DR   hPSCreg; CIRMi353-A
DR   Wikidata; Q54816826
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70120
AC   CVCL_HJ22
SY   CIRMi354-A
DR   BioSamples; SAMEA113585494
DR   Coriell; CW70120
DR   FCDI; CW70120
DR   hPSCreg; CIRMi354-A
DR   Wikidata; Q54816827
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70120; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70122
AC   CVCL_4T11
SY   CIRM-CW70122i-Affected; CIRMi355-A
DR   BioSamples; SAMEA113585497
DR   Coriell; CW70122
DR   FCDI; CW70122
DR   hPSCreg; CIRMi355-A
DR   SKIP; SKIP004214
DR   Wikidata; Q54816828
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70123
AC   CVCL_4T12
SY   CIRM-CW70123i-Affected; CIRMi356-A
DR   BioSamples; SAMEA113585499
DR   Coriell; CW70123
DR   FCDI; CW70123
DR   hPSCreg; CIRMi356-A
DR   SKIP; SKIP004215
DR   Wikidata; Q54816830
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70123; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70124
AC   CVCL_DL98
SY   CIRM-CW70124i-Affected; CIRMi357-A
DR   BioSamples; SAMEA113585501
DR   Coriell; CW70124
DR   FCDI; CW70124
DR   hPSCreg; CIRMi357-A
DR   SKIP; SKIP004216
DR   Wikidata; Q54816831
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70124; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70125
AC   CVCL_4T13
SY   CIRM-CW70125i-Affected; CIRMi358-A
DR   BioSamples; SAMEA113585503
DR   Coriell; CW70125
DR   FCDI; CW70125
DR   hPSCreg; CIRMi358-A
DR   SKIP; SKIP004217
DR   Wikidata; Q54816832
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70125; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70127
AC   CVCL_4T14
SY   CIRM-CW70127i-Affected; CIRMi359-A
DR   BioSamples; SAMEA113585505
DR   Coriell; CW70127
DR   FCDI; CW70127
DR   hPSCreg; CIRMi359-A
DR   SKIP; SKIP004218
DR   Wikidata; Q54816833
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70127; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70128
AC   CVCL_4T15
SY   CIRM-CW70128i-Affected; CIRMi360-A
DR   BioSamples; SAMEA113585507
DR   Coriell; CW70128
DR   FCDI; CW70128
DR   hPSCreg; CIRMi360-A
DR   SKIP; SKIP004219
DR   Wikidata; Q54816844
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70129
AC   CVCL_4T16
SY   CIRM-CW70129i-Affected; CIRMi361-A
DR   BioSamples; SAMEA113585509
DR   Coriell; CW70129
DR   FCDI; CW70129
DR   hPSCreg; CIRMi361-A
DR   SKIP; SKIP004220
DR   Wikidata; Q54816845
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70129; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70130
AC   CVCL_4T17
SY   CIRM-CW70130i-Affected; CIRMi362-A
DR   BioSamples; SAMEA113585511
DR   Coriell; CW70130
DR   FCDI; CW70130
DR   hPSCreg; CIRMi362-A
DR   SKIP; SKIP004221
DR   Wikidata; Q54816846
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70130; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70131
AC   CVCL_JJ40
SY   CIRMi363-A
DR   BioSamples; SAMEA113585513
DR   Coriell; CW70131
DR   FCDI; CW70131
DR   hPSCreg; CIRMi363-A
DR   Wikidata; Q54816847
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70131; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70132
AC   CVCL_HJ23
SY   CIRMi364-A
DR   BioSamples; SAMEA113585515
DR   Coriell; CW70132
DR   FCDI; CW70132
DR   hPSCreg; CIRMi364-A
DR   Wikidata; Q54816848
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70133
AC   CVCL_DL99
SY   CIRMi365-A
DR   BioSamples; SAMEA113585517
DR   Coriell; CW70133
DR   FCDI; CW70133
DR   hPSCreg; CIRMi365-A
DR   Wikidata; Q54816849
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70134
AC   CVCL_4T18
SY   CIRM-CW70134i-Affected; CIRMi366-A
DR   BioSamples; SAMEA113585519
DR   Coriell; CW70134
DR   FCDI; CW70134
DR   hPSCreg; CIRMi366-A
DR   SKIP; SKIP004222
DR   Wikidata; Q54816850
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70134; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70135
AC   CVCL_4T19
SY   CIRM-CW70135i-Affected; CIRMi367-A
DR   BioSamples; SAMEA113585521
DR   Coriell; CW70135
DR   FCDI; CW70135
DR   hPSCreg; CIRMi367-A
DR   SKIP; SKIP004223
DR   Wikidata; Q54816851
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70135; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70136
AC   CVCL_4T20
SY   CIRM-CW70136i-Affected
DR   Coriell; CW70136
DR   FCDI; CW70136
DR   SKIP; SKIP004224
DR   Wikidata; Q54816852
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70136; true.
CC   Discontinued: FCDI; CW70136; probable.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 11
//
ID   CW70137
AC   CVCL_4T21
SY   CIRM-CW70137i-Affected; CIRMi368-A
DR   BioSamples; SAMEA113585523
DR   Coriell; CW70137
DR   FCDI; CW70137
DR   hPSCreg; CIRMi368-A
DR   SKIP; SKIP004225
DR   Wikidata; Q54816853
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70137; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70138
AC   CVCL_JJ41
SY   CIRMi369-A
DR   BioSamples; SAMEA113585525
DR   Coriell; CW70138
DR   FCDI; CW70138
DR   hPSCreg; CIRMi369-A
DR   Wikidata; Q54816854
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70138; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70139
AC   CVCL_DM00
SY   CIRM-CW70139i-Affected
DR   Coriell; CW70139
DR   FCDI; CW70139
DR   SKIP; SKIP004226
DR   Wikidata; Q54816855
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70139; true.
CC   Discontinued: FCDI; CW70139; probable.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 11
//
ID   CW70140
AC   CVCL_HJ24
SY   CIRMi370-A
DR   BioSamples; SAMEA113585527
DR   Coriell; CW70140
DR   FCDI; CW70140
DR   hPSCreg; CIRMi370-A
DR   Wikidata; Q54816856
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70141
AC   CVCL_4T22
SY   CIRM-CW70141i-Affected; CIRMi371-A
DR   BioSamples; SAMEA113585529
DR   Coriell; CW70141
DR   FCDI; CW70141
DR   hPSCreg; CIRMi371-A
DR   SKIP; SKIP004227
DR   Wikidata; Q54816857
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70141; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70142
AC   CVCL_4T23
SY   CIRM-CW70142i-Affected; CIRMi372-A; low_PRS_5
DR   BioSamples; SAMEA113585531
DR   Coriell; CW70142
DR   FCDI; CW70142
DR   hPSCreg; CIRMi372-A
DR   SKIP; SKIP004228
DR   Wikidata; Q54816858
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally low polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW70142; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 16
//
ID   CW70143
AC   CVCL_LK33
SY   CIRMi373-A
DR   BioSamples; SAMEA113585533
DR   Coriell; CW70143
DR   FCDI; CW70143
DR   hPSCreg; CIRMi373-A
DR   Wikidata; Q54816859
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70143; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW70144
AC   CVCL_DM01
SY   CIRM-CW70144i-Affected; CIRMi374-A
DR   BioSamples; SAMEA113585535
DR   Coriell; CW70144
DR   FCDI; CW70144
DR   hPSCreg; CIRMi374-A
DR   SKIP; SKIP004229
DR   Wikidata; Q54816860
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70144; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70151
AC   CVCL_DM02
SY   CIRM-CW70151i-Affected; CIRMi375-A
DR   BioSamples; SAMEA113585537
DR   Coriell; CW70151
DR   FCDI; CW70151
DR   hPSCreg; CIRMi375-A
DR   SKIP; SKIP004230
DR   Wikidata; Q54816861
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70151; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70152
AC   CVCL_DM03
SY   CIRM-CW70152i-Affected; CIRMi376-A
DR   BioSamples; SAMEA113585539
DR   Coriell; CW70152
DR   FCDI; CW70152
DR   hPSCreg; CIRMi376-A
DR   SKIP; SKIP004231
DR   Wikidata; Q54816862
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70152; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70155
AC   CVCL_LK34
SY   CIRMi377-A
DR   BioSamples; SAMEA113585541
DR   Coriell; CW70155
DR   FCDI; CW70155
DR   hPSCreg; CIRMi377-A
DR   Wikidata; Q54816863
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70155; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   97Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 12
//
ID   CW70156
AC   CVCL_DM04
SY   CIRM-CW70156i-Affected; CIRMi378-A
DR   BioSamples; SAMEA113585543
DR   Coriell; CW70156
DR   FCDI; CW70156
DR   hPSCreg; CIRMi378-A
DR   SKIP; SKIP004232
DR   Wikidata; Q54816864
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70156; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70157
AC   CVCL_DM05
SY   CIRM-CW70157i-Affected
DR   Coriell; CW70157
DR   SKIP; SKIP004233
DR   Wikidata; Q54816865
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70157; true.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 9
//
ID   CW70158
AC   CVCL_DM06
SY   CIRMi379-A
DR   BioSamples; SAMEA113585545
DR   Coriell; CW70158
DR   FCDI; CW70158
DR   hPSCreg; CIRMi379-A
DR   Wikidata; Q54816866
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70158; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70159
AC   CVCL_DM07
SY   CIRM-CW70159i-Affected
DR   Coriell; CW70159
DR   SKIP; SKIP004234
DR   Wikidata; Q54816867
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70159; true.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW70160
AC   CVCL_DM08
SY   CIRM-CW70160i-Affected; CIRMi380-A
DR   BioSamples; SAMEA113585547
DR   Coriell; CW70160
DR   FCDI; CW70160
DR   hPSCreg; CIRMi380-A
DR   SKIP; SKIP004235
DR   Wikidata; Q54816868
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70160; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70161
AC   CVCL_LJ29
SY   CIRMi381-A
DR   BioSamples; SAMEA113585549
DR   Coriell; CW70161
DR   FCDI; CW70161
DR   hPSCreg; CIRMi381-A
DR   Wikidata; Q54816869
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70161; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 12
//
ID   CW70163
AC   CVCL_DM09
DR   Coriell; CW70163
DR   FCDI; CW70163
DR   Wikidata; Q54816870
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70163; true.
CC   Discontinued: FCDI; CW70163; probable.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW70164
AC   CVCL_DM10
SY   CIRM-CW70164i-Affected; CIRMi382-A
DR   BioSamples; SAMEA113585551
DR   Coriell; CW70164
DR   FCDI; CW70164
DR   hPSCreg; CIRMi382-A
DR   SKIP; SKIP004236
DR   Wikidata; Q54816871
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70164; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 16
//
ID   CW70165
AC   CVCL_DM11
SY   CIRM-CW70165i-Affected; CIRMi383-A
DR   BioSamples; SAMEA113585553
DR   Coriell; CW70165
DR   FCDI; CW70165
DR   hPSCreg; CIRMi383-A
DR   SKIP; SKIP004237
DR   Wikidata; Q54816872
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Native North American; Cherokee.
CC   Discontinued: Coriell; CW70165; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70166
AC   CVCL_DM12
DR   Coriell; CW70166
DR   FCDI; CW70166
DR   Wikidata; Q54816873
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70166; true.
CC   Discontinued: FCDI; CW70166; probable.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW70167
AC   CVCL_4T24
SY   CIRM-CW70167i-Affected; CIRMi384-A
DR   BioSamples; SAMEA113585555
DR   Coriell; CW70167
DR   FCDI; CW70167
DR   hPSCreg; CIRMi384-A
DR   SKIP; SKIP004238
DR   Wikidata; Q54816874
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70167; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70168
AC   CVCL_DM13
SY   CIRM-CW70168i-Affected; CIRMi385-A
DR   BioSamples; SAMEA113585557
DR   Coriell; CW70168
DR   FCDI; CW70168
DR   hPSCreg; CIRMi385-A
DR   SKIP; SKIP004239
DR   Wikidata; Q54816875
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70168; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70170
AC   CVCL_DM14
SY   CIRM-CW70170i-Affected; CIRMi386-A
DR   BioSamples; SAMEA113585559
DR   Coriell; CW70170
DR   FCDI; CW70170
DR   hPSCreg; CIRMi386-A
DR   SKIP; SKIP004240
DR   Wikidata; Q54816876
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70170; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70171
AC   CVCL_JJ42
SY   CIRMi387-A
DR   BioSamples; SAMEA113585561
DR   Coriell; CW70171
DR   FCDI; CW70171
DR   hPSCreg; CIRMi387-A
DR   Wikidata; Q54816877
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70171; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70172
AC   CVCL_JJ43
SY   CIRMi388-A
DR   BioSamples; SAMEA113585563
DR   Coriell; CW70172
DR   FCDI; CW70172
DR   hPSCreg; CIRMi388-A
DR   Wikidata; Q54816878
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70172; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70173
AC   CVCL_DM15
SY   CIRM-CW70173i-Affected; CIRMi389-A
DR   BioSamples; SAMEA113585565
DR   Coriell; CW70173
DR   FCDI; CW70173
DR   hPSCreg; CIRMi389-A
DR   SKIP; SKIP004241
DR   Wikidata; Q54816879
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Korean.
CC   Discontinued: Coriell; CW70173; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70174
AC   CVCL_DM16
SY   CIRM-CW70174i-Affected; CIRMi390-A
DR   BioSamples; SAMEA113585567
DR   Coriell; CW70174
DR   FCDI; CW70174
DR   hPSCreg; CIRMi390-A
DR   SKIP; SKIP004242
DR   Wikidata; Q54816880
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70174; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70175
AC   CVCL_DM17
SY   CIRM-CW70175i-Affected; CIRMi391-A
DR   BioSamples; SAMEA113585569
DR   Coriell; CW70175
DR   FCDI; CW70175
DR   hPSCreg; CIRMi391-A
DR   SKIP; SKIP004243
DR   Wikidata; Q54816881
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70175; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70176
AC   CVCL_DM18
SY   CIRMi392-A
DR   BioSamples; SAMEA113585571
DR   Coriell; CW70176
DR   FCDI; CW70176
DR   hPSCreg; CIRMi392-A
DR   Wikidata; Q54816882
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70176; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70177
AC   CVCL_JJ44
SY   CIRMi393-A
DR   BioSamples; SAMEA113585573
DR   Coriell; CW70177
DR   FCDI; CW70177
DR   hPSCreg; CIRMi393-A
DR   Wikidata; Q54816883
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70177; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70178
AC   CVCL_4T25
SY   CIRM-CW70178i-Affected
DR   Coriell; CW70178
DR   FCDI; CW70178
DR   SKIP; SKIP004244
DR   Wikidata; Q54816887
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70178; true.
CC   Discontinued: FCDI; CW70178; probable.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 10
//
ID   CW70179
AC   CVCL_DM19
SY   CIRMi394-A; low_PRS_3
DR   BioSamples; SAMEA113585575
DR   Coriell; CW70179
DR   FCDI; CW70179
DR   hPSCreg; CIRMi394-A
DR   Wikidata; Q54816888
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally low polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW70179; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 13
//
ID   CW70180
AC   CVCL_DM20
SY   CIRM-CW70180i-Affected
DR   Coriell; CW70180
DR   FCDI; CW70180
DR   SKIP; SKIP004245
DR   Wikidata; Q54816889
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70180; true.
CC   Discontinued: FCDI; CW70180; probable.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 10
//
ID   CW70181
AC   CVCL_4T26
SY   CIRM-CW70181i-Affected; CIRMi395-A
DR   BioSamples; SAMEA113585577
DR   Coriell; CW70181
DR   FCDI; CW70181
DR   hPSCreg; CIRMi395-A
DR   SKIP; SKIP004246
DR   Wikidata; Q54816890
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW70181; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 14
//
ID   CW70182
AC   CVCL_DM21
SY   CIRM-CW70182i-Affected; CIRMi396-A
DR   BioSamples; SAMEA113585579
DR   Coriell; CW70182
DR   FCDI; CW70182
DR   hPSCreg; CIRMi396-A
DR   SKIP; SKIP004247
DR   Wikidata; Q54816891
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70182; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70184
AC   CVCL_DM22
SY   CIRM-CW70184i-Affected; CIRMi401-A
DR   BioSamples; SAMEA113594238
DR   Coriell; CW70184
DR   FCDI; CW70184
DR   hPSCreg; CIRMi401-A
DR   SKIP; SKIP004248
DR   Wikidata; Q54816892
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70184; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70185
AC   CVCL_DM23
SY   CIRM-CW70185i-Affected; CIRMi402-A
DR   BioSamples; SAMEA113594240
DR   Coriell; CW70185
DR   FCDI; CW70185
DR   hPSCreg; CIRMi402-A
DR   SKIP; SKIP004249
DR   Wikidata; Q54816893
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70185; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70186
AC   CVCL_DM24
SY   CIRM-CW70186i-Affected; CIRMi403-A
DR   BioSamples; SAMEA113594242
DR   Coriell; CW70186
DR   FCDI; CW70186
DR   hPSCreg; CIRMi403-A
DR   SKIP; SKIP004250
DR   Wikidata; Q54816894
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70186; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70188
AC   CVCL_DM25
SY   CIRM-CW70188i-Affected; CIRMi404-A
DR   BioSamples; SAMEA113594244
DR   Coriell; CW70188
DR   FCDI; CW70188
DR   hPSCreg; CIRMi404-A
DR   SKIP; SKIP004251
DR   Wikidata; Q54816895
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70188; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70189
AC   CVCL_DM26
SY   CIRM-CW70189i-Affected; CIRMi405-A
DR   BioSamples; SAMEA113594246
DR   Coriell; CW70189
DR   FCDI; CW70189
DR   hPSCreg; CIRMi405-A
DR   SKIP; SKIP004252
DR   Wikidata; Q54816896
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW70189; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70190
AC   CVCL_DM27
SY   CIRM-CW70190i-Affected; CIRMi406-A
DR   BioSamples; SAMEA113594248
DR   Coriell; CW70190
DR   FCDI; CW70190
DR   hPSCreg; CIRMi406-A
DR   SKIP; SKIP004253
DR   Wikidata; Q54816897
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70190; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70191
AC   CVCL_DM28
SY   CIRM-CW70191i-Affected; CIRMi407-A
DR   BioSamples; SAMEA113594250
DR   Coriell; CW70191
DR   FCDI; CW70191
DR   hPSCreg; CIRMi407-A
DR   SKIP; SKIP004254
DR   Wikidata; Q54816898
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70191; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 15
//
ID   CW70193
AC   CVCL_DM29
SY   CIRM-CW70193i-Affected; CIRMi408-A
DR   BioSamples; SAMEA113594252
DR   Coriell; CW70193
DR   FCDI; CW70193
DR   hPSCreg; CIRMi408-A
DR   SKIP; SKIP004255
DR   Wikidata; Q54816899
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70193; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70194
AC   CVCL_DM30
SY   CIRM-CW70194i-Affected; CIRMi409-A
DR   BioSamples; SAMEA113594254
DR   Coriell; CW70194
DR   FCDI; CW70194
DR   hPSCreg; CIRMi409-A
DR   SKIP; SKIP004256
DR   Wikidata; Q54816900
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70194; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70195
AC   CVCL_DM31
SY   CIRM-CW70195i-Affected; CIRMi410-A
DR   BioSamples; SAMEA113594256
DR   Coriell; CW70195
DR   FCDI; CW70195
DR   hPSCreg; CIRMi410-A
DR   SKIP; SKIP004257
DR   Wikidata; Q54816902
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW70195; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70196
AC   CVCL_DM32
SY   CIRMi411-A
DR   BioSamples; SAMEA113594258
DR   Coriell; CW70196
DR   FCDI; CW70196
DR   hPSCreg; CIRMi411-A
DR   Wikidata; Q54816903
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70196; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70197
AC   CVCL_JJ45
SY   CIRMi412-A
DR   BioSamples; SAMEA113594260
DR   Coriell; CW70197
DR   FCDI; CW70197
DR   hPSCreg; CIRMi412-A
DR   Wikidata; Q54816904
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70197; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70198
AC   CVCL_DM33
SY   CIRM-CW70198i-Affected; CIRMi413-A
DR   BioSamples; SAMEA113594262
DR   Coriell; CW70198
DR   FCDI; CW70198
DR   hPSCreg; CIRMi413-A
DR   SKIP; SKIP004258
DR   Wikidata; Q54816905
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70198; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 17
//
ID   CW70201
AC   CVCL_LK35
SY   CIRMi414-A
DR   BioSamples; SAMEA113594264
DR   Coriell; CW70201
DR   FCDI; CW70201
DR   hPSCreg; CIRMi414-A
DR   Wikidata; Q54816906
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW70203
AC   CVCL_JJ46
SY   CIRMi415-A
DR   BioSamples; SAMEA113594266
DR   Coriell; CW70203
DR   FCDI; CW70203
DR   hPSCreg; CIRMi415-A
DR   Wikidata; Q54816907
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70205
AC   CVCL_DM34
SY   CIRM-CW70205i-CTL; CIRMi416-A
DR   BioSamples; SAMEA113594268
DR   Coriell; CW70205
DR   FCDI; CW70205
DR   hPSCreg; CIRMi416-A
DR   SKIP; SKIP004259
DR   Wikidata; Q54816908
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70206
AC   CVCL_JJ47
SY   CIRMi417-A
DR   BioSamples; SAMEA113594270
DR   Coriell; CW70206
DR   FCDI; CW70206
DR   hPSCreg; CIRMi417-A
DR   Wikidata; Q54816909
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70207
AC   CVCL_DM35
SY   CIRM-CW70207i-CTL; CIRMi418-A
DR   BioSamples; SAMEA113594272
DR   Coriell; CW70207
DR   FCDI; CW70207
DR   hPSCreg; CIRMi418-A
DR   SKIP; SKIP004260
DR   Wikidata; Q54816910
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70208
AC   CVCL_DM36
SY   CIRM-CW70208i-Affected; CIRMi419-A
DR   BioSamples; SAMEA113594274
DR   Coriell; CW70208
DR   FCDI; CW70208
DR   hPSCreg; CIRMi419-A
DR   SKIP; SKIP004261
DR   Wikidata; Q54816911
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70210
AC   CVCL_DM37
SY   CIRM-CW70210i-Affected; CIRMi420-A
DR   BioSamples; SAMEA113594276
DR   Coriell; CW70210
DR   FCDI; CW70210
DR   hPSCreg; CIRMi420-A
DR   SKIP; SKIP004262
DR   Wikidata; Q54816912
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Japanese.
CC   Discontinued: Coriell; CW70210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70211
AC   CVCL_DM38
SY   CIRM-CW70211i-Affected; CIRMi421-A
DR   BioSamples; SAMEA113594278
DR   Coriell; CW70211
DR   FCDI; CW70211
DR   hPSCreg; CIRMi421-A
DR   SKIP; SKIP004263
DR   Wikidata; Q54816913
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C35394; Primary open angle glaucoma
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70212
AC   CVCL_DM39
SY   CIRM-CW70212i-Affected; CIRMi422-A
DR   BioSamples; SAMEA113594280
DR   Coriell; CW70212
DR   FCDI; CW70212
DR   hPSCreg; CIRMi422-A
DR   SKIP; SKIP004264
DR   Wikidata; Q54816914
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70213
AC   CVCL_JJ48
SY   CIRMi423-A
DR   BioSamples; SAMEA113594282
DR   Coriell; CW70213
DR   FCDI; CW70213
DR   hPSCreg; CIRMi423-A
DR   Wikidata; Q54816915
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70214
AC   CVCL_JJ49
SY   CIRMi424-A
DR   BioSamples; SAMEA113594284
DR   Coriell; CW70214
DR   FCDI; CW70214
DR   hPSCreg; CIRMi424-A
DR   Wikidata; Q54816916
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70214; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70215
AC   CVCL_DM40
SY   CIRM-CW70215i-Affected; CIRMi425-A
DR   BioSamples; SAMEA113594286
DR   Coriell; CW70215
DR   FCDI; CW70215
DR   hPSCreg; CIRMi425-A
DR   SKIP; SKIP004265
DR   Wikidata; Q54816917
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70215; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70216
AC   CVCL_DM41
SY   CIRM-CW70216i-Affected; CIRMi426-A
DR   BioSamples; SAMEA113594288
DR   Coriell; CW70216
DR   FCDI; CW70216
DR   hPSCreg; CIRMi426-A
DR   SKIP; SKIP004266
DR   Wikidata; Q54816918
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70216; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70217
AC   CVCL_DM42
SY   CIRM-CW70217i-Affected; CIRMi427-A
DR   BioSamples; SAMEA113594290
DR   Coriell; CW70217
DR   FCDI; CW70217
DR   hPSCreg; CIRMi427-A
DR   SKIP; SKIP004267
DR   Wikidata; Q54816919
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70217; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70219
AC   CVCL_JJ50
SY   CIRMi428-A
DR   BioSamples; SAMEA113594292
DR   Coriell; CW70219
DR   FCDI; CW70219
DR   hPSCreg; CIRMi428-A
DR   Wikidata; Q54816920
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70219; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70221
AC   CVCL_DM43
SY   CIRM-CW70221i-CTL; CIRMi429-A
DR   BioSamples; SAMEA113594294
DR   Coriell; CW70221
DR   FCDI; CW70221
DR   hPSCreg; CIRMi429-A
DR   SKIP; SKIP004268
DR   Wikidata; Q54816921
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Japanese.
CC   Discontinued: Coriell; CW70221; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70224
AC   CVCL_HJ25
SY   CIRMi430-A
DR   BioSamples; SAMEA113594296
DR   Coriell; CW70224
DR   FCDI; CW70224
DR   hPSCreg; CIRMi430-A
DR   Wikidata; Q54816922
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70224; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70225
AC   CVCL_DM44
SY   CIRM-CW70225i-CTL; CIRMi431-A
DR   BioSamples; SAMEA113594298
DR   Coriell; CW70225
DR   FCDI; CW70225
DR   hPSCreg; CIRMi431-A
DR   SKIP; SKIP004269
DR   Wikidata; Q54816923
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70225; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70226
AC   CVCL_DM45
SY   CIRM-CW70226i-Affected; CIRMi432-A
DR   BioSamples; SAMEA113594300
DR   Coriell; CW70226
DR   FCDI; CW70226
DR   hPSCreg; CIRMi432-A
DR   SKIP; SKIP004270
DR   Wikidata; Q54816924
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70226; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70227
AC   CVCL_DM46
DR   Coriell; CW70227
DR   FCDI; CW70227
DR   Wikidata; Q54816925
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70227; true.
CC   Discontinued: FCDI; CW70227; probable.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   CW70229
AC   CVCL_DM47
SY   CIRM-CW70229i-Affected; CIRMi433-A
DR   BioSamples; SAMEA113594302
DR   Coriell; CW70229
DR   FCDI; CW70229
DR   hPSCreg; CIRMi433-A
DR   SKIP; SKIP004271
DR   Wikidata; Q54816926
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70229; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70230
AC   CVCL_4T27
SY   CIRM-CW70230i-Affected; CIRMi434-A
DR   BioSamples; SAMEA113594304
DR   Coriell; CW70230
DR   FCDI; CW70230
DR   hPSCreg; CIRMi434-A
DR   SKIP; SKIP004272
DR   Wikidata; Q54816927
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70230; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 15
//
ID   CW70232
AC   CVCL_HJ26
SY   CIRMi435-A
DR   BioSamples; SAMEA113594306
DR   Coriell; CW70232
DR   FCDI; CW70232
DR   hPSCreg; CIRMi435-A
DR   Wikidata; Q54816931
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW70232; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70233
AC   CVCL_HJ27
SY   CIRMi436-A
DR   BioSamples; SAMEA113594308
DR   Coriell; CW70233
DR   FCDI; CW70233
DR   hPSCreg; CIRMi436-A
DR   Wikidata; Q54816932
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70233; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70235
AC   CVCL_DM48
SY   CIRMi437-A
DR   BioSamples; SAMEA113594310
DR   Coriell; CW70235
DR   FCDI; CW70235
DR   hPSCreg; CIRMi437-A
DR   Wikidata; Q54816933
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70235; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70239
AC   CVCL_DM49
SY   CIRM-CW70239i-Affected; CIRMi438-A
DR   BioSamples; SAMEA113594312
DR   Coriell; CW70239
DR   FCDI; CW70239
DR   hPSCreg; CIRMi438-A
DR   SKIP; SKIP004273
DR   Wikidata; Q54816934
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: East Indian.
CC   Discontinued: Coriell; CW70239; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70240
AC   CVCL_DM50
SY   CIRM-CW70240i-Affected; CIRMi439-A
DR   BioSamples; SAMEA113594314
DR   Coriell; CW70240
DR   FCDI; CW70240
DR   hPSCreg; CIRMi439-A
DR   SKIP; SKIP004274
DR   Wikidata; Q54816935
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70240; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70241
AC   CVCL_DM51
SY   CIRM-CW70241i-CTL; CIRMi440-A
DR   BioSamples; SAMEA113594316
DR   Coriell; CW70241
DR   FCDI; CW70241
DR   hPSCreg; CIRMi440-A
DR   SKIP; SKIP004275
DR   Wikidata; Q54816936
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70241; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70244
AC   CVCL_DM52
SY   CIRM-CW70244i-Affected; CIRMi441-A
DR   BioSamples; SAMEA113594318
DR   Coriell; CW70244
DR   FCDI; CW70244
DR   hPSCreg; CIRMi441-A
DR   SKIP; SKIP004276
DR   Wikidata; Q54816937
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70244; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70245
AC   CVCL_DM53
SY   CIRM-CW70245i-Affected; CIRMi442-A
DR   BioSamples; SAMEA113594320
DR   Coriell; CW70245
DR   FCDI; CW70245
DR   hPSCreg; CIRMi442-A
DR   SKIP; SKIP004277
DR   Wikidata; Q54816938
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70245; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70246
AC   CVCL_DM54
SY   CIRMi443-A
DR   BioSamples; SAMEA113594322
DR   Coriell; CW70246
DR   FCDI; CW70246
DR   hPSCreg; CIRMi443-A
DR   Wikidata; Q54816939
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70246; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70247
AC   CVCL_DM55
SY   CIRM-CW70247i-Affected; CIRMi444-A
DR   BioSamples; SAMEA113594324
DR   Coriell; CW70247
DR   FCDI; CW70247
DR   hPSCreg; CIRMi444-A
DR   SKIP; SKIP004278
DR   Wikidata; Q54816940
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70247; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70248
AC   CVCL_HJ28
SY   CIRMi445-A
DR   BioSamples; SAMEA113594326
DR   Coriell; CW70248
DR   FCDI; CW70248
DR   hPSCreg; CIRMi445-A
DR   Wikidata; Q54816941
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70248; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70249
AC   CVCL_DM56
SY   CIRM-CW70249i-Affected; CIRMi446-A
DR   BioSamples; SAMEA113594328
DR   Coriell; CW70249
DR   FCDI; CW70249
DR   hPSCreg; CIRMi446-A
DR   SKIP; SKIP004279
DR   Wikidata; Q54816942
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70249; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70250
AC   CVCL_DM57
SY   CIRM-CW70250i-Affected; CIRMi447-A
DR   BioSamples; SAMEA113594330
DR   Coriell; CW70250
DR   FCDI; CW70250
DR   hPSCreg; CIRMi447-A
DR   SKIP; SKIP004280
DR   Wikidata; Q54816943
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW70250; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70251
AC   CVCL_DM58
SY   CIRM-CW70251i-CTL; CIRMi448-A
DR   BioSamples; SAMEA113594332
DR   Coriell; CW70251
DR   FCDI; CW70251
DR   hPSCreg; CIRMi448-A
DR   SKIP; SKIP004281
DR   Wikidata; Q54816944
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70251; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70252
AC   CVCL_DM59
SY   CIRMi449-A
DR   BioSamples; SAMEA113594334
DR   Coriell; CW70252
DR   FCDI; CW70252
DR   hPSCreg; CIRMi449-A
DR   Wikidata; Q54816945
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70252; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70253
AC   CVCL_DM60
SY   CIRM-CW70253i-Affected; CIRMi450-A
DR   BioSamples; SAMEA113594336
DR   Coriell; CW70253
DR   FCDI; CW70253
DR   hPSCreg; CIRMi450-A
DR   SKIP; SKIP004282
DR   Wikidata; Q54816946
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70253; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70254
AC   CVCL_DM61
SY   CIRM-CW70254i-Affected; CIRMi451-A
DR   BioSamples; SAMEA113594338
DR   Coriell; CW70254
DR   FCDI; CW70254
DR   hPSCreg; CIRMi451-A
DR   SKIP; SKIP004283
DR   Wikidata; Q54816947
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70254; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70255
AC   CVCL_HJ29
SY   CIRMi452-A
DR   BioSamples; SAMEA113594340
DR   Coriell; CW70255
DR   FCDI; CW70255
DR   hPSCreg; CIRMi452-A
DR   Wikidata; Q54816948
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70255; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70256
AC   CVCL_DM62
SY   CIRM-CW70256i-CTL; CIRMi453-A
DR   BioSamples; SAMEA113594342
DR   Coriell; CW70256
DR   FCDI; CW70256
DR   hPSCreg; CIRMi453-A
DR   SKIP; SKIP004284
DR   Wikidata; Q54816949
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70256; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70257
AC   CVCL_DM63
SY   CIRM-CW70257i-Affected; CIRMi454-A
DR   BioSamples; SAMEA113594344
DR   Coriell; CW70257
DR   FCDI; CW70257
DR   hPSCreg; CIRMi454-A
DR   SKIP; SKIP004285
DR   Wikidata; Q54816950
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70257; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70258
AC   CVCL_JJ51
SY   CIRMi455-A
DR   BioSamples; SAMEA113594346
DR   Coriell; CW70258
DR   FCDI; CW70258
DR   hPSCreg; CIRMi455-A
DR   Wikidata; Q54816951
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese.
CC   Discontinued: Coriell; CW70258; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70259
AC   CVCL_JJ52
SY   CIRMi456-A
DR   BioSamples; SAMEA113594348
DR   Coriell; CW70259
DR   FCDI; CW70259
DR   hPSCreg; CIRMi456-A
DR   Wikidata; Q54816952
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70259; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70260
AC   CVCL_DM64
SY   CIRM-CW70260i-Affected; CIRMi457-A
DR   BioSamples; SAMEA113594350
DR   Coriell; CW70260
DR   FCDI; CW70260
DR   hPSCreg; CIRMi457-A
DR   SKIP; SKIP004286
DR   Wikidata; Q54816953
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70260; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70261
AC   CVCL_JJ53
SY   CIRMi458-A
DR   BioSamples; SAMEA113594352
DR   Coriell; CW70261
DR   FCDI; CW70261
DR   hPSCreg; CIRMi458-A
DR   Wikidata; Q54816954
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70261; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70262
AC   CVCL_DM65
SY   CIRM-CW70262i-CTL; CIRMi459-A
DR   BioSamples; SAMEA113594354
DR   Coriell; CW70262
DR   FCDI; CW70262
DR   hPSCreg; CIRMi459-A
DR   SKIP; SKIP004287
DR   Wikidata; Q54816955
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70262; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70263
AC   CVCL_DM66
SY   CIRM-CW70263i-Affected; CIRMi460-A
DR   BioSamples; SAMEA113594356
DR   Coriell; CW70263
DR   FCDI; CW70263
DR   hPSCreg; CIRMi460-A
DR   SKIP; SKIP004288
DR   Wikidata; Q54816956
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70263; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70264
AC   CVCL_DM67
SY   CIRM-CW70264i-Affected; CIRMi461-A
DR   BioSamples; SAMEA113594358
DR   Coriell; CW70264
DR   FCDI; CW70264
DR   hPSCreg; CIRMi461-A
DR   SKIP; SKIP004289
DR   Wikidata; Q54816957
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70264; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW70265
AC   CVCL_JJ54
SY   CIRMi462-A
DR   BioSamples; SAMEA113594360
DR   Coriell; CW70265
DR   FCDI; CW70265
DR   hPSCreg; CIRMi462-A
DR   Wikidata; Q54816958
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70265; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70266
AC   CVCL_DM68
SY   CIRM-CW70266i-Affected; CIRMi463-A
DR   BioSamples; SAMEA113594362
DR   Coriell; CW70266
DR   FCDI; CW70266
DR   hPSCreg; CIRMi463-A
DR   SKIP; SKIP004290
DR   Wikidata; Q54816959
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW70266; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70267
AC   CVCL_DM69
SY   CIRM-CW70267i-CTL; CIRMi464-A
DR   BioSamples; SAMEA113594364
DR   Coriell; CW70267
DR   FCDI; CW70267
DR   hPSCreg; CIRMi464-A
DR   SKIP; SKIP004291
DR   Wikidata; Q54816960
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70267; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70269
AC   CVCL_DM70
SY   CIRM-CW70269i-Affected; CIRMi465-A
DR   BioSamples; SAMEA113594366
DR   Coriell; CW70269
DR   FCDI; CW70269
DR   hPSCreg; CIRMi465-A
DR   SKIP; SKIP004292
DR   Wikidata; Q54816961
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70269; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70270
AC   CVCL_JJ55
SY   CIRMi466-A
DR   BioSamples; SAMEA113594368
DR   Coriell; CW70270
DR   FCDI; CW70270
DR   hPSCreg; CIRMi466-A
DR   Wikidata; Q54816962
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70270; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70272
AC   CVCL_DM71
SY   CIRM-CW70272i-Affected; CIRMi467-A
DR   BioSamples; SAMEA113594370
DR   Coriell; CW70272
DR   FCDI; CW70272
DR   hPSCreg; CIRMi467-A
DR   SKIP; SKIP004293
DR   Wikidata; Q54816963
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70272; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70273
AC   CVCL_DM72
SY   CIRM-CW70273i-Affected; CIRMi468-A
DR   BioSamples; SAMEA113594372
DR   Coriell; CW70273
DR   FCDI; CW70273
DR   hPSCreg; CIRMi468-A
DR   SKIP; SKIP004294
DR   Wikidata; Q54816964
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70273; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70274
AC   CVCL_DM73
SY   CIRMi469-A
DR   BioSamples; SAMEA113594374
DR   Coriell; CW70274
DR   FCDI; CW70274
DR   hPSCreg; CIRMi469-A
DR   Wikidata; Q54816965
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70274; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 12
//
ID   CW70275
AC   CVCL_DM74
SY   CIRM-CW70275i-Affected; CIRMi470-A
DR   BioSamples; SAMEA113594376
DR   Coriell; CW70275
DR   FCDI; CW70275
DR   hPSCreg; CIRMi470-A
DR   SKIP; SKIP004295
DR   Wikidata; Q54816966
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: African American.
CC   Discontinued: Coriell; CW70275; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70276
AC   CVCL_DM75
SY   CIRM-CW70276i-Affected; CIRMi471-A
DR   BioSamples; SAMEA113594378
DR   Coriell; CW70276
DR   FCDI; CW70276
DR   hPSCreg; CIRMi471-A
DR   SKIP; SKIP004296
DR   Wikidata; Q54816967
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70276; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70278
AC   CVCL_DM76
SY   CIRM-CW70278i-Affected; CIRMi472-A
DR   BioSamples; SAMEA113594380
DR   Coriell; CW70278
DR   FCDI; CW70278
DR   hPSCreg; CIRMi472-A
DR   SKIP; SKIP004297
DR   Wikidata; Q54816968
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70278; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70279
AC   CVCL_DM77
SY   CIRMi473-A
DR   BioSamples; SAMEA113594382
DR   Coriell; CW70279
DR   FCDI; CW70279
DR   hPSCreg; CIRMi473-A
DR   Wikidata; Q54816969
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70279; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70280
AC   CVCL_DM78
SY   CIRM-CW70280i-Affected; CIRMi474-A
DR   BioSamples; SAMEA113594384
DR   Coriell; CW70280
DR   FCDI; CW70280
DR   hPSCreg; CIRMi474-A
DR   SKIP; SKIP004298
DR   Wikidata; Q54816970
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70280; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 15
//
ID   CW70281
AC   CVCL_DM79
SY   CIRM-CW70281i-Affected; CIRMi475-A
DR   BioSamples; SAMEA113594386
DR   Coriell; CW70281
DR   FCDI; CW70281
DR   hPSCreg; CIRMi475-A
DR   SKIP; SKIP004299
DR   Wikidata; Q54816976
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70281; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70282
AC   CVCL_DM80
SY   CIRM-CW70282i-CTL; CIRMi476-A
DR   BioSamples; SAMEA113594417
DR   Coriell; CW70282
DR   FCDI; CW70282
DR   hPSCreg; CIRMi476-A
DR   SKIP; SKIP004300
DR   Wikidata; Q54816977
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70282; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70283
AC   CVCL_HJ30
SY   CIRMi477-A
DR   BioSamples; SAMEA113594419
DR   Coriell; CW70283
DR   FCDI; CW70283
DR   hPSCreg; CIRMi477-A
DR   Wikidata; Q54816978
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70283; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70284
AC   CVCL_DM81
SY   CIRM-CW70284i-Affected; CIRMi478-A
DR   BioSamples; SAMEA113594421
DR   Coriell; CW70284
DR   FCDI; CW70284
DR   hPSCreg; CIRMi478-A
DR   SKIP; SKIP004301
DR   Wikidata; Q54816979
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70284; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70286
AC   CVCL_DM82
SY   CIRM-CW70286i-Affected; CIRMi479-A
DR   BioSamples; SAMEA113594423
DR   Coriell; CW70286
DR   FCDI; CW70286
DR   hPSCreg; CIRMi479-A
DR   SKIP; SKIP004302
DR   Wikidata; Q54816980
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70286; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70287
AC   CVCL_DM83
SY   CIRM-CW70287i-Affected; CIRMi480-A
DR   BioSamples; SAMEA113594425
DR   Coriell; CW70287
DR   FCDI; CW70287
DR   hPSCreg; CIRMi480-A
DR   SKIP; SKIP004303
DR   Wikidata; Q54816981
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70287; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70289
AC   CVCL_DM84
SY   CIRM-CW70289i-Affected; CIRMi481-A
DR   BioSamples; SAMEA113594427
DR   Coriell; CW70289
DR   FCDI; CW70289
DR   hPSCreg; CIRMi481-A
DR   SKIP; SKIP004304
DR   Wikidata; Q54816982
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70289; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70290
AC   CVCL_JJ56
SY   CIRMi482-A
DR   BioSamples; SAMEA113594429
DR   Coriell; CW70290
DR   FCDI; CW70290
DR   hPSCreg; CIRMi482-A
DR   Wikidata; Q54816983
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Vietnamese.
CC   Discontinued: Coriell; CW70290; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70292
AC   CVCL_DM85
SY   CIRM-CW70292i-Affected; CIRMi483-A
DR   BioSamples; SAMEA113594431
DR   Coriell; CW70292
DR   FCDI; CW70292
DR   hPSCreg; CIRMi483-A
DR   SKIP; SKIP004305
DR   Wikidata; Q54816984
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70292; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70296
AC   CVCL_DM86
SY   CIRM-CW70296i-Affected; CIRMi484-A
DR   BioSamples; SAMEA113594433
DR   Coriell; CW70296
DR   FCDI; CW70296
DR   hPSCreg; CIRMi484-A
DR   SKIP; SKIP004306
DR   Wikidata; Q54816985
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70296; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70297
AC   CVCL_DM87
SY   CIRM-CW70297i-Affected; CIRMi485-A
DR   BioSamples; SAMEA113594435
DR   Coriell; CW70297
DR   FCDI; CW70297
DR   hPSCreg; CIRMi485-A
DR   SKIP; SKIP004307
DR   Wikidata; Q54816986
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70297; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70298
AC   CVCL_DM88
SY   CIRM-CW70298i-Affected; CIRMi486-A
DR   BioSamples; SAMEA113594437
DR   Coriell; CW70298
DR   FCDI; CW70298
DR   hPSCreg; CIRMi486-A
DR   SKIP; SKIP004308
DR   Wikidata; Q54816987
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70298; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70299
AC   CVCL_DM89
SY   CIRM-CW70299i-Affected; CIRMi487-A
DR   BioSamples; SAMEA113594439
DR   Coriell; CW70299
DR   FCDI; CW70299
DR   hPSCreg; CIRMi487-A
DR   SKIP; SKIP004309
DR   Wikidata; Q54816988
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70299; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70300
AC   CVCL_JJ57
SY   CIRMi488-A
DR   BioSamples; SAMEA113594441
DR   Coriell; CW70300
DR   FCDI; CW70300
DR   hPSCreg; CIRMi488-A
DR   Wikidata; Q54816989
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70300; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70301
AC   CVCL_DM90
SY   CIRM-CW70301i-CTL; CIRMi489-A
DR   BioSamples; SAMEA113594443
DR   Coriell; CW70301
DR   FCDI; CW70301
DR   hPSCreg; CIRMi489-A
DR   SKIP; SKIP004310
DR   Wikidata; Q54816990
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70303
AC   CVCL_DM91
SY   CIRM-CW70303i-Affected; CIRMi490-A
DR   BioSamples; SAMEA113594445
DR   Coriell; CW70303
DR   FCDI; CW70303
DR   hPSCreg; CIRMi490-A
DR   SKIP; SKIP004311
DR   Wikidata; Q54816991
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70304
AC   CVCL_DM92
SY   CIRM-CW70304i-Affected; CIRMi491-A
DR   BioSamples; SAMEA113594447
DR   Coriell; CW70304
DR   FCDI; CW70304
DR   hPSCreg; CIRMi491-A
DR   SKIP; SKIP004312
DR   Wikidata; Q54816992
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70305
AC   CVCL_DM93
SY   CIRM-CW70305i-CTL; CIRMi492-A
DR   BioSamples; SAMEA113594449
DR   Coriell; CW70305
DR   FCDI; CW70305
DR   hPSCreg; CIRMi492-A
DR   SKIP; SKIP004313
DR   Wikidata; Q54816993
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70306
AC   CVCL_DM94
SY   CIRM-CW70306i-Affected; CIRMi493-A
DR   BioSamples; SAMEA113594451
DR   Coriell; CW70306
DR   FCDI; CW70306
DR   hPSCreg; CIRMi493-A
DR   SKIP; SKIP004314
DR   Wikidata; Q54816994
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Asian.
CC   Discontinued: Coriell; CW70306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70307
AC   CVCL_DM95
SY   CIRM-CW70307i-Affected; CIRMi494-A
DR   BioSamples; SAMEA113594453
DR   Coriell; CW70307
DR   FCDI; CW70307
DR   hPSCreg; CIRMi494-A
DR   SKIP; SKIP004315
DR   Wikidata; Q54816995
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70308
AC   CVCL_DM96
SY   CIRM-CW70308i-Affected; CIRMi495-A
DR   BioSamples; SAMEA113594455
DR   Coriell; CW70308
DR   FCDI; CW70308
DR   hPSCreg; CIRMi495-A
DR   SKIP; SKIP004316
DR   Wikidata; Q54816996
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian and Japanese.
CC   Discontinued: Coriell; CW70308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70309
AC   CVCL_DM97
SY   CIRM-CW70309i-Affected; CIRMi496-A
DR   BioSamples; SAMEA113594457
DR   Coriell; CW70309
DR   FCDI; CW70309
DR   hPSCreg; CIRMi496-A
DR   SKIP; SKIP004317
DR   Wikidata; Q54816997
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Indian.
CC   Discontinued: Coriell; CW70309; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70310
AC   CVCL_DM98
SY   CIRM-CW70310i-Affected; CIRMi497-A
DR   BioSamples; SAMEA113594459
DR   Coriell; CW70310
DR   FCDI; CW70310
DR   hPSCreg; CIRMi497-A
DR   SKIP; SKIP004318
DR   Wikidata; Q54816998
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Vietnamese.
CC   Discontinued: Coriell; CW70310; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70313
AC   CVCL_DM99
SY   CIRMi498-A
DR   BioSamples; SAMEA113594461
DR   Coriell; CW70313
DR   FCDI; CW70313
DR   hPSCreg; CIRMi498-A
DR   Wikidata; Q54816999
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70313; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70314
AC   CVCL_HJ31
SY   CIRMi499-A
DR   BioSamples; SAMEA113594463
DR   Coriell; CW70314
DR   FCDI; CW70314
DR   hPSCreg; CIRMi499-A
DR   Wikidata; Q54817000
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70315
AC   CVCL_DN00
SY   CIRMi500-A
DR   BioSamples; SAMEA113594465
DR   Coriell; CW70315
DR   FCDI; CW70315
DR   hPSCreg; CIRMi500-A
DR   Wikidata; Q54817001
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Lebanese.
CC   Discontinued: Coriell; CW70315; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70316
AC   CVCL_DN01
SY   CIRM-CW70316i-CTL; CIRMi501-A
DR   BioSamples; SAMEA113594467
DR   Coriell; CW70316
DR   FCDI; CW70316
DR   hPSCreg; CIRMi501-A
DR   SKIP; SKIP004319
DR   Wikidata; Q54817002
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70316; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70317
AC   CVCL_JJ58
SY   CIRMi502-A
DR   BioSamples; SAMEA113594469
DR   Coriell; CW70317
DR   FCDI; CW70317
DR   hPSCreg; CIRMi502-A
DR   Wikidata; Q54817003
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70317; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70318
AC   CVCL_DN02
SY   CIRMi503-A
DR   BioSamples; SAMEA113594471
DR   Coriell; CW70318
DR   FCDI; CW70318
DR   hPSCreg; CIRMi503-A
DR   Wikidata; Q54817004
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70318; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70319
AC   CVCL_DN03
SY   CIRMi504-A
DR   BioSamples; SAMEA113594473
DR   Coriell; CW70319
DR   FCDI; CW70319
DR   hPSCreg; CIRMi504-A
DR   Wikidata; Q54817005
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Korean.
CC   Discontinued: Coriell; CW70319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70320
AC   CVCL_DN04
SY   CIRM-CW70320i-Affected; CIRMi505-A
DR   BioSamples; SAMEA113594475
DR   Coriell; CW70320
DR   FCDI; CW70320
DR   hPSCreg; CIRMi505-A
DR   SKIP; SKIP004320
DR   Wikidata; Q54817006
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Discontinued: Coriell; CW70320; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 13
//
ID   CW70321
AC   CVCL_DN05
SY   CIRM-CW70321i-Affected; CIRMi506-A
DR   BioSamples; SAMEA113594477
DR   Coriell; CW70321
DR   FCDI; CW70321
DR   hPSCreg; CIRMi506-A
DR   SKIP; SKIP004321
DR   Wikidata; Q54817007
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70322
AC   CVCL_DN06
SY   CIRM-CW70322i-Affected; CIRMi507-A
DR   BioSamples; SAMEA113594479
DR   Coriell; CW70322
DR   FCDI; CW70322
DR   hPSCreg; CIRMi507-A
DR   SKIP; SKIP004327
DR   Wikidata; Q54817008
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70323
AC   CVCL_DN07
SY   CIRM-CW70323i-Affected; CIRMi508-A
DR   BioSamples; SAMEA113594481
DR   Coriell; CW70323
DR   FCDI; CW70323
DR   hPSCreg; CIRMi508-A
DR   SKIP; SKIP004322
DR   Wikidata; Q54817009
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70323; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70324
AC   CVCL_DN08
SY   CIRM-CW70324i-Affected; CIRMi509-A
DR   BioSamples; SAMEA113594483
DR   Coriell; CW70324
DR   FCDI; CW70324
DR   hPSCreg; CIRMi509-A
DR   SKIP; SKIP004323
DR   Wikidata; Q54817010
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70324; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70325
AC   CVCL_DN09
SY   CIRM-CW70325i-Affected; CIRMi510-A
DR   BioSamples; SAMEA113594485
DR   Coriell; CW70325
DR   FCDI; CW70325
DR   hPSCreg; CIRMi510-A
DR   SKIP; SKIP004324
DR   Wikidata; Q54817011
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70325; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70326
AC   CVCL_JJ59
SY   CIRMi511-A
DR   BioSamples; SAMEA113594487
DR   Coriell; CW70326
DR   FCDI; CW70326
DR   hPSCreg; CIRMi511-A
DR   Wikidata; Q54817012
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70326; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34538; Diabetic retinopathy
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70327
AC   CVCL_HJ32
SY   CIRMi512-A
DR   BioSamples; SAMEA113594489
DR   Coriell; CW70327
DR   FCDI; CW70327
DR   hPSCreg; CIRMi512-A
DR   Wikidata; Q54817013
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70327; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70330
AC   CVCL_DN10
SY   CIRM-CW70330i-CTL; CIRMi513-A
DR   BioSamples; SAMEA113594491
DR   Coriell; CW70330
DR   FCDI; CW70330
DR   hPSCreg; CIRMi513-A
DR   SKIP; SKIP004325
DR   Wikidata; Q54817014
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70330; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70332
AC   CVCL_DN11
SY   CIRM-CW70332i-Affected; CIRMi514-A
DR   BioSamples; SAMEA113594493
DR   Coriell; CW70332
DR   FCDI; CW70332
DR   hPSCreg; CIRMi514-A
DR   SKIP; SKIP004326
DR   Wikidata; Q54817015
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70332; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 15
//
ID   CW70337
AC   CVCL_HJ33
SY   CIRMi515-A
DR   BioSamples; SAMEA113594495
DR   Coriell; CW70337
DR   FCDI; CW70337
DR   hPSCreg; CIRMi515-A
DR   Wikidata; Q54817019
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70337; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70338
AC   CVCL_DN12
SY   CIRM-CW70338i-Affected; CIRMi516-A
DR   BioSamples; SAMEA113594497
DR   Coriell; CW70338
DR   FCDI; CW70338
DR   hPSCreg; CIRMi516-A
DR   SKIP; SKIP004328
DR   Wikidata; Q54817020
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70338; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 14
//
ID   CW70339
AC   CVCL_JJ60
SY   CIRMi517-A
DR   BioSamples; SAMEA113594499
DR   Coriell; CW70339
DR   FCDI; CW70339
DR   hPSCreg; CIRMi517-A
DR   Wikidata; Q54817021
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Southeast Asian; Filipino.
CC   Discontinued: Coriell; CW70339; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70341
AC   CVCL_DN13
SY   CIRMi518-A
DR   BioSamples; SAMEA113594501
DR   Coriell; CW70341
DR   FCDI; CW70341
DR   hPSCreg; CIRMi518-A
DR   Wikidata; Q54817022
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70341; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70342
AC   CVCL_DN14
SY   CIRMi519-A
DR   BioSamples; SAMEA113594503
DR   Coriell; CW70342
DR   FCDI; CW70342
DR   hPSCreg; CIRMi519-A
DR   Wikidata; Q54817023
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70342; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70343
AC   CVCL_LK36
SY   CIRMi520-A
DR   BioSamples; SAMEA113594505
DR   Coriell; CW70343
DR   FCDI; CW70343
DR   hPSCreg; CIRMi520-A
DR   Wikidata; Q54817024
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70343; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW70344
AC   CVCL_DN15
SY   CIRMi521-A
DR   BioSamples; SAMEA113594507
DR   Coriell; CW70344
DR   FCDI; CW70344
DR   hPSCreg; CIRMi521-A
DR   Wikidata; Q54817025
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70344; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70345
AC   CVCL_DN16
SY   CIRMi522-A
DR   BioSamples; SAMEA113594509
DR   Coriell; CW70345
DR   FCDI; CW70345
DR   hPSCreg; CIRMi522-A
DR   Wikidata; Q54817026
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70345; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70346
AC   CVCL_JJ61
SY   CIRMi523-A
DR   BioSamples; SAMEA113594511
DR   Coriell; CW70346
DR   FCDI; CW70346
DR   hPSCreg; CIRMi523-A
DR   Wikidata; Q54817027
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70346; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70347
AC   CVCL_DN17
SY   CIRMi524-A
DR   BioSamples; SAMEA113594513
DR   Coriell; CW70347
DR   FCDI; CW70347
DR   hPSCreg; CIRMi524-A
DR   Wikidata; Q54817028
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70347; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   CW70348
AC   CVCL_HJ34
SY   CIRMi525-A
DR   BioSamples; SAMEA113594515
DR   Coriell; CW70348
DR   FCDI; CW70348
DR   hPSCreg; CIRMi525-A
DR   Wikidata; Q54817029
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70348; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70350
AC   CVCL_HJ35
SY   CIRMi526-A
DR   BioSamples; SAMEA113594517
DR   Coriell; CW70350
DR   FCDI; CW70350
DR   hPSCreg; CIRMi526-A
DR   Wikidata; Q54817030
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70350; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70351
AC   CVCL_HJ36
SY   CIRMi527-A
DR   BioSamples; SAMEA113594519
DR   Coriell; CW70351
DR   FCDI; CW70351
DR   hPSCreg; CIRMi527-A
DR   Wikidata; Q54817031
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70351; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70353
AC   CVCL_HJ37
SY   CIRMi528-A
DR   BioSamples; SAMEA113594521
DR   Coriell; CW70353
DR   FCDI; CW70353
DR   hPSCreg; CIRMi528-A
DR   Wikidata; Q54817032
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70353; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70354
AC   CVCL_HJ38
SY   CIRMi529-A
DR   BioSamples; SAMEA113594523
DR   Coriell; CW70354
DR   FCDI; CW70354
DR   hPSCreg; CIRMi529-A
DR   Wikidata; Q54817033
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Cuban.
CC   Discontinued: Coriell; CW70354; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70355
AC   CVCL_JJ62
SY   CIRMi530-A
DR   BioSamples; SAMEA113594525
DR   Coriell; CW70355
DR   FCDI; CW70355
DR   hPSCreg; CIRMi530-A
DR   Wikidata; Q54817034
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70355; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 12
//
ID   CW70356
AC   CVCL_JJ63
SY   CIRMi531-A
DR   BioSamples; SAMEA113594527
DR   Coriell; CW70356
DR   FCDI; CW70356
DR   hPSCreg; CIRMi531-A
DR   Wikidata; Q54817035
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70356; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70358
AC   CVCL_JJ64
SY   CIRMi532-A
DR   BioSamples; SAMEA113594529
DR   Coriell; CW70358
DR   FCDI; CW70358
DR   hPSCreg; CIRMi532-A
DR   Wikidata; Q54817036
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Chinese; Taiwan.
CC   Discontinued: Coriell; CW70358; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70359
AC   CVCL_JJ65
SY   CIRMi533-A
DR   BioSamples; SAMEA113594531
DR   Coriell; CW70359
DR   FCDI; CW70359
DR   hPSCreg; CIRMi533-A
DR   Wikidata; Q54817037
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70359; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 11
//
ID   CW70363
AC   CVCL_HJ39
SY   CIRMi534-A
DR   BioSamples; SAMEA113594533
DR   Coriell; CW70363
DR   FCDI; CW70363
DR   hPSCreg; CIRMi534-A
DR   Wikidata; Q54817038
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70363; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
DI   NCIt; C27604; Non-neoplastic eye disorder
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 12
//
ID   CW70364
AC   CVCL_HJ40
SY   CIRMi535-A
DR   BioSamples; SAMEA113594535
DR   Coriell; CW70364
DR   FCDI; CW70364
DR   hPSCreg; CIRMi535-A
DR   Wikidata; Q54817039
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70364; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70366
AC   CVCL_LK37
SY   CIRMi536-A
DR   BioSamples; SAMEA113594537
DR   Coriell; CW70366
DR   FCDI; CW70366
DR   hPSCreg; CIRMi536-A
DR   Wikidata; Q54817040
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70366; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW70368
AC   CVCL_HJ41
SY   CIRMi537-A
DR   BioSamples; SAMEA113594539
DR   Coriell; CW70368
DR   FCDI; CW70368
DR   hPSCreg; CIRMi537-A
DR   Wikidata; Q54817041
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70368; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70369
AC   CVCL_HJ42
SY   CIRMi538-A
DR   BioSamples; SAMEA113594541
DR   Coriell; CW70369
DR   FCDI; CW70369
DR   hPSCreg; CIRMi538-A
DR   Wikidata; Q54817042
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70369; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70370
AC   CVCL_HJ43
SY   CIRMi539-A
DR   BioSamples; SAMEA113594543
DR   Coriell; CW70370
DR   FCDI; CW70370
DR   hPSCreg; CIRMi539-A
DR   Wikidata; Q54817043
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70370; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   CW70371
AC   CVCL_LK38
SY   CIRMi540-A
DR   BioSamples; SAMEA113594545
DR   Coriell; CW70371
DR   FCDI; CW70371
DR   hPSCreg; CIRMi540-A
DR   Wikidata; Q54817044
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Latino or Hispanic.
CC   Discontinued: Coriell; CW70371; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW70372
AC   CVCL_LK39
SY   CIRMi541-A; low_PRS_2
DR   BioSamples; SAMEA113594547
DR   Coriell; CW70372
DR   FCDI; CW70372
DR   hPSCreg; CIRMi541-A
DR   Wikidata; Q54817045
RX   PubMed=34883504;
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Donor information: Established from a donor with a exceptionally low polygenic risk score (PRS) for schizophrenia (PubMed=34883504).
CC   Discontinued: Coriell; CW70372; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 13
//
ID   CW70373
AC   CVCL_LK40
SY   CIRMi542-A
DR   BioSamples; SAMEA113594549
DR   Coriell; CW70373
DR   FCDI; CW70373
DR   hPSCreg; CIRMi542-A
DR   Wikidata; Q54817046
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian.
CC   Discontinued: Coriell; CW70373; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27604; Non-neoplastic eye disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 11
//
ID   CW70384
AC   CVCL_RW12
SY   CIRMi543-A
DR   BioSamples; SAMEA113594551
DR   Coriell; CW70384
DR   FCDI; CW70384
DR   hPSCreg; CIRMi543-A
DR   Wikidata; Q54817047
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Population: Caucasian; Norwegian.
CC   Discontinued: Coriell; CW70384; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   CW80003
AC   CVCL_C9ZD
SY   CIRMi236-A
DR   BioSamples; SAMEA113572211
DR   hPSCreg; CIRMi236-A
DR   Wikidata; Q123031115
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80007
AC   CVCL_C9ZE
SY   CIRMi237-A
DR   BioSamples; SAMEA113572213
DR   hPSCreg; CIRMi237-A
DR   Wikidata; Q123031116
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   CW80008
AC   CVCL_C9ZF
SY   CIRMi238-A
DR   BioSamples; SAMEA113572215
DR   hPSCreg; CIRMi238-A
DR   Wikidata; Q123031117
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ZG ! CW80009
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80009
AC   CVCL_C9ZG
SY   CIRMi239-A
DR   BioSamples; SAMEA113572217
DR   hPSCreg; CIRMi239-A
DR   Wikidata; Q123031118
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ZF ! CW80008
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80010
AC   CVCL_C9ZH
SY   CIRMi240-A
DR   BioSamples; SAMEA113572219
DR   hPSCreg; CIRMi240-A
DR   Wikidata; Q123031119
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80011
AC   CVCL_C9ZI
SY   CIRMi241-A
DR   BioSamples; SAMEA113572221
DR   hPSCreg; CIRMi241-A
DR   Wikidata; Q123031120
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80012
AC   CVCL_C9ZJ
SY   CIRMi242-A
DR   BioSamples; SAMEA113572223
DR   hPSCreg; CIRMi242-A
DR   Wikidata; Q123031121
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80014
AC   CVCL_C9ZK
SY   CIRMi243-A
DR   BioSamples; SAMEA113572225
DR   hPSCreg; CIRMi243-A
DR   Wikidata; Q123031122
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80018
AC   CVCL_C9ZL
SY   CIRMi246-A
DR   BioSamples; SAMEA113572231
DR   hPSCreg; CIRMi246-A
DR   Wikidata; Q123031123
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80019
AC   CVCL_C9ZM
SY   CIRMi247-A
DR   BioSamples; SAMEA113572233
DR   hPSCreg; CIRMi247-A
DR   Wikidata; Q123031124
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80021
AC   CVCL_C9ZN
SY   CIRMi249-A
DR   BioSamples; SAMEA113572237
DR   hPSCreg; CIRMi249-A
DR   Wikidata; Q123031125
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80022
AC   CVCL_C9ZP
SY   CIRMi250-A
DR   BioSamples; SAMEA113572239
DR   hPSCreg; CIRMi250-A
DR   Wikidata; Q123031126
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80024
AC   CVCL_C9ZQ
SY   CIRMi251-A
DR   BioSamples; SAMEA113572241
DR   hPSCreg; CIRMi251-A
DR   Wikidata; Q123031127
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80025
AC   CVCL_C9ZR
SY   CIRMi252-A
DR   BioSamples; SAMEA113572243
DR   hPSCreg; CIRMi252-A
DR   Wikidata; Q123031128
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80026
AC   CVCL_C9ZS
SY   CIRMi253-A
DR   BioSamples; SAMEA113572245
DR   hPSCreg; CIRMi253-A
DR   Wikidata; Q123031130
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80027
AC   CVCL_C9ZT
SY   CIRMi254-A
DR   BioSamples; SAMEA113572247
DR   hPSCreg; CIRMi254-A
DR   Wikidata; Q123031131
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80028
AC   CVCL_C9ZU
SY   CIRMi255-A
DR   BioSamples; SAMEA113572249
DR   hPSCreg; CIRMi255-A
DR   Wikidata; Q123031132
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80030
AC   CVCL_C9ZV
SY   CIRMi256-A
DR   BioSamples; SAMEA113572251
DR   hPSCreg; CIRMi256-A
DR   Wikidata; Q123031133
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ZW ! CW80031
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80031
AC   CVCL_C9ZW
SY   CIRMi257-A
DR   BioSamples; SAMEA113572253
DR   hPSCreg; CIRMi257-A
DR   Wikidata; Q123031134
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ZV ! CW80030
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80038
AC   CVCL_C9ZX
SY   CIRMi258-A
DR   BioSamples; SAMEA113572255
DR   hPSCreg; CIRMi258-A
DR   Wikidata; Q123031135
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80040
AC   CVCL_C9ZY
SY   CIRMi259-A
DR   BioSamples; SAMEA113572257
DR   hPSCreg; CIRMi259-A
DR   Wikidata; Q123031136
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80041
AC   CVCL_C9ZZ
SY   CIRMi260-A
DR   BioSamples; SAMEA113572259
DR   hPSCreg; CIRMi260-A
DR   Wikidata; Q123031137
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80042
AC   CVCL_D0A0
SY   CIRMi261-A
DR   BioSamples; SAMEA113572261
DR   hPSCreg; CIRMi261-A
DR   Wikidata; Q123031138
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80043
AC   CVCL_D0A1
SY   CIRMi262-A
DR   BioSamples; SAMEA113572263
DR   hPSCreg; CIRMi262-A
DR   Wikidata; Q123031139
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80044
AC   CVCL_D0A2
SY   CIRMi263-A
DR   BioSamples; SAMEA113572265
DR   hPSCreg; CIRMi263-A
DR   Wikidata; Q123031140
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80048
AC   CVCL_D0A3
SY   CIRMi264-A
DR   BioSamples; SAMEA113572267
DR   hPSCreg; CIRMi264-A
DR   Wikidata; Q123031141
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80049
AC   CVCL_D0A4
SY   CIRMi265-A
DR   BioSamples; SAMEA113572269
DR   hPSCreg; CIRMi265-A
DR   Wikidata; Q123031142
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80050
AC   CVCL_D0A5
SY   CIRMi266-A
DR   BioSamples; SAMEA113572271
DR   hPSCreg; CIRMi266-A
DR   Wikidata; Q123031145
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80053
AC   CVCL_D0A6
SY   CIRMi244-A
DR   BioSamples; SAMEA113572227
DR   hPSCreg; CIRMi244-A
DR   Wikidata; Q123031146
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80054
AC   CVCL_D0A7
SY   CIRMi245-A
DR   BioSamples; SAMEA113572229
DR   hPSCreg; CIRMi245-A
DR   Wikidata; Q123031147
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202047; Dyskinesia with orofacial involvement
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW80055
AC   CVCL_D0A8
SY   CIRMi248-A
DR   BioSamples; SAMEA113572235
DR   hPSCreg; CIRMi248-A
DR   Wikidata; Q123031148
CC   From: California Institute for Regenerative Medicine (CIRM); San Francisco; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CW9019
AC   CVCL_N820
SY   CW-9019
DR   cancercelllines; CVCL_N820
DR   Cell_Model_Passport; SIDM01481
DR   Cosmic; 1718358
DR   Cosmic; 2356038
DR   DepMap; ACH-001050
DR   GEO; GSM219747
DR   Wikidata; Q54817048
RX   PubMed=19235922;
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Barr, Frederic G.; School of Medicine, University of Pennsylvania; Philadelphia; USA.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   CWBR-L2
AC   CVCL_A9JH
SY   CWBRL2
DR   CCRID; 5301MAM-KCB0231LZJ
DR   KCB; KCB 200231LZJ
DR   Wikidata; Q108820097
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=248811; ! Niviventer confucianus (Chinese white-bellied rat)
OI   CVCL_A9JJ ! CWBR-S2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CWBR-S1
AC   CVCL_A9JI
SY   CWBRS1; CWBRS
DR   CCRID; 5301MAM-KCB02029ZJ
DR   KCB; KCB 200229ZJ
DR   Wikidata; Q108820098
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CWBR-S2
AC   CVCL_A9JJ
SY   CWBRS2
DR   CCRID; 5301MAM-KCB0231SZJ
DR   KCB; KCB 200231SZJ
DR   Wikidata; Q108820099
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=248811; ! Niviventer confucianus (Chinese white-bellied rat)
OI   CVCL_A9JH ! CWBR-L2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CWBR-T10
AC   CVCL_A9JK
SY   CWBRT10
DR   CCRID; 5301MAM-KCB10017ZJ
DR   KCB; KCB 2010017ZJ
DR   Wikidata; Q108820100
CC   Derived from site: In situ; Tail, skeletal muscle; UBERON=UBERON_0003665.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=248811; ! Niviventer confucianus (Chinese white-bellied rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CWBR-T11
AC   CVCL_A9JL
SY   CWBRT11
DR   CCRID; 5301MAM-KCB10018ZJ
DR   KCB; KCB 2010018ZJ
DR   Wikidata; Q108820101
CC   Derived from site: In situ; Tail, skeletal muscle; UBERON=UBERON_0003665.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=248811; ! Niviventer confucianus (Chinese white-bellied rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   CWF-hTERT patient 2
AC   CVCL_E6IA
SY   WIh; Chronic Wound Fibroblast-hTERT immortalized from patient 2
DR   ABM; T0388
RX   PubMed=29584680;
CC   Characteristics: Suitable model for chronic wound related research (PubMed=29584680).
CC   Doubling time: 48-72 hours (ABM=T0388).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin, dermis; Note=From a venous leg ulcer; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6I9 ! NF-hTERT patient 2
SX   Female
AG   75Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   CWR-R1
AC   CVCL_4833
DR   EFO; EFO_0022645
DR   ABM; T8263
DR   cancercelllines; CVCL_4833
DR   GEO; GSM2069498
DR   GEO; GSM2069499
DR   GEO; GSM2069500
DR   GEO; GSM2069501
DR   GEO; GSM2069502
DR   GEO; GSM2069503
DR   GEO; GSM2069504
DR   GEO; GSM2069505
DR   IARC_TP53; 18888
DR   Kerafast; ENC005
DR   Wikidata; Q54817049
RX   CelloPub=CLPUB00698;
RX   PubMed=11306464;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=23117885;
RX   PubMed=27036029;
RX   PubMed=27271795;
RX   PubMed=29194687;
CC   Population: Caucasian.
CC   Characteristics: Co-culture of polygonal closely aggregated epithelial cells surrounded by bipolar stromal fibroblasts.
CC   Doubling time: 33.57 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (PubMed=11306464).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=14518029).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Unspecified (PubMed=14518029).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Kerafast; ENC005; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=14518029
ST   Amelogenin: X,Y
ST   D13S317: 8,12
ST   D18S51: 13,14,15
ST   D21S11: 30
ST   D3S1358: 12,13,14
ST   D5S818: 11,12
ST   D7S820: 9,10,12
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   vWA: 15,16,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3967 ! CWR22
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   CWR-R1-AD1
AC   CVCL_ZC60
SY   R1-AD1
DR   cancercelllines; CVCL_ZC60
DR   Kerafast; EMN024-FP
DR   Wikidata; Q98125805
RX   PubMed=23117885;
RX   PubMed=24101480;
CC   Population: Caucasian.
CC   Characteristics: Clone of CWR-R1 that harbors one intact AR gene copy, express full-length AR and exhibit growth stimulation in response to androgens and growth suppression in response to AR antagonists, including enzalutamide (PubMed=24101480).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4833 ! CWR-R1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CWR-R1-D567
AC   CVCL_ZC61
SY   R1-D567
DR   cancercelllines; CVCL_ZC61
DR   Kerafast; EMN028-FP
DR   Wikidata; Q98125806
RX   PubMed=24101480;
CC   Population: Caucasian.
CC   Characteristics: Using TALEN AR introns 4-7 were deleted. This cell line exclusively expresses the ARv567es isoform that skips exons 5 to 7 (PubMed=24101480).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC60 ! CWR-R1-AD1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CWR-R1-EnzR
AC   CVCL_RA55
DR   cancercelllines; CVCL_RA55
DR   GEO; GSM2069494
DR   GEO; GSM2069495
DR   GEO; GSM2069496
DR   GEO; GSM2069497
DR   Wikidata; Q54817050
RX   PubMed=27036029;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4833 ! CWR-R1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   CWR-R1-I567
AC   CVCL_ZC62
SY   R1-I567
DR   cancercelllines; CVCL_ZC62
DR   Kerafast; EMN029-FP
DR   Wikidata; Q98125807
RX   PubMed=24101480;
CC   Population: Caucasian.
CC   Characteristics: Using TALEN AR introns 4-7 were inverted. This cell line exclusively expresses the ARv567es isoform that skips exons 5 to 7 (PubMed=24101480).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC60 ! CWR-R1-AD1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   CWR-R1ca
AC   CVCL_LI36
DR   cancercelllines; CVCL_LI36
DR   Millipore; SCC118
DR   Wikidata; Q54817051
RX   PubMed=27271795;
CC   Population: Caucasian.
CC   Characteristics: Fibroblast-free derivative of CWR-R1.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): Millipore=SCC118; PubMed=27271795
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12 (PubMed=27271795)
ST   D13S317: 8,12,13 (Millipore=SCC118)
ST   D16S539: 12
ST   D18S51: 13,14,15 (Millipore=SCC118)
ST   D18S51: 14,15 (PubMed=27271795)
ST   D21S11: 29,30 (Millipore=SCC118)
ST   D21S11: 30 (PubMed=27271795)
ST   D3S1358: 12,13,14 (Millipore=SCC118)
ST   D3S1358: 13,14,15 (PubMed=27271795)
ST   D5S818: 11,12
ST   D7S820: 9,10,12
ST   D8S1179: 13,14
ST   FGA: 20,21,23 (Millipore=SCC118)
ST   FGA: 20,23 (PubMed=27271795)
ST   Penta D: 8,9,12 (Millipore=SCC118)
ST   Penta D: 9,12 (PubMed=27271795)
ST   Penta E: 5,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,16,18,19 (Millipore=SCC118)
ST   vWA: 15,19 (PubMed=27271795)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4833 ! CWR-R1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   CWR-R1fb
AC   CVCL_LI37
DR   cancercelllines; CVCL_LI37
DR   Wikidata; Q54817052
RX   PubMed=27271795;
CC   Population: Caucasian.
CC   Characteristics: Fibroblast derivative of CWR-R1.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4833 ! CWR-R1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   CWR21
AC   CVCL_4741
SY   CWR-21; CWR 21
DR   Wikidata; Q54817053
RX   PubMed=8433392;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   CWR22
AC   CVCL_3967
SY   CWR-22; CWR 22
DR   BTO; BTO_0004594
DR   EFO; EFO_0022459
DR   cancercelllines; CVCL_3967
DR   Cosmic; 1689706
DR   NCI-DTP; CWR-22
DR   Wikidata; Q54817054
RX   PubMed=7525052;
RX   PubMed=8433392;
RX   PubMed=8674060;
RX   PubMed=10861745;
RX   PubMed=23671654;
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI) (PubMed=23671654).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (from child cell line CWR22Pc).
CC   Miscellaneous: This is not a cell line but a xenograft, it is the parent tumor for many cell lines.
CC   Misspelling: CRW22; Note=Occasionally.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   CWR22Pc
AC   CVCL_LI38
DR   cancercelllines; CVCL_LI38
DR   Wikidata; Q54817055
RX   PubMed=18829484;
RX   PubMed=21248069;
RX   PubMed=27271795;
CC   Population: Caucasian.
CC   Characteristics: Androgen-dependent. Expresses full-length AR and PSA.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (PubMed=18829484).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=27271795
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 13,14,15
ST   D5S818: 11,12
ST   D7S820: 9,10,11
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 9,12
ST   Penta E: 5,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3967 ! CWR22
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   CWR22Rv1-AR-EK
AC   CVCL_WK44
SY   CWR22Rv1-Androgen Receptor-Exon Knockout
DR   cancercelllines; CVCL_WK44
DR   Wikidata; Q93464997
RX   PubMed=31006810;
CC   Population: Caucasian.
CC   Characteristics: Has lost the ability to express full-length AR (FL-AR), but retains that of expressing alternatively spliced forms of the AR termed AR variants (AR-Vs).
CC   Characteristics: Using CRISPR/Cas9 a stop codon was introduced downstream of the DNA-binding domain in exon 5 of the AR gene.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=31006810
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,21
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   CWR31
AC   CVCL_4740
SY   CWR-31; CWR 31
DR   Wikidata; Q54817056
RX   PubMed=8433392;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   CWR91
AC   CVCL_4739
SY   CWR-91; CWR 91
DR   Wikidata; Q54817057
RX   PubMed=8433392;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   CWRU-C57BL/6-IPTEC
AC   CVCL_C3FC
SY   Case Western Reserve University-C57BL/6-Immortalized Proximal Tubule Epithelial Cell line
DR   GEO; GSM4009074
DR   GEO; GSM4009075
DR   GEO; GSM4009076
DR   Wikidata; Q114311315
RX   PubMed=22020933;
RX   PubMed=24531551;
RX   PubMed=33122286;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and of the cell line description.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   CWRU-C57BL/6 swe/swe-IPTEC
AC   CVCL_C3FD
SY   Case Western Reserve University-C57BL/6 swe/swe-Immortalized Proximal Tubule Epithelial Cell line
DR   Wikidata; Q114311316
RX   PubMed=22020933;
RX   PubMed=24531551;
CC   Knockout cell: Method=KO mouse; MGI; MGI:102462; Slc9a1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and of the cell line description.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: C57BL/6.SJL swe/swe.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   CX
AC   CVCL_C8XF
DR   Wikidata; Q123031149
RX   PubMed=8603367;
RX   PubMed=35692560;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~20 hours (PubMed=8603367).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell of uterus; CL=CL_0002149.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   CX-03
AC   CVCL_RQ40
SY   Cx-03
DR   DSMZ; ACC-816
DR   DSMZCellDive; ACC-816
DR   Wikidata; Q54817058
RX   PubMed=30411161;
CC   Population: Caucasian.
CC   Characteristics: Established after xenotransplantation in SCID-mice of primary tumor cells.
CC   Doubling time: 48-72 hours (PubMed=30411161); ~4-7 days (DSMZ=ACC-816).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): DSMZ=ACC-816; PubMed=30411161
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   DXS101: 23
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 8
//
ID   CX-1
AC   CVCL_2011
SY   HT-29/CX-1; CX1
DR   BTO; BTO_0002440
DR   CLO; CLO_0002650
DR   EFO; EFO_0006561
DR   CLDB; cl939
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473136
DR   cancercelllines; CVCL_2011
DR   ChEMBL-Cells; CHEMBL3307403
DR   ChEMBL-Targets; CHEMBL614566
DR   CLS; 300159
DR   ColonAtlas; CX1
DR   Cosmic; 948826
DR   Cosmic; 995389
DR   Cosmic; 1043809
DR   Cosmic; 1374637
DR   Cosmic; 2301971
DR   Cosmic; 2800584
DR   DSMZ; ACC-129
DR   DSMZCellDive; ACC-129
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM206466
DR   GEO; GSM274761
DR   GEO; GSM274762
DR   GEO; GSM1346835
DR   GEO; GSM1448120
DR   IARC_TP53; 4561
DR   PharmacoDB; CX1_270_2019
DR   PubChem_Cell_line; CVCL_2011
DR   Wikidata; Q54817065
RX   PubMed=7651727;
RX   PubMed=10737795;
RX   PubMed=11668190;
RX   PubMed=12601555;
RX   PubMed=16418264;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (CLS=300159); ~30 hours (DSMZ=ACC-129).
CC   HLA typing: A*01:01,24:03; B*44:02,58:01; C*04:01,04:01; DQA1*05:01,05:01; DQB1*06:13,06:13; DRB1*11:14,15:01' (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=7651727; PubMed=16418264).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CLS=300159; DSMZ=ACC-129; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   CX-2
AC   CVCL_4574
SY   CX2; Cx2
DR   CLS; 300160
DR   Wikidata; Q54817066
CC   Population: Caucasian.
CC   Discontinued: CLS; 300160; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   CX16-8 Ecto
AC   CVCL_B0AR
SY   16-8 Ecto
DR   Wikidata; Q108820102
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 11,12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AS ! CX16-8 Endo
OI   CVCL_B0AT ! CX16-8 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CX16-8 Endo
AC   CVCL_B0AS
SY   16-8 Endo
DR   Wikidata; Q108820103
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 11,12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AR ! CX16-8 Ecto
OI   CVCL_B0AT ! CX16-8 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CX16-8 TZ
AC   CVCL_B0AT
SY   16-8 TZ
DR   Wikidata; Q108820104
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 11,12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AR ! CX16-8 Ecto
OI   CVCL_B0AS ! CX16-8 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CX16-9 Ecto
AC   CVCL_B0AU
SY   16-9 Ecto
DR   Wikidata; Q108820105
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AV ! CX16-9 Endo
OI   CVCL_B0AW ! CX16-9 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CX16-9 Endo
AC   CVCL_B0AV
SY   16-9 Endo
DR   Wikidata; Q108820106
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AU ! CX16-9 Ecto
OI   CVCL_B0AW ! CX16-9 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CX16-9 TZ
AC   CVCL_B0AW
SY   16-9 TZ
DR   Wikidata; Q108820107
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AU ! CX16-9 Ecto
OI   CVCL_B0AV ! CX16-9 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   CX16-RV2 Ecto
AC   CVCL_B0A8
DR   ATCC; CRL-3458
DR   Wikidata; Q108820108
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Doubling time: ~30-40 hours (ATCC=CRL-3458).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-3458; PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0A9 ! CX16-RV2 Endo
OI   CVCL_B0AA ! CX16-RV2 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   CX16-RV2 Endo
AC   CVCL_B0A9
DR   ATCC; CRL-3459
DR   Wikidata; Q108820109
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Doubling time: ~30-40 hours (ATCC=CRL-3459).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0A8 ! CX16-RV2 Ecto
OI   CVCL_B0AA ! CX16-RV2 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV2 TZ
AC   CVCL_B0AA
DR   ATCC; CRL-3460
DR   Wikidata; Q108820111
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Doubling time: ~30-40 hours (ATCC=CRL-3460).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0A8 ! CX16-RV2 Ecto
OI   CVCL_B0A9 ! CX16-RV2 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV3 Ecto
AC   CVCL_B0AB
DR   Wikidata; Q108820112
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D5S818: 8,10
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AC ! CX16-RV3 Endo
OI   CVCL_B0AD ! CX16-RV3 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV3 Endo
AC   CVCL_B0AC
DR   Wikidata; Q108820113
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AB ! CX16-RV3 Ecto
OI   CVCL_B0AD ! CX16-RV3 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV3 TZ
AC   CVCL_B0AD
DR   Wikidata; Q108820114
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D5S818: 8,10
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AB ! CX16-RV3 Ecto
OI   CVCL_B0AC ! CX16-RV3 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV5 Ecto
AC   CVCL_B0AE
DR   Wikidata; Q108820115
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AF ! CX16-RV5 Endo
OI   CVCL_B0AG ! CX16-RV5 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV5 Endo
AC   CVCL_B0AF
DR   Wikidata; Q108820116
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AE ! CX16-RV5 Ecto
OI   CVCL_B0AG ! CX16-RV5 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV5 TZ
AC   CVCL_B0AG
DR   Wikidata; Q108820117
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AE ! CX16-RV5 Ecto
OI   CVCL_B0AF ! CX16-RV5 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV7 Ecto
AC   CVCL_B0AH
DR   Wikidata; Q108820118
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 12,14
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AI ! CX16-RV7 Endo
OI   CVCL_B0AJ ! CX16-RV7 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV7 Endo
AC   CVCL_B0AI
DR   Wikidata; Q108820119
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 12,14
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AH ! CX16-RV7 Ecto
OI   CVCL_B0AJ ! CX16-RV7 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV7 TZ
AC   CVCL_B0AJ
DR   Wikidata; Q108820120
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 12,14
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AH ! CX16-RV7 Ecto
OI   CVCL_B0AI ! CX16-RV7 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV8 Ecto
AC   CVCL_B0AK
DR   Wikidata; Q108820121
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AL ! CX16-RV8 Endo
OI   CVCL_B0AM ! CX16-RV8 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV8 Endo
AC   CVCL_B0AL
DR   Wikidata; Q108820122
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AK ! CX16-RV8 Ecto
OI   CVCL_B0AM ! CX16-RV8 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV8 TZ
AC   CVCL_B0AM
DR   Wikidata; Q108820123
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AK ! CX16-RV8 Ecto
OI   CVCL_B0AL ! CX16-RV8 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV9 Ecto
AC   CVCL_B0AN
DR   Wikidata; Q108820124
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 8,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AP ! CX16-RV9 Endo
OI   CVCL_B0AQ ! CX16-RV9 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV9 Endo
AC   CVCL_B0AP
DR   Wikidata; Q108820125
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 8,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AN ! CX16-RV9 Ecto
OI   CVCL_B0AQ ! CX16-RV9 TZ
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   CX16-RV9 TZ
AC   CVCL_B0AQ
DR   Wikidata; Q108820126
RX   PubMed=29944714;
RX   PubMed=30337615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29944714
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 8,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0AN ! CX16-RV9 Ecto
OI   CVCL_B0AP ! CX16-RV9 Endo
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   Cx30.2
AC   CVCL_4D06
DR   Wikidata; Q54817067
RX   PubMed=23877224;
CC   Characteristics: Transfected with a vector containing a Cx30.2 enhancer (PubMed=23877224).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: 129S1/SvImJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C316 ! CJ7
SX   Male
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 7
//
ID   Cx3Mab-1
AC   CVCL_D3EQ
DR   Wikidata; Q127380728
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O88410; Mouse Cxcr3/Cd183.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   Cx43KOM104-E4(+/-)
AC   CVCL_B3M8
DR   JCRB; JCRB1850
DR   Wikidata; Q110432754
RX   PubMed=9808166;
CC   Knockout cell: Method=KO mouse; MGI; MGI:95713; Gja1 (Note=1 of 2 alleles).
CC   Miscellaneous: The 3 cell lines Cx43KOM104-E7(-/-) (Cellosaurus=CVCL_B3MA), Cx43KOM104-E4(+/-) (Cellosaurus=CVCL_B3M8) and Cx43KOM104-E6(-/-) (Cellosaurus=CVCL_B3M9) originate from embryos of different Gja1 genotype which are the outcome of a cross betwee two Gja(+/-) mice.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   17-18FD
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
ID   Cx43KOM104-E6(-/-)
AC   CVCL_B3M9
DR   JCRB; JCRB1852
DR   Wikidata; Q110432755
RX   PubMed=9808166;
CC   Knockout cell: Method=KO mouse; MGI; MGI:95713; Gja1.
CC   Miscellaneous: The 3 cell lines Cx43KOM104-E7(-/-) (Cellosaurus=CVCL_B3MA), Cx43KOM104-E4(+/-) (Cellosaurus=CVCL_B3M8) and Cx43KOM104-E6(-/-) (Cellosaurus=CVCL_B3M9) originate from embryos of different Gja1 genotype which are the outcome of a cross betwee two Gja(+/-) mice.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   17-18FD
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   Cx43KOM104-E7(+/+)
AC   CVCL_B3MA
DR   JCRB; JCRB1855
DR   Wikidata; Q110432756
RX   PubMed=9808166;
CC   Miscellaneous: The 3 cell lines Cx43KOM104-E7(-/-) (Cellosaurus=CVCL_B3MA), Cx43KOM104-E4(+/-) (Cellosaurus=CVCL_B3M8) and Cx43KOM104-E6(-/-) (Cellosaurus=CVCL_B3M9) originate from embryos of different Gja1 genotype which are the outcome of a cross betwee two Gja(+/-) mice.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   17-18FD
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   Cx4Mab-1
AC   CVCL_D3ER
DR   Wikidata; Q127380729
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P70658; Mouse Cxcr4/Cd184.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   Cx5Mab-1
AC   CVCL_D3ES
DR   Wikidata; Q127380730
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04683; Mouse Cxcr5/Cd185.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   Cx6Mab-1
AC   CVCL_D2SD
DR   Wikidata; Q127380731
RX   PubMed=35736626;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9EQ16; Mouse Cxcr6/Cd186.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   CXMDJ clone 8
AC   CVCL_B4I8
DR   Wikidata; Q110432757
RX   PubMed=33567244;
CC   Sequence variation: Mutation; VGNC; VGNC:54134; DMD; Unexplicit; Ex7del; Zygosity=Hemizygous (PubMed=33567244).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C184988; Canine X-linked muscular dystrophy
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_B4I9 ! CXMDJ clone 9
SX   Male
AG   2M
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   CXMDJ clone 9
AC   CVCL_B4I9
DR   Wikidata; Q110432759
RX   PubMed=33567244;
CC   Sequence variation: Mutation; VGNC; VGNC:54134; DMD; Unexplicit; Ex7del; Zygosity=Hemizygous (PubMed=33567244).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C184988; Canine X-linked muscular dystrophy
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_B4I8 ! CXMDJ clone 8
SX   Male
AG   2M
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   CxTr
AC   CVCL_C4MT
DR   Wikidata; Q116048817
RX   PubMed=36260075;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Japanese encephalitis virus (JEV), Mayaro virus, Rift Valley fever phlebovirus (RVFV) and Vesicular stomatitis virus (VSV) (PubMed=36260075).
CC   Doubling time: 2.2-2.5 days (PubMed=36260075).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7177; ! Culex tarsalis (Encephalitis mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   CY-6
AC   CVCL_A1SD
DR   Wikidata; Q105506728
RX   CelloPub=CLPUB00592;
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Glu650Ter (c.1948G>T); Zygosity=Heterozygous (CelloPub=CLPUB00592).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 4
//
ID   CY100
AC   CVCL_1Q12
SY   GM14956
DR   CLO; CLO_0030454
DR   Coriell; GM14956
DR   Wikidata; Q54817068
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N65 ! GM08352
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY11
AC   CVCL_1Q05
SY   GM14971
DR   CLO; CLO_0030289
DR   Coriell; GM14971
DR   Wikidata; Q54817069
RX   PubMed=2714795;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N61 ! GM03005
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY110
AC   CVCL_VK20
DR   Wikidata; Q93465034
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY115
AC   CVCL_1Q13
DR   Wikidata; Q54817070
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1P22 ! GM09132
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   CY116
AC   CVCL_VK21
DR   Wikidata; Q93465041
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY117
AC   CVCL_VK22
DR   Wikidata; Q93465043
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY12
AC   CVCL_1Q06
SY   GM14955
DR   CLO; CLO_0030456
DR   Coriell; GM14955
DR   Wikidata; Q54817071
RX   PubMed=2095701;
RX   PubMed=2714795;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY120
AC   CVCL_1Q14
SY   GM13159
DR   CLO; CLO_0013621
DR   Coriell; GM13159
DR   Wikidata; Q54817072
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY121
AC   CVCL_VK23
DR   Wikidata; Q93465055
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY122
AC   CVCL_VK24
DR   Wikidata; Q93465057
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY123
AC   CVCL_VK34
DR   Wikidata; Q93465059
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY124
AC   CVCL_1Q15
SY   GM14963
DR   CLO; CLO_0030451
DR   Coriell; GM14963
DR   Wikidata; Q54817073
RX   PubMed=1505951;
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY125
AC   CVCL_VK35
DR   Wikidata; Q93465066
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY127
AC   CVCL_VK25
DR   Wikidata; Q93465068
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY128
AC   CVCL_1Q16
SY   GM14964
DR   CLO; CLO_0030450
DR   Coriell; GM14964
DR   Wikidata; Q54817074
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY13
AC   CVCL_1Q07
DR   Wikidata; Q54817075
RX   PubMed=2095701;
RX   PubMed=2714795;
RX   PubMed=3495225;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1P97 ! GM06227
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   CY130
AC   CVCL_VK13
DR   Wikidata; Q93465079
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY135
AC   CVCL_VK14
DR   Wikidata; Q93465082
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1D93 ! GM02044
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY138
AC   CVCL_VK26
DR   Wikidata; Q93465084
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY14
AC   CVCL_1Q08
SY   GM14972
DR   CLO; CLO_0030293
DR   Coriell; GM14972
DR   Wikidata; Q54817076
RX   PubMed=2095701;
RX   PubMed=2714795;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY140
AC   CVCL_1Q59
DR   Wikidata; Q54817077
RX   PubMed=2095701;
RX   PubMed=7713507;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   CY148
AC   CVCL_VK27
DR   Wikidata; Q93465095
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY15 [Human/mouse hybrid]
AC   CVCL_1Q09
DR   Wikidata; Q54817078
RX   PubMed=2095701;
RX   PubMed=2714795;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   CY15 [Mouse histiocytic tumor]
AC   CVCL_0230
DR   MCCL; MCC:0000118
DR   Wikidata; Q54817079
RX   PubMed=15805249;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: BALB/c Ifng-/-.
DI   NCIt; C134996; Mouse histiocytic and dendritic cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   CY150
AC   CVCL_VK36
DR   Wikidata; Q93465107
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY152
AC   CVCL_VK28
DR   Wikidata; Q93465109
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY153
AC   CVCL_1Q17
SY   GM13160
DR   CLO; CLO_0013650
DR   Coriell; GM13160
DR   Wikidata; Q54817080
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_F137 ! GM06316
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY155
AC   CVCL_VK29
DR   Wikidata; Q93465116
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY160
AC   CVCL_1Q18
SY   GM14975
DR   CLO; CLO_0030294
DR   Coriell; GM14975
DR   Wikidata; Q54817081
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_X328 ! GM05875
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY163
AC   CVCL_VK30
DR   Wikidata; Q93465123
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY165
AC   CVCL_1Q19
SY   GM14976
DR   CLO; CLO_0030291
DR   Coriell; GM14976
DR   Wikidata; Q54817082
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY168
AC   CVCL_VK38
DR   Wikidata; Q93465130
RX   CelloPub=CLPUB00435;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY170
AC   CVCL_1Q20
SY   GM13161
DR   CLO; CLO_0013648
DR   Coriell; GM13161
DR   Wikidata; Q54817083
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_X091 ! GM02346
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY175
AC   CVCL_VK15
DR   Wikidata; Q93465138
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY177
AC   CVCL_VK37
DR   Wikidata; Q93465140
RX   CelloPub=CLPUB00435;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY18
AC   CVCL_1Q10
SY   GM10567
DR   CLO; CLO_0024286
DR   Coriell; GM10567
DR   Wikidata; Q54817084
RX   CelloPub=CLPUB00435;
RX   CelloPub=CLPUB00447;
RX   PubMed=2005900;
RX   PubMed=2095701;
RX   PubMed=2276735;
RX   PubMed=3495225;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping. Contains a complete copy of chromosome 16.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N31 ! GM02860
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   CY180
AC   CVCL_VK16
DR   Wikidata; Q93465146
RX   PubMed=1505951;
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY182
AC   CVCL_VK17
DR   Wikidata; Q93465149
RX   CelloPub=CLPUB00435;
RX   PubMed=15148587;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY183
AC   CVCL_VK31
DR   Wikidata; Q93465151
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY185
AC   CVCL_1Q21
SY   GM14969
DR   CLO; CLO_0030440
DR   Coriell; GM14969
DR   Wikidata; Q54817085
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY19
AC   CVCL_1Q11
DR   Wikidata; Q54817086
RX   PubMed=2095701;
RX   PubMed=2714795;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1P23 ! GM07147
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   CY190
AC   CVCL_VK32
DR   Wikidata; Q93465162
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY192
AC   CVCL_1Q22
SY   GM14970
DR   CLO; CLO_0030290
DR   Coriell; GM14970
DR   Wikidata; Q54817087
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY194
AC   CVCL_VK41
DR   Wikidata; Q93465170
RX   CelloPub=CLPUB00435;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY196
AC   CVCL_VK18
DR   Wikidata; Q93465172
RX   CelloPub=CLPUB00435;
RX   PubMed=2095701;
RX   PubMed=15148587;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_VK39 ! MI-APY
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY197
AC   CVCL_VK19
DR   Wikidata; Q93465174
RX   CelloPub=CLPUB00435;
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY198
AC   CVCL_VK33
DR   Wikidata; Q93465176
RX   CelloPub=CLPUB00435;
RX   PubMed=1505951;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   CY2 [Human iPSC]
AC   CVCL_1E79
SY   ND50020
DR   NHCDR; ND50020
DR   Wikidata; Q54817088
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   CY2 [Human/mouse hybrid]
AC   CVCL_1P98
SY   GM11099
DR   CLO; CLO_0023026
DR   Coriell; GM11099
DR   Wikidata; Q54817089
RX   CelloPub=CLPUB00447;
RX   PubMed=2095701;
RX   PubMed=3495225;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 16 and X mapping (PubMed=9441767; Coriell=GM11099).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N62 ! GM03884
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   CY3
AC   CVCL_1P99
SY   GM11100
DR   CLO; CLO_0023027
DR   Coriell; GM11100
DR   Wikidata; Q54817090
RX   CelloPub=CLPUB00447;
RX   PubMed=2095701;
RX   PubMed=3495225;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 16 and X mapping (PubMed=9441767; Coriell=GM11100).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N62 ! GM03884
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   Cy34.1.2
AC   CVCL_G647
SY   Cy34.1; CY34
DR   CLO; CLO_0002651
DR   ATCC; TIB-163
DR   Wikidata; Q54817091
RX   PubMed=6984010;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   CY4 [Human/mouse hybrid]
AC   CVCL_1Q00
SY   GM13157
DR   CLO; CLO_0013623
DR   Coriell; GM13157
DR   Wikidata; Q54817092
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 8
//
ID   CY4 [Rat hybridoma against mouse Itga7]
AC   CVCL_E3ZJ
RX   PubMed=9004048;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q61738; Mouse Itga7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CY5
AC   CVCL_1Q01
SY   GM11101
DR   CLO; CLO_0023024
DR   Coriell; GM11101
DR   Wikidata; Q54817093
RX   CelloPub=CLPUB00447;
RX   PubMed=2095701;
RX   PubMed=3495225;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V804 ! GM01396
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   CY6
AC   CVCL_1Q02
SY   GM13158
DR   CLO; CLO_0013620
DR   Coriell; GM13158
DR   Wikidata; Q54817094
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   CY7
AC   CVCL_1Q03
SY   GM11102
DR   CLO; CLO_0023025
DR   Coriell; GM11102
DR   Wikidata; Q54817095
RX   CelloPub=CLPUB00447;
RX   PubMed=2095701;
RX   PubMed=3495225;
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 3 and 16 mapping (PubMed=9441767; Coriell=GM11102).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N31 ! GM02860
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   CY8 [Human/mouse hybrid]
AC   CVCL_1Q04
SY   GM14954
DR   CLO; CLO_0030441
DR   Coriell; GM14954
DR   Wikidata; Q54817096
RX   PubMed=2095701;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 16 mapping.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 8
//
ID   CY8 [Rat hybridoma against mouse Itga7]
AC   CVCL_E3ZK
RX   PubMed=9004048;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q61738; Mouse Itga7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   CyA-1
AC   CVCL_R971
SY   Cynoscion Arenarius-1
DR   Wikidata; Q54817097
RX   DOI=10.1007/BF02626743;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 18 to 34 Celsius, the optimal temperature is 24-32 Celsius (DOI=10.1007/BF02626743).
CC   Derived from site: In situ; Trunk, muscle; UBERON=UBERON_0001774.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=80640; ! Cynoscion arenarius (Sand weakfish)
OI   CVCL_R972 ! CyA-2
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   CyA-2
AC   CVCL_R972
SY   Cynoscion Arenarius-2
DR   Wikidata; Q54817098
RX   DOI=10.1007/BF02626743;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 18 to 34 Celsius, the optimal temperature is 24-32 Celsius (DOI=10.1007/BF02626743).
CC   Derived from site: In situ; Trunk, muscle; UBERON=UBERON_0001774.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=80640; ! Cynoscion arenarius (Sand weakfish)
OI   CVCL_R971 ! CyA-1
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   CyCKG
AC   CVCL_C5YS
DR   NRFC; NRFC064
DR   Wikidata; Q116048818
WW   Provider; NRFC; NRFC064; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC064.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   Cyct/Cycs KO
AC   CVCL_ZC31
DR   Kerafast; EMI021
DR   Wikidata; Q98125808
RX   PubMed=17210651;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88579; Cyct.
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:88578; Cycs.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: (cyt ct-/- x cyt cs-/-) x cyt cflox/o.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1M
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   Cyd-1
AC   CVCL_C4SM
DR   ABCD; ABCD_AE898
DR   Wikidata; Q116048819
RX   PubMed=7508080;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17562; Cytidine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   cyfH-1
AC   CVCL_JF95
SY   H-1
DR   JCRB; JCRB1654
DR   Wikidata; Q54817099
RX   PubMed=23792767;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   cyfH-2
AC   CVCL_JF96
SY   H-2
DR   Wikidata; Q54817100
RX   PubMed=23792767;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   cyfH-3
AC   CVCL_JF97
SY   H-3
DR   Wikidata; Q54817101
RX   PubMed=23792767;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   cyfH-4
AC   CVCL_JF98
SY   H-4
DR   Wikidata; Q54817102
RX   PubMed=23792767;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   cyfH-5
AC   CVCL_JF99
SY   H-5
DR   JCRB; JCRB1659
DR   Wikidata; Q54817103
RX   PubMed=23792767;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   CyN-1
AC   CVCL_DE91
SY   Cynoscion Nebulosus-1
DR   Wikidata; Q54817104
RX   DOI=10.1007/BF02618105;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin, muscle; UBERON=UBERON_2000628.
OX   NCBI_TaxID=13029; ! Cynoscion nebulosus (Spotted seatrout)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   CYHI
AC   CVCL_B5SR
DR   Wikidata; Q111733150
RX   PubMed=10341211;
CC   Senescence: Senesces at 45-60 PDL (PubMed=10341211).
CC   Derived from site: In situ; Axilla, skin; UBERON=UBERON_0015474.
CC   Cell type: Myoepithelial cell; CL=CL_0000185.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   CynESC-3X
AC   CVCL_WJ34
SY   Cyn ESC #3X
DR   Wikidata; Q93465202
RX   PubMed=30869744;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   CynESC-OTZ4
AC   CVCL_WJ35
SY   OTZ4
DR   Wikidata; Q93465204
RX   PubMed=31005787;
CC   Group: Non-human primate cell line.
CC   Characteristics: Using CRISPR/Cas9 the stop codon of POU5F1 was replaced with a P2A-tdTomato-IRES-ZeocinR construct.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
HI   CVCL_WJ34 ! CynESC-3X
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   Cyno-1
AC   CVCL_XI34
SY   Cyno 1
DR   Wikidata; Q93465205
RX   Patent=US9249388;
RX   PubMed=14504386;
CC   Group: Non-human primate cell line.
CC   Characteristics: Established from parthenogenetically activated oocytes.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   CYNOM-K1
AC   CVCL_4157
SY   Cynom-K1; CYNOMK-1; CYNOMK1; CYNOM-1
DR   CLO; CLO_0002652
DR   CLDB; cl952
DR   ECACC; 90071809
DR   IZSLER; BS CL 221
DR   RCB; RCB0471
DR   Wikidata; Q54817108
RX   PubMed=28046048;
CC   Group: Non-human primate cell line.
CC   Virology: Susceptible to infection by poliovirus type 1, type 2 and type 3 (PubMed=28046048).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   80FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
ID   cynS-1
AC   CVCL_JG00
SY   cyfS-1; S-1
DR   JCRB; JCRB1698
DR   Wikidata; Q54817109
RX   PubMed=23792767;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   CypCa-CaudalFin
AC   CVCL_ZE18
DR   Wikidata; Q98125810
RX   DOI=10.20473/jipk.v12i1.17656;
CC   Group: Fish cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the cell line description.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
OI   CVCL_ZE19 ! CypCa-Gill
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 5
//
ID   CypCa-Gill
AC   CVCL_ZE19
DR   Wikidata; Q98125813
RX   DOI=10.20473/jipk.v12i1.17656;
CC   Group: Fish cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the cell line description.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
OI   CVCL_ZE18 ! CypCa-CaudalFin
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 5
//
ID   Cys-SN2(N3306)
AC   CVCL_A6XV
SY   N3306
DR   RCB; RCB4080
DR   Wikidata; Q107114765
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   Cys-SN2(N3312)
AC   CVCL_A6XW
SY   N3312
DR   RCB; RCB4081
DR   Wikidata; Q107114768
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   Cys-SN2(N3316)
AC   CVCL_A6XX
SY   N3316
DR   RCB; RCB4082
DR   Wikidata; Q107114769
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   Cys-SN2(N3323)
AC   CVCL_A6XY
SY   N3323
DR   RCB; RCB4083
DR   Wikidata; Q107114771
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9ULM6; Human CNOT6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Cys-SN2(N3331)
AC   CVCL_A6XZ
SY   N3331
DR   RCB; RCB4084
DR   Wikidata; Q107114773
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   Cys-SN2(N3338)
AC   CVCL_A6YA
SY   N3338
DR   RCB; RCB4085
DR   Wikidata; Q107114776
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   Cys-SN2(N3349)
AC   CVCL_A6YB
SY   N3349
DR   RCB; RCB4088
DR   Wikidata; Q107114779
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   Cys-SN2(N3372)
AC   CVCL_A6YC
SY   N3372
DR   RCB; RCB4089
DR   Wikidata; Q107114781
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   Cyt c-/-
AC   CVCL_6773
DR   CLO; CLO_0002653
DR   ATCC; CRL-2613
DR   Wikidata; Q54817110
RX   PubMed=10830166;
RX   PubMed=17210651;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88578; Cycs.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-9FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   CyT203
AC   CVCL_C078
SY   VIACe005-A
DR   hPSCreg; VIACe005-A
DR   SKIP; SKIP002093
DR   Wikidata; Q54817111
RX   PubMed=17053790;
RX   PubMed=18288110;
WW   Info; LifeMap Discovery; -; https://web.archive.org/web/20241223004921/https://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells/inner-cell-mass-homo-sapiens-cyt203-viacyte-novocell-san-diego-ca
CC   From: ViaCyte, Inc. (originally from CyThera, Novocell); San Diego; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): Novocell
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 14,15
ST   D21S11: 29,31.2
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,16
ST   FGA: 21,24
ST   Penta E: 7
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   CyT49
AC   CVCL_B850
SY   VCYTe001-A
DR   EFO; EFO_0007073
DR   BioSamples; SAMEA17469418
DR   ENCODE; ENCBS882LFH
DR   ENCODE; ENCBS976TXC
DR   GEO; GSM1548607
DR   GEO; GSM1548608
DR   hPSCreg; VCYTe001-A
DR   NIHhESC; NIHhESC-10-0041
DR   SKIP; SKIP002593
DR   Wikidata; Q54817112
RX   PubMed=18288110;
RX   PubMed=22623968;
RX   PubMed=28445466;
WW   Info; LifeMap Discovery; -; https://web.archive.org/web/20221104000358/https://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells/inner-cell-mass-homo-sapiens-cyt49-viacyte-novocell-san-diego-ca
CC   From: ViaCyte, Inc. (originally from CyThera, Novocell); San Diego; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0041.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): Novocell
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D21S11: 28
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12,16
ST   FGA: 21,23
ST   Penta E: 17,20
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Cyth25
AC   CVCL_B851
SY   Cyth 25; CyT25; Cyt25; SALKe001-A
DR   hPSCreg; SALKe001-A
DR   SKIP; SKIP002066
DR   Wikidata; Q54817113
RX   PubMed=16352714;
CC   From: ViaCyte, Inc. (originally from CyThera, Novocell); San Diego; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): Novocell
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,14
ST   D18S51: 14
ST   D21S11: 29,31.2
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta E: 16,20
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 14
//
ID   CZ-1
AC   CVCL_M489
DR   Wikidata; Q54817114
RX   PubMed=12482345;
RX   PubMed=14733786;
CC   Population: Chinese.
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: ~48 hours (PubMed=14733786).
CC   Caution: From the two papers we were not able to conclude whether two distinct cell lines were established (one from bone marrow the other from the peripheral blood) or only one.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   CZ0003
AC   CVCL_8U24
DR   ECACC; 98110401
DR   Wikidata; Q54817115
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,(t2;14)(p12;q32.1) (ECACC=98110401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98110401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   CZ0004
AC   CVCL_8U25
DR   ECACC; 03061023
DR   Wikidata; Q54817116
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03061023; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   CZ2
AC   CVCL_A1TW
DR   Wikidata; Q105506731
RX   PubMed=36819558;
CC   Population: Chinese.
CC   Characteristics: Does not secrete immunoglobulins.
CC   Doubling time: ~48 hours (PubMed=36819558).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   CZD82CH
AC   CVCL_WY26
DR   Wikidata; Q93465235
RX   PubMed=10987302;
RX   PubMed=12082606;
RX   PubMed=15574327;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   CZH1
AC   CVCL_D4ZB
DR   Wikidata; Q127380733
RX   PubMed=38280070;
CC   Population: Chinese.
CC   Doubling time: ~20 hours (PubMed=38280070).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=38280070).
CC   Omics: Genomics; Whole exome sequencing.
CC   Donor information: Established from a patient that had an extensive smoking history, averaging 40 cigarettes per day over 40 years (PubMed=38280070).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
ST   Source(s): PubMed=38280070
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D6S1043: 18,19
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 24,26
ST   Penta D: 8,13
ST   Penta E: 10,11,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   D
AC   CVCL_IZ09
DR   DGRC; 13
DR   FlyBase_Cell_line; FBtc0000013
DR   Wikidata; Q54817117
RX   PubMed=98714;
RX   PubMed=17890361;
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 13; probable.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z708 ! 1182-4H
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   D 14
AC   CVCL_J750
SY   D14; M-8
DR   CLO; CLO_0002654
DR   Wikidata; Q54817118
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8439.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   D(Mh11)1
AC   CVCL_DD18
SY   D(MH11)1
DR   Wikidata; Q54817145
RX   Patent=US5543319;
RX   PubMed=8563756;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11866.
CC   Characteristics: Contains human chromosome 11.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0249 ! DT40
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 6
//
ID   D-11
AC   CVCL_2012
DR   CLO; CLO_0002660
DR   CLDB; cl953
DR   DSMZ; ACC-77
DR   DSMZCellDive; ACC-77
DR   Wikidata; Q54817119
RX   PubMed=28374170;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Oncorhynchus mykiss (trout) origin but found to be from Oncorhynchus tshawytscha (DSMZ=ACC-77).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00582.
CC   Doubling time: ~80 hours (DSMZ=ACC-77).
CC   Discontinued: DSMZ; ACC-77; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
HI   CVCL_4607 ! R1 [Oncorhynchus]
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   D-164
AC   CVCL_C8A4
SY   D164
DR   Wikidata; Q123031150
RX   PubMed=13731272;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U965 ! D-189
OI   CVCL_C8A5 ! D-227
SX   Male
AG   4D
CA   Undefined cell line type
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   D-17
AC   CVCL_1916
SY   D 17; D17; OSA-D-17
DR   BTO; BTO_0005354
DR   CLO; CLO_0002655
DR   CLO; CLO_0002664
DR   CLO; CLO_0002665
DR   CLO; CLO_0002666
DR   CLDB; cl954
DR   CLDB; cl955
DR   ATCC; CCL-183
DR   ATCC; CRL-6248
DR   BCRJ; 0276
DR   ECACC; 89090403
DR   GEO; GSM1974785
DR   IZSLER; BS TCL 15
DR   NCBI_Iran; C625
DR   TOKU-E; 1025
DR   Wikidata; Q54817120
RX   PubMed=19147538;
RX   PubMed=21552385;
RX   PubMed=21801068;
RX   PubMed=21908323;
RX   PubMed=22849686;
RX   PubMed=22916246;
RX   PubMed=23365669;
RX   PubMed=25190452;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
RX   PubMed=33126659;
RX   PubMed=34079834;
CC   Part of: FACC canine tumor cell line panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8468.
CC   Doubling time: 22.2 hours (PubMed=22916246); 22 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Glu63Lys (c.187G>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-6248; true.
CC   Discontinued: ECACC; 89090403; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231,239
ST   Dog FHC2054: 156
ST   Dog FHC2079: 275
ST   Dog PEZ1: 127
ST   Dog PEZ3: 127
ST   Dog PEZ5: 103
ST   Dog PEZ6: 179
ST   Dog PEZ8: 232
ST   Dog PEZ12: 263,290
ST   Dog PEZ20: 172,180
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   D-189
AC   CVCL_U965
SY   D189; MaVar
DR   Wikidata; Q54817121
RX   PubMed=13298708;
RX   PubMed=13731272;
RX   PubMed=14415447;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8A4 ! D-164
OI   CVCL_C8A5 ! D-227
SX   Male
AG   4D
CA   Undefined cell line type
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   D-18MG
AC   CVCL_5G62
SY   D-18 MG; D18MG
DR   Wikidata; Q54817122
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=6260907;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   D-227
AC   CVCL_C8A5
SY   D227
DR   Wikidata; Q123031151
RX   PubMed=13731272;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8A4 ! D-164
OI   CVCL_U965 ! D-189
SX   Male
AG   4D
CA   Undefined cell line type
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   D-245MG
AC   CVCL_1152
SY   D-245 MG; D245 MG; D245MG
DR   ArrayExpress; E-MTAB-783
DR   cancercelllines; CVCL_1152
DR   Cell_Model_Passport; SIDM01021
DR   Cosmic; 946366
DR   Cosmic; 2367512
DR   Cosmic-CLP; 946366
DR   DepMap; ACH-002223
DR   GEO; GSM1669714
DR   IARC_TP53; 27553
DR   PRIDE; PXD030304
DR   Wikidata; Q54817123
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2253244;
RX   PubMed=2881426;
RX   PubMed=3675803;
RX   PubMed=9220028;
RX   PubMed=10402232;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 44.10 hours (PubMed=2881426).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.72%; Native American=1.42%; East Asian, North=0.26%; East Asian, South=0.81%; South Asian=1.32%; European, North=65.72%; European, South=28.76% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946366
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 9,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   D-247MG
AC   CVCL_1153
SY   D-247 MG; D-247-MG; D247MG
DR   CLO; CLO_0009883
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1153
DR   Cell_Model_Passport; SIDM00622
DR   ChEMBL-Cells; CHEMBL3308542
DR   ChEMBL-Targets; CHEMBL2366237
DR   Cosmic; 849881
DR   Cosmic; 946367
DR   Cosmic; 2367513
DR   Cosmic-CLP; 946367
DR   DepMap; ACH-002224
DR   EGA; EGAS00001000978
DR   GDSC; 946367
DR   GEO; GSM1669715
DR   IARC_TP53; 23118
DR   IARC_TP53; 27689
DR   LINCS_LDP; LCL-1370
DR   PharmacoDB; D247MG_271_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1153
DR   Wikidata; Q54817124
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2881426;
RX   PubMed=3675803;
RX   PubMed=9220028;
RX   PubMed=9842975;
RX   PubMed=10402232;
RX   PubMed=10416987;
RX   PubMed=11351043;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=20164919;
RX   PubMed=22570425;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 30.17 hours (PubMed=2881426); 42 hours (PubMed=9842975).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.210-1G>C; ClinVar=VCV000428260; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=946367; DepMap=ACH-002224).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=14614447).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.5%; East Asian, North=0%; East Asian, South=0%; South Asian=1.46%; European, North=67.83%; European, South=30.2% (PubMed=30894373).
CC   Misspelling: D24.7; PubMed=11351043.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946367; PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D18S51: 15,17
ST   D21S11: 30
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 9,13
ST   D8S1179: 15
ST   FGA: 24,27
ST   Penta D: 11,12
ST   Penta E: 13,18
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   D-259MG
AC   CVCL_5G57
SY   D-259 MG; D259MG
DR   Wikidata; Q54817125
RX   PubMed=2881426;
RX   PubMed=3011240;
RX   PubMed=3563490;
RX   PubMed=3675803;
RX   PubMed=8204491;
CC   Doubling time: 46.30 hours (PubMed=2881426).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   D-263MG
AC   CVCL_1154
SY   D-263 MG; D263MG
DR   CLO; CLO_0009884
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1154
DR   Cell_Model_Passport; SIDM00732
DR   ChEMBL-Cells; CHEMBL3308255
DR   ChEMBL-Targets; CHEMBL2366183
DR   Cosmic; 946368
DR   Cosmic; 2367514
DR   Cosmic-CLP; 946368
DR   DepMap; ACH-002225
DR   EGA; EGAS00001000978
DR   GDSC; 946368
DR   GEO; GSM1669716
DR   IARC_TP53; 27148
DR   LINCS_LDP; LCL-1371
DR   PharmacoDB; D263MG_272_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1154
DR   Wikidata; Q54817126
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2881426;
RX   PubMed=3011240;
RX   PubMed=3675803;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 30.77 hours (PubMed=2881426).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu314Asnfs*3 (c.940del); Zygosity=Heterozygous (Cosmic-CLP=946368; DepMap=ACH-002225).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (Cosmic-CLP=946368; DepMap=ACH-002225).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=1.08%; East Asian, North=0.75%; East Asian, South=0%; South Asian=2.84%; European, North=63.92%; European, South=31.01% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946368
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   D-270MG
AC   CVCL_S751
SY   D-270 MG; D270MG
DR   EFO; EFO_0022577
DR   Wikidata; Q54817127
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2253244;
RX   PubMed=3011240;
RX   PubMed=9220028;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 13
//
ID   D-32MG
AC   CVCL_S463
SY   D-32 MG; D32MG
DR   Wikidata; Q54817128
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=3675803;
RX   PubMed=6260907;
RX   PubMed=6652614;
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   D-32MGCl2
AC   CVCL_S464
SY   D-32 MGCl2; D-32 MG C2; D-32Cl2MG
DR   Wikidata; Q54817129
RX   PubMed=3675803;
RX   PubMed=6260907;
RX   PubMed=6652614;
RX   PubMed=10402232;
CC   Misspelling: D-32C12MG; PubMed=10402232; Note=In text.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S463 ! D-32MG
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   D-336MG
AC   CVCL_1156
SY   D-336 MG; D336MG
DR   CLO; CLO_0009885
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1156
DR   Cell_Model_Passport; SIDM00620
DR   ChEMBL-Cells; CHEMBL3308844
DR   ChEMBL-Targets; CHEMBL2366113
DR   Cosmic; 946369
DR   Cosmic; 2367515
DR   Cosmic-CLP; 946369
DR   DepMap; ACH-002226
DR   EGA; EGAS00001000978
DR   GDSC; 946369
DR   GEO; GSM1669718
DR   IARC_TP53; 27149
DR   LINCS_LDP; LCL-1372
DR   PharmacoDB; D336MG_274_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1156
DR   Wikidata; Q54817130
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2253244;
RX   PubMed=10402232;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (Cosmic-CLP=946369).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.62%; Native American=0.37%; East Asian, North=0.73%; East Asian, South=0%; South Asian=1.2%; European, North=68.29%; European, South=28.79% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946369
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   D-36
AC   CVCL_2013
AS   CVCL_7258
SY   D36
DR   CLO; CLO_0002678
DR   CLDB; cl956
DR   DSMZ; ACC-184
DR   DSMZCellDive; ACC-184
DR   Wikidata; Q54817131
RX   PubMed=8288894;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=D36
CC   Characteristics: IL10 dependent.
CC   Doubling time: ~25 hours (DSMZ=ACC-184).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   D-37MG
AC   CVCL_5734
SY   D-37 MG; D37MG
DR   Wikidata; Q54817132
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2253244;
RX   PubMed=3675803;
RX   PubMed=6260907;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   D-392MG
AC   CVCL_1158
SY   D-392 MG; D392MG
DR   CLO; CLO_0009886
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1158
DR   Cell_Model_Passport; SIDM00542
DR   ChEMBL-Cells; CHEMBL3308256
DR   ChEMBL-Targets; CHEMBL2366161
DR   Cosmic; 946370
DR   Cosmic; 2367516
DR   Cosmic-CLP; 946370
DR   DepMap; ACH-002227
DR   EGA; EGAS00001000978
DR   GDSC; 946370
DR   GEO; GSM1669719
DR   IARC_TP53; 27554
DR   LINCS_LDP; LCL-1373
DR   PharmacoDB; D392MG_275_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1158
DR   Wikidata; Q54817133
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.22%; Native American=0%; East Asian, North=2.63%; East Asian, South=0%; South Asian=0%; European, North=64.41%; European, South=31.73% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946370
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,14
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   D-397MG
AC   CVCL_1159
SY   D397MG
DR   ArrayExpress; E-MTAB-783
DR   Cosmic; 946371
DR   Cosmic; 2367517
DR   IARC_TP53; 27150
DR   Wikidata; Q54817134
RX   PubMed=20164919;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   D-423MG
AC   CVCL_1160
SY   D-423 MG; D423MG
DR   CLO; CLO_0009887
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 852
DR   cancercelllines; CVCL_1160
DR   Cell_Model_Passport; SIDM00209
DR   ChEMBL-Cells; CHEMBL3308257
DR   ChEMBL-Targets; CHEMBL2366134
DR   Cosmic; 946372
DR   Cosmic; 2367518
DR   Cosmic-CLP; 946372
DR   DepMap; ACH-002228
DR   EGA; EGAS00001000978
DR   GDSC; 946372
DR   GEO; GSM1669720
DR   IARC_TP53; 27151
DR   LINCS_LDP; LCL-1374
DR   PharmacoDB; D423MG_276_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1160
DR   Wikidata; Q54817135
RX   PubMed=10402232;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (Cosmic-CLP=946372; DepMap=ACH-002228).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (Cosmic-CLP=946372; DepMap=ACH-002228).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.32%; East Asian, North=1.3%; East Asian, South=1.42%; South Asian=0.18%; European, North=68.67%; European, South=28.1% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946372
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   D-431
AC   CVCL_DG16
SY   D431
DR   GEO; GSM114609
DR   Wikidata; Q54817136
RX   PubMed=16966431;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   D-450MG
AC   CVCL_C8E3
DR   Wikidata; Q123031152
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   D-502MG
AC   CVCL_1162
SY   D-502 MG; D502MG
DR   CLO; CLO_0009888
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 853
DR   cancercelllines; CVCL_1162
DR   Cell_Model_Passport; SIDM00208
DR   ChEMBL-Cells; CHEMBL3308258
DR   ChEMBL-Targets; CHEMBL2366343
DR   Cosmic; 946373
DR   Cosmic; 2367519
DR   Cosmic-CLP; 946373
DR   DepMap; ACH-002229
DR   EGA; EGAS00001000978
DR   GDSC; 946373
DR   GEO; GSM1669721
DR   IARC_TP53; 27555
DR   LINCS_LDP; LCL-1375
DR   PharmacoDB; D502MG_277_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1162
DR   Wikidata; Q54817137
RX   PubMed=10402232;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.57%; Native American=0%; East Asian, North=0.87%; East Asian, South=0.42%; South Asian=0%; European, North=69.07%; European, South=29.07% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946373
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   D-538MG
AC   CVCL_1163
SY   D538MG
DR   ArrayExpress; E-MTAB-783
DR   Cosmic; 946376
DR   Cosmic; 2367520
DR   IARC_TP53; 27556
DR   Wikidata; Q54817138
RX   PubMed=20164919;
RX   PubMed=23637631;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1001; BCL6 + HGNC; HGNC:9829; RAF1; Name(s)=BCL6-RAF1 (PubMed=23637631).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   D-542MG
AC   CVCL_1164
SY   D542MG
DR   CLO; CLO_0009889
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 854
DR   cancercelllines; CVCL_1164
DR   Cell_Model_Passport; SIDM00207
DR   ChEMBL-Cells; CHEMBL3308259
DR   ChEMBL-Targets; CHEMBL2366208
DR   Cosmic; 753549
DR   Cosmic; 2367521
DR   Cosmic-CLP; 753549
DR   DepMap; ACH-002230
DR   EGA; EGAS00001000978
DR   GDSC; 753549
DR   GEO; GSM1669722
DR   IARC_TP53; 21297
DR   LINCS_LDP; LCL-1376
DR   PharmacoDB; D542MG_278_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1164
DR   Wikidata; Q54817139
RX   PubMed=10402232;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Asian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg335Ter (c.1003C>T); ClinVar=VCV000007833; Zygosity=Homozygous (Cosmic-CLP=753549; DepMap=ACH-002230).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg556Ter (c.1666C>T); ClinVar=VCV000013090; Zygosity=Homozygous (Cosmic-CLP=753549; DepMap=ACH-002230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (Cosmic-CLP=753549; DepMap=ACH-002230).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.45%; Native American=2.46%; East Asian, North=53.35%; East Asian, South=39.58%; South Asian=0%; European, North=1%; European, South=3.16% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=753549
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10
ST   D16S539: 10,13
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU88 ! L542
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   D-54MG
AC   CVCL_5735
AS   CVCL_7185
SY   D-54 MG; D54-MG; D54MG; D54Mg; D54; H54
DR   BTO; BTO_0005364
DR   EFO; EFO_0002782
DR   BioSample; SAMN06481110
DR   ChEMBL-Cells; CHEMBL3308484
DR   ChEMBL-Targets; CHEMBL612247
DR   Cosmic; 970092
DR   Cosmic; 1672410
DR   ENCODE; ENCBS173AAA
DR   GEO; GSM816668
DR   GEO; GSM881397
DR   GEO; GSM881398
DR   IARC_TP53; 23935
DR   Lonza; 684
DR   PubChem_Cell_line; CVCL_7185
DR   TOKU-E; 3722
DR   Wikidata; Q54817140
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=3178168;
RX   PubMed=3675803;
RX   PubMed=6260907;
RX   PubMed=9090379;
RX   PubMed=9220028;
RX   PubMed=10402232;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/D54_Crawford_protocol.pdf
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a A-172 derivative (ICLAC; personal communication of Bigner, Darell Doty). Originally thought to originate from a 39 year old female patient with a glioblastoma.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00505.
CC   Population: Caucasian.
CC   Doubling time: 40.0 +- 3.6 hours (Note=In serum-supplemented media), 46.0 +- 0.7 hours (Note=In serum-free media) (PubMed=3178168).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=9090379).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Miscellaneous: STR profile from personal communication of Bigner, Darell Doty.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 12,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 20,21
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0131 ! A-172
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   D-566MG
AC   CVCL_1166
SY   D566MG
DR   CLO; CLO_0009890
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1166
DR   Cell_Model_Passport; SIDM00206
DR   ChEMBL-Cells; CHEMBL3308543
DR   ChEMBL-Targets; CHEMBL2366336
DR   Cosmic; 946377
DR   Cosmic; 2367522
DR   Cosmic-CLP; 946377
DR   DepMap; ACH-002231
DR   EGA; EGAS00001000978
DR   GDSC; 946377
DR   GEO; GSM1669723
DR   IARC_TP53; 27152
DR   LINCS_LDP; LCL-1377
DR   PharmacoDB; D566MG_279_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1166
DR   Wikidata; Q54817141
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Ile941Serfs*13 (c.2820delC); Zygosity=Heterozygous (Cosmic-CLP=946377).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg335Ter (c.1003C>T); ClinVar=VCV000007833; Zygosity=Homozygous (Cosmic-CLP=946377; DepMap=ACH-002231).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (DepMap=ACH-002231).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.2%; Native American=0.49%; East Asian, North=0%; East Asian, South=1.47%; South Asian=0%; European, North=67.4%; European, South=30.44% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=946377
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   D-65MG
AC   CVCL_5736
SY   D-65 MG; D65MG
DR   Wikidata; Q54817142
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=3675803;
RX   PubMed=6260907;
RX   PubMed=6652614;
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   D-Meso-Sonobe
AC   CVCL_E2T6
SY   HS-Meso-1; Deciduoid-Mesothelioma established by Sonobe
RX   CelloPub=CLPUB00774;
RX   PubMed=38598046;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Unspecified (CelloPub=CLPUB00774; PubMed=38598046).
CC   Donor information: No history of asbestos exposure (CelloPub=CLPUB00774).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=38598046
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 8,11
ST   D18S51: 13,14
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8
ST   FGA: 18,19
ST   Penta D: 11
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   D-PTC
AC   CVCL_W336
DR   Wikidata; Q54817143
RX   PubMed=24567186;
CC   Population: Japanese.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   D-RHA1
AC   CVCL_S635
SY   D-RHA-1
DR   Cosmic; 802043
DR   Wikidata; Q54817144
RX   PubMed=23882450;
CC   From: Benedict, William F.; University of Texas M.D. Anderson Cancer Center; Houston; USA.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   D01
AC   CVCL_DH62
SY   D01-JEB
DR   cancercelllines; CVCL_DH62
DR   Cosmic; 2465279
DR   GEO; GSM170853
DR   GEO; GSM217356
DR   Progenetix; CVCL_DH62
DR   Wikidata; Q54817146
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=17363583; PubMed=22383533; PubMed=23890154).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   D03
AC   CVCL_DH63
DR   cancercelllines; CVCL_DH63
DR   GEO; GSM217357
DR   Progenetix; CVCL_DH63
DR   Wikidata; Q54817147
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   D04
AC   CVCL_H604
SY   DO4; D04M
DR   EFO; EFO_0022367
DR   cancercelllines; CVCL_H604
DR   ChEMBL-Cells; CHEMBL3307582
DR   ChEMBL-Targets; CHEMBL614287
DR   Cosmic; 888991
DR   GEO; GSM78836
DR   GEO; GSM78837
DR   GEO; GSM78838
DR   GEO; GSM162938
DR   GEO; GSM217358
DR   GEO; GSM4178088
DR   Progenetix; CVCL_H604
DR   PubChem_Cell_line; CVCL_H604
DR   Wikidata; Q54817150
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 20
//
ID   D05
AC   CVCL_H607
SY   D05M1
DR   cancercelllines; CVCL_H607
DR   Cosmic; 888992
DR   Cosmic; 1996409
DR   GEO; GSM162939
DR   GEO; GSM217359
DR   GEO; GSM4178089
DR   Progenetix; CVCL_H607
DR   Wikidata; Q54817151
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   D08
AC   CVCL_H608
SY   D08M
DR   cancercelllines; CVCL_H608
DR   Cosmic; 888993
DR   GEO; GSM170855
DR   GEO; GSM217360
DR   GEO; GSM4178090
DR   Progenetix; CVCL_H608
DR   Wikidata; Q54817152
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   D1 [Drosophila]
AC   CVCL_Z863
SY   Dubendorfer's line 1
DR   DGRC; 10
DR   ECACC; 90070552
DR   FlyBase_Cell_line; FBtc0000010
DR   Wikidata; Q54817153
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 23-34 hours (Note=Depending on growth medium) (DGRC=10).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 90070552; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-S.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   D1 [Human Dravet fibroblast]
AC   CVCL_A3YP
DR   Wikidata; Q105506732
RX   PubMed=25732146;
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Arg862Ter (c.2584C>T); ClinVar=VCV000189857; Zygosity=Heterozygous (PubMed=25732146).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   D1 [Mouse thymocyte]
AC   CVCL_S911
DR   Wikidata; Q54817154
RX   PubMed=10588730;
RX   PubMed=12609543;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=D1
CC   Characteristics: IL7 dependent. Withdrawal of IL7 induces arrest in G1 phase of the cell cycle, followed by apoptosis (PubMed=12609543).
CC   Characteristics: Does not express CD4 and CD8 (PubMed=12609543).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Thymocyte; CL=CL_0000893.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   D1 ORL UVA
AC   CVCL_6495
SY   D1
DR   CLO; CLO_0002657
DR   ATCC; CRL-12424
DR   Lonza; 960
DR   Wikidata; Q54817155
RX   Patent=US6082364;
RX   PubMed=8419395;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12424.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_DC09 ! D2 [Mouse bone marrow]
SX   Sex unspecified
AG   8W
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   D1-11A9
AC   CVCL_E3YT
RX   PubMed=9064283;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   D1-12F6
AC   CVCL_E3YU
RX   PubMed=9064283;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   D1-4G2-4-15
AC   CVCL_J890
DR   CLO; CLO_0002662
DR   ABCD; ABCD_AD831
DR   ATCC; HB-112
DR   BCRJ; 0268
DR   Wikidata; Q54817157
RX   PubMed=6285749;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P12823; Dengue virus type 2 genome protein (Note=AA281-775 = Envelope protein E).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   D1-HEK-293
AC   CVCL_9867
SY   D1HEK293; D1 HEK293
DR   BTO; BTO_0004075
DR   Wikidata; Q54817159
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3020; DRD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   D1-iPSC-1
AC   CVCL_C640
DR   Wikidata; Q54817160
RX   PubMed=21339753;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2888; DISC1; Simple; p.Ile808Serfs*816 (c.2420_2423delTCAT); Zygosity=Heterozygous (PubMed=21339753).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL25 ! D1-iPSC-2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   D1-iPSC-2
AC   CVCL_VL25
DR   Wikidata; Q93465400
RX   PubMed=21339753;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2888; DISC1; Simple; p.Ile808Serfs*816 (c.2420_2423delTCAT); Zygosity=Heterozygous (PubMed=21339753).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C640 ! D1-iPSC-1
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   D10
AC   CVCL_H945
SY   D10M
DR   cancercelllines; CVCL_H945
DR   Cosmic; 888994
DR   Cosmic; 1206010
DR   GEO; GSM169531
DR   GEO; GSM217361
DR   GEO; GSM4178091
DR   Progenetix; CVCL_H945
DR   Wikidata; Q54817161
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   D10/4
AC   CVCL_A0QA
DR   Wikidata; Q108820127
RX   PubMed=2146321;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00746; Human CFD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   D1008L
AC   CVCL_U102
DR   Wikidata; Q54817162
RX   PubMed=12114371;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*40:02,51:01; C*03:04,14:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   D10G41
AC   CVCL_0241
SY   D10.G4.1; D10
DR   CLO; CLO_0002659
DR   EFO; EFO_0002822
DR   MCCL; MCC:0000131
DR   CLDB; cl969
DR   ATCC; TIB-224
DR   BioSample; SAMN11397660
DR   DSMZ; ACC-45
DR   DSMZCellDive; ACC-45
DR   Wikidata; Q54817163
RX   PubMed=2953804;
RX   PubMed=6193236;
RX   PubMed=31220119;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: IL1A or IL1B dependent.
CC   Characteristics: Used extensively to study activation of T-cells (ATCC=TIB-224).
CC   Doubling time: ~30 hours (DSMZ=ACC-45).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: CD4-positive helper T cell; CL=CL_0000492.
CC   Breed/subspecies: AKR/J.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 14
ST   Mouse STR 1-2: 12,13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 10
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 11
ST   Mouse STR 6-4: 17,18,19
ST   Mouse STR 6-7: 16,17
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16,17,18,19
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 14,15
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16,17,18
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   D10S
AC   CVCL_HE72
DR   Wikidata; Q54817164
RX   PubMed=2535250;
CC   Characteristics: IL1A or IL1B dependent.
CC   Characteristics: Can be maintained without feeder layers and proliferates to subfemtomolar concentrations of recombinant human IL1 in the absence of mitogens or antigens (PubMed=2535250).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: CD4-positive helper T cell; CL=CL_0000492.
CC   Breed/subspecies: AKR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0241 ! D10G41
SX   Male
AG   Adult
CA   Factor-dependent cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 5
//
ID   D11
AC   CVCL_H946
DR   cancercelllines; CVCL_H946
DR   Cosmic; 888995
DR   Cosmic; 1206008
DR   Cosmic; 1211156
DR   GEO; GSM169530
DR   GEO; GSM217362
DR   Progenetix; CVCL_H946
DR   Wikidata; Q54817165
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Unspecified (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4KM ! D11-M2
OI   CVCL_B4KN ! D11-M3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   D11-M2
AC   CVCL_B4KM
SY   D11M2
DR   cancercelllines; CVCL_B4KM
DR   GEO; GSM4178092
DR   Wikidata; Q110432760
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H946 ! D11
OI   CVCL_B4KN ! D11-M3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   D11-M3
AC   CVCL_B4KN
DR   cancercelllines; CVCL_B4KN
DR   Wikidata; Q110432761
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H946 ! D11
OI   CVCL_B4KM ! D11-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   D11G10
AC   CVCL_CY53
DR   Wikidata; Q54817166
RX   PubMed=512581;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27731; Asialo-GM2 ganglioside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 5
//
ID   D12
AC   CVCL_AQ01
DR   ATCC; CRL-3280
DR   Wikidata; Q54817167
RX   PubMed=22796012;
CC   Derived from site: In situ; Inguinal fat pad, adipose tissue; UBERON=UBERON_0010410+UBERON_0001013.
CC   Cell type: Beige adipocyte; CL=CL_0001070.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7-9W
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   D12/DM
AC   CVCL_7257
DR   CLO; CLO_0002661
DR   CLDB; cl970
DR   ECACC; 94031007
DR   Wikidata; Q54817168
CC   Discontinued: ECACC; 94031007; true.
CC   Breed/subspecies: AKR.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   D122
AC   CVCL_0242
SY   3LL-D122; 3LLD122; 3LL clone D122; D122-84
DR   MCCL; MCC:0000132
DR   ChEMBL-Cells; CHEMBL3307891
DR   ChEMBL-Targets; CHEMBL614253
DR   PubChem_Cell_line; CVCL_0242
DR   Wikidata; Q54817169
RX   PubMed=3855489;
RX   PubMed=6490207;
RX   PubMed=8425771;
CC   Characteristics: High metastatic potential.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   D122-96
AC   CVCL_LD60
DR   Wikidata; Q54817170
RX   PubMed=10541048;
CC   Characteristics: High metastatic potential. Grows faster and is more metastatic than the parental cell line (PubMed=10541048).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0242 ! D122
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 6
//
ID   D12E9F11
AC   CVCL_XB21
DR   CCRID; 4201PAT-CCTCC00159
DR   Wikidata; Q93465443
RX   Patent=CN100376671C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200505.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03141; Hepatitis B virus genotype A2 subtype adw2 (strain Rutter 1979) envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   D13
AC   CVCL_Y039
DR   Cosmic; 686973
DR   Wikidata; Q54817171
RX   PubMed=12068308;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   D134
AC   CVCL_U814
DR   CLO; CLO_0050292
DR   RCB; RCB0644
DR   Wikidata; Q54817172
RX   DOI=10.1002/cm.970160108;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   D14
AC   CVCL_H944
DR   cancercelllines; CVCL_H944
DR   Cosmic; 888996
DR   Cosmic; 1996410
DR   GEO; GSM169529
DR   GEO; GSM217363
DR   Progenetix; CVCL_H944
DR   Wikidata; Q54817173
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4KP ! D14-M1
OI   CVCL_B4KQ ! D14-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   D14-M1
AC   CVCL_B4KP
DR   cancercelllines; CVCL_B4KP
DR   Wikidata; Q110432762
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H944 ! D14
OI   CVCL_B4KQ ! D14-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   D14-M2
AC   CVCL_B4KQ
SY   D14M2
DR   cancercelllines; CVCL_B4KQ
DR   GEO; GSM4178093
DR   Wikidata; Q110432763
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H944 ! D14
OI   CVCL_B4KP ! D14-M1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   D16 [Mouse fat cell]
AC   CVCL_AQ02
DR   ATCC; CRL-3281
DR   Wikidata; Q54817174
RX   PubMed=22796012;
CC   Derived from site: In situ; Inguinal fat pad, adipose tissue; UBERON=UBERON_0010410+UBERON_0001013.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7-9W
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   D16 [Mouse hybridoma against H.crassispina dynein IC3]
AC   CVCL_U815
DR   CLO; CLO_0050295
DR   RCB; RCB0654
DR   Wikidata; Q54817175
RX   DOI=10.1002/cm.970160108;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16960; Heliocidaris crassispina dynein intermediate chain 3, ciliary.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 8
//
ID   D17
AC   CVCL_H943
SY   D17M1
DR   cancercelllines; CVCL_H943
DR   Cosmic; 888997
DR   GEO; GSM169528
DR   GEO; GSM217364
DR   GEO; GSM4178094
DR   Progenetix; CVCL_H943
DR   Wikidata; Q54817176
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   D18
AC   CVCL_B4KG
DR   cancercelllines; CVCL_B4KG
DR   Wikidata; Q110432764
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Gly414Val (c.1241G>T); Zygosity=Heterozygous (PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   D18T
AC   CVCL_8669
DR   BioSample; SAMN03151676
DR   Wikidata; Q54817177
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00039.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   D19
AC   CVCL_H223
DR   Wikidata; Q54817178
RX   PubMed=10067924;
CC   Doubling time: 6.1 days (PubMed=10067924).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   D1902
AC   CVCL_A4VS
DR   Wikidata; Q107114783
RX   PubMed=27280270;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   D1903
AC   CVCL_A4VT
DR   Wikidata; Q107114785
RX   PubMed=27280270;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   D1904
AC   CVCL_A4VU
DR   Wikidata; Q107114787
RX   PubMed=27280270;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   D1906
AC   CVCL_A4VV
DR   Wikidata; Q107114789
RX   PubMed=27280270;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   D1911
AC   CVCL_A4VW
DR   Wikidata; Q107114791
RX   PubMed=27280270;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   D1B
AC   CVCL_3503
DR   CLO; CLO_0002667
DR   ATCC; TIB-56
DR   Wikidata; Q54817179
RX   PubMed=185295;
RX   PubMed=564410;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: Erythroid differentiation and hemoglobin synthesis are inducible by DMSO (ATCC=TIB-56).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 7
//
ID   D1F4
AC   CVCL_7184
SY   D1-F4
DR   Lonza; 1118
DR   Wikidata; Q54817180
RX   PubMed=11486081;
CC   Characteristics: IL7 dependent.
CC   Characteristics: Does not express CD4 and CD8 (from parent cell line).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Thymocyte; CL=CL_0000893.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S911 ! D1 [Mouse thymocyte]
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   D2 [Drosophila]
AC   CVCL_Z862
SY   Dubendorfer's line 2
DR   CLO; CLO_0002668
DR   CLDB; cl972
DR   ECACC; 90070546
DR   FlyBase_Cell_line; FBtc9000066
DR   Wikidata; Q54817181
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Discontinued: ECACC; 90070546; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-S.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   D2 [Human Dravet fibroblast]
AC   CVCL_A3YQ
DR   Wikidata; Q105506733
RX   PubMed=25732146;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Tyr1102Ter (c.3306C>A); ClinVar=VCV000217243; Zygosity=Heterozygous (PubMed=25732146).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   D2 [Mouse bone marrow]
AC   CVCL_DC09
DR   Wikidata; Q54817183
RX   Patent=WO1999065503A1;
RX   PubMed=8419395;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12501.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6495 ! D1 ORL UVA
SX   Sex unspecified
AG   8W
CA   Somatic stem cell
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   D2-1H4
AC   CVCL_E3YQ
SY   NKI-B20/1; 1H4
DR   ABCD; ABCD_AE708
RX   PubMed=9064283;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   D2-31-18-11
AC   CVCL_C5C1
SY   Garbu
DR   Wikidata; Q116048820
RX   PubMed=22741586;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18031; Human PTPN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   D2-4H
AC   CVCL_C0EB
DR   Wikidata; Q112929439
DR   Ximbio; 154000
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13688; Human CEACAM1/CD66a.
CC   Monoclonal antibody target: UniProtKB; P40198; Human CEACAM3/CD66d.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
CC   Monoclonal antibody target: UniProtKB; P40199; Human CEACAM6/CD66c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   D2-iPSC-1
AC   CVCL_C641
DR   Wikidata; Q54817184
RX   PubMed=21339753;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2888; DISC1; Simple; p.Ile808Serfs*816 (c.2420_2423delTCAT); Zygosity=Heterozygous (PubMed=21339753).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL26 ! D2-iPSC-2
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   D2-iPSC-2
AC   CVCL_VL26
DR   Wikidata; Q93465475
RX   PubMed=21339753;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2888; DISC1; Simple; p.Ile808Serfs*816 (c.2420_2423delTCAT); Zygosity=Heterozygous (PubMed=21339753).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C641 ! D2-iPSC-1
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   D2.0R
AC   CVCL_0I88
SY   D2.OR
DR   Wikidata; Q54817185
RX   PubMed=1586590;
RX   PubMed=8422701;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0I90 ! D2A1
OI   CVCL_0I91 ! D2F2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 4
//
ID   D2.1
AC   CVCL_0I89
DR   Wikidata; Q54817186
RX   PubMed=1586590;
RX   PubMed=8422701;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0I88 ! D2.0R
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 4
//
ID   D20
AC   CVCL_W869
SY   D20M
DR   cancercelllines; CVCL_W869
DR   Cosmic; 888998
DR   GEO; GSM169527
DR   GEO; GSM217837
DR   GEO; GSM4178095
DR   Progenetix; CVCL_W869
DR   Wikidata; Q54817187
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   D21
AC   CVCL_S349
DR   ATCC; CRL-6249
DR   Wikidata; Q54817188
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6249; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   D21-iPSC#1
AC   CVCL_B3LX
SY   AF4 iPS #12-2-C
DR   JCRB; JCRB1836
DR   Wikidata; Q110432765
RX   PubMed=30760866;
CC   Characteristics: While originating from a Down syndrome patient, this cell line has lost the extra copy of chromosome 21.
CC   Karyotypic information: 46,XX [17/20]; 45,X [1/20]; 45,XX,-12 [1/20]; 90,XXXX,-14,-17 [1/20] (JCRB=JCRB1836).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): JCRB=JCRB1836; PubMed=30760866
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 31,32
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 12,19
ST   TH01: 6,7
ST   TPOX: 10,12
ST   vWA: 14,19
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3M2 ! T21-iPSC#12
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
ID   D21-iPSC#2
AC   CVCL_B3MC
SY   AF4 iPS #12-2-D
DR   JCRB; JCRB1841
DR   Wikidata; Q110432766
RX   PubMed=30760866;
CC   Characteristics: While originating from a Down syndrome patient, this cell line has lost the extra copy of chromosome 21.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): PubMed=30760866
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 31,32
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 12,19
ST   TH01: 6,7
ST   TPOX: 10,12
ST   vWA: 14,19
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   D22 [Dog]
AC   CVCL_3458
DR   CLO; CLO_0002671
DR   ATCC; CRL-6250
DR   Wikidata; Q54817189
RX   PubMed=34079834;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-6250; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Border Collie; VBO=VBO_0200193.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   D22 [Human melanoma]
AC   CVCL_DH67
SY   D22M1
DR   cancercelllines; CVCL_DH67
DR   Cosmic; 1211158
DR   GEO; GSM169526
DR   GEO; GSM217838
DR   GEO; GSM4178096
DR   Progenetix; CVCL_DH67
DR   Wikidata; Q54817192
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Pro124Leu (c.371C>T); ClinVar=VCV000040744; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   D23
AC   CVCL_W870
SY   D23M
DR   cancercelllines; CVCL_W870
DR   Cosmic; 888999
DR   GEO; GSM78839
DR   GEO; GSM78840
DR   GEO; GSM78841
DR   GEO; GSM4178097
DR   Wikidata; Q54817193
RX   PubMed=15048078;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Val (c.1789C>G); ClinVar=VCV000013969; Zygosity=Unspecified (PubMed=15048078).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=22383533).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   D24 [Human melanoma]
AC   CVCL_W871
SY   D24M
DR   cancercelllines; CVCL_W871
DR   Cosmic; 889001
DR   GEO; GSM78842
DR   GEO; GSM78843
DR   GEO; GSM78844
DR   GEO; GSM169524
DR   GEO; GSM217839
DR   GEO; GSM4178098
DR   Progenetix; CVCL_W871
DR   Wikidata; Q54817195
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   D24 [Rat hybridoma against mouse Csf1]
AC   CVCL_8952
DR   CLO; CLO_0002672
DR   ATCC; CRL-2701
DR   Wikidata; Q54817196
RX   PubMed=2454994;
CC   Monoclonal antibody isotype: IgG1+IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07141; Mouse Csf1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   D25
AC   CVCL_W872
DR   cancercelllines; CVCL_W872
DR   Cosmic; 889002
DR   GEO; GSM169525
DR   GEO; GSM218513
DR   Progenetix; CVCL_W872
DR   Wikidata; Q54817197
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   D253-15-6
AC   CVCL_DA08
SY   CTCC 0087
DR   Wikidata; Q54817198
RX   Patent=US4677070;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8789.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8953 ! F3B6
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   D26
AC   CVCL_DH68
DR   Cosmic; 2013934
DR   Wikidata; Q54817199
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   D264
AC   CVCL_U816
DR   CLO; CLO_0050293
DR   RCB; RCB0646
DR   Wikidata; Q54817200
RX   DOI=10.1002/cm.970160108;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P39057; Heliocidaris crassispina dynein beta.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   D28
AC   CVCL_DH69
DR   cancercelllines; CVCL_DH69
DR   Cosmic; 2465280
DR   GEO; GSM170588
DR   GEO; GSM218518
DR   Progenetix; CVCL_DH69
DR   Wikidata; Q54817201
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=17363583; PubMed=22383533; PubMed=23890154).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Unspecified (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Pro124Leu (c.371C>T); ClinVar=VCV000040744; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   D283 Med
AC   CVCL_1155
SY   D283 MED; D283-MED; D283_Med; D-283 Med; D-283 Med-C; D-283MED; D283MED; D283Med; D283-Med; D-283; D283; Med 283; H283
DR   BTO; BTO_0005135
DR   CLO; CLO_0002673
DR   EFO; EFO_0002156
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-185
DR   BioGRID_ORCS_Cell_line; 438
DR   BioSample; SAMN03472736
DR   BioSample; SAMN10987924
DR   cancercelllines; CVCL_1155
DR   CCRID; 1101HUM-PUMC000341
DR   Cell_Model_Passport; SIDM00888
DR   ChEMBL-Cells; CHEMBL3307938
DR   ChEMBL-Targets; CHEMBL614476
DR   CLS; 300330
DR   Cosmic; 687772
DR   Cosmic; 906834
DR   Cosmic; 923656
DR   Cosmic; 973261
DR   Cosmic; 974280
DR   Cosmic; 975024
DR   Cosmic; 1995381
DR   Cosmic; 2362650
DR   Cosmic; 2731179
DR   Cosmic-CLP; 906834
DR   DepMap; ACH-000055
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10838-111E1
DR   GDSC; 906834
DR   GEO; GSM383762
DR   GEO; GSM482336
DR   GEO; GSM886969
DR   GEO; GSM888038
DR   GEO; GSM918116
DR   GEO; GSM919357
DR   GEO; GSM1234974
DR   GEO; GSM1234975
DR   GEO; GSM1669717
DR   IARC_TP53; 21296
DR   IGRhCellID; D283Med
DR   IZSLER; BS TCL 203
DR   KCB; KCB 2010201YJ
DR   LiGeA; CCLE_487
DR   LINCS_LDP; LCL-1577
DR   Lonza; 654
DR   PharmacoDB; D283MED_273_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1155
DR   PubChem_Cell_line; CVCL_1155
DR   Wikidata; Q54817202
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=1822845;
RX   PubMed=2180567;
RX   PubMed=3103453;
RX   PubMed=4056828;
RX   PubMed=12973738;
RX   PubMed=16946619;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=22460905;
RX   PubMed=24297863;
RX   PubMed=24300787;
RX   PubMed=27397505;
RX   PubMed=27498314;
RX   PubMed=27812533;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31963405;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.87%; Native American=0%; East Asian, North=1.34%; East Asian, South=0%; South Asian=0%; European, North=63.61%; European, South=33.18% (PubMed=30894373).
CC   Misspelling: D283 MR; Note=Occasionally.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=HTB-185; CCRID=1101HUM-PUMC000341; Cosmic-CLP=906834
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 28,30.2
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   Penta D: 9,13
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   D29
AC   CVCL_DH70
DR   cancercelllines; CVCL_DH70
DR   Cosmic; 1303035
DR   GEO; GSM170589
DR   GEO; GSM218523
DR   Progenetix; CVCL_DH70
DR   Wikidata; Q54817203
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   D2A1
AC   CVCL_0I90
DR   Wikidata; Q54817204
RX   PubMed=1586590;
RX   PubMed=2413152;
RX   PubMed=2790822;
RX   PubMed=8422701;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0I88 ! D2.0R
OI   CVCL_0I91 ! D2F2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 4
//
ID   D2F2
AC   CVCL_0I91
DR   Wikidata; Q54817205
RX   PubMed=1586590;
RX   PubMed=2413152;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0I88 ! D2.0R
OI   CVCL_0I90 ! D2A1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 4
//
ID   D2H
AC   CVCL_B4ZW
DR   Wikidata; Q110432767
RX   PubMed=22740294;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q4PRK9; Plasmodium vivax lactate dehydrogenase (PvLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   D2N
AC   CVCL_3504
DR   CLO; CLO_0002674
DR   ATCC; TIB-58
DR   Wikidata; Q54817206
RX   PubMed=185295;
RX   PubMed=564410;
RX   PubMed=6170720;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   D2SC/1
AC   CVCL_U653
SY   D2SC-1
DR   Lonza; 1302
DR   Wikidata; Q54817207
RX   Patent=US6156307;
RX   PubMed=8083532;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0C0N9; Avian retrovirus MH2 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   D2SC/1-CTLA4-Ig
AC   CVCL_U654
DR   Wikidata; Q54817208
RX   PubMed=10798768;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88556; Ctla4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0C0N9; Avian retrovirus MH2 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U653 ! D2SC/1
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   D3 [Human Dravet fibroblast]
AC   CVCL_A3YR
DR   Wikidata; Q105506736
RX   PubMed=25732146;
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Asp43Metfs*49 (c.126delA) (p.Lys42fs*50); ClinVar=VCV000496115; Zygosity=Heterozygous (PubMed=25732146).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   D3 [Human glioblastoma]
AC   CVCL_H222
DR   Wikidata; Q54817209
RX   PubMed=10067924;
CC   Doubling time: 2.8 days (PubMed=10067924).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   D3 [Mouse hybridoma against chicken NCAM1]
AC   CVCL_2014
DR   CLO; CLO_0002675
DR   DSMZ; ACC-428
DR   DSMZCellDive; ACC-428
DR   Wikidata; Q54817210
RX   PubMed=2462022;
CC   Doubling time: ~22 hours (DSMZ=ACC-428).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13590; Chicken NCAM1 (Note=Also reacts with human, mouse and other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   D3-2H2-9-21
AC   CVCL_J891
DR   CLO; CLO_0002676
DR   ATCC; HB-114
DR   Wikidata; Q54817211
RX   PubMed=6285749;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   D3-DC-Fibroblast
AC   CVCL_D6WE
CC   Miscellaneous: Cell line information from personal communication of Massaro, Angelo.
CC   Derived from site: In situ; Colon, mucosa, lamina propria; UBERON=UBERON_0007177.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   D3/71
AC   CVCL_E9DX
DR   ABCD; ABCD_AU891
RX   PubMed=30667360;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1.
CC   Miscellaneous: Because this hybridoma was no longer viable, a new recombinant mAB (D73/71R) was created de novo using the RNA sequence from a cryopreserved vial of D3/71 hybridoma cells (PubMed=30667360).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   D30
AC   CVCL_DH71
DR   cancercelllines; CVCL_DH71
DR   GEO; GSM218524
DR   Progenetix; CVCL_DH71
DR   Wikidata; Q54817212
RX   PubMed=17363583;
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   D308
AC   CVCL_U817
DR   CLO; CLO_0050294
DR   RCB; RCB0648
DR   Wikidata; Q54817213
RX   DOI=10.1002/cm.970160108;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P39057; Heliocidaris crassispina dynein beta.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   D32
AC   CVCL_DH72
SY   D32M
DR   cancercelllines; CVCL_DH72
DR   GEO; GSM171597
DR   GEO; GSM218983
DR   GEO; GSM4178099
DR   Progenetix; CVCL_DH72
DR   Wikidata; Q54817214
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   D33-3
AC   CVCL_9084
DR   Wikidata; Q54817215
RX   PubMed=8137818;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   D33C
AC   CVCL_C8Z8
DR   Wikidata; Q123031153
RX   PubMed=1693151;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   D34
AC   CVCL_HF98
DR   CancerTools; 152857
DR   Wikidata; Q54817216
DR   Ximbio; 152857
RX   PubMed=12183435;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C36262; Oral cavity leukoplakia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   D341 Med
AC   CVCL_0018
SY   D-341 Med; D-341 MED; D-341 Med-C; D-341Med; D-341MED; D341_Med; D341Med; D341MED; D341MD; D-341; D341; Med 341; H341
DR   CLO; CLO_0002677
DR   EFO; EFO_0002157
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-187
DR   BioGRID_ORCS_Cell_line; 689
DR   BioSample; SAMN03472737
DR   BioSample; SAMN10988120
DR   cancercelllines; CVCL_0018
DR   CCRID; 1101HUM-PUMC000102
DR   Cell_Model_Passport; SIDM01492
DR   ChEMBL-Cells; CHEMBL3308450
DR   ChEMBL-Targets; CHEMBL614478
DR   CLS; 305136
DR   Cosmic; 923657
DR   Cosmic; 973263
DR   Cosmic; 974282
DR   Cosmic; 975025
DR   Cosmic; 1097759
DR   Cosmic; 2362652
DR   Cosmic; 2731178
DR   Cosmic; 2772984
DR   DepMap; ACH-000095
DR   ENCODE; ENCBS254AAA
DR   GEO; GSM383763
DR   GEO; GSM482333
DR   GEO; GSM827339
DR   GEO; GSM886970
DR   GEO; GSM888039
DR   GEO; GSM918117
DR   GEO; GSM919358
DR   GEO; GSM1008577
DR   IARC_TP53; 30029
DR   IGRhCellID; D341Med
DR   KCB; KCB 2010239YJ
DR   LiGeA; CCLE_586
DR   PharmacoDB; D341Med_280_2019
DR   Progenetix; CVCL_0018
DR   PubChem_Cell_line; CVCL_0018
DR   Wikidata; Q54817217
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=1822845;
RX   PubMed=2180567;
RX   PubMed=3279793;
RX   PubMed=8275086;
RX   PubMed=16957166;
RX   PubMed=20215515;
RX   PubMed=20847082;
RX   PubMed=22460905;
RX   PubMed=27498314;
RX   PubMed=27812533;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31963405;
WW   Info; ATCC; -; https://web.archive.org/web/20160611152450/http://www.atcc.org:80/products/all/HTB-187.aspx#specifications
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/MedulloD341_Crawford_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Doubling time: 37 hours (ATCC=HTB-187).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.21%; East Asian, South=0%; South Asian=0.49%; European, North=68.21%; European, South=30.09% (PubMed=30894373).
CC   Miscellaneous: The values for the STR markers F13A01, F13B, FESFPS and LPL used to be shown on the ATCC website but are no longer displayed (see Internet archive link for archival version).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
ST   Source(s): ATCC=HTB-187; CCRID=1101HUM-PUMC000102
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12,14
ST   D18S51: 12,17
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   D8S1179: 14
ST   F13A01: 6,7
ST   F13B: 8,10
ST   FESFPS: 10,13
ST   FGA: 19,23
ST   LPL: 11
ST   Penta D: 9,13
ST   Penta E: 8,15
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   D35
AC   CVCL_DG37
SY   D35M1
DR   cancercelllines; CVCL_DG37
DR   Cosmic; 1996411
DR   GEO; GSM170590
DR   GEO; GSM218993
DR   GEO; GSM4178100
DR   Progenetix; CVCL_DG37
DR   Wikidata; Q54817218
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   D36
AC   CVCL_DH73
SY   D36M
DR   cancercelllines; CVCL_DH73
DR   Cosmic; 1996412
DR   GEO; GSM170591
DR   GEO; GSM219002
DR   GEO; GSM4178101
DR   Progenetix; CVCL_DH73
DR   Wikidata; Q54817219
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   D38 [Human leukoplakia]
AC   CVCL_HF99
DR   CancerTools; 152856
DR   Wikidata; Q54817220
DR   Ximbio; 152856
RX   PubMed=12183435;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C36262; Oral cavity leukoplakia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   D38 [Human melanoma]
AC   CVCL_DH74
SY   D38-T; D38M2
DR   cancercelllines; CVCL_DH74
DR   Cosmic; 2465281
DR   GEO; GSM170592
DR   GEO; GSM219007
DR   GEO; GSM4178102
DR   Progenetix; CVCL_DH74
DR   Wikidata; Q54817221
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23890154;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=22383533).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   D382
AC   CVCL_D1HL
DR   Wikidata; Q127380735
RX   PubMed=11914275;
RX   PubMed=21915264;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   D384 Med
AC   CVCL_1157
SY   D-384 Med; D-384 Med-C; D-384MED; D384Med; Med 384; H384
DR   ArrayExpress; E-MTAB-783
DR   cancercelllines; CVCL_1157
DR   Cell_Model_Passport; SIDM01856
DR   Cosmic; 946379
DR   Cosmic; 1175809
DR   DepMap; ACH-001052
DR   GEO; GSM482335
DR   IARC_TP53; 27690
DR   Progenetix; CVCL_1157
DR   Wikidata; Q54817222
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=1822845;
RX   PubMed=1904513;
RX   PubMed=2180567;
RX   PubMed=20164919;
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 2.44 days (PubMed=1904513).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: D384MG; Cosmic=1175809.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   D39
AC   CVCL_S498
DR   ATCC; CRL-6251
DR   Wikidata; Q54817223
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6251; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Weimaraner; VBO=VBO_0201401.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   D4 [Mouse hybridoma against human RICTOR]
AC   CVCL_B6WE
DR   Wikidata; Q111733152
RX   DOI=10.7124/bc.0008FA;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6R327; Human RICTOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   D4 [Mouse NIH 3T3 ERBB2 transfected]
AC   CVCL_B952
DR   CLO; CLO_0050605
DR   RCB; RCB2648
DR   TKG; TKG 0300
DR   Wikidata; Q54817224
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With C-terminal deletion).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   D4-B6
AC   CVCL_C5NG
DR   Wikidata; Q116048821
RX   PubMed=6419774;
CC   Monoclonal antibody isotype: IgG1+IgG2b.
CC   Monoclonal antibody target: UniProtKB; P0A879; Escherichia coli tryptophan synthase beta chain (trpB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   D4-NP124
AC   CVCL_B0BK
DR   Wikidata; Q108820128
RX   PubMed=24972717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0BL ! D4-NP135
OI   CVCL_B0BM ! D4-NP143
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   D4-NP135
AC   CVCL_B0BL
DR   Wikidata; Q108820129
RX   PubMed=24972717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0BK ! D4-NP124
OI   CVCL_B0BM ! D4-NP143
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   D4-NP143
AC   CVCL_B0BM
DR   Wikidata; Q108820130
RX   PubMed=24972717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0BK ! D4-NP124
OI   CVCL_B0BL ! D4-NP135
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   D4/11
AC   CVCL_E9DW
RX   PubMed=8938716;
RX   PubMed=37758930;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   D40
AC   CVCL_DH75
DR   cancercelllines; CVCL_DH75
DR   Cosmic; 1303036
DR   GEO; GSM170593
DR   GEO; GSM219026
DR   Progenetix; CVCL_DH75
DR   Wikidata; Q54817225
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:393; AKT3; Simple; p.Glu17Lys (c.49G>A); ClinVar=VCV000039816; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   D407
AC   CVCL_8183
SY   D-407; D 407; D407 RPE; RPE D407
DR   BTO; BTO_0004595
DR   Wikidata; Q54817226
RX   PubMed=7706045;
RX   PubMed=14551534;
RX   PubMed=21074641;
RX   PubMed=25177495;
WW   Info; LRI; -; https://web.archive.org/web/20100714222342/http://www.lerner.ccf.org/eye/crabb/research/gel_d407_cell.php
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   D41
AC   CVCL_DH76
SY   D41M
DR   cancercelllines; CVCL_DH76
DR   Cosmic; 1996413
DR   GEO; GSM170594
DR   GEO; GSM219027
DR   GEO; GSM4178103
DR   Progenetix; CVCL_DH76
DR   Wikidata; Q54817227
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   D42.M1
AC   CVCL_C6NP
DR   Wikidata; Q117704278
RX   PubMed=22383533;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   D422T
AC   CVCL_2883
DR   ATCC; CRL-1659
DR   BioSample; SAMN03472365
DR   JCRB; JCRB9112
DR   Wikidata; Q54817228
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-1659; true.
CC   Discontinued: JCRB; JCRB9112; true.
CC   Derived from site: In situ; Abdomen; Note=From a desmoid tumor; UBERON=UBERON_0000916.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB9112
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3741; Abdominal (mesenteric) fibromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2453 ! GS-109-V-20
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   D425 Med
AC   CVCL_1275
SY   D-425 Med; D-425 Med-C; D-425MED; D425_Med; D425MED; D425Med; Med 425; D-425; D425; H425
DR   BioGRID_ORCS_Cell_line; 1665
DR   cancercelllines; CVCL_1275
DR   Cell_Model_Passport; SIDM01501
DR   Cosmic; 973264
DR   Cosmic; 2362651
DR   Cosmic; 2772985
DR   DepMap; ACH-001053
DR   GEO; GSM482334
DR   GEO; GSM919359
DR   Lonza; 1683
DR   Millipore; SCC290
DR   Progenetix; CVCL_1275
DR   Wikidata; Q54817229
RX   PubMed=1822845;
RX   PubMed=1904513;
RX   PubMed=2180567;
RX   PubMed=11916498;
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=21667264;
RX   PubMed=22343310;
RX   PubMed=24297863;
RX   PubMed=24300787;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 2.58 days (PubMed=1904513).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Cys (c.820_821GT>TG); Zygosity=Unspecified (PubMed=22343310; DepMap=ACH-001053).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
ST   Source(s): Millipore=SCC290
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15,17,18
ST   D21S11: 29,33.2
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 20,24
ST   Penta D: 9,10
ST   Penta E: 14,15
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1161 ! D458 Med
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   D458 Med
AC   CVCL_1161
SY   D-458 Med; D-458MED; D458MED; D458Med; Med 458; D-458; D458
DR   ArrayExpress; E-MTAB-783
DR   BioGRID_ORCS_Cell_line; 1664
DR   cancercelllines; CVCL_1161
DR   Cell_Model_Passport; SIDM01493
DR   Cosmic; 946381
DR   DepMap; ACH-001054
DR   GEO; GSM919360
DR   GEO; GSM1234976
DR   GEO; GSM1234977
DR   IARC_TP53; 27691
DR   Progenetix; CVCL_1161
DR   Wikidata; Q54817230
RX   PubMed=1822845;
RX   PubMed=1904513;
RX   PubMed=9283596;
RX   PubMed=20164919;
RX   PubMed=20847082;
RX   PubMed=22343310;
RX   PubMed=24297863;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 3.45 days (PubMed=1904513).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=22343310).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1275 ! D425 Med
SX   Male
AG   6-7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   D487 Med
AC   CVCL_7902
SY   D-487 Med; D-487 MED; D-487MED; D487MED; D487Med; D487
DR   Wikidata; Q54817231
RX   PubMed=9283596;
RX   PubMed=27498314;
RX   PubMed=27812533;
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   D49
AC   CVCL_DH66
DR   cancercelllines; CVCL_DH66
DR   Cosmic; 1996414
DR   GEO; GSM228382
DR   Progenetix; CVCL_DH66
DR   Wikidata; Q54817232
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   D492
AC   CVCL_D1HJ
DR   Wikidata; Q127380738
RX   PubMed=11914275;
RX   PubMed=17420292;
RX   PubMed=21915264;
RX   PubMed=30684066;
CC   Characteristics: Has a basal-like phenotype and has stem cell properties as demonstrated by its ability to differentiate into luminal- and myoepithelial cells (PubMed=21915264; PubMed=30684066).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   D492M
AC   CVCL_D1HK
SY   D492 Mesenchymal
DR   GEO; GSM4224053
DR   GEO; GSM4224054
DR   GEO; GSM4224055
DR   GEO; GSM4224056
DR   Wikidata; Q127380741
RX   PubMed=21915264;
RX   PubMed=30684066;
CC   Characteristics: Has a mesenchymal phenotype, measured by a spindle like phenotype in culture and by marker expression. Has lost epithelial markers such as keratins, CDH1 and transcription factors such as TP63. Has gained mesenchymal marker expression including CDH2, VIM and alpha smooth muscle actin (PubMed=21915264; PubMed=30684066).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1HJ ! D492
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   D4C7
AC   CVCL_C4AY
DR   ABCD; ABCD_AF676
DR   Wikidata; Q116048822
RX   Patent=CN106957367B;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132His).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   D4M-3A
AC   CVCL_0P27
SY   Dartmouth murine mutant malignant melanoma-3A
DR   Millipore; SCC428
DR   Wikidata; Q54817235
RX   PubMed=24460976;
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=24460976).
CC   Breed/subspecies: C57BL/6 x Tyr::CreER;BrafCA;Ptenlox/lox transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   D4M-5A
AC   CVCL_0P28
SY   Dartmouth murine mutant malignant melanoma-5A
DR   Wikidata; Q54817236
RX   PubMed=24460976;
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=24460976).
CC   Breed/subspecies: C57BL/6 x Tyr::CreER;BrafCA;Ptenlox/lox transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   D4M-7A
AC   CVCL_0P29
SY   Dartmouth murine mutant malignant melanoma-7A
DR   Wikidata; Q54817237
RX   PubMed=24460976;
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=24460976).
CC   Breed/subspecies: C57BL/6 x Tyr::CreER;BrafCA;Ptenlox/lox transgenic.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   D5
AC   CVCL_9256
DR   CLO; CLO_0002679
DR   CLDB; cl975
DR   Wikidata; Q54817238
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   D5-NP108
AC   CVCL_B0BN
DR   Wikidata; Q108820131
RX   PubMed=24972717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0BP ! D5-NP113
OI   CVCL_B0BQ ! D5-NP118
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   D5-NP113
AC   CVCL_B0BP
DR   Wikidata; Q108820132
RX   PubMed=24972717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0BN ! D5-NP108
OI   CVCL_B0BQ ! D5-NP118
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   D5-NP118
AC   CVCL_B0BQ
DR   Wikidata; Q108820133
RX   PubMed=24972717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0BN ! D5-NP108
OI   CVCL_B0BP ! D5-NP113
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   D5-7R2
AC   CVCL_E4CW
RX   PubMed=6526402;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01019; Human AGT (Note=AA 25-32 = Angiotensin-2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   D52
AC   CVCL_U818
DR   CLO; CLO_0050323
DR   RCB; RCB0649
DR   Wikidata; Q54817239
RX   DOI=10.1002/cm.970160108;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   D54
AC   CVCL_DH65
DR   EFO; EFO_0022521
DR   cancercelllines; CVCL_DH65
DR   GEO; GSM228383
DR   Progenetix; CVCL_DH65
DR   Wikidata; Q54817241
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   D54MG fat-1
AC   CVCL_E6ZL
DR   ABM; T6266
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Population: Caucasian.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6266).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5735 ! D-54MG
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   D551 iPSC
AC   CVCL_VE97
DR   GEO; GSM1658374
DR   Wikidata; Q54817242
RX   PubMed=26004630;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2434 ! Detroit 551
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   D551-RiPS-1.1
AC   CVCL_C719
DR   SKIP; SKIP000681
DR   SKIP; SKIP004331
DR   Wikidata; Q54817243
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2434 ! Detroit 551
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   D551-RiPS-1.2
AC   CVCL_C720
DR   SKIP; SKIP000682
DR   SKIP; SKIP004330
DR   Wikidata; Q54817244
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2434 ! Detroit 551
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   D551-RiPS-1.3
AC   CVCL_C721
DR   SKIP; SKIP000683
DR   SKIP; SKIP004332
DR   Wikidata; Q54817245
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2434 ! Detroit 551
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   D556 Med
AC   CVCL_1165
SY   D-556 Med; D-556MED; D-556Med; D556MED; D556Med; D-556; D556; H556
DR   ArrayExpress; E-MTAB-783
DR   cancercelllines; CVCL_1165
DR   Cell_Model_Passport; SIDM01821
DR   Cosmic; 946380
DR   Cosmic; 2362653
DR   DepMap; ACH-001055
DR   GEO; GSM482330
DR   GEO; GSM1234978
DR   GEO; GSM1234979
DR   IARC_TP53; 27692
DR   Progenetix; CVCL_1165
DR   Wikidata; Q54817246
RX   PubMed=9283596;
RX   PubMed=11916498;
RX   PubMed=16946619;
RX   PubMed=20164919;
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=24297863;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   D58
AC   CVCL_U819
DR   CLO; CLO_0050291
DR   RCB; RCB0651
DR   Wikidata; Q54817247
RX   DOI=10.1002/cm.970160108;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16959; Heliocidaris crassispina dynein intermediate chain 2, ciliary.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 6
//
ID   D581 Med
AC   CVCL_7900
SY   D-581 Med; D-581MED; D581Med; D581MED; D-581; D581
DR   Wikidata; Q54817248
RX   PubMed=11916498;
RX   PubMed=27498314;
RX   PubMed=27812533;
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   d5krm3
AC   CVCL_A6ZJ
SY   d5krm#3
DR   RCB; RCB4666
DR   Wikidata; Q107114793
CC   Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4666).
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6ZH ! rRCCd5
SX   Male
AG   25W
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   d5krm7
AC   CVCL_A6ZI
SY   d5krm#7
DR   RCB; RCB4665
DR   Wikidata; Q107114796
CC   Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4665).
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6ZH ! rRCCd5
SX   Male
AG   25W
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   D611L
AC   CVCL_U103
DR   Wikidata; Q54817249
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; C*07:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   D64
AC   CVCL_DH64
DR   cancercelllines; CVCL_DH64
DR   GEO; GSM228384
DR   Progenetix; CVCL_DH64
DR   Wikidata; Q54817250
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   D65.30
AC   CVCL_XC75
DR   Wikidata; Q93465541
RX   Patent=US5667781;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10394.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 5
//
ID   D6D
AC   CVCL_XC20
DR   CCRID; 4201PAT-CCTCC00372
DR   Wikidata; Q93465542
RX   Patent=CN101906159B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201052.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_7719; Ochratoxin A (OTA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   D721 Med
AC   CVCL_7901
SY   D-721 Med; D-721MED; D721Med; D721MED; D-721; D721
DR   EFO; EFO_0005696
DR   ENCODE; ENCBS253AAA
DR   GEO; GSM816636
DR   Wikidata; Q54817251
RX   PubMed=9283596;
RX   PubMed=11916498;
RX   PubMed=27498314;
RX   PubMed=27812533;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/D721_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   D77
AC   CVCL_ZV50
DR   Cosmic; 850748
DR   Wikidata; Q98125815
RX   PubMed=9070656;
RX   PubMed=9090379;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   D7E
AC   CVCL_B4ZX
DR   Wikidata; Q110432769
RX   PubMed=22740294;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q4PRK9; Plasmodium vivax lactate dehydrogenase (PvLDH).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   D7F2
AC   CVCL_D6DN
DR   Wikidata; Q127380743
RX   PubMed=1315678;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13904; Xenopus laevis myod1-a.
CC   Monoclonal antibody target: UniProtKB; Q8AVZ0; Xenopus laevis myod1-b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   D8
AC   CVCL_C4ZG
DR   Wikidata; Q116252640
RX   PubMed=1804774;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01008; Human SERPINC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   D8-SBMC
AC   CVCL_W784
SY   D8-Stromal Bone Marrow Cells
DR   Wikidata; Q54817253
RX   PubMed=19473652;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   40-45D
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   D8/17
AC   CVCL_J011
DR   CLO; CLO_0002680
DR   ATCC; HB-8783
DR   Wikidata; Q54817254
RX   Patent=US4743538;
RX   PubMed=2785121;
RX   PubMed=16082074;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8783.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human rheumatic fever antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   D8G
AC   CVCL_G367
DR   TKG; TKG 0316
DR   Wikidata; Q54817255
RX   PubMed=1878337;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01027; Mouse C3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   D9
AC   CVCL_U820
DR   CLO; CLO_0050284
DR   RCB; RCB0650
DR   Wikidata; Q54817256
RX   DOI=10.1002/cm.970160108;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q16959; Heliocidaris crassispina dynein intermediate chain 2, ciliary.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 6
//
ID   D98/AH2 Clone B
AC   CVCL_2884
SY   D98/AH2 clone B; D98-AH2-CloneB
DR   CLO; CLO_0002683
DR   CLO; CLO_0050909
DR   CLDB; cl978
DR   BioSample; SAMN03151678
DR   Cosmic; 753550
DR   ECACC; 85112701
DR   Wikidata; Q54817257
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Ancestral cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00301.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_136532; 8-azahypoxanthine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=85112701
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 14
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8190 ! Detroit 98/AH-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   D98/HR-1
AC   CVCL_X203
DR   Wikidata; Q54817259
RX   PubMed=3008992;
RX   PubMed=4342246;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8190 ! Detroit 98/AH-2
HI   CVCL_2676 ! P3HR-1
CA   Hybrid cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 3
//
ID   DA
AC   CVCL_B7LK
DR   Wikidata; Q112929440
RX   PubMed=7021490;
RX   PubMed=9118943;
RX   PubMed=9287230;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9118943; PubMed=9287230).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-2Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Da Bon
AC   CVCL_3671
DR   CLO; CLO_0002684
DR   ATCC; CRL-1251
DR   Wikidata; Q54817260
RX   PubMed=1054840;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Da Cav
AC   CVCL_3672
DR   CLO; CLO_0002685
DR   ATCC; CRL-1388
DR   Wikidata; Q54817261
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118636; Stiff skin syndrome
DI   ORDO; Orphanet_2833; Stiff skin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Da Hol
AC   CVCL_3673
DR   CLO; CLO_0002686
DR   ATCC; CRL-1379
DR   Wikidata; Q54817262
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Da Kam
AC   CVCL_U672
SY   DaKam
DR   ATCC; CRL-1278
DR   Wikidata; Q54817263
CC   Discontinued: ATCC; CRL-1278; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Da Mo
AC   CVCL_3674
DR   CLO; CLO_0002687
DR   CLDB; cl979
DR   ATCC; CRL-1383
DR   Wikidata; Q54817265
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141423; Ehlers-Danlos syndrome, type V
DI   ORDO; Orphanet_75497; X-linked Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   DA-1
AC   CVCL_2015
AS   CVCL_6830
SY   DA1; Da
DR   CLO; CLO_0002688
DR   CLO; CLO_0050195
DR   CLDB; cl980
DR   BCRJ; 0074
DR   DSMZ; ACC-51
DR   DSMZCellDive; ACC-51
DR   RCB; RCB1143
DR   Wikidata; Q54817266
RX   CelloPub=CLPUB00306;
RX   PubMed=2497280;
RX   PubMed=2656885;
RX   PubMed=2988783;
RX   PubMed=3580579;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Da
CC   Characteristics: CSF2 and IL3 dependent.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   DA-1a
AC   CVCL_R770
SY   DA-1A; DA1-a; DA1a
DR   Wikidata; Q54817267
RX   PubMed=2497280;
CC   Characteristics: IL3 dependent.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2015 ! DA-1
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   DA-1ER
AC   CVCL_6G50
SY   DA-1 cl. 14
DR   Wikidata; Q54817268
RX   PubMed=2465166;
RX   PubMed=2917620;
CC   Characteristics: CSF2, EPO and IL3 dependent.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2015 ! DA-1
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   DA-3 [Mouse hybridoma against domoic acid]
AC   CVCL_U663
DR   CLO; CLO_0050325
DR   RCB; RCB1857
DR   Wikidata; Q54817269
RX   PubMed=10482392;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_34727; Domoic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 7
//
ID   DA-3 [Mouse lymphoma]
AC   CVCL_5419
SY   DA3
DR   CLO; CLO_0050174
DR   EFO; EFO_0022741
DR   ChEMBL-Cells; CHEMBL3307940
DR   ChEMBL-Targets; CHEMBL614481
DR   PubChem_Cell_line; CVCL_5419
DR   RCB; RCB1144
DR   Wikidata; Q54817271
RX   CelloPub=CLPUB00306;
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=1918995;
RX   PubMed=2656885;
RX   PubMed=3014527;
CC   Characteristics: IL3 dependent.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Caution: Not from strain BALB/c as originally published but from strain DBA/2 (DOI=10.4051/ibc.2010.2.4.0014).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 18
//
ID   DA-3/neo
AC   CVCL_D173
DR   Wikidata; Q54817272
RX   PubMed=15265901;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5419 ! DA-3 [Mouse lymphoma]
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   DA-3/sec
AC   CVCL_D171
DR   Wikidata; Q54817273
RX   PubMed=15265901;
CC   Characteristics: IL3 dependent.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5419 ! DA-3 [Mouse lymphoma]
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   DA-3/TM
AC   CVCL_D172
DR   Wikidata; Q54817274
RX   PubMed=15265901;
CC   Characteristics: IL3 dependent.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5419 ! DA-3 [Mouse lymphoma]
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   DA-7
AC   CVCL_C4U2
SY   DA 7
DR   Wikidata; Q116048825
RX   PubMed=308439;
RX   PubMed=6159300;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
CC   Breed/subspecies: AKR x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DA00001
AC   CVCL_6H00
DR   CLO; CLO_0011034
DR   Coriell; DA00001
DR   Wikidata; Q54817276
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00002
AC   CVCL_6H01
DR   CLO; CLO_0011035
DR   Coriell; DA00002
DR   Wikidata; Q54817277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00003
AC   CVCL_6H02
DR   CLO; CLO_0011036
DR   Coriell; DA00003
DR   Wikidata; Q54817278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00004
AC   CVCL_6H03
DR   CLO; CLO_0011031
DR   Coriell; DA00004
DR   Wikidata; Q54817292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00005
AC   CVCL_6H04
DR   CLO; CLO_0011032
DR   Coriell; DA00005
DR   Wikidata; Q54817293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00006
AC   CVCL_6H05
DR   CLO; CLO_0034449
DR   Coriell; DA00006
DR   Wikidata; Q54817294
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00007
AC   CVCL_6H06
DR   CLO; CLO_0034450
DR   Coriell; DA00007
DR   Wikidata; Q54817295
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00008
AC   CVCL_6H07
DR   CLO; CLO_0034457
DR   Coriell; DA00008
DR   Wikidata; Q54817296
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00009
AC   CVCL_6H08
DR   CLO; CLO_0034458
DR   Coriell; DA00009
DR   Wikidata; Q54817297
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00010
AC   CVCL_6H09
DR   CLO; CLO_0034455
DR   Coriell; DA00010
DR   Wikidata; Q54817298
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00011
AC   CVCL_6H10
DR   CLO; CLO_0034456
DR   Coriell; DA00011
DR   Wikidata; Q54817299
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00012
AC   CVCL_6H11
DR   CLO; CLO_0034453
DR   Coriell; DA00012
DR   Wikidata; Q54817300
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00013
AC   CVCL_6H12
DR   CLO; CLO_0034454
DR   Coriell; DA00013
DR   Wikidata; Q54817301
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00014
AC   CVCL_6H13
DR   CLO; CLO_0034451
DR   Coriell; DA00014
DR   Wikidata; Q54817302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00015
AC   CVCL_6H14
DR   CLO; CLO_0034452
DR   Coriell; DA00015
DR   Wikidata; Q54817303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00016
AC   CVCL_6H15
DR   CLO; CLO_0034439
DR   Coriell; DA00016
DR   Wikidata; Q54817304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00017
AC   CVCL_6H16
DR   CLO; CLO_0034440
DR   Coriell; DA00017
DR   Wikidata; Q54817305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00018
AC   CVCL_6H17
DR   CLO; CLO_0034441
DR   Coriell; DA00018
DR   Wikidata; Q54817306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00019
AC   CVCL_6H18
DR   CLO; CLO_0034445
DR   Coriell; DA00019
DR   Wikidata; Q54817307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00020
AC   CVCL_6H19
DR   CLO; CLO_0034446
DR   Coriell; DA00020
DR   Wikidata; Q54817308
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00021
AC   CVCL_6H20
DR   CLO; CLO_0034447
DR   Coriell; DA00021
DR   Wikidata; Q54817309
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00023
AC   CVCL_6H21
DR   CLO; CLO_0034448
DR   Coriell; DA00023
DR   Wikidata; Q54817310
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00024
AC   CVCL_6H22
DR   CLO; CLO_0034442
DR   Coriell; DA00024
DR   Wikidata; Q54817311
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00025
AC   CVCL_6H23
DR   CLO; CLO_0034443
DR   Coriell; DA00025
DR   Wikidata; Q54817312
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00026
AC   CVCL_6H24
DR   CLO; CLO_0034444
DR   Coriell; DA00026
DR   Wikidata; Q54817313
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00027
AC   CVCL_6H25
DR   CLO; CLO_0034484
DR   Coriell; DA00027
DR   Wikidata; Q54817314
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00028
AC   CVCL_6H26
DR   CLO; CLO_0034483
DR   Coriell; DA00028
DR   Wikidata; Q54817315
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00029
AC   CVCL_6H27
DR   CLO; CLO_0034482
DR   Coriell; DA00029
DR   Wikidata; Q54817316
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00030
AC   CVCL_6H28
DR   CLO; CLO_0034481
DR   Coriell; DA00030
DR   Wikidata; Q54817317
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00031
AC   CVCL_6H29
DR   CLO; CLO_0034478
DR   Coriell; DA00031
DR   Wikidata; Q54817318
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00032
AC   CVCL_6H30
DR   CLO; CLO_0034477
DR   Coriell; DA00032
DR   Wikidata; Q54817319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00033
AC   CVCL_6H31
DR   CLO; CLO_0034476
DR   Coriell; DA00033
DR   Wikidata; Q54817320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00034
AC   CVCL_6H32
DR   CLO; CLO_0034475
DR   Coriell; DA00034
DR   Wikidata; Q54817321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00036
AC   CVCL_6H33
DR   CLO; CLO_0034480
DR   Coriell; DA00036
DR   Wikidata; Q54817322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00037
AC   CVCL_6H34
DR   CLO; CLO_0034479
DR   Coriell; DA00037
DR   Wikidata; Q54817323
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00038
AC   CVCL_6H35
DR   CLO; CLO_0034464
DR   Coriell; DA00038
DR   Wikidata; Q54817324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00039
AC   CVCL_6H36
DR   CLO; CLO_0034466
DR   Coriell; DA00039
DR   Wikidata; Q54817325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00040
AC   CVCL_6H37
DR   CLO; CLO_0034465
DR   Coriell; DA00040
DR   Wikidata; Q54817326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00041
AC   CVCL_6H38
DR   CLO; CLO_0034468
DR   Coriell; DA00041
DR   Wikidata; Q54817327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00042
AC   CVCL_6H39
DR   CLO; CLO_0034467
DR   Coriell; DA00042
DR   Wikidata; Q54817328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00043
AC   CVCL_6H40
DR   CLO; CLO_0034460
DR   Coriell; DA00043
DR   Wikidata; Q54817329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00044
AC   CVCL_6H41
DR   CLO; CLO_0034459
DR   Coriell; DA00044
DR   Wikidata; Q54817330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00045
AC   CVCL_6H42
DR   CLO; CLO_0034462
DR   Coriell; DA00045
DR   Wikidata; Q54817331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00046
AC   CVCL_6H43
DR   CLO; CLO_0034461
DR   Coriell; DA00046
DR   Wikidata; Q54817337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00047
AC   CVCL_6H44
DR   CLO; CLO_0034463
DR   Coriell; DA00047
DR   Wikidata; Q54817338
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00048
AC   CVCL_6H45
DR   CLO; CLO_0034504
DR   Coriell; DA00048
DR   Wikidata; Q54817339
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00050
AC   CVCL_6H46
DR   CLO; CLO_0034503
DR   Coriell; DA00050
DR   Wikidata; Q54817340
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00051
AC   CVCL_6H47
DR   CLO; CLO_0034502
DR   Coriell; DA00051
DR   Wikidata; Q54817341
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00052
AC   CVCL_6H48
DR   CLO; CLO_0034501
DR   Coriell; DA00052
DR   Wikidata; Q54817342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00053
AC   CVCL_6H49
DR   CLO; CLO_0034500
DR   Coriell; DA00053
DR   Wikidata; Q54817343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00054
AC   CVCL_6H50
DR   CLO; CLO_0034499
DR   Coriell; DA00054
DR   Wikidata; Q54817344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00055
AC   CVCL_6H51
DR   CLO; CLO_0034498
DR   Coriell; DA00055
DR   Wikidata; Q54817345
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00056
AC   CVCL_6H52
DR   CLO; CLO_0034497
DR   Coriell; DA00056
DR   Wikidata; Q54817346
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00057
AC   CVCL_6H53
DR   CLO; CLO_0034496
DR   Coriell; DA00057
DR   Wikidata; Q54817347
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00058
AC   CVCL_6H54
DR   CLO; CLO_0034495
DR   Coriell; DA00058
DR   Wikidata; Q54817348
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00059
AC   CVCL_6H55
DR   CLO; CLO_0034492
DR   Coriell; DA00059
DR   Wikidata; Q54817349
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00060
AC   CVCL_6H56
DR   CLO; CLO_0034494
DR   Coriell; DA00060
DR   Wikidata; Q54817350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00061
AC   CVCL_6H57
DR   CLO; CLO_0034493
DR   Coriell; DA00061
DR   Wikidata; Q54817351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00062
AC   CVCL_6H58
DR   CLO; CLO_0034489
DR   Coriell; DA00062
DR   Wikidata; Q54817352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00063
AC   CVCL_6H59
DR   CLO; CLO_0034488
DR   Coriell; DA00063
DR   Wikidata; Q54817353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00064
AC   CVCL_6H60
DR   CLO; CLO_0034491
DR   Coriell; DA00064
DR   Wikidata; Q54817354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00065
AC   CVCL_6H61
DR   CLO; CLO_0034490
DR   Coriell; DA00065
DR   Wikidata; Q54817355
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00066
AC   CVCL_6H62
DR   CLO; CLO_0034486
DR   Coriell; DA00066
DR   Wikidata; Q54817356
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00067
AC   CVCL_6H63
DR   CLO; CLO_0034485
DR   Coriell; DA00067
DR   Wikidata; Q54817357
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00068
AC   CVCL_6H64
DR   CLO; CLO_0034487
DR   Coriell; DA00068
DR   Wikidata; Q54817358
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00069
AC   CVCL_6H65
DR   CLO; CLO_0034545
DR   Coriell; DA00069
DR   Wikidata; Q54817359
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00070
AC   CVCL_6H66
DR   CLO; CLO_0034546
DR   Coriell; DA00070
DR   Wikidata; Q54817360
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00071
AC   CVCL_6H67
DR   CLO; CLO_0034547
DR   Coriell; DA00071
DR   Wikidata; Q54817361
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00072
AC   CVCL_6H68
DR   CLO; CLO_0034548
DR   Coriell; DA00072
DR   Wikidata; Q54817362
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00073
AC   CVCL_6H69
DR   CLO; CLO_0034549
DR   Coriell; DA00073
DR   Wikidata; Q54817363
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00074
AC   CVCL_6H70
DR   CLO; CLO_0034550
DR   Coriell; DA00074
DR   Wikidata; Q54817364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00075
AC   CVCL_6H71
DR   CLO; CLO_0034551
DR   Coriell; DA00075
DR   Wikidata; Q54817365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00076
AC   CVCL_6H72
DR   CLO; CLO_0034554
DR   Coriell; DA00076
DR   Wikidata; Q54817366
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00077
AC   CVCL_6H73
DR   CLO; CLO_0034555
DR   Coriell; DA00077
DR   Wikidata; Q54817367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00078
AC   CVCL_6H74
DR   CLO; CLO_0034556
DR   Coriell; DA00078
DR   Wikidata; Q54817368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00079
AC   CVCL_6H75
DR   CLO; CLO_0034512
DR   Coriell; DA00079
DR   Wikidata; Q54817369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00080
AC   CVCL_6H76
DR   CLO; CLO_0034518
DR   Coriell; DA00080
DR   Wikidata; Q54817370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00081
AC   CVCL_6H77
DR   CLO; CLO_0034519
DR   Coriell; DA00081
DR   Wikidata; Q54817371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00082
AC   CVCL_6H78
DR   CLO; CLO_0034516
DR   Coriell; DA00082
DR   Wikidata; Q54817372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00083
AC   CVCL_6H79
DR   CLO; CLO_0034517
DR   Coriell; DA00083
DR   Wikidata; Q54817373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00084
AC   CVCL_6H80
DR   CLO; CLO_0034523
DR   Coriell; DA00084
DR   Wikidata; Q54817374
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00085
AC   CVCL_6H81
DR   CLO; CLO_0034524
DR   Coriell; DA00085
DR   Wikidata; Q54817375
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00086
AC   CVCL_6H82
DR   CLO; CLO_0034520
DR   Coriell; DA00086
DR   Wikidata; Q54817376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00088
AC   CVCL_6H83
DR   CLO; CLO_0034522
DR   Coriell; DA00088
DR   Wikidata; Q54817385
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00089
AC   CVCL_6H84
DR   CLO; CLO_0034525
DR   Coriell; DA00089
DR   Wikidata; Q54817386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00090
AC   CVCL_6H85
DR   CLO; CLO_0034598
DR   Coriell; DA00090
DR   Wikidata; Q54817387
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00091
AC   CVCL_6H86
DR   CLO; CLO_0034596
DR   Coriell; DA00091
DR   Wikidata; Q54817388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00092
AC   CVCL_6H87
DR   CLO; CLO_0034615
DR   Coriell; DA00092
DR   Wikidata; Q54817389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00092; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA00093
AC   CVCL_6H88
DR   CLO; CLO_0034616
DR   Coriell; DA00093
DR   Wikidata; Q54817390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00094
AC   CVCL_6H89
DR   CLO; CLO_0034617
DR   Coriell; DA00094
DR   Wikidata; Q54817391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00095
AC   CVCL_6H90
DR   CLO; CLO_0034618
DR   Coriell; DA00095
DR   Wikidata; Q54817392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00096
AC   CVCL_6H91
DR   CLO; CLO_0034608
DR   Coriell; DA00096
DR   Wikidata; Q54817393
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00097
AC   CVCL_6H92
DR   CLO; CLO_0034609
DR   Coriell; DA00097
DR   Wikidata; Q54817394
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00098
AC   CVCL_6H93
DR   CLO; CLO_0034611
DR   Coriell; DA00098
DR   Wikidata; Q54817395
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00099
AC   CVCL_6H94
DR   CLO; CLO_0034614
DR   Coriell; DA00099
DR   Wikidata; Q54817396
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00100
AC   CVCL_6H95
DR   CLO; CLO_0034567
DR   Coriell; DA00100
DR   Wikidata; Q54817397
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00101
AC   CVCL_6H96
DR   CLO; CLO_0034566
DR   Coriell; DA00101
DR   Wikidata; Q54817398
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00102
AC   CVCL_6H97
DR   CLO; CLO_0034564
DR   Coriell; DA00102
DR   Wikidata; Q54817399
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00103
AC   CVCL_6H98
DR   CLO; CLO_0034586
DR   Coriell; DA00103
DR   Wikidata; Q54817400
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00104
AC   CVCL_6H99
DR   CLO; CLO_0034587
DR   Coriell; DA00104
DR   Wikidata; Q54817401
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00105
AC   CVCL_6I00
DR   CLO; CLO_0034584
DR   Coriell; DA00105
DR   Wikidata; Q54817402
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00106
AC   CVCL_6I01
DR   CLO; CLO_0034585
DR   Coriell; DA00106
DR   Wikidata; Q54817403
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00107
AC   CVCL_6I02
DR   CLO; CLO_0034581
DR   Coriell; DA00107
DR   Wikidata; Q54817404
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00108
AC   CVCL_6I03
DR   CLO; CLO_0034583
DR   Coriell; DA00108
DR   Wikidata; Q54817405
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00109
AC   CVCL_6I04
DR   CLO; CLO_0034579
DR   Coriell; DA00109
DR   Wikidata; Q54817406
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00110
AC   CVCL_6I05
DR   CLO; CLO_0034878
DR   Coriell; DA00110
DR   Wikidata; Q54817407
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00111
AC   CVCL_6I06
DR   CLO; CLO_0034872
DR   Coriell; DA00111
DR   Wikidata; Q54817408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00112
AC   CVCL_6I07
DR   CLO; CLO_0034873
DR   Coriell; DA00112
DR   Wikidata; Q54817409
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00113
AC   CVCL_6I08
DR   CLO; CLO_0034870
DR   Coriell; DA00113
DR   Wikidata; Q54817410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00114
AC   CVCL_6I09
DR   CLO; CLO_0034871
DR   Coriell; DA00114
DR   Wikidata; Q54817411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00115
AC   CVCL_6I10
DR   CLO; CLO_0034876
DR   Coriell; DA00115
DR   Wikidata; Q54817412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00116
AC   CVCL_6I11
DR   CLO; CLO_0034877
DR   Coriell; DA00116
DR   Wikidata; Q54817413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00117
AC   CVCL_6I12
DR   CLO; CLO_0034874
DR   Coriell; DA00117
DR   Wikidata; Q54817414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00118
AC   CVCL_6I13
DR   CLO; CLO_0034875
DR   Coriell; DA00118
DR   Wikidata; Q54817415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00119
AC   CVCL_6I14
DR   CLO; CLO_0034869
DR   Coriell; DA00119
DR   Wikidata; Q54817416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00120
AC   CVCL_6I15
DR   CLO; CLO_0034867
DR   Coriell; DA00120
DR   Wikidata; Q54817417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00121
AC   CVCL_6I16
DR   CLO; CLO_0034868
DR   Coriell; DA00121
DR   Wikidata; Q54817418
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00122
AC   CVCL_6I17
DR   CLO; CLO_0034859
DR   Coriell; DA00122
DR   Wikidata; Q54817419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00123
AC   CVCL_6I18
DR   CLO; CLO_0034860
DR   Coriell; DA00123
DR   Wikidata; Q54817420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00125
AC   CVCL_6I19
DR   CLO; CLO_0034861
DR   Coriell; DA00125
DR   Wikidata; Q54817421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00126
AC   CVCL_6I20
DR   CLO; CLO_0034862
DR   Coriell; DA00126
DR   Wikidata; Q54817422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00127
AC   CVCL_6I21
DR   CLO; CLO_0034863
DR   Coriell; DA00127
DR   Wikidata; Q54817423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00128
AC   CVCL_6I22
DR   CLO; CLO_0034864
DR   Coriell; DA00128
DR   Wikidata; Q54817424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00129
AC   CVCL_6I23
DR   CLO; CLO_0034865
DR   Coriell; DA00129
DR   Wikidata; Q54817427
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00130
AC   CVCL_6I24
DR   CLO; CLO_0034866
DR   Coriell; DA00130
DR   Wikidata; Q54817428
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00131
AC   CVCL_6I25
DR   CLO; CLO_0034858
DR   Coriell; DA00131
DR   Wikidata; Q54817429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00132
AC   CVCL_6I26
DR   CLO; CLO_0034856
DR   Coriell; DA00132
DR   Wikidata; Q54817430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00133
AC   CVCL_6I27
DR   CLO; CLO_0034857
DR   Coriell; DA00133
DR   Wikidata; Q54817431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00134
AC   CVCL_6I28
DR   CLO; CLO_0034854
DR   Coriell; DA00134
DR   Wikidata; Q54817432
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00135
AC   CVCL_6I29
DR   CLO; CLO_0034855
DR   Coriell; DA00135
DR   Wikidata; Q54817433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00136
AC   CVCL_6I30
DR   CLO; CLO_0034852
DR   Coriell; DA00136
DR   Wikidata; Q54817434
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00137
AC   CVCL_6I31
DR   CLO; CLO_0034853
DR   Coriell; DA00137
DR   Wikidata; Q54817435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00138
AC   CVCL_6I32
DR   CLO; CLO_0034850
DR   Coriell; DA00138
DR   Wikidata; Q54817436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00139
AC   CVCL_6I33
DR   CLO; CLO_0034851
DR   Coriell; DA00139
DR   Wikidata; Q54817437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00140
AC   CVCL_6I34
DR   CLO; CLO_0034849
DR   Coriell; DA00140
DR   Wikidata; Q54817438
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00141
AC   CVCL_6I35
DR   CLO; CLO_0034845
DR   Coriell; DA00141
DR   Wikidata; Q54817439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00142
AC   CVCL_6I36
DR   CLO; CLO_0034846
DR   Coriell; DA00142
DR   Wikidata; Q54817440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00143
AC   CVCL_6I37
DR   CLO; CLO_0034847
DR   Coriell; DA00143
DR   Wikidata; Q54817441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00145
AC   CVCL_6I38
DR   CLO; CLO_0034848
DR   Coriell; DA00145
DR   Wikidata; Q54817442
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00147
AC   CVCL_6I39
DR   CLO; CLO_0034841
DR   Coriell; DA00147
DR   Wikidata; Q54817443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00148
AC   CVCL_6I40
DR   CLO; CLO_0034842
DR   Coriell; DA00148
DR   Wikidata; Q54817444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00149
AC   CVCL_6I41
DR   CLO; CLO_0034843
DR   Coriell; DA00149
DR   Wikidata; Q54817445
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00150
AC   CVCL_6I42
DR   CLO; CLO_0034844
DR   Coriell; DA00150
DR   Wikidata; Q54817446
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00151
AC   CVCL_6I43
DR   CLO; CLO_0034839
DR   Coriell; DA00151
DR   Wikidata; Q54817447
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00152
AC   CVCL_6I44
DR   CLO; CLO_0034840
DR   Coriell; DA00152
DR   Wikidata; Q54817448
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00153
AC   CVCL_6I45
DR   CLO; CLO_0034946
DR   Coriell; DA00153
DR   Wikidata; Q54817449
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00154
AC   CVCL_6I46
DR   CLO; CLO_0034954
DR   Coriell; DA00154
DR   Wikidata; Q54817450
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00155
AC   CVCL_6I47
DR   CLO; CLO_0034952
DR   Coriell; DA00155
DR   Wikidata; Q54817451
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00156
AC   CVCL_6I48
DR   CLO; CLO_0034949
DR   Coriell; DA00156
DR   Wikidata; Q54817452
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00158
AC   CVCL_6I49
DR   CLO; CLO_0034948
DR   Coriell; DA00158
DR   Wikidata; Q54817453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00159
AC   CVCL_6I50
DR   CLO; CLO_0034958
DR   Coriell; DA00159
DR   Wikidata; Q54817454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00160
AC   CVCL_6I51
DR   CLO; CLO_0034957
DR   Coriell; DA00160
DR   Wikidata; Q54817455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00161
AC   CVCL_6I52
DR   CLO; CLO_0034956
DR   Coriell; DA00161
DR   Wikidata; Q54817456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00162
AC   CVCL_6I53
DR   CLO; CLO_0034955
DR   Coriell; DA00162
DR   Wikidata; Q54817457
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00163
AC   CVCL_6I54
DR   CLO; CLO_0034959
DR   Coriell; DA00163
DR   Wikidata; Q54817458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caribbean; Jamaican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA00164
AC   CVCL_6I55
DR   CLO; CLO_0034925
DR   Coriell; DA00164
DR   Wikidata; Q54817459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00165
AC   CVCL_6I56
DR   CLO; CLO_0034924
DR   Coriell; DA00165
DR   Wikidata; Q54817460
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00166
AC   CVCL_6I57
DR   CLO; CLO_0034928
DR   Coriell; DA00166
DR   Wikidata; Q54817461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00167
AC   CVCL_6I58
DR   CLO; CLO_0034926
DR   Coriell; DA00167
DR   Wikidata; Q54817462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00168
AC   CVCL_6I59
DR   CLO; CLO_0034933
DR   Coriell; DA00168
DR   Wikidata; Q54817463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00169
AC   CVCL_6I60
DR   CLO; CLO_0034931
DR   Coriell; DA00169
DR   Wikidata; Q54817464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00170
AC   CVCL_6I61
DR   CLO; CLO_0034935
DR   Coriell; DA00170
DR   Wikidata; Q54817465
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00171
AC   CVCL_6I62
DR   CLO; CLO_0034934
DR   Coriell; DA00171
DR   Wikidata; Q54817466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00172
AC   CVCL_6I63
DR   CLO; CLO_0034937
DR   Coriell; DA00172
DR   Wikidata; Q54817473
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00173
AC   CVCL_6I64
DR   CLO; CLO_0034936
DR   Coriell; DA00173
DR   Wikidata; Q54817474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00174
AC   CVCL_6I65
DR   CLO; CLO_0034911
DR   Coriell; DA00174
DR   Wikidata; Q54817475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00175
AC   CVCL_6I66
DR   CLO; CLO_0034910
DR   Coriell; DA00175
DR   Wikidata; Q54817476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00176
AC   CVCL_6I67
DR   CLO; CLO_0034909
DR   Coriell; DA00176
DR   Wikidata; Q54817477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00177
AC   CVCL_6I68
DR   CLO; CLO_0034908
DR   Coriell; DA00177
DR   Wikidata; Q54817478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00178
AC   CVCL_6I69
DR   CLO; CLO_0034907
DR   Coriell; DA00178
DR   Wikidata; Q54817479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00179
AC   CVCL_6I70
DR   CLO; CLO_0034906
DR   Coriell; DA00179
DR   Wikidata; Q54817480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00180
AC   CVCL_6I71
DR   CLO; CLO_0034905
DR   Coriell; DA00180
DR   Wikidata; Q54817481
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00181
AC   CVCL_6I72
DR   CLO; CLO_0034923
DR   Coriell; DA00181
DR   Wikidata; Q54817482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00182
AC   CVCL_6I73
DR   CLO; CLO_0034921
DR   Coriell; DA00182
DR   Wikidata; Q54817483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00183
AC   CVCL_6I74
DR   CLO; CLO_0034918
DR   Coriell; DA00183
DR   Wikidata; Q54817484
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00184
AC   CVCL_6I75
DR   CLO; CLO_0034886
DR   Coriell; DA00184
DR   Wikidata; Q54817485
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00185
AC   CVCL_6I76
DR   CLO; CLO_0034883
DR   Coriell; DA00185
DR   Wikidata; Q54817486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00186
AC   CVCL_6I77
DR   CLO; CLO_0034888
DR   Coriell; DA00186
DR   Wikidata; Q54817487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00187
AC   CVCL_6I78
DR   CLO; CLO_0034887
DR   Coriell; DA00187
DR   Wikidata; Q54817488
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00188
AC   CVCL_6I79
DR   CLO; CLO_0034880
DR   Coriell; DA00188
DR   Wikidata; Q54817489
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00189
AC   CVCL_6I80
DR   CLO; CLO_0034879
DR   Coriell; DA00189
DR   Wikidata; Q54817490
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00190
AC   CVCL_6I81
DR   CLO; CLO_0034882
DR   Coriell; DA00190
DR   Wikidata; Q54817491
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00191
AC   CVCL_6I82
DR   CLO; CLO_0034881
DR   Coriell; DA00191
DR   Wikidata; Q54817492
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00192
AC   CVCL_6I83
DR   CLO; CLO_0034896
DR   Coriell; DA00192
DR   Wikidata; Q54817493
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00193
AC   CVCL_6I84
DR   CLO; CLO_0034894
DR   Coriell; DA00193
DR   Wikidata; Q54817494
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00194
AC   CVCL_6I85
DR   CLO; CLO_0035024
DR   Coriell; DA00194
DR   Wikidata; Q54817495
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00195
AC   CVCL_6I86
DR   CLO; CLO_0035030
DR   Coriell; DA00195
DR   Wikidata; Q54817496
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00196
AC   CVCL_6I87
DR   CLO; CLO_0035031
DR   Coriell; DA00196
DR   Wikidata; Q54817497
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00197
AC   CVCL_6I88
DR   CLO; CLO_0035032
DR   Coriell; DA00197
DR   Wikidata; Q54817498
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00198
AC   CVCL_6I89
DR   CLO; CLO_0035033
DR   Coriell; DA00198
DR   Wikidata; Q54817499
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00199
AC   CVCL_6I90
DR   CLO; CLO_0035034
DR   Coriell; DA00199
DR   Wikidata; Q54817500
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00200
AC   CVCL_6I91
DR   CLO; CLO_0035035
DR   Coriell; DA00200
DR   Wikidata; Q54817501
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00201
AC   CVCL_6I92
DR   CLO; CLO_0035036
DR   Coriell; DA00201
DR   Wikidata; Q54817502
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00202
AC   CVCL_6I93
DR   CLO; CLO_0035037
DR   Coriell; DA00202
DR   Wikidata; Q54817503
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00204
AC   CVCL_6I94
DR   CLO; CLO_0035029
DR   Coriell; DA00204
DR   Wikidata; Q54817504
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00205
AC   CVCL_6I95
DR   CLO; CLO_0035003
DR   Coriell; DA00205
DR   Wikidata; Q54817505
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00206
AC   CVCL_6I96
DR   CLO; CLO_0035002
DR   Coriell; DA00206
DR   Wikidata; Q54817506
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00207
AC   CVCL_6I97
DR   CLO; CLO_0035012
DR   Coriell; DA00207
DR   Wikidata; Q54817507
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00208
AC   CVCL_6I98
DR   CLO; CLO_0035013
DR   Coriell; DA00208
DR   Wikidata; Q54817508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00209
AC   CVCL_6I99
DR   CLO; CLO_0035010
DR   Coriell; DA00209
DR   Wikidata; Q54817509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00210
AC   CVCL_6J00
DR   CLO; CLO_0035011
DR   Coriell; DA00210
DR   Wikidata; Q54817510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00211
AC   CVCL_6J01
DR   CLO; CLO_0035016
DR   Coriell; DA00211
DR   Wikidata; Q54817511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00212
AC   CVCL_6J02
DR   CLO; CLO_0035017
DR   Coriell; DA00212
DR   Wikidata; Q54817512
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00213
AC   CVCL_6J03
DR   CLO; CLO_0035014
DR   Coriell; DA00213
DR   Wikidata; Q54817517
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00214
AC   CVCL_6J04
DR   CLO; CLO_0035015
DR   Coriell; DA00214
DR   Wikidata; Q54817518
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00215
AC   CVCL_6J05
DR   CLO; CLO_0035481
DR   Coriell; DA00215
DR   Wikidata; Q54817519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00216
AC   CVCL_6J06
DR   CLO; CLO_0035480
DR   Coriell; DA00216
DR   Wikidata; Q54817520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00217
AC   CVCL_6J07
DR   CLO; CLO_0035483
DR   Coriell; DA00217
DR   Wikidata; Q54817521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00218
AC   CVCL_6J08
DR   CLO; CLO_0035482
DR   Coriell; DA00218
DR   Wikidata; Q54817522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00219
AC   CVCL_6J09
DR   CLO; CLO_0035485
DR   Coriell; DA00219
DR   Wikidata; Q54817523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00220
AC   CVCL_6J10
DR   CLO; CLO_0035484
DR   Coriell; DA00220
DR   Wikidata; Q54817524
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00221
AC   CVCL_6J11
DR   CLO; CLO_0035487
DR   Coriell; DA00221
DR   Wikidata; Q54817525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00222
AC   CVCL_6J12
DR   CLO; CLO_0035486
DR   Coriell; DA00222
DR   Wikidata; Q54817526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00222; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA00223
AC   CVCL_6J13
DR   CLO; CLO_0035497
DR   Coriell; DA00223
DR   Wikidata; Q54817527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00224
AC   CVCL_6J14
DR   CLO; CLO_0035498
DR   Coriell; DA00224
DR   Wikidata; Q54817528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00225
AC   CVCL_6J15
DR   CLO; CLO_0035496
DR   Coriell; DA00225
DR   Wikidata; Q54817529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00226
AC   CVCL_6J16
DR   CLO; CLO_0035491
DR   Coriell; DA00226
DR   Wikidata; Q54817530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00227
AC   CVCL_6J17
DR   CLO; CLO_0035490
DR   Coriell; DA00227
DR   Wikidata; Q54817531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00228
AC   CVCL_6J18
DR   CLO; CLO_0035489
DR   Coriell; DA00228
DR   Wikidata; Q54817532
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00229
AC   CVCL_6J19
DR   CLO; CLO_0035488
DR   Coriell; DA00229
DR   Wikidata; Q54817533
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00230
AC   CVCL_6J20
DR   CLO; CLO_0035495
DR   Coriell; DA00230
DR   Wikidata; Q54817534
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00231
AC   CVCL_6J21
DR   CLO; CLO_0035494
DR   Coriell; DA00231
DR   Wikidata; Q54817535
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00234
AC   CVCL_6J22
DR   CLO; CLO_0035493
DR   Coriell; DA00234
DR   Wikidata; Q54817537
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00235
AC   CVCL_6J23
DR   CLO; CLO_0035492
DR   Coriell; DA00235
DR   Wikidata; Q54817538
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00236
AC   CVCL_6J24
DR   CLO; CLO_0035377
DR   Coriell; DA00236
DR   Wikidata; Q54817540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00237
AC   CVCL_6J25
DR   CLO; CLO_0035378
DR   Coriell; DA00237
DR   Wikidata; Q54817541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00238
AC   CVCL_6J26
DR   CLO; CLO_0035379
DR   Coriell; DA00238
DR   Wikidata; Q54817543
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00239
AC   CVCL_6J27
DR   CLO; CLO_0035382
DR   Coriell; DA00239
DR   Wikidata; Q54817544
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00240
AC   CVCL_6J28
DR   CLO; CLO_0035383
DR   Coriell; DA00240
DR   Wikidata; Q54817545
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00241
AC   CVCL_6J29
DR   CLO; CLO_0035380
DR   Coriell; DA00241
DR   Wikidata; Q54817546
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00242
AC   CVCL_6J30
DR   CLO; CLO_0035381
DR   Coriell; DA00242
DR   Wikidata; Q54817547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00243
AC   CVCL_6J31
DR   CLO; CLO_0035386
DR   Coriell; DA00243
DR   Wikidata; Q54817548
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00244
AC   CVCL_6J32
DR   CLO; CLO_0035387
DR   Coriell; DA00244
DR   Wikidata; Q54817550
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00245
AC   CVCL_6J33
DR   CLO; CLO_0035384
DR   Coriell; DA00245
DR   Wikidata; Q54817551
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00246
AC   CVCL_6J34
DR   CLO; CLO_0035385
DR   Coriell; DA00246
DR   Wikidata; Q54817552
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00247
AC   CVCL_6J35
DR   CLO; CLO_0035367
DR   Coriell; DA00247
DR   Wikidata; Q54817553
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00248
AC   CVCL_6J36
DR   CLO; CLO_0035368
DR   Coriell; DA00248
DR   Wikidata; Q54817554
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00249
AC   CVCL_6J37
DR   CLO; CLO_0035369
DR   Coriell; DA00249
DR   Wikidata; Q54817556
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00250
AC   CVCL_6J38
DR   CLO; CLO_0035370
DR   Coriell; DA00250
DR   Wikidata; Q54817557
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00251
AC   CVCL_6J39
DR   CLO; CLO_0035371
DR   Coriell; DA00251
DR   Wikidata; Q54817558
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00252
AC   CVCL_6J40
DR   CLO; CLO_0035372
DR   Coriell; DA00252
DR   Wikidata; Q54817560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00253
AC   CVCL_6J41
DR   CLO; CLO_0035373
DR   Coriell; DA00253
DR   Wikidata; Q54817561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00254
AC   CVCL_6J42
DR   CLO; CLO_0035374
DR   Coriell; DA00254
DR   Wikidata; Q54817563
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00255
AC   CVCL_6J43
DR   CLO; CLO_0035375
DR   Coriell; DA00255
DR   Wikidata; Q54817588
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00256
AC   CVCL_6J44
DR   CLO; CLO_0035376
DR   Coriell; DA00256
DR   Wikidata; Q54817589
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00257
AC   CVCL_6J45
DR   CLO; CLO_0035400
DR   Coriell; DA00257
DR   Wikidata; Q54817590
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00258
AC   CVCL_6J46
DR   CLO; CLO_0035401
DR   Coriell; DA00258
DR   Wikidata; Q54817591
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00259
AC   CVCL_6J47
DR   CLO; CLO_0035398
DR   Coriell; DA00259
DR   Wikidata; Q54817592
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00260
AC   CVCL_6J48
DR   CLO; CLO_0035399
DR   Coriell; DA00260
DR   Wikidata; Q54817594
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00261
AC   CVCL_6J49
DR   CLO; CLO_0035406
DR   Coriell; DA00261
DR   Wikidata; Q54817595
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00262
AC   CVCL_6J50
DR   CLO; CLO_0035407
DR   Coriell; DA00262
DR   Wikidata; Q54817596
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00263
AC   CVCL_6J51
DR   CLO; CLO_0035404
DR   Coriell; DA00263
DR   Wikidata; Q54817597
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00264
AC   CVCL_6J52
DR   CLO; CLO_0035405
DR   Coriell; DA00264
DR   Wikidata; Q54817598
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00265
AC   CVCL_6J53
DR   CLO; CLO_0035402
DR   Coriell; DA00265
DR   Wikidata; Q54817600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00266
AC   CVCL_6J54
DR   CLO; CLO_0035403
DR   Coriell; DA00266
DR   Wikidata; Q54817601
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00267
AC   CVCL_6J55
DR   CLO; CLO_0035392
DR   Coriell; DA00267
DR   Wikidata; Q54817602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00268
AC   CVCL_6J56
DR   CLO; CLO_0035388
DR   Coriell; DA00268
DR   Wikidata; Q54817603
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00269
AC   CVCL_6J57
DR   CLO; CLO_0035389
DR   Coriell; DA00269
DR   Wikidata; Q54817604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00270
AC   CVCL_6J58
DR   CLO; CLO_0035390
DR   Coriell; DA00270
DR   Wikidata; Q54817606
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00271
AC   CVCL_6J59
DR   CLO; CLO_0035391
DR   Coriell; DA00271
DR   Wikidata; Q54817607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00272
AC   CVCL_6J60
DR   CLO; CLO_0035394
DR   Coriell; DA00272
DR   Wikidata; Q54817608
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00273
AC   CVCL_6J61
DR   CLO; CLO_0035395
DR   Coriell; DA00273
DR   Wikidata; Q54817609
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00274
AC   CVCL_6J62
DR   CLO; CLO_0035396
DR   Coriell; DA00274
DR   Wikidata; Q54817610
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00275
AC   CVCL_6J63
DR   CLO; CLO_0035397
DR   Coriell; DA00275
DR   Wikidata; Q54817612
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00276
AC   CVCL_6J64
DR   CLO; CLO_0035393
DR   Coriell; DA00276
DR   Wikidata; Q54817613
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00277
AC   CVCL_6J65
DR   CLO; CLO_0035291
DR   Coriell; DA00277
DR   Wikidata; Q54817614
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00278
AC   CVCL_6J66
DR   CLO; CLO_0035290
DR   Coriell; DA00278
DR   Wikidata; Q54817615
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00279
AC   CVCL_6J67
DR   CLO; CLO_0035299
DR   Coriell; DA00279
DR   Wikidata; Q54817617
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00280
AC   CVCL_6J68
DR   CLO; CLO_0035297
DR   Coriell; DA00280
DR   Wikidata; Q54817619
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00281
AC   CVCL_6J69
DR   CLO; CLO_0035295
DR   Coriell; DA00281
DR   Wikidata; Q54817620
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00282
AC   CVCL_6J70
DR   CLO; CLO_0035292
DR   Coriell; DA00282
DR   Wikidata; Q54817621
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00283
AC   CVCL_6J71
DR   CLO; CLO_0035284
DR   Coriell; DA00283
DR   Wikidata; Q54817622
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00284
AC   CVCL_6J72
DR   CLO; CLO_0035283
DR   Coriell; DA00284
DR   Wikidata; Q54817623
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00285
AC   CVCL_6J73
DR   CLO; CLO_0035280
DR   Coriell; DA00285
DR   Wikidata; Q54817625
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00286
AC   CVCL_6J74
DR   CLO; CLO_0035279
DR   Coriell; DA00286
DR   Wikidata; Q54817626
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00287
AC   CVCL_6J75
DR   CLO; CLO_0035260
DR   Coriell; DA00287
DR   Wikidata; Q54817627
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00288
AC   CVCL_6J76
DR   CLO; CLO_0035263
DR   Coriell; DA00288
DR   Wikidata; Q54817628
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00289
AC   CVCL_6J77
DR   CLO; CLO_0035262
DR   Coriell; DA00289
DR   Wikidata; Q54817629
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00290
AC   CVCL_6J78
DR   CLO; CLO_0035266
DR   Coriell; DA00290
DR   Wikidata; Q54817631
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00291
AC   CVCL_6J79
DR   CLO; CLO_0035265
DR   Coriell; DA00291
DR   Wikidata; Q54817632
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00292
AC   CVCL_6J80
DR   CLO; CLO_0035270
DR   Coriell; DA00292
DR   Wikidata; Q54817633
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00293
AC   CVCL_6J81
DR   CLO; CLO_0035267
DR   Coriell; DA00293
DR   Wikidata; Q54817634
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00294
AC   CVCL_6J82
DR   CLO; CLO_0035251
DR   Coriell; DA00294
DR   Wikidata; Q54817635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00295
AC   CVCL_6J83
DR   CLO; CLO_0035249
DR   Coriell; DA00295
DR   Wikidata; Q54817660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00296
AC   CVCL_6J84
DR   CLO; CLO_0035255
DR   Coriell; DA00296
DR   Wikidata; Q54817661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00297
AC   CVCL_6J85
DR   CLO; CLO_0035361
DR   Coriell; DA00297
DR   Wikidata; Q54817662
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00299
AC   CVCL_6J86
DR   CLO; CLO_0035360
DR   Coriell; DA00299
DR   Wikidata; Q54817663
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00300
AC   CVCL_6J87
DR   CLO; CLO_0035357
DR   Coriell; DA00300
DR   Wikidata; Q54817665
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00301
AC   CVCL_6J88
DR   CLO; CLO_0035356
DR   Coriell; DA00301
DR   Wikidata; Q54817666
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00302
AC   CVCL_6J89
DR   CLO; CLO_0035354
DR   Coriell; DA00302
DR   Wikidata; Q54817667
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00303
AC   CVCL_6J90
DR   CLO; CLO_0035352
DR   Coriell; DA00303
DR   Wikidata; Q54817668
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00304
AC   CVCL_6J91
DR   CLO; CLO_0035349
DR   Coriell; DA00304
DR   Wikidata; Q54817669
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00305
AC   CVCL_6J92
DR   CLO; CLO_0035347
DR   Coriell; DA00305
DR   Wikidata; Q54817670
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00306
AC   CVCL_6J93
DR   CLO; CLO_0035346
DR   Coriell; DA00306
DR   Wikidata; Q54817672
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00307
AC   CVCL_6J94
DR   CLO; CLO_0035344
DR   Coriell; DA00307
DR   Wikidata; Q54817673
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00308
AC   CVCL_6J95
DR   CLO; CLO_0035302
DR   Coriell; DA00308
DR   Wikidata; Q54817674
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00309
AC   CVCL_6J96
DR   CLO; CLO_0035326
DR   Coriell; DA00309
DR   Wikidata; Q54817675
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00310
AC   CVCL_6J97
DR   CLO; CLO_0035324
DR   Coriell; DA00310
DR   Wikidata; Q54817676
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00311
AC   CVCL_6J98
DR   CLO; CLO_0035330
DR   Coriell; DA00311
DR   Wikidata; Q54817678
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00312
AC   CVCL_6J99
DR   CLO; CLO_0035329
DR   Coriell; DA00312
DR   Wikidata; Q54817679
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00313
AC   CVCL_6K00
DR   CLO; CLO_0035317
DR   Coriell; DA00313
DR   Wikidata; Q54817680
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00314
AC   CVCL_6K01
DR   CLO; CLO_0035315
DR   Coriell; DA00314
DR   Wikidata; Q54817681
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00315
AC   CVCL_6K02
DR   CLO; CLO_0035321
DR   Coriell; DA00315
DR   Wikidata; Q54817682
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00316
AC   CVCL_6K03
DR   CLO; CLO_0035320
DR   Coriell; DA00316
DR   Wikidata; Q54817684
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00317
AC   CVCL_6K04
DR   CLO; CLO_0035312
DR   Coriell; DA00317
DR   Wikidata; Q54817685
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00318
AC   CVCL_6K05
DR   CLO; CLO_0035785
DR   Coriell; DA00318
DR   Wikidata; Q54817686
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00319
AC   CVCL_6K06
DR   CLO; CLO_0035787
DR   Coriell; DA00319
DR   Wikidata; Q54817687
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00320
AC   CVCL_6K07
DR   CLO; CLO_0035786
DR   Coriell; DA00320
DR   Wikidata; Q54817688
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00321
AC   CVCL_6K08
DR   CLO; CLO_0035782
DR   Coriell; DA00321
DR   Wikidata; Q54817690
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00322
AC   CVCL_6K09
DR   CLO; CLO_0035781
DR   Coriell; DA00322
DR   Wikidata; Q54817691
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00323
AC   CVCL_6K10
DR   CLO; CLO_0035784
DR   Coriell; DA00323
DR   Wikidata; Q54817692
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00324
AC   CVCL_6K11
DR   CLO; CLO_0035783
DR   Coriell; DA00324
DR   Wikidata; Q54817693
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00325
AC   CVCL_6K12
DR   CLO; CLO_0035797
DR   Coriell; DA00325
DR   Wikidata; Q54817694
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00326
AC   CVCL_6K13
DR   CLO; CLO_0035798
DR   Coriell; DA00326
DR   Wikidata; Q54817695
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00328
AC   CVCL_6K14
DR   CLO; CLO_0035796
DR   Coriell; DA00328
DR   Wikidata; Q54817697
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00329
AC   CVCL_6K15
DR   CLO; CLO_0035795
DR   Coriell; DA00329
DR   Wikidata; Q54817698
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00330
AC   CVCL_6K16
DR   CLO; CLO_0035794
DR   Coriell; DA00330
DR   Wikidata; Q54817699
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00331
AC   CVCL_6K17
DR   CLO; CLO_0035793
DR   Coriell; DA00331
DR   Wikidata; Q54817700
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00332
AC   CVCL_6K18
DR   CLO; CLO_0035792
DR   Coriell; DA00332
DR   Wikidata; Q54817701
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00333
AC   CVCL_6K19
DR   CLO; CLO_0035791
DR   Coriell; DA00333
DR   Wikidata; Q54817703
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00334
AC   CVCL_6K20
DR   CLO; CLO_0035790
DR   Coriell; DA00334
DR   Wikidata; Q54817704
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00336
AC   CVCL_6K21
DR   CLO; CLO_0035789
DR   Coriell; DA00336
DR   Wikidata; Q54817705
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00337
AC   CVCL_6K22
DR   CLO; CLO_0035788
DR   Coriell; DA00337
DR   Wikidata; Q54817706
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00338
AC   CVCL_6K23
DR   CLO; CLO_0035768
DR   Coriell; DA00338
DR   Wikidata; Q54817731
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00339
AC   CVCL_6K24
DR   CLO; CLO_0035769
DR   Coriell; DA00339
DR   Wikidata; Q54817732
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00340
AC   CVCL_6K25
DR   CLO; CLO_0035759
DR   Coriell; DA00340
DR   Wikidata; Q54817734
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00341
AC   CVCL_6K26
DR   CLO; CLO_0035761
DR   Coriell; DA00341
DR   Wikidata; Q54817735
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00342
AC   CVCL_6K27
DR   CLO; CLO_0035760
DR   Coriell; DA00342
DR   Wikidata; Q54817736
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00343
AC   CVCL_6K28
DR   CLO; CLO_0035763
DR   Coriell; DA00343
DR   Wikidata; Q54817737
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00344
AC   CVCL_6K29
DR   CLO; CLO_0035762
DR   Coriell; DA00344
DR   Wikidata; Q54817738
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00345
AC   CVCL_6K30
DR   CLO; CLO_0035765
DR   Coriell; DA00345
DR   Wikidata; Q54817739
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00346
AC   CVCL_6K31
DR   CLO; CLO_0035764
DR   Coriell; DA00346
DR   Wikidata; Q54817741
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00347
AC   CVCL_6K32
DR   CLO; CLO_0035767
DR   Coriell; DA00347
DR   Wikidata; Q54817742
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00348
AC   CVCL_6K33
DR   CLO; CLO_0035766
DR   Coriell; DA00348
DR   Wikidata; Q54817743
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00349
AC   CVCL_6K34
DR   CLO; CLO_0035780
DR   Coriell; DA00349
DR   Wikidata; Q54817744
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00350
AC   CVCL_6K35
DR   CLO; CLO_0035771
DR   Coriell; DA00350
DR   Wikidata; Q54817745
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00351
AC   CVCL_6K36
DR   CLO; CLO_0035770
DR   Coriell; DA00351
DR   Wikidata; Q54817747
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00352
AC   CVCL_6K37
DR   CLO; CLO_0035775
DR   Coriell; DA00352
DR   Wikidata; Q54817748
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00353
AC   CVCL_6K38
DR   CLO; CLO_0035774
DR   Coriell; DA00353
DR   Wikidata; Q54817749
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00354
AC   CVCL_6K39
DR   CLO; CLO_0035773
DR   Coriell; DA00354
DR   Wikidata; Q54817750
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00355
AC   CVCL_6K40
DR   CLO; CLO_0035772
DR   Coriell; DA00355
DR   Wikidata; Q54817751
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00356
AC   CVCL_6K41
DR   CLO; CLO_0035779
DR   Coriell; DA00356
DR   Wikidata; Q54817752
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00357
AC   CVCL_6K42
DR   CLO; CLO_0035778
DR   Coriell; DA00357
DR   Wikidata; Q54817754
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00358
AC   CVCL_6K43
DR   CLO; CLO_0035777
DR   Coriell; DA00358
DR   Wikidata; Q54817755
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00359
AC   CVCL_6K44
DR   CLO; CLO_0035776
DR   Coriell; DA00359
DR   Wikidata; Q54817756
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00360
AC   CVCL_6K45
DR   CLO; CLO_0035726
DR   Coriell; DA00360
DR   Wikidata; Q54817757
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00361
AC   CVCL_6K46
DR   CLO; CLO_0035721
DR   Coriell; DA00361
DR   Wikidata; Q54817758
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00362
AC   CVCL_6K47
DR   CLO; CLO_0035723
DR   Coriell; DA00362
DR   Wikidata; Q54817760
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00363
AC   CVCL_6K48
DR   CLO; CLO_0035713
DR   Coriell; DA00363
DR   Wikidata; Q54817761
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00364
AC   CVCL_6K49
DR   CLO; CLO_0035714
DR   Coriell; DA00364
DR   Wikidata; Q54817762
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00365
AC   CVCL_6K50
DR   CLO; CLO_0035711
DR   Coriell; DA00365
DR   Wikidata; Q54817763
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00366
AC   CVCL_6K51
DR   CLO; CLO_0035712
DR   Coriell; DA00366
DR   Wikidata; Q54817764
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00367
AC   CVCL_6K52
DR   CLO; CLO_0035716
DR   Coriell; DA00367
DR   Wikidata; Q54817765
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00368
AC   CVCL_6K53
DR   CLO; CLO_0035717
DR   Coriell; DA00368
DR   Wikidata; Q54817766
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00369
AC   CVCL_6K54
DR   CLO; CLO_0035715
DR   Coriell; DA00369
DR   Wikidata; Q54817768
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00370
AC   CVCL_6K55
DR   CLO; CLO_0035700
DR   Coriell; DA00370
DR   Wikidata; Q54817769
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00371
AC   CVCL_6K56
DR   CLO; CLO_0035701
DR   Coriell; DA00371
DR   Wikidata; Q54817770
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00372
AC   CVCL_6K57
DR   CLO; CLO_0035703
DR   Coriell; DA00372
DR   Wikidata; Q54817771
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00373
AC   CVCL_6K58
DR   CLO; CLO_0035706
DR   Coriell; DA00373
DR   Wikidata; Q54817772
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00374
AC   CVCL_6K59
DR   CLO; CLO_0035691
DR   Coriell; DA00374
DR   Wikidata; Q54817773
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00375
AC   CVCL_6K60
DR   CLO; CLO_0035692
DR   Coriell; DA00375
DR   Wikidata; Q54817775
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00376
AC   CVCL_6K61
DR   CLO; CLO_0035693
DR   Coriell; DA00376
DR   Wikidata; Q54817776
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00377
AC   CVCL_6K62
DR   CLO; CLO_0035694
DR   Coriell; DA00377
DR   Wikidata; Q54817778
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00378
AC   CVCL_6K63
DR   CLO; CLO_0035695
DR   Coriell; DA00378
DR   Wikidata; Q54817801
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00379
AC   CVCL_6K64
DR   CLO; CLO_0035696
DR   Coriell; DA00379
DR   Wikidata; Q54817802
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00380
AC   CVCL_6K65
DR   CLO; CLO_0035685
DR   Coriell; DA00380
DR   Wikidata; Q54817803
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00381
AC   CVCL_6K66
DR   CLO; CLO_0035683
DR   Coriell; DA00381
DR   Wikidata; Q54817804
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00382
AC   CVCL_6K67
DR   CLO; CLO_0035684
DR   Coriell; DA00382
DR   Wikidata; Q54817805
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00383
AC   CVCL_6K68
DR   CLO; CLO_0035681
DR   Coriell; DA00383
DR   Wikidata; Q54817806
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00384
AC   CVCL_6K69
DR   CLO; CLO_0035682
DR   Coriell; DA00384
DR   Wikidata; Q54817807
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00385
AC   CVCL_6K70
DR   CLO; CLO_0035677
DR   Coriell; DA00385
DR   Wikidata; Q54817809
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00386
AC   CVCL_6K71
DR   CLO; CLO_0035679
DR   Coriell; DA00386
DR   Wikidata; Q54817810
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00387
AC   CVCL_6K72
DR   CLO; CLO_0035673
DR   Coriell; DA00387
DR   Wikidata; Q54817811
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00388
AC   CVCL_6K73
DR   CLO; CLO_0035675
DR   Coriell; DA00388
DR   Wikidata; Q54817812
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00389
AC   CVCL_6K74
DR   CLO; CLO_0035671
DR   Coriell; DA00389
DR   Wikidata; Q54817814
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00390
AC   CVCL_6K75
DR   CLO; CLO_0035667
DR   Coriell; DA00390
DR   Wikidata; Q54817815
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00391
AC   CVCL_6K76
DR   CLO; CLO_0035668
DR   Coriell; DA00391
DR   Wikidata; Q54817816
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00392
AC   CVCL_6K77
DR   CLO; CLO_0035663
DR   Coriell; DA00392
DR   Wikidata; Q54817817
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00393
AC   CVCL_6K78
DR   CLO; CLO_0035664
DR   Coriell; DA00393
DR   Wikidata; Q54817818
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00394
AC   CVCL_6K79
DR   CLO; CLO_0035665
DR   Coriell; DA00394
DR   Wikidata; Q54817820
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00395
AC   CVCL_6K80
DR   CLO; CLO_0035666
DR   Coriell; DA00395
DR   Wikidata; Q54817821
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00396
AC   CVCL_6K81
DR   CLO; CLO_0035656
DR   Coriell; DA00396
DR   Wikidata; Q54817822
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00397
AC   CVCL_6K82
DR   CLO; CLO_0035658
DR   Coriell; DA00397
DR   Wikidata; Q54817823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00398
AC   CVCL_6K83
DR   CLO; CLO_0035660
DR   Coriell; DA00398
DR   Wikidata; Q54817824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00399
AC   CVCL_6K84
DR   CLO; CLO_0035662
DR   Coriell; DA00399
DR   Wikidata; Q54817826
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00400
AC   CVCL_6K85
DR   CLO; CLO_0035626
DR   Coriell; DA00400
DR   Wikidata; Q54817827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00401
AC   CVCL_6K86
DR   CLO; CLO_0035624
DR   Coriell; DA00401
DR   Wikidata; Q54817828
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00402
AC   CVCL_6K87
DR   CLO; CLO_0035623
DR   Coriell; DA00402
DR   Wikidata; Q54817829
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00403
AC   CVCL_6K88
DR   CLO; CLO_0035633
DR   Coriell; DA00403
DR   Wikidata; Q54817830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00404
AC   CVCL_6K89
DR   CLO; CLO_0035631
DR   Coriell; DA00404
DR   Wikidata; Q54817832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00405
AC   CVCL_6K90
DR   CLO; CLO_0035630
DR   Coriell; DA00405
DR   Wikidata; Q54817833
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00406
AC   CVCL_6K91
DR   CLO; CLO_0035628
DR   Coriell; DA00406
DR   Wikidata; Q54817834
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00407
AC   CVCL_6K92
DR   CLO; CLO_0035640
DR   Coriell; DA00407
DR   Wikidata; Q54817835
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00408
AC   CVCL_6K93
DR   CLO; CLO_0035638
DR   Coriell; DA00408
DR   Wikidata; Q54817837
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00409
AC   CVCL_6K94
DR   CLO; CLO_0035636
DR   Coriell; DA00409
DR   Wikidata; Q54817838
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00410
AC   CVCL_6K95
DR   CLO; CLO_0035593
DR   Coriell; DA00410
DR   Wikidata; Q54817839
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DA00411
AC   CVCL_6K96
DR   CLO; CLO_0035591
DR   Coriell; DA00411
DR   Wikidata; Q54817840
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00412
AC   CVCL_6K97
DR   CLO; CLO_0035596
DR   Coriell; DA00412
DR   Wikidata; Q54817841
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00413
AC   CVCL_6K98
DR   CLO; CLO_0035595
DR   Coriell; DA00413
DR   Wikidata; Q54817843
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00414
AC   CVCL_6K99
DR   CLO; CLO_0035598
DR   Coriell; DA00414
DR   Wikidata; Q54817844
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00415
AC   CVCL_6L00
DR   CLO; CLO_0035597
DR   Coriell; DA00415
DR   Wikidata; Q54817845
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00416
AC   CVCL_6L01
DR   CLO; CLO_0035602
DR   Coriell; DA00416
DR   Wikidata; Q54817846
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00417
AC   CVCL_6L02
DR   CLO; CLO_0035600
DR   Coriell; DA00417
DR   Wikidata; Q54817847
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00418
AC   CVCL_6L03
DR   CLO; CLO_0035606
DR   Coriell; DA00418
DR   Wikidata; Q54817871
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00419
AC   CVCL_6L04
DR   CLO; CLO_0035603
DR   Coriell; DA00419
DR   Wikidata; Q54817873
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00420
AC   CVCL_6L05
DR   CLO; CLO_0035977
DR   Coriell; DA00420
DR   Wikidata; Q54817874
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00421
AC   CVCL_6L06
DR   CLO; CLO_0035975
DR   Coriell; DA00421
DR   Wikidata; Q54817875
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00422
AC   CVCL_6L07
DR   CLO; CLO_0035979
DR   Coriell; DA00422
DR   Wikidata; Q54817876
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00423
AC   CVCL_6L08
DR   CLO; CLO_0035978
DR   Coriell; DA00423
DR   Wikidata; Q54817877
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00424
AC   CVCL_6L09
DR   CLO; CLO_0035981
DR   Coriell; DA00424
DR   Wikidata; Q54817878
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00425
AC   CVCL_6L10
DR   CLO; CLO_0035980
DR   Coriell; DA00425
DR   Wikidata; Q54817880
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00426
AC   CVCL_6L11
DR   CLO; CLO_0035957
DR   Coriell; DA00426
DR   Wikidata; Q54817881
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00427
AC   CVCL_6L12
DR   CLO; CLO_0035958
DR   Coriell; DA00427
DR   Wikidata; Q54817882
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00428
AC   CVCL_6L13
DR   CLO; CLO_0035955
DR   Coriell; DA00428
DR   Wikidata; Q54817883
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00429
AC   CVCL_6L14
DR   CLO; CLO_0035956
DR   Coriell; DA00429
DR   Wikidata; Q54817885
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00430
AC   CVCL_6L15
DR   CLO; CLO_0035961
DR   Coriell; DA00430
DR   Wikidata; Q54817886
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00431
AC   CVCL_6L16
DR   CLO; CLO_0035960
DR   Coriell; DA00431
DR   Wikidata; Q54817888
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00432
AC   CVCL_6L17
DR   CLO; CLO_0035959
DR   Coriell; DA00432
DR   Wikidata; Q54817889
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00433
AC   CVCL_6L18
DR   CLO; CLO_0035965
DR   Coriell; DA00433
DR   Wikidata; Q54817891
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00434
AC   CVCL_6L19
DR   CLO; CLO_0035964
DR   Coriell; DA00434
DR   Wikidata; Q54817892
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00435
AC   CVCL_6L20
DR   CLO; CLO_0035963
DR   Coriell; DA00435
DR   Wikidata; Q54817893
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00436
AC   CVCL_6L21
DR   CLO; CLO_0035962
DR   Coriell; DA00436
DR   Wikidata; Q54817894
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00437
AC   CVCL_6L22
DR   CLO; CLO_0035994
DR   Coriell; DA00437
DR   Wikidata; Q54817895
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00438
AC   CVCL_6L23
DR   CLO; CLO_0035993
DR   Coriell; DA00438
DR   Wikidata; Q54817897
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00439
AC   CVCL_6L24
DR   CLO; CLO_0035995
DR   Coriell; DA00439
DR   Wikidata; Q54817898
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00440
AC   CVCL_6L25
DR   CLO; CLO_0036000
DR   Coriell; DA00440
DR   Wikidata; Q54817899
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00441
AC   CVCL_6L26
DR   CLO; CLO_0036001
DR   Coriell; DA00441
DR   Wikidata; Q54817900
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00442
AC   CVCL_6L27
DR   CLO; CLO_0036002
DR   Coriell; DA00442
DR   Wikidata; Q54817901
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00443
AC   CVCL_6L28
DR   CLO; CLO_0036003
DR   Coriell; DA00443
DR   Wikidata; Q54817903
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00444
AC   CVCL_6L29
DR   CLO; CLO_0035996
DR   Coriell; DA00444
DR   Wikidata; Q54817904
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00445
AC   CVCL_6L30
DR   CLO; CLO_0035997
DR   Coriell; DA00445
DR   Wikidata; Q54817905
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00446
AC   CVCL_6L31
DR   CLO; CLO_0035998
DR   Coriell; DA00446
DR   Wikidata; Q54817906
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00447
AC   CVCL_6L32
DR   CLO; CLO_0035999
DR   Coriell; DA00447
DR   Wikidata; Q54817907
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00448
AC   CVCL_6L33
DR   CLO; CLO_0035983
DR   Coriell; DA00448
DR   Wikidata; Q54817909
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00449
AC   CVCL_6L34
DR   CLO; CLO_0035982
DR   Coriell; DA00449
DR   Wikidata; Q54817910
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00450
AC   CVCL_6L35
DR   CLO; CLO_0035992
DR   Coriell; DA00450
DR   Wikidata; Q54817911
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00451
AC   CVCL_6L36
DR   CLO; CLO_0035990
DR   Coriell; DA00451
DR   Wikidata; Q54817912
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00452
AC   CVCL_6L37
DR   CLO; CLO_0035991
DR   Coriell; DA00452
DR   Wikidata; Q54817913
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00453
AC   CVCL_6L38
DR   CLO; CLO_0035988
DR   Coriell; DA00453
DR   Wikidata; Q54817915
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00454
AC   CVCL_6L39
DR   CLO; CLO_0035989
DR   Coriell; DA00454
DR   Wikidata; Q54817916
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00455
AC   CVCL_6L40
DR   CLO; CLO_0035986
DR   Coriell; DA00455
DR   Wikidata; Q54817917
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00456
AC   CVCL_6L41
DR   CLO; CLO_0035987
DR   Coriell; DA00456
DR   Wikidata; Q54817918
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00457
AC   CVCL_6L42
DR   CLO; CLO_0035984
DR   Coriell; DA00457
DR   Wikidata; Q54817919
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00458
AC   CVCL_6L43
DR   CLO; CLO_0035985
DR   Coriell; DA00458
DR   Wikidata; Q54817944
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00459
AC   CVCL_6L44
DR   CLO; CLO_0036014
DR   Coriell; DA00459
DR   Wikidata; Q54817945
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00460
AC   CVCL_6L45
DR   CLO; CLO_0036023
DR   Coriell; DA00460
DR   Wikidata; Q54817947
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00461
AC   CVCL_6L46
DR   CLO; CLO_0036024
DR   Coriell; DA00461
DR   Wikidata; Q54817948
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00462
AC   CVCL_6L47
DR   CLO; CLO_0036015
DR   Coriell; DA00462
DR   Wikidata; Q54817949
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00463
AC   CVCL_6L48
DR   CLO; CLO_0036016
DR   Coriell; DA00463
DR   Wikidata; Q54817950
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00464
AC   CVCL_6L49
DR   CLO; CLO_0036017
DR   Coriell; DA00464
DR   Wikidata; Q54817951
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00465
AC   CVCL_6L50
DR   CLO; CLO_0036018
DR   Coriell; DA00465
DR   Wikidata; Q54817952
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00466
AC   CVCL_6L51
DR   CLO; CLO_0036019
DR   Coriell; DA00466
DR   Wikidata; Q54817953
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00467
AC   CVCL_6L52
DR   CLO; CLO_0036020
DR   Coriell; DA00467
DR   Wikidata; Q54817954
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00468
AC   CVCL_6L53
DR   CLO; CLO_0036021
DR   Coriell; DA00468
DR   Wikidata; Q54817956
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00470
AC   CVCL_6L54
DR   CLO; CLO_0036022
DR   Coriell; DA00470
DR   Wikidata; Q54817957
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00471
AC   CVCL_6L55
DR   CLO; CLO_0036013
DR   Coriell; DA00471
DR   Wikidata; Q54817958
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00472
AC   CVCL_6L56
DR   CLO; CLO_0036011
DR   Coriell; DA00472
DR   Wikidata; Q54817959
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00473
AC   CVCL_6L57
DR   CLO; CLO_0036012
DR   Coriell; DA00473
DR   Wikidata; Q54817960
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00474
AC   CVCL_6L58
DR   CLO; CLO_0036006
DR   Coriell; DA00474
DR   Wikidata; Q54817961
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00475
AC   CVCL_6L59
DR   CLO; CLO_0036007
DR   Coriell; DA00475
DR   Wikidata; Q54817962
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00476
AC   CVCL_6L60
DR   CLO; CLO_0036004
DR   Coriell; DA00476
DR   Wikidata; Q54817963
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00477
AC   CVCL_6L61
DR   CLO; CLO_0036005
DR   Coriell; DA00477
DR   Wikidata; Q54817965
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00478
AC   CVCL_6L62
DR   CLO; CLO_0036009
DR   Coriell; DA00478
DR   Wikidata; Q54817966
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00479
AC   CVCL_6L63
DR   CLO; CLO_0036010
DR   Coriell; DA00479
DR   Wikidata; Q54817967
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00480
AC   CVCL_6L64
DR   CLO; CLO_0036008
DR   Coriell; DA00480
DR   Wikidata; Q54817968
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00481
AC   CVCL_6L65
DR   CLO; CLO_0035855
DR   Coriell; DA00481
DR   Wikidata; Q54817970
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00482
AC   CVCL_6L66
DR   CLO; CLO_0035854
DR   Coriell; DA00482
DR   Wikidata; Q54817971
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00483
AC   CVCL_6L67
DR   CLO; CLO_0035853
DR   Coriell; DA00483
DR   Wikidata; Q54817973
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00484
AC   CVCL_6L68
DR   CLO; CLO_0035852
DR   Coriell; DA00484
DR   Wikidata; Q54817974
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00485
AC   CVCL_6L69
DR   CLO; CLO_0035859
DR   Coriell; DA00485
DR   Wikidata; Q54817975
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00486
AC   CVCL_6L70
DR   CLO; CLO_0035858
DR   Coriell; DA00486
DR   Wikidata; Q54817976
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00487
AC   CVCL_6L71
DR   CLO; CLO_0035857
DR   Coriell; DA00487
DR   Wikidata; Q54817977
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00488
AC   CVCL_6L72
DR   CLO; CLO_0035856
DR   Coriell; DA00488
DR   Wikidata; Q54817978
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00489
AC   CVCL_6L73
DR   CLO; CLO_0035861
DR   Coriell; DA00489
DR   Wikidata; Q54817979
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00490
AC   CVCL_6L74
DR   CLO; CLO_0035860
DR   Coriell; DA00490
DR   Wikidata; Q54817980
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00491
AC   CVCL_6L75
DR   CLO; CLO_0035872
DR   Coriell; DA00491
DR   Wikidata; Q54817982
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00492
AC   CVCL_6L76
DR   CLO; CLO_0035876
DR   Coriell; DA00492
DR   Wikidata; Q54817983
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00493
AC   CVCL_6L77
DR   CLO; CLO_0035875
DR   Coriell; DA00493
DR   Wikidata; Q54817984
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00494
AC   CVCL_6L78
DR   CLO; CLO_0035878
DR   Coriell; DA00494
DR   Wikidata; Q54817985
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00495
AC   CVCL_6L79
DR   CLO; CLO_0035877
DR   Coriell; DA00495
DR   Wikidata; Q54817987
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00496
AC   CVCL_6L80
DR   CLO; CLO_0035880
DR   Coriell; DA00496
DR   Wikidata; Q54817988
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00497
AC   CVCL_6L81
DR   CLO; CLO_0035879
DR   Coriell; DA00497
DR   Wikidata; Q54817989
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00498
AC   CVCL_6L82
DR   CLO; CLO_0035882
DR   Coriell; DA00498
DR   Wikidata; Q54817990
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00499
AC   CVCL_6L83
DR   CLO; CLO_0035881
DR   Coriell; DA00499
DR   Wikidata; Q54818015
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00500
AC   CVCL_6L84
DR   CLO; CLO_0035883
DR   Coriell; DA00500
DR   Wikidata; Q54818016
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00501
AC   CVCL_6L85
DR   CLO; CLO_0035898
DR   Coriell; DA00501
DR   Wikidata; Q54818017
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00502
AC   CVCL_6L86
DR   CLO; CLO_0035896
DR   Coriell; DA00502
DR   Wikidata; Q54818018
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00503
AC   CVCL_6L87
DR   CLO; CLO_0035895
DR   Coriell; DA00503
DR   Wikidata; Q54818020
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00504
AC   CVCL_6L88
DR   CLO; CLO_0035894
DR   Coriell; DA00504
DR   Wikidata; Q54818021
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00505
AC   CVCL_6L89
DR   CLO; CLO_0035893
DR   Coriell; DA00505
DR   Wikidata; Q54818022
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00506
AC   CVCL_6L90
DR   CLO; CLO_0035891
DR   Coriell; DA00506
DR   Wikidata; Q54818023
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00507
AC   CVCL_6L91
DR   CLO; CLO_0035905
DR   Coriell; DA00507
DR   Wikidata; Q54818024
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00508
AC   CVCL_6L92
DR   CLO; CLO_0035904
DR   Coriell; DA00508
DR   Wikidata; Q54818025
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00509
AC   CVCL_6L93
DR   CLO; CLO_0035903
DR   Coriell; DA00509
DR   Wikidata; Q54818027
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00510
AC   CVCL_6L94
DR   CLO; CLO_0035902
DR   Coriell; DA00510
DR   Wikidata; Q54818028
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00511
AC   CVCL_6L95
DR   CLO; CLO_0035919
DR   Coriell; DA00511
DR   Wikidata; Q54818029
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00512
AC   CVCL_6L96
DR   CLO; CLO_0035924
DR   Coriell; DA00512
DR   Wikidata; Q54818031
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00513
AC   CVCL_6L97
DR   CLO; CLO_0035922
DR   Coriell; DA00513
DR   Wikidata; Q54818033
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00514
AC   CVCL_6L98
DR   CLO; CLO_0035913
DR   Coriell; DA00514
DR   Wikidata; Q54818034
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00515
AC   CVCL_6L99
DR   CLO; CLO_0035912
DR   Coriell; DA00515
DR   Wikidata; Q54818035
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00516
AC   CVCL_6M00
DR   CLO; CLO_0035917
DR   Coriell; DA00516
DR   Wikidata; Q54818037
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00517
AC   CVCL_6M01
DR   CLO; CLO_0035914
DR   Coriell; DA00517
DR   Wikidata; Q54818038
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00518
AC   CVCL_6M02
DR   CLO; CLO_0035926
DR   Coriell; DA00518
DR   Wikidata; Q54818040
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00519
AC   CVCL_6M03
DR   CLO; CLO_0035925
DR   Coriell; DA00519
DR   Wikidata; Q54818041
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00520
AC   CVCL_6M04
DR   CLO; CLO_0035927
DR   Coriell; DA00520
DR   Wikidata; Q54818042
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00521
AC   CVCL_6M05
DR   CLO; CLO_0036192
DR   Coriell; DA00521
DR   Wikidata; Q54818043
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00522
AC   CVCL_6M06
DR   CLO; CLO_0036189
DR   Coriell; DA00522
DR   Wikidata; Q54818045
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00523
AC   CVCL_6M07
DR   CLO; CLO_0036188
DR   Coriell; DA00523
DR   Wikidata; Q54818046
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00524
AC   CVCL_6M08
DR   CLO; CLO_0036191
DR   Coriell; DA00524
DR   Wikidata; Q54818047
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00525
AC   CVCL_6M09
DR   CLO; CLO_0036190
DR   Coriell; DA00525
DR   Wikidata; Q54818048
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00526
AC   CVCL_6M10
DR   CLO; CLO_0036180
DR   Coriell; DA00526
DR   Wikidata; Q54818050
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00527
AC   CVCL_6M11
DR   CLO; CLO_0036181
DR   Coriell; DA00527
DR   Wikidata; Q54818051
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00528
AC   CVCL_6M12
DR   CLO; CLO_0036178
DR   Coriell; DA00528
DR   Wikidata; Q54818052
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00529
AC   CVCL_6M13
DR   CLO; CLO_0036179
DR   Coriell; DA00529
DR   Wikidata; Q54818053
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00530
AC   CVCL_6M14
DR   CLO; CLO_0036177
DR   Coriell; DA00530
DR   Wikidata; Q54818054
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00531
AC   CVCL_6M15
DR   CLO; CLO_0036187
DR   Coriell; DA00531
DR   Wikidata; Q54818056
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00532
AC   CVCL_6M16
DR   CLO; CLO_0036186
DR   Coriell; DA00532
DR   Wikidata; Q54818057
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00533
AC   CVCL_6M17
DR   CLO; CLO_0036185
DR   Coriell; DA00533
DR   Wikidata; Q54818058
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00534
AC   CVCL_6M18
DR   CLO; CLO_0036184
DR   Coriell; DA00534
DR   Wikidata; Q54818060
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00535
AC   CVCL_6M19
DR   CLO; CLO_0036183
DR   Coriell; DA00535
DR   Wikidata; Q54818061
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00536
AC   CVCL_6M20
DR   CLO; CLO_0036182
DR   Coriell; DA00536
DR   Wikidata; Q54818063
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00537
AC   CVCL_6M21
DR   CLO; CLO_0036166
DR   Coriell; DA00537
DR   Wikidata; Q54818064
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00538
AC   CVCL_6M22
DR   CLO; CLO_0036167
DR   Coriell; DA00538
DR   Wikidata; Q54818065
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00539
AC   CVCL_6M23
DR   CLO; CLO_0036168
DR   Coriell; DA00539
DR   Wikidata; Q54818085
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00540
AC   CVCL_6M24
DR   CLO; CLO_0036169
DR   Coriell; DA00540
DR   Wikidata; Q54818086
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00541
AC   CVCL_6M25
DR   CLO; CLO_0036170
DR   Coriell; DA00541
DR   Wikidata; Q54818087
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00542
AC   CVCL_6M26
DR   CLO; CLO_0036172
DR   Coriell; DA00542
DR   Wikidata; Q54818089
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00543
AC   CVCL_6M27
DR   CLO; CLO_0036171
DR   Coriell; DA00543
DR   Wikidata; Q54818090
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00544
AC   CVCL_6M28
DR   CLO; CLO_0036174
DR   Coriell; DA00544
DR   Wikidata; Q54818091
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00545
AC   CVCL_6M29
DR   CLO; CLO_0036173
DR   Coriell; DA00545
DR   Wikidata; Q54818092
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00546
AC   CVCL_6M30
DR   CLO; CLO_0036176
DR   Coriell; DA00546
DR   Wikidata; Q54818093
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00547
AC   CVCL_6M31
DR   CLO; CLO_0036175
DR   Coriell; DA00547
DR   Wikidata; Q54818095
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00548
AC   CVCL_6M32
DR   CLO; CLO_0036156
DR   Coriell; DA00548
DR   Wikidata; Q54818096
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00549
AC   CVCL_6M33
DR   CLO; CLO_0036157
DR   Coriell; DA00549
DR   Wikidata; Q54818097
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00550
AC   CVCL_6M34
DR   CLO; CLO_0036155
DR   Coriell; DA00550
DR   Wikidata; Q54818098
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00551
AC   CVCL_6M35
DR   CLO; CLO_0036161
DR   Coriell; DA00551
DR   Wikidata; Q54818099
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00552
AC   CVCL_6M36
DR   CLO; CLO_0036160
DR   Coriell; DA00552
DR   Wikidata; Q54818101
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00553
AC   CVCL_6M37
DR   CLO; CLO_0036159
DR   Coriell; DA00553
DR   Wikidata; Q54818102
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00554
AC   CVCL_6M38
DR   CLO; CLO_0036158
DR   Coriell; DA00554
DR   Wikidata; Q54818103
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00557
AC   CVCL_6M39
DR   CLO; CLO_0036165
DR   Coriell; DA00557
DR   Wikidata; Q54818104
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00558
AC   CVCL_6M40
DR   CLO; CLO_0036164
DR   Coriell; DA00558
DR   Wikidata; Q54818105
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00559
AC   CVCL_6M41
DR   CLO; CLO_0036163
DR   Coriell; DA00559
DR   Wikidata; Q54818107
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00560
AC   CVCL_6M42
DR   CLO; CLO_0036162
DR   Coriell; DA00560
DR   Wikidata; Q54818108
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00561
AC   CVCL_6M43
DR   CLO; CLO_0036225
DR   Coriell; DA00561
DR   Wikidata; Q54818109
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00562
AC   CVCL_6M44
DR   CLO; CLO_0036224
DR   Coriell; DA00562
DR   Wikidata; Q54818110
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00563
AC   CVCL_6M45
DR   CLO; CLO_0036226
DR   Coriell; DA00563
DR   Wikidata; Q54818112
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00564
AC   CVCL_6M46
DR   CLO; CLO_0036231
DR   Coriell; DA00564
DR   Wikidata; Q54818113
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00565
AC   CVCL_6M47
DR   CLO; CLO_0036232
DR   Coriell; DA00565
DR   Wikidata; Q54818115
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00566
AC   CVCL_6M48
DR   CLO; CLO_0036233
DR   Coriell; DA00566
DR   Wikidata; Q54818116
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00567
AC   CVCL_6M49
DR   CLO; CLO_0036234
DR   Coriell; DA00567
DR   Wikidata; Q54818117
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00568
AC   CVCL_6M50
DR   CLO; CLO_0036227
DR   Coriell; DA00568
DR   Wikidata; Q54818118
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00569
AC   CVCL_6M51
DR   CLO; CLO_0036228
DR   Coriell; DA00569
DR   Wikidata; Q54818119
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00570
AC   CVCL_6M52
DR   CLO; CLO_0036229
DR   Coriell; DA00570
DR   Wikidata; Q54818121
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00571
AC   CVCL_6M53
DR   CLO; CLO_0036230
DR   Coriell; DA00571
DR   Wikidata; Q54818122
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00572
AC   CVCL_6M54
DR   CLO; CLO_0036213
DR   Coriell; DA00572
DR   Wikidata; Q54818123
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00573
AC   CVCL_6M55
DR   CLO; CLO_0036214
DR   Coriell; DA00573
DR   Wikidata; Q54818124
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00574
AC   CVCL_6M56
DR   CLO; CLO_0036215
DR   Coriell; DA00574
DR   Wikidata; Q54818125
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00575
AC   CVCL_6M57
DR   CLO; CLO_0036222
DR   Coriell; DA00575
DR   Wikidata; Q54818127
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00576
AC   CVCL_6M58
DR   CLO; CLO_0036223
DR   Coriell; DA00576
DR   Wikidata; Q54818128
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00577
AC   CVCL_6M59
DR   CLO; CLO_0036220
DR   Coriell; DA00577
DR   Wikidata; Q54818129
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00578
AC   CVCL_6M60
DR   CLO; CLO_0036221
DR   Coriell; DA00578
DR   Wikidata; Q54818130
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00579
AC   CVCL_6M61
DR   CLO; CLO_0036218
DR   Coriell; DA00579
DR   Wikidata; Q54818131
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00580
AC   CVCL_6M62
DR   CLO; CLO_0036219
DR   Coriell; DA00580
DR   Wikidata; Q54818132
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00581
AC   CVCL_6M63
DR   CLO; CLO_0036216
DR   Coriell; DA00581
DR   Wikidata; Q54818154
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00582
AC   CVCL_6M64
DR   CLO; CLO_0036217
DR   Coriell; DA00582
DR   Wikidata; Q54818156
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00583
AC   CVCL_6M65
DR   CLO; CLO_0036203
DR   Coriell; DA00583
DR   Wikidata; Q54818157
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00584
AC   CVCL_6M66
DR   CLO; CLO_0036204
DR   Coriell; DA00584
DR   Wikidata; Q54818158
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00585
AC   CVCL_6M67
DR   CLO; CLO_0036205
DR   Coriell; DA00585
DR   Wikidata; Q54818159
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00586
AC   CVCL_6M68
DR   CLO; CLO_0036206
DR   Coriell; DA00586
DR   Wikidata; Q54818160
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00588
AC   CVCL_6M69
DR   CLO; CLO_0036207
DR   Coriell; DA00588
DR   Wikidata; Q54818162
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00589
AC   CVCL_6M70
DR   CLO; CLO_0036208
DR   Coriell; DA00589
DR   Wikidata; Q54818163
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00590
AC   CVCL_6M71
DR   CLO; CLO_0036209
DR   Coriell; DA00590
DR   Wikidata; Q54818164
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00591
AC   CVCL_6M72
DR   CLO; CLO_0036210
DR   Coriell; DA00591
DR   Wikidata; Q54818165
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00592
AC   CVCL_6M73
DR   CLO; CLO_0036211
DR   Coriell; DA00592
DR   Wikidata; Q54818166
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00593
AC   CVCL_6M74
DR   CLO; CLO_0036212
DR   Coriell; DA00593
DR   Wikidata; Q54818168
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00595
AC   CVCL_6M75
DR   CLO; CLO_0036195
DR   Coriell; DA00595
DR   Wikidata; Q54818169
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00596
AC   CVCL_6M76
DR   CLO; CLO_0036196
DR   Coriell; DA00596
DR   Wikidata; Q54818170
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00597
AC   CVCL_6M77
DR   CLO; CLO_0036193
DR   Coriell; DA00597
DR   Wikidata; Q54818171
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00598
AC   CVCL_6M78
DR   CLO; CLO_0036194
DR   Coriell; DA00598
DR   Wikidata; Q54818172
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00599
AC   CVCL_6M79
DR   CLO; CLO_0036199
DR   Coriell; DA00599
DR   Wikidata; Q54818174
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00600
AC   CVCL_6M80
DR   CLO; CLO_0036200
DR   Coriell; DA00600
DR   Wikidata; Q54818175
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00601
AC   CVCL_6M81
DR   CLO; CLO_0036197
DR   Coriell; DA00601
DR   Wikidata; Q54818176
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00602
AC   CVCL_6M82
DR   CLO; CLO_0036198
DR   Coriell; DA00602
DR   Wikidata; Q54818177
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00603
AC   CVCL_6M83
DR   CLO; CLO_0036201
DR   Coriell; DA00603
DR   Wikidata; Q54818178
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00604
AC   CVCL_6M84
DR   CLO; CLO_0036202
DR   Coriell; DA00604
DR   Wikidata; Q54818180
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00605
AC   CVCL_6M85
DR   CLO; CLO_0036140
DR   Coriell; DA00605
DR   Wikidata; Q54818181
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian and Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00606
AC   CVCL_6M86
DR   CLO; CLO_0036144
DR   Coriell; DA00606
DR   Wikidata; Q54818182
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00607
AC   CVCL_6M87
DR   CLO; CLO_0036143
DR   Coriell; DA00607
DR   Wikidata; Q54818183
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00608
AC   CVCL_6M88
DR   CLO; CLO_0036142
DR   Coriell; DA00608
DR   Wikidata; Q54818185
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00609
AC   CVCL_6M89
DR   CLO; CLO_0036141
DR   Coriell; DA00609
DR   Wikidata; Q54818186
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00610
AC   CVCL_6M90
DR   CLO; CLO_0036138
DR   Coriell; DA00610
DR   Wikidata; Q54818187
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00611
AC   CVCL_6M91
DR   CLO; CLO_0036137
DR   Coriell; DA00611
DR   Wikidata; Q54818188
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00612
AC   CVCL_6M92
DR   CLO; CLO_0036136
DR   Coriell; DA00612
DR   Wikidata; Q54818189
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00613
AC   CVCL_6M93
DR   CLO; CLO_0036135
DR   Coriell; DA00613
DR   Wikidata; Q54818191
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00614
AC   CVCL_6M94
DR   CLO; CLO_0036139
DR   Coriell; DA00614
DR   Wikidata; Q54818192
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00615
AC   CVCL_6M95
DR   CLO; CLO_0036150
DR   Coriell; DA00615
DR   Wikidata; Q54818193
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00616
AC   CVCL_6M96
DR   CLO; CLO_0036149
DR   Coriell; DA00616
DR   Wikidata; Q54818194
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00617
AC   CVCL_6M97
DR   CLO; CLO_0036152
DR   Coriell; DA00617
DR   Wikidata; Q54818195
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00618
AC   CVCL_6M98
DR   CLO; CLO_0036151
DR   Coriell; DA00618
DR   Wikidata; Q54818196
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00619
AC   CVCL_6M99
DR   CLO; CLO_0036154
DR   Coriell; DA00619
DR   Wikidata; Q54818198
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00620
AC   CVCL_6N00
DR   CLO; CLO_0036153
DR   Coriell; DA00620
DR   Wikidata; Q54818199
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00621
AC   CVCL_6N01
DR   CLO; CLO_0036146
DR   Coriell; DA00621
DR   Wikidata; Q54818200
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00622
AC   CVCL_6N02
DR   CLO; CLO_0036145
DR   Coriell; DA00622
DR   Wikidata; Q54818201
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00623
AC   CVCL_6N03
DR   CLO; CLO_0036148
DR   Coriell; DA00623
DR   Wikidata; Q54818224
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00624
AC   CVCL_6N04
DR   CLO; CLO_0036147
DR   Coriell; DA00624
DR   Wikidata; Q54818226
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00626
AC   CVCL_6N05
DR   CLO; CLO_0036666
DR   Coriell; DA00626
DR   Wikidata; Q54818228
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00627
AC   CVCL_6N06
DR   CLO; CLO_0036667
DR   Coriell; DA00627
DR   Wikidata; Q54818229
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00628
AC   CVCL_6N07
DR   CLO; CLO_0036664
DR   Coriell; DA00628
DR   Wikidata; Q54818230
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00629
AC   CVCL_6N08
DR   CLO; CLO_0036665
DR   Coriell; DA00629
DR   Wikidata; Q54818231
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00630
AC   CVCL_6N09
DR   CLO; CLO_0036644
DR   Coriell; DA00630
DR   Wikidata; Q54818233
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00631
AC   CVCL_6N10
DR   CLO; CLO_0036643
DR   Coriell; DA00631
DR   Wikidata; Q54818234
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00632
AC   CVCL_6N11
DR   CLO; CLO_0036646
DR   Coriell; DA00632
DR   Wikidata; Q54818235
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00633
AC   CVCL_6N12
DR   CLO; CLO_0036645
DR   Coriell; DA00633
DR   Wikidata; Q54818236
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00634
AC   CVCL_6N13
DR   CLO; CLO_0036648
DR   Coriell; DA00634
DR   Wikidata; Q54818238
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00635
AC   CVCL_6N14
DR   CLO; CLO_0036647
DR   Coriell; DA00635
DR   Wikidata; Q54818239
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00636
AC   CVCL_6N15
DR   CLO; CLO_0036649
DR   Coriell; DA00636
DR   Wikidata; Q54818240
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00637
AC   CVCL_6N16
DR   CLO; CLO_0036650
DR   Coriell; DA00637
DR   Wikidata; Q54818241
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00638
AC   CVCL_6N17
DR   CLO; CLO_0036651
DR   Coriell; DA00638
DR   Wikidata; Q54818243
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00639
AC   CVCL_6N18
DR   CLO; CLO_0036652
DR   Coriell; DA00639
DR   Wikidata; Q54818244
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00640
AC   CVCL_6N19
DR   CLO; CLO_0036653
DR   Coriell; DA00640
DR   Wikidata; Q54818245
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00641
AC   CVCL_6N20
DR   CLO; CLO_0036617
DR   Coriell; DA00641
DR   Wikidata; Q54818246
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00642
AC   CVCL_6N21
DR   CLO; CLO_0036618
DR   Coriell; DA00642
DR   Wikidata; Q54818247
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00643
AC   CVCL_6N22
DR   CLO; CLO_0036619
DR   Coriell; DA00643
DR   Wikidata; Q54818248
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00644
AC   CVCL_6N23
DR   CLO; CLO_0036620
DR   Coriell; DA00644
DR   Wikidata; Q54818250
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00645
AC   CVCL_6N24
DR   CLO; CLO_0036616
DR   Coriell; DA00645
DR   Wikidata; Q54818251
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00646
AC   CVCL_6N25
DR   CLO; CLO_0036615
DR   Coriell; DA00646
DR   Wikidata; Q54818252
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00647
AC   CVCL_6N26
DR   CLO; CLO_0036614
DR   Coriell; DA00647
DR   Wikidata; Q54818253
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00648
AC   CVCL_6N27
DR   CLO; CLO_0036611
DR   Coriell; DA00648
DR   Wikidata; Q54818255
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00649
AC   CVCL_6N28
DR   CLO; CLO_0036610
DR   Coriell; DA00649
DR   Wikidata; Q54818256
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00650
AC   CVCL_6N29
DR   CLO; CLO_0036613
DR   Coriell; DA00650
DR   Wikidata; Q54818257
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00652
AC   CVCL_6N30
DR   CLO; CLO_0036612
DR   Coriell; DA00652
DR   Wikidata; Q54818258
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00653
AC   CVCL_6N31
DR   CLO; CLO_0036608
DR   Coriell; DA00653
DR   Wikidata; Q54818259
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00654
AC   CVCL_6N32
DR   CLO; CLO_0036609
DR   Coriell; DA00654
DR   Wikidata; Q54818261
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00655
AC   CVCL_6N33
DR   CLO; CLO_0036606
DR   Coriell; DA00655
DR   Wikidata; Q54818262
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00656
AC   CVCL_6N34
DR   CLO; CLO_0036607
DR   Coriell; DA00656
DR   Wikidata; Q54818264
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00657
AC   CVCL_6N35
DR   CLO; CLO_0036605
DR   Coriell; DA00657
DR   Wikidata; Q54818265
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00658
AC   CVCL_6N36
DR   CLO; CLO_0036604
DR   Coriell; DA00658
DR   Wikidata; Q54818266
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00659
AC   CVCL_6N37
DR   CLO; CLO_0036603
DR   Coriell; DA00659
DR   Wikidata; Q54818268
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00660
AC   CVCL_6N38
DR   CLO; CLO_0036602
DR   Coriell; DA00660
DR   Wikidata; Q54818269
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00661
AC   CVCL_6N39
DR   CLO; CLO_0036601
DR   Coriell; DA00661
DR   Wikidata; Q54818270
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00662
AC   CVCL_6N40
DR   CLO; CLO_0036600
DR   Coriell; DA00662
DR   Wikidata; Q54818271
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00663
AC   CVCL_6N41
DR   CLO; CLO_0036599
DR   Coriell; DA00663
DR   Wikidata; Q54818272
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00664
AC   CVCL_6N42
DR   CLO; CLO_0036640
DR   Coriell; DA00664
DR   Wikidata; Q54818274
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00665
AC   CVCL_6N43
DR   CLO; CLO_0036641
DR   Coriell; DA00665
DR   Wikidata; Q54818276
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00666
AC   CVCL_6N44
DR   CLO; CLO_0036642
DR   Coriell; DA00666
DR   Wikidata; Q54818277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00667
AC   CVCL_6N45
DR   CLO; CLO_0036633
DR   Coriell; DA00667
DR   Wikidata; Q54818278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00668
AC   CVCL_6N46
DR   CLO; CLO_0036632
DR   Coriell; DA00668
DR   Wikidata; Q54818279
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00669
AC   CVCL_6N47
DR   CLO; CLO_0036635
DR   Coriell; DA00669
DR   Wikidata; Q54818280
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00670
AC   CVCL_6N48
DR   CLO; CLO_0036634
DR   Coriell; DA00670
DR   Wikidata; Q54818281
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00671
AC   CVCL_6N49
DR   CLO; CLO_0036637
DR   Coriell; DA00671
DR   Wikidata; Q54818282
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00672
AC   CVCL_6N50
DR   CLO; CLO_0036636
DR   Coriell; DA00672
DR   Wikidata; Q54818283
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00673
AC   CVCL_6N51
DR   CLO; CLO_0036639
DR   Coriell; DA00673
DR   Wikidata; Q54818284
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00674
AC   CVCL_6N52
DR   CLO; CLO_0036638
DR   Coriell; DA00674
DR   Wikidata; Q54818285
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00675
AC   CVCL_6N53
DR   CLO; CLO_0036630
DR   Coriell; DA00675
DR   Wikidata; Q54818286
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00676
AC   CVCL_6N54
DR   CLO; CLO_0036631
DR   Coriell; DA00676
DR   Wikidata; Q54818287
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00677
AC   CVCL_6N55
DR   CLO; CLO_0036621
DR   Coriell; DA00677
DR   Wikidata; Q54818288
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00678
AC   CVCL_6N56
DR   CLO; CLO_0036625
DR   Coriell; DA00678
DR   Wikidata; Q54818289
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00679
AC   CVCL_6N57
DR   CLO; CLO_0036624
DR   Coriell; DA00679
DR   Wikidata; Q54818290
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00680
AC   CVCL_6N58
DR   CLO; CLO_0036623
DR   Coriell; DA00680
DR   Wikidata; Q54818291
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00681
AC   CVCL_6N59
DR   CLO; CLO_0036622
DR   Coriell; DA00681
DR   Wikidata; Q54818292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00682
AC   CVCL_6N60
DR   CLO; CLO_0036629
DR   Coriell; DA00682
DR   Wikidata; Q54818293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00683
AC   CVCL_6N61
DR   CLO; CLO_0036628
DR   Coriell; DA00683
DR   Wikidata; Q54818294
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00684
AC   CVCL_6N62
DR   CLO; CLO_0036627
DR   Coriell; DA00684
DR   Wikidata; Q54818295
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00685
AC   CVCL_6N63
DR   CLO; CLO_0036626
DR   Coriell; DA00685
DR   Wikidata; Q54818296
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00686
AC   CVCL_6N64
DR   CLO; CLO_0036578
DR   Coriell; DA00686
DR   Wikidata; Q54818297
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00687
AC   CVCL_6N65
DR   CLO; CLO_0036568
DR   Coriell; DA00687
DR   Wikidata; Q54818298
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00688
AC   CVCL_6N66
DR   CLO; CLO_0036570
DR   Coriell; DA00688
DR   Wikidata; Q54818299
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00689
AC   CVCL_6N67
DR   CLO; CLO_0036561
DR   Coriell; DA00689
DR   Wikidata; Q54818300
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00690
AC   CVCL_6N68
DR   CLO; CLO_0036562
DR   Coriell; DA00690
DR   Wikidata; Q54818301
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00691
AC   CVCL_6N69
DR   CLO; CLO_0036563
DR   Coriell; DA00691
DR   Wikidata; Q54818302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00692
AC   CVCL_6N70
DR   CLO; CLO_0036564
DR   Coriell; DA00692
DR   Wikidata; Q54818303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00693
AC   CVCL_6N71
DR   CLO; CLO_0036557
DR   Coriell; DA00693
DR   Wikidata; Q54818304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00694
AC   CVCL_6N72
DR   CLO; CLO_0036558
DR   Coriell; DA00694
DR   Wikidata; Q54818305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00695
AC   CVCL_6N73
DR   CLO; CLO_0036559
DR   Coriell; DA00695
DR   Wikidata; Q54818306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00696
AC   CVCL_6N74
DR   CLO; CLO_0036560
DR   Coriell; DA00696
DR   Wikidata; Q54818307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00697
AC   CVCL_6N75
DR   CLO; CLO_0036554
DR   Coriell; DA00697
DR   Wikidata; Q54818308
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00698
AC   CVCL_6N76
DR   CLO; CLO_0036552
DR   Coriell; DA00698
DR   Wikidata; Q54818309
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00699
AC   CVCL_6N77
DR   CLO; CLO_0036553
DR   Coriell; DA00699
DR   Wikidata; Q54818310
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00700
AC   CVCL_6N78
DR   CLO; CLO_0036550
DR   Coriell; DA00700
DR   Wikidata; Q54818311
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00701
AC   CVCL_6N79
DR   CLO; CLO_0036551
DR   Coriell; DA00701
DR   Wikidata; Q54818312
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00702
AC   CVCL_6N80
DR   CLO; CLO_0036548
DR   Coriell; DA00702
DR   Wikidata; Q54818313
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00703
AC   CVCL_6N81
DR   CLO; CLO_0036549
DR   Coriell; DA00703
DR   Wikidata; Q54818314
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00704
AC   CVCL_6N82
DR   CLO; CLO_0036546
DR   Coriell; DA00704
DR   Wikidata; Q54818315
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00705
AC   CVCL_6N83
DR   CLO; CLO_0036547
DR   Coriell; DA00705
DR   Wikidata; Q54818319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00706
AC   CVCL_6N84
DR   CLO; CLO_0036545
DR   Coriell; DA00706
DR   Wikidata; Q54818320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00707
AC   CVCL_6N85
DR   CLO; CLO_0036595
DR   Coriell; DA00707
DR   Wikidata; Q54818321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00708
AC   CVCL_6N86
DR   CLO; CLO_0036596
DR   Coriell; DA00708
DR   Wikidata; Q54818322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00709
AC   CVCL_6N87
DR   CLO; CLO_0036597
DR   Coriell; DA00709
DR   Wikidata; Q54818323
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00710
AC   CVCL_6N88
DR   CLO; CLO_0036598
DR   Coriell; DA00710
DR   Wikidata; Q54818324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00711
AC   CVCL_6N89
DR   CLO; CLO_0036589
DR   Coriell; DA00711
DR   Wikidata; Q54818325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00712
AC   CVCL_6N90
DR   CLO; CLO_0036590
DR   Coriell; DA00712
DR   Wikidata; Q54818326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00713
AC   CVCL_6N91
DR   CLO; CLO_0036591
DR   Coriell; DA00713
DR   Wikidata; Q54818327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00714
AC   CVCL_6N92
DR   CLO; CLO_0036592
DR   Coriell; DA00714
DR   Wikidata; Q54818328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00715
AC   CVCL_6N93
DR   CLO; CLO_0036593
DR   Coriell; DA00715
DR   Wikidata; Q54818329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00716
AC   CVCL_6N94
DR   CLO; CLO_0036594
DR   Coriell; DA00716
DR   Wikidata; Q54818330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00717
AC   CVCL_6N95
DR   CLO; CLO_0036584
DR   Coriell; DA00717
DR   Wikidata; Q54818331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00718
AC   CVCL_6N96
DR   CLO; CLO_0036587
DR   Coriell; DA00718
DR   Wikidata; Q54818332
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00720
AC   CVCL_6N97
DR   CLO; CLO_0036588
DR   Coriell; DA00720
DR   Wikidata; Q54818333
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00721
AC   CVCL_6N98
DR   CLO; CLO_0036585
DR   Coriell; DA00721
DR   Wikidata; Q54818334
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00722
AC   CVCL_6N99
DR   CLO; CLO_0036586
DR   Coriell; DA00722
DR   Wikidata; Q54818335
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00723
AC   CVCL_6P00
DR   CLO; CLO_0036581
DR   Coriell; DA00723
DR   Wikidata; Q54818336
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00724
AC   CVCL_6P01
DR   CLO; CLO_0036582
DR   Coriell; DA00724
DR   Wikidata; Q54818337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00725
AC   CVCL_6P02
DR   CLO; CLO_0036579
DR   Coriell; DA00725
DR   Wikidata; Q54818338
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00726
AC   CVCL_6P03
DR   CLO; CLO_0036580
DR   Coriell; DA00726
DR   Wikidata; Q54818339
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00727
AC   CVCL_6P04
DR   CLO; CLO_0036583
DR   Coriell; DA00727
DR   Wikidata; Q54818340
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00728
AC   CVCL_6P05
DR   CLO; CLO_0024529
DR   Coriell; DA00728
DR   Wikidata; Q54818341
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00729
AC   CVCL_6P06
DR   CLO; CLO_0024530
DR   Coriell; DA00729
DR   Wikidata; Q54818342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00730
AC   CVCL_6P07
DR   CLO; CLO_0024531
DR   Coriell; DA00730
DR   Wikidata; Q54818343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00731
AC   CVCL_6P08
DR   CLO; CLO_0024532
DR   Coriell; DA00731
DR   Wikidata; Q54818344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00732
AC   CVCL_6P09
DR   CLO; CLO_0024533
DR   Coriell; DA00732
DR   Wikidata; Q54818345
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00733
AC   CVCL_6P10
DR   CLO; CLO_0024534
DR   Coriell; DA00733
DR   Wikidata; Q54818346
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00734
AC   CVCL_6P11
DR   CLO; CLO_0024535
DR   Coriell; DA00734
DR   Wikidata; Q54818347
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00735
AC   CVCL_6P12
DR   CLO; CLO_0024536
DR   Coriell; DA00735
DR   Wikidata; Q54818348
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00736
AC   CVCL_6P13
DR   CLO; CLO_0024537
DR   Coriell; DA00736
DR   Wikidata; Q54818349
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00737
AC   CVCL_6P14
DR   CLO; CLO_0024538
DR   Coriell; DA00737
DR   Wikidata; Q54818350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00738
AC   CVCL_6P15
DR   CLO; CLO_0024698
DR   Coriell; DA00738
DR   Wikidata; Q54818351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00739
AC   CVCL_6P16
DR   CLO; CLO_0024697
DR   Coriell; DA00739
DR   Wikidata; Q54818352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00740
AC   CVCL_6P17
DR   CLO; CLO_0024696
DR   Coriell; DA00740
DR   Wikidata; Q54818353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00741
AC   CVCL_6P18
DR   CLO; CLO_0024695
DR   Coriell; DA00741
DR   Wikidata; Q54818354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00742
AC   CVCL_6P19
DR   CLO; CLO_0024694
DR   Coriell; DA00742
DR   Wikidata; Q54818355
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00743
AC   CVCL_6P20
DR   CLO; CLO_0024693
DR   Coriell; DA00743
DR   Wikidata; Q54818356
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00744
AC   CVCL_6P21
DR   CLO; CLO_0024692
DR   Coriell; DA00744
DR   Wikidata; Q54818357
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00745
AC   CVCL_6P22
DR   CLO; CLO_0024691
DR   Coriell; DA00745
DR   Wikidata; Q54818358
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00746
AC   CVCL_6P23
DR   CLO; CLO_0024690
DR   Coriell; DA00746
DR   Wikidata; Q54818361
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00747
AC   CVCL_6P24
DR   CLO; CLO_0024689
DR   Coriell; DA00747
DR   Wikidata; Q54818362
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00748
AC   CVCL_6P25
DR   CLO; CLO_0024676
DR   Coriell; DA00748
DR   Wikidata; Q54818363
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00749
AC   CVCL_6P26
DR   CLO; CLO_0024675
DR   Coriell; DA00749
DR   Wikidata; Q54818364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00750
AC   CVCL_6P27
DR   CLO; CLO_0024678
DR   Coriell; DA00750
DR   Wikidata; Q54818365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00751
AC   CVCL_6P28
DR   CLO; CLO_0024677
DR   Coriell; DA00751
DR   Wikidata; Q54818366
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00752
AC   CVCL_6P29
DR   CLO; CLO_0024672
DR   Coriell; DA00752
DR   Wikidata; Q54818367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00753
AC   CVCL_6P30
DR   CLO; CLO_0024671
DR   Coriell; DA00753
DR   Wikidata; Q54818368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00754
AC   CVCL_6P31
DR   CLO; CLO_0024674
DR   Coriell; DA00754
DR   Wikidata; Q54818369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00755
AC   CVCL_6P32
DR   CLO; CLO_0024673
DR   Coriell; DA00755
DR   Wikidata; Q54818370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00756
AC   CVCL_6P33
DR   CLO; CLO_0024670
DR   Coriell; DA00756
DR   Wikidata; Q54818371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00757
AC   CVCL_6P34
DR   CLO; CLO_0024669
DR   Coriell; DA00757
DR   Wikidata; Q54818372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00758
AC   CVCL_6P35
DR   CLO; CLO_0024664
DR   Coriell; DA00758
DR   Wikidata; Q54818373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00759
AC   CVCL_6P36
DR   CLO; CLO_0024653
DR   Coriell; DA00759
DR   Wikidata; Q54818374
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00760
AC   CVCL_6P37
DR   CLO; CLO_0024652
DR   Coriell; DA00760
DR   Wikidata; Q54818375
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00761
AC   CVCL_6P38
DR   CLO; CLO_0024651
DR   Coriell; DA00761
DR   Wikidata; Q54818376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00762
AC   CVCL_6P39
DR   CLO; CLO_0024650
DR   Coriell; DA00762
DR   Wikidata; Q54818377
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00763
AC   CVCL_6P40
DR   CLO; CLO_0024657
DR   Coriell; DA00763
DR   Wikidata; Q54818378
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00764
AC   CVCL_6P41
DR   CLO; CLO_0024656
DR   Coriell; DA00764
DR   Wikidata; Q54818380
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00765
AC   CVCL_6P42
DR   CLO; CLO_0024655
DR   Coriell; DA00765
DR   Wikidata; Q54818381
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00766
AC   CVCL_6P43
DR   CLO; CLO_0024654
DR   Coriell; DA00766
DR   Wikidata; Q54818382
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00767
AC   CVCL_6P44
DR   CLO; CLO_0024649
DR   Coriell; DA00767
DR   Wikidata; Q54818383
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00768
AC   CVCL_6P45
DR   CLO; CLO_0024643
DR   Coriell; DA00768
DR   Wikidata; Q54818384
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00769
AC   CVCL_6P46
DR   CLO; CLO_0024645
DR   Coriell; DA00769
DR   Wikidata; Q54818385
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00770
AC   CVCL_6P47
DR   CLO; CLO_0024630
DR   Coriell; DA00770
DR   Wikidata; Q54818386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00771
AC   CVCL_6P48
DR   CLO; CLO_0024629
DR   Coriell; DA00771
DR   Wikidata; Q54818387
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00772
AC   CVCL_6P49
DR   CLO; CLO_0024632
DR   Coriell; DA00772
DR   Wikidata; Q54818388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00773
AC   CVCL_6P50
DR   CLO; CLO_0024631
DR   Coriell; DA00773
DR   Wikidata; Q54818389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00774
AC   CVCL_6P51
DR   CLO; CLO_0024634
DR   Coriell; DA00774
DR   Wikidata; Q54818390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00776
AC   CVCL_6P52
DR   CLO; CLO_0024633
DR   Coriell; DA00776
DR   Wikidata; Q54818391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00777
AC   CVCL_6P53
DR   CLO; CLO_0024636
DR   Coriell; DA00777
DR   Wikidata; Q54818392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00778
AC   CVCL_6P54
DR   CLO; CLO_0024635
DR   Coriell; DA00778
DR   Wikidata; Q54818393
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00779
AC   CVCL_6P55
DR   CLO; CLO_0023673
DR   Coriell; DA00779
DR   Wikidata; Q54818394
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00780
AC   CVCL_6P56
DR   CLO; CLO_0023678
DR   Coriell; DA00780
DR   Wikidata; Q54818395
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00781
AC   CVCL_6P57
DR   CLO; CLO_0023676
DR   Coriell; DA00781
DR   Wikidata; Q54818396
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00783
AC   CVCL_6P58
DR   CLO; CLO_0023691
DR   Coriell; DA00783
DR   Wikidata; Q54818397
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00784
AC   CVCL_6P59
DR   CLO; CLO_0023692
DR   Coriell; DA00784
DR   Wikidata; Q54818398
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00785
AC   CVCL_6P60
DR   CLO; CLO_0023693
DR   Coriell; DA00785
DR   Wikidata; Q54818399
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00786
AC   CVCL_6P61
DR   CLO; CLO_0023694
DR   Coriell; DA00786
DR   Wikidata; Q54818400
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00787
AC   CVCL_6P62
DR   CLO; CLO_0023696
DR   Coriell; DA00787
DR   Wikidata; Q54818401
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian and Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00788
AC   CVCL_6P63
DR   CLO; CLO_0023697
DR   Coriell; DA00788
DR   Wikidata; Q54818404
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00789
AC   CVCL_6P64
DR   CLO; CLO_0023699
DR   Coriell; DA00789
DR   Wikidata; Q54818406
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00790
AC   CVCL_6P65
DR   CLO; CLO_0023710
DR   Coriell; DA00790
DR   Wikidata; Q54818407
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00791
AC   CVCL_6P66
DR   CLO; CLO_0023709
DR   Coriell; DA00791
DR   Wikidata; Q54818408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00793
AC   CVCL_6P67
DR   CLO; CLO_0023707
DR   Coriell; DA00793
DR   Wikidata; Q54818409
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00794
AC   CVCL_6P68
DR   CLO; CLO_0023705
DR   Coriell; DA00794
DR   Wikidata; Q54818410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00795
AC   CVCL_6P69
DR   CLO; CLO_0023714
DR   Coriell; DA00795
DR   Wikidata; Q54818411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00796
AC   CVCL_6P70
DR   CLO; CLO_0023715
DR   Coriell; DA00796
DR   Wikidata; Q54818412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00797
AC   CVCL_6P71
DR   CLO; CLO_0023712
DR   Coriell; DA00797
DR   Wikidata; Q54818413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00798
AC   CVCL_6P72
DR   CLO; CLO_0023713
DR   Coriell; DA00798
DR   Wikidata; Q54818414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00799
AC   CVCL_6P73
DR   CLO; CLO_0023717
DR   Coriell; DA00799
DR   Wikidata; Q54818415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00800
AC   CVCL_6P74
DR   CLO; CLO_0023720
DR   Coriell; DA00800
DR   Wikidata; Q54818416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00803
AC   CVCL_6P75
DR   CLO; CLO_0023731
DR   Coriell; DA00803
DR   Wikidata; Q54818417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00804
AC   CVCL_6P76
DR   CLO; CLO_0023723
DR   Coriell; DA00804
DR   Wikidata; Q54818418
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00804; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA00805
AC   CVCL_6P77
DR   CLO; CLO_0023722
DR   Coriell; DA00805
DR   Wikidata; Q54818419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00806
AC   CVCL_6P78
DR   CLO; CLO_0023726
DR   Coriell; DA00806
DR   Wikidata; Q54818420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00807
AC   CVCL_6P79
DR   CLO; CLO_0023725
DR   Coriell; DA00807
DR   Wikidata; Q54818421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00808
AC   CVCL_6P80
DR   CLO; CLO_0023738
DR   Coriell; DA00808
DR   Wikidata; Q54818422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00809
AC   CVCL_6P81
DR   CLO; CLO_0023739
DR   Coriell; DA00809
DR   Wikidata; Q54818423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00810
AC   CVCL_6P82
DR   CLO; CLO_0023740
DR   Coriell; DA00810
DR   Wikidata; Q54818424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00811
AC   CVCL_6P83
DR   CLO; CLO_0023741
DR   Coriell; DA00811
DR   Wikidata; Q54818425
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00812
AC   CVCL_6P84
DR   CLO; CLO_0023733
DR   Coriell; DA00812
DR   Wikidata; Q54818426
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00813
AC   CVCL_6P85
DR   CLO; CLO_0023751
DR   Coriell; DA00813
DR   Wikidata; Q54818427
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00814
AC   CVCL_6P86
DR   CLO; CLO_0023748
DR   Coriell; DA00814
DR   Wikidata; Q54818428
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00815
AC   CVCL_6P87
DR   CLO; CLO_0023747
DR   Coriell; DA00815
DR   Wikidata; Q54818429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00816
AC   CVCL_6P88
DR   CLO; CLO_0023746
DR   Coriell; DA00816
DR   Wikidata; Q54818430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00817
AC   CVCL_6P89
DR   CLO; CLO_0023745
DR   Coriell; DA00817
DR   Wikidata; Q54818431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00818
AC   CVCL_6P90
DR   CLO; CLO_0023742
DR   Coriell; DA00818
DR   Wikidata; Q54818432
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00819
AC   CVCL_6P91
DR   CLO; CLO_0023756
DR   Coriell; DA00819
DR   Wikidata; Q54818433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00820
AC   CVCL_6P92
DR   CLO; CLO_0023757
DR   Coriell; DA00820
DR   Wikidata; Q54818434
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00821
AC   CVCL_6P93
DR   CLO; CLO_0023754
DR   Coriell; DA00821
DR   Wikidata; Q54818435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00822
AC   CVCL_6P94
DR   CLO; CLO_0023755
DR   Coriell; DA00822
DR   Wikidata; Q54818436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00824
AC   CVCL_6P95
DR   CLO; CLO_0023764
DR   Coriell; DA00824
DR   Wikidata; Q54818437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00825
AC   CVCL_6P96
DR   CLO; CLO_0023765
DR   Coriell; DA00825
DR   Wikidata; Q54818438
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00826
AC   CVCL_6P97
DR   CLO; CLO_0023766
DR   Coriell; DA00826
DR   Wikidata; Q54818439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00828
AC   CVCL_6P98
DR   CLO; CLO_0023768
DR   Coriell; DA00828
DR   Wikidata; Q54818440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00829
AC   CVCL_6P99
DR   CLO; CLO_0023769
DR   Coriell; DA00829
DR   Wikidata; Q54818441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00830
AC   CVCL_6Q00
DR   CLO; CLO_0023772
DR   Coriell; DA00830
DR   Wikidata; Q54818442
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00831
AC   CVCL_6Q01
DR   CLO; CLO_0023774
DR   Coriell; DA00831
DR   Wikidata; Q54818443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00832
AC   CVCL_6Q02
DR   CLO; CLO_0023776
DR   Coriell; DA00832
DR   Wikidata; Q54818444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00833
AC   CVCL_6Q03
DR   CLO; CLO_0023775
DR   Coriell; DA00833
DR   Wikidata; Q54818448
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00834
AC   CVCL_6Q04
DR   CLO; CLO_0023777
DR   Coriell; DA00834
DR   Wikidata; Q54818449
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00835
AC   CVCL_6Q05
DR   CLO; CLO_0024029
DR   Coriell; DA00835
DR   Wikidata; Q54818450
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00836
AC   CVCL_6Q06
DR   CLO; CLO_0024024
DR   Coriell; DA00836
DR   Wikidata; Q54818451
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00837
AC   CVCL_6Q07
DR   CLO; CLO_0024025
DR   Coriell; DA00837
DR   Wikidata; Q54818452
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00838
AC   CVCL_6Q08
DR   CLO; CLO_0024026
DR   Coriell; DA00838
DR   Wikidata; Q54818453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00839
AC   CVCL_6Q09
DR   CLO; CLO_0024027
DR   Coriell; DA00839
DR   Wikidata; Q54818454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00840
AC   CVCL_6Q10
DR   CLO; CLO_0024020
DR   Coriell; DA00840
DR   Wikidata; Q54818455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00841
AC   CVCL_6Q11
DR   CLO; CLO_0024021
DR   Coriell; DA00841
DR   Wikidata; Q54818456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00842
AC   CVCL_6Q12
DR   CLO; CLO_0024022
DR   Coriell; DA00842
DR   Wikidata; Q54818457
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00843
AC   CVCL_6Q13
DR   CLO; CLO_0024023
DR   Coriell; DA00843
DR   Wikidata; Q54818458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00844
AC   CVCL_6Q14
DR   CLO; CLO_0024016
DR   Coriell; DA00844
DR   Wikidata; Q54818459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00845
AC   CVCL_6Q15
DR   CLO; CLO_0024105
DR   Coriell; DA00845
DR   Wikidata; Q54818460
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00846
AC   CVCL_6Q16
DR   CLO; CLO_0024107
DR   Coriell; DA00846
DR   Wikidata; Q54818461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00847
AC   CVCL_6Q17
DR   CLO; CLO_0024110
DR   Coriell; DA00847
DR   Wikidata; Q54818462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00848
AC   CVCL_6Q18
DR   CLO; CLO_0024111
DR   Coriell; DA00848
DR   Wikidata; Q54818463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00850
AC   CVCL_6Q19
DR   CLO; CLO_0024108
DR   Coriell; DA00850
DR   Wikidata; Q54818464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00851
AC   CVCL_6Q20
DR   CLO; CLO_0024109
DR   Coriell; DA00851
DR   Wikidata; Q54818465
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00852
AC   CVCL_6Q21
DR   CLO; CLO_0024100
DR   Coriell; DA00852
DR   Wikidata; Q54818466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00853
AC   CVCL_6Q22
DR   CLO; CLO_0024101
DR   Coriell; DA00853
DR   Wikidata; Q54818467
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00854
AC   CVCL_6Q23
DR   CLO; CLO_0024098
DR   Coriell; DA00854
DR   Wikidata; Q54818468
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00855
AC   CVCL_6Q24
DR   CLO; CLO_0024099
DR   Coriell; DA00855
DR   Wikidata; Q54818469
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00856
AC   CVCL_6Q25
DR   CLO; CLO_0024071
DR   Coriell; DA00856
DR   Wikidata; Q54818470
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00857
AC   CVCL_6Q26
DR   CLO; CLO_0024072
DR   Coriell; DA00857
DR   Wikidata; Q54818471
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00858
AC   CVCL_6Q27
DR   CLO; CLO_0024074
DR   Coriell; DA00858
DR   Wikidata; Q54818472
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00859
AC   CVCL_6Q28
DR   CLO; CLO_0024076
DR   Coriell; DA00859
DR   Wikidata; Q54818473
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00860
AC   CVCL_6Q29
DR   CLO; CLO_0024077
DR   Coriell; DA00860
DR   Wikidata; Q54818474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00861
AC   CVCL_6Q30
DR   CLO; CLO_0024078
DR   Coriell; DA00861
DR   Wikidata; Q54818475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00862
AC   CVCL_6Q31
DR   CLO; CLO_0024079
DR   Coriell; DA00862
DR   Wikidata; Q54818476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00862; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA00863
AC   CVCL_6Q32
DR   CLO; CLO_0024067
DR   Coriell; DA00863
DR   Wikidata; Q54818477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00864
AC   CVCL_6Q33
DR   CLO; CLO_0024068
DR   Coriell; DA00864
DR   Wikidata; Q54818478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00865
AC   CVCL_6Q34
DR   CLO; CLO_0024069
DR   Coriell; DA00865
DR   Wikidata; Q54818479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00866
AC   CVCL_6Q35
DR   CLO; CLO_0024166
DR   Coriell; DA00866
DR   Wikidata; Q54818480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00867
AC   CVCL_6Q36
DR   CLO; CLO_0024165
DR   Coriell; DA00867
DR   Wikidata; Q54818481
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00868
AC   CVCL_6Q37
DR   CLO; CLO_0024164
DR   Coriell; DA00868
DR   Wikidata; Q54818482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00869
AC   CVCL_6Q38
DR   CLO; CLO_0024163
DR   Coriell; DA00869
DR   Wikidata; Q54818483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00870
AC   CVCL_6Q39
DR   CLO; CLO_0024162
DR   Coriell; DA00870
DR   Wikidata; Q54818484
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00871
AC   CVCL_6Q40
DR   CLO; CLO_0024161
DR   Coriell; DA00871
DR   Wikidata; Q54818485
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00872
AC   CVCL_6Q41
DR   CLO; CLO_0024160
DR   Coriell; DA00872
DR   Wikidata; Q54818486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00873
AC   CVCL_6Q42
DR   CLO; CLO_0024159
DR   Coriell; DA00873
DR   Wikidata; Q54818487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00874
AC   CVCL_6Q43
DR   CLO; CLO_0024168
DR   Coriell; DA00874
DR   Wikidata; Q54818490
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00875
AC   CVCL_6Q44
DR   CLO; CLO_0024167
DR   Coriell; DA00875
DR   Wikidata; Q54818491
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00876
AC   CVCL_6Q45
DR   CLO; CLO_0024154
DR   Coriell; DA00876
DR   Wikidata; Q54818492
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00877
AC   CVCL_6Q46
DR   CLO; CLO_0024144
DR   Coriell; DA00877
DR   Wikidata; Q54818493
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00878
AC   CVCL_6Q47
DR   CLO; CLO_0024143
DR   Coriell; DA00878
DR   Wikidata; Q54818494
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00879
AC   CVCL_6Q48
DR   CLO; CLO_0024146
DR   Coriell; DA00879
DR   Wikidata; Q54818495
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00880
AC   CVCL_6Q49
DR   CLO; CLO_0024145
DR   Coriell; DA00880
DR   Wikidata; Q54818496
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00881
AC   CVCL_6Q50
DR   CLO; CLO_0024140
DR   Coriell; DA00881
DR   Wikidata; Q54818497
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00882
AC   CVCL_6Q51
DR   CLO; CLO_0024139
DR   Coriell; DA00882
DR   Wikidata; Q54818498
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00883
AC   CVCL_6Q52
DR   CLO; CLO_0024142
DR   Coriell; DA00883
DR   Wikidata; Q54818499
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00884
AC   CVCL_6Q53
DR   CLO; CLO_0024141
DR   Coriell; DA00884
DR   Wikidata; Q54818500
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00885
AC   CVCL_6Q54
DR   CLO; CLO_0024147
DR   Coriell; DA00885
DR   Wikidata; Q54818501
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00886
AC   CVCL_6Q55
DR   CLO; CLO_0024216
DR   Coriell; DA00886
DR   Wikidata; Q54818502
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00887
AC   CVCL_6Q56
DR   CLO; CLO_0024218
DR   Coriell; DA00887
DR   Wikidata; Q54818503
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00888
AC   CVCL_6Q57
DR   CLO; CLO_0024202
DR   Coriell; DA00888
DR   Wikidata; Q54818504
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00889
AC   CVCL_6Q58
DR   CLO; CLO_0024201
DR   Coriell; DA00889
DR   Wikidata; Q54818505
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00890
AC   CVCL_6Q59
DR   CLO; CLO_0024200
DR   Coriell; DA00890
DR   Wikidata; Q54818506
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00891
AC   CVCL_6Q60
DR   CLO; CLO_0024199
DR   Coriell; DA00891
DR   Wikidata; Q54818507
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00892
AC   CVCL_6Q61
DR   CLO; CLO_0024206
DR   Coriell; DA00892
DR   Wikidata; Q54818508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00893
AC   CVCL_6Q62
DR   CLO; CLO_0024205
DR   Coriell; DA00893
DR   Wikidata; Q54818509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00894
AC   CVCL_6Q63
DR   CLO; CLO_0024204
DR   Coriell; DA00894
DR   Wikidata; Q54818510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00895
AC   CVCL_6Q64
DR   CLO; CLO_0024203
DR   Coriell; DA00895
DR   Wikidata; Q54818511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00896
AC   CVCL_6Q65
DR   CLO; CLO_0024194
DR   Coriell; DA00896
DR   Wikidata; Q54818513
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00897
AC   CVCL_6Q66
DR   CLO; CLO_0024195
DR   Coriell; DA00897
DR   Wikidata; Q54818514
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00898
AC   CVCL_6Q67
DR   CLO; CLO_0024197
DR   Coriell; DA00898
DR   Wikidata; Q54818515
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00899
AC   CVCL_6Q68
DR   CLO; CLO_0024180
DR   Coriell; DA00899
DR   Wikidata; Q54818516
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00900
AC   CVCL_6Q69
DR   CLO; CLO_0024179
DR   Coriell; DA00900
DR   Wikidata; Q54818517
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00901
AC   CVCL_6Q70
DR   CLO; CLO_0024182
DR   Coriell; DA00901
DR   Wikidata; Q54818518
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00902
AC   CVCL_6Q71
DR   CLO; CLO_0024181
DR   Coriell; DA00902
DR   Wikidata; Q54818519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00903
AC   CVCL_6Q72
DR   CLO; CLO_0024184
DR   Coriell; DA00903
DR   Wikidata; Q54818520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00904
AC   CVCL_6Q73
DR   CLO; CLO_0024183
DR   Coriell; DA00904
DR   Wikidata; Q54818521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00905
AC   CVCL_6Q74
DR   CLO; CLO_0024185
DR   Coriell; DA00905
DR   Wikidata; Q54818522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00906
AC   CVCL_6Q75
DR   CLO; CLO_0025305
DR   Coriell; DA00906
DR   Wikidata; Q54818523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00907
AC   CVCL_6Q76
DR   CLO; CLO_0025306
DR   Coriell; DA00907
DR   Wikidata; Q54818524
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00908
AC   CVCL_6Q77
DR   CLO; CLO_0025307
DR   Coriell; DA00908
DR   Wikidata; Q54818525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00909
AC   CVCL_6Q78
DR   CLO; CLO_0025308
DR   Coriell; DA00909
DR   Wikidata; Q54818526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00910
AC   CVCL_6Q79
DR   CLO; CLO_0025290
DR   Coriell; DA00910
DR   Wikidata; Q54818527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00911
AC   CVCL_6Q80
DR   CLO; CLO_0025289
DR   Coriell; DA00911
DR   Wikidata; Q54818528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00912
AC   CVCL_6Q81
DR   CLO; CLO_0025292
DR   Coriell; DA00912
DR   Wikidata; Q54818529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00913
AC   CVCL_6Q82
DR   CLO; CLO_0025291
DR   Coriell; DA00913
DR   Wikidata; Q54818531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00914
AC   CVCL_6Q83
DR   CLO; CLO_0025294
DR   Coriell; DA00914
DR   Wikidata; Q54818539
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00915
AC   CVCL_6Q84
DR   CLO; CLO_0025293
DR   Coriell; DA00915
DR   Wikidata; Q54818540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00916
AC   CVCL_6Q85
DR   CLO; CLO_0025282
DR   Coriell; DA00916
DR   Wikidata; Q54818541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00917
AC   CVCL_6Q86
DR   CLO; CLO_0025287
DR   Coriell; DA00917
DR   Wikidata; Q54818542
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00919
AC   CVCL_6Q87
DR   CLO; CLO_0025288
DR   Coriell; DA00919
DR   Wikidata; Q54818543
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00920
AC   CVCL_6Q88
DR   CLO; CLO_0025285
DR   Coriell; DA00920
DR   Wikidata; Q54818544
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00921
AC   CVCL_6Q89
DR   CLO; CLO_0025286
DR   Coriell; DA00921
DR   Wikidata; Q54818545
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00922
AC   CVCL_6Q90
DR   CLO; CLO_0025272
DR   Coriell; DA00922
DR   Wikidata; Q54818546
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00923
AC   CVCL_6Q91
DR   CLO; CLO_0025271
DR   Coriell; DA00923
DR   Wikidata; Q54818547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00924
AC   CVCL_6Q92
DR   CLO; CLO_0025270
DR   Coriell; DA00924
DR   Wikidata; Q54818548
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00925
AC   CVCL_6Q93
DR   CLO; CLO_0025269
DR   Coriell; DA00925
DR   Wikidata; Q54818549
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00926
AC   CVCL_6Q94
DR   CLO; CLO_0025273
DR   Coriell; DA00926
DR   Wikidata; Q54818550
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00927
AC   CVCL_6Q95
DR   CLO; CLO_0025266
DR   Coriell; DA00927
DR   Wikidata; Q54818551
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00928
AC   CVCL_6Q96
DR   CLO; CLO_0025268
DR   Coriell; DA00928
DR   Wikidata; Q54818552
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00929
AC   CVCL_6Q97
DR   CLO; CLO_0025259
DR   Coriell; DA00929
DR   Wikidata; Q54818553
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00930
AC   CVCL_6Q98
DR   CLO; CLO_0025260
DR   Coriell; DA00930
DR   Wikidata; Q54818554
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00931
AC   CVCL_6Q99
DR   CLO; CLO_0025261
DR   Coriell; DA00931
DR   Wikidata; Q54818555
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00932
AC   CVCL_6R00
DR   CLO; CLO_0025262
DR   Coriell; DA00932
DR   Wikidata; Q54818556
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00933
AC   CVCL_6R01
DR   CLO; CLO_0025250
DR   Coriell; DA00933
DR   Wikidata; Q54818557
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00934
AC   CVCL_6R02
DR   CLO; CLO_0025249
DR   Coriell; DA00934
DR   Wikidata; Q54818559
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00935
AC   CVCL_6R03
DR   CLO; CLO_0025252
DR   Coriell; DA00935
DR   Wikidata; Q54818560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00936
AC   CVCL_6R04
DR   CLO; CLO_0025251
DR   Coriell; DA00936
DR   Wikidata; Q54818561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00937
AC   CVCL_6R05
DR   CLO; CLO_0025437
DR   Coriell; DA00937
DR   Wikidata; Q54818563
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00938
AC   CVCL_6R06
DR   CLO; CLO_0025438
DR   Coriell; DA00938
DR   Wikidata; Q54818564
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00939
AC   CVCL_6R07
DR   CLO; CLO_0025435
DR   Coriell; DA00939
DR   Wikidata; Q54818565
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00940
AC   CVCL_6R08
DR   CLO; CLO_0025436
DR   Coriell; DA00940
DR   Wikidata; Q54818566
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00941
AC   CVCL_6R09
DR   CLO; CLO_0025431
DR   Coriell; DA00941
DR   Wikidata; Q54818567
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00942
AC   CVCL_6R10
DR   CLO; CLO_0025432
DR   Coriell; DA00942
DR   Wikidata; Q54818568
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00943
AC   CVCL_6R11
DR   CLO; CLO_0025429
DR   Coriell; DA00943
DR   Wikidata; Q54818569
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00944
AC   CVCL_6R12
DR   CLO; CLO_0025430
DR   Coriell; DA00944
DR   Wikidata; Q54818570
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00945
AC   CVCL_6R13
DR   CLO; CLO_0025433
DR   Coriell; DA00945
DR   Wikidata; Q54818571
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00946
AC   CVCL_6R14
DR   CLO; CLO_0025434
DR   Coriell; DA00946
DR   Wikidata; Q54818572
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00948
AC   CVCL_6R15
DR   CLO; CLO_0025413
DR   Coriell; DA00948
DR   Wikidata; Q54818573
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00949
AC   CVCL_6R16
DR   Coriell; DA00949
DR   Wikidata; Q54818574
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00949; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00950
AC   CVCL_6R17
DR   CLO; CLO_0025412
DR   Coriell; DA00950
DR   Wikidata; Q54818575
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00951
AC   CVCL_6R18
DR   Coriell; DA00951
DR   Wikidata; Q54818576
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00951; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00952
AC   CVCL_6R19
DR   Coriell; DA00952
DR   Wikidata; Q54818577
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00952; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00953
AC   CVCL_6R20
DR   Coriell; DA00953
DR   Wikidata; Q54818578
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00953; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00954
AC   CVCL_6R21
DR   CLO; CLO_0025411
DR   Coriell; DA00954
DR   Wikidata; Q54818579
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00955
AC   CVCL_6R22
DR   CLO; CLO_0025410
DR   Coriell; DA00955
DR   Wikidata; Q54818580
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00956
AC   CVCL_6R23
DR   CLO; CLO_0025409
DR   Coriell; DA00956
DR   Wikidata; Q54818593
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00957
AC   CVCL_6R24
DR   CLO; CLO_0025418
DR   Coriell; DA00957
DR   Wikidata; Q54818594
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00958
AC   CVCL_6R25
DR   CLO; CLO_0025417
DR   Coriell; DA00958
DR   Wikidata; Q54818595
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00959
AC   CVCL_6R26
DR   CLO; CLO_0025416
DR   Coriell; DA00959
DR   Wikidata; Q54818596
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00960
AC   CVCL_6R27
DR   CLO; CLO_0025415
DR   Coriell; DA00960
DR   Wikidata; Q54818597
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00961
AC   CVCL_6R28
DR   CLO; CLO_0025414
DR   Coriell; DA00961
DR   Wikidata; Q54818598
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00962
AC   CVCL_6R29
DR   CLO; CLO_0025424
DR   Coriell; DA00962
DR   Wikidata; Q54818600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00963
AC   CVCL_6R30
DR   CLO; CLO_0025423
DR   Coriell; DA00963
DR   Wikidata; Q54818601
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00964
AC   CVCL_6R31
DR   CLO; CLO_0025420
DR   Coriell; DA00964
DR   Wikidata; Q54818602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00965
AC   CVCL_6R32
DR   Coriell; DA00965
DR   Wikidata; Q54818603
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00965; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00966
AC   CVCL_6R33
DR   CLO; CLO_0025419
DR   Coriell; DA00966
DR   Wikidata; Q54818604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00967
AC   CVCL_6R34
DR   Coriell; DA00967
DR   Wikidata; Q54818605
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00967; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00968
AC   CVCL_6R35
DR   CLO; CLO_0025422
DR   Coriell; DA00968
DR   Wikidata; Q54818606
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00969
AC   CVCL_6R36
DR   Coriell; DA00969
DR   Wikidata; Q54818607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00969; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00970
AC   CVCL_6R37
DR   CLO; CLO_0025421
DR   Coriell; DA00970
DR   Wikidata; Q54818608
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00971
AC   CVCL_GR66
DR   Coriell; DA00971
DR   Wikidata; Q54818610
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00971; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   DA00972
AC   CVCL_6R38
DR   CLO; CLO_0025426
DR   Coriell; DA00972
DR   Wikidata; Q54818611
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00973
AC   CVCL_6R39
DR   CLO; CLO_0025425
DR   Coriell; DA00973
DR   Wikidata; Q54818612
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00974
AC   CVCL_6R40
DR   CLO; CLO_0025428
DR   Coriell; DA00974
DR   Wikidata; Q54818613
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00975
AC   CVCL_6R41
DR   CLO; CLO_0025427
DR   Coriell; DA00975
DR   Wikidata; Q54818614
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00976
AC   CVCL_6R42
DR   CLO; CLO_0025391
DR   Coriell; DA00976
DR   Wikidata; Q54818615
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00977
AC   CVCL_6R43
DR   CLO; CLO_0025390
DR   Coriell; DA00977
DR   Wikidata; Q54818616
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00978
AC   CVCL_6R44
DR   Coriell; DA00978
DR   Wikidata; Q54818617
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00978; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00979
AC   CVCL_6R45
DR   CLO; CLO_0025389
DR   Coriell; DA00979
DR   Wikidata; Q54818618
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00980
AC   CVCL_6R46
DR   CLO; CLO_0025395
DR   Coriell; DA00980
DR   Wikidata; Q54818619
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00981
AC   CVCL_6R47
DR   Coriell; DA00981
DR   Wikidata; Q54818621
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00981; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00982
AC   CVCL_6R48
DR   Coriell; DA00982
DR   Wikidata; Q54818622
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00982; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00983
AC   CVCL_6R49
DR   Coriell; DA00983
DR   Wikidata; Q54818623
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00983; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00984
AC   CVCL_6R50
DR   CLO; CLO_0025394
DR   Coriell; DA00984
DR   Wikidata; Q54818624
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00985
AC   CVCL_6R51
DR   CLO; CLO_0025393
DR   Coriell; DA00985
DR   Wikidata; Q54818625
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00986
AC   CVCL_6R52
DR   CLO; CLO_0025392
DR   Coriell; DA00986
DR   Wikidata; Q54818626
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00987
AC   CVCL_6R53
DR   CLO; CLO_0025398
DR   Coriell; DA00987
DR   Wikidata; Q54818627
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00988
AC   CVCL_6R54
DR   CLO; CLO_0025397
DR   Coriell; DA00988
DR   Wikidata; Q54818628
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00989
AC   CVCL_6R55
DR   CLO; CLO_0025396
DR   Coriell; DA00989
DR   Wikidata; Q54818629
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00990
AC   CVCL_6R56
DR   Coriell; DA00990
DR   Wikidata; Q54818631
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA00990; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00991
AC   CVCL_6R57
DR   CLO; CLO_0025400
DR   Coriell; DA00991
DR   Wikidata; Q54818632
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00992
AC   CVCL_6R58
DR   CLO; CLO_0025399
DR   Coriell; DA00992
DR   Wikidata; Q54818633
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00994
AC   CVCL_6R59
DR   CLO; CLO_0025402
DR   Coriell; DA00994
DR   Wikidata; Q54818634
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00995
AC   CVCL_6R60
DR   CLO; CLO_0025401
DR   Coriell; DA00995
DR   Wikidata; Q54818635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00996
AC   CVCL_6R61
DR   CLO; CLO_0025404
DR   Coriell; DA00996
DR   Wikidata; Q54818636
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00997
AC   CVCL_6R62
DR   CLO; CLO_0025403
DR   Coriell; DA00997
DR   Wikidata; Q54818646
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00998
AC   CVCL_6R63
DR   CLO; CLO_0025406
DR   Coriell; DA00998
DR   Wikidata; Q54818647
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA00999
AC   CVCL_6R64
DR   CLO; CLO_0025405
DR   Coriell; DA00999
DR   Wikidata; Q54818648
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01000
AC   CVCL_6R65
DR   CLO; CLO_0025408
DR   Coriell; DA01000
DR   Wikidata; Q54818649
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01001
AC   CVCL_6R66
DR   Coriell; DA01001
DR   Wikidata; Q54818650
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01001; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01002
AC   CVCL_6R67
DR   CLO; CLO_0025407
DR   Coriell; DA01002
DR   Wikidata; Q54818651
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01003
AC   CVCL_6R68
DR   Coriell; DA01003
DR   Wikidata; Q54818652
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01003; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01004
AC   CVCL_6R69
DR   CLO; CLO_0025350
DR   Coriell; DA01004
DR   Wikidata; Q54818653
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01005
AC   CVCL_6R70
DR   CLO; CLO_0025367
DR   Coriell; DA01005
DR   Wikidata; Q54818654
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01006
AC   CVCL_6R71
DR   CLO; CLO_0025368
DR   Coriell; DA01006
DR   Wikidata; Q54818655
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01007
AC   CVCL_6R72
DR   Coriell; DA01007
DR   Wikidata; Q54818656
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01007; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01008
AC   CVCL_6R73
DR   CLO; CLO_0025365
DR   Coriell; DA01008
DR   Wikidata; Q54818657
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01009
AC   CVCL_6R74
DR   Coriell; DA01009
DR   Wikidata; Q54818658
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01009; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01010
AC   CVCL_6R75
DR   CLO; CLO_0025366
DR   Coriell; DA01010
DR   Wikidata; Q54818659
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01011
AC   CVCL_6R76
DR   CLO; CLO_0025363
DR   Coriell; DA01011
DR   Wikidata; Q54818660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01012
AC   CVCL_6R77
DR   CLO; CLO_0025364
DR   Coriell; DA01012
DR   Wikidata; Q54818661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01013
AC   CVCL_GR65
DR   Coriell; DA01013
DR   Wikidata; Q54818662
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01013; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   DA01014
AC   CVCL_6R78
DR   CLO; CLO_0025361
DR   Coriell; DA01014
DR   Wikidata; Q54818663
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01015
AC   CVCL_6R79
DR   CLO; CLO_0025362
DR   Coriell; DA01015
DR   Wikidata; Q54818664
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01017
AC   CVCL_6R80
DR   CLO; CLO_0025360
DR   Coriell; DA01017
DR   Wikidata; Q54818665
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01018
AC   CVCL_6R81
DR   Coriell; DA01018
DR   Wikidata; Q54818666
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01019
AC   CVCL_6R82
DR   CLO; CLO_0025370
DR   Coriell; DA01019
DR   Wikidata; Q54818667
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01020
AC   CVCL_6R83
DR   CLO; CLO_0025385
DR   Coriell; DA01020
DR   Wikidata; Q54818668
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01021
AC   CVCL_6R84
DR   Coriell; DA01021
DR   Wikidata; Q54818669
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01021; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01022
AC   CVCL_6R85
DR   CLO; CLO_0025386
DR   Coriell; DA01022
DR   Wikidata; Q54818670
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01023
AC   CVCL_6R86
DR   Coriell; DA01023
DR   Wikidata; Q54818671
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01023; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01024
AC   CVCL_6R87
DR   Coriell; DA01024
DR   Wikidata; Q54818672
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01024; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01025
AC   CVCL_6R88
DR   Coriell; DA01025
DR   Wikidata; Q54818673
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01025; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01026
AC   CVCL_6R89
DR   CLO; CLO_0025387
DR   Coriell; DA01026
DR   Wikidata; Q54818674
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01027
AC   CVCL_6R90
DR   Coriell; DA01027
DR   Wikidata; Q54818675
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01027; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01028
AC   CVCL_6R91
DR   CLO; CLO_0025388
DR   Coriell; DA01028
DR   Wikidata; Q54818676
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01029
AC   CVCL_6R92
DR   Coriell; DA01029
DR   Wikidata; Q54818677
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01029; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01030
AC   CVCL_6R93
DR   Coriell; DA01030
DR   Wikidata; Q54818678
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01030; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01031
AC   CVCL_6R94
DR   CLO; CLO_0025381
DR   Coriell; DA01031
DR   Wikidata; Q54818679
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01032
AC   CVCL_6R95
DR   CLO; CLO_0025382
DR   Coriell; DA01032
DR   Wikidata; Q54818680
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01033
AC   CVCL_6R96
DR   Coriell; DA01033
DR   Wikidata; Q54818681
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01033; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01034
AC   CVCL_6R97
DR   CLO; CLO_0025383
DR   Coriell; DA01034
DR   Wikidata; Q54818682
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01035
AC   CVCL_6R98
DR   CLO; CLO_0025384
DR   Coriell; DA01035
DR   Wikidata; Q54818683
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01036
AC   CVCL_6R99
DR   CLO; CLO_0025318
DR   Coriell; DA01036
DR   Wikidata; Q54818684
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01037
AC   CVCL_6S00
DR   CLO; CLO_0025315
DR   Coriell; DA01037
DR   Wikidata; Q54818685
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01039
AC   CVCL_6S01
DR   CLO; CLO_0025314
DR   Coriell; DA01039
DR   Wikidata; Q54818690
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01040
AC   CVCL_6S02
DR   CLO; CLO_0025325
DR   Coriell; DA01040
DR   Wikidata; Q54818691
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01043
AC   CVCL_6S03
DR   CLO; CLO_0025326
DR   Coriell; DA01043
DR   Wikidata; Q54818692
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01044
AC   CVCL_6S04
DR   CLO; CLO_0025322
DR   Coriell; DA01044
DR   Wikidata; Q54818693
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01045
AC   CVCL_6S05
DR   CLO; CLO_0025324
DR   Coriell; DA01045
DR   Wikidata; Q54818694
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01046
AC   CVCL_6S06
DR   CLO; CLO_0025328
DR   Coriell; DA01046
DR   Wikidata; Q54818696
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01047
AC   CVCL_6S07
DR   CLO; CLO_0025329
DR   Coriell; DA01047
DR   Wikidata; Q54818697
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01048
AC   CVCL_6S08
DR   CLO; CLO_0025327
DR   Coriell; DA01048
DR   Wikidata; Q54818698
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01049
AC   CVCL_6S09
DR   CLO; CLO_0025337
DR   Coriell; DA01049
DR   Wikidata; Q54818699
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01049; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA01050
AC   CVCL_6S10
DR   CLO; CLO_0025334
DR   Coriell; DA01050
DR   Wikidata; Q54818700
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01051
AC   CVCL_6S11
DR   CLO; CLO_0025340
DR   Coriell; DA01051
DR   Wikidata; Q54818701
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01052
AC   CVCL_6S12
DR   CLO; CLO_0025339
DR   Coriell; DA01052
DR   Wikidata; Q54818702
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01053
AC   CVCL_6S13
DR   CLO; CLO_0025343
DR   Coriell; DA01053
DR   Wikidata; Q54818704
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01054
AC   CVCL_6S14
DR   Coriell; DA01054
DR   Wikidata; Q54818705
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01054; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01055
AC   CVCL_6S15
DR   CLO; CLO_0025344
DR   Coriell; DA01055
DR   Wikidata; Q54818706
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01056
AC   CVCL_6S16
DR   CLO; CLO_0025345
DR   Coriell; DA01056
DR   Wikidata; Q54818707
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01057
AC   CVCL_6S17
DR   CLO; CLO_0025346
DR   Coriell; DA01057
DR   Wikidata; Q54818708
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01058
AC   CVCL_6S18
DR   CLO; CLO_0025347
DR   Coriell; DA01058
DR   Wikidata; Q54818709
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01059
AC   CVCL_6S19
DR   CLO; CLO_0025348
DR   Coriell; DA01059
DR   Wikidata; Q54818710
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01060
AC   CVCL_6S20
DR   CLO; CLO_0024776
DR   Coriell; DA01060
DR   Wikidata; Q54818711
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01062
AC   CVCL_6S21
DR   CLO; CLO_0024777
DR   Coriell; DA01062
DR   Wikidata; Q54818713
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01063
AC   CVCL_6S22
DR   CLO; CLO_0024778
DR   Coriell; DA01063
DR   Wikidata; Q54818714
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01064
AC   CVCL_6S23
DR   CLO; CLO_0024779
DR   Coriell; DA01064
DR   Wikidata; Q54818715
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01065
AC   CVCL_6S24
DR   CLO; CLO_0024780
DR   Coriell; DA01065
DR   Wikidata; Q54818716
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01066
AC   CVCL_6S25
DR   CLO; CLO_0024771
DR   Coriell; DA01066
DR   Wikidata; Q54818717
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01067
AC   CVCL_6S26
DR   CLO; CLO_0024770
DR   Coriell; DA01067
DR   Wikidata; Q54818718
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01068
AC   CVCL_6S27
DR   CLO; CLO_0024773
DR   Coriell; DA01068
DR   Wikidata; Q54818719
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01070
AC   CVCL_6S28
DR   CLO; CLO_0024772
DR   Coriell; DA01070
DR   Wikidata; Q54818720
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01071
AC   CVCL_6S29
DR   CLO; CLO_0024774
DR   Coriell; DA01071
DR   Wikidata; Q54818721
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01072
AC   CVCL_6S30
DR   CLO; CLO_0025001
DR   Coriell; DA01072
DR   Wikidata; Q54818722
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01073
AC   CVCL_6S31
DR   CLO; CLO_0024999
DR   Coriell; DA01073
DR   Wikidata; Q54818723
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01074
AC   CVCL_6S32
DR   CLO; CLO_0025000
DR   Coriell; DA01074
DR   Wikidata; Q54818724
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01075
AC   CVCL_6S33
DR   CLO; CLO_0025012
DR   Coriell; DA01075
DR   Wikidata; Q54818725
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01076
AC   CVCL_6S34
DR   CLO; CLO_0025013
DR   Coriell; DA01076
DR   Wikidata; Q54818726
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01077
AC   CVCL_6S35
DR   CLO; CLO_0025009
DR   Coriell; DA01077
DR   Wikidata; Q54818727
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01078
AC   CVCL_6S36
DR   CLO; CLO_0025010
DR   Coriell; DA01078
DR   Wikidata; Q54818728
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01079
AC   CVCL_6S37
DR   CLO; CLO_0025006
DR   Coriell; DA01079
DR   Wikidata; Q54818729
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01080
AC   CVCL_6S38
DR   CLO; CLO_0025007
DR   Coriell; DA01080
DR   Wikidata; Q54818730
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01081
AC   CVCL_6S39
DR   CLO; CLO_0025003
DR   Coriell; DA01081
DR   Wikidata; Q54818731
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01082
AC   CVCL_6S40
DR   CLO; CLO_0025019
DR   Coriell; DA01082
DR   Wikidata; Q54818732
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01083
AC   CVCL_6S41
DR   CLO; CLO_0025020
DR   Coriell; DA01083
DR   Wikidata; Q54818735
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01084
AC   CVCL_6S42
DR   CLO; CLO_0025021
DR   Coriell; DA01084
DR   Wikidata; Q54818736
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01085
AC   CVCL_6S43
DR   CLO; CLO_0025022
DR   Coriell; DA01085
DR   Wikidata; Q54818737
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01086
AC   CVCL_6S44
DR   CLO; CLO_0025023
DR   Coriell; DA01086
DR   Wikidata; Q54818738
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01087
AC   CVCL_6S45
DR   CLO; CLO_0025024
DR   Coriell; DA01087
DR   Wikidata; Q54818739
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01088
AC   CVCL_6S46
DR   CLO; CLO_0025025
DR   Coriell; DA01088
DR   Wikidata; Q54818740
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01092
AC   CVCL_6S47
DR   CLO; CLO_0025026
DR   Coriell; DA01092
DR   Wikidata; Q54818741
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01093
AC   CVCL_6S48
DR   CLO; CLO_0025027
DR   Coriell; DA01093
DR   Wikidata; Q54818742
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01095
AC   CVCL_6S49
DR   CLO; CLO_0025030
DR   Coriell; DA01095
DR   Wikidata; Q54818743
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01097
AC   CVCL_6S50
DR   CLO; CLO_0025039
DR   Coriell; DA01097
DR   Wikidata; Q54818744
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01098
AC   CVCL_6S51
DR   CLO; CLO_0025042
DR   Coriell; DA01098
DR   Wikidata; Q54818745
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01099
AC   CVCL_6S52
DR   CLO; CLO_0025043
DR   Coriell; DA01099
DR   Wikidata; Q54818746
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01100
AC   CVCL_6S53
DR   CLO; CLO_0025040
DR   Coriell; DA01100
DR   Wikidata; Q54818747
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01103
AC   CVCL_6S54
DR   CLO; CLO_0025041
DR   Coriell; DA01103
DR   Wikidata; Q54818748
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01104
AC   CVCL_6S55
DR   CLO; CLO_0025046
DR   Coriell; DA01104
DR   Wikidata; Q54818749
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01105
AC   CVCL_6S56
DR   CLO; CLO_0025047
DR   Coriell; DA01105
DR   Wikidata; Q54818750
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01106
AC   CVCL_6S57
DR   CLO; CLO_0025044
DR   Coriell; DA01106
DR   Wikidata; Q54818751
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01107
AC   CVCL_6S58
DR   CLO; CLO_0025045
DR   Coriell; DA01107
DR   Wikidata; Q54818752
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01108
AC   CVCL_6S59
DR   CLO; CLO_0025048
DR   Coriell; DA01108
DR   Wikidata; Q54818753
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01109
AC   CVCL_6S60
DR   CLO; CLO_0024946
DR   Coriell; DA01109
DR   Wikidata; Q54818754
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01110
AC   CVCL_6S61
DR   CLO; CLO_0024945
DR   Coriell; DA01110
DR   Wikidata; Q54818755
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01111
AC   CVCL_6S62
DR   CLO; CLO_0024942
DR   Coriell; DA01111
DR   Wikidata; Q54818756
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01112
AC   CVCL_6S63
DR   CLO; CLO_0024939
DR   Coriell; DA01112
DR   Wikidata; Q54818757
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01113
AC   CVCL_6S64
DR   CLO; CLO_0024938
DR   Coriell; DA01113
DR   Wikidata; Q54818758
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01114
AC   CVCL_6S65
DR   CLO; CLO_0024936
DR   Coriell; DA01114
DR   Wikidata; Q54818759
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01115
AC   CVCL_6S66
DR   CLO; CLO_0024934
DR   Coriell; DA01115
DR   Wikidata; Q54818760
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01116
AC   CVCL_6S67
DR   CLO; CLO_0024932
DR   Coriell; DA01116
DR   Wikidata; Q54818761
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01117
AC   CVCL_6S68
DR   CLO; CLO_0024931
DR   Coriell; DA01117
DR   Wikidata; Q54818762
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01118
AC   CVCL_6S69
DR   CLO; CLO_0024930
DR   Coriell; DA01118
DR   Wikidata; Q54818763
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01119
AC   CVCL_6S70
DR   CLO; CLO_0024966
DR   Coriell; DA01119
DR   Wikidata; Q54818764
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01120
AC   CVCL_6S71
DR   CLO; CLO_0024968
DR   Coriell; DA01120
DR   Wikidata; Q54818765
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01121
AC   CVCL_6S72
DR   CLO; CLO_0024967
DR   Coriell; DA01121
DR   Wikidata; Q54818766
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01122
AC   CVCL_6S73
DR   CLO; CLO_0024963
DR   Coriell; DA01122
DR   Wikidata; Q54818767
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01123
AC   CVCL_6S74
DR   CLO; CLO_0024962
DR   Coriell; DA01123
DR   Wikidata; Q54818768
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01123; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA01124
AC   CVCL_6S75
DR   CLO; CLO_0024965
DR   Coriell; DA01124
DR   Wikidata; Q54818769
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01125
AC   CVCL_6S76
DR   CLO; CLO_0024964
DR   Coriell; DA01125
DR   Wikidata; Q54818770
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01126
AC   CVCL_6S77
DR   CLO; CLO_0024960
DR   Coriell; DA01126
DR   Wikidata; Q54818771
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01127
AC   CVCL_6S78
DR   CLO; CLO_0024959
DR   Coriell; DA01127
DR   Wikidata; Q54818772
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01128
AC   CVCL_6S79
DR   CLO; CLO_0024961
DR   Coriell; DA01128
DR   Wikidata; Q54818773
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01129
AC   CVCL_6S80
DR   CLO; CLO_0024974
DR   Coriell; DA01129
DR   Wikidata; Q54818774
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01130
AC   CVCL_6S81
DR   CLO; CLO_0024973
DR   Coriell; DA01130
DR   Wikidata; Q54818778
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01131
AC   CVCL_6S82
DR   CLO; CLO_0024972
DR   Coriell; DA01131
DR   Wikidata; Q54818779
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01132
AC   CVCL_6S83
DR   CLO; CLO_0024971
DR   Coriell; DA01132
DR   Wikidata; Q54818780
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01133
AC   CVCL_6S84
DR   CLO; CLO_0024978
DR   Coriell; DA01133
DR   Wikidata; Q54818781
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01134
AC   CVCL_6S85
DR   CLO; CLO_0024977
DR   Coriell; DA01134
DR   Wikidata; Q54818782
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01135
AC   CVCL_6S86
DR   CLO; CLO_0024976
DR   Coriell; DA01135
DR   Wikidata; Q54818783
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01136
AC   CVCL_6S87
DR   CLO; CLO_0024975
DR   Coriell; DA01136
DR   Wikidata; Q54818784
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01137
AC   CVCL_6S88
DR   CLO; CLO_0024970
DR   Coriell; DA01137
DR   Wikidata; Q54818785
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01138
AC   CVCL_6S89
DR   CLO; CLO_0024969
DR   Coriell; DA01138
DR   Wikidata; Q54818786
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01139
AC   CVCL_6S90
DR   CLO; CLO_0024979
DR   Coriell; DA01139
DR   Wikidata; Q54818787
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01140
AC   CVCL_6S91
DR   CLO; CLO_0024982
DR   Coriell; DA01140
DR   Wikidata; Q54818788
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01141
AC   CVCL_6S92
DR   CLO; CLO_0024981
DR   Coriell; DA01141
DR   Wikidata; Q54818789
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01142
AC   CVCL_6S93
DR   CLO; CLO_0024984
DR   Coriell; DA01142
DR   Wikidata; Q54818790
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01143
AC   CVCL_6S94
DR   CLO; CLO_0024983
DR   Coriell; DA01143
DR   Wikidata; Q54818791
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01144
AC   CVCL_6S95
DR   CLO; CLO_0024986
DR   Coriell; DA01144
DR   Wikidata; Q54818792
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01145
AC   CVCL_6S96
DR   CLO; CLO_0024985
DR   Coriell; DA01145
DR   Wikidata; Q54818793
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01146
AC   CVCL_6S97
DR   CLO; CLO_0024988
DR   Coriell; DA01146
DR   Wikidata; Q54818794
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01147
AC   CVCL_6S98
DR   CLO; CLO_0024987
DR   Coriell; DA01147
DR   Wikidata; Q54818795
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01148
AC   CVCL_6S99
DR   CLO; CLO_0024980
DR   Coriell; DA01148
DR   Wikidata; Q54818796
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01149
AC   CVCL_6T00
DR   CLO; CLO_0024817
DR   Coriell; DA01149
DR   Wikidata; Q54818797
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01150
AC   CVCL_6T01
DR   CLO; CLO_0024815
DR   Coriell; DA01150
DR   Wikidata; Q54818798
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01151
AC   CVCL_6T02
DR   CLO; CLO_0024836
DR   Coriell; DA01151
DR   Wikidata; Q54818799
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01152
AC   CVCL_6T03
DR   CLO; CLO_0024837
DR   Coriell; DA01152
DR   Wikidata; Q54818801
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01153
AC   CVCL_6T04
DR   CLO; CLO_0024831
DR   Coriell; DA01153
DR   Wikidata; Q54818802
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01154
AC   CVCL_6T05
DR   CLO; CLO_0024833
DR   Coriell; DA01154
DR   Wikidata; Q54818803
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01155
AC   CVCL_6T06
DR   CLO; CLO_0024828
DR   Coriell; DA01155
DR   Wikidata; Q54818804
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01156
AC   CVCL_6T07
DR   CLO; CLO_0024829
DR   Coriell; DA01156
DR   Wikidata; Q54818805
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01157
AC   CVCL_6T08
DR   CLO; CLO_0024826
DR   Coriell; DA01157
DR   Wikidata; Q54818806
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01158
AC   CVCL_6T09
DR   CLO; CLO_0024827
DR   Coriell; DA01158
DR   Wikidata; Q54818807
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01159
AC   CVCL_6T10
DR   CLO; CLO_0024844
DR   Coriell; DA01159
DR   Wikidata; Q54818808
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01160
AC   CVCL_6T11
DR   CLO; CLO_0024849
DR   Coriell; DA01160
DR   Wikidata; Q54818809
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01161
AC   CVCL_6T12
DR   CLO; CLO_0024846
DR   Coriell; DA01161
DR   Wikidata; Q54818810
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01162
AC   CVCL_6T13
DR   CLO; CLO_0024861
DR   Coriell; DA01162
DR   Wikidata; Q54818811
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01163
AC   CVCL_6T14
DR   CLO; CLO_0024864
DR   Coriell; DA01163
DR   Wikidata; Q54818812
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01164
AC   CVCL_6T15
DR   CLO; CLO_0024865
DR   Coriell; DA01164
DR   Wikidata; Q54818813
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01166
AC   CVCL_6T16
DR   CLO; CLO_0024868
DR   Coriell; DA01166
DR   Wikidata; Q54818814
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01167
AC   CVCL_6T17
DR   CLO; CLO_0024857
DR   Coriell; DA01167
DR   Wikidata; Q54818815
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01168
AC   CVCL_6T18
DR   CLO; CLO_0024858
DR   Coriell; DA01168
DR   Wikidata; Q54818816
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01169
AC   CVCL_6T19
DR   CLO; CLO_0024860
DR   Coriell; DA01169
DR   Wikidata; Q54818817
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01170
AC   CVCL_6T20
DR   CLO; CLO_0024883
DR   Coriell; DA01170
DR   Wikidata; Q54818818
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01171
AC   CVCL_6T21
DR   CLO; CLO_0024882
DR   Coriell; DA01171
DR   Wikidata; Q54818822
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01172
AC   CVCL_6T22
DR   CLO; CLO_0024879
DR   Coriell; DA01172
DR   Wikidata; Q54818823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01173
AC   CVCL_6T23
DR   CLO; CLO_0024878
DR   Coriell; DA01173
DR   Wikidata; Q54818824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01174
AC   CVCL_6T24
DR   CLO; CLO_0024891
DR   Coriell; DA01174
DR   Wikidata; Q54818825
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01175
AC   CVCL_6T25
DR   CLO; CLO_0024893
DR   Coriell; DA01175
DR   Wikidata; Q54818826
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01176
AC   CVCL_6T26
DR   Coriell; DA01176
DR   Wikidata; Q54818827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01176; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01178
AC   CVCL_6T27
DR   CLO; CLO_0024887
DR   Coriell; DA01178
DR   Wikidata; Q54818828
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01180
AC   CVCL_6T28
DR   CLO; CLO_0024888
DR   Coriell; DA01180
DR   Wikidata; Q54818829
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01181
AC   CVCL_6T29
DR   CLO; CLO_0024896
DR   Coriell; DA01181
DR   Wikidata; Q54818830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01182
AC   CVCL_6T30
DR   CLO; CLO_0024897
DR   Coriell; DA01182
DR   Wikidata; Q54818831
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01183
AC   CVCL_6T31
DR   CLO; CLO_0026280
DR   Coriell; DA01183
DR   Wikidata; Q54818832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01184
AC   CVCL_6T32
DR   CLO; CLO_0026279
DR   Coriell; DA01184
DR   Wikidata; Q54818833
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01185
AC   CVCL_6T33
DR   CLO; CLO_0026284
DR   Coriell; DA01185
DR   Wikidata; Q54818834
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01186
AC   CVCL_6T34
DR   CLO; CLO_0026283
DR   Coriell; DA01186
DR   Wikidata; Q54818835
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01187
AC   CVCL_6T35
DR   CLO; CLO_0026282
DR   Coriell; DA01187
DR   Wikidata; Q54818836
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01188
AC   CVCL_6T36
DR   CLO; CLO_0026281
DR   Coriell; DA01188
DR   Wikidata; Q54818837
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01189
AC   CVCL_6T37
DR   CLO; CLO_0026288
DR   Coriell; DA01189
DR   Wikidata; Q54818838
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01190
AC   CVCL_6T38
DR   Coriell; DA01190
DR   Wikidata; Q54818839
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01190; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01191
AC   CVCL_6T39
DR   CLO; CLO_0026287
DR   Coriell; DA01191
DR   Wikidata; Q54818840
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01192
AC   CVCL_6T40
DR   CLO; CLO_0026286
DR   Coriell; DA01192
DR   Wikidata; Q54818841
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01193
AC   CVCL_6T41
DR   CLO; CLO_0026285
DR   Coriell; DA01193
DR   Wikidata; Q54818842
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01194
AC   CVCL_6T42
DR   CLO; CLO_0026336
DR   Coriell; DA01194
DR   Wikidata; Q54818843
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01195
AC   CVCL_6T43
DR   CLO; CLO_0026337
DR   Coriell; DA01195
DR   Wikidata; Q54818844
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01196
AC   CVCL_6T44
DR   Coriell; DA01196
DR   Wikidata; Q54818845
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01196; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01198
AC   CVCL_6T45
DR   CLO; CLO_0026338
DR   Coriell; DA01198
DR   Wikidata; Q54818846
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01199
AC   CVCL_6T46
DR   CLO; CLO_0026332
DR   Coriell; DA01199
DR   Wikidata; Q54818847
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01200
AC   CVCL_6T47
DR   Coriell; DA01200
DR   Wikidata; Q54818848
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01200; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01201
AC   CVCL_6T48
DR   CLO; CLO_0026333
DR   Coriell; DA01201
DR   Wikidata; Q54818849
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01202
AC   CVCL_6T49
DR   Coriell; DA01202
DR   Wikidata; Q54818850
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01202; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01203
AC   CVCL_6T50
DR   CLO; CLO_0026334
DR   Coriell; DA01203
DR   Wikidata; Q54818851
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01204
AC   CVCL_6T51
DR   CLO; CLO_0026335
DR   Coriell; DA01204
DR   Wikidata; Q54818852
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01205
AC   CVCL_6T52
DR   CLO; CLO_0026329
DR   Coriell; DA01205
DR   Wikidata; Q54818853
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01206
AC   CVCL_6T53
DR   CLO; CLO_0026330
DR   Coriell; DA01206
DR   Wikidata; Q54818854
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01207
AC   CVCL_6T54
DR   Coriell; DA01207
DR   Wikidata; Q54818855
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01207; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01208
AC   CVCL_6T55
DR   Coriell; DA01208
DR   Wikidata; Q54818856
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01208; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01209
AC   CVCL_6T56
DR   CLO; CLO_0026331
DR   Coriell; DA01209
DR   Wikidata; Q54818857
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01210
AC   CVCL_6T57
DR   CLO; CLO_0026347
DR   Coriell; DA01210
DR   Wikidata; Q54818858
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01211
AC   CVCL_6T58
DR   Coriell; DA01211
DR   Wikidata; Q54818859
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01211; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01212
AC   CVCL_6T59
DR   Coriell; DA01212
DR   Wikidata; Q54818860
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01212; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01213
AC   CVCL_6T60
DR   CLO; CLO_0026348
DR   Coriell; DA01213
DR   Wikidata; Q54818861
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01214
AC   CVCL_6T61
DR   Coriell; DA01214
DR   Wikidata; Q54818865
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01214; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01215
AC   CVCL_6T62
DR   Coriell; DA01215
DR   Wikidata; Q54818866
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01215; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA01216
AC   CVCL_6T63
DR   CLO; CLO_0026345
DR   Coriell; DA01216
DR   Wikidata; Q54818867
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01217
AC   CVCL_6T64
DR   CLO; CLO_0026346
DR   Coriell; DA01217
DR   Wikidata; Q54818868
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01219
AC   CVCL_6T65
DR   CLO; CLO_0026343
DR   Coriell; DA01219
DR   Wikidata; Q54818869
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01220
AC   CVCL_6T66
DR   CLO; CLO_0026344
DR   Coriell; DA01220
DR   Wikidata; Q54818870
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01221
AC   CVCL_6T67
DR   CLO; CLO_0026341
DR   Coriell; DA01221
DR   Wikidata; Q54818871
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01222
AC   CVCL_6T68
DR   CLO; CLO_0026342
DR   Coriell; DA01222
DR   Wikidata; Q54818872
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01223
AC   CVCL_6T69
DR   CLO; CLO_0026339
DR   Coriell; DA01223
DR   Wikidata; Q54818873
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01224
AC   CVCL_6T70
DR   CLO; CLO_0026340
DR   Coriell; DA01224
DR   Wikidata; Q54818874
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01225
AC   CVCL_6T71
DR   CLO; CLO_0026314
DR   Coriell; DA01225
DR   Wikidata; Q54818875
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01226
AC   CVCL_6T72
DR   Coriell; DA01226
DR   Wikidata; Q54818876
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01226; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01227
AC   CVCL_6T73
DR   CLO; CLO_0026315
DR   Coriell; DA01227
DR   Wikidata; Q54818877
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01228
AC   CVCL_6T74
DR   CLO; CLO_0026316
DR   Coriell; DA01228
DR   Wikidata; Q54818878
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01229
AC   CVCL_6T75
DR   CLO; CLO_0026317
DR   Coriell; DA01229
DR   Wikidata; Q54818879
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01230
AC   CVCL_6T76
DR   Coriell; DA01230
DR   Wikidata; Q54818880
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01230; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01231
AC   CVCL_6T77
DR   CLO; CLO_0026318
DR   Coriell; DA01231
DR   Wikidata; Q54818881
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01232
AC   CVCL_6T78
DR   CLO; CLO_0026309
DR   Coriell; DA01232
DR   Wikidata; Q54818882
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01233
AC   CVCL_6T79
DR   CLO; CLO_0026310
DR   Coriell; DA01233
DR   Wikidata; Q54818883
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01234
AC   CVCL_6T80
DR   CLO; CLO_0026311
DR   Coriell; DA01234
DR   Wikidata; Q54818884
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01235
AC   CVCL_6T81
DR   CLO; CLO_0026312
DR   Coriell; DA01235
DR   Wikidata; Q54818885
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01236
AC   CVCL_6T82
DR   CLO; CLO_0026313
DR   Coriell; DA01236
DR   Wikidata; Q54818886
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01237
AC   CVCL_6T83
DR   CLO; CLO_0026323
DR   Coriell; DA01237
DR   Wikidata; Q54818887
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01238
AC   CVCL_6T84
DR   CLO; CLO_0026324
DR   Coriell; DA01238
DR   Wikidata; Q54818888
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01240
AC   CVCL_6T85
DR   Coriell; DA01240
DR   Wikidata; Q54818889
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01240; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01241
AC   CVCL_6T86
DR   Coriell; DA01241
DR   Wikidata; Q54818890
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01241; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01242
AC   CVCL_6T87
DR   CLO; CLO_0026327
DR   Coriell; DA01242
DR   Wikidata; Q54818891
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01243
AC   CVCL_6T88
DR   CLO; CLO_0026328
DR   Coriell; DA01243
DR   Wikidata; Q54818892
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01244
AC   CVCL_6T89
DR   CLO; CLO_0026325
DR   Coriell; DA01244
DR   Wikidata; Q54818893
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01246
AC   CVCL_6T90
DR   CLO; CLO_0026326
DR   Coriell; DA01246
DR   Wikidata; Q54818894
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01247
AC   CVCL_6T91
DR   Coriell; DA01247
DR   Wikidata; Q54818895
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01247; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01248
AC   CVCL_6T92
DR   Coriell; DA01248
DR   Wikidata; Q54818896
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01248; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01249
AC   CVCL_6T93
DR   CLO; CLO_0026321
DR   Coriell; DA01249
DR   Wikidata; Q54818897
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01250
AC   CVCL_6T94
DR   CLO; CLO_0026322
DR   Coriell; DA01250
DR   Wikidata; Q54818898
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01251
AC   CVCL_6T95
DR   CLO; CLO_0026319
DR   Coriell; DA01251
DR   Wikidata; Q54818899
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01252
AC   CVCL_6T96
DR   CLO; CLO_0026320
DR   Coriell; DA01252
DR   Wikidata; Q54818900
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01253
AC   CVCL_6T97
DR   Coriell; DA01253
DR   Wikidata; Q54818901
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01253; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01254
AC   CVCL_6T98
DR   CLO; CLO_0026181
DR   Coriell; DA01254
DR   Wikidata; Q54818902
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01255
AC   CVCL_6T99
DR   CLO; CLO_0026179
DR   Coriell; DA01255
DR   Wikidata; Q54818903
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01256
AC   CVCL_6U00
DR   CLO; CLO_0026177
DR   Coriell; DA01256
DR   Wikidata; Q54818904
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01257
AC   CVCL_6U01
DR   CLO; CLO_0026176
DR   Coriell; DA01257
DR   Wikidata; Q54818907
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01258
AC   CVCL_6U02
DR   Coriell; DA01258
DR   Wikidata; Q54818908
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01258; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01259
AC   CVCL_6U03
DR   Coriell; DA01259
DR   Wikidata; Q54818909
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01259; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01260
AC   CVCL_6U04
DR   Coriell; DA01260
DR   Wikidata; Q54818910
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01260; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01261
AC   CVCL_6U05
DR   Coriell; DA01261
DR   Wikidata; Q54818911
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01261; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01262
AC   CVCL_6U06
DR   CLO; CLO_0026174
DR   Coriell; DA01262
DR   Wikidata; Q54818912
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01263
AC   CVCL_6U07
DR   CLO; CLO_0026172
DR   Coriell; DA01263
DR   Wikidata; Q54818913
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01264
AC   CVCL_6U08
DR   Coriell; DA01264
DR   Wikidata; Q54818914
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01264; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01265
AC   CVCL_6U09
DR   CLO; CLO_0026169
DR   Coriell; DA01265
DR   Wikidata; Q54818915
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01266
AC   CVCL_6U10
DR   CLO; CLO_0026186
DR   Coriell; DA01266
DR   Wikidata; Q54818916
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01267
AC   CVCL_6U11
DR   CLO; CLO_0026185
DR   Coriell; DA01267
DR   Wikidata; Q54818917
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01268
AC   CVCL_6U12
DR   CLO; CLO_0026184
DR   Coriell; DA01268
DR   Wikidata; Q54818918
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01269
AC   CVCL_6U13
DR   Coriell; DA01269
DR   Wikidata; Q54818919
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01269; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01270
AC   CVCL_6U14
DR   CLO; CLO_0026200
DR   Coriell; DA01270
DR   Wikidata; Q54818920
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01271
AC   CVCL_6U15
DR   CLO; CLO_0026197
DR   Coriell; DA01271
DR   Wikidata; Q54818921
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01272
AC   CVCL_6U16
DR   CLO; CLO_0026203
DR   Coriell; DA01272
DR   Wikidata; Q54818922
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01273
AC   CVCL_6U17
DR   Coriell; DA01273
DR   Wikidata; Q54818923
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01273; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01274
AC   CVCL_6U18
DR   CLO; CLO_0026202
DR   Coriell; DA01274
DR   Wikidata; Q54818924
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01275
AC   CVCL_6U19
DR   CLO; CLO_0026191
DR   Coriell; DA01275
DR   Wikidata; Q54818925
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01276
AC   CVCL_6U20
DR   CLO; CLO_0026189
DR   Coriell; DA01276
DR   Wikidata; Q54818926
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01277
AC   CVCL_6U21
DR   CLO; CLO_0026195
DR   Coriell; DA01277
DR   Wikidata; Q54818927
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01278
AC   CVCL_6U22
DR   CLO; CLO_0026194
DR   Coriell; DA01278
DR   Wikidata; Q54818928
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01279
AC   CVCL_6U23
DR   CLO; CLO_0026207
DR   Coriell; DA01279
DR   Wikidata; Q54818929
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01280
AC   CVCL_6U24
DR   CLO; CLO_0026206
DR   Coriell; DA01280
DR   Wikidata; Q54818931
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01281
AC   CVCL_6U25
DR   CLO; CLO_0026158
DR   Coriell; DA01281
DR   Wikidata; Q54818932
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01282
AC   CVCL_6U26
DR   CLO; CLO_0026146
DR   Coriell; DA01282
DR   Wikidata; Q54818933
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01283
AC   CVCL_6U27
DR   Coriell; DA01283
DR   Wikidata; Q54818934
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01283; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01284
AC   CVCL_6U28
DR   Coriell; DA01284
DR   Wikidata; Q54818935
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01284; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01285
AC   CVCL_6U29
DR   CLO; CLO_0026144
DR   Coriell; DA01285
DR   Wikidata; Q54818936
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01286
AC   CVCL_6U30
DR   CLO; CLO_0026142
DR   Coriell; DA01286
DR   Wikidata; Q54818937
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01287
AC   CVCL_6U31
DR   CLO; CLO_0026139
DR   Coriell; DA01287
DR   Wikidata; Q54818938
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01288
AC   CVCL_ZI28
DR   Coriell; DA01288
DR   Wikidata; Q98125816
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01288; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA01289
AC   CVCL_6U32
DR   CLO; CLO_0026153
DR   Coriell; DA01289
DR   Wikidata; Q54818939
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01290
AC   CVCL_6U33
DR   CLO; CLO_0026151
DR   Coriell; DA01290
DR   Wikidata; Q54818940
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01291
AC   CVCL_6U34
DR   Coriell; DA01291
DR   Wikidata; Q54818941
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01291; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01292
AC   CVCL_6U35
DR   CLO; CLO_0026150
DR   Coriell; DA01292
DR   Wikidata; Q54818942
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01293
AC   CVCL_6U36
DR   CLO; CLO_0026148
DR   Coriell; DA01293
DR   Wikidata; Q54818943
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01294
AC   CVCL_6U37
DR   CLO; CLO_0026157
DR   Coriell; DA01294
DR   Wikidata; Q54818944
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01295
AC   CVCL_6U38
DR   Coriell; DA01295
DR   Wikidata; Q54818945
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01295; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01297
AC   CVCL_6U39
DR   CLO; CLO_0026167
DR   Coriell; DA01297
DR   Wikidata; Q54818946
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01298
AC   CVCL_6U40
DR   CLO; CLO_0026168
DR   Coriell; DA01298
DR   Wikidata; Q54818947
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01299
AC   CVCL_6U41
DR   CLO; CLO_0026160
DR   Coriell; DA01299
DR   Wikidata; Q54818950
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01300
AC   CVCL_6U42
DR   CLO; CLO_0026159
DR   Coriell; DA01300
DR   Wikidata; Q54818951
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01301
AC   CVCL_6U43
DR   CLO; CLO_0026162
DR   Coriell; DA01301
DR   Wikidata; Q54818952
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01302
AC   CVCL_6U44
DR   CLO; CLO_0026161
DR   Coriell; DA01302
DR   Wikidata; Q54818953
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01303
AC   CVCL_6U45
DR   CLO; CLO_0026164
DR   Coriell; DA01303
DR   Wikidata; Q54818954
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01304
AC   CVCL_6U46
DR   CLO; CLO_0026163
DR   Coriell; DA01304
DR   Wikidata; Q54818955
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01305
AC   CVCL_6U47
DR   CLO; CLO_0026166
DR   Coriell; DA01305
DR   Wikidata; Q54818956
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01306
AC   CVCL_6U48
DR   Coriell; DA01306
DR   Wikidata; Q54818957
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01306; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01307
AC   CVCL_6U49
DR   Coriell; DA01307
DR   Wikidata; Q54818958
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01307; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01308
AC   CVCL_6U50
DR   CLO; CLO_0026165
DR   Coriell; DA01308
DR   Wikidata; Q54818959
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01309
AC   CVCL_6U51
DR   CLO; CLO_0026244
DR   Coriell; DA01309
DR   Wikidata; Q54818960
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01310
AC   CVCL_6U52
DR   CLO; CLO_0026243
DR   Coriell; DA01310
DR   Wikidata; Q54818961
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01311
AC   CVCL_6U53
DR   CLO; CLO_0026240
DR   Coriell; DA01311
DR   Wikidata; Q54818962
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01312
AC   CVCL_6U54
DR   CLO; CLO_0026237
DR   Coriell; DA01312
DR   Wikidata; Q54818963
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01313
AC   CVCL_6U55
DR   CLO; CLO_0026239
DR   Coriell; DA01313
DR   Wikidata; Q54818964
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01314
AC   CVCL_6U56
DR   CLO; CLO_0026232
DR   Coriell; DA01314
DR   Wikidata; Q54818965
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01315
AC   CVCL_6U57
DR   CLO; CLO_0026234
DR   Coriell; DA01315
DR   Wikidata; Q54818966
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01316
AC   CVCL_6U58
DR   CLO; CLO_0026230
DR   Coriell; DA01316
DR   Wikidata; Q54818967
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01317
AC   CVCL_6U59
DR   CLO; CLO_0026231
DR   Coriell; DA01317
DR   Wikidata; Q54818968
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01318
AC   CVCL_6U60
DR   Coriell; DA01318
DR   Wikidata; Q54818969
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01318; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01319
AC   CVCL_6U61
DR   Coriell; DA01319
DR   Wikidata; Q54818970
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01319; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01320
AC   CVCL_6U62
DR   CLO; CLO_0026229
DR   Coriell; DA01320
DR   Wikidata; Q54818971
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01322
AC   CVCL_6U63
DR   CLO; CLO_0025847
DR   Coriell; DA01322
DR   Wikidata; Q54818972
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01323
AC   CVCL_6U64
DR   CLO; CLO_0025845
DR   Coriell; DA01323
DR   Wikidata; Q54818973
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01324
AC   CVCL_6U65
DR   CLO; CLO_0025844
DR   Coriell; DA01324
DR   Wikidata; Q54818974
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01325
AC   CVCL_6U66
DR   CLO; CLO_0025842
DR   Coriell; DA01325
DR   Wikidata; Q54818975
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01326
AC   CVCL_6U67
DR   CLO; CLO_0025840
DR   Coriell; DA01326
DR   Wikidata; Q54818976
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01327
AC   CVCL_6U68
DR   CLO; CLO_0025839
DR   Coriell; DA01327
DR   Wikidata; Q54818977
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01328
AC   CVCL_6U69
DR   CLO; CLO_0025836
DR   Coriell; DA01328
DR   Wikidata; Q54818978
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01329
AC   CVCL_6U70
DR   CLO; CLO_0025834
DR   Coriell; DA01329
DR   Wikidata; Q54818979
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01330
AC   CVCL_6U71
DR   CLO; CLO_0025833
DR   Coriell; DA01330
DR   Wikidata; Q54818980
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01331
AC   CVCL_6U72
DR   CLO; CLO_0025848
DR   Coriell; DA01331
DR   Wikidata; Q54818981
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01332
AC   CVCL_6U73
DR   CLO; CLO_0025868
DR   Coriell; DA01332
DR   Wikidata; Q54818982
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01333
AC   CVCL_6U74
DR   CLO; CLO_0025867
DR   Coriell; DA01333
DR   Wikidata; Q54818983
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01334
AC   CVCL_6U75
DR   CLO; CLO_0025856
DR   Coriell; DA01334
DR   Wikidata; Q54818984
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01335
AC   CVCL_6U76
DR   CLO; CLO_0025854
DR   Coriell; DA01335
DR   Wikidata; Q54818985
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01337
AC   CVCL_6U77
DR   CLO; CLO_0025858
DR   Coriell; DA01337
DR   Wikidata; Q54818986
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01338
AC   CVCL_6U78
DR   CLO; CLO_0025857
DR   Coriell; DA01338
DR   Wikidata; Q54818987
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01339
AC   CVCL_6U79
DR   CLO; CLO_0025861
DR   Coriell; DA01339
DR   Wikidata; Q54818988
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01340
AC   CVCL_6U80
DR   Coriell; DA01340
DR   Wikidata; Q54818989
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01340; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01341
AC   CVCL_6U81
DR   CLO; CLO_0025859
DR   Coriell; DA01341
DR   Wikidata; Q54818993
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01342
AC   CVCL_6U82
DR   CLO; CLO_0025865
DR   Coriell; DA01342
DR   Wikidata; Q54818994
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01344
AC   CVCL_6U83
DR   CLO; CLO_0025864
DR   Coriell; DA01344
DR   Wikidata; Q54818995
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01345
AC   CVCL_6U84
DR   CLO; CLO_0025888
DR   Coriell; DA01345
DR   Wikidata; Q54818996
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01346
AC   CVCL_6U85
DR   CLO; CLO_0025887
DR   Coriell; DA01346
DR   Wikidata; Q54818997
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01347
AC   CVCL_6U86
DR   CLO; CLO_0025886
DR   Coriell; DA01347
DR   Wikidata; Q54818998
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01348
AC   CVCL_6U87
DR   CLO; CLO_0025880
DR   Coriell; DA01348
DR   Wikidata; Q54818999
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01349
AC   CVCL_6U88
DR   CLO; CLO_0025879
DR   Coriell; DA01349
DR   Wikidata; Q54819000
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01350
AC   CVCL_6U89
DR   CLO; CLO_0025878
DR   Coriell; DA01350
DR   Wikidata; Q54819001
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01351
AC   CVCL_6U90
DR   CLO; CLO_0025877
DR   Coriell; DA01351
DR   Wikidata; Q54819002
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01352
AC   CVCL_6U91
DR   CLO; CLO_0025883
DR   Coriell; DA01352
DR   Wikidata; Q54819003
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01353
AC   CVCL_6U92
DR   CLO; CLO_0025882
DR   Coriell; DA01353
DR   Wikidata; Q54819004
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01354
AC   CVCL_6U93
DR   CLO; CLO_0025881
DR   Coriell; DA01354
DR   Wikidata; Q54819005
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01355
AC   CVCL_6U94
DR   CLO; CLO_0025889
DR   Coriell; DA01355
DR   Wikidata; Q54819006
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01356
AC   CVCL_6U95
DR   CLO; CLO_0025890
DR   Coriell; DA01356
DR   Wikidata; Q54819007
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01357
AC   CVCL_6U96
DR   CLO; CLO_0025891
DR   Coriell; DA01357
DR   Wikidata; Q54819008
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01358
AC   CVCL_6U97
DR   CLO; CLO_0025892
DR   Coriell; DA01358
DR   Wikidata; Q54819009
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01359
AC   CVCL_6U98
DR   CLO; CLO_0025895
DR   Coriell; DA01359
DR   Wikidata; Q54819010
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01360
AC   CVCL_6U99
DR   CLO; CLO_0025896
DR   Coriell; DA01360
DR   Wikidata; Q54819011
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01363
AC   CVCL_6V00
DR   CLO; CLO_0025897
DR   Coriell; DA01363
DR   Wikidata; Q54819012
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01364
AC   CVCL_6V01
DR   CLO; CLO_0025898
DR   Coriell; DA01364
DR   Wikidata; Q54819013
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01365
AC   CVCL_6V02
DR   CLO; CLO_0025893
DR   Coriell; DA01365
DR   Wikidata; Q54819014
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01366
AC   CVCL_6V03
DR   CLO; CLO_0025894
DR   Coriell; DA01366
DR   Wikidata; Q54819015
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01367
AC   CVCL_6V04
DR   CLO; CLO_0025903
DR   Coriell; DA01367
DR   Wikidata; Q54819016
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01368
AC   CVCL_6V05
DR   CLO; CLO_0025901
DR   Coriell; DA01368
DR   Wikidata; Q54819017
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01369
AC   CVCL_6V06
DR   CLO; CLO_0025902
DR   Coriell; DA01369
DR   Wikidata; Q54819018
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01370
AC   CVCL_6V07
DR   CLO; CLO_0025899
DR   Coriell; DA01370
DR   Wikidata; Q54819019
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01371
AC   CVCL_6V08
DR   CLO; CLO_0025900
DR   Coriell; DA01371
DR   Wikidata; Q54819020
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01372
AC   CVCL_6V09
DR   CLO; CLO_0025907
DR   Coriell; DA01372
DR   Wikidata; Q54819021
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01373
AC   CVCL_6V10
DR   CLO; CLO_0025908
DR   Coriell; DA01373
DR   Wikidata; Q54819022
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01374
AC   CVCL_6V11
DR   CLO; CLO_0025905
DR   Coriell; DA01374
DR   Wikidata; Q54819023
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01375
AC   CVCL_6V12
DR   CLO; CLO_0025906
DR   Coriell; DA01375
DR   Wikidata; Q54819024
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01376
AC   CVCL_6V13
DR   CLO; CLO_0025904
DR   Coriell; DA01376
DR   Wikidata; Q54819025
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01377
AC   CVCL_6V14
DR   CLO; CLO_0025909
DR   Coriell; DA01377
DR   Wikidata; Q54819026
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01378
AC   CVCL_6V15
DR   CLO; CLO_0025910
DR   Coriell; DA01378
DR   Wikidata; Q54819027
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01379
AC   CVCL_6V16
DR   CLO; CLO_0025911
DR   Coriell; DA01379
DR   Wikidata; Q54819028
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01381
AC   CVCL_6V17
DR   CLO; CLO_0025912
DR   Coriell; DA01381
DR   Wikidata; Q54819029
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01382
AC   CVCL_6V18
DR   CLO; CLO_0025913
DR   Coriell; DA01382
DR   Wikidata; Q54819030
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01383
AC   CVCL_6V19
DR   CLO; CLO_0025914
DR   Coriell; DA01383
DR   Wikidata; Q54819031
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01384
AC   CVCL_6V20
DR   CLO; CLO_0025915
DR   Coriell; DA01384
DR   Wikidata; Q54819032
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01385
AC   CVCL_6V21
DR   CLO; CLO_0025916
DR   Coriell; DA01385
DR   Wikidata; Q54819035
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01386
AC   CVCL_6V22
DR   CLO; CLO_0025917
DR   Coriell; DA01386
DR   Wikidata; Q54819036
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01387
AC   CVCL_6V23
DR   CLO; CLO_0025918
DR   Coriell; DA01387
DR   Wikidata; Q54819037
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01388
AC   CVCL_6V24
DR   CLO; CLO_0025921
DR   Coriell; DA01388
DR   Wikidata; Q54819038
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01389
AC   CVCL_6V25
DR   CLO; CLO_0025919
DR   Coriell; DA01389
DR   Wikidata; Q54819039
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01390
AC   CVCL_6V26
DR   CLO; CLO_0025920
DR   Coriell; DA01390
DR   Wikidata; Q54819040
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01391
AC   CVCL_6V27
DR   CLO; CLO_0025924
DR   Coriell; DA01391
DR   Wikidata; Q54819041
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01392
AC   CVCL_6V28
DR   CLO; CLO_0025925
DR   Coriell; DA01392
DR   Wikidata; Q54819042
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01393
AC   CVCL_6V29
DR   CLO; CLO_0025922
DR   Coriell; DA01393
DR   Wikidata; Q54819043
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01394
AC   CVCL_6V30
DR   CLO; CLO_0025923
DR   Coriell; DA01394
DR   Wikidata; Q54819044
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01395
AC   CVCL_6V31
DR   CLO; CLO_0025927
DR   Coriell; DA01395
DR   Wikidata; Q54819045
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01396
AC   CVCL_6V32
DR   CLO; CLO_0025928
DR   Coriell; DA01396
DR   Wikidata; Q54819046
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01397
AC   CVCL_6V33
DR   CLO; CLO_0025926
DR   Coriell; DA01397
DR   Wikidata; Q54819047
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01398
AC   CVCL_6V34
DR   CLO; CLO_0025705
DR   Coriell; DA01398
DR   Wikidata; Q54819048
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01399
AC   CVCL_6V35
DR   CLO; CLO_0025703
DR   Coriell; DA01399
DR   Wikidata; Q54819049
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01400
AC   CVCL_6V36
DR   CLO; CLO_0025700
DR   Coriell; DA01400
DR   Wikidata; Q54819050
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01401
AC   CVCL_6V37
DR   CLO; CLO_0025699
DR   Coriell; DA01401
DR   Wikidata; Q54819051
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01402
AC   CVCL_6V38
DR   CLO; CLO_0025696
DR   Coriell; DA01402
DR   Wikidata; Q54819052
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01405
AC   CVCL_6V39
DR   CLO; CLO_0025695
DR   Coriell; DA01405
DR   Wikidata; Q54819053
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01406
AC   CVCL_6V40
DR   CLO; CLO_0025693
DR   Coriell; DA01406
DR   Wikidata; Q54819054
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01407
AC   CVCL_6V41
DR   CLO; CLO_0025691
DR   Coriell; DA01407
DR   Wikidata; Q54819055
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01408
AC   CVCL_6V42
DR   CLO; CLO_0025690
DR   Coriell; DA01408
DR   Wikidata; Q54819056
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01409
AC   CVCL_6V43
DR   CLO; CLO_0025689
DR   Coriell; DA01409
DR   Wikidata; Q54819057
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01410
AC   CVCL_6V44
DR   CLO; CLO_0025728
DR   Coriell; DA01410
DR   Wikidata; Q54819058
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01411
AC   CVCL_6V45
DR   CLO; CLO_0025721
DR   Coriell; DA01411
DR   Wikidata; Q54819059
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01412
AC   CVCL_6V46
DR   CLO; CLO_0025719
DR   Coriell; DA01412
DR   Wikidata; Q54819060
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01413
AC   CVCL_6V47
DR   CLO; CLO_0025725
DR   Coriell; DA01413
DR   Wikidata; Q54819061
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01414
AC   CVCL_6V48
DR   CLO; CLO_0025722
DR   Coriell; DA01414
DR   Wikidata; Q54819062
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01415
AC   CVCL_6V49
DR   CLO; CLO_0025712
DR   Coriell; DA01415
DR   Wikidata; Q54819063
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01416
AC   CVCL_6V50
DR   CLO; CLO_0025710
DR   Coriell; DA01416
DR   Wikidata; Q54819064
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01417
AC   CVCL_6V51
DR   CLO; CLO_0025717
DR   Coriell; DA01417
DR   Wikidata; Q54819065
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01418
AC   CVCL_6V52
DR   Coriell; DA01418
DR   Wikidata; Q54819066
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01418; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01419
AC   CVCL_6V53
DR   CLO; CLO_0025715
DR   Coriell; DA01419
DR   Wikidata; Q54819067
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01420
AC   CVCL_6V54
DR   CLO; CLO_0025709
DR   Coriell; DA01420
DR   Wikidata; Q54819068
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA01424
AC   CVCL_6V55
DR   CLO; CLO_0025747
DR   Coriell; DA01424
DR   Wikidata; Q54819069
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01426
AC   CVCL_6V56
DR   CLO; CLO_0025748
DR   Coriell; DA01426
DR   Wikidata; Q54819070
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01427
AC   CVCL_6V57
DR   CLO; CLO_0025737
DR   Coriell; DA01427
DR   Wikidata; Q54819071
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01428
AC   CVCL_6V58
DR   CLO; CLO_0025734
DR   Coriell; DA01428
DR   Wikidata; Q54819072
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01429
AC   CVCL_6V59
DR   CLO; CLO_0025732
DR   Coriell; DA01429
DR   Wikidata; Q54819073
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01431
AC   CVCL_6V60
DR   CLO; CLO_0025730
DR   Coriell; DA01431
DR   Wikidata; Q54819074
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01432
AC   CVCL_6V61
DR   Coriell; DA01432
DR   Wikidata; Q54819078
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01432; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01433
AC   CVCL_6V62
DR   CLO; CLO_0025744
DR   Coriell; DA01433
DR   Wikidata; Q54819079
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01434
AC   CVCL_6V63
DR   CLO; CLO_0025742
DR   Coriell; DA01434
DR   Wikidata; Q54819080
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01435
AC   CVCL_6V64
DR   CLO; CLO_0025741
DR   Coriell; DA01435
DR   Wikidata; Q54819081
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01436
AC   CVCL_6V65
DR   CLO; CLO_0025739
DR   Coriell; DA01436
DR   Wikidata; Q54819082
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01437
AC   CVCL_6V66
DR   CLO; CLO_0021081
DR   Coriell; DA01437
DR   Wikidata; Q54819083
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01438
AC   CVCL_6V67
DR   CLO; CLO_0021082
DR   Coriell; DA01438
DR   Wikidata; Q54819084
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01439
AC   CVCL_6V68
DR   CLO; CLO_0021085
DR   Coriell; DA01439
DR   Wikidata; Q54819085
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01440
AC   CVCL_6V69
DR   Coriell; DA01440
DR   Wikidata; Q54819086
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01440; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01441
AC   CVCL_6V70
DR   CLO; CLO_0021086
DR   Coriell; DA01441
DR   Wikidata; Q54819087
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01442
AC   CVCL_6V71
DR   CLO; CLO_0021088
DR   Coriell; DA01442
DR   Wikidata; Q54819088
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01443
AC   CVCL_6V72
DR   CLO; CLO_0021089
DR   Coriell; DA01443
DR   Wikidata; Q54819089
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01444
AC   CVCL_6V73
DR   CLO; CLO_0021090
DR   Coriell; DA01444
DR   Wikidata; Q54819090
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01445
AC   CVCL_6V74
DR   CLO; CLO_0021091
DR   Coriell; DA01445
DR   Wikidata; Q54819091
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01446
AC   CVCL_6V75
DR   CLO; CLO_0021252
DR   Coriell; DA01446
DR   Wikidata; Q54819092
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01447
AC   CVCL_6V76
DR   CLO; CLO_0021255
DR   Coriell; DA01447
DR   Wikidata; Q54819093
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01448
AC   CVCL_6V77
DR   CLO; CLO_0021277
DR   Coriell; DA01448
DR   Wikidata; Q54819094
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01449
AC   CVCL_6V78
DR   CLO; CLO_0021264
DR   Coriell; DA01449
DR   Wikidata; Q54819095
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01450
AC   CVCL_6V79
DR   CLO; CLO_0021261
DR   Coriell; DA01450
DR   Wikidata; Q54819096
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01451
AC   CVCL_6V80
DR   CLO; CLO_0021267
DR   Coriell; DA01451
DR   Wikidata; Q54819097
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01452
AC   CVCL_6V81
DR   CLO; CLO_0021266
DR   Coriell; DA01452
DR   Wikidata; Q54819098
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01453
AC   CVCL_6V82
DR   CLO; CLO_0021271
DR   Coriell; DA01453
DR   Wikidata; Q54819099
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01454
AC   CVCL_6V83
DR   CLO; CLO_0021269
DR   Coriell; DA01454
DR   Wikidata; Q54819100
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01455
AC   CVCL_6V84
DR   CLO; CLO_0021276
DR   Coriell; DA01455
DR   Wikidata; Q54819101
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01456
AC   CVCL_6V85
DR   Coriell; DA01456
DR   Wikidata; Q54819102
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01456; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01457
AC   CVCL_6V86
DR   CLO; CLO_0021274
DR   Coriell; DA01457
DR   Wikidata; Q54819103
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01458
AC   CVCL_6V87
DR   CLO; CLO_0021287
DR   Coriell; DA01458
DR   Wikidata; Q54819104
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01459
AC   CVCL_6V88
DR   CLO; CLO_0021307
DR   Coriell; DA01459
DR   Wikidata; Q54819105
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01460
AC   CVCL_6V89
DR   CLO; CLO_0021306
DR   Coriell; DA01460
DR   Wikidata; Q54819106
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01461
AC   CVCL_6V90
DR   CLO; CLO_0021296
DR   Coriell; DA01461
DR   Wikidata; Q54819107
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01462
AC   CVCL_6V91
DR   Coriell; DA01462
DR   Wikidata; Q54819108
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01462; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01463
AC   CVCL_6V92
DR   CLO; CLO_0021294
DR   Coriell; DA01463
DR   Wikidata; Q54819109
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01464
AC   CVCL_6V93
DR   Coriell; DA01464
DR   Wikidata; Q54819110
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01464; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01465
AC   CVCL_6V94
DR   CLO; CLO_0021292
DR   Coriell; DA01465
DR   Wikidata; Q54819111
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01466
AC   CVCL_6V95
DR   CLO; CLO_0021291
DR   Coriell; DA01466
DR   Wikidata; Q54819112
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01467
AC   CVCL_6V96
DR   CLO; CLO_0021305
DR   Coriell; DA01467
DR   Wikidata; Q54819113
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01468
AC   CVCL_6V97
DR   CLO; CLO_0021303
DR   Coriell; DA01468
DR   Wikidata; Q54819114
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01469
AC   CVCL_6V98
DR   CLO; CLO_0021300
DR   Coriell; DA01469
DR   Wikidata; Q54819115
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01470
AC   CVCL_6V99
DR   CLO; CLO_0021299
DR   Coriell; DA01470
DR   Wikidata; Q54819116
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01471
AC   CVCL_6W00
DR   CLO; CLO_0021334
DR   Coriell; DA01471
DR   Wikidata; Q54819117
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01472
AC   CVCL_6W01
DR   Coriell; DA01472
DR   Wikidata; Q54819122
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01472; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01473
AC   CVCL_6W02
DR   CLO; CLO_0021338
DR   Coriell; DA01473
DR   Wikidata; Q54819123
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01474
AC   CVCL_6W03
DR   CLO; CLO_0021337
DR   Coriell; DA01474
DR   Wikidata; Q54819124
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01475
AC   CVCL_6W04
DR   CLO; CLO_0021328
DR   Coriell; DA01475
DR   Wikidata; Q54819125
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01476
AC   CVCL_6W05
DR   CLO; CLO_0021327
DR   Coriell; DA01476
DR   Wikidata; Q54819126
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01477
AC   CVCL_6W06
DR   CLO; CLO_0021333
DR   Coriell; DA01477
DR   Wikidata; Q54819127
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01478
AC   CVCL_6W07
DR   CLO; CLO_0021331
DR   Coriell; DA01478
DR   Wikidata; Q54819128
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01479
AC   CVCL_6W08
DR   CLO; CLO_0021322
DR   Coriell; DA01479
DR   Wikidata; Q54819129
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01480
AC   CVCL_6W09
DR   Coriell; DA01480
DR   Wikidata; Q54819130
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01480; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01481
AC   CVCL_6W10
DR   Coriell; DA01481
DR   Wikidata; Q54819131
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01481; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01482
AC   CVCL_6W11
DR   CLO; CLO_0021320
DR   Coriell; DA01482
DR   Wikidata; Q54819132
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01483
AC   CVCL_6W12
DR   CLO; CLO_0021325
DR   Coriell; DA01483
DR   Wikidata; Q54819133
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01484
AC   CVCL_6W13
DR   CLO; CLO_0021367
DR   Coriell; DA01484
DR   Wikidata; Q54819134
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01485
AC   CVCL_6W14
DR   Coriell; DA01485
DR   Wikidata; Q54819135
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01485; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01486
AC   CVCL_6W15
DR   CLO; CLO_0021366
DR   Coriell; DA01486
DR   Wikidata; Q54819136
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01487
AC   CVCL_6W16
DR   CLO; CLO_0021364
DR   Coriell; DA01487
DR   Wikidata; Q54819137
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01488
AC   CVCL_6W17
DR   CLO; CLO_0021363
DR   Coriell; DA01488
DR   Wikidata; Q54819138
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01489
AC   CVCL_6W18
DR   CLO; CLO_0021361
DR   Coriell; DA01489
DR   Wikidata; Q54819139
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01490
AC   CVCL_6W19
DR   CLO; CLO_0021359
DR   Coriell; DA01490
DR   Wikidata; Q54819140
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01491
AC   CVCL_6W20
DR   CLO; CLO_0021356
DR   Coriell; DA01491
DR   Wikidata; Q54819141
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01492
AC   CVCL_6W21
DR   CLO; CLO_0021355
DR   Coriell; DA01492
DR   Wikidata; Q54819142
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01493
AC   CVCL_6W22
DR   CLO; CLO_0021352
DR   Coriell; DA01493
DR   Wikidata; Q54819143
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01494
AC   CVCL_6W23
DR   CLO; CLO_0021351
DR   Coriell; DA01494
DR   Wikidata; Q54819144
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01495
AC   CVCL_6W24
DR   CLO; CLO_0021369
DR   Coriell; DA01495
DR   Wikidata; Q54819145
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01496
AC   CVCL_6W25
DR   CLO; CLO_0021370
DR   Coriell; DA01496
DR   Wikidata; Q54819146
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01497
AC   CVCL_6W26
DR   CLO; CLO_0021371
DR   Coriell; DA01497
DR   Wikidata; Q54819147
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01498
AC   CVCL_6W27
DR   Coriell; DA01498
DR   Wikidata; Q54819148
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01498; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01499
AC   CVCL_6W28
DR   CLO; CLO_0021372
DR   Coriell; DA01499
DR   Wikidata; Q54819149
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01500
AC   CVCL_6W29
DR   CLO; CLO_0021373
DR   Coriell; DA01500
DR   Wikidata; Q54819150
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01501
AC   CVCL_6W30
DR   CLO; CLO_0021374
DR   Coriell; DA01501
DR   Wikidata; Q54819151
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01503
AC   CVCL_6W31
DR   CLO; CLO_0021375
DR   Coriell; DA01503
DR   Wikidata; Q54819152
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01504
AC   CVCL_6W32
DR   CLO; CLO_0021376
DR   Coriell; DA01504
DR   Wikidata; Q54819153
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01506
AC   CVCL_6W33
DR   CLO; CLO_0021377
DR   Coriell; DA01506
DR   Wikidata; Q54819154
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01507
AC   CVCL_6W34
DR   CLO; CLO_0021378
DR   Coriell; DA01507
DR   Wikidata; Q54819155
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01508
AC   CVCL_6W35
DR   CLO; CLO_0021384
DR   Coriell; DA01508
DR   Wikidata; Q54819156
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01509
AC   CVCL_6W36
DR   CLO; CLO_0021385
DR   Coriell; DA01509
DR   Wikidata; Q54819157
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01510
AC   CVCL_6W37
DR   CLO; CLO_0021388
DR   Coriell; DA01510
DR   Wikidata; Q54819158
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01511
AC   CVCL_6W38
DR   CLO; CLO_0021389
DR   Coriell; DA01511
DR   Wikidata; Q54819159
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01512
AC   CVCL_6W39
DR   CLO; CLO_0021386
DR   Coriell; DA01512
DR   Wikidata; Q54819160
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01513
AC   CVCL_6W40
DR   CLO; CLO_0021387
DR   Coriell; DA01513
DR   Wikidata; Q54819161
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01514
AC   CVCL_6W41
DR   CLO; CLO_0021392
DR   Coriell; DA01514
DR   Wikidata; Q54819165
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01515
AC   CVCL_6W42
DR   CLO; CLO_0021393
DR   Coriell; DA01515
DR   Wikidata; Q54819167
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01516
AC   CVCL_6W43
DR   CLO; CLO_0021390
DR   Coriell; DA01516
DR   Wikidata; Q54819168
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01518
AC   CVCL_6W44
DR   CLO; CLO_0021391
DR   Coriell; DA01518
DR   Wikidata; Q54819169
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01519
AC   CVCL_6W45
DR   Coriell; DA01519
DR   Wikidata; Q54819170
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01519; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01520
AC   CVCL_6W46
DR   CLO; CLO_0021417
DR   Coriell; DA01520
DR   Wikidata; Q54819171
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01522
AC   CVCL_6W47
DR   CLO; CLO_0021418
DR   Coriell; DA01522
DR   Wikidata; Q54819172
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01523
AC   CVCL_6W48
DR   CLO; CLO_0021419
DR   Coriell; DA01523
DR   Wikidata; Q54819173
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01524
AC   CVCL_6W49
DR   CLO; CLO_0021413
DR   Coriell; DA01524
DR   Wikidata; Q54819174
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01525
AC   CVCL_6W50
DR   Coriell; DA01525
DR   Wikidata; Q54819175
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01525; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01526
AC   CVCL_6W51
DR   Coriell; DA01526
DR   Wikidata; Q54819176
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01526; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01527
AC   CVCL_6W52
DR   CLO; CLO_0021414
DR   Coriell; DA01527
DR   Wikidata; Q54819177
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01528
AC   CVCL_6W53
DR   Coriell; DA01528
DR   Wikidata; Q54819178
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01528; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01529
AC   CVCL_6W54
DR   Coriell; DA01529
DR   Wikidata; Q54819179
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01529; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01530
AC   CVCL_6W55
DR   Coriell; DA01530
DR   Wikidata; Q54819180
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01530; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01531
AC   CVCL_6W56
DR   CLO; CLO_0021415
DR   Coriell; DA01531
DR   Wikidata; Q54819181
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01532
AC   CVCL_6W57
DR   CLO; CLO_0021416
DR   Coriell; DA01532
DR   Wikidata; Q54819182
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01533
AC   CVCL_6W58
DR   CLO; CLO_0021424
DR   Coriell; DA01533
DR   Wikidata; Q54819183
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01536
AC   CVCL_6W59
DR   CLO; CLO_0021426
DR   Coriell; DA01536
DR   Wikidata; Q54819184
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01537
AC   CVCL_6W60
DR   CLO; CLO_0021428
DR   Coriell; DA01537
DR   Wikidata; Q54819185
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01538
AC   CVCL_6W61
DR   Coriell; DA01538
DR   Wikidata; Q54819186
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01538; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01542
AC   CVCL_6W62
DR   Coriell; DA01542
DR   Wikidata; Q54819187
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01542; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01543
AC   CVCL_6W63
DR   CLO; CLO_0021448
DR   Coriell; DA01543
DR   Wikidata; Q54819188
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01544
AC   CVCL_6W64
DR   CLO; CLO_0021449
DR   Coriell; DA01544
DR   Wikidata; Q54819189
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01545
AC   CVCL_6W65
DR   CLO; CLO_0021446
DR   Coriell; DA01545
DR   Wikidata; Q54819190
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01546
AC   CVCL_6W66
DR   CLO; CLO_0021447
DR   Coriell; DA01546
DR   Wikidata; Q54819191
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01547
AC   CVCL_6W67
DR   Coriell; DA01547
DR   Wikidata; Q54819192
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01547; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01548
AC   CVCL_6W68
DR   Coriell; DA01548
DR   Wikidata; Q54819193
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01548; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01549
AC   CVCL_6W69
DR   CLO; CLO_0021444
DR   Coriell; DA01549
DR   Wikidata; Q54819194
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01550
AC   CVCL_6W70
DR   Coriell; DA01550
DR   Wikidata; Q54819195
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01550; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01551
AC   CVCL_6W71
DR   CLO; CLO_0021445
DR   Coriell; DA01551
DR   Wikidata; Q54819196
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01552
AC   CVCL_6W72
DR   CLO; CLO_0021442
DR   Coriell; DA01552
DR   Wikidata; Q54819197
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01554
AC   CVCL_6W73
DR   CLO; CLO_0021443
DR   Coriell; DA01554
DR   Wikidata; Q54819198
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01555
AC   CVCL_6W74
DR   CLO; CLO_0021455
DR   Coriell; DA01555
DR   Wikidata; Q54819199
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01556
AC   CVCL_6W75
DR   CLO; CLO_0021458
DR   Coriell; DA01556
DR   Wikidata; Q54819200
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01559
AC   CVCL_6W76
DR   CLO; CLO_0021162
DR   Coriell; DA01559
DR   Wikidata; Q54819201
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01561
AC   CVCL_6W77
DR   CLO; CLO_0021151
DR   Coriell; DA01561
DR   Wikidata; Q54819202
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01562
AC   CVCL_6W78
DR   CLO; CLO_0021150
DR   Coriell; DA01562
DR   Wikidata; Q54819203
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01563
AC   CVCL_6W79
DR   CLO; CLO_0021149
DR   Coriell; DA01563
DR   Wikidata; Q54819204
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01564
AC   CVCL_6W80
DR   CLO; CLO_0021148
DR   Coriell; DA01564
DR   Wikidata; Q54819205
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01565
AC   CVCL_6W81
DR   CLO; CLO_0021155
DR   Coriell; DA01565
DR   Wikidata; Q54819209
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01566
AC   CVCL_6W82
DR   CLO; CLO_0021154
DR   Coriell; DA01566
DR   Wikidata; Q54819210
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01567
AC   CVCL_6W83
DR   CLO; CLO_0021153
DR   Coriell; DA01567
DR   Wikidata; Q54819211
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01568
AC   CVCL_6W84
DR   CLO; CLO_0021152
DR   Coriell; DA01568
DR   Wikidata; Q54819212
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01569
AC   CVCL_6W85
DR   CLO; CLO_0021147
DR   Coriell; DA01569
DR   Wikidata; Q54819213
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01570
AC   CVCL_6W86
DR   CLO; CLO_0020685
DR   Coriell; DA01570
DR   Wikidata; Q54819214
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01571
AC   CVCL_6W87
DR   CLO; CLO_0020687
DR   Coriell; DA01571
DR   Wikidata; Q54819215
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01573
AC   CVCL_6W88
DR   CLO; CLO_0020689
DR   Coriell; DA01573
DR   Wikidata; Q54819216
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01574
AC   CVCL_6W89
DR   CLO; CLO_0020681
DR   Coriell; DA01574
DR   Wikidata; Q54819217
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01575
AC   CVCL_6W90
DR   CLO; CLO_0020682
DR   Coriell; DA01575
DR   Wikidata; Q54819218
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01577
AC   CVCL_6W91
DR   CLO; CLO_0020683
DR   Coriell; DA01577
DR   Wikidata; Q54819219
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01578
AC   CVCL_6W92
DR   CLO; CLO_0020684
DR   Coriell; DA01578
DR   Wikidata; Q54819220
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01579
AC   CVCL_6W93
DR   Coriell; DA01579
DR   Wikidata; Q54819221
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01579; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01580
AC   CVCL_6W94
DR   Coriell; DA01580
DR   Wikidata; Q54819222
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01580; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01581
AC   CVCL_6W95
DR   CLO; CLO_0020680
DR   Coriell; DA01581
DR   Wikidata; Q54819223
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01583
AC   CVCL_6W96
DR   Coriell; DA01583
DR   Wikidata; Q54819224
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01583; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01584
AC   CVCL_6W97
DR   CLO; CLO_0020679
DR   Coriell; DA01584
DR   Wikidata; Q54819225
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01587
AC   CVCL_6W98
DR   CLO; CLO_0020678
DR   Coriell; DA01587
DR   Wikidata; Q54819227
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01588
AC   CVCL_6W99
DR   CLO; CLO_0020672
DR   Coriell; DA01588
DR   Wikidata; Q54819228
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01589
AC   CVCL_6X00
DR   CLO; CLO_0020673
DR   Coriell; DA01589
DR   Wikidata; Q54819229
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01590
AC   CVCL_6X01
DR   CLO; CLO_0020670
DR   Coriell; DA01590
DR   Wikidata; Q54819230
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01591
AC   CVCL_6X02
DR   CLO; CLO_0020671
DR   Coriell; DA01591
DR   Wikidata; Q54819231
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01592
AC   CVCL_6X03
DR   CLO; CLO_0020676
DR   Coriell; DA01592
DR   Wikidata; Q54819232
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01593
AC   CVCL_6X04
DR   CLO; CLO_0020677
DR   Coriell; DA01593
DR   Wikidata; Q54819233
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01595
AC   CVCL_6X05
DR   CLO; CLO_0020674
DR   Coriell; DA01595
DR   Wikidata; Q54819234
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01598
AC   CVCL_6X06
DR   CLO; CLO_0020675
DR   Coriell; DA01598
DR   Wikidata; Q54819235
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01599
AC   CVCL_6X07
DR   CLO; CLO_0020669
DR   Coriell; DA01599
DR   Wikidata; Q54819236
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01600
AC   CVCL_6X08
DR   CLO; CLO_0020668
DR   Coriell; DA01600
DR   Wikidata; Q54819237
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01601
AC   CVCL_6X09
DR   CLO; CLO_0020667
DR   Coriell; DA01601
DR   Wikidata; Q54819238
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01602
AC   CVCL_6X10
DR   CLO; CLO_0020659
DR   Coriell; DA01602
DR   Wikidata; Q54819239
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01603
AC   CVCL_6X11
DR   CLO; CLO_0020660
DR   Coriell; DA01603
DR   Wikidata; Q54819240
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01604
AC   CVCL_6X12
DR   CLO; CLO_0020661
DR   Coriell; DA01604
DR   Wikidata; Q54819241
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01605
AC   CVCL_6X13
DR   CLO; CLO_0020662
DR   Coriell; DA01605
DR   Wikidata; Q54819242
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01606
AC   CVCL_6X14
DR   Coriell; DA01606
DR   Wikidata; Q54819243
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01606; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01607
AC   CVCL_6X15
DR   Coriell; DA01607
DR   Wikidata; Q54819245
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01607; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01608
AC   CVCL_6X16
DR   CLO; CLO_0020663
DR   Coriell; DA01608
DR   Wikidata; Q54819246
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01609
AC   CVCL_6X17
DR   CLO; CLO_0020664
DR   Coriell; DA01609
DR   Wikidata; Q54819247
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01610
AC   CVCL_6X18
DR   CLO; CLO_0020665
DR   Coriell; DA01610
DR   Wikidata; Q54819248
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01611
AC   CVCL_6X19
DR   CLO; CLO_0020666
DR   Coriell; DA01611
DR   Wikidata; Q54819249
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01612
AC   CVCL_6X20
DR   CLO; CLO_0020878
DR   Coriell; DA01612
DR   Wikidata; Q54819250
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01613
AC   CVCL_6X21
DR   CLO; CLO_0020892
DR   Coriell; DA01613
DR   Wikidata; Q54819254
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01614
AC   CVCL_6X22
DR   CLO; CLO_0020891
DR   Coriell; DA01614
DR   Wikidata; Q54819255
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01615
AC   CVCL_6X23
DR   CLO; CLO_0020896
DR   Coriell; DA01615
DR   Wikidata; Q54819256
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01616
AC   CVCL_6X24
DR   CLO; CLO_0020893
DR   Coriell; DA01616
DR   Wikidata; Q54819257
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01617
AC   CVCL_6X25
DR   CLO; CLO_0020900
DR   Coriell; DA01617
DR   Wikidata; Q54819258
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01618
AC   CVCL_6X26
DR   CLO; CLO_0020897
DR   Coriell; DA01618
DR   Wikidata; Q54819259
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01620
AC   CVCL_6X27
DR   CLO; CLO_0020903
DR   Coriell; DA01620
DR   Wikidata; Q54819260
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01621
AC   CVCL_6X28
DR   CLO; CLO_0020902
DR   Coriell; DA01621
DR   Wikidata; Q54819261
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01623
AC   CVCL_6X29
DR   CLO; CLO_0020907
DR   Coriell; DA01623
DR   Wikidata; Q54819262
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01624
AC   CVCL_6X30
DR   CLO; CLO_0020906
DR   Coriell; DA01624
DR   Wikidata; Q54819263
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01625
AC   CVCL_6X31
DR   CLO; CLO_0020921
DR   Coriell; DA01625
DR   Wikidata; Q54819264
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01626
AC   CVCL_6X32
DR   CLO; CLO_0020920
DR   Coriell; DA01626
DR   Wikidata; Q54819265
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01627
AC   CVCL_6X33
DR   CLO; CLO_0020919
DR   Coriell; DA01627
DR   Wikidata; Q54819266
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01628
AC   CVCL_6X34
DR   CLO; CLO_0020930
DR   Coriell; DA01628
DR   Wikidata; Q54819267
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01629
AC   CVCL_6X35
DR   CLO; CLO_0020928
DR   Coriell; DA01629
DR   Wikidata; Q54819268
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01630
AC   CVCL_6X36
DR   CLO; CLO_0020926
DR   Coriell; DA01630
DR   Wikidata; Q54819269
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01631
AC   CVCL_6X37
DR   CLO; CLO_0020924
DR   Coriell; DA01631
DR   Wikidata; Q54819270
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01632
AC   CVCL_6X38
DR   CLO; CLO_0020938
DR   Coriell; DA01632
DR   Wikidata; Q54819271
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01633
AC   CVCL_6X39
DR   CLO; CLO_0020936
DR   Coriell; DA01633
DR   Wikidata; Q54819272
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01634
AC   CVCL_6X40
DR   CLO; CLO_0020933
DR   Coriell; DA01634
DR   Wikidata; Q54819273
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01635
AC   CVCL_6X41
DR   Coriell; DA01635
DR   Wikidata; Q54819274
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01635; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01636
AC   CVCL_6X42
DR   CLO; CLO_0020829
DR   Coriell; DA01636
DR   Wikidata; Q54819275
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01637
AC   CVCL_6X43
DR   CLO; CLO_0020828
DR   Coriell; DA01637
DR   Wikidata; Q54819276
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01638
AC   CVCL_6X44
DR   CLO; CLO_0020833
DR   Coriell; DA01638
DR   Wikidata; Q54819277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01639
AC   CVCL_6X45
DR   CLO; CLO_0020831
DR   Coriell; DA01639
DR   Wikidata; Q54819278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01640
AC   CVCL_6X46
DR   CLO; CLO_0020841
DR   Coriell; DA01640
DR   Wikidata; Q54819279
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01641
AC   CVCL_6X47
DR   CLO; CLO_0020839
DR   Coriell; DA01641
DR   Wikidata; Q54819280
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01643
AC   CVCL_6X48
DR   CLO; CLO_0020847
DR   Coriell; DA01643
DR   Wikidata; Q54819281
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01644
AC   CVCL_6X49
DR   CLO; CLO_0020843
DR   Coriell; DA01644
DR   Wikidata; Q54819282
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01645
AC   CVCL_6X50
DR   CLO; CLO_0020836
DR   Coriell; DA01645
DR   Wikidata; Q54819283
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01646
AC   CVCL_6X51
DR   CLO; CLO_0020834
DR   Coriell; DA01646
DR   Wikidata; Q54819284
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01647
AC   CVCL_6X52
DR   CLO; CLO_0020866
DR   Coriell; DA01647
DR   Wikidata; Q54819285
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01648
AC   CVCL_6X53
DR   Coriell; DA01648
DR   Wikidata; Q54819286
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01648; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01649
AC   CVCL_6X54
DR   CLO; CLO_0020864
DR   Coriell; DA01649
DR   Wikidata; Q54819287
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01650
AC   CVCL_6X55
DR   CLO; CLO_0020863
DR   Coriell; DA01650
DR   Wikidata; Q54819288
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01651
AC   CVCL_6X56
DR   CLO; CLO_0020860
DR   Coriell; DA01651
DR   Wikidata; Q54819289
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01652
AC   CVCL_6X57
DR   CLO; CLO_0020858
DR   Coriell; DA01652
DR   Wikidata; Q54819290
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01653
AC   CVCL_6X58
DR   CLO; CLO_0020877
DR   Coriell; DA01653
DR   Wikidata; Q54819291
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01654
AC   CVCL_6X59
DR   CLO; CLO_0020875
DR   Coriell; DA01654
DR   Wikidata; Q54819292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01655
AC   CVCL_6X60
DR   CLO; CLO_0020873
DR   Coriell; DA01655
DR   Wikidata; Q54819293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01656
AC   CVCL_6X61
DR   CLO; CLO_0020870
DR   Coriell; DA01656
DR   Wikidata; Q54819298
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01657
AC   CVCL_6X62
DR   CLO; CLO_0020869
DR   Coriell; DA01657
DR   Wikidata; Q54819299
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01658
AC   CVCL_6X63
DR   Coriell; DA01658
DR   Wikidata; Q54819300
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01658; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01659
AC   CVCL_6X64
DR   CLO; CLO_0021013
DR   Coriell; DA01659
DR   Wikidata; Q54819301
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01660
AC   CVCL_6X65
DR   CLO; CLO_0021014
DR   Coriell; DA01660
DR   Wikidata; Q54819302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01662
AC   CVCL_6X66
DR   CLO; CLO_0021015
DR   Coriell; DA01662
DR   Wikidata; Q54819303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01663
AC   CVCL_6X67
DR   Coriell; DA01663
DR   Wikidata; Q54819304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01663; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01664
AC   CVCL_6X68
DR   CLO; CLO_0021016
DR   Coriell; DA01664
DR   Wikidata; Q54819305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01667
AC   CVCL_6X69
DR   CLO; CLO_0021017
DR   Coriell; DA01667
DR   Wikidata; Q54819306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01668
AC   CVCL_6X70
DR   Coriell; DA01668
DR   Wikidata; Q54819307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01668; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01669
AC   CVCL_6X71
DR   CLO; CLO_0021018
DR   Coriell; DA01669
DR   Wikidata; Q54819308
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01670
AC   CVCL_6X72
DR   Coriell; DA01670
DR   Wikidata; Q54819309
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01670; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01671
AC   CVCL_6X73
DR   CLO; CLO_0021004
DR   Coriell; DA01671
DR   Wikidata; Q54819310
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01672
AC   CVCL_6X74
DR   Coriell; DA01672
DR   Wikidata; Q54819311
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01672; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01673
AC   CVCL_6X75
DR   CLO; CLO_0021006
DR   Coriell; DA01673
DR   Wikidata; Q54819312
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01674
AC   CVCL_6X76
DR   CLO; CLO_0021007
DR   Coriell; DA01674
DR   Wikidata; Q54819313
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01675
AC   CVCL_6X77
DR   CLO; CLO_0021008
DR   Coriell; DA01675
DR   Wikidata; Q54819314
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01676
AC   CVCL_6X78
DR   Coriell; DA01676
DR   Wikidata; Q54819315
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01676; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01677
AC   CVCL_6X79
DR   Coriell; DA01677
DR   Wikidata; Q54819316
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01677; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01678
AC   CVCL_6X80
DR   CLO; CLO_0021043
DR   Coriell; DA01678
DR   Wikidata; Q54819317
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01679
AC   CVCL_6X81
DR   CLO; CLO_0021041
DR   Coriell; DA01679
DR   Wikidata; Q54819318
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01681
AC   CVCL_6X82
DR   CLO; CLO_0021042
DR   Coriell; DA01681
DR   Wikidata; Q54819319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01682
AC   CVCL_6X83
DR   CLO; CLO_0021046
DR   Coriell; DA01682
DR   Wikidata; Q54819320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01684
AC   CVCL_6X84
DR   Coriell; DA01684
DR   Wikidata; Q54819321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01684; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01685
AC   CVCL_6X85
DR   CLO; CLO_0021048
DR   Coriell; DA01685
DR   Wikidata; Q54819322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01686
AC   CVCL_6X86
DR   CLO; CLO_0021044
DR   Coriell; DA01686
DR   Wikidata; Q54819323
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01687
AC   CVCL_6X87
DR   CLO; CLO_0021045
DR   Coriell; DA01687
DR   Wikidata; Q54819324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01688
AC   CVCL_6X88
DR   CLO; CLO_0021034
DR   Coriell; DA01688
DR   Wikidata; Q54819325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01689
AC   CVCL_6X89
DR   CLO; CLO_0021035
DR   Coriell; DA01689
DR   Wikidata; Q54819326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01690
AC   CVCL_6X90
DR   CLO; CLO_0021032
DR   Coriell; DA01690
DR   Wikidata; Q54819327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01691
AC   CVCL_6X91
DR   CLO; CLO_0020965
DR   Coriell; DA01691
DR   Wikidata; Q54819328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01692
AC   CVCL_6X92
DR   Coriell; DA01692
DR   Wikidata; Q54819329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01692; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01693
AC   CVCL_ZI26
DR   Coriell; DA01693
DR   Wikidata; Q98125817
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01693; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA01695
AC   CVCL_6X93
DR   CLO; CLO_0020966
DR   Coriell; DA01695
DR   Wikidata; Q54819330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01696
AC   CVCL_6X94
DR   CLO; CLO_0020967
DR   Coriell; DA01696
DR   Wikidata; Q54819331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01697
AC   CVCL_6X95
DR   CLO; CLO_0020968
DR   Coriell; DA01697
DR   Wikidata; Q54819332
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01698
AC   CVCL_6X96
DR   CLO; CLO_0020961
DR   Coriell; DA01698
DR   Wikidata; Q54819333
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01699
AC   CVCL_6X97
DR   CLO; CLO_0020962
DR   Coriell; DA01699
DR   Wikidata; Q54819334
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01700
AC   CVCL_6X98
DR   CLO; CLO_0020963
DR   Coriell; DA01700
DR   Wikidata; Q54819335
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01701
AC   CVCL_6X99
DR   CLO; CLO_0020964
DR   Coriell; DA01701
DR   Wikidata; Q54819336
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01702
AC   CVCL_6Y00
DR   CLO; CLO_0020956
DR   Coriell; DA01702
DR   Wikidata; Q54819337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01703
AC   CVCL_6Y01
DR   CLO; CLO_0020958
DR   Coriell; DA01703
DR   Wikidata; Q54819342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01704
AC   CVCL_6Y02
DR   CLO; CLO_0020324
DR   Coriell; DA01704
DR   Wikidata; Q54819343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01706
AC   CVCL_6Y03
DR   CLO; CLO_0020323
DR   Coriell; DA01706
DR   Wikidata; Q54819344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01707
AC   CVCL_6Y04
DR   CLO; CLO_0020326
DR   Coriell; DA01707
DR   Wikidata; Q54819345
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01708
AC   CVCL_6Y05
DR   CLO; CLO_0020325
DR   Coriell; DA01708
DR   Wikidata; Q54819346
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01709
AC   CVCL_6Y06
DR   CLO; CLO_0020328
DR   Coriell; DA01709
DR   Wikidata; Q54819347
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01710
AC   CVCL_6Y07
DR   CLO; CLO_0020327
DR   Coriell; DA01710
DR   Wikidata; Q54819348
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01711
AC   CVCL_6Y08
DR   Coriell; DA01711
DR   Wikidata; Q54819349
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01711; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01712
AC   CVCL_6Y09
DR   CLO; CLO_0020288
DR   Coriell; DA01712
DR   Wikidata; Q54819350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01713
AC   CVCL_6Y10
DR   CLO; CLO_0020287
DR   Coriell; DA01713
DR   Wikidata; Q54819351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01714
AC   CVCL_6Y11
DR   CLO; CLO_0020285
DR   Coriell; DA01714
DR   Wikidata; Q54819352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01715
AC   CVCL_6Y12
DR   CLO; CLO_0020284
DR   Coriell; DA01715
DR   Wikidata; Q54819353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01716
AC   CVCL_6Y13
DR   CLO; CLO_0020300
DR   Coriell; DA01716
DR   Wikidata; Q54819354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01717
AC   CVCL_6Y14
DR   CLO; CLO_0020298
DR   Coriell; DA01717
DR   Wikidata; Q54819355
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01718
AC   CVCL_6Y15
DR   CLO; CLO_0020299
DR   Coriell; DA01718
DR   Wikidata; Q54819356
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01719
AC   CVCL_6Y16
DR   CLO; CLO_0020296
DR   Coriell; DA01719
DR   Wikidata; Q54819357
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01720
AC   CVCL_6Y17
DR   CLO; CLO_0020297
DR   Coriell; DA01720
DR   Wikidata; Q54819358
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01721
AC   CVCL_6Y18
DR   CLO; CLO_0020294
DR   Coriell; DA01721
DR   Wikidata; Q54819359
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01722
AC   CVCL_6Y19
DR   CLO; CLO_0020295
DR   Coriell; DA01722
DR   Wikidata; Q54819360
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01723
AC   CVCL_6Y20
DR   CLO; CLO_0020264
DR   Coriell; DA01723
DR   Wikidata; Q54819361
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01724
AC   CVCL_6Y21
DR   CLO; CLO_0020263
DR   Coriell; DA01724
DR   Wikidata; Q54819362
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01725
AC   CVCL_6Y22
DR   CLO; CLO_0020265
DR   Coriell; DA01725
DR   Wikidata; Q54819363
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01726
AC   CVCL_6Y23
DR   CLO; CLO_0020276
DR   Coriell; DA01726
DR   Wikidata; Q54819364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01727
AC   CVCL_6Y24
DR   CLO; CLO_0020277
DR   Coriell; DA01727
DR   Wikidata; Q54819365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01728
AC   CVCL_6Y25
DR   CLO; CLO_0020278
DR   Coriell; DA01728
DR   Wikidata; Q54819366
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01729
AC   CVCL_6Y26
DR   CLO; CLO_0020279
DR   Coriell; DA01729
DR   Wikidata; Q54819367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01730
AC   CVCL_6Y27
DR   CLO; CLO_0020272
DR   Coriell; DA01730
DR   Wikidata; Q54819368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01731
AC   CVCL_6Y28
DR   CLO; CLO_0020273
DR   Coriell; DA01731
DR   Wikidata; Q54819369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01732
AC   CVCL_6Y29
DR   CLO; CLO_0020274
DR   Coriell; DA01732
DR   Wikidata; Q54819370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01733
AC   CVCL_6Y30
DR   CLO; CLO_0020275
DR   Coriell; DA01733
DR   Wikidata; Q54819371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01734
AC   CVCL_6Y31
DR   CLO; CLO_0020313
DR   Coriell; DA01734
DR   Wikidata; Q54819372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01735
AC   CVCL_6Y32
DR   CLO; CLO_0020312
DR   Coriell; DA01735
DR   Wikidata; Q54819373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01736
AC   CVCL_6Y33
DR   CLO; CLO_0020314
DR   Coriell; DA01736
DR   Wikidata; Q54819374
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01738
AC   CVCL_6Y34
DR   CLO; CLO_0020317
DR   Coriell; DA01738
DR   Wikidata; Q54819375
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01739
AC   CVCL_6Y35
DR   CLO; CLO_0020318
DR   Coriell; DA01739
DR   Wikidata; Q54819376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01740
AC   CVCL_6Y36
DR   CLO; CLO_0020315
DR   Coriell; DA01740
DR   Wikidata; Q54819377
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01741
AC   CVCL_6Y37
DR   CLO; CLO_0020316
DR   Coriell; DA01741
DR   Wikidata; Q54819378
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01742
AC   CVCL_6Y38
DR   CLO; CLO_0020321
DR   Coriell; DA01742
DR   Wikidata; Q54819379
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01743
AC   CVCL_6Y39
DR   CLO; CLO_0020322
DR   Coriell; DA01743
DR   Wikidata; Q54819380
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01744
AC   CVCL_6Y40
DR   CLO; CLO_0020319
DR   Coriell; DA01744
DR   Wikidata; Q54819381
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01745
AC   CVCL_6Y41
DR   CLO; CLO_0020320
DR   Coriell; DA01745
DR   Wikidata; Q54819386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01745; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA01746
AC   CVCL_6Y42
DR   CLO; CLO_0020301
DR   Coriell; DA01746
DR   Wikidata; Q54819387
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01747
AC   CVCL_6Y43
DR   CLO; CLO_0020302
DR   Coriell; DA01747
DR   Wikidata; Q54819388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01748
AC   CVCL_6Y44
DR   CLO; CLO_0020303
DR   Coriell; DA01748
DR   Wikidata; Q54819389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA01749
AC   CVCL_6Y45
DR   Coriell; DA01749
DR   Wikidata; Q54819390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01749; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01750
AC   CVCL_6Y46
DR   CLO; CLO_0020304
DR   Coriell; DA01750
DR   Wikidata; Q54819391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01751
AC   CVCL_6Y47
DR   CLO; CLO_0020305
DR   Coriell; DA01751
DR   Wikidata; Q54819392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01752
AC   CVCL_6Y48
DR   CLO; CLO_0020306
DR   Coriell; DA01752
DR   Wikidata; Q54819393
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01753
AC   CVCL_6Y49
DR   CLO; CLO_0020307
DR   Coriell; DA01753
DR   Wikidata; Q54819394
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01755
AC   CVCL_6Y50
DR   Coriell; DA01755
DR   Wikidata; Q54819395
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01755; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01756
AC   CVCL_6Y51
DR   CLO; CLO_0020308
DR   Coriell; DA01756
DR   Wikidata; Q54819396
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01757
AC   CVCL_6Y52
DR   CLO; CLO_0020309
DR   Coriell; DA01757
DR   Wikidata; Q54819397
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01758
AC   CVCL_6Y53
DR   CLO; CLO_0020310
DR   Coriell; DA01758
DR   Wikidata; Q54819398
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01759
AC   CVCL_6Y54
DR   CLO; CLO_0020311
DR   Coriell; DA01759
DR   Wikidata; Q54819399
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01760
AC   CVCL_6Y55
DR   CLO; CLO_0020596
DR   Coriell; DA01760
DR   Wikidata; Q54819400
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01761
AC   CVCL_6Y56
DR   CLO; CLO_0020598
DR   Coriell; DA01761
DR   Wikidata; Q54819401
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01762
AC   CVCL_6Y57
DR   CLO; CLO_0020597
DR   Coriell; DA01762
DR   Wikidata; Q54819402
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01763
AC   CVCL_6Y58
DR   CLO; CLO_0020590
DR   Coriell; DA01763
DR   Wikidata; Q54819403
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01764
AC   CVCL_6Y59
DR   CLO; CLO_0020589
DR   Coriell; DA01764
DR   Wikidata; Q54819404
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01765
AC   CVCL_6Y60
DR   CLO; CLO_0020592
DR   Coriell; DA01765
DR   Wikidata; Q54819405
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01766
AC   CVCL_6Y61
DR   CLO; CLO_0020591
DR   Coriell; DA01766
DR   Wikidata; Q54819406
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01767
AC   CVCL_6Y62
DR   CLO; CLO_0020594
DR   Coriell; DA01767
DR   Wikidata; Q54819407
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01769
AC   CVCL_6Y63
DR   Coriell; DA01769
DR   Wikidata; Q54819408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01769; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01770
AC   CVCL_6Y64
DR   CLO; CLO_0020593
DR   Coriell; DA01770
DR   Wikidata; Q54819409
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01771
AC   CVCL_6Y65
DR   Coriell; DA01771
DR   Wikidata; Q54819410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01771; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01772
AC   CVCL_6Y66
DR   Coriell; DA01772
DR   Wikidata; Q54819411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01772; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01773
AC   CVCL_6Y67
DR   CLO; CLO_0020595
DR   Coriell; DA01773
DR   Wikidata; Q54819412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01774
AC   CVCL_6Y68
DR   CLO; CLO_0020615
DR   Coriell; DA01774
DR   Wikidata; Q54819413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01775
AC   CVCL_6Y69
DR   Coriell; DA01775
DR   Wikidata; Q54819414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01775; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01776
AC   CVCL_6Y70
DR   CLO; CLO_0020614
DR   Coriell; DA01776
DR   Wikidata; Q54819415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01777
AC   CVCL_6Y71
DR   CLO; CLO_0020613
DR   Coriell; DA01777
DR   Wikidata; Q54819416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01778
AC   CVCL_6Y72
DR   CLO; CLO_0020612
DR   Coriell; DA01778
DR   Wikidata; Q54819417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01779
AC   CVCL_6Y73
DR   CLO; CLO_0020604
DR   Coriell; DA01779
DR   Wikidata; Q54819418
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01780
AC   CVCL_6Y74
DR   CLO; CLO_0020603
DR   Coriell; DA01780
DR   Wikidata; Q54819419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01782
AC   CVCL_6Y75
DR   CLO; CLO_0020601
DR   Coriell; DA01782
DR   Wikidata; Q54819420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01783
AC   CVCL_6Y76
DR   Coriell; DA01783
DR   Wikidata; Q54819421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01783; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01784
AC   CVCL_6Y77
DR   CLO; CLO_0020599
DR   Coriell; DA01784
DR   Wikidata; Q54819422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01785
AC   CVCL_6Y78
DR   CLO; CLO_0020610
DR   Coriell; DA01785
DR   Wikidata; Q54819423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01786
AC   CVCL_6Y79
DR   Coriell; DA01786
DR   Wikidata; Q54819424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01786; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01788
AC   CVCL_6Y80
DR   Coriell; DA01788
DR   Wikidata; Q54819425
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01788; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01789
AC   CVCL_6Y81
DR   CLO; CLO_0020608
DR   Coriell; DA01789
DR   Wikidata; Q54819429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01790
AC   CVCL_6Y82
DR   Coriell; DA01790
DR   Wikidata; Q54819430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01790; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01791
AC   CVCL_6Y83
DR   CLO; CLO_0020636
DR   Coriell; DA01791
DR   Wikidata; Q54819431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01792
AC   CVCL_6Y84
DR   CLO; CLO_0020633
DR   Coriell; DA01792
DR   Wikidata; Q54819432
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01793
AC   CVCL_6Y85
DR   CLO; CLO_0020632
DR   Coriell; DA01793
DR   Wikidata; Q54819433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01794
AC   CVCL_6Y86
DR   CLO; CLO_0020635
DR   Coriell; DA01794
DR   Wikidata; Q54819434
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01795
AC   CVCL_6Y87
DR   CLO; CLO_0020634
DR   Coriell; DA01795
DR   Wikidata; Q54819435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01796
AC   CVCL_6Y88
DR   Coriell; DA01796
DR   Wikidata; Q54819436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01796; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01797
AC   CVCL_6Y89
DR   Coriell; DA01797
DR   Wikidata; Q54819437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01797; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01799
AC   CVCL_6Y90
DR   CLO; CLO_0020626
DR   Coriell; DA01799
DR   Wikidata; Q54819438
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01801
AC   CVCL_6Y91
DR   CLO; CLO_0020624
DR   Coriell; DA01801
DR   Wikidata; Q54819439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01802
AC   CVCL_ZI27
DR   Coriell; DA01802
DR   Wikidata; Q98125818
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA01803
AC   CVCL_6Y92
DR   CLO; CLO_0020631
DR   Coriell; DA01803
DR   Wikidata; Q54819440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01804
AC   CVCL_6Y93
DR   CLO; CLO_0020628
DR   Coriell; DA01804
DR   Wikidata; Q54819441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01805
AC   CVCL_6Y94
DR   CLO; CLO_0020621
DR   Coriell; DA01805
DR   Wikidata; Q54819442
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01806
AC   CVCL_6Y95
DR   Coriell; DA01806
DR   Wikidata; Q54819443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01806; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01807
AC   CVCL_6Y96
DR   Coriell; DA01807
DR   Wikidata; Q54819444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01807; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01808
AC   CVCL_6Y97
DR   CLO; CLO_0020657
DR   Coriell; DA01808
DR   Wikidata; Q54819445
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01809
AC   CVCL_6Y98
DR   CLO; CLO_0020656
DR   Coriell; DA01809
DR   Wikidata; Q54819446
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01810
AC   CVCL_6Y99
DR   CLO; CLO_0020655
DR   Coriell; DA01810
DR   Wikidata; Q54819447
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01811
AC   CVCL_6Z00
DR   CLO; CLO_0020654
DR   Coriell; DA01811
DR   Wikidata; Q54819448
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01812
AC   CVCL_6Z01
DR   CLO; CLO_0020652
DR   Coriell; DA01812
DR   Wikidata; Q54819449
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01812; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA01813
AC   CVCL_6Z02
DR   CLO; CLO_0020651
DR   Coriell; DA01813
DR   Wikidata; Q54819450
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01814
AC   CVCL_6Z03
DR   CLO; CLO_0020649
DR   Coriell; DA01814
DR   Wikidata; Q54819451
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01815
AC   CVCL_6Z04
DR   CLO; CLO_0020647
DR   Coriell; DA01815
DR   Wikidata; Q54819452
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01816
AC   CVCL_6Z05
DR   CLO; CLO_0020645
DR   Coriell; DA01816
DR   Wikidata; Q54819453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01817
AC   CVCL_6Z06
DR   CLO; CLO_0020644
DR   Coriell; DA01817
DR   Wikidata; Q54819454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01818
AC   CVCL_6Z07
DR   Coriell; DA01818
DR   Wikidata; Q54819455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01818; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01819
AC   CVCL_6Z08
DR   CLO; CLO_0020562
DR   Coriell; DA01819
DR   Wikidata; Q54819456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01820
AC   CVCL_6Z09
DR   Coriell; DA01820
DR   Wikidata; Q54819457
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01820; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01821
AC   CVCL_6Z10
DR   CLO; CLO_0020563
DR   Coriell; DA01821
DR   Wikidata; Q54819458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01822
AC   CVCL_6Z11
DR   CLO; CLO_0020564
DR   Coriell; DA01822
DR   Wikidata; Q54819459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01823
AC   CVCL_6Z12
DR   CLO; CLO_0020565
DR   Coriell; DA01823
DR   Wikidata; Q54819460
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01825
AC   CVCL_6Z13
DR   CLO; CLO_0020566
DR   Coriell; DA01825
DR   Wikidata; Q54819461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01826
AC   CVCL_6Z14
DR   CLO; CLO_0020567
DR   Coriell; DA01826
DR   Wikidata; Q54819462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01827
AC   CVCL_6Z15
DR   CLO; CLO_0020568
DR   Coriell; DA01827
DR   Wikidata; Q54819463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01828
AC   CVCL_6Z16
DR   CLO; CLO_0020569
DR   Coriell; DA01828
DR   Wikidata; Q54819464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01829
AC   CVCL_6Z17
DR   Coriell; DA01829
DR   Wikidata; Q54819465
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01829; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01830
AC   CVCL_6Z18
DR   CLO; CLO_0020570
DR   Coriell; DA01830
DR   Wikidata; Q54819466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01831
AC   CVCL_6Z19
DR   CLO; CLO_0020571
DR   Coriell; DA01831
DR   Wikidata; Q54819467
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01833
AC   CVCL_6Z20
DR   CLO; CLO_0019981
DR   Coriell; DA01833
DR   Wikidata; Q54819468
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01834
AC   CVCL_6Z21
DR   CLO; CLO_0019975
DR   Coriell; DA01834
DR   Wikidata; Q54819472
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01835
AC   CVCL_6Z22
DR   Coriell; DA01835
DR   Wikidata; Q54819473
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01835; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01836
AC   CVCL_6Z23
DR   CLO; CLO_0019974
DR   Coriell; DA01836
DR   Wikidata; Q54819474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01837
AC   CVCL_6Z24
DR   CLO; CLO_0019977
DR   Coriell; DA01837
DR   Wikidata; Q54819475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01838
AC   CVCL_6Z25
DR   CLO; CLO_0019976
DR   Coriell; DA01838
DR   Wikidata; Q54819476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01839
AC   CVCL_6Z26
DR   Coriell; DA01839
DR   Wikidata; Q54819477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01839; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01842
AC   CVCL_6Z27
DR   CLO; CLO_0019958
DR   Coriell; DA01842
DR   Wikidata; Q54819478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01843
AC   CVCL_6Z28
DR   CLO; CLO_0019959
DR   Coriell; DA01843
DR   Wikidata; Q54819479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01844
AC   CVCL_6Z29
DR   CLO; CLO_0019956
DR   Coriell; DA01844
DR   Wikidata; Q54819480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01845
AC   CVCL_6Z30
DR   CLO; CLO_0019957
DR   Coriell; DA01845
DR   Wikidata; Q54819481
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01846
AC   CVCL_6Z31
DR   CLO; CLO_0019960
DR   Coriell; DA01846
DR   Wikidata; Q54819482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01847
AC   CVCL_6Z32
DR   CLO; CLO_0019962
DR   Coriell; DA01847
DR   Wikidata; Q54819483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01848
AC   CVCL_6Z33
DR   CLO; CLO_0019961
DR   Coriell; DA01848
DR   Wikidata; Q54819484
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01849
AC   CVCL_6Z34
DR   CLO; CLO_0019966
DR   Coriell; DA01849
DR   Wikidata; Q54819485
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01850
AC   CVCL_6Z35
DR   CLO; CLO_0019965
DR   Coriell; DA01850
DR   Wikidata; Q54819486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01851
AC   CVCL_6Z36
DR   CLO; CLO_0019964
DR   Coriell; DA01851
DR   Wikidata; Q54819487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01852
AC   CVCL_6Z37
DR   CLO; CLO_0019963
DR   Coriell; DA01852
DR   Wikidata; Q54819488
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01853
AC   CVCL_6Z38
DR   CLO; CLO_0019945
DR   Coriell; DA01853
DR   Wikidata; Q54819489
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01854
AC   CVCL_6Z39
DR   CLO; CLO_0019946
DR   Coriell; DA01854
DR   Wikidata; Q54819490
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01855
AC   CVCL_6Z40
DR   CLO; CLO_0019947
DR   Coriell; DA01855
DR   Wikidata; Q54819491
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01856
AC   CVCL_6Z41
DR   Coriell; DA01856
DR   Wikidata; Q54819492
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01856; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01857
AC   CVCL_6Z42
DR   CLO; CLO_0019948
DR   Coriell; DA01857
DR   Wikidata; Q54819493
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01858
AC   CVCL_6Z43
DR   CLO; CLO_0019949
DR   Coriell; DA01858
DR   Wikidata; Q54819494
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01859
AC   CVCL_6Z44
DR   CLO; CLO_0019951
DR   Coriell; DA01859
DR   Wikidata; Q54819495
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01860
AC   CVCL_6Z45
DR   CLO; CLO_0019950
DR   Coriell; DA01860
DR   Wikidata; Q54819496
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01861
AC   CVCL_6Z46
DR   CLO; CLO_0019953
DR   Coriell; DA01861
DR   Wikidata; Q54819497
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01862
AC   CVCL_6Z47
DR   CLO; CLO_0019952
DR   Coriell; DA01862
DR   Wikidata; Q54819498
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01863
AC   CVCL_6Z48
DR   CLO; CLO_0019955
DR   Coriell; DA01863
DR   Wikidata; Q54819499
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01865
AC   CVCL_6Z49
DR   CLO; CLO_0019954
DR   Coriell; DA01865
DR   Wikidata; Q54819500
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01866
AC   CVCL_6Z50
DR   CLO; CLO_0019934
DR   Coriell; DA01866
DR   Wikidata; Q54819501
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01868
AC   CVCL_6Z51
DR   CLO; CLO_0019932
DR   Coriell; DA01868
DR   Wikidata; Q54819502
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01869
AC   CVCL_6Z52
DR   CLO; CLO_0019931
DR   Coriell; DA01869
DR   Wikidata; Q54819503
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01870
AC   CVCL_6Z53
DR   CLO; CLO_0019943
DR   Coriell; DA01870
DR   Wikidata; Q54819504
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01871
AC   CVCL_6Z54
DR   CLO; CLO_0019944
DR   Coriell; DA01871
DR   Wikidata; Q54819505
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01872
AC   CVCL_6Z55
DR   CLO; CLO_0019940
DR   Coriell; DA01872
DR   Wikidata; Q54819507
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01873
AC   CVCL_6Z56
DR   CLO; CLO_0019942
DR   Coriell; DA01873
DR   Wikidata; Q54819508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01874
AC   CVCL_6Z57
DR   CLO; CLO_0019938
DR   Coriell; DA01874
DR   Wikidata; Q54819509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01875
AC   CVCL_6Z58
DR   CLO; CLO_0019939
DR   Coriell; DA01875
DR   Wikidata; Q54819510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01876
AC   CVCL_6Z59
DR   CLO; CLO_0019936
DR   Coriell; DA01876
DR   Wikidata; Q54819511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01877
AC   CVCL_6Z60
DR   CLO; CLO_0019937
DR   Coriell; DA01877
DR   Wikidata; Q54819512
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01878
AC   CVCL_6Z61
DR   CLO; CLO_0019911
DR   Coriell; DA01878
DR   Wikidata; Q54819517
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01879
AC   CVCL_6Z62
DR   Coriell; DA01879
DR   Wikidata; Q54819519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01879; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01880
AC   CVCL_6Z63
DR   CLO; CLO_0019908
DR   Coriell; DA01880
DR   Wikidata; Q54819521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01881
AC   CVCL_6Z64
DR   CLO; CLO_0019922
DR   Coriell; DA01881
DR   Wikidata; Q54819523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01882
AC   CVCL_6Z65
DR   Coriell; DA01882
DR   Wikidata; Q54819524
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01882; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01883
AC   CVCL_6Z66
DR   CLO; CLO_0019918
DR   Coriell; DA01883
DR   Wikidata; Q54819526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01884
AC   CVCL_6Z67
DR   Coriell; DA01884
DR   Wikidata; Q54819527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01884; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01885
AC   CVCL_6Z68
DR   CLO; CLO_0019919
DR   Coriell; DA01885
DR   Wikidata; Q54819528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01886
AC   CVCL_6Z69
DR   CLO; CLO_0019920
DR   Coriell; DA01886
DR   Wikidata; Q54819529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01887
AC   CVCL_6Z70
DR   CLO; CLO_0019921
DR   Coriell; DA01887
DR   Wikidata; Q54819530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01888
AC   CVCL_6Z71
DR   Coriell; DA01888
DR   Wikidata; Q54819531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01888; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01889
AC   CVCL_6Z72
DR   CLO; CLO_0019914
DR   Coriell; DA01889
DR   Wikidata; Q54819532
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01890
AC   CVCL_6Z73
DR   Coriell; DA01890
DR   Wikidata; Q54819533
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01890; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01891
AC   CVCL_6Z74
DR   CLO; CLO_0019915
DR   Coriell; DA01891
DR   Wikidata; Q54819534
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01892
AC   CVCL_6Z75
DR   CLO; CLO_0019916
DR   Coriell; DA01892
DR   Wikidata; Q54819535
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01893
AC   CVCL_6Z76
DR   CLO; CLO_0019917
DR   Coriell; DA01893
DR   Wikidata; Q54819536
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01894
AC   CVCL_6Z77
DR   CLO; CLO_0019884
DR   Coriell; DA01894
DR   Wikidata; Q54819537
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01895
AC   CVCL_6Z78
DR   CLO; CLO_0019900
DR   Coriell; DA01895
DR   Wikidata; Q54819538
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01896
AC   CVCL_6Z79
DR   CLO; CLO_0019901
DR   Coriell; DA01896
DR   Wikidata; Q54819539
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01897
AC   CVCL_6Z80
DR   CLO; CLO_0019893
DR   Coriell; DA01897
DR   Wikidata; Q54819540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01898
AC   CVCL_6Z81
DR   CLO; CLO_0019894
DR   Coriell; DA01898
DR   Wikidata; Q54819541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01899
AC   CVCL_6Z82
DR   Coriell; DA01899
DR   Wikidata; Q54819542
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01899; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01900
AC   CVCL_6Z83
DR   CLO; CLO_0019889
DR   Coriell; DA01900
DR   Wikidata; Q54821102
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01901
AC   CVCL_6Z84
DR   Coriell; DA01901
DR   Wikidata; Q54821103
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01901; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01902
AC   CVCL_6Z85
DR   Coriell; DA01902
DR   Wikidata; Q54821104
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01902; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01903
AC   CVCL_6Z86
DR   CLO; CLO_0019892
DR   Coriell; DA01903
DR   Wikidata; Q54821105
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01904
AC   CVCL_6Z87
DR   CLO; CLO_0019898
DR   Coriell; DA01904
DR   Wikidata; Q54821106
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01905
AC   CVCL_6Z88
DR   CLO; CLO_0019899
DR   Coriell; DA01905
DR   Wikidata; Q54821108
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01906
AC   CVCL_6Z89
DR   CLO; CLO_0019896
DR   Coriell; DA01906
DR   Wikidata; Q54821109
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01907
AC   CVCL_6Z90
DR   CLO; CLO_0019897
DR   Coriell; DA01907
DR   Wikidata; Q54821110
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01908
AC   CVCL_6Z91
DR   CLO; CLO_0019877
DR   Coriell; DA01908
DR   Wikidata; Q54821111
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01909
AC   CVCL_6Z92
DR   CLO; CLO_0019878
DR   Coriell; DA01909
DR   Wikidata; Q54821112
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01910
AC   CVCL_6Z93
DR   Coriell; DA01910
DR   Wikidata; Q54821113
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01910; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01911
AC   CVCL_6Z94
DR   CLO; CLO_0019879
DR   Coriell; DA01911
DR   Wikidata; Q54821114
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01912
AC   CVCL_6Z95
DR   CLO; CLO_0019868
DR   Coriell; DA01912
DR   Wikidata; Q54821115
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01913
AC   CVCL_6Z96
DR   CLO; CLO_0019869
DR   Coriell; DA01913
DR   Wikidata; Q54821116
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01914
AC   CVCL_6Z97
DR   CLO; CLO_0019870
DR   Coriell; DA01914
DR   Wikidata; Q54821117
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01915
AC   CVCL_6Z98
DR   Coriell; DA01915
DR   Wikidata; Q54821118
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01915; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01916
AC   CVCL_6Z99
DR   Coriell; DA01916
DR   Wikidata; Q54821119
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01916; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01917
AC   CVCL_7A00
DR   CLO; CLO_0019872
DR   Coriell; DA01917
DR   Wikidata; Q54821121
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01918
AC   CVCL_7A01
DR   Coriell; DA01918
DR   Wikidata; Q54821122
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01918; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01919
AC   CVCL_7A02
DR   CLO; CLO_0019874
DR   Coriell; DA01919
DR   Wikidata; Q54821123
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01920
AC   CVCL_7A03
DR   CLO; CLO_0019875
DR   Coriell; DA01920
DR   Wikidata; Q54821124
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01921
AC   CVCL_7A04
DR   Coriell; DA01921
DR   Wikidata; Q54821125
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01921; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01922
AC   CVCL_7A05
DR   CLO; CLO_0019876
DR   Coriell; DA01922
DR   Wikidata; Q54821126
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01923
AC   CVCL_7A06
DR   CLO; CLO_0020200
DR   Coriell; DA01923
DR   Wikidata; Q54821127
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01924
AC   CVCL_7A07
DR   CLO; CLO_0020199
DR   Coriell; DA01924
DR   Wikidata; Q54821128
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01925
AC   CVCL_7A08
DR   Coriell; DA01925
DR   Wikidata; Q54821129
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01925; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01926
AC   CVCL_7A09
DR   Coriell; DA01926
DR   Wikidata; Q54821130
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01926; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01927
AC   CVCL_7A10
DR   CLO; CLO_0020202
DR   Coriell; DA01927
DR   Wikidata; Q54821131
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01928
AC   CVCL_7A11
DR   CLO; CLO_0020201
DR   Coriell; DA01928
DR   Wikidata; Q54821132
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01929
AC   CVCL_7A12
DR   Coriell; DA01929
DR   Wikidata; Q54821134
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01929; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01930
AC   CVCL_7A13
DR   CLO; CLO_0020206
DR   Coriell; DA01930
DR   Wikidata; Q54821135
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01931
AC   CVCL_7A14
DR   CLO; CLO_0020204
DR   Coriell; DA01931
DR   Wikidata; Q54821136
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01932
AC   CVCL_7A15
DR   CLO; CLO_0020209
DR   Coriell; DA01932
DR   Wikidata; Q54821137
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01933
AC   CVCL_7A16
DR   Coriell; DA01933
DR   Wikidata; Q54821138
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01933; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01935
AC   CVCL_7A17
DR   Coriell; DA01935
DR   Wikidata; Q54821139
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01935; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01936
AC   CVCL_7A18
DR   CLO; CLO_0020207
DR   Coriell; DA01936
DR   Wikidata; Q54821140
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01937
AC   CVCL_7A19
DR   CLO; CLO_0020213
DR   Coriell; DA01937
DR   Wikidata; Q54821141
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01938
AC   CVCL_7A20
DR   CLO; CLO_0020211
DR   Coriell; DA01938
DR   Wikidata; Q54821142
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01939
AC   CVCL_7A21
DR   CLO; CLO_0020229
DR   Coriell; DA01939
DR   Wikidata; Q54821144
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01941
AC   CVCL_7A22
DR   CLO; CLO_0020233
DR   Coriell; DA01941
DR   Wikidata; Q54821145
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01942
AC   CVCL_7A23
DR   CLO; CLO_0020232
DR   Coriell; DA01942
DR   Wikidata; Q54821157
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01943
AC   CVCL_7A24
DR   Coriell; DA01943
DR   Wikidata; Q54821158
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01943; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01944
AC   CVCL_7A25
DR   CLO; CLO_0020231
DR   Coriell; DA01944
DR   Wikidata; Q54821159
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01945
AC   CVCL_7A26
DR   Coriell; DA01945
DR   Wikidata; Q54821160
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01945; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01947
AC   CVCL_7A27
DR   CLO; CLO_0020230
DR   Coriell; DA01947
DR   Wikidata; Q54821161
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01948
AC   CVCL_7A28
DR   CLO; CLO_0020240
DR   Coriell; DA01948
DR   Wikidata; Q54821162
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01949
AC   CVCL_7A29
DR   CLO; CLO_0020238
DR   Coriell; DA01949
DR   Wikidata; Q54821163
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01950
AC   CVCL_7A30
DR   CLO; CLO_0020237
DR   Coriell; DA01950
DR   Wikidata; Q54821164
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01951
AC   CVCL_7A31
DR   CLO; CLO_0020234
DR   Coriell; DA01951
DR   Wikidata; Q54821165
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01952
AC   CVCL_7A32
DR   Coriell; DA01952
DR   Wikidata; Q54821167
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01952; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01953
AC   CVCL_7A33
DR   CLO; CLO_0020245
DR   Coriell; DA01953
DR   Wikidata; Q54821168
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01954
AC   CVCL_7A34
DR   CLO; CLO_0020155
DR   Coriell; DA01954
DR   Wikidata; Q54821169
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01955
AC   CVCL_7A35
DR   Coriell; DA01955
DR   Wikidata; Q54821170
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01955; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01956
AC   CVCL_7A36
DR   CLO; CLO_0020154
DR   Coriell; DA01956
DR   Wikidata; Q54821171
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01957
AC   CVCL_7A37
DR   CLO; CLO_0020151
DR   Coriell; DA01957
DR   Wikidata; Q54821172
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01958
AC   CVCL_7A38
DR   CLO; CLO_0020150
DR   Coriell; DA01958
DR   Wikidata; Q54821173
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01959
AC   CVCL_7A39
DR   CLO; CLO_0020153
DR   Coriell; DA01959
DR   Wikidata; Q54821174
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01960
AC   CVCL_7A40
DR   CLO; CLO_0020152
DR   Coriell; DA01960
DR   Wikidata; Q54821175
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01961
AC   CVCL_7A41
DR   Coriell; DA01961
DR   Wikidata; Q54821176
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01961; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01962
AC   CVCL_7A42
DR   CLO; CLO_0020163
DR   Coriell; DA01962
DR   Wikidata; Q54821177
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01963
AC   CVCL_7A43
DR   CLO; CLO_0020160
DR   Coriell; DA01963
DR   Wikidata; Q54821178
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01964
AC   CVCL_7A44
DR   CLO; CLO_0020166
DR   Coriell; DA01964
DR   Wikidata; Q54821179
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01965
AC   CVCL_7A45
DR   CLO; CLO_0020164
DR   Coriell; DA01965
DR   Wikidata; Q54821180
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01966
AC   CVCL_7A46
DR   CLO; CLO_0010392
DR   Coriell; DA01966
DR   Wikidata; Q54821182
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01967
AC   CVCL_7A47
DR   CLO; CLO_0010390
DR   Coriell; DA01967
DR   Wikidata; Q54821183
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01968
AC   CVCL_7A48
DR   CLO; CLO_0010389
DR   Coriell; DA01968
DR   Wikidata; Q54821184
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01969
AC   CVCL_7A49
DR   CLO; CLO_0010399
DR   Coriell; DA01969
DR   Wikidata; Q54821185
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01970
AC   CVCL_7A50
DR   CLO; CLO_0010398
DR   Coriell; DA01970
DR   Wikidata; Q54821186
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01971
AC   CVCL_7A51
DR   CLO; CLO_0010396
DR   Coriell; DA01971
DR   Wikidata; Q54821187
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01972
AC   CVCL_7A52
DR   CLO; CLO_0010393
DR   Coriell; DA01972
DR   Wikidata; Q54821188
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01973
AC   CVCL_7A53
DR   CLO; CLO_0010387
DR   Coriell; DA01973
DR   Wikidata; Q54821189
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01974
AC   CVCL_7A54
DR   CLO; CLO_0010386
DR   Coriell; DA01974
DR   Wikidata; Q54821190
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01975
AC   CVCL_7A55
DR   CLO; CLO_0010385
DR   Coriell; DA01975
DR   Wikidata; Q54821191
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01976
AC   CVCL_7A56
DR   CLO; CLO_0010369
DR   Coriell; DA01976
DR   Wikidata; Q54821192
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01977
AC   CVCL_7A57
DR   CLO; CLO_0010368
DR   Coriell; DA01977
DR   Wikidata; Q54821194
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01978
AC   CVCL_7A58
DR   CLO; CLO_0010372
DR   Coriell; DA01978
DR   Wikidata; Q54821195
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01979
AC   CVCL_7A59
DR   CLO; CLO_0010370
DR   Coriell; DA01979
DR   Wikidata; Q54821196
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01980
AC   CVCL_7A60
DR   CLO; CLO_0010375
DR   Coriell; DA01980
DR   Wikidata; Q54821197
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01981
AC   CVCL_7A61
DR   CLO; CLO_0010374
DR   Coriell; DA01981
DR   Wikidata; Q54821198
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01982
AC   CVCL_7A62
DR   CLO; CLO_0010380
DR   Coriell; DA01982
DR   Wikidata; Q54821199
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01983
AC   CVCL_7A63
DR   CLO; CLO_0010377
DR   Coriell; DA01983
DR   Wikidata; Q54821204
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01984
AC   CVCL_7A64
DR   CLO; CLO_0010367
DR   Coriell; DA01984
DR   Wikidata; Q54821205
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01985
AC   CVCL_7A65
DR   CLO; CLO_0010366
DR   Coriell; DA01985
DR   Wikidata; Q54821206
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01986
AC   CVCL_7A66
DR   Coriell; DA01986
DR   Wikidata; Q54821207
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01986; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01987
AC   CVCL_7A67
DR   CLO; CLO_0016788
DR   Coriell; DA01987
DR   Wikidata; Q54821208
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01988
AC   CVCL_7A68
DR   CLO; CLO_0016800
DR   Coriell; DA01988
DR   Wikidata; Q54821209
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01989
AC   CVCL_7A69
DR   CLO; CLO_0016798
DR   Coriell; DA01989
DR   Wikidata; Q54821211
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01990
AC   CVCL_7A70
DR   CLO; CLO_0016796
DR   Coriell; DA01990
DR   Wikidata; Q54821212
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01991
AC   CVCL_7A71
DR   CLO; CLO_0016795
DR   Coriell; DA01991
DR   Wikidata; Q54821213
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01992
AC   CVCL_7A72
DR   CLO; CLO_0016807
DR   Coriell; DA01992
DR   Wikidata; Q54821214
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01993
AC   CVCL_7A73
DR   CLO; CLO_0016806
DR   Coriell; DA01993
DR   Wikidata; Q54821215
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01994
AC   CVCL_7A74
DR   Coriell; DA01994
DR   Wikidata; Q54821216
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01994; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01995
AC   CVCL_7A75
DR   Coriell; DA01995
DR   Wikidata; Q54821217
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01995; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01996
AC   CVCL_7A76
DR   Coriell; DA01996
DR   Wikidata; Q54821218
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01996; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01997
AC   CVCL_7A77
DR   Coriell; DA01997
DR   Wikidata; Q54821219
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01997; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01998
AC   CVCL_7A78
DR   Coriell; DA01998
DR   Wikidata; Q54821220
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01998; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA01999
AC   CVCL_7A79
DR   Coriell; DA01999
DR   Wikidata; Q54821221
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA01999; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02000
AC   CVCL_7A80
DR   CLO; CLO_0016804
DR   Coriell; DA02000
DR   Wikidata; Q54821222
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02001
AC   CVCL_7A81
DR   Coriell; DA02001
DR   Wikidata; Q54821223
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02001; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02002
AC   CVCL_7A82
DR   CLO; CLO_0016802
DR   Coriell; DA02002
DR   Wikidata; Q54821225
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02003
AC   CVCL_7A83
DR   CLO; CLO_0016793
DR   Coriell; DA02003
DR   Wikidata; Q54821226
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02004
AC   CVCL_7A84
DR   CLO; CLO_0016759
DR   Coriell; DA02004
DR   Wikidata; Q54821227
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02005
AC   CVCL_7A85
DR   CLO; CLO_0016760
DR   Coriell; DA02005
DR   Wikidata; Q54821228
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02006
AC   CVCL_7A86
DR   CLO; CLO_0016766
DR   Coriell; DA02006
DR   Wikidata; Q54821229
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02007
AC   CVCL_7A87
DR   CLO; CLO_0016765
DR   Coriell; DA02007
DR   Wikidata; Q54821230
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02008
AC   CVCL_7A88
DR   CLO; CLO_0016769
DR   Coriell; DA02008
DR   Wikidata; Q54821231
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02009
AC   CVCL_7A89
DR   CLO; CLO_0016767
DR   Coriell; DA02009
DR   Wikidata; Q54821232
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02010
AC   CVCL_7A90
DR   CLO; CLO_0016772
DR   Coriell; DA02010
DR   Wikidata; Q54821233
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02011
AC   CVCL_7A91
DR   CLO; CLO_0016770
DR   Coriell; DA02011
DR   Wikidata; Q54821234
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02012
AC   CVCL_7A92
DR   CLO; CLO_0016776
DR   Coriell; DA02012
DR   Wikidata; Q54821236
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02013
AC   CVCL_7A93
DR   CLO; CLO_0016775
DR   Coriell; DA02013
DR   Wikidata; Q54821237
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02014
AC   CVCL_7A94
DR   CLO; CLO_0016725
DR   Coriell; DA02014
DR   Wikidata; Q54821238
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02015
AC   CVCL_7A95
DR   Coriell; DA02015
DR   Wikidata; Q54821239
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02015; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02016
AC   CVCL_7A96
DR   CLO; CLO_0016720
DR   Coriell; DA02016
DR   Wikidata; Q54821240
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA02017
AC   CVCL_7A97
DR   CLO; CLO_0016723
DR   Coriell; DA02017
DR   Wikidata; Q54821241
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02018
AC   CVCL_7A98
DR   CLO; CLO_0016746
DR   Coriell; DA02018
DR   Wikidata; Q54821242
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02019
AC   CVCL_7A99
DR   CLO; CLO_0016744
DR   Coriell; DA02019
DR   Wikidata; Q54821243
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02020
AC   CVCL_7B00
DR   Coriell; DA02020
DR   Wikidata; Q54821244
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02020; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02021
AC   CVCL_7B01
DR   CLO; CLO_0016743
DR   Coriell; DA02021
DR   Wikidata; Q54821245
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02022
AC   CVCL_7B02
DR   Coriell; DA02022
DR   Wikidata; Q54821246
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02022; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02023
AC   CVCL_7B03
DR   CLO; CLO_0016741
DR   Coriell; DA02023
DR   Wikidata; Q54821252
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02024
AC   CVCL_7B04
DR   Coriell; DA02024
DR   Wikidata; Q54821253
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02024; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02025
AC   CVCL_7B05
DR   Coriell; DA02025
DR   Wikidata; Q54821254
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02025; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02026
AC   CVCL_7B06
DR   CLO; CLO_0016739
DR   Coriell; DA02026
DR   Wikidata; Q54821255
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02027
AC   CVCL_7B07
DR   CLO; CLO_0016737
DR   Coriell; DA02027
DR   Wikidata; Q54821256
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02028
AC   CVCL_7B08
DR   CLO; CLO_0016734
DR   Coriell; DA02028
DR   Wikidata; Q54821258
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02029
AC   CVCL_7B09
DR   Coriell; DA02029
DR   Wikidata; Q54821259
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02029; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02030
AC   CVCL_7B10
DR   CLO; CLO_0016690
DR   Coriell; DA02030
DR   Wikidata; Q54821260
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02033
AC   CVCL_7B11
DR   Coriell; DA02033
DR   Wikidata; Q54821261
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02033; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02034
AC   CVCL_7B12
DR   CLO; CLO_0016691
DR   Coriell; DA02034
DR   Wikidata; Q54821262
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02035
AC   CVCL_7B13
DR   CLO; CLO_0016694
DR   Coriell; DA02035
DR   Wikidata; Q54821263
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02036
AC   CVCL_7B14
DR   CLO; CLO_0016696
DR   Coriell; DA02036
DR   Wikidata; Q54821264
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02037
AC   CVCL_7B15
DR   Coriell; DA02037
DR   Wikidata; Q54821265
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02037; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02038
AC   CVCL_7B16
DR   Coriell; DA02038
DR   Wikidata; Q54821266
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02038; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02039
AC   CVCL_7B17
DR   Coriell; DA02039
DR   Wikidata; Q54821267
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02039; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02040
AC   CVCL_7B18
DR   CLO; CLO_0016714
DR   Coriell; DA02040
DR   Wikidata; Q54821268
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02041
AC   CVCL_7B19
DR   CLO; CLO_0016711
DR   Coriell; DA02041
DR   Wikidata; Q54821269
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02042
AC   CVCL_7B20
DR   CLO; CLO_0016719
DR   Coriell; DA02042
DR   Wikidata; Q54821270
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02043
AC   CVCL_7B21
DR   CLO; CLO_0016716
DR   Coriell; DA02043
DR   Wikidata; Q54821271
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02044
AC   CVCL_7B22
DR   CLO; CLO_0016707
DR   Coriell; DA02044
DR   Wikidata; Q54821273
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02045
AC   CVCL_7B23
DR   CLO; CLO_0016706
DR   Coriell; DA02045
DR   Wikidata; Q54821274
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02046
AC   CVCL_7B24
DR   Coriell; DA02046
DR   Wikidata; Q54821275
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02046; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02048
AC   CVCL_7B25
DR   CLO; CLO_0016656
DR   Coriell; DA02048
DR   Wikidata; Q54821276
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02049
AC   CVCL_7B26
DR   CLO; CLO_0016670
DR   Coriell; DA02049
DR   Wikidata; Q54821277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02050
AC   CVCL_7B27
DR   CLO; CLO_0016668
DR   Coriell; DA02050
DR   Wikidata; Q54821278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02051
AC   CVCL_7B28
DR   CLO; CLO_0016667
DR   Coriell; DA02051
DR   Wikidata; Q54821279
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02052
AC   CVCL_7B29
DR   CLO; CLO_0016665
DR   Coriell; DA02052
DR   Wikidata; Q54821281
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02053
AC   CVCL_7B30
DR   CLO; CLO_0016677
DR   Coriell; DA02053
DR   Wikidata; Q54821282
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02054
AC   CVCL_7B31
DR   CLO; CLO_0016679
DR   Coriell; DA02054
DR   Wikidata; Q54821283
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02056
AC   CVCL_7B32
DR   CLO; CLO_0016673
DR   Coriell; DA02056
DR   Wikidata; Q54821284
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02056; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02057
AC   CVCL_ZI29
DR   Coriell; DA02057
DR   Wikidata; Q98125820
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02057; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02058
AC   CVCL_7B33
DR   CLO; CLO_0016674
DR   Coriell; DA02058
DR   Wikidata; Q54821285
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02059
AC   CVCL_7B34
DR   Coriell; DA02059
DR   Wikidata; Q54821286
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02059; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02060
AC   CVCL_7B35
DR   CLO; CLO_0016683
DR   Coriell; DA02060
DR   Wikidata; Q54821287
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02061
AC   CVCL_7B36
DR   CLO; CLO_0016625
DR   Coriell; DA02061
DR   Wikidata; Q54821288
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02062
AC   CVCL_7B37
DR   CLO; CLO_0016623
DR   Coriell; DA02062
DR   Wikidata; Q54821289
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02063
AC   CVCL_7B38
DR   CLO; CLO_0016629
DR   Coriell; DA02063
DR   Wikidata; Q54821291
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02064
AC   CVCL_7B39
DR   Coriell; DA02064
DR   Wikidata; Q54821292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02064; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02065
AC   CVCL_7B40
DR   Coriell; DA02065
DR   Wikidata; Q54821293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02065; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02066
AC   CVCL_7B41
DR   Coriell; DA02066
DR   Wikidata; Q54821294
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02066; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02067
AC   CVCL_7B42
DR   CLO; CLO_0016626
DR   Coriell; DA02067
DR   Wikidata; Q54821295
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02068
AC   CVCL_7B43
DR   CLO; CLO_0016632
DR   Coriell; DA02068
DR   Wikidata; Q54821302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02069
AC   CVCL_7B44
DR   CLO; CLO_0016630
DR   Coriell; DA02069
DR   Wikidata; Q54821303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02070
AC   CVCL_7B45
DR   CLO; CLO_0016634
DR   Coriell; DA02070
DR   Wikidata; Q54821304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02072
AC   CVCL_7B46
DR   CLO; CLO_0016637
DR   Coriell; DA02072
DR   Wikidata; Q54821305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02073
AC   CVCL_7B47
DR   CLO; CLO_0016639
DR   Coriell; DA02073
DR   Wikidata; Q54821306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02074
AC   CVCL_7B48
DR   CLO; CLO_0016640
DR   Coriell; DA02074
DR   Wikidata; Q54821307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02076
AC   CVCL_7B49
DR   CLO; CLO_0016587
DR   Coriell; DA02076
DR   Wikidata; Q54821308
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02077
AC   CVCL_7B50
DR   CLO; CLO_0016584
DR   Coriell; DA02077
DR   Wikidata; Q54821310
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02078
AC   CVCL_7B51
DR   CLO; CLO_0016581
DR   Coriell; DA02078
DR   Wikidata; Q54821311
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02079
AC   CVCL_7B52
DR   CLO; CLO_0016579
DR   Coriell; DA02079
DR   Wikidata; Q54821312
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02080
AC   CVCL_7B53
DR   CLO; CLO_0016577
DR   Coriell; DA02080
DR   Wikidata; Q54821313
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02081
AC   CVCL_7B54
DR   CLO; CLO_0016574
DR   Coriell; DA02081
DR   Wikidata; Q54821314
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02082
AC   CVCL_7B55
DR   CLO; CLO_0016573
DR   Coriell; DA02082
DR   Wikidata; Q54821315
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02083
AC   CVCL_7B56
DR   CLO; CLO_0016603
DR   Coriell; DA02083
DR   Wikidata; Q54821316
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02084
AC   CVCL_7B57
DR   CLO; CLO_0016605
DR   Coriell; DA02084
DR   Wikidata; Q54821317
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02086
AC   CVCL_7B58
DR   Coriell; DA02086
DR   Wikidata; Q54821318
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02086; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02089
AC   CVCL_7B59
DR   CLO; CLO_0016599
DR   Coriell; DA02089
DR   Wikidata; Q54821319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02090
AC   CVCL_7B60
DR   Coriell; DA02090
DR   Wikidata; Q54821320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02090; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02091
AC   CVCL_7B61
DR   CLO; CLO_0016547
DR   Coriell; DA02091
DR   Wikidata; Q54821321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02092
AC   CVCL_7B62
DR   Coriell; DA02092
DR   Wikidata; Q54821322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02092; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02093
AC   CVCL_7B63
DR   CLO; CLO_0016543
DR   Coriell; DA02093
DR   Wikidata; Q54821324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02094
AC   CVCL_7B64
DR   CLO; CLO_0016552
DR   Coriell; DA02094
DR   Wikidata; Q54821325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02095
AC   CVCL_7B65
DR   CLO; CLO_0016550
DR   Coriell; DA02095
DR   Wikidata; Q54821326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02096
AC   CVCL_7B66
DR   Coriell; DA02096
DR   Wikidata; Q54821327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02096; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02097
AC   CVCL_7B67
DR   CLO; CLO_0016538
DR   Coriell; DA02097
DR   Wikidata; Q54821328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02098
AC   CVCL_7B68
DR   CLO; CLO_0016534
DR   Coriell; DA02098
DR   Wikidata; Q54821329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02101
AC   CVCL_7B69
DR   CLO; CLO_0016541
DR   Coriell; DA02101
DR   Wikidata; Q54821330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02102
AC   CVCL_7B70
DR   CLO; CLO_0016539
DR   Coriell; DA02102
DR   Wikidata; Q54821331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02103
AC   CVCL_7B71
DR   Coriell; DA02103
DR   Wikidata; Q54821332
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02103; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02104
AC   CVCL_7B72
DR   CLO; CLO_0016562
DR   Coriell; DA02104
DR   Wikidata; Q54821333
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02105
AC   CVCL_7B73
DR   CLO; CLO_0016563
DR   Coriell; DA02105
DR   Wikidata; Q54821334
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02106
AC   CVCL_7B74
DR   CLO; CLO_0016313
DR   Coriell; DA02106
DR   Wikidata; Q54821335
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02107
AC   CVCL_7B75
DR   CLO; CLO_0016314
DR   Coriell; DA02107
DR   Wikidata; Q54821337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02108
AC   CVCL_7B76
DR   CLO; CLO_0016309
DR   Coriell; DA02108
DR   Wikidata; Q54821338
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02110
AC   CVCL_7B77
DR   CLO; CLO_0016310
DR   Coriell; DA02110
DR   Wikidata; Q54821339
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02111
AC   CVCL_7B78
DR   CLO; CLO_0016311
DR   Coriell; DA02111
DR   Wikidata; Q54821340
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02112
AC   CVCL_7B79
DR   CLO; CLO_0016312
DR   Coriell; DA02112
DR   Wikidata; Q54821341
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02113
AC   CVCL_7B80
DR   Coriell; DA02113
DR   Wikidata; Q54821342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02113; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02114
AC   CVCL_7B81
DR   CLO; CLO_0016315
DR   Coriell; DA02114
DR   Wikidata; Q54821343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02115
AC   CVCL_7B82
DR   Coriell; DA02115
DR   Wikidata; Q54821344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02115; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02116
AC   CVCL_7B83
DR   Coriell; DA02116
DR   Wikidata; Q54821350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02116; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02117
AC   CVCL_7B84
DR   CLO; CLO_0016316
DR   Coriell; DA02117
DR   Wikidata; Q54821351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02118
AC   CVCL_7B85
DR   Coriell; DA02118
DR   Wikidata; Q54821352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02118; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02119
AC   CVCL_7B86
DR   CLO; CLO_0016317
DR   Coriell; DA02119
DR   Wikidata; Q54821353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02120
AC   CVCL_7B87
DR   CLO; CLO_0016318
DR   Coriell; DA02120
DR   Wikidata; Q54821354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02121
AC   CVCL_7B88
DR   Coriell; DA02121
DR   Wikidata; Q54821355
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02121; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02125
AC   CVCL_7B89
DR   CLO; CLO_0016325
DR   Coriell; DA02125
DR   Wikidata; Q54821356
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02127
AC   CVCL_7B90
DR   CLO; CLO_0016323
DR   Coriell; DA02127
DR   Wikidata; Q54821357
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02128
AC   CVCL_7B91
DR   CLO; CLO_0016324
DR   Coriell; DA02128
DR   Wikidata; Q54821358
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02130
AC   CVCL_7B92
DR   CLO; CLO_0016321
DR   Coriell; DA02130
DR   Wikidata; Q54821359
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02131
AC   CVCL_7B93
DR   CLO; CLO_0016322
DR   Coriell; DA02131
DR   Wikidata; Q54821360
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02132
AC   CVCL_7B94
DR   CLO; CLO_0016319
DR   Coriell; DA02132
DR   Wikidata; Q54821361
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02133
AC   CVCL_7B95
DR   CLO; CLO_0016320
DR   Coriell; DA02133
DR   Wikidata; Q54821362
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02135
AC   CVCL_7B96
DR   CLO; CLO_0016327
DR   Coriell; DA02135
DR   Wikidata; Q54821364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02138
AC   CVCL_7B97
DR   Coriell; DA02138
DR   Wikidata; Q54821365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02138; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02139
AC   CVCL_7B98
DR   Coriell; DA02139
DR   Wikidata; Q54821366
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02139; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02140
AC   CVCL_7B99
DR   Coriell; DA02140
DR   Wikidata; Q54821367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02140; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02141
AC   CVCL_7C00
DR   CLO; CLO_0016328
DR   Coriell; DA02141
DR   Wikidata; Q54821368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02142
AC   CVCL_7C01
DR   CLO; CLO_0016326
DR   Coriell; DA02142
DR   Wikidata; Q54821369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02143
AC   CVCL_7C02
DR   CLO; CLO_0016289
DR   Coriell; DA02143
DR   Wikidata; Q54821370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02144
AC   CVCL_7C03
DR   CLO; CLO_0016290
DR   Coriell; DA02144
DR   Wikidata; Q54821371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02145
AC   CVCL_7C04
DR   Coriell; DA02145
DR   Wikidata; Q54821372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02145; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02146
AC   CVCL_7C05
DR   CLO; CLO_0016291
DR   Coriell; DA02146
DR   Wikidata; Q54821373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02147
AC   CVCL_7C06
DR   Coriell; DA02147
DR   Wikidata; Q54821375
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02147; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02148
AC   CVCL_7C07
DR   Coriell; DA02148
DR   Wikidata; Q54821376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02148; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02149
AC   CVCL_7C08
DR   Coriell; DA02149
DR   Wikidata; Q54821377
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02149; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02150
AC   CVCL_7C09
DR   Coriell; DA02150
DR   Wikidata; Q54821378
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02150; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02151
AC   CVCL_7C10
DR   CLO; CLO_0016292
DR   Coriell; DA02151
DR   Wikidata; Q54821379
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02152
AC   CVCL_7C11
DR   CLO; CLO_0016293
DR   Coriell; DA02152
DR   Wikidata; Q54821380
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02153
AC   CVCL_7C12
DR   CLO; CLO_0016294
DR   Coriell; DA02153
DR   Wikidata; Q54821381
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02154
AC   CVCL_7C13
DR   CLO; CLO_0016295
DR   Coriell; DA02154
DR   Wikidata; Q54821382
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02155
AC   CVCL_7C14
DR   Coriell; DA02155
DR   Wikidata; Q54821383
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02155; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02156
AC   CVCL_7C15
DR   Coriell; DA02156
DR   Wikidata; Q54821384
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02156; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02157
AC   CVCL_7C16
DR   CLO; CLO_0016296
DR   Coriell; DA02157
DR   Wikidata; Q54821385
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02158
AC   CVCL_7C17
DR   Coriell; DA02158
DR   Wikidata; Q54821386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02158; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02159
AC   CVCL_7C18
DR   CLO; CLO_0016297
DR   Coriell; DA02159
DR   Wikidata; Q54821388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02160
AC   CVCL_7C19
DR   CLO; CLO_0016298
DR   Coriell; DA02160
DR   Wikidata; Q54821389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02161
AC   CVCL_7C20
DR   CLO; CLO_0016308
DR   Coriell; DA02161
DR   Wikidata; Q54821390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02162
AC   CVCL_7C21
DR   CLO; CLO_0016301
DR   Coriell; DA02162
DR   Wikidata; Q54821391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02163
AC   CVCL_7C22
DR   CLO; CLO_0016302
DR   Coriell; DA02163
DR   Wikidata; Q54821392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02164
AC   CVCL_7C23
DR   Coriell; DA02164
DR   Wikidata; Q54821404
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02164; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02165
AC   CVCL_7C24
DR   Coriell; DA02165
DR   Wikidata; Q54821405
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02165; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02167
AC   CVCL_7C25
DR   CLO; CLO_0016299
DR   Coriell; DA02167
DR   Wikidata; Q54821407
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02168
AC   CVCL_7C26
DR   CLO; CLO_0016300
DR   Coriell; DA02168
DR   Wikidata; Q54821408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02169
AC   CVCL_7C27
DR   CLO; CLO_0016305
DR   Coriell; DA02169
DR   Wikidata; Q54821409
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02170
AC   CVCL_7C28
DR   CLO; CLO_0016306
DR   Coriell; DA02170
DR   Wikidata; Q54821410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02171
AC   CVCL_7C29
DR   CLO; CLO_0016303
DR   Coriell; DA02171
DR   Wikidata; Q54821411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02172
AC   CVCL_7C30
DR   CLO; CLO_0016304
DR   Coriell; DA02172
DR   Wikidata; Q54821412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02173
AC   CVCL_7C31
DR   Coriell; DA02173
DR   Wikidata; Q54821413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02173; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02174
AC   CVCL_7C32
DR   Coriell; DA02174
DR   Wikidata; Q54821414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02174; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02175
AC   CVCL_7C33
DR   Coriell; DA02175
DR   Wikidata; Q54821415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02175; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02176
AC   CVCL_7C34
DR   CLO; CLO_0016307
DR   Coriell; DA02176
DR   Wikidata; Q54821416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02177
AC   CVCL_7C35
DR   CLO; CLO_0017268
DR   Coriell; DA02177
DR   Wikidata; Q54821417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02178
AC   CVCL_7C36
DR   CLO; CLO_0017269
DR   Coriell; DA02178
DR   Wikidata; Q54821419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02179
AC   CVCL_7C37
DR   CLO; CLO_0017278
DR   Coriell; DA02179
DR   Wikidata; Q54821420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02180
AC   CVCL_7C38
DR   CLO; CLO_0017277
DR   Coriell; DA02180
DR   Wikidata; Q54821421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02181
AC   CVCL_7C39
DR   CLO; CLO_0017276
DR   Coriell; DA02181
DR   Wikidata; Q54821422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02182
AC   CVCL_7C40
DR   CLO; CLO_0017274
DR   Coriell; DA02182
DR   Wikidata; Q54821423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02188
AC   CVCL_7C41
DR   CLO; CLO_0017286
DR   Coriell; DA02188
DR   Wikidata; Q54821424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02189
AC   CVCL_7C42
DR   CLO; CLO_0017283
DR   Coriell; DA02189
DR   Wikidata; Q54821425
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02190
AC   CVCL_ZI30
DR   Coriell; DA02190
DR   Wikidata; Q98125821
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02190; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02191
AC   CVCL_7C43
DR   CLO; CLO_0017281
DR   Coriell; DA02191
DR   Wikidata; Q54821426
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02192
AC   CVCL_7C44
DR   CLO; CLO_0017279
DR   Coriell; DA02192
DR   Wikidata; Q54821427
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02194
AC   CVCL_7C45
DR   CLO; CLO_0017243
DR   Coriell; DA02194
DR   Wikidata; Q54821428
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02195
AC   CVCL_7C46
DR   Coriell; DA02195
DR   Wikidata; Q54821429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02195; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02196
AC   CVCL_7C47
DR   Coriell; DA02196
DR   Wikidata; Q54821430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02196; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02197
AC   CVCL_7C48
DR   CLO; CLO_0017244
DR   Coriell; DA02197
DR   Wikidata; Q54821431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02199
AC   CVCL_7C49
DR   CLO; CLO_0017245
DR   Coriell; DA02199
DR   Wikidata; Q54821433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02200
AC   CVCL_7C50
DR   CLO; CLO_0017247
DR   Coriell; DA02200
DR   Wikidata; Q54821434
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02202
AC   CVCL_7C51
DR   CLO; CLO_0017246
DR   Coriell; DA02202
DR   Wikidata; Q54821435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02203
AC   CVCL_7C52
DR   CLO; CLO_0017249
DR   Coriell; DA02203
DR   Wikidata; Q54821436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02204
AC   CVCL_7C53
DR   Coriell; DA02204
DR   Wikidata; Q54821437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02204; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02205
AC   CVCL_7C54
DR   CLO; CLO_0017248
DR   Coriell; DA02205
DR   Wikidata; Q54821438
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02206
AC   CVCL_7C55
DR   Coriell; DA02206
DR   Wikidata; Q54821439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02206; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02209
AC   CVCL_7C56
DR   CLO; CLO_0017253
DR   Coriell; DA02209
DR   Wikidata; Q54821440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02211
AC   CVCL_7C57
DR   Coriell; DA02211
DR   Wikidata; Q54821441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02211; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02212
AC   CVCL_7C58
DR   CLO; CLO_0017251
DR   Coriell; DA02212
DR   Wikidata; Q54821442
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02213
AC   CVCL_7C59
DR   Coriell; DA02213
DR   Wikidata; Q54821443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02213; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02214
AC   CVCL_7C60
DR   Coriell; DA02214
DR   Wikidata; Q54821444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02214; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02215
AC   CVCL_7C61
DR   Coriell; DA02215
DR   Wikidata; Q54821446
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02215; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02216
AC   CVCL_7C62
DR   Coriell; DA02216
DR   Wikidata; Q54821447
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02216; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02217
AC   CVCL_7C63
DR   Coriell; DA02217
DR   Wikidata; Q54821453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02217; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02218
AC   CVCL_7C64
DR   Coriell; DA02218
DR   Wikidata; Q54821454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02218; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02219
AC   CVCL_7C65
DR   Coriell; DA02219
DR   Wikidata; Q54821455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02219; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02220
AC   CVCL_7C66
DR   CLO; CLO_0017256
DR   Coriell; DA02220
DR   Wikidata; Q54821456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02221
AC   CVCL_7C67
DR   CLO; CLO_0017324
DR   Coriell; DA02221
DR   Wikidata; Q54821457
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02222
AC   CVCL_7C68
DR   CLO; CLO_0017325
DR   Coriell; DA02222
DR   Wikidata; Q54821458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02223
AC   CVCL_7C69
DR   Coriell; DA02223
DR   Wikidata; Q54821459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02223; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02224
AC   CVCL_7C70
DR   CLO; CLO_0017320
DR   Coriell; DA02224
DR   Wikidata; Q54821461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02225
AC   CVCL_7C71
DR   Coriell; DA02225
DR   Wikidata; Q54821462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02225; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02227
AC   CVCL_7C72
DR   CLO; CLO_0017322
DR   Coriell; DA02227
DR   Wikidata; Q54821463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02228
AC   CVCL_7C73
DR   CLO; CLO_0017347
DR   Coriell; DA02228
DR   Wikidata; Q54821464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02229
AC   CVCL_7C74
DR   Coriell; DA02229
DR   Wikidata; Q54821465
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02229; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02230
AC   CVCL_7C75
DR   CLO; CLO_0017344
DR   Coriell; DA02230
DR   Wikidata; Q54821466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02231
AC   CVCL_7C76
DR   Coriell; DA02231
DR   Wikidata; Q54821467
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02231; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02236
AC   CVCL_7C77
DR   CLO; CLO_0017343
DR   Coriell; DA02236
DR   Wikidata; Q54821468
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02237
AC   CVCL_7C78
DR   CLO; CLO_0017340
DR   Coriell; DA02237
DR   Wikidata; Q54821469
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02238
AC   CVCL_7C79
DR   CLO; CLO_0017338
DR   Coriell; DA02238
DR   Wikidata; Q54821470
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02240
AC   CVCL_7C80
DR   Coriell; DA02240
DR   Wikidata; Q54821471
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02240; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02242
AC   CVCL_7C81
DR   CLO; CLO_0017337
DR   Coriell; DA02242
DR   Wikidata; Q54821472
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02243
AC   CVCL_ZI31
DR   Coriell; DA02243
DR   Wikidata; Q98125823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02243; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02244
AC   CVCL_ZI32
DR   Coriell; DA02244
DR   Wikidata; Q98125824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02244; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02245
AC   CVCL_7C82
DR   Coriell; DA02245
DR   Wikidata; Q54821474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02245; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02246
AC   CVCL_7C83
DR   CLO; CLO_0017304
DR   Coriell; DA02246
DR   Wikidata; Q54821475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02247
AC   CVCL_7C84
DR   CLO; CLO_0017289
DR   Coriell; DA02247
DR   Wikidata; Q54821476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02249
AC   CVCL_7C85
DR   CLO; CLO_0017292
DR   Coriell; DA02249
DR   Wikidata; Q54821477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02250
AC   CVCL_7C86
DR   Coriell; DA02250
DR   Wikidata; Q54821478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02250; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02251
AC   CVCL_7C87
DR   Coriell; DA02251
DR   Wikidata; Q54821479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02251; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02252
AC   CVCL_7C88
DR   Coriell; DA02252
DR   Wikidata; Q54821480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02252; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02253
AC   CVCL_7C89
DR   Coriell; DA02253
DR   Wikidata; Q54821481
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02253; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02254
AC   CVCL_7C90
DR   Coriell; DA02254
DR   Wikidata; Q54821482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02254; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02255
AC   CVCL_7C91
DR   Coriell; DA02255
DR   Wikidata; Q54821483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02255; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02256
AC   CVCL_7C92
DR   CLO; CLO_0017294
DR   Coriell; DA02256
DR   Wikidata; Q54821484
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02257
AC   CVCL_7C93
DR   Coriell; DA02257
DR   Wikidata; Q54821485
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02257; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02258
AC   CVCL_7C94
DR   Coriell; DA02258
DR   Wikidata; Q54821486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02258; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02259
AC   CVCL_ZI33
DR   Coriell; DA02259
DR   Wikidata; Q98125825
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02259; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02260
AC   CVCL_7C95
DR   Coriell; DA02260
DR   Wikidata; Q54821487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02260; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02261
AC   CVCL_7C96
DR   Coriell; DA02261
DR   Wikidata; Q54821489
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02261; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02262
AC   CVCL_7C97
DR   CLO; CLO_0017295
DR   Coriell; DA02262
DR   Wikidata; Q54821490
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02263
AC   CVCL_7C98
DR   Coriell; DA02263
DR   Wikidata; Q54821491
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02263; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02264
AC   CVCL_7C99
DR   Coriell; DA02264
DR   Wikidata; Q54821492
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02264; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02265
AC   CVCL_7D00
DR   Coriell; DA02265
DR   Wikidata; Q54821493
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02265; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02266
AC   CVCL_7D01
DR   Coriell; DA02266
DR   Wikidata; Q54821494
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02266; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02269
AC   CVCL_7D02
DR   Coriell; DA02269
DR   Wikidata; Q54821495
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02269; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02270
AC   CVCL_7D03
DR   Coriell; DA02270
DR   Wikidata; Q54821508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02270; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02271
AC   CVCL_7D04
DR   Coriell; DA02271
DR   Wikidata; Q54821509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02271; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02273
AC   CVCL_ZI34
DR   Coriell; DA02273
DR   Wikidata; Q98125827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02273; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02274
AC   CVCL_ZI35
DR   Coriell; DA02274
DR   Wikidata; Q98125828
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02274; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02275
AC   CVCL_ZI36
DR   Coriell; DA02275
DR   Wikidata; Q98125829
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02275; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02276
AC   CVCL_7D05
DR   Coriell; DA02276
DR   Wikidata; Q54821510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02276; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02277
AC   CVCL_7D06
DR   Coriell; DA02277
DR   Wikidata; Q54821511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02277; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02280
AC   CVCL_7D07
DR   CLO; CLO_0017313
DR   Coriell; DA02280
DR   Wikidata; Q54821512
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02281
AC   CVCL_7D08
DR   Coriell; DA02281
DR   Wikidata; Q54821513
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02281; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02282
AC   CVCL_7D09
DR   Coriell; DA02282
DR   Wikidata; Q54821514
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02282; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02283
AC   CVCL_7D10
DR   Coriell; DA02283
DR   Wikidata; Q54821515
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02283; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02285
AC   CVCL_7D11
DR   Coriell; DA02285
DR   Wikidata; Q54821516
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02285; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02286
AC   CVCL_7D12
DR   Coriell; DA02286
DR   Wikidata; Q54821517
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02286; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02287
AC   CVCL_7D13
DR   Coriell; DA02287
DR   Wikidata; Q54821519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02287; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02290
AC   CVCL_7D14
DR   Coriell; DA02290
DR   Wikidata; Q54821520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02290; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02291
AC   CVCL_7D15
DR   Coriell; DA02291
DR   Wikidata; Q54821521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02291; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02292
AC   CVCL_7D16
DR   Coriell; DA02292
DR   Wikidata; Q54821522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02292; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02293
AC   CVCL_7D17
DR   Coriell; DA02293
DR   Wikidata; Q54821523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02293; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02294
AC   CVCL_7D18
DR   CLO; CLO_0017312
DR   Coriell; DA02294
DR   Wikidata; Q54821524
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02295
AC   CVCL_7D19
DR   CLO; CLO_0017316
DR   Coriell; DA02295
DR   Wikidata; Q54821525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02296
AC   CVCL_7D20
DR   CLO; CLO_0017315
DR   Coriell; DA02296
DR   Wikidata; Q54821526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02297
AC   CVCL_7D21
DR   CLO; CLO_0017308
DR   Coriell; DA02297
DR   Wikidata; Q54821527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02300
AC   CVCL_7D22
DR   CLO; CLO_0017151
DR   Coriell; DA02300
DR   Wikidata; Q54821528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02302
AC   CVCL_7D23
DR   CLO; CLO_0017147
DR   Coriell; DA02302
DR   Wikidata; Q54821529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02303
AC   CVCL_7D24
DR   CLO; CLO_0017163
DR   Coriell; DA02303
DR   Wikidata; Q54821530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02304
AC   CVCL_7D25
DR   CLO; CLO_0017160
DR   Coriell; DA02304
DR   Wikidata; Q54821531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02305
AC   CVCL_7D26
DR   CLO; CLO_0017158
DR   Coriell; DA02305
DR   Wikidata; Q54821533
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02306
AC   CVCL_7D27
DR   CLO; CLO_0017156
DR   Coriell; DA02306
DR   Wikidata; Q54821534
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02307
AC   CVCL_7D28
DR   CLO; CLO_0017181
DR   Coriell; DA02307
DR   Wikidata; Q54821535
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02309
AC   CVCL_7D29
DR   CLO; CLO_0017182
DR   Coriell; DA02309
DR   Wikidata; Q54821536
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02310
AC   CVCL_7D30
DR   Coriell; DA02310
DR   Wikidata; Q54821537
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02310; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02311
AC   CVCL_7D31
DR   Coriell; DA02311
DR   Wikidata; Q54821538
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02311; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02312
AC   CVCL_7D32
DR   Coriell; DA02312
DR   Wikidata; Q54821539
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02312; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02313
AC   CVCL_7D33
DR   CLO; CLO_0017177
DR   Coriell; DA02313
DR   Wikidata; Q54821540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02314
AC   CVCL_7D34
DR   CLO; CLO_0017178
DR   Coriell; DA02314
DR   Wikidata; Q54821541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02315
AC   CVCL_7D35
DR   Coriell; DA02315
DR   Wikidata; Q54821542
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02315; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02316
AC   CVCL_7D36
DR   CLO; CLO_0017117
DR   Coriell; DA02316
DR   Wikidata; Q54821544
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02317
AC   CVCL_7D37
DR   CLO; CLO_0017121
DR   Coriell; DA02317
DR   Wikidata; Q54821545
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02318
AC   CVCL_7D38
DR   CLO; CLO_0017120
DR   Coriell; DA02318
DR   Wikidata; Q54821546
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02319
AC   CVCL_7D39
DR   CLO; CLO_0017123
DR   Coriell; DA02319
DR   Wikidata; Q54821547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02320
AC   CVCL_7D40
DR   Coriell; DA02320
DR   Wikidata; Q54821549
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02320; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02321
AC   CVCL_7D41
DR   Coriell; DA02321
DR   Wikidata; Q54821550
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02321; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02323
AC   CVCL_7D42
DR   Coriell; DA02323
DR   Wikidata; Q54821551
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02323; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02325
AC   CVCL_7D43
DR   Coriell; DA02325
DR   Wikidata; Q54821560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02325; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02326
AC   CVCL_7D44
DR   Coriell; DA02326
DR   Wikidata; Q54821561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02326; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02327
AC   CVCL_7D45
DR   Coriell; DA02327
DR   Wikidata; Q54821562
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02327; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02328
AC   CVCL_7D46
DR   Coriell; DA02328
DR   Wikidata; Q54821563
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02328; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02329
AC   CVCL_7D47
DR   Coriell; DA02329
DR   Wikidata; Q54821564
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02329; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02330
AC   CVCL_7D48
DR   Coriell; DA02330
DR   Wikidata; Q54821566
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02330; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02331
AC   CVCL_ZI37
DR   Coriell; DA02331
DR   Wikidata; Q98125830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02331; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02332
AC   CVCL_7D49
DR   Coriell; DA02332
DR   Wikidata; Q54821567
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02332; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02334
AC   CVCL_7D50
DR   Coriell; DA02334
DR   Wikidata; Q54821568
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02334; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02335
AC   CVCL_7D51
DR   Coriell; DA02335
DR   Wikidata; Q54821569
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02335; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02337
AC   CVCL_7D52
DR   Coriell; DA02337
DR   Wikidata; Q54821570
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02337; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02338
AC   CVCL_7D53
DR   CLO; CLO_0017122
DR   Coriell; DA02338
DR   Wikidata; Q54821571
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02339
AC   CVCL_7D54
DR   CLO; CLO_0017125
DR   Coriell; DA02339
DR   Wikidata; Q54821573
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02340
AC   CVCL_7D55
DR   CLO; CLO_0017124
DR   Coriell; DA02340
DR   Wikidata; Q54821574
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02341
AC   CVCL_7D56
DR   CLO; CLO_0017137
DR   Coriell; DA02341
DR   Wikidata; Q54821575
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02342
AC   CVCL_7D57
DR   CLO; CLO_0017140
DR   Coriell; DA02342
DR   Wikidata; Q54821576
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02343
AC   CVCL_7D58
DR   Coriell; DA02343
DR   Wikidata; Q54821577
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02343; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02344
AC   CVCL_7D59
DR   Coriell; DA02344
DR   Wikidata; Q54821579
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02344; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02345
AC   CVCL_7D60
DR   CLO; CLO_0017141
DR   Coriell; DA02345
DR   Wikidata; Q54821580
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02346
AC   CVCL_7D61
DR   CLO; CLO_0016862
DR   Coriell; DA02346
DR   Wikidata; Q54821581
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02347
AC   CVCL_7D62
DR   CLO; CLO_0016864
DR   Coriell; DA02347
DR   Wikidata; Q54821582
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02348
AC   CVCL_ZI38
DR   Coriell; DA02348
DR   Wikidata; Q98125831
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02348; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02349
AC   CVCL_7D63
DR   Coriell; DA02349
DR   Wikidata; Q54821584
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02349; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DA02350
AC   CVCL_7D64
DR   Coriell; DA02350
DR   Wikidata; Q54821585
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02350; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02351
AC   CVCL_ZI39
DR   Coriell; DA02351
DR   Wikidata; Q98125832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02351; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02352
AC   CVCL_7D65
DR   Coriell; DA02352
DR   Wikidata; Q54821586
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02352; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02353
AC   CVCL_7D66
DR   Coriell; DA02353
DR   Wikidata; Q54821587
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02353; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02354
AC   CVCL_ZI40
DR   Coriell; DA02354
DR   Wikidata; Q98125834
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02354; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02355
AC   CVCL_ZI41
DR   Coriell; DA02355
DR   Wikidata; Q98125835
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02355; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02356
AC   CVCL_ZI42
DR   Coriell; DA02356
DR   Wikidata; Q98125836
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02356; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02357
AC   CVCL_7D67
DR   CLO; CLO_0016863
DR   Coriell; DA02357
DR   Wikidata; Q54821588
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02358
AC   CVCL_7D68
DR   CLO; CLO_0016866
DR   Coriell; DA02358
DR   Wikidata; Q54821591
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02359
AC   CVCL_7D69
DR   Coriell; DA02359
DR   Wikidata; Q54821592
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02359; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02360
AC   CVCL_7D70
DR   Coriell; DA02360
DR   Wikidata; Q54821593
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02360; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02361
AC   CVCL_7D71
DR   CLO; CLO_0016865
DR   Coriell; DA02361
DR   Wikidata; Q54821595
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02362
AC   CVCL_7D72
DR   Coriell; DA02362
DR   Wikidata; Q54821596
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02362; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02363
AC   CVCL_7D73
DR   Coriell; DA02363
DR   Wikidata; Q54821597
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02363; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02364
AC   CVCL_7D74
DR   Coriell; DA02364
DR   Wikidata; Q54821598
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02364; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02365
AC   CVCL_7D75
DR   CLO; CLO_0016868
DR   Coriell; DA02365
DR   Wikidata; Q54821599
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02366
AC   CVCL_7D76
DR   Coriell; DA02366
DR   Wikidata; Q54821600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02366; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02367
AC   CVCL_ZI43
DR   Coriell; DA02367
DR   Wikidata; Q98125838
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02367; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02368
AC   CVCL_7D77
DR   Coriell; DA02368
DR   Wikidata; Q54821602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02368; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02369
AC   CVCL_ZI44
DR   Coriell; DA02369
DR   Wikidata; Q98125839
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02369; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02371
AC   CVCL_ZI45
DR   Coriell; DA02371
DR   Wikidata; Q98125840
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02371; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02372
AC   CVCL_7D78
DR   Coriell; DA02372
DR   Wikidata; Q54821603
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02372; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02375
AC   CVCL_7D79
DR   CLO; CLO_0016867
DR   Coriell; DA02375
DR   Wikidata; Q54821604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02376
AC   CVCL_7D80
DR   CLO; CLO_0016870
DR   Coriell; DA02376
DR   Wikidata; Q54821605
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02377
AC   CVCL_ZI46
DR   Coriell; DA02377
DR   Wikidata; Q98125841
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02377; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02379
AC   CVCL_7D81
DR   Coriell; DA02379
DR   Wikidata; Q54821607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02379; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02380
AC   CVCL_7D82
DR   Coriell; DA02380
DR   Wikidata; Q54821609
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02380; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02383
AC   CVCL_7D83
DR   CLO; CLO_0016869
DR   Coriell; DA02383
DR   Wikidata; Q54821627
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02384
AC   CVCL_7D84
DR   Coriell; DA02384
DR   Wikidata; Q54821628
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02384; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02385
AC   CVCL_7D85
DR   Coriell; DA02385
DR   Wikidata; Q54821629
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02385; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02386
AC   CVCL_ZI47
DR   Coriell; DA02386
DR   Wikidata; Q98125842
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02386; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02387
AC   CVCL_7D86
DR   Coriell; DA02387
DR   Wikidata; Q54821630
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02387; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02388
AC   CVCL_7D87
DR   Coriell; DA02388
DR   Wikidata; Q54821631
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02388; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02389
AC   CVCL_ZI48
DR   Coriell; DA02389
DR   Wikidata; Q98125843
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02389; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02390
AC   CVCL_7D88
DR   CLO; CLO_0016871
DR   Coriell; DA02390
DR   Wikidata; Q54821632
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02391
AC   CVCL_7D89
DR   Coriell; DA02391
DR   Wikidata; Q54821633
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02391; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02393
AC   CVCL_7D90
DR   Coriell; DA02393
DR   Wikidata; Q54821634
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02393; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02394
AC   CVCL_7D91
DR   CLO; CLO_0016880
DR   Coriell; DA02394
DR   Wikidata; Q54821635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02395
AC   CVCL_7D92
DR   CLO; CLO_0016879
DR   Coriell; DA02395
DR   Wikidata; Q54821637
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02396
AC   CVCL_7D93
DR   CLO; CLO_0016886
DR   Coriell; DA02396
DR   Wikidata; Q54821638
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02397
AC   CVCL_7D94
DR   Coriell; DA02397
DR   Wikidata; Q54821639
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02397; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02398
AC   CVCL_7D95
DR   CLO; CLO_0016885
DR   Coriell; DA02398
DR   Wikidata; Q54821640
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02399
AC   CVCL_7D96
DR   CLO; CLO_0016884
DR   Coriell; DA02399
DR   Wikidata; Q54821641
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02400
AC   CVCL_7D97
DR   CLO; CLO_0016883
DR   Coriell; DA02400
DR   Wikidata; Q54821642
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02401
AC   CVCL_7D98
DR   CLO; CLO_0016890
DR   Coriell; DA02401
DR   Wikidata; Q54821644
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02402
AC   CVCL_7D99
DR   CLO; CLO_0016889
DR   Coriell; DA02402
DR   Wikidata; Q54821645
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02403
AC   CVCL_7E00
DR   CLO; CLO_0016888
DR   Coriell; DA02403
DR   Wikidata; Q54821646
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02404
AC   CVCL_7E01
DR   CLO; CLO_0016887
DR   Coriell; DA02404
DR   Wikidata; Q54821647
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02405
AC   CVCL_7E02
DR   CLO; CLO_0016816
DR   Coriell; DA02405
DR   Wikidata; Q54821648
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02406
AC   CVCL_7E03
DR   CLO; CLO_0016817
DR   Coriell; DA02406
DR   Wikidata; Q54821649
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02407
AC   CVCL_7E04
DR   CLO; CLO_0016818
DR   Coriell; DA02407
DR   Wikidata; Q54821651
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02408
AC   CVCL_7E05
DR   CLO; CLO_0016812
DR   Coriell; DA02408
DR   Wikidata; Q54821652
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02409
AC   CVCL_7E06
DR   Coriell; DA02409
DR   Wikidata; Q54821653
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02409; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02410
AC   CVCL_7E07
DR   Coriell; DA02410
DR   Wikidata; Q54821654
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02410; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02411
AC   CVCL_7E08
DR   Coriell; DA02411
DR   Wikidata; Q54821656
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02411; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02412
AC   CVCL_7E09
DR   Coriell; DA02412
DR   Wikidata; Q54821657
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02412; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02413
AC   CVCL_7E10
DR   Coriell; DA02413
DR   Wikidata; Q54821658
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02413; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02414
AC   CVCL_7E11
DR   Coriell; DA02414
DR   Wikidata; Q54821659
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02414; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02415
AC   CVCL_7E12
DR   Coriell; DA02415
DR   Wikidata; Q54821660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02415; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02416
AC   CVCL_7E13
DR   Coriell; DA02416
DR   Wikidata; Q54821661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02416; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02417
AC   CVCL_7E14
DR   Coriell; DA02417
DR   Wikidata; Q54821662
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02417; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02418
AC   CVCL_7E15
DR   CLO; CLO_0016813
DR   Coriell; DA02418
DR   Wikidata; Q54821663
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02419
AC   CVCL_7E16
DR   Coriell; DA02419
DR   Wikidata; Q54821664
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02419; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02421
AC   CVCL_7E17
DR   Coriell; DA02421
DR   Wikidata; Q54821666
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02421; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02422
AC   CVCL_7E18
DR   CLO; CLO_0016814
DR   Coriell; DA02422
DR   Wikidata; Q54821669
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02424
AC   CVCL_7E19
DR   CLO; CLO_0016815
DR   Coriell; DA02424
DR   Wikidata; Q54821670
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02425
AC   CVCL_7E20
DR   CLO; CLO_0016809
DR   Coriell; DA02425
DR   Wikidata; Q54821671
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02426
AC   CVCL_7E21
DR   Coriell; DA02426
DR   Wikidata; Q54821672
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02426; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02427
AC   CVCL_7E22
DR   CLO; CLO_0016810
DR   Coriell; DA02427
DR   Wikidata; Q54821673
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02428
AC   CVCL_7E23
DR   CLO; CLO_0016811
DR   Coriell; DA02428
DR   Wikidata; Q54821692
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02429
AC   CVCL_7E24
DR   CLO; CLO_0016827
DR   Coriell; DA02429
DR   Wikidata; Q54821693
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02430
AC   CVCL_7E25
DR   CLO; CLO_0016828
DR   Coriell; DA02430
DR   Wikidata; Q54821694
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02431
AC   CVCL_7E26
DR   Coriell; DA02431
DR   Wikidata; Q54821695
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02431; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02432
AC   CVCL_7E27
DR   Coriell; DA02432
DR   Wikidata; Q54821696
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02432; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02433
AC   CVCL_7E28
DR   CLO; CLO_0016825
DR   Coriell; DA02433
DR   Wikidata; Q54821697
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02434
AC   CVCL_7E29
DR   CLO; CLO_0016826
DR   Coriell; DA02434
DR   Wikidata; Q54821698
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02435
AC   CVCL_7E30
DR   Coriell; DA02435
DR   Wikidata; Q54821699
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02435; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02436
AC   CVCL_7E31
DR   Coriell; DA02436
DR   Wikidata; Q54821700
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02436; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02437
AC   CVCL_7E32
DR   CLO; CLO_0016823
DR   Coriell; DA02437
DR   Wikidata; Q54821702
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02438
AC   CVCL_7E33
DR   CLO; CLO_0016824
DR   Coriell; DA02438
DR   Wikidata; Q54821703
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02439
AC   CVCL_7E34
DR   Coriell; DA02439
DR   Wikidata; Q54821704
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02439; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02440
AC   CVCL_7E35
DR   Coriell; DA02440
DR   Wikidata; Q54821706
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02440; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02441
AC   CVCL_7E36
DR   Coriell; DA02441
DR   Wikidata; Q54821707
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02441; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02442
AC   CVCL_7E37
DR   Coriell; DA02442
DR   Wikidata; Q54821709
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02442; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02443
AC   CVCL_7E38
DR   CLO; CLO_0016821
DR   Coriell; DA02443
DR   Wikidata; Q54821710
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02444
AC   CVCL_7E39
DR   CLO; CLO_0016822
DR   Coriell; DA02444
DR   Wikidata; Q54821711
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02445
AC   CVCL_7E40
DR   Coriell; DA02445
DR   Wikidata; Q54821712
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02445; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02446
AC   CVCL_7E41
DR   Coriell; DA02446
DR   Wikidata; Q54821713
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02446; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02447
AC   CVCL_7E42
DR   Coriell; DA02447
DR   Wikidata; Q54821714
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02447; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02448
AC   CVCL_7E43
DR   Coriell; DA02448
DR   Wikidata; Q54821715
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02448; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02449
AC   CVCL_7E44
DR   Coriell; DA02449
DR   Wikidata; Q54821716
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02449; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02450
AC   CVCL_7E45
DR   CLO; CLO_0016819
DR   Coriell; DA02450
DR   Wikidata; Q54821718
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02451
AC   CVCL_7E46
DR   Coriell; DA02451
DR   Wikidata; Q54821719
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02451; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02452
AC   CVCL_7E47
DR   Coriell; DA02452
DR   Wikidata; Q54821720
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02452; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02453
AC   CVCL_7E48
DR   Coriell; DA02453
DR   Wikidata; Q54821721
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02453; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02454
AC   CVCL_7E49
DR   Coriell; DA02454
DR   Wikidata; Q54821723
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02454; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02455
AC   CVCL_7E50
DR   Coriell; DA02455
DR   Wikidata; Q54821724
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02455; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02456
AC   CVCL_7E51
DR   Coriell; DA02456
DR   Wikidata; Q54821725
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02456; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02457
AC   CVCL_7E52
DR   Coriell; DA02457
DR   Wikidata; Q54821727
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02457; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02458
AC   CVCL_7E53
DR   Coriell; DA02458
DR   Wikidata; Q54821728
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02458; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02459
AC   CVCL_7E54
DR   Coriell; DA02459
DR   Wikidata; Q54821729
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02459; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02460
AC   CVCL_7E55
DR   Coriell; DA02460
DR   Wikidata; Q54821730
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02460; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02461
AC   CVCL_7E56
DR   Coriell; DA02461
DR   Wikidata; Q54821731
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02461; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02463
AC   CVCL_7E57
DR   CLO; CLO_0016820
DR   Coriell; DA02463
DR   Wikidata; Q54821733
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02464
AC   CVCL_ZI49
DR   Coriell; DA02464
DR   Wikidata; Q98125844
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02464; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02465
AC   CVCL_7E58
DR   CLO; CLO_0016838
DR   Coriell; DA02465
DR   Wikidata; Q54821735
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02466
AC   CVCL_7E59
DR   CLO; CLO_0016830
DR   Coriell; DA02466
DR   Wikidata; Q54821736
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02467
AC   CVCL_7E60
DR   CLO; CLO_0016831
DR   Coriell; DA02467
DR   Wikidata; Q54821737
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02468
AC   CVCL_7E61
DR   CLO; CLO_0016832
DR   Coriell; DA02468
DR   Wikidata; Q54821738
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02469
AC   CVCL_7E62
DR   Coriell; DA02469
DR   Wikidata; Q54821739
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02469; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02470
AC   CVCL_7E63
DR   Coriell; DA02470
DR   Wikidata; Q54821779
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02470; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02471
AC   CVCL_7E64
DR   Coriell; DA02471
DR   Wikidata; Q54821780
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02471; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02473
AC   CVCL_7E65
DR   CLO; CLO_0016833
DR   Coriell; DA02473
DR   Wikidata; Q54821782
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02474
AC   CVCL_7E66
DR   CLO; CLO_0016834
DR   Coriell; DA02474
DR   Wikidata; Q54821783
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02475
AC   CVCL_7E67
DR   CLO; CLO_0016835
DR   Coriell; DA02475
DR   Wikidata; Q54821785
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02476
AC   CVCL_7E68
DR   CLO; CLO_0016836
DR   Coriell; DA02476
DR   Wikidata; Q54821786
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02479
AC   CVCL_7E69
DR   Coriell; DA02479
DR   Wikidata; Q54821787
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02479; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02480
AC   CVCL_7E70
DR   Coriell; DA02480
DR   Wikidata; Q54821788
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02480; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02481
AC   CVCL_7E71
DR   CLO; CLO_0016837
DR   Coriell; DA02481
DR   Wikidata; Q54821791
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02482
AC   CVCL_7E72
DR   CLO; CLO_0016829
DR   Coriell; DA02482
DR   Wikidata; Q54821792
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02483
AC   CVCL_ZI50
DR   Coriell; DA02483
DR   Wikidata; Q98125845
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02483; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02484
AC   CVCL_ZI51
DR   Coriell; DA02484
DR   Wikidata; Q98125846
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02484; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02485
AC   CVCL_ZI52
DR   Coriell; DA02485
DR   Wikidata; Q98125848
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02485; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02486
AC   CVCL_ZI53
DR   Coriell; DA02486
DR   Wikidata; Q98125849
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02486; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02487
AC   CVCL_7E73
DR   Coriell; DA02487
DR   Wikidata; Q54821794
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02487; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02488
AC   CVCL_7E74
DR   Coriell; DA02488
DR   Wikidata; Q54821795
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02488; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02489
AC   CVCL_7E75
DR   Coriell; DA02489
DR   Wikidata; Q54821796
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02489; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02490
AC   CVCL_7E76
DR   Coriell; DA02490
DR   Wikidata; Q54821797
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02490; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02491
AC   CVCL_7E77
DR   Coriell; DA02491
DR   Wikidata; Q54821798
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02491; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02492
AC   CVCL_7E78
DR   Coriell; DA02492
DR   Wikidata; Q54821799
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02492; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02494
AC   CVCL_7E79
DR   CLO; CLO_0016848
DR   Coriell; DA02494
DR   Wikidata; Q54821802
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02495
AC   CVCL_7E80
DR   CLO; CLO_0016847
DR   Coriell; DA02495
DR   Wikidata; Q54821803
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02496
AC   CVCL_7E81
DR   CLO; CLO_0016841
DR   Coriell; DA02496
DR   Wikidata; Q54821805
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02497
AC   CVCL_7E82
DR   CLO; CLO_0016842
DR   Coriell; DA02497
DR   Wikidata; Q54821806
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02498
AC   CVCL_7E83
DR   CLO; CLO_0016839
DR   Coriell; DA02498
DR   Wikidata; Q54821807
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02499
AC   CVCL_7E84
DR   CLO; CLO_0016840
DR   Coriell; DA02499
DR   Wikidata; Q54821808
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02500
AC   CVCL_7E85
DR   Coriell; DA02500
DR   Wikidata; Q54821809
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02500; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02501
AC   CVCL_7E86
DR   CLO; CLO_0016845
DR   Coriell; DA02501
DR   Wikidata; Q54821810
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02503
AC   CVCL_ZI54
DR   Coriell; DA02503
DR   Wikidata; Q98125851
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02503; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02504
AC   CVCL_7E87
DR   Coriell; DA02504
DR   Wikidata; Q54821812
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02504; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02505
AC   CVCL_7E88
DR   Coriell; DA02505
DR   Wikidata; Q54821813
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02505; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02506
AC   CVCL_7E89
DR   CLO; CLO_0016846
DR   Coriell; DA02506
DR   Wikidata; Q54821814
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02507
AC   CVCL_7E90
DR   Coriell; DA02507
DR   Wikidata; Q54821815
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02507; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02509
AC   CVCL_ZI55
DR   Coriell; DA02509
DR   Wikidata; Q98125852
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02509; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02510
AC   CVCL_7E91
DR   Coriell; DA02510
DR   Wikidata; Q54821817
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02510; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02511
AC   CVCL_7E92
DR   Coriell; DA02511
DR   Wikidata; Q54821819
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02511; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02512
AC   CVCL_7E93
DR   CLO; CLO_0016843
DR   Coriell; DA02512
DR   Wikidata; Q54821821
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02513
AC   CVCL_7E94
DR   CLO; CLO_0016844
DR   Coriell; DA02513
DR   Wikidata; Q54821822
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02515
AC   CVCL_7E95
DR   Coriell; DA02515
DR   Wikidata; Q54821823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02515; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02516
AC   CVCL_7E96
DR   CLO; CLO_0015682
DR   Coriell; DA02516
DR   Wikidata; Q54821824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02517
AC   CVCL_7E97
DR   CLO; CLO_0015678
DR   Coriell; DA02517
DR   Wikidata; Q54821826
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02517; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA02518
AC   CVCL_7E98
DR   CLO; CLO_0015679
DR   Coriell; DA02518
DR   Wikidata; Q54821827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02519
AC   CVCL_7E99
DR   CLO; CLO_0015659
DR   Coriell; DA02519
DR   Wikidata; Q54821829
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02520
AC   CVCL_7F00
DR   Coriell; DA02520
DR   Wikidata; Q54821830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02520; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02521
AC   CVCL_7F01
DR   Coriell; DA02521
DR   Wikidata; Q54821832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02521; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02522
AC   CVCL_7F02
DR   CLO; CLO_0015656
DR   Coriell; DA02522
DR   Wikidata; Q54821833
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02523
AC   CVCL_7F03
DR   CLO; CLO_0015654
DR   Coriell; DA02523
DR   Wikidata; Q54821853
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02524
AC   CVCL_7F04
DR   CLO; CLO_0015653
DR   Coriell; DA02524
DR   Wikidata; Q54821854
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02525
AC   CVCL_7F05
DR   CLO; CLO_0015669
DR   Coriell; DA02525
DR   Wikidata; Q54821855
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02526
AC   CVCL_7F06
DR   CLO; CLO_0015665
DR   Coriell; DA02526
DR   Wikidata; Q54821857
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02527
AC   CVCL_7F07
DR   Coriell; DA02527
DR   Wikidata; Q54821858
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02527; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02528
AC   CVCL_7F08
DR   Coriell; DA02528
DR   Wikidata; Q54821859
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02528; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02529
AC   CVCL_7F09
DR   Coriell; DA02529
DR   Wikidata; Q54821860
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02529; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02530
AC   CVCL_7F10
DR   Coriell; DA02530
DR   Wikidata; Q54821861
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02530; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02531
AC   CVCL_ZI56
DR   Coriell; DA02531
DR   Wikidata; Q98125853
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02531; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02532
AC   CVCL_7F11
DR   Coriell; DA02532
DR   Wikidata; Q54821862
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02532; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02533
AC   CVCL_7F12
DR   Coriell; DA02533
DR   Wikidata; Q54821864
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02533; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02534
AC   CVCL_7F13
DR   Coriell; DA02534
DR   Wikidata; Q54821865
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02534; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02535
AC   CVCL_7F14
DR   CLO; CLO_0015662
DR   Coriell; DA02535
DR   Wikidata; Q54821866
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02536
AC   CVCL_7F15
DR   CLO; CLO_0015637
DR   Coriell; DA02536
DR   Wikidata; Q54821867
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02537
AC   CVCL_7F16
DR   CLO; CLO_0015638
DR   Coriell; DA02537
DR   Wikidata; Q54821868
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02538
AC   CVCL_7F17
DR   Coriell; DA02538
DR   Wikidata; Q54821869
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02538; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02539
AC   CVCL_7F18
DR   Coriell; DA02539
DR   Wikidata; Q54821870
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02539; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02540
AC   CVCL_7F19
DR   Coriell; DA02540
DR   Wikidata; Q54821871
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02540; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02541
AC   CVCL_7F20
DR   Coriell; DA02541
DR   Wikidata; Q54821872
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02541; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02542
AC   CVCL_7F21
DR   Coriell; DA02542
DR   Wikidata; Q54821873
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02542; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02543
AC   CVCL_7F22
DR   CLO; CLO_0015641
DR   Coriell; DA02543
DR   Wikidata; Q54821875
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02544
AC   CVCL_7F23
DR   CLO; CLO_0015643
DR   Coriell; DA02544
DR   Wikidata; Q54821876
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02545
AC   CVCL_7F24
DR   CLO; CLO_0015612
DR   Coriell; DA02545
DR   Wikidata; Q54821877
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02546
AC   CVCL_7F25
DR   CLO; CLO_0015611
DR   Coriell; DA02546
DR   Wikidata; Q54821878
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02548
AC   CVCL_7F26
DR   Coriell; DA02548
DR   Wikidata; Q54821880
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02548; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02549
AC   CVCL_7F27
DR   Coriell; DA02549
DR   Wikidata; Q54821882
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02549; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02550
AC   CVCL_7F28
DR   Coriell; DA02550
DR   Wikidata; Q54821883
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02550; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02552
AC   CVCL_7F29
DR   Coriell; DA02552
DR   Wikidata; Q54821884
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02552; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02553
AC   CVCL_7F30
DR   Coriell; DA02553
DR   Wikidata; Q54821885
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02553; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02554
AC   CVCL_7F31
DR   Coriell; DA02554
DR   Wikidata; Q54821886
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02554; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02555
AC   CVCL_7F32
DR   Coriell; DA02555
DR   Wikidata; Q54821887
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02555; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02556
AC   CVCL_7F33
DR   CLO; CLO_0015616
DR   Coriell; DA02556
DR   Wikidata; Q54821889
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02557
AC   CVCL_7F34
DR   CLO; CLO_0015615
DR   Coriell; DA02557
DR   Wikidata; Q54821890
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02558
AC   CVCL_7F35
DR   CLO; CLO_0015621
DR   Coriell; DA02558
DR   Wikidata; Q54821892
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02559
AC   CVCL_7F36
DR   CLO; CLO_0015619
DR   Coriell; DA02559
DR   Wikidata; Q54821893
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02560
AC   CVCL_7F37
DR   Coriell; DA02560
DR   Wikidata; Q54821894
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02560; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02561
AC   CVCL_7F38
DR   CLO; CLO_0015599
DR   Coriell; DA02561
DR   Wikidata; Q54821896
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02562
AC   CVCL_7F39
DR   CLO; CLO_0015591
DR   Coriell; DA02562
DR   Wikidata; Q54821898
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02563
AC   CVCL_7F40
DR   CLO; CLO_0015594
DR   Coriell; DA02563
DR   Wikidata; Q54821900
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02564
AC   CVCL_7F41
DR   CLO; CLO_0015588
DR   Coriell; DA02564
DR   Wikidata; Q54821901
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02565
AC   CVCL_7F42
DR   CLO; CLO_0015590
DR   Coriell; DA02565
DR   Wikidata; Q54821902
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02566
AC   CVCL_7F43
DR   CLO; CLO_0015585
DR   Coriell; DA02566
DR   Wikidata; Q54821928
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02567
AC   CVCL_7F44
DR   CLO; CLO_0015583
DR   Coriell; DA02567
DR   Wikidata; Q54821929
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02568
AC   CVCL_7F45
DR   CLO; CLO_0015580
DR   Coriell; DA02568
DR   Wikidata; Q54821931
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02569
AC   CVCL_7F46
DR   CLO; CLO_0015577
DR   Coriell; DA02569
DR   Wikidata; Q54821932
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02570
AC   CVCL_7F47
DR   Coriell; DA02570
DR   Wikidata; Q54821933
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02570; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02571
AC   CVCL_7F48
DR   Coriell; DA02571
DR   Wikidata; Q54821934
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02571; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02572
AC   CVCL_7F49
DR   CLO; CLO_0015575
DR   Coriell; DA02572
DR   Wikidata; Q54821935
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02573
AC   CVCL_7F50
DR   Coriell; DA02573
DR   Wikidata; Q54821936
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02573; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02574
AC   CVCL_ZI57
DR   Coriell; DA02574
DR   Wikidata; Q98125854
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02574; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02575
AC   CVCL_ZI58
DR   Coriell; DA02575
DR   Wikidata; Q98125855
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02575; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02576
AC   CVCL_7F51
DR   Coriell; DA02576
DR   Wikidata; Q54821937
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02576; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02577
AC   CVCL_7F52
DR   CLO; CLO_0015557
DR   Coriell; DA02577
DR   Wikidata; Q54821938
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02578
AC   CVCL_7F53
DR   CLO; CLO_0015560
DR   Coriell; DA02578
DR   Wikidata; Q54821940
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02579
AC   CVCL_7F54
DR   CLO; CLO_0015545
DR   Coriell; DA02579
DR   Wikidata; Q54821941
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02580
AC   CVCL_7F55
DR   CLO; CLO_0015548
DR   Coriell; DA02580
DR   Wikidata; Q54821942
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02581
AC   CVCL_7F56
DR   CLO; CLO_0015550
DR   Coriell; DA02581
DR   Wikidata; Q54821944
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02582
AC   CVCL_7F57
DR   CLO; CLO_0015551
DR   Coriell; DA02582
DR   Wikidata; Q54821946
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02583
AC   CVCL_7F58
DR   CLO; CLO_0015539
DR   Coriell; DA02583
DR   Wikidata; Q54821947
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02584
AC   CVCL_7F59
DR   Coriell; DA02584
DR   Wikidata; Q54821948
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02584; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02585
AC   CVCL_7F60
DR   Coriell; DA02585
DR   Wikidata; Q54821949
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02585; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02586
AC   CVCL_7F61
DR   Coriell; DA02586
DR   Wikidata; Q54821950
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02586; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02587
AC   CVCL_7F62
DR   Coriell; DA02587
DR   Wikidata; Q54821951
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02587; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02588
AC   CVCL_7F63
DR   Coriell; DA02588
DR   Wikidata; Q54821952
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02588; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02589
AC   CVCL_7F64
DR   Coriell; DA02589
DR   Wikidata; Q54821954
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02589; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02590
AC   CVCL_7F65
DR   Coriell; DA02590
DR   Wikidata; Q54821955
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02590; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02591
AC   CVCL_7F66
DR   Coriell; DA02591
DR   Wikidata; Q54821956
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02591; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02592
AC   CVCL_7F67
DR   Coriell; DA02592
DR   Wikidata; Q54821957
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02592; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02593
AC   CVCL_7F68
DR   CLO; CLO_0015537
DR   Coriell; DA02593
DR   Wikidata; Q54821958
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02595
AC   CVCL_7F69
DR   Coriell; DA02595
DR   Wikidata; Q54821959
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02595; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02596
AC   CVCL_7F70
DR   CLO; CLO_0015544
DR   Coriell; DA02596
DR   Wikidata; Q54821960
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02597
AC   CVCL_7F71
DR   CLO; CLO_0015541
DR   Coriell; DA02597
DR   Wikidata; Q54821961
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02598
AC   CVCL_ZI59
DR   Coriell; DA02598
DR   Wikidata; Q98125856
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02598; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02599
AC   CVCL_7F72
DR   Coriell; DA02599
DR   Wikidata; Q54821963
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02599; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02600
AC   CVCL_7F73
DR   CLO; CLO_0015266
DR   Coriell; DA02600
DR   Wikidata; Q54821964
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02601
AC   CVCL_7F74
DR   CLO; CLO_0015265
DR   Coriell; DA02601
DR   Wikidata; Q54821966
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02602
AC   CVCL_7F75
DR   Coriell; DA02602
DR   Wikidata; Q54821967
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02602; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02603
AC   CVCL_7F76
DR   Coriell; DA02603
DR   Wikidata; Q54821968
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02603; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02604
AC   CVCL_7F77
DR   Coriell; DA02604
DR   Wikidata; Q54821969
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02604; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02605
AC   CVCL_7F78
DR   CLO; CLO_0015268
DR   Coriell; DA02605
DR   Wikidata; Q54821970
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02606
AC   CVCL_7F79
DR   Coriell; DA02606
DR   Wikidata; Q54821972
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02606; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02607
AC   CVCL_7F80
DR   Coriell; DA02607
DR   Wikidata; Q54821973
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02607; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02609
AC   CVCL_7F81
DR   Coriell; DA02609
DR   Wikidata; Q54821974
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02609; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02610
AC   CVCL_7F82
DR   CLO; CLO_0015267
DR   Coriell; DA02610
DR   Wikidata; Q54821975
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02611
AC   CVCL_7F83
DR   Coriell; DA02611
DR   Wikidata; Q54821992
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02611; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02612
AC   CVCL_7F84
DR   Coriell; DA02612
DR   Wikidata; Q54821993
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02612; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02613
AC   CVCL_7F85
DR   Coriell; DA02613
DR   Wikidata; Q54821994
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02613; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02614
AC   CVCL_7F86
DR   Coriell; DA02614
DR   Wikidata; Q54821996
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02614; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02615
AC   CVCL_7F87
DR   Coriell; DA02615
DR   Wikidata; Q54821997
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02615; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02616
AC   CVCL_7F88
DR   Coriell; DA02616
DR   Wikidata; Q54821999
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02616; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02617
AC   CVCL_7F89
DR   CLO; CLO_0015262
DR   Coriell; DA02617
DR   Wikidata; Q54822000
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02618
AC   CVCL_ZI60
DR   Coriell; DA02618
DR   Wikidata; Q98125857
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02618; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02619
AC   CVCL_7F90
DR   CLO; CLO_0015261
DR   Coriell; DA02619
DR   Wikidata; Q54822001
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02620
AC   CVCL_7F91
DR   CLO; CLO_0015264
DR   Coriell; DA02620
DR   Wikidata; Q54822003
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02621
AC   CVCL_7F92
DR   CLO; CLO_0015263
DR   Coriell; DA02621
DR   Wikidata; Q54822004
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02622
AC   CVCL_7F93
DR   Coriell; DA02622
DR   Wikidata; Q54822005
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02622; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02623
AC   CVCL_7F94
DR   Coriell; DA02623
DR   Wikidata; Q54822006
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02623; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02624
AC   CVCL_7F95
DR   Coriell; DA02624
DR   Wikidata; Q54822007
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02624; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02625
AC   CVCL_7F96
DR   Coriell; DA02625
DR   Wikidata; Q54822008
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02625; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02627
AC   CVCL_7F97
DR   CLO; CLO_0015260
DR   Coriell; DA02627
DR   Wikidata; Q54822010
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02628
AC   CVCL_7F98
DR   Coriell; DA02628
DR   Wikidata; Q54822011
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02628; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02629
AC   CVCL_7F99
DR   CLO; CLO_0015259
DR   Coriell; DA02629
DR   Wikidata; Q54822012
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02630
AC   CVCL_7G00
DR   Coriell; DA02630
DR   Wikidata; Q54822013
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02630; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02631
AC   CVCL_ZI61
DR   Coriell; DA02631
DR   Wikidata; Q98125859
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02631; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02632
AC   CVCL_7G01
DR   CLO; CLO_0015278
DR   Coriell; DA02632
DR   Wikidata; Q54822014
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02633
AC   CVCL_7G02
DR   Coriell; DA02633
DR   Wikidata; Q54822016
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02633; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02634
AC   CVCL_ZI62
DR   Coriell; DA02634
DR   Wikidata; Q98125860
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02634; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02635
AC   CVCL_7G03
DR   Coriell; DA02635
DR   Wikidata; Q54822017
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02635; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02636
AC   CVCL_7G04
DR   Coriell; DA02636
DR   Wikidata; Q54822018
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02636; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02637
AC   CVCL_7G05
DR   CLO; CLO_0015277
DR   Coriell; DA02637
DR   Wikidata; Q54822019
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02638
AC   CVCL_7G06
DR   CLO; CLO_0015276
DR   Coriell; DA02638
DR   Wikidata; Q54822020
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02639
AC   CVCL_7G07
DR   Coriell; DA02639
DR   Wikidata; Q54822021
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02639; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02640
AC   CVCL_7G08
DR   Coriell; DA02640
DR   Wikidata; Q54822023
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02640; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02641
AC   CVCL_7G09
DR   CLO; CLO_0015275
DR   Coriell; DA02641
DR   Wikidata; Q54822024
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02642
AC   CVCL_7G10
DR   Coriell; DA02642
DR   Wikidata; Q54822025
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02642; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02643
AC   CVCL_7G11
DR   Coriell; DA02643
DR   Wikidata; Q54822026
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02643; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02644
AC   CVCL_7G12
DR   Coriell; DA02644
DR   Wikidata; Q54822027
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02644; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02645
AC   CVCL_7G13
DR   Coriell; DA02645
DR   Wikidata; Q54822029
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02645; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02646
AC   CVCL_7G14
DR   Coriell; DA02646
DR   Wikidata; Q54822030
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02646; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02647
AC   CVCL_7G15
DR   Coriell; DA02647
DR   Wikidata; Q54822031
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02647; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02648
AC   CVCL_7G16
DR   CLO; CLO_0015274
DR   Coriell; DA02648
DR   Wikidata; Q54822033
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02649
AC   CVCL_7G17
DR   CLO; CLO_0015273
DR   Coriell; DA02649
DR   Wikidata; Q54822035
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02650
AC   CVCL_7G18
DR   CLO; CLO_0015272
DR   Coriell; DA02650
DR   Wikidata; Q54822036
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02651
AC   CVCL_7G19
DR   Coriell; DA02651
DR   Wikidata; Q54822037
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02651; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02652
AC   CVCL_ZI63
DR   Coriell; DA02652
DR   Wikidata; Q98125861
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02652; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02653
AC   CVCL_7G20
DR   Coriell; DA02653
DR   Wikidata; Q54822038
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02653; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02654
AC   CVCL_7G21
DR   Coriell; DA02654
DR   Wikidata; Q54822039
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02654; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02655
AC   CVCL_7G22
DR   CLO; CLO_0015271
DR   Coriell; DA02655
DR   Wikidata; Q54822040
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02656
AC   CVCL_7G23
DR   CLO; CLO_0015270
DR   Coriell; DA02656
DR   Wikidata; Q54822049
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02657
AC   CVCL_7G24
DR   CLO; CLO_0015269
DR   Coriell; DA02657
DR   Wikidata; Q54822050
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02658
AC   CVCL_7G25
DR   Coriell; DA02658
DR   Wikidata; Q54822051
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02658; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02659
AC   CVCL_7G26
DR   Coriell; DA02659
DR   Wikidata; Q54822052
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02659; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02660
AC   CVCL_7G27
DR   Coriell; DA02660
DR   Wikidata; Q54822053
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02660; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02661
AC   CVCL_7G28
DR   Coriell; DA02661
DR   Wikidata; Q54822054
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02661; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02662
AC   CVCL_7G29
DR   Coriell; DA02662
DR   Wikidata; Q54822055
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02662; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02663
AC   CVCL_7G30
DR   CLO; CLO_0015244
DR   Coriell; DA02663
DR   Wikidata; Q54822056
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02664
AC   CVCL_7G31
DR   CLO; CLO_0015243
DR   Coriell; DA02664
DR   Wikidata; Q54822057
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02665
AC   CVCL_7G32
DR   CLO; CLO_0015246
DR   Coriell; DA02665
DR   Wikidata; Q54822059
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02666
AC   CVCL_7G33
DR   CLO; CLO_0015245
DR   Coriell; DA02666
DR   Wikidata; Q54822060
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02669
AC   CVCL_7G34
DR   CLO; CLO_0015248
DR   Coriell; DA02669
DR   Wikidata; Q54822061
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02671
AC   CVCL_7G35
DR   Coriell; DA02671
DR   Wikidata; Q54822062
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02671; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02672
AC   CVCL_7G36
DR   CLO; CLO_0015247
DR   Coriell; DA02672
DR   Wikidata; Q54822063
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02673
AC   CVCL_ZI64
DR   Coriell; DA02673
DR   Wikidata; Q98125863
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02673; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02674
AC   CVCL_ZI65
DR   Coriell; DA02674
DR   Wikidata; Q98125864
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02674; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02675
AC   CVCL_7G37
DR   Coriell; DA02675
DR   Wikidata; Q54822064
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02675; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02676
AC   CVCL_7G38
DR   Coriell; DA02676
DR   Wikidata; Q54822065
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02676; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02677
AC   CVCL_7G39
DR   Coriell; DA02677
DR   Wikidata; Q54822066
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02677; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02678
AC   CVCL_7G40
DR   Coriell; DA02678
DR   Wikidata; Q54822067
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02678; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02679
AC   CVCL_7G41
DR   Coriell; DA02679
DR   Wikidata; Q54822068
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02679; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02680
AC   CVCL_7G42
DR   Coriell; DA02680
DR   Wikidata; Q54822069
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02680; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02681
AC   CVCL_7G43
DR   Coriell; DA02681
DR   Wikidata; Q54822070
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02681; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02682
AC   CVCL_7G44
DR   CLO; CLO_0015240
DR   Coriell; DA02682
DR   Wikidata; Q54822071
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02683
AC   CVCL_7G45
DR   CLO; CLO_0015239
DR   Coriell; DA02683
DR   Wikidata; Q54822072
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02684
AC   CVCL_7G46
DR   Coriell; DA02684
DR   Wikidata; Q54822073
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02684; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02685
AC   CVCL_7G47
DR   Coriell; DA02685
DR   Wikidata; Q54822074
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02685; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02686
AC   CVCL_7G48
DR   CLO; CLO_0015242
DR   Coriell; DA02686
DR   Wikidata; Q54822075
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02687
AC   CVCL_7G49
DR   Coriell; DA02687
DR   Wikidata; Q54822076
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02687; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02688
AC   CVCL_7G50
DR   Coriell; DA02688
DR   Wikidata; Q54822077
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02688; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02689
AC   CVCL_7G51
DR   Coriell; DA02689
DR   Wikidata; Q54822078
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02689; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02690
AC   CVCL_7G52
DR   CLO; CLO_0015241
DR   Coriell; DA02690
DR   Wikidata; Q54822079
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02691
AC   CVCL_7G53
DR   CLO; CLO_0015254
DR   Coriell; DA02691
DR   Wikidata; Q54822080
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02692
AC   CVCL_7G54
DR   Coriell; DA02692
DR   Wikidata; Q54822081
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02692; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02694
AC   CVCL_7G55
DR   Coriell; DA02694
DR   Wikidata; Q54822082
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02694; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02695
AC   CVCL_7G56
DR   Coriell; DA02695
DR   Wikidata; Q54822083
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02695; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02696
AC   CVCL_7G57
DR   Coriell; DA02696
DR   Wikidata; Q54822084
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02696; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02697
AC   CVCL_7G58
DR   Coriell; DA02697
DR   Wikidata; Q54822085
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02697; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02698
AC   CVCL_7G59
DR   Coriell; DA02698
DR   Wikidata; Q54822086
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02698; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02699
AC   CVCL_7G60
DR   Coriell; DA02699
DR   Wikidata; Q54822087
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02699; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02700
AC   CVCL_7G61
DR   CLO; CLO_0015253
DR   Coriell; DA02700
DR   Wikidata; Q54822088
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02701
AC   CVCL_7G62
DR   CLO; CLO_0015252
DR   Coriell; DA02701
DR   Wikidata; Q54822089
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02703
AC   CVCL_7G63
DR   CLO; CLO_0015258
DR   Coriell; DA02703
DR   Wikidata; Q54822095
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02704
AC   CVCL_7G64
DR   Coriell; DA02704
DR   Wikidata; Q54822096
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02704; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02705
AC   CVCL_7G65
DR   Coriell; DA02705
DR   Wikidata; Q54822097
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02705; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02706
AC   CVCL_7G66
DR   CLO; CLO_0015257
DR   Coriell; DA02706
DR   Wikidata; Q54822098
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02707
AC   CVCL_7G67
DR   CLO; CLO_0015256
DR   Coriell; DA02707
DR   Wikidata; Q54822099
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02708
AC   CVCL_7G68
DR   CLO; CLO_0015255
DR   Coriell; DA02708
DR   Wikidata; Q54822100
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02709
AC   CVCL_7G69
DR   CLO; CLO_0015251
DR   Coriell; DA02709
DR   Wikidata; Q54822102
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02710
AC   CVCL_7G70
DR   CLO; CLO_0015250
DR   Coriell; DA02710
DR   Wikidata; Q54822103
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02711
AC   CVCL_7G71
DR   CLO; CLO_0015249
DR   Coriell; DA02711
DR   Wikidata; Q54822104
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02712
AC   CVCL_7G72
DR   CLO; CLO_0015310
DR   Coriell; DA02712
DR   Wikidata; Q54822105
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02713
AC   CVCL_7G73
DR   CLO; CLO_0015311
DR   Coriell; DA02713
DR   Wikidata; Q54822106
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02714
AC   CVCL_7G74
DR   Coriell; DA02714
DR   Wikidata; Q54822107
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02714; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02715
AC   CVCL_7G75
DR   Coriell; DA02715
DR   Wikidata; Q54822108
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02715; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02716
AC   CVCL_7G76
DR   CLO; CLO_0015313
DR   Coriell; DA02716
DR   Wikidata; Q54822109
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02717
AC   CVCL_7G77
DR   Coriell; DA02717
DR   Wikidata; Q54822110
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02717; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02718
AC   CVCL_7G78
DR   Coriell; DA02718
DR   Wikidata; Q54822111
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02718; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02719
AC   CVCL_7G79
DR   CLO; CLO_0015315
DR   Coriell; DA02719
DR   Wikidata; Q54822112
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02720
AC   CVCL_7G80
DR   CLO; CLO_0015302
DR   Coriell; DA02720
DR   Wikidata; Q54822113
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02721
AC   CVCL_7G81
DR   Coriell; DA02721
DR   Wikidata; Q54822114
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02721; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02722
AC   CVCL_7G82
DR   Coriell; DA02722
DR   Wikidata; Q54822115
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02722; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02723
AC   CVCL_ZI66
DR   Coriell; DA02723
DR   Wikidata; Q98125865
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02723; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02724
AC   CVCL_ZI67
DR   Coriell; DA02724
DR   Wikidata; Q98125866
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02724; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02725
AC   CVCL_7G83
DR   Coriell; DA02725
DR   Wikidata; Q54822116
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02725; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02726
AC   CVCL_7G84
DR   Coriell; DA02726
DR   Wikidata; Q54822117
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02726; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02727
AC   CVCL_7G85
DR   Coriell; DA02727
DR   Wikidata; Q54822118
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02727; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02728
AC   CVCL_7G86
DR   CLO; CLO_0015305
DR   Coriell; DA02728
DR   Wikidata; Q54822119
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02729
AC   CVCL_7G87
DR   CLO; CLO_0015306
DR   Coriell; DA02729
DR   Wikidata; Q54822120
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02730
AC   CVCL_7G88
DR   CLO; CLO_0015308
DR   Coriell; DA02730
DR   Wikidata; Q54822121
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02732
AC   CVCL_7G89
DR   Coriell; DA02732
DR   Wikidata; Q54822122
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02732; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02733
AC   CVCL_7G90
DR   Coriell; DA02733
DR   Wikidata; Q54822123
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02733; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02734
AC   CVCL_7G91
DR   CLO; CLO_0015317
DR   Coriell; DA02734
DR   Wikidata; Q54822124
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02735
AC   CVCL_7G92
DR   Coriell; DA02735
DR   Wikidata; Q54822125
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02735; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02737
AC   CVCL_7G93
DR   CLO; CLO_0015318
DR   Coriell; DA02737
DR   Wikidata; Q54822126
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02738
AC   CVCL_7G94
DR   CLO; CLO_0015320
DR   Coriell; DA02738
DR   Wikidata; Q54822127
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02739
AC   CVCL_7G95
DR   CLO; CLO_0015335
DR   Coriell; DA02739
DR   Wikidata; Q54822128
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02740
AC   CVCL_7G96
DR   CLO; CLO_0015336
DR   Coriell; DA02740
DR   Wikidata; Q54822129
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02741
AC   CVCL_7G97
DR   CLO; CLO_0015331
DR   Coriell; DA02741
DR   Wikidata; Q54822130
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02742
AC   CVCL_7G98
DR   CLO; CLO_0015332
DR   Coriell; DA02742
DR   Wikidata; Q54822131
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02743
AC   CVCL_7G99
DR   Coriell; DA02743
DR   Wikidata; Q54822132
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02743; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02744
AC   CVCL_7H00
DR   CLO; CLO_0015326
DR   Coriell; DA02744
DR   Wikidata; Q54822133
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02745
AC   CVCL_7H01
DR   Coriell; DA02745
DR   Wikidata; Q54822134
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02745; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02746
AC   CVCL_7H02
DR   CLO; CLO_0015329
DR   Coriell; DA02746
DR   Wikidata; Q54822135
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02747
AC   CVCL_ZI68
DR   Coriell; DA02747
DR   Wikidata; Q98125867
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02747; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DA02749
AC   CVCL_7H03
DR   Coriell; DA02749
DR   Wikidata; Q54822139
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02749; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02750
AC   CVCL_7H04
DR   CLO; CLO_0015322
DR   Coriell; DA02750
DR   Wikidata; Q54822140
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02751
AC   CVCL_7H05
DR   CLO; CLO_0015325
DR   Coriell; DA02751
DR   Wikidata; Q54822141
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02752
AC   CVCL_7H06
DR   CLO; CLO_0015338
DR   Coriell; DA02752
DR   Wikidata; Q54822142
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02753
AC   CVCL_7H07
DR   Coriell; DA02753
DR   Wikidata; Q54822143
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02753; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02754
AC   CVCL_7H08
DR   Coriell; DA02754
DR   Wikidata; Q54822144
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02754; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02755
AC   CVCL_7H09
DR   Coriell; DA02755
DR   Wikidata; Q54822145
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02755; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02756
AC   CVCL_7H10
DR   CLO; CLO_0015280
DR   Coriell; DA02756
DR   Wikidata; Q54822146
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02757
AC   CVCL_7H11
DR   CLO; CLO_0015279
DR   Coriell; DA02757
DR   Wikidata; Q54822148
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02758
AC   CVCL_7H12
DR   CLO; CLO_0015281
DR   Coriell; DA02758
DR   Wikidata; Q54822149
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02759
AC   CVCL_7H13
DR   CLO; CLO_0015282
DR   Coriell; DA02759
DR   Wikidata; Q54822150
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02760
AC   CVCL_7H14
DR   CLO; CLO_0015283
DR   Coriell; DA02760
DR   Wikidata; Q54822151
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02761
AC   CVCL_7H15
DR   Coriell; DA02761
DR   Wikidata; Q54822152
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02761; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02763
AC   CVCL_7H16
DR   CLO; CLO_0015284
DR   Coriell; DA02763
DR   Wikidata; Q54822153
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02764
AC   CVCL_7H17
DR   Coriell; DA02764
DR   Wikidata; Q54822154
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02764; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02765
AC   CVCL_7H18
DR   Coriell; DA02765
DR   Wikidata; Q54822155
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02765; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02766
AC   CVCL_7H19
DR   CLO; CLO_0015285
DR   Coriell; DA02766
DR   Wikidata; Q54822156
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02767
AC   CVCL_7H20
DR   Coriell; DA02767
DR   Wikidata; Q54822157
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02767; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02768
AC   CVCL_7H21
DR   Coriell; DA02768
DR   Wikidata; Q54822158
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02768; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02769
AC   CVCL_7H22
DR   Coriell; DA02769
DR   Wikidata; Q54822159
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02769; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02770
AC   CVCL_7H23
DR   Coriell; DA02770
DR   Wikidata; Q54822160
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02770; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02771
AC   CVCL_7H24
DR   Coriell; DA02771
DR   Wikidata; Q54822161
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02771; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02772
AC   CVCL_7H25
DR   CLO; CLO_0015286
DR   Coriell; DA02772
DR   Wikidata; Q54822162
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02773
AC   CVCL_7H26
DR   Coriell; DA02773
DR   Wikidata; Q54822164
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02773; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02774
AC   CVCL_7H27
DR   CLO; CLO_0015287
DR   Coriell; DA02774
DR   Wikidata; Q54822165
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02775
AC   CVCL_7H28
DR   CLO; CLO_0015288
DR   Coriell; DA02775
DR   Wikidata; Q54822166
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02776
AC   CVCL_7H29
DR   CLO; CLO_0015291
DR   Coriell; DA02776
DR   Wikidata; Q54822167
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02777
AC   CVCL_7H30
DR   CLO; CLO_0015290
DR   Coriell; DA02777
DR   Wikidata; Q54822168
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02780
AC   CVCL_7H31
DR   CLO; CLO_0015289
DR   Coriell; DA02780
DR   Wikidata; Q54822169
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02781
AC   CVCL_7H32
DR   CLO; CLO_0015294
DR   Coriell; DA02781
DR   Wikidata; Q54822170
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02782
AC   CVCL_7H33
DR   CLO; CLO_0015295
DR   Coriell; DA02782
DR   Wikidata; Q54822171
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02783
AC   CVCL_7H34
DR   CLO; CLO_0015292
DR   Coriell; DA02783
DR   Wikidata; Q54822172
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02784
AC   CVCL_7H35
DR   CLO; CLO_0015293
DR   Coriell; DA02784
DR   Wikidata; Q54822173
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02785
AC   CVCL_7H36
DR   Coriell; DA02785
DR   Wikidata; Q54822174
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02785; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02786
AC   CVCL_7H37
DR   CLO; CLO_0015297
DR   Coriell; DA02786
DR   Wikidata; Q54822175
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02787
AC   CVCL_7H38
DR   CLO; CLO_0015298
DR   Coriell; DA02787
DR   Wikidata; Q54822176
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02789
AC   CVCL_7H39
DR   CLO; CLO_0015296
DR   Coriell; DA02789
DR   Wikidata; Q54822177
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02791
AC   CVCL_7H40
DR   Coriell; DA02791
DR   Wikidata; Q54822178
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02791; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02792
AC   CVCL_7H41
DR   CLO; CLO_0016205
DR   Coriell; DA02792
DR   Wikidata; Q54822179
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02793
AC   CVCL_7H42
DR   CLO; CLO_0016207
DR   Coriell; DA02793
DR   Wikidata; Q54822180
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02794
AC   CVCL_7H43
DR   CLO; CLO_0016202
DR   Coriell; DA02794
DR   Wikidata; Q54822182
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02795
AC   CVCL_7H44
DR   CLO; CLO_0016203
DR   Coriell; DA02795
DR   Wikidata; Q54822183
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02797
AC   CVCL_7H45
DR   CLO; CLO_0016175
DR   Coriell; DA02797
DR   Wikidata; Q54822184
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02798
AC   CVCL_7H46
DR   CLO; CLO_0016173
DR   Coriell; DA02798
DR   Wikidata; Q54822185
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02799
AC   CVCL_7H47
DR   CLO; CLO_0016171
DR   Coriell; DA02799
DR   Wikidata; Q54822186
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02800
AC   CVCL_7H48
DR   Coriell; DA02800
DR   Wikidata; Q54822187
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02800; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02801
AC   CVCL_7H49
DR   Coriell; DA02801
DR   Wikidata; Q54822188
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02801; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02803
AC   CVCL_7H50
DR   CLO; CLO_0016169
DR   Coriell; DA02803
DR   Wikidata; Q54822189
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02804
AC   CVCL_7H51
DR   CLO; CLO_0016183
DR   Coriell; DA02804
DR   Wikidata; Q54822190
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02805
AC   CVCL_7H52
DR   CLO; CLO_0016181
DR   Coriell; DA02805
DR   Wikidata; Q54822191
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02806
AC   CVCL_7H53
DR   CLO; CLO_0016162
DR   Coriell; DA02806
DR   Wikidata; Q54822192
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02807
AC   CVCL_7H54
DR   CLO; CLO_0016164
DR   Coriell; DA02807
DR   Wikidata; Q54822194
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02808
AC   CVCL_7H55
DR   CLO; CLO_0016165
DR   Coriell; DA02808
DR   Wikidata; Q54822195
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02809
AC   CVCL_7H56
DR   CLO; CLO_0016166
DR   Coriell; DA02809
DR   Wikidata; Q54822196
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02810
AC   CVCL_7H57
DR   CLO; CLO_0016167
DR   Coriell; DA02810
DR   Wikidata; Q54822197
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02811
AC   CVCL_7H58
DR   CLO; CLO_0016141
DR   Coriell; DA02811
DR   Wikidata; Q54822198
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02812
AC   CVCL_7H59
DR   CLO; CLO_0016140
DR   Coriell; DA02812
DR   Wikidata; Q54822199
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02813
AC   CVCL_7H60
DR   CLO; CLO_0016146
DR   Coriell; DA02813
DR   Wikidata; Q54822200
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02814
AC   CVCL_7H61
DR   CLO; CLO_0016144
DR   Coriell; DA02814
DR   Wikidata; Q54822201
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02815
AC   CVCL_7H62
DR   CLO; CLO_0016148
DR   Coriell; DA02815
DR   Wikidata; Q54822202
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02815; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA02816
AC   CVCL_7H63
DR   CLO; CLO_0015938
DR   Coriell; DA02816
DR   Wikidata; Q54822203
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02817
AC   CVCL_7H64
DR   CLO; CLO_0015936
DR   Coriell; DA02817
DR   Wikidata; Q54822204
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02818
AC   CVCL_7H65
DR   CLO; CLO_0015937
DR   Coriell; DA02818
DR   Wikidata; Q54822205
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02819
AC   CVCL_7H66
DR   CLO; CLO_0015931
DR   Coriell; DA02819
DR   Wikidata; Q54822206
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02820
AC   CVCL_7H67
DR   CLO; CLO_0015932
DR   Coriell; DA02820
DR   Wikidata; Q54822207
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02821
AC   CVCL_7H68
DR   CLO; CLO_0015929
DR   Coriell; DA02821
DR   Wikidata; Q54822208
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02822
AC   CVCL_7H69
DR   CLO; CLO_0015930
DR   Coriell; DA02822
DR   Wikidata; Q54822209
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02823
AC   CVCL_7H70
DR   CLO; CLO_0015934
DR   Coriell; DA02823
DR   Wikidata; Q54822210
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02824
AC   CVCL_7H71
DR   CLO; CLO_0015935
DR   Coriell; DA02824
DR   Wikidata; Q54822211
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02826
AC   CVCL_7H72
DR   CLO; CLO_0015933
DR   Coriell; DA02826
DR   Wikidata; Q54822212
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02827
AC   CVCL_7H73
DR   CLO; CLO_0015956
DR   Coriell; DA02827
DR   Wikidata; Q54822213
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02828
AC   CVCL_7H74
DR   CLO; CLO_0015957
DR   Coriell; DA02828
DR   Wikidata; Q54822214
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02829
AC   CVCL_7H75
DR   CLO; CLO_0015958
DR   Coriell; DA02829
DR   Wikidata; Q54822215
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02830
AC   CVCL_7H76
DR   CLO; CLO_0015959
DR   Coriell; DA02830
DR   Wikidata; Q54822216
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02831
AC   CVCL_7H77
DR   CLO; CLO_0015949
DR   Coriell; DA02831
DR   Wikidata; Q54822217
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02832
AC   CVCL_7H78
DR   CLO; CLO_0015950
DR   Coriell; DA02832
DR   Wikidata; Q54822218
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02833
AC   CVCL_7H79
DR   CLO; CLO_0015951
DR   Coriell; DA02833
DR   Wikidata; Q54822219
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02835
AC   CVCL_7H80
DR   CLO; CLO_0015952
DR   Coriell; DA02835
DR   Wikidata; Q54822220
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02836
AC   CVCL_7H81
DR   CLO; CLO_0015953
DR   Coriell; DA02836
DR   Wikidata; Q54822221
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02837
AC   CVCL_7H82
DR   CLO; CLO_0015954
DR   Coriell; DA02837
DR   Wikidata; Q54822222
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02838
AC   CVCL_7H83
DR   CLO; CLO_0015763
DR   Coriell; DA02838
DR   Wikidata; Q54822224
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02839
AC   CVCL_7H84
DR   CLO; CLO_0015760
DR   Coriell; DA02839
DR   Wikidata; Q54822225
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02840
AC   CVCL_7H85
DR   CLO; CLO_0015759
DR   Coriell; DA02840
DR   Wikidata; Q54822226
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02841
AC   CVCL_7H86
DR   CLO; CLO_0015762
DR   Coriell; DA02841
DR   Wikidata; Q54822227
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02842
AC   CVCL_7H87
DR   CLO; CLO_0015761
DR   Coriell; DA02842
DR   Wikidata; Q54822228
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02843
AC   CVCL_7H88
DR   CLO; CLO_0015766
DR   Coriell; DA02843
DR   Wikidata; Q54822229
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02844
AC   CVCL_7H89
DR   CLO; CLO_0015765
DR   Coriell; DA02844
DR   Wikidata; Q54822230
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02845
AC   CVCL_7H90
DR   CLO; CLO_0015768
DR   Coriell; DA02845
DR   Wikidata; Q54822231
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02846
AC   CVCL_7H91
DR   CLO; CLO_0015767
DR   Coriell; DA02846
DR   Wikidata; Q54822232
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02847
AC   CVCL_7H92
DR   CLO; CLO_0015764
DR   Coriell; DA02847
DR   Wikidata; Q54822233
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02848
AC   CVCL_7H93
DR   CLO; CLO_0015774
DR   Coriell; DA02848
DR   Wikidata; Q54822234
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02849
AC   CVCL_7H94
DR   CLO; CLO_0015773
DR   Coriell; DA02849
DR   Wikidata; Q54822235
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02850
AC   CVCL_7H95
DR   CLO; CLO_0015772
DR   Coriell; DA02850
DR   Wikidata; Q54822236
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02851
AC   CVCL_7H96
DR   CLO; CLO_0015771
DR   Coriell; DA02851
DR   Wikidata; Q54822237
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02852
AC   CVCL_7H97
DR   CLO; CLO_0015770
DR   Coriell; DA02852
DR   Wikidata; Q54822238
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02853
AC   CVCL_7H98
DR   CLO; CLO_0015769
DR   Coriell; DA02853
DR   Wikidata; Q54822239
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02854
AC   CVCL_7H99
DR   CLO; CLO_0015778
DR   Coriell; DA02854
DR   Wikidata; Q54822240
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02856
AC   CVCL_7I00
DR   CLO; CLO_0015777
DR   Coriell; DA02856
DR   Wikidata; Q54822241
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02857
AC   CVCL_7I01
DR   CLO; CLO_0015776
DR   Coriell; DA02857
DR   Wikidata; Q54822242
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02858
AC   CVCL_7I02
DR   CLO; CLO_0015775
DR   Coriell; DA02858
DR   Wikidata; Q54822243
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02859
AC   CVCL_7I03
DR   CLO; CLO_0015779
DR   Coriell; DA02859
DR   Wikidata; Q54822244
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02861
AC   CVCL_7I04
DR   CLO; CLO_0015781
DR   Coriell; DA02861
DR   Wikidata; Q54822245
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02862
AC   CVCL_7I05
DR   CLO; CLO_0015780
DR   Coriell; DA02862
DR   Wikidata; Q54822247
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02863
AC   CVCL_7I06
DR   CLO; CLO_0015783
DR   Coriell; DA02863
DR   Wikidata; Q54822248
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02864
AC   CVCL_7I07
DR   CLO; CLO_0015782
DR   Coriell; DA02864
DR   Wikidata; Q54822249
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02865
AC   CVCL_7I08
DR   CLO; CLO_0015785
DR   Coriell; DA02865
DR   Wikidata; Q54822250
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02866
AC   CVCL_7I09
DR   CLO; CLO_0015784
DR   Coriell; DA02866
DR   Wikidata; Q54822251
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02867
AC   CVCL_7I10
DR   CLO; CLO_0015787
DR   Coriell; DA02867
DR   Wikidata; Q54822252
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02868
AC   CVCL_7I11
DR   CLO; CLO_0015786
DR   Coriell; DA02868
DR   Wikidata; Q54822253
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02869
AC   CVCL_7I12
DR   CLO; CLO_0015788
DR   Coriell; DA02869
DR   Wikidata; Q54822254
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02870
AC   CVCL_7I13
DR   CLO; CLO_0015792
DR   Coriell; DA02870
DR   Wikidata; Q54822255
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02873
AC   CVCL_7I14
DR   CLO; CLO_0015791
DR   Coriell; DA02873
DR   Wikidata; Q54822256
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02874
AC   CVCL_7I15
DR   CLO; CLO_0015790
DR   Coriell; DA02874
DR   Wikidata; Q54822257
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02875
AC   CVCL_7I16
DR   CLO; CLO_0015789
DR   Coriell; DA02875
DR   Wikidata; Q54822258
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02876
AC   CVCL_7I17
DR   CLO; CLO_0015796
DR   Coriell; DA02876
DR   Wikidata; Q54822259
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02877
AC   CVCL_7I18
DR   CLO; CLO_0015795
DR   Coriell; DA02877
DR   Wikidata; Q54822260
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02878
AC   CVCL_7I19
DR   CLO; CLO_0015794
DR   Coriell; DA02878
DR   Wikidata; Q54822261
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02879
AC   CVCL_7I20
DR   CLO; CLO_0015793
DR   Coriell; DA02879
DR   Wikidata; Q54822262
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02880
AC   CVCL_7I21
DR   CLO; CLO_0015798
DR   Coriell; DA02880
DR   Wikidata; Q54822263
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02881
AC   CVCL_7I22
DR   CLO; CLO_0015797
DR   Coriell; DA02881
DR   Wikidata; Q54822264
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02882
AC   CVCL_7I23
DR   CLO; CLO_0015801
DR   Coriell; DA02882
DR   Wikidata; Q54822268
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02883
AC   CVCL_7I24
DR   CLO; CLO_0015812
DR   Coriell; DA02883
DR   Wikidata; Q54822269
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02884
AC   CVCL_7I25
DR   CLO; CLO_0015813
DR   Coriell; DA02884
DR   Wikidata; Q54822270
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02885
AC   CVCL_7I26
DR   CLO; CLO_0015815
DR   Coriell; DA02885
DR   Wikidata; Q54822271
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02886
AC   CVCL_7I27
DR   CLO; CLO_0015818
DR   Coriell; DA02886
DR   Wikidata; Q54822272
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02887
AC   CVCL_7I28
DR   CLO; CLO_0015805
DR   Coriell; DA02887
DR   Wikidata; Q54822273
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02889
AC   CVCL_7I29
DR   CLO; CLO_0015807
DR   Coriell; DA02889
DR   Wikidata; Q54822274
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02890
AC   CVCL_7I30
DR   CLO; CLO_0015809
DR   Coriell; DA02890
DR   Wikidata; Q54822275
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02891
AC   CVCL_7I31
DR   CLO; CLO_0015810
DR   Coriell; DA02891
DR   Wikidata; Q54822276
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02892
AC   CVCL_7I32
DR   CLO; CLO_0015804
DR   Coriell; DA02892
DR   Wikidata; Q54822277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02893
AC   CVCL_7I33
DR   CLO; CLO_0015822
DR   Coriell; DA02893
DR   Wikidata; Q54822278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02894
AC   CVCL_7I34
DR   CLO; CLO_0015820
DR   Coriell; DA02894
DR   Wikidata; Q54822279
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02895
AC   CVCL_7I35
DR   CLO; CLO_0015836
DR   Coriell; DA02895
DR   Wikidata; Q54822280
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02896
AC   CVCL_7I36
DR   CLO; CLO_0015837
DR   Coriell; DA02896
DR   Wikidata; Q54822281
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02897
AC   CVCL_7I37
DR   CLO; CLO_0015832
DR   Coriell; DA02897
DR   Wikidata; Q54822282
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02898
AC   CVCL_7I38
DR   CLO; CLO_0015833
DR   Coriell; DA02898
DR   Wikidata; Q54822283
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02899
AC   CVCL_7I39
DR   CLO; CLO_0015827
DR   Coriell; DA02899
DR   Wikidata; Q54822284
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02900
AC   CVCL_7I40
DR   CLO; CLO_0015829
DR   Coriell; DA02900
DR   Wikidata; Q54822285
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02901
AC   CVCL_7I41
DR   CLO; CLO_0015824
DR   Coriell; DA02901
DR   Wikidata; Q54822286
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02902
AC   CVCL_7I42
DR   CLO; CLO_0015825
DR   Coriell; DA02902
DR   Wikidata; Q54822287
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02903
AC   CVCL_7I43
DR   CLO; CLO_0015839
DR   Coriell; DA02903
DR   Wikidata; Q54822288
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02905
AC   CVCL_7I44
DR   CLO; CLO_0015843
DR   Coriell; DA02905
DR   Wikidata; Q54822289
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02906
AC   CVCL_7I45
DR   CLO; CLO_0015840
DR   Coriell; DA02906
DR   Wikidata; Q54822290
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02907
AC   CVCL_7I46
DR   CLO; CLO_0015845
DR   Coriell; DA02907
DR   Wikidata; Q54822291
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02908
AC   CVCL_7I47
DR   CLO; CLO_0015847
DR   Coriell; DA02908
DR   Wikidata; Q54822292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02909
AC   CVCL_7I48
DR   CLO; CLO_0015849
DR   Coriell; DA02909
DR   Wikidata; Q54822293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02910
AC   CVCL_7I49
DR   CLO; CLO_0015851
DR   Coriell; DA02910
DR   Wikidata; Q54822294
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02911
AC   CVCL_7I50
DR   CLO; CLO_0015852
DR   Coriell; DA02911
DR   Wikidata; Q54822295
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02912
AC   CVCL_7I51
DR   CLO; CLO_0015855
DR   Coriell; DA02912
DR   Wikidata; Q54822296
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02913
AC   CVCL_7I52
DR   CLO; CLO_0015856
DR   Coriell; DA02913
DR   Wikidata; Q54822297
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02914
AC   CVCL_7I53
DR   CLO; CLO_0015863
DR   Coriell; DA02914
DR   Wikidata; Q54822298
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02915
AC   CVCL_7I54
DR   CLO; CLO_0015862
DR   Coriell; DA02915
DR   Wikidata; Q54822299
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02916
AC   CVCL_7I55
DR   CLO; CLO_0015860
DR   Coriell; DA02916
DR   Wikidata; Q54822300
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02917
AC   CVCL_7I56
DR   CLO; CLO_0015859
DR   Coriell; DA02917
DR   Wikidata; Q54822301
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02918
AC   CVCL_7I57
DR   CLO; CLO_0015869
DR   Coriell; DA02918
DR   Wikidata; Q54822302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02919
AC   CVCL_7I58
DR   CLO; CLO_0015872
DR   Coriell; DA02919
DR   Wikidata; Q54822303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02920
AC   CVCL_7I59
DR   CLO; CLO_0015866
DR   Coriell; DA02920
DR   Wikidata; Q54822304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02920; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA02921
AC   CVCL_7I60
DR   CLO; CLO_0015867
DR   Coriell; DA02921
DR   Wikidata; Q54822305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02922
AC   CVCL_7I61
DR   CLO; CLO_0015876
DR   Coriell; DA02922
DR   Wikidata; Q54822306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02923
AC   CVCL_7I62
DR   CLO; CLO_0015878
DR   Coriell; DA02923
DR   Wikidata; Q54822307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02924
AC   CVCL_7I63
DR   CLO; CLO_0013909
DR   Coriell; DA02924
DR   Wikidata; Q54822312
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02925
AC   CVCL_7I64
DR   CLO; CLO_0013907
DR   Coriell; DA02925
DR   Wikidata; Q54822313
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02926
AC   CVCL_7I65
DR   CLO; CLO_0013928
DR   Coriell; DA02926
DR   Wikidata; Q54822314
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02927
AC   CVCL_7I66
DR   CLO; CLO_0013926
DR   Coriell; DA02927
DR   Wikidata; Q54822315
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02928
AC   CVCL_7I67
DR   CLO; CLO_0013923
DR   Coriell; DA02928
DR   Wikidata; Q54822316
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02928; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA02929
AC   CVCL_7I68
DR   CLO; CLO_0013922
DR   Coriell; DA02929
DR   Wikidata; Q54822317
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02930
AC   CVCL_7I69
DR   CLO; CLO_0013919
DR   Coriell; DA02930
DR   Wikidata; Q54822318
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02931
AC   CVCL_7I70
DR   CLO; CLO_0013917
DR   Coriell; DA02931
DR   Wikidata; Q54822319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02932
AC   CVCL_7I71
DR   CLO; CLO_0013915
DR   Coriell; DA02932
DR   Wikidata; Q54822320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02933
AC   CVCL_7I72
DR   CLO; CLO_0013912
DR   Coriell; DA02933
DR   Wikidata; Q54822321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02936
AC   CVCL_7I73
DR   CLO; CLO_0013855
DR   Coriell; DA02936
DR   Wikidata; Q54822322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02937
AC   CVCL_7I74
DR   CLO; CLO_0013861
DR   Coriell; DA02937
DR   Wikidata; Q54822323
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02938
AC   CVCL_7I75
DR   CLO; CLO_0013860
DR   Coriell; DA02938
DR   Wikidata; Q54822324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02939
AC   CVCL_7I76
DR   CLO; CLO_0013877
DR   Coriell; DA02939
DR   Wikidata; Q54822325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02940
AC   CVCL_7I77
DR   CLO; CLO_0013874
DR   Coriell; DA02940
DR   Wikidata; Q54822326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02941
AC   CVCL_7I78
DR   CLO; CLO_0013882
DR   Coriell; DA02941
DR   Wikidata; Q54822327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02942
AC   CVCL_7I79
DR   CLO; CLO_0013879
DR   Coriell; DA02942
DR   Wikidata; Q54822328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02943
AC   CVCL_7I80
DR   CLO; CLO_0013869
DR   Coriell; DA02943
DR   Wikidata; Q54822329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02944
AC   CVCL_7I81
DR   CLO; CLO_0013868
DR   Coriell; DA02944
DR   Wikidata; Q54822330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02945
AC   CVCL_7I82
DR   CLO; CLO_0013872
DR   Coriell; DA02945
DR   Wikidata; Q54822331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02947
AC   CVCL_7I83
DR   CLO; CLO_0013813
DR   Coriell; DA02947
DR   Wikidata; Q54822332
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02948
AC   CVCL_7I84
DR   CLO; CLO_0013811
DR   Coriell; DA02948
DR   Wikidata; Q54822334
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02949
AC   CVCL_7I85
DR   CLO; CLO_0013809
DR   Coriell; DA02949
DR   Wikidata; Q54822335
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02950
AC   CVCL_7I86
DR   CLO; CLO_0013807
DR   Coriell; DA02950
DR   Wikidata; Q54822336
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02951
AC   CVCL_LK53
DR   Coriell; DA02951
DR   Wikidata; Q54822337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   DA02952
AC   CVCL_7I87
DR   CLO; CLO_0013821
DR   Coriell; DA02952
DR   Wikidata; Q54822338
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02953
AC   CVCL_7I88
DR   CLO; CLO_0013819
DR   Coriell; DA02953
DR   Wikidata; Q54822339
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02954
AC   CVCL_7I89
DR   CLO; CLO_0013815
DR   Coriell; DA02954
DR   Wikidata; Q54822340
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02955
AC   CVCL_7I90
DR   CLO; CLO_0013831
DR   Coriell; DA02955
DR   Wikidata; Q54822341
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02956
AC   CVCL_7I91
DR   CLO; CLO_0013829
DR   Coriell; DA02956
DR   Wikidata; Q54822342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02957
AC   CVCL_7I92
DR   CLO; CLO_0013763
DR   Coriell; DA02957
DR   Wikidata; Q54822343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02958
AC   CVCL_7I93
DR   CLO; CLO_0013768
DR   Coriell; DA02958
DR   Wikidata; Q54822344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02959
AC   CVCL_7I94
DR   CLO; CLO_0013764
DR   Coriell; DA02959
DR   Wikidata; Q54822345
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02960
AC   CVCL_7I95
DR   CLO; CLO_0013773
DR   Coriell; DA02960
DR   Wikidata; Q54822348
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02961
AC   CVCL_7I96
DR   CLO; CLO_0013770
DR   Coriell; DA02961
DR   Wikidata; Q54822349
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02962
AC   CVCL_7I97
DR   CLO; CLO_0013779
DR   Coriell; DA02962
DR   Wikidata; Q54822350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02963
AC   CVCL_7I98
DR   CLO; CLO_0013776
DR   Coriell; DA02963
DR   Wikidata; Q54822351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02964
AC   CVCL_7I99
DR   CLO; CLO_0013783
DR   Coriell; DA02964
DR   Wikidata; Q54822352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02965
AC   CVCL_7J00
DR   CLO; CLO_0013780
DR   Coriell; DA02965
DR   Wikidata; Q54822353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02966
AC   CVCL_7J01
DR   CLO; CLO_0013787
DR   Coriell; DA02966
DR   Wikidata; Q54822354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02971
AC   CVCL_7J02
DR   CLO; CLO_0014206
DR   Coriell; DA02971
DR   Wikidata; Q54822362
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02972
AC   CVCL_7J03
DR   CLO; CLO_0014209
DR   Coriell; DA02972
DR   Wikidata; Q54822363
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02973
AC   CVCL_7J04
DR   CLO; CLO_0014192
DR   Coriell; DA02973
DR   Wikidata; Q54822364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02974
AC   CVCL_7J05
DR   CLO; CLO_0014194
DR   Coriell; DA02974
DR   Wikidata; Q54822365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02975
AC   CVCL_7J06
DR   CLO; CLO_0014196
DR   Coriell; DA02975
DR   Wikidata; Q54822367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02976
AC   CVCL_7J07
DR   CLO; CLO_0014201
DR   Coriell; DA02976
DR   Wikidata; Q54822368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02977
AC   CVCL_7J08
DR   CLO; CLO_0014185
DR   Coriell; DA02977
DR   Wikidata; Q54822369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02978
AC   CVCL_7J09
DR   CLO; CLO_0014186
DR   Coriell; DA02978
DR   Wikidata; Q54822370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02979
AC   CVCL_7J10
DR   CLO; CLO_0014188
DR   Coriell; DA02979
DR   Wikidata; Q54822371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02980
AC   CVCL_7J11
DR   CLO; CLO_0014189
DR   Coriell; DA02980
DR   Wikidata; Q54822372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02981
AC   CVCL_7J12
DR   CLO; CLO_0014170
DR   Coriell; DA02981
DR   Wikidata; Q54822373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02982
AC   CVCL_7J13
DR   CLO; CLO_0014162
DR   Coriell; DA02982
DR   Wikidata; Q54822374
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02983
AC   CVCL_7J14
DR   CLO; CLO_0014166
DR   Coriell; DA02983
DR   Wikidata; Q54822376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02984
AC   CVCL_7J15
DR   CLO; CLO_0014156
DR   Coriell; DA02984
DR   Wikidata; Q54822377
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02985
AC   CVCL_7J16
DR   CLO; CLO_0014159
DR   Coriell; DA02985
DR   Wikidata; Q54822378
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02986
AC   CVCL_7J17
DR   CLO; CLO_0014152
DR   Coriell; DA02986
DR   Wikidata; Q54822379
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02987
AC   CVCL_7J18
DR   CLO; CLO_0014155
DR   Coriell; DA02987
DR   Wikidata; Q54822380
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02988
AC   CVCL_7J19
DR   CLO; CLO_0014146
DR   Coriell; DA02988
DR   Wikidata; Q54822381
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02989
AC   CVCL_7J20
DR   CLO; CLO_0014148
DR   Coriell; DA02989
DR   Wikidata; Q54822382
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02990
AC   CVCL_7J21
DR   CLO; CLO_0014145
DR   Coriell; DA02990
DR   Wikidata; Q54822384
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02991
AC   CVCL_7J22
DR   CLO; CLO_0014126
DR   Coriell; DA02991
DR   Wikidata; Q54822385
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA02991; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA02992
AC   CVCL_7J23
DR   CLO; CLO_0014127
DR   Coriell; DA02992
DR   Wikidata; Q54822386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02993
AC   CVCL_7J24
DR   CLO; CLO_0014128
DR   Coriell; DA02993
DR   Wikidata; Q54822387
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02994
AC   CVCL_7J25
DR   CLO; CLO_0014129
DR   Coriell; DA02994
DR   Wikidata; Q54822388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02995
AC   CVCL_7J26
DR   CLO; CLO_0014130
DR   Coriell; DA02995
DR   Wikidata; Q54822389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02996
AC   CVCL_7J27
DR   CLO; CLO_0014131
DR   Coriell; DA02996
DR   Wikidata; Q54822390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02997
AC   CVCL_7J28
DR   CLO; CLO_0014132
DR   Coriell; DA02997
DR   Wikidata; Q54822391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02998
AC   CVCL_7J29
DR   CLO; CLO_0014133
DR   Coriell; DA02998
DR   Wikidata; Q54822392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA02999
AC   CVCL_7J30
DR   CLO; CLO_0014124
DR   Coriell; DA02999
DR   Wikidata; Q54822393
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03000
AC   CVCL_7J31
DR   CLO; CLO_0014125
DR   Coriell; DA03000
DR   Wikidata; Q54822394
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03001
AC   CVCL_7J32
DR   CLO; CLO_0014117
DR   Coriell; DA03001
DR   Wikidata; Q54822395
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03002
AC   CVCL_7J33
DR   CLO; CLO_0014107
DR   Coriell; DA03002
DR   Wikidata; Q54822396
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03003
AC   CVCL_7J34
DR   CLO; CLO_0014108
DR   Coriell; DA03003
DR   Wikidata; Q54822397
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03004
AC   CVCL_7J35
DR   CLO; CLO_0014105
DR   Coriell; DA03004
DR   Wikidata; Q54822398
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03005
AC   CVCL_7J36
DR   CLO; CLO_0014106
DR   Coriell; DA03005
DR   Wikidata; Q54822399
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03006
AC   CVCL_7J37
DR   CLO; CLO_0014111
DR   Coriell; DA03006
DR   Wikidata; Q54822400
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03007
AC   CVCL_7J38
DR   CLO; CLO_0014112
DR   Coriell; DA03007
DR   Wikidata; Q54822401
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03008
AC   CVCL_7J39
DR   CLO; CLO_0014109
DR   Coriell; DA03008
DR   Wikidata; Q54822402
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03009
AC   CVCL_7J40
DR   CLO; CLO_0014110
DR   Coriell; DA03009
DR   Wikidata; Q54822403
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03010
AC   CVCL_7J41
DR   CLO; CLO_0014104
DR   Coriell; DA03010
DR   Wikidata; Q54822404
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03011
AC   CVCL_7J42
DR   CLO; CLO_0014100
DR   Coriell; DA03011
DR   Wikidata; Q54822408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03012
AC   CVCL_7J43
DR   CLO; CLO_0014101
DR   Coriell; DA03012
DR   Wikidata; Q54822410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03013
AC   CVCL_7J44
DR   CLO; CLO_0014091
DR   Coriell; DA03013
DR   Wikidata; Q54822411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03014
AC   CVCL_7J45
DR   CLO; CLO_0014090
DR   Coriell; DA03014
DR   Wikidata; Q54822412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03015
AC   CVCL_7J46
DR   CLO; CLO_0014095
DR   Coriell; DA03015
DR   Wikidata; Q54822413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03016
AC   CVCL_7J47
DR   CLO; CLO_0014093
DR   Coriell; DA03016
DR   Wikidata; Q54822414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03017
AC   CVCL_7J48
DR   CLO; CLO_0014086
DR   Coriell; DA03017
DR   Wikidata; Q54822415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03018
AC   CVCL_7J49
DR   CLO; CLO_0014084
DR   Coriell; DA03018
DR   Wikidata; Q54822416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03019
AC   CVCL_7J50
DR   CLO; CLO_0014088
DR   Coriell; DA03019
DR   Wikidata; Q54822417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03020
AC   CVCL_7J51
DR   CLO; CLO_0014087
DR   Coriell; DA03020
DR   Wikidata; Q54822418
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03021
AC   CVCL_7J52
DR   CLO; CLO_0014082
DR   Coriell; DA03021
DR   Wikidata; Q54822419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03022
AC   CVCL_7J53
DR   CLO; CLO_0014077
DR   Coriell; DA03022
DR   Wikidata; Q54822420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03024
AC   CVCL_7J54
DR   CLO; CLO_0014079
DR   Coriell; DA03024
DR   Wikidata; Q54822421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03025
AC   CVCL_7J55
DR   CLO; CLO_0014076
DR   Coriell; DA03025
DR   Wikidata; Q54822422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03026
AC   CVCL_7J56
DR   CLO; CLO_0014074
DR   Coriell; DA03026
DR   Wikidata; Q54822423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03027
AC   CVCL_7J57
DR   CLO; CLO_0014072
DR   Coriell; DA03027
DR   Wikidata; Q54822424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03028
AC   CVCL_7J58
DR   CLO; CLO_0014070
DR   Coriell; DA03028
DR   Wikidata; Q54822425
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03029
AC   CVCL_7J59
DR   CLO; CLO_0014068
DR   Coriell; DA03029
DR   Wikidata; Q54822426
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03031
AC   CVCL_7J60
DR   CLO; CLO_0014066
DR   Coriell; DA03031
DR   Wikidata; Q54822427
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03032
AC   CVCL_7J61
DR   CLO; CLO_0014064
DR   Coriell; DA03032
DR   Wikidata; Q54822428
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03033
AC   CVCL_7J62
DR   CLO; CLO_0014723
DR   Coriell; DA03033
DR   Wikidata; Q54822429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03034
AC   CVCL_7J63
DR   CLO; CLO_0014729
DR   Coriell; DA03034
DR   Wikidata; Q54822430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03035
AC   CVCL_7J64
DR   CLO; CLO_0014730
DR   Coriell; DA03035
DR   Wikidata; Q54822431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03036
AC   CVCL_7J65
DR   CLO; CLO_0014725
DR   Coriell; DA03036
DR   Wikidata; Q54822432
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03037
AC   CVCL_7J66
DR   CLO; CLO_0014726
DR   Coriell; DA03037
DR   Wikidata; Q54822433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03038
AC   CVCL_7J67
DR   CLO; CLO_0014737
DR   Coriell; DA03038
DR   Wikidata; Q54822435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03039
AC   CVCL_7J68
DR   CLO; CLO_0014739
DR   Coriell; DA03039
DR   Wikidata; Q54822436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03040
AC   CVCL_7J69
DR   CLO; CLO_0014732
DR   Coriell; DA03040
DR   Wikidata; Q54822437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03041
AC   CVCL_7J70
DR   CLO; CLO_0014734
DR   Coriell; DA03041
DR   Wikidata; Q54822438
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03042
AC   CVCL_7J71
DR   CLO; CLO_0014666
DR   Coriell; DA03042
DR   Wikidata; Q54822439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03044
AC   CVCL_7J72
DR   CLO; CLO_0014689
DR   Coriell; DA03044
DR   Wikidata; Q54822440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03045
AC   CVCL_7J73
DR   CLO; CLO_0014690
DR   Coriell; DA03045
DR   Wikidata; Q54822441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03046
AC   CVCL_7J74
DR   CLO; CLO_0014693
DR   Coriell; DA03046
DR   Wikidata; Q54822442
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03047
AC   CVCL_7J75
DR   CLO; CLO_0014694
DR   Coriell; DA03047
DR   Wikidata; Q54822443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03048
AC   CVCL_7J76
DR   CLO; CLO_0014697
DR   Coriell; DA03048
DR   Wikidata; Q54822444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03049
AC   CVCL_7J77
DR   CLO; CLO_0014698
DR   Coriell; DA03049
DR   Wikidata; Q54822445
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03050
AC   CVCL_7J78
DR   CLO; CLO_0014701
DR   Coriell; DA03050
DR   Wikidata; Q54822446
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03051
AC   CVCL_7J79
DR   CLO; CLO_0014703
DR   Coriell; DA03051
DR   Wikidata; Q54822447
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03052
AC   CVCL_7J80
DR   CLO; CLO_0014705
DR   Coriell; DA03052
DR   Wikidata; Q54822448
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03053
AC   CVCL_7J81
DR   CLO; CLO_0014706
DR   Coriell; DA03053
DR   Wikidata; Q54822449
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03054
AC   CVCL_7J82
DR   CLO; CLO_0014542
DR   Coriell; DA03054
DR   Wikidata; Q54822452
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03055
AC   CVCL_7J83
DR   CLO; CLO_0014540
DR   Coriell; DA03055
DR   Wikidata; Q54822453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03056
AC   CVCL_7J84
DR   CLO; CLO_0014539
DR   Coriell; DA03056
DR   Wikidata; Q54822454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03057
AC   CVCL_7J85
DR   CLO; CLO_0014536
DR   Coriell; DA03057
DR   Wikidata; Q54822455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03059
AC   CVCL_7J86
DR   CLO; CLO_0014534
DR   Coriell; DA03059
DR   Wikidata; Q54822456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03060
AC   CVCL_7J87
DR   CLO; CLO_0014532
DR   Coriell; DA03060
DR   Wikidata; Q54822457
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03061
AC   CVCL_7J88
DR   CLO; CLO_0014530
DR   Coriell; DA03061
DR   Wikidata; Q54822458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03062
AC   CVCL_7J89
DR   CLO; CLO_0014529
DR   Coriell; DA03062
DR   Wikidata; Q54822459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03063
AC   CVCL_7J90
DR   CLO; CLO_0014528
DR   Coriell; DA03063
DR   Wikidata; Q54822460
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03064
AC   CVCL_7J91
DR   CLO; CLO_0014527
DR   Coriell; DA03064
DR   Wikidata; Q54822461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03065
AC   CVCL_7J92
DR   CLO; CLO_0014499
DR   Coriell; DA03065
DR   Wikidata; Q54822462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03066
AC   CVCL_7J93
DR   CLO; CLO_0014496
DR   Coriell; DA03066
DR   Wikidata; Q54822463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03067
AC   CVCL_7J94
DR   CLO; CLO_0014502
DR   Coriell; DA03067
DR   Wikidata; Q54822464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03068
AC   CVCL_7J95
DR   CLO; CLO_0014501
DR   Coriell; DA03068
DR   Wikidata; Q54822466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03069
AC   CVCL_7J96
DR   CLO; CLO_0014490
DR   Coriell; DA03069
DR   Wikidata; Q54822467
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03070
AC   CVCL_7J97
DR   CLO; CLO_0014489
DR   Coriell; DA03070
DR   Wikidata; Q54822468
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03071
AC   CVCL_7J98
DR   CLO; CLO_0014495
DR   Coriell; DA03071
DR   Wikidata; Q54822470
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03072
AC   CVCL_7J99
DR   CLO; CLO_0014493
DR   Coriell; DA03072
DR   Wikidata; Q54822471
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03073
AC   CVCL_7K00
DR   CLO; CLO_0014487
DR   Coriell; DA03073
DR   Wikidata; Q54822472
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03074
AC   CVCL_7K01
DR   CLO; CLO_0014486
DR   Coriell; DA03074
DR   Wikidata; Q54822474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03075
AC   CVCL_7K02
DR   CLO; CLO_0014615
DR   Coriell; DA03075
DR   Wikidata; Q54822475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03076
AC   CVCL_7K03
DR   CLO; CLO_0014623
DR   Coriell; DA03076
DR   Wikidata; Q54822476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03077
AC   CVCL_7K04
DR   CLO; CLO_0014620
DR   Coriell; DA03077
DR   Wikidata; Q54822477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03078
AC   CVCL_7K05
DR   CLO; CLO_0014619
DR   Coriell; DA03078
DR   Wikidata; Q54822478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03079
AC   CVCL_7K06
DR   CLO; CLO_0014616
DR   Coriell; DA03079
DR   Wikidata; Q54822479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03081
AC   CVCL_7K07
DR   CLO; CLO_0014611
DR   Coriell; DA03081
DR   Wikidata; Q54822480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03082
AC   CVCL_7K08
DR   CLO; CLO_0014609
DR   Coriell; DA03082
DR   Wikidata; Q54822482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03083
AC   CVCL_7K09
DR   CLO; CLO_0014608
DR   Coriell; DA03083
DR   Wikidata; Q54822483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03084
AC   CVCL_7K10
DR   CLO; CLO_0014605
DR   Coriell; DA03084
DR   Wikidata; Q54822484
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03085
AC   CVCL_7K11
DR   CLO; CLO_0014614
DR   Coriell; DA03085
DR   Wikidata; Q54822485
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03085; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03086
AC   CVCL_7K12
DR   CLO; CLO_0014579
DR   Coriell; DA03086
DR   Wikidata; Q54822486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03087
AC   CVCL_7K13
DR   CLO; CLO_0014577
DR   Coriell; DA03087
DR   Wikidata; Q54822487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03088
AC   CVCL_7K14
DR   CLO; CLO_0014583
DR   Coriell; DA03088
DR   Wikidata; Q54822488
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03089
AC   CVCL_7K15
DR   CLO; CLO_0014580
DR   Coriell; DA03089
DR   Wikidata; Q54822490
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03091
AC   CVCL_7K16
DR   CLO; CLO_0014589
DR   Coriell; DA03091
DR   Wikidata; Q54822491
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03092
AC   CVCL_7K17
DR   CLO; CLO_0014585
DR   Coriell; DA03092
DR   Wikidata; Q54822492
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03093
AC   CVCL_7K18
DR   CLO; CLO_0014567
DR   Coriell; DA03093
DR   Wikidata; Q54822493
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03093; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03095
AC   CVCL_7K19
DR   CLO; CLO_0014564
DR   Coriell; DA03095
DR   Wikidata; Q54822494
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03096
AC   CVCL_7K20
DR   CLO; CLO_0014570
DR   Coriell; DA03096
DR   Wikidata; Q54822495
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03097
AC   CVCL_7K21
DR   CLO; CLO_0014569
DR   Coriell; DA03097
DR   Wikidata; Q54822497
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03098
AC   CVCL_7K22
DR   CLO; CLO_0014850
DR   Coriell; DA03098
DR   Wikidata; Q54822508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03099
AC   CVCL_7K23
DR   CLO; CLO_0014852
DR   Coriell; DA03099
DR   Wikidata; Q54822509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03101
AC   CVCL_7K24
DR   CLO; CLO_0014854
DR   Coriell; DA03101
DR   Wikidata; Q54822510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03102
AC   CVCL_7K25
DR   CLO; CLO_0014841
DR   Coriell; DA03102
DR   Wikidata; Q54822511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03103
AC   CVCL_7K26
DR   CLO; CLO_0014842
DR   Coriell; DA03103
DR   Wikidata; Q54822512
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03104
AC   CVCL_7K27
DR   CLO; CLO_0014844
DR   Coriell; DA03104
DR   Wikidata; Q54822513
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03105
AC   CVCL_7K28
DR   CLO; CLO_0014846
DR   Coriell; DA03105
DR   Wikidata; Q54822514
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03106
AC   CVCL_7K29
DR   CLO; CLO_0014856
DR   Coriell; DA03106
DR   Wikidata; Q54822516
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03107
AC   CVCL_7K30
DR   CLO; CLO_0014857
DR   Coriell; DA03107
DR   Wikidata; Q54822518
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03108
AC   CVCL_7K31
DR   CLO; CLO_0014858
DR   Coriell; DA03108
DR   Wikidata; Q54822519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03111
AC   CVCL_7K32
DR   CLO; CLO_0014823
DR   Coriell; DA03111
DR   Wikidata; Q54822520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03112
AC   CVCL_7K33
DR   Coriell; DA03112
DR   Wikidata; Q54822521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03112; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03113
AC   CVCL_7K34
DR   CLO; CLO_0014825
DR   Coriell; DA03113
DR   Wikidata; Q54822522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03114
AC   CVCL_7K35
DR   CLO; CLO_0014819
DR   Coriell; DA03114
DR   Wikidata; Q54822525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03115
AC   CVCL_7K36
DR   CLO; CLO_0014820
DR   Coriell; DA03115
DR   Wikidata; Q54822526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03116
AC   CVCL_7K37
DR   CLO; CLO_0014815
DR   Coriell; DA03116
DR   Wikidata; Q54822527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03117
AC   CVCL_7K38
DR   CLO; CLO_0014816
DR   Coriell; DA03117
DR   Wikidata; Q54822528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03118
AC   CVCL_7K39
DR   CLO; CLO_0014810
DR   Coriell; DA03118
DR   Wikidata; Q54822529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03119
AC   CVCL_7K40
DR   CLO; CLO_0014812
DR   Coriell; DA03119
DR   Wikidata; Q54822530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03119; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03120
AC   CVCL_7K41
DR   CLO; CLO_0014826
DR   Coriell; DA03120
DR   Wikidata; Q54822531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03121
AC   CVCL_7K42
DR   CLO; CLO_0014828
DR   Coriell; DA03121
DR   Wikidata; Q54822532
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03122
AC   CVCL_7K43
DR   CLO; CLO_0014966
DR   Coriell; DA03122
DR   Wikidata; Q54822533
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03124
AC   CVCL_7K44
DR   CLO; CLO_0014920
DR   Coriell; DA03124
DR   Wikidata; Q54822535
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03125
AC   CVCL_7K45
DR   CLO; CLO_0014923
DR   Coriell; DA03125
DR   Wikidata; Q54822536
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03126
AC   CVCL_7K46
DR   CLO; CLO_0014925
DR   Coriell; DA03126
DR   Wikidata; Q54822537
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03127
AC   CVCL_7K47
DR   CLO; CLO_0014926
DR   Coriell; DA03127
DR   Wikidata; Q54822538
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03128
AC   CVCL_7K48
DR   CLO; CLO_0014929
DR   Coriell; DA03128
DR   Wikidata; Q54822539
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03129
AC   CVCL_7K49
DR   CLO; CLO_0014931
DR   Coriell; DA03129
DR   Wikidata; Q54822540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03130
AC   CVCL_7K50
DR   CLO; CLO_0014933
DR   Coriell; DA03130
DR   Wikidata; Q54822541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03131
AC   CVCL_7K51
DR   CLO; CLO_0014936
DR   Coriell; DA03131
DR   Wikidata; Q54822543
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03132
AC   CVCL_7K52
DR   CLO; CLO_0014940
DR   Coriell; DA03132
DR   Wikidata; Q54822544
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03133
AC   CVCL_7K53
DR   CLO; CLO_0014913
DR   Coriell; DA03133
DR   Wikidata; Q54822546
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03134
AC   CVCL_7K54
DR   CLO; CLO_0014912
DR   Coriell; DA03134
DR   Wikidata; Q54822547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03135
AC   CVCL_7K55
DR   CLO; CLO_0014875
DR   Coriell; DA03135
DR   Wikidata; Q54822548
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03136
AC   CVCL_7K56
DR   CLO; CLO_0014876
DR   Coriell; DA03136
DR   Wikidata; Q54822549
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03137
AC   CVCL_7K57
DR   CLO; CLO_0014870
DR   Coriell; DA03137
DR   Wikidata; Q54822551
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03138
AC   CVCL_7K58
DR   CLO; CLO_0014873
DR   Coriell; DA03138
DR   Wikidata; Q54822552
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03140
AC   CVCL_7K59
DR   CLO; CLO_0014883
DR   Coriell; DA03140
DR   Wikidata; Q54822553
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03141
AC   CVCL_7K60
DR   CLO; CLO_0014885
DR   Coriell; DA03141
DR   Wikidata; Q54822554
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03142
AC   CVCL_7K61
DR   CLO; CLO_0014879
DR   Coriell; DA03142
DR   Wikidata; Q54822555
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03143
AC   CVCL_7K62
DR   CLO; CLO_0014882
DR   Coriell; DA03143
DR   Wikidata; Q54822560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03145
AC   CVCL_7K63
DR   CLO; CLO_0012315
DR   Coriell; DA03145
DR   Wikidata; Q54822561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03146
AC   CVCL_7K64
DR   CLO; CLO_0012319
DR   Coriell; DA03146
DR   Wikidata; Q54822562
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03147
AC   CVCL_7K65
DR   CLO; CLO_0012308
DR   Coriell; DA03147
DR   Wikidata; Q54822563
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03148
AC   CVCL_7K66
DR   CLO; CLO_0012311
DR   Coriell; DA03148
DR   Wikidata; Q54822565
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03149
AC   CVCL_7K67
DR   CLO; CLO_0012304
DR   Coriell; DA03149
DR   Wikidata; Q54822566
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03150
AC   CVCL_7K68
DR   CLO; CLO_0012306
DR   Coriell; DA03150
DR   Wikidata; Q54822567
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03151
AC   CVCL_7K69
DR   CLO; CLO_0012300
DR   Coriell; DA03151
DR   Wikidata; Q54822568
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03152
AC   CVCL_7K70
DR   CLO; CLO_0012303
DR   Coriell; DA03152
DR   Wikidata; Q54822570
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03153
AC   CVCL_7K71
DR   CLO; CLO_0012298
DR   Coriell; DA03153
DR   Wikidata; Q54822571
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03154
AC   CVCL_7K72
DR   CLO; CLO_0012297
DR   Coriell; DA03154
DR   Wikidata; Q54822572
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03155
AC   CVCL_7K73
DR   CLO; CLO_0012279
DR   Coriell; DA03155
DR   Wikidata; Q54822574
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03156
AC   CVCL_7K74
DR   CLO; CLO_0012257
DR   Coriell; DA03156
DR   Wikidata; Q54822575
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03157
AC   CVCL_7K75
DR   CLO; CLO_0012261
DR   Coriell; DA03157
DR   Wikidata; Q54822576
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03158
AC   CVCL_7K76
DR   CLO; CLO_0012264
DR   Coriell; DA03158
DR   Wikidata; Q54822577
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03159
AC   CVCL_7K77
DR   CLO; CLO_0012267
DR   Coriell; DA03159
DR   Wikidata; Q54822578
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03160
AC   CVCL_7K78
DR   CLO; CLO_0012247
DR   Coriell; DA03160
DR   Wikidata; Q54822579
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03161
AC   CVCL_7K79
DR   CLO; CLO_0012249
DR   Coriell; DA03161
DR   Wikidata; Q54822580
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03162
AC   CVCL_7K80
DR   CLO; CLO_0012251
DR   Coriell; DA03162
DR   Wikidata; Q54822581
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03163
AC   CVCL_7K81
DR   CLO; CLO_0012255
DR   Coriell; DA03163
DR   Wikidata; Q54822582
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03164
AC   CVCL_7K82
DR   CLO; CLO_0012242
DR   Coriell; DA03164
DR   Wikidata; Q54822584
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03165
AC   CVCL_7K83
DR   CLO; CLO_0012229
DR   Coriell; DA03165
DR   Wikidata; Q54822585
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03166
AC   CVCL_7K84
DR   CLO; CLO_0012233
DR   Coriell; DA03166
DR   Wikidata; Q54822586
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03167
AC   CVCL_7K85
DR   CLO; CLO_0012213
DR   Coriell; DA03167
DR   Wikidata; Q54822587
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03168
AC   CVCL_7K86
DR   CLO; CLO_0012215
DR   Coriell; DA03168
DR   Wikidata; Q54822588
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03169
AC   CVCL_7K87
DR   CLO; CLO_0012205
DR   Coriell; DA03169
DR   Wikidata; Q54822589
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03170
AC   CVCL_7K88
DR   CLO; CLO_0012208
DR   Coriell; DA03170
DR   Wikidata; Q54822590
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03171
AC   CVCL_7K89
DR   CLO; CLO_0012224
DR   Coriell; DA03171
DR   Wikidata; Q54822591
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03173
AC   CVCL_7K90
DR   CLO; CLO_0012225
DR   Coriell; DA03173
DR   Wikidata; Q54822593
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03174
AC   CVCL_7K91
DR   CLO; CLO_0012218
DR   Coriell; DA03174
DR   Wikidata; Q54822594
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03175
AC   CVCL_7K92
DR   CLO; CLO_0012220
DR   Coriell; DA03175
DR   Wikidata; Q54822595
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03176
AC   CVCL_7K93
DR   CLO; CLO_0012189
DR   Coriell; DA03176
DR   Wikidata; Q54822596
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03177
AC   CVCL_7K94
DR   CLO; CLO_0012191
DR   Coriell; DA03177
DR   Wikidata; Q54822597
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03178
AC   CVCL_7K95
DR   CLO; CLO_0012194
DR   Coriell; DA03178
DR   Wikidata; Q54822599
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03179
AC   CVCL_7K96
DR   CLO; CLO_0012165
DR   Coriell; DA03179
DR   Wikidata; Q54822600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03180
AC   CVCL_7K97
DR   CLO; CLO_0012168
DR   Coriell; DA03180
DR   Wikidata; Q54822602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03181
AC   CVCL_7K98
DR   CLO; CLO_0012172
DR   Coriell; DA03181
DR   Wikidata; Q54822604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03182
AC   CVCL_7K99
DR   CLO; CLO_0012175
DR   Coriell; DA03182
DR   Wikidata; Q54822605
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03183
AC   CVCL_7L00
DR   CLO; CLO_0012176
DR   Coriell; DA03183
DR   Wikidata; Q54822606
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03184
AC   CVCL_7L01
DR   CLO; CLO_0012178
DR   Coriell; DA03184
DR   Wikidata; Q54822607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03185
AC   CVCL_7L02
DR   CLO; CLO_0012180
DR   Coriell; DA03185
DR   Wikidata; Q54822611
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03186
AC   CVCL_7L03
DR   CLO; CLO_0012471
DR   Coriell; DA03186
DR   Wikidata; Q54822612
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03187
AC   CVCL_7L04
DR   CLO; CLO_0012469
DR   Coriell; DA03187
DR   Wikidata; Q54822613
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03188
AC   CVCL_7L05
DR   CLO; CLO_0012467
DR   Coriell; DA03188
DR   Wikidata; Q54822614
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03189
AC   CVCL_7L06
DR   CLO; CLO_0012466
DR   Coriell; DA03189
DR   Wikidata; Q54822615
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03190
AC   CVCL_7L07
DR   CLO; CLO_0012486
DR   Coriell; DA03190
DR   Wikidata; Q54822616
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03191
AC   CVCL_7L08
DR   CLO; CLO_0012484
DR   Coriell; DA03191
DR   Wikidata; Q54822617
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03192
AC   CVCL_7L09
DR   CLO; CLO_0012483
DR   Coriell; DA03192
DR   Wikidata; Q54822618
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03193
AC   CVCL_7L10
DR   CLO; CLO_0012482
DR   Coriell; DA03193
DR   Wikidata; Q54822619
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03194
AC   CVCL_7L11
DR   CLO; CLO_0012481
DR   Coriell; DA03194
DR   Wikidata; Q54822620
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03195
AC   CVCL_7L12
DR   CLO; CLO_0012478
DR   Coriell; DA03195
DR   Wikidata; Q54822621
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03196
AC   CVCL_7L13
DR   CLO; CLO_0012431
DR   Coriell; DA03196
DR   Wikidata; Q54822622
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03198
AC   CVCL_7L14
DR   CLO; CLO_0012426
DR   Coriell; DA03198
DR   Wikidata; Q54822623
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03199
AC   CVCL_7L15
DR   CLO; CLO_0012424
DR   Coriell; DA03199
DR   Wikidata; Q54822624
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03201
AC   CVCL_7L16
DR   CLO; CLO_0012428
DR   Coriell; DA03201
DR   Wikidata; Q54822625
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03202
AC   CVCL_7L17
DR   CLO; CLO_0012427
DR   Coriell; DA03202
DR   Wikidata; Q54822626
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03203
AC   CVCL_7L18
DR   CLO; CLO_0012441
DR   Coriell; DA03203
DR   Wikidata; Q54822627
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03204
AC   CVCL_7L19
DR   CLO; CLO_0012439
DR   Coriell; DA03204
DR   Wikidata; Q54822628
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03205
AC   CVCL_7L20
DR   CLO; CLO_0012444
DR   Coriell; DA03205
DR   Wikidata; Q54822629
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03206
AC   CVCL_7L21
DR   CLO; CLO_0012443
DR   Coriell; DA03206
DR   Wikidata; Q54822630
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03207
AC   CVCL_7L22
DR   CLO; CLO_0012436
DR   Coriell; DA03207
DR   Wikidata; Q54822631
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03208
AC   CVCL_7L23
DR   CLO; CLO_0012384
DR   Coriell; DA03208
DR   Wikidata; Q54822632
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03209
AC   CVCL_7L24
DR   CLO; CLO_0012383
DR   Coriell; DA03209
DR   Wikidata; Q54822633
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03210
AC   CVCL_7L25
DR   CLO; CLO_0012397
DR   Coriell; DA03210
DR   Wikidata; Q54822634
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03211
AC   CVCL_7L26
DR   CLO; CLO_0012394
DR   Coriell; DA03211
DR   Wikidata; Q54822635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03212
AC   CVCL_7L27
DR   CLO; CLO_0012391
DR   Coriell; DA03212
DR   Wikidata; Q54822636
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03213
AC   CVCL_7L28
DR   CLO; CLO_0012389
DR   Coriell; DA03213
DR   Wikidata; Q54822637
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03214
AC   CVCL_7L29
DR   CLO; CLO_0012404
DR   Coriell; DA03214
DR   Wikidata; Q54822638
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03215
AC   CVCL_7L30
DR   CLO; CLO_0012403
DR   Coriell; DA03215
DR   Wikidata; Q54822639
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03216
AC   CVCL_7L31
DR   CLO; CLO_0012401
DR   Coriell; DA03216
DR   Wikidata; Q54822640
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03217
AC   CVCL_7L32
DR   CLO; CLO_0012399
DR   Coriell; DA03217
DR   Wikidata; Q54822641
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03218
AC   CVCL_7L33
DR   CLO; CLO_0012341
DR   Coriell; DA03218
DR   Wikidata; Q54822642
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03221
AC   CVCL_7L34
DR   CLO; CLO_0012345
DR   Coriell; DA03221
DR   Wikidata; Q54822643
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03222
AC   CVCL_7L35
DR   CLO; CLO_0012343
DR   Coriell; DA03222
DR   Wikidata; Q54822644
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03223
AC   CVCL_7L36
DR   CLO; CLO_0012350
DR   Coriell; DA03223
DR   Wikidata; Q54822645
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03224
AC   CVCL_7L37
DR   CLO; CLO_0012348
DR   Coriell; DA03224
DR   Wikidata; Q54822646
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03225
AC   CVCL_7L38
DR   CLO; CLO_0012354
DR   Coriell; DA03225
DR   Wikidata; Q54822647
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03226
AC   CVCL_7L39
DR   CLO; CLO_0012351
DR   Coriell; DA03226
DR   Wikidata; Q54822648
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03227
AC   CVCL_8B18
DR   CLO; CLO_0012358
DR   Coriell; DA03227
DR   Wikidata; Q54822649
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03228
AC   CVCL_8B19
DR   CLO; CLO_0012356
DR   Coriell; DA03228
DR   Wikidata; Q54822650
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03229
AC   CVCL_8B20
DR   CLO; CLO_0012361
DR   Coriell; DA03229
DR   Wikidata; Q54822653
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03230
AC   CVCL_8B21
DR   CLO; CLO_0012600
DR   Coriell; DA03230
DR   Wikidata; Q54822654
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03231
AC   CVCL_8B22
DR   CLO; CLO_0012601
DR   Coriell; DA03231
DR   Wikidata; Q54822655
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03232
AC   CVCL_8B23
DR   CLO; CLO_0012604
DR   Coriell; DA03232
DR   Wikidata; Q54822656
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03233
AC   CVCL_8B24
DR   CLO; CLO_0012605
DR   Coriell; DA03233
DR   Wikidata; Q54822657
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03234
AC   CVCL_8B25
DR   CLO; CLO_0012593
DR   Coriell; DA03234
DR   Wikidata; Q54822658
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03236
AC   CVCL_8B26
DR   CLO; CLO_0012594
DR   Coriell; DA03236
DR   Wikidata; Q54822659
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03237
AC   CVCL_8B27
DR   CLO; CLO_0012596
DR   Coriell; DA03237
DR   Wikidata; Q54822660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03238
AC   CVCL_7L40
DR   CLO; CLO_0012598
DR   Coriell; DA03238
DR   Wikidata; Q54822661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03239
AC   CVCL_7L41
DR   CLO; CLO_0012590
DR   Coriell; DA03239
DR   Wikidata; Q54822662
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03240
AC   CVCL_7L42
DR   CLO; CLO_0012591
DR   Coriell; DA03240
DR   Wikidata; Q54822663
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03241
AC   CVCL_7L43
DR   CLO; CLO_0012547
DR   Coriell; DA03241
DR   Wikidata; Q54822664
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03242
AC   CVCL_7L44
DR   CLO; CLO_0012573
DR   Coriell; DA03242
DR   Wikidata; Q54822665
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03243
AC   CVCL_7L45
DR   CLO; CLO_0012575
DR   Coriell; DA03243
DR   Wikidata; Q54822666
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03244
AC   CVCL_7L46
DR   CLO; CLO_0012569
DR   Coriell; DA03244
DR   Wikidata; Q54822667
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03245
AC   CVCL_7L47
DR   CLO; CLO_0012571
DR   Coriell; DA03245
DR   Wikidata; Q54822668
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03246
AC   CVCL_7L48
DR   CLO; CLO_0012565
DR   Coriell; DA03246
DR   Wikidata; Q54822669
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03247
AC   CVCL_7L49
DR   CLO; CLO_0012568
DR   Coriell; DA03247
DR   Wikidata; Q54822670
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03248
AC   CVCL_7L50
DR   CLO; CLO_0012562
DR   Coriell; DA03248
DR   Wikidata; Q54822671
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03249
AC   CVCL_7L51
DR   CLO; CLO_0012563
DR   Coriell; DA03249
DR   Wikidata; Q54822672
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03250
AC   CVCL_7L52
DR   CLO; CLO_0012560
DR   Coriell; DA03250
DR   Wikidata; Q54822673
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03251
AC   CVCL_7L53
DR   CLO; CLO_0013722
DR   Coriell; DA03251
DR   Wikidata; Q54822674
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03252
AC   CVCL_7L54
DR   CLO; CLO_0013727
DR   Coriell; DA03252
DR   Wikidata; Q54822675
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03253
AC   CVCL_7L55
DR   CLO; CLO_0013725
DR   Coriell; DA03253
DR   Wikidata; Q54822676
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03254
AC   CVCL_7L56
DR   CLO; CLO_0013715
DR   Coriell; DA03254
DR   Wikidata; Q54822677
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03255
AC   CVCL_7L57
DR   CLO; CLO_0013714
DR   Coriell; DA03255
DR   Wikidata; Q54822678
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03256
AC   CVCL_7L58
DR   CLO; CLO_0013719
DR   Coriell; DA03256
DR   Wikidata; Q54822679
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03257
AC   CVCL_7L59
DR   CLO; CLO_0013717
DR   Coriell; DA03257
DR   Wikidata; Q54822680
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03258
AC   CVCL_7L60
DR   CLO; CLO_0013731
DR   Coriell; DA03258
DR   Wikidata; Q54822681
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03259
AC   CVCL_7L61
DR   CLO; CLO_0013732
DR   Coriell; DA03259
DR   Wikidata; Q54822682
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03261
AC   CVCL_7L62
DR   CLO; CLO_0013730
DR   Coriell; DA03261
DR   Wikidata; Q54822683
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03262
AC   CVCL_7L63
DR   CLO; CLO_0013746
DR   Coriell; DA03262
DR   Wikidata; Q54822684
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03263
AC   CVCL_7L64
DR   CLO; CLO_0013744
DR   Coriell; DA03263
DR   Wikidata; Q54822685
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03264
AC   CVCL_7L65
DR   CLO; CLO_0013742
DR   Coriell; DA03264
DR   Wikidata; Q54822686
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03265
AC   CVCL_7L66
DR   CLO; CLO_0013741
DR   Coriell; DA03265
DR   Wikidata; Q54822687
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03266
AC   CVCL_7L67
DR   CLO; CLO_0013739
DR   Coriell; DA03266
DR   Wikidata; Q54822688
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03267
AC   CVCL_7L68
DR   CLO; CLO_0013737
DR   Coriell; DA03267
DR   Wikidata; Q54822689
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03268
AC   CVCL_7L69
DR   CLO; CLO_0013736
DR   Coriell; DA03268
DR   Wikidata; Q54822690
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03269
AC   CVCL_7L70
DR   CLO; CLO_0013733
DR   Coriell; DA03269
DR   Wikidata; Q54822691
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03270
AC   CVCL_7L71
DR   CLO; CLO_0013141
DR   Coriell; DA03270
DR   Wikidata; Q54822692
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03271
AC   CVCL_7L72
DR   CLO; CLO_0013139
DR   Coriell; DA03271
DR   Wikidata; Q54822695
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03272
AC   CVCL_7L73
DR   CLO; CLO_0013104
DR   Coriell; DA03272
DR   Wikidata; Q54822696
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03273
AC   CVCL_7L74
DR   CLO; CLO_0013128
DR   Coriell; DA03273
DR   Wikidata; Q54822697
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03274
AC   CVCL_7L75
DR   CLO; CLO_0013133
DR   Coriell; DA03274
DR   Wikidata; Q54822698
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03275
AC   CVCL_7L76
DR   CLO; CLO_0013122
DR   Coriell; DA03275
DR   Wikidata; Q54822699
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03276
AC   CVCL_7L77
DR   CLO; CLO_0013125
DR   Coriell; DA03276
DR   Wikidata; Q54822700
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03277
AC   CVCL_7L78
DR   CLO; CLO_0013118
DR   Coriell; DA03277
DR   Wikidata; Q54822701
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03278
AC   CVCL_7L79
DR   CLO; CLO_0013120
DR   Coriell; DA03278
DR   Wikidata; Q54822702
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03279
AC   CVCL_7L80
DR   CLO; CLO_0013113
DR   Coriell; DA03279
DR   Wikidata; Q54822703
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03280
AC   CVCL_7L81
DR   CLO; CLO_0013117
DR   Coriell; DA03280
DR   Wikidata; Q54822704
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03281
AC   CVCL_7L82
DR   CLO; CLO_0013098
DR   Coriell; DA03281
DR   Wikidata; Q54822705
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03282
AC   CVCL_7L83
DR   CLO; CLO_0013064
DR   Coriell; DA03282
DR   Wikidata; Q54822706
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03283
AC   CVCL_7L84
DR   CLO; CLO_0013068
DR   Coriell; DA03283
DR   Wikidata; Q54822707
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03284
AC   CVCL_7L85
DR   CLO; CLO_0013083
DR   Coriell; DA03284
DR   Wikidata; Q54822708
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03285
AC   CVCL_7L86
DR   CLO; CLO_0013087
DR   Coriell; DA03285
DR   Wikidata; Q54822709
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03286
AC   CVCL_7L87
DR   CLO; CLO_0013089
DR   Coriell; DA03286
DR   Wikidata; Q54822710
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03287
AC   CVCL_7L88
DR   CLO; CLO_0013091
DR   Coriell; DA03287
DR   Wikidata; Q54822711
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03288
AC   CVCL_7L89
DR   CLO; CLO_0013073
DR   Coriell; DA03288
DR   Wikidata; Q54822712
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03289
AC   CVCL_7L90
DR   CLO; CLO_0013075
DR   Coriell; DA03289
DR   Wikidata; Q54822713
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03290
AC   CVCL_7L91
DR   CLO; CLO_0013076
DR   Coriell; DA03290
DR   Wikidata; Q54822714
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03291
AC   CVCL_7L92
DR   CLO; CLO_0013081
DR   Coriell; DA03291
DR   Wikidata; Q54822715
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03292
AC   CVCL_7L93
DR   CLO; CLO_0013191
DR   Coriell; DA03292
DR   Wikidata; Q54822716
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03293
AC   CVCL_7L94
DR   CLO; CLO_0013185
DR   Coriell; DA03293
DR   Wikidata; Q54822717
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03294
AC   CVCL_7L95
DR   CLO; CLO_0013188
DR   Coriell; DA03294
DR   Wikidata; Q54822718
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03295
AC   CVCL_7L96
DR   CLO; CLO_0013200
DR   Coriell; DA03295
DR   Wikidata; Q54822719
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03296
AC   CVCL_7L97
DR   CLO; CLO_0013201
DR   Coriell; DA03296
DR   Wikidata; Q54822720
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03297
AC   CVCL_7L98
DR   CLO; CLO_0013194
DR   Coriell; DA03297
DR   Wikidata; Q54822721
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03298
AC   CVCL_7L99
DR   CLO; CLO_0013195
DR   Coriell; DA03298
DR   Wikidata; Q54822722
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03299
AC   CVCL_7M00
DR   CLO; CLO_0013209
DR   Coriell; DA03299
DR   Wikidata; Q54822723
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03300
AC   CVCL_7M01
DR   CLO; CLO_0013211
DR   Coriell; DA03300
DR   Wikidata; Q54822724
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03301
AC   CVCL_7M02
DR   CLO; CLO_0013205
DR   Coriell; DA03301
DR   Wikidata; Q54822725
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03302
AC   CVCL_7M03
DR   CLO; CLO_0013150
DR   Coriell; DA03302
DR   Wikidata; Q54822726
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03303
AC   CVCL_7M04
DR   CLO; CLO_0013154
DR   Coriell; DA03303
DR   Wikidata; Q54822727
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03304
AC   CVCL_7M05
DR   CLO; CLO_0013156
DR   Coriell; DA03304
DR   Wikidata; Q54822728
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03305
AC   CVCL_7M06
DR   CLO; CLO_0013159
DR   Coriell; DA03305
DR   Wikidata; Q54822729
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03306
AC   CVCL_7M07
DR   CLO; CLO_0013161
DR   Coriell; DA03306
DR   Wikidata; Q54822730
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03307
AC   CVCL_7M08
DR   CLO; CLO_0013165
DR   Coriell; DA03307
DR   Wikidata; Q54822731
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03308
AC   CVCL_7M09
DR   CLO; CLO_0013171
DR   Coriell; DA03308
DR   Wikidata; Q54822732
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03309
AC   CVCL_7M10
DR   CLO; CLO_0013172
DR   Coriell; DA03309
DR   Wikidata; Q54822733
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03310
AC   CVCL_7M11
DR   CLO; CLO_0013175
DR   Coriell; DA03310
DR   Wikidata; Q54822734
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03311
AC   CVCL_7M12
DR   CLO; CLO_0013178
DR   Coriell; DA03311
DR   Wikidata; Q54822736
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03312
AC   CVCL_7M13
DR   CLO; CLO_0013262
DR   Coriell; DA03312
DR   Wikidata; Q54822737
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03313
AC   CVCL_7M14
DR   CLO; CLO_0013261
DR   Coriell; DA03313
DR   Wikidata; Q54822738
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03314
AC   CVCL_7M15
DR   CLO; CLO_0013259
DR   Coriell; DA03314
DR   Wikidata; Q54822739
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03315
AC   CVCL_7M16
DR   CLO; CLO_0013258
DR   Coriell; DA03315
DR   Wikidata; Q54822740
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03316
AC   CVCL_7M17
DR   CLO; CLO_0013257
DR   Coriell; DA03316
DR   Wikidata; Q54822741
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03317
AC   CVCL_7M18
DR   CLO; CLO_0013255
DR   Coriell; DA03317
DR   Wikidata; Q54822742
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03318
AC   CVCL_7M19
DR   CLO; CLO_0013254
DR   Coriell; DA03318
DR   Wikidata; Q54822743
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03320
AC   CVCL_7M20
DR   CLO; CLO_0013252
DR   Coriell; DA03320
DR   Wikidata; Q54822744
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03321
AC   CVCL_7M21
DR   CLO; CLO_0013251
DR   Coriell; DA03321
DR   Wikidata; Q54822745
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03322
AC   CVCL_7M22
DR   CLO; CLO_0013250
DR   Coriell; DA03322
DR   Wikidata; Q54822746
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03323
AC   CVCL_7M23
DR   CLO; CLO_0013235
DR   Coriell; DA03323
DR   Wikidata; Q54822747
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03324
AC   CVCL_7M24
DR   CLO; CLO_0013233
DR   Coriell; DA03324
DR   Wikidata; Q54822748
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03325
AC   CVCL_7M25
DR   CLO; CLO_0013227
DR   Coriell; DA03325
DR   Wikidata; Q54822749
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03326
AC   CVCL_7M26
DR   CLO; CLO_0013226
DR   Coriell; DA03326
DR   Wikidata; Q54822750
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03326; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03327
AC   CVCL_7M27
DR   CLO; CLO_0013229
DR   Coriell; DA03327
DR   Wikidata; Q54822751
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03327; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03328
AC   CVCL_7M28
DR   CLO; CLO_0013228
DR   Coriell; DA03328
DR   Wikidata; Q54822752
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03329
AC   CVCL_7M29
DR   CLO; CLO_0013221
DR   Coriell; DA03329
DR   Wikidata; Q54822753
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03330
AC   CVCL_7M30
DR   CLO; CLO_0013220
DR   Coriell; DA03330
DR   Wikidata; Q54822754
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03331
AC   CVCL_7M31
DR   CLO; CLO_0013225
DR   Coriell; DA03331
DR   Wikidata; Q54822755
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03332
AC   CVCL_7M32
DR   CLO; CLO_0013223
DR   Coriell; DA03332
DR   Wikidata; Q54822756
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03333
AC   CVCL_7M33
DR   CLO; CLO_0013337
DR   Coriell; DA03333
DR   Wikidata; Q54822757
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03334
AC   CVCL_7M34
DR   CLO; CLO_0013334
DR   Coriell; DA03334
DR   Wikidata; Q54822758
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03335
AC   CVCL_7M35
DR   CLO; CLO_0013332
DR   Coriell; DA03335
DR   Wikidata; Q54822759
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03336
AC   CVCL_7M36
DR   CLO; CLO_0013345
DR   Coriell; DA03336
DR   Wikidata; Q54822760
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03337
AC   CVCL_7M37
DR   CLO; CLO_0013343
DR   Coriell; DA03337
DR   Wikidata; Q54822761
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03338
AC   CVCL_7M38
DR   CLO; CLO_0013341
DR   Coriell; DA03338
DR   Wikidata; Q54822762
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03339
AC   CVCL_7M39
DR   CLO; CLO_0013340
DR   Coriell; DA03339
DR   Wikidata; Q54822763
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03340
AC   CVCL_7M40
DR   CLO; CLO_0013326
DR   Coriell; DA03340
DR   Wikidata; Q54822764
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03342
AC   CVCL_7M41
DR   CLO; CLO_0013325
DR   Coriell; DA03342
DR   Wikidata; Q54822765
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03343
AC   CVCL_7M42
DR   CLO; CLO_0013322
DR   Coriell; DA03343
DR   Wikidata; Q54822766
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03344
AC   CVCL_7M43
DR   CLO; CLO_0013293
DR   Coriell; DA03344
DR   Wikidata; Q54822767
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03345
AC   CVCL_7M44
DR   CLO; CLO_0013291
DR   Coriell; DA03345
DR   Wikidata; Q54822768
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03346
AC   CVCL_7M45
DR   CLO; CLO_0013297
DR   Coriell; DA03346
DR   Wikidata; Q54822769
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03347
AC   CVCL_7M46
DR   CLO; CLO_0013295
DR   Coriell; DA03347
DR   Wikidata; Q54822770
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03348
AC   CVCL_7M47
DR   CLO; CLO_0013303
DR   Coriell; DA03348
DR   Wikidata; Q54822771
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03349
AC   CVCL_7M48
DR   CLO; CLO_0013301
DR   Coriell; DA03349
DR   Wikidata; Q54822772
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03350
AC   CVCL_7M49
DR   CLO; CLO_0013305
DR   Coriell; DA03350
DR   Wikidata; Q54822773
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03351
AC   CVCL_7M50
DR   CLO; CLO_0013304
DR   Coriell; DA03351
DR   Wikidata; Q54822774
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03352
AC   CVCL_7M51
DR   CLO; CLO_0013281
DR   Coriell; DA03352
DR   Wikidata; Q54822775
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03354
AC   CVCL_7M52
DR   CLO; CLO_0013278
DR   Coriell; DA03354
DR   Wikidata; Q54822777
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03355
AC   CVCL_7M53
DR   CLO; CLO_0033153
DR   Coriell; DA03355
DR   Wikidata; Q54822778
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03356
AC   CVCL_7M54
DR   CLO; CLO_0033154
DR   Coriell; DA03356
DR   Wikidata; Q54822779
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03357
AC   CVCL_7M55
DR   CLO; CLO_0033151
DR   Coriell; DA03357
DR   Wikidata; Q54822780
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03358
AC   CVCL_7M56
DR   CLO; CLO_0033152
DR   Coriell; DA03358
DR   Wikidata; Q54822781
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03359
AC   CVCL_7M57
DR   CLO; CLO_0033149
DR   Coriell; DA03359
DR   Wikidata; Q54822782
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03360
AC   CVCL_7M58
DR   CLO; CLO_0033150
DR   Coriell; DA03360
DR   Wikidata; Q54822783
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03361
AC   CVCL_7M59
DR   CLO; CLO_0033143
DR   Coriell; DA03361
DR   Wikidata; Q54822784
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03362
AC   CVCL_7M60
DR   CLO; CLO_0033142
DR   Coriell; DA03362
DR   Wikidata; Q54822785
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03363
AC   CVCL_7M61
DR   CLO; CLO_0033147
DR   Coriell; DA03363
DR   Wikidata; Q54822786
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03364
AC   CVCL_7M62
DR   CLO; CLO_0033145
DR   Coriell; DA03364
DR   Wikidata; Q54822787
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03365
AC   CVCL_7M63
DR   CLO; CLO_0033133
DR   Coriell; DA03365
DR   Wikidata; Q54822788
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03366
AC   CVCL_7M64
DR   CLO; CLO_0033134
DR   Coriell; DA03366
DR   Wikidata; Q54822789
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03367
AC   CVCL_7M65
DR   CLO; CLO_0033135
DR   Coriell; DA03367
DR   Wikidata; Q54822790
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03368
AC   CVCL_7M66
DR   CLO; CLO_0033129
DR   Coriell; DA03368
DR   Wikidata; Q54822791
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03369
AC   CVCL_7M67
DR   CLO; CLO_0033130
DR   Coriell; DA03369
DR   Wikidata; Q54822792
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03370
AC   CVCL_7M68
DR   CLO; CLO_0033131
DR   Coriell; DA03370
DR   Wikidata; Q54822793
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03371
AC   CVCL_7M69
DR   CLO; CLO_0033132
DR   Coriell; DA03371
DR   Wikidata; Q54822794
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03372
AC   CVCL_7M70
DR   CLO; CLO_0033176
DR   Coriell; DA03372
DR   Wikidata; Q54822795
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03373
AC   CVCL_7M71
DR   CLO; CLO_0033175
DR   Coriell; DA03373
DR   Wikidata; Q54822796
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03374
AC   CVCL_7M72
DR   CLO; CLO_0033174
DR   Coriell; DA03374
DR   Wikidata; Q54822797
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03375
AC   CVCL_7M73
DR   CLO; CLO_0033168
DR   Coriell; DA03375
DR   Wikidata; Q54822798
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03376
AC   CVCL_7M74
DR   CLO; CLO_0033169
DR   Coriell; DA03376
DR   Wikidata; Q54822799
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03378
AC   CVCL_7M75
DR   CLO; CLO_0033166
DR   Coriell; DA03378
DR   Wikidata; Q54822800
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03379
AC   CVCL_7M76
DR   CLO; CLO_0033167
DR   Coriell; DA03379
DR   Wikidata; Q54822801
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03380
AC   CVCL_7M77
DR   CLO; CLO_0033172
DR   Coriell; DA03380
DR   Wikidata; Q54822802
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03381
AC   CVCL_7M78
DR   CLO; CLO_0033173
DR   Coriell; DA03381
DR   Wikidata; Q54822803
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03382
AC   CVCL_7M79
DR   CLO; CLO_0033170
DR   Coriell; DA03382
DR   Wikidata; Q54822804
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03385
AC   CVCL_7M80
DR   CLO; CLO_0033171
DR   Coriell; DA03385
DR   Wikidata; Q54822805
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03386
AC   CVCL_7M81
DR   CLO; CLO_0033165
DR   Coriell; DA03386
DR   Wikidata; Q54822806
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03387
AC   CVCL_7M82
DR   CLO; CLO_0033164
DR   Coriell; DA03387
DR   Wikidata; Q54822807
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03389
AC   CVCL_7M83
DR   CLO; CLO_0033163
DR   Coriell; DA03389
DR   Wikidata; Q54822808
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03390
AC   CVCL_7M84
DR   CLO; CLO_0033155
DR   Coriell; DA03390
DR   Wikidata; Q54822809
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03392
AC   CVCL_7M85
DR   CLO; CLO_0033156
DR   Coriell; DA03392
DR   Wikidata; Q54822810
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03393
AC   CVCL_7M86
DR   CLO; CLO_0033157
DR   Coriell; DA03393
DR   Wikidata; Q54822811
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03394
AC   CVCL_7M87
DR   CLO; CLO_0033158
DR   Coriell; DA03394
DR   Wikidata; Q54822812
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03395
AC   CVCL_7M88
DR   CLO; CLO_0033159
DR   Coriell; DA03395
DR   Wikidata; Q54822813
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03396
AC   CVCL_7M89
DR   CLO; CLO_0033160
DR   Coriell; DA03396
DR   Wikidata; Q54822814
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03397
AC   CVCL_7M90
DR   CLO; CLO_0033161
DR   Coriell; DA03397
DR   Wikidata; Q54822815
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03398
AC   CVCL_7M91
DR   CLO; CLO_0033162
DR   Coriell; DA03398
DR   Wikidata; Q54822816
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03399
AC   CVCL_7M92
DR   CLO; CLO_0033177
DR   Coriell; DA03399
DR   Wikidata; Q54822818
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03400
AC   CVCL_7M93
DR   CLO; CLO_0033196
DR   Coriell; DA03400
DR   Wikidata; Q54822819
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03401
AC   CVCL_7M94
DR   CLO; CLO_0033195
DR   Coriell; DA03401
DR   Wikidata; Q54822820
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03402
AC   CVCL_7M95
DR   CLO; CLO_0033200
DR   Coriell; DA03402
DR   Wikidata; Q54822821
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03403
AC   CVCL_7M96
DR   CLO; CLO_0033198
DR   Coriell; DA03403
DR   Wikidata; Q54822822
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03404
AC   CVCL_7M97
DR   CLO; CLO_0033205
DR   Coriell; DA03404
DR   Wikidata; Q54822823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03405
AC   CVCL_7M98
DR   CLO; CLO_0033201
DR   Coriell; DA03405
DR   Wikidata; Q54822824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03406
AC   CVCL_7M99
DR   CLO; CLO_0033211
DR   Coriell; DA03406
DR   Wikidata; Q54822825
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03407
AC   CVCL_7N00
DR   CLO; CLO_0033206
DR   Coriell; DA03407
DR   Wikidata; Q54822826
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03408
AC   CVCL_7N01
DR   CLO; CLO_0033215
DR   Coriell; DA03408
DR   Wikidata; Q54822827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03409
AC   CVCL_7N02
DR   CLO; CLO_0033213
DR   Coriell; DA03409
DR   Wikidata; Q54822828
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03410
AC   CVCL_7N03
DR   CLO; CLO_0033236
DR   Coriell; DA03410
DR   Wikidata; Q54822829
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03411
AC   CVCL_7N04
DR   CLO; CLO_0033235
DR   Coriell; DA03411
DR   Wikidata; Q54822830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03412
AC   CVCL_7N05
DR   CLO; CLO_0033234
DR   Coriell; DA03412
DR   Wikidata; Q54822831
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03413
AC   CVCL_7N06
DR   CLO; CLO_0033246
DR   Coriell; DA03413
DR   Wikidata; Q54822832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03414
AC   CVCL_7N07
DR   CLO; CLO_0033243
DR   Coriell; DA03414
DR   Wikidata; Q54822833
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03415
AC   CVCL_7N08
DR   CLO; CLO_0033242
DR   Coriell; DA03415
DR   Wikidata; Q54822834
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03416
AC   CVCL_7N09
DR   CLO; CLO_0033240
DR   Coriell; DA03416
DR   Wikidata; Q54822835
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03417
AC   CVCL_7N10
DR   CLO; CLO_0033256
DR   Coriell; DA03417
DR   Wikidata; Q54822836
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03418
AC   CVCL_7N11
DR   CLO; CLO_0033254
DR   Coriell; DA03418
DR   Wikidata; Q54822837
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03419
AC   CVCL_7N12
DR   CLO; CLO_0033249
DR   Coriell; DA03419
DR   Wikidata; Q54822838
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03420
AC   CVCL_7N13
DR   CLO; CLO_0033271
DR   Coriell; DA03420
DR   Wikidata; Q54822839
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03421
AC   CVCL_7N14
DR   CLO; CLO_0033270
DR   Coriell; DA03421
DR   Wikidata; Q54822840
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03422
AC   CVCL_7N15
DR   CLO; CLO_0033273
DR   Coriell; DA03422
DR   Wikidata; Q54822841
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03423
AC   CVCL_7N16
DR   CLO; CLO_0033272
DR   Coriell; DA03423
DR   Wikidata; Q54822842
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03424
AC   CVCL_7N17
DR   CLO; CLO_0033289
DR   Coriell; DA03424
DR   Wikidata; Q54822843
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03425
AC   CVCL_7N18
DR   CLO; CLO_0033287
DR   Coriell; DA03425
DR   Wikidata; Q54822844
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03426
AC   CVCL_7N19
DR   CLO; CLO_0033297
DR   Coriell; DA03426
DR   Wikidata; Q54822845
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03427
AC   CVCL_7N20
DR   CLO; CLO_0033294
DR   Coriell; DA03427
DR   Wikidata; Q54822846
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03428
AC   CVCL_7N21
DR   CLO; CLO_0033281
DR   Coriell; DA03428
DR   Wikidata; Q54822847
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03429
AC   CVCL_7N22
DR   CLO; CLO_0033276
DR   Coriell; DA03429
DR   Wikidata; Q54822848
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03430
AC   CVCL_7N23
DR   CLO; CLO_0033315
DR   Coriell; DA03430
DR   Wikidata; Q54822849
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03431
AC   CVCL_7N24
DR   CLO; CLO_0033313
DR   Coriell; DA03431
DR   Wikidata; Q54822851
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03436
AC   CVCL_7N25
DR   CLO; CLO_0033311
DR   Coriell; DA03436
DR   Wikidata; Q54822852
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03437
AC   CVCL_7N26
DR   CLO; CLO_0033310
DR   Coriell; DA03437
DR   Wikidata; Q54822853
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03438
AC   CVCL_7N27
DR   CLO; CLO_0033309
DR   Coriell; DA03438
DR   Wikidata; Q54822854
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03439
AC   CVCL_7N28
DR   CLO; CLO_0033338
DR   Coriell; DA03439
DR   Wikidata; Q54822855
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03440
AC   CVCL_7N29
DR   CLO; CLO_0033336
DR   Coriell; DA03440
DR   Wikidata; Q54822856
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03441
AC   CVCL_7N30
DR   CLO; CLO_0033332
DR   Coriell; DA03441
DR   Wikidata; Q54822857
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03442
AC   CVCL_7N31
DR   CLO; CLO_0033329
DR   Coriell; DA03442
DR   Wikidata; Q54822858
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03444
AC   CVCL_7N32
DR   CLO; CLO_0033325
DR   Coriell; DA03444
DR   Wikidata; Q54822860
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03445
AC   CVCL_7N33
DR   CLO; CLO_0033357
DR   Coriell; DA03445
DR   Wikidata; Q54822861
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03447
AC   CVCL_7N34
DR   CLO; CLO_0033359
DR   Coriell; DA03447
DR   Wikidata; Q54822862
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03448
AC   CVCL_7N35
DR   CLO; CLO_0033361
DR   Coriell; DA03448
DR   Wikidata; Q54822863
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03449
AC   CVCL_7N36
DR   CLO; CLO_0033363
DR   Coriell; DA03449
DR   Wikidata; Q54822864
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03450
AC   CVCL_7N37
DR   CLO; CLO_0033365
DR   Coriell; DA03450
DR   Wikidata; Q54822865
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03451
AC   CVCL_7N38
DR   CLO; CLO_0033368
DR   Coriell; DA03451
DR   Wikidata; Q54822866
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03453
AC   CVCL_7N39
DR   CLO; CLO_0033349
DR   Coriell; DA03453
DR   Wikidata; Q54822867
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03454
AC   CVCL_7N40
DR   CLO; CLO_0033350
DR   Coriell; DA03454
DR   Wikidata; Q54822868
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03455
AC   CVCL_7N41
DR   CLO; CLO_0033351
DR   Coriell; DA03455
DR   Wikidata; Q54822869
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03456
AC   CVCL_7N42
DR   CLO; CLO_0033352
DR   Coriell; DA03456
DR   Wikidata; Q54822870
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03457
AC   CVCL_7N43
DR   CLO; CLO_0033388
DR   Coriell; DA03457
DR   Wikidata; Q54822871
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03458
AC   CVCL_7N44
DR   CLO; CLO_0033383
DR   Coriell; DA03458
DR   Wikidata; Q54822872
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03459
AC   CVCL_7N45
DR   CLO; CLO_0033386
DR   Coriell; DA03459
DR   Wikidata; Q54822873
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03460
AC   CVCL_7N46
DR   CLO; CLO_0033396
DR   Coriell; DA03460
DR   Wikidata; Q54822874
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03461
AC   CVCL_7N47
DR   CLO; CLO_0033398
DR   Coriell; DA03461
DR   Wikidata; Q54822875
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03462
AC   CVCL_7N48
DR   CLO; CLO_0033390
DR   Coriell; DA03462
DR   Wikidata; Q54822876
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03463
AC   CVCL_7N49
DR   CLO; CLO_0033392
DR   Coriell; DA03463
DR   Wikidata; Q54822877
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03464
AC   CVCL_7N50
DR   CLO; CLO_0033380
DR   Coriell; DA03464
DR   Wikidata; Q54822878
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03465
AC   CVCL_7N51
DR   CLO; CLO_0033381
DR   Coriell; DA03465
DR   Wikidata; Q54822879
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03466
AC   CVCL_7N52
DR   CLO; CLO_0033379
DR   Coriell; DA03466
DR   Wikidata; Q54822880
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03467
AC   CVCL_7N53
DR   CLO; CLO_0023453
DR   Coriell; DA03467
DR   Wikidata; Q54822881
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03468
AC   CVCL_7N54
DR   CLO; CLO_0023454
DR   Coriell; DA03468
DR   Wikidata; Q54822882
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03469
AC   CVCL_7N55
DR   CLO; CLO_0023451
DR   Coriell; DA03469
DR   Wikidata; Q54822883
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03470
AC   CVCL_7N56
DR   CLO; CLO_0023452
DR   Coriell; DA03470
DR   Wikidata; Q54822884
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03471
AC   CVCL_7N57
DR   CLO; CLO_0023457
DR   Coriell; DA03471
DR   Wikidata; Q54822885
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03472
AC   CVCL_7N58
DR   CLO; CLO_0023458
DR   Coriell; DA03472
DR   Wikidata; Q54822886
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03473
AC   CVCL_7N59
DR   CLO; CLO_0023455
DR   Coriell; DA03473
DR   Wikidata; Q54822887
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03474
AC   CVCL_7N60
DR   CLO; CLO_0023456
DR   Coriell; DA03474
DR   Wikidata; Q54822888
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03475
AC   CVCL_7N61
DR   CLO; CLO_0023449
DR   Coriell; DA03475
DR   Wikidata; Q54822889
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03476
AC   CVCL_7N62
DR   CLO; CLO_0023450
DR   Coriell; DA03476
DR   Wikidata; Q54822890
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03477
AC   CVCL_7N63
DR   CLO; CLO_0023429
DR   Coriell; DA03477
DR   Wikidata; Q54822891
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03478
AC   CVCL_7N64
DR   CLO; CLO_0023435
DR   Coriell; DA03478
DR   Wikidata; Q54822892
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03479
AC   CVCL_7N65
DR   CLO; CLO_0023436
DR   Coriell; DA03479
DR   Wikidata; Q54822893
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03481
AC   CVCL_7N66
DR   CLO; CLO_0023437
DR   Coriell; DA03481
DR   Wikidata; Q54822894
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03483
AC   CVCL_7N67
DR   CLO; CLO_0023438
DR   Coriell; DA03483
DR   Wikidata; Q54822895
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03484
AC   CVCL_7N68
DR   CLO; CLO_0023431
DR   Coriell; DA03484
DR   Wikidata; Q54822896
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03485
AC   CVCL_7N69
DR   CLO; CLO_0023432
DR   Coriell; DA03485
DR   Wikidata; Q54822897
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03486
AC   CVCL_7N70
DR   CLO; CLO_0023433
DR   Coriell; DA03486
DR   Wikidata; Q54822898
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03487
AC   CVCL_7N71
DR   CLO; CLO_0023434
DR   Coriell; DA03487
DR   Wikidata; Q54822899
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03488
AC   CVCL_7N72
DR   CLO; CLO_0023430
DR   Coriell; DA03488
DR   Wikidata; Q54822901
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03489
AC   CVCL_7N73
DR   CLO; CLO_0023440
DR   Coriell; DA03489
DR   Wikidata; Q54822902
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03490
AC   CVCL_7N74
DR   CLO; CLO_0023439
DR   Coriell; DA03490
DR   Wikidata; Q54822903
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03491
AC   CVCL_7N75
DR   CLO; CLO_0023447
DR   Coriell; DA03491
DR   Wikidata; Q54822904
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03492
AC   CVCL_7N76
DR   CLO; CLO_0023448
DR   Coriell; DA03492
DR   Wikidata; Q54822905
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03493
AC   CVCL_7N77
DR   CLO; CLO_0023445
DR   Coriell; DA03493
DR   Wikidata; Q54822906
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03494
AC   CVCL_7N78
DR   CLO; CLO_0023446
DR   Coriell; DA03494
DR   Wikidata; Q54822907
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03495
AC   CVCL_7N79
DR   CLO; CLO_0023443
DR   Coriell; DA03495
DR   Wikidata; Q54822908
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03496
AC   CVCL_7N80
DR   CLO; CLO_0023444
DR   Coriell; DA03496
DR   Wikidata; Q54822909
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03498
AC   CVCL_7N81
DR   CLO; CLO_0023441
DR   Coriell; DA03498
DR   Wikidata; Q54822910
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03499
AC   CVCL_7N82
DR   CLO; CLO_0023442
DR   Coriell; DA03499
DR   Wikidata; Q54822911
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03501
AC   CVCL_7N83
DR   CLO; CLO_0023399
DR   Coriell; DA03501
DR   Wikidata; Q54822912
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03502
AC   CVCL_7N84
DR   CLO; CLO_0023400
DR   Coriell; DA03502
DR   Wikidata; Q54822913
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03503
AC   CVCL_7N85
DR   CLO; CLO_0023401
DR   Coriell; DA03503
DR   Wikidata; Q54822914
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03505
AC   CVCL_7N86
DR   CLO; CLO_0023403
DR   Coriell; DA03505
DR   Wikidata; Q54822915
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03506
AC   CVCL_7N87
DR   CLO; CLO_0023402
DR   Coriell; DA03506
DR   Wikidata; Q54822916
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03507
AC   CVCL_7N88
DR   CLO; CLO_0023405
DR   Coriell; DA03507
DR   Wikidata; Q54822917
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03508
AC   CVCL_7N89
DR   CLO; CLO_0023404
DR   Coriell; DA03508
DR   Wikidata; Q54822918
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03509
AC   CVCL_7N90
DR   CLO; CLO_0023407
DR   Coriell; DA03509
DR   Wikidata; Q54822919
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03510
AC   CVCL_7N91
DR   CLO; CLO_0023406
DR   Coriell; DA03510
DR   Wikidata; Q54822920
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03511
AC   CVCL_7N92
DR   CLO; CLO_0023408
DR   Coriell; DA03511
DR   Wikidata; Q54822921
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03512
AC   CVCL_7N93
DR   CLO; CLO_0023421
DR   Coriell; DA03512
DR   Wikidata; Q54822922
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03513
AC   CVCL_7N94
DR   CLO; CLO_0023422
DR   Coriell; DA03513
DR   Wikidata; Q54822923
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03514
AC   CVCL_7N95
DR   CLO; CLO_0023419
DR   Coriell; DA03514
DR   Wikidata; Q54822924
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03515
AC   CVCL_7N96
DR   CLO; CLO_0023420
DR   Coriell; DA03515
DR   Wikidata; Q54822925
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03516
AC   CVCL_7N97
DR   CLO; CLO_0023426
DR   Coriell; DA03516
DR   Wikidata; Q54822926
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03517
AC   CVCL_7N98
DR   CLO; CLO_0023425
DR   Coriell; DA03517
DR   Wikidata; Q54822927
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03518
AC   CVCL_7N99
DR   CLO; CLO_0023424
DR   Coriell; DA03518
DR   Wikidata; Q54822928
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03519
AC   CVCL_7P00
DR   CLO; CLO_0023423
DR   Coriell; DA03519
DR   Wikidata; Q54822929
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03520
AC   CVCL_7P01
DR   CLO; CLO_0023428
DR   Coriell; DA03520
DR   Wikidata; Q54822930
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03521
AC   CVCL_7P02
DR   CLO; CLO_0023427
DR   Coriell; DA03521
DR   Wikidata; Q54822931
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03522
AC   CVCL_7P03
DR   CLO; CLO_0023377
DR   Coriell; DA03522
DR   Wikidata; Q54822932
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03523
AC   CVCL_7P04
DR   CLO; CLO_0023373
DR   Coriell; DA03523
DR   Wikidata; Q54822933
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03524
AC   CVCL_7P05
DR   CLO; CLO_0023374
DR   Coriell; DA03524
DR   Wikidata; Q54822934
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03525
AC   CVCL_7P06
DR   CLO; CLO_0023375
DR   Coriell; DA03525
DR   Wikidata; Q54822935
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03526
AC   CVCL_7P07
DR   CLO; CLO_0023376
DR   Coriell; DA03526
DR   Wikidata; Q54822936
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03527
AC   CVCL_7P08
DR   CLO; CLO_0023380
DR   Coriell; DA03527
DR   Wikidata; Q54822937
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03528
AC   CVCL_7P09
DR   CLO; CLO_0023379
DR   Coriell; DA03528
DR   Wikidata; Q54822938
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03529
AC   CVCL_7P10
DR   CLO; CLO_0023382
DR   Coriell; DA03529
DR   Wikidata; Q54822939
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03530
AC   CVCL_7P11
DR   CLO; CLO_0023381
DR   Coriell; DA03530
DR   Wikidata; Q54822940
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03531
AC   CVCL_7P12
DR   CLO; CLO_0023378
DR   Coriell; DA03531
DR   Wikidata; Q54822942
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03531; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03532
AC   CVCL_7P13
DR   CLO; CLO_0023387
DR   Coriell; DA03532
DR   Wikidata; Q54822943
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03532; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03533
AC   CVCL_7P14
DR   CLO; CLO_0023388
DR   Coriell; DA03533
DR   Wikidata; Q54822944
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03534
AC   CVCL_7P15
DR   CLO; CLO_0023385
DR   Coriell; DA03534
DR   Wikidata; Q54822945
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03535
AC   CVCL_7P16
DR   CLO; CLO_0023386
DR   Coriell; DA03535
DR   Wikidata; Q54822946
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03536
AC   CVCL_7P17
DR   CLO; CLO_0023383
DR   Coriell; DA03536
DR   Wikidata; Q54822947
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03537
AC   CVCL_7P18
DR   CLO; CLO_0023384
DR   Coriell; DA03537
DR   Wikidata; Q54822948
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03538
AC   CVCL_7P19
DR   CLO; CLO_0023392
DR   Coriell; DA03538
DR   Wikidata; Q54822949
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03539
AC   CVCL_7P20
DR   CLO; CLO_0023391
DR   Coriell; DA03539
DR   Wikidata; Q54822950
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03540
AC   CVCL_7P21
DR   CLO; CLO_0023390
DR   Coriell; DA03540
DR   Wikidata; Q54822951
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03541
AC   CVCL_7P22
DR   CLO; CLO_0023389
DR   Coriell; DA03541
DR   Wikidata; Q54822952
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03542
AC   CVCL_7P23
DR   CLO; CLO_0023338
DR   Coriell; DA03542
DR   Wikidata; Q54822953
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03543
AC   CVCL_7P24
DR   CLO; CLO_0023336
DR   Coriell; DA03543
DR   Wikidata; Q54822954
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03544
AC   CVCL_7P25
DR   CLO; CLO_0023335
DR   Coriell; DA03544
DR   Wikidata; Q54822955
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03545
AC   CVCL_7P26
DR   CLO; CLO_0023343
DR   Coriell; DA03545
DR   Wikidata; Q54822956
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03546
AC   CVCL_7P27
DR   CLO; CLO_0023342
DR   Coriell; DA03546
DR   Wikidata; Q54822957
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03547
AC   CVCL_7P28
DR   CLO; CLO_0023341
DR   Coriell; DA03547
DR   Wikidata; Q54822958
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03548
AC   CVCL_7P29
DR   CLO; CLO_0023340
DR   Coriell; DA03548
DR   Wikidata; Q54822959
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03549
AC   CVCL_7P30
DR   CLO; CLO_0023333
DR   Coriell; DA03549
DR   Wikidata; Q54822960
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03550
AC   CVCL_7P31
DR   CLO; CLO_0023334
DR   Coriell; DA03550
DR   Wikidata; Q54822961
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03553
AC   CVCL_7P32
DR   CLO; CLO_0023332
DR   Coriell; DA03553
DR   Wikidata; Q54822962
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03554
AC   CVCL_7P33
DR   CLO; CLO_0023358
DR   Coriell; DA03554
DR   Wikidata; Q54822963
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03555
AC   CVCL_7P34
DR   CLO; CLO_0023356
DR   Coriell; DA03555
DR   Wikidata; Q54822964
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03556
AC   CVCL_7P35
DR   CLO; CLO_0023360
DR   Coriell; DA03556
DR   Wikidata; Q54822965
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03557
AC   CVCL_7P36
DR   CLO; CLO_0023359
DR   Coriell; DA03557
DR   Wikidata; Q54822966
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03558
AC   CVCL_7P37
DR   CLO; CLO_0023362
DR   Coriell; DA03558
DR   Wikidata; Q54822967
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03559
AC   CVCL_7P38
DR   CLO; CLO_0023361
DR   Coriell; DA03559
DR   Wikidata; Q54822968
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03560
AC   CVCL_7P39
DR   CLO; CLO_0023364
DR   Coriell; DA03560
DR   Wikidata; Q54822969
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03561
AC   CVCL_7P40
DR   CLO; CLO_0023363
DR   Coriell; DA03561
DR   Wikidata; Q54822970
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03561; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03562
AC   CVCL_7P41
DR   CLO; CLO_0023354
DR   Coriell; DA03562
DR   Wikidata; Q54822971
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03563
AC   CVCL_7P42
DR   CLO; CLO_0023355
DR   Coriell; DA03563
DR   Wikidata; Q54822972
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03565
AC   CVCL_7P43
DR   CLO; CLO_0023311
DR   Coriell; DA03565
DR   Wikidata; Q54822973
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03566
AC   CVCL_7P44
DR   CLO; CLO_0023310
DR   Coriell; DA03566
DR   Wikidata; Q54822974
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03567
AC   CVCL_7P45
DR   CLO; CLO_0023309
DR   Coriell; DA03567
DR   Wikidata; Q54822975
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03568
AC   CVCL_7P46
DR   CLO; CLO_0023308
DR   Coriell; DA03568
DR   Wikidata; Q54822976
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03569
AC   CVCL_7P47
DR   CLO; CLO_0023307
DR   Coriell; DA03569
DR   Wikidata; Q54822977
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03570
AC   CVCL_7P48
DR   CLO; CLO_0023306
DR   Coriell; DA03570
DR   Wikidata; Q54822978
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03571
AC   CVCL_7P49
DR   CLO; CLO_0023305
DR   Coriell; DA03571
DR   Wikidata; Q54822979
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03572
AC   CVCL_7P50
DR   CLO; CLO_0023304
DR   Coriell; DA03572
DR   Wikidata; Q54822980
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03573
AC   CVCL_7P51
DR   CLO; CLO_0023303
DR   Coriell; DA03573
DR   Wikidata; Q54822981
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03574
AC   CVCL_7P52
DR   CLO; CLO_0023302
DR   Coriell; DA03574
DR   Wikidata; Q54822984
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03577
AC   CVCL_7P53
DR   CLO; CLO_0023459
DR   Coriell; DA03577
DR   Wikidata; Q54822985
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03577; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03578
AC   CVCL_7P54
DR   CLO; CLO_0023463
DR   Coriell; DA03578
DR   Wikidata; Q54822986
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03579
AC   CVCL_7P55
DR   CLO; CLO_0023461
DR   Coriell; DA03579
DR   Wikidata; Q54822987
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03580
AC   CVCL_7P56
DR   CLO; CLO_0023467
DR   Coriell; DA03580
DR   Wikidata; Q54822988
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03581
AC   CVCL_7P57
DR   CLO; CLO_0023465
DR   Coriell; DA03581
DR   Wikidata; Q54822989
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03582
AC   CVCL_7P58
DR   CLO; CLO_0023470
DR   Coriell; DA03582
DR   Wikidata; Q54822990
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03583
AC   CVCL_7P59
DR   CLO; CLO_0023468
DR   Coriell; DA03583
DR   Wikidata; Q54822991
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03584
AC   CVCL_7P60
DR   CLO; CLO_0023473
DR   Coriell; DA03584
DR   Wikidata; Q54822992
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03585
AC   CVCL_7P61
DR   CLO; CLO_0023472
DR   Coriell; DA03585
DR   Wikidata; Q54822993
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03586
AC   CVCL_7P62
DR   CLO; CLO_0023474
DR   Coriell; DA03586
DR   Wikidata; Q54822994
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03587
AC   CVCL_7P63
DR   CLO; CLO_0023809
DR   Coriell; DA03587
DR   Wikidata; Q54822995
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03588
AC   CVCL_7P64
DR   CLO; CLO_0023810
DR   Coriell; DA03588
DR   Wikidata; Q54822996
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03589
AC   CVCL_7P65
DR   CLO; CLO_0023811
DR   Coriell; DA03589
DR   Wikidata; Q54822997
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03590
AC   CVCL_7P66
DR   CLO; CLO_0023812
DR   Coriell; DA03590
DR   Wikidata; Q54822998
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03591
AC   CVCL_7P67
DR   CLO; CLO_0023813
DR   Coriell; DA03591
DR   Wikidata; Q54822999
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03592
AC   CVCL_7P68
DR   CLO; CLO_0023814
DR   Coriell; DA03592
DR   Wikidata; Q54823000
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03594
AC   CVCL_7P69
DR   CLO; CLO_0023815
DR   Coriell; DA03594
DR   Wikidata; Q54823001
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03595
AC   CVCL_7P70
DR   CLO; CLO_0023816
DR   Coriell; DA03595
DR   Wikidata; Q54823002
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03596
AC   CVCL_7P71
DR   CLO; CLO_0023817
DR   Coriell; DA03596
DR   Wikidata; Q54823003
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03597
AC   CVCL_7P72
DR   CLO; CLO_0023818
DR   Coriell; DA03597
DR   Wikidata; Q54823004
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03598
AC   CVCL_7P73
DR   CLO; CLO_0023828
DR   Coriell; DA03598
DR   Wikidata; Q54823005
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03599
AC   CVCL_7P74
DR   CLO; CLO_0023821
DR   Coriell; DA03599
DR   Wikidata; Q54823006
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03600
AC   CVCL_7P75
DR   CLO; CLO_0023822
DR   Coriell; DA03600
DR   Wikidata; Q54823007
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03601
AC   CVCL_7P76
DR   CLO; CLO_0023819
DR   Coriell; DA03601
DR   Wikidata; Q54823008
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03602
AC   CVCL_7P77
DR   CLO; CLO_0023820
DR   Coriell; DA03602
DR   Wikidata; Q54823009
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03603
AC   CVCL_7P78
DR   CLO; CLO_0023825
DR   Coriell; DA03603
DR   Wikidata; Q54823010
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03604
AC   CVCL_7P79
DR   CLO; CLO_0023826
DR   Coriell; DA03604
DR   Wikidata; Q54823011
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03605
AC   CVCL_7P80
DR   CLO; CLO_0023823
DR   Coriell; DA03605
DR   Wikidata; Q54823012
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03606
AC   CVCL_7P81
DR   CLO; CLO_0023824
DR   Coriell; DA03606
DR   Wikidata; Q54823013
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03608
AC   CVCL_7P82
DR   CLO; CLO_0023827
DR   Coriell; DA03608
DR   Wikidata; Q54823014
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03609
AC   CVCL_7P83
DR   CLO; CLO_0023838
DR   Coriell; DA03609
DR   Wikidata; Q54823015
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03610
AC   CVCL_7P84
DR   CLO; CLO_0023837
DR   Coriell; DA03610
DR   Wikidata; Q54823017
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03611
AC   CVCL_7P85
DR   CLO; CLO_0023833
DR   Coriell; DA03611
DR   Wikidata; Q54823018
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03612
AC   CVCL_7P86
DR   CLO; CLO_0023834
DR   Coriell; DA03612
DR   Wikidata; Q54823019
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03613
AC   CVCL_7P87
DR   CLO; CLO_0023835
DR   Coriell; DA03613
DR   Wikidata; Q54823020
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03614
AC   CVCL_7P88
DR   CLO; CLO_0023836
DR   Coriell; DA03614
DR   Wikidata; Q54823021
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03615
AC   CVCL_7P89
DR   CLO; CLO_0023829
DR   Coriell; DA03615
DR   Wikidata; Q54823022
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03616
AC   CVCL_7P90
DR   CLO; CLO_0023830
DR   Coriell; DA03616
DR   Wikidata; Q54823023
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03617
AC   CVCL_7P91
DR   CLO; CLO_0023831
DR   Coriell; DA03617
DR   Wikidata; Q54823024
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03618
AC   CVCL_7P92
DR   CLO; CLO_0023832
DR   Coriell; DA03618
DR   Wikidata; Q54823026
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03619
AC   CVCL_7P93
DR   CLO; CLO_0023848
DR   Coriell; DA03619
DR   Wikidata; Q54823027
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03620
AC   CVCL_7P94
DR   CLO; CLO_0023847
DR   Coriell; DA03620
DR   Wikidata; Q54823028
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03621
AC   CVCL_7P95
DR   CLO; CLO_0023846
DR   Coriell; DA03621
DR   Wikidata; Q54823029
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03622
AC   CVCL_7P96
DR   CLO; CLO_0023844
DR   Coriell; DA03622
DR   Wikidata; Q54823030
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03623
AC   CVCL_7P97
DR   CLO; CLO_0023845
DR   Coriell; DA03623
DR   Wikidata; Q54823031
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03624
AC   CVCL_7P98
DR   CLO; CLO_0023842
DR   Coriell; DA03624
DR   Wikidata; Q54823032
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03625
AC   CVCL_7P99
DR   CLO; CLO_0023843
DR   Coriell; DA03625
DR   Wikidata; Q54823033
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03626
AC   CVCL_7Q00
DR   CLO; CLO_0023840
DR   Coriell; DA03626
DR   Wikidata; Q54823034
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03627
AC   CVCL_7Q01
DR   CLO; CLO_0023841
DR   Coriell; DA03627
DR   Wikidata; Q54823035
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03628
AC   CVCL_7Q02
DR   CLO; CLO_0023839
DR   Coriell; DA03628
DR   Wikidata; Q54823036
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03629
AC   CVCL_7Q03
DR   CLO; CLO_0023855
DR   Coriell; DA03629
DR   Wikidata; Q54823037
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03630
AC   CVCL_7Q04
DR   CLO; CLO_0023856
DR   Coriell; DA03630
DR   Wikidata; Q54823038
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03631
AC   CVCL_7Q05
DR   CLO; CLO_0023857
DR   Coriell; DA03631
DR   Wikidata; Q54823039
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03632
AC   CVCL_7Q06
DR   CLO; CLO_0023858
DR   Coriell; DA03632
DR   Wikidata; Q54823040
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03633
AC   CVCL_7Q07
DR   CLO; CLO_0023850
DR   Coriell; DA03633
DR   Wikidata; Q54823041
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03634
AC   CVCL_7Q08
DR   CLO; CLO_0023849
DR   Coriell; DA03634
DR   Wikidata; Q54823042
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03635
AC   CVCL_7Q09
DR   CLO; CLO_0023852
DR   Coriell; DA03635
DR   Wikidata; Q54823043
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03636
AC   CVCL_7Q10
DR   CLO; CLO_0023851
DR   Coriell; DA03636
DR   Wikidata; Q54823044
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03637
AC   CVCL_7Q11
DR   CLO; CLO_0023854
DR   Coriell; DA03637
DR   Wikidata; Q54823045
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03638
AC   CVCL_7Q12
DR   CLO; CLO_0023853
DR   Coriell; DA03638
DR   Wikidata; Q54823046
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03639
AC   CVCL_7Q13
DR   CLO; CLO_0023864
DR   Coriell; DA03639
DR   Wikidata; Q54823047
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03640
AC   CVCL_7Q14
DR   CLO; CLO_0023867
DR   Coriell; DA03640
DR   Wikidata; Q54823048
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03641
AC   CVCL_7Q15
DR   CLO; CLO_0023868
DR   Coriell; DA03641
DR   Wikidata; Q54823049
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03642
AC   CVCL_7Q16
DR   CLO; CLO_0023865
DR   Coriell; DA03642
DR   Wikidata; Q54823050
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03643
AC   CVCL_7Q17
DR   CLO; CLO_0023866
DR   Coriell; DA03643
DR   Wikidata; Q54823051
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03644
AC   CVCL_7Q18
DR   CLO; CLO_0023862
DR   Coriell; DA03644
DR   Wikidata; Q54823052
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03645
AC   CVCL_7Q19
DR   CLO; CLO_0023861
DR   Coriell; DA03645
DR   Wikidata; Q54823053
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03646
AC   CVCL_7Q20
DR   CLO; CLO_0023860
DR   Coriell; DA03646
DR   Wikidata; Q54823054
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03647
AC   CVCL_7Q21
DR   CLO; CLO_0023859
DR   Coriell; DA03647
DR   Wikidata; Q54823055
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03648
AC   CVCL_7Q22
DR   CLO; CLO_0023863
DR   Coriell; DA03648
DR   Wikidata; Q54823056
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03649
AC   CVCL_7Q23
DR   CLO; CLO_0023877
DR   Coriell; DA03649
DR   Wikidata; Q54823057
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03650
AC   CVCL_7Q24
DR   CLO; CLO_0023878
DR   Coriell; DA03650
DR   Wikidata; Q54823058
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03651
AC   CVCL_7Q25
DR   CLO; CLO_0023873
DR   Coriell; DA03651
DR   Wikidata; Q54823059
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03652
AC   CVCL_7Q26
DR   CLO; CLO_0023874
DR   Coriell; DA03652
DR   Wikidata; Q54823060
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03653
AC   CVCL_7Q27
DR   CLO; CLO_0023875
DR   Coriell; DA03653
DR   Wikidata; Q54823061
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03655
AC   CVCL_7Q28
DR   CLO; CLO_0023876
DR   Coriell; DA03655
DR   Wikidata; Q54823062
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03656
AC   CVCL_7Q29
DR   CLO; CLO_0023870
DR   Coriell; DA03656
DR   Wikidata; Q54823063
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03657
AC   CVCL_7Q30
DR   CLO; CLO_0023869
DR   Coriell; DA03657
DR   Wikidata; Q54823064
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03658
AC   CVCL_7Q31
DR   CLO; CLO_0023872
DR   Coriell; DA03658
DR   Wikidata; Q54823065
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03659
AC   CVCL_7Q32
DR   CLO; CLO_0023871
DR   Coriell; DA03659
DR   Wikidata; Q54823067
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03660
AC   CVCL_7Q33
DR   CLO; CLO_0023898
DR   Coriell; DA03660
DR   Wikidata; Q54823068
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03661
AC   CVCL_7Q34
DR   CLO; CLO_0023896
DR   Coriell; DA03661
DR   Wikidata; Q54823069
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03662
AC   CVCL_7Q35
DR   CLO; CLO_0023897
DR   Coriell; DA03662
DR   Wikidata; Q54823070
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03663
AC   CVCL_7Q36
DR   CLO; CLO_0023894
DR   Coriell; DA03663
DR   Wikidata; Q54823071
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03664
AC   CVCL_7Q37
DR   CLO; CLO_0023895
DR   Coriell; DA03664
DR   Wikidata; Q54823072
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03665
AC   CVCL_7Q38
DR   CLO; CLO_0023892
DR   Coriell; DA03665
DR   Wikidata; Q54823073
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03666
AC   CVCL_7Q39
DR   CLO; CLO_0023893
DR   Coriell; DA03666
DR   Wikidata; Q54823074
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03667
AC   CVCL_7Q40
DR   CLO; CLO_0023891
DR   Coriell; DA03667
DR   Wikidata; Q54823075
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03668
AC   CVCL_7Q41
DR   CLO; CLO_0023889
DR   Coriell; DA03668
DR   Wikidata; Q54823076
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03669
AC   CVCL_7Q42
DR   CLO; CLO_0023886
DR   Coriell; DA03669
DR   Wikidata; Q54823077
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03670
AC   CVCL_7Q43
DR   CLO; CLO_0023684
DR   Coriell; DA03670
DR   Wikidata; Q54823078
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03671
AC   CVCL_7Q44
DR   CLO; CLO_0023682
DR   Coriell; DA03671
DR   Wikidata; Q54823079
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03674
AC   CVCL_7Q45
DR   CLO; CLO_0023681
DR   Coriell; DA03674
DR   Wikidata; Q54823080
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03675
AC   CVCL_7Q46
DR   CLO; CLO_0023680
DR   Coriell; DA03675
DR   Wikidata; Q54823081
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03676
AC   CVCL_7Q47
DR   CLO; CLO_0023688
DR   Coriell; DA03676
DR   Wikidata; Q54823082
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03677
AC   CVCL_7Q48
DR   CLO; CLO_0023687
DR   Coriell; DA03677
DR   Wikidata; Q54823083
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03678
AC   CVCL_7Q49
DR   CLO; CLO_0023686
DR   Coriell; DA03678
DR   Wikidata; Q54823084
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03679
AC   CVCL_7Q50
DR   CLO; CLO_0023685
DR   Coriell; DA03679
DR   Wikidata; Q54823085
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03680
AC   CVCL_7Q51
DR   CLO; CLO_0023689
DR   Coriell; DA03680
DR   Wikidata; Q54823086
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03681
AC   CVCL_7Q52
DR   CLO; CLO_0023690
DR   Coriell; DA03681
DR   Wikidata; Q54823087
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03682
AC   CVCL_7Q53
DR   CLO; CLO_0023953
DR   Coriell; DA03682
DR   Wikidata; Q54823088
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03683
AC   CVCL_7Q54
DR   CLO; CLO_0023952
DR   Coriell; DA03683
DR   Wikidata; Q54823089
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03684
AC   CVCL_7Q55
DR   CLO; CLO_0023945
DR   Coriell; DA03684
DR   Wikidata; Q54823090
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03685
AC   CVCL_7Q56
DR   CLO; CLO_0023943
DR   Coriell; DA03685
DR   Wikidata; Q54823091
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03686
AC   CVCL_7Q57
DR   CLO; CLO_0023949
DR   Coriell; DA03686
DR   Wikidata; Q54823092
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03687
AC   CVCL_7Q58
DR   CLO; CLO_0023946
DR   Coriell; DA03687
DR   Wikidata; Q54823093
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03688
AC   CVCL_7Q59
DR   CLO; CLO_0023939
DR   Coriell; DA03688
DR   Wikidata; Q54823094
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03689
AC   CVCL_7Q60
DR   CLO; CLO_0023938
DR   Coriell; DA03689
DR   Wikidata; Q54823095
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03690
AC   CVCL_7Q61
DR   CLO; CLO_0023941
DR   Coriell; DA03690
DR   Wikidata; Q54823096
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03691
AC   CVCL_7Q62
DR   CLO; CLO_0023940
DR   Coriell; DA03691
DR   Wikidata; Q54823097
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03692
AC   CVCL_7Q63
DR   CLO; CLO_0024007
DR   Coriell; DA03692
DR   Wikidata; Q54823098
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03693
AC   CVCL_7Q64
DR   CLO; CLO_0024006
DR   Coriell; DA03693
DR   Wikidata; Q54823099
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03694
AC   CVCL_7Q65
DR   CLO; CLO_0024003
DR   Coriell; DA03694
DR   Wikidata; Q54823100
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03695
AC   CVCL_7Q66
DR   CLO; CLO_0024014
DR   Coriell; DA03695
DR   Wikidata; Q54823101
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03696
AC   CVCL_7Q67
DR   CLO; CLO_0024013
DR   Coriell; DA03696
DR   Wikidata; Q54823102
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03697
AC   CVCL_7Q68
DR   CLO; CLO_0024011
DR   Coriell; DA03697
DR   Wikidata; Q54823103
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03698
AC   CVCL_7Q69
DR   CLO; CLO_0024009
DR   Coriell; DA03698
DR   Wikidata; Q54823104
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03699
AC   CVCL_7Q70
DR   CLO; CLO_0024002
DR   Coriell; DA03699
DR   Wikidata; Q54823105
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03700
AC   CVCL_7Q71
DR   CLO; CLO_0024001
DR   Coriell; DA03700
DR   Wikidata; Q54823106
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03701
AC   CVCL_7Q72
DR   CLO; CLO_0024000
DR   Coriell; DA03701
DR   Wikidata; Q54823108
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03702
AC   CVCL_7Q73
DR   CLO; CLO_0023984
DR   Coriell; DA03702
DR   Wikidata; Q54823109
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03703
AC   CVCL_7Q74
DR   CLO; CLO_0023983
DR   Coriell; DA03703
DR   Wikidata; Q54823110
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03704
AC   CVCL_7Q75
DR   CLO; CLO_0023987
DR   Coriell; DA03704
DR   Wikidata; Q54823111
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03705
AC   CVCL_7Q76
DR   CLO; CLO_0023985
DR   Coriell; DA03705
DR   Wikidata; Q54823112
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03706
AC   CVCL_7Q77
DR   CLO; CLO_0023991
DR   Coriell; DA03706
DR   Wikidata; Q54823113
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03707
AC   CVCL_7Q78
DR   CLO; CLO_0023988
DR   Coriell; DA03707
DR   Wikidata; Q54823114
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03708
AC   CVCL_7Q79
DR   CLO; CLO_0023994
DR   Coriell; DA03708
DR   Wikidata; Q54823115
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03709
AC   CVCL_7Q80
DR   CLO; CLO_0023993
DR   Coriell; DA03709
DR   Wikidata; Q54823116
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03710
AC   CVCL_7Q81
DR   CLO; CLO_0023982
DR   Coriell; DA03710
DR   Wikidata; Q54823117
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03711
AC   CVCL_7Q82
DR   CLO; CLO_0023981
DR   Coriell; DA03711
DR   Wikidata; Q54823118
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03712
AC   CVCL_7Q83
DR   CLO; CLO_0024328
DR   Coriell; DA03712
DR   Wikidata; Q54823119
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03713
AC   CVCL_7Q84
DR   CLO; CLO_0024320
DR   Coriell; DA03713
DR   Wikidata; Q54823120
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03714
AC   CVCL_7Q85
DR   CLO; CLO_0024321
DR   Coriell; DA03714
DR   Wikidata; Q54823121
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03715
AC   CVCL_7Q86
DR   CLO; CLO_0024322
DR   Coriell; DA03715
DR   Wikidata; Q54823122
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03716
AC   CVCL_7Q87
DR   CLO; CLO_0024323
DR   Coriell; DA03716
DR   Wikidata; Q54823123
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03717
AC   CVCL_7Q88
DR   CLO; CLO_0024324
DR   Coriell; DA03717
DR   Wikidata; Q54823124
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03718
AC   CVCL_7Q89
DR   CLO; CLO_0024325
DR   Coriell; DA03718
DR   Wikidata; Q54823125
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03719
AC   CVCL_7Q90
DR   CLO; CLO_0024326
DR   Coriell; DA03719
DR   Wikidata; Q54823126
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03720
AC   CVCL_7Q91
DR   CLO; CLO_0024327
DR   Coriell; DA03720
DR   Wikidata; Q54823127
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03721
AC   CVCL_7Q92
DR   CLO; CLO_0024319
DR   Coriell; DA03721
DR   Wikidata; Q54823128
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03722
AC   CVCL_7Q93
DR   CLO; CLO_0024338
DR   Coriell; DA03722
DR   Wikidata; Q54823129
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03723
AC   CVCL_7Q94
DR   CLO; CLO_0024337
DR   Coriell; DA03723
DR   Wikidata; Q54823130
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03725
AC   CVCL_7Q95
DR   CLO; CLO_0024331
DR   Coriell; DA03725
DR   Wikidata; Q54823131
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03726
AC   CVCL_7Q96
DR   CLO; CLO_0024332
DR   Coriell; DA03726
DR   Wikidata; Q54823132
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03727
AC   CVCL_7Q97
DR   CLO; CLO_0024329
DR   Coriell; DA03727
DR   Wikidata; Q54823133
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03728
AC   CVCL_7Q98
DR   CLO; CLO_0024330
DR   Coriell; DA03728
DR   Wikidata; Q54823134
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03729
AC   CVCL_7Q99
DR   CLO; CLO_0024335
DR   Coriell; DA03729
DR   Wikidata; Q54823135
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03730
AC   CVCL_7R00
DR   CLO; CLO_0024336
DR   Coriell; DA03730
DR   Wikidata; Q54823136
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03731
AC   CVCL_7R01
DR   CLO; CLO_0024333
DR   Coriell; DA03731
DR   Wikidata; Q54823138
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03732
AC   CVCL_7R02
DR   CLO; CLO_0024334
DR   Coriell; DA03732
DR   Wikidata; Q54823139
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03733
AC   CVCL_7R03
DR   CLO; CLO_0024306
DR   Coriell; DA03733
DR   Wikidata; Q54823140
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03734
AC   CVCL_7R04
DR   CLO; CLO_0024308
DR   Coriell; DA03734
DR   Wikidata; Q54823141
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03735
AC   CVCL_7R05
DR   CLO; CLO_0024307
DR   Coriell; DA03735
DR   Wikidata; Q54823142
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03736
AC   CVCL_7R06
DR   CLO; CLO_0024302
DR   Coriell; DA03736
DR   Wikidata; Q54823143
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03737
AC   CVCL_7R07
DR   CLO; CLO_0024303
DR   Coriell; DA03737
DR   Wikidata; Q54823144
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03738
AC   CVCL_7R08
DR   CLO; CLO_0024304
DR   Coriell; DA03738
DR   Wikidata; Q54823145
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03740
AC   CVCL_7R09
DR   CLO; CLO_0024305
DR   Coriell; DA03740
DR   Wikidata; Q54823146
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03741
AC   CVCL_7R10
DR   CLO; CLO_0024299
DR   Coriell; DA03741
DR   Wikidata; Q54823147
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03742
AC   CVCL_7R11
DR   CLO; CLO_0024300
DR   Coriell; DA03742
DR   Wikidata; Q54823148
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03743
AC   CVCL_7R12
DR   CLO; CLO_0024301
DR   Coriell; DA03743
DR   Wikidata; Q54823150
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03744
AC   CVCL_7R13
DR   CLO; CLO_0024318
DR   Coriell; DA03744
DR   Wikidata; Q54823151
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03745
AC   CVCL_7R14
DR   CLO; CLO_0024317
DR   Coriell; DA03745
DR   Wikidata; Q54823152
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03746
AC   CVCL_7R15
DR   CLO; CLO_0024316
DR   Coriell; DA03746
DR   Wikidata; Q54823153
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03747
AC   CVCL_7R16
DR   CLO; CLO_0024315
DR   Coriell; DA03747
DR   Wikidata; Q54823154
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03748
AC   CVCL_7R17
DR   CLO; CLO_0024313
DR   Coriell; DA03748
DR   Wikidata; Q54823155
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03749
AC   CVCL_7R18
DR   CLO; CLO_0024314
DR   Coriell; DA03749
DR   Wikidata; Q54823156
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03750
AC   CVCL_7R19
DR   CLO; CLO_0024311
DR   Coriell; DA03750
DR   Wikidata; Q54823157
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03751
AC   CVCL_7R20
DR   CLO; CLO_0024312
DR   Coriell; DA03751
DR   Wikidata; Q54823158
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03752
AC   CVCL_7R21
DR   CLO; CLO_0024309
DR   Coriell; DA03752
DR   Wikidata; Q54823159
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03753
AC   CVCL_7R22
DR   CLO; CLO_0024310
DR   Coriell; DA03753
DR   Wikidata; Q54823160
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03754
AC   CVCL_7R23
DR   CLO; CLO_0024374
DR   Coriell; DA03754
DR   Wikidata; Q54823161
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03755
AC   CVCL_7R24
DR   CLO; CLO_0024375
DR   Coriell; DA03755
DR   Wikidata; Q54823162
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03756
AC   CVCL_7R25
DR   CLO; CLO_0024376
DR   Coriell; DA03756
DR   Wikidata; Q54823163
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03757
AC   CVCL_7R26
DR   CLO; CLO_0024377
DR   Coriell; DA03757
DR   Wikidata; Q54823164
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03758
AC   CVCL_7R27
DR   CLO; CLO_0024378
DR   Coriell; DA03758
DR   Wikidata; Q54823165
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03759
AC   CVCL_7R28
DR   CLO; CLO_0024370
DR   Coriell; DA03759
DR   Wikidata; Q54823166
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03760
AC   CVCL_7R29
DR   CLO; CLO_0024369
DR   Coriell; DA03760
DR   Wikidata; Q54823167
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03761
AC   CVCL_7R30
DR   CLO; CLO_0024372
DR   Coriell; DA03761
DR   Wikidata; Q54823168
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03762
AC   CVCL_7R31
DR   CLO; CLO_0024371
DR   Coriell; DA03762
DR   Wikidata; Q54823169
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03763
AC   CVCL_7R32
DR   CLO; CLO_0024373
DR   Coriell; DA03763
DR   Wikidata; Q54823170
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03764
AC   CVCL_7R33
DR   CLO; CLO_0024393
DR   Coriell; DA03764
DR   Wikidata; Q54823171
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03765
AC   CVCL_7R34
DR   CLO; CLO_0024394
DR   Coriell; DA03765
DR   Wikidata; Q54823172
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03766
AC   CVCL_7R35
DR   CLO; CLO_0024397
DR   Coriell; DA03766
DR   Wikidata; Q54823173
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03767
AC   CVCL_7R36
DR   CLO; CLO_0024398
DR   Coriell; DA03767
DR   Wikidata; Q54823174
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03768
AC   CVCL_7R37
DR   CLO; CLO_0024395
DR   Coriell; DA03768
DR   Wikidata; Q54823175
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03769
AC   CVCL_7R38
DR   CLO; CLO_0024396
DR   Coriell; DA03769
DR   Wikidata; Q54823176
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03770
AC   CVCL_7R39
DR   CLO; CLO_0024385
DR   Coriell; DA03770
DR   Wikidata; Q54823177
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03771
AC   CVCL_7R40
DR   CLO; CLO_0024383
DR   Coriell; DA03771
DR   Wikidata; Q54823178
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03772
AC   CVCL_7R41
DR   CLO; CLO_0024381
DR   Coriell; DA03772
DR   Wikidata; Q54823179
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03773
AC   CVCL_7R42
DR   CLO; CLO_0024380
DR   Coriell; DA03773
DR   Wikidata; Q54823180
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03774
AC   CVCL_7R43
DR   CLO; CLO_0024356
DR   Coriell; DA03774
DR   Wikidata; Q54823181
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03775
AC   CVCL_7R44
DR   CLO; CLO_0024357
DR   Coriell; DA03775
DR   Wikidata; Q54823182
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03777
AC   CVCL_7R45
DR   CLO; CLO_0024358
DR   Coriell; DA03777
DR   Wikidata; Q54823183
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03778
AC   CVCL_7R46
DR   CLO; CLO_0024352
DR   Coriell; DA03778
DR   Wikidata; Q54823184
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03779
AC   CVCL_7R47
DR   CLO; CLO_0024353
DR   Coriell; DA03779
DR   Wikidata; Q54823185
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03780
AC   CVCL_7R48
DR   CLO; CLO_0024354
DR   Coriell; DA03780
DR   Wikidata; Q54823186
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03781
AC   CVCL_7R49
DR   CLO; CLO_0024355
DR   Coriell; DA03781
DR   Wikidata; Q54823187
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03782
AC   CVCL_7R50
DR   CLO; CLO_0024343
DR   Coriell; DA03782
DR   Wikidata; Q54823188
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03783
AC   CVCL_7R51
DR   CLO; CLO_0024341
DR   Coriell; DA03783
DR   Wikidata; Q54823189
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03785
AC   CVCL_7R52
DR   CLO; CLO_0024347
DR   Coriell; DA03785
DR   Wikidata; Q54823192
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03786
AC   CVCL_7R53
DR   CLO; CLO_0024409
DR   Coriell; DA03786
DR   Wikidata; Q54823193
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03787
AC   CVCL_7R54
DR   CLO; CLO_0024412
DR   Coriell; DA03787
DR   Wikidata; Q54823194
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03788
AC   CVCL_7R55
DR   CLO; CLO_0024413
DR   Coriell; DA03788
DR   Wikidata; Q54823195
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03789
AC   CVCL_7R56
DR   CLO; CLO_0024415
DR   Coriell; DA03789
DR   Wikidata; Q54823196
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03790
AC   CVCL_7R57
DR   CLO; CLO_0024417
DR   Coriell; DA03790
DR   Wikidata; Q54823197
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03791
AC   CVCL_7R58
DR   CLO; CLO_0024401
DR   Coriell; DA03791
DR   Wikidata; Q54823198
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03792
AC   CVCL_7R59
DR   CLO; CLO_0024402
DR   Coriell; DA03792
DR   Wikidata; Q54823199
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03793
AC   CVCL_7R60
DR   CLO; CLO_0024403
DR   Coriell; DA03793
DR   Wikidata; Q54823200
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03794
AC   CVCL_7R61
DR   CLO; CLO_0024404
DR   Coriell; DA03794
DR   Wikidata; Q54823202
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03795
AC   CVCL_7R62
DR   CLO; CLO_0024405
DR   Coriell; DA03795
DR   Wikidata; Q54823203
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03796
AC   CVCL_7R63
DR   CLO; CLO_0024522
DR   Coriell; DA03796
DR   Wikidata; Q54823204
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03797
AC   CVCL_7R64
DR   CLO; CLO_0024520
DR   Coriell; DA03797
DR   Wikidata; Q54823205
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03799
AC   CVCL_7R65
DR   CLO; CLO_0024518
DR   Coriell; DA03799
DR   Wikidata; Q54823206
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03800
AC   CVCL_7R66
DR   CLO; CLO_0024516
DR   Coriell; DA03800
DR   Wikidata; Q54823207
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03801
AC   CVCL_7R67
DR   CLO; CLO_0024515
DR   Coriell; DA03801
DR   Wikidata; Q54823208
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03802
AC   CVCL_7R68
DR   CLO; CLO_0024512
DR   Coriell; DA03802
DR   Wikidata; Q54823209
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03803
AC   CVCL_7R69
DR   CLO; CLO_0024528
DR   Coriell; DA03803
DR   Wikidata; Q54823210
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03804
AC   CVCL_7R70
DR   CLO; CLO_0024527
DR   Coriell; DA03804
DR   Wikidata; Q54823211
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03805
AC   CVCL_7R71
DR   CLO; CLO_0024526
DR   Coriell; DA03805
DR   Wikidata; Q54823212
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03806
AC   CVCL_7R72
DR   CLO; CLO_0024525
DR   Coriell; DA03806
DR   Wikidata; Q54823213
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03807
AC   CVCL_7R73
DR   CLO; CLO_0024501
DR   Coriell; DA03807
DR   Wikidata; Q54823214
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03808
AC   CVCL_7R74
DR   CLO; CLO_0024505
DR   Coriell; DA03808
DR   Wikidata; Q54823215
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03810
AC   CVCL_7R75
DR   CLO; CLO_0024502
DR   Coriell; DA03810
DR   Wikidata; Q54823216
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03811
AC   CVCL_7R76
DR   CLO; CLO_0024495
DR   Coriell; DA03811
DR   Wikidata; Q54823217
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03812
AC   CVCL_7R77
DR   CLO; CLO_0024493
DR   Coriell; DA03812
DR   Wikidata; Q54823218
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03813
AC   CVCL_7R78
DR   CLO; CLO_0024500
DR   Coriell; DA03813
DR   Wikidata; Q54823219
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03814
AC   CVCL_7R79
DR   CLO; CLO_0024497
DR   Coriell; DA03814
DR   Wikidata; Q54823220
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03815
AC   CVCL_7R80
DR   CLO; CLO_0024507
DR   Coriell; DA03815
DR   Wikidata; Q54823222
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03817
AC   CVCL_7R81
DR   CLO; CLO_0024506
DR   Coriell; DA03817
DR   Wikidata; Q54823223
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03818
AC   CVCL_7R82
DR   CLO; CLO_0024508
DR   Coriell; DA03818
DR   Wikidata; Q54823224
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03820
AC   CVCL_7R83
DR   CLO; CLO_0024478
DR   Coriell; DA03820
DR   Wikidata; Q54823225
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03821
AC   CVCL_7R84
DR   CLO; CLO_0024477
DR   Coriell; DA03821
DR   Wikidata; Q54823226
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03822
AC   CVCL_7R85
DR   CLO; CLO_0024475
DR   Coriell; DA03822
DR   Wikidata; Q54823227
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03823
AC   CVCL_7R86
DR   CLO; CLO_0024474
DR   Coriell; DA03823
DR   Wikidata; Q54823228
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03824
AC   CVCL_7R87
DR   CLO; CLO_0024485
DR   Coriell; DA03824
DR   Wikidata; Q54823229
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03825
AC   CVCL_7R88
DR   CLO; CLO_0024484
DR   Coriell; DA03825
DR   Wikidata; Q54823230
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03826
AC   CVCL_7R89
DR   CLO; CLO_0024482
DR   Coriell; DA03826
DR   Wikidata; Q54823232
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03827
AC   CVCL_7R90
DR   CLO; CLO_0024480
DR   Coriell; DA03827
DR   Wikidata; Q54823233
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03828
AC   CVCL_7R91
DR   CLO; CLO_0024488
DR   Coriell; DA03828
DR   Wikidata; Q54823234
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03829
AC   CVCL_7R92
DR   CLO; CLO_0024487
DR   Coriell; DA03829
DR   Wikidata; Q54823236
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03830
AC   CVCL_7R93
DR   Coriell; DA03830
DR   Wikidata; Q54823237
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03830; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03831
AC   CVCL_7R94
DR   CLO; CLO_0024455
DR   Coriell; DA03831
DR   Wikidata; Q54823238
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03832
AC   CVCL_7R95
DR   CLO; CLO_0024457
DR   Coriell; DA03832
DR   Wikidata; Q54823239
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03833
AC   CVCL_7R96
DR   CLO; CLO_0024456
DR   Coriell; DA03833
DR   Wikidata; Q54823240
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03834
AC   CVCL_7R97
DR   CLO; CLO_0024459
DR   Coriell; DA03834
DR   Wikidata; Q54823241
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03835
AC   CVCL_7R98
DR   CLO; CLO_0024458
DR   Coriell; DA03835
DR   Wikidata; Q54823242
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03836
AC   CVCL_7R99
DR   CLO; CLO_0024462
DR   Coriell; DA03836
DR   Wikidata; Q54823243
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03837
AC   CVCL_7S00
DR   CLO; CLO_0024461
DR   Coriell; DA03837
DR   Wikidata; Q54823244
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03838
AC   CVCL_7S01
DR   CLO; CLO_0024467
DR   Coriell; DA03838
DR   Wikidata; Q54823245
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03840
AC   CVCL_7S02
DR   CLO; CLO_0024465
DR   Coriell; DA03840
DR   Wikidata; Q54823246
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03841
AC   CVCL_7S03
DR   CLO; CLO_0024468
DR   Coriell; DA03841
DR   Wikidata; Q54823247
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03842
AC   CVCL_7S04
DR   CLO; CLO_0029002
DR   Coriell; DA03842
DR   Wikidata; Q54823248
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03843
AC   CVCL_7S05
DR   CLO; CLO_0029003
DR   Coriell; DA03843
DR   Wikidata; Q54823249
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03844
AC   CVCL_7S06
DR   CLO; CLO_0029014
DR   Coriell; DA03844
DR   Wikidata; Q54823250
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03845
AC   CVCL_7S07
DR   CLO; CLO_0029012
DR   Coriell; DA03845
DR   Wikidata; Q54823251
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03846
AC   CVCL_7S08
DR   CLO; CLO_0029007
DR   Coriell; DA03846
DR   Wikidata; Q54823252
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03847
AC   CVCL_7S09
DR   CLO; CLO_0029004
DR   Coriell; DA03847
DR   Wikidata; Q54823253
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03848
AC   CVCL_7S10
DR   CLO; CLO_0029025
DR   Coriell; DA03848
DR   Wikidata; Q54823254
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03849
AC   CVCL_7S11
DR   CLO; CLO_0029022
DR   Coriell; DA03849
DR   Wikidata; Q54823255
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03850
AC   CVCL_7S12
DR   CLO; CLO_0029018
DR   Coriell; DA03850
DR   Wikidata; Q54823256
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03851
AC   CVCL_7S13
DR   CLO; CLO_0029016
DR   Coriell; DA03851
DR   Wikidata; Q54823257
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03852
AC   CVCL_7S14
DR   CLO; CLO_0028973
DR   Coriell; DA03852
DR   Wikidata; Q54823258
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03853
AC   CVCL_7S15
DR   CLO; CLO_0028974
DR   Coriell; DA03853
DR   Wikidata; Q54823259
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03854
AC   CVCL_7S16
DR   CLO; CLO_0028975
DR   Coriell; DA03854
DR   Wikidata; Q54823260
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03855
AC   CVCL_7S17
DR   CLO; CLO_0028978
DR   Coriell; DA03855
DR   Wikidata; Q54823261
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03856
AC   CVCL_7S18
DR   CLO; CLO_0028976
DR   Coriell; DA03856
DR   Wikidata; Q54823262
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03857
AC   CVCL_7S19
DR   CLO; CLO_0028985
DR   Coriell; DA03857
DR   Wikidata; Q54823263
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03858
AC   CVCL_7S20
DR   CLO; CLO_0028980
DR   Coriell; DA03858
DR   Wikidata; Q54823264
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03859
AC   CVCL_7S21
DR   CLO; CLO_0028990
DR   Coriell; DA03859
DR   Wikidata; Q54823265
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03860
AC   CVCL_7S22
DR   CLO; CLO_0028986
DR   Coriell; DA03860
DR   Wikidata; Q54823266
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03861
AC   CVCL_7S23
DR   CLO; CLO_0028995
DR   Coriell; DA03861
DR   Wikidata; Q54823267
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03862
AC   CVCL_7S24
DR   CLO; CLO_0028951
DR   Coriell; DA03862
DR   Wikidata; Q54823268
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03864
AC   CVCL_7S25
DR   CLO; CLO_0028952
DR   Coriell; DA03864
DR   Wikidata; Q54823269
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03865
AC   CVCL_7S26
DR   CLO; CLO_0028949
DR   Coriell; DA03865
DR   Wikidata; Q54823270
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03866
AC   CVCL_7S27
DR   CLO; CLO_0028950
DR   Coriell; DA03866
DR   Wikidata; Q54823271
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03867
AC   CVCL_7S28
DR   CLO; CLO_0028965
DR   Coriell; DA03867
DR   Wikidata; Q54823272
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03868
AC   CVCL_7S29
DR   CLO; CLO_0028964
DR   Coriell; DA03868
DR   Wikidata; Q54823273
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03869
AC   CVCL_7S30
DR   CLO; CLO_0028962
DR   Coriell; DA03869
DR   Wikidata; Q54823274
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03870
AC   CVCL_7S31
DR   CLO; CLO_0028960
DR   Coriell; DA03870
DR   Wikidata; Q54823275
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03871
AC   CVCL_7S32
DR   CLO; CLO_0028958
DR   Coriell; DA03871
DR   Wikidata; Q54823277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03872
AC   CVCL_7S33
DR   CLO; CLO_0028955
DR   Coriell; DA03872
DR   Wikidata; Q54823278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03873
AC   CVCL_LK54
DR   Coriell; DA03873
DR   Wikidata; Q54823279
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   DA03874
AC   CVCL_7S34
DR   CLO; CLO_0028943
DR   Coriell; DA03874
DR   Wikidata; Q54823280
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03877
AC   CVCL_7S35
DR   CLO; CLO_0028939
DR   Coriell; DA03877
DR   Wikidata; Q54823281
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03877; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03878
AC   CVCL_7S36
DR   CLO; CLO_0028940
DR   Coriell; DA03878
DR   Wikidata; Q54823282
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03879
AC   CVCL_7S37
DR   CLO; CLO_0028941
DR   Coriell; DA03879
DR   Wikidata; Q54823283
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03880
AC   CVCL_7S38
DR   CLO; CLO_0028942
DR   Coriell; DA03880
DR   Wikidata; Q54823284
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03881
AC   CVCL_7S39
DR   CLO; CLO_0028946
DR   Coriell; DA03881
DR   Wikidata; Q54823285
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03882
AC   CVCL_7S40
DR   CLO; CLO_0028945
DR   Coriell; DA03882
DR   Wikidata; Q54823286
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03883
AC   CVCL_7S41
DR   CLO; CLO_0028948
DR   Coriell; DA03883
DR   Wikidata; Q54823287
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03884
AC   CVCL_7S42
DR   CLO; CLO_0028947
DR   Coriell; DA03884
DR   Wikidata; Q54823288
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03885
AC   CVCL_7S43
DR   CLO; CLO_0028944
DR   Coriell; DA03885
DR   Wikidata; Q54823289
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03886
AC   CVCL_7S44
DR   CLO; CLO_0028911
DR   Coriell; DA03886
DR   Wikidata; Q54823290
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03887
AC   CVCL_7S45
DR   CLO; CLO_0028909
DR   Coriell; DA03887
DR   Wikidata; Q54823291
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03888
AC   CVCL_7S46
DR   CLO; CLO_0028920
DR   Coriell; DA03888
DR   Wikidata; Q54823292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03889
AC   CVCL_7S47
DR   CLO; CLO_0028919
DR   Coriell; DA03889
DR   Wikidata; Q54823293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03890
AC   CVCL_7S48
DR   CLO; CLO_0028917
DR   Coriell; DA03890
DR   Wikidata; Q54823294
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03891
AC   CVCL_7S49
DR   CLO; CLO_0028915
DR   Coriell; DA03891
DR   Wikidata; Q54823295
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03892
AC   CVCL_7S50
DR   CLO; CLO_0028933
DR   Coriell; DA03892
DR   Wikidata; Q54823296
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03893
AC   CVCL_7S51
DR   CLO; CLO_0028935
DR   Coriell; DA03893
DR   Wikidata; Q54823297
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03894
AC   CVCL_7S52
DR   CLO; CLO_0028928
DR   Coriell; DA03894
DR   Wikidata; Q54823298
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03895
AC   CVCL_7S53
DR   CLO; CLO_0028931
DR   Coriell; DA03895
DR   Wikidata; Q54823299
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03896
AC   CVCL_7S54
DR   CLO; CLO_0028832
DR   Coriell; DA03896
DR   Wikidata; Q54823300
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03897
AC   CVCL_7S55
DR   CLO; CLO_0028831
DR   Coriell; DA03897
DR   Wikidata; Q54823301
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03898
AC   CVCL_7S56
DR   CLO; CLO_0028830
DR   Coriell; DA03898
DR   Wikidata; Q54823302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03899
AC   CVCL_7S57
DR   CLO; CLO_0028829
DR   Coriell; DA03899
DR   Wikidata; Q54823303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03900
AC   CVCL_7S58
DR   CLO; CLO_0028838
DR   Coriell; DA03900
DR   Wikidata; Q54823304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03901
AC   CVCL_7S59
DR   CLO; CLO_0028837
DR   Coriell; DA03901
DR   Wikidata; Q54823305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03902
AC   CVCL_7S60
DR   CLO; CLO_0028836
DR   Coriell; DA03902
DR   Wikidata; Q54823306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03904
AC   CVCL_7S61
DR   CLO; CLO_0028835
DR   Coriell; DA03904
DR   Wikidata; Q54823307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03905
AC   CVCL_7S62
DR   CLO; CLO_0028834
DR   Coriell; DA03905
DR   Wikidata; Q54823308
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03906
AC   CVCL_7S63
DR   CLO; CLO_0028833
DR   Coriell; DA03906
DR   Wikidata; Q54823309
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03907
AC   CVCL_7S64
DR   CLO; CLO_0028779
DR   Coriell; DA03907
DR   Wikidata; Q54823310
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03908
AC   CVCL_7S65
DR   CLO; CLO_0028781
DR   Coriell; DA03908
DR   Wikidata; Q54823311
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03909
AC   CVCL_7S66
DR   CLO; CLO_0028780
DR   Coriell; DA03909
DR   Wikidata; Q54823312
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03910
AC   CVCL_7S67
DR   CLO; CLO_0028784
DR   Coriell; DA03910
DR   Wikidata; Q54823313
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03912
AC   CVCL_7S68
DR   CLO; CLO_0028782
DR   Coriell; DA03912
DR   Wikidata; Q54823314
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03913
AC   CVCL_7S69
DR   CLO; CLO_0028786
DR   Coriell; DA03913
DR   Wikidata; Q54823315
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03914
AC   CVCL_7S70
DR   CLO; CLO_0028785
DR   Coriell; DA03914
DR   Wikidata; Q54823316
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03915
AC   CVCL_7S71
DR   CLO; CLO_0028788
DR   Coriell; DA03915
DR   Wikidata; Q54823318
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03916
AC   CVCL_7S72
DR   CLO; CLO_0028787
DR   Coriell; DA03916
DR   Wikidata; Q54823319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03917
AC   CVCL_7S73
DR   CLO; CLO_0028789
DR   Coriell; DA03917
DR   Wikidata; Q54823320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03918
AC   CVCL_7S74
DR   CLO; CLO_0028800
DR   Coriell; DA03918
DR   Wikidata; Q54823321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03919
AC   CVCL_7S75
DR   CLO; CLO_0028799
DR   Coriell; DA03919
DR   Wikidata; Q54823322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03920
AC   CVCL_7S76
DR   CLO; CLO_0028804
DR   Coriell; DA03920
DR   Wikidata; Q54823323
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03922
AC   CVCL_7S77
DR   CLO; CLO_0028803
DR   Coriell; DA03922
DR   Wikidata; Q54823324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03923
AC   CVCL_7S78
DR   CLO; CLO_0028802
DR   Coriell; DA03923
DR   Wikidata; Q54823325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03924
AC   CVCL_7S79
DR   CLO; CLO_0028801
DR   Coriell; DA03924
DR   Wikidata; Q54823326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03925
AC   CVCL_7S80
DR   CLO; CLO_0028808
DR   Coriell; DA03925
DR   Wikidata; Q54823327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03926
AC   CVCL_7S81
DR   CLO; CLO_0028807
DR   Coriell; DA03926
DR   Wikidata; Q54823328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03927
AC   CVCL_7S82
DR   CLO; CLO_0028806
DR   Coriell; DA03927
DR   Wikidata; Q54823329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03928
AC   CVCL_7S83
DR   CLO; CLO_0028805
DR   Coriell; DA03928
DR   Wikidata; Q54823330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03929
AC   CVCL_7S84
DR   CLO; CLO_0028742
DR   Coriell; DA03929
DR   Wikidata; Q54823331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03931
AC   CVCL_7S85
DR   CLO; CLO_0028744
DR   Coriell; DA03931
DR   Wikidata; Q54823332
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03932
AC   CVCL_7S86
DR   CLO; CLO_0028747
DR   Coriell; DA03932
DR   Wikidata; Q54823333
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03933
AC   CVCL_7S87
DR   CLO; CLO_0028734
DR   Coriell; DA03933
DR   Wikidata; Q54823334
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03934
AC   CVCL_7S88
DR   CLO; CLO_0028735
DR   Coriell; DA03934
DR   Wikidata; Q54823335
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03935
AC   CVCL_7S89
DR   CLO; CLO_0028737
DR   Coriell; DA03935
DR   Wikidata; Q54823336
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03936
AC   CVCL_7S90
DR   CLO; CLO_0028739
DR   Coriell; DA03936
DR   Wikidata; Q54823337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03937
AC   CVCL_7S91
DR   CLO; CLO_0028729
DR   Coriell; DA03937
DR   Wikidata; Q54823338
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03938
AC   CVCL_7S92
DR   CLO; CLO_0028730
DR   Coriell; DA03938
DR   Wikidata; Q54823339
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03939
AC   CVCL_7S93
DR   CLO; CLO_0028731
DR   Coriell; DA03939
DR   Wikidata; Q54823340
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03940
AC   CVCL_7S94
DR   CLO; CLO_0028769
DR   Coriell; DA03940
DR   Wikidata; Q54823341
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03941
AC   CVCL_7S95
DR   CLO; CLO_0028770
DR   Coriell; DA03941
DR   Wikidata; Q54823342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03942
AC   CVCL_7S96
DR   CLO; CLO_0028767
DR   Coriell; DA03942
DR   Wikidata; Q54823343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03943
AC   CVCL_7S97
DR   CLO; CLO_0028768
DR   Coriell; DA03943
DR   Wikidata; Q54823344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03944
AC   CVCL_7S98
DR   CLO; CLO_0028763
DR   Coriell; DA03944
DR   Wikidata; Q54823345
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03945
AC   CVCL_7S99
DR   CLO; CLO_0028765
DR   Coriell; DA03945
DR   Wikidata; Q54823346
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03946
AC   CVCL_7T00
DR   CLO; CLO_0028761
DR   Coriell; DA03946
DR   Wikidata; Q54823347
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03947
AC   CVCL_7T01
DR   CLO; CLO_0028762
DR   Coriell; DA03947
DR   Wikidata; Q54823348
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03948
AC   CVCL_7T02
DR   CLO; CLO_0028759
DR   Coriell; DA03948
DR   Wikidata; Q54823349
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03949
AC   CVCL_7T03
DR   CLO; CLO_0028760
DR   Coriell; DA03949
DR   Wikidata; Q54823350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03951
AC   CVCL_7T04
DR   CLO; CLO_0028704
DR   Coriell; DA03951
DR   Wikidata; Q54823351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03952
AC   CVCL_7T05
DR   CLO; CLO_0028690
DR   Coriell; DA03952
DR   Wikidata; Q54823352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03953
AC   CVCL_7T06
DR   CLO; CLO_0028691
DR   Coriell; DA03953
DR   Wikidata; Q54823353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03954
AC   CVCL_7T07
DR   CLO; CLO_0028692
DR   Coriell; DA03954
DR   Wikidata; Q54823354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03955
AC   CVCL_7T08
DR   CLO; CLO_0028693
DR   Coriell; DA03955
DR   Wikidata; Q54823355
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03956
AC   CVCL_7T09
DR   CLO; CLO_0028694
DR   Coriell; DA03956
DR   Wikidata; Q54823356
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03957
AC   CVCL_7T10
DR   CLO; CLO_0028695
DR   Coriell; DA03957
DR   Wikidata; Q54823357
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03958
AC   CVCL_7T11
DR   CLO; CLO_0028696
DR   Coriell; DA03958
DR   Wikidata; Q54823360
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03959
AC   CVCL_7T12
DR   CLO; CLO_0028697
DR   Coriell; DA03959
DR   Wikidata; Q54823361
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03960
AC   CVCL_7T13
DR   CLO; CLO_0028689
DR   Coriell; DA03960
DR   Wikidata; Q54823362
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03961
AC   CVCL_7T14
DR   CLO; CLO_0028723
DR   Coriell; DA03961
DR   Wikidata; Q54823363
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03962
AC   CVCL_7T15
DR   CLO; CLO_0028722
DR   Coriell; DA03962
DR   Wikidata; Q54823364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03963
AC   CVCL_7T16
DR   CLO; CLO_0028711
DR   Coriell; DA03963
DR   Wikidata; Q54823365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03964
AC   CVCL_7T17
DR   CLO; CLO_0028712
DR   Coriell; DA03964
DR   Wikidata; Q54823366
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03965
AC   CVCL_7T18
DR   CLO; CLO_0028709
DR   Coriell; DA03965
DR   Wikidata; Q54823367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03966
AC   CVCL_7T19
DR   CLO; CLO_0028710
DR   Coriell; DA03966
DR   Wikidata; Q54823368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03967
AC   CVCL_7T20
DR   CLO; CLO_0028715
DR   Coriell; DA03967
DR   Wikidata; Q54823369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03968
AC   CVCL_7T21
DR   CLO; CLO_0028716
DR   Coriell; DA03968
DR   Wikidata; Q54823370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03969
AC   CVCL_7T22
DR   CLO; CLO_0028713
DR   Coriell; DA03969
DR   Wikidata; Q54823371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03970
AC   CVCL_7T23
DR   CLO; CLO_0028714
DR   Coriell; DA03970
DR   Wikidata; Q54823372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03971
AC   CVCL_7T24
DR   CLO; CLO_0029606
DR   Coriell; DA03971
DR   Wikidata; Q54823373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03972
AC   CVCL_7T25
DR   CLO; CLO_0029604
DR   Coriell; DA03972
DR   Wikidata; Q54823374
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03973
AC   CVCL_7T26
DR   CLO; CLO_0029605
DR   Coriell; DA03973
DR   Wikidata; Q54823375
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03974
AC   CVCL_7T27
DR   CLO; CLO_0029617
DR   Coriell; DA03974
DR   Wikidata; Q54823376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03975
AC   CVCL_7T28
DR   CLO; CLO_0029615
DR   Coriell; DA03975
DR   Wikidata; Q54823377
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03976
AC   CVCL_7T29
DR   CLO; CLO_0029612
DR   Coriell; DA03976
DR   Wikidata; Q54823378
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03977
AC   CVCL_7T30
DR   CLO; CLO_0029609
DR   Coriell; DA03977
DR   Wikidata; Q54823379
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03978
AC   CVCL_7T31
DR   CLO; CLO_0029627
DR   Coriell; DA03978
DR   Wikidata; Q54823380
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03979
AC   CVCL_7T32
DR   CLO; CLO_0029623
DR   Coriell; DA03979
DR   Wikidata; Q54823381
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03980
AC   CVCL_7T33
DR   CLO; CLO_0029621
DR   Coriell; DA03980
DR   Wikidata; Q54823382
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03981
AC   CVCL_7T34
DR   CLO; CLO_0029584
DR   Coriell; DA03981
DR   Wikidata; Q54823383
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03982
AC   CVCL_7T35
DR   CLO; CLO_0029586
DR   Coriell; DA03982
DR   Wikidata; Q54823384
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03983
AC   CVCL_7T36
DR   CLO; CLO_0029587
DR   Coriell; DA03983
DR   Wikidata; Q54823385
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03984
AC   CVCL_7T37
DR   CLO; CLO_0029588
DR   Coriell; DA03984
DR   Wikidata; Q54823386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03985
AC   CVCL_7T38
DR   CLO; CLO_0029590
DR   Coriell; DA03985
DR   Wikidata; Q54823387
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03986
AC   CVCL_7T39
DR   CLO; CLO_0029589
DR   Coriell; DA03986
DR   Wikidata; Q54823388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03987
AC   CVCL_7T40
DR   CLO; CLO_0029593
DR   Coriell; DA03987
DR   Wikidata; Q54823389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03988
AC   CVCL_7T41
DR   CLO; CLO_0029592
DR   Coriell; DA03988
DR   Wikidata; Q54823390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03989
AC   CVCL_7T42
DR   CLO; CLO_0029597
DR   Coriell; DA03989
DR   Wikidata; Q54823391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03990
AC   CVCL_7T43
DR   CLO; CLO_0029594
DR   Coriell; DA03990
DR   Wikidata; Q54823392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03991
AC   CVCL_7T44
DR   CLO; CLO_0029643
DR   Coriell; DA03991
DR   Wikidata; Q54823393
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03992
AC   CVCL_7T45
DR   CLO; CLO_0029641
DR   Coriell; DA03992
DR   Wikidata; Q54823394
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA03992; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA03993
AC   CVCL_7T46
DR   CLO; CLO_0029642
DR   Coriell; DA03993
DR   Wikidata; Q54823395
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03994
AC   CVCL_7T47
DR   CLO; CLO_0029639
DR   Coriell; DA03994
DR   Wikidata; Q54823396
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03995
AC   CVCL_7T48
DR   CLO; CLO_0029640
DR   Coriell; DA03995
DR   Wikidata; Q54823397
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03996
AC   CVCL_7T49
DR   CLO; CLO_0029658
DR   Coriell; DA03996
DR   Wikidata; Q54823398
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03997
AC   CVCL_7T50
DR   CLO; CLO_0029656
DR   Coriell; DA03997
DR   Wikidata; Q54823399
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA03998
AC   CVCL_7T51
DR   CLO; CLO_0029654
DR   Coriell; DA03998
DR   Wikidata; Q54823401
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04000
AC   CVCL_7T52
DR   CLO; CLO_0029651
DR   Coriell; DA04000
DR   Wikidata; Q54823402
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04001
AC   CVCL_7T53
DR   CLO; CLO_0029650
DR   Coriell; DA04001
DR   Wikidata; Q54823403
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04002
AC   CVCL_7T54
DR   CLO; CLO_0029235
DR   Coriell; DA04002
DR   Wikidata; Q54823404
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04003
AC   CVCL_7T55
DR   CLO; CLO_0029236
DR   Coriell; DA04003
DR   Wikidata; Q54823405
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04005
AC   CVCL_7T56
DR   CLO; CLO_0029237
DR   Coriell; DA04005
DR   Wikidata; Q54823406
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04006
AC   CVCL_7T57
DR   CLO; CLO_0029238
DR   Coriell; DA04006
DR   Wikidata; Q54823407
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04007
AC   CVCL_7T58
DR   CLO; CLO_0029239
DR   Coriell; DA04007
DR   Wikidata; Q54823408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA04007; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA04008
AC   CVCL_7T59
DR   CLO; CLO_0029240
DR   Coriell; DA04008
DR   Wikidata; Q54823409
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04009
AC   CVCL_7T60
DR   CLO; CLO_0029241
DR   Coriell; DA04009
DR   Wikidata; Q54823410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04010
AC   CVCL_7T61
DR   Coriell; DA04010
DR   Wikidata; Q54823411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA04010; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04011
AC   CVCL_7T62
DR   CLO; CLO_0029242
DR   Coriell; DA04011
DR   Wikidata; Q54823412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04012
AC   CVCL_7T63
DR   CLO; CLO_0029243
DR   Coriell; DA04012
DR   Wikidata; Q54823413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04013
AC   CVCL_7T64
DR   CLO; CLO_0029244
DR   Coriell; DA04013
DR   Wikidata; Q54823414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04014
AC   CVCL_7T65
DR   CLO; CLO_0029446
DR   Coriell; DA04014
DR   Wikidata; Q54823415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04015
AC   CVCL_7T66
DR   CLO; CLO_0029445
DR   Coriell; DA04015
DR   Wikidata; Q54823416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04016
AC   CVCL_7T67
DR   CLO; CLO_0029448
DR   Coriell; DA04016
DR   Wikidata; Q54823417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04017
AC   CVCL_7T68
DR   CLO; CLO_0029447
DR   Coriell; DA04017
DR   Wikidata; Q54823418
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04018
AC   CVCL_7T69
DR   CLO; CLO_0029442
DR   Coriell; DA04018
DR   Wikidata; Q54823419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA04018; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA04019
AC   CVCL_7T70
DR   CLO; CLO_0029441
DR   Coriell; DA04019
DR   Wikidata; Q54823420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04020
AC   CVCL_7T71
DR   CLO; CLO_0029444
DR   Coriell; DA04020
DR   Wikidata; Q54823421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04021
AC   CVCL_7T72
DR   CLO; CLO_0029443
DR   Coriell; DA04021
DR   Wikidata; Q54823422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04023
AC   CVCL_7T73
DR   CLO; CLO_0029440
DR   Coriell; DA04023
DR   Wikidata; Q54823423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04024
AC   CVCL_7T74
DR   CLO; CLO_0029439
DR   Coriell; DA04024
DR   Wikidata; Q54823424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04025
AC   CVCL_7T75
DR   CLO; CLO_0029458
DR   Coriell; DA04025
DR   Wikidata; Q54823425
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04027
AC   CVCL_7T76
DR   CLO; CLO_0029457
DR   Coriell; DA04027
DR   Wikidata; Q54823426
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04029
AC   CVCL_7T77
DR   CLO; CLO_0029456
DR   Coriell; DA04029
DR   Wikidata; Q54823427
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04032
AC   CVCL_7T78
DR   CLO; CLO_0029455
DR   Coriell; DA04032
DR   Wikidata; Q54823428
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04033
AC   CVCL_7T79
DR   CLO; CLO_0029454
DR   Coriell; DA04033
DR   Wikidata; Q54823429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04034
AC   CVCL_7T80
DR   CLO; CLO_0029453
DR   Coriell; DA04034
DR   Wikidata; Q54823430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04035
AC   CVCL_7T81
DR   CLO; CLO_0029452
DR   Coriell; DA04035
DR   Wikidata; Q54823431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04036
AC   CVCL_7T82
DR   CLO; CLO_0029451
DR   Coriell; DA04036
DR   Wikidata; Q54823432
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04037
AC   CVCL_7T83
DR   CLO; CLO_0029450
DR   Coriell; DA04037
DR   Wikidata; Q54823433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04038
AC   CVCL_7T84
DR   CLO; CLO_0029449
DR   Coriell; DA04038
DR   Wikidata; Q54823434
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04039
AC   CVCL_7T85
DR   CLO; CLO_0029464
DR   Coriell; DA04039
DR   Wikidata; Q54823435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04040
AC   CVCL_7T86
DR   CLO; CLO_0029463
DR   Coriell; DA04040
DR   Wikidata; Q54823436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04041
AC   CVCL_7T87
DR   CLO; CLO_0029466
DR   Coriell; DA04041
DR   Wikidata; Q54823437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian and Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04042
AC   CVCL_7T88
DR   CLO; CLO_0029465
DR   Coriell; DA04042
DR   Wikidata; Q54823439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04043
AC   CVCL_7T89
DR   CLO; CLO_0029468
DR   Coriell; DA04043
DR   Wikidata; Q54823440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04044
AC   CVCL_7T90
DR   Coriell; DA04044
DR   Wikidata; Q54823441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA04044; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04045
AC   CVCL_7T91
DR   CLO; CLO_0029467
DR   Coriell; DA04045
DR   Wikidata; Q54823443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04046
AC   CVCL_7T92
DR   CLO; CLO_0029460
DR   Coriell; DA04046
DR   Wikidata; Q54823444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04048
AC   CVCL_7T93
DR   CLO; CLO_0029459
DR   Coriell; DA04048
DR   Wikidata; Q54823445
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04049
AC   CVCL_7T94
DR   CLO; CLO_0029462
DR   Coriell; DA04049
DR   Wikidata; Q54823446
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04050
AC   CVCL_7T95
DR   CLO; CLO_0029461
DR   Coriell; DA04050
DR   Wikidata; Q54823447
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04051
AC   CVCL_7T96
DR   CLO; CLO_0029484
DR   Coriell; DA04051
DR   Wikidata; Q54823448
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04053
AC   CVCL_7T97
DR   CLO; CLO_0029483
DR   Coriell; DA04053
DR   Wikidata; Q54823449
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04054
AC   CVCL_7T98
DR   CLO; CLO_0029482
DR   Coriell; DA04054
DR   Wikidata; Q54823450
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04055
AC   CVCL_7T99
DR   CLO; CLO_0029488
DR   Coriell; DA04055
DR   Wikidata; Q54823451
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04056
AC   CVCL_7U00
DR   CLO; CLO_0029487
DR   Coriell; DA04056
DR   Wikidata; Q54823452
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04057
AC   CVCL_7U01
DR   CLO; CLO_0029486
DR   Coriell; DA04057
DR   Wikidata; Q54823453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04058
AC   CVCL_7U02
DR   CLO; CLO_0029485
DR   Coriell; DA04058
DR   Wikidata; Q54823454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04059
AC   CVCL_7U03
DR   CLO; CLO_0029481
DR   Coriell; DA04059
DR   Wikidata; Q54823455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04060
AC   CVCL_7U04
DR   CLO; CLO_0029480
DR   Coriell; DA04060
DR   Wikidata; Q54823456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04061
AC   CVCL_7U05
DR   CLO; CLO_0029479
DR   Coriell; DA04061
DR   Wikidata; Q54823458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04062
AC   CVCL_7U06
DR   CLO; CLO_0029376
DR   Coriell; DA04062
DR   Wikidata; Q54823459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04063
AC   CVCL_7U07
DR   CLO; CLO_0029378
DR   Coriell; DA04063
DR   Wikidata; Q54823460
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04064
AC   CVCL_7U08
DR   CLO; CLO_0029380
DR   Coriell; DA04064
DR   Wikidata; Q54823461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04065
AC   CVCL_7U09
DR   CLO; CLO_0029382
DR   Coriell; DA04065
DR   Wikidata; Q54823462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04068
AC   CVCL_7U10
DR   CLO; CLO_0029370
DR   Coriell; DA04068
DR   Wikidata; Q54823463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04069
AC   CVCL_7U11
DR   CLO; CLO_0029372
DR   Coriell; DA04069
DR   Wikidata; Q54823464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04070
AC   CVCL_7U12
DR   CLO; CLO_0029373
DR   Coriell; DA04070
DR   Wikidata; Q54823465
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04071
AC   CVCL_7U13
DR   CLO; CLO_0029375
DR   Coriell; DA04071
DR   Wikidata; Q54823466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04072
AC   CVCL_7U14
DR   CLO; CLO_0029384
DR   Coriell; DA04072
DR   Wikidata; Q54823467
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04073
AC   CVCL_7U15
DR   CLO; CLO_0029385
DR   Coriell; DA04073
DR   Wikidata; Q54823468
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04074
AC   CVCL_7U16
DR   CLO; CLO_0029407
DR   Coriell; DA04074
DR   Wikidata; Q54823469
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04075
AC   CVCL_7U17
DR   CLO; CLO_0029402
DR   Coriell; DA04075
DR   Wikidata; Q54823470
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04076
AC   CVCL_7U18
DR   CLO; CLO_0029403
DR   Coriell; DA04076
DR   Wikidata; Q54823471
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04077
AC   CVCL_7U19
DR   CLO; CLO_0029397
DR   Coriell; DA04077
DR   Wikidata; Q54823472
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04078
AC   CVCL_7U20
DR   CLO; CLO_0029399
DR   Coriell; DA04078
DR   Wikidata; Q54823473
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04079
AC   CVCL_7U21
DR   CLO; CLO_0029393
DR   Coriell; DA04079
DR   Wikidata; Q54823474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04080
AC   CVCL_7U22
DR   CLO; CLO_0029396
DR   Coriell; DA04080
DR   Wikidata; Q54823475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04081
AC   CVCL_7U23
DR   CLO; CLO_0029390
DR   Coriell; DA04081
DR   Wikidata; Q54823476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA04083
AC   CVCL_7U24
DR   CLO; CLO_0029391
DR   Coriell; DA04083
DR   Wikidata; Q54823477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04084
AC   CVCL_7U25
DR   CLO; CLO_0029405
DR   Coriell; DA04084
DR   Wikidata; Q54823478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04085
AC   CVCL_7U26
DR   CLO; CLO_0029428
DR   Coriell; DA04085
DR   Wikidata; Q54823479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04086
AC   CVCL_7U27
DR   CLO; CLO_0029426
DR   Coriell; DA04086
DR   Wikidata; Q54823480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04087
AC   CVCL_7U28
DR   CLO; CLO_0029410
DR   Coriell; DA04087
DR   Wikidata; Q54823481
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04089
AC   CVCL_7U29
DR   CLO; CLO_0029411
DR   Coriell; DA04089
DR   Wikidata; Q54823482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04090
AC   CVCL_7U30
DR   CLO; CLO_0029413
DR   Coriell; DA04090
DR   Wikidata; Q54823483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04091
AC   CVCL_7U31
DR   CLO; CLO_0029416
DR   Coriell; DA04091
DR   Wikidata; Q54823486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04092
AC   CVCL_7U32
DR   CLO; CLO_0029418
DR   Coriell; DA04092
DR   Wikidata; Q54823487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04093
AC   CVCL_7U33
DR   CLO; CLO_0029419
DR   Coriell; DA04093
DR   Wikidata; Q54823488
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04094
AC   CVCL_7U34
DR   CLO; CLO_0029422
DR   Coriell; DA04094
DR   Wikidata; Q54823489
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04095
AC   CVCL_7U35
DR   CLO; CLO_0029424
DR   Coriell; DA04095
DR   Wikidata; Q54823490
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04096
AC   CVCL_7U36
DR   CLO; CLO_0029438
DR   Coriell; DA04096
DR   Wikidata; Q54823491
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04097
AC   CVCL_7U37
DR   CLO; CLO_0029437
DR   Coriell; DA04097
DR   Wikidata; Q54823492
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04098
AC   CVCL_7U38
DR   CLO; CLO_0029436
DR   Coriell; DA04098
DR   Wikidata; Q54823493
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04099
AC   CVCL_7U39
DR   CLO; CLO_0029431
DR   Coriell; DA04099
DR   Wikidata; Q54823494
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04101
AC   CVCL_7U40
DR   CLO; CLO_0029432
DR   Coriell; DA04101
DR   Wikidata; Q54823495
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04102
AC   CVCL_7U41
DR   CLO; CLO_0029429
DR   Coriell; DA04102
DR   Wikidata; Q54823496
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04103
AC   CVCL_7U42
DR   CLO; CLO_0029430
DR   Coriell; DA04103
DR   Wikidata; Q54823497
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04109
AC   CVCL_7U43
DR   CLO; CLO_0029434
DR   Coriell; DA04109
DR   Wikidata; Q54823498
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04110
AC   CVCL_7U44
DR   CLO; CLO_0029435
DR   Coriell; DA04110
DR   Wikidata; Q54823499
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04111
AC   CVCL_7U45
DR   CLO; CLO_0029433
DR   Coriell; DA04111
DR   Wikidata; Q54823500
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04112
AC   CVCL_7U46
DR   CLO; CLO_0030247
DR   Coriell; DA04112
DR   Wikidata; Q54823501
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04113
AC   CVCL_7U47
DR   CLO; CLO_0030248
DR   Coriell; DA04113
DR   Wikidata; Q54823502
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04114
AC   CVCL_7U48
DR   CLO; CLO_0030244
DR   Coriell; DA04114
DR   Wikidata; Q54823503
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04115
AC   CVCL_7U49
DR   CLO; CLO_0030245
DR   Coriell; DA04115
DR   Wikidata; Q54823504
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04116
AC   CVCL_7U50
DR   CLO; CLO_0030225
DR   Coriell; DA04116
DR   Wikidata; Q54823505
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04117
AC   CVCL_7U51
DR   CLO; CLO_0030223
DR   Coriell; DA04117
DR   Wikidata; Q54823506
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04118
AC   CVCL_7U52
DR   CLO; CLO_0030221
DR   Coriell; DA04118
DR   Wikidata; Q54823507
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04119
AC   CVCL_7U53
DR   CLO; CLO_0030220
DR   Coriell; DA04119
DR   Wikidata; Q54823508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04120
AC   CVCL_7U54
DR   CLO; CLO_0030235
DR   Coriell; DA04120
DR   Wikidata; Q54823509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04121
AC   CVCL_7U55
DR   CLO; CLO_0030230
DR   Coriell; DA04121
DR   Wikidata; Q54823510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04122
AC   CVCL_7U56
DR   CLO; CLO_0029926
DR   Coriell; DA04122
DR   Wikidata; Q54823511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04123
AC   CVCL_7U57
DR   CLO; CLO_0029927
DR   Coriell; DA04123
DR   Wikidata; Q54823512
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04124
AC   CVCL_7U58
DR   CLO; CLO_0029918
DR   Coriell; DA04124
DR   Wikidata; Q54823513
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04125
AC   CVCL_7U59
DR   CLO; CLO_0029920
DR   Coriell; DA04125
DR   Wikidata; Q54823514
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04126
AC   CVCL_7U60
DR   CLO; CLO_0029921
DR   Coriell; DA04126
DR   Wikidata; Q54823515
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04127
AC   CVCL_7U61
DR   CLO; CLO_0029923
DR   Coriell; DA04127
DR   Wikidata; Q54823516
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04128
AC   CVCL_7U62
DR   CLO; CLO_0029909
DR   Coriell; DA04128
DR   Wikidata; Q54823517
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04129
AC   CVCL_7U63
DR   CLO; CLO_0029911
DR   Coriell; DA04129
DR   Wikidata; Q54823518
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04130
AC   CVCL_7U64
DR   CLO; CLO_0029914
DR   Coriell; DA04130
DR   Wikidata; Q54823519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04131
AC   CVCL_7U65
DR   CLO; CLO_0029915
DR   Coriell; DA04131
DR   Wikidata; Q54823520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04133
AC   CVCL_7U66
DR   CLO; CLO_0029837
DR   Coriell; DA04133
DR   Wikidata; Q54823521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA04133; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA04134
AC   CVCL_7U67
DR   CLO; CLO_0029834
DR   Coriell; DA04134
DR   Wikidata; Q54823522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04135
AC   CVCL_7U68
DR   CLO; CLO_0029835
DR   Coriell; DA04135
DR   Wikidata; Q54823523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04136
AC   CVCL_7U69
DR   CLO; CLO_0029824
DR   Coriell; DA04136
DR   Wikidata; Q54823524
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04137
AC   CVCL_7U70
DR   CLO; CLO_0029826
DR   Coriell; DA04137
DR   Wikidata; Q54823525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04138
AC   CVCL_7U71
DR   CLO; CLO_0029819
DR   Coriell; DA04138
DR   Wikidata; Q54823527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04139
AC   CVCL_7U72
DR   CLO; CLO_0029821
DR   Coriell; DA04139
DR   Wikidata; Q54823528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04140
AC   CVCL_7U73
DR   CLO; CLO_0029830
DR   Coriell; DA04140
DR   Wikidata; Q54823529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04141
AC   CVCL_7U74
DR   CLO; CLO_0029832
DR   Coriell; DA04141
DR   Wikidata; Q54823530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04142
AC   CVCL_7U75
DR   CLO; CLO_0029827
DR   Coriell; DA04142
DR   Wikidata; Q54823531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04143
AC   CVCL_7U76
DR   CLO; CLO_0029864
DR   Coriell; DA04143
DR   Wikidata; Q54823532
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04144
AC   CVCL_7U77
DR   CLO; CLO_0029865
DR   Coriell; DA04144
DR   Wikidata; Q54823533
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04145
AC   CVCL_7U78
DR   CLO; CLO_0029867
DR   Coriell; DA04145
DR   Wikidata; Q54823534
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04146
AC   CVCL_7U79
DR   CLO; CLO_0029868
DR   Coriell; DA04146
DR   Wikidata; Q54823535
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04147
AC   CVCL_7U80
DR   CLO; CLO_0029849
DR   Coriell; DA04147
DR   Wikidata; Q54823536
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04148
AC   CVCL_7U81
DR   CLO; CLO_0029852
DR   Coriell; DA04148
DR   Wikidata; Q54823537
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04149
AC   CVCL_7U82
DR   CLO; CLO_0029853
DR   Coriell; DA04149
DR   Wikidata; Q54823538
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04150
AC   CVCL_7U83
DR   CLO; CLO_0029855
DR   Coriell; DA04150
DR   Wikidata; Q54823539
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04151
AC   CVCL_7U84
DR   CLO; CLO_0029858
DR   Coriell; DA04151
DR   Wikidata; Q54823540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04152
AC   CVCL_7U85
DR   CLO; CLO_0029859
DR   Coriell; DA04152
DR   Wikidata; Q54823541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04153
AC   CVCL_7U86
DR   CLO; CLO_0030020
DR   Coriell; DA04153
DR   Wikidata; Q54823542
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04154
AC   CVCL_7U87
DR   CLO; CLO_0030011
DR   Coriell; DA04154
DR   Wikidata; Q54823543
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04158
AC   CVCL_7U88
DR   CLO; CLO_0030010
DR   Coriell; DA04158
DR   Wikidata; Q54823544
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04159
AC   CVCL_7U89
DR   CLO; CLO_0030015
DR   Coriell; DA04159
DR   Wikidata; Q54823545
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04160
AC   CVCL_7U90
DR   CLO; CLO_0030013
DR   Coriell; DA04160
DR   Wikidata; Q54823546
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04161
AC   CVCL_7U91
DR   CLO; CLO_0030026
DR   Coriell; DA04161
DR   Wikidata; Q54823547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04162
AC   CVCL_7U92
DR   CLO; CLO_0030024
DR   Coriell; DA04162
DR   Wikidata; Q54823548
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04163
AC   CVCL_7U93
DR   CLO; CLO_0030028
DR   Coriell; DA04163
DR   Wikidata; Q54823549
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04164
AC   CVCL_7U94
DR   CLO; CLO_0030027
DR   Coriell; DA04164
DR   Wikidata; Q54823550
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04165
AC   CVCL_7U95
DR   CLO; CLO_0030022
DR   Coriell; DA04165
DR   Wikidata; Q54823551
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04166
AC   CVCL_7U96
DR   CLO; CLO_0030044
DR   Coriell; DA04166
DR   Wikidata; Q54823552
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04167
AC   CVCL_7U97
DR   CLO; CLO_0030043
DR   Coriell; DA04167
DR   Wikidata; Q54823553
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04168
AC   CVCL_7U98
DR   CLO; CLO_0030042
DR   Coriell; DA04168
DR   Wikidata; Q54823554
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04169
AC   CVCL_7U99
DR   CLO; CLO_0030041
DR   Coriell; DA04169
DR   Wikidata; Q54823555
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04170
AC   CVCL_7V00
DR   CLO; CLO_0030040
DR   Coriell; DA04170
DR   Wikidata; Q54823556
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04171
AC   CVCL_7V01
DR   CLO; CLO_0030039
DR   Coriell; DA04171
DR   Wikidata; Q54823557
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04172
AC   CVCL_7V02
DR   CLO; CLO_0030048
DR   Coriell; DA04172
DR   Wikidata; Q54823558
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04173
AC   CVCL_7V03
DR   CLO; CLO_0030047
DR   Coriell; DA04173
DR   Wikidata; Q54823559
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04175
AC   CVCL_7V04
DR   CLO; CLO_0030046
DR   Coriell; DA04175
DR   Wikidata; Q54823560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04176
AC   CVCL_7V05
DR   CLO; CLO_0030045
DR   Coriell; DA04176
DR   Wikidata; Q54823561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04177
AC   CVCL_LL59
DR   Coriell; DA04177
DR   Wikidata; Q54823562
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   DA04178
AC   CVCL_7V06
DR   CLO; CLO_0029961
DR   Coriell; DA04178
DR   Wikidata; Q54823563
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04179
AC   CVCL_7V07
DR   CLO; CLO_0029959
DR   Coriell; DA04179
DR   Wikidata; Q54823564
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04180
AC   CVCL_7V08
DR   CLO; CLO_0029963
DR   Coriell; DA04180
DR   Wikidata; Q54823565
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04181
AC   CVCL_7V09
DR   CLO; CLO_0029962
DR   Coriell; DA04181
DR   Wikidata; Q54823566
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04182
AC   CVCL_7V10
DR   CLO; CLO_0029965
DR   Coriell; DA04182
DR   Wikidata; Q54823570
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04183
AC   CVCL_7V11
DR   CLO; CLO_0029964
DR   Coriell; DA04183
DR   Wikidata; Q54823571
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04184
AC   CVCL_7V12
DR   CLO; CLO_0029967
DR   Coriell; DA04184
DR   Wikidata; Q54823572
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04185
AC   CVCL_7V13
DR   CLO; CLO_0029966
DR   Coriell; DA04185
DR   Wikidata; Q54823573
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04186
AC   CVCL_7V14
DR   CLO; CLO_0029968
DR   Coriell; DA04186
DR   Wikidata; Q54823574
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04187
AC   CVCL_7V15
DR   CLO; CLO_0029992
DR   Coriell; DA04187
DR   Wikidata; Q54823575
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04188
AC   CVCL_7V16
DR   CLO; CLO_0029990
DR   Coriell; DA04188
DR   Wikidata; Q54823576
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04189
AC   CVCL_7V17
DR   CLO; CLO_0029988
DR   Coriell; DA04189
DR   Wikidata; Q54823577
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04190
AC   CVCL_7V18
DR   CLO; CLO_0029987
DR   Coriell; DA04190
DR   Wikidata; Q54823578
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04191
AC   CVCL_7V19
DR   CLO; CLO_0029996
DR   Coriell; DA04191
DR   Wikidata; Q54823579
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04192
AC   CVCL_7V20
DR   CLO; CLO_0029995
DR   Coriell; DA04192
DR   Wikidata; Q54823580
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04193
AC   CVCL_7V21
DR   CLO; CLO_0029994
DR   Coriell; DA04193
DR   Wikidata; Q54823581
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04194
AC   CVCL_7V22
DR   CLO; CLO_0029993
DR   Coriell; DA04194
DR   Wikidata; Q54823582
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04195
AC   CVCL_7V23
DR   CLO; CLO_0029998
DR   Coriell; DA04195
DR   Wikidata; Q54823583
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04196
AC   CVCL_7V24
DR   CLO; CLO_0029997
DR   Coriell; DA04196
DR   Wikidata; Q54823584
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04197
AC   CVCL_7V25
DR   CLO; CLO_0030104
DR   Coriell; DA04197
DR   Wikidata; Q54823585
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04198
AC   CVCL_7V26
DR   CLO; CLO_0030121
DR   Coriell; DA04198
DR   Wikidata; Q54823586
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04199
AC   CVCL_7V27
DR   CLO; CLO_0030123
DR   Coriell; DA04199
DR   Wikidata; Q54823587
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04200
AC   CVCL_7V28
DR   CLO; CLO_0030126
DR   Coriell; DA04200
DR   Wikidata; Q54823588
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04201
AC   CVCL_7V29
DR   CLO; CLO_0030128
DR   Coriell; DA04201
DR   Wikidata; Q54823589
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04202
AC   CVCL_7V30
DR   CLO; CLO_0030113
DR   Coriell; DA04202
DR   Wikidata; Q54823590
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04203
AC   CVCL_7V31
DR   CLO; CLO_0030115
DR   Coriell; DA04203
DR   Wikidata; Q54823591
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04204
AC   CVCL_7V32
DR   CLO; CLO_0030119
DR   Coriell; DA04204
DR   Wikidata; Q54823592
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04205
AC   CVCL_7V33
DR   CLO; CLO_0030120
DR   Coriell; DA04205
DR   Wikidata; Q54823593
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04206
AC   CVCL_7V34
DR   CLO; CLO_0030111
DR   Coriell; DA04206
DR   Wikidata; Q54823594
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04207
AC   CVCL_7V35
DR   CLO; CLO_0030133
DR   Coriell; DA04207
DR   Wikidata; Q54823595
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04208
AC   CVCL_7V36
DR   CLO; CLO_0030130
DR   Coriell; DA04208
DR   Wikidata; Q54823596
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04209
AC   CVCL_7V37
DR   CLO; CLO_0030155
DR   Coriell; DA04209
DR   Wikidata; Q54823597
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04210
AC   CVCL_7V38
DR   CLO; CLO_0030157
DR   Coriell; DA04210
DR   Wikidata; Q54823598
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04211
AC   CVCL_7V39
DR   CLO; CLO_0030151
DR   Coriell; DA04211
DR   Wikidata; Q54823599
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04212
AC   CVCL_7V40
DR   CLO; CLO_0030153
DR   Coriell; DA04212
DR   Wikidata; Q54823600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04213
AC   CVCL_7V41
DR   CLO; CLO_0030145
DR   Coriell; DA04213
DR   Wikidata; Q54823601
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04215
AC   CVCL_7V42
DR   CLO; CLO_0030150
DR   Coriell; DA04215
DR   Wikidata; Q54823602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04216
AC   CVCL_7V43
DR   CLO; CLO_0030141
DR   Coriell; DA04216
DR   Wikidata; Q54823603
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04217
AC   CVCL_7V44
DR   CLO; CLO_0030144
DR   Coriell; DA04217
DR   Wikidata; Q54823604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04218
AC   CVCL_7V45
DR   CLO; CLO_0030054
DR   Coriell; DA04218
DR   Wikidata; Q54823605
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04219
AC   CVCL_7V46
DR   CLO; CLO_0030059
DR   Coriell; DA04219
DR   Wikidata; Q54823606
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04220
AC   CVCL_7V47
DR   CLO; CLO_0030057
DR   Coriell; DA04220
DR   Wikidata; Q54823607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04221
AC   CVCL_7V48
DR   CLO; CLO_0030064
DR   Coriell; DA04221
DR   Wikidata; Q54823608
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04222
AC   CVCL_7V49
DR   CLO; CLO_0030065
DR   Coriell; DA04222
DR   Wikidata; Q54823609
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04223
AC   CVCL_7V50
DR   CLO; CLO_0030067
DR   Coriell; DA04223
DR   Wikidata; Q54823611
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04224
AC   CVCL_7V51
DR   CLO; CLO_0030069
DR   Coriell; DA04224
DR   Wikidata; Q54823612
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04225
AC   CVCL_7V52
DR   CLO; CLO_0030071
DR   Coriell; DA04225
DR   Wikidata; Q54823613
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04226
AC   CVCL_7V53
DR   CLO; CLO_0030075
DR   Coriell; DA04226
DR   Wikidata; Q54823614
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04227
AC   CVCL_7V54
DR   CLO; CLO_0030076
DR   Coriell; DA04227
DR   Wikidata; Q54823615
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04228
AC   CVCL_7V55
DR   CLO; CLO_0030431
DR   Coriell; DA04228
DR   Wikidata; Q54823616
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04229
AC   CVCL_7V56
DR   CLO; CLO_0030420
DR   Coriell; DA04229
DR   Wikidata; Q54823617
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04230
AC   CVCL_7V57
DR   CLO; CLO_0030419
DR   Coriell; DA04230
DR   Wikidata; Q54823618
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04231
AC   CVCL_7V58
DR   CLO; CLO_0030422
DR   Coriell; DA04231
DR   Wikidata; Q54823619
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04232
AC   CVCL_7V59
DR   CLO; CLO_0030421
DR   Coriell; DA04232
DR   Wikidata; Q54823620
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04233
AC   CVCL_7V60
DR   CLO; CLO_0030424
DR   Coriell; DA04233
DR   Wikidata; Q54823621
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04234
AC   CVCL_7V61
DR   CLO; CLO_0030423
DR   Coriell; DA04234
DR   Wikidata; Q54823622
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04235
AC   CVCL_7V62
DR   CLO; CLO_0030426
DR   Coriell; DA04235
DR   Wikidata; Q54823623
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04236
AC   CVCL_7V63
DR   CLO; CLO_0030425
DR   Coriell; DA04236
DR   Wikidata; Q54823624
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04237
AC   CVCL_7V64
DR   CLO; CLO_0030460
DR   Coriell; DA04237
DR   Wikidata; Q54823625
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04238
AC   CVCL_7V65
DR   CLO; CLO_0030438
DR   Coriell; DA04238
DR   Wikidata; Q54823626
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04239
AC   CVCL_7V66
DR   CLO; CLO_0030439
DR   Coriell; DA04239
DR   Wikidata; Q54823627
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04240
AC   CVCL_7V67
DR   CLO; CLO_0030453
DR   Coriell; DA04240
DR   Wikidata; Q54823628
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04241
AC   CVCL_7V68
DR   CLO; CLO_0030455
DR   Coriell; DA04241
DR   Wikidata; Q54823629
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04242
AC   CVCL_7V69
DR   CLO; CLO_0030449
DR   Coriell; DA04242
DR   Wikidata; Q54823630
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04243
AC   CVCL_7V70
DR   CLO; CLO_0030452
DR   Coriell; DA04243
DR   Wikidata; Q54823631
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04244
AC   CVCL_7V71
DR   CLO; CLO_0030446
DR   Coriell; DA04244
DR   Wikidata; Q54823632
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04245
AC   CVCL_7V72
DR   CLO; CLO_0030447
DR   Coriell; DA04245
DR   Wikidata; Q54823633
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04246
AC   CVCL_7V73
DR   CLO; CLO_0030442
DR   Coriell; DA04246
DR   Wikidata; Q54823634
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04247
AC   CVCL_7V74
DR   CLO; CLO_0030444
DR   Coriell; DA04247
DR   Wikidata; Q54823635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04248
AC   CVCL_7V75
DR   CLO; CLO_0030471
DR   Coriell; DA04248
DR   Wikidata; Q54823636
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04249
AC   CVCL_7V76
DR   CLO; CLO_0030472
DR   Coriell; DA04249
DR   Wikidata; Q54823637
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04250
AC   CVCL_7V77
DR   CLO; CLO_0030473
DR   Coriell; DA04250
DR   Wikidata; Q54823638
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04251
AC   CVCL_7V78
DR   CLO; CLO_0030481
DR   Coriell; DA04251
DR   Wikidata; Q54823639
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04252
AC   CVCL_7V79
DR   CLO; CLO_0030484
DR   Coriell; DA04252
DR   Wikidata; Q54823640
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04253
AC   CVCL_7V80
DR   CLO; CLO_0030485
DR   Coriell; DA04253
DR   Wikidata; Q54823641
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04254
AC   CVCL_7V81
DR   CLO; CLO_0030488
DR   Coriell; DA04254
DR   Wikidata; Q54823642
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04255
AC   CVCL_7V82
DR   CLO; CLO_0030475
DR   Coriell; DA04255
DR   Wikidata; Q54823643
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04256
AC   CVCL_7V83
DR   CLO; CLO_0030476
DR   Coriell; DA04256
DR   Wikidata; Q54823644
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04257
AC   CVCL_7V84
DR   CLO; CLO_0030479
DR   Coriell; DA04257
DR   Wikidata; Q54823645
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04258
AC   CVCL_7V85
DR   CLO; CLO_0030503
DR   Coriell; DA04258
DR   Wikidata; Q54823646
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04259
AC   CVCL_7V86
DR   CLO; CLO_0030504
DR   Coriell; DA04259
DR   Wikidata; Q54823647
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04260
AC   CVCL_7V87
DR   CLO; CLO_0030499
DR   Coriell; DA04260
DR   Wikidata; Q54823648
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04261
AC   CVCL_7V88
DR   CLO; CLO_0030500
DR   Coriell; DA04261
DR   Wikidata; Q54823649
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04262
AC   CVCL_7V89
DR   CLO; CLO_0030511
DR   Coriell; DA04262
DR   Wikidata; Q54823651
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04263
AC   CVCL_7V90
DR   CLO; CLO_0030513
DR   Coriell; DA04263
DR   Wikidata; Q54823654
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04264
AC   CVCL_7V91
DR   CLO; CLO_0030506
DR   Coriell; DA04264
DR   Wikidata; Q54823655
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04265
AC   CVCL_7V92
DR   CLO; CLO_0030508
DR   Coriell; DA04265
DR   Wikidata; Q54823656
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04266
AC   CVCL_7V93
DR   CLO; CLO_0030516
DR   Coriell; DA04266
DR   Wikidata; Q54823657
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04267
AC   CVCL_7V94
DR   CLO; CLO_0030518
DR   Coriell; DA04267
DR   Wikidata; Q54823658
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04268
AC   CVCL_7V95
DR   CLO; CLO_0030529
DR   Coriell; DA04268
DR   Wikidata; Q54823659
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04269
AC   CVCL_7V96
DR   CLO; CLO_0030530
DR   Coriell; DA04269
DR   Wikidata; Q54823660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04270
AC   CVCL_7V97
DR   CLO; CLO_0030531
DR   Coriell; DA04270
DR   Wikidata; Q54823661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04271
AC   CVCL_7V98
DR   CLO; CLO_0030532
DR   Coriell; DA04271
DR   Wikidata; Q54823662
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04272
AC   CVCL_7V99
DR   CLO; CLO_0030533
DR   Coriell; DA04272
DR   Wikidata; Q54823663
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04273
AC   CVCL_7W00
DR   CLO; CLO_0030534
DR   Coriell; DA04273
DR   Wikidata; Q54823664
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04274
AC   CVCL_7W01
DR   CLO; CLO_0030535
DR   Coriell; DA04274
DR   Wikidata; Q54823665
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04275
AC   CVCL_7W02
DR   CLO; CLO_0030536
DR   Coriell; DA04275
DR   Wikidata; Q54823666
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04276
AC   CVCL_7W03
DR   CLO; CLO_0030537
DR   Coriell; DA04276
DR   Wikidata; Q54823667
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04277
AC   CVCL_7W04
DR   CLO; CLO_0030538
DR   Coriell; DA04277
DR   Wikidata; Q54823668
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04278
AC   CVCL_7W05
DR   CLO; CLO_0030588
DR   Coriell; DA04278
DR   Wikidata; Q54824547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04279
AC   CVCL_7W06
DR   CLO; CLO_0030583
DR   Coriell; DA04279
DR   Wikidata; Q54824548
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04280
AC   CVCL_7W07
DR   CLO; CLO_0030573
DR   Coriell; DA04280
DR   Wikidata; Q54824549
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04281
AC   CVCL_7W08
DR   CLO; CLO_0030571
DR   Coriell; DA04281
DR   Wikidata; Q54824550
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04282
AC   CVCL_7W09
DR   CLO; CLO_0030577
DR   Coriell; DA04282
DR   Wikidata; Q54824551
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04283
AC   CVCL_7W10
DR   CLO; CLO_0030576
DR   Coriell; DA04283
DR   Wikidata; Q54824553
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04284
AC   CVCL_7W11
DR   CLO; CLO_0030568
DR   Coriell; DA04284
DR   Wikidata; Q54824554
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04285
AC   CVCL_7W12
DR   CLO; CLO_0030567
DR   Coriell; DA04285
DR   Wikidata; Q54824555
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04286
AC   CVCL_7W13
DR   CLO; CLO_0030570
DR   Coriell; DA04286
DR   Wikidata; Q54824556
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04287
AC   CVCL_7W14
DR   CLO; CLO_0030569
DR   Coriell; DA04287
DR   Wikidata; Q54824557
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04288
AC   CVCL_7W15
DR   CLO; CLO_0030626
DR   Coriell; DA04288
DR   Wikidata; Q54824558
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04289
AC   CVCL_7W16
DR   CLO; CLO_0030622
DR   Coriell; DA04289
DR   Wikidata; Q54824559
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04290
AC   CVCL_7W17
DR   CLO; CLO_0030621
DR   Coriell; DA04290
DR   Wikidata; Q54824560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04291
AC   CVCL_7W18
DR   CLO; CLO_0030617
DR   Coriell; DA04291
DR   Wikidata; Q54824561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04292
AC   CVCL_7W19
DR   CLO; CLO_0030616
DR   Coriell; DA04292
DR   Wikidata; Q54824562
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04293
AC   CVCL_7W20
DR   CLO; CLO_0030614
DR   Coriell; DA04293
DR   Wikidata; Q54824563
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04294
AC   CVCL_7W21
DR   CLO; CLO_0030612
DR   Coriell; DA04294
DR   Wikidata; Q54824564
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04295
AC   CVCL_7W22
DR   CLO; CLO_0030609
DR   Coriell; DA04295
DR   Wikidata; Q54824565
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04297
AC   CVCL_7W23
DR   CLO; CLO_0030607
DR   Coriell; DA04297
DR   Wikidata; Q54824566
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04298
AC   CVCL_7W24
DR   CLO; CLO_0030606
DR   Coriell; DA04298
DR   Wikidata; Q54824567
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04299
AC   CVCL_7W25
DR   CLO; CLO_0030644
DR   Coriell; DA04299
DR   Wikidata; Q54824568
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Irish/Scottish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04300
AC   CVCL_7W26
DR   CLO; CLO_0030643
DR   Coriell; DA04300
DR   Wikidata; Q54824569
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04301
AC   CVCL_7W27
DR   CLO; CLO_0030649
DR   Coriell; DA04301
DR   Wikidata; Q54824570
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04302
AC   CVCL_7W28
DR   CLO; CLO_0030648
DR   Coriell; DA04302
DR   Wikidata; Q54824572
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04303
AC   CVCL_7W29
DR   CLO; CLO_0030653
DR   Coriell; DA04303
DR   Wikidata; Q54824573
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04304
AC   CVCL_7W30
DR   CLO; CLO_0030652
DR   Coriell; DA04304
DR   Wikidata; Q54824574
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04305
AC   CVCL_7W31
DR   CLO; CLO_0030658
DR   Coriell; DA04305
DR   Wikidata; Q54824575
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04306
AC   CVCL_7W32
DR   CLO; CLO_0030655
DR   Coriell; DA04306
DR   Wikidata; Q54824576
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04307
AC   CVCL_7W33
DR   CLO; CLO_0030639
DR   Coriell; DA04307
DR   Wikidata; Q54824577
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04308
AC   CVCL_7W34
DR   CLO; CLO_0030637
DR   Coriell; DA04308
DR   Wikidata; Q54824578
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04309
AC   CVCL_7W35
DR   CLO; CLO_0030664
DR   Coriell; DA04309
DR   Wikidata; Q54824579
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04310
AC   CVCL_7W36
DR   CLO; CLO_0030674
DR   Coriell; DA04310
DR   Wikidata; Q54824580
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04311
AC   CVCL_7W37
DR   CLO; CLO_0030672
DR   Coriell; DA04311
DR   Wikidata; Q54824581
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04312
AC   CVCL_7W38
DR   CLO; CLO_0030671
DR   Coriell; DA04312
DR   Wikidata; Q54824582
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04313
AC   CVCL_7W39
DR   CLO; CLO_0030670
DR   Coriell; DA04313
DR   Wikidata; Q54824583
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04314
AC   CVCL_7W40
DR   CLO; CLO_0030678
DR   Coriell; DA04314
DR   Wikidata; Q54824584
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04315
AC   CVCL_7W41
DR   CLO; CLO_0030677
DR   Coriell; DA04315
DR   Wikidata; Q54824585
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04316
AC   CVCL_7W42
DR   CLO; CLO_0030676
DR   Coriell; DA04316
DR   Wikidata; Q54824586
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04317
AC   CVCL_7W43
DR   CLO; CLO_0030675
DR   Coriell; DA04317
DR   Wikidata; Q54824587
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04318
AC   CVCL_7W44
DR   CLO; CLO_0030669
DR   Coriell; DA04318
DR   Wikidata; Q54824589
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04319
AC   CVCL_7W45
DR   CLO; CLO_0030686
DR   Coriell; DA04319
DR   Wikidata; Q54824600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04320
AC   CVCL_7W46
DR   CLO; CLO_0030683
DR   Coriell; DA04320
DR   Wikidata; Q54824602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04321
AC   CVCL_7W47
DR   CLO; CLO_0030701
DR   Coriell; DA04321
DR   Wikidata; Q54824603
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04322
AC   CVCL_7W48
DR   CLO; CLO_0030704
DR   Coriell; DA04322
DR   Wikidata; Q54824604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04323
AC   CVCL_7W49
DR   CLO; CLO_0030706
DR   Coriell; DA04323
DR   Wikidata; Q54824605
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04324
AC   CVCL_7W50
DR   CLO; CLO_0030707
DR   Coriell; DA04324
DR   Wikidata; Q54824606
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04325
AC   CVCL_7W51
DR   CLO; CLO_0030694
DR   Coriell; DA04325
DR   Wikidata; Q54824607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04327
AC   CVCL_7W52
DR   CLO; CLO_0030697
DR   Coriell; DA04327
DR   Wikidata; Q54824608
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04328
AC   CVCL_7W53
DR   CLO; CLO_0030699
DR   Coriell; DA04328
DR   Wikidata; Q54824609
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04330
AC   CVCL_7W54
DR   CLO; CLO_0030700
DR   Coriell; DA04330
DR   Wikidata; Q54824610
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04331
AC   CVCL_7W55
DR   CLO; CLO_0026847
DR   Coriell; DA04331
DR   Wikidata; Q54824611
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04332
AC   CVCL_7W56
DR   CLO; CLO_0026852
DR   Coriell; DA04332
DR   Wikidata; Q54824612
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04333
AC   CVCL_7W57
DR   CLO; CLO_0026854
DR   Coriell; DA04333
DR   Wikidata; Q54824613
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04334
AC   CVCL_7W58
DR   CLO; CLO_0026857
DR   Coriell; DA04334
DR   Wikidata; Q54824614
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04339
AC   CVCL_7W59
DR   CLO; CLO_0026839
DR   Coriell; DA04339
DR   Wikidata; Q54824615
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04340
AC   CVCL_7W60
DR   CLO; CLO_0026840
DR   Coriell; DA04340
DR   Wikidata; Q54824616
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04342
AC   CVCL_7W61
DR   CLO; CLO_0026843
DR   Coriell; DA04342
DR   Wikidata; Q54824617
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04343
AC   CVCL_7W62
DR   CLO; CLO_0026845
DR   Coriell; DA04343
DR   Wikidata; Q54824618
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04344
AC   CVCL_7W63
DR   CLO; CLO_0026801
DR   Coriell; DA04344
DR   Wikidata; Q54824619
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04345
AC   CVCL_7W64
DR   CLO; CLO_0026800
DR   Coriell; DA04345
DR   Wikidata; Q54824621
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04346
AC   CVCL_7W65
DR   CLO; CLO_0026806
DR   Coriell; DA04346
DR   Wikidata; Q54824622
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04347
AC   CVCL_7W66
DR   CLO; CLO_0026818
DR   Coriell; DA04347
DR   Wikidata; Q54824623
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04348
AC   CVCL_7W67
DR   CLO; CLO_0026820
DR   Coriell; DA04348
DR   Wikidata; Q54824624
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04349
AC   CVCL_7W68
DR   CLO; CLO_0026811
DR   Coriell; DA04349
DR   Wikidata; Q54824625
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04350
AC   CVCL_7W69
DR   CLO; CLO_0026814
DR   Coriell; DA04350
DR   Wikidata; Q54824626
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04351
AC   CVCL_7W70
DR   CLO; CLO_0026828
DR   Coriell; DA04351
DR   Wikidata; Q54824627
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04352
AC   CVCL_7W71
DR   CLO; CLO_0026830
DR   Coriell; DA04352
DR   Wikidata; Q54824628
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04359
AC   CVCL_7W72
DR   CLO; CLO_0026823
DR   Coriell; DA04359
DR   Wikidata; Q54824629
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04360
AC   CVCL_7W73
DR   CLO; CLO_0026825
DR   Coriell; DA04360
DR   Wikidata; Q54824630
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04361
AC   CVCL_7W74
DR   CLO; CLO_0026759
DR   Coriell; DA04361
DR   Wikidata; Q54824631
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04362
AC   CVCL_7W75
DR   CLO; CLO_0026775
DR   Coriell; DA04362
DR   Wikidata; Q54824632
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04363
AC   CVCL_7W76
DR   CLO; CLO_0026778
DR   Coriell; DA04363
DR   Wikidata; Q54824633
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04365
AC   CVCL_7W77
DR   CLO; CLO_0026781
DR   Coriell; DA04365
DR   Wikidata; Q54824634
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04366
AC   CVCL_7W78
DR   CLO; CLO_0026783
DR   Coriell; DA04366
DR   Wikidata; Q54824635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04367
AC   CVCL_7W79
DR   CLO; CLO_0026785
DR   Coriell; DA04367
DR   Wikidata; Q54824637
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04368
AC   CVCL_7W80
DR   CLO; CLO_0026788
DR   Coriell; DA04368
DR   Wikidata; Q54824638
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA04368; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA04369
AC   CVCL_7W81
DR   CLO; CLO_0026791
DR   Coriell; DA04369
DR   Wikidata; Q54824639
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04371
AC   CVCL_7W82
DR   CLO; CLO_0026793
DR   Coriell; DA04371
DR   Wikidata; Q54824640
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04372
AC   CVCL_7W83
DR   CLO; CLO_0026796
DR   Coriell; DA04372
DR   Wikidata; Q54824641
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04373
AC   CVCL_7W84
DR   CLO; CLO_0026799
DR   Coriell; DA04373
DR   Wikidata; Q54824642
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04374
AC   CVCL_7W85
DR   CLO; CLO_0026756
DR   Coriell; DA04374
DR   Wikidata; Q54824652
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04375
AC   CVCL_7W86
DR   CLO; CLO_0026754
DR   Coriell; DA04375
DR   Wikidata; Q54824653
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04376
AC   CVCL_7W87
DR   CLO; CLO_0026753
DR   Coriell; DA04376
DR   Wikidata; Q54824654
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04377
AC   CVCL_7W88
DR   CLO; CLO_0026751
DR   Coriell; DA04377
DR   Wikidata; Q54824655
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04379
AC   CVCL_7W89
DR   CLO; CLO_0026749
DR   Coriell; DA04379
DR   Wikidata; Q54824656
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04380
AC   CVCL_7W90
DR   CLO; CLO_0026747
DR   Coriell; DA04380
DR   Wikidata; Q54824657
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04381
AC   CVCL_7W91
DR   CLO; CLO_0026746
DR   Coriell; DA04381
DR   Wikidata; Q54824658
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04384
AC   CVCL_7W92
DR   CLO; CLO_0026744
DR   Coriell; DA04384
DR   Wikidata; Q54824659
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04385
AC   CVCL_7W93
DR   CLO; CLO_0026742
DR   Coriell; DA04385
DR   Wikidata; Q54824660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04386
AC   CVCL_7W94
DR   CLO; CLO_0026740
DR   Coriell; DA04386
DR   Wikidata; Q54824661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04387
AC   CVCL_7W95
DR   CLO; CLO_0026713
DR   Coriell; DA04387
DR   Wikidata; Q54824662
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04388
AC   CVCL_7W96
DR   CLO; CLO_0026711
DR   Coriell; DA04388
DR   Wikidata; Q54824663
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04389
AC   CVCL_7W97
DR   CLO; CLO_0026717
DR   Coriell; DA04389
DR   Wikidata; Q54824664
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04390
AC   CVCL_7W98
DR   CLO; CLO_0026714
DR   Coriell; DA04390
DR   Wikidata; Q54824665
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04392
AC   CVCL_7W99
DR   CLO; CLO_0026706
DR   Coriell; DA04392
DR   Wikidata; Q54824667
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04395
AC   CVCL_7X00
DR   CLO; CLO_0026705
DR   Coriell; DA04395
DR   Wikidata; Q54824668
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04396
AC   CVCL_7X01
DR   CLO; CLO_0026710
DR   Coriell; DA04396
DR   Wikidata; Q54824669
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04397
AC   CVCL_7X02
DR   CLO; CLO_0026709
DR   Coriell; DA04397
DR   Wikidata; Q54824670
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04400
AC   CVCL_7X03
DR   CLO; CLO_0026701
DR   Coriell; DA04400
DR   Wikidata; Q54824671
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04401
AC   CVCL_7X04
DR   CLO; CLO_0026698
DR   Coriell; DA04401
DR   Wikidata; Q54824672
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04402
AC   CVCL_7X05
DR   CLO; CLO_0026672
DR   Coriell; DA04402
DR   Wikidata; Q54824673
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04403
AC   CVCL_7X06
DR   CLO; CLO_0026676
DR   Coriell; DA04403
DR   Wikidata; Q54824674
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04404
AC   CVCL_7X07
DR   CLO; CLO_0026675
DR   Coriell; DA04404
DR   Wikidata; Q54824675
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04405
AC   CVCL_7X08
DR   CLO; CLO_0026674
DR   Coriell; DA04405
DR   Wikidata; Q54824676
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04406
AC   CVCL_7X09
DR   CLO; CLO_0026673
DR   Coriell; DA04406
DR   Wikidata; Q54824677
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04407
AC   CVCL_7X10
DR   CLO; CLO_0026666
DR   Coriell; DA04407
DR   Wikidata; Q54824678
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04408
AC   CVCL_7X11
DR   CLO; CLO_0026663
DR   Coriell; DA04408
DR   Wikidata; Q54824680
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04409
AC   CVCL_7X12
DR   CLO; CLO_0026662
DR   Coriell; DA04409
DR   Wikidata; Q54824681
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04410
AC   CVCL_7X13
DR   CLO; CLO_0026659
DR   Coriell; DA04410
DR   Wikidata; Q54824682
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04411
AC   CVCL_7X14
DR   CLO; CLO_0026671
DR   Coriell; DA04411
DR   Wikidata; Q54824683
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04412
AC   CVCL_7X15
DR   CLO; CLO_0026641
DR   Coriell; DA04412
DR   Wikidata; Q54824684
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04413
AC   CVCL_7X16
DR   CLO; CLO_0026640
DR   Coriell; DA04413
DR   Wikidata; Q54824685
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04414
AC   CVCL_7X17
DR   CLO; CLO_0026644
DR   Coriell; DA04414
DR   Wikidata; Q54824686
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04415
AC   CVCL_7X18
DR   CLO; CLO_0026642
DR   Coriell; DA04415
DR   Wikidata; Q54824687
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04416
AC   CVCL_7X19
DR   CLO; CLO_0026646
DR   Coriell; DA04416
DR   Wikidata; Q54824688
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04417
AC   CVCL_7X20
DR   CLO; CLO_0026645
DR   Coriell; DA04417
DR   Wikidata; Q54824689
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04418
AC   CVCL_7X21
DR   CLO; CLO_0026627
DR   Coriell; DA04418
DR   Wikidata; Q54824690
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04419
AC   CVCL_7X22
DR   CLO; CLO_0026626
DR   Coriell; DA04419
DR   Wikidata; Q54824691
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04421
AC   CVCL_7X23
DR   CLO; CLO_0026634
DR   Coriell; DA04421
DR   Wikidata; Q54824692
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04422
AC   CVCL_7X24
DR   CLO; CLO_0026631
DR   Coriell; DA04422
DR   Wikidata; Q54824693
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04423
AC   CVCL_7X25
DR   CLO; CLO_0026571
DR   Coriell; DA04423
DR   Wikidata; Q54824704
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04425
AC   CVCL_7X26
DR   CLO; CLO_0026574
DR   Coriell; DA04425
DR   Wikidata; Q54824705
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04426
AC   CVCL_7X27
DR   CLO; CLO_0026576
DR   Coriell; DA04426
DR   Wikidata; Q54824706
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04427
AC   CVCL_7X28
DR   CLO; CLO_0026562
DR   Coriell; DA04427
DR   Wikidata; Q54824707
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04428
AC   CVCL_7X29
DR   CLO; CLO_0026564
DR   Coriell; DA04428
DR   Wikidata; Q54824708
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04429
AC   CVCL_7X30
DR   CLO; CLO_0026566
DR   Coriell; DA04429
DR   Wikidata; Q54824709
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04430
AC   CVCL_7X31
DR   CLO; CLO_0026567
DR   Coriell; DA04430
DR   Wikidata; Q54824710
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04431
AC   CVCL_7X32
DR   CLO; CLO_0026579
DR   Coriell; DA04431
DR   Wikidata; Q54824711
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04432
AC   CVCL_7X33
DR   CLO; CLO_0026580
DR   Coriell; DA04432
DR   Wikidata; Q54824713
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04433
AC   CVCL_7X34
DR   CLO; CLO_0026581
DR   Coriell; DA04433
DR   Wikidata; Q54824714
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04434
AC   CVCL_7X35
DR   CLO; CLO_0026533
DR   Coriell; DA04434
DR   Wikidata; Q54824715
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04435
AC   CVCL_7X36
DR   CLO; CLO_0026538
DR   Coriell; DA04435
DR   Wikidata; Q54824716
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04436
AC   CVCL_7X37
DR   CLO; CLO_0026529
DR   Coriell; DA04436
DR   Wikidata; Q54824717
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04437
AC   CVCL_7X38
DR   CLO; CLO_0026531
DR   Coriell; DA04437
DR   Wikidata; Q54824718
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04438
AC   CVCL_7X39
DR   CLO; CLO_0026525
DR   Coriell; DA04438
DR   Wikidata; Q54824719
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04439
AC   CVCL_7X40
DR   CLO; CLO_0026528
DR   Coriell; DA04439
DR   Wikidata; Q54824720
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04441
AC   CVCL_7X41
DR   CLO; CLO_0026522
DR   Coriell; DA04441
DR   Wikidata; Q54824721
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04442
AC   CVCL_7X42
DR   CLO; CLO_0026523
DR   Coriell; DA04442
DR   Wikidata; Q54824722
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04443
AC   CVCL_7X43
DR   CLO; CLO_0026539
DR   Coriell; DA04443
DR   Wikidata; Q54824723
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04444
AC   CVCL_7X44
DR   CLO; CLO_0026541
DR   Coriell; DA04444
DR   Wikidata; Q54824724
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04445
AC   CVCL_7X45
DR   CLO; CLO_0026517
DR   Coriell; DA04445
DR   Wikidata; Q54824725
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04446
AC   CVCL_7X46
DR   CLO; CLO_0026481
DR   Coriell; DA04446
DR   Wikidata; Q54824726
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04447
AC   CVCL_7X47
DR   CLO; CLO_0026482
DR   Coriell; DA04447
DR   Wikidata; Q54824728
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04448
AC   CVCL_7X48
DR   CLO; CLO_0026486
DR   Coriell; DA04448
DR   Wikidata; Q54824729
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04449
AC   CVCL_7X49
DR   CLO; CLO_0026487
DR   Coriell; DA04449
DR   Wikidata; Q54824730
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04450
AC   CVCL_7X50
DR   CLO; CLO_0026489
DR   Coriell; DA04450
DR   Wikidata; Q54824731
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04451
AC   CVCL_7X51
DR   CLO; CLO_0026491
DR   Coriell; DA04451
DR   Wikidata; Q54824732
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04452
AC   CVCL_7X52
DR   CLO; CLO_0026494
DR   Coriell; DA04452
DR   Wikidata; Q54824733
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04453
AC   CVCL_7X53
DR   CLO; CLO_0026496
DR   Coriell; DA04453
DR   Wikidata; Q54824734
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04456
AC   CVCL_7X54
DR   CLO; CLO_0026499
DR   Coriell; DA04456
DR   Wikidata; Q54824735
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04457
AC   CVCL_7X55
DR   CLO; CLO_0027460
DR   Coriell; DA04457
DR   Wikidata; Q54824736
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04458
AC   CVCL_7X56
DR   CLO; CLO_0027458
DR   Coriell; DA04458
DR   Wikidata; Q54824737
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04460
AC   CVCL_7X57
DR   CLO; CLO_0027457
DR   Coriell; DA04460
DR   Wikidata; Q54824738
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04461
AC   CVCL_7X58
DR   CLO; CLO_0027455
DR   Coriell; DA04461
DR   Wikidata; Q54824739
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04462
AC   CVCL_7X59
DR   CLO; CLO_0027452
DR   Coriell; DA04462
DR   Wikidata; Q54824740
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04463
AC   CVCL_7X60
DR   CLO; CLO_0027450
DR   Coriell; DA04463
DR   Wikidata; Q54824741
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04464
AC   CVCL_7X61
DR   CLO; CLO_0027446
DR   Coriell; DA04464
DR   Wikidata; Q54824742
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04465
AC   CVCL_7X62
DR   CLO; CLO_0027336
DR   Coriell; DA04465
DR   Wikidata; Q54824744
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04466
AC   CVCL_7X63
DR   CLO; CLO_0027335
DR   Coriell; DA04466
DR   Wikidata; Q54824745
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04468
AC   CVCL_7X64
DR   CLO; CLO_0027334
DR   Coriell; DA04468
DR   Wikidata; Q54824746
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04469
AC   CVCL_7X65
DR   CLO; CLO_0027354
DR   Coriell; DA04469
DR   Wikidata; Q54824758
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04470
AC   CVCL_7X66
DR   CLO; CLO_0027357
DR   Coriell; DA04470
DR   Wikidata; Q54824759
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04471
AC   CVCL_7X67
DR   CLO; CLO_0027347
DR   Coriell; DA04471
DR   Wikidata; Q54824760
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04472
AC   CVCL_7X68
DR   CLO; CLO_0027349
DR   Coriell; DA04472
DR   Wikidata; Q54824761
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04474
AC   CVCL_7X69
DR   CLO; CLO_0027343
DR   Coriell; DA04474
DR   Wikidata; Q54824762
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04475
AC   CVCL_7X70
DR   CLO; CLO_0027345
DR   Coriell; DA04475
DR   Wikidata; Q54824763
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04476
AC   CVCL_7X71
DR   CLO; CLO_0027338
DR   Coriell; DA04476
DR   Wikidata; Q54824764
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04478
AC   CVCL_7X72
DR   CLO; CLO_0027342
DR   Coriell; DA04478
DR   Wikidata; Q54824765
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04479
AC   CVCL_7X73
DR   CLO; CLO_0027303
DR   Coriell; DA04479
DR   Wikidata; Q54824766
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04480
AC   CVCL_7X74
DR   CLO; CLO_0027302
DR   Coriell; DA04480
DR   Wikidata; Q54824767
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04481
AC   CVCL_7X75
DR   CLO; CLO_0027329
DR   Coriell; DA04481
DR   Wikidata; Q54824768
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04482
AC   CVCL_7X76
DR   CLO; CLO_0027315
DR   Coriell; DA04482
DR   Wikidata; Q54824769
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04483
AC   CVCL_7X77
DR   CLO; CLO_0027317
DR   Coriell; DA04483
DR   Wikidata; Q54824771
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04484
AC   CVCL_7X78
DR   CLO; CLO_0027321
DR   Coriell; DA04484
DR   Wikidata; Q54824772
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04485
AC   CVCL_7X79
DR   CLO; CLO_0027323
DR   Coriell; DA04485
DR   Wikidata; Q54824773
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04487
AC   CVCL_7X80
DR   CLO; CLO_0027304
DR   Coriell; DA04487
DR   Wikidata; Q54824774
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04488
AC   CVCL_7X81
DR   CLO; CLO_0027305
DR   Coriell; DA04488
DR   Wikidata; Q54824775
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04490
AC   CVCL_7X82
DR   CLO; CLO_0027307
DR   Coriell; DA04490
DR   Wikidata; Q54824776
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04491
AC   CVCL_7X83
DR   CLO; CLO_0027311
DR   Coriell; DA04491
DR   Wikidata; Q54824777
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04492
AC   CVCL_7X84
DR   CLO; CLO_0027381
DR   Coriell; DA04492
DR   Wikidata; Q54824778
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04493
AC   CVCL_7X85
DR   CLO; CLO_0027407
DR   Coriell; DA04493
DR   Wikidata; Q54824779
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04494
AC   CVCL_7X86
DR   CLO; CLO_0027409
DR   Coriell; DA04494
DR   Wikidata; Q54824780
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04495
AC   CVCL_7X87
DR   CLO; CLO_0027392
DR   Coriell; DA04495
DR   Wikidata; Q54824781
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04496
AC   CVCL_7X88
DR   CLO; CLO_0027394
DR   Coriell; DA04496
DR   Wikidata; Q54824783
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04497
AC   CVCL_7X89
DR   CLO; CLO_0027385
DR   Coriell; DA04497
DR   Wikidata; Q54824784
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04498
AC   CVCL_7X90
DR   CLO; CLO_0027387
DR   Coriell; DA04498
DR   Wikidata; Q54824785
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04499
AC   CVCL_7X91
DR   CLO; CLO_0027402
DR   Coriell; DA04499
DR   Wikidata; Q54824786
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04500
AC   CVCL_7X92
DR   CLO; CLO_0027404
DR   Coriell; DA04500
DR   Wikidata; Q54824787
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04501
AC   CVCL_7X93
DR   CLO; CLO_0027398
DR   Coriell; DA04501
DR   Wikidata; Q54824788
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04502
AC   CVCL_7X94
DR   CLO; CLO_0027400
DR   Coriell; DA04502
DR   Wikidata; Q54824789
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04503
AC   CVCL_7X95
DR   CLO; CLO_0027378
DR   Coriell; DA04503
DR   Wikidata; Q54824790
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04504
AC   CVCL_7X96
DR   CLO; CLO_0027379
DR   Coriell; DA04504
DR   Wikidata; Q54824791
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04505
AC   CVCL_7X97
DR   CLO; CLO_0027380
DR   Coriell; DA04505
DR   Wikidata; Q54824792
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04506
AC   CVCL_7X98
DR   CLO; CLO_0027362
DR   Coriell; DA04506
DR   Wikidata; Q54824793
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04507
AC   CVCL_7X99
DR   CLO; CLO_0027365
DR   Coriell; DA04507
DR   Wikidata; Q54824794
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04508
AC   CVCL_7Y00
DR   CLO; CLO_0027366
DR   Coriell; DA04508
DR   Wikidata; Q54824795
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04509
AC   CVCL_7Y01
DR   CLO; CLO_0027369
DR   Coriell; DA04509
DR   Wikidata; Q54824797
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04510
AC   CVCL_7Y02
DR   CLO; CLO_0027371
DR   Coriell; DA04510
DR   Wikidata; Q54824798
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04511
AC   CVCL_7Y03
DR   CLO; CLO_0027372
DR   Coriell; DA04511
DR   Wikidata; Q54824799
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04512
AC   CVCL_7Y04
DR   CLO; CLO_0027374
DR   Coriell; DA04512
DR   Wikidata; Q54824800
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04513
AC   CVCL_7Y05
DR   CLO; CLO_0027198
DR   Coriell; DA04513
DR   Wikidata; Q54824812
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04514
AC   CVCL_7Y06
DR   CLO; CLO_0027197
DR   Coriell; DA04514
DR   Wikidata; Q54824813
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04515
AC   CVCL_7Y07
DR   CLO; CLO_0027195
DR   Coriell; DA04515
DR   Wikidata; Q54824814
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04516
AC   CVCL_7Y08
DR   CLO; CLO_0027192
DR   Coriell; DA04516
DR   Wikidata; Q54824815
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04517
AC   CVCL_7Y09
DR   CLO; CLO_0027211
DR   Coriell; DA04517
DR   Wikidata; Q54824816
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04518
AC   CVCL_7Y10
DR   CLO; CLO_0027208
DR   Coriell; DA04518
DR   Wikidata; Q54824818
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04519
AC   CVCL_7Y11
DR   CLO; CLO_0027207
DR   Coriell; DA04519
DR   Wikidata; Q54824819
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04520
AC   CVCL_7Y12
DR   CLO; CLO_0027205
DR   Coriell; DA04520
DR   Wikidata; Q54824820
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04521
AC   CVCL_7Y13
DR   CLO; CLO_0027203
DR   Coriell; DA04521
DR   Wikidata; Q54824821
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04522
AC   CVCL_7Y14
DR   CLO; CLO_0027202
DR   Coriell; DA04522
DR   Wikidata; Q54824822
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04523
AC   CVCL_7Y15
DR   CLO; CLO_0027164
DR   Coriell; DA04523
DR   Wikidata; Q54824823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04524
AC   CVCL_7Y16
DR   CLO; CLO_0027159
DR   Coriell; DA04524
DR   Wikidata; Q54824824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04525
AC   CVCL_7Y17
DR   CLO; CLO_0027158
DR   Coriell; DA04525
DR   Wikidata; Q54824825
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04526
AC   CVCL_7Y18
DR   CLO; CLO_0027163
DR   Coriell; DA04526
DR   Wikidata; Q54824826
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04527
AC   CVCL_7Y19
DR   CLO; CLO_0027160
DR   Coriell; DA04527
DR   Wikidata; Q54824827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04528
AC   CVCL_7Y20
DR   CLO; CLO_0027174
DR   Coriell; DA04528
DR   Wikidata; Q54824829
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04529
AC   CVCL_7Y21
DR   CLO; CLO_0027172
DR   Coriell; DA04529
DR   Wikidata; Q54824830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04530
AC   CVCL_7Y22
DR   CLO; CLO_0027179
DR   Coriell; DA04530
DR   Wikidata; Q54824831
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04531
AC   CVCL_7Y23
DR   CLO; CLO_0027176
DR   Coriell; DA04531
DR   Wikidata; Q54824832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04532
AC   CVCL_7Y24
DR   CLO; CLO_0027166
DR   Coriell; DA04532
DR   Wikidata; Q54824833
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04533
AC   CVCL_7Y25
DR   CLO; CLO_0027268
DR   Coriell; DA04533
DR   Wikidata; Q54824834
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04534
AC   CVCL_7Y26
DR   CLO; CLO_0027266
DR   Coriell; DA04534
DR   Wikidata; Q54824835
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04535
AC   CVCL_7Y27
DR   CLO; CLO_0027276
DR   Coriell; DA04535
DR   Wikidata; Q54824836
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04536
AC   CVCL_7Y28
DR   CLO; CLO_0027273
DR   Coriell; DA04536
DR   Wikidata; Q54824837
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04537
AC   CVCL_7Y29
DR   CLO; CLO_0027272
DR   Coriell; DA04537
DR   Wikidata; Q54824838
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04538
AC   CVCL_7Y30
DR   CLO; CLO_0027269
DR   Coriell; DA04538
DR   Wikidata; Q54824839
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04539
AC   CVCL_7Y31
DR   CLO; CLO_0027289
DR   Coriell; DA04539
DR   Wikidata; Q54824840
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04540
AC   CVCL_7Y32
DR   CLO; CLO_0027285
DR   Coriell; DA04540
DR   Wikidata; Q54824841
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04541
AC   CVCL_7Y33
DR   CLO; CLO_0027281
DR   Coriell; DA04541
DR   Wikidata; Q54824842
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04544
AC   CVCL_7Y34
DR   CLO; CLO_0027279
DR   Coriell; DA04544
DR   Wikidata; Q54824843
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04545
AC   CVCL_7Y35
DR   CLO; CLO_0027224
DR   Coriell; DA04545
DR   Wikidata; Q54824844
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04546
AC   CVCL_7Y36
DR   CLO; CLO_0027226
DR   Coriell; DA04546
DR   Wikidata; Q54824846
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04547
AC   CVCL_7Y37
DR   CLO; CLO_0027225
DR   Coriell; DA04547
DR   Wikidata; Q54824847
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04548
AC   CVCL_7Y38
DR   CLO; CLO_0027230
DR   Coriell; DA04548
DR   Wikidata; Q54824848
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04549
AC   CVCL_7Y39
DR   CLO; CLO_0027229
DR   Coriell; DA04549
DR   Wikidata; Q54824849
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04550
AC   CVCL_7Y40
DR   CLO; CLO_0027236
DR   Coriell; DA04550
DR   Wikidata; Q54824850
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04551
AC   CVCL_7Y41
DR   CLO; CLO_0027233
DR   Coriell; DA04551
DR   Wikidata; Q54824851
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04552
AC   CVCL_7Y42
DR   CLO; CLO_0027241
DR   Coriell; DA04552
DR   Wikidata; Q54824852
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04553
AC   CVCL_7Y43
DR   CLO; CLO_0027237
DR   Coriell; DA04553
DR   Wikidata; Q54824853
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04554
AC   CVCL_7Y44
DR   CLO; CLO_0027247
DR   Coriell; DA04554
DR   Wikidata; Q54824854
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04555
AC   CVCL_7Y45
DR   CLO; CLO_0027079
DR   Coriell; DA04555
DR   Wikidata; Q54824865
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04556
AC   CVCL_7Y46
DR   CLO; CLO_0027080
DR   Coriell; DA04556
DR   Wikidata; Q54824868
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04557
AC   CVCL_7Y47
DR   CLO; CLO_0027083
DR   Coriell; DA04557
DR   Wikidata; Q54824869
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04558
AC   CVCL_7Y48
DR   CLO; CLO_0027084
DR   Coriell; DA04558
DR   Wikidata; Q54824871
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04559
AC   CVCL_7Y49
DR   CLO; CLO_0027072
DR   Coriell; DA04559
DR   Wikidata; Q54824872
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04560
AC   CVCL_7Y50
DR   CLO; CLO_0027073
DR   Coriell; DA04560
DR   Wikidata; Q54824873
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04561
AC   CVCL_7Y51
DR   CLO; CLO_0027075
DR   Coriell; DA04561
DR   Wikidata; Q54824874
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04563
AC   CVCL_7Y52
DR   CLO; CLO_0027076
DR   Coriell; DA04563
DR   Wikidata; Q54824875
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04564
AC   CVCL_7Y53
DR   CLO; CLO_0027069
DR   Coriell; DA04564
DR   Wikidata; Q54824876
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04565
AC   CVCL_7Y54
DR   CLO; CLO_0027070
DR   Coriell; DA04565
DR   Wikidata; Q54824878
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04567
AC   CVCL_7Y55
DR   CLO; CLO_0010171
DR   Coriell; DA04567
DR   Wikidata; Q54824879
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04568
AC   CVCL_7Y56
DR   CLO; CLO_0010173
DR   Coriell; DA04568
DR   Wikidata; Q54824880
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04569
AC   CVCL_7Y57
DR   CLO; CLO_0010172
DR   Coriell; DA04569
DR   Wikidata; Q54826520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04570
AC   CVCL_7Y58
DR   CLO; CLO_0010175
DR   Coriell; DA04570
DR   Wikidata; Q54826521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04571
AC   CVCL_7Y59
DR   CLO; CLO_0010174
DR   Coriell; DA04571
DR   Wikidata; Q54826522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04572
AC   CVCL_7Y60
DR   CLO; CLO_0010177
DR   Coriell; DA04572
DR   Wikidata; Q54826523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04573
AC   CVCL_7Y61
DR   CLO; CLO_0010176
DR   Coriell; DA04573
DR   Wikidata; Q54826524
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04574
AC   CVCL_7Y62
DR   CLO; CLO_0010179
DR   Coriell; DA04574
DR   Wikidata; Q54826525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04575
AC   CVCL_7Y63
DR   CLO; CLO_0010178
DR   Coriell; DA04575
DR   Wikidata; Q54826526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04576
AC   CVCL_7Y64
DR   CLO; CLO_0010180
DR   Coriell; DA04576
DR   Wikidata; Q54826527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04577
AC   CVCL_7Y65
DR   CLO; CLO_0010161
DR   Coriell; DA04577
DR   Wikidata; Q54826528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04578
AC   CVCL_7Y66
DR   CLO; CLO_0010162
DR   Coriell; DA04578
DR   Wikidata; Q54826529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04579
AC   CVCL_7Y67
DR   CLO; CLO_0010166
DR   Coriell; DA04579
DR   Wikidata; Q54826530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04580
AC   CVCL_7Y68
DR   CLO; CLO_0010165
DR   Coriell; DA04580
DR   Wikidata; Q54826531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04581
AC   CVCL_7Y69
DR   CLO; CLO_0010164
DR   Coriell; DA04581
DR   Wikidata; Q54826532
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04582
AC   CVCL_7Y70
DR   CLO; CLO_0010163
DR   Coriell; DA04582
DR   Wikidata; Q54826533
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04583
AC   CVCL_7Y71
DR   CLO; CLO_0010170
DR   Coriell; DA04583
DR   Wikidata; Q54826534
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04584
AC   CVCL_7Y72
DR   CLO; CLO_0010169
DR   Coriell; DA04584
DR   Wikidata; Q54826535
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04585
AC   CVCL_7Y73
DR   CLO; CLO_0010168
DR   Coriell; DA04585
DR   Wikidata; Q54826537
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04586
AC   CVCL_7Y74
DR   CLO; CLO_0010167
DR   Coriell; DA04586
DR   Wikidata; Q54826538
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04587
AC   CVCL_7Y75
DR   CLO; CLO_0010191
DR   Coriell; DA04587
DR   Wikidata; Q54826539
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04588
AC   CVCL_7Y76
DR   CLO; CLO_0010192
DR   Coriell; DA04588
DR   Wikidata; Q54826540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04589
AC   CVCL_7Y77
DR   CLO; CLO_0010193
DR   Coriell; DA04589
DR   Wikidata; Q54826541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04590
AC   CVCL_7Y78
DR   CLO; CLO_0010198
DR   Coriell; DA04590
DR   Wikidata; Q54826542
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04591
AC   CVCL_7Y79
DR   CLO; CLO_0010197
DR   Coriell; DA04591
DR   Wikidata; Q54826543
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04592
AC   CVCL_7Y80
DR   CLO; CLO_0010200
DR   Coriell; DA04592
DR   Wikidata; Q54826544
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04593
AC   CVCL_7Y81
DR   CLO; CLO_0010199
DR   Coriell; DA04593
DR   Wikidata; Q54826545
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04594
AC   CVCL_7Y82
DR   CLO; CLO_0010195
DR   Coriell; DA04594
DR   Wikidata; Q54826546
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04595
AC   CVCL_7Y83
DR   CLO; CLO_0010194
DR   Coriell; DA04595
DR   Wikidata; Q54826547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04598
AC   CVCL_7Y84
DR   CLO; CLO_0010196
DR   Coriell; DA04598
DR   Wikidata; Q54826548
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04599
AC   CVCL_7Y85
DR   CLO; CLO_0010183
DR   Coriell; DA04599
DR   Wikidata; Q54826549
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04600
AC   CVCL_7Y86
DR   CLO; CLO_0010184
DR   Coriell; DA04600
DR   Wikidata; Q54826550
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04601
AC   CVCL_7Y87
DR   CLO; CLO_0010181
DR   Coriell; DA04601
DR   Wikidata; Q54826552
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04602
AC   CVCL_7Y88
DR   CLO; CLO_0010182
DR   Coriell; DA04602
DR   Wikidata; Q54826553
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04603
AC   CVCL_7Y89
DR   CLO; CLO_0010190
DR   Coriell; DA04603
DR   Wikidata; Q54826554
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04604
AC   CVCL_7Y90
DR   CLO; CLO_0010189
DR   Coriell; DA04604
DR   Wikidata; Q54826555
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04605
AC   CVCL_7Y91
DR   CLO; CLO_0010188
DR   Coriell; DA04605
DR   Wikidata; Q54826556
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04606
AC   CVCL_7Y92
DR   CLO; CLO_0010187
DR   Coriell; DA04606
DR   Wikidata; Q54826558
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04607
AC   CVCL_7Y93
DR   CLO; CLO_0010186
DR   Coriell; DA04607
DR   Wikidata; Q54826559
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04608
AC   CVCL_7Y94
DR   CLO; CLO_0010185
DR   Coriell; DA04608
DR   Wikidata; Q54826560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04609
AC   CVCL_7Y95
DR   CLO; CLO_0010077
DR   Coriell; DA04609
DR   Wikidata; Q54826561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04610
AC   CVCL_7Y96
DR   CLO; CLO_0010088
DR   Coriell; DA04610
DR   Wikidata; Q54826562
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04611
AC   CVCL_7Y97
DR   CLO; CLO_0010085
DR   Coriell; DA04611
DR   Wikidata; Q54826573
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04612
AC   CVCL_7Y98
DR   CLO; CLO_0010084
DR   Coriell; DA04612
DR   Wikidata; Q54826574
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04613
AC   CVCL_7Y99
DR   CLO; CLO_0010081
DR   Coriell; DA04613
DR   Wikidata; Q54826576
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04614
AC   CVCL_7Z00
DR   CLO; CLO_0010073
DR   Coriell; DA04614
DR   Wikidata; Q54826577
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04615
AC   CVCL_7Z01
DR   CLO; CLO_0010074
DR   Coriell; DA04615
DR   Wikidata; Q54826578
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04616
AC   CVCL_7Z02
DR   CLO; CLO_0010071
DR   Coriell; DA04616
DR   Wikidata; Q54826579
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04617
AC   CVCL_7Z03
DR   CLO; CLO_0010072
DR   Coriell; DA04617
DR   Wikidata; Q54826580
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04618
AC   CVCL_7Z04
DR   CLO; CLO_0010075
DR   Coriell; DA04618
DR   Wikidata; Q54826581
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04620
AC   CVCL_7Z05
DR   CLO; CLO_0010059
DR   Coriell; DA04620
DR   Wikidata; Q54826582
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04621
AC   CVCL_7Z06
DR   CLO; CLO_0010057
DR   Coriell; DA04621
DR   Wikidata; Q54826584
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04622
AC   CVCL_7Z07
DR   CLO; CLO_0010062
DR   Coriell; DA04622
DR   Wikidata; Q54826585
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04623
AC   CVCL_7Z08
DR   CLO; CLO_0010061
DR   Coriell; DA04623
DR   Wikidata; Q54826586
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04624
AC   CVCL_7Z09
DR   CLO; CLO_0010066
DR   Coriell; DA04624
DR   Wikidata; Q54826587
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04625
AC   CVCL_7Z10
DR   CLO; CLO_0010065
DR   Coriell; DA04625
DR   Wikidata; Q54826588
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04626
AC   CVCL_7Z11
DR   CLO; CLO_0010051
DR   Coriell; DA04626
DR   Wikidata; Q54826590
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04627
AC   CVCL_7Z12
DR   CLO; CLO_0010052
DR   Coriell; DA04627
DR   Wikidata; Q54826591
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04628
AC   CVCL_7Z13
DR   CLO; CLO_0010053
DR   Coriell; DA04628
DR   Wikidata; Q54826592
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04629
AC   CVCL_7Z14
DR   CLO; CLO_0010054
DR   Coriell; DA04629
DR   Wikidata; Q54826593
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04630
AC   CVCL_7Z15
DR   CLO; CLO_0010126
DR   Coriell; DA04630
DR   Wikidata; Q54826594
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04631
AC   CVCL_7Z16
DR   CLO; CLO_0010125
DR   Coriell; DA04631
DR   Wikidata; Q54826595
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04632
AC   CVCL_7Z17
DR   CLO; CLO_0010123
DR   Coriell; DA04632
DR   Wikidata; Q54826596
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04633
AC   CVCL_7Z18
DR   CLO; CLO_0010121
DR   Coriell; DA04633
DR   Wikidata; Q54826597
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04634
AC   CVCL_7Z19
DR   CLO; CLO_0010119
DR   Coriell; DA04634
DR   Wikidata; Q54826598
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04635
AC   CVCL_7Z20
DR   CLO; CLO_0010117
DR   Coriell; DA04635
DR   Wikidata; Q54826599
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04636
AC   CVCL_7Z21
DR   CLO; CLO_0010115
DR   Coriell; DA04636
DR   Wikidata; Q54826600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04637
AC   CVCL_7Z22
DR   CLO; CLO_0010112
DR   Coriell; DA04637
DR   Wikidata; Q54826601
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04638
AC   CVCL_7Z23
DR   CLO; CLO_0010113
DR   Coriell; DA04638
DR   Wikidata; Q54826602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04639
AC   CVCL_7Z24
DR   CLO; CLO_0010111
DR   Coriell; DA04639
DR   Wikidata; Q54826603
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04640
AC   CVCL_7Z25
DR   CLO; CLO_0010102
DR   Coriell; DA04640
DR   Wikidata; Q54826604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04641
AC   CVCL_7Z26
DR   CLO; CLO_0010101
DR   Coriell; DA04641
DR   Wikidata; Q54826605
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04642
AC   CVCL_7Z27
DR   CLO; CLO_0010105
DR   Coriell; DA04642
DR   Wikidata; Q54826606
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04643
AC   CVCL_7Z28
DR   CLO; CLO_0010104
DR   Coriell; DA04643
DR   Wikidata; Q54826607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04644
AC   CVCL_7Z29
DR   CLO; CLO_0010096
DR   Coriell; DA04644
DR   Wikidata; Q54826608
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04645
AC   CVCL_7Z30
DR   CLO; CLO_0010093
DR   Coriell; DA04645
DR   Wikidata; Q54826609
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04646
AC   CVCL_7Z31
DR   CLO; CLO_0010100
DR   Coriell; DA04646
DR   Wikidata; Q54826610
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04647
AC   CVCL_7Z32
DR   CLO; CLO_0010098
DR   Coriell; DA04647
DR   Wikidata; Q54826611
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04648
AC   CVCL_7Z33
DR   CLO; CLO_0010091
DR   Coriell; DA04648
DR   Wikidata; Q54826612
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04649
AC   CVCL_7Z34
DR   CLO; CLO_0010092
DR   Coriell; DA04649
DR   Wikidata; Q54826613
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04650
AC   CVCL_7Z35
DR   CLO; CLO_0010142
DR   Coriell; DA04650
DR   Wikidata; Q54826614
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04651
AC   CVCL_7Z36
DR   CLO; CLO_0010145
DR   Coriell; DA04651
DR   Wikidata; Q54826615
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04652
AC   CVCL_7Z37
DR   CLO; CLO_0010146
DR   Coriell; DA04652
DR   Wikidata; Q54826621
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04653
AC   CVCL_7Z38
DR   CLO; CLO_0010143
DR   Coriell; DA04653
DR   Wikidata; Q54826622
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04654
AC   CVCL_7Z39
DR   CLO; CLO_0010144
DR   Coriell; DA04654
DR   Wikidata; Q54826623
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04655
AC   CVCL_7Z40
DR   CLO; CLO_0010149
DR   Coriell; DA04655
DR   Wikidata; Q54826624
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04656
AC   CVCL_7Z41
DR   CLO; CLO_0010150
DR   Coriell; DA04656
DR   Wikidata; Q54826625
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04657
AC   CVCL_7Z42
DR   CLO; CLO_0010147
DR   Coriell; DA04657
DR   Wikidata; Q54826626
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04658
AC   CVCL_7Z43
DR   CLO; CLO_0010148
DR   Coriell; DA04658
DR   Wikidata; Q54826627
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04659
AC   CVCL_7Z44
DR   CLO; CLO_0010141
DR   Coriell; DA04659
DR   Wikidata; Q54826628
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04660
AC   CVCL_7Z45
DR   CLO; CLO_0010131
DR   Coriell; DA04660
DR   Wikidata; Q54826629
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04662
AC   CVCL_7Z46
DR   CLO; CLO_0010132
DR   Coriell; DA04662
DR   Wikidata; Q54826630
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04663
AC   CVCL_7Z47
DR   CLO; CLO_0010133
DR   Coriell; DA04663
DR   Wikidata; Q54826631
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04664
AC   CVCL_7Z48
DR   CLO; CLO_0010134
DR   Coriell; DA04664
DR   Wikidata; Q54826632
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04665
AC   CVCL_7Z49
DR   CLO; CLO_0010135
DR   Coriell; DA04665
DR   Wikidata; Q54826633
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04666
AC   CVCL_7Z50
DR   CLO; CLO_0010136
DR   Coriell; DA04666
DR   Wikidata; Q54826635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04667
AC   CVCL_7Z51
DR   CLO; CLO_0010137
DR   Coriell; DA04667
DR   Wikidata; Q54826636
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04668
AC   CVCL_7Z52
DR   CLO; CLO_0010138
DR   Coriell; DA04668
DR   Wikidata; Q54826637
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04669
AC   CVCL_7Z53
DR   CLO; CLO_0010139
DR   Coriell; DA04669
DR   Wikidata; Q54826638
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04670
AC   CVCL_7Z54
DR   CLO; CLO_0010140
DR   Coriell; DA04670
DR   Wikidata; Q54826639
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04671
AC   CVCL_7Z55
DR   CLO; CLO_0010355
DR   Coriell; DA04671
DR   Wikidata; Q54826640
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04672
AC   CVCL_7Z56
DR   CLO; CLO_0010356
DR   Coriell; DA04672
DR   Wikidata; Q54826641
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04673
AC   CVCL_7Z57
DR   CLO; CLO_0010357
DR   Coriell; DA04673
DR   Wikidata; Q54826642
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04674
AC   CVCL_7Z58
DR   CLO; CLO_0010358
DR   Coriell; DA04674
DR   Wikidata; Q54826643
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04675
AC   CVCL_7Z59
DR   CLO; CLO_0010351
DR   Coriell; DA04675
DR   Wikidata; Q54826644
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04676
AC   CVCL_7Z60
DR   CLO; CLO_0010352
DR   Coriell; DA04676
DR   Wikidata; Q54826645
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04679
AC   CVCL_7Z61
DR   CLO; CLO_0010353
DR   Coriell; DA04679
DR   Wikidata; Q54826646
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04681
AC   CVCL_7Z62
DR   CLO; CLO_0010354
DR   Coriell; DA04681
DR   Wikidata; Q54826647
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04682
AC   CVCL_7Z63
DR   CLO; CLO_0010359
DR   Coriell; DA04682
DR   Wikidata; Q54826648
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04683
AC   CVCL_7Z64
DR   CLO; CLO_0010360
DR   Coriell; DA04683
DR   Wikidata; Q54826649
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04684
AC   CVCL_7Z65
DR   CLO; CLO_0010341
DR   Coriell; DA04684
DR   Wikidata; Q54826650
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04685
AC   CVCL_7Z66
DR   CLO; CLO_0010348
DR   Coriell; DA04685
DR   Wikidata; Q54826651
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04686
AC   CVCL_7Z67
DR   CLO; CLO_0010349
DR   Coriell; DA04686
DR   Wikidata; Q54826652
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04687
AC   CVCL_7Z68
DR   CLO; CLO_0010346
DR   Coriell; DA04687
DR   Wikidata; Q54826653
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04688
AC   CVCL_7Z69
DR   CLO; CLO_0010347
DR   Coriell; DA04688
DR   Wikidata; Q54826654
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04689
AC   CVCL_7Z70
DR   CLO; CLO_0010344
DR   Coriell; DA04689
DR   Wikidata; Q54826655
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04690
AC   CVCL_7Z71
DR   CLO; CLO_0010345
DR   Coriell; DA04690
DR   Wikidata; Q54826656
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04691
AC   CVCL_7Z72
DR   CLO; CLO_0010342
DR   Coriell; DA04691
DR   Wikidata; Q54826657
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04692
AC   CVCL_7Z73
DR   CLO; CLO_0010343
DR   Coriell; DA04692
DR   Wikidata; Q54826658
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04693
AC   CVCL_7Z74
DR   CLO; CLO_0010350
DR   Coriell; DA04693
DR   Wikidata; Q54826659
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04694
AC   CVCL_7Z75
DR   CLO; CLO_0010411
DR   Coriell; DA04694
DR   Wikidata; Q54826660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04696
AC   CVCL_7Z76
DR   CLO; CLO_0010412
DR   Coriell; DA04696
DR   Wikidata; Q54826661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04697
AC   CVCL_7Z77
DR   CLO; CLO_0010414
DR   Coriell; DA04697
DR   Wikidata; Q54826672
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04698
AC   CVCL_7Z78
DR   CLO; CLO_0010413
DR   Coriell; DA04698
DR   Wikidata; Q54826673
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04699
AC   CVCL_7Z79
DR   CLO; CLO_0010416
DR   Coriell; DA04699
DR   Wikidata; Q54826674
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04700
AC   CVCL_7Z80
DR   CLO; CLO_0010415
DR   Coriell; DA04700
DR   Wikidata; Q54826675
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04701
AC   CVCL_7Z81
DR   CLO; CLO_0010418
DR   Coriell; DA04701
DR   Wikidata; Q54826676
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04702
AC   CVCL_7Z82
DR   CLO; CLO_0010417
DR   Coriell; DA04702
DR   Wikidata; Q54826677
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04703
AC   CVCL_7Z83
DR   CLO; CLO_0010420
DR   Coriell; DA04703
DR   Wikidata; Q54826678
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04704
AC   CVCL_7Z84
DR   CLO; CLO_0010419
DR   Coriell; DA04704
DR   Wikidata; Q54826679
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04705
AC   CVCL_7Z85
DR   CLO; CLO_0010403
DR   Coriell; DA04705
DR   Wikidata; Q54826681
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04706
AC   CVCL_7Z86
DR   CLO; CLO_0010401
DR   Coriell; DA04706
DR   Wikidata; Q54826682
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04707
AC   CVCL_7Z87
DR   CLO; CLO_0010402
DR   Coriell; DA04707
DR   Wikidata; Q54826683
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04708
AC   CVCL_7Z88
DR   CLO; CLO_0010407
DR   Coriell; DA04708
DR   Wikidata; Q54826684
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04709
AC   CVCL_7Z89
DR   CLO; CLO_0010406
DR   Coriell; DA04709
DR   Wikidata; Q54826685
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04710
AC   CVCL_7Z90
DR   CLO; CLO_0010405
DR   Coriell; DA04710
DR   Wikidata; Q54826686
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04711
AC   CVCL_7Z91
DR   CLO; CLO_0010404
DR   Coriell; DA04711
DR   Wikidata; Q54826687
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04712
AC   CVCL_7Z92
DR   CLO; CLO_0010410
DR   Coriell; DA04712
DR   Wikidata; Q54826688
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04713
AC   CVCL_7Z93
DR   CLO; CLO_0010409
DR   Coriell; DA04713
DR   Wikidata; Q54826689
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04714
AC   CVCL_7Z94
DR   CLO; CLO_0010408
DR   Coriell; DA04714
DR   Wikidata; Q54826690
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04715
AC   CVCL_7Z95
DR   CLO; CLO_0010381
DR   Coriell; DA04715
DR   Wikidata; Q54826691
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04716
AC   CVCL_7Z96
DR   CLO; CLO_0010382
DR   Coriell; DA04716
DR   Wikidata; Q54826692
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04717
AC   CVCL_7Z97
DR   CLO; CLO_0010383
DR   Coriell; DA04717
DR   Wikidata; Q54826693
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04718
AC   CVCL_7Z98
DR   CLO; CLO_0010384
DR   Coriell; DA04718
DR   Wikidata; Q54826694
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04719
AC   CVCL_7Z99
DR   CLO; CLO_0010395
DR   Coriell; DA04719
DR   Wikidata; Q54826695
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04720
AC   CVCL_8C00
DR   CLO; CLO_0010394
DR   Coriell; DA04720
DR   Wikidata; Q54826696
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04721
AC   CVCL_8C01
DR   CLO; CLO_0010400
DR   Coriell; DA04721
DR   Wikidata; Q54826697
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04722
AC   CVCL_8C02
DR   CLO; CLO_0010397
DR   Coriell; DA04722
DR   Wikidata; Q54826698
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04723
AC   CVCL_8C03
DR   CLO; CLO_0010391
DR   Coriell; DA04723
DR   Wikidata; Q54826699
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04724
AC   CVCL_8C04
DR   CLO; CLO_0010388
DR   Coriell; DA04724
DR   Wikidata; Q54826700
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04725
AC   CVCL_8C05
DR   CLO; CLO_0010365
DR   Coriell; DA04725
DR   Wikidata; Q54826701
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04726
AC   CVCL_8C06
DR   CLO; CLO_0010363
DR   Coriell; DA04726
DR   Wikidata; Q54826702
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04727
AC   CVCL_8C07
DR   CLO; CLO_0010364
DR   Coriell; DA04727
DR   Wikidata; Q54826703
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04728
AC   CVCL_8C08
DR   CLO; CLO_0010361
DR   Coriell; DA04728
DR   Wikidata; Q54826704
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04729
AC   CVCL_8C09
DR   CLO; CLO_0010362
DR   Coriell; DA04729
DR   Wikidata; Q54826705
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04730
AC   CVCL_8C10
DR   CLO; CLO_0010379
DR   Coriell; DA04730
DR   Wikidata; Q54826706
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04731
AC   CVCL_8C11
DR   CLO; CLO_0010378
DR   Coriell; DA04731
DR   Wikidata; Q54826707
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04732
AC   CVCL_8C12
DR   CLO; CLO_0010376
DR   Coriell; DA04732
DR   Wikidata; Q54826708
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04733
AC   CVCL_8C13
DR   CLO; CLO_0010373
DR   Coriell; DA04733
DR   Wikidata; Q54826709
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04734
AC   CVCL_8C14
DR   CLO; CLO_0010371
DR   Coriell; DA04734
DR   Wikidata; Q54826710
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04735
AC   CVCL_8C15
DR   CLO; CLO_0010300
DR   Coriell; DA04735
DR   Wikidata; Q54826711
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04736
AC   CVCL_8C16
DR   CLO; CLO_0010298
DR   Coriell; DA04736
DR   Wikidata; Q54826712
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04737
AC   CVCL_8C17
DR   CLO; CLO_0010310
DR   Coriell; DA04737
DR   Wikidata; Q54826717
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04738
AC   CVCL_8C18
DR   CLO; CLO_0010308
DR   Coriell; DA04738
DR   Wikidata; Q54826718
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04739
AC   CVCL_8C19
DR   CLO; CLO_0010306
DR   Coriell; DA04739
DR   Wikidata; Q54826719
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04740
AC   CVCL_8C20
DR   CLO; CLO_0010304
DR   Coriell; DA04740
DR   Wikidata; Q54826720
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04741
AC   CVCL_8C21
DR   CLO; CLO_0010293
DR   Coriell; DA04741
DR   Wikidata; Q54826721
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04742
AC   CVCL_8C22
DR   CLO; CLO_0010294
DR   Coriell; DA04742
DR   Wikidata; Q54826722
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04743
AC   CVCL_8C23
DR   CLO; CLO_0010291
DR   Coriell; DA04743
DR   Wikidata; Q54826723
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04744
AC   CVCL_8C24
DR   CLO; CLO_0010292
DR   Coriell; DA04744
DR   Wikidata; Q54826724
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04745
AC   CVCL_8C25
DR   CLO; CLO_0010278
DR   Coriell; DA04745
DR   Wikidata; Q54826725
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04746
AC   CVCL_8C26
DR   CLO; CLO_0010282
DR   Coriell; DA04746
DR   Wikidata; Q54826726
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04747
AC   CVCL_8C27
DR   CLO; CLO_0010280
DR   Coriell; DA04747
DR   Wikidata; Q54826727
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04748
AC   CVCL_8C28
DR   CLO; CLO_0010285
DR   Coriell; DA04748
DR   Wikidata; Q54826728
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04749
AC   CVCL_8C29
DR   CLO; CLO_0010284
DR   Coriell; DA04749
DR   Wikidata; Q54826729
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04750
AC   CVCL_8C30
DR   CLO; CLO_0010290
DR   Coriell; DA04750
DR   Wikidata; Q54826730
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04751
AC   CVCL_8C31
DR   CLO; CLO_0010288
DR   Coriell; DA04751
DR   Wikidata; Q54826731
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04752
AC   CVCL_8C32
DR   CLO; CLO_0010271
DR   Coriell; DA04752
DR   Wikidata; Q54826732
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04753
AC   CVCL_8C33
DR   CLO; CLO_0010272
DR   Coriell; DA04753
DR   Wikidata; Q54826733
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04754
AC   CVCL_8C34
DR   CLO; CLO_0010273
DR   Coriell; DA04754
DR   Wikidata; Q54826734
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04755
AC   CVCL_8C35
DR   CLO; CLO_0010270
DR   Coriell; DA04755
DR   Wikidata; Q54826735
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04756
AC   CVCL_8C36
DR   CLO; CLO_0010269
DR   Coriell; DA04756
DR   Wikidata; Q54826737
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04757
AC   CVCL_8C37
DR   CLO; CLO_0010268
DR   Coriell; DA04757
DR   Wikidata; Q54826738
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04758
AC   CVCL_8C38
DR   CLO; CLO_0010266
DR   Coriell; DA04758
DR   Wikidata; Q54826739
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04759
AC   CVCL_8C39
DR   CLO; CLO_0010264
DR   Coriell; DA04759
DR   Wikidata; Q54826740
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04760
AC   CVCL_8C40
DR   CLO; CLO_0010262
DR   Coriell; DA04760
DR   Wikidata; Q54826741
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04761
AC   CVCL_8C41
DR   CLO; CLO_0010260
DR   Coriell; DA04761
DR   Wikidata; Q54826742
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04762
AC   CVCL_8C42
DR   CLO; CLO_0010259
DR   Coriell; DA04762
DR   Wikidata; Q54826743
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04763
AC   CVCL_8C43
DR   CLO; CLO_0010251
DR   Coriell; DA04763
DR   Wikidata; Q54826744
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04764
AC   CVCL_8C44
DR   CLO; CLO_0010252
DR   Coriell; DA04764
DR   Wikidata; Q54826745
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04765
AC   CVCL_8C45
DR   CLO; CLO_0010234
DR   Coriell; DA04765
DR   Wikidata; Q54826746
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04766
AC   CVCL_8C46
DR   CLO; CLO_0010248
DR   Coriell; DA04766
DR   Wikidata; Q54826747
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04767
AC   CVCL_8C47
DR   CLO; CLO_0010247
DR   Coriell; DA04767
DR   Wikidata; Q54826748
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04768
AC   CVCL_8C48
DR   CLO; CLO_0010250
DR   Coriell; DA04768
DR   Wikidata; Q54826749
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04769
AC   CVCL_8C49
DR   CLO; CLO_0010249
DR   Coriell; DA04769
DR   Wikidata; Q54826750
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04770
AC   CVCL_8C50
DR   CLO; CLO_0010242
DR   Coriell; DA04770
DR   Wikidata; Q54826751
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04771
AC   CVCL_8C51
DR   CLO; CLO_0010240
DR   Coriell; DA04771
DR   Wikidata; Q54826752
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04772
AC   CVCL_8C52
DR   CLO; CLO_0010246
DR   Coriell; DA04772
DR   Wikidata; Q54826753
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04773
AC   CVCL_8C53
DR   CLO; CLO_0010243
DR   Coriell; DA04773
DR   Wikidata; Q54826754
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04774
AC   CVCL_8C54
DR   CLO; CLO_0010231
DR   Coriell; DA04774
DR   Wikidata; Q54826755
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04775
AC   CVCL_8C55
DR   CLO; CLO_0011645
DR   Coriell; DA04775
DR   Wikidata; Q54826756
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04776
AC   CVCL_8C56
DR   CLO; CLO_0011648
DR   Coriell; DA04776
DR   Wikidata; Q54826757
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04777
AC   CVCL_8C57
DR   CLO; CLO_0011646
DR   Coriell; DA04777
DR   Wikidata; Q54826761
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04778
AC   CVCL_8C58
DR   CLO; CLO_0011651
DR   Coriell; DA04778
DR   Wikidata; Q54826762
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04779
AC   CVCL_8C59
DR   CLO; CLO_0011649
DR   Coriell; DA04779
DR   Wikidata; Q54826763
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04780
AC   CVCL_8C60
DR   CLO; CLO_0011655
DR   Coriell; DA04780
DR   Wikidata; Q54826764
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04781
AC   CVCL_8C61
DR   CLO; CLO_0011654
DR   Coriell; DA04781
DR   Wikidata; Q54826765
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04782
AC   CVCL_8C62
DR   CLO; CLO_0011643
DR   Coriell; DA04782
DR   Wikidata; Q54826766
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04783
AC   CVCL_8C63
DR   CLO; CLO_0011642
DR   Coriell; DA04783
DR   Wikidata; Q54826767
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04784
AC   CVCL_8C64
DR   CLO; CLO_0011644
DR   Coriell; DA04784
DR   Wikidata; Q54826768
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04785
AC   CVCL_8C65
DR   CLO; CLO_0011669
DR   Coriell; DA04785
DR   Wikidata; Q54826769
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04786
AC   CVCL_8C66
DR   CLO; CLO_0011668
DR   Coriell; DA04786
DR   Wikidata; Q54826770
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04787
AC   CVCL_8C67
DR   CLO; CLO_0011667
DR   Coriell; DA04787
DR   Wikidata; Q54826771
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04788
AC   CVCL_8C68
DR   CLO; CLO_0011665
DR   Coriell; DA04788
DR   Wikidata; Q54826772
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04789
AC   CVCL_8C69
DR   CLO; CLO_0011676
DR   Coriell; DA04789
DR   Wikidata; Q54826774
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04790
AC   CVCL_8C70
DR   CLO; CLO_0011675
DR   Coriell; DA04790
DR   Wikidata; Q54826775
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04791
AC   CVCL_8C71
DR   CLO; CLO_0011673
DR   Coriell; DA04791
DR   Wikidata; Q54826776
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04792
AC   CVCL_8C72
DR   CLO; CLO_0011671
DR   Coriell; DA04792
DR   Wikidata; Q54826777
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04793
AC   CVCL_8C73
DR   CLO; CLO_0011663
DR   Coriell; DA04793
DR   Wikidata; Q54826778
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04794
AC   CVCL_8C74
DR   CLO; CLO_0011662
DR   Coriell; DA04794
DR   Wikidata; Q54826779
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04795
AC   CVCL_8C75
DR   CLO; CLO_0011698
DR   Coriell; DA04795
DR   Wikidata; Q54826780
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04796
AC   CVCL_8C76
DR   CLO; CLO_0011693
DR   Coriell; DA04796
DR   Wikidata; Q54826781
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04797
AC   CVCL_8C77
DR   CLO; CLO_0011692
DR   Coriell; DA04797
DR   Wikidata; Q54826782
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04799
AC   CVCL_8C78
DR   CLO; CLO_0011697
DR   Coriell; DA04799
DR   Wikidata; Q54826783
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04800
AC   CVCL_8C79
DR   CLO; CLO_0011695
DR   Coriell; DA04800
DR   Wikidata; Q54826784
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA04801
AC   CVCL_8C80
DR   CLO; CLO_0011686
DR   Coriell; DA04801
DR   Wikidata; Q54826785
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04802
AC   CVCL_8C81
DR   CLO; CLO_0011683
DR   Coriell; DA04802
DR   Wikidata; Q54826786
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04803
AC   CVCL_8C82
DR   CLO; CLO_0011690
DR   Coriell; DA04803
DR   Wikidata; Q54826787
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04804
AC   CVCL_8C83
DR   CLO; CLO_0011688
DR   Coriell; DA04804
DR   Wikidata; Q54826788
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04805
AC   CVCL_8C84
DR   CLO; CLO_0011682
DR   Coriell; DA04805
DR   Wikidata; Q54826789
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04806
AC   CVCL_8C85
DR   CLO; CLO_0011718
DR   Coriell; DA04806
DR   Wikidata; Q54826790
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04807
AC   CVCL_8C86
DR   CLO; CLO_0011719
DR   Coriell; DA04807
DR   Wikidata; Q54826791
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04808
AC   CVCL_8C87
DR   CLO; CLO_0011717
DR   Coriell; DA04808
DR   Wikidata; Q54826792
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04809
AC   CVCL_8C88
DR   CLO; CLO_0011714
DR   Coriell; DA04809
DR   Wikidata; Q54826793
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04810
AC   CVCL_8C89
DR   CLO; CLO_0011712
DR   Coriell; DA04810
DR   Wikidata; Q54826794
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04811
AC   CVCL_8C90
DR   CLO; CLO_0011711
DR   Coriell; DA04811
DR   Wikidata; Q54826795
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04812
AC   CVCL_8C91
DR   CLO; CLO_0011708
DR   Coriell; DA04812
DR   Wikidata; Q54826796
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04813
AC   CVCL_8C92
DR   CLO; CLO_0011706
DR   Coriell; DA04813
DR   Wikidata; Q54826797
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04814
AC   CVCL_8C93
DR   CLO; CLO_0011704
DR   Coriell; DA04814
DR   Wikidata; Q54826798
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04816
AC   CVCL_8C94
DR   CLO; CLO_0011703
DR   Coriell; DA04816
DR   Wikidata; Q54826799
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04817
AC   CVCL_8C95
DR   CLO; CLO_0011609
DR   Coriell; DA04817
DR   Wikidata; Q54826800
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04818
AC   CVCL_8C96
DR   CLO; CLO_0011611
DR   Coriell; DA04818
DR   Wikidata; Q54826801
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04819
AC   CVCL_8C97
DR   CLO; CLO_0011610
DR   Coriell; DA04819
DR   Wikidata; Q54826813
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04820
AC   CVCL_8C98
DR   CLO; CLO_0011602
DR   Coriell; DA04820
DR   Wikidata; Q54826814
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04821
AC   CVCL_8C99
DR   CLO; CLO_0011603
DR   Coriell; DA04821
DR   Wikidata; Q54826815
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04822
AC   CVCL_8D00
DR   CLO; CLO_0011604
DR   Coriell; DA04822
DR   Wikidata; Q54826816
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04823
AC   CVCL_8D01
DR   CLO; CLO_0011605
DR   Coriell; DA04823
DR   Wikidata; Q54826817
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04824
AC   CVCL_8D02
DR   CLO; CLO_0011606
DR   Coriell; DA04824
DR   Wikidata; Q54826818
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04825
AC   CVCL_8D03
DR   CLO; CLO_0011607
DR   Coriell; DA04825
DR   Wikidata; Q54826819
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04826
AC   CVCL_8D04
DR   CLO; CLO_0011608
DR   Coriell; DA04826
DR   Wikidata; Q54826820
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04827
AC   CVCL_8D05
DR   CLO; CLO_0011621
DR   Coriell; DA04827
DR   Wikidata; Q54826821
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04828
AC   CVCL_8D06
DR   CLO; CLO_0011620
DR   Coriell; DA04828
DR   Wikidata; Q54826823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04829
AC   CVCL_8D07
DR   CLO; CLO_0011619
DR   Coriell; DA04829
DR   Wikidata; Q54826824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04830
AC   CVCL_8D08
DR   CLO; CLO_0011618
DR   Coriell; DA04830
DR   Wikidata; Q54826825
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04831
AC   CVCL_8D09
DR   CLO; CLO_0011614
DR   Coriell; DA04831
DR   Wikidata; Q54826826
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04832
AC   CVCL_8D10
DR   CLO; CLO_0011615
DR   Coriell; DA04832
DR   Wikidata; Q54826827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04833
AC   CVCL_8D11
DR   CLO; CLO_0011612
DR   Coriell; DA04833
DR   Wikidata; Q54826828
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04834
AC   CVCL_8D12
DR   CLO; CLO_0011613
DR   Coriell; DA04834
DR   Wikidata; Q54826830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04835
AC   CVCL_8D13
DR   CLO; CLO_0011616
DR   Coriell; DA04835
DR   Wikidata; Q54826831
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04836
AC   CVCL_8D14
DR   CLO; CLO_0011617
DR   Coriell; DA04836
DR   Wikidata; Q54826832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04837
AC   CVCL_8D15
DR   CLO; CLO_0011631
DR   Coriell; DA04837
DR   Wikidata; Q54826833
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04838
AC   CVCL_8D16
DR   CLO; CLO_0011628
DR   Coriell; DA04838
DR   Wikidata; Q54826834
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04840
AC   CVCL_8D17
DR   CLO; CLO_0011627
DR   Coriell; DA04840
DR   Wikidata; Q54826836
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04841
AC   CVCL_8D18
DR   CLO; CLO_0011630
DR   Coriell; DA04841
DR   Wikidata; Q54826837
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04842
AC   CVCL_8D19
DR   CLO; CLO_0011629
DR   Coriell; DA04842
DR   Wikidata; Q54826838
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04843
AC   CVCL_8D20
DR   CLO; CLO_0011623
DR   Coriell; DA04843
DR   Wikidata; Q54826839
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04844
AC   CVCL_8D21
DR   CLO; CLO_0011624
DR   Coriell; DA04844
DR   Wikidata; Q54826840
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04845
AC   CVCL_8D22
DR   CLO; CLO_0011625
DR   Coriell; DA04845
DR   Wikidata; Q54826841
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04846
AC   CVCL_8D23
DR   CLO; CLO_0011626
DR   Coriell; DA04846
DR   Wikidata; Q54826842
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04847
AC   CVCL_8D24
DR   CLO; CLO_0011622
DR   Coriell; DA04847
DR   Wikidata; Q54826843
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04848
AC   CVCL_8D25
DR   CLO; CLO_0011641
DR   Coriell; DA04848
DR   Wikidata; Q54826844
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04849
AC   CVCL_8D26
DR   CLO; CLO_0011640
DR   Coriell; DA04849
DR   Wikidata; Q54826845
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04850
AC   CVCL_8D27
DR   CLO; CLO_0011639
DR   Coriell; DA04850
DR   Wikidata; Q54826846
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04851
AC   CVCL_8D28
DR   CLO; CLO_0011638
DR   Coriell; DA04851
DR   Wikidata; Q54826847
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04852
AC   CVCL_8D29
DR   CLO; CLO_0011637
DR   Coriell; DA04852
DR   Wikidata; Q54826848
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04853
AC   CVCL_8D30
DR   CLO; CLO_0011636
DR   Coriell; DA04853
DR   Wikidata; Q54826849
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04855
AC   CVCL_8D31
DR   CLO; CLO_0011634
DR   Coriell; DA04855
DR   Wikidata; Q54826850
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04856
AC   CVCL_8D32
DR   CLO; CLO_0011635
DR   Coriell; DA04856
DR   Wikidata; Q54826851
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04857
AC   CVCL_8D33
DR   CLO; CLO_0011632
DR   Coriell; DA04857
DR   Wikidata; Q54826852
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04858
AC   CVCL_8D34
DR   CLO; CLO_0011633
DR   Coriell; DA04858
DR   Wikidata; Q54826853
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04859
AC   CVCL_8D35
DR   CLO; CLO_0011764
DR   Coriell; DA04859
DR   Wikidata; Q54826855
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04860
AC   CVCL_8D36
DR   CLO; CLO_0011762
DR   Coriell; DA04860
DR   Wikidata; Q54826856
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04861
AC   CVCL_8D37
DR   CLO; CLO_0011763
DR   Coriell; DA04861
DR   Wikidata; Q54826863
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04862
AC   CVCL_8D38
DR   CLO; CLO_0011767
DR   Coriell; DA04862
DR   Wikidata; Q54826864
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04864
AC   CVCL_8D39
DR   CLO; CLO_0011768
DR   Coriell; DA04864
DR   Wikidata; Q54826865
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04865
AC   CVCL_8D40
DR   CLO; CLO_0011765
DR   Coriell; DA04865
DR   Wikidata; Q54826866
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04866
AC   CVCL_8D41
DR   CLO; CLO_0011766
DR   Coriell; DA04866
DR   Wikidata; Q54826867
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04867
AC   CVCL_8D42
DR   CLO; CLO_0011776
DR   Coriell; DA04867
DR   Wikidata; Q54826868
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04868
AC   CVCL_8D43
DR   CLO; CLO_0011775
DR   Coriell; DA04868
DR   Wikidata; Q54826869
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04869
AC   CVCL_8D44
DR   CLO; CLO_0011774
DR   Coriell; DA04869
DR   Wikidata; Q54826870
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04870
AC   CVCL_8D45
DR   CLO; CLO_0011782
DR   Coriell; DA04870
DR   Wikidata; Q54826871
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04871
AC   CVCL_8D46
DR   CLO; CLO_0011783
DR   Coriell; DA04871
DR   Wikidata; Q54826872
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04872
AC   CVCL_8D47
DR   CLO; CLO_0011784
DR   Coriell; DA04872
DR   Wikidata; Q54826873
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04873
AC   CVCL_8D48
DR   CLO; CLO_0011785
DR   Coriell; DA04873
DR   Wikidata; Q54826874
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04875
AC   CVCL_8D49
DR   CLO; CLO_0011786
DR   Coriell; DA04875
DR   Wikidata; Q54826875
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04876
AC   CVCL_8D50
DR   CLO; CLO_0011787
DR   Coriell; DA04876
DR   Wikidata; Q54826876
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04877
AC   CVCL_8D51
DR   CLO; CLO_0011788
DR   Coriell; DA04877
DR   Wikidata; Q54826877
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04878
AC   CVCL_8D52
DR   CLO; CLO_0011789
DR   Coriell; DA04878
DR   Wikidata; Q54826878
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04879
AC   CVCL_8D53
DR   CLO; CLO_0011797
DR   Coriell; DA04879
DR   Wikidata; Q54826879
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04880
AC   CVCL_8D54
DR   CLO; CLO_0011796
DR   Coriell; DA04880
DR   Wikidata; Q54826880
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04881
AC   CVCL_8D55
DR   CLO; CLO_0011495
DR   Coriell; DA04881
DR   Wikidata; Q54826881
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04882
AC   CVCL_8D56
DR   CLO; CLO_0011498
DR   Coriell; DA04882
DR   Wikidata; Q54826882
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04883
AC   CVCL_8D57
DR   CLO; CLO_0011505
DR   Coriell; DA04883
DR   Wikidata; Q54826883
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04884
AC   CVCL_8D58
DR   CLO; CLO_0011508
DR   Coriell; DA04884
DR   Wikidata; Q54826884
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04885
AC   CVCL_8D59
DR   CLO; CLO_0011502
DR   Coriell; DA04885
DR   Wikidata; Q54826885
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04886
AC   CVCL_8D60
DR   CLO; CLO_0011504
DR   Coriell; DA04886
DR   Wikidata; Q54826886
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04887
AC   CVCL_8D61
DR   CLO; CLO_0011512
DR   Coriell; DA04887
DR   Wikidata; Q54826887
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04889
AC   CVCL_8D62
DR   CLO; CLO_0011515
DR   Coriell; DA04889
DR   Wikidata; Q54826888
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04890
AC   CVCL_8D63
DR   CLO; CLO_0011509
DR   Coriell; DA04890
DR   Wikidata; Q54826889
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04891
AC   CVCL_8D64
DR   CLO; CLO_0011511
DR   Coriell; DA04891
DR   Wikidata; Q54826890
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04892
AC   CVCL_8D65
DR   CLO; CLO_0011464
DR   Coriell; DA04892
DR   Wikidata; Q54826891
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04894
AC   CVCL_8D66
DR   CLO; CLO_0011467
DR   Coriell; DA04894
DR   Wikidata; Q54826892
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04895
AC   CVCL_8D67
DR   CLO; CLO_0011468
DR   Coriell; DA04895
DR   Wikidata; Q54826893
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04896
AC   CVCL_8D68
DR   CLO; CLO_0011471
DR   Coriell; DA04896
DR   Wikidata; Q54826894
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04897
AC   CVCL_8D69
DR   CLO; CLO_0011472
DR   Coriell; DA04897
DR   Wikidata; Q54826895
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04899
AC   CVCL_8D70
DR   CLO; CLO_0011474
DR   Coriell; DA04899
DR   Wikidata; Q54826896
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04900
AC   CVCL_8D71
DR   CLO; CLO_0011476
DR   Coriell; DA04900
DR   Wikidata; Q54826897
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04901
AC   CVCL_8D72
DR   CLO; CLO_0011477
DR   Coriell; DA04901
DR   Wikidata; Q54826898
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04902
AC   CVCL_8D73
DR   CLO; CLO_0011479
DR   Coriell; DA04902
DR   Wikidata; Q54826899
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04903
AC   CVCL_8D74
DR   CLO; CLO_0011482
DR   Coriell; DA04903
DR   Wikidata; Q54826900
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04904
AC   CVCL_8D75
DR   CLO; CLO_0012145
DR   Coriell; DA04904
DR   Wikidata; Q54826901
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04905
AC   CVCL_8D76
DR   CLO; CLO_0012144
DR   Coriell; DA04905
DR   Wikidata; Q54826902
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04906
AC   CVCL_8D77
DR   CLO; CLO_0012147
DR   Coriell; DA04906
DR   Wikidata; Q54826911
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04907
AC   CVCL_8D78
DR   CLO; CLO_0012146
DR   Coriell; DA04907
DR   Wikidata; Q54826912
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04908
AC   CVCL_8D79
DR   CLO; CLO_0012149
DR   Coriell; DA04908
DR   Wikidata; Q54826913
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04909
AC   CVCL_8D80
DR   CLO; CLO_0012148
DR   Coriell; DA04909
DR   Wikidata; Q54826914
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04911
AC   CVCL_8D81
DR   CLO; CLO_0012151
DR   Coriell; DA04911
DR   Wikidata; Q54826915
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04912
AC   CVCL_8D82
DR   CLO; CLO_0012150
DR   Coriell; DA04912
DR   Wikidata; Q54826916
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04913
AC   CVCL_8D83
DR   CLO; CLO_0012153
DR   Coriell; DA04913
DR   Wikidata; Q54826917
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04914
AC   CVCL_8D84
DR   CLO; CLO_0012152
DR   Coriell; DA04914
DR   Wikidata; Q54826918
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04915
AC   CVCL_8D85
DR   CLO; CLO_0012163
DR   Coriell; DA04915
DR   Wikidata; Q54826919
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04916
AC   CVCL_8D86
DR   CLO; CLO_0012157
DR   Coriell; DA04916
DR   Wikidata; Q54826920
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04917
AC   CVCL_8D87
DR   CLO; CLO_0012156
DR   Coriell; DA04917
DR   Wikidata; Q54826921
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04918
AC   CVCL_8D88
DR   CLO; CLO_0012155
DR   Coriell; DA04918
DR   Wikidata; Q54826922
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04919
AC   CVCL_8D89
DR   CLO; CLO_0012154
DR   Coriell; DA04919
DR   Wikidata; Q54826923
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04920
AC   CVCL_8D90
DR   CLO; CLO_0012161
DR   Coriell; DA04920
DR   Wikidata; Q54826924
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04921
AC   CVCL_8D91
DR   CLO; CLO_0012160
DR   Coriell; DA04921
DR   Wikidata; Q54826925
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04922
AC   CVCL_8D92
DR   CLO; CLO_0012159
DR   Coriell; DA04922
DR   Wikidata; Q54826926
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04923
AC   CVCL_8D93
DR   CLO; CLO_0012158
DR   Coriell; DA04923
DR   Wikidata; Q54826927
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04924
AC   CVCL_8D94
DR   CLO; CLO_0012162
DR   Coriell; DA04924
DR   Wikidata; Q54826929
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04925
AC   CVCL_8D95
DR   CLO; CLO_0012118
DR   Coriell; DA04925
DR   Wikidata; Q54826930
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04926
AC   CVCL_8D96
DR   CLO; CLO_0012119
DR   Coriell; DA04926
DR   Wikidata; Q54826931
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04927
AC   CVCL_8D97
DR   CLO; CLO_0012113
DR   Coriell; DA04927
DR   Wikidata; Q54826932
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04928
AC   CVCL_8D98
DR   CLO; CLO_0012112
DR   Coriell; DA04928
DR   Wikidata; Q54826933
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04929
AC   CVCL_8D99
DR   CLO; CLO_0012116
DR   Coriell; DA04929
DR   Wikidata; Q54826934
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04930
AC   CVCL_8E00
DR   CLO; CLO_0012115
DR   Coriell; DA04930
DR   Wikidata; Q54826935
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04931
AC   CVCL_8E01
DR   CLO; CLO_0012107
DR   Coriell; DA04931
DR   Wikidata; Q54826936
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04932
AC   CVCL_8E02
DR   CLO; CLO_0012104
DR   Coriell; DA04932
DR   Wikidata; Q54826938
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04933
AC   CVCL_8E03
DR   CLO; CLO_0012110
DR   Coriell; DA04933
DR   Wikidata; Q54826939
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04934
AC   CVCL_8E04
DR   CLO; CLO_0012108
DR   Coriell; DA04934
DR   Wikidata; Q54826940
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04935
AC   CVCL_8E05
DR   CLO; CLO_0012140
DR   Coriell; DA04935
DR   Wikidata; Q54826941
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04936
AC   CVCL_8E06
DR   CLO; CLO_0012138
DR   Coriell; DA04936
DR   Wikidata; Q54826942
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04937
AC   CVCL_8E07
DR   CLO; CLO_0012139
DR   Coriell; DA04937
DR   Wikidata; Q54826943
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04938
AC   CVCL_8E08
DR   CLO; CLO_0012137
DR   Coriell; DA04938
DR   Wikidata; Q54826944
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04939
AC   CVCL_8E09
DR   CLO; CLO_0012136
DR   Coriell; DA04939
DR   Wikidata; Q54826945
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04940
AC   CVCL_8E10
DR   CLO; CLO_0012134
DR   Coriell; DA04940
DR   Wikidata; Q54826946
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04941
AC   CVCL_8E11
DR   CLO; CLO_0012132
DR   Coriell; DA04941
DR   Wikidata; Q54826947
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04942
AC   CVCL_8E12
DR   CLO; CLO_0012130
DR   Coriell; DA04942
DR   Wikidata; Q54826948
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04943
AC   CVCL_8E13
DR   CLO; CLO_0012128
DR   Coriell; DA04943
DR   Wikidata; Q54826949
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04945
AC   CVCL_8E14
DR   CLO; CLO_0012126
DR   Coriell; DA04945
DR   Wikidata; Q54826950
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04946
AC   CVCL_8E15
DR   CLO; CLO_0012089
DR   Coriell; DA04946
DR   Wikidata; Q54826951
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04947
AC   CVCL_8E16
DR   CLO; CLO_0012088
DR   Coriell; DA04947
DR   Wikidata; Q54826952
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04948
AC   CVCL_8E17
DR   CLO; CLO_0012091
DR   Coriell; DA04948
DR   Wikidata; Q54826960
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04949
AC   CVCL_8E18
DR   CLO; CLO_0012090
DR   Coriell; DA04949
DR   Wikidata; Q54826961
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04950
AC   CVCL_8E19
DR   CLO; CLO_0012082
DR   Coriell; DA04950
DR   Wikidata; Q54826962
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04952
AC   CVCL_8E20
DR   CLO; CLO_0012083
DR   Coriell; DA04952
DR   Wikidata; Q54826963
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04953
AC   CVCL_8E21
DR   CLO; CLO_0012084
DR   Coriell; DA04953
DR   Wikidata; Q54826964
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04954
AC   CVCL_8E22
DR   CLO; CLO_0012085
DR   Coriell; DA04954
DR   Wikidata; Q54826965
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04955
AC   CVCL_8E23
DR   CLO; CLO_0012086
DR   Coriell; DA04955
DR   Wikidata; Q54826966
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04956
AC   CVCL_8E24
DR   CLO; CLO_0012087
DR   Coriell; DA04956
DR   Wikidata; Q54826967
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04957
AC   CVCL_8E25
DR   CLO; CLO_0012099
DR   Coriell; DA04957
DR   Wikidata; Q54826968
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04958
AC   CVCL_8E26
DR   CLO; CLO_0012103
DR   Coriell; DA04958
DR   Wikidata; Q54826969
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04961
AC   CVCL_8E27
DR   CLO; CLO_0012102
DR   Coriell; DA04961
DR   Wikidata; Q54826971
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04962
AC   CVCL_8E28
DR   CLO; CLO_0012101
DR   Coriell; DA04962
DR   Wikidata; Q54826972
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04963
AC   CVCL_8E29
DR   CLO; CLO_0012100
DR   Coriell; DA04963
DR   Wikidata; Q54826973
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04964
AC   CVCL_8E30
DR   CLO; CLO_0012096
DR   Coriell; DA04964
DR   Wikidata; Q54826974
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04965
AC   CVCL_8E31
DR   CLO; CLO_0012097
DR   Coriell; DA04965
DR   Wikidata; Q54826975
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04966
AC   CVCL_8E32
DR   CLO; CLO_0012094
DR   Coriell; DA04966
DR   Wikidata; Q54826976
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04967
AC   CVCL_8E33
DR   CLO; CLO_0012095
DR   Coriell; DA04967
DR   Wikidata; Q54826977
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04968
AC   CVCL_8E34
DR   CLO; CLO_0012098
DR   Coriell; DA04968
DR   Wikidata; Q54826978
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04969
AC   CVCL_8E35
DR   CLO; CLO_0012071
DR   Coriell; DA04969
DR   Wikidata; Q54826980
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04971
AC   CVCL_8E36
DR   CLO; CLO_0012070
DR   Coriell; DA04971
DR   Wikidata; Q54826981
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04972
AC   CVCL_8E37
DR   CLO; CLO_0012067
DR   Coriell; DA04972
DR   Wikidata; Q54826982
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04973
AC   CVCL_8E38
DR   CLO; CLO_0012066
DR   Coriell; DA04973
DR   Wikidata; Q54826983
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04974
AC   CVCL_8E39
DR   CLO; CLO_0012069
DR   Coriell; DA04974
DR   Wikidata; Q54826984
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04975
AC   CVCL_8E40
DR   CLO; CLO_0012068
DR   Coriell; DA04975
DR   Wikidata; Q54826985
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04976
AC   CVCL_8E41
DR   CLO; CLO_0012062
DR   Coriell; DA04976
DR   Wikidata; Q54826986
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04977
AC   CVCL_8E42
DR   CLO; CLO_0012063
DR   Coriell; DA04977
DR   Wikidata; Q54826987
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04980
AC   CVCL_8E43
DR   CLO; CLO_0012064
DR   Coriell; DA04980
DR   Wikidata; Q54826988
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04981
AC   CVCL_8E44
DR   CLO; CLO_0012065
DR   Coriell; DA04981
DR   Wikidata; Q54826989
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04982
AC   CVCL_8E45
DR   CLO; CLO_0012081
DR   Coriell; DA04982
DR   Wikidata; Q54826990
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04983
AC   CVCL_8E46
DR   CLO; CLO_0012080
DR   Coriell; DA04983
DR   Wikidata; Q54826991
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04984
AC   CVCL_8E47
DR   CLO; CLO_0012079
DR   Coriell; DA04984
DR   Wikidata; Q54826992
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04987
AC   CVCL_8E48
DR   CLO; CLO_0012078
DR   Coriell; DA04987
DR   Wikidata; Q54826993
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04988
AC   CVCL_8E49
DR   CLO; CLO_0012077
DR   Coriell; DA04988
DR   Wikidata; Q54826994
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04989
AC   CVCL_8E50
DR   CLO; CLO_0012076
DR   Coriell; DA04989
DR   Wikidata; Q54826995
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04990
AC   CVCL_8E51
DR   CLO; CLO_0012075
DR   Coriell; DA04990
DR   Wikidata; Q54826997
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04991
AC   CVCL_8E52
DR   CLO; CLO_0012073
DR   Coriell; DA04991
DR   Wikidata; Q54826998
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04992
AC   CVCL_8E53
DR   CLO; CLO_0012074
DR   Coriell; DA04992
DR   Wikidata; Q54826999
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04993
AC   CVCL_8E54
DR   CLO; CLO_0012072
DR   Coriell; DA04993
DR   Wikidata; Q54827001
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04994
AC   CVCL_8E55
DR   CLO; CLO_0011994
DR   Coriell; DA04994
DR   Wikidata; Q54827002
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04995
AC   CVCL_8E56
DR   CLO; CLO_0011990
DR   Coriell; DA04995
DR   Wikidata; Q54827003
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04996
AC   CVCL_8E57
DR   CLO; CLO_0011991
DR   Coriell; DA04996
DR   Wikidata; Q54827008
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA04997
AC   CVCL_8E58
DR   CLO; CLO_0011986
DR   Coriell; DA04997
DR   Wikidata; Q54827010
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05001
AC   CVCL_8E59
DR   CLO; CLO_0011987
DR   Coriell; DA05001
DR   Wikidata; Q54827011
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05002
AC   CVCL_8E60
DR   CLO; CLO_0011981
DR   Coriell; DA05002
DR   Wikidata; Q54827012
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05005
AC   CVCL_8E61
DR   CLO; CLO_0011983
DR   Coriell; DA05005
DR   Wikidata; Q54827013
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05006
AC   CVCL_8E62
DR   CLO; CLO_0011979
DR   Coriell; DA05006
DR   Wikidata; Q54827014
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05007
AC   CVCL_8E63
DR   CLO; CLO_0011980
DR   Coriell; DA05007
DR   Wikidata; Q54827015
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05009
AC   CVCL_8E64
DR   CLO; CLO_0011978
DR   Coriell; DA05009
DR   Wikidata; Q54827016
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05011
AC   CVCL_8E65
DR   CLO; CLO_0011962
DR   Coriell; DA05011
DR   Wikidata; Q54827017
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05012
AC   CVCL_8E66
DR   CLO; CLO_0011965
DR   Coriell; DA05012
DR   Wikidata; Q54827018
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05013
AC   CVCL_8E67
DR   CLO; CLO_0011952
DR   Coriell; DA05013
DR   Wikidata; Q54827019
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05015
AC   CVCL_8E68
DR   CLO; CLO_0011955
DR   Coriell; DA05015
DR   Wikidata; Q54827020
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05016
AC   CVCL_8E69
DR   CLO; CLO_0011957
DR   Coriell; DA05016
DR   Wikidata; Q54827021
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05018
AC   CVCL_8E70
DR   CLO; CLO_0011958
DR   Coriell; DA05018
DR   Wikidata; Q54827022
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05019
AC   CVCL_8E71
DR   CLO; CLO_0011945
DR   Coriell; DA05019
DR   Wikidata; Q54827023
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05020
AC   CVCL_8E72
DR   CLO; CLO_0011948
DR   Coriell; DA05020
DR   Wikidata; Q54827024
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05021
AC   CVCL_8E73
DR   CLO; CLO_0011949
DR   Coriell; DA05021
DR   Wikidata; Q54827025
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05022
AC   CVCL_8E74
DR   CLO; CLO_0011951
DR   Coriell; DA05022
DR   Wikidata; Q54827026
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05023
AC   CVCL_8E75
DR   CLO; CLO_0011925
DR   Coriell; DA05023
DR   Wikidata; Q54827027
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05024
AC   CVCL_8E76
DR   CLO; CLO_0011920
DR   Coriell; DA05024
DR   Wikidata; Q54827028
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05025
AC   CVCL_8E77
DR   CLO; CLO_0011922
DR   Coriell; DA05025
DR   Wikidata; Q54827029
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05026
AC   CVCL_8E78
DR   CLO; CLO_0011932
DR   Coriell; DA05026
DR   Wikidata; Q54827030
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05028
AC   CVCL_8E79
DR   CLO; CLO_0011934
DR   Coriell; DA05028
DR   Wikidata; Q54827031
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05029
AC   CVCL_8E80
DR   CLO; CLO_0011928
DR   Coriell; DA05029
DR   Wikidata; Q54827032
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05030
AC   CVCL_8E81
DR   CLO; CLO_0011930
DR   Coriell; DA05030
DR   Wikidata; Q54827033
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05031
AC   CVCL_8E82
DR   CLO; CLO_0011916
DR   Coriell; DA05031
DR   Wikidata; Q54827034
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05032
AC   CVCL_8E83
DR   CLO; CLO_0011917
DR   Coriell; DA05032
DR   Wikidata; Q54827036
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05033
AC   CVCL_8E84
DR   CLO; CLO_0011912
DR   Coriell; DA05033
DR   Wikidata; Q54827037
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05034
AC   CVCL_8E85
DR   CLO; CLO_0011888
DR   Coriell; DA05034
DR   Wikidata; Q54827038
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05035
AC   CVCL_8E86
DR   CLO; CLO_0011890
DR   Coriell; DA05035
DR   Wikidata; Q54827039
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05036
AC   CVCL_8E87
DR   CLO; CLO_0011892
DR   Coriell; DA05036
DR   Wikidata; Q54827040
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05037
AC   CVCL_8E88
DR   CLO; CLO_0011895
DR   Coriell; DA05037
DR   Wikidata; Q54827041
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05038
AC   CVCL_8E89
DR   CLO; CLO_0011896
DR   Coriell; DA05038
DR   Wikidata; Q54827042
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05039
AC   CVCL_8E90
DR   CLO; CLO_0011898
DR   Coriell; DA05039
DR   Wikidata; Q54827043
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05040
AC   CVCL_8E91
DR   CLO; CLO_0011901
DR   Coriell; DA05040
DR   Wikidata; Q54827044
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05041
AC   CVCL_8E92
DR   CLO; CLO_0011903
DR   Coriell; DA05041
DR   Wikidata; Q54827045
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05042
AC   CVCL_8E93
DR   CLO; CLO_0011879
DR   Coriell; DA05042
DR   Wikidata; Q54827046
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05043
AC   CVCL_8E94
DR   CLO; CLO_0011881
DR   Coriell; DA05043
DR   Wikidata; Q54827047
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05044
AC   CVCL_8E95
DR   CLO; CLO_0010881
DR   Coriell; DA05044
DR   Wikidata; Q54827048
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05045
AC   CVCL_8E96
DR   CLO; CLO_0010884
DR   Coriell; DA05045
DR   Wikidata; Q54827049
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05047
AC   CVCL_8E97
DR   CLO; CLO_0010883
DR   Coriell; DA05047
DR   Wikidata; Q54827055
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05049
AC   CVCL_8E98
DR   CLO; CLO_0010886
DR   Coriell; DA05049
DR   Wikidata; Q54827056
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05050
AC   CVCL_8E99
DR   CLO; CLO_0010885
DR   Coriell; DA05050
DR   Wikidata; Q54827057
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05053
AC   CVCL_8F00
DR   CLO; CLO_0010888
DR   Coriell; DA05053
DR   Wikidata; Q54827058
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05054
AC   CVCL_8F01
DR   CLO; CLO_0010887
DR   Coriell; DA05054
DR   Wikidata; Q54827059
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05055
AC   CVCL_8F02
DR   CLO; CLO_0010890
DR   Coriell; DA05055
DR   Wikidata; Q54827060
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05056
AC   CVCL_8F03
DR   CLO; CLO_0010889
DR   Coriell; DA05056
DR   Wikidata; Q54827061
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05057
AC   CVCL_8F04
DR   CLO; CLO_0010882
DR   Coriell; DA05057
DR   Wikidata; Q54827062
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05058
AC   CVCL_8F05
DR   CLO; CLO_0010891
DR   Coriell; DA05058
DR   Wikidata; Q54827063
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05062
AC   CVCL_8F06
DR   CLO; CLO_0010892
DR   Coriell; DA05062
DR   Wikidata; Q54827064
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05063
AC   CVCL_8F07
DR   CLO; CLO_0010896
DR   Coriell; DA05063
DR   Wikidata; Q54827065
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05064
AC   CVCL_8F08
DR   CLO; CLO_0010895
DR   Coriell; DA05064
DR   Wikidata; Q54827066
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05065
AC   CVCL_8F09
DR   CLO; CLO_0010894
DR   Coriell; DA05065
DR   Wikidata; Q54827067
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05066
AC   CVCL_8F10
DR   CLO; CLO_0010893
DR   Coriell; DA05066
DR   Wikidata; Q54827068
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05068
AC   CVCL_8F11
DR   CLO; CLO_0010900
DR   Coriell; DA05068
DR   Wikidata; Q54827069
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05070
AC   CVCL_8F12
DR   CLO; CLO_0010899
DR   Coriell; DA05070
DR   Wikidata; Q54827070
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05071
AC   CVCL_8F13
DR   CLO; CLO_0010898
DR   Coriell; DA05071
DR   Wikidata; Q54827071
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05072
AC   CVCL_8F14
DR   CLO; CLO_0010897
DR   Coriell; DA05072
DR   Wikidata; Q54827072
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05073
AC   CVCL_8F15
DR   CLO; CLO_0010901
DR   Coriell; DA05073
DR   Wikidata; Q54827073
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05074
AC   CVCL_8F16
DR   CLO; CLO_0010902
DR   Coriell; DA05074
DR   Wikidata; Q54827074
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05075
AC   CVCL_8F17
DR   CLO; CLO_0010903
DR   Coriell; DA05075
DR   Wikidata; Q54827075
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05076
AC   CVCL_8F18
DR   CLO; CLO_0010908
DR   Coriell; DA05076
DR   Wikidata; Q54827076
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05077
AC   CVCL_8F19
DR   CLO; CLO_0010907
DR   Coriell; DA05077
DR   Wikidata; Q54827077
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05078
AC   CVCL_8F20
DR   CLO; CLO_0010910
DR   Coriell; DA05078
DR   Wikidata; Q54827078
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05079
AC   CVCL_8F21
DR   CLO; CLO_0010909
DR   Coriell; DA05079
DR   Wikidata; Q54827079
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05080
AC   CVCL_8F22
DR   CLO; CLO_0010905
DR   Coriell; DA05080
DR   Wikidata; Q54827080
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05081
AC   CVCL_8F23
DR   CLO; CLO_0010904
DR   Coriell; DA05081
DR   Wikidata; Q54827081
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05082
AC   CVCL_8F24
DR   CLO; CLO_0010906
DR   Coriell; DA05082
DR   Wikidata; Q54827082
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05083
AC   CVCL_8F25
DR   CLO; CLO_0010913
DR   Coriell; DA05083
DR   Wikidata; Q54827083
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05084
AC   CVCL_8F26
DR   CLO; CLO_0010914
DR   Coriell; DA05084
DR   Wikidata; Q54827084
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05086
AC   CVCL_8F27
DR   CLO; CLO_0010911
DR   Coriell; DA05086
DR   Wikidata; Q54827085
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05087
AC   CVCL_8F28
DR   CLO; CLO_0010912
DR   Coriell; DA05087
DR   Wikidata; Q54827086
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05088
AC   CVCL_8F29
DR   CLO; CLO_0010920
DR   Coriell; DA05088
DR   Wikidata; Q54827087
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05089
AC   CVCL_8F30
DR   CLO; CLO_0010919
DR   Coriell; DA05089
DR   Wikidata; Q54827088
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05090
AC   CVCL_8F31
DR   CLO; CLO_0010918
DR   Coriell; DA05090
DR   Wikidata; Q54827089
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05091
AC   CVCL_8F32
DR   CLO; CLO_0010917
DR   Coriell; DA05091
DR   Wikidata; Q54827090
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05092
AC   CVCL_8F33
DR   CLO; CLO_0010916
DR   Coriell; DA05092
DR   Wikidata; Q54827091
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05093
AC   CVCL_8F34
DR   CLO; CLO_0010915
DR   Coriell; DA05093
DR   Wikidata; Q54827092
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05094
AC   CVCL_8F35
DR   CLO; CLO_0010921
DR   Coriell; DA05094
DR   Wikidata; Q54827093
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05095
AC   CVCL_8F36
DR   CLO; CLO_0010923
DR   Coriell; DA05095
DR   Wikidata; Q54827094
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05096
AC   CVCL_8F37
DR   CLO; CLO_0010922
DR   Coriell; DA05096
DR   Wikidata; Q54827097
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05097
AC   CVCL_8F38
DR   CLO; CLO_0010925
DR   Coriell; DA05097
DR   Wikidata; Q54827098
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05098
AC   CVCL_8F39
DR   CLO; CLO_0010924
DR   Coriell; DA05098
DR   Wikidata; Q54827099
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05099
AC   CVCL_8F40
DR   CLO; CLO_0010927
DR   Coriell; DA05099
DR   Wikidata; Q54827100
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05103
AC   CVCL_8F41
DR   CLO; CLO_0010928
DR   Coriell; DA05103
DR   Wikidata; Q54827101
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05104
AC   CVCL_8F42
DR   CLO; CLO_0010930
DR   Coriell; DA05104
DR   Wikidata; Q54827102
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05105
AC   CVCL_8F43
DR   CLO; CLO_0010932
DR   Coriell; DA05105
DR   Wikidata; Q54827103
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05106
AC   CVCL_8F44
DR   CLO; CLO_0010933
DR   Coriell; DA05106
DR   Wikidata; Q54827104
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05107
AC   CVCL_8F45
DR   CLO; CLO_0010942
DR   Coriell; DA05107
DR   Wikidata; Q54827105
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05108
AC   CVCL_8F46
DR   CLO; CLO_0010941
DR   Coriell; DA05108
DR   Wikidata; Q54827106
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05109
AC   CVCL_8F47
DR   CLO; CLO_0010946
DR   Coriell; DA05109
DR   Wikidata; Q54827107
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05110
AC   CVCL_8F48
DR   CLO; CLO_0010945
DR   Coriell; DA05110
DR   Wikidata; Q54827108
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05111
AC   CVCL_8F49
DR   CLO; CLO_0010944
DR   Coriell; DA05111
DR   Wikidata; Q54827109
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05112
AC   CVCL_8F50
DR   CLO; CLO_0010943
DR   Coriell; DA05112
DR   Wikidata; Q54827110
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05113
AC   CVCL_8F51
DR   CLO; CLO_0010950
DR   Coriell; DA05113
DR   Wikidata; Q54827111
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05114
AC   CVCL_8F52
DR   CLO; CLO_0010952
DR   Coriell; DA05114
DR   Wikidata; Q54827112
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05116
AC   CVCL_8F53
DR   CLO; CLO_0010947
DR   Coriell; DA05116
DR   Wikidata; Q54827113
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05117
AC   CVCL_8F54
DR   CLO; CLO_0010948
DR   Coriell; DA05117
DR   Wikidata; Q54827114
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05118
AC   CVCL_8F55
DR   CLO; CLO_0010775
DR   Coriell; DA05118
DR   Wikidata; Q54827115
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05119
AC   CVCL_8F56
DR   CLO; CLO_0010773
DR   Coriell; DA05119
DR   Wikidata; Q54827116
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05123
AC   CVCL_8F57
DR   CLO; CLO_0010772
DR   Coriell; DA05123
DR   Wikidata; Q54827117
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05124
AC   CVCL_8F58
DR   CLO; CLO_0010771
DR   Coriell; DA05124
DR   Wikidata; Q54827119
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05125
AC   CVCL_8F59
DR   CLO; CLO_0010760
DR   Coriell; DA05125
DR   Wikidata; Q54827120
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05127
AC   CVCL_8F60
DR   CLO; CLO_0010759
DR   Coriell; DA05127
DR   Wikidata; Q54827121
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05128
AC   CVCL_8F61
DR   CLO; CLO_0010758
DR   Coriell; DA05128
DR   Wikidata; Q54827122
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05130
AC   CVCL_8F62
DR   CLO; CLO_0010757
DR   Coriell; DA05130
DR   Wikidata; Q54827123
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05131
AC   CVCL_8F63
DR   CLO; CLO_0010766
DR   Coriell; DA05131
DR   Wikidata; Q54827124
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05132
AC   CVCL_8F64
DR   CLO; CLO_0010764
DR   Coriell; DA05132
DR   Wikidata; Q54827125
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05134
AC   CVCL_8F65
DR   CLO; CLO_0010750
DR   Coriell; DA05134
DR   Wikidata; Q54827126
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05135
AC   CVCL_8F66
DR   CLO; CLO_0010753
DR   Coriell; DA05135
DR   Wikidata; Q54827127
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05136
AC   CVCL_8F67
DR   CLO; CLO_0010752
DR   Coriell; DA05136
DR   Wikidata; Q54827128
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05137
AC   CVCL_8F68
DR   CLO; CLO_0010756
DR   Coriell; DA05137
DR   Wikidata; Q54827129
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05138
AC   CVCL_8F69
DR   CLO; CLO_0010755
DR   Coriell; DA05138
DR   Wikidata; Q54827130
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05139
AC   CVCL_8F70
DR   CLO; CLO_0010738
DR   Coriell; DA05139
DR   Wikidata; Q54827131
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05140
AC   CVCL_8F71
DR   CLO; CLO_0010737
DR   Coriell; DA05140
DR   Wikidata; Q54827132
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05141
AC   CVCL_8F72
DR   CLO; CLO_0010741
DR   Coriell; DA05141
DR   Wikidata; Q54827133
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05142
AC   CVCL_8F73
DR   CLO; CLO_0010739
DR   Coriell; DA05142
DR   Wikidata; Q54827134
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05143
AC   CVCL_8F74
DR   CLO; CLO_0010743
DR   Coriell; DA05143
DR   Wikidata; Q54827135
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05144
AC   CVCL_8F75
DR   CLO; CLO_0010802
DR   Coriell; DA05144
DR   Wikidata; Q54827136
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05145
AC   CVCL_8F76
DR   CLO; CLO_0010803
DR   Coriell; DA05145
DR   Wikidata; Q54827137
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05146
AC   CVCL_8F77
DR   CLO; CLO_0010800
DR   Coriell; DA05146
DR   Wikidata; Q54827142
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05147
AC   CVCL_8F78
DR   CLO; CLO_0010801
DR   Coriell; DA05147
DR   Wikidata; Q54827143
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05148
AC   CVCL_8F79
DR   CLO; CLO_0010798
DR   Coriell; DA05148
DR   Wikidata; Q54827144
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05149
AC   CVCL_8F80
DR   CLO; CLO_0010799
DR   Coriell; DA05149
DR   Wikidata; Q54827145
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05150
AC   CVCL_8F81
DR   CLO; CLO_0010808
DR   Coriell; DA05150
DR   Wikidata; Q54827146
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05151
AC   CVCL_8F82
DR   CLO; CLO_0010810
DR   Coriell; DA05151
DR   Wikidata; Q54827147
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05152
AC   CVCL_8F83
DR   CLO; CLO_0010805
DR   Coriell; DA05152
DR   Wikidata; Q54827148
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05153
AC   CVCL_8F84
DR   CLO; CLO_0010806
DR   Coriell; DA05153
DR   Wikidata; Q54827149
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05154
AC   CVCL_8F85
DR   CLO; CLO_0010781
DR   Coriell; DA05154
DR   Wikidata; Q54827150
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05155
AC   CVCL_8F86
DR   CLO; CLO_0010782
DR   Coriell; DA05155
DR   Wikidata; Q54827151
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05156
AC   CVCL_8F87
DR   CLO; CLO_0010783
DR   Coriell; DA05156
DR   Wikidata; Q54827152
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05157
AC   CVCL_8F88
DR   CLO; CLO_0010777
DR   Coriell; DA05157
DR   Wikidata; Q54827153
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05158
AC   CVCL_8F89
DR   CLO; CLO_0010778
DR   Coriell; DA05158
DR   Wikidata; Q54827154
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05159
AC   CVCL_8F90
DR   CLO; CLO_0010779
DR   Coriell; DA05159
DR   Wikidata; Q54827155
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05160
AC   CVCL_8F91
DR   CLO; CLO_0010780
DR   Coriell; DA05160
DR   Wikidata; Q54827156
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05161
AC   CVCL_8F92
DR   CLO; CLO_0010785
DR   Coriell; DA05161
DR   Wikidata; Q54827157
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05162
AC   CVCL_8F93
DR   CLO; CLO_0010786
DR   Coriell; DA05162
DR   Wikidata; Q54827158
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05163
AC   CVCL_8F94
DR   CLO; CLO_0010788
DR   Coriell; DA05163
DR   Wikidata; Q54827159
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05164
AC   CVCL_8F95
DR   CLO; CLO_0010855
DR   Coriell; DA05164
DR   Wikidata; Q54827160
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05165
AC   CVCL_8F96
DR   CLO; CLO_0010856
DR   Coriell; DA05165
DR   Wikidata; Q54827161
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05166
AC   CVCL_8F97
DR   CLO; CLO_0010851
DR   Coriell; DA05166
DR   Wikidata; Q54827162
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05167
AC   CVCL_8F98
DR   CLO; CLO_0010852
DR   Coriell; DA05167
DR   Wikidata; Q54827163
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05168
AC   CVCL_8F99
DR   CLO; CLO_0010863
DR   Coriell; DA05168
DR   Wikidata; Q54827164
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05169
AC   CVCL_8G00
DR   CLO; CLO_0010865
DR   Coriell; DA05169
DR   Wikidata; Q54827165
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05170
AC   CVCL_8G01
DR   CLO; CLO_0010858
DR   Coriell; DA05170
DR   Wikidata; Q54827166
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05171
AC   CVCL_8G02
DR   CLO; CLO_0010861
DR   Coriell; DA05171
DR   Wikidata; Q54827167
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05172
AC   CVCL_8G03
DR   CLO; CLO_0010868
DR   Coriell; DA05172
DR   Wikidata; Q54827168
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05173
AC   CVCL_8G04
DR   CLO; CLO_0010870
DR   Coriell; DA05173
DR   Wikidata; Q54827169
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05174
AC   CVCL_8G05
DR   CLO; CLO_0010849
DR   Coriell; DA05174
DR   Wikidata; Q54827170
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05175
AC   CVCL_8G06
DR   CLO; CLO_0010819
DR   Coriell; DA05175
DR   Wikidata; Q54827171
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05176
AC   CVCL_8G07
DR   CLO; CLO_0010821
DR   Coriell; DA05176
DR   Wikidata; Q54827172
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05177
AC   CVCL_8G08
DR   CLO; CLO_0010824
DR   Coriell; DA05177
DR   Wikidata; Q54827173
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05178
AC   CVCL_8G09
DR   CLO; CLO_0010826
DR   Coriell; DA05178
DR   Wikidata; Q54827174
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05179
AC   CVCL_8G10
DR   CLO; CLO_0010827
DR   Coriell; DA05179
DR   Wikidata; Q54827175
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05180
AC   CVCL_8G11
DR   CLO; CLO_0010829
DR   Coriell; DA05180
DR   Wikidata; Q54827176
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05181
AC   CVCL_8G12
DR   CLO; CLO_0010832
DR   Coriell; DA05181
DR   Wikidata; Q54827177
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05182
AC   CVCL_8G13
DR   CLO; CLO_0010833
DR   Coriell; DA05182
DR   Wikidata; Q54827178
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05183
AC   CVCL_8G14
DR   CLO; CLO_0010835
DR   Coriell; DA05183
DR   Wikidata; Q54827179
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05184
AC   CVCL_8G15
DR   CLO; CLO_0011261
DR   Coriell; DA05184
DR   Wikidata; Q54827180
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05185
AC   CVCL_8G16
DR   CLO; CLO_0011262
DR   Coriell; DA05185
DR   Wikidata; Q54827181
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05186
AC   CVCL_8G17
DR   CLO; CLO_0011264
DR   Coriell; DA05186
DR   Wikidata; Q54827186
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05187
AC   CVCL_8G18
DR   CLO; CLO_0011263
DR   Coriell; DA05187
DR   Wikidata; Q54827187
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05188
AC   CVCL_8G19
DR   CLO; CLO_0011266
DR   Coriell; DA05188
DR   Wikidata; Q54827188
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05189
AC   CVCL_8G20
DR   CLO; CLO_0011265
DR   Coriell; DA05189
DR   Wikidata; Q54827189
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05190
AC   CVCL_8G21
DR   CLO; CLO_0011268
DR   Coriell; DA05190
DR   Wikidata; Q54827190
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05191
AC   CVCL_8G22
DR   CLO; CLO_0011267
DR   Coriell; DA05191
DR   Wikidata; Q54827191
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05192
AC   CVCL_8G23
DR   CLO; CLO_0011270
DR   Coriell; DA05192
DR   Wikidata; Q54827192
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05193
AC   CVCL_8G24
DR   CLO; CLO_0011269
DR   Coriell; DA05193
DR   Wikidata; Q54827193
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05194
AC   CVCL_8G25
DR   CLO; CLO_0011273
DR   Coriell; DA05194
DR   Wikidata; Q54827194
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05195
AC   CVCL_8G26
DR   CLO; CLO_0011271
DR   Coriell; DA05195
DR   Wikidata; Q54827195
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05196
AC   CVCL_8G27
DR   CLO; CLO_0011272
DR   Coriell; DA05196
DR   Wikidata; Q54827196
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05197
AC   CVCL_8G28
DR   CLO; CLO_0011277
DR   Coriell; DA05197
DR   Wikidata; Q54827197
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05199
AC   CVCL_8G29
DR   CLO; CLO_0011276
DR   Coriell; DA05199
DR   Wikidata; Q54827198
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05200
AC   CVCL_8G30
DR   CLO; CLO_0011275
DR   Coriell; DA05200
DR   Wikidata; Q54827199
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05201
AC   CVCL_8G31
DR   CLO; CLO_0011274
DR   Coriell; DA05201
DR   Wikidata; Q54827200
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05202
AC   CVCL_8G32
DR   CLO; CLO_0011280
DR   Coriell; DA05202
DR   Wikidata; Q54827201
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05203
AC   CVCL_8G33
DR   CLO; CLO_0011279
DR   Coriell; DA05203
DR   Wikidata; Q54827202
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05204
AC   CVCL_8G34
DR   CLO; CLO_0011278
DR   Coriell; DA05204
DR   Wikidata; Q54827203
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05205
AC   CVCL_8G35
DR   CLO; CLO_0011241
DR   Coriell; DA05205
DR   Wikidata; Q54827204
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05206
AC   CVCL_8G36
DR   CLO; CLO_0011242
DR   Coriell; DA05206
DR   Wikidata; Q54827205
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05207
AC   CVCL_8G37
DR   CLO; CLO_0011243
DR   Coriell; DA05207
DR   Wikidata; Q54827206
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05208
AC   CVCL_8G38
DR   CLO; CLO_0011244
DR   Coriell; DA05208
DR   Wikidata; Q54827207
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05209
AC   CVCL_8G39
DR   CLO; CLO_0011248
DR   Coriell; DA05209
DR   Wikidata; Q54827208
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05210
AC   CVCL_8G40
DR   CLO; CLO_0011247
DR   Coriell; DA05210
DR   Wikidata; Q54827209
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05211
AC   CVCL_8G41
DR   CLO; CLO_0011250
DR   Coriell; DA05211
DR   Wikidata; Q54827210
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05212
AC   CVCL_8G42
DR   CLO; CLO_0011249
DR   Coriell; DA05212
DR   Wikidata; Q54827211
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05213
AC   CVCL_8G43
DR   CLO; CLO_0011246
DR   Coriell; DA05213
DR   Wikidata; Q54827212
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05214
AC   CVCL_8G44
DR   CLO; CLO_0011245
DR   Coriell; DA05214
DR   Wikidata; Q54827213
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05215
AC   CVCL_8G45
DR   CLO; CLO_0011255
DR   Coriell; DA05215
DR   Wikidata; Q54827214
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05216
AC   CVCL_8G46
DR   CLO; CLO_0011253
DR   Coriell; DA05216
DR   Wikidata; Q54827215
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05217
AC   CVCL_8G47
DR   CLO; CLO_0011254
DR   Coriell; DA05217
DR   Wikidata; Q54827216
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05218
AC   CVCL_8G48
DR   CLO; CLO_0011251
DR   Coriell; DA05218
DR   Wikidata; Q54827217
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05219
AC   CVCL_8G49
DR   CLO; CLO_0011252
DR   Coriell; DA05219
DR   Wikidata; Q54827218
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05220
AC   CVCL_8G50
DR   CLO; CLO_0011260
DR   Coriell; DA05220
DR   Wikidata; Q54827219
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05221
AC   CVCL_8G51
DR   CLO; CLO_0011259
DR   Coriell; DA05221
DR   Wikidata; Q54827220
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05222
AC   CVCL_8G52
DR   CLO; CLO_0011258
DR   Coriell; DA05222
DR   Wikidata; Q54827221
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05223
AC   CVCL_8G53
DR   CLO; CLO_0011257
DR   Coriell; DA05223
DR   Wikidata; Q54827222
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05224
AC   CVCL_8G54
DR   CLO; CLO_0011256
DR   Coriell; DA05224
DR   Wikidata; Q54827223
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05225
AC   CVCL_8G55
DR   CLO; CLO_0011166
DR   Coriell; DA05225
DR   Wikidata; Q54827224
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05226
AC   CVCL_8G56
DR   CLO; CLO_0011165
DR   Coriell; DA05226
DR   Wikidata; Q54827225
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05227
AC   CVCL_8G57
DR   CLO; CLO_0011164
DR   Coriell; DA05227
DR   Wikidata; Q54827230
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05229
AC   CVCL_8G58
DR   CLO; CLO_0011173
DR   Coriell; DA05229
DR   Wikidata; Q54827231
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05231
AC   CVCL_8G59
DR   CLO; CLO_0011172
DR   Coriell; DA05231
DR   Wikidata; Q54827232
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05232
AC   CVCL_8G60
DR   CLO; CLO_0011171
DR   Coriell; DA05232
DR   Wikidata; Q54827233
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05233
AC   CVCL_8G61
DR   CLO; CLO_0011170
DR   Coriell; DA05233
DR   Wikidata; Q54827234
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05234
AC   CVCL_8G62
DR   CLO; CLO_0011169
DR   Coriell; DA05234
DR   Wikidata; Q54827235
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05235
AC   CVCL_8G63
DR   CLO; CLO_0011168
DR   Coriell; DA05235
DR   Wikidata; Q54827236
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05236
AC   CVCL_8G64
DR   CLO; CLO_0011167
DR   Coriell; DA05236
DR   Wikidata; Q54827237
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05237
AC   CVCL_8G65
DR   CLO; CLO_0011155
DR   Coriell; DA05237
DR   Wikidata; Q54827238
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05238
AC   CVCL_8G66
DR   CLO; CLO_0011154
DR   Coriell; DA05238
DR   Wikidata; Q54827239
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05240
AC   CVCL_8G67
DR   CLO; CLO_0011157
DR   Coriell; DA05240
DR   Wikidata; Q54827240
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05241
AC   CVCL_8G68
DR   CLO; CLO_0011156
DR   Coriell; DA05241
DR   Wikidata; Q54827241
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05242
AC   CVCL_8G69
DR   CLO; CLO_0011161
DR   Coriell; DA05242
DR   Wikidata; Q54827242
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05243
AC   CVCL_8G70
DR   CLO; CLO_0011160
DR   Coriell; DA05243
DR   Wikidata; Q54827243
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05244
AC   CVCL_8G71
DR   CLO; CLO_0011163
DR   Coriell; DA05244
DR   Wikidata; Q54827244
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05246
AC   CVCL_8G72
DR   CLO; CLO_0011162
DR   Coriell; DA05246
DR   Wikidata; Q54827245
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05247
AC   CVCL_8G73
DR   CLO; CLO_0011159
DR   Coriell; DA05247
DR   Wikidata; Q54827246
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05248
AC   CVCL_8G74
DR   CLO; CLO_0011158
DR   Coriell; DA05248
DR   Wikidata; Q54827247
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05249
AC   CVCL_8G75
DR   CLO; CLO_0011144
DR   Coriell; DA05249
DR   Wikidata; Q54827248
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05250
AC   CVCL_8G76
DR   CLO; CLO_0011148
DR   Coriell; DA05250
DR   Wikidata; Q54827249
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05251
AC   CVCL_8G77
DR   CLO; CLO_0011147
DR   Coriell; DA05251
DR   Wikidata; Q54827250
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05252
AC   CVCL_8G78
DR   CLO; CLO_0011146
DR   Coriell; DA05252
DR   Wikidata; Q54827251
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05253
AC   CVCL_8G79
DR   CLO; CLO_0011145
DR   Coriell; DA05253
DR   Wikidata; Q54827252
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05254
AC   CVCL_8G80
DR   CLO; CLO_0011152
DR   Coriell; DA05254
DR   Wikidata; Q54827253
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05255
AC   CVCL_8G81
DR   CLO; CLO_0011151
DR   Coriell; DA05255
DR   Wikidata; Q54827254
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05256
AC   CVCL_8G82
DR   CLO; CLO_0011150
DR   Coriell; DA05256
DR   Wikidata; Q54827255
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05257
AC   CVCL_8G83
DR   CLO; CLO_0011149
DR   Coriell; DA05257
DR   Wikidata; Q54827256
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05258
AC   CVCL_8G84
DR   CLO; CLO_0011153
DR   Coriell; DA05258
DR   Wikidata; Q54827257
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05259
AC   CVCL_8G85
DR   CLO; CLO_0011135
DR   Coriell; DA05259
DR   Wikidata; Q54827258
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05260
AC   CVCL_8G86
DR   CLO; CLO_0011134
DR   Coriell; DA05260
DR   Wikidata; Q54827259
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05261
AC   CVCL_8G87
DR   CLO; CLO_0011137
DR   Coriell; DA05261
DR   Wikidata; Q54827260
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05262
AC   CVCL_8G88
DR   CLO; CLO_0011136
DR   Coriell; DA05262
DR   Wikidata; Q54827261
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05263
AC   CVCL_8G89
DR   CLO; CLO_0011139
DR   Coriell; DA05263
DR   Wikidata; Q54827262
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05264
AC   CVCL_8G90
DR   CLO; CLO_0011138
DR   Coriell; DA05264
DR   Wikidata; Q54827263
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05265
AC   CVCL_8G91
DR   CLO; CLO_0011141
DR   Coriell; DA05265
DR   Wikidata; Q54827264
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05266
AC   CVCL_8G92
DR   CLO; CLO_0011140
DR   Coriell; DA05266
DR   Wikidata; Q54827265
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05267
AC   CVCL_8G93
DR   CLO; CLO_0011143
DR   Coriell; DA05267
DR   Wikidata; Q54827266
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05268
AC   CVCL_8G94
DR   CLO; CLO_0011142
DR   Coriell; DA05268
DR   Wikidata; Q54827267
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05269
AC   CVCL_8G95
DR   CLO; CLO_0011233
DR   Coriell; DA05269
DR   Wikidata; Q54827268
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05270
AC   CVCL_8G96
DR   CLO; CLO_0011231
DR   Coriell; DA05270
DR   Wikidata; Q54827269
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05271
AC   CVCL_8G97
DR   CLO; CLO_0011232
DR   Coriell; DA05271
DR   Wikidata; Q54827272
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05272
AC   CVCL_8G98
DR   CLO; CLO_0011229
DR   Coriell; DA05272
DR   Wikidata; Q54827273
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05273
AC   CVCL_8G99
DR   CLO; CLO_0011230
DR   Coriell; DA05273
DR   Wikidata; Q54827274
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05274
AC   CVCL_8H00
DR   CLO; CLO_0011227
DR   Coriell; DA05274
DR   Wikidata; Q54827275
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05275
AC   CVCL_8H01
DR   CLO; CLO_0011228
DR   Coriell; DA05275
DR   Wikidata; Q54827276
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05276
AC   CVCL_8H02
DR   CLO; CLO_0011224
DR   Coriell; DA05276
DR   Wikidata; Q54827277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05277
AC   CVCL_8H03
DR   CLO; CLO_0011225
DR   Coriell; DA05277
DR   Wikidata; Q54827278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05278
AC   CVCL_8H04
DR   CLO; CLO_0011221
DR   Coriell; DA05278
DR   Wikidata; Q54827279
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05279
AC   CVCL_8H05
DR   CLO; CLO_0011210
DR   Coriell; DA05279
DR   Wikidata; Q54827280
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05280
AC   CVCL_8H06
DR   CLO; CLO_0011211
DR   Coriell; DA05280
DR   Wikidata; Q54827281
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05281
AC   CVCL_8H07
DR   CLO; CLO_0011212
DR   Coriell; DA05281
DR   Wikidata; Q54827282
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05282
AC   CVCL_8H08
DR   CLO; CLO_0011213
DR   Coriell; DA05282
DR   Wikidata; Q54827283
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05284
AC   CVCL_8H09
DR   CLO; CLO_0011206
DR   Coriell; DA05284
DR   Wikidata; Q54827284
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05285
AC   CVCL_8H10
DR   CLO; CLO_0011207
DR   Coriell; DA05285
DR   Wikidata; Q54827285
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05286
AC   CVCL_8H11
DR   CLO; CLO_0011208
DR   Coriell; DA05286
DR   Wikidata; Q54827286
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05287
AC   CVCL_8H12
DR   CLO; CLO_0011209
DR   Coriell; DA05287
DR   Wikidata; Q54827287
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05288
AC   CVCL_8H13
DR   CLO; CLO_0011200
DR   Coriell; DA05288
DR   Wikidata; Q54827288
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05291
AC   CVCL_8H14
DR   CLO; CLO_0011202
DR   Coriell; DA05291
DR   Wikidata; Q54827289
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05292
AC   CVCL_8H15
DR   CLO; CLO_0011193
DR   Coriell; DA05292
DR   Wikidata; Q54827290
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05293
AC   CVCL_8H16
DR   CLO; CLO_0011187
DR   Coriell; DA05293
DR   Wikidata; Q54827291
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05294
AC   CVCL_8H17
DR   CLO; CLO_0011188
DR   Coriell; DA05294
DR   Wikidata; Q54827292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05295
AC   CVCL_8H18
DR   CLO; CLO_0011185
DR   Coriell; DA05295
DR   Wikidata; Q54827293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05296
AC   CVCL_8H19
DR   CLO; CLO_0011186
DR   Coriell; DA05296
DR   Wikidata; Q54827294
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05297
AC   CVCL_8H20
DR   CLO; CLO_0011191
DR   Coriell; DA05297
DR   Wikidata; Q54827295
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05298
AC   CVCL_8H21
DR   CLO; CLO_0011192
DR   Coriell; DA05298
DR   Wikidata; Q54827296
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05299
AC   CVCL_8H22
DR   CLO; CLO_0011189
DR   Coriell; DA05299
DR   Wikidata; Q54827297
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05300
AC   CVCL_8H23
DR   CLO; CLO_0011190
DR   Coriell; DA05300
DR   Wikidata; Q54827298
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05301
AC   CVCL_8H24
DR   CLO; CLO_0011184
DR   Coriell; DA05301
DR   Wikidata; Q54827299
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05302
AC   CVCL_8H25
DR   CLO; CLO_0011183
DR   Coriell; DA05302
DR   Wikidata; Q54827300
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05303
AC   CVCL_8H26
DR   CLO; CLO_0011182
DR   Coriell; DA05303
DR   Wikidata; Q54827301
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05304
AC   CVCL_8H27
DR   CLO; CLO_0011174
DR   Coriell; DA05304
DR   Wikidata; Q54827302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05305
AC   CVCL_8H28
DR   CLO; CLO_0011175
DR   Coriell; DA05305
DR   Wikidata; Q54827303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05306
AC   CVCL_8H29
DR   CLO; CLO_0011176
DR   Coriell; DA05306
DR   Wikidata; Q54827304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05307
AC   CVCL_8H30
DR   CLO; CLO_0011177
DR   Coriell; DA05307
DR   Wikidata; Q54827305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05309
AC   CVCL_8H31
DR   CLO; CLO_0011178
DR   Coriell; DA05309
DR   Wikidata; Q54827306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05310
AC   CVCL_8H32
DR   CLO; CLO_0011179
DR   Coriell; DA05310
DR   Wikidata; Q54827307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05311
AC   CVCL_8H33
DR   CLO; CLO_0011180
DR   Coriell; DA05311
DR   Wikidata; Q54827308
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05312
AC   CVCL_8H34
DR   CLO; CLO_0011181
DR   Coriell; DA05312
DR   Wikidata; Q54827309
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05313
AC   CVCL_8H35
DR   CLO; CLO_0014219
DR   Coriell; DA05313
DR   Wikidata; Q54827310
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05314
AC   CVCL_8H36
DR   CLO; CLO_0014217
DR   Coriell; DA05314
DR   Wikidata; Q54827311
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05315
AC   CVCL_8H37
DR   CLO; CLO_0014216
DR   Coriell; DA05315
DR   Wikidata; Q54827317
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05318
AC   CVCL_8H38
DR   CLO; CLO_0014198
DR   Coriell; DA05318
DR   Wikidata; Q54827318
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05319
AC   CVCL_8H39
DR   CLO; CLO_0014200
DR   Coriell; DA05319
DR   Wikidata; Q54827319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05320
AC   CVCL_8H40
DR   CLO; CLO_0014191
DR   Coriell; DA05320
DR   Wikidata; Q54827320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05321
AC   CVCL_8H41
DR   CLO; CLO_0014195
DR   Coriell; DA05321
DR   Wikidata; Q54827321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05322
AC   CVCL_8H42
DR   CLO; CLO_0014205
DR   Coriell; DA05322
DR   Wikidata; Q54827322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05323
AC   CVCL_8H43
DR   CLO; CLO_0014208
DR   Coriell; DA05323
DR   Wikidata; Q54827323
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05324
AC   CVCL_8H44
DR   CLO; CLO_0014202
DR   Coriell; DA05324
DR   Wikidata; Q54827324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05325
AC   CVCL_8H45
DR   CLO; CLO_0014177
DR   Coriell; DA05325
DR   Wikidata; Q54827325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05326
AC   CVCL_8H46
DR   CLO; CLO_0014176
DR   Coriell; DA05326
DR   Wikidata; Q54827326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05327
AC   CVCL_8H47
DR   CLO; CLO_0014179
DR   Coriell; DA05327
DR   Wikidata; Q54827327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05328
AC   CVCL_8H48
DR   CLO; CLO_0014178
DR   Coriell; DA05328
DR   Wikidata; Q54827328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05329
AC   CVCL_8H49
DR   CLO; CLO_0014151
DR   Coriell; DA05329
DR   Wikidata; Q54827329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05330
AC   CVCL_8H50
DR   CLO; CLO_0014153
DR   Coriell; DA05330
DR   Wikidata; Q54827330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05331
AC   CVCL_8H51
DR   CLO; CLO_0014157
DR   Coriell; DA05331
DR   Wikidata; Q54827331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05332
AC   CVCL_8H52
DR   CLO; CLO_0014161
DR   Coriell; DA05332
DR   Wikidata; Q54827332
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05333
AC   CVCL_8H53
DR   CLO; CLO_0014164
DR   Coriell; DA05333
DR   Wikidata; Q54827333
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05335
AC   CVCL_8H54
DR   CLO; CLO_0014167
DR   Coriell; DA05335
DR   Wikidata; Q54827334
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05336
AC   CVCL_8H55
DR   CLO; CLO_0014328
DR   Coriell; DA05336
DR   Wikidata; Q54827335
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05337
AC   CVCL_8H56
DR   CLO; CLO_0014325
DR   Coriell; DA05337
DR   Wikidata; Q54827336
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05341
AC   CVCL_8H57
DR   CLO; CLO_0014339
DR   Coriell; DA05341
DR   Wikidata; Q54827337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05344
AC   CVCL_8H58
DR   CLO; CLO_0014337
DR   Coriell; DA05344
DR   Wikidata; Q54827338
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05345
AC   CVCL_8H59
DR   CLO; CLO_0014335
DR   Coriell; DA05345
DR   Wikidata; Q54827340
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05346
AC   CVCL_8H60
DR   CLO; CLO_0014333
DR   Coriell; DA05346
DR   Wikidata; Q54827341
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05347
AC   CVCL_8H61
DR   CLO; CLO_0014346
DR   Coriell; DA05347
DR   Wikidata; Q54827342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05348
AC   CVCL_8H62
DR   CLO; CLO_0014345
DR   Coriell; DA05348
DR   Wikidata; Q54827343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05349
AC   CVCL_8H63
DR   CLO; CLO_0014343
DR   Coriell; DA05349
DR   Wikidata; Q54827344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05350
AC   CVCL_8H64
DR   CLO; CLO_0014342
DR   Coriell; DA05350
DR   Wikidata; Q54827345
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05351
AC   CVCL_8H65
DR   CLO; CLO_0014357
DR   Coriell; DA05351
DR   Wikidata; Q54827346
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05352
AC   CVCL_8H66
DR   CLO; CLO_0014363
DR   Coriell; DA05352
DR   Wikidata; Q54827347
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05353
AC   CVCL_8H67
DR   CLO; CLO_0014361
DR   Coriell; DA05353
DR   Wikidata; Q54827348
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05354
AC   CVCL_8H68
DR   CLO; CLO_0014368
DR   Coriell; DA05354
DR   Wikidata; Q54827349
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   98Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05355
AC   CVCL_8H69
DR   CLO; CLO_0014365
DR   Coriell; DA05355
DR   Wikidata; Q54827350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05356
AC   CVCL_8H70
DR   CLO; CLO_0014372
DR   Coriell; DA05356
DR   Wikidata; Q54827351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05357
AC   CVCL_8H71
DR   CLO; CLO_0014370
DR   Coriell; DA05357
DR   Wikidata; Q54827352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05358
AC   CVCL_8H72
DR   CLO; CLO_0014374
DR   Coriell; DA05358
DR   Wikidata; Q54827353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05359
AC   CVCL_8H73
DR   CLO; CLO_0014373
DR   Coriell; DA05359
DR   Wikidata; Q54827354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05360
AC   CVCL_8H74
DR   CLO; CLO_0014376
DR   Coriell; DA05360
DR   Wikidata; Q54827355
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05361
AC   CVCL_8H75
DR   CLO; CLO_0014311
DR   Coriell; DA05361
DR   Wikidata; Q54827356
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05362
AC   CVCL_8H76
DR   CLO; CLO_0014312
DR   Coriell; DA05362
DR   Wikidata; Q54827357
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05363
AC   CVCL_8H77
DR   CLO; CLO_0014313
DR   Coriell; DA05363
DR   Wikidata; Q54827363
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05364
AC   CVCL_8H78
DR   CLO; CLO_0014314
DR   Coriell; DA05364
DR   Wikidata; Q54827364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05365
AC   CVCL_8H79
DR   CLO; CLO_0014307
DR   Coriell; DA05365
DR   Wikidata; Q54827365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05366
AC   CVCL_8H80
DR   CLO; CLO_0014308
DR   Coriell; DA05366
DR   Wikidata; Q54827366
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05367
AC   CVCL_8H81
DR   CLO; CLO_0014309
DR   Coriell; DA05367
DR   Wikidata; Q54827367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05371
AC   CVCL_8H82
DR   CLO; CLO_0014310
DR   Coriell; DA05371
DR   Wikidata; Q54827368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05372
AC   CVCL_8H83
DR   CLO; CLO_0014305
DR   Coriell; DA05372
DR   Wikidata; Q54827369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05373
AC   CVCL_8H84
DR   CLO; CLO_0014306
DR   Coriell; DA05373
DR   Wikidata; Q54827370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05376
AC   CVCL_8H85
DR   CLO; CLO_0014324
DR   Coriell; DA05376
DR   Wikidata; Q54827371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05377
AC   CVCL_8H86
DR   CLO; CLO_0014322
DR   Coriell; DA05377
DR   Wikidata; Q54827372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05378
AC   CVCL_8H87
DR   CLO; CLO_0014323
DR   Coriell; DA05378
DR   Wikidata; Q54827373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05382
AC   CVCL_8H88
DR   CLO; CLO_0014320
DR   Coriell; DA05382
DR   Wikidata; Q54827374
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05383
AC   CVCL_8H89
DR   CLO; CLO_0014321
DR   Coriell; DA05383
DR   Wikidata; Q54827375
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05384
AC   CVCL_8H90
DR   CLO; CLO_0014318
DR   Coriell; DA05384
DR   Wikidata; Q54827376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05385
AC   CVCL_8H91
DR   CLO; CLO_0014319
DR   Coriell; DA05385
DR   Wikidata; Q54827377
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05386
AC   CVCL_8H92
DR   CLO; CLO_0014316
DR   Coriell; DA05386
DR   Wikidata; Q54827378
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05387
AC   CVCL_8H93
DR   CLO; CLO_0014317
DR   Coriell; DA05387
DR   Wikidata; Q54827379
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05388
AC   CVCL_8H94
DR   CLO; CLO_0014315
DR   Coriell; DA05388
DR   Wikidata; Q54827380
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05389
AC   CVCL_8H95
DR   CLO; CLO_0014279
DR   Coriell; DA05389
DR   Wikidata; Q54827381
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05390
AC   CVCL_8H96
DR   CLO; CLO_0014280
DR   Coriell; DA05390
DR   Wikidata; Q54827382
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05391
AC   CVCL_8H97
DR   CLO; CLO_0014281
DR   Coriell; DA05391
DR   Wikidata; Q54827383
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05392
AC   CVCL_8H98
DR   CLO; CLO_0014282
DR   Coriell; DA05392
DR   Wikidata; Q54827384
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05393
AC   CVCL_8H99
DR   CLO; CLO_0014283
DR   Coriell; DA05393
DR   Wikidata; Q54827385
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05394
AC   CVCL_8I00
DR   CLO; CLO_0014284
DR   Coriell; DA05394
DR   Wikidata; Q54827386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05395
AC   CVCL_8I01
DR   CLO; CLO_0014275
DR   Coriell; DA05395
DR   Wikidata; Q54827387
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05396
AC   CVCL_8I02
DR   CLO; CLO_0014276
DR   Coriell; DA05396
DR   Wikidata; Q54827388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05397
AC   CVCL_8I03
DR   CLO; CLO_0014277
DR   Coriell; DA05397
DR   Wikidata; Q54827389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05398
AC   CVCL_8I04
DR   CLO; CLO_0014278
DR   Coriell; DA05398
DR   Wikidata; Q54827390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05399
AC   CVCL_8I05
DR   CLO; CLO_0014300
DR   Coriell; DA05399
DR   Wikidata; Q54827391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05401
AC   CVCL_8I06
DR   CLO; CLO_0014298
DR   Coriell; DA05401
DR   Wikidata; Q54827392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05402
AC   CVCL_8I07
DR   CLO; CLO_0014299
DR   Coriell; DA05402
DR   Wikidata; Q54827393
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05404
AC   CVCL_8I08
DR   CLO; CLO_0014303
DR   Coriell; DA05404
DR   Wikidata; Q54827394
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05405
AC   CVCL_8I09
DR   CLO; CLO_0014304
DR   Coriell; DA05405
DR   Wikidata; Q54827395
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05407
AC   CVCL_8I10
DR   CLO; CLO_0014301
DR   Coriell; DA05407
DR   Wikidata; Q54827396
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05408
AC   CVCL_8I11
DR   CLO; CLO_0014302
DR   Coriell; DA05408
DR   Wikidata; Q54827397
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05413
AC   CVCL_8I12
DR   CLO; CLO_0014296
DR   Coriell; DA05413
DR   Wikidata; Q54827398
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05414
AC   CVCL_8I13
DR   CLO; CLO_0014297
DR   Coriell; DA05414
DR   Wikidata; Q54827399
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05415
AC   CVCL_8I14
DR   CLO; CLO_0014295
DR   Coriell; DA05415
DR   Wikidata; Q54827400
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05420
AC   CVCL_8I15
DR   CLO; CLO_0014250
DR   Coriell; DA05420
DR   Wikidata; Q54827401
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05421
AC   CVCL_8I16
DR   CLO; CLO_0014249
DR   Coriell; DA05421
DR   Wikidata; Q54827402
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05422
AC   CVCL_8I17
DR   CLO; CLO_0014252
DR   Coriell; DA05422
DR   Wikidata; Q54827405
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05423
AC   CVCL_8I18
DR   CLO; CLO_0014251
DR   Coriell; DA05423
DR   Wikidata; Q54827406
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05424
AC   CVCL_8I19
DR   CLO; CLO_0014246
DR   Coriell; DA05424
DR   Wikidata; Q54827407
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05425
AC   CVCL_8I20
DR   CLO; CLO_0014245
DR   Coriell; DA05425
DR   Wikidata; Q54827408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05426
AC   CVCL_8I21
DR   CLO; CLO_0014248
DR   Coriell; DA05426
DR   Wikidata; Q54827409
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05427
AC   CVCL_8I22
DR   CLO; CLO_0014247
DR   Coriell; DA05427
DR   Wikidata; Q54827410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05428
AC   CVCL_8I23
DR   CLO; CLO_0014254
DR   Coriell; DA05428
DR   Wikidata; Q54827411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05429
AC   CVCL_8I24
DR   CLO; CLO_0014253
DR   Coriell; DA05429
DR   Wikidata; Q54827412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05430
AC   CVCL_8I25
DR   CLO; CLO_0014255
DR   Coriell; DA05430
DR   Wikidata; Q54827413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05431
AC   CVCL_8I26
DR   CLO; CLO_0014263
DR   Coriell; DA05431
DR   Wikidata; Q54827414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05432
AC   CVCL_8I27
DR   CLO; CLO_0014262
DR   Coriell; DA05432
DR   Wikidata; Q54827415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05433
AC   CVCL_8I28
DR   CLO; CLO_0014261
DR   Coriell; DA05433
DR   Wikidata; Q54827416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05434
AC   CVCL_8I29
DR   CLO; CLO_0014260
DR   Coriell; DA05434
DR   Wikidata; Q54827417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05435
AC   CVCL_8I30
DR   CLO; CLO_0014259
DR   Coriell; DA05435
DR   Wikidata; Q54827418
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05436
AC   CVCL_8I31
DR   CLO; CLO_0014258
DR   Coriell; DA05436
DR   Wikidata; Q54827419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05438
AC   CVCL_8I32
DR   CLO; CLO_0014257
DR   Coriell; DA05438
DR   Wikidata; Q54827420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05439
AC   CVCL_8I33
DR   CLO; CLO_0014256
DR   Coriell; DA05439
DR   Wikidata; Q54827421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05440
AC   CVCL_8I34
DR   CLO; CLO_0014264
DR   Coriell; DA05440
DR   Wikidata; Q54827422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05441
AC   CVCL_8I35
DR   CLO; CLO_0014225
DR   Coriell; DA05441
DR   Wikidata; Q54827423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05442
AC   CVCL_8I36
DR   CLO; CLO_0014226
DR   Coriell; DA05442
DR   Wikidata; Q54827424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05443
AC   CVCL_8I37
DR   CLO; CLO_0014228
DR   Coriell; DA05443
DR   Wikidata; Q54827425
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05444
AC   CVCL_8I38
DR   CLO; CLO_0014227
DR   Coriell; DA05444
DR   Wikidata; Q54827426
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05445
AC   CVCL_8I39
DR   CLO; CLO_0014230
DR   Coriell; DA05445
DR   Wikidata; Q54827427
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05446
AC   CVCL_8I40
DR   CLO; CLO_0014229
DR   Coriell; DA05446
DR   Wikidata; Q54827428
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05447
AC   CVCL_8I41
DR   CLO; CLO_0014232
DR   Coriell; DA05447
DR   Wikidata; Q54827429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05448
AC   CVCL_8I42
DR   CLO; CLO_0014231
DR   Coriell; DA05448
DR   Wikidata; Q54827430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05449
AC   CVCL_8I43
DR   CLO; CLO_0014234
DR   Coriell; DA05449
DR   Wikidata; Q54827431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05450
AC   CVCL_8I44
DR   CLO; CLO_0014233
DR   Coriell; DA05450
DR   Wikidata; Q54827432
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05452
AC   CVCL_8I45
DR   CLO; CLO_0014237
DR   Coriell; DA05452
DR   Wikidata; Q54827433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05453
AC   CVCL_8I46
DR   CLO; CLO_0014235
DR   Coriell; DA05453
DR   Wikidata; Q54827434
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05454
AC   CVCL_8I47
DR   CLO; CLO_0014236
DR   Coriell; DA05454
DR   Wikidata; Q54827435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05455
AC   CVCL_8I48
DR   CLO; CLO_0014241
DR   Coriell; DA05455
DR   Wikidata; Q54827436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05456
AC   CVCL_8I49
DR   CLO; CLO_0014240
DR   Coriell; DA05456
DR   Wikidata; Q54827437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05458
AC   CVCL_8I50
DR   CLO; CLO_0014239
DR   Coriell; DA05458
DR   Wikidata; Q54827438
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05459
AC   CVCL_8I51
DR   CLO; CLO_0014238
DR   Coriell; DA05459
DR   Wikidata; Q54827439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05460
AC   CVCL_8I52
DR   CLO; CLO_0014244
DR   Coriell; DA05460
DR   Wikidata; Q54827440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05461
AC   CVCL_8I53
DR   CLO; CLO_0014243
DR   Coriell; DA05461
DR   Wikidata; Q54827441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05462
AC   CVCL_8I54
DR   CLO; CLO_0014242
DR   Coriell; DA05462
DR   Wikidata; Q54827442
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05463
AC   CVCL_8I55
DR   CLO; CLO_0015096
DR   Coriell; DA05463
DR   Wikidata; Q54827443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05464
AC   CVCL_8I56
DR   CLO; CLO_0015095
DR   Coriell; DA05464
DR   Wikidata; Q54827444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05465
AC   CVCL_8I57
DR   CLO; CLO_0015092
DR   Coriell; DA05465
DR   Wikidata; Q54827449
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05466
AC   CVCL_8I58
DR   CLO; CLO_0015091
DR   Coriell; DA05466
DR   Wikidata; Q54827450
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05467
AC   CVCL_8I59
DR   CLO; CLO_0015089
DR   Coriell; DA05467
DR   Wikidata; Q54827451
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05468
AC   CVCL_8I60
DR   CLO; CLO_0015086
DR   Coriell; DA05468
DR   Wikidata; Q54827452
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05469
AC   CVCL_8I61
DR   CLO; CLO_0015084
DR   Coriell; DA05469
DR   Wikidata; Q54827453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05470
AC   CVCL_8I62
DR   CLO; CLO_0015083
DR   Coriell; DA05470
DR   Wikidata; Q54827454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05471
AC   CVCL_8I63
DR   CLO; CLO_0015080
DR   Coriell; DA05471
DR   Wikidata; Q54827455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05472
AC   CVCL_8I64
DR   CLO; CLO_0015148
DR   Coriell; DA05472
DR   Wikidata; Q54827456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05473
AC   CVCL_8I65
DR   CLO; CLO_0015133
DR   Coriell; DA05473
DR   Wikidata; Q54827458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05474
AC   CVCL_8I66
DR   CLO; CLO_0015132
DR   Coriell; DA05474
DR   Wikidata; Q54827459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05475
AC   CVCL_8I67
DR   CLO; CLO_0015120
DR   Coriell; DA05475
DR   Wikidata; Q54827460
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05476
AC   CVCL_8I68
DR   CLO; CLO_0015118
DR   Coriell; DA05476
DR   Wikidata; Q54827461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05477
AC   CVCL_8I69
DR   CLO; CLO_0015125
DR   Coriell; DA05477
DR   Wikidata; Q54827462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05478
AC   CVCL_8I70
DR   CLO; CLO_0015122
DR   Coriell; DA05478
DR   Wikidata; Q54827463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05479
AC   CVCL_8I71
DR   CLO; CLO_0015113
DR   Coriell; DA05479
DR   Wikidata; Q54827464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05480
AC   CVCL_8I72
DR   CLO; CLO_0015111
DR   Coriell; DA05480
DR   Wikidata; Q54827465
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05481
AC   CVCL_8I73
DR   CLO; CLO_0015116
DR   Coriell; DA05481
DR   Wikidata; Q54827466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05485
AC   CVCL_8I74
DR   CLO; CLO_0015114
DR   Coriell; DA05485
DR   Wikidata; Q54827467
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05486
AC   CVCL_8I75
DR   CLO; CLO_0015164
DR   Coriell; DA05486
DR   Wikidata; Q54827468
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05487
AC   CVCL_8I76
DR   CLO; CLO_0015163
DR   Coriell; DA05487
DR   Wikidata; Q54827469
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05488
AC   CVCL_8I77
DR   CLO; CLO_0015161
DR   Coriell; DA05488
DR   Wikidata; Q54827471
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05490
AC   CVCL_8I78
DR   CLO; CLO_0015156
DR   Coriell; DA05490
DR   Wikidata; Q54827472
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05491
AC   CVCL_8I79
DR   CLO; CLO_0015155
DR   Coriell; DA05491
DR   Wikidata; Q54827473
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05492
AC   CVCL_8I80
DR   CLO; CLO_0015154
DR   Coriell; DA05492
DR   Wikidata; Q54827474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05493
AC   CVCL_8I81
DR   CLO; CLO_0015153
DR   Coriell; DA05493
DR   Wikidata; Q54827475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05494
AC   CVCL_8I82
DR   CLO; CLO_0015159
DR   Coriell; DA05494
DR   Wikidata; Q54827476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05495
AC   CVCL_8I83
DR   CLO; CLO_0015158
DR   Coriell; DA05495
DR   Wikidata; Q54827477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05496
AC   CVCL_8I84
DR   CLO; CLO_0015157
DR   Coriell; DA05496
DR   Wikidata; Q54827478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05497
AC   CVCL_8I85
DR   CLO; CLO_0015181
DR   Coriell; DA05497
DR   Wikidata; Q54827479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05498
AC   CVCL_8I86
DR   CLO; CLO_0015180
DR   Coriell; DA05498
DR   Wikidata; Q54827480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05499
AC   CVCL_8I87
DR   CLO; CLO_0015184
DR   Coriell; DA05499
DR   Wikidata; Q54827481
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05500
AC   CVCL_8I88
DR   CLO; CLO_0015183
DR   Coriell; DA05500
DR   Wikidata; Q54827482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05501
AC   CVCL_8I89
DR   CLO; CLO_0015175
DR   Coriell; DA05501
DR   Wikidata; Q54827483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05502
AC   CVCL_8I90
DR   CLO; CLO_0015174
DR   Coriell; DA05502
DR   Wikidata; Q54827484
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05503
AC   CVCL_8I91
DR   CLO; CLO_0015177
DR   Coriell; DA05503
DR   Wikidata; Q54827485
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05504
AC   CVCL_8I92
DR   CLO; CLO_0015176
DR   Coriell; DA05504
DR   Wikidata; Q54827486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05505
AC   CVCL_8I93
DR   CLO; CLO_0015179
DR   Coriell; DA05505
DR   Wikidata; Q54827487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05506
AC   CVCL_8I94
DR   CLO; CLO_0015178
DR   Coriell; DA05506
DR   Wikidata; Q54827488
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05507
AC   CVCL_8I95
DR   CLO; CLO_0015044
DR   Coriell; DA05507
DR   Wikidata; Q54827489
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05508
AC   CVCL_8I96
DR   CLO; CLO_0015040
DR   Coriell; DA05508
DR   Wikidata; Q54827490
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05509
AC   CVCL_8I97
DR   CLO; CLO_0015041
DR   Coriell; DA05509
DR   Wikidata; Q54827493
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05510
AC   CVCL_8I98
DR   CLO; CLO_0015042
DR   Coriell; DA05510
DR   Wikidata; Q54827494
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05511
AC   CVCL_8I99
DR   CLO; CLO_0015043
DR   Coriell; DA05511
DR   Wikidata; Q54827495
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05512
AC   CVCL_8J00
DR   CLO; CLO_0015046
DR   Coriell; DA05512
DR   Wikidata; Q54827496
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05513
AC   CVCL_8J01
DR   CLO; CLO_0015047
DR   Coriell; DA05513
DR   Wikidata; Q54827497
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05514
AC   CVCL_8J02
DR   CLO; CLO_0015048
DR   Coriell; DA05514
DR   Wikidata; Q54827498
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05515
AC   CVCL_8J03
DR   CLO; CLO_0015049
DR   Coriell; DA05515
DR   Wikidata; Q54827500
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05516
AC   CVCL_8J04
DR   CLO; CLO_0015045
DR   Coriell; DA05516
DR   Wikidata; Q54827501
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05517
AC   CVCL_8J05
DR   CLO; CLO_0015054
DR   Coriell; DA05517
DR   Wikidata; Q54827502
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05518
AC   CVCL_8J06
DR   CLO; CLO_0015055
DR   Coriell; DA05518
DR   Wikidata; Q54827503
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05519
AC   CVCL_8J07
DR   CLO; CLO_0015052
DR   Coriell; DA05519
DR   Wikidata; Q54827504
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05520
AC   CVCL_8J08
DR   CLO; CLO_0015053
DR   Coriell; DA05520
DR   Wikidata; Q54827505
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05521
AC   CVCL_8J09
DR   CLO; CLO_0015050
DR   Coriell; DA05521
DR   Wikidata; Q54827506
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05522
AC   CVCL_8J10
DR   CLO; CLO_0015051
DR   Coriell; DA05522
DR   Wikidata; Q54827507
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05523
AC   CVCL_8J11
DR   CLO; CLO_0015058
DR   Coriell; DA05523
DR   Wikidata; Q54827508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05524
AC   CVCL_8J12
DR   CLO; CLO_0015059
DR   Coriell; DA05524
DR   Wikidata; Q54827509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05525
AC   CVCL_8J13
DR   CLO; CLO_0015056
DR   Coriell; DA05525
DR   Wikidata; Q54827510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05526
AC   CVCL_8J14
DR   CLO; CLO_0015057
DR   Coriell; DA05526
DR   Wikidata; Q54827511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05527
AC   CVCL_8J15
DR   CLO; CLO_0015060
DR   Coriell; DA05527
DR   Wikidata; Q54827512
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05528
AC   CVCL_8J16
DR   CLO; CLO_0015061
DR   Coriell; DA05528
DR   Wikidata; Q54827513
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05529
AC   CVCL_8J17
DR   CLO; CLO_0015062
DR   Coriell; DA05529
DR   Wikidata; Q54827514
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05530
AC   CVCL_8J18
DR   CLO; CLO_0015063
DR   Coriell; DA05530
DR   Wikidata; Q54827515
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05531
AC   CVCL_8J19
DR   CLO; CLO_0015064
DR   Coriell; DA05531
DR   Wikidata; Q54827516
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05532
AC   CVCL_8J20
DR   CLO; CLO_0015065
DR   Coriell; DA05532
DR   Wikidata; Q54827517
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05533
AC   CVCL_8J21
DR   CLO; CLO_0015066
DR   Coriell; DA05533
DR   Wikidata; Q54827518
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05534
AC   CVCL_8J22
DR   CLO; CLO_0015067
DR   Coriell; DA05534
DR   Wikidata; Q54827519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05535
AC   CVCL_8J23
DR   CLO; CLO_0015068
DR   Coriell; DA05535
DR   Wikidata; Q54827520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05537
AC   CVCL_8J24
DR   CLO; CLO_0015069
DR   Coriell; DA05537
DR   Wikidata; Q54827521
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05538
AC   CVCL_8J25
DR   CLO; CLO_0015072
DR   Coriell; DA05538
DR   Wikidata; Q54827522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05539
AC   CVCL_8J26
DR   CLO; CLO_0015073
DR   Coriell; DA05539
DR   Wikidata; Q54827523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05540
AC   CVCL_8J27
DR   CLO; CLO_0015070
DR   Coriell; DA05540
DR   Wikidata; Q54827524
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05541
AC   CVCL_8J28
DR   CLO; CLO_0015071
DR   Coriell; DA05541
DR   Wikidata; Q54827525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05542
AC   CVCL_8J29
DR   CLO; CLO_0015076
DR   Coriell; DA05542
DR   Wikidata; Q54827526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05545
AC   CVCL_8J30
DR   CLO; CLO_0015077
DR   Coriell; DA05545
DR   Wikidata; Q54827527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05546
AC   CVCL_8J31
DR   CLO; CLO_0015074
DR   Coriell; DA05546
DR   Wikidata; Q54827528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05547
AC   CVCL_8J32
DR   CLO; CLO_0015075
DR   Coriell; DA05547
DR   Wikidata; Q54827529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05548
AC   CVCL_8J33
DR   CLO; CLO_0015078
DR   Coriell; DA05548
DR   Wikidata; Q54827530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05550
AC   CVCL_8J34
DR   CLO; CLO_0015079
DR   Coriell; DA05550
DR   Wikidata; Q54827531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05551
AC   CVCL_8J35
DR   CLO; CLO_0014974
DR   Coriell; DA05551
DR   Wikidata; Q54827532
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05552
AC   CVCL_8J36
DR   CLO; CLO_0014992
DR   Coriell; DA05552
DR   Wikidata; Q54827533
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05553
AC   CVCL_8J37
DR   CLO; CLO_0014988
DR   Coriell; DA05553
DR   Wikidata; Q54827538
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05554
AC   CVCL_8J38
DR   CLO; CLO_0014997
DR   Coriell; DA05554
DR   Wikidata; Q54827539
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05555
AC   CVCL_8J39
DR   CLO; CLO_0014995
DR   Coriell; DA05555
DR   Wikidata; Q54827540
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05556
AC   CVCL_8J40
DR   CLO; CLO_0014984
DR   Coriell; DA05556
DR   Wikidata; Q54827541
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05557
AC   CVCL_8J41
DR   CLO; CLO_0014982
DR   Coriell; DA05557
DR   Wikidata; Q54827542
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05559
AC   CVCL_8J42
DR   CLO; CLO_0014987
DR   Coriell; DA05559
DR   Wikidata; Q54827543
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05560
AC   CVCL_8J43
DR   CLO; CLO_0014985
DR   Coriell; DA05560
DR   Wikidata; Q54827544
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05561
AC   CVCL_8J44
DR   CLO; CLO_0014979
DR   Coriell; DA05561
DR   Wikidata; Q54827545
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05562
AC   CVCL_8J45
DR   CLO; CLO_0015000
DR   Coriell; DA05562
DR   Wikidata; Q54827546
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05563
AC   CVCL_8J46
DR   CLO; CLO_0015002
DR   Coriell; DA05563
DR   Wikidata; Q54827547
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05564
AC   CVCL_8J47
DR   CLO; CLO_0015029
DR   Coriell; DA05564
DR   Wikidata; Q54827548
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05565
AC   CVCL_8J48
DR   CLO; CLO_0015025
DR   Coriell; DA05565
DR   Wikidata; Q54827549
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05566
AC   CVCL_8J49
DR   CLO; CLO_0015022
DR   Coriell; DA05566
DR   Wikidata; Q54827550
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05567
AC   CVCL_8J50
DR   CLO; CLO_0015019
DR   Coriell; DA05567
DR   Wikidata; Q54827551
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05568
AC   CVCL_8J51
DR   CLO; CLO_0015016
DR   Coriell; DA05568
DR   Wikidata; Q54827552
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05569
AC   CVCL_8J52
DR   CLO; CLO_0015014
DR   Coriell; DA05569
DR   Wikidata; Q54827553
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05570
AC   CVCL_8J53
DR   CLO; CLO_0015013
DR   Coriell; DA05570
DR   Wikidata; Q54827554
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05571
AC   CVCL_8J54
DR   CLO; CLO_0015012
DR   Coriell; DA05571
DR   Wikidata; Q54827555
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05572
AC   CVCL_8J55
DR   CLO; CLO_0012854
DR   Coriell; DA05572
DR   Wikidata; Q54827556
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05573
AC   CVCL_8J56
DR   CLO; CLO_0012858
DR   Coriell; DA05573
DR   Wikidata; Q54827557
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05574
AC   CVCL_8J57
DR   CLO; CLO_0012847
DR   Coriell; DA05574
DR   Wikidata; Q54827558
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05575
AC   CVCL_8J58
DR   CLO; CLO_0012850
DR   Coriell; DA05575
DR   Wikidata; Q54827559
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05576
AC   CVCL_8J59
DR   CLO; CLO_0012862
DR   Coriell; DA05576
DR   Wikidata; Q54827560
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05577
AC   CVCL_8J60
DR   CLO; CLO_0012863
DR   Coriell; DA05577
DR   Wikidata; Q54827561
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05578
AC   CVCL_8J61
DR   CLO; CLO_0012859
DR   Coriell; DA05578
DR   Wikidata; Q54827562
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05579
AC   CVCL_8J62
DR   CLO; CLO_0012861
DR   Coriell; DA05579
DR   Wikidata; Q54827563
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05580
AC   CVCL_8J63
DR   CLO; CLO_0012882
DR   Coriell; DA05580
DR   Wikidata; Q54827564
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05581
AC   CVCL_8J64
DR   CLO; CLO_0012881
DR   Coriell; DA05581
DR   Wikidata; Q54827565
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05582
AC   CVCL_8J65
DR   CLO; CLO_0012914
DR   Coriell; DA05582
DR   Wikidata; Q54827566
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05583
AC   CVCL_8J66
DR   CLO; CLO_0012890
DR   Coriell; DA05583
DR   Wikidata; Q54827567
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05584
AC   CVCL_8J67
DR   CLO; CLO_0012892
DR   Coriell; DA05584
DR   Wikidata; Q54827568
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05585
AC   CVCL_8J68
DR   CLO; CLO_0012896
DR   Coriell; DA05585
DR   Wikidata; Q54827569
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05586
AC   CVCL_8J69
DR   CLO; CLO_0012897
DR   Coriell; DA05586
DR   Wikidata; Q54827570
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05587
AC   CVCL_8J70
DR   CLO; CLO_0012900
DR   Coriell; DA05587
DR   Wikidata; Q54827571
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05588
AC   CVCL_8J71
DR   CLO; CLO_0012901
DR   Coriell; DA05588
DR   Wikidata; Q54827572
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05589
AC   CVCL_8J72
DR   CLO; CLO_0012902
DR   Coriell; DA05589
DR   Wikidata; Q54827573
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05590
AC   CVCL_8J73
DR   CLO; CLO_0012904
DR   Coriell; DA05590
DR   Wikidata; Q54827574
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05591
AC   CVCL_8J74
DR   CLO; CLO_0013021
DR   Coriell; DA05591
DR   Wikidata; Q54827575
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05592
AC   CVCL_8J75
DR   CLO; CLO_0013024
DR   Coriell; DA05592
DR   Wikidata; Q54827576
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05593
AC   CVCL_8J76
DR   CLO; CLO_0013023
DR   Coriell; DA05593
DR   Wikidata; Q54827577
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05594
AC   CVCL_8J77
DR   CLO; CLO_0013038
DR   Coriell; DA05594
DR   Wikidata; Q54827585
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05595
AC   CVCL_8J78
DR   CLO; CLO_0013036
DR   Coriell; DA05595
DR   Wikidata; Q54827586
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05596
AC   CVCL_8J79
DR   CLO; CLO_0013035
DR   Coriell; DA05596
DR   Wikidata; Q54827587
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05597
AC   CVCL_8J80
DR   CLO; CLO_0013034
DR   Coriell; DA05597
DR   Wikidata; Q54827588
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05598
AC   CVCL_8J81
DR   CLO; CLO_0013032
DR   Coriell; DA05598
DR   Wikidata; Q54827589
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05599
AC   CVCL_8J82
DR   CLO; CLO_0013030
DR   Coriell; DA05599
DR   Wikidata; Q54827590
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05601
AC   CVCL_8J83
DR   CLO; CLO_0013027
DR   Coriell; DA05601
DR   Wikidata; Q54827591
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05602
AC   CVCL_8J84
DR   CLO; CLO_0013026
DR   Coriell; DA05602
DR   Wikidata; Q54827592
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05603
AC   CVCL_8J85
DR   CLO; CLO_0013042
DR   Coriell; DA05603
DR   Wikidata; Q54827593
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05604
AC   CVCL_8J86
DR   CLO; CLO_0013044
DR   Coriell; DA05604
DR   Wikidata; Q54827594
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05605
AC   CVCL_8J87
DR   CLO; CLO_0013043
DR   Coriell; DA05605
DR   Wikidata; Q54827595
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05606
AC   CVCL_8J88
DR   CLO; CLO_0013055
DR   Coriell; DA05606
DR   Wikidata; Q54827596
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05607
AC   CVCL_8J89
DR   CLO; CLO_0013053
DR   Coriell; DA05607
DR   Wikidata; Q54827597
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05608
AC   CVCL_8J90
DR   CLO; CLO_0013058
DR   Coriell; DA05608
DR   Wikidata; Q54827598
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05609
AC   CVCL_8J91
DR   CLO; CLO_0013057
DR   Coriell; DA05609
DR   Wikidata; Q54827599
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05610
AC   CVCL_8J92
DR   CLO; CLO_0013048
DR   Coriell; DA05610
DR   Wikidata; Q54827600
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05611
AC   CVCL_8J93
DR   CLO; CLO_0013046
DR   Coriell; DA05611
DR   Wikidata; Q54827601
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05612
AC   CVCL_8J94
DR   CLO; CLO_0013050
DR   Coriell; DA05612
DR   Wikidata; Q54827602
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05613
AC   CVCL_8J95
DR   CLO; CLO_0012974
DR   Coriell; DA05613
DR   Wikidata; Q54827603
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05614
AC   CVCL_8J96
DR   CLO; CLO_0012973
DR   Coriell; DA05614
DR   Wikidata; Q54827604
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05615
AC   CVCL_8J97
DR   CLO; CLO_0012971
DR   Coriell; DA05615
DR   Wikidata; Q54827605
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05616
AC   CVCL_8J98
DR   CLO; CLO_0012969
DR   Coriell; DA05616
DR   Wikidata; Q54827606
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05617
AC   CVCL_8J99
DR   CLO; CLO_0012981
DR   Coriell; DA05617
DR   Wikidata; Q54827607
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05618
AC   CVCL_8K00
DR   CLO; CLO_0012980
DR   Coriell; DA05618
DR   Wikidata; Q54827608
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05619
AC   CVCL_8K01
DR   CLO; CLO_0012978
DR   Coriell; DA05619
DR   Wikidata; Q54827609
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05620
AC   CVCL_8K02
DR   CLO; CLO_0012975
DR   Coriell; DA05620
DR   Wikidata; Q54827610
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05621
AC   CVCL_8K03
DR   CLO; CLO_0012987
DR   Coriell; DA05621
DR   Wikidata; Q54827611
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA05621; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA05622
AC   CVCL_8K04
DR   CLO; CLO_0012986
DR   Coriell; DA05622
DR   Wikidata; Q54827612
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05623
AC   CVCL_8K05
DR   CLO; CLO_0012999
DR   Coriell; DA05623
DR   Wikidata; Q54827613
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05626
AC   CVCL_8K06
DR   CLO; CLO_0013002
DR   Coriell; DA05626
DR   Wikidata; Q54827614
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05627
AC   CVCL_8K07
DR   CLO; CLO_0013000
DR   Coriell; DA05627
DR   Wikidata; Q54827615
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05628
AC   CVCL_8K08
DR   CLO; CLO_0013005
DR   Coriell; DA05628
DR   Wikidata; Q54827616
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05629
AC   CVCL_8K09
DR   CLO; CLO_0013004
DR   Coriell; DA05629
DR   Wikidata; Q54827619
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05630
AC   CVCL_8K10
DR   CLO; CLO_0013008
DR   Coriell; DA05630
DR   Wikidata; Q54827620
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05631
AC   CVCL_8K11
DR   CLO; CLO_0013007
DR   Coriell; DA05631
DR   Wikidata; Q54827621
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05632
AC   CVCL_8K12
DR   CLO; CLO_0013013
DR   Coriell; DA05632
DR   Wikidata; Q54827622
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05633
AC   CVCL_8K13
DR   CLO; CLO_0013011
DR   Coriell; DA05633
DR   Wikidata; Q54827623
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05634
AC   CVCL_8K14
DR   CLO; CLO_0013016
DR   Coriell; DA05634
DR   Wikidata; Q54827624
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05635
AC   CVCL_8K15
DR   CLO; CLO_0012727
DR   Coriell; DA05635
DR   Wikidata; Q54827625
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05636
AC   CVCL_8K16
DR   CLO; CLO_0012729
DR   Coriell; DA05636
DR   Wikidata; Q54827626
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05637
AC   CVCL_8K17
DR   CLO; CLO_0012721
DR   Coriell; DA05637
DR   Wikidata; Q54827634
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05640
AC   CVCL_8K18
DR   CLO; CLO_0012722
DR   Coriell; DA05640
DR   Wikidata; Q54827635
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05643
AC   CVCL_8K19
DR   CLO; CLO_0012723
DR   Coriell; DA05643
DR   Wikidata; Q54827636
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05644
AC   CVCL_8K20
DR   CLO; CLO_0012724
DR   Coriell; DA05644
DR   Wikidata; Q54827638
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05645
AC   CVCL_8K21
DR   CLO; CLO_0012717
DR   Coriell; DA05645
DR   Wikidata; Q54827639
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05646
AC   CVCL_8K22
DR   CLO; CLO_0012718
DR   Coriell; DA05646
DR   Wikidata; Q54827640
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05647
AC   CVCL_8K23
DR   CLO; CLO_0012719
DR   Coriell; DA05647
DR   Wikidata; Q54827641
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05648
AC   CVCL_8K24
DR   CLO; CLO_0012720
DR   Coriell; DA05648
DR   Wikidata; Q54827642
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05652
AC   CVCL_8K25
DR   CLO; CLO_0012751
DR   Coriell; DA05652
DR   Wikidata; Q54827643
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05653
AC   CVCL_8K26
DR   CLO; CLO_0012745
DR   Coriell; DA05653
DR   Wikidata; Q54827644
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05654
AC   CVCL_8K27
DR   CLO; CLO_0012747
DR   Coriell; DA05654
DR   Wikidata; Q54827645
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05655
AC   CVCL_8K28
DR   CLO; CLO_0012742
DR   Coriell; DA05655
DR   Wikidata; Q54827646
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05656
AC   CVCL_8K29
DR   CLO; CLO_0012743
DR   Coriell; DA05656
DR   Wikidata; Q54827647
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05657
AC   CVCL_8K30
DR   CLO; CLO_0012738
DR   Coriell; DA05657
DR   Wikidata; Q54827648
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05659
AC   CVCL_8K31
DR   CLO; CLO_0012739
DR   Coriell; DA05659
DR   Wikidata; Q54827649
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05660
AC   CVCL_8K32
DR   CLO; CLO_0012736
DR   Coriell; DA05660
DR   Wikidata; Q54827650
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05661
AC   CVCL_8K33
DR   CLO; CLO_0012737
DR   Coriell; DA05661
DR   Wikidata; Q54827651
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05662
AC   CVCL_8K34
DR   CLO; CLO_0012735
DR   Coriell; DA05662
DR   Wikidata; Q54827652
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05663
AC   CVCL_8K35
DR   CLO; CLO_0012679
DR   Coriell; DA05663
DR   Wikidata; Q54827653
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05664
AC   CVCL_8K36
DR   CLO; CLO_0012680
DR   Coriell; DA05664
DR   Wikidata; Q54827655
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05665
AC   CVCL_8K37
DR   CLO; CLO_0012681
DR   Coriell; DA05665
DR   Wikidata; Q54827656
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05666
AC   CVCL_8K38
DR   CLO; CLO_0012683
DR   Coriell; DA05666
DR   Wikidata; Q54827657
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05667
AC   CVCL_8K39
DR   CLO; CLO_0012684
DR   Coriell; DA05667
DR   Wikidata; Q54827658
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05668
AC   CVCL_8K40
DR   CLO; CLO_0012685
DR   Coriell; DA05668
DR   Wikidata; Q54827659
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05669
AC   CVCL_8K41
DR   CLO; CLO_0012686
DR   Coriell; DA05669
DR   Wikidata; Q54827660
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05670
AC   CVCL_8K42
DR   CLO; CLO_0012687
DR   Coriell; DA05670
DR   Wikidata; Q54827661
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05671
AC   CVCL_8K43
DR   CLO; CLO_0012677
DR   Coriell; DA05671
DR   Wikidata; Q54827662
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05672
AC   CVCL_8K44
DR   CLO; CLO_0012678
DR   Coriell; DA05672
DR   Wikidata; Q54827663
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05674
AC   CVCL_8K45
DR   CLO; CLO_0012712
DR   Coriell; DA05674
DR   Wikidata; Q54827664
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05676
AC   CVCL_8K46
DR   CLO; CLO_0012702
DR   Coriell; DA05676
DR   Wikidata; Q54827665
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05677
AC   CVCL_8K47
DR   CLO; CLO_0012703
DR   Coriell; DA05677
DR   Wikidata; Q54827666
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05678
AC   CVCL_8K48
DR   CLO; CLO_0012699
DR   Coriell; DA05678
DR   Wikidata; Q54827667
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05680
AC   CVCL_8K49
DR   CLO; CLO_0012701
DR   Coriell; DA05680
DR   Wikidata; Q54827668
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05681
AC   CVCL_8K50
DR   CLO; CLO_0012706
DR   Coriell; DA05681
DR   Wikidata; Q54827669
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05684
AC   CVCL_8K51
DR   CLO; CLO_0012707
DR   Coriell; DA05684
DR   Wikidata; Q54827670
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05685
AC   CVCL_8K52
DR   CLO; CLO_0012704
DR   Coriell; DA05685
DR   Wikidata; Q54827671
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05686
AC   CVCL_8K53
DR   CLO; CLO_0012705
DR   Coriell; DA05686
DR   Wikidata; Q54827672
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05687
AC   CVCL_8K54
DR   CLO; CLO_0012697
DR   Coriell; DA05687
DR   Wikidata; Q54827673
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05688
AC   CVCL_8K55
DR   CLO; CLO_0036496
DR   Coriell; DA05688
DR   Wikidata; Q54827674
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05689
AC   CVCL_8K56
DR   CLO; CLO_0036495
DR   Coriell; DA05689
DR   Wikidata; Q54827675
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05690
AC   CVCL_8K57
DR   CLO; CLO_0036497
DR   Coriell; DA05690
DR   Wikidata; Q54827680
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05691
AC   CVCL_8K58
DR   CLO; CLO_0036498
DR   Coriell; DA05691
DR   Wikidata; Q54827681
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05692
AC   CVCL_8K59
DR   CLO; CLO_0036499
DR   Coriell; DA05692
DR   Wikidata; Q54827682
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05693
AC   CVCL_8K60
DR   CLO; CLO_0036500
DR   Coriell; DA05693
DR   Wikidata; Q54827683
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05695
AC   CVCL_8K61
DR   CLO; CLO_0036501
DR   Coriell; DA05695
DR   Wikidata; Q54827684
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05696
AC   CVCL_8K62
DR   CLO; CLO_0036502
DR   Coriell; DA05696
DR   Wikidata; Q54827685
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05697
AC   CVCL_8K63
DR   CLO; CLO_0036503
DR   Coriell; DA05697
DR   Wikidata; Q54827686
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05698
AC   CVCL_8K64
DR   CLO; CLO_0036504
DR   Coriell; DA05698
DR   Wikidata; Q54827687
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05699
AC   CVCL_8K65
DR   CLO; CLO_0036394
DR   Coriell; DA05699
DR   Wikidata; Q54827688
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05700
AC   CVCL_8K66
DR   CLO; CLO_0036395
DR   Coriell; DA05700
DR   Wikidata; Q54827689
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05701
AC   CVCL_8K67
DR   CLO; CLO_0036396
DR   Coriell; DA05701
DR   Wikidata; Q54827690
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05702
AC   CVCL_8K68
DR   CLO; CLO_0036391
DR   Coriell; DA05702
DR   Wikidata; Q54827691
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05703
AC   CVCL_8K69
DR   CLO; CLO_0036390
DR   Coriell; DA05703
DR   Wikidata; Q54827692
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05704
AC   CVCL_8K70
DR   CLO; CLO_0036393
DR   Coriell; DA05704
DR   Wikidata; Q54827693
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05705
AC   CVCL_8K71
DR   CLO; CLO_0036392
DR   Coriell; DA05705
DR   Wikidata; Q54827694
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05706
AC   CVCL_8K72
DR   CLO; CLO_0036388
DR   Coriell; DA05706
DR   Wikidata; Q54827695
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; DA05706; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DA05707
AC   CVCL_8K73
DR   CLO; CLO_0036387
DR   Coriell; DA05707
DR   Wikidata; Q54827696
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05708
AC   CVCL_8K74
DR   CLO; CLO_0036389
DR   Coriell; DA05708
DR   Wikidata; Q54827697
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05709
AC   CVCL_8K75
DR   CLO; CLO_0036405
DR   Coriell; DA05709
DR   Wikidata; Q54827698
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05710
AC   CVCL_8K76
DR   CLO; CLO_0036406
DR   Coriell; DA05710
DR   Wikidata; Q54827699
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05711
AC   CVCL_8K77
DR   CLO; CLO_0036403
DR   Coriell; DA05711
DR   Wikidata; Q54827700
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05716
AC   CVCL_8K78
DR   CLO; CLO_0036404
DR   Coriell; DA05716
DR   Wikidata; Q54827701
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05717
AC   CVCL_8K79
DR   CLO; CLO_0036402
DR   Coriell; DA05717
DR   Wikidata; Q54827703
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05718
AC   CVCL_8K80
DR   CLO; CLO_0036401
DR   Coriell; DA05718
DR   Wikidata; Q54827704
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05719
AC   CVCL_8K81
DR   CLO; CLO_0036400
DR   Coriell; DA05719
DR   Wikidata; Q54827705
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05720
AC   CVCL_8K82
DR   CLO; CLO_0036399
DR   Coriell; DA05720
DR   Wikidata; Q54827706
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05721
AC   CVCL_8K83
DR   CLO; CLO_0036398
DR   Coriell; DA05721
DR   Wikidata; Q54827707
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05722
AC   CVCL_8K84
DR   CLO; CLO_0036397
DR   Coriell; DA05722
DR   Wikidata; Q54827708
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05723
AC   CVCL_8K85
DR   CLO; CLO_0036423
DR   Coriell; DA05723
DR   Wikidata; Q54827709
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05724
AC   CVCL_8K86
DR   CLO; CLO_0036425
DR   Coriell; DA05724
DR   Wikidata; Q54827710
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05725
AC   CVCL_8K87
DR   CLO; CLO_0036426
DR   Coriell; DA05725
DR   Wikidata; Q54827711
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05726
AC   CVCL_8K88
DR   CLO; CLO_0036427
DR   Coriell; DA05726
DR   Wikidata; Q54827712
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05727
AC   CVCL_8K89
DR   CLO; CLO_0036428
DR   Coriell; DA05727
DR   Wikidata; Q54827713
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05729
AC   CVCL_8K90
DR   CLO; CLO_0036416
DR   Coriell; DA05729
DR   Wikidata; Q54827714
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05730
AC   CVCL_8K91
DR   CLO; CLO_0036415
DR   Coriell; DA05730
DR   Wikidata; Q54827715
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05731
AC   CVCL_8K92
DR   CLO; CLO_0036418
DR   Coriell; DA05731
DR   Wikidata; Q54827716
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05732
AC   CVCL_8K93
DR   CLO; CLO_0036417
DR   Coriell; DA05732
DR   Wikidata; Q54827717
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05733
AC   CVCL_8K94
DR   CLO; CLO_0036419
DR   Coriell; DA05733
DR   Wikidata; Q54827718
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05735
AC   CVCL_8K95
DR   CLO; CLO_0036439
DR   Coriell; DA05735
DR   Wikidata; Q54827719
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05736
AC   CVCL_8K96
DR   CLO; CLO_0036441
DR   Coriell; DA05736
DR   Wikidata; Q54827720
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05737
AC   CVCL_8K97
DR   CLO; CLO_0036446
DR   Coriell; DA05737
DR   Wikidata; Q54827723
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05738
AC   CVCL_8K98
DR   CLO; CLO_0036447
DR   Coriell; DA05738
DR   Wikidata; Q54827724
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05739
AC   CVCL_8K99
DR   CLO; CLO_0036444
DR   Coriell; DA05739
DR   Wikidata; Q54827725
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05740
AC   CVCL_8L00
DR   CLO; CLO_0036445
DR   Coriell; DA05740
DR   Wikidata; Q54827726
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05741
AC   CVCL_8L01
DR   CLO; CLO_0036438
DR   Coriell; DA05741
DR   Wikidata; Q54827727
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05742
AC   CVCL_8L02
DR   CLO; CLO_0036437
DR   Coriell; DA05742
DR   Wikidata; Q54827728
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05743
AC   CVCL_8L03
DR   CLO; CLO_0036436
DR   Coriell; DA05743
DR   Wikidata; Q54827729
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05744
AC   CVCL_8L04
DR   CLO; CLO_0036435
DR   Coriell; DA05744
DR   Wikidata; Q54827730
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05745
AC   CVCL_8L05
DR   CLO; CLO_0036322
DR   Coriell; DA05745
DR   Wikidata; Q54827731
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05746
AC   CVCL_8L06
DR   CLO; CLO_0036324
DR   Coriell; DA05746
DR   Wikidata; Q54827732
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05747
AC   CVCL_8L07
DR   CLO; CLO_0036323
DR   Coriell; DA05747
DR   Wikidata; Q54827733
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05748
AC   CVCL_8L08
DR   CLO; CLO_0036318
DR   Coriell; DA05748
DR   Wikidata; Q54827734
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05749
AC   CVCL_8L09
DR   CLO; CLO_0036316
DR   Coriell; DA05749
DR   Wikidata; Q54827735
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05753
AC   CVCL_8L10
DR   CLO; CLO_0036321
DR   Coriell; DA05753
DR   Wikidata; Q54827736
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05754
AC   CVCL_8L11
DR   CLO; CLO_0036319
DR   Coriell; DA05754
DR   Wikidata; Q54827737
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05755
AC   CVCL_8L12
DR   CLO; CLO_0036305
DR   Coriell; DA05755
DR   Wikidata; Q54827738
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05756
AC   CVCL_8L13
DR   CLO; CLO_0036306
DR   Coriell; DA05756
DR   Wikidata; Q54827739
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05757
AC   CVCL_8L14
DR   CLO; CLO_0036307
DR   Coriell; DA05757
DR   Wikidata; Q54827740
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05758
AC   CVCL_8L15
DR   CLO; CLO_0036344
DR   Coriell; DA05758
DR   Wikidata; Q54827741
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05759
AC   CVCL_8L16
DR   CLO; CLO_0036343
DR   Coriell; DA05759
DR   Wikidata; Q54827742
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05760
AC   CVCL_8L17
DR   CLO; CLO_0036342
DR   Coriell; DA05760
DR   Wikidata; Q54827743
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05761
AC   CVCL_8L18
DR   CLO; CLO_0036341
DR   Coriell; DA05761
DR   Wikidata; Q54827744
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05762
AC   CVCL_8L19
DR   CLO; CLO_0036340
DR   Coriell; DA05762
DR   Wikidata; Q54827745
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05763
AC   CVCL_8L20
DR   CLO; CLO_0036337
DR   Coriell; DA05763
DR   Wikidata; Q54827746
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05764
AC   CVCL_8L21
DR   CLO; CLO_0036336
DR   Coriell; DA05764
DR   Wikidata; Q54827747
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05765
AC   CVCL_8L22
DR   CLO; CLO_0036334
DR   Coriell; DA05765
DR   Wikidata; Q54827748
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05766
AC   CVCL_8L23
DR   CLO; CLO_0036325
DR   Coriell; DA05766
DR   Wikidata; Q54827749
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05767
AC   CVCL_8L24
DR   CLO; CLO_0036326
DR   Coriell; DA05767
DR   Wikidata; Q54827750
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05768
AC   CVCL_8L25
DR   CLO; CLO_0036354
DR   Coriell; DA05768
DR   Wikidata; Q54827751
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05769
AC   CVCL_8L26
DR   CLO; CLO_0036358
DR   Coriell; DA05769
DR   Wikidata; Q54827752
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05770
AC   CVCL_8L27
DR   CLO; CLO_0036357
DR   Coriell; DA05770
DR   Wikidata; Q54827753
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05771
AC   CVCL_8L28
DR   CLO; CLO_0036360
DR   Coriell; DA05771
DR   Wikidata; Q54827754
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05772
AC   CVCL_8L29
DR   CLO; CLO_0036359
DR   Coriell; DA05772
DR   Wikidata; Q54827755
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05773
AC   CVCL_8L30
DR   CLO; CLO_0036362
DR   Coriell; DA05773
DR   Wikidata; Q54827756
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05774
AC   CVCL_8L31
DR   CLO; CLO_0036361
DR   Coriell; DA05774
DR   Wikidata; Q54827757
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05775
AC   CVCL_8L32
DR   CLO; CLO_0036365
DR   Coriell; DA05775
DR   Wikidata; Q54827758
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05776
AC   CVCL_8L33
DR   CLO; CLO_0036364
DR   Coriell; DA05776
DR   Wikidata; Q54827759
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05777
AC   CVCL_8L34
DR   CLO; CLO_0036345
DR   Coriell; DA05777
DR   Wikidata; Q54827760
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05778
AC   CVCL_8L35
DR   CLO; CLO_0036373
DR   Coriell; DA05778
DR   Wikidata; Q54827761
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05779
AC   CVCL_8L36
DR   CLO; CLO_0036371
DR   Coriell; DA05779
DR   Wikidata; Q54827762
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05780
AC   CVCL_8L37
DR   CLO; CLO_0036380
DR   Coriell; DA05780
DR   Wikidata; Q54827767
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05781
AC   CVCL_8L38
DR   CLO; CLO_0036379
DR   Coriell; DA05781
DR   Wikidata; Q54827768
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05782
AC   CVCL_8L39
DR   CLO; CLO_0036378
DR   Coriell; DA05782
DR   Wikidata; Q54827769
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05783
AC   CVCL_8L40
DR   CLO; CLO_0036377
DR   Coriell; DA05783
DR   Wikidata; Q54827770
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05784
AC   CVCL_8L41
DR   CLO; CLO_0036386
DR   Coriell; DA05784
DR   Wikidata; Q54827771
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05785
AC   CVCL_8L42
DR   CLO; CLO_0036383
DR   Coriell; DA05785
DR   Wikidata; Q54827772
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05788
AC   CVCL_8L43
DR   CLO; CLO_0036382
DR   Coriell; DA05788
DR   Wikidata; Q54827773
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05789
AC   CVCL_8L44
DR   CLO; CLO_0036381
DR   Coriell; DA05789
DR   Wikidata; Q54827774
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05790
AC   CVCL_8L45
DR   CLO; CLO_0036697
DR   Coriell; DA05790
DR   Wikidata; Q54827775
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05791
AC   CVCL_8L46
DR   CLO; CLO_0036695
DR   Coriell; DA05791
DR   Wikidata; Q54827776
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05792
AC   CVCL_8L47
DR   CLO; CLO_0036696
DR   Coriell; DA05792
DR   Wikidata; Q54827777
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05793
AC   CVCL_8L48
DR   CLO; CLO_0036681
DR   Coriell; DA05793
DR   Wikidata; Q54827778
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05794
AC   CVCL_8L49
DR   CLO; CLO_0036684
DR   Coriell; DA05794
DR   Wikidata; Q54827779
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05795
AC   CVCL_8L50
DR   CLO; CLO_0036679
DR   Coriell; DA05795
DR   Wikidata; Q54827780
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05798
AC   CVCL_8L51
DR   CLO; CLO_0036680
DR   Coriell; DA05798
DR   Wikidata; Q54827781
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05799
AC   CVCL_8L52
DR   CLO; CLO_0036689
DR   Coriell; DA05799
DR   Wikidata; Q54827782
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05800
AC   CVCL_8L53
DR   CLO; CLO_0036690
DR   Coriell; DA05800
DR   Wikidata; Q54827784
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05801
AC   CVCL_8L54
DR   CLO; CLO_0036685
DR   Coriell; DA05801
DR   Wikidata; Q54827785
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05802
AC   CVCL_8L55
DR   CLO; CLO_0023071
DR   Coriell; DA05802
DR   Wikidata; Q54827786
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05806
AC   CVCL_8L56
DR   CLO; CLO_0023066
DR   Coriell; DA05806
DR   Wikidata; Q54827787
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05807
AC   CVCL_8L57
DR   CLO; CLO_0023065
DR   Coriell; DA05807
DR   Wikidata; Q54827788
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05808
AC   CVCL_8L58
DR   CLO; CLO_0023064
DR   Coriell; DA05808
DR   Wikidata; Q54827789
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05809
AC   CVCL_8L59
DR   CLO; CLO_0023063
DR   Coriell; DA05809
DR   Wikidata; Q54827790
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05810
AC   CVCL_8L60
DR   CLO; CLO_0023070
DR   Coriell; DA05810
DR   Wikidata; Q54827791
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05811
AC   CVCL_8L61
DR   CLO; CLO_0023069
DR   Coriell; DA05811
DR   Wikidata; Q54827792
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05812
AC   CVCL_8L62
DR   CLO; CLO_0023068
DR   Coriell; DA05812
DR   Wikidata; Q54827793
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05817
AC   CVCL_8L63
DR   CLO; CLO_0023067
DR   Coriell; DA05817
DR   Wikidata; Q54827794
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05818
AC   CVCL_8L64
DR   CLO; CLO_0023059
DR   Coriell; DA05818
DR   Wikidata; Q54827795
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05819
AC   CVCL_8L65
DR   CLO; CLO_0023124
DR   Coriell; DA05819
DR   Wikidata; Q54827796
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05820
AC   CVCL_8L66
DR   CLO; CLO_0023125
DR   Coriell; DA05820
DR   Wikidata; Q54827797
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05821
AC   CVCL_8L67
DR   CLO; CLO_0023121
DR   Coriell; DA05821
DR   Wikidata; Q54827798
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05822
AC   CVCL_8L68
DR   CLO; CLO_0023120
DR   Coriell; DA05822
DR   Wikidata; Q54827799
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05823
AC   CVCL_8L69
DR   CLO; CLO_0023123
DR   Coriell; DA05823
DR   Wikidata; Q54827800
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05824
AC   CVCL_8L70
DR   CLO; CLO_0023122
DR   Coriell; DA05824
DR   Wikidata; Q54827801
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05825
AC   CVCL_8L71
DR   CLO; CLO_0023117
DR   Coriell; DA05825
DR   Wikidata; Q54827802
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05826
AC   CVCL_8L72
DR   CLO; CLO_0023116
DR   Coriell; DA05826
DR   Wikidata; Q54827803
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05827
AC   CVCL_8L73
DR   CLO; CLO_0023119
DR   Coriell; DA05827
DR   Wikidata; Q54827804
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05828
AC   CVCL_8L74
DR   CLO; CLO_0023118
DR   Coriell; DA05828
DR   Wikidata; Q54827805
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05829
AC   CVCL_8L75
DR   CLO; CLO_0023105
DR   Coriell; DA05829
DR   Wikidata; Q54827806
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05830
AC   CVCL_8L76
DR   CLO; CLO_0023103
DR   Coriell; DA05830
DR   Wikidata; Q54827807
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05831
AC   CVCL_8L77
DR   CLO; CLO_0023104
DR   Coriell; DA05831
DR   Wikidata; Q54827810
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05832
AC   CVCL_8L78
DR   CLO; CLO_0023102
DR   Coriell; DA05832
DR   Wikidata; Q54827811
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05833
AC   CVCL_8L79
DR   CLO; CLO_0023101
DR   Coriell; DA05833
DR   Wikidata; Q54827812
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05834
AC   CVCL_8L80
DR   CLO; CLO_0023100
DR   Coriell; DA05834
DR   Wikidata; Q54827813
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05836
AC   CVCL_8L81
DR   CLO; CLO_0023099
DR   Coriell; DA05836
DR   Wikidata; Q54827814
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05837
AC   CVCL_8L82
DR   CLO; CLO_0023098
DR   Coriell; DA05837
DR   Wikidata; Q54827815
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05838
AC   CVCL_8L83
DR   CLO; CLO_0023097
DR   Coriell; DA05838
DR   Wikidata; Q54827816
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05839
AC   CVCL_8L84
DR   CLO; CLO_0023096
DR   Coriell; DA05839
DR   Wikidata; Q54827817
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05840
AC   CVCL_8L85
DR   CLO; CLO_0023211
DR   Coriell; DA05840
DR   Wikidata; Q54827818
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05841
AC   CVCL_8L86
DR   CLO; CLO_0023209
DR   Coriell; DA05841
DR   Wikidata; Q54827819
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05843
AC   CVCL_8L87
DR   CLO; CLO_0023208
DR   Coriell; DA05843
DR   Wikidata; Q54827820
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05844
AC   CVCL_8L88
DR   CLO; CLO_0023207
DR   Coriell; DA05844
DR   Wikidata; Q54827821
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05845
AC   CVCL_8L89
DR   CLO; CLO_0023214
DR   Coriell; DA05845
DR   Wikidata; Q54827822
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05846
AC   CVCL_8L90
DR   CLO; CLO_0023215
DR   Coriell; DA05846
DR   Wikidata; Q54827823
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05847
AC   CVCL_8L91
DR   CLO; CLO_0023212
DR   Coriell; DA05847
DR   Wikidata; Q54827824
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05848
AC   CVCL_8L92
DR   CLO; CLO_0023213
DR   Coriell; DA05848
DR   Wikidata; Q54827825
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05850
AC   CVCL_8L93
DR   CLO; CLO_0023216
DR   Coriell; DA05850
DR   Wikidata; Q54827826
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05851
AC   CVCL_8L94
DR   CLO; CLO_0023217
DR   Coriell; DA05851
DR   Wikidata; Q54827827
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05852
AC   CVCL_8L95
DR   CLO; CLO_0023187
DR   Coriell; DA05852
DR   Wikidata; Q54827828
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05853
AC   CVCL_8L96
DR   CLO; CLO_0023190
DR   Coriell; DA05853
DR   Wikidata; Q54827829
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05854
AC   CVCL_8L97
DR   CLO; CLO_0023189
DR   Coriell; DA05854
DR   Wikidata; Q54827830
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05855
AC   CVCL_8L98
DR   CLO; CLO_0023192
DR   Coriell; DA05855
DR   Wikidata; Q54827831
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05856
AC   CVCL_8L99
DR   CLO; CLO_0023191
DR   Coriell; DA05856
DR   Wikidata; Q54827832
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05857
AC   CVCL_8M00
DR   CLO; CLO_0023193
DR   Coriell; DA05857
DR   Wikidata; Q54827833
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05861
AC   CVCL_8M01
DR   CLO; CLO_0023194
DR   Coriell; DA05861
DR   Wikidata; Q54827834
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05862
AC   CVCL_8M02
DR   CLO; CLO_0023195
DR   Coriell; DA05862
DR   Wikidata; Q54827835
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05864
AC   CVCL_8M03
DR   CLO; CLO_0023196
DR   Coriell; DA05864
DR   Wikidata; Q54827836
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05865
AC   CVCL_8M04
DR   CLO; CLO_0023197
DR   Coriell; DA05865
DR   Wikidata; Q54827837
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05866
AC   CVCL_8M05
DR   CLO; CLO_0023252
DR   Coriell; DA05866
DR   Wikidata; Q54827838
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05867
AC   CVCL_8M06
DR   CLO; CLO_0023250
DR   Coriell; DA05867
DR   Wikidata; Q54827839
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05869
AC   CVCL_8M07
DR   CLO; CLO_0023249
DR   Coriell; DA05869
DR   Wikidata; Q54827840
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05870
AC   CVCL_8M08
DR   CLO; CLO_0023248
DR   Coriell; DA05870
DR   Wikidata; Q54827841
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05871
AC   CVCL_8M09
DR   CLO; CLO_0023247
DR   Coriell; DA05871
DR   Wikidata; Q54827843
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05872
AC   CVCL_8M10
DR   CLO; CLO_0023246
DR   Coriell; DA05872
DR   Wikidata; Q54827844
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05873
AC   CVCL_8M11
DR   CLO; CLO_0023257
DR   Coriell; DA05873
DR   Wikidata; Q54827845
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05874
AC   CVCL_8M12
DR   CLO; CLO_0023258
DR   Coriell; DA05874
DR   Wikidata; Q54827846
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05875
AC   CVCL_8M13
DR   CLO; CLO_0023255
DR   Coriell; DA05875
DR   Wikidata; Q54827847
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05876
AC   CVCL_8M14
DR   CLO; CLO_0023256
DR   Coriell; DA05876
DR   Wikidata; Q54827848
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05877
AC   CVCL_8M15
DR   CLO; CLO_0023231
DR   Coriell; DA05877
DR   Wikidata; Q54827849
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05878
AC   CVCL_8M16
DR   CLO; CLO_0023234
DR   Coriell; DA05878
DR   Wikidata; Q54827850
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05882
AC   CVCL_8M17
DR   CLO; CLO_0023233
DR   Coriell; DA05882
DR   Wikidata; Q54827853
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05883
AC   CVCL_8M18
DR   CLO; CLO_0023227
DR   Coriell; DA05883
DR   Wikidata; Q54827854
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05884
AC   CVCL_8M19
DR   CLO; CLO_0023226
DR   Coriell; DA05884
DR   Wikidata; Q54827855
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05885
AC   CVCL_8M20
DR   CLO; CLO_0023229
DR   Coriell; DA05885
DR   Wikidata; Q54827856
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05887
AC   CVCL_8M21
DR   CLO; CLO_0023228
DR   Coriell; DA05887
DR   Wikidata; Q54827857
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05888
AC   CVCL_8M22
DR   CLO; CLO_0023235
DR   Coriell; DA05888
DR   Wikidata; Q54827858
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05889
AC   CVCL_8M23
DR   CLO; CLO_0023236
DR   Coriell; DA05889
DR   Wikidata; Q54827859
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05890
AC   CVCL_8M24
DR   CLO; CLO_0023237
DR   Coriell; DA05890
DR   Wikidata; Q54827860
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05891
AC   CVCL_8M25
DR   CLO; CLO_0023160
DR   Coriell; DA05891
DR   Wikidata; Q54827861
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05892
AC   CVCL_8M26
DR   CLO; CLO_0023161
DR   Coriell; DA05892
DR   Wikidata; Q54827862
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05897
AC   CVCL_8M27
DR   CLO; CLO_0023158
DR   Coriell; DA05897
DR   Wikidata; Q54827863
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05900
AC   CVCL_8M28
DR   CLO; CLO_0023159
DR   Coriell; DA05900
DR   Wikidata; Q54827864
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05901
AC   CVCL_8M29
DR   CLO; CLO_0023164
DR   Coriell; DA05901
DR   Wikidata; Q54827865
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05902
AC   CVCL_8M30
DR   CLO; CLO_0023165
DR   Coriell; DA05902
DR   Wikidata; Q54827866
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05903
AC   CVCL_8M31
DR   CLO; CLO_0023162
DR   Coriell; DA05903
DR   Wikidata; Q54827867
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05904
AC   CVCL_8M32
DR   CLO; CLO_0023163
DR   Coriell; DA05904
DR   Wikidata; Q54827868
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05906
AC   CVCL_8M33
DR   CLO; CLO_0023167
DR   Coriell; DA05906
DR   Wikidata; Q54827869
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05907
AC   CVCL_8M34
DR   CLO; CLO_0023166
DR   Coriell; DA05907
DR   Wikidata; Q54827870
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05908
AC   CVCL_8M35
DR   CLO; CLO_0023156
DR   Coriell; DA05908
DR   Wikidata; Q54827871
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05909
AC   CVCL_8M36
DR   CLO; CLO_0023148
DR   Coriell; DA05909
DR   Wikidata; Q54827872
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05910
AC   CVCL_8M37
DR   CLO; CLO_0023149
DR   Coriell; DA05910
DR   Wikidata; Q54827873
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05911
AC   CVCL_8M38
DR   CLO; CLO_0023150
DR   Coriell; DA05911
DR   Wikidata; Q54827874
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05912
AC   CVCL_8M39
DR   CLO; CLO_0023151
DR   Coriell; DA05912
DR   Wikidata; Q54827875
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05913
AC   CVCL_8M40
DR   CLO; CLO_0023152
DR   Coriell; DA05913
DR   Wikidata; Q54827876
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05914
AC   CVCL_8M41
DR   CLO; CLO_0023153
DR   Coriell; DA05914
DR   Wikidata; Q54827877
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05915
AC   CVCL_8M42
DR   CLO; CLO_0023154
DR   Coriell; DA05915
DR   Wikidata; Q54827878
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05916
AC   CVCL_8M43
DR   CLO; CLO_0023155
DR   Coriell; DA05916
DR   Wikidata; Q54827879
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05919
AC   CVCL_8M44
DR   CLO; CLO_0023157
DR   Coriell; DA05919
DR   Wikidata; Q54827880
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05920
AC   CVCL_8M45
DR   CLO; CLO_0023176
DR   Coriell; DA05920
DR   Wikidata; Q54827881
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05921
AC   CVCL_8M46
DR   CLO; CLO_0023177
DR   Coriell; DA05921
DR   Wikidata; Q54827882
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05922
AC   CVCL_8M47
DR   CLO; CLO_0023174
DR   Coriell; DA05922
DR   Wikidata; Q54827883
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05924
AC   CVCL_8M48
DR   CLO; CLO_0023175
DR   Coriell; DA05924
DR   Wikidata; Q54827884
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05925
AC   CVCL_8M49
DR   CLO; CLO_0023172
DR   Coriell; DA05925
DR   Wikidata; Q54827885
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05926
AC   CVCL_8M50
DR   CLO; CLO_0023173
DR   Coriell; DA05926
DR   Wikidata; Q54827886
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05927
AC   CVCL_8M51
DR   CLO; CLO_0023170
DR   Coriell; DA05927
DR   Wikidata; Q54827887
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05928
AC   CVCL_8M52
DR   CLO; CLO_0023171
DR   Coriell; DA05928
DR   Wikidata; Q54827888
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05929
AC   CVCL_8M53
DR   CLO; CLO_0023168
DR   Coriell; DA05929
DR   Wikidata; Q54827889
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05930
AC   CVCL_8M54
DR   CLO; CLO_0023169
DR   Coriell; DA05930
DR   Wikidata; Q54827890
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05931
AC   CVCL_8M55
DR   CLO; CLO_0023555
DR   Coriell; DA05931
DR   Wikidata; Q54827891
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05932
AC   CVCL_8M56
DR   CLO; CLO_0023556
DR   Coriell; DA05932
DR   Wikidata; Q54827892
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05933
AC   CVCL_8M57
DR   CLO; CLO_0023553
DR   Coriell; DA05933
DR   Wikidata; Q54827895
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05934
AC   CVCL_8M58
DR   CLO; CLO_0023554
DR   Coriell; DA05934
DR   Wikidata; Q54827896
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05935
AC   CVCL_8M59
DR   CLO; CLO_0023551
DR   Coriell; DA05935
DR   Wikidata; Q54827898
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05936
AC   CVCL_8M60
DR   CLO; CLO_0023552
DR   Coriell; DA05936
DR   Wikidata; Q54827899
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05937
AC   CVCL_8M61
DR   CLO; CLO_0023549
DR   Coriell; DA05937
DR   Wikidata; Q54827900
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05938
AC   CVCL_8M62
DR   CLO; CLO_0023550
DR   Coriell; DA05938
DR   Wikidata; Q54827901
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05940
AC   CVCL_8M63
DR   CLO; CLO_0023547
DR   Coriell; DA05940
DR   Wikidata; Q54827902
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05941
AC   CVCL_8M64
DR   CLO; CLO_0023548
DR   Coriell; DA05941
DR   Wikidata; Q54827903
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05942
AC   CVCL_8M65
DR   CLO; CLO_0023546
DR   Coriell; DA05942
DR   Wikidata; Q54827904
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05943
AC   CVCL_8M66
DR   CLO; CLO_0023527
DR   Coriell; DA05943
DR   Wikidata; Q54827905
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05944
AC   CVCL_8M67
DR   CLO; CLO_0023526
DR   Coriell; DA05944
DR   Wikidata; Q54827906
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05945
AC   CVCL_8M68
DR   CLO; CLO_0023529
DR   Coriell; DA05945
DR   Wikidata; Q54827907
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05946
AC   CVCL_8M69
DR   CLO; CLO_0023528
DR   Coriell; DA05946
DR   Wikidata; Q54827908
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05947
AC   CVCL_8M70
DR   CLO; CLO_0023531
DR   Coriell; DA05947
DR   Wikidata; Q54827909
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05948
AC   CVCL_8M71
DR   CLO; CLO_0023530
DR   Coriell; DA05948
DR   Wikidata; Q54827910
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05949
AC   CVCL_8M72
DR   CLO; CLO_0023533
DR   Coriell; DA05949
DR   Wikidata; Q54827911
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05950
AC   CVCL_8M73
DR   CLO; CLO_0023532
DR   Coriell; DA05950
DR   Wikidata; Q54827912
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05951
AC   CVCL_8M74
DR   CLO; CLO_0023534
DR   Coriell; DA05951
DR   Wikidata; Q54827913
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05952
AC   CVCL_8M75
DR   CLO; CLO_0023524
DR   Coriell; DA05952
DR   Wikidata; Q54827914
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05953
AC   CVCL_8M76
DR   CLO; CLO_0023525
DR   Coriell; DA05953
DR   Wikidata; Q54827915
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05954
AC   CVCL_8M77
DR   CLO; CLO_0023508
DR   Coriell; DA05954
DR   Wikidata; Q54827916
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05955
AC   CVCL_8M78
DR   CLO; CLO_0023507
DR   Coriell; DA05955
DR   Wikidata; Q54827917
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05956
AC   CVCL_8M79
DR   CLO; CLO_0023506
DR   Coriell; DA05956
DR   Wikidata; Q54827918
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05958
AC   CVCL_8M80
DR   CLO; CLO_0023505
DR   Coriell; DA05958
DR   Wikidata; Q54827919
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05959
AC   CVCL_8M81
DR   CLO; CLO_0023512
DR   Coriell; DA05959
DR   Wikidata; Q54827920
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05960
AC   CVCL_8M82
DR   CLO; CLO_0023511
DR   Coriell; DA05960
DR   Wikidata; Q54827921
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05962
AC   CVCL_8M83
DR   CLO; CLO_0023510
DR   Coriell; DA05962
DR   Wikidata; Q54827922
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05963
AC   CVCL_8M84
DR   CLO; CLO_0023509
DR   Coriell; DA05963
DR   Wikidata; Q54827923
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05964
AC   CVCL_8M85
DR   CLO; CLO_0023502
DR   Coriell; DA05964
DR   Wikidata; Q54827924
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05965
AC   CVCL_8M86
DR   CLO; CLO_0023503
DR   Coriell; DA05965
DR   Wikidata; Q54827925
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05966
AC   CVCL_8M87
DR   CLO; CLO_0023504
DR   Coriell; DA05966
DR   Wikidata; Q54827927
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05967
AC   CVCL_8M88
DR   CLO; CLO_0023488
DR   Coriell; DA05967
DR   Wikidata; Q54827928
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05968
AC   CVCL_8M89
DR   CLO; CLO_0023487
DR   Coriell; DA05968
DR   Wikidata; Q54827929
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05969
AC   CVCL_8M90
DR   CLO; CLO_0023490
DR   Coriell; DA05969
DR   Wikidata; Q54827930
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05970
AC   CVCL_8M91
DR   CLO; CLO_0023489
DR   Coriell; DA05970
DR   Wikidata; Q54827931
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05971
AC   CVCL_8M92
DR   CLO; CLO_0023485
DR   Coriell; DA05971
DR   Wikidata; Q54827932
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05972
AC   CVCL_8M93
DR   CLO; CLO_0023484
DR   Coriell; DA05972
DR   Wikidata; Q54827933
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05973
AC   CVCL_8M94
DR   CLO; CLO_0023486
DR   Coriell; DA05973
DR   Wikidata; Q54827934
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05974
AC   CVCL_8M95
DR   CLO; CLO_0023482
DR   Coriell; DA05974
DR   Wikidata; Q54827935
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05975
AC   CVCL_8M96
DR   CLO; CLO_0023483
DR   Coriell; DA05975
DR   Wikidata; Q54827936
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05976
AC   CVCL_8M97
DR   CLO; CLO_0023480
DR   Coriell; DA05976
DR   Wikidata; Q54827941
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05977
AC   CVCL_8M98
DR   CLO; CLO_0023481
DR   Coriell; DA05977
DR   Wikidata; Q54827942
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05978
AC   CVCL_8M99
DR   CLO; CLO_0023471
DR   Coriell; DA05978
DR   Wikidata; Q54827943
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05979
AC   CVCL_8N00
DR   CLO; CLO_0023469
DR   Coriell; DA05979
DR   Wikidata; Q54827944
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05980
AC   CVCL_8N01
DR   CLO; CLO_0023466
DR   Coriell; DA05980
DR   Wikidata; Q54827945
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05981
AC   CVCL_8N02
DR   CLO; CLO_0023464
DR   Coriell; DA05981
DR   Wikidata; Q54827946
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05982
AC   CVCL_8N03
DR   CLO; CLO_0023462
DR   Coriell; DA05982
DR   Wikidata; Q54827947
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05984
AC   CVCL_8N04
DR   CLO; CLO_0023460
DR   Coriell; DA05984
DR   Wikidata; Q54827948
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05985
AC   CVCL_8N05
DR   CLO; CLO_0023650
DR   Coriell; DA05985
DR   Wikidata; Q54827949
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05986
AC   CVCL_8N06
DR   CLO; CLO_0023657
DR   Coriell; DA05986
DR   Wikidata; Q54827950
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05987
AC   CVCL_8N07
DR   CLO; CLO_0023656
DR   Coriell; DA05987
DR   Wikidata; Q54827951
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05988
AC   CVCL_8N08
DR   CLO; CLO_0023655
DR   Coriell; DA05988
DR   Wikidata; Q54827952
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05989
AC   CVCL_8N09
DR   CLO; CLO_0023654
DR   Coriell; DA05989
DR   Wikidata; Q54827953
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05990
AC   CVCL_8N10
DR   CLO; CLO_0023666
DR   Coriell; DA05990
DR   Wikidata; Q54827954
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05991
AC   CVCL_8N11
DR   CLO; CLO_0023667
DR   Coriell; DA05991
DR   Wikidata; Q54827955
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05993
AC   CVCL_8N12
DR   CLO; CLO_0023664
DR   Coriell; DA05993
DR   Wikidata; Q54827956
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05994
AC   CVCL_8N13
DR   CLO; CLO_0023665
DR   Coriell; DA05994
DR   Wikidata; Q54827957
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05995
AC   CVCL_8N14
DR   CLO; CLO_0023668
DR   Coriell; DA05995
DR   Wikidata; Q54827958
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05996
AC   CVCL_8N15
DR   CLO; CLO_0023633
DR   Coriell; DA05996
DR   Wikidata; Q54827959
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05997
AC   CVCL_8N16
DR   CLO; CLO_0023632
DR   Coriell; DA05997
DR   Wikidata; Q54827960
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05998
AC   CVCL_8N17
DR   CLO; CLO_0023635
DR   Coriell; DA05998
DR   Wikidata; Q54827961
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA05999
AC   CVCL_8N18
DR   CLO; CLO_0023634
DR   Coriell; DA05999
DR   Wikidata; Q54827962
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06000
AC   CVCL_8N19
DR   CLO; CLO_0023637
DR   Coriell; DA06000
DR   Wikidata; Q54827963
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06001
AC   CVCL_8N20
DR   CLO; CLO_0023636
DR   Coriell; DA06001
DR   Wikidata; Q54827964
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06002
AC   CVCL_8N21
DR   CLO; CLO_0023645
DR   Coriell; DA06002
DR   Wikidata; Q54827965
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06004
AC   CVCL_8N22
DR   CLO; CLO_0023646
DR   Coriell; DA06004
DR   Wikidata; Q54827966
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06005
AC   CVCL_8N23
DR   CLO; CLO_0023647
DR   Coriell; DA06005
DR   Wikidata; Q54827967
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06006
AC   CVCL_8N24
DR   CLO; CLO_0023648
DR   Coriell; DA06006
DR   Wikidata; Q54827969
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06007
AC   CVCL_8N25
DR   CLO; CLO_0023615
DR   Coriell; DA06007
DR   Wikidata; Q54827970
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06009
AC   CVCL_8N26
DR   CLO; CLO_0023613
DR   Coriell; DA06009
DR   Wikidata; Q54827971
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06010
AC   CVCL_8N27
DR   CLO; CLO_0023612
DR   Coriell; DA06010
DR   Wikidata; Q54827972
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06011
AC   CVCL_8N28
DR   CLO; CLO_0023611
DR   Coriell; DA06011
DR   Wikidata; Q54827973
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06012
AC   CVCL_8N29
DR   CLO; CLO_0023610
DR   Coriell; DA06012
DR   Wikidata; Q54827974
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06013
AC   CVCL_8N30
DR   CLO; CLO_0023609
DR   Coriell; DA06013
DR   Wikidata; Q54827975
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06014
AC   CVCL_8N31
DR   CLO; CLO_0023608
DR   Coriell; DA06014
DR   Wikidata; Q54827976
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06015
AC   CVCL_8N32
DR   CLO; CLO_0023627
DR   Coriell; DA06015
DR   Wikidata; Q54827977
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06016
AC   CVCL_8N33
DR   CLO; CLO_0023628
DR   Coriell; DA06016
DR   Wikidata; Q54827978
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06017
AC   CVCL_8N34
DR   CLO; CLO_0023626
DR   Coriell; DA06017
DR   Wikidata; Q54827979
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06019
AC   CVCL_8N35
DR   CLO; CLO_0023593
DR   Coriell; DA06019
DR   Wikidata; Q54827980
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06020
AC   CVCL_8N36
DR   CLO; CLO_0023591
DR   Coriell; DA06020
DR   Wikidata; Q54827981
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06022
AC   CVCL_8N37
DR   CLO; CLO_0023595
DR   Coriell; DA06022
DR   Wikidata; Q54827984
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06023
AC   CVCL_8N38
DR   CLO; CLO_0023594
DR   Coriell; DA06023
DR   Wikidata; Q54827985
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06024
AC   CVCL_8N39
DR   CLO; CLO_0023588
DR   Coriell; DA06024
DR   Wikidata; Q54827986
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06025
AC   CVCL_8N40
DR   CLO; CLO_0023587
DR   Coriell; DA06025
DR   Wikidata; Q54827987
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06026
AC   CVCL_8N41
DR   CLO; CLO_0023590
DR   Coriell; DA06026
DR   Wikidata; Q54827988
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06027
AC   CVCL_8N42
DR   CLO; CLO_0023589
DR   Coriell; DA06027
DR   Wikidata; Q54827989
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06028
AC   CVCL_8N43
DR   CLO; CLO_0023606
DR   Coriell; DA06028
DR   Wikidata; Q54827990
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06029
AC   CVCL_8N44
DR   CLO; CLO_0023607
DR   Coriell; DA06029
DR   Wikidata; Q54827991
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06030
AC   CVCL_8N45
DR   CLO; CLO_0023577
DR   Coriell; DA06030
DR   Wikidata; Q54827992
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06032
AC   CVCL_8N46
DR   CLO; CLO_0023580
DR   Coriell; DA06032
DR   Wikidata; Q54827993
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06033
AC   CVCL_8N47
DR   CLO; CLO_0023581
DR   Coriell; DA06033
DR   Wikidata; Q54827994
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06037
AC   CVCL_8N48
DR   CLO; CLO_0023578
DR   Coriell; DA06037
DR   Wikidata; Q54827995
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06038
AC   CVCL_8N49
DR   CLO; CLO_0023579
DR   Coriell; DA06038
DR   Wikidata; Q54827996
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06039
AC   CVCL_8N50
DR   CLO; CLO_0023584
DR   Coriell; DA06039
DR   Wikidata; Q54827997
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06040
AC   CVCL_8N51
DR   CLO; CLO_0023585
DR   Coriell; DA06040
DR   Wikidata; Q54827998
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06041
AC   CVCL_8N52
DR   CLO; CLO_0023582
DR   Coriell; DA06041
DR   Wikidata; Q54827999
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06042
AC   CVCL_8N53
DR   CLO; CLO_0023583
DR   Coriell; DA06042
DR   Wikidata; Q54828000
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06043
AC   CVCL_8N54
DR   CLO; CLO_0023586
DR   Coriell; DA06043
DR   Wikidata; Q54828001
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06044
AC   CVCL_8N55
DR   CLO; CLO_0023901
DR   Coriell; DA06044
DR   Wikidata; Q54828002
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06045
AC   CVCL_8N56
DR   CLO; CLO_0023899
DR   Coriell; DA06045
DR   Wikidata; Q54828003
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06046
AC   CVCL_8N57
DR   CLO; CLO_0023900
DR   Coriell; DA06046
DR   Wikidata; Q54828004
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06047
AC   CVCL_8N58
DR   CLO; CLO_0023904
DR   Coriell; DA06047
DR   Wikidata; Q54828005
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06048
AC   CVCL_8N59
DR   CLO; CLO_0023905
DR   Coriell; DA06048
DR   Wikidata; Q54828006
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06049
AC   CVCL_8N60
DR   CLO; CLO_0023902
DR   Coriell; DA06049
DR   Wikidata; Q54828007
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06051
AC   CVCL_8N61
DR   CLO; CLO_0023903
DR   Coriell; DA06051
DR   Wikidata; Q54828008
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06052
AC   CVCL_8N62
DR   CLO; CLO_0023907
DR   Coriell; DA06052
DR   Wikidata; Q54828009
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06053
AC   CVCL_8N63
DR   CLO; CLO_0023908
DR   Coriell; DA06053
DR   Wikidata; Q54828010
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06054
AC   CVCL_8N64
DR   CLO; CLO_0023906
DR   Coriell; DA06054
DR   Wikidata; Q54828011
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06055
AC   CVCL_8N65
DR   CLO; CLO_0023923
DR   Coriell; DA06055
DR   Wikidata; Q54828012
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06056
AC   CVCL_8N66
DR   CLO; CLO_0023924
DR   Coriell; DA06056
DR   Wikidata; Q54828013
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06057
AC   CVCL_8N67
DR   CLO; CLO_0023925
DR   Coriell; DA06057
DR   Wikidata; Q54828014
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06058
AC   CVCL_8N68
DR   CLO; CLO_0023926
DR   Coriell; DA06058
DR   Wikidata; Q54828015
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06059
AC   CVCL_8N69
DR   CLO; CLO_0023919
DR   Coriell; DA06059
DR   Wikidata; Q54828016
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06061
AC   CVCL_8N70
DR   CLO; CLO_0023920
DR   Coriell; DA06061
DR   Wikidata; Q54828017
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06062
AC   CVCL_8N71
DR   CLO; CLO_0023921
DR   Coriell; DA06062
DR   Wikidata; Q54828018
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06063
AC   CVCL_8N72
DR   CLO; CLO_0023922
DR   Coriell; DA06063
DR   Wikidata; Q54828019
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06065
AC   CVCL_8N73
DR   CLO; CLO_0023927
DR   Coriell; DA06065
DR   Wikidata; Q54828020
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06066
AC   CVCL_8N74
DR   CLO; CLO_0023928
DR   Coriell; DA06066
DR   Wikidata; Q54828021
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06067
AC   CVCL_8N75
DR   CLO; CLO_0023909
DR   Coriell; DA06067
DR   Wikidata; Q54828022
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06068
AC   CVCL_8N76
DR   CLO; CLO_0023916
DR   Coriell; DA06068
DR   Wikidata; Q54828023
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06069
AC   CVCL_8N77
DR   CLO; CLO_0023917
DR   Coriell; DA06069
DR   Wikidata; Q54828027
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06070
AC   CVCL_8N78
DR   CLO; CLO_0023914
DR   Coriell; DA06070
DR   Wikidata; Q54828028
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06071
AC   CVCL_8N79
DR   CLO; CLO_0023915
DR   Coriell; DA06071
DR   Wikidata; Q54828029
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06073
AC   CVCL_8N80
DR   CLO; CLO_0023912
DR   Coriell; DA06073
DR   Wikidata; Q54828030
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06074
AC   CVCL_8N81
DR   CLO; CLO_0023913
DR   Coriell; DA06074
DR   Wikidata; Q54828031
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06076
AC   CVCL_8N82
DR   CLO; CLO_0023910
DR   Coriell; DA06076
DR   Wikidata; Q54828032
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06078
AC   CVCL_8N83
DR   CLO; CLO_0023911
DR   Coriell; DA06078
DR   Wikidata; Q54828033
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06080
AC   CVCL_8N84
DR   CLO; CLO_0023918
DR   Coriell; DA06080
DR   Wikidata; Q54828034
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06081
AC   CVCL_8N85
DR   CLO; CLO_0023955
DR   Coriell; DA06081
DR   Wikidata; Q54828035
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06083
AC   CVCL_8N86
DR   CLO; CLO_0023956
DR   Coriell; DA06083
DR   Wikidata; Q54828036
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06084
AC   CVCL_8N87
DR   CLO; CLO_0023969
DR   Coriell; DA06084
DR   Wikidata; Q54828038
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06085
AC   CVCL_8N88
DR   CLO; CLO_0023968
DR   Coriell; DA06085
DR   Wikidata; Q54828039
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06086
AC   CVCL_8N89
DR   CLO; CLO_0023971
DR   Coriell; DA06086
DR   Wikidata; Q54828040
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06087
AC   CVCL_8N90
DR   CLO; CLO_0023970
DR   Coriell; DA06087
DR   Wikidata; Q54828041
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06088
AC   CVCL_8N91
DR   CLO; CLO_0023973
DR   Coriell; DA06088
DR   Wikidata; Q54828042
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06089
AC   CVCL_8N92
DR   CLO; CLO_0023972
DR   Coriell; DA06089
DR   Wikidata; Q54828043
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06092
AC   CVCL_8N93
DR   CLO; CLO_0023975
DR   Coriell; DA06092
DR   Wikidata; Q54828044
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06094
AC   CVCL_8N94
DR   CLO; CLO_0023974
DR   Coriell; DA06094
DR   Wikidata; Q54828045
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06095
AC   CVCL_8N95
DR   CLO; CLO_0023931
DR   Coriell; DA06095
DR   Wikidata; Q54828046
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06096
AC   CVCL_8N96
DR   CLO; CLO_0023929
DR   Coriell; DA06096
DR   Wikidata; Q54828047
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06097
AC   CVCL_8N97
DR   CLO; CLO_0023930
DR   Coriell; DA06097
DR   Wikidata; Q54828048
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06098
AC   CVCL_8N98
DR   CLO; CLO_0023948
DR   Coriell; DA06098
DR   Wikidata; Q54828049
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06099
AC   CVCL_8N99
DR   CLO; CLO_0023947
DR   Coriell; DA06099
DR   Wikidata; Q54828050
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06100
AC   CVCL_8P00
DR   CLO; CLO_0023944
DR   Coriell; DA06100
DR   Wikidata; Q54828051
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06101
AC   CVCL_8P01
DR   CLO; CLO_0023942
DR   Coriell; DA06101
DR   Wikidata; Q54828052
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06102
AC   CVCL_8P02
DR   CLO; CLO_0023954
DR   Coriell; DA06102
DR   Wikidata; Q54828053
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06103
AC   CVCL_8P03
DR   CLO; CLO_0023951
DR   Coriell; DA06103
DR   Wikidata; Q54828054
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06104
AC   CVCL_8P04
DR   CLO; CLO_0023950
DR   Coriell; DA06104
DR   Wikidata; Q54828055
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06105
AC   CVCL_8P05
DR   CLO; CLO_0023996
DR   Coriell; DA06105
DR   Wikidata; Q54828056
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06106
AC   CVCL_8P06
DR   CLO; CLO_0023997
DR   Coriell; DA06106
DR   Wikidata; Q54828057
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06107
AC   CVCL_8P07
DR   CLO; CLO_0023998
DR   Coriell; DA06107
DR   Wikidata; Q54828058
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06109
AC   CVCL_8P08
DR   CLO; CLO_0023999
DR   Coriell; DA06109
DR   Wikidata; Q54828059
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06110
AC   CVCL_8P09
DR   CLO; CLO_0024010
DR   Coriell; DA06110
DR   Wikidata; Q54828060
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06111
AC   CVCL_8P10
DR   CLO; CLO_0024008
DR   Coriell; DA06111
DR   Wikidata; Q54828061
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06115
AC   CVCL_8P11
DR   CLO; CLO_0024015
DR   Coriell; DA06115
DR   Wikidata; Q54828063
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06116
AC   CVCL_8P12
DR   CLO; CLO_0024012
DR   Coriell; DA06116
DR   Wikidata; Q54828064
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06118
AC   CVCL_8P13
DR   CLO; CLO_0024005
DR   Coriell; DA06118
DR   Wikidata; Q54828065
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06119
AC   CVCL_8P14
DR   CLO; CLO_0024004
DR   Coriell; DA06119
DR   Wikidata; Q54828066
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06122
AC   CVCL_8P15
DR   CLO; CLO_0023980
DR   Coriell; DA06122
DR   Wikidata; Q54828067
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06123
AC   CVCL_8P16
DR   CLO; CLO_0023978
DR   Coriell; DA06123
DR   Wikidata; Q54828068
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06124
AC   CVCL_8P17
DR   CLO; CLO_0023979
DR   Coriell; DA06124
DR   Wikidata; Q54828088
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06125
AC   CVCL_8P18
DR   CLO; CLO_0023976
DR   Coriell; DA06125
DR   Wikidata; Q54828089
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06126
AC   CVCL_8P19
DR   CLO; CLO_0023977
DR   Coriell; DA06126
DR   Wikidata; Q54828090
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06129
AC   CVCL_8P20
DR   CLO; CLO_0023995
DR   Coriell; DA06129
DR   Wikidata; Q54828091
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06130
AC   CVCL_8P21
DR   CLO; CLO_0023992
DR   Coriell; DA06130
DR   Wikidata; Q54828093
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06131
AC   CVCL_8P22
DR   CLO; CLO_0023990
DR   Coriell; DA06131
DR   Wikidata; Q54828094
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06132
AC   CVCL_8P23
DR   CLO; CLO_0023989
DR   Coriell; DA06132
DR   Wikidata; Q54828096
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06136
AC   CVCL_8P24
DR   CLO; CLO_0023986
DR   Coriell; DA06136
DR   Wikidata; Q54828097
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06137
AC   CVCL_8P25
DR   CLO; CLO_0024060
DR   Coriell; DA06137
DR   Wikidata; Q54828098
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06138
AC   CVCL_8P26
DR   CLO; CLO_0024058
DR   Coriell; DA06138
DR   Wikidata; Q54828099
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06139
AC   CVCL_8P27
DR   CLO; CLO_0024066
DR   Coriell; DA06139
DR   Wikidata; Q54828100
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06140
AC   CVCL_8P28
DR   CLO; CLO_0024065
DR   Coriell; DA06140
DR   Wikidata; Q54828101
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06141
AC   CVCL_8P29
DR   CLO; CLO_0024064
DR   Coriell; DA06141
DR   Wikidata; Q54828103
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06142
AC   CVCL_8P30
DR   CLO; CLO_0024063
DR   Coriell; DA06142
DR   Wikidata; Q54828104
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06143
AC   CVCL_8P31
DR   CLO; CLO_0024049
DR   Coriell; DA06143
DR   Wikidata; Q54828106
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06144
AC   CVCL_8P32
DR   CLO; CLO_0024050
DR   Coriell; DA06144
DR   Wikidata; Q54828107
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06145
AC   CVCL_8P33
DR   CLO; CLO_0024047
DR   Coriell; DA06145
DR   Wikidata; Q54828109
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06146
AC   CVCL_8P34
DR   CLO; CLO_0024048
DR   Coriell; DA06146
DR   Wikidata; Q54828110
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06147
AC   CVCL_8P35
DR   CLO; CLO_0024039
DR   Coriell; DA06147
DR   Wikidata; Q54828112
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06148
AC   CVCL_8P36
DR   CLO; CLO_0024042
DR   Coriell; DA06148
DR   Wikidata; Q54828113
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06149
AC   CVCL_8P37
DR   CLO; CLO_0024041
DR   Coriell; DA06149
DR   Wikidata; Q54828115
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06150
AC   CVCL_8P38
DR   CLO; CLO_0024044
DR   Coriell; DA06150
DR   Wikidata; Q54828116
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06151
AC   CVCL_8P39
DR   CLO; CLO_0024043
DR   Coriell; DA06151
DR   Wikidata; Q54828117
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06153
AC   CVCL_8P40
DR   CLO; CLO_0024046
DR   Coriell; DA06153
DR   Wikidata; Q54828118
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06154
AC   CVCL_8P41
DR   CLO; CLO_0024045
DR   Coriell; DA06154
DR   Wikidata; Q54828119
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06155
AC   CVCL_8P42
DR   CLO; CLO_0024017
DR   Coriell; DA06155
DR   Wikidata; Q54828120
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06156
AC   CVCL_8P43
DR   CLO; CLO_0024018
DR   Coriell; DA06156
DR   Wikidata; Q54828121
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06157
AC   CVCL_8P44
DR   CLO; CLO_0024019
DR   Coriell; DA06157
DR   Wikidata; Q54828123
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06158
AC   CVCL_8P45
DR   CLO; CLO_0024138
DR   Coriell; DA06158
DR   Wikidata; Q54828124
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06159
AC   CVCL_8P46
DR   CLO; CLO_0024136
DR   Coriell; DA06159
DR   Wikidata; Q54828125
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06160
AC   CVCL_8P47
DR   CLO; CLO_0024133
DR   Coriell; DA06160
DR   Wikidata; Q54828127
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06161
AC   CVCL_8P48
DR   CLO; CLO_0024132
DR   Coriell; DA06161
DR   Wikidata; Q54828128
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06163
AC   CVCL_8P49
DR   CLO; CLO_0024130
DR   Coriell; DA06163
DR   Wikidata; Q54828129
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06164
AC   CVCL_8P50
DR   CLO; CLO_0024128
DR   Coriell; DA06164
DR   Wikidata; Q54828131
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06165
AC   CVCL_8P51
DR   CLO; CLO_0024126
DR   Coriell; DA06165
DR   Wikidata; Q54828132
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06166
AC   CVCL_8P52
DR   CLO; CLO_0024124
DR   Coriell; DA06166
DR   Wikidata; Q54828134
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06169
AC   CVCL_8P53
DR   CLO; CLO_0024102
DR   Coriell; DA06169
DR   Wikidata; Q54828135
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06170
AC   CVCL_8P54
DR   CLO; CLO_0024103
DR   Coriell; DA06170
DR   Wikidata; Q54828136
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06171
AC   CVCL_8P55
DR   CLO; CLO_0023884
DR   Coriell; DA06171
DR   Wikidata; Q54828138
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06172
AC   CVCL_8P56
DR   CLO; CLO_0023883
DR   Coriell; DA06172
DR   Wikidata; Q54828139
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06173
AC   CVCL_8P57
DR   CLO; CLO_0023887
DR   Coriell; DA06173
DR   Wikidata; Q54828179
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06174
AC   CVCL_8P58
DR   CLO; CLO_0023885
DR   Coriell; DA06174
DR   Wikidata; Q54828181
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06175
AC   CVCL_8P59
DR   CLO; CLO_0023890
DR   Coriell; DA06175
DR   Wikidata; Q54828182
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06176
AC   CVCL_8P60
DR   CLO; CLO_0023888
DR   Coriell; DA06176
DR   Wikidata; Q54828183
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06177
AC   CVCL_8P61
DR   CLO; CLO_0023880
DR   Coriell; DA06177
DR   Wikidata; Q54828185
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06178
AC   CVCL_8P62
DR   CLO; CLO_0023879
DR   Coriell; DA06178
DR   Wikidata; Q54828187
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06179
AC   CVCL_8P63
DR   CLO; CLO_0023882
DR   Coriell; DA06179
DR   Wikidata; Q54828189
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06180
AC   CVCL_8P64
DR   CLO; CLO_0023881
DR   Coriell; DA06180
DR   Wikidata; Q54828190
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06181
AC   CVCL_8P65
DR   CLO; CLO_0024442
DR   Coriell; DA06181
DR   Wikidata; Q54828192
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06182
AC   CVCL_8P66
DR   CLO; CLO_0024443
DR   Coriell; DA06182
DR   Wikidata; Q54828193
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06183
AC   CVCL_8P67
DR   CLO; CLO_0024444
DR   Coriell; DA06183
DR   Wikidata; Q54828195
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06184
AC   CVCL_8P68
DR   CLO; CLO_0024445
DR   Coriell; DA06184
DR   Wikidata; Q54828196
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06185
AC   CVCL_8P69
DR   CLO; CLO_0024446
DR   Coriell; DA06185
DR   Wikidata; Q54828197
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06186
AC   CVCL_8P70
DR   CLO; CLO_0024447
DR   Coriell; DA06186
DR   Wikidata; Q54828199
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06187
AC   CVCL_8P71
DR   CLO; CLO_0024448
DR   Coriell; DA06187
DR   Wikidata; Q54828200
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06189
AC   CVCL_8P72
DR   CLO; CLO_0024439
DR   Coriell; DA06189
DR   Wikidata; Q54828202
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06190
AC   CVCL_8P73
DR   CLO; CLO_0024440
DR   Coriell; DA06190
DR   Wikidata; Q54828203
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06191
AC   CVCL_8P74
DR   CLO; CLO_0024441
DR   Coriell; DA06191
DR   Wikidata; Q54828204
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06197
AC   CVCL_8P75
DR   CLO; CLO_0024433
DR   Coriell; DA06197
DR   Wikidata; Q54828205
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06198
AC   CVCL_8P76
DR   CLO; CLO_0024434
DR   Coriell; DA06198
DR   Wikidata; Q54828206
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06199
AC   CVCL_8P77
DR   CLO; CLO_0024431
DR   Coriell; DA06199
DR   Wikidata; Q54828207
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06200
AC   CVCL_8P78
DR   CLO; CLO_0024432
DR   Coriell; DA06200
DR   Wikidata; Q54828208
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06201
AC   CVCL_8P79
DR   CLO; CLO_0024437
DR   Coriell; DA06201
DR   Wikidata; Q54828209
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06202
AC   CVCL_8P80
DR   CLO; CLO_0024438
DR   Coriell; DA06202
DR   Wikidata; Q54828210
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06204
AC   CVCL_8P81
DR   CLO; CLO_0024435
DR   Coriell; DA06204
DR   Wikidata; Q54828211
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06205
AC   CVCL_8P82
DR   CLO; CLO_0024436
DR   Coriell; DA06205
DR   Wikidata; Q54828212
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06206
AC   CVCL_8P83
DR   CLO; CLO_0024429
DR   Coriell; DA06206
DR   Wikidata; Q54828213
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06207
AC   CVCL_8P84
DR   CLO; CLO_0024430
DR   Coriell; DA06207
DR   Wikidata; Q54828214
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06208
AC   CVCL_8P85
DR   CLO; CLO_0024419
DR   Coriell; DA06208
DR   Wikidata; Q54828215
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06210
AC   CVCL_8P86
DR   CLO; CLO_0024425
DR   Coriell; DA06210
DR   Wikidata; Q54828216
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06211
AC   CVCL_8P87
DR   CLO; CLO_0024426
DR   Coriell; DA06211
DR   Wikidata; Q54828217
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06212
AC   CVCL_8P88
DR   CLO; CLO_0024427
DR   Coriell; DA06212
DR   Wikidata; Q54828218
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06213
AC   CVCL_8P89
DR   CLO; CLO_0024428
DR   Coriell; DA06213
DR   Wikidata; Q54828219
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06214
AC   CVCL_8P90
DR   CLO; CLO_0024421
DR   Coriell; DA06214
DR   Wikidata; Q54828220
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06215
AC   CVCL_8P91
DR   CLO; CLO_0024422
DR   Coriell; DA06215
DR   Wikidata; Q54828221
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06216
AC   CVCL_8P92
DR   CLO; CLO_0024423
DR   Coriell; DA06216
DR   Wikidata; Q54828222
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06217
AC   CVCL_8P93
DR   CLO; CLO_0024424
DR   Coriell; DA06217
DR   Wikidata; Q54828223
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06218
AC   CVCL_8P94
DR   CLO; CLO_0024420
DR   Coriell; DA06218
DR   Wikidata; Q54828224
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06219
AC   CVCL_8P95
DR   CLO; CLO_0024400
DR   Coriell; DA06219
DR   Wikidata; Q54828225
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06220
AC   CVCL_8P96
DR   CLO; CLO_0024399
DR   Coriell; DA06220
DR   Wikidata; Q54828226
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06221
AC   CVCL_8P97
DR   CLO; CLO_0024416
DR   Coriell; DA06221
DR   Wikidata; Q54828230
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06222
AC   CVCL_8P98
DR   CLO; CLO_0024418
DR   Coriell; DA06222
DR   Wikidata; Q54828231
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06223
AC   CVCL_8P99
DR   CLO; CLO_0024411
DR   Coriell; DA06223
DR   Wikidata; Q54828232
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06224
AC   CVCL_8Q00
DR   CLO; CLO_0024414
DR   Coriell; DA06224
DR   Wikidata; Q54828233
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06225
AC   CVCL_8Q01
DR   CLO; CLO_0024408
DR   Coriell; DA06225
DR   Wikidata; Q54828234
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06226
AC   CVCL_8Q02
DR   CLO; CLO_0024410
DR   Coriell; DA06226
DR   Wikidata; Q54828235
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06227
AC   CVCL_8Q03
DR   CLO; CLO_0024406
DR   Coriell; DA06227
DR   Wikidata; Q54828236
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06229
AC   CVCL_8Q04
DR   CLO; CLO_0024407
DR   Coriell; DA06229
DR   Wikidata; Q54828237
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06233
AC   CVCL_8Q05
DR   CLO; CLO_0024509
DR   Coriell; DA06233
DR   Wikidata; Q54828238
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06234
AC   CVCL_8Q06
DR   CLO; CLO_0024510
DR   Coriell; DA06234
DR   Wikidata; Q54828239
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06235
AC   CVCL_8Q07
DR   CLO; CLO_0024511
DR   Coriell; DA06235
DR   Wikidata; Q54828240
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06240
AC   CVCL_8Q08
DR   CLO; CLO_0024514
DR   Coriell; DA06240
DR   Wikidata; Q54828241
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06243
AC   CVCL_8Q09
DR   CLO; CLO_0024513
DR   Coriell; DA06243
DR   Wikidata; Q54828242
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06246
AC   CVCL_8Q10
DR   CLO; CLO_0024519
DR   Coriell; DA06246
DR   Wikidata; Q54828243
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06247
AC   CVCL_8Q11
DR   CLO; CLO_0024517
DR   Coriell; DA06247
DR   Wikidata; Q54828244
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06248
AC   CVCL_8Q12
DR   CLO; CLO_0024523
DR   Coriell; DA06248
DR   Wikidata; Q54828245
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06250
AC   CVCL_8Q13
DR   CLO; CLO_0024521
DR   Coriell; DA06250
DR   Wikidata; Q54828246
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06252
AC   CVCL_8Q14
DR   CLO; CLO_0024524
DR   Coriell; DA06252
DR   Wikidata; Q54828247
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06254
AC   CVCL_8Q15
DR   CLO; CLO_0024491
DR   Coriell; DA06254
DR   Wikidata; Q54828248
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06255
AC   CVCL_8Q16
DR   CLO; CLO_0024492
DR   Coriell; DA06255
DR   Wikidata; Q54828249
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06257
AC   CVCL_8Q17
DR   CLO; CLO_0024489
DR   Coriell; DA06257
DR   Wikidata; Q54828250
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06258
AC   CVCL_8Q18
DR   CLO; CLO_0024490
DR   Coriell; DA06258
DR   Wikidata; Q54828251
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06259
AC   CVCL_8Q19
DR   CLO; CLO_0024499
DR   Coriell; DA06259
DR   Wikidata; Q54828252
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06261
AC   CVCL_8Q20
DR   CLO; CLO_0024498
DR   Coriell; DA06261
DR   Wikidata; Q54828253
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06262
AC   CVCL_8Q21
DR   CLO; CLO_0024496
DR   Coriell; DA06262
DR   Wikidata; Q54828254
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06263
AC   CVCL_8Q22
DR   CLO; CLO_0024494
DR   Coriell; DA06263
DR   Wikidata; Q54828255
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06264
AC   CVCL_8Q23
DR   CLO; CLO_0024504
DR   Coriell; DA06264
DR   Wikidata; Q54828256
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06265
AC   CVCL_8Q24
DR   CLO; CLO_0024503
DR   Coriell; DA06265
DR   Wikidata; Q54828257
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06267
AC   CVCL_8Q25
DR   CLO; CLO_0024473
DR   Coriell; DA06267
DR   Wikidata; Q54828258
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06268
AC   CVCL_8Q26
DR   CLO; CLO_0024469
DR   Coriell; DA06268
DR   Wikidata; Q54828259
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06269
AC   CVCL_8Q27
DR   CLO; CLO_0024470
DR   Coriell; DA06269
DR   Wikidata; Q54828260
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06270
AC   CVCL_8Q28
DR   CLO; CLO_0024471
DR   Coriell; DA06270
DR   Wikidata; Q54828261
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06271
AC   CVCL_8Q29
DR   CLO; CLO_0024472
DR   Coriell; DA06271
DR   Wikidata; Q54828262
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06272
AC   CVCL_8Q30
DR   CLO; CLO_0024481
DR   Coriell; DA06272
DR   Wikidata; Q54828263
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06273
AC   CVCL_8Q31
DR   CLO; CLO_0024479
DR   Coriell; DA06273
DR   Wikidata; Q54828264
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06274
AC   CVCL_8Q32
DR   CLO; CLO_0024486
DR   Coriell; DA06274
DR   Wikidata; Q54828265
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06275
AC   CVCL_8Q33
DR   CLO; CLO_0024483
DR   Coriell; DA06275
DR   Wikidata; Q54828266
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06276
AC   CVCL_8Q34
DR   CLO; CLO_0024476
DR   Coriell; DA06276
DR   Wikidata; Q54828267
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06278
AC   CVCL_8Q35
DR   CLO; CLO_0024453
DR   Coriell; DA06278
DR   Wikidata; Q54828268
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06279
AC   CVCL_8Q36
DR   CLO; CLO_0024454
DR   Coriell; DA06279
DR   Wikidata; Q54828269
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06280
AC   CVCL_8Q37
DR   CLO; CLO_0024451
DR   Coriell; DA06280
DR   Wikidata; Q54828273
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06281
AC   CVCL_8Q38
DR   CLO; CLO_0024452
DR   Coriell; DA06281
DR   Wikidata; Q54828274
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06282
AC   CVCL_8Q39
DR   CLO; CLO_0024449
DR   Coriell; DA06282
DR   Wikidata; Q54828275
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06283
AC   CVCL_8Q40
DR   CLO; CLO_0024450
DR   Coriell; DA06283
DR   Wikidata; Q54828276
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06284
AC   CVCL_8Q41
DR   CLO; CLO_0024466
DR   Coriell; DA06284
DR   Wikidata; Q54828277
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06285
AC   CVCL_8Q42
DR   CLO; CLO_0024464
DR   Coriell; DA06285
DR   Wikidata; Q54828278
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06287
AC   CVCL_8Q43
DR   CLO; CLO_0024463
DR   Coriell; DA06287
DR   Wikidata; Q54828279
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06288
AC   CVCL_8Q44
DR   CLO; CLO_0024460
DR   Coriell; DA06288
DR   Wikidata; Q54828280
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06298
AC   CVCL_8Q45
DR   CLO; CLO_0024608
DR   Coriell; DA06298
DR   Wikidata; Q54828281
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06299
AC   CVCL_8Q46
DR   CLO; CLO_0024604
DR   Coriell; DA06299
DR   Wikidata; Q54828282
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06300
AC   CVCL_8Q47
DR   CLO; CLO_0024602
DR   Coriell; DA06300
DR   Wikidata; Q54828283
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06303
AC   CVCL_8Q48
DR   CLO; CLO_0024617
DR   Coriell; DA06303
DR   Wikidata; Q54828284
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06311
AC   CVCL_8Q49
DR   CLO; CLO_0024616
DR   Coriell; DA06311
DR   Wikidata; Q54828285
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06312
AC   CVCL_8Q50
DR   CLO; CLO_0024614
DR   Coriell; DA06312
DR   Wikidata; Q54828286
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06320
AC   CVCL_8Q51
DR   CLO; CLO_0024612
DR   Coriell; DA06320
DR   Wikidata; Q54828287
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06321
AC   CVCL_8Q52
DR   CLO; CLO_0024600
DR   Coriell; DA06321
DR   Wikidata; Q54828288
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06322
AC   CVCL_8Q53
DR   CLO; CLO_0024601
DR   Coriell; DA06322
DR   Wikidata; Q54828289
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06323
AC   CVCL_8Q54
DR   CLO; CLO_0024599
DR   Coriell; DA06323
DR   Wikidata; Q54828290
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06324
AC   CVCL_8Q55
DR   CLO; CLO_0024387
DR   Coriell; DA06324
DR   Wikidata; Q54828291
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06326
AC   CVCL_8Q56
DR   CLO; CLO_0024382
DR   Coriell; DA06326
DR   Wikidata; Q54828292
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06330
AC   CVCL_8Q57
DR   CLO; CLO_0024379
DR   Coriell; DA06330
DR   Wikidata; Q54828293
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06331
AC   CVCL_8Q58
DR   CLO; CLO_0024386
DR   Coriell; DA06331
DR   Wikidata; Q54828294
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06335
AC   CVCL_8Q59
DR   CLO; CLO_0024384
DR   Coriell; DA06335
DR   Wikidata; Q54828295
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06336
AC   CVCL_8Q60
DR   CLO; CLO_0024390
DR   Coriell; DA06336
DR   Wikidata; Q54828296
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06339
AC   CVCL_8Q61
DR   CLO; CLO_0024389
DR   Coriell; DA06339
DR   Wikidata; Q54828297
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06340
AC   CVCL_8Q62
DR   CLO; CLO_0024392
DR   Coriell; DA06340
DR   Wikidata; Q54828298
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06342
AC   CVCL_8Q63
DR   CLO; CLO_0024391
DR   Coriell; DA06342
DR   Wikidata; Q54828299
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06345
AC   CVCL_8Q64
DR   CLO; CLO_0024388
DR   Coriell; DA06345
DR   Wikidata; Q54828300
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06346
AC   CVCL_8Q65
DR   CLO; CLO_0024340
DR   Coriell; DA06346
DR   Wikidata; Q54828301
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06352
AC   CVCL_8Q66
DR   CLO; CLO_0024339
DR   Coriell; DA06352
DR   Wikidata; Q54828302
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06359
AC   CVCL_8Q67
DR   CLO; CLO_0024346
DR   Coriell; DA06359
DR   Wikidata; Q54828303
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06362
AC   CVCL_8Q68
DR   CLO; CLO_0024345
DR   Coriell; DA06362
DR   Wikidata; Q54828304
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06367
AC   CVCL_8Q69
DR   CLO; CLO_0024344
DR   Coriell; DA06367
DR   Wikidata; Q54828305
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06369
AC   CVCL_8Q70
DR   CLO; CLO_0024342
DR   Coriell; DA06369
DR   Wikidata; Q54828306
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06372
AC   CVCL_8Q71
DR   CLO; CLO_0024351
DR   Coriell; DA06372
DR   Wikidata; Q54828307
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06373
AC   CVCL_8Q72
DR   CLO; CLO_0024350
DR   Coriell; DA06373
DR   Wikidata; Q54828308
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06377
AC   CVCL_8Q73
DR   CLO; CLO_0024349
DR   Coriell; DA06377
DR   Wikidata; Q54828309
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06379
AC   CVCL_8Q74
DR   CLO; CLO_0024348
DR   Coriell; DA06379
DR   Wikidata; Q54828310
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06380
AC   CVCL_8Q75
DR   CLO; CLO_0024359
DR   Coriell; DA06380
DR   Wikidata; Q54828311
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06382
AC   CVCL_8Q76
DR   CLO; CLO_0024361
DR   Coriell; DA06382
DR   Wikidata; Q54828312
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06383
AC   CVCL_8Q77
DR   CLO; CLO_0024360
DR   Coriell; DA06383
DR   Wikidata; Q54828319
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06384
AC   CVCL_8Q78
DR   CLO; CLO_0024363
DR   Coriell; DA06384
DR   Wikidata; Q54828320
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06386
AC   CVCL_8Q79
DR   CLO; CLO_0024362
DR   Coriell; DA06386
DR   Wikidata; Q54828321
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06387
AC   CVCL_8Q80
DR   CLO; CLO_0024365
DR   Coriell; DA06387
DR   Wikidata; Q54828322
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06388
AC   CVCL_8Q81
DR   CLO; CLO_0024364
DR   Coriell; DA06388
DR   Wikidata; Q54828323
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06389
AC   CVCL_8Q82
DR   CLO; CLO_0024367
DR   Coriell; DA06389
DR   Wikidata; Q54828324
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06390
AC   CVCL_8Q83
DR   CLO; CLO_0024366
DR   Coriell; DA06390
DR   Wikidata; Q54828325
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06391
AC   CVCL_8Q84
DR   CLO; CLO_0024368
DR   Coriell; DA06391
DR   Wikidata; Q54828326
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06392
AC   CVCL_8Q85
DR   CLO; CLO_0025060
DR   Coriell; DA06392
DR   Wikidata; Q54828327
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06393
AC   CVCL_8Q86
DR   CLO; CLO_0025059
DR   Coriell; DA06393
DR   Wikidata; Q54828328
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06396
AC   CVCL_8Q87
DR   CLO; CLO_0025062
DR   Coriell; DA06396
DR   Wikidata; Q54828329
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06397
AC   CVCL_8Q88
DR   CLO; CLO_0025061
DR   Coriell; DA06397
DR   Wikidata; Q54828330
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06398
AC   CVCL_8Q89
DR   CLO; CLO_0025064
DR   Coriell; DA06398
DR   Wikidata; Q54828331
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06400
AC   CVCL_8Q90
DR   CLO; CLO_0025063
DR   Coriell; DA06400
DR   Wikidata; Q54828332
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06401
AC   CVCL_8Q91
DR   CLO; CLO_0025066
DR   Coriell; DA06401
DR   Wikidata; Q54828333
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06404
AC   CVCL_8Q92
DR   CLO; CLO_0025065
DR   Coriell; DA06404
DR   Wikidata; Q54828334
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06405
AC   CVCL_8Q93
DR   CLO; CLO_0025068
DR   Coriell; DA06405
DR   Wikidata; Q54828335
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06406
AC   CVCL_8Q94
DR   CLO; CLO_0025067
DR   Coriell; DA06406
DR   Wikidata; Q54828336
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06407
AC   CVCL_8Q95
DR   CLO; CLO_0025098
DR   Coriell; DA06407
DR   Wikidata; Q54828337
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06411
AC   CVCL_8Q96
DR   CLO; CLO_0025082
DR   Coriell; DA06411
DR   Wikidata; Q54828338
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06415
AC   CVCL_8Q97
DR   CLO; CLO_0025081
DR   Coriell; DA06415
DR   Wikidata; Q54828339
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06416
AC   CVCL_8Q98
DR   CLO; CLO_0025080
DR   Coriell; DA06416
DR   Wikidata; Q54828340
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06428
AC   CVCL_8Q99
DR   CLO; CLO_0025079
DR   Coriell; DA06428
DR   Wikidata; Q54828341
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06429
AC   CVCL_8R00
DR   CLO; CLO_0025086
DR   Coriell; DA06429
DR   Wikidata; Q54828342
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06430
AC   CVCL_8R01
DR   CLO; CLO_0025085
DR   Coriell; DA06430
DR   Wikidata; Q54828343
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06431
AC   CVCL_8R02
DR   CLO; CLO_0025084
DR   Coriell; DA06431
DR   Wikidata; Q54828344
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06436
AC   CVCL_8R03
DR   CLO; CLO_0025083
DR   Coriell; DA06436
DR   Wikidata; Q54828345
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06437
AC   CVCL_8R04
DR   CLO; CLO_0025087
DR   Coriell; DA06437
DR   Wikidata; Q54828346
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06438
AC   CVCL_8R05
DR   CLO; CLO_0025117
DR   Coriell; DA06438
DR   Wikidata; Q54828347
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06439
AC   CVCL_8R06
DR   CLO; CLO_0025118
DR   Coriell; DA06439
DR   Wikidata; Q54828348
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06440
AC   CVCL_8R07
DR   CLO; CLO_0025104
DR   Coriell; DA06440
DR   Wikidata; Q54828349
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06441
AC   CVCL_8R08
DR   CLO; CLO_0025103
DR   Coriell; DA06441
DR   Wikidata; Q54828350
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06442
AC   CVCL_8R09
DR   CLO; CLO_0025106
DR   Coriell; DA06442
DR   Wikidata; Q54828351
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06443
AC   CVCL_8R10
DR   CLO; CLO_0025105
DR   Coriell; DA06443
DR   Wikidata; Q54828352
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06444
AC   CVCL_8R11
DR   CLO; CLO_0025100
DR   Coriell; DA06444
DR   Wikidata; Q54828353
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06446
AC   CVCL_8R12
DR   CLO; CLO_0025099
DR   Coriell; DA06446
DR   Wikidata; Q54828354
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06447
AC   CVCL_8R13
DR   CLO; CLO_0025102
DR   Coriell; DA06447
DR   Wikidata; Q54828355
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06448
AC   CVCL_8R14
DR   CLO; CLO_0025101
DR   Coriell; DA06448
DR   Wikidata; Q54828356
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06452
AC   CVCL_8R15
DR   CLO; CLO_0025145
DR   Coriell; DA06452
DR   Wikidata; Q54828357
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06454
AC   CVCL_8R16
DR   CLO; CLO_0025143
DR   Coriell; DA06454
DR   Wikidata; Q54828359
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06455
AC   CVCL_8R17
DR   CLO; CLO_0025144
DR   Coriell; DA06455
DR   Wikidata; Q54828362
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06456
AC   CVCL_8R18
DR   CLO; CLO_0025132
DR   Coriell; DA06456
DR   Wikidata; Q54828363
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06457
AC   CVCL_8R19
DR   CLO; CLO_0025130
DR   Coriell; DA06457
DR   Wikidata; Q54828364
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06458
AC   CVCL_8R20
DR   CLO; CLO_0025129
DR   Coriell; DA06458
DR   Wikidata; Q54828365
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06459
AC   CVCL_8R21
DR   CLO; CLO_0025126
DR   Coriell; DA06459
DR   Wikidata; Q54828366
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06460
AC   CVCL_8R22
DR   CLO; CLO_0025125
DR   Coriell; DA06460
DR   Wikidata; Q54828367
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06462
AC   CVCL_8R23
DR   CLO; CLO_0025123
DR   Coriell; DA06462
DR   Wikidata; Q54828368
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06464
AC   CVCL_8R24
DR   CLO; CLO_0025120
DR   Coriell; DA06464
DR   Wikidata; Q54828369
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06465
AC   CVCL_8R25
DR   CLO; CLO_0024996
DR   Coriell; DA06465
DR   Wikidata; Q54828370
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06466
AC   CVCL_8R26
DR   CLO; CLO_0024995
DR   Coriell; DA06466
DR   Wikidata; Q54828371
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06467
AC   CVCL_8R27
DR   CLO; CLO_0024998
DR   Coriell; DA06467
DR   Wikidata; Q54828372
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06468
AC   CVCL_8R28
DR   CLO; CLO_0024997
DR   Coriell; DA06468
DR   Wikidata; Q54828373
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06469
AC   CVCL_8R29
DR   CLO; CLO_0024989
DR   Coriell; DA06469
DR   Wikidata; Q54828375
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06470
AC   CVCL_8R30
DR   CLO; CLO_0024990
DR   Coriell; DA06470
DR   Wikidata; Q54828376
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06471
AC   CVCL_8R31
DR   CLO; CLO_0024991
DR   Coriell; DA06471
DR   Wikidata; Q54828377
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06472
AC   CVCL_8R32
DR   CLO; CLO_0024992
DR   Coriell; DA06472
DR   Wikidata; Q54828378
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06473
AC   CVCL_8R33
DR   CLO; CLO_0024993
DR   Coriell; DA06473
DR   Wikidata; Q54828379
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06474
AC   CVCL_8R34
DR   CLO; CLO_0024994
DR   Coriell; DA06474
DR   Wikidata; Q54828380
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06475
AC   CVCL_8R35
DR   CLO; CLO_0025014
DR   Coriell; DA06475
DR   Wikidata; Q54828381
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06476
AC   CVCL_8R36
DR   CLO; CLO_0025018
DR   Coriell; DA06476
DR   Wikidata; Q54828382
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06477
AC   CVCL_8R37
DR   CLO; CLO_0025017
DR   Coriell; DA06477
DR   Wikidata; Q54828383
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06478
AC   CVCL_8R38
DR   CLO; CLO_0025016
DR   Coriell; DA06478
DR   Wikidata; Q54828384
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06479
AC   CVCL_8R39
DR   CLO; CLO_0025015
DR   Coriell; DA06479
DR   Wikidata; Q54828385
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06480
AC   CVCL_8R40
DR   CLO; CLO_0025005
DR   Coriell; DA06480
DR   Wikidata; Q54828386
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06483
AC   CVCL_8R41
DR   CLO; CLO_0025008
DR   Coriell; DA06483
DR   Wikidata; Q54828387
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06484
AC   CVCL_8R42
DR   CLO; CLO_0025002
DR   Coriell; DA06484
DR   Wikidata; Q54828388
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06485
AC   CVCL_8R43
DR   CLO; CLO_0025004
DR   Coriell; DA06485
DR   Wikidata; Q54828389
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06486
AC   CVCL_8R44
DR   CLO; CLO_0025011
DR   Coriell; DA06486
DR   Wikidata; Q54828390
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06487
AC   CVCL_8R45
DR   CLO; CLO_0025038
DR   Coriell; DA06487
DR   Wikidata; Q54828391
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06488
AC   CVCL_8R46
DR   CLO; CLO_0025037
DR   Coriell; DA06488
DR   Wikidata; Q54828392
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06489
AC   CVCL_8R47
DR   CLO; CLO_0025034
DR   Coriell; DA06489
DR   Wikidata; Q54828393
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06490
AC   CVCL_8R48
DR   CLO; CLO_0025033
DR   Coriell; DA06490
DR   Wikidata; Q54828394
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06491
AC   CVCL_8R49
DR   CLO; CLO_0025036
DR   Coriell; DA06491
DR   Wikidata; Q54828395
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06492
AC   CVCL_8R50
DR   CLO; CLO_0025035
DR   Coriell; DA06492
DR   Wikidata; Q54828396
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06494
AC   CVCL_8R51
DR   CLO; CLO_0025028
DR   Coriell; DA06494
DR   Wikidata; Q54828397
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06495
AC   CVCL_8R52
DR   CLO; CLO_0025029
DR   Coriell; DA06495
DR   Wikidata; Q54828398
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06496
AC   CVCL_8R53
DR   CLO; CLO_0025031
DR   Coriell; DA06496
DR   Wikidata; Q54828399
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06497
AC   CVCL_8R54
DR   CLO; CLO_0025032
DR   Coriell; DA06497
DR   Wikidata; Q54828400
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06498
AC   CVCL_8R55
DR   CLO; CLO_0024750
DR   Coriell; DA06498
DR   Wikidata; Q54828401
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06499
AC   CVCL_8R56
DR   CLO; CLO_0024749
DR   Coriell; DA06499
DR   Wikidata; Q54828402
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06500
AC   CVCL_8R57
DR   CLO; CLO_0024752
DR   Coriell; DA06500
DR   Wikidata; Q54828406
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06501
AC   CVCL_8R58
DR   CLO; CLO_0024751
DR   Coriell; DA06501
DR   Wikidata; Q54828407
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06502
AC   CVCL_8R59
DR   CLO; CLO_0024754
DR   Coriell; DA06502
DR   Wikidata; Q54828408
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06503
AC   CVCL_8R60
DR   CLO; CLO_0024753
DR   Coriell; DA06503
DR   Wikidata; Q54828409
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06504
AC   CVCL_8R61
DR   CLO; CLO_0024756
DR   Coriell; DA06504
DR   Wikidata; Q54828410
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06505
AC   CVCL_8R62
DR   CLO; CLO_0024755
DR   Coriell; DA06505
DR   Wikidata; Q54828411
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06508
AC   CVCL_8R63
DR   CLO; CLO_0024758
DR   Coriell; DA06508
DR   Wikidata; Q54828412
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06509
AC   CVCL_8R64
DR   CLO; CLO_0024757
DR   Coriell; DA06509
DR   Wikidata; Q54828413
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06510
AC   CVCL_8R65
DR   CLO; CLO_0024728
DR   Coriell; DA06510
DR   Wikidata; Q54828414
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06511
AC   CVCL_8R66
DR   CLO; CLO_0024726
DR   Coriell; DA06511
DR   Wikidata; Q54828415
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06512
AC   CVCL_8R67
DR   CLO; CLO_0024727
DR   Coriell; DA06512
DR   Wikidata; Q54828416
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06513
AC   CVCL_8R68
DR   CLO; CLO_0024724
DR   Coriell; DA06513
DR   Wikidata; Q54828417
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06515
AC   CVCL_8R69
DR   CLO; CLO_0024725
DR   Coriell; DA06515
DR   Wikidata; Q54828418
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06516
AC   CVCL_8R70
DR   CLO; CLO_0024722
DR   Coriell; DA06516
DR   Wikidata; Q54828419
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06517
AC   CVCL_8R71
DR   CLO; CLO_0024723
DR   Coriell; DA06517
DR   Wikidata; Q54828420
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06518
AC   CVCL_8R72
DR   CLO; CLO_0024720
DR   Coriell; DA06518
DR   Wikidata; Q54828421
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06519
AC   CVCL_8R73
DR   CLO; CLO_0024721
DR   Coriell; DA06519
DR   Wikidata; Q54828422
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06521
AC   CVCL_8R74
DR   CLO; CLO_0024719
DR   Coriell; DA06521
DR   Wikidata; Q54828423
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06522
AC   CVCL_8R75
DR   CLO; CLO_0024717
DR   Coriell; DA06522
DR   Wikidata; Q54828424
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06523
AC   CVCL_8R76
DR   CLO; CLO_0024718
DR   Coriell; DA06523
DR   Wikidata; Q54828425
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06524
AC   CVCL_8R77
DR   CLO; CLO_0024713
DR   Coriell; DA06524
DR   Wikidata; Q54828426
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06525
AC   CVCL_8R78
DR   CLO; CLO_0024714
DR   Coriell; DA06525
DR   Wikidata; Q54828427
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06526
AC   CVCL_8R79
DR   CLO; CLO_0024715
DR   Coriell; DA06526
DR   Wikidata; Q54828428
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06527
AC   CVCL_8R80
DR   CLO; CLO_0024716
DR   Coriell; DA06527
DR   Wikidata; Q54828429
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06528
AC   CVCL_8R81
DR   CLO; CLO_0024709
DR   Coriell; DA06528
DR   Wikidata; Q54828430
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06529
AC   CVCL_8R82
DR   CLO; CLO_0024710
DR   Coriell; DA06529
DR   Wikidata; Q54828431
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06530
AC   CVCL_8R83
DR   CLO; CLO_0024711
DR   Coriell; DA06530
DR   Wikidata; Q54828432
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06532
AC   CVCL_8R84
DR   CLO; CLO_0024712
DR   Coriell; DA06532
DR   Wikidata; Q54828433
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06533
AC   CVCL_8R85
DR   CLO; CLO_0024744
DR   Coriell; DA06533
DR   Wikidata; Q54828434
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06534
AC   CVCL_8R86
DR   CLO; CLO_0024742
DR   Coriell; DA06534
DR   Wikidata; Q54828435
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06535
AC   CVCL_8R87
DR   CLO; CLO_0024743
DR   Coriell; DA06535
DR   Wikidata; Q54828436
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06536
AC   CVCL_8R88
DR   CLO; CLO_0024747
DR   Coriell; DA06536
DR   Wikidata; Q54828437
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06537
AC   CVCL_8R89
DR   CLO; CLO_0024748
DR   Coriell; DA06537
DR   Wikidata; Q54828438
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06538
AC   CVCL_8R90
DR   CLO; CLO_0024745
DR   Coriell; DA06538
DR   Wikidata; Q54828439
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06539
AC   CVCL_8R91
DR   CLO; CLO_0024746
DR   Coriell; DA06539
DR   Wikidata; Q54828440
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06540
AC   CVCL_8R92
DR   CLO; CLO_0024740
DR   Coriell; DA06540
DR   Wikidata; Q54828441
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06541
AC   CVCL_8R93
DR   CLO; CLO_0024741
DR   Coriell; DA06541
DR   Wikidata; Q54828442
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06543
AC   CVCL_8R94
DR   CLO; CLO_0024739
DR   Coriell; DA06543
DR   Wikidata; Q54828443
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06544
AC   CVCL_8R95
DR   CLO; CLO_0024731
DR   Coriell; DA06544
DR   Wikidata; Q54828444
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06545
AC   CVCL_8R96
DR   CLO; CLO_0024732
DR   Coriell; DA06545
DR   Wikidata; Q54828445
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06546
AC   CVCL_8R97
DR   CLO; CLO_0024733
DR   Coriell; DA06546
DR   Wikidata; Q54828451
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06547
AC   CVCL_8R98
DR   CLO; CLO_0024734
DR   Coriell; DA06547
DR   Wikidata; Q54828452
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06548
AC   CVCL_8R99
DR   CLO; CLO_0024735
DR   Coriell; DA06548
DR   Wikidata; Q54828453
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06549
AC   CVCL_8S00
DR   CLO; CLO_0024736
DR   Coriell; DA06549
DR   Wikidata; Q54828454
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06550
AC   CVCL_8S01
DR   CLO; CLO_0024737
DR   Coriell; DA06550
DR   Wikidata; Q54828455
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06551
AC   CVCL_8S02
DR   CLO; CLO_0024738
DR   Coriell; DA06551
DR   Wikidata; Q54828456
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06552
AC   CVCL_8S03
DR   CLO; CLO_0024729
DR   Coriell; DA06552
DR   Wikidata; Q54828457
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06553
AC   CVCL_8S04
DR   CLO; CLO_0024730
DR   Coriell; DA06553
DR   Wikidata; Q54828458
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06554
AC   CVCL_8S05
DR   CLO; CLO_0025478
DR   Coriell; DA06554
DR   Wikidata; Q54828459
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06555
AC   CVCL_8S06
DR   CLO; CLO_0025471
DR   Coriell; DA06555
DR   Wikidata; Q54828460
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06556
AC   CVCL_8S07
DR   CLO; CLO_0025470
DR   Coriell; DA06556
DR   Wikidata; Q54828461
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06557
AC   CVCL_8S08
DR   CLO; CLO_0025473
DR   Coriell; DA06557
DR   Wikidata; Q54828462
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06558
AC   CVCL_8S09
DR   CLO; CLO_0025472
DR   Coriell; DA06558
DR   Wikidata; Q54828463
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06559
AC   CVCL_8S10
DR   CLO; CLO_0025475
DR   Coriell; DA06559
DR   Wikidata; Q54828464
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06560
AC   CVCL_8S11
DR   CLO; CLO_0025474
DR   Coriell; DA06560
DR   Wikidata; Q54828465
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06561
AC   CVCL_8S12
DR   CLO; CLO_0025477
DR   Coriell; DA06561
DR   Wikidata; Q54828466
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06562
AC   CVCL_8S13
DR   CLO; CLO_0025476
DR   Coriell; DA06562
DR   Wikidata; Q54828467
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06563
AC   CVCL_8S14
DR   CLO; CLO_0025469
DR   Coriell; DA06563
DR   Wikidata; Q54828468
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06564
AC   CVCL_8S15
DR   CLO; CLO_0025487
DR   Coriell; DA06564
DR   Wikidata; Q54828469
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06565
AC   CVCL_8S16
DR   CLO; CLO_0025488
DR   Coriell; DA06565
DR   Wikidata; Q54828470
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06566
AC   CVCL_8S17
DR   CLO; CLO_0025482
DR   Coriell; DA06566
DR   Wikidata; Q54828471
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06567
AC   CVCL_8S18
DR   CLO; CLO_0025481
DR   Coriell; DA06567
DR   Wikidata; Q54828472
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06568
AC   CVCL_8S19
DR   CLO; CLO_0025480
DR   Coriell; DA06568
DR   Wikidata; Q54828473
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06569
AC   CVCL_8S20
DR   CLO; CLO_0025479
DR   Coriell; DA06569
DR   Wikidata; Q54828474
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06570
AC   CVCL_8S21
DR   CLO; CLO_0025486
DR   Coriell; DA06570
DR   Wikidata; Q54828475
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06571
AC   CVCL_8S22
DR   CLO; CLO_0025485
DR   Coriell; DA06571
DR   Wikidata; Q54828476
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06572
AC   CVCL_8S23
DR   CLO; CLO_0025484
DR   Coriell; DA06572
DR   Wikidata; Q54828477
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06573
AC   CVCL_8S24
DR   CLO; CLO_0025483
DR   Coriell; DA06573
DR   Wikidata; Q54828478
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06574
AC   CVCL_8S25
DR   CLO; CLO_0025456
DR   Coriell; DA06574
DR   Wikidata; Q54828479
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06577
AC   CVCL_8S26
DR   CLO; CLO_0025457
DR   Coriell; DA06577
DR   Wikidata; Q54828480
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06578
AC   CVCL_8S27
DR   CLO; CLO_0025458
DR   Coriell; DA06578
DR   Wikidata; Q54828481
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06579
AC   CVCL_8S28
DR   CLO; CLO_0025453
DR   Coriell; DA06579
DR   Wikidata; Q54828482
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06582
AC   CVCL_8S29
DR   CLO; CLO_0025452
DR   Coriell; DA06582
DR   Wikidata; Q54828483
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06583
AC   CVCL_8S30
DR   CLO; CLO_0025455
DR   Coriell; DA06583
DR   Wikidata; Q54828485
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06584
AC   CVCL_8S31
DR   CLO; CLO_0025454
DR   Coriell; DA06584
DR   Wikidata; Q54828486
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06585
AC   CVCL_8S32
DR   CLO; CLO_0025450
DR   Coriell; DA06585
DR   Wikidata; Q54828487
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06586
AC   CVCL_8S33
DR   CLO; CLO_0025449
DR   Coriell; DA06586
DR   Wikidata; Q54828488
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06587
AC   CVCL_8S34
DR   CLO; CLO_0025451
DR   Coriell; DA06587
DR   Wikidata; Q54828489
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06588
AC   CVCL_8S35
DR   CLO; CLO_0025467
DR   Coriell; DA06588
DR   Wikidata; Q54828491
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06589
AC   CVCL_8S36
DR   CLO; CLO_0025468
DR   Coriell; DA06589
DR   Wikidata; Q54828492
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06590
AC   CVCL_8S37
DR   CLO; CLO_0025465
DR   Coriell; DA06590
DR   Wikidata; Q54828501
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06591
AC   CVCL_8S38
DR   CLO; CLO_0025466
DR   Coriell; DA06591
DR   Wikidata; Q54828502
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06592
AC   CVCL_8S39
DR   CLO; CLO_0025464
DR   Coriell; DA06592
DR   Wikidata; Q54828504
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06593
AC   CVCL_8S40
DR   CLO; CLO_0025463
DR   Coriell; DA06593
DR   Wikidata; Q54828505
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06594
AC   CVCL_8S41
DR   CLO; CLO_0025462
DR   Coriell; DA06594
DR   Wikidata; Q54828506
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06595
AC   CVCL_8S42
DR   CLO; CLO_0025461
DR   Coriell; DA06595
DR   Wikidata; Q54828507
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06596
AC   CVCL_8S43
DR   CLO; CLO_0025460
DR   Coriell; DA06596
DR   Wikidata; Q54828508
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06597
AC   CVCL_8S44
DR   CLO; CLO_0025459
DR   Coriell; DA06597
DR   Wikidata; Q54828509
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06598
AC   CVCL_8S45
DR   CLO; CLO_0025444
DR   Coriell; DA06598
DR   Wikidata; Q54828510
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06599
AC   CVCL_8S46
DR   CLO; CLO_0025446
DR   Coriell; DA06599
DR   Wikidata; Q54828511
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06600
AC   CVCL_8S47
DR   CLO; CLO_0025445
DR   Coriell; DA06600
DR   Wikidata; Q54828512
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06601
AC   CVCL_8S48
DR   CLO; CLO_0025448
DR   Coriell; DA06601
DR   Wikidata; Q54828513
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06602
AC   CVCL_8S49
DR   CLO; CLO_0025447
DR   Coriell; DA06602
DR   Wikidata; Q54828514
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06604
AC   CVCL_8S50
DR   CLO; CLO_0025439
DR   Coriell; DA06604
DR   Wikidata; Q54828515
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06605
AC   CVCL_8S51
DR   CLO; CLO_0025440
DR   Coriell; DA06605
DR   Wikidata; Q54828516
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06607
AC   CVCL_8S52
DR   CLO; CLO_0025441
DR   Coriell; DA06607
DR   Wikidata; Q54828517
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06608
AC   CVCL_8S53
DR   Coriell; DA06608
DR   Wikidata; Q54828518
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06609
AC   CVCL_8S54
DR   CLO; CLO_0025443
DR   Coriell; DA06609
DR   Wikidata; Q54828519
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06610
AC   CVCL_8S55
DR   CLO; CLO_0025216
DR   Coriell; DA06610
DR   Wikidata; Q54828520
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06611
AC   CVCL_8S56
DR   CLO; CLO_0025218
DR   Coriell; DA06611
DR   Wikidata; Q54828522
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06612
AC   CVCL_8S57
DR   CLO; CLO_0025217
DR   Coriell; DA06612
DR   Wikidata; Q54828523
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06613
AC   CVCL_8S58
DR   CLO; CLO_0025213
DR   Coriell; DA06613
DR   Wikidata; Q54828525
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06614
AC   CVCL_8S59
DR   CLO; CLO_0025212
DR   Coriell; DA06614
DR   Wikidata; Q54828526
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06618
AC   CVCL_8S60
DR   CLO; CLO_0025215
DR   Coriell; DA06618
DR   Wikidata; Q54828527
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06619
AC   CVCL_8S61
DR   CLO; CLO_0025214
DR   Coriell; DA06619
DR   Wikidata; Q54828528
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06620
AC   CVCL_8S62
DR   CLO; CLO_0025210
DR   Coriell; DA06620
DR   Wikidata; Q54828529
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06621
AC   CVCL_8S63
DR   CLO; CLO_0025209
DR   Coriell; DA06621
DR   Wikidata; Q54828530
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06622
AC   CVCL_8S64
DR   CLO; CLO_0025211
DR   Coriell; DA06622
DR   Wikidata; Q54828531
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA06623
AC   CVCL_8S65
DR   CLO; CLO_0025208
DR   Coriell; DA06623
DR   Wikidata; Q54828532
CC   Part of: American Diabetes Association (ADA) GENNID study cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DA1-1
AC   CVCL_5F86
DR   Wikidata; Q54828533
RX   PubMed=23177148;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   DA11B7
AC   CVCL_D5YT
DR   DSHB; DA11B7
DR   Wikidata; Q127380746
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6VVD7; Xenopus laevis sox8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA11D6
AC   CVCL_D5Z9
DR   Wikidata; Q127380750
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P24781; Xenopus laevis tbxt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA12C6
AC   CVCL_D5ZA
DR   Wikidata; Q127380752
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_189550; FLAG peptide (DYKDDDDK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   DA12H2
AC   CVCL_D5Z8
DR   DSHB; DA12H2
DR   Wikidata; Q127380754
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24781; Xenopus laevis tbxt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA1A8
AC   CVCL_D5YX
DR   DSHB; DA1A8
DR   Wikidata; Q127380755
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q91924; Xenopus laevis snai2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA1B4
AC   CVCL_D5ZG
DR   Wikidata; Q127380756
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O93264; Xenopus laevis cdh11.S.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA1D1
AC   CVCL_D5YU
DR   DSHB; DA1D1
DR   Wikidata; Q127380757
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B7ZR65; Xenopus laevis sox9-a.
CC   Monoclonal antibody target: UniProtKB; Q6DFF5; Xenopus laevis sox9-b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA2A2
AC   CVCL_D5ZE
DR   Wikidata; Q127380758
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q923J1; Mouse Trpm7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   DA2A4
AC   CVCL_D5Z4
SY   DA4Ascl1
DR   DSHB; DA4Ascl1
DR   Wikidata; Q127380759
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q06234; Xenopus laevis ascl1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA2B11
AC   CVCL_D5YV
DR   DSHB; DA2B11
DR   Wikidata; Q127380760
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A9LS46; Xenopus laevis wtip.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA2B8
AC   CVCL_D5ZC
DR   Wikidata; Q127380761
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q91715; Xenopus laevis lbh.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA2F4
AC   CVCL_D5Z0
DR   DSHB; DA2F4
DR   Wikidata; Q127380762
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q284V9; Xenopus laevis pcdh8l.S.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA4-4
AC   CVCL_J892
SY   DA4.4
DR   CLO; CLO_0002689
DR   ATCC; HB-57
DR   Wikidata; Q54828534
RX   PubMed=3923101;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   DA4B12
AC   CVCL_D5ZF
DR   Wikidata; Q127380764
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13903; Xenopus laevis twist.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA4E5
AC   CVCL_D5ZB
DR   Wikidata; Q127380765
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9DEN4; Xenopus laevis foxd3-a.
CC   Monoclonal antibody target: UniProtKB; Q9DEN3; Xenopus laevis foxd3-b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA5
AC   CVCL_C4DL
DR   ABCD; ABCD_AG203
DR   Wikidata; Q116048826
RX   PubMed=23295252;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53218; Diphenylmethane-4,4'-diisocyanate (Methylene diphenyl diisocyanate; MDI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DA5-3
AC   CVCL_5F87
DR   GEO; GSM1253010
DR   GEO; GSM1253011
DR   GEO; GSM1253012
DR   Wikidata; Q54828535
RX   PubMed=23177148;
RX   PubMed=24360884;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   DA5B9
AC   CVCL_D5ZD
SY   DA5B9Eya1
DR   DSHB; DA5B9Eya1
DR   Wikidata; Q127380767
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q98SL6; Xenopus laevis eya1.L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA5C7
AC   CVCL_D5YZ
DR   DSHB; DA5C7
DR   Wikidata; Q127380768
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O42201; Xenopus laevis rax-A.
CC   Monoclonal antibody target: UniProtKB; O42567; Xenopus laevis rax-B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA5C9
AC   CVCL_D5Z3
SY   DA5C9(flag)
DR   DSHB; DA5C9flag
DR   Wikidata; Q127380769
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_189550; FLAG peptide (DYKDDDDK).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   DA5D6
AC   CVCL_D5ZI
DR   DSHB; DA5D6
DR   Wikidata; Q127380770
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26619; Xenopus laevis pdgfra.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA5F6
AC   CVCL_D5ZJ
DR   Wikidata; Q127380771
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P26619; Xenopus laevis pdgfra.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA5F9-4
AC   CVCL_D5Z6
DR   DSHB; DA5F9-4
DR   Wikidata; Q127380772
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6VPR2; Xenopus laevis pnhd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA5H6
AC   CVCL_D5YW
DR   DSHB; DA5H6
DR   Wikidata; Q127380773
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P55863; Xenopus laevis sox3-a.
CC   Monoclonal antibody target: UniProtKB; Q5FWM3; Xenopus laevis sox3-b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA6.147
AC   CVCL_L549
DR   ECACC; 90110605
DR   NCBI_Iran; H118
DR   Wikidata; Q54828536
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   DA6.231
AC   CVCL_L550
DR   ECACC; 90110606
DR   Wikidata; Q54828537
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   DA61-vegt
AC   CVCL_D5Z5
SY   DAVegT61
DR   DSHB; DAVegT61
DR   Wikidata; Q127380774
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P87377; Xenopus laevis vegt-A.
CC   Monoclonal antibody target: UniProtKB; O13161; Xenopus laevis vegt-B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA6A4
AC   CVCL_D6DL
DR   Wikidata; Q127380775
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O12960; Xenopus laevis adam13.L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA6D11
AC   CVCL_D5YY
DR   DSHB; DA6D11
DR   Wikidata; Q127380776
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8AV69; Xenopus laevis ror2.L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA7
AC   CVCL_C4U3
SY   DA-7
DR   Wikidata; Q116048827
RX   PubMed=2461901;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   DA7A7
AC   CVCL_D5ZH
DR   Wikidata; Q127380777
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q7T0W8; Xenopus laevis mcrs1.L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA8B4
AC   CVCL_D5Z1
DR   DSHB; DA8B4
DR   Wikidata; Q127380778
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6GN19; Xenopus laevis pard3.S.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA8E6
AC   CVCL_D6DM
DR   Wikidata; Q127380779
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O12960; Xenopus laevis adam13.L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DA8G12
AC   CVCL_D5Z7
DR   Wikidata; Q127380780
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6VPR2; Xenopus laevis pnhd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DAA-3
AC   CVCL_XG48
SY   DAA3
DR   Wikidata; Q93502905
RX   PubMed=8874215;
RX   PubMed=10887139;
RX   PubMed=15735731;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   DAB2IPMab1
AC   CVCL_E2YV
SY   2A4
RX   Patent=CN104774810A;
RX   PubMed=26301927;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013148.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5VWQ8; Human DAB2IP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   DABLEC181(3)
AC   CVCL_D3X6
DR   TKG; TKG 0814
DR   Wikidata; Q127380781
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: LEC; RS=RS_0000445.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   DAC/E
AC   CVCL_R801
DR   Wikidata; Q54828539
RX   PubMed=16696042;
CC   Doubling time: 42 hours (PubMed=16696042).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
DI   NCIt; C7889; Duodenal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R802 ! DAC/S
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   DAC/S
AC   CVCL_R802
DR   Wikidata; Q54828540
RX   PubMed=16696042;
CC   Doubling time: 24 hours (PubMed=16696042).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
DI   NCIt; C7889; Duodenal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R801 ! DAC/E
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   DAc11
AC   CVCL_E8CM
WW   Provider; RRRC; RRRC_00465; https://www.rrrc.us/Strain/?x=465
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DAC17-18
AC   CVCL_D5Z2
DR   DSHB; DAC17-18
DR   Wikidata; Q127380782
RX   PubMed=36789951;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P49698; Mouse Hnf4a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DAc2
AC   CVCL_E221
SY   DA-EC2Rrrc
DR   Wikidata; Q54828541
RX   PubMed=19109898;
WW   Provider; RRRC; RRRC_00467; https://www.rrrc.us/Strain/?x=467
CC   Doubling time: ~24-48 hours (RRRC=467).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   DAc4
AC   CVCL_E8CL
RX   PubMed=20703227;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DAc8
AC   CVCL_E220
SY   DA-EC8Rrrc
DR   Wikidata; Q54828542
RX   PubMed=19109898;
RX   PubMed=20703227;
WW   Provider; RRRC; RRRC_00464; https://www.rrrc.us/Strain/?x=464
CC   Doubling time: ~24-36 hours (RRRC=464).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   DAc8-p53-1
AC   CVCL_E8CN
RX   PubMed=20703227;
CC   Characteristics: Using homologous recombination a CAG-GFP-IRES-PuroR construct replaced exons 2 to 5 of Tp53 (PubMed=20703227).
CC   Knockout cell: Method=Homologous recombination; RGD; 3889; Tp53.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E220 ! DAc8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   DAE100
AC   CVCL_Z195
SY   DAE100T
DR   Wikidata; Q54828543
RX   PubMed=11157215;
RX   PubMed=12200314;
RX   PubMed=16288906;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_2c164a746d
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=34620; ! Dermacentor andersoni (Rocky mountain wood tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   DAE100A
AC   CVCL_Z196
DR   Wikidata; Q54828544
RX   PubMed=16288906;
CC   Group: Tick cell line.
OX   NCBI_TaxID=34620; ! Dermacentor andersoni (Rocky mountain wood tick)
HI   CVCL_Z195 ! DAE100
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   DAE100H
AC   CVCL_Z197
DR   Wikidata; Q54828549
RX   PubMed=16288906;
CC   Group: Tick cell line.
OX   NCBI_TaxID=34620; ! Dermacentor andersoni (Rocky mountain wood tick)
HI   CVCL_Z195 ! DAE100
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   DAE15
AC   CVCL_Z198
DR   Wikidata; Q54828550
RX   PubMed=16288906;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=23140894;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_2c164a746d
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=34620; ! Dermacentor andersoni (Rocky mountain wood tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   DAE3
AC   CVCL_Z199
DR   Wikidata; Q54828552
RX   PubMed=16288906;
RX   PubMed=17662657;
CC   Group: Tick cell line.
OX   NCBI_TaxID=34620; ! Dermacentor andersoni (Rocky mountain wood tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   DAG-3H9
AC   CVCL_C2FX
SY   3H9
DR   Wikidata; Q114311318
RX   PubMed=25387694;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 30-653 = Alpha-dystroglycan. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DAG-6F4
AC   CVCL_A6MJ
SY   6F4
DR   DSHB; DAG-6F4
DR   Wikidata; Q107114797
RX   PubMed=25387694;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 30-653 = Alpha-dystroglycan. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   DAIT-6
AC   CVCL_W521
DR   Wikidata; Q54828553
RX   PubMed=2979201;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft maintained in nude mice.
CC   Doubling time: ~45.0 hours (PubMed=2979201).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Daju
AC   CVCL_C7U6
SY   DAJU
DR   Wikidata; Q123031154
RX   PubMed=22207316;
RX   PubMed=25950383;
CC   Characteristics: Tumorigenic (PubMed=25950383).
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   Dakiki
AC   CVCL_3675
SY   DAKIKI; DAKIKI Clone 1
DR   CLO; CLO_0002693
DR   ATCC; TIB-206
DR   BioSample; SAMN03471885
DR   Wikidata; Q54828554
RX   PubMed=6247394;
RX   PubMed=6605913;
RX   PubMed=17418236;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: African.
CC   Characteristics: Produces IgA1, lambda light chain (PubMed=6247394).
CC   Characteristics: Secretes polymeric IgA1 with some of its O-glycans Gal-deficient but these glycans contain SA-GalNAc (PubMed=17418236).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from nasopharyngeal carcinoma (PubMed=6247394).
CC   Misspelling: Daikiki; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=TIB-206
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 17,20
ST   D19S433: 13,14.2
ST   D21S11: 30,33.2
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 12,16
ST   FGA: 19.2,23
ST   Penta D: 2.2
ST   Penta E: 14,15
ST   TH01: 7
ST   TPOX: 9,10
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   Dal-4
AC   CVCL_0C93
SY   DAL-4; Dal4
DR   GEO; GSM377405
DR   Kerafast; EMN018-FP
DR   Wikidata; Q54828558
RX   PubMed=15064773;
RX   PubMed=16797414;
RX   PubMed=19461996;
RX   PubMed=24582862;
RX   PubMed=28029283;
CC   Doubling time: 5-7 days (Kerafast=EMN018-FP).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Dalmatian; VBO=VBO_0200427.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   DAL-B-01
AC   CVCL_F0VX
RX   PubMed=2161403;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human 22 and 33 kDa antigens on chronic lymphocytic leukemia B cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DAL-B-02
AC   CVCL_F0VY
RX   PubMed=2161403;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human 22 and 33 kDa antigens on chronic lymphocytic leukemia B cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DAL-K20
AC   CVCL_J823
SY   DAL K20; K20
DR   CLO; CLO_0002694
DR   ATCC; CRL-2288
DR   Wikidata; Q54828555
RX   PubMed=3530441;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on kidney carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 6
//
ID   DAL-K29
AC   CVCL_J824
SY   DAL K29; K29
DR   CLO; CLO_0002695
DR   ATCC; CRL-2291
DR   Wikidata; Q54828556
RX   PubMed=3530441;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 130/150 kDa antigen on kidney carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 6
//
ID   DAL-K45
AC   CVCL_J825
SY   DAL K45; K45
DR   CLO; CLO_0002696
DR   ATCC; CRL-2292
DR   Wikidata; Q54828557
RX   PubMed=3530441;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 150/177 kda antigen on kidney carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 7
//
ID   DALBE3
AC   CVCL_Z171
DR   Wikidata; Q54828559
RX   PubMed=9364140;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=23140894;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60249; ! Dermacentor albipictus (Winter tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Dale1
AC   CVCL_Y630
DR   Wikidata; Q54828560
RX   PubMed=17828574;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 tyrc-2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   Dalmas
AC   CVCL_ZU73
SY   NK26; NK 26
DR   Wikidata; Q98125868
RX   PubMed=4178827;
RX   PubMed=4878906;
RX   PubMed=5021706;
CC   Population: African; Kenyan.
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 6
//
ID   DaMab-2
AC   CVCL_D3CZ
DR   Wikidata; Q127380783
RX   PubMed=28742439;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P23743; Human DGKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   DaMab-8
AC   CVCL_D3D0
DR   Wikidata; Q127380784
RX   PubMed=31099705;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P23743; Human DGKA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   Dami
AC   CVCL_4360
SY   DAMI
DR   BTO; BTO_0001550
DR   ATCC; CRL-9792
DR   BioSample; SAMN03151657
DR   cancercelllines; CVCL_4360
DR   Cosmic; 1191696
DR   KCB; KCB 200782YJ
DR   Lonza; 1426
DR   Wikidata; Q54828561
RX   Patent=US5128245;
RX   PubMed=3196874;
RX   PubMed=9166871;
RX   PubMed=9326259;
RX   PubMed=9447816;
RX   PubMed=10508494;
RX   PubMed=11021758;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/dami-atcc-crl-9792
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Shown to be a HEL derivative (PubMed=9166871; PubMed=9326259; PubMed=9447816; PubMed=10508494; PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 57 year old male patient with megakaryoblastic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00116.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9792.
CC   Population: Caucasian.
CC   Doubling time: 24-30 hours (PubMed=3196874; Patent=US5128245).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-9792; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): ATCC=CRL-9792; CCRID
ST   Amelogenin: X (CCRID)
ST   Amelogenin: X,Y (ATCC=CRL-9792)
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 11,13
ST   D21S11: 29,31.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 7
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0001 ! HEL
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 34
//
ID   DAN
AC   CVCL_1917
DR   CLO; CLO_0002697
DR   ATCC; CRL-2130
DR   Wikidata; Q54828562
RX   PubMed=2524600;
CC   Group: Retrovirus packaging cell line.
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Glu63Lys (c.187G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_1916 ! D-17
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   DAN-G
AC   CVCL_0243
SY   Dan-G; DanG; DANG; DAN
DR   CLO; CLO_0002698
DR   EFO; EFO_0006562
DR   MCCL; MCC:0000133
DR   CLDB; cl982
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 688
DR   BioSample; SAMN03472896
DR   BioSample; SAMN03473390
DR   BioSample; SAMN10987807
DR   cancercelllines; CVCL_0243
DR   Cell_Model_Passport; SIDM00950
DR   ChEMBL-Cells; CHEMBL3307281
DR   ChEMBL-Targets; CHEMBL614033
DR   CLS; 300162
DR   Cosmic; 1995382
DR   Cosmic; 2434109
DR   Cosmic-CLP; 1290797
DR   DepMap; ACH-000243
DR   DSMZ; ACC-249
DR   DSMZCellDive; ACC-249
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290797
DR   GEO; GSM886971
DR   GEO; GSM888040
DR   GEO; GSM1669724
DR   IARC_TP53; 30030
DR   LiGeA; CCLE_849
DR   LINCS_LDP; LCL-1734
DR   PharmacoDB; DANG_281_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0243
DR   PubChem_Cell_line; CVCL_0243
DR   Wikidata; Q54828563
RX   DOI=10.22029/jlupub-12385;
RX   PubMed=6231986;
RX   PubMed=11668190;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=15770730;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft produced by implantation of cells from the tumor of a patient with cancer of the pancreas in a nude mouse (CLS=300162).
CC   Doubling time: ~33 hours (DSMZ=ACC-249); 17.10 hours (JWGray panel).
CC   HLA typing: A*02:01,02:01; B*07:02,13:02; C*06:02,06:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (CLS=300162; Cosmic-CLP=1290797).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.972_993+16del38; Zygosity=Homozygous (Cosmic-CLP=1290797; DepMap=ACH-000243).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.9%; Native American=1.77%; East Asian, North=3.79%; East Asian, South=0%; South Asian=0%; European, North=49.25%; European, South=44.28% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CLS=300162; Cosmic-CLP=1290797; DSMZ=ACC-249; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D12S391: 17,20
ST   D13S317: 8 (CLS=300162; Cosmic-CLP=1290797; PubMed=25877200)
ST   D13S317: 8,13 (DSMZ=ACC-249)
ST   D16S539: 8,11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D1S1656: 12,17
ST   D21S11: 29,31.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D6S1043: 12
ST   D7S820: 10,13
ST   D8S1179: 10,11
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 10
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   DAN723
AC   CVCL_E541
SY   TER245; TER-245; Ter 245; TER273; TER-273; Ter 273; TER490; TER-490; Ter 490; Extract 104; Extract 216
DR   dbMHC; 48739
DR   ECACC; 94050337
DR   IHW; IHW09258
DR   IPD-IMGT/HLA; 10468
DR   Wikidata; Q54828564
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/375cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native North American.
CC   HLA typing: A*31:01:02:01; B*15:08:01,40:02:01; C*01:02:01,03:04:01:02; DPA1*02:01:01,02:02:02; DPB1*05:01:01,14:01:01; DQA1*05:05:01:03,05:03; DQB1*03:01:01:01,03:03:02:02; DRB1*14:02:01,16:02; DRB3*01:01:02; DRB5*02:02 (IPD-IMGT/HLA=10468).
CC   HLA typing: A*31:01:02:01; B*15:08:01,40:02:01; C*01:02:01; C*03:04:01:02; DPA1*02:01:01:02,02:02:02; DPB1*05:01:01,14:01:01; DQA1*05:05:01,05:03; DQB1*03:01:01:01,03:03:02:04; DRB1*14:02:01,16:02:01:02; DRB3*01:01:02; DRB5*02:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   DANi001-A
AC   CVCL_UL98
DR   hPSCreg; DANi001-A
DR   Wikidata; Q93503158
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   DANi001-B
AC   CVCL_UL99
DR   hPSCreg; DANi001-B
DR   Wikidata; Q93503162
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   DANi001-C
AC   CVCL_UM00
SY   iPS-CCD-C3
DR   BioSamples; SAMEA4760683
DR   hPSCreg; DANi001-C
DR   Wikidata; Q93503166
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   DANi002-A
AC   CVCL_XJ21
DR   hPSCreg; DANi002-A
DR   Wikidata; Q93503171
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from autologous cell line DANi002-C).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ22 ! DANi002-B
OI   CVCL_XJ23 ! DANi002-C
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   DANi002-B
AC   CVCL_XJ22
DR   hPSCreg; DANi002-B
DR   Wikidata; Q93503175
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from autologous cell line DANi002-C).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ21 ! DANi002-A
OI   CVCL_XJ23 ! DANi002-C
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   DANi002-C
AC   CVCL_XJ23
SY   DANi-002C; GBA-002-C3
DR   BioSamples; SAMEA5912470
DR   hPSCreg; DANi002-C
DR   Wikidata; Q93503177
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31786474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ21 ! DANi002-A
OI   CVCL_XJ22 ! DANi002-B
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-A
AC   CVCL_XJ32
DR   hPSCreg; DANi003-A
DR   Wikidata; Q93503181
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line DANi003-H).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ33 ! DANi003-B
OI   CVCL_XJ34 ! DANi003-C
OI   CVCL_XJ35 ! DANi003-D
OI   CVCL_XJ36 ! DANi003-E
OI   CVCL_XJ37 ! DANi003-F
OI   CVCL_XJ38 ! DANi003-G
OI   CVCL_XJ39 ! DANi003-H
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-B
AC   CVCL_XJ33
DR   hPSCreg; DANi003-B
DR   Wikidata; Q93503182
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line DANi003-H).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ32 ! DANi003-A
OI   CVCL_XJ34 ! DANi003-C
OI   CVCL_XJ35 ! DANi003-D
OI   CVCL_XJ36 ! DANi003-E
OI   CVCL_XJ37 ! DANi003-F
OI   CVCL_XJ38 ! DANi003-G
OI   CVCL_XJ39 ! DANi003-H
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-C
AC   CVCL_XJ34
DR   hPSCreg; DANi003-C
DR   Wikidata; Q93503187
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line DANi003-H).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ32 ! DANi003-A
OI   CVCL_XJ33 ! DANi003-B
OI   CVCL_XJ35 ! DANi003-D
OI   CVCL_XJ36 ! DANi003-E
OI   CVCL_XJ37 ! DANi003-F
OI   CVCL_XJ38 ! DANi003-G
OI   CVCL_XJ39 ! DANi003-H
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-D
AC   CVCL_XJ35
DR   hPSCreg; DANi003-D
DR   Wikidata; Q93503189
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line DANi003-H).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ32 ! DANi003-A
OI   CVCL_XJ33 ! DANi003-B
OI   CVCL_XJ34 ! DANi003-C
OI   CVCL_XJ36 ! DANi003-E
OI   CVCL_XJ37 ! DANi003-F
OI   CVCL_XJ38 ! DANi003-G
OI   CVCL_XJ39 ! DANi003-H
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-E
AC   CVCL_XJ36
DR   hPSCreg; DANi003-E
DR   Wikidata; Q93503192
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line DANi003-H).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ32 ! DANi003-A
OI   CVCL_XJ33 ! DANi003-B
OI   CVCL_XJ34 ! DANi003-C
OI   CVCL_XJ35 ! DANi003-D
OI   CVCL_XJ37 ! DANi003-F
OI   CVCL_XJ38 ! DANi003-G
OI   CVCL_XJ39 ! DANi003-H
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-F
AC   CVCL_XJ37
DR   hPSCreg; DANi003-F
DR   Wikidata; Q93503196
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line DANi003-H).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ32 ! DANi003-A
OI   CVCL_XJ33 ! DANi003-B
OI   CVCL_XJ34 ! DANi003-C
OI   CVCL_XJ35 ! DANi003-D
OI   CVCL_XJ36 ! DANi003-E
OI   CVCL_XJ38 ! DANi003-G
OI   CVCL_XJ39 ! DANi003-H
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-G
AC   CVCL_XJ38
DR   hPSCreg; DANi003-G
DR   Wikidata; Q93503199
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line DANi003-H).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ32 ! DANi003-A
OI   CVCL_XJ33 ! DANi003-B
OI   CVCL_XJ34 ! DANi003-C
OI   CVCL_XJ35 ! DANi003-D
OI   CVCL_XJ36 ! DANi003-E
OI   CVCL_XJ37 ! DANi003-F
OI   CVCL_XJ39 ! DANi003-H
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi003-H
AC   CVCL_XJ39
SY   DANi-003H; GBA-003-C8
DR   BioSamples; SAMEA5912471
DR   hPSCreg; DANi003-H
DR   Wikidata; Q93503203
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=31786474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ32 ! DANi003-A
OI   CVCL_XJ33 ! DANi003-B
OI   CVCL_XJ34 ! DANi003-C
OI   CVCL_XJ35 ! DANi003-D
OI   CVCL_XJ36 ! DANi003-E
OI   CVCL_XJ37 ! DANi003-F
OI   CVCL_XJ38 ! DANi003-G
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   DANi004-A
AC   CVCL_XJ24
SY   DANi-004A; PRKN-004-C1
DR   BioSamples; SAMEA5912473
DR   hPSCreg; DANi004-A
DR   Wikidata; Q93503206
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Cys253Tyr (c.758G>A); ClinVar=VCV000645725; Zygosity=Homozygous (PubMed=31786474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   DANi005-A
AC   CVCL_XJ25
SY   DANi-005A; LRRK2-GBA-005-C1
DR   BioSamples; SAMEA5912475
DR   hPSCreg; DANi005-A
DR   Wikidata; Q93503209
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=31786474).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=31786474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   DANi006-A
AC   CVCL_YJ49
DR   hPSCreg; DANi006-A
DR   Wikidata; Q93503212
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from autologous cell line DANi006-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ50 ! DANi006-B
OI   CVCL_YJ51 ! DANi006-C
OI   CVCL_YJ52 ! DANi006-D
OI   CVCL_YJ53 ! DANi006-E
OI   CVCL_YJ54 ! DANi006-F
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   DANi006-B
AC   CVCL_YJ50
DR   hPSCreg; DANi006-B
DR   Wikidata; Q93503215
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from autologous cell line DANi006-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ49 ! DANi006-A
OI   CVCL_YJ51 ! DANi006-C
OI   CVCL_YJ52 ! DANi006-D
OI   CVCL_YJ53 ! DANi006-E
OI   CVCL_YJ54 ! DANi006-F
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   DANi006-C
AC   CVCL_YJ51
DR   hPSCreg; DANi006-C
DR   Wikidata; Q93503218
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from autologous cell line DANi006-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ49 ! DANi006-A
OI   CVCL_YJ50 ! DANi006-B
OI   CVCL_YJ52 ! DANi006-D
OI   CVCL_YJ53 ! DANi006-E
OI   CVCL_YJ54 ! DANi006-F
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   DANi006-D
AC   CVCL_YJ52
DR   hPSCreg; DANi006-D
DR   Wikidata; Q93503221
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from autologous cell line DANi006-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ49 ! DANi006-A
OI   CVCL_YJ50 ! DANi006-B
OI   CVCL_YJ51 ! DANi006-C
OI   CVCL_YJ53 ! DANi006-E
OI   CVCL_YJ54 ! DANi006-F
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   DANi006-E
AC   CVCL_YJ53
DR   hPSCreg; DANi006-E
DR   Wikidata; Q93503225
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (from autologous cell line DANi006-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ49 ! DANi006-A
OI   CVCL_YJ50 ! DANi006-B
OI   CVCL_YJ51 ! DANi006-C
OI   CVCL_YJ52 ! DANi006-D
OI   CVCL_YJ54 ! DANi006-F
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   DANi006-F
AC   CVCL_YJ54
SY   DANi-006F; GBA-006-C6
DR   BioSamples; SAMEA5912477
DR   hPSCreg; DANi006-F
DR   Wikidata; Q93503228
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31786474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ49 ! DANi006-A
OI   CVCL_YJ50 ! DANi006-B
OI   CVCL_YJ51 ! DANi006-C
OI   CVCL_YJ52 ! DANi006-D
OI   CVCL_YJ53 ! DANi006-E
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   DANi007-A
AC   CVCL_XJ26
SY   DANi-007A; PINK1-007-C1
DR   BioSamples; SAMEA5912479
DR   hPSCreg; DANi007-A
DR   Wikidata; Q93503230
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Gln456Ter (c.1366C>T); ClinVar=VCV000002415; Zygosity=Homozygous (PubMed=31786474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   DANi008-A
AC   CVCL_YJ55
DR   hPSCreg; DANi008-A
DR   Wikidata; Q93503233
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line DANi008-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ56 ! DANi008-B
OI   CVCL_YJ57 ! DANi008-C
OI   CVCL_YJ58 ! DANi008-D
OI   CVCL_YJ59 ! DANi008-E
OI   CVCL_YJ60 ! DANi008-F
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   DANi008-B
AC   CVCL_YJ56
DR   hPSCreg; DANi008-B
DR   Wikidata; Q93503237
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line DANi008-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ55 ! DANi008-A
OI   CVCL_YJ57 ! DANi008-C
OI   CVCL_YJ58 ! DANi008-D
OI   CVCL_YJ59 ! DANi008-E
OI   CVCL_YJ60 ! DANi008-F
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   DANi008-C
AC   CVCL_YJ57
DR   hPSCreg; DANi008-C
DR   Wikidata; Q93503240
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line DANi008-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ55 ! DANi008-A
OI   CVCL_YJ56 ! DANi008-B
OI   CVCL_YJ58 ! DANi008-D
OI   CVCL_YJ59 ! DANi008-E
OI   CVCL_YJ60 ! DANi008-F
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   DANi008-D
AC   CVCL_YJ58
DR   hPSCreg; DANi008-D
DR   Wikidata; Q93503242
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line DANi008-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ55 ! DANi008-A
OI   CVCL_YJ56 ! DANi008-B
OI   CVCL_YJ57 ! DANi008-C
OI   CVCL_YJ59 ! DANi008-E
OI   CVCL_YJ60 ! DANi008-F
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   DANi008-E
AC   CVCL_YJ59
DR   hPSCreg; DANi008-E
DR   Wikidata; Q93503246
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line DANi008-F).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ55 ! DANi008-A
OI   CVCL_YJ56 ! DANi008-B
OI   CVCL_YJ57 ! DANi008-C
OI   CVCL_YJ58 ! DANi008-D
OI   CVCL_YJ60 ! DANi008-F
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   DANi008-F
AC   CVCL_YJ60
SY   DANi-008F; SNCA-008-C6
DR   BioSamples; SAMEA5912481
DR   hPSCreg; DANi008-F
DR   Wikidata; Q93503248
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=31786474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ55 ! DANi008-A
OI   CVCL_YJ56 ! DANi008-B
OI   CVCL_YJ57 ! DANi008-C
OI   CVCL_YJ58 ! DANi008-D
OI   CVCL_YJ59 ! DANi008-E
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   DANi009-A
AC   CVCL_XJ29
DR   hPSCreg; DANi009-A
DR   Wikidata; Q93503251
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (from autologous cell line DANi009-C).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ30 ! DANi009-B
OI   CVCL_XJ31 ! DANi009-C
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   DANi009-B
AC   CVCL_XJ30
DR   hPSCreg; DANi009-B
DR   Wikidata; Q93503254
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (from autologous cell line DANi009-C).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ29 ! DANi009-A
OI   CVCL_XJ31 ! DANi009-C
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   DANi009-C
AC   CVCL_XJ31
SY   DANi-009C; SNCA-009-C3
DR   BioSamples; SAMEA5912487
DR   hPSCreg; DANi009-C
DR   Wikidata; Q93503258
RX   PubMed=31786474;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=31786474).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ29 ! DANi009-A
OI   CVCL_XJ30 ! DANi009-B
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   DANi010-A
AC   CVCL_XJ27
SY   GBA-010-C1
DR   BioSamples; SAMEA5912485
DR   hPSCreg; DANi010-A
DR   Wikidata; Q93503260
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (hPSCreg=DANi010-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   DANi011-A
AC   CVCL_XJ28
SY   DANi-011A; LRRK2-011-C1
DR   BioSamples; SAMEA5912483
DR   hPSCreg; DANi011-A
DR   Wikidata; Q93503263
RX   PubMed=32305865;
CC   From: Danish Research Institute of Translational Neuroscience, Aarhus University; Aarhus; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=32305865).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32305865
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D21S11: 27,32.2
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   Dante
AC   CVCL_7186
SY   Dante-BL
DR   Lonza; 1122
DR   Wikidata; Q54828565
RX   PubMed=21088132;
RX   PubMed=28960205;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Daoy
AC   CVCL_1167
AS   CVCL_7903
SY   DAOY; D324 Med; D-324 Med; D324 MED; D-324MED; D324
DR   BTO; BTO_0004328
DR   CLO; CLO_0002699
DR   EFO; EFO_0005698
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-186
DR   BCRJ; 0325
DR   BioGRID_ORCS_Cell_line; 687
DR   BioSample; SAMN03470909
DR   BioSample; SAMN10988097
DR   cancercelllines; CVCL_1167
DR   CCRID; 1101HUM-PUMC000218
DR   CCRID; 3101HUMSCSP509
DR   Cell_Model_Passport; SIDM00887
DR   ChEMBL-Cells; CHEMBL3308510
DR   ChEMBL-Targets; CHEMBL612519
DR   CLS; 305053
DR   Cosmic; 687773
DR   Cosmic; 906833
DR   Cosmic; 923654
DR   Cosmic; 973262
DR   Cosmic; 974281
DR   Cosmic; 975027
DR   Cosmic; 1404441
DR   Cosmic; 1995383
DR   Cosmic; 2362649
DR   Cosmic; 2731177
DR   Cosmic-CLP; 906833
DR   DepMap; ACH-000211
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS055ILX
DR   ENCODE; ENCBS812KQP
DR   GDSC; 906833
DR   GEO; GSM482332
DR   GEO; GSM886972
DR   GEO; GSM888041
DR   GEO; GSM919361
DR   GEO; GSM1669725
DR   GEO; GSM1938719
DR   IARC_TP53; 480
DR   KCB; KCB 2010203YJ
DR   LiGeA; CCLE_339
DR   LINCS_LDP; LCL-1576
DR   Lonza; 1438
DR   NCBI_Iran; C519
DR   PharmacoDB; Daoy_282_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1167
DR   PubChem_Cell_line; CVCL_1167
DR   Wikidata; Q29511023
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1822845;
RX   PubMed=2993532;
RX   PubMed=12973738;
RX   PubMed=18773455;
RX   PubMed=20164919;
RX   PubMed=20847082;
RX   PubMed=22343310;
RX   PubMed=22460905;
RX   PubMed=22723427;
RX   PubMed=24297863;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=27498314;
RX   PubMed=27812533;
RX   PubMed=29900115;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31346954;
RX   PubMed=31963405;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-566.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/DAOY_(biology)
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 33.6 hours (Note=At 48th passage) (PubMed=2993532); 32 +- 1.5 hours (PubMed=31346954); 34 hours (ATCC=HTB-186).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (ATCC=HTB-186).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Homozygous (PubMed=22343310; ATCC=HTB-186; Cosmic-CLP=906833; DepMap=ACH-000211).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.45%; Native American=0%; East Asian, North=1.54%; East Asian, South=0%; South Asian=1.1%; European, North=64.36%; European, South=32.54% (PubMed=30894373).
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
ST   Source(s): ATCC=HTB-186; CCRID; Cosmic-CLP=906833; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 10
ST   D18S51: 12
ST   D19S433: 14,14.2 (ATCC=HTB-186; CCRID)
ST   D19S433: 14.2 (PubMed=25877200)
ST   D21S11: 29,31.2
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 10,13
ST   Penta E: 7,11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,20
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   Daoy EZHIP KO
AC   CVCL_C8V5
SY   C67-KO Daoy
DR   Wikidata; Q123031155
RX   PubMed=33186520;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33738; EZHIP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1167 ! Daoy
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Daoy-luc2-tdT
AC   CVCL_A9DF
DR   cancercelllines; CVCL_A9DF
DR   CCRID; 1101HUM-PUMC000814
DR   Wikidata; Q108820134
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
ST   Source(s): CCRID=1101HUM-PUMC000814
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 20
ST   D13S317: 13,14
ST   D16S539: 10
ST   D18S51: 12
ST   D19S433: 14,14.2
ST   D21S11: 29,31.2
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta E: 7,11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,20
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1167 ! Daoy
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   DAP-3DPw2
AC   CVCL_V071
DR   CLO; CLO_0002702
DR   CLDB; cl986
DR   IHW; 11w 8302
DR   Wikidata; Q54828566
RX   PubMed=1429033;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   DAP-3DQ1
AC   CVCL_V072
DR   CLO; CLO_0002703
DR   CLDB; cl987
DR   IHW; 11w 8203
DR   Wikidata; Q54828567
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   DAP-3DR2a
AC   CVCL_V073
DR   CLO; CLO_0002704
DR   CLDB; cl988
DR   IHW; 11w 8107
DR   Wikidata; Q54828568
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   DAP-3DR2b
AC   CVCL_V074
DR   CLO; CLO_0002705
DR   CLDB; cl989
DR   IHW; 11w 8109
DR   Wikidata; Q54828569
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   DAP-3DRw52b
AC   CVCL_V075
DR   CLO; CLO_0002706
DR   CLDB; cl990
DR   IHW; 11w 8134
DR   Wikidata; Q54828570
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   DAP.3
AC   CVCL_V055
SY   Dap.3; DAP-3; DAP3
DR   Wikidata; Q54828571
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   DAP.3-DR1
AC   CVCL_V069
SY   DAP-3 DR1
DR   CLO; CLO_0002700
DR   CLDB; cl984
DR   IHW; 11w 8103
DR   Wikidata; Q54828572
RX   PubMed=2784508;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4947; HLA-DRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DR1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   DAP.3-DR4
AC   CVCL_V070
SY   DAP-3 DR4
DR   CLO; CLO_0002701
DR   CLDB; cl985
DR   IHW; 11w 8115
DR   Wikidata; Q54828573
RX   PubMed=2784508;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4947; HLA-DRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DR4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   DAP.3Ag7
AC   CVCL_V056
DR   Wikidata; Q54828574
RX   PubMed=9480724;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   DAP12 KO (C57)
AC   CVCL_C0L3
SY   DAP12 KO (C57) Macrophage Cell Line
DR   Kerafast; ENH170-FP
DR   Wikidata; Q112929441
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277211; Tyrobp.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   DAPT
AC   CVCL_D279
DR   BioSample; SAMN03151679
DR   Wikidata; Q54828575
RX   PubMed=1198998;
RX   PubMed=1246601;
RX   PubMed=4472134;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to originate from a 41 year old patient with an astrocytoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00040.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   DAR,E
AC   CVCL_E542
SY   DAR, E
DR   dbMHC; 48740
DR   ECACC; 94082248
DR   IHW; IHW09148
DR   IPD-IMGT/HLA; 11691
DR   Wikidata; Q54828576
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,29; B*15,44; C*03; DPB1*04:01,10:01; DQA1*05:01,02:01; DQB1*02:01,03:01; DRB1*07:01,12:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11691).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   DAR,KR
AC   CVCL_E543
SY   DAR, KR
DR   dbMHC; 48741
DR   ECACC; 94082247
DR   IHW; IHW09147
DR   IPD-IMGT/HLA; 11690
DR   Wikidata; Q54828577
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02; B*15; C*03; DPB1*04:01; DQA1*03,05:01; DQB1*03:01,03:02; DRB1*04:01,12:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Dark
AC   CVCL_A0WU
DR   Wikidata; Q108820135
RX   PubMed=22704137;
RX   PubMed=31816142;
CC   Miscellaneous: Breed from personal communication of Gola, Cecilia.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Beauceron; VBO=VBO_0200135.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   DASm244-3B10D9E3
AC   CVCL_B0SP
SY   3B10
DR   Wikidata; Q108820136
RX   PubMed=15319068;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine.
CC   Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   DASm244-4D8A4A4
AC   CVCL_B0SQ
SY   4D8
DR   Wikidata; Q108820137
RX   PubMed=15319068;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine.
CC   Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   DASm244-5A11H10A4
AC   CVCL_B0SR
SY   5A11
DR   Wikidata; Q108820138
RX   PubMed=15319068;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine.
CC   Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   DASm244-5B3C3C6
AC   CVCL_B0SS
SY   5B3
DR   Wikidata; Q108820139
RX   PubMed=15319068;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine.
CC   Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   DAT-P
AC   CVCL_D5JA
DR   Wikidata; Q127380785
RX   DOI=10.1016/S0074-7696(08)62455-9;
RX   DOI=10.1093/oxfordjournals.aob.a085964;
RX   PubMed=16666458;
RX   PubMed=16667897;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (PubMed=16666458).
CC   Characteristics: Capable of growth in vitamin-free medium (PubMed=16667897).
CC   Doubling time: ~14 days (PubMed=16666458).
CC   Derived from site: In situ; Petiole; PO=PO_0020038.
CC   Breed/subspecies: Cultivar Miller.
OX   NCBI_TaxID=4075; ! Datura inoxia (Downy thornapple)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DATK32
AC   CVCL_9169
DR   CLO; CLO_0002707
DR   ATCC; HB-294
DR   Wikidata; Q54828578
RX   PubMed=7523506;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.
CC   Monoclonal antibody target: UniProtKB; P26011; Mouse Itgb7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 7
//
ID   Daudi
AC   CVCL_0008
SY   DAUDI; NK-10A; NK-10a; NK 10a; NK10a; N; GM03190; GM3190; GM03190A; GM17346
DR   BTO; BTO_0001561
DR   CLO; CLO_0002708
DR   CLO; CLO_0013411
DR   CLO; CLO_0013740
DR   CLO; CLO_0050991
DR   EFO; EFO_0002169
DR   MCCL; MCC:0000141
DR   CLDB; cl993
DR   CLDB; cl994
DR   CLDB; cl995
DR   CLDB; cl996
DR   CLDB; cl997
DR   CLDB; cl998
DR   CLDB; cl999
DR   CLDB; cl5181
DR   AddexBio; C0003010/4669
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CCL-213
DR   ATCC; CRL-7917
DR   BCRC; 60192
DR   BioGRID_ORCS_Cell_line; 1081
DR   BioSample; SAMN00808283
DR   BioSample; SAMN01821546
DR   BioSample; SAMN01821623
DR   BioSample; SAMN03472413
DR   BioSample; SAMN10987948
DR   cancercelllines; CVCL_0008
DR   CCRID; 1101HUM-PUMC000134
DR   CCRID; 1102HUM-NIFDC00053
DR   CCRID; 3101HUMTCHu140
DR   CCRID; 4201HUM-CCTCC00097
DR   CCTCC; GDC0097
DR   Cell_Model_Passport; SIDM00845
DR   CGH-DB; 9195-4
DR   ChEMBL-Cells; CHEMBL3307579
DR   ChEMBL-Targets; CHEMBL614281
DR   CLS; 302009
DR   Coriell; GM03190
DR   Coriell; GM17346
DR   Cosmic; 687838
DR   Cosmic; 906831
DR   Cosmic; 919135
DR   Cosmic; 929815
DR   Cosmic; 931102
DR   Cosmic; 932762
DR   Cosmic; 991548
DR   Cosmic; 996304
DR   Cosmic; 998716
DR   Cosmic; 1019315
DR   Cosmic; 1037701
DR   Cosmic; 1070708
DR   Cosmic; 1071878
DR   Cosmic; 1086326
DR   Cosmic; 1093789
DR   Cosmic; 1118470
DR   Cosmic; 1176616
DR   Cosmic; 1191690
DR   Cosmic; 1517663
DR   Cosmic; 1995384
DR   Cosmic; 2649240
DR   Cosmic; 2759407
DR   Cosmic; 2760061
DR   Cosmic; 2814537
DR   Cosmic; 2815216
DR   Cosmic; 2823073
DR   Cosmic-CLP; 906831
DR   dbMHC; 48767
DR   DepMap; ACH-000786
DR   DSMZ; ACC-78
DR   DSMZCellDive; ACC-78
DR   ECACC; 85011437
DR   ECACC; 94071449
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10422-106C8
DR   GDSC; 906831
DR   GEO; GSM99381
DR   GEO; GSM862859
DR   GEO; GSM862860
DR   GEO; GSM862861
DR   GEO; GSM862862
DR   GEO; GSM886973
DR   GEO; GSM888042
DR   GEO; GSM960117
DR   GEO; GSM960118
DR   GEO; GSM960119
DR   GEO; GSM960120
DR   GEO; GSM1374459
DR   GEO; GSM1669726
DR   GEO; GSM3150242
DR   GEO; GSM7701371
DR   GEO; GSM7701372
DR   IARC_TP53; 143
DR   IARC_TP53; 21144
DR   ICLC; HTL95024
DR   IGRhCellID; Daudi
DR   IHW; IHW09366
DR   IPD-IMGT/HLA; 10471
DR   IZSLER; BS TCL 104
DR   JCRB; JCRB9071
DR   KCB; KCB 2012116YJ
DR   KCLB; 10213
DR   LiGeA; CCLE_233
DR   LINCS_LDP; LCL-2018
DR   Lonza; 490
DR   NCBI_Iran; C112
DR   PharmacoDB; Daudi_283_2019
DR   PRIDE; PXD004181
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0008
DR   PubChem_Cell_line; CVCL_0008
DR   RCB; RCB1640
DR   TKG; TKG 0362
DR   Wikidata; Q54828579
RX   CelloPub=CLPUB00447;
RX   PubMed=170370;
RX   PubMed=216485;
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=2140233;
RX   PubMed=2470097;
RX   PubMed=2985879;
RX   PubMed=2998993;
RX   PubMed=3026973;
RX   PubMed=3034807;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=3116544;
RX   PubMed=3159941;
RX   PubMed=3518877;
RX   PubMed=3785169;
RX   PubMed=3874327;
RX   PubMed=3905596;
RX   PubMed=4122458;
RX   PubMed=4174339;
RX   PubMed=4178827;
RX   PubMed=4321974;
RX   PubMed=4364259;
RX   PubMed=4878906;
RX   PubMed=5021706;
RX   PubMed=6186604;
RX   PubMed=6200433;
RX   PubMed=6231253;
RX   PubMed=6286763;
RX   PubMed=6500159;
RX   PubMed=6547209;
RX   PubMed=6582512;
RX   PubMed=6592381;
RX   PubMed=6806672;
RX   PubMed=6935474;
RX   PubMed=6954533;
RX   PubMed=7316467;
RX   PubMed=7849311;
RX   PubMed=8176200;
RX   PubMed=8197130;
RX   PubMed=8301159;
RX   PubMed=8515068;
RX   PubMed=8558913;
RX   PubMed=8558920;
RX   PubMed=8568269;
RX   PubMed=8847894;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9510473;
RX   PubMed=9685479;
RX   PubMed=9737686;
RX   PubMed=9738977;
RX   PubMed=9973220;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=11894933;
RX   PubMed=12145705;
RX   PubMed=12967475;
RX   PubMed=14504097;
RX   PubMed=15028022;
RX   PubMed=16957166;
RX   PubMed=19358282;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29892436;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=DAUDI
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-87.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/daudi-xenograft-model/
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: Human variation panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African; Kenyan.
CC   Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ=ACC-78).
CC   HLA typing: A*01:02,66:01; B*35:01,58:01; C*03:02,06:02; DQA1*01:03,01:03; DQB1*06:13,06:13; DRB1*13:02,03:27 (PubMed=25960936).
CC   HLA typing: A*01:02,66:01; B*58:01,58:01; C*03:02,06:02 (PubMed=26589293).
CC   HLA typing: A*01:02,66:01; B*58:01:01:01,58:02:01; C*03:02:02:01,06:02; DPA1*01:03:01,02:01:01:01; DPB1*02:01:02:01,106:01; DQA1*01:02,01:03; DQB1*06:04:01,06:02; DRB1*13:01:01,13:02:01; DRB3*02:02,03:01:01; DRB6*02 (IPD-IMGT/HLA=10471).
CC   HLA typing: A*01:02,66:01:01; B*58:01:01,58:02:01; C*03:02:02,06:02:01; DPA1*01:03:01,02:01:01; DPB1*02:01:02,106:01; DQA1*01:02:01,01:03:01; DQB1*06:09:01,06:02:01; DRA*01:01:01,01:02:03; DRB1*13:01:01,13:02:01 (DSMZCellDive=ACC-78).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=3116544; PubMed=6806672).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (PubMed=8197130; PubMed=11894933; Cosmic-CLP=906831; DepMap=ACH-000786).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (ATCC=CCL-213).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (Cosmic-CLP=906831; DepMap=ACH-000786).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=91.6%; Native American=0.12%; East Asian, North=2.24%; East Asian, South=0%; South Asian=1.3%; European, North=0%; European, South=4.74% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at c.637C>T in PubMed=2052620.
CC   Misspelling: Duadi; Note=Occasionally.
CC   Discontinued: ATCC; CRL-7917; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): AddexBio=C0003010/4669; ATCC=CCL-213; CCRID; Cosmic-CLP=906831; DSMZ=ACC-78; KCLB=10213; PubMed=25877200; RCB=RCB1640; TKG=TKG 0362
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 16,18
ST   D19S433: 12,14
ST   D21S11: 34,35
ST   D2S1338: 17,24
ST   D3S1358: 16,18
ST   D5S818: 8,13
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 21,26
ST   Penta D: 10,12
ST   Penta E: 7,9 (ATCC=CCL-213; DSMZ=ACC-78; PubMed=25877200)
ST   Penta E: 9 (CCRID)
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 51
//
ID   Daudi-Fluc-EmGFP
AC   CVCL_D5KF
DR   Imanis; CL158
DR   Wikidata; Q127380786
CC   Population: African; Kenyan.
CC   Characteristics: Reporter cell line, transduced with the LV-SFFV-Luc2-P2A-EmGFP vector encoding for luciferase linked via a P2A cleavage site to emerald green fluorescent protein (emGFP) and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL158).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: Daudi-Fluc-eGFP; Imanis=CL158; Note=In old versions.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Daudi-Fluc-Puro
AC   CVCL_D5KG
DR   Imanis; CL160
DR   Wikidata; Q127380787
CC   Population: African; Kenyan.
CC   Characteristics: Reporter cell line, transduced with the LV-SFFV-Luc2-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL160).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Daudi-Luc2
AC   CVCL_B5KW
DR   ATCC; CCL-213-LUC2
DR   Wikidata; Q123031156
CC   Population: African; Kenyan.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-213-LUC2).
CC   Doubling time: ~37 hours (ATCC=CCL-213-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-213-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 8,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   Daudi-TG
AC   CVCL_6220
SY   DAUDI-TG; DIT
DR   cancercelllines; CVCL_6220
DR   Wikidata; Q54828580
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Population: African; Kenyan.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   Daudi/PD-1
AC   CVCL_E5I9
DR   GenScript; M00630
CC   Population: African; Kenyan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   DB
AC   CVCL_1168
DR   CLO; CLO_0002709
DR   EFO; EFO_0002158
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2289
DR   BioSample; SAMN03471088
DR   BioSample; SAMN10987903
DR   cancercelllines; CVCL_1168
DR   Cell_Model_Passport; SIDM00886
DR   ChEMBL-Cells; CHEMBL3308866
DR   ChEMBL-Targets; CHEMBL2366331
DR   CLS; 305048
DR   Cosmic; 687839
DR   Cosmic; 906832
DR   Cosmic; 1329087
DR   Cosmic; 1517658
DR   Cosmic; 1541916
DR   Cosmic; 1629928
DR   Cosmic; 1636692
DR   Cosmic; 1661883
DR   Cosmic; 1714157
DR   Cosmic; 2276321
DR   Cosmic-CLP; 906832
DR   DepMap; ACH-000334
DR   DSMZ; ACC-539
DR   DSMZCellDive; ACC-539
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906832
DR   GEO; GSM274839
DR   GEO; GSM552401
DR   GEO; GSM562823
DR   GEO; GSM886975
DR   GEO; GSM888044
DR   GEO; GSM1035321
DR   GEO; GSM1105703
DR   GEO; GSM1669727
DR   GEO; GSM3150243
DR   IARC_TP53; 21299
DR   IGRhCellID; DB
DR   LiGeA; CCLE_212
DR   LINCS_LDP; LCL-1119
DR   PharmacoDB; DB_284_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1168
DR   PubChem_Cell_line; CVCL_1168
DR   Wikidata; Q54828581
RX   PubMed=2313723;
RX   PubMed=19358282;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=20889926;
RX   PubMed=22460905;
RX   PubMed=23699601;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-539).
CC   HLA typing: A*02; B*52/58; DQA1*05:02,05:02; DRB1*13:27,13:27 (PubMed=25960936).
CC   HLA typing: A*02:01,02:01; B*07:02,18:01; C*05:01,07:14 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=906832).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.4%; East Asian, South=0.73%; South Asian=1.98%; European, North=67.72%; European, South=29.16% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-2289; Cosmic-CLP=906832; DSMZ=ACC-539; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 11,13
ST   D21S11: 29,31.2
ST   D2S1338: 18,24
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 10
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   DB-1 [Human melanoma]
AC   CVCL_D902
DR   BTO; BTO_0002830
DR   ABM; T8273
DR   Wikidata; Q54828582
RX   PubMed=12479222;
CC   Doubling time: 48 hours (PubMed=12479222).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   DB-1 [Mouse macrophage]
AC   CVCL_6F44
DR   Wikidata; Q54828583
RX   PubMed=25599862;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/KsJ-db/db.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DB-7(fvb2)
AC   CVCL_U374
SY   DB-7fvb2
DR   Wikidata; Q54828584
RX   PubMed=16132578;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) (Note=With p.Tyr315Phe and p.Tyr322Phe).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Breed/subspecies: FVB/N-Tg(MMTV-PyVmT) (Y315F/Y322F).
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   DB-8
AC   CVCL_D903
DR   Wikidata; Q54828585
RX   PubMed=12479222;
CC   Doubling time: 48 hours (PubMed=12479222).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   DB-81
AC   CVCL_IR01
SY   DB81
DR   Wikidata; Q54828586
RX   Patent=US20060142219;
RX   PubMed=21818294;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 03002.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4 (Note=In complex with HIV-1 env).
CC   Miscellaneous: Registration number from personal communication of Burastero, Samuele E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   DB-L1
AC   CVCL_A9HV
SY   DBL1
DR   CCRID; 5301MAM-KCB0683LZJ
DR   KCB; KCB 200683LZJ
DR   Wikidata; Q108820140
CC   Group: Bat cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=58065; ! Eonycteris spelaea (Lesser dawn bat)
OI   CVCL_A9HW ! DB-M1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   DB-M1
AC   CVCL_A9HW
SY   DBM1
DR   CCRID; 5301MAM-KCB0683MZJ
DR   KCB; KCB 200683MZJ
DR   Wikidata; Q108820141
CC   Group: Bat cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=58065; ! Eonycteris spelaea (Lesser dawn bat)
OI   CVCL_A9HV ! DB-L1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   DB1
AC   CVCL_W884
DR   Cosmic; 2022592
DR   Wikidata; Q54828587
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 5
//
ID   DB1.K
AC   CVCL_S178
DR   ATCC; CRL-6257
DR   Wikidata; Q54828588
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6257; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9728; ! Delphinus delphis (Short-beaked common dolphin)
OI   CVCL_4517 ! DB1.Tes
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   DB1.Tes
AC   CVCL_4517
SY   DB1-Tes; DB1 Tes
DR   CLO; CLO_0002711
DR   CLDB; cl5183
DR   ATCC; CRL-6258
DR   IZSLER; BS CL 135
DR   Wikidata; Q54828589
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6258; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9728; ! Delphinus delphis (Short-beaked common dolphin)
OI   CVCL_S178 ! DB1.K
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   DB11
AC   CVCL_C8HH
DR   Wikidata; Q123031157
RX   PubMed=10477271;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97769; Prnp (Note=With p.Ser231_Gly254del = recPrP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein (Note=With p.Glu126Gly = R1176E1A).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8H6 ! CHOL761h
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   DB3
AC   CVCL_C7IV
DR   ABCD; ABCD_AE858
DR   Wikidata; Q117704280
RX   Patent=GB2103654A;
RX   PubMed=3102254;
RX   PubMed=3411286;
RX   PubMed=3488262;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
CC   Monoclonal antibody target: ChEBI; CHEBI_16076; 11alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7IU ! AA1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   DB333
AC   CVCL_WY29
DR   Wikidata; Q93503431
RX   PubMed=15574327;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C162694; Severe combined immunodeficiency, Athabascan type
DI   ORDO; Orphanet_275; Severe combined immunodeficiency due to DCLRE1C deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   DB9G8
AC   CVCL_4516
SY   DB 9 G.8
DR   CLO; CLO_0002710
DR   CLO; CLO_0002713
DR   CLDB; cl5182
DR   ATCC; HB-124
DR   IZSLER; BS Hy 27
DR   Wikidata; Q54828594
RX   PubMed=6193965;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01317; Bovine INS (Note=Also reacts with other species including human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   DBA A.Sp
AC   CVCL_6496
DR   CLO; CLO_0002714
DR   ATCC; CRL-6340
DR   Wikidata; Q54828595
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   30D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   DBA B.Sp
AC   CVCL_S248
DR   ATCC; CRL-6341
DR   Wikidata; Q54828596
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6341; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DBA C.Sp
AC   CVCL_6497
DR   CLO; CLO_0002715
DR   ATCC; CRL-6342
DR   Wikidata; Q54828597
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6342; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   DBA-252
AC   CVCL_0J50
SY   DBA/252; DBA 252 ES; DBA252
DR   Wikidata; Q54828598
RX   PubMed=7493652;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/1lacJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   DBAfc-1
AC   CVCL_F042
DR   RCB; AES0041
DR   RCB; RCB2190
DR   SKIP; SKIP001695
DR   Wikidata; Q54828599
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2190; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   DBAfc-2
AC   CVCL_F043
DR   RCB; AES0042
DR   RCB; RCB2191
DR   SKIP; SKIP001696
DR   Wikidata; Q54828600
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2191; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   DBAmt-1
AC   CVCL_F040
DR   RCB; AES0039
DR   RCB; RCB2188
DR   SKIP; SKIP001693
DR   Wikidata; Q54828601
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2188; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   DBAmt-2
AC   CVCL_F041
DR   RCB; AES0040
DR   RCB; RCB2189
DR   SKIP; SKIP001694
DR   Wikidata; Q54828602
RX   PubMed=15601921;
CC   Discontinued: RCB; RCB2189; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   DBB
AC   CVCL_E544
DR   dbMHC; 48742
DR   ECACC; 88052052
DR   IHW; IHW09052
DR   IPD-IMGT/HLA; 10472
DR   Wikidata; Q54828603
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=18193213;
RX   PubMed=28360230;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Amish.
CC   HLA typing: A*02:01:01:01; B*57:01:01; C*06:02:01:01; DPA1*01:03; DPB1*04:01:01; DQA1*02:01; DQB1*03:03:02; DRA*01:01; DRB1*07:01:01; DRB4*01:03:01:02N (IPD-IMGT/HLA=10472).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   DBC1.2
AC   CVCL_6534
DR   JCRB; IFO50484
DR   Wikidata; Q54828604
RX   PubMed=7586492;
RX   PubMed=10876035;
CC   Derived from site: In situ; Embryonic nose, nasal cavity, olfactory epithelium; UBERON=UBERON_0001997.
CC   Cell type: Basal cell; CL=CL_0002169.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   DBLA-1
AC   CVCL_F918
SY   DBLA 1
DR   TKG; TKG 0125
DR   Wikidata; Q54828605
RX   PubMed=317051;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   DBLA-10-TC
AC   CVCL_F919
SY   DBLA-10; DBLA 10
DR   TKG; TKG 0128
DR   TKG; TKG 0645
DR   Wikidata; Q54828606
RX   PubMed=5114634;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   DBLA-6-TC
AC   CVCL_F920
SY   DBLA-6; DBLA 6
DR   TKG; TKG 0126
DR   TKG; TKG 0643
DR   Wikidata; Q54828607
RX   PubMed=317051;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   DBLA-9-TC
AC   CVCL_F921
SY   DBLA-9; DBLA 9
DR   TKG; TKG 0127
DR   TKG; TKG 0644
DR   Wikidata; Q54828608
RX   PubMed=317051;
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   DBr
AC   CVCL_ZC17
DR   Wikidata; Q98125869
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   DBS-FCL-1
AC   CVCL_4158
SY   DBS-FCL1; Division of Biologics Standards-Fetal Cercopithecus Lung-1
DR   CLO; CLO_0002719
DR   ATCC; CCL-161
DR   Wikidata; Q54828609
RX   Patent=US4040905;
RX   PubMed=4203458;
RX   PubMed=4633070;
RX   PubMed=7065527;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-161.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
AG   135FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   DBS-FCL-2
AC   CVCL_4159
SY   DBS-FCL2; FCL-2; Division of Biologics Standards-Fetal Cercopithecus Lung-2
DR   CLO; CLO_0002720
DR   CLDB; cl1003
DR   ATCC; CCL-162
DR   ECACC; 90112815
DR   Wikidata; Q54828610
RX   Patent=US4040905;
RX   PubMed=4633070;
RX   PubMed=7065527;
CC   Group: Non-human primate cell line.
CC   Senescence: Senesces at ~12 PDL.
CC   Discontinued: ATCC; CCL-162; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
AG   141FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   DBS-FRhL-1
AC   CVCL_1E37
SY   FRhL-1; FRhL1; Division of Biologics Standards-Fetal Rhesus Lung-1
DR   Wikidata; Q54828611
RX   PubMed=4633070;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   DBS-FRhL-2
AC   CVCL_4160
SY   DBS-FRHL-2; DBSFRhL-2; DBSFRHL-2; DBSFRhL2; FRhL-2; FrHL-2; FrhL2; Division of Biologics Standards-Fetal Rhesus Lung-2
DR   CLO; CLO_0002721
DR   CLDB; cl1004
DR   ATCC; CCL-160
DR   ATCC; CL-160
DR   ECACC; 89101303
DR   IZSLER; BS CL 215
DR   Wikidata; Q54828612
RX   Patent=US4040905;
RX   PubMed=4203458;
RX   PubMed=4348695;
RX   PubMed=7065527;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-160.
CC   Biotechnology: Was used from 1997 to 1999 for the production of the rhesus rotavirus vaccine-tetravalent (RRV-TV) by Wyeth Laboratories (Trade Name: RotaShield).
CC   Senescence: Senesces at ~74 PDL.
CC   Discontinued: ATCC; CCL-160; true.
CC   Discontinued: IZSLER; BS CL 215; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   DBS/Rh.Lu
AC   CVCL_S377
SY   DBS/RH.LU; DBS/Rh-Lu
DR   ATCC; CRL-6306
DR   Wikidata; Q54828613
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6306; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   Dbt
AC   CVCL_C7HJ
DR   Wikidata; Q117704281
RX   PubMed=14577914;
RX   PubMed=19893043;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Miscellaneous: Sex of donor and species used for Bmi1 transfection from personal communication of Cudre-Mauroux, Christophe.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Muscle satellite cell; CL=CL_0000594.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   DBT piD-10
AC   CVCL_A7UX
SY   piD-10; persistently infected DBT 10
DR   Wikidata; Q107114802
RX   PubMed=8593285;
CC   Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285).
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W75 ! SR-CDF1 DBT
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   DBT piD-2
AC   CVCL_A7UY
SY   piD-2; persistently infected DBT 2
DR   Wikidata; Q107114804
RX   PubMed=8593285;
CC   Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285).
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W75 ! SR-CDF1 DBT
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   DBT piD-3
AC   CVCL_A7UZ
SY   piD-3; persistently infected DBT 3
DR   Wikidata; Q107114806
RX   PubMed=8593285;
CC   Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285).
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W75 ! SR-CDF1 DBT
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   DBT-01
AC   CVCL_WA67
SY   DiaBeTes-01
DR   IBRC; C10651
DR   Wikidata; Q93503573
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DBT-02
AC   CVCL_WA68
SY   DiaBeTes-02
DR   IBRC; C10705
DR   Wikidata; Q93503578
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DBT-03
AC   CVCL_WA69
SY   DiaBeTes-03
DR   IBRC; C10750
DR   Wikidata; Q93503581
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DBT-04
AC   CVCL_WA70
SY   DiaBeTes-04
DR   IBRC; C10774
DR   Wikidata; Q93503583
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   Dbt-indP3F
AC   CVCL_C7HK
DR   Wikidata; Q117704282
RX   PubMed=28138962;
CC   Characteristics: Transduced with a doxycycline-inducible PAX3-FOXO1 lentiviral expression construct (PubMed=28138962).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3819; FOXO1 (Note=PAX3-FOXO1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8617; PAX3 (Note=PAX3-FOXO1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Muscle satellite cell; CL=CL_0000594.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7HJ ! Dbt
SX   Male
AG   7Y
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 7
//
ID   Dbt-MYCN/indP3F
AC   CVCL_C7HL
DR   Wikidata; Q117704283
RX   PubMed=28138962;
CC   Characteristics: Transduced with a retroviral construct expressing MYCN constitutively and a doxycycline-inducible PAX3-FOXO1 lentiviral expression construct (PubMed=28138962).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3819; FOXO1 (Note=PAX3-FOXO1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8617; PAX3 (Note=PAX3-FOXO1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Muscle satellite cell; CL=CL_0000594.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7HJ ! Dbt
SX   Male
AG   7Y
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 7
//
ID   DBTRG-05MG
AC   CVCL_1169
SY   DBTRG.05MG; DBTRG05MG; DBTRG
DR   CLO; CLO_0002722
DR   CLO; CLO_0002723
DR   EFO; EFO_0002159
DR   CLDB; cl1005
DR   CLDB; cl1006
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2020
DR   BCRC; 60380
DR   BioGRID_ORCS_Cell_line; 855
DR   BioSample; SAMN03471277
DR   BioSample; SAMN03473317
DR   BioSample; SAMN10988246
DR   cancercelllines; CVCL_1169
DR   Cell_Model_Passport; SIDM00867
DR   ChEMBL-Cells; CHEMBL3308485
DR   ChEMBL-Targets; CHEMBL614801
DR   Cosmic; 685871
DR   Cosmic; 850827
DR   Cosmic; 906835
DR   Cosmic; 1746961
DR   Cosmic; 2302326
DR   Cosmic; 2367523
DR   Cosmic; 2516015
DR   Cosmic-CLP; 906835
DR   DepMap; ACH-000863
DR   DSMZ; ACC-359
DR   DSMZCellDive; ACC-359
DR   ECACC; 93061119
DR   EGA; EGAS00001000978
DR   GDSC; 906835
DR   GEO; GSM326248
DR   GEO; GSM886974
DR   GEO; GSM888043
DR   GEO; GSM1669728
DR   GEO; GSM5087478
DR   GEO; GSM5087479
DR   GEO; GSM5087480
DR   GEO; GSM5087481
DR   GEO; GSM5087482
DR   GEO; GSM5087483
DR   IARC_TP53; 21300
DR   ICLC; HTL98001
DR   IGRhCellID; DBTRG05MG
DR   LiGeA; CCLE_313
DR   LINCS_LDP; LCL-1349
DR   PharmacoDB; DBTRG05MG_285_2019
DR   PRIDE; PXD022868
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1169
DR   PubChem_Cell_line; CVCL_1169
DR   Wikidata; Q54828614
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 54 hours (PubMed=25984343); ~48 hours (DSMZ=ACC-359).
CC   HLA typing: A*02:01,68:01; B*35:01,38:01; C*12:03,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (ATCC=CRL-2020; Cosmic-CLP=906835; DepMap=ACH-000863).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.59%; East Asian, South=0%; South Asian=19.4%; European, North=16.56%; European, South=63.44% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-2020; Cosmic-CLP=906835; DepMap=ACH-000863; DSMZ=ACC-359; ECACC=93061119
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 10,12 (ATCC=CRL-2020; Cosmic-CLP=906835; DepMap=ACH-000863)
ST   D16S539: 12 (DSMZ=ACC-359; ECACC=93061119)
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 23,24
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 7,8 (ATCC=CRL-2020; Cosmic-CLP=906835; DepMap=ACH-000863)
ST   TH01: 8 (DSMZ=ACC-359; ECACC=93061119)
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   DBUG
AC   CVCL_E545
DR   dbMHC; 48743
DR   ECACC; 94050331
DR   IHW; IHW09319
DR   IPD-IMGT/HLA; 10474
DR   Wikidata; Q54828615
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: East Asian.
CC   HLA typing: A*11:01,26:01; B*07:05:01,55:02:01; C*01:02:01,07:02:01:01; DPA1*01:03,02:02:02; DPB1*04:01:01,05:01; DQA1*01:01:01,02:01; DQB1*06:02,03:03:02; DRB1*11:05,07:01:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=10474).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 16
//
ID   DC-L1
AC   CVCL_A9JF
SY   DCL1; HNDC
DR   CCRID; 5301BOV-KCB90013ZJ
DR   KCB; KCB 90013ZJ
DR   Wikidata; Q108820142
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   DC1
AC   CVCL_6B02
SY   Distal Caput 1
DR   Wikidata; Q54828616
RX   PubMed=12399533;
RX   PubMed=17233813;
WW   Provider; VCCTC; MKT14144; https://vanderbilt.technologypublisher.com/technology/15863
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Testis, epididymis, distal caput; UBERON=UBERON_0004358.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DC1.2
AC   CVCL_J410
DR   Wikidata; Q54828617
RX   PubMed=9058806;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339752; Csf2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   DC10
AC   CVCL_C4U4
DR   Wikidata; Q116048828
RX   PubMed=2461901;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   DC101
AC   CVCL_9170
DR   CLO; CLO_0002725
DR   ATCC; HB-11534
DR   Wikidata; Q54828618
RX   Patent=US5955311;
RX   Patent=US6365157;
RX   Patent=US6448077;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11534.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35918; Mouse Kdr/Cd309.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   DC2
AC   CVCL_6B03
SY   Distal Caput 2
DR   ABM; T0599
DR   Wikidata; Q54828619
RX   PubMed=12399533;
RX   PubMed=17233813;
WW   Provider; VCCTC; MKT14144; https://vanderbilt.technologypublisher.com/technology/15863
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Testis, epididymis, distal caput; UBERON=UBERON_0004358.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   DC2.4
AC   CVCL_J409
SY   DC 2.4
DR   EFO; EFO_0022830
DR   CLS; 305515
DR   Millipore; SCC142
DR   Wikidata; Q54828620
RX   PubMed=9058806;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-518.html
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339752; Csf2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC142
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   DC3 [Mouse epididymal]
AC   CVCL_6B04
SY   Distal Caput 3
DR   Wikidata; Q54828621
RX   PubMed=12399533;
RX   PubMed=17233813;
WW   Provider; VCCTC; MKT14144; https://vanderbilt.technologypublisher.com/technology/15863
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Testis, epididymis, distal caput; UBERON=UBERON_0004358.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DC3 [Rat granulosa]
AC   CVCL_6620
DR   Wikidata; Q54828622
RX   DOI=10.1007/978-1-4684-5688-2_4;
RX   PubMed=2541813;
RX   PubMed=15541573;
RX   PubMed=22517624;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   DC3F
AC   CVCL_4704
SY   DC-3F
DR   BTO; BTO_0002394
DR   ChEMBL-Cells; CHEMBL3307241
DR   ChEMBL-Targets; CHEMBL612702
DR   PubChem_Cell_line; CVCL_4704
DR   Wikidata; Q54828623
RX   PubMed=3365701;
RX   PubMed=3968181;
RX   PubMed=7744845;
CC   Doubling time: ~24 hours (PubMed=7744845).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2886 ! Dede
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   DC3F/9-OH-E
AC   CVCL_4968
SY   DC3F/9-OHE; DC-3F/9-OH-E; DC-3F/9-OH-E 0.6
DR   BTO; BTO_0002593
DR   Wikidata; Q54828624
RX   PubMed=3009009;
RX   PubMed=7055817;
CC   Selected for resistance to: ChEBI; CHEBI_88297; 9-hydroxyellipticine (9-OH-E).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   DC3F/A3
AC   CVCL_1Q35
SY   DC-3F/A3
DR   Wikidata; Q54828625
RX   PubMed=62055;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 9
//
ID   DC3F/ADII
AC   CVCL_GZ07
SY   DC-3F/ADII; DC-3F/AD II; DC-3F/AD-II
DR   ChEMBL-Cells; CHEMBL3307357
DR   ChEMBL-Targets; CHEMBL614283
DR   PubChem_Cell_line; CVCL_GZ07
DR   TOKU-E; 4117
DR   Wikidata; Q54828626
RX   PubMed=5533992;
RX   PubMed=7907088;
RX   PubMed=11455011;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   DC3F/ADIV
AC   CVCL_GZ08
SY   DC-3F/ADIV; DC-3F/AD IV; DC-3F/AD-IV
DR   Wikidata; Q54828627
RX   PubMed=5533992;
RX   PubMed=7907088;
RX   PubMed=11455011;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GZ07 ! DC3F/ADII
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 8
//
ID   DC3F/ADX
AC   CVCL_4705
SY   DC3F/Adx; DC3F-ADX; DC-3F/ADX; DC-3F/AD X
DR   BTO; BTO_0002395
DR   Wikidata; Q54828628
RX   PubMed=2158805;
RX   PubMed=3365701;
RX   PubMed=5533992;
RX   PubMed=7907088;
RX   PubMed=11455011;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GZ08 ! DC3F/ADIV
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   DC3F/ADXC
AC   CVCL_5A42
SY   DC-3F/AD XC
DR   Wikidata; Q54828629
RX   PubMed=3365701;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4705 ! DC3F/ADX
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   DC3F/C-10
AC   CVCL_E423
SY   DC-3F/C-10; DC3F/C10
DR   Wikidata; Q54828630
RX   PubMed=1312902;
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   DC3F/DMXX
AC   CVCL_5A43
SY   DC-3F/DM XX
DR   Wikidata; Q54828631
RX   PubMed=2458323;
RX   PubMed=3365701;
RX   PubMed=7907088;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   DC3F/MQ19
AC   CVCL_1Q36
SY   DC-3F/MQ19
DR   Wikidata; Q54828632
RX   PubMed=62055;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 9
//
ID   DC3F/S16
AC   CVCL_4969
SY   DC-3F/S16
DR   BTO; BTO_0002592
DR   Wikidata; Q54828633
RX   PubMed=10999940;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   DC3F/TG2
AC   CVCL_DC08
DR   Wikidata; Q54828641
RX   PubMed=7744845;
CC   Doubling time: ~24 hours (PubMed=7744845).
CC   Selected for resistance to: ChEBI; CHEBI_9516; Thapsigargin (Tg).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 10
//
ID   DC3F/VCRd5L
AC   CVCL_5A44
SY   DC-3F/VCRd-5L
DR   Wikidata; Q54828642
RX   PubMed=3365701;
RX   PubMed=3968181;
RX   PubMed=7907088;
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   DC3F/VCRm
AC   CVCL_5A45
SY   DC-3F/VCRm
DR   Wikidata; Q54828643
RX   PubMed=3365701;
RX   PubMed=3968181;
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4704 ! DC3F
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   DC4.1
AC   CVCL_J411
DR   Wikidata; Q54828644
RX   PubMed=9058806;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339752; Csf2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   DCE1.1
AC   CVCL_HM04
SY   DisCordant Epilepsy 1.1
DR   GEO; GSM181371
DR   Wikidata; Q54828645
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE1.2 (Cellosaurus=CVCL_HM05).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   DCE1.2
AC   CVCL_HM05
SY   DisCordant Epilepsy 1.2
DR   GEO; GSM181372
DR   Wikidata; Q54828646
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE1.1 (Cellosaurus=CVCL_HM04).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   DCE2.1
AC   CVCL_HM06
SY   DisCordant Epilepsy 2.1
DR   GEO; GSM181373
DR   Wikidata; Q54828647
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE2.2 (Cellosaurus=CVCL_HM07).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   DCE2.2
AC   CVCL_HM07
SY   DisCordant Epilepsy 2.2
DR   GEO; GSM181374
DR   Wikidata; Q54828648
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE2.1 (Cellosaurus=CVCL_HM06).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   DCE3.1
AC   CVCL_HM08
SY   DisCordant Epilepsy 3.1
DR   GEO; GSM181375
DR   Wikidata; Q54828649
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE3.2 (Cellosaurus=CVCL_HM09).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   DCE3.2
AC   CVCL_HM09
SY   DisCordant Epilepsy 3.2
DR   GEO; GSM181376
DR   Wikidata; Q54828651
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE3.1 (Cellosaurus=CVCL_HM08).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   DCE4.1
AC   CVCL_HM10
SY   DisCordant Epilepsy 4.1
DR   GEO; GSM181377
DR   Wikidata; Q54828652
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE4.2 (Cellosaurus=CVCL_HM11).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   DCE4.2
AC   CVCL_HM11
SY   DisCordant Epilepsy 4.2
DR   GEO; GSM181378
DR   Wikidata; Q54828653
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE4.1 (Cellosaurus=CVCL_HM10).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   DCE5.1
AC   CVCL_HM12
DR   GEO; GSM181379
DR   Wikidata; Q54828654
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE5.2 (Cellosaurus=CVCL_HM13).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129868; Juvenile absence epilepsy
DI   ORDO; Orphanet_1941; Juvenile absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   DCE5.2
AC   CVCL_HM13
DR   GEO; GSM181380
DR   Wikidata; Q54828655
RX   PubMed=18435749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of DCE5.1 (Cellosaurus=CVCL_HM12).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   DCGi001-A
AC   CVCL_YT17
SY   FS_E154#3; FOXG1-E154GfsX301-#1-3
DR   hPSCreg; DCGi001-A
DR   Wikidata; Q93503905
RX   PubMed=33096386;
CC   From: Division of Cancer and Genetics, School of Medicine, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Glu154Glyfs*301 (c.460dupG); ClinVar=VCV000095268; Zygosity=Heterozygous (PubMed=33096386).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   DCH-4
AC   CVCL_ZD58
SY   DCH4
DR   Wikidata; Q98125871
RX   PubMed=12920029;
CC   Characteristics: Produced by lentivirus tranduction of a vector encoding an HTLV-1 Tax-EYFP fusion.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1) (Note=Tax).
CC   Cell type: CD4-positive helper T cell; CL=CL_0000492.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 7
//
ID   DCH001
AC   CVCL_E546
SY   DCH 001; DCH-001
DR   dbMHC; 48744
DR   IHW; IHW09181
DR   IPD-IMGT/HLA; 11723
DR   Wikidata; Q54828656
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,24; B*75; C*08; DQA1*01:03,06:01; DQB1*03:01,06:03; DRB1*12:02,13:01; DRB3*01:01,03:01 (IPD-IMGT/HLA=11723).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH002
AC   CVCL_E547
SY   DCH 002; DCH-002; Thai-DCH002
DR   dbMHC; 48745
DR   ECACC; 94082282
DR   IHW; IHW09182
DR   IPD-IMGT/HLA; 11724
DR   Wikidata; Q54828657
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,24; B*15:02,18; C*07,08; DPB1*13:01,21:01; DQA1*01:01,06:01; DQB1*03:01,05:01; DRB1*15:02,12:02; DRB3*03:01; DRB5*01:02 (IPD-IMGT/HLA=11724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH006
AC   CVCL_E550
SY   DCH 006; DCH-006; Thai-DCH006
DR   dbMHC; 48746
DR   ECACC; 94082288
DR   IHW; IHW09188
DR   IPD-IMGT/HLA; 11730
DR   Wikidata; Q54828658
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,24; B*18,75; C*07,08; DPB1*04:01,05:01; DQA1*01:02,01:03; DQB1*06:01; DRB1*15:01,08:03; DRB4*01:01; DRB5*01:01 (IPD-IMGT/HLA=11730).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH007
AC   CVCL_E551
SY   DCH 007; DCH-007; Thai-DCH007
DR   dbMHC; 48747
DR   ECACC; 94082283
DR   IHW; IHW09183
DR   IPD-IMGT/HLA; 11725
DR   Wikidata; Q54828659
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,24; B*75,76; C*08; DPB1*05:01; DQA1*06:01,01:01; DQB1*03:01,05:02; DRB1*15:02,12:02; DRB3*03:01; DRB5*01:02 (IPD-IMGT/HLA=11725).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH008
AC   CVCL_E552
SY   DCH 008; DCH-008; Thai-DCH008
DR   dbMHC; 48748
DR   ECACC; 94082284
DR   IHW; IHW09184
DR   IPD-IMGT/HLA; 11726
DR   Wikidata; Q54828660
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,24; B*75,76; C*08,09; DPB1*03:01,41:01; DQA1*03:02,06:01; DQB1*03:01,03:03; DRB1*09,12:02; DRB3*03:01; DRB4*01:01 (IPD-IMGT/HLA=11726).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH009
AC   CVCL_E553
SY   DCH 009; DCH-009; Thai-DCH009
DR   dbMHC; 48749
DR   ECACC; 94082289
DR   IHW; IHW09189
DR   IPD-IMGT/HLA; 11731
DR   Wikidata; Q54828661
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*02,24:07; B*15:02,46; C*01,08; DPA1*02:02:02,04:01; DPB1*13:01,28:01; DQA1*01:02,03:02; DQB1*06:01,03:03; DRB1*09:01,15:01; DRB4*01:01; DRB5*01:01 (IPD-IMGT/HLA=11731).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH010
AC   CVCL_E554
SY   DCH 010; DCH-010; Thai-DCH010
DR   dbMHC; 48750
DR   ECACC; 94082285
DR   IHW; IHW09185
DR   IPD-IMGT/HLA; 11727
DR   Wikidata; Q54828662
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*24,11; B*46,15:02; C*08,12; DPB1*05:01; DQA1*01:03,03; DQB1*04:01,06:03; DRB1*13:01,04:05; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=11727).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH011
AC   CVCL_E556
SY   DCH 011; DCH-011; Thai-DCH011; THAI DCH011
DR   dbMHC; 48751
DR   ECACC; 94082286
DR   IHW; IHW09186
DR   IPD-IMGT/HLA; 11728
DR   Wikidata; Q54828663
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,24; B*15:02,46; C*03,08; DPB1*05:01; DQA1*01:03,03; DQB1*04:01,06:03; DRB1*13:01,04:05; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=11728).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH012
AC   CVCL_E558
SY   DCH 012; DCH-012; Thai-DCH012; THAI DCH012
DR   dbMHC; 48752
DR   ECACC; 94082287
DR   IHW; IHW09187
DR   IPD-IMGT/HLA; 11729
DR   Wikidata; Q54828664
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*28,33; B*08,46; C*01,07; DPB1*05:01,17:01; DQA1*05:01,03:02; DQB1*02:01,03:03; DRB1*03:01,09:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11729).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   DCH013
AC   CVCL_G027
SY   Thai-DCH013
DR   IPD-IMGT/HLA; 12419
DR   Wikidata; Q54828666
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: B*39:01,57:01 (IPD-IMGT/HLA=12419).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   DCH019
AC   CVCL_M634
SY   Thai-DCH019
DR   IPD-IMGT/HLA; 12387
DR   Wikidata; Q54828667
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: B*07,15:02 (IPD-IMGT/HLA=12387).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   DCH020
AC   CVCL_M635
SY   Thai-DCH020
DR   IPD-IMGT/HLA; 12417
DR   Wikidata; Q54828668
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: B*44:02,57:01 (IPD-IMGT/HLA=12417).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   DCH021
AC   CVCL_M636
SY   Thai-DCH021
DR   IPD-IMGT/HLA; 12382
DR   Wikidata; Q54828669
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: B*15:02,46:01 (IPD-IMGT/HLA=12382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   DCH024
AC   CVCL_M637
SY   Thai-DCH024
DR   IPD-IMGT/HLA; 12388
DR   Wikidata; Q54828670
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: B*46:01,57:01 (IPD-IMGT/HLA=12388).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   DCH027
AC   CVCL_G028
SY   Thai-DCH027
DR   IPD-IMGT/HLA; 10477
DR   Wikidata; Q54828671
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   DCH032
AC   CVCL_M638
SY   Thai-DCH032
DR   IPD-IMGT/HLA; 12386
DR   Wikidata; Q54828672
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: B*18:01,15:02 (IPD-IMGT/HLA=12386).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   DCH036
AC   CVCL_F713
SY   Thai-DCH036
DR   IPD-IMGT/HLA; 10478
DR   Wikidata; Q54828673
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*11,24:07; B*15:32 (IPD-IMGT/HLA=10478).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   Dch1
AC   CVCL_F009
DR   BioSample; SAMN03472401
DR   JCRB; JCRB3002
DR   JCRB; KURB2098
DR   Wikidata; Q54828674
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2098; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3002
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
ID   Dch2
AC   CVCL_F010
DR   BioSample; SAMN03472400
DR   JCRB; JCRB3001
DR   JCRB; KURB2099
DR   Wikidata; Q54828675
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2099; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3001
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 15
//
ID   Dch3
AC   CVCL_F011
DR   BioSample; SAMN03472403
DR   JCRB; JCRB3003
DR   JCRB; KURB2100
DR   Wikidata; Q54828676
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2100; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3003
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 9,14
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
ID   Dch4F
AC   CVCL_F012
DR   BioSample; SAMN03472404
DR   JCRB; JCRB3004
DR   JCRB; KURB2101
DR   Wikidata; Q54828677
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2101; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3004
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
ID   DCM iPSC clone 1
AC   CVCL_YT09
DR   Wikidata; Q93504153
RX   PubMed=25759365;
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Ser14450fs*4 (c.43628insAT); Zygosity=Heterozygous (PubMed=25759365).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT10 ! DCM iPSC clone 2
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   DCM iPSC clone 2
AC   CVCL_YT10
DR   Wikidata; Q93504157
RX   PubMed=25759365;
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Ser14450fs*4 (c.43628insAT); Zygosity=Heterozygous (PubMed=25759365).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT09 ! DCM iPSC clone 1
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   DCR-2
AC   CVCL_B7D4
DR   Wikidata; Q112929443
RX   Patent=WO2018094460A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Cell Bank Australia; CBA20160029.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8TDQ1; Human CD300LF/CD300f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   DCR10
AC   CVCL_EI68
SY   DCR 10
DR   cancercelllines; CVCL_EI68
DR   ColonAtlas; DCR10
DR   Cosmic; 1690659
DR   Wikidata; Q54828678
RX   PubMed=22270724;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser492Arg (c.1476C>A); ClinVar=VCV000376341; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=22270724).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C2955; Colorectal carcinoma
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6895 ! DiFi
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   DCR7
AC   CVCL_EI69
SY   DCR 7
DR   cancercelllines; CVCL_EI69
DR   ColonAtlas; DCR7
DR   Cosmic; 1690657
DR   Wikidata; Q54828679
RX   PubMed=22270724;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser492Arg (c.1476C>A); ClinVar=VCV000376341; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=22270724).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C2955; Colorectal carcinoma
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6895 ! DiFi
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   DCR9
AC   CVCL_EI70
SY   DCR 9
DR   cancercelllines; CVCL_EI70
DR   ColonAtlas; DCR9
DR   Cosmic; 1690658
DR   Wikidata; Q54828680
RX   PubMed=22270724;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser492Arg (c.1476C>A); ClinVar=VCV000376341; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=22270724).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C2955; Colorectal carcinoma
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6895 ! DiFi
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   DD
AC   CVCL_J651
DR   BioSample; SAMN03151808
DR   Cosmic; 1086349
DR   Wikidata; Q54828681
RX   PubMed=1733517;
RX   PubMed=8558920;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a patient with malignant histiocytosis in the leukemic stage.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00187.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 28
//
ID   DD-1 [Dog hemangiosarcoma]
AC   CVCL_0C94
SY   DD1
DR   GEO; GSM377407
DR   GEO; GSM1122227
DR   Kerafast; EMN009-FP
DR   Wikidata; Q54828682
RX   PubMed=15064773;
RX   PubMed=16797414;
RX   PubMed=19461996;
RX   PubMed=24582862;
RX   PubMed=30601866;
CC   Doubling time: 5-7 days (Kerafast=EMN009-FP).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Was incorrectly indicated to originate from a 9 year old dog (PubMed=19461996) but is in fact from a 11 year old dog (personal communication of Modiano, Jaime F. through Kerafast).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever x Pyrenean mountain dog; VBO=VBO_0200610+VBO_0200629.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   DD-1 [Mouse hybridoma against TCDD]
AC   CVCL_J826
DR   ATCC; HB-9741
DR   Wikidata; Q54828695
RX   Patent=US4798807;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9741.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28119; 2,3,7,8-tetrachlorodibenzodioxine (TCDD).
CC   Discontinued: ATCC; HB-9741; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   DD-3
AC   CVCL_J827
DR   Wikidata; Q54828696
RX   Patent=US4798807;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9742.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28119; 2,3,7,8-tetrachlorodibenzodioxine (TCDD).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   DD-4
AC   CVCL_J828
DR   CLO; CLO_0002732
DR   ATCC; HB-9743
DR   Wikidata; Q54828697
RX   Patent=US4798807;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9743.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28119; 2,3,7,8-tetrachlorodibenzodioxine (TCDD).
CC   Discontinued: ATCC; HB-9743; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   DD-5
AC   CVCL_J829
DR   ATCC; HB-9744
DR   Wikidata; Q54828698
RX   Patent=US4798807;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9744.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28119; 2,3,7,8-tetrachlorodibenzodioxine (TCDD).
CC   Discontinued: ATCC; HB-9744; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   DD-6
AC   CVCL_J830
DR   Wikidata; Q54828699
RX   Patent=US4798807;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9745.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_28119; 2,3,7,8-tetrachlorodibenzodioxine (TCDD).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   DD-761
AC   CVCL_8184
SY   DD761
DR   Wikidata; Q54828700
RX   CelloPub=CLPUB00034;
CC   Doubling time: 18 hours (CelloPub=CLPUB00034).
CC   Breed/subspecies: DD/Tbr.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   DD-762
AC   CVCL_8185
SY   DD762
DR   CLO; CLO_0050956
DR   JCRB; JCRB1077
DR   JCRB; NIHS0336
DR   RCB; RCB0473
DR   Wikidata; Q54828701
RX   CelloPub=CLPUB00034;
CC   Doubling time: 18 hours (CelloPub=CLPUB00034); 21 hours (Note=Lot 06232005) (JCRB=JCRB1077).
CC   Discontinued: JCRB; NIHS0336; true.
CC   Breed/subspecies: DD/Tbr.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8184 ! DD-761
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   DD-763
AC   CVCL_8186
SY   DD763
DR   Wikidata; Q54828702
RX   CelloPub=CLPUB00034;
CC   Doubling time: 18 hours (CelloPub=CLPUB00034).
CC   Breed/subspecies: DD/Tbr.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8184 ! DD-761
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   DD-764
AC   CVCL_8187
SY   DD764
DR   Wikidata; Q54828703
RX   CelloPub=CLPUB00034;
CC   Doubling time: 14 hours (CelloPub=CLPUB00034).
CC   Breed/subspecies: DD/Tbr.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8184 ! DD-761
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   DD0001
AC   CVCL_8U26
DR   ECACC; 89030312
DR   Wikidata; Q54828704
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0005
AC   CVCL_8U27
DR   ECACC; 89111401
DR   Wikidata; Q54828705
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89111401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U63 ! DD0086
SX   Female
AG   22Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0006
AC   CVCL_8U28
DR   ECACC; 90012933
DR   Wikidata; Q54828706
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90012933; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0007
AC   CVCL_8U29
DR   ECACC; 90041701
DR   Wikidata; Q54828707
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0012
AC   CVCL_8U30
DR   ECACC; 90010801
DR   Wikidata; Q54828708
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(6)(p21.33;q23.3),t(7;13) (ECACC=90010801).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90010801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9I46 ! DD2035
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0014
AC   CVCL_8U31
DR   ECACC; 90012301
DR   Wikidata; Q54828709
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90012301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0017
AC   CVCL_8U32
DR   ECACC; 90021605
DR   Wikidata; Q54828710
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0019
AC   CVCL_8U33
DR   ECACC; 90031301
DR   Wikidata; Q54828711
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90031301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0020
AC   CVCL_8U34
DR   ECACC; 90032811
DR   Wikidata; Q54828712
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,Y,del(X)(pter->q21.1::q21.2->qter)mat (ECACC=90032811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0021
AC   CVCL_8U35
DR   ECACC; 90042701
DR   Wikidata; Q54828713
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0022
AC   CVCL_8U36
DR   ECACC; 90051418
DR   Wikidata; Q54828714
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0023
AC   CVCL_8U37
DR   ECACC; 90051419
DR   Wikidata; Q54828715
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90051419; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0025
AC   CVCL_8U38
DR   ECACC; 90060802
DR   Wikidata; Q54828716
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90060802; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0026
AC   CVCL_8U39
DR   ECACC; 90060803
DR   Wikidata; Q54828717
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90060803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0029
AC   CVCL_8U40
DR   ECACC; 90080203
DR   Wikidata; Q54828718
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90080203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0031
AC   CVCL_8U41
DR   ECACC; 90091201
DR   Wikidata; Q54828719
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9D87 ! DD1092
SX   Female
AG   18Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0033
AC   CVCL_8U42
DR   ECACC; 90092604
DR   Wikidata; Q54828720
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90092604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0034
AC   CVCL_8U43
DR   ECACC; 90092605
DR   Wikidata; Q54828721
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90092605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0036
AC   CVCL_8U44
DR   ECACC; 90092708
DR   Wikidata; Q54828722
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90092708; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0037
AC   CVCL_8U45
DR   ECACC; 90092709
DR   Wikidata; Q54828723
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90092709; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0038
AC   CVCL_8U46
DR   ECACC; 90092710
DR   Wikidata; Q54828724
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0039
AC   CVCL_AQ55
DR   ECACC; 90100305
DR   Wikidata; Q54828725
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90100305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y7M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD0041
AC   CVCL_8U47
DR   ECACC; 90100701
DR   Wikidata; Q54828726
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0042
AC   CVCL_8U48
DR   ECACC; 90101001
DR   Wikidata; Q54828727
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90101001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0043
AC   CVCL_8U49
DR   ECACC; 90101607
DR   Wikidata; Q54828729
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90101607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0046
AC   CVCL_AQ56
DR   ECACC; 90101601
DR   Wikidata; Q54828730
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 90101601; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD0049
AC   CVCL_8U50
DR   ECACC; 90102417
DR   Wikidata; Q54828731
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90102417; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0051
AC   CVCL_8U51
DR   ECACC; 90110201
DR   Wikidata; Q54828732
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9F10 ! DD1306
SX   Male
AG   8Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0054
AC   CVCL_8U52
DR   ECACC; 90112722
DR   Wikidata; Q54828733
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0056
AC   CVCL_8U53
DR   ECACC; 90091701
DR   Wikidata; Q54828734
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(4;9)(p16;q32)pat (ECACC=90091701).
CC   Discontinued: ECACC; 90091701; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0057
AC   CVCL_8U54
DR   ECACC; 90091103
DR   Wikidata; Q54828735
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0058
AC   CVCL_8U55
DR   ECACC; 90090604
DR   Wikidata; Q54828740
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 90090604; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0060
AC   CVCL_8U56
DR   ECACC; 90081712
DR   Wikidata; Q54828741
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;8)(q13.1;p11) (ECACC=90081712).
CC   Discontinued: ECACC; 90081712; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0071
AC   CVCL_8U57
DR   ECACC; 90060403
DR   Wikidata; Q54828742
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+i(12p) (ECACC=90060403).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0072
AC   CVCL_8U58
DR   ECACC; 90060402
DR   Wikidata; Q54828743
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+18 (ECACC=90060402).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y8M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0073
AC   CVCL_8U59
DR   ECACC; 90042503
DR   Wikidata; Q54828744
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+mar mat (ECACC=90042503).
CC   Discontinued: ECACC; 90042503; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0074
AC   CVCL_8U60
DR   ECACC; 90042502
DR   Wikidata; Q54828745
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+14 (ECACC=90042502).
CC   Discontinued: ECACC; 90042502; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0084
AC   CVCL_8U61
DR   ECACC; 90020901
DR   Wikidata; Q54828746
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+i(12p) (ECACC=90020901).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75458; Pallister-Killian syndrome
DI   ORDO; Orphanet_884; Tetrasomy 12p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0085
AC   CVCL_8U62
DR   ECACC; 90011204
DR   Wikidata; Q54828747
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 90011204; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0086
AC   CVCL_8U63
DR   ECACC; 90010302
DR   Wikidata; Q54828748
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 46,XX,t(2;11) (ECACC=90010302).
CC   Discontinued: ECACC; 90010302; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U27 ! DD0005
SX   Female
AG   22Y10M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0090
AC   CVCL_8U64
DR   ECACC; 89120582
DR   Wikidata; Q54828749
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 89120582; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0097
AC   CVCL_8U65
DR   ECACC; 89082301
DR   Wikidata; Q54828750
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-4,+der(4)t(X;4)(p22.1;p15.2); de novo (ECACC=89082301).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U87 ! DD0144
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0098
AC   CVCL_8U66
DR   ECACC; 89070501
DR   Wikidata; Q54828751
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 89070501; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0099
AC   CVCL_8U67
DR   ECACC; 89060701
DR   Wikidata; Q54828752
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;9)(p21.2;q22.1); de novo (ECACC=89060701).
CC   Discontinued: ECACC; 89060701; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0100
AC   CVCL_8U68
DR   ECACC; 89031702
DR   Wikidata; Q54828754
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0102
AC   CVCL_8U69
DR   ECACC; 89021601
DR   Wikidata; Q54828755
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 89021601; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0104
AC   CVCL_8U70
DR   ECACC; 88122801
DR   Wikidata; Q54828756
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 88122801; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0105
AC   CVCL_8U71
DR   ECACC; 88101401
DR   Wikidata; Q54828758
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,fra(X)(q28) 16/50 (ECACC=88101401).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0106
AC   CVCL_8U72
DR   ECACC; 88052403
DR   Wikidata; Q54828759
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,19q+mat (ECACC=88052403).
CC   Discontinued: ECACC; 88052403; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0108
AC   CVCL_8U73
DR   ECACC; 870424011
DR   Wikidata; Q54828760
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+dic(15)(pter->q11::q11->pter) (ECACC=870424011).
CC   Discontinued: ECACC; 870424011; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0116
AC   CVCL_8U74
DR   ECACC; 89112412
DR   Wikidata; Q54828761
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 89112412; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0120
AC   CVCL_8U75
DR   ECACC; 90121812
DR   Wikidata; Q54828762
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90121812; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0122
AC   CVCL_8U76
DR   ECACC; 90121814
DR   Wikidata; Q54828764
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90121814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0126
AC   CVCL_8U77
DR   ECACC; 90122403
DR   Wikidata; Q54828765
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90122403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0127
AC   CVCL_8U78
DR   ECACC; 90122404
DR   Wikidata; Q54828766
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0128
AC   CVCL_8U79
DR   ECACC; 90122405
DR   Wikidata; Q54828767
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90122405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0132
AC   CVCL_8U80
DR   ECACC; 91010402
DR   Wikidata; Q54828768
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91010402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0133
AC   CVCL_8U81
DR   ECACC; 91010902
DR   Wikidata; Q54828769
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91010902; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0136
AC   CVCL_8U82
DR   ECACC; 91011104
DR   Wikidata; Q54828770
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0140
AC   CVCL_8U83
DR   ECACC; 91011103
DR   Wikidata; Q54828771
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0141
AC   CVCL_8U84
DR   ECACC; 91011506
DR   Wikidata; Q54828772
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0142
AC   CVCL_8U85
DR   ECACC; 91011606
DR   Wikidata; Q54828773
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011606; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0143
AC   CVCL_8U86
DR   ECACC; 91011607
DR   Wikidata; Q54828775
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0144
AC   CVCL_8U87
DR   ECACC; 91011608
DR   Wikidata; Q54828776
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U65 ! DD0097
SX   Female
AG   2Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0145
AC   CVCL_8U88
DR   ECACC; 91011609
DR   Wikidata; Q54828777
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0146
AC   CVCL_8U89
DR   ECACC; 91011610
DR   Wikidata; Q54828778
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011610; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0147
AC   CVCL_8U90
DR   ECACC; 91011611
DR   Wikidata; Q54828779
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91011611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0150
AC   CVCL_8U91
DR   ECACC; 91012213
DR   Wikidata; Q54828780
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91012213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0152
AC   CVCL_8U92
DR   ECACC; 91012605
DR   Wikidata; Q54828781
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91012605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0153
AC   CVCL_8U93
DR   ECACC; 91012606
DR   Wikidata; Q54828782
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0154
AC   CVCL_8U94
DR   ECACC; 91012607
DR   Wikidata; Q54828783
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,var(13p) (ECACC=91012607).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91012607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0155
AC   CVCL_8U95
DR   ECACC; 91012608
DR   Wikidata; Q54828794
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91012608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0162
AC   CVCL_8U96
DR   ECACC; 91020405
DR   Wikidata; Q54828795
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91020405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0167
AC   CVCL_AQ57
DR   ECACC; 91020511
DR   Wikidata; Q54828796
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar (ECACC=91020511).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   DD0171
AC   CVCL_8U97
DR   ECACC; 91020711
DR   Wikidata; Q54828797
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0172
AC   CVCL_8U98
DR   ECACC; 91020712
DR   Wikidata; Q54828798
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0173
AC   CVCL_8U99
DR   ECACC; 880928011
DR   Wikidata; Q54828799
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9C63 ! DD0855
SX   Female
AG   16Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0175
AC   CVCL_8V00
DR   ECACC; 91020801
DR   Wikidata; Q54828800
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91020801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0176
AC   CVCL_8V01
DR   ECACC; 91021302
DR   Wikidata; Q54828801
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;18)(p21.31;q23)mat (ECACC=91021302).
CC   Discontinued: ECACC; 91021302; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0178
AC   CVCL_8V02
DR   ECACC; 91021432
DR   Wikidata; Q54828802
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,der(X),t(X;5)(p22.33;p15.1)mat (ECACC=91021432).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0179
AC   CVCL_8V03
DR   ECACC; 91021504
DR   Wikidata; Q54828803
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91021504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0182
AC   CVCL_8V04
DR   ECACC; 91022216
DR   Wikidata; Q54828804
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(5;18)(p13;q11)pat (ECACC=91022216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0183
AC   CVCL_8V05
DR   ECACC; 91022217
DR   Wikidata; Q54828805
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91022217; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0184
AC   CVCL_8V06
DR   ECACC; 91022218
DR   Wikidata; Q54828806
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91022218; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0185
AC   CVCL_8V07
DR   ECACC; 91022219
DR   Wikidata; Q54828807
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(11;22)(q23;q11) (ECACC=91022219).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0186
AC   CVCL_8V08
DR   ECACC; 91022220
DR   Wikidata; Q54828808
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,?dup(1)(q32->q42.1) (ECACC=91022220).
CC   Discontinued: ECACC; 91022220; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0187
AC   CVCL_8V09
DR   ECACC; 91022705
DR   Wikidata; Q54828809
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0188
AC   CVCL_8V10
DR   ECACC; 91022706
DR   Wikidata; Q54828810
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91022706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0189
AC   CVCL_8V11
DR   ECACC; 91022707
DR   Wikidata; Q54828811
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91022707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0191
AC   CVCL_8V12
DR   ECACC; 91030405
DR   Wikidata; Q54828812
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0193
AC   CVCL_8V13
DR   ECACC; 91030407
DR   Wikidata; Q54828813
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91030407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0195
AC   CVCL_8V14
DR   ECACC; 91030608
DR   Wikidata; Q54828814
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91030608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0196
AC   CVCL_8V15
DR   ECACC; 91030609
DR   Wikidata; Q54828815
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91030609; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0197
AC   CVCL_8V16
DR   ECACC; 91030610
DR   Wikidata; Q54828816
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(qter->p11) (ECACC=91030610).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0198
AC   CVCL_8V17
DR   ECACC; 91030611
DR   Wikidata; Q54828818
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0199
AC   CVCL_8V18
DR   ECACC; 91030612
DR   Wikidata; Q54828819
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91030612; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0200
AC   CVCL_8V19
DR   ECACC; 91030613
DR   Wikidata; Q54828820
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91030613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0202
AC   CVCL_8V20
DR   ECACC; 91030814
DR   Wikidata; Q54828821
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91030814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0203
AC   CVCL_8V21
DR   ECACC; 91030815
DR   Wikidata; Q54828822
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(10;20)(q23;q13.3) (ECACC=91030815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0204
AC   CVCL_8V22
DR   ECACC; 91031307
DR   Wikidata; Q54828823
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91031307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0206
AC   CVCL_8V23
DR   ECACC; 91031816
DR   Wikidata; Q54828824
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;12)(q37;q24.1) (ECACC=91031816).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91031816; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G16 ! DD1502
SX   Female
AG   27Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0207
AC   CVCL_8V24
DR   ECACC; 91031817
DR   Wikidata; Q54828825
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91031817; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G17 ! DD1503
SX   Male
AG   35Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0210
AC   CVCL_8V25
DR   ECACC; 91032004
DR   Wikidata; Q54828826
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0213
AC   CVCL_8V26
DR   ECACC; 91032109
DR   Wikidata; Q54828827
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0214
AC   CVCL_8V27
DR   ECACC; 91032110
DR   Wikidata; Q54828828
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0215
AC   CVCL_8V28
DR   ECACC; 91032111
DR   Wikidata; Q54828829
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0218
AC   CVCL_8V29
DR   ECACC; 91032114
DR   Wikidata; Q54828830
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0220
AC   CVCL_8V30
DR   ECACC; 91032116
DR   Wikidata; Q54828831
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(pter->q22.3::q26.1->qter) (ECACC=91032116).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0222
AC   CVCL_8V31
DR   ECACC; 91032619
DR   Wikidata; Q54828832
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(6;22)(p21.3;q13)pat (ECACC=91032619).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032619; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0223
AC   CVCL_8V32
DR   ECACC; 91032713
DR   Wikidata; Q54828833
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032713; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0225
AC   CVCL_8V33
DR   ECACC; 91032715
DR   Wikidata; Q54828834
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0226
AC   CVCL_8V34
DR   ECACC; 91032716
DR   Wikidata; Q54828844
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032716; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0227
AC   CVCL_8V35
DR   ECACC; 91032717
DR   Wikidata; Q54828846
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar; de novo (ECACC=91032717).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9F92 ! DD1450
SX   Male
AG   3Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   DD0228
AC   CVCL_8V36
DR   ECACC; 91032718
DR   Wikidata; Q54828847
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032718; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9F91 ! DD1449
SX   Male
AG   27Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0229
AC   CVCL_8V37
DR   ECACC; 91032719
DR   Wikidata; Q54828848
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032719; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9F90 ! DD1448
SX   Female
AG   28Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0231
AC   CVCL_8V38
DR   ECACC; 91032722
DR   Wikidata; Q54828849
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,15p+ (ECACC=91032722).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0233
AC   CVCL_8V39
DR   ECACC; 91032818
DR   Wikidata; Q54828851
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032818; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0234
AC   CVCL_8V40
DR   ECACC; 91032819
DR   Wikidata; Q54828853
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032819; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0235
AC   CVCL_8V41
DR   ECACC; 91040311
DR   Wikidata; Q54828854
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91040311; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0236
AC   CVCL_8V42
DR   ECACC; 91040312
DR   Wikidata; Q54828855
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91040312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0239
AC   CVCL_8V43
DR   ECACC; 91040318
DR   Wikidata; Q54828856
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=91040318).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0241
AC   CVCL_8V44
DR   ECACC; 91040801
DR   Wikidata; Q54828857
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0242
AC   CVCL_8V45
DR   ECACC; 91040802
DR   Wikidata; Q54828859
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91040802; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0243
AC   CVCL_8V46
DR   ECACC; 91041101
DR   Wikidata; Q54828860
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0244
AC   CVCL_8V47
DR   ECACC; 91041102
DR   Wikidata; Q54828861
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0245
AC   CVCL_8V48
DR   ECACC; 91041103
DR   Wikidata; Q54828862
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0246
AC   CVCL_8V49
DR   ECACC; 91041104
DR   Wikidata; Q54828863
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0247
AC   CVCL_8V50
DR   ECACC; 91041105
DR   Wikidata; Q54828864
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0248
AC   CVCL_8V51
DR   ECACC; 91041504
DR   Wikidata; Q54828866
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;7)(q27;q32); de novo (ECACC=91041504).
CC   Discontinued: ECACC; 91041504; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0249
AC   CVCL_8V52
DR   ECACC; 91041505
DR   Wikidata; Q54828867
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0251
AC   CVCL_8V53
DR   ECACC; 91042301
DR   Wikidata; Q54828868
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95834; Congenital heart disease
DI   ORDO; Orphanet_156532; Rare syndrome with cardiac malformations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0252
AC   CVCL_8V54
DR   ECACC; 91042302
DR   Wikidata; Q54828869
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91042302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0253
AC   CVCL_8V55
DR   ECACC; 91042303
DR   Wikidata; Q54828870
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91042303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0254
AC   CVCL_8V56
DR   ECACC; 91042304
DR   Wikidata; Q54828871
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,10q- (ECACC=91042304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0255
AC   CVCL_8V57
DR   ECACC; 91042305
DR   Wikidata; Q54828872
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=91042305).
CC   Discontinued: ECACC; 91042305; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0256
AC   CVCL_8V58
DR   ECACC; 91042307
DR   Wikidata; Q54828873
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=91042307).
CC   Discontinued: ECACC; 91042307; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0257
AC   CVCL_8V59
DR   ECACC; 91042603
DR   Wikidata; Q54828874
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91042603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0260
AC   CVCL_8V60
DR   ECACC; 91043007
DR   Wikidata; Q54828875
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;4)(p22;q27); de novo,var(13p+)mat (ECACC=91043007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91043007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0261
AC   CVCL_8V61
DR   ECACC; 91050202
DR   Wikidata; Q54828876
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0262
AC   CVCL_8V62
DR   ECACC; 91050201
DR   Wikidata; Q54828877
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0263
AC   CVCL_8V63
DR   ECACC; 91050203
DR   Wikidata; Q54828878
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0264
AC   CVCL_8V64
DR   ECACC; 91050204
DR   Wikidata; Q54828879
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=91050204).
CC   Discontinued: ECACC; 91050204; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD0265
AC   CVCL_8V65
DR   ECACC; 91050205
DR   Wikidata; Q54828880
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91050205; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V69 ! DD0270
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD0266
AC   CVCL_8V66
DR   ECACC; 91050206
DR   Wikidata; Q54828881
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0268
AC   CVCL_8V67
DR   ECACC; 91050804
DR   Wikidata; Q54828882
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0269
AC   CVCL_8V68
DR   ECACC; 91050805
DR   Wikidata; Q54828883
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0270
AC   CVCL_8V69
DR   ECACC; 91050810
DR   Wikidata; Q54828884
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91050810; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V65 ! DD0265
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0272
AC   CVCL_8V70
DR   ECACC; 91050812
DR   Wikidata; Q54828885
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=91050812).
CC   Discontinued: ECACC; 91050812; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0273
AC   CVCL_8V71
DR   ECACC; 91050909
DR   Wikidata; Q54828886
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0274
AC   CVCL_8V72
DR   ECACC; 91050910
DR   Wikidata; Q54828887
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0275
AC   CVCL_8V73
DR   ECACC; 91051501
DR   Wikidata; Q54828888
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=91051501).
CC   Discontinued: ECACC; 91051501; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0277
AC   CVCL_8V74
DR   ECACC; 91051503
DR   Wikidata; Q54828894
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91051503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0278
AC   CVCL_8V75
DR   ECACC; 91051504
DR   Wikidata; Q54828895
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91051504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0279
AC   CVCL_8V76
DR   ECACC; 91051607
DR   Wikidata; Q54828896
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91051607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0280
AC   CVCL_8V77
DR   ECACC; 91051707
DR   Wikidata; Q54828897
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91051707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0281
AC   CVCL_8V78
DR   ECACC; 91052101
DR   Wikidata; Q54828898
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0282
AC   CVCL_8V79
DR   ECACC; 91052605
DR   Wikidata; Q54828899
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;11)(q42.1;q21) (ECACC=91052605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0283
AC   CVCL_8V80
DR   ECACC; 91053004
DR   Wikidata; Q54828900
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91053004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0284
AC   CVCL_8V81
DR   ECACC; 91053005
DR   Wikidata; Q54828901
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91053005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0285
AC   CVCL_8V82
DR   ECACC; 91053006
DR   Wikidata; Q54828902
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-18,+der(18),t(8;18)(q23.1;q23)pat (ECACC=91053006).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91053006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0286
AC   CVCL_8V83
DR   ECACC; 91053108
DR   Wikidata; Q54828903
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91053108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0287
AC   CVCL_8V84
DR   ECACC; 91053109
DR   Wikidata; Q54828904
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91053109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0288
AC   CVCL_8V85
DR   ECACC; 91060304
DR   Wikidata; Q54828905
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91060304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0289
AC   CVCL_8V86
DR   ECACC; 91052308
DR   Wikidata; Q54828906
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0290
AC   CVCL_8V87
DR   ECACC; 91052309
DR   Wikidata; Q54828908
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052309; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0291
AC   CVCL_8V88
DR   ECACC; 91060601
DR   Wikidata; Q54828909
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91060601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0292
AC   CVCL_8V89
DR   ECACC; 91060602
DR   Wikidata; Q54828910
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91060602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   DD0293
AC   CVCL_8V90
DR   ECACC; 91060603
DR   Wikidata; Q54828911
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91060603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0294
AC   CVCL_8V91
DR   ECACC; 91060604
DR   Wikidata; Q54828912
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91060604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0295
AC   CVCL_8V92
DR   ECACC; 91060610
DR   Wikidata; Q54828913
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91060610; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V93 ! DD0296
SX   Male
AG   28Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0296
AC   CVCL_8V93
DR   ECACC; 91060611
DR   Wikidata; Q54828914
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91060611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V92 ! DD0295
SX   Male
AG   28Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0299
AC   CVCL_8V94
DR   ECACC; 91061015
DR   Wikidata; Q54828915
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91061015; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0300
AC   CVCL_8V95
DR   ECACC; 91061016
DR   Wikidata; Q54828916
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91061016; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0304
AC   CVCL_8V96
DR   ECACC; 91061216
DR   Wikidata; Q54828917
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X(m) (ECACC=91061216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0308
AC   CVCL_8V97
DR   ECACC; 91061456
DR   Wikidata; Q54828918
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91061456; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0315
AC   CVCL_8V98
DR   ECACC; 91062104
DR   Wikidata; Q54828919
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=91062104).
CC   Discontinued: ECACC; 91062104; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0316
AC   CVCL_8V99
DR   ECACC; 91062115
DR   Wikidata; Q54828920
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91062115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0317
AC   CVCL_8Z15
DR   ECACC; 91062116
DR   Wikidata; Q54828921
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91062116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0318
AC   CVCL_8Z16
DR   ECACC; 91062448
DR   Wikidata; Q54828922
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-5,+der(5),t(1;5)(q21;p15); de novo (ECACC=91062448).
CC   Discontinued: ECACC; 91062448; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8Z18 ! DD0322
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0320
AC   CVCL_8Z17
DR   ECACC; 91062802
DR   Wikidata; Q54828923
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=91062802).
CC   Discontinued: ECACC; 91062802; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0322
AC   CVCL_8Z18
DR   ECACC; 91062804
DR   Wikidata; Q54828924
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-5,+der(5),t(1;5)(q21;p15); de novo (ECACC=91062804).
CC   Discontinued: ECACC; 91062804; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8Z16 ! DD0318
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0324
AC   CVCL_8Z19
DR   ECACC; 91062811
DR   Wikidata; Q54828925
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91062811; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0325
AC   CVCL_8Z20
DR   ECACC; 91062812
DR   Wikidata; Q54828926
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91062812; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0327
AC   CVCL_8Z21
DR   ECACC; 91070502
DR   Wikidata; Q54828927
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0328
AC   CVCL_8Z22
DR   ECACC; 91070503
DR   Wikidata; Q54828928
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X (ECACC=91070503).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0329
AC   CVCL_8Z23
DR   ECACC; 91070506
DR   Wikidata; Q54828929
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(11;22)(q23;q11)pat (ECACC=91070506).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0330
AC   CVCL_8Z24
DR   ECACC; 91070507
DR   Wikidata; Q54828930
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0331
AC   CVCL_8Z25
DR   ECACC; 91070508
DR   Wikidata; Q54828931
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070508; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0332
AC   CVCL_8Z26
DR   ECACC; 91070805
DR   Wikidata; Q54828932
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0333
AC   CVCL_8Z27
DR   ECACC; 91070806
DR   Wikidata; Q54828933
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0335
AC   CVCL_8Z28
DR   ECACC; 91070801
DR   Wikidata; Q54828934
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91070801; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0336
AC   CVCL_8Z29
DR   ECACC; 91070925
DR   Wikidata; Q54828944
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070925; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0337
AC   CVCL_8Z30
DR   ECACC; 91070926
DR   Wikidata; Q54828945
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070926; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0338
AC   CVCL_8Z31
DR   ECACC; 91070927
DR   Wikidata; Q54828946
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070927; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0342
AC   CVCL_8Z32
DR   ECACC; 91071203
DR   Wikidata; Q54828947
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0344
AC   CVCL_8Z33
DR   ECACC; 91071205
DR   Wikidata; Q54828949
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0348
AC   CVCL_8Z34
DR   ECACC; 91071217
DR   Wikidata; Q54828950
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;7)(p23.1;p22.1); de novo (ECACC=91071217).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071217; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0350
AC   CVCL_8Z35
DR   ECACC; 91071219
DR   Wikidata; Q54828951
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91071219; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0351
AC   CVCL_8Z36
DR   ECACC; 91071606
DR   Wikidata; Q54828952
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071606; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0352
AC   CVCL_8Z37
DR   ECACC; 91071607
DR   Wikidata; Q54828953
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0353
AC   CVCL_8Z38
DR   ECACC; 91071702
DR   Wikidata; Q54828954
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0357
AC   CVCL_8Z39
DR   ECACC; 91071910
DR   Wikidata; Q54828955
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar(14) (ECACC=91071910).
CC   Discontinued: ECACC; 91071910; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0358
AC   CVCL_8Z40
DR   ECACC; 91071911
DR   Wikidata; Q54828956
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071911; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0359
AC   CVCL_8Z41
DR   ECACC; 91071912
DR   Wikidata; Q54828957
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071912; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0360
AC   CVCL_8Z42
DR   ECACC; 91071916
DR   Wikidata; Q54828958
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071916; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0361
AC   CVCL_8Z43
DR   ECACC; 91071917
DR   Wikidata; Q54828959
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071917; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0362
AC   CVCL_8Z44
DR   ECACC; 91071918
DR   Wikidata; Q54828960
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071918; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0363
AC   CVCL_8Z45
DR   ECACC; 91071919
DR   Wikidata; Q54828961
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91071919; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0365
AC   CVCL_8Z46
DR   ECACC; 91072306
DR   Wikidata; Q54828962
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0366
AC   CVCL_8Z47
DR   ECACC; 91072307
DR   Wikidata; Q54828963
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0367
AC   CVCL_8Z48
DR   ECACC; 91072308
DR   Wikidata; Q54828964
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0370
AC   CVCL_8Z49
DR   ECACC; 91072509
DR   Wikidata; Q54828965
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0371
AC   CVCL_8Z50
DR   ECACC; 91072632
DR   Wikidata; Q54828966
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072632; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0372
AC   CVCL_8Z51
DR   ECACC; 91072633
DR   Wikidata; Q54828967
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072633; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0374
AC   CVCL_8Z52
DR   ECACC; 91072918
DR   Wikidata; Q54828968
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072918; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0375
AC   CVCL_8Z53
DR   ECACC; 91072919
DR   Wikidata; Q54828969
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [22]; 47,XX,+mar(19) [28] (ECACC=91072919).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072919; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0376
AC   CVCL_8Z54
DR   ECACC; 91072920
DR   Wikidata; Q54828970
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91072920; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0377
AC   CVCL_8Z55
DR   ECACC; 910730031
DR   Wikidata; Q54828971
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 910730031; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0378
AC   CVCL_8Z56
DR   ECACC; 91073003
DR   Wikidata; Q54828972
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,ins(7;18)(q32;q21.1q21.3) (ECACC=91073003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91073003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0379
AC   CVCL_8Z57
DR   ECACC; 91080101
DR   Wikidata; Q54828973
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0380
AC   CVCL_8Z58
DR   ECACC; 91080102
DR   Wikidata; Q54828974
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,fra(X)(q28) 42% FX (ECACC=91080102).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0381
AC   CVCL_8Z59
DR   ECACC; 91080103
DR   Wikidata; Q54828975
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0382
AC   CVCL_8Z60
DR   ECACC; 91080104
DR   Wikidata; Q54828976
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0383
AC   CVCL_8Z61
DR   ECACC; 91080105
DR   Wikidata; Q54828977
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0384
AC   CVCL_8Z62
DR   ECACC; 91080106
DR   Wikidata; Q54828978
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0385
AC   CVCL_8Z63
DR   ECACC; 91080107
DR   Wikidata; Q54828979
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0386
AC   CVCL_8Z64
DR   ECACC; 91080108
DR   Wikidata; Q54828980
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0387
AC   CVCL_8Z65
DR   ECACC; 91080109
DR   Wikidata; Q54828981
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0388
AC   CVCL_8Z66
DR   ECACC; 91080110
DR   Wikidata; Q54828983
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY/46,XY,del(18)(pter->q21.1) (ECACC=91080110).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0389
AC   CVCL_8Z67
DR   ECACC; 91080111
DR   Wikidata; Q54828984
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0390
AC   CVCL_8Z68
DR   ECACC; 91080501
DR   Wikidata; Q54828986
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0391
AC   CVCL_8Z69
DR   ECACC; 91080502
DR   Wikidata; Q54828991
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(6)(p21.3;?q22),t(6;17)(?q22;q23); de novo (ECACC=91080502).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   DD0392
AC   CVCL_8Z70
DR   ECACC; 91080503
DR   Wikidata; Q54828993
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0393
AC   CVCL_8Z71
DR   ECACC; 91080504
DR   Wikidata; Q54828994
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0394
AC   CVCL_8Z72
DR   ECACC; 91080505
DR   Wikidata; Q54828995
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080505; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0395
AC   CVCL_8Z73
DR   ECACC; 91080701
DR   Wikidata; Q54828996
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0398
AC   CVCL_8Z74
DR   ECACC; 91080704
DR   Wikidata; Q54828997
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(8;15)(q22;q15); de novo (ECACC=91080704).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0399
AC   CVCL_8Z75
DR   ECACC; 91080705
DR   Wikidata; Q54828998
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91080705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD03s-p
AC   CVCL_F1GH
WW   Provider; ARI-TOX MWCB; DD03s-p; https://aritox.com/mwcb/mwcb-dd03s-p/
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=29137; ! Dugong dugon (Dugong)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DD0400
AC   CVCL_8Z76
DR   ECACC; 91080805
DR   Wikidata; Q54828999
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(18)(q21.3) (ECACC=91080805).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0401
AC   CVCL_8Z77
DR   ECACC; 91081314
DR   Wikidata; Q54829000
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;7)(q27;q32); de novo (ECACC=91081314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0404
AC   CVCL_8Z78
DR   ECACC; 91081410
DR   Wikidata; Q54829001
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=91081410).
CC   Discontinued: ECACC; 91081410; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0406
AC   CVCL_8Z79
DR   ECACC; 91081609
DR   Wikidata; Q54829002
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91081609; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0407
AC   CVCL_8Z80
DR   ECACC; 91081610
DR   Wikidata; Q54829003
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;13)(q33;q?32) (ECACC=91081610).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75018; Treacher Collins syndrome
DI   ORDO; Orphanet_861; Treacher-Collins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0408
AC   CVCL_8Z81
DR   ECACC; 91081611
DR   Wikidata; Q54829005
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91081611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0409
AC   CVCL_8Z82
DR   ECACC; 91081612
DR   Wikidata; Q54829006
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91081612; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0410
AC   CVCL_8Z83
DR   ECACC; 91082012
DR   Wikidata; Q54829007
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082012; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0411
AC   CVCL_8Z84
DR   ECACC; 91082013
DR   Wikidata; Q54829008
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082013; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0415
AC   CVCL_8Z85
DR   ECACC; 91082203
DR   Wikidata; Q54829009
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0416
AC   CVCL_8Z86
DR   ECACC; 91082204
DR   Wikidata; Q54829011
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0417
AC   CVCL_8Z87
DR   ECACC; 91082315
DR   Wikidata; Q54829012
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082315; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0418
AC   CVCL_8Z88
DR   ECACC; 91082816
DR   Wikidata; Q54829013
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082816; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0422
AC   CVCL_8Z89
DR   ECACC; 91082803
DR   Wikidata; Q54829014
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0423
AC   CVCL_8Z90
DR   ECACC; 91082804
DR   Wikidata; Q54829015
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0424
AC   CVCL_8Z91
DR   ECACC; 91083005
DR   Wikidata; Q54829017
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91083005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0425
AC   CVCL_8Z92
DR   ECACC; 91083006
DR   Wikidata; Q54829018
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,var(4) cen; de novo (ECACC=91083006).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0426
AC   CVCL_8Z93
DR   ECACC; 91083007
DR   Wikidata; Q54829019
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91083007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0429
AC   CVCL_8Z94
DR   ECACC; 91090401
DR   Wikidata; Q54829020
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(7)(q22.1;q34) (ECACC=91090401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0430
AC   CVCL_9A00
DR   ECACC; 91090611
DR   Wikidata; Q54829021
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0431
AC   CVCL_9A01
DR   ECACC; 91090612
DR   Wikidata; Q54829023
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090612; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0432
AC   CVCL_9A02
DR   ECACC; 91090613
DR   Wikidata; Q54829024
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0433
AC   CVCL_9A03
DR   ECACC; 91090614
DR   Wikidata; Q54829025
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090614; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0434
AC   CVCL_9A04
DR   ECACC; 91090615
DR   Wikidata; Q54829026
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090615; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0435
AC   CVCL_9A05
DR   ECACC; 91090616
DR   Wikidata; Q54829027
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(3p) (ECACC=91090616).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090616; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0436
AC   CVCL_9A06
DR   ECACC; 91090617
DR   Wikidata; Q54829029
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91090617; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0440
AC   CVCL_9A07
DR   ECACC; 91090919
DR   Wikidata; Q54829030
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX-6,der(6)t(4;6)(q27;p25)mat (ECACC=91090919).
CC   Discontinued: ECACC; 91090919; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0442
AC   CVCL_9A08
DR   ECACC; 91091202
DR   Wikidata; Q54829031
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,fra(X)(q28) 15% fra(X) +ve (ECACC=91091202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0443
AC   CVCL_9A09
DR   ECACC; 91091302
DR   Wikidata; Q54829032
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0444
AC   CVCL_9A10
DR   ECACC; 91091303
DR   Wikidata; Q54829033
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0445
AC   CVCL_9A11
DR   ECACC; 91091304
DR   Wikidata; Q54829035
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0446
AC   CVCL_9A12
DR   ECACC; 91091305
DR   Wikidata; Q54829036
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0447
AC   CVCL_9A13
DR   ECACC; 91091306
DR   Wikidata; Q54829037
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,?inv ins(7)(q33;q22.1q21.3) (ECACC=91091306).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0448
AC   CVCL_9A14
DR   ECACC; 91091307
DR   Wikidata; Q54829047
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0450
AC   CVCL_9A15
DR   ECACC; 91091328
DR   Wikidata; Q54829048
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91091328; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0454
AC   CVCL_9A16
DR   ECACC; 91092303
DR   Wikidata; Q54829049
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX+18 (ECACC=91092303).
CC   Discontinued: ECACC; 91092303; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0455
AC   CVCL_9A17
DR   ECACC; 91092304
DR   Wikidata; Q54829050
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,+mar(Y) (ECACC=91092304).
CC   Discontinued: ECACC; 91092304; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0456
AC   CVCL_9A18
DR   ECACC; 91092305
DR   Wikidata; Q54829051
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0458
AC   CVCL_9A19
DR   ECACC; 91092532
DR   Wikidata; Q54829053
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092532; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0459
AC   CVCL_9A20
DR   ECACC; 91092533
DR   Wikidata; Q54829054
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092533; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0462
AC   CVCL_9A21
DR   ECACC; 91092603
DR   Wikidata; Q54829055
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0463
AC   CVCL_9A22
DR   ECACC; 91092604
DR   Wikidata; Q54829056
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91092604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0466
AC   CVCL_9A23
DR   ECACC; 91093004
DR   Wikidata; Q54829057
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91093004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0467
AC   CVCL_9A24
DR   ECACC; 91100407
DR   Wikidata; Q54829058
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91100407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0468
AC   CVCL_9A25
DR   ECACC; 91100408
DR   Wikidata; Q54829059
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91100408; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0478
AC   CVCL_9A26
DR   ECACC; 91101401
DR   Wikidata; Q54829060
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91101401; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0479
AC   CVCL_9A27
DR   ECACC; 91101624
DR   Wikidata; Q54829061
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91101624; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0480
AC   CVCL_9A28
DR   ECACC; 91101625
DR   Wikidata; Q54829062
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=91101625).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0481
AC   CVCL_9A29
DR   ECACC; 91101637
DR   Wikidata; Q54829063
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91101637; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0482
AC   CVCL_9A30
DR   ECACC; 91101622
DR   Wikidata; Q54829064
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91101622; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0483
AC   CVCL_9A31
DR   ECACC; 91101623
DR   Wikidata; Q54829065
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91101623; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0484
AC   CVCL_9A32
DR   ECACC; 91102209
DR   Wikidata; Q54829066
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91102209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0485
AC   CVCL_9A33
DR   ECACC; 91102210
DR   Wikidata; Q54829067
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(11;16)(q13;p13.3) (ECACC=91102210).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91102210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0486
AC   CVCL_9A34
DR   ECACC; 91102208
DR   Wikidata; Q54829068
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(11;16)(q13;p13.3)pat (ECACC=91102208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0488
AC   CVCL_9A35
DR   ECACC; 91102302
DR   Wikidata; Q54829069
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91102302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0489
AC   CVCL_9A36
DR   ECACC; 91102303
DR   Wikidata; Q54829070
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91102303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0492
AC   CVCL_9A37
DR   ECACC; 91102306
DR   Wikidata; Q54829071
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0494
AC   CVCL_9A38
DR   ECACC; 91102412
DR   Wikidata; Q54829072
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0495
AC   CVCL_9A39
DR   ECACC; 91103001
DR   Wikidata; Q54829073
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91103001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0496
AC   CVCL_9A40
DR   ECACC; 91103002
DR   Wikidata; Q54829074
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91103002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0497
AC   CVCL_9A41
DR   ECACC; 91103003
DR   Wikidata; Q54829075
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91103003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0498
AC   CVCL_9A42
DR   ECACC; 91103004
DR   Wikidata; Q54829076
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0501
AC   CVCL_9A43
DR   ECACC; 91110116
DR   Wikidata; Q54829077
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91110116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0502
AC   CVCL_9A44
DR   ECACC; 91110117
DR   Wikidata; Q54829078
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91110117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0503
AC   CVCL_9A45
DR   ECACC; 91110118
DR   Wikidata; Q54829079
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91110118; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0505
AC   CVCL_9A46
DR   ECACC; 91110601
DR   Wikidata; Q54829080
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;17)(p13;p13.1) (ECACC=91110601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91110601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0507
AC   CVCL_9A47
DR   ECACC; 91110802
DR   Wikidata; Q54829081
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91110802; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0508
AC   CVCL_9A48
DR   ECACC; 91110803
DR   Wikidata; Q54829082
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91110803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0509
AC   CVCL_9A49
DR   ECACC; 91110804
DR   Wikidata; Q54829083
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91110804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0510
AC   CVCL_9A50
DR   ECACC; 91110807
DR   Wikidata; Q54829084
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91110807; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0512
AC   CVCL_9A51
DR   ECACC; 91111201
DR   Wikidata; Q54829085
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91111201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0515
AC   CVCL_9A52
DR   ECACC; 91111801
DR   Wikidata; Q54829086
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+15 (ECACC=91111801).
CC   Discontinued: ECACC; 91111801; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0516
AC   CVCL_9A53
DR   ECACC; 91111802
DR   Wikidata; Q54829087
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91111802; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0520
AC   CVCL_9A54
DR   ECACC; 91112203
DR   Wikidata; Q54829092
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91112203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0521
AC   CVCL_9A55
DR   ECACC; 91112215
DR   Wikidata; Q54829093
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0522
AC   CVCL_9A56
DR   ECACC; 91112608
DR   Wikidata; Q54829094
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+13 (ECACC=91112608).
CC   Discontinued: ECACC; 91112608; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0523
AC   CVCL_9A57
DR   ECACC; 91112706
DR   Wikidata; Q54829095
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91112706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0524
AC   CVCL_9A58
DR   ECACC; 91112918
DR   Wikidata; Q54829096
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91112918; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0525
AC   CVCL_9A59
DR   ECACC; 91112919
DR   Wikidata; Q54829097
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91112919; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0528
AC   CVCL_9A60
DR   ECACC; 91120203
DR   Wikidata; Q54829098
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91120203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0530
AC   CVCL_9A61
DR   ECACC; 91120512
DR   Wikidata; Q54829099
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91120512; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0531
AC   CVCL_9A62
DR   ECACC; 91120513
DR   Wikidata; Q54829101
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91120513; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0532
AC   CVCL_9A63
DR   ECACC; 91120601
DR   Wikidata; Q54829102
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91120601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0535
AC   CVCL_9A64
DR   ECACC; 91120604
DR   Wikidata; Q54829103
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91120604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0541
AC   CVCL_9A65
DR   ECACC; 91121702
DR   Wikidata; Q54829104
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91121702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0542
AC   CVCL_9A66
DR   ECACC; 91121703
DR   Wikidata; Q54829105
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91121703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0543
AC   CVCL_9A67
DR   ECACC; 91121805
DR   Wikidata; Q54829106
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91121805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0544
AC   CVCL_9A68
DR   ECACC; 91121806
DR   Wikidata; Q54829107
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91121806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0546
AC   CVCL_9A69
DR   ECACC; 91121825
DR   Wikidata; Q54829108
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(2)(p11;q13)(?0) (ECACC=91121825).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91121825; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0547
AC   CVCL_9A70
DR   ECACC; 91121906
DR   Wikidata; Q54829109
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(2)?(p11,q13)pat (ECACC=91121906).
CC   Discontinued: ECACC; 91121906; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0548
AC   CVCL_9A71
DR   ECACC; 91121907
DR   Wikidata; Q54829110
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91121907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0549
AC   CVCL_9A72
DR   ECACC; 91121908
DR   Wikidata; Q54829111
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0550
AC   CVCL_9A73
DR   ECACC; 91121909
DR   Wikidata; Q54829112
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91121909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0551
AC   CVCL_9A74
DR   ECACC; 91122009
DR   Wikidata; Q54829113
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(4;8)(?q34.2;q24.13)pat (ECACC=91122009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91122009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0553
AC   CVCL_9A75
DR   ECACC; 91122011
DR   Wikidata; Q54829114
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91122011; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0554
AC   CVCL_AQ58
DR   ECACC; 91122012
DR   Wikidata; Q54829115
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD0555
AC   CVCL_9A76
DR   ECACC; 91122401
DR   Wikidata; Q54829116
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(22)(q11.21->q11.22) (ECACC=91122401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91122401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0556
AC   CVCL_9A77
DR   ECACC; 91122402
DR   Wikidata; Q54829117
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91122402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0557
AC   CVCL_9A78
DR   ECACC; 91122403
DR   Wikidata; Q54829118
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(4;5)(q21.1;q35.1)(?0) (ECACC=91122403).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91122403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0558
AC   CVCL_9A79
DR   ECACC; 91122404
DR   Wikidata; Q54829119
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91122404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0559
AC   CVCL_9A80
DR   ECACC; 91122405
DR   Wikidata; Q54829120
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9A81 ! DD0560
OI   CVCL_9A82 ! DD0561
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0560
AC   CVCL_9A81
DR   ECACC; 91122407
DR   Wikidata; Q54829121
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9A80 ! DD0559
OI   CVCL_9A82 ! DD0561
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0561
AC   CVCL_9A82
DR   ECACC; 91122406
DR   Wikidata; Q54829122
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 91122406; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9A80 ! DD0559
OI   CVCL_9A81 ! DD0560
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0567
AC   CVCL_9A83
DR   ECACC; 92010911
DR   Wikidata; Q54829123
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXX,t(8;10)(q22.1;24.1); de novo (ECACC=92010911).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92010911; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0569
AC   CVCL_9A84
DR   ECACC; 92010913
DR   Wikidata; Q54829124
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92010913; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0571
AC   CVCL_9A85
DR   ECACC; 92010922
DR   Wikidata; Q54829125
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92010922; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0572
AC   CVCL_9A86
DR   ECACC; 92010923
DR   Wikidata; Q54829126
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92010923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0576
AC   CVCL_9A87
DR   ECACC; 92011010
DR   Wikidata; Q54829127
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+21 (ECACC=92011010).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011010; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9B48 ! DD0700
SX   Male
AG   5Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0585
AC   CVCL_9A88
DR   ECACC; 92011609
DR   Wikidata; Q54829128
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011609; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0587
AC   CVCL_9A89
DR   ECACC; 92011711
DR   Wikidata; Q54829129
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0588
AC   CVCL_9A90
DR   ECACC; 92011712
DR   Wikidata; Q54829130
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011712; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0589
AC   CVCL_9A91
DR   ECACC; 92011713
DR   Wikidata; Q54829131
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011713; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0590
AC   CVCL_9A92
DR   ECACC; 92011714
DR   Wikidata; Q54829132
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011714; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0591
AC   CVCL_9A93
DR   ECACC; 92011715
DR   Wikidata; Q54829139
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011715; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0592
AC   CVCL_9A94
DR   ECACC; 92011716
DR   Wikidata; Q54829140
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92011716; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0595
AC   CVCL_9A95
DR   ECACC; 92012301
DR   Wikidata; Q54829141
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92012301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0596
AC   CVCL_9A96
DR   ECACC; 92012302
DR   Wikidata; Q54829142
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92012302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0602
AC   CVCL_9A97
DR   ECACC; 92012819
DR   Wikidata; Q54829143
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(3)(q21;q25) (ECACC=92012819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92012819; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0609
AC   CVCL_9A98
DR   ECACC; 92020312
DR   Wikidata; Q54829144
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92020312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0610
AC   CVCL_9A99
DR   ECACC; 92020313
DR   Wikidata; Q54829145
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0(P) (ECACC=92020313).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0613
AC   CVCL_9B00
DR   ECACC; 92020503
DR   Wikidata; Q54829146
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92020503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0616
AC   CVCL_9B01
DR   ECACC; 92020611
DR   Wikidata; Q54829147
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92020611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0617
AC   CVCL_9B02
DR   ECACC; 92020612
DR   Wikidata; Q54829148
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX+mar(5 or 19); de novo (ECACC=92020612).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD0618
AC   CVCL_9B03
DR   ECACC; 92020613
DR   Wikidata; Q54829150
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 6,XY; 47,XY,+mar(14) (ECACC=92020613).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92020613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0623
AC   CVCL_9B04
DR   ECACC; 92021321
DR   Wikidata; Q54829151
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92021321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0624
AC   CVCL_9B05
DR   ECACC; 92021322
DR   Wikidata; Q54829152
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(Y;15)(p11;q11)pat (ECACC=92021322).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92021322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0628
AC   CVCL_9B06
DR   ECACC; 92021918
DR   Wikidata; Q54829153
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(21)(p11;q22) (ECACC=92021918).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0630
AC   CVCL_9B07
DR   ECACC; 92021920
DR   Wikidata; Q54829154
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92021920; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0631
AC   CVCL_9B08
DR   ECACC; 92021921
DR   Wikidata; Q54829155
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92021921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0632
AC   CVCL_9B09
DR   ECACC; 92021922
DR   Wikidata; Q54829156
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(1)(pter->q43)(?0) (ECACC=92021922).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0633
AC   CVCL_9B10
DR   ECACC; 92021923
DR   Wikidata; Q54829157
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92021923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0635
AC   CVCL_9B11
DR   ECACC; 92021925
DR   Wikidata; Q54829158
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=92021925).
CC   Discontinued: ECACC; 92021925; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0636
AC   CVCL_9B12
DR   ECACC; 92022112
DR   Wikidata; Q54829159
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0637
AC   CVCL_9B13
DR   ECACC; 92022113
DR   Wikidata; Q54829160
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0638
AC   CVCL_9B14
DR   ECACC; 92022114
DR   Wikidata; Q54829161
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0644
AC   CVCL_9B15
DR   ECACC; 92022530
DR   Wikidata; Q54829162
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022530; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0645
AC   CVCL_9B16
DR   ECACC; 92022802
DR   Wikidata; Q54829163
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=92022802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022802; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0646
AC   CVCL_9B17
DR   ECACC; 92022803
DR   Wikidata; Q54829164
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0647
AC   CVCL_9B18
DR   ECACC; 92022804
DR   Wikidata; Q54829165
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0648
AC   CVCL_9B19
DR   ECACC; 92022805
DR   Wikidata; Q54829167
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0649
AC   CVCL_9B20
DR   ECACC; 92022806
DR   Wikidata; Q54829168
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0650
AC   CVCL_9B21
DR   ECACC; 92022807
DR   Wikidata; Q54829169
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-4,+?der(4)(qter->p16;?) (ECACC=92022807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35528; Wolf-Hirschhorn syndrome
DI   ORDO; Orphanet_280; Wolf-Hirschhorn syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0651
AC   CVCL_9B22
DR   ECACC; 92022808
DR   Wikidata; Q54829170
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0652
AC   CVCL_9B23
DR   ECACC; 92022809
DR   Wikidata; Q54829171
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92022809; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0654
AC   CVCL_9B24
DR   ECACC; 92030202
DR   Wikidata; Q54829172
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0655
AC   CVCL_9B25
DR   ECACC; 92030301
DR   Wikidata; Q54829173
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0660
AC   CVCL_9B26
DR   ECACC; 92030513
DR   Wikidata; Q54829174
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030513; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0661
AC   CVCL_9B27
DR   ECACC; 92030622
DR   Wikidata; Q54829175
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030622; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0664
AC   CVCL_9B28
DR   ECACC; 92030625
DR   Wikidata; Q54829176
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030625; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0665
AC   CVCL_9B29
DR   ECACC; 92030642
DR   Wikidata; Q54829177
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;13)(p22;q32)(?O) (ECACC=92030642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030642; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0666
AC   CVCL_9B30
DR   ECACC; 92030643
DR   Wikidata; Q54829178
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;13)(p22;q32)pat (ECACC=92030643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030643; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0667
AC   CVCL_9B31
DR   ECACC; 92030644
DR   Wikidata; Q54829179
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030644; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0670
AC   CVCL_9B32
DR   ECACC; 92030647
DR   Wikidata; Q54829180
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 92030647; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84767; Hydrops fetalis
DI   ORDO; Orphanet_1041; Hydrops fetalis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0671
AC   CVCL_9B33
DR   ECACC; 92031101
DR   Wikidata; Q54829188
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9B88 ! DD0759
OI   CVCL_9C80 ! DD0884
SX   Female
AG   7Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0672
AC   CVCL_9B34
DR   ECACC; 92031102
DR   Wikidata; Q54829189
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0674
AC   CVCL_9B35
DR   ECACC; 92031104
DR   Wikidata; Q54829191
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(4;9)(q21;q13); de novo (ECACC=92031104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0675
AC   CVCL_9B36
DR   ECACC; 92031314
DR   Wikidata; Q54829192
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-7,+der(7),t(7;11)(q36.1;q23.3)mat (ECACC=92031314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0676
AC   CVCL_9B37
DR   ECACC; 92031713
DR   Wikidata; Q54829193
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 46,X,+mar(Y) (ECACC=92031713).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0677
AC   CVCL_9B38
DR   ECACC; 92031805
DR   Wikidata; Q54829194
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=92031805).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0679
AC   CVCL_9B39
DR   ECACC; 92031910
DR   Wikidata; Q54829195
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0682
AC   CVCL_9B40
DR   ECACC; 92031913
DR   Wikidata; Q54829196
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92031913; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0683
AC   CVCL_9B41
DR   ECACC; 92032707
DR   Wikidata; Q54829197
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92032707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0684
AC   CVCL_9B42
DR   ECACC; 92033002
DR   Wikidata; Q54829198
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92033002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0685
AC   CVCL_9B43
DR   ECACC; 92033003
DR   Wikidata; Q54829199
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;2)(2;14)(p22;q31)(p16;q22); de novo (ECACC=92033003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   DD0689
AC   CVCL_9B44
DR   ECACC; 92033007
DR   Wikidata; Q54829200
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 92033007; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C98876; Congenital hydrocephalus
DI   ORDO; Orphanet_2185; Congenital hydrocephalus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0693
AC   CVCL_9B45
DR   ECACC; 92040308
DR   Wikidata; Q54829201
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(13;18)(q22;q21.3)(?O) (ECACC=92040308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92040308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0696
AC   CVCL_9B46
DR   ECACC; 92040902
DR   Wikidata; Q54829202
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(18)(pter->q21.1); de novo (ECACC=92040902).
CC   Discontinued: ECACC; 92040902; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0698
AC   CVCL_9B47
DR   ECACC; 92040904
DR   Wikidata; Q54829203
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXY (ECACC=92040904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0700
AC   CVCL_9B48
DR   ECACC; 92041021
DR   Wikidata; Q54829204
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+21 (ECACC=92041021).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92041021; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9A87 ! DD0576
SX   Male
AG   5Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0701
AC   CVCL_9B49
DR   ECACC; 92041022
DR   Wikidata; Q54829205
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92041022; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0704
AC   CVCL_9B50
DR   ECACC; 92041020
DR   Wikidata; Q54829206
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92041020; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0705
AC   CVCL_9B51
DR   ECACC; 92041418
DR   Wikidata; Q54829207
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(20)(p11.21;p11.23); de novo (ECACC=92041418).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD0706
AC   CVCL_9B52
DR   ECACC; 92041520
DR   Wikidata; Q54829208
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98876; Congenital hydrocephalus
DI   ORDO; Orphanet_2185; Congenital hydrocephalus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0707
AC   CVCL_9B53
DR   ECACC; 92041611
DR   Wikidata; Q54829209
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92041611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0709
AC   CVCL_9B54
DR   ECACC; 92042107
DR   Wikidata; Q54829210
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0710
AC   CVCL_9B55
DR   ECACC; 92042108
DR   Wikidata; Q54829211
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXY (ECACC=92042108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0711
AC   CVCL_9B56
DR   ECACC; 92042109
DR   Wikidata; Q54829212
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98876; Congenital hydrocephalus
DI   ORDO; Orphanet_2185; Congenital hydrocephalus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0713
AC   CVCL_9B57
DR   ECACC; 92042301
DR   Wikidata; Q54829213
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+9 (ECACC=92042301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0718
AC   CVCL_9B58
DR   ECACC; 92042404
DR   Wikidata; Q54829214
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0719
AC   CVCL_VP42
DR   Wikidata; Q93508689
RX   PubMed=12960211;
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-10Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   DD0721
AC   CVCL_9B59
DR   ECACC; 92042407
DR   Wikidata; Q54829215
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0722
AC   CVCL_9B60
DR   ECACC; 92042408
DR   Wikidata; Q54829216
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+10q+ (ECACC=92042408).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0723
AC   CVCL_9B61
DR   ECACC; 92042409
DR   Wikidata; Q54829217
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(3;10)(p24.5;q25.2)(?O) (ECACC=92042409).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0724
AC   CVCL_9B62
DR   ECACC; 92042410
DR   Wikidata; Q54829218
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0725
AC   CVCL_9B63
DR   ECACC; 92042411
DR   Wikidata; Q54829219
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042411; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0727
AC   CVCL_9B64
DR   ECACC; 92042703
DR   Wikidata; Q54829220
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0728
AC   CVCL_9B65
DR   ECACC; 92042704
DR   Wikidata; Q54829221
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92042704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0729
AC   CVCL_9B66
DR   ECACC; 92043025
DR   Wikidata; Q54829222
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043025; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0730
AC   CVCL_9B67
DR   ECACC; 92043026
DR   Wikidata; Q54829223
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(13)(q21.3;q22.3)(?O) (ECACC=92043026).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043026; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0731
AC   CVCL_9B68
DR   ECACC; 92043027
DR   Wikidata; Q54829224
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043027; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0732
AC   CVCL_9B69
DR   ECACC; 92043028
DR   Wikidata; Q54829225
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043028; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0733
AC   CVCL_9B70
DR   ECACC; 92043029
DR   Wikidata; Q54829226
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(13)(q21)?(q21.1 or q21.2) (ECACC=92043029).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0734
AC   CVCL_9B71
DR   ECACC; 92043030
DR   Wikidata; Q54829227
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,10q+ (ECACC=92043030).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043030; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0738
AC   CVCL_9B72
DR   ECACC; 92043034
DR   Wikidata; Q54829228
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,inv(X)(?q11;q21.2) (ECACC=92043034).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G00 ! DD1474
SX   Male
AG   46Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0739
AC   CVCL_9B73
DR   ECACC; 92043035
DR   Wikidata; Q54829242
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043035; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0740
AC   CVCL_9B74
DR   ECACC; 92043036
DR   Wikidata; Q54829243
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043036; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0741
AC   CVCL_9B75
DR   ECACC; 92043037
DR   Wikidata; Q54829245
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;13)(p13;p12.3)(?O) (ECACC=92043037).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043037; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0742
AC   CVCL_9B76
DR   ECACC; 92043038
DR   Wikidata; Q54829246
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92043038; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0744
AC   CVCL_9B77
DR   ECACC; 92050505
DR   Wikidata; Q54829247
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+20 (ECACC=92050505).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0745
AC   CVCL_9B78
DR   ECACC; 92050718
DR   Wikidata; Q54829248
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92050718; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0746
AC   CVCL_9B79
DR   ECACC; 92050719
DR   Wikidata; Q54829249
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92050719; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0749
AC   CVCL_9B80
DR   ECACC; 92051202
DR   Wikidata; Q54829250
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(5)(qter->p14); de novo (ECACC=92051202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   DD0750
AC   CVCL_9B81
DR   ECACC; 92051203
DR   Wikidata; Q54829252
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,inv(Y)(p11;q11.23)pat (ECACC=92051203).
CC   Discontinued: ECACC; 92051203; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0752
AC   CVCL_9B82
DR   ECACC; 92051205
DR   Wikidata; Q54829253
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+psu dic(15)(pter->q15::?q11->p11:)(?O) (ECACC=92051205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0753
AC   CVCL_9B83
DR   ECACC; 92051206
DR   Wikidata; Q54829254
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,q5 (ECACC=92051206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92051206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0754
AC   CVCL_9B84
DR   ECACC; 92051207
DR   Wikidata; Q54829255
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0755
AC   CVCL_9B85
DR   ECACC; 92051413
DR   Wikidata; Q54829256
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0756
AC   CVCL_9B86
DR   ECACC; 92051414
DR   Wikidata; Q54829257
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,inv(Y)(p11;q11.23)(?O) (ECACC=92051414).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92051414; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0757
AC   CVCL_AQ59
DR   ECACC; 92051806
DR   Wikidata; Q54829258
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92051806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y8M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD0758
AC   CVCL_9B87
DR   ECACC; 92051807
DR   Wikidata; Q54829260
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(13)(q21.3;q22.3)mat (ECACC=92051807).
CC   Discontinued: ECACC; 92051807; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0759
AC   CVCL_9B88
DR   ECACC; 92051804
DR   Wikidata; Q54829261
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9B33 ! DD0671
OI   CVCL_9C80 ! DD0884
SX   Female
AG   7Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0761
AC   CVCL_9B89
DR   ECACC; 92052001
DR   Wikidata; Q54829262
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD0762
AC   CVCL_9B90
DR   ECACC; 92052002
DR   Wikidata; Q54829263
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;5)(q33;q12); de novo (ECACC=92052002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD0763
AC   CVCL_9B91
DR   ECACC; 92052003
DR   Wikidata; Q54829264
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0764
AC   CVCL_9B92
DR   ECACC; 92052205
DR   Wikidata; Q54829266
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0765
AC   CVCL_9B93
DR   ECACC; 92052206
DR   Wikidata; Q54829267
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0766
AC   CVCL_9B94
DR   ECACC; 92052207
DR   Wikidata; Q54829268
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;10)(q35.1;q26.3)mat (ECACC=92052207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0767
AC   CVCL_9B95
DR   ECACC; 92052208
DR   Wikidata; Q54829269
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0769
AC   CVCL_9B96
DR   ECACC; 92052210
DR   Wikidata; Q54829270
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0770
AC   CVCL_9B97
DR   ECACC; 92052211
DR   Wikidata; Q54829271
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0771
AC   CVCL_9B98
DR   ECACC; 92052212
DR   Wikidata; Q54829273
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0772
AC   CVCL_9B99
DR   ECACC; 92052213
DR   Wikidata; Q54829274
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0773
AC   CVCL_9C00
DR   ECACC; 92052214
DR   Wikidata; Q54829275
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052214; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0775
AC   CVCL_9C01
DR   ECACC; 92052812
DR   Wikidata; Q54829276
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052812; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0776
AC   CVCL_9C02
DR   ECACC; 92052813
DR   Wikidata; Q54829277
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0777
AC   CVCL_9C03
DR   ECACC; 92052814
DR   Wikidata; Q54829278
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0778
AC   CVCL_9C04
DR   ECACC; 92052815
DR   Wikidata; Q54829280
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92052815; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0779
AC   CVCL_9C05
DR   ECACC; 92052925
DR   Wikidata; Q54829281
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XYY (ECACC=92052925).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0781
AC   CVCL_9C06
DR   ECACC; 92060310
DR   Wikidata; Q54829282
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060310; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0782
AC   CVCL_9C07
DR   ECACC; 92060311
DR   Wikidata; Q54829283
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060311; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0783
AC   CVCL_9C08
DR   ECACC; 92060312
DR   Wikidata; Q54829284
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0784
AC   CVCL_9C09
DR   ECACC; 92060313
DR   Wikidata; Q54829285
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0785
AC   CVCL_9C10
DR   ECACC; 92060314
DR   Wikidata; Q54829287
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0787
AC   CVCL_9C11
DR   ECACC; 92060502
DR   Wikidata; Q54829288
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0788
AC   CVCL_9C12
DR   ECACC; 92060503
DR   Wikidata; Q54829315
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0789
AC   CVCL_9C13
DR   ECACC; 92060527
DR   Wikidata; Q54829316
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+dic(15)(pter->q11::q11->pter) (ECACC=92060527).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060527; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0790
AC   CVCL_9C14
DR   ECACC; 92060528
DR   Wikidata; Q54829317
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX+?i(18p) (ECACC=92060528).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0793
AC   CVCL_9C15
DR   ECACC; 92060903
DR   Wikidata; Q54829319
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(12;22)(12p22p;12q22q)mat (ECACC=92060903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0794
AC   CVCL_9C16
DR   ECACC; 92060904
DR   Wikidata; Q54829320
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(12;22)(12p22p;12q22q)mat (ECACC=92060904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92060904; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0795
AC   CVCL_9C17
DR   ECACC; 92061001
DR   Wikidata; Q54829321
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0796
AC   CVCL_9C18
DR   ECACC; 92061002
DR   Wikidata; Q54829322
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,r(18)(p11;q23) (ECACC=92061002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0797
AC   CVCL_9C19
DR   ECACC; 92061213
DR   Wikidata; Q54829323
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0799
AC   CVCL_9C20
DR   ECACC; 92061215
DR   Wikidata; Q54829324
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061215; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0800
AC   CVCL_9C21
DR   ECACC; 92061216
DR   Wikidata; Q54829326
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXY (ECACC=92061216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0801
AC   CVCL_9C22
DR   ECACC; 92061217
DR   Wikidata; Q54829327
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061217; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0802
AC   CVCL_9C23
DR   ECACC; 92061218
DR   Wikidata; Q54829328
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061218; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0803
AC   CVCL_9C24
DR   ECACC; 92061219
DR   Wikidata; Q54829329
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061219; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0804
AC   CVCL_9C25
DR   ECACC; 92061220
DR   Wikidata; Q54829330
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061220; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0806
AC   CVCL_9C26
DR   ECACC; 92061503
DR   Wikidata; Q54829331
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0807
AC   CVCL_9C27
DR   ECACC; 92061504
DR   Wikidata; Q54829333
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92061504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0808
AC   CVCL_9C28
DR   ECACC; 92061505
DR   Wikidata; Q54829334
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XYY (ECACC=92061505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0809
AC   CVCL_9C29
DR   ECACC; 92062201
DR   Wikidata; Q54829335
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0810
AC   CVCL_9C30
DR   ECACC; 92062301
DR   Wikidata; Q54829336
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0811
AC   CVCL_9C31
DR   ECACC; 92062302
DR   Wikidata; Q54829338
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0812
AC   CVCL_9C32
DR   ECACC; 92062317
DR   Wikidata; Q54829339
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062317; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0813
AC   CVCL_9C33
DR   ECACC; 92062318
DR   Wikidata; Q54829340
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,19q+ (ECACC=92062318).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0816
AC   CVCL_9C34
DR   ECACC; 92062321
DR   Wikidata; Q54829341
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;10)(q35.3;q26.13)(?O) (ECACC=92062321).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0817
AC   CVCL_9C35
DR   ECACC; 92062572
DR   Wikidata; Q54829342
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XY+mar(16); de novo (ECACC=92062572).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062572; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0818
AC   CVCL_9C36
DR   ECACC; 92062574
DR   Wikidata; Q54829344
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062574; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0819
AC   CVCL_9C37
DR   ECACC; 92062575
DR   Wikidata; Q54829345
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(9;15)(q22;q13)(?O) (ECACC=92062575).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062575; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0820
AC   CVCL_9C38
DR   ECACC; 92062576
DR   Wikidata; Q54829346
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062576; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0821
AC   CVCL_9C39
DR   ECACC; 92062577
DR   Wikidata; Q54829347
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062577; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0822
AC   CVCL_9C40
DR   ECACC; 92062578
DR   Wikidata; Q54829348
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062578; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0823
AC   CVCL_9C41
DR   ECACC; 92062579
DR   Wikidata; Q54829349
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062579; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0824
AC   CVCL_9C42
DR   ECACC; 92062580
DR   Wikidata; Q54829351
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0825
AC   CVCL_9C43
DR   ECACC; 92062581
DR   Wikidata; Q54829352
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062581; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0826
AC   CVCL_9C44
DR   ECACC; 92062582
DR   Wikidata; Q54829353
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062582; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0827
AC   CVCL_9C45
DR   ECACC; 92062583
DR   Wikidata; Q54829354
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062583; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0828
AC   CVCL_9C46
DR   ECACC; 92062584
DR   Wikidata; Q54829355
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062584; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0829
AC   CVCL_9C47
DR   ECACC; 92062585
DR   Wikidata; Q54829356
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92062585; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0830
AC   CVCL_9C48
DR   ECACC; 92062586
DR   Wikidata; Q54829357
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 49,XXXXY (ECACC=92062586).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C185635; 49,XXXXY syndrome
DI   ORDO; Orphanet_96264; 49,XXXXY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0832
AC   CVCL_9C49
DR   ECACC; 92070111
DR   Wikidata; Q54829359
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92070111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0834
AC   CVCL_9C50
DR   ECACC; 92070113
DR   Wikidata; Q54829360
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=92070113).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0835
AC   CVCL_9C51
DR   ECACC; 92070219
DR   Wikidata; Q54829361
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 46,XY,inv(9)(?p21;q12); de novo (ECACC=92070219).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 6
//
ID   DD0836
AC   CVCL_9C52
DR   ECACC; 92070220
DR   Wikidata; Q54829376
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=92070220).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0839
AC   CVCL_9C53
DR   ECACC; 92070312
DR   Wikidata; Q54829377
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(12;13)(q24.31;q32.3); de novo (ECACC=92070312).
CC   Discontinued: ECACC; 92070312; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0840
AC   CVCL_9C54
DR   ECACC; 92070313
DR   Wikidata; Q54829378
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(13)(pter->q22.1::q32.3->qter) (ECACC=92070313).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92070313; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0841
AC   CVCL_9C55
DR   ECACC; 92070314
DR   Wikidata; Q54829379
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92070314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0843
AC   CVCL_9C56
DR   ECACC; 92070604
DR   Wikidata; Q54829380
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92070604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0844
AC   CVCL_9C57
DR   ECACC; 92070605
DR   Wikidata; Q54829381
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(8;16)(q22.1;q13)pat (ECACC=92070605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0845
AC   CVCL_9C58
DR   ECACC; 92070606
DR   Wikidata; Q54829382
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(8;16)(q22.1;q13)pat (ECACC=92070606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92070606; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0847
AC   CVCL_9C59
DR   ECACC; 92070608
DR   Wikidata; Q54829383
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=92070608).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0849
AC   CVCL_9C60
DR   ECACC; 92070714
DR   Wikidata; Q54829384
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0852
AC   CVCL_9C61
DR   ECACC; 92070717
DR   Wikidata; Q54829385
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92070717; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0853
AC   CVCL_9C62
DR   ECACC; 92070718
DR   Wikidata; Q54829386
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=92070718).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD0855
AC   CVCL_9C63
DR   ECACC; 88092801
DR   Wikidata; Q54829387
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(X;Y) (ECACC=88092801).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 88092801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U99 ! DD0173
SX   Female
AG   16Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0863
AC   CVCL_9C64
DR   ECACC; 92071008
DR   Wikidata; Q54829388
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=92071008).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0864
AC   CVCL_9C65
DR   ECACC; 92071009
DR   Wikidata; Q54829389
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;10)(p25;p11); de novo (ECACC=92071009).
CC   Discontinued: ECACC; 92071009; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0865
AC   CVCL_AQ60
DR   ECACC; 92071513
DR   Wikidata; Q54829390
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071513; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD0866
AC   CVCL_9C66
DR   ECACC; 92071514
DR   Wikidata; Q54829391
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(5p) (ECACC=92071514).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD0867
AC   CVCL_9C67
DR   ECACC; 92071515
DR   Wikidata; Q54829392
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071515; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0868
AC   CVCL_9C68
DR   ECACC; 92071701
DR   Wikidata; Q54829393
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=92071701).
CC   Discontinued: ECACC; 92071701; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0871
AC   CVCL_9C69
DR   ECACC; 92071704
DR   Wikidata; Q54829394
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0873
AC   CVCL_9C70
DR   ECACC; 92071706
DR   Wikidata; Q54829395
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;13)(q13.2;q32.3)(?O) (ECACC=92071706).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0874
AC   CVCL_9C71
DR   ECACC; 92071707
DR   Wikidata; Q54829396
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0875
AC   CVCL_9C72
DR   ECACC; 92071708
DR   Wikidata; Q54829397
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071708; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0876
AC   CVCL_9C73
DR   ECACC; 92071709
DR   Wikidata; Q54829398
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY [13]; 47,XY,+mar [21] (ECACC=92071709).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071709; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0877
AC   CVCL_9C74
DR   ECACC; 92071710
DR   Wikidata; Q54829399
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071710; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0878
AC   CVCL_9C75
DR   ECACC; 92071711
DR   Wikidata; Q54829400
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0879
AC   CVCL_9C76
DR   ECACC; 92071723
DR   Wikidata; Q54829401
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,der(Y),t(Y;15)(q12;p11)(?O) (ECACC=92071723).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071723; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0880
AC   CVCL_9C77
DR   ECACC; 92071724
DR   Wikidata; Q54829402
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071724; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0881
AC   CVCL_9C78
DR   ECACC; 92071725
DR   Wikidata; Q54829403
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92071725; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0882
AC   CVCL_9C79
DR   ECACC; 920717262
DR   Wikidata; Q54829404
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+8 (ECACC=920717262).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0884
AC   CVCL_9C80
DR   ECACC; 92072001
DR   Wikidata; Q54829405
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9B33 ! DD0671
OI   CVCL_9B88 ! DD0759
SX   Female
AG   7Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0886
AC   CVCL_9C81
DR   ECACC; 92072104
DR   Wikidata; Q54829406
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,der(Y),t(Y;15)(q12;p11)pat (ECACC=92072104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0887
AC   CVCL_9C82
DR   ECACC; 92072105
DR   Wikidata; Q54829407
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-14,+t(14;21); de novo (ECACC=92072105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DD0891
AC   CVCL_9C83
DR   ECACC; 92072322
DR   Wikidata; Q54829408
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0892
AC   CVCL_9C84
DR   ECACC; 92072323
DR   Wikidata; Q54829409
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072323; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0896
AC   CVCL_9C85
DR   ECACC; 92072327
DR   Wikidata; Q54829410
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;10)(p24.2;q25.2)mat (ECACC=92072327).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072327; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0897
AC   CVCL_9C86
DR   ECACC; 92072328
DR   Wikidata; Q54829411
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072328; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0898
AC   CVCL_9C87
DR   ECACC; 92072329
DR   Wikidata; Q54829412
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;10)(p24.2;q25.2)mat (ECACC=92072329).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072329; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0901
AC   CVCL_9C88
DR   ECACC; 92072332
DR   Wikidata; Q54829413
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072332; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0902
AC   CVCL_9C89
DR   ECACC; 92072333
DR   Wikidata; Q54829414
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXY (ECACC=92072333).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072333; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0903
AC   CVCL_9C90
DR   ECACC; 92072402
DR   Wikidata; Q54829415
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0907
AC   CVCL_9C91
DR   ECACC; 92072803
DR   Wikidata; Q54829419
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0909
AC   CVCL_9C92
DR   ECACC; 92072902
DR   Wikidata; Q54829420
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=92072902).
CC   Discontinued: ECACC; 92072902; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0910
AC   CVCL_9C93
DR   ECACC; 92073001
DR   Wikidata; Q54829421
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92073001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0912
AC   CVCL_9C94
DR   ECACC; 92073109
DR   Wikidata; Q54829422
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(8;16) (ECACC=92073109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92073109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0913
AC   CVCL_9C95
DR   ECACC; 92073110
DR   Wikidata; Q54829423
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92073110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0914
AC   CVCL_9C96
DR   ECACC; 92073111
DR   Wikidata; Q54829424
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92073111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0915
AC   CVCL_9C97
DR   ECACC; 92073112
DR   Wikidata; Q54829425
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;6)(p21.33;p21.33)mat (ECACC=92073112).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92073112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0921
AC   CVCL_9C98
DR   ECACC; 92080305
DR   Wikidata; Q54829426
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0922
AC   CVCL_9C99
DR   ECACC; 92080306
DR   Wikidata; Q54829427
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [87]; 47,XX,+mar(14) [13] (ECACC=92080306).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0923
AC   CVCL_9D00
DR   ECACC; 92080307
DR   Wikidata; Q54829428
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0928
AC   CVCL_9D01
DR   ECACC; 92080601
DR   Wikidata; Q54829429
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0929
AC   CVCL_9D02
DR   ECACC; 92080602
DR   Wikidata; Q54829430
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0936
AC   CVCL_9D03
DR   ECACC; 92080708
DR   Wikidata; Q54829431
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080708; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0937
AC   CVCL_9D04
DR   ECACC; 92080709
DR   Wikidata; Q54829432
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0942
AC   CVCL_9D05
DR   ECACC; 92081102
DR   Wikidata; Q54829433
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 46,X,r(X) (ECACC=92081102).
CC   Discontinued: ECACC; 92081102; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y8M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0946
AC   CVCL_9D06
DR   ECACC; 92081429
DR   Wikidata; Q54829434
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92081429; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0949
AC   CVCL_9D07
DR   ECACC; 92081432
DR   Wikidata; Q54829435
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=92081432).
CC   Discontinued: ECACC; 92081432; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0950
AC   CVCL_9D08
DR   ECACC; 92081433
DR   Wikidata; Q54829436
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXY (ECACC=92081433).
CC   Discontinued: ECACC; 92081433; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD0951
AC   CVCL_AQ61
DR   ECACC; 92081809
DR   Wikidata; Q54829437
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD0953
AC   CVCL_9D09
DR   ECACC; 92082002
DR   Wikidata; Q54829438
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(4;16)(q27;p13.3)mat (ECACC=92082002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92082002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0955
AC   CVCL_9D10
DR   ECACC; 92082102
DR   Wikidata; Q54829439
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(2)(q34:q36.3)pat (ECACC=92082102).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD0956
AC   CVCL_9D11
DR   ECACC; 92082103
DR   Wikidata; Q54829440
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(12;17)(q24.31;q25.3) (ECACC=92082103).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92082103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0961
AC   CVCL_9D12
DR   ECACC; 92082108
DR   Wikidata; Q54829442
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;19)(p34.3;q13.3)(?O) (ECACC=92082108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92082108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0962
AC   CVCL_9D13
DR   ECACC; 92082109
DR   Wikidata; Q54829443
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;19)(p34.3;q13.3)mat (ECACC=92082109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92082109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0963
AC   CVCL_9D14
DR   ECACC; 92082110
DR   Wikidata; Q54829444
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92082110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD0967
AC   CVCL_9D15
DR   ECACC; 92082814
DR   Wikidata; Q54829445
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92082814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0968
AC   CVCL_9D16
DR   ECACC; 92082815
DR   Wikidata; Q54829446
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+13 (ECACC=92082815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DD0969
AC   CVCL_9D17
DR   ECACC; 92082816
DR   Wikidata; Q54829447
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92082816; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0970
AC   CVCL_9D18
DR   ECACC; 92082817
DR   Wikidata; Q54829448
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX+18 (ECACC=92082817).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD0977
AC   CVCL_9D19
DR   ECACC; 92090212
DR   Wikidata; Q54829449
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92090212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0980
AC   CVCL_9D20
DR   ECACC; 92090804
DR   Wikidata; Q54829450
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(18;20)(q21.1;p12.2)pat (ECACC=92090804).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92090804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0981
AC   CVCL_9D21
DR   ECACC; 92090805
DR   Wikidata; Q54829451
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92090805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0982
AC   CVCL_9D22
DR   ECACC; 92091001
DR   Wikidata; Q54829452
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0983
AC   CVCL_9D23
DR   ECACC; 92091002
DR   Wikidata; Q54829453
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(2)(pter->q37.1); de novo (ECACC=92091002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD0986
AC   CVCL_9D24
DR   ECACC; 92091005
DR   Wikidata; Q54829454
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0987
AC   CVCL_9D25
DR   ECACC; 92091006
DR   Wikidata; Q54829455
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(3;20)(q13.2;p12.2); de novo (ECACC=92091006).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD0988
AC   CVCL_9D26
DR   ECACC; 92091007
DR   Wikidata; Q54829456
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0989
AC   CVCL_9D27
DR   ECACC; 92091008
DR   Wikidata; Q54829457
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091008; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0991
AC   CVCL_9D28
DR   ECACC; 92091019
DR   Wikidata; Q54829458
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091019; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0994
AC   CVCL_9D29
DR   ECACC; 92091413
DR   Wikidata; Q54829459
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091413; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0996
AC   CVCL_9D30
DR   ECACC; 92091623
DR   Wikidata; Q54829463
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091623; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0997
AC   CVCL_9D31
DR   ECACC; 92091624
DR   Wikidata; Q54829464
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(2)(q34;q36.3)(?O) (ECACC=92091624).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091624; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD0998
AC   CVCL_9D32
DR   ECACC; 92091702
DR   Wikidata; Q54829465
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92091702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD0999
AC   CVCL_9D33
DR   ECACC; 92092301
DR   Wikidata; Q54829466
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92092301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1
AC   CVCL_A9BK
DR   Wikidata; Q108820143
RX   PubMed=15845378;
CC   Characteristics: Highly metastatic to lung (PubMed=15845378).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C134996; Mouse histiocytic and dendritic cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BL ! DG6
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   DD10
AC   CVCL_C4DM
DR   ABCD; ABCD_AG204
DR   Wikidata; Q116048829
RX   PubMed=23295252;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53218; Diphenylmethane-4,4'-diisocyanate (Methylene diphenyl diisocyanate; MDI).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DD1000
AC   CVCL_9D34
DR   ECACC; 92092302
DR   Wikidata; Q54829467
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92092302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1002
AC   CVCL_9D35
DR   ECACC; 92092902
DR   Wikidata; Q54829468
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98876; Congenital hydrocephalus
DI   ORDO; Orphanet_2185; Congenital hydrocephalus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1003
AC   CVCL_9D36
DR   ECACC; 92092903
DR   Wikidata; Q54829469
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92092903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1009
AC   CVCL_9D37
DR   ECACC; 92100208
DR   Wikidata; Q54829470
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92100208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1012
AC   CVCL_9D38
DR   ECACC; 92100905
DR   Wikidata; Q54829471
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [38]; 47,XX,+i(8p) [30]; de novo (ECACC=92100905).
CC   Discontinued: ECACC; 92100905; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1013
AC   CVCL_9D39
DR   ECACC; 92101313
DR   Wikidata; Q54829472
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1014
AC   CVCL_9D40
DR   ECACC; 92101501
DR   Wikidata; Q54829473
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(13)(q33.2;q34)(?O) (ECACC=92101501).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92101501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1015
AC   CVCL_9D41
DR   ECACC; 92101502
DR   Wikidata; Q54829474
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92101502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1016
AC   CVCL_9D42
DR   ECACC; 92101503
DR   Wikidata; Q54829475
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(13)(q33.2;q34)mat (ECACC=92101503).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1018
AC   CVCL_9D43
DR   ECACC; 92102040
DR   Wikidata; Q54829476
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+13 (ECACC=92102040).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1021
AC   CVCL_9D44
DR   ECACC; 92102043
DR   Wikidata; Q54829477
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,+18 (ECACC=92102043).
CC   Discontinued: ECACC; 92102043; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1025
AC   CVCL_9D45
DR   ECACC; 92102101
DR   Wikidata; Q54829478
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1026
AC   CVCL_9D46
DR   ECACC; 92102208
DR   Wikidata; Q54829479
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1027
AC   CVCL_9D47
DR   ECACC; 92102359
DR   Wikidata; Q54829480
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(7)(q22.1;q34)mat (ECACC=92102359).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1028
AC   CVCL_9D48
DR   ECACC; 92102360
DR   Wikidata; Q54829481
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(13)(q21.3;q22.3)(?O) (ECACC=92102360).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102360; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1029
AC   CVCL_9D49
DR   ECACC; 92102361
DR   Wikidata; Q54829482
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102361; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1030
AC   CVCL_9D50
DR   ECACC; 92102362
DR   Wikidata; Q54829483
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102362; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1032
AC   CVCL_9D51
DR   ECACC; 92102714
DR   Wikidata; Q54829484
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,17p+; de novo (ECACC=92102714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102714; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1034
AC   CVCL_9D52
DR   ECACC; 92102902
DR   Wikidata; Q54829485
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,rec(5)del(q15;q22),ins(5)(q22.3;q14.2;q15)mat (ECACC=92102902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1035
AC   CVCL_9D53
DR   ECACC; 92102918
DR   Wikidata; Q54829486
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;10)(p23;q21.2) (ECACC=92102918).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1036
AC   CVCL_9D54
DR   ECACC; 92102919
DR   Wikidata; Q54829487
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102919; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1037
AC   CVCL_9D55
DR   ECACC; 92102920
DR   Wikidata; Q54829488
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102920; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1038
AC   CVCL_9D56
DR   ECACC; 92102921
DR   Wikidata; Q54829489
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1039
AC   CVCL_9D57
DR   ECACC; 92102922
DR   Wikidata; Q54829490
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1040
AC   CVCL_9D58
DR   ECACC; 92102923
DR   Wikidata; Q54829491
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92102923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1041
AC   CVCL_9D59
DR   ECACC; 92103017
DR   Wikidata; Q54829492
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1043
AC   CVCL_9D60
DR   ECACC; 92110201
DR   Wikidata; Q54829493
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92110201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1044
AC   CVCL_9D61
DR   ECACC; 92110202
DR   Wikidata; Q54829494
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92110202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1045
AC   CVCL_AQ62
DR   ECACC; 92110203
DR   Wikidata; Q54829495
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92110203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175241; Floating-Harbor syndrome
DI   ORDO; Orphanet_2044; Floating-Harbor syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y3M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD1046
AC   CVCL_AQ63
DR   ECACC; 92110204
DR   Wikidata; Q54829496
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92110204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y3M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD1047
AC   CVCL_AQ64
DR   ECACC; 92110205
DR   Wikidata; Q54829497
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92110205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD1048
AC   CVCL_9D62
DR   ECACC; 92110410
DR   Wikidata; Q54829498
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+15 (ECACC=92110410).
CC   Discontinued: ECACC; 92110410; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C84283; Trisomy 15
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1049
AC   CVCL_9D63
DR   ECACC; 92110609
DR   Wikidata; Q54829499
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar(15); de novo (ECACC=92110609).
CC   Discontinued: ECACC; 92110609; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1051
AC   CVCL_9D64
DR   ECACC; 92111001
DR   Wikidata; Q54829500
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1052
AC   CVCL_9D65
DR   ECACC; 92111002
DR   Wikidata; Q54829501
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1054
AC   CVCL_9D66
DR   ECACC; 92111102
DR   Wikidata; Q54829502
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1055
AC   CVCL_9D67
DR   ECACC; 92111103
DR   Wikidata; Q54829507
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1056
AC   CVCL_9D68
DR   ECACC; 92111312
DR   Wikidata; Q54829508
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+13 (ECACC=92111312).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1057
AC   CVCL_9D69
DR   ECACC; 92111313
DR   Wikidata; Q54829509
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111313; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1058
AC   CVCL_9D70
DR   ECACC; 92111314
DR   Wikidata; Q54829510
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;14)(p34.3;q22)(?0) (ECACC=92111314).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (ECACC=92111314).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (ECACC=92111314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   DD1059
AC   CVCL_9D71
DR   ECACC; 92111315
DR   Wikidata; Q54829511
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92111315; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1062
AC   CVCL_9D72
DR   ECACC; 92111318
DR   Wikidata; Q54829512
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XYY (ECACC=92111318).
CC   Discontinued: ECACC; 92111318; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1069
AC   CVCL_9D73
DR   ECACC; 92112002
DR   Wikidata; Q54829513
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92112002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1071
AC   CVCL_9D74
DR   ECACC; 92112013
DR   Wikidata; Q54829514
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92112013; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1072
AC   CVCL_9D75
DR   ECACC; 92112014
DR   Wikidata; Q54829515
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(13)(q33.2;q34)(?0) (ECACC=92112014).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1073
AC   CVCL_9D76
DR   ECACC; 92112015
DR   Wikidata; Q54829516
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92112015; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1074
AC   CVCL_9D77
DR   ECACC; 92112016
DR   Wikidata; Q54829517
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92112016; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1075
AC   CVCL_9D78
DR   ECACC; 92112017
DR   Wikidata; Q54829518
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92112017; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1076
AC   CVCL_9D79
DR   ECACC; 92112018
DR   Wikidata; Q54829519
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;14)(p34;q22)mat (ECACC=92112018).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly542Ter (c.1624G>T); ClinVar=VCV000007115; Zygosity=Heterozygous (ECACC=92112018).
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-11FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   DD1078
AC   CVCL_9D80
DR   ECACC; 92112305
DR   Wikidata; Q54829520
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 48,XX,+7,+8 (ECACC=92112305).
CC   Discontinued: ECACC; 92112305; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1082
AC   CVCL_9D81
DR   ECACC; 92112735
DR   Wikidata; Q54829521
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,fra(X)(q27.3)Y (ECACC=92112735).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1083
AC   CVCL_9D82
DR   ECACC; 92112736
DR   Wikidata; Q54829522
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,Xp+ (ECACC=92112736).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1085
AC   CVCL_9D83
DR   ECACC; 92112742
DR   Wikidata; Q54829523
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-7,+der(7),inv ins(7:12)?(p21.2;q15q22)pat (ECACC=92112742).
CC   Discontinued: ECACC; 92112742; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9D94 ! DD1103
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1089
AC   CVCL_9D84
DR   ECACC; 92120401
DR   Wikidata; Q54829524
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(1)(pter->q43) (ECACC=92120401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1090
AC   CVCL_9D85
DR   ECACC; 92120905
DR   Wikidata; Q54829525
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92120905; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1091
AC   CVCL_9D86
DR   ECACC; 92120406
DR   Wikidata; Q54829526
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92120406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1092
AC   CVCL_9D87
DR   ECACC; 92120407
DR   Wikidata; Q54829527
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(qter->p22) (ECACC=92120407).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U41 ! DD0031
SX   Female
AG   20Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1095
AC   CVCL_9D88
DR   ECACC; 92120703
DR   Wikidata; Q54829528
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+13 [6/30] (ECACC=92120703).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1097
AC   CVCL_9D89
DR   ECACC; 92120802
DR   Wikidata; Q54829529
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,17p+ (ECACC=92120802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1098
AC   CVCL_9D90
DR   ECACC; 92120803
DR   Wikidata; Q54829530
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92120803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1099
AC   CVCL_9D91
DR   ECACC; 92120804
DR   Wikidata; Q54829531
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92120804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1100
AC   CVCL_9D92
DR   ECACC; 92120805
DR   Wikidata; Q54829532
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92120805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1102
AC   CVCL_9D93
DR   ECACC; 92121013
DR   Wikidata; Q54829533
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+13 (ECACC=92121013).
CC   Discontinued: ECACC; 92121013; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1103
AC   CVCL_9D94
DR   ECACC; 92121014
DR   Wikidata; Q54829534
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-7,+der(7),inv ins(7:12)?(p21.2;q15q22)pat (ECACC=92121014).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9D83 ! DD1085
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1104
AC   CVCL_9D95
DR   ECACC; 92121113
DR   Wikidata; Q54829535
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92121113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1105
AC   CVCL_9D96
DR   ECACC; 92121502
DR   Wikidata; Q54829536
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92121502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1106
AC   CVCL_9D97
DR   ECACC; 92121505
DR   Wikidata; Q54829537
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+pseudic(15)(pter->q13::q13->pter); de novo (ECACC=92121505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD1108
AC   CVCL_9D98
DR   ECACC; 92121601
DR   Wikidata; Q54829538
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=92121601).
CC   Discontinued: ECACC; 92121601; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1109
AC   CVCL_9D99
DR   ECACC; 92121602
DR   Wikidata; Q54829539
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92121602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1110
AC   CVCL_9E00
DR   ECACC; 92121603
DR   Wikidata; Q54829540
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92121603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1112
AC   CVCL_9E01
DR   ECACC; 92121705
DR   Wikidata; Q54829541
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92121705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1113
AC   CVCL_9E02
DR   ECACC; 92121706
DR   Wikidata; Q54829542
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92121706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1115
AC   CVCL_9E03
DR   ECACC; 92121708
DR   Wikidata; Q54829543
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1116
AC   CVCL_9E04
DR   ECACC; 92121709
DR   Wikidata; Q54829544
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1117
AC   CVCL_9E05
DR   ECACC; 92121715
DR   Wikidata; Q54829545
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-9,+der(9),t(7:9)(q34.1;p24.1)pat (ECACC=92121715).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C101214; Spina bifida
DI   ORDO; Orphanet_268357; Neural tube closure defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1118
AC   CVCL_9E06
DR   ECACC; 92121716
DR   Wikidata; Q54829546
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXX (ECACC=92121716).
CC   Discontinued: ECACC; 92121716; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1123
AC   CVCL_9E07
DR   ECACC; 93010402
DR   Wikidata; Q54829552
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(18)(p11.2) (ECACC=93010402).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1128
AC   CVCL_9E08
DR   ECACC; 93010602
DR   Wikidata; Q54829553
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1129
AC   CVCL_9E09
DR   ECACC; 93010603
DR   Wikidata; Q54829554
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(3)(q21:q25)(?0) (ECACC=93010603).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1130
AC   CVCL_AQ65
DR   ECACC; 93010711
DR   Wikidata; Q54829555
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y4M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1134
AC   CVCL_9E10
DR   ECACC; 93010810
DR   Wikidata; Q54829556
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar(14) (ECACC=93010810).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010810; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1135
AC   CVCL_9E11
DR   ECACC; 93010811
DR   Wikidata; Q54829558
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar(16) (ECACC=93010811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010811; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1136
AC   CVCL_9E12
DR   ECACC; 93010812
DR   Wikidata; Q54829559
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93010812; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1139
AC   CVCL_9E13
DR   ECACC; 93011105
DR   Wikidata; Q54829560
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(18)(q21.3) (ECACC=93011105).
CC   Discontinued: ECACC; 93011105; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1140
AC   CVCL_9E14
DR   ECACC; 93011204
DR   Wikidata; Q54829561
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1141
AC   CVCL_9E15
DR   ECACC; 93011401
DR   Wikidata; Q54829562
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1142
AC   CVCL_AQ66
DR   ECACC; 93011402
DR   Wikidata; Q54829563
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD1143
AC   CVCL_9E16
DR   ECACC; 93011501
DR   Wikidata; Q54829564
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93011501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1144
AC   CVCL_9E17
DR   ECACC; 93011502
DR   Wikidata; Q54829565
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93011502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1145
AC   CVCL_9E18
DR   ECACC; 93011503
DR   Wikidata; Q54829566
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+mar(5;19) (ECACC=93011503).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1147
AC   CVCL_9E19
DR   ECACC; 93011505
DR   Wikidata; Q54829567
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+dic(15) (ECACC=93011505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1151
AC   CVCL_9E20
DR   ECACC; 93011807
DR   Wikidata; Q54829568
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;9)(q34.1;q24.1) (ECACC=93011807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101214; Spina bifida
DI   ORDO; Orphanet_268357; Neural tube closure defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1153
AC   CVCL_9E21
DR   ECACC; 93012103
DR   Wikidata; Q54829569
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1154
AC   CVCL_9E22
DR   ECACC; 93012104
DR   Wikidata; Q54829570
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(11;15)(q14.2;q26.3)(0?) (ECACC=93012104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1155
AC   CVCL_9E23
DR   ECACC; 93012105
DR   Wikidata; Q54829571
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1159
AC   CVCL_9E24
DR   ECACC; 93012204
DR   Wikidata; Q54829572
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1160
AC   CVCL_9E25
DR   ECACC; 93012205
DR   Wikidata; Q54829573
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1161
AC   CVCL_AQ67
DR   ECACC; 93012206
DR   Wikidata; Q54829574
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1162
AC   CVCL_9E26
DR   ECACC; 93012209
DR   Wikidata; Q54829575
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;22)(q23;q12)mat (ECACC=93012209).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1163
AC   CVCL_9E27
DR   ECACC; 93012210
DR   Wikidata; Q54829577
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1164
AC   CVCL_9E28
DR   ECACC; 93012211
DR   Wikidata; Q54829578
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1165
AC   CVCL_9E29
DR   ECACC; 93012212
DR   Wikidata; Q54829579
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1166
AC   CVCL_9E30
DR   ECACC; 93012737
DR   Wikidata; Q54829580
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=93012737).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1167
AC   CVCL_9E31
DR   ECACC; 93012812
DR   Wikidata; Q54829581
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012812; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1168
AC   CVCL_9E32
DR   ECACC; 93012813
DR   Wikidata; Q54829582
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1169
AC   CVCL_9E33
DR   ECACC; 93012814
DR   Wikidata; Q54829583
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93012814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1175
AC   CVCL_9E34
DR   ECACC; 93012913
DR   Wikidata; Q54829584
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1177
AC   CVCL_9E35
DR   ECACC; 93020106
DR   Wikidata; Q54829585
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;8)(q21.1;q24.13); de novo (ECACC=93020106).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD1180
AC   CVCL_9E36
DR   ECACC; 93020109
DR   Wikidata; Q54829586
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1182
AC   CVCL_9E37
DR   ECACC; 93020219
DR   Wikidata; Q54829587
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [13]; 47,XX,+mar [21] (ECACC=93020219).
CC   Discontinued: ECACC; 93020219; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1183
AC   CVCL_AQ68
DR   ECACC; 93020309
DR   Wikidata; Q54829588
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93020309; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD1185
AC   CVCL_9E38
DR   ECACC; 93020311
DR   Wikidata; Q54829589
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;5)(1p5;1q5p) (ECACC=93020311).
CC   Discontinued: ECACC; 93020311; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1187
AC   CVCL_9E39
DR   ECACC; 93020501
DR   Wikidata; Q54829590
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1189
AC   CVCL_9E40
DR   ECACC; 93020503
DR   Wikidata; Q54829592
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1196
AC   CVCL_VC46
DR   ECACC; 93020808
DR   Wikidata; Q54829593
RX   PubMed=27896104;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93020808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y7M
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   DD1198
AC   CVCL_9E41
DR   ECACC; 93021005
DR   Wikidata; Q54829594
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1199
AC   CVCL_9E42
DR   ECACC; 93021006
DR   Wikidata; Q54829600
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   51Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1202
AC   CVCL_9E43
DR   ECACC; 93021119
DR   Wikidata; Q54829601
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+dic(15)pat (ECACC=93021119).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1203
AC   CVCL_9E44
DR   ECACC; 93021120
DR   Wikidata; Q54829602
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021120; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1205
AC   CVCL_9E45
DR   ECACC; 93021122
DR   Wikidata; Q54829603
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1206
AC   CVCL_9E46
DR   ECACC; 93021123
DR   Wikidata; Q54829604
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(2)(q37.2) (ECACC=93021123).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021123; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1208
AC   CVCL_9E47
DR   ECACC; 93021125
DR   Wikidata; Q54829605
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021125; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1209
AC   CVCL_9E48
DR   ECACC; 93021126
DR   Wikidata; Q54829607
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;5)(1p5;1q5)(0?) (ECACC=93021126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1210
AC   CVCL_9E49
DR   ECACC; 93021127
DR   Wikidata; Q54829608
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021127; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1211
AC   CVCL_9E50
DR   ECACC; 93021128
DR   Wikidata; Q54829609
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 93021128; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1214
AC   CVCL_9E51
DR   ECACC; 93021820
DR   Wikidata; Q54829610
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021820; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1215
AC   CVCL_9E52
DR   ECACC; 93021821
DR   Wikidata; Q54829611
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;9)(?q13.32;p13)(?0) (ECACC=93021821).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021821; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1216
AC   CVCL_9E53
DR   ECACC; 93021822
DR   Wikidata; Q54829612
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021822; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1217
AC   CVCL_9E54
DR   ECACC; 93021823
DR   Wikidata; Q54829614
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021823; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1218
AC   CVCL_9E55
DR   ECACC; 93021824
DR   Wikidata; Q54829615
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021824; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1219
AC   CVCL_9E56
DR   ECACC; 93021901
DR   Wikidata; Q54829616
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;5)(p21;p13)mat (ECACC=93021901).
CC   Discontinued: ECACC; 93021901; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1222
AC   CVCL_9E57
DR   ECACC; 93021904
DR   Wikidata; Q54829617
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,19q+ (ECACC=93021904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1224
AC   CVCL_9E58
DR   ECACC; 93022201
DR   Wikidata; Q54829618
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1225
AC   CVCL_9E59
DR   ECACC; 93022202
DR   Wikidata; Q54829619
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9N37 ! DD3589
SX   Male
AG   48Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1226
AC   CVCL_9E60
DR   ECACC; 93022203
DR   Wikidata; Q54829621
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9N36 ! DD3588
SX   Female
AG   53Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1227
AC   CVCL_9E61
DR   ECACC; 93022204
DR   Wikidata; Q54829622
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+dic(15) (ECACC=93022204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1228
AC   CVCL_9E62
DR   ECACC; 93022205
DR   Wikidata; Q54829623
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93022205; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9F67 ! DD1404
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1229
AC   CVCL_9E63
DR   ECACC; 93022304
DR   Wikidata; Q54829624
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1230
AC   CVCL_9E64
DR   ECACC; 93022305
DR   Wikidata; Q54829625
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1232
AC   CVCL_9E65
DR   ECACC; 93022613
DR   Wikidata; Q54829626
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1233
AC   CVCL_9E66
DR   ECACC; 93022614
DR   Wikidata; Q54829627
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+mar(14)(?0) (ECACC=93022614).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93022614; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1236
AC   CVCL_9E67
DR   ECACC; 93030107
DR   Wikidata; Q54829629
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93030107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1237
AC   CVCL_9E68
DR   ECACC; 93030408
DR   Wikidata; Q54829630
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93030408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1243
AC   CVCL_9E69
DR   ECACC; 93030559
DR   Wikidata; Q54829631
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93030559; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1244
AC   CVCL_9E70
DR   ECACC; 93030560
DR   Wikidata; Q54829632
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93030560; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1247
AC   CVCL_9E71
DR   ECACC; 93031144
DR   Wikidata; Q54829633
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+22 (ECACC=93031144).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75012; Dandy-Walker malformation
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_217; Isolated Dandy-Walker malformation
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1249
AC   CVCL_9E72
DR   ECACC; 93031228
DR   Wikidata; Q54829634
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [17]; 47,XX,+mar(4) [39] (ECACC=93031228).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1250
AC   CVCL_9E73
DR   ECACC; 93031229
DR   Wikidata; Q54829636
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+mar(4) (ECACC=93031229).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1251
AC   CVCL_9E74
DR   ECACC; 93031231
DR   Wikidata; Q54829637
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+dic(15)(pter->q11::q11->pter) (ECACC=93031231).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031231; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1252
AC   CVCL_9E75
DR   ECACC; 93031232
DR   Wikidata; Q54829638
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+mar(15)mat (ECACC=93031232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031232; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1253
AC   CVCL_9E76
DR   ECACC; 93031233
DR   Wikidata; Q54829639
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031233; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1254
AC   CVCL_9E77
DR   ECACC; 93031234
DR   Wikidata; Q54829640
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031234; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1255
AC   CVCL_9E78
DR   ECACC; 93031704
DR   Wikidata; Q54829642
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1256
AC   CVCL_9E79
DR   ECACC; 93031705
DR   Wikidata; Q54829643
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1257
AC   CVCL_9E80
DR   ECACC; 93031711
DR   Wikidata; Q54829644
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1258
AC   CVCL_9E81
DR   ECACC; 93031717
DR   Wikidata; Q54829645
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031717; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1259
AC   CVCL_9E82
DR   ECACC; 93031713
DR   Wikidata; Q54829655
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031713; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1260
AC   CVCL_9E83
DR   ECACC; 93031714
DR   Wikidata; Q54829656
RX   PubMed=12960211;
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;13)(q21;p13) (ECACC=93031714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93031714; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1261
AC   CVCL_9E84
DR   ECACC; 93031902
DR   Wikidata; Q54829657
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [13]; 47,XX,+r(6) [37] (ECACC=93031902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1265
AC   CVCL_9E85
DR   ECACC; 93032301
DR   Wikidata; Q54829658
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93032301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1266
AC   CVCL_9E86
DR   ECACC; 93032302
DR   Wikidata; Q54829659
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(6;10)(q21.1;q22.1)pat (ECACC=93032302).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1270
AC   CVCL_9E87
DR   ECACC; 93032501
DR   Wikidata; Q54829661
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93032501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1271
AC   CVCL_9E88
DR   ECACC; 93032502
DR   Wikidata; Q54829662
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93032502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1272
AC   CVCL_9E89
DR   ECACC; 93032503
DR   Wikidata; Q54829663
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93032503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1275
AC   CVCL_9E90
DR   ECACC; 93032618
DR   Wikidata; Q54829664
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93032618; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1276
AC   CVCL_9E91
DR   ECACC; 93032619
DR   Wikidata; Q54829665
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93032619; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1277
AC   CVCL_9E92
DR   ECACC; 93032620
DR   Wikidata; Q54829667
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(3;10)(p23;q21.2) (ECACC=93032620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93032620; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1279
AC   CVCL_AQ69
DR   ECACC; 93040201
DR   Wikidata; Q54829668
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1282
AC   CVCL_9E93
DR   ECACC; 93040212
DR   Wikidata; Q54829669
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1283
AC   CVCL_9E94
DR   ECACC; 93040803
DR   Wikidata; Q54829670
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1284
AC   CVCL_9E95
DR   ECACC; 93040804
DR   Wikidata; Q54829671
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1285
AC   CVCL_9E96
DR   ECACC; 93040805
DR   Wikidata; Q54829672
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1287
AC   CVCL_9E97
DR   ECACC; 93040807
DR   Wikidata; Q54829673
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XYY (ECACC=93040807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1288
AC   CVCL_9E98
DR   ECACC; 93040808
DR   Wikidata; Q54829675
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1289
AC   CVCL_9E99
DR   ECACC; 93040824
DR   Wikidata; Q54829676
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,der(X)t(X;11)(Xpter->Xq26.1::11p11.2-11pter); de novo (ECACC=93040824).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD1291
AC   CVCL_9F00
DR   ECACC; 93040826
DR   Wikidata; Q54829677
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040826; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1292
AC   CVCL_9F01
DR   ECACC; 93040827
DR   Wikidata; Q54829678
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040827; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1293
AC   CVCL_9F02
DR   ECACC; 93040828
DR   Wikidata; Q54829679
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;15)(q13.1;q21.1)pat (ECACC=93040828).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1296
AC   CVCL_9F03
DR   ECACC; 93040831
DR   Wikidata; Q54829680
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040831; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1297
AC   CVCL_9F04
DR   ECACC; 93040832
DR   Wikidata; Q54829681
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93040832; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1299
AC   CVCL_9F05
DR   ECACC; 93041616
DR   Wikidata; Q54829683
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(12;16)(q21.1;q23.2)(?0) (ECACC=93041616).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93041616; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1300
AC   CVCL_9F06
DR   ECACC; 93041617
DR   Wikidata; Q54829684
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=93041617).
CC   Discontinued: ECACC; 93041617; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1302
AC   CVCL_9F07
DR   ECACC; 93042101
DR   Wikidata; Q54829685
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1303
AC   CVCL_9F08
DR   ECACC; 93042102
DR   Wikidata; Q54829686
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX+mar(15); de novo (ECACC=93042102).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   DD1304
AC   CVCL_9F09
DR   ECACC; 93042103
DR   Wikidata; Q54829687
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1306
AC   CVCL_9F10
DR   ECACC; 93042108
DR   Wikidata; Q54829688
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U51 ! DD0051
SX   Male
AG   11Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1307
AC   CVCL_9F11
DR   ECACC; 93042109
DR   Wikidata; Q54829690
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1308
AC   CVCL_9F12
DR   ECACC; 93042110
DR   Wikidata; Q54829691
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1309
AC   CVCL_9F13
DR   ECACC; 93042111
DR   Wikidata; Q54829692
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(14;16)(q35.1;p13.13)(?0) (ECACC=93042111).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1310
AC   CVCL_9F14
DR   ECACC; 93042301
DR   Wikidata; Q54829693
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1311
AC   CVCL_9F15
DR   ECACC; 93042302
DR   Wikidata; Q54829694
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar(14) (ECACC=93042302).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1312
AC   CVCL_9F16
DR   ECACC; 93042303
DR   Wikidata; Q54829695
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1313
AC   CVCL_9F17
DR   ECACC; 93042304
DR   Wikidata; Q54829696
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1314
AC   CVCL_9F18
DR   ECACC; 93042313
DR   Wikidata; Q54829697
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042313; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1315
AC   CVCL_9F19
DR   ECACC; 93042314
DR   Wikidata; Q54829698
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,mar(22) (ECACC=93042314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1319
AC   CVCL_9F20
DR   ECACC; 93042608
DR   Wikidata; Q54829700
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93042608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1321
AC   CVCL_9F21
DR   ECACC; 93042806
DR   Wikidata; Q54829703
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;5)(p21.2;q35.3) (ECACC=93042806).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1322
AC   CVCL_9F22
DR   ECACC; 93042807
DR   Wikidata; Q54829704
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;11)(p21;q13) (ECACC=93042807).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1325
AC   CVCL_9F23
DR   ECACC; 93050407
DR   Wikidata; Q54829705
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93050407; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1326
AC   CVCL_9F24
DR   ECACC; 93050703
DR   Wikidata; Q54829706
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93050703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1327
AC   CVCL_9F25
DR   ECACC; 93050704
DR   Wikidata; Q54829707
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93050704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1328
AC   CVCL_9F26
DR   ECACC; 93050705
DR   Wikidata; Q54829708
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1329
AC   CVCL_9F27
DR   ECACC; 04101811
DR   Wikidata; Q54829709
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar(6) (ECACC=04101811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1331
AC   CVCL_9F28
DR   ECACC; 93051209
DR   Wikidata; Q54829710
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9227; Hypogonadism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1333
AC   CVCL_9F29
DR   ECACC; 93051404
DR   Wikidata; Q54829711
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93051404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1335
AC   CVCL_9F30
DR   ECACC; 93052018
DR   Wikidata; Q54829712
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;9)(q33;q22.3)pat (ECACC=93052018).
CC   Discontinued: ECACC; 93052018; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1337
AC   CVCL_9F31
DR   ECACC; 93052106
DR   Wikidata; Q54829713
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1340
AC   CVCL_9F32
DR   ECACC; 93052813
DR   Wikidata; Q54829714
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1342
AC   CVCL_9F33
DR   ECACC; 93052815
DR   Wikidata; Q54829715
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar(15) (ECACC=93052815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052815; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1343
AC   CVCL_9F34
DR   ECACC; 93052816
DR   Wikidata; Q54829716
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93052816; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1346
AC   CVCL_9F35
DR   ECACC; 93060302
DR   Wikidata; Q54829717
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,var(9p)(?0) (ECACC=93060302).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1347
AC   CVCL_9F36
DR   ECACC; 93060303
DR   Wikidata; Q54829718
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93060303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1348
AC   CVCL_9F37
DR   ECACC; 93060324
DR   Wikidata; Q54829719
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93060324; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1349
AC   CVCL_9F38
DR   ECACC; 93060325
DR   Wikidata; Q54829720
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(5;6)(q22;q13) (ECACC=93060325).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93060325; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1350
AC   CVCL_9F39
DR   ECACC; 93060402
DR   Wikidata; Q54829721
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(12;17)(q13;q25) (ECACC=93060402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93060402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1351
AC   CVCL_9F40
DR   ECACC; 93060405
DR   Wikidata; Q54829722
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,?var(9p)pat (ECACC=93060405).
CC   Discontinued: ECACC; 93060405; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1355
AC   CVCL_9F41
DR   ECACC; 93060708
DR   Wikidata; Q54829723
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93060708; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1358
AC   CVCL_9F42
DR   ECACC; 93060915
DR   Wikidata; Q54829724
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+13 (ECACC=93060915).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1359
AC   CVCL_9F43
DR   ECACC; 93061116
DR   Wikidata; Q54829725
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 69,XXX (ECACC=93061116).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75012; Dandy-Walker malformation
DI   ORDO; Orphanet_217; Isolated Dandy-Walker malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1362
AC   CVCL_9F44
DR   ECACC; 93061517
DR   Wikidata; Q54829726
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+mar(9)mat (ECACC=93061517).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061517; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1363
AC   CVCL_9F45
DR   ECACC; 93061518
DR   Wikidata; Q54829727
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061518; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1364
AC   CVCL_9F46
DR   ECACC; 93061519
DR   Wikidata; Q54829728
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+mar(13;21) (ECACC=93061519).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061519; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1365
AC   CVCL_9F47
DR   ECACC; 93061520
DR   Wikidata; Q54829729
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061520; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1367
AC   CVCL_9F48
DR   ECACC; 93061522
DR   Wikidata; Q54829730
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93061522; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1368
AC   CVCL_AQ70
DR   ECACC; 93061711
DR   Wikidata; Q54829731
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y9M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1369
AC   CVCL_AQ71
DR   ECACC; 93061712
DR   Wikidata; Q54829732
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061712; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1374
AC   CVCL_9F49
DR   ECACC; 93061808
DR   Wikidata; Q54829733
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1375
AC   CVCL_9F50
DR   ECACC; 93061809
DR   Wikidata; Q54829734
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,var(20p)(?0) (ECACC=93061809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93061809; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1379
AC   CVCL_9F51
DR   ECACC; 93062503
DR   Wikidata; Q54829735
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93062503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1381
AC   CVCL_9F52
DR   ECACC; 93062510
DR   Wikidata; Q54829736
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+dic(15) (ECACC=93062510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1383
AC   CVCL_9F53
DR   ECACC; 93062901
DR   Wikidata; Q54829737
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [9]; 47,XX,+mar(9) [21] (ECACC=93062901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93062901; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1384
AC   CVCL_9F54
DR   ECACC; 93062902
DR   Wikidata; Q54829738
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93062902; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1385
AC   CVCL_9F55
DR   ECACC; 93062903
DR   Wikidata; Q54829739
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93062903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1386
AC   CVCL_9F56
DR   ECACC; 93062904
DR   Wikidata; Q54829740
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93062904; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1387
AC   CVCL_9F57
DR   ECACC; 93063007
DR   Wikidata; Q54829741
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(5;6)(q22;q13) (ECACC=93063007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1388
AC   CVCL_AQ72
DR   ECACC; 93070211
DR   Wikidata; Q54829742
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93070211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1392
AC   CVCL_9F58
DR   ECACC; 93070820
DR   Wikidata; Q54829746
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93070820; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1393
AC   CVCL_9F59
DR   ECACC; 93070821
DR   Wikidata; Q54829747
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY [8]; 47,XY,+8 [22] (ECACC=93070821).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1394
AC   CVCL_9F60
DR   ECACC; 93070822
DR   Wikidata; Q54829748
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93070822; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1395
AC   CVCL_9F61
DR   ECACC; 93070823
DR   Wikidata; Q54829749
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;10)(p21;p15)(?0) (ECACC=93070823).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93070823; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1396
AC   CVCL_9F62
DR   ECACC; 93070824
DR   Wikidata; Q54829750
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93070824; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1398
AC   CVCL_9F63
DR   ECACC; 93070819
DR   Wikidata; Q54829751
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY [49]; 47,XY,+mar [1] (ECACC=93070819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1399
AC   CVCL_9F64
DR   ECACC; 93070918
DR   Wikidata; Q54829752
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY(9qh) (ECACC=93070918).
CC   Discontinued: ECACC; 93070918; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1400
AC   CVCL_9F65
DR   ECACC; 93071205
DR   Wikidata; Q54829753
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=93071205).
CC   Discontinued: ECACC; 93071205; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1401
AC   CVCL_9F66
DR   ECACC; 93071406
DR   Wikidata; Q54829754
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [74]; 47,XX,+r(?) [8] (ECACC=93071406).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9F71 ! DD1410
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1404
AC   CVCL_9F67
DR   ECACC; 93071550
DR   Wikidata; Q54829755
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93071550; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9E62 ! DD1228
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1405
AC   CVCL_9F68
DR   ECACC; 93071542
DR   Wikidata; Q54829756
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=93071542).
CC   Discontinued: ECACC; 93071542; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1407
AC   CVCL_9F69
DR   ECACC; 93071611
DR   Wikidata; Q54829757
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(7;16)(p15;q22) (ECACC=93071611).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1408
AC   CVCL_9F70
DR   ECACC; 93071612
DR   Wikidata; Q54829758
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,?invdup(2)(q36.2;q37.3); de novo (ECACC=93071612).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD1410
AC   CVCL_9F71
DR   ECACC; 93071914
DR   Wikidata; Q54829759
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9F66 ! DD1401
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1411
AC   CVCL_9F72
DR   ECACC; 93072114
DR   Wikidata; Q54829760
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93072114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1412
AC   CVCL_9F73
DR   ECACC; 93072301
DR   Wikidata; Q54829761
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [28]; 46,XX,-18,+dic(18q) [5]; 47,XX,+18 [19] (ECACC=93072301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1413
AC   CVCL_9F74
DR   ECACC; 93072302
DR   Wikidata; Q54829762
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93072302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1418
AC   CVCL_9F75
DR   ECACC; 93072918
DR   Wikidata; Q54829763
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1421
AC   CVCL_9F76
DR   ECACC; 93080202
DR   Wikidata; Q54829764
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XYY (ECACC=93080202).
CC   Discontinued: ECACC; 93080202; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1423
AC   CVCL_9F77
DR   ECACC; 93080408
DR   Wikidata; Q54829765
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(Y)(?q11.2) (ECACC=93080408).
CC   Discontinued: ECACC; 93080408; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1424
AC   CVCL_9F78
DR   ECACC; 93080518
DR   Wikidata; Q54829766
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080518; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1425
AC   CVCL_9F79
DR   ECACC; 93080519
DR   Wikidata; Q54829767
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080519; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1426
AC   CVCL_9F80
DR   ECACC; 93080615
DR   Wikidata; Q54829768
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93080615; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1429
AC   CVCL_9F81
DR   ECACC; 93081005
DR   Wikidata; Q54829769
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(3;8)(p11.1;q13.2)pat (ECACC=93081005).
CC   Discontinued: ECACC; 93081005; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1430
AC   CVCL_9F82
DR   ECACC; 93081006
DR   Wikidata; Q54829770
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar(22)mat (ECACC=93081006).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26689; Addison's disease
DI   ORDO; Orphanet_85138; Addison disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DD1431
AC   CVCL_9F83
DR   ECACC; 93081007
DR   Wikidata; Q54829771
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1433
AC   CVCL_9F84
DR   ECACC; 93081308
DR   Wikidata; Q54829772
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,inv(Y) (ECACC=93081308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1438
AC   CVCL_9F85
DR   ECACC; 93081711
DR   Wikidata; Q54829773
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1439
AC   CVCL_9F86
DR   ECACC; 93081903
DR   Wikidata; Q54829774
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1440
AC   CVCL_9F87
DR   ECACC; 93081904
DR   Wikidata; Q54829775
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93081904; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1444
AC   CVCL_9F88
DR   ECACC; 93082011
DR   Wikidata; Q54829776
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082011; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1445
AC   CVCL_9F89
DR   ECACC; 93082012
DR   Wikidata; Q54829777
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082012; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD1446
AC   CVCL_AQ73
DR   ECACC; 93082013
DR   Wikidata; Q54829778
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082013; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1448
AC   CVCL_9F90
DR   ECACC; 93082015
DR   Wikidata; Q54829779
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082015; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V37 ! DD0229
SX   Female
AG   30Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1449
AC   CVCL_9F91
DR   ECACC; 93082016
DR   Wikidata; Q54829780
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082016; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V36 ! DD0228
SX   Male
AG   30Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1450
AC   CVCL_9F92
DR   ECACC; 93082017
DR   Wikidata; Q54829781
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar (ECACC=93082017).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V35 ! DD0227
SX   Male
AG   5Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1453
AC   CVCL_9F93
DR   ECACC; 93082334
DR   Wikidata; Q54829782
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082334; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1455
AC   CVCL_9F94
DR   ECACC; 93082336
DR   Wikidata; Q54829783
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+mar(14) (ECACC=93082336).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1456
AC   CVCL_9F95
DR   ECACC; 93082337
DR   Wikidata; Q54829784
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1463
AC   CVCL_VC47
DR   ECACC; 93082605
DR   Wikidata; Q54829785
RX   PubMed=27896104;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; CH-1 30kb del (CH-1 type CYP21A1P/CYP21A2 chimer); Zygosity=Heterozygous (PubMed=27896104).
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; CH-7 30kb del (CH-7 type CYP21A1P/CYP21A2 chimer); Zygosity=Heterozygous (PubMed=27896104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y10M
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   DD1464
AC   CVCL_VC48
DR   ECACC; 93082606
DR   Wikidata; Q54829793
RX   PubMed=27896104;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; CH-1 30kb del (CH-1 type CYP21A1P/CYP21A2 chimer); Zygosity=Heterozygous (PubMed=27896104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082606; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y10M
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 7
//
ID   DD1467
AC   CVCL_9F96
DR   ECACC; 93082614
DR   Wikidata; Q54829794
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=93082614).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1468
AC   CVCL_9F97
DR   ECACC; 93082211
DR   Wikidata; Q54829795
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1470
AC   CVCL_9F98
DR   ECACC; 93082713
DR   Wikidata; Q54829796
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93082713; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1473
AC   CVCL_9F99
DR   ECACC; 93090102
DR   Wikidata; Q54829797
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 48,XXXX (ECACC=93090102).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1474
AC   CVCL_9G00
DR   ECACC; 93090203
DR   Wikidata; Q54829798
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,inv(X)(?q11;q21.2)mat (ECACC=93090203).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9B72 ! DD0738
SX   Male
AG   47Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1477
AC   CVCL_9G01
DR   ECACC; 93090604
DR   Wikidata; Q54829799
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(9;11)(q32;q12)mat (ECACC=93090604).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93090604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1478
AC   CVCL_9G02
DR   ECACC; 93090605
DR   Wikidata; Q54829800
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93090605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1479
AC   CVCL_9G03
DR   ECACC; 93090722
DR   Wikidata; Q54829801
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(9;11)(?q34;?q13)mat (ECACC=93090722).
CC   Discontinued: ECACC; 93090722; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1480
AC   CVCL_9G04
DR   ECACC; 93090723
DR   Wikidata; Q54829802
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93090723; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1481
AC   CVCL_9G05
DR   ECACC; 93090724
DR   Wikidata; Q54829803
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,(*;18)(p21.3;p11.23)(?) (ECACC=93090724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93090724; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1482
AC   CVCL_9G06
DR   ECACC; 93090725
DR   Wikidata; Q54829804
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(8)(p23.1) (ECACC=93090725).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1485
AC   CVCL_9G07
DR   ECACC; 93091009
DR   Wikidata; Q54829805
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93091009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1487
AC   CVCL_9G08
DR   ECACC; 93091018
DR   Wikidata; Q54829806
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 46,XY,15+; de novo (ECACC=93091018).
CC   Discontinued: ECACC; 93091018; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G23 ! DD1516
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1488
AC   CVCL_9G09
DR   ECACC; 93091019
DR   Wikidata; Q54829807
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY [15]; 47,XY,+20 [5] (ECACC=93091019).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98876; Congenital hydrocephalus
DI   ORDO; Orphanet_2185; Congenital hydrocephalus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1491
AC   CVCL_9G10
DR   ECACC; 93091514
DR   Wikidata; Q54829808
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93091514; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1493
AC   CVCL_9G11
DR   ECACC; 93091754
DR   Wikidata; Q54829809
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,Yqs (ECACC=93091754).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1494
AC   CVCL_9G12
DR   ECACC; 93091755
DR   Wikidata; Q54829810
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93091755; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1495
AC   CVCL_9G13
DR   ECACC; 93091756
DR   Wikidata; Q54829811
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93091756; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1496
AC   CVCL_9G14
DR   ECACC; 93091758
DR   Wikidata; Q54829812
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(7;16)(p15;q22)(?) (ECACC=93091758).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93091758; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1497
AC   CVCL_9G15
DR   ECACC; 93091757
DR   Wikidata; Q54829813
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,13p+ (ECACC=93091757).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1502
AC   CVCL_9G16
DR   ECACC; 93092211
DR   Wikidata; Q54829814
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93092211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V23 ! DD0206
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1503
AC   CVCL_9G17
DR   ECACC; 93092212
DR   Wikidata; Q54829815
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93092212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8V24 ! DD0207
SX   Male
AG   38Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1506
AC   CVCL_9G18
DR   ECACC; 93092413
DR   Wikidata; Q54829816
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 46,XY,15p+; de novo (ECACC=93092413).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 6
//
ID   DD1507
AC   CVCL_9G19
DR   ECACC; 93092414
DR   Wikidata; Q54829817
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(5)(p14;q14)mat (ECACC=93092414).
CC   Discontinued: ECACC; 93092414; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1508
AC   CVCL_9G20
DR   ECACC; 93092702
DR   Wikidata; Q54829818
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY [25]; 46,XY,15p+ [5] (ECACC=93092702).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1510
AC   CVCL_9G21
DR   ECACC; 93092825
DR   Wikidata; Q54829819
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY [29]; 46,XY,15p+ [1] (ECACC=93092825).
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1515
AC   CVCL_9G22
DR   ECACC; 93093017
DR   Wikidata; Q54829820
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93093017; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1516
AC   CVCL_9G23
DR   ECACC; 93093020
DR   Wikidata; Q54829821
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 46,XY,15p+ (ECACC=93093020).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G08 ! DD1487
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1517
AC   CVCL_9G24
DR   ECACC; 93093021
DR   Wikidata; Q54829822
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93093021; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1518
AC   CVCL_9G25
DR   ECACC; 93093022
DR   Wikidata; Q54829823
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;17)(q32.3;p13.3)(?) (ECACC=93093022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93093022; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1519
AC   CVCL_9G26
DR   ECACC; 93093023
DR   Wikidata; Q54829824
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;17)(q32;q13)pat (ECACC=93093023).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93093023; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   DD1521
AC   CVCL_9G27
DR   ECACC; 93100405
DR   Wikidata; Q54829825
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(16;18)(q24;q21.1)(?) (ECACC=93100405).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1524
AC   CVCL_9G28
DR   ECACC; 93100723
DR   Wikidata; Q54829826
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=93100723).
CC   Discontinued: ECACC; 93100723; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1529
AC   CVCL_9G29
DR   ECACC; 93101303
DR   Wikidata; Q54829827
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1531
AC   CVCL_9G30
DR   ECACC; 93101305
DR   Wikidata; Q54829828
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(12)(p13;q21)mat (ECACC=93101305).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1535
AC   CVCL_9G31
DR   ECACC; 93101413
DR   Wikidata; Q54829829
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+18 (ECACC=93101413).
CC   Discontinued: ECACC; 93101413; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1538
AC   CVCL_9G32
DR   ECACC; 93101416
DR   Wikidata; Q54829830
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,r(18)(p11.2;q21.3) (ECACC=93101416).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101416; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1539
AC   CVCL_9G33
DR   ECACC; 93101417
DR   Wikidata; Q54829831
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101417; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1540
AC   CVCL_9G34
DR   ECACC; 93101418
DR   Wikidata; Q54829832
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93101418; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1544
AC   CVCL_9G35
DR   ECACC; 93102201
DR   Wikidata; Q54829836
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(14)(?q22;?q24)(?) (ECACC=93102201).
CC   Discontinued: ECACC; 93102201; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1546
AC   CVCL_9G36
DR   ECACC; 93102208
DR   Wikidata; Q54829837
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1547
AC   CVCL_9G37
DR   ECACC; 93102209
DR   Wikidata; Q54829838
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1548
AC   CVCL_9G38
DR   ECACC; 93102210
DR   Wikidata; Q54829839
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1549
AC   CVCL_9G39
DR   ECACC; 93192211
DR   Wikidata; Q54829840
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93192211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1550
AC   CVCL_9G40
DR   ECACC; 93102212
DR   Wikidata; Q54829841
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,der(X),t(X;10)(Xpter->q26;q24->10qter)mat (ECACC=93102212).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1551
AC   CVCL_AQ74
DR   ECACC; 93102213
DR   Wikidata; Q54829842
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y1M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD1552
AC   CVCL_9G41
DR   ECACC; 93102502
DR   Wikidata; Q54829843
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1554
AC   CVCL_9G42
DR   ECACC; 93102504
DR   Wikidata; Q54829844
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1560
AC   CVCL_9G43
DR   ECACC; 93102802
DR   Wikidata; Q54829845
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93102802; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1561
AC   CVCL_9G44
DR   ECACC; 93102803
DR   Wikidata; Q54829846
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G67 ! DD1599
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   DD1565
AC   CVCL_9G45
DR   ECACC; 93102906
DR   Wikidata; Q54829847
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1566
AC   CVCL_9G46
DR   ECACC; 93102907
DR   Wikidata; Q54829848
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(7)(p15.1;q11.23)dup(15)(q11.2;q13)(?) (ECACC=93102907).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1568
AC   CVCL_9G47
DR   ECACC; 93103002
DR   Wikidata; Q54829849
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+mar(13/21)mat (ECACC=93103002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93103002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1570
AC   CVCL_9G48
DR   ECACC; 93110106
DR   Wikidata; Q54829850
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-7,+der(7)+(7;9)(q34.1;p24.1)pat (ECACC=93110106).
CC   Discontinued: ECACC; 93110106; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C101214; Spina bifida
DI   ORDO; Orphanet_268357; Neural tube closure defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1571
AC   CVCL_9G49
DR   ECACC; 93110301
DR   Wikidata; Q54829851
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+dic(15); de novo (ECACC=93110301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1572
AC   CVCL_9G50
DR   ECACC; 93110302
DR   Wikidata; Q54829852
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1573
AC   CVCL_9G51
DR   ECACC; 93110303
DR   Wikidata; Q54829853
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1574
AC   CVCL_9G52
DR   ECACC; 93110304
DR   Wikidata; Q54829854
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1575
AC   CVCL_9G53
DR   ECACC; 93110305
DR   Wikidata; Q54829855
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1576
AC   CVCL_9G54
DR   ECACC; 93110306
DR   Wikidata; Q54829856
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(16;18)(q24;q21.1)(?) (ECACC=93110306).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1578
AC   CVCL_9G55
DR   ECACC; 93110308
DR   Wikidata; Q54829857
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(18)(q11.2;q21.1); de novo (ECACC=93110308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G63 ! DD1589
SX   Female
AG   5Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD1579
AC   CVCL_9G56
DR   ECACC; 93110414
DR   Wikidata; Q54829858
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110414; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1580
AC   CVCL_9G57
DR   ECACC; 93119415
DR   Wikidata; Q54829859
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75466; Rubinstein-Taybi syndrome
DI   ORDO; Orphanet_783; Rubinstein-Taybi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1581
AC   CVCL_9G58
DR   ECACC; 93110416
DR   Wikidata; Q54829860
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110416; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1582
AC   CVCL_9G59
DR   ECACC; 93110417
DR   Wikidata; Q54829861
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110417; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1583
AC   CVCL_AQ75
DR   ECACC; 93110418
DR   Wikidata; Q54829862
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110418; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y10M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1585
AC   CVCL_9G60
DR   ECACC; 93110601
DR   Wikidata; Q54829863
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1586
AC   CVCL_9G61
DR   ECACC; 93110602
DR   Wikidata; Q54829864
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1587
AC   CVCL_9G62
DR   ECACC; 93110603
DR   Wikidata; Q54829865
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93110603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1589
AC   CVCL_9G63
DR   ECACC; 93110605
DR   Wikidata; Q54829866
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(19)(q11.2;q21.1); de novo (ECACC=93110605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G55 ! DD1578
SX   Female
AG   5Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD1591
AC   CVCL_AQ76
DR   ECACC; 93110607
DR   Wikidata; Q54829867
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y5M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD1593
AC   CVCL_9G64
DR   ECACC; 93119609
DR   Wikidata; Q54829868
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-7,+der(7),t(7;9)(q34.1;p24.1)pat (ECACC=93119609).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C101214; Spina bifida
DI   ORDO; Orphanet_268357; Neural tube closure defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1595
AC   CVCL_9G65
DR   ECACC; 93111205
DR   Wikidata; Q54829869
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93111205; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G72 ! DD1613
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1597
AC   CVCL_9G66
DR   ECACC; 93111504
DR   Wikidata; Q54829870
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DD1599
AC   CVCL_9G67
DR   ECACC; 93111508
DR   Wikidata; Q54829871
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G44 ! DD1561
SX   Male
AG   11Y1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   DD1601
AC   CVCL_AQ77
DR   ECACC; 93111807
DR   Wikidata; Q54829872
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93111807; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1602
AC   CVCL_AQ78
DR   ECACC; 93111808
DR   Wikidata; Q54829873
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93111808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1603
AC   CVCL_9G68
DR   ECACC; 93111920
DR   Wikidata; Q54829874
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,15p+ (ECACC=93111920).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C87069; Cleft palate
DI   ORDO; Orphanet_2014; Cleft palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1604
AC   CVCL_9G69
DR   ECACC; 93111921
DR   Wikidata; Q54829875
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93111921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1607
AC   CVCL_9G70
DR   ECACC; 93111923
DR   Wikidata; Q54829878
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93111923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1609
AC   CVCL_9G71
DR   ECACC; 93112412
DR   Wikidata; Q54829879
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112412; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1610
AC   CVCL_AQ79
DR   ECACC; 93112609
DR   Wikidata; Q54829880
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112609; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y3M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1611
AC   CVCL_AQ80
DR   ECACC; 93112610
DR   Wikidata; Q54829881
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112610; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1612
AC   CVCL_AQ81
DR   ECACC; 93112611
DR   Wikidata; Q54829882
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y6M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1613
AC   CVCL_9G72
DR   ECACC; 93112612
DR   Wikidata; Q54829883
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9G65 ! DD1595
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1614
AC   CVCL_9G73
DR   ECACC; 93112613
DR   Wikidata; Q54829884
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1617
AC   CVCL_AQ82
DR   ECACC; 93112924
DR   Wikidata; Q54829885
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112924; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y1M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1618
AC   CVCL_9G74
DR   ECACC; 93112925
DR   Wikidata; Q54829886
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+der(22),t(11;22)(q23.3;q11.23)mat (ECACC=93112925).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1619
AC   CVCL_9G75
DR   ECACC; 93112926
DR   Wikidata; Q54829887
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93112926; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1620
AC   CVCL_9G76
DR   ECACC; 93112927
DR   Wikidata; Q54829888
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1622
AC   CVCL_9G77
DR   ECACC; 93112929
DR   Wikidata; Q54829889
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(2)(pter->?p22.1::?p21->qter); de novo (ECACC=93112929).
CC   Discontinued: ECACC; 93112929; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1623
AC   CVCL_9G78
DR   ECACC; 93113001
DR   Wikidata; Q54829890
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=93113001).
CC   Discontinued: ECACC; 93113001; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1624
AC   CVCL_9G79
DR   ECACC; 93113002
DR   Wikidata; Q54829891
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93113002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1625
AC   CVCL_AQ83
DR   ECACC; 93113003
DR   Wikidata; Q54829892
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93113003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1632
AC   CVCL_9G80
DR   ECACC; 93120210
DR   Wikidata; Q54829893
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93120210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1637
AC   CVCL_9G81
DR   ECACC; 93120305
DR   Wikidata; Q54829894
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+dic(15)(pter->q11::q11->pter)mat (ECACC=93120305).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93120305; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1640
AC   CVCL_9G82
DR   ECACC; 93120315
DR   Wikidata; Q54829895
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93120315; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1641
AC   CVCL_9G83
DR   ECACC; 93120316
DR   Wikidata; Q54829896
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1642
AC   CVCL_9G84
DR   ECACC; 93120317
DR   Wikidata; Q54829897
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+18 (ECACC=93120317).
CC   Discontinued: ECACC; 93120317; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1644
AC   CVCL_9G85
DR   ECACC; 93120688
DR   Wikidata; Q54829898
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93120688; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1645
AC   CVCL_9G86
DR   ECACC; 93120689
DR   Wikidata; Q54829899
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93120689; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1646
AC   CVCL_9G87
DR   ECACC; 93120690
DR   Wikidata; Q54829900
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93120690; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1648
AC   CVCL_9G88
DR   ECACC; 931207124
DR   Wikidata; Q54829901
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(22) (ECACC=931207124).
CC   Discontinued: ECACC; 931207124; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1649
AC   CVCL_9G89
DR   ECACC; 931207125
DR   Wikidata; Q54829902
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(22) (ECACC=931207125).
CC   Discontinued: ECACC; 931207125; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1654
AC   CVCL_9G90
DR   ECACC; 93121050
DR   Wikidata; Q54829903
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1655
AC   CVCL_9G91
DR   ECACC; 93121403
DR   Wikidata; Q54829904
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1656
AC   CVCL_9G92
DR   ECACC; 93121404
DR   Wikidata; Q54829905
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1658
AC   CVCL_9G93
DR   ECACC; 93121412
DR   Wikidata; Q54829906
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121412; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1660
AC   CVCL_9G94
DR   ECACC; 93121504
DR   Wikidata; Q54829907
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1661
AC   CVCL_9G95
DR   ECACC; 93121505
DR   Wikidata; Q54829908
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121505; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1662
AC   CVCL_9G96
DR   ECACC; 93121701
DR   Wikidata; Q54829909
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+18 (ECACC=93121701).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1666
AC   CVCL_9G97
DR   ECACC; 93121705
DR   Wikidata; Q54829910
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;15)(q14.2;q26.3)pat (ECACC=93121705).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1668
AC   CVCL_9G98
DR   ECACC; 93121707
DR   Wikidata; Q54829911
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1669
AC   CVCL_9G99
DR   ECACC; 93121708
DR   Wikidata; Q54829912
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;18) (ECACC=93121708).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93121708; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1674
AC   CVCL_9H00
DR   ECACC; 93122001
DR   Wikidata; Q54829913
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93122001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1675
AC   CVCL_9H01
DR   ECACC; 93122002
DR   Wikidata; Q54829914
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93122002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1679
AC   CVCL_9H02
DR   ECACC; 93122102
DR   Wikidata; Q54829915
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93122102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1684
AC   CVCL_AQ84
DR   ECACC; 93102507
DR   Wikidata; Q54829916
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93102507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1688
AC   CVCL_9H03
DR   ECACC; 93122217
DR   Wikidata; Q54829917
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=93122217).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1689
AC   CVCL_9H04
DR   ECACC; 93122304
DR   Wikidata; Q54829920
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93122304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1691
AC   CVCL_9H05
DR   ECACC; 93123002
DR   Wikidata; Q54829921
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93123002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1693
AC   CVCL_9H06
DR   ECACC; 94010501
DR   Wikidata; Q54829922
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=94010501).
CC   Discontinued: ECACC; 94010501; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1697
AC   CVCL_9H07
DR   ECACC; 94010711
DR   Wikidata; Q54829923
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXX (ECACC=94010711).
CC   Discontinued: ECACC; 94010711; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1699
AC   CVCL_9H08
DR   ECACC; 94010713
DR   Wikidata; Q54829924
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94010713; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1705
AC   CVCL_9H09
DR   ECACC; 94011318
DR   Wikidata; Q54829925
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94011318; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1706
AC   CVCL_9H10
DR   ECACC; 94011319
DR   Wikidata; Q54829926
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94011319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1707
AC   CVCL_9H11
DR   ECACC; 94011320
DR   Wikidata; Q54829927
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94011320; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1708
AC   CVCL_9H12
DR   ECACC; 94011321
DR   Wikidata; Q54829928
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1709
AC   CVCL_9H13
DR   ECACC; 94011410
DR   Wikidata; Q54829929
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 69,XXX (ECACC=94011410).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3724; Congenital cystic hygroma
DI   ORDO; Orphanet_79486; Cystic hygroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   14FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   DD1710
AC   CVCL_9H14
DR   ECACC; 94011411
DR   Wikidata; Q54829930
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+13 (ECACC=94011411).
CC   Discontinued: ECACC; 94011411; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C84767; Hydrops fetalis
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_1041; Hydrops fetalis
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1714
AC   CVCL_9H15
DR   ECACC; 94011705
DR   Wikidata; Q54829931
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1715
AC   CVCL_9H16
DR   ECACC; 94011706
DR   Wikidata; Q54829932
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94011706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1716
AC   CVCL_9H17
DR   ECACC; 94011707
DR   Wikidata; Q54829933
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94011707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1717
AC   CVCL_9H18
DR   ECACC; 94012018
DR   Wikidata; Q54829934
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012018; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1719
AC   CVCL_9H19
DR   ECACC; 94012020
DR   Wikidata; Q54829935
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012020; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1720
AC   CVCL_9H20
DR   ECACC; 94012132
DR   Wikidata; Q54829936
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012132; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1721
AC   CVCL_9H21
DR   ECACC; 94012133
DR   Wikidata; Q54829937
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(4;18)(p13;q11)mat (ECACC=94012133).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1722
AC   CVCL_9H22
DR   ECACC; 94012134
DR   Wikidata; Q54829938
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012134; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1723
AC   CVCL_9H23
DR   ECACC; 94012505
DR   Wikidata; Q54829939
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012505; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1724
AC   CVCL_9H24
DR   ECACC; 94012506
DR   Wikidata; Q54829940
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1725
AC   CVCL_9H25
DR   ECACC; 94012507
DR   Wikidata; Q54829941
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1727
AC   CVCL_9H26
DR   ECACC; 94012509
DR   Wikidata; Q54829942
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012509; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1732
AC   CVCL_9H27
DR   ECACC; 94012811
DR   Wikidata; Q54829943
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1733
AC   CVCL_9H28
DR   ECACC; 94012812
DR   Wikidata; Q54829944
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(10;16;20); de novo (ECACC=94012812).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94012812; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1735
AC   CVCL_9H29
DR   ECACC; 94012815
DR   Wikidata; Q54829945
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX [59]; 47,XX,+mar [6] (ECACC=94012815).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C95834; Congenital heart disease
DI   ORDO; Orphanet_156532; Rare syndrome with cardiac malformations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1741
AC   CVCL_AQ85
DR   ECACC; 94020204
DR   Wikidata; Q54829946
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94020204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD1742
AC   CVCL_9H30
DR   ECACC; 94020205
DR   Wikidata; Q54829947
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-8,+dir(8),t(7;8)(p21.3;p23.1)mat (ECACC=94020205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1743
AC   CVCL_9H31
DR   ECACC; 94020308
DR   Wikidata; Q54829948
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+dic(15)(pter->q11::q11->p11)mat (ECACC=94020308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94020308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1747
AC   CVCL_9H32
DR   ECACC; 94020906
DR   Wikidata; Q54829949
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94020906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1748
AC   CVCL_9H33
DR   ECACC; 94020907
DR   Wikidata; Q54829950
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+13 (ECACC=94020907).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98876; Congenital hydrocephalus
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_2185; Congenital hydrocephalus
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1750
AC   CVCL_9H34
DR   ECACC; 94020909
DR   Wikidata; Q54829951
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94020909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1752
AC   CVCL_9H35
DR   ECACC; 94021104
DR   Wikidata; Q54829952
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1753
AC   CVCL_9H36
DR   ECACC; 94021106
DR   Wikidata; Q54829953
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1755
AC   CVCL_9H37
DR   ECACC; 94021408
DR   Wikidata; Q54829954
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1756
AC   CVCL_9H38
DR   ECACC; 94021409
DR   Wikidata; Q54829955
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1759
AC   CVCL_9H39
DR   ECACC; 94021412
DR   Wikidata; Q54829956
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021412; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1760
AC   CVCL_9H40
DR   ECACC; 94021413
DR   Wikidata; Q54829957
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021413; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1762
AC   CVCL_9H41
DR   ECACC; 94021614
DR   Wikidata; Q54829958
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021614; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1763
AC   CVCL_9H42
DR   ECACC; 94021615
DR   Wikidata; Q54829959
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021615; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1764
AC   CVCL_9H43
DR   ECACC; 94021714
DR   Wikidata; Q54829962
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021714; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1765
AC   CVCL_9H44
DR   ECACC; 94021715
DR   Wikidata; Q54829963
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94021715; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1767
AC   CVCL_9H45
DR   ECACC; 94022112
DR   Wikidata; Q54829964
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-5,+der(5),t(5;11)(p15;p15.1)pat (ECACC=94022112).
CC   Discontinued: ECACC; 94022112; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H53 ! DD1778
OI   CVCL_9I25 ! DD1984
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1769
AC   CVCL_9H46
DR   ECACC; 94022304
DR   Wikidata; Q54829965
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1770
AC   CVCL_9H47
DR   ECACC; 94022305
DR   Wikidata; Q54829966
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,dup(15)(q12)mat (ECACC=94022305).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50715; Pulmonary stenosis
DI   ORDO; Orphanet_3189; Congenital pulmonary valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1771
AC   CVCL_9H48
DR   ECACC; 94022306
DR   Wikidata; Q54829967
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1772
AC   CVCL_9H49
DR   ECACC; 94022307
DR   Wikidata; Q54829968
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1773
AC   CVCL_9H50
DR   ECACC; 94022308
DR   Wikidata; Q54829969
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1775
AC   CVCL_9H51
DR   ECACC; 94022320
DR   Wikidata; Q54829970
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,inv(X),(p21.2?;q22.3) (ECACC=94022320).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022320; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1776
AC   CVCL_9H52
DR   ECACC; 94022321
DR   Wikidata; Q54829971
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY [18]; 47,XY,+8 [12] (ECACC=94022321).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1778
AC   CVCL_9H53
DR   ECACC; 94022501
DR   Wikidata; Q54829972
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-5,+der(5),t(5;11)(p15;p15)pat (ECACC=94022501).
CC   Discontinued: ECACC; 94022501; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H45 ! DD1767
OI   CVCL_9I25 ! DD1984
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1780
AC   CVCL_9H54
DR   ECACC; 94022503
DR   Wikidata; Q54829973
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1781
AC   CVCL_9H55
DR   ECACC; 94022504
DR   Wikidata; Q54829974
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;11)(p15.3;p15.1)mat (ECACC=94022504).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1783
AC   CVCL_9H56
DR   ECACC; 94022557
DR   Wikidata; Q54829975
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+mar (ECACC=94022557).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75477; Cat-eye syndrome
DI   ORDO; Orphanet_195; Cat-eye syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1784
AC   CVCL_9H57
DR   ECACC; 94022558
DR   Wikidata; Q54829976
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022558; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1785
AC   CVCL_9H58
DR   ECACC; 94022559
DR   Wikidata; Q54829977
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022559; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1787
AC   CVCL_9H59
DR   ECACC; 940302250
DR   Wikidata; Q54829978
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940302250; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1793
AC   CVCL_9H60
DR   ECACC; 94030411
DR   Wikidata; Q54829979
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-12,+der(12)t(11;12)(q21;p13.3)mat (ECACC=94030411).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1805
AC   CVCL_9H61
DR   ECACC; 94030922
DR   Wikidata; Q54829980
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 94030922; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9I75 ! DD2095
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1807
AC   CVCL_9H62
DR   ECACC; 94031114
DR   Wikidata; Q54829981
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94031114; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1808
AC   CVCL_9H63
DR   ECACC; 94031115
DR   Wikidata; Q54829982
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,var5(q11.1)mat (ECACC=94031115).
CC   Discontinued: ECACC; 94031115; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1810
AC   CVCL_9H64
DR   ECACC; 94031401
DR   Wikidata; Q54829983
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94031401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1811
AC   CVCL_9H65
DR   ECACC; 94031697
DR   Wikidata; Q54829984
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94031697; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1812
AC   CVCL_9H66
DR   ECACC; 94031698
DR   Wikidata; Q54829985
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94031698; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1815
AC   CVCL_9H67
DR   ECACC; 94031719
DR   Wikidata; Q54829986
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XYY (ECACC=94031719).
CC   Discontinued: ECACC; 94031719; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1819
AC   CVCL_9H68
DR   ECACC; 94032307
DR   Wikidata; Q54829987
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94032307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1820
AC   CVCL_9H69
DR   ECACC; 94032308
DR   Wikidata; Q54829988
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar(13/21) (ECACC=94032308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94032308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1822
AC   CVCL_9H70
DR   ECACC; 94032502
DR   Wikidata; Q54829989
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX (ECACC=94032502).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85207; True hermaphroditism
DI   ORDO; Orphanet_2138; 46,XX ovotesticular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H71 ! DD1832
SX   Sex ambiguous
AG   15Y11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1832
AC   CVCL_9H71
DR   ECACC; 94032807
DR   Wikidata; Q54829990
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX (ECACC=94032807).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
DI   NCIt; C85207; True hermaphroditism
DI   ORDO; Orphanet_2138; 46,XX ovotesticular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H70 ! DD1822
SX   Sex ambiguous
AG   15Y11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD1833
AC   CVCL_9H72
DR   ECACC; 94032907
DR   Wikidata; Q54829991
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94032907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1858
AC   CVCL_9H73
DR   ECACC; 04101814
DR   Wikidata; Q54829992
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 04101814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1860
AC   CVCL_9H74
DR   ECACC; 94042654
DR   Wikidata; Q54829993
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94042654; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1861
AC   CVCL_9H75
DR   ECACC; 94042902
DR   Wikidata; Q54829994
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94042902; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1862
AC   CVCL_9H76
DR   ECACC; 94042903
DR   Wikidata; Q54829995
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;17)(Xp17;17p); de novo (ECACC=94042903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H90 ! DD1894
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   DD1872
AC   CVCL_9H77
DR   ECACC; 94051016
DR   Wikidata; Q54829996
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,var(11)mat (ECACC=94051016).
CC   Discontinued: ECACC; 94051016; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1877
AC   CVCL_9H78
DR   ECACC; 94051604
DR   Wikidata; Q54829997
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94051604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1878
AC   CVCL_9H79
DR   ECACC; 94051605
DR   Wikidata; Q54829998
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94051605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD1880
AC   CVCL_9H80
DR   ECACC; 94051607
DR   Wikidata; Q54829999
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94051607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1882
AC   CVCL_9H81
DR   ECACC; 94051810
DR   Wikidata; Q54830000
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1883
AC   CVCL_9H82
DR   ECACC; 94051811
DR   Wikidata; Q54830001
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94051811; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1885
AC   CVCL_9H83
DR   ECACC; 94051813
DR   Wikidata; Q54830005
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94051813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1886
AC   CVCL_9H84
DR   ECACC; 94051814
DR   Wikidata; Q54830006
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94051814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1888
AC   CVCL_9H85
DR   ECACC; 94051916
DR   Wikidata; Q54830007
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98880; Persistent truncus arteriosus
DI   ORDO; Orphanet_3384; Truncus arteriosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1890
AC   CVCL_9H86
DR   ECACC; 94051917
DR   Wikidata; Q54830008
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94051917; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1891
AC   CVCL_9H87
DR   ECACC; 94052001
DR   Wikidata; Q54830009
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;4)(q13;q21)mat (ECACC=94052001).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98876; Congenital hydrocephalus
DI   ORDO; Orphanet_2185; Congenital hydrocephalus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1892
AC   CVCL_9H88
DR   ECACC; 94052002
DR   Wikidata; Q54830010
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94052002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1893
AC   CVCL_9H89
DR   ECACC; 94052003
DR   Wikidata; Q54830011
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94052003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1894
AC   CVCL_9H90
DR   ECACC; 94052312
DR   Wikidata; Q54830012
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;17)(Xp17;17p); de novo (ECACC=94052312).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H76 ! DD1862
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   DD1896
AC   CVCL_9H91
DR   ECACC; 94052314
DR   Wikidata; Q54830013
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X0 (ECACC=94052314).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84767; Hydrops fetalis
DI   ORDO; Orphanet_1041; Hydrops fetalis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   22FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1898
AC   CVCL_9H92
DR   ECACC; 94052508
DR   Wikidata; Q54830014
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94052508; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1904
AC   CVCL_9H93
DR   ECACC; 94052721
DR   Wikidata; Q54830015
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94052721; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1905
AC   CVCL_9H94
DR   ECACC; 94052722
DR   Wikidata; Q54830016
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(2)(q31.3;q37.1)(?O) (ECACC=94052722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94052722; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1906
AC   CVCL_9H95
DR   ECACC; 94052723
DR   Wikidata; Q54830017
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(2)(q31.3;q37.1) (ECACC=94052723).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1908
AC   CVCL_9H96
DR   ECACC; 94052732
DR   Wikidata; Q54830018
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94052732; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1909
AC   CVCL_9H97
DR   ECACC; 94052733
DR   Wikidata; Q54830019
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84572; Arthrogryposis
DI   ORDO; Orphanet_109007; Arthrogryposis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H99 ! DD1912
SX   Male
AG   1Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1911
AC   CVCL_9H98
DR   ECACC; 94060319
DR   Wikidata; Q54830020
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1912
AC   CVCL_9H99
DR   ECACC; 94060320
DR   Wikidata; Q54830021
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84572; Arthrogryposis
DI   ORDO; Orphanet_109007; Arthrogryposis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H97 ! DD1909
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1914
AC   CVCL_9I00
DR   ECACC; 940608135
DR   Wikidata; Q54830022
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608135; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1916
AC   CVCL_9I01
DR   ECACC; 940608137
DR   Wikidata; Q54830023
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1917
AC   CVCL_9I02
DR   ECACC; 940608138
DR   Wikidata; Q54830024
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1919
AC   CVCL_9I03
DR   ECACC; 940608140
DR   Wikidata; Q54830025
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;10)(p36.1;q24.3) (ECACC=940608140).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 940608140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1922
AC   CVCL_9I04
DR   ECACC; 94061010
DR   Wikidata; Q54830026
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1927
AC   CVCL_9I05
DR   ECACC; 94061304
DR   Wikidata; Q54830027
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;4)(q13;q21)pat (ECACC=94061304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94061304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1929
AC   CVCL_9I06
DR   ECACC; 94061306
DR   Wikidata; Q54830028
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,dup(7)(q32.1;q34); de novo (ECACC=94061306).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94061306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD1930
AC   CVCL_9I07
DR   ECACC; 94061307
DR   Wikidata; Q54830029
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50715; Pulmonary stenosis
DI   ORDO; Orphanet_3189; Congenital pulmonary valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1933
AC   CVCL_9I08
DR   ECACC; 94052010
DR   Wikidata; Q54830030
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1935
AC   CVCL_9I09
DR   ECACC; 94061709
DR   Wikidata; Q54830031
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1940
AC   CVCL_9I10
DR   ECACC; 94062010
DR   Wikidata; Q54830032
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD1946
AC   CVCL_9I11
DR   ECACC; 94062202
DR   Wikidata; Q54830033
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;4)(q13;q21)(?0) (ECACC=94062202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94062202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1950
AC   CVCL_9I12
DR   ECACC; 94062418
DR   Wikidata; Q54830034
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+mar(14/22) (ECACC=94062418).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94062418; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1951
AC   CVCL_9I13
DR   ECACC; 94062419
DR   Wikidata; Q54830035
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-4,+der(4),t(4;16)(q35.1;p13.3)mat (ECACC=94062419).
CC   Discontinued: ECACC; 94062419; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1953
AC   CVCL_9I14
DR   ECACC; 94062703
DR   Wikidata; Q54830036
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50715; Pulmonary stenosis
DI   ORDO; Orphanet_3189; Congenital pulmonary valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1956
AC   CVCL_9I15
DR   ECACC; 94062920
DR   Wikidata; Q54830037
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94062920; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1958
AC   CVCL_9I16
DR   ECACC; 94062938
DR   Wikidata; Q54830038
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+18 (ECACC=94062938).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1961
AC   CVCL_9I17
DR   ECACC; 94070302
DR   Wikidata; Q54830039
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1962
AC   CVCL_9I18
DR   ECACC; 94070303
DR   Wikidata; Q54830040
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,+der(15),t(Y;15)(p11;q13)pat (ECACC=94070303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1966
AC   CVCL_9I19
DR   ECACC; 94070434
DR   Wikidata; Q54830041
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,-1,+der(1),+der(7),t(1;7)(p21;q21.2)mat (ECACC=94070434).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD1967
AC   CVCL_AQ86
DR   ECACC; 94070435
DR   Wikidata; Q54830042
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD1969
AC   CVCL_9I20
DR   ECACC; 94070817
DR   Wikidata; Q54830043
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070817; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1970
AC   CVCL_9I21
DR   ECACC; 94070818
DR   Wikidata; Q54830044
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50715; Pulmonary stenosis
DI   ORDO; Orphanet_3189; Congenital pulmonary valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1975
AC   CVCL_9I22
DR   ECACC; 94070823
DR   Wikidata; Q54830050
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;11)(p21.2;q23.1)mat (ECACC=94070823).
CC   Discontinued: ECACC; 94070823; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD1976
AC   CVCL_9I23
DR   ECACC; 94070824
DR   Wikidata; Q54830051
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070824; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1977
AC   CVCL_9I24
DR   ECACC; 94070825
DR   Wikidata; Q54830052
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070825; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1984
AC   CVCL_9I25
DR   ECACC; 94071272
DR   Wikidata; Q54830053
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+der(5),t(5;11)(p15;p15.1)pat (ECACC=94071272).
CC   Discontinued: ECACC; 94071272; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H45 ! DD1767
OI   CVCL_9H53 ! DD1778
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD1986
AC   CVCL_9I26
DR   ECACC; 94071453
DR   Wikidata; Q54830054
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071453; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1987
AC   CVCL_9I27
DR   ECACC; 94071454
DR   Wikidata; Q54830055
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071454; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1988
AC   CVCL_9I28
DR   ECACC; 94071455
DR   Wikidata; Q54830056
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD1990
AC   CVCL_9I29
DR   ECACC; 94071511
DR   Wikidata; Q54830057
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;22),(q23;q11.2) (ECACC=94071511).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071511; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1991
AC   CVCL_9I30
DR   ECACC; 94071512
DR   Wikidata; Q54830058
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071512; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1993
AC   CVCL_9I31
DR   ECACC; 94071514
DR   Wikidata; Q54830059
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071514; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1994
AC   CVCL_9I32
DR   ECACC; 94071515
DR   Wikidata; Q54830060
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071515; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1996
AC   CVCL_9I33
DR   ECACC; 94071554
DR   Wikidata; Q54830061
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071554; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD1998
AC   CVCL_9I34
DR   ECACC; 94071556
DR   Wikidata; Q54830062
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071556; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2000
AC   CVCL_9Q32
DR   ECACC; 94072230
DR   Wikidata; Q54830063
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,X0 (ECACC=94072230).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2002
AC   CVCL_9I35
DR   ECACC; 94072513
DR   Wikidata; Q54830065
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X),(qter->p22)mat (ECACC=94072513).
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2010
AC   CVCL_9I36
DR   ECACC; 94073101
DR   Wikidata; Q54830066
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94073101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2011
AC   CVCL_9I37
DR   ECACC; 94073102
DR   Wikidata; Q54830067
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94073102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2022
AC   CVCL_9I38
DR   ECACC; 94080405
DR   Wikidata; Q54830068
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar(13/21); de novo (ECACC=94080405).
CC   Discontinued: ECACC; 94080405; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9I44 ! DD2031
OI   CVCL_9I51 ! DD2041
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2025
AC   CVCL_9I39
DR   ECACC; 94080408
DR   Wikidata; Q54830069
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;4)(q35;q35.1) (ECACC=94080408).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2026
AC   CVCL_9I40
DR   ECACC; 94080409
DR   Wikidata; Q54830070
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2027
AC   CVCL_9I41
DR   ECACC; 94080410
DR   Wikidata; Q54830071
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-4,+der(4),t(2;4)(q35;q35.1)pat (ECACC=94080410).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2028
AC   CVCL_9I42
DR   ECACC; 94080522
DR   Wikidata; Q54830072
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080522; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2029
AC   CVCL_9I43
DR   ECACC; 94080523
DR   Wikidata; Q54830073
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080523; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2031
AC   CVCL_9I44
DR   ECACC; 94080525
DR   Wikidata; Q54830074
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar(13/21); de novo (ECACC=94080525).
CC   Discontinued: ECACC; 94080525; true.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9I38 ! DD2022
OI   CVCL_9I51 ! DD2041
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2032
AC   CVCL_9I45
DR   ECACC; 94080811
DR   Wikidata; Q54830075
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-5,+der(5),t(5;11)(p15;p15)pat (ECACC=94080811).
CC   Discontinued: ECACC; 94080811; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2035
AC   CVCL_9I46
DR   ECACC; 94080814
DR   Wikidata; Q54830076
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8U30 ! DD0012
SX   Male
AG   16Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2036
AC   CVCL_9I47
DR   ECACC; 94080815
DR   Wikidata; Q54830077
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,dir dup(1)(q32.1;q42.1); de novo (ECACC=94080815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080815; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   DD2037
AC   CVCL_9I48
DR   ECACC; 94080816
DR   Wikidata; Q54830078
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080816; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2038
AC   CVCL_9I49
DR   ECACC; 94080817
DR   Wikidata; Q54830079
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94080817; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2040
AC   CVCL_9I50
DR   ECACC; 94081111
DR   Wikidata; Q54830080
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+9 (ECACC=94081111).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2041
AC   CVCL_9I51
DR   ECACC; 94081226
DR   Wikidata; Q54830081
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+mar(13/21); de novo (ECACC=94081226).
CC   Discontinued: ECACC; 94081226; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9I38 ! DD2022
OI   CVCL_9I44 ! DD2031
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2042
AC   CVCL_9I52
DR   ECACC; 94081227
DR   Wikidata; Q54830082
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081227; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2043
AC   CVCL_9I53
DR   ECACC; 94081228
DR   Wikidata; Q54830083
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081228; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2044
AC   CVCL_9I54
DR   ECACC; 94081610
DR   Wikidata; Q54830084
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2046
AC   CVCL_9I55
DR   ECACC; 94081818
DR   Wikidata; Q54830085
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94081818; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2048
AC   CVCL_9I56
DR   ECACC; 94081828
DR   Wikidata; Q54830086
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=94081828).
CC   Discontinued: ECACC; 94081828; true.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2054
AC   CVCL_9I57
DR   ECACC; 94082419
DR   Wikidata; Q54830087
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082419; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2056
AC   CVCL_9I58
DR   ECACC; 94082533
DR   Wikidata; Q54830088
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082533; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2057
AC   CVCL_9I59
DR   ECACC; 94082534
DR   Wikidata; Q54830089
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;9),(q42.13;p13.2)(?O) (ECACC=94082534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082534; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2058
AC   CVCL_9I60
DR   ECACC; 94082535
DR   Wikidata; Q54830090
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;19)(q42.13;p13) (ECACC=94082535).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082535; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2064
AC   CVCL_9I61
DR   ECACC; 94082709
DR   Wikidata; Q54830094
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082709; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2068
AC   CVCL_9I62
DR   ECACC; 94083002
DR   Wikidata; Q54830095
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=94083002).
CC   Discontinued: ECACC; 94083002; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2069
AC   CVCL_9I63
DR   ECACC; 94083003
DR   Wikidata; Q54830096
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(10)(q22.1;q23.2)mat (ECACC=94083003).
CC   Discontinued: ECACC; 94083003; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2072
AC   CVCL_9I64
DR   ECACC; 94083104
DR   Wikidata; Q54830097
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94083104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2073
AC   CVCL_9I65
DR   ECACC; 94083106
DR   Wikidata; Q54830098
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94083106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2075
AC   CVCL_9I66
DR   ECACC; 94083108
DR   Wikidata; Q54830099
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94083108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2077
AC   CVCL_9I67
DR   ECACC; 94090205
DR   Wikidata; Q54830100
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-7,+der(7),t(7;11)(q36.1;q23.3)pat (ECACC=94090205).
CC   Discontinued: ECACC; 94090205; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2078
AC   CVCL_9I68
DR   ECACC; 94090301
DR   Wikidata; Q54830101
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2080
AC   CVCL_9I69
DR   ECACC; 94090303
DR   Wikidata; Q54830102
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2089
AC   CVCL_9I70
DR   ECACC; 94090716
DR   Wikidata; Q54830103
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94090716; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2090
AC   CVCL_9I71
DR   ECACC; 94090717
DR   Wikidata; Q54830104
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;3)(q21;q25)pat (ECACC=94090717).
CC   Discontinued: ECACC; 94090717; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2091
AC   CVCL_9I72
DR   ECACC; 94091612
DR   Wikidata; Q54830105
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-11,+der(11),t(10;11)(q23.1;q25)pat (ECACC=94091612).
CC   Discontinued: ECACC; 94091612; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2092
AC   CVCL_9I73
DR   ECACC; 94091613
DR   Wikidata; Q54830106
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+13 (ECACC=94091613).
CC   Discontinued: ECACC; 94091613; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD2093
AC   CVCL_9I74
DR   ECACC; 94092003
DR   Wikidata; Q54830107
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 94092003; true.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2095
AC   CVCL_9I75
DR   ECACC; 94092109
DR   Wikidata; Q54830108
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 94092109; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9H61 ! DD1805
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2098
AC   CVCL_9I76
DR   ECACC; 94092702
DR   Wikidata; Q54830109
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;14)(q36.3;q31.3) (ECACC=94092702).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94092702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD2099
AC   CVCL_9I77
DR   ECACC; 94092807
DR   Wikidata; Q54830110
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-7,+der(7),t(7;14)(q36.3;q31.3)pat (ECACC=94092807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94092807; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2100
AC   CVCL_9I78
DR   ECACC; 94092904
DR   Wikidata; Q54830111
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2101
AC   CVCL_9I79
DR   ECACC; 94100503
DR   Wikidata; Q54830112
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=94100503).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2103
AC   CVCL_9I80
DR   ECACC; 94100615
DR   Wikidata; Q54830113
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+13 (ECACC=94100615).
CC   Discontinued: ECACC; 94100615; true.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2105
AC   CVCL_9I81
DR   ECACC; 94100724
DR   Wikidata; Q54830114
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,+(4;14)(q31.3;q24.3) (ECACC=94100724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94100724; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2108
AC   CVCL_9I82
DR   ECACC; 94102502
DR   Wikidata; Q54830115
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=94102502).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C74988; Holoprosencephaly
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_2162; Holoprosencephaly
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2109
AC   CVCL_9I83
DR   ECACC; 94102503
DR   Wikidata; Q54830116
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=94102503).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84570; Arnold-Chiari malformation
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_93969; Open spinal dysraphism with a myelomeningocele
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   DD2110
AC   CVCL_9I84
DR   ECACC; 94102707
DR   Wikidata; Q54830117
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+13 (ECACC=94102707).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3724; Congenital cystic hygroma
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_79486; Cystic hygroma
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   DD2111
AC   CVCL_9I85
DR   ECACC; 94102708
DR   Wikidata; Q54830118
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XYY (ECACC=94102708).
CC   Discontinued: ECACC; 94102708; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9I99 ! DD2135
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2112
AC   CVCL_9I86
DR   ECACC; 94102709
DR   Wikidata; Q54830119
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94102709; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2113
AC   CVCL_9I87
DR   ECACC; 94102710
DR   Wikidata; Q54830120
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2114
AC   CVCL_9I88
DR   ECACC; 941031166
DR   Wikidata; Q54830121
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 941031166; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2119
AC   CVCL_9I89
DR   ECACC; 94110437
DR   Wikidata; Q54830122
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94110437; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2120
AC   CVCL_9I90
DR   ECACC; 94110438
DR   Wikidata; Q54830123
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94110438; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2123
AC   CVCL_9I91
DR   ECACC; 94110706
DR   Wikidata; Q54830124
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+13 (ECACC=94110706).
CC   Discontinued: ECACC; 94110706; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C125597; Polysyndactyly
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_93338; Polysyndactyly
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2124
AC   CVCL_9I92
DR   ECACC; 94111030
DR   Wikidata; Q54830125
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,?var(15),(q12) (ECACC=94111030).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94111030; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD2125
AC   CVCL_9I93
DR   ECACC; 94111031
DR   Wikidata; Q54830126
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;19)(p5:q19;q5:p19)pat (ECACC=94111031).
CC   Discontinued: ECACC; 94111031; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2126
AC   CVCL_9I94
DR   ECACC; 94111135
DR   Wikidata; Q54830127
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-2,+der(2),t(2;8)(q37.3;p23.1)pat (ECACC=94111135).
CC   Discontinued: ECACC; 94111135; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2127
AC   CVCL_9I95
DR   ECACC; 94071555
DR   Wikidata; Q54830128
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,t(X;10)(q26.3;q23.2) (ECACC=94071555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94071555; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2132
AC   CVCL_9I96
DR   ECACC; 94111804
DR   Wikidata; Q54830129
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94111804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2133
AC   CVCL_9I97
DR   ECACC; 94111803
DR   Wikidata; Q54830130
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94111803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2134
AC   CVCL_9I98
DR   ECACC; 94111843
DR   Wikidata; Q54830131
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 94111843; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2135
AC   CVCL_9I99
DR   ECACC; 94112416
DR   Wikidata; Q54830132
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XYY (ECACC=94112416).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9I85 ! DD2111
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2136
AC   CVCL_9J00
DR   ECACC; 94112417
DR   Wikidata; Q54830133
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+18 (ECACC=94112417).
CC   Discontinued: ECACC; 94112417; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2142
AC   CVCL_9J01
DR   ECACC; 94113021
DR   Wikidata; Q54830137
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,mar(Y); de novo (ECACC=94113021).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   DD2143
AC   CVCL_9J02
DR   ECACC; 94113022
DR   Wikidata; Q54830138
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,der(X),t(X;10)(q26.3;q23.2)mat (ECACC=94113022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94113022; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2144
AC   CVCL_9J03
DR   ECACC; 94120408
DR   Wikidata; Q54830139
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94120408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2145
AC   CVCL_9J04
DR   ECACC; 94120409
DR   Wikidata; Q54830140
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94120409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2146
AC   CVCL_9J05
DR   ECACC; 94120410
DR   Wikidata; Q54830141
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94120410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2149
AC   CVCL_9J06
DR   ECACC; 94120402
DR   Wikidata; Q54830142
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94120402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2151
AC   CVCL_9J07
DR   ECACC; 94120703
DR   Wikidata; Q54830143
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(3),?(p21;q23) (ECACC=94120703).
CC   Discontinued: ECACC; 94120703; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2156
AC   CVCL_9J08
DR   ECACC; 94121417
DR   Wikidata; Q54830144
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7582; Nevus of Ito
DI   ORDO; Orphanet_263432; Nevus of Ito
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9J09 ! DD2157
SX   Female
AG   2Y4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2157
AC   CVCL_9J09
DR   ECACC; 94121542
DR   Wikidata; Q54830145
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7582; Nevus of Ito
DI   ORDO; Orphanet_263432; Nevus of Ito
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9J08 ! DD2156
SX   Female
AG   2Y4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2159
AC   CVCL_9J10
DR   ECACC; 94121639
DR   Wikidata; Q54830146
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94121639; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2160
AC   CVCL_9J11
DR   ECACC; 94121640
DR   Wikidata; Q54830147
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(qter->p22)mat (ECACC=94121640).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94121640; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2162
AC   CVCL_9J12
DR   ECACC; 94122022
DR   Wikidata; Q54830148
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2163
AC   CVCL_9J13
DR   ECACC; 94122023
DR   Wikidata; Q54830149
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94122023; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2168
AC   CVCL_9J14
DR   ECACC; 94122301
DR   Wikidata; Q54830150
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94122301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2169
AC   CVCL_9J15
DR   ECACC; 94122302
DR   Wikidata; Q54830151
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2173
AC   CVCL_9J16
DR   ECACC; 95010707
DR   Wikidata; Q54830152
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;12)(p22.1;q22)mat (ECACC=95010707).
CC   Discontinued: ECACC; 95010707; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2174
AC   CVCL_AQ87
DR   ECACC; 95010701
DR   Wikidata; Q54830154
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95010701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y7M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2175
AC   CVCL_AQ88
DR   ECACC; 95010702
DR   Wikidata; Q54830155
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+mar (ECACC=95010702).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2176
AC   CVCL_AQ89
DR   ECACC; 95010703
DR   Wikidata; Q54830156
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95010703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2180
AC   CVCL_9J17
DR   ECACC; 95011002
DR   Wikidata; Q54830157
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95011002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2181
AC   CVCL_9J18
DR   ECACC; 94071904
DR   Wikidata; Q54830158
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50715; Pulmonary stenosis
DI   ORDO; Orphanet_3189; Congenital pulmonary valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2182
AC   CVCL_9J19
DR   ECACC; 95011617
DR   Wikidata; Q54830159
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75458; Pallister-Killian syndrome
DI   ORDO; Orphanet_884; Tetrasomy 12p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2184
AC   CVCL_9J20
DR   ECACC; 95011909
DR   Wikidata; Q54830160
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(10)(p11;q21.2) (ECACC=95011909).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95011909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2187
AC   CVCL_9J21
DR   ECACC; 950120162
DR   Wikidata; Q54830161
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 950120162; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2204
AC   CVCL_9J22
DR   ECACC; 95021305
DR   Wikidata; Q54830162
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2205
AC   CVCL_9J23
DR   ECACC; 95021304
DR   Wikidata; Q54830163
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95021304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2206
AC   CVCL_9J24
DR   ECACC; 95021601
DR   Wikidata; Q54830164
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95021601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2207
AC   CVCL_9J25
DR   ECACC; 95021602
DR   Wikidata; Q54830165
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2208
AC   CVCL_9J26
DR   ECACC; 95021603
DR   Wikidata; Q54830166
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2217
AC   CVCL_9J27
DR   ECACC; 95022815
DR   Wikidata; Q54830167
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(10)?(p11;q11) (ECACC=95022815).
CC   Discontinued: ECACC; 95022815; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2218
AC   CVCL_AQ90
DR   ECACC; 95022816
DR   Wikidata; Q54830168
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 95022816; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C126326; Roberts syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD2221
AC   CVCL_AQ91
DR   ECACC; 95030626
DR   Wikidata; Q54830169
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY; 47,XY,+7 (ECACC=95030626).
CC   Discontinued: ECACC; 95030626; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD2222
AC   CVCL_9J28
DR   ECACC; 95030627
DR   Wikidata; Q54830170
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 46,X,r(X) (ECACC=95030627).
CC   Discontinued: ECACC; 95030627; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2224
AC   CVCL_9J29
DR   ECACC; 95031007
DR   Wikidata; Q54830171
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(qter->p11.4) (ECACC=95031007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2226
AC   CVCL_9J30
DR   ECACC; 95031507
DR   Wikidata; Q54830172
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95031507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2227
AC   CVCL_9J31
DR   ECACC; 95031508
DR   Wikidata; Q54830173
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95031508; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2228
AC   CVCL_9J32
DR   ECACC; 95031509
DR   Wikidata; Q54830174
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95031509; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2233
AC   CVCL_9J33
DR   ECACC; 95032230
DR   Wikidata; Q54830175
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(7;11)(p12.2;p14.2) (ECACC=95032230).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2235
AC   CVCL_9J34
DR   ECACC; 95032427
DR   Wikidata; Q54830176
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2236
AC   CVCL_9J35
DR   ECACC; 95032428
DR   Wikidata; Q54830177
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(5;15)(q22.3;q13) (ECACC=95032428).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95032428; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2242
AC   CVCL_AQ92
DR   ECACC; 95033118
DR   Wikidata; Q54830181
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95033118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2243
AC   CVCL_AQ93
DR   ECACC; 95033119
DR   Wikidata; Q54830182
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95033119; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2248
AC   CVCL_9J36
DR   ECACC; 95040614
DR   Wikidata; Q54830183
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX.ish,22q11.2(cH748x2) (ECACC=95040614).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84681; Ebstein anomaly
DI   ORDO; Orphanet_1880; Ebstein malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2253
AC   CVCL_9J37
DR   ECACC; 95041308
DR   Wikidata; Q54830184
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(9)(qter->p22) (ECACC=95041308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2255
AC   CVCL_9J38
DR   ECACC; 95042114
DR   Wikidata; Q54830185
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(2)(q31.3;q37.1)mat (ECACC=95042114).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2259
AC   CVCL_9J39
DR   ECACC; 95042830
DR   Wikidata; Q54830186
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+8 (ECACC=95042830).
CC   Discontinued: ECACC; 95042830; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2260
AC   CVCL_9J40
DR   ECACC; 95050104
DR   Wikidata; Q54830187
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+13 (ECACC=95050104).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2261
AC   CVCL_9J41
DR   ECACC; 95050105
DR   Wikidata; Q54830188
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+18 (ECACC=95050105).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2264
AC   CVCL_AQ94
DR   ECACC; 95050520
DR   Wikidata; Q54830189
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD2267
AC   CVCL_AQ95
DR   ECACC; 95050523
DR   Wikidata; Q54830190
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD2274
AC   CVCL_9J42
DR   ECACC; 95051228
DR   Wikidata; Q54830191
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(17)(p11.2;p11.2) (ECACC=95051228).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9J49 ! DD2291
SX   Male
AG   9Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2276
AC   CVCL_9J43
DR   ECACC; 95052401
DR   Wikidata; Q54830192
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95052401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2278
AC   CVCL_9J44
DR   ECACC; 95052403
DR   Wikidata; Q54830193
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95052403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2281
AC   CVCL_9J45
DR   ECACC; 95053002
DR   Wikidata; Q54830194
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95053002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2282
AC   CVCL_9J46
DR   ECACC; 95053003
DR   Wikidata; Q54830195
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95053003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2285
AC   CVCL_9J47
DR   ECACC; 95053109
DR   Wikidata; Q54830196
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95053109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2286
AC   CVCL_9J48
DR   ECACC; 95053110
DR   Wikidata; Q54830197
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95053110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2291
AC   CVCL_9J49
DR   ECACC; 95060215
DR   Wikidata; Q54830198
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(17)(p11.2;p11.2) (ECACC=95060215).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9J42 ! DD2274
SX   Male
AG   9Y1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2295
AC   CVCL_9J50
DR   ECACC; 95060304
DR   Wikidata; Q54830199
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95060304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2299
AC   CVCL_9J51
DR   ECACC; 95060704
DR   Wikidata; Q54830200
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95060704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2301
AC   CVCL_9J52
DR   ECACC; 95060908
DR   Wikidata; Q54830201
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-13,+der(13),t(Y;13)(q12;p11)mat (ECACC=95060908).
CC   Discontinued: ECACC; 95060908; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2305
AC   CVCL_AQ96
DR   ECACC; 95060912
DR   Wikidata; Q54830202
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   17Y6M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2307
AC   CVCL_9J53
DR   ECACC; 95060914
DR   Wikidata; Q54830203
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,dup(15)(q11:q13) (ECACC=95060914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2308
AC   CVCL_9J54
DR   ECACC; 95060915
DR   Wikidata; Q54830204
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95060915; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2309
AC   CVCL_9J55
DR   ECACC; 95061206
DR   Wikidata; Q54830205
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2310
AC   CVCL_9J56
DR   ECACC; 95061207
DR   Wikidata; Q54830206
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2311
AC   CVCL_9J57
DR   ECACC; 95061208
DR   Wikidata; Q54830207
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2312
AC   CVCL_9J58
DR   ECACC; 95061310
DR   Wikidata; Q54830208
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061310; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2313
AC   CVCL_9J59
DR   ECACC; 95061501
DR   Wikidata; Q54830209
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2314
AC   CVCL_9J60
DR   ECACC; 95061502
DR   Wikidata; Q54830210
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2315
AC   CVCL_9J61
DR   ECACC; 95061503
DR   Wikidata; Q54830211
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2319
AC   CVCL_9J62
DR   ECACC; 95061609
DR   Wikidata; Q54830212
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061609; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2320
AC   CVCL_9J63
DR   ECACC; 95061610
DR   Wikidata; Q54830213
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061610; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2323
AC   CVCL_9J64
DR   ECACC; 95061613
DR   Wikidata; Q54830214
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2324
AC   CVCL_9J65
DR   ECACC; 95061634
DR   Wikidata; Q54830215
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061634; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2325
AC   CVCL_9J66
DR   ECACC; 95061635
DR   Wikidata; Q54830216
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061635; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2326
AC   CVCL_9J67
DR   ECACC; 95061636
DR   Wikidata; Q54830217
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95061636; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2329
AC   CVCL_9J68
DR   ECACC; 95062006
DR   Wikidata; Q54830218
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2331
AC   CVCL_9J69
DR   ECACC; 95062108
DR   Wikidata; Q54830219
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2332
AC   CVCL_9J70
DR   ECACC; 95062107
DR   Wikidata; Q54830220
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062107; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2333
AC   CVCL_9J71
DR   ECACC; 95062308
DR   Wikidata; Q54830225
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2335
AC   CVCL_9J72
DR   ECACC; 95062310
DR   Wikidata; Q54830226
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062310; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2336
AC   CVCL_AQ97
DR   ECACC; 95062311
DR   Wikidata; Q54830227
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 95062311; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 6
//
ID   DD2337
AC   CVCL_9J73
DR   ECACC; 95062312
DR   Wikidata; Q54830228
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2338
AC   CVCL_9J74
DR   ECACC; 95062313
DR   Wikidata; Q54830229
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062313; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2339
AC   CVCL_9J75
DR   ECACC; 95062314
DR   Wikidata; Q54830230
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2340
AC   CVCL_9J76
DR   ECACC; 95062315
DR   Wikidata; Q54830231
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+psu dic(15)(pter->q12::q12->pter) (ECACC=95062315).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2341
AC   CVCL_AQ98
DR   ECACC; 95062316
DR   Wikidata; Q54830232
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX.ish:22q11.2(cH748x22) (ECACC=95062316).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD2342
AC   CVCL_9J77
DR   ECACC; 95062321
DR   Wikidata; Q54830233
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2344
AC   CVCL_9J78
DR   ECACC; 95062707
DR   Wikidata; Q54830234
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2345
AC   CVCL_9J79
DR   ECACC; 95062708
DR   Wikidata; Q54830235
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2347
AC   CVCL_9J80
DR   ECACC; 95062818
DR   Wikidata; Q54830236
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062818; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2348
AC   CVCL_9J81
DR   ECACC; 95062819
DR   Wikidata; Q54830237
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062819; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2349
AC   CVCL_9J82
DR   ECACC; 95062820
DR   Wikidata; Q54830238
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062820; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2350
AC   CVCL_9J83
DR   ECACC; 95062821
DR   Wikidata; Q54830239
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95062821; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2351
AC   CVCL_9J84
DR   ECACC; 95062822
DR   Wikidata; Q54830240
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+10 (ECACC=95062822).
CC   Discontinued: ECACC; 95062822; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2352
AC   CVCL_9J85
DR   ECACC; 95063008
DR   Wikidata; Q54830241
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95063008; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2353
AC   CVCL_9J86
DR   ECACC; 95063009
DR   Wikidata; Q54830242
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95063009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2356
AC   CVCL_9J87
DR   ECACC; 95063112
DR   Wikidata; Q54830243
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95063112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2358
AC   CVCL_9J88
DR   ECACC; 95063014
DR   Wikidata; Q54830244
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95063014; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2360
AC   CVCL_9J89
DR   ECACC; 95063016
DR   Wikidata; Q54830245
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,var(6)cen (ECACC=95063016).
CC   Discontinued: ECACC; 95063016; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2361
AC   CVCL_9J90
DR   ECACC; 95070101
DR   Wikidata; Q54830246
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X; 46,X,r(X) (ECACC=95070101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2363
AC   CVCL_9J91
DR   ECACC; 95070103
DR   Wikidata; Q54830247
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95070103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2370
AC   CVCL_9J92
DR   ECACC; 95070801
DR   Wikidata; Q54830248
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95070801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2388
AC   CVCL_AQ99
DR   ECACC; 95072401
DR   Wikidata; Q54830249
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+21 (ECACC=95072401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95072401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   DD2389
AC   CVCL_9J93
DR   ECACC; 95072402
DR   Wikidata; Q54830250
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(5)(p15.2); de novo (ECACC=95072402).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 6
//
ID   DD2391
AC   CVCL_9J94
DR   ECACC; 95080202
DR   Wikidata; Q54830251
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95080202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2393
AC   CVCL_9J95
DR   ECACC; 95080801
DR   Wikidata; Q54830252
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2403
AC   CVCL_AR00
DR   ECACC; 95081711
DR   Wikidata; Q54830253
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95081711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y7M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2404
AC   CVCL_AR01
DR   ECACC; 95081712
DR   Wikidata; Q54830254
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95081712; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y1M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2405
AC   CVCL_9J96
DR   ECACC; 95081713
DR   Wikidata; Q54830255
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,add(10)(q26) (ECACC=95081713).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2410
AC   CVCL_9J97
DR   ECACC; 95082410
DR   Wikidata; Q54830256
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95082410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2411
AC   CVCL_9J98
DR   ECACC; 95082411
DR   Wikidata; Q54830257
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,+psu dic(15) (ECACC=95082411).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2413
AC   CVCL_9J99
DR   ECACC; 95090506
DR   Wikidata; Q54830258
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95090506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2414
AC   CVCL_AR02
DR   ECACC; 95090507
DR   Wikidata; Q54830259
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2415
AC   CVCL_9K00
DR   ECACC; 95090605
DR   Wikidata; Q54830260
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95090605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2419
AC   CVCL_9K01
DR   ECACC; 95091402
DR   Wikidata; Q54830261
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(8;11)(q24.11;q23.1) (ECACC=95091402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2422
AC   CVCL_9K02
DR   ECACC; 95091603
DR   Wikidata; Q54830262
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95091603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2428
AC   CVCL_9K03
DR   ECACC; 95092606
DR   Wikidata; Q54830263
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95092606; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2431
AC   CVCL_9K04
DR   ECACC; 95092706
DR   Wikidata; Q54830264
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y10M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2439
AC   CVCL_AR03
DR   ECACC; 95101713
DR   Wikidata; Q54830266
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   DD2442
AC   CVCL_9K05
DR   ECACC; 95102509
DR   Wikidata; Q54830267
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,ins(7)(q42.1;q34.1;q35) (ECACC=95102509).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2450
AC   CVCL_9K06
DR   ECACC; 95103002
DR   Wikidata; Q54830268
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,-7,+der(7),t(7;19)(q36.1;q13.43)pat (ECACC=95103002).
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2451
AC   CVCL_9K07
DR   ECACC; 95103003
DR   Wikidata; Q54830269
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-6,+der(6),t(6;16)(q2;q2)mat (ECACC=95103003).
CC   Discontinued: ECACC; 95103003; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2452
AC   CVCL_9K08
DR   ECACC; 95103113
DR   Wikidata; Q54830270
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(9)(?p24); de novo (ECACC=95103113).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 6
//
ID   DD2456
AC   CVCL_9K09
DR   ECACC; 95110314
DR   Wikidata; Q54830271
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98967; Klippel-Feil syndrome
DI   ORDO; Orphanet_2345; Isolated Klippel-Feil syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2461
AC   CVCL_AR04
DR   ECACC; 95111033
DR   Wikidata; Q54830272
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y6M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD2464
AC   CVCL_9K10
DR   ECACC; 95111601
DR   Wikidata; Q54830273
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(qter->p21.2) (ECACC=95111601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2468
AC   CVCL_9K11
DR   ECACC; 95111617
DR   Wikidata; Q54830274
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2470
AC   CVCL_9K12
DR   ECACC; 95112009
DR   Wikidata; Q54830275
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2482
AC   CVCL_9K13
DR   ECACC; 95112801
DR   Wikidata; Q54830276
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95112801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2485
AC   CVCL_9K14
DR   ECACC; 95113001
DR   Wikidata; Q54830277
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95113001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2486
AC   CVCL_9K15
DR   ECACC; 95120102
DR   Wikidata; Q54830278
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95120102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2489
AC   CVCL_9K16
DR   ECACC; 95120417
DR   Wikidata; Q54830279
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95120417; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2490
AC   CVCL_9K17
DR   ECACC; 95120419
DR   Wikidata; Q54830280
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(3)(q21;q25) (ECACC=95120419).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ECACC=95120419).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   DD2496
AC   CVCL_9K18
DR   ECACC; 95120824
DR   Wikidata; Q54830281
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95120824; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2510
AC   CVCL_9K19
DR   ECACC; 95121514
DR   Wikidata; Q54830282
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95121514; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2513
AC   CVCL_9K20
DR   ECACC; 95122209
DR   Wikidata; Q54830283
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95122209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2519
AC   CVCL_AR05
DR   ECACC; 96010516
DR   Wikidata; Q54830284
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96010516; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y10M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2520
AC   CVCL_9K21
DR   ECACC; 96010949
DR   Wikidata; Q54830285
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96010949; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2521
AC   CVCL_9K22
DR   ECACC; 96010950
DR   Wikidata; Q54830286
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96010950; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2522
AC   CVCL_AR06
DR   ECACC; 96010956
DR   Wikidata; Q54830287
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96010956; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2524
AC   CVCL_9K23
DR   ECACC; 96011145
DR   Wikidata; Q54830288
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2530
AC   CVCL_9K24
DR   ECACC; 96011601
DR   Wikidata; Q54830289
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2539
AC   CVCL_9K25
DR   ECACC; 96011902
DR   Wikidata; Q54830290
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2540
AC   CVCL_9K26
DR   ECACC; 96011903
DR   Wikidata; Q54830291
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2544
AC   CVCL_9K27
DR   ECACC; 96012504
DR   Wikidata; Q54830292
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2545
AC   CVCL_9K28
DR   ECACC; 96012910
DR   Wikidata; Q54830293
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2550
AC   CVCL_9K29
DR   ECACC; 96020215
DR   Wikidata; Q54830294
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2552
AC   CVCL_9K30
DR   ECACC; 96020519
DR   Wikidata; Q54830295
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(2),ins(2;6) (ECACC=96020519).
CC   Discontinued: ECACC; 96020519; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2553
AC   CVCL_9K31
DR   ECACC; 96020520
DR   Wikidata; Q54830297
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(2),ins(2;6) (ECACC=96020520).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2558
AC   CVCL_9K32
DR   ECACC; 96021201
DR   Wikidata; Q54830298
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2562
AC   CVCL_AR07
DR   ECACC; 96021505
DR   Wikidata; Q54830299
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,8p+ (ECACC=96021505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2563
AC   CVCL_9K33
DR   ECACC; 96021601
DR   Wikidata; Q54830300
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96021601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2564
AC   CVCL_9K34
DR   ECACC; 96021602
DR   Wikidata; Q54830301
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96021602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2565
AC   CVCL_9K35
DR   ECACC; 96022001
DR   Wikidata; Q54830303
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2566
AC   CVCL_9K36
DR   ECACC; 96022101
DR   Wikidata; Q54830304
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(4),t(4;9) (ECACC=96022101).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2569
AC   CVCL_9K37
DR   ECACC; 96022310
DR   Wikidata; Q54830305
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2570
AC   CVCL_9K38
DR   ECACC; 96022311
DR   Wikidata; Q54830306
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2574
AC   CVCL_9K39
DR   ECACC; 96022712
DR   Wikidata; Q54830307
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2584
AC   CVCL_AR08
DR   ECACC; 96030701
DR   Wikidata; Q54830311
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96030701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2586
AC   CVCL_AR09
DR   ECACC; 96030703
DR   Wikidata; Q54830312
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2587
AC   CVCL_9K40
DR   ECACC; 96030801
DR   Wikidata; Q54830313
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96030801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2589
AC   CVCL_9K41
DR   ECACC; 96031527
DR   Wikidata; Q54830314
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2591
AC   CVCL_9K42
DR   ECACC; 96031552
DR   Wikidata; Q54830315
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2592
AC   CVCL_9K43
DR   ECACC; 96032001
DR   Wikidata; Q54830316
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2606
AC   CVCL_9K44
DR   ECACC; 96032941
DR   Wikidata; Q54830317
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7582; Nevus of Ito
DI   ORDO; Orphanet_263432; Nevus of Ito
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2609
AC   CVCL_AR10
DR   ECACC; 96032944
DR   Wikidata; Q54830318
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96032944; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2620
AC   CVCL_9K45
DR   ECACC; 96040932
DR   Wikidata; Q54830319
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;19)(p10;q10)mat (ECACC=96040932).
CC   Discontinued: ECACC; 96040932; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2628
AC   CVCL_9K46
DR   ECACC; 96041602
DR   Wikidata; Q54830320
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96041602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2634
AC   CVCL_9K47
DR   ECACC; 96042602
DR   Wikidata; Q54830321
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96042602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2635
AC   CVCL_9K48
DR   ECACC; 96043002
DR   Wikidata; Q54830322
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96043002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2642
AC   CVCL_9K49
DR   ECACC; 96050825
DR   Wikidata; Q54830323
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(4),t(4;12)(p16.2;q24.11) (ECACC=96050825).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2644
AC   CVCL_9K50
DR   ECACC; 96050810
DR   Wikidata; Q54830324
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY.ish 22q11-2(cH748x2) (ECACC=96050810).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85071; Smith-Lemli-Opitz syndrome
DI   ORDO; Orphanet_818; Smith-Lemli-Opitz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2647
AC   CVCL_9K51
DR   ECACC; 96051348
DR   Wikidata; Q54830325
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,?dup(15)(q11;q13),+21 (ECACC=96051348).
CC   Discontinued: ECACC; 96051348; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2650
AC   CVCL_9K52
DR   ECACC; 96051713
DR   Wikidata; Q54830326
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,dup(15)(q21;q24) (ECACC=96051713).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2651
AC   CVCL_9K53
DR   ECACC; 96052108
DR   Wikidata; Q54830327
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,add(20)(q13.3) (ECACC=96052108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2654
AC   CVCL_AR11
DR   ECACC; 96052436
DR   Wikidata; Q54830329
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96052436; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2660
AC   CVCL_9K54
DR   ECACC; 96060306
DR   Wikidata; Q54830330
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96060306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2664
AC   CVCL_9K55
DR   ECACC; 96060434
DR   Wikidata; Q54830331
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;11)(p12.2;p15.1) (ECACC=96060434).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2667
AC   CVCL_9K56
DR   ECACC; 96060638
DR   Wikidata; Q54830332
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96060638; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2681
AC   CVCL_9K57
DR   ECACC; 96061934
DR   Wikidata; Q54830333
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96061934; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2682
AC   CVCL_AR12
DR   ECACC; 96061935
DR   Wikidata; Q54830334
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96061935; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y9M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2683
AC   CVCL_AR13
DR   ECACC; 96061936
DR   Wikidata; Q54830335
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96061936; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2684
AC   CVCL_9K58
DR   ECACC; 96062414
DR   Wikidata; Q54830336
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,?del(2)(p13;p12.1)mat (ECACC=96062414).
CC   Discontinued: ECACC; 96062414; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2685
AC   CVCL_9K59
DR   ECACC; 96062638
DR   Wikidata; Q54830337
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(2)(?q31.3;q33.3); de novo (ECACC=96062638).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 6
//
ID   DD2687
AC   CVCL_9K60
DR   ECACC; 96062822
DR   Wikidata; Q54830338
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96062822; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2699
AC   CVCL_9K61
DR   ECACC; 96071701
DR   Wikidata; Q54830339
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(8)t(2;8)(q37.3;p23.1)pat (ECACC=96071701).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2700
AC   CVCL_AR14
DR   ECACC; 96071702
DR   Wikidata; Q54830340
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AR15 ! DD2703
SX   Female
AG   14Y5M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD2703
AC   CVCL_AR15
DR   ECACC; 96071724
DR   Wikidata; Q54830341
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AR14 ! DD2700
SX   Female
AG   14Y5M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   DD2704
AC   CVCL_9K62
DR   ECACC; 96072315
DR   Wikidata; Q54830342
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96072315; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2705
AC   CVCL_9K63
DR   ECACC; 96072617
DR   Wikidata; Q54830343
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96072617; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2706
AC   CVCL_9K64
DR   ECACC; 96072618
DR   Wikidata; Q54830344
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96072618; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   96Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2707
AC   CVCL_9K65
DR   ECACC; 96072638
DR   Wikidata; Q54830345
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AR16 ! DD2727
SX   Female
AG   18Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2710
AC   CVCL_9K66
DR   ECACC; 96073102
DR   Wikidata; Q54830346
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96073102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2711
AC   CVCL_9K67
DR   ECACC; 96080127
DR   Wikidata; Q54830347
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,add(2)(q37.3) (ECACC=96080127).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2714
AC   CVCL_9K68
DR   ECACC; 96080601
DR   Wikidata; Q54830348
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96080601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2717
AC   CVCL_9K69
DR   ECACC; 96080802
DR   Wikidata; Q54830349
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,dup(11)(p15.1;p15.3); de novo (ECACC=96080802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD2721
AC   CVCL_9K70
DR   ECACC; 96080931
DR   Wikidata; Q54830350
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96080931; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2722
AC   CVCL_9K71
DR   ECACC; 96080932
DR   Wikidata; Q54830351
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96080932; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2727
AC   CVCL_AR16
DR   ECACC; 96081915
DR   Wikidata; Q54830355
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96081915; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9K65 ! DD2707
SX   Female
AG   18Y5M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 6
//
ID   DD2731
AC   CVCL_9K72
DR   ECACC; 96090601
DR   Wikidata; Q54830356
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9K79 ! DD2743
SX   Female
AG   36Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2732
AC   CVCL_9K73
DR   ECACC; 96090602
DR   Wikidata; Q54830357
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96090602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2733
AC   CVCL_AR17
DR   ECACC; 96090603
DR   Wikidata; Q54830358
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96090603; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y4M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 6
//
ID   DD2735
AC   CVCL_AR18
DR   ECACC; 96091931
DR   Wikidata; Q54830359
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96091931; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y5M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 6
//
ID   DD2736
AC   CVCL_AR19
DR   ECACC; 96092001
DR   Wikidata; Q54830360
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96092001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2737
AC   CVCL_9K74
DR   ECACC; 96092002
DR   Wikidata; Q54830361
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;13) (ECACC=96092002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2738
AC   CVCL_9K75
DR   ECACC; 96092003
DR   Wikidata; Q54830362
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96092003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2739
AC   CVCL_9K76
DR   ECACC; 96092004
DR   Wikidata; Q54830363
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96092004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2740
AC   CVCL_9K77
DR   ECACC; 96092005
DR   Wikidata; Q54830364
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2741
AC   CVCL_AR20
DR   ECACC; 96092006
DR   Wikidata; Q54830365
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96092006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2742
AC   CVCL_9K78
DR   ECACC; 96092615
DR   Wikidata; Q54830366
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96092615; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2743
AC   CVCL_9K79
DR   ECACC; 96092701
DR   Wikidata; Q54830367
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96092701; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9K72 ! DD2731
SX   Female
AG   36Y11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2745
AC   CVCL_9K80
DR   ECACC; 96100116
DR   Wikidata; Q54830368
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96100116; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y10M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2749
AC   CVCL_9K81
DR   ECACC; 96100411
DR   Wikidata; Q54830369
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96100411; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2750
AC   CVCL_9K82
DR   ECACC; 96100407
DR   Wikidata; Q54830370
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96100407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2751
AC   CVCL_9K83
DR   ECACC; 96100605
DR   Wikidata; Q54830371
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96100605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2753
AC   CVCL_AR21
DR   ECACC; 96100907
DR   Wikidata; Q54830372
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96100907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2755
AC   CVCL_9K84
DR   ECACC; 96101701
DR   Wikidata; Q54830373
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96101701; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2756
AC   CVCL_9K85
DR   ECACC; 96101702
DR   Wikidata; Q54830374
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96101702; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2758
AC   CVCL_9K86
DR   ECACC; 96102533
DR   Wikidata; Q54830375
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96102533; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2759
AC   CVCL_9K87
DR   ECACC; 96102534
DR   Wikidata; Q54830376
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96102534; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2760
AC   CVCL_9K88
DR   ECACC; 96103101
DR   Wikidata; Q54830377
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96103101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2761
AC   CVCL_AR22
DR   ECACC; 96103102
DR   Wikidata; Q54830378
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96103102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2762
AC   CVCL_9K89
DR   ECACC; 96103103
DR   Wikidata; Q54830379
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96103103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2764
AC   CVCL_AR23
DR   ECACC; 96110129
DR   Wikidata; Q54830380
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96110129; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 6
//
ID   DD2765
AC   CVCL_9K90
DR   ECACC; 96110215
DR   Wikidata; Q54830381
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96110215; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2767
AC   CVCL_9K91
DR   ECACC; 96110503
DR   Wikidata; Q54830382
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96110503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2768
AC   CVCL_9K92
DR   ECACC; 96110504
DR   Wikidata; Q54830383
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96110504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2770
AC   CVCL_9K93
DR   ECACC; 96110622
DR   Wikidata; Q54830384
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XYY (ECACC=96110622).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2771
AC   CVCL_9K94
DR   ECACC; 96110701
DR   Wikidata; Q54830385
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96110701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2772
AC   CVCL_9K95
DR   ECACC; 96110808
DR   Wikidata; Q54830386
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96110808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2773
AC   CVCL_9K96
DR   ECACC; 96110809
DR   Wikidata; Q54830387
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96110809; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2775
AC   CVCL_9K97
DR   ECACC; 96111115
DR   Wikidata; Q54830388
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2776
AC   CVCL_9K98
DR   ECACC; 96111116
DR   Wikidata; Q54830389
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2777
AC   CVCL_9K99
DR   ECACC; 96111117
DR   Wikidata; Q54830390
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2779
AC   CVCL_9L00
DR   ECACC; 96111202
DR   Wikidata; Q54830391
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2782
AC   CVCL_9L01
DR   ECACC; 96111517
DR   Wikidata; Q54830392
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111517; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2783
AC   CVCL_AR24
DR   ECACC; 96111708
DR   Wikidata; Q54830393
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111708; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y3M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2784
AC   CVCL_9L02
DR   ECACC; 96111816
DR   Wikidata; Q54830394
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111816; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2785
AC   CVCL_9L03
DR   ECACC; 96111813
DR   Wikidata; Q54830398
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96111813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2786
AC   CVCL_9L04
DR   ECACC; 96111814
DR   Wikidata; Q54830399
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96111814; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2788
AC   CVCL_9L05
DR   ECACC; 96112023
DR   Wikidata; Q54830400
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 96112023; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2791
AC   CVCL_9L06
DR   ECACC; 96112026
DR   Wikidata; Q54830401
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96112026; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2792
AC   CVCL_9L07
DR   ECACC; 96112027
DR   Wikidata; Q54830402
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96112027; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2793
AC   CVCL_9L08
DR   ECACC; 96112321
DR   Wikidata; Q54830403
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96112321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2794
AC   CVCL_9L09
DR   ECACC; 96112322
DR   Wikidata; Q54830404
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96112322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2795
AC   CVCL_9L10
DR   ECACC; 96112801
DR   Wikidata; Q54830405
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96112801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2799
AC   CVCL_9L11
DR   ECACC; 96112908
DR   Wikidata; Q54830406
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2800
AC   CVCL_9L12
DR   ECACC; 96112922
DR   Wikidata; Q54830407
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96112922; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2801
AC   CVCL_9L13
DR   ECACC; 96112923
DR   Wikidata; Q54830408
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96112923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2802
AC   CVCL_9L14
DR   ECACC; 96120205
DR   Wikidata; Q54830409
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96120205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2803
AC   CVCL_9L15
DR   ECACC; 96120206
DR   Wikidata; Q54830410
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96120206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2804
AC   CVCL_9L16
DR   ECACC; 96120207
DR   Wikidata; Q54830411
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96120207; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2806
AC   CVCL_9L17
DR   ECACC; 96120401
DR   Wikidata; Q54830412
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96120401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2812
AC   CVCL_9L18
DR   ECACC; 96121319
DR   Wikidata; Q54830413
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,dup(3)(q25.3;q26.2).ish dup(3),(wcp3+) (ECACC=96121319).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2817
AC   CVCL_9L19
DR   ECACC; 96122210
DR   Wikidata; Q54830414
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96122210; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2822
AC   CVCL_9L20
DR   ECACC; 96122308
DR   Wikidata; Q54830415
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96122308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2825
AC   CVCL_AR25
DR   ECACC; 97010803
DR   Wikidata; Q54830416
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97010803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y4M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2826
AC   CVCL_AR26
DR   ECACC; 97010804
DR   Wikidata; Q54830417
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97010804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2829
AC   CVCL_9L21
DR   ECACC; 97011421
DR   Wikidata; Q54830418
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97011421; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2830
AC   CVCL_9L22
DR   ECACC; 97011606
DR   Wikidata; Q54830419
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97011606; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2831
AC   CVCL_9L23
DR   ECACC; 97011702
DR   Wikidata; Q54830420
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97011702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2833
AC   CVCL_9L24
DR   ECACC; 97012101
DR   Wikidata; Q54830421
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97012101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2835
AC   CVCL_9L25
DR   ECACC; 97012402
DR   Wikidata; Q54830422
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75466; Rubinstein-Taybi syndrome
DI   ORDO; Orphanet_783; Rubinstein-Taybi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2838
AC   CVCL_9L26
DR   ECACC; 97013108
DR   Wikidata; Q54830423
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97013108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2839
AC   CVCL_9L27
DR   ECACC; 97013123
DR   Wikidata; Q54830424
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(2),t(2;7)(2pter->2q37.2::7q36.3->7qter)mat (ECACC=97013123).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131001; Rieger syndrome
DI   ORDO; Orphanet_91483; Rieger anomaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2845
AC   CVCL_9L28
DR   ECACC; 97021126
DR   Wikidata; Q54830425
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97021126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2846
AC   CVCL_AR27
DR   ECACC; 97021201
DR   Wikidata; Q54830426
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97021201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y9M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2847
AC   CVCL_9L29
DR   ECACC; 97021202
DR   Wikidata; Q54830427
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2848
AC   CVCL_AR28
DR   ECACC; 97021203
DR   Wikidata; Q54830428
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97021203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y10M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2849
AC   CVCL_AR29
DR   ECACC; 97021319
DR   Wikidata; Q54830429
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97021319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2850
AC   CVCL_AR30
DR   ECACC; 97021410
DR   Wikidata; Q54830430
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97021410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y1M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2851
AC   CVCL_AR31
DR   ECACC; 97021411
DR   Wikidata; Q54830431
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2853
AC   CVCL_AR32
DR   ECACC; 97022127
DR   Wikidata; Q54830432
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y6M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2855
AC   CVCL_9L30
DR   ECACC; 97022602
DR   Wikidata; Q54830433
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2856
AC   CVCL_AR33
DR   ECACC; 97022603
DR   Wikidata; Q54830434
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97022603; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2857
AC   CVCL_AR34
DR   ECACC; 97022604
DR   Wikidata; Q54830435
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97022604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y7M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2859
AC   CVCL_9L31
DR   ECACC; 97022802
DR   Wikidata; Q54830436
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97022802; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2863
AC   CVCL_9L32
DR   ECACC; 97030901
DR   Wikidata; Q54830437
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97030901; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2866
AC   CVCL_9L33
DR   ECACC; 97031403
DR   Wikidata; Q54830441
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(15)t(10;15)(p11;p11)mat (ECACC=97031403).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2867
AC   CVCL_9L34
DR   ECACC; 97031404
DR   Wikidata; Q54830442
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(18)t(18;21)(q12;q22)mat (ECACC=97031404).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2868
AC   CVCL_9L35
DR   ECACC; 97031817
DR   Wikidata; Q54830443
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97031817; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2870
AC   CVCL_9L36
DR   ECACC; 97032105
DR   Wikidata; Q54830444
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97032105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2871
AC   CVCL_9L37
DR   ECACC; 97032501
DR   Wikidata; Q54830445
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97032501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2872
AC   CVCL_9L38
DR   ECACC; 97032502
DR   Wikidata; Q54830446
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97032502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2873
AC   CVCL_9L39
DR   ECACC; 97040111
DR   Wikidata; Q54830447
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97040111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2875
AC   CVCL_AR35
DR   ECACC; 97040128
DR   Wikidata; Q54830448
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   DD2876
AC   CVCL_9L40
DR   ECACC; 97040608
DR   Wikidata; Q54830449
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97040608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2878
AC   CVCL_9L41
DR   ECACC; 97041117
DR   Wikidata; Q54830450
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97041117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2880
AC   CVCL_9L42
DR   ECACC; 97040923
DR   Wikidata; Q54830451
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97040923; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2883
AC   CVCL_9L43
DR   ECACC; 97041710
DR   Wikidata; Q54830452
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97041710; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2884
AC   CVCL_9L44
DR   ECACC; 97041711
DR   Wikidata; Q54830453
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97041711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2885
AC   CVCL_9L45
DR   ECACC; 97041801
DR   Wikidata; Q54830454
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97041801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2889
AC   CVCL_9L46
DR   ECACC; 97042201
DR   Wikidata; Q54830455
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 97042201; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2891
AC   CVCL_9L47
DR   ECACC; 97042203
DR   Wikidata; Q54830456
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(13)inv(13)(q31.2;q32.3)t(13;18)(q32.3;q23)mat (ECACC=97042203).
CC   Discontinued: ECACC; 97042203; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2893
AC   CVCL_AR36
DR   ECACC; 97042212
DR   Wikidata; Q54830457
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   DD2896
AC   CVCL_9L48
DR   ECACC; 97043012
DR   Wikidata; Q54830458
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(14;16)(q24;q11.1) (ECACC=97043012).
CC   Discontinued: ECACC; 97043012; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2897
AC   CVCL_9L49
DR   ECACC; 97043013
DR   Wikidata; Q54830459
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(5,7)t(4;5;7)(q31:p13;q13:q21)mat (ECACC=97043013).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2898
AC   CVCL_9L50
DR   ECACC; 97043014
DR   Wikidata; Q54830460
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2903
AC   CVCL_9L51
DR   ECACC; 97051108
DR   Wikidata; Q54830461
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97051108; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2904
AC   CVCL_9L52
DR   ECACC; 97051109
DR   Wikidata; Q54830462
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97051109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2905
AC   CVCL_9L53
DR   ECACC; 97051204
DR   Wikidata; Q54830463
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(12;20)(q24;q13.3)pat (ECACC=97051204).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2912
AC   CVCL_9L54
DR   ECACC; 97052204
DR   Wikidata; Q54830464
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(8;16)(q22;q13)mat (ECACC=97052204).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2913
AC   CVCL_9L55
DR   ECACC; 97052205
DR   Wikidata; Q54830465
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97052205; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2918
AC   CVCL_9L56
DR   ECACC; 97053006
DR   Wikidata; Q54830466
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97053006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2919
AC   CVCL_9L57
DR   ECACC; 97060207
DR   Wikidata; Q54830467
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar pat (ECACC=97060207).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2920
AC   CVCL_9Q36
DR   ECACC; 97060901
DR   Wikidata; Q54830468
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q34 ! DD2935
SX   Sex ambiguous
AG   16Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2922
AC   CVCL_9L58
DR   ECACC; 97061002
DR   Wikidata; Q54830469
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(5)(p1?3.3;p14.2)pat (ECACC=97061002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97061002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2923
AC   CVCL_9L59
DR   ECACC; 97061003
DR   Wikidata; Q54830470
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(10)(qter->p15.1); de novo (ECACC=97061003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD2924
AC   CVCL_9Q33
DR   ECACC; 97061504
DR   Wikidata; Q54830471
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97061504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2925
AC   CVCL_9L60
DR   ECACC; 97061820
DR   Wikidata; Q54830472
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,dup(17)(q25.1;q25.3) (ECACC=97061820).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2928
AC   CVCL_9L61
DR   ECACC; 97062604
DR   Wikidata; Q54830473
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 6,XX,t(7;11),inv(11) (ECACC=97062604).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2929
AC   CVCL_9L62
DR   ECACC; 97062606
DR   Wikidata; Q54830474
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar (ECACC=97062606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   DD2930
AC   CVCL_9L63
DR   ECACC; 97070208
DR   Wikidata; Q54830475
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97070208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2932
AC   CVCL_9L64
DR   ECACC; 97070310
DR   Wikidata; Q54830476
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(2),t(2;7)mat (ECACC=97070310).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131001; Rieger syndrome
DI   ORDO; Orphanet_91483; Rieger anomaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2935
AC   CVCL_9Q34
DR   ECACC; 97070313
DR   Wikidata; Q54830477
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q36 ! DD2920
SX   Sex ambiguous
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2938
AC   CVCL_9L65
DR   ECACC; 97071612
DR   Wikidata; Q54830478
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2939
AC   CVCL_9L66
DR   ECACC; 97071613
DR   Wikidata; Q54830479
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,add(2)(q37.3) (ECACC=97071613).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97071613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2940
AC   CVCL_9Q41
DR   ECACC; 97071614
DR   Wikidata; Q54830480
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,add(2)(q37.3) (ECACC=97071614).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97071614; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2941
AC   CVCL_9L67
DR   ECACC; 97071615
DR   Wikidata; Q54830483
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,dup(11)(p15.1;p15.3) (ECACC=97071615).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2943
AC   CVCL_9L68
DR   ECACC; 97071617
DR   Wikidata; Q54830484
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97071617; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2944
AC   CVCL_9L69
DR   ECACC; 97071618
DR   Wikidata; Q54830485
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84632; Chondrodysplasia punctata
DI   ORDO; Orphanet_93442; Chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2947
AC   CVCL_9L70
DR   ECACC; 97072101
DR   Wikidata; Q54830486
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(4;5)(p12;q13.1)mat (ECACC=97072101).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD2949
AC   CVCL_9L71
DR   ECACC; 97072204
DR   Wikidata; Q54830487
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2952
AC   CVCL_9L72
DR   ECACC; 97072207
DR   Wikidata; Q54830488
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(6)(p24.3) (ECACC=97072207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2955
AC   CVCL_9L73
DR   ECACC; 97072713
DR   Wikidata; Q54830489
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9227; Hypogonadism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2958
AC   CVCL_9L74
DR   ECACC; 97080402
DR   Wikidata; Q54830490
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(17;20)(p13.3;q13.31) (ECACC=97080402).
CC   Discontinued: ECACC; 97080402; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2965
AC   CVCL_AR37
DR   ECACC; 97081302
DR   Wikidata; Q54830491
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97081302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2968
AC   CVCL_9L75
DR   ECACC; 97082209
DR   Wikidata; Q54830492
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(p22.13;p22.31) (ECACC=97082209).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2969
AC   CVCL_9L76
DR   ECACC; 97082210
DR   Wikidata; Q54830493
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(12)(q11.2;q13.11) (ECACC=97082210).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3267; Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD2973
AC   CVCL_9L77
DR   ECACC; 97090505
DR   Wikidata; Q54830494
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97090505; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD2976
AC   CVCL_9L78
DR   ECACC; 97091130
DR   Wikidata; Q54830495
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(14)(q24.11;q32.1)pat (ECACC=97091130).
CC   Discontinued: ECACC; 97091130; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2977
AC   CVCL_9L79
DR   ECACC; 97091131
DR   Wikidata; Q54830496
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9L80 ! DD2982
SX   Female
AG   30Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD2982
AC   CVCL_9L80
DR   ECACC; 97092514
DR   Wikidata; Q54830497
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 97092514; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9L79 ! DD2977
SX   Female
AG   30Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD2985
AC   CVCL_AR38
DR   ECACC; 97100211
DR   Wikidata; Q54830498
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97100211; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y1M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2986
AC   CVCL_AR39
DR   ECACC; 97100212
DR   Wikidata; Q54830499
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97100212; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y8M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2987
AC   CVCL_AR40
DR   ECACC; 97100307
DR   Wikidata; Q54830500
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97100307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y6M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2989
AC   CVCL_9L81
DR   ECACC; 97100915
DR   Wikidata; Q54830501
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2992
AC   CVCL_9L82
DR   ECACC; 97101303
DR   Wikidata; Q54830502
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 97101303; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD2993
AC   CVCL_AR41
DR   ECACC; 97101401
DR   Wikidata; Q54830503
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97101401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y3M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   DD2994
AC   CVCL_9L83
DR   ECACC; 97101704
DR   Wikidata; Q54830504
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2996
AC   CVCL_9L84
DR   ECACC; 97102306
DR   Wikidata; Q54830505
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY.ish 22q11.2(cH748X2) (ECACC=97102306).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2997
AC   CVCL_9L85
DR   ECACC; 97102401
DR   Wikidata; Q54830506
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(7)(p12.2;p21.3)pat (ECACC=97102401).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD2998
AC   CVCL_AR42
DR   ECACC; 97102402
DR   Wikidata; Q54830507
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y9M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD2999
AC   CVCL_AR43
DR   ECACC; 97102403
DR   Wikidata; Q54830508
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y9M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   DD3000
AC   CVCL_9L86
DR   ECACC; 97102707
DR   Wikidata; Q54830509
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX.ish der(X)t(X;Y)(pHU14+) (ECACC=97102707).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3004
AC   CVCL_9L87
DR   ECACC; 97110612
DR   Wikidata; Q54830510
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar.ish der(22)(D22Z3+) (ECACC=97110612).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3005
AC   CVCL_9N66
DR   ECACC; 97110613
DR   Wikidata; Q54830511
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3006
AC   CVCL_9L88
DR   ECACC; 97110614
DR   Wikidata; Q54830512
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97110614; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3007
AC   CVCL_9L89
DR   ECACC; 97111308
DR   Wikidata; Q54830513
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97111308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3011
AC   CVCL_9L90
DR   ECACC; 97112202
DR   Wikidata; Q54830514
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(9;20)(p24.1;p11.2?3) (ECACC=97112202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97112202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3012
AC   CVCL_9L91
DR   ECACC; 97112203
DR   Wikidata; Q54830515
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97112203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3013
AC   CVCL_9L92
DR   ECACC; 97112204
DR   Wikidata; Q54830516
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97112204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3017
AC   CVCL_9L93
DR   ECACC; 97120402
DR   Wikidata; Q54830517
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97120402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3023
AC   CVCL_9L94
DR   ECACC; 97121102
DR   Wikidata; Q54830518
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97121102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3024
AC   CVCL_9N67
DR   ECACC; 97121507
DR   Wikidata; Q54830519
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97121507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3025
AC   CVCL_9N68
DR   ECACC; 97121508
DR   Wikidata; Q54830520
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97121508; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3026
AC   CVCL_9N69
DR   ECACC; 97121509
DR   Wikidata; Q54830521
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3027
AC   CVCL_9N70
DR   ECACC; 97121905
DR   Wikidata; Q54830522
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3028
AC   CVCL_9N71
DR   ECACC; 97122203
DR   Wikidata; Q54830526
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   DD3030
AC   CVCL_9L95
DR   ECACC; 97122306
DR   Wikidata; Q54830527
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97122306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3031
AC   CVCL_9L96
DR   ECACC; 97123102
DR   Wikidata; Q54830528
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3032
AC   CVCL_9N72
DR   ECACC; 97123103
DR   Wikidata; Q54830529
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD3033
AC   CVCL_9L97
DR   ECACC; 98010201
DR   Wikidata; Q54830530
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98010201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3034
AC   CVCL_9L98
DR   ECACC; 98010202
DR   Wikidata; Q54830531
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98010202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3036
AC   CVCL_9L99
DR   ECACC; 98010803
DR   Wikidata; Q54830532
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98010803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3041
AC   CVCL_9M00
DR   ECACC; 98011601
DR   Wikidata; Q54830533
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98011601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3044
AC   CVCL_9N73
DR   ECACC; 98011910
DR   Wikidata; Q54830534
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98011910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3045
AC   CVCL_9N74
DR   ECACC; 98011911
DR   Wikidata; Q54830535
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98011911; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3047
AC   CVCL_9M01
DR   ECACC; 98012701
DR   Wikidata; Q54830536
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXX (ECACC=98012701).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD3048
AC   CVCL_9M02
DR   ECACC; 98012702
DR   Wikidata; Q54830537
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98012702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3062
AC   CVCL_9M03
DR   ECACC; 98022304
DR   Wikidata; Q54830538
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3066
AC   CVCL_9M04
DR   ECACC; 98030404
DR   Wikidata; Q54830539
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98030404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3067
AC   CVCL_9M05
DR   ECACC; 98030405
DR   Wikidata; Q54830540
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98030405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3069
AC   CVCL_9M06
DR   ECACC; 98030602
DR   Wikidata; Q54830541
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98030602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3071
AC   CVCL_9M07
DR   ECACC; 98031001
DR   Wikidata; Q54830542
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98031001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3072
AC   CVCL_9M08
DR   ECACC; 98031002
DR   Wikidata; Q54830543
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98031002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3073
AC   CVCL_9M09
DR   ECACC; 98031003
DR   Wikidata; Q54830544
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;8)(p32;q13); de novo (ECACC=98031003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD3075
AC   CVCL_9M10
DR   ECACC; 98031010
DR   Wikidata; Q54830545
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(14;18)?(q10:q10) (ECACC=98031010).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD3076
AC   CVCL_9M11
DR   ECACC; 98031011
DR   Wikidata; Q54830546
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84740; Goldenhar syndrome
DI   ORDO; Orphanet_374; Goldenhar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD3077
AC   CVCL_9M12
DR   ECACC; 98031012
DR   Wikidata; Q54830547
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C7582; Nevus of Ito
DI   ORDO; Orphanet_263432; Nevus of Ito
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9M13 ! DD3078
SX   Female
AG   7Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3078
AC   CVCL_9M13
DR   ECACC; 98031013
DR   Wikidata; Q54830548
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C7582; Nevus of Ito
DI   ORDO; Orphanet_263432; Nevus of Ito
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9M12 ! DD3077
SX   Female
AG   7Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3079
AC   CVCL_9M14
DR   ECACC; 98031015
DR   Wikidata; Q54830549
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98031015; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3082
AC   CVCL_9M15
DR   ECACC; 98031908
DR   Wikidata; Q54830550
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27049; Congenital eyelid ptosis
DI   ORDO; Orphanet_91411; Congenital ptosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3083
AC   CVCL_9M16
DR   ECACC; 98031909
DR   Wikidata; Q54830551
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98031909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27049; Congenital eyelid ptosis
DI   ORDO; Orphanet_91411; Congenital ptosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3084
AC   CVCL_9M17
DR   ECACC; 98032001
DR   Wikidata; Q54830552
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98032001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3085
AC   CVCL_9M18
DR   ECACC; 98032002
DR   Wikidata; Q54830553
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3086
AC   CVCL_9M19
DR   ECACC; 98032003
DR   Wikidata; Q54830554
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98032003; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3087
AC   CVCL_9M20
DR   ECACC; 98032402
DR   Wikidata; Q54830555
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3088
AC   CVCL_9M21
DR   ECACC; 98032403
DR   Wikidata; Q54830556
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98032403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3089
AC   CVCL_9M22
DR   ECACC; 98032404
DR   Wikidata; Q54830557
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98032404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3090
AC   CVCL_9M23
DR   ECACC; 98032405
DR   Wikidata; Q54830558
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXY,t(3;4)(q26.32;q31.1)mat (ECACC=98032405).
CC   Discontinued: ECACC; 98032405; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3092
AC   CVCL_9M24
DR   ECACC; 98032410
DR   Wikidata; Q54830559
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD3095
AC   CVCL_9M25
DR   ECACC; 98040201
DR   Wikidata; Q54830560
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98040201; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3096
AC   CVCL_9M26
DR   ECACC; 98040202
DR   Wikidata; Q54830561
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98040202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3097
AC   CVCL_9M27
DR   ECACC; 98040203
DR   Wikidata; Q54830562
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3098
AC   CVCL_9M28
DR   ECACC; 98040204
DR   Wikidata; Q54830563
CC   Part of: ECACC chromosomal abnormality collection.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3099
AC   CVCL_9M29
DR   ECACC; 98040205
DR   Wikidata; Q54830564
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3100
AC   CVCL_9M30
DR   ECACC; 98040801
DR   Wikidata; Q54830565
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y10
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3102
AC   CVCL_9M31
DR   ECACC; 98041501
DR   Wikidata; Q54830568
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98041501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3105
AC   CVCL_9M32
DR   ECACC; 98041711
DR   Wikidata; Q54830569
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98041711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3106
AC   CVCL_9M33
DR   ECACC; 98041712
DR   Wikidata; Q54830570
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98041712; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3107
AC   CVCL_9N75
DR   ECACC; 98042003
DR   Wikidata; Q54830571
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,(16q11.1v) (ECACC=98042003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3108
AC   CVCL_9N76
DR   ECACC; 98042004
DR   Wikidata; Q54830572
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98042004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3113
AC   CVCL_9M34
DR   ECACC; 98042009
DR   Wikidata; Q54830573
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(22)(q13) (ECACC=98042009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3115
AC   CVCL_9M35
DR   ECACC; 98042011
DR   Wikidata; Q54830574
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98042011; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3117
AC   CVCL_9M36
DR   ECACC; 98042201
DR   Wikidata; Q54830576
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3120
AC   CVCL_9N77
DR   ECACC; 98042302
DR   Wikidata; Q54830577
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98042302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3121
AC   CVCL_9N78
DR   ECACC; 98042303
DR   Wikidata; Q54830578
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98042303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3126
AC   CVCL_9M37
DR   ECACC; 980427186
DR   Wikidata; Q54830579
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3127
AC   CVCL_9M38
DR   ECACC; 980427187
DR   Wikidata; Q54830580
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 980427187; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3128
AC   CVCL_9M39
DR   ECACC; 98042906
DR   Wikidata; Q54830581
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98042906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3129
AC   CVCL_9M40
DR   ECACC; 98050115
DR   Wikidata; Q54830582
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98050115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3130
AC   CVCL_9M41
DR   ECACC; 98050116
DR   Wikidata; Q54830583
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98050116; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3131
AC   CVCL_9M42
DR   ECACC; 98050117
DR   Wikidata; Q54830584
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3132
AC   CVCL_9M43
DR   ECACC; 98050123
DR   Wikidata; Q54830585
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98050123; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3133
AC   CVCL_9M44
DR   ECACC; 98050124
DR   Wikidata; Q54830586
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(p22.33) (ECACC=98050124).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3134
AC   CVCL_9M45
DR   ECACC; 98050504
DR   Wikidata; Q54830587
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98050504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3136
AC   CVCL_9M46
DR   ECACC; 98050506
DR   Wikidata; Q54830588
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98050506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3144
AC   CVCL_9M47
DR   ECACC; 98050514
DR   Wikidata; Q54830589
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98050514; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3145
AC   CVCL_9M48
DR   ECACC; 98050515
DR   Wikidata; Q54830590
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98050515; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3150
AC   CVCL_9M49
DR   ECACC; 98051401
DR   Wikidata; Q54830591
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,der(3)t(2;3)?(p21;q26)pat (ECACC=98051401).
CC   Discontinued: ECACC; 98051401; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3154
AC   CVCL_9N79
DR   ECACC; 98052032
DR   Wikidata; Q54830592
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(p11.2) (ECACC=98052032).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3156
AC   CVCL_9N80
DR   ECACC; 98052033
DR   Wikidata; Q54830593
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98052033; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3168
AC   CVCL_9M50
DR   ECACC; 98061112
DR   Wikidata; Q54830594
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD3173
AC   CVCL_9M51
DR   ECACC; 98061916
DR   Wikidata; Q54830595
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98061916; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3175
AC   CVCL_9M52
DR   ECACC; 98062508
DR   Wikidata; Q54830596
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98062508; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3177
AC   CVCL_9M53
DR   ECACC; 98062902
DR   Wikidata; Q54830597
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98062902; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3185
AC   CVCL_9N81
DR   ECACC; 98070702
DR   Wikidata; Q54830598
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98070702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3186
AC   CVCL_9N82
DR   ECACC; 98071001
DR   Wikidata; Q54830599
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98071001; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3193
AC   CVCL_9M54
DR   ECACC; 98071704
DR   Wikidata; Q54830600
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98071704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3194
AC   CVCL_9M55
DR   ECACC; 98071705
DR   Wikidata; Q54830601
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98071705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3195
AC   CVCL_9M56
DR   ECACC; 98071706
DR   Wikidata; Q54830602
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98071706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3196
AC   CVCL_9M57
DR   ECACC; 98071902
DR   Wikidata; Q54830603
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98071902; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3198
AC   CVCL_9M58
DR   ECACC; 98072101
DR   Wikidata; Q54830604
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3199
AC   CVCL_9M59
DR   ECACC; 98072102
DR   Wikidata; Q54830605
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3200
AC   CVCL_9M60
DR   ECACC; 98072103
DR   Wikidata; Q54830606
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3201
AC   CVCL_9M61
DR   ECACC; 98072104
DR   Wikidata; Q54830607
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072104; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3202
AC   CVCL_9M62
DR   ECACC; 98072105
DR   Wikidata; Q54830608
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3203
AC   CVCL_9M63
DR   ECACC; 98072106
DR   Wikidata; Q54830611
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3204
AC   CVCL_9N83
DR   ECACC; 98072204
DR   Wikidata; Q54830612
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98072204; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3206
AC   CVCL_9M64
DR   ECACC; 98072411
DR   Wikidata; Q54830613
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072411; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3207
AC   CVCL_9M65
DR   ECACC; 98072412
DR   Wikidata; Q54830614
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98072412; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3208
AC   CVCL_9M66
DR   ECACC; 98072413
DR   Wikidata; Q54830615
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072413; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3213
AC   CVCL_9N84
DR   ECACC; 98072907
DR   Wikidata; Q54830616
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3214
AC   CVCL_9N85
DR   ECACC; 98072908
DR   Wikidata; Q54830617
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072908; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3215
AC   CVCL_9N86
DR   ECACC; 98072909
DR   Wikidata; Q54830618
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98072909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3216
AC   CVCL_9M67
DR   ECACC; 98080411
DR   Wikidata; Q54830619
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98080411; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3218
AC   CVCL_9N87
DR   ECACC; 98080702
DR   Wikidata; Q54830620
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98080702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3219
AC   CVCL_9N88
DR   ECACC; 98080703
DR   Wikidata; Q54830621
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98080703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3220
AC   CVCL_9N89
DR   ECACC; 98081005
DR   Wikidata; Q54830622
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98081005; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3224
AC   CVCL_9N90
DR   ECACC; 98081406
DR   Wikidata; Q54830623
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98081406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3225
AC   CVCL_9N91
DR   ECACC; 98081407
DR   Wikidata; Q54830624
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98081407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3226
AC   CVCL_9N92
DR   ECACC; 98081701
DR   Wikidata; Q54830625
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(14;19)(q24.3;p13.3)mat (ECACC=98081701).
CC   Discontinued: ECACC; 98081701; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3230
AC   CVCL_9N93
DR   ECACC; 98082509
DR   Wikidata; Q54830626
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(4;12)(q32.2;21.2)mat (ECACC=98082509).
CC   Discontinued: ECACC; 98082509; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3235
AC   CVCL_9M68
DR   ECACC; 98090101
DR   Wikidata; Q54830627
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(2;5)(q31.1;q23.2); de novo (ECACC=98090101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98090101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3236
AC   CVCL_9M69
DR   ECACC; 98090102
DR   Wikidata; Q54830628
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,?dup(5)(p14.2;p15.1) (ECACC=98090102).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98090102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3237
AC   CVCL_9N94
DR   ECACC; 98090301
DR   Wikidata; Q54830629
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98090301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3238
AC   CVCL_9N95
DR   ECACC; 98090302
DR   Wikidata; Q54830630
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98090302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3241
AC   CVCL_9N96
DR   ECACC; 98091012
DR   Wikidata; Q54830631
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98091012; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3244
AC   CVCL_9N97
DR   ECACC; 98100710
DR   Wikidata; Q54830632
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98100710; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C50462; Aortic valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3245
AC   CVCL_9N98
DR   ECACC; 98100906
DR   Wikidata; Q54830633
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98100906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3246
AC   CVCL_9N99
DR   ECACC; 98100907
DR   Wikidata; Q54830634
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98100907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3248
AC   CVCL_9P00
DR   ECACC; 98100909
DR   Wikidata; Q54830635
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98100909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3249
AC   CVCL_9P01
DR   ECACC; 98100910
DR   Wikidata; Q54830636
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98100910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3250
AC   CVCL_9P02
DR   ECACC; 98100911
DR   Wikidata; Q54830637
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98100911; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3252
AC   CVCL_9M70
DR   ECACC; 98101201
DR   Wikidata; Q54830638
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98101201; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3254
AC   CVCL_9M71
DR   ECACC; 98101806
DR   Wikidata; Q54830639
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98101806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3255
AC   CVCL_9M72
DR   ECACC; 98101807
DR   Wikidata; Q54830640
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98101807; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3257
AC   CVCL_9M73
DR   ECACC; 98102002
DR   Wikidata; Q54830641
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3259
AC   CVCL_9P03
DR   ECACC; 98102201
DR   Wikidata; Q54830642
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;4)(q23;p15.3)mat (ECACC=98102201).
CC   Discontinued: ECACC; 98102201; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3260
AC   CVCL_9P04
DR   ECACC; 98102202
DR   Wikidata; Q54830643
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(11)t(3;11)(q27.3;q24.2)pat (ECACC=98102202).
CC   Discontinued: ECACC; 98102202; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3261
AC   CVCL_9P05
DR   ECACC; 98102203
DR   Wikidata; Q54830644
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3262
AC   CVCL_9M74
DR   ECACC; 98102204
DR   Wikidata; Q54830645
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102204; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3263
AC   CVCL_9M75
DR   ECACC; 98102401
DR   Wikidata; Q54830646
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9P34 ! DD3324
SX   Female
AG   9Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3264
AC   CVCL_9M76
DR   ECACC; 98102607
DR   Wikidata; Q54830647
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3265
AC   CVCL_9M77
DR   ECACC; 98102706
DR   Wikidata; Q54830648
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3266
AC   CVCL_9M78
DR   ECACC; 98102817
DR   Wikidata; Q54830649
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102817; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3268
AC   CVCL_9P06
DR   ECACC; 98102902
DR   Wikidata; Q54830650
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102902; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3269
AC   CVCL_9P07
DR   ECACC; 98102903
DR   Wikidata; Q54830653
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3270
AC   CVCL_9P08
DR   ECACC; 98102904
DR   Wikidata; Q54830654
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102904; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3271
AC   CVCL_9P09
DR   ECACC; 98102905
DR   Wikidata; Q54830655
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102905; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3272
AC   CVCL_9P10
DR   ECACC; 98102906
DR   Wikidata; Q54830656
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3273
AC   CVCL_9P11
DR   ECACC; 98102907
DR   Wikidata; Q54830657
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3274
AC   CVCL_9P12
DR   ECACC; 98102908
DR   Wikidata; Q54830658
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102908; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3275
AC   CVCL_9P13
DR   ECACC; 98102909
DR   Wikidata; Q54830659
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3276
AC   CVCL_9P14
DR   ECACC; 98102910
DR   Wikidata; Q54830660
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3277
AC   CVCL_9P15
DR   ECACC; 98102911
DR   Wikidata; Q54830661
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102911; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3278
AC   CVCL_9P16
DR   ECACC; 98102912
DR   Wikidata; Q54830662
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102912; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3279
AC   CVCL_9P17
DR   ECACC; 98102913
DR   Wikidata; Q54830663
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102913; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3280
AC   CVCL_9P18
DR   ECACC; 98102914
DR   Wikidata; Q54830664
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102914; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3281
AC   CVCL_9P19
DR   ECACC; 98102915
DR   Wikidata; Q54830665
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102915; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3282
AC   CVCL_9P20
DR   ECACC; 98102916
DR   Wikidata; Q54830666
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102916; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3283
AC   CVCL_9P21
DR   ECACC; 98102917
DR   Wikidata; Q54830667
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102917; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3284
AC   CVCL_9P22
DR   ECACC; 98102918
DR   Wikidata; Q54830668
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102918; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3285
AC   CVCL_9P23
DR   ECACC; 98102919
DR   Wikidata; Q54830669
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102919; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3286
AC   CVCL_9P24
DR   ECACC; 98102920
DR   Wikidata; Q54830670
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102920; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3287
AC   CVCL_9P25
DR   ECACC; 98102921
DR   Wikidata; Q54830671
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98102921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3288
AC   CVCL_9M79
DR   ECACC; 98103007
DR   Wikidata; Q54830672
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98103007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3289
AC   CVCL_9M80
DR   ECACC; 98103008
DR   Wikidata; Q54830673
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98103008; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3290
AC   CVCL_9M81
DR   ECACC; 98103009
DR   Wikidata; Q54830674
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98103009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3291
AC   CVCL_9M82
DR   ECACC; 98103010
DR   Wikidata; Q54830675
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98103010; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3292
AC   CVCL_9M83
DR   ECACC; 98103011
DR   Wikidata; Q54830676
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98103011; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9P47 ! DD3379
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3293
AC   CVCL_9M84
DR   ECACC; 98103012
DR   Wikidata; Q54830677
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98103012; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3296
AC   CVCL_9M85
DR   ECACC; 98110617
DR   Wikidata; Q54830678
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(17)(qter->p13.3).ish del(17) (ECACC=98110617).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3298
AC   CVCL_9P26
DR   ECACC; 98111007
DR   Wikidata; Q54830679
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98111007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3300
AC   CVCL_9P27
DR   ECACC; 98111009
DR   Wikidata; Q54830680
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98111009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3302
AC   CVCL_9M86
DR   ECACC; 98111203
DR   Wikidata; Q54830681
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3303
AC   CVCL_9P28
DR   ECACC; 98111204
DR   Wikidata; Q54830682
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD3306
AC   CVCL_9M87
DR   ECACC; 98111707
DR   Wikidata; Q54830683
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(17)(p?11;q?12) (ECACC=98111707).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   DD3309
AC   CVCL_9P29
DR   ECACC; 98111803
DR   Wikidata; Q54830684
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98111803; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3310
AC   CVCL_9M88
DR   ECACC; 98111804
DR   Wikidata; Q54830685
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98111804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3312
AC   CVCL_9P30
DR   ECACC; 98111903
DR   Wikidata; Q54830686
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(1)t(1;13)(q32.3;q32.3)mat (ECACC=98111903).
CC   Discontinued: ECACC; 98111903; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3313
AC   CVCL_9M89
DR   ECACC; 98112006
DR   Wikidata; Q54830687
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98112006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3316
AC   CVCL_9M90
DR   ECACC; 98112715
DR   Wikidata; Q54830688
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98112715; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3319
AC   CVCL_9M91
DR   ECACC; 98120202
DR   Wikidata; Q54830689
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98120202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3320
AC   CVCL_9P31
DR   ECACC; 98120401
DR   Wikidata; Q54830690
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98120401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3322
AC   CVCL_9P32
DR   ECACC; 98120705
DR   Wikidata; Q54830691
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98120705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3323
AC   CVCL_9P33
DR   ECACC; 98120706
DR   Wikidata; Q54830692
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98120706; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3324
AC   CVCL_9P34
DR   ECACC; 98120707
DR   Wikidata; Q54830697
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98120707; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9M75 ! DD3263
SX   Female
AG   9Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3327
AC   CVCL_9M92
DR   ECACC; 98120710
DR   Wikidata; Q54830698
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98120710; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3328
AC   CVCL_9M93
DR   ECACC; 98121011
DR   Wikidata; Q54830699
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98121011; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3329
AC   CVCL_9P35
DR   ECACC; 98121012
DR   Wikidata; Q54830700
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98121012; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3330
AC   CVCL_9P36
DR   ECACC; 98121013
DR   Wikidata; Q54830701
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98121013; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3333
AC   CVCL_9P37
DR   ECACC; 98121502
DR   Wikidata; Q54830702
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 98121502; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3335
AC   CVCL_9M94
DR   ECACC; 98121705
DR   Wikidata; Q54830703
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98121705; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3340
AC   CVCL_9M95
DR   ECACC; 98122306
DR   Wikidata; Q54830704
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98122306; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3341
AC   CVCL_9M96
DR   ECACC; 98122307
DR   Wikidata; Q54830705
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98122307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3344
AC   CVCL_9P38
DR   ECACC; 99010601
DR   Wikidata; Q54830706
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99010601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3349
AC   CVCL_9M97
DR   ECACC; 99011807
DR   Wikidata; Q54830707
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99011807; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3354
AC   CVCL_9P39
DR   ECACC; 99020323
DR   Wikidata; Q54830708
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99020323; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3356
AC   CVCL_9M98
DR   ECACC; 99020504
DR   Wikidata; Q54830709
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;13)(p25.1;q22.1)pat (ECACC=99020504).
CC   Discontinued: ECACC; 99020504; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3358
AC   CVCL_9M99
DR   ECACC; 99021006
DR   Wikidata; Q54830710
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99021006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3359
AC   CVCL_9P40
DR   ECACC; 99021505
DR   Wikidata; Q54830711
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99021505; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3362
AC   CVCL_9N00
DR   ECACC; 99021607
DR   Wikidata; Q54830712
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99021607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3364
AC   CVCL_9P41
DR   ECACC; 99021916
DR   Wikidata; Q54830713
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99021916; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3365
AC   CVCL_9P42
DR   ECACC; 99021917
DR   Wikidata; Q54830714
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99021917; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3372
AC   CVCL_9N01
DR   ECACC; 99030917
DR   Wikidata; Q54830715
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99030917; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3373
AC   CVCL_9N02
DR   ECACC; 99031005
DR   Wikidata; Q54830716
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3374
AC   CVCL_9P43
DR   ECACC; 99031813
DR   Wikidata; Q54830717
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3375
AC   CVCL_9P44
DR   ECACC; 99031814
DR   Wikidata; Q54830718
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031814; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3376
AC   CVCL_9P45
DR   ECACC; 99031815
DR   Wikidata; Q54830719
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031815; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3377
AC   CVCL_9P46
DR   ECACC; 99031903
DR   Wikidata; Q54830720
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3379
AC   CVCL_9P47
DR   ECACC; 99031905
DR   Wikidata; Q54830721
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031905; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9M83 ! DD3292
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3380
AC   CVCL_9P48
DR   ECACC; 99031906
DR   Wikidata; Q54830722
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3381
AC   CVCL_9P49
DR   ECACC; 99031907
DR   Wikidata; Q54830723
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3382
AC   CVCL_9P50
DR   ECACC; 99031908
DR   Wikidata; Q54830724
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031908; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3383
AC   CVCL_9P51
DR   ECACC; 99031909
DR   Wikidata; Q54830725
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99031909; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3384
AC   CVCL_9P52
DR   ECACC; 99032308
DR   Wikidata; Q54830726
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99032308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3389
AC   CVCL_9P53
DR   ECACC; 99033110
DR   Wikidata; Q54830727
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99033110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3390
AC   CVCL_9P54
DR   ECACC; 99033111
DR   Wikidata; Q54830728
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99033111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3398
AC   CVCL_9P55
DR   ECACC; 99040914
DR   Wikidata; Q54830729
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99040914; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3400
AC   CVCL_9N03
DR   ECACC; 99042001
DR   Wikidata; Q54830730
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99042001; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3406
AC   CVCL_9P56
DR   ECACC; 99051301
DR   Wikidata; Q54830731
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99051301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3409
AC   CVCL_9P57
DR   ECACC; 99051707
DR   Wikidata; Q54830732
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99051707; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3410
AC   CVCL_9P58
DR   ECACC; 99052013
DR   Wikidata; Q54830733
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99052013; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3416
AC   CVCL_9P59
DR   ECACC; 99060203
DR   Wikidata; Q54830734
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99060203; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7W
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3417
AC   CVCL_9P60
DR   ECACC; 99060325
DR   Wikidata; Q54830735
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99060325; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3418
AC   CVCL_9P61
DR   ECACC; 99060326
DR   Wikidata; Q54830736
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99060326; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3419
AC   CVCL_9P62
DR   ECACC; 99060327
DR   Wikidata; Q54830739
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3420
AC   CVCL_9N04
DR   ECACC; 99060428
DR   Wikidata; Q54830740
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99060428; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3421
AC   CVCL_9P63
DR   ECACC; 99060718
DR   Wikidata; Q54830741
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99060718; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3422
AC   CVCL_9P64
DR   ECACC; 99060719
DR   Wikidata; Q54830742
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99060719; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3435
AC   CVCL_9P65
DR   ECACC; 99070513
DR   Wikidata; Q54830743
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99070513; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3439
AC   CVCL_9N05
DR   ECACC; 99070736
DR   Wikidata; Q54830744
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99070736; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3443
AC   CVCL_9N06
DR   ECACC; 99071436
DR   Wikidata; Q54830745
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(2)(q14.1;q14.2) (ECACC=99071436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99071436; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3444
AC   CVCL_9P66
DR   ECACC; 99071437
DR   Wikidata; Q54830746
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99071437; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3445
AC   CVCL_9P67
DR   ECACC; 99071438
DR   Wikidata; Q54830747
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99071438; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3447
AC   CVCL_9N07
DR   ECACC; 99072419
DR   Wikidata; Q54830748
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99072419; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3450
AC   CVCL_9N08
DR   ECACC; 99080629
DR   Wikidata; Q54830749
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 99080629; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3454
AC   CVCL_9P68
DR   ECACC; 99081610
DR   Wikidata; Q54830750
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99081610; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3455
AC   CVCL_9P69
DR   ECACC; 99081611
DR   Wikidata; Q54830751
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99081611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3458
AC   CVCL_9N09
DR   ECACC; 99802743
DR   Wikidata; Q54830752
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(12)?(p11.21;q21.2); de novo (ECACC=99802743).
CC   Discontinued: ECACC; 99802743; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3459
AC   CVCL_9P70
DR   ECACC; 99090117
DR   Wikidata; Q54830753
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;9)?(q34;p21.2); de novo (ECACC=99090117).
CC   Discontinued: ECACC; 99090117; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3460
AC   CVCL_9P71
DR   ECACC; 99091819
DR   Wikidata; Q54830754
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99091819; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3466
AC   CVCL_9P72
DR   ECACC; 99092423
DR   Wikidata; Q54830755
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(10;11)(q24.?31;p15.5); de novo (ECACC=99092423).
CC   Discontinued: ECACC; 99092423; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3467
AC   CVCL_9P73
DR   ECACC; 99100611
DR   Wikidata; Q54830756
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(13)(q33.2;q34)pat (ECACC=99100611).
CC   Discontinued: ECACC; 99100611; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3470
AC   CVCL_9P74
DR   ECACC; 99102243
DR   Wikidata; Q54830757
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99102243; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3471
AC   CVCL_9N10
DR   ECACC; 99102831
DR   Wikidata; Q54830758
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(4)(q15.32;q13.2)pat (ECACC=99102831).
CC   Discontinued: ECACC; 99102831; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3477
AC   CVCL_9N11
DR   ECACC; 99112428
DR   Wikidata; Q54830759
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;13)(p11;p12) (ECACC=99112428).
CC   Discontinued: ECACC; 99112428; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3479
AC   CVCL_9P75
DR   ECACC; 99112430
DR   Wikidata; Q54830760
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99112430; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3480
AC   CVCL_9P76
DR   ECACC; 99120301
DR   Wikidata; Q54830761
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 99120301; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y10M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3481
AC   CVCL_9N12
DR   ECACC; 99120302
DR   Wikidata; Q54830762
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD3482
AC   CVCL_9N13
DR   ECACC; 99120701
DR   Wikidata; Q54830763
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99120701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3483
AC   CVCL_9N14
DR   ECACC; 99120702
DR   Wikidata; Q54830764
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99120702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3484
AC   CVCL_9P77
DR   ECACC; 99120703
DR   Wikidata; Q54830765
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99120703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3493
AC   CVCL_9P78
DR   ECACC; 00111020
DR   Wikidata; Q54830766
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00111020; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3499
AC   CVCL_9P79
DR   ECACC; 00013124
DR   Wikidata; Q54830767
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+mar (ECACC=00013124).
CC   Discontinued: ECACC; 00013124; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3502
AC   CVCL_9P80
DR   ECACC; 00021514
DR   Wikidata; Q54830768
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00021514; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3503
AC   CVCL_9P81
DR   ECACC; 00021515
DR   Wikidata; Q54830769
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00021515; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3505
AC   CVCL_9P82
DR   ECACC; 00021517
DR   Wikidata; Q54830770
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00021517; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3506
AC   CVCL_9P83
DR   ECACC; 00021518
DR   Wikidata; Q54830771
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00021518; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3508
AC   CVCL_9P84
DR   ECACC; 00021614
DR   Wikidata; Q54830772
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00021614; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3509
AC   CVCL_9P85
DR   ECACC; 00021807
DR   Wikidata; Q54830773
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(2)(p24.2;q35)pat (ECACC=00021807).
CC   Discontinued: ECACC; 00021807; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3510
AC   CVCL_9P86
DR   ECACC; 00022416
DR   Wikidata; Q54830774
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(9)(q22.33;q34.3)mat (ECACC=00022416).
CC   Discontinued: ECACC; 00022416; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3512
AC   CVCL_9N15
DR   ECACC; 00022418
DR   Wikidata; Q54830775
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,add(X)(q28) (ECACC=00022418).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00022418; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3513
AC   CVCL_9N16
DR   ECACC; 00022828
DR   Wikidata; Q54830776
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(6;9)(q25.1;p24.1)mat (ECACC=00022828).
CC   Discontinued: ECACC; 00022828; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3514
AC   CVCL_9P87
DR   ECACC; 00022829
DR   Wikidata; Q54830777
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 69,XXX; 46,XY (ECACC=00022829).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00022829; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3517
AC   CVCL_9N17
DR   ECACC; 00030115
DR   Wikidata; Q54830778
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00030115; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3518
AC   CVCL_9P88
DR   ECACC; 00031007
DR   Wikidata; Q54830783
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00031007; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3520
AC   CVCL_9P89
DR   ECACC; 00031405
DR   Wikidata; Q54830784
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00031405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3521
AC   CVCL_9P90
DR   ECACC; 00031406
DR   Wikidata; Q54830785
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00031406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3522
AC   CVCL_9N18
DR   ECACC; 00031407
DR   Wikidata; Q54830786
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00031407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3528
AC   CVCL_9P91
DR   ECACC; 00032003
DR   Wikidata; Q54830787
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   DD3531
AC   CVCL_9P92
DR   ECACC; 00041222
DR   Wikidata; Q54830788
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00041222; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3532
AC   CVCL_9N19
DR   ECACC; 00041223
DR   Wikidata; Q54830789
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041223; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3533
AC   CVCL_9N20
DR   ECACC; 00041319
DR   Wikidata; Q54830790
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103921; Lissencephaly
DI   ORDO; Orphanet_48471; Lissencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3535
AC   CVCL_9P93
DR   ECACC; 00042514
DR   Wikidata; Q54830791
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,inv(X)(q13.1;q24) (ECACC=00042514).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00042514; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3536
AC   CVCL_9N21
DR   ECACC; 00042707
DR   Wikidata; Q54830792
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00042707; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C50715; Pulmonary stenosis
DI   ORDO; Orphanet_3189; Congenital pulmonary valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3540
AC   CVCL_9N22
DR   ECACC; 00050204
DR   Wikidata; Q54830793
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;22)(q25;?q13.1) (ECACC=00050204).
CC   Discontinued: ECACC; 00050204; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3541
AC   CVCL_9N23
DR   ECACC; 00050205
DR   Wikidata; Q54830794
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(11;22)(23.3;q11.2)mat (ECACC=00050205).
CC   Discontinued: ECACC; 00050205; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3542
AC   CVCL_9N24
DR   ECACC; 00050408
DR   Wikidata; Q54830795
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00050408; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3543
AC   CVCL_9N25
DR   ECACC; 00050604
DR   Wikidata; Q54830796
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,ins(3;2)(p23;q13q23); de novo (ECACC=00050604).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   DD3544
AC   CVCL_9N26
DR   ECACC; 00050802
DR   Wikidata; Q54830797
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;18)(q11.2;q23) (ECACC=00050802).
CC   Discontinued: ECACC; 00050802; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3545
AC   CVCL_9N27
DR   ECACC; 00050803
DR   Wikidata; Q54830798
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(15;17)(p10;p10)mat (ECACC=00050803).
CC   Discontinued: ECACC; 00050803; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3546
AC   CVCL_9P94
DR   ECACC; 00051011
DR   Wikidata; Q54830799
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00051011; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3547
AC   CVCL_9N28
DR   ECACC; 00051012
DR   Wikidata; Q54830800
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;21)(q22.1;q21.2)pat (ECACC=00051012).
CC   Discontinued: ECACC; 00051012; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3550
AC   CVCL_9P95
DR   ECACC; 00060704
DR   Wikidata; Q54830801
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(X)(qter->p22.31 or p22.32) (ECACC=00060704).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3551
AC   CVCL_9P96
DR   ECACC; 00060705
DR   Wikidata; Q54830802
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3553
AC   CVCL_9P97
DR   ECACC; 00061421
DR   Wikidata; Q54830803
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(1)(p36.2) (ECACC=00061421).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3555
AC   CVCL_9N29
DR   ECACC; 00062022
DR   Wikidata; Q54830804
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 45,XY,der(14;21)(q10;q10)mat (ECACC=00062022).
CC   Discontinued: ECACC; 00062022; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3556
AC   CVCL_9P98
DR   ECACC; 00062234
DR   Wikidata; Q54830805
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00062234; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3559
AC   CVCL_9P99
DR   ECACC; 00062916
DR   Wikidata; Q54830806
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00062916; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3560
AC   CVCL_9N30
DR   ECACC; 00070601
DR   Wikidata; Q54830807
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(6)(p24;q16.2); de novo (ECACC=00070601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00070601; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3569
AC   CVCL_9Q00
DR   ECACC; 00080319
DR   Wikidata; Q54830808
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00080319; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3572
AC   CVCL_9N31
DR   ECACC; 00081101
DR   Wikidata; Q54830809
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;7) (ECACC=00081101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00081101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3573
AC   CVCL_9N32
DR   ECACC; 00081102
DR   Wikidata; Q54830810
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00081102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3575
AC   CVCL_9Q01
DR   ECACC; 00081509
DR   Wikidata; Q54830811
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XXX (ECACC=00081509).
CC   Discontinued: ECACC; 00081509; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3576
AC   CVCL_9N33
DR   ECACC; 00090409
DR   Wikidata; Q54830812
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(5;11)(q13.1;p15.1)mat (ECACC=00090409).
CC   Discontinued: ECACC; 00090409; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3579
AC   CVCL_9Q02
DR   ECACC; 00092101
DR   Wikidata; Q54830813
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00092101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3581
AC   CVCL_9N34
DR   ECACC; 00092208
DR   Wikidata; Q54830814
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(13)t(13;18)(q31.2;q32.3)(q32.3;q23)mat (ECACC=00092208).
CC   Discontinued: ECACC; 00092208; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3583
AC   CVCL_9N35
DR   ECACC; 00092813
DR   Wikidata; Q54830815
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(2;18) (ECACC=00092813).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00092813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3585
AC   CVCL_9Q03
DR   ECACC; 00092902
DR   Wikidata; Q54830816
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(19;14)?(q31.2;q32.11)mat or ?(q22.33;q24.33)mat (ECACC=00092902).
CC   Discontinued: ECACC; 00092902; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3588
AC   CVCL_9N36
DR   ECACC; 00101121
DR   Wikidata; Q54830817
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00101121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9E60 ! DD1226
SX   Female
AG   61Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3589
AC   CVCL_9N37
DR   ECACC; 00101122
DR   Wikidata; Q54830818
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00101122; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9E59 ! DD1225
SX   Male
AG   60Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3590
AC   CVCL_9Q04
DR   ECACC; 00101217
DR   Wikidata; Q54830819
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00101217; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3593
AC   CVCL_9Q05
DR   ECACC; 00102515
DR   Wikidata; Q54830820
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,add(1)(p36.3) (ECACC=00102515).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3599
AC   CVCL_9N38
DR   ECACC; 00110722
DR   Wikidata; Q54830821
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00110722; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3606
AC   CVCL_9N39
DR   ECACC; 00111602
DR   Wikidata; Q54830822
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3608
AC   CVCL_9N40
DR   ECACC; 00112301
DR   Wikidata; Q54830826
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00112301; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3609
AC   CVCL_9Q06
DR   ECACC; 00112701
DR   Wikidata; Q54830827
CC   Part of: ECACC chromosomal abnormality collection.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   DD3611
AC   CVCL_9N41
DR   ECACC; 00112921
DR   Wikidata; Q54830828
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 00112921; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3615
AC   CVCL_9Q07
DR   ECACC; 00122017
DR   Wikidata; Q54830829
RX   PubMed=15635069;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;13)(q31.3;q21.3); de novo, inv(11)(p15.3;p15.5)pat (ECACC=00122017).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00122017; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3616
AC   CVCL_9Q08
DR   ECACC; 00122018
DR   Wikidata; Q54830830
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00122018; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3617
AC   CVCL_9N42
DR   ECACC; 00122019
DR   Wikidata; Q54830831
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv dup(16)(q11.2;q12.1)pat (ECACC=00122019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00122019; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3619
AC   CVCL_9Q09
DR   ECACC; 01010201
DR   Wikidata; Q54830832
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 01010201; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3620
AC   CVCL_9N43
DR   ECACC; 01010301
DR   Wikidata; Q54830833
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(4)(q2?5;q?28) (ECACC=01010301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01010301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3625
AC   CVCL_9N44
DR   ECACC; 01011217
DR   Wikidata; Q54830834
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv(9)(q?13;q22.33)pat (ECACC=01011217).
CC   Discontinued: ECACC; 01011217; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3626
AC   CVCL_9N45
DR   ECACC; 01011711
DR   Wikidata; Q54830835
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(Xq) (ECACC=01011711).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01011711; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3627
AC   CVCL_9N46
DR   ECACC; 01011712
DR   Wikidata; Q54830836
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01011712; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3628
AC   CVCL_9Q10
DR   ECACC; 01011713
DR   Wikidata; Q54830837
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,X,del(X)(q21.3) (ECACC=01011713).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01011713; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3635
AC   CVCL_9N47
DR   ECACC; 01020503
DR   Wikidata; Q54830838
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 01020503; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3637
AC   CVCL_9N48
DR   ECACC; 01021301
DR   Wikidata; Q54830839
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3638
AC   CVCL_9N49
DR   ECACC; 01021302
DR   Wikidata; Q54830840
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01021302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3639
AC   CVCL_9N50
DR   ECACC; 01021303
DR   Wikidata; Q54830841
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01021303; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3650
AC   CVCL_9Q11
DR   ECACC; 01031602
DR   Wikidata; Q54830842
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01031602; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3655
AC   CVCL_9Q12
DR   ECACC; 01040309
DR   Wikidata; Q54830843
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX t(5;13)(p15.1;q32.3)pat (ECACC=01040309).
CC   Discontinued: ECACC; 01040309; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3657
AC   CVCL_9N51
DR   ECACC; 01050304
DR   Wikidata; Q54830844
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01050304; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3658
AC   CVCL_9N52
DR   ECACC; 01050501
DR   Wikidata; Q54830845
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01050501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3660
AC   CVCL_9Q13
DR   ECACC; 01050916
DR   Wikidata; Q54830846
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01050916; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3661
AC   CVCL_9Q14
DR   ECACC; 01052221
DR   Wikidata; Q54830847
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3662
AC   CVCL_9Q15
DR   ECACC; 01052222
DR   Wikidata; Q54830848
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 01052222; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3664
AC   CVCL_9Q16
DR   ECACC; 01052422
DR   Wikidata; Q54830849
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,add(1)(p?36.2) (ECACC=01052422).
CC   Discontinued: ECACC; 01052422; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3665
AC   CVCL_9Q17
DR   ECACC; 01052513
DR   Wikidata; Q54830850
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01052513; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3668
AC   CVCL_9N53
DR   ECACC; 01060418
DR   Wikidata; Q54830851
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+der(15)t(11;15)mat (ECACC=01060418).
CC   Discontinued: ECACC; 01060418; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3669
AC   CVCL_9N54
DR   ECACC; 01060516
DR   Wikidata; Q54830852
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 01060516; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3671
AC   CVCL_9Q18
DR   ECACC; 01052920
DR   Wikidata; Q54830853
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;4)?(q31;q28) (ECACC=01052920).
CC   Discontinued: ECACC; 01052920; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3672
AC   CVCL_9Q19
DR   ECACC; 01052919
DR   Wikidata; Q54830854
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 01052919; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3675
AC   CVCL_9Q20
DR   ECACC; 01061528
DR   Wikidata; Q54830855
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,+I(12p) (ECACC=01061528).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01061528; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3680
AC   CVCL_9N65
DR   ECACC; 01070531
DR   Wikidata; Q54830856
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 01070531; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3681
AC   CVCL_9Q21
DR   ECACC; 01062518
DR   Wikidata; Q54830857
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+I(18p); de novo (ECACC=01062518).
CC   Discontinued: ECACC; 01062518; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3685
AC   CVCL_9Q22
DR   ECACC; 01072513
DR   Wikidata; Q54830858
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3686
AC   CVCL_9Q23
DR   ECACC; 01080715
DR   Wikidata; Q54830859
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01080715; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3687
AC   CVCL_9N55
DR   ECACC; 01081516
DR   Wikidata; Q54830860
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX.ish 22q11.2(cH748x2) (ECACC=01081516).
CC   Discontinued: ECACC; 01081516; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3688
AC   CVCL_9Q24
DR   ECACC; 01081517
DR   Wikidata; Q54830861
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,t18 (ECACC=01081517).
CC   Discontinued: ECACC; 01081517; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3694
AC   CVCL_9Q25
DR   ECACC; 01082905
DR   Wikidata; Q54830862
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(1;8)(p3?1.2;p21.?1); de novo (ECACC=01082905).
CC   Discontinued: ECACC; 01082905; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3695
AC   CVCL_9Q26
DR   ECACC; 01082906
DR   Wikidata; Q54830863
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(6;10)(p23;q26.2)mat (ECACC=01082906).
CC   Discontinued: ECACC; 01082906; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3696
AC   CVCL_9Q27
DR   ECACC; 01091705
DR   Wikidata; Q54830864
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(9)(p23).ish(wcp9+34H2-) (ECACC=01091705).
CC   Discontinued: ECACC; 01091705; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   DD3697
AC   CVCL_9Q28
DR   ECACC; 01092723
DR   Wikidata; Q54830865
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(10;18)?(q21.2;q12.2); de novo (ECACC=01092723).
CC   Discontinued: ECACC; 01092723; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   DD3702
AC   CVCL_9N56
DR   ECACC; 01111319
DR   Wikidata; Q54830896
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111319; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3703
AC   CVCL_9N57
DR   ECACC; 01111320
DR   Wikidata; Q54830897
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111320; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3704
AC   CVCL_9N58
DR   ECACC; 01111321
DR   Wikidata; Q54830898
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,dup(15)(pter->q15::q11.2->q13::q15->qter) (ECACC=01111321).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111321; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3705
AC   CVCL_9N59
DR   ECACC; 01111322
DR   Wikidata; Q54830899
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111322; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3706
AC   CVCL_9N60
DR   ECACC; 01111417
DR   Wikidata; Q54830900
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3707
AC   CVCL_9N61
DR   ECACC; 01111418
DR   Wikidata; Q54830901
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111418; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3708
AC   CVCL_9N62
DR   ECACC; 01111419
DR   Wikidata; Q54830902
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111419; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3709
AC   CVCL_9N63
DR   ECACC; 01111420
DR   Wikidata; Q54830903
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111420; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3710
AC   CVCL_9N64
DR   ECACC; 01111421
DR   Wikidata; Q54830904
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,inv ins(9;2)(9p;2q3.?3->2q31) (ECACC=01111421).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01111421; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3712
AC   CVCL_9Q29
DR   ECACC; 02021931
DR   Wikidata; Q54830905
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3713
AC   CVCL_9Q30
DR   ECACC; 02030406
DR   Wikidata; Q54830906
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(10,22)(q24.3;q13.31) (ECACC=02030406).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02030406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3714
AC   CVCL_9Q31
DR   ECACC; 02052801
DR   Wikidata; Q54830907
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02052801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3715
AC   CVCL_8Z95
DR   ECACC; 02062019
DR   Wikidata; Q54830908
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: t(5;12)(q14.2;q14.2); de novo (ECACC=02062019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02062019; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3716
AC   CVCL_8Z96
DR   ECACC; 02062018
DR   Wikidata; Q54830909
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: inv(7)(p13;q11.23); de novo (ECACC=02062018).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02062018; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3717
AC   CVCL_8Z97
DR   ECACC; 02062020
DR   Wikidata; Q54830910
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,dup(X)(q27.2;q28) (ECACC=02062020).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02062020; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3719
AC   CVCL_8Z98
DR   ECACC; 02071761
DR   Wikidata; Q54830911
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02071761; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3720
AC   CVCL_8Z99
DR   ECACC; 02071762
DR   Wikidata; Q54830913
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02071762; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3721
AC   CVCL_8W00
DR   ECACC; 02071763
DR   Wikidata; Q54830915
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02071763; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3722
AC   CVCL_8W01
DR   ECACC; 02071764
DR   Wikidata; Q54830917
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02071764; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3723
AC   CVCL_8W02
DR   ECACC; 02071765
DR   Wikidata; Q54830919
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02071765; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3724
AC   CVCL_9Q35
DR   ECACC; 02072402
DR   Wikidata; Q54830921
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02072402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3725
AC   CVCL_8W03
DR   ECACC; 02081614
DR   Wikidata; Q54830923
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(4;8)(p14;q22.3) (ECACC=02081614).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02081614; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9227; Hypogonadism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3726
AC   CVCL_9Q37
DR   ECACC; 02082963
DR   Wikidata; Q54830924
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DD3727
AC   CVCL_9Q38
DR   ECACC; 02100101
DR   Wikidata; Q54830926
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XX,+idic(15)(q13) (ECACC=02100101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 02100101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3746
AC   CVCL_9Q39
DR   ECACC; 03101442
DR   Wikidata; Q54830928
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03101442; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3747
AC   CVCL_9Q40
DR   ECACC; 03101443
DR   Wikidata; Q54830930
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;9)(q10;p21.2) (ECACC=03101443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03101443; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   DD3748
AC   CVCL_8W04
DR   ECACC; 03101444
DR   Wikidata; Q54830931
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(1;9)(q10;p21.2) (ECACC=03101444).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DD3749
AC   CVCL_9Q42
DR   ECACC; 31126101
DR   Wikidata; Q54830932
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 31126101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3750
AC   CVCL_9Q43
DR   ECACC; 31126102
DR   Wikidata; Q54830933
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 31126102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3751
AC   CVCL_9Q44
DR   ECACC; 31126103
DR   Wikidata; Q54830934
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 31126103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3752
AC   CVCL_9Q45
DR   ECACC; 31126106
DR   Wikidata; Q54830935
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 31126106; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DD3753
AC   CVCL_9Q46
DR   ECACC; 31211100
DR   Wikidata; Q54830936
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 47,XY,+mar (ECACC=31211100).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 31211100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   DDaF-1
AC   CVCL_C5YQ
SY   Dario Dario Fin-1
DR   NRFC; NRFC068
DR   Wikidata; Q116048830
WW   Provider; NRFC; NRFC068; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC068.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=248993; ! Dario dario (Scarlet badis)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   DDCS2
AC   CVCL_B6GT
DR   Wikidata; Q111733154
RX   PubMed=34767468;
CC   Doubling time: 60-72 hours (PubMed=34767468).
CC   Derived from site: In situ; Right distal femur, cartilage; UBERON=UBERON_0010129.
ST   Source(s): PubMed=34767468
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12,15
ST   D21S11: 30,32.2
ST   D2S1338: 22,25
ST   D3S1358: 14,17
ST   D5S818: 8
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   DDHK62-MEL
AC   CVCL_VU93
DR   GEO; GSM483281
DR   GEO; GSM483282
DR   GEO; GSM483283
DR   GEO; GSM483284
DR   Wikidata; Q93525174
RX   PubMed=20099279;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   DDLS8817
AC   CVCL_M814
DR   cancercelllines; CVCL_M814
DR   GEO; GSM529097
DR   GEO; GSM1228008
DR   Progenetix; CVCL_M814
DR   Wikidata; Q54830937
RX   PubMed=20713527;
RX   PubMed=21138865;
RX   PubMed=21335544;
RX   PubMed=21693658;
RX   PubMed=22170698;
RX   PubMed=22328974;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   DdMab-1
AC   CVCL_D3D7
DR   Wikidata; Q127380788
RX   PubMed=32944659;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q16760; Human DGKD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   DDT/TG4muM
AC   CVCL_DC07
DR   Wikidata; Q54830939
RX   PubMed=9742259;
CC   Selected for resistance to: ChEBI; CHEBI_9516; Thapsigargin (Tg).
CC   Transformant: ChEBI; CHEBI_41922; Diethylstilbestrol.
CC   Derived from site: In situ; Vas deferens, smooth muscle; UBERON=UBERON_0004224.
DI   NCIt; C134567; Hamster ductus deferens leiomyosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_DC06 ! DDT/TG500nM
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   DDT/TG500nM
AC   CVCL_DC06
DR   Wikidata; Q54830938
RX   PubMed=9742259;
CC   Selected for resistance to: ChEBI; CHEBI_9516; Thapsigargin (Tg).
CC   Transformant: ChEBI; CHEBI_41922; Diethylstilbestrol.
CC   Derived from site: In situ; Vas deferens, smooth muscle; UBERON=UBERON_0004224.
DI   NCIt; C134567; Hamster ductus deferens leiomyosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_3459 ! DDT1-MF2
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   DDT1
AC   CVCL_DC05
SY   DDT-1; Ductus Deferens Tumor 1
DR   Wikidata; Q54830940
RX   PubMed=4363020;
CC   Transformant: ChEBI; CHEBI_41922; Diethylstilbestrol.
CC   Derived from site: In situ; Vas deferens, smooth muscle; UBERON=UBERON_0004224.
DI   NCIt; C134567; Hamster ductus deferens leiomyosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   DDT1-MF2
AC   CVCL_3459
SY   DDT-1 MF-2; DDT1 MF-2; DDT1-MF-2; DDT1 MF2; DDT1MF-2; DDT1MF2; DDT1 clone MF-2; DDT-WT
DR   BTO; BTO_0002594
DR   CLO; CLO_0002734
DR   CLO; CLO_0002735
DR   CLO; CLO_0002736
DR   CLDB; cl1014
DR   ATCC; CRL-1701
DR   BCRC; 60498
DR   ECACC; 89051703
DR   Wikidata; Q54830941
RX   PubMed=179138;
RX   PubMed=1314696;
RX   PubMed=4058427;
RX   PubMed=6662552;
RX   PubMed=6708513;
RX   PubMed=8314862;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12051.
CC   Transformant: ChEBI; CHEBI_41922; Diethylstilbestrol.
CC   Derived from site: In situ; Vas deferens, smooth muscle; UBERON=UBERON_0004224.
DI   NCIt; C134567; Hamster ductus deferens leiomyosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_DC05 ! DDT1
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   DDT1-MF2 GR1
AC   CVCL_C7S1
SY   DDT1 MF2 GR1; GR1; DDT1 MF-2 GR
DR   Wikidata; Q117704284
RX   PubMed=4058427;
RX   PubMed=8314862;
CC   Characteristics: Glucocorticold receptor-poor variant. Growth of this cell line is completely resistant to the inhibitory action of glucocorticoids (PubMed=4058427; PubMed=8314862).
CC   Transformant: ChEBI; CHEBI_41922; Diethylstilbestrol.
CC   Derived from site: In situ; Vas deferens, smooth muscle; UBERON=UBERON_0004224.
DI   NCIt; C134567; Hamster ductus deferens leiomyosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_3459 ! DDT1-MF2
SX   Male
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   De Gin
AC   CVCL_2885
DR   ATCC; CRL-1133
DR   BioSample; SAMN03470922
DR   JCRB; JCRB9078
DR   Wikidata; Q54830942
RX   PubMed=25877200;
CC   Discontinued: ATCC; CRL-1133; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB9078; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 13,16
ST   D21S11: 29,30
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 8,13
ST   FGA: 21
ST   Penta D: 13,14
ST   Penta E: 10,17
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   De Te
AC   CVCL_3460
DR   CLO; CLO_0002738
DR   ATCC; CRL-1249
DR   Wikidata; Q54830943
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   DE-K10
AC   CVCL_C1CY
DR   Wikidata; Q114311319
RX   PubMed=2478685;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13645; Human KRT10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   DE-SCK
AC   CVCL_C1CZ
DR   Wikidata; Q114311320
RX   PubMed=2478685;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human stratum corneum keratins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   DE6
AC   CVCL_E5PN
RX   Patent=WO1991006668A1;
RX   PubMed=2479375;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10203.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2 (Note=neutralizing antibody).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DE7
AC   CVCL_A0PK
DR   Wikidata; Q108820144
RX   PubMed=19239370;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFB1, AFG2 and AFM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   DEAU
AC   CVCL_H210
DR   Wikidata; Q54830944
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2679917;
RX   PubMed=15122589;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   DEC 99
AC   CVCL_JF07
SY   DEC99; Duck Embryo Cell line 1999
DR   Wikidata; Q54830957
RX   CelloPub=CLPUB00393;
RX   CelloPub=CLPUB00394;
CC   Group: Bird cell line.
CC   Group: Vaccine production cell line.
CC   Doubling time: ~36 hours (Note=At 20-30th passages), ~72 hours (Note=At 60-70th passages) (CelloPub=CLPUB00393).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
SX   Sex unspecified
AG   14FD
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   DEC-205
AC   CVCL_9171
SY   NLDC-145
DR   CLO; CLO_0002740
DR   ATCC; HB-290
DR   Wikidata; Q54830958
RX   PubMed=3950549;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q60767; Mouse Ly75/Cd205.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   Dede
AC   CVCL_2886
SY   DeDe; DEDE
DR   BTO; BTO_0002995
DR   CLO; CLO_0002741
DR   EFO; EFO_0022824
DR   CLDB; cl1017
DR   CLDB; cl1018
DR   ATCC; CCL-39
DR   ECACC; 87091502
DR   IZSLER; BS CL 25
DR   Wikidata; Q54830959
RX   DOI=10.1007/BF02618370;
RX   PubMed=4359990;
RX   PubMed=7065527;
RX   PubMed=7320057;
RX   PubMed=14171598;
RX   PubMed=14328610;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CCL-39
CC   Misspelling: CC139; Note=Based on the ATCC catalog number.
CC   Misspelling: CCI 39; Note=Based on the ATCC catalog number.
CC   Misspelling: CCI-39; Note=Based on the ATCC catalog number.
CC   Misspelling: CCI39; Note=Based on the ATCC catalog number.
CC   Misspelling: CCL39; Note=Based on the ATCC catalog number.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   DEE
AC   CVCL_9T91
SY   Duck Embryo Epithelial
DR   Wikidata; Q54830960
RX   PubMed=26739426;
RX   PubMed=31658691;
CC   Group: Bird cell line.
CC   Virology: Susceptible to infection by duck hepatitis A type 1 virus (DHAV-1) (PubMed=26739426).
CC   Doubling time: ~18 hours (PubMed=26739426).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
SX   Sex unspecified
AG   11FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   DEE ExIGF2BP1
AC   CVCL_E6ZB
SY   ExIGF2BP1 DEE
RX   PubMed=31658691;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:28866; IGF2BP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
HI   CVCL_9T91 ! DEE
SX   Sex unspecified
AG   11FD
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   DEF-TA
AC   CVCL_ZZ32
SY   Duck Embryo Fibroblast-T antigen
DR   Wikidata; Q102113763
RX   PubMed=22633926;
CC   Group: Bird cell line.
CC   Virology: Susceptible to infection by duck hepatitis virus type 1 (DHV-1) (PubMed=22633926).
CC   Doubling time: 30-48 hours (PubMed=22633926).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   DeFew
AC   CVCL_0083
SY   Defew; De Few
DR   CLO; CLO_0002737
DR   CLDB; cl1015
DR   Cosmic; 850214
DR   GEO; GSM862867
DR   GEO; GSM862868
DR   GEO; GSM862869
DR   GEO; GSM862870
DR   Wikidata; Q54830961
RX   PubMed=9787181;
RX   PubMed=22885699;
CC   Virology: EBV-negative.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: Defaw; Cosmic=850214.
CC   Misspelling: De FOW; CLDB=cl1015; Note=In old versions. This error has propagated to other places.
CC   Misspelling: Defauw; Note=Occasionally.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   Deglis
AC   CVCL_A793
SY   DEGLIS
DR   Cosmic; 1086350
DR   Wikidata; Q54830962
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1319235;
RX   PubMed=8558920;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Characteristics: Displays a dual B-cell and T-cell phenotype (PubMed=1319235).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural cavity; UBERON=UBERON_0002402.
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   DeH128 (M)
AC   CVCL_6894
SY   DeH128(m); DeH128
DR   Wikidata; Q54830963
RX   PubMed=1703129;
CC   Doubling time: 30 hours (PubMed=1703129).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36-62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   DEL
AC   CVCL_1170
DR   CLO; CLO_0002742
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473352
DR   BioSample; SAMN10988540
DR   cancercelllines; CVCL_1170
DR   Cell_Model_Passport; SIDM00949
DR   ChEMBL-Cells; CHEMBL3308516
DR   ChEMBL-Targets; CHEMBL2366186
DR   Cosmic; 906836
DR   Cosmic; 1086361
DR   Cosmic-CLP; 906836
DR   DepMap; ACH-000233
DR   DSMZ; ACC-338
DR   DSMZCellDive; ACC-338
DR   EGA; EGAS00001000978
DR   GDSC; 906836
DR   GEO; GSM886976
DR   GEO; GSM888045
DR   GEO; GSM1669729
DR   IARC_TP53; 21301
DR   LiGeA; CCLE_293
DR   PharmacoDB; DEL_286_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1170
DR   PubChem_Cell_line; CVCL_1170
DR   Wikidata; Q54830964
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2307542;
RX   PubMed=8558920;
RX   PubMed=15356658;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28356514;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Contains 4 copies of an integrated murine leukemia virus closely related to that found in EKVX. Three of the integration sites are within the introns of genes OPA1, TNFRSF6B and ZNF767 (PubMed=25355872; PubMed=30629668).
CC   Doubling time: ~30 hours (DSMZ=ACC-338).
CC   HLA typing: A*02:01,26:01; B*14:01,27:05; C*08:02,08:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,26:01:01; B*14:01:01,27:05:02; C*05:01:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,04:02:01; DQA1*02:01:01,04:01:01; DQB1*02:02:01,04:02:01; DRA*01:01:01,01:02:02; DRB1*07:01:01,08:01:01 (DSMZCellDive=ACC-338).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Ala88Glu (c.263C>A); Zygosity=Heterozygous (Cosmic-CLP=906836).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Cys (c.643A>T); ClinVar=VCV001753522; Zygosity=Homozygous (Cosmic-CLP=906836).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.65%; Native American=0%; East Asian, North=1.56%; East Asian, South=0%; South Asian=0.96%; European, North=56.65%; European, South=40.18% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906836; DSMZ=ACC-338
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,18
ST   D19S433: 14,16
ST   D21S11: 28,31
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 19,22
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   del-AR1034ZIMA clone 1.2
AC   CVCL_A9PR
SY   del-ARiPS cl 1.2; dARiPS_clone1.2
DR   GEO; GSM1342465
DR   GEO; GSM1342466
DR   Wikidata; Q102113764
RX   PubMed=24713299;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9PQ ! fl-AR1034ZIMA clone 1
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   del-AR1034ZIMA clone 1.4
AC   CVCL_A9PS
SY   del-ARiPS cl 1.4; dARiPS_clone1.4
DR   GEO; GSM1342467
DR   GEO; GSM1342469
DR   Wikidata; Q102113765
RX   PubMed=24713299;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9PQ ! fl-AR1034ZIMA clone 1
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   DELSH-5
AC   CVCL_LJ93
SY   Delsh-5
DR   Wikidata; Q54830965
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6257270;
CC   Population: Indian.
CC   Doubling time: 32-40 hours (PubMed=6257270).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   delta l(3)mbt-OSC
AC   CVCL_XF58
SY   delta mbt-OSC; l(3)mbt-OSC
DR   DGRC; 289
DR   FlyBase_Cell_line; FBtc0000289
DR   Wikidata; Q93525448
RX   PubMed=27474440;
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0002441; l(3)mbt.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_IY73 ! OSC
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   delta TA4-1
AC   CVCL_J893
SY   dTA4-1; TA4-1
DR   CLO; CLO_0009738
DR   ATCC; HB-70
DR   Wikidata; Q54830966
RX   PubMed=6815220;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Human IgD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   delta-47
AC   CVCL_2887
SY   Delta-47; DELTA-47; Delta 47; DELTA 47; Delta47; DELTA47
DR   Cosmic; 720783
DR   Cosmic; 760400
DR   Cosmic; 2081378
DR   Cosmic; 2302420
DR   Cosmic; 2367274
DR   Cosmic; 2391802
DR   JCRB; JCRB1344
DR   JCRB; NIHS0543
DR   SKY/M-FISH/CGH; 2517
DR   Wikidata; Q54830967
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1329502;
RX   PubMed=8943038;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Doubling time: 40 hours (PubMed=1329502).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ5 (CelloPub=CLPUB00604).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: JCRB; NIHS0543; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1344
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,20
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   Delta-Rad51+hRad51-DT40
AC   CVCL_9U92
DR   CLO; CLO_0051499
DR   RCB; RCB1631
DR   Wikidata; Q54830968
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 3336; RAD51.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9817; RAD51.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   Delta-Rad54+hRad54-DT40
AC   CVCL_9U93
DR   CLO; CLO_0051492
DR   RCB; RCB1672
DR   Wikidata; Q54830969
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7881; RAD54L.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9826; RAD54L.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   Delta-Ubc9+cUbc9-DT40
AC   CVCL_AS94
SY   DT40 UBC9-/-/- tetUBC9
DR   CLO; CLO_0051495
DR   RCB; RCB1845
DR   Wikidata; Q54830970
RX   PubMed=12413887;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 4844; UBE2I.
CC   Genetic integration: Method=Transfection; Gene=CGNC; 4844; UBE2I.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   DeltaST3GAL3 clone 1
AC   CVCL_D6RR
SY   DeltaSt3Gal-III iPSC
RX   PubMed=30089820;
CC   From: Department of Functional Genomics - Human Molecular Genetics, University Medicine Greifswald; Greifswald; Germany.
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:10866; ST3GAL3; Simple; p.Ala320Pro (c.958G>C); ClinVar=VCV000039592; Zygosity=Homozygous (PubMed=30089820).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84788; West syndrome
DI   ORDO; Orphanet_3451; Infantile spasms syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   deltaTCAR-3
AC   CVCL_A0EN
SY   dTCAR-3; deltaTCS1
DR   Wikidata; Q108820145
RX   Patent=US5024940;
RX   Patent=US6171799;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9578.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B7Z8K6; Human TRDC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   DeltaWTNdeMYC
AC   CVCL_0Q78
DR   DGRC; 153
DR   FlyBase_Cell_line; FBtc0000153
DR   Wikidata; Q54830971
RX   PubMed=9658166;
CC   Group: Insect cell line.
CC   Doubling time: 52 hours (DGRC=153).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 9
//
ID   DEM
AC   CVCL_E559
DR   dbMHC; 48753
DR   ECACC; 88052007
DR   IHW; IHW09007
DR   IPD-IMGT/HLA; 11627
DR   Wikidata; Q54830972
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; German.
CC   HLA typing: A*02:01:01:01; B*57:01:01; C*06:02:01:01; DPA1*01; DPB1*03:01:01,04:01:01; DQA1*01:02:02,03:01; DQB1*05:02:01,03:02:01; DRA*01:01; DRB1*04:01:01,16:02:01; DRB4*01:01; DRB5*02; DRB6*02:02 (IPD-IMGT/HLA=11627).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   Demel
AC   CVCL_W330
SY   DEMEL
DR   Wikidata; Q54830973
RX   PubMed=1390335;
RX   PubMed=14692828;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   DEMF
AC   CVCL_LJ50
SY   Duroc Ear Marginal Fibroblast
DR   Wikidata; Q54830974
RX   CelloPub=CLPUB00405;
CC   Doubling time: ~26 hours (CelloPub=CLPUB00405).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Duroc; VBO=VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 9
//
ID   DEMI
AC   CVCL_A1YM
DR   Wikidata; Q105506737
RX   PubMed=19276180;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 56.5 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   DemKT1
AC   CVCL_YZ68
SY   DEMKT1
DR   Wikidata; Q98125872
RX   DOI=10.14943/doctoral.k12177;
RX   PubMed=24131711;
RX   PubMed=26605499;
RX   PubMed=30718752;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9408; ! Rousettus leschenaultii (Leschenault's rousette)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   Dempsey
AC   CVCL_2888
DR   CLO; CLO_0002743
DR   ATCC; CCL-28
DR   BioSample; SAMN01821547
DR   BioSample; SAMN01821676
DR   BioSample; SAMN03471280
DR   JCRB; JCRB9088
DR   KCLB; 10028
DR   Wikidata; Q54830975
RX   DOI=10.1007/BF02618370;
RX   PubMed=5889982;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~30 PDL (ATCC=CCL-28).
CC   Misspelling: Dempsy; Note=Occasionally.
CC   Discontinued: JCRB; JCRB9088; true.
CC   Discontinued: KCLB; 10028; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-28; JCRB=JCRB9088
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15,18
ST   D19S433: 12,14
ST   D21S11: 28,30.2
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   Penta D: 12,13
ST   Penta E: 14,17
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   DEN-HSA
AC   CVCL_1R33
SY   DEN; HSA-Den
DR   GEO; GSM1974786
DR   Wikidata; Q54830976
RX   PubMed=16256156;
RX   PubMed=17338158;
RX   PubMed=21908323;
RX   PubMed=22594682;
RX   PubMed=22849686;
RX   PubMed=26842912;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Doubling time: 16 hours (PubMed=27257868).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 231,235
ST   Dog FHC2054: 168,172
ST   Dog FHC2079: 275,279
ST   Dog PEZ1: 115,123
ST   Dog PEZ3: 119,121
ST   Dog PEZ5: 103
ST   Dog PEZ6: 183
ST   Dog PEZ8: 228,240
ST   Dog PEZ12: 285,288
ST   Dog PEZ20: 176,180
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   DENA-RH 13
AC   CVCL_D7CQ
RX   PubMed=569065;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_D7CR ! DENA-RH 13A
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   DENA-RH 13A
AC   CVCL_D7CR
RX   PubMed=569065;
CC   Characteristics: Established from the original tumor that was passed by intraperitoneal injection through Wistar rats (PubMed=569065).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_D7CQ ! DENA-RH 13
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   DEOC-1
AC   CVCL_4161
SY   DEOC1
DR   CLO; CLO_0050137
DR   EFO; EFO_0006563
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472898
DR   Cosmic; 874387
DR   Cosmic; 1007159
DR   EGA; EGAS00001000610
DR   PharmacoDB; DEOC1_287_2019
DR   RCB; RCB2831
DR   Wikidata; Q54830977
RX   PubMed=17547717;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Japanese.
CC   Doubling time: 81.2 hours (Note=At 6th passage), 100 hours (Note=At 20th passage) (PubMed=17547717).
CC   HLA typing: A*24:02,26:01; B*40:02,52:01; C*03:04,12:02 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Heel, skin; UBERON=UBERON_0015873.
ST   Source(s): PubMed=25877200; RCB=RCB2831
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 21
ST   D21S11: 29,32
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 11
ST   FGA: 19,26
ST   Penta D: 9,11
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Der(22)-iPS-C2
AC   CVCL_UG56
DR   Wikidata; Q93525645
RX   PubMed=21949351;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 12
ST   FGA: 21,22.2
ST   Penta D: 13
ST   Penta E: 12,15
ST   TH01: 9.3,10
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V547 ! GM00084
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   Der(22)-iPS-C4
AC   CVCL_UG57
DR   Wikidata; Q93525652
RX   PubMed=21949351;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 12
ST   FGA: 21,22.2
ST   Penta D: 13
ST   Penta E: 12,15
ST   TH01: 9.3,10
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V547 ! GM00084
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   DERL-2
AC   CVCL_2016
SY   DERL2; DERL-NK2
DR   CLO; CLO_0037049
DR   BioSample; SAMN03473525
DR   cancercelllines; CVCL_2016
DR   Cell_Model_Passport; SIDM01509
DR   DepMap; ACH-001057
DR   DSMZ; ACC-531
DR   DSMZCellDive; ACC-531
DR   GEO; GSM1374460
DR   LINCS_LDP; LCL-1116
DR   Wikidata; Q54830978
RX   PubMed=10800166;
RX   PubMed=11587224;
RX   PubMed=28122867;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 72 hours (PubMed=11587224); ~60 hours (DSMZ=ACC-531).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-531; PubMed=11587224
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 14,15
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20,22 (DSMZ=ACC-531)
ST   FGA: 21,22 (PubMed=11587224)
ST   Penta D: 11,13
ST   Penta E: 11,14
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C8459; Hepatosplenic T-cell lymphoma
DI   ORDO; Orphanet_86882; Hepatosplenic T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2017 ! DERL-7
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   DERL-7
AC   CVCL_2017
SY   DERL7; DERL-NK7
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   Cell_Model_Passport; SIDM01508
DR   Cosmic; 2785208
DR   DSMZ; ACC-524
DR   DSMZCellDive; ACC-524
DR   Wikidata; Q54830979
RX   PubMed=10800166;
RX   PubMed=11587224;
RX   PubMed=28122867;
RX   PubMed=31160637;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Doubling time: 72 hours (PubMed=11587224); ~30 hours (DSMZ=ACC-524).
CC   HLA typing: A*02:01:01,26:01:01; B*38:01:01,51:01:01; C*02:02:02,12:03:01 (DSMZCellDive=ACC-524).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-524; PubMed=11587224
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 14,15
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20,22 (DSMZ=ACC-524)
ST   FGA: 21,22 (PubMed=11587224)
ST   Penta D: 11,13
ST   Penta E: 11,14
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C8459; Hepatosplenic T-cell lymphoma
DI   ORDO; Orphanet_86882; Hepatosplenic T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2016 ! DERL-2
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   DERM
AC   CVCL_B7LI
DR   Wikidata; Q112929445
RX   PubMed=7721350;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   DerP2
AC   CVCL_A9KF
DR   CCRID; 4201PAT-CCTCC00458
DR   Wikidata; Q108820146
RX   Patent=CN105319371B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014112.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus allergen Der p 2 (DERP2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   DES-28
AC   CVCL_M728
DR   Wikidata; Q54830980
RX   PubMed=4052977;
RX   PubMed=6861146;
CC   Transformant: ChEBI; CHEBI_41922; Diethylstilbestrol.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   deSc
AC   CVCL_E7AM
SY   dedifferentiated Stephanolepis cirrhifer
RX   Patent=US9777254;
RX   PubMed=35087061;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-1369.
CC   Doubling time: 14-28 hours (Patent=US9777254).
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=143348; ! Stephanolepis cirrhifer (Thread-sail filefish)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Desmond
AC   CVCL_A0WV
DR   Wikidata; Q108820147
RX   PubMed=22704137;
RX   PubMed=31816142;
RX   PubMed=34079834;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia.
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Greyhound; VBO=VBO_0200638.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   Detroit 116P
AC   CVCL_8672
SY   Detroit-116P; Det-116P
DR   Wikidata; Q54830981
RX   PubMed=13370509;
RX   PubMed=13460970;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Detroit 143
AC   CVCL_8671
SY   Detroit-143
DR   Wikidata; Q54830982
RX   PubMed=13460970;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 4
//
ID   Detroit 173B
AC   CVCL_8673
SY   Detroit-173B; Det-173B
DR   Wikidata; Q54830983
RX   PubMed=13460970;
RX   PubMed=13596418;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Detroit 30A
AC   CVCL_8674
SY   Detroit-30A; Det-30A; Det30A
DR   BioSample; SAMN03151680
DR   Wikidata; Q54830984
RX   PubMed=1246601;
RX   PubMed=5668122;
RX   PubMed=13307201;
RX   PubMed=13370509;
RX   PubMed=13460970;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388). Originally thought to originate from the ascitic fluid of a 43 year old breast cancer patient.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00041.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Detroit 32
AC   CVCL_8675
SY   Detroit-32; Det-32
DR   Wikidata; Q54830985
RX   PubMed=13307201;
RX   PubMed=13370509;
RX   PubMed=13460970;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Detroit 34
AC   CVCL_8676
SY   Detroit-34; Det-34
DR   Wikidata; Q54830986
RX   PubMed=13307201;
RX   PubMed=13370509;
RX   PubMed=13460970;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Detroit 501
AC   CVCL_8677
SY   Detroit-501
DR   Wikidata; Q54830987
RX   PubMed=13460970;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5751; Liver mesenchymal hamartoma
DI   ORDO; Orphanet_386; Hepatic cystic hamartoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Detroit 510
AC   CVCL_2427
SY   Detroit-510; Det 510
DR   CLO; CLO_0002744
DR   CLDB; cl1020
DR   CLDB; cl1021
DR   ATCC; CCL-72
DR   BioSample; SAMN03471284
DR   ECACC; 90102531
DR   IZSLER; BS CL 27
DR   JCRB; JCRB9104
DR   Wikidata; Q54830988
RX   DOI=10.1007/BF02618370;
RX   PubMed=5668122;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~30 PDL.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-72; ECACC=90102531; IZSLER=BS CL 27; JCRB=JCRB9104
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,18
ST   D19S433: 12,15
ST   D21S11: 27,30
ST   D2S1338: 23,24
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   D8S1179: 12,15
ST   FGA: 23,26
ST   Penta D: 13,14
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   Detroit 52
AC   CVCL_8678
SY   Detroit-52; Det-52
DR   Wikidata; Q54830989
RX   PubMed=13307201;
RX   PubMed=13370509;
RX   PubMed=13460970;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   Detroit 525
AC   CVCL_2428
SY   Detroit-525; Detroit525; Det 525
DR   CLO; CLO_0002745
DR   CLDB; cl1022
DR   CLDB; cl1023
DR   ATCC; CCL-65
DR   BioSample; SAMN01821548
DR   BioSample; SAMN01821677
DR   BioSample; SAMN03471282
DR   ECACC; 90121002
DR   IZSLER; BS CL 28
DR   JCRB; JCRB9102
DR   Wikidata; Q54830990
RX   DOI=10.1007/BF02618370;
RX   PubMed=5668122;
RX   PubMed=6988327;
RX   PubMed=14253578;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-65; ECACC=90121002; IZSLER=BS CL 28; JCRB=JCRB9102
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 12
ST   D19S433: 15,15.2
ST   D21S11: 27,30
ST   D2S1338: 17,25
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3-4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Detroit 529
AC   CVCL_2429
SY   Detroit-529; Detroit529; Det 529
DR   CLO; CLO_0002746
DR   CLDB; cl1024
DR   CLDB; cl1025
DR   ATCC; CCL-66
DR   BioSample; SAMN01821549
DR   BioSample; SAMN01821679
DR   BioSample; SAMN03471283
DR   ECACC; 87021203
DR   IZSLER; BS CL 29
DR   JCRB; JCRB9043
DR   Wikidata; Q54830991
RX   DOI=10.1007/BF02618370;
RX   PubMed=5668122;
RX   PubMed=11416159;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~30 PDL (ATCC=CCL-66).
CC   Discontinued: ECACC; 87021203; true.
CC   Discontinued: JCRB; JCRB9043; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-66; IZSLER=BS CL 29; JCRB=JCRB9043; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 13,14
ST   D18S51: 17,19
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 8,14
ST   FGA: 18,22
ST   Penta D: 10,12
ST   Penta E: 10,16
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2-3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   Detroit 532
AC   CVCL_2430
SY   Detroit-532; Detroit532; Det 532; DS-Fibr
DR   CLO; CLO_0002747
DR   CLDB; cl1026
DR   CLDB; cl1027
DR   ATCC; CCL-54
DR   BioSample; SAMN01821550
DR   BioSample; SAMN01821678
DR   BioSample; SAMN03471281
DR   ECACC; 87032602
DR   GEO; GSM1053958
DR   GEO; GSM1053959
DR   GEO; GSM1053960
DR   GEO; GSM1053982
DR   GEO; GSM1053983
DR   GEO; GSM1053984
DR   IZSLER; BS CL 30
DR   JCRB; JCRB9044
DR   NCBI_Iran; C438
DR   Wikidata; Q54830992
RX   DOI=10.1007/BF02618370;
RX   PubMed=5668122;
RX   PubMed=6988327;
RX   PubMed=7329430;
RX   PubMed=7471105;
RX   PubMed=17254797;
RX   PubMed=23225669;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CCL-54; ECACC=87032602; IZSLER=BS CL 30; JCRB=JCRB9044; PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 11 (PubMed=17254797)
ST   CSF1PO: 12 (ATCC=CCL-54; ECACC=87032602; IZSLER=BS CL 30; JCRB=JCRB9044)
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 30,31 (PubMed=17254797)
ST   D21S11: 30,31.2 (ATCC=CCL-54; IZSLER=BS CL 30)
ST   D2S1338: 22,25
ST   D3S1358: 17,18
ST   D5S818: 9,12
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 20,24
ST   Penta D: 8,9,13
ST   Penta E: 13,16
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   Detroit 539
AC   CVCL_2431
SY   Detroit-539
DR   CLO; CLO_0002748
DR   CLDB; cl1028
DR   CLDB; cl1029
DR   ATCC; CCL-84
DR   BioSample; SAMN03471288
DR   BioSample; SAMN03472411
DR   ECACC; 91031102
DR   IZSLER; BS CL 31
DR   JCRB; JCRB9045
DR   Wikidata; Q54830993
RX   DOI=10.1007/BF02618370;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-84; ECACC=91031102; JCRB=JCRB9045
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 14,20
ST   D19S433: 13,14
ST   D21S11: 29,30,31
ST   D2S1338: 16,17
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 9,11,14
ST   Penta E: 7,11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Detroit 548
AC   CVCL_2432
SY   Detroit-548
DR   CLO; CLO_0002749
DR   CLDB; cl1030
DR   ATCC; CCL-116
DR   BioSample; SAMN03472696
DR   IZSLER; BS CL 32
DR   Wikidata; Q54830994
RX   DOI=10.1007/BF02618370;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-116; IZSLER=BS CL 32
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 22,24
ST   D3S1358: 14,17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   Penta D: 11,14
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Detroit 550
AC   CVCL_2433
SY   Detroit-550
DR   CLO; CLO_0002750
DR   CLDB; cl1032
DR   ATCC; CCL-109
DR   IZSLER; BS CL 33
DR   Wikidata; Q54830995
RX   DOI=10.1007/BF02618370;
CC   Discontinued: ATCC; CCL-109; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): IZSLER=BS CL 33
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D21S11: 29,30.2
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   Detroit 551
AC   CVCL_2434
SY   Detroit-551; Detroit551; D551
DR   BTO; BTO_0005826
DR   CLO; CLO_0002751
DR   CLDB; cl1033
DR   CLDB; cl1034
DR   ATCC; CCL-110
DR   BCRC; 60118
DR   BCRJ; 0302
DR   BioSample; SAMN03472693
DR   BioSample; SAMN04504657
DR   ChEMBL-Cells; CHEMBL3307358
DR   ChEMBL-Targets; CHEMBL614284
DR   ECACC; 86082802
DR   GEO; GSM1658371
DR   GEO; GSM1658373
DR   GEO; GSM1658375
DR   GEO; GSM1658397
DR   GEO; GSM2061359
DR   IZSLER; BS CL 34
DR   KCLB; 10110
DR   PubChem_Cell_line; CVCL_2434
DR   Wikidata; Q54830996
RX   DOI=10.1007/BF02618370;
RX   PubMed=26004630;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~25 PDL (ATCC=CCL-110).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: BCRJ; 0302; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-110; ECACC=86082802; IZSLER=BS CL 34; KCLB=10110
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 13,14.2
ST   D21S11: 29,31.2
ST   D2S1338: 24,25
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10
ST   FGA: 22,24
ST   Penta D: 9,12
ST   Penta E: 8,18
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Detroit 562
AC   CVCL_1171
SY   DETROIT 562; Detroit-562; Detroit562; DETROIT562; Det 562; Det. 562; Det562; D562
DR   BTO; BTO_0000834
DR   CLO; CLO_0002752
DR   EFO; EFO_0002170
DR   CLDB; cl1035
DR   CLDB; cl1036
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-138
DR   ATCC; CRL-7919
DR   BCRC; 60119
DR   BCRJ; 0076
DR   BioGRID_ORCS_Cell_line; 686
DR   BioSample; SAMN03473286
DR   BioSample; SAMN10988307
DR   cancercelllines; CVCL_1171
DR   CCRID; 3101HUMTCHu231
DR   Cell_Model_Passport; SIDM00831
DR   ChEMBL-Cells; CHEMBL3308486
DR   ChEMBL-Targets; CHEMBL1075432
DR   CLS; 300399
DR   Cosmic; 686974
DR   Cosmic; 906837
DR   Cosmic; 921830
DR   Cosmic; 1006472
DR   Cosmic; 1017788
DR   Cosmic; 1041673
DR   Cosmic; 1339917
DR   Cosmic; 1752763
DR   Cosmic; 2043891
DR   Cosmic; 2296294
DR   Cosmic-CLP; 906837
DR   DepMap; ACH-000207
DR   ECACC; 87042205
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10723-110A3
DR   GDSC; 906837
DR   GEO; GSM301580
DR   GEO; GSM827340
DR   GEO; GSM886977
DR   GEO; GSM888046
DR   GEO; GSM1374461
DR   GEO; GSM1374462
DR   GEO; GSM1643590
DR   GEO; GSM1669730
DR   IARC_TP53; 2327
DR   IGRhCellID; Detroit562
DR   IZSLER; BS TCL 16
DR   LiGeA; CCLE_046
DR   LINCS_LDP; LCL-1226
DR   PharmacoDB; Detroit562_288_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1171
DR   PubChem_Cell_line; CVCL_1171
DR   Wikidata; Q54831001
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=5668122;
RX   PubMed=6220172;
RX   PubMed=6401685;
RX   PubMed=6500159;
RX   PubMed=6988327;
RX   PubMed=10760816;
RX   PubMed=12124801;
RX   PubMed=15197768;
RX   PubMed=18973137;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=22460905;
RX   PubMed=24201445;
RX   PubMed=25275298;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26754630;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=29423072;
RX   PubMed=30877674;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 88.5 +- 34.7 hours (PubMed=29423072).
CC   HLA typing: A*03,11; B*13 (PubMed=77569).
CC   HLA typing: A*26:01,30:01; B*13:02,55:01; C*01:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25275298).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.82%; Native American=0%; East Asian, North=1.93%; East Asian, South=0%; South Asian=1.05%; European, North=61.34%; European, South=34.86% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7919; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CCL-138; CLS=300399; Cosmic-CLP=906837; ECACC=87042205; IZSLER=BS TCL 16; PubMed=21868764; PubMed=25275298; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8 (CLS=300399)
ST   D7S820: 8,10 (ATCC=CCL-138; Cosmic-CLP=906837; ECACC=87042205; IZSLER=BS TCL 16; PubMed=21868764; PubMed=25275298; PubMed=25877200)
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 8 (CLS=300399)
ST   TH01: 8,9 (ATCC=CCL-138; Cosmic-CLP=906837; ECACC=87042205; IZSLER=BS TCL 16; PubMed=21868764; PubMed=25275298; PubMed=25877200)
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   Detroit 56A
AC   CVCL_8679
SY   Detroit-56A; Det-56A
DR   Wikidata; Q54831002
RX   PubMed=13307201;
RX   PubMed=13370509;
RX   PubMed=13460970;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Detroit 573
AC   CVCL_2435
SY   Detroit-573
DR   CLO; CLO_0002753
DR   CLDB; cl1037
DR   CLDB; cl1038
DR   ATCC; CCL-117
DR   BioSample; SAMN03472699
DR   ECACC; 90112601
DR   IZSLER; BS CL 35
DR   Wikidata; Q54831003
RX   DOI=10.1007/BF02618370;
CC   Population: Caucasian.
CC   Discontinued: ATCC; CCL-117; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-117; IZSLER=BS CL 35
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,14
ST   D21S11: 27,31.2
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Detroit 6
AC   CVCL_2436
SY   Detroit-6; Det-6; Det6
DR   CLO; CLO_0002754
DR   CLDB; cl1039
DR   CLDB; cl1040
DR   ATCC; CCL-3
DR   BioSample; SAMN03151685
DR   IZSLER; BS CL 26
DR   Wikidata; Q54831004
RX   DOI=10.1007/BF02618370;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=5668122;
RX   PubMed=13307201;
RX   PubMed=13370509;
RX   PubMed=13460970;
RX   PubMed=14185313;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from the bone marrow of a 58 year old male lung carcinoma patient.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00004.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-3; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): IZSLER=BS CL 26
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 14
ST   D16S539: 9,10
ST   D21S11: 27,28
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Detroit 6 clone 12
AC   CVCL_M618
SY   Detroit-6 cl.12; Det6 clone 12
DR   ATCC; CCL-3.1
DR   Wikidata; Q54831005
RX   DOI=10.1007/BF02618370;
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=14185313;
CC   Problematic cell line: Contaminated. Parent cell line (Detroit 6) has been shown to be a HeLa derivative (PubMed=6451928; PubMed=1246601).
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-3.1; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2436 ! Detroit 6
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   Detroit 98
AC   CVCL_8188
SY   Detroit-98; Det-98; Det98; D98
DR   ATCC; CCL-18
DR   BioSample; SAMN03151686
DR   ChEMBL-Cells; CHEMBL3307294
DR   ChEMBL-Targets; CHEMBL614059
DR   PubChem_Cell_line; CVCL_8188
DR   Wikidata; Q54831006
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=13370509;
RX   PubMed=13460970;
RX   PubMed=14185313;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from the bone marrow of a non cancerous individual.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00005.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-18; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Detroit 98/AG
AC   CVCL_8189
SY   Det98/AG; D98/AG
DR   ATCC; CCL-18.2
DR   BioSample; SAMN03151681
DR   Wikidata; Q54831007
RX   CelloPub=CLPUB00640;
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=13980043;
RX   PubMed=14278461;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Grand-parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00019.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-18.2; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8192 ! Detroit 98S
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Detroit 98/AGR
AC   CVCL_A9AQ
SY   D98/AGR
DR   Wikidata; Q108820148
RX   CelloPub=CLPUB00640;
RX   PubMed=14278461;
CC   Problematic cell line: Contaminated. Ancestral cell line (Detroit 98) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8189 ! Detroit 98/AG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   Detroit 98/AH
AC   CVCL_U961
SY   Det98/AH; D98/AH
DR   BioSample; SAMN03151677
DR   Wikidata; Q54831008
RX   CelloPub=CLPUB00640;
RX   PubMed=13980043;
RX   PubMed=14278461;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Ancestral cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00115.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_136532; 8-azahypoxanthine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8189 ! Detroit 98/AG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   Detroit 98/AH-2
AC   CVCL_8190
SY   Det98/AH-2; D98/AH-2; D98-AH2
DR   ATCC; CCL-18.3
DR   BioSample; SAMN03151682
DR   BioSample; SAMN03472006
DR   FANTOM5_SSTAR; 10552-107I3
DR   RCB; RCB2105
DR   TKG; TKG 0191
DR   Wikidata; Q54831009
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=13980043;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Ancestral cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00020.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_136532; 8-azahypoxanthine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Misspelling: Detroit 98/AT-2; PubMed=1246601.
CC   Discontinued: ATCC; CCL-18.3; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB2105; TKG=TKG 0191
ST   Amelogenin: X
ST   CSF1PO: 9,10 (TKG=TKG 0191)
ST   CSF1PO: 9,10,11 (RCB=RCB2105)
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8189 ! Detroit 98/AG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Detroit 98/AH-R
AC   CVCL_8191
SY   Det98/AH-R; Det98/AHR; D98/AH-R
DR   ATCC; CCL-18.4
DR   BioSample; SAMN03151683
DR   Wikidata; Q54831010
RX   CelloPub=CLPUB00640;
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=13980043;
RX   PubMed=14278461;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Ancestral cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00021.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_136532; 8-azahypoxanthine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-18.4; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U961 ! Detroit 98/AH
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Detroit 98/Apt
AC   CVCL_A9AR
SY   D98/Apt
DR   Wikidata; Q108820149
RX   PubMed=13980043;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Detroit 98) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_22526; 4-aminofolic acid (Aminopterin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8192 ! Detroit 98S
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   Detroit 98S
AC   CVCL_8192
SY   Detroit 98s; D98S; D98s
DR   ATCC; CCL-18.1
DR   BioSample; SAMN03151684
DR   Wikidata; Q54831011
RX   CelloPub=CLPUB00640;
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=13980043;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (Detroit 98) has been shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00022.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-18.1; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8188 ! Detroit 98
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   Detroit B110
AC   CVCL_8680
SY   Detroit-B110
DR   Wikidata; Q54831012
RX   PubMed=13596418;
RX   PubMed=13596947;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Detroit B16
AC   CVCL_8681
SY   Detroit-B16
DR   Wikidata; Q54831013
RX   PubMed=5668122;
RX   PubMed=13460970;
RX   PubMed=13596418;
RX   PubMed=13596947;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Detroit B17
AC   CVCL_8682
SY   Detroit-B17
DR   Wikidata; Q54831014
RX   PubMed=13460970;
RX   PubMed=13596418;
RX   PubMed=13596947;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Detroit B78
AC   CVCL_8683
SY   Detroit-B78
DR   Wikidata; Q54831015
RX   PubMed=5668122;
RX   PubMed=13596418;
RX   PubMed=13596947;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Detroit B96
AC   CVCL_8684
SY   Detroit-B96
DR   Wikidata; Q54831016
RX   PubMed=13596418;
RX   PubMed=13596947;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   DEU
AC   CVCL_E560
DR   dbMHC; 48754
DR   ECACC; 94122032
DR   IHW; IHW09025
DR   IPD-IMGT/HLA; 11628
DR   Wikidata; Q54831017
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*31:01:02:01; B*35:01:01:02; C*04:01:01:01; DPA1*01; DPB1*04:01:01:01; DQA1*03:02; DQB1*03:01:01:01; DRA*01:01; DRB1*04:01:01; DRB4*01:01 (IPD-IMGT/HLA=11628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   DEV [Human lymphoma]
AC   CVCL_7187
DR   Cosmic; 1293254
DR   GEO; GSM1897960
DR   Lonza; 268
DR   Wikidata; Q54831018
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=3881158;
RX   PubMed=12581897;
RX   PubMed=19648161;
RX   PubMed=27998726;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be from a nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).
CC   Doubling time: ~3 days (PubMed=3881158).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7258; Nodular lymphocyte predominant Hodgkin lymphoma
DI   ORDO; Orphanet_86893; Nodular lymphocyte predominant Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   DEV [Human medulloblastoma]
AC   CVCL_M703
DR   Wikidata; Q54831019
RX   PubMed=7850027;
RX   PubMed=11433425;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   DEW1
AC   CVCL_YD98
DR   Wikidata; Q93526191
RX   CelloPub=CLPUB00548;
RX   PubMed=3026962;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   DEX-Faza 967
AC   CVCL_S742
SY   Dex-Faza 967
DR   Wikidata; Q54831020
RX   PubMed=2431944;
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4775 ! Faza 967
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 14
//
ID   DF
AC   CVCL_W108
DR   CLO; CLO_0002755
DR   CLDB; cl1041
DR   Wikidata; Q54831021
RX   PubMed=3225639;
CC   Doubling time: 48 hours (Note=At 37th passage), 36 hours (Note=At 77th passage) (PubMed=3225639).
CC   Anecdotal: Cell line name corresponds to the initials of the patient from which it was established.
CC   Derived from site: In situ; Brain, right parasagittal parietal region.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 9
//
ID   Df
AC   CVCL_2437
SY   DF
DR   ECACC; 86072802
DR   Wikidata; Q54831022
RX   PubMed=3763403;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   DF-1 O/E-ST3
AC   CVCL_A4AG
SY   O/E-ST3
DR   ABM; T6524
DR   Wikidata; Q105506739
RX   PubMed=33413322;
CC   Group: Bird cell line.
CC   Genetic integration: Method=PiggyBac transposition; Gene=CGNC; 84170; ST3GAL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   DF-1 O/E-ST3T2
AC   CVCL_A4AH
SY   O/E-ST3T2
DR   ABM; T6525
DR   Wikidata; Q105506742
RX   PubMed=33413322;
CC   Group: Bird cell line.
CC   Virology: Allows efficient propagation of influenza virus in the absence of exogenous trypsin (PubMed=33413322).
CC   Genetic integration: Method=PiggyBac transposition; Gene=CGNC; 84170; ST3GAL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=CGNC; 12069; TMPRSS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   DF-1 O/E-T2
AC   CVCL_A4AI
SY   O/E-T2
DR   ABM; T6522
DR   Wikidata; Q105506744
RX   PubMed=33413322;
CC   Group: Bird cell line.
CC   Genetic integration: Method=PiggyBac transposition; Gene=CGNC; 12069; TMPRSS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   DF-1 O/E-T4
AC   CVCL_A4AJ
SY   O/E-T4
DR   ABM; T6523
DR   Wikidata; Q105506747
RX   PubMed=33413322;
CC   Group: Bird cell line.
CC   Genetic integration: Method=PiggyBac transposition; Gene=CGNC; 5591; TMPRSS4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   DF-1-AvBD2
AC   CVCL_A9LC
DR   Wikidata; Q108820150
RX   DOI=10.7668/hbnxb.20191413;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transduction; Gene=CGNC; 49507; DEFB4A/Gallinacin-2.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   DF-1-AvBD9
AC   CVCL_B7JM
DR   Wikidata; Q112929448
RX   DOI=10.13836/j.jjau.2020061;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transduction; Gene=CGNC; 49917; AvBD9/Gallinacin-9.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   DF-1/A
AC   CVCL_XF08
DR   CCRID; 4201PAT-CCTCC00511
DR   Wikidata; Q93526254
RX   DOI=10.1016/S2095-3119(16)61453-3;
RX   Patent=CN104560865B;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014180.
CC   Virology: Not susceptible to infection by avian leukosis virus subgroup A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03397; Avian leukosis virus subgroup A (isolate RSA) envelope protein (Env).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   DF-1/B
AC   CVCL_XF09
DR   CCRID; 4201PAT-CCTCC00822
DR   Wikidata; Q93526259
RX   Patent=CN105861444B;
RX   PubMed=31376350;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201609.
CC   Virology: Not susceptible to infection by avian leukosis virus subgroup B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Avian leukosis virus subgroup B (isolate CD08) envelope protein (Env).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   DF-1/K
AC   CVCL_XF10
DR   CCRID; 4201PAT-CCTCC00823
DR   Wikidata; Q93526264
RX   Patent=CN105861445A;
RX   PubMed=28986681;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201610.
CC   Virology: Not susceptible to infection by avian leukosis virus subgroup K.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A0A0H4LXT3; Avian leukosis virus subgroup K (isolate GDFX0601) envelope protein (Env).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   DF-1\J
AC   CVCL_XF11
DR   Wikidata; Q93526271
RX   PubMed=10544146;
CC   Group: Bird cell line.
CC   Virology: Not susceptible to infection by avian leukosis virus subgroup J.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9YJY0; Avian leukosis virus subgroup J (isolate ADOL-Hc-1) envelope protein (Env).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   DF-15
AC   CVCL_A1FG
DR   Cosmic; 1305322
DR   Wikidata; Q102113766
RX   PubMed=19956657;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   DF-22
AC   CVCL_A1FH
DR   Cosmic; 1305323
DR   Wikidata; Q102113767
RX   PubMed=19956657;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   DF-23
AC   CVCL_A1FI
DR   Cosmic; 1305324
DR   Wikidata; Q102113769
RX   PubMed=19956657;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   DF15
AC   CVCL_Y429
DR   Wikidata; Q54831023
RX   Patent=US20070027175;
RX   PubMed=22552008;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 6
//
ID   DF15R
AC   CVCL_Y430
DR   Wikidata; Q54831024
RX   PubMed=22552008;
CC   Selected for resistance to: ChEBI; CHEBI_72690; Pomalidomide (3-amino-thalidomide; CC-4047).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y429 ! DF15
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 8
//
ID   DF4
AC   CVCL_XY02
DR   CCRID; 4201PAT-CCTCC00275
DR   Wikidata; Q93526311
RX   Patent=CN101560257B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200907.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_29036; Copper(2+).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   DF5
AC   CVCL_E5RE
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DF508 2
AC   CVCL_B336
SY   RC2 200
DR   Wikidata; Q54831025
RX   PubMed=20715179;
WW   Provider; CReM; 557; https://stemcellbank.bu.edu/Catalog/Item/Details/557
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20715179).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L744 ! GM01012
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   DF508 4
AC   CVCL_B337
DR   Wikidata; Q54831026
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20715179).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L744 ! GM01012
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   DF508 5
AC   CVCL_B338
DR   Wikidata; Q54831028
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20715179).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L744 ! GM01012
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   DF508 6
AC   CVCL_B339
DR   Wikidata; Q54831029
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20715179).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L744 ! GM01012
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   DF8
AC   CVCL_E5R1
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DFB
AC   CVCL_9V17
SY   DFBmel
DR   Wikidata; Q54831030
RX   PubMed=9331097;
RX   PubMed=10395702;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   DFCI-LU011
AC   CVCL_0F29
SY   DFCILU-011; DFCI-LU-011; Dana-Farber Cancer Institute-LUng 011
DR   ATCC; CRL-2883
DR   BioSample; SAMN03471809
DR   cancercelllines; CVCL_0F29
DR   Wikidata; Q54831031
RX   PubMed=16983123;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Unspecified (PubMed=16983123).
CC   Discontinued: ATCC; CRL-2883; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2883
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   DFCI024
AC   CVCL_A762
SY   DFCI 024; DFCI.024; Dana-Farber Cancer Institute 024
DR   Cosmic; 1165894
DR   DepMap; ACH-001058
DR   GEO; GSM794264
DR   PharmacoDB; DFCI024_289_2019
DR   Wikidata; Q54831032
RX   PubMed=18594010;
RX   PubMed=20679594;
RX   PubMed=26929325;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   HLA typing: A*24:02,33:01:01; B*04:02:01,35:02:01; C*08:02,04:01:01 (PubMed=26929325).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: DepMap; ACH-001058; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 8,13
ST   D5S818: 10,12
ST   D7S820: 9
ST   TH01: 6,9.3
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   DFCI032
AC   CVCL_A763
SY   DFCI 032; DFCI.032; Dana-Farber Cancer Institute 032
DR   Cosmic; 1165895
DR   GEO; GSM794265
DR   Wikidata; Q54831034
RX   PubMed=18594010;
RX   PubMed=20679594;
RX   PubMed=26929325;
RX   PubMed=28196595;
RX   PubMed=29681454;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   HLA typing: A*02:01:01; B*44:02,51:01; C*05:01:01 (PubMed=26929325).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (PubMed=18594010).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   DFK1
AC   CVCL_WK33
DR   Wikidata; Q93526457
RX   PubMed=503857;
RX   PubMed=571524;
RX   PubMed=716215;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   DFK3
AC   CVCL_L863
DR   CLO; CLO_0002763
DR   CLDB; cl1047
DR   Wikidata; Q54831035
RX   PubMed=503857;
RX   PubMed=571524;
RX   PubMed=643600;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 8
//
ID   DFSC
AC   CVCL_B7FN
SY   hDFSC; Dental Follicle Stem Cells
DR   CLS; 300701
DR   Wikidata; Q112929451
CC   Derived from site: In situ; Dental follicle; UBERON=UBERON_0008969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15-30Y
CA   Somatic stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   DFSP
AC   CVCL_N706
DR   Wikidata; Q54831036
RX   PubMed=2600273;
CC   Population: Japanese.
CC   Doubling time: ~45 hours (PubMed=2600273).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   DFT2.JV
AC   CVCL_A1TN
SY   JV
DR   Wikidata; Q105506748
RX   PubMed=26711993;
RX   PubMed=32937435;
CC   Group: Marsupial cell line.
DI   NCIt; C176224; Devil facial tumor disease 2
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_LB80 ! DFT2.RV
OI   CVCL_A1YH ! DFT2.SN
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   DFT2.RV
AC   CVCL_LB80
SY   DFT2_RV; RV; 202T2
DR   Wikidata; Q54951476
RX   PubMed=26711993;
RX   PubMed=27936237;
RX   PubMed=30103855;
CC   Group: Marsupial cell line.
DI   NCIt; C176224; Devil facial tumor disease 2
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_A1TN ! DFT2.JV
OI   CVCL_A1YH ! DFT2.SN
SX   Male
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   DFT2.SN
AC   CVCL_A1YH
SY   DFT2_SN; 203T3
DR   Wikidata; Q105506750
RX   PubMed=26711993;
RX   PubMed=29634948;
RX   PubMed=30103855;
CC   Group: Marsupial cell line.
DI   NCIt; C176224; Devil facial tumor disease 2
OX   NCBI_TaxID=9305; ! Sarcophilus harrisii (Tasmanian devil)
OI   CVCL_A1TN ! DFT2.JV
OI   CVCL_LB80 ! DFT2.RV
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   DFW
AC   CVCL_9V18
SY   DFWmel
DR   NCBI_Iran; C496
DR   Wikidata; Q54831037
RX   PubMed=9331097;
RX   PubMed=10395702;
RX   PubMed=17254797;
RX   PubMed=24416993;
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9V17 ! DFB
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   DG
AC   CVCL_S101
DR   Wikidata; Q54831038
RX   PubMed=7073944;
CC   Doubling time: 50 hours (PubMed=7073944).
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3790; Ganglioneuroblastoma
DI   ORDO; Orphanet_251877; Ganglioneuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y5M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   DG-75
AC   CVCL_0244
SY   D.G.-75; DG 75; DG75
DR   BTO; BTO_0003637
DR   CLO; CLO_0002767
DR   EFO; EFO_0002160
DR   MCCL; MCC:0000134
DR   CLDB; cl1051
DR   ABM; T8013
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2625
DR   BioSample; SAMN03471755
DR   BioSample; SAMN03473403
DR   cancercelllines; CVCL_0244
DR   Cell_Model_Passport; SIDM00948
DR   CGH-DB; 9196-4
DR   ChEMBL-Cells; CHEMBL3308527
DR   ChEMBL-Targets; CHEMBL2366199
DR   Cosmic; 906838
DR   Cosmic; 931103
DR   Cosmic; 1086327
DR   Cosmic; 1118471
DR   Cosmic; 1191698
DR   Cosmic; 1588563
DR   Cosmic-CLP; 906838
DR   DepMap; ACH-002232
DR   DSMZ; ACC-83
DR   DSMZCellDive; ACC-83
DR   EGA; EGAS00001000978
DR   GDSC; 906838
DR   GEO; GSM710428
DR   GEO; GSM710444
DR   GEO; GSM827239
DR   GEO; GSM1669731
DR   IARC_TP53; 8094
DR   IGRhCellID; DG75
DR   LINCS_LDP; LCL-2019
DR   NCBI_Iran; C495
DR   PharmacoDB; DG75_290_2019
DR   PRIDE; PXD004181
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0244
DR   PubChem_Cell_line; CVCL_0244
DR   TOKU-E; 3578
DR   Wikidata; Q54831039
RX   PubMed=188769;
RX   PubMed=2985879;
RX   PubMed=3037521;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6169305;
RX   PubMed=8558920;
RX   PubMed=8896424;
RX   PubMed=9473234;
RX   PubMed=9525742;
RX   PubMed=9583678;
RX   PubMed=9685479;
RX   PubMed=9770427;
RX   PubMed=11425244;
RX   PubMed=12706092;
RX   PubMed=17254797;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=24590883;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Jewish; Ashkenazi.
CC   Virology: EBV-negative.
CC   Virology: Infected by DG-75 retrovirus, a replication-competent, murine leukemia-related retrovirus. Constitutively produces the virus.
CC   Doubling time: 18-20 hours (PubMed=188769); 24 hours (PubMed=6169305); ~40-50 hours (DSMZ=ACC-83).
CC   HLA typing: A*02,11; B*39,41 (PubMed=3037521).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=9583678; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Homozygous (PubMed=9583678).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283His (c.848G>A); ClinVar=VCV000142324; Zygosity=Heterozygous (PubMed=9525742).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.72%; Native American=1.16%; East Asian, North=0%; East Asian, South=1.7%; South Asian=7.84%; European, North=25.56%; European, South=62.01% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2625; Cosmic-CLP=906838; DSMZ=ACC-83; PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10,11,12 (DSMZ=ACC-83)
ST   CSF1PO: 10 (PubMed=17254797)
ST   CSF1PO: 10,11,12 (ATCC=CRL-2625; Cosmic-CLP=906838)
ST   D13S317: 9,11 (PubMed=17254797)
ST   D13S317: 10,11 (DSMZ=ACC-83)
ST   D13S317: 11 (ATCC=CRL-2625; Cosmic-CLP=906838)
ST   D16S539: 11 (PubMed=17254797)
ST   D16S539: 11,12 (Cosmic-CLP=906838)
ST   D16S539: 11,12,13 (DSMZ=ACC-83)
ST   D16S539: 12 (ATCC=CRL-2625)
ST   D18S51: 11,13 (PubMed=17254797)
ST   D18S51: 11,14,15,16 (ATCC=CRL-2625; DSMZ=ACC-83)
ST   D19S433: 12,13
ST   D21S11: 27,30 (PubMed=17254797)
ST   D21S11: 29,31.2 (ATCC=CRL-2625; DSMZ=ACC-83)
ST   D2S1338: 17,22,23 (DSMZ=ACC-83)
ST   D2S1338: 17,23 (ATCC=CRL-2625)
ST   D3S1358: 15,16,17 (ATCC=CRL-2625; DSMZ=ACC-83)
ST   D3S1358: 16,17 (PubMed=17254797)
ST   D5S818: 12
ST   D7S820: 11,12 (PubMed=17254797)
ST   D7S820: 11.3,12 (DSMZ=ACC-83)
ST   D7S820: 11.3,12,12.3 (ATCC=CRL-2625)
ST   D7S820: 12 (Cosmic-CLP=906838)
ST   D8S1179: 13,15 (ATCC=CRL-2625; PubMed=17254797)
ST   D8S1179: 14,15 (DSMZ=ACC-83)
ST   FGA: 20,21,22,23,24 (DSMZ=ACC-83)
ST   FGA: 20,21,23 (ATCC=CRL-2625)
ST   FGA: 20,23 (PubMed=17254797)
ST   Penta D: 12,13
ST   Penta E: 6,7,17,19 (ATCC=CRL-2625)
ST   Penta E: 7,16,17 (DSMZ=ACC-83)
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17,18,19 (DSMZ=ACC-83)
ST   vWA: 17,18 (ATCC=CRL-2625; PubMed=17254797)
ST   vWA: 17,18,19 (Cosmic-CLP=906838)
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   DG-75 CBF1 KO clone SM166C52
AC   CVCL_E5V5
RX   PubMed=15994772;
CC   Population: Jewish; Ashkenazi.
CC   Virology: EBV-negative.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5724; RBPJ (Note=1 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283His (c.848G>A); ClinVar=VCV000142324; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0244 ! DG-75
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   DG-75 CBF1 KO clone SM223E3
AC   CVCL_E5V7
RX   PubMed=15994772;
CC   Population: Jewish; Ashkenazi.
CC   Virology: EBV-negative.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5724; RBPJ (Note=2 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283His (c.848G>A); ClinVar=VCV000142324; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5V6 ! DG-75 CBF1 KO clone SM224.9
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DG-75 CBF1 KO clone SM224.9
AC   CVCL_E5V6
SY   SM224.9
RX   PubMed=15994772;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: While only 1 of 3 alleles was knocked-out, this cell line is RBPJ/CBF1 negative and does not support EBNA-2 activation of CBF1 dependent reporter genes (PubMed=15994772).
CC   Characteristics: The neo and DsRed2 genes of the parent cell line were removed by CRE-recombinase processing (PubMed=15994772).
CC   Virology: EBV-negative.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5724; RBPJ (Note=1 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283His (c.848G>A); ClinVar=VCV000142324; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5V5 ! DG-75 CBF1 KO clone SM166C52
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DG-75 CBF1 KO clone SM261D11
AC   CVCL_E5V9
SY   SM261D11
DR   ABM; T6056
RX   PubMed=15994772;
CC   Population: Jewish; Ashkenazi.
CC   Virology: EBV-negative.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5724; RBPJ (Note=3 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283His (c.848G>A); ClinVar=VCV000142324; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5V8 ! DG-75 CBF1 KO clone SM267C18
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   DG-75 CBF1 KO clone SM267C18
AC   CVCL_E5V8
SY   SM267C18
RX   PubMed=15994772;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: The hygR and eGFP genes of the parent cell line were removed by CRE-recombinase processing (PubMed=15994772).
CC   Virology: EBV-negative.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5724; RBPJ (Note=2 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283His (c.848G>A); ClinVar=VCV000142324; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5V7 ! DG-75 CBF1 KO clone SM223E3
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DG-K1
AC   CVCL_XB93
DR   CCRID; 5301OVI-KCB10064ZJ
DR   KCB; KCB 2010064K
DR   Wikidata; Q93526571
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 8
//
ID   DG-S1
AC   CVCL_XB94
DR   CCRID; 5301OVI-KCB10073ZJ
DR   KCB; KCB 2010073S
DR   Wikidata; Q93526576
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   DG-S2
AC   CVCL_A9EU
DR   CCRID; 5301OVI-KCB15062YJ
DR   KCB; KCB 2015062YJ
DR   Wikidata; Q108820151
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   DG1
AC   CVCL_L852
SY   DG 1
DR   CLO; CLO_0002764
DR   CLDB; cl1048
DR   Wikidata; Q54831040
RX   PubMed=22358579;
CC   Doubling time: 39 hours (PubMed=22358579).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L853 ! DG2 [Human lung carcinoma]
OI   CVCL_L854 ! DG3
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 10
//
ID   DG2 [Human lung carcinoma]
AC   CVCL_L853
SY   DG 2
DR   CLO; CLO_0002765
DR   CLDB; cl1049
DR   Wikidata; Q54831041
RX   PubMed=22358579;
CC   Doubling time: 48 hours (PubMed=22358579).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L852 ! DG1
OI   CVCL_L854 ! DG3
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 10
//
ID   DG2 [Mouse hybridoma against human FGF2]
AC   CVCL_E5PP
RX   Patent=WO1991006668A1;
RX   PubMed=2479375;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10202.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2 (Note=neutralizing antibody).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DG3
AC   CVCL_L854
SY   DG 3
DR   CLO; CLO_0002766
DR   CLDB; cl1050
DR   Wikidata; Q54831042
RX   PubMed=22358579;
CC   Doubling time: 60 hours (PubMed=22358579).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L852 ! DG1
OI   CVCL_L853 ! DG2 [Human lung carcinoma]
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   DG4-1
AC   CVCL_K135
DR   Wikidata; Q54831045
RX   PubMed=6833281;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   DG6
AC   CVCL_A9BL
DR   Wikidata; Q108820152
RX   DOI=10.3969/j.issn.1000-8179.2012.12.001;
RX   PubMed=15845378;
CC   Characteristics: Poorly metastatic to lung (PubMed=15845378).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C134996; Mouse histiocytic and dendritic cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BK ! DD1
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   DG6-GFP
AC   CVCL_A9BM
DR   CCRID; 1101MOU-PUMC000395
DR   Wikidata; Q108820153
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
DI   NCIt; C134996; Mouse histiocytic and dendritic cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9BL ! DG6
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   DG6-VAP33-GFP
AC   CVCL_A9BN
SY   DG6-VAP33
DR   CCRID; 1101MOU-PUMC000396
DR   Wikidata; Q108820154
RX   DOI=10.3969/j.issn.1000-8179.2012.12.001;
CC   Characteristics: Transfected with a VAPA-GFP construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12648; VAPA.
DI   NCIt; C134996; Mouse histiocytic and dendritic cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9BL ! DG6
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   Dgcr8 knockout ES
AC   CVCL_5I66
SY   DGCR8 knockout ES
DR   Wikidata; Q54831046
RX   PubMed=17259983;
WW   Provider; Novus; NBA1-19349; https://www.novusbio.com/products/dgcr8-knockout-mouse-embryonic-stem-cells_nba1-19349
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2151114; Dgcr8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   DGF
AC   CVCL_C8GD
SY   Dwarf Gourami Fin
DR   Wikidata; Q123031158
RX   PubMed=37372114;
CC   Group: Fish cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-00522.
CC   Characteristics: Capable of growing from 25 to 30 Celsius, the optimal temperature is 28 to 30 Celsius (PubMed=37372114).
CC   Virology: Susceptible to infection by infectious spleen and kidney necrosis virus (ISKNV), red sea bream iridovirus (RSIV) and to the rhabdoviruses hirame rhabdovirus (HIRRV), spring viremia of carp virus (SVCV) and viral hemorrhagic septicemia virus (VHSV) (PubMed=37372114).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=1749025; ! Trichogaster lalius (Dwarf gourami)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DgMab-6
AC   CVCL_D3D1
DR   Wikidata; Q127380789
RX   PubMed=30362931;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49619; Human DGKG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   DGMEC
AC   CVCL_E9DE
SY   Dairy Goat Mammary Gland Epithelial Cell
RX   PubMed=22271314;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Guanzhong dairy; VBO=VBO_0009429.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DH B-LCL
AC   CVCL_C5VU
DR   Wikidata; Q116048831
RX   PubMed=10843661;
CC   HLA typing: A*02,11; B*27:04,40 (PubMed=10843661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   DH-BL
AC   CVCL_RW76
DR   Wikidata; Q54831047
RX   PubMed=3019376;
RX   PubMed=8896424;
CC   Population: Caucasian; British.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RW77 ! DH-LCL
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 8
//
ID   DH-LCL
AC   CVCL_RW77
DR   Wikidata; Q54831048
RX   PubMed=3019376;
CC   Population: Caucasian; British.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RW76 ! DH-BL
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   DH-My6
AC   CVCL_WV40
DR   Wikidata; Q93526724
RX   PubMed=30323893;
CC   Population: Japanese.
CC   Doubling time: 20 hours (PubMed=30323893).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1001; BCL6 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL6 (PubMed=30323893).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=30323893).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=30323893
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D21S11: 30
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   dH1cf16-iPS-1
AC   CVCL_C962
SY   dH1cF16-iPS1; DH1CF16-IPS1
DR   Wikidata; Q54831049
RX   PubMed=18157115;
RX   PubMed=18600223;
RX   PubMed=21368825;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   dH1cf16-iPS-5
AC   CVCL_C963
SY   dH1cf16-iPS5; DH1CF16-IPS5; dH1CF16_iPS5
DR   GEO; GSM248205
DR   GEO; GSM248206
DR   GEO; GSM579892
DR   GEO; GSM579893
DR   GEO; GSM579894
DR   GEO; GSM579895
DR   Wikidata; Q54831050
RX   PubMed=18157115;
RX   PubMed=18600223;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   dH1cf32-iPS-2
AC   CVCL_C964
SY   dH1cf32-iPS2; DH1CF32-IPS2
DR   GEO; GSM248207
DR   GEO; GSM248208
DR   Wikidata; Q54831051
RX   PubMed=18157115;
RX   PubMed=18600223;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   dH1cf32-iPS-4
AC   CVCL_C965
SY   DH1CF32-IPS4
DR   Wikidata; Q54831052
RX   PubMed=18157115;
RX   PubMed=18600223;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   dH1f-iPS3-12
AC   CVCL_C966
SY   DH1F-IPS3-12
DR   Wikidata; Q54831053
RX   PubMed=18157115;
RX   PubMed=18600223;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   dH1f-iPS3-3
AC   CVCL_C967
SY   DH1F-IPS3-3
DR   GEO; GSM248203
DR   Wikidata; Q54831054
RX   PubMed=18157115;
RX   PubMed=18600223;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   dH1f-RiPS-1.11
AC   CVCL_C697
DR   SKIP; SKIP000671
DR   SKIP; SKIP005170
DR   Wikidata; Q54831055
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   dH1f-RiPS-1.13
AC   CVCL_C698
DR   SKIP; SKIP000672
DR   SKIP; SKIP005174
DR   Wikidata; Q54831056
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   dH1f-RiPS-1.14
AC   CVCL_C699
DR   SKIP; SKIP000673
DR   SKIP; SKIP005172
DR   Wikidata; Q54831057
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   dH1f-RiPS-1.2
AC   CVCL_C700
SY   dH1F_RiPS_1.2
DR   GEO; GSM579903
DR   SKIP; SKIP000666
DR   SKIP; SKIP005169
DR   Wikidata; Q54831058
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   dH1f-RiPS-1.3
AC   CVCL_C701
SY   dH1F_RiPS_1.3
DR   GEO; GSM579904
DR   SKIP; SKIP000667
DR   SKIP; SKIP005168
DR   Wikidata; Q54831059
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   dH1f-RiPS-1.5
AC   CVCL_C702
DR   SKIP; SKIP000669
DR   SKIP; SKIP005175
DR   Wikidata; Q54831060
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   dH1f-RiPS-1.6
AC   CVCL_C703
SY   dH1F_RiPS_1.6
DR   GEO; GSM579905
DR   SKIP; SKIP000668
DR   SKIP; SKIP005173
DR   Wikidata; Q54831061
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   dH1f-RiPS-1.7
AC   CVCL_C704
SY   dH1F_RiPS_1.7
DR   GEO; GSM579906
DR   SKIP; SKIP000670
DR   SKIP; SKIP005171
DR   Wikidata; Q54831063
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U159 ! H1 Oct4-EGFP
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   DH679
AC   CVCL_W746
SY   DH 679
DR   Wikidata; Q54831064
RX   PubMed=6286763;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 8
//
ID   DH82
AC   CVCL_2018
SY   DH-82; DH 82
DR   CLO; CLO_0002775
DR   CLDB; cl1058
DR   CLDB; cl1059
DR   ATCC; CRL-3590
DR   ATCC; CRL-10389
DR   BCRC; 60110
DR   BCRJ; 0077
DR   CCRID; 1101CAN-PUMC000818
DR   CCRID; 3101CANTCO3
DR   CLS; 305003
DR   ECACC; 94062922
DR   GEO; GSM1974787
DR   ICLC; ATL96008
DR   KCB; KCB 2014070YJ
DR   Wikidata; Q54831065
RX   Patent=US5192679;
RX   PubMed=3350786;
RX   PubMed=11377712;
RX   PubMed=11585095;
RX   PubMed=12234001;
RX   PubMed=21908323;
RX   PubMed=25534080;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=28620374;
RX   PubMed=31175136;
RX   PubMed=33389257;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Part of: FACC canine tumor cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10389.
CC   Characteristics: Can be infected by Trypanosoma cruzi which can then replicate and differentiate inside the cell.
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=11585095; PubMed=12234001).
CC   Virology: Supports the replication of equine infectious anemia virus (EIAV) (PubMed=11377712).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 26 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:45168; PTPN11; Simple; p.Gly503Val (c.1508G>T); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-10389; true.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231
ST   Dog FHC2054: 156,168
ST   Dog FHC2079: 275
ST   Dog PEZ1: 119,123
ST   Dog PEZ3: 121
ST   Dog PEZ5: 107
ST   Dog PEZ6: 179
ST   Dog PEZ8: 232,240
ST   Dog PEZ12: 270,285
ST   Dog PEZ20: 176
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   DH82ECOK
AC   CVCL_3461
SY   DH82 Ehrlichia Canis OKlahoma
DR   CLO; CLO_0002776
DR   Wikidata; Q54831066
RX   Patent=US5192679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10390.
CC   Characteristics: In vitro infected by the intracellular pathogen Ehrlichia canis isolate Oklahoma.
CC   Sequence variation: Mutation; VGNC; VGNC:45168; PTPN11; Simple; p.Gly503Val (c.1508G>T); Zygosity=Homozygous (from parent cell line).
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_2018 ! DH82
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   DH978
AC   CVCL_IV32
DR   Wikidata; Q54831067
RX   PubMed=7757991;
RX   PubMed=7882347;
RX   PubMed=8515068;
CC   Sequence variation: Mutation; HGNC; HGNC:1784; CDKN1A; Simple; p.Phe63Leu (c.189C>A); Zygosity=Heterozygous (PubMed=7882347).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=7757991).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   DHA3-1
AC   CVCL_U805
DR   CLO; CLO_0050239
DR   RCB; RCB1604
DR   Wikidata; Q54831068
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   DHA3-26
AC   CVCL_U806
DR   CLO; CLO_0050240
DR   RCB; RCB1605
DR   Wikidata; Q54831069
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   DHA9-13
AC   CVCL_U807
DR   CLO; CLO_0050242
DR   RCB; RCB1608
DR   Wikidata; Q54831070
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   DHA9-15
AC   CVCL_U808
DR   CLO; CLO_0050243
DR   RCB; RCB1609
DR   Wikidata; Q54831071
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   DHA9-3
AC   CVCL_U809
DR   CLO; CLO_0050245
DR   RCB; RCB1607
DR   Wikidata; Q54831072
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   DHAV-MAb1
AC   CVCL_C4B5
DR   CCRID; 4201PAT-CCTCC01000
DR   Wikidata; Q116048832
RX   Patent=CN106811444A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201701.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Duck hepatitis virus type 1 (DHV-1).
CC   Monoclonal antibody target: Duck hepatitis virus type 3 (DHV-3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   DHD/K12/TR
AC   CVCL_S572
SY   DHD K12/TR; DHD-K12 TR; K12/TR; TR
DR   Wikidata; Q54831073
RX   PubMed=3804494;
RX   PubMed=4018914;
RX   PubMed=6358055;
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S573 ! DHD/K12/TS
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   DHD/K12/TRb
AC   CVCL_0245
SY   DHD K12/TRb; DHD-K12 TRb; TRb
DR   CLO; CLO_0002777
DR   MCCL; MCC:0000135
DR   CLDB; cl1060
DR   ECACC; 90062901
DR   Wikidata; Q54831074
RX   PubMed=4018914;
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_S572 ! DHD/K12/TR
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   DHD/K12/TS
AC   CVCL_S573
SY   DHD K12/TS; DHD-K12 TS; TS
DR   Wikidata; Q54831075
RX   PubMed=4018914;
RX   PubMed=6358055;
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S572 ! DHD/K12/TR
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   DHFR-G8
AC   CVCL_6254
SY   DHFR/G8; DHFR G8; DHFR/G-8; G8-DHFR
DR   CLO; CLO_0002778
DR   ATCC; CRL-1915
DR   Wikidata; Q54831076
RX   PubMed=3001730;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2561; Erbb2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   DHIF
AC   CVCL_E561
SY   DHF
DR   dbMHC; 48755
DR   ECACC; 88052104
DR   IHW; IHW09104
DR   IPD-IMGT/HLA; 10492
DR   Wikidata; Q54831077
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; English.
CC   HLA typing: A*31:01:02:01; B*38:01:01; C*12:03:01:01; DPB1*04:01:01; DQB1*03:01:01; DRB1*11:01:01 (IPD-IMGT/HLA=10492).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   DhMab-1
AC   CVCL_D3D2
DR   Wikidata; Q127380790
RX   PubMed=32640865;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86XP1; Human DGKH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   DhMab-4
AC   CVCL_D3D4
DR   Wikidata; Q127380791
RX   PubMed=32486932;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86XP1; Human DGKH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   DHMCi001-A
AC   CVCL_UM01
SY   TH-1 iPSC
DR   BioSamples; SAMEA5341048
DR   hPSCreg; DHMCi001-A
DR   Wikidata; Q93527298
RX   PubMed=27934587;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Arg129Ter (c.385C>T) (p.Arg98Ter, c.292C>T); ClinVar=VCV000374732; Zygosity=Heterozygous (PubMed=27934587).
CC   Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Arg231Pro (c.692G>C); Zygosity=Heterozygous (PubMed=27934587).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C157158; Tyrosine hydroxylase deficiency
DI   ORDO; Orphanet_101150; Autosomal recessive dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   DHMCi002-A
AC   CVCL_QX40
SY   HDMC0061i-GCH1; GCH6-1 iPS
DR   hPSCreg; DHMCi002-A
DR   Wikidata; Q54882187
RX   PubMed=28395739;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:4193; GCH1; Simple; p.Leu79_Ser80del (c.235_240del); Zygosity=Heterozygous (PubMed=28395739).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C141442; GTP cyclohydrolase I deficiency
DI   ORDO; Orphanet_98808; Autosomal dominant dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM02 ! DHMCi002-B
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   DHMCi002-B
AC   CVCL_UM02
SY   GCH6-6 iPS
DR   hPSCreg; DHMCi002-B
DR   Wikidata; Q93527322
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:4193; GCH1; Simple; p.Leu79_Ser80del (c.235_240del); Zygosity=Heterozygous (from autologous cell line DHMCi002-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C141442; GTP cyclohydrolase I deficiency
DI   ORDO; Orphanet_98808; Autosomal dominant dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX40 ! DHMCi002-A
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   DHMCi003-A
AC   CVCL_UM03
SY   DNAJC12-1 iPS 6
DR   hPSCreg; DHMCi003-A
DR   Wikidata; Q93527328
RX   PubMed=30901742;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:28908; DNAJC12; Simple; p.Arg72Pro (c.215G>C); ClinVar=VCV000393302; Zygosity=Homozygous (PubMed=30901742).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C159654; Mild non-BH4-deficient hyperphenylalaninemia
DI   ORDO; Orphanet_508523; Hyperphenylalaninemia due to DNAJC12 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM04 ! DHMCi003-B
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   DHMCi003-B
AC   CVCL_UM04
SY   DNAJC12-1 iPS 10
DR   hPSCreg; DHMCi003-B
DR   Wikidata; Q93527333
RX   PubMed=30901742;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:28908; DNAJC12; Simple; p.Arg72Pro (c.215G>C); ClinVar=VCV000393302; Zygosity=Homozygous (PubMed=30901742).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C159654; Mild non-BH4-deficient hyperphenylalaninemia
DI   ORDO; Orphanet_508523; Hyperphenylalaninemia due to DNAJC12 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM03 ! DHMCi003-A
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   DHMCi004-A
AC   CVCL_VS00
SY   NBAS_2A_IPS
DR   hPSCreg; DHMCi004-A
DR   Wikidata; Q93527337
RX   PubMed=30772683;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15625; NBAS; Simple; p.Leu903Arg (c.2708T>G); ClinVar=VCV000204582; Zygosity=Homozygous (PubMed=30772683).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C158135; Infantile liver failure syndrome 2
DI   ORDO; Orphanet_464724; Fever-associated acute infantile liver failure syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   DHMCi005-A
AC   CVCL_WG65
SY   SCYL1_1B_IPS
DR   hPSCreg; DHMCi005-A
DR   Wikidata; Q93527342
RX   PubMed=30959346;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14372; SCYL1; Simple; p.Gln628Ter (c.1882C>T); ClinVar=VCV000446290; Zygosity=Homozygous (PubMed=30959346).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C159655; CALFAN syndrome
DI   ORDO; Orphanet_466794; Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   DHMCi006-A
AC   CVCL_B3NW
SY   Neph001D
DR   hPSCreg; DHMCi006-A
DR   Wikidata; Q110432770
RX   PubMed=34695767;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Arg2111Gly (c.6331A>G); Zygosity=Heterozygous (PubMed=34695767).
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Arg2573Cys (c.7717C>T); ClinVar=VCV000499806; Zygosity=Heterozygous (PubMed=34695767).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   DHMCi007-A
AC   CVCL_B3NX
SY   Neph005B
DR   hPSCreg; DHMCi007-A
DR   Wikidata; Q110432771
RX   PubMed=34688127;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Asp2762Val (c.8285A>T); ClinVar=VCV000522472; Zygosity=Homozygous (PubMed=34688127).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   DHMCi008-A
AC   CVCL_C0JQ
SY   TUBA1A-1
DR   hPSCreg; DHMCi008-A
DR   Wikidata; Q112929452
RX   PubMed=35636247;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:20766; TUBA1A; Simple; p.Ala174Val (c.521C>T); ClinVar=VCV000160159; Zygosity=Heterozygous; Note=De novo mutation (PubMed=35636247).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148461; Lissencephaly 3
DI   ORDO; Orphanet_171680; Lissencephaly due to TUBA1A mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   DHMCi009-A
AC   CVCL_C0JR
SY   TUBB2A-2
DR   hPSCreg; DHMCi009-A
DR   Wikidata; Q112929453
RX   PubMed=35930870;
CC   From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12412; TUBB2A; Simple; p.Ala248Val (c.743C>T); ClinVar=VCV000127101; Zygosity=Heterozygous (PubMed=35930870).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C189285; Complex cortical dysplasia with other brain malformations 5
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   DHMi001-A
AC   CVCL_A8HF
SY   Control_S
DR   BioSamples; SAMEA8958652
DR   hPSCreg; DHMi001-A
DR   Wikidata; Q107114808
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   DHMi002-A
AC   CVCL_A8HG
SY   HLHS_606
DR   BioSamples; SAMEA8944462
DR   hPSCreg; DHMi002-A
DR   Wikidata; Q107114810
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: African.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   DHMi003-A
AC   CVCL_A8HH
SY   HLHS_612
DR   BioSamples; SAMEA8944466
DR   hPSCreg; DHMi003-A
DR   Wikidata; Q107114812
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   DHMi004-A
AC   CVCL_B5EP
SY   HOS_1460
DR   BioSamples; SAMEA10332705
DR   hPSCreg; DHMi004-A
DR   Wikidata; Q110432773
RX   PubMed=34894535;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=De novo mutation (PubMed=34894535).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   DHMi004-A-1
AC   CVCL_D0DX
SY   HOS_1460corr 127 Clone 31
DR   BioSamples; SAMEA112137054
DR   hPSCreg; DHMi004-A-1
DR   Wikidata; Q123031160
RX   PubMed=37253295;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_corrected; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37253295).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EP ! DHMi004-A
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   DHMi004-A-2
AC   CVCL_D0DY
SY   HOS_1460_FLAG Clone 4
DR   BioSamples; SAMEA112152464
DR   hPSCreg; DHMi004-A-2
DR   Wikidata; Q123031161
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (hPSCreg=DHMi004-A-2).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=De novo mutation (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EP ! DHMi004-A
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   DHMi004-A-3
AC   CVCL_D0DZ
SY   HOS_1460corr 127 Clone 31_FLAG Clone 18
DR   BioSamples; SAMEA112152875
DR   hPSCreg; DHMi004-A-3
DR   Wikidata; Q123031162
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (hPSCreg=DHMi004-A-3).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_corrected; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0DX ! DHMi004-A-1
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   DHMi004-A-4
AC   CVCL_D0E3
SY   1460corr_IDT Cl.127_FlagT Clone 7
DR   BioSamples; SAMEA114295304
DR   hPSCreg; DHMi004-A-4
DR   Wikidata; Q123031163
RX   PubMed=38100916;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (PubMed=38100916).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_corrected; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0DX ! DHMi004-A-1
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   DHMi004-A-5
AC   CVCL_D0E4
SY   1460corr_IDT Cl.127_FlagT Clone 25
DR   BioSamples; SAMEA114295305
DR   hPSCreg; DHMi004-A-5
DR   Wikidata; Q123031164
RX   PubMed=38100916;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (PubMed=38100916).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_corrected; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0DX ! DHMi004-A-1
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   DHMi004-A-6
AC   CVCL_D0E5
SY   1460corr_IDT Cl.127_FlagT Clone 26
DR   BioSamples; SAMEA114295303
DR   hPSCreg; DHMi004-A-6
DR   Wikidata; Q123031165
RX   PubMed=38100916;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (PubMed=38100916).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_corrected; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0DX ! DHMi004-A-1
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   DHMi005-A
AC   CVCL_B5EQ
SY   Control_L
DR   BioSamples; SAMEA11305579
DR   hPSCreg; DHMi005-A
DR   Wikidata; Q110432774
RX   PubMed=35033855;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   DHMi005-A-1
AC   CVCL_B5SK
SY   L_mut
DR   BioSamples; SAMEA11744856
DR   hPSCreg; DHMi005-A-1
DR   Wikidata; Q111733156
RX   PubMed=35121196;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_edited; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35121196).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EQ ! DHMi005-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   DHMi005-A-2
AC   CVCL_C0IU
SY   L_FLAG Clone 5
DR   BioSamples; SAMEA14269283
DR   hPSCreg; DHMi005-A-2
DR   Wikidata; Q112929454
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (hPSCreg=DHMi005-A-2).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EQ ! DHMi005-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   DHMi005-A-3
AC   CVCL_C0IS
SY   L_FLAG Clone 6
DR   BioSamples; SAMEA14491815
DR   hPSCreg; DHMi005-A-3
DR   Wikidata; Q112929455
RX   PubMed=36610218;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (PubMed=36610218).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EQ ! DHMi005-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   DHMi005-A-4
AC   CVCL_C0IT
SY   L_FLAG Clone 7
DR   BioSamples; SAMEA14493160
DR   hPSCreg; DHMi005-A-4
DR   Wikidata; Q112929456
RX   PubMed=36610218;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of one allele of TBX5 (PubMed=36610218).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EQ ! DHMi005-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   DHMi005-A-5
AC   CVCL_D0E0
SY   L_mut_FLAG Clone 4
DR   BioSamples; SAMEA111493297
DR   hPSCreg; DHMi005-A-5
DR   Wikidata; Q123031166
RX   PubMed=37210946;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of the mutated allele of TBX5 (PubMed=37210946).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_edited; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SK ! DHMi005-A-1
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   DHMi005-A-6
AC   CVCL_D0E1
SY   L_mut_FLAG Clone 14
DR   BioSamples; SAMEA111493346
DR   hPSCreg; DHMi005-A-6
DR   Wikidata; Q123031167
RX   PubMed=37210946;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of the mutated allele of TBX5 (PubMed=37210946).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_edited; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SK ! DHMi005-A-1
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   DHMi005-A-7
AC   CVCL_D0E2
SY   L_mut_FLAG Clone 15
DR   BioSamples; SAMEA111493368
DR   hPSCreg; DHMi005-A-7
DR   Wikidata; Q123031168
RX   PubMed=37210946;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a FLAG tag was introduced at the C-terminus of the mutated allele of TBX5 (PubMed=37210946).
CC   Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_edited; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SK ! DHMi005-A-1
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   DHMi005-A-8
AC   CVCL_E3U7
SY   L Delta B2M Clone 6
DR   BioSamples; SAMEA114632708
DR   hPSCreg; DHMi005-A-8
RX   PubMed=40784045;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M (Note=1 of 2 alleles).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EQ ! DHMi005-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   DHMi005-A-9
AC   CVCL_E3U8
SY   L Delta B2M Clone 11
DR   BioSamples; SAMEA114633093
DR   hPSCreg; DHMi005-A-9
RX   PubMed=40784045;
CC   From: German Heart Center Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EQ ! DHMi005-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   DHO
AC   CVCL_E562
DR   dbMHC; 48756
DR   IHW; IHW09329
DR   IPD-IMGT/HLA; 10494
DR   Wikidata; Q54831078
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24; B*51; DPB1*09:01; DQB1*06:01; DRB1*15:02:01; DRB5*01:02 (IPD-IMGT/HLA=10494).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   DHSA-1426
AC   CVCL_ZB61
DR   BioSample; SAMN12659355
DR   Kerafast; EMN017-FP
DR   Wikidata; Q98125873
CC   Characteristics: Forms hemangiosarcoma xenografts in immunodeficient mice when injected subcutaneously in Matrigel (Kerafast=EMN017-FP).
CC   Doubling time: ~24 hours (Kerafast=EMN017-FP).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   DHSF-BR16
AC   CVCL_C0V0
SY   Department of Health Science of Florence-Breast 16
DR   Wikidata; Q112929457
RX   PubMed=33863935;
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive (PubMed=33863935).
CC   Doubling time: 28 hours (PubMed=33863935).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   DI TNC1
AC   CVCL_0247
AS   CVCL_0246
SY   DITNC1; DI-TNC1; DI TNC-1
DR   CLO; CLO_0002779
DR   MCCL; MCC:0000136
DR   MCCL; MCC:0000137
DR   ATCC; CRL-2005
DR   CLS; 305343
DR   ECACC; 98102214
DR   IZSLER; BS TCL 178
DR   Wikidata; Q54831079
RX   PubMed=1378628;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: DI TNC; MCCL=MCC:0000136.
CC   Derived from site: In situ; Brain, diencephalon; UBERON=UBERON_0001894.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   DI-OH1
AC   CVCL_S873
DR   Wikidata; Q54831080
RX   PubMed=12904596;
RX   PubMed=23665679;
RX   PubMed=23882450;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   DI0058
AC   CVCL_8W05
DR   ECACC; 00082507
DR   Wikidata; Q54831081
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00082507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DI0078
AC   CVCL_8W06
DR   ECACC; 01120518
DR   Wikidata; Q54831082
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(Y)(q11;q12) (ECACC=01120518).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   DI8
AC   CVCL_AS16
DR   TKG; TKG 0713
DR   Wikidata; Q54831083
RX   PubMed=15809345;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_26829; Sulfoglycolipid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 6
//
ID   Dicer +/- line D4
AC   CVCL_AW05
SY   Dicer +/- (D4)
DR   Wikidata; Q54831084
RX   PubMed=16099834;
RX   PubMed=18311153;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2177178; Dicer1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 7
//
ID   Dicer -/- line 27H10
AC   CVCL_AW06
SY   Dicer -/- (27H10)
DR   GEO; GSM210972
DR   GEO; GSM210973
DR   GEO; GSM210974
DR   GEO; GSM210975
DR   GEO; GSM210976
DR   GEO; GSM210977
DR   Wikidata; Q54831085
RX   PubMed=16099834;
RX   PubMed=18311153;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2177178; Dicer1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 8
//
ID   Dicer1-/-
AC   CVCL_DC67
DR   ATCC; CRL-3221
DR   Wikidata; Q54831089
RX   PubMed=22698408;
CC   Doubling time: ~15 hours (PubMed=22698408).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2177178; Dicer1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Dicer1tm1Bdh/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC68 ! Dicer1f/f
SX   Female
AG   1Y1M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   Dicer1f/f
AC   CVCL_DC68
DR   ATCC; CRL-3220
DR   Wikidata; Q54831090
RX   PubMed=22698408;
CC   Doubling time: ~12 hours (PubMed=22698408).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Dicer1tm1Bdh/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y1M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 8
//
ID   DIF10
AC   CVCL_UF09
DR   cancercelllines; CVCL_UF09
DR   Wikidata; Q93527489
RX   PubMed=2580049;
CC   Population: African; Kenyan.
CC   Characteristics: Resistant to both the antiviral and antiproliferative actions of interferons.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   DIF2
AC   CVCL_UF10
DR   cancercelllines; CVCL_UF10
DR   Wikidata; Q93527496
RX   PubMed=6319552;
RX   PubMed=6420510;
CC   Population: African; Kenyan.
CC   Characteristics: Moderately resistant to both the antiviral and antiproliferative actions of interferons.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   DIF3
AC   CVCL_UF11
DR   cancercelllines; CVCL_UF11
DR   Wikidata; Q93527502
RX   PubMed=2937878;
RX   PubMed=3785169;
RX   PubMed=6319552;
RX   PubMed=6420510;
RX   PubMed=8301159;
CC   Population: African; Kenyan.
CC   Characteristics: Strongly resistant to both the antiviral and antiproliferative actions of interferons.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   DIF3-17
AC   CVCL_UF12
DR   cancercelllines; CVCL_UF12
DR   Wikidata; Q93527510
RX   PubMed=3785169;
CC   Population: African; Kenyan.
CC   Characteristics: Strongly resistant to both the antiviral and antiproliferative actions of interferons.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF11 ! DIF3
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   DIF3REV5
AC   CVCL_UF13
SY   DIF3-REV5
DR   cancercelllines; CVCL_UF13
DR   Wikidata; Q93527513
RX   PubMed=3785169;
RX   PubMed=8301159;
CC   Population: African; Kenyan.
CC   Characteristics: Interferon sensitive revertant of DIF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF11 ! DIF3
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   DIF8
AC   CVCL_UF14
DR   cancercelllines; CVCL_UF14
DR   Wikidata; Q93527520
RX   PubMed=2580049;
RX   PubMed=2937878;
RX   PubMed=3785169;
RX   PubMed=8301159;
CC   Population: African; Kenyan.
CC   Characteristics: Resistant to both the antiviral and antiproliferative actions of interferons.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   DIF9
AC   CVCL_UF15
DR   cancercelllines; CVCL_UF15
DR   Wikidata; Q93527528
RX   PubMed=2580049;
RX   PubMed=2937878;
CC   Population: African; Kenyan.
CC   Characteristics: Resistant to both the antiviral and antiproliferative actions of interferons.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   DiFi
AC   CVCL_6895
SY   DIFI
DR   BTO; BTO_0005902
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 856
DR   cancercelllines; CVCL_6895
DR   Cell_Model_Passport; SIDM00049
DR   Cosmic; 1479628
DR   Cosmic; 1519358
DR   Cosmic; 2841360
DR   Cosmic-CLP; 1789883
DR   DepMap; ACH-002233
DR   EGA; EGAS00001000978
DR   GDSC; 1789883
DR   GEO; GSM1448175
DR   GEO; GSM1669732
DR   KCB; KCB 2014033YJ
DR   PharmacoDB; DIFI_291_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_6895
DR   Wikidata; Q54831091
RX   DOI=10.1007/978-4-431-68337-7_80;
RX   PubMed=8385096;
RX   PubMed=20570890;
RX   PubMed=22270724;
RX   PubMed=22722830;
RX   PubMed=25623215;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (PubMed=8385096).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu443fs*16 (c.1328_1329delAA); Zygosity=Heterozygous (Cosmic-CLP=1789883; DepMap=ACH-002233).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1151Ter (c.3451G>T); Zygosity=Heterozygous (Cosmic-CLP=1789883; DepMap=ACH-002233).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (Cosmic-CLP=1789883; DepMap=ACH-002233).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=2.91%; Native American=0.44%; East Asian, North=1.85%; East Asian, South=0%; South Asian=0%; European, North=54.25%; European, South=40.55% (PubMed=30894373).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0002000000030). It was one of the sources for the STR profile of this entry.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID; Cosmic-CLP=1789883; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 32
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 23,27
ST   Penta D: 12
ST   Penta E: 12,18
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C2955; Colorectal carcinoma
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   DiFi R1 Cetux
AC   CVCL_A2BW
DR   cancercelllines; CVCL_A2BW
DR   Cosmic; 2841361
DR   Wikidata; Q105506752
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu443fs*16 (c.1328_1329delAA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1151Ter (c.3451G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C2955; Colorectal carcinoma
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6895 ! DiFi
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   DiFi R2 Cetux
AC   CVCL_A2BX
DR   cancercelllines; CVCL_A2BX
DR   Cosmic; 2841362
DR   Wikidata; Q105506755
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu443fs*16 (c.1328_1329delAA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1151Ter (c.3451G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C2955; Colorectal carcinoma
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6895 ! DiFi
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Dig 24-2F8
AC   CVCL_B0Q3
DR   Wikidata; Q108820158
RX   Patent=US4803167;
RX   PubMed=6179995;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4090 ! 45.6.TG1.7
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   Dig 25-54
AC   CVCL_B0Q4
DR   Wikidata; Q108820159
RX   Patent=US4803167;
RX   PubMed=6179995;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   Dig 26-10
AC   CVCL_B0Q1
SY   26-10; 26 / 10
DR   ABCD; ABCD_AH064
DR   Wikidata; Q108820155
RX   Patent=US4803167;
RX   PubMed=1999439;
RX   PubMed=4033667;
RX   PubMed=6179995;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   Dig 26-10 LB4
AC   CVCL_C4DV
SY   26-10 LB4; LB4
DR   ABCD; ABCD_AE801
DR   Wikidata; Q116048833
RX   PubMed=1999439;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B0Q1 ! Dig 26-10
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 26-10 LL2
AC   CVCL_C4DW
SY   26-10 LL2; LL2
DR   ABCD; ABCD_AE800
DR   Wikidata; Q116048834
RX   PubMed=1999439;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B0Q1 ! Dig 26-10
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 26-20
AC   CVCL_B0Q2
DR   Wikidata; Q108820156
RX   Patent=US4803167;
RX   PubMed=6179995;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   Dig 35-20
AC   CVCL_B0Q5
SY   35-20
DR   ABCD; ABCD_AE882
DR   Wikidata; Q108820160
RX   Patent=US4803167;
RX   PubMed=3655367;
RX   PubMed=4033667;
RX   PubMed=6179995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8113.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   Dig 40-120
AC   CVCL_C4DN
SY   40-120
DR   ABCD; ABCD_AE883
DR   Wikidata; Q116048835
RX   PubMed=3655367;
RX   PubMed=4033667;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 40-140
AC   CVCL_C4DP
SY   40-140
DR   ABCD; ABCD_AE881
DR   Wikidata; Q116048836
RX   PubMed=3655367;
RX   PubMed=4033667;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 40-150
AC   CVCL_C4DS
SY   40-150
DR   ABCD; ABCD_AE886
DR   Wikidata; Q116048837
RX   PubMed=1565100;
RX   PubMed=3129726;
RX   PubMed=4033667;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 40-150 A2.4
AC   CVCL_C4DT
SY   40-150 A2.4
DR   Wikidata; Q116048838
RX   PubMed=1565100;
RX   PubMed=3129726;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4DS ! Dig 40-150
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 40-150 A2.4 P.10
AC   CVCL_C4DU
SY   40-150 A2.4 P.10
DR   Wikidata; Q116048839
RX   PubMed=1565100;
RX   PubMed=3129726;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4DT ! Dig 40-150 A2.4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 40-160
AC   CVCL_C4DQ
SY   40-160
DR   ABCD; ABCD_AE885
DR   Wikidata; Q116048840
RX   PubMed=3655367;
RX   PubMed=4033667;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 40-40
AC   CVCL_C4DR
SY   40-40
DR   ABCD; ABCD_AE884
DR   Wikidata; Q116048841
RX   PubMed=3655367;
RX   PubMed=4033667;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Dig 40-50
AC   CVCL_B0Q6
SY   40-50
DR   ABCD; ABCD_AE985
DR   Wikidata; Q108820161
RX   PubMed=4033667;
RX   PubMed=7739045;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   DIG104.10H.1
AC   CVCL_J289
SY   DIG 104.H10.1
DR   JCRB; JCRB1213.3
DR   Wikidata; Q54831092
RX   PubMed=1364357;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   DIG222.4D.5
AC   CVCL_J290
SY   DIG 222.4D.5
DR   JCRB; JCRB1213.2
DR   Wikidata; Q54831093
RX   PubMed=1364357;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   DIG64.2B.5
AC   CVCL_J291
SY   DIG 64.2B.5
DR   JCRB; JCRB1213.1
DR   Wikidata; Q54831094
RX   PubMed=1364357;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   DII 33.1
AC   CVCL_G692
SY   DII33.1
DR   CLO; CLO_0002780
DR   ATCC; CRL-1827
DR   Wikidata; Q54831095
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06213; Human INSR/CD220.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   DIMF
AC   CVCL_UC81
SY   Diploid Misgurnus Fin
DR   Wikidata; Q93527624
RX   PubMed=25721100;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013109.
CC   Doubling time: 48.43 hours (Note=At 50th passage) (PubMed=25721100).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75329; ! Misgurnus anguillicaudatus (Oriental weatherloach)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   DIPG-1114
AC   CVCL_E5GE
SY   DIPG 1114; DIPG1114
DR   GEO; GSM4969582
DR   GEO; GSM4969583
DR   GEO; GSM4969584
DR   GEO; GSM4969585
DR   GEO; GSM4969652
DR   GEO; GSM4969653
DR   GEO; GSM4969654
DR   GEO; GSM5356019
RX   PubMed=34078608;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=34078608).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DiPS-H1.5
AC   CVCL_C955
SY   NYSCF-DE-1000-1000-Skin-RV-IPSC1
DR   SKIP; SKIP004668
DR   SKIP; SKIP004871
DR   Wikidata; Q54831098
RX   PubMed=19720998;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   DiPS-H2.1
AC   CVCL_C956
SY   NYSCF-DE-1005-1005-Skin-RV-IPSC1
DR   SKIP; SKIP004670
DR   SKIP; SKIP004872
DR   Wikidata; Q54831099
RX   PubMed=19720998;
CC   From: Harvard University; Boston; USA.
CC   Caution: It seems not to be known which of DiPS-H2.1 or DiPS-H2.4 is NYSCF-DE-1005-1005-Skin-RV-IPSC1 (personal communication of Egli, Dietrich Meinrad).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C957 ! DiPS-H2.4
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   DiPS-H2.4
AC   CVCL_C957
SY   NYSCF-DE-1005-1005-Skin-RV-IPSC1
DR   SKIP; SKIP004669
DR   Wikidata; Q54831100
RX   PubMed=19720998;
CC   From: Harvard University; Boston; USA.
CC   Caution: It seems not to be known which of DiPS-H2.1 or DiPS-H2.4 is NYSCF-DE-1005-1005-Skin-RV-IPSC1 (personal communication of Egli, Dietrich Meinrad).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C956 ! DiPS-H2.1
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   DIT29
AC   CVCL_J028
DR   CLO; CLO_0051618
DR   RCB; RCB2945
DR   Wikidata; Q54831101
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C134571; Medaka hepatoma
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   DITRUD-1
AC   CVCL_6216
SY   DITRUD; Ditrud
DR   Wikidata; Q54831102
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6220 ! Daudi-TG
HI   CVCL_ZI13 ! RUD
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   DJA,N
AC   CVCL_E563
SY   DJA, N
DR   dbMHC; 48757
DR   ECACC; 94082224
DR   IHW; IHW09125
DR   IPD-IMGT/HLA; 11668
DR   Wikidata; Q54831103
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02; B*15,46; C*01; DPB1*13:01,21:01; DQA1*01:02,06:01; DQB1*03:01,05:02; DRB1*12:02; DRB3*03:01 (IPD-IMGT/HLA=11668).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   DJM-1
AC   CVCL_1172
SY   DJM1
DR   CLO; CLO_0050680
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0375
DR   BioSample; SAMN03472223
DR   cancercelllines; CVCL_1172
DR   Cell_Model_Passport; SIDM00281
DR   ChEMBL-Cells; CHEMBL3308190
DR   ChEMBL-Targets; CHEMBL2366264
DR   Cosmic; 906841
DR   Cosmic-CLP; 906841
DR   DepMap; ACH-002100
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10412-106B7
DR   GDSC; 906841
DR   GEO; GSM1669733
DR   IARC_TP53; 21302
DR   LINCS_LDP; LCL-1405
DR   PharmacoDB; DJM1_292_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1172
DR   RCB; RCB0736
DR   Wikidata; Q54831104
RX   PubMed=1919059;
RX   PubMed=2439611;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser144Ter (c.431C>G); Zygosity=Homozygous (Cosmic-CLP=906841; DepMap=ACH-002100).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Heterozygous (Cosmic-CLP=906841; DepMap=ACH-002100).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=79.62%; East Asian, South=19.44%; South Asian=0.93%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Cosmic-CLP=906841; RCB=RCB0736
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 10,13
ST   D7S820: 7,8
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   DJS
AC   CVCL_E564
DR   dbMHC; 48758
DR   ECACC; 94050317
DR   IHW; IHW09269
DR   IPD-IMGT/HLA; 10500
DR   Wikidata; Q54831105
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*37:01,35:01; C*06:02:01:01,04:01; DPA1*01:03; DPB1*04:01,04:02; DQA1*01:02,01:01; DQB1*05:02,05:01; DRB1*16:01,01:01 (IPD-IMGT/HLA=10500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   DJU,S
AC   CVCL_E565
SY   DJU, S
DR   dbMHC; 48759
DR   ECACC; 940822103
DR   IHW; IHW09199
DR   IPD-IMGT/HLA; 11740
DR   Wikidata; Q54831106
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Indonesian.
CC   HLA typing: A*02,24; B*15:02,15:13; C*08; DPB1*04:01,13:01; DQA1*06:01; DQB1*03:01; DRB1*12:02 (IPD-IMGT/HLA=11740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   DK
AC   CVCL_4162
SY   Dog Kidney
DR   CLO; CLO_0002781
DR   CLDB; cl1061
DR   CLDB; cl1062
DR   ATCC; CRL-6247
DR   ECACC; 93120836
DR   IZSLER; BS CL 36
DR   Wikidata; Q54831107
RX   PubMed=7129476;
RX   PubMed=13465769;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: ~34 hours (PubMed=7129476).
CC   Discontinued: ATCC; CRL-6247; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   DK (SK&F)
AC   CVCL_WX12
SY   Dog Kidney (Smith Kline and French)
DR   Wikidata; Q93527823
RX   Patent=GB1070764A;
RX   PubMed=4301040;
RX   PubMed=13789894;
CC   Group: Patented cell line.
CC   Virology: Supports growth of canine distemper virus, infectious canine hepatic virus, canine herpes virus and rabies virus.
CC   Doubling time: 13 hours (PubMed=4301040).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   DK-MG
AC   CVCL_1173
SY   DKMG
DR   CLO; CLO_0002782
DR   EFO; EFO_0002161
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 857
DR   BioSample; SAMN03470927
DR   BioSample; SAMN10988036
DR   cancercelllines; CVCL_1173
DR   Cell_Model_Passport; SIDM00947
DR   ChEMBL-Cells; CHEMBL3308814
DR   ChEMBL-Targets; CHEMBL1075433
DR   Cosmic; 687566
DR   Cosmic; 906839
DR   Cosmic; 2302329
DR   Cosmic; 2367524
DR   Cosmic; 2516016
DR   Cosmic-CLP; 906839
DR   DepMap; ACH-000244
DR   DSMZ; ACC-277
DR   DSMZCellDive; ACC-277
DR   EGA; EGAS00001000978
DR   GDSC; 906839
DR   GEO; GSM326231
DR   GEO; GSM886978
DR   GEO; GSM888047
DR   GEO; GSM1669734
DR   IARC_TP53; 21303
DR   IGRhCellID; DKMG
DR   LiGeA; CCLE_375
DR   LINCS_LDP; LCL-1350
DR   PharmacoDB; DKMG_293_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1173
DR   PubChem_Cell_line; CVCL_1173
DR   Wikidata; Q54831108
RX   CelloPub=CLPUB00261;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 80 hours (PubMed=25984343); ~50 hours (DSMZ=ACC-277).
CC   HLA typing: A*01:01,03:01; B*08:01,57:01; C*06:02,07:01; DQB1*03:04,03:04; DRB1*04:03,04:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.82%; Native American=0%; East Asian, North=4.28%; East Asian, South=0%; South Asian=0.04%; European, North=60.17%; European, South=34.69% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): Cosmic-CLP=906839; DSMZ=ACC-277; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10,11
ST   D18S51: 13,17
ST   D19S433: 13,15.2 (PubMed=25877200)
ST   D19S433: 13,16 (DSMZ=ACC-277)
ST   D21S11: 29,30
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 19,24
ST   Penta D: 9,12
ST   Penta E: 7,17
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   DK.1A4
AC   CVCL_D5YL
DR   DSHB; DK-1A4
DR   Wikidata; Q127380792
RX   PubMed=6791831;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q24247; Drosophila melanogaster mew.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DK0006
AC   CVCL_8W07
DR   ECACC; 94062421
DR   Wikidata; Q54831109
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(5)(5q) (ECACC=94062421).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   NCIt; C84905; Muir-Torre syndrome
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
DI   ORDO; Orphanet_587; Muir-Torre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DK0064
AC   CVCL_R778
SY   SCKL1
DR   Wikidata; Q54831110
RX   PubMed=15496423;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly674Gly (c.2022A>G) (2101A>G); ClinVar=VCV000008307; Zygosity=Homozygous; Note=Silent mutation that causes increased levels of skipping exon 9 and activation of two cryptic splicing events from sites in exon 9 leading to termination in exon 10 (from autologous cell lines GM18366; GM18367).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Could be identical to GM18367 (Cellosaurus=CVCL_6G81).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125488; Seckel syndrome
DI   ORDO; Orphanet_808; Seckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G80 ! GM18366
OI   CVCL_6G81 ! GM18367
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   DK0099
AC   CVCL_8W08
DR   ECACC; 98110405
DR   Wikidata; Q54831111
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Gly322Asp (c.965G>A); ClinVar=VCV000001762; Zygosity=Unspecified (ECACC=98110405).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120083; Hereditary nonpolyposis colorectal cancer syndrome
DI   ORDO; Orphanet_443909; Hereditary nonpolyposis colon cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   DK1 [Human B-cell IHW]
AC   CVCL_E566
DR   dbMHC; 48760
DR   ECACC; 94050327
DR   IHW; IHW09210
DR   IPD-IMGT/HLA; 10501
DR   Wikidata; Q54831113
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*02:03:01,33:01; B*44:03:01,40:01; C*03:04,14:03; DPB1*04:01,05:01; DQB1*01; DRB1*09,13 (IPD-IMGT/HLA=10501).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   DK1 [Tursiops]
AC   CVCL_R774
SY   CDK; Carvan Dolphin Kidney
DR   Wikidata; Q54831112
RX   DOI=10.1111/j.1748-7692.1994.tb00389.x;
RX   PubMed=15003703;
CC   Group: Cetacean cell line.
CC   Doubling time: 1.31 days (DOI=10.1111/j.1748-7692.1994.tb00389.x).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   DK1631
AC   CVCL_IU50
SY   DK 1631
DR   cancercelllines; CVCL_IU50
DR   Wikidata; Q54831114
RX   PubMed=8344493;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=8344493).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   DKAT
AC   CVCL_VQ65
DR   cancercelllines; CVCL_VQ65
DR   GEO; GSM820811
DR   GEO; GSM820812
DR   GEO; GSM820813
DR   Lonza; 1676
DR   Wikidata; Q93527903
RX   Patent=US20110085982;
RX   PubMed=23049838;
CC   Group: Patented cell line.
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10322.
CC   Characteristics: Highly tumorigenic. Only 10 DKAT cells are needed to form, in immunocompromised mice, xenograft tumors which display a range of epithelial and mesenchymal phenotypes (PubMed=23049838).
CC   Doubling time: ~24 hours (PubMed=23049838).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=23049838).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   DKAT-SCGM
AC   CVCL_VQ66
SY   SCGM-DKAT; DKAT-Stromal Cell Growth Media
DR   cancercelllines; CVCL_VQ66
DR   Wikidata; Q93527908
RX   PubMed=23049838;
CC   Group: Serum/protein free medium cell line.
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ65 ! DKAT
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 7
//
ID   DKB
AC   CVCL_E567
SY   DkB
DR   dbMHC; 48761
DR   ECACC; 88052074
DR   IHW; IHW09075
DR   IPD-IMGT/HLA; 10503
DR   Wikidata; Q54831115
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=6417008;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*24:02:01:08; B*40:01:02:01; C*03:04:01:01; DPA1*01:03; DPB1*04:01:01; DQA1*03:02; DQB1*03:03:02; DRA*01:01; DRB1*09:01:02/09:21; DRB4*01:03:01:01 (IPD-IMGT/HLA=10503).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   DKC-8
AC   CVCL_6896
SY   DCT; mDCT; MDCT 210B3
DR   BTO; BTO_0003950
DR   Wikidata; Q54831116
RX   CelloPub=CLPUB00159;
RX   PubMed=15016722;
RX   PubMed=18593564;
RX   PubMed=22718890;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Kidney, distal convoluted tubule; UBERON=UBERON_0001292.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   DKFZ-BT308
AC   CVCL_C7GU
DR   Wikidata; Q117704285
RX   PubMed=35977048;
CC   Characteristics: Transduced with a doxycycline-inducible system coding for SV40 large T antigen and GFP (PubMed=35977048).
CC   Senescence: Withdrawal of doxycycline leads to senescence (PubMed=35977048).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1097; BRAF + HGNC; HGNC:22219; KIAA1549; Name(s)=KIAA1549-BRAF (PubMed=35977048).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4047; Pilocytic astrocytoma
DI   ORDO; Orphanet_251612; Pilocytic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   DKFZ-BT314
AC   CVCL_C7GV
DR   Wikidata; Q117704286
RX   PubMed=35977048;
CC   Characteristics: Transduced with a doxycycline-inducible system coding for SV40 large T antigen and GFP (PubMed=35977048).
CC   Senescence: Withdrawal of doxycycline leads to senescence (PubMed=35977048).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=35977048).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, optic chiasma; UBERON=UBERON_0000959.
DI   NCIt; C4047; Pilocytic astrocytoma
DI   ORDO; Orphanet_251612; Pilocytic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   DKFZ-BT317
AC   CVCL_C7GW
DR   Wikidata; Q117704287
RX   PubMed=35977048;
CC   Characteristics: Transduced with a doxycycline-inducible system coding for SV40 large T antigen and GFP (PubMed=35977048).
CC   Senescence: Withdrawal of doxycycline leads to senescence (PubMed=35977048).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1097; BRAF + HGNC; HGNC:22219; KIAA1549; Name(s)=KIAA1549-BRAF (PubMed=35977048).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4047; Pilocytic astrocytoma
DI   ORDO; Orphanet_251612; Pilocytic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   DKFZ-BT66
AC   CVCL_JX58
DR   Wikidata; Q54831117
RX   PubMed=28002790;
RX   PubMed=35977048;
CC   Characteristics: Transduced with a doxycycline-inducible system coding for SV40 large T antigen and RFP (PubMed=28002790).
CC   Senescence: Withdrawal of doxycycline leads to senescence (PubMed=28002790).
CC   Doubling time: 45 hours (PubMed=28002790).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1097; BRAF + HGNC; HGNC:22219; KIAA1549; Name(s)=KIAA1549-BRAF; Note=KIAA1549 exon 16 fused to BRAF exon 9 (PubMed=28002790).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C4047; Pilocytic astrocytoma
DI   ORDO; Orphanet_251612; Pilocytic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   DKFZi001-A
AC   CVCL_E3U9
SY   clone 30
DR   BioSamples; SAMEA115055430
DR   hPSCreg; DKFZi001-A
RX   PubMed=39106599;
CC   From: German Cancer Research Center (DKFZ); Heidelberg; Germany.
CC   Donor information: Established from a patient suffering from SHH-medullabloastoma (PubMed=39106599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212893; 6q27 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3UA ! DKFZi001-B
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DKFZi001-B
AC   CVCL_E3UA
SY   clone 102
DR   BioSamples; SAMEA115055489
DR   hPSCreg; DKFZi001-B
RX   PubMed=39106599;
CC   From: German Cancer Research Center (DKFZ); Heidelberg; Germany.
CC   Donor information: Established from a patient suffering from SHH-medullabloastoma (PubMed=39106599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212893; 6q27 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3U9 ! DKFZi001-A
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DKN1
AC   CVCL_7899
DR   Wikidata; Q54831118
RX   PubMed=15003703;
RX   PubMed=17389150;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
HI   CVCL_R774 ! DK1 [Tursiops]
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   DKO-1
AC   CVCL_9798
SY   DKO1
DR   EFO; EFO_0022522
DR   TOKU-E; 4094
DR   Wikidata; Q54831119
RX   PubMed=8465203;
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the normal allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   DKO-3
AC   CVCL_9799
SY   DKO3
DR   Wikidata; Q54831120
RX   PubMed=8465203;
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   DKO-4
AC   CVCL_9800
SY   DKO4
DR   Wikidata; Q54831121
RX   PubMed=8465203;
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   DKO35
AC   CVCL_K036
DR   Wikidata; Q54831122
RX   PubMed=16794253;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96878; Blnk.
CC   Knockout cell: Method=KO mouse; MGI; MGI:88319; Cd19.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   DKs-5
AC   CVCL_9801
SY   Dks-5; Dks5
DR   Wikidata; Q54831123
RX   PubMed=8465203;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 9
//
ID   DKs-8
AC   CVCL_9802
SY   Dks-8; DKS-8; DKS8; Dks8
DR   Wikidata; Q54831124
RX   PubMed=8465203;
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   DL [Human B-cell IHW]
AC   CVCL_E568
DR   dbMHC; 48762
DR   ECACC; 94050328
DR   IHW; IHW09268
DR   IPD-IMGT/HLA; 10505
DR   Wikidata; Q54831125
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*03,33; B*35:02:01,35:03; C*04; DPB1*04:01,30:01 (IPD-IMGT/HLA=10505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94050328; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   DL [Human lung rhabdoid tumor]
AC   CVCL_U760
DR   cancercelllines; CVCL_U760
DR   Cell_Model_Passport; SIDM01507
DR   Cosmic; 802238
DR   DepMap; ACH-001059
DR   Wikidata; Q54831126
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   DL [Human melanoma]
AC   CVCL_9V00
SY   DLmel
DR   Wikidata; Q54831127
RX   PubMed=9331097;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   DL-1
AC   CVCL_C8ND
DR   Wikidata; Q123031169
RX   PubMed=6350167;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   DL-110
AC   CVCL_IR14
SY   DL110
DR   Wikidata; Q54831128
RX   PubMed=9266949;
RX   PubMed=9499341;
RX   PubMed=10639591;
CC   Population: Japanese.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   DL-221
AC   CVCL_DQ91
DR   cancercelllines; CVCL_DQ91
DR   Wikidata; Q54831134
RX   PubMed=27270875;
CC   Doubling time: 30 hours (PubMed=27270875).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=27270875).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=27270875).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Arg (c.374C>G); ClinVar=VCV000376667; Zygosity=Heterozygous (PubMed=27270875).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (PubMed=27270875).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   DL-3
AC   CVCL_J397
DR   Wikidata; Q54831135
RX   PubMed=6350167;
RX   PubMed=10437788;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   DL-4 [Human Burkitt lymphoma]
AC   CVCL_IU45
DR   Wikidata; Q54831136
RX   PubMed=9454894;
RX   PubMed=9747876;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   DL-4 [Mouse lymphoma]
AC   CVCL_C8NE
DR   Wikidata; Q123031170
RX   PubMed=6350167;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   DL-40
AC   CVCL_2889
SY   DL40
DR   cancercelllines; CVCL_2889
DR   Cell_Model_Passport; SIDM01506
DR   DepMap; ACH-001060
DR   GEO; GSM2527953
DR   JCRB; JCRB1337
DR   JCRB; NIHS0542
DR   Wikidata; Q54831137
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1979248;
RX   PubMed=8957066;
RX   PubMed=10639591;
RX   PubMed=15356658;
RX   PubMed=28356514;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=1979248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (DepMap=ACH-001060).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: JCRB; NIHS0542; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB1337
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   DL-5
AC   CVCL_J398
DR   Wikidata; Q54831138
RX   PubMed=6350167;
RX   PubMed=10437788;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   DL-8
AC   CVCL_J399
DR   Wikidata; Q54831139
RX   PubMed=2159524;
RX   PubMed=6350167;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   dl-884-3Y1-KO1
AC   CVCL_K110
DR   RCB; RCB0347
DR   Wikidata; Q54831140
RX   PubMed=2553277;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=dl-884).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   dl-884-3Y1-KO2
AC   CVCL_B6R0
DR   Wikidata; Q111733158
RX   PubMed=2553277;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=dl-884).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   DL-95
AC   CVCL_IR15
SY   DL95
DR   Wikidata; Q54831141
RX   PubMed=9499341;
RX   PubMed=10639591;
CC   Population: Japanese.
CC   Characteristics: IL6 dependent.
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   DL10
AC   CVCL_E9V8
RX   PubMed=9418192;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Carbohydrate antigen on HLA class I antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DL3580 clone 1
AC   CVCL_W825
DR   Wikidata; Q54831142
RX   PubMed=8320182;
CC   Doubling time: 25.5 hours (PubMed=8320182).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_W826 ! DL3580 clone 2
OI   CVCL_W827 ! DL3580 clone 3
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   DL3580 clone 2
AC   CVCL_W826
SY   DL3580c2
DR   Wikidata; Q54831143
RX   PubMed=8320182;
RX   PubMed=10933043;
CC   Characteristics: Grows anchorage-independently, over-expresses EGFR and is tumorigenic in athymic mice (PubMed=8320182; PubMed=10933043).
CC   Doubling time: 49.0 hours (PubMed=8320182).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_W825 ! DL3580 clone 1
OI   CVCL_W827 ! DL3580 clone 3
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   DL3580 clone 3
AC   CVCL_W827
DR   Wikidata; Q54831144
RX   PubMed=8320182;
CC   Doubling time: 50.1 hours (PubMed=8320182).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_W825 ! DL3580 clone 1
OI   CVCL_W826 ! DL3580 clone 2
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   DLB-1
AC   CVCL_HG31
SY   Dicentrarchus Labrax Brain-1
DR   ABM; T0730
DR   Wikidata; Q54831145
RX   DOI=10.3390/fishes7060354;
RX   PubMed=27746373;
CC   Group: Fish cell line.
CC   Characteristics: Used to study the toxicity of cadmium chloride, methylmercury (II) chloride, lead (II) nitrate and trioxide arsenic (PubMed=27746373).
CC   Doubling time: 22.41 +- 4.5 hours (PubMed=27746373).
CC   Transformant: NCBI_TaxID; 40270; Snakehead retrovirus.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=13489; ! Dicentrarchus labrax (European seabass)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   DLC 01
AC   CVCL_FA12
SY   DLC-01
DR   Wikidata; Q54831146
RX   Patent=WO2000070024A2;
RX   PubMed=10450758;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2200.
CC   Virology: Infected by a retrovirus called DLCV-1.
CC   Doubling time: 24 hours (PubMed=10450758).
CC   Misspelling: DCL-01; Note=Occasionally.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 11
//
ID   DLC 02
AC   CVCL_FA13
SY   DLC-02
DR   Wikidata; Q54831147
RX   PubMed=10896392;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Siberian Husky; VBO=VBO_0201233.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 6
//
ID   DLD-1
AC   CVCL_0248
SY   DLD 1; DLD1; CoCL3
DR   BTO; BTO_0000391
DR   CLO; CLO_0002785
DR   EFO; EFO_0006389
DR   MCCL; MCC:0000138
DR   CLDB; cl1065
DR   CLDB; cl1066
DR   AddexBio; C0009007/36
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CCL-221
DR   BCRC; 60132
DR   BioGRID_ORCS_Cell_line; 158
DR   BioSample; SAMN01821551
DR   BioSample; SAMN01821680
DR   BioSample; SAMN03472323
DR   cancercelllines; CVCL_0248
DR   CCRID; 1101HUM-PUMC000671
DR   CCRID; 3101HUMTCHu134
DR   CCRID; 4201HUM-CCTCC00620
DR   Cell_Model_Passport; SIDM00787
DR   ChEMBL-Cells; CHEMBL3307580
DR   ChEMBL-Targets; CHEMBL614285
DR   CLS; 300220
DR   ColonAtlas; DLD1
DR   Cosmic; 687519
DR   Cosmic; 755307
DR   Cosmic; 870451
DR   Cosmic; 873699
DR   Cosmic; 876713
DR   Cosmic; 905005
DR   Cosmic; 913890
DR   Cosmic; 934560
DR   Cosmic; 948123
DR   Cosmic; 983737
DR   Cosmic; 985994
DR   Cosmic; 1043810
DR   Cosmic; 1066204
DR   Cosmic; 1122323
DR   Cosmic; 1154643
DR   Cosmic; 1175839
DR   Cosmic; 1184082
DR   Cosmic; 1184331
DR   Cosmic; 1187305
DR   Cosmic; 1223137
DR   Cosmic; 1310949
DR   Cosmic; 1466813
DR   Cosmic; 1479591
DR   Cosmic; 1481418
DR   Cosmic; 1519360
DR   Cosmic; 1524004
DR   Cosmic; 1552176
DR   Cosmic; 1571767
DR   Cosmic; 1609511
DR   Cosmic; 1676737
DR   Cosmic; 1805251
DR   Cosmic; 2301544
DR   Cosmic; 2301972
DR   Cosmic; 2389573
DR   Cosmic; 2464668
DR   Cosmic; 2550352
DR   Cosmic; 2646769
DR   Cosmic; 2650774
DR   Cosmic; 2651870
DR   Cosmic; 2664050
DR   Cosmic; 2667971
DR   Cosmic; 2668249
DR   Cosmic; 2727471
DR   Cosmic; 2727478
DR   Cosmic; 2760067
DR   Cosmic; 2787544
DR   Cosmic; 2811050
DR   DepMap; ACH-001061
DR   DSMZ; ACC-278
DR   DSMZCellDive; ACC-278
DR   ECACC; 90102540
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS580BTU
DR   ENCODE; ENCBS621AWM
DR   GEO; GSM206467
DR   GEO; GSM274715
DR   GEO; GSM274716
DR   GEO; GSM274727
DR   GEO; GSM513817
DR   GEO; GSM514291
DR   GEO; GSM741247
DR   GEO; GSM886979
DR   GEO; GSM888048
DR   GEO; GSM1346869
DR   GEO; GSM1374463
DR   GEO; GSM1448161
DR   GEO; GSM1696579
DR   GEO; GSM1696580
DR   GEO; GSM1696581
DR   GEO; GSM1696582
DR   GEO; GSM2549997
DR   IARC_TP53; 18
DR   ICLC; HTL95011
DR   JCRB; JCRB9094
DR   KCB; KCB 2011096YJ
DR   KCLB; 10221
DR   LINCS_LDP; LCL-1175
DR   Lonza; 806
DR   MetaboLights; MTBLS227
DR   PharmacoDB; DLD1_294_2019
DR   PRIDE; PXD000218
DR   PRIDE; PXD001550
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Progenetix; CVCL_0248
DR   PubChem_Cell_line; CVCL_0248
DR   RCB; RCB1957
DR   SKY/M-FISH/CGH; 1992
DR   SKY/M-FISH/CGH; 2763
DR   TKG; TKG 0379
DR   TOKU-E; 1078
DR   Wikidata; Q54831148
RX   PubMed=427742;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=6652615;
RX   PubMed=7247963;
RX   PubMed=7621404;
RX   PubMed=7651727;
RX   PubMed=7874267;
RX   PubMed=7972006;
RX   PubMed=8197130;
RX   PubMed=8422623;
RX   PubMed=8464898;
RX   PubMed=9290701;
RX   PubMed=9294210;
RX   PubMed=9515795;
RX   PubMed=9809040;
RX   PubMed=10612807;
RX   PubMed=10674020;
RX   PubMed=10700188;
RX   PubMed=11226274;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=12615714;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=22490663;
RX   PubMed=23272949;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25841592;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26295583;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=28179481;
RX   PubMed=28192450;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32172478;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/DLD-1.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/dld-1-xenograft-model/
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 20 hours (PubMed=427742); 25.27 hours (PubMed=25944804); 33 hours (PubMed=25984343); ~15 hours (CLS=300220); ~48 hours (DSMZ=ACC-278).
CC   HLA typing: A*02:01,24:02; B*08:01,35:01; C*04:01,07:01 (PubMed=25960936).
CC   HLA typing: A*02:01,24:02; B*08:01,08:01; C*04:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=24042735; PubMed=24755471; PubMed=28683746; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=8197130).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (PubMed=8197130).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Glu1014Ter (c.3040G>T); Zygosity=Heterozygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=7651727; PubMed=16418264; PubMed=28683746).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.31%; East Asian, North=0%; East Asian, South=0.3%; South Asian=2.26%; European, North=64.92%; European, South=32.2% (PubMed=30894373).
CC   Misspelling: DLD; Cosmic=1571767; Cosmic=1676737.
CC   Discontinued: RCB; RCB1957; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): AddexBio=C0009007/36; ATCC=CCL-221; CCRID; CLS=300220; DSMZ=ACC-278; ECACC=90102540; JCRB=JCRB9094; KCLB=10221; PubMed=11416159; PubMed=25877200; PubMed=25926053; TKG=TKG 0379
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12 (AddexBio=C0009007/36; ATCC=CCL-221; CCRID; DSMZ=ACC-278; ECACC=90102540; JCRB=JCRB9094; KCLB=10221; PubMed=25877200; PubMed=25926053)
ST   CSF1PO: 12 (CLS=300220; TKG=TKG 0379)
ST   D12S391: 19,22
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D2S441: 13,15
ST   D3S1358: 17
ST   D5S818: 13
ST   D6S1043: 11,13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 9,14
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3449 ! __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   DLD-1 AKT1(-/-)
AC   CVCL_HD52
SY   AKT1 (-/-) DLD-1
DR   Horizon_Discovery; HD+R00-001
DR   Wikidata; Q54831149
RX   PubMed=20133737;
RX   PubMed=27878243;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:391; AKT1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 AKT2(-/-)
AC   CVCL_HD53
SY   AKT2 (-/-) DLD-1
DR   Horizon_Discovery; HD+R00-002
DR   Wikidata; Q54831150
RX   PubMed=20133737;
RX   PubMed=27878243;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:392; AKT2.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 AKT3(-/-)
AC   CVCL_A2PQ
SY   AKT3 (-/-) DLD-1
DR   Horizon_Discovery; HD+R00-003
DR   Wikidata; Q105506757
RX   PubMed=27878243;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:393; AKT3.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   DLD-1 ATG7(+/-)
AC   CVCL_HD54
SY   ATG7 (+/-) DLD-1
DR   Horizon_Discovery; HD+105-016
DR   Wikidata; Q54831151
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:16935; ATG7 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   DLD-1 BBC3(-/-)
AC   CVCL_HD55
SY   BBC3 (-/-) DLD-1; DLD-1 PUMA-/-
DR   Horizon_Discovery; HD+R00-029
DR   Wikidata; Q54831152
RX   PubMed=12574499;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17868; BBC3.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 BRCA2(+/-)
AC   CVCL_HD56
SY   BRCA2 (+/-) DLD-1
DR   Horizon_Discovery; HD+105-027
DR   Wikidata; Q54831153
RX   PubMed=18593900;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1101; BRCA2 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   DLD-1 BRCA2(-/-)
AC   CVCL_HD57
SY   BRCA2 (-/-) DLD-1
DR   Horizon_Discovery; HD+105-007
DR   Wikidata; Q54831154
RX   PubMed=18593900;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1101; BRCA2.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 CDKN1A(-/-)
AC   CVCL_HD58
SY   CDKN1A (-/-) DLD-1; DLD1 p21-/-
DR   Horizon_Discovery; HD+R00-020
DR   Wikidata; Q54831155
RX   PubMed=8756351;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1784; CDKN1A.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 clone A
AC   CVCL_V011
SY   DLD-1 Clone A; Clone A; CLONE A; CloneA
DR   cancercelllines; CVCL_V011
DR   Cosmic; 1374647
DR   Cosmic; 1481425
DR   Wikidata; Q54831156
RX   PubMed=427742;
RX   PubMed=7247963;
RX   PubMed=7651727;
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=427742).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=7651727).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   DLD-1 clone D
AC   CVCL_V012
SY   DLD-1 Clone D; Clone D; CLONE D; CLONE_D
DR   cancercelllines; CVCL_V012
DR   ColonAtlas; CLONE_D
DR   Cosmic; 1374643
DR   Wikidata; Q54831157
RX   PubMed=427742;
RX   PubMed=7247963;
RX   PubMed=7651727;
CC   Population: Caucasian.
CC   Doubling time: 20 hours (PubMed=427742).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=7651727).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   DLD-1 clone#1-Luc
AC   CVCL_J250
DR   JCRB; JCRB1382
DR   JCRB; NIHS0650
DR   Wikidata; Q54831158
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0650; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): JCRB=JCRB1382
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   DLD-1 DICER1(-/-)
AC   CVCL_HD59
SY   DICER1 (-/-) DLD-1
DR   Horizon_Discovery; HD+R00-009
DR   Wikidata; Q54831159
RX   PubMed=16505370;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17098; DICER1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 FBXW7(+/-)
AC   CVCL_HD60
SY   FBXW7 (+/-) DLD-1
DR   Horizon_Discovery; HD+R00-006
DR   Wikidata; Q54831160
RX   PubMed=14999283;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:16712; FBXW7 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   DLD-1 FBXW7(-/-)
AC   CVCL_HD61
SY   FBXW7 (-/-) DLD-1; DLD-1 hCDC4 -/-
DR   Horizon_Discovery; HD+R00-005
DR   Wikidata; Q54831161
RX   PubMed=14999283;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:16712; FBXW7.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 human PDL1
AC   CVCL_XZ51
SY   DLD-1 human PD-L1
DR   KYinno; KC-1227
DR   Wikidata; Q93528603
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-1227).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: KYinno; KC-1227; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   DLD-1 KRAS(+/-) 1
AC   CVCL_HD62
SY   KRAS (+/-) DLD-1
DR   Horizon_Discovery; HD+105-002
DR   Wikidata; Q54831162
RX   PubMed=19661383;
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles, that with p.Gly13Asp).
CC   Miscellaneous: Horizon distributes two DLD-1 KRAS(+/-) cell lines, one developed internally (Cellosaurus=CVCL_HE28) and one originating from the group of Volgenstein (Cellosaurus=CVCL_HD62).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   DLD-1 KRAS(+/-) 2
AC   CVCL_HE28
SY   KRAS (+/-) DLD-1
DR   Horizon_Discovery; HD+105-040
DR   Wikidata; Q54831163
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles, that with p.Gly13Asp).
CC   Miscellaneous: Horizon distributes two DLD-1 KRAS(+/-) cell lines, one developed internally (Cellosaurus=CVCL_HE28) and one originating from the group of Volgenstein (Cellosaurus=CVCL_HD62).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   DLD-1 PIK3CA (E545K/-)
AC   CVCL_D4XI
SY   PIK3CA^(E545K/-) DLD-1
DR   Horizon_Discovery; HD+105-012
DR   Wikidata; Q127380795
RX   PubMed=15950905;
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two PIK3CA alleles has a p.Glu545Lys mutation. This cell line is KO for the wild-type allele (PubMed=15950905).
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:8975; PIK3CA (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   DLD-1 PIK3CA E545K KO
AC   CVCL_RQ05
SY   PIK3CA^(+/-) DLD-1
DR   Horizon_Discovery; HD+105-001
DR   Wikidata; Q54831164
RX   PubMed=15950905;
CC   Population: Caucasian.
CC   Characteristics: In DLD-1 one of the two PIK3CA alleles has a p.Glu545Lys mutation. This cell line is KO for the mutant allele (PubMed=15950905).
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:8975; PIK3CA (Note=1 of 2 alleles, that with p.Glu545Lys).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   DLD-1 SIRT1 Het
AC   CVCL_ZC13
SY   DLD1 SIRT1 Het; SIRT1 Het DLD1
DR   Wikidata; Q98125875
RX   PubMed=28162896;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 SIRT1 KO
AC   CVCL_ZC12
SY   DLD1 SIRT1 KO; SIRT1 KO DLD1
DR   Kerafast; ENH130-FP
DR   Wikidata; Q98125876
RX   PubMed=28162896;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   DLD-1 SLC2A1(-/-)
AC   CVCL_HD63
SY   GLUT1 (-/-) DLD-1
DR   Horizon_Discovery; HD+R00-024
DR   Wikidata; Q54831165
RX   PubMed=19661383;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11005; SLC2A1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1 USP7(-/-)
AC   CVCL_HD64
SY   USP7 (-/-) DLD-1
DR   Horizon_Discovery; HD+115-028
DR   Wikidata; Q54831166
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12630; USP7.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   DLD-1/alpha-cat cell
AC   CVCL_1Y05
DR   BTO; BTO_0005484
DR   Wikidata; Q54831167
RX   PubMed=9792660;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2509; CTNNA1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y04 ! DLD-1/delta-alpha
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 7
//
ID   DLD-1/delta-alpha
AC   CVCL_1Y04
SY   DLD-1/delta alpha
DR   Wikidata; Q54831168
RX   PubMed=9792660;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 5
//
ID   DLD-2
AC   CVCL_Y034
SY   DLD2
DR   Wikidata; Q54831169
RX   PubMed=7139607;
RX   PubMed=7247963;
RX   PubMed=8422623;
CC   Doubling time: ~50 hours (PubMed=7139607); 48 hours (PubMed=7247963).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   DLD1-FX-R
AC   CVCL_C4RW
DR   Wikidata; Q116048842
RX   PubMed=36230735;
CC   Population: Caucasian.
CC   Characteristics: Resistant to FOLFOXIRI, the combination of 5-FU, folinic acic, oxaliplatin and SN-38.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Selected for resistance to: ChEBI; CHEBI_15640; 5-formyltetrahydrofolic acid (Folinic acid; Leucovorin).
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   DLDSNR6
AC   CVCL_4V49
DR   Wikidata; Q54831170
RX   PubMed=16546964;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 6
//
ID   DLEC
AC   CVCL_6F79
SY   Dicentrarchus Labrax Embryonic Cells
DR   Kerafast; ETS001
DR   Wikidata; Q54831171
RX   CelloPub=CLPUB00590;
RX   PubMed=16249966;
RX   PubMed=23839298;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=13489; ! Dicentrarchus labrax (European seabass)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DLEC-NNV
AC   CVCL_A1QR
DR   Wikidata; Q102113771
RX   CelloPub=CLPUB00590;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G8GVZ5; Dicentrarchus labrax betanodavirus capsid protein alpha.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=13489; ! Dicentrarchus labrax (European seabass)
HI   CVCL_6F79 ! DLEC
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   DLKP
AC   CVCL_H737
SY   Dublin Lung patient KP
DR   CancerTools; 157658
DR   ChEMBL-Cells; CHEMBL3308451
DR   ChEMBL-Targets; CHEMBL614482
DR   ECACC; 20082601
DR   PubChem_Cell_line; CVCL_H737
DR   Wikidata; Q54831172
RX   PubMed=1581877;
RX   PubMed=17593620;
CC   Omics: Proteomics; 2DE-MS.
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (PubMed=1581877).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=20082601
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 13
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 11
ST   Penta E: 7,15
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   DLKP-A
AC   CVCL_H741
DR   Wikidata; Q54831173
RX   PubMed=1369413;
RX   PubMed=19242932;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DLKP-A10
AC   CVCL_H742
DR   CancerTools; 161752
DR   Wikidata; Q54831178
RX   PubMed=9260877;
RX   PubMed=19242932;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H741 ! DLKP-A
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DLKP-A2B
AC   CVCL_H744
DR   Wikidata; Q54831179
RX   PubMed=9180164;
RX   PubMed=19242932;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H741 ! DLKP-A
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DLKP-A5F
AC   CVCL_H743
DR   Wikidata; Q54831180
RX   PubMed=9180164;
RX   PubMed=19242932;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H741 ! DLKP-A
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DLKP-I
AC   CVCL_H738
SY   DLKP-Intermediate clone
DR   CancerTools; 157985
DR   ECACC; 20082602
DR   Wikidata; Q54831181
RX   PubMed=9486560;
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=20082602
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 13
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 11
ST   Penta E: 7,15
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DLKP-M
AC   CVCL_H739
SY   DLKP-Mesenchymal-like clone
DR   CancerTools; 157660
DR   Wikidata; Q54831182
RX   PubMed=9486560;
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DLKP-Mitox
AC   CVCL_4U31
SY   DLKP-MITOX
DR   Wikidata; Q54831183
RX   PubMed=15239124;
RX   PubMed=17593620;
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Omics: Proteomics; 2DE-MS.
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   DLKP-SQ
AC   CVCL_H740
SY   DLKP-SQuamous clone
DR   CancerTools; 157659
DR   Wikidata; Q54831184
RX   PubMed=9486560;
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DLM8
AC   CVCL_6669
SY   Dunn LM8; LM8
DR   CLO; CLO_0050199
DR   RCB; RCB1450
DR   Wikidata; Q54902749
RX   PubMed=9579581;
RX   PubMed=26018200;
RX   PubMed=26320182;
CC   Characteristics: Highly metastatic to lung (PubMed=9579581).
CC   Doubling time: 13 hours (PubMed=9579581).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W629 ! Dunn osteosarcoma
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   DLRP
AC   CVCL_J019
SY   Dublin Lung patient RP
DR   DSMZ; ACC-881
DR   DSMZCellDive; ACC-881
DR   ECACC; 20082610
DR   Wikidata; Q54831185
RX   PubMed=1581877;
CC   Doubling time: ~1 week (DSMZ=ACC-881).
CC   Donor information: Established from a patient that smoked approximately 40 cigarettes a day for most of his adult life (PubMed=1581877).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): DSMZ=ACC-881
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12,14
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 31.2
ST   D2S1338: 18,21
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,16
ST   FGA: 24,25
ST   Penta D: 15
ST   Penta E: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   dLu
AC   CVCL_E4DG
RX   PubMed=38148353;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   DM [Human B-cell IHW]
AC   CVCL_F549
SY   30458; Extract 190; Extract 275; Extract 439
DR   IPD-IMGT/HLA; 11815
DR   Wikidata; Q54831186
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/338cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01,44:08; C*05:01,07:01; DQA1*03,05; DQB1*02:01,03; DRB1*03,04:01; DRB3*01; DRB4*01 (IPD-IMGT/HLA=11815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   DM [Human macrophage]
AC   CVCL_C0PG
DR   Wikidata; Q112929458
RX   PubMed=6316162;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   DM(act10)
AC   CVCL_VS27
SY   DMact10; DM-15/AD-R10; AD-R10
DR   Wikidata; Q93528865
RX   PubMed=6941912;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
HI   CVCL_L864 ! DM-15
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   DM(act12)
AC   CVCL_4V32
SY   DMact12; DM-15/AD-R12; AD-R12
DR   Wikidata; Q54831191
RX   PubMed=6941912;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
HI   CVCL_L864 ! DM-15
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   DM(act6)
AC   CVCL_VS28
SY   DMact6; DM-15/AD-R6; AD-R6
DR   Wikidata; Q93528876
RX   PubMed=6941912;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
HI   CVCL_L864 ! DM-15
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   DM(adb-0.8)
AC   CVCL_4V33
SY   DMadb-0.8
DR   Wikidata; Q54831192
RX   PubMed=2988876;
RX   PubMed=4006597;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
HI   CVCL_L864 ! DM-15
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   DM(cap)
AC   CVCL_L865
SY   DMcap; DMCAP
DR   Wikidata; Q54831193
RX   PubMed=4006597;
RX   PubMed=6957361;
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
HI   CVCL_L864 ! DM-15
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   DM(ch-2/1)
AC   CVCL_4W09
SY   DMch-2/1; DM-15CH-R1/2; DM15/2
DR   Wikidata; Q54831194
RX   PubMed=6957361;
RX   PubMed=7261678;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
HI   CVCL_L864 ! DM-15
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   DM-15
AC   CVCL_L864
AS   CVCL_L866
SY   Dm-15; DM(6-MP)
DR   CLO; CLO_0002790
DR   CLDB; cl1071
DR   Wikidata; Q54831187
RX   PubMed=196977;
RX   PubMed=4006597;
RX   PubMed=6941912;
RX   PubMed=6957361;
CC   Doubling time: 20.15 +- 1.3 hours (PubMed=196977).
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10044; ! Phodopus sungorus (Striped hairy-footed hamster)
HI   CVCL_VS26 ! 4/21
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   DM-3
AC   CVCL_2019
SY   DM3
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473059
DR   BioSample; SAMN10988453
DR   cancercelllines; CVCL_2019
DR   Cell_Model_Passport; SIDM01505
DR   DepMap; ACH-000742
DR   DSMZ; ACC-595
DR   DSMZCellDive; ACC-595
DR   IARC_TP53; 30031
DR   LiGeA; CCLE_782
DR   PharmacoDB; DM3_295_2019
DR   Progenetix; CVCL_2019
DR   Wikidata; Q54831188
RX   DOI=10.1101/166199;
RX   PubMed=15372243;
RX   PubMed=23840376;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=33567673;
CC   Problematic cell line: May be misclassified. While still annotated as a pleural sarcomatoid mesothelioma cell line, a variety of omics methods are classifying this cell line as a fibroblast (DOI=10.1101/166199; DepMap=ACH-000742).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 54 hours (PubMed=23840376); ~50-60 hours (DSMZ=ACC-595).
CC   HLA typing: A*02:14,02:14; B*13:02,50:01; C*06:02,06:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg496Leu (c.1487G>T); Zygosity=Homozygous (DepMap=ACH-000742).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.58%; East Asian, South=0.68%; South Asian=2.16%; European, North=58.64%; European, South=37.94% (PubMed=30894373).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): DSMZ=ACC-595; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 11,15
ST   FGA: 19,20
ST   Penta D: 11,12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   DM-4
AC   CVCL_5644
DR   BTO; BTO_0004415
DR   Cosmic; 932704
DR   Cosmic; 1238115
DR   Cosmic; 1303037
DR   Wikidata; Q54831189
RX   PubMed=1826230;
RX   PubMed=2297053;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   DM-77
AC   CVCL_XH43
DR   Wikidata; Q93528933
RX   DOI=10.1134/S102279541908012X;
CC   Group: Tick cell line.
CC   Doubling time: 2.8 +- 0.3 days (DOI=10.1134/S102279541908012X).
OX   NCBI_TaxID=49202; ! Dermacentor marginatus (Ornate sheep tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   DM-II-AM
AC   CVCL_C2SX
SY   DM-2
DR   ICLDB; dm-ii-am-bcirl
DR   Wikidata; Q114311321
RX   PubMed=1017845;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=74065; ! Dalbulus maidis (Corn leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   DM100
AC   CVCL_ZL64
SY   Duke Melanoma 100
DR   Wikidata; Q98125877
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*29; B*44 (PubMed=2785141).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   DM105
AC   CVCL_F867
SY   Duke Melanoma 105
DR   Wikidata; Q54831195
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*01,10; B*18,53; C*01,02 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM12 [Human melanoma]
AC   CVCL_ZL62
SY   Duke Melanoma 12
DR   Wikidata; Q98125878
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*03,31; B*05 (PubMed=2785141).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   DM12 [Human OCSCC]
AC   CVCL_1Q83
DR   BioSample; SAMN03151988
DR   Wikidata; Q54831196
RX   PubMed=16978912;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00397.
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11,12,14
ST   D13S317: 8,11,13
ST   D16S539: 9,12,13
ST   D5S818: 9,11,13
ST   D7S820: 8,9,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,18,20
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   DM12-TK
AC   CVCL_E9CF
RX   PubMed=11916247;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZL62 ! DM12 [Human melanoma]
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DM122
AC   CVCL_6623
SY   Duke Melanoma 122
DR   GEO; GSM1672066
DR   GEO; GSM1672086
DR   GEO; GSM1672094
DR   GEO; GSM1672100
DR   GEO; GSM1672114
DR   GEO; GSM1672129
DR   Wikidata; Q54831197
RX   PubMed=2404572;
RX   PubMed=2785141;
RX   PubMed=14871852;
RX   PubMed=21654344;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*03,33; B*07,18 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   DM128
AC   CVCL_F868
SY   Duke Melanoma 128
DR   Wikidata; Q54831198
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*28,29; B*14,35; C*04 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM13
AC   CVCL_6621
SY   DM-13; Duke Melanoma 13
DR   cancercelllines; CVCL_6621
DR   GEO; GSM1572817
DR   GEO; GSM1572818
DR   GEO; GSM1572819
DR   GEO; GSM1572820
DR   GEO; GSM1572821
DR   GEO; GSM1572822
DR   GEO; GSM1671960
DR   GEO; GSM1671989
DR   GEO; GSM1672012
DR   GEO; GSM1672071
DR   GEO; GSM1672076
DR   GEO; GSM1672098
DR   GEO; GSM1672101
DR   GEO; GSM1672115
DR   GEO; GSM1672131
DR   Wikidata; Q54831199
RX   PubMed=2404572;
RX   PubMed=2785141;
RX   PubMed=7703289;
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=21654344;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*02,31; B*13,18 (PubMed=2404572).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   DM13/B7-7
AC   CVCL_ZL67
DR   Wikidata; Q98125879
RX   PubMed=7703289;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6621 ! DM13
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   DM14 [Human melanoma]
AC   CVCL_6622
SY   Duke Melanoma 14
DR   Wikidata; Q54831200
RX   PubMed=2404572;
RX   PubMed=2785141;
RX   PubMed=10752474;
RX   PubMed=14871852;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*11,68; B*05,08; C*02,04 (PubMed=10752474).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   DM14 [Human OCSCC]
AC   CVCL_1Q84
DR   BioSample; SAMN03151989
DR   Wikidata; Q54831201
RX   PubMed=16978912;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00398.
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11,12,14
ST   D13S317: 8,11,13
ST   D16S539: 9,12,13
ST   D5S818: 9,11,13
ST   D7S820: 8,9,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17,18,20
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   DM141
AC   CVCL_ZL65
SY   Duke Melanoma 141
DR   Wikidata; Q98125881
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*02,28; B*07 (PubMed=2785141).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   DM144
AC   CVCL_ZL66
SY   Duke Melanoma 144
DR   Wikidata; Q98125882
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*01; B*03,15; C*03 (PubMed=2785141).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   DM150
AC   CVCL_F869
SY   DM-150; DM 150; Duke Melanoma 150
DR   Wikidata; Q54831202
RX   PubMed=7703289;
RX   PubMed=8037761;
CC   From: Duke University Medical Center; Durham; USA.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM150/B7-8
AC   CVCL_ZL68
DR   Wikidata; Q98125883
RX   PubMed=7703289;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F869 ! DM150
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   DM154
AC   CVCL_F870
SY   Duke Melanoma 154
DR   Wikidata; Q54831203
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*11,29; B*05,12 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM161
AC   CVCL_F871
SY   Duke Melanoma 161
DR   Wikidata; Q54831204
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*02,11; B*07,49; C*01 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM165
AC   CVCL_ZM05
SY   Duke Melanoma 165
DR   Wikidata; Q98125885
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*02; B*12,44 (PubMed=2785141).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   DM166
AC   CVCL_F872
SY   Duke Melanoma 166
DR   Wikidata; Q54831205
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*02; B*05,40 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM169
AC   CVCL_F873
SY   Duke Melanoma 169
DR   Wikidata; Q54831206
RX   PubMed=2404572;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*01,02; B*08,40 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM175
AC   CVCL_F874
SY   DM-175; Duke Melanoma 175
DR   Cosmic; 1477320
DR   GEO; GSM276724
DR   Wikidata; Q54831207
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DM179
AC   CVCL_F875
SY   DM-179; Duke Melanoma 179
DR   Wikidata; Q54831208
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*02; B*07 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM196
AC   CVCL_F876
SY   Duke Melanoma 196
DR   Wikidata; Q54831209
RX   PubMed=11123321;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   Dm2008Wb1
AC   CVCL_Z816
DR   Wikidata; Q54831210
RX   PubMed=20198874;
CC   Group: Insect cell line.
CC   Characteristics: Infected by the intracellular symbiont Wolbachia pipientis.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Chernomorka x F12.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   DM208
AC   CVCL_F877
SY   Duke Melanoma 208
DR   Wikidata; Q54831211
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   DM268
AC   CVCL_F878
SY   Duke Melanoma 268
DR   Wikidata; Q54831212
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   DM277
AC   CVCL_ZL71
SY   Duke Melanoma 277
DR   Wikidata; Q98125886
RX   PubMed=9241074;
RX   PubMed=11520076;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM281
AC   CVCL_6624
SY   Duke Melanoma 281
DR   Wikidata; Q54831213
RX   PubMed=10752474;
RX   PubMed=14871852;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   DM319
AC   CVCL_6625
SY   Duke Melanoma 319
DR   Wikidata; Q54831214
RX   PubMed=9241074;
RX   PubMed=11520076;
RX   PubMed=14871852;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   DM331
AC   CVCL_6626
SY   Duke Melanoma 331
DR   cancercelllines; CVCL_6626
DR   GEO; GSM1671956
DR   GEO; GSM1671958
DR   GEO; GSM1671963
DR   GEO; GSM1671971
DR   GEO; GSM1671973
DR   GEO; GSM1671979
DR   GEO; GSM1671992
DR   GEO; GSM1671994
DR   GEO; GSM1671999
DR   GEO; GSM1672010
DR   GEO; GSM1672028
DR   GEO; GSM1672031
DR   GEO; GSM1672033
DR   GEO; GSM1672034
DR   GEO; GSM1672037
DR   GEO; GSM1672052
DR   GEO; GSM1672057
DR   GEO; GSM1672058
DR   Wikidata; Q54831215
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=21654344;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*01,02; B*15,62 (PubMed=10752474).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   DM336
AC   CVCL_F879
SY   Duke Melanoma 336
DR   Wikidata; Q54831216
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   DM341
AC   CVCL_ZL72
SY   Duke Melanoma 341
DR   Wikidata; Q98125887
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM343
AC   CVCL_ZL73
SY   Duke Melanoma 343
DR   Wikidata; Q98125888
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM349
AC   CVCL_ZL74
SY   Duke Melanoma 349
DR   Wikidata; Q98125890
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM366
AC   CVCL_F880
SY   Duke Melanoma 366
DR   Cosmic; 1477311
DR   GEO; GSM276735
DR   Wikidata; Q54831217
RX   PubMed=11520076;
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DM368
AC   CVCL_F881
SY   Duke Melanoma 368
DR   GEO; GSM276728
DR   Wikidata; Q54831220
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM377
AC   CVCL_F882
SY   Duke Melanoma 377
DR   Wikidata; Q54831221
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   DM382
AC   CVCL_IS49
SY   Duke Melanoma 382
DR   GEO; GSM276751
DR   Wikidata; Q54831222
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   DM385
AC   CVCL_ZL75
SY   Duke Melanoma 385
DR   Wikidata; Q98125891
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM387
AC   CVCL_ZL76
SY   Duke Melanoma 387
DR   Wikidata; Q98125893
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM390
AC   CVCL_ZL77
SY   Duke Melanoma 390
DR   Wikidata; Q98125894
RX   PubMed=11520076;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM391
AC   CVCL_F883
SY   Duke Melanoma 391
DR   GEO; GSM276731
DR   Wikidata; Q54831223
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM400
AC   CVCL_ZL78
SY   Duke Melanoma 400
DR   Wikidata; Q98125895
RX   PubMed=9241074;
RX   PubMed=11520076;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM401
AC   CVCL_IS50
SY   DM401p; Duke Melanoma 401
DR   GEO; GSM276769
DR   Wikidata; Q54831224
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   DM406
AC   CVCL_ZL79
SY   Duke Melanoma 406
DR   Wikidata; Q98125896
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM414
AC   CVCL_F884
SY   Duke Melanoma 414
DR   Cosmic; 1477312
DR   GEO; GSM276744
DR   Wikidata; Q54831225
RX   PubMed=9241074;
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DM422
AC   CVCL_F885
SY   Duke Melanoma 422
DR   GEO; GSM276758
DR   Wikidata; Q54831226
RX   PubMed=9241074;
RX   PubMed=11520076;
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DM424
AC   CVCL_F886
SY   Duke Melanoma 424
DR   GEO; GSM276745
DR   Wikidata; Q54831227
RX   PubMed=9241074;
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DM425
AC   CVCL_F887
SY   Duke Melanoma 425
DR   GEO; GSM276756
DR   Wikidata; Q54831228
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM426
AC   CVCL_ZL80
SY   Duke Melanoma 426
DR   Wikidata; Q98125898
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM434
AC   CVCL_ZL81
SY   Duke Melanoma 434
DR   Wikidata; Q98125902
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM440
AC   CVCL_F888
SY   Duke Melanoma 440
DR   Cosmic; 1477316
DR   GEO; GSM276729
DR   Wikidata; Q54831229
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM441
AC   CVCL_ZL82
SY   Duke Melanoma 441
DR   Wikidata; Q98125905
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM443
AC   CVCL_F889
SY   Duke Melanoma 443
DR   Cosmic; 1477317
DR   GEO; GSM276742
DR   Wikidata; Q54831230
RX   PubMed=11520076;
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DM451
AC   CVCL_F890
SY   Duke Melanoma 451
DR   GEO; GSM276727
DR   Wikidata; Q54831231
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM459
AC   CVCL_IS51
SY   Duke Melanoma 459
DR   GEO; GSM276768
DR   Wikidata; Q54831232
RX   PubMed=9241074;
RX   PubMed=11520076;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   DM465
AC   CVCL_ZL83
SY   Duke Melanoma 465
DR   Wikidata; Q98125908
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   DM467
AC   CVCL_IS52
SY   Duke Melanoma 467
DR   GEO; GSM276766
DR   Wikidata; Q54831233
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM472
AC   CVCL_6627
SY   Duke Melanoma 472
DR   Wikidata; Q54831234
RX   PubMed=9241074;
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   DM49
AC   CVCL_ZL63
SY   Duke Melanoma 49
DR   Wikidata; Q98125911
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*01,10; B*08,51; C*02,04 (PubMed=2785141).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   DM497
AC   CVCL_IS53
SY   Duke Melanoma 497
DR   GEO; GSM276746
DR   Wikidata; Q54831235
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM515
AC   CVCL_F891
SY   Duke Melanoma 515
DR   Wikidata; Q54831236
CC   From: Duke University Medical Center; Durham; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   DM555
AC   CVCL_IS54
SY   Duke Melanoma 555
DR   GEO; GSM276772
DR   Wikidata; Q54831237
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM578
AC   CVCL_F892
SY   Duke Melanoma 578
DR   GEO; GSM276752
DR   Wikidata; Q54831238
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM589
AC   CVCL_IS55
SY   Duke Melanoma 589
DR   GEO; GSM276753
DR   Wikidata; Q54831239
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM595
AC   CVCL_IS56
SY   Duke Melanoma 595
DR   GEO; GSM276765
DR   Wikidata; Q54831240
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM598
AC   CVCL_F893
SY   Duke Melanoma 598
DR   Cosmic; 1477313
DR   GEO; GSM276759
DR   Wikidata; Q54831241
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM6
AC   CVCL_6628
SY   DM-6; DM006; Duke Melanoma 6
DR   BTO; BTO_0002957
DR   cancercelllines; CVCL_6628
DR   Cosmic; 1477315
DR   GEO; GSM276737
DR   GEO; GSM1672064
DR   GEO; GSM1672081
DR   GEO; GSM1672089
DR   GEO; GSM1672109
DR   GEO; GSM1672123
DR   GEO; GSM1672130
DR   Millipore; SCC221
DR   Wikidata; Q54831242
RX   PubMed=2404572;
RX   PubMed=2785141;
RX   PubMed=10752474;
RX   PubMed=11520076;
RX   PubMed=14871852;
RX   PubMed=19147755;
RX   PubMed=21654344;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   From: Duke University Medical Center; Durham; USA.
CC   Characteristics: Pigmented.
CC   HLA typing: A*02:01; B*12,13; C*01,02 (PubMed=10752474).
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Millipore=SCC221
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 12
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 7,11
ST   D8S1179: 14
ST   FGA: 24,27,28
ST   Penta D: 10,12
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   DM602
AC   CVCL_IS57
SY   Duke Melanoma 602
DR   GEO; GSM276770
DR   Wikidata; Q54831243
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM608
AC   CVCL_F895
SY   Duke Melanoma 608
DR   GEO; GSM276743
DR   Wikidata; Q54831244
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM636
AC   CVCL_F896
SY   Duke Melanoma 636
DR   GEO; GSM276726
DR   Wikidata; Q54831245
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM643
AC   CVCL_IS58
SY   Duke Melanoma 643
DR   GEO; GSM276734
DR   Wikidata; Q54831246
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM646
AC   CVCL_F897
SY   Duke Melanoma 646
DR   Cosmic; 1477321
DR   GEO; GSM276738
DR   Wikidata; Q54831247
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM7
AC   CVCL_F898
SY   Duke Melanoma 7
DR   Wikidata; Q54831248
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*09,29; B*15,38; C*03 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM711
AC   CVCL_F899
SY   Duke Melanoma 711
DR   GEO; GSM276754
DR   Wikidata; Q54831249
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM733
AC   CVCL_F900
SY   Duke Melanoma 733
DR   GEO; GSM276747
DR   Wikidata; Q54831250
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM738
AC   CVCL_F901
SY   Duke Melanoma 738
DR   Cosmic; 1477318
DR   GEO; GSM276732
DR   Wikidata; Q54831251
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM745
AC   CVCL_IS59
SY   Duke Melanoma 745
DR   GEO; GSM276755
DR   Wikidata; Q54831252
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM751
AC   CVCL_F902
SY   Duke Melanoma 751
DR   GEO; GSM276723
DR   Wikidata; Q54831253
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM779
AC   CVCL_IS60
SY   Duke Melanoma 779
DR   GEO; GSM276764
DR   Wikidata; Q54831254
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM787
AC   CVCL_IS61
SY   Duke Melanoma 787
DR   GEO; GSM276767
DR   Wikidata; Q54831255
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM792
AC   CVCL_F903
SY   Duke Melanoma 792
DR   Cosmic; 1477314
DR   GEO; GSM276748
DR   Wikidata; Q54831256
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM798
AC   CVCL_IS62
SY   Duke Melanoma 798
DR   GEO; GSM276763
DR   Wikidata; Q54831257
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM806
AC   CVCL_IS63
SY   Duke Melanoma 806
DR   GEO; GSM276757
DR   Wikidata; Q54831258
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   DM833
AC   CVCL_F904
SY   Duke Melanoma 833
DR   Cosmic; 1477322
DR   GEO; GSM276725
DR   Wikidata; Q54831259
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM868
AC   CVCL_F905
SY   Duke Melanoma 868
DR   GEO; GSM276740
DR   Wikidata; Q54831264
RX   PubMed=19147755;
CC   From: Duke University Medical Center; Durham; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DM87
AC   CVCL_9126
SY   DM; Indian Muntjac; M cell; Muntjac 157 cell; M; Indian Muntjac (M)
DR   CLO; CLO_0006952
DR   ATCC; CCL-157
DR   BCRC; 60278
DR   ECACC; 90112813
DR   JCRB; JCRB9100
DR   Wikidata; Q54831265
RX   CelloPub=CLPUB00768;
RX   PubMed=2157503;
RX   PubMed=3013792;
RX   PubMed=5444269;
RX   PubMed=7989438;
RX   PubMed=25509114;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/muntjac/muntjaccells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
CC   Virology: Susceptible to infection by herpes simplex virus, vaccinia virus, vesicular stomatitis virus (VSV) and poliovirus type 1 (ATCC=CCL-157).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   DM92
AC   CVCL_F906
SY   Duke Melanoma 92
DR   Wikidata; Q54831266
RX   PubMed=2404572;
RX   PubMed=2785141;
RX   PubMed=11520076;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*01,03; B*15; C*03 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   DM93
AC   CVCL_6629
SY   DM-93; Duke Melanoma 93
DR   BTO; BTO_0002958
DR   GEO; GSM1572811
DR   GEO; GSM1572812
DR   GEO; GSM1572813
DR   GEO; GSM1572814
DR   GEO; GSM1572815
DR   GEO; GSM1572816
DR   Wikidata; Q54831267
RX   PubMed=2404572;
RX   PubMed=2785141;
RX   PubMed=7703289;
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=21654344;
CC   From: Duke University Medical Center; Durham; USA.
CC   Characteristics: Pigmented.
CC   HLA typing: A*02:01,33; B*08,49 (PubMed=10752474).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   DM93-TK
AC   CVCL_E9CG
RX   PubMed=11916247;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6629 ! DM93
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DM93/B7-3
AC   CVCL_ZL69
DR   Wikidata; Q98125914
RX   PubMed=7703289;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6629 ! DM93
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   DMBA-8
AC   CVCL_F716
SY   DMBA#8; DMBA 8; DMBA8
DR   Wikidata; Q54831268
RX   PubMed=3679743;
RX   PubMed=4547337;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   DMBA-8 clone 4
AC   CVCL_F717
DR   Wikidata; Q54831269
RX   PubMed=3679743;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F716 ! DMBA-8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   DMBi001-A
AC   CVCL_ZC40
DR   BioSamples; SAMEA8770926
DR   hPSCreg; DMBi001-A
DR   Wikidata; Q98125916
RX   PubMed=34509921;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   DMBi001-A-1
AC   CVCL_A7LC
DR   BioSamples; SAMEA8770928
DR   hPSCreg; DMBi001-A-1
DR   Wikidata; Q107114814
RX   PubMed=34509921;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6482; LAMA2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC40 ! DMBi001-A
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   DMBi001-A-2
AC   CVCL_C1T0
DR   BioSamples; SAMEA110380676
DR   hPSCreg; DMBi001-A-2
DR   Wikidata; Q114311322
RX   PubMed=36801567;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31543; MIR15A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31545; MIR16-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC40 ! DMBi001-A
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   DMBi002-A
AC   CVCL_B3NY
SY   SMA6.26
DR   hPSCreg; DMBi002-A
DR   Wikidata; Q110432775
RX   PubMed=34678665;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=34678665).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   DMBi003-A
AC   CVCL_B6RS
DR   BioSamples; SAMEA13057983
DR   hPSCreg; DMBi003-A
DR   Wikidata; Q111733159
RX   PubMed=35973333;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   DMBi004-A
AC   CVCL_B6RT
DR   BioSamples; SAMEA13058064
DR   hPSCreg; DMBi004-A
DR   Wikidata; Q111733161
RX   PubMed=35973333;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   DMBi005-A
AC   CVCL_C7FV
DR   hPSCreg; DMBi005-A
DR   Wikidata; Q117704288
RX   PubMed=36565681;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5013; HMOX1; Unexplicit; (GT)>=29 promoter repeat; ClinVar=VCV000015897; Zygosity=Heterozygous (PubMed=36565681).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   DMBi005-A-1
AC   CVCL_C7FW
DR   hPSCreg; DMBi005-A-1
DR   Wikidata; Q117704289
RX   PubMed=36565681;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit_edited; Ex50del; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=36565681).
CC   Sequence variation: Mutation; HGNC; HGNC:5013; HMOX1; Unexplicit; (GT)>=29 promoter repeat; ClinVar=VCV000015897; Zygosity=Heterozygous (PubMed=36565681).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7FV ! DMBi005-A
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   DMBi006-A
AC   CVCL_C7FX
DR   hPSCreg; DMBi006-A
DR   Wikidata; Q117704290
RX   PubMed=36565681;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5013; HMOX1; Unexplicit; (GT)>=29 promoter repeat; ClinVar=VCV000015897; Zygosity=Homozygous (PubMed=36565681).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   DMBi006-A-1
AC   CVCL_C7FY
DR   hPSCreg; DMBi006-A-1
DR   Wikidata; Q117704291
RX   PubMed=36565681;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit_edited; Ex50del; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=36565681).
CC   Sequence variation: Mutation; HGNC; HGNC:5013; HMOX1; Unexplicit; (GT)>=29 promoter repeat; ClinVar=VCV000015897; Zygosity=Homozygous (PubMed=36565681).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7FX ! DMBi006-A
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   DMBi007-A
AC   CVCL_D0E6
SY   30.8
DR   BioSamples; SAMEA114216497
DR   hPSCreg; DMBi007-A
DR   Wikidata; Q123031172
RX   PubMed=37979431;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0E7 ! DMBi008-A
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   DMBi008-A
AC   CVCL_D0E7
SY   300.25
DR   BioSamples; SAMEA114216501
DR   hPSCreg; DMBi008-A
DR   Wikidata; Q123031173
RX   PubMed=37979431;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0E6 ! DMBi007-A
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   DMBi009-A
AC   CVCL_D6HJ
DR   BioSamples; SAMEA114789052
DR   hPSCreg; DMBi009-A
DR   Wikidata; Q127380796
RX   PubMed=38324931;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-9del; Zygosity=Hemizygous (PubMed=38324931).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   DMBi009-A-1
AC   CVCL_D6HK
DR   BioSamples; SAMEA114789068
DR   hPSCreg; DMBi009-A-1
DR   Wikidata; Q127380797
RX   PubMed=38324931;
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit_corrected; Ex3-9del; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=38324931).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6HJ ! DMBi009-A
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   DMBi010-A
AC   CVCL_D6HL
DR   BioSamples; SAMEA115417782
DR   hPSCreg; DMBi010-A
DR   Wikidata; Q127380798
CC   From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128191; Lymphedema-distichiasis syndrome
DI   ORDO; Orphanet_33001; Lymphedema-distichiasis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DMBM-1
AC   CVCL_D561
DR   Wikidata; Q54831270
RX   PubMed=9103234;
CC   Doubling time: 18-22 hours (PubMed=9103234).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   DMBM-2
AC   CVCL_2020
DR   CLO; CLO_0002793
DR   CLDB; cl1075
DR   DSMZ; ACC-269
DR   DSMZCellDive; ACC-269
DR   Wikidata; Q54831271
RX   PubMed=9103234;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Doubling time: 16-20 hours (PubMed=9103234); ~50 hours (DSMZ=ACC-269).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   DMBM-3
AC   CVCL_D562
DR   Wikidata; Q54831272
RX   PubMed=9103234;
CC   Doubling time: 16-20 hours (PubMed=9103234).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   DMBM-4
AC   CVCL_D563
DR   Wikidata; Q54831273
RX   PubMed=9103234;
CC   Doubling time: 30-40 hours (PubMed=9103234).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   DMBM-5
AC   CVCL_D564
DR   Wikidata; Q54831274
RX   PubMed=9103234;
CC   Doubling time: 18-22 hours (PubMed=9103234).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   DMBM-6
AC   CVCL_D565
DR   Wikidata; Q54831275
RX   PubMed=9103234;
CC   Doubling time: 50-60 hours (PubMed=9103234).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   DMD-iPS (DYS-HAC)1
AC   CVCL_C981
DR   SKIP; SKIP001465
DR   Wikidata; Q54831276
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)2
AC   CVCL_C982
DR   SKIP; SKIP001466
DR   Wikidata; Q54831277
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)3
AC   CVCL_C983
DR   SKIP; SKIP001467
DR   Wikidata; Q54831278
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)4
AC   CVCL_C984
DR   SKIP; SKIP001468
DR   Wikidata; Q54831279
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)5
AC   CVCL_C985
DR   SKIP; SKIP001469
DR   Wikidata; Q54831280
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)6
AC   CVCL_C986
DR   SKIP; SKIP001470
DR   Wikidata; Q54831281
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)7
AC   CVCL_C987
DR   SKIP; SKIP001471
DR   Wikidata; Q54831282
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)8
AC   CVCL_C988
DR   SKIP; SKIP001472
DR   Wikidata; Q54831283
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS (DYS-HAC)9
AC   CVCL_C989
DR   SKIP; SKIP001473
DR   Wikidata; Q54831284
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS1 [Human iPSC Boston]
AC   CVCL_C990
SY   DMD-IPS1
DR   Wikidata; Q54831285
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-53del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8521 ! GM04981
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   DMD-iPS1 [Human iPSC Tottori]
AC   CVCL_C991
DR   SKIP; SKIP001474
DR   Wikidata; Q54831286
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMD-iPS2 [Human iPSC Boston]
AC   CVCL_C992
SY   DMD-IPS2
DR   Wikidata; Q54831287
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-53del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8521 ! GM04981
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   DMD-iPS2 [Human iPSC Tottori]
AC   CVCL_C993
DR   SKIP; SKIP001475
DR   Wikidata; Q54831288
RX   PubMed=19997091;
CC   From: Tottori University; Tottori; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   DMDCl2
AC   CVCL_6B26
DR   Wikidata; Q54831289
RX   PubMed=22040608;
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex48-50del; Zygosity=Hemizygous (PubMed=22040608).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   DMEPF-5
AC   CVCL_YB68
SY   Diseased Marbled Eel Pectoral Fin-5
DR   Wikidata; Q93530099
RX   PubMed=30632177;
CC   Group: Fish cell line.
CC   Virology: Infected with both marbled eel adomavirus (MEAdoV) and marbled eel aquareovirus (MERV).
CC   Derived from site: In situ; Pectoral fin; UBERON=UBERON_0000151.
OX   NCBI_TaxID=7939; ! Anguilla marmorata (Giant mottled eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 6
//
ID   DMF10.167.4
AC   CVCL_A2KD
SY   DMF10-167-4
DR   Wikidata; Q105506760
RX   Patent=US8444972;
RX   Patent=WO2004083387A2;
RX   PubMed=16024647;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-405.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60327; Ganglioside GM2.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   DMF10.34.36
AC   CVCL_A2KF
SY   DMF10-34-36
DR   Wikidata; Q105506764
RX   Patent=US8444972;
RX   Patent=WO2004083387A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-404.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60327; Ganglioside GM2.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   DMF10.62.3
AC   CVCL_A2KE
SY   DMF10-62-3
DR   Wikidata; Q105506766
RX   Patent=US8444972;
RX   Patent=WO2004083387A2;
RX   PubMed=10415028;
RX   PubMed=16024647;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-377.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60327; Ganglioside GM2.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   DMS 106
AC   CVCL_Z037
SY   Darmouth Medical School 106
DR   Wikidata; Q54831290
RX   PubMed=6266631;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   DMS 114
AC   CVCL_1174
SY   DMS-114; DMS114; Darmouth Medical School 114
DR   BTO; BTO_0004813
DR   CLO; CLO_0002795
DR   EFO; EFO_0002162
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2066
DR   BioGRID_ORCS_Cell_line; 805
DR   BioSample; SAMN03471429
DR   BioSample; SAMN10988190
DR   cancercelllines; CVCL_1174
DR   Cell_Model_Passport; SIDM00865
DR   ChEMBL-Cells; CHEMBL3307670
DR   ChEMBL-Targets; CHEMBL614642
DR   Cosmic; 687983
DR   Cosmic; 1436016
DR   Cosmic; 2125177
DR   Cosmic; 2648005
DR   Cosmic-CLP; 687983
DR   DepMap; ACH-000530
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10841-111E4
DR   GDSC; 687983
DR   GEO; GSM784211
DR   GEO; GSM886980
DR   GEO; GSM888049
DR   GEO; GSM1374464
DR   GEO; GSM1374465
DR   GEO; GSM1374466
DR   GEO; GSM1669735
DR   GEO; GSM1887902
DR   GEO; GSM1887985
DR   IARC_TP53; 21305
DR   IARC_TP53; 21640
DR   IGRhCellID; DMS114
DR   LiGeA; CCLE_413
DR   LINCS_LDP; LCL-1830
DR   NCI-DTP; DMS-114
DR   PharmacoDB; DMS114_297_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1174
DR   PubChem_Cell_line; CVCL_1174
DR   Wikidata; Q54831291
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=2986244;
RX   PubMed=3335022;
RX   PubMed=6266631;
RX   PubMed=7718330;
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=12712436;
RX   PubMed=15900046;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22336246;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=38180245;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 3.8 days (PubMed=6266631); 1.6 days (PubMed=2986244); 27 hours (PubMed=7718330).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex2-14del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Glu1310Ter (c.3928G>T); Zygosity=Homozygous (DepMap=ACH-000530).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (PubMed=15900046; Cosmic-CLP=687983; DepMap=ACH-000530).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.44%; Native American=0.11%; East Asian, North=2.38%; East Asian, South=0%; South Asian=0%; European, North=55.93%; European, South=41.14% (PubMed=30894373).
CC   Caution: Originally classified as originating from a lung small cell carcinoma, but is reclassified as a thoracic SMARCA4-deficient undifferentiated tumor based on a number of criteria (PubMed=38180245).
CC   Misspelling: DMS 144; FANTOM5_SSTAR=10841-111E4.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-2066; Cosmic-CLP=687983
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 11,13
ST   Penta E: 7,13
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C183115; Thoracic SMARCA4-deficient undifferentiated tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   DMS 139
AC   CVCL_Z038
SY   Darmouth Medical School 139
DR   Wikidata; Q54831292
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Doubling time: 35 days (PubMed=6266631; PubMed=2986244).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z039 ! DMS 148
OI   CVCL_Z040 ! DMS 149
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DMS 148
AC   CVCL_Z039
SY   Darmouth Medical School 148
DR   Wikidata; Q54831293
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Doubling time: 28-35 days (PubMed=6266631; PubMed=2986244).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z038 ! DMS 139
OI   CVCL_Z040 ! DMS 149
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DMS 149
AC   CVCL_Z040
SY   Darmouth Medical School 149
DR   Wikidata; Q54831294
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Doubling time: 28-35 days (PubMed=6266631; PubMed=2986244).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z038 ! DMS 139
OI   CVCL_Z039 ! DMS 148
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   DMS 153
AC   CVCL_1175
SY   DMS-153; DMS153; Darmouth Medical School 153
DR   CLO; CLO_0002796
DR   EFO; EFO_0002163
DR   CLDB; cl1078
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2064
DR   BioSample; SAMN03471428
DR   BioSample; SAMN03472954
DR   BioSample; SAMN10988118
DR   cancercelllines; CVCL_1175
DR   CCRID; 1101HUM-PUMC000397
DR   CCRID; 4201HUM-CCTCC00167
DR   CCTCC; GDC0167
DR   Cell_Model_Passport; SIDM01504
DR   ChEMBL-Cells; CHEMBL3308260
DR   ChEMBL-Targets; CHEMBL2366167
DR   Cosmic; 687984
DR   Cosmic; 2125220
DR   Cosmic; 2648004
DR   DepMap; ACH-000594
DR   ECACC; 95062827
DR   GDSC; 687984
DR   GEO; GSM827561
DR   GEO; GSM886981
DR   GEO; GSM888050
DR   IARC_TP53; 19177
DR   IARC_TP53; 21306
DR   IGRhCellID; DMS153
DR   LiGeA; CCLE_646
DR   LINCS_LDP; LCL-1831
DR   PharmacoDB; DMS153_298_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_1175
DR   PubChem_Cell_line; CVCL_1175
DR   Wikidata; Q54831295
RX   PubMed=2986244;
RX   PubMed=6266631;
RX   PubMed=9744504;
RX   PubMed=12712436;
RX   PubMed=14660794;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 28 days (PubMed=6266631); 5.8 days (PubMed=2986244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Pro (c.463A>C); Zygosity=Homozygous (PubMed=14660794; DepMap=ACH-000594).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.64%; Native American=0.56%; East Asian, North=3.7%; East Asian, South=0%; South Asian=0%; European, North=51.44%; European, South=43.66% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-2064; CCRID; ECACC=95062827; PubMed=25877200
ST   Amelogenin: X (ATCC=CRL-2064; CCRID)
ST   Amelogenin: X,Y (ECACC=95062827; PubMed=25877200)
ST   CSF1PO: 10
ST   D13S317: 12,13 (PubMed=25877200)
ST   D13S317: 13 (ATCC=CRL-2064; CCRID; ECACC=95062827)
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D19S433: 12.1,15
ST   D21S11: 26.2,30
ST   D2S1338: 17,20
ST   D3S1358: 14,17 (PubMed=25877200)
ST   D3S1358: 17 (ATCC=CRL-2064; CCRID)
ST   D5S818: 12
ST   D6S1043: 11,18
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 12 (ATCC=CRL-2064; CCRID)
ST   Penta E: 12,13 (PubMed=25877200)
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z033 ! DMS 154
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   DMS 154
AC   CVCL_Z033
SY   Darmouth Medical School 154
DR   Wikidata; Q54831296
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Population: Caucasian.
CC   Doubling time: 35 days (PubMed=6266631; PubMed=2986244).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1175 ! DMS 153
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   DMS 187
AC   CVCL_Z041
DR   GEO; GSM1887903
DR   GEO; GSM1887986
DR   Wikidata; Q54831297
RX   PubMed=2986244;
RX   PubMed=3335022;
RX   PubMed=6266631;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=32586373;
CC   Doubling time: 8 days (PubMed=6266631); 4.1 days (PubMed=2986244).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   DMS 217
AC   CVCL_Z042
SY   Darmouth Medical School 217
DR   Wikidata; Q54831298
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Doubling time: 28 days (PubMed=6266631; PubMed=2986244).
CC   Derived from site: Metastatic; Pericardial mass; UBERON=UBERON_8480061.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DMS 235
AC   CVCL_Z043
SY   Darmouth Medical School 235
DR   Wikidata; Q54831299
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Doubling time: 8.5 days (PubMed=6266631); 4.6 days (PubMed=2986244).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DMS 240
AC   CVCL_JZ18
SY   DMS-240; DMS240; Darmouth Medical School 240
DR   Wikidata; Q54831300
RX   PubMed=2986244;
CC   Doubling time: 4.6 days (PubMed=2986244).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 7
//
ID   DMS 273
AC   CVCL_1176
SY   DMS-273; DMS273; Darmouth Medical School 273
DR   BTO; BTO_0005903
DR   CLO; CLO_0002797
DR   EFO; EFO_0002164
DR   CLDB; cl1079
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472955
DR   BioSample; SAMN10987982
DR   cancercelllines; CVCL_1176
DR   Cell_Model_Passport; SIDM00522
DR   ChEMBL-Cells; CHEMBL3308487
DR   ChEMBL-Targets; CHEMBL614034
DR   Cosmic; 687985
DR   Cosmic; 1436015
DR   Cosmic; 1609521
DR   Cosmic; 2125191
DR   Cosmic; 2648003
DR   Cosmic-CLP; 687985
DR   DepMap; ACH-000749
DR   ECACC; 95062830
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687985
DR   GEO; GSM827419
DR   GEO; GSM886982
DR   GEO; GSM888051
DR   GEO; GSM1669736
DR   GEO; GSM1887904
DR   GEO; GSM1887987
DR   IARC_TP53; 21307
DR   IGRhCellID; DMS273
DR   LiGeA; CCLE_304
DR   LINCS_LDP; LCL-1807
DR   PharmacoDB; DMS273_299_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1176
DR   PubChem_Cell_line; CVCL_1176
DR   Wikidata; Q54831301
RX   PubMed=2041050;
RX   PubMed=2986244;
RX   PubMed=3335022;
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=12712436;
RX   PubMed=15900046;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22336246;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/dms273-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 6.2 days (PubMed=2986244).
CC   HLA typing: A*03:01,23:01; B*35:03,44:03; C*04:01,04:01; DRB1*07:01,07:01 (PubMed=25960936).
CC   HLA typing: A*03:01,23:01; B*35:03,44:03; C*04:01,04:01; DRB1*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Asp173del (c.511_513delGAT); Zygosity=Heterozygous (Cosmic-CLP=687985; DepMap=ACH-000749).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Homozygous (PubMed=15900046; Cosmic-CLP=687985; DepMap=ACH-000749).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.51%; Native American=0.88%; East Asian, North=1.83%; East Asian, South=0%; South Asian=0%; European, North=66.84%; European, South=29.94% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=687985; ECACC=95062830; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 12,16
ST   D21S11: 28,31
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 13
ST   TH01: 9.3
ST   TPOX: 10
ST   vWA: 15
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   DMS 406
AC   CVCL_0B91
SY   DMS-406; DMS406; Darmouth Medical School 406
DR   Cosmic; 2648002
DR   Wikidata; Q54831302
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=12712436;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   DMS 44
AC   CVCL_Z034
SY   Darmouth Medical School 44
DR   Wikidata; Q54831303
RX   PubMed=190410;
RX   PubMed=222962;
RX   PubMed=6266631;
CC   Doubling time: 2 weeks (PubMed=6266631).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DMS 454
AC   CVCL_2438
SY   DMS-454; DMS454; Darmouth Medical School 454
DR   CLO; CLO_0002798
DR   EFO; EFO_0006390
DR   CLDB; cl1080
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472956
DR   BioSample; SAMN10987979
DR   cancercelllines; CVCL_2438
DR   Cell_Model_Passport; SIDM01503
DR   DepMap; ACH-000844
DR   ECACC; 95062832
DR   EGA; EGAS00001000610
DR   GEO; GSM886983
DR   GEO; GSM888052
DR   IARC_TP53; 28369
DR   LiGeA; CCLE_801
DR   PharmacoDB; DMS454_296_2019
DR   Progenetix; CVCL_2438
DR   Wikidata; Q54831307
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*18:01,51:01; C*12:03,14:02 (PubMed=25960936).
CC   HLA typing: A*02:01,24:02; B*18:01,51:01; C*12:03,14:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (DepMap=ACH-000844).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.12%; Native American=0.07%; East Asian, North=2.95%; East Asian, South=0%; South Asian=0%; European, North=58.47%; European, South=36.39% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ECACC=95062832; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 10,14
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   DMS 456
AC   CVCL_0B92
SY   DMS-456; DMS456; Darmouth Medical School 456
DR   Cosmic; 2648001
DR   Wikidata; Q54831308
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=12712436;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   DMS 47
AC   CVCL_Z035
SY   Darmouth Medical School 47
DR   Wikidata; Q54831309
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Doubling time: 28 days (PubMed=6266631; PubMed=2986244).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DMS 53
AC   CVCL_1177
SY   DMS-53; DMS53; Darmouth Medical School 53
DR   BTO; BTO_0005668
DR   CLO; CLO_0002799
DR   EFO; EFO_0002165
DR   CLDB; cl1081
DR   AddexBio; C0016027/4988
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2062
DR   BioSample; SAMN03472957
DR   BioSample; SAMN10987596
DR   cancercelllines; CVCL_1177
DR   Cell_Model_Passport; SIDM00523
DR   ChEMBL-Cells; CHEMBL3308726
DR   ChEMBL-Targets; CHEMBL1075434
DR   Cosmic; 907295
DR   Cosmic; 1995386
DR   Cosmic; 2125221
DR   Cosmic; 2648008
DR   Cosmic-CLP; 907295
DR   DepMap; ACH-000698
DR   ECACC; 95062823
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907295
DR   GEO; GSM17307
DR   GEO; GSM169436
DR   GEO; GSM170721
DR   GEO; GSM170722
DR   GEO; GSM886984
DR   GEO; GSM888053
DR   GEO; GSM1669737
DR   GEO; GSM1887955
DR   GEO; GSM1888032
DR   IARC_TP53; 21308
DR   IGRhCellID; DMS53
DR   LiGeA; CCLE_721
DR   LINCS_LDP; LCL-1808
DR   PharmacoDB; DMS53_300_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1177
DR   PubChem_Cell_line; CVCL_1177
DR   Wikidata; Q54831310
RX   PubMed=2986244;
RX   PubMed=6266631;
RX   PubMed=9744504;
RX   PubMed=12712436;
RX   PubMed=15016488;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32586373;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=DMS%2053
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 5.7 days (PubMed=6266631); 4.9 days (PubMed=2986244).
CC   HLA typing: A*01:01,03:01; B*08:01,35:03; C*04:01,07:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,14:76 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*08:01,35:03; C*04:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Heterozygous (Cosmic-CLP=907295; DepMap=ACH-000698).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (Cosmic-CLP=907295; DepMap=ACH-000698).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.98%; Native American=0%; East Asian, North=4.32%; East Asian, South=0%; South Asian=0%; European, North=55.34%; European, South=37.36% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016027/4988; ATCC=CRL-2062; Cosmic-CLP=907295; ECACC=95062823; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 13
ST   D21S11: 33.2
ST   D2S1338: 25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 12
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 13
ST   TH01: 8,9.3
ST   TPOX: 12
ST   vWA: 15,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   DMS 53 HTT KO
AC   CVCL_D6U0
RX   PubMed=39257448;
CC   From: Fanti, Rebeka; Structural Genomics Consortium, University of Toronto; Toronto; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1177 ! DMS 53
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   DMS 55
AC   CVCL_Z036
SY   Darmouth Medical School 55
DR   Wikidata; Q54831311
RX   PubMed=2986244;
RX   PubMed=6266631;
CC   Doubling time: 6 days (PubMed=6266631); 4.8 days (PubMed=2986244).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DMS 79
AC   CVCL_1178
SY   DMS-79; DMS79; Darmouth Medical School 79
DR   CLO; CLO_0002800
DR   CLO; CLO_0002802
DR   EFO; EFO_0002166
DR   CLDB; cl1082
DR   CLDB; cl4907
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2049
DR   BioSample; SAMN03473247
DR   BioSample; SAMN10988337
DR   cancercelllines; CVCL_1178
DR   Cell_Model_Passport; SIDM00524
DR   ChEMBL-Cells; CHEMBL3307581
DR   ChEMBL-Targets; CHEMBL614286
DR   CLS; 300164
DR   Cosmic; 753551
DR   Cosmic; 1609526
DR   Cosmic; 2648007
DR   Cosmic-CLP; 753551
DR   DepMap; ACH-000703
DR   ECACC; 95062824
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753551
DR   GEO; GSM17308
DR   GEO; GSM169445
DR   GEO; GSM886985
DR   GEO; GSM888054
DR   GEO; GSM1669738
DR   GEO; GSM1887956
DR   GEO; GSM1888033
DR   IARC_TP53; 21309
DR   ICLC; HTL98009
DR   IGRhCellID; DMS79
DR   LiGeA; CCLE_666
DR   LINCS_LDP; LCL-1832
DR   PharmacoDB; DMS79_301_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1178
DR   PubChem_Cell_line; CVCL_1178
DR   Wikidata; Q54831312
RX   PubMed=2986244;
RX   PubMed=6266631;
RX   PubMed=8383976;
RX   PubMed=9744504;
RX   PubMed=12712436;
RX   PubMed=15016488;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32586373;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-growth-of-item-crl-2049
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=DMS%2079
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 3.9 days (PubMed=6266631); 5.8 days (PubMed=2986244); ~4 days (CLS=300164).
CC   HLA typing: A*01:01,02:01; B*08:01,35:01; C*04:01,07:01; DQB1*03:09,05:03; DRB1*11:30,11:30 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*08:01,35:01; C*04:01,07:01; DQB1*03:09,05:03; DRB1*11:30,11:30 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9683; PTPRU; Simple; p.Glu442Ter (c.1324G>T); Zygosity=Heterozygous (Cosmic-CLP=753551; DepMap=ACH-000703).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly801Ter (c.2401G>T); ClinVar=VCV002751030; Zygosity=Homozygous (Cosmic-CLP=753551; DepMap=ACH-000703).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Glufs*65 (c.837delG) (p.G279fs); Zygosity=Unspecified (DepMap=ACH-000703).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.52%; Native American=0%; East Asian, North=0.95%; East Asian, South=0%; South Asian=1.45%; European, North=66.84%; European, South=30.24% (PubMed=30894373).
CC   Misspelling: DMS76; Note=In text of PubMed 20439192.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2049; CLS=300164; Cosmic-CLP=753551; ECACC=95062824; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 13.2,15
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 18
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 21
ST   Penta D: 11,13
ST   Penta E: 7
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   DMS 92
AC   CVCL_2439
SY   DMS-92; DMS92; Darmouth Medical School 92
DR   CLO; CLO_0002801
DR   CLDB; cl1083
DR   BioSample; SAMN03472958
DR   cancercelllines; CVCL_2439
DR   Cosmic; 929980
DR   Cosmic; 2648006
DR   Cosmic; 2668271
DR   ECACC; 95062825
DR   GEO; GSM827447
DR   IARC_TP53; 120
DR   Progenetix; CVCL_2439
DR   Wikidata; Q54831313
RX   PubMed=1855224;
RX   PubMed=2986244;
RX   PubMed=6266631;
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=20215515;
RX   PubMed=25877200;
CC   Doubling time: 5.5 days (PubMed=6266631; PubMed=2986244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (PubMed=1855224).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ECACC=95062825; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D21S11: 28,31
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   DMSCi001-A
AC   CVCL_E3UB
DR   BioSamples; SAMEA114786335
DR   hPSCreg; DMSCi001-A
RX   PubMed=39504763;
CC   From: Department of Medical Sciences (DMSC); Nonthaburi; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   DMSCi002-A
AC   CVCL_E3UC
DR   BioSamples; SAMEA115832302
DR   hPSCreg; DMSCi002-A
RX   PubMed=39778439;
CC   From: Department of Medical Sciences (DMSC); Nonthaburi; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   DMyc3-45
AC   CVCL_U810
DR   CLO; CLO_0050241
DR   RCB; RCB1606
DR   Wikidata; Q54831314
RX   PubMed=10590261;
CC   Characteristics: T-cell hybridoma expressing double Myc-tagged Hs1bp3-C2.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1913224; Hs1bp3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4163 ! Do-11-10
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 6
//
ID   DMyc9-36
AC   CVCL_U811
DR   CLO; CLO_0050244
DR   RCB; RCB1610
DR   Wikidata; Q54831315
RX   PubMed=10590261;
CC   Characteristics: T-cell hybridoma expressing double Myc-tagged Hs1bp3.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1913224; Hs1bp3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4163 ! Do-11-10
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 6
//
ID   DN-30
AC   CVCL_IQ99
SY   DN30
DR   Wikidata; Q54831316
RX   Patent=EP2127683A1;
RX   PubMed=9405310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 05006.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   DN435.5
AC   CVCL_V372
DR   IPD-IMGT/HLA; 14468
DR   Wikidata; Q54831317
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:02,25:05; B*14:02,18:01; C*08:02,12:03; DQB1*03:01,06:02; DRB1*13:03,15:01 (IPD-IMGT/HLA=14468).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   DNA 1
AC   CVCL_C4XY
SY   DNA1
DR   Wikidata; Q116048843
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 10
AC   CVCL_C4XZ
SY   DNA10
DR   Wikidata; Q116048844
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 11
AC   CVCL_C4Y0
SY   DNA11
DR   ABCD; ABCD_AE221
DR   Wikidata; Q116048845
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 12
AC   CVCL_C4Y1
SY   DNA12
DR   ABCD; ABCD_AE222
DR   Wikidata; Q116048847
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 13
AC   CVCL_C4Y2
SY   DNA13
DR   ABCD; ABCD_AE223
DR   Wikidata; Q116048848
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 2
AC   CVCL_C4Y3
SY   DNA2
DR   ABCD; ABCD_AE220
DR   Wikidata; Q116048849
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 3
AC   CVCL_C4Y4
SY   DNA3
DR   ABCD; ABCD_AE225
DR   Wikidata; Q116048850
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 4
AC   CVCL_C4Y5
SY   DNA4
DR   ABCD; ABCD_AE224
DR   Wikidata; Q116048851
RX   PubMed=2118934;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 5
AC   CVCL_C4Y6
SY   DNA5
DR   ABCD; ABCD_AE227
DR   Wikidata; Q116048852
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 6
AC   CVCL_C4Y7
SY   DNA6
DR   ABCD; ABCD_AE226
DR   Wikidata; Q116048854
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 7
AC   CVCL_C4Y8
SY   DNA7
DR   ABCD; ABCD_AE228
DR   Wikidata; Q116048855
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 8
AC   CVCL_C4Y9
SY   DNA8
DR   Wikidata; Q116048856
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DNA 9
AC   CVCL_C4YA
SY   DNA9
DR   ABCD; ABCD_AE219
DR   Wikidata; Q116048857
RX   PubMed=2118934;
RX   PubMed=2786025;
RX   PubMed=7198664;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=ssDNA>dsDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   DND-10B
AC   CVCL_E994
SY   DND
DR   Cosmic; 733813
DR   IARC_TP53; 23622
DR   Wikidata; Q54831318
RX   CelloPub=CLPUB00035;
RX   PubMed=1568228;
RX   PubMed=3334988;
CC   Doubling time: 48 hours (CelloPub=CLPUB00035).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   DND-39
AC   CVCL_2021
SY   DND39
DR   BioSample; SAMN03473461
DR   CGH-DB; 9197-4
DR   Cosmic; 919151
DR   DSMZ; ACC-648
DR   DSMZCellDive; ACC-648
DR   Wikidata; Q54831319
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=9510473;
CC   Virology: EBV-negative.
CC   Doubling time: ~30-50 hours (DSMZ=ACC-648).
CC   Misspelling: OND39; PubMed=9510473.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-648
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11
ST   FGA: 20,22
ST   Penta D: 10,13
ST   Penta E: 11,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 22
//
ID   DND-41
AC   CVCL_2022
SY   DND 41; DND41; Dnd41
DR   CLO; CLO_0009834
DR   EFO; EFO_0007074
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473521
DR   BioSample; SAMN10988451
DR   cancercelllines; CVCL_2022
DR   Cell_Model_Passport; SIDM00946
DR   Cosmic; 721705
DR   Cosmic; 801725
DR   Cosmic; 913405
DR   Cosmic; 933551
DR   Cosmic; 944546
DR   Cosmic; 998728
DR   Cosmic; 1037686
DR   Cosmic; 1115582
DR   Cosmic; 1118466
DR   Cosmic; 1151777
DR   Cosmic; 1175127
DR   Cosmic; 1224375
DR   Cosmic; 1281366
DR   Cosmic; 1330488
DR   Cosmic; 1375579
DR   Cosmic; 1524795
DR   Cosmic; 1641377
DR   Cosmic; 1664514
DR   Cosmic; 1760521
DR   Cosmic; 2165710
DR   Cosmic; 2602912
DR   Cosmic-CLP; 1297446
DR   DepMap; ACH-000981
DR   DSMZ; ACC-525
DR   DSMZCellDive; ACC-525
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS282AAA
DR   ENCODE; ENCBS439IWV
DR   ENCODE; ENCBS688JZQ
DR   GDSC; 1297446
DR   GEO; GSM886986
DR   GEO; GSM888055
DR   GEO; GSM1669739
DR   GEO; GSM5137715
DR   IARC_TP53; 10567
DR   LiGeA; CCLE_079
DR   LINCS_LDP; LCL-1036
DR   Lonza; 1410
DR   NCBI_Iran; C183
DR   PharmacoDB; DND41_302_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2022
DR   Wikidata; Q54831320
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=9933131;
RX   PubMed=10071127;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=15472075;
RX   PubMed=17170727;
RX   PubMed=17308084;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Dnd41_Bernstein_protocol.pdf
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/dnd-41/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~35 hours (DSMZ=ACC-525).
CC   HLA typing: A*02:01:01,32:01:01; B*15:17:01,27:05:02; C*01:02:01,07:01:02 (DSMZCellDive=ACC-525).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:13532; TLX3; Name(s)=TLX3-BCL11B, HOX11L2-BCL11B (PubMed=17308084; PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gln71Ter (c.211C>T); ClinVar=VCV002183948; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=1297446).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Ala279Thr (c.835G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=1297446).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593Pro (c.4778T>C); ClinVar=VCV001719188; Zygosity=Heterozygous (PubMed=15472075; PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp1609Val (c.4826A>T); Zygosity=Heterozygous (PubMed=15472075; PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Val2443fs*35 (c.7327_7327G>TGT); Zygosity=Heterozygous (PubMed=15472075; PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=1297446; DepMap=ACH-000981).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; p.Gln127Ter (c.379C>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=1297446).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Asp421Asn (c.1261G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=1297446).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Ser1002Asn (c.3005G>A); ClinVar=VCV000241355; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=1297446).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg373Gly (c.1117A>G); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=1297446).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=10071127; Cosmic-CLP=1297446).
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.28%; Native American=0%; East Asian, North=1%; East Asian, South=0%; South Asian=4.99%; European, North=46.97%; European, South=45.76% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=1297446; DSMZ=ACC-525
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 10,14
ST   D18S51: 12,17
ST   D19S433: 12,13
ST   D21S11: 29,32.2
ST   D2S1338: 18,22
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 22,26
ST   Penta D: 11,13
ST   Penta E: 7,12
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   DNI.Bl
AC   CVCL_R958
DR   ATCC; CRL-6002
DR   Wikidata; Q54831321
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6002; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R959 ! DNI.F
OI   CVCL_R960 ! DNI.Ht
OI   CVCL_R961 ! DNI.K
OI   CVCL_R962 ! DNI.Lu
OI   CVCL_R963 ! DNI.Sk
OI   CVCL_R964 ! DNI.Sp
OI   CVCL_3676 ! DNI.Tr
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DNI.F
AC   CVCL_R959
DR   ATCC; CRL-6003
DR   Wikidata; Q54831322
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6003; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R958 ! DNI.Bl
OI   CVCL_R960 ! DNI.Ht
OI   CVCL_R961 ! DNI.K
OI   CVCL_R962 ! DNI.Lu
OI   CVCL_R963 ! DNI.Sk
OI   CVCL_R964 ! DNI.Sp
OI   CVCL_3676 ! DNI.Tr
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DNI.Ht
AC   CVCL_R960
DR   ATCC; CRL-6004
DR   Wikidata; Q54831323
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6004; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R958 ! DNI.Bl
OI   CVCL_R959 ! DNI.F
OI   CVCL_R961 ! DNI.K
OI   CVCL_R962 ! DNI.Lu
OI   CVCL_R963 ! DNI.Sk
OI   CVCL_R964 ! DNI.Sp
OI   CVCL_3676 ! DNI.Tr
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DNI.K
AC   CVCL_R961
DR   ATCC; CRL-6005
DR   Wikidata; Q54831324
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6005; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R958 ! DNI.Bl
OI   CVCL_R959 ! DNI.F
OI   CVCL_R960 ! DNI.Ht
OI   CVCL_R962 ! DNI.Lu
OI   CVCL_R963 ! DNI.Sk
OI   CVCL_R964 ! DNI.Sp
OI   CVCL_3676 ! DNI.Tr
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DNI.Lu
AC   CVCL_R962
DR   ATCC; CRL-6006
DR   Wikidata; Q54831325
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6006; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R958 ! DNI.Bl
OI   CVCL_R959 ! DNI.F
OI   CVCL_R960 ! DNI.Ht
OI   CVCL_R961 ! DNI.K
OI   CVCL_R963 ! DNI.Sk
OI   CVCL_R964 ! DNI.Sp
OI   CVCL_3676 ! DNI.Tr
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DNI.Sk
AC   CVCL_R963
DR   ATCC; CRL-6007
DR   Wikidata; Q54831326
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6007; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R958 ! DNI.Bl
OI   CVCL_R959 ! DNI.F
OI   CVCL_R960 ! DNI.Ht
OI   CVCL_R961 ! DNI.K
OI   CVCL_R962 ! DNI.Lu
OI   CVCL_R964 ! DNI.Sp
OI   CVCL_3676 ! DNI.Tr
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DNI.Sp
AC   CVCL_R964
DR   ATCC; CRL-6008
DR   Wikidata; Q54831327
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6008; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R958 ! DNI.Bl
OI   CVCL_R959 ! DNI.F
OI   CVCL_R960 ! DNI.Ht
OI   CVCL_R961 ! DNI.K
OI   CVCL_R962 ! DNI.Lu
OI   CVCL_R963 ! DNI.Sk
OI   CVCL_3676 ! DNI.Tr
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   DNI.Tr
AC   CVCL_3676
DR   CLO; CLO_0002803
DR   ATCC; CRL-6009
DR   Wikidata; Q54831328
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
OI   CVCL_R958 ! DNI.Bl
OI   CVCL_R959 ! DNI.F
OI   CVCL_R960 ! DNI.Ht
OI   CVCL_R961 ! DNI.K
OI   CVCL_R962 ! DNI.Lu
OI   CVCL_R963 ! DNI.Sk
OI   CVCL_R964 ! DNI.Sp
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   DNL1.9
AC   CVCL_D6SV
SY   DNL-1.9; DNL 1.9
RX   PubMed=6678795;
RX   PubMed=6788569;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45 (Note=Recognizes exon C, CD45RC isoform).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   DNL3.7
AC   CVCL_D6UL
RX   PubMed=6678795;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse antigen on bone marrow cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   DNL4.4
AC   CVCL_D6UM
RX   PubMed=6678795;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse antigen on myeloid cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Dnmt1-/- ES (clone 36)
AC   CVCL_JY34
SY   Dnmt1(c/c) clone 36
DR   RCB; AES0161
DR   SKIP; SKIP002990
DR   Wikidata; Q54831329
RX   PubMed=8898232;
RX   PubMed=10555141;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:94912; Dnmt1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6412 ! J1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   Dnmt1-/-Dnmt3a-/-Dnmt3b-/- ES (clone19)
AC   CVCL_1T48
DR   RCB; AES0146
DR   SKIP; SKIP003036
DR   Wikidata; Q54831330
RX   PubMed=16824199;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:94912; Dnmt1.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1261827; Dnmt3a.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1261819; Dnmt3b.
CC   Discontinued: RCB; AES0146; probable.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6412 ! J1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   Dnmt1(Y495C)-1
AC   CVCL_B3PW
SY   Dnmt1Y495C-1
DR   Wikidata; Q110432776
RX   PubMed=34634759;
CC   From: Birla Institute of Technology and Science Pilani, Hyderabad Campus; Hyderabad; India.
CC   Genetic integration: Method=Homologous recombination; Gene=MGI; MGI:94912; Dnmt1 (Note=With p.Tyr501Cys; equivalent to human p.Tyr495Cys).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   Dnmt3a-/- ES (clone 6aa)
AC   CVCL_0J16
SY   Line 6aa
DR   RCB; AES0164
DR   SKIP; SKIP002991
DR   Wikidata; Q54831331
RX   PubMed=10555141;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1261827; Dnmt3a.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6412 ! J1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Dnmt3b-/- ES (clone 8bb)
AC   CVCL_0J17
SY   Line 8bb
DR   RCB; AES0165
DR   SKIP; SKIP002922
DR   Wikidata; Q54831332
RX   PubMed=10555141;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1261819; Dnmt3b.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6412 ! J1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   DNRR1
AC   CVCL_M723
DR   Wikidata; Q54831333
RX   PubMed=6135505;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_M722 ! CHO-AUXE29
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   DNRR15
AC   CVCL_M724
DR   Wikidata; Q54831334
RX   PubMed=6135505;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_M722 ! CHO-AUXE29
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   DNRR159
AC   CVCL_M725
DR   Wikidata; Q54831335
RX   PubMed=2412130;
RX   PubMed=6135505;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_M722 ! CHO-AUXE29
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   DNRR5
AC   CVCL_M726
DR   Wikidata; Q54831336
RX   PubMed=6135505;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   DNRR51
AC   CVCL_M727
DR   Wikidata; Q54831337
RX   PubMed=2412130;
RX   PubMed=6135505;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   Do MG(R) 1
AC   CVCL_C8RI
DR   Wikidata; Q123031174
RX   PubMed=730773;
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8RB ! L6D
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   Do-11-10
AC   CVCL_4163
SY   DO-11.10; DO 11.10; Do11.10; DO11.10
DR   BTO; BTO_0004333
DR   EFO; EFO_0022775
DR   ECACC; 85082301
DR   Lonza; 881
DR   TOKU-E; 4126
DR   Wikidata; Q54831338
RX   PubMed=6185566;
RX   PubMed=10200546;
RX   PubMed=10590261;
RX   PubMed=23110081;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-77.html
CC   Characteristics: T-cell hybridoma originally elicited by vaccination of BALB/c mice (H-2d haplotype) with chicken ovalbumin. Popular model system to study CD4+ T cell responses.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Do-11-10 mutant 51
AC   CVCL_WK48
SY   DO11.10 mutant 51; Mutant 51
DR   Wikidata; Q93530601
RX   PubMed=10200546;
CC   Characteristics: T-cell hybridoma that has defects in the TCR-mediated apoptotic pathway (reduced death in response to dexamethasone).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4163 ! Do-11-10
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   DO-24
AC   CVCL_IR00
DR   Wikidata; Q54831339
RX   PubMed=9405310;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   DO-m
AC   CVCL_C4N3
SY   DO-monolayer
DR   Wikidata; Q116048858
RX   PubMed=2548714;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5478 ! DO-s
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DO-s
AC   CVCL_5478
SY   DO-suspension
DR   Wikidata; Q54831340
RX   PubMed=2548714;
CC   Doubling time: ~47 hours (PubMed=2548714).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4N3 ! DO-m
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   DO208915
AC   CVCL_E540
SY   D0208915; DO 208915; WIL-JON
DR   dbMHC; 48738
DR   ECACC; 95010407
DR   IHW; IHW09008
DR   IPD-IMGT/HLA; 10516
DR   Wikidata; Q54831341
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*25:01:01; B*18:01:01:02; C*12:03:01:01; DPA1*01:03:01; DPB1*02:01:02/02:01:19,23:01:01; DQA1*01:02:01,01:02:02; DQB1*06:02:01,06:03:01; DRA*01:02; DRB1*15:01:01; DRB5*01:01; DRB6*02:01 (IPD-IMGT/HLA=10516).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   DOBIL-6
AC   CVCL_M490
SY   DOBIL6
DR   Wikidata; Q54831342
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9674742;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Non-secretory.
CC   Doubling time: ~36 hours (PubMed=9674742).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   DOBSKI
AC   CVCL_C8GL
DR   Wikidata; Q123031175
RX   PubMed=15585611;
RX   PubMed=18698046;
RX   PubMed=22892449;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*01,02; B*08,51; C*07,14 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DoCl1 (S+L-)
AC   CVCL_4164
SY   S+L- DoCl1
DR   CLO; CLO_0002804
DR   CLDB; cl1085
DR   ATCC; CCL-34.1
DR   ECACC; 90102523
DR   Wikidata; Q54831343
RX   PubMed=52940;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   Dog-OralMel-18249
AC   CVCL_C0MM
DR   Wikidata; Q112929459
RX   CelloPub=CLPUB00708;
RX   PubMed=35053440;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Sex, age and breed of donor from personal communication of Hedan, Benoit.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Shih Tzu; VBO=VBO_0201223.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10-11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   Dog-OralMel-18333
AC   CVCL_C0MN
DR   Wikidata; Q112929460
RX   CelloPub=CLPUB00708;
RX   PubMed=35053440;
CC   Sequence variation: Gene deletion; VGNC; VGNC:109332; CDKN2A; Zygosity=Unspecified (CelloPub=CLPUB00708).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: Exact sampling site, sex, age and breed of donor from personal communication of Hedan, Benoit.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   14-15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Dog-OralMel-18395
AC   CVCL_C0MP
DR   Wikidata; Q112929461
RX   CelloPub=CLPUB00708;
RX   PubMed=35053440;
CC   Sequence variation: Gene deletion; VGNC; VGNC:109332; CDKN2A; Zygosity=Unspecified (CelloPub=CLPUB00708).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: Sex, age and breed of donor from personal communication of Hedan, Benoit.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Dog-OralMel-18657
AC   CVCL_C0MQ
DR   Wikidata; Q112929462
RX   CelloPub=CLPUB00708;
RX   PubMed=35053440;
CC   Miscellaneous: Exact sampling site, sex, age and breed of donor from personal communication of Hedan, Benoit.
CC   Derived from site: In situ; Oral cavity, palate; UBERON=UBERON_0001716.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   Dog-OralMel-18848
AC   CVCL_C0MR
DR   Wikidata; Q112929463
RX   CelloPub=CLPUB00708;
RX   PubMed=35053440;
CC   Miscellaneous: Sex, age and breed of donor from personal communication of Hedan, Benoit.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Yorkshire Terrier; VBO=VBO_0201448.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   DoGKiT
AC   CVCL_2023
SY   DOGKIT
DR   BioSample; SAMN03473509
DR   DSMZ; ACC-629
DR   DSMZCellDive; ACC-629
DR   Wikidata; Q54831344
RX   PubMed=17562080;
RX   PubMed=17622530;
RX   PubMed=26727417;
CC   Virology: EBV-negative.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-629
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 15,16
ST   Penta E: 7,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   DogL1
AC   CVCL_BS94
SY   Dog Lung-1
DR   CCRID; 5301CAN-KCB90014ZJ
DR   KCB; KCB 90014ZJ
DR   Wikidata; Q54831345
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   DogMTC
AC   CVCL_WS15
DR   Wikidata; Q93530688
RX   PubMed=31144267;
CC   Doubling time: 33.3 hours (PubMed=31144267).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned one temporarily pending the authors responding to our emails.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
DI   NCIt; C161006; Canine thyroid gland medullary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 7
//
ID   DOGUM
AC   CVCL_2024
SY   DoGum
DR   BioSample; SAMN03473458
DR   DepMap; ACH-001493
DR   DSMZ; ACC-644
DR   DSMZCellDive; ACC-644
DR   Wikidata; Q54831346
RX   PubMed=17562080;
RX   PubMed=26727417;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Virology: EBV-negative.
CC   Doubling time: ~50 hours, ~100 hours (Note=After recovery from liquid nitrogen freezing) (DSMZ=ACC-644).
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, centroblastic-type.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-644
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 14,16
ST   D21S11: 29,30
ST   D2S1338: 25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 12,17
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
ID   DoHH2
AC   CVCL_1179
SY   DOHH2; DoHH-2; DOHH-2
DR   CLO; CLO_0002805
DR   CLO; CLO_0037050
DR   EFO; EFO_0002167
DR   CLDB; cl1086
DR   CLDB; cl4974
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03472093
DR   BioSample; SAMN10988489
DR   cancercelllines; CVCL_1179
DR   Cell_Model_Passport; SIDM00981
DR   ChEMBL-Cells; CHEMBL3308537
DR   ChEMBL-Targets; CHEMBL2366181
DR   Cosmic; 906842
DR   Cosmic; 1086332
DR   Cosmic; 1629929
DR   Cosmic; 1995387
DR   Cosmic; 2297004
DR   Cosmic; 2437317
DR   Cosmic-CLP; 906842
DR   DepMap; ACH-000056
DR   DSMZ; ACC-47
DR   DSMZCellDive; ACC-47
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS100ZVH
DR   ENCODE; ENCBS652PBR
DR   ENCODE; ENCBS662OGM
DR   ENCODE; ENCBS898JGF
DR   GDSC; 906842
DR   GEO; GSM115817
DR   GEO; GSM179646
DR   GEO; GSM201345
DR   GEO; GSM886987
DR   GEO; GSM888056
DR   GEO; GSM1035327
DR   GEO; GSM1374467
DR   GEO; GSM1527310
DR   GEO; GSM1527311
DR   GEO; GSM1527312
DR   GEO; GSM1527313
DR   GEO; GSM1527314
DR   GEO; GSM1527315
DR   GEO; GSM1669740
DR   IARC_TP53; 21310
DR   IARC_TP53; 25029
DR   ICLC; HTL99022
DR   IGRhCellID; DOHH2
DR   IZSLER; BS TCL 228
DR   LiGeA; CCLE_934
DR   LINCS_LDP; LCL-1143
DR   Lonza; 666
DR   PharmacoDB; DOHH2_303_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1179
DR   PubChem_Cell_line; CVCL_1179
DR   Wikidata; Q54831350
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1849602;
RX   PubMed=7849311;
RX   PubMed=8057678;
RX   PubMed=8558920;
RX   PubMed=16960149;
RX   PubMed=17363600;
RX   PubMed=17495976;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=23699601;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30165192;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/dohh2-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (Note=In RPMI 1640 + 5% FBS) (PubMed=1849602); ~40 hours (DSMZ=ACC-47).
CC   HLA typing: A*01:01,01:01; B*08:01,44:02; C*07:04,07:04; DQA1*01:02,01:02; DQB1*05:01,06:02; DRB1*15:01,01:01 (PubMed=25960936).
CC   HLA typing: A*01:01,01:01; B*08:01,44:02; C*07:01,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,01:01:01; B*08:01:01,44:02:01; C*07:01:01,07:04:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,02:01:02; DQA1*01:02:01,01:01:01; DQB1*05:01:01,06:02:01; DRA*01:01:01,01:02:03; DRB1*01:01:01,15:01:01 (DSMZCellDive=ACC-47).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.28%; Native American=1.29%; East Asian, North=0%; East Asian, South=0%; South Asian=1.29%; European, North=69.22%; European, South=27.92% (PubMed=30894373).
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, immunoblastic-type.
CC   Caution: A TP53 mutation is indicated as being at p.Ala138Pro (c.412G>C) in PubMed=17363600 but has not been confirmed by CCLE and Cosmic-CLP.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906842; DSMZ=ACC-47; IZSLER=BS TCL 228; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,14
ST   D18S51: 11,14
ST   D19S433: 14.2,15.2
ST   D21S11: 30
ST   D2S1338: 22,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21,27
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   DOK
AC   CVCL_1180
SY   Dysplastic Oral Keratinocyte
DR   CLO; CLO_0002806
DR   EFO; EFO_0006564
DR   CLDB; cl1087
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 858
DR   BioSample; SAMN03473147
DR   cancercelllines; CVCL_1180
DR   CancerTools; 153251
DR   Cell_Model_Passport; SIDM00540
DR   ChEMBL-Cells; CHEMBL3308727
DR   ChEMBL-Targets; CHEMBL1075435
DR   Cosmic; 910936
DR   Cosmic; 1339915
DR   Cosmic-CLP; 910936
DR   DepMap; ACH-002234
DR   ECACC; 94122104
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910936
DR   GEO; GSM827453
DR   GEO; GSM1374468
DR   GEO; GSM1431134
DR   GEO; GSM1669741
DR   IARC_TP53; 21311
DR   PharmacoDB; DOK_304_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1180
DR   PubChem_Cell_line; CVCL_1180
DR   Wikidata; Q54831351
DR   Ximbio; 153251
RX   PubMed=1459732;
RX   PubMed=7917902;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25169794;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26234610;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (PubMed=1459732).
CC   HLA typing: A*02:01,29:02; B*08:01,44:03; C*07:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex4-5del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu188_Pro191del (c.563_574del12); Zygosity=Unspecified (PubMed=7917902).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=0.7%; East Asian, North=2.72%; East Asian, South=0%; South Asian=0%; European, North=66.66%; European, South=29.51% (PubMed=30894373).
CC   Discontinued: ECACC; 94122104; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): Cosmic-CLP=910936; ECACC=94122104; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D21S11: 29,31
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11,13
ST   D8S1179: 9,15
ST   FGA: 20,23
ST   Penta D: 9,14
ST   Penta E: 10,12
ST   TH01: 6,8
ST   TPOX: 10
ST   vWA: 14,18
DI   NCIt; C129863; Oral epithelial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   DOLA
AC   CVCL_UZ38
DR   Wikidata; Q93530739
RX   PubMed=10341211;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 45-60 PDL (PubMed=10341211).
CC   Derived from site: In situ; Axilla, skin; UBERON=UBERON_0015474.
CC   Cell type: Myoepithelial cell; CL=CL_0000185.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   DOLA/bmi1/TERT
AC   CVCL_UZ39
DR   Wikidata; Q93530743
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Axilla, skin; UBERON=UBERON_0015474.
CC   Cell type: Myoepithelial cell; CL=CL_0000185.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ38 ! DOLA
SX   Male
AG   19Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   Don
AC   CVCL_3472
SY   DON; CCL16; CHD; Chinese Hamster Don; CHL-Don
DR   BTO; BTO_0000354
DR   CLO; CLO_0002807
DR   CLDB; cl1088
DR   CLDB; cl1089
DR   ATCC; CCL-16
DR   ChEMBL-Cells; CHEMBL3307359
DR   ChEMBL-Targets; CHEMBL614288
DR   ECACC; 87091501
DR   IZSLER; BS CL 37
DR   KCB; KCB 82010YJ
DR   Wikidata; Q54831352
RX   DOI=10.1007/BF02618370;
RX   PubMed=483122;
RX   PubMed=1027147;
RX   PubMed=4038934;
RX   PubMed=4531035;
RX   PubMed=7065527;
RX   PubMed=14171598;
RX   PubMed=14185313;
RX   PubMed=14328610;
RX   PubMed=18605421;
RX   PubMed=19291904;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   Don D-6
AC   CVCL_5634
SY   Don(D-6)
DR   CLO; CLO_0051574
DR   RCB; RCB0096
DR   Wikidata; Q54831353
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3472 ! Don
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Don Q
AC   CVCL_J503
SY   CdtR-Q; CdtRQ
DR   Wikidata; Q54831354
RX   PubMed=1816487;
RX   PubMed=8636120;
RX   PubMed=9295324;
CC   Characteristics: Highly resistant to the two Rho-modifying glucosyltransferase toxins A and B of Clostridium difficile (PubMed=1816487; PubMed=8636120).
CC   Sequence variation: Mutation; UniProtKB; O35156; Ugp2; Simple; p.Gly116Asp; Zygosity=Homozygous (PubMed=9295324).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3472 ! Don
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Don QR
AC   CVCL_D3W6
SY   CdtRQ-Rev
DR   Wikidata; Q127380799
RX   PubMed=9295324;
CC   Characteristics: Revertant, lost the resistance to the Rho-modifying glucosyltransferase toxins A and B of Clostridium difficile (PubMed=9295324).
CC   Sequence variation: Mutation; UniProtKB; O35156; Ugp2; Simple; p.Gly116Asp; Zygosity=Heterozygous (PubMed=9295324).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_J503 ! Don Q
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Don/a23
AC   CVCL_K265
SY   a23; A23; A-23
DR   Wikidata; Q54831355
RX   CelloPub=CLPUB00259;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3472 ! Don
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Don/a3
AC   CVCL_1Q37
SY   DON-a3; a3; A3
DR   Wikidata; Q54831356
RX   CelloPub=CLPUB00259;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3472 ! Don
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   DOP-M1
AC   CVCL_RL91
DR   Wikidata; Q54831357
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1581583;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=1581583).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   DOP-ND
AC   CVCL_E569
DR   dbMHC; 48763
DR   ECACC; 94022527
DR   IHW; IHW09225
DR   IPD-IMGT/HLA; 10517
DR   Wikidata; Q54831358
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African.
CC   HLA typing: A*02:01,33:03; B*44:03:01,15:16; C*04:01,14:02; DPB1*04:01,11:01:01 (IPD-IMGT/HLA=10517).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Dopa.4U
AC   CVCL_1E61
DR   Wikidata; Q54831359
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20170912220740/http://axiogenesis.com/products/neuronal-cells/dopa-4u-hipsc-dopaminergic-neurons.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Cell type: Dopaminergic neuron; CL=CL_0000700.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ52 ! Astro.4U
OI   CVCL_1E62 ! Peri.4U
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 7
//
ID   Dor Bel
AC   CVCL_U678
DR   ATCC; CRL-1188
DR   Wikidata; Q54831360
RX   PubMed=3860870;
CC   Discontinued: ATCC; CRL-1188; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Dor Son
AC   CVCL_U687
DR   ATCC; CRL-1126
DR   Wikidata; Q54831361
CC   Discontinued: ATCC; CRL-1126; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   DOR-1
AC   CVCL_VN18
DR   Wikidata; Q93530888
RX   PubMed=15390308;
CC   Doubling time: 72-96 hours (PubMed=15390308).
DI   NCIt; C114483; Childhood Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   DOS16
AC   CVCL_C1HQ
SY   DOS-16; LMS-LFS
DR   cancercelllines; CVCL_C1HQ
DR   Wikidata; Q114311323
RX   CelloPub=CLPUB00712;
RX   DOI=10.26190/unsworks/20387;
RX   PubMed=19935656;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Doubling time: 44 hours (DOI=10.26190/unsworks/20387).
CC   Karyotypic information: Near triploid karyotype (DOI=10.26190/unsworks/20387).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (DOI=10.26190/unsworks/20387).
CC   Miscellaneous: STR profile from personal communication of MacKenzie, Karen L.
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30,32.2
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 21,23
ST   Penta D: 11
ST   Penta E: 7,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   NCIt; C27904; Retroperitoneal leiomyosarcoma
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   DoSa01
AC   CVCL_VW38
DR   IBRC; C10004
DR   Wikidata; Q93530895
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sangsari; VBO=VBO_0201456.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   DoSa02
AC   CVCL_VW39
DR   IBRC; C10005
DR   Wikidata; Q93530901
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sangsari; VBO=VBO_0201456.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   DoSa03
AC   CVCL_VW40
DR   IBRC; C10006
DR   Wikidata; Q93530904
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sarabi Mastiff; VBO=VBO_0201178.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   DoSa04
AC   CVCL_VW41
DR   IBRC; C10008
DR   Wikidata; Q93530911
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sangsari; VBO=VBO_0201456.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   DoSa05
AC   CVCL_VW42
DR   IBRC; C10009
DR   Wikidata; Q93530916
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sangsari; VBO=VBO_0201456.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   DoSa06
AC   CVCL_VW43
DR   IBRC; C10010
DR   Wikidata; Q93530919
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sarabi Mastiff; VBO=VBO_0201178.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   DoSa07
AC   CVCL_VW44
DR   IBRC; C10011
DR   Wikidata; Q93530925
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sarabi Mastiff; VBO=VBO_0201178.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   DoSmi
AC   CVCL_CZ87
SY   DOSMI
DR   Wikidata; Q54831362
RX   PubMed=2720636;
RX   PubMed=4038916;
RX   PubMed=6988327;
RX   PubMed=7153601;
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 6
//
ID   DOT1
AC   CVCL_F0J2
RX   PubMed=2606940;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Trypanosoma brucei brucei flagellar attachment zone and distal tip of flagellum.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DoTc2 4510
AC   CVCL_1181
SY   DoTc2-4510; DOTC2-4510; DOTC24510; DoTc2
DR   CLO; CLO_0002808
DR   EFO; EFO_0002171
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7920
DR   BioSample; SAMN03471123
DR   cancercelllines; CVCL_1181
DR   Cell_Model_Passport; SIDM00864
DR   ChEMBL-Cells; CHEMBL3308728
DR   ChEMBL-Targets; CHEMBL1075436
DR   Cosmic; 687508
DR   Cosmic; 906843
DR   Cosmic; 1995388
DR   Cosmic-CLP; 906843
DR   DepMap; ACH-001341
DR   EGA; EGAS00001000978
DR   GDSC; 906843
DR   GEO; GSM113862
DR   GEO; GSM675734
DR   GEO; GSM685440
DR   GEO; GSM1669742
DR   IARC_TP53; 21314
DR   IGRhCellID; DoTc2
DR   LINCS_LDP; LCL-1303
DR   PharmacoDB; DoTc24510_306_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1181
DR   PubChem_Cell_line; CVCL_1181
DR   Wikidata; Q54831363
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.27%; Native American=0.72%; East Asian, North=2.19%; East Asian, South=0%; South Asian=1.9%; European, North=68.76%; European, South=25.17% (PubMed=30894373).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell of uterus; CL=CL_0002149.
ST   Source(s): ATCC=CRL-7920; Cosmic-CLP=906843; DepMap=ACH-001341
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 14
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   DOUG
AC   CVCL_A0WS
DR   Wikidata; Q108820162
RX   PubMed=33446089;
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: Metastatic; Bone, right proximal humerus; UBERON=UBERON_0004411.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   DOV13
AC   CVCL_6774
SY   DOV-13; DOV 13
DR   BTO; BTO_0003638
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 859
DR   BioSample; SAMN03470841
DR   BioSample; SAMN10988354
DR   cancercelllines; CVCL_6774
DR   Cell_Model_Passport; SIDM00969
DR   ChEMBL-Cells; CHEMBL3307753
DR   ChEMBL-Targets; CHEMBL615004
DR   Cosmic; 924143
DR   Cosmic; 927565
DR   Cosmic-CLP; 1479987
DR   DepMap; ACH-001063
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1479987
DR   GEO; GSM659373
DR   GEO; GSM711724
DR   GEO; GSM851916
DR   GEO; GSM1340578
DR   GEO; GSM1341128
DR   GEO; GSM1669743
DR   IARC_TP53; 28278
DR   Millipore; SCC186
DR   PharmacoDB; DOV13_307_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_6774
DR   PubChem_Cell_line; CVCL_6774
DR   Wikidata; Q54831365
RX   PubMed=1536252;
RX   PubMed=7836420;
RX   PubMed=10318951;
RX   PubMed=10972993;
RX   PubMed=16380993;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Doubling time: 36.05 hours (JWGray panel).
CC   HLA typing: A*30:02,74:01; B*15:03,51:01; C*02:02,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (DepMap=ACH-001063).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=86.88%; Native American=0.11%; East Asian, North=5.26%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=7.75% (PubMed=30894373).
CC   Misspelling: DOR 13; ArrayExpress=E-MTAB-2706; PubMed=25485619; PubMed=25877200.
CC   Misspelling: DOR13; PubMed=26589293.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1479987; Millipore=SCC186; PubMed=22710073; PubMed=25877200; PubMed=30485824; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D10S1248: 13
ST   D12S391: 16,20
ST   D13S317: 11
ST   D16S539: 10,13
ST   D18S51: 12,16
ST   D19S433: 13,14
ST   D1S1656: 15,16.3
ST   D21S11: 32.2,33.2
ST   D22S1045: 17
ST   D2S1338: 20,24
ST   D2S441: 14
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10 (Cosmic-CLP=1479987; Millipore=SCC186; PubMed=22710073; PubMed=25877200; Technion Genomics Center)
ST   D7S820: 10,11 (PubMed=30485824)
ST   D8S1179: 12,14 (Millipore=SCC186)
ST   D8S1179: 14 (PubMed=22710073; PubMed=25877200; Technion Genomics Center)
ST   FGA: 21,24
ST   Penta D: 3.2,8
ST   Penta E: 8
ST   TH01: 6,9.3
ST   TPOX: 6,8
ST   vWA: 17,19 (Millipore=SCC186)
ST   vWA: 19 (Cosmic-CLP=1479987; PubMed=22710073; PubMed=25877200; PubMed=30485824; Technion Genomics Center)
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   DOVC-1
AC   CVCL_RK28
DR   Wikidata; Q54831366
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   DOVC-2
AC   CVCL_RK29
DR   Wikidata; Q54831367
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   Dox-pDC
AC   CVCL_RX86
SY   Doxycycline-inducible plasmacytoid Dendritic Cells
DR   Wikidata; Q54831364
RX   PubMed=29489861;
CC   Characteristics: Stably proliferates by doxycycline-induction of the expression of the SV40 large T antigen. After withdrawal of doxycycline will stop proliferate and will undergo apoptosis within 3 days.
CC   Doubling time: 2.4 +- 0.3 days (PubMed=29489861).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
CC   Breed/subspecies: Rosa-rtTA-flox-Tag+ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   DP-1
AC   CVCL_UI24
SY   Dental Pulp-1
DR   Wikidata; Q93531020
RX   PubMed=15250834;
CC   Population: Japanese.
CC   Doubling time: 32.0 hours (PubMed=15250834).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   DP-6
AC   CVCL_9542
SY   DP6
DR   Wikidata; Q54831368
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8656685;
RX   PubMed=10936422;
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=25015330;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA lambda.
CC   Characteristics: IL6 dependent.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   DP0002
AC   CVCL_8W09
DR   ECACC; 95100605
DR   Wikidata; Q54831369
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   DP002
AC   CVCL_C6GY
SY   DP2; Dental Pulp cells 2
DR   RCB; RCB5043
DR   Wikidata; Q116048859
RX   PubMed=20554890;
CC   Population: Japanese.
CC   Senescence: Senesces at 60-66 PDL (RCB=RCB5043).
CC   Doubling time: 38 hours (RCB=RCB5043).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP005
AC   CVCL_C6GZ
SY   DP5; Dental Pulp cells 5
DR   RCB; RCB5044
DR   Wikidata; Q116048860
RX   PubMed=20554890;
CC   Population: Japanese.
CC   Senescence: Senesces at 60-66 PDL (RCB=RCB5044).
CC   Doubling time: 38 hours (RCB=RCB5044).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP006
AC   CVCL_C6H0
SY   DP6; Dental Pulp cells 6
DR   RCB; RCB5045
DR   Wikidata; Q116048861
RX   PubMed=20554890;
CC   Population: Japanese.
CC   Senescence: Senesces at 60-66 PDL (RCB=RCB5045).
CC   Doubling time: 38 hours (RCB=RCB5045).
CC   HLA typing: A*02,02; B*35,61 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP007
AC   CVCL_C6H1
SY   DP7; Dental Pulp cells 7
DR   RCB; RCB5046
DR   Wikidata; Q116048862
RX   PubMed=20554890;
CC   Population: Japanese.
CC   Senescence: Senesces at 60-66 PDL (RCB=RCB5046).
CC   Doubling time: 38 hours (RCB=RCB5046).
CC   HLA typing: A*03,24; B*44,52 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP010
AC   CVCL_C6H2
SY   DP10; Dental Pulp cells 10
DR   RCB; RCB5047
DR   Wikidata; Q116048863
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,26; B*13,52 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP011
AC   CVCL_C6H3
SY   DP11; Dental Pulp cells 10
DR   RCB; RCB5048
DR   Wikidata; Q116048864
RX   PubMed=20554890;
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP012
AC   CVCL_C6H4
SY   DP12; Dental Pulp cells 12
DR   RCB; RCB5049
DR   Wikidata; Q116048865
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,31; B*07,56 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP014
AC   CVCL_C6H5
SY   DP14; Dental Pulp cells 14
DR   RCB; RCB5050
DR   Wikidata; Q116048866
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,31; B*52,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP015
AC   CVCL_C6H6
SY   DP15; Dental Pulp cells 15
DR   RCB; RCB5051
DR   Wikidata; Q116048867
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,02; B*46,75 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP017
AC   CVCL_C6H7
SY   DP17; Dental Pulp cells 17
DR   RCB; RCB5052
DR   Wikidata; Q116048868
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,26; B*52,54 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP018
AC   CVCL_C6H8
SY   DP18; Dental Pulp cells 18
DR   RCB; RCB5053
DR   Wikidata; Q116048869
RX   PubMed=20554890;
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP025
AC   CVCL_C6H9
SY   DP25; Dental Pulp cells 25
DR   RCB; RCB5054
DR   Wikidata; Q116048870
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*35,51 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP026
AC   CVCL_C6HA
SY   DP26; Dental Pulp cells 26
DR   RCB; RCB5055
DR   Wikidata; Q116048871
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,02; B*35,71 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP028
AC   CVCL_RM96
SY   DP28; Dental Pulp cells 28
DR   GEO; GSM265496
DR   GEO; GSM265497
DR   RCB; RCB5056
DR   Wikidata; Q54831370
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,31; B*35,46 (PubMed=20554890).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   DP030
AC   CVCL_C6HB
SY   DP30; Dental Pulp cells 30
DR   RCB; RCB5057
DR   Wikidata; Q116048872
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,31; B*52,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP031
AC   CVCL_DP75
SY   DP31; Dental Pulp cells 31
DR   GEO; GSM265498
DR   GEO; GSM265499
DR   RCB; RCB5058
DR   Wikidata; Q54831371
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*11,31; B*48,55 (PubMed=20554890).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=20554890
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   Penta D: 12,14
ST   Penta E: 16,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   DP032
AC   CVCL_C6HC
SY   DP32; Dental Pulp cells 32
DR   RCB; RCB5059
DR   Wikidata; Q116048873
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,26; B*61,61 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP035
AC   CVCL_C6HD
SY   DP35; Dental Pulp cells 35
DR   RCB; RCB5060
DR   Wikidata; Q116048874
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*33,33; B*44,44 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP038
AC   CVCL_C6HE
SY   DP38; Dental Pulp cells 38
DR   RCB; RCB5061
DR   Wikidata; Q116048875
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*11,31; B*51,61 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP039
AC   CVCL_C6HF
SY   DP39; Dental Pulp cells 39
DR   RCB; RCB5062
DR   Wikidata; Q116048877
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*11,24; B*61,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP040
AC   CVCL_C6HG
SY   DP40; Dental Pulp cells 40
DR   RCB; RCB5063
DR   Wikidata; Q116048878
RX   PubMed=20554890;
CC   Population: Japanese.
CC   Senescence: Senesces at 60-66 PDL (RCB=RCB5063).
CC   Doubling time: 38 hours (RCB=RCB5063).
CC   HLA typing: A*24,26; B*52,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP041
AC   CVCL_C6HH
SY   DP41; Dental Pulp cells 41
DR   RCB; RCB5064
DR   Wikidata; Q116048879
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,26; B*54,54 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP042
AC   CVCL_C6HI
SY   DP42; Dental Pulp cells 42
DR   RCB; RCB5065
DR   Wikidata; Q116048881
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,24; B*07,51 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP044
AC   CVCL_C6HJ
SY   DP44; Dental Pulp cells 44
DR   RCB; RCB5066
DR   Wikidata; Q116048883
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,24; B*52,60 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP046
AC   CVCL_C6HK
SY   DP46; Dental Pulp cells 46
DR   RCB; RCB5067
DR   Wikidata; Q116048884
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*11,24; B*51,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP048
AC   CVCL_C6HL
SY   DP48; Dental Pulp cells 48
DR   RCB; RCB5068
DR   Wikidata; Q116048885
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,26; B*52,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP049
AC   CVCL_C6HM
SY   DP49; Dental Pulp cells 49
DR   RCB; RCB5069
DR   Wikidata; Q116048886
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,33; B*07,44 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP052
AC   CVCL_C6HN
SY   DP52; Dental Pulp cells 52
DR   RCB; RCB5070
DR   Wikidata; Q116048887
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*11,26; B*55,67 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP053
AC   CVCL_C6HP
SY   DP53; Dental Pulp cells 53
DR   RCB; RCB5071
DR   Wikidata; Q116048889
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,31; B*07,54 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP054
AC   CVCL_C6HQ
SY   DP54; Dental Pulp cells 54
DR   RCB; RCB5072
DR   Wikidata; Q116048890
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,26; B*46,61 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP056
AC   CVCL_C6HR
SY   DP56; Dental Pulp cells 56
DR   RCB; RCB5073
DR   Wikidata; Q116048891
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,24; B*52,61 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP057
AC   CVCL_C6HS
SY   DP57; Dental Pulp cells 57
DR   RCB; RCB5074
DR   Wikidata; Q116048892
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,33; B*44,54 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP060
AC   CVCL_C6HT
SY   DP60; Dental Pulp cells 60
DR   RCB; RCB5075
DR   Wikidata; Q116048893
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*46,52 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP062
AC   CVCL_C6HU
SY   DP62; Dental Pulp cells 62
DR   RCB; RCB5076
DR   Wikidata; Q116048894
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,24; B*48,59 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP064
AC   CVCL_C6HV
SY   DP64; Dental Pulp cells 64
DR   RCB; RCB5077
DR   Wikidata; Q116048895
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,02; B*46,60 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP065
AC   CVCL_C6HW
SY   DP65; Dental Pulp cells 65
DR   RCB; RCB5078
DR   Wikidata; Q116048896
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,24; B*61,61 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP066
AC   CVCL_C6HX
SY   DP66; Dental Pulp cells 66
DR   RCB; RCB5079
DR   Wikidata; Q116048897
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,24; B*51,60 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP068
AC   CVCL_C6HY
SY   DP68; Dental Pulp cells 68
DR   RCB; RCB5080
DR   Wikidata; Q116048898
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,33; B*55,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP069
AC   CVCL_C6HZ
SY   DP69; Dental Pulp cells 69
DR   RCB; RCB5081
DR   Wikidata; Q116048899
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*46,52 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP072
AC   CVCL_C6I0
SY   DP72; Dental Pulp cells 72
DR   RCB; RCB5082
DR   Wikidata; Q116048900
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,11; B*46,60 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP073
AC   CVCL_C6I1
SY   DP73; Dental Pulp cells 73
DR   RCB; RCB5083
DR   Wikidata; Q116048901
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,31; B*60,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP074
AC   CVCL_DP68
SY   DP74; Dental Pulp cells 74
DR   GEO; GSM1040300
DR   GEO; GSM1040370
DR   GEO; GSM1493717
DR   Wikidata; Q54831372
RX   PubMed=20554890;
RX   PubMed=21460823;
RX   PubMed=24259714;
CC   Population: Japanese.
CC   HLA typing: A*24,24; B*52,52 (PubMed=20554890).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 10,14
ST   D16S539: 9,10
ST   D18S51: 13,19
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   DP075
AC   CVCL_DP76
SY   DP75; Dental Pulp cells 75
DR   Wikidata; Q54831373
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*51,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=20554890
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,11
ST   D16S539: 8,11
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 8,11
ST   Penta E: 12,16
ST   TH01: 5,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   DP083
AC   CVCL_C6I2
SY   DP83; Dental Pulp cells 83
DR   RCB; RCB5084
DR   Wikidata; Q116048902
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,26; B*60,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP086
AC   CVCL_C6I3
SY   DP86; Dental Pulp cells 86
DR   RCB; RCB5085
DR   Wikidata; Q116048903
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,31; B*51,52 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP087
AC   CVCL_C6I4
SY   DP87; Dental Pulp cells 87
DR   RCB; RCB5086
DR   Wikidata; Q116048904
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,33; B*51,52 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP092
AC   CVCL_C6I5
SY   DP92; Dental Pulp cells 92
DR   RCB; RCB5087
DR   Wikidata; Q116048905
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*35,71 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP094
AC   CVCL_DQ50
SY   DP94; Dental Pulp cells 94
DR   RCB; RCB5088
DR   Wikidata; Q54831374
RX   PubMed=20554890;
RX   PubMed=21460823;
CC   Population: Japanese.
CC   HLA typing: A*11,11; B*62,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   DP099
AC   CVCL_C6I6
SY   DP99; Dental Pulp cells 99
DR   RCB; RCB5089
DR   Wikidata; Q116048907
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*24,31; B*52,62 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP100
AC   CVCL_C6I7
SY   Dental Pulp cells 100
DR   RCB; RCB5090
DR   Wikidata; Q116048908
RX   PubMed=20554890;
CC   Population: Japanese.
CC   HLA typing: A*02,33; B*35,51 (PubMed=20554890).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   DP264-CD-iPS
AC   CVCL_F0A4
SY   DP264-CD-iPS-2
RX   PubMed=25521610;
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0A5 ! DP264-M-iPS
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DP264-M-iPS
AC   CVCL_F0A5
SY   DP264-M-iPS-5
RX   PubMed=25521610;
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0A4 ! DP264-CD-iPS
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DP265-CD-iPS
AC   CVCL_F0A6
RX   PubMed=25521610;
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0A7 ! DP265-M-iPS
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DP265-M-iPS
AC   CVCL_F0A7
RX   PubMed=25521610;
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0A6 ! DP265-CD-iPS
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   DP2(D5203-1D8-31)
AC   CVCL_A6ZE
SY   D5203-1D8-31; D5203-1D8; 1D8
DR   RCB; RCB4889
DR   Wikidata; Q107114816
RX   PubMed=28394950;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9Z2J6; Mouse Ptgdr2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   DP5-2
AC   CVCL_XG52
DR   Wikidata; Q93531076
RX   PubMed=21559698;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Breed/subspecies: Lister Hooded; RS=RS_0004568.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   DPC-1
AC   CVCL_DN59
SY   DPC1; Dog Prostate Carcinoma-1
DR   Wikidata; Q54831375
RX   Patent=US20030013191;
RX   PubMed=11170126;
RX   PubMed=21882212;
RX   PubMed=26714499;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2279.
CC   Doubling time: 27 hours (PubMed=11170126).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   DPC-X1
AC   CVCL_D4ZI
DR   Wikidata; Q127380800
RX   PubMed=37213400;
CC   Population: Chinese.
CC   Doubling time: 48 hours (PubMed=37213400).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
ST   Source(s): PubMed=37213400
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 19,22
ST   D13S317: 9,10
ST   D16S539: 10,13
ST   D18S51: 15
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D6S1043: 11,19
ST   D7S820: 11,12
ST   D8S1179: 8,17
ST   FGA: 22,25
ST   Penta D: 9,10
ST   Penta E: 15,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DPC-X4
AC   CVCL_D4ZJ
DR   CCRID; 4201PAT-CCTCC02620
DR   Wikidata; Q127380801
RX   PubMed=38253956;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023379.
CC   Population: Chinese.
CC   Doubling time: 70 hours (PubMed=38253956).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
ST   Source(s): PubMed=38253956
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 17
ST   D12S391: 21,22
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 15
ST   D1S1656: 17
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 13
ST   D6S1043: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   DPCP2
AC   CVCL_A9RM
DR   Wikidata; Q102113772
WW   Provider; Beyotime; C6229; https://www.beyotime.com/Manual/C6229%20DPCP2%20(Human%20Dental%20Pulp%20Cells).pdf
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): Beyotime
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   DPEDi001-A
AC   CVCL_D0E8
SY   T12
DR   BioSamples; SAMEA112625001
DR   hPSCreg; DPEDi001-A
DR   Wikidata; Q123031176
RX   PubMed=37028180;
CC   From: Division of Paediatric Endocrinology and Diabetes, Medical Faculty, TU Dresden; Dresden; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   DPEDi001-A-1
AC   CVCL_D0E9
SY   T12 SHOX2 KO; UKHGi019-A-1
DR   BioSamples; SAMEA112657099
DR   hPSCreg; DPEDi001-A-1
DR   Wikidata; Q123031177
RX   PubMed=37028180;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10854; SHOX2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0E8 ! DPEDi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   DPH1.1
AC   CVCL_B4H9
SY   HG-HMGB1
DR   ABCD; ABCD_AU121
DR   Wikidata; Q110432777
RX   Patent=US9045534;
RX   PubMed=21655107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 10002.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1 (Note=Also reacts with mouse and rat. Immunized with AA 165-181 which is conserved in mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 8
//
ID   DPK
AC   CVCL_7188
DR   Lonza; 1306
DR   Wikidata; Q54831376
RX   PubMed=1423605;
CC   Breed/subspecies: AND-TCR transgenic.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   DPK-SKDF-H
AC   CVCL_U979
SY   Dominion PharmaKine-SKin Dermal Fibroblasts-H
DR   BTO; BTO_0003254
DR   Wikidata; Q54831377
CC   From: Dominion Pharmakine (which ceased operation); Bizkaia; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   DPLC1
AC   CVCL_A9FL
DR   CCRID; 5301CAN-KCB1845PLC
DR   KCB; KCB 2018045PLC
DR   Wikidata; Q108820163
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
CC   Breed/subspecies: Corgi; VBO=VBO_0200995.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   DPM
AC   CVCL_0P21
SY   Dental Papilla Mesenchyme
DR   Wikidata; Q54831378
RX   PubMed=16927272;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic tooth bud, dental papilla; UBERON=UBERON_0001763.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Conditionally immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   DPNJMUi001-A
AC   CVCL_C0CG
DR   BioSamples; SAMEA13371559
DR   hPSCreg; DPNJMUi001-A
DR   Wikidata; Q112929464
RX   PubMed=35413567;
CC   From: Children's Hospital of Nanjing Medical University; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14880; GTPBP3; Simple; p.Gly182Glu (c.545G>A); Zygosity=Heterozygous (PubMed=35413567).
CC   Sequence variation: Mutation; HGNC; HGNC:14880; GTPBP3; Simple; p.Cys398Tyr (c.1193G>A) (p.Cys430Tyr, c.1289G>A); Zygosity=Heterozygous (PubMed=35413567).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187986; Combined oxidative phosphorylation deficiency 23
DI   ORDO; Orphanet_444013; Combined oxidative phosphorylation defect type 23
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   DPNJMUi002-A
AC   CVCL_E3UD
DR   BioSamples; SAMEA117610312
DR   hPSCreg; DPNJMUi002-A
CC   From: Children's Hospital of Nanjing Medical University; Nanjing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217090; Progressive familial intrahepatic cholestasis type 3
DI   ORDO; Orphanet_79305; Progressive familial intrahepatic cholestasis type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   DPNJMUi003-A
AC   CVCL_E3UE
DR   hPSCreg; DPNJMUi003-A
RX   PubMed=40266456;
CC   From: Children's Hospital of Nanjing Medical University; Nanjing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7784; NFIA; Simple; chr1:g.61650967_61842967del; Zygosity=Heterozygous (PubMed=40266456).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217084; Brain malformations with or without urinary tract defects
DI   ORDO; Orphanet_401986; 1p31p32 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   DpN1
AC   CVCL_Z404
DR   ICLDB; dpn1
DR   Wikidata; Q54831379
RX   PubMed=12573024;
RX   PubMed=20574041;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13037; ! Danaus plexippus (Monarch butterfly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   DPS-1
AC   CVCL_WD02
SY   Dental Pulp Stem cells-1
DR   IBRC; C10265
DR   Wikidata; Q93531176
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-10
AC   CVCL_WD03
SY   Dental Pulp Stem cells-10
DR   IBRC; C10377
DR   Wikidata; Q93531180
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-11
AC   CVCL_WD04
SY   Dental Pulp Stem cells-11
DR   IBRC; C10453
DR   Wikidata; Q93531184
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-12
AC   CVCL_WD05
SY   Dental Pulp Stem cells-12
DR   IBRC; C10894
DR   Wikidata; Q93531188
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-13
AC   CVCL_WD06
SY   Dental Pulp Stem cells-13
DR   IBRC; C10896
DR   Wikidata; Q93531193
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-2
AC   CVCL_WD07
SY   Dental Pulp Stem cells-2
DR   IBRC; C10266
DR   Wikidata; Q93531196
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-3
AC   CVCL_WD08
SY   Dental Pulp Stem cells-3
DR   IBRC; C10267
DR   Wikidata; Q93531201
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-4
AC   CVCL_WD09
SY   Dental Pulp Stem cells-4
DR   IBRC; C10268
DR   Wikidata; Q93531206
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-6
AC   CVCL_WD10
SY   Dental Pulp Stem cells-6
DR   IBRC; C10372
DR   Wikidata; Q93531210
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-7
AC   CVCL_WD11
SY   Dental Pulp Stem cells-7
DR   IBRC; C10371
DR   Wikidata; Q93531215
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-8
AC   CVCL_WD12
SY   Dental Pulp Stem cells-8
DR   IBRC; C10375
DR   Wikidata; Q93531220
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPS-9
AC   CVCL_WD13
SY   Dental Pulp Stem cells-9
DR   IBRC; C10376
DR   Wikidata; Q93531226
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   DPSC
AC   CVCL_AV90
SY   hDPSC; Dental Pulp Stem Cells
DR   CLS; 300702
DR   Wikidata; Q54831380
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18-25Y
CA   Somatic stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   DPSO 114/74
AC   CVCL_6386
SY   DPSO114/74
DR   CLO; CLO_0002811
DR   ATCC; CCL-194
DR   Wikidata; Q54831381
RX   PubMed=7065527;
RX   PubMed=11528123;
WW   Info; KCCMR; -; https://web.archive.org/web/20110829112150/http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=495297; ! Saimiri boliviensis peruviensis (Peruvian squirrel monkey)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   DPW 5
AC   CVCL_V076
DR   CLO; CLO_0002812
DR   CLDB; cl1093
DR   IHW; 11w 8307
DR   Wikidata; Q54831382
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   DPX2
AC   CVCL_UK01
SY   DPX-2
DR   CLO; CLO_0037254
DR   cancercelllines; CVCL_UK01
DR   PubChem_Cell_line; CVCL_UK01
DR   Wikidata; Q93531270
RX   PubMed=15466163;
RX   PubMed=16146350;
RX   PubMed=22912432;
WW   Info; Promega; -; https://www.promegaconnections.com/tag/dpx2-cells/
CC   Population: Caucasian.
CC   Biotechnology: Used in cell-based assays for a parallel assessment of CYP3A4 induction, metabolism and inhibition at the cellular level.
CC   Characteristics: The luciferase reporter gene is under the control of CYP3A4 response elements (proximal promoter and distal xenobiotic-responsive enhancer module).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 15
//
ID   DPZcj_iPSC1
AC   CVCL_RH22
DR   GEO; GSM1585270
DR   GEO; GSM1585271
DR   GEO; GSM1585272
DR   GEO; GSM1585273
DR   SKIP; SKIP001428
DR   Wikidata; Q54831383
RX   PubMed=25785453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   DPZcj_iPSC2
AC   CVCL_RH23
DR   SKIP; SKIP001429
DR   Wikidata; Q54831384
RX   PubMed=25785453;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   DPZcj_iPSC3
AC   CVCL_RH24
DR   SKIP; SKIP001430
DR   Wikidata; Q54831385
RX   PubMed=25785453;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   DPZcj_iPSC4
AC   CVCL_RH25
DR   SKIP; SKIP001431
DR   Wikidata; Q54831386
RX   PubMed=25785453;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   DPZcj_iPSC5
AC   CVCL_RH26
DR   SKIP; SKIP001432
DR   Wikidata; Q54831387
RX   PubMed=25785453;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   DPZcj_iPSC6
AC   CVCL_RH27
DR   SKIP; SKIP001433
DR   Wikidata; Q54831388
RX   PubMed=25785453;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   DPZcjESC1
AC   CVCL_RH28
DR   GEO; GSM1821431
DR   GEO; GSM1821432
DR   SKIP; SKIP001424
DR   Wikidata; Q54831389
RX   PubMed=27385131;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   DPZcjESC2
AC   CVCL_RH29
DR   GEO; GSM1821433
DR   GEO; GSM1821434
DR   SKIP; SKIP001425
DR   Wikidata; Q54831392
RX   PubMed=27385131;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   DPZcjESC3
AC   CVCL_RH30
DR   GEO; GSM1821435
DR   GEO; GSM1821436
DR   SKIP; SKIP001426
DR   Wikidata; Q54831393
RX   PubMed=27385131;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   DPZcjESC4
AC   CVCL_RH31
DR   GEO; GSM1821437
DR   GEO; GSM1821438
DR   SKIP; SKIP001427
DR   Wikidata; Q54831394
RX   PubMed=27385131;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   DR 9
AC   CVCL_V077
DR   CLO; CLO_0002813
DR   CLDB; cl1094
DR   IHW; 11w 8139
DR   Wikidata; Q54831396
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   DR-EcoScreen
AC   CVCL_EG66
DR   JCRB; JCRB1630
DR   Wikidata; Q54831397
RX   PubMed=18835618;
RX   PubMed=26087926;
CC   Biotechnology: Used in a bioassay for the determination of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and dioxin-like polychlorinated biphenyls (DL-PCBs) in environmental and food samples.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 16
//
ID   DR-EcoScreen-HS
AC   CVCL_B3MB
DR   JCRB; JCRB1853
DR   Wikidata; Q110432778
CC   Biotechnology: Used in a bioassay for the determination of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and dioxin-like polychlorinated biphenyls (DL-PCBs) in environmental and food samples.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Characteristics: Has higher responsiveness to TCDD than DR-EcoScreen (JCRB=JCRB1853).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 11
//
ID   DR-Wildtype
AC   CVCL_J238
DR   ATCC; CRL-2977
DR   Wikidata; Q54831398
CC   Characteristics: Control cell line for the CHOP-KO-DR (Cellosaurus=CVCL_B046), GCN2-KO-DR (Cellosaurus=CVCL_B049) and PERK-KO-DR (Cellosaurus=CVCL_B067) cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   DR177
AC   CVCL_A1YN
DR   Wikidata; Q105506769
RX   PubMed=22257080;
RX   PubMed=24443327;
CC   Population: Caucasian.
CC   Doubling time: 32.9 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   DRA12
AC   CVCL_XG49
DR   Wikidata; Q93531463
RX   PubMed=8874215;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   DRCF
AC   CVCL_ZE21
SY   Danio Rerio Caudal Fin
DR   Wikidata; Q98125919
RX   PubMed=32232614;
CC   Group: Fish cell line.
CC   Characteristics: Grows at temperatures ranging from 20 to 32 Celsius. The highest growth rate is obtained at 28 Celsius (PubMed=32232614).
CC   Doubling time: 36 hours (Note=At 25th passage) (PubMed=32232614).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: Wild strain from Brahmaputra river.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   DRE/LULS60
AC   CVCL_C1GP
DR   Wikidata; Q114311324
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=57047; ! Dermacentor reticulatus (Ornate cow tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   DREG200
AC   CVCL_G117
SY   DREG-200
DR   CLO; CLO_0002817
DR   ABCD; ABCD_AD348
DR   ATCC; HB-302
DR   Wikidata; Q54831399
RX   PubMed=2179952;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   DREG56
AC   CVCL_G133
SY   Dreg56; DREG-56; DREG 56
DR   CLO; CLO_0002818
DR   ATCC; HB-300
DR   Wikidata; Q54831400
RX   PubMed=2179952;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   DrF
AC   CVCL_UZ52
SY   DRF; Danio rerio Fin
DR   Wikidata; Q93531494
RX   PubMed=30762877;
WW   Provider; AAHL; -; https://aahl.res.in/zebra-fish-danio-rerio-eye-dre-fin-drf-and-gill-drg-cell-lines/
CC   Group: Fish cell line.
CC   Doubling time: ~34 hours (Note=In L-15 medium + 10% FBS) (PubMed=30762877).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   DrG
AC   CVCL_IX16
SY   DRG; Danio rerio Gill
DR   NRFC; NRFC053
DR   Wikidata; Q54831401
RX   PubMed=28257922;
WW   Provider; AAHL; -; https://aahl.res.in/zebra-fish-danio-rerio-eye-dre-fin-drf-and-gill-drg-cell-lines/
WW   Provider; NRFC; NRFC053; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC053.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   DRHEp2
AC   CVCL_W888
SY   DrHep-2
DR   Cosmic; 1530735
DR   Wikidata; Q54831402
RX   PubMed=17637738;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   DRI,SM
AC   CVCL_E570
SY   DRI, SM
DR   dbMHC; 48764
DR   ECACC; 94082227
DR   IHW; IHW09128
DR   IPD-IMGT/HLA; 11671
DR   Wikidata; Q54831403
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*03; B*07; C*04:01; DPB1*04:01; DQA1*01:01,01:02; DQB1*05:01,06:02; DRB1*01:01,15:01; DRB5*01:01 (IPD-IMGT/HLA=11671).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   DRICUi001-A
AC   CVCL_B3NZ
SY   ADANG14202UC
DR   BioSamples; SAMEA9361358
DR   EBiSC; DRICUi001-A
DR   ECACC; 66770022
DR   hPSCreg; DRICUi001-A
DR   Wikidata; Q110432779
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Discontinued: ECACC; 66770022; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi002-A
AC   CVCL_B3P0
SY   ADANG10242CA; ADCAR24365UC
DR   BioSamples; SAMEA9362829
DR   EBiSC; DRICUi002-A
DR   ECACC; 66770023
DR   hPSCreg; DRICUi002-A
DR   Wikidata; Q110432781
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Discontinued: ECACC; 66770023; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi003-A
AC   CVCL_B3P1
SY   LC56A10005A
DR   BioSamples; SAMEA9362831
DR   EBiSC; DRICUi003-A
DR   ECACC; 66770024
DR   hPSCreg; DRICUi003-A
DR   Wikidata; Q110432782
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770024; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi004-A
AC   CVCL_B3P2
SY   LC56A10012A
DR   BioSamples; SAMEA9362934
DR   EBiSC; DRICUi004-A
DR   ECACC; 66770025
DR   hPSCreg; DRICUi004-A
DR   Wikidata; Q110432783
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770025; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi005-A
AC   CVCL_B3P3
SY   LW44A10001
DR   BioSamples; SAMEA9363135
DR   EBiSC; DRICUi005-A
DR   ECACC; 66770026
DR   hPSCreg; DRICUi005-A
DR   Wikidata; Q110432784
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770026; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi006-A
AC   CVCL_B3P4
SY   ADANG10496CA
DR   BioSamples; SAMEA10291413
DR   EBiSC; DRICUi006-A
DR   ECACC; 66770030
DR   hPSCreg; DRICUi006-A
DR   Wikidata; Q110432785
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770030; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi007-A
AC   CVCL_B3P5
SY   ADANG10605CA
DR   BioSamples; SAMEA10291414
DR   EBiSC; DRICUi007-A
DR   ECACC; 66770032
DR   hPSCreg; DRICUi007-A
DR   Wikidata; Q110432786
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770032; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi008-A
AC   CVCL_B3P6
SY   ADANG14293UC
DR   BioSamples; SAMEA10291415
DR   EBiSC; DRICUi008-A
DR   ECACC; 66770031
DR   hPSCreg; DRICUi008-A
DR   Wikidata; Q110432787
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Discontinued: ECACC; 66770031; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi009-A
AC   CVCL_B3P7
SY   ADLON44426UC
DR   BioSamples; SAMEA10291416
DR   EBiSC; DRICUi009-A
DR   ECACC; 66770033
DR   hPSCreg; DRICUi009-A
DR   Wikidata; Q110432788
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770033; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 6
//
ID   DRICUi010-A
AC   CVCL_C1PG
SY   BS38A10004A
DR   BioSamples; SAMEA11549531
DR   EBiSC; DRICUi010-A
DR   ECACC; 66770099
DR   hPSCreg; DRICUi010-A
DR   Wikidata; Q114311325
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770099; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 5
//
ID   DRICUi011-A
AC   CVCL_C1PH
SY   BS38A10002A
DR   BioSamples; SAMEA11549533
DR   EBiSC; DRICUi011-A
DR   ECACC; 66770100
DR   hPSCreg; DRICUi011-A
DR   Wikidata; Q114311327
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 5
//
ID   DRICUi012-A
AC   CVCL_C1PI
SY   NT18A10014A
DR   BioSamples; SAMEA11603400
DR   EBiSC; DRICUi012-A
DR   ECACC; 66770101
DR   hPSCreg; DRICUi012-A
DR   Wikidata; Q114311328
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 5
//
ID   DRICUi013-A
AC   CVCL_C1PJ
SY   SC45A10021A
DR   BioSamples; SAMEA11603441
DR   EBiSC; DRICUi013-A
DR   ECACC; 66770102
DR   hPSCreg; DRICUi013-A
DR   Wikidata; Q114311329
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 5
//
ID   DRICUi014-A
AC   CVCL_C1PK
SY   CF00C90323A
DR   BioSamples; SAMEA11604265
DR   EBiSC; DRICUi014-A
DR   ECACC; 66770103
DR   hPSCreg; DRICUi014-A
DR   Wikidata; Q114311330
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66770103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 5
//
ID   DRICUi015-A
AC   CVCL_C1PL
SY   CF00C90378a
DR   BioSamples; SAMEA11604664
DR   EBiSC; DRICUi015-A
DR   hPSCreg; DRICUi015-A
DR   Wikidata; Q114311331
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   DRICUi016-A
AC   CVCL_C6P4
SY   GU66A10008a
DR   BioSamples; SAMEA111486615
DR   EBiSC; DRICUi016-A
DR   hPSCreg; DRICUi016-A
DR   Wikidata; Q117704292
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi017-A
AC   CVCL_C6P5
SY   FB12A10007a
DR   BioSamples; SAMEA111486616
DR   EBiSC; DRICUi017-A
DR   hPSCreg; DRICUi017-A
DR   Wikidata; Q117704293
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi018-A
AC   CVCL_C6P6
SY   BH09A10003A
DR   BioSamples; SAMEA111486617
DR   EBiSC; DRICUi018-A
DR   hPSCreg; DRICUi018-A
DR   Wikidata; Q117704294
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi019-A
AC   CVCL_C6P7
SY   NE37A10024a
DR   BioSamples; SAMEA111486618
DR   EBiSC; DRICUi019-A
DR   hPSCreg; DRICUi019-A
DR   Wikidata; Q117704295
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi020-A
AC   CVCL_C6P8
SY   CF00C90474a
DR   BioSamples; SAMEA111486619
DR   EBiSC; DRICUi020-A
DR   hPSCreg; DRICUi020-A
DR   Wikidata; Q117704296
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi021-A
AC   CVCL_C6P9
SY   24725
DR   BioSamples; SAMEA111486620
DR   EBiSC; DRICUi021-A
DR   hPSCreg; DRICUi021-A
DR   Wikidata; Q117704297
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi022-A
AC   CVCL_C6PA
SY   CF00C90161A
DR   BioSamples; SAMEA111486621
DR   EBiSC; DRICUi022-A
DR   hPSCreg; DRICUi022-A
DR   Wikidata; Q117704298
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi023-A
AC   CVCL_C6PB
SY   NF35A00021A
DR   BioSamples; SAMEA111486814
DR   EBiSC; DRICUi023-A
DR   hPSCreg; DRICUi023-A
DR   Wikidata; Q117704299
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi024-A
AC   CVCL_C6PC
SY   SS31A10002A
DR   BioSamples; SAMEA111486815
DR   EBiSC; DRICUi024-A
DR   hPSCreg; DRICUi024-A
DR   Wikidata; Q117704300
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi025-A
AC   CVCL_C6PD
SY   CF00C90472A
DR   BioSamples; SAMEA111486816
DR   EBiSC; DRICUi025-A
DR   hPSCreg; DRICUi025-A
DR   Wikidata; Q117704301
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi026-A
AC   CVCL_C6PE
SY   24745
DR   BioSamples; SAMEA111486817
DR   EBiSC; DRICUi026-A
DR   hPSCreg; DRICUi026-A
DR   Wikidata; Q117704302
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi027-A
AC   CVCL_C6PF
SY   ADCAR20186CA
DR   BioSamples; SAMEA111486818
DR   EBiSC; DRICUi027-A
DR   hPSCreg; DRICUi027-A
DR   Wikidata; Q117704303
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi028-A
AC   CVCL_C6PG
SY   NE37A10025A
DR   BioSamples; SAMEA111486819
DR   EBiSC; DRICUi028-A
DR   hPSCreg; DRICUi028-A
DR   Wikidata; Q117704304
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi029-A
AC   CVCL_C6PH
SY   MW14A10014A
DR   BioSamples; SAMEA111486820
DR   EBiSC; DRICUi029-A
DR   hPSCreg; DRICUi029-A
DR   Wikidata; Q117704305
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi030-A
AC   CVCL_C6PI
SY   CF00C90028A
DR   BioSamples; SAMEA111486821
DR   EBiSC; DRICUi030-A
DR   hPSCreg; DRICUi030-A
DR   Wikidata; Q117704306
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi031-A
AC   CVCL_C6PJ
SY   ADANG10149CA
DR   BioSamples; SAMEA111486822
DR   EBiSC; DRICUi031-A
DR   hPSCreg; DRICUi031-A
DR   Wikidata; Q117704307
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi032-A
AC   CVCL_C6PK
SY   ADCAR20298CA
DR   BioSamples; SAMEA111486823
DR   EBiSC; DRICUi032-A
DR   hPSCreg; DRICUi032-A
DR   Wikidata; Q117704308
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi033-A
AC   CVCL_C6PL
SY   LC56A10022a
DR   BioSamples; SAMEA111486824
DR   EBiSC; DRICUi033-A
DR   hPSCreg; DRICUi033-A
DR   Wikidata; Q117704310
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   DRICUi034-A
AC   CVCL_D0EC
SY   ADLON40400CA
DR   BioSamples; SAMEA112652152
DR   EBiSC; DRICUi034-A
DR   hPSCreg; DRICUi034-A
DR   Wikidata; Q123031179
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi035-A
AC   CVCL_D0ED
SY   ADCAR20268CA
DR   BioSamples; SAMEA112652151
DR   EBiSC; DRICUi035-A
DR   hPSCreg; DRICUi035-A
DR   Wikidata; Q123031180
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi036-A
AC   CVCL_D0EE
SY   DB29A10005A
DR   BioSamples; SAMEA112652150
DR   EBiSC; DRICUi036-A
DR   hPSCreg; DRICUi036-A
DR   Wikidata; Q123031181
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi037-A
AC   CVCL_D0EF
SY   ADLON44274UC
DR   BioSamples; SAMEA112652149
DR   EBiSC; DRICUi037-A
DR   hPSCreg; DRICUi037-A
DR   Wikidata; Q123031182
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi038-A
AC   CVCL_D0EG
SY   ADANG14287UC
DR   BioSamples; SAMEA112652145
DR   EBiSC; DRICUi038-A
DR   hPSCreg; DRICUi038-A
DR   Wikidata; Q123031183
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   DRICUi039-A
AC   CVCL_D0EH
SY   ADCAR24398UC
DR   BioSamples; SAMEA112652147
DR   EBiSC; DRICUi039-A
DR   hPSCreg; DRICUi039-A
DR   Wikidata; Q123031184
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi040-A
AC   CVCL_D0EI
SY   ADANG14061UC
DR   BioSamples; SAMEA112652148
DR   EBiSC; DRICUi040-A
DR   hPSCreg; DRICUi040-A
DR   Wikidata; Q123031185
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   DRICUi041-A
AC   CVCL_D0EJ
SY   ADCAR20406CA
DR   BioSamples; SAMEA113429071
DR   EBiSC; DRICUi041-A
DR   hPSCreg; DRICUi041-A
DR   Wikidata; Q123031186
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi042-A
AC   CVCL_D0EK
SY   ADANG10489CA
DR   BioSamples; SAMEA113429072
DR   EBiSC; DRICUi042-A
DR   hPSCreg; DRICUi042-A
DR   Wikidata; Q123031187
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi043-A
AC   CVCL_D0EL
SY   ADCAR20174CA
DR   BioSamples; SAMEA113429073
DR   EBiSC; DRICUi043-A
DR   hPSCreg; DRICUi043-A
DR   Wikidata; Q123031188
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi044-A
AC   CVCL_D0EM
SY   ADANG14363UC
DR   BioSamples; SAMEA113429074
DR   EBiSC; DRICUi044-A
DR   hPSCreg; DRICUi044-A
DR   Wikidata; Q123031189
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi045-A
AC   CVCL_D0EN
SY   ADANG10432CA
DR   BioSamples; SAMEA113429075
DR   EBiSC; DRICUi045-A
DR   hPSCreg; DRICUi045-A
DR   Wikidata; Q123031190
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   DRICUi046-A
AC   CVCL_D0EP
SY   ADCAR24372UC
DR   BioSamples; SAMEA113429076
DR   EBiSC; DRICUi046-A
DR   hPSCreg; DRICUi046-A
DR   Wikidata; Q123031191
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   DRICUi047-A
AC   CVCL_E3UF
SY   NE37A10018A
DR   BioSamples; SAMEA116075869
DR   EBiSC; DRICUi047-A
DR   hPSCreg; DRICUi047-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi048-A
AC   CVCL_E3UG
SY   MW14A10019A
DR   BioSamples; SAMEA116075871
DR   EBiSC; DRICUi048-A
DR   hPSCreg; DRICUi048-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi049-A
AC   CVCL_E3UH
SY   NT18A10004A
DR   BioSamples; SAMEA116075875
DR   EBiSC; DRICUi049-A
DR   hPSCreg; DRICUi049-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi050-A
AC   CVCL_E3UI
SY   NT18A10009A
DR   BioSamples; SAMEA116075881
DR   EBiSC; DRICUi050-A
DR   hPSCreg; DRICUi050-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi051-A
AC   CVCL_E3UJ
SY   CF00C90203A
DR   BioSamples; SAMEA116075883
DR   EBiSC; DRICUi051-A
DR   hPSCreg; DRICUi051-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi052-A
AC   CVCL_E3UK
SY   CF00C90003A
DR   BioSamples; SAMEA116075885
DR   EBiSC; DRICUi052-A
DR   hPSCreg; DRICUi052-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi053-A
AC   CVCL_E3UL
SY   ADLON40138CA
DR   BioSamples; SAMEA116075986
DR   EBiSC; DRICUi053-A
DR   hPSCreg; DRICUi053-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi054-A
AC   CVCL_E3UM
SY   ADLON40385CA
DR   BioSamples; SAMEA116075988
DR   EBiSC; DRICUi054-A
DR   hPSCreg; DRICUi054-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   DRICUi055-A
AC   CVCL_E3UN
SY   ADCAR20352CA
DR   BioSamples; SAMEA116075990
DR   EBiSC; DRICUi055-A
DR   hPSCreg; DRICUi055-A
CC   From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Drill A
AC   CVCL_R789
SY   Drill iPSC line A
DR   Wikidata; Q54831404
RX   PubMed=21892153;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Anecdotal: Established from Loon, a drill that lived in the San Diego zoo and who was trained to accept regular blood sampling and insulin injection in order to treat his diabetes mellitus.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9568; ! Mandrillus leucophaeus (Drill)
OI   CVCL_R790 ! Drill C
OI   CVCL_R791 ! Drill H
OI   CVCL_R792 ! Drill J
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Drill C
AC   CVCL_R790
SY   Drill iPSC line C
DR   Wikidata; Q54831405
RX   PubMed=21892153;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Anecdotal: Established from Loon, a drill that lived in the San Diego zoo and who was trained to accept regular blood sampling and insulin injection in order to treat his diabetes mellitus.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9568; ! Mandrillus leucophaeus (Drill)
OI   CVCL_R789 ! Drill A
OI   CVCL_R791 ! Drill H
OI   CVCL_R792 ! Drill J
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Drill H
AC   CVCL_R791
SY   Drill iPSC line H
DR   Wikidata; Q54831406
RX   PubMed=21892153;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Anecdotal: Established from Loon, a drill that lived in the San Diego zoo and who was trained to accept regular blood sampling and insulin injection in order to treat his diabetes mellitus.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9568; ! Mandrillus leucophaeus (Drill)
OI   CVCL_R789 ! Drill A
OI   CVCL_R790 ! Drill C
OI   CVCL_R792 ! Drill J
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Drill J
AC   CVCL_R792
SY   Drill iPSC line J
DR   Wikidata; Q54831407
RX   PubMed=21892153;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Anecdotal: Established from Loon, a drill that lived in the San Diego zoo and who was trained to accept regular blood sampling and insulin injection in order to treat his diabetes mellitus.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9568; ! Mandrillus leucophaeus (Drill)
OI   CVCL_R789 ! Drill A
OI   CVCL_R790 ! Drill C
OI   CVCL_R791 ! Drill H
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   DriPS16
AC   CVCL_0H62
DR   SKIP; SKIP000586
DR   Wikidata; Q54831408
RX   PubMed=25479750;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   dRLa-74
AC   CVCL_L636
DR   Wikidata; Q54831409
RX   PubMed=4258665;
RX   PubMed=4955999;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   247D
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   dRLa-74 Clone 2
AC   CVCL_6535
SY   dRLa-74 cl-2; JTC-36; Japanese Tissue Culture-36
DR   JCRB; JCRB0409
DR   Wikidata; Q54831410
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L636 ! dRLa-74
SX   Male
AG   247D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   dRLh-82
AC   CVCL_A9C2
DR   Wikidata; Q102113774
RX   PubMed=4955999;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   330D
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   dRLh-84
AC   CVCL_6536
SY   dRLh84
DR   JCRB; JCRB0410
DR   Wikidata; Q54831411
RX   PubMed=4258665;
RX   PubMed=4955999;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   406D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   dRLN-4
AC   CVCL_6537
DR   JCRB; JCRB0418
DR   Wikidata; Q54831412
RX   DOI=10.4044/joma1947.90.11-12_1377;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   95D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   dRLN-53
AC   CVCL_E900
DR   Wikidata; Q54831413
RX   PubMed=4258665;
RX   PubMed=4955999;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   110D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   dRLN-6
AC   CVCL_6538
DR   JCRB; JCRB0420
DR   Wikidata; Q54831414
RX   DOI=10.4044/joma1947.90.11-12_1377;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   127D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   dRLN-60
AC   CVCL_L637
DR   Wikidata; Q54831415
RX   PubMed=4258665;
RX   PubMed=4955999;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   160D
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   dRLN-61
AC   CVCL_L638
DR   Wikidata; Q54831416
RX   PubMed=4258665;
RX   PubMed=4955999;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   195D
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   dRLN-9
AC   CVCL_6539
DR   JCRB; JCRB0419
DR   Wikidata; Q54831417
RX   DOI=10.4044/joma1947.90.11-12_1377;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   98D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   DRM
AC   CVCL_1G81
SY   Danio Rerio Muscle
DR   NRFC; NRFC050
DR   Wikidata; Q54831418
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=26985868;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC050.
CC   Miscellaneous: Cell line is no longer available (NRFC=NRFC050).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Male
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   DRO
AC   CVCL_6286
SY   DRO-90-1; DRO 90-1; DRO90-1; DRO-90; RO 90-D-1; UCLA RO 90-D-1
DR   BioSample; SAMN03151608
DR   BioSample; SAMN03151609
DR   cancercelllines; CVCL_6286
DR   Cosmic; 886551
DR   Cosmic; 888278
DR   Cosmic; 913249
DR   Cosmic; 1155330
DR   Wikidata; Q54831419
RX   PubMed=8871538;
RX   PubMed=18713817;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a A-375 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
CC   From: Juillard, Guy Jean-Felix; University of California, Los Angeles; Los Angeles; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00188.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): PubMed=18713817; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,14
ST   FGA: 20,23
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   DRP 153
AC   CVCL_T701
DR   Wikidata; Q54831420
RX   PubMed=2569015;
RX   PubMed=2910704;
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_4345 ! ICR-2A
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   DRP 36
AC   CVCL_T700
SY   DRP36
DR   Wikidata; Q54831421
RX   PubMed=2569015;
RX   PubMed=2910704;
RX   PubMed=3500873;
RX   PubMed=3860965;
RX   PubMed=4033674;
CC   Group: Amphibian cell line.
CC   Doubling time: 48 hours (PubMed=3500873).
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_4345 ! ICR-2A
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   DrRPE
AC   CVCL_UZ53
SY   DRE; Danio rerio Retinal Pigment Epithelium
DR   NRFC; NRFC054
DR   Wikidata; Q93531750
RX   PubMed=25517103;
WW   Provider; AAHL; -; https://aahl.res.in/zebra-fish-danio-rerio-eye-dre-fin-drf-and-gill-drg-cell-lines/
WW   Provider; NRFC; NRFC054; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC054.
CC   Characteristics: UV-B exposure results in morphological alterations. Optimal growth at 28 Celsius (PubMed=25517103).
CC   Doubling time: ~40 hours (Note=In L-15 medium + 10% FBS) (PubMed=25517103).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   DRS [Rabbit]
AC   CVCL_3677
DR   CLO; CLO_0002819
DR   ATCC; CRL-6497
DR   Wikidata; Q54831422
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6497; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   DRS [Xenopus]
AC   CVCL_C3M4
SY   Danio Rero Skin
DR   Wikidata; Q116048909
RX   PubMed=36289143;
CC   Group: Fish cell line.
CC   Doubling time: 31 hours (Note=At 11th passage) (PubMed=36289143).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   Drsub-H
AC   CVCL_DF36
DR   Wikidata; Q54831423
RX   PubMed=16948501;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7241; ! Drosophila subobscura (Fruit fly)
SX   Sex unspecified
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   Drsub-WT
AC   CVCL_DF37
DR   Wikidata; Q54831424
RX   PubMed=16948501;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7241; ! Drosophila subobscura (Fruit fly)
SX   Sex unspecified
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   DRXT18s02
AC   CVCL_C1E3
SY   DRXT 18s02
DR   Wikidata; Q114311332
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/DRXT18s02_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DRXT18s03
AC   CVCL_C1E4
SY   DRXT 18s03
DR   Wikidata; Q114311334
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/DRXT18s03_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DRXT28s04
AC   CVCL_C1E5
SY   DRXT 28s04
DR   Wikidata; Q114311335
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/DRXT28s04_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DRXT28s05
AC   CVCL_C1E6
SY   DRXT 28s05
DR   Wikidata; Q114311336
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/DRXT28s05_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DRXT28s17
AC   CVCL_C1E7
SY   DRXT 28s17
DR   Wikidata; Q114311337
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/DRXT28s17_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DS
AC   CVCL_QX99
DR   ATCC; CRL-3381
DR   Cosmic; 1086333
DR   Wikidata; Q54831425
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8035608;
RX   PubMed=8558920;
RX   PubMed=20664054;
RX   PubMed=20889926;
RX   PubMed=26727417;
RX   PubMed=29416618;
RX   PubMed=29666304;
CC   Population: Caucasian.
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, immunoblastic-type.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-3381
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 9
//
ID   DS-1 [Human]
AC   CVCL_5278
DR   CLO; CLO_0002821
DR   ATCC; CRL-3589
DR   ATCC; CRL-11102
DR   BioSample; SAMN03471329
DR   FANTOM5_SSTAR; 10727-110A7
DR   Wikidata; Q54831426
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5556947;
RX   Patent=WO1994004659A1;
RX   PubMed=8142604;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=DS-1
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11102.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Discontinued: ATCC; CRL-11102; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3589
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 8,14
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   NCIt; C97087; Lymphangiectasia
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   DS-1 [Mouse hybridoma against dog SFTPA1]
AC   CVCL_5279
DR   CLO; CLO_0002822
DR   ATCC; HB-8906
DR   Wikidata; Q54831427
RX   Patent=US4656253;
RX   PubMed=3277500;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8906.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   DS-1-iPSC
AC   CVCL_A3ZB
DR   SKIP; SKIP003049
DR   Wikidata; Q105506772
RX   PubMed=29295803;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:4976; HLCS; Simple; p.Gly261Valfs*20 (c.782delG); ClinVar=VCV000203777; Zygosity=Heterozygous (PubMed=29295803).
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Gly1410Trp (c.4261G>T); Zygosity=Heterozygous (PubMed=29295803).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   DS-2-iPSC
AC   CVCL_A3ZC
DR   SKIP; SKIP003050
DR   Wikidata; Q105506776
RX   PubMed=29295803;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Ile1183Cysfs*21 (c.3576_3580delTCAAA); Zygosity=Heterozygous (PubMed=29295803).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   DS-3
AC   CVCL_C450
DR   CLO; CLO_0002825
DR   ATCC; HB-8651
DR   Wikidata; Q54831428
RX   Patent=US4656253;
RX   PubMed=3277500;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8651.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   DS-5
AC   CVCL_C449
DR   CLO; CLO_0002826
DR   ATCC; HB-8653
DR   Wikidata; Q54831429
RX   Patent=US4656253;
RX   PubMed=3277500;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8653.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   DS-6
AC   CVCL_C448
DR   CLO; CLO_0002827
DR   ATCC; HB-8652
DR   Wikidata; Q54831430
RX   Patent=US4656253;
RX   PubMed=3277500;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8652.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   DS-T3
AC   CVCL_R775
SY   Dolphin Skin-Transformed 3
DR   Wikidata; Q54831431
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIP SV 776-1).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   DS-T4
AC   CVCL_R776
SY   Dolphin Skin-Transformed 4
DR   Wikidata; Q54831435
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIP SV 776-1).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   DS1 [Dog bone marrow]
AC   CVCL_D1HT
SY   DS-1
DR   ABM; T0687
DR   Wikidata; Q127380802
RX   PubMed=20816818;
RX   PubMed=23520463;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_D1HU ! DS2 [Dog bone marrow]
OI   CVCL_D1HV ! DS3 [Dog bone marrow]
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   DS1 [Mouse hybridoma]
AC   CVCL_G559
DR   ATCC; CRL-2484
DR   Wikidata; Q54831436
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   DS1 [Tursiops]
AC   CVCL_7893
SY   Dolphin Skin 1
DR   Wikidata; Q54831437
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   DS1-iPS
AC   CVCL_ZA02
SY   DS-iPS clone 18; C18
DR   GEO; GSM1053970
DR   GEO; GSM1053971
DR   GEO; GSM1053972
DR   GEO; GSM1053994
DR   GEO; GSM1053995
DR   GEO; GSM1053996
DR   Wikidata; Q98125921
RX   PubMed=23225669;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2430 ! Detroit 532
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   DS1-iPS4
AC   CVCL_D012
SY   DS1-IPS4
DR   Wikidata; Q54831438
RX   Patent=US20110151447;
RX   PubMed=18691744;
RX   PubMed=22344463;
RX   PubMed=23045682;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L780 ! AG05397
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   DS1-iPS4-Disomic
AC   CVCL_C1XZ
DR   Wikidata; Q114311338
RX   PubMed=23045682;
CC   Population: Caucasian.
CC   Karyotypic information: Lost the third copy of chromosome 21 (PubMed=23045682).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D012 ! DS1-iPS4
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   DS1-iPS4-Trisomic
AC   CVCL_C1Y0
DR   Wikidata; Q114311339
RX   PubMed=23045682;
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D012 ! DS1-iPS4
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   DS179
AC   CVCL_W747
SY   DS 179
DR   cancercelllines; CVCL_W747
DR   Cosmic; 2808225
DR   Wikidata; Q54831439
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=6286763;
RX   PubMed=8176200;
RX   PubMed=8220424;
RX   PubMed=8344493;
RX   PubMed=8568269;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=8344493).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 15
//
ID   DS2 [Dog bone marrow]
AC   CVCL_D1HU
SY   DS-2
DR   Wikidata; Q127380803
RX   PubMed=20816818;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_D1HT ! DS1 [Dog bone marrow]
OI   CVCL_D1HV ! DS3 [Dog bone marrow]
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   DS2 [Tursiops]
AC   CVCL_7894
SY   Dolphin Skin 2
DR   Wikidata; Q54831440
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 11
//
ID   DS2-iPS
AC   CVCL_ZA03
SY   DS-iPS clone 11; C11
DR   GEO; GSM1053964
DR   GEO; GSM1053965
DR   GEO; GSM1053966
DR   GEO; GSM1053991
DR   GEO; GSM1053992
DR   GEO; GSM1053993
DR   Wikidata; Q98125923
RX   PubMed=23225669;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2430 ! Detroit 532
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   DS2-iPS1
AC   CVCL_D013
SY   DS2-IPS1
DR   Wikidata; Q54831441
RX   Patent=US20110151447;
RX   PubMed=18691744;
RX   PubMed=23045682;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D014 ! DS2-iPS10
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   DS2-iPS10
AC   CVCL_D014
SY   DS2-IPS10
DR   Wikidata; Q54831442
RX   Patent=US20110151447;
RX   PubMed=18691744;
RX   PubMed=23045682;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D013 ! DS2-iPS1
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   DS2D3
AC   CVCL_B0SU
DR   CCRID; 4201PAT-CCTCC00750
DR   Wikidata; Q108820164
RX   Patent=CN105198990B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015145.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Bacillus thuringiensis crystal proteins Cry1A to Cry1F.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   DS3 [Dog bone marrow]
AC   CVCL_D1HV
SY   DS-3
DR   Wikidata; Q127380804
RX   PubMed=20816818;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_D1HT ! DS1 [Dog bone marrow]
OI   CVCL_D1HU ! DS2 [Dog bone marrow]
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   DS3 [Tursiops]
AC   CVCL_7895
SY   Dolphin Skin 3
DR   Wikidata; Q54831443
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 11
//
ID   DS4
AC   CVCL_7896
SY   Dolphin Skin 4
DR   Wikidata; Q54831444
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   DS5
AC   CVCL_7897
SY   Dolphin Skin 5
DR   Wikidata; Q54831445
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   DS6
AC   CVCL_7898
SY   Dolphin Skin 6
DR   Wikidata; Q54831447
RX   PubMed=16281302;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   DSA31N
AC   CVCL_JD70
SY   Extract 385; Extract 565
DR   IPD-IMGT/HLA; 14513
DR   Wikidata; Q54831448
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/325cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/370cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:02:01,31:14N; B*35:03,44; C*04:KBG,16; DQB1*02:02; DRB1*07:01; DRB4*01:01 (IPD-IMGT/HLA=14513).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   DSCS
AC   CVCL_D2PK
SY   Dental Stem Cells SV40
DR   Wikidata; Q127380805
RX   PubMed=36585930;
CC   Doubling time: 23.46 hours (PubMed=36585930).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tooth root, apical papilla; UBERON=UBERON_8480031.
CC   Cell type: Mesenchymal stem cell of the apical papilla; CL=CL_4040005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   DSDh
AC   CVCL_1918
DR   CLO; CLO_0002828
DR   ATCC; CRL-2131
DR   Wikidata; Q54831449
RX   PubMed=2304918;
CC   Group: Retrovirus packaging cell line.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Glu63Lys (c.187G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:94890; Dhfr (Note=With p.Leu23Arg; methotrexate-resistant).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03399; Avian reticuloendotheliosis virus env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03360; Avian reticuloendotheliosis virus gag-pol.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_1916 ! D-17
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   DSH1
AC   CVCL_1182
DR   CLO; CLO_0037158
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1182
DR   Cell_Model_Passport; SIDM00970
DR   ChEMBL-Cells; CHEMBL3308520
DR   ChEMBL-Targets; CHEMBL2366079
DR   Cosmic; 753552
DR   Cosmic; 1046688
DR   Cosmic; 1175826
DR   Cosmic; 1285116
DR   Cosmic; 1285991
DR   Cosmic; 2050441
DR   Cosmic; 2057445
DR   Cosmic; 2444226
DR   Cosmic; 2685943
DR   Cosmic-CLP; 753552
DR   DepMap; ACH-002235
DR   EGA; EGAS00001000978
DR   GDSC; 753552
DR   GEO; GSM1669744
DR   IARC_TP53; 21312
DR   LINCS_LDP; LCL-1706
DR   PharmacoDB; DSH1_308_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1182
DR   Wikidata; Q54831450
RX   PubMed=11921286;
RX   PubMed=15846775;
RX   PubMed=20164919;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Homozygous (Cosmic-CLP=753552; DepMap=ACH-002235).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.74%; Native American=0%; East Asian, North=71.8%; East Asian, South=26.84%; South Asian=0%; European, North=0%; European, South=0.61% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Cosmic-CLP=753552
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   DSH1PV
AC   CVCL_L867
SY   Dyschromatosis Symmetrica Hereditaria 1 PaVia
DR   CLO; CLO_0002830
DR   CLDB; cl1102
DR   Wikidata; Q54831451
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   DSH2PV
AC   CVCL_L868
SY   Dyschromatosis Symmetrica Hereditaria 2 PaVia
DR   CLO; CLO_0002831
DR   CLDB; cl1103
DR   Wikidata; Q54831452
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   DSH3PV
AC   CVCL_L869
SY   Dyschromatosis Symmetrica Hereditaria 3 PaVia
DR   CLO; CLO_0002832
DR   CLDB; cl1104
DR   Wikidata; Q54831453
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   DSH4PV
AC   CVCL_L870
SY   Dyschromatosis Symmetrica Hereditaria 4 PaVia
DR   CLO; CLO_0002833
DR   CLDB; cl1105
DR   Wikidata; Q54831454
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118435; Dyschromatosis symmetrica hereditaria
DI   ORDO; Orphanet_41; Dyschromatosis symmetrica hereditaria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   DSHB-GFP-12A6
AC   CVCL_C2JH
SY   12A6
DR   DSHB; DSHB-GFP-12A6
DR   Wikidata; Q114311340
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DSHB-GFP-12E6
AC   CVCL_C2JI
SY   12E6
DR   DSHB; DSHB-GFP-12E6
DR   Wikidata; Q114311341
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DSHB-GFP-1D2
AC   CVCL_C2JJ
DR   DSHB; DSHB-GFP-1D2
DR   Wikidata; Q114311342
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   DSHB-GFP-1G9
AC   CVCL_C2JK
SY   1G9
DR   DSHB; DSHB-GFP-1G9
DR   Wikidata; Q114311343
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DSHB-GFP-2G6
AC   CVCL_C2JL
SY   2G6
DR   DSHB; DSHB-GFP-2G6
DR   Wikidata; Q114311344
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DSHB-GFP-4C9
AC   CVCL_C2JM
SY   4C9
DR   DSHB; DSHB-GFP-4C9
DR   Wikidata; Q114311345
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DSHB-GFP-4D5
AC   CVCL_E7CU
SY   4D5
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DSHB-GFP-7F11
AC   CVCL_E7CT
SY   7F11
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DSHB-GFP-8H11
AC   CVCL_C2JN
SY   8H11
DR   DSHB; DSHB-GFP-8H11
DR   Wikidata; Q114311346
RX   PubMed=24746148;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   DSHB-GFP3-1F5
AC   CVCL_C2JP
DR   DSHB; DSHB-GFP3-1F5
DR   Wikidata; Q114311348
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   DSHB-GFP3-2F6
AC   CVCL_C2JQ
DR   DSHB; DSHB-GFP3-2F6
DR   Wikidata; Q114311349
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   DSHB-hGAPDH-2G7
AC   CVCL_E7CR
SY   2G7
DR   DSHB; DSHB-hGAPDH-2G7
RX   PubMed=27556912;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04406; Human GAPDH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DSHB-hGAPDH-4B7
AC   CVCL_E7CS
SY   4B7
DR   DSHB; DSHB-hGAPDH-4B7
RX   PubMed=27556912;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04406; Human GAPDH.
CC   Discontinued: DSHB; DSHB-hGAPDH-4B7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DSHB-LUC-16
AC   CVCL_C2JR
DR   DSHB; DSHB-LUC-16
DR   Wikidata; Q114311350
RX   PubMed=29474160;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   DSHB-LUC-2
AC   CVCL_C2JT
DR   DSHB; DSHB-LUC-2
DR   Wikidata; Q114311352
RX   PubMed=29474160;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   DSHB-LUC-24
AC   CVCL_C2JS
DR   DSHB; DSHB-LUC-24
DR   Wikidata; Q114311351
RX   PubMed=29474160;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: DSHB; DSHB-LUC-24; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   DSHB-LUC-3
AC   CVCL_C2JU
DR   DSHB; DSHB-LUC-3
DR   Wikidata; Q114311353
RX   PubMed=29474160;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: DSHB; DSHB-LUC-3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   DSHB-LUC-9
AC   CVCL_C2JV
DR   DSHB; DSHB-LUC-9
DR   Wikidata; Q114311354
RX   PubMed=29474160;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: DSHB; DSHB-LUC-9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   DSHB-MBP-2A1
AC   CVCL_C2JW
DR   DSHB; DSHB-MBP-2A1
DR   Wikidata; Q114311355
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0AEX9; Escherichia coli malE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   DSHB-MBP-3D7
AC   CVCL_C2JX
DR   DSHB; DSHB-MBP-3D7
DR   Wikidata; Q114311357
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0AEX9; Escherichia coli malE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   DSHB-mCherry-3A11
AC   CVCL_C2JY
DR   DSHB; DSHB-mCherry-3A11
DR   Wikidata; Q114311358
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   DSHB-mCherry-3D5
AC   CVCL_C2JZ
DR   DSHB; DSHB-mCherry-3D5
DR   Wikidata; Q114311359
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   DSIR-HA-1179
AC   CVCL_Z330
SY   DSIR-HA1179
DR   ICLDB; dsir-ha1179
DR   Wikidata; Q54831455
RX   DOI=10.1007/BF02796321;
RX   DOI=10.1080/03014223.1983.10423936;
RX   DOI=10.26021/1964;
RX   PubMed=8799737;
RX   PubMed=16409117;
RX   PubMed=23979321;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Oryctes rhinoceros nudivirus (OrNV).
CC   Doubling time: 6 days (DOI=10.1007/BF02796321).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=295550; ! Heteronychus arator (African black beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   DSL-6A/C1
AC   CVCL_4166
SY   DSL-6A-C1; DSL6A/C1
DR   CLO; CLO_0002834
DR   AddexBio; C0018011/4883
DR   ATCC; CRL-2132
DR   ChEMBL-Cells; CHEMBL4802058
DR   CLS; 500166
DR   ECACC; 94022431
DR   PubChem_Cell_line; CVCL_4166
DR   Wikidata; Q54831456
RX   PubMed=8391218;
CC   Transformant: ChEBI; CHEBI_74846; Azaserine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_W197 ! DSL-6B/C1
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   DSL-6B/C1
AC   CVCL_W197
SY   DSL-6B-C1; DSL6B/C1
DR   Wikidata; Q54831457
RX   PubMed=8391218;
CC   Transformant: ChEBI; CHEBI_74846; Azaserine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4166 ! DSL-6A/C1
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   DSL-6B/C2
AC   CVCL_4167
SY   DSL-6B-C2; DSL6B/C2
DR   CLO; CLO_0002835
DR   ATCC; CRL-2133
DR   CLS; 500167
DR   Wikidata; Q54831458
RX   PubMed=8391218;
CC   Transformant: ChEBI; CHEBI_74846; Azaserine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_W197 ! DSL-6B/C1
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   DSM ACC2258
AC   CVCL_B5TF
DR   Wikidata; Q111733162
RX   Patent=US6395542;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2258.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   DSN
AC   CVCL_1919
DR   CLO; CLO_0002836
DR   ATCC; CRL-9939
DR   Wikidata; Q54831459
RX   Patent=US5124263;
RX   PubMed=2524600;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9939.
CC   Sequence variation: Mutation; VGNC; VGNC:42508; KRAS; Simple; p.Glu63Lys (c.187G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03399; Avian reticuloendotheliosis virus env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03360; Avian reticuloendotheliosis virus gag-pol.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_1916 ! D-17
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   DSPT200
AC   CVCL_2890
DR   JCRB; JCRB0217
DR   Wikidata; Q54831460
CC   Transformant: Unknown.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   DSS3
AC   CVCL_Y626
DR   Wikidata; Q54831461
RX   PubMed=23954875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   DSV2
AC   CVCL_Y627
DR   Wikidata; Q54831462
RX   PubMed=21861759;
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   DSY127
AC   CVCL_ZC38
SY   DSY127_ES
DR   GEO; GSM4610405
DR   Wikidata; Q98125925
RX   PubMed=31178141;
RX   PubMed=32151954;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   DSY127-BV8VT1
AC   CVCL_ZC39
DR   SKIP; SKIP005695
DR   Wikidata; Q98125926
RX   PubMed=32151954;
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; F7GM67; PRDM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_ZC38 ! DSY127
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   DT-6I
AC   CVCL_YQ04
SY   DT6I
DR   Wikidata; Q93532057
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=25015330;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 5
//
ID   DT1CPEx
AC   CVCL_1G82
SY   Dascyllus Trimaculatus 1 Caudal Peduncle Explant
DR   NRFC; NRFC024
DR   Wikidata; Q54831463
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC024; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC024.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=50790; ! Dascyllus trimaculatus (Tree-spot damselfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   DT1CPTr
AC   CVCL_1G83
SY   Dascyllus Trimaculatus 1 Caudal Peduncle Trypsinised
DR   NRFC; NRFC026
DR   Wikidata; Q54831464
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC026; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC026.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=50790; ! Dascyllus trimaculatus (Tree-spot damselfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   DT1F4Ex
AC   CVCL_1G84
SY   Dascyllus Trimaculatus 1 Fin 4 Explant
DR   NRFC; NRFC025
DR   Wikidata; Q54831465
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC025; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC025.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=50790; ! Dascyllus trimaculatus (Tree-spot damselfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   DT28
AC   CVCL_D4YK
DR   Wikidata; Q127380806
RX   PubMed=24567196;
RX   PubMed=34216317;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: When injected into the mammary fat pad of NOD/SCID mice, forms spontaneous metastasis from the orthotopic site to lymph nodes and lung (PubMed=24567196).
CC   Doubling time: 48 hours (PubMed=24567196).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   DT40
AC   CVCL_0249
SY   DT-40; DT 40; DT40B; LSCC-DT40
DR   BTO; BTO_0004814
DR   CLO; CLO_0002837
DR   CLO; CLO_0051524
DR   EFO; EFO_0006274
DR   MCCL; MCC:0000139
DR   ATCC; CRL-2111
DR   DSMZ; ACC-636
DR   DSMZCellDive; ACC-636
DR   JCRB; JCRB9130
DR   Lonza; 267
DR   NCBI_Iran; C618
DR   RCB; RCB1464
DR   TOKU-E; 1101
DR   Wikidata; Q54831466
RX   PubMed=2998040;
RX   PubMed=11226459;
RX   PubMed=17675859;
RX   PubMed=18766641;
RX   PubMed=19181659;
RX   PubMed=25227228;
RX   PubMed=26217713;
WW   Info; -; -; https://web.archive.org/web/20151216020045/http://www2.mrc-lmb.cam.ac.uk/groups/jes/pages/dt40.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-140.html
CC   Group: Bird cell line.
CC   Doubling time: ~48 hours (DSMZ=ACC-636); ~1 day (Note=Lot 02272006) (JCRB=JCRB9130).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   DT40 CL18
AC   CVCL_J437
SY   DT40 cl18; CL18; CL-18; Clone 18
DR   Wikidata; Q54831467
RX   PubMed=2155784;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   DT40 Cre1
AC   CVCL_6D46
DR   RCB; RCB1851
DR   Wikidata; Q54831468
RX   PubMed=17363341;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01104; Avian myeloblastosis virus v-myb.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40(v-myb)delta-pol-beta
AC   CVCL_6D43
DR   RCB; RCB1818
DR   Wikidata; Q54831550
RX   PubMed=17363341;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 2752; POLB.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01104; Avian myeloblastosis virus v-myb.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40(v-myb)delta-pol-beta-delta-pol-lambda
AC   CVCL_6D45
DR   RCB; RCB1820
DR   Wikidata; Q54831551
RX   PubMed=17363341;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 2752; POLB.
CC   Knockout cell: Method=Targeted integration; CGNC; 5862; POLL.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01104; Avian myeloblastosis virus v-myb.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40(v-myb)delta-pol-lambda
AC   CVCL_6D44
DR   RCB; RCB1819
DR   Wikidata; Q54831552
RX   PubMed=17363341;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 5862; POLL.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01104; Avian myeloblastosis virus v-myb.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40(v-myb)WT
AC   CVCL_6D42
DR   RCB; RCB1817
DR   Wikidata; Q54831553
RX   PubMed=17363341;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01104; Avian myeloblastosis virus v-myb.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40-ATM(-/-)
AC   CVCL_1T23
SY   ATM-/- DT40; Delta-Atm-DT40
DR   CLO; CLO_0051493
DR   RCB; RCB1649
DR   Wikidata; Q54831469
RX   PubMed=10597300;
RX   PubMed=10654944;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12888; ATM.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-ATM(-/-)-RAD5L(-/-) hRad54
AC   CVCL_LH54
SY   delta-Atm-delta-Rad54+hRad54-DT40; DT40 ATM-/-/RAD54-/- Rad54+
DR   CLO; CLO_0051494
DR   RCB; RCB1651
DR   Wikidata; Q54831470
RX   PubMed=10654944;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12888; ATM.
CC   Knockout cell: Method=Targeted integration; CGNC; 7881; RAD54L.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9826; RAD54L.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_1T34 ! DT40-RAD54L(-/-)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   DT40-ATM(-/-)-XRCC6(-/-)
AC   CVCL_1T24
SY   ATM-/- Ku70-/- DT40; Delta-Atm-delta-Ku70-DT40
DR   CLO; CLO_0051500
DR   RCB; RCB1650
DR   Wikidata; Q54831471
RX   PubMed=10654944;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12888; ATM.
CC   Knockout cell: Method=Targeted integration; CGNC; 9044; XRCC6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_1T23 ! DT40-ATM(-/-)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-BLM(-/-)
AC   CVCL_1T25
SY   BLM-/- DT40; Delta-BLM-DT40
DR   CLO; CLO_0051518
DR   RCB; RCB1811
DR   Wikidata; Q54831472
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 6254; BLM.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-BLM(-/-)-WRN(-/-)
AC   CVCL_2H96
SY   Delta-WRN-delta-BLM-DT40
DR   CLO; CLO_0051521
DR   RCB; RCB1813
DR   Wikidata; Q54831473
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 6254; BLM.
CC   Knockout cell: Method=Targeted integration; CGNC; 7822; WRN.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-BLNK(-/-)
AC   CVCL_1T38
SY   BLNK-/- DT40; BLNK^(-) DT40
DR   CLO; CLO_0051487
DR   RCB; RCB1510
DR   Wikidata; Q54831474
RX   PubMed=10023776;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 5261; SH2D6/BLNK.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-BLNK(-/-)-GRB2(-/-)
AC   CVCL_4E62
SY   BLNK^(-)Grb2^(-)DT40
DR   CLO; CLO_0051471
DR   RCB; RCB1860
DR   Wikidata; Q54831475
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 5261; SH2D6/BLNK.
CC   Knockout cell: Method=Targeted integration; CGNC; 6067; GRB2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-BLNK(-/-)-SYK(-/-)
AC   CVCL_1T52
SY   BLNK^(-)/Syk^(-) DT40; Syk-BLNK- DT40
DR   CLO; CLO_0051475
DR   RCB; RCB1704
DR   Wikidata; Q54831479
RX   PubMed=10993915;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 5261; SH2D6/BLNK.
CC   Knockout cell: Method=Targeted integration; CGNC; 53036; SYK.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_1T38 ! DT40-BLNK(-/-)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-BTK(-/-)
AC   CVCL_1T45
SY   BTK-/- DT40; Btk^(-) DT40
DR   CLO; CLO_0051476
DR   RCB; RCB1468
DR   Wikidata; Q54831480
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 3685; BTK.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-CARD11(-/-)
AC   CVCL_1T40
SY   CARMA1-/- DT40; CARMA1^(-)DT40
DR   CLO; CLO_0051525
DR   RCB; RCB2296
DR   Wikidata; Q54831481
RX   PubMed=16301747;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 50263; CARD11.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-CBL(-/-)
AC   CVCL_1T46
SY   CBL-/- DT40; Cbl^(-) DT40
DR   CLO; CLO_0051488
DR   RCB; RCB1675
DR   Wikidata; Q54831482
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49015; CBL.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-GRAP(-/-)
AC   CVCL_1U33
SY   GRAP-/- DT40; Grap^(-) DT40
DR   CLO; CLO_0051480
DR   RCB; RCB1498
DR   Wikidata; Q54831483
RX   PubMed=9763608;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 50277; GRAPL.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-GRB2(-/-)
AC   CVCL_1U32
SY   GRB2-/- DT40; Grb2^(-) DT40
DR   CLO; CLO_0051473
DR   RCB; RCB1499
DR   Wikidata; Q54831484
RX   PubMed=9763608;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 6067; GRB2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-GRB2(-/-)-GRAP(-/-)
AC   CVCL_4E68
SY   Grb2^(-)/Grap^(-) DT40
DR   CLO; CLO_0051483
DR   RCB; RCB1836
DR   Wikidata; Q54831485
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 6067; GRB2.
CC   Knockout cell: Method=Targeted integration; CGNC; 50277; GRAPL.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-INPP5D(-/-)
AC   CVCL_2G93
SY   SHIP^(-) DT40; SHIP-deficient DT40
DR   CLO; CLO_0051472
DR   RCB; RCB1465
DR   Wikidata; Q54831486
RX   PubMed=9244303;
RX   PubMed=9547347;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 52250; INPP5D.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-ITRP1(-/-)-ITPR2(-/-)
AC   CVCL_8B31
SY   IP3R type1^(-)/2^(-) DT40
DR   CLO; CLO_0051501
DR   RCB; RCB1717
DR   Wikidata; Q54831487
RX   PubMed=9214625;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49305; ITPR1.
CC   Knockout cell: Method=Targeted integration; CGNC; 10502; ITPR2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40-ITRP1(-/-)-ITPR2(-/-)-ITPR3(-/-)
AC   CVCL_4634
AS   CVCL_8B34
SY   IP3R^(-) DT40; DT40-3KO; DT40 3KO; DT-40 3KO; Dt-40 3ko
DR   BTO; BTO_0005034
DR   CLO; CLO_0051504
DR   RCB; RCB1467
DR   Wikidata; Q54831488
RX   PubMed=9214625;
RX   PubMed=27048566;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49305; ITPR1.
CC   Knockout cell: Method=Targeted integration; CGNC; 10502; ITPR2.
CC   Knockout cell: Method=Targeted integration; CGNC; 2283; ITPR3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   DT40-ITRP1(-/-)-ITPR3(-/-)
AC   CVCL_8B32
SY   IP3R type1^(-)/3^(-) DT40
DR   CLO; CLO_0051481
DR   RCB; RCB1718
DR   Wikidata; Q54831489
RX   PubMed=10064596;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49305; ITPR1.
CC   Knockout cell: Method=Targeted integration; CGNC; 2283; ITPR3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40-ITRP2(-/-)-ITPR3(-/-)
AC   CVCL_8B33
SY   IP3R type2^(-)/3^(-) DT40
DR   CLO; CLO_0051482
DR   RCB; RCB1719
DR   Wikidata; Q54831490
RX   PubMed=10064596;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10502; ITPR2.
CC   Knockout cell: Method=Targeted integration; CGNC; 2283; ITPR3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40-LIG4(-/-)
AC   CVCL_1T44
SY   Delta-ligIV-DT40
DR   CLO; CLO_0051528
DR   RCB; RCB1766
DR   Wikidata; Q54831491
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12647; LIG4.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-LYN(-/-)
AC   CVCL_1T41
SY   LYN-/- DT40; Lyn^(-) DT40
DR   CLO; CLO_0051479
DR   RCB; RCB1471
DR   Wikidata; Q54831492
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 51418; LYN.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-LYN(-/-)-SYK(-/-)
AC   CVCL_2H33
SY   Lyn^(-)/Syk^(-) DT40
DR   CLO; CLO_0051497
DR   RCB; RCB1500
DR   Wikidata; Q54831493
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 51418; LYN.
CC   Knockout cell: Method=Targeted integration; CGNC; 53036; SYK.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-MAP3K7(-/-)
AC   CVCL_1T50
SY   TAK1-/- DT40; TAK1^(-)DT40
DR   CLO; CLO_0051527
DR   RCB; RCB2298
DR   Wikidata; Q54831494
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 11625; MAP3K7.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-MRE11(-/-) clone #190
AC   CVCL_JE98
SY   Delta-Mre11-DT40(#190)
DR   CLO; CLO_0051503
DR   RCB; RCB1630
DR   Wikidata; Q54831495
RX   PubMed=10581236;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12932; MRE11.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 9
//
ID   DT40-MRE11(-/-) clone #194
AC   CVCL_JE99
SY   Delta-Mre11-DT40(#194)
DR   CLO; CLO_0051502
DR   RCB; RCB1629
DR   Wikidata; Q54831496
RX   PubMed=10581236;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12932; MRE11.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 10
//
ID   DT40-MRE11(-/-)-XRCC6(-/-)
AC   CVCL_4Z66
SY   Delta-Mre11-delta-Ku70-DT40; DT40 MRE11-/-/KU70-/-
DR   CLO; CLO_0051530
DR   RCB; RCB1633
DR   Wikidata; Q54831497
RX   PubMed=10581236;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12932; MRE11.
CC   Knockout cell: Method=Targeted integration; CGNC; 9044; XRCC6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-NBN(-/-)
AC   CVCL_1T33
SY   Delta-NBS1-DT40
DR   CLO; CLO_0051505
DR   RCB; RCB1747
DR   Wikidata; Q54831498
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 11872; NBN.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-ORAI1(-/-)
AC   CVCL_1T26
SY   Orai1^(-/-)DT40
DR   RCB; RCB4518
DR   Wikidata; Q54831499
RX   PubMed=20679432;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 3116; ORAI1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-ORAI2(-/-)
AC   CVCL_1T27
SY   Orai2^(-/-)DT40
DR   RCB; RCB4519
DR   Wikidata; Q54831500
RX   PubMed=20679432;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 1293; ORAI2/ORAI3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-PIK3AP1(-/-)
AC   CVCL_1T39
SY   BCAP^(-) DT40
DR   CLO; CLO_0051489
DR   RCB; RCB1716
DR   Wikidata; Q54831501
RX   PubMed=11163197;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 4133; PIK3AP1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-PIK3CA(-/-)
AC   CVCL_4E64
SY   PI3Kp110alpha^(-) DT40
DR   CLO; CLO_0051491
DR   RCB; RCB1810
DR   Wikidata; Q54831502
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 6785; PIK3CA.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-PLCG2(-/-)
AC   CVCL_1T47
SY   PLC-gamma2^(-) DT40
DR   CLO; CLO_0051477
DR   RCB; RCB1469
DR   Wikidata; Q54831503
RX   PubMed=9763608;
RX   PubMed=14676298;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 4062; PLCG2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-POLK(-/-)
AC   CVCL_1T32
SY   Delta-DinB-DT40
DR   CLO; CLO_0051506
DR   RCB; RCB1749
DR   Wikidata; Q54831504
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 48998; POLK.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-POLK(-/-)-XPA(-/-)
AC   CVCL_4E66
SY   Delta-DinB-delta-XPA-DT40
DR   CLO; CLO_0051516
DR   RCB; RCB1814
DR   Wikidata; Q54831505
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 48998; POLK.
CC   Knockout cell: Method=Targeted integration; CGNC; 66210; XPA.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-PRKCB(-/-)
AC   CVCL_1T42
SY   PKCbeta^(-)DT40
DR   CLO; CLO_0051526
DR   RCB; RCB2297
DR   Wikidata; Q54831506
RX   PubMed=16301747;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 50286; PRKCB.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-PRKDC(-/-)
AC   CVCL_1Y06
SY   Delta-DNAPK-DT40
DR   CLO; CLO_0051498
DR   RCB; RCB1620
DR   Wikidata; Q54831507
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49288; PRKDC.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-PRKDC(-/-)-XRCC6(-/-)
AC   CVCL_9Q56
SY   Delta-DNAPK-delta-Ku70-DT40
DR   CLO; CLO_0051522
DR   RCB; RCB1759
DR   Wikidata; Q54831508
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49288; PRKDC.
CC   Knockout cell: Method=Targeted integration; CGNC; 9044; XRCC6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40-PTPN11(-/-)
AC   CVCL_2G90
SY   SHP2^(-) DT40; SHP-2-deficient DT40
DR   CLO; CLO_0051485
DR   RCB; RCB1502
DR   Wikidata; Q54831509
RX   PubMed=9547347;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49495; PTPN11.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-PTPN6(-/-)
AC   CVCL_2G91
SY   SHP1^(-) DT40; SHP-1-deficient DT40
DR   CLO; CLO_0051460
DR   RCB; RCB1466
DR   Wikidata; Q54831510
RX   PubMed=9244303;
RX   PubMed=9547347;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10812; PTPN6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-PTPN6(-/-)-PTPN11(-/-)
AC   CVCL_2G92
SY   SHP1^(-)/SHP2^(-) DT40; SHP-1/SHP-2-deficient DT40
DR   CLO; CLO_0051474
DR   RCB; RCB1501
DR   Wikidata; Q54831511
RX   PubMed=9547347;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10812; PTPN6.
CC   Knockout cell: Method=Targeted integration; CGNC; 49495; PTPN11.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_2G91 ! DT40-PTPN6(-/-)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-RAD18(-/-)
AC   CVCL_1U31
SY   RAD18-/- DT40; Delta-Rad18-DT40
DR   CLO; CLO_0051507
DR   RCB; RCB1750
DR   Wikidata; Q54831512
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 6341; RAD18.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-RAD18(-/-)-POLK(-/-)
AC   CVCL_4E67
SY   Delta-Rad18-delta-DinB-DT40
DR   CLO; CLO_0051520
DR   RCB; RCB1795
DR   Wikidata; Q54831513
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 48998; POLK.
CC   Knockout cell: Method=Targeted integration; CGNC; 6341; RAD18.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-RAD18(-/-)-XPA(-/-)
AC   CVCL_4E65
SY   Delta-Rad18-delta-XPA-DT40
DR   CLO; CLO_0051519
DR   RCB; RCB1794
DR   Wikidata; Q54831514
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 6341; RAD18.
CC   Knockout cell: Method=Targeted integration; CGNC; 66210; XPA.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-RAD51AP1 Het-1
AC   CVCL_F1KJ
SY   DT40 AP1 Het-1
RX   PubMed=25288561;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12989; RAD51AP1 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-RAD51AP1 Het-2
AC   CVCL_F1KK
SY   DT40 AP1 Het-2
RX   PubMed=25288561;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12989; RAD51AP1 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-RAD51AP1 KO-1
AC   CVCL_F1KL
SY   DT40 AP1 KO-1
RX   PubMed=25288561;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12989; RAD51AP1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_F1KJ ! DT40-RAD51AP1 Het-1
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-RAD51AP1 KO-1 FLAG-GgRAD51AP1
AC   CVCL_F1KN
SY   DT40 AP1 KO-1 + GgAP1
RX   PubMed=25288561;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12989; RAD51AP1.
CC   Genetic integration: Method=Transduction; Gene=CGNC; 12989; RAD51AP1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_F1KL ! DT40-RAD51AP1 KO-1
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-RAD51AP1 KO-1 FLAG-HsRAD51AP1
AC   CVCL_F1KP
SY   DT40 AP1 KO-1 + HsAP1
RX   PubMed=25288561;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12989; RAD51AP1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16956; RAD51AP1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_F1KL ! DT40-RAD51AP1 KO-1
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-RAD51AP1 KO-2
AC   CVCL_F1KM
SY   DT40 AP1 KO-2
RX   PubMed=25288561;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 12989; RAD51AP1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_F1KK ! DT40-RAD51AP1 Het-2
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-RAD51B(-/-)
AC   CVCL_X637
SY   RAD51B-/- DT40; Delta-Rad51B-DT40
DR   CLO; CLO_0051462
DR   RCB; RCB1622
DR   Wikidata; Q54831515
RX   PubMed=10938124;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7219; RAD51B.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 12
//
ID   DT40-RAD51C(-/-)
AC   CVCL_X638
SY   RAD51C-/- DT40; Delta-Rad51C-DT40
DR   CLO; CLO_0051463
DR   RCB; RCB1623
DR   Wikidata; Q54831516
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 66288; RAD51C.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 12
//
ID   DT40-RAD51D(-/-)
AC   CVCL_X639
SY   RAD51D-/- DT40; Delta-Rad51D-DT40
DR   CLO; CLO_0051464
DR   RCB; RCB1624
DR   Wikidata; Q54831517
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 1582; RAD51D.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 12
//
ID   DT40-RAD52(-/-)
AC   CVCL_X640
SY   RAD52-/- DT40; Delta-Rad52-DT40
DR   CLO; CLO_0051466
DR   RCB; RCB1627
DR   Wikidata; Q54831518
RX   PubMed=9774659;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 9834; RAD52.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 12
//
ID   DT40-RAD52(-/-)-XRCC3(-/-)
AC   CVCL_2H95
SY   Delta-Rad52-delta-XRCC3-DT40
DR   CLO; CLO_0051510
DR   RCB; RCB1767
DR   Wikidata; Q54831524
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 9834; RAD52.
CC   Knockout cell: Method=Targeted integration; CGNC; 8765; XRCC3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-RAD54B(-/-)-XRCC6(-/-)
AC   CVCL_6D41
SY   Delta-Ku70-delta-Rad54B-DT40
DR   CLO; CLO_0051469
DR   RCB; RCB1632
DR   Wikidata; Q54831525
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49325; RAD54B.
CC   Knockout cell: Method=Targeted integration; CGNC; 9044; XRCC6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   DT40-RAD54L(-/-)
AC   CVCL_1T34
SY   RAD54-/- DT40; Delta-Rad54-DT40
DR   CLO; CLO_0051468
DR   RCB; RCB1628
DR   Wikidata; Q54831526
RX   PubMed=9108474;
RX   PubMed=10938124;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7881; RAD54L.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_J437 ! DT40 CL18
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-RAD54L(-/-)-RAD54B(-/-)
AC   CVCL_1Y07
SY   Delta-Rad54-delta-Rad54B-DT40
DR   CLO; CLO_0051467
DR   RCB; RCB1634
DR   Wikidata; Q54831527
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 49325; RAD54B.
CC   Knockout cell: Method=Targeted integration; CGNC; 7881; RAD54L.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-RAD54L(-/-)-XRCC6(-/-)
AC   CVCL_4W13
SY   Delta-Rad54.delta-Ku70-DT40
DR   CLO; CLO_0051508
DR   RCB; RCB1687
DR   Wikidata; Q54831529
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7881; RAD54L.
CC   Knockout cell: Method=Targeted integration; CGNC; 9044; XRCC6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-RASGRP1(-/-)
AC   CVCL_1U38
SY   GRP1^(-)DT40
DR   CLO; CLO_0051496
DR   RCB; RCB1863
DR   Wikidata; Q54831530
RX   PubMed=14676298;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7404; RASGRP1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-RASGRP1(-/-)-RASGRP3(-/-)
AC   CVCL_1U39
SY   GRP1^(-)/GRP3^(-)DT40
DR   CLO; CLO_0051511
DR   RCB; RCB1865
DR   Wikidata; Q54831531
RX   PubMed=14676298;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7404; RASGRP1.
CC   Knockout cell: Method=Targeted integration; CGNC; 7943; RASGRP3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-RASGRP3(-/-)
AC   CVCL_1U40
SY   GRP3^(-)DT40
DR   CLO; CLO_0051512
DR   RCB; RCB1864
DR   Wikidata; Q54831532
RX   PubMed=14676298;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7943; RASGRP3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-REV3L(-/-)
AC   CVCL_1T51
SY   Delta-Rev3-DT40
DR   CLO; CLO_0051509
DR   RCB; RCB1764
DR   Wikidata; Q54831533
RX   PubMed=15988022;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 11179; REV3L.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_J437 ! DT40 CL18
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-SHC1(-/-)
AC   CVCL_1U34
SY   Shc^(-) DT40
DR   CLO; CLO_0051486
DR   RCB; RCB1503
DR   Wikidata; Q54831534
RX   PubMed=9763608;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 5182; SHC1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-SOS1(-/-)
AC   CVCL_1U35
SY   SOS1-/- DT40; Sos1^(-)DT40
DR   CLO; CLO_0051513
DR   RCB; RCB1866
DR   Wikidata; Q54831535
RX   PubMed=14676298;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 54157; SOS1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-SOS1(-/-)-SOS2(-/-)
AC   CVCL_1U37
SY   SOS1-/ SOS2-/- DT40; Sos1^(-)/Sos2^(-)DT40
DR   CLO; CLO_0051515
DR   RCB; RCB1868
DR   Wikidata; Q54831536
RX   PubMed=14676298;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 54157; SOS1.
CC   Knockout cell: Method=Targeted integration; CGNC; 9322; SOS2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-SOS2(-/-)
AC   CVCL_1U36
SY   SOS2-/- DT40; Sos2^(-)DT40
DR   CLO; CLO_0051514
DR   RCB; RCB1867
DR   Wikidata; Q54831537
RX   PubMed=14676298;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 9322; SOS2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-STIM1(-/-)
AC   CVCL_1T28
SY   STIM1-/- DT40; STIM1^(-/-)DT40; STIM1^-DT40; S1-/-; DT40 STIM1 KO
DR   CLO; CLO_0051529
DR   RCB; RCB2402
DR   Wikidata; Q54831538
RX   PubMed=19376967;
RX   PubMed=20679432;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 13037; STIM1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-STIM1(-/-)-STIM2(-/-)
AC   CVCL_1T29
SY   STIM1-/ STIM2-/- DT40; STIM1^(-/-)STIM2^(-/-)DT40; S1/S2-/-
DR   RCB; RCB4517
DR   Wikidata; Q54831540
RX   PubMed=19376967;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 13037; STIM1.
CC   Knockout cell: Method=Targeted integration; CGNC; 10686; STIM2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-STIM2(-/-)
AC   CVCL_1T30
SY   STIM2-/- DT40; STIM2^(-/-)DT40; S2-/-
DR   RCB; RCB4516
DR   Wikidata; Q54831541
RX   PubMed=19376967;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10686; STIM2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-SYK(-/-)
AC   CVCL_1T43
SY   Syk^(-) DT40
DR   CLO; CLO_0051478
DR   RCB; RCB1470
DR   Wikidata; Q54831542
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 53036; SYK.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-TDP2(-/-/-) clone 8
AC   CVCL_F1BX
SY   TDP2-/-/- clone 8
RX   PubMed=21030584;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10219; TDP2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-TDP2(-/-/-) clone 93
AC   CVCL_F1BY
SY   TDP2-/-/- clone 93
RX   PubMed=21030584;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10219; TDP2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-TDP2(-/-/-) hTDP2
AC   CVCL_F1KQ
SY   TDP2-/-/- hTDP2
RX   PubMed=21030584;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10219; TDP2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17768; TDP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_F1BX ! DT40-TDP2(-/-/-) clone 8
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-TDP2(-/-/-) hTDP2 D262A
AC   CVCL_F1KR
SY   TDP2-/-/- hTDP2D262A
RX   PubMed=21030584;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10219; TDP2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17768; TDP2 (Note=With p.Asp262Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_F1BX ! DT40-TDP2(-/-/-) clone 8
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-TDP2(-/-/+) clone H13
AC   CVCL_F1BZ
SY   TDP2-/-/- clone H13
RX   PubMed=21030584;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 10219; TDP2 (Note=2 of 3 alleles).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DT40-TRPC1(-/-)
AC   CVCL_2I01
SY   TRP1^(-) DT40
DR   CLO; CLO_0051484
DR   RCB; RCB1824
DR   Wikidata; Q54831543
RX   PubMed=11901194;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 1899; TRPC1.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   DT40-VAV3(-/-)
AC   CVCL_1T49
SY   Vav3^(-) DT40
DR   CLO; CLO_0051490
DR   RCB; RCB1809
DR   Wikidata; Q54831544
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 1353; VAV3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-WRN(-/-)
AC   CVCL_1T35
SY   Delta-WRN-DT40
DR   CLO; CLO_0051523
DR   RCB; RCB1812
DR   Wikidata; Q54831545
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 7822; WRN.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-XRCC2(-/-)
AC   CVCL_1T36
SY   Delta-XRCC2-DT40
DR   CLO; CLO_0051465
DR   RCB; RCB1625
DR   Wikidata; Q54831546
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 66375; XRCC2.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-XRCC3(+/-)
AC   CVCL_2G89
SY   XRCC3+/--DT40
DR   CLO; CLO_0051517
DR   RCB; RCB1770
DR   Wikidata; Q54831547
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 8765; XRCC3 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-XRCC3(-/-)
AC   CVCL_1T37
SY   Delta-XRCC3-DT40
DR   CLO; CLO_0051470
DR   RCB; RCB1626
DR   Wikidata; Q54831548
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 8765; XRCC3.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT40-XRCC6(-/-)
AC   CVCL_1T31
SY   Ku70-/- DT40; Delta-Ku70-DT40
DR   CLO; CLO_0051461
DR   RCB; RCB1621
DR   Wikidata; Q54831549
RX   PubMed=10654944;
CC   Group: Bird cell line.
CC   Knockout cell: Method=Targeted integration; CGNC; 9044; XRCC6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   DT45
AC   CVCL_T442
SY   DT-45; LSCC-DT45
DR   Wikidata; Q54831554
RX   PubMed=2998040;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   DT4994
AC   CVCL_A0VW
DR   Wikidata; Q108820165
RX   PubMed=25416195;
RX   PubMed=34033220;
CC   From: Tuveson, David Arthur; Cold Spring Harbor Laboratory; Cold Spring Harbor; USA.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Tg(Pdx1-cre),LSL-Kras(G12D/+).
DI   NCIt; C34045; Mouse pancreatic intraepithelial neoplasia-1
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   DT6606
AC   CVCL_A0VX
DR   Wikidata; Q108820166
RX   PubMed=25416195;
CC   From: Tuveson, David Arthur; Cold Spring Harbor Laboratory; Cold Spring Harbor; USA.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Tg(Pdx1-cre),LSL-Kras(G12D/+).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   DT6606-OVA
AC   CVCL_A0VY
SY   DT6606-ovalbumin
DR   Wikidata; Q108820167
RX   PubMed=25416195;
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Tg(Pdx1-cre),LSL-Kras(G12D/+).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0VX ! DT6606
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   DT8082
AC   CVCL_XD11
DR   Wikidata; Q93532988
RX   PubMed=19460966;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R270H:Pdx1-Cre (KPC).
ST   Source(s): CRUK Cambridge RICS
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 14
ST   Mouse STR 2-1: 10
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 18.3
ST   Mouse STR 5-5: 13,17
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 18
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 12
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   Dt81Hepa1-6
AC   CVCL_IU28
DR   Wikidata; Q54831555
RX   PubMed=28152020;
CC   Doubling time: 32.12 +- 2.11 hours (PubMed=28152020).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 8
//
ID   DT95
AC   CVCL_3462
SY   DT-95; LSCC-DT95
DR   CLO; CLO_0002839
DR   ATCC; CRL-2112
DR   Wikidata; Q54831556
RX   PubMed=2998040;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   DTA-1
AC   CVCL_F1CY
RX   PubMed=11812990;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O35714; Mouse Tnfrsf18/Cd357.
CC   Caution: Isotype indicated as IgG2a in PubMed=11812990 but IgG2b in some sites distributing the produced mAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DTC1
AC   CVCL_0J31
SY   DTC-1
DR   Wikidata; Q54831557
RX   PubMed=7753552;
RX   PubMed=12966428;
RX   PubMed=15150091;
RX   PubMed=16766266;
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=7753552; PubMed=15150091).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   DTE 1-6-4
AC   CVCL_U417
DR   Wikidata; Q54831558
RX   PubMed=6300143;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 8
//
ID   DTF 1-5-1
AC   CVCL_U418
DR   Wikidata; Q54831559
RX   PubMed=6300143;
RX   PubMed=6480694;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 8
//
ID   DTG 1-5-4
AC   CVCL_U419
SY   DTG 1-5-4-22
DR   Wikidata; Q54831560
RX   PubMed=6480694;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 8
//
ID   DTK-E
AC   CVCL_Y463
DR   Wikidata; Q54831561
RX   PubMed=25267010;
CC   Doubling time: 24 hours (PubMed=25267010).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_JJ86 ! DTK-F
OI   CVCL_Y464 ! DTK-SME
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 11
//
ID   DTK-F
AC   CVCL_JJ86
DR   Wikidata; Q54831562
RX   PubMed=25882637;
CC   Characteristics: Spindle-shaped, does not express HSP27, non-tumorigenic in nude mice and sensitive to doxorubicin.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_Y463 ! DTK-E
OI   CVCL_Y464 ! DTK-SME
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   DTK-SME
AC   CVCL_Y464
DR   Wikidata; Q54831563
RX   PubMed=25267010;
CC   Doubling time: 18 hours (PubMed=25267010).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_Y463 ! DTK-E
OI   CVCL_JJ86 ! DTK-F
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 11
//
ID   DU #2
AC   CVCL_5528
SY   DU 2; DU-2
DR   BTO; BTO_0002944
DR   Wikidata; Q54831564
RX   PubMed=994214;
RX   PubMed=2624919;
CC   Doubling time: 44 hours (Note=At 61th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   DU-145 R
AC   CVCL_4Y36
DR   cancercelllines; CVCL_4Y36
DR   Wikidata; Q54831571
RX   PubMed=21982118;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   DU-145-Luc
AC   CVCL_J251
DR   cancercelllines; CVCL_J251
DR   JCRB; JCRB1387
DR   JCRB; NIHS0655
DR   Wikidata; Q54831565
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0655; true.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=JCRB1387
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12,13
ST   D5S818: 10,13
ST   D7S820: 7,10,10.3,11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   DU-ALL-1
AC   CVCL_A1LH
SY   DU ALL 1
DR   Wikidata; Q102113775
RX   PubMed=6958929;
WW   Provider; Duke ORI; T-000738; https://olv.duke.edu/technologies/du-all-1-monoclonal-antibody/
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21926; Human CD9.
CC   Caution: Isotype indicated as IgG2a in PubMed=6958929 but IgG1 in sites distributing the produced mAB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   DU0001
AC   CVCL_8W10
DR   ECACC; 94070810
DR   Wikidata; Q54831572
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94070810; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   Du1-29
AC   CVCL_G118
SY   DU1-29; Du 1-29
DR   CLO; CLO_0002841
DR   ATCC; HB-263
DR   ECACC; 91060553
DR   Wikidata; Q54831573
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; W5PMK6; Sheep SELL/CD62L (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   DU145
AC   CVCL_0105
SY   DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145
DR   BTO; BTO_0001332
DR   CLO; CLO_0002840
DR   CLO; CLO_0051536
DR   EFO; EFO_0005441
DR   MCCL; MCC:0000140
DR   CLDB; cl1108
DR   CLDB; cl1109
DR   CLDB; cl4961
DR   CLDB; cl5184
DR   AddexBio; C0019004/4984
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-81
DR   BCRC; 60348
DR   BCRJ; 0078
DR   BioGRID_ORCS_Cell_line; 860
DR   BioSample; SAMN03472017
DR   BioSample; SAMN03472041
DR   BioSample; SAMN03472757
DR   BioSample; SAMN05292468
DR   BioSample; SAMN10988253
DR   cancercelllines; CVCL_0105
DR   CCRID; 1101HUM-PUMC000006
DR   CCRID; 3101HUMSCSP5024
DR   CCRID; 3101HUMTCHu222
DR   Cell_Model_Passport; SIDM00120
DR   ChEMBL-Cells; CHEMBL3308034
DR   ChEMBL-Targets; CHEMBL613508
DR   CLS; 300168
DR   Cosmic; 688116
DR   Cosmic; 699306
DR   Cosmic; 704850
DR   Cosmic; 721367
DR   Cosmic; 721558
DR   Cosmic; 755299
DR   Cosmic; 759893
DR   Cosmic; 801349
DR   Cosmic; 809223
DR   Cosmic; 809224
DR   Cosmic; 850415
DR   Cosmic; 850824
DR   Cosmic; 869156
DR   Cosmic; 875891
DR   Cosmic; 876395
DR   Cosmic; 897454
DR   Cosmic; 905935
DR   Cosmic; 911998
DR   Cosmic; 918501
DR   Cosmic; 921050
DR   Cosmic; 922550
DR   Cosmic; 923401
DR   Cosmic; 923956
DR   Cosmic; 943177
DR   Cosmic; 948075
DR   Cosmic; 949247
DR   Cosmic; 974300
DR   Cosmic; 1028649
DR   Cosmic; 1028700
DR   Cosmic; 1057758
DR   Cosmic; 1070887
DR   Cosmic; 1071478
DR   Cosmic; 1071905
DR   Cosmic; 1075274
DR   Cosmic; 1092597
DR   Cosmic; 1172627
DR   Cosmic; 1175887
DR   Cosmic; 1176617
DR   Cosmic; 1212490
DR   Cosmic; 1218869
DR   Cosmic; 1305381
DR   Cosmic; 1312368
DR   Cosmic; 1330912
DR   Cosmic; 1436047
DR   Cosmic; 1481419
DR   Cosmic; 1542078
DR   Cosmic; 1689715
DR   Cosmic; 1712065
DR   Cosmic; 1995389
DR   Cosmic; 1998439
DR   Cosmic; 2580127
DR   Cosmic; 2585152
DR   Cosmic; 2585229
DR   Cosmic; 2592487
DR   Cosmic; 2651768
DR   Cosmic; 2669167
DR   Cosmic; 2674179
DR   Cosmic; 2816220
DR   Cosmic-CLP; 905935
DR   DepMap; ACH-000979
DR   DSMZ; ACC-261
DR   DSMZCellDive; ACC-261
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS077VSE
DR   ENCODE; ENCBS721QHV
DR   FANTOM5_SSTAR; 10490-107B4
DR   GDSC; 905935
DR   GEO; GSM2120
DR   GEO; GSM50224
DR   GEO; GSM50288
DR   GEO; GSM91924
DR   GEO; GSM142455
DR   GEO; GSM142456
DR   GEO; GSM482671
DR   GEO; GSM525794
DR   GEO; GSM648818
DR   GEO; GSM648819
DR   GEO; GSM743479
DR   GEO; GSM750774
DR   GEO; GSM750834
DR   GEO; GSM784791
DR   GEO; GSM799369
DR   GEO; GSM799379
DR   GEO; GSM799432
DR   GEO; GSM799442
DR   GEO; GSM843494
DR   GEO; GSM886988
DR   GEO; GSM888057
DR   GEO; GSM1153440
DR   GEO; GSM1153441
DR   GEO; GSM1181273
DR   GEO; GSM1181302
DR   GEO; GSM1181306
DR   GEO; GSM1181328
DR   GEO; GSM1374469
DR   GEO; GSM1374470
DR   GEO; GSM1669745
DR   GEO; GSM2124639
DR   IARC_TP53; 751
DR   ICLC; HTL99013
DR   IZSLER; BS TCL 141
DR   KCB; KCB 200701YJ
DR   KCLB; 30081
DR   LiGeA; CCLE_356
DR   LINCS_LDP; LCL-1146
DR   Lonza; 761
DR   NCBI_Iran; C428
DR   NCI-DTP; DU-145
DR   PharmacoDB; DU145_309_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0105
DR   PubChem_Cell_line; CVCL_0105
DR   RCB; RCB2143
DR   SKY/M-FISH/CGH; 2792
DR   TKG; TKG 0604
DR   TOKU-E; 1103
DR   Wikidata; Q5206280
RX   CelloPub=CLPUB00698;
RX   PubMed=631930;
RX   PubMed=1574572;
RX   PubMed=1873816;
RX   PubMed=2744886;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=8104329;
RX   PubMed=8510267;
RX   PubMed=8612713;
RX   PubMed=9018337;
RX   PubMed=9214606;
RX   PubMed=9331090;
RX   PubMed=9460501;
RX   PubMed=10700174;
RX   PubMed=10702678;
RX   PubMed=10972993;
RX   PubMed=11135431;
RX   PubMed=11172901;
RX   PubMed=11280753;
RX   PubMed=11304728;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=12606952;
RX   PubMed=12615715;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=15486987;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17254797;
RX   PubMed=17440963;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22275356;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23671654;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=23957452;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30244336;
RX   PubMed=30629668;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
RX   PubMed=38892296;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=54
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544441
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-135.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/DU145
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/prostate-cancer-xenograft/du145-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 34 hours (Note=At 39th passage) (PubMed=631930); ~29 hours (ATCC=HTB-81); 28-38 hours (CLS=300168); ~30-40 hours (DSMZ=ACC-261); 32.3 hours (NCI-DTP=DU-145); ~29 hours (PBCF); 51.21 hours (JWGray panel).
CC   HLA typing: A*03:01:01,33:03; B*50:01,57:01:01; C*06:02; DPB1*04:01; DQB1*03:03:02,05:01:01 (PubMed=15748285).
CC   HLA typing: A*33:03,33:03; B*50:01,57:01; C*06:02,06:02; DQB1*05:01,05:01; DRB1*01:01,01:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=23671654; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (PubMed=17088437; ATCC=HTB-81; Cosmic-CLP=905935; DepMap=ACH-000979).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (PubMed=17088437; ATCC=HTB-81).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (PubMed=1873816; PubMed=8104329; PubMed=8510267; PubMed=9331090; PubMed=11304728; PubMed=17088437; ATCC=HTB-81).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (PubMed=1873816; PubMed=8104329; PubMed=8510267; PubMed=11304728; PubMed=17088437; ATCC=HTB-81).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.75%; Native American=0%; East Asian, North=2.66%; East Asian, South=0%; South Asian=0.04%; European, North=63.74%; European, South=32.8% (PubMed=30894373).
CC   Misspelling: DU145T; GEO=GSM843494.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): AddexBio=C0019004/4984; ATCC=HTB-81; CCRID; CLS=300168; Cosmic-CLP=905935; COG; DSMZ=ACC-261; KCLB=30081; PubMed=11304728; PubMed=11416159; PubMed=14518029; PubMed=17254797; PubMed=19372543; PubMed=25877200; RCB=RCB2143; Technion Genomics Center; TKG=TKG 0604
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 12,13
ST   D12S391: 17,18,20,21
ST   D13S317: 12,13,14 (AddexBio=C0019004/4984; ATCC=HTB-81; CCRID; CLS=300168; COG; DSMZ=ACC-261; PubMed=11304728; PubMed=14518029; PubMed=25877200; Technion Genomics Center)
ST   D13S317: 12,14 (Cosmic-CLP=905935; KCLB=30081; PubMed=17254797; PubMed=19372543; RCB=RCB2143; TKG=TKG 0604)
ST   D16S539: 11,12,13 (Technion Genomics Center)
ST   D16S539: 11,13 (ATCC=HTB-81; CCRID; CLS=300168; COG; DSMZ=ACC-261; PubMed=25877200)
ST   D18S51: 11,12 (PubMed=11304728; PubMed=14518029)
ST   D18S51: 12 (ATCC=HTB-81; CCRID; DSMZ=ACC-261; PubMed=17254797; PubMed=19372543; PubMed=25877200)
ST   D18S51: 12,13 (CLS=300168; Technion Genomics Center)
ST   D19S433: 13 (ATCC=HTB-81; CCRID; DSMZ=ACC-261)
ST   D19S433: 13,14 (Technion Genomics Center)
ST   D1S1656: 14,15,16,17.3
ST   D21S11: 29,30 (PubMed=17254797)
ST   D21S11: 29,30,33 (PubMed=11416159)
ST   D21S11: 30,32,33,34 (PubMed=14518029; Technion Genomics Center)
ST   D21S11: 30,33 (CCRID; DSMZ=ACC-261; PubMed=11304728; PubMed=19372543; PubMed=25877200)
ST   D21S11: 30,33,34 (ATCC=HTB-81; CLS=300168)
ST   D22S1045: 16
ST   D2S1338: 16 (ATCC=HTB-81; CCRID; DSMZ=ACC-261)
ST   D2S1338: 16,17 (Technion Genomics Center)
ST   D2S441: 9,13,14
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,10,11 (AddexBio=C0019004/4984; ATCC=HTB-81; CCRID; COG; Cosmic-CLP=905935; DSMZ=ACC-261; KCLB=30081; PubMed=11304728; PubMed=14518029; PubMed=17254797; PubMed=25877200; Technion Genomics Center)
ST   D7S820: 7,10,11,12 (CLS=300168)
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 21,22 (DSMZ=ACC-261)
ST   FGA: 21,22,23 (ATCC=HTB-81)
ST   FGA: 22 (CCRID; PubMed=11304728; PubMed=14518029; PubMed=17254797; PubMed=25877200; Technion Genomics Center)
ST   FGA: 22,23 (CLS=300168)
ST   Penta D: 9,13
ST   Penta E: 12,14
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,17,18 (PubMed=17254797)
ST   vWA: 17,18 (COG; DSMZ=ACC-261; KCLB=30081; PubMed=11304728; PubMed=14518029; PubMed=19372543; PubMed=25877200; TKG=TKG 0604)
ST   vWA: 17,18,19 (AddexBio=C0019004/4984; ATCC=HTB-81; CCRID; CLS=300168; Cosmic-CLP=905935; PubMed=11416159; RCB=RCB2143; Technion Genomics Center)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   DU145 fat-1
AC   CVCL_E6ZG
DR   ABM; T6271
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Population: Caucasian.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6271).
CC   Doubling time: 20-30 hours (ABM=T6271).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   DU145-AR
AC   CVCL_VE02
SY   DU-AR
DR   cancercelllines; CVCL_VE02
DR   Wikidata; Q54831574
RX   PubMed=14649544;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   DU145-Cas9-539
AC   CVCL_A9CI
DR   cancercelllines; CVCL_A9CI
DR   CCRID; 1101HUM-PUMC000539
DR   Wikidata; Q108820168
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): CCRID=1101HUM-PUMC000539
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 18,21
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13
ST   D21S11: 30,33,34
ST   D2S1338: 16
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 7,11
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta E: 12,14
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   DU145-Cas9-540
AC   CVCL_A9CJ
DR   cancercelllines; CVCL_A9CJ
DR   CCRID; 1101HUM-PUMC000540
DR   Wikidata; Q108820169
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): CCRID=1101HUM-PUMC000540
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 18,20
ST   D13S317: 12,14
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13
ST   D21S11: 31,32,33
ST   D2S1338: 16
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 7,10,11
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   DU145-Cas9-541
AC   CVCL_A9CK
DR   cancercelllines; CVCL_A9CK
DR   CCRID; 1101HUM-PUMC000541
DR   Wikidata; Q108820170
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): CCRID=1101HUM-PUMC000541
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 18,21
ST   D13S317: 12,14
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 12,13
ST   D21S11: 30,31,33
ST   D2S1338: 16
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 10,11
ST   D7S820: 7,10,11
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta E: 12,14
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   DU145-R
AC   CVCL_C0QR
DR   cancercelllines; CVCL_C0QR
DR   Wikidata; Q112929465
RX   PubMed=30244336;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   DU145-TxR
AC   CVCL_ZX03
DR   cancercelllines; CVCL_ZX03
DR   Wikidata; Q102113777
RX   PubMed=17440963;
RX   PubMed=29662635;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   DU145-TxR/CxR
AC   CVCL_ZX04
DR   cancercelllines; CVCL_ZX04
DR   Wikidata; Q102113779
RX   PubMed=29662635;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX03 ! DU145-TxR
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   DU145/Cas9-hyg
AC   CVCL_C9GA
DR   GeneCopoeia; SL548
DR   Wikidata; Q123031192
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL548).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   DU145/RC0.1
AC   CVCL_AS75
SY   DU145 RC0.1; RC0.1; RCO.1; RC01
DR   cancercelllines; CVCL_AS75
DR   GEO; GSM750772
DR   GEO; GSM799380
DR   GEO; GSM799443
DR   GEO; GSM1153443
DR   GEO; GSM1181318
DR   GEO; GSM1181329
DR   Progenetix; CVCL_AS75
DR   Wikidata; Q54831575
RX   PubMed=11280753;
RX   PubMed=12615715;
RX   PubMed=19372543;
RX   PubMed=22347499;
RX   PubMed=24670534;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90225; Rubitecan (Orathecin; 9-nitrocamptothecin; 9NC).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg364His (c.1091G>A); Zygosity=Homozygous (PubMed=11280753).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=19372543
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D18S51: 12
ST   D19S433: 13
ST   D21S11: 30,33
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,11
ST   D8S1179: 13,14
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   DU145/RC1
AC   CVCL_D639
SY   DU-145/RC1; DU-145/RC; RC1
DR   cancercelllines; CVCL_D639
DR   Wikidata; Q54831576
RX   PubMed=8993507;
RX   PubMed=11280753;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90225; Rubitecan (Orathecin; 9-nitrocamptothecin; 9NC).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg364His (c.1091G>A); Zygosity=Homozygous (PubMed=11280753).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   DU249
AC   CVCL_RW35
SY   249
DR   Wikidata; Q54831577
RX   PubMed=4363662;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C134558; Chicken hepatoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   DU4475
AC   CVCL_1183
SY   Du4475; DU-4475; Du-4475; DU 4475; Du 4475; Duke University 4475
DR   CLO; CLO_0002842
DR   EFO; EFO_0002168
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7921
DR   ATCC; HTB-123
DR   BioGRID_ORCS_Cell_line; 684
DR   BioSample; SAMN03471772
DR   BioSample; SAMN03473595
DR   BioSample; SAMN05292453
DR   BioSample; SAMN10987660
DR   cancercelllines; CVCL_1183
DR   CCRID; 1101HUM-PUMC000342
DR   Cell_Model_Passport; SIDM01001
DR   ChEMBL-Cells; CHEMBL3308261
DR   ChEMBL-Targets; CHEMBL2366246
DR   CLS; 300371
DR   Cosmic; 685863
DR   Cosmic; 871141
DR   Cosmic; 904355
DR   Cosmic; 906844
DR   Cosmic; 921975
DR   Cosmic; 934523
DR   Cosmic; 997915
DR   Cosmic; 1046952
DR   Cosmic; 1047716
DR   Cosmic; 1091340
DR   Cosmic; 1152520
DR   Cosmic; 1287936
DR   Cosmic; 1289387
DR   Cosmic; 1609476
DR   Cosmic; 2164988
DR   Cosmic-CLP; 906844
DR   DepMap; ACH-000258
DR   DSMZ; ACC-427
DR   DSMZCellDive; ACC-427
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906844
DR   GEO; GSM217568
DR   GEO; GSM274659
DR   GEO; GSM344345
DR   GEO; GSM344395
DR   GEO; GSM421865
DR   GEO; GSM783961
DR   GEO; GSM886989
DR   GEO; GSM888058
DR   GEO; GSM1053707
DR   GEO; GSM1669746
DR   IARC_TP53; 21043
DR   IGRhCellID; DU4475
DR   LiGeA; CCLE_395
DR   LINCS_HMS; 50577
DR   LINCS_LDP; LCL-1323
DR   PharmacoDB; DU4475_310_2019
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1183
DR   PubChem_Cell_line; CVCL_1183
DR   SLKBase; 3415
DR   Wikidata; Q54831578
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=221108;
RX   PubMed=10862037;
RX   PubMed=11343771;
RX   PubMed=11414198;
RX   PubMed=12068308;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=18397470;
RX   PubMed=19593635;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/DU4475.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544500
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 2.9 days (PubMed=221108); 90 hours (PubMed=25984343); ~80-100 hours (DSMZ=ACC-427); ~32 hours (PBCF).
CC   HLA typing: A*03:01,31:01; B*07:02,40:01; C*03:04,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1577Ter (c.4729G>T); Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-123).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=18397470; PubMed=19593635; ATCC=HTB-123; Cosmic-CLP=906844; DepMap=ACH-000258).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.87%; Native American=0%; East Asian, North=3.81%; East Asian, South=0%; South Asian=0%; European, North=61.27%; European, South=34.04% (PubMed=30894373).
CC   Caution: Reported by some sites and publications to originate from a 62 year old woman, but the cell line was established when she was 70 year old.
CC   Misspelling: DU-475; Note=In text of PubMed 12702766.
CC   Misspelling: DU447; Cosmic=1609476.
CC   Discontinued: ATCC; CRL-7921; true.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=HTB-123; CCRID=1101HUM-PUMC000342; CLS=300371; Cosmic-CLP=906844; DSMZ=ACC-427; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D12S391: 18.3,25
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 20,25
ST   D3S1358: 14,16
ST   D5S818: 6,11 (DSMZ=ACC-427)
ST   D5S818: 11 (ATCC=HTB-123; CCRID=1101HUM-PUMC000342; CLS=300371; Cosmic-CLP=906844; PubMed=25877200)
ST   D6S1043: 11
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 13,14
ST   Penta E: 7,13
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   DU4475/Cas9-hyg
AC   CVCL_C9CJ
DR   GeneCopoeia; SL547
DR   Wikidata; Q123031193
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL547).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1577Ter (c.4729G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1183 ! DU4475
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 6
//
ID   DU528
AC   CVCL_5617
SY   DU-528; Du-528; DU.528; Duke University 528
DR   Cosmic; 913423
DR   Cosmic; 1115590
DR   Cosmic; 1151778
DR   Cosmic; 1281367
DR   Cosmic; 2602913
DR   IARC_TP53; 21651
DR   Wikidata; Q54831579
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2144611;
RX   PubMed=2740341;
RX   PubMed=4056659;
RX   PubMed=15472075;
RX   PubMed=17117183;
RX   PubMed=17170727;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/du-528/
CC   Doubling time: 48-72 hours (PubMed=4056659); 40 hours (PubMed=17117183).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=2144611).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   DU5873
AC   CVCL_6G37
SY   DU 5873; Duke University 5873
DR   Wikidata; Q54831580
RX   PubMed=590019;
RX   PubMed=6244232;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   DU7-2E8
AC   CVCL_E8D1
WW   Provider; Creative Diagnostics; CSC-H0450; https://www.creative-diagnostics.com/Anti-FCGR1A-Hybridoma-136111-197.htm
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P12314; Human FCGR1A/CD64.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DU9479
AC   CVCL_4828
SY   9479; Duke University 9479
DR   Wikidata; Q54831581
RX   DOI=10.1002/pros.2990070405;
CC   Derived from site: Metastatic; Iliac crest; UBERON=UBERON_0014437.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Dubca
AC   CVCL_3678
SY   Dubai camel
DR   CLO; CLO_0002843
DR   ATCC; CRL-2276
DR   Wikidata; Q54831582
RX   PubMed=8556315;
RX   PubMed=18837913;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9838; ! Camelus dromedarius (Dromedary)
SX   Female
AG   2FM
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   DUCAF
AC   CVCL_E571
DR   dbMHC; 48765
DR   ECACC; 88052019
DR   IHW; IHW09019
DR   IPD-IMGT/HLA; 10536
DR   Wikidata; Q54831583
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*30:02:01:01; B*18:01:01:01; C*05:01:01:01; DPA1*01:03; DPB1*02:02; DQA1*05:01:01; DQB1*02:01:01; DRA*01:01; DRB1*03:01:01; DRB3*02:02 (IPD-IMGT/HLA=10536).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   DuCaP
AC   CVCL_2025
SY   DUCaP; Ducap; Dura mater Cancer of the Prostate
DR   cancercelllines; CVCL_2025
DR   Cosmic; 1028647
DR   Cosmic; 1043329
DR   Cosmic; 1995390
DR   IARC_TP53; 18892
DR   Wikidata; Q54831584
RX   CelloPub=CLPUB00698;
RX   PubMed=11317521;
RX   PubMed=14518029;
RX   PubMed=14518030;
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft produced by implantation of tumor cells in a SCID mouse.
CC   Doubling time: 72-216 hours (PubMed=11317521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=14518029).
CC   Derived from site: Metastatic; Brain, meningeal dura mater; UBERON=UBERON_0010506.
ST   Source(s): PubMed=14518029
ST   Amelogenin: X,Y
ST   D13S317: 11,12
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 21,26
ST   vWA: 18,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2235 ! VCaP
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   Duck embryo
AC   CVCL_T281
SY   Duck Embryo; SPDC-CCL141
DR   CLDB; cl1111
DR   CLDB; cl1112
DR   ATCC; CCL-141
DR   CCTCC; GDC0160
DR   ECACC; 89051503
DR   IZSLER; BS CL 38
DR   Wikidata; Q54831585
RX   PubMed=4368600;
RX   PubMed=4911850;
RX   PubMed=18766641;
RX   PubMed=32005267;
CC   Group: Bird cell line.
CC   Virology: Highly susceptible to infection by aquatic bird bornavirus 1 (ABBV-1) strain UoG-CG (PubMed=32005267).
CC   Discontinued: ECACC; 89051503; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   DuckCelt-T17
AC   CVCL_JF18
SY   DuckCeltTM-T17; T17
DR   Wikidata; Q54831586
RX   CelloPub=CLPUB00392;
RX   PubMed=28571695;
CC   Group: Bird cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Transgene SA; Illkirch-Graffenstaden; France.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; B7S5K9; Cairina moschata TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
SX   Sex unspecified
AG   Embryo
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   DUG150
AC   CVCL_E572
DR   dbMHC; 48766
DR   IHW; IHW09397
DR   IPD-IMGT/HLA; 26001
DR   Wikidata; Q54831587
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02,68:01:01; B*45:01,58:02; C*06:02,16:01; DPA1*02:01:01; DPB1*01:01:02,85:01; DQA1*01:01:01,04:01:01; DQB1*03:01,05:01:01; DRB1*08:04,12:01; DRB3*02:02 (IPD-IMGT/HLA=26001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   DUK10464
AC   CVCL_F1VD
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1766+1G>A (1898+1G>A); ClinVar=VCV000007168; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK13521
AC   CVCL_F1VE
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[56]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK15576
AC   CVCL_F1VF
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Leu88Ilefs*22 (c.262_263delTT) (394delTT); ClinVar=VCV000007232; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK19946
AC   CVCL_F1VG
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly12Valfs*2 (c.35delG); ClinVar=VCV000017004; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK21185
AC   CVCL_F1VH
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Homozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183526; Methylmalonic aciduria and homocystinuria, cblJ type
DI   ORDO; Orphanet_369955; Methylmalonic acidemia with homocystinuria, type cblJ
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK22472
AC   CVCL_F1VI
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Ser65Cys (c.193A>T); ClinVar=VCV000000011; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK24771
AC   CVCL_F1VJ
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK29765
AC   CVCL_F1VK
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK32053
AC   CVCL_F1VL
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Homozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK34385
AC   CVCL_F1VM
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (PubMed=16166172).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Ser65Cys (c.193A>T); ClinVar=VCV000000011; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK40878
AC   CVCL_F1VN
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser1235Arg (c.3705T>G); ClinVar=VCV000035872; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DuK50
AC   CVCL_4742
DR   Wikidata; Q54831588
RX   PubMed=8826087;
CC   Doubling time: 40.4 hours (PubMed=8826087).
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   DUK53834
AC   CVCL_F1VP
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK54361
AC   CVCL_F1VQ
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Lys684Asnfs*38 (c.2052delA) (2184delA); ClinVar=VCV000038493; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK54732
AC   CVCL_F1VR
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile148Thr (c.443T>C); ClinVar=VCV000038850; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK58698
AC   CVCL_F1VS
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1766+1G>A (1898+1G>A); ClinVar=VCV000007168; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK60302
AC   CVCL_F1VT
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Pro250Arg (c.749C>G); ClinVar=VCV000016340; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84904; Muenke syndrome
DI   ORDO; Orphanet_53271; Muenke syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK61832
AC   CVCL_F1VU
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Homozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183526; Methylmalonic aciduria and homocystinuria, cblJ type
DI   ORDO; Orphanet_369955; Methylmalonic acidemia with homocystinuria, type cblJ
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK62150
AC   CVCL_F1VV
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile148Thr (c.443T>C); ClinVar=VCV000038850; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK64169
AC   CVCL_F1VW
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1766+1G>A (1898+1G>A); ClinVar=VCV000007168; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK65584
AC   CVCL_F1VX
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe316Leufs*12 (c.948del) (1078delT); ClinVar=VCV000007163; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK66652
AC   CVCL_F1VY
RX   PubMed=16166172;
CC   Sequence variation: Gene deletion; HGNC; HGNC:4823; HBA1; Zygosity=Homozygous; Note=In SEA deletion (PubMed=16166172).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4824; HBA2; Zygosity=Homozygous; Note=In SEA deletion (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK69915
AC   CVCL_F1VZ
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[31] (c.52CAG(31)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK71006
AC   CVCL_F1W0
RX   PubMed=16166172;
CC   Sequence variation: Gene deletion; HGNC; HGNC:4823; HBA1; Zygosity=Homozygous; Note=In SEA deletion (PubMed=16166172).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4824; HBA2; Zygosity=Homozygous; Note=In SEA deletion (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK82747
AC   CVCL_F1W1
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile148Thr (c.443T>C); ClinVar=VCV000038850; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK84629
AC   CVCL_F1W2
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Homozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183526; Methylmalonic aciduria and homocystinuria, cblJ type
DI   ORDO; Orphanet_369955; Methylmalonic acidemia with homocystinuria, type cblJ
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK87691
AC   CVCL_F1W3
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Ser65Cys (c.193A>T); ClinVar=VCV000000011; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUK99211
AC   CVCL_F1W4
RX   PubMed=16166172;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1766+1G>A (1898+1G>A); ClinVar=VCV000007168; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: No information is provided on the patient sex, age and exact disease status.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   DUL LCL
AC   CVCL_XA38
DR   Wikidata; Q93533346
RX   PubMed=2155117;
RX   PubMed=2156585;
CC   Doubling time: 48-60 hours (PubMed=2156585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Dun
AC   CVCL_VU94
SY   DUN
DR   Wikidata; Q93533348
RX   PubMed=8044791;
RX   PubMed=11751535;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   DUN1
AC   CVCL_YE02
DR   Wikidata; Q93533354
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   Dunatis
AC   CVCL_QW68
SY   DUNATIS
DR   Wikidata; Q54831590
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7919343;
RX   PubMed=9444937;
RX   PubMed=10071072;
CC   Doubling time: 5-7 days (PubMed=9444937).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   Dunn osteosarcoma
AC   CVCL_W629
SY   Dunn's osteosarcoma; Dunn
DR   BTO; BTO_0002054
DR   Wikidata; Q54831591
RX   PubMed=9579581;
RX   PubMed=14173606;
RX   PubMed=26320182;
CC   Doubling time: 14.7 hours (PubMed=9579581).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   DuPro-1
AC   CVCL_4738
SY   DuPro; DUPRO
DR   BTO; BTO_0004186
DR   BioSample; SAMN03151892
DR   cancercelllines; CVCL_4738
DR   ChEMBL-Cells; CHEMBL3307488
DR   ChEMBL-Targets; CHEMBL614289
DR   IARC_TP53; 2303
DR   PubChem_Cell_line; CVCL_4738
DR   Wikidata; Q27972077
RX   PubMed=1875519;
RX   PubMed=8510267;
RX   PubMed=14518029;
RX   PubMed=15643172;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029; PubMed=20143388). Originally thought to originate from the metastasis in the left supraclavicular lymph node of a 58 year old patient with advanced prostate adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00189.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   DUR 10R
AC   CVCL_B6Q5
DR   Wikidata; Q111733164
RX   PubMed=69325;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DD99 ! 1R [Mouse L cells]
HI   CVCL_B6Q2 ! DUV
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   DUR 4R
AC   CVCL_B6Q3
DR   Wikidata; Q111733165
RX   PubMed=69325;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DD99 ! 1R [Mouse L cells]
HI   CVCL_B6Q2 ! DUV
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   DUR 5R
AC   CVCL_B6Q4
DR   Wikidata; Q111733166
RX   PubMed=69325;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DD99 ! 1R [Mouse L cells]
HI   CVCL_B6Q2 ! DUV
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   DUS
AC   CVCL_IZ46
SY   Dog Uterine Stromal
DR   Wikidata; Q54831592
RX   PubMed=27862405;
CC   Characteristics: After dbcAMP-mediated in vitro decidualization, express a wide spectrum of decidualization markers.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 6
//
ID   DUS1
AC   CVCL_IZ47
SY   Dog Uterine Stromal 1
DR   Wikidata; Q54831593
RX   PubMed=27862405;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 6
//
ID   DUS2
AC   CVCL_IZ48
SY   Dog Uterine Stromal 2
DR   Wikidata; Q54831594
RX   PubMed=27862405;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 6
//
ID   DUT
AC   CVCL_ZI16
DR   cancercelllines; CVCL_ZI16
DR   Wikidata; Q98125927
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Population: African; Kenyan.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   DUTi001-A
AC   CVCL_VM16
SY   NTDi4_09A
DR   hPSCreg; DUTi001-A
DR   Wikidata; Q93533439
RX   PubMed=30007220;
CC   From: Dell Pediatric Research Institute, University of Texas at Austin; Austin; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C101201; Myelomeningocele
DI   ORDO; Orphanet_93969; Open spinal dysraphism with a myelomeningocele
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 8
//
ID   DUTKO-1
AC   CVCL_6217
SY   DUTKO1; DUTKO
DR   Wikidata; Q54831595
RX   PubMed=3930277;
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI16 ! DUT
HI   CVCL_0004 ! K-562
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   DUV
AC   CVCL_B6Q2
DR   Wikidata; Q111733167
RX   PubMed=69325;
RX   PubMed=603627;
CC   Karyotypic information: 46,X,t(X;15) (PubMed=69325).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
ID   DV-1
AC   CVCL_AQ54
DR   Wikidata; Q54831596
RX   PubMed=3033590;
CC   Characteristics: Secretes IgM.
CC   Doubling time: 18-25 hours (PubMed=3033590).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from SCID and immunoblastic lymphoma.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   DV-90
AC   CVCL_1184
SY   DV90
DR   CLO; CLO_0002847
DR   EFO; EFO_0006565
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473076
DR   BioSample; SAMN10988133
DR   cancercelllines; CVCL_1184
DR   Cell_Model_Passport; SIDM01510
DR   ChEMBL-Cells; CHEMBL3308729
DR   ChEMBL-Targets; CHEMBL1075437
DR   Cosmic; 753553
DR   Cosmic; 1146951
DR   DepMap; ACH-000925
DR   DSMZ; ACC-307
DR   DSMZCellDive; ACC-307
DR   EGA; EGAS00001000610
DR   GDSC; 753553
DR   GEO; GSM434301
DR   GEO; GSM784284
DR   GEO; GSM886990
DR   GEO; GSM888059
DR   IARC_TP53; 21313
DR   IGRhCellID; DV-90_02GEO
DR   LiGeA; CCLE_820
DR   LINCS_LDP; LCL-1636
DR   PharmacoDB; DV90_311_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_1184
DR   PubChem_Cell_line; CVCL_1184
DR   Wikidata; Q54831597
RX   PubMed=7839470;
RX   PubMed=10908148;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=7839470); ~95 hours (DSMZ=ACC-307).
CC   HLA typing: A*03:01,11:01; B*15:17,35:11; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Val104Met (c.310G>A); ClinVar=VCV000376410; Zygosity=Heterozygous (DepMap=ACH-000925).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (DepMap=ACH-000925).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.68%; Native American=0%; East Asian, North=2.16%; East Asian, South=0%; South Asian=3.04%; European, North=41.86%; European, South=52.26% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-307; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 13,17
ST   D21S11: 31,31.2
ST   D2S1338: 17,24
ST   D3S1358: 13,16
ST   D5S818: 11,13
ST   D7S820: 11,14
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 10,13
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   DV-90-GFP
AC   CVCL_LM80
SY   DV-90 - GFP
DR   Wikidata; Q54831598
WW   Provider; Creative Biogene; CSC-RR0334; https://www.creative-biogene.com/GFP-Reporter-Cell-Line-DV-90-CSC-RR0334-1401091-13.html
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Val104Met (c.310G>A); ClinVar=VCV000376410; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1184 ! DV-90
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   DV2-M14
AC   CVCL_XB22
DR   CCRID; 4201PAT-CCTCC00223
DR   Wikidata; Q93533510
RX   Patent=CN101226196B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200737.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P29990; Dengue virus type 2 genome polyprotein (Note=AA 776-1127 = Non-structural protein 1 (NS1)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 6
//
ID   DV2-M6
AC   CVCL_XB23
DR   CCRID; 4201PAT-CCTCC00222
DR   Wikidata; Q93533515
RX   Patent=CN101226196B;
RX   Patent=CN101726593B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200736.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29990; Dengue virus type 2 genome polyprotein (Note=AA 776-1127 = Non-structural protein 1 (NS1)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   DV3-M11
AC   CVCL_XY01
SY   4B14A1; M11
DR   CCRID; 4201PAT-CCTCC00267
DR   Wikidata; Q93533520
RX   Patent=CN101726593B;
RX   PubMed=21228146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200857.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99D35; Dengue virus type 3 genome polyprotein (Note=AA 774-1125 = Non-structural protein 1 (NS1). Also reacts with dengue type 1 NS1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   DV3-M15
AC   CVCL_XX80
SY   5D32A17; M15
DR   Wikidata; Q93533522
RX   Patent=CN101576560A;
RX   PubMed=21228146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200820.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99D35; Dengue virus type 3 genome polyprotein (Note=AA 774-1125 = Non-structural protein 1 (NS1)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   DV3-M24
AC   CVCL_XY00
SY   3B1A15; M24
DR   CCRID; 4201PAT-CCTCC00268
DR   Wikidata; Q93533528
RX   Patent=CN101726593B;
RX   PubMed=21228146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200859.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99D35; Dengue virus type 3 genome polyprotein (Note=AA 774-1125 = Non-structural protein 1 (NS1)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 7
//
ID   DV3-M3
AC   CVCL_XX81
SY   1D14A2A10; M3
DR   CCRID; 4201PAT-CCTCC00246
DR   Wikidata; Q93533534
RX   Patent=CN101576560A;
RX   PubMed=21228146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200819.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99D35; Dengue virus type 3 genome polyprotein (Note=AA 774-1125 = Non-structural protein 1 (NS1)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   DV4-M12
AC   CVCL_XX82
SY   2E8A5; M12
DR   CCRID; 4201PAT-CCTCC00266
DR   Wikidata; Q93533538
RX   Patent=CN101551393B;
RX   Patent=CN101726593B;
RX   PubMed=21228146;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200855.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   DV4-M6
AC   CVCL_XX83
SY   7A6A1; M6
DR   CCRID; 4201PAT-CCTCC00265
DR   Wikidata; Q93533544
RX   Patent=CN101551393B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200854.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09866; Dengue virus type 4 genome polyprotein (Note=AA 775-1126 = Non-structural protein 1 (NS1)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 7
//
ID   DV68F
AC   CVCL_7953
DR   CLO; CLO_0002846
DR   ATCC; CRL-6345
DR   Wikidata; Q54831599
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6345; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   DV9540M
AC   CVCL_LM88
DR   Wikidata; Q54831600
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   DVE1
AC   CVCL_Z190
DR   Wikidata; Q54831601
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_2c164a746d
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=34621; ! Dermacentor variabilis (American dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   DVSi001-A
AC   CVCL_D0ES
SY   KRAS-Q70L-iPSC
DR   BioSamples; SAMEA114323041
DR   hPSCreg; DVSi001-A
DR   Wikidata; Q123031194
RX   PubMed=39106598;
CC   From: Department of Vascular Surgery, The Second Affiliated Hospital of Soochow University; Suzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln70Leu (c.209A>T); Zygosity=Heterozygous (PubMed=39106598).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35114; Varicose vein
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   DW
AC   CVCL_A1IA
DR   Wikidata; Q102113784
RX   DOI=10.5282/edoc.3898;
RX   PubMed=15706405;
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma. The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   DW0001
AC   CVCL_8W11
DR   ECACC; 94081259
DR   Wikidata; Q54831602
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 94081259; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 5
//
ID   DW0002
AC   CVCL_8W12
DR   ECACC; 94081260
DR   Wikidata; Q54831603
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 94081260; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 5
//
ID   DW34
AC   CVCL_5280
DR   Wikidata; Q54831604
RX   PubMed=2787384;
RX   PubMed=3264531;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=DW34
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BC8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2205 ! ST2
SX   Sex unspecified
AG   Age unspecified
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   DW6
AC   CVCL_N702
SY   DW 6
DR   Cosmic; 2808226
DR   Wikidata; Q54831605
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=8176200;
RX   PubMed=8220424;
RX   PubMed=8515068;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: DW36; Cosmic=2808226; PubMed=8220424.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   DWFb1
AC   CVCL_E3BU
RX   PubMed=15913645;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   DWFb1-rho0
AC   CVCL_4U14
SY   Rho0-DWFb1
DR   GEO; GSE24945
DR   Wikidata; Q54831606
RX   PubMed=15913645;
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0) (PubMed=15913645).
CC   Doubling time: 23.09 hours (PubMed=15913645).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3BU ! DWFb1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   DWH24
AC   CVCL_E6FE
RX   PubMed=37612784;
CC   Characteristics: The antibody produced by this hybridoma enables excellent visualisation and quantification of dead cells using immunofluorescence, fluorescence microscopy and flow cytometry (PubMed=37612784).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Recognizes many different proteins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   DWM-R
AC   CVCL_A2ZY
DR   CCLV; CCLV-RIE 0766
DR   Wikidata; Q105506780
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=30532; ! Dama dama (Fallow deer)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   DX
AC   CVCL_Z822
DR   DGRC; 176
DR   FlyBase_Cell_line; FBtc0000176
DR   Wikidata; Q54831607
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 103 hours (DGRC=176).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon R-C; FlyBase_Strain=FBsn0000277.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z425 ! 67j25D
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   DX3-LT5.1
AC   CVCL_LI22
SY   DX3.LT5.1; DX3 LT5.1; DX3LT5.1; DX3-azaC-LT5.1; LT5.1
DR   Wikidata; Q54831608
RX   PubMed=2060182;
RX   PubMed=2416434;
RX   PubMed=7780963;
CC   Characteristics: Highly metastatic in mice.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5650 ! SK-MEL-93 DX-3
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   DX3-LT5.1 HmR1
AC   CVCL_VS22
SY   LT5.1 HmR1; LT5.1 HmR 1
DR   Wikidata; Q93533703
RX   DOI=10.1111/j.1755-148X.2009.00641.x;
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LI22 ! DX3-LT5.1
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   DX3-puro/beta6
AC   CVCL_1D33
SY   DX3purobeta6
DR   Wikidata; Q54831609
DR   Ximbio; 151625
RX   PubMed=17699789;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6161; ITGB6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Ximbio; 151625; probable.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5650 ! SK-MEL-93 DX-3
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   DY36T2
AC   CVCL_EQ21
SY   Dy36T2
DR   cancercelllines; CVCL_EQ21
DR   GEO; GSM1401663
DR   Wikidata; Q54831610
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1657Ser (c.4970A>G); ClinVar=VCV000409419; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met52Ile (c.156G>C) (p.Asp67His, c.199G>C); ClinVar=VCV002132254; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys567Arg (c.1700A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0620 ! MDA-MB-361
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   DYSF1
AC   CVCL_VG56
SY   814
DR   Wikidata; Q54831611
RX   PubMed=22367358;
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Leu1341Pro (c.4022T>C) (p.Leu1359Pro, c.4076T>C); ClinVar=VCV000555968; Zygosity=Homozygous (PubMed=22367358).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   60Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 11
//
ID   DYSF2
AC   CVCL_VG57
SY   107
DR   Wikidata; Q54831614
RX   PubMed=22367358;
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Gly299Arg (c.895G>A) (p.Gly331Arg, c.991G>A); ClinVar=VCV000006681; Zygosity=Heterozygous (PubMed=22367358).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.951+1delG (c.855+1delG); ClinVar=VCV000006684; Zygosity=Heterozygous; Note=Causes mRNA decay (PubMed=22367358).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   DYSF3
AC   CVCL_VG58
SY   379
DR   Wikidata; Q54831615
RX   PubMed=22367358;
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.*107T>A; ClinVar=VCV000290170; Zygosity=Heterozygous; Note=3'UTR mutation (PubMed=22367358).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Ser483Ter (c.1448C>A) (p.Ser515Ter, c.1544C>A); ClinVar=VCV000554057; Zygosity=Heterozygous (PubMed=22367358).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 15
//
ID   DYSF4
AC   CVCL_VG59
SY   578
DR   Wikidata; Q54831616
RX   PubMed=22367358;
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.2864+2T>A (c.2810+2T>A); ClinVar=VCV000498750; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=22367358).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, triceps brachii; UBERON=UBERON_0001509.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   DZ0001
AC   CVCL_8W13
DR   ECACC; 94083008
DR   Wikidata; Q54831617
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,del(14)(q22.1->q22.3) (ECACC=94083008).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   DZ-MAb
AC   CVCL_B6IN
DR   Wikidata; Q111733169
RX   PubMed=25236207;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_42202; Daidzin (Daidzein 7-O-beta-D-glucoside).
CC   Monoclonal antibody target: ChEBI; CHEBI_27514; Genistin (Genistein 7-O-beta-D-glucoside).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   DzMab-1
AC   CVCL_D3D3
DR   Wikidata; Q127380807
RX   PubMed=31403910;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q13574; Human DGKZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   DZNU-Bm-1
AC   CVCL_Z082
SY   Bm-1
DR   ICLDB; dznu-bm-1
DR   Wikidata; Q54831618
RX   CelloPub=CLPUB00164;
RX   CelloPub=CLPUB00557;
RX   PubMed=16713602;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Swarnandhra.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   DZNU-Bm-12
AC   CVCL_Z115
SY   DZNU-BM-12; Bm-12
DR   ICLDB; dznu-bm-12
DR   Wikidata; Q54831619
RX   CelloPub=CLPUB00164;
RX   PubMed=19357932;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Kolar Gold.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   DZNU-Bm-16
AC   CVCL_Z304
SY   Bm-16
DR   ICLDB; dznu-bm-16
DR   Wikidata; Q54831620
RX   CelloPub=CLPUB00164;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   DZNU-Bm-17
AC   CVCL_Z116
SY   Bm-17
DR   Wikidata; Q54831621
RX   CelloPub=CLPUB00164;
RX   DOI=10.1016/j.aspen.2012.09.004;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Kolar Gold.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   E 20
AC   CVCL_J751
SY   E20; M-13
DR   CLO; CLO_0002850
DR   Wikidata; Q54831622
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8443.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   E-1E4
AC   CVCL_E4JK
SY   1E4
RX   Patent=US6210670;
RX   PubMed=7528571;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   E-2D4
AC   CVCL_E4JL
SY   2D4
RX   Patent=US6210670;
RX   PubMed=7528571;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   E-8
AC   CVCL_J885
DR   CLO; CLO_0002865
DR   ATCC; HB-10179
DR   Wikidata; Q54831623
RX   Patent=WO1991002250A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10179.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Ictalurus punctatus Ig heavy chain.
CC   Discontinued: ATCC; HB-10179; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   E-Adh-n1
AC   CVCL_Z901
SY   E Adh(n-1); E adn(n1); Eadh(n1)
DR   DGRC; 12
DR   FlyBase_Cell_line; FBtc0000012
DR   Wikidata; Q54831624
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: 27-35 hours (Note=Depending on growth medium) (DGRC=12).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   E-Aldox-n1
AC   CVCL_WK71
SY   E Aldox(n-1); Ealdox(n1)
DR   Wikidata; Q93533900
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   E-CS
AC   CVCL_Z893
SY   ECS
DR   DGRC; 22
DR   FlyBase_Cell_line; FBtc0000022
DR   Wikidata; Q54831625
RX   CelloPub=CLPUB00207;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 51-86 hours (Note=Depending on growth medium) (DGRC=22).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Canton-S; FlyBase_Strain=FBsn0000274.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   E-E12[ts] mal[1]
AC   CVCL_Z902
SY   EE12(ts)mal(1); EE12(ts)
DR   DGRC; 14
DR   FlyBase_Cell_line; FBtc0000014
DR   Wikidata; Q54831626
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   E-FM1
AC   CVCL_Z903
SY   EFM1
DR   DGRC; 20
DR   FlyBase_Cell_line; FBtc0000020
DR   Wikidata; Q54831627
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: 42 hours (DGRC=20).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Df(1)N8(Notch)/FM1.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   e-hChon-1
AC   CVCL_B7TU
DR   Wikidata; Q112929466
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 46<2n>XX,del(2)(q3?),-4,add(7)(p14),+21,add(22)(q13) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7TV ! e-hChon-2
OI   CVCL_B7TW ! e-hChon-3
OI   CVCL_B7TX ! e-hChon-4
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   e-hChon-2
AC   CVCL_B7TV
DR   Wikidata; Q112929467
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7TU ! e-hChon-1
OI   CVCL_B7TW ! e-hChon-3
OI   CVCL_B7TX ! e-hChon-4
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hChon-3
AC   CVCL_B7TW
DR   Wikidata; Q112929468
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7TU ! e-hChon-1
OI   CVCL_B7TV ! e-hChon-2
OI   CVCL_B7TX ! e-hChon-4
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hChon-4
AC   CVCL_B7TX
DR   Wikidata; Q112929469
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7TU ! e-hChon-1
OI   CVCL_B7TV ! e-hChon-2
OI   CVCL_B7TW ! e-hChon-3
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hDFib2
AC   CVCL_B7TZ
DR   Wikidata; Q112929471
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 44<2n>XY,der(2)t(2;4)(p24;p11),-4,-13,add(14)(p11) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7TY ! CI-huFIB
OI   CVCL_B7U0 ! e-hDFib3
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hDFib3
AC   CVCL_B7U0
DR   Wikidata; Q112929474
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7TY ! CI-huFIB
OI   CVCL_B7TZ ! e-hDFib2
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hFib-1
AC   CVCL_B7U1
DR   Wikidata; Q112929475
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 78<3n>XXYY,+1,add(2)(p24),-3,+6,+7,+del(8)(q21),+9,add(9)(p2?),+10,der(10)t(5;10)(q15:p15),+11,+18,der(19)t(11;19)(q13;p13),+20,+21,+22,+2mar (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:667; RHOA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0266 ! FS-4 [Human foreskin]
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hFib-2
AC   CVCL_B7U2
DR   Wikidata; Q112929476
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 69<3n>XXYY,+X/Y,t(2;5)(p16;q13),+3,+5,-9,+11,-13,+16,+20,-21,-22 (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0266 ! FS-4 [Human foreskin]
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   e-hFib-3
AC   CVCL_B7U3
DR   Wikidata; Q112929477
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0266 ! FS-4 [Human foreskin]
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hLEC-1
AC   CVCL_B7U4
DR   Wikidata; Q112929478
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Endothelial cell of lymphatic vessel; CL=CL_0002138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U5 ! e-hLEC-2
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hLEC-2
AC   CVCL_B7U5
DR   Wikidata; Q112929479
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Endothelial cell of lymphatic vessel; CL=CL_0002138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U4 ! e-hLEC-1
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hMEC-1
AC   CVCL_B7U6
DR   Wikidata; Q112929481
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4317; GLI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U7 ! e-hMEC-2
OI   CVCL_B7U8 ! e-hMEC-3
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   e-hMEC-2
AC   CVCL_B7U7
DR   Wikidata; Q112929484
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2.
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U6 ! e-hMEC-1
OI   CVCL_B7U8 ! e-hMEC-3
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hMEC-3
AC   CVCL_B7U8
DR   Wikidata; Q112929488
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U6 ! e-hMEC-1
OI   CVCL_B7U7 ! e-hMEC-2
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hOB-1
AC   CVCL_B7U9
DR   Wikidata; Q112929490
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 46<2n>XX (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7UA ! e-hOB-2
OI   CVCL_B7UB ! e-hOB-3
OI   CVCL_B7UC ! e-hOB-4
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   e-hOB-2
AC   CVCL_B7UA
DR   Wikidata; Q112929493
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 40-47<2n>add(X)(q27),add(10)(p11),-13,add(14)(q32),+20,+21,+22 (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U9 ! e-hOB-1
OI   CVCL_B7UB ! e-hOB-3
OI   CVCL_B7UC ! e-hOB-4
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   e-hOB-3
AC   CVCL_B7UB
DR   Wikidata; Q112929496
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 46<2n>XX,add(22)(q13) (at 21th passage); 46<2n>XX,ins(15)(q11),add(22)(q13) (at 66th passage) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U9 ! e-hOB-1
OI   CVCL_B7UA ! e-hOB-2
OI   CVCL_B7UC ! e-hOB-4
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   e-hOB-4
AC   CVCL_B7UC
DR   Wikidata; Q112929497
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2514; CTNNB1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7U9 ! e-hOB-1
OI   CVCL_B7UA ! e-hOB-2
OI   CVCL_B7UB ! e-hOB-3
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   e-hStr-1
AC   CVCL_B7UD
DR   Wikidata; Q112929498
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 111<5n>XXXX,-X,del(X)(q25),del(1)(p22),i(21)(q10) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7UE ! e-hStr-2
OI   CVCL_B7UF ! e-hStr-3
OI   CVCL_B7UG ! e-hStr-4
OI   CVCL_B7UH ! e-hStr-5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hStr-2
AC   CVCL_B7UE
DR   Wikidata; Q112929499
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 44<2n>XY,der(5)t(5;14)(p12;q11),-13,-21 (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7UD ! e-hStr-1
OI   CVCL_B7UF ! e-hStr-3
OI   CVCL_B7UG ! e-hStr-4
OI   CVCL_B7UH ! e-hStr-5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hStr-3
AC   CVCL_B7UF
DR   Wikidata; Q112929500
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7UD ! e-hStr-1
OI   CVCL_B7UE ! e-hStr-2
OI   CVCL_B7UG ! e-hStr-4
OI   CVCL_B7UH ! e-hStr-5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hStr-4
AC   CVCL_B7UG
DR   Wikidata; Q112929501
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7UD ! e-hStr-1
OI   CVCL_B7UE ! e-hStr-2
OI   CVCL_B7UF ! e-hStr-3
OI   CVCL_B7UH ! e-hStr-5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hStr-5
AC   CVCL_B7UH
DR   Wikidata; Q112929502
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7UD ! e-hStr-1
OI   CVCL_B7UE ! e-hStr-2
OI   CVCL_B7UF ! e-hStr-3
OI   CVCL_B7UG ! e-hStr-4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   e-hUVEC-1
AC   CVCL_B7UI
DR   Wikidata; Q112929503
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-10
AC   CVCL_B7US
DR   Wikidata; Q112929517
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Karyotypic information: 84-88<4n>XXXX,-3,-4,+9,i(21)(q10) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-3
AC   CVCL_B7UK
DR   Wikidata; Q112929505
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-4
AC   CVCL_B7UL
DR   Wikidata; Q112929506
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5363; ID4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17101; SUZ12.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-5
AC   CVCL_B7UM
DR   Wikidata; Q112929507
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-6
AC   CVCL_B7UN
DR   Wikidata; Q112929510
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-7
AC   CVCL_B7UP
DR   Wikidata; Q112929512
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-8
AC   CVCL_B7UQ
DR   Wikidata; Q112929515
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   e-hUVEC-9
AC   CVCL_B7UR
DR   Wikidata; Q112929516
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   E-mal[1]
AC   CVCL_Z904
SY   E-mal(1); Emal(1); Emal1
DR   DGRC; 24
DR   FlyBase_Cell_line; FBtc0000024
DR   Wikidata; Q54831628
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: 36-51 hours (Note=Depending on growth medium) (DGRC=24).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   E-mal[F3]
AC   CVCL_Z905
SY   E-mal(F3); Emal(F3); EmalF3; E malF3
DR   DGRC; 17
DR   FlyBase_Cell_line; FBtc0000017
DR   Wikidata; Q54831629
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   e-mHepA
AC   CVCL_B7UT
DR   Wikidata; Q112929518
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   e-mHepC
AC   CVCL_B7UV
DR   Wikidata; Q112929520
RX   PubMed=29520052;
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   E-OR
AC   CVCL_Z894
SY   EOR
DR   DGRC; 21
DR   FlyBase_Cell_line; FBtc0000021
DR   Wikidata; Q54831630
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 109 hours (DGRC=21).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   E-PR293
AC   CVCL_VV75
DR   Wikidata; Q93533965
RX   PubMed=16815068;
CC   Characteristics: Can be used to screen HIV-1 protease inhibitors. Produces HIV-1 PR fused to GFP in the presence of doxycycline.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12497; HIV-1 isolate NY5 pol.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V349 ! HEK 293 Tet-Off
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   E-r[1]
AC   CVCL_Z906
SY   Er1; Er(1); r1; Er1a
DR   DGRC; 15
DR   FlyBase_Cell_line; FBtc0000015
DR   Wikidata; Q54831631
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1007/BF00848269;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: 159 hours (DGRC=15).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   E-r[36]
AC   CVCL_Z907
SY   Er36; Er(36); r26
DR   DGRC; 18
DR   FlyBase_Cell_line; FBtc0000018
DR   Wikidata; Q54831632
RX   CelloPub=CLPUB00207;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1007/BF00848269;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: 200 hours (DGRC=18).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   E. C.
AC   CVCL_C8NL
DR   Wikidata; Q123031195
RX   PubMed=1374683;
CC   Doubling time: 43.1 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   E. Derm
AC   CVCL_3368
SY   E.Derm; E. Derm (NBL-6); NBL-6; Eq.Derm; EC1D
DR   CLO; CLO_0002852
DR   CLO; CLO_0002853
DR   CLDB; cl1117
DR   CLDB; cl1118
DR   CLDB; cl1119
DR   ATCC; CCL-57
DR   ATCC; CRL-6288
DR   ECACC; 88032803
DR   ICLC; AL97004
DR   IZSLER; BS CL 40
DR   Lonza; 49
DR   Wikidata; Q54831633
RX   DOI=10.1007/BF02618370;
RX   PubMed=6988327;
RX   PubMed=14984103;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/nbl6/nbl6cells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Senescence: Senesces at ~40 PDL (ATCC=CCL-57).
CC   Discontinued: ATCC; CRL-6288; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: American Quarter Horse; VBO=VBO_0001057.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   E.G7-OVA
AC   CVCL_3505
SY   E.G7-Ova
DR   CLO; CLO_0002854
DR   ATCC; CRL-2113
DR   BCRC; 60418
DR   Wikidata; Q54831634
RX   PubMed=3261634;
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   E.H.IV
AC   CVCL_2440
SY   E.H. IV; EHIV; Elaine IV
DR   CLO; CLO_0002855
DR   CLO; CLO_0002856
DR   CLDB; cl1120
DR   ATCC; CCL-104
DR   BioSample; SAMN03472691
DR   ECACC; 90121307
DR   KCLB; 10104
DR   Wikidata; Q54831635
RX   PubMed=5242134;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Established from Elaine Hutkin, a young technician in the Henles laboratory. She caught infectious mononucleosis and her blood cells became positive for EBV thus allowing the link to be made between EBV and mononucleosis.
CC   Misspelling: Elanine IV; KCLB=10104.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CCL-104; KCLB=10104
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 10,13
ST   D18S51: 13,15
ST   D19S433: 13,15
ST   D21S11: 29,30.2
ST   D2S1338: 21,23
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 15,17
ST   FGA: 20,25
ST   Penta D: 11
ST   Penta E: 7,18
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   E006AA
AC   CVCL_4834
SY   E006AA-Par; E006AA-Pr
DR   cancercelllines; CVCL_4834
DR   Millipore; SCC102
DR   Wikidata; Q38514722
RX   CelloPub=CLPUB00549;
RX   PubMed=15162380;
RX   PubMed=25076860;
RX   PubMed=31416301;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a 786-O derivative (PubMed=31416301). Originally thought to originate from a 50 year old patient with prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00585.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Millipore; SCC102; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Millipore=SCC102
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,14
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 7,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   E006AA ZIC2-/- E5
AC   CVCL_YI81
DR   cancercelllines; CVCL_YI81
DR   Wikidata; Q93534054
RX   CelloPub=CLPUB00549;
CC   Problematic cell line: Contaminated. Parent cell line (E006AA) has been shown to be a 786-O derivative.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12873; ZIC2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4834 ! E006AA
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   E006AA ZIC2-/- G12
AC   CVCL_YI82
DR   cancercelllines; CVCL_YI82
DR   Wikidata; Q93534059
RX   CelloPub=CLPUB00549;
CC   Problematic cell line: Contaminated. Parent cell line (E006AA) has been shown to be a 786-O derivative.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12873; ZIC2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4834 ! E006AA
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   E006AA-hT
AC   CVCL_X480
SY   E006AA-highly Tumorigenic
DR   ATCC; CRL-3277
DR   cancercelllines; CVCL_X480
DR   Wikidata; Q38514377
RX   PubMed=25076860;
RX   PubMed=30787054;
RX   PubMed=31416301;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (E006AA) has been shown to be a 786-O derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00586.
CC   Population: Caucasian.
CC   Doubling time: ~18 hours (PubMed=25076860).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-3277; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3277
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 9
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4834 ! E006AA
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 19
//
ID   E01F
AC   CVCL_A8XW
DR   GEO; GSM4610403
DR   GEO; GSM4617893
DR   GEO; GSM4617894
DR   Wikidata; Q108820171
RX   PubMed=31178141;
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   95FD
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   E01F A-2-2 iPSC
AC   CVCL_A8YG
SY   E01F_A2_2_iPS
DR   GEO; GSM4617891
DR   Wikidata; Q108820172
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8XW ! E01F
SX   Female
AG   95FD
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   E01F A-2-6 iPSC
AC   CVCL_A8YH
DR   Wikidata; Q108820173
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8XW ! E01F
SX   Female
AG   95FD
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   E01F A-2-7 iPSC
AC   CVCL_A8YI
DR   Wikidata; Q108820174
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8XW ! E01F
SX   Female
AG   95FD
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   E02M
AC   CVCL_A8YJ
DR   GEO; GSM4617896
DR   Wikidata; Q108820175
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   96FD
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   E02M B-0-7 iPSC
AC   CVCL_A8YK
SY   E02M_B0_7_iPS
DR   GEO; GSM4617895
DR   Wikidata; Q108820176
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8YJ ! E02M
SX   Male
AG   96FD
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   E10.3
AC   CVCL_0E81
DR   ATCC; CRL-2145
DR   Wikidata; Q54831636
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-2145; true.
CC   Derived from site: In situ; Endoderm; UBERON=UBERON_0000925.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-9FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   E10F10D5
AC   CVCL_XY56
DR   Wikidata; Q93534093
RX   Patent=CN1311073C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200502.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04134; Porcine transmissible gastroenteritis coronavirus (TGEV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   E10V
AC   CVCL_AZ86
DR   Wikidata; Q54831637
RX   PubMed=8041783;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   E11
AC   CVCL_5737
DR   CLS; 400494
DR   Wikidata; Q54831639
RX   PubMed=15200416;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   E111
AC   CVCL_2441
SY   EIII
DR   CLO; CLO_0002904
DR   CLDB; cl1151
DR   ECACC; 86072804
DR   Wikidata; Q54831640
RX   PubMed=3763403;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0439 ! MNNG/HOS Cl #5
HI   CVCL_0594 ! NIH 3T3
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   E12
AC   CVCL_D6UP
RX   PubMed=25723276;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P11680; Mouse Cfp.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   E13 161-7
AC   CVCL_9172
DR   CLO; CLO_0002858
DR   ATCC; HB-215
DR   Wikidata; Q54831641
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05533; Mouse Ly6a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   E14
AC   CVCL_B4P5
DR   Wikidata; Q110432790
RX   PubMed=7171457;
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   E14-nlsrtTA-7
AC   CVCL_X727
DR   Wikidata; Q54831642
RX   PubMed=11780141;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   E14Tg2aSc4TP6.3
AC   CVCL_XV39
DR   Wikidata; Q93534186
RX   PubMed=11087623;
CC   Characteristics: Transfected with construct expressing a MAPT/Tau-GFP fusion protein.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=FPbase; CQ6UF; MmGFP (mmGFP6; derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:57143; Bovine MAPT.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   E15
AC   CVCL_RU18
SY   PureStem E15, Meso-prx/latp progenitor; ACTC98
DR   Wikidata; Q54831643
RX   Patent=US8685386;
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-98; https://web.archive.org/web/20141202115710/http://www.esibio.com/purestemr-e15-ncr-fac-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10341.
CC   Senescence: Can undergo >50 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C342 ! MA03
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   E15.3
AC   CVCL_0E82
DR   ATCC; CRL-2152
DR   Wikidata; Q54831644
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-2152; true.
CC   Derived from site: In situ; Endoderm; UBERON=UBERON_0000925.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-9FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   E18
AC   CVCL_C4FS
DR   Wikidata; Q116048910
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   E195
AC   CVCL_EP95
DR   Wikidata; Q54831645
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4872; Breast carcinoma
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E1a
AC   CVCL_V078
DR   CLO; CLO_0002859
DR   CLDB; cl1122
DR   IHW; 11w 8025
DR   Wikidata; Q54831646
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   E1A-3Y1-1
AC   CVCL_H226
DR   JCRB; JCRB0738
DR   RCB; RCB0332
DR   Wikidata; Q54831647
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   E1A-3Y1-2
AC   CVCL_H231
DR   RCB; RCB0333
DR   Wikidata; Q54831648
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   E1A-3Y1-3
AC   CVCL_H232
DR   RCB; RCB0334
DR   Wikidata; Q54831649
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   E1A-NR.3
AC   CVCL_5I34
SY   E1A-NR3; E1A.NR3
DR   ABM; T0370
DR   Kerafast; EUR202
DR   Kerafast; EUR204
DR   Kerafast; EUR206
DR   Wikidata; Q54831650
RX   PubMed=8907116;
RX   PubMed=24644404;
WW   Info; Kerafast; -; https://news.kerafast.com/2012/10/31/on-the-road-to-retinal-cells/
CC   Doubling time: ~24 hours (Kerafast=EUR202).
CC   Transformant: Psi2 defective retrovirus adenovirus E1A.
CC   Derived from site: In situ; Eye, retina, neuroretina; UBERON=UBERON_0003902.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   6D
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   E1C1
AC   CVCL_6967
SY   POWHe001-A-1
DR   CCRID; 4201PAT-CCTCC00197
DR   hPSCreg; POWHe001-A-1
DR   SKIP; SKIP002024
DR   Wikidata; Q54831651
RX   Patent=US20070160974;
RX   PubMed=18271699;
CC   Group: Patented cell line.
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200626.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6966 ! Endeavour-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   E1C2
AC   CVCL_6968
SY   POWHe001-A-2
DR   CCRID; 4201PAT-CCTCC00198
DR   hPSCreg; POWHe001-A-2
DR   SKIP; SKIP002025
DR   Wikidata; Q54831652
RX   Patent=US20070160974;
RX   PubMed=18271699;
CC   Group: Patented cell line.
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200627.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6966 ! Endeavour-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   E1C3
AC   CVCL_6969
SY   POWHe001-A-3
DR   hPSCreg; POWHe001-A-3
DR   SKIP; SKIP002026
DR   Wikidata; Q54831653
RX   Patent=US20070160974;
RX   PubMed=18271699;
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6966 ! Endeavour-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   E1C4
AC   CVCL_6970
SY   POWHe001-A-4
DR   CCRID; 4201PAT-CCTCC00199
DR   hPSCreg; POWHe001-A-4
DR   SKIP; SKIP002027
DR   Wikidata; Q54831657
RX   Patent=US20070160974;
RX   PubMed=18271699;
CC   Group: Patented cell line.
CC   From: University of New South Wales; Sidney; Australia.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200628.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6966 ! Endeavour-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   E1D1
AC   CVCL_F0WK
RX   PubMed=3029407;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q1HVD2; Epstein-Barr virus (strain B95-8) glycoprotein H (BXLF2).
CC   Monoclonal antibody target: UniProtKB; Q1HVF6; Epstein-Barr virus (strain B95-8) envelope glycoprotein L (BKRF2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   E1SM
AC   CVCL_C5QK
SY   E(1)SM
DR   Wikidata; Q116048911
RX   PubMed=6179471;
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   E2
AC   CVCL_S003
SY   AD-Ca E2
DR   Wikidata; Q54831658
RX   PubMed=20631921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S004 ! E4
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   E2.3
AC   CVCL_XC76
DR   Wikidata; Q93534364
RX   Patent=US5667781;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10746.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   E22758
AC   CVCL_E573
DR   dbMHC; 48768
DR   IHW; IHW09399
DR   IPD-IMGT/HLA; 26003
DR   Wikidata; Q54831659
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*11:01,33:03; B*48:01,56:04; C*01:02,08:01 (IPD-IMGT/HLA=26003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   E242
AC   CVCL_EP96
DR   Wikidata; Q54831660
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E245
AC   CVCL_EP82
DR   Wikidata; Q54831661
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E246
AC   CVCL_EP83
DR   Wikidata; Q54831662
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E247
AC   CVCL_EP84
DR   Wikidata; Q54831663
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E248
AC   CVCL_EP85
DR   Wikidata; Q54831664
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E249
AC   CVCL_EP86
DR   Wikidata; Q54831665
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E250
AC   CVCL_EP87
DR   Wikidata; Q54831666
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E252
AC   CVCL_EP97
DR   Wikidata; Q54831667
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E253
AC   CVCL_EP98
DR   Wikidata; Q54831668
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E254
AC   CVCL_EP99
DR   Wikidata; Q54831669
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E264
AC   CVCL_EQ00
DR   Wikidata; Q54831670
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E265
AC   CVCL_EQ01
DR   Wikidata; Q54831671
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E270
AC   CVCL_EQ02
DR   Wikidata; Q54831672
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E2A5
AC   CVCL_F0WD
RX   PubMed=2159529;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03218; Epstein-Barr virus (strain B95-8) glycoprotein BILF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   E2F4C5
AC   CVCL_XK38
DR   Wikidata; Q93534546
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_35720; Enrofloxacin (ENR) (Note=Also recognizes ciprofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   E3 [Mouse hybridoma against PEDV spike]
AC   CVCL_E3A2
RX   PubMed=26492620;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A142II16; Porcine epidemic diarrhea virus (strain CH-SDBZ-1-2015) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   E3 [Mouse mammary tumor]
AC   CVCL_W345
DR   CancerTools; 152597
DR   Wikidata; Q54831674
DR   Ximbio; 152597
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W343 ! 410.4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   E3-B7(X)
AC   CVCL_E3A8
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W345 ! E3 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   E3-B7(Y)
AC   CVCL_E3A9
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W345 ! E3 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   E3-B7(Z)
AC   CVCL_E3AA
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W345 ! E3 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   E3-neo
AC   CVCL_E3A7
RX   PubMed=10457219;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W345 ! E3 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   E301
AC   CVCL_EP88
DR   Wikidata; Q54831675
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E302
AC   CVCL_EP89
DR   Wikidata; Q54831676
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E303
AC   CVCL_EP90
DR   Wikidata; Q54831677
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E305
AC   CVCL_EQ03
DR   Wikidata; Q54831678
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E306
AC   CVCL_EQ04
DR   Wikidata; Q54831679
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E307
AC   CVCL_EQ05
DR   Wikidata; Q54831680
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E308
AC   CVCL_EQ06
DR   Wikidata; Q54831681
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E311
AC   CVCL_EQ07
DR   Wikidata; Q54831682
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E313
AC   CVCL_EP91
DR   Wikidata; Q54831683
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E314
AC   CVCL_EP92
DR   Wikidata; Q54831685
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E319
AC   CVCL_EQ08
DR   Wikidata; Q54831686
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   NCIt; C3493; Lung squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   E320
AC   CVCL_EQ09
DR   Wikidata; Q54831687
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E321
AC   CVCL_EQ10
DR   Wikidata; Q54831688
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E322
AC   CVCL_EQ11
DR   Wikidata; Q54831689
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E325
AC   CVCL_EQ12
DR   Wikidata; Q54831690
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E326
AC   CVCL_EQ13
DR   Wikidata; Q54831691
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E329
AC   CVCL_EQ14
DR   Wikidata; Q54831692
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E330
AC   CVCL_EQ15
DR   Wikidata; Q54831693
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4872; Breast carcinoma
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E331
AC   CVCL_EQ16
DR   Wikidata; Q54831694
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E332
AC   CVCL_EQ17
DR   Wikidata; Q54831695
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   NCIt; C3493; Lung squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   E333
AC   CVCL_EQ18
DR   Wikidata; Q54831696
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35427; Malignant neoplasm of multiple primary sites
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   E334
AC   CVCL_EP93
DR   Wikidata; Q54831697
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E335
AC   CVCL_EP94
DR   Wikidata; Q54831698
RX   PubMed=22825601;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   E3C/O
AC   CVCL_Y441
DR   ATCC; CRL-6179
DR   Wikidata; Q54831705
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6179; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Undefined cell line type
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   E3D7
AC   CVCL_C3T7
DR   Wikidata; Q116048912
RX   PubMed=3014046;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P89452; Human herpesvirus 2 (HHV-2) major DNA-binding protein (DBP) (Note=Also reacts with HHV-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   E3GS2.4
AC   CVCL_DH86
DR   cancercelllines; CVCL_DH86
DR   GEO; GSM784711
DR   Progenetix; CVCL_DH86
DR   Wikidata; Q54831706
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 5
//
ID   E3STn
AC   CVCL_W346
SY   E3-STn; E3 STn
DR   CancerTools; 151847
DR   Wikidata; Q54831707
DR   Ximbio; 151847
RX   PubMed=19436292;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341826; St6galnac1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W345 ! E3 [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   E4
AC   CVCL_S004
SY   AD-Ca E4
DR   Wikidata; Q54831708
RX   PubMed=20631921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S003 ! E2
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   E4181324
AC   CVCL_E574
SY   E481324
DR   dbMHC; 48769
DR   ECACC; 88052011
DR   IHW; IHW09011
DR   IPD-IMGT/HLA; 10546
DR   Wikidata; Q54831709
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01:01; B*52:01:01:02; C*12:02:02:01; DPA1*01:03; DPB1*02:01:02/02:01:19,04:01:01; DQA1*01:03; DQB1*06:01:01/06:01:15; DRA*01:02; DRB1*15:02:01; DRB5*01:02; DRB6*02:01 (IPD-IMGT/HLA=10546).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   E42/02
AC   CVCL_A3AV
DR   CCLV; CCLV-RIE 0891
DR   Wikidata; Q105506781
RX   PubMed=23893605;
DI   NCIt; C134995; Horse sarcoid
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   E46.4
AC   CVCL_VU25
DR   Wikidata; Q93534923
RX   Patent=US7429644;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3357.
CC   Biotechnology: Used to produce hCBE 11, a humanized antibody against human LTBR (lymphotoxin-beta receptor).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 9
//
ID   E487
AC   CVCL_6G66
DR   IPD-IMGT/HLA; 12602
DR   Wikidata; Q54831710
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01:01,30:01; B*44:27,13:02 (IPD-IMGT/HLA=12602).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   E4D
AC   CVCL_0E83
DR   ATCC; CRL-2144
DR   Wikidata; Q54831711
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-2144; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-9FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   E5
AC   CVCL_A7UH
DR   Wikidata; Q107114819
RX   PubMed=3329310;
RX   PubMed=3900854;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=3329310; PubMed=3900854).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   E522L
AC   CVCL_U104
DR   Wikidata; Q54831712
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17511773;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   HLA typing: A*02:07,24:02; B*40:06,59:01; C*01:02,08:01 (PubMed=12114371).
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Homozygous (PubMed=17725806).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   E5ab2
AC   CVCL_V079
DR   CLO; CLO_0002862
DR   CLDB; cl1125
DR   IHW; 11w 8029
DR   Wikidata; Q54831713
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   E5BB3IIA2
AC   CVCL_J894
DR   CLO; CLO_0002863
DR   ATCC; HB-121
DR   Wikidata; Q54831714
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human IgE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   E5B7E8
AC   CVCL_XK39
DR   Wikidata; Q93534992
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_35720; Enrofloxacin (ENR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   E6
AC   CVCL_B6C7
DR   Wikidata; Q111733170
RX   PubMed=25749913;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Labeo rohita thymocyte 166.2 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   E6-E7 4-5-2G
AC   CVCL_F0TS
RX   PubMed=9772298;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   E6-E7 4-5-2G/v-Ki-ras
AC   CVCL_F0TT
SY   v-Ki-ras/E6-E7 4-5-2G
RX   PubMed=9772298;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0TS ! E6-E7 4-5-2G
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   E6(2)2
AC   CVCL_J895
SY   E6 (2) 2
DR   CLO; CLO_0002864
DR   IZSLER; BS Hy 63
DR   Wikidata; Q54831715
RX   Patent=US4465776;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8172.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_27306; Vitamin B6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   E68
AC   CVCL_RU19
SY   ACTC207
DR   Millipore; SCC124
DR   Millipore; SCR224
DR   Wikidata; Q54831717
RX   PubMed=18462054;
CC   Discontinued: Millipore; SCC124; true.
CC   Discontinued: Millipore; SCR224; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C342 ! MA03
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   E6SM
AC   CVCL_W081
SY   E(6)SM
DR   ChEMBL-Cells; CHEMBL3307548
DR   ChEMBL-Targets; CHEMBL614149
DR   PubChem_Cell_line; CVCL_W081
DR   Wikidata; Q54831718
RX   PubMed=6179471;
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   E710.2
AC   CVCL_A2KG
DR   Wikidata; Q105506785
RX   PubMed=1828825;
CC   Characteristics: Has an immature phenotype (CD4-CD8-) (PubMed=1828825).
CC   Characteristics: Proliferates in response to thymocytes or phorbol 12-myristate 13-acetate (PMA) when cultured at low density. Proliferates spontaneously when grown at high density (PubMed=1828825).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   E710.2.3
AC   CVCL_A2KH
DR   Wikidata; Q105506787
RX   PubMed=10415028;
CC   Characteristics: Has an immature phenotype (CD4-CD8-) (PubMed=10415028).
CC   Characteristics: Proliferates in response to thymocytes or phorbol 12-myristate 13-acetate (PMA) when cultured at low density. Proliferates spontaneously when grown at high density (PubMed=10415028).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2KG ! E710.2
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   E77.4
AC   CVCL_VU26
DR   Wikidata; Q93535054
RX   Patent=US7429644;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3765.
CC   Biotechnology: Used to produce hCBE 11, a humanized antibody against human LTBR (lymphotoxin-beta receptor).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 9
//
ID   E8
AC   CVCL_B6M6
DR   Wikidata; Q111733172
RX   PubMed=32512615;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_18418; (RS)-norcoclaurine (Higenamine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   E85
AC   CVCL_B4H7
SY   E85 (GLHB)
DR   ATCC; HB-10616
DR   Wikidata; Q110432791
RX   Patent=US5183739;
RX   PubMed=2066560;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10616.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P69905; Human HBA1 (Note=Glycated; N-deoxyfructosyllysine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   E8B3
AC   CVCL_F0WL
RX   PubMed=3021971;
RX   PubMed=3029407;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Epstein-Barr virus (strain B95-8) early membrane protein p105.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   E8D2
AC   CVCL_F0WM
RX   PubMed=3021971;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Epstein-Barr virus (strain B95-8) early membrane protein p105.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   E95A-BL-28
AC   CVCL_C5V3
DR   Wikidata; Q116048913
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*01; B*08,16 (PubMed=3037521).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M567 ! BL-28
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   E95A-BL-41
AC   CVCL_C5V5
DR   Wikidata; Q116048914
RX   PubMed=2645221;
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*32; B*35,49 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   E95B-BL-28
AC   CVCL_C5V4
DR   Wikidata; Q116048915
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*01; B*08,16 (PubMed=3037521).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M567 ! BL-28
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   E95B-BL-41
AC   CVCL_C5V6
DR   Wikidata; Q116048916
RX   PubMed=2645221;
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*32; B*35,49 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   E95C-BL-41
AC   CVCL_C5V7
DR   Wikidata; Q116048917
RX   PubMed=2645221;
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*32; B*35,49 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   E9F10
AC   CVCL_C3T8
DR   Wikidata; Q116048918
RX   PubMed=3014046;
RX   PubMed=6325164;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P89452; Human herpesvirus 2 (HHV-2) major DNA-binding protein (DBP) (Note=Also reacts with HHV-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   EA
AC   CVCL_E575
DR   dbMHC; 48770
DR   ECACC; 88052080
DR   IHW; IHW09081
DR   IPD-IMGT/HLA; 11629
DR   Wikidata; Q54831719
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Scandinavian.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01; DPB1*04:01:01; DQA1*01:02:01; DQB1*06:02:01; DRA*01:02; DRB1*15:01:01; DRB5*01:01; DRB6*02 (IPD-IMGT/HLA=11629).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   EA-1
AC   CVCL_IR16
SY   Endometrial Adenocarcinoma-1
DR   Cosmic; 713490
DR   Wikidata; Q54831720
RX   PubMed=1696575;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   EA-285
AC   CVCL_C8FF
SY   EA 285; EA285
DR   Wikidata; Q123031196
RX   PubMed=4612115;
RX   PubMed=6950179;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344 CDF (F344/DuCrl); RS=RS_0000179.
DI   NCIt; C60436; Rat malignant astrocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   EA-285A
AC   CVCL_C8FG
DR   Wikidata; Q123031197
RX   PubMed=6950179;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344 CDF (F344/DuCrl); RS=RS_0000179.
DI   NCIt; C60436; Rat malignant astrocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8FF ! EA-285
SX   Male
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   Ea.4
AC   CVCL_Z256
SY   Ea-4; Ea4
DR   CLO; CLO_0002866
DR   ECACC; 96073116
DR   ICLDB; ea4
DR   Wikidata; Q54831721
RX   DOI=10.1038/nbt0296-197;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 36 hours (ECACC=96073116).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=56594; ! Estigmene acrea (Salt marsh moth)
HI   CVCL_Z253 ! BTI-EAA
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   EA.hy 926
AC   CVCL_3901
SY   EA. hy 926; EA hy 926; EA-hy926; EAhy 926; EAHY-926; EA.Hy926; EA.hy926; EAhy926; EaHy926; Eahy926
DR   BTO; BTO_0000396
DR   EFO; EFO_0003039
DR   ABM; T0735
DR   ATCC; CRL-2922
DR   BCRJ; 0345
DR   BioSample; SAMN03471700
DR   CCRID; 1101HUM-PUMC000475
DR   CCRID; 3101HUMGNHu39
DR   Cell_Model_Passport; SIDM01986
DR   ChEMBL-Cells; CHEMBL4295452
DR   ChEMBL-Targets; CHEMBL4296410
DR   CLS; 305034
DR   GEO; GSM46371
DR   GEO; GSM46380
DR   GEO; GSM46382
DR   GEO; GSM46383
DR   GEO; GSM46384
DR   GEO; GSM46385
DR   GEO; GSM46392
DR   GEO; GSM46393
DR   KCB; KCB 2014048YJ
DR   Lonza; 685
DR   NCBI_Iran; C641
DR   PubChem_Cell_line; CVCL_3901
DR   Ubigene; YC-C032
DR   Wikidata; Q54831722
RX   PubMed=3130908;
RX   PubMed=6407019;
RX   PubMed=7791520;
RX   PubMed=12453433;
RX   PubMed=16575254;
RX   PubMed=26345505;
RX   PubMed=28199884;
RX   PubMed=30108515;
RX   PubMed=30977987;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Produced by the fusion of A549/8 with human umbilical vein endothelial cells.
CC   Doubling time: 12 hours (PubMed=6407019).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Anecdotal: Have been flown in space on Shijian-10 and on the ISS in 2016 to study growth and secretion in microgravity (PubMed=28199884; PubMed=30108515; PubMed=30977987).
CC   Misspelling: EA.hy 296; Note=Occasionally.
CC   Misspelling: EA-hy 296; Note=Occasionally.
CC   Misspelling: EA.hy296; Note=Occasionally.
ST   Source(s): ATCC=CRL-2922
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,15,17
ST   D19S433: 13,14
ST   D21S11: 28,29,32
ST   D2S1338: 22,24
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,9,10
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 7,11,12
ST   TH01: 6,8,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY87 ! A549/8
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   EA.hy926-EGFP
AC   CVCL_C8WK
DR   Ubigene; YC-C032-EGFP-P
DR   Wikidata; Q123031198
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3901 ! EA.hy 926
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   EA.hy926-Luc
AC   CVCL_C8VU
DR   Ubigene; YC-C032-Luc-P
DR   Wikidata; Q123031199
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3901 ! EA.hy 926
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   EA1.Lu
AC   CVCL_R941
DR   ATCC; CRL-6015
DR   Wikidata; Q54831723
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6015; true.
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
CC   Derived from site: In situ; Lung; Note=Uncertainty of sampling site; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9643; ! Ursus americanus (American black bear)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 8
//
ID   EA13.5
AC   CVCL_DD02
DR   Wikidata; Q54831724
RX   Patent=US5198428;
RX   PubMed=8445326;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10934.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Ea1C-35
AC   CVCL_A9EM
DR   Wikidata; Q108820177
RX   Patent=US7566567;
CC   Group: Patented cell line.
CC   From: MultiCell Technologies, Inc.; Woonsocket; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5565.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   EA2.31
AC   CVCL_B6NX
SY   EA2
DR   Wikidata; Q111733174
RX   Patent=US20100298545;
RX   PubMed=14633720;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4380.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P29317; Human EPHA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 5
//
ID   Ea3
AC   CVCL_HE66
DR   Wikidata; Q54831725
RX   PubMed=6201749;
RX   PubMed=6422470;
CC   Characteristics: IL3 dependent.
CC   Doubling time: 16 hours (PubMed=6422470); 15-17 hours (PubMed=6201749).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   Ea3.10
AC   CVCL_B6LX
SY   Ea3 clone 10
DR   Wikidata; Q111733175
RX   PubMed=6201749;
CC   Characteristics: IL3 dependent.
CC   Doubling time: 20 hours (PubMed=6201749).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE66 ! Ea3
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   Ea3.11
AC   CVCL_B6LY
SY   Ea3 clone 11
DR   Wikidata; Q111733176
RX   PubMed=6201749;
CC   Characteristics: IL3 dependent.
CC   Doubling time: 15-17 hours (PubMed=6201749).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE66 ! Ea3
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   Ea3.123
AC   CVCL_HE67
SY   123
DR   Wikidata; Q54831726
RX   PubMed=3089920;
RX   PubMed=3491256;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE66 ! Ea3
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   Ea3.13
AC   CVCL_B6LZ
SY   Ea3 clone 13
DR   Wikidata; Q111733177
RX   PubMed=6201749;
RX   PubMed=6422470;
CC   Characteristics: IL3 dependent.
CC   Doubling time: 15-17 hours (PubMed=6201749).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE66 ! Ea3
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   Ea3.15
AC   CVCL_B6M0
SY   Ea3 clone 15
DR   Wikidata; Q111733178
RX   PubMed=6201749;
CC   Characteristics: IL3 dependent.
CC   Doubling time: 19 hours (PubMed=6201749).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE66 ! Ea3
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   Ea3.17
AC   CVCL_5281
SY   Ea3-17; Ea 3-17; Ea3 clone 17
DR   Wikidata; Q54831727
RX   PubMed=2497280;
RX   PubMed=6201749;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Ea3.17
CC   Characteristics: IL3 dependent.
CC   Doubling time: 15-17 hours (PubMed=6201749).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE66 ! Ea3
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   Ea3.2
AC   CVCL_B6M1
SY   Ea3 clone 2
DR   Wikidata; Q111733179
RX   PubMed=6201749;
CC   Characteristics: IL3 dependent.
CC   Doubling time: 15-17 hours (PubMed=6201749).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE66 ! Ea3
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   EA5.12
AC   CVCL_B6NY
SY   EA5
DR   Wikidata; Q111733180
RX   Patent=US20100298545;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4381.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P29317; Human EPHA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 4
//
ID   EA7
AC   CVCL_E9E5
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/EA7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O76039; Human CDKL5 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   EAC-E2G8
AC   CVCL_WJ08
DR   CCRID; 4201MOU-CCTCC00133
DR   CCTCC; GDC0133
DR   Wikidata; Q93535191
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3873 ! Ehrlich-Lettre ascites strain E
SX   Female
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   EACH-1
AC   CVCL_E5VA
SY   Extra-Axial CHordoma-1
DR   ABM; T8000
RX   PubMed=20439670;
CC   Doubling time: 37 hours (PubMed=20439670).
CC   Derived from site: In situ; Bone, scapula; UBERON=UBERON_0006849.
DI   NCIt; C215036; Extra-axial chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   EAG3
AC   CVCL_A9CE
SY   Endometrial Adenocarcinoma G3
DR   CCRID; 1101HUM-PUMC000484
DR   Wikidata; Q108820178
RX   DOI=10.13390/j.issn.1672-1861.2014.02.013;
CC   Population: Chinese.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   EAGB
AC   CVCL_R892
SY   Epinephelus Akaara Grouper Brain
DR   Wikidata; Q54831728
RX   DOI=10.1016/j.aquaculture.2010.11.037;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=215347; ! Epinephelus akaara (Hong Kong grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   EAGK
AC   CVCL_R893
SY   Epinephelus Akaara Grouper Kidney
DR   Wikidata; Q54831729
RX   PubMed=21838711;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Singapore grouper iridovirus (SGIV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=215347; ! Epinephelus akaara (Hong Kong grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   EAGL
AC   CVCL_R894
SY   Epinephelus Akaara Grouper Liver
DR   Wikidata; Q54831730
RX   PubMed=21039492;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Singapore grouper iridovirus (SGIV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=215347; ! Epinephelus akaara (Hong Kong grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   EAGS
AC   CVCL_R895
SY   Epinephelus Akaara Grouper Spleen
DR   Wikidata; Q54831731
RX   DOI=10.1016/j.aquaculture.2009.04.019;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=215347; ! Epinephelus akaara (Hong Kong grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   EAGSB
AC   CVCL_R896
SY   Epinephelus Akaara Grouper Swim Bladder
DR   Wikidata; Q54831732
RX   DOI=10.1016/j.aquaculture.2009.04.019;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=215347; ! Epinephelus akaara (Hong Kong grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   EAM306
AC   CVCL_AV62
SY   THJ-306T
DR   ABM; T8259
DR   cancercelllines; CVCL_AV62
DR   Wikidata; Q54831733
RX   CelloPub=CLPUB00321;
RX   PubMed=25675381;
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu326Ter (c.976G>T); ClinVar=VCV000231815; Zygosity=Unspecified (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 12,15
ST   D21S11: 28,31.2
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 21
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   EAP1
AC   CVCL_J956
DR   Wikidata; Q54831734
WW   Info; MMRRC; -; https://mmrrc.ucdavis.edu/files/protocols/ESC-culture-EAP1.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6NCrl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   EAV,AC
AC   CVCL_E576
SY   EAV, AC
DR   dbMHC; 48771
DR   ECACC; 94082251
DR   IHW; IHW09151
DR   IPD-IMGT/HLA; 11694
DR   Wikidata; Q54831735
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*19,02; B*21,37; DPB1*02:01,03:01; DQA1*01:05,02:01; DQB1*02:02:01,05:01:01/05:01:24; DRB1*07,10:01 (IPD-IMGT/HLA=11694).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   EB [Human colon carcinoma]
AC   CVCL_F287
SY   HCT-EB; HCT EB
DR   cancercelllines; CVCL_F287
DR   ColonAtlas; EB
DR   Cosmic; 711274
DR   Cosmic; 887228
DR   Cosmic; 889530
DR   Cosmic; 948124
DR   Cosmic; 1057762
DR   GEO; GSM2549998
DR   Wikidata; Q54831736
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=7329817;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11526487;
RX   PubMed=24042735;
RX   PubMed=28683746;
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=24042735; PubMed=28683746).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=24042735
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 21,22.2
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   EB [Human skin fibroblast]
AC   CVCL_5282
DR   CLO; CLO_0002867
DR   ATCC; CRL-1365
DR   Wikidata; Q54831737
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   EB (JC)
AC   CVCL_4169
SY   EB(JC)
DR   CLO; CLO_0002868
DR   CLDB; cl1126
DR   ArrayExpress; E-MTAB-1511
DR   ECACC; 89072703
DR   Wikidata; Q54831738
RX   PubMed=24380390;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   EB-1
AC   CVCL_YK89
DR   Wikidata; Q93535360
RX   Patent=US7622560;
RX   Patent=US9746474;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00010.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16150; Human SPN/CD43.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   EB-A1
AC   CVCL_A6CX
DR   Wikidata; Q107114821
RX   PubMed=1375195;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   EB-A2
AC   CVCL_A6CY
SY   EBA2
DR   Wikidata; Q107114823
RX   PubMed=1375195;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   EB-A3
AC   CVCL_A6CZ
DR   Wikidata; Q107114826
RX   PubMed=1375195;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   EB-A4
AC   CVCL_A6DA
DR   Wikidata; Q107114827
RX   PubMed=1375195;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   EB-A5
AC   CVCL_A6DB
DR   Wikidata; Q107114829
RX   PubMed=1375195;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   EB-A6
AC   CVCL_A6DC
DR   Wikidata; Q107114831
RX   PubMed=1375195;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   EB-A7
AC   CVCL_A6DD
DR   Wikidata; Q107114833
RX   PubMed=1375195;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   EB-BS-AkSak
AC   CVCL_ZM75
DR   Wikidata; Q98125928
RX   PubMed=6099120;
RX   PubMed=6299928;
RX   PubMed=17407155;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser186_Lys187delinsTer (c.557_559delCAA) (S186*); ClinVar=VCV000005455; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; c.2074+1G>T; ClinVar=VCV000042066; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 78(AkSak) (BSR78).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   EB-BS-NoKi-1
AC   CVCL_ZS84
DR   Wikidata; Q98125930
RX   PubMed=6099120;
RX   PubMed=6299928;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (from autologous cell lines BS1KA; HG1805).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 86(NoKi) (BSR86).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L951 ! BS1KA
OI   CVCL_WX76 ! HG1805
OI   CVCL_ZS85 ! EB-BS-NoKi-2
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   EB-BS-NoKi-2
AC   CVCL_ZS85
DR   Wikidata; Q98125931
RX   PubMed=6099120;
RX   PubMed=6299928;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (from autologous cell lines BS1KA; HG1805).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 86(NoKi) (BSR86).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L951 ! BS1KA
OI   CVCL_WX76 ! HG1805
OI   CVCL_ZS84 ! EB-BS-NoKi-1
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   EB-PE
AC   CVCL_F014
DR   Wikidata; Q54831739
RX   PubMed=9558375;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=EB-PE
CC   Characteristics: Primitive erythroid (EryP) lineage cell line obtained after retroviral insertion (PubMed=9558375).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Primitive erythroid lineage cell; CL=CL_0002417.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C313 ! CCE
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   EB-Y8
AC   CVCL_A6DE
SY   EBY8
DR   Wikidata; Q107114835
RX   CelloPub=CLPUB00618;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Yersinia enterocolitica serogroup O:8 lipopolysaccharide.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   EB.Sk
AC   CVCL_S388
DR   ATCC; CRL-6524
DR   Wikidata; Q54831740
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6524; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=39304; ! Erignathus barbatus (Bearded seal)
SX   Female
AG   1-2Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   EB0405
AC   CVCL_WY97
SY   EB
DR   Wikidata; Q93535391
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu137Aspfs*9 (c.409_416del7); Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line name, age at sampling and TP53 mutation cDNA coordinates from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D12S391: 18,23
ST   D13S317: 12
ST   D16S539: 11,15
ST   D18S51: 14
ST   D19S433: 16.2
ST   D1S1656: 17
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D6S1043: 12,18
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY92 ! 15876
OI   CVCL_WY93 ! 16106
OI   CVCL_WY94 ! 17066
OI   CVCL_WY95 ! 17201
OI   CVCL_WY96 ! 17268
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   EB1
AC   CVCL_2027
AS   CVCL_2026
SY   EB-1; Epstein-Barr-1
DR   BTO; BTO_0003000
DR   CLO; CLO_0002869
DR   CLO; CLO_0002870
DR   EFO; EFO_0002172
DR   CLDB; cl1127
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-60
DR   BioSample; SAMN03472402
DR   BioSample; SAMN03473402
DR   BioSample; SAMN10987945
DR   cancercelllines; CVCL_2027
DR   Cell_Model_Passport; SIDM00862
DR   CLS; 300403
DR   Cosmic; 1086328
DR   Cosmic; 1818341
DR   DepMap; ACH-000877
DR   DSMZ; ACC-80
DR   DSMZCellDive; ACC-80
DR   EGA; EGAS00001000610
DR   GEO; GSM827341
DR   GEO; GSM886991
DR   GEO; GSM888060
DR   IARC_TP53; 21315
DR   IGRhCellID; EB1
DR   LiGeA; CCLE_384
DR   LINCS_LDP; LCL-2030
DR   PharmacoDB; EB1_313_2019
DR   Progenetix; CVCL_2027
DR   Wikidata; Q54831741
RX   PubMed=2998993;
RX   PubMed=3518877;
RX   PubMed=4894370;
RX   PubMed=5884338;
RX   PubMed=6018567;
RX   PubMed=7316467;
RX   PubMed=8515068;
RX   PubMed=8558920;
RX   PubMed=12145705;
RX   PubMed=14090852;
RX   PubMed=14293790;
RX   PubMed=14293791;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=24590883;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African; Ugandan.
CC   Doubling time: ~2 days (CLS=300403); ~30-40 hours (DSMZ=ACC-80).
CC   HLA typing: A*29:02,31:04; B*47:03,57:03; C*07:01,07:01; DQA1*01:02,05:01; DQB1*03:01,06:09; DRB1*11:02,13:02' (PubMed=26589293).
CC   HLA typing: A*29:02:01,31:04:01; B*47:03:01,57:03:01; C*07:01:02,07:18:01; DPB1*13:01:01G,30:01:01; DQA1*01:02:01,05:05:01; DQB1*03:01,06:04:01; DRB1*11:02:01,13:02:01 (CLS=300403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Unspecified (DepMap=ACH-000877).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=94.08%; Native American=0%; East Asian, North=1.53%; East Asian, South=0%; South Asian=1.12%; European, North=0%; European, South=3.27% (PubMed=30894373).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=HTB-60; CLS=300403; DSMZ=ACC-80; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 8,10
ST   D18S51: 15,16
ST   D19S433: 14,14.2 (ATCC=HTB-60)
ST   D19S433: 14,15 (DSMZ=ACC-80)
ST   D21S11: 30,32.2
ST   D2S1338: 21,24
ST   D3S1358: 16,17
ST   D5S818: 8,12
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 24,30
ST   Penta D: 6.3,13 (PubMed=25877200)
ST   Penta D: 6.4,13 (ATCC=HTB-60; CLS=300403)
ST   Penta D: 7,13 (DSMZ=ACC-80)
ST   Penta E: 13,17
ST   TH01: 9,9.3 (ATCC=HTB-60; CLS=300403; PubMed=25877200)
ST   TH01: 9,10 (DSMZ=ACC-80)
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   EB11
AC   CVCL_ZE28
DR   Wikidata; Q98125932
RX   PubMed=21490615;
RX   PubMed=28765827;
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Glu475Gly (c.1424A>G); ClinVar=VCV000014638; Zygosity=Heterozygous (PubMed=21490615).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE29 ! EB12
OI   CVCL_UJ78 ! MLi002-A
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   EB12
AC   CVCL_ZE29
DR   Wikidata; Q98125933
RX   PubMed=21490615;
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Glu475Gly (c.1424A>G); ClinVar=VCV000014638; Zygosity=Heterozygous (PubMed=21490615).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE28 ! EB11
OI   CVCL_UJ78 ! MLi002-A
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   EB14
AC   CVCL_4Z57
DR   Wikidata; Q54831742
RX   DOI=10.1007/978-1-4020-5476-1_101;
RX   Patent=US7432101;
RX   Patent=US9382513;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   From: Valneva SE; Saint-Herblain; France.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: S86N.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_4Z58 ! EB45
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   EB16-MEL
AC   CVCL_VU95
DR   cancercelllines; CVCL_VU95
DR   Wikidata; Q93535437
RX   PubMed=20099279;
RX   PubMed=22850568;
RX   PubMed=23472218;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22850568).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   EB176 (JC)
AC   CVCL_3816
SY   EB176(JC); EB176
DR   CLO; CLO_0002871
DR   CLDB; cl1129
DR   ArrayExpress; E-MTAB-1511
DR   ECACC; 89072704
DR   Wikidata; Q54831743
RX   PubMed=24380390;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   EB185 (JC)
AC   CVCL_4170
SY   EB185(JC); EB185
DR   CLO; CLO_0002872
DR   CLDB; cl1130
DR   ArrayExpress; E-MTAB-1511
DR   ECACC; 89072705
DR   Wikidata; Q54831744
RX   PubMed=24380390;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   EB2 [Human Burkitt lymphoma]
AC   CVCL_1186
SY   EB-2; Epstein-Barr-2
DR   CLO; CLO_0002873
DR   EFO; EFO_0002173
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-61
DR   BioSample; SAMN10987938
DR   cancercelllines; CVCL_1186
DR   Cell_Model_Passport; SIDM00863
DR   ChEMBL-Cells; CHEMBL3308867
DR   ChEMBL-Targets; CHEMBL2366338
DR   Cosmic; 906846
DR   Cosmic; 1818342
DR   Cosmic-CLP; 906846
DR   DepMap; ACH-001064
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906846
DR   GEO; GSM886992
DR   GEO; GSM888061
DR   GEO; GSM1669747
DR   IARC_TP53; 21316
DR   IGRhCellID; EB2
DR   LINCS_LDP; LCL-2031
DR   PharmacoDB; EB2_314_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1186
DR   PubChem_Cell_line; CVCL_1186
DR   Wikidata; Q54831747
RX   PubMed=2998993;
RX   PubMed=3518877;
RX   PubMed=4736620;
RX   PubMed=4894370;
RX   PubMed=5884338;
RX   PubMed=6018567;
RX   PubMed=7316467;
RX   PubMed=8515068;
RX   PubMed=14284371;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African; Ugandan.
CC   HLA typing: A*29:02,31:04; B*47:03,57:03; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gln501Ter (c.1501C>T); Zygosity=Heterozygous (Cosmic-CLP=906846).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Homozygous (Cosmic-CLP=906846).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=92.74%; Native American=0%; East Asian, North=2.43%; East Asian, South=0%; South Asian=0.02%; European, North=0%; European, South=4.8% (PubMed=30894373).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=HTB-61; Cosmic-CLP=906846
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 8,10
ST   D18S51: 15,16
ST   D19S433: 14,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 21,24
ST   D3S1358: 16,17
ST   D5S818: 8,12
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 24,30
ST   Penta D: 6.4,13
ST   Penta E: 13,17
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   EB2 [Mouse hybridoma against vaccinia D8L]
AC   CVCL_E5QK
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   EB21
AC   CVCL_ZE24
DR   Wikidata; Q98125934
RX   PubMed=19157792;
RX   PubMed=21490615;
RX   PubMed=28765827;
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Val186Leu (c.556G>T); ClinVar=VCV000014652; Zygosity=Heterozygous (PubMed=19157792).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE25 ! EB22
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   EB22
AC   CVCL_ZE25
DR   Wikidata; Q98125936
RX   PubMed=19157792;
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Val186Leu (c.556G>T); ClinVar=VCV000014652; Zygosity=Heterozygous (PubMed=19157792).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE24 ! EB21
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   EB3 [Human Burkitt lymphoma]
AC   CVCL_1185
SY   EB-3; Epstein-Barr-3; GM04679
DR   CLO; CLO_0002874
DR   CLO; CLO_0019013
DR   EFO; EFO_0002174
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-85
DR   BioSample; SAMN03473119
DR   cancercelllines; CVCL_1185
DR   CCRID; 1101HUM-PUMC000343
DR   Cell_Model_Passport; SIDM00793
DR   CGH-DB; 9198-4
DR   ChEMBL-Cells; CHEMBL3308824
DR   ChEMBL-Targets; CHEMBL2366369
DR   CLS; 300373
DR   Coriell; GM04679
DR   Cosmic; 687840
DR   Cosmic; 906847
DR   Cosmic; 1818343
DR   Cosmic-CLP; 906847
DR   DepMap; ACH-002236
DR   ECACC; 90121003
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 906847
DR   GEO; GSM1669748
DR   IARC_TP53; 155
DR   IARC_TP53; 21145
DR   IGRhCellID; EB3
DR   JCRB; IFO50028
DR   LINCS_LDP; LCL-2032
DR   PharmacoDB; EB3_312_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1185
DR   PubChem_Cell_line; CVCL_1185
DR   Wikidata; Q54831748
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/BF02618370;
RX   PubMed=2052620;
RX   PubMed=2985879;
RX   PubMed=2998993;
RX   PubMed=3159941;
RX   PubMed=3518877;
RX   PubMed=3874327;
RX   PubMed=4169243;
RX   PubMed=4342611;
RX   PubMed=4736620;
RX   PubMed=4894370;
RX   PubMed=5884338;
RX   PubMed=6018567;
RX   PubMed=6286763;
RX   PubMed=7316467;
RX   PubMed=8515068;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Partially contaminated. Some stocks (such as IFO50028) were contaminated by Daudi.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00380.
CC   Population: African; Ugandan.
CC   Doubling time: 48 hours (PubMed=5884338).
CC   HLA typing: A*03:01,30:02; B*15:03,47:03; C*02:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Heterozygous (Cosmic-CLP=906847; DepMap=ACH-002236).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn345Argfs*24 (c.1034_1037del); Zygosity=Heterozygous (Cosmic-CLP=906847; DepMap=ACH-002236).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>G; ClinVar=VCV000141332; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=906847; DepMap=ACH-002236).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=83.99%; Native American=0.51%; East Asian, North=5.96%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=9.53% (PubMed=30894373).
CC   Discontinued: JCRB; IFO50028; true.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-85; CCRID=1101HUM-PUMC000343; CLS=300373; Cosmic-CLP=906847; ECACC=90121003; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12,15
ST   D12S391: 15
ST   D13S317: 12,14
ST   D16S539: 10,12
ST   D18S51: 15,17
ST   D19S433: 12.2,16.2
ST   D21S11: 29
ST   D2S1338: 17,22
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D6S1043: 11,13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 10,11
ST   Penta E: 14,16
ST   TH01: 7
ST   TPOX: 6,9
ST   vWA: 16,17,19 (Cosmic-CLP=906847)
ST   vWA: 17,19 (ATCC=CCL-85; CCRID=1101HUM-PUMC000343; CLS=300373; ECACC=90121003; PubMed=25877200)
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   EB3 [Mouse ESC]
AC   CVCL_J647
DR   RCB; AES0139
DR   RCB; RCB2717
DR   SKIP; SKIP003030
DR   Wikidata; Q54831749
RX   PubMed=11839818;
RX   PubMed=15741176;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: RCB; RCB2717; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   EB33
AC   CVCL_8344
SY   EB 33; EB-33
DR   BioSample; SAMN03151687
DR   Wikidata; Q54831750
RX   CelloPub=CLPUB00262;
RX   PubMed=87387;
RX   PubMed=93571;
RX   PubMed=372824;
RX   PubMed=535908;
RX   PubMed=1246601;
RX   PubMed=4374785;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=93571; PubMed=6451928; PubMed=1246601; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00023.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   EB4
AC   CVCL_W738
SY   EB-4; Epstein-Barr-4
DR   Wikidata; Q54831751
RX   PubMed=2998993;
RX   PubMed=3923440;
RX   PubMed=5922251;
RX   PubMed=6074691;
RX   PubMed=7316467;
CC   Population: Caucasian; British.
CC   Doubling time: 24 hours (PubMed=5922251).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 12
//
ID   EB45
AC   CVCL_4Z58
SY   S86N45
DR   Wikidata; Q54831752
RX   Patent=US7432101;
CC   Group: Bird cell line.
CC   From: Valneva SE; Saint-Herblain; France.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: S86N.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   EB5 [Human Burkitt lymphoma]
AC   CVCL_W739
SY   EB-5; Epstein-Barr-5
DR   Wikidata; Q54831753
RX   PubMed=5922251;
CC   Population: African; Ugandan.
CC   Doubling time: 36 hours (PubMed=5922251).
CC   Derived from site: In situ; Mesentery; UBERON=UBERON_0002095.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 11
//
ID   EB5 [Mouse ESC]
AC   CVCL_J648
DR   RCB; AES0151
DR   SKIP; SKIP002995
DR   Wikidata; Q54831754
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   EB66
AC   CVCL_G703
DR   Wikidata; Q54831755
RX   Patent=US9260694;
RX   PubMed=20562528;
RX   PubMed=21502045;
RX   PubMed=25903999;
RX   PubMed=26409141;
WW   Provider; Valneva SE; -; https://valneva.com/products/eb66-cell-line/
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Valneva SE; Saint-Herblain; France.
CC   Doubling time: 12-14 hours (PubMed=20562528).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: GL30; VBO=VBO_0017524.
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 19
//
ID   EB81-EBV
AC   CVCL_VU96
DR   Wikidata; Q93535585
RX   PubMed=14999777;
RX   PubMed=15657293;
CC   HLA typing: A*01:01,02:01; B*50,57; C*06 (PubMed=14999777).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU97 ! EB81-MEL
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   EB81-MEL
AC   CVCL_VU97
SY   EB81-Mel
DR   GEO; GSM483285
DR   GEO; GSM483286
DR   GEO; GSM483287
DR   GEO; GSM483288
DR   Wikidata; Q93535590
RX   PubMed=14871852;
RX   PubMed=15657293;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU96 ! EB81-EBV
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   EB81-MEL.2
AC   CVCL_VU98
DR   Wikidata; Q93535594
RX   PubMed=14999777;
RX   PubMed=21216894;
CC   HLA typing: A*01:01,02:01; B*50,57; C*06 (PubMed=14999777).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VU97 ! EB81-MEL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   EBA
AC   CVCL_B7K3
DR   Wikidata; Q112929521
RX   PubMed=10725724;
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; p.Glu102Ter (c.304G>T); Zygosity=Homozygous (PubMed=10725724).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EBC-1
AC   CVCL_2891
SY   EBC-1/original; EBC1
DR   BTO; BTO_0003001
DR   CLO; CLO_0050039
DR   EFO; EFO_0003115
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 861
DR   BioSample; SAMN03472045
DR   BioSample; SAMN03472311
DR   BioSample; SAMN10987674
DR   cancercelllines; CVCL_2891
DR   Cell_Model_Passport; SIDM00486
DR   CGH-DB; 185-1
DR   CGH-DB; 9172-4
DR   ChEMBL-Cells; CHEMBL4295447
DR   ChEMBL-Targets; CHEMBL4296411
DR   Cosmic; 753554
DR   Cosmic; 801583
DR   Cosmic; 844845
DR   Cosmic; 876170
DR   Cosmic; 889089
DR   Cosmic; 917995
DR   Cosmic; 932929
DR   Cosmic; 946069
DR   Cosmic; 1048220
DR   Cosmic; 1219069
DR   Cosmic; 1239905
DR   Cosmic; 1571731
DR   Cosmic; 1656904
DR   Cosmic; 1694670
DR   Cosmic; 1802303
DR   Cosmic; 2060527
DR   Cosmic; 2125222
DR   Cosmic; 2546867
DR   Cosmic; 2645028
DR   Cosmic; 2668327
DR   Cosmic-CLP; 753554
DR   DepMap; ACH-000563
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10486-107A9
DR   GDSC; 753554
DR   GEO; GSM274671
DR   GEO; GSM827595
DR   GEO; GSM886993
DR   GEO; GSM888062
DR   GEO; GSM1374471
DR   GEO; GSM1669749
DR   IARC_TP53; 11876
DR   IARC_TP53; 21134
DR   JCRB; JCRB0820
DR   LiGeA; CCLE_474
DR   LINCS_LDP; LCL-1584
DR   PharmacoDB; EBC1_315_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2891
DR   PubChem_Cell_line; CVCL_2891
DR   RCB; RCB1965
DR   TKG; TKG 0481
DR   Wikidata; Q54831756
RX   DOI=10.2482/haigan.22.53;
RX   DOI=10.4044/joma1947.97.7-8_691;
RX   DOI=10.4044/joma1947.97.7-8_701;
RX   PubMed=8286010;
RX   PubMed=9290701;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12569360;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=17325662;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22313637;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28676216;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38639832;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-570.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Chinese; Taiwan.
CC   Doubling time: 42 hours (DOI=10.4044/joma1947.97.7-8_691); 38.7 hours (PubMed=8286010).
CC   HLA typing: A*24:02,24:02; B*07:02,07:02; C*07:02,07:02; DQA1*01:01,01:01; DQB1*05:01,05:01; DRB1*01:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2731; DDR2; Simple; p.Thr681Ile (c.2042C>T); ClinVar=VCV001435412; Zygosity=Heterozygous (PubMed=28676216; Cosmic-CLP=753554).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=In 10% of cells (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (PubMed=10536175; PubMed=20557307; Cosmic-CLP=753554; DepMap=ACH-000563).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.01%; Native American=0%; East Asian, North=85.35%; East Asian, South=10.91%; South Asian=0%; European, North=0%; European, South=2.73% (PubMed=30894373).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): Cosmic-CLP=753554; JCRB=JCRB0820; PubMed=25877200; RCB=RCB1965; TKG=TKG 0481
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 8,9 (RCB=RCB1965)
ST   D16S539: 9 (Cosmic-CLP=753554; JCRB=JCRB0820; PubMed=25877200; TKG=TKG 0481)
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 16
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   EBC-1 KRAS (G12D/+/+/+)
AC   CVCL_LC83
SY   KRAS (G12D/+/+/+) EBC-1
DR   cancercelllines; CVCL_LC83
DR   Horizon_Discovery; HD+121-001
DR   Wikidata; Q54831757
CC   Population: Chinese; Taiwan.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:2731; DDR2; Simple; p.Thr681Ile (c.2042C>T); ClinVar=VCV001435412; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+121-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2891 ! EBC-1
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   EBC-1/bone
AC   CVCL_U892
DR   cancercelllines; CVCL_U892
DR   Wikidata; Q54831758
RX   PubMed=14965364;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Bone metastatic. Established from parent cell line in athymic mice after 5 cycles of in vivo serial passage of the cells in the mouse bone metastatic lesions.
CC   Sequence variation: Mutation; HGNC; HGNC:2731; DDR2; Simple; p.Thr681Ile (c.2042C>T); ClinVar=VCV001435412; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2891 ! EBC-1
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   EBC-1/brain
AC   CVCL_U893
DR   cancercelllines; CVCL_U893
DR   Wikidata; Q54831759
RX   PubMed=14965364;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Brain metastatic. Established from parent cell line in athymic mice after 5 cycles of in vivo serial passage of the cells in the mouse brain metastatic lesions.
CC   Sequence variation: Mutation; HGNC; HGNC:2731; DDR2; Simple; p.Thr681Ile (c.2042C>T); ClinVar=VCV001435412; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2891 ! EBC-1
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   EBC-2
AC   CVCL_DH99
SY   EBC2
DR   Wikidata; Q54831760
RX   PubMed=10213231;
RX   PubMed=11844606;
CC   Population: Japanese.
CC   HLA typing: A*31:12,33:03; B*35:01,44:31; C*03:03,14:03; DQB1*03:02;06:04 (PubMed=10213231).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI00 ! EBC-2/R
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   EBC-2/R
AC   CVCL_DI00
DR   Wikidata; Q54831761
RX   PubMed=11844606;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH99 ! EBC-2
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   EBKC-iPSCs case1 #1
AC   CVCL_A4HU
DR   SKIP; SKIP003125
DR   Wikidata; Q105506791
RX   PubMed=29229433;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gly2575Arg (c.7723G>A); ClinVar=VCV000265078; Zygosity=Heterozygous (PubMed=29229433).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Glu2857Ter (c.8569G>T); ClinVar=VCV001339053; Zygosity=Heterozygous (PubMed=29229433).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C156446; Epidermolysis bullosa dystrophica, autosomal recessive
DI   ORDO; Orphanet_79408; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HV ! EBKC-iPSCs case1 #2
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   EBKC-iPSCs case1 #2
AC   CVCL_A4HV
DR   SKIP; SKIP003126
DR   Wikidata; Q105506793
RX   PubMed=29229433;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gly2575Arg (c.7723G>A); ClinVar=VCV000265078; Zygosity=Heterozygous (PubMed=29229433).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Glu2857Ter (c.8569G>T); ClinVar=VCV001339053; Zygosity=Heterozygous (PubMed=29229433).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C156446; Epidermolysis bullosa dystrophica, autosomal recessive
DI   ORDO; Orphanet_79408; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HU ! EBKC-iPSCs case1 #1
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   EBKC-iPSCs case2 #1
AC   CVCL_A4HW
DR   SKIP; SKIP003127
DR   Wikidata; Q105506796
RX   PubMed=29229433;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gly1815Arg (c.5444G>A); Zygosity=Heterozygous (PubMed=29229433).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Pro1940Argfs*65 (c.5819delC); ClinVar=VCV000017428; Zygosity=Heterozygous (PubMed=29229433).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C156446; Epidermolysis bullosa dystrophica, autosomal recessive
DI   ORDO; Orphanet_79408; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HX ! EBKC-iPSCs case2 #2
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   EBKC-iPSCs case2 #2
AC   CVCL_A4HX
DR   SKIP; SKIP003128
DR   Wikidata; Q105506800
RX   PubMed=29229433;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gly1815Arg (c.5444G>A); Zygosity=Heterozygous (PubMed=29229433).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Pro1940Argfs*65 (c.5819delC); ClinVar=VCV000017428; Zygosity=Heterozygous (PubMed=29229433).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C156446; Epidermolysis bullosa dystrophica, autosomal recessive
DI   ORDO; Orphanet_79408; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HW ! EBKC-iPSCs case2 #1
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   EBL
AC   CVCL_2028
SY   Embryonic Bovine Lung
DR   CLO; CLO_0002875
DR   CLDB; cl1131
DR   DSMZ; ACC-192
DR   DSMZCellDive; ACC-192
DR   Wikidata; Q54831762
CC   Doubling time: ~70 hours (DSMZ=ACC-192).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   7FM
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   EBLC-1
AC   CVCL_DF73
SY   Enzootic Bovine Leukosis Cell line-1
DR   Wikidata; Q54831763
RX   PubMed=3012214;
CC   Breed/subspecies: Japanese black; VBO=VBO_0004987.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 5
//
ID   EBRTcH3
AC   CVCL_J649
DR   RCB; AES0054
DR   RCB; RCB2325
DR   SKIP; SKIP001663
DR   Wikidata; Q54831764
RX   PubMed=15741176;
CC   Discontinued: RCB; RCB2325; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J647 ! EB3 [Mouse ESC]
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   EBRTcH3(serum)
AC   CVCL_U953
DR   RCB; AES0119
DR   RCB; RCB2659
DR   SKIP; SKIP001665
DR   Wikidata; Q54831765
CC   Discontinued: RCB; RCB2659; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J649 ! EBRTcH3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   EBSM
AC   CVCL_VU39
DR   IPD-IMGT/HLA; 13063
DR   Wikidata; Q93535710
RX   PubMed=12652907;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Japanese.
CC   HLA typing: DRB1*14:05:01,15:02 (IPD-IMGT/HLA=13063).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 6
//
ID   EBT-8
AC   CVCL_8445
DR   Wikidata; Q54831766
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8057683;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: 60-70 hours (Note=At 50th passage) (PubMed=8057683).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C4664; T-cell large granular lymphocyte leukemia
DI   ORDO; Orphanet_86872; T-cell large granular lymphocyte leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   EBTr
AC   CVCL_2442
SY   EBTr (NBL-4); NBL-4; Embryonic Bovine Tracheal cells
DR   BTO; BTO_0001199
DR   CLO; CLO_0002876
DR   CLO; CLO_0002877
DR   CLDB; cl1132
DR   CLDB; cl1133
DR   ATCC; CCL-44
DR   ATCC; CRL-6565
DR   CCRID; 3101BOVGNO5
DR   ECACC; 87090202
DR   IZSLER; BS CL 39
DR   JCRB; JCRB9038
DR   KCLB; 10044
DR   Wikidata; Q54831767
RX   DOI=10.1007/BF02618370;
RX   PubMed=5587551;
RX   PubMed=7065527;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6565; true.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   EBTr clone A11
AC   CVCL_JF08
DR   Wikidata; Q54831768
RX   PubMed=15664048;
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2442 ! EBTr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   EBTr clone B7
AC   CVCL_JF09
DR   Wikidata; Q54831769
RX   PubMed=15664048;
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2442 ! EBTr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   EBTr clone B8
AC   CVCL_JF10
DR   Wikidata; Q54831770
RX   PubMed=15664048;
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2442 ! EBTr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   EBTr clone C6
AC   CVCL_JF11
DR   Wikidata; Q54831771
RX   PubMed=15664048;
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2442 ! EBTr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   EBTr clone D10
AC   CVCL_JF12
DR   Wikidata; Q54831772
RX   PubMed=15664048;
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2442 ! EBTr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   EBTr clone E7
AC   CVCL_JF13
DR   Wikidata; Q54831773
RX   PubMed=15664048;
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2442 ! EBTr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   EBTr clone G9
AC   CVCL_JF14
DR   Wikidata; Q54831774
RX   PubMed=15664048;
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_2442 ! EBTr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   EBV-BS1-1
AC   CVCL_WX60
SY   BS1-1
DR   Wikidata; Q93535826
RX   PubMed=3002731;
RX   PubMed=6303556;
RX   PubMed=6305496;
RX   PubMed=8374900;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX61 ! EBV-BS1-2
OI   CVCL_WX67 ! BST-SY1
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-BS1-2
AC   CVCL_WX61
SY   BS1-2
DR   Wikidata; Q93535832
RX   PubMed=3002731;
RX   PubMed=6303556;
RX   PubMed=6305496;
RX   PubMed=8374900;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX60 ! EBV-BS1-1
OI   CVCL_WX67 ! BST-SY1
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-BS2-1
AC   CVCL_WX62
SY   BS2-1
DR   Wikidata; Q93535837
RX   PubMed=3875094;
RX   PubMed=6303556;
RX   PubMed=6305496;
RX   PubMed=8374900;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX63 ! EBV-BS2-2
OI   CVCL_WX68 ! BST-SY2
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-BS2-2
AC   CVCL_WX63
SY   BS2-2
DR   Wikidata; Q93535841
RX   PubMed=3002731;
RX   PubMed=3875094;
RX   PubMed=6303556;
RX   PubMed=6305496;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX62 ! EBV-BS2-1
OI   CVCL_WX68 ! BST-SY2
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-BS3-1
AC   CVCL_WX64
DR   Wikidata; Q93535846
RX   PubMed=6303556;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-BS4-1
AC   CVCL_WX65
DR   Wikidata; Q93535849
RX   PubMed=6303556;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Could be identical to BS-SHI-4 (Cellosaurus=CVCL_6G17).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-BS5-1
AC   CVCL_WX66
DR   Wikidata; Q93535854
RX   PubMed=6303556;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-CLL-1
AC   CVCL_F0VZ
SY   EBV-CLL(1); EBV CLL(1)
RX   PubMed=2161403;
RX   PubMed=3008990;
RX   PubMed=3260125;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia. This cell line was established before any treatment (PubMed=3008990).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0W0 ! EBV-CLL-3
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EBV-CLL-1 clone D10-1
AC   CVCL_F0W3
RX   PubMed=3260125;
CC   Population: Caucasian.
CC   Characteristics: Established from the lymph node metastasis of a subcutaneous tumor transplant in the fourth serial in vivo passage of the parent cell line in irradiated nude mice (PubMed=3260125).
CC   Karyotypic information: 46,XY,dup(1)(q11->q32) (PubMed=3260125).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0VZ ! EBV-CLL-1
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EBV-CLL-3
AC   CVCL_F0W0
SY   EBV-CLL(3); EBV CLL(3)
RX   PubMed=3008990;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia. This cell line was established after treatment with chlorambucil (PubMed=3008990).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0VZ ! EBV-CLL-1
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EBV-David
AC   CVCL_F0W1
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EBV-NL1-1
AC   CVCL_WX58
DR   Wikidata; Q93535859
RX   PubMed=6303556;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   EBV-NL2-1
AC   CVCL_WX59
DR   Wikidata; Q93535864
RX   PubMed=6303556;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   EBV-Paul
AC   CVCL_F0W2
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EBV-RS
AC   CVCL_WN99
DR   Wikidata; Q93535866
RX   PubMed=11123321;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   EC [Human B-cell IHW]
AC   CVCL_E577
DR   dbMHC; 48772
DR   ECACC; 94050330
DR   IHW; IHW09312
DR   IPD-IMGT/HLA; 10550
DR   Wikidata; Q54831775
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*02:01:01:01,68:02:01:01; B*14:02:01:01,40:04; C*08:02:01:01,03:04:01:02; DPB1*14:01:01,27:01; DQB1*02:01:01,03:02:01; DRB1*04:11:01,03:01:01 (IPD-IMGT/HLA=10550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   EC [Human ovarian carcinoma]
AC   CVCL_A5PU
DR   Wikidata; Q107125109
RX   PubMed=8557231;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   EC [Human ovarian yolk sac tumor]
AC   CVCL_W130
DR   Wikidata; Q54831776
RX   DOI=10.1063/1.1291135;
RX   PubMed=8718548;
RX   PubMed=15677628;
RX   PubMed=21597681;
CC   Population: Japanese.
CC   Doubling time: 36.1 hours (PubMed=21597681).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   EC-50
AC   CVCL_IR37
SY   EC50
DR   Wikidata; Q54831777
RX   PubMed=629296;
RX   PubMed=7448794;
CC   Doubling time: ~16 hours (PubMed=629296).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   EC-82
AC   CVCL_IR38
DR   Wikidata; Q54831778
RX   PubMed=629296;
RX   PubMed=7448794;
CC   Doubling time: 20 hours (PubMed=629296).
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
DI   NCIt; C7736; Vaginal squamous cell carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   EC-Acvrl1tm1Dgen
AC   CVCL_RY78
SY   EC-Acvrl1(tm1Dgen)
DR   Wikidata; Q54831779
WW   Provider; JAX; 009162C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1338946; Acvrl1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Adam21tm1Dgen
AC   CVCL_RY79
SY   EC-Adam21(tm1Dgen)
DR   Wikidata; Q54831780
WW   Provider; JAX; 009239C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1861229; Adam21.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Adamts4tm1Dgen
AC   CVCL_RY80
SY   EC-Adamts4(tm1Dgen)
DR   Wikidata; Q54831781
WW   Provider; JAX; 009130C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1339949; Adamts4.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Adamts5tm1Dgen
AC   CVCL_RY81
SY   EC-Adamts5(tm1Dgen)
DR   Wikidata; Q54831782
WW   Provider; JAX; 009164C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1346321; Adamts5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Adcy3tm1Dgen
AC   CVCL_RY82
SY   EC-Adcy3(tm1Dgen)
DR   Wikidata; Q54831783
WW   Provider; JAX; 009165C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99675; Adcy3.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Adcy7tm1Dgen
AC   CVCL_RY83
SY   EC-Adcy7(tm1Dgen)
DR   Wikidata; Q54831784
WW   Provider; JAX; 009166C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:102891; Adcy7.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Adipor2tm1Dgen
AC   CVCL_RY84
SY   EC-Adipor2(tm1Dgen)
DR   Wikidata; Q54831785
WW   Provider; JAX; 009167C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:93830; Adipor2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Atp8a1tm1Dgen
AC   CVCL_RY85
SY   EC-Atp8a1(tm1Dgen)
DR   Wikidata; Q54831786
WW   Provider; JAX; 009240C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1330848; Atp8a1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Avpr1atm1Dgen
AC   CVCL_RY86
SY   EC-Avpr1a(tm1Dgen)
DR   Wikidata; Q54831804
WW   Provider; JAX; 009168C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1859216; Avpr1a.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Axltm1Dgen
AC   CVCL_RY87
SY   EC-Axl(tm1Dgen)
DR   Wikidata; Q54831805
WW   Provider; JAX; 009169C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1347244; Axl.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Birc1atm1Dgen
AC   CVCL_RY88
SY   EC-Birc1a(tm1Dgen)
DR   Wikidata; Q54831806
WW   Provider; JAX; 009170C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1298223; Naip1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cacna1ctm1Dgen
AC   CVCL_RY89
SY   EC-Cacna1c(tm1Dgen)
DR   Wikidata; Q54831807
WW   Provider; JAX; 009171C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:103013; Cacna1c.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cacna2d3tm1Dgen
AC   CVCL_RY90
SY   EC-Cacna2d3(tm1Dgen)
DR   Wikidata; Q54831808
WW   Provider; JAX; 009173C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1338890; Cacna2d3.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cacng3tm1Dgen
AC   CVCL_RY91
SY   EC-Cacng3(tm1Dgen)
DR   Wikidata; Q54831809
WW   Provider; JAX; 009174C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1859165; Cacng3.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cacng4tm1Dgen
AC   CVCL_RY92
SY   EC-Cacng4(tm1Dgen)
DR   Wikidata; Q54831810
WW   Provider; JAX; 009175C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1859167; Cacng4.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Capn5tm1Dgen
AC   CVCL_RY93
SY   EC-Capn5(tm1Dgen)
DR   Wikidata; Q54831811
WW   Provider; JAX; 009176C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1100859; Capn5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Capn7tm1Dgen
AC   CVCL_RY94
SY   EC-Capn7(tm1Dgen)
DR   Wikidata; Q54831812
WW   Provider; JAX; 009177C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1338030; Capn7.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ccr1l1tm1Dgen
AC   CVCL_RY95
SY   EC-Ccr1l1(tm1Dgen)
DR   Wikidata; Q54831813
WW   Provider; JAX; 009178C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:104617; Ccr1l1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ccr6tm1Dgen
AC   CVCL_RY96
SY   EC-Ccr6(tm1Dgen)
DR   Wikidata; Q54831814
WW   Provider; JAX; 009179C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1333797; Ccr6.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ccr7tm1Dgen
AC   CVCL_RY97
SY   EC-Ccr7(tm1Dgen)
DR   Wikidata; Q54831815
WW   Provider; JAX; 009180C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:103011; Ccr7.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ccrl2tm1Dgen
AC   CVCL_RY98
SY   EC-Ccrl2(tm1Dgen)
DR   Wikidata; Q54831816
WW   Provider; JAX; 009181C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1920904; Ccrl2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cd97tm1Dgen
AC   CVCL_RY99
SY   EC-Cd97(tm1Dgen)
DR   Wikidata; Q54831817
WW   Provider; JAX; 009182C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1347095; Adgre5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Celsr2tm1Dgen
AC   CVCL_RZ00
SY   EC-Celsr2(tm1Dgen)
DR   Wikidata; Q54831818
WW   Provider; JAX; 009183C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1858235; Celsr2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cer1tm1Dgen
AC   CVCL_RZ01
SY   EC-Cer1(tm1Dgen)
DR   Wikidata; Q54831819
WW   Provider; JAX; 009184C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1201414; Cer1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Chrna2tm1Dgen
AC   CVCL_RZ02
SY   EC-Chrna2(tm1Dgen)
DR   Wikidata; Q54831820
WW   Provider; JAX; 009185C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:87886; Chrna2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cnr2tm1Dgen
AC   CVCL_RZ03
SY   EC-Cnr2(tm1Dgen)
DR   Wikidata; Q54831821
WW   Provider; JAX; 009186C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:104650; Cnr2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ctsctm1Dgen
AC   CVCL_RZ04
SY   EC-Ctsc(tm1Dgen)
DR   Wikidata; Q54831822
WW   Provider; JAX; 009187C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:109553; Ctsc.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Cxcr3tm1Dgen
AC   CVCL_RZ05
SY   EC-Cxcr3(tm1Dgen)
DR   Wikidata; Q54831823
WW   Provider; JAX; 009188C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1277207; Cxcr3.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Drd5tm1Dgen
AC   CVCL_RZ06
SY   EC-Drd5(tm1Dgen)
DR   Wikidata; Q54831824
WW   Provider; JAX; 009189C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:94927; Drd5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Efemp2tm1Dgen
AC   CVCL_RZ07
SY   EC-Efemp2(tm1Dgen)
DR   Wikidata; Q54831825
WW   Provider; JAX; 009191C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1891209; Efemp2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Esrratm1Dgen
AC   CVCL_RZ08
SY   EC-Esrra(tm1Dgen)
DR   Wikidata; Q54831826
WW   Provider; JAX; 009241C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1346831; Esrra.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Faim2tm1Dgen
AC   CVCL_RZ09
SY   EC-Faim2(tm1Dgen)
DR   Wikidata; Q54831827
WW   Provider; JAX; 009192C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1919643; Faim2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Fzd1tm1Dgen
AC   CVCL_RZ10
SY   EC-Fzd1(tm1Dgen)
DR   Wikidata; Q54831828
WW   Provider; JAX; 009193C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1196625; Fzd1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Fzd8tm1Dgen
AC   CVCL_RZ11
SY   EC-Fzd8(tm1Dgen)
DR   Wikidata; Q54831829
WW   Provider; JAX; 009194C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:108460; Fzd8.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gabra3tm1Dgen
AC   CVCL_RZ12
SY   EC-Gabra3(tm1Dgen)
DR   Wikidata; Q54831830
WW   Provider; JAX; 009195C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:95615; Gabra3.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gabra4tm1Dgen
AC   CVCL_RZ13
SY   EC-Gabra4(tm1Dgen)
DR   Wikidata; Q54831831
WW   Provider; JAX; 009196C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:95616; Gabra4.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gabrptm1Dgen
AC   CVCL_RZ14
SY   EC-Gabrp(tm1Dgen)
DR   Wikidata; Q54831832
WW   Provider; JAX; 009197C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2387597; Gabrp.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Galr1tm1Dgen
AC   CVCL_RZ15
SY   EC-Galr1(tm1Dgen)
DR   Wikidata; Q54831833
WW   Provider; JAX; 009242C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1096364; Galr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-GI-10
AC   CVCL_1187
SY   ECGI10; EC-GI
DR   CLO; CLO_0051378
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 862
DR   BioSample; SAMN03472227
DR   BioSample; SAMN10987728
DR   cancercelllines; CVCL_1187
DR   Cell_Model_Passport; SIDM00278
DR   ChEMBL-Cells; CHEMBL3308289
DR   ChEMBL-Targets; CHEMBL2366240
DR   Cosmic; 753555
DR   Cosmic-CLP; 753555
DR   DepMap; ACH-000305
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10463-106H4
DR   GDSC; 753555
DR   GEO; GSM886996
DR   GEO; GSM888065
DR   GEO; GSM1669753
DR   IARC_TP53; 21317
DR   LiGeA; CCLE_378
DR   LINCS_LDP; LCL-1151
DR   PharmacoDB; ECGI10_316_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1187
DR   PubChem_Cell_line; CVCL_1187
DR   RCB; RCB0774
DR   Wikidata; Q54831834
RX   PubMed=2824416;
RX   PubMed=3261732;
RX   PubMed=11416159;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from a mouse xenograft.
CC   Doubling time: ~31 hours (PubMed=2824416).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02; DQB1*03:02,03:02; DRB1*10:01,11:30 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Heterozygous (Cosmic-CLP=753555; DepMap=ACH-000305).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Heterozygous (Cosmic-CLP=753555; DepMap=ACH-000305).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.68%; Native American=0%; East Asian, North=89.75%; East Asian, South=5.81%; South Asian=0.73%; European, North=0%; European, South=1.02% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=753555; PubMed=11416159; RCB=RCB0774
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 19
ST   D21S11: 31
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 9,13
ST   FGA: 21,24
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   EC-Glra3tm1Dgen
AC   CVCL_RZ16
SY   EC-Glra3(tm1Dgen)
DR   Wikidata; Q54831835
WW   Provider; JAX; 009198C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:95749; Glra3.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gpr151tm1Dgen
AC   CVCL_RZ17
SY   EC-Gpr151(tm1Dgen)
DR   Wikidata; Q54831836
WW   Provider; JAX; 009199C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2441887; Gpr151.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gpr21tm1Dgen
AC   CVCL_E9CX
SY   Gpr21 KO ES
RX   PubMed=22653059;
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2441890; Gpr21.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   EC-Gpr37tm1Dgen
AC   CVCL_RZ18
SY   EC-Gpr37(tm1Dgen)
DR   Wikidata; Q54831837
WW   Provider; JAX; 009200C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1313297; Gpr37.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gpr6tm1Dgen
AC   CVCL_RZ19
SY   EC-Gpr6(tm1Dgen)
DR   Wikidata; Q54831838
WW   Provider; JAX; 009201C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2155249; Gpr6.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gprk5tm1Dgen
AC   CVCL_RZ20
SY   EC-Gprk5(tm1Dgen)
DR   Wikidata; Q54831839
WW   Provider; JAX; 009202C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:109161; Grk5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Grik5tm1Dgen
AC   CVCL_RZ21
SY   EC-Grik5(tm1Dgen)
DR   Wikidata; Q54831840
WW   Provider; JAX; 009203C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:95818; Grik5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Grm1tm1Dgen
AC   CVCL_RZ22
SY   EC-Grm1(tm1Dgen)
DR   Wikidata; Q54831841
WW   Provider; JAX; 009204C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1351338; Grm1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Grm3tm1Dgen
AC   CVCL_RZ23
SY   EC-Grm3(tm1Dgen)
DR   Wikidata; Q54831842
WW   Provider; JAX; 009205C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1351340; Grm3.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Gsk3btm1Dgen
AC   CVCL_RZ24
SY   EC-Gsk3b(tm1Dgen)
DR   Wikidata; Q54831843
WW   Provider; JAX; 009206C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1861437; Gsk3b.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Hcrtr1tm1Dgen
AC   CVCL_RZ25
SY   EC-Hcrtr1(tm1Dgen)
DR   Wikidata; Q54831847
WW   Provider; JAX; 009207C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2385650; Hcrtr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Htr4tm1Dgen
AC   CVCL_RZ26
SY   EC-Htr4(tm1Dgen)
DR   Wikidata; Q54831848
WW   Provider; JAX; 009127C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:109246; Htr4.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Htr5atm1Dgen
AC   CVCL_RZ27
SY   EC-Htr5a(tm1Dgen)
DR   Wikidata; Q54831849
WW   Provider; JAX; 009128C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96283; Htr5a.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Htr7tm1Dgen
AC   CVCL_RZ28
SY   EC-Htr7(tm1Dgen)
DR   Wikidata; Q54831850
WW   Provider; JAX; 009129C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99841; Htr7.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Il8ratm1Dgen
AC   CVCL_RZ29
SY   EC-Il8ra(tm1Dgen)
DR   Wikidata; Q54831851
WW   Provider; JAX; 009208C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2448715; Cxcr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Insl5tm1Dgen
AC   CVCL_RZ30
SY   EC-Insl5(tm1Dgen)
DR   Wikidata; Q54831852
WW   Provider; JAX; 009209C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1346085; Insl5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Kcnq2tm1Dgen
AC   CVCL_RZ31
SY   EC-Kcnq2(tm1Dgen)
DR   Wikidata; Q54831853
WW   Provider; JAX; 009210C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1309503; Kcnq2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Lats2tm1Dgen
AC   CVCL_RZ32
SY   EC-Lats2(tm1Dgen)
DR   Wikidata; Q54831854
WW   Provider; JAX; 009211C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1354386; Lats2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Lmbr1tm1Dgen
AC   CVCL_RZ33
SY   EC-Lmbr1(tm1Dgen)
DR   Wikidata; Q54831855
WW   Provider; JAX; 009212C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1861746; Lmbr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Lrp5tm1Dgen
AC   CVCL_RZ34
SY   EC-Lrp5(tm1Dgen)
DR   Wikidata; Q54831856
WW   Provider; JAX; 009213C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1278315; Lrp5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Mapkapk2tm1Dgen
AC   CVCL_RZ35
SY   EC-Mapkapk2(tm1Dgen)
DR   Wikidata; Q54831857
WW   Provider; JAX; 009214C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:109298; Mapkapk2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Mmp17tm1Dgen
AC   CVCL_RZ36
SY   EC-Mmp17(tm1Dgen)
DR   Wikidata; Q54831858
WW   Provider; JAX; 009215C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1346076; Mmp17.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Mtmr1tm1Dgen
AC   CVCL_RZ37
SY   EC-Mtmr1(tm1Dgen)
DR   Wikidata; Q54831859
WW   Provider; JAX; 009216C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1858271; Mtmr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-MZ-1
AC   CVCL_L445
SY   Endometrial Carcinoma-MainZ-1
DR   Wikidata; Q54831860
RX   PubMed=7681807;
CC   Doubling time: 26 hours (PubMed=7681807).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   EC-MZ-11
AC   CVCL_L446
SY   Endometrial Carcinoma-MainZ-11
DR   Wikidata; Q54831861
RX   PubMed=7681807;
CC   Doubling time: 3 weeks (PubMed=7681807).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   EC-MZ-2
AC   CVCL_L447
SY   Endometrial Carcinoma-MainZ-2
DR   Wikidata; Q54831862
RX   PubMed=7681807;
CC   Doubling time: 72 hours (PubMed=7681807).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   EC-MZ-3
AC   CVCL_L448
SY   Endometrial Carcinoma-MainZ-3
DR   Wikidata; Q54831863
RX   PubMed=7681807;
CC   Doubling time: 50 hours (PubMed=7681807).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   EC-MZ-5
AC   CVCL_L449
SY   Endometrial Carcinoma-MainZ-5
DR   Wikidata; Q54831864
RX   PubMed=7681807;
CC   Doubling time: 27 hours (PubMed=7681807).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   EC-MZ-9
AC   CVCL_L450
SY   Endometrial Carcinoma-MainZ-9
DR   Wikidata; Q54831865
RX   PubMed=7681807;
CC   Doubling time: 2.5 weeks (PubMed=7681807).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   EC-Ntsr1tm1Dgen
AC   CVCL_RZ38
SY   EC-Ntsr1(tm1Dgen)
DR   Wikidata; Q54831866
WW   Provider; JAX; 009217C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:97386; Ntsr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Pkd2l2tm1Dgen
AC   CVCL_RZ39
SY   EC-Pkd2l2(tm1Dgen)
DR   Wikidata; Q54831867
WW   Provider; JAX; 009218C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1858231; Pkd2l2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ppardtm1Dgen
AC   CVCL_RZ40
SY   EC-Ppard(tm1Dgen)
DR   Wikidata; Q54831868
WW   Provider; JAX; 009243C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:101884; Ppard.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ppm1ftm1Dgen
AC   CVCL_RZ41
SY   EC-Ppm1f(tm1Dgen)
DR   Wikidata; Q54831869
WW   Provider; JAX; 009219C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1918464; Ppm1f.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ptch2tm1Dgen
AC   CVCL_RZ42
SY   EC-Ptch2(tm1Dgen)
DR   Wikidata; Q54831871
WW   Provider; JAX; 009220C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1095405; Ptch2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Ptprotm1Dgen
AC   CVCL_RZ43
SY   EC-Ptpro(tm1Dgen)
DR   Wikidata; Q54831872
WW   Provider; JAX; 009221C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1097152; Ptpro.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   ec-r.0
AC   CVCL_0A37
DR   Wikidata; Q54831873
RX   PubMed=9542648;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ec-r.1
AC   CVCL_0A38
DR   Wikidata; Q54831874
RX   PubMed=9542648;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ec-r.2
AC   CVCL_0A39
DR   Wikidata; Q54831875
RX   PubMed=9542648;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   EC-RF24
AC   CVCL_AX74
SY   ECRF24; ECRF 24; ECRF; EC-RF
DR   BTO; BTO_0004188
DR   ABM; T0003
DR   Wikidata; Q54831876
RX   PubMed=7813621;
RX   PubMed=10428507;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX75 ! EC-RF7
AG   <1D
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 15
//
ID   EC-RF7
AC   CVCL_AX75
DR   Wikidata; Q54831877
RX   PubMed=7813621;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX74 ! EC-RF24
AG   <1D
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   EC-Rgs4tm1Dgen
AC   CVCL_RZ44
SY   EC-Rgs4(tm1Dgen)
DR   Wikidata; Q54831878
WW   Provider; JAX; 009222C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:108409; Rgs4.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   ec-rh.3
AC   CVCL_0A40
DR   Wikidata; Q54831879
RX   PubMed=9542648;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   EC-S1pr4tm1Dgen
AC   CVCL_RZ45
SY   EC-S1pr4(tm1Dgen)
DR   Wikidata; Q54831880
WW   Provider; JAX; 009190C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1333809; S1pr4.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Scn11atm1Dgen
AC   CVCL_RZ46
SY   EC-Scn11a(tm1Dgen)
DR   Wikidata; Q54831881
WW   Provider; JAX; 009223C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1345149; Scn11a.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Scn9atm1Dgen
AC   CVCL_RZ47
SY   EC-Scn9a(tm1Dgen)
DR   Wikidata; Q54831883
WW   Provider; JAX; 009224C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:107636; Scn9a.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Sema5atm1Dgen
AC   CVCL_RZ48
SY   EC-Sema5a(tm1Dgen)
DR   Wikidata; Q54831884
WW   Provider; JAX; 009225C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:107556; Sema5a.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Sema6ctm1Dgen
AC   CVCL_RZ49
SY   EC-Sema6c(tm1Dgen)
DR   Wikidata; Q54831885
WW   Provider; JAX; 009226C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1338032; Sema6c.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Slc18a1tm1Dgen
AC   CVCL_RZ50
SY   EC-Slc18a1(tm1Dgen)
DR   Wikidata; Q54831886
WW   Provider; JAX; 009244C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:106684; Slc18a1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Slc22a12tm1Dgen
AC   CVCL_RZ51
SY   EC-Slc22a12(tm1Dgen)
DR   Wikidata; Q54831887
WW   Provider; JAX; 009227C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1195269; Slc22a12.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Slc22a6tm1Dgen
AC   CVCL_RZ65
SY   EC-Slc22a6(tm1Dgen)
DR   Wikidata; Q54831888
WW   Provider; JAX; 009228C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:892001; Slc22a6.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Slc6a9tm1Dgen
AC   CVCL_RZ52
SY   EC-Slc6a9(tm1Dgen)
DR   Wikidata; Q54831895
WW   Provider; JAX; 009230C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:95760; Slc6a9.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Slc7a8tm1Dgen
AC   CVCL_RZ53
SY   EC-Slc7a8(tm1Dgen)
DR   Wikidata; Q54831896
WW   Provider; JAX; 009231C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1355323; Slc7a8.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Slc9a6tm1Dgen
AC   CVCL_RZ54
SY   EC-Slc9a6(tm1Dgen)
DR   Wikidata; Q54831897
WW   Provider; JAX; 009232C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2443511; Slc9a6.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Sstr1tm1Dgen
AC   CVCL_RZ55
SY   EC-Sstr1(tm1Dgen)
DR   Wikidata; Q54831898
WW   Provider; JAX; 009233C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:98327; Sstr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Tgfbr1tm1Dgen
AC   CVCL_RZ56
SY   EC-Tgfbr1(tm1Dgen)
DR   Wikidata; Q54831899
WW   Provider; JAX; 009234C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:98728; Tgfbr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Thbs4tm1Dgen
AC   CVCL_RZ57
SY   EC-Thbs4(tm1Dgen)
DR   Wikidata; Q54831900
WW   Provider; JAX; 009235C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1101779; Thbs4.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Tlr2tm1Dgen
AC   CVCL_RZ58
SY   EC-Tlr2(tm1Dgen)
DR   Wikidata; Q54831901
WW   Provider; JAX; 009245C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1346060; Tlr2.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Tmprss11atm1Dgen
AC   CVCL_RZ59
SY   EC-Tmprss11a(tm1Dgen)
DR   Wikidata; Q54831902
WW   Provider; JAX; 009236C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2684853; Tmprss11a.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Tmprss13tm1Dgen
AC   CVCL_RZ60
SY   EC-Tmprss13(tm1Dgen)
DR   Wikidata; Q54831903
WW   Provider; JAX; 009246C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2682935; Tmprss13.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Tpp1tm1Dgen
AC   CVCL_RZ61
SY   EC-Tpp1(tm1Dgen)
DR   Wikidata; Q54831904
WW   Provider; JAX; 009247C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1336194; Tpp1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Trpm5tm1Dgen
AC   CVCL_RZ62
SY   EC-Trpm5(tm1Dgen)
DR   Wikidata; Q54831905
WW   Provider; JAX; 009237C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1861718; Trpm5.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC-Xcr1tm1Dgen
AC   CVCL_RZ63
SY   EC-Xcr1(tm1Dgen)
DR   Wikidata; Q54831906
WW   Provider; JAX; 009238C01; https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/biospecimens/deltagen-knockout-es-cell-lines
CC   Part of: Deltagen knockout ES cell lines.
CC   Characteristics: A IRES-LacZ-Neo cassette is inserted in the targeted gene region.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1346338; Xcr1.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EC/CUHK1
AC   CVCL_RY08
SY   Ec/CUHK1; EC1.71; EC-1.71; Esophageal Carcinoma/Chinese University of Hong Kong 1
DR   Wikidata; Q54831907
RX   DOI=10.5897/AJPP11.695;
RX   PubMed=3631894;
RX   PubMed=11854902;
DI   NCIt; C3513; Esophageal carcinoma
DI   ORDO; Orphanet_70482; Carcinoma of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   EC/CUHK2
AC   CVCL_RX98
SY   Ec/CUHK2; EC-18; EC18; Esophageal Carcinoma/Chinese University of Hong Kong 2
DR   BTO; BTO_0006195
DR   Wikidata; Q54831908
RX   PubMed=1888151;
RX   PubMed=11854902;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   EC/PC-DR-mESC
AC   CVCL_XX13
DR   Wikidata; Q93536992
RX   PubMed=35139658;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: CD-1/129 x Flk1:eGFP/+;NG2:dsRed/+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   EC1
AC   CVCL_DC74
DR   Wikidata; Q54831909
RX   PubMed=8069445;
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   EC109/CDDP
AC   CVCL_6897
DR   Wikidata; Q54831910
RX   PubMed=19513506;
CC   Population: Chinese.
CC   Doubling time: 36.12 +- 0.99 hours (PubMed=19513506).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6898 ! Eca-109
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   EC109/Taxol
AC   CVCL_T047
DR   Wikidata; Q54831911
RX   PubMed=24002547;
CC   Population: Chinese.
CC   Doubling time: 31.3 +- 0.39 hours (PubMed=24002547).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6898 ! Eca-109
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   EC23
AC   CVCL_B7BW
DR   Wikidata; Q112929522
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 1
AC   CVCL_B7BX
DR   Wikidata; Q112929523
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 2
AC   CVCL_B7BY
DR   Wikidata; Q112929524
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BW ! EC23
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 3
AC   CVCL_B7BZ
DR   Wikidata; Q112929525
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BW ! EC23
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 4
AC   CVCL_B7C0
DR   Wikidata; Q112929526
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BW ! EC23
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 5
AC   CVCL_B7C1
DR   Wikidata; Q112929527
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BW ! EC23
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 7
AC   CVCL_B7C2
DR   Wikidata; Q112929528
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BW ! EC23
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 8
AC   CVCL_B7C3
DR   Wikidata; Q112929529
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BW ! EC23
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC23 clone 9
AC   CVCL_B7C4
DR   Wikidata; Q112929530
RX   CelloPub=CLPUB00692;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BW ! EC23
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EC8501
AC   CVCL_4N02
DR   Wikidata; Q54831912
RX   PubMed=9531643;
CC   Population: Chinese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   EC8712
AC   CVCL_E314
DR   Wikidata; Q54831913
RX   PubMed=9531643;
RX   PubMed=10921044;
CC   Population: Chinese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   EC8733
AC   CVCL_E315
DR   Wikidata; Q54831914
RX   PubMed=9531643;
RX   PubMed=10921044;
CC   Population: Chinese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   EC9706
AC   CVCL_E307
SY   Ec9706; EC-9706
DR   BTO; BTO_0005757
DR   EFO; EFO_0022576
DR   ChEMBL-Cells; CHEMBL4295473
DR   ChEMBL-Targets; CHEMBL4296412
DR   PubChem_Cell_line; CVCL_E307
DR   TOKU-E; 3567
DR   Wikidata; Q54831915
RX   PubMed=12476413;
RX   PubMed=21191746;
RX   PubMed=28807831;
RX   PubMed=28851942;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 65 year old male patient with a esophagal squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00633.
CC   Population: African American.
CC   Doubling time: 26 hours (PubMed=12476413).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=28851942
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   EC9706 clone EC1
AC   CVCL_5V05
SY   EC1
DR   Wikidata; Q54831916
RX   PubMed=17989041;
CC   Problematic cell line: Contaminated. Parent cell line (EC9706) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E307 ! EC9706
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   EC9706 clone EC2
AC   CVCL_5V06
SY   EC2
DR   Wikidata; Q54831917
RX   PubMed=17989041;
CC   Problematic cell line: Contaminated. Parent cell line (EC9706) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E307 ! EC9706
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   EC9706 clone EC3
AC   CVCL_5V07
SY   EC3
DR   Wikidata; Q54831918
RX   PubMed=17989041;
CC   Problematic cell line: Contaminated. Parent cell line (EC9706) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E307 ! EC9706
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   Eca-109
AC   CVCL_6898
SY   Eca109; Eca 109; EC-109; EC109
DR   BTO; BTO_0005758
DR   EFO; EFO_0022422
DR   AddexBio; C0013001/37
DR   CCRID; 1101HUM-PUMC000246
DR   CCRID; 4201HUM-CCTCC00207
DR   CCTCC; GDC0207
DR   ChEMBL-Cells; CHEMBL3308477
DR   ChEMBL-Targets; CHEMBL614668
DR   Cosmic; 932976
DR   Cosmic; 2267320
DR   Cosmic; 2395000
DR   PubChem_Cell_line; CVCL_6898
DR   Wikidata; Q54831919
RX   PubMed=6525939;
RX   PubMed=9531643;
RX   PubMed=19513506;
RX   PubMed=24002547;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks of this cell line are contaminated with HeLa (ICLAC).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00611.
CC   Population: Chinese.
CC   Doubling time: 20.74 +- 1.31 hours (PubMed=19513506); 28.57 +- 0.12 hours (PubMed=24002547).
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 19
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D2S441: 11,13
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 13
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 28
//
ID   Ecad-231-7
AC   CVCL_A9BP
SY   Ecad231-7
DR   cancercelllines; CVCL_A9BP
DR   CCRID; 1101HUM-PUMC000398
DR   Wikidata; Q108820180
RX   PubMed=21215101;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1748; CDH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   Ecad-231-9
AC   CVCL_A9BQ
SY   Ecad231-9
DR   cancercelllines; CVCL_A9BQ
DR   CCRID; 1101HUM-PUMC000399
DR   Wikidata; Q108820181
RX   PubMed=21215101;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1748; CDH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   eCAS
AC   CVCL_7189
SY   e-CAS
DR   Wikidata; Q54831920
RX   PubMed=14700538;
RX   PubMed=17686531;
RX   PubMed=29844485;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of horse origin but found to be a mouse RAW 264.7 derivative (PubMed=29844485). Originally thought to be established by telomerase transfection of bone marrow cells from two 10 year old horses.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00601.
CC   Doubling time: 9.7 hours (PubMed=14700538).
CC   Miscellaneous: Conversion of STR profile from fragment lengths to alleles value from personal communication of Wigger, Georges.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=29844485
ST   Mouse STR 4-2: 22.3,23.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 18-3: 18
ST   Mouse STR X-1: 25
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   ECC-1
AC   CVCL_7260
SY   ECC1; EnCa1
DR   BTO; BTO_0005365
DR   CLO; CLO_0037231
DR   EFO; EFO_0005231
DR   ATCC; CRL-2923
DR   BioSample; SAMN03151801
DR   BioSample; SAMN03472871
DR   cancercelllines; CVCL_7260
DR   Cosmic; 1102375
DR   Cosmic; 1576451
DR   Cosmic; 1622895
DR   Cosmic; 2030461
DR   ENCODE; ENCBS034DOC
DR   ENCODE; ENCBS159ITB
DR   ENCODE; ENCBS222DWG
DR   ENCODE; ENCBS312UTV
DR   ENCODE; ENCBS336PJO
DR   ENCODE; ENCBS347ANJ
DR   ENCODE; ENCBS624SHM
DR   ENCODE; ENCBS670ZEX
DR   ENCODE; ENCBS731RSG
DR   ENCODE; ENCBS743VIZ
DR   ENCODE; ENCBS758FSP
DR   ENCODE; ENCBS767JJY
DR   ENCODE; ENCBS862NRL
DR   ENCODE; ENCBS896YZO
DR   GEO; GSM843495
DR   GEO; GSM843496
DR   GEO; GSM923422
DR   GEO; GSM923423
DR   GEO; GSM923426
DR   GEO; GSM923427
DR   GEO; GSM1008574
DR   GEO; GSM1008597
DR   Lonza; 1319
DR   Wikidata; Q54831921
RX   PubMed=10478797;
RX   PubMed=16707768;
RX   PubMed=20218740;
RX   PubMed=22710073;
RX   PubMed=23325432;
RX   PubMed=25877200;
RX   PubMed=33174010;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/ECC1_Myers_protocol.pdf
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/ecc1-xenograft-model/
CC   Problematic cell line: Contaminated. Shown to be a Ishikawa 3-H-12 derivative (PubMed=22710073).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00460.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-2923; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ATCC=CRL-2923; PubMed=22710073; PubMed=25877200; PubMed=33174010
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 12,19
ST   D19S433: 12.2,14
ST   D21S11: 28
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 10,11
ST   Penta E: 11,19.1
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D199 ! Ishikawa 3-H-12
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   ECC10
AC   CVCL_1188
SY   ECC-10; ECC 10
DR   CLO; CLO_0050796
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472196
DR   BioSample; SAMN10987724
DR   cancercelllines; CVCL_1188
DR   Cell_Model_Passport; SIDM00280
DR   ChEMBL-Cells; CHEMBL3308191
DR   ChEMBL-Targets; CHEMBL2366117
DR   Cosmic; 848376
DR   Cosmic; 906848
DR   Cosmic; 1187269
DR   Cosmic-CLP; 906848
DR   DepMap; ACH-000560
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10610-108F7
DR   GDSC; 906848
DR   GEO; GSM886994
DR   GEO; GSM888063
DR   GEO; GSM1669750
DR   IARC_TP53; 21318
DR   LiGeA; CCLE_472
DR   LINCS_LDP; LCL-1897
DR   PharmacoDB; ECC10_317_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1188
DR   PubChem_Cell_line; CVCL_1188
DR   RCB; RCB0983
DR   Wikidata; Q54831922
RX   PubMed=8392984;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 85 hours (PubMed=8392984).
CC   HLA typing: A*03:01,24:02; B*40:01,44:02; C*03:04,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (Cosmic-CLP=906848; DepMap=ACH-000560).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Leu755Ser (c.2264T>C); ClinVar=VCV000376035; Zygosity=Heterozygous (Cosmic-CLP=906848; DepMap=ACH-000560).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln685Ter (c.2053C>T); ClinVar=VCV000237668; Zygosity=Heterozygous (Cosmic-CLP=906848; DepMap=ACH-000560).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.3%; Native American=0.44%; East Asian, North=81.45%; East Asian, South=16.3%; South Asian=0%; European, North=0%; European, South=0.51% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): Cosmic-CLP=906848; RCB=RCB0983
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C6764; Gastric small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   ECC12
AC   CVCL_1189
SY   ECC-12; ECC 12
DR   CLO; CLO_0050807
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472198
DR   BioSample; SAMN10987760
DR   cancercelllines; CVCL_1189
DR   Cell_Model_Passport; SIDM00279
DR   ChEMBL-Cells; CHEMBL3308192
DR   ChEMBL-Targets; CHEMBL2366180
DR   Cosmic; 848377
DR   Cosmic; 906849
DR   Cosmic; 1187270
DR   Cosmic-CLP; 906849
DR   DepMap; ACH-000225
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10615-108G3
DR   GDSC; 906849
DR   GEO; GSM886995
DR   GEO; GSM888064
DR   GEO; GSM1669751
DR   IARC_TP53; 21319
DR   LiGeA; CCLE_821
DR   LINCS_LDP; LCL-1898
DR   PharmacoDB; ECC12_318_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1189
DR   PubChem_Cell_line; CVCL_1189
DR   RCB; RCB1009
DR   Wikidata; Q54831923
RX   PubMed=8392984;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 92 hours (PubMed=8392984).
CC   HLA typing: A*24:02,26:01; B*35:21,51:01; C*03:03,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Homozygous (Cosmic-CLP=906849; DepMap=ACH-000225).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.31%; Native American=0.33%; East Asian, North=84.02%; East Asian, South=12.58%; South Asian=0%; European, North=0%; European, South=0.75% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): Cosmic-CLP=906849; RCB=RCB1009
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C6764; Gastric small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   ECC18
AC   CVCL_L207
SY   ECC 18
DR   Wikidata; Q54831924
RX   PubMed=8392984;
CC   Population: Japanese.
CC   Doubling time: 57 hours (PubMed=8392984).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C6762; Esophageal small cell carcinoma
DI   ORDO; Orphanet_506136; Neuroendocrine neoplasm of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   ECC3
AC   CVCL_A1VE
SY   ICC15
DR   cancercelllines; CVCL_A1VE
DR   Cell_Model_Passport; SIDM01977
DR   DepMap; ACH-001841
DR   Wikidata; Q105509597
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1718His (c.5152A>C); Zygosity=Unspecified (DepMap=ACH-001841).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Trp2788Ter (c.8363G>A); ClinVar=VCV000052564; Zygosity=Unspecified (DepMap=ACH-001841).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141Tyr (c.422G>A); ClinVar=VCV000140801; Zygosity=Unspecified (DepMap=ACH-001841).
ST   Source(s): DepMap=ACH-001841
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 10,12
ST   D18S51: 18
ST   D21S11: 31.2,32.2
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   ECC4 [Human cholangiocarcinoma]
AC   CVCL_A1ZB
SY   ICC3
DR   cancercelllines; CVCL_A1ZB
DR   Cell_Model_Passport; SIDM01979
DR   DepMap; ACH-001843
DR   Wikidata; Q105509600
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Ala615fs (c.1843_1844insC); Zygosity=Homozygous (DepMap=ACH-001843).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Pro (c.97T>C); ClinVar=VCV000376391; Zygosity=Heterozygous (DepMap=ACH-001843).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-001843).
ST   Source(s): DepMap=ACH-001843
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 27,28
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 7,11
ST   D8S1179: 12,14
ST   FGA: 20,23
ST   Penta D: 10,12
ST   Penta E: 5,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   ECC4 [Human rectal adenocarcinoma]
AC   CVCL_1190
SY   ECC 4
DR   CLO; CLO_0051398
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472195
DR   cancercelllines; CVCL_1190
DR   Cell_Model_Passport; SIDM00069
DR   ChEMBL-Cells; CHEMBL3308162
DR   ChEMBL-Targets; CHEMBL2366367
DR   Cosmic; 906850
DR   DepMap; ACH-002024
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10609-108F6
DR   GDSC; 906850
DR   GEO; GSM1669752
DR   IARC_TP53; 21320
DR   LINCS_LDP; LCL-1115
DR   PharmacoDB; ECC4_319_2019
DR   PubChem_Cell_line; CVCL_1190
DR   RCB; RCB0982
DR   Wikidata; Q54831925
RX   PubMed=8392984;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 140 hours (PubMed=8392984).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): DepMap=ACH-002024; RCB=RCB0982
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 9,10
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   ECCD-1
AC   CVCL_A6WW
DR   RCB; RCB5258
DR   Wikidata; Q107114839
RX   PubMed=6692973;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09803; Mouse Cdh1/Cd324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   ECCD-2
AC   CVCL_A6WX
DR   RCB; RCB5259
DR   Wikidata; Q107114842
RX   PubMed=3768962;
RX   PubMed=6692973;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09803; Mouse Cdh1/Cd324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   ECF-R
AC   CVCL_5738
DR   CLS; 601469
DR   Wikidata; Q54831926
CC   Group: Bird cell line.
CC   Senescence: Senesces at 50-60 PDL (CLS=601469).
CC   Discontinued: CLS; 601469; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   11FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ECF50.Ht
AC   CVCL_S054
DR   ATCC; CRL-6252
DR   Wikidata; Q54831927
CC   Discontinued: ATCC; CRL-6252; true.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S378 ! ECF50.Lu
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   ECF50.Lu
AC   CVCL_S378
DR   ATCC; CRL-6346
DR   Wikidata; Q54831928
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6346; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_S054 ! ECF50.Ht
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   eCG 100.2
AC   CVCL_C4M8
SY   100.2
DR   Wikidata; Q116048919
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   eCG 100.6
AC   CVCL_9W10
SY   100.6
DR   Wikidata; Q54831930
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   eCG 50.1
AC   CVCL_C4M3
SY   50.1
DR   Wikidata; Q116048920
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   eCG 50.4
AC   CVCL_C4M4
SY   50.4
DR   Wikidata; Q116048922
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   eCG 50.5
AC   CVCL_9W11
SY   50.5
DR   Wikidata; Q54831931
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   eCG 50.7
AC   CVCL_C4M5
SY   50.7
DR   Wikidata; Q116048923
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   eCG 50.8
AC   CVCL_C4M6
SY   50.8
DR   Wikidata; Q116048924
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   eCG 50.9
AC   CVCL_C4M7
SY   50.9
DR   Wikidata; Q116048925
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   eCG 500.1
AC   CVCL_9W12
SY   500.1
DR   Wikidata; Q54831932
RX   PubMed=11572789;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Chorionic girdle cell; CL=CL_4040001.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   33FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   ECGI-21
AC   CVCL_E7B5
RX   DOI=10.1016/j.aquaculture.2022.738771;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by red-spotted grouper nervous necrosis virus (RGNNV) and Singapore grouper iridovirus (SGIV) (DOI=10.1016/j.aquaculture.2022.738771).
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ECH037.2
AC   CVCL_B0VC
DR   Wikidata; Q108820182
RX   Patent=EP0327365B1;
CC   Characteristics: Tetradoma obtained by the biological fusion of two hybridomas.
CC   Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA (Note=The antibody binds to the chelated In+++ metal ion).
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B0VB ! CEM231.6.7
HI   CVCL_B0V9 ! CHA255
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   Eckert
AC   CVCL_A2WS
DR   Wikidata; Q105506806
RX   PubMed=3491677;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   ECL-2
AC   CVCL_J412
DR   Wikidata; Q54831933
RX   PubMed=11437454;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: FVB/N Nkx2.5-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_J413 ! ECL-32
OI   CVCL_J414 ! ECL-38
OI   CVCL_J415 ! ECL-41
SX   Sex unspecified
AG   21D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   ECL-32
AC   CVCL_J413
DR   Wikidata; Q54831934
RX   PubMed=11437454;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: FVB/N Nkx2.5-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_J412 ! ECL-2
OI   CVCL_J414 ! ECL-38
OI   CVCL_J415 ! ECL-41
SX   Sex unspecified
AG   21D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   ECL-38
AC   CVCL_J414
DR   Wikidata; Q54831935
RX   PubMed=11437454;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: FVB/N Nkx2.5-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_J412 ! ECL-2
OI   CVCL_J413 ! ECL-32
OI   CVCL_J415 ! ECL-41
SX   Sex unspecified
AG   21D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   ECL-41
AC   CVCL_J415
DR   Wikidata; Q54831940
RX   PubMed=11437454;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: FVB/N Nkx2.5-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_J412 ! ECL-2
OI   CVCL_J413 ! ECL-32
OI   CVCL_J414 ! ECL-38
SX   Sex unspecified
AG   21D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   ECMA-1
AC   CVCL_A1QK
SY   P1-CL; CL1
DR   cancercelllines; CVCL_A1QK
DR   GEO; GSM4563055
DR   Wikidata; Q102114699
RX   PubMed=33087752;
CC   Population: Caucasian.
CC   Doubling time: 87 hours (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Heterozygous (PubMed=33087752).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=33087752
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 15,16
ST   D16S539: 11,12.1
ST   D5S818: 13
ST   D7S820: 9.2,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   ECN90
AC   CVCL_VJ07
DR   Wikidata; Q93537272
RX   Patent=US9493743;
RX   Patent=WO2017046335A1;
CC   Group: Patented cell line.
CC   HLA typing: A*02:01,03; B*40,49; C*03,07 (Patent=WO2017046335A1).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   ECoM-G
AC   CVCL_E6BC
SY   E2a/Pbx1-mediated Conditional Myeloid-Granulocyte
DR   ABM; T0200
RX   PubMed=11588024;
RX   PubMed=12916872;
CC   Characteristics: Exhibits restricted granulocytic differentiation. Neutrophil progenitor cells that express a conditional form of TCF3-PBX1 (E2a-Pbx1) in an estrogen responsive manner (PubMed=11588024).
CC   Characteristics: CSF2 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=With p.Met1_Gly281del and p.Gly400Val in a E2a/Pbx1Delta487-623ER fusion = EPD623ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8632; PBX1 (Note=With p.Met1_Asp232del in a E2a/Pbx1Delta487-623ER fusion = EPD623ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11633; TCF3 (Note=With p.Gly484_Met654del in a E2a/Pbx1Delta487-623ER fusion = EPD623ER).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: TCF3-PBX1 (E2A-PBX1).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Breed of donor mouse erroneously indicated as being from BALB/c in PubMed=11588024. Correct breed from personal communication of Sykes, David Brian through ABM.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ECoM-M
AC   CVCL_E6BD
SY   E2a/Pbx1-mediated Conditional Myeloid-Monocyte
DR   ABM; T0201
RX   PubMed=11588024;
RX   PubMed=12916872;
CC   Characteristics: Exhibits restricted monocytic differentiation. Neutrophil progenitor cells that express a conditional form of TCF3-PBX1 (E2a-Pbx1) in an estrogen responsive manner (PubMed=11588024).
CC   Characteristics: SCF dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=With p.Met1_Gly281del and p.Gly400Val in a E2a/Pbx1Delta487-623ER fusion = EPD623ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8632; PBX1 (Note=With p.Met1_Asp232del in a E2a/Pbx1Delta487-623ER fusion = EPD623ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11633; TCF3 (Note=With p.Gly484_Met654del in a E2a/Pbx1Delta487-623ER fusion = EPD623ER).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: TCF3-PBX1 (E2A-PBX1).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Breed of donor mouse erroneously indicated as being from BALB/c in PubMed=11588024. Correct breed from personal communication of Sykes, David Brian through ABM.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ECPC-3
AC   CVCL_4835
DR   CLO; CLO_0050206
DR   RCB; RCB1286
DR   Wikidata; Q54831941
RX   PubMed=8878450;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Breed/subspecies: C57BL/6 IgH-T-Ag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_4836 ! ECPC-4
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   ECPC-4
AC   CVCL_4836
SY   ECPC4
DR   CLO; CLO_0050205
DR   RCB; RCB1287
DR   Wikidata; Q54831942
RX   PubMed=8878450;
RX   PubMed=26794622;
RX   PubMed=26833402;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Breed/subspecies: C57BL/6 IgH-T-Ag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_4835 ! ECPC-3
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   EcR-293
AC   CVCL_7261
SY   EcR 293; EcR293
DR   Lonza; 695
DR   TOKU-E; 3682
DR   Wikidata; Q54831944
RX   PubMed=15218237;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-144.html
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=15218237
ST   Amelogenin: X
ST   D13S317: 12,14
ST   D18S51: 17
ST   D21S11: 28,30.2
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   EcR-293-LacZ
AC   CVCL_D3XP
SY   E2-lacZ
DR   Wikidata; Q127380808
RX   PubMed=15218237;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7261 ! EcR-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 6
//
ID   EcR-293-MEN1
AC   CVCL_RQ23
SY   E2-MEN1; E2-M1
DR   Wikidata; Q54831945
RX   PubMed=12915678;
RX   PubMed=15218237;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7010; MEN1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7261 ! EcR-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   EcR-RKO/KLF4
AC   CVCL_9807
DR   EFO; EFO_0002052
DR   cancercelllines; CVCL_9807
DR   Wikidata; Q54831943
RX   PubMed=17017123;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1342287; Klf4.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Ect1/E6E7
AC   CVCL_3679
SY   ECT1/E6E7; Ect1
DR   CLO; CLO_0002879
DR   EFO; EFO_0005264
DR   ATCC; CRL-2614
DR   BioSample; SAMN03471693
DR   Wikidata; Q54831946
RX   PubMed=9314589;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-2614
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 19,20
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 11
ST   FGA: 21,23
ST   Penta D: 10,12
ST   Penta E: 12,13
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3684 ! End1/E6E7
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   ECTC
AC   CVCL_4518
SY   Embryonic Calf Thyroid Cell
DR   CLO; CLO_0002880
DR   CLDB; cl1135
DR   BioSample; SAMN03152037
DR   IZSLER; BS CL 96
DR   Wikidata; Q54831947
RX   PubMed=14505435;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of bovine origin but found to be a monkey Vero derivative (PubMed=14505435; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00190.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   ECV-304
AC   CVCL_2029
SY   ECV 304; ECV304; ECV; E304; T24(ECV304)
DR   BTO; BTO_0002043
DR   CLO; CLO_0002881
DR   CLO; CLO_0002882
DR   EFO; EFO_0022389
DR   CLDB; cl1136
DR   CLDB; cl5185
DR   ATCC; CRL-1998
DR   BCRJ; 0283
DR   BioSample; SAMN03151937
DR   BioSample; SAMN03471274
DR   cancercelllines; CVCL_2029
DR   ChEMBL-Cells; CHEMBL3307513
DR   ChEMBL-Targets; CHEMBL614035
DR   CLS; 300452
DR   Cosmic; 1466801
DR   DSMZ; ACC-310
DR   DSMZCellDive; ACC-310
DR   ECACC; 92091712
DR   IZSLER; BS CL 137
DR   JCRB; JCRB0744
DR   JCRB; NIHS0220
DR   PRIDE; PXD004340
DR   PubChem_Cell_line; CVCL_2029
DR   Wikidata; Q54831948
RX   DOI=10.11418/jtca1981.18.4_329;
RX   PubMed=1378828;
RX   PubMed=1690702;
RX   PubMed=1817644;
RX   PubMed=9290701;
RX   PubMed=10508494;
RX   PubMed=10614862;
RX   PubMed=10653001;
RX   PubMed=11416159;
RX   PubMed=11669284;
RX   PubMed=12197766;
RX   PubMed=12453433;
RX   PubMed=20143388;
RX   PubMed=27554326;
RX   PubMed=33389257;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ecv-304-atcc-crl-1998
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-2.html
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=10508494; PubMed=10614862; PubMed=12197766; PubMed=20143388). Originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00117.
CC   Population: Caucasian; Swedish.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 35 hours (PubMed=1817644); ~2 days (DSMZ=ACC-310).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Tyrosine phosphorylation.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3111C0002000000074, 3142C0001000000023). They were one of the sources for the STR profile of this entry.
CC   Discontinued: ATCC; CRL-1998; true.
CC   Discontinued: BCRJ; 0283; probable.
CC   Discontinued: DSMZ; ACC-310; true.
CC   Discontinued: JCRB; NIHS0220; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-1998; CCRID; CLS=300452; DSMZ=ACC-310; ECACC=92091712; JCRB=JCRB0744; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 10,14 (DSMZ=ACC-310)
ST   D8S1179: 14 (CLS=300452; PubMed=11416159)
ST   FGA: 17,22
ST   Penta D: 11,15
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   Ed Leb
AC   CVCL_ZN93
DR   ATCC; CRL-1372
DR   Wikidata; Q98125937
CC   Discontinued: ATCC; CRL-1372; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   ED(27)
AC   CVCL_8345
SY   ED27
DR   BioSample; SAMN03151688
DR   Wikidata; Q54831952
RX   PubMed=1415390;
RX   PubMed=11869090;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a WISH derivative (PubMed=11869090; PubMed=20143388). Originally thought to originate from a chorionic villus sample from a 35 year old female donor.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00191.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1909 ! WISH
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   ED-40515
AC   CVCL_JF68
SY   ED-40515(+); ED40515
DR   GEO; GSE168552
DR   RCB; RCB3533
DR   Wikidata; Q54831949
RX   PubMed=2866223;
RX   PubMed=7662981;
RX   PubMed=15638850;
RX   PubMed=16314839;
RX   PubMed=32210945;
RX   PubMed=34794206;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF69 ! ED-40810
OI   CVCL_A6SI ! ED-41214
OI   CVCL_A6SJ ! ED-70423C
OI   CVCL_A6SK ! ED-50823
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   ED-40515(-)
AC   CVCL_JF70
DR   RCB; RCB3534
DR   Wikidata; Q54831950
RX   PubMed=7662981;
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JF68 ! ED-40515
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   ED-40810
AC   CVCL_JF69
SY   ED-40810S; ED-40810(+); ED40810; ED-S
DR   Wikidata; Q54831951
RX   PubMed=2866223;
RX   PubMed=8957066;
RX   PubMed=9116292;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF68 ! ED-40515
OI   CVCL_A6SI ! ED-41214
OI   CVCL_A6SJ ! ED-70423C
OI   CVCL_A6SK ! ED-50823
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   ED-40810(-)
AC   CVCL_A6TT
DR   RCB; RCB3556
DR   Wikidata; Q107114844
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JF69 ! ED-40810
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ED-41214
AC   CVCL_A6SI
SY   ED-41214C(+); ED-41214T
DR   Wikidata; Q107114845
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF68 ! ED-40515
OI   CVCL_JF69 ! ED-40810
OI   CVCL_A6SJ ! ED-70423C
OI   CVCL_A6SK ! ED-50823
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ED-41214(-)
AC   CVCL_A6TV
DR   RCB; RCB3557
DR   Wikidata; Q107114850
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6SI ! ED-41214
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ED-50823
AC   CVCL_A6SK
SY   ED-50823(+)
DR   RCB; RCB3539
DR   Wikidata; Q107114851
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF68 ! ED-40515
OI   CVCL_JF69 ! ED-40810
OI   CVCL_A6SI ! ED-41214
OI   CVCL_A6SJ ! ED-70423C
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ED-50823(-)
AC   CVCL_A6TH
DR   RCB; RCB3540
DR   Wikidata; Q107114852
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6SK ! ED-50823
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ED-70423C
AC   CVCL_A6SJ
SY   ED-70423C(+); ED-70423CB
DR   Wikidata; Q107114853
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF68 ! ED-40515
OI   CVCL_JF69 ! ED-40810
OI   CVCL_A6SI ! ED-41214
OI   CVCL_A6SK ! ED-50823
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ED-70423C(-)
AC   CVCL_A6TW
SY   ED-70423CB(-)
DR   RCB; RCB3558
DR   Wikidata; Q107114855
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6SJ ! ED-70423C
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   ED-S/ADM
AC   CVCL_A7QM
DR   Wikidata; Q107114856
RX   PubMed=9116292;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JF69 ! ED-40810
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   ED1
AC   CVCL_M036
DR   ECACC; 89040701
DR   Wikidata; Q54831953
RX   PubMed=3882559;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   ED1-19-1-6-5
AC   CVCL_9173
DR   CLO; CLO_0002883
DR   ATCC; HB-90
DR   Wikidata; Q54831954
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse IgG2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   Ed100
AC   CVCL_C8EI
DR   Wikidata; Q123031200
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed104
AC   CVCL_C8EJ
DR   Wikidata; Q123031202
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed105
AC   CVCL_C8EK
DR   Wikidata; Q123031203
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed106
AC   CVCL_C8EL
DR   Wikidata; Q123031204
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed109
AC   CVCL_C8EM
DR   Wikidata; Q123031205
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed110
AC   CVCL_C8EN
DR   Wikidata; Q123031206
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed111
AC   CVCL_C8EP
DR   Wikidata; Q123031207
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed113
AC   CVCL_C8EQ
DR   Wikidata; Q123031208
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed114
AC   CVCL_C8ER
DR   Wikidata; Q123031209
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed116
AC   CVCL_C8ES
DR   Wikidata; Q123031211
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed117
AC   CVCL_C8ET
DR   Wikidata; Q123031212
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed118
AC   CVCL_C8EU
DR   Wikidata; Q123031213
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed119
AC   CVCL_C8EV
DR   Wikidata; Q123031214
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed120
AC   CVCL_C8EW
DR   Wikidata; Q123031215
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed121
AC   CVCL_C8EX
DR   Wikidata; Q123031216
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed129
AC   CVCL_C8E9
DR   Wikidata; Q123031217
RX   PubMed=10448865;
CC   Characteristics: Early passage culture.
CC   Karyotypic information: 46,XY [1]; 46,X,+7 [8]; 46,XY,+7,-20 [1] (PubMed=10448865).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed135
AC   CVCL_C8EA
DR   Wikidata; Q123031218
RX   PubMed=10448865;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed141.MEL
AC   CVCL_GR69
DR   TOKU-E; 4006
DR   Wikidata; Q54831955
RX   PubMed=11950413;
CC   Characteristics: Early passage culture.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   Ed147.BT
AC   CVCL_GR70
SY   Ed147
DR   TOKU-E; 4007
DR   Wikidata; Q54831956
RX   PubMed=10448865;
RX   PubMed=10807250;
RX   PubMed=11950413;
CC   Characteristics: Early passage culture.
CC   Karyotypic information: 46,XY [1]; 45,X [4]; 44,X,-8 [1]; 45,XY,-22 [1] (PubMed=10448865).
CC   Caution: Indicated as originating from a 52 year old at sampling in PubMed=11950413 and 57 year old in PubMed=10807250.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   Ed149.BT
AC   CVCL_GR71
SY   Ed149
DR   TOKU-E; 4008
DR   Wikidata; Q54831957
RX   PubMed=10448865;
RX   PubMed=10807250;
RX   PubMed=11950413;
CC   Characteristics: Early passage culture.
CC   Karyotypic information: 52,XY,+X,+Y,+del(1)(p21),dic(1;2)(q25;p24),+3,-16,+18,+20,+21,+mar (PubMed=10448865).
CC   Caution: Indicated as originating from a 49 year old at sampling in PubMed=11950413 and 45 year old in PubMed=10807250.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ED16
AC   CVCL_M039
DR   Wikidata; Q54831958
RX   PubMed=2016566;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   ED17
AC   CVCL_M040
DR   ECACC; 95110627
DR   Wikidata; Q54831959
RX   PubMed=2016566;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   ED18Im-pre-TII
AC   CVCL_C5SU
SY   Embryonic day 18 immortalized pre-type II cells
DR   Wikidata; Q116048926
RX   PubMed=1316350;
CC   Doubling time: ~44 hours (PubMed=1316350).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Embryonic lung, alveolus; UBERON=UBERON_0005597+UBERON_0002299.
CC   Cell type: Pre-type 2 pneumocyte; CL=CL_4040003.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   ED19Im-pre-TII
AC   CVCL_C5SV
SY   Embryonic day 19 immortalized pre-type II cells
DR   Wikidata; Q116048927
RX   PubMed=1316350;
CC   Doubling time: ~53 hours (PubMed=1316350).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Embryonic lung, alveolus; UBERON=UBERON_0005597+UBERON_0002299.
CC   Cell type: Pre-type 2 pneumocyte; CL=CL_4040003.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   19FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   ED2
AC   CVCL_M037
DR   ECACC; 89040702
DR   Wikidata; Q54831960
RX   PubMed=3882559;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   ED3
AC   CVCL_M038
DR   ECACC; 89040703
DR   Wikidata; Q54831961
RX   PubMed=3882559;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   ED4
AC   CVCL_M044
DR   Wikidata; Q54831962
RX   PubMed=2572659;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   ED7
AC   CVCL_M041
DR   ECACC; 95110624
DR   Wikidata; Q54831963
RX   PubMed=2572659;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JI30; Rat Itgam/Cd11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   Ed77
AC   CVCL_C8EB
DR   Wikidata; Q123031219
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed79
AC   CVCL_C8EC
DR   Wikidata; Q123031220
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   ED8
AC   CVCL_M042
DR   ECACC; 95110625
DR   Wikidata; Q54831964
RX   PubMed=2572659;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JI30; Rat Itgam/Cd11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   Ed84
AC   CVCL_C8ED
DR   Wikidata; Q123031221
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed85
AC   CVCL_C8EE
DR   Wikidata; Q123031222
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   ED9
AC   CVCL_M043
DR   ECACC; 95110626
DR   Wikidata; Q54831965
RX   PubMed=2572659;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   Ed93
AC   CVCL_C8EF
DR   Wikidata; Q123031223
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed98
AC   CVCL_C8EG
DR   Wikidata; Q123031224
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ed99
AC   CVCL_C8EH
DR   Wikidata; Q123031225
RX   PubMed=10807250;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Eda Bel
AC   CVCL_U679
DR   ATCC; CRL-1190
DR   Wikidata; Q54831966
RX   PubMed=6726265;
CC   Discontinued: ATCC; CRL-1190; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Edi 1
AC   CVCL_A233
SY   Edi-1; EDI-1; Edi1; EDe008-A
DR   hPSCreg; EDe008-A
DR   SKIP; SKIP001927
DR   Wikidata; Q54831967
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0012.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-004, Steering comm. appl. SCSC04-29.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Edi 2
AC   CVCL_A234
SY   Edi-2; EDI-2; EDI2; Edi2; EDe009-A
DR   BioSamples; SAMEA104628038
DR   hPSCreg; EDe009-A
DR   SKIP; SKIP001928
DR   Wikidata; Q54831968
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/edi-2.aspx
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0032.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-023, Steering comm. appl. SCSC07-12(1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   Edi 3
AC   CVCL_A235
SY   Edi-3; EDI-3; Edi3; CAMe003-A; EDe010-A
DR   hPSCreg; EDe010-A
DR   SKIP; SKIP001929
DR   Wikidata; Q54831969
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-024, Steering comm. appl. SCSC07-12.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   Edi 4
AC   CVCL_A236
SY   Edi-4; EDI-4; EDI4; Edi4; CAMe004-A; EDe011-A
DR   hPSCreg; EDe011-A
DR   SKIP; SKIP001930
DR   Wikidata; Q54831970
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/edi-4.aspx
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-025, Steering comm. appl. SCSC07-13.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   EDi001-A
AC   CVCL_AW97
SY   AST22; AST23
DR   BioSamples; SAMEA3319992
DR   EBiSC; EDi001-A
DR   ECACC; 66540058
DR   hPSCreg; EDi001-A
DR   SKIP; SKIP002512
DR   Wikidata; Q54831971
RX   PubMed=21863007;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=21863007).
CC   Discontinued: ECACC; 66540058; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   EDi001-A-1
AC   CVCL_LE51
SY   AST22-C; AST23-C
DR   BioSamples; SAMEA3323836
DR   EBiSC; EDi001-A-1
DR   ECACC; 66540166
DR   hPSCreg; EDi001-A-1
DR   Wikidata; Q54831972
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 66540166; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AW97 ! EDi001-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   EDi001-A-2
AC   CVCL_LE52
SY   AST22-1KO-3; AST23-1KO-3; AST-22_SNCAKO Clone 3; AST-23_SCAKO Clone 3
DR   BioSamples; SAMEA3323846
DR   EBiSC; EDi001-A-2
DR   ECACC; 66540167
DR   hPSCreg; EDi001-A-2
DR   Wikidata; Q54831973
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Characteristics: The donor of the original cell line has 4 copies of SNCA. This edited cell line clone has 1 of the 4 alleles KO by CRISPR/Cas9 (hPSCreg=EDi001-A-2).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=1 of 4 alleles).
CC   Discontinued: ECACC; 66540167; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AW97 ! EDi001-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   EDi001-A-3
AC   CVCL_LE53
SY   AST22-1KO-1; AST23-1KO-1; AST22_SNCAKO Clone 1; AST23_SNCAKO Clone 1
DR   BioSamples; SAMEA3323899
DR   EBiSC; EDi001-A-3
DR   ECACC; 66540168
DR   hPSCreg; EDi001-A-3
DR   Wikidata; Q54831974
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Characteristics: The donor of the original cell line has 4 copies of SNCA. This edited cell line clone has 1 of the 4 alleles KO by CRISPR/Cas9 (hPSCreg=EDi001-A-3).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=1 of 4 alleles).
CC   Discontinued: ECACC; 66540168; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AW97 ! EDi001-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   EDi001-A-4
AC   CVCL_LE54
SY   AST22-2KO-6; AST23-2KO-6; AST22_SNCAKO Clone 6; AST23_SNCAKO Clone 6
DR   BioSamples; SAMEA3323960
DR   EBiSC; EDi001-A-4
DR   ECACC; 66540169
DR   hPSCreg; EDi001-A-4
DR   Wikidata; Q54831975
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Characteristics: The donor of the original cell line has 4 copies of SNCA. This edited cell line clone has 2 of the 4 alleles KO by CRISPR/Cas9 (hPSCreg=EDi001-A-4).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=2 of 4 alleles).
CC   Discontinued: EBiSC; EDi001-A-4; true.
CC   Discontinued: ECACC; 66540169; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AW97 ! EDi001-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   EDi001-A-5
AC   CVCL_D0VC
SY   AST23-2KO-II8B
DR   BioSamples; SAMEA7111748
DR   EBiSC; EDi001-A-5
DR   ECACC; 66770006
DR   hPSCreg; EDi001-A-5
DR   Wikidata; Q123031227
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Characteristics: The donor of the original cell line has 4 copies of SNCA. This edited cell line clone has 2 of the 4 alleles KO by CRISPR/Cas9 (hPSCreg=EDi001-A-5).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=2 of 4 alleles).
CC   Discontinued: ECACC; 66770006; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AW97 ! EDi001-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   EDi001-B
AC   CVCL_ZA47
SY   AST18; AST18 iPS cells; Alpha-synuclein triplication 18
DR   BioSamples; SAMEA7111749
DR   EBiSC; EDi001-B
DR   ECACC; 66770007
DR   hPSCreg; EDi001-B
DR   Wikidata; Q98125938
RX   PubMed=21863007;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 66770007; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   EDi001-B-1
AC   CVCL_A1XP
SY   AST18-7A
DR   BioSamples; SAMEA7111750
DR   EBiSC; EDi001-B-1
DR   ECACC; 66770008
DR   hPSCreg; EDi001-B-1
DR   Wikidata; Q105506809
RX   PubMed=30472757;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Discontinued: ECACC; 66770008; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA47 ! EDi001-B
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   EDi001-B-2
AC   CVCL_A1XQ
SY   AST18-7B
DR   BioSamples; SAMEA7111751
DR   EBiSC; EDi001-B-2
DR   ECACC; 66770009
DR   hPSCreg; EDi001-B-2
DR   Wikidata; Q105506812
RX   PubMed=30472757;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Discontinued: ECACC; 66770009; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA47 ! EDi001-B
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   EDi001-B-3
AC   CVCL_A1XR
SY   AST18-5D
DR   BioSamples; SAMEA7111752
DR   EBiSC; EDi001-B-3
DR   ECACC; 66770010
DR   hPSCreg; EDi001-B-3
DR   Wikidata; Q105506816
RX   PubMed=30472757;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Discontinued: ECACC; 66770010; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA47 ! EDi001-B
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   EDi001-B-4
AC   CVCL_A1XS
SY   AST18-6A
DR   BioSamples; SAMEA7111753
DR   EBiSC; EDi001-B-4
DR   ECACC; 66770011
DR   hPSCreg; EDi001-B-4
DR   Wikidata; Q105506819
RX   PubMed=30472757;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Discontinued: ECACC; 66770011; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA47 ! EDi001-B
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   EDi002-A
AC   CVCL_AW98
SY   NAS2; NAS2 iPS cells
DR   BioSamples; SAMEA3333374
DR   EBiSC; EDi002-A
DR   ECACC; 66540059
DR   hPSCreg; EDi002-A
DR   SKIP; SKIP002513
DR   Wikidata; Q54831976
RX   PubMed=21863007;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Discontinued: ECACC; 66540059; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 12
//
ID   EDi008-A
AC   CVCL_LE55
SY   G51D-3
DR   BioSamples; SAMEA3174308
DR   EBiSC; EDi008-A
DR   ECACC; 66540060
DR   hPSCreg; EDi008-A
DR   Wikidata; Q54831977
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Gly51Asp (c.152G>A); ClinVar=VCV000097000; Zygosity=Heterozygous (from autologous cell line EDi008-B).
CC   Discontinued: EBiSC; EDi008-A; true.
CC   Discontinued: ECACC; 66540060; true.
CC   Discontinued: hPSCreg; EDi008-A; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE56 ! EDi008-B
SX   Female
AG   40-50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   EDi008-B
AC   CVCL_LE56
SY   G51D-4; EDIi008-B; EDINi008-B
DR   BioSamples; SAMEA3174606
DR   EBiSC; EDi008-B
DR   ECACC; 66540061
DR   hPSCreg; EDi008-B
DR   Wikidata; Q54831978
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Gly51Asp (c.152G>A); ClinVar=VCV000097000; Zygosity=Heterozygous (EBiSC=EDi008-B).
CC   Discontinued: ECACC; 66540061; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE55 ! EDi008-A
SX   Female
AG   40-50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   EDi010-A
AC   CVCL_LE57
SY   RCi136
DR   BioSamples; SAMEA4459354
DR   EBiSC; EDi010-A
DR   ECACC; 66540447
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi010-A
DR   Wikidata; Q54831979
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540447; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE58 ! EDi010-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi010-B
AC   CVCL_LE58
SY   RCi138
DR   BioSamples; SAMEA4459356
DR   EBiSC; EDi010-B
DR   ECACC; 66540448
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi010-B
DR   Wikidata; Q54831986
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540448; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE57 ! EDi010-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi011-A
AC   CVCL_LE59
SY   RCi139
DR   BioSamples; SAMEA4459357
DR   EBiSC; EDi011-A
DR   ECACC; 66540449
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi011-A
DR   Wikidata; Q54831987
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540449; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE60 ! EDi011-B
OI   CVCL_LE61 ! EDi011-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi011-B
AC   CVCL_LE60
SY   RCi140
DR   BioSamples; SAMEA4459359
DR   EBiSC; EDi011-B
DR   ECACC; 66540450
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi011-B
DR   Wikidata; Q54831988
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540450; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE59 ! EDi011-A
OI   CVCL_LE61 ! EDi011-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi011-C
AC   CVCL_LE61
SY   RCi141
DR   BioSamples; SAMEA4459360
DR   EBiSC; EDi011-C
DR   ECACC; 66540451
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi011-C
DR   Wikidata; Q54831989
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540451; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE59 ! EDi011-A
OI   CVCL_LE60 ! EDi011-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi012-A
AC   CVCL_LE62
SY   RCi163
DR   BioSamples; SAMEA4459361
DR   EBiSC; EDi012-A
DR   ECACC; 66540452
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi012-A
DR   Wikidata; Q54831990
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540452; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE63 ! EDi012-B
OI   CVCL_LE64 ! EDi012-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi012-B
AC   CVCL_LE63
SY   RCi164
DR   BioSamples; SAMEA4459363
DR   EBiSC; EDi012-B
DR   ECACC; 66540453
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi012-B
DR   Wikidata; Q54831991
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540453; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE62 ! EDi012-A
OI   CVCL_LE64 ! EDi012-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi012-C
AC   CVCL_LE64
SY   RCi165
DR   BioSamples; SAMEA4459364
DR   EBiSC; EDi012-C
DR   ECACC; 66540454
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi012-C
DR   Wikidata; Q54831992
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540454; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE62 ! EDi012-A
OI   CVCL_LE63 ! EDi012-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi013-A
AC   CVCL_LE65
SY   RCi192
DR   BioSamples; SAMEA4459365
DR   EBiSC; EDi013-A
DR   ECACC; 66540455
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi013-A
DR   Wikidata; Q54831993
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi013-A; true.
CC   Discontinued: ECACC; 66540455; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE66 ! EDi013-B
OI   CVCL_LE67 ! EDi013-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi013-B
AC   CVCL_LE66
SY   RCi193
DR   BioSamples; SAMEA4459367
DR   EBiSC; EDi013-B
DR   ECACC; 66540456
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi013-B
DR   Wikidata; Q54831994
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi013-B; true.
CC   Discontinued: ECACC; 66540456; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE65 ! EDi013-A
OI   CVCL_LE67 ! EDi013-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi013-C
AC   CVCL_LE67
SY   RCi214
DR   BioSamples; SAMEA4459368
DR   EBiSC; EDi013-C
DR   ECACC; 66540457
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi013-C
DR   Wikidata; Q54831995
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi013-C; true.
CC   Discontinued: ECACC; 66540457; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE65 ! EDi013-A
OI   CVCL_LE66 ! EDi013-B
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi014-A
AC   CVCL_LE68
SY   RCi175
DR   BioSamples; SAMEA4459369
DR   EBiSC; EDi014-A
DR   ECACC; 66540458
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi014-A
DR   Wikidata; Q54831996
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi014-A; true.
CC   Discontinued: ECACC; 66540458; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE69 ! EDi014-B
OI   CVCL_WP76 ! EDi014-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   EDi014-B
AC   CVCL_LE69
SY   RCi185
DR   BioSamples; SAMEA4459371
DR   EBiSC; EDi014-B
DR   ECACC; 66540459
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi014-B
DR   Wikidata; Q54831997
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi014-B; true.
CC   Discontinued: ECACC; 66540459; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE68 ! EDi014-A
OI   CVCL_WP76 ! EDi014-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   EDi014-C
AC   CVCL_WP76
DR   BioSamples; SAMEA4459372
DR   EBiSC; EDi014-C
DR   ECACC; 66540494
DR   hPSCreg; EDi014-C
DR   Wikidata; Q93537880
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Discontinued: EBiSC; EDi014-C; true.
CC   Discontinued: ECACC; 66540494; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE68 ! EDi014-A
OI   CVCL_LE69 ! EDi014-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 8
//
ID   EDi015-A
AC   CVCL_LE70
SY   RCi176
DR   BioSamples; SAMEA4459373
DR   EBiSC; EDi015-A
DR   ECACC; 66540460
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi015-A
DR   Wikidata; Q54831998
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi015-A; true.
CC   Discontinued: ECACC; 66540460; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE71 ! EDi015-B
OI   CVCL_LE72 ! EDi015-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi015-B
AC   CVCL_LE71
SY   RCi183
DR   BioSamples; SAMEA4459375
DR   EBiSC; EDi015-B
DR   ECACC; 66540461
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi015-B
DR   Wikidata; Q54831999
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi015-B; true.
CC   Discontinued: ECACC; 66540461; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE70 ! EDi015-A
OI   CVCL_LE72 ! EDi015-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi015-C
AC   CVCL_LE72
SY   RCi184
DR   BioSamples; SAMEA4459376
DR   EBiSC; EDi015-C
DR   ECACC; 66540462
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi015-C
DR   Wikidata; Q54832000
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi015-C; true.
CC   Discontinued: ECACC; 66540462; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE70 ! EDi015-A
OI   CVCL_LE71 ! EDi015-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi016-A
AC   CVCL_LE73
SY   RCi189
DR   BioSamples; SAMEA4562366
DR   EBiSC; EDi016-A
DR   ECACC; 66540463
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi016-A
DR   Wikidata; Q54832001
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi016-A; true.
CC   Discontinued: ECACC; 66540463; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE74 ! EDi016-B
OI   CVCL_LE75 ! EDi016-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi016-B
AC   CVCL_LE74
SY   RCi190
DR   BioSamples; SAMEA4767418
DR   EBiSC; EDi016-B
DR   hPSCreg; EDi016-B
DR   Wikidata; Q54832002
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Discontinued: EBiSC; EDi016-B; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE73 ! EDi016-A
OI   CVCL_LE75 ! EDi016-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   EDi016-C
AC   CVCL_LE75
SY   RCi191
DR   BioSamples; SAMEA4768168
DR   EBiSC; EDi016-C
DR   ECACC; 66540465
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi016-C
DR   Wikidata; Q54832003
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi016-C; true.
CC   Discontinued: ECACC; 66540465; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE73 ! EDi016-A
OI   CVCL_LE74 ! EDi016-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi017-A
AC   CVCL_LE76
SY   RCi174
DR   BioSamples; SAMEA4768918
DR   EBiSC; EDi017-A
DR   ECACC; 66540466
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi017-A
DR   Wikidata; Q54832004
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi017-A; true.
CC   Discontinued: ECACC; 66540466; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE77 ! EDi017-B
OI   CVCL_LE78 ! EDi017-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi017-B
AC   CVCL_LE77
SY   RCi181
DR   BioSamples; SAMEA4770418
DR   EBiSC; EDi017-B
DR   ECACC; 66540467
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi017-B
DR   Wikidata; Q54832005
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi017-B; true.
CC   Discontinued: ECACC; 66540467; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE76 ! EDi017-A
OI   CVCL_LE78 ! EDi017-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi017-C
AC   CVCL_LE78
SY   RCi182
DR   BioSamples; SAMEA4771168
DR   EBiSC; EDi017-C
DR   ECACC; 66540468
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi017-C
DR   Wikidata; Q54832006
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi017-C; true.
CC   Discontinued: ECACC; 66540468; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE76 ! EDi017-A
OI   CVCL_LE77 ! EDi017-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   EDi018-A
AC   CVCL_LE79
SY   RCi211
DR   BioSamples; SAMEA4771918
DR   EBiSC; EDi018-A
DR   ECACC; 66540469
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi018-A
DR   Wikidata; Q54832007
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi018-A; true.
CC   Discontinued: ECACC; 66540469; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE80 ! EDi018-B
OI   CVCL_LE81 ! EDi018-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi018-B
AC   CVCL_LE80
SY   RCi212
DR   BioSamples; SAMEA4773418
DR   EBiSC; EDi018-B
DR   ECACC; 66540470
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi018-B
DR   Wikidata; Q54832008
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi018-B; true.
CC   Discontinued: ECACC; 66540470; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE79 ! EDi018-A
OI   CVCL_LE81 ! EDi018-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi018-C
AC   CVCL_LE81
SY   RCi213
DR   BioSamples; SAMEA4774168
DR   EBiSC; EDi018-C
DR   ECACC; 66540471
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi018-C
DR   Wikidata; Q54832009
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; EDi018-C; true.
CC   Discontinued: ECACC; 66540471; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE79 ! EDi018-A
OI   CVCL_LE80 ! EDi018-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi019-A
AC   CVCL_LE82
SY   RCi166
DR   BioSamples; SAMEA4774918
DR   EBiSC; EDi019-A
DR   ECACC; 66540472
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi019-A
DR   Wikidata; Q54832010
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540472; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE83 ! EDi019-B
OI   CVCL_LE84 ! EDi019-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi019-B
AC   CVCL_LE83
SY   RCi167
DR   BioSamples; SAMEA4776418
DR   EBiSC; EDi019-B
DR   ECACC; 66540473
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi019-B
DR   Wikidata; Q54832011
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540473; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE82 ! EDi019-A
OI   CVCL_LE84 ! EDi019-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi019-C
AC   CVCL_LE84
SY   RCi168
DR   BioSamples; SAMEA4777168
DR   EBiSC; EDi019-C
DR   ECACC; 66540474
DR   EGA; EGAS00001002755
DR   hPSCreg; EDi019-C
DR   Wikidata; Q54832012
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540474; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE82 ! EDi019-A
OI   CVCL_LE83 ! EDi019-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   EDi021-A
AC   CVCL_VT07
SY   CS0395iCTR-LBCn3
DR   BioSamples; SAMEA5447460
DR   hPSCreg; EDi021-A
DR   Wikidata; Q93538069
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y8M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   EDi022-A
AC   CVCL_VT08
SY   CS0617iCTR-LBCn1
DR   BioSamples; SAMEA5274197
DR   hPSCreg; EDi022-A
DR   Wikidata; Q93538072
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y2M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   EDi023-A
AC   CVCL_VT09
SY   CS0791iCTR-LBCn1
DR   BioSamples; SAMEA5274199
DR   hPSCreg; EDi023-A
DR   Wikidata; Q93538077
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 8,13
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   EDi024-A
AC   CVCL_XY79
SY   CS0036iCTR-LBCn2
DR   BioSamples; SAMEA6154502
DR   hPSCreg; EDi024-A
DR   Wikidata; Q93538083
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12,14
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi025-A
AC   CVCL_XY78
SY   CS0051iCTR-LBCn3
DR   BioSamples; SAMEA6154498
DR   hPSCreg; EDi025-A
DR   Wikidata; Q93538085
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi026-A
AC   CVCL_YB19
SY   CS0087iCTR-LBCn1
DR   BioSamples; SAMEA6154499
DR   hPSCreg; EDi026-A
DR   Wikidata; Q93538090
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,13
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 8
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y4M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi027-A
AC   CVCL_YB20
SY   CS1045iCTR-LBCn1
DR   BioSamples; SAMEA6154500
DR   hPSCreg; EDi027-A
DR   Wikidata; Q93538093
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi028-A
AC   CVCL_YB21
SY   CS0172iCTR-LBCn2
DR   BioSamples; SAMEA6154501
DR   hPSCreg; EDi028-A
DR   Wikidata; Q93538099
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi029-A
AC   CVCL_YB22
SY   CS0188iCTR-LBCn3
DR   BioSamples; SAMEA6154503
DR   hPSCreg; EDi029-A
DR   Wikidata; Q93538101
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi030-A
AC   CVCL_YB16
SY   CS0228iCTR-LBCn3
DR   BioSamples; SAMEA6154504
DR   hPSCreg; EDi030-A
DR   Wikidata; Q93538106
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 7,8
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi031-A
AC   CVCL_YB23
SY   CS0416iCTR-LBCn1
DR   BioSamples; SAMEA6154505
DR   hPSCreg; EDi031-A
DR   Wikidata; Q93538113
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi032-A
AC   CVCL_YB24
SY   CS0424iCTR-LBCn3
DR   BioSamples; SAMEA6154506
DR   hPSCreg; EDi032-A
DR   Wikidata; Q93538116
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y2M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi033-A
AC   CVCL_YB25
SY   CS0459iCTR-LBCn5
DR   BioSamples; SAMEA6154507
DR   hPSCreg; EDi033-A
DR   Wikidata; Q93538121
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi034-A
AC   CVCL_YB26
SY   CS0465iCTR-LBCn2
DR   BioSamples; SAMEA6171397
DR   hPSCreg; EDi034-A
DR   Wikidata; Q93538125
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi035-A
AC   CVCL_YB27
SY   CS0484iCTR-LBCn3
DR   BioSamples; SAMEA6171398
DR   hPSCreg; EDi035-A
DR   Wikidata; Q93538128
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y7M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi036-A
AC   CVCL_YB28
SY   CS0594iCTR-LBCn2
DR   BioSamples; SAMEA6171399
DR   hPSCreg; EDi036-A
DR   Wikidata; Q93538133
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y2M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi037-A
AC   CVCL_YB29
SY   CS0702iCTR-LBCn1
DR   BioSamples; SAMEA6171400
DR   hPSCreg; EDi037-A
DR   Wikidata; Q93538139
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi038-A
AC   CVCL_YB30
SY   CS0771iCTR-LBCn5
DR   BioSamples; SAMEA6171401
DR   hPSCreg; EDi038-A
DR   Wikidata; Q93538142
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi039-A
AC   CVCL_YB31
SY   CS0809iCTR-LBCn7
DR   BioSamples; SAMEA6171402
DR   hPSCreg; EDi039-A
DR   Wikidata; Q93538147
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi040-A
AC   CVCL_YB32
SY   CS0908iCTR-LBCn3
DR   BioSamples; SAMEA6178157
DR   hPSCreg; EDi040-A
DR   Wikidata; Q93538151
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi041-A
AC   CVCL_YB33
SY   CS1031iCTR-LBCn6
DR   BioSamples; SAMEA6178623
DR   hPSCreg; EDi041-A
DR   Wikidata; Q93538155
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi042-A
AC   CVCL_YB34
SY   CS1034iCTR-LBCn3
DR   BioSamples; SAMEA6178624
DR   hPSCreg; EDi042-A
DR   Wikidata; Q93538158
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y4M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi043-A
AC   CVCL_YB35
SY   CS1050iCTR-LBCn3
DR   BioSamples; SAMEA6178625
DR   hPSCreg; EDi043-A
DR   Wikidata; Q93538164
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 5,7
ST   TPOX: 8
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y2M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi044-A
AC   CVCL_YB36
SY   CS1185iCTR-LBCn2
DR   BioSamples; SAMEA6178626
DR   hPSCreg; EDi044-A
DR   Wikidata; Q93538168
RX   PubMed=32450543;
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y8M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   EDi045-A
AC   CVCL_YB37
SY   CS1247iCTR-LBCn2
DR   BioSamples; SAMEA6178627
DR   hPSCreg; EDi045-A
DR   Wikidata; Q93538173
RX   PubMed=32450543;
RX   PubMed=36764301;
CC   Part of: Answer ALS consortium iPSC collection.
CC   Part of: Lothian Birth Cohort 1936 iPSC collection.
CC   From: Cedars-Sinai Medical Center iPSC Core Facility; Los Angeles; USA.
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cedars-Sinai
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y3M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   EDi046-A
AC   CVCL_C6PM
DR   BioSamples; SAMEA111436933
DR   hPSCreg; EDi046-A
DR   Wikidata; Q117704311
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   EDJ#22
AC   CVCL_C260
DR   ATCC; SCRC-1021
DR   CCRID; 3101MOUSCSP220
DR   Wikidata; Q54832013
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   Edmin337
AC   CVCL_8364
SY   Edmin 337; L-337
DR   Wikidata; Q54832015
CC   Caution: We are not certain that Edmin337 and L-337 are the same cell line.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Edom-iPS-#r-23
AC   CVCL_Y537
DR   SKIP; SKIP000410
DR   Wikidata; Q54832016
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   Edom-iPS-#r-5
AC   CVCL_Y536
DR   SKIP; SKIP000409
DR   Wikidata; Q54832017
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   Edom-iPS-#r30
AC   CVCL_Y538
DR   SKIP; SKIP000411
DR   Wikidata; Q54832018
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   Edom-iPS-#r35
AC   CVCL_Y539
DR   SKIP; SKIP000412
DR   Wikidata; Q54832019
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   Edom-iPS-#r49
AC   CVCL_Y540
DR   SKIP; SKIP000413
DR   Wikidata; Q54832020
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   Edom-iPS-#S-31
AC   CVCL_Y535
DR   SKIP; SKIP000408
DR   Wikidata; Q54832021
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   Edom-iPS-1
AC   CVCL_L431
SY   Edom-iPS-1(#k-1)
DR   GEO; GSM607987
DR   SKIP; SKIP000405
DR   Wikidata; Q54832022
RX   PubMed=21637780;
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 16
ST   D21S11: 30,31
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 9,11
ST   Penta E: 8,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   Edom-iPS-2
AC   CVCL_L432
SY   Edom-iPS-1(#k-2)
DR   GEO; GSM607988
DR   GEO; GSM607989
DR   GEO; GSM607990
DR   GEO; GSM608017
DR   GEO; GSM608018
DR   GEO; GSM608019
DR   SKIP; SKIP000406
DR   Wikidata; Q54832023
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 16
ST   D21S11: 30,31
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 9,11
ST   Penta E: 8,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   Edom-iPS-3
AC   CVCL_L433
SY   Edom-iPS-1(#k-3)
DR   GEO; GSM607991
DR   GEO; GSM608020
DR   SKIP; SKIP000407
DR   Wikidata; Q54832024
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 16
ST   D21S11: 30,31
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 9,11
ST   Penta E: 8,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L430 ! Edom22
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   Edom22
AC   CVCL_L430
DR   GEO; GSM607986
DR   GEO; GSM608016
DR   GEO; GSM1906542
DR   JCRB; JCRB1581
DR   Wikidata; Q54832025
RX   PubMed=21637780;
RX   PubMed=23631808;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Menstrual fluid; UBERON=UBERON_8480042.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1581; PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 16
ST   D21S11: 30,31
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 9,11
ST   Penta E: 8,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Somatic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   EDS 100
AC   CVCL_IM44
DR   CLO; CLO_0002884
DR   CLDB; cl1137
DR   Wikidata; Q54832026
CC   From: Departement Scienze Biomediche e Biotecnologie, Universita degli Studi di Brescia; Brescia; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   EDS 101
AC   CVCL_IM45
DR   CLO; CLO_0002885
DR   CLDB; cl1138
DR   Wikidata; Q54832032
CC   From: Departement Scienze Biomediche e Biotecnologie, Universita degli Studi di Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   EDS 105
AC   CVCL_IM46
DR   CLO; CLO_0002886
DR   CLDB; cl1139
DR   Wikidata; Q54832033
CC   From: Departement Scienze Biomediche e Biotecnologie, Universita degli Studi di Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   EE11
AC   CVCL_E5QI
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   EE39C
AC   CVCL_9978
SY   EE39c
DR   Cosmic; 902794
DR   Wikidata; Q54832034
RX   PubMed=1730573;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9979 ! EE39LN
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   EE39LN
AC   CVCL_9979
DR   Wikidata; Q54832035
RX   PubMed=1730573;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9978 ! EE39C
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   EE7
AC   CVCL_D6DS
DR   Wikidata; Q127380809
RX   PubMed=17466113;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Bovine milk alkaline phosphatase.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   EEB
AC   CVCL_8685
DR   CLO; CLO_0051023
DR   BioSample; SAMN03471963
DR   FANTOM5_SSTAR; 10835-111D7
DR   JCRB; JCRB1846
DR   RCB; RCB2345
DR   Wikidata; Q54832036
RX   PubMed=16332389;
CC   Population: Japanese.
CC   Doubling time: 38 hours (PubMed=16332389).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1846; RCB=RCB2345
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17 (RCB=RCB2345)
ST   vWA: 17 (JCRB=JCRB1846)
DI   NCIt; C8923; Acute erythroid leukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   EEC145T
AC   CVCL_0Q75
SY   EEC 145T
DR   Wikidata; Q54832037
RX   PubMed=10027626;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   EEC16
AC   CVCL_YZ61
SY   iEEC16
DR   GEO; GSM1663008
DR   GEO; GSM1663009
DR   GEO; GSM1663010
DR   GEO; GSM1663011
DR   GEO; GSM1663012
DR   GEO; GSM1663013
DR   GEO; GSM1663014
DR   GEO; GSM1663015
DR   Wikidata; Q98125939
RX   PubMed=24502583;
RX   PubMed=24972189;
RX   PubMed=25804953;
RX   PubMed=32106286;
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   EEC16-TERT-L
AC   CVCL_YZ62
SY   EEC16-TERT-Lentiviral
DR   Wikidata; Q98125944
RX   PubMed=24972189;
CC   Doubling time: 28.5 +- 9.8 days (PubMed=24972189).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=24972189
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 17,20
ST   D21S11: 29,31.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 10,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ61 ! EEC16
SX   Female
AG   34Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   EEC16-TERT-R
AC   CVCL_YZ63
SY   EEC16-TERT-Retroviral
DR   Wikidata; Q98125947
RX   PubMed=24972189;
CC   Doubling time: 30.7 +- 4.1 days (PubMed=24972189).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=24972189
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 17,20
ST   D21S11: 29,31.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 10,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ61 ! EEC16
SX   Female
AG   34Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   EEK
AC   CVCL_8346
SY   Embryonic Equine Kidney
DR   BioSample; SAMN03151865
DR   Wikidata; Q54832038
RX   PubMed=1321530;
RX   PubMed=14505435;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of horse origin but found to be a pig NSK derivative (PubMed=14505435; PubMed=20143388).
CC   From: Mumford, Jennifer Anne; Equine Virology Unit, Animal Health Trust; Newmarket; United Kingdom.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00192.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_8378 ! NSK
SX   Sex unspecified
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   EEL
AC   CVCL_8347
SY   Embryonic Equine Lung
DR   Wikidata; Q54832039
RX   PubMed=1321530;
RX   PubMed=2543748;
CC   Caution: Not certain if this is really a cell line or primary cells.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   EelB
AC   CVCL_AZ88
SY   eelB; Eel Brain; EelBrain
DR   Wikidata; Q54832040
RX   PubMed=24357037;
RX   PubMed=26714751;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=7938; ! Anguilla rostrata (American eel)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   Een217
AC   CVCL_X679
SY   Een 217
DR   BEI_Resources; ARP-755
DR   Wikidata; Q54832041
RX   PubMed=2969774;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9ND ! Een69
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 9
//
ID   Een69
AC   CVCL_A9ND
DR   Wikidata; Q108820183
RX   PubMed=2969774;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X679 ! Een217
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   eEnd.1
AC   CVCL_6273
DR   Wikidata; Q54832042
RX   PubMed=2736622;
RX   PubMed=3345558;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   eEnd.2
AC   CVCL_6274
DR   Wikidata; Q54832043
RX   PubMed=2379237;
RX   PubMed=2736622;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   EES-1
AC   CVCL_W468
DR   Cosmic; 1085909
DR   Wikidata; Q54832044
RX   PubMed=9738976;
RX   PubMed=12237927;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=9738976).
CC   Caution: Not to be confused with extraosseous Ewing sarcoma cell line EES1 (Cellosaurus=CVCL_T757).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   EES1
AC   CVCL_T757
DR   Wikidata; Q54832045
RX   PubMed=17077599;
CC   Population: Japanese.
CC   Characteristics: Established from a nude mouse xenograft (PubMed=17077599).
CC   Doubling time: 24 hours (PubMed=17077599).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=17077599).
CC   Caution: Not to be confused with Ewing sarcoma cell line EES-1 (Cellosaurus=CVCL_W468).
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
DI   NCIt; C7135; Extraskeletal Ewing sarcoma
DI   ORDO; Orphanet_370334; Extraskeletal Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 14
//
ID   EfB1-3
AC   CVCL_D3RM
DR   DSHB; mAb-EfB1-3
DR   Wikidata; Q127380810
RX   PubMed=16786562;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52796; Rat Efnb1 (Note=Also reacts with mouse, chicken and zebrafish. Also recognizes EphB2 and EPhb3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   EFC-1
AC   CVCL_AS06
SY   Efc-1
DR   Wikidata; Q54832046
RX   PubMed=2129226;
RX   PubMed=16244654;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   EFC-2
AC   CVCL_ZV49
DR   IARC_TP53; 22882
DR   Wikidata; Q98125951
RX   PubMed=2964515;
RX   PubMed=9070656;
RX   PubMed=9090379;
RX   PubMed=9230885;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=9090379).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   EFC007
AC   CVCL_9U91
DR   Wikidata; Q54832047
RX   PubMed=8639765;
RX   PubMed=9108096;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   EFE-184
AC   CVCL_1191
SY   EFE184
DR   CLO; CLO_0002887
DR   CLDB; cl1140
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470928
DR   BioSample; SAMN10987812
DR   cancercelllines; CVCL_1191
DR   Cell_Model_Passport; SIDM01502
DR   ChEMBL-Cells; CHEMBL3308103
DR   ChEMBL-Targets; CHEMBL1075438
DR   Cosmic; 924109
DR   Cosmic; 1576452
DR   Cosmic; 2030462
DR   DepMap; ACH-000435
DR   DSMZ; ACC-230
DR   DSMZCellDive; ACC-230
DR   GDSC; 924109
DR   GEO; GSM374971
DR   GEO; GSM375430
DR   GEO; GSM886997
DR   GEO; GSM888066
DR   IARC_TP53; 27153
DR   LiGeA; CCLE_747
DR   LINCS_LDP; LCL-1494
DR   PharmacoDB; EFE184_320_2019
DR   Progenetix; CVCL_1191
DR   PubChem_Cell_line; CVCL_1191
DR   Wikidata; Q54832048
RX   PubMed=20164919;
RX   PubMed=20944090;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 90 hours (PubMed=25984343); ~92 hours (DSMZ=ACC-230).
CC   HLA typing: A*01:01,03:01; B*08:01,51:01; C*01:02,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; None_reported; -; Zygosity=- (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (DepMap=ACH-000435).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.39%; Native American=0.31%; East Asian, North=1.81%; East Asian, South=0%; South Asian=0%; European, North=58.73%; European, South=38.76% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-230; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 12,18 (DSMZ=ACC-230)
ST   D18S51: 12,19 (PubMed=25877200)
ST   D19S433: 14
ST   D21S11: 30,33.2
ST   D2S1338: 18,20
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 21
ST   Penta D: 10,13 (PubMed=25877200)
ST   Penta D: 13 (DSMZ=ACC-230)
ST   Penta E: 16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   EFF
AC   CVCL_E7AV
SY   Epinephelus Fuscoguttatus Fin
RX   DOI=10.1007/s00343-024-4054-4;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 16 to 32 Celsius, the optimal temperature is 28 Celsius (DOI=10.1007/s00343-024-4054-4).
CC   Virology: Susceptible to infection by crustacean covert mortality nodavirus (CMNV) (DOI=10.1007/s00343-024-4054-4).
CC   Doubling time: 22.01 hours (Note=At 28 Celsius), 23.44 hours (Note=At 32 Celsius), 24.43 hours (Note=At 22 Celsius), 27.83 hours (Note=At 16 Celsius) (DOI=10.1007/s00343-024-4054-4).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=293821; ! Epinephelus fuscoguttatus (Brown-marbled grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   EFH-12
AC   CVCL_A3AY
DR   CCLV; CCLV-RIE 0170
DR   Wikidata; Q105506823
RX   PubMed=19941903;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   EFK
AC   CVCL_Y449
SY   Equine Fetal Kidney
DR   ATCC; CRL-6289
DR   Wikidata; Q54832049
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6289; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   Efk1B
AC   CVCL_C5B8
SY   Efk-1B; Efk3 clone 1B; Eptesicus fuscus kidney 1B
DR   Wikidata; Q116048928
RX   PubMed=27639955;
RX   PubMed=34737324;
CC   Group: Bat cell line.
CC   Transformant: Myotis polyomavirus large T-antigen (MyPVTag).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=29078; ! Eptesicus fuscus (Big brown bat)
OI   CVCL_C5B9 ! Efk2F
OI   CVCL_GZ34 ! Efk3B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Efk2F
AC   CVCL_C5B9
SY   Efk-2F; Efk3 clone 2F; Eptesicus fuscus kidney 2F
DR   Wikidata; Q116048929
RX   PubMed=27639955;
RX   PubMed=34737324;
CC   Group: Bat cell line.
CC   Transformant: Myotis polyomavirus large T-antigen (MyPVTag).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=29078; ! Eptesicus fuscus (Big brown bat)
OI   CVCL_C5B8 ! Efk1B
OI   CVCL_GZ34 ! Efk3B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Efk3B
AC   CVCL_GZ34
SY   EFK3B; Efk-3B; Efk3 clone 3B; Eptesicus fuscus kidney 3B
DR   ABM; T0827
DR   Kerafast; ESA001
DR   Wikidata; Q54832050
RX   PubMed=27639955;
RX   PubMed=32511316;
RX   PubMed=34737324;
CC   Group: Bat cell line.
CC   Virology: Can be used to cultivate viruses from the Coronaviridae, Filoviridae, Herpesviridae, Paramyxoviridae and Rhabdoviridae.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=32511316).
CC   Doubling time: 24 hours (Kerafast=ESA001).
CC   Transformant: Myotis polyomavirus large T-antigen (MyPVTag).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=29078; ! Eptesicus fuscus (Big brown bat)
OI   CVCL_C5B8 ! Efk1B
OI   CVCL_C5B9 ! Efk2F
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   EFM-19
AC   CVCL_0253
SY   EFM19
DR   BTO; BTO_0006447
DR   CLO; CLO_0002888
DR   EFO; EFO_0002175
DR   MCCL; MCC:0000144
DR   CLDB; cl1141
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 683
DR   BioSample; SAMN03471840
DR   BioSample; SAMN10988267
DR   cancercelllines; CVCL_0253
DR   Cell_Model_Passport; SIDM01056
DR   ChEMBL-Cells; CHEMBL3308502
DR   ChEMBL-Targets; CHEMBL1075439
DR   Cosmic; 906851
DR   Cosmic; 1603196
DR   Cosmic; 2165019
DR   Cosmic-CLP; 906851
DR   DepMap; ACH-000330
DR   DSMZ; ACC-231
DR   DSMZCellDive; ACC-231
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906851
DR   GEO; GSM344364
DR   GEO; GSM344414
DR   GEO; GSM350527
DR   GEO; GSM783976
DR   GEO; GSM843497
DR   GEO; GSM847250
DR   GEO; GSM847460
DR   GEO; GSM886999
DR   GEO; GSM888068
DR   GEO; GSM1172949
DR   GEO; GSM1669754
DR   IARC_TP53; 21321
DR   IGRhCellID; EFM19
DR   LiGeA; CCLE_105
DR   LINCS_HMS; 51113
DR   LINCS_LDP; LCL-1311
DR   PharmacoDB; EFM19_321_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0253
DR   PubChem_Cell_line; CVCL_0253
DR   SLKBase; 3411
DR   Wikidata; Q54832051
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=6589426;
RX   PubMed=10969801;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 81 hours (PubMed=25984343); ~50-60 hours (DSMZ=ACC-231); 51.18 hours (JWGray panel).
CC   HLA typing: A*29:02,33:03; B*35:01,44:04; C*03:02,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Homozygous (Cosmic-CLP=906851; DepMap=ACH-000330).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (Cosmic-CLP=906851; DepMap=ACH-000330).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.96%; Native American=0%; East Asian, North=3.54%; East Asian, South=0%; South Asian=0%; European, North=58.92%; European, South=35.58% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=906851; DSMZ=ACC-231; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 27,28 (DSMZ=ACC-231)
ST   D21S11: 28 (PubMed=25877200)
ST   D2S1338: 19,20
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 14
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   EFM-192A
AC   CVCL_1812
SY   EFM192A; EFM192
DR   CLO; CLO_0002889
DR   EFO; EFO_0006568
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471045
DR   BioSample; SAMN10988213
DR   cancercelllines; CVCL_1812
DR   Cell_Model_Passport; SIDM01002
DR   Cosmic; 1309000
DR   Cosmic; 1995391
DR   Cosmic; 2165004
DR   Cosmic-CLP; 1290798
DR   DepMap; ACH-000117
DR   DSMZ; ACC-258
DR   DSMZCellDive; ACC-258
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290798
DR   GEO; GSM274641
DR   GEO; GSM344365
DR   GEO; GSM344415
DR   GEO; GSM350532
DR   GEO; GSM843498
DR   GEO; GSM847316
DR   GEO; GSM847470
DR   GEO; GSM886998
DR   GEO; GSM888067
DR   GEO; GSM1172858
DR   GEO; GSM1172950
DR   GEO; GSM1421429
DR   GEO; GSM1669755
DR   IARC_TP53; 28290
DR   LiGeA; CCLE_198
DR   LINCS_HMS; 51114
DR   LINCS_LDP; LCL-1478
DR   PharmacoDB; EFM192A_322_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1812
DR   Wikidata; Q54832052
RX   PubMed=10969801;
RX   PubMed=19582160;
RX   PubMed=22460905;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~9 days (DSMZ=ACC-258); 80.21 hours (JWGray panel).
CC   HLA typing: A*01:01,24:02; B*07:02,39:01; C*07:02,12:03; DQB1*06:02,02:02; DRB1*15:01,09:10 (PubMed=25960936).
CC   HLA typing: A*01:01,24:02; B*07:02,39:01; C*07:02,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (Cosmic-CLP=1290798; DepMap=ACH-000117).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271fs*1 (c.807_808insT); Zygosity=Heterozygous (Cosmic-CLP=1290798; DepMap=ACH-000117).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.34%; Native American=0%; East Asian, North=2.91%; East Asian, South=0%; South Asian=0.06%; European, North=67.61%; European, South=29.07% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1290798; DSMZ=ACC-258; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,14
ST   D16S539: 8,13
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 9,15 (PubMed=25877200)
ST   D8S1179: 10 (DSMZ=ACC-258)
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 14,16
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1813 ! EFM-192B
OI   CVCL_1814 ! EFM-192C
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   EFM-192B
AC   CVCL_1813
SY   EFM192B
DR   CLO; CLO_0002890
DR   EFO; EFO_0006569
DR   ArrayExpress; E-MTAB-2706
DR   Cell_Model_Passport; SIDM01054
DR   DSMZ; ACC-308
DR   DSMZCellDive; ACC-308
DR   EGA; EGAS00001000610
DR   GEO; GSM1172859
DR   GEO; GSM1172951
DR   LINCS_HMS; 51115
DR   LINCS_LDP; LCL-1312
DR   PharmacoDB; EFM192B_323_2019
DR   Wikidata; Q54832053
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~4-5 days (DSMZ=ACC-308); 68.47 hours (JWGray panel).
CC   HLA typing: A*01:01,24:02; B*07:02,39:01; C*07:02,12:03; DQB1*06:02,02:02; DRB1*15:01,09:10 (PubMed=25960936).
CC   HLA typing: A*01:01,24:02; B*07:02,39:01; C*07:02,12:03 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-308
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,14
ST   D16S539: 8,13
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 17,25
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 14,16
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1812 ! EFM-192A
OI   CVCL_1814 ! EFM-192C
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   EFM-192C
AC   CVCL_1814
SY   EFM192C
DR   CLO; CLO_0002891
DR   EFO; EFO_0006570
DR   ArrayExpress; E-MTAB-2706
DR   Cell_Model_Passport; SIDM01053
DR   DSMZ; ACC-311
DR   DSMZCellDive; ACC-311
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM1172860
DR   GEO; GSM1172952
DR   LINCS_HMS; 51116
DR   LINCS_LDP; LCL-1479
DR   PharmacoDB; EFM192C_324_2019
DR   Wikidata; Q54832054
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~4 days (DSMZ=ACC-311); 40.64 hours (JWGray panel).
CC   HLA typing: A*01:01,24:02; B*07:02,39:01; C*07:02,12:03; DQB1*06:13,06:13; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*01:01,24:02; B*07:02,39:01; C*07:02,12:03 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-311
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,14
ST   D16S539: 8,13
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 17,25
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 10
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 14,16
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1812 ! EFM-192A
OI   CVCL_1813 ! EFM-192B
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   EFM-30
AC   CVCL_1B48
DR   Wikidata; Q54832055
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   EFM-36
AC   CVCL_1B49
DR   Wikidata; Q54832056
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   EFM-40
AC   CVCL_1B50
DR   Wikidata; Q54832057
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   EFM-49
AC   CVCL_1B51
DR   Wikidata; Q54832058
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   EFM-55
AC   CVCL_1B52
DR   Wikidata; Q54832059
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   EFM-56
AC   CVCL_1B53
DR   Wikidata; Q54832060
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   EFM-61
AC   CVCL_1B54
DR   Wikidata; Q54832061
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   EFM-63
AC   CVCL_W957
DR   Wikidata; Q54832062
RX   PubMed=6405069;
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C76328; Metastatic breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   EFM-76
AC   CVCL_1B55
DR   Wikidata; Q54832063
RX   PubMed=6589426;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   EfMS
AC   CVCL_E7AN
SY   Epinephelus fuscoguttatus Muscle Stem
RX   PubMed=39719457;
CC   Group: Fish cell line.
CC   Characteristics: Efficiently induced to myogenic differentiation or adipogenic trans-differentiation in both 2D and 3D culture systems (PubMed=39719457).
CC   Doubling time: ~26.67 hours (Note=In SCM-A medium), ~28.83 hours (Note=In SCM-B medium), ~33.19 hours (Note=In SCM-C medium), ~34.19 hours (Note=In SCM-D medium), ~43.02 hours (Note=In SCM-E medium) (PubMed=39719457).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Muscle satellite cell; CL=CL_0000594.
OX   NCBI_TaxID=293821; ! Epinephelus fuscoguttatus (Brown-marbled grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   EFN-R
AC   CVCL_0I48
SY   EFN
DR   CCLV; CCLV-RIE 0086
DR   Wikidata; Q54832064
RX   DOI=10.4236/jbise.2017.102004;
RX   PubMed=19941903;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   EFO-21
AC   CVCL_0029
SY   EFO 21; EFO21
DR   CLO; CLO_0002892
DR   CLDB; cl1142
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 682
DR   BioSample; SAMN03473384
DR   BioSample; SAMN10988346
DR   cancercelllines; CVCL_0029
DR   Cell_Model_Passport; SIDM01052
DR   ChEMBL-Cells; CHEMBL3308730
DR   ChEMBL-Targets; CHEMBL1075440
DR   Cosmic; 911905
DR   Cosmic; 1305325
DR   Cosmic; 1707571
DR   Cosmic-CLP; 911905
DR   DepMap; ACH-000308
DR   DSMZ; ACC-235
DR   DSMZCellDive; ACC-235
DR   EGA; EGAS00001000978
DR   GDSC; 911905
DR   GEO; GSM274698
DR   GEO; GSM659374
DR   GEO; GSM711716
DR   GEO; GSM887000
DR   GEO; GSM888069
DR   GEO; GSM1669756
DR   GEO; GSM7701397
DR   GEO; GSM7701398
DR   IARC_TP53; 21322
DR   LiGeA; CCLE_252
DR   LINCS_LDP; LCL-1515
DR   PharmacoDB; EFO21_325_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0029
DR   PubChem_Cell_line; CVCL_0029
DR   Wikidata; Q54832065
RX   PubMed=6405069;
RX   PubMed=12661003;
RX   PubMed=16957166;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=25984343); ~40-60 hours (DSMZ=ACC-235); 43.71 hours (JWGray panel).
CC   HLA typing: A*26:01,32:01; B*07:02,14:01; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Arg (c.370T>C); Zygosity=Homozygous (Cosmic-CLP=911905; DepMap=ACH-000308).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.88%; Native American=0%; East Asian, North=4.99%; East Asian, South=0%; South Asian=0%; European, North=61.52%; European, South=31.61% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=911905; DSMZ=ACC-235; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 15,18
ST   D19S433: 13,14
ST   D21S11: 31,32.2
ST   D2S1338: 23,24
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 11,12
ST   FGA: 19
ST   Penta D: 13,14
ST   Penta E: 16,19
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   EFO-21rCDDP2000
AC   CVCL_RT14
DR   Wikidata; Q54832066
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Arg (c.370T>C); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0029 ! EFO-21
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   EFO-27
AC   CVCL_1192
SY   EFO 27; EFO27
DR   BTO; BTO_0002033
DR   CLO; CLO_0002893
DR   EFO; EFO_0006571
DR   CLDB; cl1143
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 436
DR   BioSample; SAMN03473290
DR   BioSample; SAMN03473370
DR   BioSample; SAMN10988215
DR   cancercelllines; CVCL_1192
DR   Cell_Model_Passport; SIDM01051
DR   ChEMBL-Cells; CHEMBL3308134
DR   ChEMBL-Targets; CHEMBL1075441
DR   Cosmic; 906852
DR   Cosmic; 1305326
DR   Cosmic; 1707565
DR   Cosmic-CLP; 906852
DR   DepMap; ACH-000936
DR   DSMZ; ACC-191
DR   DSMZCellDive; ACC-191
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906852
DR   GEO; GSM659375
DR   GEO; GSM887001
DR   GEO; GSM888070
DR   GEO; GSM1340579
DR   GEO; GSM1669757
DR   IARC_TP53; 21323
DR   LiGeA; CCLE_238
DR   LINCS_LDP; LCL-1521
DR   PharmacoDB; EFO27_326_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1192
DR   PubChem_Cell_line; CVCL_1192
DR   Wikidata; Q54832067
RX   PubMed=3476184;
RX   PubMed=6405069;
RX   PubMed=12661003;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (PubMed=25984343); ~50-80 hours (DSMZ=ACC-191); 26.68 hours (JWGray panel).
CC   HLA typing: A*02:01,03:01; B*35:01,40:01; C*03:04,04:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=12661003; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (Cosmic-CLP=906852; DepMap=ACH-000936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (Cosmic-CLP=906852; DepMap=ACH-000936).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.18%; Native American=0%; East Asian, North=1.36%; East Asian, South=0%; South Asian=0%; European, North=70.88%; European, South=27.58% (PubMed=30894373).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): Cosmic-CLP=906852; DSMZ=ACC-191; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 9,10,13,14
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 27,30 (DSMZ=ACC-191; PubMed=25877200)
ST   D21S11: 27,30,31 (PubMed=30485824)
ST   D2S1338: 22,25
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13 (DSMZ=ACC-191)
ST   D8S1179: 13,15 (PubMed=25877200)
ST   FGA: 23,26
ST   Penta D: 9
ST   Penta E: 7,10
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 13,18
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   EFO-27rCDDP2000
AC   CVCL_RS28
DR   cancercelllines; CVCL_RS28
DR   Wikidata; Q54832068
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1192 ! EFO-27
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   EFO-3
AC   CVCL_D309
SY   EFO3
DR   Wikidata; Q54832069
RX   PubMed=6405069;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   EFO-47
AC   CVCL_D310
SY   EFO47
DR   Wikidata; Q54832070
RX   PubMed=6405069;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   eFOP1-1
AC   CVCL_W543
DR   SKIP; SKIP000346
DR   Wikidata; Q54832071
RX   PubMed=24321451;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   eFOP1-10
AC   CVCL_W544
DR   SKIP; SKIP000347
DR   Wikidata; Q54832074
RX   PubMed=24321451;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Misspelling: eFOP1-11; Note=In Cellosaurus releases 9 to 24.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   eFOP2-3
AC   CVCL_W545
DR   SKIP; SKIP000337
DR   Wikidata; Q54832075
RX   PubMed=24321451;
CC   Population: African American.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W542 ! GM00783
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   eFOP2-8
AC   CVCL_W546
DR   SKIP; SKIP000344
DR   Wikidata; Q54832076
RX   PubMed=24321451;
CC   Population: African American.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W542 ! GM00783
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   eFOP3-2
AC   CVCL_W547
DR   SKIP; SKIP000342
DR   Wikidata; Q54832077
RX   PubMed=24321451;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W548 ! eFOP3-4
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   eFOP3-4
AC   CVCL_W548
DR   SKIP; SKIP000343
DR   Wikidata; Q54832078
RX   PubMed=24321451;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W547 ! eFOP3-2
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   efrnB1
AC   CVCL_D3RN
DR   DSHB; mAb-efrnB1
DR   Wikidata; Q127380811
RX   PubMed=16786562;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P52795; Mouse Efnb1.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   EG [Human HTLV-1 transformed]
AC   CVCL_ZD47
DR   Wikidata; Q98125953
RX   PubMed=8105609;
RX   PubMed=12920029;
CC   Population: Caribbean; Jamaican.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   EG [Human ovarian carcinoma]
AC   CVCL_A5PV
DR   IARC_TP53; 5552
DR   Wikidata; Q107114857
RX   PubMed=8557231;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143fs (c.427_458del32); Zygosity=Unspecified (PubMed=8557231).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   EG1C4B1
AC   CVCL_F1DB
SY   E.1
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Schistosoma mansoni cercariae/schistosomula surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EG2H5A9
AC   CVCL_F1DC
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Schistosoma mansoni egg/larvae surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EG564C7
AC   CVCL_F1DD
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Schistosoma mansoni egg/larvae surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EG5H1
AC   CVCL_F1DE
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Schistosoma mansoni egg/larvae surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EG6
AC   CVCL_E9ZS
SY   EG6-H6
DR   ABCD; ABCD_BF018
RX   PubMed=32302507;
RX   PubMed=32579494;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_156221; 1,3-bis(6-isocyanatohexyl)-1,3-diazetidine-2,4-dione (Hexamethylene diisocyanate (HDI) uretdione) (Note=Also reacts with monomer hexamethylene diisocyanate and isocyanurate homopolymer (biuret)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   EG.Lu
AC   CVCL_S390
DR   ATCC; CRL-6560
DR   Wikidata; Q54832079
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6560; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9764; ! Eschrichtius robustus (California gray whale)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   EGC/PK060399egfr
AC   CVCL_8856
DR   CLO; CLO_0002894
DR   ATCC; CRL-2690
DR   Wikidata; Q54832080
RX   PubMed=11169131;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/egc/egccells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells
CC   Transformant: egfr-neu chimer.
CC   Derived from site: In situ; Small intestine, jejunum, myenteric nerve plexus; UBERON=UBERON_0002439.
CC   Cell type: Enteric glial cell; CL=CL_4040002.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   EGC/PK240899egfr
AC   CVCL_0E01
DR   ATCC; CRL-2621
DR   Wikidata; Q54832081
RX   PubMed=11169131;
CC   Transformant: egfr-neu chimer.
CC   Discontinued: ATCC; CRL-2621; true.
CC   Derived from site: In situ; Small intestine, jejunum, myenteric nerve plexus; UBERON=UBERON_0002439.
CC   Cell type: Enteric glial cell; CL=CL_4040002.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   EGE-R
AC   CVCL_0I52
SY   EGE
DR   CCLV; CCLV-RIE 0271
DR   Wikidata; Q54832082
RX   PubMed=19941903;
CC   Group: Bird cell line.
OX   NCBI_TaxID=34924; ! Pica pica (Eurasian magpie)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   EGFP-CEM-NKr
AC   CVCL_1G54
SY   EGFP-CEMNKR; EGFP-CEMNKr
DR   BEI_Resources; ARP-11698
DR   cancercelllines; CVCL_1G54
DR   Wikidata; Q54832083
RX   PubMed=16884734;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X622 ! CEM.NKR
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   EGFP-K562
AC   CVCL_1G55
DR   BEI_Resources; ARP-11699
DR   Wikidata; Q54832084
RX   PubMed=12505723;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   EGFR-T17
AC   CVCL_6D48
SY   EGFR T17; EGFRT17; NIH EGFR-T17
DR   CLO; CLO_0008170
DR   EFO; EFO_0022732
DR   CLDB; cl3699
DR   Wikidata; Q54832086
RX   PubMed=1550855;
RX   PubMed=3500513;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   EGG
AC   CVCL_5739
DR   CLS; 400171
DR   Wikidata; Q54832087
CC   Breed/subspecies: DBA.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   EGI-1
AC   CVCL_1193
SY   Egi-1; EGI1
DR   CLO; CLO_0002895
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 863
DR   BioSample; SAMN03473571
DR   cancercelllines; CVCL_1193
DR   Cell_Model_Passport; SIDM01050
DR   ChEMBL-Cells; CHEMBL3308731
DR   ChEMBL-Targets; CHEMBL1075442
DR   Cosmic; 906853
DR   Cosmic; 927186
DR   Cosmic; 1373548
DR   Cosmic; 2674064
DR   Cosmic-CLP; 906853
DR   DepMap; ACH-001494
DR   DSMZ; ACC-385
DR   DSMZCellDive; ACC-385
DR   EGA; EGAS00001000978
DR   GDSC; 906853
DR   GEO; GSM1669758
DR   IARC_TP53; 21324
DR   LINCS_LDP; LCL-1787
DR   PharmacoDB; EGI1_327_2019
DR   PubChem_Cell_line; CVCL_1193
DR   Wikidata; Q54832088
RX   CelloPub=CLPUB00275;
RX   PubMed=20164919;
RX   PubMed=26956050;
RX   PubMed=27231123;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=32899426;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: >45 hours (DSMZ=ACC-385).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=906853; DepMap=ACH-001494).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (Cosmic-CLP=906853; DepMap=ACH-001494).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.79%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=77.61%; European, South=21.59% (PubMed=30894373).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): Cosmic-CLP=906853; DepMap=ACH-001494; DSMZ=ACC-385
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12,13 (DepMap=ACH-001494)
ST   D16S539: 12,13 (Cosmic-CLP=906853; DSMZ=ACC-385)
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 28,33.2
ST   D2S1338: 19,24
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 9,13
ST   D8S1179: 11,16
ST   FGA: 20,24,25
ST   Penta D: 7,9
ST   Penta E: 5,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18,19 (DepMap=ACH-001494)
ST   vWA: 17,19 (Cosmic-CLP=906853; DSMZ=ACC-385)
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   EGPE
AC   CVCL_VF92
SY   Echinococcus Granulosus ProtoscolEsces
DR   Wikidata; Q54832089
RX   PubMed=20844980;
OX   NCBI_TaxID=6210; ! Echinococcus granulosus (Hydatid tapeworm)
SX   Sex unspecified
AG   Protoscolex stage
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   EGR-101
AC   CVCL_0J01
DR   RCB; AES0184
DR   SKIP; SKIP002928
DR   Wikidata; Q54832090
RX   PubMed=22826106;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   EGR-G101
AC   CVCL_0J00
DR   RCB; AES0182
DR   SKIP; SKIP002927
DR   Wikidata; Q54832091
RX   PubMed=22826106;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6NCr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   EGV-10T
AC   CVCL_5U38
SY   EGV10T; EGV 10T; EGV10-T; Enhanced Growth Variant-10 Tumorigenic
DR   Wikidata; Q54832092
RX   PubMed=1971176;
RX   PubMed=3319569;
RX   PubMed=3470760;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   EGV-3T
AC   CVCL_5U39
SY   EGV3T; EGV 3T; EGV3-T; Enhanced Growth Variant-3 Tumorigenic
DR   Wikidata; Q54832093
RX   PubMed=1971176;
RX   PubMed=3319569;
RX   PubMed=3470760;
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   EGV-4T
AC   CVCL_5500
SY   EGV4T; EGV 4T; EGV4-T; Enhanced Growth Variant-4 Tumorigenic
DR   JCRB; JCRB0229
DR   Wikidata; Q54832094
RX   PubMed=3319569;
RX   PubMed=3470760;
CC   Doubling time: ~37 hours (Note=Lot 03222005) (JCRB=JCRB0229).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   EGV-5T
AC   CVCL_5U40
SY   EGV5T; EGV 5T; EGV5-T; Enhanced Growth Variant-5 Tumorigenic
DR   Wikidata; Q54832095
RX   PubMed=1971176;
RX   PubMed=3319569;
RX   PubMed=3470760;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   EGV-6T
AC   CVCL_5U41
SY   EGV6T; EGV 6T; EGV6-T; Enhanced Growth Variant-6 Tumorigenic
DR   Wikidata; Q54832097
RX   PubMed=1971176;
RX   PubMed=3319569;
RX   PubMed=3470760;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   EH
AC   CVCL_L804
DR   BioSample; SAMN03151773
DR   Cosmic; 1809509
DR   Wikidata; Q54832098
RX   PubMed=2827813;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HK derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a separate patient (68 year old female) than HK (male).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00193.
CC   Doubling time: 24 hours (PubMed=2827813).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L805 ! HK
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   EH-118MG
AC   CVCL_T447
AS   CVCL_S097
SY   EH118MG; 118 MG-EH; KC; KC-R; KC RAND
DR   ATCC; CRL-7719
DR   cancercelllines; CVCL_T447
DR   Wikidata; Q54832099
RX   PubMed=4312117;
RX   PubMed=4313504;
RX   PubMed=4337530;
RX   PubMed=4343952;
RX   PubMed=4351391;
RX   PubMed=6500159;
CC   Problematic cell line: Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Strain Engelbreth-Holm; RSV-EH).
CC   Discontinued: ATCC; CRL-7719; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0633 ! U-118MG
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   EH-A2
AC   CVCL_C8CR
SY   EHime Adenocarcinoma 2
DR   Wikidata; Q123031228
RX   PubMed=21607393;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   EH-A8
AC   CVCL_C8CS
SY   EHime Adenocarcinoma 8
DR   Wikidata; Q123031229
RX   PubMed=21607393;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   EH-A9
AC   CVCL_C8CT
SY   EHime Adenocarcinoma 9
DR   Wikidata; Q123031230
RX   PubMed=21607393;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   EH-GB1
AC   CVCL_IU73
SY   Eastern Hepatobiliary surgery hospital-GallBladder cancer 1
DR   Wikidata; Q54832100
RX   PubMed=20403235;
CC   Population: Chinese.
CC   Doubling time: 24 hours (PubMed=20403235).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   EH-GB2
AC   CVCL_6899
SY   Eastern Hepatobiliary surgery hospital-GallBladder cancer 2
DR   cancercelllines; CVCL_6899
DR   Wikidata; Q54832101
RX   PubMed=22134783;
CC   Population: Chinese.
CC   Doubling time: ~48 hours (PubMed=22134783).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   EH/A44
AC   CVCL_H578
DR   CLO; CLO_0002896
DR   CLDB; cl1145
DR   Wikidata; Q54832102
RX   PubMed=208448;
RX   PubMed=214606;
CC   Transformant: NCBI_TaxID; 10298; Human herpesvirus 1 (HHV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_H576 ! EHT
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   EH11
AC   CVCL_ZE30
DR   Wikidata; Q98125957
RX   PubMed=20977447;
CC   Sequence variation: Mutation; HGNC; HGNC:6412; KRT1; Simple; p.Val176_Lys197del (c.591+1G>C); ClinVar=VCV000066656; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=20977447).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C62569; Epidermolytic ichthyosis
DI   ORDO; Orphanet_312; Autosomal dominant epidermolytic ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   EH17a
AC   CVCL_J896
DR   CLO; CLO_0002897
DR   ATCC; CRL-2209
DR   BCRC; 60538
DR   Wikidata; Q54832103
RX   PubMed=1707872;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04083; Human ANXA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   EH21
AC   CVCL_ZE31
DR   Wikidata; Q98125959
RX   PubMed=20977447;
CC   Sequence variation: Mutation; HGNC; HGNC:6413; KRT10; Simple; p.Arg156Gly (c.466C>G); ClinVar=VCV000066969; Zygosity=Heterozygous (PubMed=20977447).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C62569; Epidermolytic ichthyosis
DI   ORDO; Orphanet_312; Autosomal dominant epidermolytic ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   EH31
AC   CVCL_ZE32
DR   Wikidata; Q98125960
RX   PubMed=20977447;
CC   Sequence variation: Mutation; HGNC; HGNC:6413; KRT10; Simple; p.Leu161_Asp162del (c.481_486delTTGGAC); ClinVar=VCV000066179; Zygosity=Heterozygous (PubMed=20977447).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C62569; Epidermolytic ichthyosis
DI   ORDO; Orphanet_312; Autosomal dominant epidermolytic ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   EH34A3
AC   CVCL_Z865
DR   DGRC; 7
DR   FlyBase_Cell_line; FBtc0000007
DR   Wikidata; Q54832104
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=6825955;
CC   Group: Insect cell line.
CC   Doubling time: 26-58 hours (Note=Depending on growth medium) (DGRC=7).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   EH7a
AC   CVCL_J897
DR   CLO; CLO_0002898
DR   ATCC; CRL-2194
DR   BCRC; 60537
DR   Wikidata; Q54832105
RX   PubMed=1707872;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   eHAP A11
AC   CVCL_5J32
SY   eHAPA11; Engineered-HAPloid clone A11
DR   cancercelllines; CVCL_5J32
DR   Wikidata; Q54832106
RX   PubMed=25373145;
CC   Group: Haploid karyotype cell line.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   eHAP E9
AC   CVCL_5J33
SY   eHAPE9; eHAP; Engineered-HAPloid clone E9
DR   cancercelllines; CVCL_5J33
DR   Horizon_Discovery; C669
DR   Wikidata; Q54832107
RX   PubMed=25373145;
RX   PubMed=31962144;
CC   Group: Haploid karyotype cell line.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   EHBC-512
AC   CVCL_WI70
DR   CCRID; 4201PAT-CCTCC00279
DR   Wikidata; Q93539204
RX   DOI=10.3724/SP.J.1008.2009.01115;
RX   Patent=CN101824397B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200911.
CC   Population: Chinese.
CC   Doubling time: 48 hours (DOI=10.3724/SP.J.1008.2009.01115).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 9
//
ID   EHC4
AC   CVCL_A1KX
DR   Wikidata; Q102113785
RX   PubMed=8652393;
CC   Karyotypic information: 47,XY,t(14;18)(q32;q21),+12 (PubMed=8652393).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Leu).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EHD E2C5
AC   CVCL_B3R7
DR   CCRID; 4201PAT-CCTCC01938
DR   Wikidata; Q110432792
RX   Patent=CN113528457B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021180.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Epizootic hemorrhagic disease virus 2 (EHDV-2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   EHEB
AC   CVCL_1194
DR   BTO; BTO_0003276
DR   CLO; CLO_0002899
DR   CLDB; cl1146
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473424
DR   BioSample; SAMN10988486
DR   cancercelllines; CVCL_1194
DR   Cell_Model_Passport; SIDM01049
DR   ChEMBL-Cells; CHEMBL3308163
DR   ChEMBL-Targets; CHEMBL2366258
DR   Cosmic; 906854
DR   Cosmic-CLP; 906854
DR   DepMap; ACH-000038
DR   DSMZ; ACC-67
DR   DSMZCellDive; ACC-67
DR   EGA; EGAS00001000978
DR   GDSC; 906854
DR   GEO; GSM887002
DR   GEO; GSM888071
DR   GEO; GSM1374472
DR   GEO; GSM1669759
DR   IARC_TP53; 21325
DR   LiGeA; CCLE_701
DR   LINCS_LDP; LCL-1085
DR   NCBI_Iran; C494
DR   PharmacoDB; EHEB_328_2019
DR   Progenetix; CVCL_1194
DR   PubChem_Cell_line; CVCL_1194
DR   Wikidata; Q54832108
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2159091;
RX   PubMed=11705877;
RX   PubMed=12592342;
RX   PubMed=20164919;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=23297799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Probably misclassified. Originally thought to be a leukemia cell line but is probably a B-lymphoblastoid cell line (PubMed=12592342).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~50-70 hours (DSMZ=ACC-67).
CC   HLA typing: A*02:01,02:01; B*15:01,27:05; C*01:02,03:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.03%; East Asian, North=0%; East Asian, South=0%; South Asian=1.9%; European, North=69.25%; European, South=27.82% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=906854; DSMZ=ACC-67
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 12,14
ST   D19S433: 13
ST   D21S11: 30.2,31.2
ST   D2S1338: 23,25
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 9,15
ST   Penta E: 5,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   ehiPSC
AC   CVCL_WN89
SY   episomal vector-derived human iPSC
DR   Wikidata; Q93539226
RX   PubMed=31173371;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 4
//
ID   ehiPSC-derived pNSCs
AC   CVCL_WN94
SY   pNSCs; primitive Neural Stem Cells
DR   Wikidata; Q93539228
RX   PubMed=31173371;
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN89 ! ehiPSC
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 6
//
ID   EHM
AC   CVCL_E578
DR   dbMHC; 48773
DR   ECACC; 88052079
DR   IHW; IHW09080
DR   IPD-IMGT/HLA; 11630
DR   Wikidata; Q54832109
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; German.
CC   HLA typing: A*03:01:01:01; B*35:01:01:02,35:03:01:01; C*04:01:01:01; DPA1*01; DPB1*04:01:01,04:02:01; DQA1*01:01; DQB1*05:01:01; DRA*01:01; DRB1*01:01:01; DRB6*01 (IPD-IMGT/HLA=11630).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   EHMES-1
AC   CVCL_M207
SY   EH-Mes-1; EHime MESothelioma-1
DR   Wikidata; Q54832110
RX   CelloPub=CLPUB00241;
RX   PubMed=21607393;
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   EHMES-10
AC   CVCL_M208
SY   EH-Mes-10; EHime MESothelioma-10
DR   Wikidata; Q54832111
RX   CelloPub=CLPUB00241;
RX   PubMed=16542214;
RX   PubMed=21607393;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=16542214).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   EHRA-BL-41
AC   CVCL_C5V8
DR   Wikidata; Q116048930
RX   PubMed=2645221;
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (PubMed=3037521).
CC   HLA typing: A*32; B*35,49 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   EHRB-BL-41
AC   CVCL_C5V9
DR   Wikidata; Q116048931
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (PubMed=3037521).
CC   HLA typing: A*32; B*35,49 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   Ehrlich-Lettre ascites strain E
AC   CVCL_3873
SY   Ehrlich-Lettre; Ehrlich Lettre; E-La; EAT; EAT strain E; Ehrlich ascites; Ehrlich
DR   BTO; BTO_0001920
DR   CLO; CLO_0002900
DR   CLO; CLO_0050165
DR   CLDB; cl1148
DR   ATCC; CCL-77
DR   ChEMBL-Cells; CHEMBL3307669
DR   ChEMBL-Targets; CHEMBL614641
DR   CLS; 400169
DR   ECACC; 87032503
DR   JCRB; JCRB9090
DR   KCLB; 10077
DR   PubChem_Cell_line; CVCL_3873
DR   RCB; RCB0142
DR   TKG; TKG 0147
DR   Wikidata; Q54832112
RX   PubMed=5829538;
RX   PubMed=13709454;
RX   PubMed=25277546;
WW   Info; -; -; https://web.archive.org/web/20240304160904/http://what-when-how.com/molecular-biology/ehrlich-cells-molecular-biology/
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CCL-77; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5299 ! JTC-11
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   EHS
AC   CVCL_3506
SY   Englebreth-Holm-Swarm
DR   CLO; CLO_0002901
DR   ATCC; CRL-2108
DR   JCRB; IFO50268
DR   Wikidata; Q54832114
CC   Discontinued: ATCC; CRL-2108; true.
CC   Breed/subspecies: ST/Eh.
DI   NCIt; C24018; Mouse chondrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0J39 ! BAM [Mouse chondrosarcoma]
OI   CVCL_0J38 ! EHSPEL
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   EHSPEL
AC   CVCL_0J38
SY   EHS parietal Endoderm-Like
DR   Wikidata; Q54832115
RX   PubMed=15172037;
CC   Breed/subspecies: ST/Eh.
DI   NCIt; C24018; Mouse chondrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0J39 ! BAM [Mouse chondrosarcoma]
OI   CVCL_3506 ! EHS
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   EHT
AC   CVCL_H576
DR   CLO; CLO_0002902
DR   CLDB; cl1150
DR   Wikidata; Q54832150
RX   PubMed=208448;
RX   PubMed=214606;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_H578 ! EH/A44
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   EHT C10
AC   CVCL_C0X5
DR   Wikidata; Q114311360
RX   PubMed=214606;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_H576 ! EHT
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   EHTJUi001-A
AC   CVCL_YT18
SY   DF-GMP-ZB11AP-I
DR   BioSamples; SAMEA6703334
DR   hPSCreg; EHTJUi001-A
DR   Wikidata; Q93539309
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   EHTJUi002-A
AC   CVCL_YT19
SY   DF-GMP-ZB11AR-H
DR   BioSamples; SAMEA6703336
DR   hPSCreg; EHTJUi002-A
DR   Wikidata; Q93539315
RX   PubMed=32889247;
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4042; FZD4; Simple; p.Trp226Ter (c.678G>A); ClinVar=VCV000940196; Zygosity=Heterozygous (PubMed=32889247).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C175048; Exudative vitreoretinopathy 1
DI   ORDO; Orphanet_891; Familial exudative vitreoretinopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   EHTJUi003-A
AC   CVCL_A5EW
SY   DF-GMP-ZB12AD-H
DR   BioSamples; SAMEA7829861
DR   hPSCreg; EHTJUi003-A
DR   Wikidata; Q107114858
RX   PubMed=34087980;
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Leu460Trpfs*6 (c.1377delC); ClinVar=VCV000188548; Zygosity=Heterozygous (PubMed=34087980).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   EHTJUi004-A
AC   CVCL_A8KR
SY   DF-GMP-ZB12AN-I
DR   BioSamples; SAMEA8394198
DR   hPSCreg; EHTJUi004-A
DR   Wikidata; Q108820184
RX   PubMed=34087998;
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Leu1563Glufs*63 (c.4687_4688delCT) (c.4683_4684delCT); ClinVar=VCV001072470; Zygosity=Heterozygous (PubMed=34087998).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   EHTJUi005-A
AC   CVCL_A8KS
SY   DF-GMP-ZB11AL-D; DFGMP-ZB11AL-D
DR   BioSamples; SAMEA8883194
DR   hPSCreg; EHTJUi005-A
DR   Wikidata; Q108820185
RX   PubMed=34464854;
RX   PubMed=34507144;
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   EHTJUi005-A-1
AC   CVCL_B0JM
SY   ZB11ALD-S16-5
DR   BioSamples; SAMEA8904410
DR   hPSCreg; EHTJUi005-A-1
DR   Wikidata; Q108820186
RX   PubMed=34464854;
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8KS ! EHTJUi005-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   EHTJUi005-A-3
AC   CVCL_B0JN
SY   ZB11ALD-L4
DR   BioSamples; SAMEA8904409
DR   hPSCreg; EHTJUi005-A-3
DR   Wikidata; Q108820187
RX   PubMed=34507144;
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8KS ! EHTJUi005-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   EHTJUi006-A
AC   CVCL_D0ET
SY   DFGMP-ZB11AN-B
DR   BioSamples; SAMEA114305984
DR   hPSCreg; EHTJUi006-A
DR   Wikidata; Q123031231
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   EHTJUi007-A
AC   CVCL_D0EU
SY   DFGMP-ZB11AO-F
DR   BioSamples; SAMEA114305986
DR   hPSCreg; EHTJUi007-A
DR   Wikidata; Q123031232
CC   From: East Hospital Affiliated to Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   EI
AC   CVCL_F958
DR   TKG; TKG 0693
DR   Wikidata; Q54832152
RX   PubMed=7669752;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 50.5 hours (PubMed=7669752).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): TKG=TKG 0693
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12,13,14
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10,11,12
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 14,21
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   Ei 151
AC   CVCL_B7PQ
DR   Wikidata; Q112929531
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PM ! Ei 26
OI   CVCL_B7PN ! Ei 39
OI   CVCL_B7PP ! Ei 81
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   Ei 26
AC   CVCL_B7PM
DR   Wikidata; Q112929532
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PN ! Ei 39
OI   CVCL_B7PP ! Ei 81
OI   CVCL_B7PQ ! Ei 151
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   Ei 39
AC   CVCL_B7PN
DR   Wikidata; Q112929533
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PM ! Ei 26
OI   CVCL_B7PP ! Ei 81
OI   CVCL_B7PQ ! Ei 151
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   Ei 81
AC   CVCL_B7PP
DR   Wikidata; Q112929534
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PM ! Ei 26
OI   CVCL_B7PN ! Ei 39
OI   CVCL_B7PQ ! Ei 151
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   EIAV 12E8.1
AC   CVCL_4519
SY   12E8.1
DR   CLO; CLO_0002903
DR   CLDB; cl5186
DR   ATCC; HB-8917
DR   IZSLER; BS Hy 46
DR   Wikidata; Q54832154
RX   Patent=US4806467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8917.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P69732; Equine infectious anemia virus (strain Wyoming) gag (Note=AA 125-354 = p26).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   EidheAEC.B-3
AC   CVCL_QW40
SY   Eidolon helvum Airway Epithelial Cells B subclone 3
DR   Wikidata; Q54832156
RX   PubMed=24454736;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Age of donor from personal communication of Eckerle, Isabella.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 5
//
ID   EidLu/20
AC   CVCL_RX11
DR   Wikidata; Q54832157
RX   PubMed=26698106;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   EidLu/43
AC   CVCL_RX50
SY   EidLu-43
DR   Wikidata; Q54832159
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   EidNi/41
AC   CVCL_RX45
SY   EidNi-41
DR   Wikidata; Q54832160
RX   CelloPub=CLPUB00422;
RX   PubMed=22140523;
RX   PubMed=25100832;
RX   PubMed=25741010;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   EidNi/41.1
AC   CVCL_RX12
DR   Wikidata; Q54832162
RX   PubMed=22140523;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
HI   CVCL_RX45 ! EidNi/41
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   EidNi/41.2
AC   CVCL_RX13
DR   Wikidata; Q54832164
RX   PubMed=22140523;
RX   PubMed=26698106;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
HI   CVCL_RX45 ! EidNi/41
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   EidNi/41.3
AC   CVCL_RX14
DR   Wikidata; Q54832165
RX   PubMed=22140523;
RX   PubMed=26698106;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
HI   CVCL_RX45 ! EidNi/41
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   eIF2ak(4KO)
AC   CVCL_A7BH
SY   Eif2ak 4KO MEF
DR   RCB; RCB4718
DR   Wikidata; Q107114859
RX   PubMed=27633668;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7BM ! WT(MEF) SV40-immortalized
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   eIF2ak(4KO+GCN2)
AC   CVCL_A7BL
SY   Eif2ak 4KO MEF mGCN2-FLAG
DR   RCB; RCB4722
DR   Wikidata; Q107114860
RX   PubMed=27633668;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1353427; Eif2ak4 (Note=With a FLAG tag).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7BH ! eIF2ak(4KO)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   eIF2ak(4KO+HRI)
AC   CVCL_A7BI
SY   Eif2ak 4KO MEF mHRI-FLAG
DR   RCB; RCB4719
DR   Wikidata; Q107114861
RX   PubMed=27633668;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1353448; Eif2ak1 (Note=With a FLAG tag).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7BH ! eIF2ak(4KO)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   eIF2ak(4KO+PERK)
AC   CVCL_A7BJ
SY   Eif2ak 4KO MEF mPERK-FLAG
DR   RCB; RCB4720
DR   Wikidata; Q107114873
RX   PubMed=27633668;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1353449; Eif2ak2 (Note=With a FLAG tag).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7BH ! eIF2ak(4KO)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   eIF2ak(4KO+PKR)
AC   CVCL_A7BK
SY   Eif2ak 4KO MEF mPKR-FLAG
DR   RCB; RCB4721
DR   Wikidata; Q107114874
RX   PubMed=27633668;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1341830; Eif2ak3 (Note=With a FLAG tag).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7BH ! eIF2ak(4KO)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   EIFIIIi001-A
AC   CVCL_E3UP
SY   HA
DR   BioSamples; SAMEA116117950
DR   hPSCreg; EIFIIIi001-A
CC   From: EIF3F research foundation; Krakow; Poland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   EIFIIIi002-A
AC   CVCL_E3UQ
SY   KR
DR   hPSCreg; EIFIIIi002-A
CC   From: EIF3F research foundation; Krakow; Poland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   EIIL
AC   CVCL_W441
DR   cancercelllines; CVCL_W441
DR   Wikidata; Q54832166
RX   PubMed=7699285;
RX   PubMed=8718550;
RX   PubMed=10381137;
CC   Population: Japanese.
CC   Characteristics: Estrogen-independent (PubMed=7699285).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   EJ [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC18
DR   Wikidata; Q98125961
RX   PubMed=16099873;
RX   PubMed=20889926;
RX   PubMed=29416618;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   EJ [Human endometrial adenocarcinoma]
AC   CVCL_7039
DR   TKG; TKG 0664
DR   Wikidata; Q54832167
RX   PubMed=12889855;
CC   Population: Japanese.
CC   Doubling time: 16 hours (PubMed=12889855).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): TKG=TKG 0664
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D5S818: 11,14
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   EJ-1
AC   CVCL_2893
SY   EJ1
DR   BTO; BTO_0003639
DR   BioSample; SAMN03151938
DR   cancercelllines; CVCL_2893
DR   JCRB; JCRB0710
DR   RCB; RCB2137
DR   TKG; TKG 0441
DR   Wikidata; Q54832168
RX   DOI=10.11418/jtca1981.18.4_329;
RX   PubMed=9290701;
RX   PubMed=11416159;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (DOI=10.11418/jtca1981.18.4_329; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00194.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: RCB; RCB2137; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): JCRB=JCRB0710; PubMed=11416159; TKG=TKG 0441
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 16,18
ST   D21S11: 29
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 17,22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   EJ-28
AC   CVCL_5983
SY   EJ/28; EJ28
DR   CLS; 300172
DR   Wikidata; Q54832169
RX   PubMed=7490993;
RX   PubMed=11207054;
RX   PubMed=12127398;
RX   PubMed=29732388;
CC   Discontinued: CLS; 300172; true.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   EJ-30
AC   CVCL_LN34
SY   EJ30
DR   cancercelllines; CVCL_LN34
DR   Wikidata; Q54832170
RX   PubMed=9419347;
RX   PubMed=10453083;
CC   Problematic cell line: Contaminated. Parent cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2443 ! Ej138
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   EJ-30 clone A3
AC   CVCL_LN35
SY   A3
DR   cancercelllines; CVCL_LN35
DR   Wikidata; Q54832171
RX   PubMed=11228547;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN34 ! EJ-30
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 15
//
ID   EJ-30 clone B3
AC   CVCL_LN36
SY   B3
DR   cancercelllines; CVCL_LN36
DR   Wikidata; Q54832172
RX   PubMed=11228547;
RX   PubMed=12827497;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN34 ! EJ-30
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 15
//
ID   EJ-30 clone B3-WrnDN1
AC   CVCL_LN37
SY   B3-WrnDN1
DR   cancercelllines; CVCL_LN37
DR   Wikidata; Q54832173
RX   PubMed=12827497;
CC   Problematic cell line: Contaminated. Ancestral cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Characteristics: Expresses WRN p.Lys577Met under the control of a tetracycline-inducible promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12791; WRN (Note=With p.Lys577Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN36 ! EJ-30 clone B3
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 15
//
ID   EJ-30tgr
AC   CVCL_F666
SY   EJ30tgr; GM16260
DR   CLO; CLO_0019447
DR   cancercelllines; CVCL_F666
DR   Coriell; GM16260
DR   Wikidata; Q54832174
RX   PubMed=9419347;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Characteristics: Spontaneous HPRT- mutant of EJ30.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN34 ! EJ-30
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   EJ-6-2-Bam-6a
AC   CVCL_5741
DR   CLO; CLO_0002907
DR   ATCC; CRL-1888
DR   Wikidata; Q54832175
RX   PubMed=7207618;
CC   Characteristics: Transfected with Bam H1 digested DNA from bladder carcinoma cell line Ej138 (Cellosaurus=CVCL_2443).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   EJ1.Th
AC   CVCL_UT92
DR   ATCC; CRL-6532
DR   Wikidata; Q93539522
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6532; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   Ej138
AC   CVCL_2443
SY   EJ138; EJ 138; MGH-U1; MGHU1; MGH-UI; MGH-U1 (EJ); EJ; EJ/T24
DR   BTO; BTO_0003553
DR   CLO; CLO_0002905
DR   CLO; CLO_0002906
DR   EFO; EFO_0022418
DR   CLDB; cl1152
DR   CLDB; cl1154
DR   BioSample; SAMN03151939
DR   BioSample; SAMN03151949
DR   cancercelllines; CVCL_2443
DR   ChEMBL-Cells; CHEMBL3307583
DR   ChEMBL-Targets; CHEMBL614292
DR   Cosmic; 760480
DR   Cosmic; 925828
DR   Cosmic; 1093986
DR   Cosmic; 1927289
DR   ECACC; 85061108
DR   GEO; GSM827443
DR   GEO; GSM1374473
DR   LINCS_LDP; LCL-1704
DR   NCBI_Iran; C429
DR   Progenetix; CVCL_2443
DR   PubChem_Cell_line; CVCL_2443
DR   Wikidata; Q54832176
RX   PubMed=651066;
RX   PubMed=663932;
RX   PubMed=864752;
RX   PubMed=870558;
RX   PubMed=2903891;
RX   PubMed=3708594;
RX   PubMed=4027986;
RX   PubMed=6244232;
RX   PubMed=6286138;
RX   PubMed=6823318;
RX   PubMed=6826254;
RX   PubMed=7185004;
RX   PubMed=11416159;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=23401075;
RX   PubMed=25336970;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00080.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00195.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 20 hours (PubMed=3708594).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: Cell line where the first human oncogene, HRAS was first discovered (PubMed=6286138).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16,18
ST   D21S11: 29
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 6
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 38
//
ID   EJ2.K
AC   CVCL_UT93
DR   ATCC; CRL-6531
DR   Wikidata; Q93539544
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6531; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   EJ32B
AC   CVCL_E579
DR   dbMHC; 48774
DR   ECACC; 95042756
DR   IHW; IHW09085
DR   IPD-IMGT/HLA; 11631
DR   Wikidata; Q54832177
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*30:02:01:01; B*18:01:01:01; C*05:01:01:01; DPB1*02:01:02/02:01:19,02:02; DQA1*05:01; DQB1*02:01:01; DRB1*03:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=11631).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   EJG
AC   CVCL_3817
DR   CLO; CLO_0002908
DR   CLDB; cl1155
DR   ATCC; CRL-8659
DR   ECACC; 93051803
DR   Wikidata; Q54832178
RX   Patent=US4670394;
RX   PubMed=3927288;
RX   PubMed=7989438;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8659.
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Doubling time: 4.6 days (PubMed=3927288); 110 hours (ATCC=CRL-8659).
CC   Discontinued: ATCC; CRL-8659; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   EJM
AC   CVCL_2030
DR   CLO; CLO_0009835
DR   EFO; EFO_0006572
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472928
DR   BioSample; SAMN10989569
DR   cancercelllines; CVCL_2030
DR   Cell_Model_Passport; SIDM01048
DR   ChEMBL-Cells; CHEMBL4295413
DR   ChEMBL-Targets; CHEMBL4296413
DR   Cosmic; 720776
DR   Cosmic; 742955
DR   Cosmic; 2081379
DR   Cosmic; 2367286
DR   Cosmic-CLP; 1297447
DR   DepMap; ACH-000821
DR   DSMZ; ACC-560
DR   DSMZCellDive; ACC-560
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1297447
DR   GEO; GSM827296
DR   GEO; GSM887003
DR   GEO; GSM888072
DR   GEO; GSM1669760
DR   IARC_TP53; 358
DR   LiGeA; CCLE_840
DR   LINCS_LDP; LCL-2042
DR   Lonza; 1540
DR   PharmacoDB; EJM_329_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2030
DR   PubChem_Cell_line; CVCL_2030
DR   Wikidata; Q54832179
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=2117464;
RX   PubMed=10087940;
RX   PubMed=10557056;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Characteristics: Produces IgG lambda (PubMed=2117464).
CC   Doubling time: 72 hours (PubMed=2117464); 40 hours (PubMed=25984343); ~50-60 hours (DSMZ=ACC-560).
CC   HLA typing: A*01:01,32:01; B*08:01,55:01; C*03:03,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=11157491).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>C); ClinVar=VCV000376624; Zygosity=Homozygous (PubMed=1373872; Cosmic-CLP=1297447; DepMap=ACH-000821).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.97%; East Asian, North=3.05%; East Asian, South=0%; South Asian=0%; European, North=63.97%; European, South=32.01% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=1297447; DSMZ=ACC-560; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 18,25
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 20,22
ST   Penta D: 14
ST   Penta E: 16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   EK [Anguilla]
AC   CVCL_UM49
SY   Eel Kidney
DR   Wikidata; Q93539585
RX   PubMed=30429125;
CC   Group: Fish cell line.
CC   Doubling time: 50.27 hours (PubMed=30429125).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7936; ! Anguilla anguilla (European freshwater eel)
SX   Sex unspecified
AG   Elver
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   EK [Horse]
AC   CVCL_Y450
SY   Equine Kidney
DR   ATCC; CRL-6290
DR   Wikidata; Q54832180
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6290; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   EK [Human B-cell IHW]
AC   CVCL_E580
SY   EK(OH); EK/OH; OH/EK
DR   dbMHC; 48775
DR   ECACC; 88052054
DR   IHW; IHW09054
DR   IPD-IMGT/HLA; 10557
DR   Wikidata; Q54832181
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Scandinavian.
CC   HLA typing: A*02:01:01:01; B*44:02:01:01; C*05:01:01:02; DPA1*01:03; DPB1*04:02:01; DQA1*01:04:01; DQB1*05:03:01; DRA*01:02; DRB1*14:54:01; DRB3*02:02 (IPD-IMGT/HLA=10557).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   EK-1
AC   CVCL_8348
SY   Eel Kidney-1; Ek-1
DR   CCLV; CCLV-RIE 0809
DR   IZSLER; BS CL 232
DR   Wikidata; Q54832182
RX   CelloPub=CLPUB00022;
RX   CelloPub=CLPUB00103;
RX   CelloPub=CLPUB00137;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   EK-TOK
AC   CVCL_E581
DR   dbMHC; 48776
DR   ECACC; 94061622
DR   IHW; IHW09354
DR   IPD-IMGT/HLA; 10558
DR   Wikidata; Q54832185
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*26:02; B*35,46; C*01,09; DPA1*01:03; DPB1*04:02; DRB1*04:05,11:01 (IPD-IMGT/HLA=10558).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   EK_R1
AC   CVCL_WZ07
DR   cancercelllines; CVCL_WZ07
DR   Wikidata; Q93539632
RX   PubMed=31150822;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Unspecified (PubMed=31150822).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age at sampling from personal communication of Castillo-Tong, Dan Cacsire.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=31150822
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D19S433: 10,14
ST   D1S1656: 10,17.3
ST   D21S11: 33.2
ST   D2S1338: 18,24
ST   D3S1358: 17,20
ST   D5S818: 12,13
ST   D6S1043: 18,19
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21.2
ST   Penta D: 9,10
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ05 ! 8714
OI   CVCL_WZ06 ! 17457
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   eKA3
AC   CVCL_RH45
SY   iPS_eKA3; DF(KA)-derived iPSC, clone #3
DR   GEO; GSM2038541
DR   GEO; GSM2185130
DR   SKIP; SKIP000829
DR   Wikidata; Q54832187
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX86 ! KA(DF)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   eKA4
AC   CVCL_RH46
SY   iPS_eKA4
DR   GEO; GSM2038542
DR   SKIP; SKIP000830
DR   Wikidata; Q54832189
RX   PubMed=26905201;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX86 ! KA(DF)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   EKL
AC   CVCL_5742
DR   CLO; CLO_0002909
DR   CLDB; cl1156
DR   Wikidata; Q54832191
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   EKOP
AC   CVCL_6755
SY   Exip KOP
DR   CLO; CLO_0050527
DR   RCB; RCB2150
DR   Wikidata; Q54832193
RX   PubMed=16198317;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346865; Mapk14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6876; MAPK14 (Note=Isoform Exip).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6753 ! KOP
SX   Female
AG   12-13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   EKS3
AC   CVCL_5283
DR   Wikidata; Q54832195
RX   PubMed=1693429;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=EKS3
CC   Characteristics: Produces significant quantity of IL6 (PubMed=1693429).
DI   NCIt; C3992; AIDS-related Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   EKVX
AC   CVCL_1195
DR   BTO; BTO_0004077
DR   CLO; CLO_0009997
DR   EFO; EFO_0006786
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0298
DR   BioGRID_ORCS_Cell_line; 680
DR   BioSample; SAMN03471437
DR   BioSample; SAMN10989588
DR   cancercelllines; CVCL_1195
DR   Cell_Model_Passport; SIDM00119
DR   ChEMBL-Cells; CHEMBL3307626
DR   ChEMBL-Targets; CHEMBL614487
DR   Cosmic; 687781
DR   Cosmic; 875848
DR   Cosmic; 905970
DR   Cosmic; 974288
DR   Cosmic; 1092598
DR   Cosmic; 1146952
DR   Cosmic; 1175860
DR   Cosmic; 1305343
DR   Cosmic; 1312329
DR   Cosmic; 1995392
DR   Cosmic; 1998440
DR   Cosmic-CLP; 905970
DR   DepMap; ACH-000706
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905970
DR   GEO; GSM2142
DR   GEO; GSM50210
DR   GEO; GSM50273
DR   GEO; GSM206468
DR   GEO; GSM274783
DR   GEO; GSM274817
DR   GEO; GSM434292
DR   GEO; GSM743449
DR   GEO; GSM750810
DR   GEO; GSM794266
DR   GEO; GSM799337
DR   GEO; GSM799400
DR   GEO; GSM843499
DR   GEO; GSM846290
DR   GEO; GSM1153407
DR   GEO; GSM1178081
DR   GEO; GSM1178082
DR   GEO; GSM1181255
DR   GEO; GSM1181350
DR   GEO; GSM1669761
DR   GEO; GSM2124664
DR   IARC_TP53; 21117
DR   IGRhCellID; EKVX_02GEO
DR   LiGeA; CCLE_108
DR   LINCS_LDP; LCL-2054
DR   NCI-DTP; EKVX
DR   PharmacoDB; EKVX_330_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1195
DR   PubChem_Cell_line; CVCL_1195
DR   SKY/M-FISH/CGH; 2793
DR   Wikidata; Q54832197
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=3335022;
RX   PubMed=3957463;
RX   PubMed=7718330;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=21698104;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22355448;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24618588;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=9
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Virology: Produces a human cell infectious xenotropic murine leukemia virus (X-MLV) (PubMed=21698104).
CC   Doubling time: 72 hours (PubMed=7718330); 43.6 hours (NCI-DTP=EKVX).
CC   HLA typing: A*01:01:01; B*37:01; C*06:02; DPB1*04:01; DQB1*06:02; DRB1*15:01:01 (PubMed=15748285).
CC   HLA typing: A*01:01,01:01; B*37:01,37:01; C*06:02,06:02; DQA1*02:01,02:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (PubMed=17088437).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.21%; Native American=0.92%; East Asian, North=1.76%; East Asian, South=0.01%; South Asian=1.21%; European, North=67.1%; European, South=28.8% (PubMed=30894373).
CC   Misspelling: ERVX; Cosmic=875848.
ST   Source(s): Cosmic-CLP=905970; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 30,31 (PubMed=19372543)
ST   D21S11: 31 (PubMed=25877200)
ST   D2S1338: 17,19
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 15
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   EL
AC   CVCL_YP04
SY   Eel Liver
DR   Wikidata; Q93539708
RX   PubMed=31814207;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 15 to 32 Celsius, the optimal growth temperature is 27 Celsius.
CC   Doubling time: 29.64 hours (PubMed=31814207).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=7936; ! Anguilla anguilla (European freshwater eel)
SX   Sex unspecified
AG   Elver
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   EL 1
AC   CVCL_3680
DR   CLO; CLO_0002910
DR   ATCC; CRL-9854
DR   cancercelllines; CVCL_3680
DR   Wikidata; Q54832198
RX   Patent=US5447861;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. On the basis of the STR profile seems to be a U-937 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00524.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9854.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-9854; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-9854
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   El Don
AC   CVCL_3681
DR   CLO; CLO_0002912
DR   ATCC; CRL-1149
DR   Wikidata; Q54832200
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   El Man
AC   CVCL_X712
SY   Elman
DR   ATCC; CRL-1101
DR   Wikidata; Q54832202
CC   Discontinued: ATCC; CRL-1101; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   El San
AC   CVCL_U688
DR   ATCC; CRL-1222
DR   Wikidata; Q54832203
RX   PubMed=3860870;
CC   Discontinued: ATCC; CRL-1222; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   EL16
AC   CVCL_A6UH
DR   Wikidata; Q107114876
RX   PubMed=10192391;
RX   PubMed=10520993;
CC   Karyotypic information: 40,XX [30%]; 39,X0 [70%] (PubMed=10192391).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Cast/EiJ x 129SvJae.
OX   NCBI_TaxID=477816; ! Mus musculus musculus x Mus musculus castaneus (Hybrid house mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   EL16.7
AC   CVCL_A6UI
SY   16.7
DR   GEO; GSM2472811
DR   Wikidata; Q107114880
RX   PubMed=10520993;
CC   Karyotypic information: 40,XX, one chromosome X from M.m.musculus and the other from M.m.castaneus (PubMed=10520993).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Cast/EiJ x 129SvJae.
OX   NCBI_TaxID=477816; ! Mus musculus musculus x Mus musculus castaneus (Hybrid house mouse)
HI   CVCL_A6UH ! EL16
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   EL-4 6.1
AC   CVCL_A0DM
SY   EL4-6.1; EL4-16 BuOu6.1
DR   Wikidata; Q108820188
RX   PubMed=2415592;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   EL-4 6.1 C10
AC   CVCL_0254
SY   EL4 6.1 C10; EL461C10
DR   MCCL; MCC:0000145
DR   Wikidata; Q54832204
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0DM ! EL-4 6.1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   EL-4-B5
AC   CVCL_5I39
SY   EL-4 B5; EL4-B5; EL4B5
DR   Kerafast; EVU301
DR   Wikidata; Q54832205
RX   PubMed=7691726;
CC   Characteristics: Can be used as a feeder layer to generate B cell cultures yielding human monoclonal antibodies (Kerafast=EVU301).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5680 ! EL4.BU.1.OUAr.1.1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   EL-4/cCD20
AC   CVCL_E3E7
RX   PubMed=32651429;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:52268; Dog MS4A1 (Note=With a C-terminal FLAG tag).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   EL-4ad
AC   CVCL_8603
DR   JCRB; JCRB1352
DR   Wikidata; Q54832227
RX   PubMed=1505120;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   EL-E
AC   CVCL_0C08
DR   Wikidata; Q54832228
RX   PubMed=7736387;
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   EL-NC-1S
AC   CVCL_J898
SY   anti NAP-1
DR   CLO; CLO_0002920
DR   ATCC; HB-9647
DR   Wikidata; Q54832229
RX   Patent=US6475741;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9647.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10145; Human IL8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   EL08-1D2
AC   CVCL_VV34
SY   EL08.1D2
DR   Wikidata; Q93539818
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:106651; Ly6e.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: Ly-6E.1/LacZ (BL1b) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Stromal cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   EL4
AC   CVCL_0255
SY   EL-4; EL 4; E.L.4
DR   BTO; BTO_0003432
DR   CLO; CLO_0002913
DR   CLO; CLO_0050166
DR   EFO; EFO_0022736
DR   MCCL; MCC:0000146
DR   CLDB; cl1158
DR   CLDB; cl1159
DR   CLDB; cl1160
DR   ATCC; TIB-39
DR   BCRC; 60179
DR   CCRID; 1101MOU-PUMC000136
DR   CCRID; 3101MOUTCM41
DR   CCRID; 4201MOU-CCTCC00136
DR   CCTCC; GDC0136
DR   ChEMBL-Cells; CHEMBL3308380
DR   ChEMBL-Targets; CHEMBL614293
DR   CLS; 300653
DR   DSMZ; ACC-831
DR   DSMZCellDive; ACC-831
DR   ECACC; 85023105
DR   JCRB; IFO50027
DR   JCRB; JCRB1350
DR   KCB; KCB 2013027YJ
DR   KCLB; 40039
DR   Lonza; 760
DR   NCBI_Iran; C114
DR   PRIDE; PXD008733
DR   PubChem_Cell_line; CVCL_0255
DR   RCB; RCB1641
DR   TKG; TKG 0150
DR   Wikidata; Q54832230
RX   PubMed=4099030;
RX   PubMed=4867923;
RX   PubMed=14801344;
RX   PubMed=30084848;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=EL4
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-141.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/el4-xenograft-model/
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~15-20 hours (DSMZ=ACC-831); ~14 hours (Note=Lot 10262015), ~12 hours (Note=Lot 02052018) (JCRB=JCRB1350).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Discontinued: JCRB; IFO50027; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   EL4-B7-1+B7-2
AC   CVCL_B6PI
SY   B7-1+B7-2-EL4
DR   Wikidata; Q111733181
RX   PubMed=10075975;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101773; Cd86.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6PG ! EL4B7-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   EL4-B7-2
AC   CVCL_B6PH
SY   B7-2-EL4
DR   Wikidata; Q111733182
RX   PubMed=10075975;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101773; Cd86.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Caution: There are two EL4 Cd86 (B7-2) transfected cell lines: EL4B7-2 (Cellosaurus=CVCL_B6PL) and EL4-B7-2 (Cellosaurus=CVCL_B6PH).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   EL4-hCD19-LZ
AC   CVCL_E8H0
SY   genO-EL4-hCD19-LZ
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/el4-hcd19-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1633; CD19.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   EL4-hCD20-LZ
AC   CVCL_E6BL
SY   genO-EL4-hCD20-LZ
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/el4-hcd20-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7315; MS4A1.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   EL4-Luc2 [ATCC]
AC   CVCL_A4BN
DR   ATCC; TIB-39-LUC2
DR   Wikidata; Q105506825
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=TIB-39-LUC2).
CC   Doubling time: ~19 hours (ATCC=TIB-39-LUC2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   EL4-luc2 [Caliper]
AC   CVCL_5J22
DR   Revvity/PerkinElmer; 124088
DR   Wikidata; Q54832231
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: Revvity/PerkinElmer; 124088; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   EL4-TK
AC   CVCL_F943
DR   TKG; TKG 0192
DR   Wikidata; Q54832232
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   EL4-Zbtb1 KO
AC   CVCL_A0PX
SY   Zbtb1 KO-EL4
DR   Wikidata; Q108820189
RX   PubMed=34290994;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2442326; Zbtb1.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   EL4/E2
AC   CVCL_B6PK
SY   EL4-E2; EL-4/E2
DR   Wikidata; Q111733183
RX   PubMed=15687706;
RX   PubMed=17638915;
WW   Provider; WSU OTC; 06-834; https://wayne.technologypublisher.com/technology/36289
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   EL4.BU
AC   CVCL_3818
SY   EL4 BU; E.L.4-BUdr
DR   CLO; CLO_0002914
DR   ATCC; TIB-40
DR   Wikidata; Q54832233
RX   PubMed=4099030;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   EL4.BU.1.OUAr.1.1
AC   CVCL_5680
DR   CLO; CLO_0002915
DR   ATCC; TIB-41
DR   Wikidata; Q54832234
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   EL4.BU.OU6
AC   CVCL_3819
DR   CLO; CLO_0002916
DR   CLDB; cl1161
DR   ECACC; 85121301
DR   Wikidata; Q54832235
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3818 ! EL4.BU
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   EL4.E1
AC   CVCL_0256
SY   EL4E1
DR   MCCL; MCC:0000147
DR   Wikidata; Q54832236
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   EL4.IL-2
AC   CVCL_5681
SY   EL4-IL2
DR   CLO; CLO_0002917
DR   ATCC; TIB-181
DR   BCRC; 60275
DR   CCRID; 3101MOUTCM21
DR   CLS; 400425
DR   Wikidata; Q54832237
RX   PubMed=6968789;
RX   PubMed=34737324;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: Produces IL2 in response to phorbol-12-myristate-13-acetate (PMA).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: CLS; 400425; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   EL4.NOB-1
AC   CVCL_0257
SY   EL4NOB1; NOB-1
DR   CLO; CLO_0002918
DR   MCCL; MCC:0000148
DR   CLDB; cl1162
DR   ECACC; 87020408
DR   Wikidata; Q54832238
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=NOB-1
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3819 ! EL4.BU.OU6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   EL4B7-1
AC   CVCL_B6PG
SY   EL4-B7-1; B7-1-EL4; B7-EL-4
DR   Wikidata; Q111733184
RX   PubMed=7527298;
RX   PubMed=10075975;
RX   PubMed=10477562;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   EL4B7-2
AC   CVCL_B6PL
DR   Wikidata; Q111733185
RX   PubMed=10477562;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101773; Cd86.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Caution: There are two EL4 Cd86 (B7-2) transfected cell lines: EL4B7-2 (Cellosaurus=CVCL_B6PL) and EL4-B7-2 (Cellosaurus=CVCL_B6PH).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   Eland 895
AC   CVCL_A7UB
DR   Wikidata; Q107114882
RX   PubMed=9577776;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9945; ! Tragelaphus oryx (Eland)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ELC1.We
AC   CVCL_S379
SY   ELC1We
DR   ATCC; CRL-6495
DR   Wikidata; Q54832239
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6495; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=67771; ! Callipepla californica (California quail)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   ElCo
AC   CVCL_8686
SY   ELCO
DR   BioSample; SAMN03151689
DR   Wikidata; Q54832240
RX   CelloPub=CLPUB00262;
RX   PubMed=212193;
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=6988327;
RX   PubMed=9215216;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00042.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   ELD-1
AC   CVCL_VN20
DR   cancercelllines; CVCL_VN20
DR   Wikidata; Q93539948
RX   CelloPub=CLPUB00437;
RX   PubMed=15922715;
WW   Info; KAKEN; 09670754; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-09670754/
CC   Problematic cell line: Contaminated. Grand-parent cell line (MOBS-1) has been shown to be a U-937 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RX32 ! MABS-1
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   ELD-1 C-11
AC   CVCL_VN21
SY   ELD-1 subclone C-11
DR   cancercelllines; CVCL_VN21
DR   Wikidata; Q93539953
RX   DOI=10.14930/jsma1939.62.310;
CC   Problematic cell line: Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN20 ! ELD-1
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   ELD-1 C-8
AC   CVCL_VN22
SY   ELD-1 subclone C-8; C-8
DR   cancercelllines; CVCL_VN22
DR   Wikidata; Q93539956
RX   DOI=10.14930/jsma1939.62.310;
RX   PubMed=15922715;
CC   Problematic cell line: Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN20 ! ELD-1
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   ELD-1 D-9
AC   CVCL_VN23
SY   ELD-1 subclone D-9; D-9
DR   cancercelllines; CVCL_VN23
DR   Wikidata; Q93539960
RX   DOI=10.14930/jsma1939.62.310;
RX   PubMed=15922715;
CC   Problematic cell line: Contaminated. Ancestral cell line (MOBS-1) has been shown to be a U-937 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN20 ! ELD-1
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   Elec-106
AC   CVCL_C2WU
DR   Wikidata; Q114311361
RX   PubMed=3105603;
RX   PubMed=7649165;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O42275; Electrophorus electricus acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Elec-118
AC   CVCL_C2WV
DR   Wikidata; Q114311362
RX   PubMed=2445915;
RX   PubMed=3105603;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
CC   Miscellaneous: Target specificity based on the recognition of the same epitope as Elec-39 (Cellosaurus=CVCL_C2WY).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   Elec-121
AC   CVCL_C2WW
DR   Wikidata; Q114311364
RX   PubMed=2445915;
RX   PubMed=3105603;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
CC   Miscellaneous: Target specificity based on the recognition of the same epitope as Elec-39 (Cellosaurus=CVCL_C2WY).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   Elec-39
AC   CVCL_C2WY
DR   Wikidata; Q114311365
RX   PubMed=2445915;
RX   PubMed=3105603;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   Elec-403
AC   CVCL_C2WZ
DR   Wikidata; Q114311366
RX   PubMed=7649165;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O42275; Electrophorus electricus acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Elec-408
AC   CVCL_C2X0
DR   Wikidata; Q114311367
RX   PubMed=7649165;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O42275; Electrophorus electricus acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Elec-409
AC   CVCL_C2X1
DR   Wikidata; Q114311368
RX   PubMed=7649165;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O42275; Electrophorus electricus acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Elec-410
AC   CVCL_C2X2
DR   Wikidata; Q114311370
RX   PubMed=7649165;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O42275; Electrophorus electricus acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   ELF-153
AC   CVCL_2031
SY   Elf-153; ELF153
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473443
DR   Cosmic; 787427
DR   Cosmic; 975245
DR   Cosmic; 1012064
DR   Cosmic; 1281310
DR   Cosmic; 1465954
DR   Cosmic; 2306197
DR   DSMZ; ACC-693
DR   DSMZCellDive; ACC-693
DR   Wikidata; Q54832241
RX   CelloPub=CLPUB00037;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7488550;
RX   PubMed=7519473;
RX   PubMed=16408098;
RX   PubMed=31160637;
RX   PubMed=36982453;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Characteristics: CSF2 dependent (CelloPub=CLPUB00037; PubMed=7488550).
CC   Doubling time: 36 hours (PubMed=7488550; PubMed=7519473); ~40-60 hours (DSMZ=ACC-693).
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,35:01:01; C*07:01:01,07:01:01; DPA1*01:03:01,02:01:01; DPB1*14:01:01,04:02:01; DQB1*03:01:01,03:01:01; DRA*01:01:01,01:01:01; DRB1*09:01:02,11:01:01 (DSMZCellDive=ACC-693).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-693; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,14
ST   D12S391: 19
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D19S433: 13,14.2 (Technion Genomics Center)
ST   D19S433: 13,15 (DSMZ=ACC-693)
ST   D1S1656: 15.3,16
ST   D21S11: 31,32.2
ST   D22S1045: 16
ST   D2S1338: 18,25
ST   D2S441: 11,14
ST   D3S1358: 17,18 (Technion Genomics Center)
ST   D3S1358: 18 (DSMZ=ACC-693)
ST   D5S818: 11
ST   D7S820: 9,10 (DSMZ=ACC-693)
ST   D7S820: 9.3 (Technion Genomics Center)
ST   D8S1179: 12,13
ST   FGA: 19,23
ST   Penta D: 12,13
ST   Penta E: 12,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   Elf1
AC   CVCL_C115
SY   Elf-1; ELF-1
DR   EFO; EFO_0005901
DR   ENCODE; ENCBS467EKW
DR   ENCODE; ENCBS706FDR
DR   NIHhESC; NIHhESC-12-0156
DR   WiCell; elf1
DR   Wikidata; Q54832242
RX   PubMed=24623855;
RX   PubMed=28445466;
RX   PubMed=29466914;
CC   From: University of Washington; Seattle; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0156.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=elf1
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 15,18
ST   D21S11: 29,31
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 5,12
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Elf1-iCas9
AC   CVCL_VR49
DR   Wikidata; Q93539988
RX   PubMed=29466914;
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9. Can be used for rapid and highly efficient generation of biallelic knockout hPSCs for loss-of-function studies.
CC   Characteristics: Using TALEN two constructs SA-2A-PuroR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C115 ! Elf1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   Elf3
AC   CVCL_LC23
DR   NIHhESC; NIHhESC-18-0397
DR   Wikidata; Q54832243
RX   PubMed=29466914;
CC   From: University of Washington; Seattle; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0397.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   Elf4
AC   CVCL_LC24
DR   NIHhESC; NIHhESC-18-0398
DR   Wikidata; Q54832244
RX   PubMed=29466914;
CC   From: University of Washington; Seattle; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0398.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   ElFa
AC   CVCL_CZ88
SY   EIFa
DR   Wikidata; Q54832245
RX   PubMed=2720636;
RX   PubMed=4038916;
RX   PubMed=7153601;
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   ELGH
AC   CVCL_W729
SY   Epinephelus Lanceolatus Grouper Heart
DR   Wikidata; Q54832246
RX   PubMed=24372271;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=310571; ! Epinephelus lanceolatus (Giant grouper)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ElGr
AC   CVCL_E6XB
RX   PubMed=12836015;
CC   HLA typing: A*03,30; B*13,35; DQB1*03:02,06:02; DRB1*04:04,15:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ELGSN
AC   CVCL_VG75
SY   Epinephelus Lanceolatus Grouper SNout
DR   Wikidata; Q54832247
RX   DOI=10.1016/j.aquaculture.2014.04.044;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=310571; ! Epinephelus lanceolatus (Giant grouper)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   ELGSNe
AC   CVCL_VG76
SY   Epinephelus Lanceolatus Grouper SNout epithelial
DR   Wikidata; Q54832248
RX   DOI=10.1016/j.aquaculture.2014.04.044;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=310571; ! Epinephelus lanceolatus (Giant grouper)
HI   CVCL_VG75 ! ELGSN
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   ELGSNf
AC   CVCL_VG77
SY   Epinephelus Lanceolatus Grouper SNout fibroblastic
DR   Wikidata; Q54832249
RX   DOI=10.1016/j.aquaculture.2014.04.044;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=310571; ! Epinephelus lanceolatus (Giant grouper)
HI   CVCL_VG75 ! ELGSN
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   ELHK
AC   CVCL_B7I3
SY   Epinephelus Lanceolatus Head Kidney
DR   Wikidata; Q112929535
RX   DOI=10.1016/j.aqrep.2021.100899;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at temperatures ranging from 24 to 32 Celsius with an optimal growth temperature at 28 Celsius (DOI=10.1016/j.aqrep.2021.100899).
CC   Virology: Susceptible to infection by Singapore grouper iridovirus (SGIV) and red-spotted grouper nervous necrosis virus (RGNNV) (DOI=10.1016/j.aqrep.2021.100899).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=310571; ! Epinephelus lanceolatus (Giant grouper)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   Elijah
AC   CVCL_M653
SY   ELIJAH; ELI-BL; ELI BL; Eli-BL; Eli BL; ELI; Eli
DR   cancercelllines; CVCL_M653
DR   Cosmic; 2297022
DR   GEO; GSM115809
DR   Progenetix; CVCL_M653
DR   Wikidata; Q54832250
RX   PubMed=2824665;
RX   PubMed=2898508;
RX   PubMed=2943927;
RX   PubMed=2985508;
RX   PubMed=16960149;
RX   PubMed=28960205;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Misspelling: Elija; Note=Occasionally.
CC   Derived from site: In situ; Bone, jaw; UBERON=UBERON_0001708.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   elkRK13
AC   CVCL_0A22
DR   Wikidata; Q54832251
RX   CelloPub=CLPUB00223;
RX   PubMed=22673102;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P67986; Cervus elaphus nelsoni prion protein.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   ELLU clone #104
AC   CVCL_B6BC
SY   Erythroid Line from Lund University clone #104
DR   Wikidata; Q111733186
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1. Also expresses HBB (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #110
AC   CVCL_B6BD
SY   Erythroid Line from Lund University clone #110
DR   Wikidata; Q111733187
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1. This clone does not express BCL11A and thus expresses HBE1 and HBZ instead of adult beta globin (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #116
AC   CVCL_B6BE
SY   Erythroid Line from Lund University clone #116
DR   Wikidata; Q111733188
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1. Also expresses HBB (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #121
AC   CVCL_B6BF
SY   Erythroid Line from Lund University clone #121
DR   Wikidata; Q111733189
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #123
AC   CVCL_B6BG
SY   Erythroid Line from Lund University clone #123
DR   Wikidata; Q111733190
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #125
AC   CVCL_B6BH
SY   Erythroid Line from Lund University clone #125
DR   Wikidata; Q111733192
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #126
AC   CVCL_B6BI
SY   Erythroid Line from Lund University clone #126
DR   Wikidata; Q111733193
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #127
AC   CVCL_B6BJ
SY   Erythroid Line from Lund University clone #127
DR   Wikidata; Q111733194
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BK ! ELLU clone #131
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #131
AC   CVCL_B6BK
SY   Erythroid Line from Lund University clone #131
DR   Wikidata; Q111733195
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BL ! ELLU clone #136
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELLU clone #136
AC   CVCL_B6BL
SY   Erythroid Line from Lund University clone #136
DR   Wikidata; Q111733196
RX   PubMed=34817797;
CC   Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6BC ! ELLU clone #104
OI   CVCL_B6BD ! ELLU clone #110
OI   CVCL_B6BE ! ELLU clone #116
OI   CVCL_B6BF ! ELLU clone #121
OI   CVCL_B6BG ! ELLU clone #123
OI   CVCL_B6BH ! ELLU clone #125
OI   CVCL_B6BI ! ELLU clone #126
OI   CVCL_B6BJ ! ELLU clone #127
OI   CVCL_B6BK ! ELLU clone #131
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ELM-D
AC   CVCL_X174
DR   Wikidata; Q54832252
RX   PubMed=2460423;
RX   PubMed=8355701;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H/HeNSlc.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   ELM-I-1
AC   CVCL_2032
DR   CLO; CLO_0002919
DR   CLDB; cl1163
DR   DSMZ; ACC-44
DR   DSMZCellDive; ACC-44
DR   Wikidata; Q54832253
RX   PubMed=2319808;
RX   PubMed=2460423;
RX   PubMed=8355701;
CC   Doubling time: ~20-40 hours (DSMZ=ACC-44).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H/HeNSlc.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X174 ! ELM-D
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Elm2
AC   CVCL_LC25
DR   NIHhESC; NIHhESC-18-0396
DR   Wikidata; Q54832254
RX   PubMed=29466914;
CC   From: University of Washington; Seattle; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0396.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   ELO
AC   CVCL_C0VG
SY   Epithelium-Like Ovary
DR   Wikidata; Q112929536
RX   DOI=10.48048/wjst.2021.10857;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=337887; ! Clarias nieuhofii (Slender walking catfish)
SX   Female
AG   6-8M
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   ELON
AC   CVCL_E582
DR   dbMHC; 48777
DR   ECACC; 94022528
DR   IHW; IHW09236
DR   IPD-IMGT/HLA; 10559
DR   Wikidata; Q54832255
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*23:01,03:01; B*38:01:01,35; C*04:01,12:03; DPB1*04:01,04:02 (IPD-IMGT/HLA=10559).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   EL-S1
AC   CVCL_XZ71
SY   ELS1
DR   CCRID; 5301MAM-KCB00021ZJ
DR   KCB; KCB 200021ZJ
DR   Wikidata; Q93540093
RX   PubMed=22086079;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=13125; ! Lynx lynx (Eurasian lynx)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   ELT10
AC   CVCL_4615
SY   ELT-10; ELT 10; Eker Leiomyoma Tumor-10
DR   Wikidata; Q54832256
RX   PubMed=7539981;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   ELT3
AC   CVCL_4616
SY   ELT-3; ELT 3; Eker Leiomyoma Tumor-3
DR   BTO; BTO_0003253
DR   ATCC; CRL-3371
DR   Wikidata; Q54832257
RX   PubMed=7539981;
RX   PubMed=15039427;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   ELT3 TSC2
AC   CVCL_F0KL
SY   TSC2 ELT-3
RX   PubMed=15039427;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12363; TSC2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4616 ! ELT3
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ELT4
AC   CVCL_4617
SY   ELT-4; ELT 4; Eker Leiomyoma Tumor-4
DR   Wikidata; Q54832258
RX   PubMed=7539981;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   ELT5A
AC   CVCL_4618
SY   ELT-5A; ELT 5A; Eker Leiomyoma Tumor-5A
DR   Wikidata; Q54832259
RX   PubMed=7539981;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4619 ! ELT5B
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   ELT5B
AC   CVCL_4619
SY   ELT-5B; ELT 5B; Eker Leiomyoma Tumor-5B
DR   Wikidata; Q54832260
RX   PubMed=7539981;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4618 ! ELT5A
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   ELT6
AC   CVCL_4620
SY   ELT-6; ELT 6; Eker Leiomyoma Tumor-6
DR   Wikidata; Q54832261
RX   PubMed=7539981;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   ELT9
AC   CVCL_4621
SY   ELT-9; ELT 9; Eker Leiomyoma Tumor-9
DR   Wikidata; Q54832262
RX   PubMed=7539981;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C60426; Rat leiomyoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   11-19M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   Em Ar
AC   CVCL_3682
SY   EmAr
DR   CLO; CLO_0002921
DR   ATCC; CRL-1168
DR   Wikidata; Q54832263
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Heterozygous (from familial inference of XP8BE; XP9BE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   EM-2
AC   CVCL_1196
SY   EM2
DR   BTO; BTO_0005904
DR   CLO; CLO_0002922
DR   EFO; EFO_0002176
DR   CLDB; cl1164
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03472895
DR   BioSample; SAMN10988561
DR   cancercelllines; CVCL_1196
DR   Cell_Model_Passport; SIDM01047
DR   ChEMBL-Cells; CHEMBL3308889
DR   ChEMBL-Targets; CHEMBL2366281
DR   Cosmic; 787491
DR   Cosmic; 906855
DR   Cosmic; 994175
DR   Cosmic; 1026572
DR   Cosmic; 1078728
DR   Cosmic; 1498416
DR   Cosmic-CLP; 906855
DR   DepMap; ACH-000295
DR   DSMZ; ACC-135
DR   DSMZCellDive; ACC-135
DR   EGA; EGAS00001000978
DR   GDSC; 906855
DR   GEO; GSM887004
DR   GEO; GSM888073
DR   GEO; GSM1374474
DR   GEO; GSM1669762
DR   IARC_TP53; 340
DR   IARC_TP53; 21326
DR   IGRhCellID; EM2
DR   LiGeA; CCLE_641
DR   LINCS_LDP; LCL-1112
DR   PharmacoDB; EM2_331_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1196
DR   PubChem_Cell_line; CVCL_1196
DR   Wikidata; Q54832264
RX   CelloPub=CLPUB00038;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3030532;
RX   PubMed=3332852;
RX   PubMed=3856862;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10637496;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20809971;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 2 days (CelloPub=CLPUB00038); ~35-40 hours (DSMZ=ACC-135).
CC   HLA typing: A*02:01,03:01; B*07:02,44:02; C*05:01,07:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,03:01:01; B*07:02:01,44:02:01; C*05:01:01,07:02:01; DQB1*06:02:01,06:03:01; DRB1*15:01:01,15:01:01 (DSMZCellDive=ACC-135).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=20809971; DepMap=ACH-000295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=906855; DepMap=ACH-000295).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.62%; Native American=0%; East Asian, North=2.74%; East Asian, South=0%; South Asian=0%; European, North=68.28%; European, South=28.35% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=906855; DSMZ=ACC-135; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 15,16
ST   D21S11: 30
ST   D2S1338: 22,24
ST   D3S1358: 14,16
ST   D5S818: 8,12
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 13,14
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2033 ! EM-3
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   EM-3
AC   CVCL_2033
SY   EM3
DR   BTO; BTO_0005905
DR   CLO; CLO_0002923
DR   CLDB; cl1165
DR   Cell_Model_Passport; SIDM01046
DR   Cosmic; 787492
DR   Cosmic; 798662
DR   Cosmic; 994179
DR   Cosmic; 1026571
DR   DSMZ; ACC-134
DR   DSMZCellDive; ACC-134
DR   Wikidata; Q54832265
RX   CelloPub=CLPUB00038;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3030532;
RX   PubMed=3332852;
RX   PubMed=3856862;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10637496;
RX   PubMed=15843827;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Doubling time: 2 days (CelloPub=CLPUB00038); ~40 hours (DSMZ=ACC-134).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-134; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 15,16
ST   D21S11: 30
ST   D2S1338: 22,24
ST   D3S1358: 14,16
ST   D5S818: 8,12
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 13,14
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1196 ! EM-2
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   EM-C11
AC   CVCL_V249
SY   EMC11; C-G11; GM16133
DR   CLO; CLO_0018831
DR   Coriell; GM16133
DR   Wikidata; Q54832266
RX   PubMed=1518409;
RX   PubMed=8187089;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D898 ! CHO-9
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 9
//
ID   EM-E6E7TERT-1
AC   CVCL_4W29
DR   BTO; BTO_0006272
DR   Wikidata; Q54832269
RX   PubMed=14633600;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Endometrium, glandular epithelium; UBERON=UBERON_0012276.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W30 ! EM-E6E7TERT-2
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   EM-E6E7TERT-2
AC   CVCL_4W30
SY   EM-E6/E7/hTERT-2
DR   BTO; BTO_0006273
DR   JCRB; JCRB1545
DR   Wikidata; Q54832270
RX   PubMed=14633600;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Endometrium, glandular epithelium; UBERON=UBERON_0012276.
ST   Source(s): JCRB=JCRB1545
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W29 ! EM-E6E7TERT-1
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   EM-E6E7TERT-3
AC   CVCL_4W31
DR   BTO; BTO_0006274
DR   Wikidata; Q54832271
RX   PubMed=14633600;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Endometrium, glandular epithelium; UBERON=UBERON_0012276.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   EM-G3
AC   CVCL_5499
SY   EMG3
DR   GEO; GSM81460
DR   Wikidata; Q54832272
RX   PubMed=17063277;
RX   PubMed=17366476;
CC   Population: Caucasian.
CC   Doubling time: ~34 hours (PubMed=17063277).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   EM0001
AC   CVCL_8W14
DR   ECACC; 95110312
DR   Wikidata; Q54832273
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95110312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   em13.5
AC   CVCL_A7WA
SY   13.5
DR   BEI_Resources; MRA-658
DR   Wikidata; Q107114885
RX   PubMed=3278220;
RX   PubMed=9783454;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P90574; Plasmodium chabaudi 93 kDa erythrocyte membrane protein (Pc(em)-93).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   em16.3
AC   CVCL_A7WB
SY   16.3
DR   BEI_Resources; MRA-659
DR   Wikidata; Q107114888
RX   PubMed=3278220;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium chabaudi 65 kDa erythrocyte membrane protein (Pc(em)-65).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   em16.8
AC   CVCL_A7WC
SY   16.8
DR   BEI_Resources; MRA-660
DR   Wikidata; Q107114890
RX   PubMed=3278220;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium chabaudi 65 kDa erythrocyte membrane protein (Pc(em)-65).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   em17.4
AC   CVCL_A7WD
SY   17.4
DR   BEI_Resources; MRA-661
DR   Wikidata; Q107114892
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plasmodium chabaudi 46 kDa erythrocyte membrane protein (Pc(em)-46).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   EM2GEx a
AC   CVCL_1G86
SY   EM2GEx; Epinephelus Merra 2 Gills Explant
DR   NRFC; NRFC031
DR   Wikidata; Q54832274
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC031; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC031.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=215346; ! Epinephelus merra (Honeycomb grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   EM2HTr
AC   CVCL_1G85
SY   Epinephelus Merra 2 Heart Trypsinised
DR   NRFC; NRFC030
DR   Wikidata; Q54832275
RX   DOI=10.1007/s40009-015-0365-5;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC030.
CC   Miscellaneous: Cell line is available for distribution but not authenticated (NRFC=NRFC030).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=162300; ! Epinephelus malabaricus (Malabar grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   EM3GEx
AC   CVCL_1G87
SY   Epinephelus Merra 3 Gills Explant
DR   NRFC; NRFC032
DR   Wikidata; Q54832276
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC032; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC032.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=215346; ! Epinephelus merra (Honeycomb grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   EM4SPEx
AC   CVCL_1G88
SY   EM4SpEx; Epinephelus Merra 4 SPleen Explant
DR   NRFC; NRFC033
DR   Wikidata; Q54832277
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC033; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC033.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=215346; ! Epinephelus merra (Honeycomb grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   Ema
AC   CVCL_L350
DR   GEO; GSM2282268
DR   Wikidata; Q54832278
RX   PubMed=23196801;
RX   PubMed=27639374;
CC   Doubling time: 26.6 hours (PubMed=23196801).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: English Springer Spaniel; VBO=VBO_0200497.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   EMA-1
AC   CVCL_D3VY
DR   DSHB; EMA-1
DR   Wikidata; Q127380812
RX   DOI=10.1002/mrd.1120150104;
RX   PubMed=3598980;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse glycolipids of cell surface glycoproteins specific of primordial germ cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   EMA-6
AC   CVCL_D3VZ
DR   Wikidata; Q127380813
RX   DOI=10.1002/mrd.1120150104;
RX   PubMed=3598980;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse cell surface antigen of mouse primordial germ cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   EMab-134
AC   CVCL_D2SK
DR   Wikidata; Q127380814
RX   PubMed=29090976;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   EMab-17
AC   CVCL_D2SM
DR   Wikidata; Q127380815
RX   PubMed=32218834;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   EMab-300
AC   CVCL_D2SH
DR   Wikidata; Q127380816
RX   PubMed=37489364;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01279; Mouse Egfr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   EMab-51
AC   CVCL_D2SL
DR   Wikidata; Q127380817
RX   PubMed=29090976;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   EMB
AC   CVCL_A8WB
SY   Epinephelus Moara Brain
DR   Wikidata; Q108820190
RX   PubMed=29333652;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 18 to 30 Celsius, the optimal temperature is between 24 and 30 Celsius (PubMed=29333652).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=300413; ! Epinephelus moara (Kelp grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   EMC-1
AC   CVCL_WH36
DR   Wikidata; Q93540258
RX   PubMed=30268330;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   EMC-BAC-1
AC   CVCL_X486
SY   EMCBAC1
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X486
DR   Cell_Model_Passport; SIDM00048
DR   Cosmic-CLP; 1503369
DR   DepMap; ACH-002101
DR   EGA; EGAS00001000978
DR   GDSC; 1503369
DR   GEO; GSM1669763
DR   PharmacoDB; EMCBAC1_332_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54832279
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Glu165Ter (c.493G>T) (c.637C>T); Zygosity=Homozygous (Cosmic-CLP=1503369; DepMap=ACH-002101).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=1503369; DepMap=ACH-002101).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=74.47%; Native American=0%; East Asian, North=2.69%; East Asian, South=12.82%; South Asian=0%; European, North=3.5%; European, South=6.52% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1503369
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 10
ST   vWA: 15,16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 21
//
ID   EMC-BAC-2
AC   CVCL_X487
SY   EMCBAC2
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X487
DR   Cell_Model_Passport; SIDM00047
DR   Cosmic-CLP; 1503370
DR   DepMap; ACH-002102
DR   EGA; EGAS00001000978
DR   GDSC; 1503370
DR   GEO; GSM1669764
DR   PharmacoDB; EMCBAC2_333_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54832280
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Homozygous (Cosmic-CLP=1503370; DepMap=ACH-002102).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (Cosmic-CLP=1503370; DepMap=ACH-002102).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.13%; Native American=0%; East Asian, North=1.05%; East Asian, South=0%; South Asian=0%; European, North=72.26%; European, South=26.55% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1503370
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 7,9
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 22
//
ID   EMC-G5
AC   CVCL_E4IF
SY   G5
RX   Patent=US8039231;
RX   PubMed=18240028;
RX   PubMed=18546152;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1069; BMP2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   EMC-G5 G5P.7A 3C9
AC   CVCL_E4IG
SY   G5P.7A subclone 3C9; 3C9
RX   PubMed=18240028;
RX   PubMed=18546152;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1069; BMP2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8568; FURIN (Note=Soluble version).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4IF ! EMC-G5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   EMC100
AC   CVCL_4W32
SY   EPC-100; EPC100
DR   JCRB; JCRB1538
DR   Wikidata; Q54832281
RX   PubMed=18420831;
RX   PubMed=21155951;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient undergoing hysterectomy (PubMed=18420831).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
ST   Source(s): JCRB=JCRB1538
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W33 ! EMC214
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   EMC214
AC   CVCL_4W33
SY   EPC-214
DR   JCRB; JCRB1544
DR   Wikidata; Q54832282
RX   PubMed=18420831;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient undergoing hysterectomy (PubMed=18420831).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
ST   Source(s): JCRB=JCRB1544
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W32 ! EMC100
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   EMCi127-A
AC   CVCL_YZ93
SY   EMC127i-A; ACD871C4
DR   hPSCreg; EMCi127-A
DR   Wikidata; Q98125962
RX   PubMed=32169823;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3809; FOXF1; Simple; p.Leu56Val (c.166C>G); ClinVar=VCV000869491; Zygosity=Heterozygous (PubMed=32169823).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98809; Alveolar capillary dysplasia
DI   ORDO; Orphanet_210122; Congenital alveolar capillary dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ94 ! EMCi127-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   EMCi127-B
AC   CVCL_YZ94
SY   EMC127i-B; ACD871C8
DR   hPSCreg; EMCi127-B
DR   Wikidata; Q98125964
RX   PubMed=32169823;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3809; FOXF1; Simple; p.Leu56Val (c.166C>G); ClinVar=VCV000869491; Zygosity=Heterozygous (PubMed=32169823).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98809; Alveolar capillary dysplasia
DI   ORDO; Orphanet_210122; Congenital alveolar capillary dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ93 ! EMCi127-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   EMCi128-A
AC   CVCL_YZ95
SY   EMC128i-A; ACD874C9
DR   hPSCreg; EMCi128-A
DR   Wikidata; Q98125965
RX   PubMed=32169823;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3809; FOXF1; Simple; p.Phe85Ile (c.253T>A); Zygosity=Heterozygous (PubMed=32169823).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98809; Alveolar capillary dysplasia
DI   ORDO; Orphanet_210122; Congenital alveolar capillary dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   EMCi169-A
AC   CVCL_D0VD
SY   Clone_1
DR   BioSamples; SAMEA114004130
DR   hPSCreg; EMCi169-A
DR   Wikidata; Q123031234
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VE ! EMCi169-B
OI   CVCL_D0VF ! EMCi169-C
OI   CVCL_D0VG ! EMCi169-D
OI   CVCL_D0VH ! EMCi169-E
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   EMCi169-B
AC   CVCL_D0VE
SY   Clone_3
DR   BioSamples; SAMEA114023698
DR   hPSCreg; EMCi169-B
DR   Wikidata; Q123031235
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VD ! EMCi169-A
OI   CVCL_D0VF ! EMCi169-C
OI   CVCL_D0VG ! EMCi169-D
OI   CVCL_D0VH ! EMCi169-E
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   EMCi169-C
AC   CVCL_D0VF
SY   Clone_9
DR   BioSamples; SAMEA114071816
DR   hPSCreg; EMCi169-C
DR   Wikidata; Q123031236
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VD ! EMCi169-A
OI   CVCL_D0VE ! EMCi169-B
OI   CVCL_D0VG ! EMCi169-D
OI   CVCL_D0VH ! EMCi169-E
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   EMCi169-D
AC   CVCL_D0VG
SY   Clone_4
DR   BioSamples; SAMEA114071817
DR   hPSCreg; EMCi169-D
DR   Wikidata; Q123031237
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VD ! EMCi169-A
OI   CVCL_D0VE ! EMCi169-B
OI   CVCL_D0VF ! EMCi169-C
OI   CVCL_D0VH ! EMCi169-E
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   EMCi169-E
AC   CVCL_D0VH
SY   Clone_11
DR   BioSamples; SAMEA114072284
DR   hPSCreg; EMCi169-E
DR   Wikidata; Q123031238
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VD ! EMCi169-A
OI   CVCL_D0VE ! EMCi169-B
OI   CVCL_D0VF ! EMCi169-C
OI   CVCL_D0VG ! EMCi169-D
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   EMCi225-A
AC   CVCL_D0VI
SY   Clone_2
DR   BioSamples; SAMEA113416300
DR   hPSCreg; EMCi225-A
DR   Wikidata; Q123031239
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:5035; HNRNPC; Simple; p.Arg284_Asp292del (c.850_876del); ClinVar=VCV000973074; Zygosity=Heterozygous (PubMed=37541189).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VJ ! EMCi225-B
OI   CVCL_D0VK ! EMCi225-C
OI   CVCL_D0VL ! EMCi225-D
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   EMCi225-B
AC   CVCL_D0VJ
SY   Clone_5
DR   BioSamples; SAMEA114072401
DR   hPSCreg; EMCi225-B
DR   Wikidata; Q123031240
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:5035; HNRNPC; Simple; p.Arg284_Asp292del (c.850_876del); ClinVar=VCV000973074; Zygosity=Heterozygous (PubMed=37541189).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VI ! EMCi225-A
OI   CVCL_D0VK ! EMCi225-C
OI   CVCL_D0VL ! EMCi225-D
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   EMCi225-C
AC   CVCL_D0VK
SY   Clone_6
DR   BioSamples; SAMEA114072402
DR   hPSCreg; EMCi225-C
DR   Wikidata; Q123031241
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:5035; HNRNPC; Simple; p.Arg284_Asp292del (c.850_876del); ClinVar=VCV000973074; Zygosity=Heterozygous (PubMed=37541189).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VI ! EMCi225-A
OI   CVCL_D0VJ ! EMCi225-B
OI   CVCL_D0VL ! EMCi225-D
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   EMCi225-D
AC   CVCL_D0VL
SY   Clone_8
DR   BioSamples; SAMEA114072403
DR   hPSCreg; EMCi225-D
DR   Wikidata; Q123031242
RX   PubMed=37541189;
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:5035; HNRNPC; Simple; p.Arg284_Asp292del (c.850_876del); ClinVar=VCV000973074; Zygosity=Heterozygous (PubMed=37541189).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VI ! EMCi225-A
OI   CVCL_D0VJ ! EMCi225-B
OI   CVCL_D0VK ! EMCi225-C
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   EMCi230-A
AC   CVCL_C1PM
SY   EMC230i
DR   BioSamples; SAMEA11722233
DR   hPSCreg; EMCi230-A
DR   Wikidata; Q114311371
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   EMCi238-A
AC   CVCL_C1PN
DR   BioSamples; SAMEA11646665
DR   hPSCreg; EMCi238-A
DR   Wikidata; Q114311372
CC   From: Erasmus University Medical Center; Rotterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   EMe-NH6W523K17
AC   CVCL_A0KN
SY   403-S7-KI-17
DR   Wikidata; Q108820191
RX   PubMed=34182254;
CC   From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11079; SLC9A6; Simple_corrected; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=34182254).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C181001; Intellectual developmental disorder, X-linked syndromic, Christianson type
DI   ORDO; Orphanet_85278; Christianson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0KL ! EMe-NH6W523XS7
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   EMe-NH6W523K5
AC   CVCL_A0KM
SY   403-S7-KI-5
DR   Wikidata; Q108820192
RX   PubMed=34182254;
CC   From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11079; SLC9A6; Simple_corrected; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=34182254).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C181001; Intellectual developmental disorder, X-linked syndromic, Christianson type
DI   ORDO; Orphanet_85278; Christianson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0KL ! EMe-NH6W523XS7
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   EMe-NH6W523S1
AC   CVCL_A0KK
SY   Ctl-404-S1
DR   Wikidata; Q108820193
RX   PubMed=34182254;
CC   From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   EMe-NH6W523XS7
AC   CVCL_A0KL
SY   CS-403-S7
DR   Wikidata; Q108820194
RX   PubMed=34182254;
CC   From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11079; SLC9A6; Simple; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous (PubMed=34182254).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C181001; Intellectual developmental disorder, X-linked syndromic, Christianson type
DI   ORDO; Orphanet_85278; Christianson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   EMF-011
AC   CVCL_B7S1
DR   Wikidata; Q112929537
WW   Provider; Fox Chase; -; https://www.foxchase.org/sites/default/files/assets/310-MC.pdf
WW   Provider; Fox Chase; -; https://www.foxchase.org/sites/default/files/assets/503-MC_Summary.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7S0 ! FC-IBC-02
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   EMJ
AC   CVCL_E583
SY   EMJH
DR   dbMHC; 48778
DR   ECACC; 86021103
DR   IHW; IHW09097
DR   IPD-IMGT/HLA; 10562
DR   Wikidata; Q54832283
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01,03:01:01:01; B*40:01:02:01; C*03:04:01:01; DPA1*01; DPB1*03:01:01,04:01:01; DQA1*01:02:01; DQB1*06:04:01; DRA*01:02; DRB1*13:02:01; DRB3*03:01:01 (IPD-IMGT/HLA=10562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   EMK
AC   CVCL_RG61
SY   Epinephelus Moara Kidney
DR   Wikidata; Q54832284
RX   PubMed=29214431;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by Singapore grouper iridovirus (SGIV) or nervous necrosis virus (NNV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=300413; ! Epinephelus moara (Kelp grouper)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   EMK-F7
AC   CVCL_B6CK
DR   Wikidata; Q111733197
RX   PubMed=1368811;
RX   PubMed=2121682;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Human antigen on stomach cancer cell lines.
CC   Anecdotal: The peripheral blood cells that were hybridized with the HO-323 cell line were obtained from Kotaro Koyama who injected himself with stomach cancer cell lines MKN-28 and MKN-45 (PubMed=2121682).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   EML clone 1
AC   CVCL_9107
SY   EML C1; EML C.1; EML Cell Line, Clone 1; EML
DR   CLO; CLO_0002925
DR   ABM; T0679
DR   ATCC; CRL-3610
DR   ATCC; CRL-11691
DR   Wikidata; Q54832285
RX   Patent=US5830760;
RX   PubMed=7995521;
RX   PubMed=9808058;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11691.
CC   Characteristics: KITLG dependent.
CC   Doubling time: 18-20 hours (PubMed=7995521).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=With p.Gly404_Pro462del = RARalpha403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: ABM wrongly indicates that this cell line is immortalized using SV40 (ABM=T0679).
CC   Discontinued: ATCC; CRL-11691; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Factor-dependent cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   EML clone 1.4
AC   CVCL_D1L0
SY   EML C1.4
DR   Wikidata; Q127380818
RX   PubMed=7995521;
CC   Characteristics: KITLG dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9107 ! EML clone 1
SX   Male
CA   Factor-dependent cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   EML-3C
AC   CVCL_7190
SY   EML3C; Equine Macrophage Like-3C
DR   ATCC; CRL-2996
DR   Wikidata; Q54832286
RX   PubMed=19038510;
CC   Misspelling: EMBL3C; Note=In Cellosaurus releases 7 to 34.
CC   Discontinued: ATCC; CRL-2996; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: Portuguese Garrano; VBO=VBO_0011693.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   Emma-brain
AC   CVCL_0C96
SY   EmmaBrain; Emma-HSA; Emma; EFB
DR   GEO; GSM1122236
DR   Kerafast; EMN010-FP
DR   Wikidata; Q54832287
RX   PubMed=19461996;
RX   PubMed=24582862;
RX   PubMed=28029283;
RX   PubMed=30601866;
CC   Doubling time: ~5-7 days (Kerafast=EMN010-FP).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_5I29 ! Emma-spleen
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 18
//
ID   Emma-spleen
AC   CVCL_5I29
SY   EmmaSpleen; EFS
DR   GEO; GSM1122237
DR   Kerafast; EMN011-FP
DR   Wikidata; Q54832288
RX   PubMed=24582862;
RX   PubMed=30601866;
CC   Doubling time: ~3 days (Kerafast=EMN011-FP).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_0C96 ! Emma-brain
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   EMosis-CC/TERT1
AC   CVCL_YZ48
SY   EMOsis-CC/TERT1; EMosis-CC/TERT-1
DR   Wikidata; Q98125966
RX   PubMed=22353808;
RX   PubMed=28482330;
RX   PubMed=32106286;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ50 ! EMosis-E6/E7/TERT1
SX   Female
AG   27Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   EMosis-CC/TERT1/ER
AC   CVCL_YZ49
SY   EMOsis-CC/TERT1/ER
DR   Wikidata; Q98125967
RX   PubMed=22353808;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ48 ! EMosis-CC/TERT1
SX   Female
AG   27Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   EMosis-CC/TERT1/PRA
AC   CVCL_YZ78
DR   Wikidata; Q98125968
RX   PubMed=28482330;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8910; PGR (Note=Isoform A).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ48 ! EMosis-CC/TERT1
SX   Female
AG   27Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   EMosis-CC/TERT1/PRA-/PRB+
AC   CVCL_YZ79
DR   Wikidata; Q98125969
RX   PubMed=28482330;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8910; PGR (Note=Isoform B).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ48 ! EMosis-CC/TERT1
SX   Female
AG   27Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   EMosis-E6/E7/TERT1
AC   CVCL_YZ50
DR   Wikidata; Q98125971
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ48 ! EMosis-CC/TERT1
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   EMosis-CC/TERT2
AC   CVCL_YZ51
SY   EMOsis-CC/TERT2
DR   Wikidata; Q98125972
RX   PubMed=22353808;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ52 ! EMosis-E6/E7/TERT2
SX   Female
AG   44Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   EMosis-E6/E7/TERT2
AC   CVCL_YZ52
DR   Wikidata; Q98125973
RX   PubMed=22353808;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ51 ! EMosis-CC/TERT2
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   EMRK1184
AC   CVCL_C5RW
SY   EMRK-1184
DR   ChEMBL-Cells; CHEMBL4569157
DR   ChEMBL-Targets; CHEMBL4569158
DR   Wikidata; Q116048932
RX   PubMed=30069049;
CC   Characteristics: Established from a tumor resulting from the expression of Myc under the control of the IgH enhancer (PubMed=30069049).
CC   Transformant: Myc.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   EMRK1184luc
AC   CVCL_C5RX
DR   GEO; GSE114962
DR   Wikidata; Q116048933
RX   PubMed=30069049;
CC   Characteristics: Established from a tumor resulting from the expression of Myc under the control of the IgH enhancer (PubMed=30069049).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: Myc.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C5RW ! EMRK1184
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   EMS-3
AC   CVCL_WN68
DR   Wikidata; Q93540346
RX   PubMed=11332741;
WW   Info; -; -; https://www.nasa.gov/mission/station/research-explorer/investigation/?#id=978
CC   Group: Space-flown cell line (cellonaut).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Anecdotal: Have been flown in space on the ISS in 2011 to study growth in microgravity.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 4
//
ID   EMT-1
AC   CVCL_W832
SY   Equine Melanoma Tokyo-1
DR   Wikidata; Q54832289
RX   DOI=10.1294/jes.11.75;
CC   Doubling time: 42 hours (DOI=10.1294/jes.11.75).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
DI   NCIt; C134569; Horse melanoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   EMT-2
AC   CVCL_W833
SY   Equine Melanoma Tokyo-2
DR   Wikidata; Q54832290
RX   DOI=10.1294/jes.11.75;
CC   Doubling time: 33 hours (DOI=10.1294/jes.11.75).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
DI   NCIt; C134569; Horse melanoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   EMT-3
AC   CVCL_W834
SY   Equine Melanoma Tokyo-3
DR   Wikidata; Q54832291
RX   DOI=10.1294/jes.11.75;
CC   Doubling time: 32 hours (DOI=10.1294/jes.11.75).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
DI   NCIt; C134569; Horse melanoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   EMT-6-1.1(1)
AC   CVCL_4T81
DR   Wikidata; Q54832292
RX   Patent=US6013520;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12184.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27967; Barley nitrate reductase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 8
//
ID   EMT-6-1.1(2)
AC   CVCL_4T82
DR   Wikidata; Q54832293
RX   Patent=US6013520;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12185.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27967; Barley nitrate reductase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 8
//
ID   EMT6
AC   CVCL_1923
SY   EMT-6; Experimental Mammary Tumour-6
DR   BTO; BTO_0003329
DR   CLO; CLO_0002926
DR   ATCC; CRL-2755
DR   BioGRID_ORCS_Cell_line; 1262
DR   BioSample; SAMN11397651
DR   ChEMBL-Cells; CHEMBL3307584
DR   ChEMBL-Targets; CHEMBL614294
DR   CLS; 305159
DR   NCI-DTP; EMT-6
DR   PubChem_Cell_line; CVCL_1923
DR   Wikidata; Q54832294
RX   PubMed=4647494;
RX   PubMed=31220119;
CC   Characteristics: Established from the transplantable mammary tumour KHJJ.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 13,15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 24
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   EMT6-eGFP-Neo/Fluc-Puro
AC   CVCL_D5KD
DR   Imanis; CL155
DR   Wikidata; Q127380819
CC   Characteristics: Reporter cell line, transduced with both the LV-eGFP-P2A-Neo and LV-Fluc-P2A-Puro vectors. LV-eGFP-P2A-Neo encodes for eGFP linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter and LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL155).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   EMT6-eGFP-Puro
AC   CVCL_D5KC
DR   Imanis; CL153
DR   Wikidata; Q127380820
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL153).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   EMT6-Fluc-Puro
AC   CVCL_D5KE
DR   Imanis; CL154
DR   Wikidata; Q127380821
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL154).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   EMT6-LM2
AC   CVCL_RS43
SY   EMT6-Lung Metastasis passage 2
DR   Wikidata; Q54832295
RX   PubMed=29467918;
CC   Characteristics: Established from parent cell line by two passages in nude mice from spontaneous lung metastases following subcutaneous growth.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 6
//
ID   EMT6/AR1
AC   CVCL_1924
SY   EMT6/AR1.0; EMT6/AR 1.0
DR   ECACC; 96042327
DR   Wikidata; Q54832296
RX   PubMed=1968761;
RX   PubMed=2571735;
CC   Doubling time: 12-15 hours (ECACC=96042327).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4173 ! EMT6/P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   EMT6/AR10.0
AC   CVCL_1925
SY   EMT6/AR 10.0
DR   ECACC; 96042326
DR   Wikidata; Q54832297
RX   PubMed=2571735;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4173 ! EMT6/P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   EMT6/CPR
AC   CVCL_4171
DR   ECACC; 96042318
DR   Wikidata; Q54832298
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4173 ! EMT6/P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   EMT6/MTXR
AC   CVCL_4172
SY   EMT6/MR 1.0
DR   ECACC; 96042322
DR   Wikidata; Q54832299
RX   PubMed=2571735;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4173 ! EMT6/P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   EMT6/P
AC   CVCL_4173
SY   EMT6/Parent
DR   ECACC; 96042344
DR   Wikidata; Q54832300
RX   PubMed=1968761;
RX   PubMed=2571735;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   EMT6/Ro
AC   CVCL_C8D2
SY   EMT6/Rochester
DR   Wikidata; Q123031243
RX   PubMed=2303323;
RX   PubMed=2303324;
RX   PubMed=6695045;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1923 ! EMT6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 3
//
ID   EMT6/VCR/R
AC   CVCL_4174
DR   ECACC; 96042323
DR   Wikidata; Q54832301
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4173 ! EMT6/P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   EMT6/VRP/R
AC   CVCL_4175
SY   EMT6/VRP
DR   ECACC; 96042319
DR   Wikidata; Q54832302
RX   PubMed=1968761;
CC   Selected for resistance to: ChEBI; CHEBI_9948; Verapamil (VPL).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cCRGL.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4173 ! EMT6/P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   EMTOKA
AC   CVCL_E115
DR   cancercelllines; CVCL_E115
DR   Cell_Model_Passport; SIDM01806
DR   DepMap; ACH-001495
DR   JCRB; JCRB1601
DR   Wikidata; Q54832303
RX   PubMed=8431860;
RX   PubMed=9311600;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 66 hours (PubMed=8431860).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (DepMap=ACH-001495).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): DepMap=ACH-001495; JCRB=JCRB1601
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   EMTOKA 107
AC   CVCL_A1IL
DR   cancercelllines; CVCL_A1IL
DR   Wikidata; Q102113786
RX   PubMed=9311600;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E115 ! EMTOKA
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EMTOKA 107-D1
AC   CVCL_A1IM
DR   cancercelllines; CVCL_A1IM
DR   Wikidata; Q102113787
RX   PubMed=9311600;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1IL ! EMTOKA 107
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EMTOKA 117
AC   CVCL_A1IN
DR   cancercelllines; CVCL_A1IN
DR   Wikidata; Q102113788
RX   PubMed=9311600;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E115 ! EMTOKA
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EMTOKA 124
AC   CVCL_A1IP
DR   cancercelllines; CVCL_A1IP
DR   Wikidata; Q102113789
RX   PubMed=9311600;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E115 ! EMTOKA
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EMTOKA 2B10
AC   CVCL_A1IQ
DR   cancercelllines; CVCL_A1IQ
DR   Wikidata; Q102113791
RX   PubMed=9311600;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E115 ! EMTOKA
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EMTOKA 5D9
AC   CVCL_A1IR
DR   cancercelllines; CVCL_A1IR
DR   Wikidata; Q102113792
RX   PubMed=9311600;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E115 ! EMTOKA
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EMTOKA 5E4
AC   CVCL_A1IS
DR   cancercelllines; CVCL_A1IS
DR   Wikidata; Q102113793
RX   PubMed=9311600;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E115 ! EMTOKA
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   EN
AC   CVCL_2034
DR   CLO; CLO_0037161
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473481
DR   BioSample; SAMN10988280
DR   cancercelllines; CVCL_2034
DR   Cell_Model_Passport; SIDM01045
DR   Cosmic; 1576453
DR   Cosmic; 1995393
DR   Cosmic; 2030463
DR   Cosmic-CLP; 1240127
DR   DepMap; ACH-000978
DR   DSMZ; ACC-564
DR   DSMZCellDive; ACC-564
DR   EGA; EGAS00001000978
DR   GDSC; 1240127
DR   GEO; GSM887005
DR   GEO; GSM888074
DR   GEO; GSM1669765
DR   IARC_TP53; 17882
DR   LiGeA; CCLE_777
DR   LINCS_LDP; LCL-1495
DR   PharmacoDB; EN_334_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2034
DR   TKG; TKG 0665
DR   Wikidata; Q54832304
RX   PubMed=12581894;
RX   PubMed=20944090;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 24.4 hours (PubMed=12581894); ~50-80 hours (DSMZ=ACC-564).
CC   HLA typing: A*24:02,26:01; B*35:01,54:01; C*01:02,03:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu186Valfs (c.556C>CG); Zygosity=Heterozygous (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Leu264Pro (c.791T>C); Zygosity=Heterozygous (Cosmic-CLP=1240127; DepMap=ACH-000978).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Glnfs (c.817_818insA); Zygosity=Unspecified (PubMed=12581894).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.78%; Native American=0%; East Asian, North=80.75%; East Asian, South=16.89%; South Asian=0%; European, North=0.4%; European, South=1.18% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Cosmic-CLP=1240127; DSMZ=ACC-564; TKG=TKG 0665
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 16,17
ST   D21S11: 30,34.2
ST   D2S1338: 20,25
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 11 (Cosmic-CLP=1240127; TKG=TKG 0665)
ST   D7S820: 11,11.1 (DSMZ=ACC-564)
ST   D8S1179: 15,17
ST   FGA: 18,19,20
ST   Penta D: 10,13
ST   Penta E: 11,17
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   En Son
AC   CVCL_U774
SY   EN SON; EnSon
DR   ATCC; CRL-1139
DR   Wikidata; Q54832305
RX   DOI=10.1016/B978-012361946-4/50009-0;
CC   Discontinued: ATCC; CRL-1139; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   EN-1
AC   CVCL_C7TA
DR   Wikidata; Q117704312
RX   PubMed=12354749;
DI   NCIt; C3007; Enchondroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   EN-1078D
AC   CVCL_A423
SY   EN1078D; En1078D
DR   CancerTools; 161896
DR   Cosmic; 1576454
DR   Wikidata; Q54832306
RX   PubMed=17894888;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 14.3 hours (Note=At 13th passage), 13.8 hours (Note=At 23th passage) (PubMed=17894888).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 12
ST   D21S11: 29,30
ST   D5S818: 9,13
ST   D7S820: 8,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   EN-2
AC   CVCL_C7TB
DR   Wikidata; Q117704313
RX   PubMed=12354749;
DI   NCIt; C3007; Enchondroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   11Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   EN-L2C
AC   CVCL_JX20
DR   Wikidata; Q54832307
RX   PubMed=62799;
RX   PubMed=1034020;
RX   PubMed=1262783;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
DI   NCIt; C134564; Guinea pig leukemia
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
HI   CVCL_2547 ! L2C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 7
//
ID   EN-MSC/TERT352-B
AC   CVCL_F0RB
DR   Evercyte; CHT-060-0352-B
CC   Doubling time: 24-26 hours (Evercyte=CHT-060-0352-B).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
ST   Source(s): Evercyte=CHT-060-0352-B
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22,23
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   EN-TRL-67T
AC   CVCL_DH77
SY   EN-TRL 67T; EN-TRL67T
DR   Wikidata; Q54832308
RX   PubMed=19222485;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 6
//
ID   EN7
AC   CVCL_RU20
SY   PureStem EN7 progenitor; ACTC184
DR   Wikidata; Q54832313
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-184; https://web.archive.org/web/20141202091542/http://www.esibio.com/purestemr-en7-progenitor/
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Senescence: Can undergo >50 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   EN9F10
AC   CVCL_J899
DR   CLO; CLO_0002927
DR   ATCC; CRL-2403
DR   Wikidata; Q54832314
RX   DOI=10.1080/09540109109354743;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_4822; Ergometrine (Ergonovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   ENA
AC   CVCL_E584
DR   dbMHC; 48779
DR   IHW; IHW09260
DR   IPD-IMGT/HLA; 10564
DR   Wikidata; Q54832315
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*34:01:01; B*56:02; DPA1*01:03; DPB1*02:01:02 (IPD-IMGT/HLA=10564).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   ENAMI-1
AC   CVCL_RX89
SY   ENAM I; ENAMI
DR   Wikidata; Q54832316
RX   CelloPub=CLPUB00141;
RX   CelloPub=CLPUB00142;
RX   PubMed=6682628;
CC   Population: Japanese.
CC   Doubling time: 72 hours (CelloPub=CLPUB00142).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   EnCL-1
AC   CVCL_F705
SY   Endothelial Corpus Luteum-1
DR   Wikidata; Q54832317
RX   PubMed=21349168;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, corpus luteum; UBERON=UBERON_0002512.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   End M
AC   CVCL_WG35
DR   IBRC; C10128
DR   Wikidata; Q93540577
CC   Population: Iranian; Persian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   END-1
AC   CVCL_B5JE
DR   Wikidata; Q111733198
RX   PubMed=380083;
RX   PubMed=1176207;
RX   PubMed=6171715;
CC   Characteristics: Established from an undifferentiated endometrial carcinoma serially transplanted into nude mice (PubMed=1176207).
CC   Doubling time: 14 hours (PubMed=1176207).
DI   NCIt; C40156; Endometrial undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   END-2
AC   CVCL_B5KE
DR   Wikidata; Q111733199
RX   PubMed=1176207;
CC   Characteristics: Established from an undifferentiated endometrial carcinoma serially transplanted into nude mice (PubMed=1176207).
CC   Doubling time: 16 hours (PubMed=1176207).
DI   NCIt; C40156; Endometrial undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   End1/E6E7
AC   CVCL_3684
SY   END1/E6E7
DR   CLO; CLO_0002928
DR   ATCC; CRL-2615
DR   BioSample; SAMN03471694
DR   Wikidata; Q54832318
RX   PubMed=9314589;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-2615
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 19,20
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 11
ST   FGA: 21,23
ST   Penta D: 10,12
ST   Penta E: 12,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3679 ! Ect1/E6E7
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   Endeavour-1
AC   CVCL_6966
SY   Endeavour 1; E1; POWHe001-A
DR   CCRID; 4201PAT-CCTCC00177
DR   hPSCreg; POWHe001-A
DR   SKIP; SKIP001922
DR   Wikidata; Q54832319
RX   Patent=US20070160974;
RX   PubMed=18271699;
CC   Group: Patented cell line.
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-14.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200602.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 19
//
ID   Endeavour-2
AC   CVCL_9003
SY   Endeavour 2; E2; POWHe002-A
DR   hPSCreg; POWHe002-A
DR   NIHhESC; NIHhESC-10-0073
DR   SKIP; SKIP001978
DR   Wikidata; Q54832320
RX   PubMed=20178001;
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0073.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   Endo.4M
AC   CVCL_1E64
SY   Endo.4M GFP
DR   Wikidata; Q54832321
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20150509040552/http://axiogenesis.com/products/murine-endothelial-cells/endo-4m.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Characteristics: Expression of GFP is under the control of the endothelial cell-specific Flt1 promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 9
//
ID   endo-iPS 10
AC   CVCL_YD72
SY   endo-iPS clone 10
DR   Wikidata; Q93540623
RX   PubMed=20160486;
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD73 ! endo-iPS 12
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   endo-iPS 12
AC   CVCL_YD73
SY   endo-iPS clone 12
DR   Wikidata; Q93540627
RX   PubMed=20160486;
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD72 ! endo-iPS 10
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   Endo-kun
AC   CVCL_A2BM
SY   Endokun
DR   IARC_TP53; 28431
DR   Wikidata; Q105506829
RX   PubMed=20147975;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:4977; HLF + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-HLF, E2A-HLF (PubMed=20147975).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C199241; B acute lymphoblastic leukemia with TCF3-HLF rearrangement
DI   ORDO; Orphanet_641375; B-lymphoblastic leukemia/lymphoma with t(17;19)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 7
//
ID   EndoC-betaH1
AC   CVCL_L909
SY   EndoC-BH1
DR   GEO; GSE118588
DR   GEO; GSM7029168
DR   GEO; GSM7029169
DR   GEO; GSM7029170
DR   GEO; GSM7029171
DR   GEO; GSM7029172
DR   PRIDE; PXD027920
DR   Wikidata; Q54832322
RX   PubMed=21865645;
RX   PubMed=21865653;
RX   PubMed=25803449;
RX   PubMed=25822155;
RX   PubMed=26901817;
RX   PubMed=29307512;
RX   PubMed=30251567;
RX   PubMed=31976379;
WW   Provider; Human Cell Design; -; https://www.humancelldesign.com/endoc-bh1/
CC   Characteristics: Secretes insulin in response to glucose challenge.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (PubMed=26901817).
CC   Doubling time: 5 days (PubMed=21865645); 174 hours (PubMed=25803449).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9me2.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sex assignment derived from omics analysis.
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-11FW
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 25
//
ID   EndoC-betaH1 IDE-KO
AC   CVCL_YB06
DR   Wikidata; Q93540644
RX   PubMed=31976379;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9n; HGNC; HGNC:5381; IDE.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L909 ! EndoC-betaH1
SX   Female
AG   7-11FW
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   EndoC-betaH1 INS-KO
AC   CVCL_YB07
DR   Wikidata; Q93540650
RX   PubMed=31976379;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9n; HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L909 ! EndoC-betaH1
SX   Female
AG   7-11FW
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   EndoC-betaH1 NEUROD1-KO
AC   CVCL_YB08
DR   Wikidata; Q93540654
RX   PubMed=31976379;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9n; HGNC; HGNC:7762; NEUROD1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L909 ! EndoC-betaH1
SX   Female
AG   7-11FW
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   EndoC-betaH1 PAM-KO
AC   CVCL_YB09
DR   Wikidata; Q93540660
RX   PubMed=31976379;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9n; HGNC; HGNC:8596; PAM.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L909 ! EndoC-betaH1
SX   Female
AG   7-11FW
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   EndoC-betaH1 SLC30A8-KO
AC   CVCL_YB10
DR   Wikidata; Q93540663
RX   PubMed=31976379;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9n; HGNC; HGNC:20303; SLC30A8.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L909 ! EndoC-betaH1
SX   Female
AG   7-11FW
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   EndoC-betaH2
AC   CVCL_IS71
SY   EndoC-BH2
DR   GEO; GSE48101
DR   Wikidata; Q54832323
RX   PubMed=24667639;
RX   PubMed=26901817;
RX   PubMed=26909308;
WW   Provider; Human Cell Design; -; https://web.archive.org/web/20170502035118/http://www.endocells.com/products-and-services/
CC   Characteristics: The lentiviral vector insert containing the SV40 LT and hTERT can be excised by the Cre recombinase. Following excision of immortalizing transgenes, cell proliferation sharply decreases and in parallel there is a massive enhancement of beta cell-specific features such as increased INS gene expression.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (PubMed=26901817).
CC   Doubling time: 5-7 days (PubMed=24667639).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9FW
CA   Conditionally immortalized cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 13
//
ID   EndoC-betaH2-OFP-GFZ
AC   CVCL_A1TU
DR   Wikidata; Q105506832
RX   PubMed=25259951;
CC   Characteristics: The lentiviral vector insert containing the SV40 LT and hTERT can be excised by the Cre recombinase upon addition of tamixofen. Following excision of immortalizing transgenes, cell proliferation sharply decreases and in parallel there is a massive enhancement of beta cell-specific features such as increased INS gene expression.
CC   Characteristics: Transduced with the Fucci probe which consist of the fusion of monomeric Kusabira-Orange2 (mKO2) to the ubiquitination domain of human CDT1 (AA 30-120) and monomeric AzamiGreen (mAG) to the ubiquitination domain of human geminin (AA 1-110).
CC   Characteristics: In this cell line the Fucci probe was produced by transducing two different constructs: LTR-mKO2/CDT1-IRES-PuroR-LTR and LTR-mAG/GMNN-IRES-ZeoR-LTR.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; HC91W; AzamiGreen (Note=Green fluorescent protein from G.fascicularis).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 134NN; mKusabira-Orange2 (Note=mKO2, orange fluorescent protein derived from F.concinna Kusabira-Orange (KO)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IS71 ! EndoC-betaH2
SX   Sex unspecified
AG   9FW
CA   Conditionally immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 12
//
ID   EndoC-betaH21-PGF2AOF
AC   CVCL_A1TV
DR   Wikidata; Q105506836
RX   PubMed=25259951;
CC   Characteristics: The lentiviral vector insert containing the SV40 LT and hTERT can be excised by the Cre recombinase upon addition of tamixofen. Following excision of immortalizing transgenes, cell proliferation sharply decreases and in parallel there is a massive enhancement of beta cell-specific features such as increased INS gene expression.
CC   Characteristics: Transduced with the Fucci probe which consist of the fusion of monomeric Kusabira-Orange2 (mKO2) to the ubiquitination domain of human CDT1 (AA 30-120) and monomeric AzamiGreen (mAG) to the ubiquitination domain of human geminin (AA 1-110).
CC   Characteristics: In this cell line the Fucci probe was produced by transducing with a construct LTR-PuroR-IRES-mAG/GMNN-2A-mKO2/CDT1-LTR.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; HC91W; AzamiGreen (Note=Green fluorescent protein from G.fascicularis).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 134NN; mKusabira-Orange2 (Note=mKO2, orange fluorescent protein derived from F.concinna Kusabira-Orange (KO)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IS71 ! EndoC-betaH2
SX   Sex unspecified
AG   9FW
CA   Conditionally immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 12
//
ID   EndoC-betaH3
AC   CVCL_IS72
SY   EndoC-BH3
DR   Wikidata; Q54832324
RX   PubMed=26909308;
WW   Provider; Human Cell Design; -; https://www.humancelldesign.com/endoc-bh3/
CC   Characteristics: The lentiviral vector insert containing the SV40 LT and hTERT can be excised by the Cre recombinase upon addition of tamixofen. Following excision of immortalizing transgenes, cell proliferation sharply decreases and in parallel there is a massive enhancement of beta cell-specific features such as increased INS gene expression.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IS71 ! EndoC-betaH2
SX   Sex unspecified
AG   9FW
CA   Conditionally immortalized cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 13
//
ID   EndoC-betaH5
AC   CVCL_C7TU
SY   EndoC-BH5
DR   GEO; GSM7029173
DR   GEO; GSM7029174
DR   GEO; GSM7029175
DR   GEO; GSM7029176
DR   GEO; GSM7029177
DR   Wikidata; Q117704314
RX   PubMed=37442376;
WW   Provider; Human Cell Design; -; https://www.humancelldesign.com/endoc-bh5/
CC   Characteristics: Displays robust GLP-1 and GIP receptor activity associated with insulin content and glucose stimulated insulin secretion levels, close to those of native human beta cells (Human Cell Design).
CC   Characteristics: First transduced with two vectors pTRIP DeltaU3loxP-pY-TK-RIP405-SV40LT and pTRIP DeltaU3loxP-pY-TK-RIP405-SV40-hTERT where RIP405 is a beta cell specific rat insulin promoter and pY, the polyoma virus enhancer. Was then transduced with a Lv-RIP-CreERT2, treated with tamoxifen and gancyclovir thus removing the SV40LT and hTERT immortalizing genes as well as HSV-1 TK (PubMed=37442376).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8FW
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   EndoC-betaH5 HLA-A2
AC   CVCL_E7A7
SY   EndoC-betaH5-HLA-A2; HLA-A2 EndoC-betaH5
RX   PubMed=37442376;
WW   Provider; Human Cell Design; BH5-A2-350; https://www.humancelldesign.com/hla-a2-endoc-bh5/
CC   Characteristics: Combines T-cell killing attack with measuring the indirect impact on insulin secretion and function loss (Human Cell Design=BH5-A2-350).
CC   Characteristics: First transduced with two vectors pTRIP DeltaU3loxP-pY-TK-RIP405-SV40LT and pTRIP DeltaU3loxP-pY-TK-RIP405-SV40-hTERT where RIP405 is a beta cell specific rat insulin promoter and pY, the polyoma virus enhancer. Was then transduced with a Lv-RIP-CreERT2, treated with tamoxifen and gancyclovir thus removing the SV40LT and hTERT immortalizing genes as well as HSV-1 TK (from parent cell line).
CC   Characteristics: Transduced with a HLA-A2-IRES-PuroR construct (PubMed=37442376).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7TU ! EndoC-betaH5
SX   Female
AG   8FW
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Endor-CLS
AC   CVCL_5740
DR   CLS; 600173
DR   Wikidata; Q54832325
CC   Discontinued: CLS; 600173; true.
CC   Derived from site: In situ; Vein, endothelium; UBERON=UBERON_0001919.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   ENG-R
AC   CVCL_0I69
DR   CCLV; CCLV-RIE 0242
DR   Wikidata; Q54832326
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   ENKL-J1
AC   CVCL_E8FI
DR   GEO; GSM7985990
RX   PubMed=38029851;
CC   Population: Japanese.
CC   Characteristics: Eprenetapopt, tazemetostat and vorinostat efficiently induced apoptosis in this cell line (PubMed=38029851).
CC   Doubling time: 80.6 hours (Note=In normoxic culture conditions), 66.46 hours (Note=In hypoxic culture conditions, 1% O2) (PubMed=38029851).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Pro29Arg (c.86C>G); ClinVar= VCV000135316; Zygosity=Heterozygous (PubMed=38029851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (PubMed=38029851).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: NK T-cell; CL=CL_0000814.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ENL-2
AC   CVCL_A3AT
DR   CCLV; CCLV-RIE 0856
DR   Wikidata; Q105506841
RX   PubMed=31561506;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9783; ! Elephas maximus (Indian elephant)
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   ENS 53
AC   CVCL_C8J8
DR   Wikidata; Q123031244
RX   CelloPub=CLPUB00742;
RX   PubMed=4287821;
CC   Virology: Susceptible to infection by foot-and-mouth disease virus (CelloPub=CLPUB00742; PubMed=4287821).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ENStem-A
AC   CVCL_GS51
DR   Millipore; SCC003
DR   Millipore; SCR055
DR   Wikidata; Q54832327
RX   CelloPub=CLPUB00589;
RX   PubMed=24232252;
CC   Discontinued: Millipore; SCC003; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ENTZ HLC 1
AC   CVCL_B3N8
SY   HLC-1
DR   Wikidata; Q110432793
RX   PubMed=2427339;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ENTZ HLC 2
AC   CVCL_B3N9
SY   HLC-2
DR   Wikidata; Q110432794
RX   PubMed=2427339;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ENTZ HTC 1
AC   CVCL_B3NA
SY   HTC-1
DR   Wikidata; Q110432795
RX   PubMed=2427339;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ENTZ HTC 2
AC   CVCL_B3NB
SY   HTC-2
DR   Wikidata; Q110432796
RX   PubMed=2427339;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ENU-T-1
AC   CVCL_B397
SY   ENU-T1; ENUT-1
DR   Wikidata; Q54832328
RX   PubMed=1339105;
RX   PubMed=2575302;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60478; Rat nephroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   ENU1564 Br7-C5
AC   CVCL_C8F5
DR   Wikidata; Q123031245
RX   PubMed=7912494;
RX   PubMed=8039303;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Does_anyone_have_ENU1564_rat_mammary_adenocarcinoma_cells/1
CC   Characteristics: Highly metastatic. Obtained after seven passage of the parent cell line by inoculation in the left cardiac ventricle of rats and culturing of the resulting brain metastases (PubMed=7912494).
CC   Doubling time: 12.8 hours (PubMed=8039303).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Miscellaneous: Cell line no longer available (personal communication of Balinda, Henriette Uwimpuhwe).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Berlin-Druckrey IV (BD-IV); RS=RS_0000089.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8F4 ! ENU1564 FP1
SX   Female
AG   400D
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   ENU1564 FP1
AC   CVCL_C8F4
DR   Wikidata; Q123031246
RX   PubMed=8039303;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Does_anyone_have_ENU1564_rat_mammary_adenocarcinoma_cells/1
CC   Characteristics: Spontaneously metastasizes to regional lymph nodes and lung following orthotopic inoculation into mammary fat pad (mfp) and metastasizes widely following left cardiac ventricle (LV) inoculation (PubMed=8039303).
CC   Doubling time: 12 hours (PubMed=8039303).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Miscellaneous: Cell line no longer available (personal communication of Balinda, Henriette Uwimpuhwe).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Berlin-Druckrey IV (BD-IV); RS=RS_0000089.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   400D
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   ENU1564 FP2-A11
AC   CVCL_C8F6
DR   Wikidata; Q123031247
RX   PubMed=7912494;
RX   PubMed=8039303;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Does_anyone_have_ENU1564_rat_mammary_adenocarcinoma_cells/1
CC   Characteristics: Highly metastatic. Obtained by reculturing the parent cell line from a mammary fat pad (mfp) tumor. Grows slowly (PubMed=7912494).
CC   Doubling time: 27 hours (PubMed=8039303).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Miscellaneous: Cell line no longer available (personal communication of Balinda, Henriette Uwimpuhwe).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Berlin-Druckrey IV (BD-IV); RS=RS_0000089.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8F4 ! ENU1564 FP1
SX   Female
AG   400D
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   Envy
AC   CVCL_9004
SY   ENVY; hESC-ENVY; ESIBIe003-A-4; MONUe001-A; MONUe004-A-4
DR   BioSamples; SAMEA104620500
DR   hPSCreg; ESIBIe003-A-4
DR   SKIP; SKIP002281
DR   Wikidata; Q54832329
RX   PubMed=15782217;
RX   PubMed=18772870;
RX   PubMed=29503086;
CC   From: Monash University; Melbourne; Australia.
CC   Characteristics: The eGFP gene is under the control of an actin promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
ID   EO-1
AC   CVCL_B6YF
DR   Wikidata; Q111733200
RX   PubMed=28668559;
CC   Doubling time: 28.4 hours (PubMed=28668559).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: English Bulldog; VBO=VBO_0200485.
DI   NCIt; C186279; Canine cutaneous T-cell lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   EO-2
AC   CVCL_8349
SY   Eel Ovary-2
DR   Wikidata; Q54832330
RX   CelloPub=CLPUB00022;
RX   CelloPub=CLPUB00103;
RX   DOI=10.3147/jsfp.16.129;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   EO-NY
AC   CVCL_A2HI
SY   EONY#17
DR   Wikidata; Q105506844
RX   PubMed=28301575;
RX   PubMed=31519152;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17234; ANKRD30A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 7
//
ID   EO-NY/PX458/#1
AC   CVCL_A2HJ
SY   EO-NY/#1
DR   Wikidata; Q105506849
RX   PubMed=28301575;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17234; ANKRD30A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HI ! EO-NY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Eo1
AC   CVCL_D6ST
RX   PubMed=6678804;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human eosinophils, granulocytes and monocytes 95 kDa surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EO771
AC   CVCL_GR23
SY   Eo771; E0771; EO 771
DR   ATCC; CRL-3461
DR   ChEMBL-Cells; CHEMBL4483168
DR   ChEMBL-Targets; CHEMBL4483234
DR   PubChem_Cell_line; CVCL_GR23
DR   Wikidata; Q54832331
RX   PubMed=16312045;
RX   PubMed=24391448;
RX   PubMed=32699527;
RX   PubMed=33026171;
WW   Provider; CH3 Biosystems; 940001; https://ch3biosystems.com/product/e0771/
CC   Characteristics: Belongs to the luminal subtype B; ERalpha-, ERbeta+, PR+ and ErbB2+ (PubMed=32699527).
CC   Miscellaneous: STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 17,18,19
ST   Mouse STR 1-2: 20,22
ST   Mouse STR 2-1: 16,18
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 21.3,22.3,24.3
ST   Mouse STR 5-5: 17,21,22
ST   Mouse STR 6-4: 18,19,20,21
ST   Mouse STR 6-7: 15,16
ST   Mouse STR 7-1: 25.2,26,26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15.3,16.3
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17,18
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,16,17
ST   Mouse STR 18-3: 16,18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27,29
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 13
//
ID   EO771-Luc
AC   CVCL_C9CA
SY   E0771-Luc
DR   Ubigene; YC-C034-Luc-P
DR   Wikidata; Q123031248
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   EO771.lmb
AC   CVCL_B0A2
SY   E0771-LMB
DR   ATCC; CRL-3405
DR   Wikidata; Q108820195
CC   Characteristics: Metastatic to lung.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   EO771E2
AC   CVCL_VE17
SY   E0771E2
DR   Wikidata; Q54832332
RX   PubMed=24391448;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   EOC 13.31
AC   CVCL_5743
SY   EOC-13.31; EOC 13; EOC13
DR   BTO; BTO_0006390
DR   CLO; CLO_0002929
DR   ATCC; CRL-2468
DR   BCRC; 60490
DR   Wikidata; Q54832333
RX   PubMed=8550814;
RX   PubMed=22651808;
CC   Characteristics: CSF1 dependent.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10D
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   EOC 2
AC   CVCL_5744
SY   EOC-2; EOC2
DR   CLO; CLO_0002930
DR   ATCC; CRL-2467
DR   Wikidata; Q54832334
RX   PubMed=8550814;
RX   PubMed=22651808;
CC   Characteristics: CSF1 dependent.
CC   Characteristics: Do not constitutively express high levels of MHC II antigens and expression is not upregulated by recombinant murine interferon-gamma (ATCC=CRL-2467).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10D
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   EOC 20
AC   CVCL_5745
SY   EOC-20; EOC20
DR   CLO; CLO_0002931
DR   ATCC; CRL-2469
DR   BioSample; SAMN11397646
DR   Wikidata; Q54832335
RX   PubMed=8550814;
RX   PubMed=22651808;
RX   PubMed=31220119;
CC   Characteristics: CSF1 dependent.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C3H/HeJ.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 25.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10D
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   EOC 8
AC   CVCL_K168
DR   Wikidata; Q54832336
RX   PubMed=8550814;
CC   Characteristics: CSF1 dependent.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10D
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EOC 9
AC   CVCL_K169
DR   Wikidata; Q54832337
RX   PubMed=8550814;
CC   Characteristics: CSF1 dependent.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10D
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EOE-2M
AC   CVCL_WN32
SY   EOE 2M; Enamel Organ Epithelium-2M
DR   Wikidata; Q93540844
RX   PubMed=31074144;
CC   Characteristics: Useful for studies regarding enamel bioengineering.
CC   Characteristics: Expresses enamel matrix markers and produces a mineralized extracellular matrix.
CC   Doubling time: 92.78 +- 11.35 hours (PubMed=31074144).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Tooth, enamel organ, dental epithelium; UBERON=UBERON_0003843.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   EOE-3M
AC   CVCL_WN33
SY   EOE 3M; Enamel Organ Epithelium-3M
DR   Wikidata; Q93540847
RX   PubMed=31074144;
CC   Characteristics: Useful for studies regarding enamel bioengineering.
CC   Characteristics: Expresses enamel matrix markers and produces a mineralized extracellular matrix.
CC   Doubling time: 53.24 +- 9.50 hours (PubMed=31074144).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Tooth, enamel organ, dental epithelium; UBERON=UBERON_0003843.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   EoL-1
AC   CVCL_0258
SY   EOL-1; EOL1; EoL-1-cell; EoL-1 cell; AML-EOL-1
DR   BTO; BTO_0002405
DR   CLO; CLO_0002932
DR   CLO; CLO_0002933
DR   CLO; CLO_0050996
DR   EFO; EFO_0022659
DR   MCCL; MCC:0000149
DR   CLDB; cl1166
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 209
DR   BioSample; SAMN01821624
DR   BioSample; SAMN03473158
DR   BioSample; SAMN10988490
DR   cancercelllines; CVCL_0258
DR   Cell_Model_Passport; SIDM00277
DR   ChEMBL-Cells; CHEMBL3308381
DR   ChEMBL-Targets; CHEMBL614489
DR   Cosmic; 787428
DR   Cosmic; 798671
DR   Cosmic; 906856
DR   Cosmic; 975246
DR   Cosmic; 994180
DR   Cosmic; 999731
DR   Cosmic; 1012065
DR   Cosmic; 1278780
DR   Cosmic; 1623638
DR   Cosmic; 2131562
DR   Cosmic-CLP; 906856
DR   DepMap; ACH-000198
DR   DSMZ; ACC-386
DR   DSMZCellDive; ACC-386
DR   ECACC; 94042252
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10832-111D4
DR   GDSC; 906856
DR   GEO; GSM887006
DR   GEO; GSM888075
DR   GEO; GSM1374475
DR   GEO; GSM1446733
DR   GEO; GSM1669766
DR   IARC_TP53; 21331
DR   IARC_TP53; 30032
DR   LiGeA; CCLE_554
DR   PharmacoDB; EoL1cell_335_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0258
DR   PubChem_Cell_line; CVCL_0258
DR   RCB; RCB0641
DR   RCB; RCB3679
DR   TKG; TKG 0476
DR   Wikidata; Q54832338
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=1477652;
RX   PubMed=2415185;
RX   PubMed=8558913;
RX   PubMed=14630792;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-386).
CC   HLA typing: A*24:02,29:02; B*35:03,44:03; C*04:01,16:01 (PubMed=26589293).
CC   HLA typing: A*24:02:01,29:02:01; B*35:03:01,44:03:01; C*04:01:01,16:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,02:01:02; DQA1*03:03:01,03:03:01; DQB1*03:01:01,03:01:01; DRA*01:01:01,01:02:02; DRB1*04:07:01,12:01:01 (DSMZCellDive=ACC-386).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:19124; FIP1L1 + HGNC; HGNC:8803; PDGFRA; Name(s)=FIP1L1-PDGFRA (PubMed=14630792).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.14%; Native American=0%; East Asian, North=2.93%; East Asian, South=0%; South Asian=0%; European, North=52.17%; European, South=43.75% (PubMed=30894373).
CC   Discontinued: RCB; RCB3679; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=906856; DSMZ=ACC-386; ECACC=94042252; PubMed=25877200; RCB=RCB0641; TKG=TKG 0476
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 12,13
ST   D16S539: 8,10
ST   D18S51: 12,14
ST   D19S433: 12,13
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 7,10,11 (DSMZ=ACC-386)
ST   Penta D: 7,11 (PubMed=25877200)
ST   Penta E: 5,7
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4563; Chronic eosinophilic leukemia, not otherwise specified
DI   ORDO; Orphanet_168940; Chronic eosinophilic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S960 ! EoL-2
OI   CVCL_4069 ! EoL-3
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   EoL-2
AC   CVCL_S960
DR   Wikidata; Q54832339
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2415185;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4563; Chronic eosinophilic leukemia, not otherwise specified
DI   ORDO; Orphanet_168940; Chronic eosinophilic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0258 ! EoL-1
OI   CVCL_4069 ! EoL-3
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   EoL-3
AC   CVCL_4069
DR   CLO; CLO_0050997
DR   BioSample; SAMN03472016
DR   Cosmic; 2089673
DR   FANTOM5_SSTAR; 10833-111D5
DR   RCB; RCB2142
DR   TKG; TKG 0508
DR   Wikidata; Q54832340
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2415185;
RX   PubMed=23955599;
CC   Population: Caucasian.
CC   Discontinued: RCB; RCB2142; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2142; TKG=TKG 0508
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 12,13
ST   D16S539: 8,10
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4563; Chronic eosinophilic leukemia, not otherwise specified
DI   ORDO; Orphanet_168940; Chronic eosinophilic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0258 ! EoL-1
OI   CVCL_S960 ! EoL-2
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   EOL4G8
AC   CVCL_E5F8
RX   PubMed=12036930;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P35330; Mouse Icam2/Cd102.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   EOL5F5
AC   CVCL_E5F7
RX   PubMed=11376871;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse 35 kDa protein (p35) on surface of endothelial cells and platelets.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   EOM-29
AC   CVCL_6900
SY   EOM29
DR   Cosmic; 848326
DR   Wikidata; Q54832341
RX   PubMed=8621261;
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   EOM-3
AC   CVCL_6901
SY   EOM3
DR   Cosmic; 848325
DR   Cosmic; 899891
DR   Wikidata; Q54832342
RX   PubMed=8621261;
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   EOMA
AC   CVCL_3507
DR   BTO; BTO_0002685
DR   CLO; CLO_0002934
DR   ATCC; CRL-2586
DR   BCRJ; 0079
DR   CCRID; 1101MOU-PUMC000689
DR   CLS; 305241
DR   JCRB; NIHS0318
DR   Wikidata; Q54832343
RX   PubMed=2166185;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/eoma/eomacells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/endothelialindex
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells
CC   Discontinued: JCRB; NIHS0318; true.
CC   Derived from site: In situ; Blood vessel; UBERON=UBERON_0001981.
CC   Cell type: Endothelial cell of blood vessel; CL=CL_0000071.
CC   Breed/subspecies: 129.
DI   NCIt; C22931; Hemangioendothelioma of the mouse blood vessel, malignant
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   EOMA-GFP
AC   CVCL_3508
DR   CLO; CLO_0002935
DR   ATCC; CRL-2587
DR   Wikidata; Q54832345
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blood vessel; UBERON=UBERON_0001981.
CC   Cell type: Endothelial cell of blood vessel; CL=CL_0000071.
CC   Breed/subspecies: 129.
DI   NCIt; C22931; Hemangioendothelioma of the mouse blood vessel, malignant
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3507 ! EOMA
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   Eos-HL-60
AC   CVCL_2892
DR   CLO; CLO_0002936
DR   CLDB; cl5062
DR   cancercelllines; CVCL_2892
DR   ECACC; 96100920
DR   GEO; GSM827454
DR   LINCS_LDP; LCL-2055
DR   Progenetix; CVCL_2892
DR   Wikidata; Q54832346
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=96100920
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   EP [Human breast carcinoma]
AC   CVCL_WS82
DR   Wikidata; Q93540959
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1961733;
RX   PubMed=3971380;
CC   Doubling time: 27 hours (PubMed=3971380).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   EP [Human LCL]
AC   CVCL_C4PH
DR   Wikidata; Q116048934
RX   PubMed=198669;
RX   PubMed=2580779;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_194097; 3,5-dinitro-4-hydroxyphenylacetic acid (NNP).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   EP-1
AC   CVCL_8350
SY   Eel cells Persistently infected with P.anguillurum
DR   Wikidata; Q54832348
RX   DOI=10.1016/0044-8486(94)00394-4;
CC   Group: Fish cell line.
CC   Characteristics: Infected with Heterosporis anguillarum (DOI=10.1016/0044-8486(94)00394-4).
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Sex unspecified
AG   Elver
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   Ep-1
AC   CVCL_A5QQ
SY   EP1
DR   Wikidata; Q107114894
RX   PubMed=24348039;
RX   PubMed=33626495;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   Ep-16
AC   CVCL_2894
SY   EP-16; Ep 16; Ep16
DR   CLO; CLO_0002937
DR   CLO; CLO_0002938
DR   CLDB; cl5187
DR   ATCC; HB-155
DR   IZSLER; BS Hy 43
DR   Wikidata; Q54832349
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=2578308;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on epithelial cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   EP-1D8
AC   CVCL_E4JN
SY   1D8.10
RX   Patent=US6210670;
RX   PubMed=7528571;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   EP-2C9
AC   CVCL_E4JP
SY   2C9.11
RX   Patent=US6210670;
RX   PubMed=7528571;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   EP-5C7
AC   CVCL_E4JQ
SY   EP5C7; 5C7.29
DR   ABCD; ABCD_AS282
RX   Patent=US6210670;
RX   PubMed=7528571;
RX   PubMed=9551944;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11640.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ep-C4
AC   CVCL_A1KJ
DR   Wikidata; Q102113795
RX   PubMed=1541975;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on ependymoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   EP1
AC   CVCL_D6SX
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP10
AC   CVCL_D6SW
RX   PubMed=2605504;
RX   PubMed=7685234;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08247; Human SYP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP11
AC   CVCL_D6T1
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP13
AC   CVCL_D6T2
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP14
AC   CVCL_D6T3
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP15
AC   CVCL_D6T4
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP16
AC   CVCL_D6T5
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP17
AC   CVCL_D6T6
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP19
AC   CVCL_D6T7
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP2-15
AC   CVCL_E4CG
SY   EP215
RX   PubMed=33558651;
RX   PubMed=36202854;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4CF ! 2242-5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   EP5
AC   CVCL_CW57
SY   EP-5
DR   NCBI_Iran; H169
DR   Wikidata; Q54832350
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   EP7
AC   CVCL_D6SY
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP8
AC   CVCL_D6SZ
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EP9
AC   CVCL_D6T0
RX   PubMed=2605504;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   EPa
AC   CVCL_Z874
SY   E Pa
DR   Wikidata; Q54832351
RX   CelloPub=CLPUB00492;
RX   PubMed=4810369;
RX   PubMed=5759611;
RX   PubMed=5777433;
RX   PubMed=5777434;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6978; ! Periplaneta americana (American cockroach)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   EPC
AC   CVCL_4361
SY   Epithelioma Papulosum Cyprini
DR   CLO; CLO_0002940
DR   CLDB; cl1167
DR   CLDB; cl1168
DR   ATCC; CRL-2872
DR   BioSample; SAMN03152008
DR   CCLV; CCLV-RIE 0173
DR   CCTCC; GDC0174
DR   CCTCC; GDC0182
DR   ECACC; 93120820
DR   IZSLER; BS CL 41
DR   Wikidata; Q26882920
RX   CelloPub=CLPUB00103;
RX   DOI=10.1016/S0769-2617(83)80060-4;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=11673072;
RX   PubMed=20143388;
RX   PubMed=20497291;
RX   PubMed=33053677;
RX   PubMed=34382581;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/epc-atcc-crl-2872
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Wikipedia; -; https://de.wikipedia.org/wiki/EPC-Zellen
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Originally deposited as a carp (Cyprinus carpio) cell line, is in fact a fathead minnow (Pimephales promelas) cell line (PubMed=20497291).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00302.
CC   Doubling time: ~36 hours (ATCC=CRL-2872).
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   EPC-1
AC   CVCL_4W34
DR   JCRB; JCRB1536
DR   Wikidata; Q54832352
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1536
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   EPC-EC
AC   CVCL_E3AG
RX   PubMed=38951796;
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Grand-parent cell line (EPC) was originally deposited as a carp (Cyprinus carpio) cell line, is in fact a fathead minnow (Pimephales promelas) cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
HI   CVCL_4361 ! EPC
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   EPC-EC-Vip-C11
AC   CVCL_E3AK
RX   PubMed=38951796;
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Grand-parent cell line (EPC) was originally deposited as a carp (Cyprinus carpio) cell line, is in fact a fathead minnow (Pimephales promelas) cell line.
CC   Characteristics: The parent cell line was transiently transfected with a mix of sgRNAs designed against stat2 and against mEGFP. mEGFP-deficient cells were isolated (PubMed=38951796).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A096ZN79; Viperin (Vig1).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
HI   CVCL_E3AG ! EPC-EC
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   EPC-EC-Vip-C7
AC   CVCL_E3AJ
RX   PubMed=38951796;
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Grand-parent cell line (EPC) was originally deposited as a carp (Cyprinus carpio) cell line, is in fact a fathead minnow (Pimephales promelas) cell line.
CC   Characteristics: The parent cell line was transiently transfected with a mix of sgRNAs designed against stat2 and against mEGFP. mEGFP-deficient cells were isolated (PubMed=38951796).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A096ZN79; Viperin (Vig1).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Nuclear version; nCas9n).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
HI   CVCL_E3AG ! EPC-EC
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   EPCtiHSP70
AC   CVCL_6E02
DR   Wikidata; Q54832353
RX   PubMed=11869883;
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Parent cell line (EPC) was originally deposited as a carp (Cyprinus carpio) cell line, is in fact a fathead minnow (Pimephales promelas) cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
HI   CVCL_4361 ! EPC
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   EPFLi001-A
AC   CVCL_VD34
SY   hiPS43; ips43; iPS clone 43
DR   BioSamples; SAMEA104012163
DR   EBiSC; EPFLi001-A
DR   ECACC; 66540573
DR   GEO; GSM1395305
DR   hPSCreg; EPFLi001-A
DR   Wikidata; Q54832356
RX   PubMed=24879558;
CC   From: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; EPFLi001-A; true.
CC   Discontinued: ECACC; 66540573; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD35 ! EPFLi002-A
OI   CVCL_VD36 ! EPFLi003-A
OI   CVCL_VD37 ! EPFLi004-A
OI   CVCL_VD38 ! EPFLi005-A
OI   CVCL_VD39 ! EPFLi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   EPFLi002-A
AC   CVCL_VD35
SY   hiPS9; ips9; iPS clone 9
DR   BioSamples; SAMEA104012164
DR   EBiSC; EPFLi002-A
DR   ECACC; 66540574
DR   GEO; GSM1395303
DR   hPSCreg; EPFLi002-A
DR   Wikidata; Q54832357
RX   PubMed=24879558;
CC   From: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; EPFLi002-A; true.
CC   Discontinued: ECACC; 66540574; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD34 ! EPFLi001-A
OI   CVCL_VD36 ! EPFLi003-A
OI   CVCL_VD37 ! EPFLi004-A
OI   CVCL_VD38 ! EPFLi005-A
OI   CVCL_VD39 ! EPFLi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   EPFLi003-A
AC   CVCL_VD36
SY   hiPS6; ips6; iPS clone 6
DR   BioSamples; SAMEA104012165
DR   EBiSC; EPFLi003-A
DR   ECACC; 66540575
DR   GEO; GSM1395302
DR   hPSCreg; EPFLi003-A
DR   Wikidata; Q54832358
RX   PubMed=24879558;
CC   From: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; EPFLi003-A; true.
CC   Discontinued: ECACC; 66540575; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD34 ! EPFLi001-A
OI   CVCL_VD35 ! EPFLi002-A
OI   CVCL_VD37 ! EPFLi004-A
OI   CVCL_VD38 ! EPFLi005-A
OI   CVCL_VD39 ! EPFLi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   EPFLi004-A
AC   CVCL_VD37
SY   hiPS2; ips2; iPS clone 2
DR   BioSamples; SAMEA104012166
DR   EBiSC; EPFLi004-A
DR   ECACC; 66540576
DR   GEO; GSM1395301
DR   hPSCreg; EPFLi004-A
DR   Wikidata; Q54832359
RX   PubMed=24879558;
CC   From: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; EPFLi004-A; true.
CC   Discontinued: ECACC; 66540576; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD34 ! EPFLi001-A
OI   CVCL_VD35 ! EPFLi002-A
OI   CVCL_VD36 ! EPFLi003-A
OI   CVCL_VD38 ! EPFLi005-A
OI   CVCL_VD39 ! EPFLi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   EPFLi005-A
AC   CVCL_VD38
SY   hiPS45; ips45; iPS clone 45
DR   BioSamples; SAMEA104012167
DR   EBiSC; EPFLi005-A
DR   ECACC; 66540577
DR   GEO; GSM1395306
DR   hPSCreg; EPFLi005-A
DR   Wikidata; Q54832360
RX   PubMed=24879558;
CC   From: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; EPFLi005-A; true.
CC   Discontinued: ECACC; 66540577; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD34 ! EPFLi001-A
OI   CVCL_VD35 ! EPFLi002-A
OI   CVCL_VD36 ! EPFLi003-A
OI   CVCL_VD37 ! EPFLi004-A
OI   CVCL_VD39 ! EPFLi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   EPFLi006-A
AC   CVCL_VD39
SY   hiPS14; ips14; iPS clone 14
DR   BioSamples; SAMEA104012168
DR   EBiSC; EPFLi006-A
DR   ECACC; 66540578
DR   GEO; GSM1395304
DR   hPSCreg; EPFLi006-A
DR   Wikidata; Q54832361
RX   PubMed=24879558;
CC   From: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; EPFLi006-A; true.
CC   Discontinued: ECACC; 66540578; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD34 ! EPFLi001-A
OI   CVCL_VD35 ! EPFLi002-A
OI   CVCL_VD36 ! EPFLi003-A
OI   CVCL_VD37 ! EPFLi004-A
OI   CVCL_VD38 ! EPFLi005-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   EPG
AC   CVCL_R841
SY   Epithelioma Papulosum of Goldfish
DR   Wikidata; Q54832362
RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   EPG85-257DAU
AC   CVCL_X177
SY   257DAU
DR   Wikidata; Q54832363
RX   PubMed=7773504;
RX   PubMed=9180151;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X333 ! EPG85-257P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 7
//
ID   EPG85-257P
AC   CVCL_X333
SY   EPG85-257-P; EPG85-257/P; EPG85-257; 257P
DR   Wikidata; Q54832364
RX   PubMed=1975514;
RX   PubMed=9180151;
RX   PubMed=10949126;
RX   PubMed=15812352;
RX   PubMed=15875780;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 7
//
ID   EPG85-257P-TR
AC   CVCL_X178
DR   Wikidata; Q54832365
RX   PubMed=15812352;
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X333 ! EPG85-257P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 5
//
ID   EPG85-257RDB
AC   CVCL_X175
SY   EPG85-257-RDB; EPG85-257/RDB; EPG85-257RDB/K3; EPG85-257P-RDB; 257RD
DR   Wikidata; Q54832366
RX   PubMed=10949126;
RX   PubMed=15812352;
RX   PubMed=15875780;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X333 ! EPG85-257P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   EPG85-257RDB-TR
AC   CVCL_X179
DR   Wikidata; Q54832367
RX   PubMed=15812352;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X175 ! EPG85-257RDB
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 7
//
ID   EPG85-257RNOV
AC   CVCL_X176
SY   EPG85-257-RNOV; EPG85-257RNOV/K3; EPG85-257/RNOV; EPG85-257 RNOV; EPG85-257RN; EPG85-257NOV; 257RN
DR   Wikidata; Q54832368
RX   PubMed=1975514;
RX   PubMed=9180151;
RX   PubMed=10949126;
RX   PubMed=15812352;
RX   PubMed=15875780;
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X333 ! EPG85-257P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   EPG85-257RNOV-TR
AC   CVCL_X180
DR   Wikidata; Q54832369
RX   PubMed=15812352;
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X176 ! EPG85-257RNOV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 7
//
ID   Eph099B-102.147
AC   CVCL_B6NM
DR   Wikidata; Q111733201
RX   Patent=US20100278838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4572.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P29317; Human EPHA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NI ! P3XBcl-2-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 4
//
ID   Eph099B-208.261
AC   CVCL_B6NN
DR   Wikidata; Q111733202
RX   Patent=US20100278838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4573.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P29317; Human EPHA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NI ! P3XBcl-2-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 4
//
ID   Eph099B-210.248
AC   CVCL_B6NP
DR   Wikidata; Q111733203
RX   Patent=US20100278838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4574.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P29317; Human EPHA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NI ! P3XBcl-2-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 4
//
ID   Eph099B-233.152
AC   CVCL_B6NQ
DR   Wikidata; Q111733204
RX   Patent=US20100278838;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5194.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P29317; Human EPHA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NI ! P3XBcl-2-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 4
//
ID   Eph101.530.241
AC   CVCL_B6NZ
DR   Wikidata; Q111733205
RX   Patent=US7786273;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4724.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P29317; Human EPHA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 4
//
ID   EpH4
AC   CVCL_0073
SY   EPH4; Eph4; EpH-4
DR   BioGRID_ORCS_Cell_line; 1444
DR   Lonza; 282
DR   Millipore; SCC284
DR   Wikidata; Q54832370
RX   PubMed=7720705;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
ST   Source(s): Millipore=SCC284
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 13,17
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,13
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 13,16
ST   Mouse STR 11-2: 15,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 11
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S574 ! IM-Ep-1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   EpH4 1424
AC   CVCL_S643
DR   ATCC; CRL-3071
DR   Wikidata; Q54832371
RX   PubMed=12183438;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346866; Map2k1 (Note=With p.Ser218Asp and p.Ser222Asp = MEKDD, constitutively activated form).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S646 ! EpH4 betaMEKDD-116
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   EpH4 1424.1
AC   CVCL_S644
DR   ATCC; CRL-3209
DR   Wikidata; Q54832372
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346866; Map2k1 (Note=With p.Ser218Asp218 and p.Ser222Asp = MEKDD, constitutively activated form).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S643 ! EpH4 1424
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   EpH4 1424.2
AC   CVCL_S645
DR   ATCC; CRL-3210
DR   Wikidata; Q54832373
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346866; Map2k1 (Note=With p.Ser218Asp218 and p.Ser222Asp = MEKDD, constitutively activated form).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S643 ! EpH4 1424
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   Eph4 A6
AC   CVCL_DC66
SY   Eph4-A6
DR   ATCC; CRL-3058
DR   Wikidata; Q54832374
RX   PubMed=12150823;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 11
//
ID   EpH4 betaMEKDD-116
AC   CVCL_S646
SY   EpH4 DD-116; B-MEKDD 116
DR   ATCC; CRL-3069
DR   Wikidata; Q54832375
RX   PubMed=12183438;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346866; Map2k1 (Note=With p.Ser218Asp218 and p.Ser222Asp = MEKDD, constitutively activated form).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   EpH4 betaMEKDD-47
AC   CVCL_S647
SY   EpH4 DD-47; B-MEKDD 47
DR   Wikidata; Q54832376
RX   PubMed=12183438;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346866; Map2k1 (Note=With p.Ser218Asp218 and p.Ser222Asp = MEKDD, constitutively activated form).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   EpH4-Be1a
AC   CVCL_S575
SY   Be1a
DR   Wikidata; Q54832377
RX   PubMed=9661050;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   EpH4-Be4a
AC   CVCL_S576
SY   Be4a
DR   Wikidata; Q54832378
RX   PubMed=9661050;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   EpH4-Ev
AC   CVCL_S648
SY   Eph4-Empty vector
DR   ATCC; CRL-3063
DR   Wikidata; Q54832379
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   EpH4-H1B
AC   CVCL_S577
SY   H1B
DR   Wikidata; Q54832380
RX   PubMed=9661050;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   EpH4-I3G2
AC   CVCL_S578
SY   I3G2
DR   Wikidata; Q54832381
RX   PubMed=9661050;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   EpH4-J3B1
AC   CVCL_S579
SY   J3B1
DR   Wikidata; Q54832382
RX   PubMed=9661050;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   EpH4-K3A3
AC   CVCL_S580
SY   K3A3
DR   Wikidata; Q54832383
RX   PubMed=9661050;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0073 ! EpH4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Ephb266
AC   CVCL_E7G1
RX   PubMed=20639864;
CC   Characteristics: Transduced with an EphB2-IRES-RFP construct. Transduced cells were implanted into the cerebral cortex of CD-1 nu/nu mice and the cell line was established from a tumor (PubMed=20639864).
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Genetic integration: Method=Transduction; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99611; Ephb2.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Embryonic brain, forebrain; UBERON=UBERON_0006240.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: Ink4a/Arf-null Blbp-eGFP transgenic.
DI   NCIt; C21951; Mouse ependymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   EPI
AC   CVCL_F741
DR   CLO; CLO_0002941
DR   CLDB; cl1169
DR   Wikidata; Q54832384
RX   PubMed=1540965;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0P18 ! R3230AC clone H
OI   CVCL_0P19 ! R3230AC clone I
OI   CVCL_0P20 ! R3230AC clone L
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   Epi-544
AC   CVCL_N843
SY   Epi544
DR   GEO; GSM1632454
DR   GEO; GSM1632455
DR   GEO; GSM1632458
DR   GEO; GSM1632459
DR   Wikidata; Q54832386
RX   PubMed=21357725;
RX   PubMed=26365879;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Doubling time: ~48 hours (PubMed=21357725).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=26365879).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   epiHFF1-B1
AC   CVCL_DQ54
SY   epiHFF1_iPS_B1
DR   Wikidata; Q54832387
RX   PubMed=27345787;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   epiHUVEC
AC   CVCL_9S75
DR   Wikidata; Q54832388
RX   PubMed=26987922;
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   EpiSC 129Ba1
AC   CVCL_C5QL
DR   RCB; AES0204
DR   Wikidata; Q116048935
RX   PubMed=25818811;
CC   Cell type: Epiblast; CL=CL_0000352.
CC   Breed/subspecies: 129S2/Sv x C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6FD
CA   Somatic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EpiSC 129Ba2
AC   CVCL_C5QM
DR   Wikidata; Q116048936
RX   PubMed=25818811;
CC   Cell type: Epiblast; CL=CL_0000352.
CC   Breed/subspecies: 129S2/Sv x C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6FD
CA   Somatic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EpiSC B129a7
AC   CVCL_C5QN
DR   Wikidata; Q116048937
RX   PubMed=25818811;
CC   Cell type: Epiblast; CL=CL_0000352.
CC   Breed/subspecies: 129S2/Sv x C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6FD
CA   Somatic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EpiSC B129b1
AC   CVCL_C5QP
DR   Wikidata; Q116048939
RX   PubMed=25818811;
CC   Cell type: Epiblast; CL=CL_0000352.
CC   Breed/subspecies: 129S2/Sv x C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6FD
CA   Somatic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EpiSC BNa1
AC   CVCL_C5QQ
DR   Wikidata; Q116048940
RX   PubMed=25818811;
CC   Cell type: Epiblast; CL=CL_0000352.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6FD
CA   Somatic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EpiSC BNa17
AC   CVCL_C5QR
DR   Wikidata; Q116048941
RX   PubMed=25818811;
CC   Cell type: Epiblast; CL=CL_0000352.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6FD
CA   Somatic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EpiSC BNa18
AC   CVCL_C5QS
DR   Wikidata; Q116048942
RX   PubMed=25818811;
CC   Cell type: Epiblast; CL=CL_0000352.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6FD
CA   Somatic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EpiSC-5
AC   CVCL_Y499
SY   EpiSC5
DR   ENCODE; ENCBS177ENC
DR   GEO; GSM450280
DR   Wikidata; Q54832389
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/EpiSC-5_Gilbert_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Cell type: Epiblast; CL=CL_0000352.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Somatic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   EpiSC-7
AC   CVCL_Y500
SY   EpiSC7
DR   ENCODE; ENCBS178ENC
DR   GEO; GSM450281
DR   Wikidata; Q54832390
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/EpiSC-7_Gilbert_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Cell type: Epiblast; CL=CL_0000352.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Somatic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   EPLC-272H
AC   CVCL_1197
SY   EPLC272H; EPidermoid Lung Cancer-272H
DR   CLO; CLO_0002942
DR   EFO; EFO_0006573
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 679
DR   BioSample; SAMN03473099
DR   BioSample; SAMN10987954
DR   cancercelllines; CVCL_1197
DR   Cell_Model_Passport; SIDM01044
DR   ChEMBL-Cells; CHEMBL3308104
DR   ChEMBL-Targets; CHEMBL1075443
DR   Cosmic; 753556
DR   Cosmic; 1995394
DR   Cosmic-CLP; 753556
DR   DepMap; ACH-000585
DR   DSMZ; ACC-383
DR   DSMZCellDive; ACC-383
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753556
DR   GEO; GSM784228
DR   GEO; GSM827194
DR   GEO; GSM887007
DR   GEO; GSM888076
DR   GEO; GSM1669767
DR   IARC_TP53; 21327
DR   LiGeA; CCLE_588
DR   LINCS_LDP; LCL-1581
DR   PharmacoDB; EPLC272H_336_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1197
DR   PubChem_Cell_line; CVCL_1197
DR   Wikidata; Q54832391
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-383).
CC   HLA typing: A*03:01,03:01; B*15:01,15:01; C*03:04,03:04; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*04:03,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr107Ter (c.321C>G); ClinVar=VCV001073381; Zygosity=Homozygous (Cosmic-CLP=753556; DepMap=ACH-000585).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=7.58%; Native American=0%; East Asian, North=9.18%; East Asian, South=0%; South Asian=0%; European, North=35.01%; European, South=48.24% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753556; DSMZ=ACC-383; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 31.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8,9
ST   D8S1179: 12
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   EPLC-32M1
AC   CVCL_8193
SY   EPLC 32M1; EPLC3-2M1; EPLC32M1; EPidermoid Lung Cancer-31M1
DR   ATCC; CRL-2182
DR   BioSample; SAMN03151690
DR   BioSample; SAMN03472559
DR   Wikidata; Q54832392
RX   PubMed=1845952;
RX   PubMed=2438285;
RX   PubMed=2473086;
RX   PubMed=2840315;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 68 year old male patient with lung squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00118.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CRL-2182; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-2182
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3,14.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12,13
ST   vWA: 17,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   EPLC-65H
AC   CVCL_8194
SY   EPLC 65H; EPLC-65; EPidermoid Lung Cancer-65H
DR   BioSample; SAMN03151691
DR   Wikidata; Q54832393
RX   PubMed=2438285;
RX   PubMed=2840315;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from the lymph node metastasis of a 48 year old male patient with lung squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00119.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   EPLC-65M2
AC   CVCL_WM74
SY   EPidermoid Lung Cancer-65M2
DR   Wikidata; Q93541409
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2840315;
CC   Problematic cell line: Contaminated. Parent cell line (EPLC-65H) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8194 ! EPLC-65H
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   EPMab-16
AC   CVCL_D2TM
DR   Wikidata; Q127380822
RX   PubMed=33125138;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   EPMab-37
AC   CVCL_D2TN
DR   Wikidata; Q127380823
RX   PubMed=35735360;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   EPN
AC   CVCL_B7JE
SY   Epithelial Prostate Normal
DR   Wikidata; Q112929538
RX   PubMed=12026165;
RX   PubMed=16783820;
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   EPN-1
AC   CVCL_QY94
DR   Wikidata; Q54832394
RX   Patent=US20170226482;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00318.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   EPN-PKM3
AC   CVCL_B7JF
DR   Wikidata; Q112929539
RX   PubMed=16783820;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9612; PTK2B (Note=With p.Lys457Ala).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7JE ! EPN
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   EpN1.10
AC   CVCL_AV26
DR   Wikidata; Q54832395
RX   PubMed=20167219;
CC   Group: Insect cell line.
CC   Doubling time: ~36 hours (PubMed=20167219).
OX   NCBI_TaxID=65032; ! Epiphyas postvittana (Light brown apple moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   EPNT-5
AC   CVCL_4622
DR   CLO; CLO_0002943
DR   CLDB; cl1170
DR   CLDB; cl1171
DR   Wikidata; Q54832398
RX   PubMed=560733;
RX   PubMed=6269518;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   EpoNi/22.1
AC   CVCL_RX73
DR   Wikidata; Q54832400
RX   PubMed=21987760;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=1410044; ! Epomops buettikoferi (Buettikofer's epauletted fruit bat)
OI   CVCL_RX51 ! EpoNi/22.3
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   EpoNi/22.3
AC   CVCL_RX51
SY   EpoNi-22.3
DR   Wikidata; Q54832401
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=1410044; ! Epomops buettikoferi (Buettikofer's epauletted fruit bat)
OI   CVCL_RX73 ! EpoNi/22.1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   EPP85-181P
AC   CVCL_X181
SY   EPP85-181-P; EPP85-181; 181P
DR   Wikidata; Q54832402
RX   PubMed=10949126;
RX   PubMed=12136248;
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 4
//
ID   EPP85-181RDB
AC   CVCL_X182
SY   EPP85-181-RDB; EPP85-181RDB/K3; 181RD
DR   Wikidata; Q54832403
RX   PubMed=10949126;
RX   PubMed=12136248;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X181 ! EPP85-181P
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 6
//
ID   EPP85-181RNOV
AC   CVCL_X183
SY   EPP85-181-RNOV; EPP85-181RNOV/K2; 181RN
DR   Wikidata; Q54832404
RX   PubMed=10949126;
RX   PubMed=12136248;
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X181 ! EPP85-181P
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 6
//
ID   EPTC1
AC   CVCL_VY51
SY   EPididymis Testis Cat 1
DR   IBRC; C11092
DR   Wikidata; Q93541501
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_VZ62 ! ATTC1
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   EPTC2
AC   CVCL_VY52
SY   EPididymis Testis Cat 2
DR   IBRC; C11093
DR   Wikidata; Q93541505
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_VZ63 ! ATTC2
OI   CVCL_VZ64 ! SMTC2
OI   CVCL_VZ65 ! VTTC2
SX   Male
AG   6Y6M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   EPTH2
AC   CVCL_WA37
SY   EPididymis Testis Human 2
DR   IBRC; C11136
DR   Wikidata; Q93541508
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WA36 ! ACTH2
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   EPYP-1
AC   CVCL_D574
SY   EPYP1
DR   Wikidata; Q54832405
RX   PubMed=8687134;
RX   PubMed=8900919;
CC   Doubling time: 20 hours (PubMed=8900919).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMT10D).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   EPYP-2
AC   CVCL_0J53
SY   EPYP2
DR   Wikidata; Q54832406
RX   PubMed=8687134;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   EPYP-3
AC   CVCL_0J54
SY   EPYP3
DR   Wikidata; Q54832407
RX   PubMed=8687134;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   EqPalFS6-1
AC   CVCL_9W07
SY   S6-1
DR   Wikidata; Q54951961
RX   PubMed=18191170;
CC   Characteristics: Transfected with a full length BPV-1 genome fromm a sarcoid sample (PubMed=18191170).
CC   Doubling time: 26.2 hours (PubMed=18191170).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Fetal oral cavity, palate; UBERON=UBERON_0001716.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_9W08 ! EqPalFS6-2
OI   CVCL_9W09 ! EqPalFS6-3
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   EqPalFS6-2
AC   CVCL_9W08
SY   S6-2
DR   Wikidata; Q54951962
RX   PubMed=18191170;
CC   Characteristics: Transfected with a full length BPV-1 genome fromm a sarcoid sample (PubMed=18191170).
CC   Doubling time: 24 hours (PubMed=18191170).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Fetal oral cavity, palate; UBERON=UBERON_0001716.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_9W07 ! EqPalFS6-1
OI   CVCL_9W09 ! EqPalFS6-3
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   EqPalFS6-3
AC   CVCL_9W09
SY   S6-3
DR   Wikidata; Q54951971
RX   PubMed=18191170;
CC   Characteristics: Transfected with a full length BPV-1 genome fromm a sarcoid sample (PubMed=18191170).
CC   Doubling time: 32.6 hours (PubMed=18191170).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 3085316; Bovine papillomavirus type 1 (BPV-1).
CC   Derived from site: In situ; Fetal oral cavity, palate; UBERON=UBERON_0001716.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_9W07 ! EqPalFS6-1
OI   CVCL_9W08 ! EqPalFS6-2
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   EqS01a
AC   CVCL_B5WQ
DR   Wikidata; Q111733206
RX   PubMed=18191170;
CC   Virology: Infected by bovine papillomavirus-1 (BPV-1).
CC   Doubling time: 32.7 hours (PubMed=18191170).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C134995; Horse sarcoid
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 6
//
ID   EqS02a
AC   CVCL_9W05
DR   Wikidata; Q54832408
RX   PubMed=18191170;
CC   Virology: Infected by bovine papillomavirus-1 (BPV-1).
CC   Doubling time: 32.2 hours (PubMed=18191170).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C134995; Horse sarcoid
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   EqS04b
AC   CVCL_9W06
DR   Wikidata; Q54832409
RX   PubMed=18191170;
CC   Virology: Infected by bovine papillomavirus-1 (BPV-1).
CC   Doubling time: 26.7 hours (PubMed=18191170).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C134995; Horse sarcoid
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   EqT8888
AC   CVCL_7191
DR   Wikidata; Q54832410
RX   PubMed=1604800;
RX   PubMed=17686531;
RX   PubMed=29844485;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Arabian; VBO=VBO_0000905.
DI   NCIt; C134778; Horse lymphoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   EquiPSC clone H
AC   CVCL_TZ69
DR   Wikidata; Q54832411
RX   PubMed=24555755;
CC   Characteristics: LIF dependent.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_TZ70 ! EquiPSC clone I
OI   CVCL_TZ71 ! EquiPSC clone K
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   EquiPSC clone I
AC   CVCL_TZ70
DR   Wikidata; Q54832412
RX   PubMed=24555755;
CC   Characteristics: LIF dependent.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_TZ69 ! EquiPSC clone H
OI   CVCL_TZ71 ! EquiPSC clone K
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   EquiPSC clone K
AC   CVCL_TZ71
DR   Wikidata; Q54832413
RX   PubMed=24555755;
CC   Characteristics: LIF dependent.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_TZ69 ! EquiPSC clone H
OI   CVCL_TZ70 ! EquiPSC clone I
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   EquiPSC Line B
AC   CVCL_C5PZ
DR   Wikidata; Q116048943
RX   PubMed=22897112;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_C5Q0 ! EquiPSC Line E
OI   CVCL_C5Q1 ! EquiPSC Line H
OI   CVCL_C5Q2 ! EquiPSC Line U
SX   Male
AG   <1Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EquiPSC Line E
AC   CVCL_C5Q0
DR   Wikidata; Q116048944
RX   PubMed=22897112;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_C5PZ ! EquiPSC Line B
OI   CVCL_C5Q1 ! EquiPSC Line H
OI   CVCL_C5Q2 ! EquiPSC Line U
SX   Male
AG   <1Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EquiPSC Line K1
AC   CVCL_C7F1
SY   K1
DR   Wikidata; Q117704315
RX   PubMed=24548115;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_C7F2 ! EquiPSC Line K2
OI   CVCL_C7F3 ! EquiPSC Line K3
SX   Female
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   EquiPSC Line K2
AC   CVCL_C7F2
SY   K2
DR   Wikidata; Q117704316
RX   PubMed=24548115;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_C7F1 ! EquiPSC Line K1
OI   CVCL_C7F3 ! EquiPSC Line K3
SX   Female
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   EquiPSC Line K3
AC   CVCL_C7F3
SY   K3
DR   Wikidata; Q117704317
RX   PubMed=24548115;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_C7F1 ! EquiPSC Line K1
OI   CVCL_C7F2 ! EquiPSC Line K2
SX   Female
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   EquiPSC Line H
AC   CVCL_C5Q1
DR   Wikidata; Q116048945
RX   PubMed=22897112;
RX   PubMed=30207795;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_C5PZ ! EquiPSC Line B
OI   CVCL_C5Q0 ! EquiPSC Line E
OI   CVCL_C5Q2 ! EquiPSC Line U
SX   Male
AG   <1Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   EquiPSC Line U
AC   CVCL_C5Q2
DR   Wikidata; Q116048946
RX   PubMed=22897112;
RX   PubMed=30207795;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_C5PZ ! EquiPSC Line B
OI   CVCL_C5Q0 ! EquiPSC Line E
OI   CVCL_C5Q1 ! EquiPSC Line H
SX   Male
AG   <1Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ER
AC   CVCL_VG62
DR   Wikidata; Q54832414
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Gly1628Arg (c.4882G>A) (p.Gly1667Val, c.5000G>T); ClinVar=VCV000658470; Zygosity=Homozygous (Jain Foundation).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 12
//
ID   ER-1
AC   CVCL_L896
DR   BTO; BTO_0004815
DR   Wikidata; Q54832415
RX   PubMed=1618698;
RX   PubMed=8276719;
CC   Characteristics: Weakly tumorigenic and non-metastatic (PubMed=1618698).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6B46 ! c-SST-2 clone 4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   ER-Cal-27
AC   CVCL_EI26
DR   GEO; GSM1519077
DR   GEO; GSM1519078
DR   GEO; GSM1519079
DR   Wikidata; Q54832416
RX   PubMed=25888065;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C173807; Tongue adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1107 ! CAL-27
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   ER-Fadu
AC   CVCL_EI27
DR   cancercelllines; CVCL_EI27
DR   GEO; GSM1524313
DR   GEO; GSM1524314
DR   GEO; GSM1524315
DR   Wikidata; Q54832418
RX   PubMed=25888065;
CC   Population: Indian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 16
//
ID   ER-SCC-25
AC   CVCL_EI28
DR   GEO; GSM1519071
DR   GEO; GSM1519072
DR   GEO; GSM1519073
DR   Wikidata; Q54832419
RX   PubMed=25888065;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1682 ! SCC-25
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   ER-SQ20B
AC   CVCL_EI29
DR   cancercelllines; CVCL_EI29
DR   GEO; GSM1524319
DR   GEO; GSM1524320
DR   GEO; GSM1524321
DR   Wikidata; Q54832420
RX   PubMed=25888065;
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7138 ! SQ-20B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   ER4.7G11
AC   CVCL_J179
SY   ER4.7G.11; 7G11
DR   CLO; CLO_0002944
DR   ATCC; HB-11642
DR   Wikidata; Q54832421
RX   Patent=US7592007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11642.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   ER5.3D8
AC   CVCL_DD27
SY   3D8; CTLA4.3
DR   Wikidata; Q54832422
RX   Patent=US7592007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11641.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   ER5.4D3
AC   CVCL_DD28
SY   4D3; CTLA4.1
DR   Wikidata; Q54832423
RX   Patent=US7592007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11645.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   ERC-13
AC   CVCL_WW93
SY   Eker Renal Carcinoma-13
DR   Wikidata; Q93541704
RX   CelloPub=CLPUB00521;
RX   PubMed=1910479;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   ERC-15
AC   CVCL_WW94
SY   ERC 15; Eker Renal Carcinoma-15
DR   Wikidata; Q93541708
RX   CelloPub=CLPUB00521;
RX   PubMed=1868463;
RX   PubMed=1910479;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-17
AC   CVCL_WW95
SY   ERC 17; Eker Renal Carcinoma-17
DR   Wikidata; Q93541713
RX   CelloPub=CLPUB00521;
RX   PubMed=1868463;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-18
AC   CVCL_WW96
SY   ERC 18; Eker Renal Carcinoma-18
DR   Wikidata; Q93541718
RX   CelloPub=CLPUB00521;
RX   PubMed=1868463;
RX   PubMed=1910479;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-18M
AC   CVCL_WW97
SY   Eker Renal Carcinoma-18M
DR   Wikidata; Q93541721
RX   CelloPub=CLPUB00521;
RX   PubMed=8419937;
CC   Characteristics: Established from a tumor in SCID mice implanted with the parent cell line in the testis.
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WW96 ! ERC-18
SX   Female
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-19
AC   CVCL_WW98
SY   ERC 19; Eker Renal Carcinoma-19
DR   Wikidata; Q93541726
RX   CelloPub=CLPUB00521;
RX   PubMed=1868463;
RX   PubMed=1910479;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-21
AC   CVCL_WW99
SY   ERC 21; Eker Renal Carcinoma-21
DR   Wikidata; Q93541729
RX   CelloPub=CLPUB00521;
RX   PubMed=1868463;
RX   PubMed=1910479;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (PubMed=1910479).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-23
AC   CVCL_WX00
SY   Eker Renal Carcinoma-23
DR   Wikidata; Q93541735
RX   CelloPub=CLPUB00521;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   ERC-24
AC   CVCL_WX01
SY   ERC 24; Eker Renal Carcinoma-24
DR   Wikidata; Q93541740
RX   CelloPub=CLPUB00521;
RX   PubMed=1868463;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-27
AC   CVCL_WX02
SY   Eker Renal Carcinoma-27
DR   Wikidata; Q93541743
RX   CelloPub=CLPUB00521;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   ERC-31(A)
AC   CVCL_WX03
SY   ERC31; Eker Renal Carcinoma-31
DR   Wikidata; Q93541748
RX   CelloPub=CLPUB00521;
RX   PubMed=7704028;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   ERC-33(A)
AC   CVCL_WX04
SY   ERC33; Eker Renal Carcinoma-33
DR   Wikidata; Q93541752
RX   CelloPub=CLPUB00521;
RX   PubMed=7559744;
RX   PubMed=8419937;
RX   PubMed=11011112;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   ERC-37
AC   CVCL_WX05
SY   ERC 37; Eker Renal Carcinoma-37
DR   Wikidata; Q93541758
RX   CelloPub=CLPUB00521;
RX   PubMed=1868463;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   ERC-39
AC   CVCL_WX06
SY   Eker Renal Carcinoma-39
DR   Wikidata; Q93541763
RX   CelloPub=CLPUB00521;
RX   PubMed=8419937;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gly13Val (c.38_39GC>TT); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Val14Ile (c.40G>A); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Ala18Val (c.53C>T); Zygosity=Unspecified (from inference of genetic background of other Eker-derived cell lines).
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from inference of genetic background of other Eker-derived cell lines).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10-11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   EREB2-5
AC   CVCL_W845
SY   EREB2.5; ER/EB2-5
DR   DSMZ; ACC-914
DR   DSMZCellDive; ACC-914
DR   Wikidata; Q54832424
RX   PubMed=7828599;
CC   Doubling time: ~24-48 hours (DSMZ=ACC-914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-914
ST   Amelogenin: X
ST   CSF1PO: 9,12,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 17,21
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 9,13
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 10
//
ID   EREp
AC   CVCL_4520
SY   EREP; Embryonic Rabbit Epidermal
DR   CLO; CLO_0002945
DR   CLDB; cl1172
DR   ATCC; CRL-6498
DR   IZSLER; BS CL 112
DR   Wikidata; Q54832425
RX   PubMed=1318416;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6498; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   ERIC-1
AC   CVCL_F0QK
RX   PubMed=1895159;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13591; Human NCAM1/CD56.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Ericka
AC   CVCL_6F57
DR   Wikidata; Q54832426
RX   PubMed=1690682;
RX   PubMed=16702430;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ERLD/T
AC   CVCL_VS70
DR   Wikidata; Q93541799
RX   PubMed=1066184;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   ERLD/Two
AC   CVCL_VS71
DR   Wikidata; Q93541804
RX   PubMed=1066184;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   ERLD/Y3
AC   CVCL_VS72
DR   Wikidata; Q93541808
RX   PubMed=1066184;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   ERMCL
AC   CVCL_B3PB
SY   EpiRetinal Membrane Cell Line
DR   Wikidata; Q110432797
RX   PubMed=2925321;
CC   Miscellaneous: As no cell line name was provided in the papers, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Eye, retina, neuroretina; UBERON=UBERON_0003902.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ERPLi001-A
AC   CVCL_YT20
SY   AR28072001
DR   hPSCreg; ERPLi001-A
DR   SKIP; SKIP005737
DR   Wikidata; Q93541812
RX   PubMed=32278301;
CC   From: Eyestem Research Private Ltd; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5018+5G>A; ClinVar=VCV000438098; Zygosity=Heterozygous (PubMed=32278301).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32278301
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D21S11: 28,29
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 8,15
ST   FGA: 19,24
ST   TH01: 8,9
ST   TPOX: 9,10
ST   vWA: 15,16
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   ERPLi002-A
AC   CVCL_YT21
SY   PD24072008
DR   hPSCreg; ERPLi002-A
DR   SKIP; SKIP005736
DR   Wikidata; Q93541815
RX   PubMed=32278301;
CC   From: Eyestem Research Private Ltd; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Ser13Ter (c.38C>A); ClinVar=VCV000977812; Zygosity=Homozygous (PubMed=32278301).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32278301
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,14
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 11,13
ST   D8S1179: 11,13
ST   FGA: 20,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   ERPLi003-A
AC   CVCL_YT22
SY   TS30072010; RS30072010
DR   hPSCreg; ERPLi003-A
DR   SKIP; SKIP005735
DR   Wikidata; Q93541819
RX   PubMed=32278301;
CC   From: Eyestem Research Private Ltd; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Cys91Tyr (c.272G>A); ClinVar=VCV000039977; Zygosity=Heterozygous (PubMed=32278301).
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Arg278Ter (c.832C>T); ClinVar=VCV000099583; Zygosity=Heterozygous (PubMed=32278301).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32278301
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D21S11: 31,31.2
ST   D2S1338: 20,21
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 9,15
ST   FGA: 23,25
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   ERPLi004-A
AC   CVCL_E3UR
SY   A1AT iPSC C1
DR   BioSamples; SAMEA116043910
DR   hPSCreg; ERPLi004-A
CC   From: Eyestem Research Private, Ltd; Bangalore; India.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ERpP
AC   CVCL_L897
DR   BTO; BTO_0004816
DR   Wikidata; Q54832427
RX   PubMed=8276719;
RX   PubMed=9568647;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L896 ! ER-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   ery ED3 SiPSA
AC   CVCL_X730
DR   SKIP; SKIP004438
DR   Wikidata; Q54832428
CC   From: Harvard University; Boston; USA.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X731 ! ery ED4 SiPSA
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   ery ED4 SiPSA
AC   CVCL_X731
DR   SKIP; SKIP004439
DR   Wikidata; Q54832429
CC   From: Harvard University; Boston; USA.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X730 ! ery ED3 SiPSA
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   ERY-1
AC   CVCL_9492
DR   Wikidata; Q54832430
RX   PubMed=15475075;
CC   Doubling time: ~40 hours (PubMed=15475075).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Es Ho
AC   CVCL_U775
DR   ATCC; CRL-1274
DR   Wikidata; Q54832431
CC   Discontinued: ATCC; CRL-1274; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Es Ke
AC   CVCL_F120
DR   ATCC; CRL-1299
DR   ATCC; CRL-1409
DR   Wikidata; Q54832432
RX   PubMed=2722184;
RX   PubMed=3337712;
CC   Discontinued: ATCC; CRL-1299; true.
CC   Discontinued: ATCC; CRL-1409; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   ES Tet-On/Ngn3
AC   CVCL_EG65
SY   ES (Tet-On/Ngn3)
DR   BCGO; BCGO_0000108
DR   Wikidata; Q54832433
RX   PubMed=17932425;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:893591; Neurog3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/OlaHsd-Hprt<b-m3>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C315 ! HM-1 ES
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 6
//
ID   ES-1-OT
AC   CVCL_5122
SY   ES-10T
DR   cancercelllines; CVCL_5122
DR   Cosmic; 801762
DR   Cosmic; 1078365
DR   Cosmic; 1381109
DR   GEO; GSM393028
DR   IARC_TP53; 1271
DR   IGRhCellID; ES1OT%20GEO
DR   Progenetix; CVCL_5122
DR   Wikidata; Q54832434
RX   PubMed=1792900;
RX   PubMed=7591257;
RX   PubMed=8221663;
RX   PubMed=18082704;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr284Glnfs*61 (c.849delC) (p.Arg283fs); Zygosity=Unspecified (PubMed=8221663).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   ES-2
AC   CVCL_3509
SY   ES2
DR   BTO; BTO_0004424
DR   CLO; CLO_0002947
DR   EFO; EFO_0002177
DR   AddexBio; C0017006/4971
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1978
DR   BCRC; 60067
DR   BCRJ; 0080
DR   BioGRID_ORCS_Cell_line; 435
DR   BioSample; SAMN02800400
DR   BioSample; SAMN03472439
DR   BioSample; SAMN10988319
DR   cancercelllines; CVCL_3509
DR   CCRID; 1101HUM-PUMC000371
DR   CCRID; 3101HUMTCHu111
DR   CCRID; 4201HUM-CCTCC00322
DR   CCTCC; GDC0322
DR   Cell_Model_Passport; SIDM00861
DR   CGH-DB; 323-2
DR   CLS; 305038
DR   Cosmic; 844353
DR   Cosmic; 897429
DR   Cosmic; 1044235
DR   Cosmic; 1102814
DR   Cosmic; 1113277
DR   Cosmic; 1139225
DR   Cosmic; 1223312
DR   Cosmic; 1305327
DR   Cosmic; 1312191
DR   Cosmic; 1328071
DR   Cosmic; 1450145
DR   Cosmic; 1708382
DR   Cosmic; 1709256
DR   Cosmic; 1995396
DR   Cosmic; 2074240
DR   Cosmic-CLP; 1240128
DR   DepMap; ACH-000906
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240128
DR   GEO; GSM95455
DR   GEO; GSM274699
DR   GEO; GSM313713
DR   GEO; GSM383926
DR   GEO; GSM416675
DR   GEO; GSM659376
DR   GEO; GSM784563
DR   GEO; GSM887008
DR   GEO; GSM888077
DR   GEO; GSM1001491
DR   GEO; GSM1176276
DR   GEO; GSM1291140
DR   GEO; GSM1340580
DR   GEO; GSM1341129
DR   GEO; GSM1669769
DR   GEO; GSM2474975
DR   IARC_TP53; 28314
DR   IGRhCellID; ES2
DR   LiGeA; CCLE_094
DR   LINCS_LDP; LCL-1806
DR   PharmacoDB; ES2_337_2019
DR   PRIDE; PXD000901
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3509
DR   Ubigene; YC-C139
DR   Wikidata; Q54832435
RX   DOI=10.26502/ogr072;
RX   PubMed=1717140;
RX   PubMed=9698466;
RX   PubMed=11103784;
RX   PubMed=12960427;
RX   PubMed=16382445;
RX   PubMed=17671176;
RX   PubMed=18560578;
RX   PubMed=18720132;
RX   PubMed=20081105;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=22328975;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25049276;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26388441;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-457.html
CC   Problematic cell line: Probably misclassified. It is dubious that this cell line originates from an African American 47 year old patient diagnosed with an ovarian clear cell adenocarcinoma. Immunohistochemical and qPCR analysis as well as its mutational profile support an ovarian serous adenocarcinoma origin (PubMed=25049276; DOI=10.26502/ogr072). Furthermore its genome ancestry clearly shows a Caucasian/European decent (PubMed=30894373) which is confirmed by mtDNA haplotyping (DOI=10.26502/ogr072).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 31.11 hours (JWGray panel); ~24 hours (ATCC=CRL-1978).
CC   HLA typing: A*03:01,68:02; B*14:02,41:01; C*07:01,08:02; DRB1*01:02,13:07 (PubMed=25960936).
CC   HLA typing: A*03:01,68:02; B*14:02,41:01; C*07:01,08:04; DQA1*04:01,04:01; DRB1*01:02,13:05' (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22705003; PubMed=25230021; PubMed=28273451; Cosmic-CLP=1240128; DepMap=ACH-000906).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (PubMed=20204287; PubMed=24023729; PubMed=25230021; PubMed=28273451; Cosmic-CLP=1240128; DepMap=ACH-000906).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.57%; Native American=0%; East Asian, North=3.68%; East Asian, South=0.75%; South Asian=7.03%; European, North=27.14%; European, South=58.83% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): AddexBio=C0017006/4971; ATCC=CRL-1978; Cosmic-CLP=1240128; PubMed=22710073; PubMed=25230021; PubMed=25877200; PubMed=30485824; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D10S1248: 14,16
ST   D12S391: 20,21
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D19S433: 15,15.2
ST   D1S1656: 13,16
ST   D21S11: 32.2 (PubMed=25230021)
ST   D21S11: 32.2,33.2 (ATCC=CRL-1978; PubMed=22710073; PubMed=25877200; PubMed=30485824; Technion Genomics Center)
ST   D22S1045: 14,16
ST   D2S1338: 17,23
ST   D2S441: 11
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 21
ST   Penta D: 8,13
ST   Penta E: 13,16
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   ES-2/GFP
AC   CVCL_JY93
DR   cancercelllines; CVCL_JY93
DR   Cell_Biolabs; AKR-206
DR   Wikidata; Q54832436
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Cell_Biolabs; AKR-206; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   ES-2/T80
AC   CVCL_CZ94
SY   ES-2 T80; ES-2T80
DR   cancercelllines; CVCL_CZ94
DR   GEO; GSM95464
DR   Progenetix; CVCL_CZ94
DR   Wikidata; Q54832437
RX   PubMed=16382445;
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   ES-2/TxT50
AC   CVCL_CZ95
SY   ES-2 TxT50; ES-2TxT50
DR   cancercelllines; CVCL_CZ95
DR   GEO; GSM95429
DR   Progenetix; CVCL_CZ95
DR   Wikidata; Q54832438
RX   PubMed=16382445;
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   ES-2R
AC   CVCL_M715
DR   cancercelllines; CVCL_M715
DR   Wikidata; Q54832439
RX   PubMed=1717140;
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41576; 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (Cyanomorpholinoadriamycin; MRA-CN).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   ES-5838
AC   CVCL_6255
SY   5838 Ewing's; 5838; #5838
DR   Cosmic; 1079353
DR   Lonza; 628
DR   Wikidata; Q54832442
RX   PubMed=327080;
RX   PubMed=2620246;
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=3518877;
RX   PubMed=6750238;
RX   PubMed=29464090;
RX   PubMed=30879952;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 9,11
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 11
ST   FGA: 20,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   ES-8040 20-2
AC   CVCL_F750
DR   CLO; CLO_0050777
DR   RCB; RCB1847
DR   Wikidata; Q54832443
RX   PubMed=1946997;
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   ES-8047 2-1
AC   CVCL_F751
DR   CLO; CLO_0050778
DR   RCB; RCB1848
DR   Wikidata; Q54832444
RX   PubMed=1946997;
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   ES-C57BL/6
AC   CVCL_5746
SY   Line 693; #693
DR   CLO; CLO_0002948
DR   ATCC; SCRC-1002
DR   Wikidata; Q54832445
RX   PubMed=11730008;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   ES-D3
AC   CVCL_4378
SY   ES D3; D3; D3 ES; D3_ES; D3 mESC; D3 mES
DR   BTO; BTO_0001582
DR   CLO; CLO_0002949
DR   CLO; CLO_0002950
DR   EFO; EFO_0005910
DR   ATCC; CRL-1934
DR   ATCC; CRL-11632
DR   BCRC; 60205
DR   CCRID; 3101MOUSCSP202
DR   ENCODE; ENCBS029ENC
DR   FCS-free; 104-5-158-2-3-3
DR   GEO; GSM450273
DR   GEO; GSM450278
DR   GEO; GSM450279
DR   GEO; GSM450282
DR   GEO; GSM450285
DR   PRIDE; PXD000589
DR   TOKU-E; 3545
DR   Wikidata; Q54832446
RX   PubMed=3897439;
RX   PubMed=9353641;
RX   PubMed=14705957;
RX   PubMed=21376803;
RX   PubMed=25894527;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-crl-1934-vs-atcc-crl-11632
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-148.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-265.html
WW   Provider; Michigan TCPS; -; https://medresearch.umich.edu/office-research/about-office-research/biomedical-research-core-facilities/transgenic-animal-model/transgenic-core-products-services
CC   Part of: ENCODE project mouse cell lines.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11632.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Discontinued: ATCC; CRL-11632; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   ES-D3 GL
AC   CVCL_5747
DR   CLO; CLO_0002951
DR   ATCC; SCRC-1003
DR   BCRC; 60469
DR   Wikidata; Q54832447
CC   Discontinued: ATCC; SCRC-1003; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   ES-E14
AC   CVCL_C320
SY   E14; E-14; ES (E14)
DR   BTO; BTO_0005136
DR   EFO; EFO_0007075
DR   4DN; 4DNSRR6CIPYP
DR   BioSamples; SAMEA2155660
DR   ENCODE; ENCBS033ENC
DR   ENCODE; ENCBS042ENC
DR   ENCODE; ENCBS043ENC
DR   ENCODE; ENCBS054SMP
DR   ENCODE; ENCBS324NLT
DR   GEO; GSE53149
DR   GEO; GSM344759
DR   GEO; GSM344760
DR   GEO; GSM397410
DR   GEO; GSM397411
DR   GEO; GSM413111
DR   GEO; GSM413112
DR   GEO; GSM413113
DR   GEO; GSM413117
DR   GEO; GSM413118
DR   GEO; GSM413119
DR   GEO; GSM413123
DR   GEO; GSM413124
DR   GEO; GSM413125
DR   GEO; GSM413129
DR   GEO; GSM413130
DR   GEO; GSM413131
DR   GEO; GSM413135
DR   GEO; GSM413136
DR   GEO; GSM413137
DR   GEO; GSM413141
DR   GEO; GSM413142
DR   GEO; GSM413143
DR   GEO; GSM413147
DR   GEO; GSM413148
DR   GEO; GSM413149
DR   GEO; GSM413153
DR   GEO; GSM413154
DR   GEO; GSM413155
DR   GEO; GSM1000121
DR   GEO; GSM1000123
DR   GEO; GSM1000124
DR   GEO; GSM1000125
DR   GEO; GSM1000126
DR   GEO; GSM1003750
DR   GEO; GSM1003751
DR   GEO; GSM1003756
DR   GEO; GSM1003799
DR   GEO; GSM1003807
DR   GEO; GSM1003809
DR   GEO; GSM1003810
DR   GEO; GSM1014154
DR   Wikidata; Q54832448
RX   PubMed=3821905;
RX   PubMed=19581487;
RX   PubMed=23850244;
RX   PubMed=25004115;
RX   PubMed=26484140;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/ES-E14_Stam_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me2.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   ES-E14 MLL3,MLL4 DKO
AC   CVCL_VC44
SY   Mll3/Mll4 double KO; mll3-4DKO
DR   4DN; 4DNSRBLYZQIV
DR   Wikidata; Q54832449
CC   Knockout cell: Method=Cre/loxP; MGI; MGI:109565; Kmt2b.
CC   Knockout cell: Method=Cre/loxP; MGI; MGI:2444959; Kmt2c.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 4
//
ID   ES-E14TG2a
AC   CVCL_9108
SY   E14TG2a; E14Tg2a; E14tg2a; E14.Tg2a; E14 Tg2a
DR   CLO; CLO_0002952
DR   EFO; EFO_0006275
DR   ATCC; CRL-1821
DR   BCRC; 60206
DR   CCRID; 3101MOUSCSP204
DR   ECACC; 08021401
DR   ENCODE; ENCBS340HTQ
DR   ENCODE; ENCBS841DCQ
DR   ENCODE; ENCBS917UCO
DR   PRIDE; PXD000589
DR   RCB; AES0135
DR   SKIP; SKIP003029
DR   TOKU-E; 1158
DR   Wikidata; Q54832450
RX   PubMed=3821905;
RX   PubMed=25277546;
RX   PubMed=25894527;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-571.html
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C320 ! ES-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   ES-E14TG2a EGFP-MBD-nls
AC   CVCL_U952
SY   EGFP-MBD-nls
DR   RCB; AES0134
DR   RCB; RCB2708
DR   SKIP; SKIP003028
DR   Wikidata; Q54832085
RX   PubMed=17397393;
CC   Characteristics: Transfected with a CAGGS-EGFP-MBD-nls construct that contains eGFP fused to the binding domain for methylated DNA of MBD1 and a nuclear localization signal (nls) (PubMed=17397393).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6916; MBD1 (Note=With p.Lys85_Gln605del = MBD).
CC   Discontinued: RCB; RCB2708; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   ES-E14TG2a Psmb8 KO clone 1-12
AC   CVCL_E7BY
SY   KO1-12
RX   DOI=10.1134/S1990519X24600741;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1346527; Psmb8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ES-E14TG2a Psmb8 KO clone 1-5
AC   CVCL_E7BX
SY   KO1-5
RX   DOI=10.1134/S1990519X24600741;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1346527; Psmb8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ES-E14TG2a Psmb8 KO clone 2-4
AC   CVCL_E7BZ
SY   KO2-4
RX   DOI=10.1134/S1990519X24600741;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1346527; Psmb8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ES-E14TG2a.4
AC   CVCL_Y481
SY   E14TG2a.4; E14Tg2a.4; E14Tg2a.IV; E14Tg2a clone4
DR   EFO; EFO_0007751
DR   ENCODE; ENCBS171HGC
DR   ENCODE; ENCBS705LKU
DR   MMRRC; MMRRC:015890-UCD
DR   Wikidata; Q54832451
WW   Provider; Michigan TCPS; -; https://medresearch.umich.edu/office-research/about-office-research/biomedical-research-core-facilities/transgenic-animal-model/transgenic-core-products-services
CC   Characteristics: Feeder free.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   ES-OMC-MN
AC   CVCL_5242
SY   Epithelioid Sarcoma-Osaka Medical College-MN
DR   Wikidata; Q54832452
RX   PubMed=9143739;
RX   PubMed=10929770;
RX   PubMed=16557275;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=ES-OMC-MN
CC   Population: Japanese.
CC   Doubling time: 68.5 hours (Note=At 90th passage) (PubMed=9143739).
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   ES-R1
AC   CVCL_2167
SY   R1; R1 ES; R-1
DR   BTO; BTO_0004500
DR   CLO; CLO_0008697
DR   EFO; EFO_0002076
DR   ATCC; SCRC-1011
DR   CCRID; 3101MOUSCSP223
DR   ChEMBL-Cells; CHEMBL3307379
DR   ChEMBL-Targets; CHEMBL614383
DR   ECACC; 07072001
DR   ENCODE; ENCBS054ZRK
DR   ENCODE; ENCBS388DNV
DR   ENCODE; ENCBS398YOV
DR   MMRRC; MMRRC:011978-UCD
DR   PRIDE; PRD000194
DR   PRIDE; PXD000589
DR   PubChem_Cell_line; CVCL_2167
DR   Wikidata; Q54832454
RX   PubMed=8378314;
RX   PubMed=9353641;
RX   PubMed=20512790;
RX   PubMed=25277546;
RX   PubMed=25894527;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-521.html
WW   Provider; Michigan TCPS; -; https://medresearch.umich.edu/office-research/about-office-research/biomedical-research-core-facilities/transgenic-animal-model/transgenic-core-products-services
CC   Omics: Proteomics.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   ES-R1 CAG-S-hCOUP-TFI
AC   CVCL_BW90
DR   Wikidata; Q54832455
RX   PubMed=20382891;
WW   Provider; NURSA; -; https://web.archive.org/web/20191214045210/https://nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/RQEXOC2BJV
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:7975; NR2F1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ES-R1 CAG-S-hERalpha
AC   CVCL_BW91
DR   Wikidata; Q54832456
RX   PubMed=20382891;
WW   Provider; NURSA; -; https://web.archive.org/web/20191214045214/https://www.nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/82JR1QYCBV
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:3467; ESR1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ES-R1 CAG-S-hERRalpha
AC   CVCL_BW92
DR   Wikidata; Q54832457
RX   PubMed=20382891;
WW   Provider; NURSA; -; https://web.archive.org/web/20191214045218/https://nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/4N3X5DWGI3
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:3471; ESRRA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ES-R1 CAG-S-hPPARgamma2
AC   CVCL_BW93
DR   Wikidata; Q54832458
RX   PubMed=20382891;
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:9236; PPARG.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ES-R1 CAG-S-hRXRalpha
AC   CVCL_BW94
DR   Wikidata; Q54832459
RX   PubMed=20382891;
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:10477; RXRA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ES-R1 CAG-S-hSRC-1
AC   CVCL_BW95
DR   Wikidata; Q54832460
RX   PubMed=20382891;
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7668; NCOA1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ES-R1 CAG-S-hSRC-2
AC   CVCL_BW96
DR   Wikidata; Q54832461
RX   PubMed=20382891;
WW   Provider; NURSA; -; https://web.archive.org/web/20191214045227/https://nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/B7O7PAMCCC
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:7669; NCOA2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ES-R1 CAG-S-mPPARalpha
AC   CVCL_BW97
DR   Wikidata; Q54832462
RX   PubMed=20382891;
WW   Provider; NURSA; -; https://web.archive.org/web/20191214045235/https://nursa.org/nursa/reagents/cellLine.jsf?doi=10.1621/BZFRSZYLIW
CC   Characteristics: The integrated construct consist of a ubiquitous CAGGS (hybrid chicken beta actin and cytomegalovirus) promoter, a loxP-STOP-loxP (LSL) cassette and the Myc-FLAG-tagged NR/CoR cDNA followed by a polyadenylation signal. The contruct is silent and the integrated gene can be conditionally overexpressed after cre recombinase mediated activation (PubMed=20382891).
CC   Genetic integration: Method=Homologous recombination; Gene=MGI; MGI:104740; Ppara.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ES-R1/7AC5/EYFP
AC   CVCL_6767
SY   7AC5/EYFP; ES-R1-EYFP 7AC5/EYFP
DR   CLO; CLO_0001489
DR   ATCC; SCRC-1033
DR   ECACC; 07072003
DR   Wikidata; Q54832463
RX   PubMed=10951501;
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   ES-R1/B5/EGFP
AC   CVCL_AR60
SY   B5/EGFP; ES-R1-EGFP B5/EGFP
DR   ECACC; 07072007
DR   Wikidata; Q54832464
RX   PubMed=9867352;
RX   PubMed=10951501;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 7
//
ID   ES-R1/CK6/ECFP
AC   CVCL_AR61
SY   ES-R1-ECFP CK6/ECFP
DR   ECACC; 07072004
DR   Wikidata; Q54832465
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 6
//
ID   ES-R1/CK8/ECFP
AC   CVCL_AR62
SY   ES-R1-ECFP CK8/ECFP
DR   ECACC; 07072005
DR   Wikidata; Q54832466
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 6
//
ID   ES-R1/D4/XEGFP
AC   CVCL_AR63
SY   ES-R1-EGFP D4/XEGFP
DR   ECACC; 07072006
DR   Wikidata; Q54832467
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 7
//
ID   ES-R1/E
AC   CVCL_6516
SY   R1/E
DR   CLO; CLO_0008700
DR   ATCC; SCRC-1036
DR   CCRID; 3101MOUSCSP201
DR   Wikidata; Q54832468
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   ES-R1/YC5/EYFP
AC   CVCL_AR64
SY   YC5/EYFP; ES-R1-EYFP YC5/EYFP
DR   ECACC; 07072002
DR   Wikidata; Q54832469
RX   PubMed=10951501;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 6
//
ID   ES-ZSS-1
AC   CVCL_E4C6
RX   PubMed=39475964;
CC   Population: Chinese.
CC   Characteristics: Established from a mice patient-derived xenograft (PubMed=39475964).
CC   Doubling time: ~61 hours (PubMed=39475964).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=39475964).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln963Serfs; Zygosity=Unspecified (PubMed=39475964).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Abdominal wall, hypodermis; UBERON=UBERON_0003697+UBERON_0002072.
ST   Source(s): PubMed=39475964
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C7135; Extraskeletal Ewing sarcoma
DI   ORDO; Orphanet_370334; Extraskeletal Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ES[MC1R(20):tet4932441K18Rik(9)]
AC   CVCL_H859
DR   GEO; GSM778036
DR   GEO; GSM778037
DR   GEO; GSM778038
DR   GEO; GSM778039
DR   Wikidata; Q54832470
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=4932441K18Rik
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAes(24)]
AC   CVCL_H795
SY   AG23197
DR   Coriell; AG23197
DR   GEO; GSM364239
DR   GEO; GSM364240
DR   GEO; GSM364241
DR   GEO; GSM364242
DR   Wikidata; Q54832471
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Aes
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAff1(9)]
AC   CVCL_H860
DR   GEO; GSM777812
DR   GEO; GSM777813
DR   GEO; GSM777814
DR   GEO; GSM777815
DR   Wikidata; Q54832472
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Aff1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAnkrd22(9)]
AC   CVCL_H861
SY   AG23563
DR   Coriell; AG23563
DR   GEO; GSM777816
DR   GEO; GSM777817
DR   GEO; GSM777818
DR   GEO; GSM777819
DR   Wikidata; Q54832473
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ankrd22
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetArnt2(26)]
AC   CVCL_H862
DR   GEO; GSM777820
DR   GEO; GSM777821
DR   GEO; GSM777822
DR   GEO; GSM777823
DR   Wikidata; Q54832474
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Arnt2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAscl1(12)]
AC   CVCL_H796
SY   AG23178
DR   Coriell; AG23178
DR   GEO; GSM364346
DR   GEO; GSM364347
DR   GEO; GSM364348
DR   GEO; GSM364349
DR   Wikidata; Q54832475
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Ascl1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAscl2(21)]
AC   CVCL_H797
SY   AG23168
DR   Coriell; AG23168
DR   GEO; GSM364329
DR   GEO; GSM364330
DR   GEO; GSM364331
DR   GEO; GSM364332
DR   Wikidata; Q54832476
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Ascl2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAsh2l(6)]
AC   CVCL_H863
SY   AG23568
DR   Coriell; AG23568
DR   GEO; GSM777824
DR   GEO; GSM777825
DR   GEO; GSM777826
DR   GEO; GSM777827
DR   Wikidata; Q54832477
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ash2l
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAtf3(5)]
AC   CVCL_H798
SY   AG23171
DR   Coriell; AG23171
DR   GEO; GSM364209
DR   GEO; GSM364210
DR   GEO; GSM364211
DR   GEO; GSM364212
DR   Wikidata; Q54832478
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Atf3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetAtxn1(20)]
AC   CVCL_H864
DR   GEO; GSM777828
DR   GEO; GSM777829
DR   GEO; GSM777830
DR   GEO; GSM777831
DR   Wikidata; Q54832479
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Atxn1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetBatf3(35)]
AC   CVCL_H865
SY   AG23512
DR   Coriell; AG23512
DR   GEO; GSM777832
DR   GEO; GSM777833
DR   GEO; GSM777834
DR   GEO; GSM777835
DR   Wikidata; Q54832480
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Batf3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetBcl6(32)]
AC   CVCL_H866
SY   AG23582
DR   Coriell; AG23582
DR   GEO; GSM777836
DR   GEO; GSM777837
DR   GEO; GSM777838
DR   GEO; GSM777839
DR   Wikidata; Q54832481
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Bcl6
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetCbx8(9)]
AC   CVCL_H801
SY   AG23200
DR   Coriell; AG23200
DR   GEO; GSM364231
DR   GEO; GSM364232
DR   GEO; GSM364233
DR   GEO; GSM364234
DR   Wikidata; Q54832482
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Cbx8
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetCdx2(6)]
AC   CVCL_H802
SY   AG23174
DR   Coriell; AG23174
DR   GEO; GSM364205
DR   GEO; GSM364370
DR   GEO; GSM364371
DR   GEO; GSM364372
DR   Wikidata; Q54832488
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Cdx2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetCdyl(12)]
AC   CVCL_H867
SY   AG23538
DR   Coriell; AG23538
DR   GEO; GSM777840
DR   GEO; GSM777841
DR   GEO; GSM777842
DR   GEO; GSM777843
DR   Wikidata; Q54832489
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Cdyl
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetCdyl2(24)]
AC   CVCL_H868
SY   AG23546
DR   Coriell; AG23546
DR   GEO; GSM777844
DR   GEO; GSM777845
DR   GEO; GSM777846
DR   GEO; GSM777847
DR   Wikidata; Q54832490
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Cdyl2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetChes1(2)]
AC   CVCL_H869
SY   AG23533
DR   Coriell; AG23533
DR   GEO; GSM777848
DR   GEO; GSM777849
DR   GEO; GSM777850
DR   GEO; GSM777851
DR   Wikidata; Q54832491
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ches1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetControl(13)]
AC   CVCL_H811
SY   AG23205
DR   Coriell; AG23205
DR   GEO; GSM364262
DR   GEO; GSM364375
DR   GEO; GSM364376
DR   GEO; GSM364377
DR   Wikidata; Q54832492
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Control
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetCtbp2(23)]
AC   CVCL_H870
DR   GEO; GSM766433
DR   GEO; GSM766434
DR   GEO; GSM766435
DR   GEO; GSM766436
DR   Wikidata; Q54832493
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ctbp2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetCtnnb1(20)]
AC   CVCL_H812
SY   AG23202
DR   Coriell; AG23202
DR   GEO; GSM364193
DR   GEO; GSM364194
DR   GEO; GSM364195
DR   GEO; GSM364196
DR   Wikidata; Q54832494
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Ctnnb1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetDedd2(23)]
AC   CVCL_H871
DR   GEO; GSM777852
DR   GEO; GSM777853
DR   GEO; GSM777854
DR   GEO; GSM777855
DR   Wikidata; Q54832495
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Dedd2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetDlx3(3)]
AC   CVCL_H813
SY   AG23173
DR   Coriell; AG23173
DR   GEO; GSM364317
DR   GEO; GSM364318
DR   GEO; GSM364319
DR   GEO; GSM364320
DR   Wikidata; Q54832496
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Dlx3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetDmrt1(21)]
AC   CVCL_H872
SY   AG23561
DR   Coriell; AG23561
DR   GEO; GSM777856
DR   GEO; GSM777857
DR   GEO; GSM777858
DR   GEO; GSM777859
DR   Wikidata; Q54832497
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Dmrt1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetDnmt3b(22)]
AC   CVCL_H814
SY   AG23203
DR   Coriell; AG23203
DR   GEO; GSM364357
DR   GEO; GSM364358
DR   GEO; GSM364359
DR   GEO; GSM364360
DR   Wikidata; Q54832498
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Dnmt3b
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetDppa3(7)]
AC   CVCL_H873
SY   AG23549
DR   Coriell; AG23549
DR   GEO; GSM777860
DR   GEO; GSM777861
DR   GEO; GSM777862
DR   GEO; GSM777863
DR   Wikidata; Q54832499
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Dppa3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetDppa5(7)]
AC   CVCL_H815
SY   AG23219
DR   Coriell; AG23219
DR   GEO; GSM364235
DR   GEO; GSM364236
DR   GEO; GSM364237
DR   GEO; GSM364238
DR   Wikidata; Q54832500
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Dppa5a
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEed(36)]
AC   CVCL_H816
DR   GEO; GSM364217
DR   GEO; GSM364218
DR   GEO; GSM364219
DR   GEO; GSM364220
DR   Wikidata; Q54832501
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Eed
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetElf1(21)]
AC   CVCL_H817
SY   AG23176
DR   Coriell; AG23176
DR   GEO; GSM364367
DR   GEO; GSM364400
DR   GEO; GSM364401
DR   GEO; GSM364402
DR   Wikidata; Q54832502
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Elf1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetElf5(18)]
AC   CVCL_H874
DR   GEO; GSM777864
DR   GEO; GSM777865
DR   GEO; GSM777866
DR   GEO; GSM777867
DR   Wikidata; Q54832503
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Elf5
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEll2(38)]
AC   CVCL_H875
SY   AG23557
DR   Coriell; AG23557
DR   GEO; GSM777868
DR   GEO; GSM777869
DR   GEO; GSM777870
DR   GEO; GSM777871
DR   Wikidata; Q54832504
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ell2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEomes(35)]
AC   CVCL_H818
SY   AG23201
DR   Coriell; AG23201
DR   GEO; GSM364269
DR   GEO; GSM364270
DR   GEO; GSM364271
DR   GEO; GSM364272
DR   Wikidata; Q54832505
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Eomes
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEsx1(16)]
AC   CVCL_H819
SY   AG23175
DR   Coriell; AG23175
DR   GEO; GSM364227
DR   GEO; GSM364228
DR   GEO; GSM364229
DR   GEO; GSM364230
DR   Wikidata; Q54832506
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Esx1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEts1(6)]
AC   CVCL_H876
SY   AG23559
DR   Coriell; AG23559
DR   GEO; GSM777872
DR   GEO; GSM777873
DR   GEO; GSM777874
DR   GEO; GSM777875
DR   Wikidata; Q54832507
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ets1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEtv1(15)]
AC   CVCL_H877
SY   AG23535
DR   Coriell; AG23535
DR   GEO; GSM777876
DR   GEO; GSM777877
DR   GEO; GSM777878
DR   GEO; GSM777879
DR   Wikidata; Q54832508
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Etv1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEtv3(15)]
AC   CVCL_H820
SY   AG23199
DR   Coriell; AG23199
DR   GEO; GSM364333
DR   GEO; GSM364334
DR   GEO; GSM364335
DR   GEO; GSM364336
DR   Wikidata; Q54832509
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Etv3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetEtv5(24)]
AC   CVCL_H878
DR   GEO; GSM766420
DR   GEO; GSM766421
DR   GEO; GSM766422
DR   GEO; GSM766423
DR   Wikidata; Q54832510
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Etv5
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFbxo15(14)]
AC   CVCL_H879
SY   AG23539
DR   Coriell; AG23539
DR   GEO; GSM777880
DR   GEO; GSM777881
DR   GEO; GSM777882
DR   GEO; GSM777883
DR   Wikidata; Q54832511
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fbxo15
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFem1b(6)]
AC   CVCL_H821
DR   GEO; GSM364297
DR   GEO; GSM364298
DR   GEO; GSM364299
DR   GEO; GSM364300
DR   Wikidata; Q54832512
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Fem1b
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFgfbp1(2)]
AC   CVCL_H880
SY   AG23586
DR   Coriell; AG23586
DR   GEO; GSM777884
DR   GEO; GSM777885
DR   GEO; GSM777886
DR   GEO; GSM777887
DR   Wikidata; Q54832513
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fgfbp1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFhl2(7)]
AC   CVCL_H881
DR   GEO; GSM777888
DR   GEO; GSM777889
DR   GEO; GSM777890
DR   GEO; GSM777891
DR   Wikidata; Q54832514
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fhl2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFosl2(1)]
AC   CVCL_H882
SY   AG23545
DR   Coriell; AG23545
DR   GEO; GSM777892
DR   GEO; GSM777893
DR   GEO; GSM777894
DR   GEO; GSM777895
DR   Wikidata; Q54832515
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Fosl2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFoxa1(36)]
AC   CVCL_H883
DR   GEO; GSM777896
DR   GEO; GSM777897
DR   GEO; GSM777898
DR   GEO; GSM777899
DR   Wikidata; Q54832516
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxa1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFoxc1(18)]
AC   CVCL_H884
DR   GEO; GSM777900
DR   GEO; GSM777901
DR   GEO; GSM777902
DR   GEO; GSM777903
DR   Wikidata; Q54832517
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxc1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFoxg1(8)]
AC   CVCL_H885
SY   AG23525
DR   Coriell; AG23525
DR   GEO; GSM777904
DR   GEO; GSM777905
DR   GEO; GSM777906
DR   GEO; GSM777907
DR   Wikidata; Q54832518
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxg1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFoxj2(6)]
AC   CVCL_H822
SY   AG23217
DR   Coriell; AG23217
DR   GEO; GSM364321
DR   GEO; GSM364322
DR   GEO; GSM364323
DR   GEO; GSM364324
DR   Wikidata; Q54832519
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Foxj2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFoxl2(15)]
AC   CVCL_H886
SY   AG23514
DR   Coriell; AG23514
DR   GEO; GSM777908
DR   GEO; GSM777909
DR   GEO; GSM777910
DR   GEO; GSM777911
DR   Wikidata; Q54832520
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxl2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetFoxp3(12)]
AC   CVCL_H887
DR   GEO; GSM777912
DR   GEO; GSM777913
DR   GEO; GSM777914
DR   GEO; GSM777915
DR   Wikidata; Q54832521
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Foxp3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetGadd45a(6)]
AC   CVCL_H823
SY   AG23218
DR   Coriell; AG23218
DR   GEO; GSM364281
DR   GEO; GSM364282
DR   GEO; GSM364283
DR   GEO; GSM364284
DR   Wikidata; Q54832522
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Gadd45a
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetGata2(7)]
AC   CVCL_H888
SY   AG23519
DR   Coriell; AG23519
DR   GEO; GSM777916
DR   GEO; GSM777917
DR   GEO; GSM777918
DR   GEO; GSM777919
DR   Wikidata; Q54832523
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Gata2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetGata3(14)]
AC   CVCL_H824
SY   AG23181
DR   Coriell; AG23181
DR   GEO; GSM364309
DR   GEO; GSM364310
DR   GEO; GSM364311
DR   GEO; GSM364312
DR   Wikidata; Q54832524
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Gata3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetGbx2(8)]
AC   CVCL_H889
SY   AG23558
DR   Coriell; AG23558
DR   GEO; GSM777920
DR   GEO; GSM777921
DR   GEO; GSM777922
DR   GEO; GSM777923
DR   Wikidata; Q54832525
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Gbx2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetGrhl2(22)]
AC   CVCL_H890
DR   GEO; GSM777924
DR   GEO; GSM777925
DR   GEO; GSM777926
DR   GEO; GSM777927
DR   Wikidata; Q54832526
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Grhl2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetHesx1(8)]
AC   CVCL_H891
SY   AG23516
DR   Coriell; AG23516
DR   GEO; GSM777928
DR   GEO; GSM777929
DR   GEO; GSM777930
DR   GEO; GSM777931
DR   Wikidata; Q54832527
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hesx1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetHmga2(18)]
AC   CVCL_H892
SY   AG23571
DR   Coriell; AG23571
DR   GEO; GSM777932
DR   GEO; GSM777933
DR   GEO; GSM777934
DR   GEO; GSM777935
DR   Wikidata; Q54832533
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hmga2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetHnf4a(1)]
AC   CVCL_H893
SY   AG23520
DR   Coriell; AG23520
DR   GEO; GSM777936
DR   GEO; GSM777937
DR   GEO; GSM777938
DR   GEO; GSM777939
DR   Wikidata; Q54832534
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hnf4a
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetHoxa2(12)]
AC   CVCL_H894
SY   AG23534
DR   Coriell; AG23534
DR   GEO; GSM777940
DR   GEO; GSM777941
DR   GEO; GSM777942
DR   GEO; GSM777943
DR   Wikidata; Q54832535
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hoxa2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetHoxa9(19)]
AC   CVCL_H895
SY   AG23532
DR   Coriell; AG23532
DR   GEO; GSM777944
DR   GEO; GSM777945
DR   GEO; GSM777946
DR   GEO; GSM777947
DR   Wikidata; Q54832536
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hoxa9
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetHsf2bp(10)]
AC   CVCL_H896
DR   GEO; GSM777948
DR   GEO; GSM777949
DR   GEO; GSM777950
DR   GEO; GSM777951
DR   Wikidata; Q54832537
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Hsf2bp
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetId1(1)]
AC   CVCL_H825
SY   AG23206
DR   Coriell; AG23206
DR   GEO; GSM364366
DR   GEO; GSM364397
DR   GEO; GSM364398
DR   GEO; GSM364399
DR   Wikidata; Q54832539
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Id1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetId3(18)]
AC   CVCL_H897
DR   GEO; GSM777952
DR   GEO; GSM777953
DR   GEO; GSM777954
DR   GEO; GSM777955
DR   Wikidata; Q54832540
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Id3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetInppl1(21)]
AC   CVCL_H898
DR   GEO; GSM777956
DR   GEO; GSM777957
DR   GEO; GSM777958
DR   GEO; GSM777959
DR   Wikidata; Q54832541
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Inppl1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetIrf2(7)]
AC   CVCL_H899
SY   AG23560
DR   Coriell; AG23560
DR   GEO; GSM777960
DR   GEO; GSM777961
DR   GEO; GSM777962
DR   GEO; GSM777963
DR   Wikidata; Q54832542
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Irf2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetJarid1a(21)]
AC   CVCL_H900
DR   GEO; GSM777964
DR   GEO; GSM777965
DR   GEO; GSM777966
DR   GEO; GSM777967
DR   Wikidata; Q54832543
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jarid1a
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetJarid2(37)]
AC   CVCL_H901
DR   GEO; GSM766425
DR   GEO; GSM766426
DR   GEO; GSM766427
DR   GEO; GSM766428
DR   Wikidata; Q54832544
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jarid2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetJmjd2c(14)]
AC   CVCL_H902
DR   GEO; GSM766429
DR   GEO; GSM766430
DR   GEO; GSM766431
DR   GEO; GSM766432
DR   Wikidata; Q54832545
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jmjd2c
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetJun(4)]
AC   CVCL_H903
SY   AG23526
DR   Coriell; AG23526
DR   GEO; GSM777968
DR   GEO; GSM777969
DR   GEO; GSM777970
DR   GEO; GSM777971
DR   Wikidata; Q54832546
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Jun
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetKlf3(11)]
AC   CVCL_H904
DR   GEO; GSM777972
DR   GEO; GSM777973
DR   GEO; GSM777974
DR   GEO; GSM777975
DR   Wikidata; Q54832547
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Klf3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetKlf4(16)]
AC   CVCL_H826
SY   AG23193
DR   Coriell; AG23193
DR   GEO; GSM364263
DR   GEO; GSM364264
DR   GEO; GSM364392
DR   GEO; GSM364393
DR   Wikidata; Q54832548
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Klf4
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetKlf9(23)]
AC   CVCL_H905
SY   AG23562
DR   Coriell; AG23562
DR   GEO; GSM777976
DR   GEO; GSM777977
DR   GEO; GSM777978
DR   GEO; GSM777979
DR   Wikidata; Q54832549
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Klf9
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetLass2(12)]
AC   CVCL_H906
SY   AG23565
DR   Coriell; AG23565
DR   GEO; GSM777980
DR   GEO; GSM777981
DR   GEO; GSM777982
DR   GEO; GSM777983
DR   Wikidata; Q54832550
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Lass2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetLhx2(13)]
AC   CVCL_H907
SY   AG23523
DR   Coriell; AG23523
DR   GEO; GSM777984
DR   GEO; GSM777985
DR   GEO; GSM777986
DR   GEO; GSM777987
DR   Wikidata; Q54832551
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Lhx2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMbd3(12)]
AC   CVCL_H908
SY   AG23536
DR   Coriell; AG23536
DR   GEO; GSM777988
DR   GEO; GSM777989
DR   GEO; GSM777990
DR   GEO; GSM777991
DR   Wikidata; Q54832552
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Mbd3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMef2c(5)]
AC   CVCL_H827
SY   AG23180
DR   Coriell; AG23180
DR   GEO; GSM364277
DR   GEO; GSM364278
DR   GEO; GSM364279
DR   GEO; GSM364280
DR   Wikidata; Q54832553
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Mef2c
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMeis2(40)]
AC   CVCL_H909
SY   AG23522
DR   Coriell; AG23522
DR   GEO; GSM777992
DR   GEO; GSM777993
DR   GEO; GSM777994
DR   GEO; GSM777995
DR   Wikidata; Q54832554
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Meis2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMettl5(15)]
AC   CVCL_H910
DR   GEO; GSM766437
DR   GEO; GSM766438
DR   GEO; GSM766439
DR   GEO; GSM766440
DR   Wikidata; Q54832555
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Mettl5
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMkrn1(15)]
AC   CVCL_H911
SY   AG23552
DR   Coriell; AG23552
DR   GEO; GSM777996
DR   GEO; GSM777997
DR   GEO; GSM777998
DR   GEO; GSM777999
DR   Wikidata; Q54832556
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Mkrn1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMsc(24)]
AC   CVCL_H828
DR   GEO; GSM364203
DR   GEO; GSM364204
DR   GEO; GSM364385
DR   GEO; GSM364386
DR   Wikidata; Q54832557
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Msc
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMybl2(6)]
AC   CVCL_H829
SY   AG23212
DR   Coriell; AG23212
DR   GEO; GSM364206
DR   GEO; GSM364387
DR   GEO; GSM364388
DR   GEO; GSM364389
DR   Wikidata; Q54832558
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Mybl2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMyc(16)]
AC   CVCL_H830
SY   AG23204
DR   Coriell; AG23204
DR   GEO; GSM364213
DR   GEO; GSM364214
DR   GEO; GSM364215
DR   GEO; GSM364216
DR   Wikidata; Q54832559
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Myc
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMycn(44)]
AC   CVCL_H831
SY   AG23207
DR   Coriell; AG23207
DR   GEO; GSM364221
DR   GEO; GSM364222
DR   GEO; GSM364223
DR   GEO; GSM364406
DR   Wikidata; Q54832560
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Mycn
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetMyod1(14)]
AC   CVCL_H832
SY   AG23183
DR   Coriell; AG23183
DR   GEO; GSM364289
DR   GEO; GSM364290
DR   GEO; GSM364291
DR   GEO; GSM364292
DR   Wikidata; Q54832561
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Myod1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNanog(24)]
AC   CVCL_H833
SY   AG23194
DR   Coriell; AG23194
DR   GEO; GSM364361
DR   GEO; GSM364362
DR   GEO; GSM364363
DR   GEO; GSM364364
DR   Wikidata; Q54832562
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nanog
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNkx2-5(12)]
AC   CVCL_H912
SY   AG23527
DR   Coriell; AG23527
DR   GEO; GSM778000
DR   GEO; GSM778001
DR   GEO; GSM778002
DR   GEO; GSM778003
DR   Wikidata; Q54832563
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nkx2-5
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNr0b1(15)]
AC   CVCL_H834
SY   AG23187; AG23187*A
DR   Coriell; AG23187
DR   GEO; GSM364202
DR   GEO; GSM364378
DR   GEO; GSM364379
DR   GEO; GSM364380
DR   Wikidata; Q54832564
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nr0b1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   ES[MC1R(20):tetNr2f1(14)]
AC   CVCL_H913
DR   GEO; GSM778004
DR   GEO; GSM778005
DR   GEO; GSM778006
DR   GEO; GSM778007
DR   Wikidata; Q54832565
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nr2f1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNr2f2(5)]
AC   CVCL_H835
SY   AG23167
DR   Coriell; AG23167
DR   GEO; GSM364313
DR   GEO; GSM364314
DR   GEO; GSM364315
DR   GEO; GSM364316
DR   Wikidata; Q54832566
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nr2f2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNr5a2(7)]
AC   CVCL_H836
SY   AG23188
DR   Coriell; AG23188
DR   GEO; GSM364207
DR   GEO; GSM364208
DR   GEO; GSM364390
DR   GEO; GSM364391
DR   Wikidata; Q54832567
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nr5a2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNrip1(20)]
AC   CVCL_H837
SY   AG23170
DR   Coriell; AG23170
DR   GEO; GSM364305
DR   GEO; GSM364306
DR   GEO; GSM364307
DR   GEO; GSM364308
DR   Wikidata; Q54832568
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Nrip1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNsbp1(6)]
AC   CVCL_H914
SY   AG23515
DR   Coriell; AG23515
DR   GEO; GSM778008
DR   GEO; GSM778009
DR   GEO; GSM778010
DR   GEO; GSM778011
DR   Wikidata; Q54832569
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nsbp1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetNupr1(17)]
AC   CVCL_H915
SY   AG23564
DR   Coriell; AG23564
DR   GEO; GSM778012
DR   GEO; GSM778013
DR   GEO; GSM778014
DR   GEO; GSM778015
DR   Wikidata; Q54832570
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Nupr1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetOstf1(15)]
AC   CVCL_H916
DR   GEO; GSM778016
DR   GEO; GSM778017
DR   GEO; GSM778018
DR   GEO; GSM778019
DR   Wikidata; Q54832571
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ostf1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetOtx1(6)]
AC   CVCL_H917
SY   AG23524
DR   Coriell; AG23524
DR   GEO; GSM778020
DR   GEO; GSM778021
DR   GEO; GSM778022
DR   GEO; GSM778023
DR   Wikidata; Q54832572
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Otx1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetOtx2(15)]
AC   CVCL_H838
SY   AG23179
DR   Coriell; AG23179
DR   GEO; GSM364265
DR   GEO; GSM364266
DR   GEO; GSM364267
DR   GEO; GSM364268
DR   Wikidata; Q54832573
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Otx2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetPdlim1(15)]
AC   CVCL_H918
SY   AG23541
DR   Coriell; AG23541
DR   GEO; GSM778024
DR   GEO; GSM778025
DR   GEO; GSM778026
DR   GEO; GSM778027
DR   Wikidata; Q54832577
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Pdlim1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetPou5f1(18)]
AC   CVCL_H839
SY   AG23191
DR   Coriell; AG23191
DR   GEO; GSM364251
DR   GEO; GSM364252
DR   GEO; GSM364253
DR   GEO; GSM364254
DR   Wikidata; Q54832578
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Pou5f1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetPrickle1(11)]
AC   CVCL_H919
DR   GEO; GSM778028
DR   GEO; GSM778029
DR   GEO; GSM778030
DR   GEO; GSM778031
DR   Wikidata; Q54832579
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Prickle1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetRest(19)]
AC   CVCL_H920
SY   AG23576
DR   Coriell; AG23576
DR   GEO; GSM778032
DR   GEO; GSM778033
DR   GEO; GSM778034
DR   GEO; GSM778035
DR   Wikidata; Q54832580
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Rest
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetRhox6(24)]
AC   CVCL_H840
DR   GEO; GSM364354
DR   GEO; GSM364355
DR   GEO; GSM364356
DR   GEO; GSM364408
DR   Wikidata; Q54832581
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Rhox6
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetRxra(2)]
AC   CVCL_H841
SY   AG23236
DR   Coriell; AG23236
DR   GEO; GSM364350
DR   GEO; GSM364351
DR   GEO; GSM364352
DR   GEO; GSM364353
DR   Wikidata; Q54832582
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Rxra
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSall4(17)]
AC   CVCL_H842
SY   AG23189
DR   Coriell; AG23189
DR   GEO; GSM364381
DR   GEO; GSM364382
DR   GEO; GSM364383
DR   GEO; GSM364384
DR   Wikidata; Q54832583
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sall4
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSap30(12)]
AC   CVCL_H921
SY   AG23537
DR   Coriell; AG23537
DR   GEO; GSM778040
DR   GEO; GSM778041
DR   GEO; GSM778042
DR   GEO; GSM778043
DR   Wikidata; Q54832584
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sap30
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSfpi1(10)]
AC   CVCL_H843
SY   AG23213
DR   Coriell; AG23213
DR   GEO; GSM364365
DR   GEO; GSM364394
DR   GEO; GSM364395
DR   GEO; GSM364396
DR   Wikidata; Q54832585
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sfpi1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSfrs6(2)]
AC   CVCL_H922
SY   AG23556
DR   Coriell; AG23556
DR   GEO; GSM778044
DR   GEO; GSM778045
DR   GEO; GSM778046
DR   GEO; GSM778047
DR   Wikidata; Q54832586
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sfrs6
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSirt3(19)]
AC   CVCL_H923
SY   AG23528
DR   Coriell; AG23528
DR   GEO; GSM778048
DR   GEO; GSM778049
DR   GEO; GSM778050
DR   GEO; GSM778051
DR   Wikidata; Q54832587
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sirt3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSix1(15)]
AC   CVCL_H924
SY   AG23550
DR   Coriell; AG23550
DR   GEO; GSM778052
DR   GEO; GSM778053
DR   GEO; GSM778054
DR   GEO; GSM778055
DR   Wikidata; Q54832588
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Six1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSmad1(5)]
AC   CVCL_H844
SY   AG23196
DR   Coriell; AG23196
DR   GEO; GSM364273
DR   GEO; GSM364274
DR   GEO; GSM364275
DR   GEO; GSM364276
DR   Wikidata; Q54832589
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Smad1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSmad4(14)]
AC   CVCL_H845
DR   GEO; GSM364325
DR   GEO; GSM364326
DR   GEO; GSM364327
DR   GEO; GSM364328
DR   Wikidata; Q54832590
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Smad4
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSmad6(9)]
AC   CVCL_H925
SY   AG23530
DR   Coriell; AG23530
DR   GEO; GSM778056
DR   GEO; GSM778057
DR   GEO; GSM778058
DR   GEO; GSM778059
DR   Wikidata; Q54832591
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Smad6
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSmad7(3)]
AC   CVCL_H846
SY   AG23195
DR   Coriell; AG23195
DR   GEO; GSM364338
DR   GEO; GSM364339
DR   GEO; GSM364340
DR   GEO; GSM364341
DR   Wikidata; Q54832592
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Smad7
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSox11(2)]
AC   CVCL_H926
DR   GEO; GSM778060
DR   GEO; GSM778061
DR   GEO; GSM778062
DR   GEO; GSM778063
DR   Wikidata; Q54832593
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sox11
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSox15(10)]
AC   CVCL_H927
DR   GEO; GSM778064
DR   GEO; GSM778065
DR   GEO; GSM778066
DR   GEO; GSM778067
DR   Wikidata; Q54832594
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sox15
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSox2(3)]
AC   CVCL_H847
SY   AG23190
DR   Coriell; AG23190
DR   GEO; GSM364255
DR   GEO; GSM364256
DR   GEO; GSM364257
DR   GEO; GSM364258
DR   Wikidata; Q54832595
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sox2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSox7(32)]
AC   CVCL_H928
SY   AG23544
DR   Coriell; AG23544
DR   GEO; GSM778068
DR   GEO; GSM778069
DR   GEO; GSM778070
DR   GEO; GSM778071
DR   Wikidata; Q54832596
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sox7
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSox9(13)]
AC   CVCL_H848
SY   AG23177
DR   Coriell; AG23177
DR   GEO; GSM364285
DR   GEO; GSM364286
DR   GEO; GSM364287
DR   GEO; GSM364288
DR   Wikidata; Q54832597
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Sox9
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetStat3(15)]
AC   CVCL_H849
DR   GEO; GSM364243
DR   GEO; GSM364244
DR   GEO; GSM364245
DR   GEO; GSM364246
DR   Wikidata; Q54832598
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Stat3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetStra13(12)]
AC   CVCL_H929
DR   GEO; GSM778072
DR   GEO; GSM778073
DR   GEO; GSM778074
DR   GEO; GSM778075
DR   Wikidata; Q54832599
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Stra13
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSub1(12)]
AC   CVCL_H930
DR   GEO; GSM778076
DR   GEO; GSM778077
DR   GEO; GSM778078
DR   GEO; GSM778079
DR   Wikidata; Q54832600
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Sub1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetSuz12(9)]
AC   CVCL_H850
SY   AG23208
DR   Coriell; AG23208
DR   GEO; GSM364224
DR   GEO; GSM364225
DR   GEO; GSM364226
DR   GEO; GSM364407
DR   Wikidata; Q54832601
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Suz12
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetT(21)]
AC   CVCL_H851
SY   AG23215
DR   Coriell; AG23215
DR   GEO; GSM364247
DR   GEO; GSM364248
DR   GEO; GSM364249
DR   GEO; GSM364250
DR   Wikidata; Q54832602
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=T
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTbx3(15)]
AC   CVCL_H931
SY   AG23594
DR   Coriell; AG23594
DR   GEO; GSM766424
DR   GEO; GSM766441
DR   GEO; GSM766442
DR   GEO; GSM766443
DR   Wikidata; Q54832603
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tbx3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTbx5(2)]
AC   CVCL_H932
SY   AG23521
DR   Coriell; AG23521
DR   GEO; GSM778080
DR   GEO; GSM778081
DR   GEO; GSM778082
DR   GEO; GSM778083
DR   Wikidata; Q54832604
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tbx5
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTcea2]
AC   CVCL_DN42
SY   AG23185
DR   Coriell; AG23185
DR   Wikidata; Q54832605
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcea2
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   ES[MC1R(20):tetTcea3(22)]
AC   CVCL_H852
DR   GEO; GSM364197
DR   GEO; GSM364198
DR   GEO; GSM364199
DR   GEO; GSM364200
DR   Wikidata; Q54832606
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcea3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTcf3(7)]
AC   CVCL_H853
SY   AG23192
DR   Coriell; AG23192
DR   GEO; GSM364368
DR   GEO; GSM364403
DR   GEO; GSM364404
DR   GEO; GSM364405
DR   Wikidata; Q54832607
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcf3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTcf4(9)]
AC   CVCL_H854
SY   AG23172
DR   Coriell; AG23172
DR   GEO; GSM364293
DR   GEO; GSM364294
DR   GEO; GSM364295
DR   GEO; GSM364296
DR   Wikidata; Q54832608
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tcf4
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTcfap2c(18)]
AC   CVCL_H933
SY   AG23567
DR   Coriell; AG23567
DR   GEO; GSM778084
DR   GEO; GSM778085
DR   GEO; GSM778086
DR   GEO; GSM778087
DR   Wikidata; Q54832609
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tcfap2c
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTcfcp2l1(6)]
AC   CVCL_H934
SY   AG23551
DR   Coriell; AG23551
DR   GEO; GSM778088
DR   GEO; GSM778089
DR   GEO; GSM778090
DR   GEO; GSM778091
DR   Wikidata; Q54832610
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tcfcp2l1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTcl1(6)]
AC   CVCL_H935
DR   GEO; GSM766416
DR   GEO; GSM766417
DR   GEO; GSM766418
DR   GEO; GSM766419
DR   Wikidata; Q54832611
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tcl1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTgif1(8)]
AC   CVCL_H936
SY   AG23572
DR   Coriell; AG23572
DR   GEO; GSM778092
DR   GEO; GSM778093
DR   GEO; GSM778094
DR   GEO; GSM778095
DR   Wikidata; Q54832612
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tgif1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTgm2(14)]
AC   CVCL_H937
SY   AG23570
DR   Coriell; AG23570
DR   GEO; GSM778096
DR   GEO; GSM778097
DR   GEO; GSM778098
DR   GEO; GSM778099
DR   Wikidata; Q54832613
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Tgm2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTrpv2(9)]
AC   CVCL_H938
SY   AG23529
DR   Coriell; AG23529
DR   GEO; GSM778100
DR   GEO; GSM778101
DR   GEO; GSM778102
DR   GEO; GSM778103
DR   Wikidata; Q54832614
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Trpv2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetTuba1a(12)]
AC   CVCL_H855
SY   AG23210
DR   Coriell; AG23210
DR   GEO; GSM364201
DR   GEO; GSM364373
DR   GEO; GSM364374
DR   GEO; GSM364409
DR   Wikidata; Q54832615
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Tuba1a
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetUgp2(20)]
AC   CVCL_H939
SY   AG23540
DR   Coriell; AG23540
DR   GEO; GSM778104
DR   GEO; GSM778105
DR   GEO; GSM778106
DR   GEO; GSM778107
DR   Wikidata; Q54832616
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Ugp2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetUtf1(7)]
AC   CVCL_DN43
SY   AG23596
DR   Coriell; AG23596
DR   Wikidata; Q54832624
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Utf1
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ES[MC1R(20):tetWhsc2(18)]
AC   CVCL_H856
SY   AG23209
DR   Coriell; AG23209
DR   GEO; GSM364259
DR   GEO; GSM364260
DR   GEO; GSM364261
DR   GEO; GSM364369
DR   Wikidata; Q54832626
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Whsc2
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetZfand3(6)]
AC   CVCL_H857
SY   AG23198
DR   Coriell; AG23198
DR   GEO; GSM364301
DR   GEO; GSM364302
DR   GEO; GSM364303
DR   GEO; GSM364304
DR   Wikidata; Q54832627
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Zfand3
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetZfp57(22)]
AC   CVCL_H940
SY   AG23573
DR   Coriell; AG23573
DR   GEO; GSM778108
DR   GEO; GSM778109
DR   GEO; GSM778110
DR   GEO; GSM778111
DR   Wikidata; Q54832628
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Zfp57
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetZic1(6)]
AC   CVCL_H941
DR   GEO; GSM778112
DR   GEO; GSM778113
DR   GEO; GSM778114
DR   GEO; GSM778115
DR   Wikidata; Q54832629
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Zic1
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetZmat4(15)]
AC   CVCL_H942
SY   AG23531
DR   Coriell; AG23531
DR   GEO; GSM778116
DR   GEO; GSM778117
DR   GEO; GSM778118
DR   GEO; GSM778119
DR   Wikidata; Q54832630
RX   PubMed=22355682;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESSecondInfo.cgi?gene=Zmat4
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES[MC1R(20):tetZscan4c(5)]
AC   CVCL_H858
SY   AG23166
DR   Coriell; AG23166
DR   GEO; GSM364342
DR   GEO; GSM364343
DR   GEO; GSM364344
DR   GEO; GSM364345
DR   Wikidata; Q54832631
RX   PubMed=19796622;
WW   Info; NIA; -; https://web.archive.org/web/20210318000729/https://esbank.nia.nih.gov/bin/ShowESPInfo.cgi?gene=Zscan4c
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H810 ! MC1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   ES020488
AC   CVCL_N844
DR   Wikidata; Q54832632
RX   PubMed=7685133;
CC   Doubling time: ~60 hours (PubMed=7685133).
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   ES1
AC   CVCL_1198
SY   ES-1
DR   CLO; CLO_0009859
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1198
DR   Cell_Model_Passport; SIDM00266
DR   ChEMBL-Cells; CHEMBL3308820
DR   ChEMBL-Targets; CHEMBL2366146
DR   Cosmic; 684053
DR   Cosmic; 949158
DR   Cosmic; 1995395
DR   Cosmic; 2228222
DR   Cosmic-CLP; 949158
DR   DepMap; ACH-002103
DR   EGA; EGAS00001000978
DR   GDSC; 949158
DR   GEO; GSM1669768
DR   GEO; GSM1676361
DR   GEO; GSM1701628
DR   IARC_TP53; 27154
DR   LINCS_LDP; LCL-1439
DR   PharmacoDB; ES1_338_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1198
DR   Wikidata; Q54832633
RX   PubMed=20164919;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.83%; Native American=0.47%; East Asian, North=0.13%; East Asian, South=0%; South Asian=0.81%; European, North=70.63%; European, South=27.13% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949158; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 19
ST   D19S433: 15,15.2
ST   D21S11: 29,30
ST   D2S1338: 23,25
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 9.3,10
ST   TPOX: 10
ST   vWA: 16,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   ES2
AC   CVCL_AX39
SY   ES-2
DR   cancercelllines; CVCL_AX39
DR   Cosmic; 684054
DR   Cosmic; 2228223
DR   GEO; GSM1676356
DR   GEO; GSM1701686
DR   Progenetix; CVCL_AX39
DR   Wikidata; Q54832635
RX   PubMed=25010205;
RX   PubMed=26351324;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 3 fusion (Ex10/Ex6) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Glu523Ter (c.1567G>T); Zygosity=Unspecified (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25010205).
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13,14
ST   D16S539: 13
ST   D18S51: 13,19
ST   D19S433: 14
ST   D21S11: 29,30.2
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10
ST   FGA: 24
ST   TH01: 6,9
ST   TPOX: 8
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   ES2/GFP
AC   CVCL_E8YD
SY   ES2 / GFP
WW   Provider; GenTarget; SC066-G; https://www.gentarget.com/product/human-es2-gfp-stable-cells/
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-eGFP-Rsv-PuroR-WPRE construct (GenTarget=SC066-G).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ES2/Luciferase
AC   CVCL_E8YE
SY   ES2 / Luciferase
WW   Provider; GenTarget; SC066-Luc; https://www.gentarget.com/product/human-es2-luciferase-stable-cells/
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-Rsv-PuroR-WPRE construct (GenTarget=SC066-Luc).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ES2/Luciferase-2A-GFP
AC   CVCL_E8YF
SY   ES2 / Luciferase & GFP
WW   Provider; GenTarget; SC066-LG; https://www.gentarget.com/product/human-es2-luciferase-gfp-stable-cells/
CC   Problematic cell line: Probably misclassified. Parent cell line seems to originate from a Caucasian patient with an ovarian serous adenocarcinoma origin.
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-2A-GFP-Rsv-PuroR-WPRE construct (GenTarget=SC066-LG).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Lys295_Met296insTer (c.886delA) (p.Met296Terfs); ClinVar=VCV000143979; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3509 ! ES-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ES3
AC   CVCL_1199
SY   ES-3
DR   CLO; CLO_0009860
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1199
DR   Cell_Model_Passport; SIDM00265
DR   ChEMBL-Cells; CHEMBL3308150
DR   ChEMBL-Targets; CHEMBL2366135
DR   Cosmic; 684055
DR   Cosmic; 1995397
DR   Cosmic-CLP; 684055
DR   DepMap; ACH-002104
DR   EGA; EGAS00001000978
DR   GDSC; 684055
DR   GEO; GSM1669770
DR   GEO; GSM1676368
DR   GEO; GSM1701629
DR   IARC_TP53; 27155
DR   LINCS_LDP; LCL-1440
DR   PharmacoDB; ES3_339_2019
DR   PubChem_Cell_line; CVCL_1199
DR   Wikidata; Q54832636
RX   PubMed=20164919;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (Cosmic-CLP=684055; DepMap=ACH-002104).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Ter (c.708C>A); Zygosity=Heterozygous (Cosmic-CLP=684055; DepMap=ACH-002104).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=1.17%; South Asian=1.4%; European, North=64.94%; European, South=32.49% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=684055
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,20
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   ES4
AC   CVCL_1200
SY   ES-4
DR   CLO; CLO_0009861
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 886
DR   cancercelllines; CVCL_1200
DR   Cell_Model_Passport; SIDM00264
DR   ChEMBL-Cells; CHEMBL3308151
DR   ChEMBL-Targets; CHEMBL2366118
DR   Cosmic; 684056
DR   Cosmic; 949156
DR   Cosmic; 2228224
DR   Cosmic-CLP; 949156
DR   DepMap; ACH-002105
DR   EGA; EGAS00001000978
DR   GDSC; 949156
DR   GEO; GSM1669771
DR   GEO; GSM1676340
DR   GEO; GSM1676369
DR   GEO; GSM1701630
DR   GEO; GSM1701671
DR   GEO; GSM1701698
DR   IARC_TP53; 27157
DR   LINCS_LDP; LCL-1441
DR   PharmacoDB; ES4_340_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1200
DR   Wikidata; Q54832637
RX   PubMed=20164919;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.29%; Native American=7.84%; East Asian, North=0%; East Asian, South=1.09%; South Asian=1.81%; European, North=61.75%; European, South=26.22% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949156; PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 16,18
ST   D19S433: 12,15
ST   D21S11: 29
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   ES5
AC   CVCL_1201
DR   CLO; CLO_0009862
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 887
DR   cancercelllines; CVCL_1201
DR   Cell_Model_Passport; SIDM00263
DR   ChEMBL-Cells; CHEMBL3308517
DR   ChEMBL-Targets; CHEMBL2366312
DR   Cosmic; 684057
DR   Cosmic-CLP; 684057
DR   DepMap; ACH-002106
DR   EGA; EGAS00001000978
DR   GDSC; 684057
DR   GEO; GSM1669772
DR   IARC_TP53; 27156
DR   LINCS_LDP; LCL-1442
DR   PharmacoDB; ES5_341_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1201
DR   Wikidata; Q54832638
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=684057).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.1%; Native American=0%; East Asian, North=1.85%; East Asian, South=0%; South Asian=0.47%; European, North=64.55%; European, South=32.03% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=684057
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   ES5.2D8
AC   CVCL_DD29
SY   ES5.2d8; 2D8
DR   ATCC; HB-11374
DR   Wikidata; Q54832639
RX   Patent=US5883223;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11374.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21926; Human CD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   ES5.3D6
AC   CVCL_DD30
SY   3D6; CTLA4.2
DR   Wikidata; Q54832640
RX   Patent=US7592007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11644.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   ES5.4E3
AC   CVCL_DD31
SY   4E3; CTLA4.4
DR   Wikidata; Q54832642
RX   Patent=US7592007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11643.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   ES6
AC   CVCL_1202
SY   ES-6
DR   CLO; CLO_0009863
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1202
DR   Cell_Model_Passport; SIDM00262
DR   ChEMBL-Cells; CHEMBL3308152
DR   ChEMBL-Targets; CHEMBL2366373
DR   Cosmic; 684058
DR   Cosmic; 949157
DR   Cosmic; 2228225
DR   Cosmic-CLP; 949157
DR   DepMap; ACH-002107
DR   EGA; EGAS00001000978
DR   GDSC; 949157
DR   GEO; GSM1669773
DR   GEO; GSM1676357
DR   GEO; GSM1701687
DR   IARC_TP53; 27158
DR   LINCS_LDP; LCL-1443
DR   PharmacoDB; ES6_342_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1202
DR   Wikidata; Q54832643
RX   PubMed=20164919;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=EWSR1 exon 9 fused to FLI1 exon 4 (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Leu264Pro (c.791T>C); Zygosity=Homozygous (PubMed=25010205; Cosmic-CLP=949157; DepMap=ACH-002107).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=949157; DepMap=ACH-002107).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.57%; East Asian, South=0%; South Asian=2.66%; European, North=67.61%; European, South=29.16% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949157; PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 12,15
ST   D21S11: 29
ST   D2S1338: 22,25
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 18,22
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   ES7
AC   CVCL_1203
SY   ES-7
DR   CLO; CLO_0009864
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1203
DR   Cell_Model_Passport; SIDM00269
DR   ChEMBL-Cells; CHEMBL3308821
DR   ChEMBL-Targets; CHEMBL2366297
DR   Cosmic; 684059
DR   Cosmic; 1995398
DR   Cosmic; 2228226
DR   Cosmic-CLP; 684059
DR   DepMap; ACH-002108
DR   EGA; EGAS00001000978
DR   GDSC; 684059
DR   GEO; GSM1669774
DR   GEO; GSM1676296
DR   GEO; GSM1701631
DR   IARC_TP53; 27159
DR   LINCS_LDP; LCL-1444
DR   PharmacoDB; ES7_343_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1203
DR   Wikidata; Q54832644
RX   DOI=10.5282/edoc.27750;
RX   PubMed=20164919;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 4 fusion (Ex10/Ex5) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Gln (c.537T>G); ClinVar=VCV000376607; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.94%; Native American=0%; East Asian, North=1.71%; East Asian, South=0%; South Asian=0%; European, North=63.25%; European, South=33.1% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=684059; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 27
ST   D2S1338: 16,24
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 10
ST   FGA: 20
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   ES8
AC   CVCL_1204
SY   ES-8
DR   CLO; CLO_0009865
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 888
DR   cancercelllines; CVCL_1204
DR   Cell_Model_Passport; SIDM00261
DR   ChEMBL-Cells; CHEMBL3308153
DR   ChEMBL-Targets; CHEMBL2366069
DR   Cosmic; 684060
DR   Cosmic; 949155
DR   Cosmic; 1995399
DR   Cosmic; 2060799
DR   Cosmic; 2228227
DR   Cosmic-CLP; 949155
DR   DepMap; ACH-002109
DR   EGA; EGAS00001000978
DR   GDSC; 949155
DR   GEO; GSM1669775
DR   GEO; GSM1676297
DR   GEO; GSM1701632
DR   IARC_TP53; 27160
DR   LINCS_LDP; LCL-1445
DR   PharmacoDB; ES8_344_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1204
DR   Wikidata; Q54832645
RX   PubMed=20164919;
RX   PubMed=25010205;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=34413129;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (PubMed=25010205; Cosmic-CLP=949155).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.48%; Native American=0.07%; East Asian, North=0.25%; East Asian, South=1.89%; South Asian=9.11%; European, North=26.16%; European, South=61.04% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949155; PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 15,17
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 7,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   ES8-SLFN11-KO
AC   CVCL_C6N6
DR   Wikidata; Q116048948
RX   PubMed=34413129;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1204 ! ES8
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Esa-1
AC   CVCL_J512
DR   ATCC; HTB-83
DR   Wikidata; Q54832646
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   Discontinued: ATCC; HTB-83; true.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   ESC 9
AC   CVCL_A9X9
DR   BCRC; SC81017
DR   Wikidata; Q102113796
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   ESC 98B01
AC   CVCL_GT24
DR   BCRC; SC81023
DR   Wikidata; Q54832648
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   ESC 98B02
AC   CVCL_QY19
DR   BCRC; SC81024
DR   Wikidata; Q54832649
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   ESC 98B11
AC   CVCL_QY20
DR   BCRC; SC81025
DR   Wikidata; Q54832650
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   ESC 98B27
AC   CVCL_QY21
DR   BCRC; SC81027
DR   Wikidata; Q54832651
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   ESC 98B28
AC   CVCL_QY22
DR   BCRC; SC81028
DR   Wikidata; Q54832652
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   ESC 98B34
AC   CVCL_QY23
DR   BCRC; SC81029
DR   Wikidata; Q54832653
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   ESC 98B37
AC   CVCL_QY24
DR   BCRC; SC81030
DR   Wikidata; Q54832654
CC   From: Agricultural Technology Research Institute (ATRI); Hsinchu; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   ESC-410
AC   CVCL_E310
DR   Wikidata; Q54832655
RX   PubMed=20819098;
CC   Population: Chinese.
CC   Doubling time: ~53 hours (PubMed=20819098).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   ESC-BLC 1
AC   CVCL_A6QU
SY   BLC 1; BLC-1
DR   Wikidata; Q107114897
RX   PubMed=6535640;
RX   PubMed=6598577;
RX   PubMed=6714319;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv-ter/+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   ESC-BLC 1 T1
AC   CVCL_A6QV
SY   T1
DR   Wikidata; Q107114899
RX   PubMed=6535640;
RX   PubMed=6598577;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv-ter/+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6QU ! ESC-BLC 1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   ESC-BLC 1 T2/K26
AC   CVCL_A6QW
SY   T2/K26
DR   Wikidata; Q107114901
RX   PubMed=6535640;
RX   PubMed=6598577;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv-ter/+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6QU ! ESC-BLC 1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ESC-ICR
AC   CVCL_JA30
DR   Wikidata; Q54832656
RX   PubMed=6950406;
CC   Anecdotal: ESC-ICR and CCE (Cellosaurus=CVCL_C313) from Martin John Evans and Matthew Howard Kaufman are the first embryonic stem cell lines to have been established, in 1981.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: ICR x SWR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 6
//
ID   ESC/LCM10T-N
AC   CVCL_Y209
DR   CGH-DB; 220-1
DR   Wikidata; Q54832658
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 5
//
ID   ESC/LCM11T-N
AC   CVCL_Y210
DR   CGH-DB; 221-1
DR   Wikidata; Q54832659
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM12T-N
AC   CVCL_Y211
DR   CGH-DB; 222-1
DR   Wikidata; Q54832660
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM14T-N
AC   CVCL_Y212
DR   CGH-DB; 223-1
DR   Wikidata; Q54832661
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM15T-N
AC   CVCL_Y213
DR   CGH-DB; 224-1
DR   Wikidata; Q54832662
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM16T-N
AC   CVCL_Y214
DR   CGH-DB; 225-1
DR   Wikidata; Q54832663
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM17T-N
AC   CVCL_Y215
DR   CGH-DB; 226-1
DR   Wikidata; Q54832664
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM18T
AC   CVCL_Y216
DR   CGH-DB; 227-1
DR   Wikidata; Q54832665
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM1T
AC   CVCL_Y279
DR   CGH-DB; 211-1
DR   Wikidata; Q54832657
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM20T-N
AC   CVCL_Y218
DR   CGH-DB; 228-1
DR   Wikidata; Q54832667
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM21T-N
AC   CVCL_Y219
DR   CGH-DB; 229-1
DR   Wikidata; Q54832673
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM22T-N
AC   CVCL_Y220
DR   CGH-DB; 230-1
DR   Wikidata; Q54832674
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM23T
AC   CVCL_Y221
DR   CGH-DB; 231-1
DR   Wikidata; Q54832675
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM24T-N
AC   CVCL_Y222
DR   CGH-DB; 232-1
DR   Wikidata; Q54832676
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM25T-N
AC   CVCL_Y223
DR   CGH-DB; 233-1
DR   Wikidata; Q54832677
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM26T-N
AC   CVCL_Y224
DR   CGH-DB; 234-1
DR   Wikidata; Q54832678
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM27T-N
AC   CVCL_Y225
DR   CGH-DB; 235-1
DR   Wikidata; Q54832679
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM29T-N
AC   CVCL_Y226
DR   CGH-DB; 236-1
DR   Wikidata; Q54832680
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM2T-N
AC   CVCL_Y217
DR   CGH-DB; 212-1
DR   Wikidata; Q54832666
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM31T-N
AC   CVCL_Y228
DR   CGH-DB; 237-1
DR   Wikidata; Q54832682
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM32T-N
AC   CVCL_Y229
DR   CGH-DB; 238-1
DR   Wikidata; Q54832683
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM33T
AC   CVCL_Y230
DR   CGH-DB; 239-1
DR   Wikidata; Q54832684
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM34T-N
AC   CVCL_Y231
DR   CGH-DB; 240-1
DR   Wikidata; Q54832685
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM35T-N
AC   CVCL_Y232
DR   CGH-DB; 241-1
DR   Wikidata; Q54832686
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM36T
AC   CVCL_Y233
DR   CGH-DB; 242-1
DR   Wikidata; Q54832687
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM37T-N
AC   CVCL_Y234
DR   CGH-DB; 243-1
DR   Wikidata; Q54832688
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM38T-N
AC   CVCL_Y235
DR   CGH-DB; 244-1
DR   Wikidata; Q54832689
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM39T-N
AC   CVCL_Y236
DR   CGH-DB; 245-1
DR   Wikidata; Q54832690
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM3T-N
AC   CVCL_Y227
DR   CGH-DB; 213-1
DR   Wikidata; Q54832681
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM40T
AC   CVCL_Y238
DR   CGH-DB; 246-1
DR   Wikidata; Q54832693
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM41T-N
AC   CVCL_Y239
DR   CGH-DB; 247-1
DR   Wikidata; Q54832694
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM42T-N
AC   CVCL_Y240
DR   CGH-DB; 248-1
DR   Wikidata; Q54832695
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM43T-N
AC   CVCL_Y241
DR   CGH-DB; 249-1
DR   Wikidata; Q54832696
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM44T-N
AC   CVCL_Y242
DR   CGH-DB; 250-1
DR   Wikidata; Q54832697
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM45T-N
AC   CVCL_Y243
DR   CGH-DB; 251-1
DR   Wikidata; Q54832698
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM46T-N
AC   CVCL_Y244
DR   CGH-DB; 252-1
DR   Wikidata; Q54832699
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM47T-N
AC   CVCL_Y245
DR   CGH-DB; 253-1
DR   Wikidata; Q54832700
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM48T-N
AC   CVCL_Y246
DR   CGH-DB; 254-1
DR   Wikidata; Q54832701
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM49T-N
AC   CVCL_Y247
DR   CGH-DB; 255-1
DR   Wikidata; Q54832702
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM4T-N
AC   CVCL_Y237
DR   CGH-DB; 214-1
DR   Wikidata; Q54832691
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM50T-N
AC   CVCL_Y249
DR   CGH-DB; 256-1
DR   Wikidata; Q54832704
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM51T-N
AC   CVCL_Y250
DR   CGH-DB; 257-1
DR   Wikidata; Q54832707
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM52T-N
AC   CVCL_Y251
DR   CGH-DB; 258-1
DR   Wikidata; Q54832708
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM53T-N
AC   CVCL_Y252
DR   CGH-DB; 259-1
DR   Wikidata; Q54832709
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM54T-N
AC   CVCL_Y253
DR   CGH-DB; 260-1
DR   Wikidata; Q54832710
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM55T-N
AC   CVCL_Y254
DR   CGH-DB; 261-1
DR   Wikidata; Q54832711
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM56T-N
AC   CVCL_Y255
DR   CGH-DB; 262-1
DR   Wikidata; Q54832712
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM57T-N
AC   CVCL_Y256
DR   CGH-DB; 263-1
DR   Wikidata; Q54832714
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM58T-N
AC   CVCL_Y257
DR   CGH-DB; 264-1
DR   Wikidata; Q54832715
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM59T-N
AC   CVCL_Y258
DR   CGH-DB; 265-1
DR   Wikidata; Q54832716
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM5T
AC   CVCL_Y248
DR   CGH-DB; 215-1
DR   Wikidata; Q54832703
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM60T-N
AC   CVCL_Y260
DR   CGH-DB; 266-1
DR   Wikidata; Q54832726
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM61T-N
AC   CVCL_Y261
DR   CGH-DB; 267-1
DR   Wikidata; Q54832727
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM62T-N
AC   CVCL_Y262
DR   CGH-DB; 268-1
DR   Wikidata; Q54832728
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM66T-N
AC   CVCL_Y263
DR   CGH-DB; 269-1
DR   Wikidata; Q54832729
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM67T-N
AC   CVCL_Y264
DR   CGH-DB; 270-1
DR   Wikidata; Q54832730
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM69T-N
AC   CVCL_Y265
DR   CGH-DB; 271-1
DR   Wikidata; Q54832731
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM6T
AC   CVCL_Y259
DR   CGH-DB; 216-1
DR   Wikidata; Q54832725
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM70T-N
AC   CVCL_Y267
DR   CGH-DB; 272-1
DR   Wikidata; Q54832733
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM71T-N
AC   CVCL_Y268
DR   CGH-DB; 273-1
DR   Wikidata; Q54832734
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM7T
AC   CVCL_Y266
DR   CGH-DB; 217-1
DR   Wikidata; Q54832732
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM8T-N
AC   CVCL_Y269
DR   CGH-DB; 218-1
DR   Wikidata; Q54832735
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESC/LCM9T-N
AC   CVCL_Y270
DR   CGH-DB; 219-1
DR   Wikidata; Q54832736
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   ESCC-CL-Iran
AC   CVCL_A8WC
SY   Esophageal Squamous Cell Carcinoma-Cell Line-Iran
DR   Wikidata; Q108820196
RX   PubMed=22441127;
RX   PubMed=23539416;
CC   Population: Iranian; Persian.
CC   Omics: Proteomics; 2DE-MS.
CC   Miscellaneous: As no cell line name was provided in the papers, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   ESCC-DR
AC   CVCL_R804
DR   ABM; T8334
DR   Wikidata; Q54832737
RX   PubMed=17352229;
RX   PubMed=20128822;
RX   PubMed=24551170;
RX   PubMed=31215094;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Thorax; UBERON=UBERON_0000915.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C63892; Squamous cell carcinoma of the rat esophagus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 7
//
ID   ESCC-DRtca2
AC   CVCL_E7ES
RX   PubMed=24551170;
RX   PubMed=31215094;
CC   Characteristics: High malignancy. Induced by continuous stimulation with 2 mM of taurocholic acid (TCA) stimulation for 2 months (PubMed=24551170).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Thorax; UBERON=UBERON_0000915.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C63892; Squamous cell carcinoma of the rat esophagus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_R804 ! ESCC-DR
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESCDL-1
AC   CVCL_JE75
SY   Embryonic Stem Cell Derived Line-1
DR   Wikidata; Q54832738
RX   PubMed=28406989;
CC   Group: Bird cell line.
CC   Doubling time: ~40 hours (PubMed=28406989).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: Brown Leghorn; VBO=VBO_0000505.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Somatic stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   ESCDL-1-Venus clone 7
AC   CVCL_E5SV
SY   ESCDL-1-Venus/Clone7
RX   PubMed=28406989;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Breed/subspecies: Brown Leghorn; VBO=VBO_0000505.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_JE75 ! ESCDL-1
SX   Sex unspecified
AG   Embryo
CA   Somatic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESF 158
AC   CVCL_C257
DR   ATCC; SCRC-1016
DR   CCRID; 3101MOUSCSP221
DR   Wikidata; Q54832739
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 6
//
ID   ESe009-A
AC   CVCL_C769
SY   ES[2]; ES-2; ES2
DR   BioSamples; SAMEA104012537
DR   hPSCreg; ESe009-A
DR   SKIP; SKIP001819
DR   Wikidata; Q54832740
RX   PubMed=20177997;
RX   PubMed=20736931;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/ES2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES2_VD.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/anesos_es_2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01; DQB1*02:01,02:01; DRB1*03:01,03:01 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   D13S317: 13
ST   D18S51: 17,21
ST   D21S11: 28
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 20,22
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   ESe010-A
AC   CVCL_C770
SY   ES[3]; ES-3; ES3
DR   BioSamples; SAMEA104012539
DR   hPSCreg; ESe010-A
DR   SKIP; SKIP001820
DR   Wikidata; Q54832741
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/ES3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES3_VD.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/anexos_es_3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01; DQB1*02:01,02:01; DRB1*03:01,03:01 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   D13S317: 8
ST   D18S51: 14,16
ST   D21S11: 28,31
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 15,17
ST   FGA: 18,22
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   ESe014-A
AC   CVCL_C771
SY   ES[4]; ES-4; ES4
DR   BioSamples; SAMEA7778668
DR   hPSCreg; ESe014-A
DR   SKIP; SKIP001958
DR   Wikidata; Q54832742
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/ES4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos__ES4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*02:01,32:01; B*14:02,44:02; C*05:01,08:02; DQB1*03:01,06:03; DRB1*13:01,13:03 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   ESe015-A
AC   CVCL_C773
SY   ES[6]; ES-6; ES6
DR   hPSCreg; ESe015-A
DR   SKIP; SKIP001959
DR   Wikidata; Q54832743
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/ES6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_ES6.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*01:01,24:02; B*15:01,27:02; C*02:02,03:03; DQB1*03:01,06:03; DRB1*11:01,13:01 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   ESe016-A
AC   CVCL_C772
SY   ES[5]; ES-5; ES5
DR   hPSCreg; ESe016-A
DR   SKIP; SKIP001960
DR   Wikidata; Q54832744
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/ES5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_ES5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*03:01,24:02; B*27:02,49:01; C*02:02,07:01; DRB1*04:05,11:01 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   ESe022-A
AC   CVCL_C774
SY   ES[7]; ES-7; ES7
DR   hPSCreg; ESe022-A
DR   SKIP; SKIP002343
DR   Wikidata; Q54832745
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_v32_ES7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES-7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_%2520ES-7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*03,11; B*35,47; C*04,06; DQB1*02:05; DRB1*01:07 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   ESe023-A
AC   CVCL_C775
SY   ES[8]; ES-8; ES8
DR   hPSCreg; ESe023-A
DR   SKIP; SKIP002344
DR   Wikidata; Q54832747
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_v32_ES8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_ES-8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*02; B*18,44; C*07,16; DQB1*02:04; DRB1*07:08 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   ESe024-A
AC   CVCL_C776
SY   ES[9]; ES-9; ES9
DR   hPSCreg; ESe024-A
DR   SKIP; SKIP002345
DR   Wikidata; Q54832748
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_v32_ES9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_%2520ES-9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*02,33; B*14,51; C*08,14; DQB1*02:06; DRB1*03:15 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   ESe025-A
AC   CVCL_C767
SY   ES[10]; ES-10; ES10
DR   BioSamples; SAMEA7780168
DR   hPSCreg; ESe025-A
DR   SKIP; SKIP002346
DR   Wikidata; Q54832749
RX   PubMed=20177997;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_v32_Es10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_%2520ES-10.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*02,25; B*18,44; C*12,16; DQB1*02:05; DRB1*07:05 (PubMed=20177997).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   ESe026-A
AC   CVCL_C768
SY   ES[11EM]; ES[11-EM]; ES-11EM; ES11-EM
DR   hPSCreg; ESe026-A
DR   SKIP; SKIP002347
DR   Wikidata; Q54832750
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_v32_ES11-EM.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/ES-11-EM.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_ES-11-EM.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*01,02; B*41,53; C*04,17; DQB1*03:06; DRB1*13,15 (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:3513; EXT2; Simple; p.Gln162Argfs*108 (c.484delC); Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C5183; Hereditary multiple exostoses
DI   ORDO; Orphanet_321; Multiple osteochondromas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   ESe027-A
AC   CVCL_C101
SY   pES[12]; pES(12); pES12; PES12
DR   hPSCreg; ESe027-A
DR   SKIP; SKIP002363
DR   Wikidata; Q54832751
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_pES12.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Lineas_pES12.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_deposito_pES12.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*02; B*18; C*07; DQB1*03; DRB1*11 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   ESe028-A
AC   CVCL_V175
SY   bES[13]; BES[13]; bES(13); bES13
DR   hPSCreg; ESe028-A
DR   SKIP; SKIP002538
DR   Wikidata; Q54832752
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Lineas_bES13.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_deposito_bES13.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   HLA typing: A*11,26; B*35,38; C*04,12; DQB1*03,06; DRB1*08,13 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   ESH5
AC   CVCL_C8NZ
DR   Wikidata; Q123031250
RX   PubMed=1264187;
RX   PubMed=7323948;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8190 ! Detroit 98/AH-2
HI   CVCL_U380 ! GM00077
CA   Hybrid cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ESI-013
AC   CVCL_B852
SY   SSCCe001-A
DR   hPSCreg; SSCCe001-A
DR   SKIP; SKIP002085
DR   Wikidata; Q54832753
RX   PubMed=18371388;
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ESI-014
AC   CVCL_B853
SY   SSCCe002-A
DR   hPSCreg; SSCCe002-A
DR   NIHhESC; NIHhESC-11-0092
DR   SKIP; SKIP002086
DR   Wikidata; Q54832754
RX   PubMed=18371388;
CC   Group: Clinical grade pluripotent cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0092.
CC   Donor information: Embryo is sibling to that giving rise to ESI-017 (Cellosaurus=CVCL_B854).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   ESI-017
AC   CVCL_B854
SY   ESI017; SSCCe003-A
DR   hPSCreg; SSCCe003-A
DR   NIHhESC; NIHhESC-11-0093
DR   SKIP; SKIP002087
DR   Wikidata; Q54832755
RX   PubMed=18371388;
RX   PubMed=20177998;
RX   PubMed=22265736;
RX   PubMed=27109637;
RX   PubMed=28445466;
WW   Provider; ESI BIO; ES-700; https://web.archive.org/web/20141201204316/http://www.esibio.com/esi-017-human-embryonic-stem-cell-line-46-xx/
CC   Group: Clinical grade pluripotent cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0093.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to ESI-014 (Cellosaurus=CVCL_B853).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): ESI BIO
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 13,16
ST   D21S11: 30,33.2
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 13,14
ST   Penta E: 7,14
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   ESI-027
AC   CVCL_B855
SY   SSCCe006-A
DR   hPSCreg; SSCCe006-A
DR   SKIP; SKIP002090
DR   Wikidata; Q54832756
RX   PubMed=18371388;
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   ESI-035
AC   CVCL_B856
SY   ESI035; SSCCe007-A
DR   hPSCreg; SSCCe007-A
DR   NIHhESC; NIHhESC-11-0129
DR   SKIP; SKIP002091
DR   Wikidata; Q54832758
RX   PubMed=18371388;
RX   PubMed=20177998;
RX   PubMed=22265736;
RX   PubMed=28445466;
WW   Provider; ESI BIO; ES-701; https://web.archive.org/web/20141201204321/http://www.esibio.com/esi-035-human-embryonic-stem-cell-line-46-xx/
CC   Group: Clinical grade pluripotent cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0129.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-01.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Gly (c.817C>G); ClinVar=VCV000634682; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): ESI BIO
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14,17
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 11,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   ESI-049
AC   CVCL_B857
SY   ESI049; SSCCe004-A
DR   hPSCreg; SSCCe004-A
DR   NIHhESC; NIHhESC-11-0130
DR   SKIP; SKIP002088
DR   Wikidata; Q54832759
RX   PubMed=18371388;
RX   PubMed=20177998;
RX   PubMed=22265736;
RX   PubMed=28445466;
WW   Provider; ESI BIO; ES-702; https://web.archive.org/web/20141201204330/http://www.esibio.com/esi-049-human-embryonic-stem-cell-line-46-xy/
CC   Group: Clinical grade pluripotent cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0130.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): ESI BIO
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 10,13
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 14,15
ST   FGA: 18,20
ST   Penta D: 11,15
ST   Penta E: 15,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   ESI-051
AC   CVCL_B858
SY   ESI051; SSCCe005-A
DR   hPSCreg; SSCCe005-A
DR   NIHhESC; NIHhESC-11-0131
DR   SKIP; SKIP002089
DR   Wikidata; Q54832760
RX   PubMed=18371388;
RX   PubMed=22265736;
RX   PubMed=28445466;
WW   Provider; ESI BIO; ES-703; https://web.archive.org/web/20141201204342/http://www.esibio.com/esi-051-human-embryonic-stem-cell-line-46-xx/
CC   Group: Clinical grade pluripotent cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0131.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to ESI-053 (Cellosaurus=CVCL_B859).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): ESI BIO
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 18
ST   D21S11: 24.2,31.2
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 20,22.2
ST   Penta D: 9,11
ST   Penta E: 5,17
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   ESI-053
AC   CVCL_B859
SY   ESI053; SSCCe008-A
DR   hPSCreg; SSCCe008-A
DR   NIHhESC; NIHhESC-11-0132
DR   SKIP; SKIP002092
DR   Wikidata; Q53996685
RX   PubMed=18371388;
RX   PubMed=20177998;
RX   PubMed=22265736;
RX   PubMed=28445466;
WW   Provider; ESI BIO; ES-704; https://web.archive.org/web/20141201204353/http://www.esibio.com/esi-053-human-embryonic-stem-cell-line-46-xx/
CC   Group: Clinical grade pluripotent cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0132.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to ESI-051 (Cellosaurus=CVCL_B858).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): ESI BIO
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 16,18
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 11,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 13,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   ESi003-A
AC   CVCL_V154
SY   [CRTRd]FiPS3819-4F-2
DR   BioSamples; SAMEA3303029
DR   EBiSC; ESi003-A
DR   ECACC; 66540064
DR   hPSCreg; ESi003-A
DR   SKIP; SKIP002421
DR   Wikidata; Q54832762
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/VFDeposito_Lineas_-CRTRdFiPS3819-4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/solicitud_deposito_Lineas_CRTRd-FiPS3819-4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_CRTRd_FiPS3819-4F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gly466Arg (c.1396G>A); ClinVar=VCV000804101; Zygosity=Hemizygous (BNLC).
CC   Discontinued: ECACC; 66540064; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 24
//
ID   ESi004-A
AC   CVCL_V156
SY   [GD]FiPS-4F-21c; GD-FiPS-4F-21c; GD-FiPS 21c
DR   BioSamples; SAMEA3303117
DR   EBiSC; ESi004-A
DR   ECACC; 66540069
DR   hPSCreg; ESi004-A
DR   SKIP; SKIP002422
DR   Wikidata; Q54832763
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/GDFIPS-4F-21C.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Linea_GD_FiPS-4F-21c.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_GDFiPS-4F-21c.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Gly241Arg (c.721G>A) (G202R); ClinVar=VCV000093459; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (BNLC).
CC   Discontinued: ECACC; 66540069; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 26
//
ID   ESi030-A
AC   CVCL_C792
SY   [GA]FiPS4F; GA-FiPS4F
DR   hPSCreg; ESi030-A
DR   SKIP; SKIP002413
DR   Wikidata; Q54832765
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_GAFiPS4F_vfinal.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/GA_FiPS4F.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_GA_FiPS4F.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   ESi034-A
AC   CVCL_C744
SY   CBiPS30-4F-3; CBiPS 4F-3
DR   hPSCreg; ESi034-A
DR   SKIP; SKIP002417
DR   Wikidata; Q54832766
RX   PubMed=19796614;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_CBiPS30-4F-3_vfinal.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CBiPS30-4F-3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_CBiPS30-4F-3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C745 ! ESi034-B
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   ESi034-B
AC   CVCL_C745
SY   CBiPS30-4F-5; CBiPS 4F-5
DR   hPSCreg; ESi034-B
DR   SKIP; SKIP002418
DR   Wikidata; Q54832767
RX   PubMed=19796614;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_CBiPS30-4F-5_vfinal.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_CBiPS30-4F-5_vfinal_FIRMA.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_CBiPS30-4F-5_VFINAL.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C744 ! ESi034-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   ESi035-A
AC   CVCL_V152
SY   [AD]FiPSAG07645-4F-17
DR   hPSCreg; ESi035-A
DR   SKIP; SKIP002537
DR   Wikidata; Q54832768
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/ADAG07645-4F-172.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_ADFiPSAG07645-4F-17.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_ADFiPS-AG07645-4F-17.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V148 ! AG07645
SX   Female
AG   15Y6M
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 23
//
ID   ESi036-A
AC   CVCL_V153
SY   [CRTRd]FiPS3067-4F-9
DR   hPSCreg; ESi036-A
DR   SKIP; SKIP002539
DR   Wikidata; Q54832784
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/VFDeposito_Lineas_-CRTRdFiPS3067-4F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/solicitud_deposito-CRTRd-FiPS3067-4F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_CRTRd_FiPS3067-4F-9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Pro544Leu (c.1631C>T); ClinVar=VCV000065692; Zygosity=Hemizygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 21
//
ID   ESi037-A
AC   CVCL_V198
SY   HKiPS4F; HKiPS-4F
DR   BioSamples; SAMEA4091844
DR   hPSCreg; ESi037-A
DR   SKIP; SKIP002583
DR   Wikidata; Q54832785
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_v32_modelo_HKiPS4F_vfinal.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/HKiPS4F.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_HKiPS4F.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   ESi038-A
AC   CVCL_V180
SY   CBiPS32-2F-2
DR   hPSCreg; ESi038-A
DR   SKIP; SKIP002584
DR   Wikidata; Q54832786
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Linea_CB32-2F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Solicitud_Deposito_Linea_CBiPS32-2F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_CBiPS32-2F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V177 ! ESi038-B
OI   CVCL_V178 ! ESi038-C
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   ESi038-B
AC   CVCL_V177
SY   CBiPS32-3F-10; CBiPS 3F-10
DR   hPSCreg; ESi038-B
DR   SKIP; SKIP002585
DR   Wikidata; Q54832788
RX   PubMed=19796614;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_CBiPS32-3F-10_vdef.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Linea_CBiPS32-3F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_CBiPS32-3F-10.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V180 ! ESi038-A
OI   CVCL_V178 ! ESi038-C
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   ESi038-C
AC   CVCL_V178
SY   CBiPS32-3F-12; CBiPS 3F-12; CBiPS3F-12
DR   hPSCreg; ESi038-C
DR   SKIP; SKIP002586
DR   Wikidata; Q54832789
RX   PubMed=19796614;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_CBiPS30-3F-12.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento_Deposito_Lineas_CBiPS30-3F-12pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_CBiPS32-3F-12.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V180 ! ESi038-A
OI   CVCL_V177 ! ESi038-B
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   ESi039-A
AC   CVCL_9S12
SY   [PD]FiPS031-4F-1; [PD] FiPS031-4F-1
DR   BioSamples; SAMEA5070573
DR   hPSCreg; ESi039-A
DR   Wikidata; Q54832790
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_linea-PDFiPS031-4F-11.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS031-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS031-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D21S11: 30,31.2
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q0 ! FFF-031
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 19
//
ID   ESi040-A
AC   CVCL_9S09
SY   [PD]FiPS006-4F-11; [PD] FiPS006-4F-11
DR   hPSCreg; ESi040-A
DR   SKIP; SKIP002590
DR   Wikidata; Q54832791
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_linea-PDFiPS006-4F-111.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS006-4F-11.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS006_4F_11.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Gln456Ter (c.1366C>T); ClinVar=VCV000002415; Zygosity=Homozygous (BNLC).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 13,14
ST   D21S11: 29,33.2
ST   D5S818: 13
ST   D7S820: 8
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 19
//
ID   ESi042-A
AC   CVCL_9S11
SY   [TSD]FiPS-4F-3-1; [TSD] FiPS-4F-3-1
DR   BioSamples; SAMEA5398472
DR   hPSCreg; ESi042-A
DR   SKIP; SKIP002589
DR   Wikidata; Q54832793
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito-Linea-TSDFiPS-4F-3-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Linea_TSD-FiPS-4F-3-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_TSD-FiPS-4F-3-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp420Cys (c.1260G>C); ClinVar=VCV000003901; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1330+1G>A (IVS11+1G>A); ClinVar=VCV000371490; Zygosity=Heterozygous; Note=Splice donor mutation (BNLC).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U385 ! GM00527
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 20
//
ID   ESi043-A
AC   CVCL_9S10
SY   [ctrl.PD]FiPS005-4F-9; [Ctrl.PD] FiPS005-4F-9
DR   hPSCreg; ESi043-A
DR   SKIP; SKIP002591
DR   Wikidata; Q54832794
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_linea-CtrlPDFiPS005-4F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS005-4F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_ctrl_PDFiPS005-4F-9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D21S11: 31.2,33.2
ST   D5S818: 13
ST   D7S820: 10,14
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   ESi044-A
AC   CVCL_9S18
SY   FiPS Ctrl1-mR5F-6
DR   BioSamples; SAMEA104008500
DR   hPSCreg; ESi044-A
DR   Wikidata; Q54832795
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS-Ctrl1-mR5F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS_Ctrl1-mR5F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS_Ctrl1-mR5F-6.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,10,12.5
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD40 ! ESi044-B
OI   CVCL_9S19 ! ESi044-C
OI   CVCL_VD41 ! ESi044-D
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   ESi044-B
AC   CVCL_VD40
SY   FiPS Ctrl1-Ep6F-5; [FiPS] Ctrl1-Ep6F-5
DR   BioSamples; SAMEA104008502
DR   hPSCreg; ESi044-B
DR   Wikidata; Q54832796
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS-Ctrl1-Ep6F-5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_FiPS_Ctrl1-Ep6F-5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS_Ctrl1-Ep6F-5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,10,12.5
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S18 ! ESi044-A
OI   CVCL_9S19 ! ESi044-C
OI   CVCL_VD41 ! ESi044-D
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi044-C
AC   CVCL_9S19
SY   FiPS Ctrl1-SV4F-7
DR   BioSamples; SAMEA104129970
DR   hPSCreg; ESi044-C
DR   Wikidata; Q54832797
RX   PubMed=35172160;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS-Ctrl1-SV4F-7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS_Ctrl1-SV4F-7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS-Ctrl1-SV4F-7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,10,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S18 ! ESi044-A
OI   CVCL_VD40 ! ESi044-B
OI   CVCL_VD41 ! ESi044-D
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   ESi044-D
AC   CVCL_VD41
SY   FiPS Ctrl1-R4F-4
DR   BioSamples; SAMEA104135350
DR   hPSCreg; ESi044-D
DR   Wikidata; Q54832799
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS-Ctrl1-R4F-4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito__FiPS_Ctrl1-R4F-4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS_Ctrl1-R4F-4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,10,12.5
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S18 ! ESi044-A
OI   CVCL_VD40 ! ESi044-B
OI   CVCL_9S19 ! ESi044-C
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi045-A
AC   CVCL_9S21
SY   FiPS Ctrl2-mR5F-6
DR   BioSamples; SAMEA104130288
DR   hPSCreg; ESi045-A
DR   Wikidata; Q54832800
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS-Ctrl2-mR5F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS_Ctrl2-mR5F_6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS-Ctrl2-mR5F-6.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Scrotum, skin, dermis; UBERON=UBERON_0015479+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 28,33.2
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S20 ! ESi045-B
OI   CVCL_9S22 ! ESi045-C
OI   CVCL_VD42 ! ESi045-D
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   ESi045-B
AC   CVCL_9S20
SY   FiPS Ctrl2-Ep6F-8
DR   BioSamples; SAMEA104130290
DR   hPSCreg; ESi045-B
DR   Wikidata; Q54832801
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS-Ctrl2-Ep6F-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS_Ctrl2-Ep6F-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS-Ctrl2-Ep6F-8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Scrotum, skin, dermis; UBERON=UBERON_0015479+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 28,33.2
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S21 ! ESi045-A
OI   CVCL_9S22 ! ESi045-C
OI   CVCL_VD42 ! ESi045-D
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   ESi045-C
AC   CVCL_9S22
SY   FiPS Ctrl2-SV4F-1
DR   BioSamples; SAMEA104130310
DR   hPSCreg; ESi045-C
DR   Wikidata; Q54832802
RX   PubMed=35569737;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS-Ctrl2-SV4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento%2520Deposito%2520FiPS%2520Ctrl2-SV4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_FiPS+Ctrl2-SV4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Scrotum, skin, dermis; UBERON=UBERON_0015479+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 28,33.2
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S21 ! ESi045-A
OI   CVCL_9S20 ! ESi045-B
OI   CVCL_VD42 ! ESi045-D
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   ESi045-D
AC   CVCL_VD42
SY   FiPS Ctrl2-R4F-5
DR   BioSamples; SAMEA104130490
DR   hPSCreg; ESi045-D
DR   Wikidata; Q54832803
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_FiPS_Ctrl2-R4F-5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS_Ctrl2-R4F-5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Scrotum, skin, dermis; UBERON=UBERON_0015479+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 28,33.2
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S21 ! ESi045-A
OI   CVCL_9S20 ! ESi045-B
OI   CVCL_9S22 ! ESi045-C
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi046-A
AC   CVCL_VD45
SY   [UCiPS]Ctrl5-R4F-25; [UCiPS] Ctrl5-R4F-25; UCiPS-Ctrl5-R4F-25
DR   BioSamples; SAMEA104130550
DR   hPSCreg; ESi046-A
DR   Wikidata; Q54832804
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/UCiPS-Ctrl5-R4F-25.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_deposito_UCiPS_Ctrl5-R4F-25.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_UCiPS_Ctrl5-R4F-25.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,13
ST   D21S11: 29,32.2
ST   D5S818: 12
ST   D7S820: 7,9
ST   TH01: 6,8
ST   TPOX: 8,13
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   ESi047-A
AC   CVCL_VD53
SY   GLC-FiPS4F1
DR   hPSCreg; ESi047-A
DR   SKIP; SKIP003169
DR   Wikidata; Q54832805
RX   PubMed=29453128;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_GLC-FiPS4F1-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:2597; CYP1B1; Simple; p.Arg468_Ser476dup (c.1403_1429dupAGAAAGTTCTTCGCCAATGCACCGCCT); ClinVar=VCV002864518; Zygosity=Homozygous (PubMed=29453128).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148260; Primary congenital glaucoma 3A
DI   ORDO; Orphanet_98976; Congenital glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 15
//
ID   ESi048-A
AC   CVCL_VD54
SY   [MS]FiPS1-R4F-3; [MS] FiPS1-R4F-3; MS_FiPS1_R4F_3
DR   BioSamples; SAMEA4892800
DR   hPSCreg; ESi048-A
DR   Wikidata; Q54832806
RX   PubMed=29034884;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/MS-FiPS-1-R4F-3-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_MS_FiPS1-R4F-3-ajj06.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_MS_FiPS1-R4F-3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034884
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 9,11
ST   D7S820: 9,12
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi049-A
AC   CVCL_VD55
SY   [MS]FiPS2-R4F-10; [MS] FiPS2-R4F-10; MS_FiPS2_R4F_10
DR   BioSamples; SAMEA4999620
DR   hPSCreg; ESi049-A
DR   Wikidata; Q54832807
RX   PubMed=29034884;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/MS-FiPS2-R4F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_05Documento_Deposito_MS_FiPS2-R4F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_05Anexo_deposito__MS_FiPS2-R4F-10.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034884
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 31
ST   D5S818: 11,13
ST   D7S820: 9
ST   TH01: 6,7
ST   TPOX: 9,10,12.5
ST   vWA: 14,15
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi050-A
AC   CVCL_VD56
SY   [MS]FiPS3-R4F-1; [MS] FiPS3-R4F-1; MS_FiPS3_R4F_1
DR   BioSamples; SAMEA5573705
DR   hPSCreg; ESi050-A
DR   Wikidata; Q54832808
RX   PubMed=29034884;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/MS-FiPS3-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_05Documento_Deposito_MS_FiPS3-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_05Anexo_deposito_MS_FiPS3-R4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034884
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 30,31
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi051-A
AC   CVCL_VD57
SY   [MS]FiPS4-R4F-1; [MS] FiPS4-R4F-1; MS_FiPS4_R4F_1
DR   BioSamples; SAMEA5696677
DR   hPSCreg; ESi051-A
DR   Wikidata; Q54832809
RX   PubMed=29034884;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/MS-FiPS4-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_05Documento_Deposito_MS_FiPS4-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_05Anexo_deposito_MS_FiPS4-R4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034884
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D21S11: 28
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 6,11
ST   vWA: 17,18
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi052-A
AC   CVCL_VD58
SY   [MS]FiPS5-R4F-6; [MS] FiPS5-R4F-6; MS_FiPS5_R4F_6
DR   BioSamples; SAMEA5696679
DR   hPSCreg; ESi052-A
DR   Wikidata; Q54832810
RX   PubMed=29034884;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/MS-FiPS5-R4F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_05Documento_Deposito_MS_FiPS5-R4F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_05Anexo_deposito_MS_FiPS_5-R4F-6.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034884
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D21S11: 28,30
ST   D5S818: 13,14
ST   D7S820: 7,12
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 16,17
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi053-A
AC   CVCL_VD59
SY   [MS]FiPS6-R4F-2; [MS] FiPS6-R4F-2; MS_FiPS6_R4F_2
DR   BioSamples; SAMEA5696681
DR   hPSCreg; ESi053-A
DR   Wikidata; Q54832811
RX   PubMed=29034884;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/MS-FiPS6-R4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_05Documento_Deposito_MS_FiPS6-R4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_05Anexo_deposito_MS_FiPS6-R4F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034884
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D21S11: 28
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ESi054-A
AC   CVCL_VD44
SY   [AS]FiPS1-Ep6F-2; AS-FiPS1-Ep6F-2; AS FiPS1 Ep6F-2; AS FiPS 1-Ep6F-2; [AS] FiPS 1-Ep6F-2
DR   BioSamples; SAMEA104134610
DR   hPSCreg; ESi054-A
DR   SKIP; SKIP003091
DR   Wikidata; Q54832812
RX   PubMed=29246570;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/AS-FiPS-1-Ep6F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_AS-FiPS-1-Ep6F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_AS-FiPS-1-Ep6F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Pro116Leufs*37 (c.345delG); ClinVar=VCV000554004; Zygosity=Homozygous (PubMed=29246570).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29246570
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D21S11: 30.2,32.2
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   ESi055-A
AC   CVCL_VE11
SY   [AS]FiPS2-Ep6F-28; AS-FiPS2-Ep6F-28; AS FiPS2 Ep6F-28; AS FiPS 2-Ep6F-28; [AS] FiPS 2-Ep6F-28
DR   BioSamples; SAMEA104134630
DR   hPSCreg; ESi055-A
DR   Wikidata; Q54832813
RX   PubMed=29150092;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/AS-FiPS-2-Ep6F-28.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_AS-FiPS-2-Ep6F-28.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_AS-FiPS-2-Ep6F-28.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1241Asp (c.3722G>A); ClinVar=VCV000934057; Zygosity=Hemizygous (PubMed=29150092).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29150092
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D21S11: 28,29
ST   D5S818: 11,13
ST   D7S820: 12
ST   TH01: 6,9.3
ST   TPOX: 9,12.5
ST   vWA: 15,18
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   ESi056-A
AC   CVCL_VD43
SY   [AS]FiPS3-Ep6F-9; AS-FiPS3-Ep6F-9; AS FiPS3 Ep6F-9; AS FiPS 3-Ep6F-9; [AS] FiPS 3-Ep6F-9
DR   BioSamples; SAMEA104134950
DR   hPSCreg; ESi056-A
DR   Wikidata; Q54832814
RX   PubMed=29150092;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/AS-FiPS-3-Ep6F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_AS-FiPS-3-Ep6F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_AS-FiPS-3-Ep6F-9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1351Asp (c.4052G>A); Zygosity=Hemizygous (PubMed=29150092).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29150092
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 11
ST   D21S11: 28,29
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 9.3
ST   TPOX: 8,12.5
ST   vWA: 17,18
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   ESi057-A
AC   CVCL_VD46
SY   [DUP7]FiPS-4F-3-1; [DUP7] FiPS-4F-3-1
DR   BioSamples; SAMEA104135250
DR   hPSCreg; ESi057-A
DR   Wikidata; Q54832815
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2021/03/DUP7-FiPS-4F-3-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas__DUP7_FiPS-4F-3-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_DUP7_FiPS-4F-3-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D21S11: 31.2,32.2
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   ESi057-B
AC   CVCL_VD60
SY   [DUPSW]FiPS301 R4F-1; DUPSW FiPS301 R4F-1; 301.1
DR   BioSamples; SAMEA5696683
DR   hPSCreg; ESi057-B
DR   Wikidata; Q54832816
RX   PubMed=33254092;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/DUPSW-FiPS301-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+2017_06_12Documento_Deposito_Lineas_iPS-DUPSW_FiPS301-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+2017_06_12Anexo_deposito_DUPSW_FiPS301-R4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 15
//
ID   ESi058-A
AC   CVCL_VD47
SY   [DUP7]FiPS-4F-4-6; [DUP7] FiPS-4F-4-6
DR   BioSamples; SAMEA104235580
DR   hPSCreg; ESi058-A
DR   Wikidata; Q54832817
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2021/03/DUP7-FiPS-4F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_DUP7_FiPS-4F-4-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_DUP7_FiPS-4F-4-6-6-3-17.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 27,29
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD52 ! ESi058-B
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   ESi058-B
AC   CVCL_VD52
SY   [DUP7]FiPS4-R4F-2; [DUP7] FiPS4-R4F-2; DUP7 FiPS4 R4F-2
DR   BioSamples; SAMEA5696684
DR   hPSCreg; ESi058-B
DR   Wikidata; Q54832818
RX   PubMed=33254092;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/DUP7-FiPS4-R4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_12Documento_Deposito_Lineas_iPS-DUP7FiPS4-R4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_12Anexo_deposito_DUP7FiPS4-R4F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 27,29
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD47 ! ESi058-A
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   ESi059-A
AC   CVCL_VD48
SY   [SWB]FiPS-4F-1-1; [SWB] FiPS-4F-1-1; ESi059A
DR   BioSamples; SAMEA104235610
DR   hPSCreg; ESi059-A
DR   Wikidata; Q54832819
RX   PubMed=33370870;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2021/03/SWB-FiPS-4F-1-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_SWB_FiPS-4F-1-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_SWB_FiPS-4F-1-1-_6_3_17.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD51 ! ESi059-B
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   ESi059-B
AC   CVCL_VD51
SY   [SWB]FiPS1-R4F-5; [SWB] FiPS1-R4F-5
DR   BioSamples; SAMEA5697079
DR   hPSCreg; ESi059-B
DR   Wikidata; Q54832820
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/SWB-FiPS1-R4F-5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_12Documento_Deposito_Linea-SWB_FiPS1-R4F-5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_12Anexo_deposito_SWBFiPS1-R4F-5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD48 ! ESi059-A
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 15
//
ID   ESi060-A
AC   CVCL_VD49
SY   [SWB]FiPS-4F-5-6; [SWB] FiPS-4F-5-6
DR   BioSamples; SAMEA104235615
DR   hPSCreg; ESi060-A
DR   Wikidata; Q54832821
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2021/03/SWB-FiPS-4F-5-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_SWB_FiPS-4F-5-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_SWB_FiPS-4F-5-6.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D21S11: 31.2,32.2
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD50 ! ESi060-B
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   ESi060-B
AC   CVCL_VD50
SY   [SWB]FiPS5-R4F-1; [SWB] FiPS5-R4F-1; ESi060B
DR   BioSamples; SAMEA5712208
DR   hPSCreg; ESi060-B
DR   Wikidata; Q54832822
RX   PubMed=33370870;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/SWB-FiPS5-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_12Documento_Deposito_Linea__SWB_FiPS5-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_12Anexo_deposito_SWB_FiPS5-R4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D21S11: 31.2,32.2
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD49 ! ESi060-A
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 15
//
ID   ESi061-A
AC   CVCL_V157
SY   [PD]FiPS022-V4F-15; [PD] FiPS022-V4F-15
DR   hPSCreg; ESi061-A
DR   Wikidata; Q54832823
RX   PubMed=23075850;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/PDFiPS022-V4F-151.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito-Linea-PDFiPS022-V4F-15.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-deposito-PDFiPS022-V4F-15.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=23075850).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9P7 ! FFF-022
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   ESi062-A
AC   CVCL_VF80
SY   Ctrl2-FiPS5F2
DR   hPSCreg; ESi062-A
DR   SKIP; SKIP003167
DR   Wikidata; Q54832824
RX   PubMed=29499498;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520de%2520registro%2520y%2520de%2520deposito%2520Ctrl2_FiPS5F2-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Population: Caucasian.
CC   Caution: Indicated as originating from a 4 year old boy in PubMed=29499498, but this cell line was derived from CCD-1112Sk which is from a newborn male.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   ESi063-A
AC   CVCL_VP83
SY   ARS-FiPS4F1
DR   hPSCreg; ESi063-A
DR   Wikidata; Q93545354
RX   PubMed=30144656;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Formulario%2520de%2520deposito%2520ARS-FiPS4F1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo%2520ARS-FiPS4F1-V2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:10519; SACS; Simple; p.Gln3313Glyfs*11 (c.9938delC); Zygosity=Heterozygous (PubMed=30144656).
CC   Sequence variation: Mutation; HGNC; HGNC:10519; SACS; Simple; p.Arg3792Ter (c.11374C>T); ClinVar=VCV000370283; Zygosity=Heterozygous (PubMed=30144656).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D21S11: 28,29
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C154614; Autosomal recessive spastic ataxia of Charlevoix-Saguenay
DI   ORDO; Orphanet_98; Autosomal recessive spastic ataxia of Charlevoix-Saguenay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 14
//
ID   ESi064-A
AC   CVCL_UG20
SY   CARS-FiPS4F1
DR   hPSCreg; ESi064-A
DR   Wikidata; Q93545359
RX   PubMed=30384130;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Formulario%2520de%2520deposito%2520CARS-FiPS4F1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520CARS-FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:10519; SACS; Simple; p.Arg3792Ter (c.11374C>T); ClinVar=VCV000370283; Zygosity=Heterozygous (PubMed=30384130).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   ESi065-A
AC   CVCL_VD61
SY   [IDDM1]FiPS-1.13-Ep6F-9; [IDDM1] FiPS 1.13-Ep6F-9
DR   BioSamples; SAMEA4880777
DR   hPSCreg; ESi065-A
DR   Wikidata; Q54423214
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/FiPS113-Ep6F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_deposito_IDDM1_FiPS_1.13-Ep6F-9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_IDDM1_FiPS_1.13-Ep6F-9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 9,19
ST   D13S317: 8,14
ST   D16S539: 11,13
ST   D21S11: 30,32.2
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 10
ST   vWA: 16,20
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   ESi066-A
AC   CVCL_WN56
SY   RP3-FiPS4F1
DR   hPSCreg; ESi066-A
DR   Wikidata; Q93545375
RX   PubMed=31082679;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520de%2520deposito%2520RP3-FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21699; CERKL; Simple; p.Arg283Ter (c.847C>T) (p.Arg257Ter, c.769C>T); ClinVar=VCV000002364; Zygosity=Homozygous (PubMed=31082679).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   ESi067-A
AC   CVCL_WN57
SY   Ctrl3-FiPS4F1; CTRL3-FiPS4F1
DR   hPSCreg; ESi067-A
DR   Wikidata; Q93545380
RX   PubMed=31082679;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520de%2520deposito%2520CTRL-FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   ESi068-A
AC   CVCL_WP77
SY   [SWB]FiPS 159-R4F-4; SWB FiPS 159-R4F-4; ESi068A
DR   BioSamples; SAMEA5763656
DR   hPSCreg; ESi068-A
DR   Wikidata; Q93545382
RX   PubMed=33370870;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/SWB-FiPS-159-R4F-4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/SWB%2520FiPS%2520159-R4F-4-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_SWB+FiPS+159-R4F-4-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 29,32.2
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7T0 ! ESi068-B
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   ESi068-B
AC   CVCL_E7T0
SY   [SWB]FiPS 159-R4F-8; SWB FiPS 159-R4F-8
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SWB+FiPSC159-R4F-8+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/SWB%2520FiPSC159-R4F-8%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP77 ! ESi068-A
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESi069-A
AC   CVCL_WP78
SY   [SWB]FiPS 344-R4F-2; SWB FiPS 344-R4F-2; ESi069A
DR   BioSamples; SAMEA5763658
DR   hPSCreg; ESi069-A
DR   Wikidata; Q93545387
RX   PubMed=33370870;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/SWB-FiPS-344-R4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/SWB%2520FiPS%2520344-R4F-2-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_SWB+FiPS+344-R4F-2-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D21S11: 30,32
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7T1 ! ESi069-B
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   ESi069-B
AC   CVCL_E7T1
SY   [SWB]FiPS 344-R4F-3; SWB FiPS344-R4F-3
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SWB+FiPS344-R4F-3+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/SWB%2520FiPS344-R4F-3%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP78 ! ESi069-A
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESi070-A
AC   CVCL_WP79
SY   [DUPSW]FiPS 501-R4F-2; DUPSW FiPS 501-R4F-2; DUPSW FiPS501 R4F-2
DR   BioSamples; SAMEA5843914
DR   hPSCreg; ESi070-A
DR   Wikidata; Q93545391
RX   PubMed=33254092;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/DUPSW-FiPS-501-RAF-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/DUPSW%2520FiPS%2520501-R4F-2-V2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_DUPSW+FiPS+501-R4F-2-V2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D21S11: 27,28
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7T3 ! ESi070-B
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   ESi070-B
AC   CVCL_E7T3
SY   [DUPSW]FiPS 501-R4F-5; DUPSW FiPS 501-R4F-5; DUPSW FiPS501-R4F-5
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+DUPSW+FiPS501-R4F-5+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/DUPSW%2520FiPS501-R4F-5%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP79 ! ESi070-A
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESi071-A
AC   CVCL_WP80
SY   [DUPSW]FiPS 701-R4F-6; DUPSW FiPS 701-R4F-6; DUPSW FiPS701 R4F-6
DR   BioSamples; SAMEA5873408
DR   hPSCreg; ESi071-A
DR   Wikidata; Q93545393
RX   PubMed=33254092;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/DUPSW-FiPS701-R4F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/DUPSW%2520FiPS701%2520R4F-6-v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_DUPSW+FiPS701+R4F-6-v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D21S11: 28,31
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 18
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7T2 ! ESi071-B
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   ESi071-B
AC   CVCL_E7T2
SY   [DUPSW]FiPS 701-R4F-4; DUPSW FiPS701-R4F-4; DUPSW FiPS 701 R4F#4
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+DUPSW+FiPS701-R4F-4+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/DUPSW%2520FiPS701-R4F-4%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP80 ! ESi071-A
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESi072-A
AC   CVCL_UR67
SY   OCD FiPS 1-Ep6F-16; OCD FiPS1-Ep6F-16
DR   BioSamples; SAMEA5873410
DR   hPSCreg; ESi072-A
DR   Wikidata; Q93545398
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/OCD-FiPS-1-Ep6F-16.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_OCD%2520FiPS1-Ep6F-16.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_OCD+FiPS+1-Ep6F-16.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Laboratorio de Neurociencia Elena Pessino Gornez del Campo; Madrid; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 29,31
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10,12.5
ST   vWA: 18
DI   NCIt; C88411; Obsessive compulsive disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   ESi073-A
AC   CVCL_UR68
SY   OCD FiPS 2-Ep6F-10; OCD FiPS2-Ep6F-10
DR   BioSamples; SAMEA5873412
DR   hPSCreg; ESi073-A
DR   Wikidata; Q93545403
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/OCD-FiPS-2-Ep6F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_%2520OCD%2520Fips2-Ep6F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_OCD+FiPS+2-Ep6F-10.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Laboratorio de Neurociencia Elena Pessino Gornez del Campo; Madrid; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 29,30
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C88411; Obsessive compulsive disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   ESi074-A
AC   CVCL_WP81
SY   CT PBiPS1-Sv4F-1
DR   BioSamples; SAMEA5885934
DR   hPSCreg; ESi074-A
DR   Wikidata; Q93545406
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento%2520_Deposito%2520CT%2520PBiPS1-Sv4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_CT+PBiPS1-Sv4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Donor information: Established from a patient showing cardiotoxicity to anthracyclines.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D21S11: 31,31.2
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   ESi075-A
AC   CVCL_YB97
SY   BST PBiPS1-Sv4F-1
DR   BioSamples; SAMEA5945664
DR   hPSCreg; ESi075-A
DR   Wikidata; Q93545409
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/BST-PBiPS1-SV4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_BST%2520PBiPS1-Sv4F-1-Revisado.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_BST+PBiPS1-SV4F-1.doc.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D21S11: 24.2,30
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   ESi076-A
AC   CVCL_YB98
SY   BST PBiPS2-Sv4F-6
DR   BioSamples; SAMEA5945667
DR   hPSCreg; ESi076-A
DR   Wikidata; Q93545413
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/BST-PBiPS2-SV4F-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_BST%2520PBiPS2-SV4F-6-Revisado.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_BST+PBiPS2-SV4F-6.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D21S11: 29,32.2
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   ESi077-A
AC   CVCL_UJ71
SY   OF0081-PRPF31c3; PRPF31-MiPS4F3; CABi001-A
DR   BioSamples; SAMEA7484330
DR   hPSCreg; ESi077-A
DR   Wikidata; Q93545418
RX   PubMed=30921587;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Solicitud+depo%CC%81sito+PRPF31-MiPS4F3_v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+anexos+deposito+li%CC%81nea+PRPF31-MiPS4F3_v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Trp55Ter (c.165G>A); ClinVar=VCV000804153; Zygosity=Heterozygous (PubMed=30921587).
CC   Caution: The second allele of D7S820 is unreadable in the cell line documentation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 8,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 30,31
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   ESi078-A
AC   CVCL_YB99
SY   cPRPF31-MiPS4F7
DR   BioSamples; SAMEA7484329
DR   hPSCreg; ESi078-A
DR   Wikidata; Q93545423
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_cPRPF31-MiPS4F7-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+anexos+deposito+l%C3%ADnea+cPRPF31-MiPS4F7-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D21S11: 33,33.2
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   ESi079-A
AC   CVCL_YC00
SY   cAMDdh09-MiPS4F17
DR   BioSamples; SAMEA8072989
DR   hPSCreg; ESi079-A
DR   Wikidata; Q93545428
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+cAMDdh09-MipS4F17+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/cAMDdh09-MipS4F17%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D21S11: 30,30.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   ESi080-A
AC   CVCL_YK96
SY   N1-FiPS4F#7; iPS637#7
DR   BioSamples; SAMEA6534024
DR   hPSCreg; ESi080-A
DR   Wikidata; Q93545431
RX   PubMed=31962233;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Deposito_Lineas_iPS-+N1-FiPS4F+7-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+ANEXOS+-+N1-FiPS4F+clon+7-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: El Instituto de Investigacion Biomedica de A Coruna, University of Coruna; Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31962233
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   ESi082-A
AC   CVCL_A1ZA
SY   CRB1-MiPS4F1
DR   BioSamples; SAMEA8028721
DR   hPSCreg; ESi082-A
DR   Wikidata; Q105506852
RX   PubMed=33773389;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CRB1-MiPS4F1-Solicitud+de+dep%C3%B3sito-v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/CRB1-MiPS4F1-Anexo-v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Ile167_Gly169del (c.498_506delAATTGATGG); ClinVar=VCV000096659; Zygosity=Heterozygous (PubMed=33773389).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Ile205Aspfs*13 (c.613_619delATAGGAA); ClinVar=VCV000099913; Zygosity=Heterozygous (PubMed=33773389).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D21S11: 28,31
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   ESi083-A
AC   CVCL_A8HZ
SY   MOA1-FiPS4F#7
DR   hPSCreg; ESi083-A
DR   Wikidata; Q107114904
RX   PubMed=32144293;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_Lineas_iPS-MOA1-FiPS4F-7-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520%2520MOA1-FiPS4F-7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: El Instituto de Investigacion Biomedica de A Coruna, University of Coruna; Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32144293
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   ESi084-A
AC   CVCL_A8IA
SY   MOA2-FiPS4F#17
DR   hPSCreg; ESi084-A
DR   Wikidata; Q107114906
RX   PubMed=32144293;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_Lineas_iPS-MOA2-FiPS4F-17-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520%2520MOA2-FiPS4F-17.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: El Instituto de Investigacion Biomedica de A Coruna, University of Coruna; Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32144293
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D21S11: 30,33.2
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   ESi085-A
AC   CVCL_A8HY
SY   cAMDdh01-MiPS4F8; DH01 c8
DR   BioSamples; SAMEA8686791
DR   hPSCreg; ESi085-A
DR   Wikidata; Q107114907
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+cAMDdh01-MiPS4F8+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/cAMDdh01-MiPS4F8%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 8,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 30,31
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ESi086-A
AC   CVCL_A8KT
SY   CBiPS8-3F-4
DR   hPSCreg; ESi086-A
DR   Wikidata; Q108820197
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CBiPS8-3F-4+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/CBiPS8-3F-4%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   ESi086-A-1
AC   CVCL_A8KU
SY   CBiPS8-3F-4 GATA2-R396Q-12
DR   hPSCreg; ESi086-A-1
DR   Wikidata; Q108820198
RX   PubMed=34284273;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CBiPS8-3F-4+GATA2-R396Q-12+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/CBiPS8-3F-4%2520GATA2-R396Q-12%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4171; GATA2; Simple_edited; p.Arg396Gln (c.1187G>A); ClinVar=VCV000472437; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34284273).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8KT ! ESi086-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   ESi086-A-2
AC   CVCL_A8KV
SY   CBiPS8-3F-4 GATA2 R398W-8
DR   hPSCreg; ESi086-A-2
DR   Wikidata; Q108820199
RX   PubMed=34284273;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CBiPS8-3F-4+GATA2-R398W-8+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/CBiPS8-3F-4%2520GATA2-R398W-8%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4171; GATA2; Simple_edited; p.Arg398Trp (c.1192C>T); ClinVar=VCV000029709; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34284273).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8KT ! ESi086-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   ESi086-A-3
AC   CVCL_C1PT
SY   CBiPS8-3F-4 SAMD9 p.I1567M; CBiPS8-3F-4 SAMD9 I1567M; IDIBELi087-A-3
DR   BioSamples; SAMEA110684462
DR   hPSCreg; ESi086-A-3
DR   Wikidata; Q114311373
RX   PubMed=36087523;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CBiPS8-3F-4+SAMD9+I1567M+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/CBiPS8-3F-4%2520SAMD9%2520I1567M%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:1348; SAMD9; Simple_edited; p.Ile1567Met (c.4701A>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36087523).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8KT ! ESi086-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   ESi087-A
AC   CVCL_C1PP
SY   BT1-UCiPS4F1; BT-iPSCs 1
DR   BioSamples; SAMEA110357663
DR   hPSCreg; ESi087-A
DR   Wikidata; Q114311376
RX   PubMed=36776860;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Donor information: Established from a patient suffering from a low grade glioma (PubMed=36776860).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=36776860
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D21S11: 31
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y7M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   ESi088-A
AC   CVCL_C1PQ
SY   BT2-UCiPS4F1; BT-iPSCs 2
DR   BioSamples; SAMEA110466389
DR   hPSCreg; ESi088-A
DR   Wikidata; Q114311379
RX   PubMed=36776860;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Donor information: Established from a patient suffering from a metastatic brain tumor (PubMed=36776860).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=36776860
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D21S11: 32.2,33.2
ST   D5S818: 13
ST   D7S820: 8,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   ESi089-A
AC   CVCL_C1PR
SY   Ctrl1-UCiPS4F1; nonT-iPSCs 1
DR   BioSamples; SAMEA110471152
DR   hPSCreg; ESi089-A
DR   Wikidata; Q114311381
RX   PubMed=36776860;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Donor information: Established from a patient suffering from an inguinal hernia (PubMed=36776860).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=36776860
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,13
ST   D21S11: 31.2,32.2
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   ESi090-A
AC   CVCL_C1PS
SY   Ctrl2-UCiPS4F1; nonT-iPSCs 2
DR   BioSamples; SAMEA110472298
DR   hPSCreg; ESi090-A
DR   Wikidata; Q114311382
RX   PubMed=36776860;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   Donor information: Established from a patient suffering from cryptorchidism (PubMed=36776860).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=36776860
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y8M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   ESi091-A
AC   CVCL_C3RD
SY   HLA91-MiPS4F3
DR   BioSamples; SAMEA111406533
DR   hPSCreg; ESi091-A
DR   Wikidata; Q116048949
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+HLA91-MiPS4F3+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/HLA91-MiPS4F3%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   HLA typing: A*29; B*44; C*16 (BNLC).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 13
ST   D21S11: 30,31
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   ESi092-A
AC   CVCL_C6PU
SY   HLA98-MiPS4F15
DR   BioSamples; SAMEA111440892
DR   hPSCreg; ESi092-A
DR   Wikidata; Q117704318
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+HLA98-MiPS4F15+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/HLA98-MiPS4F15_Anexos.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Population: Caucasian.
CC   HLA typing: A*23; B*03,44; C*04,01:09N (BNLC).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi093-A
AC   CVCL_C6PV
SY   CD34 iPS1-Sv4F-B8
DR   BioSamples; SAMEA112246740
DR   hPSCreg; ESi093-A
DR   Wikidata; Q117704319
RX   PubMed=38093328;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CD34+iPS1-Sv4F-B8+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+CD34+iPS1-Sv4F-B8+Anexo+dep%C3%B3sito.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   HLA typing: A*29:02,29:02; B*44:03,44:03; C*16:01,16:01; DPB1*11:01,11:01; DQB1*02:02,02:02; DRB1*07:01,07:01 (PubMed=38093328).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D21S11: 29
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi094-A
AC   CVCL_C6PN
SY   Hz 1-8-3 CBiPS4-Sv4F-F6
DR   BioSamples; SAMEA112371432
DR   hPSCreg; ESi094-A
DR   Wikidata; Q117704320
RX   PubMed=38093328;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Hz+1-8-3+CBiPS4-Sv4F-F6+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Hz+1-8-3+CBiPS4-Sv4F-F6+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01; DPB1*01:01,03:01; DQB1*02:01,02:01; DRB1*03:01,03:01 (PubMed=38093328).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 16
ST   vWA: 8,10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi095-A
AC   CVCL_C6PP
SY   Hz 3-7-15 CBiPS3-Sv4F-E9
DR   BioSamples; SAMEA112445418
DR   hPSCreg; ESi095-A
DR   Wikidata; Q117704321
RX   PubMed=38093328;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Hz+3-7-15+CBiPS3-Sv4F-E9+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Hz%25203-7-15%2520CBiPS3-Sv4F-E9%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   HLA typing: A*03:01,03:01; B*07:02; C*:07:02,07:02; DPB1*02:01,04:01; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=38093328).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 28,31
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi096-A
AC   CVCL_C6PQ
SY   Hz 11-27-1 CBiPS8-Sv4F-J1
DR   BioSamples; SAMEA112464106
DR   hPSCreg; ESi096-A
DR   Wikidata; Q117704322
RX   PubMed=38093328;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Hz-11-27-1+CBiPS8-Sv4F-J1+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Hz-11-27-1%2520CBiPS8-Sv4F-J1%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   HLA typing: A*11:01,11:01; B*27:05,27:05; C*01:02,01:02; DPB1*04:01,11:01; DQB1*05:01,05:01; DRB1*01:01,01:01 (PubMed=38093328).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi097-A
AC   CVCL_C6PR
SY   Hz 24-7-15 CBiPS7-Sv4F-I12
DR   BioSamples; SAMEA112465908
DR   hPSCreg; ESi097-A
DR   Wikidata; Q117704323
RX   PubMed=38093328;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Hz+24-7-15+CBiPS7-Sv4F-I12+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Hz%252024-7-15%2520CBiPS7-Sv4F-I12%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   HLA typing: A*24:02,24:02; B*07:02,07:02; C*07:02,07:02; DPB1*04:01P,04:01P; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=38093328).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 8,13
ST   D21S11: 28,32.2
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi098-A
AC   CVCL_C6PS
SY   Hz 30-18-3 CBiPS2-Sv4F-D10
DR   BioSamples; SAMEA112471790
DR   hPSCreg; ESi098-A
DR   Wikidata; Q117704324
RX   PubMed=38093328;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Hz%252030-18-3%2520CBiPS2-Sv4F-D10-Solicitud%2520de%2520deposito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Hz%252030-18-3%2520CBiPS2-Sv4F-D10%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   HLA typing: A*30:02,30:02; B*18:01,18:01; C*05:01,05:01; DPB1*02:02,04:01; DQB1*02:01,02:01; DRB1*03:01,03:01 (PubMed=38093328).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D21S11: 28,32.2
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 5,9.3
ST   TPOX: 9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi099-A
AC   CVCL_C6PT
SY   Hz 33-14-1 CBiPS6-Sv4F-H6
DR   BioSamples; SAMEA112622728
DR   hPSCreg; ESi099-A
DR   Wikidata; Q117704325
RX   PubMed=38093328;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Hz+33-14-1+CBiPS6-Sv4F-H6+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Hz%252033-14-1%2520CBiPS6-Sv4F-H6%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   HLA typing: A*33:01,33:01; B*14:02,14:02; C*08:02,08:02; DPB1*02:01P,02:01P; DQB1*06:02,06:02; DRB1*01:02,01:02 (PubMed=38093328).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D21S11: 32.2,33.3
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi100-A
AC   CVCL_A7HK
SY   NW FiPS 10II.3-R4F-1
DR   BioSamples; SAMEA112641362
DR   hPSCreg; ESi100-A
DR   Wikidata; Q107116600
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+dep%C3%B3sito_NW+FiPS+10II.3-R4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_NW+FiPS+10II.3-R4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7T5 ! ESi100-B
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   ESi100-B
AC   CVCL_E7T5
SY   NW FiPS 10II.3-R4F-H3
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+NW+FiPSC10II3-R4F-3+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/NW%2520FiPSC10II3-R4F-3%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7HK ! ESi100-A
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESi101-A
AC   CVCL_A8IB
SY   THD FiPS A1 Ep6F-17
DR   BioSamples; SAMEA113580416
DR   hPSCreg; ESi101-A
DR   Wikidata; Q107117035
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2021/03/THD-FiPS-A1-Ep6F-17.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento%2520registro_THD%2520FiPS%2520A1%2520Ep6F-17.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_THD+FiPS+A1+Ep6F-17.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Arg233His (c.698G>A); ClinVar=VCV000016236; Zygosity=Homozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,14
ST   D21S11: 30,33.2
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C157158; Tyrosine hydroxylase deficiency
DI   ORDO; Orphanet_101150; Autosomal recessive dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   ESi102-A
AC   CVCL_A8IC
SY   THD FiPS B1 Ep6F-15
DR   BioSamples; SAMEA114381978
DR   hPSCreg; ESi102-A
DR   Wikidata; Q107117037
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2021/03/THD-FiPS-B1-Ep6F-15.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_THD%2520FiPS%2520B1%2520Ep6F-15.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_THD+FiPS+B1+Ep6F-15.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Arg328Trp (c.982C>T); Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Thr399Met (c.1196C>T) (p.Thr368Met, c.1103C>T); ClinVar=VCV000378729; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C157158; Tyrosine hydroxylase deficiency
DI   ORDO; Orphanet_101150; Autosomal recessive dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   ESi103-A
AC   CVCL_A8ID
SY   OCD FiPS3-Ep6F-6
DR   BioSamples; SAMEA114383869
DR   hPSCreg; ESi103-A
DR   Wikidata; Q107116602
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+OCD+FiPS3-Ep6F-6+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/OCD%2520FiPS3-Ep6F-6%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D21S11: 30,31.2
ST   D5S818: 11,13
ST   D7S820: 9,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C88411; Obsessive compulsive disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   ESi104-A
AC   CVCL_C6PW
SY   PMM2-CDG FiPS48-Sv4F-7
DR   BioSamples; SAMEA114409456
DR   hPSCreg; ESi104-A
DR   Wikidata; Q117704326
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+PMM2-CDG+FiPS48-Sv4F-7+Solicitud+de+dep%C3%B3sito-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/PMM2-CDG%2520FiPS48-Sv4F-7%2520Anexo-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Pro213_Gly214ins23 (c.640-9T>G) (IVS7-9T>G); ClinVar=VCV000632945; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Thr237Met (c.710C>T); ClinVar=VCV000021145; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   ESi106-A
AC   CVCL_C6PX
SY   MD FiPS3304-Sv4F-5
DR   BioSamples; SAMEA114462810
DR   hPSCreg; ESi106-A
DR   Wikidata; Q117704327
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+MD+FiPS3304-Sv4F-5+Solicitud+de+dep%C3%B3sito-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+MD+FiPS3304-Sv4F-5+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: University of Zaragoza; Zaragoza; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,10
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ESi107-A
AC   CVCL_C9E5
SY   ATTR-CM PBiPS1-Sv4F-3; TAC PBiPS1-Sv4F-3; UNAVi001-A
DR   BioSamples; SAMEA114241720
DR   hPSCreg; ESi107-A
DR   Wikidata; Q123031251
RX   PubMed=37660554;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+ATTR-CM+PBiPS1-Sv4F-3+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ATTR-CM%2520PBiPS1-Sv4F-3%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Ser43Asn (c.128G>A); ClinVar=VCV000661615; Zygosity=Heterozygous (PubMed=37660554).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,12
ST   D21S11: 31.2,33.2
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   ESi108-A
AC   CVCL_C9E6
SY   AFib-C53
DR   BioSamples; SAMEA113602179
DR   hPSCreg; ESi108-A
DR   Wikidata; Q123031252
RX   PubMed=37922745;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ESi109-A
AC   CVCL_D0EQ
DR   hPSCreg; ESi109-A
DR   Wikidata; Q123031253
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   ESi110-A
AC   CVCL_D0ER
SY   HLA89-MiPS4F8
DR   BioSamples; SAMEA114376323
DR   hPSCreg; ESi110-A
DR   Wikidata; Q123031254
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/anexos_HLA89-MiPS4F8_+09.10.2024.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/solicitud+deposito_+HLA89-MiPS4F8_09.10.2024_fdo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 10,14
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   ESi111-A
AC   CVCL_D6HM
SY   Ctrl EiPSJ9-mR6F-8; Ctrl EiPS J9 mR6F-8
DR   BioSamples; SAMEA114664545
DR   hPSCreg; ESi111-A
DR   Wikidata; Q127380824
RX   PubMed=39541769;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Ctrl%2520EiPSJ9-mR6F-8%2520Deposito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Ctrl%2520EiPSJ9-mR6F-8%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial cell of blood vessel; CL=CL_0000071.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 14,16
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 24,25
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi112-A
AC   CVCL_E3US
SY   CT_FiPS1_Sv4F_1; CTL1
DR   BioSamples; SAMEA114771410
DR   hPSCreg; ESi112-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/CTL1_annex.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/CTL1_deposito_firma.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Barcelona; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 14,17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 17,25
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi113-A
AC   CVCL_E3UT
SY   CT_PBiPS2_Sv4F_1; CTL3
DR   BioSamples; SAMEA114776667
DR   hPSCreg; ESi113-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/3e4e7451-90f0-68e7-2b01-750042627acc
WW   Provider; BNLC; -; https://www.isciii.es/documents/d/guest/ctl3_annex-pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Barcelona; Spain.
CC   Caution: The second allele value for D21S11 is missing in the STR report.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 11
ST   D18S51: 15,17
ST   D19S433: 12.2,14.2
ST   D21S11: 28
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 7,12
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi114-A
AC   CVCL_E3UU
SY   CT_FiPS3_Sv4F_1; CTL4
DR   BioSamples; SAMEA114777029
DR   hPSCreg; ESi114-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/CTL4_annex.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/CTL4_deposito_firma.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Barcelona; Spain.
CC   Caution: The second allele values for D2S1338 and D7S820 are missing in the STR report.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D19S433: 13,16
ST   D21S11: 29,32.2
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 8,14
ST   FGA: 21,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi115-A
AC   CVCL_D6HN
SY   IBM_FiPS1_Sv4F_1; IBM1
DR   BioSamples; SAMEA114777031
DR   hPSCreg; ESi115-A
DR   Wikidata; Q127380826
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/IBM1_annex.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/IBM1_deposito_firma.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Barcelona; Spain.
CC   Caution: The second allele value for D2S1338 is missing in the STR report.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D18S51: 16,18
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 17,19
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C84786; Inclusion body myositis
DI   ORDO; Orphanet_611; Inclusion body myositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi116-A
AC   CVCL_D6HP
SY   IBM_FiPS2_Sv4F_1; IBM2
DR   BioSamples; SAMEA114777033
DR   hPSCreg; ESi116-A
DR   Wikidata; Q127380827
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/IBM2_annex.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/IBM2_deposito_firma.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Barcelona; Spain.
CC   Caution: The second allele value for D21S11 is missing in the STR report.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D19S433: 11,14
ST   D21S11: 29
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 15
ST   FGA: 20,23
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C84786; Inclusion body myositis
DI   ORDO; Orphanet_611; Inclusion body myositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi117-A
AC   CVCL_D6HQ
SY   IBM_FiPS3_Sv4F_1; IBM3
DR   BioSamples; SAMEA114777035
DR   hPSCreg; ESi117-A
DR   Wikidata; Q127380828
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/IBM3_annex.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/IBM3_deposito_firma.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Barcelona; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 20
ST   D3S1358: 16,18
ST   D5S818: 9
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 22
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C84786; Inclusion body myositis
DI   ORDO; Orphanet_611; Inclusion body myositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi118-A
AC   CVCL_C6PY
AS   CVCL_D6HR
SY   MD FiPS3236-Sv4F-9
DR   BioSamples; SAMEA115022805
DR   hPSCreg; ESi118-A
DR   Wikidata; Q117704690
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+MD+FiPS3236-Sv4F-9+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+MD+FiPS3236-Sv4F-9+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: University of Zaragoza; Zaragoza; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:32151; ATAD3C; Simple; c.152+1G>A; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:32151; ATAD3C; Simple; c.692T>C; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 30,31
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   ESi119-A
AC   CVCL_E3UV
SY   SPG FiPS1-Ep6F-4
DR   BioSamples; SAMEA115045326
DR   hPSCreg; ESi119-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SPG+FiPS1-Ep6F-4+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/SPG%2520FiPS1-Ep6F-4%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:575; AP4S1; Simple; p.Arg97Ter (c.289C>T); ClinVar=VCV000234924; Zygosity=Homozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11,14
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C212890; Spastic paraplegia 52, autosomal recessive
DI   ORDO; Orphanet_280763; Severe intellectual disability and progressive spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi120-A
AC   CVCL_D6HS
SY   RRMS PBiPS11-Sv4F-7
DR   BioSamples; SAMEA115161812
DR   hPSCreg; ESi120-A
DR   Wikidata; Q127380830
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+RRMS+PBiPS11-Sv4F-7+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/RRMS%2520PBiPS11-Sv4F-7%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D21S11: 30,31
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi121-A
AC   CVCL_D6HT
SY   RRMS PBiPS12-Sv4F-6
DR   BioSamples; SAMEA115170607
DR   hPSCreg; ESi121-A
DR   Wikidata; Q127380831
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+RRMS+PBiPS12-Sv4F-6+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/RRMS%2520PBiPS12-Sv4F-6%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 29
ST   D5S818: 12,13
ST   D7S820: 8,14
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi122-A
AC   CVCL_D6HU
SY   PPMS PBiPS7-Sv4F-5
DR   BioSamples; SAMEA115177380
DR   hPSCreg; ESi122-A
DR   Wikidata; Q127380832
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_PPMS%2520PBiPS7-Sv4F-5%2520%28003%29.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_PPMS+PBiPS7-Sv4F-5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 13
ST   D21S11: 30,31
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 15,19
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi123-A
AC   CVCL_D6HV
SY   PPMS PBiPS8-Sv4F-13
DR   BioSamples; SAMEA115184505
DR   hPSCreg; ESi123-A
DR   Wikidata; Q127380833
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento_Deposito_PPMS+PBiPS8-Sv4F-13.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_PPMS+PBiPS8-Sv4F-13.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 8,14
ST   D21S11: 28,32.2
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi124-A
AC   CVCL_D6HW
SY   PPMS PBiPS9-Sv4F-12
DR   BioSamples; SAMEA115283713
DR   hPSCreg; ESi124-A
DR   Wikidata; Q127380834
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento_Deposito_PPMS+PBiPS9-Sv4F-12.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_PPMS+PBiPS9-Sv4F-12.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   HLA typing: DRB1*15:01 (hPSCreg=ESi124-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   ESi125-A
AC   CVCL_E3UW
SY   [CORD]-FiPSC1-Ep5F-2
DR   hPSCreg; ESi125-A
RX   PubMed=38956727;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/ANEXO_Deposito_Lineas_%5BCORD%5D-FiPSC1-Ep5F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Lineas_%5BCORD%5D-FiPSC1-Ep5F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9454; PROM1; Simple; p.Tyr452Leufs*13 (c.1354dupT); ClinVar=VCV000372711; Zygosity=Homozygous (PubMed=38956727).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D21S11: 28,30
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C212886; Cone-rod dystrophy 12
DI   ORDO; Orphanet_1872; Cone rod dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi126-A
AC   CVCL_E3UX
SY   [RP]-FiPSC1-Ep5F-10
DR   hPSCreg; ESi126-A
RX   PubMed=38956727;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/ANEXO_Deposito_Lineas_%5BRP%5D-FiPSC1-Ep5F-10.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Lineas_%5BRP%5D-FiPSC1-Ep5F-10.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9454; PROM1; Simple; p.Tyr452Leufs*13 (c.1354dupT); ClinVar=VCV000372711; Zygosity=Homozygous (PubMed=38956727).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D21S11: 28,29
ST   D5S818: 12,13
ST   D7S820: 9
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi127-A
AC   CVCL_E3UY
SY   [STGD4]-FiPSC1-Ep5F-8
DR   hPSCreg; ESi127-A
RX   PubMed=38956727;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/ANEXO_Deposito_Lineas_%5BSTGD4%5D-FiPSC1-Ep5F-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Lineas_%5BSTGD4%5D-FiPSC1-Ep5F-8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9454; PROM1; Simple; p.Tyr452Leufs*13 (c.1354dupT); ClinVar=VCV000372711; Zygosity=Homozygous (PubMed=38956727).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 13,14
ST   D21S11: 28,31.2
ST   D5S818: 9,12
ST   D7S820: 11,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi128-A
AC   CVCL_E3UZ
SY   PPMS PBiPS10-Sv4F-1
DR   BioSamples; SAMEA115285185
DR   hPSCreg; ESi128-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento_Deposito_PPMS+PBiPS10-Sv4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_PPMS+PBiPS10-Sv4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 29,33.2
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 9,10
ST   vWA: 19,22
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi129-A
AC   CVCL_E3V0
SY   RRMS PBiPS13-Sv4F-1
DR   BioSamples; SAMEA115288902
DR   hPSCreg; ESi129-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento_Deposito_RRMS+PBiPS13-Sv4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_RRMS+PBiPS13-Sv4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 12,16
ST   D21S11: 29,31.2
ST   D2S1338: 21,25
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi130-A
AC   CVCL_E3V1
SY   RRMS PBiPS14-Sv4F-7
DR   BioSamples; SAMEA115292728
DR   hPSCreg; ESi130-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento_Deposito_RRMS+PBiPS14-Sv4F-7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_RRMS+PBiPS14-Sv4F-7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,14
ST   D16S539: 13
ST   D21S11: 24.2,31
ST   D5S818: 9,13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 15,20
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi132-A
AC   CVCL_E3V2
SY   PRPF3181-MiPS4F5
DR   BioSamples; SAMEA115425275
DR   hPSCreg; ESi132-A
RX   PubMed=39755010;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/anexos+deposito+l%C3%ADnea+PRPF31-MiPS4F5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_+PRPF3181-MiPS4F5+01.10.24+sg.pdf
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Trp55Ter (c.165G>A); ClinVar=VCV000804153; Zygosity=Heterozygous (PubMed=39755010).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 12,15.2
ST   D21S11: 30,31
ST   D2S1338: 17
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi133-A
AC   CVCL_E3V3
SY   CT PBiPS2-Sv4F-1
DR   BioSamples; SAMEA115675286
DR   hPSCreg; ESi133-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_CT%2520PBiPS2-Sv4F-1-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+Anexo_dep%C3%B3sito_CT+PBiPS2-Sv4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11
ST   D21S11: 30.2,33.2
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C35569; Chemically induced cardiotoxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESi134-A
AC   CVCL_E3V4
SY   SYS FiPS63-mR6F-1
DR   hPSCreg; ESi134-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS63+ANEXO.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS63_signedSBSB_signed.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Departament de Genetica de la Facultat de Biologia de la Universidad de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:6814; MAGEL2; Simple; p.Gln638Ter (c.1912C>T); ClinVar=VCV000208684; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215157; Schaaf-Yang syndrome
DI   ORDO; Orphanet_398069; Schaaf-Yang syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ESI136-A
AC   CVCL_E7T9
SY   NDD PBiPS1-Sv4F-1
DR   BioSamples; SAMEA116329554
DR   hPSCreg; ESi136-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_NDD+PBiPS1-Sv4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_dep%C3%B3sito_NDD+PBiPS1-Sv4F-1.pdf/
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D18S51: 13,19
ST   D19S433: 13,15
ST   D21S11: 31.2,33.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 8,11
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 23,26
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C215153; Developmental and epileptic encephalopathy 43
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESI137-A
AC   CVCL_E7TA
SY   SSP PBiPS P1-Sv4F-2
DR   BioSamples; SAMEA117691747
DR   hPSCreg; ESi137-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/240614+Documento_Deposito_SSP+PBiPS+P1-Sv4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_SSP+PBiPS+P1-Sv4F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 16,18
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7TB ! ESI137-B
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESI137-B
AC   CVCL_E7TB
SY   SSP PBiPS P1-Sv4F-7
DR   BioSamples; SAMEA117691749
DR   hPSCreg; ESi137-B
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/240513+Documento_Deposito_SSP+PBiPS+P1-Sv4F-7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_SSP+PBiPS+P1-Sv4F-7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 16,18
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7TA ! ESI137-A
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESI138-A
AC   CVCL_E7TC
SY   ATTR CM PBiPS3-Sv4F-14
DR   BioSamples; SAMEA117491926
DR   hPSCreg; ESi138-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_ATTR+CM+PBiPS3-Sv4F-14.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Documento_Deposito_ATTR+CM+PBiPS3-Sv4F-14.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D19S433: 14,18
ST   D21S11: 28,30
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 25
ST   TH01: 7,10
ST   TPOX: 9,10
ST   vWA: 15,16
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESI139-A
AC   CVCL_E7TD
SY   ATTR CM PBiPS4-Sv4F-13
DR   BioSamples; SAMEA117624545
DR   hPSCreg; ESi139-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_ATTR+CM+PBiPS4-Sv4F-13.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Documento_Deposito_ATTR+CM+PBiPS4-Sv4F-13.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 13,14
ST   D21S11: 28.2,30
ST   D2S1338: 17
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESI140-A
AC   CVCL_E7SM
SY   CT PBiPS3-Sv4F-3
DR   BioSamples; SAMEA117691746
DR   hPSCreg; ESi140-A
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+CT+PBiPS3-Sv4F-3+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/CT%2520PBiPS3-Sv4F-3%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C35569; Chemically induced cardiotoxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ESIBIe002-A-1
AC   CVCL_QX78
SY   HES2-KLF15-KO
DR   BioSamples; SAMEA104236770
DR   hPSCreg; ESIBIe002-A-1
DR   Wikidata; Q54832825
RX   PubMed=28925362;
CC   Knockout cell: Method=CRISPR/Cas9n; HGNC; HGNC:14536; KLF15.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D093 ! HES-2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   ESIBIe003-A-10
AC   CVCL_C0CN
SY   HES3 INS-GFP GCG-mCh; INSGFP/wGCGmCh/w hESC; MCRIe004-A-10
DR   BioSamples; SAMEA9462434
DR   hPSCreg; ESIBIe003-A-10
DR   Wikidata; Q112929540
RX   PubMed=34619644;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Characteristics: Reporter cell line that expresses GFP and mCherry fluorescent proteins under the control of the endogenous insulin (INS) and glucagon (GCG) loci respectively. Using homologous recombination an EGFP reporter gene was introduced in one allele of the INS locus. Using TALEN a mCherry reporter was introduced at the N-terminus in one allele of the GCG locus (PubMed=34619644).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA15 ! HES-3 INSGFP/w
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   ESIBIe003-A-11
AC   CVCL_C0GQ
SY   KIT+/- ES cell; KIT+/- ESC; UKAe004-A-11
DR   BioSamples; SAMEA10774665
DR   hPSCreg; ESIBIe003-A-11
DR   Wikidata; Q112929541
RX   PubMed=35279545;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   ESIBIe003-A-12
AC   CVCL_C0GR
SY   KIT-/- ES cell; KIT-/- ESC; UKAe004-A-12
DR   BioSamples; SAMEA10775080
DR   hPSCreg; ESIBIe003-A-12
DR   Wikidata; Q112929542
RX   PubMed=35279545;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ESIBIe003-A-5
AC   CVCL_WR46
SY   HES3NKX2.1_CFTRTomatoK38; MHHe004-A-5
DR   hPSCreg; ESIBIe003-A-5
DR   Wikidata; Q93545447
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   ESIBIe003-A-6
AC   CVCL_A5HA
SY   ULBe007-A-6
DR   BioSamples; SAMEA6724118
DR   hPSCreg; ESIBIe003-A-6
DR   Wikidata; Q107114911
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Characteristics: Transduced with a lentiviral cassette containing an NKX2.1-IRES-PAX8 construct under the control of a promoter inducible by doxycycline via a tetracycline response element.
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the INS locus.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11825; NKX2-1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8622; PAX8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5HB ! HES-3 NKX2.1GFP/w
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   ESIBIe003-A-7
AC   CVCL_C3LB
SY   HES-3_44; IRF8-/- ES cell; UKAe004-A-7
DR   BioSamples; SAMEA8325230
DR   hPSCreg; ESIBIe003-A-7
DR   Wikidata; Q114311383
RX   PubMed=28090699;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   ESK-4
AC   CVCL_3685
SY   ESK4; Embryonic Swine Kidney-4
DR   CLO; CLO_0002953
DR   CLDB; cl1174
DR   CLDB; cl1175
DR   ATCC; CL-184
DR   BCRC; 60202
DR   ECACC; 93120821
DR   IZSLER; BS CL 42
DR   Wikidata; Q54832826
RX   Patent=US4070453;
RX   PubMed=7989438;
RX   PubMed=19508353;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-184.
CC   Virology: Susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   11-12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   ESKOL
AC   CVCL_B398
SY   Eskol
DR   Cosmic; 1809510
DR   Cosmic; 2690007
DR   GEO; GSM1374476
DR   Wikidata; Q54832831
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1895754;
RX   PubMed=11060441;
RX   PubMed=11755467;
RX   PubMed=22653958;
CC   Problematic cell line: Possibly misclassified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   ESM
AC   CVCL_F1G6
SY   Etroplus Suratensis Muscle
RX   PubMed=40957357;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 28 Celsius. Little/no growth at 21 Celsius; reduced growth at 26 and 32 Celsius (PubMed=40957357).
CC   Doubling time: 29 hours (Note=At 8th passage) (PubMed=40957357).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=238232; ! Etroplus suratensis (Green chromide)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ESO-26
AC   CVCL_2035
SY   ESO26
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 889
DR   BioSample; SAMN03473393
DR   cancercelllines; CVCL_2035
DR   Cell_Model_Passport; SIDM00539
DR   Cosmic; 1599336
DR   Cosmic-CLP; 1503366
DR   DepMap; ACH-001496
DR   DSMZ; ACC-708
DR   DSMZCellDive; ACC-708
DR   ECACC; 11012009
DR   EGA; EGAS00001000978
DR   GDSC; 1503366
DR   GEO; GSM1669776
DR   PharmacoDB; ESO26_345_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54832832
RX   PubMed=20075370;
RX   PubMed=23795680;
RX   PubMed=27594985;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~35-50 hours (DSMZ=ACC-708).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=20075370).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=3.22%; Native American=0%; East Asian, North=0%; East Asian, South=2.45%; South Asian=0.14%; European, North=50.67%; European, South=43.52% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus, distal; UBERON=UBERON_0013473.
ST   Source(s): Cosmic-CLP=1503366; DepMap=ACH-001496; DSMZ=ACC-708; ECACC=11012009; PubMed=20075370
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 10
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 7,9
ST   vWA: 14,18
DI   NCIt; C9296; Gastroesophageal junction adenocarcinoma
DI   ORDO; Orphanet_70482; Carcinoma of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   ESO-51
AC   CVCL_2036
SY   ESO51
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 890
DR   BioSample; SAMN03473444
DR   cancercelllines; CVCL_2036
DR   Cell_Model_Passport; SIDM00538
DR   Cosmic; 1599338
DR   Cosmic-CLP; 1503367
DR   DepMap; ACH-001497
DR   DSMZ; ACC-694
DR   DSMZCellDive; ACC-694
DR   ECACC; 11012010
DR   EGA; EGAS00001000978
DR   GDSC; 1503367
DR   GEO; GSM1669777
DR   PharmacoDB; ESO51_346_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54832833
RX   PubMed=20075370;
RX   PubMed=23795680;
RX   PubMed=27397505;
RX   PubMed=27594985;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=20075370).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=3.22%; Native American=0.59%; East Asian, North=0%; East Asian, South=1.07%; South Asian=1.19%; European, North=50.02%; European, South=43.9% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus, distal; UBERON=UBERON_0013473.
ST   Source(s): Cosmic-CLP=1503367; DepMap=ACH-001497; DSMZ=ACC-694; ECACC=11012010; PubMed=20075370
ST   Amelogenin: X (DSMZ=ACC-694; ECACC=11012010; PubMed=20075370)
ST   Amelogenin: X,Y (Cosmic-CLP=1503367)
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 17,20
ST   D19S433: 12
ST   D21S11: 30,33.2 (DepMap=ACH-001497; PubMed=20075370)
ST   D21S11: 33.2 (DSMZ=ACC-694)
ST   D2S1338: 25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8 (Cosmic-CLP=1503367; DepMap=ACH-001497; DSMZ=ACC-694; PubMed=20075370)
ST   D7S820: 8.2 (ECACC=11012010)
ST   D8S1179: 10 (DSMZ=ACC-694)
ST   D8S1179: 10,11,12 (DepMap=ACH-001497; PubMed=20075370)
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 17
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   ESP
AC   CVCL_A2ZZ
DR   CCLV; CCLV-RIE 0201
DR   Wikidata; Q105506855
RX   PubMed=19941903;
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal brain, choroid plexus; UBERON=UBERON_0006238+UBERON_0001886.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   ESP-1
AC   CVCL_8351
SY   ESP1
DR   BioSample; SAMN03151692
DR   Wikidata; Q54832834
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00043.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   ESS-1
AC   CVCL_1205
SY   ESS1; Endometrial Stromal Sarcoma-1
DR   CLO; CLO_0002954
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 678
DR   BioSample; SAMN03473556
DR   BioSample; SAMN10988289
DR   cancercelllines; CVCL_1205
DR   Cell_Model_Passport; SIDM01043
DR   ChEMBL-Cells; CHEMBL3308384
DR   ChEMBL-Targets; CHEMBL1075444
DR   Cosmic; 907000
DR   Cosmic; 1105622
DR   Cosmic; 1576456
DR   Cosmic-CLP; 907000
DR   DepMap; ACH-000913
DR   DSMZ; ACC-461
DR   DSMZCellDive; ACC-461
DR   EGA; EGAS00001000978
DR   GDSC; 907000
DR   GEO; GSM887009
DR   GEO; GSM888078
DR   GEO; GSM1669778
DR   IARC_TP53; 21328
DR   LiGeA; CCLE_688
DR   LINCS_LDP; LCL-1507
DR   Lonza; 1422
DR   PharmacoDB; ESS1_347_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1205
DR   PubChem_Cell_line; CVCL_1205
DR   Wikidata; Q54832835
RX   PubMed=9663606;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 63 hours (PubMed=9663606); ~120 hours (DSMZ=ACC-461).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (Cosmic-CLP=907000; DepMap=ACH-000913).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Glu694Ter (c.2080G>T); Zygosity=Heterozygous (Cosmic-CLP=907000; DepMap=ACH-000913).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=907000; DepMap=ACH-000913).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg142Trp (c.424C>T); ClinVar=VCV000197662; Zygosity=Heterozygous (Cosmic-CLP=907000; DepMap=ACH-000913).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=907000; DepMap=ACH-000913).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=1.73%; East Asian, South=0%; South Asian=0.47%; European, North=65.49%; European, South=31.95% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
ST   Source(s): Cosmic-CLP=907000; DSMZ=ACC-461
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 20,25
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   D8S1179: 13,16
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 10,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8973; Endometrioid stromal sarcoma
DI   ORDO; Orphanet_213711; Endometrial stromal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   ESSA1
AC   CVCL_6E07
SY   Embryonic Stem-like cell Sparus Aurata 1
DR   Wikidata; Q54832836
RX   PubMed=22903186;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   ESSA2
AC   CVCL_6E08
SY   Embryonic Stem-like cell Sparus Aurata 2
DR   Wikidata; Q54832837
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   Esther
AC   CVCL_X932
SY   NK-8; NK 8; NK8; NK8b
DR   Wikidata; Q54832838
RX   PubMed=4174339;
RX   PubMed=4178827;
RX   PubMed=4320167;
RX   PubMed=4878906;
RX   PubMed=5786183;
RX   PubMed=11515428;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 10
//
ID   ETC
AC   CVCL_F272
DR   BCRJ; 0081
DR   Wikidata; Q54832839
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   ETCC
AC   CVCL_ZZ38
SY   Equine Transitional Cell Carcinoma
DR   Wikidata; Q102113798
RX   PubMed=558280;
RX   PubMed=4421147;
RX   PubMed=23594411;
CC   Virology: Susceptible to infection by equine herpesvirus type 3 (EHV-3) (PubMed=558280).
CC   Doubling time: 16 hours (PubMed=4421147).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
DI   NCIt; C173624; Horse transitional cell carcinoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   ETCC001
AC   CVCL_6G18
SY   ETCC-001
DR   Wikidata; Q54832840
RX   PubMed=25264427;
CC   Population: Chinese; Singaporian.
CC   Doubling time: 18.4 hours (PubMed=25264427).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=25264427
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   ETCC006
AC   CVCL_6G19
SY   ETCC-006
DR   DSMZ; ACC-790
DR   DSMZCellDive; ACC-790
DR   Wikidata; Q54832841
RX   PubMed=25264427;
RX   PubMed=34238275;
CC   Population: Chinese; Singaporian.
CC   Doubling time: 19.2 hours (PubMed=25264427); 30.7 hours (PubMed=34238275); ~2-4 days (DSMZ=ACC-790).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DSMZ=ACC-790
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,21
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G18 ! ETCC001
SX   Female
AG   47Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   ETCC007
AC   CVCL_6G20
SY   ETCC-007
DR   DSMZ; ACC-791
DR   DSMZCellDive; ACC-791
DR   Wikidata; Q54832842
RX   PubMed=25264427;
CC   Population: Chinese; Singaporian.
CC   Doubling time: 21.7 hours (PubMed=25264427); ~40 hours (DSMZ=ACC-791).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DSMZ=ACC-791
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,21
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G18 ! ETCC001
SX   Female
AG   47Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   ETCC008
AC   CVCL_6G21
SY   ETCC 008
DR   DSMZ; ACC-792
DR   DSMZCellDive; ACC-792
DR   Wikidata; Q54832843
RX   PubMed=25264427;
CC   Population: Chinese; Singaporian.
CC   Doubling time: 9.4 hours (PubMed=25264427); ~24 hours (DSMZ=ACC-792).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DSMZ=ACC-792
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,21
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G18 ! ETCC001
SX   Female
AG   47Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   ETCC010
AC   CVCL_6G22
SY   ETCC-010
DR   DSMZ; ACC-793
DR   DSMZCellDive; ACC-793
DR   Wikidata; Q54832844
RX   PubMed=25264427;
RX   PubMed=34238275;
CC   Population: Chinese; Singaporian.
CC   Doubling time: 19.8 hours (PubMed=25264427); 29.7 hours (PubMed=34238275); ~30 hours (DSMZ=ACC-793).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DSMZ=ACC-793
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,21
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G18 ! ETCC001
SX   Female
AG   47Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   ETCC011
AC   CVCL_6G23
SY   ETCC-011
DR   DSMZ; ACC-797
DR   DSMZCellDive; ACC-797
DR   Wikidata; Q54832845
RX   PubMed=25264427;
CC   Population: Chinese; Singaporian.
CC   Doubling time: 12.8 hours (PubMed=25264427); ~2-4 days (DSMZ=ACC-797).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DSMZ=ACC-797
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,21
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G18 ! ETCC001
SX   Female
AG   47Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   ETCC016
AC   CVCL_Y086
SY   ETCC-016
DR   DepMap; ACH-002650
DR   DSMZ; ACC-798
DR   DSMZCellDive; ACC-798
DR   Wikidata; Q54832846
RX   PubMed=25126481;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Chinese; Singaporian.
CC   Characteristics: Has 4 copies of EGFR (PubMed=25126481).
CC   Doubling time: 24 hours (PubMed=25126481); ~50 hours (DSMZ=ACC-798).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 16
ST   D21S11: 31.2
ST   D2S1338: 20,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   FGA: 19,24
ST   Penta D: 9
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   ETH-1-R
AC   CVCL_XH25
DR   CCLV; CCLV-RIE 0025
DR   Wikidata; Q93545651
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   ETH-2-R
AC   CVCL_XH26
DR   CCLV; CCLV-RIE 0026
DR   Wikidata; Q93545655
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   ETH-R
AC   CVCL_XH24
DR   CCLV; CCLV-RIE 0024
DR   Wikidata; Q93545659
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   ETK-1
AC   CVCL_1206
SY   ETK1
DR   CLO; CLO_0009831
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03151925
DR   cancercelllines; CVCL_1206
DR   Cell_Model_Passport; SIDM00276
DR   ChEMBL-Cells; CHEMBL3308831
DR   ChEMBL-Targets; CHEMBL2366116
DR   Cosmic; 906861
DR   Cosmic-CLP; 906861
DR   DepMap; ACH-002237
DR   EGA; EGAS00001000978
DR   GDSC; 906861
DR   GEO; GSM1669779
DR   IARC_TP53; 21329
DR   LINCS_LDP; LCL-1789
DR   PharmacoDB; ETK1_348_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1206
DR   RCB; RCB1289
DR   Wikidata; Q54832847
RX   CelloPub=CLPUB00275;
RX   PubMed=9252136;
RX   PubMed=10761710;
RX   PubMed=16643607;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35640676;
RX   PubMed=35839778;
RX   PubMed=39026794;
WW   Info; RCB; -; https://cell.brc.riken.jp/en/rcb/rbessp-25_announce
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (Cosmic-CLP=906861; DepMap=ACH-002237).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.1%; Native American=0%; East Asian, North=74.88%; East Asian, South=17.31%; South Asian=0%; European, North=0.67%; European, South=4.05% (PubMed=30894373).
CC   Caution: Was incorrectly reported to be a SSP-25 contaminated cell line by Riken and thus also by ICLAC but it was later found out that SSP-25 was in fact contaminated by ETK-1 and not the other way around.
CC   Discontinued: RCB; RCB1289; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=906861
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   eTKA4
AC   CVCL_RH47
SY   TiPS_eTKA4
DR   GEO; GSM2038547
DR   SKIP; SKIP000839
DR   Wikidata; Q54832848
RX   PubMed=26905201;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   eTKA5
AC   CVCL_RH48
SY   TiPS_eTKA5
DR   GEO; GSM2038548
DR   SKIP; SKIP000840
DR   Wikidata; Q54832849
RX   PubMed=26905201;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   ETN-1
AC   CVCL_7954
SY   ETN1
DR   Cosmic; 1576455
DR   Wikidata; Q54832850
RX   PubMed=2732002;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 72 hours (PubMed=2732002).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   EtOH-1
AC   CVCL_RL20
DR   SKIP; SKIP000850
DR   Wikidata; Q54832851
RX   PubMed=27160314;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   EtOH-2
AC   CVCL_RL21
DR   SKIP; SKIP000851
DR   Wikidata; Q54832852
RX   PubMed=27160314;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   EtOH-3
AC   CVCL_RL22
DR   SKIP; SKIP000852
DR   Wikidata; Q54832853
RX   PubMed=27160314;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   ETU
AC   CVCL_B7M2
DR   Wikidata; Q112929543
RX   PubMed=10663561;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu1051_Asp1078del (c.3153_3236del84); Zygosity=Heterozygous (PubMed=10663561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Etv2-Venus-KI
AC   CVCL_1Q68
DR   RCB; AES0176
DR   SKIP; SKIP002925
DR   Wikidata; Q54832854
RX   PubMed=21911838;
CC   Characteristics: Using homologous recombination, a Venus construct was inserted in one allele of the Etv2 locus (PubMed=21911838).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 9
//
ID   Etv2-Venus-KO
AC   CVCL_1Q69
DR   RCB; AES0177
DR   SKIP; SKIP002926
DR   Wikidata; Q54832855
RX   PubMed=21911838;
CC   Characteristics: Using homologous recombination, a Venus construct was inserted in one allele of the Etv2 locus (PubMed=21911838).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99253; Etv2 (Note=1 of 2 alleles, the 2nd alleles being disrupted by the Venus construct).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1Q68 ! Etv2-Venus-KI
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 8
//
ID   Eu Ken
AC   CVCL_U691
SY   EuKen
DR   ATCC; CRL-1108
DR   Wikidata; Q54832856
CC   Discontinued: ATCC; CRL-1108; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   EU-1
AC   CVCL_8857
SY   855; Line 855; Emory University-1
DR   BioSample; SAMN03151904
DR   cancercelllines; CVCL_8857
DR   Wikidata; Q54832857
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8152261;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; Emory OTT; 12176; https://emoryott.technologypublisher.com/techcase/12176
CC   Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00197.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 8,9,10
ST   D18S51: 10,14
ST   D19S433: 12,13
ST   D21S11: 28,30,31
ST   D2S1338: 20,22
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 9,12,13
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1650 ! Reh
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 32
//
ID   EU-10
AC   CVCL_LI24
SY   Emory University-10
DR   cancercelllines; CVCL_LI24
DR   IARC_TP53; 10047
DR   Wikidata; Q54832858
RX   PubMed=7630190;
RX   PubMed=9823951;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9823951).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   EU-11
AC   CVCL_LI25
SY   Emory University-11
DR   cancercelllines; CVCL_LI25
DR   IARC_TP53; 10048
DR   Wikidata; Q54832859
RX   PubMed=7630190;
RX   PubMed=9823951;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9823951).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   EU-12
AC   CVCL_8858
SY   EU12; Emory University-12
DR   Wikidata; Q54832860
RX   PubMed=7630190;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=12393550;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 12
//
ID   EU-13
AC   CVCL_8859
SY   Emory University-13
DR   cancercelllines; CVCL_8859
DR   IARC_TP53; 10049
DR   Wikidata; Q54832861
RX   PubMed=7630190;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9823951).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   EU-18
AC   CVCL_LI26
SY   Emory University-18
DR   cancercelllines; CVCL_LI26
DR   IARC_TP53; 10050
DR   Wikidata; Q54832862
RX   PubMed=9823951;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=9823951).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   EU-2
AC   CVCL_K034
AS   CVCL_8860
SY   207; Line 207; Emory University-2
DR   cancercelllines; CVCL_K034
DR   Wikidata; Q54832863
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6982733;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Doubling time: ~60-70 hours (PubMed=6982733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=7888679).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   EU-4
AC   CVCL_8862
SY   870; Line 870 Emory University-4
DR   Wikidata; Q54832864
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
WW   Provider; Emory OTT; 12177; https://emoryott.technologypublisher.com/techcase/12177
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   EU-5
AC   CVCL_8863
SY   916; Line 916; Emory University-5
DR   Wikidata; Q54832865
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   EU-6
AC   CVCL_8864
SY   920; Line 920; Emory University-6
DR   cancercelllines; CVCL_8864
DR   IARC_TP53; 3826
DR   Wikidata; Q54832866
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
WW   Provider; Emory OTT; 12178; https://emoryott.technologypublisher.com/techcase/12178
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=7888679).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 9,12
ST   D18S51: 12,13,16
ST   D19S433: 12,14
ST   D21S11: 27,29
ST   D2S1338: 17,24,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   EU-7
AC   CVCL_8865
SY   91-17; Emory University-7
DR   BioSample; SAMN03151619
DR   cancercelllines; CVCL_8865
DR   IARC_TP53; 3827
DR   Wikidata; Q54832867
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00198.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   EU-8
AC   CVCL_8866
SY   91-06; Emory University-8
DR   Wikidata; Q54832869
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=14671638;
CC   Doubling time: 75-85 hours (DOI=10.1016/B978-0-12-221970-2.50457-5).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   EU-9
AC   CVCL_8867
SY   93-10; Emory University-9
DR   Wikidata; Q54832870
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   EU93-2
AC   CVCL_DR53
DR   Wikidata; Q54832871
RX   PubMed=7494598;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_DR54 ! EU93-3
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   EU93-3
AC   CVCL_DR54
DR   Wikidata; Q54832877
RX   PubMed=7494598;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_DR53 ! EU93-2
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   euDS-iPS
AC   CVCL_ZA04
SY   DS-iPS clone 87; C87
DR   GEO; GSM1053973
DR   GEO; GSM1053974
DR   GEO; GSM1053975
DR   Wikidata; Q98125974
RX   PubMed=23225669;
CC   Population: Caucasian.
CC   Karyotypic information: Lost the third copy of chromosome 21 (PubMed=23225669).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2430 ! Detroit 532
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   EUE
AC   CVCL_7262
SY   Epiteliali Umane Embrionali
DR   BTO; BTO_0000430
DR   BioSample; SAMN03151693
DR   Wikidata; Q54832878
RX   DOI=10.1038/196600a0;
RX   PubMed=2654098;
RX   PubMed=6033947;
RX   PubMed=6451928;
RX   PubMed=9691432;
RX   PubMed=13580596;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from the skin and muscle explant of an embryo.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00044.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 26
//
ID   EUE6
AC   CVCL_A5LI
SY   E6D
DR   Wikidata; Q107114914
RX   DOI=10.1038/196600a0;
RX   PubMed=6033947;
CC   Problematic cell line: Contaminated. Parent cell line (EUE) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7262 ! EUE
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   EUFA001
AC   CVCL_G051
SY   92VU001
DR   Wikidata; Q54832879
RX   PubMed=7662964;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA006
AC   CVCL_G052
SY   92VU006
DR   Wikidata; Q54832880
RX   PubMed=7662964;
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.1360_1826del467 (Ex15-20del); Zygosity=Heterozygous (PubMed=10094191).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Phe1263del (c.3788_3790delTCT); ClinVar=VCV000041003; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   EUFA007
AC   CVCL_AK50
SY   EUFA 007
DR   Wikidata; Q54832881
RX   PubMed=9713825;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA043
AC   CVCL_AK51
DR   Wikidata; Q54832882
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.3061_3154del94 (Ex31-32del); Zygosity=Homozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA056
AC   CVCL_G053
SY   92VU056
DR   Wikidata; Q54832883
RX   PubMed=7662964;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA121
AC   CVCL_G040
SY   EUFA121L; GM16757
DR   CLO; CLO_0018433
DR   EFO; EFO_0022589
DR   Coriell; GM16757
DR   Wikidata; Q54832884
RX   PubMed=11001585;
RX   PubMed=12065746;
CC   Sequence variation: Mutation; HGNC; HGNC:3587; FANCF; Simple; p.Gln6Ter (c.16C>T); ClinVar=VCV000006342; Zygosity=Heterozygous (Coriell=GM16757).
CC   Sequence variation: Mutation; HGNC; HGNC:3587; FANCF; Simple; p.Gly120Profs*17 (c.351_397del47) (349_395del); ClinVar=VCV000006341; Zygosity=Heterozygous (Coriell=GM16757).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125707; Fanconi anemia, complementation group F
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   EUFA123
AC   CVCL_G054
SY   93VU123
DR   Wikidata; Q54832885
RX   PubMed=7662964;
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.597-2A>G (IVS6-2A>G); ClinVar=VCV000974288; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   EUFA127
AC   CVCL_AK52
DR   Wikidata; Q54832886
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Gln55Ter (c.163C>T); ClinVar=VCV000550581; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   EUFA130
AC   CVCL_G055
SY   93VU130
DR   Wikidata; Q54832887
RX   PubMed=7662964;
RX   PubMed=9713825;
RX   PubMed=11001585;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125709; Fanconi anemia, complementation group E
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA1333
AC   CVCL_GR84
DR   Wikidata; Q54832888
RX   PubMed=14630800;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129027; Fanconi anemia, complementation group J
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA134
AC   CVCL_G056
SY   93VU134
DR   Wikidata; Q54832889
RX   PubMed=7662964;
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Asp598Asn (c.1792G>A); ClinVar=VCV000974125; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   EUFA1341
AC   CVCL_D7EG
SY   EUFA1341-F SV40
DR   EFO; EFO_0022524
RX   PubMed=17200672;
RX   PubMed=28319063;
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Tyr551Ter (c.1653T>A); ClinVar=VCV000001243; Zygosity=Heterozygous (PubMed=17200672).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Unexplicit; Ex4del; Zygosity=Heterozygous (PubMed=17200672).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176894; Fanconi anemia, complementation group N
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D7EH ! EUFA1341 LCL
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   EUFA1341 LCL
AC   CVCL_D7EH
RX   PubMed=17200672;
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Tyr551Ter (c.1653T>A); ClinVar=VCV000001243; Zygosity=Heterozygous (PubMed=17200672).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Unexplicit; Ex4del; Zygosity=Heterozygous (PubMed=17200672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176894; Fanconi anemia, complementation group N
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D7EG ! EUFA1341
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   EUFA139
AC   CVCL_AK53
DR   Wikidata; Q54832890
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.4010+(1_18)del (IVS40+1-18del); Zygosity=Homozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA143
AC   CVCL_G057
SY   EUFA143B
DR   EFO; EFO_0022588
DR   Wikidata; Q54832891
RX   PubMed=9806548;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Glu105Ter (c.313G>T); ClinVar=VCV000006712; Zygosity=Homozygous (PubMed=9806548).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   EUFA158
AC   CVCL_G058
SY   93VU158
DR   Wikidata; Q54832892
RX   PubMed=7662964;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA166
AC   CVCL_G059
SY   93VU166
DR   Wikidata; Q54832893
RX   PubMed=7662964;
RX   PubMed=10468606;
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Asp23Ilefs*23 (c.67delG) (322delG); ClinVar=VCV000012049; Zygosity=Homozygous (PubMed=10468606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   EUFA186
AC   CVCL_AK54
DR   Wikidata; Q54832894
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser858Arg (c.2574C>G); ClinVar=VCV000134256; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   EUFA202
AC   CVCL_G060
SY   93VU202
DR   Wikidata; Q54832895
RX   PubMed=7662964;
RX   PubMed=10468606;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125706; Fanconi anemia, complementation group D2
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA223
AC   CVCL_AK55
DR   Wikidata; Q54832896
RX   PubMed=12955722;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser947Ter (c.2840C>G); ClinVar=VCV000558253; Zygosity=Homozygous (PubMed=12955722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA232
AC   CVCL_AK56
DR   Wikidata; Q54832897
RX   PubMed=12955722;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser858Arg (c.2574C>G); ClinVar=VCV000134256; Zygosity=Heterozygous (PubMed=12955722).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.3762_3763insAG; Zygosity=Heterozygous (PubMed=12955722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA245
AC   CVCL_AK57
DR   Wikidata; Q54832898
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Asp598Asn (c.1792G>A); ClinVar=VCV000974125; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   EUFA255
AC   CVCL_AK58
DR   Wikidata; Q54832899
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Gln1307Argfs*2 (c.3920delA); ClinVar=VCV000974357; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   EUFA262
AC   CVCL_AK59
DR   Wikidata; Q54832900
RX   PubMed=12955722;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA263
AC   CVCL_AK60
DR   Wikidata; Q54832901
RX   PubMed=12955722;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA268
AC   CVCL_G062
DR   Wikidata; Q54832902
RX   PubMed=10468606;
RX   PubMed=12955722;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Gln772Ter (c.2314C>T); ClinVar=VCV000656626; Zygosity=Homozygous (PubMed=10468606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   EUFA275
AC   CVCL_G061
SY   EUFA 275
DR   Wikidata; Q54832903
RX   PubMed=9713825;
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Glu1254Ter (c.3760G>T); ClinVar=VCV000974261; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   EUFA316
AC   CVCL_G063
SY   EUFA 316C
DR   Wikidata; Q54832904
RX   PubMed=9806548;
RX   PubMed=10468606;
RX   PubMed=11050007;
RX   PubMed=16166284;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Glu105Ter (c.313G>T); ClinVar=VCV000006712; Zygosity=Heterozygous (PubMed=9806548).
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Glu395Trpfs*5 (c.1183_1192delTGAGGTGTTTTinsC) (1184-1194del); ClinVar=VCV000041224; Zygosity=Heterozygous (PubMed=9806548).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3-9Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   EUFA337
AC   CVCL_AK61
DR   Wikidata; Q54832905
RX   PubMed=12955722;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA349
AC   CVCL_G064
DR   Wikidata; Q54832906
RX   PubMed=9806548;
RX   PubMed=10468606;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Glu105Ter (c.313G>T); ClinVar=VCV000006712; Zygosity=Heterozygous (PubMed=9806548).
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.1480+1G>C (IVS11+1G>C); ClinVar=VCV000006717; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=9806548).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-8Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   EUFA353
AC   CVCL_G065
DR   Wikidata; Q54832907
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Arg52Ter (c.154C>T); ClinVar=VCV000371668; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   EUFA388
AC   CVCL_AK62
DR   Wikidata; Q54832908
RX   PubMed=12955722;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA409
AC   CVCL_G066
DR   Wikidata; Q54832909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125709; Fanconi anemia, complementation group E
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA410
AC   CVCL_G067
DR   Wikidata; Q54832910
RX   PubMed=10468606;
RX   PubMed=11001585;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125709; Fanconi anemia, complementation group E
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA418
AC   CVCL_AK63
DR   Wikidata; Q54832913
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Val372Alafs*42 (c.1111_1114TTGG[1]) (c.1115_1118delTTGG); ClinVar=VCV000003440; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA423F
AC   CVCL_AK16
SY   EUFA423
DR   Wikidata; Q54832911
RX   PubMed=12065746;
RX   PubMed=22152194;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asp2489Terfs (c.7464_7465insTA) (7691insAT); Zygosity=Heterozygous (PubMed=12065746).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr3225Ilefs*30 (c.9672dupA) (9900insA); ClinVar=VCV000126217; Zygosity=Heterozygous (PubMed=12065746).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G068 ! EUFA423L
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   EUFA423L
AC   CVCL_G068
SY   EUFA423
DR   Wikidata; Q54832912
RX   PubMed=10468606;
RX   PubMed=12065746;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asp2489Terfs (c.7464_7465insTA) (7691insAT); Zygosity=Heterozygous (PubMed=12065746).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr3225Ilefs*30 (c.9672dupA) (9900insA); ClinVar=VCV000126217; Zygosity=Heterozygous (PubMed=12065746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK16 ! EUFA423F
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   EUFA426
AC   CVCL_G069
DR   Wikidata; Q54832914
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Val135Cysfs*46 (c.401dupC) (c.401insC); ClinVar=VCV000558097; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   EUFA444
AC   CVCL_G070
SY   EUFA 444
DR   Wikidata; Q54832915
RX   PubMed=9713825;
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.827_1225del399 (Ex10-13del); Zygosity=Heterozygous (PubMed=10094191).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Val372Alafs*42 (c.1111_1114TTGG[1]) (c.1115_1118delTTGG); ClinVar=VCV000003440; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   EUFA445
AC   CVCL_AK64
SY   EUFA 445
DR   Wikidata; Q54832916
RX   PubMed=9713825;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA471
AC   CVCL_AK65
SY   EUFA 471
DR   Wikidata; Q54832930
RX   PubMed=9713825;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA483
AC   CVCL_AK66
DR   Wikidata; Q54832931
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Phe1263del (c.3788_3790delTCT); ClinVar=VCV000041003; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA507
AC   CVCL_AK67
DR   Wikidata; Q54832932
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Phe1263del (c.3788_3790delTCT); ClinVar=VCV000041003; Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA528
AC   CVCL_G071
SY   EUFA 528
DR   Wikidata; Q54832933
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Phe1263del (c.3788_3790delTCT); ClinVar=VCV000041003; Zygosity=Heterozygous (PubMed=10094191).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.4267_4404del138 (Ex42del); Zygosity=Heterozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   EUFA543
AC   CVCL_GR85
DR   TOKU-E; 4017
DR   Wikidata; Q54832934
RX   PubMed=14630800;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129027; Fanconi anemia, complementation group J
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA586
AC   CVCL_AK68
DR   Wikidata; Q54832935
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.894_1359del466 (Ex11-14del); Zygosity=Homozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   EUFA592
AC   CVCL_GR86
DR   TOKU-E; 4011
DR   Wikidata; Q54832937
RX   PubMed=14630800;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129026; Fanconi anemia, complementation group I
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA598
AC   CVCL_G072
DR   Wikidata; Q54832938
RX   PubMed=10094191;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.4267_4404del138 (Ex42del); Zygosity=Homozygous (PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   EUFA622
AC   CVCL_G073
DR   Wikidata; Q54832939
RX   PubMed=10468606;
RX   PubMed=11001585;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125709; Fanconi anemia, complementation group E
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA689
AC   CVCL_G074
DR   Wikidata; Q54832940
RX   PubMed=10094191;
RX   PubMed=10468606;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Phe1263del (c.3788_3790delTCT); ClinVar=VCV000041003; Zygosity=Homozygous (PubMed=10468606; PubMed=10094191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   EUFA696
AC   CVCL_GR87
DR   TOKU-E; 4014
DR   Wikidata; Q54832941
RX   PubMed=14630800;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129027; Fanconi anemia, complementation group J
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA704
AC   CVCL_G075
DR   Wikidata; Q54832942
RX   PubMed=10094191;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   EUFA763
AC   CVCL_AK69
DR   Wikidata; Q54832943
RX   PubMed=10094191;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA816
AC   CVCL_GR88
DR   TOKU-E; 4012
DR   Wikidata; Q54832944
RX   PubMed=14630800;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129026; Fanconi anemia, complementation group I
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   EUFA961
AC   CVCL_GR89
DR   TOKU-E; 4013
DR   Wikidata; Q54832945
RX   PubMed=14630800;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129026; Fanconi anemia, complementation group I
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   EuHe
AC   CVCL_WT21
SY   EU-HE
DR   Wikidata; Q93546783
RX   CelloPub=CLPUB00512;
RX   PubMed=29533902;
CC   Doubling time: 16 hours (CelloPub=CLPUB00512).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 6
//
ID   EURACi001-A
AC   CVCL_VE38
SY   B2CAV3
DR   hPSCreg; EURACi001-A
DR   SKIP; SKIP002984
DR   Wikidata; Q54832946
RX   PubMed=29304398;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1529; CAV3; Simple; p.Tyr62_Thr64del (c.184_192del); Zygosity=Heterozygous (PubMed=29304398).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29304398
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 15,21
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 14,20
ST   D19S433: 12,13
ST   D1S1656: 14,17.3
ST   D21S11: 31.2,32.2
ST   D2S1338: 20,23
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D6S1043: 11,18
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   Penta D: 11,12
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C148318; Limb-girdle muscular dystrophy type 1C
DI   ORDO; Orphanet_265; Autosomal dominant limb-girdle muscular dystrophy type 1C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   EURACi002-A
AC   CVCL_VE39
SY   L1CAV3
DR   hPSCreg; EURACi002-A
DR   SKIP; SKIP002985
DR   Wikidata; Q54832947
RX   PubMed=29304398;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1529; CAV3; Simple; p.Trp101Cys (c.303G>C); ClinVar=VCV000265072; Zygosity=Heterozygous (PubMed=29304398).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29304398
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 17,19
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 13,18
ST   D19S433: 12,16.2
ST   D1S1656: 16.3,17
ST   D21S11: 29
ST   D2S1338: 23,25
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D6S1043: 11,12
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 12,13
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C148327; HyperCKmia
DI   ORDO; Orphanet_206599; Isolated asymptomatic elevation of creatine phosphokinase
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   EURACi003-A
AC   CVCL_VE40
SY   N1CAV3
DR   hPSCreg; EURACi003-A
DR   SKIP; SKIP002986
DR   Wikidata; Q54832948
RX   PubMed=29304398;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1529; CAV3; Simple; p.Thr78Lys (c.233C>A); ClinVar=VCV000132978; Zygosity=Heterozygous (PubMed=29304398).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29304398
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D12S391: 20,25
ST   D13S317: 11,14
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13
ST   D1S1656: 15,15.3
ST   D21S11: 29,32.2
ST   D2S1338: 20,24
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 12,18
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23,25
ST   Penta D: 12,13
ST   Penta E: 5,13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C148327; HyperCKmia
DI   NCIt; C148325; Rippling muscle disease 2
DI   ORDO; Orphanet_206599; Isolated asymptomatic elevation of creatine phosphokinase
DI   ORDO; Orphanet_97238; Rippling muscle disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   EURACi004-A
AC   CVCL_VR55
DR   hPSCreg; EURACi004-A
DR   Wikidata; Q93546834
RX   PubMed=30219716;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; c.2569_2577+41del (c.2569_3018del50); ClinVar=VCV000406553; Zygosity=Heterozygous (PubMed=30219716).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   EURACi005-A
AC   CVCL_YC01
SY   iPS-2011; iPSC-2011
DR   BioSamples; SAMEA5922750
DR   hPSCreg; EURACi005-A
DR   Wikidata; Q93546841
RX   PubMed=31715428;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Homozygous (PubMed=31715428).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   EURACi006-A
AC   CVCL_A0LT
SY   M003#9.3; LUMCi047-A
DR   hPSCreg; EURACi006-A
DR   Wikidata; Q108820200
RX   PubMed=34134068;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Gly548Valfs*15 (c.1643delG); ClinVar=VCV000202035; Zygosity=Heterozygous (PubMed=34134068).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   EURACi006-A-1
AC   CVCL_A0LU
SY   iso M003#9.3-C12; LUMCi047-A-1
DR   hPSCreg; EURACi006-A-1
DR   Wikidata; Q108820201
RX   PubMed=34134068;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple_corrected; p.Gly548Valfs*15 (c.1643delG); ClinVar=VCV000202035; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34134068).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0LT ! EURACi006-A
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   EURACi007-A
AC   CVCL_A0LV
SY   PZE#8
DR   hPSCreg; EURACi007-A
DR   Wikidata; Q108820202
RX   PubMed=34298432;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Asn346Leufs*12 (c.1035-5203_1171-13298del); Zygosity=Heterozygous (PubMed=34298432).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   EURACi008-A
AC   CVCL_A0LW
SY   PZG#4
DR   hPSCreg; EURACi008-A
DR   Wikidata; Q108820203
RX   PubMed=34298432;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Characteristics: While harboring the same PKP2 mutation as a family member from which EURACi007-A (Cellosaurus=CVCL_A0LV) was derived, the donor of this cell line did not show any symptom of arrhythmogenic right ventricular dysplasia.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Asn346Leufs*12 (c.1035-5203_1171-13298del); Zygosity=Heterozygous (PubMed=34298432).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   EURACi009-A
AC   CVCL_A0LX
SY   PZB#4
DR   hPSCreg; EURACi009-A
DR   Wikidata; Q108820204
RX   PubMed=34298432;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   EURACi010-A
AC   CVCL_C0FB
SY   iPS BD#5
DR   hPSCreg; EURACi010-A
DR   Wikidata; Q112929544
RX   PubMed=35121197;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex7del; Zygosity=Heterozygous (PubMed=35121197).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   EURACi011-A
AC   CVCL_C0FC
SY   iPS BC#6
DR   hPSCreg; EURACi011-A
DR   Wikidata; Q112929545
RX   PubMed=35121197;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   EURACi012-A
AC   CVCL_C0FD
SY   iPS AD#4
DR   hPSCreg; EURACi012-A
DR   Wikidata; Q112929546
RX   PubMed=35121197;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex7del; Zygosity=Heterozygous (PubMed=35121197).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   EURACi013-A
AC   CVCL_C0FE
SY   iPS DI#5
DR   hPSCreg; EURACi013-A
DR   Wikidata; Q112929547
RX   PubMed=35121197;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   EURACi014-A
AC   CVCL_C0FA
SY   iPS 1.1; iPS-1.1
DR   hPSCreg; EURACi014-A
DR   Wikidata; Q112929548
RX   PubMed=35189566;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=35189566).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   EURACi015-A
AC   CVCL_C9IA
SY   LMNA #9
DR   hPSCreg; EURACi015-A
DR   Wikidata; Q123031255
RX   PubMed=37535990;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Glu161Lys (c.481G>A); ClinVar=VCV000014504; Zygosity=Heterozygous (PubMed=37535990).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   EV-SCC-1
AC   CVCL_RK00
SY   EVSCC 1; EVSCC1; Eastern Virginia-Squamous Cell Carcinoma-1
DR   cancercelllines; CVCL_RK00
DR   Wikidata; Q54832949
RX   PubMed=1394225;
RX   PubMed=8552396;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (PubMed=1394225).
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   EV-SCC-10M
AC   CVCL_RK05
SY   EVSCC 10M; EVSCC10M; Eastern Virginia-Squamous Cell Carcinoma-10M
DR   Wikidata; Q54832950
RX   PubMed=8552396;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   EV-SCC-14M
AC   CVCL_RK06
SY   EVSCC 14M; EVSCC14M; Eastern Virginia-Squamous Cell Carcinoma-14M
DR   Wikidata; Q54832951
RX   PubMed=8552396;
RX   PubMed=9815580;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   EV-SCC-17M
AC   CVCL_RK07
SY   EVSCC17M; Eastern Virginia-Squamous Cell Carcinoma-17M
DR   Wikidata; Q54832952
RX   PubMed=9815580;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK08 ! EV-SCC-17P
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   EV-SCC-17P
AC   CVCL_RK08
SY   EVSCC 17; EVSCC17P; Eastern Virginia-Squamous Cell Carcinoma-17P
DR   Wikidata; Q54832953
RX   PubMed=8552396;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK07 ! EV-SCC-17M
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   EV-SCC-18
AC   CVCL_RK09
SY   EVSCC 18; EVSCC18; Eastern Virginia-Squamous Cell Carcinoma-18
DR   Wikidata; Q54832954
RX   PubMed=8552396;
RX   PubMed=9815580;
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   EV-SCC-19M
AC   CVCL_RK10
SY   EVSCC 19M; EVSCC19M; Eastern Virginia-Squamous Cell Carcinoma-19M
DR   Wikidata; Q54832956
RX   PubMed=8552396;
RX   PubMed=9815580;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK11 ! EV-SCC-19P
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   EV-SCC-19P
AC   CVCL_RK11
SY   EVSCC 19; EVSCC19P; Eastern Virginia-Squamous Cell Carcinoma-19P
DR   Wikidata; Q54832957
RX   PubMed=8552396;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK10 ! EV-SCC-19M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   EV-SCC-2
AC   CVCL_RK01
SY   EVSCC 2; EVSCC2; Eastern Virginia-Squamous Cell Carcinoma-2
DR   Wikidata; Q54832958
RX   PubMed=8552396;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   EV-SCC-3
AC   CVCL_RK02
SY   EVSCC3; Eastern Virginia-Squamous Cell Carcinoma-3
DR   Wikidata; Q54832960
RX   PubMed=1394225;
RX   PubMed=17312569;
CC   Characteristics: Established from a nude mouse xenograft.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   EV-SCC-4
AC   CVCL_RK03
SY   EVSCC4; Eastern Virginia-Squamous Cell Carcinoma-4
DR   Wikidata; Q54832961
RX   PubMed=1394225;
RX   PubMed=17312569;
CC   Characteristics: Established from a nude mouse xenograft.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   EV-SCC-7
AC   CVCL_RK04
SY   EVSCC 7; EVSCC7; Eastern Virginia-Squamous Cell Carcinoma-7
DR   Wikidata; Q54832962
RX   PubMed=8552396;
RX   PubMed=17312569;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   Ev248
AC   CVCL_DD91
SY   EV248; EV-248
DR   ATCC; HB-8565
DR   Wikidata; Q54832963
RX   Patent=US4695538;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8565.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   EV7_VP1_11G12_IgA
AC   CVCL_XD49
DR   CCRID; 4201PAT-CCTCC00932
DR   Wikidata; Q93546979
RX   Patent=CN106119209A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016132.
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; Q66479; Human enterovirus 71 (EV71) genome polyprotein (Note=AA 568-862 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   EV7_VP1_20K2_IgG
AC   CVCL_XD50
SY   20K2-IgG; 20K2
DR   CCRID; 4201PAT-CCTCC00933
DR   Wikidata; Q93546981
RX   Patent=CN106119209A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016133.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q66479; Human enterovirus 71 (EV71) genome polyprotein (Note=AA 568-862 = Capsid protein VP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   EVA,LW
AC   CVCL_E585
SY   EVA, LW
DR   dbMHC; 48780
DR   IHW; IHW09119
DR   IPD-IMGT/HLA; 11664
DR   Wikidata; Q54832964
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*11:01,29:02; B*18:01,44:03; C*07:01,16:01; DPB1*04:01,11:01:01; DQA1*05:01,02:01; DQB1*02:01,03:01; DRB1*07,11:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11664).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   EVA,SP
AC   CVCL_E586
SY   EVA, SP
DR   dbMHC; 48781
DR   ECACC; 94082234
DR   IHW; IHW09135
DR   IPD-IMGT/HLA; 11678
DR   Wikidata; Q54832965
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,19; B*18; C*05; DPB1*02:02,04:01; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*02:02 (IPD-IMGT/HLA=11678).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082234; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   Eveline
AC   CVCL_A1LI
SY   Friend-Eveline-Layer-Stamm; FLV-Eveline suspension cell
DR   Wikidata; Q102113800
RX   PubMed=54978;
RX   PubMed=64623;
RX   PubMed=130004;
RX   PubMed=4127971;
RX   PubMed=4371954;
CC   Virology: Produces high yields of Friend murine leukemia virus (FrMLV), up to 6.1 mg of virus protein per liter of cell supernatant (PubMed=4371954).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Anecdotal: Cell line name corresponds to the first name of the person who established it, Eveline Seifert.
CC   Breed/subspecies: STU.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   EVLB3
AC   CVCL_W816
SY   Endothelial Venous Line clone B3
DR   Wikidata; Q54832966
RX   PubMed=10691096;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 10
//
ID   EVLC2
AC   CVCL_8687
SY   Endothelial Venous Line clone C2
DR   BioSample; SAMN03151993
DR   Wikidata; Q54832968
RX   PubMed=10691096;
RX   PubMed=11407081;
RX   PubMed=12453433;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00199.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   EVLK1
AC   CVCL_W817
SY   Endothelial Venous Line clone K1
DR   Wikidata; Q54832969
RX   PubMed=10691096;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 10
//
ID   EVLK2
AC   CVCL_W818
SY   Endothelial Venous Line clone K2
DR   Wikidata; Q54832970
RX   PubMed=10691096;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 10
//
ID   EVMSe001-A
AC   CVCL_C079
SY   ES-76
DR   hPSCreg; EVMSe001-A
DR   SKIP; SKIP002051
DR   Wikidata; Q54832971
RX   PubMed=11438331;
CC   From: Eastern Virginia Medical School; Norfolk; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   EVMSe002-A
AC   CVCL_C080
SY   ES-78-1
DR   hPSCreg; EVMSe002-A
DR   SKIP; SKIP002052
DR   Wikidata; Q54832972
RX   PubMed=11438331;
CC   From: Eastern Virginia Medical School; Norfolk; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   EVMSe003-A
AC   CVCL_C081
SY   ES-78-2
DR   hPSCreg; EVMSe003-A
DR   SKIP; SKIP002053
DR   Wikidata; Q54832973
RX   PubMed=11438331;
CC   From: Eastern Virginia Medical School; Norfolk; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   Evsa-E
AC   CVCL_5G37
SY   Evsa E; EVSa-E
DR   Wikidata; Q54832984
RX   PubMed=212193;
RX   PubMed=1000504;
RX   PubMed=1000506;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1207 ! Evsa-T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Evsa-T
AC   CVCL_1207
SY   EVSA-T; EVSa-T; EVSA/T; Evsa T; EVSAT; EvsaT
DR   CLO; CLO_0002955
DR   EFO; EFO_0006574
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 885
DR   BioSample; SAMN03472910
DR   BioSample; SAMN03473598
DR   BioSample; SAMN10988228
DR   cancercelllines; CVCL_1207
DR   Cell_Model_Passport; SIDM01042
DR   ChEMBL-Cells; CHEMBL3307361
DR   ChEMBL-Targets; CHEMBL614295
DR   Cosmic; 906862
DR   Cosmic; 944298
DR   Cosmic; 997931
DR   Cosmic; 1046926
DR   Cosmic; 1287906
DR   Cosmic; 1289388
DR   Cosmic; 2165020
DR   Cosmic; 2750518
DR   Cosmic; 2787554
DR   Cosmic-CLP; 906862
DR   DepMap; ACH-001065
DR   DSMZ; ACC-433
DR   DSMZCellDive; ACC-433
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906862
DR   GEO; GSM274650
DR   GEO; GSM344366
DR   GEO; GSM344416
DR   GEO; GSM421866
DR   GEO; GSM783964
DR   GEO; GSM843500
DR   GEO; GSM843501
DR   GEO; GSM847317
DR   GEO; GSM847471
DR   GEO; GSM1172953
DR   GEO; GSM1374477
DR   GEO; GSM1661978
DR   GEO; GSM1669780
DR   IARC_TP53; 24357
DR   LINCS_LDP; LCL-1313
DR   PharmacoDB; EVSAT_349_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1207
DR   PubChem_Cell_line; CVCL_1207
DR   TOKU-E; 4049
DR   Wikidata; Q54832986
RX   PubMed=212193;
RX   PubMed=1000504;
RX   PubMed=1000505;
RX   PubMed=3702420;
RX   PubMed=9488600;
RX   PubMed=9570382;
RX   PubMed=16142302;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19593635;
RX   PubMed=20164919;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26759240;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 25 hours (PubMed=9488600); ~50 hours (DSMZ=ACC-433).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; c.687+1_687+2delGT; ClinVar=VCV000483268; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.951_954delACTT) (p.VL317fs) (V317fs*3); Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Homozygous (PubMed=16541312; Cosmic-CLP=906862).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.86%; Native American=1.1%; East Asian, North=2.9%; East Asian, South=0%; South Asian=8.5%; European, North=19.45%; European, South=67.19% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=906862; DSMZ=ACC-433; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12 (Cosmic-CLP=906862; DSMZ=ACC-433)
ST   D13S317: 12 (PubMed=25877200)
ST   D16S539: 9
ST   D18S51: 12,17
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 24
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 16
ST   FGA: 21,24,25
ST   Penta D: 12,14
ST   Penta E: 12,16
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5G37 ! Evsa-E
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Evsa-T GDC-0941-resistant clone 1
AC   CVCL_A1FL
DR   cancercelllines; CVCL_A1FL
DR   Cosmic; 2787555
DR   Wikidata; Q102113801
RX   PubMed=26759240;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_65326; Pictrelisib (Pictilisib; GDC-0941).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; c.687+1_687+2delGT; ClinVar=VCV000483268; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Asp1067Tyr (c.3199G>T); Zygosity=Heterozygous; Note=Responsible for pictrelisib resistance (PubMed=26759240).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.951_954delACTT) (p.VL317fs) (V317fs*3); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1207 ! Evsa-T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   EW 7476
AC   CVCL_EQ72
SY   EW7476
DR   GDSC; 1290801
DR   PharmacoDB; EW7476_360_2019
DR   Wikidata; Q54832988
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 6
//
ID   EW-1
AC   CVCL_1208
SY   EW1; IARC-EW1; IARC-EW-1; IARC-EW 1
DR   CLO; CLO_0009866
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 884
DR   cancercelllines; CVCL_1208
DR   Cell_Model_Passport; SIDM00205
DR   ChEMBL-Cells; CHEMBL3308164
DR   ChEMBL-Targets; CHEMBL2366364
DR   Cosmic; 684061
DR   Cosmic; 949163
DR   Cosmic; 2250470
DR   Cosmic; 2301552
DR   Cosmic-CLP; 949163
DR   DepMap; ACH-002110
DR   EGA; EGAS00001000978
DR   GDSC; 949163
DR   GEO; GSM1669781
DR   GEO; GSM5359646
DR   GEO; GSM5359647
DR   GEO; GSM5359648
DR   GEO; GSM5359649
DR   GEO; GSM5359650
DR   GEO; GSM5359651
DR   GEO; GSM5362892
DR   GEO; GSM5362893
DR   GEO; GSM5362894
DR   GEO; GSM5362895
DR   GEO; GSM5362896
DR   GEO; GSM5362897
DR   GEO; GSM5363951
DR   GEO; GSM5363952
DR   GEO; GSM5363953
DR   GEO; GSM5363954
DR   GEO; GSM5363955
DR   IARC_TP53; 27161
DR   LINCS_LDP; LCL-1446
DR   PharmacoDB; EW1_350_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1208
DR   Wikidata; Q54832989
RX   DOI=10.5282/edoc.27750;
RX   PubMed=6713356;
RX   PubMed=11423975;
RX   PubMed=20164919;
RX   PubMed=25223734;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=25223734).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=11423975; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=25223734).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.04%; Native American=1.76%; East Asian, North=0%; East Asian, South=0%; South Asian=0.17%; European, North=53.73%; European, South=44.3% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=949163
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 12
ST   D5S818: 11,15
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3446 ! EW-2
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   EW-11
AC   CVCL_1209
SY   EW11; IARC-EW11; IARC-EW-11; IARC-EW 11
DR   CLO; CLO_0009867
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1209
DR   Cell_Model_Passport; SIDM00203
DR   ChEMBL-Cells; CHEMBL3308193
DR   ChEMBL-Targets; CHEMBL2366223
DR   Cosmic; 684062
DR   Cosmic; 965554
DR   Cosmic; 1084592
DR   Cosmic-CLP; 684062
DR   DepMap; ACH-002111
DR   EGA; EGAS00001000978
DR   GDSC; 684062
DR   GEO; GSM1669782
DR   IARC_TP53; 27162
DR   LINCS_LDP; LCL-1447
DR   PharmacoDB; EW11_351_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1209
DR   Wikidata; Q54832990
RX   PubMed=6713356;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (Cosmic-CLP=684062).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=20.84%; Native American=0.67%; East Asian, North=0%; East Asian, South=2.32%; South Asian=4.42%; European, North=15.83%; European, South=55.92% (PubMed=30894373).
CC   Derived from site: Metastatic; Mediastinal lymph node; UBERON=UBERON_0002524.
ST   Source(s): Cosmic-CLP=684062
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   EW-12
AC   CVCL_1210
SY   EW12; IARC-EW12; IARC-EW-12; IARC-EW 12
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1210
DR   Cell_Model_Passport; SIDM00200
DR   ChEMBL-Cells; CHEMBL3308528
DR   ChEMBL-Targets; CHEMBL2366255
DR   Cosmic; 684063
DR   Cosmic; 949162
DR   Cosmic; 2804872
DR   Cosmic-CLP; 949162
DR   DepMap; ACH-002112
DR   EGA; EGAS00001000978
DR   GDSC; 949162
DR   GEO; GSM1669783
DR   IARC_TP53; 27163
DR   PharmacoDB; EW12_352_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1210
DR   Wikidata; Q54832991
RX   PubMed=8108117;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (Cosmic-CLP=949162).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=21.92%; Native American=0%; East Asian, North=2.41%; East Asian, South=0.17%; South Asian=6.25%; European, North=15.31%; European, South=53.94% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949162
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,20
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   EW-13
AC   CVCL_1211
SY   EW13; IARC-EW13; IARC-EW-13; IARC-EW 13
DR   CLO; CLO_0009868
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1211
DR   Cell_Model_Passport; SIDM00621
DR   ChEMBL-Cells; CHEMBL3308194
DR   ChEMBL-Targets; CHEMBL2366124
DR   Cosmic; 684064
DR   Cosmic; 949166
DR   Cosmic; 1995400
DR   Cosmic-CLP; 949166
DR   DepMap; ACH-002113
DR   EGA; EGAS00001000978
DR   GDSC; 949166
DR   GEO; GSM1669784
DR   IARC_TP53; 27164
DR   LINCS_LDP; LCL-1448
DR   PharmacoDB; EW13_353_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1211
DR   Wikidata; Q54832992
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser315Leufs*30 (c.942delC); Zygosity=Heterozygous (Cosmic-CLP=949166; DepMap=ACH-002113).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=18.44%; Native American=0%; East Asian, North=0.58%; East Asian, South=2.48%; South Asian=1.96%; European, North=15.79%; European, South=60.76% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949166
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 13
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   EW-16
AC   CVCL_1212
SY   EW16; IARC-EW16; IARC-EW-16; IARC-EW 16
DR   CLO; CLO_0009869
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 883
DR   cancercelllines; CVCL_1212
DR   Cell_Model_Passport; SIDM00198
DR   ChEMBL-Cells; CHEMBL3308195
DR   ChEMBL-Targets; CHEMBL2366358
DR   Cosmic; 684065
DR   Cosmic; 949165
DR   Cosmic; 1995401
DR   Cosmic; 2250472
DR   Cosmic-CLP; 949165
DR   DepMap; ACH-002114
DR   EGA; EGAS00001000978
DR   GDSC; 949165
DR   GEO; GSM1669785
DR   IARC_TP53; 27165
DR   LINCS_LDP; LCL-1449
DR   PharmacoDB; EW16_354_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1212
DR   Wikidata; Q54832993
RX   DOI=10.5282/edoc.27750;
RX   PubMed=11423975;
RX   PubMed=20164919;
RX   PubMed=25223734;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=25223734).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=EWSR1 exon 8 fused to FLI1 exon 7 (PubMed=11423975).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys120Serfs*3 (c.359delA); Zygosity=Heterozygous (PubMed=25223734; Cosmic-CLP=949165; DepMap=ACH-002114).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.19%; Native American=1.1%; East Asian, North=0%; East Asian, South=0.45%; South Asian=0.79%; European, North=55.49%; European, South=41.99% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949165
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12,14
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   EW-17
AC   CVCL_3445
SY   EW17; IARC-EW17; IARC-EW-17; IARC-EW 17
DR   Cosmic; 1084593
DR   Wikidata; Q54832994
RX   DOI=10.5282/edoc.27750;
RX   PubMed=11423975;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=11423975).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   EW-18
AC   CVCL_1213
SY   EW18; IARC-EW-18
DR   CLO; CLO_0009870
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1213
DR   Cell_Model_Passport; SIDM00197
DR   ChEMBL-Cells; CHEMBL3308832
DR   ChEMBL-Targets; CHEMBL2366097
DR   Cosmic; 684066
DR   Cosmic; 949164
DR   Cosmic; 1081697
DR   Cosmic; 1995402
DR   Cosmic; 2250476
DR   Cosmic-CLP; 949164
DR   DepMap; ACH-002115
DR   EGA; EGAS00001000978
DR   GDSC; 949164
DR   GEO; GSM1669786
DR   IARC_TP53; 27166
DR   LINCS_LDP; LCL-1450
DR   PharmacoDB; EW18_355_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1213
DR   Wikidata; Q54832995
RX   DOI=10.5282/edoc.27750;
RX   PubMed=20164919;
RX   PubMed=23637631;
RX   PubMed=25223734;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=25223734).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.97%; East Asian, North=0.41%; East Asian, South=0%; South Asian=0.22%; European, North=68.25%; European, South=30.15% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949164
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   EW-19
AC   CVCL_A463
SY   EW19; IARC-EW-19
DR   Cosmic; 684067
DR   Wikidata; Q54832997
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   EW-2
AC   CVCL_3446
SY   EW2; IARC-EW2; IARC-EW-2; IARC-EW 2
DR   cancercelllines; CVCL_3446
DR   Cell_Model_Passport; SIDM00204
DR   Cosmic; 1388895
DR   Cosmic; 2228228
DR   Cosmic; 2804870
DR   IARC_TP53; 706
DR   Wikidata; Q54832998
RX   PubMed=6713356;
RX   PubMed=8108117;
RX   PubMed=8378080;
RX   PubMed=25010205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8378080).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 12
ST   D18S51: 11,12
ST   D19S433: 13,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 15
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 22,26
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1208 ! EW-1
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   EW-22
AC   CVCL_1214
SY   EW22; IARC-EW-22
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 882
DR   cancercelllines; CVCL_1214
DR   Cell_Model_Passport; SIDM00196
DR   ChEMBL-Cells; CHEMBL3308196
DR   ChEMBL-Targets; CHEMBL2366162
DR   Cosmic; 684068
DR   Cosmic; 949167
DR   Cosmic; 1995403
DR   Cosmic; 2250461
DR   Cosmic-CLP; 949167
DR   DepMap; ACH-002116
DR   EGA; EGAS00001000978
DR   GDSC; 949167
DR   GEO; GSM1669787
DR   GEO; GSM5359652
DR   GEO; GSM5359653
DR   GEO; GSM5359654
DR   GEO; GSM5359655
DR   GEO; GSM5359656
DR   GEO; GSM5359657
DR   GEO; GSM5362900
DR   GEO; GSM5362903
DR   GEO; GSM5362906
DR   GEO; GSM5362907
DR   GEO; GSM5362908
DR   GEO; GSM5362909
DR   GEO; GSM5363956
DR   GEO; GSM5363957
DR   GEO; GSM5363958
DR   GEO; GSM5363959
DR   GEO; GSM5363960
DR   IARC_TP53; 27167
DR   PharmacoDB; EW22_356_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1214
DR   Wikidata; Q54832999
RX   DOI=10.5282/edoc.27750;
RX   PubMed=20164919;
RX   PubMed=25223734;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25223734).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=1.44%; European, North=60.63%; European, South=37.61% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949167
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   EW-23
AC   CVCL_EI71
DR   cancercelllines; CVCL_EI71
DR   Cosmic; 2250462
DR   Wikidata; Q54833000
RX   PubMed=25223734;
CC   From: Delattre, Olivier; Institut Curie; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Arg807fs; Zygosity=Unspecified (PubMed=25223734).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=25223734).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   EW-24
AC   CVCL_1215
SY   EW24; IARC-EW-24
DR   CLO; CLO_0009871
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1215
DR   Cell_Model_Passport; SIDM00195
DR   ChEMBL-Cells; CHEMBL3308197
DR   ChEMBL-Targets; CHEMBL2366206
DR   Cosmic; 684069
DR   Cosmic; 949168
DR   Cosmic; 1995404
DR   Cosmic-CLP; 949168
DR   DepMap; ACH-002117
DR   EGA; EGAS00001000978
DR   GDSC; 949168
DR   GEO; GSM1669788
DR   GEO; GSM5359658
DR   GEO; GSM5359659
DR   GEO; GSM5359660
DR   GEO; GSM5359661
DR   GEO; GSM5359662
DR   GEO; GSM5359663
DR   GEO; GSM5362870
DR   GEO; GSM5362871
DR   GEO; GSM5362872
DR   GEO; GSM5362873
DR   GEO; GSM5362874
DR   GEO; GSM5362875
DR   GEO; GSM5363961
DR   GEO; GSM5363962
DR   GEO; GSM5363963
DR   GEO; GSM5363964
DR   GEO; GSM5363965
DR   IARC_TP53; 27168
DR   LINCS_LDP; LCL-1451
DR   PharmacoDB; EW24_357_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1215
DR   Wikidata; Q54833001
RX   DOI=10.5282/edoc.27750;
RX   PubMed=11423975;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=11423975; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (Cosmic-CLP=949168; DepMap=ACH-002117).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Glu (c.490A>G); ClinVar=VCV000246416; Zygosity=Homozygous (Cosmic-CLP=949168; DepMap=ACH-002117).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=1.24%; South Asian=0%; European, North=60.48%; European, South=38.28% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949168
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 6,9.3
ST   TPOX: 10,12
ST   vWA: 15,16
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   EW-3
AC   CVCL_1216
SY   EW3; IARC-EW3; IARC-EW-3; IARC-EW 3
DR   CLO; CLO_0009872
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1216
DR   Cell_Model_Passport; SIDM00202
DR   ChEMBL-Cells; CHEMBL3308521
DR   ChEMBL-Targets; CHEMBL2366307
DR   Cosmic; 684070
DR   Cosmic; 949161
DR   Cosmic; 1995405
DR   Cosmic; 2250460
DR   Cosmic-CLP; 949161
DR   DepMap; ACH-002118
DR   EGA; EGAS00001000978
DR   GDSC; 949161
DR   GEO; GSM510005
DR   GEO; GSM1669789
DR   GEO; GSM5359664
DR   GEO; GSM5359665
DR   GEO; GSM5359666
DR   GEO; GSM5359667
DR   GEO; GSM5359668
DR   GEO; GSM5359669
DR   GEO; GSM5362912
DR   GEO; GSM5362913
DR   GEO; GSM5362914
DR   GEO; GSM5362915
DR   GEO; GSM5362916
DR   GEO; GSM5362917
DR   GEO; GSM5363966
DR   GEO; GSM5363967
DR   GEO; GSM5363968
DR   GEO; GSM5363969
DR   GEO; GSM5363970
DR   IARC_TP53; 27038
DR   IARC_TP53; 27169
DR   LINCS_LDP; LCL-1452
DR   PharmacoDB; EW3_358_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1216
DR   PubChem_Cell_line; CVCL_1216
DR   Wikidata; Q54833002
RX   DOI=10.5282/edoc.27750;
RX   PubMed=6713356;
RX   PubMed=11423975;
RX   PubMed=16631476;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=21822310;
RX   PubMed=25223734;
RX   PubMed=26428435;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG; Note=EWSR1 exon 7 with ERG exon 6 (PubMed=11423975; PubMed=16631476; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Arg216Ter (c.646C>T); Zygosity=Homozygous (PubMed=25223734; DepMap=ACH-002118).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.852_858del7; Zygosity=Unspecified (PubMed=19787792; PubMed=26428435).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg462His (c.1385G>A); ClinVar=VCV000050193; Zygosity=Heterozygous (DepMap=ACH-002118).
CC   Omics: Genomics; ChIP-seq; ERG.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.33%; East Asian, North=0.83%; East Asian, South=0.4%; South Asian=6.18%; European, North=47.05%; European, South=45.2% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=949161; PubMed=19787792
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D19S433: 13,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,22
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 22,25
ST   SE33: 15.3,16
ST   TH01: 9.3,10
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   EW-7
AC   CVCL_1217
SY   EW7; IARC-EW7; IARC-EW-7; IARC-EW 7
DR   CLO; CLO_0009873
DR   EFO; EFO_0022700
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 881
DR   cancercelllines; CVCL_1217
DR   Cell_Model_Passport; SIDM00201
DR   ChEMBL-Cells; CHEMBL3308165
DR   ChEMBL-Targets; CHEMBL2366112
DR   Cosmic; 684071
DR   Cosmic; 949160
DR   Cosmic; 1995406
DR   Cosmic; 2250471
DR   Cosmic; 2804871
DR   Cosmic-CLP; 949160
DR   DepMap; ACH-002119
DR   EGA; EGAS00001000978
DR   GDSC; 949160
DR   GEO; GSM1669790
DR   GEO; GSM5359724
DR   GEO; GSM5359725
DR   GEO; GSM5359726
DR   GEO; GSM5359727
DR   GEO; GSM5359728
DR   GEO; GSM5359729
DR   GEO; GSM5362965
DR   GEO; GSM5362966
DR   GEO; GSM5362967
DR   GEO; GSM5362968
DR   GEO; GSM5362969
DR   GEO; GSM5362970
DR   GEO; GSM5363971
DR   GEO; GSM5363972
DR   GEO; GSM5363973
DR   GEO; GSM5363974
DR   GEO; GSM5363975
DR   IARC_TP53; 27170
DR   LINCS_LDP; LCL-1453
DR   PharmacoDB; EW7_359_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1217
DR   Wikidata; Q54833003
RX   DOI=10.5282/edoc.27750;
RX   PubMed=6713356;
RX   PubMed=8108117;
RX   PubMed=11423975;
RX   PubMed=16631476;
RX   PubMed=20164919;
RX   PubMed=25223734;
RX   PubMed=26428435;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=25223734).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=11423975; PubMed=16631476; PubMed=36476851).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=3.39%; European, North=57.71%; European, South=38.66% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=949160
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 10,13
ST   D7S820: 9
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   EW-8
AC   CVCL_1658
AS   CVCL_5915; CVCL_V618
SY   EW8; EW8(Rh1); RH1; Rh1; RH-1; Rh-1; SJRH-1; SJRH1
DR   BTO; BTO_0005378
DR   CLO; CLO_0009878
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 172
DR   BioSample; SAMN03473566
DR   BioSample; SAMN10988420
DR   cancercelllines; CVCL_1658
DR   Cell_Model_Passport; SIDM00427
DR   Cell_Model_Passport; SIDM01500
DR   ChEMBL-Cells; CHEMBL3308524
DR   ChEMBL-Targets; CHEMBL2366078
DR   Cosmic; 801755
DR   Cosmic; 971773
DR   Cosmic; 1037294
DR   Cosmic; 1048107
DR   Cosmic; 1097750
DR   Cosmic; 1104556
DR   Cosmic; 1108744
DR   Cosmic; 2228229
DR   Cosmic; 2294583
DR   Cosmic-CLP; 971773
DR   DepMap; ACH-000499
DR   DepMap; ACH-002194
DR   DSMZ; ACC-493
DR   DSMZCellDive; ACC-493
DR   EGA; EGAS00001000978
DR   GDSC; 971773
DR   GEO; GSM1670376
DR   GEO; GSM1676298
DR   GEO; GSM1701633
DR   GEO; GSM5359688
DR   GEO; GSM5359689
DR   GEO; GSM5359690
DR   GEO; GSM5359691
DR   GEO; GSM5359692
DR   GEO; GSM5359693
DR   GEO; GSM5362948
DR   GEO; GSM5362949
DR   GEO; GSM5362950
DR   GEO; GSM5362951
DR   GEO; GSM5362952
DR   GEO; GSM5362953
DR   GEO; GSM5363996
DR   GEO; GSM5363997
DR   GEO; GSM5363998
DR   GEO; GSM5363999
DR   GEO; GSM5364000
DR   IARC_TP53; 27229
DR   LINCS_LDP; LCL-1456
DR   PharmacoDB; EW8_361_2019
DR   PharmacoDB; RH1_1310_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_V618
DR   PubChem_Cell_line; CVCL_1658
DR   Wikidata; Q54833004
RX   DOI=10.5282/edoc.27750;
RX   PubMed=7536457;
RX   PubMed=8275086;
RX   PubMed=11051265;
RX   PubMed=17154184;
RX   PubMed=20164919;
RX   PubMed=23578105;
RX   PubMed=23882450;
RX   PubMed=25010205;
RX   PubMed=25984343;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Problematic cell line: Misclassified. Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=17154184).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343); ~30-40 hours (DSMZ=ACC-493).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=17154184; PubMed=25010205; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg55Trp (c.163A>T); Zygosity=Heterozygous (Cosmic-CLP=971773; DepMap=ACH-000499).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=25010205; Cosmic-CLP=971773; DepMap=ACH-000499).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.08%; East Asian, South=0%; South Asian=0%; European, North=66.53%; European, South=32.38% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-002194; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=971773; DSMZ=ACC-493; PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 13,15.2 (PubMed=25010205)
ST   D19S433: 13,16 (DSMZ=ACC-493)
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 11,18 (PubMed=25010205)
ST   D3S1358: 18 (DSMZ=ACC-493)
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 9,13
ST   Penta E: 5,16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   EW36
AC   CVCL_W742
SY   Ew36; EW-36; EW 36
DR   Cosmic; 931104
DR   Wikidata; Q54833005
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=6286763;
RX   PubMed=7757991;
RX   PubMed=8176200;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8568269;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9973220;
CC   Virology: EBV-negative.
CC   Doubling time: 24 hours (PubMed=8402660).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   EW93
AC   CVCL_VK44
DR   Cosmic; 1085910
DR   Wikidata; Q93547290
RX   PubMed=9738976;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=9738976).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   Ewing1
AC   CVCL_WN30
DR   Wikidata; Q93547295
RX   PubMed=31062478;
CC   Population: Malaysian.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   EWS-502
AC   CVCL_S740
SY   EWS/502; EWS502
DR   BioGRID_ORCS_Cell_line; 174
DR   BioSample; SAMN10988395
DR   cancercelllines; CVCL_S740
DR   Cell_Model_Passport; SIDM01499
DR   Cosmic; 2294584
DR   DepMap; ACH-000279
DR   GEO; GSM2527268
DR   GEO; GSM2527269
DR   PharmacoDB; EWS502_362_2019
DR   Progenetix; CVCL_S740
DR   Wikidata; Q54833006
RX   PubMed=16766266;
RX   PubMed=23145994;
RX   PubMed=25984343;
RX   PubMed=29866822;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Doubling time: 46 hours (PubMed=25984343).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=23145994).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (DepMap=ACH-000279).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=5.9%; Native American=0%; East Asian, North=4.68%; East Asian, South=0%; South Asian=0%; European, North=38.28%; European, South=51.14% (PubMed=30894373).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 23
//
ID   EWS-834
AC   CVCL_AW95
SY   EWS834
DR   cancercelllines; CVCL_AW95
DR   Cell_Model_Passport; SIDM01713
DR   Cosmic; 2294585
DR   DepMap; ACH-001066
DR   Wikidata; Q54833007
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Met (c.746G>T); ClinVar=VCV000376653; Zygosity=Unspecified (DepMap=ACH-001066).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   EWS-925
AC   CVCL_M142
DR   Wikidata; Q54833008
RX   PubMed=11504746;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   eWT-1323-2
AC   CVCL_0G83
DR   SKIP; SKIP000538
DR   Wikidata; Q54833009
RX   PubMed=24321451;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G84 ! eWT-1323-4
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   eWT-1323-4
AC   CVCL_0G84
DR   SKIP; SKIP000539
DR   Wikidata; Q54833010
RX   PubMed=24321451;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G83 ! eWT-1323-2
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   eWT-BJ2
AC   CVCL_0G85
DR   SKIP; SKIP000540
DR   Wikidata; Q54833011
RX   PubMed=24321451;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   eWT-BJ4
AC   CVCL_0G86
DR   SKIP; SKIP000541
DR   Wikidata; Q54833012
RX   PubMed=24321451;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Ex-3LL
AC   CVCL_5748
SY   Ex3LL
DR   JCRB; JCRB1349
DR   Wikidata; Q54833013
RX   PubMed=10408901;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Ex-3LL/CMV-Luc#1
AC   CVCL_JG92
DR   JCRB; JCRB1716
DR   JCRB; NIHS1068
DR   Wikidata; Q54833014
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1716).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1068; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5748 ! Ex-3LL
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   EX5.3D10
AC   CVCL_DD32
SY   3D10
DR   ATCC; HB-11373
DR   Wikidata; Q54833015
RX   Patent=US5883223;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11373.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10747; Human CD28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   Exo-RBM-4
AC   CVCL_VZ71
SY   Exosome-compatible-Rat Bone Marrow-4
DR   IBRC; C11134
DR   Wikidata; Q93547431
CC   Characteristics: Established from parent cell line using exosome free serum.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_VZ70 ! RBM-4
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   Expi293F
AC   CVCL_D615
DR   Wikidata; Q54833016
WW   Provider; Thermo Fisher; A14527; https://www.thermofisher.com/order/catalog/product/A14527
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6642 ! HEK293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   Expi293F GnTI-
AC   CVCL_B0J7
DR   Wikidata; Q108820205
WW   Provider; Thermo Fisher; A39240; https://www.thermofisher.com/order/catalog/product/A39240
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Lacks N-acetylglucosaminyltransferase I activity and accordingly predominantly modifies glycoproteins with the Man5GlcNAc2 N-glycan.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D615 ! Expi293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   Expi293F Inducible
AC   CVCL_B0J8
DR   Wikidata; Q108820206
WW   Provider; Thermo Fisher; A39241; https://www.thermofisher.com/order/catalog/product/A39241
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Stably expresses high levels of tetR. When used with compatible inducible vectors the gene of interest is repressed with very low levels of basal expression until induction with tetracycline. Expression can be modulated by addition of different amounts of tetracycline (Thermo Fisher).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D615 ! Expi293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   Expi293F Inducible GnTI-
AC   CVCL_B0J9
DR   Wikidata; Q108820207
WW   Provider; Thermo Fisher; A39242; https://www.thermofisher.com/order/catalog/product/A39242
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Lacks N-acetylglucosaminyltransferase I activity and accordingly predominantly modifies glycoproteins with the Man5GlcNAc2 N-glycan.
CC   Characteristics: Stably expresses high levels of tetR. When used with compatible inducible vectors the gene of interest is repressed with very low levels of basal expression until induction with tetracycline. Expression can be modulated by addition of different amounts of tetracycline (Thermo Fisher).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0J7 ! Expi293F GnTI-
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   ExpiCHO-S
AC   CVCL_5J31
DR   Wikidata; Q54833017
WW   Provider; Thermo Fisher; A29127; https://www.thermofisher.com/order/catalog/product/A29127
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Has been selected for high protein expression.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   EXSURGi001-A
AC   CVCL_E3V5
SY   SevXC_MTARC1
DR   BioSamples; SAMEA115836031
DR   hPSCreg; EXSURGi001-A
RX   PubMed=39094505;
CC   From: Experimental Surgery, Charite, Universitatsmedizin Berlin; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:26189; MTARC1; Simple; p.Ala165Thr (c.493G>A); dbSNP=rs2642438; Zygosity=Homozygous (PubMed=39094505).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   extEqFK
AC   CVCL_WL34
SY   extended-lifespan Equine Fetal Kidney
DR   ABM; T0084
DR   Wikidata; Q93547462
RX   PubMed=27173610;
CC   Senescence: Has an extended life span, but it is not sure if it is immortal.
CC   Virology: Susceptible to infection by equine herpesvirus type 2 (EHV-2) and equine herpesvirus type 5 (EHV-5). Can produce a high titer of EHV-5.
CC   Doubling time: ~24 hours (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: Doubling time, sex of donor and breed of donor from personal communication of Thorsteinsdottir, Lilja.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Icelandic; VBO=VBO_0000991.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_WL35 ! extEqFL
SX   Female
AG   5FM
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   extEqFL
AC   CVCL_WL35
SY   extended-lifespan Equine Fetal Liver
DR   ABM; T0095
DR   Wikidata; Q93547467
RX   PubMed=27173610;
CC   Senescence: Has an extended life span, but it is not sure if it is immortal.
CC   Virology: Susceptible to infection by equine herpesvirus type 2 (EHV-2) and equine herpesvirus type 5 (EHV-5).
CC   Doubling time: ~24 hours (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: Doubling time, sex of donor and breed of donor from personal communication of Thorsteinsdottir, Lilja.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Icelandic; VBO=VBO_0000991.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_WL34 ! extEqFK
SX   Female
AG   5FM
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   EYQ2-20
AC   CVCL_E4CE
RX   PubMed=33558651;
RX   PubMed=36202854;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   EZB-ICR
AC   CVCL_A5GV
DR   Wikidata; Q107114916
RX   PubMed=33507685;
CC   Population: Iranian.
CC   Doubling time: ~31 hours (Note=At 25th passage) (PubMed=33507685).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   Ezem-BL
AC   CVCL_7192
SY   Ezem
DR   Wikidata; Q54833018
RX   PubMed=9882297;
RX   PubMed=16051863;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   EZQ-3 iPSC
AC   CVCL_GP79
DR   Wikidata; Q54833019
RX   PubMed=27558610;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   EZQ-4 iPSC
AC   CVCL_GP80
DR   Wikidata; Q54833020
RX   PubMed=27558610;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   EZQ-9 iPSC
AC   CVCL_GP81
DR   Wikidata; Q54833021
RX   PubMed=27558610;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   EZZ (TOU II-4)
AC   CVCL_2781
SY   EZZ; TOU II-4
DR   CLO; CLO_0002956
DR   CLDB; cl1177
DR   ECACC; 93093003
DR   Wikidata; Q54833022
RX   PubMed=6438434;
RX   PubMed=6817143;
WW   Info; IMGT; -; https://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html
CC   Population: Tunisian; Berber.
CC   Characteristics: Homozygous for deletion of IGH G1-EP1-A1-GP-G2-G4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:5523; IGHEP1; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5525; IGHG1; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5526; IGHG2; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5528; IGHG4; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5529; IGHGP; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   F C3H
AC   CVCL_HA23
DR   BCRJ; 0082
DR   Wikidata; Q54833023
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   F clone 1
AC   CVCL_D3XJ
DR   Wikidata; Q127380835
RX   PubMed=38049592;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from the frontal region of a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3XK ! F clone 2
OI   CVCL_D3XL ! F clone 3
OI   CVCL_D3XM ! O clone 1
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   F clone 2
AC   CVCL_D3XK
DR   Wikidata; Q127380836
RX   PubMed=38049592;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from the frontal region of a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3XJ ! F clone 1
OI   CVCL_D3XL ! F clone 3
OI   CVCL_D3XM ! O clone 1
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   F clone 3
AC   CVCL_D3XL
DR   Wikidata; Q127380837
RX   PubMed=38049592;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from the frontal region of a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3XJ ! F clone 1
OI   CVCL_D3XK ! F clone 2
OI   CVCL_D3XM ! O clone 1
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   F-11
AC   CVCL_H605
SY   F11
DR   CLO; CLO_0002962
DR   CLDB; cl1188
DR   ECACC; 08062601
DR   Wikidata; Q54833050
RX   PubMed=3494104;
RX   PubMed=3858835;
RX   PubMed=32636736;
WW   Info; NCBI; -; https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=266798&lvl=3
CC   Characteristics: Derived from the fusion of rat embryonic day 13-14 dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=3858835).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   F-137
AC   CVCL_1Q45
SY   F 137; F137
DR   cancercelllines; CVCL_1Q45
DR   Wikidata; Q54833024
RX   PubMed=1180485;
RX   PubMed=4736620;
RX   PubMed=5287057;
RX   PubMed=18623934;
CC   Problematic cell line: Contaminated. Shown to be a Jiyoye derivative (PubMed=4736620). Originally thought to originate from the lymph node of a male chronic lymphocytic leukemia patient.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1317 ! Jiyoye
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   F-2-1
AC   CVCL_F0WJ
RX   PubMed=2831373;
RX   PubMed=6177865;
RX   PubMed=7539502;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03205; Epstein-Barr virus (strain B95-8) glyprotein 42 (BZLF2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F-25
AC   CVCL_C7EW
DR   Wikidata; Q117704328
RX   PubMed=6432682;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   F-26
AC   CVCL_C7EX
DR   Wikidata; Q117704329
RX   PubMed=6432682;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   F-3
AC   CVCL_CW34
SY   F 3; F3
DR   Wikidata; Q54833025
RX   Patent=US4678747;
RX   Patent=US5168043;
RX   PubMed=6208122;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8217.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_140912; Lewis Y antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   F-3-3
AC   CVCL_XC19
DR   Wikidata; Q93547581
RX   Patent=CN107513522B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.14303.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_7719; Ochratoxin A (OTA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 5
//
ID   F-36E
AC   CVCL_7227
SY   F36E; F-36EGM; F-36-EGM; F36EGM
DR   CLO; CLO_0051545
DR   BioSample; SAMN03472229
DR   Cell_Model_Passport; SIDM01625
DR   Cosmic; 787429
DR   Cosmic; 919126
DR   Cosmic; 1281312
DR   FANTOM5_SSTAR; 10836-111D8
DR   RCB; RCB0776
DR   Wikidata; Q54833026
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1834251;
RX   PubMed=9510473;
RX   PubMed=36982453;
CC   Population: Japanese.
CC   Characteristics: EPO dependent (PubMed=1834251).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB0776
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 10
ST   D16S539: 10,12
ST   D5S818: 9,13
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C8923; Acute erythroid leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2037 ! F-36P
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   F-36P
AC   CVCL_2037
SY   F36P
DR   CLO; CLO_0051549
DR   AddexBio; C0003014/4881
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03472228
DR   BioSample; SAMN03473531
DR   BioSample; SAMN10989568
DR   cancercelllines; CVCL_2037
DR   Cell_Model_Passport; SIDM01498
DR   Cosmic; 975247
DR   Cosmic; 1012066
DR   Cosmic; 1465955
DR   Cosmic; 2089665
DR   Cosmic; 2306204
DR   DepMap; ACH-000487
DR   DSMZ; ACC-543
DR   DSMZCellDive; ACC-543
DR   ECACC; 99072808
DR   FANTOM5_SSTAR; 10837-111D9
DR   GEO; GSM482505
DR   GEO; GSM887010
DR   GEO; GSM888079
DR   GEO; GSM1374478
DR   GEO; GSM1446734
DR   GEO; GSM2124120
DR   IARC_TP53; 28392
DR   LiGeA; CCLE_670
DR   Lonza; 262
DR   PharmacoDB; F36P_363_2019
DR   Progenetix; CVCL_2037
DR   RCB; RCB0775
DR   TOKU-E; 4108
DR   Wikidata; Q54833036
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1834251;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27750403;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=F-36P
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: CSF2 or IL3 dependent (PubMed=1834251).
CC   Doubling time: 55 hours (PubMed=25984343); ~24-36 hours (DSMZ=ACC-543).
CC   HLA typing: A*24:02,33:03; B*40:06,58:01; C*03:02,08:01 (PubMed=26589293).
CC   HLA typing: A*24:02:01,33:03:01; B*40:06:01,58:01:01; C*03:02:02,08:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,02:01:02; DQA1*01:02:01,01:02:01; DQB1*04:02:01,06:09:01; DRA*01:02:02,01:02:02; DRB1*08:02:01,13:02:01 (DSMZCellDive=ACC-543).
CC   Sequence variation: Mutation; HGNC; HGNC:7132; KMT2A; Simple; p.Glu766Gln (c.2296G>C); Zygosity=Heterozygous (PubMed=27750403; DepMap=ACH-000487).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=27750403; DepMap=ACH-000487).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.61%; Native American=0%; East Asian, North=78.68%; East Asian, South=18.21%; South Asian=0%; European, North=0%; European, South=1.5% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0003014/4881; DSMZ=ACC-543; ECACC=99072808; RCB=RCB0775
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 15
ST   D19S433: 12,13
ST   D21S11: 31
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 12,15
ST   FGA: 21,24
ST   Penta D: 10,11
ST   Penta E: 16,17
ST   TH01: 8 (AddexBio=C0003014/4881; ECACC=99072808; RCB=RCB0775)
ST   TH01: 8,9 (DSMZ=ACC-543)
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C8923; Acute erythroid leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   F-49-1
AC   CVCL_A5VW
DR   Wikidata; Q107114919
RX   PubMed=169818;
CC   Problematic cell line: Contaminated. Parent cell line (AV3) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1904 ! AV3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   F-502
AC   CVCL_DG17
DR   GEO; GSM114610
DR   Wikidata; Q54833037
RX   PubMed=16966431;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   F-89
AC   CVCL_C1J7
SY   F89
DR   Wikidata; Q114311384
RX   PubMed=2998993;
RX   PubMed=5287057;
RX   PubMed=18623934;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7539; Lymphoid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   f/k
AC   CVCL_E8DY
RX   DOI=10.1016/B978-012442710-5.50265-3;
RX   PubMed=9914916;
CC   Group: Amphibian cell line.
CC   Characteristics: Expresses MHC class I and MHC class II molecules (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Tumorigenic in larval but not adult syngeneic hosts (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: f/k.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F.M.
AC   CVCL_S456
DR   ATCC; CRL-6169
DR   Wikidata; Q54833038
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6169; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=61378; ! Felis margarita (Sand cat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   F.thy 62891
AC   CVCL_6394
DR   CLO; CLO_0002957
DR   ATCC; CRL-10936
DR   BioSample; SAMN03471324
DR   Wikidata; Q54833039
RX   Patent=US5283354;
RX   Patent=US5621090;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10936.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Discontinued: ATCC; CRL-10936; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
ST   Source(s): ATCC=CRL-10936
ST   Amelogenin: X
ST   CSF1PO: 7,13
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   F002-2.18
AC   CVCL_C5I5
DR   Wikidata; Q116048950
RX   Patent=WO1993023435A1;
RX   PubMed=8913788;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10997; Human IAPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   F0022E
AC   CVCL_A5DQ
DR   Wikidata; Q107114920
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-fibroblasts-catalogue-isenet.pdf
CC   Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   F0075E
AC   CVCL_A5DR
DR   Wikidata; Q107114922
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-fibroblasts-catalogue-isenet.pdf
CC   Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   F01/240
AC   CVCL_WY33
SY   F01-240
DR   Wikidata; Q93547664
RX   PubMed=15574327;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C162694; Severe combined immunodeficiency, Athabascan type
DI   ORDO; Orphanet_275; Severe combined immunodeficiency due to DCLRE1C deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   F02/385
AC   CVCL_WY34
SY   F02-385; FO2-385
DR   Wikidata; Q93547667
RX   PubMed=15574327;
RX   PubMed=16874298;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C162694; Severe combined immunodeficiency, Athabascan type
DI   ORDO; Orphanet_275; Severe combined immunodeficiency due to DCLRE1C deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   F02/98 hTERT
AC   CVCL_ZV77
DR   Wikidata; Q98125977
RX   PubMed=18757420;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly674Gly (c.2022A>G) (2101A>G); ClinVar=VCV000008307; Zygosity=Homozygous; Note=Silent mutation that causes increased levels of skipping exon 9 and activation of two cryptic splicing events from sites in exon 9 leading to termination in exon 10 (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125488; Seckel syndrome
DI   ORDO; Orphanet_808; Seckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6G80 ! GM18366
SX   Male
AG   6Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   F024-4.4
AC   CVCL_C5I6
DR   Wikidata; Q116048951
RX   Patent=WO1993023435A1;
RX   PubMed=8913788;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10997; Human IAPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   F025-27.4
AC   CVCL_C5I7
SY   F025-27
DR   Wikidata; Q116048952
RX   Patent=WO1993023435A1;
RX   PubMed=8913788;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11045.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10997; Human IAPP (Note=Amidated).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   F055-24
AC   CVCL_C5I8
DR   Wikidata; Q116048953
RX   PubMed=8913788;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10997; Human IAPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   F058-5
AC   CVCL_C5I9
DR   Wikidata; Q116048954
RX   PubMed=8913788;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10997; Human IAPP (Note=With p.Ala58Pro, p.Ser61Pro and p.Ser62Pro = pramlintide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   F059-27.3
AC   CVCL_C5IA
DR   Wikidata; Q116048955
RX   PubMed=8913788;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10997; Human IAPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   F062-4
AC   CVCL_C5IB
DR   Wikidata; Q116048956
RX   PubMed=8913788;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10997; Human IAPP (Note=With p.Ala58Pro, p.Ser61Pro and p.Ser62Pro = pramlintide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   F07/402
AC   CVCL_WX38
DR   Wikidata; Q93547672
RX   PubMed=19056826;
RX   PubMed=23818183;
CC   Sequence variation: Mutation; HGNC; HGNC:25737; NHEJ1; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV001323363; Zygosity=Homozygous (PubMed=19056826; PubMed=23818183).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=23818183
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D18S51: 10,20
ST   D21S11: 30.2,31
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14,16
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C162695; Severe combined immunodeficiency due to NHEJ1 deficiency
DI   ORDO; Orphanet_169079; Cernunnos-XLF deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   F07/402-iPSC
AC   CVCL_WX39
SY   F07/402 iPSC
DR   Wikidata; Q93547679
RX   PubMed=23818183;
CC   Sequence variation: Mutation; HGNC; HGNC:25737; NHEJ1; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV001323363; Zygosity=Homozygous (PubMed=23818183).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=23818183
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D18S51: 10,20
ST   D21S11: 30.2,31
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14,16
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C162695; Severe combined immunodeficiency due to NHEJ1 deficiency
DI   ORDO; Orphanet_169079; Cernunnos-XLF deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WX38 ! F07/402
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   F09128
AC   CVCL_A9T5
DR   CLO; CLO_0037416
DR   LINCS_LDP; LPC-1017
DR   Wikidata; Q102113804
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (from child cell line ND50080).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 10
//
ID   F09152
AC   CVCL_ZD02
SY   CS52; ALS52
DR   CLO; CLO_0037419
DR   LINCS_LDP; LPC-1020
DR   Wikidata; Q98125978
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (from child cell line ND50075).
CC   Caution: Indicated as originating from a 60 year old male donor in LINCS.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   F09229
AC   CVCL_A9SR
DR   CLO; CLO_0037417
DR   LINCS_LDP; LPC-1018
DR   Wikidata; Q102113805
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (from child cell line ND50076).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 10
//
ID   F1 2-1
AC   CVCL_XY63
DR   Wikidata; Q93547681
RX   PubMed=18267073;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Cast/EiJ x 129SvJae.
OX   NCBI_TaxID=477816; ! Mus musculus musculus x Mus musculus castaneus (Hybrid house mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   F1-0e
AC   CVCL_RG49
DR   PRIDE; PXD060521
DR   Wikidata; Q54833040
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00420; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f1-0/
CC   Characteristics: Has an epithelioid morphology; subnormal subcategory (Sbnl) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 45 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E7HY ! F1-0f
SX   Female
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   F1-0f
AC   CVCL_E7HY
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00420; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f1-0/
CC   Characteristics: Has an epithelioid morphology; subnormal subcategory (Sbnl) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 38 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_RG49 ! F1-0e
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F1-1
AC   CVCL_E7HZ
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00407; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f1-1/
CC   Characteristics: Has an epithelioid morphology; preneoplastic intermediary subcategory (PNint) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 30 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F1-2 [Mouse hybridoma against C.botulinum botA]
AC   CVCL_C6GN
DR   Wikidata; Q116048957
RX   PubMed=18452945;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DPI1; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) botulinum neurotoxin type A (botA) (Note=AA 449-1296 = Heavy chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   F1-2 [Rat mesothelial]
AC   CVCL_E7I0
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00409; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f1-2/
CC   Characteristics: Has an epithelioid morphology; preneoplastic intermediary subcategory (PNint) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 90 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F1-3
AC   CVCL_E7I1
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00408; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f1-3/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia low subcategory (PNsarc1) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 41 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F1-3G8-1
AC   CVCL_J226
SY   3G8
DR   CLO; CLO_0002966
DR   ATCC; HB-192
DR   Wikidata; Q54833041
RX   PubMed=6380787;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P26948; Yersina pestis F1 antigen (caf1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   F1-40
AC   CVCL_C6GP
DR   Wikidata; Q116048959
RX   PubMed=18452945;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DPI1; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) botulinum neurotoxin type A (botA) (Note=AA 2-448 = Light chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   F1-5
AC   CVCL_C6GQ
DR   Wikidata; Q116048960
RX   PubMed=18452945;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DPI1; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) botulinum neurotoxin type A (botA) (Note=AA 449-1296 = Heavy chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   F1-652
AC   CVCL_2038
AS   CVCL_B6XD
SY   F1.652
DR   CLO; CLO_0002961
DR   CLO; CLO_0002967
DR   ATCC; CRL-2039
DR   DSHB; F1-652
DR   DSMZ; ACC-309
DR   DSMZCellDive; ACC-309
DR   Wikidata; Q54833042
RX   PubMed=3530499;
RX   PubMed=7531198;
CC   Doubling time: ~30-36 hours (DSMZ=ACC-309).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11055; Human MYH3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 9
//
ID   F1-73
AC   CVCL_N340
DR   ATCC; CRL-7922
DR   Wikidata; Q54833043
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7922; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3605 ! T1-73
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   F1-F
AC   CVCL_2G59
DR   Wikidata; Q54833044
RX   PubMed=7989764;
RX   PubMed=11046045;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   F10-150
AC   CVCL_M394
DR   ECACC; 91060552
DR   Wikidata; Q54833045
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q4QWZ3; Sheep ITGAL/CD11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   F10-150.58
AC   CVCL_M395
DR   ECACC; 93100509
DR   Wikidata; Q54833046
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q4QWZ3; Sheep ITGAL/CD11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M394 ! F10-150
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   F10-89-4
AC   CVCL_M396
DR   ECACC; 89062101
DR   NCBI_Iran; H119
DR   Wikidata; Q54833048
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   F1012L
AC   CVCL_TZ79
DR   Wikidata; Q54833049
RX   PubMed=17511773;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   F105
AC   CVCL_F1FQ
DR   ABCD; ABCD_BF051
RX   PubMed=1710248;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 33-511 = gp120. Also reacts with RF, SF2, and MN strains).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F10CE7-BF9
AC   CVCL_F1LA
RX   PubMed=3436625;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F11 [Mouse hybridoma against human 100 kDa glycoprotein]
AC   CVCL_D5Y3
DR   Wikidata; Q127380838
RX   PubMed=6208129;
RX   PubMed=7046918;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 100 kDa secreted glycoprotein from melanoma cells.
CC   Caution: While PubMed=7046918 indicates that Sp2/0-Ag14 was used for the fusion, PubMed=6208129 states it was P3X63Ag8.653.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   F11 [Mouse hybridoma against human ALPP]
AC   CVCL_YI83
DR   Wikidata; Q93547831
RX   PubMed=6756203;
RX   PubMed=7074621;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05187; Human ALPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 02-05-24; Version: 5
//
ID   F111
AC   CVCL_6C52
SY   F-111; F 111
DR   EFO; EFO_0022831
DR   Wikidata; Q54833051
RX   PubMed=50281;
RX   PubMed=2463382;
RX   PubMed=8455944;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   F1121EBV-B
AC   CVCL_TZ78
SY   F1121-EBV-B
DR   Wikidata; Q54833052
RX   PubMed=16651449;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U092 ! F1121L
SX   Sex unspecified
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   F1121L
AC   CVCL_U092
DR   Wikidata; Q54833053
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   HLA typing: A*24:02,02:01; B*15:07,40:06; C*03:03,08:01 (PubMed=17131342).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ78 ! F1121EBV-B
SX   Sex unspecified
AG   69Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   F11430
AC   CVCL_A8YT
DR   Wikidata; Q108820208
RX   PubMed=30045758;
RX   PubMed=39079290;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.His163Arg (c.488A>G); ClinVar=VCV000018124; Zygosity=Heterozygous (PubMed=30045758).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   F119
AC   CVCL_J278
DR   JCRB; JCRB1324
DR   Wikidata; Q54833054
RX   PubMed=15671532;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   F11CD9-B5
AC   CVCL_F1LB
RX   PubMed=3436625;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F11DE2-F4
AC   CVCL_F1LC
RX   PubMed=3436625;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F11G
AC   CVCL_J237
DR   TKG; TKG 0315
DR   Wikidata; Q54833056
RX   PubMed=1878337;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01027; Mouse C3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   F12
AC   CVCL_M045
DR   ECACC; 92032412
DR   Wikidata; Q54833057
RX   PubMed=2272497;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q06304; Aeromonas sobria aerolysin/hemolysin (asa1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 30-01-24; Version: 6
//
ID   F12-1
AC   CVCL_C628
DR   SKIP; SKIP004730
DR   Wikidata; Q54833058
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F12-3
AC   CVCL_C629
DR   SKIP; SKIP004737
DR   Wikidata; Q54833059
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F12-4
AC   CVCL_C630
DR   SKIP; SKIP004738
DR   Wikidata; Q54833060
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F12-5
AC   CVCL_C631
DR   SKIP; SKIP004734
DR   Wikidata; Q54833061
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F12-6
AC   CVCL_C632
DR   SKIP; SKIP004736
DR   Wikidata; Q54833063
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F12-8
AC   CVCL_C633
DR   SKIP; SKIP004731
DR   Wikidata; Q54833064
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F121-9
AC   CVCL_VC42
SY   F121-9-CASTx129
DR   EFO; EFO_0010807
DR   4DN; 4DNSRMG5APUM
DR   Wikidata; Q54833065
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Castaneus x S129/SvJae.
OX   NCBI_TaxID=10091; ! Mus musculus castaneus (Southeastern Asian house mouse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 6
//
ID   F123
AC   CVCL_VC43
SY   F123-CASTx129
DR   EFO; EFO_0009319
DR   4DN; 4DNSRTNKUDSA
DR   Wikidata; Q54833066
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Castaneus x S129/SvJae.
OX   NCBI_TaxID=10091; ! Mus musculus castaneus (Southeastern Asian house mouse)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   F124-10
AC   CVCL_C635
DR   SKIP; SKIP004733
DR   Wikidata; Q54833067
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F124-5
AC   CVCL_C634
DR   SKIP; SKIP004729
DR   Wikidata; Q54833068
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F12424
AC   CVCL_A8YU
DR   Wikidata; Q108820209
RX   PubMed=30045758;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala79Val (c.236C>T); ClinVar=VCV000018157; Zygosity=Heterozygous (PubMed=30045758).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   F12434
AC   CVCL_A8YV
DR   Wikidata; Q108820210
RX   PubMed=30045758;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Gly217Arg (c.649G>C); ClinVar=VCV000018159; Zygosity=Heterozygous (PubMed=30045758).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   F12448
AC   CVCL_A8YW
DR   Wikidata; Q108820211
RX   PubMed=30045758;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=30045758).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   F124B-3
AC   CVCL_C636
DR   SKIP; SKIP004732
DR   Wikidata; Q54833069
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C637 ! F124B-4
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F124B-4
AC   CVCL_C637
DR   SKIP; SKIP004735
DR   Wikidata; Q54833070
RX   PubMed=18849973;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C628 ! F12-1
OI   CVCL_C629 ! F12-3
OI   CVCL_C630 ! F12-4
OI   CVCL_C631 ! F12-5
OI   CVCL_C632 ! F12-6
OI   CVCL_C633 ! F12-8
OI   CVCL_C634 ! F124-5
OI   CVCL_C635 ! F124-10
OI   CVCL_C636 ! F124B-3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   F13
AC   CVCL_RZ87
DR   EFO; EFO_0002711
DR   Wikidata; Q54833071
RX   PubMed=18298655;
CC   Omics: Transcriptomics; Microarray.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 4
//
ID   F13L-3
AC   CVCL_B6MX
SY   F13L-3.1; F13L
DR   Wikidata; Q111733208
RX   DOI=10.1007/BF01404820;
RX   PubMed=8799617;
RX   PubMed=8988857;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   F15-42-1-5
AC   CVCL_M397
DR   ECACC; 89062107
DR   Wikidata; Q54833072
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04216; Human THY1/CD90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   F15553
AC   CVCL_A8YX
DR   Wikidata; Q108820212
RX   PubMed=30045758;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Leu (c.2149G>C); ClinVar=VCV000018105; Zygosity=Heterozygous (PubMed=30045758).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   F16-4-4-11
AC   CVCL_M398
DR   ECACC; 89062109
DR   Wikidata; Q54833073
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   F16574
AC   CVCL_A8YY
DR   Wikidata; Q108820213
RX   PubMed=30045758;
RX   PubMed=34088002;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=30045758).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   F17-23-2
AC   CVCL_M399
DR   ECACC; 89062110
DR   Wikidata; Q54833074
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   F1706
AC   CVCL_6C53
SY   F-1706; F 1706
DR   Wikidata; Q54833075
RX   PubMed=50281;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6C52 ! F111
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   F18 AF1
AC   CVCL_G648
SY   F18
DR   CLO; CLO_0002969
DR   ATCC; HB-8208
DR   Wikidata; Q54833076
RX   Patent=US4504586;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8208.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09603; Human CSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   F18/12
AC   CVCL_D5Y7
DR   Wikidata; Q127380839
RX   PubMed=6765320;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human >500 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   F180
AC   CVCL_A5CN
SY   F-180
DR   BTO; BTO_0006448
DR   Wikidata; Q107114924
RX   PubMed=31537844;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   F184
AC   CVCL_A5CP
SY   F-184
DR   BTO; BTO_0006449
DR   Wikidata; Q107114928
RX   PubMed=31537844;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   F19
AC   CVCL_K209
DR   CLO; CLO_0002970
DR   ATCC; CRL-2733
DR   Wikidata; Q54833077
RX   Patent=US5059523;
RX   PubMed=2877731;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8269.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human F19 antigen.
CC   Discontinued: ATCC; CRL-2733; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 7
//
ID   F1A3-23
AC   CVCL_G649
SY   A3
DR   CLO; CLO_0002971
DR   Wikidata; Q54833078
RX   Patent=US4504586;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8207.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09603; Human CSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 7
//
ID   F1B
AC   CVCL_6318
SY   F 1 B; F1B(N)
DR   CLO; CLO_0002964
DR   ATCC; CRL-6168
DR   Wikidata; Q54833082
RX   PubMed=5066602;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6168; true.
CC   Derived from site: In situ; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   F1G
AC   CVCL_C4MU
DR   Wikidata; Q116048961
RX   PubMed=36246297;
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Transduced with a fluorescent reporter (F1G) which is a construct that contains the substrate of the nsp5 protease (SAVLQSGF) between a NLS-eGFP and a membrane anchor. Thus GFP, upon cleavage of the nsp5 protease site by the SARS-CoV-2 main protease, re-localizes from the cytoplasm in non-infected cells to the nucleus in infected cells (PubMed=36246297).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   F1G-red
AC   CVCL_C4MV
DR   Wikidata; Q116048962
RX   PubMed=36246297;
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Transduced with a fluorescent reporter (F1G) which is a construct that contains the substrate of the nsp5 protease (SAVLQSGF) between a NLS-eGFP and a membrane anchor. Thus GFP, upon cleavage of the nsp5 protease site by the SARS-CoV-2 main protease, re-localizes from the cytoplasm in non-infected cells to the nucleus in infected cells (PubMed=36246297).
CC   Characteristics: Also transduced with a red fluorescent mCherry-NLS construct. Thus SARS-CoV-2 infection can be scored automatically in living cells by comparing the patterns of green and red fluorescence signals (PubMed=36246297).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_C4MU ! F1G
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   F2
AC   CVCL_XK46
SY   F
DR   Wikidata; Q93548278
RX   CelloPub=CLPUB00541;
RX   PubMed=4353638;
RX   PubMed=11946918;
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: Lak:LVG(SYR); VBO=VBO_0017488.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_XK45 ! F5-1
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   F2-0
AC   CVCL_E7I2
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00410; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f2-0/
CC   Characteristics: Has an epithelioid morphology; subnormal subcategory (Sbnl) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 30 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F2-1
AC   CVCL_E7I3
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00411; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f2-1/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia high subcategory (PNsarc2) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 144 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F2-2
AC   CVCL_E7I4
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00460; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f2-2/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia low subcategory (PNsarc1) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 26 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F2-3
AC   CVCL_E7IC
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00412; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f2-3/
CC   Characteristics: Has an epithelioid morphology; preneoplastic epithelioid subcategory (PNep) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 32 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F2-4
AC   CVCL_E7ID
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00413; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f2-4/
CC   Characteristics: Has an epithelioid morphology; preneoplastic epithelioid subcategory (PNep) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 46 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F2-43
AC   CVCL_C6GR
DR   Wikidata; Q116048963
RX   PubMed=18452945;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DPI1; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) botulinum neurotoxin type A (botA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   F2.4A3
AC   CVCL_A039
DR   Wikidata; Q54833083
RX   PubMed=7514905;
CC   Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A038 ! FEC.2
SX   Sex unspecified
AG   9FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   F2.4E5
AC   CVCL_A040
SY   F2-4E5
DR   BioSample; SAMN03151917
DR   cancercelllines; CVCL_A040
DR   Wikidata; Q54833084
RX   PubMed=7514905;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 9 week old fetal thymus.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00120.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   F2-5
AC   CVCL_E7IE
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00414; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f2-5/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); miscellaneous subcategory (PNMisc) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 28 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F2.5B6
AC   CVCL_A041
SY   F2-5B6
DR   BioSample; SAMN03151918
DR   cancercelllines; CVCL_A041
DR   Wikidata; Q54833085
RX   PubMed=7514905;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 9 week old fetal thymus.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00121.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   F20NiV-34
AC   CVCL_C7XM
DR   Wikidata; Q123031256
RX   PubMed=36016279;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9IH62; Nipah virus glycoprotein G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   F20NiV-65
AC   CVCL_C7XN
DR   Wikidata; Q123031257
RX   PubMed=36016279;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9IH62; Nipah virus glycoprotein G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   F20T
AC   CVCL_E2X3
RX   PubMed=33157036;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient undergoing corneal transplant surgery (PubMed=33157036).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
DI   NCIt; C84721; Fuchs endothelial dystrophy
DI   ORDO; Orphanet_98974; Fuchs endothelial corneal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   F21-1D3G7C8
AC   CVCL_G650
DR   CLO; CLO_0002973
DR   Wikidata; Q54833086
RX   Patent=US5037755;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9463.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Agrobacterium tumefaciens biovar 3 strain CG-49.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 7
//
ID   F23
AC   CVCL_N322
SY   F.sub.23; URO3
DR   Wikidata; Q54833087
RX   Patent=US4713352;
RX   Patent=US4935344;
RX   PubMed=3857626;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8231.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen URO3 on renal cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   F23.1
AC   CVCL_D665
DR   BCRJ; 0083
DR   Wikidata; Q54833088
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-beta-8.
CC   Discontinued: BCRJ; 0083; probable.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 6
//
ID   F23.2
AC   CVCL_D666
DR   BCRJ; 0084
DR   Wikidata; Q54833089
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-beta-8.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 5
//
ID   F239hTert
AC   CVCL_VL08
DR   Wikidata; Q93548392
RX   PubMed=19409520;
RX   PubMed=21149446;
CC   Sequence variation: Mutation; HGNC; HGNC:9816; RAD50; Simple; p.Arg1093Ter (c.3277C>T); ClinVar=VCV000005872; Zygosity=Heterozygous (PubMed=19409520).
CC   Sequence variation: Mutation; HGNC; HGNC:9816; RAD50; Simple; p.Ter1313Tyrext*66 (c.3939A>T); ClinVar=VCV000005873; Zygosity=Heterozygous (PubMed=19409520).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153178; Nijmegen breakage syndrome-like disorder
DI   ORDO; Orphanet_240760; Nijmegen breakage syndrome-like disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   F24
AC   CVCL_K210
DR   CLO; CLO_0002974
DR   Wikidata; Q54833090
RX   Patent=US5059523;
RX   PubMed=2877731;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9527.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   F24-1
AC   CVCL_C6GG
DR   ABCD; ABCD_AA519
DR   Wikidata; Q116048964
RX   PubMed=20548779;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10844; Clostridium botulinum botulinum neurotoxin type B (botB) (Note=AA 2-441 = Light chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   F24-4
AC   CVCL_C6GH
DR   Wikidata; Q116048965
RX   PubMed=20548779;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10844; Clostridium botulinum botulinum neurotoxin type B (botB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   F2408
AC   CVCL_8352
SY   F 2408
DR   JCRB; IFO50015
DR   Wikidata; Q54833091
RX   PubMed=6307528;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   F2408 EBNA2 cl-14
AC   CVCL_E943
SY   F2408-E2 Cl.14
DR   JCRB; JCRB0143.5
DR   JCRB; NIHS0223.5
DR   Wikidata; Q54833093
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.5; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   F2408 EBNA2 cl-16
AC   CVCL_E944
SY   F2408-E2 Cl.16
DR   JCRB; JCRB0143.2
DR   JCRB; NIHS0223.2
DR   Wikidata; Q54833094
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.2; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   F2408 EBNA2 cl-18
AC   CVCL_E945
SY   F2408-E2 Cl.18
DR   JCRB; JCRB0143.3
DR   JCRB; NIHS0223.3
DR   Wikidata; Q54833095
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.3; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   F2408 EBNA2 cl-23
AC   CVCL_E946
SY   F2408-E2 Cl.23
DR   JCRB; JCRB0143.6
DR   JCRB; NIHS0223.6
DR   Wikidata; Q54833096
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.6; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   F2408 EBNA2 cl-24
AC   CVCL_E947
SY   F2408-E2 Cl.24
DR   JCRB; JCRB0143.4
DR   JCRB; NIHS0223.4
DR   Wikidata; Q54833097
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.4; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   F2408 EBNA2 cl-28
AC   CVCL_E948
SY   F2408-E2 Cl.28
DR   JCRB; JCRB0143.7
DR   JCRB; NIHS0223.7
DR   Wikidata; Q54833098
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.7; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   F2408 EBNA2 cl-9
AC   CVCL_E949
SY   F2408-E2 Cl.9
DR   JCRB; JCRB0143.1
DR   JCRB; NIHS0223.1
DR   Wikidata; Q54833099
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12978; Epstein-Barr virus (strain B95-8) EBNA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.1; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   F2408 pZipNeo
AC   CVCL_E950
DR   JCRB; JCRB0143.0
DR   JCRB; NIHS0223.0
DR   Wikidata; Q54833100
RX   PubMed=7556601;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: JCRB; NIHS0223.0; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   F2408-B812
AC   CVCL_E951
SY   B812
DR   JCRB; IFO50099
DR   Wikidata; Q54833101
RX   PubMed=6829165;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L072 ! F2408-No.7
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   F2408-B993
AC   CVCL_E952
DR   JCRB; IFO50100
DR   Wikidata; Q54833102
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L072 ! F2408-No.7
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   F2408-No.20
AC   CVCL_L070
DR   JCRB; IFO50101
DR   Wikidata; Q54833103
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   F2408-No.3
AC   CVCL_L071
DR   JCRB; IFO50098
DR   Wikidata; Q54833104
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   F2408-No.7
AC   CVCL_L072
DR   JCRB; IFO50102
DR   Wikidata; Q54833105
RX   PubMed=6829165;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   F25 [Cat erythroleukemia]
AC   CVCL_6387
DR   CLO; CLO_0002975
DR   ATCC; CRL-6566
DR   NCBI_Iran; C593
DR   Wikidata; Q54833106
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6566; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C134770; Feline erythroleukemia
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   1-2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   F25 [Mouse hybridoma against human FCRL5]
AC   CVCL_J279
DR   JCRB; JCRB1323
DR   Wikidata; Q54833107
RX   PubMed=15671532;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   F25.2
AC   CVCL_J950
DR   Wikidata; Q54833108
RX   Patent=US4522918;
RX   PubMed=6789331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8109.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   F255A4
AC   CVCL_8688
DR   BioSample; SAMN03151694
DR   Wikidata; Q54833109
RX   PubMed=6451928;
RX   PubMed=6988327;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00045.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   F26-16
AC   CVCL_C6GI
DR   ABCD; ABCD_AA518
DR   Wikidata; Q116048966
RX   PubMed=20548779;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; P10844; Clostridium botulinum botulinum neurotoxin type B (botB) (Note=AA 442-1291 = Heavy chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   F26G1
AC   CVCL_YZ06
DR   Wikidata; Q98125979
RX   DOI=10.1089/153685904774129757;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   F26G18
AC   CVCL_YZ09
DR   Wikidata; Q98125980
RX   DOI=10.1089/153685904774129757;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   F26G19
AC   CVCL_YZ10
DR   Wikidata; Q98125981
RX   DOI=10.1089/153685904774129757;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   F26G6
AC   CVCL_YZ07
DR   Wikidata; Q98125986
RX   DOI=10.1089/153685904774129757;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   F26G8
AC   CVCL_YZ08
DR   Wikidata; Q98125991
RX   DOI=10.1089/153685904774129757;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   F27-33
AC   CVCL_C6GJ
DR   ABCD; ABCD_AA517
DR   Wikidata; Q116048967
RX   PubMed=20548779;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10844; Clostridium botulinum botulinum neurotoxin type B (botB) (Note=AA 2-441 = Light chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   F29-38
AC   CVCL_C6GK
DR   Wikidata; Q116048968
RX   PubMed=20548779;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P10844; Clostridium botulinum botulinum neurotoxin type B (botB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   F29-40
AC   CVCL_C6GL
DR   ABCD; ABCD_AA516
DR   Wikidata; Q116048969
RX   PubMed=20548779;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10844; Clostridium botulinum botulinum neurotoxin type B (botB) (Note=AA 442-1291 = Heavy chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   F2C03
AC   CVCL_EQ51
DR   ArrayExpress; E-MEXP-1956
DR   Wikidata; Q54833110
RX   PubMed=20569274;
CC   Characteristics: This cell line only expresses the non-mutated MECP2 allele (PubMed=20569274).
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg255Ter (c.763C>T) (p.Arg267Ter, c.799C>T); ClinVar=VCV000011829; Zygosity=Heterozygous (PubMed=20569274).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EQ52 ! F2C14
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   F2C14
AC   CVCL_EQ52
DR   ArrayExpress; E-MEXP-1956
DR   Wikidata; Q54833111
RX   PubMed=20569274;
CC   Characteristics: This cell line only expresses the mutated MECP2 allele (PubMed=20569274).
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg255Ter (c.763C>T) (p.Arg267Ter, c.799C>T); ClinVar=VCV000011829; Zygosity=Heterozygous (PubMed=20569274).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EQ51 ! F2C03
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   F2N78
AC   CVCL_VK71
SY   F2N clone 78; Fusion of 293 cells with Namalwa, clone 78
DR   Wikidata; Q93548602
RX   PubMed=23296943;
RX   PubMed=26454770;
RX   PubMed=28054185;
CC   Characteristics: Developed for recombinant proteins production.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
HI   CVCL_0067 ! Namalwa
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 5
//
ID   F3
AC   CVCL_A2GF
DR   PRIDE; PXD019354
DR   Wikidata; Q105506858
RX   PubMed=19914712;
RX   PubMed=20975254;
RX   PubMed=29017582;
RX   PubMed=32942559;
CC   Characteristics: Susceptible to infection by Neospora caninum isolates Nc-Spain7 and Nc-Spain1H (PubMed=29017582).
CC   Doubling time: ~24 hours (Note=In FSM medium) (PubMed=19914712).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   5FM
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   F3-1
AC   CVCL_E7IF
RX   PubMed=27129173;
RX   PubMed=32290283;
CC   Characteristics: Has an epithelioid morphology; preneoplastic epithelioid subcategory (PNep) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 125 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F3-2
AC   CVCL_E7IG
RX   PubMed=27129173;
RX   PubMed=32290283;
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); miscellaneous subcategory (PNMisc) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 21 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F3-20-7
AC   CVCL_T985
DR   ECACC; 89062112
DR   Wikidata; Q54833112
RX   PubMed=6111855;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; J9P7X2; Dog THY1/CD90.
CC   Discontinued: ECACC; 89062112; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 5
//
ID   F3-87-8-1
AC   CVCL_T976
DR   ECACC; 89062108
DR   Wikidata; Q54833113
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   F3-B2
AC   CVCL_A9J9
DR   Wikidata; Q102113806
RX   PubMed=32822285;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; P33706; Dog CD8A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   F3-effLuc
AC   CVCL_B7F6
DR   Wikidata; Q112929549
RX   PubMed=25198726;
CC   Characteristics: Transduced with a CMV promoter controlled effLuc-IRES-Thy1.1 construct (PubMed=25198726).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98747; Thy1 (Note=With p.Gln108Arg = Thy1.1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = effLuc).
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ44 ! HB1.F3
SX   Female
AG   14FW
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   F3(B6)
AC   CVCL_B6D5
DR   Wikidata; Q111733209
RX   DOI=10.1007/BF00163280;
RX   PubMed=1367377;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P47712; Human PLA2G4A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   F31
AC   CVCL_N323
SY   F.sub.31; URO8; URO-8
DR   Wikidata; Q54833114
RX   Patent=US4713352;
RX   Patent=US4935344;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8548.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen URO8 on renal cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   F32 VIII C4
AC   CVCL_L512
SY   F-32 VIII C4
DR   CLO; CLO_0002977
DR   ATCC; CRL-1653
DR   Wikidata; Q54833115
RX   PubMed=6376344;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; F1S379; Pig REN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   F344-Tg.EC4011
AC   CVCL_5F85
DR   Wikidata; Q54833116
RX   PubMed=23437152;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   F35T
AC   CVCL_E2X2
RX   DOI=10.1101/2024.03.27.587034;
RX   Patent=US11512312;
RX   PubMed=33157036;
RX   PubMed=38024683;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Repeat_expansion; g.54765TGC[~4500] (g.54765TGC[51_?]) (CTG18.1); ClinVar=VCV000204360; Zygosity=Heterozygous; Note=The other allele has 21 repeats (PubMed=33157036).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient undergoing corneal transplant surgery (PubMed=33157036).
CC   Miscellaneous: STR profile and donor ethnicity from personal communication of Zarouchlioti, Christina.
CC   Caution: PubMed=38024683 and Patent=US11512312 erroneously indicate the number of CTG18.1 repeats to be ~1500.
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 18,20
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D1S1656: 11,17.3
ST   D21S11: 29,32.2
ST   D22S1045: 15,16
ST   D2S1338: 20
ST   D2S441: 12
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21,22
ST   SE33: 26.2,27.2
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C84721; Fuchs endothelial dystrophy
DI   ORDO; Orphanet_98974; Fuchs endothelial corneal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   F36/22
AC   CVCL_C9BC
DR   Wikidata; Q123031258
RX   Patent=EP0118365B1;
RX   Patent=US5871936;
RX   PubMed=6339043;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8215.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human high molecular weight glycoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   F3B6
AC   CVCL_8953
DR   CLO; CLO_0002978
DR   ATCC; HB-8785
DR   NCBI_Iran; C197
DR   Wikidata; Q54833117
RX   Patent=US4677070;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8785.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 9
//
ID   F3C15
AC   CVCL_EQ53
DR   ArrayExpress; E-MEXP-1956
DR   Wikidata; Q54833118
RX   PubMed=20569274;
CC   Characteristics: This cell line only expresses the mutated MECP2 allele (PubMed=20569274).
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg270Ter (c.808C>T) (p.Arg282Ter, c.844C>T); ClinVar=VCV000011815; Zygosity=Heterozygous (PubMed=20569274).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EQ54 ! F3C18
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   F3C18
AC   CVCL_EQ54
DR   ArrayExpress; E-MEXP-1956
DR   Wikidata; Q54833119
RX   PubMed=20569274;
CC   Characteristics: This cell line only expresses the non-mutated MECP2 allele (PubMed=20569274).
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg270Ter (c.808C>T) (p.Arg282Ter, c.844C>T); ClinVar=VCV000011815; Zygosity=Heterozygous (PubMed=20569274).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EQ53 ! F3C15
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   F3D1-2F6
AC   CVCL_F1L6
RX   PubMed=3436625;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F3F5
AC   CVCL_E4RC
DR   ABCD; ABCD_AW138
RX   PubMed=32860273;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12661; Bovine RBP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F3II
AC   CVCL_E119
DR   Wikidata; Q54833120
RX   CelloPub=CLPUB00707;
RX   DOI=10.1158/1538-7445.AM2020-2649;
RX   PubMed=8691844;
CC   Doubling time: 17.7 hours (PubMed=8691844); 22.80 hours (CelloPub=CLPUB00707).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4Y25 ! M3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   F3II-NM
AC   CVCL_B7TQ
SY   F3II NM
DR   Wikidata; Q112929550
RX   CelloPub=CLPUB00707;
RX   DOI=10.1158/1538-7445.AM2020-2649;
CC   Characteristics: Established through the following protocol: the parental cell line was inoculated in the subcutis of BALB/c mice, a pulmonary metastatic tumor was transplanted by surgery in another mouse. The transplantation process was repeated twice and the cell line was established from primary culture of the resulting tumor (CelloPub=CLPUB00707).
CC   Doubling time: 31.71 hours (CelloPub=CLPUB00707).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E119 ! F3II
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 5
//
ID   F3II-TP
AC   CVCL_B7TR
SY   F3II TP
DR   Wikidata; Q112929551
RX   CelloPub=CLPUB00707;
RX   DOI=10.1158/1538-7445.AM2020-2649;
CC   Characteristics: Established through the following protocol: the parental cell line was inoculated in the subcutis of BALB/c mice, the produced tumor was transplanted by surgery in another mouse. The transplantation process was repeated twice and the cell line was established from primary culture of the resulting tumor (CelloPub=CLPUB00707).
CC   Doubling time: 25.52 hours (CelloPub=CLPUB00707).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E119 ! F3II
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 5
//
ID   F4
AC   CVCL_B0FL
DR   Wikidata; Q108820214
RX   Patent=US5503984;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11325.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F4 G6PD Knockout
AC   CVCL_JM60
DR   ATCC; CRL-3309
DR   Wikidata; Q54833121
RX   PubMed=26576833;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:105979; G6pdx.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JM59 ! BNL CL.2 High Passage
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   F4.4
AC   CVCL_A7WH
DR   BEI_Resources; MRA-665
DR   Wikidata; Q107114930
RX   PubMed=3539609;
RX   PubMed=9108554;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q25645; Plasmodium berghei merozoite surface protein 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   F4-T2
AC   CVCL_E7IH
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00419; https://technology-offers.inserm-transfert.com/offer/rat-mesothelioma-cell-line-f4-t2/
CC   Characteristics: Neoplastic. Invasive phenotype (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 46 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F4/4.K6
AC   CVCL_4606
DR   CLO; CLO_0002979
DR   CLDB; cl1194
DR   DSMZ; ACC-52
DR   DSMZCellDive; ACC-52
DR   Wikidata; Q54833122
RX   PubMed=2785556;
CC   Characteristics: IL4 dependent.
CC   Discontinued: DSMZ; ACC-52; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   F4/80
AC   CVCL_7263
DR   CLO; CLO_0002980
DR   ATCC; HB-198
DR   Wikidata; Q54833135
RX   PubMed=7308288;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q61549; Mouse Adgre1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   F4/B8
AC   CVCL_9R59
SY   B8
DR   Wikidata; Q54833136
RX   PubMed=1057176;
RX   PubMed=4514957;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9R58 ! FSD1/F4
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 6
//
ID   F4/B8/3
AC   CVCL_6368
SY   B8/3
DR   JCRB; JCRB0238
DR   Wikidata; Q54833137
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9R59 ! F4/B8
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 7
//
ID   F4/CB5/K18
AC   CVCL_B0KN
DR   Wikidata; Q108820215
RX   PubMed=6649980;
RX   PubMed=6874913;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   F4/CB5/K104
AC   CVCL_B0KP
DR   Wikidata; Q108820216
RX   PubMed=6649980;
RX   PubMed=6874913;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   F4/JD3.8/K101
AC   CVCL_B0KQ
DR   Wikidata; Q108820217
RX   PubMed=6649980;
RX   PubMed=6874913;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   F422
AC   CVCL_J510
SY   F-422
DR   Wikidata; Q54833138
RX   PubMed=2822586;
RX   PubMed=8138999;
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   F4374
AC   CVCL_6F46
DR   Wikidata; Q54833141
RX   PubMed=12441130;
RX   PubMed=15322275;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   F4374 hTERT
AC   CVCL_6F50
SY   OF4374 hTERT
DR   Wikidata; Q54833142
RX   PubMed=12441130;
RX   PubMed=15322275;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_6F49 ! OF4374
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   F45J
AC   CVCL_L513
SY   45J
DR   CLO; CLO_0002981
DR   ATCC; HB-9740
DR   Wikidata; Q54833143
RX   Patent=US5091512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9740.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02671; Human FGA.
CC   Discontinued: ATCC; HB-9740; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   F4869
AC   CVCL_6F47
DR   Wikidata; Q54833144
RX   PubMed=12441130;
RX   PubMed=15322275;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   F4869 hTERT
AC   CVCL_6F48
DR   Wikidata; Q54833145
RX   PubMed=15322275;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_6F47 ! F4869
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   F4C1
AC   CVCL_IV56
DR   Wikidata; Q54833146
RX   PubMed=178673;
CC   Doubling time: 48 hours (PubMed=178673).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_H712 ! MtT/E
OI   CVCL_H713 ! MtT/S
OI   CVCL_H714 ! MtT/Se
OI   CVCL_H715 ! MtT/SM
SX   Female
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   F4N
AC   CVCL_4176
SY   F4N (MEL); F4N(MEL); F4N MEL; MEL-F4N
DR   CLO; CLO_0002982
DR   ECACC; 96121718
DR   Wikidata; Q33121044
RX   PubMed=1057176;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/F4N
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9R58 ! FSD1/F4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 8
//
ID   F4N-S
AC   CVCL_4344
SY   F4N-Sofia; F4N (Sofia); F4N-S MEL; F4N clone Sofia
DR   Wikidata; Q54833147
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4176 ! F4N
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   F5
AC   CVCL_V616
DR   BTO; BTO_0004530
DR   BioGRID_ORCS_Cell_line; 434
DR   cancercelllines; CVCL_V616
DR   Cell_Model_Passport; SIDM01497
DR   DepMap; ACH-001067
DR   PharmacoDB; F5_364_2019
DR   Progenetix; CVCL_V616
DR   Wikidata; Q54833148
RX   PubMed=7542695;
RX   PubMed=7585498;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=34850056;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 46 hours (PubMed=25984343); 1 day (PubMed=34850056).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (DepMap=ACH-001067).
CC   Omics: Genomics; Whole exome sequencing.
CC   Genome ancestry: African=2.76%; Native American=0%; East Asian, North=3.58%; East Asian, South=0%; South Asian=0%; European, North=60.4%; European, South=33.25% (PubMed=30894373).
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   F5-1
AC   CVCL_XK45
DR   Wikidata; Q93548857
RX   CelloPub=CLPUB00541;
RX   PubMed=4353638;
RX   PubMed=11946918;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: Lak:LVG(SYR); VBO=VBO_0017488.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   F5-2
AC   CVCL_E7II
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00431; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-f5-2/
CC   Characteristics: Has an epithelioid morphology; preneoplastic intermediary subcategory (PNint) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 41 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F5-3
AC   CVCL_E7IJ
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00458; https://technology-offers.inserm-transfert.com/offer/rat-transformed-mesothelial-cell-line-f5-3/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia high subcategory (PNsarc2) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 250 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F5-5.F1
AC   CVCL_4177
SY   F5-5.fl
DR   CLO; CLO_0050783
DR   ECACC; 99072803
DR   RCB; RCB0560
DR   Wikidata; Q54833149
RX   PubMed=1071084;
CC   Breed/subspecies: DDD.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4312 ! T-3-Cl-2
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   F5-A-1/22.8.13
AC   CVCL_L514
SY   F5
DR   CLO; CLO_0002984
DR   ATCC; HB-8051
DR   Wikidata; Q54833151
RX   Patent=US4446122;
RX   PubMed=6205972;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8051.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   F5-T1
AC   CVCL_E7IK
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00421; https://technology-offers.inserm-transfert.com/offer/rat-mesothelioma-cell-line-f5-t1/
CC   Characteristics: Neoplastic. Invasive phenotype (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 22 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F56 [Misidentified human neoplasm]
AC   CVCL_WJ23
DR   CCRID; 4201HUM-CCTCC00044
DR   CCTCC; GDC0044
DR   Wikidata; Q93548880
RX   PubMed=28851942;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of human origin but found to be from mouse (PubMed=28851942). Originally thought to originate from an adenocarcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   F56 [Mouse hybridoma against human FCRL5]
AC   CVCL_J280
DR   JCRB; JCRB1189
DR   Wikidata; Q54833152
RX   PubMed=15671532;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   F5B6-A6
AC   CVCL_F1L7
RX   PubMed=3436625;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F5C9-AD2
AC   CVCL_F1L8
RX   PubMed=3436625;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F6 [Mouse hybridoma against human SIPA1]
AC   CVCL_C7XE
DR   Wikidata; Q123031259
RX   Patent=US5998585;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4839.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96FS4; Human SIPA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   F6 [Rat ESC]
AC   CVCL_E8CK
SY   F344/NHsd-ES6/Qly
WW   Provider; RRRC; RRRC_00466; https://www.rrrc.us/Strain/?x=466
CC   Doubling time: ~24-36 hours (RRRC=466).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   F60
AC   CVCL_ZV51
DR   cancercelllines; CVCL_ZV51
DR   Cosmic; 850743
DR   Wikidata; Q98125994
RX   PubMed=9070656;
RX   PubMed=9090379;
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg335Ter (c.1003C>T); ClinVar=VCV000007833; Zygosity=Unspecified (PubMed=9090379).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   F64.5
AC   CVCL_J951
DR   Wikidata; Q54833153
RX   PubMed=6789331;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   F6B3
AC   CVCL_4Y23
SY   SR-C3H/St glioma
DR   JCRB; JCRB1571
DR   RCB; RCB4473
DR   Wikidata; Q54833154
RX   DOI=10.2220/biomedres.5.517;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C3H/St.
DI   NCIt; C21962; Mouse glial tumours of uncertain origin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   f6b4g7b4
AC   CVCL_C8KB
DR   Wikidata; Q123031260
RX   PubMed=12797735;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_61987; 2-methylisoborneol (MIB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   F6C01
AC   CVCL_EQ55
DR   ArrayExpress; E-MEXP-1956
DR   Wikidata; Q54833155
RX   PubMed=20569274;
CC   Characteristics: This cell line only expresses the non-mutated MECP2 allele (PubMed=20569274).
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Hisfs*5 (c.1157_1197del41) (p.Leu398Hisfs*5, c.1193_1233del41) (c.1156del41); ClinVar=VCV000143369; Zygosity=Heterozygous (PubMed=20569274).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EQ56 ! F6C04
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   F6C04
AC   CVCL_EQ56
DR   ArrayExpress; E-MEXP-1956
DR   Wikidata; Q54833157
RX   PubMed=20569274;
CC   Characteristics: This cell line only expresses the mutated MECP2 allele (PubMed=20569274).
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Hisfs*5 (c.1157_1197del41) (p.Leu398Hisfs*5, c.1193_1233del41) (c.1156del41); ClinVar=VCV000143369; Zygosity=Heterozygous (PubMed=20569274).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EQ55 ! F6C01
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   F6D2
AC   CVCL_B6FG
DR   Wikidata; Q111733210
RX   PubMed=22358881;
CC   Population: African American.
CC   Characteristics: The expression of the beta-galactosidase gene (lacZ) is under the control of a hypoxia-inducible EPO promoter (PubMed=22358881).
CC   Doubling time: 45 hours (PubMed=22358881).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   F6T
AC   CVCL_B7P1
DR   Wikidata; Q112929552
RX   PubMed=1472476;
RX   PubMed=1719236;
RX   PubMed=9357968;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   F7
AC   CVCL_C8HM
DR   Wikidata; Q123031261
RX   PubMed=193040;
RX   PubMed=11894926;
RX   PubMed=20493099;
CC   Characteristics: Tumorigenic when injected subcutaneously in mice (PubMed=193040).
CC   Doubling time: ~24 hours (PubMed=11894926).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UJ36 ! HT9-C7
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   F7-1A9D10
AC   CVCL_D7D8
RX   PubMed=25897608;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P03420; Human respiratory syncytial virus A (strain A2) F (Note=AA 346-360 = B-cell epitope F7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   F7.2.38
AC   CVCL_D7DM
RX   PubMed=11101629;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07766; Human CD3E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   F71B12
AC   CVCL_C4RE
DR   Wikidata; Q116048970
RX   PubMed=2073131;
RX   PubMed=2695015;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   F71D7
AC   CVCL_C4RF
DR   Wikidata; Q116048971
RX   PubMed=2073131;
RX   PubMed=2695015;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   F71H10
AC   CVCL_C4RG
DR   Wikidata; Q116048972
RX   PubMed=2073131;
RX   PubMed=2695015;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   F71H9
AC   CVCL_C4RH
DR   Wikidata; Q116048973
RX   PubMed=2073131;
RX   PubMed=2695015;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   F8
AC   CVCL_6388
DR   CLO; CLO_0002986
DR   ATCC; CRL-6074
DR   Wikidata; Q54833158
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6074; true.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   F8-11-13
AC   CVCL_T977
DR   ECACC; 89062102
DR   NCBI_Iran; H122
DR   Wikidata; Q54833159
RX   PubMed=6166706;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45 (Note=Isoform CD45RA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 7
//
ID   F81
AC   CVCL_9259
SY   F-81; FK81
DR   CCRID; 3101MAMGNO13
DR   CLS; 305015
DR   KCB; KCB 2006104YJ
DR   Wikidata; Q54833160
RX   PubMed=24525403;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_7216 ! Clone 81
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   F81G2
AC   CVCL_C4RI
DR   Wikidata; Q116048974
RX   PubMed=2695015;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   F89/160.1.5
AC   CVCL_B0HX
SY   F89/160 clone 1.5
DR   ATCC; HB-12403
DR   Wikidata; Q108820218
RX   Patent=US6261790;
RX   Patent=US6514707;
RX   PubMed=9620413;
RX   PubMed=10970367;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12403.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with sheep, mule deer, elk and many other species; recognizes the epitope 'Ile-His-Phe-Gly').
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F89/193.1.5
AC   CVCL_B0HY
DR   Wikidata; Q108820219
RX   Patent=US6261790;
RX   Patent=US6514707;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-114.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with sheep, mule deer and elk).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   F8B7-B8
AC   CVCL_F1L9
RX   PubMed=3436625;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F9
AC   CVCL_0259
DR   BTO; BTO_0000095
DR   CLO; CLO_0002988
DR   CLO; CLO_0050537
DR   CLO; CLO_0050539
DR   EFO; EFO_0002053
DR   MCCL; MCC:0000150
DR   CLDB; cl1198
DR   CLDB; cl1199
DR   CLDB; cl1200
DR   CLDB; cl1201
DR   CLDB; cl4950
DR   ATCC; CRL-1720
DR   CCRID; 1101MOU-PUMC000276
DR   CCRID; 3101MOUTCM4
DR   ChEMBL-Cells; CHEMBL3307489
DR   ChEMBL-Targets; CHEMBL614296
DR   CLS; 400174
DR   DSMZ; ACC-112
DR   DSMZCellDive; ACC-112
DR   ECACC; 85061803
DR   ICLC; ATL99006
DR   JCRB; JCRB0721
DR   KCLB; 21720
DR   PubChem_Cell_line; CVCL_0259
DR   RCB; RCB1555
DR   RCB; RCB2643
DR   TKG; TKG 0519
DR   TOKU-E; 1176
DR   Wikidata; Q54833162
RX   PubMed=61803;
RX   PubMed=214238;
RX   PubMed=2412863;
RX   PubMed=4521215;
RX   PubMed=6479493;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-206.html
CC   Doubling time: ~24 hours (DSMZ=ACC-112).
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   F9-11
AC   CVCL_A5VP
DR   Wikidata; Q107114931
RX   PubMed=8710496;
CC   Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496).
CC   Characteristics: Mixture of cells containing small integrations of yeast DNA (27% of cells), cells containing large numbers of small extrachromosomal elements (32% of cells, Fig. 2C) and cells containing no yeast DNA (40% of cells) (PubMed=8710496).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   F9-12
AC   CVCL_A5VQ
DR   BTO; BTO_0004958
DR   Wikidata; Q107114933
RX   PubMed=8710496;
CC   Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496).
CC   Characteristics: Mixture of cells with small integrations of yeast DNA (23%), cells with large numbers of small extrachromosomal elements (17%), cells with very large integrations of yeast DNA (18%), cells with a large novel chromosome (14%) and cells with no signal (28%) (PubMed=8710496).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   F9-13
AC   CVCL_A5VR
DR   Wikidata; Q107114935
RX   PubMed=8710496;
CC   Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496).
CC   Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   F9-15
AC   CVCL_A5VS
DR   Wikidata; Q107114938
RX   PubMed=8710496;
CC   Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496).
CC   Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   F9-1A6C8
AC   CVCL_D7D9
RX   PubMed=25897608;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P03420; Human respiratory syncytial virus A (strain A2) F (Note=AA 393-407 = B-cell epitope F9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   F9-41
AC   CVCL_8300
DR   JCRB; JCRB0001
DR   Wikidata; Q54833163
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0259 ! F9
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   F9-5
AC   CVCL_A5VT
DR   Wikidata; Q107114943
RX   PubMed=8710496;
CC   Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496).
CC   Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   F9/LM(1+10)
AC   CVCL_T372
DR   CLO; CLO_0050535
DR   RCB; RCB2315
DR   Wikidata; Q54833164
RX   PubMed=16314080;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:105382; Lama5.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0259 ! F9
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   F9/LM10
AC   CVCL_T373
DR   CLO; CLO_0050534
DR   RCB; RCB2314
DR   Wikidata; Q54833165
RX   PubMed=16314080;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:105382; Lama5.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0259 ! F9
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   F918-17-1
AC   CVCL_E4S3
RX   Patent=US6114507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F918-2-4
AC   CVCL_E4S4
RX   Patent=US6114507;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F918-20-2
AC   CVCL_E4S5
RX   Patent=US6114507;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F918-23-1
AC   CVCL_E4S6
RX   Patent=US6114507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F918-4-5
AC   CVCL_E4S7
RX   Patent=US6114507;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F918-7-3
AC   CVCL_E4S8
RX   Patent=US6114507;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5533.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F918-9-4
AC   CVCL_E4S9
RX   Patent=US6114507;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5534.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F919-9-18
AC   CVCL_E4SA
DR   ABCD; ABCD_AD825
RX   Patent=US6114507;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5535.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   F945
AC   CVCL_F1LG
DR   ABCD; ABCD_BG478
RX   PubMed=40692775;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O50917; Borreliella burgdorferi (strain ATCC 35210 / DSM 4680 / CIP 102532 / B31) decorin-binding protein A (dbpA).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG40 ! HMMA2.5
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   F96/224
AC   CVCL_WY35
SY   F96-224
DR   Wikidata; Q93549042
RX   PubMed=10416610;
RX   PubMed=16540517;
CC   Sequence variation: Mutation; HGNC; HGNC:17642; DCLRE1C; Simple; p.Leu70del (c.201_203GTT[2]) (c.207_209delGTT); ClinVar=VCV000858042; Zygosity=Heterozygous (PubMed=16540517).
CC   Sequence variation: Mutation; HGNC; HGNC:17642; DCLRE1C; Simple; p.Gly126Asp (c.377G>A); Zygosity=Heterozygous (PubMed=16540517).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C162694; Severe combined immunodeficiency, Athabascan type
DI   ORDO; Orphanet_275; Severe combined immunodeficiency due to DCLRE1C deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4-5Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 12
//
ID   F97/6-9A2C
AC   CVCL_B0J4
SY   6-9A
DR   Wikidata; Q108820220
RX   Patent=US5830681;
RX   PubMed=7682482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F97/8-11H2C
AC   CVCL_B0J2
SY   8-11H
DR   Wikidata; Q108820221
RX   Patent=US5830681;
RX   PubMed=7682482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F97/9-1A.6B
AC   CVCL_B0J3
SY   9-1A
DR   Wikidata; Q108820222
RX   Patent=US5830681;
RX   PubMed=7682482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F98
AC   CVCL_3510
DR   CLO; CLO_0002992
DR   ATCC; CRL-2397
DR   BCRJ; 0085
DR   MetaboLights; MTBLS6212
DR   Wikidata; Q54833166
RX   PubMed=7435138;
RX   PubMed=12036929;
RX   PubMed=19381449;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   20FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   F98 EGFR
AC   CVCL_B047
SY   F98(EGFR)
DR   ATCC; CRL-2948
DR   Wikidata; Q54833167
RX   PubMed=12036929;
RX   PubMed=15671565;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3510 ! F98
SX   Female
AG   20FD
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   F98/2-7C.6B
AC   CVCL_B0J0
SY   2-7C
DR   Wikidata; Q108820223
RX   Patent=US5830681;
RX   PubMed=7682482;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F98/5-10H.7G
AC   CVCL_B0J1
SY   5-10H
DR   Wikidata; Q108820224
RX   Patent=US5830681;
RX   PubMed=7682482;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F98/5-3B.2C.4G
AC   CVCL_B0IZ
SY   F98/5-3B.2C; 5-3B
DR   Wikidata; Q108820225
RX   Patent=US5830681;
RX   PubMed=7682482;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10291.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   F98npEGFRvIII
AC   CVCL_B048
DR   ATCC; CRL-2949
DR   Wikidata; Q54833168
RX   PubMed=15671565;
CC   Doubling time: ~17 hours (ATCC=CRL-2949).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3510 ! F98
SX   Female
AG   20FD
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   F99/97.6.1
AC   CVCL_B0HW
SY   F99/97 clone 6.1
DR   ATCC; HB-12696
DR   Wikidata; Q108820226
RX   Patent=US6261790;
RX   PubMed=10970367;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12696.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with sheep, mule deer, elk and many other species; recognizes the epitope 'Gln-Tyr-Gln-Arg-Glu-Ser').
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   F9K4b2
AC   CVCL_B5MT
DR   Wikidata; Q111733211
RX   PubMed=2155426;
RX   PubMed=2833421;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0259 ! F9
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   FA-1073
AC   CVCL_C0NR
DR   Wikidata; Q112929553
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   FA-1073-SV
AC   CVCL_C0NS
DR   Wikidata; Q112929555
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0NR ! FA-1073
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   FA-AML1
AC   CVCL_A6IQ
DR   cancercelllines; CVCL_A6IQ
DR   Wikidata; Q107114945
RX   PubMed=12750298;
CC   Population: Japanese.
CC   Characteristics: CSF2 and IL3 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12750298).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted (PubMed=12750298).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JH25 ! AP37P
OI   CVCL_WD00 ! AP37P(L)
OI   CVCL_JH26 ! FA-AML1A
OI   CVCL_A6IR ! FA-AML1C
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   FA-AML1A
AC   CVCL_JH26
SY   KH-AML
DR   cancercelllines; CVCL_JH26
DR   JCRB; JCRB3043
DR   JCRB; KURB2758
DR   Wikidata; Q54899857
RX   PubMed=12750298;
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12750298).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted. This cell line contains both the mutated allele and the reverted allele (PubMed=12750298).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Ter (c.8504C>G) (8732C>A); ClinVar=VCV000267091; Zygosity=Heterozygous; Note=Mutated. This cell line contains both the mutated allele and the reverted allele (PubMed=12750298).
CC   Discontinued: JCRB; KURB2758; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB3043
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JH25 ! AP37P
OI   CVCL_WD00 ! AP37P(L)
OI   CVCL_A6IQ ! FA-AML1
OI   CVCL_A6IR ! FA-AML1C
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   FA-AML1C
AC   CVCL_A6IR
DR   cancercelllines; CVCL_A6IR
DR   Wikidata; Q107114947
RX   PubMed=12750298;
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12750298).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted (PubMed=12750298).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JH25 ! AP37P
OI   CVCL_WD00 ! AP37P(L)
OI   CVCL_A6IQ ! FA-AML1
OI   CVCL_JH26 ! FA-AML1A
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   FA14(SVT)
AC   CVCL_VH73
DR   JCRB; KURB1467
DR   Wikidata; Q54833170
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Gln356Ter (c.1066C>T); ClinVar=VCV000006715; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH72 ! FA14P
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   FA14P
AC   CVCL_VH72
DR   JCRB; KURB1465
DR   Wikidata; Q54833169
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Gln356Ter (c.1066C>T); ClinVar=VCV000006715; Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   FA17P
AC   CVCL_VH74
DR   JCRB; KURB1468
DR   Wikidata; Q54833171
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   FA17P(SVT)
AC   CVCL_VH75
DR   JCRB; KURB1469
DR   Wikidata; Q54833173
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH74 ! FA17P
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   FA18JTO
AC   CVCL_2895
SY   FA18P; Fanconi Anemia 18 Japan TOkyo
DR   BioSample; SAMN03470923
DR   JCRB; JCRB0315
DR   JCRB; KURB1386
DR   Wikidata; Q54833174
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.1811delT; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0315; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21,22
ST   Penta D: 11,13
ST   Penta E: 8,11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   FA18JTO hTERT
AC   CVCL_D253
DR   JCRB; JCRB3007
DR   JCRB; KURB1389
DR   Wikidata; Q54833175
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.1811delT; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; KURB1389; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3007
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2895 ! FA18JTO
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   FA18JTO(SVT)-1
AC   CVCL_XE06
SY   FA18JTOP(SVT)-1
DR   JCRB; KURB1387
DR   Wikidata; Q93549181
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.1811delT; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=KURB1387
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2895 ! FA18JTO
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 13
//
ID   FA18JTO(SVT)-2
AC   CVCL_XD28
SY   FA18JTOP(SVT)-2
DR   JCRB; JCRB3060
DR   JCRB; KURB1388
DR   Wikidata; Q93549184
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.1811delT; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; KURB1388; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3060
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2895 ! FA18JTO
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 13
//
ID   FA20F
AC   CVCL_JG65
DR   JCRB; KURB1391
DR   Wikidata; Q54833176
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000435134; Zygosity=Heterozygous (from familial inference of FA20P).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   FA20P
AC   CVCL_J286
DR   BioSample; SAMN03472406
DR   JCRB; JCRB3010
DR   JCRB; KURB1390
DR   Wikidata; Q54833177
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000435134; Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Discontinued: JCRB; KURB1390; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3010
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 7,11
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   FA21P
AC   CVCL_VH76
DR   JCRB; KURB1471
DR   Wikidata; Q54833178
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   FA21P(SVT)
AC   CVCL_VH77
DR   JCRB; KURB1472
DR   Wikidata; Q54833179
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH76 ! FA21P
SX   Male
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   FA23P
AC   CVCL_JG75
DR   JCRB; KURB1392
DR   Wikidata; Q54833194
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.3766_3828del (Ex38del); Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   FA24(SVT)
AC   CVCL_VH79
DR   JCRB; KURB1475
DR   Wikidata; Q54833197
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.1761-2A>G (IVS13-2A>G); Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH78 ! FA24P
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   FA24P
AC   CVCL_VH78
SY   FA2KY
DR   JCRB; KURB1474
DR   Wikidata; Q54833195
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.1761-2A>G (IVS13-2A>G); Zygosity=Homozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   FA29(SVT)
AC   CVCL_VH81
DR   JCRB; KURB1478
DR   Wikidata; Q54833199
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.1761-2A>G (IVS13-2A>G); Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH80 ! FA29P
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   FA29P
AC   CVCL_VH80
DR   JCRB; KURB1477
DR   Wikidata; Q54833198
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.1761-2A>G (IVS13-2A>G); Zygosity=Homozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   Fa2N-4
AC   CVCL_0267
SY   Fa2N4
DR   CLO; CLO_0037255
DR   MCCL; MCC:0000158
DR   Wikidata; Q54833201
RX   Patent=US7566567;
RX   PubMed=14722322;
RX   PubMed=18332078;
CC   Group: Patented cell line.
CC   From: MultiCell Technologies, Inc.; Woonsocket; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5566.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   FA31P
AC   CVCL_VH82
DR   JCRB; KURB1479
DR   Wikidata; Q54833202
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   Fa32
AC   CVCL_0268
DR   MCCL; MCC:0000159
DR   Wikidata; Q54833203
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4775 ! Faza 967
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 10
//
ID   FA32P
AC   CVCL_VH83
DR   JCRB; KURB1482
DR   Wikidata; Q54833204
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   FA33P
AC   CVCL_VH90
DR   JCRB; KURB1394
DR   Wikidata; Q54833205
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Met1Leu (c.1A>T); ClinVar=VCV000553965; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.2606-2A>T (IVS27-2A>T) (p.Phe868_Gln869del); ClinVar=VCV000555572; Zygosity=Heterozygous; Note=Splice acceptor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   FA34
AC   CVCL_IU78
DR   Cosmic; 2559131
DR   Wikidata; Q54833206
RX   PubMed=25653542;
CC   Doubling time: ~34 hours (PubMed=25653542).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v2 fusion (PubMed=25653542).
CC   Donor information: Established from a patient treated prior to cell line establishment with paclitaxel, pemetrexed, cisplatinum and erlotinib (PubMed=25653542).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 6
//
ID   FA38P
AC   CVCL_VH91
DR   JCRB; KURB1397
DR   Wikidata; Q54833207
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH92 ! FAL38P
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   FA44
AC   CVCL_IU79
DR   Cosmic; 2559132
DR   Wikidata; Q54833208
RX   PubMed=25653542;
CC   Doubling time: ~22 hours (PubMed=25653542).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=25653542).
CC   Donor information: Established from a chronic smoker. Treated prior to cell line establishment with paclitaxel and carboplatin (PubMed=25653542).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 6
//
ID   FA46P
AC   CVCL_VH93
DR   JCRB; KURB1400
DR   Wikidata; Q54833209
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=10090479;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; c.3766_3828del (Ex38del); Zygosity=Homozygous (DOI=10.1007/0-387-33776-8_11; PubMed=10090479).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   FA49
AC   CVCL_IU80
DR   Cosmic; 2559133
DR   Wikidata; Q54833210
RX   PubMed=25653542;
CC   Doubling time: ~22 hours (PubMed=25653542).
CC   Donor information: Established from a chronic smoker. Treated prior to cell line establishment with paclitaxel and carboplatin (PubMed=25653542).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 6
//
ID   FA50P
AC   CVCL_B5M0
SY   N0608
DR   JCRB; KURB1635
DR   Wikidata; Q111733212
RX   PubMed=33355142;
RX   PubMed=33512438;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33355142).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33355142).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 6
//
ID   FA50P-iPSC#1
AC   CVCL_B5M1
DR   Wikidata; Q111733213
RX   PubMed=33512438;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33512438).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5M0 ! FA50P
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 6
//
ID   FA50P-iPSC#2
AC   CVCL_B5M3
DR   Wikidata; Q111733214
RX   PubMed=33512438;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33512438).
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185246; AMeD syndrome
DI   ORDO; Orphanet_611216; Aplastic anemia-intellectual disability-dwarfism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5M0 ! FA50P
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 6
//
ID   FA5P
AC   CVCL_VH84
DR   JCRB; KURB1457
DR   Wikidata; Q54833211
RX   DOI=10.1007/0-387-33776-8_11;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Heterozygous; Note=Splice donor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; p.Gln356Ter (c.1066C>T); ClinVar=VCV000006715; Zygosity=Heterozygous (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   FA6
AC   CVCL_4034
SY   FA-6
DR   EFO; EFO_0006392
DR   cancercelllines; CVCL_4034
DR   Cosmic; 710855
DR   IARC_TP53; 16738
DR   Wikidata; Q54833212
RX   PubMed=2543550;
RX   PubMed=11169959;
RX   PubMed=11787853;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/FA6.html
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=11169959; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11169959; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser149fs (c.445del840); Zygosity=Unspecified (PubMed=11169959; PubMed=11787853).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   FA6 IIG5
AC   CVCL_LB89
DR   CCRID; 4201PAT-CCTCC00017
DR   Wikidata; Q54833213
RX   Patent=GB2192185A;
RX   Patent=US4834976;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9130.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21184; Pseudomonas aeruginosa A-type flagellin (fliC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 7
//
ID   FA6-152
AC   CVCL_C4R1
DR   Wikidata; Q116048975
RX   PubMed=2480109;
RX   PubMed=3940553;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16671; Human CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FA98
AC   CVCL_IU81
DR   Cosmic; 2559134
DR   Wikidata; Q54833214
RX   PubMed=25653542;
CC   Doubling time: ~22 hours (PubMed=25653542).
CC   Donor information: Established from a chronic smoker. Treated prior to cell line establishment with erlotinib (PubMed=25653542).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 6
//
ID   FA9JTO
AC   CVCL_2896
SY   FA9P; FA9; Fanconi Anemia 9 Japan TOkyo
DR   BioSample; SAMN03470919
DR   JCRB; JCRB0314
DR   JCRB; KURB1460
DR   Wikidata; Q54833215
RX   DOI=10.1007/0-387-33776-8_11;
RX   PubMed=1180926;
RX   PubMed=7300843;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (DOI=10.1007/0-387-33776-8_11).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0314; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D19S433: 14,16.2
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 10
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 14,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   FA9JTO hTERT-1
AC   CVCL_D254
DR   JCRB; JCRB3006
DR   JCRB; KURB1463
DR   Wikidata; Q54833216
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; KURB1463; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3006
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2896 ! FA9JTO
SX   Male
AG   7Y
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   FA9JTO(SVT)-1
AC   CVCL_VH70
DR   JCRB; KURB1461
DR   Wikidata; Q54833217
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2896 ! FA9JTO
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   FA9JTO(SVT)-2
AC   CVCL_VH71
DR   JCRB; KURB1462
DR   Wikidata; Q54833218
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2896 ! FA9JTO
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   FA9JTOTERT
AC   CVCL_2897
DR   JCRB; JCRB1060
DR   JCRB; NIHS0310
DR   Wikidata; Q54833219
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3588; FANCG; Simple; c.307+1G>C (IVS3+1G>C); ClinVar=VCV000006714; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; NIHS0310; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1060
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2896 ! FA9JTO
SX   Male
AG   7Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   FAA-HTC1
AC   CVCL_E111
DR   BTO; BTO_0005827
DR   JCRB; JCRB0249
DR   Wikidata; Q54833220
RX   DOI=10.15114/tr.22.71;
RX   PubMed=1295697;
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   FaDu
AC   CVCL_1218
SY   FaDU; FADU; JHU-SCC-FaDu
DR   BTO; BTO_0003233
DR   CLO; CLO_0002993
DR   EFO; EFO_0002178
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-43
DR   BCRC; 60214
DR   BCRJ; 0301
DR   BioGRID_ORCS_Cell_line; 676
DR   BioSample; SAMN03471972
DR   BioSample; SAMN10987898
DR   cancercelllines; CVCL_1218
DR   CCRID; 3101HUMTCHu132
DR   Cell_Model_Passport; SIDM00860
DR   ChEMBL-Cells; CHEMBL3307943
DR   ChEMBL-Targets; CHEMBL612250
DR   CLS; 305033
DR   Cosmic; 686975
DR   Cosmic; 906863
DR   Cosmic; 921832
DR   Cosmic; 1006466
DR   Cosmic; 1017792
DR   Cosmic; 1122668
DR   Cosmic; 1339914
DR   Cosmic; 1530736
DR   Cosmic; 1752764
DR   Cosmic; 2301587
DR   Cosmic; 2592979
DR   Cosmic; 2646650
DR   Cosmic; 2668290
DR   Cosmic-CLP; 906863
DR   DepMap; ACH-000846
DR   DSMZ; ACC-784
DR   DSMZCellDive; ACC-784
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906863
DR   GEO; GSM482707
DR   GEO; GSM482708
DR   GEO; GSM482709
DR   GEO; GSM482710
DR   GEO; GSM887011
DR   GEO; GSM888080
DR   GEO; GSM1374479
DR   GEO; GSM1374480
DR   GEO; GSM1524310
DR   GEO; GSM1524311
DR   GEO; GSM1524312
DR   GEO; GSM1669791
DR   GEO; GSM5104698
DR   GEO; GSM5104717
DR   IARC_TP53; 1681
DR   IGRhCellID; FaDu
DR   KCLB; 30043
DR   LiGeA; CCLE_224
DR   LINCS_LDP; LCL-1201
DR   PharmacoDB; FADU_365_2019
DR   PRIDE; PXD002132
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1218
DR   PubChem_Cell_line; CVCL_1218
DR   Wikidata; Q54833221
RX   CelloPub=CLPUB00484;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1394225;
RX   PubMed=2990217;
RX   PubMed=3138611;
RX   PubMed=3518877;
RX   PubMed=4332311;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=8552396;
RX   PubMed=9815580;
RX   PubMed=11799138;
RX   PubMed=17848307;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21314983;
RX   PubMed=21833476;
RX   PubMed=21868764;
RX   PubMed=22460905;
RX   PubMed=23613873;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25888065;
RX   PubMed=26122845;
RX   PubMed=26589293;
RX   PubMed=26754630;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28476783;
RX   PubMed=28844650;
RX   PubMed=29156801;
RX   PubMed=30135316;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31541927;
RX   PubMed=31978347;
RX   PubMed=33802339;
RX   PubMed=34249502;
RX   PubMed=35839778;
RX   PubMed=36912284;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/fadu-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Indian.
CC   Doubling time: ~50 hours (Note=At 16th passage) (PubMed=4332311); 48.1 hours (PubMed=21314983); ~30 hours (DSMZ=ACC-784).
CC   HLA typing: A*01:01,01:01; B*15:17,37:04; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (ATCC=HTB-43; Cosmic-CLP=906863; DepMap=ACH-000846).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (Cosmic-CLP=906863; DepMap=ACH-000846).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=1394225; PubMed=11799138; PubMed=23613873; ATCC=HTB-43; Cosmic-CLP=906863; DepMap=ACH-000846).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (PubMed=1394225; PubMed=11799138; PubMed=23613873; ATCC=HTB-43; Cosmic-CLP=906863; DepMap=ACH-000846).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.06%; Native American=0%; East Asian, North=11.01%; East Asian, South=0%; South Asian=79.51%; European, North=0%; European, South=7.42% (PubMed=30894373).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=HTB-43; Cosmic-CLP=906863; DSMZ=ACC-784; KCLB=30043; PubMed=21868764; PubMed=25877200; PubMed=33802339; PubMed=36912284; Technion Genomics Center
ST   Amelogenin: X (KCLB=30043)
ST   Amelogenin: Not_detected (ATCC=HTB-43; Cosmic-CLP=906863; DSMZ=ACC-784; PubMed=21868764; PubMed=25877200; PubMed=33802339; PubMed=36912284; Technion Genomics Center)
ST   CSF1PO: 12
ST   D10S1248: 15,17
ST   D12S391: 17,21
ST   D13S317: 8,9 (ATCC=HTB-43; PubMed=21868764; PubMed=25877200; PubMed=33802339; PubMed=36912284; Technion Genomics Center)
ST   D13S317: 9 (DSMZ=ACC-784)
ST   D16S539: 11 (ATCC=HTB-43; Cosmic-CLP=906863; PubMed=21868764; PubMed=25877200; PubMed=33802339; PubMed=36912284; Technion Genomics Center)
ST   D16S539: 11,12 (DSMZ=ACC-784)
ST   D18S51: 16
ST   D19S433: 14,16
ST   D1S1656: 16,16.3
ST   D21S11: 31 (DSMZ=ACC-784)
ST   D21S11: 31.2 (ATCC=HTB-43; PubMed=25877200; PubMed=33802339; Technion Genomics Center)
ST   D22S1045: 11
ST   D2S1338: 19
ST   D2S441: 11
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 11
ST   Penta E: 17,19
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 15,17 (ATCC=HTB-43; Cosmic-CLP=906863; KCLB=30043; PubMed=21868764; PubMed=25877200; PubMed=36912284; Technion Genomics Center)
ST   vWA: 15,17,18 (DSMZ=ACC-784; PubMed=33802339)
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   FaDu 2A3
AC   CVCL_0D71
SY   2A3
DR   ATCC; CRL-3212
DR   cancercelllines; CVCL_0D71
DR   Wikidata; Q54584291
RX   PubMed=21314983;
CC   Population: Indian.
CC   Doubling time: 51.8 hours (PubMed=21314983); ~51 hours (ATCC=CRL-3212).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-3212
ST   Amelogenin: Not_detected
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 18
//
ID   FaDu ATM KO clone 1B5
AC   CVCL_E8SL
SY   FaDu-ATM-KO-1B5
DR   KYinno; KC-4288
CC   Population: Indian.
CC   Doubling time: ~50 hours (KYinno=KC-4288).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FaDu ATM KO clone 1B6
AC   CVCL_E8SM
SY   FaDu-ATM-KO-1B6
DR   KYinno; KC-4287
CC   Population: Indian.
CC   Doubling time: ~50 hours (KYinno=KC-4287).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FaDu Fat-1
AC   CVCL_E8FQ
DR   ABM; T6268
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FaDu(DD)
AC   CVCL_VP44
SY   FaDuDD; FADUDD; FaDudd; FaDu DD; FADU DD
DR   cancercelllines; CVCL_VP44
DR   GEO; GSM1716417
DR   GEO; GSM1716418
DR   GEO; GSM1716419
DR   GEO; GSM1716420
DR   GEO; GSM1716421
DR   GEO; GSM1716422
DR   GEO; GSM1716427
DR   GEO; GSM1716428
DR   GEO; GSM1716429
DR   GEO; GSM1716430
DR   Wikidata; Q93549515
RX   PubMed=11799138;
RX   PubMed=20429727;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=11799138).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 14
//
ID   FaDu-Luc2
AC   CVCL_A4CG
DR   ATCC; HTB-43-LUC2
DR   cancercelllines; CVCL_A4CG
DR   Wikidata; Q105506862
CC   Population: Indian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=HTB-43-LUC2).
CC   Doubling time: ~30 hours (ATCC=HTB-43-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=HTB-43-LUC2
ST   Amelogenin: Not_detected
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   FaDu-R
AC   CVCL_SA75
DR   cancercelllines; CVCL_SA75
DR   Wikidata; Q54833222
RX   PubMed=28844650;
CC   Population: Indian.
CC   Characteristics: Established from parent cell line after a cumulative irradiation dose of 90 Gy.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   FaDu/DDP4
AC   CVCL_D5YF
DR   GEO; GSM5104699
DR   GEO; GSM5104718
DR   Wikidata; Q127380840
RX   PubMed=34249502;
CC   Population: Indian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   FaDu/T
AC   CVCL_EG58
SY   FaDu/T-200
DR   cancercelllines; CVCL_EG58
DR   Wikidata; Q54833223
RX   PubMed=21833476;
CC   Population: Indian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 16
//
ID   FAF-28
AC   CVCL_WN54
SY   FAF28; Fibroblast Adult Female-28
DR   Wikidata; Q93549540
RX   PubMed=13787312;
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FAFU&CU-Px-1
AC   CVCL_A8XN
DR   Wikidata; Q108820227
RX   DOI=10.1111/1744-7917.12533;
CC   Group: Insect cell line.
CC   Doubling time: 19 hours (DOI=10.1111/1744-7917.12533).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Geneva 88.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FAFU&CU-Px-2
AC   CVCL_A8XP
DR   Wikidata; Q108820228
RX   DOI=10.1111/1744-7917.12533;
CC   Group: Insect cell line.
CC   Doubling time: 20 hours (DOI=10.1111/1744-7917.12533).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Geneva 88.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FAFU&CU-Px-3
AC   CVCL_A8XQ
DR   Wikidata; Q108820229
RX   DOI=10.1111/1744-7917.12533;
CC   Group: Insect cell line.
CC   Doubling time: 23 hours (DOI=10.1111/1744-7917.12533).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Geneva 88.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FAFU&CU-Px-4
AC   CVCL_A8XR
DR   Wikidata; Q108820230
RX   DOI=10.1111/1744-7917.12533;
CC   Group: Insect cell line.
CC   Doubling time: 18 hours (DOI=10.1111/1744-7917.12533).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Geneva 88.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FAFU&CU-Px-5
AC   CVCL_A8XS
DR   Wikidata; Q108820231
RX   DOI=10.1111/1744-7917.12533;
CC   Group: Insect cell line.
CC   Doubling time: 19 hours (DOI=10.1111/1744-7917.12533).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Geneva 88.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FAFU&CU-Px-6
AC   CVCL_A8XT
DR   Wikidata; Q108820232
RX   DOI=10.1111/1744-7917.12533;
CC   Group: Insect cell line.
CC   Doubling time: 18 hours (DOI=10.1111/1744-7917.12533).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Geneva 88.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FAHXMUi001-A
AC   CVCL_D6IA
SY   LQTS-iPSCs clone-02
DR   hPSCreg; FAHXMUi001-A
DR   Wikidata; Q127380841
RX   PubMed=36010573;
CC   From: The First Affiliated Hospital of Xinjiang Medical University; Xinjiang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly219Glu (c.656G>A); ClinVar=VCV003003778; Zygosity=Heterozygous (PubMed=36010573).
CC   Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Thr160Met (c.479C>T); ClinVar=VCV001743158; Zygosity=Heterozygous (PubMed=36010573).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36010573
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 14,21
ST   D19S433: 13,14
ST   D1S1656: 11,17
ST   D21S11: 30,31
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D6S1043: 18,20
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   FAHZUe001-A
AC   CVCL_A8ZW
SY   iCas9-H1-ELTD1-/-
DR   hPSCreg; FAHZUe001-A
DR   Wikidata; Q108820233
RX   PubMed=34087984;
CC   From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20822; ADGRL4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   FAHZUi001-A
AC   CVCL_A7MC
SY   CXL-ips
DR   hPSCreg; FAHZUi001-A
DR   Wikidata; Q107114948
RX   PubMed=34087990;
CC   From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:22947; NLRP7; Simple; p.Gln421Ter (c.1261C>T); Zygosity=Homozygous (PubMed=34087990).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3110; Hydatidiform mole
DI   ORDO; Orphanet_99927; Hydatidiform mole
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   FAIK1-10
AC   CVCL_A5EA
SY   Fibroblastoid Atypical Interstitial Kidney 1-10
DR   Wikidata; Q107114950
RX   PubMed=30502050;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: B6D2;C57BL/6N-Tg(EPO::Cre)1Rhw x B6.Cg-Gt(ROSA)26Sor/J).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   FAIK2-5
AC   CVCL_A5EB
SY   Fibroblastoid Atypical Interstitial Kidney 2-5
DR   Wikidata; Q107114953
RX   PubMed=30502050;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: B6D2;C57BL/6N-Tg(EPO::Cre)1Rhw x B6.Cg-Gt(ROSA)26Sor/J).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   FAIK3-5
AC   CVCL_A5EC
SY   Fibroblastoid Atypical Interstitial Kidney 3-5
DR   DSMZ; ACC-861
DR   DSMZCellDive; ACC-861
DR   Wikidata; Q107114956
RX   PubMed=30502050;
CC   Characteristics: Produces Epo under hypoxia.
CC   Doubling time: ~20-30 hours (DSMZ=ACC-861).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: B6D2;C57BL/6N-Tg(EPO::Cre)1hw x B6.Cg-Gt(ROSA)26Sor/J).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   FAK+/+
AC   CVCL_8955
DR   CLO; CLO_0002995
DR   ATCC; CRL-2645
DR   Wikidata; Q54833225
RX   PubMed=7566154;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8FD
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   FAK-/-
AC   CVCL_8954
SY   FAK null
DR   CLO; CLO_0002994
DR   ATCC; CRL-2644
DR   Wikidata; Q54833224
RX   PubMed=7566154;
CC   Knockout cell: Method=KO mouse; MGI; MGI:95481; Ptk2.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8FD
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   FAL3
AC   CVCL_F946
DR   BioSample; SAMN03471954
DR   RCB; RCB2284
DR   TKG; TKG 0564
DR   Wikidata; Q54833226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: RCB; RCB2284; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2284; TKG=TKG 0564
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 10
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   FAL38P
AC   CVCL_VH92
DR   JCRB; KURB1399
DR   Wikidata; Q54833227
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Simple; p.Ser849Phefs*40 (c.2546delC); ClinVar=VCV000408166; Zygosity=Homozygous (from autologous cell line FA38P).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH91 ! FA38P
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   Fall-3
AC   CVCL_CW07
DR   ATCC; SCRC-1009
DR   Wikidata; Q54833228
RX   PubMed=2056275;
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: ATCC; SCRC-1009; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   fALS
AC   CVCL_UF87
DR   Wikidata; Q93549602
RX   PubMed=24379375;
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (PubMed=24379375).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   FALS-2e2
AC   CVCL_RH73
DR   SKIP; SKIP000774
DR   Wikidata; Q54833229
RX   PubMed=26997647;
RX   PubMed=30127392;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Asp (c.1549C>G); ClinVar=VCV000016221; Zygosity=Heterozygous (PubMed=26997647).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH74 ! FALS-2e3
OI   CVCL_RH75 ! FALS-2e23
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   FALS-2e23
AC   CVCL_RH75
DR   SKIP; SKIP000773
DR   Wikidata; Q54833230
RX   PubMed=26997647;
RX   PubMed=30127392;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Asp (c.1549C>G); ClinVar=VCV000016221; Zygosity=Heterozygous (PubMed=26997647).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH73 ! FALS-2e2
OI   CVCL_RH74 ! FALS-2e3
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   FALS-2e3
AC   CVCL_RH74
DR   SKIP; SKIP000772
DR   Wikidata; Q54833231
RX   PubMed=26997647;
RX   PubMed=30127392;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Asp (c.1549C>G); ClinVar=VCV000016221; Zygosity=Heterozygous (PubMed=26997647).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH73 ! FALS-2e2
OI   CVCL_RH75 ! FALS-2e23
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   FALS-e46
AC   CVCL_RH76
DR   SKIP; SKIP000776
DR   Wikidata; Q54833232
RX   PubMed=26997647;
RX   PubMed=30127392;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Asp (c.1549C>G); ClinVar=VCV000016221; Zygosity=Heterozygous (PubMed=26997647).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH77 ! FALS-e48
OI   CVCL_RH78 ! FALS-e54
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   FALS-e48
AC   CVCL_RH77
DR   SKIP; SKIP000777
DR   Wikidata; Q54833233
RX   PubMed=26997647;
RX   PubMed=30127392;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Asp (c.1549C>G); ClinVar=VCV000016221; Zygosity=Heterozygous (PubMed=26997647).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH76 ! FALS-e46
OI   CVCL_RH78 ! FALS-e54
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   FALS-e54
AC   CVCL_RH78
DR   SKIP; SKIP000775
DR   Wikidata; Q54833234
RX   PubMed=26997647;
RX   PubMed=30127392;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Asp (c.1549C>G); ClinVar=VCV000016221; Zygosity=Heterozygous (PubMed=26997647).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH76 ! FALS-e46
OI   CVCL_RH77 ! FALS-e48
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   FAMPAC
AC   CVCL_5749
SY   FamPAC; Fampac; PA-CLS-13; PA-CLS 13
DR   cancercelllines; CVCL_5749
DR   CLS; 300309
DR   Cosmic; 2664044
DR   IARC_TP53; 20736
DR   Wikidata; Q54833235
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=15112280;
RX   PubMed=22753594;
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (PubMed=15112280).
CC   HLA typing: A*03:01:01; B*27:05:01; C*15:02:01; DPB1*03.01:01; DQA1*05:05:01; DQB1*03:01:01; DRB1*12:01:01 (CLS=300309).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (CLS=300309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=15112280).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CLS=300309
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 14
ST   D18S51: 15
ST   D21S11: 32.2
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 11
ST   Penta D: 11
ST   Penta E: 12,13
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
DI   NCIt; C43298; Hereditary pancreatic carcinoma
DI   ORDO; Orphanet_1333; Familial pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   FAMPAC-A
AC   CVCL_5750
SY   PA-CLS-13A; PA-CLS 13A
DR   cancercelllines; CVCL_5750
DR   CLS; 300310
DR   Wikidata; Q54833240
CC   Population: Caucasian.
CC   Doubling time: ~32 hours (CLS=300310).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (CLS=300310).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CLS=300310
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 14
ST   D18S51: 15
ST   D21S11: 32.2
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 12,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
DI   NCIt; C43298; Hereditary pancreatic carcinoma
DI   ORDO; Orphanet_1333; Familial pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5749 ! FAMPAC
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   FAMRCi001-A
AC   CVCL_QX88
DR   BioSamples; SAMEA104387930
DR   hPSCreg; FAMRCi001-A
DR   Wikidata; Q54833241
RX   PubMed=29034900;
RX   PubMed=31221065;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Tyr119Metfs*23 (c.354delT); Zygosity=Heterozygous (PubMed=29034900).
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Lys859Arg (c.2576A>G); Zygosity=Heterozygous (PubMed=29034900).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD62 ! FAMRCi001-B
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   FAMRCi001-B
AC   CVCL_VD62
DR   BioSamples; SAMEA4675132
DR   hPSCreg; FAMRCi001-B
DR   Wikidata; Q54833242
RX   PubMed=31221065;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Tyr119Metfs*23 (c.354delT); Zygosity=Heterozygous (from autologous cell line FAMRCi001-A).
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Lys859Arg (c.2576A>G); Zygosity=Heterozygous (from autologous cell line FAMRCi001-A).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX88 ! FAMRCi001-A
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   FAMRCi002-A
AC   CVCL_QX89
DR   BioSamples; SAMEA104387932
DR   hPSCreg; FAMRCi002-A
DR   Wikidata; Q54833243
RX   PubMed=29034897;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; c.735+1G>A (Ex3del); ClinVar=VCV000163027; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29034897).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   FAMRCi003-A
AC   CVCL_VD63
SY   108-iPSCs
DR   BioSamples; SAMEA104626792
DR   hPSCreg; FAMRCi003-A
DR   Wikidata; Q54833244
RX   PubMed=31221065;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD64 ! FAMRCi003-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 8
//
ID   FAMRCi003-B
AC   CVCL_VD64
DR   BioSamples; SAMEA4675133
DR   hPSCreg; FAMRCi003-B
DR   Wikidata; Q54833245
RX   PubMed=31221065;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD63 ! FAMRCi003-A
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 8
//
ID   FAMRCi004-A
AC   CVCL_WP82
SY   DSPL1
DR   BioSamples; SAMEA6260535
DR   hPSCreg; FAMRCi004-A
DR   SKIP; SKIP005860
DR   Wikidata; Q93549748
RX   PubMed=32062131;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.His1684Arg (c.5051A>G); ClinVar=VCV000431487; Zygosity=Heterozygous (PubMed=32062131).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C62244; Sick sinus syndrome
DI   NCIt; C126651; Progressive familial heart block, type Ia
DI   ORDO; Orphanet_166282; Familial sick sinus syndrome
DI   ORDO; Orphanet_871; Familial progressive cardiac conduction defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP83 ! FAMRCi004-B
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   FAMRCi004-B
AC   CVCL_WP83
SY   DSPL10
DR   BioSamples; SAMEA6276783
DR   hPSCreg; FAMRCi004-B
DR   SKIP; SKIP005858
DR   Wikidata; Q93549754
RX   PubMed=32062131;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.His1684Arg (c.5051A>G); ClinVar=VCV000431487; Zygosity=Heterozygous (PubMed=32062131).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C62244; Sick sinus syndrome
DI   NCIt; C126651; Progressive familial heart block, type Ia
DI   ORDO; Orphanet_166282; Familial sick sinus syndrome
DI   ORDO; Orphanet_871; Familial progressive cardiac conduction defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP82 ! FAMRCi004-A
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   FAMRCi005-A
AC   CVCL_WP84
SY   LMNA B4
DR   BioSamples; SAMEA6268134
DR   hPSCreg; FAMRCi005-A
DR   SKIP; SKIP005856
DR   Wikidata; Q93549759
RX   PubMed=32062135;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Asp357Val (c.1070A>T); ClinVar=VCV000428603; Zygosity=Heterozygous (PubMed=32062135).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP85 ! FAMRCi005-B
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   FAMRCi005-B
AC   CVCL_WP85
SY   LMNA B5
DR   BioSamples; SAMEA6268135
DR   hPSCreg; FAMRCi005-B
DR   SKIP; SKIP005855
DR   Wikidata; Q93549762
RX   PubMed=32062135;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Asp357Val (c.1070A>T); ClinVar=VCV000428603; Zygosity=Heterozygous (PubMed=32062135).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP84 ! FAMRCi005-A
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   FAMRCi006-A
AC   CVCL_WP86
SY   LMNA T3
DR   BioSamples; SAMEA6275229
DR   hPSCreg; FAMRCi006-A
DR   SKIP; SKIP005853
DR   Wikidata; Q93549770
RX   PubMed=32059175;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Pro (c.1580G>C); ClinVar=VCV000014481; Zygosity=Heterozygous (PubMed=32059175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148369; Muscular dystrophy congenital, LMNA-related
DI   ORDO; Orphanet_157973; Congenital muscular dystrophy due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP87 ! FAMRCi006-B
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   FAMRCi006-B
AC   CVCL_WP87
SY   LMNA T4
DR   BioSamples; SAMEA6275650
DR   hPSCreg; FAMRCi006-B
DR   SKIP; SKIP005854
DR   Wikidata; Q93549774
RX   PubMed=32059175;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Pro (c.1580G>C); ClinVar=VCV000014481; Zygosity=Heterozygous (PubMed=32059175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148369; Muscular dystrophy congenital, LMNA-related
DI   ORDO; Orphanet_157973; Congenital muscular dystrophy due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP86 ! FAMRCi006-A
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   FAMRCi007-A
AC   CVCL_WP88
SY   LMNA #4
DR   BioSamples; SAMEA6276784
DR   hPSCreg; FAMRCi007-A
DR   Wikidata; Q93549779
RX   PubMed=32659731;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg249Gln (c.746G>A); ClinVar=VCV000066931; Zygosity=Heterozygous (PubMed=32659731).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32659731
ST   Amelogenin: X,Y
ST   D12S391: 17,23
ST   D13S317: 10
ST   D18S51: 11,17
ST   D21S11: 25,28.2
ST   D2S441: 9,13
ST   D3S1358: 16,17
ST   D7S820: 7,8
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17,18.2,19
DI   NCIt; C126745; Emery-Dreifuss muscular dystrophy 2, autosomal dominant
DI   ORDO; Orphanet_98853; Autosomal dominant Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP89 ! FAMRCi007-B
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   FAMRCi007-B
AC   CVCL_WP89
SY   LMNA #19
DR   BioSamples; SAMEA6276786
DR   hPSCreg; FAMRCi007-B
DR   Wikidata; Q93549782
RX   PubMed=32659731;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg249Gln (c.746G>A); ClinVar=VCV000066931; Zygosity=Heterozygous (PubMed=32659731).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32659731
ST   Amelogenin: X,Y
ST   D12S391: 17,23
ST   D13S317: 10
ST   D18S51: 11,17
ST   D21S11: 25,28.2
ST   D2S441: 9,13
ST   D3S1358: 16,17
ST   D7S820: 7,8
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17,18.2,19
DI   NCIt; C126745; Emery-Dreifuss muscular dystrophy 2, autosomal dominant
DI   ORDO; Orphanet_98853; Autosomal dominant Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP88 ! FAMRCi007-A
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   FAMRCi008-A
AC   CVCL_ZD98
SY   10X-12
DR   BioSamples; SAMEA6983570
DR   hPSCreg; FAMRCi008-A
DR   Wikidata; Q98125998
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 6
//
ID   FAMRCi009-A
AC   CVCL_B5H7
SY   RCMP43
DR   BioSamples; SAMEA9687263
DR   hPSCreg; FAMRCi009-A
DR   Wikidata; Q110432798
RX   PubMed=34971933;
RX   PubMed=39315490;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Val2297Met (c.6889G>A) (p.Val2264Met, c.6790G>A); ClinVar=VCV000641618; Zygosity=Heterozygous (PubMed=34971933).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183309; Familial restrictive cardiomyopathy 5
DI   ORDO; Orphanet_75249; Familial isolated restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   FAMRCi010-A
AC   CVCL_B5H6
SY   RCMP48
DR   BioSamples; SAMEA9687265
DR   hPSCreg; FAMRCi010-A
DR   Wikidata; Q110432799
RX   PubMed=34971931;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Gly2011Arg (c.6031G>A); ClinVar=VCV000472122; Zygosity=Heterozygous (PubMed=34971931).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183309; Familial restrictive cardiomyopathy 5
DI   ORDO; Orphanet_75249; Familial isolated restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   FAMRCi011-A
AC   CVCL_B5H4
SY   ARVC51
DR   BioSamples; SAMEA9687267
DR   hPSCreg; FAMRCi011-A
DR   Wikidata; Q110432800
RX   PubMed=39315490;
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Arg1267Gln (c.3800G>A); ClinVar=VCV000539409; Zygosity=Heterozygous (PubMed=39315490).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183309; Familial restrictive cardiomyopathy 5
DI   ORDO; Orphanet_75249; Familial isolated restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5H5 ! FAMRCi011-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   FAMRCi011-B
AC   CVCL_B5H5
SY   ARVC51b
DR   BioSamples; SAMEA9687269
DR   hPSCreg; FAMRCi011-B
DR   Wikidata; Q110432801
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Arg1267Gln (c.3800G>A); ClinVar=VCV000539409; Zygosity=Heterozygous (hPSCreg=FAMRCi011-B).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183309; Familial restrictive cardiomyopathy 5
DI   ORDO; Orphanet_75249; Familial isolated restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5H4 ! FAMRCi011-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   FAMRCi012-A
AC   CVCL_E3YE
SY   Brug/VT-83
DR   BioSamples; SAMEA116046782
DR   hPSCreg; FAMRCi012-A
CC   From: Federal Almazov North-West Medical Research Centre; St. Petersburg; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Ser805Leu (c.2414C>T); ClinVar=VCV000452038; Zygosity=Heterozygous (hPSCreg=FAMRCi012-A).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Fang-8
AC   CVCL_6G29
DR   Wikidata; Q54833246
RX   PubMed=265551;
RX   PubMed=6244232;
CC   Population: African American.
CC   Doubling time: ~24 hours (PubMed=265551).
CC   Anecdotal: Cell line name is derived from the name of the researcher that derived this cell line.
CC   Derived from site: Metastatic; Abdominal cavity; UBERON=UBERON_0003684.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   Fao
AC   CVCL_0269
SY   FaO; FAO; FAO-1
DR   BTO; BTO_0001517
DR   CLO; CLO_0002996
DR   EFO; EFO_0022750
DR   MCCL; MCC:0000160
DR   CLDB; cl1206
DR   CLDB; cl4908
DR   ECACC; 89042701
DR   ICLC; ATL99001
DR   Lonza; 260
DR   Wikidata; Q54833247
RX   PubMed=3431441;
RX   PubMed=4157008;
RX   PubMed=6932027;
CC   Doubling time: 24 hours (PubMed=6932027).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4775 ! Faza 967
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   Faof1C2
AC   CVCL_4722
SY   FaoFlC2; C2
DR   CLO; CLO_0002105
DR   CLDB; cl559
DR   ECACC; 94101906
DR   Wikidata; Q54833248
RX   PubMed=4157008;
RX   PubMed=6932027;
CC   Doubling time: 18.5 hours (PubMed=6932027).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   FAP 3948-1
AC   CVCL_A9Z6
SY   FAP3948-1; FAP3948
DR   Wikidata; Q102113807
RX   PubMed=30024920;
WW   Provider; CReM; 671; https://stemcellbank.bu.edu/Catalog/Item/Details/671
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (PubMed=30024920).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L946 ! GM03948
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 10
//
ID   FAP 3954-1
AC   CVCL_A9Z7
SY   FAP3954-1; FAP3954
DR   Wikidata; Q102113808
RX   PubMed=30024920;
WW   Provider; CReM; 672; https://stemcellbank.bu.edu/Catalog/Item/Details/672
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (PubMed=30024920).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CY43 ! GM03954
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 10
//
ID   FAP 6888-1
AC   CVCL_A9Z8
SY   FAP6888-1; FAP6888
DR   Wikidata; Q102113809
RX   PubMed=30024920;
WW   Provider; CReM; 673; https://stemcellbank.bu.edu/Catalog/Item/Details/673
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (PubMed=30024920).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CY45 ! GM06888
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   FAP 6965-1
AC   CVCL_A9Z9
SY   FAP6965-1; FAP6965
DR   Wikidata; Q102113811
RX   PubMed=30024920;
WW   Provider; CReM; 670; https://stemcellbank.bu.edu/Catalog/Item/Details/670
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (PubMed=30024920).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F300 ! GM06965
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   Farage
AC   CVCL_3302
SY   FARAGE; Farage OL; Farage Original Line
DR   CLO; CLO_0002997
DR   EFO; EFO_0006393
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2630
DR   BioSample; SAMN03471757
DR   cancercelllines; CVCL_3302
DR   CCRID; 4201HUM-CCTCC00319
DR   CCTCC; GDC0319
DR   Cell_Model_Passport; SIDM00859
DR   ChEMBL-Cells; CHEMBL4483171
DR   ChEMBL-Targets; CHEMBL4483236
DR   CLS; 305071
DR   Cosmic; 1295510
DR   Cosmic; 1517602
DR   Cosmic; 1541919
DR   Cosmic; 1945180
DR   Cosmic; 2022591
DR   Cosmic; 2276315
DR   Cosmic-CLP; 1297449
DR   DepMap; ACH-001498
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1297449
DR   GEO; GSM380125
DR   GEO; GSM552429
DR   GEO; GSM907525
DR   GEO; GSM1035331
DR   GEO; GSM1374481
DR   GEO; GSM1669792
DR   IGRhCellID; Farage
DR   LINCS_LDP; LCL-1131
DR   PharmacoDB; Farage_366_2019
DR   PRIDE; PXD028647
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3302
DR   PubChem_Cell_line; CVCL_3302
DR   Wikidata; Q54833249
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.3109/10428199209053591;
RX   PubMed=9172815;
RX   PubMed=11378582;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (DOI=10.3109/10428199209053591).
CC   HLA typing: A*03:01,24:02; B*14:02,51:01; C*08:02,16:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=31068700; Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.2%; Native American=0%; East Asian, North=0%; East Asian, South=1.9%; South Asian=11.86%; European, North=23.94%; European, South=60.11% (PubMed=30894373).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-2630; Cosmic-CLP=1297449; DepMap=ACH-001498
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 24,25
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 20,23
ST   Penta D: 9,12
ST   Penta E: 7,18
ST   TH01: 8,9
ST   TPOX: 9
ST   vWA: 14,15
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Farage 10.6.1
AC   CVCL_J602
SY   10.6.1
DR   Wikidata; Q54833250
RX   PubMed=11378582;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3302 ! Farage
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   Farage-Luc2
AC   CVCL_B6JL
DR   ATCC; CRL-2630-LUC2
DR   Wikidata; Q123031262
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-2630-LUC2).
CC   Doubling time: 33 hours (ATCC=CRL-2630-LUC2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-2630-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 8,9
ST   TPOX: 9
ST   vWA: 14,15
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3302 ! Farage
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   Faraz-ICR
AC   CVCL_IU69
DR   Wikidata; Q54833251
RX   PubMed=28215484;
RX   PubMed=28719245;
CC   Population: Iranian.
CC   Doubling time: 35 hours (PubMed=28215484).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
DI   NCIt; C7977; Pancreatic acinar cell carcinoma
DI   ORDO; Orphanet_424046; Acinar cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   FARP
AC   CVCL_C8GM
DR   Wikidata; Q123031263
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   From: Childs, Richard W.; National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*02; B*51; C*16 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   FAT 2C1
AC   CVCL_YP06
SY   FormAldehyde-derived Tumor 2C1
DR   Wikidata; Q93549848
RX   PubMed=8148052;
CC   Doubling time: 18 hours (PubMed=8148052).
CC   Transformant: ChEBI; CHEBI_16842; Formaldehyde.
CC   Derived from site: In situ; Nose, nasal cavity, nasal vestibule; UBERON=UBERON_0000402.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   FAT 3
AC   CVCL_YP07
SY   FormAldehyde-derived Tumor 3
DR   Wikidata; Q93549852
RX   PubMed=8148052;
CC   Doubling time: 23 hours (PubMed=8148052).
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Simple; p.Phe132Leu (c.396C>A); Zygosity=Unspecified (PubMed=8148052).
CC   Transformant: ChEBI; CHEBI_16842; Formaldehyde.
CC   Derived from site: In situ; Nose, nasal cavity, nasal vestibule; UBERON=UBERON_0000402.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   FAT 7
AC   CVCL_3511
SY   FAT-7; FAT7; FormAldehyde-derived Tumor 7
DR   CLO; CLO_0002998
DR   ATCC; CRL-2109
DR   Wikidata; Q54833252
RX   PubMed=8148052;
RX   PubMed=15523466;
CC   Doubling time: 24 hours (PubMed=8148052).
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Simple; p.Arg271His (c.812G>A); Zygosity=Unspecified (PubMed=8148052).
CC   Transformant: ChEBI; CHEBI_16842; Formaldehyde.
CC   Derived from site: In situ; Nose, nasal cavity, nasal vestibule; UBERON=UBERON_0000402.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   FAT 8
AC   CVCL_YP08
SY   FormAldehyde-derived Tumor 8
DR   Wikidata; Q93549863
RX   PubMed=8148052;
CC   Doubling time: 20 hours (PubMed=8148052).
CC   Transformant: ChEBI; CHEBI_16842; Formaldehyde.
CC   Derived from site: In situ; Nose, nasal cavity, nasal vestibule; UBERON=UBERON_0000402.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   Faza 967
AC   CVCL_4775
SY   FAZA 967; Faza967; FAZA; Faza
DR   BTO; BTO_0001189
DR   Wikidata; Q54833253
RX   PubMed=3431441;
RX   PubMed=4157008;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5125 ! Fu5-5
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   Faza 967 clone 2
AC   CVCL_S739
SY   Faza 967clone2
DR   ChEMBL-Cells; CHEMBL3308588
DR   ChEMBL-Targets; CHEMBL614495
DR   PubChem_Cell_line; CVCL_S739
DR   Wikidata; Q54833254
RX   PubMed=2431944;
RX   PubMed=6617662;
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_S742 ! DEX-Faza 967
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 16
//
ID   FB-1
AC   CVCL_A603
SY   FB1
DR   BTO; BTO_0005162
DR   Cosmic; 849975
DR   Cosmic; 891252
DR   Cosmic; 1162840
DR   Cosmic; 1507374
DR   Cosmic; 1533550
DR   Cosmic; 1536127
DR   Cosmic; 1889005
DR   Cosmic; 2319856
DR   Cosmic; 2791083
DR   Wikidata; Q54833255
RX   PubMed=9398720;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   FB-2
AC   CVCL_9917
SY   FB2
DR   BioSample; SAMN03151972
DR   Cosmic; 1084278
DR   IARC_TP53; 25010
DR   Wikidata; Q54833256
RX   PubMed=11807785;
RX   PubMed=17725429;
RX   PubMed=19087340;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=19087340; PubMed=20143388). Originally thought to originate from a 36 year old female patient with a well-differentiated thyroid papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00200.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6298 ! TPC-1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   FB-LCH01
AC   CVCL_WH14
SY   French Bulldog-Langerhans Cell Histiocytosis 01
DR   Wikidata; Q93549900
RX   PubMed=30884050;
CC   Doubling time: ~35.4 hours (PubMed=30884050).
CC   Breed/subspecies: French Bulldog; VBO=VBO_0201455.
DI   NCIt; C158785; Canine Langerhans cell histiocytosis
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y4M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   FB0001
AC   CVCL_8W15
DR   ECACC; 94091617
DR   Wikidata; Q54833257
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv ins(5;2)(q22.3:q32.1:q2+.3) or dir ins(q22.1:q24.3:q32.1) (ECACC=94091617).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FB2
AC   CVCL_G688
DR   CLO; CLO_0002999
DR   ATCC; CRL-1891
DR   KCLB; 21891
DR   Wikidata; Q54833258
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_74956; O(4)-phosphotyrosine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   FB2.Bm
AC   CVCL_S346
DR   ATCC; CRL-6032
DR   Wikidata; Q54833259
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6032; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4178 ! FB2.K
OI   CVCL_4179 ! FB2.Ln
OI   CVCL_4180 ! FB2.Sp
OI   CVCL_4181 ! FB2.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FB2.K
AC   CVCL_4178
DR   CLO; CLO_0003000
DR   ATCC; CRL-6033
DR   Wikidata; Q54833260
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_S346 ! FB2.Bm
OI   CVCL_4179 ! FB2.Ln
OI   CVCL_4180 ! FB2.Sp
OI   CVCL_4181 ! FB2.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FB2.Ln
AC   CVCL_4179
DR   CLO; CLO_0003001
DR   ATCC; CRL-6034
DR   Wikidata; Q54833261
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6034; true.
CC   Derived from site: In situ; Fetal lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_S346 ! FB2.Bm
OI   CVCL_4178 ! FB2.K
OI   CVCL_4180 ! FB2.Sp
OI   CVCL_4181 ! FB2.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   FB2.Sp
AC   CVCL_4180
DR   CLO; CLO_0003002
DR   CLDB; cl1207
DR   ATCC; CRL-6035
DR   ECACC; 90031908
DR   Wikidata; Q54833262
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6035; true.
CC   Discontinued: ECACC; 90031908; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_S346 ! FB2.Bm
OI   CVCL_4178 ! FB2.K
OI   CVCL_4179 ! FB2.Ln
OI   CVCL_4181 ! FB2.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   FB2.Thy
AC   CVCL_4181
SY   FB2.Sp/Thy
DR   CLO; CLO_0003003
DR   ATCC; CRL-6036
DR   Wikidata; Q54833263
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6036; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_S346 ! FB2.Bm
OI   CVCL_4178 ! FB2.K
OI   CVCL_4179 ! FB2.Ln
OI   CVCL_4180 ! FB2.Sp
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FB2303
AC   CVCL_A1TZ
DR   Wikidata; Q105506867
RX   PubMed=11779494;
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg580Ter (c.1738C>T); ClinVar=VCV000007672; Zygosity=Heterozygous (PubMed=11779494).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg814Ter (c.2440C>T); ClinVar=VCV000007673; Zygosity=Heterozygous (PubMed=11779494).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   46Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FB3.Bm
AC   CVCL_N501
DR   ATCC; CRL-6037
DR   Wikidata; Q54833264
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6037; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4182 ! FB3.Ln
OI   CVCL_4183 ! FB3.Thy
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FB3.Ln
AC   CVCL_4182
DR   CLO; CLO_0003004
DR   ATCC; CRL-6038
DR   Wikidata; Q54833265
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6038; true.
CC   Derived from site: In situ; Fetal lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_N501 ! FB3.Bm
OI   CVCL_4183 ! FB3.Thy
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   FB3.Thy
AC   CVCL_4183
SY   FB3.Sp/Thy
DR   CLO; CLO_0003005
DR   ATCC; CRL-6039
DR   Wikidata; Q54833266
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6039; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_N501 ! FB3.Bm
OI   CVCL_4182 ! FB3.Ln
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   FB4.Bm
AC   CVCL_N502
DR   ATCC; CRL-6040
DR   Wikidata; Q54833267
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6040; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4184 ! FB4.Ln
OI   CVCL_4185 ! FB4.Sp/Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FB4.Ln
AC   CVCL_4184
DR   CLO; CLO_0003006
DR   ATCC; CRL-6041
DR   Wikidata; Q54833268
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6041; true.
CC   Derived from site: In situ; Fetal lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_N502 ! FB4.Bm
OI   CVCL_4185 ! FB4.Sp/Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   FB4.Sp/Thy
AC   CVCL_4185
DR   CLO; CLO_0003007
DR   ATCC; CRL-6042
DR   Wikidata; Q54833269
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6042; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_N502 ! FB4.Bm
OI   CVCL_4184 ! FB4.Ln
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FB5
AC   CVCL_C3VU
DR   Wikidata; Q116048976
RX   PubMed=1438285;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized ontuxizumab (MORAb-004) therapeutic antibody which was used in clinical trials for the treatment of metastatic melanoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HCU0; Human CD248.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FB5.Bm
AC   CVCL_4186
DR   CLO; CLO_0003008
DR   ATCC; CRL-6043
DR   Wikidata; Q54833270
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6043; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4187 ! FB5.Ln
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   FB5.Ln
AC   CVCL_4187
DR   CLO; CLO_0003009
DR   ATCC; CRL-6044
DR   Wikidata; Q54833271
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6044; true.
CC   Derived from site: In situ; Fetal lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_4186 ! FB5.Bm
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   FB8H3
AC   CVCL_B399
SY   Mab8H3
DR   CLO; CLO_0003010
DR   ATCC; CRL-2402
DR   Wikidata; Q54833272
RX   DOI=10.1021/jf00045a043;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_38221; Fumonisin B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 6
//
ID   FB9
AC   CVCL_A0GN
DR   Wikidata; Q108820234
RX   Patent=US7087396;
RX   PubMed=10868795;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10190.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   FBBC-1
AC   CVCL_F709
SY   Fetal Bovine Brain Cell line-1
DR   Wikidata; Q54833273
RX   PubMed=19032985;
CC   Doubling time: ~24 hours (PubMed=19032985).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   28-32FW
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   FBD-102b
AC   CVCL_C6DV
SY   FBD102b; 102b; Fetal Brain Derived-102b
DR   RCB; RCB4965
DR   Wikidata; Q116048977
RX   PubMed=9669038;
RX   PubMed=16884801;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Oligodendrocyte precursor cell; CL=CL_0002453.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a
AC   CVCL_C6DW
SY   FBD103a; 103a; Fetal Brain Derived-103a
DR   Wikidata; Q116048978
RX   PubMed=9669038;
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A1
AC   CVCL_C6FR
DR   Wikidata; Q116048979
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A10
AC   CVCL_C6FS
DR   Wikidata; Q116048981
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A11
AC   CVCL_C6FT
DR   Wikidata; Q116048983
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A12
AC   CVCL_C6FU
DR   Wikidata; Q116048984
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A13
AC   CVCL_C6FV
DR   Wikidata; Q116048986
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A14
AC   CVCL_C6FW
DR   Wikidata; Q116048987
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A15
AC   CVCL_C6FX
DR   Wikidata; Q116048988
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Glial cell precursor; CL=CL_0000681.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A16
AC   CVCL_C6FY
DR   Wikidata; Q116048989
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A17
AC   CVCL_C6FZ
DR   Wikidata; Q116048990
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Glial cell precursor; CL=CL_0000681.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A19
AC   CVCL_C6G0
DR   Wikidata; Q116048991
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A2
AC   CVCL_C6G1
DR   Wikidata; Q116048992
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A20
AC   CVCL_C6G2
DR   Wikidata; Q116048994
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Glial cell precursor; CL=CL_0000681.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A3
AC   CVCL_C6G3
DR   Wikidata; Q116048995
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A4
AC   CVCL_C6G4
DR   Wikidata; Q116048996
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A5
AC   CVCL_C6G5
DR   Wikidata; Q116048997
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A6
AC   CVCL_C6G6
DR   Wikidata; Q116048998
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A7
AC   CVCL_C6G7
DR   Wikidata; Q116048999
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A8
AC   CVCL_C6G8
DR   Wikidata; Q116049000
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-103a subline A9
AC   CVCL_C6G9
DR   Wikidata; Q116049001
RX   PubMed=16336944;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6DW ! FBD-103a
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-104
AC   CVCL_C6DX
SY   FBD104; Fetal Brain Derived-104
DR   Wikidata; Q116049002
RX   PubMed=9669038;
RX   PubMed=16054258;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Immature astrocyte; CL=CL_0002626.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FBD-51
AC   CVCL_C6EN
SY   FBD51; Fetal Brain Derived-51
DR   Wikidata; Q116049003
RX   PubMed=9669038;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FbEM-1
AC   CVCL_0Q76
DR   Wikidata; Q54833274
RX   PubMed=9286736;
RX   PubMed=10956554;
RX   PubMed=32106286;
CC   Doubling time: ~38 hours (PubMed=9286736).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   FBHE
AC   CVCL_2898
SY   Fetal Bovine Heart Endothelial
DR   CLO; CLO_0003011
DR   CLDB; cl1208
DR   CLDB; cl1209
DR   ATCC; CRL-1395
DR   CLS; 302159
DR   ECACC; 87043002
DR   IZSLER; BS CL 113
DR   IZSLER; BS CL 212
DR   JCRB; IFO50154
DR   Wikidata; Q54833275
RX   CelloPub=CLPUB00632;
RX   PubMed=1069301;
RX   PubMed=7989438;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CRL%201395
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FBHE
CC   Characteristics: FGF dependent.
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Discontinued: CLS; 302159; true.
CC   Discontinued: ECACC; 87043002; true.
CC   Discontinued: IZSLER; BS CL 113; probable.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   FBK-34
AC   CVCL_RT34
SY   Fetal Bovine Kidney-34
DR   Wikidata; Q54833276
RX   PubMed=12033770;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q64843; Bovine adenovirus B serotype 3 E1B 157R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q64844; Bovine adenovirus B serotype 3 E1B 420R.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 7
//
ID   FBKT1
AC   CVCL_YZ69
DR   Wikidata; Q98126001
RX   DOI=10.14943/doctoral.k12177;
RX   PubMed=24131711;
RX   PubMed=26605499;
RX   PubMed=30718752;
RX   PubMed=31940478;
CC   Group: Bat cell line.
CC   Virology: Susceptible to infection by many filoviruses except Marburg virus (MARV). This is due to specific sequence changes in NPC1 that acts as a receptor for filoviruses (PubMed=31940478).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=126282; ! Pteropus dasymallus (Ryukyu flying fox)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   FBL-1
AC   CVCL_C8RA
DR   Wikidata; Q123031264
RX   PubMed=4867923;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FBL-3
AC   CVCL_0J68
SY   FBL3
DR   NCI-DTP; FBL-3
DR   Wikidata; Q54833277
RX   PubMed=185295;
RX   PubMed=564410;
RX   PubMed=4867923;
RX   PubMed=6064953;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 5
//
ID   FBL-J5
AC   CVCL_9253
SY   FBL-J 5; Fetal Bovine Lung from cow J 5
DR   CLO; CLO_0003012
DR   CLDB; cl1210
DR   Wikidata; Q54833278
RX   PubMed=4372838;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Breed/subspecies: Jersey; VBO=VBO_0000250.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FBM-17
AC   CVCL_X195
SY   Fetal Bovine Macrophage-17
DR   Wikidata; Q54833279
RX   PubMed=8593321;
CC   Doubling time: 48 hours (PubMed=8593321).
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
CC   Cell type: Thymic macrophage; CL=CL_0000866.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   24FW
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   FBP146
AC   CVCL_C5WD
DR   Wikidata; Q116049004
RX   PubMed=8194901;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FBP343
AC   CVCL_C5WE
DR   Wikidata; Q116049006
RX   PubMed=8194901;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FBP458
AC   CVCL_C5WF
DR   Wikidata; Q116049007
RX   PubMed=8194901;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FBP741
AC   CVCL_C5WG
DR   Wikidata; Q116049008
RX   PubMed=8194901;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FBrMEC
AC   CVCL_A1CI
SY   F Br MEC; Feline Brain Microvascular Endothelial Cells
DR   Wikidata; Q102113812
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4257.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal brain, endothelium; UBERON=UBERON_0006238+UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FBT [Bovine]
AC   CVCL_J446
SY   Foetal Bovine Turbinate
DR   CLO; CLO_0003013
DR   CLDB; cl1211
DR   CLDB; cl1212
DR   Wikidata; Q54833294
CC   Derived from site: In situ; Fetal nose, nasal cavity, nasal turbinate; UBERON=UBERON_0035612.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   FBT [Goat]
AC   CVCL_YP02
DR   Wikidata; Q93550206
RX   PubMed=31805146;
CC   Virology: Susceptible to infection by ORFV.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ear; UBERON=UBERON_0001690.
CC   Breed/subspecies: Anglo-Nubian; VBO=VBO_0000722.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_YP03 ! GTT
SX   Male
AG   2W
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   Fbx15^(Beta geo/Beta geo)ES
AC   CVCL_T794
SY   Fbx15 Beta geo/Beta geo ES
DR   RCB; AES0120
DR   RCB; RCB2661
DR   SKIP; SKIP001666
DR   Wikidata; Q54833295
RX   PubMed=12665572;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1354755; Fbxo15.
CC   Discontinued: RCB; RCB2661; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T793 ! RF8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   FC-2.15
AC   CVCL_B6SD
DR   Wikidata; Q111733215
RX   PubMed=7641216;
RX   PubMed=7829891;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
ID   FC-5.01
AC   CVCL_B6RV
DR   Wikidata; Q111733216
RX   PubMed=9790070;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   FC-IBC-02
AC   CVCL_B7S0
SY   FC-IBC02; FCIBC02; Fox Chase-Inflammatory Breast Cancer-02
DR   ArrayExpress; E-MTAB-11134
DR   GEO; GSM3145567
DR   GEO; GSM3145704
DR   Wikidata; Q112929556
RX   DOI=10.4172/2161-0681.1000119;
RX   PubMed=23784380;
RX   PubMed=35042871;
WW   Provider; Fox Chase; -; https://www.foxchase.org/sites/default/files/assets/310-MC.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7S1 ! EMF-011
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   FC-muMCL1
AC   CVCL_B7S2
SY   Fox Chase-murine Mantle Cell Lymphoma 1
DR   Wikidata; Q112929557
RX   PubMed=23271511;
CC   Doubling time: ~24 hours (PubMed=23271511).
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C57BL/6 Em-cyclin D1 transgenic.
DI   NCIt; C187985; Mouse mantle cell lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   FC0002
AC   CVCL_8W16
DR   ECACC; 95082301
DR   Wikidata; Q54833296
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   FC0003
AC   CVCL_8W17
DR   ECACC; 96082002
DR   Wikidata; Q54833297
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96082002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   FC0004
AC   CVCL_8W18
DR   ECACC; 96082301
DR   Wikidata; Q54833298
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96082301; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   FC0005
AC   CVCL_8W19
DR   ECACC; 96082302
DR   Wikidata; Q54833299
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96082302; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   FC0006
AC   CVCL_8W20
DR   ECACC; 96091307
DR   Wikidata; Q54833300
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96091307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   FC0007
AC   CVCL_8W21
DR   ECACC; 97102213
DR   Wikidata; Q54833301
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35710; Triple A syndrome
DI   ORDO; Orphanet_869; Triple A syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   FC018
AC   CVCL_B349
SY   CEBe001-A
DR   hPSCreg; CEBe001-A
DR   SKIP; SKIP001760
DR   Wikidata; Q54833302
RX   PubMed=15153613;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   FC100.Ln
AC   CVCL_4926
DR   CLO; CLO_0003016
DR   ATCC; CRL-6117
DR   Wikidata; Q54833303
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6117; true.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4927 ! FC100.Sp
OI   CVCL_4928 ! FC100.T
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC100.Sp
AC   CVCL_4927
DR   CLO; CLO_0003017
DR   ATCC; CRL-6116
DR   Wikidata; Q54833304
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6116; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4926 ! FC100.Ln
OI   CVCL_4928 ! FC100.T
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC100.T
AC   CVCL_4928
DR   CLO; CLO_0003018
DR   ATCC; CRL-6115
DR   Wikidata; Q54833305
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6115; true.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4926 ! FC100.Ln
OI   CVCL_4927 ! FC100.Sp
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   FC101
AC   CVCL_4929
DR   CLO; CLO_0003019
DR   ATCC; CRL-6118
DR   Wikidata; Q54833306
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6118; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC1010
AC   CVCL_D9SY
RX   PubMed=7720572;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   FC102
AC   CVCL_4930
DR   CLO; CLO_0003020
DR   ATCC; CRL-6119
DR   Wikidata; Q54833307
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6119; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC103.En
AC   CVCL_S220
SY   FC103.Cn
DR   ATCC; CRL-6151
DR   Wikidata; Q54833308
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6151; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC104.We
AC   CVCL_4931
SY   Fc104WE
DR   CLO; CLO_0003021
DR   ATCC; CRL-6152
DR   Wikidata; Q54833309
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6152; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   FC105.We
AC   CVCL_N500
DR   ATCC; CRL-6153
DR   Wikidata; Q54833310
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6153; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC106.We
AC   CVCL_4932
DR   CLO; CLO_0003022
DR   ATCC; CRL-6154
DR   Wikidata; Q54833311
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6154; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC107.We
AC   CVCL_4933
DR   CLO; CLO_0003023
DR   ATCC; CRL-6155
DR   Wikidata; Q54833312
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6155; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC108.We
AC   CVCL_4934
DR   CLO; CLO_0003024
DR   ATCC; CRL-6156
DR   Wikidata; Q54833313
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6156; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC109.We
AC   CVCL_4935
DR   CLO; CLO_0003025
DR   ATCC; CRL-6157
DR   Wikidata; Q54833314
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6157; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC11.BM
AC   CVCL_4936
DR   CLO; CLO_0003026
DR   ATCC; CRL-6088
DR   Wikidata; Q54833315
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6088; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C135008; Feline reticulum cell sarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S209 ! FC11th
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC110.We
AC   CVCL_4937
DR   CLO; CLO_0003027
DR   ATCC; CRL-6158
DR   Wikidata; Q54833317
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6158; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC112
AC   CVCL_4938
DR   CLO; CLO_0003028
DR   ATCC; CRL-6120
DR   Wikidata; Q54833318
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6120; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC113
AC   CVCL_4939
DR   CLO; CLO_0003029
DR   ATCC; CRL-6121
DR   Wikidata; Q54833319
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6121; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   35FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC114A.Int
AC   CVCL_S221
DR   ATCC; CRL-6159
DR   Wikidata; Q54833320
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6159; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S222 ! FC114A.Tr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC114A.Tr
AC   CVCL_S222
DR   ATCC; CRL-6160
DR   Wikidata; Q54833321
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6160; true.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S221 ! FC114A.Int
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC114B.Int
AC   CVCL_S223
DR   ATCC; CRL-6161
DR   Wikidata; Q54833322
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6161; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC114C.Int
AC   CVCL_S224
DR   ATCC; CRL-6162
DR   Wikidata; Q54833323
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6162; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S225 ! FC114C.Tr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC114C.Tr
AC   CVCL_S225
DR   ATCC; CRL-6163
DR   Wikidata; Q54833324
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6163; true.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S224 ! FC114C.Int
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC114D.Int
AC   CVCL_S226
DR   ATCC; CRL-6164
DR   Wikidata; Q54833325
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6164; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S227 ! FC114D.Tr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC114D.Tr
AC   CVCL_S227
DR   ATCC; CRL-6165
DR   Wikidata; Q54833326
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6165; true.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S226 ! FC114D.Int
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC114E.Int
AC   CVCL_S228
DR   ATCC; CRL-6166
DR   Wikidata; Q54833328
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6166; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4940 ! FC114E.Tr
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC114E.Tr
AC   CVCL_4940
DR   CLO; CLO_0003030
DR   ATCC; CRL-6167
DR   Wikidata; Q54833329
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S228 ! FC114E.Int
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC115.K
AC   CVCL_4941
DR   CLO; CLO_0003031
DR   ATCC; CRL-6122
DR   Wikidata; Q54833330
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6122; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC116.Sk
AC   CVCL_S190
DR   ATCC; CRL-6123
DR   Wikidata; Q54833331
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6123; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC118
AC   CVCL_4942
DR   CLO; CLO_0003032
DR   ATCC; CRL-6124
DR   Wikidata; Q54833332
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6124; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC119
AC   CVCL_4943
DR   CLO; CLO_0003033
DR   ATCC; CRL-6125
DR   Wikidata; Q54833333
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6125; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC11th
AC   CVCL_S209
DR   ATCC; CRL-6089
DR   Wikidata; Q54833316
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6089; true.
DI   NCIt; C135008; Feline reticulum cell sarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4936 ! FC11.BM
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   FC16.Sp
AC   CVCL_4944
DR   CLO; CLO_0003034
DR   ATCC; CRL-6174
DR   Wikidata; Q54833334
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6174; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_6415 ! LFC16.Ln
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   FC2.K
AC   CVCL_4188
SY   Fc2K
DR   CLO; CLO_0003035
DR   ATCC; CRL-6126
DR   Wikidata; Q54833343
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6126; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4189 ! FC2.Lu
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   FC2.Lu
AC   CVCL_4189
SY   Fc2Lu; Fc 2Lu; Fc 2 Lu
DR   CLO; CLO_0003014
DR   CLO; CLO_0003036
DR   CLO; CLO_0003038
DR   CLDB; cl1213
DR   CLDB; cl1214
DR   ATCC; CCL-217
DR   ATCC; CRL-6569
DR   ECACC; 90112712
DR   IZSLER; BS CL 43
DR   Wikidata; Q54833344
RX   PubMed=7065527;
RX   PubMed=7989438;
RX   PubMed=15705889;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Discontinued: ATCC; CRL-6569; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4188 ! FC2.K
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   FC25.T
AC   CVCL_N527
SY   FC25T
DR   ATCC; CRL-6090
DR   Wikidata; Q54833345
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6090; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C132825; Feline osteosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC26
AC   CVCL_S208
DR   ATCC; CRL-6091
DR   Wikidata; Q54833346
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6091; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC28.Lu
AC   CVCL_4190
SY   Fc28Lu
DR   CLO; CLO_0003037
DR   ATCC; CRL-6130
DR   Wikidata; Q54833347
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6130; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S193 ! FC28.Sp/Thy
SX   Sex unspecified
AG   40FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC28.Sp/Thy
AC   CVCL_S193
DR   ATCC; CRL-6131
DR   Wikidata; Q54833348
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6131; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4190 ! FC28.Lu
SX   Sex unspecified
AG   40FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC3.K
AC   CVCL_S191
DR   ATCC; CRL-6128
DR   Wikidata; Q54833349
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6128; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S192 ! FC3.Lu
OI   CVCL_4191 ! FC3.Tg
OI   CVCL_S217 ! FC3.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC3.Lu
AC   CVCL_S192
DR   ATCC; CRL-6129
DR   Wikidata; Q54833350
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6129; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S191 ! FC3.K
OI   CVCL_4191 ! FC3.Tg
OI   CVCL_S217 ! FC3.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC3.Tg
AC   CVCL_4191
SY   Fc3Tg; Fc 3Tg; Fc 3 Tg
DR   CLO; CLO_0003015
DR   CLO; CLO_0003039
DR   CLDB; cl1215
DR   CLDB; cl1216
DR   ATCC; CCL-176
DR   ATCC; CRL-6570
DR   ECACC; 90073002
DR   IZSLER; BS CL 44
DR   Wikidata; Q54833351
RX   PubMed=6160900;
RX   PubMed=7989438;
RX   PubMed=15705889;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Senescence: Can undergo 50 PDL.
CC   Virology: Not susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Discontinued: ATCC; CRL-6570; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S191 ! FC3.K
OI   CVCL_S192 ! FC3.Lu
OI   CVCL_S217 ! FC3.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   FC3.Thy
AC   CVCL_S217
SY   FC0003 Thm; Fc3Th
DR   ATCC; CRL-6075
DR   Wikidata; Q54833352
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6075; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S191 ! FC3.K
OI   CVCL_S192 ! FC3.Lu
OI   CVCL_4191 ! FC3.Tg
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC33
AC   CVCL_XB48
DR   Wikidata; Q93550876
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:933; BACE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000137). It was the sole source of information for this entry.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   FC36.22
AC   CVCL_8195
DR   BEI_Resources; ARP-3194
DR   Wikidata; Q54833353
RX   PubMed=8525373;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8165 ! 67-1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   FC4.14F8
AC   CVCL_AR45
DR   ECACC; 93100516
DR   Wikidata; Q54833354
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 4
//
ID   FC4.K
AC   CVCL_K170
SY   FC4
DR   ATCC; CRL-6076
DR   Wikidata; Q54833355
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6076; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   FC42.Bm
AC   CVCL_S207
DR   ATCC; CRL-6092
DR   Wikidata; Q54833356
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6092; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   <1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC43
AC   CVCL_S206
DR   ATCC; CRL-6093
DR   Wikidata; Q54833357
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6093; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC47
AC   CVCL_4945
DR   CLO; CLO_0003040
DR   ATCC; CRL-6094
DR   Wikidata; Q54833358
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC5.Bm
AC   CVCL_S216
DR   ATCC; CRL-6077
DR   Wikidata; Q54833359
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6077; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4946 ! FC5.K
OI   CVCL_S215 ! FC5.Sp
OI   CVCL_S214 ! FC5.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC5.K
AC   CVCL_4946
DR   CLO; CLO_0003041
DR   ATCC; CRL-6078
DR   Wikidata; Q54833360
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6078; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S216 ! FC5.Bm
OI   CVCL_S215 ! FC5.Sp
OI   CVCL_S214 ! FC5.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC5.Sp
AC   CVCL_S215
DR   ATCC; CRL-6079
DR   Wikidata; Q54833361
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6079; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S216 ! FC5.Bm
OI   CVCL_4946 ! FC5.K
OI   CVCL_S214 ! FC5.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC5.Thy
AC   CVCL_S214
DR   ATCC; CRL-6080
DR   Wikidata; Q54833362
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6080; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S216 ! FC5.Bm
OI   CVCL_4946 ! FC5.K
OI   CVCL_S215 ! FC5.Sp
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC54.Sp
AC   CVCL_S194
DR   ATCC; CRL-6095
DR   ATCC; CRL-6132
DR   Wikidata; Q54833363
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6095; true.
CC   Discontinued: ATCC; CRL-6132; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S195 ! FC54.Thy
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC54.Thy
AC   CVCL_S195
DR   ATCC; CRL-6133
DR   Wikidata; Q54833364
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6133; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S194 ! FC54.Sp
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC55.Sp
AC   CVCL_S204
DR   ATCC; CRL-6096
DR   Wikidata; Q54833365
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6096; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC56.Thy
AC   CVCL_4192
SY   Fc56Thy
DR   CLO; CLO_0003042
DR   ATCC; CRL-6134
DR   Wikidata; Q54833366
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6134; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC57.Sp
AC   CVCL_S196
DR   ATCC; CRL-6135
DR   Wikidata; Q54833367
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6135; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4193 ! FC57.Thy
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC57.Thy
AC   CVCL_4193
SY   Fc57Thy
DR   CLO; CLO_0003043
DR   ATCC; CRL-6136
DR   Wikidata; Q54833368
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6136; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S196 ! FC57.Sp
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC58.Thy
AC   CVCL_4194
SY   Fc58Thy
DR   CLO; CLO_0003044
DR   ATCC; CRL-6137
DR   Wikidata; Q54833369
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6137; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC59.Sp
AC   CVCL_S197
DR   ATCC; CRL-6138
DR   Wikidata; Q54833370
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6138; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4195 ! FC59.Thy
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC59.Thy
AC   CVCL_4195
SY   Fc59Thy
DR   CLO; CLO_0003045
DR   ATCC; CRL-6139
DR   Wikidata; Q54833371
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6139; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S197 ! FC59.Sp
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC6.Bm
AC   CVCL_4196
SY   Fc6Bm
DR   CLO; CLO_0003046
DR   ATCC; CRL-6081
DR   Wikidata; Q54833372
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6081; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4197 ! FC6.K
OI   CVCL_S213 ! FC6.Sp
OI   CVCL_S212 ! FC6.Thm
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC6.K
AC   CVCL_4197
SY   Fc6K
DR   CLO; CLO_0003047
DR   ATCC; CRL-6082
DR   Wikidata; Q54833373
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6082; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4196 ! FC6.Bm
OI   CVCL_S213 ! FC6.Sp
OI   CVCL_S212 ! FC6.Thm
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC6.Sp
AC   CVCL_S213
DR   ATCC; CRL-6083
DR   Wikidata; Q54833374
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6083; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4196 ! FC6.Bm
OI   CVCL_4197 ! FC6.K
OI   CVCL_S212 ! FC6.Thm
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC6.Thm
AC   CVCL_S212
DR   ATCC; CRL-6085
DR   Wikidata; Q54833375
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6085; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4196 ! FC6.Bm
OI   CVCL_4197 ! FC6.K
OI   CVCL_S213 ! FC6.Sp
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC60(A).Cvx
AC   CVCL_S203
DR   ATCC; CRL-6097
DR   Wikidata; Q54833376
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6097; true.
CC   Derived from site: In situ; Fetal uterus, cervix; UBERON=UBERON_0005795+UBERON_0000002.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4947 ! FC60(A).We
OI   CVCL_4948 ! FC60(B).We
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC60(A).We
AC   CVCL_4947
AS   CVCL_4949
SY   FC60A.We
DR   CLO; CLO_0003048
DR   CLO; CLO_0003050
DR   ATCC; CRL-6140
DR   ATCC; CRL-6571
DR   Wikidata; Q54833377
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6140; true.
CC   Discontinued: ATCC; CRL-6571; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S203 ! FC60(A).Cvx
OI   CVCL_4948 ! FC60(B).We
SX   Female
AG   30-40FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   FC60(B).We
AC   CVCL_4948
AS   CVCL_4950
SY   FC60B.We
DR   CLO; CLO_0003049
DR   CLO; CLO_0003051
DR   ATCC; CRL-6098
DR   ATCC; CRL-6141
DR   Wikidata; Q54833378
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6098; true.
CC   Discontinued: ATCC; CRL-6141; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S203 ! FC60(A).Cvx
OI   CVCL_4947 ! FC60(A).We
SX   Female
AG   30-40FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   FC61
AC   CVCL_4951
DR   CLO; CLO_0003052
DR   ATCC; CRL-6099
DR   Wikidata; Q54833379
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6099; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC63.Br
AC   CVCL_S198
DR   ATCC; CRL-6142
DR   Wikidata; Q54833380
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6142; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4952 ! FC63.Res
SX   Sex unspecified
AG   45FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   FC63.Res
AC   CVCL_4952
DR   CLO; CLO_0003053
DR   ATCC; CRL-6143
DR   Wikidata; Q54833381
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6143; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S198 ! FC63.Br
SX   Sex unspecified
AG   45FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC65.T
AC   CVCL_S200
SY   FC65T
DR   ATCC; CRL-6084
DR   ATCC; CRL-6100
DR   Wikidata; Q54833382
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6084; true.
CC   Discontinued: ATCC; CRL-6100; true.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   FC69
AC   CVCL_S189
DR   ATCC; CRL-6101
DR   Wikidata; Q54833392
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6101; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   30FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FC70.We
AC   CVCL_4953
DR   CLO; CLO_0003054
DR   ATCC; CRL-6102
DR   Wikidata; Q54833393
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6102; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   20FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC71A.We
AC   CVCL_4954
DR   CLO; CLO_0003055
DR   ATCC; CRL-6145
DR   Wikidata; Q54833394
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6145; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_S199 ! FC71B.Sg
SX   Sex unspecified
AG   55FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC71B.Sg
AC   CVCL_S199
DR   ATCC; CRL-6144
DR   Wikidata; Q54833396
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6144; true.
CC   Derived from site: In situ; Fetal salivary gland, sublingual gland; UBERON=UBERON_0006297.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4954 ! FC71A.We
SX   Sex unspecified
AG   55FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FC72A.Br
AC   CVCL_S201
DR   ATCC; CRL-6146
DR   Wikidata; Q54833397
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6146; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   FC72B.Br
AC   CVCL_S202
SY   FC72B.Ns
DR   ATCC; CRL-6147
DR   Wikidata; Q54833398
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6147; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   FC72C.Br
AC   CVCL_S218
DR   ATCC; CRL-6148
DR   Wikidata; Q54833399
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6148; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   FC72D.Br
AC   CVCL_S219
DR   ATCC; CRL-6149
DR   Wikidata; Q54833400
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6149; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   FC74
AC   CVCL_S188
DR   ATCC; CRL-6104
DR   Wikidata; Q54833401
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6104; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   FC77.T
AC   CVCL_4955
DR   CLO; CLO_0003056
DR   ATCC; CRL-6105
DR   ATCC; CRL-6105_FL
DR   Wikidata; Q54833402
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6105; true.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC79.We
AC   CVCL_4956
DR   CLO; CLO_0003057
DR   ATCC; CRL-6106
DR   Wikidata; Q54833403
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6106; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FC8
AC   CVCL_S211
DR   ATCC; CRL-6086
DR   Wikidata; Q54833404
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6086; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC81.Sp
AC   CVCL_4957
DR   CLO; CLO_0003058
DR   ATCC; CRL-6107
DR   Wikidata; Q54833405
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6107; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4958 ! FC81.T
OI   CVCL_4959 ! FC81.Thy
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC81.T
AC   CVCL_4958
DR   CLO; CLO_0003059
DR   ATCC; CRL-6108
DR   Wikidata; Q54833406
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6108; true.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4957 ! FC81.Sp
OI   CVCL_4959 ! FC81.Thy
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC81.Thy
AC   CVCL_4959
DR   CLO; CLO_0003060
DR   ATCC; CRL-6109
DR   Wikidata; Q54833407
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6109; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4957 ! FC81.Sp
OI   CVCL_4958 ! FC81.T
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC83.Bm
AC   CVCL_N669
DR   ATCC; CRL-6111
DR   Wikidata; Q54833408
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6111; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4960 ! FC83.Res
OI   CVCL_4961 ! FC83.Sp
OI   CVCL_N670 ! FC83.Thy
SX   Male
AG   1M2W
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC83.Res
AC   CVCL_4960
DR   CLO; CLO_0003061
DR   ATCC; CRL-6567
DR   Wikidata; Q54833409
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6567; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_N669 ! FC83.Bm
OI   CVCL_4961 ! FC83.Sp
OI   CVCL_N670 ! FC83.Thy
SX   Male
AG   1M2W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   FC83.Sp
AC   CVCL_4961
DR   CLO; CLO_0003062
DR   ATCC; CRL-6110
DR   Wikidata; Q54833410
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6110; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_N669 ! FC83.Bm
OI   CVCL_4960 ! FC83.Res
OI   CVCL_N670 ! FC83.Thy
SX   Male
AG   1M2W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC83.Thy
AC   CVCL_N670
DR   ATCC; CRL-6112
DR   Wikidata; Q54833411
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6112; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_N669 ! FC83.Bm
OI   CVCL_4960 ! FC83.Res
OI   CVCL_4961 ! FC83.Sp
SX   Male
AG   1M2W
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   FC87.Sk
AC   CVCL_4962
DR   CLO; CLO_0003064
DR   ATCC; CRL-6150
DR   Wikidata; Q54833412
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Karyotypic information: 38,XX; 38,XY (ATCC=CRL-6150).
CC   Discontinued: ATCC; CRL-6150; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC94.T
AC   CVCL_4963
DR   CLO; CLO_0003065
DR   ATCC; CRL-6113
DR   Wikidata; Q54833413
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6113; true.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FC95.Thy
AC   CVCL_4964
DR   CLO; CLO_0003066
DR   ATCC; CRL-6114
DR   Wikidata; Q54833414
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6114; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FC9WF
AC   CVCL_S210
SY   Fc9WF; Felis catus 9; Fc9
DR   ATCC; CRL-6087
DR   Wikidata; Q54833415
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6087; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FCA-K1
AC   CVCL_A9FD
SY   CAT-K1; CATK1; Cat Kidney 1
DR   CCRID; 5301MAM-KCB0006KZJ
DR   KCB; KCB 200006KZJ
DR   Wikidata; Q108820235
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_XB50 ! FCA-L2
OI   CVCL_XB62 ! FCA-S1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   FCA-L1
AC   CVCL_XB61
SY   CatL1; Cat Lung 1
DR   CCRID; 5301MAM-KCB89002ZJ
DR   KCB; KCB 89002ZJ
DR   Wikidata; Q93551617
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   FCA-L2
AC   CVCL_XB50
SY   CatL2; Cat Lung 2
DR   CCRID; 5301MAM-KCB0006LZJ
DR   KCB; KCB 200006LZJ
DR   Wikidata; Q93551622
RX   PubMed=12067210;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_A9FD ! FCA-K1
OI   CVCL_XB62 ! FCA-S1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
//
ID   FCA-S1
AC   CVCL_XB62
SY   CatS2; Cat Skin 2
DR   CCRID; 5301MAM-KCB0006SZJ
DR   KCB; KCB 200006SZJ
DR   Wikidata; Q93551627
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_A9FD ! FCA-K1
OI   CVCL_XB50 ! FCA-L2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   FCC-1
AC   CVCL_RJ65
DR   Wikidata; Q54833416
RX   PubMed=2203882;
RX   PubMed=6205259;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   FCCM-2
AC   CVCL_X045
SY   FCCM2
DR   Wikidata; Q54833417
RX   PubMed=8095141;
RX   PubMed=8385463;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   FCCM-9
AC   CVCL_F730
SY   FCCM9
DR   Wikidata; Q54833418
RX   PubMed=8095141;
RX   PubMed=8385463;
CC   Doubling time: 26.7 +- 2.6 hours (PubMed=8095141).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   FCI-P1p
AC   CVCL_DH00
DR   GEO; GSM1001417
DR   GEO; GSM1001454
DR   Wikidata; Q54833419
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   FCI-P2p
AC   CVCL_DH01
DR   cancercelllines; CVCL_DH01
DR   ECACC; 20012009
DR   GEO; GSM1001435
DR   Wikidata; Q54833420
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   FCK
AC   CVCL_DB45
SY   Felis Catus Kidney
DR   ATCC; CRL-6568
DR   Wikidata; Q54833421
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6568; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   FCP-S1M
AC   CVCL_L884
DR   CLO; CLO_0050681
DR   BioSample; SAMN03472232
DR   RCB; RCB0783
DR   Wikidata; Q54833422
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from familial colon polyposis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0783
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 11
//
ID   FCP-S2H
AC   CVCL_L885
DR   CLO; CLO_0050682
DR   BioSample; SAMN03472233
DR   RCB; RCB0784
DR   Wikidata; Q54833423
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from familial colon polyposis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0784
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 11
//
ID   FCP-S3H
AC   CVCL_L886
DR   CLO; CLO_0050683
DR   BioSample; SAMN03472234
DR   RCB; RCB0785
DR   Wikidata; Q54833424
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from familial colon polyposis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0785
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 11
//
ID   FCP-S4H
AC   CVCL_L887
DR   CLO; CLO_0050684
DR   BioSample; SAMN03472235
DR   RCB; RCB0786
DR   Wikidata; Q54833425
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from familial colon polyposis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0786
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 11
//
ID   FCP-S5H
AC   CVCL_L888
DR   CLO; CLO_0050685
DR   BioSample; SAMN03472236
DR   RCB; RCB0787
DR   Wikidata; Q54833426
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from familial colon polyposis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0787
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 11
//
ID   FCP-S6H
AC   CVCL_L889
DR   CLO; CLO_0050686
DR   BioSample; SAMN03472237
DR   RCB; RCB0788
DR   Wikidata; Q54833428
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from familial colon polyposis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0788
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 11
//
ID   FCR-HS02
AC   CVCL_IU61
SY   Flat-Coated Retriever-Histiocytic Sarcoma 02
DR   Wikidata; Q54833429
RX   PubMed=28178429;
RX   PubMed=30884050;
CC   Doubling time: 56.5 hours (PubMed=28178429).
CC   Derived from site: In situ; Shoulder joint; UBERON=UBERON_0016884.
CC   Breed/subspecies: Flat-coated Retriever; VBO=VBO_0200528.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 11
//
ID   Fcwf-4
AC   CVCL_6389
SY   fcwf-4; FCWF-4; FCWF4; Fcwf4; fcwf4; Fcwf; FCWF; Felis catus whole fetus-4
DR   BTO; BTO_0006392
DR   CLO; CLO_0003069
DR   ATCC; CRL-2787
DR   BCRJ; 0334
DR   Wikidata; Q54833430
RX   PubMed=6267959;
RX   PubMed=21029758;
RX   PubMed=21593079;
CC   Virology: Susceptible to infection by feline coronavirus (FCoV).
CC   Doubling time: 31 hours (ATCC=CRL-2787).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   FD-1-Cor
AC   CVCL_C6TR
SY   FD1(cor); DDLABi001-A
DR   hPSCreg; DDLABi001-A
DR   Wikidata; Q117704330
RX   PubMed=31981984;
RX   PubMed=36516658;
CC   From: Korea Advanced Institute of Science and Technology; Daejeon; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple_corrected; p.Leu268fs*1 (c.803_806del); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=31981984; PubMed=36516658).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6TP ! FD-1-iPSC
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   FD-1-iPSC
AC   CVCL_C6TP
DR   Wikidata; Q117704331
RX   PubMed=31981984;
CC   From: Korea Advanced Institute of Science and Technology; Daejeon; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Leu268fs*1 (c.803_806del); Zygosity=Hemizygous (PubMed=31981984).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   FD-1-TSP-1-/-
AC   CVCL_C6TQ
DR   Wikidata; Q117704332
RX   PubMed=31981984;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11785; THBS1.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Leu268fs*1 (c.803_806del); Zygosity=Hemizygous (PubMed=31981984).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6TP ! FD-1-iPSC
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   FD-LS-6
AC   CVCL_D1GE
DR   Wikidata; Q127380842
RX   PubMed=37759147;
CC   Population: Chinese.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=37759147
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 18,25
ST   D3S1358: 15
ST   D5S818: 7,13
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 17,18
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   FD-LSC-1
AC   CVCL_S891
DR   cancercelllines; CVCL_S891
DR   Wikidata; Q54833431
RX   PubMed=24001612;
CC   Population: Chinese.
CC   Characteristics: Highly tumorigenic in NOD/SCID mice.
CC   Doubling time: 24 hours (PubMed=24001612).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (PubMed=24001612).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (PubMed=24001612).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   FD104
AC   CVCL_ZT70
DR   Wikidata; Q98126005
RX   PubMed=15380105;
RX   PubMed=19303373;
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (PubMed=15380105).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   FD104-m21
AC   CVCL_ZT71
DR   Wikidata; Q98126008
RX   PubMed=19303373;
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15984; APTX.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT70 ! FD104
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FD105
AC   CVCL_ZT72
DR   BTO; BTO_0006419
DR   Wikidata; Q98126009
RX   PubMed=15380105;
RX   PubMed=19303373;
RX   PubMed=19643912;
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (PubMed=15380105).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   FD105-m20
AC   CVCL_ZT73
SY   FD105 M20
DR   Wikidata; Q98126010
RX   PubMed=19643912;
CC   Characteristics: Transfected with an empty vector. Control line for FD105-m21.
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT72 ! FD105
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   FD105-m21
AC   CVCL_ZT74
SY   FD105 M21
DR   Wikidata; Q98126011
RX   PubMed=19303373;
RX   PubMed=19643912;
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15984; APTX.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT72 ! FD105
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FD106
AC   CVCL_ZT75
DR   Wikidata; Q98126015
RX   PubMed=15380105;
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (PubMed=15380105).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   FD4
AC   CVCL_E5RN
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FD441.8
AC   CVCL_9174
DR   CLO; CLO_0003070
DR   ATCC; TIB-213
DR   Wikidata; Q54833432
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P24063; Mouse Itgal/Cd11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   FDC-1
AC   CVCL_0F06
DR   ATCC; CRL-2729
DR   BioSample; SAMN03471779
DR   Wikidata; Q54833433
RX   PubMed=1375241;
RX   PubMed=7608535;
CC   Discontinued: ATCC; CRL-2729; true.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): ATCC=CRL-2729
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   FDC-P1
AC   CVCL_2039
SY   FDCP-1; FDCP1; Factor Dependent Continuous-Paterson 1; Factor Dependent Cell-Paterson 1
DR   BTO; BTO_0000595
DR   CLO; CLO_0003072
DR   CLO; CLO_0003073
DR   EFO; EFO_0022739
DR   ATCC; CRL-12103
DR   BCRJ; 0086
DR   CCRID; 1101MOU-PUMC000007
DR   DSMZ; ACC-368
DR   DSMZCellDive; ACC-368
DR   Lonza; 759
DR   Wikidata; Q27653134
RX   PubMed=2656885;
RX   PubMed=6968334;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FDCP1
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12103.
CC   Characteristics: IL3 dependent.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-368).
CC   Caution: According to PubMed=6968334 originate from DBA/2 mice but in the original deposit document for DSMZ ACC-268 it is said to originate from C57BL/6 x DBA/2 (B6D2F1) (personal communication of MacLeod, Roderick A.F.).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   FDC-P1 Beta6
AC   CVCL_A0ML
SY   Beta6-FDC-P1
DR   Wikidata; Q108820236
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96615; Itgb6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   FDC-P1 FGFR-1L
AC   CVCL_C8GU
SY   FD FGFR-1L
DR   Wikidata; Q123031265
RX   PubMed=1373496;
RX   PubMed=1715572;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95522; Fgfr1 (Note=Isoform long).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   FDC-P1 FGFR-1L.A
AC   CVCL_C8GV
SY   FD FGFR-1L.A
DR   Wikidata; Q123031266
RX   PubMed=1373496;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95522; Fgfr1 (Note=Isoform long).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8GU ! FDC-P1 FGFR-1L
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   FDC-P1 FGFR-1L.B
AC   CVCL_C8GW
SY   FD FGFR-1L.B
DR   Wikidata; Q123031267
RX   PubMed=1373496;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95522; Fgfr1 (Note=Isoform long).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8GU ! FDC-P1 FGFR-1L
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   FDC-P1 FGFR-1S
AC   CVCL_C8GX
DR   Wikidata; Q123031268
RX   PubMed=1715572;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95522; Fgfr1 (Note=Isoform short).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   FDC-P1 KIT N822K
AC   CVCL_ZE10
SY   FDC-P1 N822K
DR   Wikidata; Q98126018
RX   PubMed=32477598;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=With p.Asn822Lys).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   FDC-P2
AC   CVCL_5284
SY   FDCP-2; FDCP2; Factor Dependent Continuous-Paterson 2; Factor Dependent Cell-Paterson 2; AD-3
DR   BCRJ; 0037
DR   Wikidata; Q54833447
RX   PubMed=2497280;
RX   PubMed=2656885;
RX   PubMed=3079807;
RX   PubMed=3089920;
RX   PubMed=6968334;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FDCP2
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   FDC-P3
AC   CVCL_H543
SY   FDCP-3; FDCP3; Factor Dependent Continuous-Paterson 3
DR   Wikidata; Q54833448
RX   PubMed=6968334;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   FDC/HK
AC   CVCL_IY38
SY   HK
DR   CLS; 300204
DR   Wikidata; Q54833449
RX   PubMed=7522246;
RX   PubMed=7543513;
RX   PubMed=11243383;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was indicated to have been established in the absence of EBV (PubMed=7522246), but contains EBV (CLS=300204).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Follicular dendritic cell; CL=CL_0000442.
ST   Source(s): CLS=300204
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 12,19
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 10,14
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 7,11
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 10
//
ID   FDCHDPi001-A
AC   CVCL_A9ZP
SY   FDCHDP01
DR   BioSamples; SAMEA7059987
DR   hPSCreg; FDCHDPi001-A
DR   Wikidata; Q102113814
RX   PubMed=33607468;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   FDCHi001-A
AC   CVCL_XC56
SY   BM-iPSCs-1
DR   hPSCreg; FDCHi001-A
DR   Wikidata; Q93551882
RX   PubMed=31404746;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FDCHi002-A
AC   CVCL_XC57
SY   BM-iPSCs-2
DR   hPSCreg; FDCHi002-A
DR   Wikidata; Q93551885
RX   PubMed=31404746;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FDCHi003-A
AC   CVCL_A1DF
SY   iPSx-y-ALMS1-m
DR   hPSCreg; FDCHi003-A
DR   Wikidata; Q102113815
RX   PubMed=33264725;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:428; ALMS1; Simple; p.Ser1301Ter (c.3902C>A); ClinVar=VCV000264657; Zygosity=Heterozygous (PubMed=33264725).
CC   Sequence variation: Mutation; HGNC; HGNC:428; ALMS1; Simple; p.Arg2146Ter (c.6436C>T); ClinVar=VCV000210129; Zygosity=Heterozygous (PubMed=33264725).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84549; Alstrom syndrome
DI   ORDO; Orphanet_64; Alstrom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   FDCHi003-A-1
AC   CVCL_A1DG
SY   iPSx-y-ALMS1-c; FDCHi003-B
DR   hPSCreg; FDCHi003-A-1
DR   Wikidata; Q102113816
RX   PubMed=33264725;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:428; ALMS1; Simple_corrected; p.Ser1301Ter (c.3902C>A); ClinVar=VCV000264657; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33264725).
CC   Sequence variation: Mutation; HGNC; HGNC:428; ALMS1; Simple; p.Arg2146Ter (c.6436C>T); ClinVar=VCV000210129; Zygosity=Heterozygous (PubMed=33264725).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84549; Alstrom syndrome
DI   ORDO; Orphanet_64; Alstrom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1DF ! FDCHi003-A
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   FDCHi004-A
AC   CVCL_ZX40
SY   CHFUi001-A; iPS-39
DR   BioSamples; SAMEA7002467
DR   hPSCreg; FDCHi004-A
DR   SKIP; SKIP005864
DR   Wikidata; Q102113817
RX   PubMed=32659730;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly328Ser (c.982G>A); ClinVar=VCV000456848; Zygosity=Heterozygous (PubMed=32659730).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   FDCHi005-A
AC   CVCL_A5EX
SY   iPSCx-y-DYRK1A-m
DR   hPSCreg; FDCHi005-A
DR   Wikidata; Q107114958
RX   PubMed=33813175;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3091; DYRK1A; Simple; p.Val577Asp (c.1730T>A); Zygosity=Heterozygous (PubMed=33813175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179708; Intellectual developmental disorder, autosomal dominant 7
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   FDCHi005-B
AC   CVCL_A5EY
SY   iPSCx-y-DYRK1A-m; iPSCx-y-DYRK1A-c
DR   hPSCreg; FDCHi005-B
DR   Wikidata; Q107114960
RX   PubMed=33813175;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3091; DYRK1A; Simple_corrected; p.Val577Asp (c.1730T>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33813175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179708; Intellectual developmental disorder, autosomal dominant 7
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5EX ! FDCHi005-A
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   FDCHi006-A
AC   CVCL_B5IJ
SY   CPP-hiPSC-1
DR   hPSCreg; FDCHi006-A
DR   Wikidata; Q110432802
RX   PubMed=34619645;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C113217; Gonadotropin-dependent precocious puberty
DI   ORDO; Orphanet_759; Central precocious puberty
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   FDCHi007-A
AC   CVCL_B5IK
SY   ips-104
DR   BioSamples; SAMEA10886707
DR   hPSCreg; FDCHi007-A
DR   Wikidata; Q110432803
RX   PubMed=35184021;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Sequence variation: Mutation; HGNC; HGNC:2972; DNM1; Simple; p.Ala182Asp (c.545C>A); ClinVar=VCV000421787; Zygosity=Heterozygous; Note=De novo mutation (PubMed=35184021).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185237; Developmental and epileptic encephalopathy 31
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   FDCHi008-A
AC   CVCL_C0F9
SY   JYIPS0087; iPS87
DR   BioSamples; SAMEA111265056
DR   hPSCreg; FDCHi008-A
DR   Wikidata; Q112929559
RX   PubMed=36842377;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192634; Chronic intestinal pseudo-obstruction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   FDCHi009-A
AC   CVCL_C6TS
SY   iPSCx-y-CHD7-m
DR   hPSCreg; FDCHi009-A
DR   Wikidata; Q117704333
RX   PubMed=36502621;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Leu980Pro (c.2939T>C); Zygosity=Heterozygous (PubMed=36502621).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   FDCHi010-A
AC   CVCL_D0EV
SY   iPSCx-y-AHDC1-m
DR   BioSamples; SAMEA112938947
DR   hPSCreg; FDCHi010-A
DR   Wikidata; Q123031269
RX   PubMed=37216737;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:25230; AHDC1; Simple; p.Arg688Ter (c.2062C>T); ClinVar=VCV000438276; Zygosity=Heterozygous (PubMed=37216737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192092; Xia-Gibbs syndrome
DI   ORDO; Orphanet_412069; AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y2M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FDCHi011-A
AC   CVCL_D0EW
SY   iPSC-XX-700-WDR45-m
DR   BioSamples; SAMEA115068018
DR   hPSCreg; FDCHi011-A
DR   Wikidata; Q123031271
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   FDCHi012-A
AC   CVCL_D6HX
SY   iPSCx-x-DYRK1A-m
DR   BioSamples; SAMEA114604817
DR   hPSCreg; FDCHi012-A
DR   Wikidata; Q127380843
RX   PubMed=38382213;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3091; DYRK1A; Simple; p.Gly348Trp (c.1042G>T) (p.Gly339Trp, c.1015G>T); ClinVar=VCV000932454; Zygosity=Heterozygous (PubMed=38382213).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179708; Intellectual developmental disorder, autosomal dominant 7
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 4
//
ID   FDCHi013-A
AC   CVCL_D6HY
SY   iPSCx-x-ADNP-F
DR   BioSamples; SAMEA114714399
DR   hPSCreg; FDCHi013-A
DR   Wikidata; Q127380844
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Discontinued: hPSCreg; FDCHi013-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   FDCHi014-A
AC   CVCL_D6HZ
SY   iPSCx-y-NOVA2-m
DR   BioSamples; SAMEA115062566
DR   hPSCreg; FDCHi014-A
DR   Wikidata; Q127380845
RX   PubMed=38430735;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7887; NOVA2; Simple; p.Cys209Alafs*187 (c.625delT); Zygosity=Heterozygous (PubMed=38430735).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38430735
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C205642; Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y2M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   FDCHi015-A
AC   CVCL_D6I0
SY   ALDOB-IPSC-M
DR   BioSamples; SAMEA115068019
DR   hPSCreg; FDCHi015-A
DR   Wikidata; Q127380846
RX   PubMed=38820866;
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:417; ALDOB; Simple; p.Asn120Lysfs*32 (c.360_363delCAAA); ClinVar=VCV000188861; Zygosity=Heterozygous (PubMed=38820866).
CC   Sequence variation: Mutation; HGNC; HGNC:417; ALDOB; Simple; p.Ala338Val (c.1013C>T); ClinVar=VCV000188739; Zygosity=Heterozygous (PubMed=38820866).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38820866
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 9,13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C84720; Hereditary fructose intolerance
DI   ORDO; Orphanet_469; Hereditary fructose intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   FDCHi016-A
AC   CVCL_E4G5
SY   iPSC-XX-888-WDR45-m
DR   BioSamples; SAMEA117082082
DR   hPSCreg; FDCHi016-A
CC   From: Children's Hospital of Fudan University; Shanghai; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FDCP Mix A4/LRARa403SN c.1
AC   CVCL_D1L1
DR   Wikidata; Q127380847
RX   Patent=US5830760;
RX   PubMed=1334022;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2040 ! FDCP-Mix cl.A4
CA   Factor-dependent cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   FDCP Mix A4/LRARa403SN c.2
AC   CVCL_D1L2
DR   Wikidata; Q127380848
RX   Patent=US5830760;
RX   PubMed=1334022;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2040 ! FDCP-Mix cl.A4
CA   Factor-dependent cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   FDCP Mix A4/LRARa403SN c.3
AC   CVCL_D1L3
DR   Wikidata; Q127380849
RX   Patent=US5830760;
RX   PubMed=1334022;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2040 ! FDCP-Mix cl.A4
CA   Factor-dependent cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   FDCP Mix A4/LRARa403SN c.4
AC   CVCL_D1L4
DR   Wikidata; Q127380850
RX   Patent=US5830760;
RX   PubMed=1334022;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2040 ! FDCP-Mix cl.A4
CA   Factor-dependent cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   FDCP Mix A4/LRARa403SN c.5
AC   CVCL_D1L5
DR   Wikidata; Q127380851
RX   Patent=US5830760;
RX   PubMed=1334022;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2040 ! FDCP-Mix cl.A4
CA   Factor-dependent cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   FDCP-Mix cl.A4
AC   CVCL_2040
SY   FDCP-mix; FDCPmix; FDCP MIX A4; FDPC-mix A4; FDCP mix A4; FDCPmixA4
DR   BTO; BTO_0000446
DR   CLO; CLO_0003074
DR   DSMZ; ACC-401
DR   DSMZCellDive; ACC-401
DR   Lonza; 721
DR   Wikidata; Q54833451
RX   Patent=US5830760;
RX   PubMed=1334022;
RX   PubMed=3091439;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FDCPmix
CC   Characteristics: IL3 dependent.
CC   Doubling time: ~70-80 hours (DSMZ=ACC-401).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   FDCP1-2A5
AC   CVCL_C8H5
DR   Wikidata; Q123031273
RX   PubMed=12193278;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1632; CD164.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   FDCP1-P4C10
AC   CVCL_C8H4
DR   Wikidata; Q123031274
RX   PubMed=12193278;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6153; ITGB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   FDCW2
AC   CVCL_0260
SY   FDCP1-WEHI2; FDC2
DR   MCCL; MCC:0000151
DR   TOKU-E; 3701
DR   Wikidata; Q54833452
RX   PubMed=9345037;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2039 ! FDC-P1
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FDEENTi001-A
AC   CVCL_UM43
SY   LP-IPS
DR   BioSamples; SAMEA5309469
DR   hPSCreg; FDEENTi001-A
DR   SKIP; SKIP005539
DR   Wikidata; Q93551907
RX   PubMed=30611020;
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157149; Pathological myopia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   FDEENTi002-A
AC   CVCL_WP90
SY   XTW-C5
DR   BioSamples; SAMEA5712219
DR   hPSCreg; FDEENTi002-A
DR   Wikidata; Q93551912
RX   PubMed=31146250;
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12703; BEST1; Simple; p.Asn296Lys (c.888C>A); ClinVar=VCV000546666; Zygosity=Heterozygous (PubMed=31146250).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118788; Vitelliform macular dystrophy
DI   ORDO; Orphanet_1243; Best vitelliform macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   FDEENTi003-A
AC   CVCL_XD97
SY   ZSY-IPS
DR   hPSCreg; FDEENTi003-A
DR   SKIP; SKIP005554
DR   Wikidata; Q93551917
RX   PubMed=31376721;
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157149; Pathological myopia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FDEENTi004-A
AC   CVCL_C1T1
SY   GD0901201-iPSC P5
DR   BioSamples; SAMEA110694760
DR   hPSCreg; FDEENTi004-A
DR   Wikidata; Q114311386
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   FDEENTi005-A
AC   CVCL_C1T2
SY   GD0901301-iPSC P5
DR   hPSCreg; FDEENTi005-A
DR   Wikidata; Q114311387
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   FDEENTi006-A
AC   CVCL_E4G6
SY   CLEC11A KO hiPSC
DR   hPSCreg; FDEENTi006-A
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FDHPIi001-A
AC   CVCL_C6PZ
SY   FDHPIi001-WDR45-344
DR   BioSamples; SAMEA111491449
DR   hPSCreg; FDHPIi001-A
DR   Wikidata; Q117704334
RX   PubMed=36502619;
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; c.344+5G>T; Zygosity=Heterozygous (PubMed=36502619).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36502619
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 17,18
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 13
ST   D1S1656: 15,17
ST   D21S11: 31,32.2
ST   D2S1338: 23
ST   D2S441: 11,12
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D6S1043: 13,20
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,26
ST   Penta D: 9,11
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   FDHSi001-A
AC   CVCL_C1T3
SY   FDH-iPS-OPDM-GIPC1; GD09003
DR   BioSamples; SAMEA14509620
DR   hPSCreg; FDHSi001-A
DR   Wikidata; Q114311388
RX   PubMed=36055118;
CC   From: Huashan Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1226; GIPC1; Repeat_expansion; c.-211GGC(163); c.-211GGC[(73_?)]; ClinVar=VCV000972742; Zygosity=Heterozygous (PubMed=36055118).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C190873; Oculopharyngodistal myopathy 2
DI   ORDO; Orphanet_98897; Oculopharyngodistal myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   FDHSi002-A
AC   CVCL_D0EX
SY   FDITBRi002-A
DR   BioSamples; SAMEA114184886
DR   hPSCreg; FDHSi002-A
DR   Wikidata; Q123031276
RX   PubMed=38631182;
CC   From: Huashan Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:21645; CHCHD2; Simple; p.Arg145Gln (c.434G>A); ClinVar=VCV000218883; Zygosity=Heterozygous (PubMed=38631182).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C205643; Parkinson disease 22, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   FDHSi003-A
AC   CVCL_D6I1
DR   BioSamples; SAMEA114663965
DR   hPSCreg; FDHSi003-A
DR   Wikidata; Q127380852
RX   PubMed=38377650;
CC   From: Huashan Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:21698; RNF216; Simple; p.Glu650Ter (c.1948G>T); Zygosity=Homozygous (PubMed=38377650).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C205640; Gordon Holmes syndrome
DI   ORDO; Orphanet_1173; Cerebellar ataxia-hypogonadism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   FDHSi005-A
AC   CVCL_E4G7
SY   FDH-iPS-IBM-GNE
DR   BioSamples; SAMEA115920917
DR   hPSCreg; FDHSi005-A
RX   PubMed=39303320;
CC   From: Huashan Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:23657; GNE; Simple; p.Arg129Ter (c.385C>T) (p.Arg160Ter, c.478C>T); ClinVar=VCV000370849; Zygosity=Heterozygous (PubMed=39303320).
CC   Sequence variation: Mutation; HGNC; HGNC:23657; GNE; Simple; c.862+870C>T; Zygosity=Heterozygous (PubMed=39303320).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FDO28B
AC   CVCL_D6DE
DR   Wikidata; Q127380853
RX   PubMed=3950429;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on placenta.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   FDO31C
AC   CVCL_D6DF
DR   Wikidata; Q127380854
RX   PubMed=3950429;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on placenta.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   FDOV1
AC   CVCL_VL77
DR   cancercelllines; CVCL_VL77
DR   Wikidata; Q93551920
RX   Patent=CN108504637A;
RX   PubMed=29986747;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.13812.
CC   Population: Chinese.
CC   Doubling time: 37.4 hours (PubMed=29986747).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asn201fs (c.602_603delCT); Zygosity=Unspecified (PubMed=29986747).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Leu2106fs (c.6317_6318delG); Zygosity=Unspecified (PubMed=29986747).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Glu1668Ter (c.5002G>T) (p.Glu1681Ter, c.5041G>T); Zygosity=Unspecified (PubMed=29986747).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=29986747).
CC   Sequence variation: Mutation; HGNC; HGNC:11254; SPOP; Simple; p.Asp82His (c.244G>C); ClinVar=VCV000694137; Zygosity=Unspecified (PubMed=29986747).
CC   Sequence variation: Mutation; HGNC; HGNC:13009; ZNF217; Simple; p.Thr985Ile (c.2954C>T); Zygosity=Unspecified (PubMed=29986747).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   FDOVL
AC   CVCL_B7MN
DR   cancercelllines; CVCL_B7MN
DR   Wikidata; Q112929560
RX   Patent=CN110835623B;
RX   PubMed=36982170;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.15484.
CC   Population: Chinese.
CC   Doubling time: 87 hours (Patent=CN110835623B; PubMed=36982170).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ile1432Thr (c.4295C>T); Zygosity=Homozygous (PubMed=36982170).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Cys702fs (c.2104_2111del); Zygosity=Heterozygous (PubMed=36982170).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu252del (c.754_756delCTC); ClinVar=VCV000998484; Zygosity=Heterozygous (PubMed=36982170).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pelvic lymph node; UBERON=UBERON_0015876.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   FdR-1a
AC   CVCL_E8UX
RX   PubMed=1282843;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30438; Cat major allergen I polypeptide chain 1 (Fel d I-A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FdR-1b
AC   CVCL_E8UY
RX   PubMed=1282843;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30438; Cat major allergen I polypeptide chain 1 (Fel d I-A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FdR-2a
AC   CVCL_E8UZ
RX   PubMed=1282843;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30440; Cat major allergen I polypeptide chain 2 (Fel d I-B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FdR-2b
AC   CVCL_E8V0
RX   PubMed=1282843;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30440; Cat major allergen I polypeptide chain 2 (Fel d I-B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FDZSi001-A
AC   CVCL_QX59
SY   HKLDS-iPSC
DR   BioSamples; SAMEA104012356
DR   hPSCreg; FDZSi001-A
DR   Wikidata; Q54834711
RX   PubMed=28395736;
CC   From: Zhongshan Hospital of Fudan University; Shanghai; China.
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Arg193Trp (c.577C>T); ClinVar=VCV000213941; Zygosity=Heterozygous (PubMed=28395736).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114768; Loeys-Dietz syndrome type 2
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   FDZSi002-A
AC   CVCL_ZA48
DR   hPSCreg; FDZSi002-A
DR   Wikidata; Q98126021
CC   From: Zhongshan Hospital of Fudan University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   FDZSi003-A
AC   CVCL_B5H1
DR   hPSCreg; FDZSi003-A
DR   Wikidata; Q110432804
CC   From: Zhongshan Hospital of Fudan University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   Fe Bos
AC   CVCL_3303
DR   CLO; CLO_0003075
DR   ATCC; CRL-1177
DR   Wikidata; Q54834712
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Fe Mus #1
AC   CVCL_C7SE
DR   Wikidata; Q117704335
RX   PubMed=4524119;
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Fe Mus #5
AC   CVCL_C7SF
DR   Wikidata; Q117704336
RX   PubMed=4524119;
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Fe Sin
AC   CVCL_U776
SY   Fesin
DR   ATCC; CRL-1106
DR   Wikidata; Q54834713
RX   PubMed=1054840;
CC   Discontinued: ATCC; CRL-1106; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-22FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Fe Sk #1
AC   CVCL_C7SG
DR   Wikidata; Q117704337
RX   PubMed=4524119;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Fe Sk #5
AC   CVCL_C7SH
DR   Wikidata; Q117704338
RX   PubMed=4524119;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   FE-6
AC   CVCL_E9WM
SY   FE6
RX   PubMed=3533793;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4086 ! 208F
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FE-8
AC   CVCL_GS30
SY   FE8
DR   TOKU-E; 3546
DR   Wikidata; Q54834714
RX   PubMed=3125552;
RX   PubMed=3533793;
CC   Characteristics: Highly tumorigenic in athymic mice and newborn rats (PubMed=3125552).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4086 ! 208F
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 14
//
ID   FE-A
AC   CVCL_LC29
SY   FEA
DR   Wikidata; Q54834715
RX   PubMed=2479170;
RX   PubMed=2558081;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   FE-PD
AC   CVCL_H614
SY   FEPD; FePD
DR   BTO; BTO_0005005
DR   cancercelllines; CVCL_H614
DR   Cell_Model_Passport; SIDM01496
DR   ChEMBL-Cells; CHEMBL3307722
DR   ChEMBL-Targets; CHEMBL614866
DR   Cosmic; 1086362
DR   Cosmic; 2013354
DR   Cosmic; 2024370
DR   Cosmic; 2402467
DR   Cosmic; 2674500
DR   Cosmic; 2814459
DR   DepMap; ACH-001068
DR   GEO; GSM1217152
DR   GEO; GSM2527948
DR   Progenetix; CVCL_H614
DR   PubChem_Cell_line; CVCL_H614
DR   Wikidata; Q54834716
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8035614;
RX   PubMed=8558920;
RX   PubMed=15356658;
RX   PubMed=16596703;
RX   PubMed=26657151;
RX   PubMed=28356514;
RX   PubMed=29533902;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 56 hours (PubMed=8035614).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Gly1097Val (c.3290_3291delinsTT); Zygosity=Unspecified (PubMed=28356514).
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Gly618Arg (c.1852G>C); ClinVar=VCV001192236; Zygosity=Unspecified (PubMed=28356514).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 23
//
ID   FE0001
AC   CVCL_8W22
DR   ECACC; 94100312
DR   Wikidata; Q54834717
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94100312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   FE0002
AC   CVCL_8W23
DR   ECACC; 94110944
DR   Wikidata; Q54834718
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94110944; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99105; VACTERL association
DI   ORDO; Orphanet_887; VACTERL/VATER association
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   FE0003
AC   CVCL_8W24
DR   ECACC; 94120857
DR   Wikidata; Q54834719
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94120857; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   FE0005
AC   CVCL_8W25
DR   ECACC; 95011615
DR   Wikidata; Q54834720
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95011615; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0008
AC   CVCL_8W26
DR   ECACC; 95033056
DR   Wikidata; Q54834721
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95033056; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0010
AC   CVCL_8W27
DR   ECACC; 95042117
DR   Wikidata; Q54834722
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95042117; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0015
AC   CVCL_8W28
DR   ECACC; 95090703
DR   Wikidata; Q54834723
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95090703; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0024
AC   CVCL_8W29
DR   ECACC; 96030619
DR   Wikidata; Q54834724
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96030619; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0030
AC   CVCL_8W30
DR   ECACC; 96091906
DR   Wikidata; Q54834725
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96091906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0033
AC   CVCL_8W31
DR   ECACC; 97012316
DR   Wikidata; Q54834726
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97012316; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0035
AC   CVCL_8W32
DR   ECACC; 97012318
DR   Wikidata; Q54834727
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97012318; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0036
AC   CVCL_8W33
DR   ECACC; 97040401
DR   Wikidata; Q54834728
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97040401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0037
AC   CVCL_8W34
DR   ECACC; 97040402
DR   Wikidata; Q54834729
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97040402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0042
AC   CVCL_8W35
DR   ECACC; 98051805
DR   Wikidata; Q54834730
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98051805; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0043
AC   CVCL_8W36
DR   ECACC; 98051806
DR   Wikidata; Q54834731
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98051806; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FE0046
AC   CVCL_8W37
DR   ECACC; 98090704
DR   Wikidata; Q54834732
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98090704; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C102979; Congenital hydronephrosis
DI   ORDO; Orphanet_93546; Non-syndromic renal or urinary tract malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   FE1
AC   CVCL_C6KP
DR   ArrayExpress; E-MEXP-1054
DR   Wikidata; Q116049010
RX   PubMed=14556224;
RX   PubMed=19406224;
RX   PubMed=28843037;
CC   Characteristics: Can be employed for in vitro mutagenicity assessment. Established from a MutaMouse that contains 40 copies of the lacZ reporter gene in a single locus on chromosome 3.
CC   Doubling time: 18.7 +- 1.2 hours (PubMed=14556224).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: MutaMouse 40.6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   FE11
AC   CVCL_E5QY
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FE25
AC   CVCL_C6JL
SY   FE 25
DR   Wikidata; Q116049011
RX   PubMed=26363031;
RX   PubMed=36430324;
CC   Doubling time: 35.8 hours (PubMed=26363031).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fallopian tube, fimbria; UBERON=UBERON_8410010.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   FE25L
AC   CVCL_C6JM
DR   Wikidata; Q116049012
RX   PubMed=36430324;
CC   Characteristics: Tumorigenic.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fallopian tube, fimbria; UBERON=UBERON_8410010.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6JL ! FE25
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   FE8
AC   CVCL_E5PQ
RX   Patent=WO1991006668A1;
RX   PubMed=2479375;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FEA
AC   CVCL_UG17
DR   Wikidata; Q93552160
RX   PubMed=3007539;
RX   PubMed=4127732;
RX   PubMed=21029758;
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   FEA4 + PFSC/C1
AC   CVCL_4198
DR   CLO; CLO_0003077
DR   CLDB; cl1220
DR   ECACC; 90031402
DR   Wikidata; Q54834733
CC   Virology: Infected with feline leukemia virus (FeLV) subgroup C.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_UG17 ! FEA
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   FEAB10
AC   CVCL_LC31
DR   Wikidata; Q54834734
RX   PubMed=2558081;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HHV-2).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LC29 ! FE-A
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   FEAT
AC   CVCL_LC30
DR   Wikidata; Q54834735
RX   PubMed=2558081;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_37537; 12-O-tetradecanoylphorbol-13-acetate (TPA).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LC29 ! FE-A
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 8
//
ID   FEC
AC   CVCL_R875
SY   Flounder Embryonic Cell line
DR   Wikidata; Q54834736
RX   CelloPub=CLPUB00053;
RX   PubMed=15521323;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gastrula; UBERON=UBERON_0004734.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   FEC.2
AC   CVCL_A038
DR   Wikidata; Q54834737
RX   PubMed=7514905;
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   FEH18L
AC   CVCL_LC32
DR   Wikidata; Q54834738
RX   PubMed=2479170;
RX   PubMed=2558081;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   FEK
AC   CVCL_D697
SY   Fetal Equine Kidney
DR   BCRJ; 0088
DR   Wikidata; Q54834739
CC   Discontinued: BCRJ; 0088; probable.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   FEL
AC   CVCL_4199
SY   Fibroblastes Embryonnaires de Lapin
DR   CLO; CLO_0003078
DR   CLDB; cl1221
DR   ECACC; 89020802
DR   Wikidata; Q54834740
RX   Patent=FR2564320A1;
RX   PubMed=4043531;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-304.
CC   Virology: Susceptible to infection by rabies virus (Patent=FR2564320A1; PubMed=4043531).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fauve de Bourgogne; VBO=VBO_0001248.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   FEL 1A
AC   CVCL_D2QN
DR   Wikidata; Q127380855
RX   PubMed=5278152;
CC   Virology: Susceptible to infection by feline panleukopenia virus (PubMed=5278152).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   FeLV-3281
AC   CVCL_4521
SY   FeLV 3281; FeLV3281; 3281
DR   CLO; CLO_0003079
DR   CLO; CLO_0003080
DR   CLDB; cl1222
DR   ATCC; CRL-9116
DR   IZSLER; BS TCL 86
DR   Wikidata; Q54834741
RX   Patent=US5352449;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9116.
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
CC   Discontinued: ATCC; CRL-9116; true.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 10
//
ID   FELV3281-AD
AC   CVCL_8689
DR   CLO; CLO_0050153
DR   RCB; RCB2610
DR   Wikidata; Q54834742
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_4521 ! FeLV-3281
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 9
//
ID   FEMX-I
AC   CVCL_A011
SY   FEMX-1; FEMX1; FEMX
DR   ChEMBL-Cells; CHEMBL4295472
DR   Cosmic; 922391
DR   Wikidata; Q54834743
RX   PubMed=3390834;
RX   PubMed=7806588;
RX   PubMed=18359977;
RX   PubMed=18802032;
CC   Characteristics: Established from a first generation nude mouse xenograft of the original tumor.
CC   Doubling time: ~15 hours (PubMed=18802032).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 13
//
ID   FEMX-I/SUPER1618
AC   CVCL_F1B1
RX   PubMed=18802032;
CC   Doubling time: 17 hours (PubMed=18802032).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:9454; PROM1.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A011 ! FEMX-I
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   FEMX-I/SUPER733
AC   CVCL_HA94
DR   GEO; GSM329201
DR   GEO; GSM329202
DR   Wikidata; Q54834745
RX   PubMed=18802032;
CC   Doubling time: 20.5 hours (PubMed=18802032).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:9454; PROM1.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A011 ! FEMX-I
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 8
//
ID   FEMX-I/SUPERctr
AC   CVCL_HA93
DR   GEO; GSM329155
DR   GEO; GSM329195
DR   Wikidata; Q54834744
RX   PubMed=18802032;
CC   Characteristics: Control cell line for FEMX-I/SUPER733 (Cellosaurus=CVCL_HA94).
CC   Doubling time: ~15 hours (PubMed=18802032).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A011 ! FEMX-I
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 8
//
ID   FEMX-V
AC   CVCL_HA92
DR   Wikidata; Q54834746
RX   PubMed=7806588;
RX   PubMed=18359977;
CC   Characteristics: Established from a fifth generation nude mouse xenograft of the original tumor.
CC   Characteristics: Cell line with no metastatic potential.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A011 ! FEMX-I
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 7
//
ID   Fen
AC   CVCL_W773
SY   FEN
DR   Wikidata; Q54834747
RX   PubMed=7534804;
RX   PubMed=8512807;
RX   PubMed=10948322;
RX   PubMed=12127398;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   Fen Cl 3.7
AC   CVCL_W774
SY   Fen cl.3.7
DR   Wikidata; Q54834748
RX   PubMed=11180296;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W773 ! Fen
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   FeOSCC-Sidney
AC   CVCL_IZ41
DR   Wikidata; Q54834749
RX   PubMed=24631063;
CC   Doubling time: 39.9 hours (PubMed=24631063).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: American shorthair; VBO=VBO_0100018.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   FEP18-11
AC   CVCL_LC34
SY   FEP-1811; HPV-1811; 1811
DR   Wikidata; Q54834750
RX   PubMed=1846447;
RX   PubMed=2479170;
RX   PubMed=2558081;
RX   PubMed=8527399;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   FEP18-5
AC   CVCL_LC33
DR   Wikidata; Q54834752
RX   PubMed=2479170;
RX   PubMed=2558081;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 8
//
ID   FEPE1L-8
AC   CVCL_LC35
SY   FEPE1L8
DR   Wikidata; Q54834753
RX   PubMed=2543780;
RX   PubMed=2558081;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 8
//
ID   FEPE1L-9
AC   CVCL_LC36
SY   FEPE1L9
DR   Wikidata; Q54834754
RX   PubMed=2543780;
RX   PubMed=2558081;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 8
//
ID   FER
AC   CVCL_4200
DR   CLO; CLO_0003081
DR   CLDB; cl1223
DR   ECACC; 90031401
DR   Wikidata; Q54834755
RX   PubMed=21029758;
CC   Virology: Produces feline endogenous retrovirus RD-114.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Fer Ray
AC   CVCL_H577
DR   CLO; CLO_0003082
DR   CLDB; cl1224
DR   ATCC; CRL-1156
DR   Wikidata; Q54834756
CC   Discontinued: ATCC; CRL-1156; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   FER1
AC   CVCL_E9WN
RX   PubMed=3533793;
CC   Characteristics: Produced from the fusion of the FE-8 cell line with Rat embryo fibroblasts (REF) (PubMed=3533793).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GS30 ! FE-8
CA   Hybrid cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FER2
AC   CVCL_E9WP
RX   PubMed=3533793;
CC   Characteristics: Produced from the fusion of the FE-8 cell line with Rat embryo fibroblasts (REF) (PubMed=3533793).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GS30 ! FE-8
CA   Hybrid cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FER5
AC   CVCL_E9WQ
RX   PubMed=3533793;
CC   Characteristics: Produced from the fusion of the FE-6 cell line with Rat embryo fibroblasts (REF) (PubMed=3533793).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E9WM ! FE-6
CA   Hybrid cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FER8
AC   CVCL_E9WR
RX   PubMed=3533793;
CC   Characteristics: Produced from the fusion of the FE-8 cell line with Rat embryo fibroblasts (REF) (PubMed=3533793).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GS30 ! FE-8
CA   Hybrid cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FER9
AC   CVCL_E9WS
RX   PubMed=3533793;
CC   Characteristics: Produced from the fusion of the FE-6 cell line with Rat embryo fibroblasts (REF) (PubMed=3533793).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E9WM ! FE-6
CA   Hybrid cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Fern
AC   CVCL_B7LZ
DR   Wikidata; Q112929561
RX   PubMed=10501838;
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Phe962Ser (c.2885T>C) (F961S); Zygosity=Homozygous (PubMed=10501838).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   27Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Ferry
AC   CVCL_B6PS
DR   Rockland; CB-0201
DR   Wikidata; Q111733217
WW   Info; Cellaria; -; https://web.archive.org/web/20230529030700/https://cellariainc.com/product/ferry-cell-model/
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Cys282Arg (c.844T>C) (p.Cys350Arg, c.1048T>C); Zygosity=Heterozygous (Cellaria).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cellaria
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 10,12
ST   D18S51: 14,18
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 13,17
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 13,17
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   FES 21
AC   CVCL_B132
SY   FES21; UHe001-A
DR   hPSCreg; UHe001-A
DR   IGRhCellID; FES21%20p51-2
DR   SKIP; SKIP001847
DR   Wikidata; Q54834757
RX   PubMed=16895598;
RX   PubMed=17572666;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   FES 22
AC   CVCL_B133
SY   FES22; UHe002-A
DR   hPSCreg; UHe002-A
DR   IGRhCellID; FES22%20p41-2
DR   SKIP; SKIP001848
DR   Wikidata; Q54834758
RX   PubMed=16895598;
RX   PubMed=17572666;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.
CC   Doubling time: 24 hours (Note=When cultivated on MEF), 36 hours (Note=When cultivated on HFF) (PubMed=16895598).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 15
//
ID   FES 29
AC   CVCL_B134
SY   FES29; UHe003-A
DR   hPSCreg; UHe003-A
DR   IGRhCellID; FES29%20p37-2
DR   SKIP; SKIP001849
DR   Wikidata; Q54834759
RX   PubMed=16895598;
RX   PubMed=17572666;
RX   PubMed=23341440;
RX   PubMed=24098444;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   FES 30
AC   CVCL_B135
SY   FES30; UHe004-A
DR   hPSCreg; UHe004-A
DR   SKIP; SKIP001850
DR   Wikidata; Q54834760
RX   PubMed=16895598;
RX   PubMed=17572666;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   FES 61
AC   CVCL_B136
SY   FES61; UHe005-A
DR   hPSCreg; UHe005-A
DR   IGRhCellID; FES61%20p48-2
DR   SKIP; SKIP001851
DR   Wikidata; Q54834761
RX   PubMed=16895598;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-19.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   FES 75
AC   CVCL_B137
SY   FES75; UHe006-A
DR   hPSCreg; UHe006-A
DR   IGRhCellID; FES75%20p19-2
DR   SKIP; SKIP001852
DR   Wikidata; Q54834762
CC   From: University of Helsinki; Helsinki; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   FET
AC   CVCL_A604
SY   HCT-FET; HCT FET
DR   EFO; EFO_0022636
DR   cancercelllines; CVCL_A604
DR   ColonAtlas; FET
DR   Cosmic; 711265
DR   Cosmic; 887232
DR   Cosmic; 1131684
DR   Cosmic; 2667880
DR   GEO; GSM1448154
DR   IARC_TP53; 6476
DR   Wikidata; Q54834763
RX   PubMed=2835152;
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=7329817;
RX   PubMed=7761852;
RX   PubMed=8895552;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11526487;
RX   PubMed=17363507;
RX   PubMed=25926053;
RX   PubMed=25944804;
CC   Doubling time: 35.49 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=9000147).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 28,32.2
ST   D5S818: 14
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   FeT-1C
AC   CVCL_3686
DR   CLO; CLO_0003083
DR   ATCC; CRL-11968
DR   Wikidata; Q54834764
RX   Patent=US5846825;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11968.
CC   Characteristics: IL2 dependent.
CC   Virology: Susceptible to infection by feline immunodeficiency virus (FIV) (ATCC=CRL-11968).
CC   Discontinued: ATCC; CRL-11968; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   FeT-1M
AC   CVCL_M765
SY   FIV-Fet1M
DR   Wikidata; Q54834765
RX   Patent=US5275813;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10775.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_3686 ! FeT-1C
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FeT-2D
AC   CVCL_M766
DR   Wikidata; Q54834766
RX   Patent=US5275813;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10774.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FeT-J
AC   CVCL_3687
SY   FeTJ-1
DR   CLO; CLO_0003084
DR   ATCC; CRL-11967
DR   Wikidata; Q54834767
RX   Patent=US5846825;
RX   PubMed=18366545;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11967.
CC   Characteristics: IL2 independent.
CC   Virology: Susceptible to infection by feline immunodeficiency virus (FIV) (ATCC=CRL-11967).
CC   Discontinued: ATCC; CRL-11967; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_3686 ! FeT-1C
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   FetMSC
AC   CVCL_6F27
DR   Wikidata; Q54834768
RX   PubMed=22567895;
RX   PubMed=25697001;
CC   Doubling time: 33.0 +- 1.4 hours (PubMed=25697001).
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F28 ! M-FetMSC
SX   Male
AG   5-6FW
CA   Somatic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   FF
AC   CVCL_U308
DR   ATCC; CRL-1479
DR   Wikidata; Q54834769
RX   Patent=US4307082;
RX   PubMed=3734481;
RX   PubMed=4522794;
RX   PubMed=5556532;
CC   Characteristics: Pigmented.
CC   Discontinued: ATCC; CRL-1479; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_2711 ! RPMI-1846
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   FF-1
AC   CVCL_RP34
SY   FF1
DR   cancercelllines; CVCL_RP34
DR   IARC_TP53; 27014
DR   Wikidata; Q54834770
RX   PubMed=11439348;
RX   PubMed=14522906;
RX   PubMed=25675381;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=14522906).
CC   Miscellaneous: STR profile from personal communication of Marlow, Laura A.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 14
ST   D18S51: 12,16
ST   D3S1358: 17,19
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 20
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   FF-11
AC   CVCL_R897
SY   Flounder Fin-11
DR   Wikidata; Q54834771
RX   DOI=10.3147/jsfp.26.69;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   ff-2
AC   CVCL_E8B7
RX   DOI=10.1016/B978-012442710-5.50265-3;
RX   PubMed=7620321;
RX   PubMed=9914916;
RX   PubMed=19273061;
WW   Provider; URMC; -; https://www.urmc.rochester.edu/microbiology-immunology/research/xenopus-laevis/models/cell-lines
CC   Group: Amphibian cell line.
CC   Characteristics: Expresses MHC class I but not MHC class II molecules (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Tumorigenic in larval but not adult syngeneic hosts (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Displays a dual B-cell and T-cell phenotype (PubMed=9914916).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: ff.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   ff-2.64
AC   CVCL_E8BA
RX   DOI=10.1016/B978-012442710-5.50265-3;
RX   PubMed=9914916;
CC   Group: Amphibian cell line.
CC   Characteristics: Expresses MHC class I but not MHC class II molecules (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Characteristics: Tumorigenic in larval but not adult syngeneic hosts (DOI=10.1016/B978-012442710-5.50265-3; PubMed=9914916).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: ff.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_E8B7 ! ff-2
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ff-CLs14
AC   CVCL_C1EU
SY   Ff-CL s14
DR   Wikidata; Q114311389
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EQ ! ILCLs14
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EW ! Ff-CLs23
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-CLs21
AC   CVCL_C1EV
SY   Ff-CL s21
DR   Wikidata; Q114311390
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EQ ! ILCLs14
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EW ! Ff-CLs23
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-CLs23
AC   CVCL_C1EW
SY   Ff-CL s23
DR   Wikidata; Q114311391
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EQ ! ILCLs14
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-CLs31
AC   CVCL_C1EX
SY   Ff-CL s31
DR   Wikidata; Q114311392
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EQ ! ILCLs14
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EW ! Ff-CLs23
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-I01s01
AC   CVCL_C1DX
SY   Ff-I01 s01
DR   Wikidata; Q114311393
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-I01s04
AC   CVCL_C1DY
SY   Ff-I01 s04
DR   Wikidata; Q114311394
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-I01s04 ABII KO #16
AC   CVCL_C1F6
SY   Ff-I01s04-AB II-KO-16; 21B80
DR   Wikidata; Q114311395
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_Ff-I01s04-ABII-KO-16.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DY ! Ff-I01s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I01s04 ABII KO #50
AC   CVCL_C1F7
SY   Ff-I01s04-AB II-KO-50; 21B81
DR   Wikidata; Q114311396
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_Ff-I01s04-ABII-KO-50.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DY ! Ff-I01s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I01s04 ABII KO #54
AC   CVCL_C1F8
SY   Ff-I01s04-AB II-KO-54; 21B82
DR   Wikidata; Q114311397
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_Ff-I01s04-ABII-KO-54.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DY ! Ff-I01s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s03
AC   CVCL_C1DZ
SY   Ff-I14 s03
DR   Wikidata; Q114311398
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-I14s04
AC   CVCL_C1DM
SY   Ff-I14 s04
DR   Wikidata; Q114311399
RX   PubMed=31497180;
RX   PubMed=35304548;
RX   PubMed=35755947;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (PubMed=35755947).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-I14s04 ABII KO #13
AC   CVCL_C1FD
SY   Ff-I14s04-AB II-KO-13; 21B78
DR   Wikidata; Q114311400
RX   PubMed=35755947;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_Ff-I14s04-ABII-KO-13.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #14
AC   CVCL_C1FE
SY   Ff-I14s04-AB II-KO-14
DR   Wikidata; Q114311401
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #15
AC   CVCL_C1FF
SY   Ff-I14s04-AB II-KO-15
DR   Wikidata; Q114311402
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #16
AC   CVCL_C1FG
SY   Ff-I14s04-AB II-KO-16
DR   Wikidata; Q114311403
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #18
AC   CVCL_C1FH
SY   Ff-I14s04-AB II-KO-18
DR   Wikidata; Q114311405
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #2
AC   CVCL_C1F9
SY   Ff-I14s04-AB II-KO-2
DR   Wikidata; Q114311406
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #22
AC   CVCL_C1FI
SY   Ff-I14s04-AB II-KO-22
DR   Wikidata; Q114311407
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #24
AC   CVCL_C1FJ
SY   Ff-I14s04-AB II-KO-24; 21B79
DR   Wikidata; Q114311408
RX   PubMed=35755947;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_Ff-I14s04-ABII-KO-24.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #6
AC   CVCL_C1FA
SY   Ff-I14s04-AB II-KO-6
DR   Wikidata; Q114311409
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #7
AC   CVCL_C1FB
SY   Ff-I14s04-AB II-KO-7; 21B77
DR   Wikidata; Q114311410
RX   PubMed=35755947;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_Ff-I14s04-ABII-KO-7.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-I14s04 ABII KO #8
AC   CVCL_C1FC
SY   Ff-I14s04-AB II-KO-8
DR   Wikidata; Q114311411
RX   PubMed=35755947;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1DM ! Ff-I14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-KVs09
AC   CVCL_C1F2
SY   Ff-KV s09
DR   Wikidata; Q114311412
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EY ! GLKVs09
OI   CVCL_C1EZ ! GLKVs13
OI   CVCL_C1F0 ! GLKVs16
OI   CVCL_C1F1 ! GLKVs31
OI   CVCL_C1F3 ! Ff-KVs13
OI   CVCL_C1F4 ! Ff-KVs16
OI   CVCL_C1F5 ! Ff-KVs31
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-KVs13
AC   CVCL_C1F3
SY   Ff-KV s13
DR   Wikidata; Q114311413
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EY ! GLKVs09
OI   CVCL_C1EZ ! GLKVs13
OI   CVCL_C1F0 ! GLKVs16
OI   CVCL_C1F1 ! GLKVs31
OI   CVCL_C1F2 ! Ff-KVs09
OI   CVCL_C1F4 ! Ff-KVs16
OI   CVCL_C1F5 ! Ff-KVs31
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-KVs16
AC   CVCL_C1F4
SY   Ff-KV s16
DR   Wikidata; Q114311414
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EY ! GLKVs09
OI   CVCL_C1EZ ! GLKVs13
OI   CVCL_C1F0 ! GLKVs16
OI   CVCL_C1F1 ! GLKVs31
OI   CVCL_C1F2 ! Ff-KVs09
OI   CVCL_C1F3 ! Ff-KVs13
OI   CVCL_C1F5 ! Ff-KVs31
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-KVs31
AC   CVCL_C1F5
SY   Ff-KV s31
DR   Wikidata; Q114311415
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EY ! GLKVs09
OI   CVCL_C1EZ ! GLKVs13
OI   CVCL_C1F0 ! GLKVs16
OI   CVCL_C1F1 ! GLKVs31
OI   CVCL_C1F2 ! Ff-KVs09
OI   CVCL_C1F3 ! Ff-KVs13
OI   CVCL_C1F4 ! Ff-KVs16
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-MH09s01
AC   CVCL_C1DP
SY   Ff-MH 09s01
DR   Wikidata; Q114311416
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DV ! RWMH15s02
OI   CVCL_C1DW ! RWMH23s01
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-MH15s01
AC   CVCL_C1DQ
SY   Ff-MH 15s01
DR   Wikidata; Q114311417
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DV ! RWMH15s02
OI   CVCL_C1DW ! RWMH23s01
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-MH15s02
AC   CVCL_C1DR
SY   Ff-MH 15s02
DR   Wikidata; Q114311418
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DV ! RWMH15s02
OI   CVCL_C1DW ! RWMH23s01
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-MH23s01
AC   CVCL_C1DS
SY   Ff-MH 23s01
DR   Wikidata; Q114311419
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DV ! RWMH15s02
OI   CVCL_C1DW ! RWMH23s01
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-WIs03
AC   CVCL_C1ED
SY   Ff-WI s03
DR   Wikidata; Q114311420
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*54:01; DRB1*04:05 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EE ! RJWIs03
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-WJs513
AC   CVCL_C1EK
SY   Ff-WJ s513
DR   Wikidata; Q114311421
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-WJs516
AC   CVCL_C1EL
SY   Ff-WJ s516
DR   Wikidata; Q114311422
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-WJs524
AC   CVCL_C1EM
SY   Ff-WJ s524
DR   Wikidata; Q114311423
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-WJs527
AC   CVCL_C1EN
SY   Ff-WJ s527
DR   Wikidata; Q114311424
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-WJs531
AC   CVCL_C1EP
SY   Ff-WJ s531
DR   Wikidata; Q114311425
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-XT18s02
AC   CVCL_C1E8
SY   Ff-XT 18s02
DR   Wikidata; Q114311426
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-XT18s03
AC   CVCL_C1E9
SY   Ff-XT 18s03
DR   Wikidata; Q114311427
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-XT28s04
AC   CVCL_C1EA
SY   Ff-XT 28s04
DR   Wikidata; Q114311428
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-XT28s05
AC   CVCL_C1EB
SY   Ff-XT 28s05
DR   Wikidata; Q114311429
RX   Patent=US20200407693;
RX   PubMed=30853558;
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01; DQB1*05:01; DRB1*01:01 (PubMed=30853558).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   Ff-XT28s05-ABo #14
AC   CVCL_C1FP
DR   Wikidata; Q114311430
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-ABo_To #14-3
AC   CVCL_C1FQ
DR   Wikidata; Q114311431
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1FP ! Ff-XT28s05-ABo #14
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-ABo_To #14-4
AC   CVCL_C1FR
SY   Ff-XT28s05_Abo_To # 14-4; 19A77
DR   Wikidata; Q114311433
RX   Patent=US20200407693;
RX   PubMed=30853558;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/E_Ff-XT28s05_ABo_To.pdf
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1FP ! Ff-XT28s05-ABo #14
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Ff-XT28s05-Mo #1
AC   CVCL_C1FS
DR   Wikidata; Q114311434
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-Mo #2
AC   CVCL_C1FT
DR   Wikidata; Q114311435
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-Mo #3
AC   CVCL_C1FU
DR   Wikidata; Q114311436
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-Mo #5
AC   CVCL_C1FV
DR   Wikidata; Q114311437
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-MTo #15
AC   CVCL_C1FW
DR   Wikidata; Q114311438
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-MTo #5
AC   CVCL_C1FX
DR   Wikidata; Q114311440
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s05-MTo #8
AC   CVCL_C1FY
DR   Wikidata; Q114311441
RX   Patent=US20200407693;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Ff-XT28s17
AC   CVCL_C1EC
SY   Ff-XT 28s17
DR   Wikidata; Q114311442
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E8 ! Ff-XT18s02
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
ID   FF101
AC   CVCL_8562
DR   JCRB; JCRB1040
DR   JCRB; NIHS0323
DR   Wikidata; Q54834772
RX   PubMed=1281996;
RX   PubMed=2702652;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 78 hours (Note=At 25th passage) (PubMed=2702652).
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Discontinued: JCRB; NIHS0323; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   FF452-3
AC   CVCL_IU56
SY   FF452 clone 3; HR-1 FF452 Cl3
DR   cancercelllines; CVCL_IU56
DR   Wikidata; Q54834774
RX   PubMed=6276755;
RX   PubMed=6294333;
RX   PubMed=6302703;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 14
//
ID   FFA-C
AC   CVCL_XJ50
DR   CCRID; 4201PAT-CCTCC00701
DR   Wikidata; Q93552441
RX   Patent=CN105004860B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201575.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_87185; Florfenicol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   FFB-L3
AC   CVCL_A9HS
SY   FFBL3
DR   CCRID; 5301MAM-KCB0520LZJ
DR   KCB; KCB 200520LZJ
DR   Wikidata; Q108820237
CC   Group: Bat cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9408; ! Rousettus leschenaultii (Leschenault's rousette)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   FFB-S3
AC   CVCL_A9HT
SY   FFBS3
DR   CCRID; 5301MAM-KCB0521SZJ
DR   KCB; KCB 200521SZJ
DR   Wikidata; Q108820238
CC   Group: Bat cell line.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9408; ! Rousettus leschenaultii (Leschenault's rousette)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   FFF-022
AC   CVCL_A9P7
SY   FFF0962009
DR   Wikidata; Q102113819
RX   PubMed=22666358;
RX   PubMed=23075850;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22666358).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   FFF-028
AC   CVCL_A9P8
SY   FFF0112010
DR   Wikidata; Q102113821
RX   PubMed=22666358;
RX   PubMed=23075850;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (PubMed=22666358).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   FFF-031
AC   CVCL_A9Q0
SY   FFF0322010
DR   Wikidata; Q102113822
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from child cell line ESi039-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   FFF-051
AC   CVCL_C9IC
SY   FFF0592011
DR   Wikidata; Q123031277
RX   PubMed=37524028;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Gln456Ter (c.1366C>T); ClinVar=VCV000002415; Zygosity=Homozygous (PubMed=37524028).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FFF0082001
AC   CVCL_A5RS
SY   CD#01; 22276; TNGB-22276
DR   TNGB; 22276
DR   Wikidata; Q107114963
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu129Argfs*8 (c.382delC); ClinVar=VCV000551932; Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Arg168Cys (c.502C>T); ClinVar=VCV000813438; Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D21S11: 30,31
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   FFF0282000
AC   CVCL_A5RQ
SY   CD#00; 22217; TNGB-22217
DR   TNGB; 22217
DR   Wikidata; Q107114965
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.His244Arg (c.731A>G); ClinVar=VCV000371086; Zygosity=Homozygous (PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   FFF0312002
AC   CVCL_A9YD
SY   25664; TNGB-25664
DR   TNGB; 25664
DR   Wikidata; Q102113823
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   FF08711992
AC   CVCL_A5RN
SY   CD#92; 21282; TNGB-21282
DR   TNGB; 21282
DR   Wikidata; Q107114967
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Met82Asnfs*7 (c.244dupA); Zygosity=Homozygous (PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 29,30
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   FFN
AC   CVCL_R898
SY   Flounder FiN
DR   Wikidata; Q54834778
RX   PubMed=14710758;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   FFPRI-SpIm-2AM
AC   CVCL_Z546
DR   ICLDB; ffpri-spim-2am
DR   NISES; SK0031
DR   Wikidata; Q54834775
RX   CelloPub=CLPUB00196;
CC   Group: Insect cell line.
CC   Doubling time: ~3.5 days (CelloPub=CLPUB00196).
CC   Discontinued: NGRC Genebank; Catalog number 275022.
OX   NCBI_TaxID=1578839; ! Lemyra imparilis (Mulberry tiger moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   FFPRI-SpIm-2AM-IPL
AC   CVCL_Z547
DR   ICLDB; ffpri-spim-2am-ipl
DR   Wikidata; Q54834776
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275053.
OX   NCBI_TaxID=1578839; ! Lemyra imparilis (Mulberry tiger moth)
HI   CVCL_Z546 ! FFPRI-SpIm-2AM
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   FFPRI-SpIm-2AM-SF
AC   CVCL_Z548
DR   ICLDB; ffpri-spim-2am-sf
DR   Wikidata; Q54834777
WW   Provider; NGRC Genebank; 275052; https://web.archive.org/web/20231205194359/https://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275052
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275052.
OX   NCBI_TaxID=1578839; ! Lemyra imparilis (Mulberry tiger moth)
HI   CVCL_Z546 ! FFPRI-SpIm-2AM
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   FG-9307
AC   CVCL_8197
AS   CVCL_IP73
SY   FG9307; Flounder Gill-9307; FG
DR   BTO; BTO_0006536
DR   CCTCC; GDC0194
DR   Wikidata; Q54834780
RX   DOI=10.1007/BF02842790;
RX   DOI=10.1007/s10661-010-1533-1;
RX   DOI=10.1016/S0044-8486(97)00070-7;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.1577/1548-8454(2003)065<0044:SNTOTG>2.0.CO;2;
CC   Group: Fish cell line.
CC   Misspelling: FG-9703; DOI=10.1007/s10661-010-1533-1.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   FG4003
AC   CVCL_ZT69
DR   Wikidata; Q98126025
RX   PubMed=15044383;
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Glu232Glyfs*38 (c.689dupT) (167insT) (689insT); ClinVar=VCV000004425; Zygosity=Heterozygous (PubMed=15044383).
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Ser281Leufs*8 (c.841delT) (318delT) (840delT); ClinVar=VCV000004427; Zygosity=Heterozygous (PubMed=15044383).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   FG5
AC   CVCL_E5RV
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68440; Vaccinia virus scaffold protein OPG125 (D13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FGC12
AC   CVCL_E3EZ
RX   PubMed=2128461;
CC   Characteristics: The expression of gpt is under the control of an albumin promoter (PubMed=2128461).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   FGC3
AC   CVCL_E3EW
RX   PubMed=2128461;
CC   Characteristics: The expression of gpt is under the control of an albumin promoter (PubMed=2128461).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   FGC4
AC   CVCL_0261
SY   FGC-4
DR   CLO; CLO_0003093
DR   MCCL; MCC:0000152
DR   CLDB; cl1234
DR   ECACC; 94101904
DR   Wikidata; Q54834781
RX   PubMed=2128461;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-600.html
CC   Characteristics: The expression of gpt is under the control of an albumin promoter (PubMed=2128461).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 18
//
ID   FGC5
AC   CVCL_E3EX
RX   PubMed=2128461;
CC   Characteristics: The expression of gpt is under the control of an albumin promoter (PubMed=2128461).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   FGH
AC   CVCL_F273
DR   BCRJ; 0089
DR   Wikidata; Q54834783
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
ST   Source(s): BCRJ=0089
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 8
//
ID   FGM
AC   CVCL_E6ZN
RX   PubMed=9384677;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   fGS/OSS
AC   CVCL_1B45
SY   Female germ-line Stem/Ovarian Somatic Sheath
DR   EFO; EFO_0005745
DR   DGRC; 191
DR   ENCODE; ENCBS091DQU
DR   FlyBase_Cell_line; FBtc0000191
DR   GEO; GSM915680
DR   Wikidata; Q54834782
RX   PubMed=17056713;
RX   PubMed=24434506;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Characteristics: Co-culture of ovarian germline stem cells (GSCs) and somatic sheath cells.
CC   Doubling time: 2 days (DGRC=191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 13
//
ID   FH fl/fl
AC   CVCL_HG00
DR   CancerTools; 153291
DR   Wikidata; Q54834784
DR   Ximbio; 153291
RX   PubMed=21849978;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Ncr x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E222 ! G4 [Mouse ESC]
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   FH patient 1 line 1
AC   CVCL_WV73
SY   FH line 1
DR   Wikidata; Q93552507
RX   PubMed=20739751;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   FH-/- CL 1
AC   CVCL_HG01
DR   CancerTools; 153289
DR   Wikidata; Q54834785
DR   Ximbio; 153289
RX   PubMed=21849978;
CC   Knockout cell: Method=Cre/loxP; MGI; MGI:95530; Fh1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Ncr x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG00 ! FH fl/fl
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   FH-/- CL 19
AC   CVCL_HG02
DR   CancerTools; 153290
DR   Wikidata; Q54834786
DR   Ximbio; 153290
RX   PubMed=21849978;
CC   Knockout cell: Method=Cre/loxP; MGI; MGI:95530; Fh1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Ncr x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG00 ! FH fl/fl
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   FH-BNB
AC   CVCL_F700
DR   Wikidata; Q54834787
RX   PubMed=22672995;
CC   Characteristics: At the non-permissive temperature (37 Celsius) the cells stop growing and die after 7 days (PubMed=22672995).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   FH01
AC   CVCL_E587
SY   FH1
DR   dbMHC; 48782
DR   IHW; IHW09373
DR   IPD-IMGT/HLA; 13543
DR   Wikidata; Q54834788
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:05,68:02; B*14:02,58:01; C*07:01,08:02; DPA1*01:03; DPB1*04:02,104:01; DQA1*01:01,01:02; DQB1*05:01:01,06:09; DRB1*01:02:01,13:02:01; DRB3*03:01:01 (IPD-IMGT/HLA=13543).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH02
AC   CVCL_E588
SY   FH2
DR   dbMHC; 48793
DR   IHW; IHW09374
DR   IPD-IMGT/HLA; 25984
DR   Wikidata; Q54834789
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,34:02; B*40:01,44:02; C*03:04,05:01; DPB1*02:01:02; DQB1*06:03,06:04:01; DRB1*13:01,13:02; DRB3*01:01:02:01,03:01:01 (IPD-IMGT/HLA=25984).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH03
AC   CVCL_E589
SY   FH3
DR   dbMHC; 48804
DR   IHW; IHW09375
DR   IPD-IMGT/HLA; 25985
DR   Wikidata; Q54834790
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*31:01:02,33:01; B*14:02,35:02; C*04:01:01,08:02; DPA1*01:03:01,02:02:03; DPB1*04:01:01,05:01; DQA1*05:05; DQB1*03:01:01,03:01:01; DRB1*11:01:01,11:04:01; DRB3*02:02:01 (IPD-IMGT/HLA=25985).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH04
AC   CVCL_E590
SY   FH4
DR   dbMHC; 48814
DR   IHW; IHW09376
DR   IPD-IMGT/HLA; 13541
DR   Wikidata; Q54834791
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Mexican.
CC   HLA typing: A*01:01:01; B*27:03,27:05:02; C*02:02:02; DPA1*01:03:01,02:01:01; DPB1*02:01:02,14:01; DQA1*01:02,02:01; DQB1*02:02,06:02; DRB1*07:01:01,11:01:02; DRB3*02:02:01; DRB4*01:01:01 (IPD-IMGT/HLA=13541).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH05
AC   CVCL_E591
SY   FH5; Extract 145; Extract 477
DR   dbMHC; 48825
DR   IHW; IHW09377
DR   IPD-IMGT/HLA; 17341
DR   Wikidata; Q54834792
RX   PubMed=29171935;
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/348cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01,29:02:01:01; B*27:09,44:03:01:01; C*01:02:01,16:01:01:01; DPA1*01:03:01,02:01:01; DPB1*11:01:01,04:01:01; DQA1*02:01,01:04; DQB1*02:02:01,05:03:01; DRB1*07:01:01,14:54:01; DRB3*02:02:01; DRB4*01:01:02 (IPD-IMGT/HLA=17341).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH06
AC   CVCL_E592
SY   FH6; Extract 387
DR   dbMHC; 48836
DR   IHW; IHW09380
DR   IPD-IMGT/HLA; 17350
DR   Wikidata; Q54834794
RX   PubMed=29171935;
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/325cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*24:02:01:01,29:01:01:01; B*07:05:01:01,27:02:01:04; C*02:02:02:01,15:05:02; DPA1*01:03; DPB1*02:01:02/02:01:19,04:01:01; DQA1*01:01:01,01:02:01; DQB1*05:02:01,05:01:01; DRB1*16:01:01,10:01:01; DRB5*02:02 (IPD-IMGT/HLA=17350).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH07
AC   CVCL_E593
SY   FH7; TER317; TER-317; Ter 317; TER391; TER-391; Ter 391; Extract 466
DR   dbMHC; 48847
DR   IHW; IHW09381
DR   IPD-IMGT/HLA; 14085
DR   Wikidata; Q54834795
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/326cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/345cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:06,30:02; B*18:01:01,39:08; C*05:01,07:02; DPA1*01:03; DPB1*02:02,04:02; DQA1*03:01,05:01:01; DQB1*02:01:01,03:02:01; DRB1*03:15,04:07:01; DRB3*02:02:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=14085).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH08
AC   CVCL_E594
SY   FH8
DR   dbMHC; 48857
DR   IHW; IHW09382
DR   IPD-IMGT/HLA; 17342
DR   Wikidata; Q54834796
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*11:01:01:01,34:02:01; B*82:01,27:05:02; C*03:02:02:04,01:02:01; DPB1*04:02:01,01:01:01; DQB1*02:02:01,06:02:01; DRB1*07:01:01,15:03:01; DRB4*01:01:01 (IPD-IMGT/HLA=17342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH09
AC   CVCL_E595
SY   FH9; TER333; TER-333; Ter 333; TER377; TER-377; Ter 377; TER476; TER-476; Ter 476; Extract 450
DR   dbMHC; 48858
DR   IHW; IHW09383
DR   IPD-IMGT/HLA; 25992
DR   Wikidata; Q54834797
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/341cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/367cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24:02,33:03; B*44:03:02,48:01; C*07:01,08:01; DRB1*04:10,07 (IPD-IMGT/HLA=25992).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH1
AC   CVCL_ZT82
DR   Wikidata; Q98126028
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
RX   PubMed=9681890;
CC   Senescence: Senesces at 55 PDL (PubMed=9649131).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=8794843; PubMed=9018113; PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   FH10
AC   CVCL_E596
DR   dbMHC; 48783
DR   IHW; IHW09384
DR   IPD-IMGT/HLA; 25993
DR   Wikidata; Q54834798
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:06,24:02; B*40:02,55:02; C*01:02,15:02; DRB1*09,14:08 (IPD-IMGT/HLA=25993).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH11
AC   CVCL_E597
SY   Extract 142; Extract 203; Extract 498
DR   dbMHC; 48784
DR   IHW; IHW09385
DR   IPD-IMGT/HLA; 25994
DR   Wikidata; Q54834799
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/353cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,29:02; B*07:02:01,44:04; C*07:02,16:01; DPB1*02:01:02,11:01:01; DQB1*03:01,05:01; DRB1*01:01,11:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=25994).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH12
AC   CVCL_E598
DR   dbMHC; 48785
DR   IHW; IHW09386
DR   IPD-IMGT/HLA; 25995
DR   Wikidata; Q54834800
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,11:01; B*27:05:02,44:02; C*02:02:02,05:01; DPB1*02:01:02,04:01; DQB1*03:01,03:02; DRB1*04:04,12:01:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=25995).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH13
AC   CVCL_E599
SY   ws148
DR   dbMHC; 48786
DR   IHW; IHW09387
DR   IPD-IMGT/HLA; 13295
DR   Wikidata; Q54834801
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*34:02:01,68:02:01:01; B*44:03:01:01,15:10:01; C*03:04:02,04:01:01:01; DPB1*02:01:02/02:01:19,133:01; DQB1*02:01:01,06:02:01; DRB1*15:03:01,03:01:01; DRB3*02:02:01; DRB5*01:01:01 (IPD-IMGT/HLA=13295).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH14
AC   CVCL_E600
DR   dbMHC; 48787
DR   IHW; IHW09388
DR   IPD-IMGT/HLA; 25996
DR   Wikidata; Q54834802
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,11:01:01; B*40:01:01; C*03:04:01; DPA1*01:03; DPB1*04:01,04:02; DQA1*03:01,03:02; DQB1*03:01,03:02; DRB1*04:01:01,04:04; DRB4*01:01:01,01:03:02 (IPD-IMGT/HLA=25996).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH15
AC   CVCL_E601
DR   dbMHC; 48788
DR   IHW; IHW09389
DR   IPD-IMGT/HLA; 20677
DR   Wikidata; Q54834803
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01:01,24:02:01:01; B*08:01:01:01,15:01:01:01; C*03:03:01:01,07:01:01:01; DPB1*04:01:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,11:03:01; DRB3*01:01:02:01,02:02:01 (IPD-IMGT/HLA=20677).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH16
AC   CVCL_E602
DR   dbMHC; 48789
DR   IHW; IHW09390
DR   IPD-IMGT/HLA; 25997
DR   Wikidata; Q54834804
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01,27:09; C*01:02,07:01; DPB1*01:01:01,04:02; DQB1*02:01,05:03:01; DRB1*03:01,14:01; DRB3*01:01:02:01,02:02:01 (IPD-IMGT/HLA=25997).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH17
AC   CVCL_E603
DR   dbMHC; 48790
DR   IHW; IHW09391
DR   IPD-IMGT/HLA; 25998
DR   Wikidata; Q54834805
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01:01,68:01; B*08:01,51:01:01; C*07:01,14:02; DPB1*04:01; DQB1*03:01:01,06:03; DRB1*11:01,13:01; DRB3*01:01:02:01,02:02:01 (IPD-IMGT/HLA=25998).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH18
AC   CVCL_E604
DR   dbMHC; 48791
DR   IHW; IHW09398
DR   IPD-IMGT/HLA; 26002
DR   Wikidata; Q54834806
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*36:01,74:01; B*53:01,57:03; C*04:01,07:01; DPB1*03:01,11:01:01; DQB1*02:01,03:01; DRB1*08:04,13:03; DRB3*02:02:01 (IPD-IMGT/HLA=26002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH19
AC   CVCL_E605
DR   dbMHC; 48792
DR   IHW; IHW09400
DR   IPD-IMGT/HLA; 26004
DR   Wikidata; Q54834807
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Chinese.
CC   HLA typing: A*02:03,34:01; B*15,38:02; C*04,07; DQB1*05:01,06:01; DRB1*15:02 (IPD-IMGT/HLA=26004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH20
AC   CVCL_E606
DR   dbMHC; 48794
DR   IHW; IHW09402
DR   IPD-IMGT/HLA; 26006
DR   Wikidata; Q54834808
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*01:01,02:01; B*44:02,44:05; C*02:02:02,16:04:01; DPB1*04:01; DQB1*03:01,05:01; DRB1*01:01,11:04 (IPD-IMGT/HLA=26006).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH21
AC   CVCL_E607
DR   dbMHC; 48795
DR   IHW; IHW09403
DR   IPD-IMGT/HLA; 26007
DR   Wikidata; Q54834809
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:30,03:01:01:01; B*35:01:01:02,38:01:01; C*04:01:01,12:03:01:01; DPA1*01:03:01:03,01:03:01:04; DPB1*03:01:01,04:01:01:01; DQA1*01:01:01,01:03:01:02; DQB1*05:01:01:02,06:03:01; DRB1*01:01:01,13:01:01 (IPD-IMGT/HLA=26007).
CC   HLA typing: A*02:30:01,03:01:01:01; B*38:01:01,35:01:01:02; C*04:01:01:01,12:03:01:01; DPA1*01:03:01:03,01:03:01:04; DPB1*03:01:01(124:01),04:01:01:01(350:01); DQA1*01:03:01,01:01:01; DQB1*06:03:01,05:01:01:03; DRB1*13:01:01,01:01:01; DRB3*01:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   FH22
AC   CVCL_E608
SY   Extract 386
DR   dbMHC; 48796
DR   IHW; IHW09404
DR   IPD-IMGT/HLA; 26008
DR   Wikidata; Q54834810
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/325cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01,02:01; B*08:01,51:09; C*07:01,16:02; DPA1*01:03:01; DPB1*02:01:02,51:01; DQA1*03,05; DQB1*02:01,03:02; DRB1*03:01,04:04 (IPD-IMGT/HLA=26008).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH23
AC   CVCL_E609
DR   dbMHC; 48797
DR   IHW; IHW09405
DR   IPD-IMGT/HLA; 26009
DR   Wikidata; Q54834811
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,31:01; B*07:02:01,27:07; C*07:02,15:02; DPB1*04:01,14:01; DQB1*03:01,06:02; DRB1*13:03,15:01 (IPD-IMGT/HLA=26009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH24
AC   CVCL_E610
DR   dbMHC; 48798
DR   IHW; IHW09406
DR   IPD-IMGT/HLA; 26010
DR   Wikidata; Q54834812
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*24:02,29:02; B*39:09,44:03:01; C*07:02,16:01; DPB1*04:02,14:01; DQB1*03:02,03:03; DRB1*04:04,13:01 (IPD-IMGT/HLA=26010).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH25
AC   CVCL_E611
DR   dbMHC; 48799
DR   IHW; IHW09407
DR   IPD-IMGT/HLA; 26011
DR   Wikidata; Q54834813
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:05,26:01; B*07:02,39:03; C*07:02; DPB1*04:02,05:01; DQB1*05:01,06:02; DRB1*01:01,15:01 (IPD-IMGT/HLA=26011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH26
AC   CVCL_E612
DR   dbMHC; 48800
DR   IHW; IHW09408
DR   IPD-IMGT/HLA; 26012
DR   Wikidata; Q54834814
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:06,26:01; B*35:01,48:03; C*03:03,08:01; DPB1*02:02,05:01; DQB1*03:01,03:02; DRB1*04:06,11:01 (IPD-IMGT/HLA=26012).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH27
AC   CVCL_E613
DR   dbMHC; 48801
DR   IHW; IHW09409
DR   IPD-IMGT/HLA; 26013
DR   Wikidata; Q54834815
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Native North American.
CC   HLA typing: A*31:01:02,34:01; B*35:01:01,38:02:01; C*04:01,07:02; DPB1*01:01:01,04:02; DQB1*04:02,05:02; DRB1*08:11,15:02; DRB5*01:01 (IPD-IMGT/HLA=26013).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH28
AC   CVCL_E614
DR   dbMHC; 48802
DR   IHW; IHW09410
DR   IPD-IMGT/HLA; 26014
DR   Wikidata; Q54834816
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,11:01; B*08:01,27:04; C*07:01,08:01; DPB1*01:01:01,02:02; DQB1*02:01,03:03; DRB1*03:01,09 (IPD-IMGT/HLA=26014).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH29
AC   CVCL_E615
DR   dbMHC; 48803
DR   IHW; IHW09411
DR   IPD-IMGT/HLA; 26015
DR   Wikidata; Q54834817
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*02:01,29:02; B*15:16,44:03:01; C*14:02,16:01; DPB1*04:01,11:01:01; DQB1*02:01,05:01; DRB1*01:02,07 (IPD-IMGT/HLA=26015).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH30
AC   CVCL_E616
DR   dbMHC; 48805
DR   IHW; IHW09412
DR   IPD-IMGT/HLA; 26016
DR   Wikidata; Q54834818
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01,29:02; B*27,27:12; C*01,02:02; DQB1*06:02,06:03; DRB1*13:01,15:01 (IPD-IMGT/HLA=26016).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH31
AC   CVCL_E617
DR   dbMHC; 48806
DR   IHW; IHW09413
DR   IPD-IMGT/HLA; 26017
DR   Wikidata; Q54834819
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*29,32:01; B*27:08,44; DRB1*03,11 (IPD-IMGT/HLA=26017).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH32
AC   CVCL_E618
DR   dbMHC; 48807
DR   IHW; IHW09414
DR   IPD-IMGT/HLA; 26018
DR   Wikidata; Q54834820
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01,32:01; B*08:01,27:08; C*06:02:01:01,07; DQB1*02,03:01; DRB1*03:01,11:01 (IPD-IMGT/HLA=26018).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH33
AC   CVCL_F541
DR   IHW; IHW09511
DR   IPD-IMGT/HLA; 12668
DR   Wikidata; Q54834821
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01,03:01; B*44:23N,07:02; C*05,07; DQB1*02,03:01; DRB1*03:01,01:03; DRB3*02 (IPD-IMGT/HLA=12668).
CC   HLA typing: A*03:01:01:01,02:01:01:01; B*07:02:01,44:23N; C*07:02:01:03,05:01:01:02; DPA1*01:03:01:02,01:03:01:04; DPB1*04:01:01:01; DQA1*05:05:01,05:01:01:03; DQB1*02:01:01,03:01:01:03; DRB1*03:01:01,01:03; DRB3*02:02:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   FH34
AC   CVCL_E619
DR   dbMHC; 48808
DR   IHW; IHW09415
DR   IPD-IMGT/HLA; 26019
DR   Wikidata; Q54834822
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*34:01,34:01; B*15,15:21; C*04:03,07; DPA1*02:02; DPB1*01:01:01; DQB1*04:02,06:01:01; DRB1*04:05,08:03 (IPD-IMGT/HLA=26019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH35
AC   CVCL_E620
DR   dbMHC; 48809
DR   IHW; IHW09416
DR   IPD-IMGT/HLA; 26020
DR   Wikidata; Q54834823
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*34:01,34:01; B*15,15:02; C*03:03,04; DQB1*04:01,06:01; DRB1*04:05,08:03 (IPD-IMGT/HLA=26020).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH36
AC   CVCL_E621
DR   dbMHC; 48810
DR   IHW; IHW09423
DR   IPD-IMGT/HLA; 26026
DR   Wikidata; Q54834824
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*34:02,74:01; B*08:01,15:03; C*02:02:04,07:01; DPB1*01:01:01; DQB1*02,04:02; DRB1*03:01,03:02 (IPD-IMGT/HLA=26026).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH37
AC   CVCL_E622
DR   dbMHC; 48811
DR   IHW; IHW09424
DR   IPD-IMGT/HLA; 26027
DR   Wikidata; Q54834825
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:05; B*07:02,39:01; C*06:02:01:01,07:01:01; DQB1*04:02,06:02; DRB1*08:01,15:01 (IPD-IMGT/HLA=26027).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH38
AC   CVCL_E623
SY   FH 38; SH38
DR   dbMHC; 48812
DR   IHW; IHW09426
DR   IPD-IMGT/HLA; 12641
DR   Wikidata; Q54834826
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,23:08N; B*44:03:01,51:29; C*07; DPB1*02:01:02,04:01:01; DRB1*11:01,07; DRB3*02 (IPD-IMGT/HLA=12641).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH39
AC   CVCL_E624
SY   TER315; TER-315; Ter 315; TER373; TER-373; Ter 373; TER472; TER-472; Ter 472
DR   dbMHC; 48813
DR   IHW; IHW09427
DR   IPD-IMGT/HLA; 26029
DR   Wikidata; Q54834827
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/366cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*26:01,34:01; B*07:06,40:01:01; C*03:04,07:02; DPB1*05:01,135:01; DQA1*01:02:01,01:04:01; DQB1*05:02:01,06:02; DRB1*11:05,15:02:01; DRB3*02:02:01; DRB5*01:02,01:08N (IPD-IMGT/HLA=26029).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH4
AC   CVCL_E5QM
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FH40
AC   CVCL_E625
AS   CVCL_F563
SY   JL; TER316; TER-316; Ter 316; TER386; TER-386; Ter 386; TER518; TER-518; Ter-518; Ter 518
DR   dbMHC; 48815
DR   IHW; IHW09428
DR   IPD-IMGT/HLA; 10850
DR   Wikidata; Q54834828
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX388F.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,29:02:01; B*18:01,44:03; C*07:01,16:01; DPB1*02:01,04:02; DQA1*02:01,05:05; DQB1*02:01,03:01; DRB1*07:01:01,11:08:01; DRB3*02:02:01; DRB4*01:01:01 (IPD-IMGT/HLA=10850).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH41
AC   CVCL_E626
SY   FH 41; R.G; RG; TER323; TER-323; Ter 323; TER414; TER-414; Ter 414; TER513; TER-513; Ter-513; Ter 513
DR   dbMHC; 48816
DR   IHW; IHW09429
DR   IPD-IMGT/HLA; 11285
DR   Wikidata; Q54834829
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/336cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX386F.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Brazilian.
CC   HLA typing: A*02:05,31:01; B*35:04,49:01; C*04:01/04:09N/04:30/04:82,07:01/07:06/07:18; DPB1*04:01:01,04:02; DQA1*03:03,04:01:01; DQB1*03:02:01,04:02; DRB1*04:05:01,08:07; DRB4*01:03 (IPD-IMGT/HLA=11285).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH42
AC   CVCL_E627
AS   CVCL_F539
SY   ARA016; TER324; TER-324; Ter 324; TER383; TER-383; Ter 383; Extract 563
DR   dbMHC; 48817
DR   IHW; IHW09430
DR   IPD-IMGT/HLA; 10261
DR   Wikidata; Q54834830
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/369cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Native North American; Tlingit.
CC   HLA typing: A*02,24; B*35,51; C*01:02,04:04; DPB1*04:02; DQA1*03:02,04:01; DQB1*03:03,04:02; DRB1*08:11,09:01; DRB4*01:03 (IPD-IMGT/HLA=10261).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   FH43
AC   CVCL_E628
AS   CVCL_F560
SY   HW; TER307; TER-307; Ter 307; TER427; TER-427; Ter 427
DR   dbMHC; 48818
DR   IHW; IHW09431
DR   IPD-IMGT/HLA; 10782
DR   Wikidata; Q54834831
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/343cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*30:01,33:01; B*53:01,81:01; C*04,08; DPB1*03:01:01,11:01:01; DQA1*02:01,03:03; DQB1*02:02,02:02; DRB1*07:01:01,11:08:02; DRB3*03:01:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=10782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   FH44
AC   CVCL_E629
SY   KE; TER334; TER-334; Ter 334; TER384; TER-384; Ter 384; TER467; TER-467; Ter 467; TER522; TER-522; Ter-522; Ter 522
DR   dbMHC; 48819
DR   IHW; IHW09432
DR   IPD-IMGT/HLA; 10908
DR   Wikidata; Q54834832
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/364cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX390reportFinal.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:03:01,11:01:01:01; B*15:02:01:01,38:02:01; C*07:02:01:01,08:147; DPA1*02:02:02:01; DPB1*02:02,05:01:01; DQA1*01:03:01:05,03:03:01:03; DQB1*04:01:01:01; DRB1*04:05:01:01;08:14:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=10908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH45
AC   CVCL_E630
SY   TER339; TER-339; Ter 339; TER390; TER-390; Ter 390
DR   dbMHC; 48820
DR   IHW; IHW09433
DR   IPD-IMGT/HLA; 26034
DR   Wikidata; Q54834833
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/325cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02,11:01; B*38:02,41:01; C*07:02,17; DQB1*03:01,05:02; DRB1*11:01,15:04 (IPD-IMGT/HLA=26034).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH46
AC   CVCL_E631
DR   dbMHC; 48821
DR   IHW; IHW09434
DR   IPD-IMGT/HLA; 26035
DR   Wikidata; Q54834836
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*11:01,24:33; B*27:22,51:06; C*03,12; DRB1*12:02,15:02 (IPD-IMGT/HLA=26035).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH47
AC   CVCL_E632
DR   dbMHC; 48822
DR   IHW; IHW09435
DR   IPD-IMGT/HLA; 26036
DR   Wikidata; Q54834837
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,26; B*35:02,38:01; C*04,12; DRB1*11:04 (IPD-IMGT/HLA=26036).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH48
AC   CVCL_E633
SY   Extract 222; Extract 299; Extract 449
DR   dbMHC; 48823
DR   IHW; IHW09436
DR   IPD-IMGT/HLA; 12966
DR   Wikidata; Q54834838
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/341cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*07:02,44:27; C*07:02,07:04; DQB1*06:04,06:02; DRB1*13:02,15:01 (IPD-IMGT/HLA=12966).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH49
AC   CVCL_E634
DR   dbMHC; 48824
DR   IHW; IHW09437
DR   IPD-IMGT/HLA; 26037
DR   Wikidata; Q54834839
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02; B*07:02,39:01; C*07; DRB1*08:01,15:01 (IPD-IMGT/HLA=26037).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH50
AC   CVCL_E635
DR   dbMHC; 48826
DR   IHW; IHW09438
DR   IPD-IMGT/HLA; 12967
DR   Wikidata; Q54834840
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*44:27,08:01; C*07,07; DQB1*02,03; DRB1*04:02,03:01 (IPD-IMGT/HLA=12967).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH51
AC   CVCL_E636
DR   dbMHC; 48827
DR   IHW; IHW09439
DR   IPD-IMGT/HLA; 26038
DR   Wikidata; Q54834841
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*23:01,24; B*40:02,44:03 (IPD-IMGT/HLA=26038).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH52
AC   CVCL_E637
DR   dbMHC; 48828
DR   IHW; IHW09440
DR   IPD-IMGT/HLA; 26039
DR   Wikidata; Q54834842
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*11:01,24:33; B*51:06; C*12:04; DRB1*07,11 (IPD-IMGT/HLA=26039).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH53
AC   CVCL_E638
DR   dbMHC; 48829
DR   IHW; IHW09441
DR   IPD-IMGT/HLA; 26040
DR   Wikidata; Q54834843
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*24:03,24:07; B*35:05,51:06; C*04:01:01,12:04:02; DRB1*12,12:02 (IPD-IMGT/HLA=26040).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH54
AC   CVCL_E639
DR   dbMHC; 48830
DR   IHW; IHW09442
DR   IPD-IMGT/HLA; 26041
DR   Wikidata; Q54834844
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*02:06,24:33; B*38:01,51:06; C*07:02,12:04; DQB1*05:02; DRB1*12:02,15:02 (IPD-IMGT/HLA=26041).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH55
AC   CVCL_E640
DR   dbMHC; 48831
DR   IHW; IHW09443
DR   IPD-IMGT/HLA; 26042
DR   Wikidata; Q54834845
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01,24; B*15,40; C*02:02,03; DRB1*04:04,07 (IPD-IMGT/HLA=26042).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH56
AC   CVCL_E641
DR   dbMHC; 48832
DR   IHW; IHW09444
DR   IPD-IMGT/HLA; 26043
DR   Wikidata; Q54834846
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:05,03:01; B*41:02,49; C*04,07; DRB1*11:01,11:04 (IPD-IMGT/HLA=26043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH57
AC   CVCL_E642
DR   dbMHC; 48833
DR   IHW; IHW09445
DR   IPD-IMGT/HLA; 26044
DR   Wikidata; Q54834847
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02,24:02; B*39:01,44; C*05,07; DRB1*04,08:01 (IPD-IMGT/HLA=26044).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH58
AC   CVCL_E643
DR   dbMHC; 48834
DR   IHW; IHW09446
DR   IPD-IMGT/HLA; 26045
DR   Wikidata; Q54834848
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,02:20:02; B*40:01,44:02; C*03,05; DRB1*11:04,15:01 (IPD-IMGT/HLA=26045).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH59
AC   CVCL_E644
DR   dbMHC; 48835
DR   IHW; IHW09447
DR   IPD-IMGT/HLA; 12743
DR   Wikidata; Q54834849
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01:01,03:01; B*07:02,51:29; C*02:02,07; DQB1*03:01,06; DRB1*11:01,15:01; DRB3*03; DRB5*01:01 (IPD-IMGT/HLA=12743).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH60
AC   CVCL_E645
SY   FH 60
DR   dbMHC; 48837
DR   IHW; IHW09448
DR   IPD-IMGT/HLA; 12753
DR   Wikidata; Q54834850
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01:01,02:17; B*15:72,35:03; C*04,07; DQB1*05:01; DRB1*01:01,01:02 (IPD-IMGT/HLA=12753).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH61
AC   CVCL_E646
DR   dbMHC; 48838
DR   IHW; IHW09449
DR   IPD-IMGT/HLA; 26046
DR   Wikidata; Q54834851
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01,26; B*38:01,40; C*03,12; DQB1*04,11; DRB1*04,11:04 (IPD-IMGT/HLA=26046).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH62
AC   CVCL_E647
DR   dbMHC; 48839
DR   IHW; IHW09450
DR   IPD-IMGT/HLA; 26047
DR   Wikidata; Q54834852
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01:01,24; B*35,52:01; C*03,12:02; DRB1*13:02,15:02 (IPD-IMGT/HLA=26047).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH63
AC   CVCL_E648
DR   dbMHC; 48840
DR   IHW; IHW09451
DR   IPD-IMGT/HLA; 26048
DR   Wikidata; Q54834853
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24; B*15:01,44; C*05,15; DRB1*01:01,11:03 (IPD-IMGT/HLA=26048).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH64
AC   CVCL_E649
DR   dbMHC; 48841
DR   IHW; IHW09452
DR   IPD-IMGT/HLA; 26049
DR   Wikidata; Q54834854
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02,32:01; B*18:01,44; C*05,07; DRB1*04:01,11:04 (IPD-IMGT/HLA=26049).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH65
AC   CVCL_E650
DR   dbMHC; 48842
DR   IHW; IHW09453
DR   IPD-IMGT/HLA; 26050
DR   Wikidata; Q54834855
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*29,30; B*45:01,53:01; C*04,06:02; DRB1*07,13:02 (IPD-IMGT/HLA=26050).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH66
AC   CVCL_E651
SY   FH 66
DR   dbMHC; 48843
DR   IHW; IHW09454
DR   IPD-IMGT/HLA; 12745
DR   Wikidata; Q54834856
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02,03; B*15:71,40:01; C*03; DQB1*03:01,06:04; DRB1*11:01,13:02 (IPD-IMGT/HLA=12745).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH67
AC   CVCL_E652
SY   FH 67; Extract 213; Extract 311; Extract 458
DR   dbMHC; 48844
DR   IHW; IHW09455
DR   IPD-IMGT/HLA; 12746
DR   Wikidata; Q54834857
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/343cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,03:01:01:01; B*15:71,40:01:02; C*03:03:01,03:04:01:01; DPA1*01:03:01:04; DPB1*02:01:02,04:01:01; DQA1*01:02:01:04,05:09; DQB1*03:01:01:03,06:04:01; DRB1*11:01:01,13:02:01; DRB3*02:02:01:01,03:01:01 (IPD-IMGT/HLA=12746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   FH68
AC   CVCL_E653
DR   dbMHC; 48845
DR   IHW; IHW09456
DR   IPD-IMGT/HLA; 26051
DR   Wikidata; Q54834858
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,30:01; B*18,41; C*06:02:01:01,07; DRB1*01:01,04:05 (IPD-IMGT/HLA=26051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH69
AC   CVCL_E654
DR   dbMHC; 48846
DR   IHW; IHW09457
DR   IPD-IMGT/HLA; 26052
DR   Wikidata; Q54834859
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:03,11; B*52,58:01; C*03,12:03; DRB1*10,13:02 (IPD-IMGT/HLA=26052).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH70EY
AC   CVCL_E655
DR   dbMHC; 48848
DR   IHW; IHW09458
DR   IPD-IMGT/HLA; 26053
DR   Wikidata; Q54834860
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*30:02,68:02; B*08:01,53:01; C*04:01,07; DPB1*02:01:02; DQB1*02:01,03:01:01; DRB1*03:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=26053).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   FH71
AC   CVCL_E656
SY   TER462; TER-462; Ter 462; TER480; TER-480; Ter 480
DR   dbMHC; 48849
DR   IHW; IHW09460
DR   IPD-IMGT/HLA; 20647
DR   Wikidata; Q54834861
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/360cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/370cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*30:01,74:01; B*15:03,35:01; C*02:10,04:01; DQB1*06:05; DRB1*13:02,13:02; DRB3*03:01,03:01 (IPD-IMGT/HLA=20647).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH72
AC   CVCL_E657
SY   TER465; TER-465; Ter 465; Extract 515
DR   dbMHC; 48850
DR   IHW; IHW09461
DR   IPD-IMGT/HLA; 26055
DR   Wikidata; Q54834862
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/362cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01,68:02; B*44,44:05; C*01:02,02:02; DRB1*04:26 (IPD-IMGT/HLA=26055).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   FH73
AC   CVCL_G558
DR   dbMHC; 48851
DR   IHW; IHW09462
DR   IPD-IMGT/HLA; 13328
DR   Wikidata; Q54834863
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*02,29; B*45:01; C*06:09,14; DQB1*02,06; DRB1*15:03,09:01 (IPD-IMGT/HLA=13328).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   FH74
AC   CVCL_E658
DR   dbMHC; 48852
DR   IHW; IHW09463
DR   IPD-IMGT/HLA; 26056
DR   Wikidata; Q54834864
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*23,29; B*14:01,45:01; C*06:02:01:01,14; DQB1*02,06; DRB1*09:01,15:03 (IPD-IMGT/HLA=26056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FH75
AC   CVCL_E659
DR   dbMHC; 48853
DR   IHW; IHW09464
DR   IPD-IMGT/HLA; 26057
DR   Wikidata; Q54834865
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01; B*07:02,27; C*01:02,07:10 (IPD-IMGT/HLA=26057).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   FH76
AC   CVCL_E660
DR   dbMHC; 48854
DR   IHW; IHW09466
DR   IPD-IMGT/HLA; 26059
DR   Wikidata; Q54834866
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Jewish.
CC   HLA typing: A*24:02:01:02L; B*55:01,55:01; C*01:02 (IPD-IMGT/HLA=26059).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   FH77
AC   CVCL_E661
DR   dbMHC; 48855
DR   IHW; IHW09467
DR   IPD-IMGT/HLA; 26060
DR   Wikidata; Q54834867
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,24; B*15:07,48:01; C*01:02,08:03; DQB1*03:01,04:02; DRB1*08:02,12 (IPD-IMGT/HLA=26060).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   FH78
AC   CVCL_E662
DR   dbMHC; 48856
DR   IHW; IHW09468
DR   IPD-IMGT/HLA; 26061
DR   Wikidata; Q54834868
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,11:01; B*07:02,27; C*07:02,15; DQB1*03,05:01; DRB1*01:01,04:04 (IPD-IMGT/HLA=26061).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   FH79
AC   CVCL_A7QZ
DR   IHW; IHW09469
DR   Wikidata; Q107114970
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*11:01:01:01,02:01:01:01; B*18:01:01:02,50:01:01; C*07:36,06:02:01:02; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*05:05:01,02:01:01; DQB1*03:01:01:03,02:02:01:01; DRB1*11:01:01:01,07:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FH80
AC   CVCL_A7RA
DR   IHW; IHW09470
DR   Wikidata; Q107114972
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,02:03:01; B*40:01:02; C*03:17,07:02:01:01; DPA1*02:02:02; DPB1*135:01,05:01:01; DQA1*01:04:01,03:02; DQB1*05:03:01,03:03:02; DRB1*14:54:01,09:01:02; DRB3*02:02:01:01; DRB4*01:03:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FH81
AC   CVCL_A7RB
DR   IHW; IHW09471
DR   Wikidata; Q107114974
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01:01:01:01,02:01:01:01; B*40:02:01,07:05:01:01; C*02:02:02:01,15:23; DPA1*01:03:01:04,01:03:01:05; DPB1*04:02:01:01(105:01),04:01:01:01(126:01); DQA1*01:02:02,05:05:01; DQB1*05:02:01,03:01:01:03; DRB1*16:02:01:02,01:03; DRB5*02:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   FH82
AC   CVCL_A7RC
DR   IHW; IHW09472
DR   Wikidata; Q107114975
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FH83
AC   CVCL_A7RD
DR   IHW; IHW09473
DR   Wikidata; Q107114979
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01; B*07:02:01,40:02:01; C*07:02:01:03,02:06:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FH85
AC   CVCL_A7RE
DR   IHW; IHW09475
DR   Wikidata; Q107114981
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*03:01:01:01,32:01:01; B*18:01:01:02,40:02:01; C*07:01:01:01,15:02:01:02; DPA1*01:03:01:02,02:02:02; DPB1*04:02:01:02(105:01),04:01:01:01(126:01); DQA1*05:05:01,03:01:01; DQB1*03:01:01:03,03:02:01; DRB1*11:01:01:01,04:03:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   FH86
AC   CVCL_A7RF
DR   IHW; IHW09476
DR   Wikidata; Q107114983
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FH87
AC   CVCL_A7RG
DR   IHW; IHW09477
DR   Wikidata; Q107114986
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,01:01:01:01; B*40:02:01,08:01:01:01; C*15:02:01:02,07:01:01:01; DPA1*01:03:01:01; DPB1*02:01:02; DQA1*02:01:01,05:01:01:02; DQB1*02:02:01:01,02:01:01; DRB1*07:01:01,03:01:01; DRB3*01:01:02; DRB4*01:01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FH89
AC   CVCL_A7RH
DR   IHW; IHW09479
DR   Wikidata; Q107114988
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01; B*15:01:01:01; C*03:04:01:01; DPA1*01:03:01:02,01:03:01:03; DPB1*03:01:01(124:01),04:01:01:01(350:01); DQA1*03:01:01; DQB1*03:02:01; DRB1*04:01:01; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   FH90
AC   CVCL_A7RK
DR   IHW; IHW09483
DR   Wikidata; Q107114990
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*11:01:01:01,26:01:01:01; B*35:01:01:02; C*08:01:01; C*03:03:01:01; DPA1*02:02:02,01:03:01:01; DPB1*05:01:01,02:01:02; DQA1*05:03,01:04:01; DQB1*03:01:01:01,05:03:01; DRB1*14:03:01,14:07:01; DRB3*01:01:02,02:02:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHBN
AC   CVCL_A7RL
SY   LCL13W09501
DR   IHW; IHW09501
DR   Wikidata; Q107114992
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01; B*15:01:01:01,44:03:01:01; C*03:03:01:01,04:09N; DPA1*01:03:01:01,01:03:01:02; DPB1*04:01:01:01(350:01),13:01:01; DQA1*02:01:01,01:02:01; DQB1*02:02:01:01,06:02:01; DRB1*07:01:01,15:01:01; DRB4*01:01:01:01; DRB5*01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   FHC
AC   CVCL_3688
SY   Fetal Human Colon
DR   BTO; BTO_0003808
DR   CLO; CLO_0003236
DR   AddexBio; P0009022/4980
DR   ATCC; CRL-1831
DR   BioSample; SAMN03471253
DR   CCRID; 5301HUM-KCB18026YJ
DR   ChEMBL-Cells; CHEMBL3308603
DR   ChEMBL-Targets; CHEMBL614654
DR   GEO; GSM1448155
DR   IARC_TP53; 28522
DR   KCB; KCB 2017068YJ
DR   KCB; KCB 2018026YJ
DR   PubChem_Cell_line; CVCL_3688
DR   Wikidata; Q54834869
RX   PubMed=6519668;
RX   PubMed=20193843;
CC   Characteristics: Forms solid tumors after transplantation into SCID mice.
CC   Doubling time: ~62 hours (PubMed=6519668).
CC   Karyotypic information: Is hypotriploid, has >20 copies of the 8q23~8q24.3 region containing MYC (PubMed=20193843).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=20193843).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): AddexBio=P0009022/4980; ATCC=CRL-1831
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 13,14.2
ST   D21S11: 28,29
ST   D2S1338: 17,20
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 14,17
ST   FGA: 21,24.3
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13FW
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   FHC1-hiPSC1
AC   CVCL_C415
SY   FHC.1.H.iPSC.1
DR   RSCB; RSCB0046
DR   Wikidata; Q54834870
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C422 ! FHC1-hiPSC8
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHC1-hiPSC2
AC   CVCL_C416
SY   FHC.1.H.iPSC.2
DR   RSCB; RSCB0047
DR   Wikidata; Q54834871
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C422 ! FHC1-hiPSC8
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHC1-hiPSC3
AC   CVCL_C417
SY   FHC.1.H.iPSC.3; RIi003-A
DR   hPSCreg; RIi003-A
DR   RSCB; RSCB0048
DR   SKIP; SKIP002398
DR   SKIP; SKIP005832
DR   Wikidata; Q54834872
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C422 ! FHC1-hiPSC8
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   FHC1-hiPSC4
AC   CVCL_C418
SY   FHC.1.H.iPSC.4
DR   RSCB; RSCB0050
DR   Wikidata; Q54834873
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C422 ! FHC1-hiPSC8
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHC1-hiPSC5
AC   CVCL_C419
SY   FHC.1.H.iPSC.5
DR   RSCB; RSCB0051
DR   Wikidata; Q54834874
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C422 ! FHC1-hiPSC8
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHC1-hiPSC6
AC   CVCL_C420
SY   FHC.1.H.iPSC.6
DR   RSCB; RSCB0052
DR   Wikidata; Q54834875
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C422 ! FHC1-hiPSC8
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHC1-hiPSC7
AC   CVCL_C421
SY   FHC.1.H.iPSC.7
DR   RSCB; RSCB0053
DR   Wikidata; Q54834879
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C422 ! FHC1-hiPSC8
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHC1-hiPSC8
AC   CVCL_C422
SY   FHC.1.H.iPSC.8
DR   RSCB; RSCB0065
DR   Wikidata; Q54834880
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C423 ! FHC1-hiPSC9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHC1-hiPSC9
AC   CVCL_C423
SY   FHC.1.H.iPSC.9
DR   RSCB; RSCB0066
DR   Wikidata; Q54834881
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C415 ! FHC1-hiPSC1
OI   CVCL_C416 ! FHC1-hiPSC2
OI   CVCL_C417 ! FHC1-hiPSC3
OI   CVCL_C418 ! FHC1-hiPSC4
OI   CVCL_C419 ! FHC1-hiPSC5
OI   CVCL_C420 ! FHC1-hiPSC6
OI   CVCL_C421 ! FHC1-hiPSC7
OI   CVCL_C422 ! FHC1-hiPSC8
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   FHCC-98
AC   CVCL_L437
DR   BTO; BTO_0006450
DR   Wikidata; Q54834882
RX   PubMed=15133854;
CC   Population: Chinese.
CC   Doubling time: 21.4 hours (PubMed=15133854).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   FHCR-1-2075/FH4
AC   CVCL_K272
SY   FH4
DR   CLO; CLO_0003237
DR   ATCC; HB-8775
DR   Wikidata; Q54834883
RX   Patent=US4876199;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8775.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Difucosylated and trifucosylated type 2 chain glycolipids.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   FHCR-1-2075/FH5
AC   CVCL_K273
SY   FH5
DR   CLO; CLO_0003238
DR   ATCC; HB-8770
DR   Wikidata; Q54834884
RX   Patent=US4876199;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8770.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Trifucosylated type 2 chain glycolipids.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   FHCR-1-2516/FH7
AC   CVCL_K274
SY   FH7
DR   CLO; CLO_0003239
DR   ATCC; HB-8861
DR   Wikidata; Q54834885
RX   Patent=US4851511;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8861.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   FHCR-1-2624/FH6/FHOT-1-3019
AC   CVCL_K275
SY   FH6
DR   CLO; CLO_0003240
DR   ATCC; HB-8873
DR   Wikidata; Q54834886
RX   Patent=US4904596;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8873.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61093; Alpha-Neu5Ac-(2->3)-beta-D-Gal (1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer (Ganglioside B6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   FHCR-1-2813/FDC-6
AC   CVCL_K276
SY   FDC-6
DR   CLO; CLO_0003241
DR   ATCC; HB-9018
DR   Wikidata; Q54834887
RX   Patent=US4894326;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9018.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   fHDF/TERT166
AC   CVCL_GZ73
DR   Evercyte; CHT-031-0166
DR   GEO; GSM7701492
DR   GEO; GSM7701493
DR   Wikidata; Q54834888
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: ~48 hours (Evercyte=CHT-031-0166).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): Evercyte=CHT-031-0166
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   FHDO-7
AC   CVCL_H747
SY   Fred Hutchinson Dog-7
DR   Wikidata; Q54834889
RX   PubMed=18065395;
RX   PubMed=18632696;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   FHeMEC
AC   CVCL_A1CJ
SY   F He MEC; Feline Heart Microvascular Endothelial Cells
DR   Wikidata; Q102113825
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4256.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal heart, microvascular endothelium; UBERON=UBERON_0003084+UBERON_0008339.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FHES-00
AC   CVCL_A7RS
DR   IHW; IHW09508
DR   Wikidata; Q107114996
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*35:01:01:02,35:12:01; C*04:01:01:01; DPA1*01:03:01:05; DPB1*04:02:01:02; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:07:01; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHES-01
AC   CVCL_A7RU
DR   IHW; IHW09512
DR   Wikidata; Q107114998
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*68:03:01,02:01:01:01; B*40:02:01; C*03:05,02:02:02:01; DPA1*01:03:01:04,02:02:02; DPB1*02:01:02,05:01:01; DQA1*03:01:01,05:05:01; DQB1*03:02:01,03:01:01:03; DRB1*04:07:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHJQ-00
AC   CVCL_A7RM
DR   IHW; IHW09503
DR   Wikidata; Q107114999
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01:02L,02:01:01:01; B*37:01:01,07:02:01; C*01:02:01,07:02:01:03; DPA1*01:03:01:01,01:03:01:02; DPB1*04:01:01:01,02:01:02; DQA1*03:03:01:01,05:05:01; DQB1*03:01:01:01,03:01:01:03; DRB1*04:07:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHJQ-01
AC   CVCL_A7RN
DR   IHW; IHW09504
DR   Wikidata; Q107115001
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01:02L,01:01:01:01; B*37:01:01,08:01:01:01; C*01:02:01,07:01:01:01; DPA1*01:03:01:02,02:01:02; DPB1*04:01:01:01,01:01:01; DQA1*03:03:01:01,05:01:01:02; DQB1*03:01:01:01,02:01:01; DRB1*04:07:01,03:01:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHK-78
AC   CVCL_X361
SY   FHK78; Fetal Horse Kidney-78; EFK-78; Equine Fetal Kidney-78
DR   Wikidata; Q54834890
RX   CelloPub=CLPUB00148;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   FHK-Tcl3
AC   CVCL_7214
SY   Fetal Horse Kidney-Transformed clone 3
DR   Wikidata; Q54834891
RX   PubMed=17917390;
CC   Virology: Supports the growth of equine herpesvirus type 1 (EHV-1), equine herpesvirus type 2 (EHV-2), equine herpesvirus type 3 (EHV-3) and equine herpesvirus type 4 (EHV-4) (PubMed=17917390).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 11
//
ID   FHK-Tcl3.1
AC   CVCL_7193
SY   Fetal Horse Kidney-Transformed clone 3.1
DR   Wikidata; Q54834892
RX   PubMed=23594411;
RX   PubMed=24833964;
CC   Virology: Supports the growth of equine herpesvirus type 1 (EHV-1), equine herpesvirus type 2 (EHV-2), equine herpesvirus type 3 (EHV-3) and equine herpesvirus type 4 (EHV-4) (PubMed=23594411; PubMed=24833964).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: FHK-13.1; PubMed=23594411; Note=In the title in the PubMed record, the original title is correct.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
HI   CVCL_7214 ! FHK-Tcl3
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   FHKW
AC   CVCL_6G63
SY   13W09502; Extract 226; Extract 303; Extract 431
DR   IHW; IHW09502
DR   IPD-IMGT/HLA; 12644
DR   Wikidata; Q54581781
RX   PubMed=11782282;
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/336cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:05; B*39:25N,50:01; C*06:02,12:03; DRB1*04:01,11:01 (IPD-IMGT/HLA=12644).
CC   HLA typing: A*02:01:01:01,02:05:01; B*39:25N,50:01:01; C*06:02:01:02,12:03:01:01; DPA1*01:03:01:03,01:03:01:02; DPB1*03:01:01(124:01),04:01:01:01(350:01); DQA1*03:03:01:01,05:05:01; DQB1*03:01:01:01,03:01:01:03; DRB1*04:01:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   FHL124
AC   CVCL_S908
SY   FHL-124; FHL 124; Fetal Human Lens-124
DR   Wikidata; Q54834893
RX   CelloPub=CLPUB00039;
RX   PubMed=11095618;
RX   PubMed=17679943;
RX   PubMed=22415099;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal eye, ocular lens, epithelium; UBERON=UBERON_0010312+UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   FHM
AC   CVCL_3820
SY   Fat Head Minnow
DR   CLO; CLO_0003242
DR   CLDB; cl1320
DR   CLDB; cl1321
DR   CLDB; cl1322
DR   CLDB; cl1323
DR   ATCC; CCL-42
DR   BCRC; 60351
DR   CCLV; CCLV-RIE 0057
DR   ECACC; 88102401
DR   IZSLER; BS CL 45
DR   KCB; KCB 89020YJ
DR   Wikidata; Q54834894
RX   CelloPub=CLPUB00103;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1139/f78-164;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=5220177;
RX   PubMed=5461163;
RX   PubMed=19941903;
RX   PubMed=23891577;
RX   PubMed=34382581;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   FHML2-6
AC   CVCL_L022
SY   Fat Head Minnow Liver 2-6
DR   Wikidata; Q54834895
RX   DOI=10.1007/s11626-009-9201-x;
RX   PubMed=24357037;
CC   Group: Fish cell line.
CC   Doubling time: 2-3 days (DOI=10.1007/s11626-009-9201-x).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 13
//
ID   FHMskin
AC   CVCL_F0Y5
SY   Fat Head Minnow skin
RX   PubMed=30468892;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 25-30 Celsius (PubMed=30468892).
CC   Virology: Susceptible and permissive to infection by viral hemorrhagic septicemia virus IVb (VHSV-IVb) (PubMed=30468892).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   FHMT-W1
AC   CVCL_L018
SY   FHMT; Fat Head Minnow Testis
DR   Wikidata; Q54834896
RX   CelloPub=CLPUB00325;
RX   PubMed=21086187;
RX   PubMed=24357037;
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 11
//
ID   FHNG-00
AC   CVCL_A7RR
DR   IHW; IHW09507
DR   Wikidata; Q107115003
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*23:01:01,24:39; B*44:03:01:01,40:02:01; C*04:01:01:01,02:02:02:01; DPA1*01:03:01:01,02:01:01:02; DPB1*16:01:01,10:01:01; DQA1*03:01:01,05:05:01; DQB1*03:05:01,03:01:01:03; DRB1*04:03:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHNG-01
AC   CVCL_A7RT
DR   IHW; IHW09510
DR   Wikidata; Q107115007
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24:39,29:02:01:01; B*15:17:01:01,40:02:01; C*07:01:02,02:02:02:01; DPA1*01:03:01:01; DPB1*02:01:02,16:01:01; DQA1*01:02:01,05:05:01; DQB1*06:04:01,03:01:01:03; DRB1*13:02:01,11:01:01:01; DRB3*03:01:01,02:02:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHO6T1-1
AC   CVCL_C5TQ
DR   Wikidata; Q116049013
RX   PubMed=2642270;
RX   PubMed=6462235;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Activated HRAS.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   FHs 173We
AC   CVCL_3308
SY   FHs 173 WE
DR   CLO; CLO_0003243
DR   ATCC; HTB-158
DR   BCRC; 60229
DR   Wikidata; Q54834897
CC   Population: African American.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=HTB-158
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0661 ! Hs 173.Sp
OI   CVCL_0662 ! Hs 173.We
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   FHs 738Bl
AC   CVCL_T279
DR   ATCC; HTB-160
DR   IARC_TP53; 3718
DR   Wikidata; Q54834898
RX   PubMed=7787250;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.226_278del53; Zygosity=Unspecified (PubMed=7787250).
CC   Discontinued: ATCC; HTB-160; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=HTB-160
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3309 ! FHs 738Lu
OI   CVCL_R767 ! Hs 738.Bl
OI   CVCL_S035 ! Hs 738.Eye
OI   CVCL_S314 ! Hs 738.K/Ad/Ts
OI   CVCL_0879 ! Hs 738.Lu
OI   CVCL_0880 ! Hs 738.St/Int
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   FHs 738Lu
AC   CVCL_3309
DR   CLO; CLO_0003244
DR   ATCC; HTB-157
DR   Wikidata; Q54834899
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=HTB-157
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 17,22
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9,10
ST   Penta E: 11,15
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T279 ! FHs 738Bl
OI   CVCL_R767 ! Hs 738.Bl
OI   CVCL_S035 ! Hs 738.Eye
OI   CVCL_S314 ! Hs 738.K/Ad/Ts
OI   CVCL_0879 ! Hs 738.Lu
OI   CVCL_0880 ! Hs 738.St/Int
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   FHs 74 Int
AC   CVCL_2899
SY   FHs74Int; FHs74 Int; 74Int
DR   CLO; CLO_0003245
DR   AddexBio; P0021002/4996
DR   ATCC; CCL-241
DR   BioSample; SAMN03471479
DR   BioSample; SAMN03472360
DR   CCRID; 3101HUMSCSP574
DR   FANTOM5_SSTAR; 10812-111B2
DR   GEO; GSE11678
DR   IZSLER; BS CL 192
DR   JCRB; JCRB9076
DR   Wikidata; Q54834900
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Senescence: Can undergo 15 PDL.
CC   Doubling time: 6-7 days (PubMed=176412); 65 hours (Note=With EGF), 168 hours (Note=Without EGF) (JCRB=JCRB9076).
CC   Caution: Could be identical to Hs 74.Int (Cellosaurus=CVCL_S089).
CC   Misspelling: 741Int; PubMed=761205.
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
ST   Source(s): AddexBio=P0021002/4996; ATCC=CCL-241; IZSLER=BS CL 192; JCRB=JCRB9076
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 20,24
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 5,7
ST   TH01: 7,9.3 (AddexBio=P0021002/4996; ATCC=CCL-241; IZSLER=BS CL 192)
ST   TH01: 7,9.3,11 (JCRB=JCRB9076)
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12-16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   FHS-1
AC   CVCL_UW72
SY   Feline Histiocytic Sarcoma-1
DR   Wikidata; Q93553571
RX   PubMed=29914686;
CC   Breed/subspecies: Domestic shorthair.
DI   NCIt; C157503; Feline histiocytic sarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   FHS001i-sh10950A
AC   CVCL_YY32
SY   iPSC - 10950A
DR   BioSample; SAMN06093749
DR   GEO; GSM2411797
DR   WiCell; fhs001i-sh10950a
DR   Wikidata; Q98126031
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY33 ! FHS002i-sh10950C
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS002i-sh10950C
AC   CVCL_YY33
SY   iPSC - 10950C
DR   BioSample; SAMN06093748
DR   GEO; GSM2411798
DR   WiCell; fhs002i-sh10950c
DR   Wikidata; Q98126034
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY32 ! FHS001i-sh10950A
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS003i-sh12022B
AC   CVCL_YY34
SY   iPSC - 12022B
DR   BioSample; SAMN06093747
DR   GEO; GSM2411799
DR   WiCell; fhs003i-sh12022b
DR   Wikidata; Q98126037
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY35 ! FHS004i-sh12022C
SX   Female
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS004i-sh12022C
AC   CVCL_YY35
SY   iPSC - 12022C
DR   BioSample; SAMN06093746
DR   GEO; GSM2411800
DR   WiCell; fhs004i-sh12022c
DR   Wikidata; Q98126039
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY34 ! FHS003i-sh12022B
SX   Female
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS005i-sh1236B
AC   CVCL_YY36
SY   iPSC - 1236B
DR   BioSample; SAMN06093745
DR   GEO; GSM2411801
DR   WiCell; fhs005i-sh1236b
DR   Wikidata; Q98126041
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY37 ! FHS006i-sh1236C
SX   Female
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS006i-sh1236C
AC   CVCL_YY37
SY   iPSC - 1236C
DR   BioSample; SAMN06093744
DR   GEO; GSM2411802
DR   WiCell; fhs006i-sh1236c
DR   Wikidata; Q98126042
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY36 ! FHS005i-sh1236B
SX   Female
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS007i-sh12569A
AC   CVCL_YY38
SY   iPSC - 12569A
DR   BioSample; SAMN06093695
DR   GEO; GSM2411763
DR   WiCell; fs007i-sh12569a
DR   Wikidata; Q98126043
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY39 ! FHS008i-sh12569B
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS008i-sh12569B
AC   CVCL_YY39
SY   iPSC - 12569B
DR   BioSample; SAMN06093694
DR   GEO; GSM2411764
DR   WiCell; fhs008i-sh12569b
DR   Wikidata; Q98126045
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY38 ! FHS007i-sh12569A
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS009i-sh12888A
AC   CVCL_YY40
SY   iPSC - 12888A
DR   BioSample; SAMN06093743
DR   GEO; GSM2411803
DR   WiCell; fhs009i-sh12888a
DR   Wikidata; Q98126046
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY41 ! FHS010i-sh12888B
SX   Female
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS010i-sh12888B
AC   CVCL_YY41
SY   iPSC - 12888B
DR   BioSample; SAMN06093742
DR   GEO; GSM2411804
DR   WiCell; fhs010i-sh12888b
DR   Wikidata; Q98126047
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY40 ! FHS009i-sh12888A
SX   Female
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS011i-sh1293A
AC   CVCL_YY42
SY   iPSC - 1293A
DR   BioSample; SAMN06093693
DR   GEO; GSM2411765
DR   WiCell; fhs011i-sh1293a
DR   Wikidata; Q98126048
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY43 ! FHS012i-sh1293B
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS012i-sh1293B
AC   CVCL_YY43
SY   iPSC - 1293B
DR   BioSample; SAMN06093692
DR   GEO; GSM2411766
DR   WiCell; fhs012i-sh1293b
DR   Wikidata; Q98126050
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY42 ! FHS011i-sh1293A
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS013i-sh1296C
AC   CVCL_YY44
SY   iPSC - 1296C
DR   BioSample; SAMN06093741
DR   GEO; GSM2411805
DR   WiCell; fhs013i-sh1296c
DR   Wikidata; Q98126053
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY45 ! FHS014i-sh1296E
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS014i-sh1296E
AC   CVCL_YY45
SY   iPSC - 1296E
DR   BioSample; SAMN06093740
DR   GEO; GSM2411806
DR   WiCell; fhs014i-sh1296e
DR   Wikidata; Q98126056
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY44 ! FHS013i-sh1296C
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS015i-sh13352A
AC   CVCL_YY46
SY   iPSC - 13352A
DR   BioSample; SAMN06093739
DR   GEO; GSM2411807
DR   WiCell; fhs015i-sh13352a
DR   Wikidata; Q98126060
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY47 ! FHS016i-sh13352E
SX   Male
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS016i-sh13352E
AC   CVCL_YY47
SY   iPSC - 13352E
DR   BioSample; SAMN06093738
DR   GEO; GSM2411808
DR   WiCell; fhs016i-sh13352e
DR   Wikidata; Q98126063
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY46 ! FHS015i-sh13352A
SX   Male
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS017i-sh14157A
AC   CVCL_YY48
SY   iPSC - 14157A
DR   BioSample; SAMN06093737
DR   GEO; GSM2411809
DR   WiCell; fhs017i-sh14157a
DR   Wikidata; Q98126066
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY49 ! FHS018i-sh14157C
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS018i-sh14157C
AC   CVCL_YY49
SY   iPSC - 14157C
DR   BioSample; SAMN06093736
DR   GEO; GSM2411810
DR   WiCell; fhs018i-sh14157c
DR   Wikidata; Q98126069
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY48 ! FHS017i-sh14157A
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS019i-sh1441F
AC   CVCL_YY50
SY   iPSC - 1441F
DR   BioSample; SAMN06093676
DR   GEO; GSM2411767
DR   WiCell; fhs019i-sh1441f
DR   Wikidata; Q98126072
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY51 ! FHS020i-sh1441G
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS020i-sh1441G
AC   CVCL_YY51
SY   iPSC - 1441G
DR   BioSample; SAMN06093675
DR   GEO; GSM2411768
DR   WiCell; fhs020i-sh1441g
DR   Wikidata; Q98126075
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY50 ! FHS019i-sh1441F
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS021i-sh14685A
AC   CVCL_YY52
SY   iPSC - 14685A
DR   BioSample; SAMN06093735
DR   GEO; GSM2411811
DR   WiCell; fhs021i-sh14685a
DR   Wikidata; Q98126078
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY53 ! FHS022i-sh14685B
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS022i-sh14685B
AC   CVCL_YY53
SY   iPSC - 14685B
DR   BioSample; SAMN06093734
DR   GEO; GSM2411812
DR   WiCell; fhs022i-sh14685b
DR   Wikidata; Q98126081
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY52 ! FHS021i-sh14685A
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS023i-sh16126C
AC   CVCL_YY54
SY   iPSC - 16126C
DR   BioSample; SAMN06093733
DR   GEO; GSM2411813
DR   WiCell; fhs023i-sh16126c
DR   Wikidata; Q98126084
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY55 ! FHS024i-sh16126E
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS024i-sh16126E
AC   CVCL_YY55
SY   iPSC - 16126E
DR   BioSample; SAMN06093732
DR   GEO; GSM2411814
DR   WiCell; fhs024i-sh16126e
DR   Wikidata; Q98126085
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY54 ! FHS023i-sh16126C
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS025i-sh1649A
AC   CVCL_YY56
SY   iPSC - 1649A
DR   BioSample; SAMN06093674
DR   GEO; GSM2411769
DR   WiCell; fhs025i-sh1649a
DR   Wikidata; Q98126087
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY57 ! FHS026i-sh1649B
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS026i-sh1649B
AC   CVCL_YY57
SY   iPSC - 1649B
DR   BioSample; SAMN06093673
DR   GEO; GSM2411770
DR   WiCell; fhs026i-sh1649b
DR   Wikidata; Q98126088
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY56 ! FHS025i-sh1649A
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS027i-sh1660E
AC   CVCL_YY58
SY   iPSC - 1660E
DR   BioSample; SAMN06093668
DR   GEO; GSM2411771
DR   WiCell; fhs027i-sh1660e
DR   Wikidata; Q98126089
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY59 ! FHS028i-sh1660F
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS028i-sh1660F
AC   CVCL_YY59
SY   iPSC - 1660F
DR   BioSample; SAMN06093667
DR   GEO; GSM2411772
DR   WiCell; fhs028i-sh1660f
DR   Wikidata; Q98126091
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY58 ! FHS027i-sh1660E
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS029i-sh1673B
AC   CVCL_YY60
SY   iPSC - 1673B
DR   BioSample; SAMN06093666
DR   GEO; GSM2411773
DR   WiCell; fhs029i-sh1673b
DR   Wikidata; Q98126092
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY61 ! FHS030i-sh1673F
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS030i-sh1673F
AC   CVCL_YY61
SY   iPSC - 1673F
DR   BioSample; SAMN06093665
DR   GEO; GSM2411774
DR   WiCell; fhs030i-sh1673f
DR   Wikidata; Q98126093
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY60 ! FHS029i-sh1673B
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS031i-sh16939A
AC   CVCL_YY62
SY   iPSC - 16939A
DR   BioSample; SAMN06093731
DR   GEO; GSM2411815
DR   WiCell; fhs031i-sh16939a
DR   Wikidata; Q98126094
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY63 ! FHS032i-sh16939B
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS032i-sh16939B
AC   CVCL_YY63
SY   iPSC - 16939B
DR   BioSample; SAMN06093730
DR   GEO; GSM2411816
DR   WiCell; fhs032i-sh16939b
DR   Wikidata; Q98126146
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY62 ! FHS031i-sh16939A
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS033i-sh18719B
AC   CVCL_YY64
SY   iPSC - 18719B
DR   BioSample; SAMN06093669
DR   GEO; GSM2411775
DR   WiCell; fhs033i-sh18719b
DR   Wikidata; Q98126149
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY65 ! FHS034i-sh18719D
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS034i-sh18719D
AC   CVCL_YY65
SY   iPSC - 18719D
DR   BioSample; SAMN06093672
DR   GEO; GSM2411776
DR   WiCell; fhs034i-sh18719d
DR   Wikidata; Q98126151
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY64 ! FHS033i-sh18719B
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS035i-sh18961A
AC   CVCL_YY66
SY   iPSC - 18961A
DR   BioSample; SAMN06093671
DR   GEO; GSM2411777
DR   WiCell; fhs035i-sh18961a
DR   Wikidata; Q98126155
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY67 ! FHS036i-sh18961C
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS036i-sh18961C
AC   CVCL_YY67
SY   iPSC - 18961C
DR   BioSample; SAMN06093670
DR   GEO; GSM2411778
DR   WiCell; fhs036i-sh18961c
DR   Wikidata; Q98126157
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY66 ! FHS035i-sh18961A
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS037i-sh1998E
AC   CVCL_YY68
SY   iPSC - 1998E
DR   BioSample; SAMN06093729
DR   GEO; GSM2411817
DR   WiCell; fhs037i-sh1998e
DR   Wikidata; Q98126159
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY69 ! FHS038i-sh1998G
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS038i-sh1998G
AC   CVCL_YY69
SY   iPSC - 1998G
DR   BioSample; SAMN06093728
DR   GEO; GSM2411818
DR   WiCell; fhs038i-sh1998g
DR   Wikidata; Q98126162
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY68 ! FHS037i-sh1998E
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS039i-sh2098A
AC   CVCL_YY70
SY   iPSC - 2098A
DR   BioSample; SAMN06093664
DR   GEO; GSM2411779
DR   WiCell; fhs039i-sh2098a
DR   Wikidata; Q98126165
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY71 ! FHS040i-sh2098B
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS040i-sh2098B
AC   CVCL_YY71
SY   iPSC - 2098B
DR   BioSample; SAMN06093663
DR   GEO; GSM2411780
DR   WiCell; fhs040i-sh2098b
DR   Wikidata; Q98126169
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY70 ! FHS039i-sh2098A
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS041i-sh22512A
AC   CVCL_YY72
SY   iPSC - 22512A
DR   BioSample; SAMN06093727
DR   GEO; GSM2411819
DR   WiCell; fhs041i-sh22512a
DR   Wikidata; Q98126172
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY73 ! FHS042i-sh22512D
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS042i-sh22512D
AC   CVCL_YY73
SY   iPSC - 22512D
DR   BioSample; SAMN06093726
DR   GEO; GSM2411820
DR   WiCell; fhs042i-sh22512d
DR   Wikidata; Q98126174
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY72 ! FHS041i-sh22512A
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS043i-sh24472D
AC   CVCL_YY74
SY   iPSC - 24472D
DR   BioSample; SAMN06093725
DR   GEO; GSM2411821
DR   WiCell; fhs043i-sh24472d
DR   Wikidata; Q98126178
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY75 ! FHS044i-sh24472K
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS044i-sh24472K
AC   CVCL_YY75
SY   iPSC - 24472K
DR   BioSample; SAMN06093724
DR   GEO; GSM2411822
DR   WiCell; fhs044i-sh24472k
DR   Wikidata; Q98126180
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY74 ! FHS043i-sh24472D
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS045i-sh25642B
AC   CVCL_YY76
SY   iPSC - 25642B
DR   BioSample; SAMN06093723
DR   GEO; GSM2411823
DR   WiCell; fhs045i-sh25642b
DR   Wikidata; Q98126183
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY77 ! FHS046i-sh25642C
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS046i-sh25642C
AC   CVCL_YY77
SY   iPSC - 25642C
DR   BioSample; SAMN06093722
DR   GEO; GSM2411824
DR   WiCell; fhs046i-sh25642c
DR   Wikidata; Q98126185
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY76 ! FHS045i-sh25642B
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS047i-sh25727B
AC   CVCL_YY78
SY   iPSC - 25727B
DR   BioSample; SAMN06093721
DR   GEO; GSM2411825
DR   WiCell; fhs047i-sh25727b
DR   Wikidata; Q98126188
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY79 ! FHS048i-sh25727G
SX   Male
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS048i-sh25727G
AC   CVCL_YY79
SY   iPSC - 25727G
DR   BioSample; SAMN06093720
DR   GEO; GSM2411826
DR   WiCell; fhs048i-sh25727g
DR   Wikidata; Q98126191
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY78 ! FHS047i-sh25727B
SX   Male
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS049i-sh2633B
AC   CVCL_YY80
SY   iPSC - 2633B
DR   BioSample; SAMN06093565
DR   GEO; GSM2411827
DR   WiCell; fhs049i-sh2633b
DR   Wikidata; Q98126195
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY81 ! FHS050i-sh2633D
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS050i-sh2633D
AC   CVCL_YY81
SY   iPSC - 2633D
DR   BioSample; SAMN06093564
DR   GEO; GSM2411828
DR   WiCell; fhs050i-sh2633d
DR   Wikidata; Q98126197
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY80 ! FHS049i-sh2633B
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS051i-sh2945A
AC   CVCL_YY82
SY   iPSC - 2945A
DR   BioSample; SAMN06093662
DR   GEO; GSM2411781
DR   WiCell; fhs051i-sh2945a
DR   Wikidata; Q98126200
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY83 ! FHS052i-sh2945B
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS052i-sh2945B
AC   CVCL_YY83
SY   iPSC - 2945B
DR   BioSample; SAMN06093661
DR   GEO; GSM2411782
DR   WiCell; fhs052i-sh2945b
DR   Wikidata; Q98126203
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY82 ! FHS051i-sh2945A
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS053i-sh3726A
AC   CVCL_YY84
SY   iPSC - 3726A
DR   BioSample; SAMN06093660
DR   GEO; GSM2411783
DR   WiCell; fhs053i-sh3726a
DR   Wikidata; Q98126205
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY85 ! FHS054i-sh3726B
SX   Female
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS054i-sh3726B
AC   CVCL_YY85
SY   iPSC - 3726B
DR   BioSample; SAMN06093659
DR   GEO; GSM2411784
DR   WiCell; fhs054i-sh3726b
DR   Wikidata; Q98126207
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY84 ! FHS053i-sh3726A
SX   Female
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS055i-sh4064A
AC   CVCL_YY86
SY   iPSC - 4064A
DR   BioSample; SAMN06093658
DR   GEO; GSM2411785
DR   WiCell; fhs055i-sh4064a
DR   Wikidata; Q98126211
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY87 ! FHS056i-sh4064B
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS056i-sh4064B
AC   CVCL_YY87
SY   iPSC - 4064B
DR   BioSample; SAMN06093657
DR   GEO; GSM2411786
DR   WiCell; fhs056i-sh4064b
DR   Wikidata; Q98126213
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY86 ! FHS055i-sh4064A
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS057i-sh4105B
AC   CVCL_YY88
SY   iPSC - 4105B
DR   BioSample; SAMN06093563
DR   GEO; GSM2411829
DR   WiCell; fhs057i-sh4105b
DR   Wikidata; Q98126216
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY89 ! FHS058i-sh4105D
SX   Female
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS058i-sh4105D
AC   CVCL_YY89
SY   iPSC - 4105D
DR   BioSample; SAMN06093562
DR   GEO; GSM2411830
DR   WiCell; fhs058i-sh4105d
DR   Wikidata; Q98126220
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY88 ! FHS057i-sh4105B
SX   Female
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS059i-sh4756A
AC   CVCL_YY90
SY   iPSC - 4756A
DR   BioSample; SAMN06093656
DR   GEO; GSM2411787
DR   WiCell; fhs059i-sh4756a
DR   Wikidata; Q98126223
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY91 ! FHS060i-sh4756B
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS060i-sh4756B
AC   CVCL_YY91
SY   iPSC - 4756B
DR   BioSample; SAMN06093655
DR   GEO; GSM2411788
DR   WiCell; fhs060i-sh4756b
DR   Wikidata; Q98126225
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY90 ! FHS059i-sh4756A
SX   Male
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS061i-sh521C
AC   CVCL_YY92
SY   iPSC - 521C
DR   BioSample; SAMN06093654
DR   GEO; GSM2411789
DR   WiCell; fhs061i-sh521c
DR   Wikidata; Q98126227
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY93 ! FHS062i-sh521E
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS062i-sh521E
AC   CVCL_YY93
SY   iPSC - 521E
DR   BioSample; SAMN06093653
DR   GEO; GSM2411790
DR   WiCell; fhs062i-sh521e
DR   Wikidata; Q98126228
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY92 ! FHS061i-sh521C
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS063i-sh554A
AC   CVCL_YY94
SY   iPSC - 554A
DR   BioSample; SAMN06093652
DR   GEO; GSM2411791
DR   WiCell; fhs063i-sh554a
DR   Wikidata; Q98126229
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY95 ! FHS064i-sh554D
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS064i-sh554D
AC   CVCL_YY95
SY   iPSC - 554D
DR   BioSample; SAMN06093651
DR   GEO; GSM2411792
DR   WiCell; fhs064i-sh554d
DR   Wikidata; Q98126230
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY94 ! FHS063i-sh554A
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS065i-sh921B
AC   CVCL_YY96
SY   iPSC - 921B
DR   BioSample; SAMN06093650
DR   GEO; GSM2411793
DR   WiCell; fhs065i-sh921b
DR   Wikidata; Q98126231
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY97 ! FHS066i-sh921C
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS066i-sh921C
AC   CVCL_YY97
SY   iPSC - 921C
DR   BioSample; SAMN06093649
DR   GEO; GSM2411794
DR   WiCell; fhs066i-sh921c
DR   Wikidata; Q98126232
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY96 ! FHS065i-sh921B
SX   Male
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS067i-sh9462A
AC   CVCL_YY98
SY   iPSC - 9462A
DR   BioSample; SAMN06093648
DR   GEO; GSM2411795
DR   WiCell; fhs067i-sh9462a
DR   Wikidata; Q98126235
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY99 ! FHS068i-sh9462B
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS068i-sh9462B
AC   CVCL_YY99
SY   iPSC - 9462B
DR   BioSample; SAMN06093647
DR   GEO; GSM2411796
DR   WiCell; fhs068i-sh9462b
DR   Wikidata; Q98126236
RX   PubMed=28388431;
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YY98 ! FHS067i-sh9462A
SX   Female
AG   71-80Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   FHS069i-sh14564C
AC   CVCL_YZ00
DR   WiCell; fhs069i-sh14564c
DR   Wikidata; Q98126237
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G>T (chr1:g.109274968G>T); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Minor haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61-70Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 11
//
ID   FHS070i-sh4670A
AC   CVCL_YZ01
DR   WiCell; fhs070i-sh4670a
DR   Wikidata; Q98126238
CC   Part of: Framingham Heart Study (FHS) collection.
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3231; CELSR2; Simple; c.*919G (chr1:g.109274968G); ClinVar=VCV000007081; Zygosity=Homozygous; Note=Major haplotype (PubMed=28388431).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81-90Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 11
//
ID   FHSL-00
AC   CVCL_A7RQ
DR   IHW; IHW09506
DR   Wikidata; Q107115008
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*30:02:01:01; B*07:02:01,35:01:01:02; C*07:02:01:03,04:01:01:01; DPA1*01:03:01:01,01:03:01:04; DPB1*04:01:01:01,02:01:02; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHSL-01
AC   CVCL_A7RP
DR   IHW; IHW09505
DR   Wikidata; Q107115011
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*11:01:01:01; B*07:02:01; C*07:02:01:03; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*01:02:01,03:03:01:01; DQB1*06:02:01,03:01:01:01; DRB1*15:01:01,04:01:01; DRB4*01:03:01; DRB5*01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   FHUi001-A
AC   CVCL_YT23
SY   MEN1-iPS-01; MEN1_01; 01_3066A2-2
DR   hPSCreg; FHUi001-A
DR   SKIP; SKIP005758
DR   Wikidata; Q93553578
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg171_Val173del (c.512_520delGGGATGTCC); Zygosity=Heterozygous (PubMed=32460232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT24 ! FHUi001-B
OI   CVCL_YT25 ! FHUi001-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   FHUi001-B
AC   CVCL_YT24
SY   MEN1-iPS-19; MEN1_19; 19_3061C2
DR   hPSCreg; FHUi001-B
DR   SKIP; SKIP005781
DR   Wikidata; Q93553581
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg171_Val173del (c.512_520delGGGATGTCC); Zygosity=Heterozygous (PubMed=32460232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT23 ! FHUi001-A
OI   CVCL_YT25 ! FHUi001-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   FHUi001-C
AC   CVCL_YT25
SY   MEN1-iPS-20; MEN1_20; 20_3063A1
DR   hPSCreg; FHUi001-C
DR   SKIP; SKIP005760
DR   Wikidata; Q93553585
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg171_Val173del (c.512_520delGGGATGTCC); Zygosity=Heterozygous (PubMed=32460232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT23 ! FHUi001-A
OI   CVCL_YT24 ! FHUi001-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   FHUi002-A
AC   CVCL_YT26
SY   MEN1-iPS-08; MEN1_08; 08_3056A3-2
DR   hPSCreg; FHUi002-A
DR   SKIP; SKIP005761
DR   Wikidata; Q93553589
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT27 ! FHUi002-B
OI   CVCL_YT28 ! FHUi002-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   FHUi002-B
AC   CVCL_YT27
SY   MEN1-iPS-12; MEN1_12; 12_3052B1
DR   hPSCreg; FHUi002-B
DR   SKIP; SKIP005762
DR   Wikidata; Q93553593
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT26 ! FHUi002-A
OI   CVCL_YT28 ! FHUi002-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   FHUi002-C
AC   CVCL_YT28
SY   MEN1-iPS-17; MEN1_17; 17_3052C2a3
DR   hPSCreg; FHUi002-C
DR   SKIP; SKIP005763
DR   Wikidata; Q93553597
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT26 ! FHUi002-A
OI   CVCL_YT27 ! FHUi002-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   FHUi003-A
AC   CVCL_A9XT
SY   A1b2as1; FNDI-iPS-A1b; FNDI-A1b
DR   hPSCreg; FHUi003-A
DR   Wikidata; Q102113826
RX   PubMed=32927425;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:894; AVP; Simple; p.Cys105Ser (c.314G>C); Zygosity=Heterozygous (PubMed=32927425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XU ! FHUi003-B
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   FHUi003-B
AC   CVCL_A9XU
SY   A11b; FNDI-iPS-A11b; FNDI-A11b
DR   hPSCreg; FHUi003-B
DR   Wikidata; Q102113828
RX   PubMed=32927425;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:894; AVP; Simple; p.Cys105Ser (c.314G>C); Zygosity=Heterozygous (PubMed=32927425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XT ! FHUi003-A
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   FHUi004-A
AC   CVCL_A9XV
SY   B3a; FNDI-iPS-B3a; FNDI-B3a
DR   hPSCreg; FHUi004-A
DR   Wikidata; Q102113830
RX   PubMed=32927425;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:894; AVP; Simple; p.Cys105Ser (c.314G>C); Zygosity=Heterozygous (PubMed=32927425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XW ! FHUi004-B
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   FHUi004-B
AC   CVCL_A9XW
SY   B7as1; FNDI-iPS-B7a; FNDI-B7a
DR   hPSCreg; FHUi004-B
DR   Wikidata; Q102113831
RX   PubMed=32927425;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:894; AVP; Simple; p.Cys105Ser (c.314G>C); Zygosity=Heterozygous (PubMed=32927425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XV ! FHUi004-A
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   FHUSTCi001-A
AC   CVCL_C0FQ
DR   BioSamples; SAMEA12056141
DR   hPSCreg; FHUSTCi001-A
DR   Wikidata; Q112929562
RX   PubMed=35395622;
CC   From: The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China; Hefei; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3778; FN1; Simple; p.Val1868Met (c.5602G>A); ClinVar=VCV001051358; Zygosity=Heterozygous (PubMed=35395622).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187984; Glomerulopathy with fibronectin deposits-2
DI   ORDO; Orphanet_84090; Fibronectin glomerulopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   FHUSTCi002-A
AC   CVCL_C1T4
DR   BioSamples; SAMEA110183697
DR   hPSCreg; FHUSTCi002-A
DR   Wikidata; Q114311443
RX   PubMed=35914483;
CC   From: The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China; Hefei; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:25538; DARS2; Simple; p.Arg76Serfs*5 (c.228-21_228-20delinsC); ClinVar=VCV000001057; Zygosity=Heterozygous (PubMed=35914483).
CC   Sequence variation: Mutation; HGNC; HGNC:25538; DARS2; Simple; p.Tyr173Cys (c.518A>G); Zygosity=Heterozygous (PubMed=35914483).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188991; Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation
DI   ORDO; Orphanet_137898; Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   FIB-MARFAN1
AC   CVCL_LM01
DR   CLO; CLO_0003279
DR   CLDB; cl1340
DR   Wikidata; Q54834901
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   FIB-MARFAN3
AC   CVCL_LM02
DR   CLO; CLO_0003280
DR   CLDB; cl5480
DR   Wikidata; Q54834902
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   FIB-MARFAN4
AC   CVCL_LM03
DR   CLO; CLO_0003281
DR   CLDB; cl5481
DR   Wikidata; Q54834903
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   FIB-MARFAN5
AC   CVCL_LL37
DR   CLO; CLO_0003282
DR   CLDB; cl5482
DR   Wikidata; Q54834904
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   FIB-MARFAN6
AC   CVCL_LL38
DR   CLO; CLO_0003283
DR   CLDB; cl5483
DR   Wikidata; Q54834905
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   FIB-MOR1
AC   CVCL_LL39
DR   CLO; CLO_0003284
DR   CLDB; cl1341
DR   Wikidata; Q54834906
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61263; Morquio syndrome
DI   ORDO; Orphanet_582; Mucopolysaccharidosis type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   FIB-PSE1
AC   CVCL_VH46
DR   CLO; CLO_0003312
DR   CLDB; cl1354
DR   Wikidata; Q54834907
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE12
AC   CVCL_VH49
DR   CLO; CLO_0003313
DR   CLDB; cl5500
DR   Wikidata; Q54834908
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE13
AC   CVCL_VH50
DR   CLO; CLO_0003314
DR   CLDB; cl5501
DR   Wikidata; Q54834909
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE14
AC   CVCL_VH51
DR   CLO; CLO_0003315
DR   CLDB; cl5502
DR   Wikidata; Q54834910
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE15
AC   CVCL_VH52
DR   CLO; CLO_0003316
DR   CLDB; cl5503
DR   Wikidata; Q54834911
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE17
AC   CVCL_VH53
DR   CLO; CLO_0003317
DR   CLDB; cl5504
DR   Wikidata; Q54834912
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE2
AC   CVCL_VH47
DR   CLO; CLO_0003318
DR   CLDB; cl1355
DR   Wikidata; Q54834913
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE26
AC   CVCL_VH54
DR   CLO; CLO_0003319
DR   CLDB; cl5505
DR   Wikidata; Q54834914
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE3
AC   CVCL_VH48
DR   CLO; CLO_0003320
DR   CLDB; cl1356
DR   Wikidata; Q54834915
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE32
AC   CVCL_VH55
DR   CLO; CLO_0003321
DR   CLDB; cl5506
DR   Wikidata; Q54834916
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE34
AC   CVCL_VH56
DR   CLO; CLO_0003322
DR   CLDB; cl5512
DR   Wikidata; Q54834917
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE35
AC   CVCL_VH57
DR   CLO; CLO_0003323
DR   CLDB; cl5514
DR   Wikidata; Q54834918
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE39
AC   CVCL_VH58
DR   CLO; CLO_0003324
DR   CLDB; cl5513
DR   Wikidata; Q54834920
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE40
AC   CVCL_VH59
DR   CLO; CLO_0003325
DR   CLDB; cl5515
DR   Wikidata; Q54834921
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE43
AC   CVCL_VH60
DR   CLO; CLO_0003326
DR   CLDB; cl5516
DR   Wikidata; Q54834922
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE44
AC   CVCL_VH61
DR   CLO; CLO_0003327
DR   CLDB; cl5517
DR   Wikidata; Q54834923
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE45
AC   CVCL_VH62
DR   CLO; CLO_0003328
DR   CLDB; cl5518
DR   Wikidata; Q54834924
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE46
AC   CVCL_VH63
DR   CLO; CLO_0003329
DR   CLDB; cl5519
DR   Wikidata; Q54834925
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE47
AC   CVCL_VH64
DR   CLO; CLO_0003330
DR   CLDB; cl5520
DR   Wikidata; Q54834926
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE50
AC   CVCL_VH65
DR   CLO; CLO_0003331
DR   CLDB; cl5521
DR   Wikidata; Q54834927
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE51
AC   CVCL_VH66
DR   CLO; CLO_0003332
DR   CLDB; cl5522
DR   Wikidata; Q54834928
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE52
AC   CVCL_VH67
DR   CLO; CLO_0003333
DR   CLDB; cl5523
DR   Wikidata; Q54834929
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE53
AC   CVCL_VH68
DR   CLO; CLO_0003334
DR   CLDB; cl5524
DR   Wikidata; Q54834930
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB-PSE54
AC   CVCL_VH69
DR   CLO; CLO_0003335
DR   CLDB; cl5525
DR   Wikidata; Q54834931
CC   From: Istituto di Patologia Generale, Universita degli Studi di Modena; Modena; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   FIB1-11
AC   CVCL_XA78
SY   FIB 1-11
DR   CCRID; 4201PAT-CCTCC00055
DR   JCRB; IFO50174
DR   Wikidata; Q93553951
RX   DOI=10.1038/nbt1189-1163;
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1796414;
RX   PubMed=2107601;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2081.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02675; Human FGB.
CC   Discontinued: JCRB; IFO50174; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   FIB2-11
AC   CVCL_XA79
SY   FIB 2-11
DR   CCRID; 4201PAT-CCTCC00056
DR   JCRB; IFO50175
DR   Wikidata; Q93553953
RX   Patent=US5506135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2082.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02675; Human FGB.
CC   Discontinued: JCRB; IFO50175; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   FIB21
AC   CVCL_8868
SY   Fib21
DR   CLO; CLO_0003246
DR   ATCC; HB-295
DR   Wikidata; Q54834932
RX   PubMed=7523506;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P26011; Mouse Itgb7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 7
//
ID   FIB504.64
AC   CVCL_8869
SY   Fib504
DR   CLO; CLO_0003247
DR   ATCC; HB-293
DR   Wikidata; Q54834933
RX   PubMed=7523506;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P26011; Mouse Itgb7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 7
//
ID   FIBRNPC
AC   CVCL_UK07
DR   CLO; CLO_0037518
DR   LINCS_LDP; LSC-1021
DR   Wikidata; Q93553976
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   FIGR
AC   CVCL_K211
SY   FiGR
DR   CLO; CLO_0003357
DR   ATCC; CRL-2173
DR   Wikidata; Q54834934
RX   PubMed=2019585;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06536; Rat Nr3c1/Grl (Note=Also reacts with mouse but not with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   Fin-4
AC   CVCL_UW81
DR   Wikidata; Q93553986
RX   PubMed=30537062;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   FINCBi001-A
AC   CVCL_YD66
SY   F56L cl33
DR   hPSCreg; FINCBi001-A
DR   Wikidata; Q93553991
RX   PubMed=32771908;
CC   From: Fondazione IRCCS Istituto Neurologico C. Besta; Milan; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7455; MT-ND1; Simple; p.Ala52Thr (m.3460G>A); ClinVar=VCV000009722; Zygosity=Homoplasmic (PubMed=32771908).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   FINCBi002-A
AC   CVCL_A4XD
SY   mt8742#118
DR   hPSCreg; FINCBi002-A
DR   Wikidata; Q107115013
RX   PubMed=33434818;
CC   From: Fondazione IRCCS Istituto Neurologico C. Besta; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.9449_14550del; Zygosity=Heteroplasmic; Note=In 80% (PubMed=33434818).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FINCBi003-A
AC   CVCL_A4XE
SY   mt8792#118
DR   hPSCreg; FINCBi003-A
DR   Wikidata; Q107115016
RX   PubMed=33434818;
CC   From: Fondazione IRCCS Istituto Neurologico C. Besta; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.8469_13460del; Zygosity=Heteroplasmic; Note=In 30% (PubMed=33434818).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FINCBi004-A
AC   CVCL_C9D7
SY   140395
DR   BioSamples; SAMEA113537083
DR   hPSCreg; FINCBi004-A
DR   Wikidata; Q123031278
RX   PubMed=37689041;
CC   From: Fondazione IRCCS Istituto Neurologico C. Besta; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:25443; C19orf12; Simple; p.Gly47Ser (c.139G>A); Zygosity=Homozygous (PubMed=37689041).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175707; Neurodegeneration with brain iron accumulation 4
DI   ORDO; Orphanet_289560; Mitochondrial membrane protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FINCBi005-A
AC   CVCL_D6I4
SY   mt1072 clone #103; mt1072 #103; #103
DR   BioSamples; SAMEA115082457
DR   hPSCreg; FINCBi005-A
DR   Wikidata; Q127380856
RX   PubMed=38552355;
CC   From: Fondazione IRCCS Istituto Neurologico C. Besta; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7460; MT-ND4L; Simple; p.Ala71Thr (m.10680G>A); ClinVar=VCV000693310; Zygosity=Homoplasmic; Note=The donor fibroblasts were heteroplasmic in 73% of the cells (PubMed=38552355).
CC   Sequence variation: Mutation; HGNC; HGNC:7462; MT-ND6; Simple; p.Met64Val (m.14484T>C); ClinVar=VCV000009688; Zygosity=Homoplasmic; Note=The donor fibroblasts were heteroplasmic in 70% of the cells (PubMed=38552355).
CC   Donor information: Established from monozygotic twin of FINCBi006-A (Cellosaurus=CVCL_D6I5). The donor for FINCBi005-A is affected with LHON while its sibling is not affected (PubMed=38552355).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   FINCBi006-A
AC   CVCL_D6I5
SY   mt1108 clone #121; mt1108 #121; #121
DR   BioSamples; SAMEA115082791
DR   hPSCreg; FINCBi006-A
DR   Wikidata; Q127380857
RX   PubMed=38552355;
CC   From: Fondazione IRCCS Istituto Neurologico C. Besta; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7460; MT-ND4L; Simple; p.Ala71Thr (m.10680G>A); ClinVar=VCV000693310; Zygosity=Heteroplasmic; Note=The donor fibroblasts were heteroplasmic in 74% of the cells, the iPSC in 4% of the cells (PubMed=38552355).
CC   Sequence variation: Mutation; HGNC; HGNC:7462; MT-ND6; Simple; p.Met64Val (m.14484T>C); ClinVar=VCV000009688; Zygosity=Heteroplasmic; Note=The donor fibroblasts were heteroplasmic in 68% of the cells, the iPSC in 8% of the cells (PubMed=38552355).
CC   Donor information: Established from monozygotic twin of FINCBi005-A (Cellosaurus=CVCL_D6I4). At sampling the donor for FINCBi006-A is unaffected with LHON while its sibling is affected (PubMed=38552355).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   FINi001-A
AC   CVCL_C8H7
SY   FI.SPSM.SCN2A.R1882Q.009
DR   BioSamples; SAMEA112835221
DR   hPSCreg; FINi001-A
DR   Wikidata; Q123031279
RX   PubMed=37597357;
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10588; SCN2A; Simple; p.Arg1882Gln (c.5645G>A); ClinVar=VCV000196039; Zygosity=Heterozygous (PubMed=37597357).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172096; Developmental and epileptic encephalopathy 11
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FINi002-A
AC   CVCL_C8H8
SY   FI.CPLT.PRKN.R275W+del_e8.PK006
DR   BioSamples; SAMEA112835223
DR   hPSCreg; FINi002-A
DR   Wikidata; Q123031280
RX   PubMed=37890334;
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=37890334).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex8del; Zygosity=Heterozygous (PubMed=37890334).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FINi002-A-1
AC   CVCL_C8SS
SY   FI.PK006(AAVS1::CAGG-iM.jRCaMP1b)
DR   hPSCreg; FINi002-A-1
DR   Wikidata; Q123031281
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex8del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8H8 ! FINi002-A
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FINi003-A
AC   CVCL_C8SP
SY   FI.SPSM.SCN2A.E1211K.008
DR   hPSCreg; FINi003-A
DR   Wikidata; Q123031282
RX   PubMed=38479087;
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10588; SCN2A; Simple; p.Glu1211Lys (c.3631G>A); ClinVar=VCV000029886; Zygosity=Heterozygous (PubMed=38479087).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172096; Developmental and epileptic encephalopathy 11
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   FINi004-A
AC   CVCL_C8SQ
SY   PPMI14557.107LRRK2R1441G(het.AAVS1.CAGG.iM.jRCaMP1b)
DR   hPSCreg; FINi004-A
DR   Wikidata; Q123031283
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5RY ! PPMI.I.1075.1
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   FINi005-A
AC   CVCL_C8SR
SY   PPMI11555.104SNCA.A53T(AAVS1::CAGG-iM.jRCaMP1b)
DR   hPSCreg; FINi005-A
DR   Wikidata; Q123031284
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5SL ! PPMI.I.1083.2
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   FINi006-A
AC   CVCL_D6I6
SY   FI.CS.PRKNDex2/Dex5-7.F@40
DR   hPSCreg; FINi006-A
DR   Wikidata; Q127380858
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   FINi007-A
AC   CVCL_E3WS
SY   FI.SP.SLC6A1/GAT1.G307R.032
DR   hPSCreg; FINi007-A
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FINi102-A
AC   CVCL_E3WT
SY   FI.SP.KCNT1(R950Q/+).NGF026; FI.SP.KCNT1(R950Q/+).NGF026C3
DR   hPSCreg; FINi102-A
RX   PubMed=40912205;
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18865; KCNT1; Simple; p.Arg950Gln (c.2849G>A); ClinVar=VCV000286710; Zygosity=Heterozygous (PubMed=40912205).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188141; Developmental and epileptic encephalopathy 14
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   FINi103-A
AC   CVCL_E3WU
SY   FI.ASAP.PRKN01/060.dex3/transtni7
DR   hPSCreg; FINi103-A
CC   From: The Florey Institute of Neuroscience and Mental Health, University of Melbourne; Melbourne; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FIntMEC
AC   CVCL_A1CK
SY   F Int MEC; Feline Intestine Microvascular Endothelial Cells
DR   Wikidata; Q102113832
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4250.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal intestine, microvascular endothelium; UBERON=UBERON_0000160+UBERON_0008339.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FIP293
AC   CVCL_6902
DR   Wikidata; Q54834935
CC   Characteristics: Transfected with a RAB11-FIP protein but not indicated which one it is.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000138). It was the sole source of information for this entry.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   FiPS 5-7
AC   CVCL_Y607
DR   Wikidata; Q54834936
RX   PubMed=20419109;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   FiPS 6-14
AC   CVCL_Y608
DR   Wikidata; Q54834937
RX   PubMed=20419109;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   FiPS Ctrl1-SV4F-7 NF1_C
AC   CVCL_E7AH
SY   NF1C-FiPS-SV4F7; NF1_C; NF1(-/-) edited FiPS Ctrl1-SV4F-7
RX   PubMed=35172160;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+NF1%28--%29+edited+FiPS+Ctrl1-SV4F-7+Solicitud+de+dep%C3%B3sito.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Germans Trias i Pujol (IGTP); Barcelona; Spain.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S19 ! ESi044-C
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   fiPS-1
AC   CVCL_A8WP
SY   fiPS_1; ferret iPS-1
DR   GEO; GSM5159063
DR   Wikidata; Q108820239
RX   PubMed=34088013;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   FiPS-3F-1
AC   CVCL_V191
SY   ESi031-B
DR   hPSCreg; ESi031-B
DR   SKIP; SKIP002577
DR   Wikidata; Q54834938
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_Linea_-FiPS-3F-1_VDEF.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_Linea_FiPS-3F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_FiPS-3F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S07 ! FiPS-4F-7
OI   CVCL_9S08 ! FiPS-4F-8
OI   CVCL_C106 ! XFiPS-F44-3F-1
OI   CVCL_C107 ! XFiPS-F44-3F-2
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   FiPS-4F-7
AC   CVCL_9S07
SY   ESi031-D
DR   hPSCreg; ESi031-D
DR   SKIP; SKIP002587
DR   Wikidata; Q54834939
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_Linea-FiPS-4F-7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_Lineas_FiPS-4F-7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V191 ! FiPS-3F-1
OI   CVCL_9S08 ! FiPS-4F-8
OI   CVCL_C106 ! XFiPS-F44-3F-1
OI   CVCL_C107 ! XFiPS-F44-3F-2
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   FiPS-4F-8
AC   CVCL_9S08
SY   ESi031-C
DR   GEO; GSM1012131
DR   hPSCreg; ESi031-C
DR   SKIP; SKIP002588
DR   Wikidata; Q54834940
RX   PubMed=23118351;
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Deposito_Linea-FiPS-4F-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_Lineas_FiPS-4F-8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V191 ! FiPS-3F-1
OI   CVCL_9S07 ! FiPS-4F-7
OI   CVCL_C106 ! XFiPS-F44-3F-1
OI   CVCL_C107 ! XFiPS-F44-3F-2
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   FIRDI-iPSC-002-30
AC   CVCL_LG34
SY   FIRDI-iPSC-02-30; FIRDIi001-A
DR   BCRC; SC81037
DR   BCRC; SC81102
DR   hPSCreg; FIRDIi001-A
DR   SKIP; SKIP005625
DR   SKIP; SKIP005706
DR   Wikidata; Q54834941
RX   PubMed=33592568;
CC   From: Food Industry Research and Development Institute; Hsinchu; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Homozygous; Note=Allele ALDH2*2 (PubMed=33592568).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   FIRE1CS clone 1
AC   CVCL_E6HQ
SY   FIRE1CS-178A3
RX   PubMed=39824193;
CC   Characteristics: Expresses a Fe-IRE (FIRE) biosensor that senses IRP activity and cellular iron status (PubMed=39824193).
CC   Characteristics: This cell line contains a FIRE1 biosensor (mClover3-sensor, mCherry-control) and is transposed with two PiggyBac constructs FIRES-PBCS-CLV3 and FIREC-PBCS-MC2 flanking FIRE sensor and control fluorescent protein, respectively. The FIRE sensor is composed of a 740 bp sequence synthesized based on known mammalian IRP1/2 binding sites (PubMed=39824193).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; RYFE4; mClover3 (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FIRE1CS clone 2
AC   CVCL_E6HR
SY   FIRE1CS-R11-3
RX   PubMed=39824193;
CC   Characteristics: Expresses a Fe-IRE (FIRE) biosensor that senses IRP activity and cellular iron status (PubMed=39824193).
CC   Characteristics: This cell line contains a FIRE1 biosensor (mClover3-sensor, mCherry-control) and is transposed with two PiggyBac constructs FIRES-PBCS-CLV3 and FIREC-PBCS-MC2 flanking FIRE sensor and control fluorescent protein, respectively. The FIRE sensor is composed of a 740 bp sequence synthesized based on known mammalian IRP1/2 binding sites (PubMed=39824193).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; RYFE4; mClover3 (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FIRE2CS clone 1
AC   CVCL_E6HS
SY   FIRE2CS-5092-2
RX   PubMed=39824193;
CC   Characteristics: Expresses a Fe-IRE (FIRE) biosensor that senses IRP activity and cellular iron status (PubMed=39824193).
CC   Characteristics: This cell line contains a FIRE2 biosensor (emiRFP670-sensor, mRuby3-control) and is transposed with two PiggyBac constructs FIRES-PBCS-E670 and FIREC-PBCS-MR3 flanking FIRE sensor and control fluorescent protein, respectively. The FIRE sensor is composed of a 740 bp sequence synthesized based on known mammalian IRP1/2 binding sites (PubMed=39824193).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; YHJV5; emiRFP670 (Note=Constitutively fluorescent near IR fluoresent protein from R.palustris).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; MZMFB; mRuby3 (Note=Bright red fluorescent protein derived from eqFP611).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FIRE2FLIPCS clone 1
AC   CVCL_E6HT
SY   FIRE2FLPCS-520-8
RX   PubMed=39824193;
CC   Characteristics: Expresses a Fe-IRE (FIRE) biosensor that senses IRP activity and cellular iron status (PubMed=39824193).
CC   Characteristics: This cell line contains a FIRE2 biosensor (emiRFP670-sensor, mRuby3-control) and is transposed with two PiggyBac constructs FIRES-FLIP-PBCS-E670 and FIREC-PBCS-MR3 flanking FIRE sensor and control fluorescent protein, respectively. The FLIP-FIRE sensor is composed of a 740 bp sequence synthesized in backwards orientation and based on known mammalian IRP1/2 binding sites (PubMed=39824193).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; YHJV5; emiRFP670 (Note=Constitutively fluorescent near IR fluoresent protein from R.palustris).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; MZMFB; mRuby3 (Note=Bright red fluorescent protein derived from eqFP611).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FIRS-1
AC   CVCL_A5ZR
SY   FIscher Rat Spleen-1
DR   Wikidata; Q107115018
RX   PubMed=2788356;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   FIRT-1
AC   CVCL_A5ZS
SY   FIscher Rat Thymus-1
DR   Wikidata; Q107115020
RX   PubMed=2788356;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Miscellaneous: Cell line has been lost (PubMed=2788356).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   FISK
AC   CVCL_C8P4
DR   BTO; BTO_0006498
DR   Wikidata; Q123031285
RX   PubMed=18425327;
CC   From: Versteeg, Rogier; Department of Human Genetics, Academical Medical Centre; Amsterdam; Netherlands.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   FIS,VJ
AC   CVCL_E663
SY   FIS, VJ
DR   dbMHC; 48859
DR   ECACC; 94082259
DR   IHW; IHW09159
DR   IPD-IMGT/HLA; 11702
DR   Wikidata; Q54834942
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01; B*07,08; C*07; DPB1*02:01,04:02; DQA1*05:01,01:01; DQB1*05:01,02:01; DRB1*01:01,03:01; DRB3*01:01 (IPD-IMGT/HLA=11702).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Fitz-HSA
AC   CVCL_1R34
SY   FITZ-HSA; FITZ; Fitz; DEN-HSA/Fitz; HSA-Fitz
DR   BioSample; SAMN03151633
DR   GEO; GSM1974788
DR   Wikidata; Q54834943
RX   PubMed=17338158;
RX   PubMed=21908323;
RX   PubMed=22594682;
RX   PubMed=22849686;
RX   PubMed=27197945;
RX   PubMed=30601866;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a DEN-HSA derivative (PubMed=21908323).
CC   Part of: FACC canine tumor cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00400.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
ST   Source(s): PubMed=27197945
ST   Dog FHC2010: 231,235
ST   Dog FHC2054: 168,172
ST   Dog FHC2079: 275,279
ST   Dog PEZ1: 115,123
ST   Dog PEZ3: 119,121
ST   Dog PEZ5: 103
ST   Dog PEZ6: 183
ST   Dog PEZ8: 228,240
ST   Dog PEZ12: 285,288
ST   Dog PEZ20: 176,180
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_1R33 ! DEN-HSA
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 18
//
ID   FJMA0001i-HCM
AC   CVCL_A3ZE
SY   20180803 CQ-C2-P6
DR   Wikidata; Q105506869
RX   PubMed=33388705;
CC   From: Fujian Academy of Medical Sciences; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Cys1124Leufs*25 (c.3369_3370insC); Zygosity=Heterozygous (PubMed=33388705).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33388705
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 21,22
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 13,18
ST   D19S433: 11,13
ST   D1S1656: 13,18
ST   D21S11: 29,32.2
ST   D2S1338: 21,24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D6S1043: 19,20
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 19,27
ST   Penta D: 10,13
ST   Penta E: 15
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   FJMAi001-A
AC   CVCL_E3WY
DR   BioSamples; SAMEA115597159
DR   hPSCreg; FJMAi001-A
CC   From: Fujian Academy of Medical Sciences; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys926Tyr (c.2777G>A); ClinVar=VCV000527216; Zygosity=Heterozygous (hPSCreg=FJMAi001-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FJMUi001-A
AC   CVCL_UL68
SY   hiPS-SPG76-001; hiPS-SPG76
DR   BioSamples; SAMEA4966481
DR   hPSCreg; FJMUi001-A
DR   SKIP; SKIP005536
DR   Wikidata; Q93554086
RX   PubMed=30611022;
CC   From: Fujian Medical University; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1476; CAPN1; Simple; p.Pro498Leu (c.1493C>T); Zygosity=Heterozygous (PubMed=30611022).
CC   Sequence variation: Mutation; HGNC; HGNC:1476; CAPN1; Simple; p.Arg618Trp (c.1852C>T); Zygosity=Heterozygous (PubMed=30611022).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157150; Spastic paraplegia 76
DI   ORDO; Orphanet_488594; Autosomal recessive spastic paraplegia type 76
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   FJMUNi001-A
AC   CVCL_C0FR
DR   BioSamples; SAMEA12095262
DR   hPSCreg; FJMUNi001-A
DR   Wikidata; Q112929563
RX   PubMed=35247844;
CC   From: Department of Neurology, Fujian Institute of Neurology, First Affiliated Hospital, Fujian Medical University; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.4518+512T>A; Zygosity=Hemizygous; Note=Induces a cryptic exon activation (PubMed=35247844).
CC   Caution: Indicated in PubMed=35247844 both as being established from a 8 year old and a 10 year old boy.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8-10Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   FJMUUHi001-A
AC   CVCL_A1WA
DR   BioSamples; SAMEA7211865
DR   hPSCreg; FJMUUHi001-A
DR   Wikidata; Q105506873
RX   PubMed=33485186;
CC   From: Fujian Medical University Union Hospital; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple; p.Glu64Argfs*5 (c.189dupA); ClinVar=VCV000623671; Zygosity=Homozygous (PubMed=33485186).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FJMUUHi002-A
AC   CVCL_D0EY
SY   hiPS-RTT
DR   BioSamples; SAMEA113413704
DR   hPSCreg; FJMUUHi002-A
DR   Wikidata; Q123031286
RX   PubMed=38100910;
CC   From: Fujian Medical University Union Hospital; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg133Cys (c.397C>T) (p.Arg145Cys, c.433C>T); ClinVar=VCV000011809; Zygosity=Heterozygous (PubMed=38100910).
CC   Misspelling: FJMUi002-A; PubMed=38100910; Note=In abstract.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 5
//
ID   FJMUUHi003-A
AC   CVCL_D0EZ
DR   hPSCreg; FJMUUHi003-A
DR   Wikidata; Q123031287
CC   From: Fujian Medical University Union Hospital; Fuzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FJO
AC   CVCL_E664
DR   dbMHC; 48860
DR   ECACC; 94071432
DR   IHW; IHW09330
DR   IPD-IMGT/HLA; 10582
DR   Wikidata; Q54834944
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*02,03; B*07,39; DPB1*04:01; DQB1*05:02:01; DRB1*16:01:01; DRB5*02:02 (IPD-IMGT/HLA=10582).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 16
//
ID   FK-91
AC   CVCL_6C51
SY   PC-91; PK-91; Feline Kidney-91
DR   Wikidata; Q54834945
RX   Patent=RU2121501;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 49.
CC   Derived from site: In situ; Kidney, cortex; UBERON=UBERON_0001225.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   4-5M
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   FK-A6
AC   CVCL_C0Z7
DR   Wikidata; Q114311444
RX   PubMed=17494075;
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) and produces progeny virus (PubMed=17494075).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1631; CD163.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_C0Z5 ! NLFK
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 8
//
ID   FK-D4
AC   CVCL_C0Z6
SY   FKD4
DR   Wikidata; Q114311445
RX   PubMed=17494075;
RX   PubMed=24398227;
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) and produces progeny virus (PubMed=17494075).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q2VLG4; Chlorocebus aethiops CD163.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_C0Z5 ! NLFK
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   FKAd1
AC   CVCL_WK29
DR   Wikidata; Q93554114
RX   PubMed=571524;
RX   PubMed=716215;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   FKAd3
AC   CVCL_WK30
DR   Wikidata; Q93554118
RX   PubMed=571524;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   FKAd5
AC   CVCL_WK31
DR   Wikidata; Q93554119
RX   PubMed=503857;
RX   PubMed=571524;
RX   PubMed=716215;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   FKAd6
AC   CVCL_WK32
DR   Wikidata; Q93554124
RX   PubMed=571524;
RX   PubMed=716215;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   FKAugDNA3
AC   CVCL_WK34
SY   FKAugustDNA3
DR   Wikidata; Q93554130
RX   PubMed=503857;
RX   PubMed=571524;
RX   PubMed=716215;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   FKD-1-R
AC   CVCL_A3AA
SY   FKD-R1
DR   CCLV; CCLV-RIE 0970
DR   Wikidata; Q105506876
RX   PubMed=19941903;
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   FKDR
AC   CVCL_E7RQ
SY   Fetal Kidney Desmodus Rotundus
RX   PubMed=40038190;
CC   Group: Bat cell line.
CC   Virology: Susceptible to infection by rabies virus (PubMed=40038190).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9430; ! Desmodus rotundus (Vampire bat)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FKH-1
AC   CVCL_2041
SY   FKH1
DR   CLO; CLO_0050983
DR   BioSample; SAMN01821625
DR   BioSample; SAMN03473503
DR   Cosmic; 975248
DR   Cosmic; 1465949
DR   Cosmic; 2306205
DR   DSMZ; ACC-614
DR   DSMZCellDive; ACC-614
DR   FANTOM5_SSTAR; 10830-111D2
DR   GEO; GSM1446758
DR   RCB; RCB1428
DR   Wikidata; Q54834946
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9753053;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=28751768;
CC   Population: Japanese.
CC   Doubling time: ~54 hours (PubMed=9753053); ~60-100 hours (DSMZ=ACC-614).
CC   Karyotypic information: 46,XY,t(6;9)(p23;q34) (PubMed=9753053).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:3495; ETV6; Name(s)=ETV6-ABL1; Note=In frame (PubMed=28751768).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2768; DEK + HGNC; HGNC:8064; NUP214; Name(s)=DEK-NUP214, DEK-CAN (PubMed=9753053).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: RCB; RCB1428; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-614; RCB=RCB1428
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 15,17
ST   D19S433: 14,16
ST   D21S11: 29,32
ST   D2S1338: 18,22
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 19,22
ST   Penta D: 10,13
ST   Penta E: 12,16
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   FKH1
AC   CVCL_B6SC
DR   Wikidata; Q111733218
RX   PubMed=3756874;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human melanoma 50/70 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   FkMTp
AC   CVCL_AE02
DR   Wikidata; Q54834947
RX   PubMed=26883919;
CC   Doubling time: 24 hours (PubMed=26883919).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   FKNp
AC   CVCL_T989
DR   Wikidata; Q54834948
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 36.6 hours (PubMed=16397390).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   FL
AC   CVCL_1905
AS   CVCL_2900
SY   FL*; FL (HeLa derivative)
DR   BTO; BTO_0003130
DR   CLO; CLO_0003358
DR   CLDB; cl1365
DR   CLDB; cl1366
DR   CLDB; cl1367
DR   ATCC; CCL-62
DR   BioSample; SAMN03151695
DR   CCLV; CCLV-RIE 0012
DR   ECACC; 90111910
DR   IZSLER; BS CL 46
DR   JCRB; JCRB9016
DR   TOKU-E; 1269
DR   Wikidata; Q54834949
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=1246601;
RX   PubMed=5668122;
RX   PubMed=8397027;
RX   PubMed=13408317;
RX   PubMed=20143388;
RX   PubMed=23925245;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388). Originally thought to originate from a normal amnion.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00046.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Discontinued: JCRB; JCRB9016; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-62; ECACC=90111910; IZSLER=BS CL 46
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (ATCC=CCL-62)
ST   D13S317: 12,14 (ECACC=90111910; IZSLER=BS CL 46)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28 (IZSLER=BS CL 46)
ST   D21S11: 27,28,29 (ATCC=CCL-62)
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   FL 62891
AC   CVCL_6390
SY   FL62891
DR   CLO; CLO_0003359
DR   ATCC; CRL-11005
DR   BioSample; SAMN03471327
DR   Wikidata; Q54834950
RX   Patent=US5621090;
RX   Patent=US5912133;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11005.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Discontinued: ATCC; CRL-11005; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-11005
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   FL-106
AC   CVCL_2042
SY   FL 106
DR   DSMZ; ACC-620
DR   DSMZCellDive; ACC-620
DR   Wikidata; Q54834951
RX   CelloPub=CLPUB00363;
CC   Doubling time: ~2-3 days (DSMZ=ACC-620).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   FL-18
AC   CVCL_8093
SY   FL18
DR   BTO; BTO_0002518
DR   cancercelllines; CVCL_8093
DR   Cosmic; 2396144
DR   GEO; GSM3150244
DR   IARC_TP53; 5999
DR   PRIDE; PXD012087
DR   Wikidata; Q54834952
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1967982;
RX   PubMed=2822175;
RX   PubMed=3034807;
RX   PubMed=3928551;
RX   PubMed=8847894;
RX   PubMed=8878455;
RX   PubMed=12967475;
RX   PubMed=14990977;
RX   PubMed=15028022;
RX   PubMed=26727417;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3928551); 25.3 hours (PubMed=8847894).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Unspecified (PubMed=8878455).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: AKA96-3; IARC_TP53=5999; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J353 ! FL-18-EB
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   FL-18-EB
AC   CVCL_J353
SY   FL-18EB
DR   Wikidata; Q54834953
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2822175;
RX   PubMed=3034807;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8093 ! FL-18
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   FL-218
AC   CVCL_8094
SY   FL218
DR   BTO; BTO_0002519
DR   cancercelllines; CVCL_8094
DR   IARC_TP53; 6002
DR   Wikidata; Q54834954
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2180570;
RX   PubMed=8847894;
RX   PubMed=8878455;
RX   PubMed=12967475;
RX   PubMed=14990977;
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Doubling time: 26.7 hours (PubMed=8847894).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=8878455).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: AKA96-6; IARC_TP53=6002; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   FL-318
AC   CVCL_8095
SY   FL318
DR   BTO; BTO_0002520
DR   cancercelllines; CVCL_8095
DR   GEO; GSM380126
DR   IARC_TP53; 6005
DR   Wikidata; Q54834955
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2180570;
RX   PubMed=8847894;
RX   PubMed=8878455;
RX   PubMed=12967475;
RX   PubMed=14990977;
RX   PubMed=19278952;
CC   Population: Japanese.
CC   Doubling time: 45.2 hours (PubMed=8847894).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Leu (c.820G>C); ClinVar=VCV000376678; Zygosity=Unspecified (PubMed=8878455).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Misspelling: AKA96-9; IARC_TP53=6005; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   FL-4
AC   CVCL_M767
DR   Wikidata; Q54834956
RX   Patent=US5275813;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10772.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_M765 ! FeT-1M
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FL-418
AC   CVCL_IU40
SY   FL418
DR   cancercelllines; CVCL_IU40
DR   IARC_TP53; 6004
DR   Wikidata; Q54834957
RX   PubMed=8878455;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8878455).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: AKA96-8; IARC_TP53=6004; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   FL-518
AC   CVCL_IU41
SY   FL518
DR   IARC_TP53; 6001
DR   Wikidata; Q54834958
RX   PubMed=8878455;
RX   PubMed=12967475;
RX   PubMed=14990977;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.527G>C); Zygosity=Unspecified (PubMed=8878455).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: AKA96-5; IARC_TP53=6001; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   FL-6
AC   CVCL_M768
DR   Wikidata; Q54834959
RX   Patent=US5275813;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10773.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_M765 ! FeT-1M
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   FL-618
AC   CVCL_IU42
SY   FL618
DR   Wikidata; Q54834962
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   FL-64
AC   CVCL_2043
SY   FL 64
DR   DSMZ; ACC-616
DR   DSMZCellDive; ACC-616
DR   Wikidata; Q54834963
RX   CelloPub=CLPUB00363;
CC   Doubling time: ~60-100 hours (DSMZ=ACC-616).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   FL-718
AC   CVCL_IU43
SY   FL718
DR   Wikidata; Q54834964
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   FL-74
AC   CVCL_Y090
SY   FL74; FLA
DR   Wikidata; Q54834965
RX   PubMed=75945;
RX   PubMed=172437;
RX   PubMed=1313703;
RX   PubMed=2822586;
RX   PubMed=5818677;
RX   PubMed=8138999;
CC   Virology: Infected with feline leukemia virus (FeLV).
CC   Doubling time: ~36 hours (PubMed=5818677).
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 9
//
ID   FL-74-UCD-1
AC   CVCL_6391
SY   FL74-UCD-1
DR   CLO; CLO_0003360
DR   ATCC; CRL-8012
DR   BCRC; 60496
DR   Wikidata; Q54834966
RX   Patent=US4264587;
RX   PubMed=18366545;
RX   PubMed=32409536;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8012.
CC   Virology: Produces large amounts of feline leukemia virus (FeLV) strain KT-FeLV-UCD-1.
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_Y090 ! FL-74
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   FL-818
AC   CVCL_IU44
SY   FL818
DR   Wikidata; Q54834967
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   fl-AR1034ZIMA clone 1
AC   CVCL_A9PQ
SY   fl-AR1034ZIMA 001; fl-ARiPS cl1; AR1034ZIMA loxP modified iPSC; ARiPS_clone1
DR   GEO; GSM1342461
DR   GEO; GSM1342463
DR   Wikidata; Q102113833
RX   PubMed=24713299;
RX   PubMed=25392050;
CC   Characteristics: Contains a loxP flanked STEMCCA polycistronic (OSKM) vector.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9PP ! AR1034ZIMA
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   FL-OH1
AC   CVCL_S870
SY   FLOH1
DR   Wikidata; Q54834968
RX   PubMed=12904596;
RX   PubMed=23665679;
RX   PubMed=23882450;
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   FL-SJC
AC   CVCL_ZU78
DR   cancercelllines; CVCL_ZU78
DR   Wikidata; Q98126239
RX   PubMed=32459397;
CC   Population: Chinese.
CC   Doubling time: 24 hours (PubMed=32459397).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=32459397).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=32459397).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Ser1680del (c.5036_5038CCT[1]) (c.5039_5041delCCT) (p.Ser1642del, c.4922_4924CCT[1]); ClinVar=VCV000158384; Zygosity=Unspecified (PubMed=32459397).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Met1379Valfs*52 (c.4135_4136delAT); ClinVar=VCV000094216; Zygosity=Unspecified (PubMed=32459397).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   FL-Y
AC   CVCL_6C45
DR   Wikidata; Q54834969
RX   PubMed=17015706;
RX   PubMed=21911600;
CC   Characteristics: TNF dependent.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Follicular dendritic cell; CL=CL_0000442.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8-12W
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   FL-YB
AC   CVCL_6C46
DR   RCB; RCB4452
DR   Wikidata; Q54834970
RX   PubMed=21911600;
CC   Characteristics: TNF dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1344376; Tnfsf13b.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Follicular dendritic cell; CL=CL_0000442.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6C45 ! FL-Y
SX   Male
AG   8-12W
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   FL.1
AC   CVCL_M051
DR   ECACC; 92092319
DR   Wikidata; Q54834971
RX   PubMed=1834558;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   FL5.12
AC   CVCL_0262
SY   FL5.12A; Fetal Liver clone 5.12
DR   BTO; BTO_0003328
DR   EFO; EFO_0022789
DR   MCCL; MCC:0000153
DR   BioGRID_ORCS_Cell_line; 1592
DR   ChEMBL-Cells; CHEMBL4295395
DR   ChEMBL-Targets; CHEMBL4296414
DR   Lonza; 259
DR   PubChem_Cell_line; CVCL_0262
DR   Wikidata; Q54834972
RX   PubMed=3933007;
RX   PubMed=8358790;
RX   PubMed=8798452;
RX   PubMed=10200549;
RX   PubMed=11486081;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FL5%2e12
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-468.html
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   FL5.12 Bax CL16
AC   CVCL_HE70
SY   FL5.12 Bax CL-16
DR   Wikidata; Q54834973
RX   PubMed=8358790;
RX   PubMed=9863016;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:99702; Bax.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0262 ! FL5.12
SX   Sex unspecified
AG   13FD
CA   Factor-dependent cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 10
//
ID   FL5.12 Bcl-xL
AC   CVCL_C4LY
SY   FL5.12/Bcl-xL; FL5.12.Flag-Bcl-xL
DR   Wikidata; Q116049014
RX   PubMed=8798452;
CC   Characteristics: IL3 dependent (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88139; Bcl2l1 (Note=Isoform Bcl-xL; with a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0262 ! FL5.12
SX   Sex unspecified
AG   13FD
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   FL653
AC   CVCL_5A32
SY   FL-653
DR   Wikidata; Q54834974
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   FL8.1
AC   CVCL_C8TU
DR   Wikidata; Q123031288
RX   PubMed=7685659;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8TS ! FL8.2
SX   Sex unspecified
AG   8FW
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FL8.2
AC   CVCL_C8TS
SY   FL#8-2
DR   Wikidata; Q123031289
RX   PubMed=7685659;
RX   PubMed=7723690;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8TU ! FL8.1
SX   Sex unspecified
AG   8FW
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FL8.2.1.4
AC   CVCL_C8TV
SY   1.4; Clone 1.4
DR   Wikidata; Q123031290
RX   PubMed=7685659;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TS ! FL8.2
SX   Sex unspecified
AG   8FW
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FL8.2.2.1
AC   CVCL_C8TW
SY   2.1; Clone 2.1
DR   Wikidata; Q123031291
RX   PubMed=7685659;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TS ! FL8.2
SX   Sex unspecified
AG   8FW
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FL8.2.4.10
AC   CVCL_C8TX
SY   4.10; Clone 4.10
DR   Wikidata; Q123031292
RX   PubMed=7685659;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TS ! FL8.2
SX   Sex unspecified
AG   8FW
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FL8.2.4.11
AC   CVCL_C8TY
SY   4.11; Clone 4.11
DR   Wikidata; Q123031293
RX   PubMed=7685659;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TS ! FL8.2
SX   Sex unspecified
AG   8FW
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FL8.2.4.4
AC   CVCL_C8TT
SY   FL4.4; 4.4; Clone 4.4
DR   Wikidata; Q123031294
RX   PubMed=7685659;
RX   PubMed=7723690;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TS ! FL8.2
SX   Sex unspecified
AG   8FW
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FL83B
AC   CVCL_4691
SY   FL-83B
DR   BTO; BTO_0003327
DR   CLO; CLO_0003361
DR   ATCC; CRL-2390
DR   BCRC; 60325
DR   Lonza; 1394
DR   PRIDE; PXD001792
DR   Wikidata; Q54834975
RX   CelloPub=CLPUB00349;
RX   PubMed=4572697;
RX   PubMed=26280412;
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   FLAM-76
AC   CVCL_2901
SY   Flam-76; FLAM76
DR   Cosmic; 720784
DR   Cosmic; 2081380
DR   Cosmic; 2302405
DR   Cosmic; 2367287
DR   JCRB; JCRB1346
DR   JCRB; NIHS0538
DR   Wikidata; Q54834976
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1516003;
RX   PubMed=8943038;
RX   PubMed=9738977;
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Japanese.
CC   Characteristics: Non-secretory.
CC   Characteristics: IL6 dependent.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: JCRB; NIHS0538; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1346
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 9,12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   FLC 3Cl8
AC   CVCL_W804
SY   FLC-3CL-8; 3Cl8 FLC; FLC (clone 3Cl8); MRI 745 3CL8
DR   Wikidata; Q54834977
RX   PubMed=3106522;
RX   PubMed=6179295;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   FLC clone 745
AC   CVCL_3988
SY   FLC clone 745A; 745-A; 745A; FLC 745 A; 745 A clone; Friend leukemic cell clone #745; MEL-745A; MEL 745A; MEL745A; MELC strain 745A; GM00086; GM-86; GM86; GM0086; GM00086E; GM0086E; GM86 Clone 745A
DR   BTO; BTO_0002885
DR   CLO; CLO_0003363
DR   CLO; CLO_0003538
DR   CLO; CLO_0025155
DR   CLDB; cl1370
DR   CLDB; cl1506
DR   Coriell; GM00086
DR   Wikidata; Q54834978
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3106522;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9R58 ! FSD1/F4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   FLC clone 745 A 19
AC   CVCL_W806
SY   745 A 19
DR   Wikidata; Q54834979
RX   PubMed=428460;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   FLC clone M2
AC   CVCL_L877
SY   Clone M2
DR   CLO; CLO_0003364
DR   CLDB; cl1371
DR   Wikidata; Q54834980
RX   PubMed=4136752;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   FLC-4
AC   CVCL_D204
SY   FLC4; Functional Liver Cell-4
DR   cancercelllines; CVCL_D204
DR   Cosmic; 2321031
DR   Wikidata; Q54834981
RX   Patent=US5804441;
RX   PubMed=17241388;
RX   PubMed=21960466;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5165.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Cys78Ter (c.234T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: FLC-4 is often stated to be synonymous with JHH-4 (Cellosaurus=CVCL_2787), but the patent reference (Patent=US5804441) seems to indicate that FLC-4 is derived from JHH-4 and has a different karyotype.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2787 ! JHH-4
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 13
//
ID   FLC-707-02
AC   CVCL_WN47
DR   Wikidata; Q93554513
RX   PubMed=8118409;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Optimized hemoglobin biosynthesis.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Anecdotal: Have been flown in space on shuttle flight STS-42 (Spacelab IML-1) to study growth in microgravity (PubMed=8118409).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   FLE1
AC   CVCL_YE03
DR   Wikidata; Q93554531
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   FLEBV
AC   CVCL_XX68
DR   Wikidata; Q93554534
RX   PubMed=21112256;
RX   PubMed=25942615;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   FLENIi001-A
AC   CVCL_A7IY
SY   FFAD1.2 c4
DR   hPSCreg; FLENIi001-A
DR   Wikidata; Q107115021
RX   PubMed=33839546;
CC   From: Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia; Buenos Aires; Argentina.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Thr119Ile (c.356C>T); ClinVar=VCV000625849; Zygosity=Heterozygous (PubMed=33839546).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   FLENIi002-A
AC   CVCL_E3WZ
DR   hPSCreg; FLENIi002-A
CC   From: Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia; Buenos Aires; Argentina.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FLENIi003-A
AC   CVCL_E3X0
DR   hPSCreg; FLENIi003-A
CC   From: Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia; Buenos Aires; Argentina.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FLF92
AC   CVCL_UJ97
SY   FLF; Fetal Lung Fibroblasts 1992
DR   Wikidata; Q93554538
RX   PubMed=7622881;
RX   PubMed=22158077;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   FLFMM-34
AC   CVCL_0I20
DR   cancercelllines; CVCL_0I20
DR   Wikidata; Q54834982
RX   PubMed=25639772;
CC   Population: Chinese; Han.
CC   Doubling time: 2-3 days (PubMed=25639772).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25639772).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181His (c.542G>A); ClinVar=VCV000142320; Zygosity=Unspecified (PubMed=25639772).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   FLG 29.1
AC   CVCL_RL92
SY   FLG29.1
DR   Wikidata; Q54834983
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1309813;
RX   PubMed=22642494;
CC   Doubling time: ~22 hours (PubMed=1309813).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7171; Acute monoblastic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   FLG-ID
AC   CVCL_RW67
DR   CCLV; CCLV-RIE 1152
DR   Wikidata; Q54834984
RX   PubMed=24973239;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=3371021; ! Cnephaeus serotinus (Serotine bat)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   FLG-R
AC   CVCL_0I97
DR   CCLV; CCLV-RIE 1093
DR   Wikidata; Q54834985
RX   PubMed=24973239;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=3371021; ! Cnephaeus serotinus (Serotine bat)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   FLiMEC
AC   CVCL_A1CL
SY   F Li MEC; Feline Liver Microvascular Endothelial Cells
DR   Wikidata; Q102113835
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4253.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal liver, microvascular endothelium; UBERON=UBERON_0002107+UBERON_0008339.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FLK
AC   CVCL_9T05
SY   Fetal Lamb Kidney
DR   BTO; BTO_0003326
DR   IZSLER; BS CL 154
DR   Wikidata; Q54834986
CC   Transformant: NCBI_TaxID; 11902; Bovine leukemia virus (BLV) (isolate American FLK).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   FLK-1
AC   CVCL_M788
DR   Wikidata; Q54834987
RX   PubMed=11243383;
RX   PubMed=26727417;
CC   Population: Japanese.
CC   Characteristics: Dependent on the FDC/HK (Cellosaurus=CVCL_IY38) cell line for its growth and survival.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   FLK-BLV-044
AC   CVCL_2044
SY   FLK/BLV
DR   CLO; CLO_0003365
DR   CLDB; cl1372
DR   CCLV; CCLV-RIE 0044
DR   DSMZ; ACC-153
DR   DSMZCellDive; ACC-153
DR   Wikidata; Q54834988
CC   Doubling time: ~50 hours (DSMZ=ACC-153).
CC   Transformant: NCBI_TaxID; 11902; Bovine leukemia virus (BLV) (isolate American FLK).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   FLK-N3
AC   CVCL_N594
SY   Fetal Lamb Kidney-N3
DR   Wikidata; Q54834989
RX   PubMed=21695582;
RX   PubMed=27795464;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   FLN-R
AC   CVCL_0I53
DR   CCLV; CCLV-RIE 1091
DR   Wikidata; Q54834990
RX   PubMed=19941903;
RX   PubMed=24973239;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=3371021; ! Cnephaeus serotinus (Serotine bat)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   Flo Tel
AC   CVCL_Y123
SY   Culture 344
DR   ATCC; CRL-1128
DR   Wikidata; Q54834991
RX   PubMed=4582519;
CC   Discontinued: ATCC; CRL-1128; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   FLO-1
AC   CVCL_2045
SY   Flo-1; Flo 1; FLO1; FLO
DR   BTO; BTO_0003641
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 880
DR   BioSample; SAMN03473447
DR   cancercelllines; CVCL_2045
DR   Cell_Model_Passport; SIDM01041
DR   Cosmic; 1599339
DR   Cosmic-CLP; 1503361
DR   DepMap; ACH-001500
DR   DSMZ; ACC-698
DR   DSMZCellDive; ACC-698
DR   ECACC; 11012001
DR   EGA; EGAS00001000978
DR   GDSC; 1503361
DR   GEO; GSM1669793
DR   IARC_TP53; 21628
DR   PharmacoDB; FLO1_367_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54834992
RX   PubMed=9407969;
RX   PubMed=10078940;
RX   PubMed=20075370;
RX   PubMed=23795680;
RX   PubMed=27397505;
RX   PubMed=27594985;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-698).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Homozygous (PubMed=20075370; Cosmic-CLP=1503361; DepMap=ACH-001500).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.63%; Native American=0.21%; East Asian, North=0%; East Asian, South=0.68%; South Asian=0.12%; European, North=71.2%; European, South=27.15% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=1503361; DepMap=ACH-001500; DSMZ=ACC-698; ECACC=11012001; PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 16
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12,14
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 11,12
ST   Penta E: 5,17
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   Flow1000
AC   CVCL_5615
SY   Flow 1000; Flow-1000
DR   Wikidata; Q54834993
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Flow11000
AC   CVCL_F663
SY   Flow 11000; Flow-11000; F11000
DR   Wikidata; Q54834994
RX   DOI=10.1007/978-94-009-8715-9_45;
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Senescence: Senesces at ~50 PDL (DOI=10.1007/978-94-009-8715-9_45).
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   Flow12000
AC   CVCL_B6NR
SY   Flow 12000
DR   Wikidata; Q111733219
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Derived from site: In situ; Nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   Flow13000
AC   CVCL_F664
SY   Flow 13000
DR   BioSample; SAMN03151849
DR   Wikidata; Q54834995
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   Problematic cell line: Contaminated. Shown to be a MRC-5 derivative (PubMed=20143388).
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00303.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   Flow2000
AC   CVCL_2902
SY   FLOW2000; Flow-2000; Flow 2000; FLOW 2000; F2000
DR   BioSample; SAMN03471057
DR   ChEMBL-Cells; CHEMBL3307954
DR   ChEMBL-Targets; CHEMBL612415
DR   JCRB; IFO50089
DR   JCRB; JCRB0067
DR   PubChem_Cell_line; CVCL_2902
DR   TKG; TKG 0196
DR   Wikidata; Q54834996
RX   PubMed=6988327;
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Discontinued: JCRB; JCRB0067; true.
CC   Discontinued: TKG; TKG 0196; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=IFO50089
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   Flow2002
AC   CVCL_F661
SY   FLOW 2002; Flow 2002; Flow-2002; F2002
DR   CLO; CLO_0003366
DR   CLDB; cl1373
DR   ChEMBL-Cells; CHEMBL3308387
DR   ChEMBL-Targets; CHEMBL614727
DR   PubChem_Cell_line; CVCL_F661
DR   Wikidata; Q54834997
RX   PubMed=6971834;
RX   PubMed=20803435;
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   Flow3000
AC   CVCL_2903
SY   Flow 3000
DR   BioSample; SAMN03471058
DR   JCRB; JCRB0068
DR   Wikidata; Q54834998
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Caution: Indicated as originating from a male fetus but has a X,X karyotype.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB0068
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   Flow4000
AC   CVCL_5909
SY   Flow 4000; Flow-4000; F4000
DR   Wikidata; Q54834999
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Flow5000
AC   CVCL_5910
SY   Flow-5000; Flow 5000; Flow #5,000
DR   BioSample; SAMN03151640
DR   Wikidata; Q54835000
RX   PubMed=6988327;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Flow1000 derivative.
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00304.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5615 ! Flow1000
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Flow6000
AC   CVCL_F662
SY   Flow-6000; Flow 6000
DR   CLO; CLO_0003367
DR   CLDB; cl1375
DR   BioSample; SAMN03151641
DR   Wikidata; Q54835001
RX   PubMed=6988327;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   Problematic cell line: Contaminated. Shown to be a Flow1000 derivative.
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00305.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5615 ! Flow1000
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 23
//
ID   Flow7000
AC   CVCL_2904
SY   Flow-7000; Flow 7000; F7000
DR   CLO; CLO_0002985
DR   CLDB; cl1196
DR   BioSample; SAMN03151642
DR   JCRB; IFO50079
DR   Wikidata; Q54835003
RX   PubMed=6988327;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://web.archive.org/web/20230607162130/https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/flow_cells.html
CC   Problematic cell line: Contaminated. Shown to be a Flow3000 derivative. Originally thought to be a foresking fibroblast cell line.
CC   From: Flow Laboratories (which ceased operation); Rockville; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00306.
CC   Doubling time: ~3 days (Note=Lot 04092004) (JCRB=IFO50079).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=IFO50079
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2903 ! Flow3000
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Flp-In-293
AC   CVCL_U421
SY   Flp-In 293; 293 Flp-In; HEK-293-Flp-In
DR   EFO; EFO_0022568
DR   ChEMBL-Cells; CHEMBL3989342
DR   PubChem_Cell_line; CVCL_U421
DR   Wikidata; Q54835004
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-217.html
WW   Provider; Thermo Fisher; R75007; https://www.thermofisher.com/order/catalog/product/R75007
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   Flp-In-293-MSR
AC   CVCL_KS18
SY   Flp-In 293-MSR; FlpIn MSR
DR   Wikidata; Q54835005
RX   Patent=US7217566;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5076.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U428 ! GripTite 293 MSR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   Flp-In-3T3
AC   CVCL_U422
SY   Flp-In 3T3; NIH 3T3 Flp-In
DR   Wikidata; Q54835006
WW   Provider; Thermo Fisher; R76107; https://www.thermofisher.com/order/catalog/product/R76107
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (Thermo Fisher=R76107).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   Flp-In-BHK
AC   CVCL_U423
SY   Flp-In BHK; BHK Flp-In
DR   Wikidata; Q54835007
WW   Provider; Thermo Fisher; R76007; https://www.thermofisher.com/order/catalog/product/R76007
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (Thermo Fisher=R76007).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   Flp-In-CHO
AC   CVCL_U424
SY   Flp-In CHO; CHO Flp-In; CHO-Flp-In
DR   Lonza; 1465
DR   Wikidata; Q54835008
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-538.html
WW   Provider; Thermo Fisher; R75807; https://www.thermofisher.com/order/catalog/product/R75807
CC   Characteristics: Transfected with a pFRT/lacZeo2 construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (Thermo Fisher=R75807).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   Flp-In-CV-1
AC   CVCL_U425
SY   Flp-In CV-1
DR   Wikidata; Q54835009
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-539.html
WW   Provider; Thermo Fisher; R75207; https://www.thermofisher.com/order/catalog/product/R75207
CC   Group: Non-human primate cell line.
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (Thermo Fisher=R75207).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   Flp-In-Jurkat
AC   CVCL_U426
SY   Flp-In Jurkat
DR   cancercelllines; CVCL_U426
DR   Wikidata; Q54835010
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-616.html
WW   Provider; Thermo Fisher; R76207; https://www.thermofisher.com/order/catalog/product/R76207
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (Thermo Fisher=R76207).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 20
//
ID   Flp-In-T-REx-293
AC   CVCL_U427
SY   Flp-In-T-REx 293; Flp-In T-REx-293; Flp-In T-REx 293; Flp-In T-Rex HEK293; Flp-In 293 T-Rex; Flp-In-T-REx; 293-Flip-in-TRex; HEK293 Flp-In T-REx; HEK293FlpIN; 293FlpIn T-Rex
DR   BTO; BTO_0006149
DR   EFO; EFO_0022682
DR   ENCODE; ENCBS749QJL
DR   GEO; GSM1009421
DR   MetaboLights; MTBLS61
DR   PRIDE; PXD002127
DR   PRIDE; PXD030782
DR   Wikidata; Q54835011
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-596.html
WW   Provider; Thermo Fisher; R78007; https://www.thermofisher.com/order/catalog/product/R78007
CC   Characteristics: Contains a single stably integrated FRT site at a transcriptionally active genomic locus (Thermo Fisher).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 25
//
ID   Flp-In-T-REx-293 eGFP-mHCN2
AC   CVCL_D4B1
DR   Wikidata; Q127380859
RX   PubMed=38377199;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, mouse Hcn2 N-terminally tagged with eGFP was integrated in a single site and its expression is regulated by tetracycline (PubMed=38377199).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1298210; Hcn2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 6
//
ID   Flp-In-T-REx-293 hNav1.5-F1760A
AC   CVCL_E4WP
SY   hNav1.5-F1760A HEK-Flp-In
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10593; SCN5A (Note=With p.Phe1760Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Hausmann, Ralf.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Flp-In-T-REx-293 hNav1.5-N1765K
AC   CVCL_E4WQ
SY   hNav1.5-N1765K HEK-Flp-In
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10593; SCN5A (Note=With p.Asn1765Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Hausmann, Ralf.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Flp-In-T-REx-293 VPS13C-mClover3-Flp-In
AC   CVCL_E6IS
SY   VPS13C-mClover-Flp-In
WW   Info; protocols.io; -; https://dx.doi.org/10.17504/protocols.io.36wgqnnnxgk5/v1
CC   Characteristics: Expresses VPS13C-mClover3 under a tetracycline inducible promoter. Transfected with a pcDNA5/FRT/TO-VPS13C-mClover3 construct (protocols.io).
CC   Genetic integration: Method=Transfection; Gene=FPbase; RYFE4; mClover3 (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23594; VPS13C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Flp293A
AC   CVCL_U006
DR   Wikidata; Q54835012
RX   PubMed=16697259;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   FLS11
AC   CVCL_5502
DR   TKG; TKG 0193
DR   Wikidata; Q54835013
RX   PubMed=2133543;
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FLS3
AC   CVCL_5503
DR   JCRB; IFO50377
DR   TKG; TKG 0194
DR   Wikidata; Q54835014
RX   PubMed=2133543;
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FLS4.1
AC   CVCL_5629
DR   Wikidata; Q54835015
RX   PubMed=1346335;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FLS4.1
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   FLS5
AC   CVCL_5504
DR   JCRB; IFO50378
DR   TKG; TKG 0195
DR   Wikidata; Q54835016
RX   PubMed=2133543;
CC   Derived from site: In situ; Embryonic liver, stroma; UBERON=UBERON_0016478.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FLT
AC   CVCL_C0VH
SY   Fibroblast-Like Testis
DR   Wikidata; Q112929564
RX   DOI=10.48048/wjst.2021.10857;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=337887; ! Clarias nieuhofii (Slender walking catfish)
SX   Male
AG   6-8M
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   Flt-3A20.9
AC   CVCL_B6NJ
DR   Wikidata; Q111733220
RX   PubMed=9890713;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36888; Human FLT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NI ! P3XBcl-2-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   Flt-3B3.33
AC   CVCL_B6NK
DR   Wikidata; Q111733221
RX   PubMed=9890713;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36888; Human FLT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NI ! P3XBcl-2-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   Flt-3B7.5
AC   CVCL_B6NL
DR   Wikidata; Q111733222
RX   PubMed=9890713;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P36888; Human FLT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NI ! P3XBcl-2-13
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   FLuDero
AC   CVCL_QX22
SY   Fetal Lung Desmodus rotundus
DR   Wikidata; Q54835017
RX   PubMed=29122634;
CC   Group: Bat cell line.
CC   Doubling time: 48 hours (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Doubling time and lack of info on sex of fetus from personal communication of Lacoste, Vincent.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9430; ! Desmodus rotundus (Vampire bat)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 9
//
ID   FLuMEC
AC   CVCL_A1CM
SY   F Lu MEC; Feline Lung Microvascular Endothelial Cells
DR   Wikidata; Q102113836
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4258.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal lung, endothelium; UBERON=UBERON_0005597+UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FLYA-JET
AC   CVCL_EG37
DR   cancercelllines; CVCL_EG37
DR   Wikidata; Q54835018
RX   PubMed=10488763;
CC   Group: Retrovirus packaging cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8870 ! FLYA13
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   FLYA13
AC   CVCL_8870
SY   FLY-A13; FLY-AF-13
DR   CLO; CLO_0003368
DR   CLDB; cl1376
DR   cancercelllines; CVCL_8870
DR   CancerTools; 151655
DR   ECACC; 95091901
DR   GEO; GSM827429
DR   LINCS_LDP; LCL-1437
DR   Progenetix; CVCL_8870
DR   Wikidata; Q54835019
DR   Ximbio; 151655
RX   PubMed=7494248;
RX   PubMed=20215515;
CC   Group: Retrovirus packaging cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 95091901; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=95091901
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   FLYRD18
AC   CVCL_8871
SY   FLY-RD18; FLY-RDF-18
DR   CLO; CLO_0003369
DR   CLDB; cl1377
DR   cancercelllines; CVCL_8871
DR   CancerTools; 151446
DR   ECACC; 95091902
DR   Wikidata; Q54835020
DR   Ximbio; 151446
RX   PubMed=7494248;
CC   Group: Retrovirus packaging cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 95091902; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 26
//
ID   FM
AC   CVCL_UI98
DR   Wikidata; Q93554964
RX   PubMed=2155676;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   FMD patient III.4 LCL
AC   CVCL_E7TW
RX   PubMed=25305078;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:3057; DTNA; Simple; p.Val742Phe (c.2224G>T); ClinVar=VCV000140609; Zygosity=Heterozygous; Note=Produces a novel splice site which skips exon 21 and leads to a shorter alternative transcript (PubMed=25305078).
CC   Sequence variation: Mutation; HGNC; HGNC:25911; FAM136A; Simple; p.Gln76Ter (c.226C>T) (p.Gln183Ter, c.547C>T); ClinVar=VCV000140608; Zygosity=Heterozygous (PubMed=25305078).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185243; Meniere disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5H2 ! GENYOi007-A
SX   Female
AG   >22Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FM-62
AC   CVCL_9706
DR   Wikidata; Q54835021
RX   PubMed=1320624;
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   FM116
AC   CVCL_4W88
DR   cancercelllines; CVCL_4W88
DR   Cosmic; 1047660
DR   GEO; GSM156031
DR   IARC_TP53; 26087
DR   Progenetix; CVCL_4W88
DR   Wikidata; Q54835022
RX   PubMed=17260012;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   FM2
AC   CVCL_C576
DR   cancercelllines; CVCL_C576
DR   Cosmic; 851407
DR   Cosmic; 874436
DR   Cosmic; 1047661
DR   GEO; GSM156026
DR   IARC_TP53; 26088
DR   Progenetix; CVCL_C576
DR   Wikidata; Q54835023
RX   PubMed=7656272;
RX   PubMed=9288767;
RX   PubMed=9688544;
RX   PubMed=17260012;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   FM28
AC   CVCL_C583
SY   FM-28; FM 28
DR   cancercelllines; CVCL_C583
DR   Cosmic; 808545
DR   Cosmic; 972279
DR   Cosmic; 1047662
DR   Cosmic; 2163766
DR   ECACC; 13012412
DR   ESTDAB; ESTDAB-006
DR   GEO; GSM156041
DR   IARC_TP53; 26089
DR   Progenetix; CVCL_C583
DR   Wikidata; Q54835024
RX   PubMed=7656272;
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*01,02; B*08,15 (PubMed=7656272).
CC   HLA typing: A*01:01,02:01; B*08:01,15:01:01:01; C*07:01:01,07:02; DPB1*04:01,01:01:01; DQB1*03:02,02:01; DRB1*04:01:01,03:01:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Pro (c.1637A>C); ClinVar=VCV000375898; Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012412; ESTDAB=ESTDAB-006
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   FGA: 22,24
ST   TH01: 6
ST   TPOX: 8 (ESTDAB=ESTDAB-006)
ST   TPOX: 9.3 (ECACC=13012412)
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   FM28.4
AC   CVCL_UI33
DR   cancercelllines; CVCL_UI33
DR   Wikidata; Q93554997
RX   PubMed=9688544;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C583 ! FM28
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   FM3
AC   CVCL_2046
SY   FM-3
DR   cancercelllines; CVCL_2046
DR   Cosmic; 808544
DR   Cosmic; 851400
DR   Cosmic; 1047663
DR   ECACC; 13012407
DR   ESTDAB; ESTDAB-007
DR   GEO; GSM156042
DR   IARC_TP53; 26090
DR   Progenetix; CVCL_2046
DR   Wikidata; Q54835025
RX   PubMed=7656272;
RX   PubMed=7899823;
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*02,03; B*07,44 (PubMed=7656272).
CC   HLA typing: A*02:01; B*07:02,44:02; C*05:01; DPB1*04:01; DQB1*06:02,03:01:01; DRB1*04:01:01,15:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): ECACC=13012407; ESTDAB=ESTDAB-007
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12,13
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   FM3.13
AC   CVCL_C578
SY   FM-3.13
DR   ECACC; 13012516
DR   ESTDAB; ESTDAB-008
DR   Wikidata; Q54835026
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): ECACC=13012516; ESTDAB=ESTDAB-008
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12,13
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2046 ! FM3
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   FM3.26
AC   CVCL_C579
SY   FM-3.26
DR   ECACC; 13012554
DR   ESTDAB; ESTDAB-009
DR   Wikidata; Q54835027
RX   PubMed=15592718;
CC   HLA typing: A*02:01,03:01; B*07:02,44:02; C*07:02,05:01; DPB1*04:01,13:01; DQB1*06:02,03:01:01; DRB1*04:01,15:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): ECACC=13012554; ESTDAB=ESTDAB-009
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12,13
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2046 ! FM3
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   FM3.29
AC   CVCL_C580
SY   FM-3.29; FM3-29; FM3-29-MEL
DR   ECACC; 13012502
DR   ESTDAB; ESTDAB-010
DR   Wikidata; Q54835028
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): ECACC=13012502; ESTDAB=ESTDAB-010
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12,13
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10
ST   FGA: 20,23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2046 ! FM3
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   FM3.D
AC   CVCL_UI31
SY   FM3D; FM3.Differentiated
DR   Cosmic; 1132578
DR   Wikidata; Q93555035
RX   PubMed=8665567;
RX   PubMed=9688544;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2046 ! FM3
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   FM3.P
AC   CVCL_UI32
SY   FM3P; FM3.Progressed
DR   Cosmic; 1132579
DR   Wikidata; Q93555038
RX   PubMed=9688544;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2046 ! FM3
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   FM34
AC   CVCL_X923
SY   Formosan Monkey 34
DR   Wikidata; Q54835029
RX   PubMed=2579038;
CC   Group: Non-human primate cell line.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=78449; ! Macaca cyclopis (Taiwan macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   FM37
AC   CVCL_C584
DR   Wikidata; Q54835030
RX   PubMed=7656272;
RX   PubMed=9288767;
RX   PubMed=11225993;
CC   HLA typing: A*02,03; B*07,40; C*03 (PubMed=7656272).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   FM39
AC   CVCL_9673
DR   Cosmic; 808542
DR   Cosmic; 851417
DR   Cosmic; 874438
DR   Wikidata; Q54835031
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=9688544;
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr225fs*31 (c.675_676insTA) (675insTA); Zygosity=Unspecified (PubMed=9288767).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   FM3A
AC   CVCL_3869
SY   FM3A clone 28; FM3A cl28
DR   BTO; BTO_0000472
DR   CLO; CLO_0003370
DR   CLO; CLO_0050963
DR   CLDB; cl1378
DR   ChEMBL-Cells; CHEMBL3307585
DR   ChEMBL-Targets; CHEMBL614297
DR   ECACC; 87100804
DR   JCRB; JCRB0701
DR   Lonza; 1054
DR   PubChem_Cell_line; CVCL_3869
DR   RCB; RCB0086
DR   TKG; TKG 0151
DR   Wikidata; Q54835032
RX   PubMed=2428648;
RX   PubMed=2581712;
RX   PubMed=3856858;
RX   PubMed=5920633;
RX   PubMed=5956504;
RX   PubMed=8344958;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-198.html
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   FM3A AC1
AC   CVCL_A5LE
SY   AC1; AC 1
DR   Wikidata; Q107115023
RX   PubMed=2122528;
CC   Selected for resistance to: ChEBI; CHEBI_2766; Aphidicolin.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A AC2
AC   CVCL_A5LF
SY   AC2; AC 2
DR   Wikidata; Q107115025
RX   PubMed=2122528;
CC   Selected for resistance to: ChEBI; CHEBI_2766; Aphidicolin.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A AC3
AC   CVCL_A5LG
SY   AC3; AC 3
DR   Wikidata; Q107115029
RX   PubMed=2122528;
CC   Selected for resistance to: ChEBI; CHEBI_2766; Aphidicolin.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A APRT~
AC   CVCL_J368
DR   JCRB; JCRB0703
DR   Wikidata; Q54835033
RX   PubMed=7105014;
CC   Selected for resistance to: ChEBI; CHEBI_88290; 5-hydroxy-1H-imidazole-4-carboxamide (4-carbamoylimidazolium 5-olate; SM-108).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   FM3A EM6-TG cl.13
AC   CVCL_VI65
SY   EM6-TG cl.13; EMS-induced 6-TG resistant clone 13
DR   Wikidata; Q93555081
RX   PubMed=230835;
RX   PubMed=1170081;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VI64 ! FM3A H-5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 7
//
ID   FM3A F28-7
AC   CVCL_D687
SY   FM3A/F28-7; F28-7
DR   BTO; BTO_0001618
DR   Wikidata; Q54835038
RX   PubMed=2122528;
RX   PubMed=6725415;
RX   PubMed=6784257;
RX   PubMed=7105014;
RX   PubMed=7678417;
RX   PubMed=8420989;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   FM3A FSthy-4
AC   CVCL_F0B0
RX   PubMed=6994265;
CC   Characteristics: Thymidylate synthase defective (PubMed=6994265).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FM3A FSthy-7
AC   CVCL_F0B1
RX   PubMed=6994265;
CC   Characteristics: Thymidylate synthase defective (PubMed=6994265).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FM3A FSthy-8
AC   CVCL_F0B2
RX   PubMed=6994265;
CC   Characteristics: Thymidylate synthase defective (PubMed=6994265).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FM3A FSthy21
AC   CVCL_C564
SY   FSthy21; FSthy-21
DR   JCRB; JCRB0719
DR   Wikidata; Q54835210
CC   Characteristics: Thymidylate synthase defective.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   FM3A FUA169
AC   CVCL_D688
SY   FUA169; FUA 169
DR   Wikidata; Q54835259
RX   PubMed=7678417;
RX   PubMed=8420989;
CC   Characteristics: Compared to the parent cell line, shows a dramatic reduction in lactosylceramide (LacCer), the presence of a ganglioside GM3 and a high activity of CMP-sialic acid:LacCer 2,3-sialosyltransferase (PubMed=7678417).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   FM3A G258
AC   CVCL_A5LA
SY   G258
DR   Wikidata; Q107115030
RX   PubMed=1995072;
RX   PubMed=6725415;
RX   PubMed=10410677;
CC   Characteristics: Temperature-sensitive. Deficient in cell growth, asparagine glycosylation and synthesis of oligosaccharide-lipid. Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated mannose and stored so as to allow time for cells that had taken up the mannose to be killed by radiation damage (PubMed=1995072; PubMed=6725415).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A H-5
AC   CVCL_VI64
SY   H-5
DR   Wikidata; Q93555091
RX   PubMed=1170081;
CC   Doubling time: 15 hours (PubMed=1170081).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 6
//
ID   FM3A Had-1
AC   CVCL_J854
SY   Had-1
DR   CLO; CLO_0050964
DR   RCB; RCB0476
DR   Wikidata; Q54872318
RX   PubMed=2535724;
RX   PubMed=2808320;
CC   Characteristics: Deficient in UDP-galactose transport into Golgi vesicles (PubMed=2808320).
CC   Virology: Not susceptible to infection by Newcastle disease virus (NDV) and Sendai virus (PubMed=2535724).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   FM3A HPRT~
AC   CVCL_J369
DR   JCRB; JCRB0702
DR   Wikidata; Q54835035
RX   PubMed=7105014;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   FM3A SR-01
AC   CVCL_A5LB
SY   SR-01
DR   Wikidata; Q107115032
RX   PubMed=1995072;
CC   Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A5LA ! FM3A G258
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A SR-1
AC   CVCL_S164
SY   SR-1
DR   Wikidata; Q54955625
RX   PubMed=2426230;
RX   PubMed=7528891;
RX   PubMed=7681929;
RX   PubMed=9582343;
RX   PubMed=11133995;
CC   Doubling time: 15.4 hours (PubMed=2426230); 12 hours (PubMed=7528891).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D687 ! FM3A F28-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 8
//
ID   FM3A SR-11
AC   CVCL_A5LC
SY   SR-11
DR   Wikidata; Q107115045
RX   PubMed=1995072;
CC   Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A5LA ! FM3A G258
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A SR-12
AC   CVCL_A5LD
SY   SR-12
DR   Wikidata; Q107115047
RX   PubMed=1995072;
CC   Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A5LA ! FM3A G258
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A SX10
AC   CVCL_S163
SY   SX10
DR   Wikidata; Q54971262
RX   PubMed=2426230;
RX   PubMed=7528891;
RX   PubMed=9582343;
RX   PubMed=11133995;
CC   Characteristics: Radiation-sensitive. The parent cell line was irradiated with 2 Gy and this clone was hypersensitive to X-ray killing (PubMed=2426230).
CC   Doubling time: 18.5 hours (PubMed=2426230); 24 hours (PubMed=7528891).
CC   Selected for resistance to: NCIt; C17262; X-Ray.
CC   Sequence variation: Mutation; MGI; MGI:1335098; Lig4; Simple; p.Trp471Ter (c.1413G>A); Zygosity=Heterozygous (PubMed=11133995).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S164 ! FM3A SR-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   FM3A SX9
AC   CVCL_D700
SY   SX9; SX-9
DR   Wikidata; Q54971263
RX   PubMed=2426230;
RX   PubMed=7528891;
RX   PubMed=9582343;
CC   Characteristics: Radiation-sensitive. The parent cell line was irradiated with 2 Gy and this clone was hypersensitive to X-ray killing (PubMed=2426230).
CC   Doubling time: 17.7 hours (PubMed=2426230); 20 hours (PubMed=7528891).
CC   Selected for resistance to: NCIt; C17262; X-Ray.
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Leu3191Pro (c.9572T>C); Zygosity=Unspecified (PubMed=9582343).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S164 ! FM3A SR-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   FM3A TK~
AC   CVCL_J370
DR   JCRB; JCRB0704
DR   Wikidata; Q54835036
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   FM3A ts T244
AC   CVCL_U141
SY   T244
DR   CLO; CLO_0050962
DR   RCB; RCB0034
DR   Wikidata; Q54835037
RX   PubMed=230835;
CC   Characteristics: Temperature sensitive phenotype. Defective in DNA replication at the non-permissive temperature.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VI65 ! FM3A EM6-TG cl.13
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   FM3A ts85R-MN3
AC   CVCL_A5JW
SY   ts85R-MN3
DR   Wikidata; Q107115051
RX   PubMed=6327059;
RX   PubMed=7284331;
CC   Characteristics: Revertant of parent cell line (ts85).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4201 ! FM3Ats C1.T85
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A tsFT101
AC   CVCL_J378
SY   FM3A FT-101; tsFT101
DR   CLO; CLO_0050961
DR   JCRB; JCRB0706
DR   RCB; RCB0032
DR   Wikidata; Q54835034
RX   PubMed=2581712;
RX   PubMed=9211798;
RX   PubMed=33187357;
CC   Characteristics: Temperature sensitive phenotype. Cytokinesis is blocked at 39 Celsius.
CC   Sequence variation: Mutation; MGI; MGI:1927222; Diaph3; Simple; p.Ile733Asn (c.2198T>A); Zygosity=Homozygous (PubMed=33187357).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   FM3A tsFT20
AC   CVCL_VI63
SY   tsFT20
DR   Wikidata; Q93555121
RX   PubMed=3856858;
RX   PubMed=8125989;
CC   Characteristics: Temperature sensitive phenotype. Stop growing at 39 Celsius. Defective in DNA replication at the non-permissive temperature (PubMed=3856858).
CC   Doubling time: 16 hours (PubMed=3856858).
CC   Sequence variation: Mutation; MGI; MGI:99660; Pola1; Simple; p.Ser1180Phe (c.3539C>T); Zygosity=Unspecified (PubMed=8125989).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   FM3A tsFT210
AC   CVCL_H224
SY   tsFT210; FT210
DR   Wikidata; Q54835215
RX   PubMed=1475706;
RX   PubMed=1903331;
RX   PubMed=2208288;
RX   PubMed=2428648;
RX   PubMed=9043671;
CC   Characteristics: Temperature sensitive phenotype. Stop growing at 39 Celsius. Cells are arrested at the G2 phase at 39 Celsius (PubMed=2428648).
CC   Doubling time: 16 hours (PubMed=2428648).
CC   Sequence variation: Mutation; MGI; MGI:88351; Cdk1; Simple; p.Pro272Ser (c.814C>T); Zygosity=Homozygous (PubMed=1903331; PubMed=2208288).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Caution: An additional Cdk1 mutation p.Ile52Val (c.154A>G) was reported by PubMed=2208288 but was not found by PubMed=1903331.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   FM3A tsFT5
AC   CVCL_A5JX
SY   tsFT5
DR   Wikidata; Q107115052
RX   PubMed=8344958;
CC   Characteristics: Temperature sensitive phenotype. Stop growing at 39 Celsius. Defective in DNA replication. Contains a thermolabile Uba1 (PubMed=8344958).
CC   Doubling time: ~18 hours (PubMed=8344958).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A tsFT50
AC   CVCL_A5JY
SY   tsFT50
DR   Wikidata; Q107115053
RX   PubMed=33187357;
CC   Characteristics: Temperature sensitive phenotype. Cytokinesis is blocked at 39 Celsius.
CC   Sequence variation: Mutation; MGI; MGI:1927222; Diaph3; Simple; p.Gln668Ter (c.2002C>T); Zygosity=Homozygous (PubMed=33187357).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   FM3A-Luc
AC   CVCL_F0YF
SY   FM3A/Luc
RX   PubMed=23328410;
CC   Characteristics: Expresses firefly luciferase under control of the CMV promoter (PubMed=23328410).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   FM3A/R
AC   CVCL_F975
DR   TKG; TKG 0152
DR   Wikidata; Q54835039
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   FM3Ats C1.T85
AC   CVCL_4201
SY   FM3A tscl.T85 Tsai; FM3A ts85; FM3Ats85; ts85; Ts85
DR   CLO; CLO_0003371
DR   CLO; CLO_0050960
DR   CLDB; cl1379
DR   ECACC; 87111904
DR   JCRB; JCRB0705
DR   RCB; RCB0033
DR   Wikidata; Q54835040
RX   PubMed=2156848;
RX   PubMed=3049611;
RX   PubMed=6153988;
RX   PubMed=6327059;
RX   PubMed=7284331;
CC   Characteristics: Has a thermolabile ubiquitin-like modifier-activating enzyme 1 (Uba1) (PubMed=6327059).
CC   Doubling time: 18 hours (PubMed=6153988).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   FM45
AC   CVCL_9674
SY   FM-45; FM 45
DR   cancercelllines; CVCL_9674
DR   Cosmic; 808543
DR   Cosmic; 851409
DR   Cosmic; 972262
DR   Cosmic; 1047664
DR   Cosmic; 1132581
DR   Cosmic; 2163767
DR   ECACC; 13012410
DR   ESTDAB; ESTDAB-011
DR   GEO; GSM156047
DR   IARC_TP53; 26091
DR   Progenetix; CVCL_9674
DR   Wikidata; Q54835041
RX   PubMed=7656272;
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=9688544;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*23,28; B*17,35; C*04 (PubMed=7656272).
CC   HLA typing: A*24:02,68:02; B*53:01,57:01; C*04:01:01,06:02; DPB1*04:01; DQB1*06:04,03:03:02; DRB1*07:01,13:02 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.165-18T>A; Zygosity=Unspecified (PubMed=9288767; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ECACC=13012410; ESTDAB=ESTDAB-011
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 9,12
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 9,11
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   FM48
AC   CVCL_C587
DR   cancercelllines; CVCL_C587
DR   Cosmic; 1047665
DR   GEO; GSM156027
DR   IARC_TP53; 26092
DR   Progenetix; CVCL_C587
DR   Wikidata; Q54835042
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=17260012;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   FM49
AC   CVCL_9675
DR   Cosmic; 808550
DR   Cosmic; 851411
DR   Wikidata; Q54835044
RX   PubMed=9288767;
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val317_Lys322del (c.949_966del18); Zygosity=Unspecified (PubMed=9288767).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   FM516SV
AC   CVCL_Z436
SY   FM516SV3/3; FM-516-SV
DR   BTO; BTO_0005456
DR   Wikidata; Q54835045
RX   PubMed=2543501;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   FM55M1
AC   CVCL_C589
SY   FM-55-M1
DR   Cosmic; 808538
DR   Cosmic; 1006221
DR   ECACC; 13012546
DR   ESTDAB; ESTDAB-012
DR   Wikidata; Q54835046
RX   PubMed=7656272;
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=9688544;
RX   PubMed=11225993;
RX   PubMed=15592718;
CC   HLA typing: A*01,02; B*15,28; C*03 (PubMed=7656272).
CC   HLA typing: A*02:01,01:01; B*08:01,15:01:01:01; C*03:04,07:01:01; DPB1*04:01; DQB1*03:02,03:01:01; DRB1*04:01:01,11:03:01 (PubMed=15592718).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ECACC=13012546; ESTDAB=ESTDAB-012
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   FGA: 24
ST   TH01: 5,7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C590 ! FM55M2
OI   CVCL_C591 ! FM55p
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 18
//
ID   FM55M2
AC   CVCL_C590
SY   FM-55-M2; FM 55 M2; FM55II
DR   cancercelllines; CVCL_C590
DR   Cosmic; 808540
DR   Cosmic; 972266
DR   Cosmic; 1006225
DR   Cosmic; 1047666
DR   Cosmic; 2163768
DR   ECACC; 13012559
DR   ESTDAB; ESTDAB-013
DR   GEO; GSM156043
DR   IARC_TP53; 26093
DR   Progenetix; CVCL_C590
DR   Wikidata; Q54835047
RX   PubMed=7656272;
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=11225993;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*01,02; B*15,28; C*03 (PubMed=7656272).
CC   HLA typing: A*01:01,02:01; B*08:01,15:01:01:01; C*07:01:01,03:04; DPB1*04:01,13:01; DQB1*03:02,03:01:01; DRB1*11:01,04:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu199Ter (c.596T>A); ClinVar=VCV000376329; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ECACC=13012559; ESTDAB=ESTDAB-013
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   FGA: 24
ST   TH01: 5,7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C589 ! FM55M1
OI   CVCL_C591 ! FM55p
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   FM55p
AC   CVCL_C591
SY   FM55P; FM-55-P; FM 55P
DR   Cosmic; 808536
DR   Cosmic; 972263
DR   Cosmic; 1006223
DR   ECACC; 13012417
DR   ESTDAB; ESTDAB-014
DR   Wikidata; Q54835048
RX   PubMed=7656272;
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=9688544;
RX   PubMed=11225993;
RX   PubMed=15592718;
CC   HLA typing: A*01,02; B*15,28; C*03 (PubMed=7656272).
CC   HLA typing: A*01:01,02:01; B*08:01,15:01:01:01; C*03:04,07:01:01; DPB1*04:01; DQB1*03:02,03:01:01; DRB1*04:02,04:01:01 (PubMed=15592718).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012417; ESTDAB=ESTDAB-014
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   FGA: 24
ST   TH01: 5,7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C589 ! FM55M1
OI   CVCL_C590 ! FM55M2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   FM55p.R22.2
AC   CVCL_C592
SY   FM-55-p.R22.2; FM55P.R22
DR   ECACC; 13012462
DR   ESTDAB; ESTDAB-015
DR   Wikidata; Q54835049
RX   PubMed=8665567;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012462; ESTDAB=ESTDAB-015
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   FGA: 24
ST   TH01: 5,7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C591 ! FM55p
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 13
//
ID   FM56
AC   CVCL_C593
SY   FM-56
DR   cancercelllines; CVCL_C593
DR   Cosmic; 1047667
DR   Cosmic; 2163769
DR   ECACC; 13012427
DR   ESTDAB; ESTDAB-016
DR   GEO; GSM156039
DR   IARC_TP53; 26094
DR   Progenetix; CVCL_C593
DR   Wikidata; Q54835050
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   HLA typing: A*31:01:02,68:01:02; B*27:05:02,44:02; C*07:01:01; DPB1*04:01; DQB1*03:02,03:01:01; DRB1*04:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Leu (c.71G>T); ClinVar=VCV000376377; Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012427; ESTDAB=ESTDAB-016
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   FGA: 21,24
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   FM57
AC   CVCL_C594
SY   FM-57
DR   cancercelllines; CVCL_C594
DR   Cosmic; 808546
DR   Cosmic; 874439
DR   Cosmic; 1047668
DR   Cosmic; 2163770
DR   ECACC; 13012418
DR   ESTDAB; ESTDAB-017
DR   GEO; GSM156034
DR   IARC_TP53; 26095
DR   Progenetix; CVCL_C594
DR   Wikidata; Q54835051
RX   PubMed=7656272;
RX   PubMed=8968104;
RX   PubMed=9688544;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*02:01; B*07:02,51:01:01; C*07:02,15:02; DPB1*04:01; DQB1*06:02,03:01:01; DRB1*04:01,15:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012418; ESTDAB=ESTDAB-017
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9 (ESTDAB=ESTDAB-017)
ST   D13S317: 12 (ECACC=13012418)
ST   D16S539: 11,12
ST   D3S1358: 15,17
ST   D5S818: 12,13 (ESTDAB=ESTDAB-017)
ST   D5S818: 13 (ECACC=13012418)
ST   D7S820: 8,10
ST   FGA: 22,23
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 22
//
ID   FM58
AC   CVCL_C595
SY   FM-58; FM 58
DR   cancercelllines; CVCL_C595
DR   Cosmic; 808555
DR   Cosmic; 874440
DR   Cosmic; 972265
DR   Cosmic; 1006229
DR   Cosmic; 1047669
DR   Cosmic; 2163771
DR   ECACC; 13012414
DR   ESTDAB; ESTDAB-018
DR   GEO; GSM156046
DR   IARC_TP53; 26096
DR   Progenetix; CVCL_C595
DR   Wikidata; Q54835052
RX   PubMed=7656272;
RX   PubMed=8968104;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*02:01; B*07:02,15:01:01:01; C*03:04,07:02; DPB1*02:01:02,04:01; DQB1*03:02,05:01; DRB1*10:01,04:01:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012414; ESTDAB=ESTDAB-018
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   FM59
AC   CVCL_C596
DR   Wikidata; Q54835053
RX   PubMed=7656272;
RX   PubMed=8665567;
RX   PubMed=9288767;
RX   PubMed=9688544;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   FM6
AC   CVCL_C581
SY   FM-6; FM 6
DR   cancercelllines; CVCL_C581
DR   Cosmic; 808554
DR   Cosmic; 874437
DR   Cosmic; 972278
DR   Cosmic; 1047670
DR   Cosmic; 2163772
DR   ECACC; 13012409
DR   ESTDAB; ESTDAB-019
DR   GEO; GSM156021
DR   Progenetix; CVCL_C581
DR   Wikidata; Q54835054
RX   PubMed=7656272;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=9688544;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
RX   PubMed=25728708;
CC   HLA typing: A*01,02; B*07,08 (PubMed=7656272).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01:01,07:02; DPB1*04:01,01:01:01; DQB1*06:02,02:01; DRB1*03:01:01,15:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=17260012; PubMed=25728708).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ECACC=13012409; ESTDAB=ESTDAB-019
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D3S1358: 14
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   FGA: 23,24
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 15,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 26
//
ID   FM60
AC   CVCL_C597
DR   Cosmic; 808551
DR   Cosmic; 851442
DR   Cosmic; 1006230
DR   Wikidata; Q54835055
RX   PubMed=7656272;
RX   PubMed=8665567;
RX   PubMed=8968104;
RX   PubMed=9288767;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Unspecified (PubMed=9288767).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   FM62
AC   CVCL_9676
DR   cancercelllines; CVCL_9676
DR   Cosmic; 808548
DR   Cosmic; 851419
DR   Cosmic; 1047671
DR   GEO; GSM156011
DR   IARC_TP53; 26097
DR   Progenetix; CVCL_9676
DR   Wikidata; Q54835056
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=17260012;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu139Ter (c.416T>G); ClinVar=VCV000427590; Zygosity=Unspecified (PubMed=9288767; PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   FM66
AC   CVCL_C599
DR   cancercelllines; CVCL_C599
DR   Cosmic; 808547
DR   Cosmic; 1047672
DR   GEO; GSM156028
DR   IARC_TP53; 26098
DR   Progenetix; CVCL_C599
DR   Wikidata; Q54835057
RX   PubMed=7656272;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=17260012;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   FM69
AC   CVCL_C600
DR   cancercelllines; CVCL_C600
DR   Cosmic; 1047673
DR   GEO; GSM156023
DR   IARC_TP53; 26099
DR   Progenetix; CVCL_C600
DR   Wikidata; Q54835058
RX   PubMed=9288767;
RX   PubMed=17260012;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   FM7
AC   CVCL_ZX42
SY   FM7-1
DR   Wikidata; Q102113838
RX   Patent=US5635376;
RX   PubMed=12441130;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   FM7-H11
AC   CVCL_ZX43
DR   Wikidata; Q102113839
RX   Patent=US5635376;
CC   Group: Patented cell line.
CC   Characteristics: Contains human chromosome 11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_ZX42 ! FM7
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FM70
AC   CVCL_C601
SY   FM-70
DR   cancercelllines; CVCL_C601
DR   Cosmic; 808553
DR   Cosmic; 851408
DR   Cosmic; 2163773
DR   ECACC; 13012491
DR   ESTDAB; ESTDAB-020
DR   Wikidata; Q54835059
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=9288767; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ECACC=13012491; ESTDAB=ESTDAB-020
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   FGA: 22,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   FM72
AC   CVCL_C602
SY   FM-72
DR   cancercelllines; CVCL_C602
DR   Cosmic; 851401
DR   Cosmic; 1047674
DR   Cosmic; 2163774
DR   ECACC; 13012415
DR   ESTDAB; ESTDAB-021
DR   GEO; GSM156040
DR   IARC_TP53; 26100
DR   Progenetix; CVCL_C602
DR   Wikidata; Q54835060
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*02:01; B*07:02,18:01; C*05:01,07:02; DPB1*04:01,03:01; DQB1*06:02,02:01; DRB1*03:01:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012415; ESTDAB=ESTDAB-021
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12
ST   FGA: 21,25
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   FM74
AC   CVCL_C603
SY   FM-74
DR   cancercelllines; CVCL_C603
DR   Cosmic; 808559
DR   Cosmic; 1047675
DR   ECACC; 13012422
DR   ESTDAB; ESTDAB-022
DR   GEO; GSM156015
DR   IARC_TP53; 26101
DR   Progenetix; CVCL_C603
DR   Wikidata; Q54835061
RX   PubMed=7656272;
RX   PubMed=8968104;
RX   PubMed=15592718;
RX   PubMed=17260012;
CC   HLA typing: A*31:01:02,24:02; B*15:01:01:01,35:01; C*03:03,04:01:01; DPB1*04:01; DQB1*03:02,05:01; DRB1*01:01,04:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012422; ESTDAB=ESTDAB-022
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9 (ECACC=13012422)
ST   D13S317: 12 (ESTDAB=ESTDAB-022)
ST   D16S539: 12
ST   D3S1358: 15,16
ST   D5S818: 12,13 (ECACC=13012422)
ST   D5S818: 13 (ESTDAB=ESTDAB-022)
ST   D7S820: 8,9 (ECACC=13012422)
ST   D7S820: 8,10 (ESTDAB=ESTDAB-022)
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   FM76
AC   CVCL_9677
DR   cancercelllines; CVCL_9677
DR   Cosmic; 808549
DR   Cosmic; 1047676
DR   GEO; GSM156037
DR   IARC_TP53; 26102
DR   Progenetix; CVCL_9677
DR   Wikidata; Q54835062
RX   PubMed=7656272;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=9688544;
RX   PubMed=17260012;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro38Ser (c.112C>T); ClinVar=VCV000127688; Zygosity=Unspecified (PubMed=9288767).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9678 ! FM81
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   FM77
AC   CVCL_C605
DR   Cosmic; 808552
DR   Wikidata; Q54835063
RX   PubMed=8968104;
RX   PubMed=9288767;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   FM78
AC   CVCL_C606
SY   FM-78
DR   cancercelllines; CVCL_C606
DR   Cosmic; 1047677
DR   Cosmic; 2163775
DR   ECACC; 13012420
DR   ESTDAB; ESTDAB-023
DR   GEO; GSM156029
DR   IARC_TP53; 26103
DR   Progenetix; CVCL_C606
DR   Wikidata; Q54835064
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*31:01:02,03:01; B*15:01:01:01,27:04; C*02:02:02,03:03; DPB1*04:01; DQB1*03:01:01,05:01:01; DRB1*01:01:01,04:01:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Gly (c.815T>G); ClinVar=VCV000233323; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012420; ESTDAB=ESTDAB-023
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10
ST   FGA: 22,24
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 22
//
ID   FM79
AC   CVCL_C607
SY   FM-79
DR   cancercelllines; CVCL_C607
DR   Cosmic; 808556
DR   Cosmic; 874441
DR   Cosmic; 1047678
DR   Cosmic; 1181766
DR   Cosmic; 2163776
DR   ECACC; 13012423
DR   ESTDAB; ESTDAB-024
DR   GEO; GSM156048
DR   IARC_TP53; 26104
DR   Progenetix; CVCL_C607
DR   Wikidata; Q54835065
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*32:01,25:01; B*18:01,44:02; C*12:03,05:01; DPB1*04:02,02:01:02; DQB1*06:02,03:01:01; DRB1*15:01,12:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012423; ESTDAB=ESTDAB-024
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D3S1358: 14,18
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   FM81
AC   CVCL_9678
SY   FM-81
DR   cancercelllines; CVCL_9678
DR   Cosmic; 851415
DR   Cosmic; 2163777
DR   ECACC; 13012428
DR   ESTDAB; ESTDAB-026
DR   Wikidata; Q54835066
RX   PubMed=9288767;
RX   PubMed=9688544;
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*02:01,68:01:02; B*15:01:01:01,44:02; C*03:03,07:04; DPB1*04:02; DQB1*05:01,03:01:01; DRB1*01:01,12:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799_1800delTGinsAA); ClinVar=VCV000376069; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro38Ser (c.112C>T); ClinVar=VCV000127688; Zygosity=Unspecified (PubMed=9288767; PubMed=23851445).
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ECACC=13012428; ESTDAB=ESTDAB-026
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 9
ST   FGA: 20,26
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9677 ! FM76
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   FM82
AC   CVCL_C609
SY   FM-82
DR   cancercelllines; CVCL_C609
DR   Cosmic; 851404
DR   Cosmic; 1047679
DR   Cosmic; 1181749
DR   Cosmic; 2163778
DR   ECACC; 13012426
DR   ESTDAB; ESTDAB-027
DR   GEO; GSM156030
DR   IARC_TP53; 26105
DR   Progenetix; CVCL_C609
DR   Wikidata; Q54835067
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
RX   PubMed=27600516;
CC   HLA typing: A*01:01,02:01; B*08:01,15:01:01:01; C*03:04,07:04; DPB1*04:01,03:01; DQB1*03:02,03:01:01; DRB1*04:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012426; ESTDAB=ESTDAB-027
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8 (ECACC=13012426)
ST   D13S317: 8,10 (ESTDAB=ESTDAB-027)
ST   D16S539: 11,13
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 11
ST   FGA: 24,25
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   FM86
AC   CVCL_C610
SY   FM-86
DR   cancercelllines; CVCL_C610
DR   Cosmic; 1047680
DR   Cosmic; 2163779
DR   ESTDAB; ESTDAB-028
DR   GEO; GSM156035
DR   IARC_TP53; 26106
DR   Progenetix; CVCL_C610
DR   Wikidata; Q54835068
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*02:01; B*15:01:01:01,44:02; C*03:04,05:01; DPB1*04:01; DQB1*03:02,03:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.171_172CC>TT) (p.Pro72Leu, c.214_215CC>TT); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ESTDAB=ESTDAB-028
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   FGA: 20,21
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   FM87
AC   CVCL_C611
DR   Cosmic; 1132582
DR   Wikidata; Q54835069
RX   PubMed=9288767;
RX   PubMed=9688544;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   FM88
AC   CVCL_9679
SY   FM-88
DR   cancercelllines; CVCL_9679
DR   Cosmic; 851422
DR   Cosmic; 874442
DR   Cosmic; 1047681
DR   Cosmic; 1181745
DR   Cosmic; 1221591
DR   Cosmic; 2163780
DR   ECACC; 13012421
DR   ESTDAB; ESTDAB-029
DR   GEO; GSM156049
DR   IARC_TP53; 26107
DR   Progenetix; CVCL_9679
DR   Wikidata; Q54835070
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*02:01,02:05; B*27:04,49:01; C*01:02,07:01:01; DPB1*04:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:01:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly127Glu (c.380G>A); ClinVar=VCV000428225; Zygosity=Unspecified (PubMed=9288767; PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012421; ESTDAB=ESTDAB-029
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 12
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   FM89
AC   CVCL_C613
DR   Wikidata; Q54835071
RX   PubMed=9288767;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   FM9
AC   CVCL_C582
SY   FM-9
DR   cancercelllines; CVCL_C582
DR   Cosmic; 808557
DR   Cosmic; 874475
DR   Cosmic; 1047682
DR   Cosmic; 2163781
DR   ECACC; 13012416
DR   ESTDAB; ESTDAB-030
DR   GEO; GSM156036
DR   IARC_TP53; 26108
DR   Progenetix; CVCL_C582
DR   Wikidata; Q54835072
RX   PubMed=7656272;
RX   PubMed=8968104;
RX   PubMed=9288767;
RX   PubMed=9688544;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*01,03; B*08,35; C*04 (PubMed=7656272).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Gly (c.95A>G); ClinVar=VCV000017578; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000007827; Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ECACC=13012416; ESTDAB=ESTDAB-030
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 8,11
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   FGA: 22
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 15,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   FM91
AC   CVCL_C614
DR   Cosmic; 874443
DR   Wikidata; Q54835073
RX   PubMed=9288767;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   FM91.2
AC   CVCL_UI34
DR   Wikidata; Q93555437
RX   PubMed=9688544;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C614 ! FM91
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   FM91.5
AC   CVCL_UI35
DR   Wikidata; Q93555441
RX   PubMed=9688544;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C614 ! FM91
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   FM92
AC   CVCL_C615
SY   FM-92
DR   cancercelllines; CVCL_C615
DR   Cosmic; 851402
DR   Cosmic; 1006227
DR   Cosmic; 1047683
DR   Cosmic; 2163782
DR   ECACC; 13012429
DR   ESTDAB; ESTDAB-032
DR   GEO; GSM156044
DR   IARC_TP53; 26109
DR   Progenetix; CVCL_C615
DR   Wikidata; Q54835074
RX   PubMed=9288767;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ECACC=13012429; ESTDAB=ESTDAB-032
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   FGA: 20
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   FM93
AC   CVCL_9680
DR   cancercelllines; CVCL_9680
DR   Cosmic; 1047684
DR   GEO; GSM156038
DR   IARC_TP53; 26110
DR   Progenetix; CVCL_9680
DR   Wikidata; Q54835075
RX   PubMed=9288767;
RX   PubMed=17260012;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.795_796GG>AA); Zygosity=Unspecified (PubMed=17260012).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   FM93/2
AC   CVCL_C617
SY   FM-93/2
DR   cancercelllines; CVCL_C617
DR   Cosmic; 2163783
DR   ECACC; 13012419
DR   ESTDAB; ESTDAB-033
DR   Wikidata; Q54835076
RX   PubMed=15592718;
RX   PubMed=23851445;
RX   PubMed=27600516;
CC   HLA typing: A*02:01,26:01; B*40:01,44:02; C*03:04,05:01; DPB1*04:02,03:01:01; DQB1*03:01:01,05:01; DRB1*14:01:01,04:01:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.795_796GG>AA); Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Proteomics; HLA class I peptidome.
ST   Source(s): ECACC=13012419; ESTDAB=ESTDAB-033
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 11,12
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9
ST   FGA: 20
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 17 (ESTDAB=ESTDAB-033)
ST   vWA: 17,18 (ECACC=13012419)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9680 ! FM93
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   FM94
AC   CVCL_UI29
DR   Wikidata; Q93555469
RX   PubMed=9688544;
RX   PubMed=22178978;
CC   Characteristics: Very highly pigmented.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   FM95
AC   CVCL_C618
SY   FM-95
DR   cancercelllines; CVCL_C618
DR   Cosmic; 851403
DR   Cosmic; 1047685
DR   Cosmic; 2163784
DR   ECACC; 13012425
DR   ESTDAB; ESTDAB-034
DR   GEO; GSM156012
DR   IARC_TP53; 26111
DR   Progenetix; CVCL_C618
DR   Wikidata; Q54835077
RX   PubMed=9288767;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*03:01,33:01; B*07:02,51:01:01; C*07:02,14:02:01; DPB1*04:01,10:01; DQB1*03:01:01,05:03:01; DRB1*12:01,14:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Ser (c.1789_1790delCTinsTC); ClinVar=VCV000375942; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ESTDAB; ESTDAB-034; probable.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012425
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   FM95-14
AC   CVCL_EQ50
SY   Fetal Myoblast 95-14
DR   GEO; GSM86678
DR   GEO; GSM86679
DR   GEO; GSM86680
DR   GEO; GSM86681
DR   GEO; GSM86682
DR   GEO; GSM86683
DR   GEO; GSM86684
DR   GEO; GSM86685
DR   GEO; GSM86686
DR   GEO; GSM86687
DR   GEO; GSM86688
DR   GEO; GSM86689
DR   GEO; GSM86690
DR   GEO; GSM86691
DR   GEO; GSM86692
DR   GEO; GSM86693
DR   GEO; GSM86694
DR   GEO; GSM86695
DR   GEO; GSM86696
DR   GEO; GSM86697
DR   GEO; GSM86698
DR   GEO; GSM86699
DR   GEO; GSM86700
DR   GEO; GSM86701
DR   GEO; GSM86702
DR   GEO; GSM86703
DR   GEO; GSM86704
DR   GEO; GSM86705
DR   GEO; GSM86706
DR   GEO; GSM86707
DR   GEO; GSM86708
DR   GEO; GSM86709
DR   GEO; GSM86710
DR   GEO; GSM86711
DR   GEO; GSM86712
DR   GEO; GSM86713
DR   GEO; GSM86714
DR   GEO; GSM86715
DR   GEO; GSM86716
DR   GEO; GSM86717
DR   GEO; GSM86718
DR   GEO; GSM86719
DR   GEO; GSM86720
DR   GEO; GSM86721
DR   GEO; GSM86722
DR   GEO; GSM86723
DR   GEO; GSM86724
DR   GEO; GSM86725
DR   GEO; GSM86726
DR   GEO; GSM86727
DR   GEO; GSM86728
DR   GEO; GSM86729
DR   GEO; GSM86730
DR   GEO; GSM86731
DR   GEO; GSM86732
DR   GEO; GSM86733
DR   GEO; GSM86734
DR   GEO; GSM86735
DR   GEO; GSM86736
DR   GEO; GSM86737
DR   Wikidata; Q54835078
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   FM97
AC   CVCL_UI30
DR   Wikidata; Q93555493
RX   PubMed=9688544;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   FMA
AC   CVCL_UZ20
DR   Wikidata; Q93555496
RX   DOI=10.2220/biomedres.5.19;
RX   PubMed=134824;
CC   Breed/subspecies: LAF1.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 5
//
ID   FMA3
AC   CVCL_0264
SY   FMA-3; FMA/3
DR   MCCL; MCC:0000155
DR   Wikidata; Q54835079
RX   DOI=10.2220/biomedres.5.19;
RX   PubMed=3934308;
RX   PubMed=8547652;
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Thr577_His583del; Zygosity=Unspecified; Note=Constitutive activation (PubMed=8547652).
CC   Breed/subspecies: LAF1.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UZ20 ! FMA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 8
//
ID   FMB
AC   CVCL_E665
DR   dbMHC; 48861
DR   ECACC; 94022529
DR   IHW; IHW09233
DR   IPD-IMGT/HLA; 10585
DR   Wikidata; Q54835080
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*01:01,32:01; B*44:02:01:01,57; C*05:01,06:02; DPB1*02:01:02,04:01 (IPD-IMGT/HLA=10585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022529; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   FMC-Hu-1-B
AC   CVCL_QY00
SY   FMC-HU-1-B
DR   Wikidata; Q54835081
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3872973;
CC   Characteristics: Produces IgM.
CC   Doubling time: 36 hours (PubMed=3872973).
CC   Derived from site: In situ; Abdominal cavity; UBERON=UBERON_0003684.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   FMC-RB1
AC   CVCL_S615
SY   Flinders Medical Centre-RetinoBlastoma 1
DR   Wikidata; Q54835082
RX   PubMed=2838158;
RX   PubMed=2935245;
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   FMC46
AC   CVCL_B3SS
DR   Wikidata; Q110432805
RX   PubMed=1711069;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   FMC63
AC   CVCL_C5R3
SY   FMC-63
DR   ABCD; ABCD_AA898
DR   ABCD; ABCD_AQ159
DR   Wikidata; Q116049015
RX   PubMed=1725979;
RX   PubMed=9566763;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15391; Human CD19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMCm
AC   CVCL_T990
DR   Wikidata; Q54835083
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 29.7 hours (PubMed=16397390).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Domestic Japanese.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_T991 ! FMCp1
OI   CVCL_T992 ! FMCp2
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   FMCp1
AC   CVCL_T991
DR   Wikidata; Q54835085
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 37.9 hours (PubMed=16397390).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Domestic Japanese.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_T990 ! FMCm
OI   CVCL_T992 ! FMCp2
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   FMCp2
AC   CVCL_T992
DR   Wikidata; Q54835086
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 41.9 hours (PubMed=16397390).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Domestic Japanese.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_T990 ! FMCm
OI   CVCL_T991 ! FMCp1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   FMCPGHi001-A
AC   CVCL_C0FP
SY   301-iPSC-Normal-001A
DR   BioSamples; SAMEA12120255
DR   hPSCreg; FMCPGHi001-A
DR   Wikidata; Q112929565
RX   PubMed=35247846;
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   FMCPGHi002-A
AC   CVCL_D0F0
SY   301-iPSC-normal-002B
DR   BioSamples; SAMEA112262703
DR   hPSCreg; FMCPGHi002-A
DR   Wikidata; Q123031295
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FMCPGHi003-A
AC   CVCL_D0F1
SY   301-iPSC-FHM-001A
DR   BioSamples; SAMEA115171192
DR   hPSCreg; FMCPGHi003-A
DR   Wikidata; Q123031296
RX   PubMed=38880015;
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Phe1774Cys (c.5321A>C); Zygosity=Heterozygous (PubMed=38880015).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C205634; Familial hemiplegic migraine-3
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   FMCPGHi004-A
AC   CVCL_D0F2
DR   hPSCreg; FMCPGHi004-A
DR   Wikidata; Q123031297
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FMCPGHi005-A
AC   CVCL_D0F3
DR   hPSCreg; FMCPGHi005-A
DR   Wikidata; Q123031298
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   FMCPGHi006-A
AC   CVCL_D6I9
DR   BioSamples; SAMEA115483581
DR   hPSCreg; FMCPGHi006-A
DR   Wikidata; Q127380860
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   FMCPGHi007-A
AC   CVCL_E3X5
DR   hPSCreg; FMCPGHi007-A
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FMCPGHi008-A
AC   CVCL_E3X6
DR   hPSCreg; FMCPGHi008-A
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FMCPGHi009-A
AC   CVCL_E3X7
DR   hPSCreg; FMCPGHi009-A
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FMCPGHi010-A
AC   CVCL_E3X8
DR   hPSCreg; FMCPGHi010-A
CC   From: The First Medical Center of PLA General Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FME
AC   CVCL_0B57
DR   ChEMBL-Cells; CHEMBL3307885
DR   ChEMBL-Targets; CHEMBL614156
DR   PubChem_Cell_line; CVCL_0B57
DR   Wikidata; Q54835087
RX   PubMed=7426299;
RX   PubMed=7999427;
CC   Characteristics: Established from a xenograft produced in BALB/c nude mice.
CC   Doubling time: 18 hours (Note=In RPMI 1640 + 15% FCS) (PubMed=7426299).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   FMEC UCD-04-2
AC   CVCL_IX40
SY   FMEC; Feline Mammary Epithelial Cell line University California Davis-04-2
DR   Wikidata; Q54835088
RX   PubMed=19103225;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 7
//
ID   FMG-R
AC   CVCL_XJ74
SY   FMG
DR   CCLV; CCLV-RIE 1129
DR   Wikidata; Q93555580
RX   PubMed=19941903;
RX   PubMed=31513859;
CC   Virology: Susceptible to infection by cowpox virus, murine gammaherpesvirus 68 (MHV-68), Rift Valley fever virus (RVFV) and vaccinia virus.
CC   Donor information: Established from the brains of six newborn common voles minced together.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=47230; ! Microtus arvalis (Common vole)
SX   Mixed sex
AG   4-6D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   FMK-H3
AC   CVCL_B6CL
DR   Wikidata; Q111733223
RX   PubMed=1368811;
RX   PubMed=2121682;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on stomach cancer cell lines.
CC   Anecdotal: The peripheral blood cells that were hybridized with the HO-323 cell line were obtained from Kotaro Koyama who injected himself with stomach cancer cell lines MKN-28 and MKN-45 (PubMed=2121682).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   FMMUNIi001-A
AC   CVCL_E3X9
SY   I-WT
DR   BioSamples; SAMEA115497541
DR   hPSCreg; FMMUNIi001-A
CC   From: Faculty of Medicine, Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FMMUNIi002-A
AC   CVCL_E3XA
SY   I-IF
DR   BioSamples; SAMEA115853743
DR   hPSCreg; FMMUNIi002-A
CC   From: Faculty of Medicine, Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Tyr4734Cys (c.14201A>G); ClinVar=VCV000960225; Zygosity=Unspecified (hPSCreg=FMMUNIi002-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FMMUNIi003-A
AC   CVCL_E3XB
SY   I-CPVT
DR   BioSamples; SAMEA115853744
DR   hPSCreg; FMMUNIi003-A
CC   From: Faculty of Medicine, Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Tyr4734Cys (c.14201A>G); ClinVar=VCV000960225; Zygosity=Unspecified (hPSCreg=FMMUNIi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FMN-R
AC   CVCL_0I54
SY   FMN
DR   CCLV; CCLV-RIE 1102
DR   Wikidata; Q54835089
RX   PubMed=19941903;
RX   PubMed=31513859;
CC   Virology: Susceptible to infection by cowpox virus, encephalomyocarditis virus, murine gammaherpesvirus 68 (MHV-68), Rift Valley fever virus (RVFV), Sindbis virus, Tula orthohantavirus (TULV) and vaccinia virus.
CC   Donor information: Established from the kidneys of six newborn common voles minced together.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=47230; ! Microtus arvalis (Common vole)
SX   Mixed sex
AG   4-6D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   FMS
AC   CVCL_9V01
SY   FMSmel; FMS mel
DR   Wikidata; Q54835090
RX   PubMed=9331097;
RX   PubMed=10395702;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   FMS-1
AC   CVCL_IS33
DR   Wikidata; Q54835091
RX   PubMed=19921253;
CC   Population: Japanese.
CC   Doubling time: ~38.5 hours (PubMed=19921253).
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   FMU-hBAP31.1
AC   CVCL_C5C5
DR   Wikidata; Q116049016
RX   PubMed=19519245;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51572; Human BCAP31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-hBAP31.2
AC   CVCL_C5C6
DR   Wikidata; Q116049017
RX   PubMed=19519245;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51572; Human BCAP31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-hBAP31.3
AC   CVCL_C5C7
DR   Wikidata; Q116049018
RX   PubMed=19519245;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51572; Human BCAP31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-hBAP31.4
AC   CVCL_C5C8
DR   Wikidata; Q116049019
RX   PubMed=19519245;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51572; Human BCAP31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-hBAP31.5
AC   CVCL_C5C9
DR   Wikidata; Q116049020
RX   PubMed=19519245;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51572; Human BCAP31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-hBAP31.6
AC   CVCL_C5CA
DR   Wikidata; Q116049021
RX   PubMed=19519245;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51572; Human BCAP31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-hBAP31.7
AC   CVCL_C5CB
DR   Wikidata; Q116049022
RX   PubMed=19519245;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51572; Human BCAP31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-PEX14
AC   CVCL_C5C4
DR   Wikidata; Q116049023
RX   PubMed=22509920;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O75381; Human PEX14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU-ratBAP31
AC   CVCL_C5CC
DR   Wikidata; Q116049024
RX   PubMed=19857118;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6AY58; Rat Bcap31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU1
AC   CVCL_C4ZP
DR   Wikidata; Q116049025
RX   PubMed=11152401;
RX   PubMed=11304406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU2
AC   CVCL_C4ZQ
DR   Wikidata; Q116049026
RX   PubMed=11152401;
RX   PubMed=11304406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU3
AC   CVCL_C4ZR
DR   Wikidata; Q116049027
RX   PubMed=11152401;
RX   PubMed=11304406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU4
AC   CVCL_C4ZS
DR   Wikidata; Q116049028
RX   PubMed=11152401;
RX   PubMed=11304406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU5
AC   CVCL_C4ZT
DR   Wikidata; Q116049029
RX   PubMed=11152401;
RX   PubMed=11304406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU6
AC   CVCL_C4ZU
DR   Wikidata; Q116049030
RX   PubMed=11152401;
RX   PubMed=11304406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMU7
AC   CVCL_C4ZV
DR   Wikidata; Q116049031
RX   PubMed=11152401;
RX   PubMed=11304406;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FMUFAHi001-A
AC   CVCL_C0FU
SY   FSHD-DRQ01
DR   BioSamples; SAMEA9462435
DR   hPSCreg; FMUFAHi001-A
DR   Wikidata; Q112929566
RX   PubMed=35093715;
CC   From: The First Affiliated Hospital, Fujian Medical University; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 2 repeats) (PubMed=35093715).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   FMUFAHi002-A
AC   CVCL_C0FV
SY   FSHD-WW01
DR   hPSCreg; FMUFAHi002-A
DR   Wikidata; Q112929567
RX   PubMed=35093715;
CC   From: The First Affiliated Hospital, Fujian Medical University; Fuzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 4 repeats) (PubMed=35093715).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   FMUPDCi001-A
AC   CVCL_B7E1
SY   ADAT3c.219dupA/c.587C>T iPSC
DR   BioSamples; SAMEA11423628
DR   hPSCreg; FMUPDCi001-A
DR   Wikidata; Q112929568
RX   PubMed=35405382;
CC   From: Fetal Medicine unit and Prenatal Diagnosis Center, Shanghai 1st Maternity and Infant Hospital of Tongji University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:25151; ADAT3; Simple; p.Arg58Thrfs (c.171dupA) (p.Arg74Thrfs, c.219dupA); dbSNP=rs1267546394; Zygosity=Heterozygous (PubMed=35405382).
CC   Sequence variation: Mutation; HGNC; HGNC:25151; ADAT3; Simple; p.Ala180Val (c.539C>T) (p.Ala196Val, c.587C>T); ClinVar=VCV004086440; Zygosity=Heterozygous (PubMed=35405382).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C186789; Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies
DI   ORDO; Orphanet_363528; Intellectual disability-strabismus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 6
//
ID   FN
AC   CVCL_ZC19
DR   Wikidata; Q98126240
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   FN-E
AC   CVCL_0C09
DR   Wikidata; Q54835092
RX   PubMed=7736387;
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   FNB6
AC   CVCL_YY01
DR   Wikidata; Q98126241
RX   PubMed=12183435;
CC   Senescence: Senesces at 11-12 PDL (PubMed=12183435).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   FNB6 hTERT
AC   CVCL_F734
SY   FNB6-TERT; FNB6 TERT
DR   Wikidata; Q54835093
DR   Ximbio; 151634
RX   PubMed=27846777;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: Ximbio; 151634; probable.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YY01 ! FNB6
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   FNC-A6
AC   CVCL_1D74
SY   FNCA6
DR   Wikidata; Q54835094
RX   PubMed=7790915;
CC   Derived from site: In situ; Fetal nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8-12FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   FNC-B4
AC   CVCL_1D75
SY   FNCB4
DR   Wikidata; Q54835095
RX   PubMed=7790915;
CC   Derived from site: In situ; Fetal nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   FNCB4-hTERT
AC   CVCL_M960
SY   FNC-B4-hTERT
DR   Wikidata; Q54835096
RX   CelloPub=CLPUB00248;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D75 ! FNC-B4
SX   Male
AG   8FW
CA   Telomerase immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   FNE1
AC   CVCL_ZZ89
DR   ECACC; 20012021
DR   Wikidata; Q102113841
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ECACC; 20012021; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ90 ! FNLE1
OI   CVCL_ZZ91 ! FNLER1
OI   CVCL_ZZ92 ! OCE1
OI   CVCL_ZZ93 ! OCLE1
OI   CVCL_ZZ94 ! OCLER1
SX   Female
AG   56Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   FNE2
AC   CVCL_ZZ95
DR   ECACC; 20012024
DR   Wikidata; Q102113842
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ECACC; 20012024; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ96 ! FNLE2
OI   CVCL_ZZ97 ! FNLER2
OI   CVCL_ZZ98 ! OCE2
OI   CVCL_ZZ99 ! OCLE2
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   FNLE1
AC   CVCL_ZZ90
DR   ECACC; 20012022
DR   Wikidata; Q102113843
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 20012022; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ89 ! FNE1
OI   CVCL_ZZ91 ! FNLER1
OI   CVCL_ZZ92 ! OCE1
OI   CVCL_ZZ93 ! OCLE1
OI   CVCL_ZZ94 ! OCLER1
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   FNLE2
AC   CVCL_ZZ96
DR   ECACC; 20012025
DR   Wikidata; Q102113844
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 20012025; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ95 ! FNE2
OI   CVCL_ZZ97 ! FNLER2
OI   CVCL_ZZ98 ! OCE2
OI   CVCL_ZZ99 ! OCLE2
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   FNLER1
AC   CVCL_ZZ91
DR   ECACC; 20012023
DR   Wikidata; Q102113846
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 20012023; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ89 ! FNE1
OI   CVCL_ZZ90 ! FNLE1
OI   CVCL_ZZ92 ! OCE1
OI   CVCL_ZZ93 ! OCLE1
OI   CVCL_ZZ94 ! OCLER1
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FNLER2
AC   CVCL_ZZ97
DR   ECACC; 20012026
DR   Wikidata; Q102113847
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 20012026; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ95 ! FNE2
OI   CVCL_ZZ96 ! FNLE2
OI   CVCL_ZZ98 ! OCE2
OI   CVCL_ZZ99 ! OCLE2
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FNNm
AC   CVCL_T993
DR   Wikidata; Q54835097
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 19.1 hours (PubMed=16397390).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   FNR-85-Cl 1
AC   CVCL_ZZ44
SY   FNR-85-1
DR   cancercelllines; CVCL_ZZ44
DR   Wikidata; Q102113848
RX   PubMed=6269117;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 9
//
ID   FNR-85-Cl 2
AC   CVCL_ZZ45
SY   FNR-85-2
DR   cancercelllines; CVCL_ZZ45
DR   Wikidata; Q102113851
RX   PubMed=6269117;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 9
//
ID   FNR-85-Cl 3
AC   CVCL_ZZ46
SY   FNR-85-3
DR   cancercelllines; CVCL_ZZ46
DR   Wikidata; Q102113852
RX   PubMed=6269117;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 9
//
ID   FNR-85-Cl 5
AC   CVCL_ZZ47
SY   FNR-85-5
DR   cancercelllines; CVCL_ZZ47
DR   Wikidata; Q102113853
RX   PubMed=6269117;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 9
//
ID   FNS
AC   CVCL_6392
DR   CLO; CLO_0003376
DR   ATCC; CRL-6170
DR   Wikidata; Q54835098
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6170; true.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   FO [Human B-cell IHW]
AC   CVCL_E666
SY   FORE-9334
DR   dbMHC; 48863
DR   IHW; IHW09334
DR   IPD-IMGT/HLA; 10586
DR   Wikidata; Q54835099
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*11,31; B*39,51; C*07; DQA1*01:03,05:01; DQB1*06:01,03:01; DRB1*08:03:02,12:01:01; DRB3*01:01 (IPD-IMGT/HLA=10586).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FO [Mouse myeloma]
AC   CVCL_6972
SY   F/0; F0
DR   CLO; CLO_0003377
DR   AddexBio; C0003017/4886
DR   ATCC; CRL-1646
DR   BCRC; 60040
DR   CCRID; 1101MOU-PUMC000821
DR   CCRID; 3101MOUTCM31
DR   KCB; KCB 2014046YJ
DR   Wikidata; Q54835100
RX   PubMed=7009747;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   FO-4
AC   CVCL_6393
DR   CLO; CLO_0003378
DR   ATCC; CRL-6171
DR   Wikidata; Q54835101
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6171; true.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   FO1-12
AC   CVCL_GZ38
SY   Fo1-12; FO-1 #12
DR   cancercelllines; CVCL_GZ38
DR   TOKU-E; 3586
DR   Wikidata; Q54835102
RX   Patent=US6063375;
RX   PubMed=10746551;
RX   PubMed=10983636;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12177.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: Metastatic; Iliac lymph node; UBERON=UBERON_0015878.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5619 ! MEL-CLS-1
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   FOC1.K
AC   CVCL_U959
SY   FOc1K; FOC1
DR   ATCC; CRL-6499
DR   Wikidata; Q54835103
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6499; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 5
//
ID   FOCUS
AC   CVCL_7955
SY   Focus; Friendship Of China and United States
DR   CLO; CLO_0009985
DR   EFO; EFO_0022510
DR   Cosmic; 873400
DR   Cosmic; 948067
DR   Cosmic; 979731
DR   Cosmic; 2321034
DR   LINCS_LDP; LCL-2078
DR   Wikidata; Q54835104
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6086498;
RX   PubMed=8224613;
RX   PubMed=25574106;
CC   Doubling time: 42-48 hours (PubMed=6086498).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 22
//
ID   foec-1
AC   CVCL_C6F7
SY   fetal oral epithelial cell-1
DR   Wikidata; Q116049032
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   foec-2
AC   CVCL_C6F8
SY   fetal oral epithelial cell-2
DR   Wikidata; Q116049033
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   foec-3
AC   CVCL_C6F9
SY   fetal oral epithelial cell-3
DR   Wikidata; Q116049034
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   foec-4
AC   CVCL_C6FA
SY   fetal oral epithelial cell-4
DR   Wikidata; Q116049035
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   foec-5
AC   CVCL_C6FB
SY   fetal oral epithelial cell-5
DR   Wikidata; Q116049036
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   foec-6
AC   CVCL_C6FC
SY   fetal oral epithelial cell-6
DR   Wikidata; Q116049037
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   foec-7
AC   CVCL_C6FD
SY   fetal oral epithelial cell-7
DR   Wikidata; Q116049038
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   foec-8
AC   CVCL_C6FE
SY   fetal oral epithelial cell-8
DR   Wikidata; Q116049039
RX   PubMed=20033791;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   FoLu
AC   CVCL_3310
SY   Folu; Fox Lung
DR   CLO; CLO_0003379
DR   CLDB; cl1383
DR   ATCC; CCL-168
DR   ECACC; 90120501
DR   IZSLER; BS CL 171
DR   KCB; KCB 94021YJ
DR   Wikidata; Q54835105
RX   PubMed=7065527;
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=55040; ! Urocyon cinereoargenteus (Gray fox)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   FOM 71
AC   CVCL_5751
SY   FOM71; FOreskin Melanocyte 71
DR   BTO; BTO_0004818
DR   Wikidata; Q54835106
RX   PubMed=19620624;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   FOM 78
AC   CVCL_5752
SY   FOM-78; FOM78; FOreskin Melanocyte 78
DR   BTO; BTO_0004819
DR   Wikidata; Q54835107
RX   PubMed=19620624;
RX   PubMed=21857157;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   FON EBV
AC   CVCL_C7U1
SY   EBV FON
DR   Wikidata; Q123031300
RX   PubMed=9103444;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7U2 ! FON G1
OI   CVCL_C7U3 ! FON G2
OI   CVCL_C7U4 ! FON T1
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   FON G1
AC   CVCL_C7U2
SY   G1 FON; G1
DR   Wikidata; Q123031301
RX   PubMed=9103444;
RX   PubMed=25950383;
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7U1 ! FON EBV
OI   CVCL_C7U3 ! FON G2
OI   CVCL_C7U4 ! FON T1
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   FON G2
AC   CVCL_C7U3
SY   G2 FON
DR   Wikidata; Q123031302
RX   PubMed=9103444;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7U1 ! FON EBV
OI   CVCL_C7U2 ! FON G1
OI   CVCL_C7U4 ! FON T1
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 3
//
ID   FON T1
AC   CVCL_C7U4
SY   T1 FON
DR   Wikidata; Q123031303
RX   PubMed=9103444;
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7U1 ! FON EBV
OI   CVCL_C7U2 ! FON G1
OI   CVCL_C7U3 ! FON G2
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   FONm
AC   CVCL_T994
DR   Wikidata; Q54835108
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 54.0 hours (PubMed=16397390).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Siamese; VBO=VBO_0100221.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_T995 ! FONp
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   FONp
AC   CVCL_T995
DR   Wikidata; Q54835109
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 29.4 hours (PubMed=16397390).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Siamese; VBO=VBO_0100221.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_T994 ! FONm
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   FORE
AC   CVCL_E667
SY   FORE-9317; TER330
DR   dbMHC; 48862
DR   ECACC; 94050305
DR   IHW; IHW09317
DR   IPD-IMGT/HLA; 10587
DR   Wikidata; Q54835110
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*51:01:01,15:01:01:01; C*14:02:01,03:03:01; DPA1*01:03:01:03; DPB1*03:01:01,06:01; DQA1*03:01:01,01:02:02; DQB1*03:02:01,05:02:01; DRB1*04:04:01,16:04; DRB4*01:03:01:03; DRB5*02:02; DRB6*02:02 (IPD-IMGT/HLA=10587).
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*51:01:01:01,15:01:01:01; C*14:02:01:01,03:03:01:01; DPA1*01:03:01:03; DPB1*03:01:01,06:01:01; DQA1*01:02:02,03:01:01; DQB1*03:02:01,05:02:01; DRB1*04:04:01,16:04; DRB4*01:03:01; DRB5*02:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   FORTHi001A
AC   CVCL_A4VI
SY   hiPS line 1
DR   GEO; GSM1422435
DR   GEO; GSM1422436
DR   Wikidata; Q107115055
RX   PubMed=27879223;
CC   From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   FORTHi001B
AC   CVCL_A4VJ
SY   hiPS line 2
DR   GEO; GSM1422437
DR   GEO; GSM1422438
DR   Wikidata; Q107115057
RX   PubMed=27879223;
CC   From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   FORTHi001C
AC   CVCL_A4VK
SY   hiPS line 3
DR   GEO; GSM1422439
DR   GEO; GSM1422440
DR   Wikidata; Q107115061
RX   PubMed=27879223;
CC   From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   FOS_1077
AC   CVCL_FA26
DR   Wikidata; Q54835111
RX   PubMed=29056719;
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
CC   Breed/subspecies: European shorthair; VBO=VBO_0100063.
DI   NCIt; C132825; Feline osteosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   FOS_1140
AC   CVCL_FA27
DR   Wikidata; Q54835112
RX   PubMed=29056719;
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
CC   Breed/subspecies: European shorthair; VBO=VBO_0100063.
DI   NCIt; C132825; Feline osteosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   FOSE2
AC   CVCL_F0B8
RX   PubMed=29440125;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: KrasG12D/wtPtenloxP/loxPCD95loxP/loxPAmhr2-Cre transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   FOX-NY
AC   CVCL_6971
SY   Fox-NY; Fox/NY; FOXNY; NS-1/FOX-NY; FOX
DR   CLO; CLO_0003380
DR   ATCC; CRL-1732
DR   CCRID; 1101MOU-PUMC000065
DR   Wikidata; Q54835113
RX   PubMed=6402815;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   FP-R
AC   CVCL_A3AB
DR   CCLV; CCLV-RIE 0972
DR   Wikidata; Q105506879
RX   PubMed=19941903;
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal rumen; UBERON=UBERON_0007365.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   FP0
AC   CVCL_E2UB
SY   Fusion partner 0
RX   Patent=US8859278;
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   FP0-AgR
AC   CVCL_E2UC
RX   Patent=US8859278;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UB ! FP0
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   FP0-AgR-neo
AC   CVCL_E2UD
RX   Patent=US8859278;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7466.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UC ! FP0-AgR
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   FP1.0
AC   CVCL_E2UE
SY   FP1; Fusion partner 1
RX   Patent=US8859278;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7465.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   FP2
AC   CVCL_E2UF
SY   Fusion partner 2
RX   Patent=US8859278;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   FP3
AC   CVCL_E2UP
SY   Fusion partner 3
RX   Patent=US8859278;
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   FP5-3-1
AC   CVCL_XX34
DR   Wikidata; Q93555840
RX   PubMed=31529417;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Mammary placode; UBERON=UBERON_0005311.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   FP5-3-1 clone K1
AC   CVCL_XX35
SY   K1
DR   Wikidata; Q93555845
RX   PubMed=31529417;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Mammary placode; UBERON=UBERON_0005311.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XX34 ! FP5-3-1
SX   Female
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   FP5-3-1 clone L3
AC   CVCL_XX36
SY   L3
DR   Wikidata; Q93555847
RX   PubMed=31529417;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Mammary placode; UBERON=UBERON_0005311.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XX34 ! FP5-3-1
SX   Female
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   FP5-3-1 clone M5
AC   CVCL_XX37
SY   M5
DR   Wikidata; Q93555852
RX   PubMed=31529417;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Mammary placode; UBERON=UBERON_0005311.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XX34 ! FP5-3-1
SX   Female
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   FP5-3-1 clone O1
AC   CVCL_XX38
SY   O1
DR   Wikidata; Q93555856
RX   PubMed=31529417;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Mammary placode; UBERON=UBERON_0005311.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XX34 ! FP5-3-1
SX   Female
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   FPa#11
AC   CVCL_C8LA
DR   Wikidata; Q123031304
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPa#12
AC   CVCL_C8LB
DR   Wikidata; Q123031305
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPa#21
AC   CVCL_C8LC
DR   Wikidata; Q123031306
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPa#31
AC   CVCL_C8LD
DR   Wikidata; Q123031307
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPa#37
AC   CVCL_C8LE
DR   Wikidata; Q123031308
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPAF
AC   CVCL_E668
SY   FPF; FPA; GM03106; GM3106
DR   CLO; CLO_0013568
DR   Coriell; GM03106
DR   dbMHC; 48864
DR   ECACC; 95051624
DR   IHW; IHW09105
DR   IPD-IMGT/HLA; 10588
DR   Wikidata; Q54835114
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Jewish; Ashkenazi.
CC   HLA typing: A*01:01:01:01; B*35:02:01:01; C*04:01:01:01; DPA1*02:01:01; DPB1*02:01:02/02:01:19; DQA1*01:03; DQB1*06:03:01; DRB1*11:04:01; DRB3*02:02 (IPD-IMGT/HLA=10588).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   FPAH-control-1
AC   CVCL_A4LY
SY   FPAH family 1-control
DR   SKIP; SKIP002949
DR   Wikidata; Q105506881
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   FPAH-control-2
AC   CVCL_A4LZ
SY   FPAH family 2-control
DR   SKIP; SKIP002950
DR   Wikidata; Q105506885
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   FPAH-control-3
AC   CVCL_A4MA
SY   FPAH family 3-control
DR   SKIP; SKIP002951
DR   Wikidata; Q105506888
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   FPAH-1-P1
AC   CVCL_A4MC
SY   FPAH family 1-Patient 1 iPSC
DR   SKIP; SKIP002953
DR   Wikidata; Q105506890
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPAH-1-P2
AC   CVCL_A4MD
SY   FPAH family 1-Patient 2 iPSC
DR   SKIP; SKIP002954
DR   Wikidata; Q105506894
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPAH-1-P3
AC   CVCL_A4ME
SY   FPAH family 1-Patient 3 iPSC
DR   SKIP; SKIP002955
DR   Wikidata; Q105506897
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPAH-1-UMC
AC   CVCL_A4MB
SY   FPAH-UMC-1; FPAH family-1 Unaffected Mutation Carrier
DR   SKIP; SKIP002952
DR   Wikidata; Q105506901
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys118Trp (c.354T>G) (T354G); ClinVar=VCV000008799; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPAH-2-P
AC   CVCL_A4MG
SY   FPAH-2-P1; FPAH family 2-Patient iPSC
DR   SKIP; SKIP002957
DR   Wikidata; Q105506906
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Thr835Lysfs*4 (c.2504delC); ClinVar=VCV000425991; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPAH-2 UMC
AC   CVCL_A4MF
SY   FPAH-UMC-2; FPAH family-2 Unaffected Mutation Carrier
DR   SKIP; SKIP002956
DR   Wikidata; Q105506910
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Thr835Lysfs*4 (c.2504delC); ClinVar=VCV000425991; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPAH-3-P
AC   CVCL_A4MI
SY   FPAH-3-P1; FPAH family 3-Patient iPSC
DR   SKIP; SKIP002959
DR   Wikidata; Q105506912
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys117Tyr (c.350G>A); ClinVar=VCV000425766; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPAH-3 UMC
AC   CVCL_A4MH
SY   FPAH-UMC-3; FPAH family-3 Unaffected Mutation Carrier
DR   SKIP; SKIP002958
DR   Wikidata; Q105506914
RX   PubMed=28017794;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys117Tyr (c.350G>A); ClinVar=VCV000425766; Zygosity=Unspecified (PubMed=28017794).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FPb#12
AC   CVCL_C8LF
DR   Wikidata; Q123031309
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPb#220
AC   CVCL_C8LG
DR   Wikidata; Q123031310
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPb#223
AC   CVCL_C8LH
DR   Wikidata; Q123031311
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPb#32
AC   CVCL_C8LI
DR   Wikidata; Q123031312
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPb#36
AC   CVCL_C8LJ
DR   Wikidata; Q123031313
RX   PubMed=30902271;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_83070; Fluopyram.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   FPBH
AC   CVCL_F123
DR   IARC_TP53; 23654
DR   Wikidata; Q54835115
RX   PubMed=8378080;
RX   PubMed=15192123;
CC   From: Vetterlein, Monika; Institute of Tumour Biology and Cancer Research, University of Vienna; Vienna; Austria.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   FPC15JTO
AC   CVCL_2905
SY   Familial Polyposis Colon 15 Japan TOkyo; PL15
DR   JCRB; JCRB0319
DR   JCRB; KURB2028
DR   Wikidata; Q54835116
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0319
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   FPC1LO
AC   CVCL_C3QR
SY   Familial Polyposis Colon 1 LOndon
DR   Wikidata; Q116049040
RX   PubMed=6459055;
RX   PubMed=6831374;
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   FPC5JTO
AC   CVCL_2906
SY   Familial Polyposis Colon 5 Japan TOkyo
DR   JCRB; JCRB0318
DR   Wikidata; Q54835117
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Virology: Infected with Human parvovirus B19 (PubMed=29892436).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0318
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   FPKLPV-BPH
AC   CVCL_B6YL
SY   BPH cell line; Fujian Province Key Laboratory of Plant Virology-Brown PlantHopper
DR   Wikidata; Q111733225
RX   PubMed=24478421;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=108931; ! Nilaparvata lugens (Brown planthopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   FPKLPV-SBPH
AC   CVCL_B6YI
SY   SBPH cell line; Fujian Province Key Laboratory of Plant Virology-Small Brown PlantHopper
DR   ICLDB; fpklpv-sbph
DR   Wikidata; Q111733226
RX   PubMed=23468422;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=195883; ! Laodelphax striatellus (Small brown planthopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   FPKLPV-WBPH
AC   CVCL_B6YJ
SY   WBPH cell line; Fujian Province Key Laboratory of Plant Virology-White-Backed PlantHopper
DR   Wikidata; Q111733227
RX   PubMed=23576499;
RX   PubMed=34905203;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=113103; ! Sogatella furcifera (White-backed planthopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   FPLNMEC
AC   CVCL_A1CN
SY   F PLN MEC; Feline Peripheral Lymph Node Microvascular Endothelial Cells
DR   Wikidata; Q102113855
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4251.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal peripheral lymph node, microvascular endothelium; UBERON=UBERON_0003968+UBERON_0008339.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FPMI-CF-200
AC   CVCL_WV83
SY   IPRI-CF-200
DR   ICLDB; fpmi-cf-200
DR   Wikidata; Q93555907
RX   CelloPub=CLPUB00186;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-203
AC   CVCL_Z469
SY   FPMI-Cf-203; FPMI-CF203; CF-203; IPRI-CF-203
DR   BTO; BTO_0004105
DR   ICLDB; fpmi-cf-203
DR   Wikidata; Q54835118
RX   CelloPub=CLPUB00186;
RX   PubMed=8806500;
RX   PubMed=11680386;
RX   PubMed=14745824;
RX   PubMed=33276037;
CC   Group: Insect cell line.
CC   Doubling time: 47.3 hours (PubMed=33276037).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   FPMI-CF-204
AC   CVCL_WV84
SY   IPRI-CF-204
DR   ICLDB; fpmi-cf-204
DR   Wikidata; Q93555924
RX   CelloPub=CLPUB00186;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-205
AC   CVCL_WV85
SY   IPRI-CF-205
DR   ICLDB; fpmi-cf-205
DR   Wikidata; Q93555927
RX   CelloPub=CLPUB00186;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-22
AC   CVCL_WV87
DR   ICLDB; fpmi-cf-22
DR   Wikidata; Q93555932
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-27
AC   CVCL_WV88
DR   ICLDB; fpmi-cf-27
DR   Wikidata; Q93555938
RX   PubMed=7615077;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-30
AC   CVCL_WV89
DR   ICLDB; fpmi-cf-30
DR   Wikidata; Q93555940
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-300
AC   CVCL_WV86
DR   ICLDB; fpmi-cf-300
DR   Wikidata; Q93555945
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   FPMI-CF-33
AC   CVCL_WV90
DR   ICLDB; fpmi-cf-33
DR   Wikidata; Q93555950
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-34
AC   CVCL_WV91
DR   ICLDB; fpmi-cf-34
DR   Wikidata; Q93555954
RX   PubMed=7615077;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-40
AC   CVCL_WV92
DR   ICLDB; fpmi-cf-40
DR   Wikidata; Q93555957
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-41
AC   CVCL_WV93
DR   ICLDB; fpmi-cf-41
DR   Wikidata; Q93555962
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   FPMI-CF-50
AC   CVCL_Z470
SY   CF-50
DR   ICLDB; fpmi-cf-50
DR   Wikidata; Q54835119
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   FPMI-CF-60
AC   CVCL_Z471
SY   CF-60
DR   ICLDB; fpmi-cf-60
DR   Wikidata; Q54835120
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   FPMI-CF-70
AC   CVCL_Z472
SY   FPMI-Cf-70; CF-70
DR   ICLDB; fpmi-cf-70
DR   Wikidata; Q54835121
RX   CelloPub=CLPUB00491;
RX   DOI=10.1016/0022-1910(94)00139-8;
RX   DOI=10.1139/z85-337;
RX   PubMed=7615077;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   FPMI-CO-112
AC   CVCL_C2QL
DR   ICLDB; fpmi-co-112
DR   Wikidata; Q114311446
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-113
AC   CVCL_C2QM
DR   ICLDB; fpmi-co-113
DR   Wikidata; Q114311447
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-114
AC   CVCL_C2QN
DR   ICLDB; fpmi-co-114
DR   Wikidata; Q114311448
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-115
AC   CVCL_C2QP
DR   ICLDB; fpmi-co-115
DR   Wikidata; Q114311449
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-131
AC   CVCL_C2QQ
DR   ICLDB; fpmi-co-131
DR   Wikidata; Q114311450
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-132
AC   CVCL_C2QR
DR   ICLDB; fpmi-co-132
DR   Wikidata; Q114311451
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-134
AC   CVCL_C2QS
DR   ICLDB; fpmi-co-134
DR   Wikidata; Q114311452
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-162
AC   CVCL_C2QT
DR   ICLDB; fpmi-co-162
DR   Wikidata; Q114311453
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-163
AC   CVCL_C2QU
DR   ICLDB; fpmi-co-163
DR   Wikidata; Q114311454
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-164
AC   CVCL_C2QV
DR   ICLDB; fpmi-co-164
DR   Wikidata; Q114311455
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-21
AC   CVCL_C2QW
DR   ICLDB; fpmi-co-21
DR   Wikidata; Q114311456
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-63
AC   CVCL_C2QX
DR   ICLDB; fpmi-co-63
DR   Wikidata; Q114311457
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-67
AC   CVCL_C2QY
DR   ICLDB; fpmi-co-67
DR   Wikidata; Q114311458
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-70
AC   CVCL_C2QZ
DR   ICLDB; fpmi-co-70
DR   Wikidata; Q114311459
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-71
AC   CVCL_C2R0
DR   ICLDB; fpmi-co-71
DR   Wikidata; Q114311460
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-73
AC   CVCL_C2R1
DR   ICLDB; fpmi-co-73
DR   Wikidata; Q114311461
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-75
AC   CVCL_C2R2
DR   ICLDB; fpmi-co-75
DR   Wikidata; Q114311462
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-77
AC   CVCL_C2R3
DR   ICLDB; fpmi-co-77
DR   Wikidata; Q114311463
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-80
AC   CVCL_C2R4
DR   ICLDB; fpmi-co-80
DR   Wikidata; Q114311464
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-81
AC   CVCL_C2R5
DR   ICLDB; fpmi-co-81
DR   Wikidata; Q114311465
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-86
AC   CVCL_C2R6
DR   ICLDB; fpmi-co-86
DR   Wikidata; Q114311466
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-CO-8681
AC   CVCL_C2R7
DR   ICLDB; fpmi-co-8681
DR   Wikidata; Q114311467
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=27541; ! Choristoneura occidentalis (Western spruce budworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-LD-301
AC   CVCL_C2SH
DR   ICLDB; fpmi-ld-301
DR   Wikidata; Q114311468
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   FPMI-LD-400
AC   CVCL_C2SI
DR   ICLDB; fpmi-ld-400
DR   Wikidata; Q114311469
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-LD-404
AC   CVCL_C2SJ
DR   ICLDB; fpmi-ld-404
DR   Wikidata; Q114311470
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-LD-8
AC   CVCL_C2SK
DR   ICLDB; fpmi-ld-8
DR   Wikidata; Q114311471
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   FPMI-MS-12
AC   CVCL_Z446
DR   ICLDB; fpmi-ms-12
DR   Wikidata; Q54835122
RX   CelloPub=CLPUB00492;
RX   DOI=10.1385/0-89603-272-8:397;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   FPMI-MS-4
AC   CVCL_Z448
DR   ICLDB; fpmi-ms-4
DR   Wikidata; Q54835123
RX   DOI=10.1385/0-89603-272-8:397;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   FPMI-MS-5
AC   CVCL_Z449
SY   FPMI-Ms-5
DR   ICLDB; fpmi-ms-5
DR   Wikidata; Q54835124
RX   DOI=10.1385/0-89603-272-8:397;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   FPMI-MS-7
AC   CVCL_Z450
DR   ICLDB; fpmi-ms-7
DR   Wikidata; Q54835128
RX   DOI=10.1385/0-89603-272-8:397;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   FPMI-NL-1
AC   CVCL_GZ68
SY   NL-1
DR   ICLDB; fpmi-nl-1
DR   Wikidata; Q54835129
RX   CelloPub=CLPUB00187;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   FPMI-NL-10
AC   CVCL_Z491
SY   NL-10
DR   ICLDB; fpmi-nl-10
DR   Wikidata; Q54835130
RX   CelloPub=CLPUB00187;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-NL-18
AC   CVCL_Z492
SY   NL-18
DR   ICLDB; fpmi-nl-18
DR   Wikidata; Q54835131
RX   CelloPub=CLPUB00187;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-NL-2
AC   CVCL_Z493
SY   NL-2
DR   ICLDB; fpmi-nl-2
DR   Wikidata; Q54835132
RX   CelloPub=CLPUB00187;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-NL-21
AC   CVCL_Z494
SY   NL-21
DR   ICLDB; fpmi-nl-21
DR   Wikidata; Q54835133
RX   CelloPub=CLPUB00187;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-NL-22
AC   CVCL_Z495
SY   NL-22
DR   ICLDB; fpmi-nl-22
DR   Wikidata; Q54835134
RX   CelloPub=CLPUB00187;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-NL-27
AC   CVCL_GZ69
SY   NL-27
DR   ICLDB; fpmi-nl-27
DR   Wikidata; Q54835135
RX   CelloPub=CLPUB00187;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   FPMI-NL-28
AC   CVCL_Z496
SY   NL-28
DR   ICLDB; fpmi-nl-28
DR   Wikidata; Q54835136
RX   CelloPub=CLPUB00187;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-NL-31
AC   CVCL_GZ70
SY   NL-31
DR   ICLDB; fpmi-nl-31
DR   Wikidata; Q54835137
RX   CelloPub=CLPUB00187;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   FPMI-NL-32
AC   CVCL_Z497
SY   NL-32
DR   ICLDB; fpmi-nl-32
DR   Wikidata; Q54835138
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-NL-4
AC   CVCL_Z498
SY   NL-4
DR   ICLDB; fpmi-nl-4
DR   Wikidata; Q54835139
RX   CelloPub=CLPUB00187;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=441921; ! Neodiprion lecontei (Redheaded pine sawfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   FPMI-PS-1
AC   CVCL_C2SL
DR   ICLDB; fpmi-ps-1
DR   Wikidata; Q114311472
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=49927; ! Pissodes strobi (White pine weevil)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-PS-4
AC   CVCL_C2SM
DR   ICLDB; fpmi-ps-4
DR   Wikidata; Q114311473
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=49927; ! Pissodes strobi (White pine weevil)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-PS-5
AC   CVCL_C2SN
DR   ICLDB; fpmi-ps-5
DR   Wikidata; Q114311474
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=49927; ! Pissodes strobi (White pine weevil)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPMI-PS-6
AC   CVCL_C2SP
DR   ICLDB; fpmi-ps-6
DR   Wikidata; Q114311475
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=49927; ! Pissodes strobi (White pine weevil)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   FPPMEC
AC   CVCL_A1CQ
SY   F PP MEC; Feline Peyer's Patches Microvascular Endothelial Cells
DR   Wikidata; Q102113856
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4255.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal intestine, Peyer's patch; UBERON=UBERON_0001211.
CC   Cell type: Endothelial cell of Peyer's patch; CL=CL_1000411.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FPS-1
AC   CVCL_M792
DR   Wikidata; Q54835140
RX   PubMed=17094458;
CC   Population: Japanese.
CC   Doubling time: ~36.5 hours (PubMed=17094458).
CC   Karyotypic information: Has lost chromosome Y.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   FQ
AC   CVCL_L984
DR   BioSample; SAMN03151876
DR   Wikidata; Q54835141
RX   PubMed=68093;
RX   PubMed=265539;
RX   PubMed=7005696;
RX   PubMed=7192801;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=29533902;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NYT; -; https://www.nytimes.com/1981/01/22/us/cells-in-disease-study-said-to-come-from-monkeys.html
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to derive from OMK-210 from owl monkey (PubMed=7192801; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00047.
CC   Anecdotal: Part of a set of 4 cell lines that were fraudulently stated to originate from Hodgkin lymphoma (PubMed=265539).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9505; ! Aotus trivirgatus (Three-striped night monkey)
HI   CVCL_L983 ! OMK-210
SX   Female
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   FQ-2G3
AC   CVCL_XK32
DR   Wikidata; Q93556190
RX   Patent=CN104262486B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014106.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34632; Chlorpyrifos-methyl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   FQ-4F12
AC   CVCL_XK25
DR   CCRID; 4201PAT-CCTCC00469
DR   Wikidata; Q93556192
RX   Patent=CN104130330A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014131.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_16793; Mercury(2+).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   FQ-6E
AC   CVCL_XK26
DR   Wikidata; Q93556197
RX   Patent=CN103589688B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013105.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38704; Isocarbophos.
CC   Monoclonal antibody target: ChEBI; CHEBI_6009; Isofenphos.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   FQ-Aa4
AC   CVCL_XK27
SY   Aa4
DR   Wikidata; Q93556202
RX   PubMed=17715887;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_48775; Cadmium(2+) (Note=When chelated).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   FQ-Aa6
AC   CVCL_XK28
SY   Aa6
DR   CCRID; 4201PAT-CCTCC00606
DR   Wikidata; Q93556206
RX   Patent=CN104151431A;
RX   PubMed=17715887;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201458.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_48775; Cadmium(2+) (Note=When chelated).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   FQ-Ac4
AC   CVCL_XK29
SY   Ac4
DR   Wikidata; Q93556211
RX   PubMed=17715887;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_48775; Cadmium(2+) (Note=When chelated).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   FQ-Ba2
AC   CVCL_XK30
SY   Ba2
DR   Wikidata; Q93556216
RX   PubMed=17715887;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_48775; Cadmium(2+) (Note=When chelated).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   FQ-E7
AC   CVCL_XK31
DR   CCRID; 4201PAT-CCTCC00453
DR   Wikidata; Q93556219
RX   Patent=CN104311669A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014107.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_39169; (Z)-imidacloprid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   Fq/11
AC   CVCL_WX35
SY   EF88
DR   Wikidata; Q93556225
RX   PubMed=9765229;
RX   PubMed=10336475;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-487.html
CC   Knockout cell: Method=KO mouse; MGI; MGI:95766; Gna11.
CC   Knockout cell: Method=KO mouse; MGI; MGI:95776; Gnaq.
CC   Caution: We are not certain that Fq/11 and EF88 are the same cell line.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   FR
AC   CVCL_4202
DR   CLO; CLO_0003384
DR   CLDB; cl1384
DR   ATCC; CRL-1213
DR   ECACC; 87020503
DR   IZSLER; BS CL 195
DR   Wikidata; Q54835142
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-504.html
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   FR-E
AC   CVCL_0C10
DR   NCBI_Iran; C564
DR   Wikidata; Q54835143
RX   PubMed=7736387;
RX   PubMed=10100721;
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   FR-M-101
AC   CVCL_C544
DR   cancercelllines; CVCL_C544
DR   Cosmic; 2163847
DR   ESTDAB; ESTDAB-160
DR   Wikidata; Q54835144
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-160
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 9,11
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   FR-M-119
AC   CVCL_C545
DR   cancercelllines; CVCL_C545
DR   Cosmic; 2163848
DR   ESTDAB; ESTDAB-161
DR   Wikidata; Q54835145
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-161
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   FGA: 22,25
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   FR-M-134
AC   CVCL_C546
DR   ESTDAB; ESTDAB-162
DR   Wikidata; Q54835146
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-162
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 12
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   FR-M-170
AC   CVCL_C547
DR   cancercelllines; CVCL_C547
DR   Cosmic; 2163849
DR   ESTDAB; ESTDAB-163
DR   Wikidata; Q54835147
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-163
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 9,12
ST   FGA: 21,22
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   FR-M-204
AC   CVCL_C548
DR   cancercelllines; CVCL_C548
DR   Cosmic; 2163850
DR   ESTDAB; ESTDAB-164
DR   Wikidata; Q54835148
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Gly (c.653T>G); ClinVar=VCV000528249; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-164
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 11
ST   FGA: 19,22
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   FR10B4
AC   CVCL_CW50
DR   NCBI_Iran; H165
DR   Wikidata; Q54835149
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20273; Human CD22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   fR2
AC   CVCL_2444
DR   CLO; CLO_0003385
DR   cancercelllines; CVCL_2444
DR   CancerTools; 153246
DR   ECACC; 98031102
DR   GEO; GSM827430
DR   Progenetix; CVCL_2444
DR   Wikidata; Q54835151
DR   Ximbio; 153246
RX   PubMed=6279290;
RX   PubMed=20215515;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 98031102; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
ST   Source(s): ECACC=98031102
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2445 ! fR5
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   FR37-CMT
AC   CVCL_CW16
DR   ABM; T8002
DR   Wikidata; Q54835152
RX   PubMed=27140424;
CC   Doubling time: 17 hours (PubMed=27140424).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   FR3T3
AC   CVCL_C691
SY   FR-3T3; FR 3T3; Fr 3T3; Fisher rat 3T3
DR   Wikidata; Q54835153
RX   PubMed=201774;
RX   PubMed=2535681;
RX   PubMed=6330980;
RX   PubMed=8455944;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   FR4
AC   CVCL_M505
SY   FR-4
DR   Cosmic; 720785
DR   Cosmic; 2081381
DR   Cosmic; 2367267
DR   GEO; GSM143352
DR   GEO; GSM290289
DR   Wikidata; Q54835150
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1697013;
RX   PubMed=10557056;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=17171682;
RX   PubMed=17229644;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: 131 hours (PubMed=1697013).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M504 ! AD3 [Human myeloma]
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 21
//
ID   fR5
AC   CVCL_2445
DR   CLO; CLO_0003386
DR   CancerTools; 153247
DR   ECACC; 98031103
DR   Wikidata; Q54835154
DR   Ximbio; 153247
RX   PubMed=6279290;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 98031103; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2444 ! fR2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   Fr994
AC   CVCL_UW82
DR   Wikidata; Q93556377
RX   PubMed=30537062;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious salmon anaemia virus (ISAV).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: INRA Sy; VBO=VBO_0017493.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 9
//
ID   FRA
AC   CVCL_A6IM
SY   FR-A; Fischer Rat Autonomous tumor
DR   Wikidata; Q107115065
RX   PubMed=391743;
RX   PubMed=7042315;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C179056; Rat thyroid neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FRAN4
AC   CVCL_J149
SY   Fran4
DR   CLO; CLO_0003387
DR   ATCC; HB-10830
DR   Wikidata; Q54835155
RX   PubMed=8426087;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10830.
CC   Monoclonal antibody isotype: IgM (PubMed=8426087); IgG1, kappa (ATCC=HB-10830).
CC   Monoclonal antibody target: Francisella tularensis subsp. holarctica strain LVS lipopolysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 6
//
ID   Fravel
AC   CVCL_M509
SY   FRAVEL; Fr
DR   Wikidata; Q54835156
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2537114;
RX   PubMed=6804081;
RX   PubMed=10087940;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: 62 hours (PubMed=6804081).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   FraWu
AC   CVCL_E6XC
SY   FraW
RX   PubMed=12836015;
CC   HLA typing: A*02,02; B*44,44; DQB1*06:03,06:03; DRB1*13:01:01,13:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRD-R
AC   CVCL_A3AC
DR   CCLV; CCLV-RIE 0979
DR   Wikidata; Q105506917
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal gut; UBERON=UBERON_0007026.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   FRDA130
AC   CVCL_ZB89
SY   F130; 130
DR   ABM; T5442
DR   GEO; GSM2794418
DR   Wikidata; Q98126242
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[136]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[540]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA179
AC   CVCL_E6E5
SY   F179; 179
DR   ABM; T5480
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[600]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5480).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[920]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5480).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA156
AC   CVCL_ZB90
SY   F156; 156
DR   GEO; GSM2794419
DR   Wikidata; Q98126243
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[495]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[505]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA188
AC   CVCL_ZB91
SY   F188; 188
DR   GEO; GSM2794420
DR   Wikidata; Q98126245
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[490]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[680]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA203
AC   CVCL_ZB92
SY   F203; 203
DR   GEO; GSM2794421
DR   Wikidata; Q98126247
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[916]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1382]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA281
AC   CVCL_ZB93
SY   F281; 281
DR   ABM; T5446
DR   GEO; GSM2794422
DR   Wikidata; Q98126248
RX   PubMed=27002638;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[630]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[806]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4078
AC   CVCL_E6E7
SY   F4078; 4078
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[341]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[480]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4090
AC   CVCL_E6E2
SY   F4090; 4090
DR   ABM; T5448
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[541]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5448).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[783]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5448).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4111
AC   CVCL_E6E8
SY   F4111; 4111
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[392]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[485]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4182
AC   CVCL_E6E9
SY   F4182; 4182
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[457]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[684]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4192
AC   CVCL_ZB96
SY   F4192; 4192
DR   GEO; GSM2794425
DR   Wikidata; Q98126249
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[400]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[967]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4193
AC   CVCL_E6EA
SY   F4193; 4193
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[650]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[719]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4194
AC   CVCL_ZB97
SY   F4194; 4194
DR   Wikidata; Q98126250
RX   PubMed=27002638;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[540]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Simple; p.Gly130Val (c.389G>T); ClinVar=VCV000003982; Zygosity=Heterozygous (PubMed=27002638).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4230
AC   CVCL_ZB98
SY   F4230; 4230
DR   GEO; GSM2794426
DR   Kerafast; ECP001
DR   Wikidata; Q98126251
RX   PubMed=27002638;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[870]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1470]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6E6 ! FRDA4230B
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4230B
AC   CVCL_E6E6
SY   F4230B; 4230B
DR   ABM; T5478
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[567]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5478).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[744]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5478).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB98 ! FRDA4230
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4249
AC   CVCL_E6EB
SY   F4249; 4249
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[596]; ClinVar=VCV000561195; Zygosity=Homozygous (PubMed=35850241).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4259
AC   CVCL_ZB99
SY   F4259; 4259
DR   GEO; GSM2794427
DR   Wikidata; Q98126252
RX   PubMed=27002638;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[404]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[920]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4491
AC   CVCL_ZC00
SY   F4491; 4491
DR   Wikidata; Q98126253
RX   PubMed=27002638;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[559]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Simple; p.Gly130Val (c.389G>T); ClinVar=VCV000003982; Zygosity=Heterozygous (PubMed=27002638).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4497
AC   CVCL_ZC01
SY   F4497; 4497
DR   GEO; GSM2794428
DR   Wikidata; Q98126254
RX   PubMed=27002638;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[526]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[826]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4509
AC   CVCL_ZC02
SY   F4509; 4509
DR   GEO; GSM2794429
DR   Wikidata; Q98126255
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[211]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1428]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4627
AC   CVCL_ZC03
SY   F4627; 4627
DR   GEO; GSM2794430
DR   Wikidata; Q98126258
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[501]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[670]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: According to PubMed=29125828, the number of GAA repeats are 468/807.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4654
AC   CVCL_ZC04
SY   F4654; 4654
DR   GEO; GSM2794431
DR   Kerafast; ECP002
DR   Wikidata; Q98126259
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[190]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[500]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4675
AC   CVCL_ZC05
SY   F4675; 4675
DR   GEO; GSM2794432
DR   Wikidata; Q98126261
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[185]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1130]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA4687
AC   CVCL_E6EC
SY   F4687; 4687
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[450]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1270]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA4743
AC   CVCL_E6E0
SY   F4743; 4743
DR   ABM; T5477
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[498]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1043]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=32291635).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA50
AC   CVCL_ZC06
SY   F50; 50
DR   Wikidata; Q98126262
RX   PubMed=27002638;
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[353]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[616]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA6237
AC   CVCL_E6E1
SY   F6237; 6237
DR   ABM; T5444
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[397]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5444).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[507]; ClinVar=VCV000561195; Zygosity=Heterozygous (ABM=T5444).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA6247
AC   CVCL_E6ED
SY   F6247; 6247
RX   PubMed=35850241;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[478]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1017]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=35850241).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FRDA66
AC   CVCL_ZC07
SY   F66; 66
DR   GEO; GSM2794433
DR   Wikidata; Q98126263
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[110]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[590]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA68
AC   CVCL_ZC08
SY   F68; 68
DR   ABM; T5479
DR   GEO; GSM2794434
DR   Wikidata; Q98126264
RX   PubMed=25758173;
RX   PubMed=27002638;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[570]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1200]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRDA88
AC   CVCL_ZC09
SY   F88; 88
DR   GEO; GSM2794435
DR   Wikidata; Q98126265
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: Friedreich's ataxia primary fibroblast repository.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[422]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[520]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=29125828; PubMed=32291635).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FRE
AC   CVCL_0B88
DR   Wikidata; Q54835157
RX   PubMed=3034934;
RX   PubMed=7171457;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   FreeStyle 293-F
AC   CVCL_D603
SY   Freestyle-293F; FreeStyle 293F; Freestyle 293F; FreeStyle293-F; FreeStyle293F; FreeStyle 293; Freestyle 293; FreeStyle293; Freestyle HEK293F; 293-F FreeStyle; FS-293F
DR   BTO; BTO_0005267
DR   FCS-free; 38-2-44-1-8-3
DR   Lonza; 885
DR   Wikidata; Q54835158
RX   Patent=US7217566;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-421.html
WW   Provider; Thermo Fisher; R79007; https://www.thermofisher.com/order/catalog/product/R79007
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5080.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6642 ! HEK293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 23
//
ID   FreeStyle CHO-S
AC   CVCL_D604
SY   CHO-S FreeStyle
DR   Lonza; 1124
DR   Wikidata; Q54835159
WW   Provider; Thermo Fisher; R80007; https://www.thermofisher.com/order/catalog/product/R80007
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   FRF
AC   CVCL_WY73
DR   Wikidata; Q93556441
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
OX   NCBI_TaxID=201710; ! Sebastes vulpes (Rockfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 4
//
ID   FRFCB
AC   CVCL_V373
DR   IPD-IMGT/HLA; 14469
DR   Wikidata; Q54835160
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,24:13:02; B*35:02,44:02; C*04:01,05:01; DQB1*03:01; DRB1*04:01,11:01 (IPD-IMGT/HLA=14469).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   FRhK-4
AC   CVCL_4522
SY   FRHK-4; Frhk-4; FRhK4; Fetal Rhesus Kidney-4
DR   CLO; CLO_0003388
DR   CLDB; cl1385
DR   ATCC; CRL-1688
DR   BCRC; 60095
DR   CCLV; CCLV-RIE 0873
DR   CCRID; 3101MONGNO18
DR   CCRID; 4201MON-CCTCC00036
DR   CCTCC; GDC0036
DR   CLS; 305151
DR   IZSLER; BS CL 115
DR   Wikidata; Q54835161
RX   PubMed=4633070;
RX   PubMed=28046048;
CC   Group: Non-human primate cell line.
CC   Virology: Susceptible to infection by poliovirus type 1, type 2 and type 3 (PubMed=28046048).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_1E36 ! FRhL-4
SX   Female
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 21
//
ID   FRhK-4/R
AC   CVCL_7223
SY   Frhk-4/R; FRhK-4R
DR   CLO; CLO_0003389
DR   CLDB; cl1387
DR   Wikidata; Q54835162
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_4522 ! FRhK-4
SX   Female
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 13
//
ID   FRhL-4
AC   CVCL_1E36
SY   Fetal Rhesus Lung-4
DR   Wikidata; Q54835163
RX   PubMed=4203458;
RX   PubMed=4633070;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_4522 ! FRhK-4
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   FRI
AC   CVCL_J359
SY   Fri; HCT-FRI; HCT FRI
DR   cancercelllines; CVCL_J359
DR   ColonAtlas; FRI
DR   Cosmic; 711269
DR   Cosmic; 887235
DR   GEO; GSM2549999
DR   IARC_TP53; 15971
DR   Wikidata; Q54835164
RX   PubMed=3349466;
RX   PubMed=7329817;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11526487;
RX   PubMed=24042735;
RX   PubMed=28683746;
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Homozygous (PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Homozygous (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=24042735
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 12.2,14
ST   D21S11: 27,29
ST   D2S1338: 18
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 15,16
ST   FGA: 20
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   FRI-AnCo-5B
AC   CVCL_Z269
DR   ICLDB; fri-anco-5b
DR   Wikidata; Q29579249
RX   DOI=10.11519/jjfs1953.71.12_491;
CC   Group: Insect cell line.
CC   Doubling time: ~4.5 days (DOI=10.11519/jjfs1953.71.12_491).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1069816; ! Anomala costata (Larger striated chafer)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   FRI-AnCu-35
AC   CVCL_Z270
SY   AnCu-35
DR   ICLDB; fri-ancu-35
DR   Wikidata; Q54835165
RX   PubMed=15117233;
CC   Group: Insect cell line.
CC   Doubling time: ~4.5 days (PubMed=15117233).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=121601; ! Anomala cuprea (Cupreous chafer beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   FRI-MntH-520A
AC   CVCL_Z369
DR   Wikidata; Q54835166
RX   CelloPub=CLPUB00163;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Doubling time: 6.93 days (CelloPub=CLPUB00163).
CC   Discontinued: NGRC Genebank; Catalog number 275039.
OX   NCBI_TaxID=7098; ! Malacosoma neustria (Lackey moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   FRI-SpIm-1229
AC   CVCL_Z133
DR   CLO; CLO_0050005
DR   ICLDB; fri-spim-1229
DR   NISES; SK0015
DR   RCB; RCB0281
DR   Wikidata; Q54835167
RX   CelloPub=CLPUB00320;
RX   DOI=10.1303/aez.23.488;
RX   PubMed=9282311;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; RCB; -; https://web.archive.org/web/20230328160254/https://cell.brc.riken.jp/en/DNA_barcoding
CC   Group: Insect cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Lemyra imparilis origin but found to be from Mamestra brassicae (RCB=RCB0281).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00566.
CC   Misspelling: FRI-Splm-1229; Note=Occasionally.
CC   Discontinued: NGRC Genebank; Catalog number 275021.
CC   Discontinued: RCB; RCB0281; true.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   FRIMOi001-A
AC   CVCL_UM39
SY   RP1_FiPS4F1.6
DR   BioSamples; SAMEA7340580
DR   hPSCreg; FRIMOi001-A
DR   Wikidata; Q93556539
RX   PubMed=30685614;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520deposito_RP1_FiPS4F1.6-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520RP1_FiPS4F1.6-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Fundacio de Recerca de l'Institut de Microcirurgia Ocular; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8785; PDE6A; Simple; p.Arg102His (c.305G>A); ClinVar=VCV000971026; Zygosity=Heterozygous (PubMed=30685614).
CC   Sequence variation: Mutation; HGNC; HGNC:8785; PDE6A; Simple; p.Leu423Ter (c.1268delT); Zygosity=Heterozygous (PubMed=30685614).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D21S11: 32.2,33.2
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11
ST   FGA: 20,21
ST   Penta D: 11,12
ST   Penta E: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   FRIMOi002-A
AC   CVCL_UM40
SY   RP2_FiPS4F2.2
DR   BioSamples; SAMEA7352791
DR   hPSCreg; FRIMOi002-A
DR   Wikidata; Q93556541
RX   PubMed=30685615;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520deposito_RP2_FiPS4F2.2-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520RP2_FiPS4F2.2-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Fundacio de Recerca de l'Institut de Microcirurgia Ocular; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Arg737Ter (c.2209C>T); ClinVar=VCV000002361; Zygosity=Heterozygous (PubMed=30685615).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Tyr2898Ser (c.8693A>C); ClinVar=VCV000557316; Zygosity=Heterozygous (PubMed=30685615).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D21S11: 31
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   Penta D: 2.2,12
ST   Penta E: 10,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   FRIMOi003-A
AC   CVCL_UM41
SY   STGD1_FiPS4F1.5; STGD_1
DR   BioSamples; SAMEA7352793
DR   hPSCreg; FRIMOi003-A
DR   Wikidata; Q93556544
RX   PubMed=30798147;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520deposito_STGD1_FiPS4F1.5-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520STGD1_FiPS4F1.5-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Fundacio de Recerca de l'Institut de Microcirurgia Ocular; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.4253+4C>T; ClinVar=VCV000099266; Zygosity=Heterozygous (PubMed=30798147).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg2030Gln (c.6089G>A); ClinVar=VCV000099428; Zygosity=Heterozygous (PubMed=30798147).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 13,16
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 9,13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 19,22
ST   Penta D: 10,13
ST   Penta E: 11,13
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 14,19
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 14
//
ID   FRIMOi004-A
AC   CVCL_UM42
SY   STGD2_FiPS4F1.7; STGD_2
DR   BioSamples; SAMEA7352795
DR   hPSCreg; FRIMOi004-A
DR   Wikidata; Q93556548
RX   PubMed=30798147;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/solicitud_STGD2_FiPS4F1.7%2520_v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520STGD2_FiPS4F1.7_v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Fundacio de Recerca de l'Institut de Microcirurgia Ocular; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Gly172Ser (c.514G>A); ClinVar=VCV000099347; Zygosity=Heterozygous (PubMed=30798147).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Val675Ile (c.2023G>A); ClinVar=VCV000288341; Zygosity=Heterozygous (PubMed=30798147).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Ser1071Cysfs*14 (c.3210_3211dupGT) (c.3211_3212insGT); ClinVar=VCV000372290; Zygosity=Heterozygous (PubMed=30798147).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Val2050Leu (c.6148G>C); ClinVar=VCV000007884; Zygosity=Heterozygous (PubMed=30798147).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 30,31.2
ST   D3S1358: 15,19
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 17,22
ST   Penta D: 14
ST   Penta E: 11,15
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 15,17
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 15
//
ID   FRIMOi005-A
AC   CVCL_WS11
SY   RP3_FiPSC4F11; RP3_FiPS4F11
DR   BioSamples; SAMEA7352797
DR   hPSCreg; FRIMOi005-A
DR   Wikidata; Q93556550
RX   PubMed=31146251;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520deposito_RP3_FiPSC4F11_V2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520RP3_FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Fundacio de Recerca de l'Institut de Microcirurgia Ocular; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Pro215Leu (c.644C>T); ClinVar=VCV000870955; Zygosity=Heterozygous (PubMed=31146251).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 8,12
ST   D18S51: 13,18
ST   D19S433: 13,15
ST   D21S11: 28,31.2
ST   D2S1338: 17,19
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 12,14
ST   D8S1179: 12,14
ST   FGA: 21
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   FRIMOi006-A
AC   CVCL_XJ88
SY   BEST1_FiPS4F1
DR   BioSamples; SAMEA7352799
DR   hPSCreg; FRIMOi006-A
DR   Wikidata; Q93556554
RX   PubMed=31518904;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/solicitud_BEST1_FiPS4F1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520BEST1_FiPS4F1_V2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Fundacio de Recerca de l'Institut de Microcirurgia Ocular; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12703; BEST1; Simple; p.Pro77Ser (c.229C>T); Zygosity=Heterozygous (PubMed=31518904).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 18,23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 24,26
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C118788; Vitelliform macular dystrophy
DI   ORDO; Orphanet_1243; Best vitelliform macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   FRIMOi007-A
AC   CVCL_XJ80
SY   PDE6C_FiPS4F1
DR   BioSamples; SAMEA7352801
DR   hPSCreg; FRIMOi007-A
DR   Wikidata; Q93556558
RX   PubMed=31520890;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/solicitud_PDE6C_FiPS4F1_v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520PDE6C_FiPS4F1_v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Fundacio de Recerca de l'Institut de Microcirurgia Ocular; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8787; PDE6C; Simple; p.Arg557Gln (c.1670G>A); ClinVar=VCV002053050; Zygosity=Homozygous (PubMed=31520890).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C164226; Achromatopsia 5
DI   ORDO; Orphanet_49382; Achromatopsia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   FRIWT-8
AC   CVCL_4908
SY   WT-8; WT8
DR   BTO; BTO_0003313
DR   Wikidata; Q54835169
RX   PubMed=1889088;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:104878; Prkar1a.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5124 ! FTO-2B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   FRM [Cat mammary tumor]
AC   CVCL_T988
DR   Wikidata; Q54835170
RX   PubMed=9764406;
RX   PubMed=10333454;
RX   PubMed=15705889;
CC   Doubling time: 22.4 hours (PubMed=10333454).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: Domestic Japanese.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   FRM [Human melanoma]
AC   CVCL_M212
DR   Wikidata; Q54835171
RX   PubMed=12417263;
RX   PubMed=19133143;
CC   From: Zupi, Gabriella; Laboratory of Chemotherapy, Regina Elena Institute for Cancer Research; Rome; Italy.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   FRO
AC   CVCL_6287
SY   FRO81-2; Fro81-2; FRO 81-2
DR   CCRID; 3101HUMSCSP577
DR   CGH-DB; 56-1
DR   Cosmic; 685604
DR   Cosmic; 849973
DR   Cosmic; 918182
DR   Cosmic; 931243
DR   Cosmic; 990534
DR   Cosmic; 1005457
DR   Cosmic; 1094761
DR   Cosmic; 1239981
DR   Cosmic; 1699418
DR   Cosmic; 2613251
DR   TOKU-E; 4067
DR   Wikidata; Q54835172
RX   PubMed=9348181;
RX   PubMed=11439348;
RX   PubMed=15613457;
RX   PubMed=16924234;
RX   PubMed=18713817;
RX   PubMed=25675381;
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X,Y
ST   D13S317: 9
ST   D18S51: 12,15
ST   D21S11: 28,30
ST   D3S1358: 17
ST   D5S818: 10,14
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 22
ST   vWA: 16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Frog-HSA
AC   CVCL_0C97
SY   FROG; Frog
DR   GEO; GSM377401
DR   Kerafast; EMN012
DR   Wikidata; Q54835173
RX   PubMed=16797414;
RX   PubMed=19461996;
RX   PubMed=28029283;
CC   Doubling time: ~24 hours (Kerafast=EMN012).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Kerafast; EMN012; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   FROv
AC   CVCL_IS35
SY   FROV; Fetalen Rinder Ovar
DR   Wikidata; Q54835174
RX   Patent=US5804430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2051.
CC   Virology: Supports the replication of a multiplicity of virus types, such as bovine adenoviruses (BAV) types 1, 3, 4, 5, 6, 7, and 8, parainfluenza virus type 3, bovine respiratory syncytial virus (BRSV), bovine herpesviruses types 1 and 4, equine herpesviruses type 1; mucosal disease virus strain Ug5 and bovine parvovirus strain Haden (Patent=US5804430).
CC   Derived from site: In situ; Fetal ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7FM
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   Frp/3
AC   CVCL_W665
SY   FrP3; Frp3
DR   IZSLER; BS CL 169
DR   Wikidata; Q54835175
RX   PubMed=2997478;
RX   PubMed=28046048;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_4522 ! FRhK-4
SX   Female
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 12
//
ID   FRSK
AC   CVCL_5501
SY   Fetal Rat Skin Keratinocytes
DR   JCRB; JCRB0005
DR   Wikidata; Q54835176
RX   PubMed=894748;
RX   PubMed=2172343;
RX   PubMed=2428814;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   FRSN
AC   CVCL_6F51
DR   Wikidata; Q54835177
RX   PubMed=22567895;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Somatic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FRTK-1
AC   CVCL_4W35
DR   Wikidata; Q54835178
RX   PubMed=16820901;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=16820901).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Glu300Ter (c.898G>T); Zygosity=Unspecified (PubMed=16820901).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   FRT
AC   CVCL_A6IE
SY   FR-T; Fischer Rat Thyroid
DR   CLO; CLO_0003390
DR   CLDB; cl1388
DR   Wikidata; Q107115068
RX   PubMed=391743;
RX   PubMed=1577825;
RX   PubMed=2992984;
RX   PubMed=7042315;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FRT-L KiKi
AC   CVCL_A6II
SY   FRT-L Ki-MSV(Ki-MuLV)
DR   CLO; CLO_0003393
DR   CLDB; cl1390
DR   Wikidata; Q107115071
RX   PubMed=6275984;
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5753 ! FRTL
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FRT-U10
AC   CVCL_A6ID
DR   CLO; CLO_0003397
DR   CLDB; cl1393
DR   Wikidata; Q107115079
RX   PubMed=1577825;
RX   PubMed=7814270;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1706; CD8A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6IE ! FRT
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   FRTL
AC   CVCL_5753
SY   FRT-L; FR-TL; Fischer Rat Thyroid in Low-serum
DR   CLO; CLO_0003392
DR   ATCC; CRL-1468
DR   CLS; 500202
DR   TOKU-E; 1281
DR   Wikidata; Q54835179
RX   PubMed=391743;
RX   PubMed=1726925;
RX   PubMed=6106191;
RX   PubMed=6275984;
RX   PubMed=7042315;
CC   Doubling time: 5-7 days (PubMed=1726925).
CC   Discontinued: ATCC; CRL-1468; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6IE ! FRT
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   FRTL-5
AC   CVCL_0265
SY   FRTL 5; FRTL5; FRTL-5 Cl 2
DR   BTO; BTO_0001875
DR   CLO; CLO_0003396
DR   MCCL; MCC:0000156
DR   CLDB; cl1395
DR   ChEMBL-Cells; CHEMBL3308088
DR   ChEMBL-Targets; CHEMBL613879
DR   CLS; 500407
DR   ECACC; 91030711
DR   PubChem_Cell_line; CVCL_0265
DR   Wikidata; Q54835180
RX   CelloPub=CLPUB00429;
RX   CelloPub=CLPUB00430;
RX   DOI=10.1128/mcb.00663-17;
RX   Patent=US4608341;
RX   PubMed=1694496;
RX   PubMed=1726925;
RX   PubMed=1846098;
RX   PubMed=2545492;
RX   PubMed=2551628;
RX   PubMed=2868604;
RX   PubMed=3475907;
RX   PubMed=3670314;
RX   PubMed=6327870;
RX   PubMed=7836899;
RX   PubMed=7912172;
RX   PubMed=8761378;
RX   PubMed=9709917;
RX   PubMed=20151827;
RX   PubMed=21087161;
CC   Group: Patented cell line.
CC   Group: Space-flown cell line (cellonaut).
CC   Problematic cell line: Probably misclassified/misidentified. ECACC has discontinued this cell line because it does not display the non-diploid karyotype originally reported therefore its authenticity cannot be assured.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8305.
CC   Doubling time: 34 hours (CelloPub=CLPUB00429); 30 hours (PubMed=3670314).
CC   Anecdotal: Have been flown in space on the ISS in 2005 to study the effect of UVC radiation (PubMed=21087161).
CC   Discontinued: ECACC; 91030711; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5753 ! FRTL
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   FRTL-5 AG1
AC   CVCL_UG77
SY   AG1
DR   Wikidata; Q93556668
RX   PubMed=2545492;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   FRTL-5 AG2
AC   CVCL_UG78
SY   AG2
DR   Wikidata; Q93556674
RX   PubMed=2545492;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   FRTL-5 H-RAS(V12) clone V13
AC   CVCL_E5TV
SY   V13
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 H-RAS(V12) clone V26
AC   CVCL_E5TW
SY   V26
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 H-RAS(V12) clone V27
AC   CVCL_E5TX
SY   V27
RX   PubMed=15388794;
RX   PubMed=27125250;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 H-RAS(V12) clone V29
AC   CVCL_E5TY
SY   V29; FRTL5-Ras-V29; FRTL5-Ras clone V29; FRTL5-Ras
RX   PubMed=15388794;
RX   PubMed=27125250;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 H-RAS(V12) clone V30
AC   CVCL_E5TZ
SY   V30
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 H-RAS(V12) clone V31
AC   CVCL_E5U0
SY   V31
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 H-RAS(V12) clone V32
AC   CVCL_E5U1
SY   V32
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 Miami
AC   CVCL_VG49
DR   Wikidata; Q54835181
RX   CelloPub=CLPUB00430;
RX   PubMed=1846098;
CC   Karyotypic information: Near tetraploid karyotype.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 10
//
ID   FRTL-5 v-Ha-RAS clone H31
AC   CVCL_E5U2
SY   H31
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 v-Ha-RAS clone H35
AC   CVCL_E5U3
SY   H35
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 v-Ha-RAS clone H45
AC   CVCL_E5U4
SY   H45
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 v-Ha-RAS clone H6
AC   CVCL_E5U5
SY   H6
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 v-Ki-RAS clone K1
AC   CVCL_E5U6
SY   K1
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 v-Ki-RAS clone K2
AC   CVCL_E5U7
SY   K2
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 v-Ki-RAS clone K28
AC   CVCL_E5U8
SY   K28
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5 v-Ki-RAS clone K37
AC   CVCL_E5U9
SY   K37
RX   PubMed=15388794;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL-5/T
AC   CVCL_A6IJ
DR   Wikidata; Q107115080
RX   PubMed=1694496;
RX   PubMed=8761378;
CC   Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5 in C3H nu/nu nude mice (PubMed=1694496).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0265 ! FRTL-5
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FRTL-5/TA
AC   CVCL_A6IK
DR   Wikidata; Q107115081
RX   PubMed=1694496;
RX   PubMed=8761378;
CC   Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5/T in C3H nu/nu nude mice (PubMed=1694496).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6IJ ! FRTL-5/T
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FRTL-5/TP
AC   CVCL_A6IL
DR   Wikidata; Q107115082
RX   PubMed=1694496;
RX   PubMed=8761378;
CC   Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5/T in C3H nu/nu nude mice (PubMed=1694496).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6IJ ! FRTL-5/T
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   FRTL-Tc
AC   CVCL_J436
DR   Wikidata; Q54835182
RX   PubMed=1968381;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5753 ! FRTL
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   FRTL5-Ras-Backbone Vector clone 8
AC   CVCL_E5UE
SY   FR-BV8; BV8
RX   PubMed=27125250;
RX   PubMed=30744101;
CC   Characteristics: Control cell line for the FRTL5-Ras-PATZ1 cell lines (PubMed=27125250).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E5TY ! FRTL-5 H-RAS(V12) clone V29
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL5-Ras-Backbone Vector clone 9
AC   CVCL_E5UF
SY   FR-BV9
RX   PubMed=27125250;
CC   Characteristics: Control cell line for the FRTL5-Ras-PATZ1 cell lines (PubMed=27125250).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E5TY ! FRTL-5 H-RAS(V12) clone V29
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL5-Ras-Backbone Vector clone MP
AC   CVCL_E5UG
SY   FR-BVMP; BVMP
RX   PubMed=27125250;
RX   PubMed=30744101;
CC   Characteristics: Control cell line for the FRTL5-Ras-PATZ1 cell lines (PubMed=27125250).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E5TY ! FRTL-5 H-RAS(V12) clone V29
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL5-Ras-PATZ1 clone 22
AC   CVCL_E5UB
SY   FR-PA22
RX   PubMed=27125250;
RX   PubMed=30744101;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13071; PATZ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E5TY ! FRTL-5 H-RAS(V12) clone V29
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL5-Ras-PATZ1 clone 28
AC   CVCL_E5UC
SY   FR-PA28
RX   PubMed=27125250;
RX   PubMed=30744101;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13071; PATZ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E5TY ! FRTL-5 H-RAS(V12) clone V29
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FRTL5-Ras-PATZ1 clone 33
AC   CVCL_E5UD
SY   FR-PA33
DR   ABM; T6116
RX   PubMed=27125250;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13071; PATZ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E5TY ! FRTL-5 H-RAS(V12) clone V29
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   FS
AC   CVCL_ZD48
DR   Wikidata; Q98126266
RX   PubMed=8105609;
RX   PubMed=12920029;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   FS 6
AC   CVCL_CW15
SY   FS6
DR   ATCC; CRL-3099
DR   Wikidata; Q54835183
RX   PubMed=17952114;
CC   Characteristics: Provides a powerful and convenient model for assaying potential tumor promoters and for testing potential antitumor and antiproliferative agents that might act on the v-Ha-ras pathways (ATCC=CRL-3099).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: Activated HRAS.
CC   Breed/subspecies: BALB/c F1 Tg.AC transgenic.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   FS-1 [Human EBV-transformed]
AC   CVCL_WD55
DR   IBRC; C10111
DR   Wikidata; Q93556708
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-1 [Human leukemia]
AC   CVCL_2907
SY   FS-A
DR   BioSample; SAMN03472797
DR   JCRB; IFO50477
DR   Wikidata; Q54835184
RX   PubMed=8724543;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FS-1
CC   Population: Japanese.
CC   Doubling time: ~7 days (PubMed=8724543).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): JCRB=IFO50477
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   FS-1 [Human maxillary sinus SCC]
AC   CVCL_W511
DR   cancercelllines; CVCL_W511
DR   IARC_TP53; 28404
DR   Wikidata; Q54835185
RX   PubMed=7591301;
RX   PubMed=7872892;
RX   PubMed=10741724;
CC   Population: Japanese.
CC   Doubling time: 72 hours (Note=At 9th passage) (PubMed=7872892).
CC   HLA typing: A*02:06,24:02 (PubMed=10741724).
CC   HLA typing: A*09,28; B*48,54; C*01,04 (PubMed=7872892).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=10741724).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   FS-11
AC   CVCL_C762
SY   FS11; ForeSkin-11
DR   Wikidata; Q54835186
RX   PubMed=467436;
RX   PubMed=2580922;
RX   PubMed=7173401;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8D
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   FS-13
AC   CVCL_WD56
DR   IBRC; C10131
DR   Wikidata; Q93556736
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-133
AC   CVCL_6965
SY   ForeSkin-133
DR   Wikidata; Q54835187
RX   PubMed=9658180;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   FS-14
AC   CVCL_WD57
DR   IBRC; C10132
DR   Wikidata; Q93556749
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-15
AC   CVCL_WD58
DR   IBRC; C10133
DR   Wikidata; Q93556752
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-162
AC   CVCL_WD59
DR   IBRC; C10222
DR   Wikidata; Q93556753
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-163
AC   CVCL_WD60
DR   IBRC; C10236
DR   Wikidata; Q93556757
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-167
AC   CVCL_WD61
DR   IBRC; C10252
DR   Wikidata; Q93556759
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-169
AC   CVCL_WD62
DR   IBRC; C10225
DR   Wikidata; Q93556763
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-171
AC   CVCL_WD63
DR   IBRC; C10271
DR   Wikidata; Q93556767
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-174
AC   CVCL_WD64
DR   IBRC; C10253
DR   Wikidata; Q93556769
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-179
AC   CVCL_WD65
DR   IBRC; C10229
DR   Wikidata; Q93556773
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-185
AC   CVCL_WD66
DR   IBRC; C10246
DR   Wikidata; Q93556775
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-186
AC   CVCL_WD67
DR   IBRC; C10321
DR   Wikidata; Q93556780
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-187
AC   CVCL_WD68
DR   IBRC; C10322
DR   Wikidata; Q93556784
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-189
AC   CVCL_WD69
DR   IBRC; C10324
DR   Wikidata; Q93556786
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-190
AC   CVCL_WD70
DR   IBRC; C10325
DR   Wikidata; Q93556790
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-195
AC   CVCL_WD71
DR   IBRC; C10355
DR   Wikidata; Q93556792
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-196
AC   CVCL_WD72
DR   IBRC; C10356
DR   Wikidata; Q93556797
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-199
AC   CVCL_WD73
DR   IBRC; C10359
DR   Wikidata; Q93556800
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-2
AC   CVCL_WD74
DR   IBRC; C10112
DR   Wikidata; Q93556803
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-200
AC   CVCL_WD75
DR   IBRC; C10368
DR   Wikidata; Q93556806
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-203
AC   CVCL_WD76
DR   IBRC; C10366
DR   Wikidata; Q93556809
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-204
AC   CVCL_WD77
DR   IBRC; C10369
DR   Wikidata; Q93556812
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-205
AC   CVCL_WD78
DR   IBRC; C10410
DR   Wikidata; Q93556815
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-206
AC   CVCL_WD79
DR   IBRC; C10381
DR   Wikidata; Q93556818
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-207
AC   CVCL_WD80
DR   IBRC; C10379
DR   Wikidata; Q93556822
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-209
AC   CVCL_WD81
DR   IBRC; C10382
DR   Wikidata; Q93556825
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-21
AC   CVCL_WD82
DR   IBRC; C10134
DR   Wikidata; Q93556828
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-210
AC   CVCL_WD83
DR   IBRC; C10383
DR   Wikidata; Q93556831
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-212
AC   CVCL_WD84
DR   IBRC; C10385
DR   Wikidata; Q93556835
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-219
AC   CVCL_WD85
DR   IBRC; C10392
DR   Wikidata; Q93556837
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-22
AC   CVCL_WD86
DR   IBRC; C10120
DR   Wikidata; Q93556840
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-220
AC   CVCL_WD87
DR   IBRC; C10393
DR   Wikidata; Q93556841
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-222
AC   CVCL_WD88
DR   IBRC; C10395
DR   Wikidata; Q93556844
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-226
AC   CVCL_WD89
DR   IBRC; C10458
DR   Wikidata; Q93556848
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-236
AC   CVCL_WD90
DR   IBRC; C10500
DR   Wikidata; Q93556850
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-290
AC   CVCL_WD91
DR   IBRC; C10639
DR   Wikidata; Q93556853
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-295
AC   CVCL_WD92
DR   IBRC; C10713
DR   Wikidata; Q93556856
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-3 [Human EBV-transformed]
AC   CVCL_WD93
DR   IBRC; C10113
DR   Wikidata; Q93556859
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-3 [Human foreskin]
AC   CVCL_VS58
SY   ForeSkin-3
DR   Wikidata; Q93556862
RX   PubMed=4670440;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   FS-300
AC   CVCL_WD94
DR   IBRC; C10763
DR   Wikidata; Q93556865
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-302
AC   CVCL_WD95
DR   IBRC; C10794
DR   Wikidata; Q93556866
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-308
AC   CVCL_WD96
DR   IBRC; C10799
DR   Wikidata; Q93556869
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-311
AC   CVCL_WD97
DR   IBRC; C10766
DR   Wikidata; Q93556873
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-312
AC   CVCL_WD98
DR   IBRC; C10765
DR   Wikidata; Q93556877
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-315
AC   CVCL_WD99
DR   IBRC; C10807
DR   Wikidata; Q93556879
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-318
AC   CVCL_WE00
DR   IBRC; C10795
DR   Wikidata; Q93556882
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-321
AC   CVCL_WE01
DR   IBRC; C10802
DR   Wikidata; Q93556886
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-325
AC   CVCL_WE02
DR   IBRC; C10809
DR   Wikidata; Q93556887
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-328
AC   CVCL_WE03
DR   IBRC; C10789
DR   Wikidata; Q93556892
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-329 [1st copy]
AC   CVCL_WE05
DR   IBRC; C10779
DR   Wikidata; Q93556895
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There are two cell lines named FS-329 at IBRC.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-329 [2nd copy]
AC   CVCL_WE04
DR   IBRC; C10792
DR   Wikidata; Q93556897
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There are two cell lines named FS-329 at IBRC.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-336
AC   CVCL_WE06
DR   IBRC; C10776
DR   Wikidata; Q93556899
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-337
AC   CVCL_WE07
DR   IBRC; C10753
DR   Wikidata; Q93556904
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-339
AC   CVCL_WE08
DR   IBRC; C10758
DR   Wikidata; Q93556907
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-340
AC   CVCL_WE09
DR   IBRC; C10751
DR   Wikidata; Q93556910
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-341
AC   CVCL_WE10
DR   IBRC; C10772
DR   Wikidata; Q93556913
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-344
AC   CVCL_WE11
DR   IBRC; C10845
DR   Wikidata; Q93556916
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-4 [Human EBV-transformed]
AC   CVCL_WE12
DR   IBRC; C10114
DR   Wikidata; Q93556919
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   FS-4 [Human foreskin]
AC   CVCL_0266
SY   FS4; ForeSkin-4
DR   MCCL; MCC:0000157
DR   Wikidata; Q54835188
RX   PubMed=81646;
RX   PubMed=227987;
RX   PubMed=291901;
RX   PubMed=6159644;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   FS-42
AC   CVCL_WE13
DR   IBRC; C10162
DR   Wikidata; Q93556932
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-7
AC   CVCL_C761
SY   FS7; ForeSkin-7
DR   Wikidata; Q54835189
RX   PubMed=6159644;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   FS-8
AC   CVCL_WE14
DR   IBRC; C10118
DR   Wikidata; Q93556945
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-9
AC   CVCL_WE15
DR   IBRC; C10130
DR   Wikidata; Q93556947
RX   PubMed=32358742;
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   FS-Balb
AC   CVCL_5754
DR   CLS; 400272
DR   Wikidata; Q54835190
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   FS-C3H
AC   CVCL_5755
DR   CLS; 400418
DR   Wikidata; Q54835191
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   FS-C57BL
AC   CVCL_5756
DR   CLS; 400420
DR   Wikidata; Q54835192
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   FS-M1
AC   CVCL_AS90
DR   Wikidata; Q54835193
RX   PubMed=8083436;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 14 hours (PubMed=8083436).
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   FS-SC-1
AC   CVCL_V014
SY   FS I
DR   Wikidata; Q54835194
RX   PubMed=21527782;
CC   Breed/subspecies: European shorthair; VBO=VBO_0100063.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   FS-SC-2
AC   CVCL_V015
SY   FS II
DR   Wikidata; Q54835195
RX   PubMed=21527782;
CC   Breed/subspecies: European shorthair; VBO=VBO_0100063.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   FS-SC-3
AC   CVCL_V016
SY   FS III
DR   Wikidata; Q54835196
RX   PubMed=21527782;
CC   Breed/subspecies: European shorthair; VBO=VBO_0100063.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   12-13Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   FS-SC-4
AC   CVCL_V017
SY   FS IV
DR   Wikidata; Q54835197
RX   PubMed=21527782;
CC   Breed/subspecies: European shorthair; VBO=VBO_0100063.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   FS-SC-5
AC   CVCL_V018
SY   FS V
DR   Wikidata; Q54835198
RX   PubMed=21527782;
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   FS/D1h
AC   CVCL_U365
DR   Wikidata; Q54835199
RX   PubMed=12538636;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Cell type: Folliculostellate cell; CL=CL_0000642.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   FS1
AC   CVCL_C8X2
DR   GEO; GSM5209347
DR   GEO; GSM5209348
DR   GEO; GSM5209349
DR   GEO; GSM5209350
DR   GEO; GSM5209351
DR   GEO; GSM5209352
DR   GEO; GSM5209353
DR   GEO; GSM5209354
DR   Wikidata; Q123031314
RX   PubMed=18271004;
RX   PubMed=27688058;
RX   PubMed=34153645;
RX   PubMed=36899312;
CC   Characteristics: Homogenous cell morphology with prominent nucleoli and long cytoplasmic processes. Expresses WT1 and show reversion of the WT1+-KTS isoform ratio. Expresses Sertoli cell markers SOX9, MIC2, AR and INHA. Strongly positive for vimentin, which is expressed in Sertoli cells. Negative for the germ cell marker VASA1 and for the Leydig cell marker LHCGR (Direct_author_submission).
CC   Karyotypic information: 46,XY (PubMed=18271004).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; c.1447+5G>A (IVS9+5G>A); ClinVar=VCV000003493; Zygosity=Heterozygous (PubMed=18271004).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Detailed characteristics from personal communication of Schulz, Birte.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
DI   NCIt; C122805; Frasier syndrome
DI   ORDO; Orphanet_347; Frasier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   FS6-14.13
AC   CVCL_C6VM
DR   Wikidata; Q117704340
RX   PubMed=6968339;
CC   Characteristics: T-cell hybridoma. Produces IL2 when stimulated by concanavalin A (ConA) (PubMed=6968339).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   FS6-14.13 Ag2.1
AC   CVCL_M112
SY   FS6-14.13.AG2
DR   ECACC; 85082303
DR   Wikidata; Q54835201
RX   PubMed=6166712;
RX   PubMed=32419056;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: T-cell hybridoma. Produces IL2 when stimulated by concanavalin A (ConA) (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6VM ! FS6-14.13
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 6
//
ID   FS6-14.13.AG2.OU8
AC   CVCL_C6VN
DR   Wikidata; Q117704341
RX   PubMed=6166712;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: T-cell hybridoma. Produces IL2 when stimulated by concanavalin A (ConA) (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M112 ! FS6-14.13 Ag2.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   FS7-20
AC   CVCL_C4TV
DR   Wikidata; Q116049041
RX   PubMed=6223094;
CC   Characteristics: T-cell hybridoma. Produces IL2, IL10, IFNG, macrophage-activating factor (MAF) and Ia induction factor (IaIF) when stimulated by concanavalin A (ConA) (PubMed=6223094).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FS7-20.12
AC   CVCL_C4TW
DR   Wikidata; Q116049042
RX   PubMed=6197379;
RX   PubMed=6223094;
CC   Characteristics: T-cell hybridoma. Produces IL2, IL10, IFNG, macrophage-activating factor (MAF) and Ia induction factor (IaIF) when stimulated by concanavalin A (ConA). Compared to the parent cell line, produces relatively high level of IL2 and undectable quantity of the four other lymphokines (PubMed=6223094).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4TV ! FS7-20
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FS7-20.22
AC   CVCL_C4TX
DR   Wikidata; Q116049043
RX   PubMed=6223094;
CC   Characteristics: T-cell hybridoma. Compared to the parent cell line, does not produce any detectable quantity of lymphokines (PubMed=6223094).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4TV ! FS7-20
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FS7-20.3
AC   CVCL_C4TY
DR   Wikidata; Q116049044
RX   PubMed=6223094;
CC   Characteristics: T-cell hybridoma. Produces IL2, IL10, IFNG, macrophage-activating factor (MAF) and Ia induction factor (IaIF) when stimulated by concanavalin A (ConA) (PubMed=6223094).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4TV ! FS7-20
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FS7-20.5
AC   CVCL_C4TZ
DR   Wikidata; Q116049045
RX   PubMed=6223094;
CC   Characteristics: T-cell hybridoma. Produces IL2, IL10, IFNG, macrophage-activating factor (MAF) and Ia induction factor (IaIF) when stimulated by concanavalin A (ConA). Compared to the parent cell line, produces relatively little IL2 (PubMed=6223094).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4TV ! FS7-20
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FS7-20.6
AC   CVCL_C4U0
DR   Wikidata; Q116049046
RX   PubMed=6223094;
CC   Characteristics: T-cell hybridoma. Produces IL2, IL10, IFNG, macrophage-activating factor (MAF) and Ia induction factor (IaIF) when stimulated by concanavalin A (ConA) (PubMed=6223094).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4TV ! FS7-20
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FS7-20.6.18
AC   CVCL_C4U1
DR   Wikidata; Q116049047
RX   PubMed=6197379;
RX   PubMed=6223094;
CC   Characteristics: T-cell hybridoma. Produces IL2, IL10, IFNG, macrophage-activating factor (MAF) and Ia induction factor (IaIF) when stimulated by concanavalin A (ConA). Produces high level of IFNG (PubMed=6223094).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4U0 ! FS7-20.6
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   FSA0001
AC   CVCL_E4YN
SY   FSA-00001
DR   GEO; GSM7036156
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   FSA0002
AC   CVCL_E4YP
SY   FSA-00002
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   FSA0004
AC   CVCL_E4YQ
SY   FSA-00004
DR   GEO; GSM7036157
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   FSA0005
AC   CVCL_E4YR
SY   FSA-00005
RX   PubMed=30267684;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   FSA0006
AC   CVCL_E4YS
SY   FSA-00006
DR   GEO; GSM7036172
DR   GEO; GSM7043202
DR   GEO; GSM7043203
DR   GEO; GSM7043204
DR   GEO; GSM7043205
DR   GEO; GSM7043206
DR   GEO; GSM7043207
DR   GEO; GSM7043208
DR   GEO; GSM7043209
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   FSA0010
AC   CVCL_E4YT
SY   FSA-00010
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FSA0012
AC   CVCL_E4YU
SY   FSA-00012
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FSA0013
AC   CVCL_E4YV
SY   FSA-00013
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FSA0019
AC   CVCL_E4YW
SY   FSA-00019
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FSA0024
AC   CVCL_E4YX
SY   FSA-00024
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FSA0026
AC   CVCL_E4YY
SY   FSA-00026
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FSA0027
AC   CVCL_E4YZ
SY   FSA-00027
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   FSCP-1
AC   CVCL_M616
AS   CVCL_D606
SY   Fscp-1; FS090; FS
DR   Cosmic; 848244
DR   Wikidata; Q54835202
RX   PubMed=8689637;
RX   PubMed=10632461;
RX   PubMed=10906887;
RX   PubMed=11854598;
RX   PubMed=12168675;
RX   PubMed=12354749;
RX   PubMed=15547702;
CC   Doubling time: 36-48 hours (PubMed=15547702).
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 12
//
ID   FSCSC
AC   CVCL_A0WT
SY   Feline Synovial Cell Sarcoma Cell line
DR   Wikidata; Q108820240
RX   PubMed=25901004;
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Right hindlimb, synovium; UBERON=UBERON_0002103+UBERON_0007616.
DI   NCIt; C181658; Feline synovial cell sarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   2-3Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FSD1/F4
AC   CVCL_9R58
SY   FSD1-F4; FSD-1-F4; FSD-1 clone F4; F4
DR   Wikidata; Q54835203
RX   PubMed=4507803;
RX   PubMed=4514957;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   FSDC
AC   CVCL_VS59
SY   Fetal Skin Dendritic Cell line
DR   Wikidata; Q93557049
RX   PubMed=7664779;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-517.html
CC   Transformant: Env(AKR)-Myc(MH2).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   17-19FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   FSHDCl17
AC   CVCL_6B27
DR   Wikidata; Q54835204
RX   PubMed=22040608;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 2 repeats) (PubMed=22040608).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Subscapularis muscle; UBERON=UBERON_0001129.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   27Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   FSHR-18
AC   CVCL_E977
DR   CLO; CLO_0003399
DR   ATCC; CRL-2688
DR   Wikidata; Q54835205
RX   PubMed=8634264;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23945; Human FSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   FSHR-323
AC   CVCL_E978
SY   FSHR 323
DR   CLO; CLO_0003400
DR   ATCC; CRL-2689
DR   Wikidata; Q54835206
RX   PubMed=8634264;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P23945; Human FSHR.
CC   Discontinued: ATCC; CRL-2689; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   FSI
AC   CVCL_B7M4
DR   Wikidata; Q112929569
RX   PubMed=10395672;
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln321Ter (c.961C>T); Zygosity=Heterozygous (PubMed=10395672).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   FSkMEC
AC   CVCL_A1CR
SY   F Sk MEC; Feline Skin Microvascular Endothelial Cells
DR   Wikidata; Q102113857
RX   Patent=US9228173;
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4254.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FSP
AC   CVCL_R899
SY   Flounder SPleen
DR   Wikidata; Q54835207
RX   CelloPub=CLPUB00463;
RX   PubMed=14710758;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   Fsp 62891
AC   CVCL_S457
DR   ATCC; CRL-10935
DR   BioSample; SAMN03471323
DR   Wikidata; Q54835208
RX   Patent=US5283354;
RX   Patent=US5621090;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10935.
CC   Discontinued: ATCC; CRL-10935; true.
ST   Source(s): ATCC=CRL-10935
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10,12,13
ST   D13S317: 8,11,14
ST   D16S539: 11,12,13
ST   D5S818: 12
ST   D7S820: 8,9,11,12
ST   TH01: 6,7,8,9.3
ST   TPOX: 8,9,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   FT
AC   CVCL_4203
SY   Frog Tongue
DR   CLO; CLO_0003401
DR   CLDB; cl1397
DR   ATCC; CCL-41
DR   ECACC; 90102525
DR   Wikidata; Q54835211
RX   DOI=10.1007/BF02618370;
RX   PubMed=14169344;
CC   Group: Amphibian cell line.
CC   Karyotypic information: Near triploid karyoty (PubMed=14169344).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
OX   NCBI_TaxID=8400; ! Aquarana catesbeiana (American bullfrog)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   FT-1
AC   CVCL_J508
DR   Wikidata; Q54835212
RX   PubMed=2822586;
RX   PubMed=10976746;
RX   PubMed=18366545;
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   FT-1/ADM
AC   CVCL_J509
DR   Wikidata; Q54835213
RX   PubMed=10976746;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_J508 ! FT-1
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   FT-2
AC   CVCL_5123
SY   FT-2 (TK-)
DR   Wikidata; Q54835214
RX   PubMed=6203516;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5125 ! Fu5-5
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   FT-MZ-1
AC   CVCL_A2BS
DR   cancercelllines; CVCL_A2BS
DR   IARC_TP53; 3508
DR   Wikidata; Q105506921
RX   PubMed=7926016;
CC   Doubling time: 14 days (PubMed=7926016).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=7926016).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
DI   NCIt; C3867; Fallopian tube carcinoma
DI   ORDO; Orphanet_180242; Malignant tumor of fallopian tubes
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   FT190
AC   CVCL_UH57
AS   CVCL_B0A3
SY   hTERT FT190; hTERT FT 190
DR   ATCC; CRL-3444
DR   Wikidata; Q93557130
RX   PubMed=24332043;
RX   PubMed=26364602;
CC   Doubling time: ~32 hours (ATCC=CRL-3444).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   FT194
AC   CVCL_UH58
AS   CVCL_A4AW
SY   hTERT FT194; hTERT FT 194
DR   ATCC; CRL-3445
DR   Wikidata; Q93557134
RX   PubMed=24332043;
RX   PubMed=26364602;
CC   Doubling time: ~32 hours (ATCC=CRL-3445).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
ST   Source(s): ATCC=CRL-3445
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   FT194-MXIV
AC   CVCL_E3FJ
RX   PubMed=26364602;
CC   Characteristics: Control cell line for FT194-YAP (Cellosaurus=CVCL_E3FE) and FT194-YAP(S127A) (Cellosaurus=CVCL_E3FF) (PubMed=26364602).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UH58 ! FT194
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   FT194-YAP
AC   CVCL_E3FE
RX   PubMed=26364602;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UH58 ! FT194
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   FT194-YAP(S127A)
AC   CVCL_E3FF
SY   FT194-YAPS127A
RX   PubMed=26364602;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser127Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UH58 ! FT194
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   FT2-14
AC   CVCL_XA90
SY   FT 2-14
DR   CCRID; 4201PAT-CCTCC00061
DR   JCRB; IFO50180
DR   Wikidata; Q93557138
RX   DOI=10.1038/nbt1189-1163;
RX   Patent=US5506135;
RX   PubMed=2107601;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2158.
CC   Characteristics: This is a tetradoma, a fusion of two hybridomas.
CC   Monoclonal antibody target: UniProtKB; P02675; Human FGB.
CC   Monoclonal antibody target: UniProtKB; P00750; Human PLAT.
CC   Discontinued: JCRB; IFO50180; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA78 ! FIB1-11
HI   CVCL_XA82 ! TPA1-41
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   FT237
AC   CVCL_UH59
SY   hTERT FT237; hTERT FT 237
DR   ATCC; CRL-3446
DR   Wikidata; Q93557154
RX   PubMed=22936217;
RX   PubMed=26364602;
CC   Doubling time: ~32 hours (ATCC=CRL-3446).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   FT240
AC   CVCL_UH60
SY   hTERT FT240; hTERT FT 240
DR   ABM; T0762
DR   ATCC; CRL-3447
DR   Wikidata; Q93557159
RX   PubMed=22936217;
RX   PubMed=26364602;
CC   Doubling time: ~32 hours (ATCC=CRL-3447).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   FT246
AC   CVCL_UH61
SY   iFTSEC246; hTERT FT 246
DR   ATCC; CRL-3448
DR   GEO; GSM1663016
DR   GEO; GSM1663017
DR   GEO; GSM1663018
DR   GEO; GSM1663019
DR   GEO; GSM1663020
DR   GEO; GSM1663021
DR   GEO; GSM1663022
DR   GEO; GSM1663023
DR   Wikidata; Q93557163
RX   PubMed=22936217;
RX   PubMed=25804953;
RX   PubMed=26364602;
RX   PubMed=30487138;
CC   Doubling time: ~32 hours (ATCC=CRL-3448).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
ST   Source(s): ATCC=CRL-3448
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   FT246-MXIV
AC   CVCL_E3FI
RX   PubMed=26364602;
CC   Characteristics: Control cell line for FT246-YAP (Cellosaurus=CVCL_E3FG) and FT246-YAP(S127A) (Cellosaurus=CVCL_E3FH) (PubMed=26364602).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UH61 ! FT246
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   FT246-YAP
AC   CVCL_E3FG
RX   PubMed=26364602;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UH61 ! FT246
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   FT246-YAP(S127A)
AC   CVCL_E3FH
SY   FT246-YAPS127A
RX   PubMed=26364602;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser127Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UH61 ! FT246
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   FT282
AC   CVCL_A4AX
SY   hTERT FT282; hTERT FT 282
DR   ATCC; CRL-3449
DR   Wikidata; Q105506925
CC   Doubling time: ~32 hours (ATCC=CRL-3449).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
ST   Source(s): ATCC=CRL-3449
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   FT33-shp53-R24C
AC   CVCL_RK66
SY   FT33; iFTSEC33
DR   ABM; T0609
DR   GEO; GSM1663024
DR   GEO; GSM1663025
DR   GEO; GSM1663026
DR   GEO; GSM1663027
DR   GEO; GSM1663028
DR   GEO; GSM1663029
DR   GEO; GSM1663030
DR   GEO; GSM1663031
DR   Wikidata; Q54835216
RX   PubMed=21502498;
RX   PubMed=22936217;
RX   PubMed=25804953;
RX   PubMed=30487138;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Discontinued: ABM; T0609; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   FTC-133
AC   CVCL_1219
SY   FTC133
DR   BTO; BTO_0001889
DR   CLO; CLO_0003402
DR   CLDB; cl1398
DR   CLDB; cl1399
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471027
DR   BioSample; SAMN10987983
DR   cancercelllines; CVCL_1219
DR   CCRID; 1101HUM-PUMC000687
DR   Cell_Model_Passport; SIDM00213
DR   ChEMBL-Cells; CHEMBL3308732
DR   ChEMBL-Targets; CHEMBL1075445
DR   Cosmic; 906864
DR   Cosmic; 928831
DR   Cosmic; 1239976
DR   Cosmic; 1280044
DR   Cosmic; 1507371
DR   Cosmic; 1533556
DR   Cosmic; 1536124
DR   Cosmic; 1889011
DR   Cosmic; 2054103
DR   Cosmic; 2319848
DR   Cosmic; 2791091
DR   Cosmic-CLP; 906864
DR   DepMap; ACH-000903
DR   ECACC; 94060901
DR   EGA; EGAS00001000978
DR   GDSC; 906864
DR   GEO; GSM827308
DR   GEO; GSM887012
DR   GEO; GSM888081
DR   GEO; GSM1669794
DR   IARC_TP53; 21332
DR   ICLC; HTL97015
DR   LiGeA; CCLE_543
DR   LINCS_LDP; LCL-1677
DR   PharmacoDB; FTC133_368_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1219
DR   PubChem_Cell_line; CVCL_1219
DR   Wikidata; Q54835217
RX   PubMed=1384245;
RX   PubMed=1726925;
RX   PubMed=2247845;
RX   PubMed=14522906;
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23162534;
RX   PubMed=23833040;
RX   PubMed=23866977;
RX   PubMed=24196587;
RX   PubMed=25675381;
RX   PubMed=25877200;
RX   PubMed=25930030;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29066502;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=34445479;
RX   PubMed=35839778;
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Has a near-homozygous genome (NHG) (PubMed=29066502).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02; DQA1*01:02,01:02; DQB1*06:01,06:01; DRB1*03:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.His429Thrfs*39 (c.1285delC); ClinVar=VCV000003364; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1045fs (c.3135delG); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Cys167Ter (c.501T>A); ClinVar=VCV001048706; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (PubMed=23162534; PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Homozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=14522906; PubMed=23162534; PubMed=30737244).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.29%; Native American=1.18%; East Asian, North=4.32%; East Asian, South=0%; South Asian=0%; European, North=56.94%; European, South=36.26% (PubMed=30894373).
CC   Anecdotal: Have been flown in space on Shenzhou-8 and on the ISS to study growth in microgravity (PubMed=23866977; PubMed=24196587; PubMed=25930030).
CC   Misspelling: FTC-113; Cosmic=1889011.
CC   Misspelling: CFT-133; PubMed=1384245; Note=In the French and Spanish abstracts where the abbreviation 'FTC' was translated to 'CFT' and thus also the cell line names.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=906864; ECACC=94060901; PubMed=18713817; PubMed=25877200; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10 (Cosmic-CLP=906864; ECACC=94060901; PubMed=25877200)
ST   CSF1PO: 10,11 (PubMed=30737244)
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 11,12
ST   D19S433: 12,13
ST   D21S11: 32.2
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 11,12 (PubMed=30737244)
ST   D5S818: 12 (Cosmic-CLP=906864; ECACC=94060901; PubMed=18713817; PubMed=25877200)
ST   D7S820: 9,10 (Cosmic-CLP=906864; ECACC=94060901; PubMed=18713817; PubMed=30737244)
ST   D7S820: 10 (PubMed=25877200)
ST   D8S1179: 10
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 13
ST   TH01: 6.1,9.3 (PubMed=25877200)
ST   TH01: 9.3 (Cosmic-CLP=906864; ECACC=94060901; PubMed=30737244)
ST   TPOX: 9
ST   vWA: 15,18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2446 ! FTC-236
OI   CVCL_2447 ! FTC-238
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   FTC-236
AC   CVCL_2446
SY   FTC236
DR   BTO; BTO_0003875
DR   cancercelllines; CVCL_2446
DR   Cell_Model_Passport; SIDM00229
DR   Cosmic; 1239977
DR   ECACC; 06030202
DR   Wikidata; Q54835218
RX   PubMed=1384245;
RX   PubMed=29066502;
RX   PubMed=30737244;
RX   PubMed=31443247;
CC   Population: Caucasian.
CC   Characteristics: Has a near-homozygous genome (NHG) (PubMed=29066502).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1045fs (c.3135delG); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Homozygous; Note=In promoter (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: CFT-236; PubMed=1384245; Note=In the French and Spanish abstracts where the abbreviation 'FTC' was translated to 'CFT' and thus also the cell line names.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): ECACC=06030202; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 11,12
ST   D21S11: 32.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 15,18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1219 ! FTC-133
OI   CVCL_2447 ! FTC-238
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   FTC-238
AC   CVCL_2447
SY   FTC238
DR   CLO; CLO_0003403
DR   CLDB; cl1400
DR   CLDB; cl1401
DR   AddexBio; C0025001/38
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470981
DR   BioSample; SAMN10987981
DR   cancercelllines; CVCL_2447
DR   Cell_Model_Passport; SIDM00228
DR   Cosmic; 1239978
DR   DepMap; ACH-000897
DR   ECACC; 94060902
DR   GEO; GSM827316
DR   IARC_TP53; 27013
DR   ICLC; HTL96003
DR   LiGeA; CCLE_558
DR   LINCS_LDP; LCL-1678
DR   PharmacoDB; FTC238_369_2019
DR   Progenetix; CVCL_2447
DR   TOKU-E; 4078
DR   Wikidata; Q54835219
RX   PubMed=1384245;
RX   PubMed=14522906;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29066502;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/ftc-238-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Highly invasive.
CC   Characteristics: Has a near-homozygous genome (NHG) (PubMed=29066502).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1045fs (c.3135delG); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Homozygous (PubMed=30737244; DepMap=ACH-000897).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Homozygous; Note=In promoter (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=14522906; PubMed=30737244).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.72%; Native American=2.05%; East Asian, North=2%; East Asian, South=0%; South Asian=0%; European, North=60.8%; European, South=33.42% (PubMed=30894373).
CC   Misspelling: CFT-238; PubMed=1384245; Note=In the French and Spanish abstracts where the abbreviation 'FTC' was translated to 'CFT' and thus also the cell line names.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ECACC=94060902; PubMed=25877200; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 11,12
ST   D19S433: 13
ST   D21S11: 32.2
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 13
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 15,18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1219 ! FTC-133
OI   CVCL_2446 ! FTC-236
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   FTD1#1-iPSC
AC   CVCL_ZI75
DR   Wikidata; Q98126267
RX   PubMed=25556567;
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; c.-8+5G>C (IVS1+5G>C) (g-3826G>C); ClinVar=VCV000098119; Zygosity=Unspecified (PubMed=25556567).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   FTD142
AC   CVCL_ZC68
SY   fFTD line 142; SHF-142
DR   Wikidata; Q98126270
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FTD2#5-iPSC
AC   CVCL_ZI76
DR   Wikidata; Q98126271
RX   PubMed=25556567;
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; c.-8+5G>C (IVS1+5G>C) (g-3826G>C); ClinVar=VCV000098119; Zygosity=Unspecified (PubMed=25556567).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   FTD2E1
AC   CVCL_RH62
SY   FTLD-Tau1
DR   SKIP; SKIP001265
DR   Wikidata; Q54835220
RX   PubMed=27721502;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+14C>T (c.2091+14C>T) (c.1866+14C>T) (c.915+14C>T) (c.828+14C>T) (IVS10+14C>T); ClinVar=VCV000014248; Zygosity=Unspecified (PubMed=27721502).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   FTD2E1 corrected 36-20
AC   CVCL_RH63
SY   FTLD-Tau1 corrected
DR   SKIP; SKIP001266
DR   Wikidata; Q54835221
RX   PubMed=27721502;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; c.1920+14C>T (c.2091+14C>T) (c.1866+14C>T) (c.915+14C>T) (c.828+14C>T) (IVS10+14C>T); ClinVar=VCV000014248; Zygosity=Unspecified; Note=By CRISPR/Cas9 (PubMed=27721502).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH62 ! FTD2E1
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   FTD3#6-iPSC
AC   CVCL_ZI77
DR   Wikidata; Q98126272
RX   PubMed=25556567;
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; c.-8+5G>C (IVS1+5G>C) (g-3826G>C); ClinVar=VCV000098119; Zygosity=Unspecified (PubMed=25556567).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   FTD3#6-PGRN
AC   CVCL_ZI78
DR   Wikidata; Q98126273
RX   PubMed=25556567;
CC   Characteristics: Using ZFN GRN was introduced in the AAVS1 safe harbor locus.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; c.-8+5G>C (IVS1+5G>C) (g-3826G>C); ClinVar=VCV000098119; Zygosity=Unspecified (PubMed=25556567).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:4601; GRN.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI77 ! FTD3#6-iPSC
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   FTD3009
AC   CVCL_ZC69
SY   fFTD line 3009
DR   Wikidata; Q98126274
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FTD3678
AC   CVCL_ZC70
SY   fFTD line 3678
DR   Wikidata; Q98126275
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FTD3682
AC   CVCL_ZC71
SY   fFTD line 3682
DR   Wikidata; Q98126277
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   FTDP-17-1-I
AC   CVCL_A9R2
DR   Wikidata; Q102113858
RX   PubMed=26143746;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (PubMed=26143746).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY37 ! ND32945
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FTDP-17-1-II
AC   CVCL_A9R3
DR   Wikidata; Q102113859
RX   PubMed=26143746;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (PubMed=26143746).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY37 ! ND32945
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   FTDP-17-2-I
AC   CVCL_A9R4
DR   Wikidata; Q102113860
RX   PubMed=26143746;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (PubMed=26143746).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY39 ! ND32951
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   FTDP-17-2-II
AC   CVCL_A9R5
DR   Wikidata; Q102113861
RX   PubMed=26143746;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (PubMed=26143746).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY39 ! ND32951
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   FTE01
AC   CVCL_C3H3
DR   Wikidata; Q114311476
RX   PubMed=24070420;
CC   Donor information: Established from a patient suffering from a mucinous cyst on the left ovary.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   FTE02
AC   CVCL_C3H4
SY   FTSEC02
DR   GEO; GSM1240674
DR   GEO; GSM1240675
DR   GEO; GSM1240680
DR   GEO; GSM1240681
DR   GEO; GSM1240686
DR   GEO; GSM1240687
DR   Wikidata; Q114311477
RX   PubMed=24070420;
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a patient suffering from a benign fibrosis.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   FTE03
AC   CVCL_C3H5
SY   FTSEC03
DR   GEO; GSM1240676
DR   GEO; GSM1240677
DR   GEO; GSM1240682
DR   GEO; GSM1240683
DR   GEO; GSM1240688
DR   GEO; GSM1240689
DR   Wikidata; Q114311478
RX   PubMed=24070420;
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a patient suffering from fibroid adenomyosis.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   FTE05
AC   CVCL_C3H6
SY   FTSEC05
DR   Wikidata; Q114311479
RX   PubMed=24070420;
CC   Karyotypic information: 46,XX,t(6;6)(p21;q21) (PubMed=24070420).
CC   Donor information: Established from a patient suffering from a complex hyperplasia with atypia.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   FTE283
AC   CVCL_C3H7
SY   FTSEC283
DR   GEO; GSM1240678
DR   GEO; GSM1240679
DR   GEO; GSM1240684
DR   GEO; GSM1240685
DR   GEO; GSM1240690
DR   GEO; GSM1240691
DR   Wikidata; Q114311480
RX   PubMed=24070420;
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a patient suffering from a grade 2-3 endometrial cancer.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   FTE284
AC   CVCL_C3H8
SY   FTSEC284
DR   Wikidata; Q114311481
RX   PubMed=24070420;
CC   Donor information: Established from a patient with history of endometrial cancer.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   FtGB
AC   CVCL_B7Q8
SY   Fantail Goldfish Brain
DR   Wikidata; Q112929570
RX   PubMed=33556411;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=33556411).
CC   Doubling time: 79.79 hours (PubMed=33556411).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fantail; VBO=VBO_0017499.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   FtGF
AC   CVCL_A8S3
SY   Fantail Goldfish Fin
DR   NRFC; NRFC058
DR   Wikidata; Q102113862
RX   PubMed=33005480;
WW   Provider; NRFC; NRFC058; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC058.
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=33005480).
CC   Doubling time: 33.9 hours (Note=At 25th passage) (PubMed=33005480).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: Fantail; VBO=VBO_0017499.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   FtGG
AC   CVCL_B7Q9
SY   Fantail Goldfish Gill
DR   NRFC; NRFC083
DR   Wikidata; Q112929571
RX   PubMed=33556411;
WW   Provider; NRFC; NRFC083; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC083.
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=33556411).
CC   Doubling time: 41.47 hours (PubMed=33556411).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Breed/subspecies: Fantail; VBO=VBO_0017499.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   FtGL
AC   CVCL_B7QA
SY   Fantail Goldfish Liver
DR   Wikidata; Q112929572
RX   PubMed=33556411;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=33556411).
CC   Doubling time: 63.43 hours (PubMed=33556411).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fantail; VBO=VBO_0017499.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   ftiPSf-1
AC   CVCL_A8WQ
SY   iPS#1
DR   Wikidata; Q108820241
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WS ! ftiPSf-2
OI   CVCL_A8WT ! ftiPSf-4
OI   CVCL_A8WR ! ftiPSf-19
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSf-19
AC   CVCL_A8WR
SY   iPS#19
DR   Wikidata; Q108820242
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WQ ! ftiPSf-1
OI   CVCL_A8WS ! ftiPSf-2
OI   CVCL_A8WT ! ftiPSf-4
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSf-2
AC   CVCL_A8WS
SY   iPS#2
DR   Wikidata; Q108820243
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WQ ! ftiPSf-1
OI   CVCL_A8WT ! ftiPSf-4
OI   CVCL_A8WR ! ftiPSf-19
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSf-4
AC   CVCL_A8WT
DR   Wikidata; Q108820244
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WQ ! ftiPSf-1
OI   CVCL_A8WS ! ftiPSf-2
OI   CVCL_A8WR ! ftiPSf-19
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSm-1
AC   CVCL_A8WU
SY   ftiPS #M1
DR   Wikidata; Q108820245
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WV ! ftiPSm-2
OI   CVCL_A8WW ! ftiPSm-3
OI   CVCL_A8WX ! ftiPSm-4
OI   CVCL_A8WY ! ftiPSm-5
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSm-2
AC   CVCL_A8WV
SY   ftiPS #M2
DR   Wikidata; Q108820246
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WU ! ftiPSm-1
OI   CVCL_A8WW ! ftiPSm-3
OI   CVCL_A8WX ! ftiPSm-4
OI   CVCL_A8WY ! ftiPSm-5
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSm-3
AC   CVCL_A8WW
SY   ftiPS #M3
DR   Wikidata; Q108820247
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WU ! ftiPSm-1
OI   CVCL_A8WV ! ftiPSm-2
OI   CVCL_A8WX ! ftiPSm-4
OI   CVCL_A8WY ! ftiPSm-5
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSm-4
AC   CVCL_A8WX
SY   iPS#4; iPS #M4; ftiPS #M4
DR   Wikidata; Q108820248
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WU ! ftiPSm-1
OI   CVCL_A8WV ! ftiPSm-2
OI   CVCL_A8WW ! ftiPSm-3
OI   CVCL_A8WY ! ftiPSm-5
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   ftiPSm-5
AC   CVCL_A8WY
SY   ftiPS #M5
DR   Wikidata; Q108820249
RX   PubMed=32073882;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
OI   CVCL_A8WU ! ftiPSm-1
OI   CVCL_A8WV ! ftiPSm-2
OI   CVCL_A8WW ! ftiPSm-3
OI   CVCL_A8WX ! ftiPSm-4
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   FTO 9.1
AC   CVCL_E6IT
SY   FTO9.1
RX   PubMed=9918938;
CC   Virology: Susceptible to hepatitis B virus (HBV) infection (PubMed=9918938).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:543; ANXA5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5124 ! FTO-2B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   FTO-2B
AC   CVCL_5124
SY   FTO 2B; FTO2B
DR   BTO; BTO_0003234
DR   Wikidata; Q54835222
RX   PubMed=9745712;
RX   PubMed=9918938;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-168.html
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5123 ! FT-2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   FTRS-AbL81
AC   CVCL_Z298
SY   FTRS-AbL-81
DR   Wikidata; Q54835223
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 30 hours (CelloPub=CLPUB00170).
OX   NCBI_TaxID=571296; ! Archips breviplicana (Asiatic leafroller moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   FTRS-AfL
AC   CVCL_Z296
DR   Wikidata; Q54835224
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 26 hours (CelloPub=CLPUB00170).
OX   NCBI_TaxID=85585; ! Adoxophyes honmai (Smaller tea tortrix moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   FTRS-AoL1
AC   CVCL_Z294
DR   Wikidata; Q54835225
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 24 hours (CelloPub=CLPUB00170).
OX   NCBI_TaxID=480707; ! Adoxophyes orana (Summer fruit tortrix moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   FTRS-AoL2
AC   CVCL_Z295
DR   Wikidata; Q54835226
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 20 hours (CelloPub=CLPUB00170).
OX   NCBI_TaxID=480707; ! Adoxophyes orana (Summer fruit tortrix moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   FTRS-HlL1
AC   CVCL_Z300
DR   Wikidata; Q54835227
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 32 hours (CelloPub=CLPUB00170).
CC   Misspelling: FTRS-H1L1; Note=In Cellosaurus releases 12 to 34.
OX   NCBI_TaxID=928821; ! Choristoneura longicellana (Common apple leafroller moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   FTRS-HlL2
AC   CVCL_Z301
DR   Wikidata; Q54835228
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 36 hours (CelloPub=CLPUB00170).
CC   Misspelling: FTRS-H1L2; Note=In Cellosaurus releases 12 to 34.
OX   NCBI_TaxID=928821; ! Choristoneura longicellana (Common apple leafroller moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   FTRS-HmL45
AC   CVCL_Z299
DR   Wikidata; Q54835229
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 48 hours (CelloPub=CLPUB00170).
OX   NCBI_TaxID=410822; ! Homona magnanima (Oriental tea tortrix moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   FTRS-PhL
AC   CVCL_Z297
DR   Wikidata; Q54835230
RX   CelloPub=CLPUB00170;
RX   CelloPub=CLPUB00171;
CC   Group: Insect cell line.
CC   Doubling time: 28 hours (CelloPub=CLPUB00170).
OX   NCBI_TaxID=192191; ! Pandemis heparana (Dark fruit-tree tortrix)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   FU-01
AC   CVCL_E2WD
SY   FU-1; 13.1; #13.1
DR   BTO; BTO_0003843
RX   CelloPub=CLPUB00776;
RX   DOI=10.1007/BF02632209;
RX   PubMed=12889790;
RX   PubMed=18836188;
CC   Group: Plant cell line.
CC   Characteristics: Produces primarily the anthocyanin peonidin 3-p-coumaroylglucoside and to a lesser amount malvidin monoglucoside (DOI=10.1007/BF02632209).
CC   Characteristics: Intermediate pigmented (CelloPub=CLPUB00776).
CC   Caution: Two cell lines, 13.1 and 5.4 are described in DOI=10.1007/BF02632209. We believe that FU-01 is 13.1 based on the fact that the group that developed these 2 cell lines have subsequently only used 13.1 in publications.
CC   Breed/subspecies: Cultivar Gamay Freaux.
OX   NCBI_TaxID=29760; ! Vitis vinifera (Grape)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   FU-02
AC   CVCL_E2WE
SY   FU-2
RX   CelloPub=CLPUB00776;
RX   PubMed=12889790;
CC   Group: Plant cell line.
CC   Characteristics: Has a high anthocyanin level; highly pigmented (CelloPub=CLPUB00776).
CC   Breed/subspecies: Cultivar Gamay Freaux.
OX   NCBI_TaxID=29760; ! Vitis vinifera (Grape)
HI   CVCL_E2WD ! FU-01
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   FU-03
AC   CVCL_E2WF
RX   CelloPub=CLPUB00776;
CC   Group: Plant cell line.
CC   Characteristics: Has a very low anthocyanin level; non-pigmented (CelloPub=CLPUB00776).
CC   Breed/subspecies: Cultivar Gamay Freaux.
OX   NCBI_TaxID=29760; ! Vitis vinifera (Grape)
HI   CVCL_E2WD ! FU-01
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   FU-266
AC   CVCL_J235
SY   FU 266
DR   cancercelllines; CVCL_J235
DR   Wikidata; Q54835231
RX   Patent=US4574116;
RX   PubMed=6316357;
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 21
//
ID   FU-266 clone E1
AC   CVCL_J236
SY   FU-266 (E1)
DR   Wikidata; Q54835232
RX   Patent=US4574116;
RX   PubMed=6316357;
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J235 ! FU-266
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   FU-DDLS-1
AC   CVCL_M815
SY   FU-DD-LS1; Fukuoka University-DeDifferentiated LipoSarcoma-1
DR   cancercelllines; CVCL_M815
DR   Cosmic; 2307718
DR   Cosmic; 2800520
DR   GEO; GSM529099
DR   Progenetix; CVCL_M815
DR   Wikidata; Q54835233
RX   PubMed=12579306;
RX   PubMed=17354236;
RX   PubMed=22911243;
RX   PubMed=24726063;
RX   PubMed=26643872;
CC   Population: Japanese.
CC   Doubling time: ~52 hours (PubMed=12579306).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   FU-EPS-1
AC   CVCL_E311
SY   Fukuoka University-EPitheloid Sarcoma-1
DR   Wikidata; Q54835234
RX   PubMed=16010416;
RX   PubMed=19756736;
CC   Population: Japanese.
CC   Doubling time: ~45 hours (PubMed=16010416).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   FU-GBC-1
AC   CVCL_H703
SY   Fukuoka University-Gall Bladder Carcinoma-1
DR   Wikidata; Q54835235
RX   PubMed=2680052;
RX   PubMed=9502079;
CC   Population: Japanese.
CC   Doubling time: 120 hours (PubMed=2680052).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   FU-GBC-2
AC   CVCL_H704
SY   Fukuoka University-Gall Bladder Carcinoma-2
DR   Wikidata; Q54835236
RX   PubMed=9211524;
CC   Population: Japanese.
CC   Doubling time: 43 hours (Note=At 20th passage) (PubMed=9211524).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   FU-GC-16
AC   CVCL_A5XE
SY   Fukuoka University-Gastric Cancer-16
DR   Wikidata; Q107115083
RX   PubMed=7680948;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   FU-MFH-1
AC   CVCL_M816
SY   Fukuoka University-Malignant Fibrous Histiocytoma-1
DR   Wikidata; Q54835237
RX   PubMed=12810255;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=12810255).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   FU-MFH-2
AC   CVCL_M817
SY   Fukuoka University-Malignant Fibrous Histiocytoma-2
DR   Wikidata; Q54835238
RX   PubMed=21092322;
CC   Population: Japanese.
CC   Doubling time: ~56 hours (PubMed=21092322).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   FU-MK-1
AC   CVCL_A5WZ
DR   Wikidata; Q107115086
RX   PubMed=7680948;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   FU-MMT-1
AC   CVCL_U143
SY   Fukuoka University-Malignant mixed Mullerian Tumor-1
DR   Wikidata; Q54835239
RX   PubMed=1312893;
CC   Population: Japanese.
CC   Doubling time: 26 hours (Note=At 5th passage) (PubMed=1312893).
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   FU-MMT-2
AC   CVCL_U144
SY   Fukuoka University-Malignant mixed Mullerian Tumor-2
DR   Wikidata; Q54835240
RX   PubMed=1312893;
RX   PubMed=8774655;
CC   Population: Japanese.
CC   Doubling time: 30 hours (Note=At 5th passage) (PubMed=1312893).
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   FU-MMT-2-C1
AC   CVCL_U145
DR   Wikidata; Q54835241
RX   PubMed=7683967;
CC   Population: Japanese.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U144 ! FU-MMT-2
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   FU-MMT-2-S1
AC   CVCL_U146
DR   Wikidata; Q54835242
RX   PubMed=7683967;
CC   Population: Japanese.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U144 ! FU-MMT-2
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   FU-MMT-3
AC   CVCL_U148
SY   Fukuoka University-Malignant mixed Mullerian Tumor-3
DR   Wikidata; Q54835243
RX   PubMed=9368662;
CC   Population: Japanese.
CC   Doubling time: 29 hours (Note=At 5th passage) (PubMed=9368662).
DI   NCIt; C3359; Rhabdomyosarcoma
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   FU-NB-2006
AC   CVCL_AQ51
SY   FU-NB-06
DR   Wikidata; Q54835244
RX   PubMed=28340497;
WW   Info; -; -; http://www.christithomas.blogspot.ch/2006_12_01_archive.html
CC   Anecdotal: Established from a sample taken just after the death of Christi Thomas who died in September 2006 aged 9. The cell line was named by Christi's father to show how angry (FU...) he was against neuroblastoma (NB).
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 11,16
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 16,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   FU-OV-1
AC   CVCL_2047
SY   FUOV-1; FUOV1; Fukuoka University-OVarian-1
DR   CLO; CLO_0003406
DR   EFO; EFO_0022689
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471610
DR   BioSample; SAMN10988241
DR   cancercelllines; CVCL_2047
DR   Cell_Model_Passport; SIDM01040
DR   Cosmic; 1305328
DR   Cosmic; 1995408
DR   Cosmic-CLP; 1240129
DR   DepMap; ACH-000574
DR   DSMZ; ACC-444
DR   DSMZCellDive; ACC-444
DR   EGA; EGAS00001000978
DR   GDSC; 1240129
DR   GEO; GSM274702
DR   GEO; GSM645842
DR   GEO; GSM711719
DR   GEO; GSM851917
DR   GEO; GSM887014
DR   GEO; GSM888083
DR   GEO; GSM1669796
DR   IARC_TP53; 28353
DR   LiGeA; CCLE_783
DR   LINCS_LDP; LCL-1695
DR   PharmacoDB; FUOV1_370_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2047
DR   Wikidata; Q54835245
RX   PubMed=10337661;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 25 hours (Note=In serum-free medium), 21 hours (Note=In FBS-supplemented medium) (PubMed=10337661); 71 hours (PubMed=25984343); ~120 hours (DSMZ=ACC-444).
CC   HLA typing: A*24:02,24:02; B*51:01,52:01; C*12:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asp (c.535C>G); ClinVar=VCV000376610; Zygosity=Homozygous (Cosmic-CLP=1240129; DepMap=ACH-000574).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.66%; East Asian, North=78.56%; East Asian, South=18.72%; South Asian=0%; European, North=0%; European, South=2.06% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1240129; DSMZ=ACC-444; PubMed=22710073; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13 (DSMZ=ACC-444)
ST   D19S433: 13,14 (PubMed=22710073)
ST   D21S11: 29,30 (PubMed=30485824)
ST   D21S11: 30 (DSMZ=ACC-444; PubMed=22710073; PubMed=25877200)
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 20
ST   Penta D: 10,13
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,19 (Cosmic-CLP=1240129; DSMZ=ACC-444; PubMed=22710073; PubMed=25877200)
ST   vWA: 14,19,20 (PubMed=30485824)
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   FU-PNET-3
AC   CVCL_IU17
SY   Fukuoka University-Primitive NeuroEctodermal Tumor-3
DR   Wikidata; Q54835246
RX   PubMed=27613543;
CC   Population: Japanese.
CC   Doubling time: 40.8 hours (PubMed=27613543).
CC   Derived from site: In situ; Abdomen, left inguinal part; UBERON=UBERON_0035410.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   FU-PNET-4
AC   CVCL_IU18
SY   Fukuoka University-Primitive NeuroEctodermal Tumor-4
DR   Wikidata; Q54835247
RX   PubMed=27613543;
CC   Population: Japanese.
CC   Doubling time: 45.6 hours (PubMed=27613543).
CC   Derived from site: In situ; Left chest wall, hypodermis; UBERON=UBERON_0016435+UBERON_0002072.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   FU-RPNT-1
AC   CVCL_4837
SY   FU-PNET-1
DR   CLO; CLO_0050891
DR   BioSample; SAMN03473644
DR   FANTOM5_SSTAR; 10637-108I7
DR   RCB; RCB1495
DR   Wikidata; Q54835248
RX   PubMed=9559290;
RX   PubMed=27613543;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=9559290).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB1495
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   FU-RPNT-2
AC   CVCL_4838
SY   FU-PNET-2
DR   CLO; CLO_0050901
DR   BioSample; SAMN03472054
DR   FANTOM5_SSTAR; 10663-109C6
DR   RCB; RCB1496
DR   RCB; RCB2078
DR   Wikidata; Q54835249
RX   PubMed=9559290;
RX   PubMed=20143388;
RX   PubMed=27613543;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a FU-RPNT-1 derivative (PubMed=20143388). Was orignally thought to originate from a 10 year old male patient with a kidney tumor.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00352.
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=9559290).
CC   Misspelling: FU-FRNT-2; RCB=RCB1496.
CC   Discontinued: RCB; RCB1496; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB2078
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4837 ! FU-RPNT-1
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   FU-SFT8611
AC   CVCL_ZE76
DR   Wikidata; Q98126278
RX   PubMed=17088980;
RX   PubMed=32642732;
CC   Population: Japanese.
CC   Doubling time: ~50 hours (PubMed=17088980).
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   FU-SFT8710
AC   CVCL_ZE77
DR   Wikidata; Q98126279
RX   PubMed=17088980;
RX   PubMed=32642732;
CC   Population: Japanese.
CC   Doubling time: ~68 hours (PubMed=17088980).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   FU-SFT9817
AC   CVCL_ZE78
DR   Wikidata; Q98126281
RX   PubMed=17088980;
RX   PubMed=32642732;
CC   Population: Japanese.
CC   Doubling time: ~19 hours (PubMed=17088980).
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   FU-SY-1
AC   CVCL_N583
SY   Fukuoka University-SYnovial-1
DR   Wikidata; Q54835252
RX   PubMed=12063544;
CC   Population: Japanese.
CC   Doubling time: ~96 hours (PubMed=12063544).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=12063544).
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   FU-UR-1
AC   CVCL_6997
DR   Cosmic; 1184243
DR   Wikidata; Q54835253
RX   PubMed=15138551;
RX   PubMed=23288701;
CC   Population: Japanese.
CC   Doubling time: 32 hours (Note=At 51th passage) (PubMed=15138551).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13825; ASPSCR1 + HGNC; HGNC:11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3 (PubMed=15138551; PubMed=23288701).
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   FU-UrC-1
AC   CVCL_W469
DR   Wikidata; Q54835254
RX   PubMed=1888704;
CC   Population: Japanese.
CC   Characteristics: Established from a nude mouse xenograft (PubMed=1888704).
CC   Doubling time: 53 hours (PubMed=1888704).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
DI   NCIt; C8993; Ureter carcinoma
DI   ORDO; Orphanet_598216; Upper tract urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 11
//
ID   FU0045
AC   CVCL_8W38
DR   ECACC; 96082706
DR   Wikidata; Q54835255
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   FU0054
AC   CVCL_8W39
DR   ECACC; 98011408
DR   Wikidata; Q54835256
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   FU1-74
AC   CVCL_XA91
SY   FU 1-74
DR   CCRID; 4201PAT-CCTCC00062
DR   JCRB; IFO50185
DR   Wikidata; Q93557388
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1796414;
RX   PubMed=2107601;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2334.
CC   Characteristics: This is a tetradoma, a fusion of two hybridomas.
CC   Monoclonal antibody target: UniProtKB; P02675; Human FGB.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Discontinued: JCRB; IFO50185; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA78 ! FIB1-11
HI   CVCL_XA87 ! UK1-3
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   FU2-16
AC   CVCL_XA92
SY   FU 2-16
DR   CCRID; 4201PAT-CCTCC00064
DR   JCRB; IFO50207
DR   Wikidata; Q93557391
RX   Patent=US5506135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2547.
CC   Characteristics: This is a tetradoma, a fusion of two hybridomas.
CC   Monoclonal antibody target: UniProtKB; P02675; Human FGB.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Discontinued: JCRB; IFO50207; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA78 ! FIB1-11
HI   CVCL_XA88 ! UK1-6
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   Fu5-5
AC   CVCL_5125
SY   FU5-5; Fu 5-5
DR   Wikidata; Q54835257
RX   PubMed=3431441;
RX   PubMed=4157008;
RX   PubMed=6203516;
RX   PubMed=6932027;
CC   Doubling time: 20 hours (PubMed=6932027).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0285 ! H4-II-E-C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   Fu5-C8
AC   CVCL_F0W6
RX   PubMed=496972;
RX   PubMed=6378929;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5125 ! Fu5-5
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Fu97
AC   CVCL_2908
SY   FU97; FU-97
DR   BTO; BTO_0005906
DR   CLO; CLO_0037138
DR   EFO; EFO_0002054
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 432
DR   BioSample; SAMN03473260
DR   BioSample; SAMN10987784
DR   cancercelllines; CVCL_2908
DR   Cell_Model_Passport; SIDM00503
DR   Cosmic; 1187271
DR   Cosmic; 1995407
DR   Cosmic; 2807623
DR   Cosmic-CLP; 1290806
DR   DepMap; ACH-000633
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290806
DR   GEO; GSM552357
DR   GEO; GSM562400
DR   GEO; GSM827164
DR   GEO; GSM843502
DR   GEO; GSM887013
DR   GEO; GSM888082
DR   GEO; GSM1237673
DR   GEO; GSM1237698
DR   GEO; GSM1669795
DR   GEO; GSM2267426
DR   IARC_TP53; 28332
DR   JCRB; JCRB1074
DR   JCRB; NIHS0332
DR   LiGeA; CCLE_657
DR   LINCS_HMS; 50013
DR   LINCS_LDP; LCL-1894
DR   PharmacoDB; FU97_371_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2908
DR   Wikidata; Q54835258
RX   PubMed=10614861;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Produces high level of AFP.
CC   Doubling time: ~72 hours (PubMed=10614861); 30 hours (Note=Lot 08072007), ~34 hours (Note=Lot 02022011), ~31 hours (Note=Lot 03132015) (JCRB=JCRB1074).
CC   HLA typing: A*33:03,33:03; B*44:03,46:01; C*14:03,14:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Asp (c.658T>G); ClinVar=VCV000376689; Zygosity=Homozygous (DepMap=ACH-000633).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=80.85%; East Asian, South=19.14%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0332; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): Cosmic-CLP=1290806; JCRB=JCRB1074; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 19
ST   Penta D: 14
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 17
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   FuB-1
AC   CVCL_YJ24
SY   Fundulus Brain-1
DR   ABM; T0848
DR   Wikidata; Q93557419
RX   DOI=10.3390/fishes7060354;
RX   PubMed=31791770;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious pancreatic necrosis virus (IPNV) and spring viremia carp virus (SVCV) but not by nervous necrosis virus (NNV) (PubMed=31791770).
CC   Doubling time: 37.3 +- 2.81 hours (PubMed=31791770).
CC   Miscellaneous: Age of donor from personal communication of Cuesta, Alberto.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8078; ! Fundulus heteroclitus (Killifish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   FUB-1
AC   CVCL_YJ47
DR   Wikidata; Q93557420
RX   PubMed=1592367;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   Fufe-R
AC   CVCL_0I55
SY   Fufe
DR   CCLV; CCLV-RIE 0322
DR   Wikidata; Q54835260
RX   PubMed=19941903;
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   Fugu eye
AC   CVCL_R807
SY   Fre; Fugu rubripes eye; F. rubripes eye
DR   ATCC; CRL-2641
DR   Wikidata; Q54835261
RX   PubMed=9418286;
RX   PubMed=18471100;
CC   Group: Fish cell line.
CC   Doubling time: ~2.5 days (PubMed=9418286).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=31033; ! Takifugu rubripes (Japanese pufferfish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Fugu fry
AC   CVCL_R808
SY   Fnf; Fugu niphobles fry; F. niphobles fry
DR   ATCC; CRL-2642
DR   Wikidata; Q54835262
RX   PubMed=9418286;
CC   Group: Fish cell line.
CC   Doubling time: ~2.5 days (PubMed=9418286).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=433688; ! Takifugu niphobles (Grass puffer)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 10
//
ID   FUHEN
AC   CVCL_4U91
SY   Frog-derived Unique HEmatopoietic Non-adherent
DR   Wikidata; Q54835263
RX   PubMed=26322253;
RX   PubMed=34224189;
WW   Provider; Niigata Univ.; -; https://www.sc.niigata-u.ac.jp/biologyindex/sugimoto/saranifuhen.html
CC   Group: Amphibian cell line.
CC   Doubling time: 197 hours (Note=At 28 Celsius) (PubMed=26322253).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Megakaryocyte; CL=CL_0000556.
OX   NCBI_TaxID=109175; ! Dryophytes japonicus (Japanese tree frog)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 11
//
ID   FUHS-1
AC   CVCL_L351
SY   Hum-Mel FUHS-1
DR   Wikidata; Q54835264
RX   PubMed=1090262;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   FUHSi001-A
AC   CVCL_C0H5
SY   GD09006
DR   BioSamples; SAMEA11347817
DR   hPSCreg; FUHSi001-A
DR   Wikidata; Q112929573
RX   PubMed=35339882;
CC   From: Huashan Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Pro620Ser (c.1858C>T); ClinVar=VCV000924443; Zygosity=Heterozygous (PubMed=35339882).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99704; Arterial dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   FUi001-A
AC   CVCL_T891
SY   D1-6
DR   SKIP; SKIP000234
DR   SKIP; SKIP003130
DR   Wikidata; Q54817158
RX   PubMed=23639079;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Arg1645Ter (c.4933C>T); ClinVar=VCV000189921; Zygosity=Heterozygous (PubMed=23639079).
CC   Discontinued: SKIP; SKIP000234; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T890 ! FUi001-B
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   FUi001-A-1
AC   CVCL_RX87
SY   D1-1 TALEN
DR   hPSCreg; FUi001-A
DR   Wikidata; Q54835265
RX   PubMed=29453127;
CC   From: Central Research Institute for the Pathomechanisms of Epilepsy, Fukuoka University; Fukuoka; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple_corrected; p.Arg1645Ter (c.4933C>T); ClinVar=VCV000189921; Zygosity=Heterozygous; Note=By TALEN (PubMed=29453127).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T890 ! FUi001-B
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   FUi001-B
AC   CVCL_T890
AS   CVCL_RX88
SY   D1-1
DR   hPSCreg; FUi001-B
DR   SKIP; SKIP000233
DR   Wikidata; Q54835266
RX   PubMed=23639079;
RX   PubMed=29453127;
CC   From: Central Research Institute for the Pathomechanisms of Epilepsy, Fukuoka University; Fukuoka; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Arg1645Ter (c.4933C>T); ClinVar=VCV000189921; Zygosity=Heterozygous (PubMed=29453127).
CC   Discontinued: SKIP; SKIP000233; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T891 ! FUi001-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   FUi002-A
AC   CVCL_VM11
SY   D6-5; D6#5
DR   hPSCreg; FUi002-A
DR   SKIP; SKIP005529
DR   Wikidata; Q93557469
RX   PubMed=29981888;
CC   From: Central Research Institute for the Pathomechanisms of Epilepsy, Fukuoka University; Fukuoka; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Arg1525Ter (c.4573C>T); ClinVar=VCV000189911; Zygosity=Heterozygous (PubMed=29981888).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   FUi003-A1
AC   CVCL_ZW11
SY   D7-1
DR   SKIP; SKIP005773
DR   Wikidata; Q102113863
RX   PubMed=32599563;
CC   From: Central Research Institute for the Pathomechanisms of Epilepsy, Fukuoka University; Fukuoka; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Tyr1102Ter (c.3306C>A); ClinVar=VCV000217243; Zygosity=Heterozygous (PubMed=32599563).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3YQ ! D2 [Human Dravet fibroblast]
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   FUi003-A2
AC   CVCL_ZW12
SY   D7-3
DR   SKIP; SKIP005774
DR   Wikidata; Q102113864
RX   PubMed=32599563;
CC   From: Central Research Institute for the Pathomechanisms of Epilepsy, Fukuoka University; Fukuoka; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Tyr1102Ter (c.3306C>A); ClinVar=VCV000217243; Zygosity=Heterozygous (PubMed=32599563).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3YQ ! D2 [Human Dravet fibroblast]
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   Fuji
AC   CVCL_D880
SY   FUJI
DR   EFO; EFO_0022358
DR   cancercelllines; CVCL_D880
DR   Cosmic; 1217474
DR   Cosmic; 1319813
DR   Cosmic; 2307726
DR   DepMap; ACH-001272
DR   GEO; GSM482568
DR   GEO; GSM2887624
DR   GEO; GSM2887625
DR   Progenetix; CVCL_D880
DR   Wikidata; Q54835267
RX   PubMed=2171298;
RX   PubMed=7539744;
RX   PubMed=24726063;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (PubMed=7539744).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   Fujimaki-I
AC   CVCL_JF82
DR   Wikidata; Q54835268
RX   PubMed=210075;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C80291; High grade B-cell lymphoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF83 ! Fujimaki-II
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 7
//
ID   Fujimaki-II
AC   CVCL_JF83
DR   Wikidata; Q54835269
RX   PubMed=210075;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C80291; High grade B-cell lymphoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF82 ! Fujimaki-I
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   FULA1
AC   CVCL_A9KV
SY   FULA 1; FVB Urethane-induced Lung Adenocarcinoma 1
DR   GEO; GSM2492148
DR   GEO; GSM2492149
DR   GEO; GSM2492150
DR   Wikidata; Q108820250
RX   PubMed=30828726;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726).
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: FVB.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   FULA2
AC   CVCL_A9KW
SY   FULA 2; FVB Urethane-induced Lung Adenocarcinoma 2
DR   Wikidata; Q108820251
RX   PubMed=30828726;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726).
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: FVB.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   FULA3
AC   CVCL_A9KX
SY   FULA 3; FVB Urethane-induced Lung Adenocarcinoma 3
DR   GEO; GSM2492151
DR   Wikidata; Q108820252
RX   PubMed=30828726;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726).
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: FVB.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   FULA4
AC   CVCL_A9KY
SY   FULA 4; FVB Urethane-induced Lung Adenocarcinoma 4
DR   GEO; GSM2492152
DR   Wikidata; Q108820253
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: FVB.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y0M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   FUmEC
AC   CVCL_A1CP
SY   FUm EC; Feline Umbilical Endothelial Cells
DR   Wikidata; Q102113865
RX   PubMed=21637717;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4252.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Misspelling: FOmEC; PubMed=21637717.
CC   Derived from site: In situ; Fetal umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   45FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   FUN
AC   CVCL_VV76
DR   Wikidata; Q93557492
RX   PubMed=18253707;
CC   Population: Japanese.
CC   Doubling time: ~30 hours (PubMed=18253707).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=18253707).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   FUN-1
AC   CVCL_E5KA
RX   PubMed=8492223;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P42081; Human CD86.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FUR,RE
AC   CVCL_E669
SY   FUR, RE
DR   dbMHC; 48865
DR   ECACC; 94082245
DR   IHW; IHW09145
DR   IPD-IMGT/HLA; 11688
DR   Wikidata; Q54835270
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*17,60; C*03; DPB1*03:01,04:01; DQA1*01:02,02:01; DQB1*03:03,06:04; DRB1*07,13:02; DRB3*03:01; DRB4*01:01 (IPD-IMGT/HLA=11688).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082245; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   FUS1
AC   CVCL_VF85
DR   SKIP; SKIP001729
DR   Wikidata; Q54835271
RX   PubMed=28082870;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521Cys (c.1561C>T); ClinVar=VCV000016224; Zygosity=Heterozygous (PubMed=28082870).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   FUS2
AC   CVCL_VF86
DR   SKIP; SKIP001728
DR   Wikidata; Q54835272
RX   PubMed=28082870;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg495Glufs*34 (c.1483delC); Zygosity=Heterozygous (PubMed=28082870).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 10
//
ID   FUS2 corrected
AC   CVCL_VF87
SY   ISOGENIC CNTL; R495QfsX527c.1483insC
DR   SKIP; SKIP001734
DR   Wikidata; Q54835273
RX   PubMed=28082870;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_corrected; p.Arg495Glufs*34 (c.1483delC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28082870).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VF86 ! FUS2
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   FUS3
AC   CVCL_VF88
DR   SKIP; SKIP001730
DR   Wikidata; Q54835274
RX   PubMed=28082870;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Asp502Thrfs*27 (c.1504delG); ClinVar=VCV000521661; Zygosity=Heterozygous (PubMed=28082870).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   FVAF1
AC   CVCL_JM05
SY   Feline Vaccine-Associated Fibrosarcoma 1
DR   Wikidata; Q54835275
RX   PubMed=22893503;
DI   NCIt; C134560; Feline fibrosarcoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   8Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   FVB-1
AC   CVCL_F046
DR   RCB; AES0045
DR   RCB; RCB2194
DR   SKIP; SKIP001658
DR   Wikidata; Q54835276
CC   Discontinued: RCB; RCB2194; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   FVB-2
AC   CVCL_4E28
DR   RCB; RCB2195
DR   Wikidata; Q54835277
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Caution: Not from strain FVB as originally assigned (DOI=10.4051/ibc.2010.2.4.0014).
CC   Discontinued: RCB; RCB2195; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   FVMUT-CFMG-1
AC   CVCL_0A28
DR   Wikidata; Q54835278
RX   PubMed=23375365;
CC   Doubling time: 25 hours (PubMed=23375365).
CC   Omics: Proteomics; 2DE.
CC   Breed/subspecies: Terrier; VBO=VBO_0201343.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   Fvp^(r)B350
AC   CVCL_U119
DR   CLO; CLO_0050860
DR   RCB; RCB0764
DR   Wikidata; Q54835279
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3869 ! FM3A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   FVTCT.fl
AC   CVCL_H732
DR   CLO; CLO_0050774
DR   RCB; RCB0571
DR   Wikidata; Q54835280
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   FW-4
AC   CVCL_B7RY
SY   FW4
DR   Wikidata; Q112929574
RX   Patent=EP0111344A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8456.
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P60568; Human IL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   FW11-10-3
AC   CVCL_G119
SY   FW 11.10.3; FW11.10.3; mAb 11.10
DR   CLO; CLO_0003408
DR   ATCC; HB-257
DR   ECACC; 93070776
DR   Wikidata; Q54835281
RX   PubMed=7507492;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   FW11-24-17-36
AC   CVCL_G120
SY   FW 11.24.7.36; FW11.24.7.36; mAb 11.24
DR   CLO; CLO_0003409
DR   ATCC; HB-258
DR   ECACC; 93070775
DR   Wikidata; Q54835282
RX   PubMed=7507492;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   FW11-9-2
AC   CVCL_G121
SY   FW 11.9.2.2; FW11.9.2.2; mAb 11.9
DR   CLO; CLO_0003410
DR   ATCC; HB-256
DR   ECACC; 93070778
DR   Wikidata; Q54835283
RX   PubMed=7507492;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   FW14-14
AC   CVCL_DB31
SY   mAb 14-14
DR   Wikidata; Q54835284
RX   PubMed=7507492;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   FW14-14-15
AC   CVCL_DB32
DR   ATCC; HB-259
DR   Wikidata; Q54835285
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
CC   Discontinued: ATCC; HB-259; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DB31 ! FW14-14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   FW14-14-18
AC   CVCL_L676
SY   FW14.14.18
DR   ECACC; 93100512
DR   Wikidata; Q54835286
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DB31 ! FW14-14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   FW3-132.6
AC   CVCL_AR46
SY   FW3.132.6
DR   ECACC; 93100514
DR   Wikidata; Q54835287
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 4
//
ID   FW3-151
AC   CVCL_AR47
SY   FW3.151
DR   ECACC; 93100515
DR   Wikidata; Q54835288
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 4
//
ID   FW3-218-1
AC   CVCL_G122
SY   218
DR   CLO; CLO_0003411
DR   ATCC; HB-261
DR   Wikidata; Q54835289
RX   PubMed=1372559;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; W5Q5Y1; Sheep ITGA4/CD49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   FW3-47
AC   CVCL_L675
SY   47
DR   ECACC; 91060559
DR   Wikidata; Q54835290
RX   PubMed=1372559;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B0FYY4; Sheep ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   FW4-101-1-1
AC   CVCL_G123
SY   FW 4.101; FW4/101
DR   CLO; CLO_0003412
DR   ATCC; HB-289
DR   ECACC; 93070777
DR   Wikidata; Q54835291
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B0FYY4; Sheep ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   FW5H6
AC   CVCL_A9NE
DR   Wikidata; Q108820254
RX   Patent=US10048280;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2996.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   FWL
AC   CVCL_E7E6
RX   PubMed=7757991;
RX   PubMed=8402660;
RX   PubMed=9563901;
CC   Doubling time: 25 hours (PubMed=8402660).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   FX1G5
AC   CVCL_A9NF
DR   Wikidata; Q108820255
RX   Patent=US10048280;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2993.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   FX7A7
AC   CVCL_A9NG
DR   Wikidata; Q108820256
RX   Patent=US10048280;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2997.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   FY-3PN
AC   CVCL_B138
DR   Wikidata; Q54835293
RX   PubMed=18611919;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   FY-hES-1
AC   CVCL_9922
DR   Wikidata; Q54835294
RX   PubMed=18611919;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   FY-hES-10
AC   CVCL_9929
SY   GZHMCe003-A
DR   hPSCreg; GZHMCe003-A
DR   SKIP; SKIP002306
DR   Wikidata; Q54835295
RX   PubMed=19376483;
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   FY-hES-11
AC   CVCL_9930
SY   GZHMCe004-A
DR   hPSCreg; GZHMCe004-A
DR   SKIP; SKIP002307
DR   Wikidata; Q54835296
RX   PubMed=19376483;
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   FY-hES-12
AC   CVCL_9931
DR   Wikidata; Q54835297
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-13
AC   CVCL_9932
DR   Wikidata; Q54835298
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-14
AC   CVCL_9933
DR   Wikidata; Q54835299
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-15
AC   CVCL_9934
DR   Wikidata; Q54835300
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-16
AC   CVCL_9935
DR   Wikidata; Q54835301
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-17
AC   CVCL_9936
DR   Wikidata; Q54835302
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-18
AC   CVCL_9937
DR   Wikidata; Q54835303
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-19
AC   CVCL_9938
DR   Wikidata; Q54835304
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-20
AC   CVCL_9939
DR   Wikidata; Q54835305
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-21
AC   CVCL_9940
DR   Wikidata; Q54835306
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-22
AC   CVCL_9941
DR   Wikidata; Q54835307
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-23
AC   CVCL_9942
DR   Wikidata; Q54835308
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-24
AC   CVCL_9943
DR   Wikidata; Q54835309
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-25
AC   CVCL_9944
DR   Wikidata; Q54835310
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-27
AC   CVCL_L646
DR   Wikidata; Q54835311
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-28
AC   CVCL_L647
DR   Wikidata; Q54835312
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-29
AC   CVCL_L648
DR   Wikidata; Q54835313
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-3
AC   CVCL_9923
DR   Wikidata; Q54835314
RX   PubMed=18611919;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   FY-hES-30
AC   CVCL_L649
DR   Wikidata; Q54835315
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-31
AC   CVCL_L650
DR   Wikidata; Q54835316
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-32
AC   CVCL_L651
DR   Wikidata; Q54835317
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-33
AC   CVCL_L652
DR   Wikidata; Q54835318
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-34
AC   CVCL_L653
DR   Wikidata; Q54835319
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-35
AC   CVCL_L654
DR   Wikidata; Q54835320
RX   PubMed=22527897;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
ID   FY-hES-4
AC   CVCL_9924
DR   Wikidata; Q54835321
RX   PubMed=18611919;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   FY-hES-5
AC   CVCL_9925
SY   GZHMCe001-A
DR   hPSCreg; GZHMCe001-A
DR   SKIP; SKIP002304
DR   Wikidata; Q54835322
RX   PubMed=18611919;
RX   PubMed=19376483;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   FY-hES-7
AC   CVCL_9926
DR   Wikidata; Q54835323
RX   PubMed=18611919;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   FY-hES-8
AC   CVCL_9927
DR   Wikidata; Q54835324
RX   PubMed=18611919;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   FY-hES-9
AC   CVCL_9928
SY   GZHMCe002-A
DR   hPSCreg; GZHMCe002-A
DR   SKIP; SKIP002305
DR   Wikidata; Q54835325
RX   PubMed=19376483;
RX   PubMed=20657158;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   FY0028
AC   CVCL_8W40
DR   ECACC; 95090812
DR   Wikidata; Q54835326
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FY0031
AC   CVCL_8W41
DR   ECACC; 95091118
DR   Wikidata; Q54835327
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   FY1181
AC   CVCL_8W42
DR   ECACC; 99080911
DR   Wikidata; Q54835328
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99080911; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   FY1197
AC   CVCL_8W43
DR   ECACC; 00012901
DR   Wikidata; Q54835329
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: t(11;22)(q23.3;q11.2) (ECACC=00012901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00012901; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   FY1198
AC   CVCL_8W44
DR   ECACC; 00012902
DR   Wikidata; Q54835330
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: t(11;22)(q23.3;q11.2) (ECACC=00012902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   FY1199
AC   CVCL_8W45
DR   ECACC; 00012903
DR   Wikidata; Q54835331
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: t(11;22)(q23.3;q11.2) (ECACC=00012903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00012903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   FYC
AC   CVCL_IX17
SY   fyc
DR   Wikidata; Q54835332
RX   PubMed=15705889;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   FYMp
AC   CVCL_T996
DR   Wikidata; Q54835336
RX   PubMed=16397390;
RX   PubMed=24041801;
CC   Doubling time: 24.0 hours (PubMed=16397390).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Domestic Japanese.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   FZ01
AC   CVCL_XY22
DR   CCRID; 4201PAT-CCTCC00146
DR   Wikidata; Q93557928
RX   Patent=CN1169837C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200002.
CC   Characteristics: This seems to be a tetradoma, a fusion of two hybridomas.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human fibrin.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Misspelling: FZ201; CCRID=4201PAT-CCTCC00146.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   FZA
AC   CVCL_B7K4
DR   Wikidata; Q112929575
RX   PubMed=10725724;
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; p.Leu195Pro (c.584T>C); ClinVar=VCV000827735; Zygosity=Homozygous (PubMed=10725724).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   G
AC   CVCL_GT44
DR   Wikidata; Q54835337
RX   PubMed=1634619;
RX   PubMed=2431625;
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   G-11
AC   CVCL_U962
DR   BioSample; SAMN03151696
DR   Wikidata; Q54835338
RX   PubMed=884688;
RX   PubMed=1000504;
RX   PubMed=1000505;
RX   PubMed=1000506;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=884688; PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00048.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D281 ! HBT-3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   G-1163GM
AC   CVCL_UN47
DR   cancercelllines; CVCL_UN47
DR   IARC_TP53; 20248
DR   Wikidata; Q93557947
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 4.44 days (Note=In 0.5% FCS), 2.02 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   G-1187GM
AC   CVCL_UN48
DR   cancercelllines; CVCL_UN48
DR   IARC_TP53; 20249
DR   Wikidata; Q93557950
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 11.74 days (Note=In 0.5% FCS), 2.34 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   G-1265GM
AC   CVCL_UN49
DR   cancercelllines; CVCL_UN49
DR   IARC_TP53; 20250
DR   Wikidata; Q93557954
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 5.45 days (Note=In 0.5% FCS), 2.07 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly105Ser (c.313G>A); ClinVar=VCV000428884; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   G-1301GM
AC   CVCL_UN50
DR   cancercelllines; CVCL_UN50
DR   IARC_TP53; 20251
DR   Wikidata; Q93557957
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 3.93 days (Note=In 0.5% FCS), 2.32 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   78Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   G-1408GM
AC   CVCL_UN51
DR   IARC_TP53; 21044
DR   Wikidata; Q93557959
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 5.15 days (Note=In 0.5% FCS), 1.73 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   69Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   G-1410
AC   CVCL_F704
DR   Wikidata; Q54835339
RX   PubMed=21786362;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   G-166
AC   CVCL_E9ZQ
RX   PubMed=2517544;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   G-201
AC   CVCL_E078
SY   G201
DR   Wikidata; Q54835340
RX   PubMed=7533171;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   G-208
AC   CVCL_E9ZR
RX   PubMed=2517544;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   G-210GM
AC   CVCL_UN43
DR   cancercelllines; CVCL_UN43
DR   IARC_TP53; 20244
DR   Wikidata; Q93557974
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 2.94 days (Note=In 0.5% FCS), 1.68 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   G-211GM
AC   CVCL_UN44
DR   cancercelllines; CVCL_UN44
DR   IARC_TP53; 20245
DR   Wikidata; Q93557975
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 5.13 days (Note=In 0.5% FCS), 1.56 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asp (c.535C>G); ClinVar=VCV000376610; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   G-292 clone A141B1
AC   CVCL_2909
SY   G 292 Clone A 141B1; G-292, clone A141B1; G292CLONEA141B1; G-292; G292
DR   BTO; BTO_0003877
DR   CLO; CLO_0003428
DR   CLO; CLO_0009874
DR   EFO; EFO_0022578
DR   CLDB; cl1406
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1423
DR   BCRC; 60225
DR   BioGRID_ORCS_Cell_line; 674
DR   BioSample; SAMN03470921
DR   BioSample; SAMN10988164
DR   cancercelllines; CVCL_2909
DR   Cell_Model_Passport; SIDM00858
DR   ChEMBL-Cells; CHEMBL3307362
DR   ChEMBL-Targets; CHEMBL614298
DR   Cosmic; 931041
DR   Cosmic; 931914
DR   Cosmic; 1074401
DR   Cosmic; 1733127
DR   Cosmic-CLP; 1290807
DR   DepMap; ACH-000082
DR   ECACC; 90110522
DR   EGA; EGAS00001000978
DR   GDSC; 1290807
DR   GEO; GSM320832
DR   GEO; GSM827342
DR   GEO; GSM887015
DR   GEO; GSM888084
DR   GEO; GSM1669797
DR   IARC_TP53; 21657
DR   IARC_TP53; 30033
DR   JCRB; IFO50107
DR   KCLB; 21423
DR   LiGeA; CCLE_486
DR   LINCS_LDP; LCL-1420
DR   NCBI_Iran; C116
DR   PharmacoDB; G292_clone_A141B1_372_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2909
DR   PubChem_Cell_line; CVCL_2909
DR   Wikidata; Q54835341
RX   DOI=10.1203/00006450-197804001-00732;
RX   PubMed=2233717;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30214690;
RX   PubMed=30872698;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2681; DAXX + HGNC; HGNC:6326; KIFC3; Name(s)=DAXX-KIFC3; Note=In frame (PubMed=30214690; PubMed=30872698).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.61%; Native American=0%; East Asian, North=5.38%; East Asian, South=0%; South Asian=0%; European, North=50.9%; European, South=42.1% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-1423; Cosmic-CLP=1290807; JCRB=IFO50107; KCLB=21423; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 16.2
ST   D21S11: 31
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 17
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   G-3-1
AC   CVCL_F0WY
RX   PubMed=6177865;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03205; Epstein-Barr virus (strain B95-8) glyprotein 42 (BZLF2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G-3-5
AC   CVCL_C554
SY   G.3.5; G3.5
DR   CLO; CLO_0003431
DR   ATCC; CRL-2252
DR   Wikidata; Q54835342
RX   PubMed=9853368;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35609; Human ACTN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   G-361
AC   CVCL_1220
SY   G361; G361-mel; G361mel
DR   BTO; BTO_0001584
DR   CLO; CLO_0003433
DR   CLO; CLO_0050698
DR   EFO; EFO_0006394
DR   CLDB; cl1407
DR   CLDB; cl1408
DR   CLDB; cl4941
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1424
DR   BioSample; SAMN01821552
DR   BioSample; SAMN01821727
DR   BioSample; SAMN03471453
DR   BioSample; SAMN03472419
DR   BioSample; SAMN10988270
DR   cancercelllines; CVCL_1220
DR   Cell_Model_Passport; SIDM00857
DR   CGH-DB; 9315-4
DR   ChEMBL-Cells; CHEMBL3307514
DR   ChEMBL-Targets; CHEMBL614036
DR   CLS; 302157
DR   Cosmic; 687435
DR   Cosmic; 874385
DR   Cosmic; 905228
DR   Cosmic; 906865
DR   Cosmic; 928692
DR   Cosmic; 933005
DR   Cosmic; 1006557
DR   Cosmic; 1007157
DR   Cosmic; 1022275
DR   Cosmic; 1155277
DR   Cosmic; 1459650
DR   Cosmic; 1995409
DR   Cosmic; 2036701
DR   Cosmic; 2159446
DR   Cosmic; 2630487
DR   Cosmic-CLP; 906865
DR   DepMap; ACH-000572
DR   ECACC; 88030401
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10465-106H6
DR   GDSC; 906865
DR   GEO; GSM206469
DR   GEO; GSM274684
DR   GEO; GSM827495
DR   GEO; GSM887016
DR   GEO; GSM888085
DR   GEO; GSM1374482
DR   GEO; GSM1669798
DR   IARC_TP53; 21333
DR   ICLC; HTL99001
DR   JCRB; IFO50009
DR   JCRB; JCRB9074
DR   KCLB; 21424
DR   LiGeA; CCLE_062
DR   LINCS_LDP; LCL-1246
DR   Lonza; 987
DR   PharmacoDB; G361_373_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1220
DR   PubChem_Cell_line; CVCL_1220
DR   RCB; RCB0991
DR   TKG; TKG 0197
DR   Wikidata; Q54835343
RX   DOI=10.1203/00006450-197804001-00732;
RX   PubMed=2174414;
RX   PubMed=12068308;
RX   PubMed=15467732;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-crl-1424-morphology
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*23:01,26:01; B*38:01,44:03; C*04:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=15467732; ATCC=CRL-1424; Cosmic-CLP=906865; DepMap=ACH-000572).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.03%; East Asian, North=1.43%; East Asian, South=0%; South Asian=0%; European, North=70.33%; European, South=28.21% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-1424; Cosmic-CLP=906865; ECACC=88030401; JCRB=IFO50009; JCRB=JCRB9074; KCLB=21424; PubMed=25877200; RCB=RCB0991; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 14
ST   D12S391: 17,18
ST   D13S317: 11
ST   D16S539: 15
ST   D18S51: 15,16
ST   D19S433: 12,16
ST   D1S1656: 17.3
ST   D21S11: 29,30
ST   D22S1045: 11
ST   D2S1338: 16,17
ST   D2S441: 10,11
ST   D3S1358: 11,16 (ATCC=CRL-1424; PubMed=25877200; Technion Genomics Center)
ST   D3S1358: 16 (KCLB=21424)
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 19,21
ST   Penta D: 9,10,11
ST   Penta E: 10,14
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   G-361/CMV-Luc
AC   CVCL_4Y12
SY   G361/CMV-Luc
DR   cancercelllines; CVCL_4Y12
DR   JCRB; JCRB1455
DR   JCRB; NIHS0705
DR   Wikidata; Q54835344
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1455).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; JCRB1455; probable.
CC   Discontinued: JCRB; NIHS0705; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1220 ! G-361
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   G-361/CMV-Luc#1(c-1)
AC   CVCL_VN82
DR   cancercelllines; CVCL_VN82
DR   JCRB; JCRB1682
DR   JCRB; NIHS1039
DR   Wikidata; Q93558011
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1682).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; JCRB1682; probable.
CC   Discontinued: JCRB; NIHS1039; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): JCRB=JCRB1682
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 15
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1220 ! G-361
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 13
//
ID   G-361/CMV-Luc#2(c-2.5)
AC   CVCL_JG86
DR   cancercelllines; CVCL_JG86
DR   JCRB; JCRB1687
DR   JCRB; NIHS1040
DR   Wikidata; Q54835346
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1687).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1040; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): JCRB=JCRB1687
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 15
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1220 ! G-361
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 16
//
ID   G-401
AC   CVCL_0270
SY   G401; G 401
DR   BTO; BTO_0002586
DR   CLO; CLO_0003434
DR   EFO; EFO_0002179
DR   MCCL; MCC:0000161
DR   CLDB; cl1409
DR   4DN; 4DNSR6XERO32
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1441
DR   BCRJ; 0418
DR   BioSample; SAMN03470969
DR   BioSample; SAMN03472819
DR   BioSample; SAMN10987919
DR   cancercelllines; CVCL_0270
DR   CCRID; 1101HUM-PUMC000034
DR   Cell_Model_Passport; SIDM00856
DR   ChEMBL-Cells; CHEMBL3308394
DR   ChEMBL-Targets; CHEMBL613509
DR   Cosmic; 683682
DR   Cosmic; 802044
DR   Cosmic; 802245
DR   Cosmic; 907299
DR   Cosmic-CLP; 907299
DR   DepMap; ACH-000096
DR   ECACC; 87042204
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS062JBT
DR   ENCODE; ENCBS432GBV
DR   ENCODE; ENCBS629BMK
DR   ENCODE; ENCBS659PBH
DR   FANTOM5_SSTAR; 10809-111A8
DR   GDSC; 907299
DR   GEO; GSM827165
DR   GEO; GSM887017
DR   GEO; GSM888086
DR   GEO; GSM1669799
DR   GEO; GSM1676299
DR   GEO; GSM1701634
DR   GEO; GSM2033123
DR   GEO; GSM2033124
DR   GEO; GSM2033125
DR   GEO; GSM2033126
DR   GEO; GSM2033127
DR   GEO; GSM2033128
DR   GEO; GSM2409659
DR   GEO; GSM2409660
DR   GEO; GSM2409661
DR   GEO; GSM2409662
DR   GEO; GSM2409663
DR   GEO; GSM2495985
DR   GEO; GSM2787352
DR   IARC_TP53; 21334
DR   IGRhCellID; G401
DR   JCRB; JCRB9065
DR   LiGeA; CCLE_546
DR   LINCS_LDP; LCL-1511
DR   PharmacoDB; G401_374_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0270
DR   PubChem_Cell_line; CVCL_0270
DR   TOKU-E; 1303
DR   Wikidata; Q54835347
RX   PubMed=8382007;
RX   PubMed=9671307;
RX   PubMed=10397258;
RX   PubMed=10602515;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=28945250;
RX   PubMed=30894373;
RX   PubMed=30924592;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-286.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/g401-xenograft-model/
CC   Problematic cell line: Misclassified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (PubMed=8382007; PubMed=30924592).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307; PubMed=10602515; PubMed=28945250).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.48%; Native American=0.75%; East Asian, North=2.12%; East Asian, South=0.55%; South Asian=8.63%; European, North=29.24%; European, South=56.23% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1441; CCRID=1101HUM-PUMC000034; Cosmic-CLP=907299; ECACC=87042204; JCRB=JCRB9065; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,14
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 31,32.2 (CCRID=1101HUM-PUMC000034)
ST   D21S11: 31,32.2,33.2 (ATCC=CRL-1441; PubMed=25877200)
ST   D2S1338: 18,24
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 11,14
ST   D8S1179: 13,14
ST   FGA: 24,26,27 (ATCC=CRL-1441)
ST   FGA: 24,27 (CCRID=1101HUM-PUMC000034; PubMed=25877200)
ST   Penta D: 10,11
ST   Penta E: 7
ST   TH01: 8,9.3 (ATCC=CRL-1441; CCRID=1101HUM-PUMC000034; Cosmic-CLP=907299; ECACC=87042204; JCRB=JCRB9065)
ST   TH01: 9.3 (PubMed=25877200)
ST   TPOX: 8,11 (ATCC=CRL-1441; CCRID=1101HUM-PUMC000034; Cosmic-CLP=907299; ECACC=87042204; JCRB=JCRB9065)
ST   TPOX: 11 (PubMed=25877200)
ST   vWA: 16
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   G-401 BAF47
AC   CVCL_QW55
SY   G401 BAF47; G401_BAF47
DR   GEO; GSM2409664
DR   GEO; GSM2409665
DR   GEO; GSM2409666
DR   GEO; GSM2409667
DR   GEO; GSM2409668
DR   GEO; GSM2409669
DR   GEO; GSM2787353
DR   Wikidata; Q54835348
RX   PubMed=28945250;
CC   Problematic cell line: Misclassified. Parent cell line (G-401) was originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line.
CC   Population: Caucasian.
CC   Characteristics: Transduction of SMARCB1 rescues the phenotype of the parent cell line which is homozygous for its deletion (PubMed=28945250).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11103; SMARCB1 (Note=With a C-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0270 ! G-401
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 12
//
ID   G-401-Luc
AC   CVCL_J252
SY   G401-Luc
DR   JCRB; JCRB1390
DR   JCRB; NIHS0654
DR   Wikidata; Q54835349
CC   Problematic cell line: Misclassified. Parent cell line (G-401) was originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0654; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1390
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,14
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 11,14
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0270 ! G-401
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 19
//
ID   G-402
AC   CVCL_1221
SY   G402
DR   BTO; BTO_0000678
DR   CLO; CLO_0003435
DR   EFO; EFO_0002180
DR   CLDB; cl1410
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1440
DR   BioGRID_ORCS_Cell_line; 175
DR   BioSample; SAMN03473165
DR   BioSample; SAMN10988323
DR   cancercelllines; CVCL_1221
DR   Cell_Model_Passport; SIDM00855
DR   ChEMBL-Cells; CHEMBL3308733
DR   ChEMBL-Targets; CHEMBL1075446
DR   Cosmic; 687593
DR   Cosmic; 907298
DR   Cosmic-CLP; 907298
DR   DepMap; ACH-000375
DR   ECACC; 90112715
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10721-110A1
DR   GDSC; 907298
DR   GEO; GSM827166
DR   GEO; GSM887018
DR   GEO; GSM888087
DR   GEO; GSM1669800
DR   IARC_TP53; 21335
DR   IGRhCellID; G402
DR   IZSLER; BS TCL 212
DR   JCRB; JCRB9070
DR   KCLB; 21440
DR   LiGeA; CCLE_658
DR   LINCS_LDP; LCL-1751
DR   PharmacoDB; G402_375_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1221
DR   PubChem_Cell_line; CVCL_1221
DR   Wikidata; Q54835350
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 24.4 hours (Note=Lot 062392) (JCRB=JCRB9070).
CC   HLA typing: A*24:02,24:02; B*07:02,08:01; C*07:06,07:06; DQB1*06:13,06:13; DRB1*11:08,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=32.1%; Native American=0.17%; East Asian, North=0.64%; East Asian, South=0%; South Asian=1.72%; European, North=46.83%; European, South=18.54% (PubMed=30894373).
CC   Caution: This cell line is said to originate from a 'renal leiomyoblastoma'. This is an antiquated/imprecise terminology that can not be assigned to a precise cancer type. As there is no information on the exact origin of this cell line, except that it was deposited by Peebles P.T at ATCC, we have assigned it to the generic 'kidney neoplasm' of NCIt.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1440; Cosmic-CLP=907298; ECACC=90112715; JCRB=JCRB9070; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 13,17
ST   D21S11: 30,31
ST   D2S1338: 18,21
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 22,27
ST   Penta D: 9,13
ST   Penta E: 8,15
ST   TH01: 7,9
ST   TPOX: 10
ST   vWA: 13,17
DI   NCIt; C3150; Kidney neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   G-415
AC   CVCL_8198
SY   G415
DR   CLO; CLO_0050017
DR   BioSample; SAMN03471927
DR   cancercelllines; CVCL_8198
DR   Cell_Model_Passport; SIDM01807
DR   Cosmic; 2674060
DR   DepMap; ACH-001850
DR   RCB; RCB2640
DR   TKG; TKG 0642
DR   Wikidata; Q54835351
RX   PubMed=7429092;
RX   PubMed=11713577;
RX   PubMed=27231123;
RX   PubMed=32293552;
RX   PubMed=32899426;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 48 hours (Note=At 30th passage) (PubMed=7429092); 30 hours (PubMed=32293552).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (DepMap=ACH-001850).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001850; RCB=RCB2640; TKG=TKG 0642
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9,12 (DepMap=ACH-001850; RCB=RCB2640)
ST   D16S539: 12 (TKG=TKG 0642)
ST   D18S51: 12,14
ST   D21S11: 32.2
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 12,14
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15,16 (TKG=TKG 0642)
ST   vWA: 16 (DepMap=ACH-001850; RCB=RCB2640)
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   G-599GM
AC   CVCL_UN45
DR   cancercelllines; CVCL_UN45
DR   IARC_TP53; 20246
DR   Wikidata; Q93558070
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 2.19 days (Note=In 0.5% FCS), 2.04 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Met (c.746G>T); ClinVar=VCV000376653; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   33Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   G-7
AC   CVCL_3821
SY   G7
DR   CLO; CLO_0003436
DR   CLDB; cl1411
DR   CLDB; cl5188
DR   ATCC; CRL-1447
DR   BCRC; 60236
DR   ECACC; 90110520
DR   IZSLER; BS TCL 133
DR   Wikidata; Q54835352
CC   Doubling time: ~17-19 hours (ATCC=CRL-1447).
CC   Derived from site: In situ; Embryonic skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3822 ! G-8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   G-750GM
AC   CVCL_UN46
DR   cancercelllines; CVCL_UN46
DR   IARC_TP53; 20247
DR   Wikidata; Q93558081
RX   PubMed=12894509;
RX   PubMed=15035290;
CC   Doubling time: 1.71 days (Note=In 0.5% FCS), 1.20 days (Note=In 10% FCS) (PubMed=12894509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=15035290).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   70Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   G-8
AC   CVCL_3822
SY   G.8; G8
DR   CLO; CLO_0003416
DR   CLO; CLO_0003437
DR   CLDB; cl1412
DR   CLDB; cl5189
DR   ATCC; CRL-1456
DR   BCRC; 60237
DR   ECACC; 89050906
DR   IZSLER; BS CL 130
DR   NCBI_Iran; C141
DR   Wikidata; Q54835353
RX   PubMed=193191;
CC   Doubling time: 25-27 hours (ATCC=CRL-1456).
CC   Derived from site: In situ; Embryonic skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3821 ! G-7
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   G-mel
AC   CVCL_W798
SY   G-MEL
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_W798
DR   Cell_Model_Passport; SIDM00129
DR   Cosmic; 706101
DR   Cosmic-CLP; 1240130
DR   DepMap; ACH-002121
DR   EGA; EGAS00001000978
DR   GDSC; 1240130
DR   GEO; GSM1669811
DR   PharmacoDB; GMEL_376_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54835354
RX   PubMed=10766161;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (Cosmic-CLP=1240130; DepMap=ACH-002121).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.75%; Native American=0.58%; East Asian, North=2.61%; East Asian, South=0.16%; South Asian=0%; European, North=66.24%; European, South=29.66% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240130
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 23
//
ID   G-OF1iPS1
AC   CVCL_WL15
SY   G-OF1iPS clone 1; G1-1
DR   GEO; GSM2802513
DR   GEO; GSM2802514
DR   Wikidata; Q93558105
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Leu447fs (c.1341_1344delACTC); Zygosity=Heterozygous (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-65Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF1iPS6
AC   CVCL_WL16
SY   G-OF1iPS clone 6; G1-6
DR   GEO; GSM2802515
DR   GEO; GSM2802516
DR   Wikidata; Q93558114
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Leu447fs (c.1341_1344delACTC); Zygosity=Heterozygous (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-65Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF2iPS10
AC   CVCL_WL24
DR   Wikidata; Q93558117
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF2iPS3
AC   CVCL_WL23
DR   Wikidata; Q93558120
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF2iPS5
AC   CVCL_WL17
SY   G-OF2iPS clone 5; G2-5
DR   GEO; GSM2802517
DR   GEO; GSM2802518
DR   Wikidata; Q93558122
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF2iPS8
AC   CVCL_WL18
SY   G-OF2iPS clone 8; G2-8
DR   GEO; GSM2802519
DR   GEO; GSM2802520
DR   Wikidata; Q93558125
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF3iPS25
AC   CVCL_WL19
DR   Wikidata; Q93558128
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Asp461fs (c.1383delC); Zygosity=Heterozygous (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-35Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF3iPS26
AC   CVCL_WL20
DR   Wikidata; Q93558130
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Asp461fs (c.1383delC); Zygosity=Heterozygous (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-35Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF4iPS12
AC   CVCL_WL21
DR   Wikidata; Q93558133
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Leu506Arg (c.1517T>G); Zygosity=Heterozygous (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-25Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF4iPS15
AC   CVCL_WL28
DR   Wikidata; Q93558134
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF4iPS18
AC   CVCL_WL25
DR   Wikidata; Q93558137
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF4iPS23
AC   CVCL_WL22
DR   Wikidata; Q93558138
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Leu506Arg (c.1517T>G); Zygosity=Heterozygous (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-25Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF4iPS3
AC   CVCL_WL26
DR   Wikidata; Q93558141
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-OF4iPS8
AC   CVCL_WL27
DR   Wikidata; Q93558144
RX   PubMed=28915250;
RX   PubMed=29088246;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; c.652G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28915250).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   G-Olig2
AC   CVCL_9109
SY   G-olig2; GFP-Olig2
DR   CLO; CLO_0003549
DR   ATCC; SCRC-1037
DR   CCRID; 3101MOUSCSP222
DR   Wikidata; Q54835355
RX   PubMed=12529550;
CC   Characteristics: Using homologous recombination, a eGFP-PGK-Neo construct was introduced at the N-terminus of Olig2 (PubMed=12529550).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6442 ! RW4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   G-S1
AC   CVCL_YE04
DR   Wikidata; Q93558154
RX   CelloPub=CLPUB00548;
RX   PubMed=2998993;
RX   PubMed=4330463;
RX   PubMed=4333769;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   G. A.
AC   CVCL_C8NM
DR   Wikidata; Q123031315
RX   PubMed=1374683;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G. J.
AC   CVCL_C8NN
DR   Wikidata; Q123031316
RX   PubMed=1374683;
CC   Doubling time: 64.6 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G. M.
AC   CVCL_C8NP
DR   Wikidata; Q123031317
RX   PubMed=1374683;
CC   Doubling time: 46.7 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G. T.
AC   CVCL_C8NQ
DR   Wikidata; Q123031318
RX   PubMed=1374683;
CC   Doubling time: 46.7 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   g/G
AC   CVCL_2048
SY   G/G
DR   CLO; CLO_0003417
DR   CLDB; cl1426
DR   DSMZ; ACC-224
DR   DSMZCellDive; ACC-224
DR   Wikidata; Q54835356
RX   PubMed=7687588;
CC   Doubling time: ~35-50 hours (DSMZ=ACC-224).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C3H/E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   3-5D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   G01-874
AC   CVCL_Z988
DR   Wikidata; Q54835357
RX   CelloPub=CLPUB00206;
RX   CelloPub=CLPUB00496;
CC   Group: Insect cell line.
CC   Doubling time: 48 hours (CelloPub=CLPUB00206).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   G06A
AC   CVCL_D2PP
DR   Wikidata; Q127380861
RX   PubMed=22002975;
RX   PubMed=27251041;
RX   PubMed=28480569;
RX   PubMed=37254642;
RX   PubMed=37365849;
CC   Miscellaneous: STR profile carried out by CLS and provided by Schrock, Morgan S. The STR profile has 3 additional loci not in standard set: PEZ2:128,140, PEZ15:216,220 and PEZ17:202,206.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Australian Shepherd; VBO=VBO_0200095.
ST   Source(s): Direct_author_submission
ST   Dog FHC2010: 233,237
ST   Dog FHC2054: 150,154
ST   Dog FHC2079: 278
ST   Dog PEZ1: 110,122
ST   Dog PEZ6: 180,189
ST   Dog PEZ8: 228,236
ST   Dog PEZ12: 258,278
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   G085
AC   CVCL_E670
SY   GO85
DR   dbMHC; 48869
DR   ECACC; 94050313
DR   IHW; IHW09263
DR   IPD-IMGT/HLA; 10596
DR   Wikidata; Q54835358
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Gypsy.
CC   HLA typing: A*01:01:01:01,29:01:01:01; B*40:06:01:02,52:01:01:02; C*12:02:02:01,15:02:01:01; DPA1*01:03:01; DPB1*02:01:02/02:01:19; DQA1*01:03,01:04; DQB1*05:03:01,06:01:01/06:01:15; DRB1*14:04:01,15:02:01; DRB3*02:02:01; DRB5*01:02 (IPD-IMGT/HLA=10596).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   G088
AC   CVCL_E671
SY   GO88
DR   dbMHC; 48866
DR   ECACC; 94050314
DR   IHW; IHW09264
DR   IPD-IMGT/HLA; 10597
DR   Wikidata; Q54835359
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Gypsy.
CC   HLA typing: A*01,11; B*57,40; C*06:02:01:01,15:02:01; DPB1*04:01,14:01 (IPD-IMGT/HLA=10597).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94050314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   G1 [Drosophila]
AC   CVCL_Z792
SY   Gehring's line G; Gehring-1
DR   DGRC; 16
DR   FlyBase_Cell_line; FBtc0000016
DR   Wikidata; Q54835361
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=26772746;
WW   Info; FlyBase; -; http://flybase.org/reports/FBrf0205934.html
CC   Group: Insect cell line.
CC   Doubling time: 28-50 hours (Note=Depending on growth medium) (DGRC=16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   G1 [Mouse germ stem cell]
AC   CVCL_B6W8
DR   Wikidata; Q111733228
RX   CelloPub=CLPUB00689;
RX   DOI=10.7124/bc.00073C;
RX   DOI=10.7124/bc.000742;
RX   DOI=10.7124/bc.000772;
RX   DOI=10.7124/bc.00083D;
RX   PubMed=16933853;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12-13FD
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   G1 [Mouse hybridoma against imidacloprid]
AC   CVCL_C3ML
DR   Wikidata; Q116049048
RX   Patent=CN114591916B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202211.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_5870; Imidacloprid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   G1-2
AC   CVCL_E6K5
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G1-21
AC   CVCL_E6K7
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G1-5
AC   CVCL_E6K6
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G1-OA
AC   CVCL_B6WC
DR   Wikidata; Q111733229
RX   DOI=10.7124/bc.000772;
RX   PubMed=16933853;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6W8 ! G1 [Mouse germ stem cell]
SX   Female
AG   12-13FD
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   G1-T
AC   CVCL_B6WD
DR   Wikidata; Q111733230
RX   DOI=10.7124/bc.000772;
RX   PubMed=16933853;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6W8 ! G1 [Mouse germ stem cell]
SX   Female
AG   12-13FD
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   G10-1
AC   CVCL_XC62
SY   HB G10-1
DR   ABCD; ABCD_AF109
DR   CCRID; 4201PAT-CCTCC00047
DR   Wikidata; Q93558189
RX   Patent=US6010902;
RX   PubMed=3921621;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10268.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human CD8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   G11-6
AC   CVCL_D2QV
DR   Wikidata; Q127380862
RX   PubMed=29571514;
RX   PubMed=37095139;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog CD274 (Note=Also react with mouse CD274).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   G12
AC   CVCL_H221
DR   Wikidata; Q54835362
RX   PubMed=10067924;
CC   Doubling time: 2.3 days (PubMed=10067924).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   g12
AC   CVCL_A7WG
SY   mAb-g12
DR   BEI_Resources; MRA-664
DR   Wikidata; Q107115089
RX   PubMed=3315732;
RX   PubMed=12756555;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08505; Plasmodium berghei p23-like protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   G12.1
AC   CVCL_X926
AS   CVCL_ZD49
SY   PanG 12.1; PanG 12-1
DR   Wikidata; Q54937569
RX   PubMed=2247455;
RX   PubMed=8105609;
CC   Population: Native Central American; Ngabe from Panama.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 6
//
ID   G144
AC   CVCL_DG64
DR   Wikidata; Q54835363
RX   PubMed=19497285;
RX   PubMed=23468990;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG65 ! G144ED
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   G144ED
AC   CVCL_DG65
DR   Wikidata; Q54835364
RX   PubMed=19497285;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG64 ! G144
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   G14D
AC   CVCL_5505
DR   CLO; CLO_0003422
DR   ATCC; CRL-2760
DR   Wikidata; Q54835365
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   G15.AO
AC   CVCL_V192
SY   G15_AO
DR   Wikidata; Q54835366
RX   PubMed=27345779;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/solicitud-G15-AO.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Annex_G15_AO.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigacion Medica Aplicada (CIMA); Pamplona; Spain.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   G15.D
AC   CVCL_V193
SY   G15_D
DR   Wikidata; Q54835367
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/solicitud-G15-D.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Annex_G15_D.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigacion Medica Aplicada (CIMA); Pamplona; Spain.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   G166
AC   CVCL_DG66
DR   cancercelllines; CVCL_DG66
DR   GEO; GSM1026858
DR   Progenetix; CVCL_DG66
DR   Wikidata; Q54835368
RX   PubMed=19497285;
RX   PubMed=23468990;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   G16L1.1c8
AC   CVCL_DC17
DR   Wikidata; Q54835369
RX   Patent=US5854010;
RX   PubMed=8812265;
RX   PubMed=18969542;
RX   PubMed=21394221;
RX   PubMed=26366531;
WW   Provider; XDSI; -; http://www.dioxins.com/products/
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C134563; Guinea pig colon adenocarcinoma
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
HI   CVCL_3463 ! GPC-16
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 14
//
ID   G16L7.5c1
AC   CVCL_DC18
DR   Wikidata; Q54835370
RX   PubMed=26366531;
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C134563; Guinea pig colon adenocarcinoma
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
HI   CVCL_3463 ! GPC-16
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   G17/1
AC   CVCL_D5Y5
DR   Wikidata; Q127380863
RX   PubMed=6208121;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   G17-2
AC   CVCL_XC63
SY   HB G17-2
DR   CCRID; 4201PAT-CCTCC00042
DR   Wikidata; Q93558218
RX   Patent=US6010902;
RX   PubMed=2448606;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   G171
AC   CVCL_K212
DR   ATCC; HB-9254
DR   Wikidata; Q54835371
RX   Patent=US5059523;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9254.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   G174
AC   CVCL_DG68
DR   Wikidata; Q54835372
RX   PubMed=19497285;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C6959; Anaplastic oligoastrocytoma
DI   ORDO; Orphanet_251663; Anaplastic oligoastrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   G179
AC   CVCL_DG69
DR   cancercelllines; CVCL_DG69
DR   GEO; GSM1026859
DR   Progenetix; CVCL_DG69
DR   Wikidata; Q54835373
RX   PubMed=19497285;
RX   PubMed=23468990;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4325; Giant cell glioblastoma
DI   ORDO; Orphanet_251579; Giant cell glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   G19-2
AC   CVCL_XC64
DR   Wikidata; Q93558231
RX   Patent=US6010902;
RX   PubMed=2448606;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10324.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   G19-4
AC   CVCL_XC65
SY   HB G19-4
DR   CCRID; 4201PAT-CCTCC00045
DR   Wikidata; Q93558233
RX   Patent=US6010902;
RX   PubMed=3084650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9536.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human CD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   G1B
AC   CVCL_5506
DR   CLO; CLO_0003423
DR   ATCC; CRL-2536
DR   BCRC; 60559
DR   Wikidata; Q54835374
RX   CelloPub=CLPUB00706;
RX   DOI=10.1139/f81-125;
RX   Patent=US4219543;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by channel catfish virus (CelloPub=CLPUB00706; DOI=10.1139/f81-125).
CC   Misspelling: GIB; Note=Occasionally.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   G1E
AC   CVCL_D046
SY   GATA-1(-) Erythroid
DR   EFO; EFO_0002034
DR   ENCODE; ENCBS159ZTO
DR   ENCODE; ENCBS324ENC
DR   ENCODE; ENCBS431QXW
DR   ENCODE; ENCBS503ARZ
DR   ENCODE; ENCBS566SQH
DR   ENCODE; ENCBS602TAQ
DR   ENCODE; ENCBS807UWB
DR   Wikidata; Q54835375
RX   PubMed=9032291;
RX   PubMed=10381501;
RX   PubMed=12832487;
RX   PubMed=25729644;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/G1E_Hardison_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Characteristics: Proliferates continuously in culture as immature erythroblasts and undergo terminal maturation when Gata1 function is restored.
CC   Characteristics: EPO and KITLG dependent.
CC   Doubling time: ~12 hours (ENCODE=ENCBS159ZTO).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WI94 ! GATA-1- ES cell clone 74
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   G1E-ER2
AC   CVCL_D4C9
DR   Wikidata; Q127380864
RX   PubMed=10381501;
CC   Characteristics: Transfected with a GATA-1-ER construct (Gata1 fused to the ligand-binding domains of ESR1).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:95661; Gata1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D046 ! G1E
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   G1E-ER4
AC   CVCL_D047
DR   EFO; EFO_0002055
DR   ENCODE; ENCBS031ZRK
DR   ENCODE; ENCBS158MXR
DR   ENCODE; ENCBS214CAT
DR   ENCODE; ENCBS325ENC
DR   ENCODE; ENCBS326ENC
DR   ENCODE; ENCBS327ENC
DR   ENCODE; ENCBS328ENC
DR   ENCODE; ENCBS329ENC
DR   ENCODE; ENCBS330ENC
DR   ENCODE; ENCBS529DMU
DR   ENCODE; ENCBS840HQL
DR   ENCODE; ENCBS870UYF
DR   GEO; GSE128162
DR   Wikidata; Q54835376
RX   PubMed=12832487;
RX   PubMed=25729644;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/G1E_Hardison_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Characteristics: Transfected with a GATA-1-ER construct (Gata1 fused to the ligand-binding domains of ESR1).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:95661; Gata1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D046 ! G1E
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   G1M2
AC   CVCL_FG73
DR   Wikidata; Q54835378
RX   PubMed=1727655;
CC   Derived from site: Metastatic; Left groin, hypodermis; UBERON=UBERON_0008337+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FG74 ! L1M1
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   G1MF285D
AC   CVCL_T774
DR   CLO; CLO_0050281
DR   RCB; RCB1652
DR   Wikidata; Q54835379
RX   PubMed=2324505;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG1 allotype G1M F.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   G1SV1
AC   CVCL_6630
DR   Wikidata; Q54835380
RX   PubMed=12096332;
RX   PubMed=15541573;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=776).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_E3G9 ! T1SV2
OI   CVCL_E3GA ! T1SV3
SX   Female
AG   3-6Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   G2 [Drosophila]
AC   CVCL_Z793
SY   G 2; Gehring-2
DR   CLO; CLO_0003414
DR   EFO; EFO_0005746
DR   CLDB; cl1404
DR   DGRC; 4
DR   FlyBase_Cell_line; FBtc0000004
DR   Wikidata; Q54835381
RX   DOI=10.1016/0020-1790(83)90040-9;
RX   PubMed=24985917;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 25-43 hours (Note=Depending on growth medium) (DGRC=4).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   G2 [Human leukemia]
AC   CVCL_R868
DR   Wikidata; Q54835382
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1531243;
RX   PubMed=7845014;
CC   Doubling time: 72 hours (PubMed=1531243).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   G2-10
AC   CVCL_F1EC
RX   PubMed=8798471;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP40 last 8 residues; Abeta(33-40)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G2-11
AC   CVCL_F1ED
RX   PubMed=8798471;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 8 residues; Abeta(35-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G2-12
AC   CVCL_E6K9
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G2-13
AC   CVCL_E6KA
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G2-6
AC   CVCL_E6K8
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G24
AC   CVCL_F1HF
RX   PubMed=2471746;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G253
AC   CVCL_K213
DR   CLO; CLO_0003424
DR   ATCC; HB-9706
DR   Wikidata; Q54835383
RX   Patent=US5059523;
RX   PubMed=2877731;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9207.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9706.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P50895; Human BCAM/CD239.
CC   Discontinued: ATCC; HB-9706; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   G26.4.1C3/86
AC   CVCL_L515
SY   RAT 1C3/86; RAT-1C3/86
DR   CLO; CLO_0003426
DR   ATCC; HB-9893
DR   Wikidata; Q54835384
RX   Patent=US5413913;
RX   PubMed=2404188;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9893.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human red blood cells.
CC   Discontinued: ATCC; HB-9893; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   G266
AC   CVCL_4Z51
DR   GEO; GSM1496088
DR   GEO; GSM1496089
DR   GEO; GSM1496093
DR   GEO; GSM1496094
DR   Wikidata; Q54835385
RX   PubMed=21359817;
RX   PubMed=22922019;
RX   PubMed=26864856;
CC   Group: Bird cell line.
CC   Doubling time: 8.92 hours (Note=At 186 days of culture) (PubMed=21359817).
CC   Karyotypic information: Diploid karyotype (PubMed=21359817).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C134785; Zebra finch neoplasm
OX   NCBI_TaxID=59729; ! Taeniopygia guttata (Zebra finch)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   G28-5
AC   CVCL_L516
DR   CLO; CLO_0003427
DR   ABCD; ABCD_AA951
DR   ATCC; HB-9110
DR   NCBI_Iran; H150
DR   Wikidata; Q54835386
RX   Patent=US5182368;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9110.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25942; Human CD40.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   G2a.5
AC   CVCL_K214
DR   CLO; CLO_0003429
DR   ATCC; HB-110
DR   Wikidata; Q54835387
RX   PubMed=6417068;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   G2b.2
AC   CVCL_K215
DR   CLO; CLO_0003430
DR   ATCC; HB-109
DR   Wikidata; Q54835388
RX   PubMed=6417068;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   G2C51A2
AC   CVCL_WV62
DR   CCRID; 4201PAT-CCTCC00261
DR   Wikidata; Q93558357
RX   Patent=CN101955531B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200851.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04558; Porcine reproductive and respiratory syndrome virus (strain Lelystad) nucleoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   G3-136
AC   CVCL_F1Z5
RX   PubMed=1370558;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with RF and HAT3 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G3-211
AC   CVCL_B0ND
DR   Wikidata; Q108820257
RX   Patent=US6309880;
RX   PubMed=2474670;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 5
//
ID   G3-299
AC   CVCL_B0NE
DR   Wikidata; Q108820258
RX   Patent=US6309880;
RX   PubMed=2474670;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   G3-3
AC   CVCL_W456
DR   Wikidata; Q54835389
RX   PubMed=18395706;
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C715 ! ZHBTc4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   G3-4
AC   CVCL_F1YX
RX   PubMed=1717992;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with HIV-1 isolate RF/HAT3).
CC   Caution: Isotype indicated as IgG2b in PubMed=1717992 but IgG2a in later publication Pubmed=1370558.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G3-42
AC   CVCL_B0NF
DR   Wikidata; Q108820259
RX   Patent=US6309880;
RX   PubMed=2474670;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   G3-47
AC   CVCL_E6KB
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G3-508
AC   CVCL_B0NG
DR   Wikidata; Q108820260
RX   Patent=US6309880;
RX   PubMed=2474670;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10748.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   G3-519
AC   CVCL_B0NH
DR   Wikidata; Q108820261
RX   Patent=US6309880;
RX   PubMed=2474670;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10747.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   G3-536
AC   CVCL_B0NI
DR   Wikidata; Q108820262
RX   Patent=US6309880;
RX   PubMed=2474670;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   G3-537
AC   CVCL_B0NJ
DR   Wikidata; Q108820263
RX   Patent=US6309880;
RX   PubMed=2474670;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   G3.32.2
AC   CVCL_1Q46
DR   cancercelllines; CVCL_1Q46
DR   Wikidata; Q54835392
RX   PubMed=6686281;
RX   PubMed=6951167;
CC   Problematic cell line: Contaminated. Parent cell line (F-137) has been shown to be a Jiyoye derivative.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q45 ! F-137
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   G3/F11
AC   CVCL_0D18
DR   BTO; BTO_0005631
DR   Wikidata; Q54835391
RX   PubMed=19663697;
RX   PubMed=20423655;
RX   PubMed=21466288;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q12797; Human ASPH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 5
//
ID   G355
AC   CVCL_GR56
DR   Wikidata; Q54835393
RX   PubMed=8392609;
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   G355-5
AC   CVCL_5659
DR   CLO; CLO_0003432
DR   ATCC; CRL-2033
DR   TOKU-E; 1301
DR   Wikidata; Q54835394
RX   PubMed=2983093;
RX   PubMed=8392609;
RX   PubMed=21029758;
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_GR56 ! G355
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   G355-5/fOX40
AC   CVCL_GR55
DR   Wikidata; Q54835395
RX   PubMed=18584886;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:66411; Cat TNFRSF4.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_5659 ! G355-5
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   G361
AC   CVCL_C8ZL
SY   G361NS
DR   Wikidata; Q123031319
RX   PubMed=30995489;
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G361 MSH6-/-
AC   CVCL_C9AG
DR   Wikidata; Q123031320
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZN ! G440
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   G361/R
AC   CVCL_IW13
DR   cancercelllines; CVCL_IW13
DR   Wikidata; Q54835390
RX   PubMed=26365896;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90295; PLX-4720 (PLX4720).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1220 ! G-361
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   G361NS-Cas9
AC   CVCL_C8ZY
DR   BioGRID_ORCS_Cell_line; 1068
DR   Wikidata; Q123031321
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZL ! G361
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G3A5
AC   CVCL_E8VW
RX   PubMed=1394465;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00461; Human GOLIM4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   G3S1
AC   CVCL_5507
DR   Wikidata; Q54835396
RX   PubMed=19444860;
RX   PubMed=20198326;
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5499 ! EM-G3
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   G4 [Mouse ESC]
AC   CVCL_E222
SY   G4 ES
DR   MMRRC; MMRRC:011986-UCD
DR   Wikidata; Q54835397
RX   PubMed=17360545;
WW   Provider; MMRRC; -; https://www.mmrrc.org/strains/Nagy/G4_info.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Ncr x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   G4 [Mouse germ stem cell]
AC   CVCL_B6XA
DR   Wikidata; Q111733231
RX   CelloPub=CLPUB00689;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   12-13FD
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   G4-2 [Mouse ESC]
AC   CVCL_E223
DR   RCB; AES0150
DR   SKIP; SKIP002996
DR   Wikidata; Q54835398
RX   PubMed=18395706;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J647 ! EB3 [Mouse ESC]
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   G4-2 [Mouse hybridoma against DNA/RNA]
AC   CVCL_E6KC
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G4-20
AC   CVCL_E6KF
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G4-8
AC   CVCL_E6KD
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G4-9
AC   CVCL_E6KE
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G401.6
AC   CVCL_L269
DR   EFO; EFO_0005703
DR   ENCODE; ENCBS257AAA
DR   Wikidata; Q54835399
RX   PubMed=3031816;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/MRTG401.6_Crawford_protocol.pdf
CC   Problematic cell line: Misclassified. Parent cell line (G-401) was originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0270 ! G-401
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   G411
AC   CVCL_C8ZZ
DR   Wikidata; Q123031323
RX   PubMed=36989359;
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   G422
AC   CVCL_E3KP
DR   ABM; T9124
CC   Characteristics: Established from a transplantable tumor.
CC   Doubling time: 24-48 hours (ABM=T9124).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Kunming.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   G432
AC   CVCL_C8ZM
SY   G432NS
DR   Wikidata; Q123031324
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G432NS-Cas9
AC   CVCL_C9AI
DR   BioGRID_ORCS_Cell_line; 1070
DR   Wikidata; Q123031325
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZM ! G432
SX   Male
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G440
AC   CVCL_C8ZN
SY   G440NS
DR   Wikidata; Q123031326
RX   PubMed=30995489;
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G440 MSH6-/-
AC   CVCL_C9AH
DR   Wikidata; Q123031327
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZN ! G440
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   G440NS-Cas9
AC   CVCL_C9A0
DR   BioGRID_ORCS_Cell_line; 1069
DR   Wikidata; Q123031329
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZN ! G440
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G45
AC   CVCL_F1HI
RX   PubMed=3428925;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G45-16
AC   CVCL_B0NK
DR   Wikidata; Q108820264
RX   Patent=US6309880;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   G45-60
AC   CVCL_B0NL
DR   Wikidata; Q108820265
RX   Patent=US6309880;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10749.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   G45-70
AC   CVCL_B0NM
DR   Wikidata; Q108820266
RX   Patent=US6309880;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   G45-89
AC   CVCL_B0NN
DR   Wikidata; Q108820267
RX   Patent=US6309880;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   G472
AC   CVCL_C8ZP
SY   G472NS
DR   Wikidata; Q123031330
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G472NS-Cas9
AC   CVCL_C9A1
DR   BioGRID_ORCS_Cell_line; 1072
DR   Wikidata; Q123031331
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZP ! G472
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G477
AC   CVCL_C8ZQ
SY   G477NS
DR   Wikidata; Q123031332
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G477NS-Cas9
AC   CVCL_C9A2
DR   BioGRID_ORCS_Cell_line; 1074
DR   Wikidata; Q123031333
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZQ ! G477
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G4b
AC   CVCL_9W62
DR   Wikidata; Q54835400
RX   PubMed=11930168;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic dorsal root ganglion; UBERON=UBERON_0000044.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-16FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   G4B1
AC   CVCL_B7LR
SY   P44D9(1)G4(1)B1#8
DR   RCB; RCB5678
DR   Wikidata; Q112929576
RX   PubMed=35343032;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08138; Human NGFR/CD271 (Note=Recognizes the glycosylated protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   G5
AC   CVCL_U450
DR   Wikidata; Q54835401
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   G5-14
AC   CVCL_E6KH
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G5-17
AC   CVCL_E6KI
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA and ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G5-32
AC   CVCL_E6KJ
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G5-33
AC   CVCL_E6KK
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G5-8
AC   CVCL_E6KG
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G508
AC   CVCL_C9AE
DR   Wikidata; Q123031334
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G510
AC   CVCL_C8ZR
SY   G510NS
DR   Wikidata; Q123031335
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G510NS-Cas9
AC   CVCL_C9A3
DR   BioGRID_ORCS_Cell_line; 1071
DR   Wikidata; Q123031336
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZR ! G510
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G523
AC   CVCL_B4P6
SY   G523NS
DR   EGA; EGAS00001003493
DR   EGA; EGAS00001003700
DR   GEO; GSM3439929
DR   GEO; GSM3439930
DR   GEO; GSM3439931
DR   GEO; GSM3439938
DR   GEO; GSM3439939
DR   GEO; GSM3439940
DR   Wikidata; Q110432806
RX   PubMed=30995489;
RX   PubMed=31249064;
RX   PubMed=36989359;
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   G523NS-Cas9
AC   CVCL_C9AB
DR   BioGRID_ORCS_Cell_line; 1067
DR   Wikidata; Q123031337
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4P6 ! G523
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G532
AC   CVCL_C9AF
DR   Wikidata; Q123031338
RX   PubMed=36989359;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G549
AC   CVCL_C9A4
SY   G549NS
DR   Wikidata; Q123031339
RX   PubMed=30995489;
RX   PubMed=36989359;
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   G549NS-Cas9
AC   CVCL_C9AJ
DR   BioGRID_ORCS_Cell_line; 1063
DR   Wikidata; Q123031340
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G564
AC   CVCL_C8ZS
SY   G564NS
DR   Wikidata; Q123031341
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   G564NS-Cas9
AC   CVCL_C9A5
DR   BioGRID_ORCS_Cell_line; 1073
DR   Wikidata; Q123031342
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZS ! G564
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G567
AC   CVCL_B4P7
SY   G567NS
DR   EGA; EGAS00001003493
DR   EGA; EGAS00001003700
DR   GEO; GSM3439932
DR   GEO; GSM3439933
DR   GEO; GSM3439934
DR   GEO; GSM3439941
DR   GEO; GSM3439942
DR   GEO; GSM3439943
DR   Wikidata; Q110432807
RX   PubMed=30995489;
RX   PubMed=31249064;
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   G567NS-Cas9
AC   CVCL_C9AC
DR   Wikidata; Q123031343
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4P7 ! G567
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G583
AC   CVCL_B4P8
SY   G583NS
DR   EGA; EGAS00001003493
DR   EGA; EGAS00001003700
DR   GEO; GSM3439935
DR   GEO; GSM3439936
DR   GEO; GSM3439937
DR   GEO; GSM3439944
DR   GEO; GSM3439945
DR   GEO; GSM3439946
DR   Wikidata; Q110432808
RX   PubMed=30995489;
RX   PubMed=31249064;
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   G583NS-Cas9
AC   CVCL_C9AD
DR   BioGRID_ORCS_Cell_line; 1064
DR   Wikidata; Q123031344
RX   PubMed=30995489;
CC   Group: Cancer stem cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4P8 ! G583
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   G5B1
AC   CVCL_U451
DR   Wikidata; Q54835402
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U450 ! G5
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   G5B2
AC   CVCL_U452
DR   Wikidata; Q54835403
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U450 ! G5
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   G5B3
AC   CVCL_U453
DR   Wikidata; Q54835404
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U450 ! G5
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   G5F2
AC   CVCL_U454
DR   Wikidata; Q54835405
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U450 ! G5
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   G5G2
AC   CVCL_U455
DR   Wikidata; Q54835406
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U450 ! G5
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   G5T/VGH
AC   CVCL_M731
SY   G5T; G-5-T
DR   BCRC; 60194
DR   Cosmic; 1237540
DR   Wikidata; Q54835407
RX   PubMed=3858282;
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): BCRC=60194
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   G6 [Mouse ESC]
AC   CVCL_B6XB
DR   Wikidata; Q111733232
RX   CelloPub=CLPUB00689;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   12-13FD
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
ID   G6 [Mouse hybridoma against human PRSS1]
AC   CVCL_F0UZ
RX   PubMed=2347596;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07477; Human PRSS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   G6-20
AC   CVCL_E6KN
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G6-22
AC   CVCL_E6KP
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G6-23
AC   CVCL_E6KQ
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA and ssDNA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G6-7
AC   CVCL_E6KL
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA and ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G6-9
AC   CVCL_E6KM
RX   DOI=10.1080/12265071.1998.9647433;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA>ssDNA).
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G603AD
AC   CVCL_U090
DR   Wikidata; Q54835408
RX   PubMed=15573370;
CC   Population: Chinese; Han.
CC   Doubling time: 23 hours (PubMed=15573370).
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C45542; Lung pleomorphic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ77 ! G603EBV-B
OI   CVCL_U091 ! G603L
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   G603EBV-B
AC   CVCL_TZ77
SY   G603 EBV-B
DR   Wikidata; Q54835409
RX   PubMed=15573370;
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U090 ! G603AD
OI   CVCL_U091 ! G603L
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 6
//
ID   G603L
AC   CVCL_U091
DR   cancercelllines; CVCL_U091
DR   Cosmic; 1513407
DR   RCB; RCB3529
DR   Wikidata; Q54835410
RX   PubMed=15573370;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=21498706;
RX   PubMed=38639832;
CC   Population: Chinese; Han.
CC   Doubling time: 23 hours (PubMed=15573370).
CC   HLA typing: A*26:02,31:012; B*15:01,40:02; C*03:03,03:04 (PubMed=17131342).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=21498706).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C45542; Lung pleomorphic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U090 ! G603AD
OI   CVCL_TZ77 ! G603EBV-B
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   G613M
AC   CVCL_A5AK
DR   Wikidata; Q107115091
RX   PubMed=17131342;
CC   HLA typing: A*24:02,11:01; B*52:01,55:02; C*12:02,12:03 (PubMed=17131342).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   G7
AC   CVCL_B6XC
DR   Wikidata; Q111733233
RX   CelloPub=CLPUB00689;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   12-13FD
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   G705
AC   CVCL_C9A6
DR   Wikidata; Q123031345
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   G729
AC   CVCL_C9A7
DR   Wikidata; Q123031346
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   G797
AC   CVCL_C9A8
DR   Wikidata; Q123031347
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   G8 [Mouse hybridoma against human AMACR]
AC   CVCL_E7DK
RX   PubMed=28234557;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9UHK6; Human AMACR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   G8 [Mouse hybridoma against human TERT]
AC   CVCL_C4YS
DR   Wikidata; Q116049049
RX   PubMed=11604111;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   G8 [Mouse hybridoma against PEDV spike]
AC   CVCL_E3A3
RX   PubMed=26492620;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A142II16; Porcine epidemic diarrhea virus (strain CH-SDBZ-1-2015) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   G8-1
AC   CVCL_J424
DR   Wikidata; Q54835411
CC   Derived from site: In situ; Embryonic skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3822 ! G-8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   G8-2
AC   CVCL_B0FI
DR   Wikidata; Q108820268
RX   PubMed=2568171;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   G800
AC   CVCL_C9A9
DR   Wikidata; Q123031348
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   G821L
AC   CVCL_U108
DR   Wikidata; Q54835412
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17725806;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   HLA typing: A*26:02; B*51:01; C*14:02 (PubMed=17131342).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   G837
AC   CVCL_C9AA
DR   Wikidata; Q123031349
RX   PubMed=38089093;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   G8B11
AC   CVCL_A0TR
DR   Wikidata; Q108820269
RX   Patent=WO2020103691A1;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03971; Human AMH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   G9
AC   CVCL_E3A4
RX   PubMed=26492620;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A142II16; Porcine epidemic diarrhea virus (strain CH-SDBZ-1-2015) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   G9/1
AC   CVCL_D5Y4
DR   Wikidata; Q127380866
RX   PubMed=6208121;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4090 ! 45.6.TG1.7
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   G9G7
AC   CVCL_C5CK
DR   Wikidata; Q116049050
RX   PubMed=22509914;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   G9T/VGH
AC   CVCL_D276
SY   G9T; G-9-T
DR   BTO; BTO_0003880
DR   Cosmic; 1237541
DR   Wikidata; Q54835413
RX   PubMed=3858282;
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   Ga Va
AC   CVCL_3689
DR   CLO; CLO_0003438
DR   ATCC; CRL-1394
DR   Wikidata; Q54835414
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   GA-10
AC   CVCL_1222
SY   GA10
DR   CLO; CLO_0003439
DR   EFO; EFO_0002181
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2392
DR   BioSample; SAMN03473120
DR   BioSample; SAMN10987941
DR   cancercelllines; CVCL_1222
DR   Cell_Model_Passport; SIDM00854
DR   ChEMBL-Cells; CHEMBL4523538
DR   ChEMBL-Targets; CHEMBL4523569
DR   Cosmic; 1303896
DR   Cosmic-CLP; 1303896
DR   DepMap; ACH-000162
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1303896
DR   GEO; GSM827343
DR   GEO; GSM887019
DR   GEO; GSM888088
DR   GEO; GSM1669801
DR   IARC_TP53; 16698
DR   IGRhCellID; GA10
DR   LiGeA; CCLE_930
DR   LINCS_LDP; LCL-2020
DR   PharmacoDB; GA10_395_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1222
DR   PubChem_Cell_line; CVCL_1222
DR   Wikidata; Q54835415
RX   PubMed=11482875;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: ~24 hours (PubMed=11482875).
CC   HLA typing: A*02:01,32:01; B*07:02,55:01; C*03:03,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (PubMed=11482875).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Asn (c.695T>A); ClinVar=VCV000850008; Zygosity=Heterozygous (PubMed=11482875).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.05%; Native American=0%; East Asian, North=0%; East Asian, South=0.44%; South Asian=1.46%; European, North=68.9%; European, South=28.14% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2392; Cosmic-CLP=1303896; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,18
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   GA-10 clone 20
AC   CVCL_1223
SY   GA-10 (Clone 20); GA-10-Clone-20
DR   CLO; CLO_0003440
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-2394
DR   cancercelllines; CVCL_1223
DR   Cell_Model_Passport; SIDM01255
DR   Cosmic; 906866
DR   LINCS_LDP; LCL-2035
DR   Wikidata; Q54835416
RX   PubMed=11482875;
RX   PubMed=20164919;
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Asn (c.695T>A); ClinVar=VCV000850008; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2394
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,18
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1222 ! GA-10
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   GA-10 clone 4
AC   CVCL_1224
SY   GA-10 (Clone 4); GA-10-Clone-4
DR   CLO; CLO_0003441
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2393
DR   cancercelllines; CVCL_1224
DR   Cell_Model_Passport; SIDM01252
DR   Cosmic; 687841
DR   Cosmic; 906867
DR   GEO; GSM1669802
DR   IARC_TP53; 21336
DR   PharmacoDB; GA10Clone4_396_2019
DR   Wikidata; Q54835417
RX   PubMed=11482875;
RX   PubMed=20164919;
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Asn (c.695T>A); ClinVar=VCV000850008; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2393
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,18
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 11,13,14
ST   FGA: 20,23
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1222 ! GA-10
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   GA-15
AC   CVCL_C0NP
DR   Wikidata; Q112929577
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   GA-15-SV
AC   CVCL_C0NQ
DR   Wikidata; Q112929578
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0NP ! GA-15
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   GA28
AC   CVCL_A2FJ
DR   ABM; T0864
DR   Wikidata; Q105506928
RX   PubMed=32432378;
CC   Characteristics: Expresses KISS1, PDYN, PGR and TACR3 and weakly expresses OPRK1 (PubMed=32432378).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain, hypothalamus, arcuate nucleus; UBERON=UBERON_0006238+UBERON_0001932.
CC   Cell type: KNDy neuron; CL=CL_4023125.
CC   Breed/subspecies: Shiba; VBO=VBO_0017514.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_A2FK ! GP11
OI   CVCL_A2FL ! GP31
OI   CVCL_A2FM ! GP64
SX   Female
AG   118FD
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   GA4
AC   CVCL_J883
DR   ECACC; 85062502
DR   Wikidata; Q54835419
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 3
//
ID   GAB-LCL
AC   CVCL_SA50
DR   Wikidata; Q54835420
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Discontinued: NHPRR; Catalog number 125.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   GABAA1-CHO
AC   CVCL_C5TV
SY   GABA(A1)-CHO
DR   Wikidata; Q116049051
RX   PubMed=35762541;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4075; GABRA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4082; GABRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D586 ! T-REx-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 9
//
ID   GAC-1
AC   CVCL_W470
DR   Wikidata; Q54835421
RX   PubMed=1467326;
CC   Population: Japanese.
CC   Doubling time: ~18.5 hours (PubMed=1467326).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   GAD-1
AC   CVCL_G124
DR   CLO; CLO_0003447
DR   ATCC; HB-184
DR   ECACC; 92020601
DR   Wikidata; Q54835422
RX   PubMed=2430303;
RX   PubMed=3385490;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A1D5PLC8; Chicken GAD2 (Note=Also reacts with other species).
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in ATCC=HB-184.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   GAD-2
AC   CVCL_E5TH
RX   PubMed=2430303;
RX   PubMed=3385490;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A1D5PLC8; Chicken GAD2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GAD-3
AC   CVCL_E5TI
RX   PubMed=2430303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A1D5PLC8; Chicken GAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GAD-4
AC   CVCL_E5TJ
RX   PubMed=2430303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A1D5PLC8; Chicken GAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GAD-5
AC   CVCL_E5TK
RX   PubMed=2430303;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A1D5PLC8; Chicken GAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GAD-6
AC   CVCL_E5TL
RX   PubMed=3385490;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q05683; Rat Gad2 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GAGI8381AN
AC   CVCL_V374
DR   IPD-IMGT/HLA; 14466
DR   Wikidata; Q54835423
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:02:01,30:02; B*14:02,42:01; C*07:18,12:19; DPB1*01:VVY,04:BDVT; DQB1*05:03,03:AF; DRB1*11:17,08:04; DRB3*02 (IPD-IMGT/HLA=14466).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 11
//
ID   GAK
AC   CVCL_1225
DR   CLO; CLO_0037126
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472868
DR   cancercelllines; CVCL_1225
DR   Cell_Model_Passport; SIDM00543
DR   CGH-DB; 9290-4
DR   ChEMBL-Cells; CHEMBL3308154
DR   ChEMBL-Targets; CHEMBL2366301
DR   Cosmic; 905204
DR   Cosmic; 910932
DR   Cosmic; 1995410
DR   Cosmic-CLP; 910932
DR   DepMap; ACH-002120
DR   EGA; EGAS00001000978
DR   GDSC; 910932
DR   GEO; GSM1669803
DR   IARC_TP53; 21337
DR   JCRB; FDSC0034
DR   JCRB; IFO50321
DR   JCRB; JCRB0180
DR   LINCS_LDP; LCL-1272
DR   PharmacoDB; GAK_397_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1225
DR   Wikidata; Q54835424
RX   PubMed=6431036;
RX   PubMed=15467732;
RX   PubMed=20164919;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=6431036); ~55 hours (Note=Lot 07202012) (JCRB=IFO50321); ~32 hours (Note=Lot 02242012) (JCRB=JCRB0180).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (Cosmic-CLP=910932; DepMap=ACH-002120).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.89%; East Asian, South=22.1%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0034; true.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Cosmic-CLP=910932; JCRB=IFO50321; JCRB=JCRB0180; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,13
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 9,10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C40329; Vulvar melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   GAK14
AC   CVCL_T052
SY   Gata1 gene knockdown c-Kit+ leukemia-derived cell line 14
DR   Wikidata; Q54835425
RX   PubMed=23890289;
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   GaKl
AC   CVCL_E6XD
RX   PubMed=12836015;
CC   HLA typing: A*02,80; B*18,44; DQB1*03:01,06:09; DRB1*11:01:01,13:02 (PubMed=12836015).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GAKS
AC   CVCL_5508
DR   CLO; CLO_0051594
DR   CLO; CLO_0051595
DR   RCB; RCB0082
DR   RCB; RCB1452
DR   Wikidata; Q54835426
RX   PubMed=18494573;
CC   Group: Fish cell line.
CC   Doubling time: 24 hours (PubMed=18494573).
CC   Discontinued: RCB; RCB0082; probable.
CC   Discontinued: RCB; RCB1452; probable.
CC   Derived from site: In situ; Scale; UBERON=UBERON_0002542.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   GAL-01
AC   CVCL_M549
DR   Wikidata; Q54835427
RX   PubMed=16856916;
CC   Virology: EBV-negative.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M550 ! GAL-02
SX   Male
AG   58-59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
ID   GAL-02
AC   CVCL_M550
DR   Wikidata; Q54835428
RX   PubMed=16856916;
CC   Virology: EBV-negative.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M549 ! GAL-01
SX   Male
AG   58-59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
ID   GAL-FR21
AC   CVCL_XQ70
DR   ABCD; ABCD_AM333
DR   Wikidata; Q93558743
RX   Patent=US10138301;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9586.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21802; Human FGFR2/CD332 (Note=Isoform IgIIIb/K-sam-II. Also reacts with mouse and monkeys).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 7
//
ID   GAL-FR22
AC   CVCL_XS99
DR   ABCD; ABCD_AM335
DR   Wikidata; Q93558746
RX   Patent=US10138301;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9587.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21802; Human FGFR2/CD332 (Note=Isoform IgIIIb/K-sam-II).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   GAL-FR23
AC   CVCL_XT67
DR   Wikidata; Q93558751
RX   Patent=US10138301;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9408.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21802; Human FGFR2/CD332 (Note=Isoform IgIIIb/K-sam-II).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   GaL23
AC   CVCL_2T27
DR   Wikidata; Q54835429
RX   PubMed=9590507;
RX   PubMed=9792049;
CC   Population: Caucasian.
CC   Characteristics: Tumorigenic and invasive. Forms metastases in immunodeficient mice (PubMed=9590507).
CC   Doubling time: 36 hours (Note=At 30th passage), 33 hours (Note=At 50th passage), 29 hours (Note=At 30th passage) (PubMed=9590507).
CC   Derived from site: In situ; Lung, right upper lobe; UBERON=UBERON_0002170.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 05-10-23; Version: 7
//
ID   GaL23LZ
AC   CVCL_2T28
DR   Wikidata; Q54835430
RX   PubMed=9792049;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Lung, right upper lobe; UBERON=UBERON_0002170.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2T27 ! GaL23
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 9
//
ID   GAL30.19
AC   CVCL_VT27
SY   GAL 30.19; HB GAL30.19
DR   CCRID; 4201PAT-CCTCC00096
DR   Wikidata; Q93558777
RX   Patent=US5855886;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 92042211.
CC   Characteristics: Fusoma, fusion of two hybridomas.
CC   Monoclonal antibody target: UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Monoclonal antibody target: UniProtKB; Q8IWL2; Human SFTPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 7
//
ID   Gam Per
AC   CVCL_3311
DR   CLO; CLO_0003449
DR   ATCC; CRL-1326
DR   Wikidata; Q54835431
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GaMe-LF1
AC   CVCL_Z117
DR   Wikidata; Q54835432
RX   PubMed=16618204;
CC   Group: Insect cell line.
CC   Characteristics: Grows at temperatures ranging from 15 to 35 Celsius. Maximum growth rate at 25 Celsius (PubMed=16618204).
CC   Doubling time: 1.4-1.7 days (PubMed=16618204).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7137; ! Galleria mellonella (Greater wax moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GaMG
AC   CVCL_1226
SY   GaMg; GAMG; GA-MG
DR   BTO; BTO_0004860
DR   CLO; CLO_0003450
DR   CLDB; cl1441
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 673
DR   BioSample; SAMN03473386
DR   BioSample; SAMN10988278
DR   cancercelllines; CVCL_1226
DR   Cell_Model_Passport; SIDM01055
DR   ChEMBL-Cells; CHEMBL3308734
DR   ChEMBL-Targets; CHEMBL1075447
DR   Cosmic; 687567
DR   Cosmic; 906868
DR   Cosmic; 1175810
DR   Cosmic; 1746947
DR   Cosmic; 2302330
DR   Cosmic; 2367525
DR   Cosmic-CLP; 906868
DR   DepMap; ACH-000098
DR   DSMZ; ACC-242
DR   DSMZCellDive; ACC-242
DR   EGA; EGAS00001000978
DR   GDSC; 906868
DR   GEO; GSM326237
DR   GEO; GSM887020
DR   GEO; GSM888089
DR   GEO; GSM1669804
DR   GEO; GSM7701389
DR   GEO; GSM7701390
DR   IARC_TP53; 21338
DR   LiGeA; CCLE_700
DR   LINCS_LDP; LCL-1351
DR   Lonza; 1009
DR   PharmacoDB; GAMG_398_2019
DR   PRIDE; PXD002395
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1226
DR   PubChem_Cell_line; CVCL_1226
DR   Wikidata; Q54835434
RX   PubMed=3178168;
RX   PubMed=8239502;
RX   PubMed=20164919;
RX   PubMed=22278370;
RX   PubMed=22460905;
RX   PubMed=24618588;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 32.3 +- 0.5 hours (Note=In serum-supplemented media), 41.7 +- 1.4 hours (Note=In serum-free media) (PubMed=3178168); ~40-50 hours (DSMZ=ACC-242).
CC   HLA typing: A*02:01,03:01; B*07:02,15:01; C*03:03,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu265Pro (c.794T>C); ClinVar=VCV000245777; Zygosity=Homozygous (Cosmic-CLP=906868; DepMap=ACH-000098).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.47%; East Asian, South=0%; South Asian=0%; European, North=71.47%; European, South=27.05% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=906868; DSMZ=ACC-242
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 17
ST   D3S1358: 11,15
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   Penta D: 10,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   Gamma-4-A4
AC   CVCL_ZF11
DR   Wikidata; Q98126284
RX   PubMed=19454181;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Pig gamma-crystallin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   Gamma-ENaC-TetOn-mCCD
AC   CVCL_E9V3
RX   PubMed=24179170;
CC   Characteristics: Conditionally overexpresses Scnn1g in response to doxycycline (PubMed=24179170).
CC   Characteristics: Transfected with two constructs, one is the reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and the other a pTet(tight)-Snn1g-IRES-HygR construct (PubMed=24179170).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104695; Scnn1g.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Cell type: Kidney collecting duct principal cell; CL=CL_1001431.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7HR ! mCCDcl1
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   gamma2-11.1
AC   CVCL_6F34
SY   gamma 2-11.1
DR   ATCC; HB-8699
DR   Wikidata; Q54835435
RX   Patent=US4681848;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8699.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-242.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   gamma3-11.1
AC   CVCL_2770
SY   gamma 3-11.1
DR   CLO; CLO_0009737
DR   ATCC; HB-8700
DR   Wikidata; Q54835436
RX   Patent=US4681848;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8700.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-243.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   Gan-BL
AC   CVCL_7194
SY   Gan
DR   Wikidata; Q54835437
RX   PubMed=9882297;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   GAP 8.3
AC   CVCL_G651
DR   CLO; CLO_0003451
DR   ATCC; HB-12
DR   Wikidata; Q54835438
RX   PubMed=6975769;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   GAP A3
AC   CVCL_G652
DR   CLO; CLO_0003452
DR   ATCC; HB-122
DR   Wikidata; Q54835439
RX   PubMed=6208124;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes allele A*03).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 5
//
ID   Gap Per
AC   CVCL_3312
DR   CLO; CLO_0003453
DR   ATCC; CRL-1335
DR   BioSample; SAMN03471352
DR   Wikidata; Q54835440
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1335
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Gard
AC   CVCL_V418
DR   Wikidata; Q54835441
RX   PubMed=22552293;
RX   PubMed=22893632;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   GarL
AC   CVCL_B7NB
SY   GARL; Gar Liver
DR   Wikidata; Q112929579
RX   PubMed=31626921;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Miscellaneous: Age at sampling from personal communication of Bols, Niels C.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=34771; ! Lepisosteus osseus (Long-nosed gar)
SX   Sex unspecified
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 6
//
ID   Garvin-1
AC   CVCL_Y588
DR   Wikidata; Q54835442
RX   PubMed=6546671;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Miscellaneous: Cell line name is not official. Was assigned by PubMed=23665679.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GASH
AC   CVCL_M709
SY   Gash
DR   Wikidata; Q54835443
RX   CelloPub=CLPUB00041;
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   GATA-1- ES cell clone 74
AC   CVCL_WI94
DR   Wikidata; Q93558896
RX   PubMed=1987478;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:95661; Gata1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C313 ! CCE
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GATAGM-96
AC   CVCL_W350
SY   Gulhane Askeri Tip Akademisi-Glioblastoma Multiforme-96
DR   Wikidata; Q54835444
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=9595044;
CC   Population: Turkish.
CC   Doubling time: 38-42 hours (PubMed=9595044).
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GAY2911
AC   CVCL_7956
DR   BioSamples; SAMEA100803
DR   cancercelllines; CVCL_7956
DR   Cosmic; 1522762
DR   GEO; GSM726263
DR   Progenetix; CVCL_7956
DR   Wikidata; Q54835445
RX   PubMed=21642991;
RX   PubMed=28387650;
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Arg57fs*15 (c.170delG); Zygosity=Heterozygous (PubMed=21642991).
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GB
AC   CVCL_S928
SY   Grouper Brain
DR   Wikidata; Q54835446
RX   DOI=10.1046/j.1365-2761.2001.00303.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 10
//
ID   GB 26.16
AC   CVCL_D5FS
SY   GB26.16
DR   Wikidata; Q127380867
RX   PubMed=6480024;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17833; Gentamicin (Gentamycin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 5
//
ID   GB-1
AC   CVCL_1227
SY   GB1
DR   CLO; CLO_0009891
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 672
DR   BioSample; SAMN03470918
DR   BioSample; SAMN10988051
DR   cancercelllines; CVCL_1227
DR   Cell_Model_Passport; SIDM00581
DR   CGH-DB; 141-1
DR   ChEMBL-Cells; CHEMBL3308166
DR   ChEMBL-Targets; CHEMBL2366292
DR   Cosmic; 687568
DR   Cosmic; 2367526
DR   Cosmic; 2516017
DR   Cosmic-CLP; 687568
DR   DepMap; ACH-000738
DR   EGA; EGAS00001000978
DR   GDSC; 687568
DR   GEO; GSM888090
DR   GEO; GSM1669805
DR   IARC_TP53; 21339
DR   JCRB; IFO50489
DR   LiGeA; CCLE_130
DR   LINCS_LDP; LCL-1378
DR   PharmacoDB; GB1_399_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1227
DR   PubChem_Cell_line; CVCL_1227
DR   Wikidata; Q54835447
RX   PubMed=2754458;
RX   PubMed=3777953;
RX   PubMed=4056904;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=25984343); ~35 hours (Note=Lot 01232006) (JCRB=IFO50489).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239_Ser240insAsn (c.716_717insTAA); Zygosity=Homozygous (Cosmic-CLP=687568; DepMap=ACH-000738).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.07%; East Asian, North=80.28%; East Asian, South=17.3%; South Asian=0%; European, North=0%; European, South=1.34% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=687568; JCRB=IFO50489; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13,14
ST   D19S433: 13,15.2
ST   D21S11: 30
ST   D2S1338: 20,22
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 16
ST   FGA: 23.2
ST   Penta D: 9,13
ST   Penta E: 15,21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   GB-2
AC   CVCL_S826
SY   GB2
DR   Wikidata; Q54835448
RX   PubMed=2754458;
RX   PubMed=3777953;
RX   PubMed=4056904;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   GB-3
AC   CVCL_S827
SY   GB3
DR   Wikidata; Q54835449
RX   PubMed=3777953;
RX   PubMed=4056904;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   GB-CL-1
AC   CVCL_M732
DR   Cosmic; 927194
DR   Wikidata; Q54835450
RX   PubMed=7680730;
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   GB-d1
AC   CVCL_H705
SY   GB-D1; GBD-1; GBD1
DR   Wikidata; Q54835451
RX   PubMed=7559084;
RX   PubMed=9502079;
RX   PubMed=32293552;
RX   PubMed=32899426;
CC   Population: Japanese.
CC   Doubling time: 23-25 hours (Note=In 10% FBS) (PubMed=7559084); 28 hours (PubMed=32293552).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GB-d2
AC   CVCL_H706
SY   GB-D2
DR   Wikidata; Q54835452
RX   PubMed=9502079;
CC   Population: Japanese.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GB-h3
AC   CVCL_H707
SY   GB-H3; GBH-3; GBH3; GBh3
DR   Wikidata; Q54835453
RX   PubMed=9502079;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 13
//
ID   GB-val4
AC   CVCL_XZ67
DR   cancercelllines; CVCL_XZ67
DR   Wikidata; Q93558992
RX   PubMed=31388924;
CC   Doubling time: 22 hours (PubMed=31388924).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=31388924).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305Arg (c.914A>G); Zygosity=Unspecified (PubMed=31388924).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=31388924
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D21S11: 30,31
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   GB10
AC   CVCL_E5RK
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GB11 [E.coioides]
AC   CVCL_YD08
DR   Wikidata; Q93558997
RX   DOI=10.1016/j.aquaculture.2019.734211;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by megalocytivirus OSGIV-HN11, ranavirus-type grouper iridovirus GIV-R-SY1301 and red-spotted grouper nervous necrosis virus (RGNNV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   GB11 [Mouse hybridoma against vaccinia D13L]
AC   CVCL_E5RW
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68440; Vaccinia virus scaffold protein OPG125 (D13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GB2
AC   CVCL_E4KM
DR   DepMap; ACH-001961
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): DepMap=ACH-001961
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 16
ST   FGA: 22,23
ST   Penta D: 8,10
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GB3
AC   CVCL_E4KN
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Caucasian.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GB4
AC   CVCL_E4KP
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GB5AF6
AC   CVCL_B0KL
SY   GB5-AF6
DR   ATCC; HB-10453
DR   Wikidata; Q108820270
RX   Patent=US5248594;
RX   PubMed=1890189;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10453.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZXP3; Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) groEL (Note=Also reacts with many other Legionella species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   GB5BE8
AC   CVCL_B0KM
SY   GB5-BE8
DR   ATCC; HB-10459
DR   Wikidata; Q108820272
RX   Patent=US5248594;
RX   PubMed=1890189;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10459.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZXP3; Legionella pneumophila subsp. pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) groEL (Note=Also reacts with many other Legionella species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   GB60
AC   CVCL_M021
SY   GB 60
DR   Wikidata; Q54835454
RX   PubMed=16961149;
RX   PubMed=20461036;
RX   PubMed=21253487;
CC   Problematic cell line: Misclassified. Originally thought to be a chordoma cell line but is either contaminated or established from nonchordoma cells (PubMed=21253487).
CC   Misspelling: GP 60; PubMed=20461036.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 10
//
ID   GB8
AC   CVCL_A0QH
DR   Wikidata; Q108820273
RX   Patent=US10683364;
RX   Patent=US10730945;
RX   PubMed=22615450;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   GBC-SD
AC   CVCL_6903
SY   GBCSD
DR   BTO; BTO_0004112
DR   CCRID; 1101HUM-PUMC000676
DR   CCRID; 3101HUMTCHu16
DR   KCB; KCB 2011087YJ
DR   Wikidata; Q54835455
RX   CelloPub=CLPUB00378;
RX   PubMed=17064616;
RX   PubMed=23802572;
RX   PubMed=31367188;
CC   Population: Chinese.
CC   Doubling time: 21.4 hours (CelloPub=CLPUB00378); 33.5 hours (PubMed=31367188).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GBC-SD-Cas9-766
AC   CVCL_A9DL
DR   CCRID; 1101HUM-PUMC000766
DR   Wikidata; Q108820274
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000766
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-767
AC   CVCL_A9DM
DR   CCRID; 1101HUM-PUMC000767
DR   Wikidata; Q108820275
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000767
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-768
AC   CVCL_A9DN
DR   CCRID; 1101HUM-PUMC000768
DR   Wikidata; Q108820276
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000768
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-769
AC   CVCL_A9DP
DR   CCRID; 1101HUM-PUMC000769
DR   Wikidata; Q108820277
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000769
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-770
AC   CVCL_A9DQ
DR   CCRID; 1101HUM-PUMC000770
DR   Wikidata; Q108820278
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000770
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-771
AC   CVCL_A9DR
DR   CCRID; 1101HUM-PUMC000771
DR   Wikidata; Q108820279
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000771
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-772
AC   CVCL_A9DS
DR   CCRID; 1101HUM-PUMC000772
DR   Wikidata; Q108820280
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000772
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-773
AC   CVCL_A9DT
DR   CCRID; 1101HUM-PUMC000773
DR   Wikidata; Q108820281
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000773
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-774
AC   CVCL_A9DU
DR   CCRID; 1101HUM-PUMC000774
DR   Wikidata; Q108820282
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000774
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Cas9-775
AC   CVCL_A9DV
DR   CCRID; 1101HUM-PUMC000775
DR   Wikidata; Q108820283
CC   Population: Chinese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000775
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   GBC-SD-Luc2-tdT
AC   CVCL_A9DK
DR   CCRID; 1101HUM-PUMC000805
DR   Wikidata; Q108820284
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): CCRID=1101HUM-PUMC000805
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19,20
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   GBC-SD/ATO
AC   CVCL_M738
DR   Wikidata; Q54835456
RX   DOI=10.1007/s10330-009-0173-9;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI_30621; Diarsenic trioxide (ATO; As2O3).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   GBC-SD/HL
AC   CVCL_M739
DR   Wikidata; Q54835457
RX   PubMed=22093790;
CC   Population: Chinese.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GBC-SD/M
AC   CVCL_IU74
DR   Wikidata; Q54835458
RX   PubMed=17064616;
CC   Population: Chinese.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   GBC-SD/M3
AC   CVCL_M740
DR   Wikidata; Q54835459
RX   PubMed=22093790;
CC   Population: Chinese.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6903 ! GBC-SD
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GBC-X1
AC   CVCL_E7GL
RX   PubMed=39271742;
CC   Population: Chinese.
CC   Doubling time: 32 hours (PubMed=39271742).
CC   Karyotypic information: Hypertetraploid karyotype (PubMed=39271742).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=39271742
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 16,17,18
ST   D12S391: 19,20
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 17,19
ST   D19S433: 14,15.2
ST   D1S1656: 17.3,18.3
ST   D21S11: 30,31.2
ST   D2S1338: 19,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 16
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 10,20
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GBC1
AC   CVCL_R900
SY   Grouper Brain Clone 1
DR   Wikidata; Q54835461
RX   DOI=10.1016/j.aquaculture.2008.03.020;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
OI   CVCL_R901 ! GBC4
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   GBC4
AC   CVCL_R901
SY   Grouper Brain Clone 4
DR   Wikidata; Q54835462
RX   DOI=10.1016/j.aquaculture.2008.03.020;
RX   PubMed=19248839;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
OI   CVCL_R900 ! GBC1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   GBCi001-A
AC   CVCL_C1T5
SY   FNAIThiPSC
DR   BioSamples; SAMEA10791933
DR   hPSCreg; GBCi001-A
DR   Wikidata; Q114311483
CC   From: Guangzhou Blood Centre; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Gbeta2AR13
AC   CVCL_6631
DR   Wikidata; Q54835463
RX   PubMed=8961254;
RX   PubMed=11064152;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   GBJd
AC   CVCL_XB49
DR   CCRID; 5301FIS-KCB85023ZJ
DR   KCB; KCB 85023ZJ
DR   Wikidata; Q93559071
CC   Group: Fish cell line.
CC   Caution: We are not certain of the species due to contradictory information in CCRID and KCB.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 8
//
ID   GBK
AC   CVCL_A3AW
SY   Georgia Bovine Kidney
DR   Wikidata; Q105506931
RX   PubMed=1119944;
RX   PubMed=2834598;
RX   PubMed=6160900;
CC   From: Solorzano, Robert F.; College of Veterinary Medicine, University of Missouri; Columbia; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   GBK-1
AC   CVCL_M736
DR   Wikidata; Q54835464
RX   PubMed=3082828;
CC   Population: Japanese.
CC   Doubling time: 43 hours (PubMed=3082828).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C9167; Gallbladder undifferentiated carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GBL-HU12
AC   CVCL_7195
DR   Wikidata; Q54835465
RX   PubMed=1320358;
CC   Doubling time: 34 hours (PubMed=1320358).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   GBM-18
AC   CVCL_S551
SY   G-7
DR   Wikidata; Q54835466
RX   PubMed=1653364;
RX   PubMed=2839097;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   GBM-18-A3
AC   CVCL_S552
SY   GBM-18-A3 (MDR)
DR   Wikidata; Q54835467
RX   PubMed=1317362;
RX   PubMed=1653364;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S551 ! GBM-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   GBM-18-B2
AC   CVCL_E3XZ
SY   GBM-18-B2 (MDR)
RX   PubMed=1653364;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S551 ! GBM-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GBM-18-B3
AC   CVCL_S553
SY   GBM-18-B3 (MDR)
DR   Wikidata; Q54835468
RX   PubMed=1317362;
RX   PubMed=1653364;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S551 ! GBM-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   GBM-HSF
AC   CVCL_W351
DR   Wikidata; Q54835469
RX   PubMed=24390806;
CC   Population: Chinese.
CC   Doubling time: ~51 hours (PubMed=24390806).
CC   Derived from site: In situ; Brain, left prefrontal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GBM1
AC   CVCL_DG57
SY   GBM 1
DR   Wikidata; Q54835470
RX   PubMed=19147502;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   GBM2
AC   CVCL_DG58
SY   GBM 2
DR   cancercelllines; CVCL_DG58
DR   GEO; GSM1026856
DR   Progenetix; CVCL_DG58
DR   Wikidata; Q54835471
RX   PubMed=19147502;
RX   PubMed=23468990;
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   GBM2603
AC   CVCL_4W89
SY   GBM 2603
DR   Wikidata; Q54835472
RX   PubMed=11351043;
CC   Population: Chinese.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   GBM3
AC   CVCL_DG59
SY   GBM 3
DR   Wikidata; Q54835473
RX   PubMed=19147502;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   GBM4
AC   CVCL_DG60
SY   GBM 4
DR   Wikidata; Q54835474
RX   PubMed=19147502;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   GBM43
AC   CVCL_E5GD
RX   PubMed=25401693;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25401693).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe270Cys (c.809T>G); ClinVar=VCV000376597; Zygosity=Unspecified (PubMed=25401693).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GBM5
AC   CVCL_DG61
SY   GBM 5
DR   Wikidata; Q54835475
RX   PubMed=19147502;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   GBM6
AC   CVCL_DG62
SY   GBM 6
DR   Wikidata; Q54835476
RX   PubMed=19147502;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   GBM6840
AC   CVCL_B050
SY   GBM 6840
DR   cancercelllines; CVCL_B050
DR   Wikidata; Q54835477
RX   PubMed=10736064;
RX   PubMed=11351043;
CC   Population: Chinese.
CC   Doubling time: 32 hours (PubMed=10736064).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10736064).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C5150; Cerebellar glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GBM7
AC   CVCL_DG63
SY   GBM 7
DR   cancercelllines; CVCL_DG63
DR   GEO; GSM1026857
DR   Progenetix; CVCL_DG63
DR   Wikidata; Q54835478
RX   PubMed=19147502;
RX   PubMed=23468990;
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   GBM8401
AC   CVCL_B051
SY   GBM-8401; GBM 8401; GBM8401/TSGH,NDMC; GlioBlastoma Multiforme 1984 No. 1/Tri-Service General Hospital,National Defense Medical Center
DR   BTO; BTO_0003879
DR   BCRC; 60163
DR   Cosmic; 1237539
DR   Wikidata; Q54835479
RX   PubMed=1657334;
RX   PubMed=2839737;
RX   PubMed=33952458;
CC   Population: Chinese.
CC   Doubling time: ~38 hours (PubMed=2839737).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): BCRC=60163
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GBM8401/Luc2
AC   CVCL_C0UX
SY   GBM 8401/Luc2; GBM 8401/luc2
DR   Wikidata; Q112929580
RX   PubMed=35008959;
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B051 ! GBM8401
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   GBM8401/TMZR
AC   CVCL_C0UW
SY   GBM-8401/TMZR
DR   Wikidata; Q112929581
RX   PubMed=33952458;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI_72564; Temozolomide (TMZ).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B051 ! GBM8401
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   GBM8901
AC   CVCL_B052
SY   GBM-8901; GBM 8901
DR   BCRC; 60164
DR   Wikidata; Q54835480
RX   PubMed=1657334;
CC   Problematic cell line: Contaminated. Shown to be a GBM8401 derivative (BCRC=60164). Originally thought to originate from a 73 year old female patient with glioblastoma.
CC   Population: Chinese.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): BCRC=60164
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B051 ! GBM8401
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
ID   GBM8902
AC   CVCL_A9Z0
SY   GBM-8902; GBM 8902
DR   Wikidata; Q102113867
RX   PubMed=1657334;
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GBRS
AC   CVCL_B7IU
SY   Gokasho Bay Red Sea Bream
DR   Wikidata; Q112929582
RX   PubMed=34382581;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=143350; ! Pagrus major (Red sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   GBS-01
AC   CVCL_WA71
SY   GloBozooSpermia-01
DR   IBRC; C10653
DR   Wikidata; Q93559161
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-02
AC   CVCL_WA72
SY   GloBozooSpermia-02
DR   IBRC; C10707
DR   Wikidata; Q93559164
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-03
AC   CVCL_WA73
SY   GloBozooSpermia-03
DR   IBRC; C10708
DR   Wikidata; Q93559165
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-04
AC   CVCL_WA74
SY   GloBozooSpermia-04
DR   IBRC; C10777
DR   Wikidata; Q93559168
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-05
AC   CVCL_WA75
SY   GloBozooSpermia-05
DR   IBRC; C10775
DR   Wikidata; Q93559170
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-06
AC   CVCL_WA76
SY   GloBozooSpermia-06
DR   IBRC; C10783
DR   Wikidata; Q93559173
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-07
AC   CVCL_WA77
SY   GloBozooSpermia-07
DR   IBRC; C10820
DR   Wikidata; Q93559174
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-08
AC   CVCL_WA78
SY   GloBozooSpermia-08
DR   IBRC; C10822
DR   Wikidata; Q93559177
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158500; Globozoospermia
DI   ORDO; Orphanet_171709; Male infertility due to globozoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GBS-1
AC   CVCL_M818
DR   Wikidata; Q54835481
RX   PubMed=11862471;
CC   Population: Japanese.
CC   Doubling time: ~30 hours (PubMed=11862471).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   GBS6
AC   CVCL_C3GF
DR   GEO; GSE12320
DR   Wikidata; Q114311484
RX   PubMed=15729702;
RX   PubMed=20203285;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:9221; POU5F1; Name(s)=EWSR1-POU5F1, EWS-POU5F1, EWS-Oct-4 Note=In frame (PubMed=15729702).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, pelvis; UBERON=UBERON_0012179.
DI   NCIt; C9312; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   GC-006-03
AC   CVCL_A2BE
SY   gc-006-03; gc_006_03
DR   cancercelllines; CVCL_A2BE
DR   CCRID; 1101HUM-PUMC000913
DR   CCRID; 4201PAT-CCTCC00948
DR   Wikidata; Q105506934
RX   Patent=CN106367392B;
RX   PubMed=30271482;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016152.
CC   Population: Chinese.
CC   Doubling time: 36 hours (PubMed=30271482).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu33Argfs*20 (c.97delG); Zygosity=Unspecified (PubMed=30271482).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (PubMed=30271482).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID; Patent=CN106367392B
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 16,17,18,19 (CCRID)
ST   D12S391: 16,17,20 (Patent=CN106367392B)
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 15,16,17 (CCRID)
ST   D18S51: 15,17 (Patent=CN106367392B)
ST   D19S433: 14
ST   D1S1656: 16,17
ST   D21S11: 29,30
ST   D2S1338: 18,22
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 16
ST   D7S820: 10,11,12 (CCRID)
ST   D7S820: 11,12 (Patent=CN106367392B)
ST   D8S1179: 11,15
ST   FGA: 23,26
ST   Penta D: 12
ST   Penta E: 11,22
ST   TH01: 7,8
ST   TPOX: 11,12
ST   vWA: 18,19
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   GC-030-35
AC   CVCL_VT58
DR   Wikidata; Q93559184
RX   PubMed=30799954;
CC   Population: Chinese.
CC   Doubling time: 29.2 hours (PubMed=30799954).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C95747; Gastric hepatoid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   GC-1spg
AC   CVCL_8872
SY   GC-1 spg; GC-1; GC1-SPG
DR   BTO; BTO_0006321
DR   CLO; CLO_0003457
DR   ATCC; CRL-2053
DR   BCRC; 60312
DR   CCRID; 5301MOU-KCB16078YJ
DR   CLS; 300375
DR   KCB; KCB 2016078YJ
DR   NCBI_Iran; C164
DR   PRIDE; PXD002593
DR   Wikidata; Q54835482
RX   PubMed=1322317;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatocyte; CL=CL_0000017.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   GC-2spd(ts)
AC   CVCL_6633
SY   GC-2
DR   BTO; BTO_0006500
DR   CLO; CLO_0003459
DR   EFO; EFO_0022723
DR   ATCC; CRL-2196
DR   BCRC; 60313
DR   CCRID; 3101MOUSCSP5055
DR   CCRID; 5301MOU-KCB16075YJ
DR   CLS; 300376
DR   KCB; KCB 2016075YJ
DR   Wikidata; Q54835483
RX   PubMed=7736662;
RX   PubMed=8202522;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala132Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Misspelling: GC-2 spg(ts); CCRID=5301MOU-KCB16075YJ.
CC   Discontinued: CLS; 300376; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatocyte; CL=CL_0000017.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   GC-3spc(ts)
AC   CVCL_9V31
DR   Wikidata; Q54835484
RX   PubMed=8202522;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala132Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatocyte; CL=CL_0000017.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   GC-4spc
AC   CVCL_C3M1
DR   Wikidata; Q116049052
RX   PubMed=11058565;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis, seminiferous tubule; UBERON=UBERON_0001343.
CC   Cell type: Spermatocyte; CL=CL_0000017.
CC   Breed/subspecies: TC transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   GC-5spg
AC   CVCL_9V39
SY   A303
DR   Wikidata; Q54606742
RX   PubMed=11956167;
RX   PubMed=20650884;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonial stem cell; CL=CL_0000016.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-11W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   GC-6spg
AC   CVCL_9V40
SY   A304
DR   Wikidata; Q54606744
RX   PubMed=11956167;
RX   PubMed=20650884;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonial stem cell; CL=CL_0000016.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-11W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   GC-BJAB
AC   CVCL_5758
SY   Genome Containing-BJAB; BJAB-B95.8
DR   cancercelllines; CVCL_5758
DR   Wikidata; Q54835485
RX   PubMed=62724;
RX   PubMed=170210;
RX   PubMed=171663;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=170210).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GC1a
AC   CVCL_6632
DR   Wikidata; Q54835486
RX   PubMed=12770728;
RX   PubMed=15541573;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   GC302
AC   CVCL_A5XA
SY   GC 302
DR   Wikidata; Q107115095
RX   PubMed=3325673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 40 kDa stomach oncofetal antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   GC3/Cl
AC   CVCL_1B34
SY   GC3/cl
DR   ChEMBL-Cells; CHEMBL3308634
DR   ChEMBL-Targets; CHEMBL614728
DR   PubChem_Cell_line; CVCL_1B34
DR   Wikidata; Q54835487
RX   PubMed=1378304;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1B32 ! GC3/M
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 7
//
ID   GC3/M
AC   CVCL_1B32
DR   ChEMBL-Cells; CHEMBL3308591
DR   ChEMBL-Targets; CHEMBL614500
DR   Wikidata; Q54835488
RX   PubMed=1378304;
RX   PubMed=3829001;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y076 ! HxGC3
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 5
//
ID   GC3/M TK-
AC   CVCL_1B33
SY   GC3/MTK-
DR   ChEMBL-Cells; CHEMBL3307886
DR   ChEMBL-Targets; CHEMBL614157
DR   PubChem_Cell_line; CVCL_1B33
DR   Wikidata; Q54835489
RX   PubMed=3829001;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1B32 ! GC3/M
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 9
//
ID   GC48C
AC   CVCL_6634
DR   Wikidata; Q54835490
RX   PubMed=221196;
RX   PubMed=15541573;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6620 ! DC3 [Rat granulosa]
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GC7
AC   CVCL_5757
SY   GC-7
DR   BTO; BTO_0003459
DR   Wikidata; Q54835491
RX   PubMed=167187;
RX   PubMed=4039633;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   GC9811-P
AC   CVCL_0U28
DR   Wikidata; Q54835492
RX   PubMed=17404872;
CC   Population: Chinese.
CC   Characteristics: Highly metastatic to the peritoneum. The parent cell line was injected in the stomach of nude mice producing peritoneum metastatic foci which were expanded in vitro and subsequently implanted to the stomach wall of nude mice. This process was repeated 4 times (PubMed=17404872).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0U26 ! XGC9811
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   GCBr
AC   CVCL_E8WE
SY   Grass Carp Brain
RX   DOI=10.1016/j.aquaculture.2025.742629;
CC   Group: Fish cell line.
CC   Characteristics: Can grow between 23 to 33 Celsius, with an optimal growth temperature of 28 Celsius (DOI=10.1016/j.aquaculture.2025.742629).
CC   Virology: Permissive for the propagation of grass carp reovirus genotype II (GCRV-II) (DOI=10.1016/j.aquaculture.2025.742629).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GCC-SV(c)
AC   CVCL_GS26
SY   GCC-SV(C); GCC-SV
DR   Wikidata; Q54835493
RX   PubMed=2580800;
RX   PubMed=6582512;
RX   PubMed=6956527;
CC   Population: Caucasian.
CC   HLA typing: A*02,w30; B*08,10 (PubMed=6956527).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 7
//
ID   GCCF-2
AC   CVCL_XE36
SY   Grass Carp Caudal Fin-2
DR   Wikidata; Q93559231
RX   CelloPub=CLPUB00538;
RX   CelloPub=CLPUB00675;
RX   CelloPub=CLPUB00676;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by grass carp reovirus (GCRV) (CelloPub=CLPUB00675).
CC   Doubling time: 21-33 hours (CelloPub=CLPUB00675).
CC   Misspelling: GCTF-2; CelloPub=CLPUB00676.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 8
//
ID   GCCOT-1
AC   CVCL_U178
DR   Wikidata; Q54835494
RX   PubMed=15010838;
CC   Population: Japanese.
CC   Doubling time: 36.95 hours (PubMed=15010838).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
DI   ORDO; Orphanet_213833; Glassy cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 8
//
ID   GCCRK
AC   CVCL_U179
DR   Wikidata; Q54835495
RX   PubMed=15010838;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
DI   ORDO; Orphanet_213833; Glassy cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 8
//
ID   GCF
AC   CVCL_R973
SY   Grass Carp Fin
DR   Wikidata; Q54835496
RX   CelloPub=CLPUB00103;
RX   CelloPub=CLPUB00704;
RX   PubMed=2108122;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 32 Celsius (PubMed=2108122).
CC   Virology: Susceptible to infection by chum salmon virus (CSV), golden shiner virus (GSV), infectious hematopoietic necrosis virus (IHNV), infectious pancreatic necrosis virus (IPNV), and spring viremia of carp virus (SVCV) (PubMed=2108122; CelloPub=CLPUB00704).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GCH-1
AC   CVCL_W852
SY   GCH-1nu
DR   IARC_TP53; 21420
DR   Wikidata; Q54835497
RX   CelloPub=CLPUB00141;
RX   CelloPub=CLPUB00142;
RX   PubMed=2520787;
RX   PubMed=2878840;
RX   PubMed=3658923;
RX   PubMed=6167351;
RX   PubMed=6682628;
RX   PubMed=7819056;
RX   PubMed=11014955;
CC   Population: Japanese.
CC   Doubling time: 63 hours (CelloPub=CLPUB00142); 23 hours (PubMed=2520787).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 11
//
ID   GCH-1:RI
AC   CVCL_W855
SY   GCH-1 : RI
DR   Wikidata; Q54835498
RX   PubMed=6542580;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W852 ! GCH-1
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 10
//
ID   GCH-1:RII
AC   CVCL_W856
SY   GCH-1 : RII
DR   Wikidata; Q54835499
RX   PubMed=6542580;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W852 ! GCH-1
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 10
//
ID   GCH-1m
AC   CVCL_W854
SY   GCH-1(m); GCH-1 (m)
DR   Wikidata; Q54835500
RX   PubMed=2520787;
RX   PubMed=3585108;
RX   PubMed=3658923;
RX   PubMed=3734524;
RX   PubMed=11014955;
CC   Population: Japanese.
CC   Characteristics: Compared to the parent cell line, will more effectively produces pulmonary metastasis when transplanted in nude mice (PubMed=2520787).
CC   Doubling time: 36.2 hours (PubMed=3585108).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W852 ! GCH-1
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 8
//
ID   GCH-2
AC   CVCL_W853
SY   GCH-2ham
DR   IARC_TP53; 21421
DR   Wikidata; Q54835504
RX   CelloPub=CLPUB00141;
RX   CelloPub=CLPUB00142;
RX   PubMed=7819056;
CC   Population: Japanese.
CC   Doubling time: 69 hours (CelloPub=CLPUB00142).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 9
//
ID   GCH-nu
AC   CVCL_AR87
DR   Wikidata; Q54835505
RX   CelloPub=CLPUB00317;
RX   DOI=10.5795/jjscc.21.160;
CC   Population: Japanese.
CC   Caution: Established from gestational carcinoma of a woman patient, but the cell line is from the male fetus.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   GCH-nu-YS
AC   CVCL_2910
DR   BioSample; SAMN03470917
DR   BioSample; SAMN03472434
DR   JCRB; JCRB1201
DR   JCRB; NIHS0409
DR   Wikidata; Q54835506
RX   CelloPub=CLPUB00317;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Doubling time: ~35 hours (Note=Lot 04062012) (JCRB=JCRB1201).
CC   Donor information: Established from gestational carcinoma of a woman patient, but the cell line is from the male fetus.
CC   Discontinued: JCRB; NIHS0409; true.
ST   Source(s): JCRB=JCRB1201; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,13
ST   D16S539: 9
ST   D18S51: 15,16,17
ST   D19S433: 13.2,16.2
ST   D21S11: 28,29,31
ST   D2S1338: 17,18,19
ST   D3S1358: 14,17,18
ST   D5S818: 11,12,14
ST   D7S820: 8
ST   D8S1179: 16,17,18
ST   FGA: 19,20
ST   Penta D: 9,9.1,11
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18,19 (JCRB=JCRB1201)
ST   vWA: 17,18,19,20 (PubMed=25877200)
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR87 ! GCH-nu
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   GCIY
AC   CVCL_1228
DR   CLO; CLO_0050793
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 671
DR   BioSample; SAMN03472290
DR   BioSample; SAMN10987813
DR   cancercelllines; CVCL_1228
DR   Cell_Model_Passport; SIDM00274
DR   ChEMBL-Cells; CHEMBL3308825
DR   ChEMBL-Targets; CHEMBL2366234
DR   Cosmic; 889110
DR   Cosmic; 906869
DR   Cosmic; 983729
DR   Cosmic; 1001652
DR   Cosmic; 1187272
DR   Cosmic-CLP; 906869
DR   DepMap; ACH-000047
DR   EGA; EGAS00001000978
DR   GDSC; 906869
DR   GEO; GSM887021
DR   GEO; GSM888091
DR   GEO; GSM1669806
DR   IARC_TP53; 21340
DR   LiGeA; CCLE_311
DR   LINCS_LDP; LCL-1891
DR   PharmacoDB; GCIY_400_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1228
DR   PubChem_Cell_line; CVCL_1228
DR   RCB; RCB0555
DR   RCB; RCB1883
DR   TKG; TKG 0405
DR   Wikidata; Q54835507
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1653599;
RX   PubMed=9290701;
RX   PubMed=11314020;
RX   PubMed=15767549;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=24587255;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: Produces AFP (PubMed=11314020).
CC   Doubling time: 55 hours (PubMed=1653599); 60 hours (PubMed=25984343).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Homozygous (Cosmic-CLP=906869).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Gln (c.537T>G); ClinVar=VCV000376607; Zygosity=Homozygous (Cosmic-CLP=906869).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.08%; Native American=0.43%; East Asian, North=86.12%; East Asian, South=13.37%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: RCB; RCB1883; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=906869; RCB=RCB0555
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 13
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   GCIY-EGFP
AC   CVCL_UW55
DR   cancercelllines; CVCL_UW55
DR   Wikidata; Q93559311
RX   PubMed=16077911;
RX   PubMed=16428473;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Gln (c.537T>G); ClinVar=VCV000376607; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1228 ! GCIY
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   GCK-84
AC   CVCL_B5E3
SY   GCK84
DR   Wikidata; Q110432809
RX   CelloPub=CLPUB00676;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   GCLP
AC   CVCL_A0TV
DR   CCRID; 4201PAT-CCTCC00525
DR   Wikidata; Q108820285
RX   Patent=CN104388391B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014195.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   GCN-01
AC   CVCL_A2GN
SY   GCN; Granulosa Cells Normal-01
DR   IBRC; C11327
DR   Wikidata; Q105506937
RX   PubMed=32989584;
CC   Population: Iranian.
CC   Doubling time: 86 hours (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Miscellaneous: Doubling time and info on hygromycin vector from personal communication of Nasimian, Ahmad.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): PubMed=32989584
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 23,25
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D7S820: 7,12
ST   D8S1179: 13
ST   FGA: 23,25
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   GCN2-KO-DR
AC   CVCL_B049
DR   ATCC; CRL-2978
DR   Wikidata; Q54835508
RX   PubMed=11106749;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1353427; Eif2ak4.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   GCP
AC   CVCL_YB61
SY   Grass Carp Peduncle
DR   Wikidata; Q93559326
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   GCP-01
AC   CVCL_A2GP
SY   GCP; Granulosa Cells PCOS-01
DR   IBRC; C11334
DR   Wikidata; Q105506941
RX   PubMed=32989584;
CC   Population: Iranian.
CC   Doubling time: 75 hours (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Miscellaneous: Doubling time and info on hygromycin vector from personal communication of Nasimian, Ahmad.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): PubMed=32989584
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 13,18
ST   D19S433: 13.2
ST   D21S11: 30,31
ST   D2S1338: 20,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 24,25
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C26862; Polycystic ovary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   GCS-2
AC   CVCL_R974
SY   Grass Carp Snout-2
DR   Wikidata; Q54835509
RX   CelloPub=CLPUB00704;
RX   PubMed=2108122;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 32 Celsius (PubMed=2108122).
CC   Virology: Susceptible to infection by chum salmon virus (CSV), golden shiner virus (GSV), infectious hematopoietic necrosis virus (IHNV), infectious pancreatic necrosis virus (IPNV), and spring viremia of carp virus (SVCV) (PubMed=2108122; CelloPub=CLPUB00704).
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GCS19K6
AC   CVCL_C5PQ
DR   Wikidata; Q116049053
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCS29K7
AC   CVCL_C5PR
DR   Wikidata; Q116049054
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCS6K1
AC   CVCL_C5PS
DR   Wikidata; Q116049055
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCSB
AC   CVCL_R975
SY   Grass Carp Swim Bladder
DR   Wikidata; Q54835510
RX   CelloPub=CLPUB00704;
RX   PubMed=2108122;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 32 Celsius (PubMed=2108122).
CC   Virology: Susceptible to infection by chum salmon virus (CSV), golden shiner virus (GSV), infectious hematopoietic necrosis virus (IHNV), infectious pancreatic necrosis virus (IPNV), and spring viremia of carp virus (SVCV) (PubMed=2108122; CelloPub=CLPUB00704).
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GCSK2
AC   CVCL_C5PT
DR   Wikidata; Q116049056
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCSR1
AC   CVCL_HF51
SY   GCSR-1
DR   cancercelllines; CVCL_HF51
DR   Wikidata; Q54835511
RX   PubMed=25892440;
CC   Population: Chinese.
CC   Doubling time: ~67.65 hours (PubMed=25892440).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=25892440).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GCT
AC   CVCL_1229
SY   Giant Cell Tumor; UR-HCL-1; University of Rochester-Human Cell Line-1
DR   CLO; CLO_0003464
DR   EFO; EFO_0002182
DR   CLDB; cl1445
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; TIB-223
DR   BCRC; 60474
DR   BioSample; SAMN03471887
DR   BioSample; SAMN10987909
DR   cancercelllines; CVCL_1229
DR   Cell_Model_Passport; SIDM00853
DR   ChEMBL-Cells; CHEMBL3308471
DR   ChEMBL-Targets; CHEMBL1075448
DR   CLS; 300155
DR   Cosmic; 684227
DR   Cosmic; 906999
DR   Cosmic-CLP; 906999
DR   DepMap; ACH-000835
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10711-109H9
DR   GDSC; 906999
DR   GEO; GSM184402
DR   GEO; GSM184403
DR   GEO; GSM827496
DR   GEO; GSM887022
DR   GEO; GSM888092
DR   GEO; GSM1669807
DR   IARC_TP53; 21341
DR   IGRhCellID; GCT
DR   IZSLER; BS TCL 94
DR   LiGeA; CCLE_019
DR   LINCS_LDP; LCL-1752
DR   PharmacoDB; GCT_401_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1229
DR   PubChem_Cell_line; CVCL_1229
DR   Wikidata; Q54835514
RX   PubMed=304748;
RX   PubMed=6299509;
RX   PubMed=7689482;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Caucasian.
CC   Doubling time: 55 hours (PubMed=304748).
CC   HLA typing: A*01:01,23:01; B*08:01,15:17; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; ATCC=TIB-223; Cosmic-CLP=906999; DepMap=ACH-000835).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu32Arg (c.95_96TG>GT); Zygosity=Homozygous (ATCC=TIB-223; Cosmic-CLP=906999; DepMap=ACH-000835).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (ATCC=TIB-223; Cosmic-CLP=906999; DepMap=ACH-000835).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.948_949delinsTT) (c.948_949CC>TT); Zygosity=Heterozygous (ATCC=TIB-223; Cosmic-CLP=906999; DepMap=ACH-000835).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.07%; Native American=0%; East Asian, North=2.31%; East Asian, South=0%; South Asian=1.28%; European, North=63.83%; European, South=32.51% (PubMed=30894373).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=TIB-223; CLS=300155; Cosmic-CLP=906999; IZSLER=BS TCL 94
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 17,19
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 13,15
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 12,13
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   GCT 27
AC   CVCL_A344
SY   GCT-27; GCT27
DR   cancercelllines; CVCL_A344
DR   Cosmic; 971771
DR   Cosmic; 2077190
DR   DepMap; ACH-001502
DR   DSMZ; ACC-743
DR   DSMZCellDive; ACC-743
DR   GEO; GSM863897
DR   Progenetix; CVCL_A344
DR   Wikidata; Q54835515
RX   PubMed=2442105;
RX   PubMed=11416159;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~35-40 hours (DSMZ=ACC-743).
ST   Source(s): DSMZ=ACC-743; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 13
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 18
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 16
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 10,12
ST   vWA: 15,17 (PubMed=11416159)
ST   vWA: 17 (DSMZ=ACC-743)
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 17
//
ID   GCT 35
AC   CVCL_A345
SY   GCT35
DR   Wikidata; Q54835516
RX   PubMed=2442105;
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   GCT 44
AC   CVCL_A346
SY   GCT44
DR   Cosmic; 971772
DR   Wikidata; Q54835517
RX   PubMed=2442105;
CC   Derived from site: Metastatic; Para-aortic lymph node; UBERON=UBERON_0016386.
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   GCT 46
AC   CVCL_A347
SY   GCT46
DR   Wikidata; Q54835518
RX   PubMed=2442105;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   GCT 48
AC   CVCL_A348
SY   GCT48
DR   Wikidata; Q54835519
RX   PubMed=2442105;
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   GCT 72
AC   CVCL_A349
SY   GCT72
DR   Wikidata; Q54835520
RX   PubMed=2442105;
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   GCT-C
AC   CVCL_E4CX
SY   UR-HCL-1 clone A
RX   PubMed=304748;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu32Arg (c.95_96TG>GT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.948_949delinsTT) (c.948_949CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1229 ! GCT
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GCTB28
AC   CVCL_XF37
DR   Wikidata; Q93559420
RX   PubMed=26801673;
CC   Population: Chinese.
CC   Doubling time: 44 hours (PubMed=26801673).
CC   Derived from site: In situ; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   GCTB28-luc
AC   CVCL_XG83
DR   CCRID; 4201PAT-CCTCC01289
DR   Wikidata; Q93559422
RX   Patent=CN109749998A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018178.
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF37 ! GCTB28
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   GCTTSC
AC   CVCL_JL58
SY   Giant Cell Tumor of Tendon Sheath Cell line
DR   Wikidata; Q54835521
RX   PubMed=11845350;
RX   PubMed=16228675;
CC   Population: Japanese.
CC   Doubling time: 150 hours (Note=At 9th passage) (PubMed=11845350).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ankle, tendon sheath; UBERON=UBERON_0001488+UBERON_0000304.
DI   NCIt; C6535; Malignant tenosynovial giant cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GCW04
AC   CVCL_C5P6
DR   Wikidata; Q116049057
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW07
AC   CVCL_C5P7
DR   Wikidata; Q116049058
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW08
AC   CVCL_C5P8
DR   Wikidata; Q116049059
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW10
AC   CVCL_C5P9
DR   Wikidata; Q116049060
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW11
AC   CVCL_C5PA
DR   Wikidata; Q116049061
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW17
AC   CVCL_C5PB
DR   Wikidata; Q116049062
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW18
AC   CVCL_C5PC
DR   Wikidata; Q116049063
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW20
AC   CVCL_C5PD
DR   Wikidata; Q116049064
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW21
AC   CVCL_C5PE
DR   Wikidata; Q116049065
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW22
AC   CVCL_C5PF
DR   Wikidata; Q116049066
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW24
AC   CVCL_C5PG
DR   Wikidata; Q116049067
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW25
AC   CVCL_C5PH
DR   Wikidata; Q116049068
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW26
AC   CVCL_C5PI
DR   Wikidata; Q116049069
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW27
AC   CVCL_C5PJ
DR   Wikidata; Q116049071
RX   PubMed=36230775;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GCW28
AC   CVCL_C5PK
DR   Wikidata; Q116049072
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW29
AC   CVCL_C5PL
DR   Wikidata; Q116049073
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW30
AC   CVCL_C5PM
DR   Wikidata; Q116049074
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW31
AC   CVCL_C5PN
DR   Wikidata; Q116049075
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GCW33
AC   CVCL_C5PP
DR   Wikidata; Q116049076
RX   PubMed=36230775;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GD-iPS1
AC   CVCL_C948
SY   GD-IPS1
DR   SKIP; SKIP004333
DR   Wikidata; Q54835522
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu29Alafs*18 (c.84dupG) (c.84_85insG) (84GG); ClinVar=VCV000004302; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8515 ! GM00852
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 25
//
ID   GD-iPS3
AC   CVCL_C949
SY   GD-IPS3
DR   Wikidata; Q54835523
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu29Alafs*18 (c.84dupG) (c.84_85insG) (84GG); ClinVar=VCV000004302; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8515 ! GM00852
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   GD149
AC   CVCL_B4UH
DR   PRIDE; PXD012308
DR   Wikidata; Q110432810
RX   PubMed=28832583;
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*01:01,24:02; B*38:01,44:03; C*06:02,12:03 (PubMed=28832583).
CC   HLA typing: DPA1*01:03,02:01; DPB1*03:01(124:01),04:01(350:01); DQA1*01:10,02:01; DQB1*02:02,06:03; DRB1*07:01,13:01; DRB3*01:01; DRB4*01:01 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   GD1I
AC   CVCL_S929
DR   Wikidata; Q54835524
RX   CelloPub=CLPUB00706;
RX   DOI=10.1139/f81-125;
RX   Patent=US4219543;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by channel catfish virus (CelloPub=CLPUB00706; DOI=10.1139/f81-125).
CC   Misspelling: GDII; Note=Occasionally.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   Gd1T
AC   CVCL_5479
DR   CLO; CLO_0003465
DR   ATCC; CRL-6180
DR   Wikidata; Q54835525
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6180; true.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_3690 ! Gd1WE
SX   Sex unspecified
AG   Embryo
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Gd1WE
AC   CVCL_3690
DR   CLO; CLO_0003466
DR   ATCC; CRL-6181
DR   Wikidata; Q54835526
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6181; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_5479 ! Gd1T
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GD25
AC   CVCL_7264
DR   EFO; EFO_0022803
DR   Wikidata; Q54835527
RX   PubMed=7533171;
RX   PubMed=8567726;
RX   PubMed=10574722;
RX   PubMed=10601344;
WW   Info; -; -; https://web.archive.org/web/20160325165513/http://bioinfoweb.com/CLDB-GD25.htm
CC   Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E078 ! G-201
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GD25T
AC   CVCL_GR75
DR   TOKU-E; 4081
DR   Wikidata; Q54835528
RX   PubMed=10574722;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7264 ! GD25
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   GD5
AC   CVCL_D6DT
DR   Wikidata; Q127380869
RX   PubMed=17466113;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Bovine milk alkaline phosphatase.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GDEFC
AC   CVCL_C7WF
SY   Guangling Donkey Ear Fibroblast Cell line
DR   Wikidata; Q123031350
RX   DOI=10.16431/j.cnki.1671-7236.2018.03.012;
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Guangling; VBO=VBO_0001800.
OX   NCBI_TaxID=9793; ! Equus asinus (Donkey)
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   GDM-1
AC   CVCL_1230
SY   GDM1
DR   CLO; CLO_0003467
DR   EFO; EFO_0002183
DR   CLDB; cl1446
DR   CLDB; cl5541
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2627
DR   BioSample; SAMN03473160
DR   BioSample; SAMN10987916
DR   cancercelllines; CVCL_1230
DR   Cell_Model_Passport; SIDM01057
DR   CGH-DB; 9221-4
DR   ChEMBL-Cells; CHEMBL3308198
DR   ChEMBL-Targets; CHEMBL2366157
DR   Cosmic; 787430
DR   Cosmic; 906870
DR   Cosmic; 947368
DR   Cosmic; 975249
DR   Cosmic; 999777
DR   Cosmic; 1012067
DR   Cosmic; 1177802
DR   Cosmic; 1197932
DR   Cosmic; 1281313
DR   Cosmic; 2089666
DR   Cosmic; 2131537
DR   Cosmic; 2306196
DR   Cosmic-CLP; 906870
DR   DepMap; ACH-000081
DR   DSMZ; ACC-87
DR   DSMZCellDive; ACC-87
DR   EGA; EGAS00001000978
DR   GDSC; 906870
DR   GEO; GSM887023
DR   GEO; GSM888093
DR   GEO; GSM1446735
DR   GEO; GSM1669808
DR   IARC_TP53; 21342
DR   ICLC; HTL01008
DR   IGRhCellID; GDM1
DR   LiGeA; CCLE_860
DR   LINCS_LDP; LCL-1052
DR   PharmacoDB; GDM1_402_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1230
DR   PubChem_Cell_line; CVCL_1230
DR   Wikidata; Q54835529
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6296552;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 96-12 hours (PubMed=6296552); ~40-50 hours (DSMZ=ACC-87).
CC   HLA typing: A*02:01,68:02; B*35:03,38:01; C*04:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.71%; Native American=1.16%; East Asian, North=0%; East Asian, South=2.32%; South Asian=9.02%; European, North=27.3%; European, South=58.5% (PubMed=30894373).
CC   Misspelling: GMD-1; Cosmic=2131537.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2627; Cosmic-CLP=906870; DSMZ=ACC-87; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 17,20
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 8,11
ST   Penta E: 15,20
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   GDSRMi001-A
AC   CVCL_C7RF
SY   iPSC-ZPR-4-P10; JD3415; JD-3415
DR   hPSCreg; GDSRMi001-A
DR   Wikidata; Q117704342
RX   PubMed=36868039;
CC   From: Guangdong Provincial People's Hospital; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:25636; MCTP2; Simple; p.Ter879Gluext (c.2635T>G); Zygosity=Homozygous (PubMed=36868039).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50461; Aortic dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   GE
AC   CVCL_S930
SY   Grouper Eye
DR   Wikidata; Q54835530
RX   PubMed=12962209;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
OI   CVCL_S931 ! GF
OI   CVCL_S932 ! GH [Epinephelus]
OI   CVCL_S934 ! GSB
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 12
//
ID   Ge Mar
AC   CVCL_4J64
DR   ATCC; CRL-1103
DR   Wikidata; Q54835531
CC   Discontinued: ATCC; CRL-1103; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 7
//
ID   GE#21
AC   CVCL_RL33
SY   GE #21
DR   SKIP; SKIP001741
DR   Wikidata; Q54835533
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple_corrected; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Homozygous; Note=By TALEN (PubMed=28052261).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   GE#22
AC   CVCL_RL34
SY   GE #22
DR   SKIP; SKIP001740
DR   Wikidata; Q54835534
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple_corrected; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Homozygous; Note=By TALEN (PubMed=28052261).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   GE#24
AC   CVCL_RL35
SY   GE #24
DR   SKIP; SKIP001739
DR   Wikidata; Q54835535
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple_corrected; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Homozygous; Note=By TALEN (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GE#51
AC   CVCL_RL36
SY   GE #51
DR   SKIP; SKIP001745
DR   Wikidata; Q54835536
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous (PubMed=28052261).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple_corrected; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous; Note=By TALEN (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GE#81
AC   CVCL_RL37
SY   GE #81
DR   SKIP; SKIP001744
DR   Wikidata; Q54835537
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous (PubMed=28052261).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple_corrected; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous; Note=By TALEN (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GE#83
AC   CVCL_RL38
SY   GE #83
DR   SKIP; SKIP001743
DR   Wikidata; Q54835538
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous (PubMed=28052261).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple_corrected; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous; Note=By TALEN (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GE#91
AC   CVCL_RL39
SY   GE #91
DR   SKIP; SKIP001742
DR   Wikidata; Q54835539
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous (PubMed=28052261).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple_corrected; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous; Note=By TALEN (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GE-1
AC   CVCL_T724
SY   Gekko Embryo-1
DR   Wikidata; Q54835532
RX   PubMed=4365679;
CC   Group: Reptilian cell line.
OX   NCBI_TaxID=481883; ! Eublepharis macularius (Leopard gecko)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   GE-2
AC   CVCL_VN47
SY   Gekko Embryo-2
DR   Wikidata; Q93559622
RX   PubMed=4365679;
CC   Group: Reptilian cell line.
OX   NCBI_TaxID=481883; ! Eublepharis macularius (Leopard gecko)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   GE1
AC   CVCL_E112
SY   GE 1
DR   CLO; CLO_0050207
DR   RCB; RCB1709
DR   Wikidata; Q54835540
RX   PubMed=11334466;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Epithelial cell of gingiva; CL=CL_0002621.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2-3M
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   Ge1
AC   CVCL_DD92
SY   Ge-1
DR   Wikidata; Q54835541
RX   Patent=US4695538;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8574.
CC   Monoclonal antibody isotype: IgA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8119 ! HMy.2 B
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   GE11
AC   CVCL_8873
SY   GE-11
DR   BTO; BTO_0003325
DR   Wikidata; Q54835542
RX   PubMed=10601344;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96610; Itgb1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E078 ! G-201
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   GE47192
AC   CVCL_F552
SY   TER287; TER-287; Ter 287; TER354; TER-354; Ter 354; TER463; TER-463; Ter 463
DR   IPD-IMGT/HLA; 10607
DR   Wikidata; Q54835543
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/362cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,31; B*18,51; DPB1*04:01:01,04:01:01; DQA1*01:02:02,03:03; DQB1*03:01:01,05:02:01; DRB1*04:31,16:02:01; DRB4*01:03:01:01; DRB5*02:02 (IPD-IMGT/HLA=10607).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   GE6
AC   CVCL_E113
SY   GE 6
DR   Wikidata; Q54835544
RX   PubMed=11334466;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Epithelial cell of gingiva; CL=CL_0002621.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2-3M
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   GEAMP
AC   CVCL_ZW85
SY   Gastro Esophageal Adenocarcinoma derived from a Malignant Pleural effusion
DR   cancercelllines; CVCL_ZW85
DR   Wikidata; Q102113869
RX   PubMed=31292541;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser836Ter (c.2507C>A); ClinVar=VCV001072880; Zygosity=Unspecified (PubMed=31292541).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Alafs*16 (c.459delG); Zygosity=Unspecified (PubMed=31292541).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=31292541
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,14
ST   D12S391: 17,20
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 14
ST   D1S1656: 15,16
ST   D21S11: 32.2
ST   D2S1338: 19,21
ST   D2S441: 12.3
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 13,15
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C9296; Gastroesophageal junction adenocarcinoma
DI   ORDO; Orphanet_70482; Carcinoma of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   GEC
AC   CVCL_S009
SY   GP; Grouper Embryonic Cell line
DR   Wikidata; Q54835545
RX   CelloPub=CLPUB00043;
RX   PubMed=18931085;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Singapore grouper iridovirus (SGIV).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=203262; ! Epinephelus tauvina (Greasy grouper)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   GEE
AC   CVCL_RY59
SY   Goose Embryo Epithelial
DR   Wikidata; Q54835548
RX   PubMed=29494688;
RX   PubMed=38870251;
CC   Group: Bird cell line.
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=29494688) has been retracted due to concern from the journal editors (PubMed=38870251). Whether or not the cell line exists is therefore not known.
CC   Doubling time: 16.3 hours (Note=At 20th passage), 18.12 hours (Note=At 45th passage), 18.98 hours (Note=At 65th passage) (PubMed=29494688).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8844; ! Anser anser anser (Western greylag goose)
SX   Sex unspecified
AG   11FD
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   GEE018
AC   CVCL_E672
DR   dbMHC; 48867
DR   ECACC; 94050329
DR   IHW; IHW09255
DR   IPD-IMGT/HLA; 10608
DR   Wikidata; Q54835549
RX   PubMed=29171935;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:03:01,29:01:01:01; B*07:05:01:01,15:19; C*04:03:01,15:05:02; DPB1*02:01:02/02:01:19,104:01; DQB1*05:01:01,05:02:01; DRB1*10:01:01,15:02:01 (IPD-IMGT/HLA=10608).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   GEEP
AC   CVCL_3823
DR   CLO; CLO_0003470
DR   CLDB; cl1449
DR   ECACC; 92062401
DR   Wikidata; Q54835550
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 4
//
ID   GEK
AC   CVCL_GU03
SY   Goat Embryonic Kidney
DR   Wikidata; Q54835551
RX   DOI=10.56093/ijans.v85i8.50930;
CC   Group: Vaccine production cell line.
CC   Doubling time: ~49.5 hours (DOI=10.56093/ijans.v85i8.50930).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Matou; VBO=VBO_0009447.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   GeLu
AC   CVCL_3313
SY   Gerbil Lung
DR   CLO; CLO_0003472
DR   CLDB; cl1450
DR   ATCC; CCL-100
DR   ECACC; 90102534
DR   Wikidata; Q54835552
RX   PubMed=7065527;
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
CC   Discontinued: ECACC; 90102534; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
SX   Female
AG   403D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   GEM-199
AC   CVCL_4204
SY   GEM 199; GEM199; Goldfish Erythrophoroma-199
DR   CLO; CLO_0051589
DR   RCB; RCB1175
DR   Wikidata; Q54835553
RX   CelloPub=CLPUB00627;
RX   PubMed=6408467;
RX   PubMed=6468803;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Wakin; VBO=VBO_0017501.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   GEM-218
AC   CVCL_4205
SY   GEM 218; GEM218; Goldfish Erythrophoroma-218
DR   CLO; CLO_0051590
DR   RCB; RCB1176
DR   Wikidata; Q54835554
RX   CelloPub=CLPUB00627;
RX   PubMed=6468803;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Ryukin; VBO=VBO_0017500.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   GEM-322
AC   CVCL_A6RS
SY   GEM 322; GEM322; Goldfish Erythrophoroma-322
DR   Wikidata; Q107115097
RX   CelloPub=CLPUB00627;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Ryukin; VBO=VBO_0017500.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   GEM-49
AC   CVCL_A6RR
SY   GEM 49; GEM49; Goldfish Erythrophoroma-49
DR   Wikidata; Q107115100
RX   CelloPub=CLPUB00627;
RX   PubMed=6928999;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Comet; VBO=VBO_0017498.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   GEM-81
AC   CVCL_4206
SY   GEM 81; GEM81; Goldfish Erythrophoroma-81
DR   CLO; CLO_0051592
DR   RCB; RCB1174
DR   Wikidata; Q54835555
RX   CelloPub=CLPUB00627;
RX   PubMed=2793781;
RX   PubMed=6287577;
RX   PubMed=6468803;
RX   PubMed=6928999;
CC   Group: Fish cell line.
CC   Doubling time: 31 hours (PubMed=6928999).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Wakin; VBO=VBO_0017501.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   GEM-81 clone P15
AC   CVCL_6G55
SY   P15
DR   Wikidata; Q54835556
RX   PubMed=2514977;
RX   PubMed=2793781;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Wakin; VBO=VBO_0017501.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
HI   CVCL_4206 ! GEM-81
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 13
//
ID   GEM-81 clone P15D
AC   CVCL_6G56
SY   P15D
DR   Wikidata; Q54835557
RX   PubMed=2514977;
RX   PubMed=2793781;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Wakin; VBO=VBO_0017501.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
HI   CVCL_6G55 ! GEM-81 clone P15
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 13
//
ID   GEM-81 clone P15DI
AC   CVCL_6G57
SY   P15DI
DR   Wikidata; Q54835558
RX   PubMed=2514977;
RX   PubMed=2793781;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Wakin; VBO=VBO_0017501.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
HI   CVCL_6G56 ! GEM-81 clone P15D
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 13
//
ID   GEM-MIA PaCa-2
AC   CVCL_HA89
SY   GEM,MIA PaCa-2
DR   cancercelllines; CVCL_HA89
DR   Wikidata; Q54835559
RX   PubMed=14508125;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GEM4A-1A8
AC   CVCL_C2DF
SY   GEM4A(1A8); GEM4A; 1A8
DR   Wikidata; Q114311485
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P57678; Human GEMIN4 (Note=Also reacts with mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM4B-1G4
AC   CVCL_C2DG
SY   GEM4B(1G4); GEM4B; 1G4
DR   DSHB; GEM4B-1G4
DR   Wikidata; Q114311486
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P57678; Human GEMIN4 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM4C-9E6
AC   CVCL_C2DH
SY   GEM4C(9E6); GEM4C; 9E6
DR   DSHB; GEM4C-9E6
DR   Wikidata; Q114311487
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P57678; Human GEMIN4 (Note=Also reacts with mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM4D-2H8
AC   CVCL_C2DI
SY   GEM4D(2H8); GEM4D; 2H8
DR   Wikidata; Q114311488
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P57678; Human GEMIN4 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM4E-7B5
AC   CVCL_C2DJ
SY   GEM4E(7B5); GEM4E; 7B5
DR   Wikidata; Q114311489
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P57678; Human GEMIN4 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM4F-2A2
AC   CVCL_C2DK
SY   GEM4F(2A2); GEM4F; 2A2
DR   Wikidata; Q114311490
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P57678; Human GEMIN4 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5A-1A5
AC   CVCL_C2DL
SY   GEM5A(1A5); GEM5A; 1A5
DR   DSHB; GEM5A-1A5
DR   Wikidata; Q114311491
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM5B-1B1
AC   CVCL_C2DM
SY   GEM5B(1B1); GEM5B; 1B1
DR   Wikidata; Q114311492
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5C-1C10
AC   CVCL_C2DN
SY   GEM5C(1C10); GEM5C; 1C10
DR   DSHB; GEM5C-1C10
DR   Wikidata; Q114311493
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM5D-2A12
AC   CVCL_C2DP
SY   GEM5D(2A12); GEM5D; 2A12
DR   Wikidata; Q114311494
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5E-2B11
AC   CVCL_C2DQ
SY   GEM5E(2B11); GEM5E; 2B11
DR   Wikidata; Q114311495
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5F-5C3
AC   CVCL_C2DR
SY   GEM5F(5C3); GEM5F; 5C3
DR   Wikidata; Q114311496
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5G-6C4
AC   CVCL_C2DS
SY   GEM5G(6C4); GEM5G; 6C4
DR   DSHB; GEM5G-6C4
DR   Wikidata; Q114311497
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM5H-6E2
AC   CVCL_C2DT
SY   GEM5H(6E2); GEM5H; 6E2
DR   Wikidata; Q114311498
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5I-7A1
AC   CVCL_C2DU
SY   GEM5I(7A1); GEM5I; 7A1
DR   Wikidata; Q114311499
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5J-7F1
AC   CVCL_C2DV
SY   GEM5J(7F1); GEM5J; 7F1
DR   Wikidata; Q114311500
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5K-8C7
AC   CVCL_C2DW
SY   GEM5K(8C7); GEM5K; 8C7
DR   Wikidata; Q114311502
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5L-8E7
AC   CVCL_C2DX
SY   GEM5L(8E7); GEM5L; 8E7
DR   DSHB; GEM5L-8E7
DR   Wikidata; Q114311503
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM5M-1E12
AC   CVCL_C2DY
SY   GEM5M(1E12); GEM5M; 1E12
DR   DSHB; GEM5M-1E12
DR   Wikidata; Q114311504
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM5N-2E6
AC   CVCL_C2DZ
SY   GEM5N(2E6); GEM5N; 2E6
DR   Wikidata; Q114311505
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5O-3E11
AC   CVCL_C2E0
SY   GEM5O(3E11); GEM5O; 3E11
DR   Wikidata; Q114311506
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5P-3G2
AC   CVCL_C2E1
SY   GEM5P(3G2); GEM5P; 3G2
DR   Wikidata; Q114311507
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5Q-4G7
AC   CVCL_C2E2
SY   GEM5Q(4G7); GEM5Q; 4G7
DR   Wikidata; Q114311509
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with mouse and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM5R-6G5
AC   CVCL_C2E3
SY   GEM5R(6G5); GEM5R; 6G5
DR   DSHB; GEM5R-6G5
DR   Wikidata; Q114311510
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TEQ6; Human GEMIN5 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM6A-2C11
AC   CVCL_C2E4
SY   GEM6A(2C11); GEM6A; 2C11
DR   DSHB; GEM6A-2C11
DR   Wikidata; Q114311511
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WXD5; Human GEMIN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM6B-4H6
AC   CVCL_C2E5
SY   GEM6B(4H6); GEM6B; 4H6
DR   DSHB; GEM6B-4H6
DR   Wikidata; Q114311513
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WXD5; Human GEMIN6 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM6C-5E9
AC   CVCL_C2E6
SY   GEM6C(5E9); GEM6C; 5E9
DR   DSHB; GEM6C-5E9
DR   Wikidata; Q114311514
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXD5; Human GEMIN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM6D-6F5
AC   CVCL_C2E7
SY   GEM6D(6F5); GEM6D; 6F5
DR   Wikidata; Q114311516
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WXD5; Human GEMIN6 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM6E-8A9
AC   CVCL_C2E8
SY   GEM6E(8A9); GEM6E; 8A9
DR   DSHB; GEM6E-8A9
DR   Wikidata; Q114311517
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WXD5; Human GEMIN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM6F-8D8
AC   CVCL_C2E9
SY   GEM6F(8D8); GEM6F; 8D8
DR   DSHB; GEM6F-8D8
DR   Wikidata; Q114311518
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WXD5; Human GEMIN6 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM6G-3F12
AC   CVCL_C2EA
SY   GEM6G(3F12); GEM6G; 3F12
DR   DSHB; GEM6G-3F12
DR   Wikidata; Q114311519
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WXD5; Human GEMIN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM7A-2A11
AC   CVCL_C2EB
SY   GEM7A(2A11); GEM7A; 2A11
DR   Wikidata; Q114311521
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H840; Human GEMIN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM7B-6A2
AC   CVCL_C2EC
SY   GEM7B(6A2); GEM7B; 6A2
DR   Wikidata; Q114311522
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H840; Human GEMIN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM7C-6A9
AC   CVCL_C2ED
SY   GEM7C(6A9); GEM7C; 6A9
DR   DSHB; GEM7C-6A9
DR   Wikidata; Q114311523
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H840; Human GEMIN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM7D-7A12
AC   CVCL_C2EE
SY   GEM7D(7A12); GEM7D; 7A12
DR   Wikidata; Q114311524
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H840; Human GEMIN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM7E-8D8
AC   CVCL_C2EF
SY   GEM7E(8D8); GEM7E; 8D8
DR   DSHB; GEM7E-8D8
DR   Wikidata; Q114311525
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H840; Human GEMIN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEM7F-8H1
AC   CVCL_C2EG
SY   GEM7F(8H1); GEM7F; 8H1
DR   Wikidata; Q114311526
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H840; Human GEMIN7 (Note=Also reacts with pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   GEM7G-10C12
AC   CVCL_C2EH
SY   GEM7G(10C12); GEM7G; 10C12
DR   DSHB; GEM7G-10C12
DR   Wikidata; Q114311527
RX   PubMed=17640370;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H840; Human GEMIN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GEMi001-A
AC   CVCL_E8XE
SY   GN-IPS-12-1
DR   BioSamples; SAMEA115423609
DR   hPSCreg; GEMi001-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi002-A
AC   CVCL_E8XF
SY   GN-IPS-14-2
DR   BioSamples; SAMEA115425257
DR   hPSCreg; GEMi002-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi003-A
AC   CVCL_E8XG
SY   GN-IPS-15-2
DR   BioSamples; SAMEA115918360
DR   hPSCreg; GEMi003-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi004-A
AC   CVCL_E8XH
SY   GN-IPS-135-1
DR   BioSamples; SAMEA115921444
DR   hPSCreg; GEMi004-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi005-A
AC   CVCL_E8XI
SY   GN-IPS-160-1
DR   BioSamples; SAMEA115926260
DR   hPSCreg; GEMi005-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi006-A
AC   CVCL_E8XJ
SY   GN-IPS-201-1
DR   BioSamples; SAMEA115932678
DR   hPSCreg; GEMi006-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi007-A
AC   CVCL_E8XK
SY   GN-IPS-202-1
DR   BioSamples; SAMEA115935053
DR   hPSCreg; GEMi007-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi008-A
AC   CVCL_E8XL
SY   GN-IPS-203-1
DR   BioSamples; SAMEA115938035
DR   hPSCreg; GEMi008-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi009-A
AC   CVCL_E8XM
SY   GN-IPS-204-1
DR   BioSamples; SAMEA115938049
DR   hPSCreg; GEMi009-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi010-A
AC   CVCL_E8XN
SY   GN-IPS-205-1
DR   BioSamples; SAMEA115942823
DR   hPSCreg; GEMi010-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi011-A
AC   CVCL_E8XP
SY   GN-IPS-206-1
DR   BioSamples; SAMEA115947781
DR   hPSCreg; GEMi011-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi012-A
AC   CVCL_E8XQ
SY   GN-IPS-207-1
DR   BioSamples; SAMEA115948474
DR   hPSCreg; GEMi012-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi013-A
AC   CVCL_E8XR
SY   GN-IPS-208-1
DR   BioSamples; SAMEA115948476
DR   hPSCreg; GEMi013-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi014-A
AC   CVCL_E8XS
SY   GN-IPS-209-1
DR   BioSamples; SAMEA115955727
DR   hPSCreg; GEMi014-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi015-A
AC   CVCL_E8XT
SY   GN-IPS-210-1
DR   BioSamples; SAMEA115957031
DR   hPSCreg; GEMi015-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi016-A
AC   CVCL_E8XU
SY   GN-IPS-211-1
DR   BioSamples; SAMEA115975719
DR   hPSCreg; GEMi016-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi017-A
AC   CVCL_E8XV
SY   GN-IPS-212-1
DR   BioSamples; SAMEA115992324
DR   hPSCreg; GEMi017-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi018-A
AC   CVCL_E8XW
SY   GN-IPS-213-1
DR   BioSamples; SAMEA116000139
DR   hPSCreg; GEMi018-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi019-A
AC   CVCL_E8XX
SY   GN-IPS-214-1
DR   BioSamples; SAMEA116000141
DR   hPSCreg; GEMi019-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi020-A
AC   CVCL_E8XY
SY   GN-IPS-215-1
DR   BioSamples; SAMEA116000143
DR   hPSCreg; GEMi020-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi021-A
AC   CVCL_E8XZ
SY   GN-IPS-216-1
DR   BioSamples; SAMEA116000165
DR   hPSCreg; GEMi021-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi022-A
AC   CVCL_E8Y0
SY   GN-IPS-217-1
DR   BioSamples; SAMEA115963428
DR   hPSCreg; GEMi022-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi022-A-1
AC   CVCL_E8Y7
SY   GN-JY02-01-001(APP c.2010-2011 inv)
DR   BioSamples; SAMEA116043122
DR   hPSCreg; GEMi022-A-1
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Lys670_Met671delinsAsnLeu (c.2010_2011inv) (c.2010_2011delGAinsTC); ClinVar=VCV000018093; Zygosity=Unspecified; Note=By CRISPR/Cas9 (hPSCreg=GEMi022-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8Y0 ! GEMi022-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi022-A-2
AC   CVCL_E8Y1
SY   GN-JY02-01-008(PSEN1 c.313T>C)
DR   BioSamples; SAMEA116144572
DR   hPSCreg; GEMi022-A-2
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Cys105Arg (c.313T>C); ClinVar=VCV002628372; Zygosity=Unspecified; Note=By CRISPR/Cas9 (hPSCreg=GEMi022-A-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8Y0 ! GEMi022-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi022-A-3
AC   CVCL_E8Y2
SY   GN-JY02-01-012(APP c.2149G>A)
DR   BioSamples; SAMEA117481767
DR   hPSCreg; GEMi022-A-3
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Unspecified; Note=By CRISPR/Cas9 (hPSCreg=GEMi022-A-3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8Y0 ! GEMi022-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi022-A-4
AC   CVCL_E8Y8
DR   hPSCreg; GEMi022-A-4
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8Y0 ! GEMi022-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi023-A
AC   CVCL_E8Y3
SY   GN-IPS-218-1
DR   BioSamples; SAMEA116001533
DR   hPSCreg; GEMi023-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi024-A
AC   CVCL_E8Y4
SY   GN-IPS-219-1
DR   BioSamples; SAMEA116001537
DR   hPSCreg; GEMi024-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi025-A
AC   CVCL_E8Y5
SY   GN-IPS-220-1
DR   BioSamples; SAMEA115972111
DR   hPSCreg; GEMi025-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GEMi026-A
AC   CVCL_E8Y6
SY   GN-IPS-46-3
DR   BioSamples; SAMEA116089724
DR   hPSCreg; GEMi026-A
CC   From: Shanghai Gemple Biotech Co., Ltd; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Gen
AC   CVCL_WH23
DR   Wikidata; Q93559757
RX   PubMed=28283079;
DI   NCIt; C129299; Canine lung adenocarcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   GEN2.2
AC   CVCL_5G44
SY   Gen2.2; GEN 2.2; Gen 2.2; HLA-A*0201+ pDC line
DR   Wikidata; Q54835560
RX   Patent=US7341870;
RX   PubMed=16365416;
RX   PubMed=22696054;
WW   Info; -; -; https://web.archive.org/web/20160706131224/http://www.clg.niigata-u.ac.jp:80/~matak/eng/resmat12.pdf
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2938.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5G45 ! GEN3
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   GEN3
AC   CVCL_5G45
SY   GEN 3
DR   Wikidata; Q54835561
RX   Patent=US7341870;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3110.
DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5G44 ! GEN2.2
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   GENEA001
AC   CVCL_9010
SY   SIVF001; SIVF-01; SIVF01; GENEAe001-A
DR   BioSamples; SAMEA104012400
DR   hPSCreg; GENEAe001-A
DR   NIHhESC; NIHhESC-16-0370
DR   Wikidata; Q54835562
RX   PubMed=20198447;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0370.
CC   Registration: Swiss research registry; BAG-hES-IMP-0025.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   GENEA002
AC   CVCL_9011
SY   Genea002; SIVF002; SIVF-02; SIVF02
DR   NIHhESC; NIHhESC-12-0151
DR   Wikidata; Q54835563
RX   PubMed=20198447;
RX   PubMed=20428235;
RX   PubMed=25316320;
RX   PubMed=27217344;
RX   PubMed=27345802;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0151.
CC   Registration: Swiss research registry; BAG-hES-IMP-0026.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-38.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to GENEA048 (Cellosaurus=CVCL_9057).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27345802
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 23
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 19,21
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   GENEA003
AC   CVCL_9012
SY   SIVF003; SIVF03; GENEAe002-A
DR   BioSamples; SAMEA104012402
DR   hPSCreg; GENEAe002-A
DR   Wikidata; Q54835564
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C37866; Trisomy 16
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   GENEA004
AC   CVCL_9013
SY   SIVF004; SIVF04; GENEAe003-A
DR   BioSamples; SAMEA104012404
DR   hPSCreg; GENEAe003-A
DR   Wikidata; Q54835565
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA005
AC   CVCL_9014
SY   SIVF005; SIVF05; GENEAe004-A
DR   BioSamples; SAMEA104012406
DR   hPSCreg; GENEAe004-A
DR   Wikidata; Q54835567
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA006
AC   CVCL_9015
SY   SIVF006; SIVF06; GENEAe005-A
DR   BioSamples; SAMEA104012408
DR   hPSCreg; GENEAe005-A
DR   Wikidata; Q54835568
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA007
AC   CVCL_9016
SY   SIVF007; SIVF07; GENEAe006-A
DR   BioSamples; SAMEA104012410
DR   hPSCreg; GENEAe006-A
DR   Wikidata; Q54835569
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA008
AC   CVCL_9017
SY   SIVF008; SIVF08; GENEAe007-A
DR   BioSamples; SAMEA104012412
DR   hPSCreg; GENEAe007-A
DR   Wikidata; Q54835570
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA009
AC   CVCL_9018
SY   SIVF009; SIVF09; GENEAe008-A
DR   BioSamples; SAMEA104012414
DR   hPSCreg; GENEAe008-A
DR   Wikidata; Q54835571
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA010
AC   CVCL_9019
SY   SIVF010; SIVF10; GENEAe009-A
DR   BioSamples; SAMEA104012416
DR   hPSCreg; GENEAe009-A
DR   Wikidata; Q54835572
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA011
AC   CVCL_9020
SY   SIVF011; SIVF11; GENEAe010-A
DR   BioSamples; SAMEA104012418
DR   hPSCreg; GENEAe010-A
DR   Wikidata; Q54835573
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36433; Trisomy 5
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   GENEA012
AC   CVCL_9021
SY   SIVF012; SIVF12; GENEAe011-A
DR   BioSamples; SAMEA104012420
DR   hPSCreg; GENEAe011-A
DR   Wikidata; Q54835574
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA013
AC   CVCL_9022
SY   SIVF013; SIVF13; GENEAe012-A
DR   BioSamples; SAMEA104012422
DR   hPSCreg; GENEAe012-A
DR   Wikidata; Q54835575
RX   PubMed=18386991;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   GENEA014
AC   CVCL_9023
SY   SIVF014
DR   Wikidata; Q54835576
RX   PubMed=20198447;
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   GENEA015
AC   CVCL_9024
SY   Genea015; SIVF015
DR   NIHhESC; NIHhESC-13-0228
DR   Wikidata; Q54835577
RX   PubMed=27217344;
RX   PubMed=27346028;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0228.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-37.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to GENEA016 (Cellosaurus=CVCL_9025).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346028
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,15
ST   D19S433: 15,16.2
ST   D21S11: 29,31.2
ST   D2S1338: 18,23
ST   D3S1358: 16,19
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   TH01: 6,8
ST   TPOX: 8,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GENEA016
AC   CVCL_9025
SY   Genea016; SIVF016
DR   NIHhESC; NIHhESC-13-0229
DR   Wikidata; Q54835578
RX   PubMed=27345780;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0229.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-37.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to GENEA015 (Cellosaurus=CVCL_9024).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27345780
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D18S51: 13,19
ST   D19S433: 15,16.2
ST   D21S11: 28,29
ST   D2S1338: 18,19
ST   D3S1358: 16,19
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 6,8
ST   TPOX: 8,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA017-HD
AC   CVCL_9026
SY   GENEA017; Genea017; SIVF017; SIVF017-HD; SIV017
DR   NIHhESC; NIHhESC-12-0166
DR   Wikidata; Q54835579
RX   PubMed=20649476;
RX   PubMed=25316320;
RX   PubMed=27346022;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0166.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-44.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Genea).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346022
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,14
ST   D16S539: 11,12
ST   D18S51: 15,18
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   GENEA018-HD
AC   CVCL_9027
SY   GENEA018; Genea018; GENEA-018; SIVF018; SIVF018-HD; SIV018
DR   NIHhESC; NIHhESC-12-0169
DR   Wikidata; Q54835580
RX   PubMed=20649476;
RX   PubMed=25316320;
RX   PubMed=27346005;
RX   PubMed=35805069;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0169.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-45.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Genea).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346005
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 24,25
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   GENEA019
AC   CVCL_9028
SY   Genea019; GENEA-019; SIVF019; SIV019; GENEAe020-A
DR   BioSamples; SAMEA104013010
DR   hPSCreg; GENEAe020-A
DR   SKIP; SKIP002919
DR   Wikidata; Q54835581
RX   PubMed=20649476;
RX   PubMed=25316320;
RX   PubMed=27217344;
RX   PubMed=27346002;
RX   PubMed=35805069;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-62.
CC   Omics: Proteomics.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Embryo is sibling to that giving rise to GENEA020 (Cellosaurus=CVCL_9029).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346002
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   TH01: 9.3,10
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA020
AC   CVCL_9029
SY   GENEA020-HD; Genea020; GENEA-020; SIVF020; SIVF020-HD; SIV020; GENEAe015-A
DR   BioSamples; SAMEA104012534
DR   hPSCreg; GENEAe015-A
DR   SKIP; SKIP002918
DR   Wikidata; Q54835582
RX   PubMed=20649476;
RX   PubMed=25316320;
RX   PubMed=27346007;
RX   PubMed=35805069;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-62.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[48] (c.52CAG(48)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Genea).
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Embryo is sibling to that giving rise to GENEA019 (Cellosaurus=CVCL_9028).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346007
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13,16.2
ST   D21S11: 30,33.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 12,13
ST   FGA: 19,20
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GENEA021
AC   CVCL_9030
SY   Genea021; GEN021; SIVF021; SIVF-021; GENEAe021-A
DR   BioSamples; SAMEA104130950
DR   hPSCreg; GENEAe021-A
DR   Wikidata; Q54835584
RX   PubMed=25645121;
RX   PubMed=27346003;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: Swiss research registry; BAG-hES-IMP-0027.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to those giving rise to GENEA022 (Cellosaurus=CVCL_9031) and GENEA023 (Cellosaurus=CVCL_9032).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346003
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 13,19
ST   D19S433: 14.2,15
ST   D21S11: 29,30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   GENEA022
AC   CVCL_9031
SY   Genea022; GEN022; SIVF022; SIVF-022; GENEAe016-A
DR   BioSamples; SAMEA104130951
DR   hPSCreg; GENEAe016-A
DR   Wikidata; Q54835585
RX   PubMed=25316320;
RX   PubMed=25645121;
RX   PubMed=27346017;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: Swiss research registry; BAG-hES-IMP-0028.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to those giving rise to GENEA021 (Cellosaurus=CVCL_9030) and GENEA023 (Cellosaurus=CVCL_9032).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346017
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA023
AC   CVCL_9032
SY   Genea023; GEN023; SIVF023; SIVF-023; GENEAe017-A
DR   BioSamples; SAMEA104236911
DR   hPSCreg; GENEAe017-A
DR   Wikidata; Q54835586
RX   PubMed=25316320;
RX   PubMed=25645121;
RX   PubMed=27346015;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: Swiss research registry; BAG-hES-IMP-0029.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to those giving rise to GENEA021 (Cellosaurus=CVCL_9030) and GENEA022 (Cellosaurus=CVCL_9031).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346015
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 14
ST   FGA: 22,24
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA024
AC   CVCL_9033
SY   SIVF024
DR   NIHhESC; NIHhESC-12-0170
DR   Wikidata; Q54835587
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0170.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-45.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA025
AC   CVCL_9034
SY   SIVF025; 121
DR   Wikidata; Q54835588
RX   PubMed=24745836;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GENEA026
AC   CVCL_9035
SY   SIVF026; 171
DR   Wikidata; Q54835589
RX   PubMed=24745836;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GENEA027
AC   CVCL_9036
SY   SIVF027; 273
DR   Wikidata; Q54835593
RX   PubMed=24745836;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GENEA028
AC   CVCL_9037
SY   SIVF028; 326
DR   Wikidata; Q54835594
RX   PubMed=24745836;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GENEA029
AC   CVCL_9038
SY   SIVF029; 438; GENEAe014-A
DR   BioSamples; SAMEA104012532
DR   hPSCreg; GENEAe014-A
DR   Wikidata; Q54835595
RX   PubMed=24745836;
RX   PubMed=25316320;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-60.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   GENEA030
AC   CVCL_9039
SY   SIVF030
DR   Wikidata; Q54835596
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84685; Emery-Dreifuss muscular dystrophy
DI   ORDO; Orphanet_261; Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   GENEA031
AC   CVCL_9040
SY   SIVF031
DR   Wikidata; Q54835597
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Donor information: Embryo is sibling to those giving rise to GENEA032 (Cellosaurus=CVCL_9041) and GENEA033 (Cellosaurus=CVCL_9042).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   GENEA032
AC   CVCL_9041
SY   SIVF032
DR   Wikidata; Q54835598
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Donor information: Embryo is sibling to those giving rise to GENEA031 (Cellosaurus=CVCL_9040) and GENEA033 (Cellosaurus=CVCL_9042).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GENEA033
AC   CVCL_9042
SY   SIVF033
DR   Wikidata; Q54835599
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Donor information: Embryo is sibling to those giving rise to GENEA031 (Cellosaurus=CVCL_9040) and GENEA032 (Cellosaurus=CVCL_9041).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GENEA034
AC   CVCL_9043
DR   Wikidata; Q54835600
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   GENEA035
AC   CVCL_9044
DR   Wikidata; Q54835602
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   GENEA036
AC   CVCL_9045
DR   Wikidata; Q54835603
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   GENEA037
AC   CVCL_9046
DR   Wikidata; Q54835604
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   GENEA038
AC   CVCL_9047
DR   Wikidata; Q54835605
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   GENEA039
AC   CVCL_9048
DR   Wikidata; Q54835606
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   GENEA040
AC   CVCL_9049
SY   SIVF040
DR   NIHhESC; NIHhESC-12-0171
DR   Wikidata; Q54835607
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0171.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-45.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Genea).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   GENEA041
AC   CVCL_9050
SY   SIVF041
DR   NIHhESC; NIHhESC-12-0167
DR   Wikidata; Q54835608
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0167.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-44.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Genea).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Genea).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   GENEA042
AC   CVCL_9051
SY   Genea042; SIVF042
DR   NIHhESC; NIHhESC-13-0231
DR   Wikidata; Q54835609
RX   PubMed=27345994;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0231.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-40.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27345994
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 16,23
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GENEA043
AC   CVCL_9052
SY   Genea043; SIVF043
DR   NIHhESC; NIHhESC-13-0232
DR   Wikidata; Q54835610
RX   PubMed=27345801;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0232.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-40.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27345801
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 30,30.2
ST   D2S1338: 16,18
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GENEA044
AC   CVCL_9053
SY   SIVF044
DR   Wikidata; Q54835611
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   GENEA045
AC   CVCL_9054
SY   SIVF045
DR   Wikidata; Q54835612
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   GENEA046-HD
AC   CVCL_9055
SY   GENEA046; Genea046; SIVF046; SIVF046-HD
DR   NIHhESC; NIHhESC-12-0180
DR   Wikidata; Q54835613
RX   PubMed=20649476;
RX   PubMed=25316320;
RX   PubMed=27346012;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0180.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-46.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Genea).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346012
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D18S51: 14,18
ST   D19S433: 13.2,14
ST   D21S11: 29,30
ST   D2S1338: 18,24
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 7,11
ST   D8S1179: 10,14
ST   FGA: 20,25
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   GENEA047
AC   CVCL_9056
SY   Genea047; SIVF047
DR   NIHhESC; NIHhESC-13-0230
DR   Wikidata; Q54835614
RX   PubMed=27345995;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0230.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-41.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27345995
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 12,14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 10,13
ST   FGA: 20,22
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GENEA048
AC   CVCL_9057
SY   SIVF048
DR   NIHhESC; NIHhESC-12-0152
DR   Wikidata; Q54835615
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0152.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-38.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to GENEA002 (Cellosaurus=CVCL_9011).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA049
AC   CVCL_9058
SY   Genea049; SIVF049
DR   NIHhESC; NIHhESC-12-0183
DR   Wikidata; Q54835616
RX   PubMed=27217344;
RX   PubMed=27346016;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0183.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-54.
CC   Donor information: Embryo is sibling to that giving rise to GENEA050 (Cellosaurus=CVCL_9059).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346016
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 15,21
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 20,23
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 20,23
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   GENEA050
AC   CVCL_9059
SY   Genea050; SIVF050
DR   NIHhESC; NIHhESC-12-0184
DR   Wikidata; Q54835617
RX   PubMed=27217344;
RX   PubMed=27346025;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0184.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-54.
CC   Donor information: Embryo is sibling to that giving rise to GENEA049 (Cellosaurus=CVCL_9058).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346025
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 11,15
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 20,25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GENEA051
AC   CVCL_9060
DR   Wikidata; Q54835618
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   GENEA052
AC   CVCL_9061
SY   Genea052; SIVF052
DR   NIHhESC; NIHhESC-13-0234
DR   Wikidata; Q54835619
RX   PubMed=27345996;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0234.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-36.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27345996
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 27,32.2
ST   D2S1338: 19,24
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   GENEA053
AC   CVCL_9062
SY   Genea053; GEN053; SIVF053
DR   Wikidata; Q54835620
RX   PubMed=25645121;
RX   PubMed=27346024;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346024
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 19,24
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 15,17
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GENEA054
AC   CVCL_9063
DR   Wikidata; Q54835621
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   GENEA055
AC   CVCL_9064
SY   SIVF055
DR   Wikidata; Q54835622
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-61.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   GENEA056
AC   CVCL_9065
DR   Wikidata; Q54835623
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-63.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   GENEA057
AC   CVCL_9066
SY   Genea057; SIVF057
DR   NIHhESC; NIHhESC-13-0233
DR   Wikidata; Q54835625
RX   PubMed=27345782;
RX   PubMed=28445466;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0233.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-39.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27345782
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 28,31
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GENEA058
AC   CVCL_9067
SY   SIVF058
DR   NIHhESC; NIHhESC-13-0199
DR   Wikidata; Q54835626
RX   PubMed=27217344;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0199.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA059
AC   CVCL_9068
SY   SIVF059
DR   NIHhESC; NIHhESC-12-0175
DR   Wikidata; Q54835627
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0175.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GENEA060
AC   CVCL_9069
SY   SIVF060
DR   NIHhESC; NIHhESC-12-0172
DR   Wikidata; Q54835628
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0172.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC   Donor information: Embryo is sibling to that giving rise to GENEA061 (Cellosaurus=CVCL_9070).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA061
AC   CVCL_9070
SY   SIVF061
DR   NIHhESC; NIHhESC-12-0173
DR   Wikidata; Q54835629
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0173.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC   Donor information: Embryo is sibling to that giving rise to GENEA060 (Cellosaurus=CVCL_9069).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA062
AC   CVCL_9071
SY   SIVF062
DR   NIHhESC; NIHhESC-12-0187
DR   Wikidata; Q54835630
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0187.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Donor information: Embryo is sibling to that giving rise to GENEA063 (Cellosaurus=CVCL_9072).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   GENEA063
AC   CVCL_9072
SY   SIVF063
DR   NIHhESC; NIHhESC-12-0188
DR   Wikidata; Q54835631
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0188.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Donor information: Embryo is sibling to that giving rise to GENEA062 (Cellosaurus=CVCL_9071).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   GENEA064
AC   CVCL_9073
SY   SIVF064
DR   NIHhESC; NIHhESC-12-0174
DR   Wikidata; Q54835632
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0174.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GENEA065
AC   CVCL_9074
SY   SIVF065
DR   NIHhESC; NIHhESC-13-0200
DR   Wikidata; Q54835633
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0200.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-48.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA066
AC   CVCL_9075
SY   Genea066; SIVF066
DR   NIHhESC; NIHhESC-12-0189
DR   Wikidata; Q54835634
RX   PubMed=27346023;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0189.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346023
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 16,17
ST   D19S433: 14,14.2
ST   D21S11: 28,32.2
ST   D2S1338: 19,24
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   TH01: 6
ST   TPOX: 11,12
ST   vWA: 15,18
DI   NCIt; C84680; Dystrophia myotonica 2
DI   ORDO; Orphanet_606; Proximal myotonic myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   GENEA067
AC   CVCL_9076
SY   Genea067; SIVF067
DR   NIHhESC; NIHhESC-12-0190
DR   Wikidata; Q54835637
RX   PubMed=27346009;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0190.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346009
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 17,18
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   GENEA068
AC   CVCL_9077
SY   SIVF068
DR   NIHhESC; NIHhESC-12-0168
DR   Wikidata; Q54835638
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0168.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-44.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA069
AC   CVCL_9078
SY   SIVF069
DR   NIHhESC; NIHhESC-12-0181
DR   Wikidata; Q54835639
RX   CelloPub=CLPUB00370;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0181.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-51.
CC   Sequence variation: Mutation; HGNC; HGNC:12703; BEST1; Simple; p.Phe305Ser (c.914T>C); ClinVar=VCV000099778; Zygosity=Unspecified (CelloPub=CLPUB00370).
CC   Donor information: Embryo is sibling to that giving rise to GENEA070 (Cellosaurus=CVCL_9079).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118788; Vitelliform macular dystrophy
DI   ORDO; Orphanet_1243; Best vitelliform macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   GENEA070
AC   CVCL_9079
SY   SIVF070
DR   NIHhESC; NIHhESC-12-0182
DR   Wikidata; Q54835640
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0182.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-51.
CC   Donor information: Embryo is sibling to that giving rise to GENEA069 (Cellosaurus=CVCL_9078).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118788; Vitelliform macular dystrophy
DI   ORDO; Orphanet_1243; Best vitelliform macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA071
AC   CVCL_9080
SY   SIVF071
DR   NIHhESC; NIHhESC-12-0191
DR   Wikidata; Q54835641
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0191.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA072
AC   CVCL_9081
SY   SIVF072
DR   NIHhESC; NIHhESC-12-0192
DR   Wikidata; Q54835642
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0192.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA073
AC   CVCL_9082
SY   SIVF073
DR   NIHhESC; NIHhESC-12-0193
DR   Wikidata; Q54835644
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0193.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   GENEA074
AC   CVCL_9083
SY   SIVF074
DR   NIHhESC; NIHhESC-12-0194
DR   Wikidata; Q54835645
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0194.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA075
AC   CVCL_B883
SY   SIVF075
DR   Wikidata; Q54835646
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-64.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GENEA076
AC   CVCL_B884
SY   SIVF076
DR   Wikidata; Q54835647
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-64.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GENEA077
AC   CVCL_B885
SY   SIVF077
DR   NIHhESC; NIHhESC-14-0261
DR   Wikidata; Q54835648
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0261.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-55.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118697; Hypochondroplasia
DI   ORDO; Orphanet_429; Hypochondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GENEA078
AC   CVCL_B886
SY   Genea078; SIVF078
DR   NIHhESC; NIHhESC-14-0252
DR   Wikidata; Q54835649
RX   PubMed=27346006;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0252.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.15110dupA; Zygosity=Heterozygous (PubMed=27346006).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Unexplicit; Ex55del; Zygosity=Heterozygous (PubMed=27346006).
CC   Donor information: Embryo is sibling to those giving rise to GENEA079 (Cellosaurus=CVCL_B887) and GENEA080 (Cellosaurus=CVCL_B888).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346006
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   GENEA079
AC   CVCL_B887
SY   Genea079; SIVF079
DR   NIHhESC; NIHhESC-14-0253
DR   Wikidata; Q54835650
RX   PubMed=27346010;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0253.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Donor information: Embryo is sibling to those giving rise to GENEA078 (Cellosaurus=CVCL_B886) and GENEA080 (Cellosaurus=CVCL_B888).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346010
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D21S11: 29,30.2
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   GENEA080
AC   CVCL_B888
SY   Genea080; SIVF080
DR   NIHhESC; NIHhESC-14-0254
DR   Wikidata; Q54835651
RX   PubMed=27346011;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0254.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Donor information: Embryo is sibling to those giving rise to GENEA078 (Cellosaurus=CVCL_B886) and GENEA079 (Cellosaurus=CVCL_B887).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346011
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D19S433: 14,14.3
ST   D21S11: 28,30.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   GENEA081
AC   CVCL_B889
SY   SIVF081
DR   NIHhESC; NIHhESC-14-0255
DR   Wikidata; Q54835653
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0255.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GENEA082
AC   CVCL_B890
SY   SIVF082
DR   NIHhESC; NIHhESC-14-0251
DR   Wikidata; Q54835654
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0251.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-56.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C67383; Epidermolysis bullosa
DI   ORDO; Orphanet_79361; Inherited epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GENEA083
AC   CVCL_M234
DR   NIHhESC; NIHhESC-14-0256
DR   Wikidata; Q54835655
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0256.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-52.
CC   Donor information: Embryo is sibling to that giving rise to GENEA084 (Cellosaurus=CVCL_M235).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C114768; Loeys-Dietz syndrome type 2
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GENEA084
AC   CVCL_M235
DR   NIHhESC; NIHhESC-14-0257
DR   Wikidata; Q54835656
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0257.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-53.
CC   Donor information: Embryo is sibling to that giving rise to GENEA083 (Cellosaurus=CVCL_M234).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C114768; Loeys-Dietz syndrome type 2
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GENEA085
AC   CVCL_M236
DR   NIHhESC; NIHhESC-14-0250
DR   Wikidata; Q54835657
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0250.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-53.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GENEA086
AC   CVCL_M237
DR   NIHhESC; NIHhESC-14-0258
DR   Wikidata; Q54835658
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0258.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Donor information: Embryo is sibling to that giving rise to GENEA087 (Cellosaurus=CVCL_M238).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GENEA087
AC   CVCL_M238
DR   NIHhESC; NIHhESC-14-0259
DR   Wikidata; Q54835659
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0259.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Donor information: Embryo is sibling to that giving rise to GENEA086 (Cellosaurus=CVCL_M237).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GENEA088
AC   CVCL_M239
DR   NIHhESC; NIHhESC-14-0260
DR   Wikidata; Q54835660
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0260.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-50.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118787; Simpson Golabi Behmel syndrome type 1
DI   ORDO; Orphanet_373; Simpson-Golabi-Behmel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GENEA089
AC   CVCL_M240
SY   Genea089; SIVF089; GENEAe013-A
DR   BioSamples; SAMEA104012530
DR   hPSCreg; GENEAe013-A
DR   NIHhESC; NIHhESC-14-0247
DR   Wikidata; Q54835661
RX   PubMed=25316320;
RX   PubMed=27346008;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0247.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Genea).
CC   Donor information: Embryo is sibling to those giving rise to GENEA090 (Cellosaurus=CVCL_M241) and GENEA091 (Cellosaurus=CVCL_M242).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346008
ST   Amelogenin: X
ST   CSF1PO: 11,15
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,19
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GENEA090
AC   CVCL_M241
SY   Genea090; GENEAe018-A
DR   BioSamples; SAMEA104130590
DR   hPSCreg; GENEAe018-A
DR   NIHhESC; NIHhESC-14-0245
DR   Wikidata; Q54835662
RX   PubMed=25316320;
RX   PubMed=27346026;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0245.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Genea).
CC   Donor information: Embryo is sibling to those giving rise to GENEA089 (Cellosaurus=CVCL_M240) and GENEA091 (Cellosaurus=CVCL_M242).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346026
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GENEA091
AC   CVCL_M242
SY   Genea091; GENEAe019-A
DR   BioSamples; SAMEA104130930
DR   hPSCreg; GENEAe019-A
DR   NIHhESC; NIHhESC-14-0246
DR   Wikidata; Q54835663
RX   PubMed=25316320;
RX   PubMed=27346013;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0246.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-49.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (Genea).
CC   Donor information: Embryo is sibling to those giving rise to GENEA089 (Cellosaurus=CVCL_M240) and GENEA090 (Cellosaurus=CVCL_M241).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346013
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 12,13
ST   D21S11: 29,31
ST   D2S1338: 17
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GENEA093
AC   CVCL_V432
DR   NIHhESC; NIHhESC-16-0371
DR   Wikidata; Q54835664
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0371.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-42.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GENEA094
AC   CVCL_V433
DR   NIHhESC; NIHhESC-16-0372
DR   Wikidata; Q54835665
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0372.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-43.
CC   Donor information: Embryo is sibling to that giving rise to GENEA095 (Cellosaurus=CVCL_V434).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GENEA095
AC   CVCL_V434
DR   NIHhESC; NIHhESC-16-0373
DR   Wikidata; Q54835666
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0373.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-43.
CC   Donor information: Embryo is sibling to that giving rise to GENEA094 (Cellosaurus=CVCL_V433).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GENEA096
AC   CVCL_M243
SY   Genea096
DR   NIHhESC; NIHhESC-14-0244
DR   Wikidata; Q54835667
RX   PubMed=27217344;
RX   PubMed=27346027;
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0244.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-57.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346027
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,11
ST   FGA: 22
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GENEA097
AC   CVCL_M244
DR   NIHhESC; NIHhESC-14-0248
DR   Wikidata; Q54835668
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0248.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
CC   Donor information: Embryo is sibling to that giving rise to GENEA098 (Cellosaurus=CVCL_M245).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C5183; Hereditary multiple exostoses
DI   ORDO; Orphanet_321; Multiple osteochondromas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GENEA098
AC   CVCL_M245
DR   NIHhESC; NIHhESC-14-0249
DR   Wikidata; Q54835669
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0249.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-47.
CC   Donor information: Embryo is sibling to that giving rise to GENEA097 (Cellosaurus=CVCL_M244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C5183; Hereditary multiple exostoses
DI   ORDO; Orphanet_321; Multiple osteochondromas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GENEA099
AC   CVCL_V737
DR   NIHhESC; NIHhESC-16-0378
DR   Wikidata; Q54835670
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0378.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-58.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C129981; Spastic paraplegia 4
DI   ORDO; Orphanet_100985; Autosomal dominant spastic paraplegia type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GENEA100
AC   CVCL_2G85
DR   NIHhESC; NIHhESC-16-0376
DR   Wikidata; Q54835671
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0376.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-59.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GENEA101
AC   CVCL_2G86
DR   NIHhESC; NIHhESC-16-0377
DR   Wikidata; Q54835672
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0377.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-59.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GENEA104
AC   CVCL_2G87
DR   NIHhESC; NIHhESC-16-0374
DR   Wikidata; Q54835673
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0374.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GENEA105
AC   CVCL_2G88
DR   NIHhESC; NIHhESC-16-0375
DR   Wikidata; Q54835674
WW   Provider; Genea; -; https://web.archive.org/web/20180912205435/http://geneabiocells.com/services/shelf-products/human-embryonic-stem-cells/
CC   From: Genea Biocells, Ltd; Sydney; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0375.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36425; Trisomy 3
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GeneBLAzer 5TH1A-Galpha15-NFAT-bla CHO-K1
AC   CVCL_ZK39
SY   5TH1A-Galpha5-NFAT-bla CHO-K1
DR   Wikidata; Q98126285
WW   Provider; Thermo Fisher; K1712; https://www.thermofisher.com/order/catalog/product/K1712
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5286; HTR1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS23 ! GeneBLAzer Galpha15-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer ADORA2A-CRE-bla CHO-K1
AC   CVCL_KR99
SY   ADORA2A-CRE-bla CHO-K1
DR   Wikidata; Q54835675
WW   Provider; Thermo Fisher; K1530; https://www.thermofisher.com/order/catalog/product/K1530
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:263; ADORA2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer ADORA2B-CRE-bla CHO-K1
AC   CVCL_ZK40
SY   ADORA2B-CRE-bla CHO-K1
DR   Wikidata; Q98126286
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:264; ADORA2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1780.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer ADORA3-Galpha15-NFAT-bla CHO-K1
AC   CVCL_KS25
SY   ADORA3-Galpha15-NFAT-bla CHO-K1
DR   Wikidata; Q54835676
WW   Provider; Thermo Fisher; K1837; https://www.thermofisher.com/order/catalog/product/K1837
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:268; ADORA3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS23 ! GeneBLAzer Galpha15-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer ADRA1A-NFAT-bla CHO-K1
AC   CVCL_KB30
SY   ADRA1A-NFAT-bla CHO-K1
DR   Wikidata; Q54835677
WW   Provider; Thermo Fisher; K1470; https://www.thermofisher.com/order/catalog/product/K1470
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:277; ADRA1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   GeneBLAzer ADRA1B-NFAT-bla CHO-K1
AC   CVCL_KB31
SY   ADRA1B-NFAT-bla CHO-K1
DR   Wikidata; Q54835678
WW   Provider; Thermo Fisher; K1471; https://www.thermofisher.com/order/catalog/product/K1471
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:278; ADRA1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   GeneBLAzer ADRA2A-Gqo5-NFAT-bla CHO-K1
AC   CVCL_KS26
SY   ADRA2A-Gqo5-NFAT-bla CHO-K1
DR   Wikidata; Q54835683
WW   Provider; Thermo Fisher; K1743; https://www.thermofisher.com/order/catalog/product/K1743
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:281; ADRA2A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS24 ! GeneBLAzer Gqo5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer ADRB1-CRE-bla CHO-K1
AC   CVCL_ZK41
SY   ADRB1-CRE-bla CHO-K1
DR   Wikidata; Q98126288
WW   Provider; Thermo Fisher; K1553; https://www.thermofisher.com/order/catalog/product/K1553
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:285; ADRB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer ADRB2-CRE-bla CHO-K1
AC   CVCL_ZK42
SY   ADRB2-CRE-bla CHO-K1
DR   Wikidata; Q98126289
WW   Provider; Thermo Fisher; K1472; https://www.thermofisher.com/order/catalog/product/K1472
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer ADRB3-CRE-bla CHO-K1
AC   CVCL_ZK43
SY   ADRB3-CRE-bla CHO-K1
DR   Wikidata; Q98126290
WW   Provider; Thermo Fisher; K1745; https://www.thermofisher.com/order/catalog/product/K1745
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:288; ADRB3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer AR-UAS-bla Griptite 293
AC   CVCL_ZI94
SY   GeneBLAzer AR-UAS-bla Griptite; AR-UAS-bla GripTite 293; AR-UAS-bla Griptite
DR   Wikidata; Q98126291
WW   Provider; Thermo Fisher; K1698; https://www.thermofisher.com/order/catalog/product/K1698
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of rat AR fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2147; Ar (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI83 ! GeneBLAzer UAS-bla GripTite 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer AVPR1a-NFAT-bla CHO-K1
AC   CVCL_LB56
SY   AVPR1a-NFAT-bla CHO-K1
DR   Wikidata; Q54835684
WW   Provider; Thermo Fisher; K1715; https://www.thermofisher.com/order/catalog/product/K1715
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:895; AVPR1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   GeneBLAzer AVPR2-CRE-bla CHO-K1
AC   CVCL_ZI81
SY   AVPR2-CRE-bla CHO-K1
DR   Wikidata; Q98126292
WW   Provider; Thermo Fisher; K1718; https://www.thermofisher.com/order/catalog/product/K1718
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:897; AVPR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer BDKRB1-NFAT-bla CHO-K1
AC   CVCL_KB32
SY   BDKRB1-NFAT-bla CHO-K1
DR   Wikidata; Q54835685
WW   Provider; Thermo Fisher; K1734; https://www.thermofisher.com/order/catalog/product/K1734
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1029; BDKRB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer Bradykinin-B2-NFAT-bla CHO-K1
AC   CVCL_KB33
SY   Bradykinin-B2-NFAT-bla CHO-K1
DR   Wikidata; Q54835686
WW   Provider; Thermo Fisher; K1790; https://www.thermofisher.com/order/catalog/product/K1790
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   GeneBLAzer C5aR1-Galpha15-NFAT-bla CHO-K1
AC   CVCL_ZJ77
SY   C5aR1-Galpha15-NFAT-bla CHO-K1
DR   Wikidata; Q98126294
WW   Provider; Thermo Fisher; K1746; https://www.thermofisher.com/order/catalog/product/K1746
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1338; C5AR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS23 ! GeneBLAzer Galpha15-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer CALCR-CRE-bla FreeStyle 293F
AC   CVCL_ZK44
SY   CALCR-CRE-bla FreeStyle 293F Cells
DR   Wikidata; Q98126295
WW   Provider; Thermo Fisher; K1480; https://www.thermofisher.com/order/catalog/product/K1480
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS56 ! CellSensor CRE-bla FreeStyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer CALCRL:RAMP1-CRE-bla FreeStyle 293F
AC   CVCL_ZK45
SY   CALCRL:RAMP1-CRE-bla FreeStyle 293F
DR   Wikidata; Q98126297
WW   Provider; Thermo Fisher; K1437; https://www.thermofisher.com/order/catalog/product/K1437
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS56 ! CellSensor CRE-bla FreeStyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer CALCRL:RAMP2-CRE-bla FreeStyle 293F
AC   CVCL_ZK46
SY   CALCRL:RAMP2-CRE-bla FreeStyle 293F
DR   Wikidata; Q98126298
WW   Provider; Thermo Fisher; K1438; https://www.thermofisher.com/order/catalog/product/K1438
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS56 ! CellSensor CRE-bla FreeStyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer CALCRL:RAMP3-CRE-bla FreeStyle 293F
AC   CVCL_ZK47
SY   CALCRL:RAMP3-CRE-bla FreeStyle 293F
DR   Wikidata; Q98126299
WW   Provider; Thermo Fisher; K1439; https://www.thermofisher.com/order/catalog/product/K1439
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS56 ! CellSensor CRE-bla FreeStyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer CaSR-Gqo5-NFAT-bla CHO-K1
AC   CVCL_ZK52
SY   GeneBLAzer CASR-Gqo5-NFAT-bla CHO-K1; CaSR-Gqo5-NFAT-bla CHO-K1; CASR-Gqo5-NFAT-bla CHO-K1
DR   Wikidata; Q98126300
WW   Provider; Thermo Fisher; K1833; https://www.thermofisher.com/order/catalog/product/K1833
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1514; CASR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS24 ! GeneBLAzer Gqo5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer CCKAR-NFAT-bla HEK 293T
AC   CVCL_ZK48
SY   CCKAR-NFAT-bla HEK 293T; CCKAR-NFAT-bla HEK293T
DR   Wikidata; Q98126301
WW   Provider; Thermo Fisher; K1548; https://www.thermofisher.com/order/catalog/product/K1548
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1570; CCKAR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB26 ! CellSensor NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   GeneBLAzer CCKBR-NFAT-bla HEK 293T
AC   CVCL_KB27
SY   CCKBR-NFAT-bla HEK 293T; CCKBR-NFAT-bla HEK293T
DR   Wikidata; Q54835687
WW   Provider; Thermo Fisher; K1742; https://www.thermofisher.com/order/catalog/product/K1742
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1571; CCKBR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB26 ! CellSensor NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   GeneBLAzer CMV-bla CHO-K1
AC   CVCL_KR96
SY   GeneBLAzer CMV-BLA CHO-K1; CMV-BLA CHO-K1; CMV-BLA CHO K1
DR   Wikidata; Q54835688
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1100.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   GeneBLAzer CMV-bla Jurkat
AC   CVCL_ZK91
SY   GeneBLAzer CMV-bla Jurkat Positive Control; CMV-bla Jurkat Positive Control; CMV-bla Jurkat
DR   cancercelllines; CVCL_ZK91
DR   Wikidata; Q98126302
WW   Provider; Thermo Fisher; K1045; https://www.thermofisher.com/order/catalog/product/K1045
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer CNR1-Galpha15-NFAT-bla CHO-K1
AC   CVCL_ZK49
SY   CNR1-Galpha15-NFAT-bla CHO-K1
DR   Wikidata; Q98126303
WW   Provider; Thermo Fisher; K1529; https://www.thermofisher.com/order/catalog/product/K1529
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS23 ! GeneBLAzer Galpha15-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer CRHR1-CRE-bla CHO-K1
AC   CVCL_ZK50
SY   CRHR1-CRE-bla CHO-K1
DR   Wikidata; Q98126304
WW   Provider; Thermo Fisher; K1736; https://www.thermofisher.com/order/catalog/product/K1736
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2357; CRHR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer CRHR2-CRE-bla CHO-K1
AC   CVCL_ZK51
SY   CRHR2-CRE-bla CHO-K1
DR   Wikidata; Q98126306
WW   Provider; Thermo Fisher; K1733; https://www.thermofisher.com/order/catalog/product/K1733
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2358; CRHR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer CysLT2-NFAT-bla CHO-K1
AC   CVCL_ZK69
SY   CysLT2-NFAT-bla CHO-K1
DR   Wikidata; Q98126307
WW   Provider; Thermo Fisher; K1721; https://www.thermofisher.com/order/catalog/product/K1721
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18274; CYSLTR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer D1-CRE-bla CHO-K1
AC   CVCL_YR48
SY   D1-CRE-bla CHO-K1
DR   Wikidata; Q98126309
WW   Provider; Thermo Fisher; K1709; https://www.thermofisher.com/order/catalog/product/K1709
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3020; DRD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer D2-Gqo5-NFAT-bla CHO-K1
AC   CVCL_ZI82
SY   D2-Gqo5-NFAT-bla CHO-K1
DR   Wikidata; Q98126310
WW   Provider; Thermo Fisher; K1708; https://www.thermofisher.com/order/catalog/product/K1708
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3023; DRD2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS24 ! GeneBLAzer Gqo5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer D5-CRE-bla CHO-K1
AC   CVCL_YR49
SY   D5-CRE-bla CHO-K1
DR   Wikidata; Q98126311
WW   Provider; Thermo Fisher; K1784; https://www.thermofisher.com/order/catalog/product/K1784
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3026; DRD5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer EDG3-Galpha15-NFAT-bla HEK 293T
AC   CVCL_ZI79
SY   EDG3-Galpha15-NFAT-bla HEK 293T
DR   Wikidata; Q98126312
WW   Provider; Thermo Fisher; K1713; https://www.thermofisher.com/order/catalog/product/K1713
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3167; S1PR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB35 ! GeneBLAzer Galpha15-NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   GeneBLAzer EDG7-NFAT-bla HEK 293T
AC   CVCL_XA29
SY   EDG7-NFAT-bla HEK 293T
DR   Wikidata; Q93560569
WW   Provider; Thermo Fisher; K1511; https://www.thermofisher.com/order/catalog/product/K1511
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14298; LPAR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB26 ! CellSensor NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer EDNRA-NFAT-bla HEK 293T
AC   CVCL_KB34
SY   EDNRA-NFAT-bla HEK 293T; EDNRA-NFAT-bla HEK293T
DR   Wikidata; Q54835689
WW   Provider; Thermo Fisher; K1726; https://www.thermofisher.com/order/catalog/product/K1726
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3179; EDNRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB26 ! CellSensor NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   GeneBLAzer EDNRB-NFAT-bla HEK 293T
AC   CVCL_YU25
SY   EDNRB-NFAT-bla HEK 293T; EDNRB-NFAT-bla HEK293T
DR   Wikidata; Q98126313
WW   Provider; Thermo Fisher; K1727; https://www.thermofisher.com/order/catalog/product/K1727
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3180; EDNRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB26 ! CellSensor NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   GeneBLAzer ERalpha-UAS-bla GripTite 293
AC   CVCL_ZI95
SY   GeneBLAzer ERalpha-UAS-bla GripTite; ERalpha-UAS-bla GripTite 293; ERalpha-UAS-bla GripTite
DR   Wikidata; Q98126314
WW   Provider; Thermo Fisher; K1688; https://www.thermofisher.com/order/catalog/product/K1688
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of ESR1 fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI83 ! GeneBLAzer UAS-bla GripTite 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer ERbeta-UAS-bla GripTite 293
AC   CVCL_ZI96
SY   GeneBLAzer ERbeta-UAS-bla GripTite; ERbeta-UAS-bla GripTite 293; ERbeta-UAS-bla GripTite
DR   Wikidata; Q98126315
WW   Provider; Thermo Fisher; K1689B; https://www.thermofisher.com/order/catalog/product/K1689B
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of ESR2 fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3468; ESR2 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI83 ! GeneBLAzer UAS-bla GripTite 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer ERRalpha-UAS-bla HEK 293T
AC   CVCL_LF42
SY   ERRalpha-UAS-bla HEK 293T; ERR alpha-UAS-bla HEK 293T
DR   Wikidata; Q54835690
WW   Provider; Thermo Fisher; K1702; https://www.thermofisher.com/order/catalog/product/K1702
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of ESRRA fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3471; ESRRA (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 15
//
ID   GeneBLAzer FPRL-1-Galpha15-NFAT-bla CHO-K1
AC   CVCL_ZK57
SY   FPRL-1-Galpha15-NFAT-bla CHO-K1
DR   Wikidata; Q98126317
WW   Provider; Thermo Fisher; K1532; https://www.thermofisher.com/order/catalog/product/K1532
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3827; FPR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS23 ! GeneBLAzer Galpha15-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer FXR-UAS-bla HEK 293T
AC   CVCL_LF43
SY   FXR-UAS-bla HEK 293T
DR   Wikidata; Q54835691
WW   Provider; Thermo Fisher; K1691B; https://www.thermofisher.com/order/catalog/product/K1691B
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of NR1H4/FXR fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7967; NR1H4 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer Galpha15-NFAT-bla CHO-K1
AC   CVCL_KS23
SY   Galpha15-NFAT-bla CHO-K1
DR   Wikidata; Q54835692
WW   Provider; Thermo Fisher; K1537; https://www.thermofisher.com/order/catalog/product/K1537
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer Galpha15-NFAT-bla HEK 293T
AC   CVCL_KB35
SY   Galpha15-NFAT-bla HEK 293T; Galpha15-NFAT-bla HEK293T
DR   Wikidata; Q54835693
WW   Provider; Thermo Fisher; K1539; https://www.thermofisher.com/order/catalog/product/K1539
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB26 ! CellSensor NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   GeneBLAzer GCGR-CRE-bla CHO-K1
AC   CVCL_ZK66
SY   GCGR-CRE-bla CHO-K1
DR   Wikidata; Q98126318
WW   Provider; Thermo Fisher; K1855; https://www.thermofisher.com/order/catalog/product/K1855
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer GIPR-CRE-bla HEK 293T
AC   CVCL_ZK67
SY   GIPR-CRE-bla HEK 293T
DR   Wikidata; Q98126320
WW   Provider; Thermo Fisher; K1864; https://www.thermofisher.com/order/catalog/product/K1864
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4271; GIPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS57 ! CellSensor CRE-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer GLP1R-CRE-bla CHO-K1
AC   CVCL_KR98
SY   GLP1R-CRE-bla CHO-K1
DR   Wikidata; Q54835694
WW   Provider; Thermo Fisher; K1783; https://www.thermofisher.com/order/catalog/product/K1783
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer GnRHR-NFAT-bla CHO-K1
AC   CVCL_ZI70
SY   GnRHR-NFAT-bla CHO-K1
DR   Wikidata; Q98126321
WW   Provider; Thermo Fisher; K1854; https://www.thermofisher.com/order/catalog/product/K1854
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4421; GNRHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer GPR10-NFAT-bla CHO-K1
AC   CVCL_KB36
SY   GPR10-NFAT-bla CHO-K1
DR   Wikidata; Q54835695
WW   Provider; Thermo Fisher; K1732; https://www.thermofisher.com/order/catalog/product/K1732
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4464; PRLHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer GPR24-Gqi5-NFAT-bla CHO-K1
AC   CVCL_ZI74
SY   GPR24-Gqi5-NFAT-bla CHO-K1
DR   Wikidata; Q98126322
WW   Provider; Thermo Fisher; K1730; https://www.thermofisher.com/order/catalog/product/K1730
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4479; MCHR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_JM68 ! GeneBLAzer Gqi5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer GPR54-NFAT-bla CHO-K1
AC   CVCL_KB37
SY   GPR54-NFAT-bla CHO-K1
DR   Wikidata; Q54835696
WW   Provider; Thermo Fisher; K1720; https://www.thermofisher.com/order/catalog/product/K1720
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4510; KISS1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer Gqi5-NFAT-bla CHO-K1
AC   CVCL_JM68
SY   Gqi5-NFAT-bla CHO-K1
DR   Wikidata; Q54835697
WW   Provider; Thermo Fisher; K1725; https://www.thermofisher.com/order/catalog/product/K1725
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer Gqi5-NFAT-bla FreeStyle 293F
AC   CVCL_XA25
SY   Gqi5-NFAT-bla FreeStyle 293F
DR   Wikidata; Q93560641
WW   Provider; Thermo Fisher; K1731; https://www.thermofisher.com/order/catalog/product/K1731
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA24 ! CellSensor NFAT-bla Freestyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer Gqo5-NFAT-bla CHO-K1
AC   CVCL_KS24
SY   Gqo5-NFAT-bla CHO-K1
DR   Wikidata; Q54835698
WW   Provider; Thermo Fisher; K1536; https://www.thermofisher.com/order/catalog/product/K1536
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer Gqo5-NFAT-bla FreeStyle 293F
AC   CVCL_ZK68
SY   Gqo5-NFAT-bla FreeStyle 293F
DR   Wikidata; Q98126323
WW   Provider; Thermo Fisher; K1747; https://www.thermofisher.com/order/catalog/product/K1747
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA24 ! CellSensor NFAT-bla Freestyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer GR-UAS-bla HEK 293T
AC   CVCL_LF44
SY   GR-UAS-bla HEK 293T
DR   Wikidata; Q54835699
WW   Provider; Thermo Fisher; K1687; https://www.thermofisher.com/order/catalog/product/K1687
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of NR3C1/GR fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer GRPR-NFAT-bla CHO-K1
AC   CVCL_ZK86
SY   GRPR-NFAT-bla CHO-K1
DR   Wikidata; Q98126324
WW   Provider; Thermo Fisher; K1561; https://www.thermofisher.com/order/catalog/product/K1561
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4609; GRPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer H1-NFAT-bla HEK 293T
AC   CVCL_XA28
SY   H1-NFAT-bla HEK 293T
DR   Wikidata; Q93560660
WW   Provider; Thermo Fisher; K1703; https://www.thermofisher.com/order/catalog/product/K1703
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5182; HRH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB26 ! CellSensor NFAT-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer H2-CRE-bla HEK 293T
AC   CVCL_ZK70
SY   H2-CRE-bla HEK 293T
DR   Wikidata; Q98126325
WW   Provider; Thermo Fisher; K1707; https://www.thermofisher.com/order/catalog/product/K1707
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5183; HRH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS57 ! CellSensor CRE-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer HCRTR1-NFAT-bla CHO-K1
AC   CVCL_LB57
SY   HCRTR1-NFAT-bla CHO-K1
DR   Wikidata; Q54835700
WW   Provider; Thermo Fisher; K1446; https://www.thermofisher.com/order/catalog/product/K1446
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4848; HCRTR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer HCRTR2-Galpha15-NFAT-bla CHO-K1
AC   CVCL_ZI72
SY   HCRTR2-Galpha15-NFAT-bla CHO-K1
DR   Wikidata; Q98126326
WW   Provider; Thermo Fisher; K1737; https://www.thermofisher.com/order/catalog/product/K1737
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4849; HCRTR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS23 ! GeneBLAzer Galpha15-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer HTR2B-NFAT-bla CHO-K1
AC   CVCL_ZK71
SY   HTR2B-NFAT-bla CHO-K1
DR   Wikidata; Q98126328
WW   Provider; Thermo Fisher; K1847; https://www.thermofisher.com/order/catalog/product/K1847
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5294; HTR2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer HTR2C-NFAT-bla CHO-K1
AC   CVCL_ZJ76
SY   HTR2C-NFAT-bla CHO-K1
DR   Wikidata; Q98126329
WW   Provider; Thermo Fisher; K1877; https://www.thermofisher.com/order/catalog/product/K1877
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer HTR7-CRE-bla CHO-K1
AC   CVCL_KS00
SY   HTR7-CRE-bla CHO-K1
DR   Wikidata; Q54835701
WW   Provider; Thermo Fisher; K1704; https://www.thermofisher.com/order/catalog/product/K1704
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5302; HTR7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer LTB4R-Galpha15-NFAT-bla CHO-K1
AC   CVCL_ZK72
SY   LTB4R-Galpha15-NFAT-bla CHO-K1
DR   Wikidata; Q98126331
WW   Provider; Thermo Fisher; K1748; https://www.thermofisher.com/order/catalog/product/K1748
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6713; LTB4R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS23 ! GeneBLAzer Galpha15-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer LXRalpha-UAS-bla HEK 293T
AC   CVCL_LF45
SY   LXRalpha-UAS-bla HEK 293T; LXR alpha-UAS-bla HEK 293T
DR   Wikidata; Q54835702
WW   Provider; Thermo Fisher; K1692; https://www.thermofisher.com/order/catalog/product/K1692
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of NR1H3/LXRA fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7966; NR1H3 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer LXRbeta-UAS-bla HEK 293T
AC   CVCL_LF46
SY   LXRbeta-UAS-bla HEK 293T; LXR beta-UAS-bla HEK 293T
DR   Wikidata; Q54835703
WW   Provider; Thermo Fisher; K1699; https://www.thermofisher.com/order/catalog/product/K1699
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of NR1H2/LXRB fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7965; NR1H2 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer M1-NFAT-bla CHO-K1
AC   CVCL_ZI71
SY   M1-NFAT-bla CHO-K1
DR   Wikidata; Q98126332
WW   Provider; Thermo Fisher; K1735; https://www.thermofisher.com/order/catalog/product/K1735
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer M1-NFAT-bla Jurkat
AC   CVCL_ZK76
SY   M1-NFAT-bla Jurkat
DR   cancercelllines; CVCL_ZK76
DR   Wikidata; Q98126333
WW   Provider; Thermo Fisher; K1710; https://www.thermofisher.com/order/catalog/product/K1710
CC   Population: Caucasian.
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB42 ! CellSensor NFAT-bla Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer M3-NFAT-bla CHO-K1
AC   CVCL_KB38
SY   M3-NFAT-bla CHO-K1
DR   Wikidata; Q54835704
WW   Provider; Thermo Fisher; K1716; https://www.thermofisher.com/order/catalog/product/K1716
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1952; CHRM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer M4-Gqo5-NFAT-bla CHO-K1
AC   CVCL_ZK78
SY   M4-Gqo5-NFAT-bla CHO-K1
DR   Wikidata; Q98126334
WW   Provider; Thermo Fisher; K1741; https://www.thermofisher.com/order/catalog/product/K1741
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1953; CHRM4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS24 ! GeneBLAzer Gqo5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer M5-NFAT-bla CHO-K1
AC   CVCL_ZK79
SY   M5-NFAT-bla CHO-K1
DR   Wikidata; Q98126335
WW   Provider; Thermo Fisher; K1728; https://www.thermofisher.com/order/catalog/product/K1728
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1954; CHRM5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer MC1R-CRE-bla CHO-K1
AC   CVCL_ZK77
SY   MC1R-CRE-bla CHO-K1
DR   Wikidata; Q98126336
WW   Provider; Thermo Fisher; K1724; https://www.thermofisher.com/order/catalog/product/K1724
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6929; MC1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer MC2R-CRE-bla CHO-K1
AC   CVCL_KS01
SY   MC2R-CRE-bla CHO-K1; MC2R-CRE-bla-CHO-K1
DR   Wikidata; Q54835705
WW   Provider; Thermo Fisher; K1483; https://www.thermofisher.com/order/catalog/product/K1483
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6930; MC2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer MC3R-CRE-bla CHO-K1
AC   CVCL_ZK73
SY   MC3R-CRE-bla CHO-K1
DR   Wikidata; Q98126337
WW   Provider; Thermo Fisher; K1744; https://www.thermofisher.com/order/catalog/product/K1744
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6931; MC3R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer MC4R-CRE-bla CHO-K1
AC   CVCL_ZK74
SY   MC4R-CRE-bla CHO-K1
DR   Wikidata; Q98126338
WW   Provider; Thermo Fisher; K1738; https://www.thermofisher.com/order/catalog/product/K1738
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6932; MC4R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer MC5R-CRE-bla CHO-K1
AC   CVCL_ZK75
SY   MC5R-CRE-bla CHO-K1
DR   Wikidata; Q98126339
WW   Provider; Thermo Fisher; K1740; https://www.thermofisher.com/order/catalog/product/K1740
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6933; MC5R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer MCHR2-NFAT-bla CHO-K1
AC   CVCL_ZK87
SY   MCHR2-NFAT-bla CHO-K1
DR   Wikidata; Q98126342
WW   Provider; Thermo Fisher; K1852; https://www.thermofisher.com/order/catalog/product/K1852
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20867; MCHR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer MR-UAS-bla HEK 293T
AC   CVCL_LF47
SY   MR-UAS-bla HEK 293T
DR   Wikidata; Q54835706
WW   Provider; Thermo Fisher; K1696; https://www.thermofisher.com/order/catalog/product/K1696
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of NR3C2/MR fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7979; NR3C2 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer NMUR1-NFAT-bla CHO-K1
AC   CVCL_ZK64
SY   NMUR1-NFAT-bla CHO-K1
DR   Wikidata; Q98126343
WW   Provider; Thermo Fisher; K1719; https://www.thermofisher.com/order/catalog/product/K1719
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4518; NMUR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer NPSR1-A-NFAT-bla CHO-K1
AC   CVCL_ZK61
SY   NPSR1-A-NFAT-bla CHO-K1
DR   Wikidata; Q98126344
WW   Provider; Thermo Fisher; K1477; https://www.thermofisher.com/order/catalog/product/K1477
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23631; NPSR1 (Note=Isoform A).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer NPSR1-B-NFAT-bla CHO-K1
AC   CVCL_LB58
SY   NPSR1-B-NFAT-bla CHO-K1
DR   Wikidata; Q54835707
WW   Provider; Thermo Fisher; K1481B; https://www.thermofisher.com/order/catalog/product/K1481B
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23631; NPSR1 (Note=Isoform B).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer NTSR1-NFAT-bla CHO-K1
AC   CVCL_ZK62
SY   NTSR1-NFAT-bla CHO-K1
DR   Wikidata; Q98126345
WW   Provider; Thermo Fisher; K1781; https://www.thermofisher.com/order/catalog/product/K1781
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8039; NTSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer OPRK1-Gqo5-NFAT-bla CHO-K1
AC   CVCL_ZK83
SY   OPRK1-Gqo5-NFAT-bla CHO-K1
DR   Wikidata; Q98126346
WW   Provider; Thermo Fisher; K1533; https://www.thermofisher.com/order/catalog/product/K1533
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8154; OPRK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS24 ! GeneBLAzer Gqo5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer OPRL1-Gqi5-NFAT-bla FreeStyle 293F
AC   CVCL_XA26
SY   OPRL1-Gqi5-NFAT-bla FreeStyle 293F
DR   Wikidata; Q93560724
WW   Provider; Thermo Fisher; K1714; https://www.thermofisher.com/order/catalog/product/K1714
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8155; OPRL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA25 ! GeneBLAzer Gqi5-NFAT-bla FreeStyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer OXTR-Gqo5-NFAT-bla CHO-K1
AC   CVCL_ZK65
SY   OXTR-Gqo5-NFAT-bla CHO-K1
DR   Wikidata; Q98126347
WW   Provider; Thermo Fisher; K1835; https://www.thermofisher.com/order/catalog/product/K1835
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqo5, with 355-GCGLY-359 from GNAO1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8529; OXTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KS24 ! GeneBLAzer Gqo5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer P2RY11-NFAT-bla CHO-K1
AC   CVCL_ZI73
SY   P2RY11-NFAT-bla CHO-K1
DR   Wikidata; Q98126348
WW   Provider; Thermo Fisher; K1729; https://www.thermofisher.com/order/catalog/product/K1729
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8540; P2RY11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer P2RY2-NFAT-bla CHO-K1
AC   CVCL_ZK58
SY   P2RY2-NFAT-bla CHO-K1 Cells
DR   Wikidata; Q98126349
WW   Provider; Thermo Fisher; K1722; https://www.thermofisher.com/order/catalog/product/K1722
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8541; P2RY2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer P2RY4-NFAT-bla CHO-K1
AC   CVCL_ZK59
SY   P2RY4-NFAT-bla CHO-K1
DR   Wikidata; Q98126350
WW   Provider; Thermo Fisher; K1863; https://www.thermofisher.com/order/catalog/product/K1863
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8542; P2RY4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer P2RY6-NFAT-bla CHO-K1
AC   CVCL_ZK60
SY   P2RY6-NFAT-bla CHO-K1
DR   Wikidata; Q98126351
WW   Provider; Thermo Fisher; K1717; https://www.thermofisher.com/order/catalog/product/K1717
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8543; P2RY6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer PAC1-CRE-bla CHO-K1
AC   CVCL_LC84
SY   PAC1-CRE-bla CHO-K1
DR   Wikidata; Q54835708
WW   Provider; Thermo Fisher; K1525; https://www.thermofisher.com/order/catalog/product/K1525
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   GeneBLAzer PPARalpha-UAS-bla HEK 293T
AC   CVCL_LF48
SY   PPARalpha-UAS-bla HEK 293T; PPAR alpha-UAS-bla HEK 293T
DR   Wikidata; Q54835709
WW   Provider; Thermo Fisher; K1875; https://www.thermofisher.com/order/catalog/product/K1875
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of PPARA fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9232; PPARA (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer PPARdelta-UAS-bla HEK 293T
AC   CVCL_LF41
SY   PPARdelta-UAS-bla HEK 293T; PPAR delta-UAS-bla HEK 293T
DR   Wikidata; Q54835710
WW   Provider; Thermo Fisher; K1690; https://www.thermofisher.com/order/catalog/product/K1690
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of PPARD fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9235; PPARD (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer PPARgamma-UAS-bla HEK 293H
AC   CVCL_ZK99
SY   PPARgamma-UAS-bla HEK 293H
DR   Wikidata; Q98126352
WW   Provider; Thermo Fisher; K1701; https://www.thermofisher.com/order/catalog/product/K1701
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9236; PPARG (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZK98 ! GeneBLAzer UAS-bla HEK 293H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer PR-UAS-bla HEK 293T
AC   CVCL_LF49
SY   PR-UAS-bla HEK 293T
DR   Wikidata; Q54835712
WW   Provider; Thermo Fisher; K1693; https://www.thermofisher.com/order/catalog/product/K1693
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of PGR fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8910; PGR (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer PROKR2-Gqi5-NFAT-bla CHO-K1
AC   CVCL_ZK63
SY   PROKR2-Gqi5-NFAT-bla CHO-K1
DR   Wikidata; Q98126355
WW   Provider; Thermo Fisher; K1856; https://www.thermofisher.com/order/catalog/product/K1856
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4390; GNAQ (Note=Gqi5, with 355-DCGLF-359 from GNAI1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15836; PROKR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_JM68 ! GeneBLAzer Gqi5-NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer PTGDR-CRE-bla CHO-K1
AC   CVCL_ZI80
SY   PTGDR-CRE-bla CHO-K1
DR   Wikidata; Q98126356
WW   Provider; Thermo Fisher; K1739; https://www.thermofisher.com/order/catalog/product/K1739
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9591; PTGDR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer PTGER1-NFAT-bla CHO-K1
AC   CVCL_ZK80
SY   PTGER1-NFAT-bla CHO-K1
DR   Wikidata; Q98126357
WW   Provider; Thermo Fisher; K1851; https://www.thermofisher.com/order/catalog/product/K1851
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9593; PTGER1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer PTGER2-NFAT-bla CHO-K1
AC   CVCL_ZK81
SY   PTGER2-NFAT-bla CHO-K1
DR   Wikidata; Q98126358
WW   Provider; Thermo Fisher; K1723; https://www.thermofisher.com/order/catalog/product/K1723
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9594; PTGER2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer PTGIR-CRE-bla CHO-K1
AC   CVCL_ZK82
SY   PTGIR-CRE-bla CHO-K1
DR   Wikidata; Q98126359
WW   Provider; Thermo Fisher; K1850; https://www.thermofisher.com/order/catalog/product/K1850
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9602; PTGIR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer RARalpha-UAS-bla HEK 293T
AC   CVCL_LF50
SY   RARalpha-UAS-bla HEK 293T; RAR alpha-UAS-bla HEK 293T
DR   Wikidata; Q54835713
WW   Provider; Thermo Fisher; K1685; https://www.thermofisher.com/order/catalog/product/K1685
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of RARA fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9864; RARA (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer RARbeta-UAS-bla HEK 293T
AC   CVCL_LF51
SY   RARbeta-UAS-bla HEK 293T; RAR beta-UAS-bla HEK 293T
DR   Wikidata; Q54835714
WW   Provider; Thermo Fisher; K1695; https://www.thermofisher.com/order/catalog/product/K1695
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of RARB fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9865; RARB (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer RARgamma-UAS-bla HEK 293T
AC   CVCL_LF52
SY   RARgamma-UAS-bla HEK 293T; RAR gamma-UAS-bla HEK 293T
DR   Wikidata; Q54835715
WW   Provider; Thermo Fisher; K1763; https://www.thermofisher.com/order/catalog/product/K1763
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of RARG fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9866; RARG (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer RXRalpha-UAS-bla HEK 293T
AC   CVCL_LF53
SY   RXRalpha-UAS-bla HEK 293T; RXR alpha-UAS-bla HEK 293T
DR   Wikidata; Q54835716
WW   Provider; Thermo Fisher; K1697; https://www.thermofisher.com/order/catalog/product/K1697
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of RXRA fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer RXRbeta-UAS-bla HEK 293T
AC   CVCL_LF54
SY   RXRbeta-UAS-bla HEK 293T; RXR beta-UAS-bla HEK 293T
DR   Wikidata; Q54835717
WW   Provider; Thermo Fisher; K1694; https://www.thermofisher.com/order/catalog/product/K1694
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of RXRB fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10478; RXRB (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer SCTR-CRE-bla CHO-K1
AC   CVCL_ZK88
SY   SCTR-CRE-bla CHO-K1
DR   Wikidata; Q98126360
WW   Provider; Thermo Fisher; K1805; https://www.thermofisher.com/order/catalog/product/K1805
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10608; SCTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer T-REx-G2A-NFAT-bla FreeStyle 293F
AC   CVCL_XA27
SY   T-REx-G2A-NFAT-bla FreeStyle 293F
DR   Wikidata; Q93560817
WW   Provider; Thermo Fisher; K1749; https://www.thermofisher.com/order/catalog/product/K1749
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17482; GPR132.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA24 ! CellSensor NFAT-bla Freestyle 293F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer T-Rex GPR119-CRE-bla CHO-K1
AC   CVCL_ZK90
SY   T-Rex GPR119-CRE-bla CHO-K1
DR   Wikidata; Q98126361
WW   Provider; Thermo Fisher; K1486; https://www.thermofisher.com/order/catalog/product/K1486
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19060; GPR119.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer TACR2-NFAT-bla CHO-K1
AC   CVCL_ZK89
SY   TACR2-NFAT-bla CHO-K1
DR   Wikidata; Q98126363
WW   Provider; Thermo Fisher; K1844; https://www.thermofisher.com/order/catalog/product/K1844
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the NFAT response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11527; TACR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KB29 ! CellSensor NFAT-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer TRalpha-UAS-bla HEK 293T
AC   CVCL_LF55
SY   TRalpha-UAS-bla HEK 293T; TR alpha-UAS-bla HEK 293T
DR   Wikidata; Q54835718
WW   Provider; Thermo Fisher; K1684; https://www.thermofisher.com/order/catalog/product/K1684
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of THRA fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11796; THRA (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer TRbeta-UAS-bla HEK 293T
AC   CVCL_LF56
SY   TRbeta-UAS-bla HEK 293T; TR beta-UAS-bla HEK 293T
DR   Wikidata; Q54835719
WW   Provider; Thermo Fisher; K1686; https://www.thermofisher.com/order/catalog/product/K1686
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of THRB fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer UAS-bla GripTite 293
AC   CVCL_ZI83
DR   Wikidata; Q98126364
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U428 ! GripTite 293 MSR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer UAS-bla HEK 293H
AC   CVCL_ZK98
SY   UAS-bla HEK 293H; CellSensor UAS-bla 293H
DR   Wikidata; Q98126365
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GeneBLAzer UAS-bla HEK 293T
AC   CVCL_LF40
SY   UAS-bla HEK 293T; UAS-bla HEK 293T Master
DR   Wikidata; Q54835720
WW   Provider; Thermo Fisher; K1711; https://www.thermofisher.com/order/catalog/product/K1711
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   GeneBLAzer VDR-UAS-bla HEK 293T
AC   CVCL_LF57
SY   VDR-UAS-bla HEK 293T
DR   Wikidata; Q54835721
WW   Provider; Thermo Fisher; K1700; https://www.thermofisher.com/order/catalog/product/K1700
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of an upstream activator sequence (UAS).
CC   Characteristics: Transfected with the ligand-binding domain (LBD) of VDR fused to the DNA-binding domain (DBD) of GAL4. When an agonist binds to the LBD of the DBD-LBD fusion protein, the protein binds to the UAS, resulting in expression of the beta-lactamase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12679; VDR (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LF40 ! GeneBLAzer UAS-bla HEK 293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   GeneBLAzer VPAC1-CRE-bla CHO-K1
AC   CVCL_ZK84
SY   VPAC1-CRE-bla CHO-K1
DR   Wikidata; Q98126368
WW   Provider; Thermo Fisher; K1705; https://www.thermofisher.com/order/catalog/product/K1705
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12694; VIPR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneBLAzer VPAC2-CRE-bla CHO-K1
AC   CVCL_ZK85
SY   VPAC2-CRE-bla CHO-K1
DR   Wikidata; Q98126369
WW   Provider; Thermo Fisher; K1706; https://www.thermofisher.com/order/catalog/product/K1706
CC   Characteristics: Transfected with a plasmid containing a beta-lactamase reporter gene under control of the CRE response element.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12695; VIPR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KR97 ! CellSensor CRE-bla CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GeneCopoeia SV40-hAMsc
AC   CVCL_C9G2
SY   SV40-immortalized Adipose-derived Mesenchymal stem cells
DR   GeneCopoeia; SL431
DR   Wikidata; Q123031351
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): GeneCopoeia=SL431
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,17
ST   D21S11: 28,30
ST   D22S1045: 11,16
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 5,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40-hBmMsc
AC   CVCL_C9G1
SY   SV40-immortalized Bone marrow-derived Mesenchymal stem cells
DR   GeneCopoeia; SL427
DR   Wikidata; Q123031352
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): GeneCopoeia=SL427
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 15,18
ST   D21S11: 29,30
ST   D22S1045: 11,15
ST   D3S1358: 10,15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 11,14
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9G4 ! GeneCopoeia SV40/TERT-hBmMsc
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40-hGBE
AC   CVCL_C9FY
SY   SV40-immortalized Human gallbladder epithelium cells
DR   GeneCopoeia; SL421
DR   Wikidata; Q123031354
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
CC   Cell type: Epithelial cell of gallbladder; CL=CL_1000415.
ST   Source(s): GeneCopoeia=SL421
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 15,20
ST   D21S11: 30
ST   D22S1045: 15,16
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 11,15
ST   TH01: 9,9.3
ST   TPOX: 8,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40-hGBE/Cas9-hyg
AC   CVCL_C9FZ
DR   GeneCopoeia; SL587
DR   Wikidata; Q123031355
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL587).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
CC   Cell type: Epithelial cell of gallbladder; CL=CL_1000415.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9FY ! GeneCopoeia SV40-hGBE
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40-hSF
AC   CVCL_C9G0
SY   SV40-immortalized Human skin fibroblast cells
DR   GeneCopoeia; SL422
DR   Wikidata; Q123031356
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): GeneCopoeia=SL422
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,19
ST   D21S11: 29,30
ST   D22S1045: 15
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40-hSMC
AC   CVCL_C9FW
SY   SV40-immortalized Human smooth muscle cells
DR   GeneCopoeia; SL423
DR   Wikidata; Q123031357
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Carotid artery; UBERON=UBERON_0005396.
CC   Cell type: Carotid artery smooth muscle cell; CL=CL_0002596.
ST   Source(s): GeneCopoeia=SL423
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 14
ST   D21S11: 31.2,33.2
ST   D22S1045: 15
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 10,14
ST   Penta E: 13
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40-hSMC/Cas9-hyg
AC   CVCL_C9FX
DR   GeneCopoeia; SL586
DR   Wikidata; Q123031358
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL586).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Carotid artery; UBERON=UBERON_0005396.
CC   Cell type: Carotid artery smooth muscle cell; CL=CL_0002596.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9FW ! GeneCopoeia SV40-hSMC
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40-hUcMsc
AC   CVCL_C9G3
SY   SV40-immortalized Umbilical cord-derived Mesenchymal stem cells
DR   GeneCopoeia; SL433
DR   Wikidata; Q123031359
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): GeneCopoeia=SL433
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 28,29
ST   D22S1045: 15,17
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   Penta D: 11,12
ST   Penta E: 15,18
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9G5 ! GeneCopoeia SV40/TERT-hUcMsc
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GeneCopoeia SV40/TERT-hBmMsc
AC   CVCL_C9G4
SY   SV40+hTERT-immortalized Bone marrow-derived Mesenchymal stem cells
DR   GeneCopoeia; SL428
DR   Wikidata; Q123031360
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): GeneCopoeia=SL428
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 15,18
ST   D21S11: 29,30
ST   D22S1045: 11,15
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 11,14
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9G1 ! GeneCopoeia SV40-hBmMsc
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   GeneCopoeia SV40/TERT-hUcMsc
AC   CVCL_C9G5
SY   SV40+hTERT-immortalized Umbilical cord-derived Mesenchymal stem cells
DR   GeneCopoeia; SL434
DR   Wikidata; Q123031361
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): GeneCopoeia=SL434
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 28,29
ST   D22S1045: 15,17
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   Penta D: 11,12
ST   Penta E: 15,18
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9G3 ! GeneCopoeia SV40-hUcMsc
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   Genomeditech A-498 Luc
AC   CVCL_E6MR
SY   Luciferase A-498
DR   Genomeditech; GM-C25666
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Asp1067Val (c.3200A>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly144Serfs*14 (c.426_429delTGAC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1056 ! A-498
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech B16-F10 Luc
AC   CVCL_E6MS
SY   Luciferase B16-F10
DR   Genomeditech; GM-C25561
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Ba/F3 H_CXCR3
AC   CVCL_E6MT
SY   Human CXCR3 Ba/F3; Human CD183 Ba/F3; H_CXCR3 Ba/F3
DR   Genomeditech; GM-C15635
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4540; CXCR3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Ba/F3 H_EGFR(WT)
AC   CVCL_E4IT
SY   Human EGFR WT Ba/F3; H_EGFR(WT) Ba/F3
DR   Genomeditech; GM-C28267
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech Ba/F3 H_KRAS(G12C)
AC   CVCL_E6MU
SY   Human KRAS(G12C) Ba/F3; H_KRAS(G12C) Ba/F3
DR   Genomeditech; GM-C06742
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Cys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Ba/F3 H_KRAS(G12V)
AC   CVCL_E6MV
SY   Human KRAS(G12V) Ba/F3; H_KRAS(G12V) Ba/F3
DR   Genomeditech; GM-C05672
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_ADAM9
AC   CVCL_E6MW
SY   Cynomolgus ADAM9 CHO-K1; Cynomolgus_ADAM9 CHO-K1
DR   Genomeditech; GM-C20021
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X4X8; Macaca fascicularis ADAM9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CCR8
AC   CVCL_E6MX
SY   Cynomolgus CCR8 CHO-K1; Cynomolgus_CCR8 CHO-K1
DR   Genomeditech; GM-C15476
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7NYJ2; Macaca fascicularis CCR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CD24
AC   CVCL_E6MY
SY   Cynomolgus CD24 CHO-K1; Cynomolgus_CD24 CHO-K1
DR   Genomeditech; GM-C10650
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9D3B9; Macaca fascicularis CD24.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CD276
AC   CVCL_E6MZ
SY   Cynomolgus CD276 CHO-K1; Cynomolgus_CD276 CHO-K1
DR   Genomeditech; GM-C23914
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9CYV2; Macaca fascicularis CD276.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CD40(TNFRSF5)
AC   CVCL_E6N0
SY   Cynomolgus CD40 CHO-K1; Cynomolgus TNFRSF5 CHO-K1; Cynomolgus_CD40(TNFRSF5) CHO-K1
DR   Genomeditech; GM-C09602
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5V585; Macaca fascicularis CD40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CD47
AC   CVCL_E6N1
SY   Cynomolgus CD47 CHO-K1; Cynomolgus_CD47 CHO-K1
DR   Genomeditech; GM-C23916
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X4I2; Macaca fascicularis CD47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CD93
AC   CVCL_E6N2
SY   Cynomolgus CD93 CHO-K1; Cynomolgus_CD93 CHO-K1
DR   Genomeditech; GM-C22128
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VH53; Macaca fascicularis CD93.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CDH3
AC   CVCL_E6N3
SY   Cynomolgus CDH3 CHO-K1; Cynomolgus_CDH3 CHO-K1
DR   Genomeditech; GM-C24264
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WPN9; Macaca fascicularis CDH3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CDH6
AC   CVCL_E6N4
SY   Cynomolgus CDH6 CHO-K1; Cynomolgus_CDH6 CHO-K1
DR   Genomeditech; GM-C24265
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TW62; Macaca fascicularis CDH6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CLDN6
AC   CVCL_E6N5
SY   Cynomolgus CLDN6 CHO-K1; Cynomolgus_CLDN6 CHO-K1
DR   Genomeditech; GM-C21210
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7Q0B0; Macaca fascicularis CLDN6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CLEC4C(BDCA2)+FCER1G
AC   CVCL_E6N6
SY   Cynomolgus CLEC4C+FCER1G CHO-K1; Cynomolgus BDCA2+FCER1G CHO-K1; Cynomolgus_CLEC4C(BDCA2)+FCER1G CHO-K1
DR   Genomeditech; GM-C13188
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UWP4; Macaca fascicularis CLEC4C.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8SPW1; Macaca fascicularis FCER1G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_CXCR4
AC   CVCL_E6N7
SY   Cynomolgus CXCR4 CHO-K1; Cynomolgus_CXCR4 CHO-K1
DR   Genomeditech; GM-C23920
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q28474; Macaca fascicularis CXCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_EGFR
AC   CVCL_E6N8
SY   Cynomolgus EGFR CHO-K1; Cynomolgus_EGFR CHO-K1
DR   Genomeditech; GM-C21327
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WK39; Macaca fascicularis EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_ERBB2(HER2)
AC   CVCL_E6N9
SY   Cynomolgus ERBB2 CHO-K1; Cynomolgus HER2 CHO-K1; Cynomolgus_ERBB2(HER2) CHO-K1
DR   Genomeditech; GM-C21325
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WUT7; Macaca fascicularis ERBB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_ERBB3(HER3)
AC   CVCL_E6NA
SY   Cynomolgus ERBB3 CHO-K1; Cynomolgus HER3 CHO-K1; Cynomolgus_ERBB3(HER3) CHO-K1
DR   Genomeditech; GM-C21326
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PIG5; Macaca fascicularis ERBB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_FOLR1
AC   CVCL_E6NB
SY   Cynomolgus FOLR1 CHO-K1; Cynomolgus_FOLR1 CHO-K1
DR   Genomeditech; GM-C20032
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UR19; Macaca fascicularis FOLR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_GPA33
AC   CVCL_E6NC
SY   Cynomolgus GPA33 CHO-K1; Cynomolgus_GPA33 CHO-K1
DR   Genomeditech; GM-C24363
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7NU40; Macaca fascicularis GPA33.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_MELTF(CD228)
AC   CVCL_E6ND
SY   Cynomolgus MELTF CHO-K1; Cynomolgus CD228 CHO-K1; Cynomolgus_MELTF(CD228) CHO-K1
DR   Genomeditech; GM-C21679
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WMB7; Macaca fascicularis MELTF.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_MET
AC   CVCL_E6NE
SY   Cynomolgus MET CHO-K1; Cynomolgus_MET CHO-K1
DR   Genomeditech; GM-C21328
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UM36; Macaca fascicularis MET (Note=With p.Leu820Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_MICB
AC   CVCL_E6NF
SY   Cynomolgus MICB CHO-K1; Cynomolgus_MICB CHO-K1
DR   Genomeditech; GM-C24541
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9CZU7; Macaca fascicularis MICB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_MUCL3(C6orf37)
AC   CVCL_E6NG
SY   Cynomolgus MUCL3 CHO-K1; Cynomolgus C6orf37 CHO-K1; Cynomolgus_MUCL3(C6orf37) CHO-K1
DR   Genomeditech; GM-C21322
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7P4N0; Macaca fascicularis MUCL3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_NECTIN4
AC   CVCL_E6NH
SY   Cynomolgus NECTIN4 CHO-K1; Cynomolgus_NECTIN4 CHO-K1
DR   Genomeditech; GM-C19258
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; L0N6D9; Macaca fascicularis NECTIN4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_NT5E(CD73)
AC   CVCL_E6NI
SY   Cynomolgus NT5E CHO-K1; Cynomolgus CD73 CHO-K1; Cynomolgus_NT5E(CD73) CHO-K1
DR   Genomeditech; GM-C25730
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5V5U7; Macaca fascicularis NT5E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_PDCD1(PD1)
AC   CVCL_E6NJ
SY   Cynomolgus PDCD1 CHO-K1; Cynomolgus PD1 CHO-K1; Cynomolgus_PD1 CHO-K1
DR   Genomeditech; GM-C19512
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; B0LAJ3; Macaca fascicularis PDCD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_PRLR
AC   CVCL_E6NK
SY   Cynomolgus PRLR CHO-K1; Cynomolgus_PRLR CHO-K1
DR   Genomeditech; GM-C20046
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WXK1; Macaca fascicularis PRLR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_PVRIG(CD112R)
AC   CVCL_E6NL
SY   Cynomolgus PVRIG CHO-K1; Cynomolgus CD112R CHO-K1; Cynomolgus_PVRIG(CD112R) CHO-K1
DR   Genomeditech; GM-C24818
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WVV8; Macaca fascicularis PVRIG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_ROR1
AC   CVCL_E6NM
SY   Cynomolgus ROR1 CHO-K1; Cynomolgus_ROR1 CHO-K1
DR   Genomeditech; GM-C24586
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WTX7; Macaca fascicularis ROR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_SIGLEC15+TYROBP
AC   CVCL_E6NN
SY   Cynomolgus SIGLEC15+TYROBP CHO-K1; Cynomolgus_SIGLEC15+TYROBP CHO-K1
DR   Genomeditech; GM-C23927
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UY47; Macaca fascicularis SIGLEC15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PXB4; Macaca fascicularis TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_SLC34A2
AC   CVCL_E6NP
SY   Cynomolgus SLC34A2 CHO-K1; Cynomolgus_SLC34A2 CHO-K1
DR   Genomeditech; GM-C15490
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UHY1; Macaca fascicularis SLC34A2 (Note=With p.Leu574_Leu690del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_SLC39A6
AC   CVCL_E6NQ
SY   Cynomolgus SLC39A6 CHO-K1; Cynomolgus_SLC39A6 CHO-K1
DR   Genomeditech; GM-C15382
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5WH46; Macaca fascicularis SLC39A6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_STEAP1
AC   CVCL_E6NR
SY   Cynomolgus STEAP1 CHO-K1; Cynomolgus_STEAP1 CHO-K1
DR   Genomeditech; GM-C21521
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X1J3; Macaca fascicularis STEAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_TIGIT
AC   CVCL_E6NS
SY   Cynomolgus TIGIT CHO-K1; Cynomolgus_TIGIT CHO-K1
DR   Genomeditech; GM-C21597
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A5F8AKQ5; Macaca fascicularis TIGIT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_TNFRSF17(BCMA)
AC   CVCL_E6NT
SY   Cynomolgus TNFRS17 CHO-K1; Cynomolgus BCMA CHO-K1; Cynomolgus_TNFRSF17(BCMA) CHO-K1
DR   Genomeditech; GM-C24899
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UD97; Macaca fascicularis TNFRSF17 (Note=With p.Arg77_Arg183del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_TNFRSF1B(TNFR2)
AC   CVCL_E6NU
SY   Cynomolgus TNFRSF1B CHO-K1; Cynomolgus TNFR2 CHO-K1; Cynomolgus_TNFRSF1B(TNFR2) CHO-K1
DR   Genomeditech; GM-C25238
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VET2; Macaca fascicularis TNFRSF1B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_TNFRSF9(4-1BB)
AC   CVCL_E6NV
SY   Cynomolgus TNFRSF9 CHO-K1; Cynomolgus 4-1BB CHO-K1; Cynomolgus_TNFRSF9(4-1BB) CHO-K1
DR   Genomeditech; GM-C09585
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A9YYE7; Macaca fascicularis TNFRSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_TPBG
AC   CVCL_E6NW
SY   Cynomolgus TPBG CHO-K1; Cynomolgus_TPBG CHO-K1
DR   Genomeditech; GM-C19131
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q4R8Y9; Macaca fascicularis TPBG (Note=With p.Asn377_Val420del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_TREM1+TYROBP
AC   CVCL_E6NX
SY   Cynomolgus TREM1+TYROBP CHO-K1; Cynomolgus_TREM1+TYROBP CHO-K1
DR   Genomeditech; GM-C13366
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VHG8; Macaca fascicularis TREM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PXB4; Macaca fascicularis TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_TREM2+TYROBP
AC   CVCL_E6NY
SY   Cynomolgus TREM2+TYROBP CHO-K1; Cynomolgus_TREM2+TYROBP CHO-K1
DR   Genomeditech; GM-C15414
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; H9FW03; Macaca fascicularis TREM2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PXB4; Macaca fascicularis TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Cynomolgus_VTCN1(B7H4)
AC   CVCL_E6NZ
SY   Cynomolgus VTCN1 CHO-K1; Cynomolgus B7H4 CHO-K1; Cynomolgus_VTCN1(B7H4) CHO-K1
DR   Genomeditech; GM-C25394
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5U6P5; Macaca fascicularis VTCN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ADAM9
AC   CVCL_E6P0
SY   Human ADAM9 CHO-K1; H_ADAM9 CHO-K1
DR   Genomeditech; GM-C19655
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:216; ADAM9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ALCAM(CD166)
AC   CVCL_E6P1
SY   Human ALCAM CHO-K1; Human CD166 CHO-K1; H_ALCAM(CD166) CHO-K1
DR   Genomeditech; GM-C19057
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:400; ALCAM (Note=With p.Met1_Gly27del and Leu528_Ala583del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_AMHR2
AC   CVCL_E6P2
SY   Human AMHR2 CHO-K1; H_AMHR2 CHO-K1
DR   Genomeditech; GM-C15629
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:465; AMHR2 (Note=With p.Met1_Ala17del and p.Val150_Val573del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_BTLA
AC   CVCL_E6P3
SY   Human BTLA CHO-K1; Human CD272 CHO-K1; H_BTLA CHO-K1
DR   Genomeditech; GM-C19148
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21087; BTLA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CA9
AC   CVCL_E6P4
SY   Human CA9 CHO-K1; H_CA9 CHO-K1
DR   Genomeditech; GM-C19081
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1383; CA9 (Note=With p.Arg434_Ala459del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CCR4
AC   CVCL_E6P5
SY   Human CCR4 CHO-K1; H_CCR4 CHO-K1
DR   Genomeditech; GM-C03235
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1605; CCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CCR8
AC   CVCL_E6P6
SY   Human CCR8 CHO-K1; H_CCR8 CHO-K1
DR   Genomeditech; GM-C09425
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD19
AC   CVCL_E6P7
SY   Human CD19 CHO-K1; H_CD19 CHO-K1
DR   Genomeditech; GM-C19025
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD20
AC   CVCL_E6P8
SY   Human CD20 CHO-K1; H_CD20 CHO-K1
DR   Genomeditech; GM-C09616
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7315; MS4A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD200
AC   CVCL_E6P9
SY   Human CD200 CHO-K1; H_CD200 CHO-K1
DR   Genomeditech; GM-C25422
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7203; CD200.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD200R1
AC   CVCL_E6PA
SY   Human CD200R1 CHO-K1; H_CD200R1 CHO-K1
DR   Genomeditech; GM-C24720
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24235; CD200R1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD22
AC   CVCL_E6PB
SY   Human CD22 CHO-K1; H_CD22 CHO-K1
DR   Genomeditech; GM-C18998
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1643; CD22.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD226
AC   CVCL_E6PC
SY   Human CD226 CHO-K1; H_CD226 CHO-K1
DR   Genomeditech; GM-C19185
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16961; CD226.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD24
AC   CVCL_E6PD
SY   Human CD24 CHO-K1; H_CD24 CHO-K1
DR   Genomeditech; GM-C03862
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1645; CD24.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD274(PD-L1)
AC   CVCL_E6PE
SY   Human CD274 CHO-K1; Human PD-L1 CHO-K1; H_CD274(PD-L1) CHO-K1
DR   Genomeditech; GM-C01115
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD274(PD-L1) aAPC
AC   CVCL_E6PF
SY   Human CD274 aAPC CHO-K1; Human PD-L1 aAPC CHO-K1; H_CD274(PD-L1) aAPC CHO-K1
DR   Genomeditech; GM-C05269
CC   Characteristics: Constitutively expresses the ScFV sequence of anti-human CD3 mAb OKT3 and human CD274 (Genomeditech=GM-C05269).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD276(B7H3)
AC   CVCL_E6PG
SY   Human CD276 CHO-K1; Human B7H3 CHO-K1; H_CD276(B7H3) CHO-K1
DR   Genomeditech; GM-C09618
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19137; CD276.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD28
AC   CVCL_E6PH
SY   Human CD28 CHO-K1; H_CD28 CHO-K1
DR   Genomeditech; GM-C18999
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1653; CD28.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD3
AC   CVCL_E4IL
SY   Human CD3 complex CHO-K1; H_CD3 complex CHO-K1
DR   Genomeditech; GM-C32931
CC   Characteristics: Constitutively expresses human CD3 complex (Genomeditech=GM-C32931).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1677; CD247.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1673; CD3D.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1674; CD3E.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1675; CD3G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD33
AC   CVCL_E6PI
SY   Human CD33 CHO-K1; H_CD33 CHO-K1
DR   Genomeditech; GM-C19019
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1659; CD33.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD38
AC   CVCL_E6PJ
SY   Human CD38 CHO-K1; H_CD38 CHO-K1
DR   Genomeditech; GM-C19006
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1667; CD38.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD4
AC   CVCL_E6PK
SY   Human CD4 CHO-K1; H_CD4 CHO-K1
DR   Genomeditech; GM-C15451
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4 (Note=With p.Met397_Ile458del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD40(TNFRSF5)
AC   CVCL_E6PL
SY   Human CD40 CHO-K1; Human TNFRSF5 CHO-K1; H_CD40(TNFRSF5) CHO-K1
DR   Genomeditech; GM-C09470
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11919; CD40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD46
AC   CVCL_E6PM
SY   Human CD46 CHO-K1; H_CD46 CHO-K1
DR   Genomeditech; GM-C19165
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6953; CD46.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD47
AC   CVCL_E6PN
SY   Human CD47 CHO-K1; H_CD47 CHO-K1
DR   Genomeditech; GM-C09241
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD47 aAPC
AC   CVCL_E6PP
SY   Human CD47 aAPC CHO-K1; H_CD47 aAPC CHO-K1
DR   Genomeditech; GM-C13353
CC   Characteristics: Constitutively expresses the ScFV sequence of anti-human CD3 mAb OKT3 and human CD47 (Genomeditech=GM-C13353).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD70
AC   CVCL_E6PQ
SY   Human CD70 CHO-K1; H_CD70 CHO-K1
DR   Genomeditech; GM-C12749
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11937; CD70.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD79B
AC   CVCL_E6PR
SY   Human CD79B CHO-K1; H_CD79B CHO-K1
DR   Genomeditech; GM-C19031
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1699; CD79B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CD93
AC   CVCL_E6PS
SY   Human CD93 CHO-K1; H_CD93 CHO-K1
DR   Genomeditech; GM-C22126
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15855; CD93.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CDH3
AC   CVCL_E6PT
SY   Human CDH3 CHO-K1; H_CDH3 CHO-K1
DR   Genomeditech; GM-C24261
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1762; CDH3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CDH6
AC   CVCL_E6PU
SY   Human CDH6 CHO-K1; H_CDH6 CHO-K1
DR   Genomeditech; GM-C24263
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1765; CDH6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CEACAM1(CD66a)
AC   CVCL_E6PV
SY   Human CEACAM1 CHO-K1; Human CD66a CHO-K1; H_CEACAM1(CD66a) CHO-K1
DR   Genomeditech; GM-C19187
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1814; CEACAM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CEACAM5(CEA)
AC   CVCL_E6PW
SY   Human CEACAM5 CHO-K1; Human CEA CHO-K1; Human CD66e CHO-K1; H_CEACAM5(CEA) CHO-K1
DR   Genomeditech; GM-C12814
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CEACAM6(CD66c)
AC   CVCL_E6PX
SY   Human CEACAM6 CHO-K1; Human CD66c CHO-K1; H_CEACAM6(CD66c) CHO-K1
DR   Genomeditech; GM-C19188
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1818; CEACAM6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CKAP4
AC   CVCL_E6PY
SY   Human CKAP4 CHO-K1; H_CKAP4 CHO-K1
DR   Genomeditech; GM-C25627
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16991; CKAP4 (Note=With p.Met1_Val127del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CLDN18(isoform2)
AC   CVCL_E2SZ
SY   Human CLDN18(isoform2); H_CLDN18(isoform2) CHO-K1
DR   Genomeditech; GM-C05273
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Genomeditech CHO-K1 H_CLDN6
AC   CVCL_E6PZ
SY   Human CLDN6 CHO-K1; H_CLDN6 CHO-K1
DR   Genomeditech; GM-C03905
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2048; CLDN6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CLDN9
AC   CVCL_E6Q0
SY   Human CLDN9 CHO-K1; H_CLDN9 CHO-K1
DR   Genomeditech; GM-C15749
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2051; CLDN9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CLEC12A
AC   CVCL_E6Q1
SY   Human CLEC12A CHO-K1; H_CLEC12A CHO-K1
DR   Genomeditech; GM-C19082
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:31713; CLEC12A (Note=With p.Met1_Phe64del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CLEC4C(BDCA2)+FCER1G
AC   CVCL_E6Q2
SY   Human CLEC4C+FCER1G CHO-K1; Human BDCA2+FCER1G CHO-K1; Human CD303+FCER1G CHO-K1; H_CLEC4C(BDCA2)+FCER1G CHO-K1
DR   Genomeditech; GM-C13187
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13258; CLEC4C.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CNR1(CB1)
AC   CVCL_E4J0
SY   Human CNR1 CHO-K1; Human CB1 CHO-K1; H_CNR1(CB1) CHO-K1
DR   Genomeditech; GM-C22608
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech CHO-K1 H_CSF1R
AC   CVCL_E6Q3
SY   Human CSF1R CHO-K1; Human CD115 CHO-K1; H_CSF1R CHO-K1
DR   Genomeditech; GM-C19080
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2433; CSF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CTLA4
AC   CVCL_E6Q4
SY   Human CTLA4 CHO-K1; Human CD152 CHO-K1; H_CTLA4 CHO-K1
DR   Genomeditech; GM-C23829
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2505; CTLA4 (Note=With p.Tyr201_Asn223del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_CXCR4
AC   CVCL_E6Q5
SY   Human CXCR4 CHO-K1; H_CXCR4 CHO-K1
DR   Genomeditech; GM-C05165
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_DLL4
AC   CVCL_E6Q6
SY   Human DLL4 CHO-K1; H_DLL4 CHO-K1
DR   Genomeditech; GM-C19190
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2910; DLL4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_EGFR
AC   CVCL_E4J3
SY   Human EGFR CHO-K1; H_EGFR CHO-K1
DR   Genomeditech; GM-C19964
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech CHO-K1 H_ENPP3
AC   CVCL_E6Q7
SY   Human ENPP3 CHO-K1; Human CD203c CHO-K1; H_ENPP3(CD203c) CHO-K1
DR   Genomeditech; GM-C19168
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3358; ENPP3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_EPCAM
AC   CVCL_E6Q8
SY   Human EPCAM CHO-K1; H_EPCAM CHO-K1
DR   Genomeditech; GM-C19181
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11529; EPCAM.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ERBB2(HER2)
AC   CVCL_E6Q9
SY   Human ERBB2 CHO-K1; Human HER2 CHO-K1; Human CD340 CHO-K1; H_ERBB2(HER2) CHO-K1
DR   Genomeditech; GM-C18996
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ERBB3(HER3)
AC   CVCL_E6QA
SY   Human ERBB3 CHO-K1; Human HER3 CHO-K1; H_ERBB3(HER3) CHO-K1
DR   Genomeditech; GM-C12969
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3431; ERBB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_F3
AC   CVCL_E6QB
SY   Human F3 CHO-K1; Human CD142 CHO-K1; H_F3 CHO-K1
DR   Genomeditech; GM-C19060
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3541; F3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_FAP
AC   CVCL_E6QC
SY   Human FAP CHO-K1; H_FAP CHO-K1
DR   Genomeditech; GM-C19182
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3590; FAP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_FCGR2A(CD32A)
AC   CVCL_E6QD
SY   Human FCGR2A CHO-K1; Human CD32A CHO-K1; H_FCGR2A(CD32A) CHO-K1
DR   Genomeditech; GM-C24472
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3616; FCGR2A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_FCGR2B(CD32B)
AC   CVCL_E2SY
SY   Human EGFR FCGR2B CHO-K1; Human EGFR CD32B CHO-K1; H_FCGR2B(CD32B) CHO-K1
DR   Genomeditech; GM-C16925
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3618; FCGR2B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Genomeditech CHO-K1 H_FCGR2B(CD32B) aAPC
AC   CVCL_E6QE
SY   Human FCGR2B aAPC CHO-K1; Human CD32B aAPC CHO-K1; H_FCGR2B(CD32B) aAPC CHO-K1
DR   Genomeditech; GM-C25754
CC   Characteristics: Constitutively expresses the ScFV sequence of anti-human CD3 mAb OKT3 and human FCGR2B (Genomeditech=GM-C25754).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3618; FCGR2B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_FCGRT(FcRn)+B2M
AC   CVCL_E6QF
SY   Human FCGRT+B2M CHO-K1; Human FcRn+B2M CHO-K1; H_FCGRT(FcRn)+B2M CHO-K1
DR   Genomeditech; GM-C09637
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3621; FCGRT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_FOLH1(PSMA)
AC   CVCL_E6QG
SY   Human FOLH1 CHO-K1; Human PSMA CHO-K1; H_FOLH1(PSMA) CHO-K1
DR   Genomeditech; GM-C19180
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3788; FOLH1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_FOLR1
AC   CVCL_E6QH
SY   Human FOLR1 CHO-K1; H_FOLR1 CHO-K1
DR   Genomeditech; GM-C19083
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3791; FOLR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_FSHR Reporter
AC   CVCL_E6QI
SY   Human FSHR Reporter CHO-K1; H_FSHR Reporter CHO-K1
DR   Genomeditech; GM-C25571
CC   Characteristics: Constitutively expresses human FSHR along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C25571).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3969; FSHR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_GCGR Reporter
AC   CVCL_E4JA
SY   Human GCGR Reporter CHO-K1; H_GCGR Reporter CHO-K1
DR   Genomeditech; GM-C09151
CC   Characteristics: Constitutively expresses human GCGR along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C09151).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4192; GCGR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech CHO-K1 H_GIPR Reporter
AC   CVCL_E6QJ
SY   Human GIPR Reporter CHO-K1; H_GIPR Reporter CHO-K1
DR   Genomeditech; GM-C25536
CC   Characteristics: Constitutively expresses human GIPR along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C25536).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4271; GIPR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_GLP1R Reporter
AC   CVCL_E6QK
SY   Human GLP1R Reporter CHO-K1; H_GLP1R Reporter CHO-K1
DR   Genomeditech; GM-C09150
CC   Characteristics: Constitutively expresses human GLP1R along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C09150).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_GPA33
AC   CVCL_E6QL
SY   Human GPA33 CHO-K1; H_GPA33 CHO-K1
DR   Genomeditech; GM-C24354
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4445; GPA33.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_GPRC5D
AC   CVCL_E6QM
SY   Human GPRC5D CHO-K1; H_GPRC5D CHO-K1
DR   Genomeditech; GM-C03857
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13310; GPRC5D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_GUCY2C
AC   CVCL_E6QN
SY   Human GUCY2C CHO-K1; H_GUCY2C CHO-K1
DR   Genomeditech; GM-C19042
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4688; GUCY2C.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_HAVCR2(TIM3)
AC   CVCL_E6QP
SY   Human HAVCR2 CHO-K1; Human TIM3 CHO-K1; Human CD366 CHO-K1; H_HAVCR2(TIM3) CHO-K1
DR   Genomeditech; GM-C19183
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18437; HAVCR2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_HLA-G+B2M
AC   CVCL_E6QQ
SY   Human HLA-G+B2M CHO-K1; H_HLA-G+B2M CHO-K1
DR   Genomeditech; GM-C15840
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ICOSLG(CD275)
AC   CVCL_E6QR
SY   Human ICOSLG CHO-K1; Human CD275 CHO-K1; H_ICOSLG(CD275) CHO-K1
DR   Genomeditech; GM-C19186
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17087; ICOSLG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_IGF1R
AC   CVCL_E6QS
SY   Human IGF1R CHO-K1; Human CD221 CHO-K1; H_IGF-1R CHO-K1
DR   Genomeditech; GM-C19054
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5465; IGF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_IL3RA(CD123)
AC   CVCL_E6QT
SY   Human IL3RA CHO-K1; Human CD123 CHO-K1; H_IL3RA(CD123) CHO-K1
DR   Genomeditech; GM-C19010
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6012; IL3RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_IL4R
AC   CVCL_E6QU
SY   Human IL4R CHO-K1; Human CD124 CHO-K1; H_IL4R CHO-K1
DR   Genomeditech; GM-C01521
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6015; IL4R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_IL5RA
AC   CVCL_E6QV
SY   Human IL5RA CHO-K1; Human CD125 CHO-K1; H_IL5RA CHO-K1
DR   Genomeditech; GM-C06724
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6017; IL5RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_INSR
AC   CVCL_E6QW
SY   Human INSR CHO-K1; Human CD220 CHO-K1; H_INSR CHO-K1
DR   Genomeditech; GM-C19193
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ITGB6
AC   CVCL_E4IS
SY   Human ITGB6 CHO-K1; H_ITGB6 CHO-K1
DR   Genomeditech; GM-C29044
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6161; ITGB6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LAG3
AC   CVCL_E6QX
SY   Human LAG3 CHO-K1; Human CD223 CHO-K1; H_LAG3 CHO-K1
DR   Genomeditech; GM-C19016
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6476; LAG3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LGR5
AC   CVCL_E6QY
SY   Human LGR5 CHO-K1; H_LGR5 CHO-K1
DR   Genomeditech; GM-C22690
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4504; LGR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LILRB1(ILT2)
AC   CVCL_E6QZ
SY   Human LILRB1 CHO-K1; Human ILT2 CHO-K1; Human CD85 CHO-K1; H_LILRB1(ILT2) CHO-K1
DR   Genomeditech; GM-C15859
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6605; LILRB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LILRB2(ILT4)
AC   CVCL_E6R0
SY   Human LILRB2 CHO-K1; Human ILT4 CHO-K1; H_LILRB2(ILT4) CHO-K1
DR   Genomeditech; GM-C15863
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6606; LILRB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LILRB3(ILT5)
AC   CVCL_E6R1
SY   Human LILRB3 CHO-K1; Human ILT5 CHO-K1; H_LILRB3(ILT5) CHO-K1
DR   Genomeditech; GM-C20074
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6607; LILRB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LILRB4(ILT3)
AC   CVCL_E6R2
SY   Human LILRB4 CHO-K1; Human ILT3 CHO-K1; H_LILRB4(ILT3) CHO-K1
DR   Genomeditech; GM-C16832
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6608; LILRB4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LILRB5
AC   CVCL_E6R3
SY   Human LILRB5 CHO-K1; H_LILRB5 CHO-K1
DR   Genomeditech; GM-C19932
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6609; LILRB5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LRRC32(GARP)
AC   CVCL_E4J8
SY   Human LRRC32 CHO-K1; Human GARP CHO-K1; H_LRRC32(GARP) CHO-K1
DR   Genomeditech; GM-C12824
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4161; LRRC32.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Genomeditech CHO-K1 H_LY6E
AC   CVCL_E6R4
SY   Human LY6E CHO-K1; H_LY6E CHO-K1
DR   Genomeditech; GM-C19355
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6727; LY6E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_MELTF(CD228)
AC   CVCL_E6R5
SY   Human MELTF CHO-K1; Human CD228 CHO-K1; H_MELTF(CD228) CHO-K1
DR   Genomeditech; GM-C21677
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7037; MELTF.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_MET
AC   CVCL_E6R6
SY   Human MET CHO-K1; H_MET CHO-K1
DR   Genomeditech; GM-C19962
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7029; MET.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_MICA
AC   CVCL_E6R7
SY   Human MICA CHO-K1; H_MICA CHO-K1
DR   Genomeditech; GM-C22346
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7090; MICA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_MSLN
AC   CVCL_E6R8
SY   Human MSLN CHO-K1; H_MSLN CHO-K1
DR   Genomeditech; GM-C18992
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7371; MSLN.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_MUC1(CD227)
AC   CVCL_E6R9
SY   Human MUC1 CHO-K1; Human CD227 CHO-K1; H_MUC1(CD227) CHO-K1
DR   Genomeditech; GM-C19062
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_MUCL3(C6orf37)
AC   CVCL_E6RA
SY   Human MUCL3 CHO-K1; Human C6orf37 CHO-K1; H_MUCL3(C6orf37) CHO-K1
DR   Genomeditech; GM-C19735
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21666; MUCL3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_NCR1(NKp46)
AC   CVCL_E6RB
SY   Human NCR1 CHO-K1; Human NKp46 CHO-K1; Human CD335 CHO-K1; H_NCR1(NKp46) CHO-K1
DR   Genomeditech; GM-C17927
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6731; NCR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_NECTIN2(CD112) aAPC
AC   CVCL_E6RC
SY   Human NECTIN2 aAPC CHO-K1; Human CD112 aAPC CHO-K1; H_NECTIN(CD112) aAPC CHO-K1
DR   Genomeditech; GM-C18951
CC   Characteristics: Constitutively expresses the ScFV sequence of anti-human CD3 mAb OKT3 and human NECTIN2 (Genomeditech=GM-C18951).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9707; NECTIN2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_NECTIN4
AC   CVCL_E6RD
SY   Human NECTIN4 CHO-K1; H_NECTIN4 CHO-K1
DR   Genomeditech; GM-C09528
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19688; NECTIN4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_NKG2A+CD94
AC   CVCL_E6RE
SY   Human CD94+NKG2A CHO-K1; H_NKG2A+CD94 CHO-K1
DR   Genomeditech; GM-C15621
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6374; KLRC1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6378; KLRD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_NT5E(CD73)
AC   CVCL_E6RF
SY   Human NT5E CHO-K1; Human CD73 CHO-K1; H_NT5E(CD73) CHO-K1
DR   Genomeditech; GM-C19009
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8021; NT5E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_PDCD1(PD-1)
AC   CVCL_E6RG
SY   Human PDCD1 CHO-K1; Human PD-1 CHO-K1; Human CD279 CHO-K1; H_PDCD1(PD-1) CHO-K1
DR   Genomeditech; GM-C09097
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_PDCD1LG2(PDL2)
AC   CVCL_E6RH
SY   Human PDCD1LG2 CHO-K1; Human PDL2 CHO-K1; H_PDCD1LG2(PDL2) CHO-K1
DR   Genomeditech; GM-C19936
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18731; PDCD1LG2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_PRLR
AC   CVCL_E6RI
SY   Human PRLR CHO-K1; H_PRLR CHO-K1
DR   Genomeditech; GM-C19002
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9446; PRLR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_PVR(CD155)
AC   CVCL_E6RJ
SY   Human PVR CHO-K1; Human CD155 CHO-K1; H_PVR(CD155) CHO-K1
DR   Genomeditech; GM-C19146
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9705; PVR (Note=With p.Ser368_Arg417del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_PVRIG(CD112R)
AC   CVCL_E6RK
SY   Human PVRIG CHO-K1; Human CD112R CHO-K1; H_PVRIG(CD112R) CHO-K1
DR   Genomeditech; GM-C18950
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:32190; PVRIG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ROR1
AC   CVCL_E6RL
SY   Human ROR1 CHO-K1; H_ROR1 CHO-K1
DR   Genomeditech; GM-C19169
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10256; ROR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_ROR2
AC   CVCL_E6RM
SY   Human ROR2 CHO-K1; H_ROR2 CHO-K1
DR   Genomeditech; GM-C19164
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10257; ROR2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech CHO-K1 H_RSPO1
AC   CVCL_E6RN
SY   Human RSPO1 CHO-K1; H_RSPO1 CHO-K1
DR   Genomeditech; GM-C19910
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21679; RSPO1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_SIGLEC10
AC   CVCL_E6RP
SY   Human SIGLEC10 CHO-K1; H_SIGLEC10 CHO-K1
DR   Genomeditech; GM-C03881
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15620; SIGLEC10.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_SIGLEC15+TYROBP
AC   CVCL_E6RQ
SY   Human SIGLEC15+TYROBP CHO-K1; H_SIGLEC15+TYROBP CHO-K1
DR   Genomeditech; GM-C14335
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:27596; SIGLEC15.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12449; TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_SIGLEC8
AC   CVCL_E6RR
SY   Human SIGLEC8 CHO-K1; H_SIGLEC8 CHO-K1
DR   Genomeditech; GM-C13008
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10877; SIGLEC8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_SIGLEC9
AC   CVCL_E6RS
SY   Human SIGLEC9 CHO-K1; Human CD329 CHO-K1; H_SIGLEC9 CHO-K1
DR   Genomeditech; GM-C19110
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10878; SIGLEC9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_SIRPA
AC   CVCL_E6RT
SY   Human SIRPA CHO-K1; H_SIRPA CHO-K1
DR   Genomeditech; GM-C11721
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9662; SIRPA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_SLC34A2
AC   CVCL_E6RU
SY   Human SLC34A2 CHO-K1; H_SLC34A2 CHO-K1
DR   Genomeditech; GM-C13372
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11020; SLC34A2 (Note=With p.Leu574_Leu690del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_SLC39A6
AC   CVCL_E6RV
SY   Human SLC39A6 CHO-K1; H_SLC39A6 CHO-K1
DR   Genomeditech; GM-C13341
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18607; SLC39A6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_STEAP1
AC   CVCL_E6RW
SY   Human STEAP1 CHO-K1; H_STEAP1 CHO-K1
DR   Genomeditech; GM-C21519
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:27962; STING1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TACSTD2(TROP2)
AC   CVCL_E6RX
SY   Human TACSTD2 CHO-K1; Human TROP2 CHO-K1; H_TACSTD2(TROP2) CHO-K1
DR   Genomeditech; GM-C12880
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11530; TACSTD2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TFRC(CD71)
AC   CVCL_E6RY
SY   Human TFRC CHO-K1; Human CD71 CHO-K1; H_TFRC(CD71) CHO-K1
DR   Genomeditech; GM-C19162
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11763; TFRC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TIGIT
AC   CVCL_E6RZ
SY   Human TIGIT CHO-K1; H_TIGIT CHO-K1
DR   Genomeditech; GM-C18929
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:26838; TIGIT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNF(Membrane bound)
AC   CVCL_E6S0
SY   Human TNF(Membrane bound) CHO-K1; H_TNF(Membrane bound) CHO-K1
DR   Genomeditech; GM-C25239
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11892; TNF.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFRSF14(HVEM)
AC   CVCL_E6S1
SY   Human TNFRSF14 CHO-K1; Human HVEM CHO-K1; Human CD270 CHO-K1; H_TNFRSF14(HVEM) CHO-K1
DR   Genomeditech; GM-C25498
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11912; TNFRSF14.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFRSF14(HVEM) aAPC
AC   CVCL_E6S2
SY   Human HVEM aAPC CHO-K1; Human TNFRSF14 aAPC CHO-K1; Human CD270 aAPC CHO-K1; H_TNFRSF14(HVEM) aAPC CHO-K1
DR   Genomeditech; GM-C25499
CC   Characteristics: Constitutively expresses the ScFV sequence of anti-human CD3 mAb OKT3 and human TNFRSF14 (Genomeditech=GM-C25499).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11912; TNFRSF14.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFRSF17(BCMA)
AC   CVCL_E6S3
SY   Human TNFRSF17 CHO-K1; Human BCMA CHO-K1; H_TNFRSF17(BCMA) CHO-K1
DR   Genomeditech; GM-C24849
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11913; TNFRSF17.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFRSF1B(TNFR2)
AC   CVCL_E6S4
SY   Human TNFRSF1B CHO-K1; Human TNFR2 CHO-K1; H_TNFRSF1B(TNFR2) CHO-K1
DR   Genomeditech; GM-C19192
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFRSF4(CD134)
AC   CVCL_E6S5
SY   Human TNFRSF4 CHO-K1; Human CD134 CHO-K1; H_TNFRS4(CD134) CHO-K1
DR   Genomeditech; GM-C18986
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11918; TNFRSF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFRSF8(CD30)
AC   CVCL_E6S6
SY   Human TNFRSF8 CHO-K1; Human CD30 CHO-K1; H_TNFRSF8(CD30) CHO-K1
DR   Genomeditech; GM-C19027
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11923; TNFRSF8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFRSF9(4-1BB)
AC   CVCL_E6S7
SY   Human TNFRSF9 CHO-K1; Human 4-1BB CHO-K1; Human CD137 CHO-K1; H_TNFRSF9(4-1BB) CHO-K1
DR   Genomeditech; GM-C05171
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFSF14(LIGHT)
AC   CVCL_E6S8
SY   Human TNFSF14 CHO-K1; Human LIGHT CHO-K1; Human CD258 CHO-K1; H_TNFSF14(LIGHT) CHO-K1
DR   Genomeditech; GM-C19158
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11930; TNFSF14.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TNFSF15(TL1A)
AC   CVCL_E6S9
SY   Human TNFSF15 CHO-K1; Human TL1A CHO-K1; H_TNFSF15(TL1A) CHO-K1
DR   Genomeditech; GM-C19170
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11931; TNFSF15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TPBG
AC   CVCL_E6SA
SY   Human TPBG CHO-K1; H_TPBG CHO-K1
DR   Genomeditech; GM-C19130
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12004; TPBG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TREM1+TYROBP
AC   CVCL_E6SB
SY   Human TREM1+TYROBP CHO-K1; Human CD354+TYROBP CHO-K1; H_TREM1+TYROBP CHO-K1
DR   Genomeditech; GM-C13367
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17760; TREM1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12449; TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_TREM2
AC   CVCL_E6SC
SY   Human TREM2 CHO-K1; H_TREM2 CHO-K1
DR   Genomeditech; GM-C25370
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17761; TREM2 (Note=With p.Thr173_Thr230del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_VTCN1(B7H4)
AC   CVCL_E6SD
SY   Human VTCN1 CHO-K1; Human B7H4 CHO-K1; H_VTCN1(B7H4) CHO-K1
DR   Genomeditech; GM-C09625
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:28873; VTCN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 H_WNT3A
AC   CVCL_E6SE
SY   Human WNT3A CHO-K1; H_WNT3A CHO-K1
DR   Genomeditech; GM-C22345
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15983; WNT3A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Ccr8
AC   CVCL_E6SF
SY   Mouse Ccr8 CHO-K1; Mouse_Ccr8 CHO-K1
DR   Genomeditech; GM-C09426
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1201402; Ccr8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Cd274(PD-L1) aAPC
AC   CVCL_E4IW
SY   Mouse Cd274 aAPC CHO-K1; Mouse PD-L1 aAPC CHO-K1; Mouse_Cd274(PD-L1) aAPC CHO-K1
DR   Genomeditech; GM-C25791
CC   Characteristics: Constitutively expresses the ScFV sequence of anti-human CD3 mAb OKT3 and mouse Cd274 (Genomeditech=GM-C25791).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1926446; Cd274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech CHO-K1 Mouse_Cd47
AC   CVCL_E6SG
SY   Mouse Cd47 CHO-K1; Mouse_Cd47 CHO-K1
DR   Genomeditech; GM-C23915
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96617; Cd47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Cd93
AC   CVCL_E6SH
SY   Mouse Cd93 CHO-K1; Mouse_Cd93 CHO-K1
DR   Genomeditech; GM-C22125
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:106664; Cd93.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Cldn18(isoform 2)-eGFP
AC   CVCL_E6SI
SY   Mouse Cldn18(isoform 2)-eGFP CHO-K1; Mouse_Cldn18(isoform 2)-eGFP CHO-K1
DR   Genomeditech; GM-C09557
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1929209; Cldn18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Cldn6
AC   CVCL_E6SJ
SY   Mouse Cldn6 CHO-K1; Mouse_Cldn6 CHO-K1
DR   Genomeditech; GM-C23917
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1859284; Cldn6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Erbb3(Her3)
AC   CVCL_E6SK
SY   Mouse Erbb3 CHO-K1; Mouse Her3 CHO-K1; Mouse_Her3(Erbb3) CHO-K1
DR   Genomeditech; GM-C23923
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:95411; Erbb3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Meltf(Cd228)
AC   CVCL_E6SL
SY   Mouse Meltf CHO-K1; Mouse Cd228 CHO-K1; Mouse_Meltf(Cd228) CHO-K1
DR   Genomeditech; GM-C23924
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1353421; Meltf.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Nectin4
AC   CVCL_E6SM
SY   Mouse Nectin4 CHO-K1; Mouse_Nectin4 CHO-K1
DR   Genomeditech; GM-C23925
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1918990; Nectin4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Pdcd1(PD-1)
AC   CVCL_E6SN
SY   Mouse Pdcd1 CHO-K1; Mouse PD-1 CHO-K1; Mouse_PDCD1(PD-1) CHO-K1
DR   Genomeditech; GM-C19255
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104879; Pdcd1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Prlr
AC   CVCL_E6SP
SY   Mouse Prlr CHO-K1; Mouse_Prlr CHO-K1
DR   Genomeditech; GM-C20045
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97490; Prlr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Ror1
AC   CVCL_E6SQ
SY   Mouse Ror1 CHO-K1; Mouse_Ror1 CHO-K1
DR   Genomeditech; GM-C24588
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1347520; Ror1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Siglec15+Tyrobp
AC   CVCL_E6SR
SY   Mouse Siglec15+Tyrobp CHO-K1; Mouse_Siglec15+Tyrobp CHO-K1
DR   Genomeditech; GM-C23926
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:3646642; Siglec15.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1277211; Tyrobp.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Mouse_Trem1+Tyrobp
AC   CVCL_E6SS
SY   Mouse Trem1+Tyrobp CHO-K1; Mouse_Trem1+Tyrobp CHO-K1
DR   Genomeditech; GM-C13368
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1930005; Trem1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1277211; Tyrobp.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rat_Cldn18(isoform 2)-eGFP
AC   CVCL_E6ST
SY   Rat Cldn18(isoform 2)-eGFP CHO-K1; Rat_Cldn18(isoform 2)-eGFP CHO-K1
DR   Genomeditech; GM-C09555
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=RGD; 1359696; Cldn18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rat_Cldn6
AC   CVCL_E6SU
SY   Rat Cldn6 CHO-K1; Rat_Cldn6 CHO-K1
DR   Genomeditech; GM-C20073
CC   Genetic integration: Method=Transduction; Gene=RGD; 1308837; Cldn6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rhesus_CCR8-eGFP
AC   CVCL_E6SV
SY   Rhesus CCR8-eGFP CHO-K1; Rhesus_CCR8-eGFP CHO-K1
DR   Genomeditech; GM-C11689
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; O97665; Macaca mulatta CCR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rhesus_CLDN18(isoform 2)-eGFP
AC   CVCL_E6SW
SY   Rhesus CLDN18(isoform 2)-eGFP CHO-K1; Rhesus_CLDN18(isoform 2)-eGFP CHO-K1
DR   Genomeditech; GM-C07799
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F6YQZ9; Macaca mulatta CLDN18 (Note=Isoform X2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rhesus_LGR5
AC   CVCL_E6SX
SY   Rhesus LGR5 CHO-K1; Rhesus_LGR5 CHO-K1
DR   Genomeditech; GM-C24931
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7N7N3; Macaca mulatta LGR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rhesus_LILRB1
AC   CVCL_E6SY
SY   Rhesus LILRB1 CHO-K1; Rhesus_LILRB1 CHO-K1
DR   Genomeditech; GM-C24276
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F7H3G7; Macaca mulatta LILRB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rhesus_NCR1(NKp46)
AC   CVCL_E6SZ
SY   Rhesus NCR1 CHO-K1; Rhesus NKp46 CHO-K1; Rhesus_NCR1(NKp46) CHO-K1
DR   Genomeditech; GM-C17929
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8MIZ9; Macaca mulatta NCR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CHO-K1 Rhesus_SLC34A2
AC   CVCL_E6T0
SY   Rhesus SLC34A2 CHO-K1; Rhesus_SLC34A2 CHO-K1
DR   Genomeditech; GM-C13371
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F7HDA3; Macaca mulatta SLC34A2 (Note=With p.Ser577_Leu690del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech CT26 H_CLDN18(isoform 2)-eGFP
AC   CVCL_E6T1
SY   Human CLDN18(isoform 2)-eGFP CT26; H_CLDN18(isoform 2)-eGFP CT26
DR   Genomeditech; GM-C09674
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Genomeditech CT26 H_GPA33
AC   CVCL_E6T2
SY   Human GPA33 CT26; H_GPA33 CT26
DR   Genomeditech; GM-C24364
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4445; GPA33.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HCT116 H_CDH17
AC   CVCL_E4IN
SY   Human CDH17 HCT116; H_CDH17 HCT116
DR   Genomeditech; GM-C30949
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1756; CDH17 (Note=With p.Arg809_Ser832del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 Cynomolgus_AMHR2
AC   CVCL_E6T3
SY   Cynomolgus AMHR2 HEK-293; Cynomolgus_AMHR2 HEK-293
DR   Genomeditech; GM-C09687
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A8J8XFT0; Macaca fascicularis AMHR2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Cynomolgus_CCR4
AC   CVCL_E6T4
SY   Cynomolgus CCR4 HEK-293; Cynomolgus_CCR4 HEK-293
DR   Genomeditech; GM-C24421
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7NYB7; Macaca fascicularis CCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Cynomolgus_CDH17
AC   CVCL_E6T5
SY   Cynomolgus CDH17 HEK-293; Cynomolgus_CDH17 HEK-293
DR   Genomeditech; GM-C25982
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5X8I8; Macaca fascicularis CDH17 (Note=With p.Met1_Pro57del and p.Ala796_Ser840del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Cynomolgus_CTLA4
AC   CVCL_E6T6
SY   Cynomolgus CTLA4 HEK-293; Cynomolgus_CTLA4 HEK-293
DR   Genomeditech; GM-C25122
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PL88; Macaca fascicularis CTLA4 (Note=With p.Tyr201_Asn223del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Cynomolgus_LGR5
AC   CVCL_E6T7
SY   Cynomolgus LGR5 HEK-293; Cynomolgus_LGR5 HEK-293
DR   Genomeditech; GM-C22699
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A7N9CTA7; Macaca fascicularis LGR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Cynomolgus_SLC34A2
AC   CVCL_E6T8
SY   Cynomolgus SLC34A2 HEK-293; Cynomolgus_SLC34A2 HEK-293
DR   Genomeditech; GM-C21535
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UHY1; Macaca fascicularis SLC34A2 (Note=With p.Leu574_Leu690del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Cynomolgus_TREM1+TYROBP
AC   CVCL_E6T9
SY   Cynomolgus TREM1+TYROBP HEK-293; Cynomolgus_TREM1+TYROBP HEK-293
DR   Genomeditech; GM-C13377
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5VHG8; Macaca fascicularis TREM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PXB4; Macaca fascicularis TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Cynomolgus_TREM2+TYROBP
AC   CVCL_E6TA
SY   Cynomolgus TREM2+TYROBP HEK-293; Cynomolgus_TREM2+TYROBP HEK-293
DR   Genomeditech; GM-C15499
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; H9FW03; Macaca fascicularis TREM2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; G7PXB4; Macaca fascicularis TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_ADAM9
AC   CVCL_E6TB
SY   Human ADAM9 HEK-293; Human MDC9 HEK-293; H_ADAM9 HEK-293
DR   Genomeditech; GM-C19705
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:216; ADAM9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_alphaVbeta6
AC   CVCL_E4J4
SY   Human alphaVbeta6 HEK-293; H_alphaVbeta6 HEK-293
DR   Genomeditech; GM-C19431
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6161; ITGB6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_BTN3A1
AC   CVCL_E6TC
SY   Human BTN3A1 HEK-293; H_BTN3A1 HEK-293
DR   Genomeditech; GM-C19701
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1138; BTN3A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CALCRL+RAMP1 Reporter
AC   CVCL_E4J2
SY   Human CALCRL+RAMP1 Reporter HEK-293; H_CALCRL+RAMP1 Reporter HEK-293
DR   Genomeditech; GM-C19979
CC   Characteristics: Constitutively expresses human CALCRL and RAMP1 along with cAMP signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C19979).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9843; RAMP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_CCR8
AC   CVCL_E6TD
SY   Human CCR8 HEK-293; H_CCR8 HEK-293
DR   Genomeditech; GM-C15638
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CD274(PD-L1)
AC   CVCL_E6TE
SY   Human CD274 HEK-293; Human PD-L1 HEK-293; H_CD274(PD-L1) HEK-293
DR   Genomeditech; GM-C11722
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CD3
AC   CVCL_E4AD
SY   Human CD3 complex HEK-293; H_CD3 HEK-293
DR   Genomeditech; GM-C30877
CC   Characteristics: Constitutively expresses human CD3 complex (Genomeditech=GM-C30877).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1677; CD247.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1673; CD3D.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1674; CD3E.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1675; CD3G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_CD40(TNFRSF5) Reporter
AC   CVCL_E6TF
SY   Human CD40 Reporter HEK-293; Human TNFRSF5 Reporter HEK-293; H_CD40(TNFRSF5) Reporter HEK-293
DR   Genomeditech; GM-C03829
CC   Characteristics: Constitutively expresses human CD40 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C03829).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11919; CD40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CD93
AC   CVCL_E6TG
SY   Human CD93 HEK-293; H_CD93 HEK-293
DR   Genomeditech; GM-C22127
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15855; CD93.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CDH17
AC   CVCL_E6TH
SY   Human CDH17 HEK-293; H_CDH17 HEK-293
DR   Genomeditech; GM-C25981
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1756; CDH17 (Note=With p.Ala788_Ser832del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CDH3
AC   CVCL_E6TI
SY   Human CDH3 HEK-293; H_CDH3 HEK-293
DR   Genomeditech; GM-C24260
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1762; CDH3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CDH6
AC   CVCL_E6TJ
SY   Human CDH6 HEK-293; H_CDH6 HEK-293
DR   Genomeditech; GM-C24262
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1765; CDH6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CEACAM5(CEA)
AC   CVCL_E6TK
SY   Human CEACAM5 HEK-293; Human CEA HEK-293; H_CEACAM5(CEA) HEK-293
DR   Genomeditech; GM-C24838
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CEACAM6(CD66c)
AC   CVCL_E6TL
SY   Human CEACAM6 HEK-293; Human CD66c HEK-293; H_CEACAM6(CD66c) HEK-293
DR   Genomeditech; GM-C24404
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1818; CEACAM6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CLDN18(isoform 1)-eGFP
AC   CVCL_E6TM
SY   Human CLDN18(isoform 1)-eGFP HEK-293; H_CLDN18(isoform 1)-eGFP HEK-293
DR   Genomeditech; GM-C07884
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CLDN18(isoform 2)-eGFP
AC   CVCL_E6TN
SY   Human CLDN18(isoform 2)-eGFP HEK-293; H_CLDN18(isoform 2)-eGFP HEK-293
DR   Genomeditech; GM-C02120
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CLDN3
AC   CVCL_E6TP
SY   Human CLDN3 HEK-293; H_CLDN3 HEK-293
DR   Genomeditech; GM-C22368
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2045; CLDN3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CLDN6
AC   CVCL_E6TQ
SY   Human CLDN6 HEK-293; H_CLDN6 HEK-293
DR   Genomeditech; GM-C15737
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2048; CLDN6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CLDN9-eGFP
AC   CVCL_E6TR
SY   Human CLDN9-eGFP HEK-293; H_CLDN9-eGFP HEK-293
DR   Genomeditech; GM-C20108
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2051; CLDN9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CLEC4C(BDCA2)+FCER1G
AC   CVCL_E6TS
SY   Human CLEC4C+FCER1G HEK-293; Human BDCA2+FCER1G HEK-293; Human CD303+FCER1G HEK-293; H_CLEC4C(BDCA2)+FCER1G HEK-293
DR   Genomeditech; GM-C13222
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13258; CLEC4C.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CNR1(CB1)
AC   CVCL_E6TT
SY   Human CNR1 HEK-293; Human CB1 HEK-293; H_CNR1(CB1) HEK-293
DR   Genomeditech; GM-C22609
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CTLA4
AC   CVCL_E6TU
SY   Human CTLA4 HEK-293; Human CD152 HEK-293; H_CTLA4 HEK-293
DR   Genomeditech; GM-C23830
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2505; CTLA4 (Note=With p.Tyr201_Asn223del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_CXCR4
AC   CVCL_E6TV
SY   Human CXCR4 HEK-293; H_CXCR4 HEK-293
DR   Genomeditech; GM-C02175
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_DDR1
AC   CVCL_E6TW
SY   Human DDR1 HEK-293; Human CD167 HEK-293; H_DDR1 HEK-293
DR   Genomeditech; GM-C24270
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2730; DDR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_DLL3
AC   CVCL_E4J7
SY   Human DLL3 HEK-293; H_DLL3 HEK-293
DR   Genomeditech; GM-C12896
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2909; DLL3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_EGFR
AC   CVCL_E6TX
SY   Human EGFR HEK-293; H_EGFR HEK-293
DR   Genomeditech; GM-C25101
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_FOLR1
AC   CVCL_E6TY
SY   Human FOLR1 HEK-293; H_FOLR1 HEK-293
DR   Genomeditech; GM-C20033
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3791; FOLR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_GCGR Reporter
AC   CVCL_E4IM
SY   Human GCGR Reporter HEK-293; H_GCGR Reporter HEK-293
DR   Genomeditech; GM-C31698
CC   Characteristics: Constitutively expresses human GCGR along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C31698).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4192; GCGR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_GIPR Reporter
AC   CVCL_E4IZ
SY   Human GIPR Reporter HEK-293; H_GIPR Reporter HEK-293
DR   Genomeditech; GM-C24030
CC   Characteristics: Constitutively expresses human GIPR along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C24030).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4271; GIPR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_GLP1R Reporter
AC   CVCL_E4IY
SY   Human GLP1R Reporter HEK-293; H_GLP1R Reporter HEK-293
DR   Genomeditech; GM-C25537
CC   Characteristics: Constitutively expresses human GLP1R along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C25537).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_GLP1R Reporter subclone DDX35
AC   CVCL_E4IV
SY   Human GLP1R Reporter HEK-293 Cell subclone DDX35; H_GLP1R Reporter HEK-293 DDX35
DR   Genomeditech; GM-C26019
CC   Characteristics: Constitutively expresses human GLP1R along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C26019).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4IY ! Genomeditech HEK-293 H_GLP1R Reporter
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_GPA33
AC   CVCL_E6TZ
SY   Human GPA33 HEK-293; H_GPA33 HEK-293
DR   Genomeditech; GM-C24361
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4445; GPA33.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_GPC3
AC   CVCL_E6U0
SY   Human GPC3 HEK-293; H_GPC3 HEK-293
DR   Genomeditech; GM-C15633
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4451; GPC3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_GPRC5D
AC   CVCL_E6U1
SY   Human GPRC5D HEK-293; H_GPRC5D HEK-293
DR   Genomeditech; GM-C19519
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13310; GPRC5D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_HLA-E
AC   CVCL_E6U2
SY   Human HLA-E HEK-293; H_HLA-E HEK-293
DR   Genomeditech; GM-C19357
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4962; HLA-E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_HLA-G
AC   CVCL_E6U3
SY   Human HLA-G HEK-293; H_HLA-G HEK-293
DR   Genomeditech; GM-C15838
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL10 Reporter
AC   CVCL_E6U4
SY   Human IL10 Reporter HEK-293; H_IL10 Reporter HEK-293
DR   Genomeditech; GM-C06719
CC   Characteristics: Constitutively expresses human IL10RA and IL10RB along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C06719).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5964; IL10RA.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5965; IL10RB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL13RA2
AC   CVCL_E6U5
SY   Human IL13RA2 HEK-293; Human CD213a2 HEK-293; H_IL13RA2 HEK-293
DR   Genomeditech; GM-C06730
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5975; IL13RA2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL17A Reporter
AC   CVCL_E4JD
SY   Human IL17A Reporter HEK-293; H_IL17A Reporter HEK-293
DR   Genomeditech; GM-C06721
CC   Characteristics: Constitutively expresses human IL17RA, IL17RC and TRAF3IP2 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C06721).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5985; IL17RA.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18358; IL17RC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1343; TRAF3IP2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_IL18 Reporter
AC   CVCL_E6U6
SY   Human IL18 Reporter HEK-293; H_IL18 Reporter HEK-293
DR   Genomeditech; GM-C21147
CC   Characteristics: Constitutively expresses human IL18R1 and IL18RAP along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C21147).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5988; IL18R1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5989; IL18RAP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL23 Reporter
AC   CVCL_E4JC
SY   Human IL23 Reporter HEK-293; H_IL23 Reporter HEK-293
DR   Genomeditech; GM-C06722
CC   Characteristics: Constitutively expresses human IL12RB1 and IL23R along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C06722).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5971; IL12RB1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19100; IL23R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_IL27 Reporter
AC   CVCL_E6U7
SY   Human IL27 Reporter HEK-293; H_IL27 Reporter HEK-293
DR   Genomeditech; GM-C24822
CC   Characteristics: Constitutively expresses Human IL27RA along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C24822).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17290; IL27RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL33 Reporter
AC   CVCL_E6U8
SY   Human IL33 Reporter HEK-293; H_IL33 Reporter HEK-293
DR   Genomeditech; GM-C12812
CC   Characteristics: Constitutively expresses human IL1RL1 and IL1RAP along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C12812).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5995; IL1RAP.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5998; IL1RL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL36 Reporter
AC   CVCL_E6U9
SY   Human IL36 Reporter HEK-293; H_IL36 Reporter HEK-293
DR   Genomeditech; GM-C09527
CC   Characteristics: Constitutively expresses human IL1RL2 and IL1RAP along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C09527).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5995; IL1RAP.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5999; IL1RL2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL5RA
AC   CVCL_E6UA
SY   Human IL5RA HEK-293; Human CD125 HEK-293; H_IL5RA HEK-293
DR   Genomeditech; GM-C24583
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6017; IL5RA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_IL6 Reporter
AC   CVCL_E6UB
SY   Human IL6 Reporter HEK-293; H_IL6 Reporter HEK-293
DR   Genomeditech; GM-C01951
CC   Characteristics: Constitutively expresses human IL6 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C01951).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6018; IL6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_LGR5
AC   CVCL_E6UC
SY   Human LGR5 HEK-293; H_LGR5 HEK-293
DR   Genomeditech; GM-C22691
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4504; LGR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_LILRB1(ILT2)
AC   CVCL_E6UD
SY   Human LILRB1 HEK-293; Human ILT2 HEK-293; Human CD85 HEK-293; H_LILRB1(ILT2) HEK-293
DR   Genomeditech; GM-C15860
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6605; LILRB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_LILRB2(ILT4)
AC   CVCL_E6UE
SY   Human LILRB2 HEK-293; Human ILT4 HEK-293; H_LILRB2(ILT4) HEK-293
DR   Genomeditech; GM-C15864
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6606; LILRB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_LILRB3(ILT5)
AC   CVCL_E6UF
SY   Human LILRB3 HEK-293; Human ILT5 HEK-293; H_LILRB3(ILT5) HEK-293
DR   Genomeditech; GM-C24705
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6607; LILRB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_LILRB4(ILT3)
AC   CVCL_E6UG
SY   Human LILRB4 HEK-293; Human ILT3 HEK-293; H_LILRB4(ILT3) HEK-293
DR   Genomeditech; GM-C16833
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6608; LILRB4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_LRRC32(GARP)
AC   CVCL_E4J9
SY   Human LRRC32 HEK-293; Human GARP HEK-293; H_LRRC32(GARP) HEK-293 Cell
DR   Genomeditech; GM-C12809
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4161; LRRC32.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 H_LY6E
AC   CVCL_E6UH
SY   Human LY6E HEK-293; H_LY6E HEK-293
DR   Genomeditech; GM-C19356
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6727; LY6E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_MELTF(CD228)
AC   CVCL_E6UI
SY   Human MELTF HEK-293; Human CD228 HEK-293; H_MELTF(CD228) HEK-293
DR   Genomeditech; GM-C21678
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7037; MELTF.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_MET
AC   CVCL_E6UJ
SY   Human MET HEK-293; H_MET HEK-293
DR   Genomeditech; GM-C19037
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7029; MET.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_MICA
AC   CVCL_E6UK
SY   Human MICA HEK-293; H_MICA HEK-293
DR   Genomeditech; GM-C24921
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7090; MICA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_MICB
AC   CVCL_E6UL
SY   Human MICB HEK-293; H_MICB HEK-293
DR   Genomeditech; GM-C24872
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7091; MICB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_MUC1(CD227)
AC   CVCL_E6UM
SY   Human MUC1 HEK-293; Human CD227 HEK-293; H_MUC1(CD227) HEK-293
DR   Genomeditech; GM-C22129
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_MUCL3(C6orf37)
AC   CVCL_E6UN
SY   Human MUCL3 HEK-293; Human C6orf37 HEK-293; H_MUCL3(C6orf37) HEK-293
DR   Genomeditech; GM-C21280
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21666; MUCL3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_NCR1(NKp46)
AC   CVCL_E6UP
SY   Human NCR1 HEK-293; Human NKp46 HEK-293; Human CD335 HEK-293; H_NCR1(NKp46) HEK-293
DR   Genomeditech; GM-C17926
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6731; NCR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_NECTIN4
AC   CVCL_E6UQ
SY   Human NECTIN4 HEK-293; H_NECTIN4 HEK-293
DR   Genomeditech; GM-C19280
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19688; NECTIN4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_NT5E(CD73)
AC   CVCL_E6UR
SY   Human NT5E HEK-293; Human CD73 HEK-293; H_NT5E(CD73) HEK-293
DR   Genomeditech; GM-C25729
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8021; NT5E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_PVRIG(CD112R)
AC   CVCL_E6US
SY   Human PVRIG HEK-293; Human CD112R HEK-293; H_PVRIG(CD112R) HEK-293
DR   Genomeditech; GM-C24819
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:32190; PVRIG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_ROR1
AC   CVCL_E6UT
SY   Human ROR1 HEK-293; H_ROR1 HEK-293
DR   Genomeditech; GM-C24550
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10256; ROR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_SIGLEC15+TYROBP
AC   CVCL_E6UU
SY   Human SIGLEC15+TYROBP HEK-293; H_SIGLEC15+TYROBP HEK-293
DR   Genomeditech; GM-C13116
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:27596; SIGLEC15.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12449; TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_SIGLEC8
AC   CVCL_E6UV
SY   Human SIGLEC8 HEK-293; H_SIGLEC8 HEK-293
DR   Genomeditech; GM-C13009
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10877; SIGLEC8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_SIGLEC9
AC   CVCL_E6UW
SY   Human SIGLEC9 HEK-293; Human CD329 HEK-293; H_SIGLEC9 HEK-293
DR   Genomeditech; GM-C17014
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10878; SIGLEC9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_SLC34A2
AC   CVCL_E6UX
SY   Human SLC34A2 HEK-293; H_SLC34A2 HEK-293
DR   Genomeditech; GM-C13321
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11020; SLC34A2 (Note=With p.Leu574_Leu690del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_SLC39A6
AC   CVCL_E6UY
SY   Human SLC39A6 HEK-293; H_SLC39A6 HEK-293
DR   Genomeditech; GM-C13340
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18607; SLC39A6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_STEAP1
AC   CVCL_E6UZ
SY   Human STEAP1 HEK-293; H_STEAP1 HEK-293
DR   Genomeditech; GM-C21520
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:27962; STING1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TLR4 Reporter
AC   CVCL_E6V0
SY   Human TLR4 Reporter HEK-293; H_TLR4 Reporter HEK-293
DR   Genomeditech; GM-C02416
CC   Characteristics: Constitutively expresses human TLR4, CD14 and LY96(MD2) along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C02416).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11850; TLR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TLR7 Reporter
AC   CVCL_E6V1
SY   Human TLR7 Reporter HEK-293; H_TLR7 Reporter HEK-293
DR   Genomeditech; GM-C15426
CC   Characteristics: Constitutively expresses human TLR7 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C15426).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15631; TLR7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TLR8
AC   CVCL_E6V2
SY   Human TLR8 HEK-293; Human CD288 HEK-293; H_TLR8 HEK-293
DR   Genomeditech; GM-C22252
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15632; TLR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TLR8 Reporter
AC   CVCL_E6V3
SY   Human TLR8 Reporter HEK-293; H_TLR8 Reporter HEK-293
DR   Genomeditech; GM-C15427
CC   Characteristics: Constitutively expresses human TLR8 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C15427).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15632; TLR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TLR9 Reporter
AC   CVCL_E6V4
SY   Human TLR9 Reporter HEK-293; H_TLR9 Reporter HEK-293
DR   Genomeditech; GM-C15428
CC   Characteristics: Constitutively expresses human TLR9 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C15428).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TNFRSF11A(RANK) Reporter
AC   CVCL_E6V5
SY   Human TNFRSF11A Reporter HEK-293; RANK Reporter HEK-293; H_TNFRSF11A(RANK) Reporter HEK-293
DR   Genomeditech; GM-C19909
CC   Characteristics: Constitutively expresses human TNFRSF11A along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C19909).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11908; TNFRSF11A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TNFRSF17(BCMA)
AC   CVCL_E6V6
SY   Human TNFRSF17 HEK-293; Human BCMA HEK-293; H_TNFRSF17(BCMA) HEK-293
DR   Genomeditech; GM-C24896
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11913; TNFRSF17.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TNFRSF1B(TNFR2)
AC   CVCL_E6V7
SY   Human TNFRSF1B HEK-293; Human TNFR2 HEK-293; H_TNFRSF1B(TNFR2) HEK-293
DR   Genomeditech; GM-C25237
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TNFRSF9(4-1BB) Reporter
AC   CVCL_E6V8
SY   Human TNFRSF9 Reporter HEK-293; Human 4-1BB Reporter HEK-293; Human CD137 Reporter HEK-293; H_TNFRSF9(4-1BB) Reporter HEK-293
DR   Genomeditech; GM-C04832
CC   Characteristics: Constitutively expresses human TNFRSF9 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C04832).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TREM1+TYROBP
AC   CVCL_E6V9
SY   Human TREM1+TYROBP HEK-293; Human CD354+TYROBP HEK-293; H_TREM1+TYTOBP HEK-293
DR   Genomeditech; GM-C13365
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17760; TREM1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12449; TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_TREM2+TYROBP
AC   CVCL_E6VA
SY   Human TREM2+TYROBP HEK-293; H_TREM2+TYROBP HEK-293
DR   Genomeditech; GM-C24478
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17761; TREM2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12449; TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 H_VTCN1(BTH4)
AC   CVCL_E6VB
SY   Human VTCN1 HEK-293; Human B7H4 HEK-293; H_VTCN1(B7H4) HEK-293
DR   Genomeditech; GM-C25393
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:28873; VTCN1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Mouse_Amhr2
AC   CVCL_E6VC
SY   Mouse Amhr2 HEK-293; Mouse_Amhr2 HEK-293
DR   Genomeditech; GM-C09685
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:105062; Amhr2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Mouse_Cd3
AC   CVCL_E4IK
SY   Mouse Cd3 complex HEK-293; Mouse_Cd3 HEK-293
DR   Genomeditech; GM-C38730
CC   Characteristics: Constitutively expresses mouse Cd3 complex (Genomeditech=GM-C38730).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88334; Cd247.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88331; Cd3d.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88332; Cd3e.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88333; Cd3g.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 Mouse_Il18 Reporter
AC   CVCL_E4J1
SY   Mouse Il18 Reporter HEK-293; Mouse_Il18 Reporter HEK-293
DR   Genomeditech; GM-C22445
CC   Characteristics: Constitutively expresses mouse Il18r1 and Il18rap along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C22445).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:105383; Il18r1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1338888; Il18rap.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 Mouse_Prlr
AC   CVCL_E6VD
SY   Mouse Prlr HEK-293; Mouse_Prlr HEK-293
DR   Genomeditech; GM-C21323
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97763; Prlr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Mouse_Slc34a2
AC   CVCL_E6VE
SY   Mouse Slc34a2 HEK-293; Mouse_Slc34a2 HEK-293
DR   Genomeditech; GM-C21238
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1342284; Slc34a2 (Note=With p.Arg573_Phe697del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Mouse_Tlr3 Reporter
AC   CVCL_E4IU
SY   Mouse Tlr3 Reporter HEK-293; Mouse_Tlr3 Reporter HEK-293
DR   Genomeditech; GM-C27575
CC   Characteristics: Constitutively expresses mouse Tlr3 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C27575).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2156367; Tlr3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 Mouse_Tlr7 Reporter
AC   CVCL_E4J5
SY   Mouse Tlr7 Reporter HEK-293; Mouse_Tlr7 Reporter HEK-293
DR   Genomeditech; GM-C15439
CC   Characteristics: Constitutively expresses mouse Tlr7 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C15439).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2176882; Tlr7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 Mouse_Tlr9 Reporter
AC   CVCL_E4IR
SY   Mouse Tlr9 Reporter HEK-293; Mouse_Tlr9 Reporter HEK-293
DR   Genomeditech; GM-C29312
CC   Characteristics: Constitutively expresses mouse Tlr9 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C29312).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1932389; Tlr9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech HEK-293 Mouse_Trem2+Tyrobp
AC   CVCL_E6VF
SY   Mouse Trem2+Tyrobp HEK-293; Mouse_Trem2+Tyrobp HEK-293
DR   Genomeditech; GM-C15496
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1913150; Trem2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1277211; Tyrobp.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 NFkB Luc Reporter
AC   CVCL_E6VG
SY   NFkB luciferase Reporter HEK-293; NFkB luc Reporter HEK-293
DR   Genomeditech; GM-C29472
CC   Characteristics: Expresses firefly luciferase under the control of the NF-kappaB response element (Genomeditech=GM-C29472).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Rat_Amhr2
AC   CVCL_E6VH
SY   Rat Amhr2 HEK-293; Rat_Amhr2 HEK-293
DR   Genomeditech; GM-C09686
CC   Genetic integration: Method=Transduction; Gene=RGD; 70964; Amhr2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Rhesus_LILRB1
AC   CVCL_E6VI
SY   Rhesus LILRB1 HEK-293; Rhesus_LILRB1 HEK-293
DR   Genomeditech; GM-C24275
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F7H3G7; Macaca mulatta LILRB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Rhesus_MAMU-AG
AC   CVCL_E6VJ
SY   Rhesus MAMU-AG HEK-293; Rhesus_MAMU-AG HEK-293
DR   Genomeditech; GM-C19278
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; O02948; Macaca mulatta MAMU-AG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Rhesus_NCR1(NKp46)
AC   CVCL_E6VK
SY   Rhesus NCR1 HEK-293; Rhesus NKp46 HEK-293; Rhesus_NCR1(NKp46) HEK-293
DR   Genomeditech; GM-C17928
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8MIZ9; Macaca mulatta NCR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293 Rhesus_SLC34A2
AC   CVCL_E6VL
SY   Rhesus SLC34A2 HEK-293; Rhesus_SLC34A2 HEK-293
DR   Genomeditech; GM-C13322
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; F7HDA3; Macaca mulatta SLC34A2 (Note=With p.Ser577_Leu690del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech HEK-293T H_ACE2
AC   CVCL_E6VM
SY   Human ACE2 HEK-293T; H_ACE2 HEK-293T
DR   Genomeditech; GM-C12968
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat Cynomolgus_CLEC4C(BDCA2)+FCER1G
AC   CVCL_E6VN
SY   Cynomolgus CLEC4C+FCER1G Jurkat; Cynomolgus BDCA2+FCER1G Jurkat; Cynomolgus_CLEC4C(BDCA2)+FCER1G Jurkat
DR   Genomeditech; GM-C20051
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UWP4; Macaca fascicularis CLEC4C.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8SPW1; Macaca fascicularis FCER1G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_CCR8
AC   CVCL_E6VP
SY   Human CCR8 Jurkat; H_CCR8 Jurkat
DR   Genomeditech; GM-C15568
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_CD40(TNFRSF5) Reporter
AC   CVCL_E6VQ
SY   Human CD40 Reporter Jurkat; Human TNFRSF5 Reporter Jurkat; H_CD40(TNFRSF5) Reporter Jurkat
DR   Genomeditech; GM-C09520
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human CD40 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C09520).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11919; CD40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_CLEC4C(BDCA2) Reporter
AC   CVCL_E4J6
SY   Human CLEC4C Reporter Jurkat; Human BDCA2 Reporter Jurkat; Human CD303 Reporter Jurkat; H_CLEC4C(BDCA2) Reporter Jurkat
DR   Genomeditech; GM-C13225
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human CLEC4C and FCER1G along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C13225).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13258; CLEC4C.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech Jurkat H_CLEC4C(BDCA2)+FCER1G
AC   CVCL_E6VR
SY   Human CLEC4C+FCER1G Jurkat; Human BDCA2+FCER1G Jurkat; Human CD303+FCER1G Jurkat; H_CLEC4C(BDCA2)+FCER1G Jurkat
DR   Genomeditech; GM-C20052
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13258; CLEC4C.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_CTLA4
AC   CVCL_E6VS
SY   Human CTLA4 Jurkat; Human CD152 Jurkat; H_CTLA4 Jurkat
DR   Genomeditech; GM-C24465
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Genomeditech Jurkat H_CTLA4 Reporter
AC   CVCL_E6VT
SY   Human CTLA4 Reporter Jurkat; Human CD152 Reporter Jurkat; H_CTLA4 Reporter Jurkat
DR   Genomeditech; GM-C23902
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human CTLA4 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C23902).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_FCGR3A Reporter
AC   CVCL_E4JE
SY   Human FCGR3 Reporter Jurkat; Human FcgammaRIIIa Reporter Jurkat; H_FCGR3A Reporter Jurkat
DR   Genomeditech; GM-C05619
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human FCGR3A (p.Phe176Val) along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C05619).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech Jurkat H_LILRB1(ILT2) Reporter
AC   CVCL_E6VU
SY   Human LILRB1 Reporter Jurkat; Human ILT2 Reporter Jurkat; H_LILRB1(ILT2) Reporter Jurkat
DR   Genomeditech; GM-C15867
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human LILRB1 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C15867).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6605; LILRB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_LILRB2(ILT4) Reporter
AC   CVCL_E6VV
SY   Human LILRB2 Reporter Jurkat; Human ILT4 Reporter Jurkat; H_LILRB2(ILT4) Reporter Jurkat
DR   Genomeditech; GM-C16968
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human LILRB2 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C16968).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6606; LILRB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_NCR1(NKp46) Reporter
AC   CVCL_E6VW
SY   Human NCR1 Reporter Jurkat; Human NKp46 Reporter Jurkat; Human CD335 Reporter Jurkat; H_NCR1(NKp46) Reporter Jurkat
DR   Genomeditech; GM-C17954
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human NCR1 and FCER1G along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C17954).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6731; NCR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_PDCD1(PD-1) Reporter
AC   CVCL_E6VX
SY   Human PDCD1 Reporter Jurkat; Human PD-1 Reporter Jurkat; H_PDCD1(PD-1) Reporter Jurkat
DR   Genomeditech; GM-C07928
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses Human PDCD1 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C07928).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_PVRIG(CD112R) Reporter
AC   CVCL_E6VY
SY   Human PVRIG Reporter Jurkat; Human CD112R Reporter Jurkat; H_PVRIG(CD112R) Reporter Jurkat
DR   Genomeditech; GM-C18952
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human CD112R along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C18952).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:32190; PVRIG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_TIGIT+CD226 Reporter
AC   CVCL_E6VZ
SY   Human TIGIT+CD226 Reporter Jurkat; H_TIGIT+CD226 Reporter Jurkat
DR   Genomeditech; GM-C20072
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human TIGIT and CD226 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C20072).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16961; CD226.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:26838; TIGIT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_TNFRSF14(HVEM) Reporter
AC   CVCL_E6W0
SY   Human TNFRSF14 Reporter Jurkat; Human HVEM Reporter Jurkat; Human CD270 Reporter Jurkat; H_TNFRSF14(HVEM) Reporter Jurkat
DR   Genomeditech; GM-C25497
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human TNFRSF14 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C25497).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11912; TNFRSF14.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_TNFRSF1B(TNFR2) Reporter
AC   CVCL_E6W1
SY   Human TNFRS1B Reporter Jurkat; Human TNFRS2 Reporter Jurkat; H_TNFRSF1B(TNFR2) Reporter Jurkat
DR   Genomeditech; GM-C25209
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human TNFRSF1B along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C25209).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat H_TNFRSF25(DR3) Reporter
AC   CVCL_E4IQ
SY   Human TNFRSF25(DR3) Reporter Jurkat; Human DR3 Reporter Jurkat; H_TNFRSF25(DR3) Reporter Jurkat
DR   Genomeditech; GM-C30290
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses human TNFRSF25 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C30290).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11910; TNFRSF25.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech Jurkat H_TNFRSF9(4-1BB) Reporter
AC   CVCL_E6W2
SY   Human TNFRSF9 Reporter Jurkat; Human 4-1BB Reporter Jurkat; Human CD137 Reporter Jurkat; H_TNFRSF9(4-1BB) Reporter Jurkat
DR   Genomeditech; GM-C09468
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses Human TNFRSF9 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C09468).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat IL2-promoter Luc Reporter
AC   CVCL_E6W3
SY   IL2-promoter luciferase Reporter Jurkat; IL2-promoter Luc Reporter Jurkat
DR   Genomeditech; GM-C25629
CC   Population: Caucasian.
CC   Characteristics: Expresses firefly luciferase under the control of a IL2-responsive promoter (Genomeditech=GM-C25629).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Genomeditech Jurkat Mouse_Fcgr4 Reporter
AC   CVCL_E4JB
SY   Mouse Fcgr4 Reporter Jurkat; M_FcgammaRIV Reporter Jurkat
DR   Genomeditech; GM-C09105
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses mouse Fcgr4 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C09105).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2179523; Fcgr4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech Jurkat Mouse_Pdcd1(PD-1) Reporter
AC   CVCL_E4IX
SY   Mouse Pdcd1 Reporter Jurkat; Mouse PD-1 Reporter Jurkat; Mouse_Pdcd1(PD-1) Reporter Jurkat
DR   Genomeditech; GM-C25661
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses mouse Pdcd1 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C25661).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104879; Pdcd1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech Jurkat Mouse_Tnfrsf25(DR3) Reporter
AC   CVCL_E4IP
SY   Mouse Tnfrsf25 Reporter Jurkat; Mouse DR3 Reporter Jurkat; Mouse_Tnfrsf25(DR3) Reporter Jurkat
DR   Genomeditech; GM-C30291
CC   Population: Caucasian.
CC   Characteristics: Constitutively expresses mouse Tnfrsf25 along with signal-dependent expression of a luciferase reporter gene (Genomeditech=GM-C30291).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1934667; Tnfrsf25.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Genomeditech Jurkat NFAT Luc Reporter
AC   CVCL_E6W4
SY   NFAT luciferase Reporter Jurkat; NFAT Luc Reporter Jurkat
DR   Genomeditech; GM-C01459
CC   Population: Caucasian.
CC   Characteristics: Expresses firefly luciferase under the control of the NFAT response element (Genomeditech=GM-C01459).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat NFkB Luc Reporter
AC   CVCL_E6W5
SY   NFkB luciferase Reporter Jurkat; NFkB luc Reporter Jurkat
DR   Genomeditech; GM-C24918
CC   Population: Caucasian.
CC   Characteristics: Expresses firefly luciferase under the control of the NF-kappaB response elements (Genomeditech=GM-C24918).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech Jurkat FOXP3-promoter Luc Reporter
AC   CVCL_E6W6
SY   FOXP3-promoter luciferase Reporter Jurkat; FOXP3-promoter luc Reporter Jurkat
DR   Genomeditech; GM-C13108
CC   Population: Caucasian.
CC   Characteristics: Expresses firefly luciferase under the control of the human FOXP3 promoter (Genomeditech=GM-C13108).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech K-562 H_HLA-G+B2M
AC   CVCL_E6W7
SY   Human HLA-G+B2M K-562; H_HLA-G+B2M K-562
DR   Genomeditech; GM-C15868
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech K-562 H_IL21(Membrane bound)
AC   CVCL_E6W8
SY   Human IL21 (Membrane bound) K-562; H_IL21(Membrane bound) K-562
DR   Genomeditech; GM-C15709
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6005; IL21 (Note=With p.Met1_Asn7del; membrane bound).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech LLC1 H_SLC39A6
AC   CVCL_E6W9
SY   Human SLC39A6 LLC1; H_SLC39A6 LLC1
DR   Genomeditech; GM-C25070
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18607; SLC39A6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech MC-38 H_AMHR2
AC   CVCL_E6WA
SY   Human AMHR2 MC-38; H_AMHR2 MC-38
DR   Genomeditech; GM-C15537
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:465; AMHR2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_CD24
AC   CVCL_E6WB
SY   Human CD24 MC-38; H_CD24 MC-38
DR   Genomeditech; GM-C15769
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1645; CD24.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_CD274(PD-L1)
AC   CVCL_E6WC
SY   Human CD274 MC-38; Human PD-L1 MC-38; H_CD274(PD-L1) MC-38
DR   Genomeditech; GM-C07854
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_CD47
AC   CVCL_E6WD
SY   Human CD47 MC-38; H_CD47 MC-38
DR   Genomeditech; GM-C19314
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_CEACAM5(CEA)
AC   CVCL_E6WE
SY   Human CEACAM5 MC-38; Human CEA MC-38; Human CD66e MC-38; H_CEACAM5(CEA) MC-38
DR   Genomeditech; GM-C19421
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_CLDN18(isoform 2)
AC   CVCL_E6WF
SY   Human CLDN18(isoform 2) MC-38; H_CLDN18(isoform 2) MC-38
DR   Genomeditech; GM-C21506
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_ERBB2(HER2)
AC   CVCL_E6WG
SY   Human ERBB2 MC-38; Human HER2 MC-38; H_HER2(ERBB2) MC-38
DR   Genomeditech; GM-C19495
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_ERBB2(HER2)+ERBB3(HER3)
AC   CVCL_E6WH
SY   Human ERBB2+ERBB3 MC-38; Human HER2+HER3 MC-38; H_ERBB2(HER2)+ERBB3(HER3) MC-38
DR   Genomeditech; GM-C19496
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3431; ERBB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_ERBB3(HER3)
AC   CVCL_E6WI
SY   Human ERBB3 MC-38; Human HER3 MC-38; H_ERBB3(HER3) MC-38
DR   Genomeditech; GM-C19427
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3431; ERBB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_GPRC5D
AC   CVCL_E6WJ
SY   Human GPRC5D MC-38; H_GPRC5D MC-38
DR   Genomeditech; GM-C13232
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13310; GPRC5D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_HLA-G+B2M
AC   CVCL_E6WK
SY   Human HLA-G+B2M MC-38; H_HLA-G+B2M MC-38
DR   Genomeditech; GM-C16967
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech MC-38 H_SIGLEC15+TYROBP
AC   CVCL_E6WL
SY   Human SIGLEC15+TYROBP MC-38; H_SIGLEC15+TYROBP MC-38
DR   Genomeditech; GM-C15785
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:27596; SIGLEC15.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12449; TYROBP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   Genomeditech Raji H_CD274(PD-L1)
AC   CVCL_E6WM
SY   Human CD274 Raji; Human PD-L1 Raji; H_CD274(PD-L1) Raji
DR   Genomeditech; GM-C03541
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Genomeditech Raji H_PVR(CD155)
AC   CVCL_E6WN
SY   Human PVR Raji; Human CD155 Raji; H_PVR(CD155) Raji
DR   Genomeditech; GM-C09243
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9705; PVR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech RKO H_AMHR2
AC   CVCL_E6WP
SY   Human AMHR2 RKO; H_AMHR2 RKO
DR   Genomeditech; GM-C11728
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:465; AMHR2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genomeditech SK-OV-3 H_HLA-G
AC   CVCL_E6WQ
SY   Human HLA-G SK-OV-3; H_HLA-G SK-OV-3
DR   Genomeditech; GM-C16966
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Genox 3.53
AC   CVCL_K216
SY   Genox3.53; Genox 353
DR   CLO; CLO_0003473
DR   ATCC; HB-103
DR   IZSLER; BS Hy 62
DR   Wikidata; Q54835722
RX   PubMed=95015;
RX   PubMed=6162228;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   GENYOi001-A
AC   CVCL_9U44
SY   PBMC1-iPS4F1
DR   BioSamples; SAMEA7124962
DR   hPSCreg; GENYOi001-A
DR   Wikidata; Q54938366
RX   PubMed=26987924;
RX   PubMed=27346199;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito%2520PBMC1-iPS4F1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-PBMC1-iPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=27346199
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 10,16
ST   D19S433: 12,14
ST   D21S11: 30,34
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,16
ST   FGA: 18,22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GENYOi001-A-1
AC   CVCL_DQ82
SY   PBMC1-iPS4F1 shSCR; PBMC1-iPS4F1 NEO
DR   hPSCreg; GENYOi001-A-1
DR   Wikidata; Q54938369
RX   PubMed=27346199;
RX   PubMed=29246573;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SOLICITUD+DEP%C3%93SITO+iPS-PBMC1-iPS4F1-NEO_v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=27346199
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 10,16
ST   D19S433: 12,14
ST   D21S11: 30,34
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,16
ST   FGA: 18,22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U44 ! GENYOi001-A
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GENYOi001-A-2
AC   CVCL_DQ81
SY   PBMC1-iPS4F1 shDLL4; PBMC1-iPS4F1 DLL4
DR   hPSCreg; GENYOi001-A-2
DR   Wikidata; Q54938367
RX   PubMed=27346199;
RX   PubMed=29246573;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_PBMC1-iPS4F1-DLL4_v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_PBMC1-iPS4F1-shDLL4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:2910; DLL4.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=27346199
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 10,16
ST   D19S433: 12,14
ST   D21S11: 30,34
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,16
ST   FGA: 18,22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U44 ! GENYOi001-A
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   GENYOi004-A
AC   CVCL_WM08
SY   ASD-PBMC1-iPS4F2; ASD-PBMC-iPS4F2
DR   BioSamples; SAMEA5679957
DR   hPSCreg; GENYOi004-A
DR   Wikidata; Q93560853
RX   PubMed=31035039;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_deposito_lineas_iPS_ASD-PBMC1-iPS4F2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Population: Caucasian; Spanish.
CC   HLA typing: A*03,24; B*35,55; DQA1*01,01; DQB1*05:03,05:03; DRB1*14:01,14:01 (PubMed=31035039).
CC   Sequence variation: Mutation; HGNC; HGNC:15766; ADNP; Simple; p.Tyr719Ter (c.2157C>G); ClinVar=VCV000139635; Zygosity=Heterozygous (PubMed=31035039).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,10
ST   D16S539: 13
ST   D21S11: 28
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C160662; Intellectual developmental disorder, autosomal dominant 28
DI   ORDO; Orphanet_404448; ADNP syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 13
//
ID   GENYOi005-A
AC   CVCL_WZ24
SY   FPD/AML-PBMC-iPSC4F73
DR   BioSamples; SAMEA5959283
DR   hPSCreg; GENYOi005-A
DR   Wikidata; Q93560855
RX   PubMed=31698193;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento%2520Deposito%2520Lineas%2520FPD%2520AML-PBMC2-iPS4F73%2520v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo%2520Deposito%2520Linea%2520FPD%2520AML-PBMC2-iPS4F73.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:10471; RUNX1; Simple; p.Thr196Ala (c.586A>G); ClinVar=VCV000988811; Zygosity=Heterozygous (PubMed=31698193).
CC   Misspelling: FDP/AML-PBMC-iPSC4F73; Note=In Spanish stem cell bank documentation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 16,19
ST   D19S433: 11,14
ST   D21S11: 28,33.2
ST   D2S1338: 18,19
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13,16
ST   FGA: 19,27
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C162696; Familial platelet disorder with associated myeloid malignancy
DI   ORDO; Orphanet_71290; Familial platelet disorder with associated myeloid malignancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 11
//
ID   GENYOi006-A
AC   CVCL_9S76
SY   GRX-MCiPS4F-A2
DR   BioSamples; SAMEA6438545
DR   hPSCreg; GENYOi006-A
DR   Wikidata; Q54871709
RX   PubMed=26284980;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento%2520Deposito%2520Lineas%2520GRX-MCiPS4F-A2-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS%2520%2520GRX-MCiPS4F-A2-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Population: Caucasian; Spanish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,15
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 27,30
ST   D2S1338: 21,22
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   D8S1179: 15
ST   FGA: 20,23
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GENYOi006-A-1
AC   CVCL_YN83
SY   GRX-MCiPS4F-A2-ETO2-GLIS2
DR   BioSamples; SAMEA6438547
DR   hPSCreg; GENYOi006-A-1
DR   Wikidata; Q93560863
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SOLICITUD+DEP%C3%93SITO+GRX-MCiPS4F-A2-ETO2-GLIS2_v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Population: Caucasian; Spanish.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1537; CBFA2T3 (Note=CBFA2T3-GLIS2 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29450; GLIS2 (Note=CBFA2T3-GLIS2 fusion).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,14
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 27,30
ST   D2S1338: 21,22
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   D8S1179: 15
ST   FGA: 20,23
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S76 ! GENYOi006-A
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   GENYOi006-A-2
AC   CVCL_YN84
SY   GRX-MCiPS4F-A2-NEO
DR   BioSamples; SAMEA6438548
DR   hPSCreg; GENYOi006-A-2
DR   Wikidata; Q93560865
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SOLICITUD+DEP%C3%93SITO+GRX-MCiPS4F-A2-NEO_v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Population: Caucasian; Spanish.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,14
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 27,30
ST   D2S1338: 21,22
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   D8S1179: 15
ST   FGA: 20,23
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S76 ! GENYOi006-A
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   GENYOi007-A
AC   CVCL_B5H2
SY   W8
DR   BioSamples; SAMEA9438115
DR   hPSCreg; GENYOi007-A
DR   Wikidata; Q110432812
RX   CelloPub=CLPUB00799;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:3057; DTNA; Simple; p.Val742Phe (c.2224G>T); ClinVar=VCV000140609; Zygosity=Heterozygous; Note=Produces a novel splice site which skips exon 21 and leads to a shorter alternative transcript (from autologous cell line FMD patient III.4 LCL).
CC   Sequence variation: Mutation; HGNC; HGNC:25911; FAM136A; Simple; p.Gln76Ter (c.226C>T) (p.Gln183Ter, c.547C>T); ClinVar=VCV000140608; Zygosity=Heterozygous (from autologous cell line FMD patient III.4 LCL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185243; Meniere disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7TW ! FMD patient III.4 LCL
SX   Female
AG   >22Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   GEO
AC   CVCL_0271
SY   Geo; HCT-GEO; HCT GEO
DR   BTO; BTO_0002892
DR   MCCL; MCC:0000162
DR   cancercelllines; CVCL_0271
DR   Cell_Model_Passport; SIDM00068
DR   ColonAtlas; GEO
DR   Cosmic; 738930
DR   Cosmic; 889529
DR   Cosmic; 1131685
DR   Cosmic; 1479567
DR   Cosmic; 1708407
DR   Cosmic-CLP; 2164691
DR   DepMap; ACH-002394
DR   GDSC; 2164691
DR   GEO; GSM1448176
DR   PharmacoDB; Geo_403_2019
DR   PRIDE; PXD005235
DR   Wikidata; Q54835723
RX   PubMed=2835152;
RX   PubMed=3349466;
RX   PubMed=6578361;
RX   PubMed=7329817;
RX   PubMed=7761852;
RX   PubMed=17363507;
RX   PubMed=20570890;
RX   PubMed=25926053;
RX   PubMed=28854368;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Cys344fs*110 (c.1030delT); Zygosity=Homozygous (Cosmic-CLP=2164691; DepMap=ACH-002394).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1536Ter (c.4606G>T); ClinVar=VCV001050551; Zygosity=Homozygous (Cosmic-CLP=2164691; DepMap=ACH-002394).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=20570890; Cosmic-CLP=2164691; DepMap=ACH-002394).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=61.65%; Native American=2.66%; East Asian, North=1.33%; East Asian, South=0%; South Asian=0%; European, North=19.42%; European, South=14.94% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   D13S317: 8,12
ST   D16S539: 12
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,11,11.1
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   GEOC4
AC   CVCL_1Q48
DR   Wikidata; Q54835726
RX   PubMed=6686281;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1Q47 ! PCC4AO
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Ger
AC   CVCL_8353
SY   GER
DR   BTO; BTO_0002865
DR   cancercelllines; CVCL_8353
DR   Cosmic; 710856
DR   IARC_TP53; 16740
DR   Wikidata; Q54835727
RX   PubMed=435363;
RX   PubMed=11787853;
CC   Doubling time: 36 hours (Note=At 11th passage) (PubMed=435363).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Leu (c.814G>T); ClinVar=VCV000012358; Zygosity=Unspecified (PubMed=11787853).
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GERK
AC   CVCL_C8GN
DR   Wikidata; Q123031362
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*03,26; B*35,40; C*03 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   GES-1
AC   CVCL_EQ22
SY   GES1
DR   BTO; BTO_0006394
DR   EFO; EFO_0022672
DR   ChEMBL-Cells; CHEMBL4295483
DR   ChEMBL-Targets; CHEMBL4296415
DR   CLS; 305428
DR   GEO; GSM1152880
DR   GEO; GSM1152881
DR   GEO; GSM1152882
DR   GEO; GSM1152883
DR   GEO; GSM1152884
DR   GEO; GSM1152885
DR   GEO; GSM1923245
DR   GEO; GSM1923246
DR   GEO; GSM1923247
DR   GEO; GSM1923248
DR   GEO; GSM1923249
DR   GEO; GSM1923250
DR   PubChem_Cell_line; CVCL_EQ22
DR   Wikidata; Q54835728
RX   PubMed=8033753;
RX   PubMed=25633122;
RX   PubMed=26690385;
RX   PubMed=29717028;
RX   PubMed=29963172;
WW   Provider; Beyotime; C6268; https://www.beyotime.com/Manual/C6268%20GES-1%20(Human%20Gastric%20Epithelial%20Cells).pdf
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: GSE-1; Note=Occasionally. And more specifically in a number of papers that seem to be produced by paper mills.
CC   Derived from site: In situ; Fetal stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
ST   Source(s): Beyotime
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18,19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9FM
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   GES-1/miR-23a
AC   CVCL_VL75
DR   Wikidata; Q93560884
RX   PubMed=29963172;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:31605; MIR23A.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ22 ! GES-1
SX   Sex unspecified
AG   9FM
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   GEV
AC   CVCL_E673
DR   IHW; 9w 0904
DR   Wikidata; Q54835729
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*03,26; B*55,62; C*w03 (IHW=9w 0904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   GF
AC   CVCL_S931
SY   Grouper Fin
DR   Wikidata; Q54835730
RX   PubMed=12962209;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
OI   CVCL_S930 ! GE
OI   CVCL_S932 ! GH [Epinephelus]
OI   CVCL_S934 ! GSB
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 12
//
ID   GF-1
AC   CVCL_J030
SY   Grouper Fin-1
DR   Wikidata; Q54835731
RX   DOI=10.1046/j.1365-2761.1999.00152.x;
RX   Patent=US6566117;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-859.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 14
//
ID   GF-D8
AC   CVCL_0272
SY   GFD8
DR   CLO; CLO_0003477
DR   MCCL; MCC:0000163
DR   CLDB; cl7058
DR   BioSample; SAMN03473504
DR   Cosmic; 787431
DR   Cosmic; 975250
DR   Cosmic; 1281314
DR   Cosmic; 2306206
DR   Cosmic; 2750858
DR   DSMZ; ACC-615
DR   DSMZCellDive; ACC-615
DR   GEO; GSM1446759
DR   ICLC; HTL01009
DR   Wikidata; Q54835732
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8443395;
RX   PubMed=9195772;
RX   PubMed=10451701;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=GF-D8
CC   Characteristics: CSF2 or IL3 dependent.
CC   Doubling time: ~48-72 hours (DSMZ=ACC-615).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-615; ICLC=HTL01009
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 12
ST   D21S11: 29,31.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 11,13
ST   Penta E: 7,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GF-R
AC   CVCL_XH22
DR   CCLV; CCLV-RIE 0045
DR   Wikidata; Q93560908
CC   Group: Bird cell line.
CC   Senescence: Senesces at 30-35 PDL (CCLV=CCLV-RIE 0045).
OX   NCBI_TaxID=8844; ! Anser anser anser (Western greylag goose)
SX   Sex unspecified
AG   15FD
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   GF1053
AC   CVCL_8W46
DR   ECACC; 98061807
DR   Wikidata; Q54835733
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98061807; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   GF1054
AC   CVCL_8W47
DR   ECACC; 98061808
DR   Wikidata; Q54835734
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98061808; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   GFB
AC   CVCL_XX40
SY   GoldFish Brain
DR   Wikidata; Q93560913
RX   PubMed=31471871;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   GFB3C-W1
AC   CVCL_L019
SY   GFB3C
DR   Wikidata; Q54835735
RX   CelloPub=CLPUB00251;
RX   PubMed=21086187;
RX   PubMed=24357037;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 14
//
ID   GFF
AC   CVCL_A8VV
SY   GoldFish Fin
DR   Wikidata; Q108820286
RX   CelloPub=CLPUB00639;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   GFKf
AC   CVCL_6D93
SY   GoldFish Kidney fibroblast
DR   Wikidata; Q54835736
RX   PubMed=26419476;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GFM
AC   CVCL_S161
SY   GoldFish Muscle
DR   Wikidata; Q54835737
RX   PubMed=17972754;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   GFM1SV.25
AC   CVCL_9U77
DR   Wikidata; Q54835738
RX   PubMed=27345796;
WW   Provider; BNLC; -; https://web.archive.org/web/20240420001352/https://www.isciii.es/QueHacemos/Servicios/BIOBANCOS/BNLC/Lists/Lneas%20iPS/Attachments/76/Caracteristicas%20-%20SOLICITUD_DE_DEPOSITO_GFM1SV25_FIRMADA.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigaciones Biomedicas Alberto Sols; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:13780; GFM1; Simple; p.Gly469Valfs*84 (c.1404delA); ClinVar=VCV000812087; Zygosity=Heterozygous (PubMed=27345796).
CC   Sequence variation: Mutation; HGNC; HGNC:13780; GFM1; Simple; p.Arg671Cys (c.2011C>T); ClinVar=VCV000214500; Zygosity=Heterozygous (PubMed=27345796).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125663; Combined oxidative phosphorylation deficiency 1
DI   ORDO; Orphanet_137681; Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-6Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GFP+LJES1
AC   CVCL_DF58
SY   GFP(+)LJES1
DR   Wikidata; Q54835742
RX   PubMed=17136469;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
HI   CVCL_M753 ! LJES1
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   GFP-CD16-F/F.NK-92
AC   CVCL_W733
DR   Wikidata; Q54835739
RX   Patent=US9181322;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8837.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GFP-CD16-V/V.NK-92
AC   CVCL_W734
DR   Wikidata; Q54835740
RX   Patent=US9181322;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8836.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   GFP-KSC4
AC   CVCL_W142
DR   CancerTools; 151713
DR   ECACC; 11081701
DR   Wikidata; Q54835741
DR   Ximbio; 151713
RX   PubMed=19907996;
CC   Characteristics: Can be used for the generation of in vitro epidermal 'skin equivalents' to be used as screening tools to look at the activity of new chemical and/or biological entities of dermatological interest, and/or to screen for such entities in high throughput systems (CancerTools=151713).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Discontinued: ECACC; 11081701; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Keratinocyte stem cell; CL=CL_0002337.
CC   Breed/subspecies: C57BL/6-Tg(CAG EGFP)10sb/J transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   GFP2
AC   CVCL_A8DW
DR   TKG; TKG 0766
DR   Wikidata; Q107115102
RX   PubMed=29760187;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: FPbase; R9NL8; eGFP (Note=Enhanced GFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   GFP5
AC   CVCL_A8EM
DR   TKG; TKG 0765
DR   Wikidata; Q107115104
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: FPbase; R9NL8; eGFP (Note=Enhanced GFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   GFPu-1
AC   CVCL_5285
SY   GFPu1
DR   CLO; CLO_0003478
DR   ATCC; CRL-2794
DR   Wikidata; Q54835743
RX   PubMed=11375494;
CC   Characteristics: Reporter cell line to study protein aggregation and the function of the ubiquitin-proteasome system (UPS).
CC   Characteristics: Expresses GFP tagged at the C-terminus with the degradation signal CL1 (ACKNWFSSLSHFVIHL).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2794
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   GFS
AC   CVCL_L020
SY   GoldFish Scale; GF-scale
DR   Wikidata; Q54835744
RX   DOI=10.1002/etc.5620100212;
RX   DOI=10.1016/S1873-0140(05)80005-0;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Scale; UBERON=UBERON_0002542.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 13
//
ID   GFSB
AC   CVCL_S162
SY   GoldFish Swim Bladder
DR   Wikidata; Q54835745
RX   PubMed=17972754;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   GFSe
AC   CVCL_6D94
SY   GoldFish Snout epithelial
DR   Wikidata; Q54835746
RX   PubMed=26419476;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GFSHR-17
AC   CVCL_6635
SY   GFSHR17
DR   BTO; BTO_0002289
DR   ABM; T0605
DR   Wikidata; Q54835747
RX   PubMed=8243796;
RX   PubMed=8961254;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2632; Fshr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   25D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   GFSk-S1
AC   CVCL_L021
SY   GFSK-S1; GoldFish Skin-Saskatoon 1
DR   Wikidata; Q54835748
RX   PubMed=7766144;
RX   PubMed=9088943;
RX   PubMed=24357037;
CC   Group: Fish cell line.
CC   Characteristics: Produces collagen in response to ascorbic acid treatment (PubMed=9088943).
CC   Characteristics: Optimal growth temperature is 22 Celsius (PubMed=9088943).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   GFT
AC   CVCL_S936
SY   Guppy Fetal Tissue
DR   Wikidata; Q54835749
RX   DOI=10.1139/z85-427;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8081; ! Poecilia reticulata (Guppy)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   GFTF
AC   CVCL_R843
SY   GoldFish Tail Fin
DR   Wikidata; Q54835750
RX   PubMed=21916901;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   GG
AC   CVCL_A1IB
DR   Wikidata; Q102113870
RX   DOI=10.5282/edoc.3898;
RX   PubMed=9384677;
RX   PubMed=10359208;
RX   PubMed=12836015;
RX   PubMed=15706405;
CC   HLA typing: A*02,32; B*07,27; C*01,07; DQA1*04:01,05:01; DQB1*03:01,04; DRB1*08,11 (PubMed=10359208).
CC   HLA typing: A*02,32; B*07,27; DQB1*03,04:02; DRB1*08:01,11:03 (PubMed=12836015).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   GG-62
AC   CVCL_9707
SY   GG62
DR   Wikidata; Q54835751
RX   PubMed=11004677;
RX   PubMed=12021921;
RX   PubMed=12966428;
RX   PubMed=15150091;
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=12021921; PubMed=15150091).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, fibula; UBERON=UBERON_0001446.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   GG-CL
AC   CVCL_WK94
DR   ABM; T0596
DR   Wikidata; Q93560944
RX   PubMed=9528980;
RX   PubMed=9564855;
RX   PubMed=9675014;
CC   Characteristics: Responds to stimulation by PRL, estradiol and cAMP, making the cells a useful model for studies involving gene expression and regulation of luteal cells (ABM=T0596).
CC   Characteristics: At the permissive temperature (33 Celsius) these cells are small and compact and divide. At the non-permissive temperature (40 Celsius) the cells assume a monolayer appearance and become differentiated (PubMed=9528980).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Ovary, corpus luteum; UBERON=UBERON_0002512.
CC   Cell type: Luteal cell; CL=CL_0000175.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 12
//
ID   GG-CL PRL-R(L)
AC   CVCL_WK95
SY   GG-CL PRL-RL
DR   Wikidata; Q93560946
RX   PubMed=9528980;
RX   PubMed=9564855;
CC   Genetic integration: Method=Transfection; Gene=RGD; 3407; Prlr (Note=Isoform Long).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Ovary, corpus luteum; UBERON=UBERON_0002512.
CC   Cell type: Luteal cell; CL=CL_0000175.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WK94 ! GG-CL
SX   Female
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   GG013
AC   CVCL_A2DI
DR   ArrayExpress; E-MTAB-1511
DR   Wikidata; Q105506944
RX   PubMed=24380390;
CC   Group: Non-human primate cell line.
CC   From: Tyler-Smith, Chris; Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   GG2EE
AC   CVCL_8602
SY   GG2
DR   Wikidata; Q54835752
RX   PubMed=2695237;
RX   PubMed=2778838;
RX   PubMed=3119352;
RX   PubMed=9039268;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   GG618-13
AC   CVCL_IU57
SY   GG618 clone 13; P3HR1-Cl13
DR   cancercelllines; CVCL_IU57
DR   Wikidata; Q54835754
RX   PubMed=3021971;
RX   PubMed=6276755;
RX   PubMed=6301144;
RX   PubMed=6302703;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 14
//
ID   GG618-5
AC   CVCL_F0WE
SY   GG618 clone 5; P3HR1-Cl5
RX   PubMed=3021971;
RX   PubMed=6276755;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GG8
AC   CVCL_E6X6
RX   PubMed=9384677;
RX   PubMed=10359208;
CC   Characteristics: Teatment with INFG renders the cell line immunogenic and results in T cell proliferation (PubMed=9384677).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1IB ! GG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GGA-E
AC   CVCL_A9GY
DR   CCRID; 5301BIR-KCB15040ZJ
DR   KCB; KCB 2015040ZJ
DR   Wikidata; Q108820287
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_A9GZ ! GGA-EH
SX   Sex unspecified
AG   11FD
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GGA-EH
AC   CVCL_A9GZ
DR   CCRID; 5301BIR-KCB1540HZJ
DR   KCB; KCB 2015040HZJ
DR   Wikidata; Q108820288
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_A9GY ! GGA-E
SX   Sex unspecified
AG   11FD
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GGD
AC   CVCL_6G51
DR   Wikidata; Q54835755
RX   PubMed=2778838;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6-Ly-5a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GGE-R
AC   CVCL_0I70
DR   CCLV; CCLV-RIE 0456
DR   Wikidata; Q54835756
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   GGO00326IN
AC   CVCL_E162
DR   Wikidata; Q54835757
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   GGR41
AC   CVCL_J985
DR   CLO; CLO_0050337
DR   RCB; RCB2021
DR   Wikidata; Q54835758
RX   PubMed=8221098;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Gangliosides GQ1balpha.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   GGR51
AC   CVCL_CW93
DR   Wikidata; Q54835759
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_90151; Ganglioside GM1b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 5
//
ID   GGSK
AC   CVCL_YE17
SY   Gentian Grouper SKin
DR   CCRID; 4201PAT-CCTCC00637
DR   Wikidata; Q93560948
RX   Patent=CN104818241B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201515.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=310571; ! Epinephelus lanceolatus (Giant grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 7
//
ID   GGZ-01
AC   CVCL_WA79
SY   Gorlin-GoltZ-01
DR   IBRC; C10771
DR   Wikidata; Q93560949
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GH [Carassius]
AC   CVCL_IS36
SY   GFH; Goldfish Heart
DR   Wikidata; Q54835760
RX   PubMed=28097494;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 9
//
ID   GH [Epinephelus]
AC   CVCL_S932
SY   Grouper Heart
DR   Wikidata; Q54835761
RX   PubMed=12962209;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
OI   CVCL_S930 ! GE
OI   CVCL_S931 ! GF
OI   CVCL_S934 ! GSB
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 12
//
ID   GH [Human embryonal carcinoma]
AC   CVCL_LM99
DR   DSMZ; ACC-811
DR   DSMZCellDive; ACC-811
DR   Wikidata; Q54835762
RX   PubMed=6202829;
RX   PubMed=8506289;
CC   Doubling time: ~50 hours (DSMZ=ACC-811).
ST   Source(s): DSMZ=ACC-811
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 27,28
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 5
ST   Penta D: 11,13
ST   Penta E: 5,13
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 02-05-24; Version: 7
//
ID   GH-1
AC   CVCL_6C07
SY   GH 1; GH1; Gecko Heart-1; Gekko Heart-1
DR   Wikidata; Q54835763
RX   PubMed=4314147;
RX   PubMed=5659169;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=36310; ! Gekko gecko (Tokay gecko)
OI   CVCL_4207 ! GL-1 [Gecko]
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GH-2
AC   CVCL_6C08
SY   GH 2; GH2; Gecko Heart-2; Gekko Heart-2
DR   Wikidata; Q54835764
RX   PubMed=4314147;
RX   PubMed=5659169;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=36310; ! Gekko gecko (Tokay gecko)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GH-L2C
AC   CVCL_JX21
DR   Wikidata; Q54835766
RX   PubMed=1034020;
RX   PubMed=1262783;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
DI   NCIt; C134564; Guinea pig leukemia
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
HI   CVCL_2547 ! L2C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 7
//
ID   GH-M1
AC   CVCL_A9HU
SY   GHR2
DR   CCRID; 5301HAM-KCB03004ZJ
DR   KCB; KCB 200304ZJ
DR   Wikidata; Q108820289
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GH-S1
AC   CVCL_XB63
SY   GHS1
DR   CCRID; 5301HAM-KCB02013ZJ
DR   KCB; KCB 200213ZJ
DR   Wikidata; Q93560950
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   GH1
AC   CVCL_0610
SY   GH 1
DR   CLO; CLO_0003481
DR   CLO; CLO_0003483
DR   CLO; CLO_0003486
DR   CLDB; cl1453
DR   CLDB; cl1454
DR   ATCC; CCL-82
DR   ECACC; 89072610
DR   IZSLER; BS TCL 17
DR   JCRB; IFO50269
DR   JCRB; JCRB9046
DR   Wikidata; Q54835767
RX   DOI=10.1007/BF02618370;
RX   PubMed=218079;
RX   PubMed=4288399;
RX   PubMed=4327442;
RX   PubMed=4951281;
RX   PubMed=5513559;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GH1-2C1
AC   CVCL_UJ45
SY   GH12C1
DR   Wikidata; Q93560951
RX   PubMed=218079;
RX   PubMed=4951281;
RX   PubMed=5513559;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0610 ! GH1
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   GH1002
AC   CVCL_F1DR
DR   ABCD; ABCD_BF048
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH1081
AC   CVCL_F1DS
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH1151
AC   CVCL_F1DT
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH149
AC   CVCL_F1DU
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH3 [Mouse hybridoma against vaccinia A13L]
AC   CVCL_E5R0
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GH3
AC   CVCL_0273
SY   GH 3
DR   BTO; BTO_0001410
DR   CLO; CLO_0003482
DR   CLO; CLO_0003484
DR   CLO; CLO_0003487
DR   MCCL; MCC:0000164
DR   CLDB; cl1455
DR   CLDB; cl1456
DR   CLDB; cl1457
DR   CLDB; cl1458
DR   ATCC; CCL-82.1
DR   BCRC; 60015
DR   BCRJ; 0090
DR   CCRID; 1101RAT-PUMC000008
DR   ChEMBL-Cells; CHEMBL3307652
DR   ChEMBL-Targets; CHEMBL614571
DR   CLS; 300383
DR   DSMZ; ACC-469
DR   DSMZCellDive; ACC-469
DR   ECACC; 87012603
DR   ICLC; ATL96003
DR   IZSLER; BS TCL 18
DR   JCRB; IFO50105
DR   JCRB; JCRB9047
DR   KCLB; 10082.1
DR   Lonza; 613
DR   PubChem_Cell_line; CVCL_0273
DR   TOKU-E; 1327
DR   Wikidata; Q54835769
RX   PubMed=218079;
RX   PubMed=4327442;
RX   PubMed=4951281;
RX   PubMed=5513559;
RX   PubMed=15541569;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-288.html
CC   Doubling time: ~60-90 hours (DSMZ=ACC-469).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0610 ! GH1
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   GH3-ha7-22
AC   CVCL_F0SI
RX   PubMed=15695160;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1960; CHRNA7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH3/GH-EYFP
AC   CVCL_U370
DR   Wikidata; Q54835770
RX   PubMed=15923356;
CC   Characteristics: Transfected with a Gh1-EYFP fusion protein (PubMed=15923356).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2686; Gh1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   GH329
AC   CVCL_6395
SY   GH-3-29
DR   CLO; CLO_0003488
DR   ATCC; CRL-13002
DR   Wikidata; Q54835771
RX   Patent=US6365394;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-803.
CC   Population: African American.
CC   Characteristics: Transfected with plasmid constructs carrying a 3.4 kb DNA fragment of Ad 5 genome spanning 511 to 3924 bp (E1a and E1b open reading frames and part of the pIX gene) under the control of a phosphoglycerate kinase (PGK) promoter (ATCC=CRL-13002).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-13002
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GH354
AC   CVCL_6396
SY   GH-3-54
DR   CLO; CLO_0003489
DR   ATCC; CRL-13003
DR   Wikidata; Q54835772
RX   Patent=US6365394;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3404.
CC   Population: African American.
CC   Characteristics: Transfected with plasmid constructs carrying a 3.4 kb DNA fragment of Ad 5 genome spanning 511 to 3924 bp (E1a and E1b open reading frames and part of the pIX gene) under the control of a phosphoglycerate kinase (PGK) promoter (Patent=US6365394).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-13003
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   GH364
AC   CVCL_K171
SY   GH-3-64
DR   ATCC; CRL-13004
DR   Wikidata; Q54835773
RX   Patent=US6365394;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3405.
CC   Population: African American.
CC   Characteristics: Transfected with plasmid constructs carrying a 3.4 kb DNA fragment of Ad 5 genome spanning 511 to 3924 bp (E1a and E1b open reading frames and part of the pIX gene) under the control of a phosphoglycerate kinase (PGK) promoter (Patent=US6365394).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CRL-13004; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   GH368
AC   CVCL_F1DV
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH3B6
AC   CVCL_0274
SY   GH3.B6; GH3/B6
DR   MCCL; MCC:0000165
DR   BCRJ; 0091
DR   NCBI_Iran; C610
DR   Wikidata; Q54835774
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GH3C1
AC   CVCL_UJ46
DR   Wikidata; Q93560955
RX   PubMed=5513559;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   GH3C6
AC   CVCL_UJ47
DR   Wikidata; Q93560956
RX   PubMed=5513559;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   GH464
AC   CVCL_F1DW
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH4C1
AC   CVCL_0276
AS   CVCL_0275
SY   GH(4)C(1); GH4 C 1; GH4-C1; GH4
DR   BTO; BTO_0002767
DR   CLO; CLO_0003485
DR   CLO; CLO_0003490
DR   MCCL; MCC:0000166
DR   MCCL; MCC:0000167
DR   CLDB; cl1459
DR   ATCC; CCL-82.2
DR   ChEMBL-Cells; CHEMBL3307497
DR   ChEMBL-Targets; CHEMBL614572
DR   DSMZ; ACC-482
DR   DSMZCellDive; ACC-482
DR   ICLC; ATL96006
DR   PubChem_Cell_line; CVCL_0276
DR   TOKU-E; 3555
DR   Wikidata; Q54835776
RX   PubMed=218079;
RX   PubMed=1620544;
RX   PubMed=15541569;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-289.html
CC   Doubling time: ~60-80 hours (DSMZ=ACC-482).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   GH4I12
AC   CVCL_8154
DR   Wikidata; Q54835777
RX   PubMed=8171043;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2520; Drd2 (Note=Isoform long).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0276 ! GH4C1
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   GH4T2
AC   CVCL_WX20
SY   GH4 T2
DR   Wikidata; Q93560965
RX   PubMed=1620544;
RX   PubMed=9388230;
RX   PubMed=11518800;
CC   Characteristics: Produced from a tumor produced by the passage of the parent cell line through female Wistar Furth rats (PubMed=1620544).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0276 ! GH4C1
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   GH4ZR7
AC   CVCL_0277
DR   MCCL; MCC:0000168
DR   Wikidata; Q54835778
RX   PubMed=1688845;
RX   PubMed=8171043;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2520; Drd2 (Note=Isoform short).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0276 ! GH4C1
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   GH518
AC   CVCL_F1DX
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH586
AC   CVCL_F1DY
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH704
AC   CVCL_F1DZ
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH786
AC   CVCL_F1E0
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody (Note=Also recognizes Human melanoma COLO 38 (Cellosaurus=CVCL_3934) cell line).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GH827
AC   CVCL_F1E1
RX   PubMed=7686858;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human anti-idiotypic MK2-23 antibody.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GHB-L3
AC   CVCL_A9HX
SY   GHBL3
DR   CCRID; 5301MAM-KCB0605LZJ
DR   KCB; KCB 200605LZJ
DR   Wikidata; Q108820290
CC   Group: Bat cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=59479; ! Rhinolophus ferrumequinum (Greater horseshoe bat)
OI   CVCL_A9HY ! GHB-S3
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GHB-S3
AC   CVCL_A9HY
SY   GHBS3
DR   CCRID; 5301MAM-KCB0605SZJ
DR   KCB; KCB 200605SZJ
DR   Wikidata; Q108820291
CC   Group: Bat cell line.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=59479; ! Rhinolophus ferrumequinum (Greater horseshoe bat)
OI   CVCL_A9HX ! GHB-L3
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GHBP116
AC   CVCL_J277
DR   JCRB; JCRB1226
DR   Wikidata; Q54835779
RX   PubMed=10443474;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10912; Human GHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   GHE
AC   CVCL_8199
SY   Glioblastome Humain E
DR   BioSample; SAMN03151940
DR   cancercelllines; CVCL_8199
DR   Wikidata; Q54835780
RX   PubMed=10508494;
RX   PubMed=18472955;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an astrocytoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00122.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   GHE-L
AC   CVCL_8153
DR   Wikidata; Q54835781
RX   PubMed=2181436;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   GHFT1-5
AC   CVCL_J506
SY   GHFT1
DR   Wikidata; Q54835782
RX   PubMed=8096199;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: GHF-Tag transgenic.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   GHINK-1
AC   CVCL_W390
DR   Wikidata; Q54835783
RX   PubMed=15369136;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8691 ! HFWT
SX   Male
AG   5M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 11
//
ID   Ghm
AC   CVCL_XZ84
DR   KCB; KCB 90010
DR   Wikidata; Q93560973
RX   PubMed=12067210;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9662; ! Meles meles (Eurasian badger)
SX   Female
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   GHOST(3)
AC   CVCL_S489
SY   GHOST (3); GHOST Parental cells; GHOST (3) Parental
DR   BEI_Resources; ARP-3679
DR   cancercelllines; CVCL_S489
DR   Wikidata; Q54835784
WW   Provider; NIBSC; 0082; http://www.nibsc.org/Default.aspx?pageid=597&ID=0082
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   GHOST(3)-CCR5 DRiP78 and NHERF1 knockdown
AC   CVCL_LI03
DR   cancercelllines; CVCL_LI03
DR   Wikidata; Q54835798
RX   PubMed=26018859;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:24581; DNAJC14.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11075; NHERF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S491 ! GHOST(3).CCR5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 15
//
ID   GHOST(3)-CXCR4 DRiP78 and NHERF1 knockdown
AC   CVCL_LI04
DR   cancercelllines; CVCL_LI04
DR   Wikidata; Q54835799
RX   PubMed=26018859;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:24581; DNAJC14.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11075; NHERF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S492 ! GHOST(3).CXCR4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 15
//
ID   GHOST(3).BOB/GPR15
AC   CVCL_1E05
SY   GHOST (3) BOB/GPR15; GHOST cell BOB/GPR15; GHOST (3) BoB+
DR   BEI_Resources; ARP-3686
DR   cancercelllines; CVCL_1E05
DR   Wikidata; Q54835785
WW   Provider; NIBSC; 0080; http://www.nibsc.org/Default.aspx?pageid=597&ID=0080
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4469; GPR15.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GHOST(3).CCR1
AC   CVCL_1E06
SY   GHOST (3) CCR1; GHOST cell CCR1; GHOST (3) CCR1+
DR   BEI_Resources; ARP-3680
DR   cancercelllines; CVCL_1E06
DR   Wikidata; Q54835786
WW   Provider; NIBSC; 0074; http://www.nibsc.org/Default.aspx?pageid=597&ID=0074
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1602; CCR1.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GHOST(3).CCR2b
AC   CVCL_1E07
SY   GHOST (3) CCR2b; GHOST cell CCR2; GHOST (3) CCR2b+
DR   BEI_Resources; ARP-3681
DR   cancercelllines; CVCL_1E07
DR   Wikidata; Q54835787
WW   Provider; NIBSC; 0075; http://www.nibsc.org/Default.aspx?pageid=597&ID=0075
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1603; CCR2 (Note=Isoform B).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GHOST(3).CCR3
AC   CVCL_S490
SY   GHOST (3) CCR3; GHOST cell CCR3; GHOST (3) CCR3+
DR   BEI_Resources; ARP-3682
DR   cancercelllines; CVCL_S490
DR   Wikidata; Q54835788
RX   PubMed=11878871;
RX   PubMed=16061987;
WW   Provider; NIBSC; 0076; http://www.nibsc.org/Default.aspx?pageid=597&ID=0076
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   GHOST(3).CCR4
AC   CVCL_S497
SY   GHOST(3) CCR4; GHOST (3) CCR4; GHOST cell CCR4; GHOST (3) CCR4+
DR   BEI_Resources; ARP-3683
DR   cancercelllines; CVCL_S497
DR   Wikidata; Q54835789
WW   Provider; NIBSC; 0077; http://www.nibsc.org/Default.aspx?pageid=597&ID=0077
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1605; CCR4.
CC   Caution: Was discontinued from BEI_Resources because the cell line was negative for CCR4 (personal communication of Rashid, Sujatha).
CC   Discontinued: BEI_Resources; ARP-3683; true.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   GHOST(3).CCR5
AC   CVCL_S491
SY   GHOST(3)-CCR5; GHOST CCR5; GHOST cell CCR5
DR   cancercelllines; CVCL_S491
DR   ChEMBL-Cells; CHEMBL3308560
DR   ChEMBL-Targets; CHEMBL614502
DR   PubChem_Cell_line; CVCL_S491
DR   Wikidata; Q54835790
RX   PubMed=11878871;
RX   PubMed=16061987;
WW   Provider; NIBSC; 0078; http://www.nibsc.org/Default.aspx?pageid=597&ID=0078
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   GHOST(3).CCR8
AC   CVCL_S494
SY   GHOST (3) CCR8; GHOST(3) CCR8; GHOST cell CCR8; GHOST (3) CCR8+
DR   BEI_Resources; ARP-3940
DR   cancercelllines; CVCL_S494
DR   Wikidata; Q54835791
WW   Provider; NIBSC; 0083; http://www.nibsc.org/Default.aspx?pageid=597&ID=0083
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1609; CCR8.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   GHOST(3).CXCR4
AC   CVCL_S492
SY   GHOST(3)-CXCR4; GHOST (3) CXCR4; GHOST(3) CXCR4; GHOST CXCR4; Ghost-CXCR4; GHOST cell CXCR4; GHOST (3) CXCR4+
DR   BEI_Resources; ARP-3685
DR   cancercelllines; CVCL_S492
DR   ChEMBL-Cells; CHEMBL3307789
DR   ChEMBL-Targets; CHEMBL612253
DR   PubChem_Cell_line; CVCL_S492
DR   Wikidata; Q54835792
RX   PubMed=11878871;
RX   PubMed=16061987;
WW   Provider; NIBSC; 0079; http://www.nibsc.org/Default.aspx?pageid=597&ID=0079
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   GHOST(3).CXCR6
AC   CVCL_S493
SY   GHOST (3) Bonzo/STRL33; GHOST cell BONZO/STRL33; GHOST (3) Bonzo+
DR   BEI_Resources; ARP-3687
DR   cancercelllines; CVCL_S493
DR   Wikidata; Q54835793
RX   PubMed=16061987;
WW   Provider; NIBSC; 0081; http://www.nibsc.org/Default.aspx?pageid=597&ID=0081
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16647; CXCR6.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   GHOST(3).Hi-5
AC   CVCL_1E17
SY   GHOST (3) Hi-5; GHOST(3) Hi-5; GHOST(3) Hi5; GHOST-Hi5; Ghost-Hi5; GHOST Hi5; Ghost HI-5; GHOST cell Hi5; GHOST (3) CCR5+
DR   BEI_Resources; ARP-3944
DR   cancercelllines; CVCL_1E17
DR   Wikidata; Q54835794
WW   Provider; NIBSC; 0086; http://www.nibsc.org/Default.aspx?pageid=597&ID=0086
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GHOST(3).R3/X4/R5
AC   CVCL_1E08
SY   GHOST (3) R3/X4/R5; GHOST(3)R3/X4/R5; GHOST-R3/X4/R5; Ghost R3-X4-R5; Ghost-R5-X4-R3; GHOST cell R3/X4/R5; GHOST (3) CCR3+ CXCR4+ CCR5+
DR   BEI_Resources; ARP-3943
DR   cancercelllines; CVCL_1E08
DR   Wikidata; Q54835795
WW   Provider; NIBSC; 0085; http://www.nibsc.org/Default.aspx?pageid=597&ID=0085
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GHOST(3).V28/CX3CR1
AC   CVCL_1E09
SY   GHOST (3) V28/CX3CR1; GHOST cell V28 CXCR1; GHOST (3) CX3CR1+
DR   BEI_Resources; ARP-3939
DR   cancercelllines; CVCL_1E09
DR   Wikidata; Q54835796
WW   Provider; NIBSC; 0087; http://www.nibsc.org/Default.aspx?pageid=597&ID=0087
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2558; CX3CR1.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GHOST(3).X4/R5
AC   CVCL_1E10
SY   GHOST (3) X4/R5; GHOST cell X4/R5; GHOST (3) CXCR4+CCR5+
DR   BEI_Resources; ARP-3942
DR   cancercelllines; CVCL_1E10
DR   Wikidata; Q54835797
WW   Provider; NIBSC; 0084; http://www.nibsc.org/Default.aspx?pageid=597&ID=0084
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S489 ! GHOST(3)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GHR3
AC   CVCL_H544
SY   GM15923
DR   CLO; CLO_0018740
DR   cancercelllines; CVCL_H544
DR   Coriell; GM15923
DR   Wikidata; Q54835800
RX   PubMed=9419347;
CC   Problematic cell line: Contaminated. Ancestral cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Characteristics: Derived from spontaneous HPRT- mutant of EJ30.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F666 ! EJ-30tgr
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   GhrasT-NIH/Swiss
AC   CVCL_WS34
DR   Wikidata; Q93561017
RX   PubMed=26254261;
CC   Doubling time: 17 hours (PubMed=26254261).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 27-11-25; Version: 8
//
ID   GHY-238
AC   CVCL_WE16
DR   IBRC; C10502
DR   Wikidata; Q93561023
CC   Population: Iranian; Ghashghayi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GHY-268
AC   CVCL_WE17
DR   IBRC; C10538
DR   Wikidata; Q93561026
RX   PubMed=32358742;
CC   Population: Iranian; Ghashghayi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GHY-369
AC   CVCL_WE18
DR   IBRC; C11178
DR   Wikidata; Q93561029
CC   Population: Iranian; Ghashghayi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GI
AC   CVCL_R842
SY   Gill; G1
DR   Wikidata; Q54835360
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   GI-1
AC   CVCL_1231
SY   GI1
DR   CLO; CLO_0050634
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 670
DR   BioSample; SAMN03470902
DR   BioSample; SAMN10987799
DR   cancercelllines; CVCL_1231
DR   Cell_Model_Passport; SIDM00273
DR   ChEMBL-Cells; CHEMBL3308167
DR   ChEMBL-Targets; CHEMBL2366272
DR   Cosmic; 687569
DR   Cosmic; 906871
DR   Cosmic; 2367527
DR   Cosmic-CLP; 906871
DR   DepMap; ACH-000756
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10413-106B8
DR   GDSC; 906871
DR   GEO; GSM887024
DR   GEO; GSM888094
DR   GEO; GSM1669809
DR   IARC_TP53; 21343
DR   LiGeA; CCLE_649
DR   LINCS_LDP; LCL-1379
DR   PharmacoDB; GI1_404_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1231
DR   PubChem_Cell_line; CVCL_1231
DR   RCB; RCB0763
DR   Wikidata; Q54835802
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=1545891;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 18 hours (PubMed=1545891).
CC   HLA typing: A*02:06,26:01; B*35:01,48:01; C*03:03,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Ser1680del (c.5036_5038CCT[1]) (c.5039_5041delCCT) (p.Ser1642del, c.4922_4924CCT[1]); ClinVar=VCV000158384; Zygosity=Heterozygous (Cosmic-CLP=906871; DepMap=ACH-000756).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg552Ter (c.1654C>T); ClinVar=VCV000126840; Zygosity=Homozygous (Cosmic-CLP=906871; DepMap=ACH-000756).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Homozygous (Cosmic-CLP=906871; DepMap=ACH-000756).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.75%; East Asian, South=20.38%; South Asian=0.63%; European, North=0%; European, South=0.24% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left fronto-parietal lobe.
ST   Source(s): Cosmic-CLP=906871; PubMed=25877200; RCB=RCB0763
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 16,18
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 10,16
ST   FGA: 23,24
ST   Penta D: 11,12
ST   Penta E: 12,15
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   GI-101A
AC   CVCL_0278
AS   CVCL_5214
SY   GI101A; GI 101A; GI-101; GI 101; GI101
DR   MCCL; MCC:0000169
DR   cancercelllines; CVCL_0278
DR   Cosmic; 687469
DR   GEO; GSM217569
DR   GEO; GSM219931
DR   Progenetix; CVCL_0278
DR   Wikidata; Q54835803
RX   Patent=US6037520;
RX   PubMed=10328849;
RX   PubMed=12800145;
RX   PubMed=14598885;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/GI%20101.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12420.
CC   Characteristics: Established from a athymic mice xenograft.
CC   Doubling time: 36 hours (Note=In a medium with 10% serum) (PubMed=14598885).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   GI-102
AC   CVCL_D589
DR   BTO; BTO_0005302
DR   Wikidata; Q54835804
RX   PubMed=12601555;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   GI-103
AC   CVCL_D616
DR   Wikidata; Q54835805
RX   PubMed=12601555;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   GI-112
AC   CVCL_D617
DR   Wikidata; Q54835806
RX   PubMed=12601555;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   GI-117
AC   CVCL_D618
DR   Wikidata; Q54835807
RX   PubMed=12601555;
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   GI-CA-N
AC   CVCL_3369
SY   Gi-CA-N; GICAN; Gaslini Institute-CA-Neuroblastoma
DR   CLO; CLO_0003492
DR   CLDB; cl1460
DR   ICLC; HTL96025
DR   Wikidata; Q54835808
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2307545;
RX   PubMed=3204111;
CC   Discontinued: ICLC; HTL96025; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GI-CO-T-9
AC   CVCL_C5WN
SY   Gaslini Institute-CO-T cell-9
DR   Wikidata; Q116049077
RX   PubMed=3210814;
RX   PubMed=3257694;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2493fs*67 (c.7476_7477ins11); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1641 ! PF-382
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GI-LA-N
AC   CVCL_8874
SY   GILAN; Gaslini Institute-LA-Neuroblastoma
DR   BTO; BTO_0005807
DR   Wikidata; Q54835809
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=3422578;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y3M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   GI-LI-N
AC   CVCL_3370
SY   Gi-Li-N; GILIN; Gaslini Institute-LI-Neuroblastoma
DR   CLO; CLO_0003493
DR   CLDB; cl1462
DR   Cosmic; 753617
DR   IARC_TP53; 21344
DR   ICLC; HTL96013
DR   Wikidata; Q54835812
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=3204111;
CC   Discontinued: ICLC; HTL96013; true.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GI-ME-N
AC   CVCL_1232
SY   Gi-ME-N; Gi-MEN; GIMEN; Gimen; Gimen1; Gaslini Institute-ME-Neuroblastoma
DR   BTO; BTO_0005808
DR   CLO; CLO_0003494
DR   CLDB; cl1464
DR   CLDB; cl4931
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473467
DR   cancercelllines; CVCL_1232
DR   Cell_Model_Passport; SIDM00227
DR   ChEMBL-Cells; CHEMBL3308868
DR   ChEMBL-Targets; CHEMBL2366074
DR   CLS; 300179
DR   Cosmic; 755616
DR   Cosmic; 906872
DR   Cosmic; 1167992
DR   Cosmic; 1518065
DR   Cosmic; 1526625
DR   Cosmic; 1543771
DR   Cosmic; 2239471
DR   Cosmic-CLP; 906872
DR   DepMap; ACH-001344
DR   DSMZ; ACC-654
DR   DSMZCellDive; ACC-654
DR   EGA; EGAS00001000978
DR   GDSC; 906872
DR   GEO; GSM692856
DR   GEO; GSM1669810
DR   GEO; GSM3145615
DR   GEO; GSM3145705
DR   IARC_TP53; 23838
DR   IARC_TP53; 27693
DR   ICLC; HTL98011
DR   LINCS_LDP; LCL-1983
DR   PharmacoDB; GIMEN_405_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1232
DR   Wikidata; Q54835813
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2296463;
RX   PubMed=2535035;
RX   PubMed=2917605;
RX   PubMed=3204111;
RX   PubMed=3406012;
RX   PubMed=3422578;
RX   PubMed=3615018;
RX   PubMed=7838528;
RX   PubMed=9283597;
RX   PubMed=9516836;
RX   PubMed=11550280;
RX   PubMed=17506115;
RX   PubMed=20164919;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=24466371;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~25 hours (CLS=300179); ~24 hours (DSMZ=ACC-654).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (PubMed=20655465).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Microdeletion; Zygosity=Heterozygous (PubMed=20655465).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.35%; Native American=0.42%; East Asian, North=0.23%; East Asian, South=0%; South Asian=7.63%; European, North=34.54%; European, South=55.82% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): CLS=300179; Cosmic-CLP=906872; DepMap=ACH-001344; DSMZ=ACC-654
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12 (Cosmic-CLP=906872; DepMap=ACH-001344; DSMZ=ACC-654)
ST   D13S317: 12 (CLS=300179)
ST   D16S539: 9,12
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 31
ST   D2S1338: 19,20
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,14 (DepMap=ACH-001344)
ST   D8S1179: 11,15 (DSMZ=ACC-654)
ST   FGA: 19,22
ST   Penta D: 9,13
ST   Penta E: 15,20 (DepMap=ACH-001344)
ST   Penta E: 15,21 (DSMZ=ACC-654)
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   GI-ME-NrCDDP500
AC   CVCL_RS22
DR   Wikidata; Q54835814
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Microdeletion; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1232 ! GI-ME-N
SX   Female
AG   3Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   GI-ME-NrDOX5
AC   CVCL_RS07
DR   Wikidata; Q54835815
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Microdeletion; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1232 ! GI-ME-N
SX   Female
AG   3Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   GI-ME-NrVCR14
AC   CVCL_RR32
DR   Wikidata; Q54835816
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Microdeletion; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1232 ! GI-ME-N
SX   Female
AG   3Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   GI0001
AC   CVCL_8W48
DR   ECACC; 95081041
DR   Wikidata; Q54835817
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95081041; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   36Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   GI0002
AC   CVCL_8W49
DR   ECACC; 95081042
DR   Wikidata; Q54835818
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95081042; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   GI191E/A8
AC   CVCL_E9UT
SY   GI191E
RX   PubMed=16046671;
WW   Info; EuroMAbNet; -; https://www.euromabnet.com/monoclonal-antibodies/bcl6/12.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P41182; Human BCL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GI29-2B4
AC   CVCL_VV35
SY   GI29.2B4
DR   Wikidata; Q93561070
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   Gibco B6-Puro Mouse Embryonic Fibroblasts, Irradiated
AC   CVCL_RB11
SY   Irradiated Gibco B6-Puro Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835819
WW   Provider; Thermo Fisher; A34965; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0017059-B6-PuroMouseEmbryonicFibroblastsIrradiated-UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher=A34965).
CC   Characteristics: Growth-arrested by irradiation (Thermo Fisher=A34965).
CC   Characteristics: Expresses pac from a pPWL88puro transgene (Thermo Fisher=A34965).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J-Tg(pPwL88puro)2EMS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   Gibco C57BL/6 Mouse Embryonic Fibroblasts, Irradiated
AC   CVCL_RB07
SY   Irradiated Gibco C57BL/6 Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835820
WW   Provider; Thermo Fisher; A34960/A34961; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0017062-C57BL-6-MouseEmbryonicFibroblastsIrradiated-UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher=A34960/A34961).
CC   Characteristics: Growth-arrested by irradiation (Thermo Fisher=A34960/A34961).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   Gibco C57BL/6 Mouse Embryonic Fibroblasts, MitC-Treated
AC   CVCL_RB08
SY   Mitomycin C-treated Gibco C57BL/6 Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835821
WW   Provider; Thermo Fisher; A34962; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0017061-C57BL-6-MouseEmbryonicFibroblastsMitC-Treated_UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher=A34962).
CC   Characteristics: Growth-arrested by mitomycin C (Thermo Fisher=A34962).
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   Gibco CF1 Mouse Embryonic Fibroblasts, Irradiated
AC   CVCL_RB05
SY   Irradiated Gibco CF1 Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835822
WW   Provider; Thermo Fisher; A34180/A34181; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0016852_CF1_MouseEmbryonicFibroblastsIrradiated_UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher=A34180/A34181).
CC   Characteristics: Growth-arrested by irradiation (Thermo Fisher=A34180/A34181).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   Gibco CF1 Mouse Embryonic Fibroblasts, MitC-Treated
AC   CVCL_RB06
SY   Mitomycin C-treated Gibco CF1 Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835823
WW   Provider; Thermo Fisher; A34958/A34959; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0016995_CF1_Mouse_EmbryonicFibroblasts_MitC_Treated_UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher=A34958/A34959).
CC   Characteristics: Growth-arrested by mitomycin C (Thermo Fisher=A34958/A34959).
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   Gibco CF6-Neo Mouse Embryonic Fibroblasts, Irradiated
AC   CVCL_RB09
SY   Irradiated Gibco CF6-Neo Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835824
WW   Provider; Thermo Fisher; A34963; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0016996_CF6Neo_Mouse_Embryonic_Fibroblasts_Irradiated_UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher=A34963).
CC   Characteristics: Growth-arrested by irradiation (Thermo Fisher=A34963).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1 x C57BL/6J-Tg(pPGKneobpA)3Ems/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   Gibco CF6-Neo Mouse Embryonic Fibroblasts, MitC-Treated
AC   CVCL_RB10
SY   Mitomycin C-treated Gibco CF6-Neo Mouse Embryonic Fibroblasts
DR   Wikidata; Q54811227
WW   Provider; Thermo Fisher; A34964; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0016997_CF6Neo_Mouse_Embryonic_Fibroblasts_MitCTreated_UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher; A34964).
CC   Characteristics: Growth-arrested by mitomycin C (Thermo Fisher; A34964).
CC   Characteristics: Expresses neo from a pPGKneobPa transgene (Thermo Fisher; A34964).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: CF-1 x C57BL/6J-Tg(pPGKneobpA)3Ems/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   Gibco DR4 Mouse Embryonic Fibroblasts, Irradiated
AC   CVCL_RB12
SY   Irradiated Gibco DR4 Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835825
WW   Provider; Thermo Fisher; A34966; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0017060-DR4-MouseEmbryonicFibroblastsIrradiated-UG.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher; A34966).
CC   Characteristics: Growth-arrested by irradiation (Thermo Fisher; A34966).
CC   Characteristics: Expresses transgenes that make this cell line resistant to four different drugs: geneticin (G418), puromycin, hygromycin and 6-tioguanine (Thermo Fisher; A34966).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: DR4 x CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   Gibco ICR Mouse Embryonic Fibroblasts, Irradiated
AC   CVCL_RB13
SY   Irradiated Gibco ICR Mouse Embryonic Fibroblasts
DR   Wikidata; Q54835826
WW   Provider; Thermo Fisher; A24903; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/mef_icr_inactivated_man.pdf
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state (Thermo Fisher=A24903).
CC   Characteristics: Growth-arrested by irradiation (Thermo Fisher=A24903).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13-14FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   GIBH001
AC   CVCL_XG84
DR   CCRID; 4201PAT-CCTCC00257
DR   Wikidata; Q93561124
RX   Patent=CN101492676B;
CC   Group: Patented cell line.
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200838.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   GIBHe001-A
AC   CVCL_UM32
SY   ASGR1-C3
DR   hPSCreg; GIBHe001-A
DR   Wikidata; Q93561127
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GIBHe001-B
AC   CVCL_UM33
DR   hPSCreg; GIBHe001-B
DR   Wikidata; Q93561131
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GIBHe013-A
AC   CVCL_C0JV
SY   H1-RNF1-/-
DR   BioSamples; SAMEA12038600
DR   hPSCreg; GIBHe013-A
DR   Wikidata; Q112929583
RX   PubMed=35567848;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   GIBHe015-B
AC   CVCL_C6TX
SY   H1-FIS1-KO; H1-FIS1-/--#2
DR   hPSCreg; GIBHe015-B
DR   Wikidata; Q117704343
RX   PubMed=36436397;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21689; FIS1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   GIBHi001-A
AC   CVCL_XJ81
SY   ASD-hiPSC
DR   BioSamples; SAMEA5928136
DR   hPSCreg; GIBHi001-A
DR   SKIP; SKIP005559
DR   Wikidata; Q93561133
RX   PubMed=31520889;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3614; FCGR1BP; Simple; p.Arg139Ter (c.415C>T); Zygosity=Heterozygous (PubMed=31520889).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   GIBHi002-A
AC   CVCL_YC25
AS   CVCL_YE67
SY   UC S0730-iPS C11; C11; C11-WT; iPSN0003
DR   BioSamples; SAMEA6293374
DR   hPSCreg; GIBHi002-A
DR   Wikidata; Q93561137
RX   PubMed=21636641;
RX   PubMed=31698191;
RX   PubMed=32339904;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D21S11: 28,30
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   Penta D: 8,11
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   GIBHi002-A-1
AC   CVCL_YC27
SY   C5-PARK2-KO
DR   BioSamples; SAMEA6114040
DR   hPSCreg; GIBHi002-A-1
DR   SKIP; SKIP005578
DR   Wikidata; Q93561140
RX   PubMed=31698191;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:8607; PRKN.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YC25 ! GIBHi002-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   GIBHi002-A-2
AC   CVCL_YC28
SY   NKX2-5 GFP-Puro/wt iPSC; CIBi006-A-2
DR   hPSCreg; GIBHi002-A-2
DR   Wikidata; Q93561142
RX   PubMed=33352530;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Caucasian.
CC   Characteristics: Using TALEN a construct containing eGFP and PuroR was integrated in the first coding exon of NKX2-5 (PubMed=33352530).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YC25 ! GIBHi002-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   GIBHi002-A-3
AC   CVCL_ZE03
SY   C11-LRRK2-KO1; C11-LRRK2-KO
DR   BioSamples; SAMEA6642738
DR   hPSCreg; GIBHi002-A-3
DR   SKIP; SKIP005739
DR   Wikidata; Q98126370
RX   PubMed=32339904;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YC25 ! GIBHi002-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   GIBHi002-A-4
AC   CVCL_ZE04
SY   C11-LRRK2-KO2
DR   hPSCreg; GIBHi002-A-4
DR   SKIP; SKIP005740
DR   Wikidata; Q98126371
RX   PubMed=32339904;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YC25 ! GIBHi002-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   GIBHi002-A-5
AC   CVCL_C1T6
SY   RRAGA-KO-22#; CIBi006-A-5
DR   hPSCreg; GIBHi002-A-5
DR   Wikidata; Q114311528
RX   PubMed=35870248;
CC   From: Cell Inspire Biotechnology; Shenzhen; China.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16963; RRAGA.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YC25 ! GIBHi002-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   GIBHi003-A
AC   CVCL_YC26
SY   PINK1-I368N-C2
DR   BioSamples; SAMEA6114046
DR   hPSCreg; GIBHi003-A
DR   Wikidata; Q93561145
RX   PubMed=31778937;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (PubMed=31778937).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ44 ! ND40066
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   GIBHi004-A
AC   CVCL_YT02
SY   PARK7-L10P-C2
DR   BioSamples; SAMEA6592712
DR   hPSCreg; GIBHi004-A
DR   SKIP; SKIP005753
DR   Wikidata; Q93561149
RX   PubMed=32534165;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple; p.Leu10Pro (c.29T>C); Zygosity=Homozygous (PubMed=32534165).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GIBHi006-A
AC   CVCL_YT03
SY   PARKIN-C253Y-C2
DR   hPSCreg; GIBHi006-A
DR   SKIP; SKIP005804
DR   Wikidata; Q93561151
RX   PubMed=32387897;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Cys253Tyr (c.758G>A); ClinVar=VCV000645725; Zygosity=Homozygous (PubMed=32387897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT04 ! GIBHi006-B
OI   CVCL_YT05 ! GIBHi006-C
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GIBHi006-B
AC   CVCL_YT04
SY   PARKIN-C253Y-C3
DR   hPSCreg; GIBHi006-B
DR   SKIP; SKIP005805
DR   Wikidata; Q93561154
RX   PubMed=32387897;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Cys253Tyr (c.758G>A); ClinVar=VCV000645725; Zygosity=Homozygous (PubMed=32387897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT03 ! GIBHi006-A
OI   CVCL_YT05 ! GIBHi006-C
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GIBHi006-C
AC   CVCL_YT05
SY   PARKIN-C253Y-C4
DR   hPSCreg; GIBHi006-C
DR   SKIP; SKIP005806
DR   Wikidata; Q93561157
RX   PubMed=32387897;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Cys253Tyr (c.758G>A); ClinVar=VCV000645725; Zygosity=Homozygous (PubMed=32387897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT03 ! GIBHi006-A
OI   CVCL_YT04 ! GIBHi006-B
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GiCB
AC   CVCL_CW64
SY   Gibel Carp Brain
DR   Wikidata; Q54835827
RX   Patent=US9598671;
RX   PubMed=25912023;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013179.
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=25912023).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=101364; ! Carassius gibelio (Prussian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 12
//
ID   GiCF
AC   CVCL_UC73
SY   Gibelio Caudal Fin; GiCF-LJF-SHOU
DR   CCRID; 4201PAT-CCTCC01181
DR   Wikidata; Q93561166
RX   Patent=CN108546672B;
RX   PubMed=30268797;
RX   PubMed=34871462;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201856.
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=30268797).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=101364; ! Carassius gibelio (Prussian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 11
//
ID   GICIN-1
AC   CVCL_9476
SY   GI-CI-N-1
DR   Cosmic; 1526624
DR   Wikidata; Q54835828
RX   PubMed=10640144;
CC   Misspelling: GICIN; Cosmic=1526624.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 13
//
ID   Gie-No3B11
AC   CVCL_6A81
SY   MCNr3B11
DR   ABM; T0049
DR   Wikidata; Q54835829
RX   PubMed=18771458;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: Cell line recommended name and sex of donor from author direct submission.
CC   Discontinued: ABM; T0049; true.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 18
//
ID   GIK
AC   CVCL_XA31
DR   CCTCC; GDC0081
DR   Wikidata; Q93561184
CC   Group: Fish cell line.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3142C0001000000101, 3142C0001000000105). They were the sole source of information for this entry.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 8
//
ID   GILM1
AC   CVCL_D255
DR   Wikidata; Q54835830
RX   PubMed=14598885;
CC   Characteristics: Metastatic phenotype obtained by injection of parent cell line in nude mice and selection of cells from lung metastases.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0278 ! GI-101A
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GILM2
AC   CVCL_D256
DR   Wikidata; Q54835831
RX   PubMed=14598885;
CC   Characteristics: Metastatic phenotype obtained by injection of parent cell line in nude mice and selection of cells from lung metastases.
CC   Doubling time: 24 hours (Note=In a medium with 10% serum) (PubMed=14598885).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D255 ! GILM1
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GILM3
AC   CVCL_S917
DR   Wikidata; Q54835832
RX   PubMed=14598885;
CC   Characteristics: Metastatic phenotype obtained by injection of parent cell line in nude mice and selection of cells from lung metastases.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D256 ! GILM2
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   GIMSC
AC   CVCL_E8BY
SY   Grouper Immortalized Muscle Satellite Cells
RX   PubMed=39302606;
CC   Group: Fish cell line.
CC   Doubling time: 18.88 +- 0.21 hours (Note=At 20th passage), 18.28 +- 0.14 hours (Note=At 30th passage), 17.78 +- 0.14 hours (Note=At 40th passage), 18.08 +- 0.11 hours (Note=At 50th passage) (PubMed=39302606).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Muscle satellite cell; CL=CL_0000594.
OX   NCBI_TaxID=232417; ! Hyporthodus septemfasciatus (Convict grouper)
SX   Sex unspecified
AG   Sub-adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Gin-1
AC   CVCL_F842
SY   GIN-1; Gin 1; Gingiva-1
DR   ATCC; CRL-1292
DR   Wikidata; Q54835833
CC   Discontinued: ATCC; CRL-1292; true.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GingF12
AC   CVCL_L241
DR   Wikidata; Q54835834
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L231 ! OKG12
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 8
//
ID   Girardi Heart
AC   CVCL_2254
SY   Girardi heart; GIRARDI HEART
DR   CLO; CLO_0003495
DR   CLDB; cl1466
DR   CLDB; cl1467
DR   CLDB; cl1468
DR   ATCC; CCL-27
DR   BioSample; SAMN03151697
DR   ECACC; 93120822
DR   IZSLER; BS CL 47
DR   Wikidata; Q54835835
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=13554528;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from normal heart cells.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00006.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-27; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): IZSLER=BS CL 47
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,14
ST   D16S539: 9,10
ST   D21S11: 27,28
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Girardi Heart clone 2
AC   CVCL_1815
SY   GIRARDI HEART C2; GHc2
DR   CLO; CLO_0003496
DR   CLDB; cl1469
DR   DSMZ; ACC-116
DR   DSMZCellDive; ACC-116
DR   Wikidata; Q54835836
RX   PubMed=20143388;
CC   Problematic cell line: Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: DSMZ; ACC-116; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DSMZ=ACC-116
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21,22
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2254 ! Girardi Heart
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Girardi Heart clone 7
AC   CVCL_1816
SY   GIRARDI HEART C7; GHc7
DR   CLO; CLO_0003497
DR   CLDB; cl1470
DR   DSMZ; ACC-121
DR   DSMZCellDive; ACC-121
DR   Wikidata; Q54835837
RX   DOI=10.1007/BF03191992;
RX   PubMed=20143388;
CC   Problematic cell line: Contaminated. Parent cell line (Girardi Heart) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: DSMZ; ACC-121; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DSMZ=ACC-121
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2254 ! Girardi Heart
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GIS2014-SB2C20
AC   CVCL_QX34
DR   Wikidata; Q54835838
RX   PubMed=28395737;
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)47 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (PubMed=28395737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395737
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 13,14
ST   D12S391: 19,21
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13
ST   D1S1656: 16,17.3
ST   D21S11: 29,30
ST   D22S1045: 15,17
ST   D2S1338: 18
ST   D2S441: 10,12
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,13
ST   D8S1179: 14,15
ST   DYS391: 6
ST   FGA: 20,22
ST   SE33: 15,30.2
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   GIS2014-SB3C16
AC   CVCL_QX35
DR   Wikidata; Q54835839
RX   PubMed=28395737;
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)43 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (PubMed=28395737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395737
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,15
ST   D12S391: 15,17
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D1S1656: 10,15
ST   D21S11: 28,30
ST   D22S1045: 17,19
ST   D2S1338: 20
ST   D2S441: 11,14
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   DYS391: 10
ST   FGA: 23,25
ST   SE33: 28.2,31.2
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   GIS2014-WT2C15
AC   CVCL_QX36
DR   Wikidata; Q54835841
RX   PubMed=28395737;
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)26 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (PubMed=28395737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395737
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 13,14
ST   D12S391: 19,24
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D19S433: 13,16
ST   D1S1656: 16,17.3
ST   D21S11: 29,32
ST   D22S1045: 16,17
ST   D2S1338: 18,23
ST   D2S441: 10,12
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 15,16
ST   DYS391: 6
ST   FGA: 20,22
ST   SE33: 25.2,30.2
ST   TH01: 9,9.3
ST   TPOX: 8,12
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 8
//
ID   GIS2014-WT3C16
AC   CVCL_QX37
DR   Wikidata; Q54835842
RX   PubMed=28395737;
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)22 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (PubMed=28395737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395737
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 15
ST   D12S391: 15,21
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D1S1656: 10,14
ST   D21S11: 28,30
ST   D22S1045: 11
ST   D2S1338: 20
ST   D2S441: 11,11.3
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   DYS391: 10
ST   FGA: 18,22
ST   SE33: 17,31.2
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 8
//
ID   GIS2014-WT4C10
AC   CVCL_QX38
DR   Wikidata; Q54835843
RX   PubMed=28395737;
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)24 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (PubMed=28395737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395737
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 14,15
ST   D12S391: 17,20
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 14,15
ST   D19S433: 16
ST   D1S1656: 11,16
ST   D21S11: 28,32.2
ST   D22S1045: 11,17
ST   D2S1338: 19,25
ST   D2S441: 11,14
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   DYS391: 10
ST   FGA: 20,24
ST   SE33: 19,23.2
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 8
//
ID   GIST-DR
AC   CVCL_M444
DR   Wikidata; Q54835844
RX   PubMed=15882927;
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 7
//
ID   GIST-H1
AC   CVCL_M440
DR   Wikidata; Q54835845
RX   PubMed=21131734;
CC   Population: Chinese.
CC   Doubling time: 47.5 hours (PubMed=21131734).
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 11
//
ID   GIST-M
AC   CVCL_C1HV
SY   DOS15
DR   Wikidata; Q114311529
RX   CelloPub=CLPUB00712;
RX   DOI=10.26190/unsworks/20387;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Pro573_Thr574insSerPro (c.1720_1725insGCCCCA); Zygosity=Heterozygous (DOI=10.26190/unsworks/20387).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   GIST-R1
AC   CVCL_A9N3
DR   Wikidata; Q102113871
RX   PubMed=32736695;
CC   Population: Korean.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   GIST-R2m
AC   CVCL_A9N4
DR   Wikidata; Q102113873
RX   PubMed=32736695;
CC   Population: Korean.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   GIST-R3
AC   CVCL_A9N5
DR   Wikidata; Q102113875
RX   PubMed=32736695;
CC   Population: Korean.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   GIST-R4ma
AC   CVCL_A9N6
DR   Wikidata; Q102113877
RX   PubMed=32736695;
CC   Population: Korean.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   GIST-R5
AC   CVCL_A9N7
DR   Wikidata; Q102113878
RX   PubMed=32736695;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:20091; AK7 + HGNC; HGNC:24968; EXOC2; Name(s)=EXOC2-AK7; Note=In frame (PubMed=32736695).
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   GIST-T1
AC   CVCL_4976
SY   GIST-T-1; GISTT1; T1
DR   ChEMBL-Cells; CHEMBL4482986
DR   ChEMBL-Targets; CHEMBL4483238
DR   Cosmic; 1029465
DR   Cosmic; 1873953
DR   Cosmic; 2607430
DR   Cosmic; 2805388
DR   DepMap; ACH-002332
DR   GEO; GSM1701539
DR   GEO; GSM2527248
DR   GEO; GSM2527250
DR   GEO; GSM2527251
DR   GEO; GSM2527316
DR   GEO; GSM2527317
DR   GEO; GSM2527318
DR   GEO; GSM2527319
DR   GEO; GSM3070588
DR   PubChem_Cell_line; CVCL_4976
DR   Wikidata; Q54835846
RX   PubMed=12004007;
RX   PubMed=16077968;
RX   PubMed=19706776;
RX   PubMed=22665524;
RX   PubMed=23716303;
RX   PubMed=25239608;
RX   PubMed=27997714;
RX   PubMed=29866822;
RX   PubMed=32736695;
RX   PubMed=34738628;
WW   Provider; Cosmo Bio; PMC-GIST01C; https://www.cosmobiousa.com/pages/cell-cell-culture-products/gist-t1-cells
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=12004007).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (PubMed=12004007; PubMed=16077968).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; PTM; Tyrosine phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GIST-T1-117
AC   CVCL_QW91
SY   GIST-117; T117
DR   GEO; GSM1701540
DR   Wikidata; Q54835847
RX   PubMed=27997714;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   GIST-T1-R2
AC   CVCL_QW82
SY   GIST-R2; R2
DR   Cosmic; 2607434
DR   GEO; GSM1701544
DR   Wikidata; Q54835848
RX   PubMed=23716303;
RX   PubMed=27997714;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   GIST-T1-R8
AC   CVCL_QW86
SY   GIST-R8; R8
DR   cancercelllines; CVCL_QW86
DR   Cosmic; 2607431
DR   GEO; GSM1701541
DR   Wikidata; Q54835849
RX   PubMed=23716303;
RX   PubMed=27997714;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp820Tyr (c.2458G>T); ClinVar=VCV000375928; Zygosity=Heterozygous (PubMed=27997714).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   GIST-T1-R9
AC   CVCL_QW90
SY   GIST-R9; R9
DR   cancercelllines; CVCL_QW90
DR   Cosmic; 2607433
DR   GEO; GSM1701543
DR   Wikidata; Q54835850
RX   PubMed=27997714;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp820Tyr (c.2458G>T); ClinVar=VCV000375928; Zygosity=Heterozygous (PubMed=27997714).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   GIST-T1-RA2
AC   CVCL_QW89
SY   GIST-RA2; RA2
DR   Cosmic; 2607432
DR   GEO; GSM1701542
DR   Wikidata; Q54835851
RX   PubMed=27997714;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   GIST-T1/670
AC   CVCL_A9M9
SY   GIST-T1 T670I; GIST-5R
DR   cancercelllines; CVCL_A9M9
DR   Cosmic; 2805391
DR   Wikidata; Q102113880
RX   PubMed=25239608;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (PubMed=25239608).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Thr670Ile (c.2009C>T); ClinVar=VCV000376058; Zygosity=Heterozygous (PubMed=25239608).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   GIST-T1/816
AC   CVCL_A9N0
DR   cancercelllines; CVCL_A9N0
DR   GEO; GSM2527258
DR   GEO; GSM2527259
DR   Wikidata; Q102113881
RX   PubMed=25239608;
RX   PubMed=29866822;
RX   PubMed=32736695;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (PubMed=25239608).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp820Glu (c.2460T>A) (D816E); ClinVar=VCV000375929; Zygosity=Heterozygous (PubMed=25239608).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   GIST-T1/829
AC   CVCL_S983
DR   cancercelllines; CVCL_S983
DR   Cosmic; 1873952
DR   Wikidata; Q54835853
RX   PubMed=22665524;
RX   PubMed=25239608;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (PubMed=22665524).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Ala829Pro (c.2485G>C); ClinVar=VCV000375933; Zygosity=Heterozygous (PubMed=22665524).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   GIST-T1/IM-R
AC   CVCL_C3M2
DR   Wikidata; Q116049078
RX   PubMed=34738628;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (PubMed=34738628).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Pro567Pro (c.1701A>G); ClinVar=VCV000259949; Zygosity=Unspecified (PubMed=34738628).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   GIST226
AC   CVCL_A9M8
SY   GIST-226
DR   cancercelllines; CVCL_A9M8
DR   GEO; GSM2527264
DR   GEO; GSM2527265
DR   GEO; GSM2786734
DR   Wikidata; Q102113882
RX   PubMed=25239608;
RX   PubMed=29866822;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Lys550_Trp557del (c.1648_1671del); Zygosity=Heterozygous (PubMed=29866822).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Tyr823Asp (c.2467T>G); ClinVar=VCV000376101; Zygosity=Heterozygous (PubMed=29866822).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   GIST430
AC   CVCL_7040
SY   GIST-430; GIST 430
DR   cancercelllines; CVCL_7040
DR   ChEMBL-Cells; CHEMBL4482996
DR   ChEMBL-Targets; CHEMBL4483237
DR   Cosmic; 1180674
DR   Cosmic; 1873951
DR   GEO; GSM486233
DR   GEO; GSM2527256
DR   GEO; GSM2527257
DR   GEO; GSM2786735
DR   Progenetix; CVCL_7040
DR   PubChem_Cell_line; CVCL_7040
DR   Wikidata; Q54835857
RX   PubMed=16954519;
RX   PubMed=16982758;
RX   PubMed=22665524;
RX   PubMed=25239608;
RX   PubMed=29866822;
RX   PubMed=30488756;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Leu576del (c.1678_1728del); ClinVar=VCV000523644; Zygosity=Heterozygous (PubMed=16954519; PubMed=16982758; PubMed=25239608).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val654Ala (c.1961T>C); ClinVar=VCV000375921; Zygosity=Heterozygous (PubMed=16954519; PubMed=16982758; PubMed=25239608).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GIST430B
AC   CVCL_A9N1
DR   cancercelllines; CVCL_A9N1
DR   GEO; GSM2527266
DR   GEO; GSM2527267
DR   Wikidata; Q102113883
RX   PubMed=29866822;
RX   PubMed=30488756;
CC   Characteristics: Has lost KIT protein expression (PubMed=30488756).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560_Leu576del (c.1678_1728del); ClinVar=VCV000523644; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val654Ala (c.1961T>C); ClinVar=VCV000375921; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7040 ! GIST430
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   GIST48
AC   CVCL_7041
SY   GIST-48; GIST 48
DR   cancercelllines; CVCL_7041
DR   ChEMBL-Cells; CHEMBL4513107
DR   ChEMBL-Targets; CHEMBL4513125
DR   Cosmic; 1180673
DR   Cosmic; 1873950
DR   GEO; GSM486229
DR   GEO; GSM2527252
DR   GEO; GSM2527253
DR   GEO; GSM2786737
DR   Progenetix; CVCL_7041
DR   PubChem_Cell_line; CVCL_7041
DR   Wikidata; Q54835858
RX   PubMed=16954519;
RX   PubMed=16982758;
RX   PubMed=19706776;
RX   PubMed=22294416;
RX   PubMed=22665524;
RX   PubMed=29866822;
RX   PubMed=30488756;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560Asp (c.1679T>A); ClinVar=VCV000375914; Zygosity=Homozygous (PubMed=16954519; PubMed=16982758).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp820Ala (c.2459A>C); ClinVar=VCV000953798; Zygosity=Heterozygous (PubMed=16954519; PubMed=16982758).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GIST48B
AC   CVCL_M441
SY   GIST-48B
DR   cancercelllines; CVCL_M441
DR   Cosmic; 2805390
DR   GEO; GSM2527249
DR   GEO; GSM2527262
DR   GEO; GSM2527263
DR   GEO; GSM2786736
DR   Wikidata; Q54835859
RX   PubMed=19706776;
RX   PubMed=25239608;
RX   PubMed=29866822;
RX   PubMed=30488756;
CC   Characteristics: Expresses KIT transcript and protein at essentially undetectable levels (PubMed=19706776).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560Asp (c.1679T>A); ClinVar=VCV000375914; Zygosity=Homozygous (PubMed=19706776).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp820Ala (c.2459A>C); ClinVar=VCV000953798; Zygosity=Heterozygous (PubMed=19706776).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7041 ! GIST48
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GIST522
AC   CVCL_7042
SY   GIST-522
DR   cancercelllines; CVCL_7042
DR   Cosmic; 1180676
DR   GEO; GSM486231
DR   Progenetix; CVCL_7042
DR   Wikidata; Q54835860
RX   PubMed=19706776;
RX   PubMed=30488756;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Glu554_Lys558del (c.1661_1675del); Zygosity=Heterozygous (PubMed=19706776).
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   GIST62
AC   CVCL_7043
SY   GIST-62; GIST 62
DR   cancercelllines; CVCL_7043
DR   Cosmic; 1180675
DR   GEO; GSM486230
DR   Progenetix; CVCL_7043
DR   Wikidata; Q54835861
RX   PubMed=16982758;
RX   PubMed=19706776;
RX   PubMed=30488756;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Unexplicit; Ex11del; Zygosity=Unspecified (PubMed=16982758; PubMed=19706776).
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   GIST882
AC   CVCL_7044
SY   GIST-882; GIST 882
DR   EFO; EFO_0022342
DR   cancercelllines; CVCL_7044
DR   ChEMBL-Cells; CHEMBL4513108
DR   ChEMBL-Targets; CHEMBL4513126
DR   Cosmic; 1180672
DR   Cosmic; 1217560
DR   Cosmic; 1244759
DR   Cosmic; 1477623
DR   Cosmic; 1873949
DR   Cosmic; 2805389
DR   GEO; GSM486234
DR   GEO; GSM2527254
DR   GEO; GSM2527255
DR   GEO; GSM2786738
DR   Lonza; 694
DR   Progenetix; CVCL_7044
DR   PubChem_Cell_line; CVCL_7044
DR   Wikidata; Q54835862
RX   PubMed=11526490;
RX   PubMed=16077968;
RX   PubMed=16982758;
RX   PubMed=19706776;
RX   PubMed=25239608;
RX   PubMed=29866822;
RX   PubMed=30488756;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Lys642Glu (c.1924A>G); ClinVar=VCV000013866; Zygosity=Homozygous (PubMed=11526490; PubMed=16077968).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GIST882IMR
AC   CVCL_A9N2
DR   cancercelllines; CVCL_A9N2
DR   Wikidata; Q102113884
RX   PubMed=30488756;
CC   Characteristics: Has lost KIT protein expression (PubMed=30488756).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Lys642Glu (c.1924A>G); ClinVar=VCV000013866; Zygosity=Homozygous (from parent cell line).
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7044 ! GIST882
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GJC
AC   CVCL_Z598
DR   Wikidata; Q54835863
RX   PubMed=8943096;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z599 ! GJR
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GJR
AC   CVCL_Z599
DR   Wikidata; Q54835864
RX   PubMed=8943096;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z598 ! GJC
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GK [Epinephelus amblycephalus]
AC   CVCL_UW79
SY   Grouper Kidney
DR   Wikidata; Q93561443
RX   DOI=10.1007/BF02623580;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=308561; ! Epinephelus amblycephalus (Banded grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   GK [Epinephelus awoara]
AC   CVCL_R902
SY   Grouper Kidney
DR   Wikidata; Q54835865
RX   DOI=10.1046/j.1365-2761.2000.00247.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   GK-5
AC   CVCL_7265
DR   CLO; CLO_0003499
DR   ATCC; CRL-1834
DR   Wikidata; Q54835866
CC   Group: Hybridoma fusion partner cell line.
CC   Problematic cell line: Misclassified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-1834
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,18
ST   D19S433: 15,15.2
ST   D21S11: 30,33.2
ST   D2S1338: 20,22
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 16,17
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H616 ! GM1500-6TG-A12
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GK-7
AC   CVCL_IV57
SY   Grouper Kidney-7
DR   Wikidata; Q54835867
RX   DOI=10.4172/2155-9910.1000192;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 7
//
ID   GK0001
AC   CVCL_8W50
DR   ECACC; 95101919
DR   Wikidata; Q54835868
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;15)(p11;p11) (ECACC=95101919).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   GK0002
AC   CVCL_8W51
DR   ECACC; 95101920
DR   Wikidata; Q54835869
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;15)(p11;p11) (ECACC=95101920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   GK0003
AC   CVCL_8W52
DR   ECACC; 95101921
DR   Wikidata; Q54835870
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(7;15)(p11;p11) (ECACC=95101921).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95101921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   GK1.5
AC   CVCL_4523
SY   GK 1.5; GK-1.5
DR   CLO; CLO_0003498
DR   CLDB; cl5190
DR   ATCC; TIB-207
DR   BCRC; 60472
DR   BCRJ; 0092
DR   IZSLER; BS Hy 25
DR   KCLB; 40207
DR   Wikidata; Q54835871
RX   PubMed=6195085;
RX   PubMed=6195255;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   GK129
AC   CVCL_5A07
SY   GK-129; GK 129
DR   Wikidata; Q54835872
RX   PubMed=1604321;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/OlaHsd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   GK129/1
AC   CVCL_5A08
DR   Wikidata; Q54835873
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/OlaHsd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A07 ! GK129
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
ID   GK1C
AC   CVCL_M442
DR   cancercelllines; CVCL_M442
DR   Wikidata; Q54835874
RX   PubMed=23619463;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Lys550_Lys558del (c.1648_1674del); ClinVar=VCV000013857; Zygosity=Unspecified (PubMed=23619463).
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   GK2
AC   CVCL_WH04
DR   cancercelllines; CVCL_WH04
DR   IARC_TP53; 13989
DR   Wikidata; Q93561536
RX   PubMed=9723033;
RX   PubMed=10841287;
CC   Doubling time: ~48 hours (PubMed=9723033).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10841287).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   GK3C
AC   CVCL_M443
DR   Wikidata; Q54835875
RX   PubMed=23619463;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Phe590_Gly591del; Zygosity=Unspecified (PubMed=23619463).
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 9
//
ID   GKA
AC   CVCL_6G36
DR   Wikidata; Q54835876
RX   PubMed=6690059;
RX   PubMed=6825111;
CC   Doubling time: 48-72 hours (PubMed=6825111).
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   GKE
AC   CVCL_C8J6
SY   REPI; Guinea pig Kidney Epithelial
DR   Wikidata; Q123031364
RX   PubMed=27387220;
CC   Virology: Susceptible to infection by guinea pig cytomegalovirus (GPCMV) (PubMed=27387220).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   GKP2
AC   CVCL_2G65
DR   BCGO; BCGO_0000109
DR   Wikidata; Q54835877
WW   Info; -; -; https://www.betacell.org/pdf/betacell-resource-1038.pdf
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   GKP4
AC   CVCL_2G66
DR   BCGO; BCGO_0000110
DR   Wikidata; Q54835878
WW   Info; -; -; https://www.betacell.org/pdf/betacell-resource-1038.pdf
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   GKW.A3
AC   CVCL_LC21
DR   Wikidata; Q54835879
RX   PubMed=7511044;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   GL
AC   CVCL_R903
SY   Grouper Liver
DR   Wikidata; Q54835880
RX   DOI=10.1046/j.1365-2761.2000.00247.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   GL PK/1
AC   CVCL_A9AS
SY   GLPK/1; Glaxo Laboratories Pig Kidney 1
DR   Wikidata; Q108820292
RX   PubMed=13881104;
RX   PubMed=13881105;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of pig kidney origin but found to be a human cell line (PubMed=13881104; PubMed=13881105).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   GL-1 [Dog leukemia]
AC   CVCL_L352
DR   Wikidata; Q54835881
RX   PubMed=8741612;
RX   PubMed=22236332;
RX   PubMed=23363222;
RX   PubMed=23365669;
RX   PubMed=24975508;
RX   PubMed=29674676;
CC   Doubling time: 27.3 hours (Note=At 33th passage) (PubMed=8741612).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   GL-1 [Gecko]
AC   CVCL_4207
SY   GL 1; GL1; Gecko Lung-1; Gekko Lung-1
DR   CLO; CLO_0003471
DR   CLO; CLO_0003500
DR   CLDB; cl1471
DR   ATCC; CCL-111
DR   ECACC; 89072612
DR   Wikidata; Q54835882
RX   PubMed=4314147;
RX   PubMed=4350126;
RX   PubMed=5659169;
RX   PubMed=6062904;
RX   PubMed=7065527;
RX   PubMed=23891577;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=36310; ! Gekko gecko (Tokay gecko)
OI   CVCL_6C07 ! GH-1
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   GL-175
AC   CVCL_WE19
DR   IBRC; C10227
DR   Wikidata; Q93561572
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-176
AC   CVCL_WE20
DR   IBRC; C10241
DR   Wikidata; Q93561575
RX   PubMed=32358742;
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-194
AC   CVCL_WE21
DR   IBRC; C10358
DR   Wikidata; Q93561577
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GL-24
AC   CVCL_WE22
SY   Gl-24
DR   IBRC; C10135
DR   Wikidata; Q93561580
RX   PubMed=32358742;
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-29
AC   CVCL_WE23
DR   IBRC; C10123
DR   Wikidata; Q93561583
RX   PubMed=32358742;
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-31
AC   CVCL_WE24
DR   IBRC; C10124
DR   Wikidata; Q93561585
RX   PubMed=32358742;
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-310
AC   CVCL_WE25
SY   Gl-310
DR   IBRC; C10804
DR   Wikidata; Q93561587
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-324
AC   CVCL_WE26
DR   IBRC; C10768
DR   Wikidata; Q93561590
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-338
AC   CVCL_WE27
DR   IBRC; C10756
DR   Wikidata; Q93561592
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   GL-40
AC   CVCL_C0Q1
DR   Wikidata; Q112929584
RX   PubMed=23363222;
RX   PubMed=24975508;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L352 ! GL-1 [Dog leukemia]
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GL-400
AC   CVCL_ZJ61
DR   IBRC; C11227
DR   Wikidata; Q98126372
RX   PubMed=32358742;
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GL-E
AC   CVCL_0C11
DR   Cosmic; 2239093
DR   Wikidata; Q54835883
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
RX   PubMed=10037197;
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GL-Mel
AC   CVCL_M741
DR   Cosmic; 1295334
DR   Cosmic; 2647642
DR   Wikidata; Q54835884
RX   PubMed=11121133;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   From: Guadagni, Fiorella; Regina Elena Institute for Cancer Research; Rome; Italy.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   GL-V3
AC   CVCL_DC65
SY   V3; Glaxo Laboratories-Vervet no. 3
DR   ATCC; CRL-1433
DR   Wikidata; Q54835885
RX   PubMed=4043530;
RX   PubMed=4318075;
CC   Group: Non-human primate cell line.
CC   Doubling time: ~90 hours (PubMed=4318075).
CC   Discontinued: ATCC; CRL-1433; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GL1
AC   CVCL_9175
DR   CLO; CLO_0003501
DR   ATCC; HB-253
DR   BCRC; 60291
DR   NCBI_Iran; H136
DR   Wikidata; Q54835886
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P42082; Mouse Cd86.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   GL113
AC   CVCL_D1F5
SY   GL 113
DR   Wikidata; Q123031365
RX   PubMed=2970507;
RX   PubMed=8393043;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   GL117
AC   CVCL_D1F6
SY   GL 117
DR   Wikidata; Q123031366
RX   PubMed=2970507;
RX   PubMed=8393043;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   GL15
AC   CVCL_5H95
SY   GL-15
DR   Wikidata; Q54835887
RX   PubMed=1655272;
RX   PubMed=8237465;
RX   PubMed=8845742;
RX   PubMed=10074188;
RX   PubMed=16391870;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
ID   GL183
AC   CVCL_C0BY
DR   Wikidata; Q112929585
RX   PubMed=2137855;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P43627; Human KIR2DL2/CD158b1.
CC   Monoclonal antibody target: UniProtKB; P43628; Human KIR2DL3/CD158b2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GL22
AC   CVCL_5H96
DR   Wikidata; Q54835888
RX   PubMed=1655272;
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 6
//
ID   GL261
AC   CVCL_Y003
SY   Glioma 261; GLIOMA 261; Glioma-261; GL-261
DR   BTO; BTO_0006483
DR   BCRJ; 0299
DR   ChEMBL-Cells; CHEMBL4483160
DR   ChEMBL-Targets; CHEMBL4483239
DR   CLS; 305225
DR   DSMZ; ACC-802
DR   DSMZCellDive; ACC-802
DR   NCI-DTP; Glioma 261
DR   PRIDE; PXD000589
DR   PRIDE; PXD008733
DR   PubChem_Cell_line; CVCL_Y003
DR   Wikidata; Q27547979
RX   PubMed=16734735;
RX   PubMed=23248259;
RX   PubMed=23686484;
RX   PubMed=25894527;
RX   PubMed=30084848;
RX   PubMed=30524896;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Glioma_261
CC   Doubling time: ~100-120 hours (DSMZ=ACC-802).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Misspelling: GI261; Note=Occasionally.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 17
//
ID   GL261-Fluc
AC   CVCL_E9YA
RX   PubMed=33241215;
CC   Characteristics: Transduced with a SV40-Fluc-mPGK-HygR construct (PubMed=33241215).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GL261-Luc
AC   CVCL_C9CB
DR   Ubigene; YC-C045-Luc-P
DR   Wikidata; Q123031367
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   GL261-luc2
AC   CVCL_X986
DR   Revvity/PerkinElmer; 134246
DR   Wikidata; Q54835889
WW   Provider; Revvity/PerkinElmer; 134246; https://web.archive.org/web/20150518034753/http://www.perkinelmer.com/catalog/product/id/134246
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: Revvity/PerkinElmer; 134246; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   GL261-Red-FLuc
AC   CVCL_5I93
SY   GL261 Red-FLuc; Bioware Brite GL261 Red-FLuc; IVISbrite GL261 Red F-luc
DR   Revvity/PerkinElmer; BW134246
DR   Wikidata; Q54835890
CC   Doubling time: 26 hours (Revvity/PerkinElmer=BW134246).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   GL261-Venus-Akaluc
AC   CVCL_E9YB
RX   PubMed=33241215;
CC   Characteristics: Transduced with a hPGK-Venus-Akaluc-WPRE-mPGK-Neo construct (PubMed=33241215).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=Photinus pyralis Akaluciferase (Akaluc) (Note=A luciferase-derived fluorescent protein).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GL261-Venus-Fluc
AC   CVCL_E9YC
RX   PubMed=33241215;
CC   Characteristics: Transduced with a hPGK-Venus-Fluc-WPRE-mPGK-PuroR construct (PubMed=33241215).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GL37
AC   CVCL_XA32
SY   GL-37
DR   CCRID; 1102MON-NIFDC00068
DR   Wikidata; Q93561639
RX   DOI=10.1007/978-4-431-68255-4_132;
RX   PubMed=19860892;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   GL7
AC   CVCL_9176
DR   CLO; CLO_0003503
DR   ATCC; HB-254
DR   Wikidata; Q54835891
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   GLAG-66
AC   CVCL_9918
DR   BTO; BTO_0006406
DR   cancercelllines; CVCL_9918
DR   Wikidata; Q54835892
RX   PubMed=8330267;
RX   PubMed=19087340;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from child cell line K1).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from child cell line K1).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from child cell line K1).
CC   Derived from site: Metastatic; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   GLC-1
AC   CVCL_8200
SY   GLC 1; GLC1; OC-Roi
DR   cancercelllines; CVCL_8200
DR   Cosmic; 2239118
DR   GEO; GSM986185
DR   PRIDE; PXD000132
DR   Progenetix; CVCL_8200
DR   Wikidata; Q54835893
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2859106;
RX   PubMed=2998591;
RX   PubMed=9559344;
RX   PubMed=10709110;
RX   PubMed=23651173;
CC   Doubling time: 21 hours (PubMed=2998591).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GLC-1-M13
AC   CVCL_8201
SY   GLC1-M13; GLC1 M13; GLC1M13; GLC-1-13
DR   PRIDE; PXD000132
DR   Wikidata; Q54835894
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2998591;
RX   PubMed=23651173;
CC   Doubling time: 42 hours (PubMed=2998591).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8200 ! GLC-1
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GLC-11
AC   CVCL_8202
SY   GLC 11; GLC11
DR   Wikidata; Q54835895
RX   PubMed=2838297;
CC   Doubling time: 80 hours (PubMed=2838297).
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   GLC-12
AC   CVCL_8203
SY   GLC 12; GLC12
DR   Wikidata; Q54835896
RX   PubMed=1314232;
RX   PubMed=2409557;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   GLC-14
AC   CVCL_8204
SY   GLC 14; GLC14
DR   cancercelllines; CVCL_8204
DR   Cosmic; 2239124
DR   Cosmic; 2648013
DR   GEO; GSM554391
DR   IARC_TP53; 11282
DR   Progenetix; CVCL_8204
DR   Wikidata; Q54835898
RX   PubMed=1314232;
RX   PubMed=2846164;
RX   PubMed=9212023;
RX   PubMed=9559344;
RX   PubMed=9744504;
RX   PubMed=10408787;
RX   PubMed=10709110;
RX   PubMed=12712436;
RX   PubMed=20631050;
CC   Doubling time: 65 hours (PubMed=2846164).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=10408787).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8205 ! GLC-16
OI   CVCL_8206 ! GLC-19
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GLC-15
AC   CVCL_6904
DR   KCB; KCB 90028YJ
DR   Wikidata; Q54835899
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   GLC-16
AC   CVCL_8205
SY   GLC 16; GLC16
DR   Cosmic; 2648012
DR   Wikidata; Q54835900
RX   PubMed=1320893;
RX   PubMed=2574988;
RX   PubMed=2846164;
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=10709110;
RX   PubMed=12712436;
CC   Doubling time: 40 hours (PubMed=2846164).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8204 ! GLC-14
OI   CVCL_8206 ! GLC-19
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   GLC-19
AC   CVCL_8206
SY   GLC 19; GLC19
DR   Cosmic; 2648011
DR   Wikidata; Q54835901
RX   PubMed=2846164;
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=10709110;
RX   PubMed=12712436;
CC   Doubling time: 40 hours (PubMed=2846164).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8204 ! GLC-14
OI   CVCL_8205 ! GLC-16
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   GLC-2
AC   CVCL_8207
SY   GLC 2; GLC2; OC-Ny; OC-NYH; NYH
DR   BTO; BTO_0005499
DR   cancercelllines; CVCL_8207
DR   Cosmic; 1759250
DR   Cosmic; 2239119
DR   Cosmic; 2648015
DR   GEO; GSM986182
DR   IARC_TP53; 11280
DR   Progenetix; CVCL_8207
DR   Wikidata; Q54835902
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2574988;
RX   PubMed=2998591;
RX   PubMed=9212023;
RX   PubMed=9559344;
RX   PubMed=9744504;
RX   PubMed=10408787;
RX   PubMed=10416608;
RX   PubMed=10709110;
RX   PubMed=12044890;
RX   PubMed=12712436;
RX   PubMed=24586258;
CC   Doubling time: 37 hours (PubMed=2998591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex8del14; Zygosity=Unspecified (PubMed=10408787).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=24586258
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 14
ST   D16S539: 12
ST   D18S51: 15,18
ST   D21S11: 30,32
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 12
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 7,10
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GLC-20
AC   CVCL_8208
SY   GLC 20; GLC20
DR   Cosmic; 877400
DR   Cosmic; 2239125
DR   Wikidata; Q54835903
RX   PubMed=1314232;
RX   PubMed=9559344;
RX   PubMed=10709110;
CC   Misspelling: 6LC20; Cosmic=877400.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   GLC-22
AC   CVCL_8209
SY   GLC 22; GLC22
DR   Wikidata; Q54835904
RX   PubMed=1314232;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   GLC-26
AC   CVCL_8210
SY   GLC 26; GLC26
DR   Cosmic; 2648010
DR   Wikidata; Q54835905
RX   PubMed=8410137;
RX   PubMed=9212023;
RX   PubMed=9744504;
RX   PubMed=12712436;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8211 ! GLC-28
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   GLC-28
AC   CVCL_8211
SY   GLC 28; GLC28
DR   cancercelllines; CVCL_8211
DR   Cosmic; 2239126
DR   Cosmic; 2648009
DR   IARC_TP53; 11284
DR   Wikidata; Q54835906
RX   PubMed=1320893;
RX   PubMed=8410137;
RX   PubMed=9212023;
RX   PubMed=9559344;
RX   PubMed=9744504;
RX   PubMed=10408787;
RX   PubMed=10709110;
RX   PubMed=12712436;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8210 ! GLC-26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   GLC-3
AC   CVCL_8212
SY   GLC 3; GLC3; OC-Tol; OC-TOL
DR   cancercelllines; CVCL_8212
DR   Cosmic; 2239120
DR   Cosmic; 2648014
DR   IARC_TP53; 11272
DR   Wikidata; Q54835907
RX   PubMed=1314232;
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2574988;
RX   PubMed=2998591;
RX   PubMed=9212023;
RX   PubMed=9559344;
RX   PubMed=9744504;
RX   PubMed=10408787;
RX   PubMed=12712436;
CC   Doubling time: 56 hours (PubMed=2998591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.159G>A); ClinVar=VCV000420659; Zygosity=Unspecified (PubMed=10408787).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GLC-33
AC   CVCL_8213
SY   GLC 33; GLC33
DR   Wikidata; Q54835908
RX   PubMed=1314232;
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GLC-34
AC   CVCL_8214
SY   GLC 34; GLC34
DR   Cosmic; 2239127
DR   Wikidata; Q54835909
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   GLC-35
AC   CVCL_0B61
SY   GLC35
DR   cancercelllines; CVCL_0B61
DR   Cosmic; 2239128
DR   IARC_TP53; 11275
DR   Wikidata; Q54835910
RX   PubMed=1320893;
RX   PubMed=9559344;
RX   PubMed=10408787;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.437G>A); ClinVar=VCV000634785; Zygosity=Unspecified (PubMed=10408787).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   GLC-36
AC   CVCL_8215
SY   GLC 36; GLC36
DR   cancercelllines; CVCL_8215
DR   Cosmic; 2239129
DR   GEO; GSM986186
DR   IARC_TP53; 11276
DR   Progenetix; CVCL_8215
DR   Wikidata; Q54835911
RX   PubMed=1320893;
RX   PubMed=9559344;
RX   PubMed=10408787;
RX   PubMed=24586258;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Unspecified (PubMed=10408787).
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=24586258
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   D8S1179: 9,12
ST   FGA: 23,25
ST   Penta D: 10,14
ST   Penta E: 5,10
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GLC-4
AC   CVCL_0279
SY   GLC 4; GLC4
DR   BTO; BTO_0002385
DR   MCCL; MCC:0000170
DR   cancercelllines; CVCL_0279
DR   ChEMBL-Cells; CHEMBL3307807
DR   ChEMBL-Targets; CHEMBL612707
DR   Cosmic; 1429646
DR   Cosmic; 1998274
DR   Cosmic; 2239121
DR   GEO; GSM536324
DR   IARC_TP53; 11273
DR   Progenetix; CVCL_0279
DR   PubChem_Cell_line; CVCL_0279
DR   Wikidata; Q54835912
RX   PubMed=1320893;
RX   PubMed=1657425;
RX   PubMed=2846161;
RX   PubMed=3028613;
RX   PubMed=3040227;
RX   PubMed=8980384;
RX   PubMed=9559344;
RX   PubMed=10025956;
RX   PubMed=10408787;
RX   PubMed=10709110;
RX   PubMed=15150577;
RX   PubMed=20615970;
CC   Doubling time: 24 +- 1.4 hours (PubMed=2846161); 26 hours (PubMed=3028613); 16.9 hours (PubMed=8980384).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (PubMed=10408787).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   GLC-4/ADR
AC   CVCL_4997
SY   GLC4-Adr; GLC4/ADR; GLC(4)/ADR; GLC4/ADR350x; GLC4-ADR150; GLC4-Adr1
DR   BTO; BTO_0002386
DR   ChEMBL-Cells; CHEMBL3833703
DR   PubChem_Cell_line; CVCL_4997
DR   Wikidata; Q54835913
RX   PubMed=1657425;
RX   PubMed=3028613;
RX   PubMed=3040227;
RX   PubMed=7729950;
RX   PubMed=7809167;
RX   PubMed=8980384;
RX   PubMed=11309308;
CC   Doubling time: 26 hours (PubMed=3028613).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GLC-4/ADRpr
AC   CVCL_A5AZ
SY   GLC4/ADRpr; GLC4-Adr2
DR   Wikidata; Q107115108
RX   PubMed=3040227;
RX   PubMed=7809167;
CC   Characteristics: Partial revertant of GLC-4/ADR obtained after culturing in drug-free medium for a number of months (3 according to PubMed=3040227 and 6 according to PubMed=7809167).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4997 ! GLC-4/ADR
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   GLC-4/AM3x
AC   CVCL_Y299
SY   GLC4/AM3x
DR   Wikidata; Q54835914
RX   PubMed=8980384;
CC   Doubling time: 18.6 hours (PubMed=8980384).
CC   Selected for resistance to: ChEBI; CHEBI_2687; Amsacrine.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   GLC-4/CDDP
AC   CVCL_4998
SY   GLC4-CDDP; GLC4/CDDP; GLC4/cDDP
DR   BTO; BTO_0002388
DR   cancercelllines; CVCL_4998
DR   Cosmic; 1998275
DR   GEO; GSM536325
DR   Progenetix; CVCL_4998
DR   Wikidata; Q54835915
RX   PubMed=1657425;
RX   PubMed=2163989;
RX   PubMed=2846161;
RX   PubMed=12093475;
RX   PubMed=20615970;
CC   Doubling time: 43 +- 3 hours (PubMed=2846161).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 21
//
ID   GLC-4/CDDP11
AC   CVCL_Y297
SY   GLC4/CDDP11
DR   Wikidata; Q54835916
RX   PubMed=2163989;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
ID   GLC-4/CDDP3
AC   CVCL_Y298
SY   GLC4-CDDP3
DR   Wikidata; Q54835917
RX   PubMed=2163989;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
ID   GLC-4/MIT60x
AC   CVCL_4999
AS   CVCL_Y300
SY   GLC4/MIT60X; GLC4-MITO; GLC4/MITO; GLC-4/MITO
DR   BTO; BTO_0002387
DR   Wikidata; Q54835918
RX   PubMed=8980384;
RX   PubMed=15150577;
CC   Doubling time: 16.9 hours (PubMed=8980384).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GLC-4/VM20x
AC   CVCL_Y301
SY   GLC4/VM20x
DR   Wikidata; Q54835919
RX   PubMed=8980384;
CC   Doubling time: 22 hours (PubMed=8980384).
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   GLC-42
AC   CVCL_8216
SY   GLC 42; GLC42
DR   Cosmic; 2239130
DR   IARC_TP53; 11286
DR   Wikidata; Q54835920
RX   PubMed=1320893;
RX   PubMed=9559344;
RX   PubMed=10408787;
RX   PubMed=10709110;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile332Serfs*13 (c.994delA); Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   GLC-44
AC   CVCL_0B62
SY   GLC44
DR   cancercelllines; CVCL_0B62
DR   Cosmic; 2239131
DR   IARC_TP53; 11285
DR   Wikidata; Q54835921
RX   PubMed=9559344;
RX   PubMed=10408787;
RX   PubMed=10709110;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu326Ter (c.976G>T); ClinVar=VCV000231815; Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   GLC-45
AC   CVCL_0B63
SY   GLC45
DR   cancercelllines; CVCL_0B63
DR   Cosmic; 2239132
DR   IARC_TP53; 11278
DR   TOKU-E; 3618
DR   Wikidata; Q54835922
RX   PubMed=9559344;
RX   PubMed=10408787;
RX   PubMed=10709110;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Gly (c.653T>G); ClinVar=VCV000528249; Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   GLC-5
AC   CVCL_WM59
SY   GLC5
DR   Wikidata; Q93561867
RX   PubMed=1845952;
RX   PubMed=2473086;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   GLC-7
AC   CVCL_8217
SY   GLC 7; GLC7
DR   cancercelllines; CVCL_8217
DR   Cosmic; 2239122
DR   IARC_TP53; 11274
DR   Wikidata; Q54835923
RX   PubMed=2409557;
RX   PubMed=9559344;
RX   PubMed=10408787;
RX   PubMed=10709110;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Pro (c.431A>C); ClinVar=VCV000186594; Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   GLC-8
AC   CVCL_8218
SY   GLC 8; GLC8
DR   cancercelllines; CVCL_8218
DR   Cosmic; 2239123
DR   GEO; GSM554390
DR   GEO; GSM986183
DR   IARC_TP53; 11283
DR   Progenetix; CVCL_8218
DR   Wikidata; Q54835924
RX   PubMed=1320893;
RX   PubMed=2409557;
RX   PubMed=2838297;
RX   PubMed=9559344;
RX   PubMed=10408787;
RX   PubMed=10709110;
RX   PubMed=20631050;
CC   Doubling time: 34 hours (PubMed=2838297).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Gly (c.838A>G); ClinVar=VCV000376658; Zygosity=Unspecified (PubMed=10408787).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   GLC-82
AC   CVCL_3371
SY   Glc-82; GLC82; Gejiu Lung Carcinoma-82
DR   BTO; BTO_0004113
DR   CLO; CLO_0003505
DR   Cell_Model_Passport; SIDM01939
DR   Cosmic; 753557
DR   DepMap; ACH-001071
DR   IARC_TP53; 21345
DR   ICLC; HTL98006
DR   KCB; KCB 200435YJ
DR   KCB; KCB 86017YJ
DR   PharmacoDB; GLC82_406_2019
DR   TOKU-E; 3607
DR   Wikidata; Q54835925
RX   PubMed=2838234;
RX   PubMed=3471311;
RX   PubMed=4006684;
RX   PubMed=20545000;
RX   PubMed=25433501;
RX   PubMed=26116706;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 32 year old female patient with a lung adenocarcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00572.
CC   Population: African American.
CC   Doubling time: 48 hours (PubMed=4006684).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Genome ancestry: African=66.32%; Native American=1.23%; East Asian, North=2.62%; East Asian, South=0%; South Asian=0%; European, North=15.73%; European, South=14.1% (PubMed=30894373).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000067). It was one of the sources for the STR profile of this entry.
CC   Discontinued: ICLC; HTL98006; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   GLC-A1
AC   CVCL_WM60
SY   GLCA1
DR   Wikidata; Q93561898
RX   PubMed=2473086;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 4
//
ID   GLC-A2
AC   CVCL_WM61
SY   GLCA2
DR   cancercelllines; CVCL_WM61
DR   IARC_TP53; 11281
DR   Wikidata; Q93561902
RX   PubMed=2473086;
RX   PubMed=10408787;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   GLC-A3
AC   CVCL_WM62
SY   GLCA3
DR   Wikidata; Q93561906
RX   PubMed=2473086;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 4
//
ID   GLC-P1
AC   CVCL_0B59
SY   GLCP1
DR   cancercelllines; CVCL_0B59
DR   IARC_TP53; 11279
DR   Wikidata; Q54835926
RX   PubMed=10408787;
RX   PubMed=10709110;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Unspecified (PubMed=10408787).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Unspecified (PubMed=10408787).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   GLC-P2
AC   CVCL_0B60
DR   Wikidata; Q54835927
RX   PubMed=10709110;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   GLC4/Sb30
AC   CVCL_C5RI
DR   ChEMBL-Cells; CHEMBL3833704
DR   Wikidata; Q116049079
RX   PubMed=10025956;
CC   Selected for resistance to: ChEBI; CHEBI_2761; Dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate (Antimony potassium tartrate; KAT).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0279 ! GLC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GLHR-15
AC   CVCL_6636
SY   GLHR15
DR   BTO; BTO_0002288
DR   ABM; T0606
DR   Wikidata; Q54835928
RX   PubMed=1328253;
RX   PubMed=8961254;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=RGD; 3007; Lhcgr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   25D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   Gli-17
AC   CVCL_C8F8
DR   Wikidata; Q123031368
RX   PubMed=11153144;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Gli-22
AC   CVCL_C8F7
DR   Wikidata; Q123031369
RX   PubMed=11153144;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 3
//
ID   Gli-38
AC   CVCL_C8F9
DR   Wikidata; Q123031370
RX   PubMed=11153144;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain, left fronto-parietal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Gli-6
AC   CVCL_A600
SY   Gli 6
DR   Cosmic; 1175811
DR   Cosmic; 1217679
DR   Wikidata; Q54835929
RX   PubMed=11153144;
RX   PubMed=14605880;
CC   Characteristics: Early passage culture.
CC   Doubling time: 36 hours (PubMed=14605880).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   GLI-H7
AC   CVCL_JK05
SY   GLIH7; GL1H7; JL-H7
DR   Wikidata; Q54835930
RX   PubMed=1286873;
RX   PubMed=8063404;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 4
//
ID   Gli36
AC   CVCL_RL88
SY   GLI-36
DR   Wikidata; Q54835931
RX   PubMed=20215515;
CC   From: Campagnoni, Anthony T.; University of California, Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex3-10del; Zygosity=Homozygous (PubMed=20215515).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   GliNS2
AC   CVCL_DG67
SY   GLINS2
DR   cancercelllines; CVCL_DG67
DR   GEO; GSM1026860
DR   Progenetix; CVCL_DG67
DR   Wikidata; Q54835932
RX   PubMed=19497285;
RX   PubMed=23468990;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   Glis3-iPSC2
AC   CVCL_E5KG
RX   PubMed=29100368;
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): PubMed=29100368
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 31,33.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5KH ! Glis3-iPSC3
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Glis3-iPSC3
AC   CVCL_E5KH
RX   PubMed=29100368;
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5KG ! Glis3-iPSC2
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GLKVs09
AC   CVCL_C1EY
SY   GLKV s09
DR   Wikidata; Q114311530
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/GLKVs09_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EZ ! GLKVs13
OI   CVCL_C1F0 ! GLKVs16
OI   CVCL_C1F1 ! GLKVs31
OI   CVCL_C1F2 ! Ff-KVs09
OI   CVCL_C1F3 ! Ff-KVs13
OI   CVCL_C1F4 ! Ff-KVs16
OI   CVCL_C1F5 ! Ff-KVs31
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   GLKVs13
AC   CVCL_C1EZ
SY   GLKV s13
DR   Wikidata; Q114311531
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/GLKVs13_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EY ! GLKVs09
OI   CVCL_C1F0 ! GLKVs16
OI   CVCL_C1F1 ! GLKVs31
OI   CVCL_C1F2 ! Ff-KVs09
OI   CVCL_C1F3 ! Ff-KVs13
OI   CVCL_C1F4 ! Ff-KVs16
OI   CVCL_C1F5 ! Ff-KVs31
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   GLKVs16
AC   CVCL_C1F0
SY   GLKV s16
DR   Wikidata; Q114311532
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/GLKVs16_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EY ! GLKVs09
OI   CVCL_C1EZ ! GLKVs13
OI   CVCL_C1F1 ! GLKVs31
OI   CVCL_C1F2 ! Ff-KVs09
OI   CVCL_C1F3 ! Ff-KVs13
OI   CVCL_C1F4 ! Ff-KVs16
OI   CVCL_C1F5 ! Ff-KVs31
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   GLKVs31
AC   CVCL_C1F1
SY   GLKV s31
DR   Wikidata; Q114311534
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/GLKVs31_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EY ! GLKVs09
OI   CVCL_C1EZ ! GLKVs13
OI   CVCL_C1F0 ! GLKVs16
OI   CVCL_C1F2 ! Ff-KVs09
OI   CVCL_C1F3 ! Ff-KVs13
OI   CVCL_C1F4 ! Ff-KVs16
OI   CVCL_C1F5 ! Ff-KVs31
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   GLL-1
AC   CVCL_W996
DR   Wikidata; Q54835933
RX   PubMed=7600027;
CC   Population: Japanese.
CC   Characteristics: Established from a 15th generation xenograft established in nude mice.
CC   Doubling time: ~28 hours (PubMed=7600027).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   GLL-19
AC   CVCL_W181
SY   Gll-19; GLL19
DR   Wikidata; Q54835934
RX   PubMed=2174414;
RX   PubMed=2467885;
RX   PubMed=6746112;
CC   From: Blanquet, Paul & Safi, Nour; Hopital Saint Andre; Bordeaux; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 8
//
ID   GLM-1
AC   CVCL_X019
SY   Gastric Liver Metastasis-1
DR   Wikidata; Q54835935
RX   PubMed=16086234;
CC   Population: Japanese.
CC   Characteristics: Established from a transplantable tumor established in nude mice.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GLM-2
AC   CVCL_X020
SY   Gastric Liver Metastasis-2
DR   Wikidata; Q54835936
RX   PubMed=16086234;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GLM-3
AC   CVCL_X021
SY   Gastric Liver Metastasis-3
DR   Wikidata; Q54835937
RX   PubMed=16086234;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GLNNFi001-A
AC   CVCL_B0PQ
SY   MCD855iclone2
DR   BioSamples; SAMEA9908056
DR   hPSCreg; GLNNFi001-A
DR   Wikidata; Q108820294
RX   PubMed=35472829;
CC   From: GROW Laboratory; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:6938; CHST6; Simple; p.Val172Leu; Zygosity=Homozygous (PubMed=35472829).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34793; Macular corneal dystrophy
DI   ORDO; Orphanet_98969; Macular corneal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   GloFish
AC   CVCL_KB56
DR   Wikidata; Q54835942
RX   PubMed=24357037;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
CC   Breed/subspecies: GloFish; VBO=VBO_0017496.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   glomotel
AC   CVCL_3473
SY   Glomotel
DR   CLO; CLO_0003506
DR   ATCC; CRL-2597
DR   BioSample; SAMN03471686
DR   Wikidata; Q54835944
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ATCC; CRL-2597; true.
CC   Derived from site: In situ; Kidney; Note=From a glomus; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-2597
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 5,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C5350; Hereditary glomangioma
DI   ORDO; Orphanet_83454; Glomuvenous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Glor-BL
AC   CVCL_7196
SY   Glor
DR   Wikidata; Q54835945
RX   PubMed=9882297;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   GloResponse 9XGAL4UAS-luc2P HEK293
AC   CVCL_LB59
DR   Wikidata; Q54835946
WW   Provider; Promega; E5830; https://www.promega.com/products/reporter-assays-and-transfection/reporter-vectors-and-cell-lines/gloresponse-9xgal4uas-luc2p-hek293-cell-line/?catNum=E8530
CC   Characteristics: The luciferase reporter gene is under the control of nine repeats of GAL4 Upstream Activator Sequence (UAS). The luciferase is expressed in response to binding of a fusion protein containing the Gal4 DNA Binding Domain when activated by a ligand.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   GloResponse CRE-luc2P HEK293
AC   CVCL_LB60
DR   Wikidata; Q54835947
WW   Provider; Promega; E5800; https://www.promega.com/products/reporter-assays-and-transfection/reporter-vectors-and-cell-lines/gloresponse-cre-luc2p-hek293-cell-line/?catNum=E8500
CC   Characteristics: The luciferase reporter gene is under the control of a minimal Herpes Simplex Virus thymidine kinase promoter with multiple cAMP response elements (CREs).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   GloResponse NF-kappaB-RE-luc2P HEK293
AC   CVCL_LB61
SY   GloResponse NF-kB-RE-luc2P HEK293; GloResponse NF-KB-RE-luc2P HEK293
DR   Wikidata; Q54835948
WW   Provider; Promega; E5820; https://www.promega.com/products/reporter-assays-and-transfection/reporter-vectors-and-cell-lines/gloresponse-nf-kb-re-luc2p-hek293-cell-line/?catNum=E8520
CC   Characteristics: The luciferase reporter gene is under the control of a minimal TATA promoter with multiple copies of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   GloResponse NFAT-RE-luc2 Jurkat
AC   CVCL_LB63
SY   NFAT-RE-luc2-Jurkat
DR   cancercelllines; CVCL_LB63
DR   Wikidata; Q54835949
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of a minimal TATA promoter with multiple copies of the NFAT response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Promega; Catalog number CS176403.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   GloResponse NFAT-RE-luc2P HEK293
AC   CVCL_LB62
DR   Wikidata; Q54835950
WW   Provider; Promega; E5810; https://www.promega.com/products/reporter-assays-and-transfection/reporter-vectors-and-cell-lines/gloresponse-nfat-re-luc2p-hek293-cell-line/?catNum=E8510
CC   Characteristics: The luciferase reporter gene is under the control of a minimal TATA promoter with multiple copies of the NFAT response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   GLRK 11
AC   CVCL_D2PZ
SY   GL RK/11; GLRK/11; GLRK11; Glaxo Laboratories Rabbit Kidney 11
DR   Wikidata; Q127380870
RX   PubMed=4297026;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   3-6W
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GLRK 3
AC   CVCL_D2PY
SY   GL RK/3; GLRK/3; GLRK3; Glaxo Laboratories Rabbit Kidney 3
DR   Wikidata; Q127380871
RX   PubMed=4297026;
CC   Virology: Susceptible to infection by rubella virus (PubMed=4297026).
CC   Doubling time: ~81 hours (PubMed=4297026).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   3-6W
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GLRK 7
AC   CVCL_A9AT
SY   GL RK/7; GLRK/7; GLRK7; Glaxo Laboratories Rabbit Kidney 7
DR   Wikidata; Q108820293
RX   PubMed=4297026;
RX   PubMed=13881104;
RX   PubMed=13881105;
CC   Virology: Susceptible to infection by rubella virus (PubMed=4297026).
CC   Doubling time: ~120 hours (PubMed=4297026).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   3-6W
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 5
//
ID   GLS-1
AC   CVCL_UA32
DR   Wikidata; Q93562119
RX   PubMed=4350126;
CC   Group: Reptilian cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=36310; ! Gekko gecko (Tokay gecko)
HI   CVCL_4207 ! GL-1 [Gecko]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 02-05-24; Version: 7
//
ID   Glut1(D3638-22)
AC   CVCL_A6YD
SY   D3638-22
DR   RCB; RCB4811
DR   Wikidata; Q107115110
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Glut1(D3643-9)
AC   CVCL_A6YE
SY   D3643-9
DR   RCB; RCB4812
DR   Wikidata; Q107115112
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Glut1(D4402-6)
AC   CVCL_A6YI
SY   D4402-6
DR   RCB; RCB4816
DR   Wikidata; Q107115114
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Glut1(D4404-9)
AC   CVCL_A6YK
SY   D4404-9
DR   RCB; RCB4818
DR   Wikidata; Q107115116
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Glut1(D4416-3)
AC   CVCL_A6YG
SY   D4416-3
DR   RCB; RCB4814
DR   Wikidata; Q107115118
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Glut1(D4417-14)
AC   CVCL_A6YH
SY   D4417-14
DR   RCB; RCB4815
DR   Wikidata; Q107115120
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Glut1(D4418-30)
AC   CVCL_A6YJ
SY   D4418-30
DR   RCB; RCB4817
DR   Wikidata; Q107115122
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Glut1(D4425-2)
AC   CVCL_A6YF
SY   D4425-2
DR   RCB; RCB4813
DR   Wikidata; Q107115126
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   GLUTag
AC   CVCL_J406
DR   Lonza; 1427
DR   Millipore; SCC652
DR   TOKU-E; 3556
DR   Wikidata; Q54835951
RX   PubMed=1491697;
RX   PubMed=29787050;
WW   Info; -; -; https://www.glucagon.com/glutagcells.html
CC   Characteristics: Established from fragments of a colonic tumour which were subcutaneously propagated in nude mice (PubMed=1491697).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: GLUTag-Y transgenic.
ST   Source(s): Millipore=SCC652
ST   Mouse STR 1-1: 10,11
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 10
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12,14
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 15
ST   Mouse STR 11-2: 14
ST   Mouse STR 12-1: 18,19
ST   Mouse STR 13-1: 15
ST   Mouse STR 15-3: 20.3,22.3
ST   Mouse STR 17-2: 13
ST   Mouse STR 18-3: 22
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
DI   NCIt; C22163; Neuroendocrine cell carcinoma of the mouse intestinal tract
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   GLY
AC   CVCL_R733
SY   Gly; HCT-GLY; HCT GLY
DR   cancercelllines; CVCL_R733
DR   IARC_TP53; 6477
DR   Wikidata; Q54835952
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=6578361;
RX   PubMed=7329817;
RX   PubMed=9000147;
RX   PubMed=9000572;
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=9000147).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GM-1
AC   CVCL_C7TS
DR   Wikidata; Q117704344
RX   PubMed=2101929;
CC   Characteristics: Amelanotic. Tumorigenic in nude mice (PubMed=2101929).
CC   Doubling time: ~46 hours (PubMed=2101929).
CC   Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857.
CC   Breed/subspecies: Angora; VBO=VBO_0000723.
DI   NCIt; C198601; Goat melanoma
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_C7TT ! GM-F
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   GM-20
AC   CVCL_F939
SY   MEC-1
DR   Wikidata; Q54835953
RX   PubMed=3053466;
RX   PubMed=8146177;
CC   Doubling time: 21.0 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4772 ! MEB-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 10
//
ID   GM-490
AC   CVCL_F263
SY   GM 490
DR   CLO; CLO_0003507
DR   CLDB; cl1474
DR   Wikidata; Q54835954
RX   CelloPub=CLPUB00042;
RX   PubMed=12357381;
RX   PubMed=16222707;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3167; Acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   GM-70
AC   CVCL_F940
SY   MEC-2
DR   Wikidata; Q54835955
RX   PubMed=3053466;
RX   PubMed=8146177;
CC   Doubling time: 19.8 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4772 ! MEB-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 10
//
ID   GM-89
AC   CVCL_F941
SY   MEC-3
DR   Wikidata; Q54835957
RX   PubMed=3053466;
RX   PubMed=8146177;
CC   Doubling time: 18.0 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4772 ! MEB-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 10
//
ID   GM-95
AC   CVCL_F938
SY   GM95; MEC-4
DR   BTO; BTO_0005962
DR   CLO; CLO_0050760
DR   RCB; RCB1026
DR   Wikidata; Q54835958
RX   PubMed=3053466;
RX   PubMed=8146177;
CC   Characteristics: Has a defect in ceramide glucosyltransferase (Ugcg) (PubMed=8146177).
CC   Doubling time: 30.4 hours (PubMed=3053466); 27 hours (Note=In serum-free medium) (PubMed=8146177).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4772 ! MEB-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 13
//
ID   GM-F
AC   CVCL_C7TT
DR   Wikidata; Q117704345
RX   PubMed=2101929;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Angora; VBO=VBO_0000723.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_C7TS ! GM-1
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   GM-I62M
AC   CVCL_WX28
DR   Wikidata; Q93562199
RX   PubMed=7489718;
RX   PubMed=9312131;
CC   Characteristics: IL3 dependent.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX27 ! LGM-1
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   GM-S3D
AC   CVCL_WX29
DR   Wikidata; Q93562202
RX   PubMed=9312131;
CC   Characteristics: IL3 dependent (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:103038; Stat3 (Note=With p.Glu434Ala and p.Glu435Ala = STAT3D).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX28 ! GM-I62M
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   GM-S3F
AC   CVCL_WX30
DR   Wikidata; Q93562207
RX   PubMed=9312131;
CC   Characteristics: IL3 dependent (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:103038; Stat3 (Note=With p.Tyr705Phe = STAT3F).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX28 ! GM-I62M
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   GM-Y1M
AC   CVCL_WX31
DR   Wikidata; Q93562211
RX   PubMed=7489718;
CC   Characteristics: IL3 dependent (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r (Note=With p.Tyr728Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX27 ! LGM-1
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   GM-Y2M
AC   CVCL_WX32
DR   Wikidata; Q93562214
RX   PubMed=7489718;
CC   Characteristics: IL3 dependent (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r (Note=With p.Tyr753Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX27 ! LGM-1
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   GM-Y3M
AC   CVCL_WX33
DR   Wikidata; Q93562217
RX   PubMed=7489718;
CC   Characteristics: IL3 dependent (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r (Note=With p.Tyr768Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX27 ! LGM-1
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   GM-Y4M
AC   CVCL_WX34
DR   Wikidata; Q93562222
RX   PubMed=7489718;
CC   Characteristics: IL3 dependent (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339755; Csf3r (Note=With p.Tyr788Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX27 ! LGM-1
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   GM/SO
AC   CVCL_6905
SY   GM:SO
DR   Cosmic; 787493
DR   Wikidata; Q54835959
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2198961;
RX   PubMed=9195772;
RX   PubMed=10071072;
RX   PubMed=10576511;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=GM%2FSO
CC   Characteristics: CSF2 dependent.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=2198961; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM00002
AC   CVCL_CX31
SY   GM-2
DR   Coriell; GM00002
DR   Wikidata; Q54835960
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00002; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00003
AC   CVCL_H163
SY   GM-3
DR   CLO; CLO_0025207
DR   Coriell; GM00003
DR   Wikidata; Q54835961
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM00004
AC   CVCL_H555
SY   GM0004; GM-4
DR   CLO; CLO_0025206
DR   Coriell; GM00004
DR   Wikidata; Q54835962
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM00005
AC   CVCL_H556
SY   GM-5; GM005
DR   CLO; CLO_0025205
DR   Coriell; GM00005
DR   Wikidata; Q54835964
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4780772;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XX,der(14;22)(14qter->14q10::22q10->22qter) (Coriell=GM00005).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM00006
AC   CVCL_W146
SY   GM0006; GM-6
DR   CLO; CLO_0025202
DR   Coriell; GM00006
DR   Wikidata; Q54835965
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Pro281Leu (c.842C>T); ClinVar=VCV000000589; Zygosity=Heterozygous (Coriell=GM00006).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg408Gln (c.1223G>A); ClinVar=VCV000000612; Zygosity=Heterozygous (Coriell=GM00006).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM00007
AC   CVCL_Y930
SY   GM0007; GM-7
DR   CLO; CLO_0025201
DR   Coriell; GM00007
DR   Wikidata; Q54835966
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM00008
AC   CVCL_W227
SY   GM0008; GM-8; GM 8; GM8
DR   CLO; CLO_0025200
DR   Coriell; GM00008
DR   Wikidata; Q54835967
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Homozygous (PubMed=9792862).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM00009
AC   CVCL_JD96
SY   GM0009; GM-9; GM 9; GM9
DR   Coriell; GM00009
DR   Wikidata; Q54835968
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00600;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
RX   PubMed=6621576;
CC   Discontinued: Coriell; GM00009; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM00010
AC   CVCL_7266
SY   GM0010; GM-10; GM 10; GM00010A; GM00010B
DR   CLO; CLO_0025199
DR   BioSample; SAMN00794710
DR   Coriell; GM00010
DR   Wikidata; Q54835970
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.1007/BF02431733;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Puerto Rican.
CC   Senescence: Senesces at 31 PDL.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7318 ! GM01380
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM00011
AC   CVCL_7267
SY   GM0011; GM-11; GM 11; GM11; GM00011A
DR   CLO; CLO_0025204
DR   Coriell; GM00011
DR   GEO; GSM909336
DR   GEO; GSM909337
DR   Wikidata; Q54835971
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=694721;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM00013
AC   CVCL_8514
SY   GM-13; GM 13; GM00013A
DR   CLO; CLO_0025203
DR   Coriell; GM00013
DR   Wikidata; Q54835972
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=18691744;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM00014
AC   CVCL_JB70
SY   GM-14
DR   Coriell; GM00014
DR   Wikidata; Q54835973
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00014; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00016
AC   CVCL_0P11
SY   GM0016; GM-16
DR   CLO; CLO_0025194
DR   Coriell; GM00016
DR   GEO; GSM1257721
DR   GEO; GSM1266906
DR   GEO; GSM1267001
DR   GEO; GSM1288413
DR   Wikidata; Q54835974
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   GM00017
AC   CVCL_X222
SY   GM-17; GM-0017; GM0017; GM 17; GM17
DR   CLO; CLO_0025196
DR   Coriell; GM00017
DR   Wikidata; Q54835975
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4780773;
RX   PubMed=6293786;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM00018
AC   CVCL_Y981
SY   GM0018; GM-18; GM 18
DR   CLO; CLO_0025195
DR   Coriell; GM00018
DR   Wikidata; Q54835976
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8530005;
RX   PubMed=9792862;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 14
//
ID   GM00020
AC   CVCL_Y982
SY   GM0020; GM-20
DR   CLO; CLO_0025198
DR   Coriell; GM00020
DR   Wikidata; Q54835977
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   GM00022
AC   CVCL_W228
SY   GM0022; GM-22
DR   CLO; CLO_0025197
DR   Coriell; GM00022
DR   GEO; GSM1257722
DR   GEO; GSM1266907
DR   GEO; GSM1267002
DR   GEO; GSM1288414
DR   Wikidata; Q54835978
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM00023
AC   CVCL_7268
SY   GM0023; GM-23; GM00023A
DR   CLO; CLO_0025190
DR   Coriell; GM00023
DR   Wikidata; Q54835979
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19896956;
RX   PubMed=26184184;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM00024
AC   CVCL_7269
SY   GM0024; GM-24; GM00024A
DR   CLO; CLO_0025189
DR   Coriell; GM00024
DR   Wikidata; Q54835980
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM00025
AC   CVCL_CX21
SY   GM-25
DR   Coriell; GM00025
DR   Wikidata; Q54835982
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00025; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00028
AC   CVCL_0U52
SY   GM-28
DR   CLO; CLO_0025192
DR   Coriell; GM00028
DR   Wikidata; Q54835983
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Lebanese.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C101328; Mitochondrial myopathy
DI   ORDO; Orphanet_206966; Mitochondrial myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM00031
AC   CVCL_W030
SY   GM-31
DR   CLO; CLO_0025193
DR   Coriell; GM00031
DR   GEO; GSM1257680
DR   GEO; GSM1266949
DR   GEO; GSM1267034
DR   GEO; GSM1288415
DR   Wikidata; Q54835985
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   GM00032
AC   CVCL_0P12
SY   GM-32
DR   CLO; CLO_0025183
DR   Coriell; GM00032
DR   Wikidata; Q54835986
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM00033
AC   CVCL_0P13
SY   GM-33
DR   CLO; CLO_0025184
DR   Coriell; GM00033
DR   Wikidata; Q54835991
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM00034
AC   CVCL_V527
SY   GM-34; GM00034B; GM 00034B
DR   CLO; CLO_0025181
DR   Coriell; GM00034
DR   GEO; GSM1266950
DR   Wikidata; Q54835992
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM00035
AC   CVCL_V047
SY   GM-35
DR   CLO; CLO_0025182
DR   Coriell; GM00035
DR   Wikidata; Q54835993
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00036
AC   CVCL_V048
SY   GM-36
DR   CLO; CLO_0025179
DR   Coriell; GM00036
DR   Wikidata; Q54835994
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00037
AC   CVCL_7270
SY   GM0037; GM-37; GM37; GM00037A; GM0037A; GM0037B; GM00037E; GM17071
DR   BTO; BTO_0003592
DR   CLO; CLO_0014602
DR   CLO; CLO_0025180
DR   Coriell; GM00037
DR   Coriell; GM17071
DR   Wikidata; Q54835995
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=198418;
RX   PubMed=694721;
RX   PubMed=9584159;
RX   PubMed=19896956;
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM00038
AC   CVCL_7271
SY   GM0038; GM-38; GM 38; Gm 38; GM38; GM00038A; GM0038A; GM00038B; GM00038C
DR   CLO; CLO_0025187
DR   EFO; EFO_0004921
DR   Coriell; GM00038
DR   GEO; GSM88289
DR   GEO; GSM88290
DR   GEO; GSM88291
DR   GEO; GSM88307
DR   GEO; GSM88308
DR   GEO; GSM88309
DR   GEO; GSM992926
DR   GEO; GSM992927
DR   GEO; GSM3124635
DR   Wikidata; Q54835996
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=656543;
RX   PubMed=2897722;
RX   PubMed=6409440;
RX   PubMed=6843573;
RX   PubMed=7380831;
RX   PubMed=7779715;
RX   PubMed=9650596;
RX   PubMed=12665480;
RX   PubMed=15268757;
RX   PubMed=17668376;
RX   PubMed=19329487;
RX   PubMed=30567591;
CC   Population: African American.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM00039
AC   CVCL_W651
SY   GM-39
DR   CLO; CLO_0025188
DR   Coriell; GM00039
DR   Wikidata; Q54835997
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00041
AC   CVCL_7272
SY   GM0041; GM-41; GM 41; GM41; GM0041A; GM41A; GM00041B
DR   CLO; CLO_0025185
DR   Coriell; GM00041
DR   Wikidata; Q54835998
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2705456;
RX   PubMed=3863481;
RX   PubMed=7380831;
RX   PubMed=17668376;
RX   PubMed=19896956;
CC   Population: Puerto Rican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 20
//
ID   GM00042
AC   CVCL_D340
SY   GM-42
DR   CLO; CLO_0025186
DR   Coriell; GM00042
DR   GEO; GSM1257679
DR   GEO; GSM1266948
DR   GEO; GSM1267033
DR   GEO; GSM1288416
DR   Wikidata; Q54835999
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   GM00043
AC   CVCL_7273
SY   GM0043; GM-43; GM43; GM00043A; GM00043B
DR   CLO; CLO_0025173
DR   Coriell; GM00043
DR   GEO; GSM3124654
DR   Wikidata; Q54836000
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=694721;
RX   PubMed=7779715;
RX   PubMed=19896956;
RX   PubMed=30567591;
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM00044
AC   CVCL_H953
SY   GM-44; GM-0044; GM 0044; GM044; GM 44
DR   CLO; CLO_0025174
DR   Coriell; GM00044
DR   Wikidata; Q54836001
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1132253;
RX   PubMed=6293786;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,der(7)(7qter->7p21.2::10q11.21->10qter),der(10)(10pter->10q11.21::7p22.1->7pter) (Coriell=GM00044).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H954 ! GM00633
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM00045
AC   CVCL_W109
SY   GM-45
DR   CLO; CLO_0025175
DR   Coriell; GM00045
DR   Wikidata; Q54836002
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00046
AC   CVCL_W234
SY   GM0046; GM-46; GM 46; GM46
DR   CLO; CLO_0025169
DR   Coriell; GM00046
DR   Wikidata; Q54836003
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Ile69Argfs*5 (c.206_210delTCCTT); ClinVar=VCV000455787; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Heterozygous (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM00047
AC   CVCL_W652
SY   GM-47
DR   CLO; CLO_0025170
DR   Coriell; GM00047
DR   Wikidata; Q54836004
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00048
AC   CVCL_H952
SY   GM-48
DR   CLO; CLO_0025171
DR   Coriell; GM00048
DR   Wikidata; Q54836005
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H951 ! GM00083
SX   Sex ambiguous
AG   1Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM00054
AC   CVCL_D342
SY   GM-54; GM54; GM0054
DR   CLO; CLO_0025177
DR   BioSample; SAMN00794772
DR   Coriell; GM00054
DR   Wikidata; Q54836006
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=694721;
RX   PubMed=6256643;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Val44Met (c.130G>A); ClinVar=VCV000003611; Zygosity=Heterozygous (from autologous cell line GM02795).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Met142Lys (c.425T>A); ClinVar=VCV000003609; Zygosity=Heterozygous (from autologous cell line GM02795).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F026 ! GM01907
OI   CVCL_F027 ! GM02795
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   GM00056
AC   CVCL_2N22
SY   GM-56; GM00056A; GM0056A
DR   CLO; CLO_0025178
DR   Coriell; GM00056
DR   Wikidata; Q54836007
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00057
AC   CVCL_2N23
SY   GM-57; GM00057A; GM0057A
DR   CLO; CLO_0025161
DR   Coriell; GM00057
DR   Wikidata; Q54836008
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=5101292;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00059
AC   CVCL_0P14
SY   GM-59; GM00059A; CD#59
DR   CLO; CLO_0025162
DR   Coriell; GM00059
DR   Wikidata; Q54836009
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19815695;
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=19815695; PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000126510; Zygosity=Homozygous (Coriell=GM00059).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM00060
AC   CVCL_0P15
SY   GM-60; GM00060A; CD#60
DR   CLO; CLO_0025159
DR   Coriell; GM00060
DR   Wikidata; Q54836010
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=33304759;
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=33304759).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM00064
AC   CVCL_JB79
SY   GM-64
DR   Coriell; GM00064
DR   Wikidata; Q54836011
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Swiss.
CC   Discontinued: Coriell; GM00064; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84526; Acatalasemia
DI   ORDO; Orphanet_926; Acatalasemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00065
AC   CVCL_JB80
SY   GM-65
DR   Coriell; GM00065
DR   Wikidata; Q54836013
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Japanese.
CC   Discontinued: Coriell; GM00065; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84526; Acatalasemia
DI   ORDO; Orphanet_926; Acatalasemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00066
AC   CVCL_JB81
SY   GM-66
DR   Coriell; GM00066
DR   Wikidata; Q54836014
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Japanese.
CC   Discontinued: Coriell; GM00066; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84526; Acatalasemia
DI   ORDO; Orphanet_926; Acatalasemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00068
AC   CVCL_L482
SY   GM-68; GM 68
DR   CLO; CLO_0025160
DR   Coriell; GM00068
DR   Wikidata; Q54836015
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   GM00072
AC   CVCL_V746
SY   GM-72; GM-0072; GM 72
DR   CLO; CLO_0025166
DR   Coriell; GM00072
DR   Wikidata; Q54836016
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=560288;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35528; Wolf-Hirschhorn syndrome
DI   ORDO; Orphanet_280; Wolf-Hirschhorn syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM00073
AC   CVCL_H955
SY   GM-73; GM073; GM0073; GM 0073
DR   CLO; CLO_0025163
DR   Coriell; GM00073
DR   Wikidata; Q54836017
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4796242;
RX   PubMed=6293786;
RX   PubMed=6947233;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;14)(q13;q32) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H956 ! GM10073
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM00074
AC   CVCL_H957
SY   GM-74; GM-0074; GM 74
DR   CLO; CLO_0025164
DR   Coriell; GM00074
DR   Wikidata; Q54836018
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4752868;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H958 ! GM10074
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM00077
AC   CVCL_U380
SY   GM0077; GM-77; GM77
DR   CLO; CLO_0025167
DR   Coriell; GM00077
DR   Wikidata; Q54836019
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=20927602;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Val146Phefs*53 (c.436delG); ClinVar=VCV000371314; Zygosity=Homozygous (Coriell=GM00077).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=20927602
ST   Amelogenin: X,Y
ST   CSF1PO: 8,10
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 8,14
ST   TH01: 6,9.3
ST   TPOX: 8,10
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 19
//
ID   GM00078
AC   CVCL_6B30
SY   GM-78; GM 78
DR   CLO; CLO_0025168
DR   Coriell; GM00078
DR   Wikidata; Q54836020
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=36611;
CC   Discontinued: Coriell; GM00078; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00080
AC   CVCL_9Q85
SY   GM-80
DR   CLO; CLO_0025149
DR   Coriell; GM00080
DR   Wikidata; Q54836021
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Cys528Valfs*19 (c.1581delC) (1744delC); ClinVar=VCV000038414; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM00081
AC   CVCL_9Q86
SY   GM-81
DR   CLO; CLO_0025150
DR   Coriell; GM00081
DR   Wikidata; Q54836022
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Thr284Leufs*5 (c.850delA) (1012delA); ClinVar=VCV000038434; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM00082
AC   CVCL_L495
SY   GM-82; GM82
DR   CLO; CLO_0025151
DR   Coriell; GM00082
DR   JCRB; KURB1026
DR   Wikidata; Q54836023
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=9671271;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   GM00083
AC   CVCL_H951
SY   GM-83
DR   CLO; CLO_0025152
DR   Coriell; GM00083
DR   Wikidata; Q54836024
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H952 ! GM00048
SX   Sex ambiguous
AG   1Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM00084
AC   CVCL_V547
SY   GM-84; GM-0084; GM 84; GM84; GM00084A; Der(22) fibroblast
DR   CLO; CLO_0025153
DR   Coriell; GM00084
DR   Wikidata; Q54836026
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=7329430;
RX   PubMed=7471105;
RX   PubMed=21949351;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+der(22)(22pter->22q11::11q23->11qter)mat (Coriell=GM00084).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 12
ST   FGA: 21,22.2
ST   Penta D: 13
ST   Penta E: 12,15
ST   TH01: 9.3,10
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM00085
AC   CVCL_H950
SY   GM-85; GM-0085; GM 85; GM85
DR   CLO; CLO_0025154
DR   Coriell; GM00085
DR   Wikidata; Q54836027
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=7329430;
RX   PubMed=7471105;
CC   Population: African American.
CC   Karyotypic information: 46,XY,t(13;13)(13qter->13q10::13q10->13qter),+13 (Coriell=GM00085).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2W
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM00087
AC   CVCL_CX24
SY   GM-87
DR   Coriell; GM00087
DR   Wikidata; Q54836028
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Thr284Leufs*5 (c.850delA) (1012delA); ClinVar=VCV000038434; Zygosity=Heterozygous (from familial inference of GM03066).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Cys528Valfs*19 (c.1581delC) (1744delC); ClinVar=VCV000038414; Zygosity=Heterozygous (from familial inference of GM03066).
CC   Discontinued: Coriell; GM00087; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX25 ! GM00521
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   GM00088
AC   CVCL_X224
SY   GM-88; GM-0088; GM0088; GM 88
DR   CLO; CLO_0025156
DR   Coriell; GM00088
DR   Wikidata; Q54836029
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4780774;
RX   PubMed=6661932;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,i(X)(p11.21) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   GM00089
AC   CVCL_F600
SY   GM-89; GM0089; GM089
DR   CLO; CLO_0025157
DR   Coriell; GM00089
DR   Wikidata; Q54836030
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6293786;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;19)(q22;q13.3) (PubMed=10377420).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM00090
AC   CVCL_H959
SY   GM0090; GM-90; GM 90; GM00090A; GM0090A
DR   CLO; CLO_0025158
DR   Coriell; GM00090
DR   Wikidata; Q54836031
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW96 ! GM00093
OI   CVCL_H960 ! GM00304
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   GM00093
AC   CVCL_CW96
SY   GM-93
DR   Coriell; GM00093
DR   Wikidata; Q54836032
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00093; probable.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H959 ! GM00090
OI   CVCL_H960 ! GM00304
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM00097
AC   CVCL_V747
SY   GM-97; GM0097; GM 0097; GM00097A
DR   CLO; CLO_0025819
DR   Coriell; GM00097
DR   Wikidata; Q54836039
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1679663;
RX   PubMed=2498246;
RX   PubMed=4139001;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;1)(q26;q21) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118787; Simpson Golabi Behmel syndrome type 1
DI   ORDO; Orphanet_373; Simpson-Golabi-Behmel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 15
//
ID   GM00098
AC   CVCL_V748
SY   GM-98; GM-0098; GM 98
DR   CLO; CLO_0025820
DR   Coriell; GM00098
DR   Wikidata; Q54836040
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1149496;
RX   PubMed=6661932;
CC   Karyotypic information: 46,XY,der(21)(21qter->21p12::4p11->4pter)mat (Coriell=GM00098).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM00107
AC   CVCL_0P99
SY   GM-107; GM0107; WG0464
DR   CLO; CLO_0025822
DR   Coriell; GM00107
DR   Wikidata; Q54836041
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=29982630;
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Trp162Ter (c.485G>A); ClinVar=VCV000196226; Zygosity=Hemizygous (PubMed=29982630).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM00109
AC   CVCL_4D75
SY   GM-109
DR   CLO; CLO_0025821
DR   Coriell; GM00109
DR   Wikidata; Q54836042
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,r(6) (Coriell=GM00109).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00110
AC   CVCL_W054
SY   GM-110; GM00110A
DR   CLO; CLO_0025824
DR   Coriell; GM00110
DR   Wikidata; Q54836043
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (Coriell=GM00110).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Phe740_Ser741del (c.2217_2222delCTTTTC); Zygosity=Heterozygous (Coriell=GM00110).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM00111
AC   CVCL_1F01
SY   GM-111
DR   CLO; CLO_0025823
DR   Coriell; GM00111
DR   Wikidata; Q54836044
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00112
AC   CVCL_F268
SY   GM-112; GM00112A
DR   CLO; CLO_0003508
DR   CLO; CLO_0025826
DR   CLDB; cl1475
DR   BioSamples; SAME43457
DR   Coriell; GM00112
DR   Wikidata; Q54836045
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Homozygous (PubMed=19815695).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM00113
AC   CVCL_9R60
SY   GM-113; GM00113A
DR   CLO; CLO_0025825
DR   Coriell; GM00113
DR   Wikidata; Q54836046
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Lys4Gln (c.10A>C); ClinVar=VCV000002774; Zygosity=Homozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM00118
AC   CVCL_V749
SY   GM-118; GM-0118; GM 118
DR   CLO; CLO_0025828
DR   Coriell; GM00118
DR   Wikidata; Q54836047
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1225503;
RX   PubMed=6661932;
CC   Population: Caucasian; Danish.
CC   Karyotypic information: 46,XX,der(15)(15qter->15p1::Yq11->Yqter)pat (Coriell=GM00118).
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00119
AC   CVCL_V750
SY   GM-119
DR   CLO; CLO_0025827
DR   Coriell; GM00119
DR   Wikidata; Q54836048
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1132250;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(17;22)(17qter->17p13::22q11->22qter;22pter->22q11::17p13->17pter) (Coriell=GM00119).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00120
AC   CVCL_4J08
SY   GM-120; GM 120
DR   CLO; CLO_0025831
DR   Coriell; GM00120
DR   Wikidata; Q54836049
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4502820;
RX   PubMed=6156493;
RX   PubMed=7803800;
CC   Population: African; Kenyan.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Asn126Asp (c.376A>G) (p.Asn156Asp, c.466A>G); ClinVar=VCV000100055; Zygosity=Heterozygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   GM00121
AC   CVCL_V751
SY   GM-121; GM00121A
DR   CLO; CLO_0025829
DR   Coriell; GM00121
DR   Wikidata; Q54836051
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=817873;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4696; GUSB; Simple; p.Arg357Ter (c.1069C>T); ClinVar=VCV000000908; Zygosity=Heterozygous (Coriell=GM00121).
CC   Sequence variation: Mutation; HGNC; HGNC:4696; GUSB; Simple; p.Trp627Cys (c.1881G>T); ClinVar=VCV000000907; Zygosity=Heterozygous (Coriell=GM00121).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84903; Sly syndrome
DI   ORDO; Orphanet_584; Mucopolysaccharidosis type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM00126
AC   CVCL_V752
SY   GM-126; GM126
DR   CLO; CLO_0025830
DR   Coriell; GM00126
DR   Wikidata; Q54836052
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1132252;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;15)(1qter->1p36.1::15q11.2->15qter;15pter->15q11.2::1p36.1->1pter) (Coriell=GM00126).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM00130
AC   CVCL_7274
SY   GM-130; GM 130; GM130; GM00130B; GM17201
DR   CLO; CLO_0013839
DR   CLO; CLO_0025838
DR   Coriell; GM00130
DR   Coriell; GM17201
DR   GEO; GSM569492
DR   GEO; GSM596265
DR   GEO; GSM596627
DR   GEO; GSM924803
DR   Wikidata; Q54836053
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1702221;
RX   PubMed=14583597;
RX   PubMed=16081512;
RX   PubMed=16244288;
RX   PubMed=16260726;
RX   PubMed=17668376;
RX   PubMed=20164059;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*35:08:01,39:01:01; C*04:01:01,17:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*01:05:01,05:05:01; DQB1*03:01:01,05:01:01; DRB1*10:01:01,11:04:01; DRB3*02:02:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.4243-35delT (4375-36delT); ClinVar=VCV000035885; Zygosity=Heterozygous (Coriell=GM00130).
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM17201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   GM00131
AC   CVCL_7275
SY   GM-131; GM131; GM0131; GM00131A; GM17202
DR   CLO; CLO_0013837
DR   CLO; CLO_0025837
DR   Coriell; GM00131
DR   Coriell; GM17202
DR   GEO; GSM569498
DR   GEO; GSM596266
DR   GEO; GSM596628
DR   GEO; GSM924804
DR   Lonza; 1323
DR   Wikidata; Q54836054
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1702221;
RX   PubMed=14583597;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM00132
AC   CVCL_6B31
SY   GM-132; GM00132A
DR   CLO; CLO_0025835
DR   Coriell; GM00132
DR   Wikidata; Q54836055
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM00133
AC   CVCL_CX52
SY   GM-133
DR   Coriell; GM00133
DR   Wikidata; Q54836056
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00133; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00135
AC   CVCL_R904
SY   GM-135; GM 135; GM135; GM00135A
DR   CLO; CLO_0003509
DR   CLO; CLO_0025832
DR   CLDB; cl1476
DR   Coriell; GM00135
DR   Wikidata; Q54836057
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM00137
AC   CVCL_X225
SY   GM-137; GM-0137; GM 137; GM00137B
DR   CLO; CLO_0025846
DR   Coriell; GM00137
DR   Wikidata; Q54836058
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM00140
AC   CVCL_W653
SY   GM-140
DR   CLO; CLO_0025843
DR   BioSample; SAMN00794838
DR   Coriell; GM00140
DR   Wikidata; Q54836060
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM00142
AC   CVCL_V204
SY   GM-142; GM00142A
DR   CLO; CLO_0025841
DR   BioSample; SAMN00794840
DR   Coriell; GM00142
DR   Wikidata; Q54836061
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM00142).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Coriell=GM00142).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM00143
AC   CVCL_X226
SY   GM-143; GM-0143; GM 143; GM143
DR   CLO; CLO_0025849
DR   Coriell; GM00143
DR   GEO; GSM795
DR   Wikidata; Q54836062
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=694721;
RX   PubMed=6087472;
RX   PubMed=6661932;
RX   PubMed=11687795;
CC   Population: African American.
CC   Karyotypic information: 47,XX,+18 (Coriell=GM00143).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM00144
AC   CVCL_V459
SY   GM-144; GM-0144; GM 144
DR   CLO; CLO_0025850
DR   Coriell; GM00144
DR   GEO; GSM426280
DR   Wikidata; Q54836063
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4139000;
RX   PubMed=6661932;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM00148
AC   CVCL_9Q63
SY   GM-148; GM148; GM 148
DR   Coriell; GM00148
DR   Wikidata; Q54836064
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1766867;
RX   PubMed=2011574;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00148; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM00149
AC   CVCL_H557
SY   GM-149
DR   CLO; CLO_0025851
DR   Coriell; GM00149
DR   Wikidata; Q54836065
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Lys285Asn (c.855G>T); ClinVar=VCV000003621; Zygosity=Heterozygous (Coriell=GM00149).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM00151
AC   CVCL_Y523
SY   GM-151; GM 151
DR   CLO; CLO_0025852
DR   Coriell; GM00151
DR   Wikidata; Q54836066
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=908752;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84903; Sly syndrome
DI   ORDO; Orphanet_584; Mucopolysaccharidosis type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM00152
AC   CVCL_L483
SY   GM-152; GM 152
DR   CLO; CLO_0025862
DR   Coriell; GM00152
DR   Wikidata; Q54836067
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
RX   PubMed=6286839;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   GM00156
AC   CVCL_0L90
SY   GM-156; GM 00156
DR   CLO; CLO_0025860
DR   Coriell; GM00156
DR   Wikidata; Q54836068
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8650226;
RX   PubMed=34411609;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg626Ter (c.1876C>T); ClinVar=VCV000001561; Zygosity=Homozygous (Coriell=GM00156).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM00157
AC   CVCL_V753
SY   GM-157; GM-0157; GM 157
DR   CLO; CLO_0025866
DR   Coriell; GM00157
DR   Wikidata; Q54836069
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1132249;
RX   PubMed=1183238;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 49,XXXXY,t(4;11)(q35;q23).arr(X)x4,(Y)x1 (Coriell=GM00157).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185635; 49,XXXXY syndrome
DI   ORDO; Orphanet_96264; 49,XXXXY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM00158
AC   CVCL_V427
SY   GM-158; GM 158
DR   Coriell; GM00158
DR   Wikidata; Q54836070
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
CC   Discontinued: Coriell; GM00158; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM00159
AC   CVCL_L484
SY   GM-159; GM 159
DR   CLO; CLO_0025863
DR   Coriell; GM00159
DR   Wikidata; Q54836071
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   GM00164
AC   CVCL_CX26
SY   GM-164
DR   Coriell; GM00164
DR   Wikidata; Q54836072
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00164; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00165
AC   CVCL_AX11
SY   GM-165
DR   CLO; CLO_0025855
DR   Coriell; GM00165
DR   Wikidata; Q54836073
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61269; Niemann-Pick disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM00166
AC   CVCL_V754
SY   GM-166
DR   CLO; CLO_0025853
DR   Coriell; GM00166
DR   Wikidata; Q54836074
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1183236;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XY,-9 [28]; 46,XY,r(9) [22] (Coriell=GM00166).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM00172
AC   CVCL_CV48
SY   GM 172
DR   Coriell; GM00172
DR   Wikidata; Q54836075
CC   Discontinued: Coriell; GM00172; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00185
AC   CVCL_JD92
SY   GM-185
DR   Coriell; GM00185
DR   Wikidata; Q54836076
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00185; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00194
AC   CVCL_H961
SY   GM-194; GM0194
DR   CLO; CLO_0025667
DR   Coriell; GM00194
DR   Wikidata; Q54836077
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1225501;
RX   PubMed=2498246;
CC   Population: Caucasian; Finnish.
CC   Karyotypic information: 46,X,t(X;3)(q28;q21) (Coriell=GM00194).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H962 ! GM02899
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM00196
AC   CVCL_6B32
SY   GM-196; GM 196
DR   CLO; CLO_0025668
DR   Coriell; GM00196
DR   Wikidata; Q54836078
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6132606;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00197
AC   CVCL_6B33
SY   GM-197; GM 197
DR   CLO; CLO_0025661
DR   Coriell; GM00197
DR   Wikidata; Q54836079
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=36611;
RX   PubMed=6132606;
RX   PubMed=32950023;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:713; ARSA; Simple; p.Thr393Ser (c.1178C>G) (p.Thr391Ser, c.1172C>G); ClinVar=VCV000021184; Zygosity=Heterozygous (PubMed=32950023).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32950023
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D18S51: 12
ST   D19S433: 15
ST   D21S11: 30.2,31.2
ST   D2S1338: 19,20
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM00200
AC   CVCL_6B34
SY   GM-200
DR   CLO; CLO_0025662
DR   Coriell; GM00200
DR   Wikidata; Q54836080
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=18077418;
CC   Population: Caucasian.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM00201
AC   CVCL_V460
SY   GM-201; GM-0201; GM 201; GM201; GM00201A; GM 0201A
DR   CLO; CLO_0025659
DR   Coriell; GM00201
DR   Wikidata; Q54836088
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   Patent=US5773219;
RX   PubMed=1132251;
RX   PubMed=6293786;
RX   PubMed=6661932;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 15
//
ID   GM00203
AC   CVCL_1Y40
SY   GM-203; GM 203; GM00203A; GM203A
DR   CLO; CLO_0025660
DR   Coriell; GM00203
DR   Wikidata; Q54836089
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=817596;
RX   PubMed=3017984;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00204
AC   CVCL_1Y41
SY   GM-204
DR   CLO; CLO_0025665
DR   Coriell; GM00204
DR   Wikidata; Q54836090
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00212
AC   CVCL_0D82
SY   GM0212; GM-212; WG1802
DR   CLO; CLO_0025666
DR   Coriell; GM00212
DR   Wikidata; Q54836091
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   GM00213
AC   CVCL_V755
SY   GM-213
DR   CLO; CLO_0025663
DR   Coriell; GM00213
DR   Wikidata; Q54836092
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=124242;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(8;12)(8qter->8p23::12p11->12pter;12qter->12p11::8p23->8pter) (Coriell=GM00213).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00214
AC   CVCL_V756
SY   GM-214; GM-0214; GM0214; GM 214
DR   CLO; CLO_0025664
DR   Coriell; GM00214
DR   Wikidata; Q54836094
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=436455;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM00216
AC   CVCL_V757
SY   GM-216
DR   CLO; CLO_0025500
DR   Coriell; GM00216
DR   Wikidata; Q54836095
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1132254;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(10;17)(10pter->10q24::17p13->17pter;17qter->17p13::10q24->10qter) (Coriell=GM00216).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00217
AC   CVCL_V758
SY   GM-217; GM-0217; GM 217
DR   Coriell; GM00217
DR   Wikidata; Q54836096
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1132255;
RX   PubMed=6661932;
CC   Discontinued: Coriell; GM00217; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM00218
AC   CVCL_CX17
SY   GM-218
DR   Coriell; GM00218
DR   Wikidata; Q54836098
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00218; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00220
AC   CVCL_H963
SY   GM-220
DR   CLO; CLO_0025499
DR   Coriell; GM00220
DR   Wikidata; Q54836099
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438975;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM00221
AC   CVCL_U381
SY   GM-221
DR   CLO; CLO_0025508
DR   Coriell; GM00221
DR   Wikidata; Q54836100
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=30220252;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM00221).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=30220252
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 13,15
ST   D21S11: 31.2,33.2
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 20,25
ST   Penta D: 13,15
ST   Penta E: 11,14
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM00222
AC   CVCL_JB94
SY   GM-222
DR   Coriell; GM00222
DR   Wikidata; Q54836101
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00222; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_79354; Ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2D
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00226
AC   CVCL_1F02
SY   GM-226
DR   CLO; CLO_0025507
DR   Coriell; GM00226
DR   Wikidata; Q54836102
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00228
AC   CVCL_W725
SY   GM 00228; GM-228; GM 228; GM228
DR   CLO; CLO_0025506
DR   Coriell; GM00228
DR   Wikidata; Q54836103
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM00229
AC   CVCL_CV37
SY   GM-229; GM00229A
DR   CLO; CLO_0025505
DR   Coriell; GM00229
DR   Wikidata; Q54836104
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34466; Cartilage development disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM00230
AC   CVCL_X227
SY   GM-230; GM-0230; GM 230; GM00230C
DR   CLO; CLO_0025504
DR   Coriell; GM00230
DR   Wikidata; Q54836105
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6087472;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00232
AC   CVCL_Y965
SY   GM-232; GM 232
DR   CLO; CLO_0025503
DR   EFO; EFO_0022555
DR   Coriell; GM00232
DR   LINCS_LDP; LPC-1021
DR   Wikidata; Q54836106
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
RX   PubMed=26190808;
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (Coriell=GM00232).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 19
//
ID   GM00235
AC   CVCL_J103
SY   GM-235; GM235; UM-21; UM 21; University of Michigan lymphoid line no.21; University of Michigan long-term lymphocyte line 21
DR   CLO; CLO_0025502
DR   Coriell; GM00235
DR   Wikidata; Q54836107
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=869901;
RX   PubMed=1180883;
RX   PubMed=4323795;
RX   PubMed=4732110;
RX   PubMed=7174798;
CC   HLA typing: A*09,w31/33; B*w15,12 (Coriell=GM00235).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 15
//
ID   GM00236
AC   CVCL_JD97
SY   GM-236
DR   Coriell; GM00236
DR   Wikidata; Q54836108
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00236; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00241
AC   CVCL_1F03
SY   GM-241; GM241
DR   CLO; CLO_0025490
DR   Coriell; GM00241
DR   Wikidata; Q54836109
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9671271;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00242
AC   CVCL_W229
SY   GM0242
DR   CLO; CLO_0025489
DR   Coriell; GM00242
DR   GEO; GSM1266908
DR   Wikidata; Q54836110
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   GM00243
AC   CVCL_6B35
SY   GM-243; GM 243
DR   CLO; CLO_0025492
DR   Coriell; GM00243
DR   Wikidata; Q54836111
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2864994;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00244
AC   CVCL_M920
SY   GM-244; GM 244; GM244; GM17061
DR   CLO; CLO_0014562
DR   CLO; CLO_0025491
DR   Coriell; GM00244
DR   Coriell; GM17061
DR   Wikidata; Q54836112
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6220706;
RX   PubMed=6401921;
RX   PubMed=11416159;
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Met318Thr (c.953T>C); ClinVar=VCV000004021; Zygosity=Heterozygous (PubMed=1652892; Coriell=GM00244).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Heterozygous (PubMed=1652892; Coriell=GM00244).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 14,16
ST   D21S11: 28,33.2
ST   D8S1179: 13,14
ST   FGA: 24
ST   TH01: 7,9.3
ST   vWA: 19,20
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   GM00245
AC   CVCL_W623
SY   GM-245
DR   CLO; CLO_0025496
DR   Coriell; GM00245
DR   Wikidata; Q54836113
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438975;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM00248
AC   CVCL_1K46
SY   GM-248; GM 248
DR   CLO; CLO_0025495
DR   Coriell; GM00248
DR   Wikidata; Q54836114
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6401921;
RX   PubMed=6418414;
RX   PubMed=33375166;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (Coriell=GM00248).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM00254
AC   CVCL_7276
SY   GM-254; GM 00254; GM 254
DR   CLO; CLO_0025498
DR   Coriell; GM00254
DR   Wikidata; Q54836115
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 47,XXX [48]; 46,XX [2] (Coriell=GM00254).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM00257
AC   CVCL_V759
SY   GM-257
DR   CLO; CLO_0025497
DR   Coriell; GM00257
DR   Wikidata; Q54836116
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1149497;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00260
AC   CVCL_L934
SY   GM-260; GM-0260; GM 260; GM00069
DR   CLO; CLO_0025494
DR   Coriell; GM00069
DR   Coriell; GM00260
DR   Wikidata; Q54836117
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00069; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   GM00264
AC   CVCL_CX16
SY   GM-264
DR   Coriell; GM00264
DR   Wikidata; Q54836118
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00264; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00267
AC   CVCL_2Z45
SY   GM-267
DR   CLO; CLO_0025493
DR   Coriell; GM00267
DR   Wikidata; Q54836119
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00268
AC   CVCL_2Z46
SY   GM-268
DR   CLO; CLO_0025519
DR   Coriell; GM00268
DR   Wikidata; Q54836120
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00269
AC   CVCL_9R17
SY   GM-269
DR   CLO; CLO_0025523
DR   Coriell; GM00269
DR   Wikidata; Q54836121
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM00271
AC   CVCL_V760
SY   GM-271
DR   CLO; CLO_0025522
DR   Coriell; GM00271
DR   Wikidata; Q54836123
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1169138;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00275
AC   CVCL_9W73
SY   GM-275; GM 275; GM275; GM0275A; GM0275B; GM00275D
DR   CLO; CLO_0025521
DR   Coriell; GM00275
DR   Wikidata; Q54836124
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 12
//
ID   GM00282
AC   CVCL_L935
SY   GM-282; GM00061
DR   CLO; CLO_0025520
DR   Coriell; GM00061
DR   Coriell; GM00282
DR   Wikidata; Q54836125
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00061; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128119; Fructose-1,6-bisphosphatase deficiency
DI   ORDO; Orphanet_348; Fructose-1,6-bisphosphatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   GM00283
AC   CVCL_L936
SY   GM-283; GM0283; GM00102; GM0102
DR   CLO; CLO_0025527
DR   Coriell; GM00102
DR   Coriell; GM00283
DR   Wikidata; Q54836127
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00102; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   GM00285
AC   CVCL_4D76
SY   GM-285
DR   CLO; CLO_0025526
DR   Coriell; GM00285
DR   Wikidata; Q54836128
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Karyotypic information: 46,XY,r(13) (Coriell=GM00285).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00286
AC   CVCL_L937
SY   GM-286; GM00058
DR   CLO; CLO_0025525
DR   Coriell; GM00058
DR   Coriell; GM00286
DR   Wikidata; Q54836129
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Val166Gly (c.497T>G) (553T>G); ClinVar=VCV000558415; Zygosity=Heterozygous (Coriell=GM00286).
CC   Discontinued: Coriell; GM00058; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   GM00288
AC   CVCL_L938
SY   GM0288; GM-288; GM 288; GM288; GM00288A; GM0288A; GM00095; GM0095; C288
DR   CLO; CLO_0025524
DR   Coriell; GM00095
DR   Coriell; GM00288
DR   GEO; GSM2794407
DR   Wikidata; Q54836131
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=6220707;
RX   PubMed=7299037;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; GM00095; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   GM00289
AC   CVCL_V761
SY   GM-289
DR   CLO; CLO_0025528
DR   BioSample; SAMN00794930
DR   Coriell; GM00289
DR   GEO; GSM651110
DR   GEO; GSM651111
DR   GEO; GSM1257693
DR   GEO; GSM1266951
DR   GEO; GSM1267035
DR   GEO; GSM1288417
DR   Wikidata; Q54836132
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1192845;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln286Arg (c.857A>G) (Q281R); ClinVar=VCV000000691; Zygosity=Heterozygous (from autologous cell line GM01023).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V791 ! GM01023
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM00290
AC   CVCL_V762
SY   GM-290
DR   CLO; CLO_0025510
DR   BioSample; SAMN00794932
DR   Coriell; GM00290
DR   GEO; GSM651160
DR   GEO; GSM651161
DR   GEO; GSM1257694
DR   GEO; GSM1266952
DR   GEO; GSM1267036
DR   GEO; GSM1288418
DR   Wikidata; Q54836138
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1192845;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln82Ter (c.244C>T) (Q77*); ClinVar=VCV000000685; Zygosity=Heterozygous (from autologous cell line GM01026).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V794 ! GM01026
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM00291
AC   CVCL_V763
SY   GM-291
DR   CLO; CLO_0025509
DR   BioSample; SAMN00794934
DR   Coriell; GM00291
DR   Wikidata; Q54836139
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1192845;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln82Ter (c.244C>T) (Q77*); ClinVar=VCV000000685; Zygosity=Heterozygous (from autologous cell line GM01024).
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln286Arg (c.857A>G) (Q281R); ClinVar=VCV000000691; Zygosity=Heterozygous (from autologous cell line GM01024).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V792 ! GM01024
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM00292
AC   CVCL_V764
SY   GM-292
DR   CLO; CLO_0025512
DR   BioSample; SAMN00794936
DR   Coriell; GM00292
DR   GEO; GSM651112
DR   GEO; GSM651113
DR   GEO; GSM1266953
DR   GEO; GSM1267037
DR   Wikidata; Q54836140
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1192845;
RX   PubMed=21418647;
RX   PubMed=25326100;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln82Ter (c.244C>T) (Q77*); ClinVar=VCV000000685; Zygosity=Heterozygous (from autologous cell line GM01025).
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln286Arg (c.857A>G) (Q281R); ClinVar=VCV000000691; Zygosity=Heterozygous (from autologous cell line GM01025).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V793 ! GM01025
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM00294
AC   CVCL_1Y42
SY   GM-294; GM 294
DR   CLO; CLO_0025511
DR   Coriell; GM00294
DR   Wikidata; Q54836141
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=817596;
RX   PubMed=3017984;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00296
AC   CVCL_W230
SY   GM0296; GM-296
DR   CLO; CLO_0025514
DR   Coriell; GM00296
DR   Wikidata; Q54836142
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM00297
AC   CVCL_W231
SY   GM0297; GM-297
DR   CLO; CLO_0025513
DR   Coriell; GM00297
DR   Wikidata; Q54836143
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM00298
AC   CVCL_W654
SY   GM-298
DR   CLO; CLO_0025516
DR   Coriell; GM00298
DR   Wikidata; Q54836145
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00301
AC   CVCL_B4KX
SY   GM 301
DR   Coriell; GM00301
DR   Wikidata; Q110432813
RX   PubMed=7380831;
CC   Discontinued: Coriell; GM00301; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM00302
AC   CVCL_7277
SY   GM0302; GM-302; GM 302; GM00302A; GM0302A; GM302A; GM 302A; GM00075; GM0075
DR   CLO; CLO_0025515
DR   Coriell; GM00075
DR   Coriell; GM00302
DR   Wikidata; Q54836146
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
RX   PubMed=2445735;
RX   PubMed=2705456;
RX   PubMed=3745952;
CC   Discontinued: Coriell; GM00075; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   GM00303
AC   CVCL_J995
SY   GM-303; GM00055
DR   CLO; CLO_0025518
DR   Coriell; GM00055
DR   Coriell; GM00303
DR   Wikidata; Q54836148
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00055; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM00304
AC   CVCL_H960
SY   GM0304; GM-304; GM 304; GM00091; GM-91
DR   CLO; CLO_0025517
DR   Coriell; GM00091
DR   Coriell; GM00304
DR   Wikidata; Q54836149
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00091; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H959 ! GM00090
OI   CVCL_CW96 ! GM00093
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 16
//
ID   GM00305
AC   CVCL_L939
SY   GM-305; GM 305; GM305; GM00305A; GM0305A; GM00094; GM-94
DR   CLO; CLO_0025548
DR   Coriell; GM00094
DR   Coriell; GM00305
DR   Wikidata; Q54836150
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=6458814;
RX   PubMed=7067035;
RX   PubMed=25928884;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Discontinued: Coriell; GM00094; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   GM00306
AC   CVCL_L941
SY   GM0306; GM-306; GM00051; GM0051
DR   CLO; CLO_0025546
DR   Coriell; GM00051
DR   Coriell; GM00306
DR   Wikidata; Q54836151
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00051; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   GM00312
AC   CVCL_0L91
SY   GM-312
DR   CLO; CLO_0025547
DR   Coriell; GM00312
DR   Wikidata; Q54836152
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM00314
AC   CVCL_X228
SY   GM-314; GM 314; GM0314
DR   CLO; CLO_0025544
DR   Coriell; GM00314
DR   Wikidata; Q54836153
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 45,X [30%]; 46,X,i(X)(p22) [70%] (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 12
//
ID   GM00316
AC   CVCL_7278
SY   GM-316; GM 316; GM316; GM00316A; GM0316A; GM00316B; GM0316B
DR   CLO; CLO_0025545
DR   Coriell; GM00316
DR   GEO; GSM88292
DR   GEO; GSM88293
DR   GEO; GSM88294
DR   GEO; GSM88310
DR   GEO; GSM88311
DR   GEO; GSM88312
DR   GEO; GSM3124640
DR   Wikidata; Q54836154
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
RX   PubMed=2987007;
RX   PubMed=6492896;
RX   PubMed=7301938;
RX   PubMed=12665480;
RX   PubMed=15268757;
RX   PubMed=19896956;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (PubMed=6492896).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; GM00316; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM00317
AC   CVCL_1Y43
SY   GM-317; GM 317; GM00317A
DR   CLO; CLO_0025542
DR   Coriell; GM00317
DR   Wikidata; Q54836155
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=817596;
RX   PubMed=3017984;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00318
AC   CVCL_L958
SY   GM-318; GM00134; GM-134; GM0134
DR   CLO; CLO_0025543
DR   Coriell; GM00134
DR   Coriell; GM00318
DR   Wikidata; Q54836156
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Discontinued: Coriell; GM00134; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   GM00321
AC   CVCL_7279
SY   GM0321; GM-321; GM321; DMPK CTG5; DMPK CTG(5)
DR   CLO; CLO_0025540
DR   Coriell; GM00321
DR   GEO; GSM520734
DR   GEO; GSM520735
DR   GEO; GSM520736
DR   GEO; GSM520737
DR   GEO; GSM520738
DR   GEO; GSM608313
DR   GEO; GSM608314
DR   Wikidata; Q54836157
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=21177337;
CC   Population: Caucasian; Sardinian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM00322
AC   CVCL_JD94
SY   GM0322; GM-322; GM 322
DR   Coriell; GM00322
DR   Wikidata; Q54836159
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
CC   Population: Caucasian; Sardinian.
CC   Discontinued: Coriell; GM00322; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM00323
AC   CVCL_7280
SY   GM0323; GM-323; GM 323; GM323; GM00323A
DR   CLO; CLO_0025541
DR   Coriell; GM00323
DR   GEO; GSM520733
DR   GEO; GSM520734
DR   GEO; GSM520735
DR   GEO; GSM520736
DR   GEO; GSM520737
DR   GEO; GSM608315
DR   GEO; GSM608316
DR   Wikidata; Q54836160
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00454;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=21177337;
CC   Population: Caucasian; Sardinian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM00324
AC   CVCL_4J09
SY   GM-324; GM0324
DR   CLO; CLO_0025539
DR   Coriell; GM00324
DR   Wikidata; Q54836161
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
RX   PubMed=10377420;
CC   Population: Caucasian; Sardinian.
CC   Karyotypic information: 47,XY,t(X;7)(q24;q32) (PubMed=10377420).
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM00325
AC   CVCL_4J10
SY   GM-325
DR   CLO; CLO_0025535
DR   Coriell; GM00325
DR   Wikidata; Q54836162
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian; Sardinian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM00326
AC   CVCL_D341
SY   GM-326; GM-0326; GM-00326; GM 326; GM00326B
DR   CLO; CLO_0025536
DR   Coriell; GM00326
DR   GEO; GSM608317
DR   GEO; GSM608318
DR   Wikidata; Q54836164
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=21177337;
CC   Population: Caucasian; Sardinian.
CC   Karyotypic information: 49,XXXXY (Coriell=GM00326).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185635; 49,XXXXY syndrome
DI   ORDO; Orphanet_96264; 49,XXXXY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   GM00327
AC   CVCL_V765
SY   GM-327; GM327
DR   CLO; CLO_0025537
DR   Coriell; GM00327
DR   Wikidata; Q54836165
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=872631;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(2;8)(2pter->2q13::8q24->8qter;8pter->8q24::2q13->2qter) (Coriell=GM00327).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00333
AC   CVCL_7281
SY   GM-333; GM 333; GM00333C; GM18001
DR   CLO; CLO_0015991
DR   CLO; CLO_0025531
DR   Coriell; GM00333
DR   Coriell; GM18001
DR   Wikidata; Q54836166
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6096450;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM00334
AC   CVCL_W232
SY   GM-334; GM00334A
DR   CLO; CLO_0025532
DR   Coriell; GM00334
DR   Wikidata; Q54836168
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7670469;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4118; GALK1; Simple; p.Val32Met (c.94G>A); ClinVar=VCV000005628; Zygosity=Homozygous (PubMed=7670469).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C114767; Galactokinase deficiency
DI   ORDO; Orphanet_79237; Galactokinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM00335
AC   CVCL_W722
SY   GM-335
DR   CLO; CLO_0025533
DR   Coriell; GM00335
DR   Wikidata; Q54836169
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7670469;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4118; GALK1; Simple; p.Val32Met (c.94G>A); ClinVar=VCV000005628; Zygosity=Heterozygous (PubMed=7670469).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM00336
AC   CVCL_W723
SY   GM-336
DR   CLO; CLO_0025534
DR   Coriell; GM00336
DR   Wikidata; Q54836170
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7670469;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4118; GALK1; Simple; p.Val32Met (c.94G>A); ClinVar=VCV000005628; Zygosity=Heterozygous (PubMed=7670469).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM00337
AC   CVCL_9R18
SY   GM-337
DR   CLO; CLO_0025529
DR   Coriell; GM00337
DR   Wikidata; Q54836171
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM00338
AC   CVCL_1K47
SY   GM-338; GM 338
DR   CLO; CLO_0025530
DR   Coriell; GM00338
DR   Wikidata; Q54836172
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6401921;
RX   PubMed=33375166;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (Coriell=GM00338).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM00339
AC   CVCL_X229
SY   GM-339; GM 339; GM339
DR   CLO; CLO_0025568
DR   Coriell; GM00339
DR   Wikidata; Q54836173
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 45,X [60%]; 46,X,i(X)(p11) [40%] (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C6831; Isodicentric chromosome
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 14
//
ID   GM00342
AC   CVCL_W233
SY   GM0342; GM-342
DR   CLO; CLO_0025562
DR   Coriell; GM00342
DR   Wikidata; Q54836174
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM00343
AC   CVCL_V766
SY   GM-343; GM 343
DR   CLO; CLO_0025563
DR   Coriell; GM00343
DR   Wikidata; Q54836175
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35528; Wolf-Hirschhorn syndrome
DI   ORDO; Orphanet_280; Wolf-Hirschhorn syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM00344
AC   CVCL_V767
SY   GM-344; GM-0344; GM 344; GM344
DR   CLO; CLO_0025560
DR   Coriell; GM00344
DR   Wikidata; Q54836176
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1225499;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XY,der(5)(5qter->5p14::15q11->15qter),t(9;11)(9qter->9p24::11q23->11qter;11pter->11q23::9p24->9pter),-15 (Coriell=GM00344).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00357
AC   CVCL_6B36
SY   GM-357
DR   CLO; CLO_0025565
DR   Coriell; GM00357
DR   Wikidata; Q54836177
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00359
AC   CVCL_1N81
SY   GM-359
DR   CLO; CLO_0025559
DR   Coriell; GM00359
DR   Wikidata; Q54836178
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00361
AC   CVCL_V828
SY   GM-361; GM00966; GM-966
DR   Coriell; GM00361
DR   Coriell; GM00966
DR   Wikidata; Q54836179
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=177249;
CC   Discontinued: Coriell; GM00361; probable.
CC   Discontinued: Coriell; GM00966; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00362
AC   CVCL_Y316
SY   GM-362
DR   CLO; CLO_0025558
DR   Coriell; GM00362
DR   Wikidata; Q54836180
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F199 ! GM03654
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   GM00364
AC   CVCL_2Z42
AS   CVCL_X759
SY   GM-364; GM00364D; AG00364; AG0364; AG-364; AG00364C; AG00364D; AG00364E
DR   CLO; CLO_0025557
DR   CLO; CLO_0036915
DR   Coriell; AG00364
DR   Coriell; GM00364
DR   Wikidata; Q54836181
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=8247227;
RX   PubMed=10408806;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Cys410Tyr (c.1229G>A); ClinVar=VCV000018127; Zygosity=Unspecified (PubMed=10408806).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM00366
AC   CVCL_X230
SY   GM-366; GM-0366; GM 366
DR   CLO; CLO_0025549
DR   Coriell; GM00366
DR   Wikidata; Q54836182
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,rec(3)(qter->p25::q21->qter) (Coriell=GM00366).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00367
AC   CVCL_W055
SY   GM-367; GM 367; GM00367B
DR   CLO; CLO_0025550
DR   Coriell; GM00367
DR   Wikidata; Q54836185
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=865488;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00368
AC   CVCL_W056
SY   GM-368; GM 368; GM0368; GM00368A; C17
DR   CLO; CLO_0025551
DR   Coriell; GM00368
DR   Wikidata; Q54836186
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1214005;
RX   PubMed=2878433;
CC   Population: African American.
CC   Doubling time: 30.7 +- 1.6 hours (PubMed=1214005).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 15
//
ID   GM00369
AC   CVCL_W057
SY   GM-369; C12
DR   CLO; CLO_0025552
DR   Coriell; GM00369
DR   Wikidata; Q54836187
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1214005;
CC   Population: Caucasian.
CC   Doubling time: 30.6 +- 0.8 hours (PubMed=1214005).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   GM00370
AC   CVCL_W058
SY   GM-370
DR   CLO; CLO_0025553
DR   Coriell; GM00370
DR   Wikidata; Q54836188
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00371
AC   CVCL_2N24
SY   GM0371; GM-371
DR   CLO; CLO_0025554
DR   Coriell; GM00371
DR   Wikidata; Q54836189
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00372
AC   CVCL_U478
SY   GM-372; GM372
DR   CLO; CLO_0025555
DR   Coriell; GM00372
DR   Wikidata; Q54836190
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2464926;
RX   PubMed=6593712;
RX   PubMed=30497978;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu29Alafs*18 (c.84dupG) (c.84_85insG) (84GG); ClinVar=VCV000004302; Zygosity=Heterozygous (PubMed=30497978).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=30497978).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM00376
AC   CVCL_L940
SY   GM-376; GM 376; GM0376; GM00099; GM0099
DR   CLO; CLO_0025556
DR   Coriell; GM00099
DR   Coriell; GM00376
DR   Wikidata; Q54836191
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6986448;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00099; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM00377
AC   CVCL_L481
SY   GM-377; GM 377; GM377; GM00377A; GM00029; GM-29; GM 29; GM29; WG0389; WG 389
DR   CLO; CLO_0026289
DR   Coriell; GM00029
DR   Coriell; GM00377
DR   Wikidata; Q54836192
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
RX   PubMed=872438;
CC   Discontinued: Coriell; GM00029; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 17
//
ID   GM00378
AC   CVCL_Y983
SY   GM0378; GM-378
DR   CLO; CLO_0026290
DR   Coriell; GM00378
DR   Wikidata; Q54836193
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Trp138Ter (c.414G>A); ClinVar=VCV000004443; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; c.970+2T>C (IVS11+2T>C); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   GM00379
AC   CVCL_Y984
SY   GM0379; GM-379
DR   CLO; CLO_0026291
DR   Coriell; GM00379
DR   Wikidata; Q54836194
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Trp138Ter (c.414G>A); ClinVar=VCV000004443; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; c.970+2T>C (IVS11+2T>C); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   GM00380
AC   CVCL_V768
SY   GM-380
DR   CLO; CLO_0026293
DR   Coriell; GM00380
DR   Wikidata; Q54836195
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1149495;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;11)(4pter->4q23::11q11->11qter;11pter->11q11::4q23->4qter) (Coriell=GM00380).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V808 ! GM01561
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00390
AC   CVCL_J104
SY   GM-390; GM00390A
DR   CLO; CLO_0026292
DR   Coriell; GM00390
DR   Wikidata; Q54836196
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM00391
AC   CVCL_JD74
SY   GM-391
DR   Coriell; GM00391
DR   Wikidata; Q54836197
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00391; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00392
AC   CVCL_V769
SY   GM-392
DR   CLO; CLO_0026295
DR   Coriell; GM00392
DR   Wikidata; Q54836198
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1058758;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XX,der(13;22)(13qter->13q10::22q10->22qter) (Coriell=GM00392).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00403
AC   CVCL_2N25
SY   GM-403
DR   CLO; CLO_0026294
DR   Coriell; GM00403
DR   Wikidata; Q54836199
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00405
AC   CVCL_2N26
SY   GM-405
DR   CLO; CLO_0026297
DR   Coriell; GM00405
DR   Wikidata; Q54836200
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00406
AC   CVCL_AX12
SY   GM-406
DR   CLO; CLO_0026296
DR   Coriell; GM00406
DR   Wikidata; Q54836201
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM00407
AC   CVCL_V428
SY   GM-407; GM 407
DR   Coriell; GM00407
DR   Wikidata; Q54836202
RX   PubMed=180603;
CC   Discontinued: Coriell; GM00407; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   GM00408
AC   CVCL_U506
SY   GM0408; GM-408; GM00408A; GM0408A; GM00408C
DR   CLO; CLO_0026298
DR   Coriell; GM00408
DR   GEO; GSM1316968
DR   GEO; GSM1317003
DR   Wikidata; Q54836203
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8247227;
RX   PubMed=17668376;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Discontinued: Coriell; GM00408; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   GM00409
AC   CVCL_7282
SY   GM0409; GM-409; GM 409; GM00409A; GM 0409A; GM0409A; C3
DR   CLO; CLO_0026120
DR   Coriell; GM00409
DR   GEO; GSM3124632
DR   Wikidata; Q54836204
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   Patent=US5773219;
RX   PubMed=180603;
RX   PubMed=8643543;
RX   PubMed=19896956;
RX   PubMed=25059784;
RX   PubMed=26247043;
RX   PubMed=26831110;
RX   PubMed=28284873;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM00412
AC   CVCL_4J11
SY   GM-412
DR   CLO; CLO_0026127
DR   Coriell; GM00412
DR   Wikidata; Q54836205
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   GM00413
AC   CVCL_4D77
SY   GM-413
DR   CLO; CLO_0026128
DR   Coriell; GM00413
DR   Wikidata; Q54836206
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Karyotypic information: 46,XY,inv(4)(pter->p14::q2?->p14::q2?->qter)mat (Coriell=GM00413).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00414
AC   CVCL_4D78
SY   GM-414
DR   CLO; CLO_0026125
DR   Coriell; GM00414
DR   Wikidata; Q54836207
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Karyotypic information: 46,XX,inv(4)(pter->p14::q2?->p14::q2?->qter)mat (Coriell=GM00414).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00415
AC   CVCL_V529
SY   GM-415; GM 00415
DR   CLO; CLO_0026126
DR   Coriell; GM00415
DR   Wikidata; Q54836208
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
RX   PubMed=30052969;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00417
AC   CVCL_0P58
SY   GM0417; GM-417
DR   CLO; CLO_0026123
DR   Coriell; GM00417
DR   Wikidata; Q54836209
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM00419
AC   CVCL_X131
SY   GM-419; GM419
DR   Coriell; GM00419
DR   Wikidata; Q54836210
RX   PubMed=694721;
CC   Discontinued: Coriell; GM00419; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   GM00422
AC   CVCL_1Y19
SY   GM-422; GM 422
DR   CLO; CLO_0026124
DR   Coriell; GM00422
DR   Wikidata; Q54836211
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1766867;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM00422).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln344Lys (c.1030C>A); ClinVar=VCV000025320; Zygosity=Heterozygous (Coriell=GM00422).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 17
//
ID   GM00423
AC   CVCL_2G95
SY   GM0423; GM-423
DR   CLO; CLO_0026121
DR   Coriell; GM00423
DR   Wikidata; Q54836212
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00424
AC   CVCL_0D83
SY   GM-424; GM0424A
DR   CLO; CLO_0026122
DR   Coriell; GM00424
DR   Wikidata; Q54836213
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00424; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   GM00425
AC   CVCL_7283
SY   GM 425
DR   CLO; CLO_0003510
DR   CLO; CLO_0026109
DR   CLDB; cl1477
DR   Coriell; GM00425
DR   Wikidata; Q54836214
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Karyotypic information: 47,XY,+8,inv(9)(pter->p11::q21->p11::q21->qter) (Coriell=GM00425).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM00427
AC   CVCL_CX06
SY   GM-427
DR   Coriell; GM00427
DR   Wikidata; Q54836215
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00427; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98964; Isovaleric acidemia
DI   ORDO; Orphanet_33; Isovaleric acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00432
AC   CVCL_CV38
SY   GM-432
DR   CLO; CLO_0026110
DR   Coriell; GM00432
DR   Wikidata; Q54836216
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34650; Gout
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM00433
AC   CVCL_1Y20
SY   GM-433; GM 433
DR   CLO; CLO_0026111
DR   Coriell; GM00433
DR   Wikidata; Q54836217
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1766867;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Ser135Leu (c.404C>T); ClinVar=VCV000003618; Zygosity=Homozygous (Coriell=GM00433).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM00437
AC   CVCL_X071
SY   GM-437; GM-0437; GM 437
DR   CLO; CLO_0026115
DR   Coriell; GM00437
DR   Wikidata; Q54836221
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=7329430;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(13)(qter->q21::p1->q21) (Coriell=GM00437).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00438
AC   CVCL_V770
SY   GM-438
DR   CLO; CLO_0026116
DR   Coriell; GM00438
DR   GEO; GSM1257723
DR   GEO; GSM1267066
DR   GEO; GSM1288419
DR   Wikidata; Q54836222
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=181209;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM00438).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM00439
AC   CVCL_V771
SY   GM-439; GM0439
DR   CLO; CLO_0026117
DR   Coriell; GM00439
DR   GEO; GSM1257724
DR   GEO; GSM1266990
DR   GEO; GSM1267067
DR   GEO; GSM1288420
DR   Wikidata; Q54836223
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=181209;
RX   PubMed=2498246;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM00439).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V795 ! GM01029
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   GM00440
AC   CVCL_V430
SY   GM-440
DR   CLO; CLO_0026118
DR   Coriell; GM00440
DR   GEO; GSM1266991
DR   Wikidata; Q54836224
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=181209;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM00440).
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V431 ! GM01028
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM00441
AC   CVCL_L973
SY   GM-441
DR   CLO; CLO_0026119
DR   Coriell; GM00441
DR   Wikidata; Q54836227
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=181209;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM00441).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L972 ! GM02412
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   GM00442
AC   CVCL_V772
SY   GM-442
DR   CLO; CLO_0026101
DR   Coriell; GM00442
DR   Wikidata; Q54836228
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=181209;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM00443
AC   CVCL_1K48
SY   GM-443; GM 443
DR   CLO; CLO_0026099
DR   Coriell; GM00443
DR   Wikidata; Q54836229
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6401921;
RX   PubMed=6418414;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM00443).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM00444
AC   CVCL_5M48
SY   GM-444
DR   CLO; CLO_0026100
DR   Coriell; GM00444
DR   Wikidata; Q54836230
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85040; Pyruvate carboxylase deficiency
DI   ORDO; Orphanet_3008; Pyruvate carboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM00445
AC   CVCL_X072
SY   GM-445; GM 445
DR   CLO; CLO_0026104
DR   Coriell; GM00445
DR   Wikidata; Q54836231
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(9)(pter->p11::q13->p11::q13->qter) (Coriell=GM00445).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00446
AC   CVCL_JD81
SY   GM-446
DR   Coriell; GM00446
DR   Wikidata; Q54836232
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00446; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00447
AC   CVCL_X073
SY   GM-447; GM 447
DR   CLO; CLO_0026105
DR   Coriell; GM00447
DR   Wikidata; Q54836233
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(9)(pter->p11::q13->p11::q13->qter)pat (Coriell=GM00447).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00448
AC   CVCL_X074
SY   GM-448; GM 448
DR   CLO; CLO_0026102
DR   Coriell; GM00448
DR   Wikidata; Q54836234
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(10)(pter->p11::q21->p11::q21->qter)pat (Coriell=GM00448).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00449
AC   CVCL_F125
SY   GM-449; GM449; GM0449A; GM 0449A; GM00449B
DR   CLO; CLO_0026103
DR   BioSample; SAMN00795078
DR   Coriell; GM00449
DR   Wikidata; Q54836235
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7994019;
RX   PubMed=19815695;
RX   PubMed=22282976;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; c.456+4A>T (IVS4+4A>T); ClinVar=VCV000012045; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM00449).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   GM00450
AC   CVCL_X051
SY   GM-450; GM 450
DR   CLO; CLO_0026107
DR   Coriell; GM00450
DR   Wikidata; Q54836236
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(9)(pter->p13::q13->p13::q13->qter) (Coriell=GM00450).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X052 ! GM00451
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00451
AC   CVCL_X052
SY   GM-451; GM 451
DR   CLO; CLO_0026108
DR   Coriell; GM00451
DR   Wikidata; Q54836237
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(9)(pter->p13::q13->p13::q13->qter) (Coriell=GM00451).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X051 ! GM00450
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00452
AC   CVCL_X053
SY   GM-452; GM 452
DR   CLO; CLO_0026106
DR   Coriell; GM00452
DR   Wikidata; Q54836239
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(10)(pter->p11::q21->p11::q21->qter) (Coriell=GM00452).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00453
AC   CVCL_JD79
SY   GM-453
DR   Coriell; GM00453
DR   Wikidata; Q54836240
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00453; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00463
AC   CVCL_JE15
SY   GM-463
DR   Coriell; GM00463
DR   Wikidata; Q54836241
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00463; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00467
AC   CVCL_J105
SY   GM-467; GM 0467; GM0467; GM00467A
DR   CLO; CLO_0025976
DR   Coriell; GM00467
DR   Wikidata; Q54836242
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6286839;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM00468
AC   CVCL_7284
SY   GM0468; GM-468; GM00468A
DR   CLO; CLO_0025975
DR   Coriell; GM00468
DR   Wikidata; Q54836243
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM00469
AC   CVCL_7285
SY   GM 0469; GM-469; GM 469
DR   CLO; CLO_0003511
DR   CLO; CLO_0025974
DR   CLDB; cl1478
DR   Coriell; GM00469
DR   Wikidata; Q54836244
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1346349;
RX   PubMed=2567118;
RX   PubMed=7380831;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM00470
AC   CVCL_M921
SY   GM-470; GM 470; GM17062
DR   CLO; CLO_0014561
DR   CLO; CLO_0025971
DR   Coriell; GM00470
DR   Coriell; GM17062
DR   Wikidata; Q54836246
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=817596;
RX   PubMed=3017984;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM00471
AC   CVCL_JB68
SY   GM-471
DR   Coriell; GM00471
DR   Wikidata; Q54836247
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00471; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00472
AC   CVCL_7286
SY   GM-472; GM 00472; GM 472
DR   CLO; CLO_0025969
DR   Coriell; GM00472
DR   Wikidata; Q54836248
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6451249;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM00473
AC   CVCL_7287
SY   GM-473
DR   CLO; CLO_0025968
DR   Coriell; GM00473
DR   Wikidata; Q54836249
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GM00474
AC   CVCL_H130
SY   GM-474
DR   CLO; CLO_0025965
DR   Coriell; GM00474
DR   Wikidata; Q54836250
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM00477
AC   CVCL_H131
SY   GM-477; GM 0477
DR   CLO; CLO_0025964
DR   Coriell; GM00477
DR   Wikidata; Q54836251
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM00479
AC   CVCL_V773
SY   GM-479
DR   CLO; CLO_0025958
DR   Coriell; GM00479
DR   Wikidata; Q54836253
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=949908;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XX,der(14;15)(14qter->q10::q10->15qter)pat (Coriell=GM00479).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00480
AC   CVCL_4N03
SY   GM-480
DR   CLO; CLO_0025955
DR   Coriell; GM00480
DR   Wikidata; Q54836254
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00483
AC   CVCL_7288
SY   GM-483; GM 483
DR   CLO; CLO_0003512
DR   CLO; CLO_0025954
DR   CLDB; cl1479
DR   Coriell; GM00483
DR   Wikidata; Q54836255
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6986448;
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys667Tyr (c.2000G>A) (C646Y); ClinVar=VCV000003689; Zygosity=Heterozygous (Coriell=GM00483).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N16 ! GM01460
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GM00486
AC   CVCL_4N04
SY   GM-486; GM00486A; GM00486C
DR   CLO; CLO_0025957
DR   Coriell; GM00486
DR   Wikidata; Q54836256
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N15 ! GM01459
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00488
AC   CVCL_F265
SY   GM-488; GM 488; GM488; GM00488C
DR   CLO; CLO_0003513
DR   CLO; CLO_0025956
DR   CLDB; cl1480
DR   Coriell; GM00488
DR   Wikidata; Q54836257
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6986448;
RX   PubMed=29308438;
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys667Tyr (c.2000G>A) (C646Y); ClinVar=VCV000003689; Zygosity=Homozygous (PubMed=29308438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM00489
AC   CVCL_Y985
SY   GM0489; GM-489; GM 489
DR   CLO; CLO_0025951
DR   Coriell; GM00489
DR   Wikidata; Q54836258
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
RX   PubMed=26247043;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   GM00490
AC   CVCL_F264
SY   GM-490
DR   CLO; CLO_0025950
DR   Coriell; GM00490
DR   Wikidata; Q54836259
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but at risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM00492
AC   CVCL_V420
SY   GM-492
DR   CLO; CLO_0025953
DR   Coriell; GM00492
DR   Wikidata; Q54836260
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00495
AC   CVCL_7289
SY   GM0495; GM-495; GM 495; GM495; GM00495A; GM00104; GM0104
DR   CLO; CLO_0025952
DR   Coriell; GM00104
DR   Coriell; GM00495
DR   GEO; GSM3124680
DR   Wikidata; Q54836261
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=225015;
RX   PubMed=3111682;
RX   PubMed=19896956;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; GM00104; true.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM00496
AC   CVCL_X231
SY   GM-496; GM-0496; GM 496; GM496
DR   CLO; CLO_0025949
DR   Coriell; GM00496
DR   Wikidata; Q54836262
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=694721;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM00497
AC   CVCL_9W74
SY   GM0497; GM-497; GM 497; GM497; GM0497B; GM00497C
DR   CLO; CLO_0025944
DR   Coriell; GM00497
DR   GEO; GSM1316969
DR   GEO; GSM1317004
DR   Wikidata; Q54836263
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=6773986;
RX   PubMed=6782112;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Discontinued: Coriell; GM00497; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM00498
AC   CVCL_7290
SY   GM0498; GM 00498; GM-498; GM 498; GM498; GM00498A; GM0498A; GM00498B; GM498B; GM00498E
DR   CLO; CLO_0025943
DR   Coriell; GM00498
DR   GEO; GSM3124628
DR   SKIP; SKIP003237
DR   Wikidata; Q54836264
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7301938;
RX   PubMed=7380831;
RX   PubMed=19896956;
RX   PubMed=28284873;
RX   PubMed=30497978;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 8,12
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM00499
AC   CVCL_7291
SY   GM0499; GM-499; GM00499A; GM0499A; GM00499B
DR   CLO; CLO_0025948
DR   Coriell; GM00499
DR   GEO; GSM1317005
DR   GEO; GSM3124633
DR   Wikidata; Q54836265
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8247227;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=GM00499).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM00500
AC   CVCL_7292
SY   GM0500; GM 0500; GM-500; GM 500; GM00500B; GM0500B; GM 500B
DR   CLO; CLO_0025947
DR   Coriell; GM00500
DR   GEO; GSM3124637
DR   Wikidata; Q54836266
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1634904;
RX   PubMed=2897722;
RX   PubMed=3860870;
RX   PubMed=19896956;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM00501
AC   CVCL_V774
SY   GM-501; GM-0501; GM 501
DR   CLO; CLO_0025946
DR   Coriell; GM00501
DR   Wikidata; Q54836267
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1017322;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 14
//
ID   GM00502
AC   CVCL_U382
SY   GM-502; GM00502B
DR   CLO; CLO_0025945
DR   Coriell; GM00502
DR   Wikidata; Q54836268
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=25732146;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM00502).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1421+1G>C (IVS12+1G>C); ClinVar=VCV000003890; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM00502).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM00503
AC   CVCL_X232
SY   GM-503; GM 503
DR   CLO; CLO_0025942
DR   Coriell; GM00503
DR   GEO; GSE135500
DR   Wikidata; Q54836269
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=31582743;
CC   Karyotypic information: 47,XY,+13 [8]; 46,XY,arr(1-22)x2,(X,Y)x1 [11] (Coriell=GM00503).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM00504
AC   CVCL_J106
SY   GM-504
DR   CLO; CLO_0025941
DR   Coriell; GM00504
DR   Wikidata; Q54836273
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly542Ter (c.1624G>T); ClinVar=VCV000007115; Zygosity=Heterozygous (Coriell=GM00504).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.His609Arg (c.1826A>G); ClinVar=VCV000053398; Zygosity=Heterozygous (Coriell=GM00504).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM00505
AC   CVCL_JE09
SY   GM-505; GM00505B
DR   Coriell; GM00505
DR   Wikidata; Q54836274
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00505; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM00506
AC   CVCL_JE10
SY   GM-506
DR   Coriell; GM00506
DR   Wikidata; Q54836275
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00506; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00509
AC   CVCL_L952
SY   GM-509; GM-0509; GM 509; GM00509A; GM 509 A; GM00250; GM-250; GM250
DR   CLO; CLO_0025940
DR   Coriell; GM00250
DR   Coriell; GM00509
DR   Wikidata; Q54836277
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1183234;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=7329430;
RX   PubMed=7471105;
CC   Population: African American.
CC   Karyotypic information: 46,XX,del(13)(pter->q14) (Coriell=GM00509).
CC   Discontinued: Coriell; GM00250; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   GM00512
AC   CVCL_1V21
SY   GM-512
DR   CLO; CLO_0025934
DR   Coriell; GM00512
DR   Wikidata; Q54836279
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Indian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00513
AC   CVCL_W541
SY   GM-513; HDF-FOP1
DR   CLO; CLO_0025933
DR   Coriell; GM00513
DR   Wikidata; Q54836280
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24321451;
RX   PubMed=34139597;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=34139597).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM00514
AC   CVCL_U383
SY   GM-514
DR   CLO; CLO_0025936
DR   Coriell; GM00514
DR   Wikidata; Q54836281
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp392Ter (c.1176G>A); ClinVar=VCV000003936; Zygosity=Heterozygous (from familial inference of GM00515).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (from familial inference of GM00515).
CC   Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   GM00515
AC   CVCL_U384
SY   GM-515; GM515; GM00515A
DR   CLO; CLO_0025935
DR   Coriell; GM00515
DR   Wikidata; Q54836282
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3375249;
RX   PubMed=30220252;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp392Ter (c.1176G>A); ClinVar=VCV000003936; Zygosity=Heterozygous (Coriell=GM00515).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM00515).
CC   Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
ST   Source(s): PubMed=30220252
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,14
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 19,25
ST   Penta D: 12
ST   Penta E: 11,13
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 14,15
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   GM00517
AC   CVCL_0R00
SY   GM-517; GM 517
DR   CLO; CLO_0025938
DR   Coriell; GM00517
DR   Wikidata; Q54836283
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6087472;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00519
AC   CVCL_V775
SY   GM-519; GM 519
DR   CLO; CLO_0025937
DR   Coriell; GM00519
DR   GEO; GSM651166
DR   GEO; GSM651167
DR   GEO; GSM1266911
DR   GEO; GSM1267005
DR   Wikidata; Q54836285
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=36611;
RX   PubMed=806052;
RX   PubMed=826372;
RX   PubMed=21418647;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V790 ! GM01022
OI   CVCL_V821 ! GM05358
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM00520
AC   CVCL_V776
SY   GM-520
DR   CLO; CLO_0025930
DR   Coriell; GM00520
DR   GEO; GSM651162
DR   GEO; GSM651163
DR   GEO; GSM1257719
DR   GEO; GSM1266909
DR   GEO; GSM1267003
DR   GEO; GSM1288421
DR   Wikidata; Q54836286
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=826372;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   GM00521
AC   CVCL_CX25
SY   GM-521
DR   Coriell; GM00521
DR   Wikidata; Q54836287
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Thr284Leufs*5 (c.850delA) (1012delA); ClinVar=VCV000038434; Zygosity=Heterozygous (from familial inference of GM03066).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Cys528Valfs*19 (c.1581delC) (1744delC); ClinVar=VCV000038414; Zygosity=Heterozygous (from familial inference of GM03066).
CC   Discontinued: Coriell; GM00521; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX24 ! GM00087
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   GM00525
AC   CVCL_4Z87
SY   GM0525; GM-525
DR   CLO; CLO_0026042
DR   Coriell; GM00525
DR   Wikidata; Q54836290
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   GM00526
AC   CVCL_X075
SY   GM-526; GM-0526; GM 526
DR   CLO; CLO_0026043
DR   Coriell; GM00526
DR   Wikidata; Q54836291
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=7329430;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM00527
AC   CVCL_U385
SY   GM-527
DR   CLO; CLO_0026040
DR   Coriell; GM00527
DR   Wikidata; Q54836292
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp420Cys (c.1260G>C); ClinVar=VCV000003901; Zygosity=Heterozygous (Coriell=GM00527).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1330+1G>A (IVS11+1G>A); ClinVar=VCV000371490; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM00527).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   GM00528
AC   CVCL_1Y21
SY   GM-528
DR   CLO; CLO_0026041
DR   Coriell; GM00528
DR   Wikidata; Q54836293
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM00528).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM00533
AC   CVCL_4Z88
SY   GM0533; GM-533
DR   CLO; CLO_0026038
DR   Coriell; GM00533
DR   Wikidata; Q54836294
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   GM00536
AC   CVCL_7293
SY   GM0536; GM-536; GM 536; GM536; GM17203
DR   BTO; BTO_0005521
DR   CLO; CLO_0013836
DR   CLO; CLO_0026039
DR   Coriell; GM00536
DR   Coriell; GM17203
DR   GEO; GSM569493
DR   GEO; GSM596267
DR   GEO; GSM596629
DR   GEO; GSM924805
DR   Wikidata; Q54836295
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6173245;
RX   PubMed=14583597;
RX   PubMed=16244288;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,26:01:01; B*14:01:01,35:01:01; C*04:01:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,16:01:01; DQA1*01:04:01,02:01:01; DQB1*02:02:01,05:03:01; DRB1*07:01:01,14:54:01; DRB3*02:02:01; DRB4*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   GM00537
AC   CVCL_L485
SY   GM-537; GM 537
DR   CLO; CLO_0026036
DR   Coriell; GM00537
DR   Wikidata; Q54836297
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   GM00538
AC   CVCL_9W75
SY   GM-538
DR   CLO; CLO_0026037
DR   Coriell; GM00538
DR   Wikidata; Q54836299
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00540
AC   CVCL_4Z89
SY   GM0540; GM-540
DR   CLO; CLO_0026045
DR   Coriell; GM00540
DR   Wikidata; Q54836300
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   GM00543
AC   CVCL_JD91
SY   GM-543
DR   Coriell; GM00543
DR   Wikidata; Q54836301
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00543; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00546
AC   CVCL_M922
SY   GM-546; GM17204
DR   CLO; CLO_0013835
DR   Coriell; GM00546
DR   Coriell; GM17204
DR   GEO; GSM569628
DR   GEO; GSM596268
DR   GEO; GSM596630
DR   GEO; GSM924806
DR   Wikidata; Q54836303
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=14583597;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=26621101;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,02:01:01; B*39:06:02,50:01:01; C*06:02:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*02:01:01,05:01:01; DQB1*02:01:01,02:02:01; DRB1*03:01:01,07:01:01; DRB3*02:02:01; DRB4*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: Coriell; GM00546; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM00552
AC   CVCL_CX35
SY   GM-552
DR   Coriell; GM00552
DR   Wikidata; Q54836304
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00552; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00558
AC   CVCL_7294
SY   GM-558; GM 558; GM558; GM00558B; GM17205
DR   CLO; CLO_0013834
DR   CLO; CLO_0026035
DR   Coriell; GM00558
DR   Coriell; GM17205
DR   GEO; GSM569499
DR   GEO; GSM596269
DR   GEO; GSM596631
DR   GEO; GSM924807
DR   Wikidata; Q54836305
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=6096450;
RX   PubMed=6451249;
RX   PubMed=14583597;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03,11; B*w15,w22 (Coriell=GM00558).
CC   HLA typing: A*03:01:01,11:01:01; B*15:01:01,56:01:01; C*01:02:01,03:03:01; DPA1*01:03:01,02:01:01; DPB1*04:01:01,26:01:02; DQA1*01:03:01,02:01:01; DQB1*02:02:01,06:01:01; DRB1*07:01:01,15:02:02; DRB4*01:03:01; DRB5*01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   GM00559
AC   CVCL_AX18
SY   GM-559
DR   CLO; CLO_0026019
DR   Coriell; GM00559
DR   Wikidata; Q54836306
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Phe333Serfs*52 (c.996delC) (P330fs, 990delC); ClinVar=VCV000002990; Zygosity=Heterozygous (Coriell=GM00559).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM00560
AC   CVCL_CX49
SY   GM-560
DR   Coriell; GM00560
DR   Wikidata; Q54836307
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00560; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00561
AC   CVCL_CX50
SY   GM-561
DR   Coriell; GM00561
DR   Wikidata; Q54836308
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00561; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00562
AC   CVCL_X233
SY   GM-562; GM 562
DR   CLO; CLO_0026020
DR   Coriell; GM00562
DR   Wikidata; Q54836309
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 45,X0 [46]; 46,XX [4] (Coriell=GM00562).
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X234 ! GM00563
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00563
AC   CVCL_X234
SY   GM-563; GM 563
DR   CLO; CLO_0026021
DR   Coriell; GM00563
DR   Wikidata; Q54836310
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 45,X0 (Coriell=GM00563).
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X233 ! GM00562
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00568
AC   CVCL_X446
SY   GM-568
DR   CLO; CLO_0026022
DR   Coriell; GM00568
DR   Wikidata; Q54836311
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1904874;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:318; AGA; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000809707; Zygosity=Heterozygous (PubMed=1904874).
CC   Sequence variation: Mutation; HGNC; HGNC:318; AGA; Simple; p.Cys163Ser (c.488G>C); ClinVar=VCV000000219; Zygosity=Heterozygous (PubMed=1904874).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61273; Aspartylglycosaminuria
DI   ORDO; Orphanet_93; Aspartylglucosaminuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   GM00572
AC   CVCL_1K49
SY   GM-572; GM 0572; GM572
DR   CLO; CLO_0026015
DR   Coriell; GM00572
DR   Wikidata; Q54836312
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220706;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84737; Glycogen storage disease type IV
DI   ORDO; Orphanet_367; Glycogen storage disease due to glycogen branching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00573
AC   CVCL_1F04
SY   GM-573
DR   CLO; CLO_0026016
DR   Coriell; GM00573
DR   Wikidata; Q54836313
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00574
AC   CVCL_V389
SY   GM-574
DR   CLO; CLO_0026017
DR   Coriell; GM00574
DR   Wikidata; Q54836314
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7814621;
RX   PubMed=33329388;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gly222Arg (c.666G>C) (G743C); Zygosity=Heterozygous (PubMed=7814621).
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Heterozygous (PubMed=7814621).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   GM00575
AC   CVCL_1N13
SY   GM-575
DR   CLO; CLO_0026018
DR   Coriell; GM00575
DR   Wikidata; Q54836315
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00576
AC   CVCL_M923
SY   GM-576; GM17011
DR   CLO; CLO_0018025
DR   CLO; CLO_0026023
DR   Coriell; GM00576
DR   Coriell; GM17011
DR   Wikidata; Q54836318
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM00577
AC   CVCL_1K50
SY   GM-577
DR   CLO; CLO_0026014
DR   Coriell; GM00577
DR   Wikidata; Q54836319
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00578
AC   CVCL_1F05
SY   GM-578
DR   CLO; CLO_0026013
DR   Coriell; GM00578
DR   Wikidata; Q54836320
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00579
AC   CVCL_CX19
SY   GM-579
DR   CLO; CLO_0025996
DR   Coriell; GM00579
DR   Wikidata; Q54836321
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126875; Glycogen storage disease type VI
DI   ORDO; Orphanet_369; Glycogen storage disease due to liver glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM00583
AC   CVCL_5M49
SY   GM-583
DR   CLO; CLO_0025997
DR   Coriell; GM00583
DR   Wikidata; Q54836322
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C103968; Pyruvate dehydrogenase deficiency
DI   ORDO; Orphanet_765; Pyruvate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM00584
AC   CVCL_2G96
SY   GM0584; GM-584
DR   CLO; CLO_0025994
DR   Coriell; GM00584
DR   Wikidata; Q54836323
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*02,03; B*07,18 (Coriell=GM00584).
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Arg224His (c.676G>A); Zygosity=Unspecified (from familial inference of GM01559).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2H24 ! GM01560
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM00585
AC   CVCL_2G97
SY   GM0585; GM-585
DR   CLO; CLO_0025995
DR   Coriell; GM00585
DR   Wikidata; Q54836324
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*03,15; B*15,27 (Coriell=GM00585).
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Arg224His (c.676G>A); Zygosity=Heterozygous (from autologous cell line GM01559).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2H23 ! GM01559
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM00589
AC   CVCL_V777
SY   GM-589; GM589
DR   CLO; CLO_0026000
DR   Coriell; GM00589
DR   Wikidata; Q54836325
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=872630;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(5;14)(5qter->5p14::14q21->14qter;14pter->14q21::5p14->5pter) (Coriell=GM00589).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM00593
AC   CVCL_9W76
SY   GM-593
DR   CLO; CLO_0026001
DR   Coriell; GM00593
DR   Wikidata; Q54836326
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8910459;
CC   Population: Mexican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84901; Mucopolysaccharidosis type IVA
DI   ORDO; Orphanet_309297; Mucopolysaccharidosis type 4A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00594
AC   CVCL_0P59
SY   GM0594; GM-594
DR   CLO; CLO_0025998
DR   Coriell; GM00594
DR   Wikidata; Q54836327
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM00595
AC   CVCL_AW72
SY   GM0595; GM-595
DR   CLO; CLO_0025999
DR   Coriell; GM00595
DR   Wikidata; Q54836328
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM00596
AC   CVCL_AW73
SY   GM0596; GM-596
DR   CLO; CLO_0028998
DR   Coriell; GM00596
DR   Wikidata; Q54836330
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM00599
AC   CVCL_AA10
SY   GM-599; GM00599A
DR   CLO; CLO_0029001
DR   Coriell; GM00599
DR   Wikidata; Q54836331
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00600
AC   CVCL_AA11
SY   GM-600
DR   CLO; CLO_0029000
DR   Coriell; GM00600
DR   Wikidata; Q54836332
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00601
AC   CVCL_AA12
SY   GM-601
DR   CLO; CLO_0029017
DR   Coriell; GM00601
DR   Wikidata; Q54836333
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00602
AC   CVCL_AA13
SY   GM-602; GM00602A
DR   CLO; CLO_0029019
DR   Coriell; GM00602
DR   Wikidata; Q54836334
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM00603
AC   CVCL_AA14
SY   GM-603
DR   CLO; CLO_0029023
DR   Coriell; GM00603
DR   Wikidata; Q54836335
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00604
AC   CVCL_H133
SY   GM-604
DR   CLO; CLO_0029024
DR   Coriell; GM00604
DR   Wikidata; Q54836336
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C28397; Asthma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   GM00605
AC   CVCL_X062
SY   GM-605; GM-0605; GM 605
DR   Coriell; GM00605
DR   Wikidata; Q54836337
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6451249;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00605; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00606
AC   CVCL_IP63
SY   GM-606; GM0606; GM606
DR   Coriell; GM00606
DR   Wikidata; Q54836338
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8316623;
RX   PubMed=8823375;
RX   PubMed=9447232;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00606; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 10
//
ID   GM00607
AC   CVCL_7295
SY   GM-607; GM607; GM00607B; GM17206
DR   CLO; CLO_0013833
DR   CLO; CLO_0029006
DR   Coriell; GM00607
DR   Coriell; GM17206
DR   GEO; GSM569508
DR   GEO; GSM596270
DR   GEO; GSM596740
DR   GEO; GSM924808
DR   Wikidata; Q54836339
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,03:01:01; B*07:02:01,18:01:01; C*07:01:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02G,04:02:01G; DQA1*01:02:01,01:03:01; DQB1*06:02:01,06:03:01; DRB1*13:01:01,15:01:01; DRB3*01:01:02; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM00608
AC   CVCL_H132
SY   GM-608
DR   CLO; CLO_0029008
DR   Coriell; GM00608
DR   Wikidata; Q54836340
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 13
//
ID   GM00609
AC   CVCL_GR91
SY   GM-609
DR   CLO; CLO_0029010
DR   Coriell; GM00609
DR   Wikidata; Q54836341
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM00610
AC   CVCL_V778
SY   GM-610
DR   CLO; CLO_0028972
DR   Coriell; GM00610
DR   Wikidata; Q54836342
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1225500;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(6;18)(6pter->6q21::18p11->18pter;18qter->18p11::6q21->6qter) (Coriell=GM00610).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M3W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00612
AC   CVCL_AD58
SY   GM0612; GM-612
DR   CLO; CLO_0028969
DR   Coriell; GM00612
DR   Wikidata; Q54836343
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2698; DBT; Simple; p.Cys26Trpfs*2 (c.75_76delAT); ClinVar=VCV000011950; Zygosity=Heterozygous (Coriell=GM00612).
CC   Sequence variation: Mutation; HGNC; HGNC:2698; DBT; Simple; p.Glu224Ter (c.670G>T) (E163X); ClinVar=VCV000094009; Zygosity=Heterozygous (Coriell=GM00612).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   GM00613
AC   CVCL_4D18
SY   GM-613
DR   CLO; CLO_0028968
DR   Coriell; GM00613
DR   Wikidata; Q54836344
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00614
AC   CVCL_W655
SY   GM-614
DR   CLO; CLO_0028967
DR   Coriell; GM00614
DR   Wikidata; Q54836345
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00615
AC   CVCL_W656
SY   GM-615; GM00615B
DR   CLO; CLO_0028992
DR   Coriell; GM00615
DR   Wikidata; Q54836346
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=34990619;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00620
AC   CVCL_AB42
SY   GM-620
DR   CLO; CLO_0028994
DR   Coriell; GM00620
DR   Wikidata; Q54836347
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM00621
AC   CVCL_7296
SY   GM-621; GM 621; GM00621C; GM17207
DR   CLO; CLO_0013881
DR   CLO; CLO_0028987
DR   Coriell; GM00621
DR   Coriell; GM17207
DR   GEO; GSM569505
DR   GEO; GSM596271
DR   GEO; GSM596632
DR   GEO; GSM924809
DR   Wikidata; Q54836348
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=6096450;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,68:01:02; B*35:01:01,44:03:01; C*04:01:01,14:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02G,04:02:01G; DQA1*01:01:01,02:01:01; DQB1*02:02:01,05:01:01; DRB1*01:01:01,07:01:01; DRB4*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM00622
AC   CVCL_5M64
SY   GM-622
DR   CLO; CLO_0028991
DR   Coriell; GM00622
DR   Wikidata; Q54836349
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM00623
AC   CVCL_JB78
SY   GM-623
DR   Coriell; GM00623
DR   Wikidata; Q54836350
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00623; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00624
AC   CVCL_V779
SY   GM-624
DR   CLO; CLO_0028981
DR   Coriell; GM00624
DR   Wikidata; Q54836351
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1183237;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;15)(4pter->4q11::15p11->15pter;15qter->15p11::4q11->4qter) (Coriell=GM00624).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00625
AC   CVCL_2G98
SY   GM0625; GM-625
DR   CLO; CLO_0028984
DR   Coriell; GM00625
DR   Wikidata; Q54836352
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00627
AC   CVCL_M978
SY   GM-627; GM17151
DR   CLO; CLO_0013957
DR   CLO; CLO_0028869
DR   Coriell; GM00627
DR   Coriell; GM17151
DR   GEO; GSM924661
DR   Wikidata; Q54836353
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1225502;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Karyotypic information: 46,XX,t(13;22)(13pter->13q22::22q13->22qter;22pter->22q13::13q22->13qter) (Coriell=GM00627).
CC   Omics: Genomics; DNA methylation analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM00629
AC   CVCL_0L92
SY   GM-629
DR   CLO; CLO_0028870
DR   Coriell; GM00629
DR   Wikidata; Q54836354
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Ser66Trp (c.197C>G); ClinVar=VCV000005111; Zygosity=Heterozygous (Coriell=GM00629).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM00630
AC   CVCL_JC75
SY   GM-630
DR   Coriell; GM00630
DR   Wikidata; Q54836355
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00630; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99041; Renal agenesis
DI   ORDO; Orphanet_411709; Renal agenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00632
AC   CVCL_AV85
SY   GM-632; GM0632
DR   CLO; CLO_0028871
DR   Coriell; GM00632
DR   Wikidata; Q54836356
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2837086;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98944; Hereditary orotic aciduria
DI   ORDO; Orphanet_30; Hereditary orotic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM00633
AC   CVCL_H954
SY   GM-633
DR   CLO; CLO_0028872
DR   Coriell; GM00633
DR   Wikidata; Q54836357
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H953 ! GM00044
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM00636
AC   CVCL_H162
SY   GM-636
DR   CLO; CLO_0028873
DR   Coriell; GM00636
DR   Wikidata; Q54836358
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; c.1187delAAG; Zygosity=Hemizygous (Coriell=GM00636).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM00637
AC   CVCL_7297
SY   GM-637; GM 637; GM637; GM0637; GM637A; GM637-SV; GM00637B; GM00637F; GM00637H; GM00637I; HG2855
DR   BTO; BTO_0003591
DR   CLO; CLO_0003514
DR   CLO; CLO_0028881
DR   CLDB; cl1481
DR   Coriell; GM00637
DR   IPD-IMGT/HLA; 10615
DR   TOKU-E; 4106
DR   Wikidata; Q54836363
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00712;
RX   DOI=10.2307/1308677;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=198418;
RX   PubMed=2011574;
RX   PubMed=2762303;
RX   PubMed=2821020;
RX   PubMed=2903889;
RX   PubMed=3023120;
RX   PubMed=3180052;
RX   PubMed=6256643;
RX   PubMed=7273335;
RX   PubMed=8069455;
RX   PubMed=8464385;
RX   PubMed=8808599;
RX   PubMed=9650596;
RX   PubMed=10521302;
RX   PubMed=11172010;
RX   PubMed=12060391;
RX   PubMed=12361951;
RX   PubMed=14662655;
RX   PubMed=16081512;
RX   PubMed=16520097;
RX   PubMed=16714754;
RX   PubMed=18433479;
RX   PubMed=18470933;
RX   PubMed=18955168;
RX   PubMed=19935656;
CC   Population: Puerto Rican.
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   HLA typing: A*02:01:01:01,26:01:01; C*15:02:01,16:01:01 (IPD-IMGT/HLA=10615).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7270 ! GM00037
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 31
//
ID   GM00638
AC   CVCL_7298
SY   GM-638; GM0638; GM 638; GM638; GM00638A; GM54VA
DR   CLO; CLO_0003515
DR   CLO; CLO_0028878
DR   CLDB; cl1482
DR   Coriell; GM00638
DR   Wikidata; Q54836364
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=189310;
RX   PubMed=191830;
RX   PubMed=1766867;
RX   PubMed=2463881;
RX   PubMed=6256643;
RX   PubMed=12361951;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Val44Met (c.130G>A); ClinVar=VCV000003611; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Met142Lys (c.425T>A); ClinVar=VCV000003609; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D342 ! GM00054
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   GM00639
AC   CVCL_7299
SY   GM-639; GM0639; GM 639; GM639; GM52VA
DR   CLO; CLO_0003516
DR   CLDB; cl1483
DR   Coriell; GM00639
DR   Wikidata; Q54836366
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=191830;
RX   PubMed=1766867;
RX   PubMed=2011574;
RX   PubMed=2762303;
RX   PubMed=3413074;
RX   PubMed=9175740;
RX   PubMed=10606667;
RX   PubMed=11416159;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Ser135Leu (c.404C>T); ClinVar=VCV000003618; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Phe171Ser (c.512T>C); ClinVar=VCV000003616; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Coriell; GM00639; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 14,16
ST   D21S11: 30,31
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 9.3
ST   vWA: 15,17
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2779 ! CHP 4 (W.W.)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   GM00640
AC   CVCL_6B38
SY   GM-640
DR   CLO; CLO_0028883
DR   Coriell; GM00640
DR   Wikidata; Q54836367
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00641
AC   CVCL_CX55
SY   GM-641
DR   Coriell; GM00641
DR   Wikidata; Q54836368
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00641; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00643
AC   CVCL_0L93
SY   GM-643
DR   CLO; CLO_0028882
DR   Coriell; GM00643
DR   Wikidata; Q54836369
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Val361Serfs*52 (c.1080delC) (1091delC); ClinVar=VCV000518268; Zygosity=Heterozygous (Coriell=GM00643).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM00644
AC   CVCL_CX56
SY   GM-644
DR   Coriell; GM00644
DR   Wikidata; Q54836370
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00644; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00645
AC   CVCL_JB61
SY   GM-645
DR   Coriell; GM00645
DR   Wikidata; Q54836372
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00645; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00646
AC   CVCL_6B23
SY   GM-646; C25
DR   CLO; CLO_0028885
DR   Coriell; GM00646
DR   Wikidata; Q54836373
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1214005;
CC   Population: Caucasian.
CC   Doubling time: 30.9 +- 1.2 hours (PubMed=1214005).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   GM00647
AC   CVCL_1L40
SY   GM-647; GM00647A
DR   CLO; CLO_0028849
DR   Coriell; GM00647
DR   Wikidata; Q54836374
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00648
AC   CVCL_K091
SY   GM-648; GM648; GM00648B
DR   CLO; CLO_0028850
DR   Coriell; GM00648
DR   Wikidata; Q54836375
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM00649
AC   CVCL_AD59
SY   GM0649; GM-649; GM649; GM00649A
DR   CLO; CLO_0028853
DR   Coriell; GM00649
DR   Wikidata; Q54836376
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8037208;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Gly288Valfs*11 (c.861_868delAGGCCCCG); ClinVar=VCV000198433; Zygosity=Heterozygous (PubMed=8037208).
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Tyr438Asn (c.1312T>A) (Y393N); ClinVar=VCV000100009; Zygosity=Heterozygous (PubMed=8037208).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   GM00650
AC   CVCL_AD60
SY   GM0650; GM-650; GM650
DR   CLO; CLO_0028854
DR   Coriell; GM00650
DR   Wikidata; Q54836377
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8037208;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Tyr438Asn (c.1312T>A) (Y393N); ClinVar=VCV000100009; Zygosity=Heterozygous (PubMed=8037208).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM00651
AC   CVCL_AD61
SY   GM0651; GM-651; GM651
DR   CLO; CLO_0028851
DR   Coriell; GM00651
DR   Wikidata; Q54836378
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8037208;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Gly288Valfs*11 (c.861_868delAGGCCCCG); ClinVar=VCV000198433; Zygosity=Heterozygous (PubMed=8037208).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM00654
AC   CVCL_AB43
SY   GM-654
DR   CLO; CLO_0028852
DR   Coriell; GM00654
DR   Wikidata; Q54836379
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:6826; MAN2B1; Simple; p.Gln639Ter (c.1915C>T); ClinVar=VCV000001686; Zygosity=Heterozygous (Coriell=GM00654).
CC   Sequence variation: Mutation; HGNC; HGNC:6826; MAN2B1; Simple; p.Arg750Trp (c.2248C>T); ClinVar=VCV000001687; Zygosity=Heterozygous (Coriell=GM00654).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84548; Alpha-mannosidosis
DI   ORDO; Orphanet_61; Alpha-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM00657
AC   CVCL_V780
SY   GM-657; GM-0657; GM 657
DR   CLO; CLO_0028863
DR   Coriell; GM00657
DR   Wikidata; Q54836380
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477406;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM00667
AC   CVCL_DN44
SY   GM-667
DR   CLO; CLO_0028861
DR   Coriell; GM00667
DR   Wikidata; Q54836381
RX   CelloPub=CLPUB00447;
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18640; LDLRAP1; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV000004775; Zygosity=Homozygous (Coriell=GM00667).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128114; Hypercholesterolemia, familial, 4
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM00668
AC   CVCL_JB83
SY   GM-668
DR   Coriell; GM00668
DR   Wikidata; Q54836382
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00668; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00681
AC   CVCL_X132
SY   GM681
DR   Coriell; GM00681
DR   Wikidata; Q54836387
RX   PubMed=694721;
CC   Discontinued: Coriell; GM00681; probable.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   GM00682
AC   CVCL_X133
DR   CLO; CLO_0028921
DR   Coriell; GM00682
DR   Wikidata; Q54836388
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Karyotypic information: 46,XX [32]; 47,XX,+15 [18] (Coriell=GM00682).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00683
AC   CVCL_CX20
SY   GM-683
DR   Coriell; GM00683
DR   Wikidata; Q54836389
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00683; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM00690
AC   CVCL_W657
SY   GM-690
DR   CLO; CLO_0028910
DR   Coriell; GM00690
DR   Wikidata; Q54836390
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM00692
AC   CVCL_X235
SY   GM-692; GM-0692; GM 692
DR   CLO; CLO_0028912
DR   Coriell; GM00692
DR   Wikidata; Q54836391
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 14
//
ID   GM00693
AC   CVCL_V461
SY   GM-693
DR   CLO; CLO_0028913
DR   Coriell; GM00693
DR   Wikidata; Q54836392
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;21)(2pter->2q37::21q21->21qter;21pter->21q21::2q37->2qter) (Coriell=GM00693).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00694
AC   CVCL_DN45
SY   GM-694
DR   CLO; CLO_0028914
DR   Coriell; GM00694
DR   Wikidata; Q54836393
RX   CelloPub=CLPUB00447;
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18640; LDLRAP1; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV000004775; Zygosity=Homozygous (Coriell=GM00694).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128114; Hypercholesterolemia, familial, 4
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM00695
AC   CVCL_CX57
SY   GM-695; GM00695A
DR   CLO; CLO_0028937
DR   Coriell; GM00695
DR   Wikidata; Q54836394
RX   CelloPub=CLPUB00447;
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18640; LDLRAP1; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV000004775; Zygosity=Heterozygous (Coriell=GM00695).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM00696
AC   CVCL_DN46
SY   GM-696
DR   CLO; CLO_0028936
DR   Coriell; GM00696
DR   Wikidata; Q54836395
RX   CelloPub=CLPUB00447;
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18640; LDLRAP1; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV000004775; Zygosity=Homozygous (Coriell=GM00696).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128114; Hypercholesterolemia, familial, 4
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM00697
AC   CVCL_DN47
SY   GM-697
DR   CLO; CLO_0028938
DR   Coriell; GM00697
DR   Wikidata; Q54836396
RX   CelloPub=CLPUB00447;
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18640; LDLRAP1; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV000004775; Zygosity=Homozygous (Coriell=GM00697).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128114; Hypercholesterolemia, familial, 4
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM00700
AC   CVCL_4N05
SY   GM-700; GM 700 GM00700A
DR   CLO; CLO_0028895
DR   Coriell; GM00700
DR   Wikidata; Q54836397
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6986448;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys681Ter (c.2043C>A) (C660X); ClinVar=VCV000003699; Zygosity=Heterozygous (from familial inference of GM00701).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   GM00701
AC   CVCL_4N06
SY   GM-701; GM 701 GM00701B; GM00701C
DR   CLO; CLO_0028896
DR   Coriell; GM00701
DR   Wikidata; Q54836398
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6986448;
RX   PubMed=29308438;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys681Ter (c.2043C>A) (C660X); ClinVar=VCV000003699; Zygosity=Homozygous (PubMed=29308438).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM00705
AC   CVCL_0P86
SY   GM-705; GM0705; GM00705A; GM0705A; GMO 705; AnLy
DR   CLO; CLO_0028893
DR   Coriell; GM00705
DR   Wikidata; Q54836399
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=113895;
RX   PubMed=559490;
RX   PubMed=1056018;
RX   PubMed=2338345;
RX   PubMed=8268921;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;9)(q13.1;p24) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   GM00706
AC   CVCL_W235
SY   GM0706; GM-706; GM 706; GM706
DR   CLO; CLO_0028894
DR   Coriell; GM00706
DR   Wikidata; Q54836400
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Homozygous (PubMed=9792862).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM00711
AC   CVCL_0P82
SY   GM-711; AG00711; AG-711; AG 711; AG0711
DR   CLO; CLO_0028889
DR   Coriell; AG00711
DR   Coriell; GM00711
DR   Wikidata; Q54836403
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM00711).
CC   Discontinued: Coriell; AG00711; probable.
CC   Derived from site: In situ; Cartilage; UBERON=UBERON_0002418.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P83 ! GM00712
OI   CVCL_0P84 ! GM00713
OI   CVCL_0P85 ! GM00714
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM00712
AC   CVCL_0P83
SY   GM-712; AG00712; AG-712; AG 712; AG0712
DR   CLO; CLO_0028890
DR   Coriell; AG00712
DR   Coriell; GM00712
DR   Wikidata; Q54836404
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM00712).
CC   Discontinued: Coriell; AG00712; probable.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast of spleen; CL=CL_2000051.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P82 ! GM00711
OI   CVCL_0P84 ! GM00713
OI   CVCL_0P85 ! GM00714
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM00713
AC   CVCL_0P84
SY   GM-713; AG00713; AG-713; AG 713; AG0713
DR   CLO; CLO_0028907
DR   Coriell; AG00713
DR   Coriell; GM00713
DR   Wikidata; Q54836409
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM00713).
CC   Discontinued: Coriell; AG00713; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P82 ! GM00711
OI   CVCL_0P83 ! GM00712
OI   CVCL_0P85 ! GM00714
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM00714
AC   CVCL_0P85
SY   GM-714; AG00714; AG-714; AG 714; AG0714
DR   CLO; CLO_0028906
DR   Coriell; AG00714
DR   Coriell; GM00714
DR   Wikidata; Q54836410
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM00714).
CC   Discontinued: Coriell; AG00714; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P82 ! GM00711
OI   CVCL_0P83 ! GM00712
OI   CVCL_0P84 ! GM00713
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM00718
AC   CVCL_H135
SY   GM-718; GM00718A
DR   CLO; CLO_0028798
DR   Coriell; GM00718
DR   Wikidata; Q54836412
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM00719
AC   CVCL_7300
SY   GM-719; GM719; GM00719A
DR   CLO; CLO_0028797
DR   EFO; EFO_0004922
DR   Coriell; GM00719
DR   Wikidata; Q54836413
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=2805228;
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM00720
AC   CVCL_2G99
SY   GM0720; GM-720
DR   CLO; CLO_0028796
DR   Coriell; GM00720
DR   Wikidata; Q54836414
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00721
AC   CVCL_L953
SY   GM0721; GM-721; GM00547; GM0547
DR   CLO; CLO_0028795
DR   Coriell; GM00547
DR   Coriell; GM00721
DR   Wikidata; Q54836415
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00547; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   GM00722
AC   CVCL_L954
SY   GM0722; GM-722; GM00548; GM0548
DR   CLO; CLO_0028794
DR   Coriell; GM00548
DR   Coriell; GM00722
DR   Wikidata; Q54836416
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00548; true.
CC   Discontinued: Coriell; GM00722; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   GM00724
AC   CVCL_2H00
SY   GM0724; GM-724
DR   CLO; CLO_0028793
DR   Coriell; GM00724
DR   Wikidata; Q54836417
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00725
AC   CVCL_L955
SY   GM0725; GM-725
DR   CLO; CLO_0028792
DR   Coriell; GM00725
DR   Wikidata; Q54836418
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   GM00726
AC   CVCL_M979
SY   GM0726; GM-726; GM726; GM00726A; GM0726A; GM17081
DR   CLO; CLO_0014483
DR   CLO; CLO_0028791
DR   Coriell; GM00726
DR   Coriell; GM17081
DR   GEO; GSM3124683
DR   Wikidata; Q54836419
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=7301938;
RX   PubMed=19896956;
RX   PubMed=30567591;
CC   Part of: Human variation panel.
CC   Population: Korean.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM00727
AC   CVCL_1Y22
SY   GM-727; GM00727A
DR   CLO; CLO_0028783
DR   Coriell; GM00727
DR   Wikidata; Q54836420
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM00727).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM00729
AC   CVCL_V548
SY   GM-729; GM 729; GM729
DR   CLO; CLO_0028810
DR   Coriell; GM00729
DR   Wikidata; Q54836421
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7329430;
RX   PubMed=7471105;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00730
AC   CVCL_L944
SY   GM0730; GM-730; GM 730; GM730; GM 00730; GM00730A; GM0730A; GM00238; GM0238
DR   CLO; CLO_0028809
DR   Coriell; GM00238
DR   Coriell; GM00730
DR   GEO; GSM1316970
DR   GEO; GSM1317006
DR   Wikidata; Q54836422
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2897722;
RX   PubMed=2903889;
RX   PubMed=2973075;
RX   PubMed=3180052;
RX   PubMed=6220707;
RX   PubMed=6307543;
RX   PubMed=6442144;
RX   PubMed=6600729;
RX   PubMed=6843573;
RX   PubMed=7067035;
RX   PubMed=11219864;
RX   PubMed=18079351;
RX   PubMed=19896956;
RX   PubMed=26984941;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Discontinued: Coriell; GM00238; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 21
//
ID   GM00731
AC   CVCL_7301
SY   GM0731; GM 0731; GM-731; GM 731; GM00731A; GM0731A; GM 0731A
DR   CLO; CLO_0028816
DR   Coriell; GM00731
DR   Wikidata; Q54836423
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3860870;
RX   PubMed=15450399;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM00732
AC   CVCL_GS52
SY   GM-732
DR   CLO; CLO_0028815
DR   Coriell; GM00732
DR   Wikidata; Q54836424
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3501; Peripheral sensory neuropathy
DI   ORDO; Orphanet_98496; Rare peripheral neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM00733
AC   CVCL_AM61
SY   GM-733
DR   CLO; CLO_0028818
DR   Coriell; GM00733
DR   Wikidata; Q54836425
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM00734
AC   CVCL_X236
SY   GM-734; GM 734
DR   CLO; CLO_0028817
DR   Coriell; GM00734
DR   Wikidata; Q54836427
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Karyotypic information: 47,XX,+18 (Coriell=GM00734).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM00735
AC   CVCL_X076
SY   GM-735; GM-0735; GM 735; GM0735
DR   CLO; CLO_0028812
DR   Coriell; GM00735
DR   Wikidata; Q54836428
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,i(X)(p11) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C6831; Isodicentric chromosome
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM00736
AC   CVCL_J107
SY   GM-736
DR   CLO; CLO_0028811
DR   Coriell; GM00736
DR   Wikidata; Q54836429
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM00737
AC   CVCL_0L94
SY   GM-737
DR   CLO; CLO_0028814
DR   Coriell; GM00737
DR   Wikidata; Q54836431
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Tyr140Cys (c.419A>G); ClinVar=VCV000371634; Zygosity=Heterozygous (Coriell=GM00737).
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Leu682Arg (c.2045T>G); ClinVar=VCV001323323; Zygosity=Heterozygous (Coriell=GM00737).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM00738
AC   CVCL_4J12
SY   GM-738
DR   CLO; CLO_0028813
DR   Coriell; GM00738
DR   Wikidata; Q54836432
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00740
AC   CVCL_9W77
SY   GM-740
DR   CLO; CLO_0028820
DR   Coriell; GM00740
DR   Wikidata; Q54836434
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00741
AC   CVCL_CX36
SY   GM-741
DR   Coriell; GM00741
DR   Wikidata; Q54836435
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00741; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128116; Neuronal ceroid lipofuscinosis type 4B
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   GM00743
AC   CVCL_BW98
SY   GM-743; GM0743
DR   CLO; CLO_0028819
DR   Coriell; GM00743
DR   Wikidata; Q54836436
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2001457;
RX   PubMed=3840329;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8896; PGK1; Simple; p.Leu88Pro (c.263T>C); ClinVar=VCV000009946; Zygosity=Hemizygous; Note=PGK-Matsue (PubMed=2001457).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126738; Phosphoglycerate kinase 1 deficiency
DI   ORDO; Orphanet_713; Glycogen storage disease due to phosphoglycerate kinase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM00744
AC   CVCL_DD65
SY   GM-744; IMR-744
DR   CLO; CLO_0028825
DR   Coriell; GM00744
DR   Wikidata; Q54836437
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6689020;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM00747
AC   CVCL_CX01
SY   GM0747; GM-747
DR   CLO; CLO_0028824
DR   Coriell; GM00747
DR   Wikidata; Q54836438
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM00751
AC   CVCL_2H01
SY   GM0751; GM-751
DR   CLO; CLO_0028823
DR   Coriell; GM00751
DR   Wikidata; Q54836439
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Ile278Thr (c.833T>C); ClinVar=VCV000000120; Zygosity=Unspecified (from familial inference of GM01808).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM00752
AC   CVCL_2H02
SY   GM0752; GM-752
DR   CLO; CLO_0028822
DR   Coriell; GM00752
DR   Wikidata; Q54836440
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Ile278Thr (c.833T>C); ClinVar=VCV000000120; Zygosity=Unspecified (from familial inference of GM01808).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM00753
AC   CVCL_2H03
SY   GM-753; GM0753A; GM00753C
DR   CLO; CLO_0028828
DR   Coriell; GM00753
DR   Wikidata; Q54836441
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*02,10; B*12,27 (Coriell=GM00753).
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Ile278Thr (c.833T>C); ClinVar=VCV000000120; Zygosity=Heterozygous (from autologous cell line GM01808).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2H25 ! GM01808
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM00754
AC   CVCL_CX51
SY   GM-754
DR   Coriell; GM00754
DR   Wikidata; Q54836442
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00754; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   GM00757
AC   CVCL_JA42
SY   GM-757; GM0757
DR   Coriell; GM00757
DR   Wikidata; Q54836443
RX   CelloPub=CLPUB00387;
CC   Discontinued: Coriell; GM00757; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00758
AC   CVCL_JA43
SY   GM-758; GM0758
DR   Coriell; GM00758
DR   Wikidata; Q54836444
RX   CelloPub=CLPUB00387;
CC   Discontinued: Coriell; GM00758; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C133088; Canine globoid cell leukodystrophy
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00760
AC   CVCL_W236
SY   GM0760; GM-760; GM 760; GM760
DR   CLO; CLO_0028827
DR   Coriell; GM00760
DR   Wikidata; Q54836447
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Trp138Ter (c.414G>A); ClinVar=VCV000004443; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Heterozygous (PubMed=28649545).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM00768
AC   CVCL_H138
SY   GM-768
DR   CLO; CLO_0028826
DR   Coriell; GM00768
DR   Wikidata; Q54836448
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg347Pro (c.1040G>C); ClinVar=VCV000007110; Zygosity=Heterozygous (Coriell=GM00768).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM00768).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H137 ! GM00897
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   GM00770
AC   CVCL_V205
SY   GM-770; GM00770A
DR   CLO; CLO_0028840
DR   Coriell; GM00770
DR   Wikidata; Q54836449
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM00770).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM00773
AC   CVCL_V781
SY   GM-773
DR   CLO; CLO_0028839
DR   Coriell; GM00773
DR   Wikidata; Q54836450
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=891261;
CC   Karyotypic information: 46,XX,t(4;7)(4qter->4p16::7q34->7qter;7pter->7q34::4p16->4pter) (Coriell=GM00773).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00775
AC   CVCL_JD82
SY   GM-775; GM00775A
DR   Coriell; GM00775
DR   Wikidata; Q54836451
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00775; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00781
AC   CVCL_J108
SY   GM-781
DR   CLO; CLO_0028842
DR   Coriell; GM00781
DR   Wikidata; Q54836452
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM00782
AC   CVCL_4E27
SY   GM-782
DR   CLO; CLO_0028841
DR   Coriell; GM00782
DR   Wikidata; Q54836455
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM00783
AC   CVCL_W542
SY   GM-783; HDF-FOP2
DR   CLO; CLO_0028844
DR   Coriell; GM00783
DR   Wikidata; Q54836456
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24321451;
CC   Population: African American.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM00798
AC   CVCL_V528
SY   GM-798; GM 00798
DR   CLO; CLO_0028843
DR   Coriell; GM00798
DR   Wikidata; Q54836457
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Homozygous (Coriell=GM00798).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM00799
AC   CVCL_1V09
SY   GM-799
DR   CLO; CLO_0028846
DR   Coriell; GM00799
DR   Wikidata; Q54836458
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (from familial inference of GM00798).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 9
//
ID   GM00800
AC   CVCL_1V10
SY   GM-800
DR   CLO; CLO_0028845
DR   Coriell; GM00800
DR   Wikidata; Q54836459
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (from familial inference of GM00798).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 9
//
ID   GM00801
AC   CVCL_1B69
SY   GM-801; GM 801; GM801
DR   CLO; CLO_0028848
DR   Coriell; GM00801
DR   Wikidata; Q54836460
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4074382;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00802
AC   CVCL_1B70
SY   GM-802; GM 802; GM802
DR   CLO; CLO_0028847
DR   Coriell; GM00802
DR   Wikidata; Q54836461
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4074382;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM00803
AC   CVCL_X077
SY   GM-803; GM 803
DR   CLO; CLO_0029645
DR   Coriell; GM00803
DR   Wikidata; Q54836462
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM00804
AC   CVCL_H175
SY   GM-804
DR   CLO; CLO_0029644
DR   Coriell; GM00804
DR   Wikidata; Q54836463
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM00805
AC   CVCL_JD85
SY   GM-805
DR   Coriell; GM00805
DR   Wikidata; Q54836464
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00805; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00806
AC   CVCL_CX43
SY   GM-806; GM 806
DR   Coriell; GM00806
DR   Wikidata; Q54836465
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8910459;
CC   Discontinued: Coriell; GM00806; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IJ33 ! GM04305
SX   Female
AG   2Y6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM00811
AC   CVCL_U702
SY   GM-811; GM0811; GM811; GM 811; GM00811B
DR   CLO; CLO_0029646
DR   Coriell; GM00811
DR   GEO; GSM1317007
DR   Wikidata; Q54836466
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=436333;
RX   PubMed=908169;
RX   PubMed=2878433;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (Coriell=GM00811).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 3(HoCo) (BSR3).
CC   Discontinued: Coriell; GM00811; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U705 ! GM02932
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 20
//
ID   GM00813
AC   CVCL_2H04
SY   GM0813; GM-813
DR   CLO; CLO_0029647
DR   Coriell; GM00813
DR   Wikidata; Q54836467
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00843
AC   CVCL_4E23
SY   GM-843
DR   CLO; CLO_0029648
DR   Coriell; GM00843
DR   Wikidata; Q54836468
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85062; Sea-blue histiocyte syndrome
DI   ORDO; Orphanet_158029; Sea-blue histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00844
AC   CVCL_4E24
SY   GM-844
DR   CLO; CLO_0029649
DR   Coriell; GM00844
DR   Wikidata; Q54836469
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85062; Sea-blue histiocyte syndrome
DI   ORDO; Orphanet_158029; Sea-blue histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00845
AC   CVCL_V782
SY   GM-845
DR   CLO; CLO_0029652
DR   Coriell; GM00845
DR   Wikidata; Q54836470
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=648194;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;8)(2pter->2q37::8q13->8qter;8pter->8q13::2q37->2qter)mat (Coriell=GM00845).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00846
AC   CVCL_V783
SY   GM-846
DR   CLO; CLO_0029653
DR   Coriell; GM00846
DR   Wikidata; Q54836471
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=565692;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;8)(2pter->2q37::8q13->8qter;8pter->8q13::2q37->2qter) (Coriell=GM00846).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00847
AC   CVCL_7908
SY   LN-SV; LNSV; GM-847; GM 847; GM847
DR   CLO; CLO_0029655
DR   EFO; EFO_0022519
DR   Coriell; GM00847
DR   Wikidata; Q54836472
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00712;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=174085;
RX   PubMed=191830;
RX   PubMed=1260760;
RX   PubMed=3413074;
RX   PubMed=9175740;
RX   PubMed=11359895;
RX   PubMed=12361951;
RX   PubMed=19935656;
RX   PubMed=26001292;
CC   Population: African American.
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F127 ! GM02063
SX   Male
AG   5Y6M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 24
//
ID   GM00850
AC   CVCL_7302
SY   GM-850; GM 850; GM00850A
DR   CLO; CLO_0029657
DR   Coriell; GM00850
DR   GEO; GSM3592403
DR   GEO; GSM3592409
DR   Wikidata; Q54836473
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
RX   PubMed=30905397;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30905397).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM00851
AC   CVCL_JB84
SY   GM-851
DR   Coriell; GM00851
DR   Wikidata; Q54836474
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00851; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00852
AC   CVCL_8515
SY   GM-852
DR   CLO; CLO_0029631
DR   Coriell; GM00852
DR   Wikidata; Q54836475
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6593712;
RX   PubMed=18691744;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu29Alafs*18 (c.84dupG) (c.84_85insG) (84GG); ClinVar=VCV000004302; Zygosity=Heterozygous (PubMed=19815695).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=19815695).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   GM00853
AC   CVCL_CX47
SY   GM-853
DR   Coriell; GM00853
DR   Wikidata; Q54836476
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00853; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00854
AC   CVCL_CX48
SY   GM-854
DR   Coriell; GM00854
DR   Wikidata; Q54836477
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00854; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00855
AC   CVCL_CX42
SY   GM-855
DR   Coriell; GM00855
DR   Wikidata; Q54836478
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00855; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00857
AC   CVCL_X237
SY   GM-857; GM 857; GM00857A; TS3 fibroblast
DR   CLO; CLO_0029630
DR   Coriell; GM00857
DR   Wikidata; Q54836480
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=21949351;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   GM00860
AC   CVCL_X238
SY   GM-860; GM 860
DR   CLO; CLO_0029629
DR   Coriell; GM00860
DR   Wikidata; Q54836481
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM00860; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM00861
AC   CVCL_4D79
SY   GM-861
DR   CLO; CLO_0029634
DR   Coriell; GM00861
DR   Wikidata; Q54836482
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,ins(5;1)(5pter->5q15::1q25->1q32::5q15->5qter;1pter->1q25::1q32->1qter) (Coriell=GM00861).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM00862
AC   CVCL_4D19
SY   GM-862
DR   CLO; CLO_0029635
DR   Coriell; GM00862
DR   Wikidata; Q54836484
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Puerto Rican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00863
AC   CVCL_7303
SY   GM-863; GM 0863
DR   CLO; CLO_0003517
DR   CLO; CLO_0029632
DR   CLDB; cl1484
DR   Coriell; GM00863
DR   Wikidata; Q54836485
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6782865;
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Thr97Arg (c.290C>G); Zygosity=Heterozygous (Coriell=GM00863).
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Gly118Asp (c.353G>A); Zygosity=Heterozygous (Coriell=GM00863).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GM00864
AC   CVCL_2H05
SY   GM0864; GM-864
DR   CLO; CLO_0029633
DR   Coriell; GM00864
DR   Wikidata; Q54836486
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00865
AC   CVCL_7304
SY   GM0865; GM-865
DR   CLO; CLO_0029637
DR   Coriell; GM00865
DR   Wikidata; Q54836487
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM00866
AC   CVCL_2H06
SY   GM0866; GM-866
DR   CLO; CLO_0029638
DR   Coriell; GM00866
DR   Wikidata; Q54836488
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00867
AC   CVCL_2H07
SY   GM0867; GM-867
DR   CLO; CLO_0029636
DR   Coriell; GM00867
DR   Wikidata; Q54836489
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM00868
AC   CVCL_JD86
SY   GM-868
DR   Coriell; GM00868
DR   Wikidata; Q54836491
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00868; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   26Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM00869
AC   CVCL_JC76
SY   GM-869
DR   Coriell; GM00869
DR   Wikidata; Q54836492
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00869; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99041; Renal agenesis
DI   ORDO; Orphanet_411709; Renal agenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00870
AC   CVCL_V784
SY   GM-870; GM-0870; GM 870
DR   CLO; CLO_0029601
DR   Coriell; GM00870
DR   Wikidata; Q54836493
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1017321;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 13
//
ID   GM00876
AC   CVCL_AW74
SY   GM0876; GM-876; GM00876A
DR   CLO; CLO_0029600
DR   Coriell; GM00876
DR   Wikidata; Q54836495
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM00877
AC   CVCL_0R27
SY   GM-877; GM877
DR   CLO; CLO_0029603
DR   Coriell; GM00877
DR   Wikidata; Q54836496
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2464926;
RX   PubMed=6593712;
RX   PubMed=30497978;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=30497978).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Ala495Pro (c.1483G>C) (A456P); ClinVar=VCV000093450; Zygosity=Heterozygous (PubMed=30497978).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Val499Val (c.1497G>C) (V460V); ClinVar=VCV000093451; Zygosity=Heterozygous (PubMed=30497978).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   GM00878
AC   CVCL_0R28
SY   GM-878
DR   CLO; CLO_0029602
DR   Coriell; GM00878
DR   Wikidata; Q54836497
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (Coriell=GM00878).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   GM00879
AC   CVCL_0L95
SY   GM-879
DR   CLO; CLO_0029618
DR   Coriell; GM00879
DR   Wikidata; Q54836498
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Arg245His (c.734G>A); ClinVar=VCV000005107; Zygosity=Heterozygous (Coriell=GM00879).
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Glu447Lys (c.1339G>A); ClinVar=VCV000005114; Zygosity=Heterozygous (Coriell=GM00879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM00880
AC   CVCL_CX02
SY   GM0880; GM-880
DR   CLO; CLO_0029620
DR   Coriell; GM00880
DR   Wikidata; Q54836502
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM00881
AC   CVCL_7305
SY   GM-881
DR   CLO; CLO_0003518
DR   CLO; CLO_0029624
DR   CLDB; cl1485
DR   Coriell; GM00881
DR   Wikidata; Q54836504
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=29982630;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000167140; Zygosity=Hemizygous (PubMed=29982630).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GM00882
AC   CVCL_0Q46
SY   GM-882
DR   CLO; CLO_0029628
DR   Coriell; GM00882
DR   Wikidata; Q54836506
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=29982630;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg301Gly (c.901C>G); ClinVar=VCV000179546; Zygosity=Hemizygous (PubMed=29982630).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM00883
AC   CVCL_2H08
SY   GM0883; GM-883
DR   CLO; CLO_0029610
DR   Coriell; GM00883
DR   Wikidata; Q54836507
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00885
AC   CVCL_2H09
SY   GM0885; GM-885
DR   CLO; CLO_0029611
DR   Coriell; GM00885
DR   Wikidata; Q54836508
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Ile278Thr (c.833T>C); ClinVar=VCV000000120; Zygosity=Heterozygous (from familial inference of GM01808).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM00886
AC   CVCL_0L96
SY   GM-886
DR   CLO; CLO_0029585
DR   Coriell; GM00886
DR   Wikidata; Q54836509
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM00887
AC   CVCL_V530
SY   GM-887; GM 00887
DR   CLO; CLO_0029583
DR   Coriell; GM00887
DR   Wikidata; Q54836510
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00888
AC   CVCL_CX18
SY   GM-888
DR   Coriell; GM00888
DR   Wikidata; Q54836511
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00888; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00891
AC   CVCL_JE19
SY   GM-891
DR   Coriell; GM00891
DR   Wikidata; Q54836513
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00891; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00892
AC   CVCL_H136
AS   CVCL_H692
SY   GM-892; GM-0892; GM 892; GM0892; GM892; GM00892A; GM892A; GM00892B
DR   CLO; CLO_0029582
DR   ChEMBL-Cells; CHEMBL3308595
DR   ChEMBL-Targets; CHEMBL614505
DR   Coriell; GM00892
DR   PubChem_Cell_line; CVCL_H136
DR   Wikidata; Q54836514
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 15
//
ID   GM00893
AC   CVCL_7306
SY   GM-893; GM00893A; GM17208
DR   CLO; CLO_0013884
DR   CLO; CLO_0029581
DR   Coriell; GM00893
DR   Coriell; GM17208
DR   GEO; GSM569509
DR   GEO; GSM596272
DR   GEO; GSM596633
DR   GEO; GSM924810
DR   Wikidata; Q54836515
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=22152194;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,30:01:01; B*08:01:01,13:02:01; C*06:02:01,07:01:01; DPA1*01:03:01,02:01:01; DPB1*04:01:01,17:01:01; DQA1*02:01:01,05:01:01; DQB1*02:01:01,02:02:01; DRB1*03:01:01,07:01:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM00894
AC   CVCL_JE18
SY   GM-894
DR   Coriell; GM00894
DR   Wikidata; Q54836516
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00894; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00897
AC   CVCL_H137
SY   GM-897
DR   CLO; CLO_0029580
DR   Coriell; GM00897
DR   Wikidata; Q54836517
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg347Pro (c.1040G>C); ClinVar=VCV000007110; Zygosity=Heterozygous (Coriell=GM00897).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM00897).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H138 ! GM00768
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM00898
AC   CVCL_CX65
SY   GM-898
DR   Coriell; GM00898
DR   Wikidata; Q54836518
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00898; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM00901
AC   CVCL_CX32
SY   GM-901
DR   Coriell; GM00901
DR   Wikidata; Q54836519
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00901; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00902
AC   CVCL_CX33
SY   GM-902
DR   Coriell; GM00902
DR   Wikidata; Q54836520
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00902; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00903
AC   CVCL_CX34
SY   GM-903
DR   Coriell; GM00903
DR   Wikidata; Q54836521
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00903; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00904
AC   CVCL_CX39
SY   GM-904
DR   Coriell; GM00904
DR   Wikidata; Q54836522
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00904; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00905
AC   CVCL_6B39
SY   GM-905; GM 905
DR   CLO; CLO_0029598
DR   Coriell; GM00905
DR   Wikidata; Q54836523
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6132606;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM00906
AC   CVCL_CW98
SY   GM0906; GM-906
DR   CLO; CLO_0029599
DR   Coriell; GM00906
DR   Wikidata; Q54836524
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Trp138Ter (c.414G>A); ClinVar=VCV000004443; Zygosity=Heterozygous (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM00907
AC   CVCL_CW99
SY   GM0907; GM-907
DR   CLO; CLO_0029595
DR   Coriell; GM00907
DR   Wikidata; Q54836525
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; c.970+2T>C (IVS11+2T>C); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM00908
AC   CVCL_Y986
SY   GM0908; GM-908
DR   CLO; CLO_0029596
DR   Coriell; GM00908
DR   Wikidata; Q54836526
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Leu158Pro (c.473T>C); ClinVar=VCV000021439; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Heterozygous (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   GM00909
AC   CVCL_Y987
SY   GM0909; GM-909
DR   CLO; CLO_0029591
DR   Coriell; GM00909
DR   Wikidata; Q54836527
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Heterozygous (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM00910
AC   CVCL_Y988
SY   GM0910; GM-910; GM00910A; GM0910A
DR   CLO; CLO_0029560
DR   Coriell; GM00910
DR   Wikidata; Q54836528
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Leu158Pro (c.473T>C); ClinVar=VCV000021439; Zygosity=Heterozygous (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM00911
AC   CVCL_4T28
SY   GM0911; GM-911; GM 00911
DR   CLO; CLO_0029561
DR   Coriell; GM00911
DR   Wikidata; Q54836529
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7560086;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6903; MAT1A; Simple; p.Leu305Pro (c.914T>C); ClinVar=VCV000001205; Zygosity=Heterozygous (PubMed=7560086).
CC   Sequence variation: Mutation; HGNC; HGNC:6903; MAT1A; Simple; p.Ile322Met (c.966T>G); ClinVar=VCV000001202; Zygosity=Heterozygous (PubMed=7560086).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123435; Methionine adenosyltransferase deficiency
DI   ORDO; Orphanet_168598; Brain demyelination due to methionine adenosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM00913
AC   CVCL_JC79
SY   GM-913; AG00913; AG0913
DR   Coriell; AG00913
DR   Coriell; GM00913
DR   Wikidata; Q54836530
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG00913; probable.
CC   Discontinued: Coriell; GM00913; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M67 ! GM00914
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM00914
AC   CVCL_5M67
SY   GM-914; AG00914; AG0914
DR   CLO; CLO_0029562
DR   Coriell; AG00914
DR   Coriell; GM00914
DR   Wikidata; Q54836531
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Population: Caucasian.
CC   Discontinued: Coriell; AG00914; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC79 ! GM00913
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 12
//
ID   GM00915
AC   CVCL_CX53
SY   GM-915
DR   Coriell; GM00915
DR   Wikidata; Q54836532
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00915; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84908; Multiple sulfatase deficiency disease
DI   ORDO; Orphanet_585; Multiple sulfatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM00917
AC   CVCL_JC77
SY   GM-917
DR   Coriell; GM00917
DR   Wikidata; Q54836533
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00917; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00918
AC   CVCL_CX44
SY   GM-918; GM0918; GM00918A
DR   CLO; CLO_0029563
DR   Coriell; GM00918
DR   Wikidata; Q54836534
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM00919
AC   CVCL_H176
SY   GM-919
DR   CLO; CLO_0029564
DR   Coriell; GM00919
DR   Wikidata; Q54836535
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM00922
AC   CVCL_7307
SY   GM-922; GM 0922; GM00922A; GM17209
DR   CLO; CLO_0013875
DR   CLO; CLO_0029565
DR   Coriell; GM00922
DR   Coriell; GM17209
DR   GEO; GSM569629
DR   GEO; GSM596273
DR   GEO; GSM596634
DR   GEO; GSM924811
DR   Wikidata; Q54836536
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,26:01:01; B*07:02:01,14:01:01; C*07:02:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:02:01,02:01:01; DQB1*02:02:01,06:02:01; DRB1*07:01:01,15:01:01; DRB4*01:01:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM00923
AC   CVCL_JE16
SY   GM-923
DR   Coriell; GM00923
DR   Wikidata; Q54836537
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00923; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00924
AC   CVCL_JE17
SY   GM-924
DR   Coriell; GM00924
DR   Wikidata; Q54836538
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM00924; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00930
AC   CVCL_AW75
SY   GM0930; GM-930
DR   CLO; CLO_0029568
DR   Coriell; GM00930
DR   Wikidata; Q54836539
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00930; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM00931
AC   CVCL_4J13
SY   GM-931
DR   CLO; CLO_0029567
DR   Coriell; GM00931
DR   Wikidata; Q54836540
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1165472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Arg26Cys (c.76C>T); ClinVar=VCV000645443; Zygosity=Heterozygous (Coriell=GM00931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM00932
AC   CVCL_4J14
SY   GM-932
DR   CLO; CLO_0029571
DR   Coriell; GM00932
DR   Wikidata; Q54836541
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1165472;
CC   Population: Caucasian.
CC   Characteristics: Has decreased HMBS activity.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Arg26Cys (c.76C>T); ClinVar=VCV000645443; Zygosity=Heterozygous (from familial inference of GM00931).
CC   Donor information: At sampling donor was not affected with acute intermittent porphyria but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM00933
AC   CVCL_4J15
SY   GM-933
DR   CLO; CLO_0029570
DR   Coriell; GM00933
DR   Wikidata; Q54836542
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1165472;
CC   Population: Caucasian.
CC   Characteristics: Has decreased HMBS activity.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Arg26Cys (c.76C>T); ClinVar=VCV000645443; Zygosity=Heterozygous (from familial inference of GM00931).
CC   Donor information: At sampling donor was not affected with acute intermittent porphyria but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM00934
AC   CVCL_0L97
SY   GM-934
DR   CLO; CLO_0029541
DR   Coriell; GM00934
DR   Wikidata; Q54836543
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM00935
AC   CVCL_V785
SY   GM-935
DR   CLO; CLO_0029539
DR   Coriell; GM00935
DR   GEO; GSM651164
DR   GEO; GSM651165
DR   GEO; GSM1257720
DR   GEO; GSM1266910
DR   GEO; GSM1267004
DR   GEO; GSM1288422
DR   Wikidata; Q54836544
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=826372;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   GM00937
AC   CVCL_W147
SY   GM0937; GM-937
DR   CLO; CLO_0029545
DR   Coriell; GM00937
DR   Wikidata; Q54836547
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=38555716;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Phe39Leu (c.117C>G); ClinVar=VCV000000605; Zygosity=Heterozygous (Coriell=GM00937).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.1066-11G>A (IVS10-11G>A); ClinVar=VCV000000607; Zygosity=Heterozygous (Coriell=GM00937).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y7M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 21
//
ID   GM00939
AC   CVCL_W223
SY   GM-939
DR   CLO; CLO_0029546
DR   Coriell; GM00939
DR   GEO; GSM1266956
DR   Wikidata; Q54836548
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Arg195Cys (c.583C>T); ClinVar=VCV000161251; Zygosity=Heterozygous (Coriell=GM00939).
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W224 ! GM02135
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM00940
AC   CVCL_M925
SY   GM-940
DR   CLO; CLO_0029542
DR   Coriell; GM00940
DR   GEO; GSM1257705
DR   GEO; GSM1266955
DR   GEO; GSM1267039
DR   GEO; GSM1288423
DR   Wikidata; Q54836549
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M924 ! GM02134
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   GM00941
AC   CVCL_4J16
SY   GM-941
DR   CLO; CLO_0029543
DR   Coriell; GM00941
DR   GEO; GSM1257706
DR   GEO; GSM1266954
DR   GEO; GSM1267038
DR   GEO; GSM1288424
DR   Wikidata; Q54836550
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J46 ! GM02133
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM00942
AC   CVCL_9W78
SY   GM-942
DR   CLO; CLO_0029552
DR   Coriell; GM00942
DR   Wikidata; Q54836551
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00943
AC   CVCL_V786
SY   GM-943
DR   CLO; CLO_0029550
DR   Coriell; GM00943
DR   Wikidata; Q54836552
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=826372;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM00945
AC   CVCL_X078
SY   GM-945; GM-0945; GM 945
DR   CLO; CLO_0029549
DR   Coriell; GM00945
DR   Wikidata; Q54836553
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Asian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM00946
AC   CVCL_7308
SY   GM-946; GM00946B; GM17210
DR   CLO; CLO_0013891
DR   CLO; CLO_0029523
DR   Coriell; GM00946
DR   Coriell; GM17210
DR   GEO; GSM569510
DR   GEO; GSM596274
DR   GEO; GSM596635
DR   GEO; GSM924812
DR   Wikidata; Q54836554
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=14583597;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*26:01:01,66:01:01; B*38:01:01,38:01:01; C*12:03:01,12:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRB1*04:02:01,11:01:01; DRB3*02:02:01; DRB4*01:03:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM17210).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; c.506-1G>A (IVSDS3,G-A,+1); ClinVar=VCV000016889; Zygosity=Heterozygous; Note=Splice acceptor mutation. CYP2D6*4 allele (Coriell=GM17210).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   GM00947
AC   CVCL_4W19
SY   GM0947; GM-947
DR   CLO; CLO_0029524
DR   Coriell; GM00947
DR   Wikidata; Q54836555
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98964; Isovaleric acidemia
DI   ORDO; Orphanet_33; Isovaleric acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   GM00948
AC   CVCL_IL05
SY   GM-948
DR   CLO; CLO_0029525
DR   Coriell; GM00948
DR   Wikidata; Q54836557
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C85061; Scleromyxedema
DI   ORDO; Orphanet_167635; Scleromyxedema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL06 ! GM00950
OI   CVCL_IL07 ! GM00951
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   GM00950
AC   CVCL_IL06
SY   GM-950
DR   CLO; CLO_0029526
DR   Coriell; GM00950
DR   Wikidata; Q54836558
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85061; Scleromyxedema
DI   ORDO; Orphanet_167635; Scleromyxedema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL05 ! GM00948
OI   CVCL_IL07 ! GM00951
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM00951
AC   CVCL_IL07
SY   GM-951
DR   CLO; CLO_0029519
DR   Coriell; GM00951
DR   Wikidata; Q54836559
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85061; Scleromyxedema
DI   ORDO; Orphanet_167635; Scleromyxedema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL05 ! GM00948
OI   CVCL_IL06 ! GM00950
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM00954
AC   CVCL_V029
SY   GM0954; GM-954
DR   CLO; CLO_0029520
DR   Coriell; GM00954
DR   Wikidata; Q54836560
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V030 ! GM02011
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM00956
AC   CVCL_X060
SY   GM-956; GM 956
DR   Coriell; GM00956
DR   Wikidata; Q54836561
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6451249;
CC   Discontinued: Coriell; GM00956; probable.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM00957
AC   CVCL_7309
SY   GM-957; GM 957; GM00957A
DR   CLO; CLO_0029521
DR   Coriell; GM00957
DR   Wikidata; Q54836562
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6451249;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM00958
AC   CVCL_9W79
SY   GM-958
DR   CLO; CLO_0029522
DR   Coriell; GM00958
DR   Wikidata; Q54836563
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8910459;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84901; Mucopolysaccharidosis type IVA
DI   ORDO; Orphanet_309297; Mucopolysaccharidosis type 4A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM00959
AC   CVCL_V787
SY   GM-959; GM-0959; GM 959
DR   CLO; CLO_0029532
DR   Coriell; GM00959
DR   Wikidata; Q54836564
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1017324;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM00961
AC   CVCL_4J17
SY   GM-961
DR   CLO; CLO_0029531
DR   Coriell; GM00961
DR   Wikidata; Q54836565
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C27725; Porphyria cutanea tarda
DI   ORDO; Orphanet_101330; Porphyria cutanea tarda
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00962
AC   CVCL_W225
SY   GM-962
DR   CLO; CLO_0029499
DR   Coriell; GM00962
DR   Wikidata; Q54836566
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84759; Hereditary coproporphyria
DI   ORDO; Orphanet_79273; Hereditary coproporphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W226 ! GM02302
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM00963
AC   CVCL_1V22
SY   GM-963
DR   CLO; CLO_0029506
DR   Coriell; GM00963
DR   Wikidata; Q54836567
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=30052969;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00964
AC   CVCL_JD93
SY   GM0964; GM-964; GM964; GM00964B; GM0964B
DR   Coriell; GM00964
DR   Wikidata; Q54836568
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00964; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM00967
AC   CVCL_7310
SY   GM0967; GM-967; GM967; GM00967C; GM0967C; GM00967D
DR   CLO; CLO_0029507
DR   BioSample; SAMN00803523
DR   Coriell; GM00967
DR   GEO; GSM3124661
DR   Wikidata; Q54836569
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=3863481;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X802 ! AG16504
OI   CVCL_1M95 ! AG20457
OI   CVCL_1M96 ! AG22339
OI   CVCL_7316 ! GM01310
OI   CVCL_7531 ! GM13335
OI   CVCL_7532 ! GM13336
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM00969
AC   CVCL_7311
SY   GM0969; GM-969; GM 969; GM00969A; GM 969A; GM0969B; GM00969C; GM00969F; C4
DR   CLO; CLO_0029504
DR   Coriell; GM00969
DR   GEO; GSM1316971
DR   GEO; GSM1317008
DR   GEO; GSM3124626
DR   Wikidata; Q54836570
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2837086;
RX   PubMed=3745952;
RX   PubMed=6458814;
RX   PubMed=6726265;
RX   PubMed=7380831;
RX   PubMed=12665480;
RX   PubMed=17668376;
RX   PubMed=19896956;
RX   PubMed=26831110;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   GM00970
AC   CVCL_7312
SY   GM0970; GM-970; GM 970; GM00970A; GM 0970A; GM00970B; GM0970B; GM970B; GM00970C; IMR-970
DR   CLO; CLO_0029505
DR   Coriell; GM00970
DR   Wikidata; Q54836572
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2705456;
RX   PubMed=3010096;
RX   PubMed=3745952;
RX   PubMed=6280044;
RX   PubMed=6689020;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 22
//
ID   GM00972
AC   CVCL_H140
SY   GM-972
DR   CLO; CLO_0029502
DR   Coriell; GM00972
DR   Wikidata; Q54836573
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H139 ! GM01063
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   GM00975
AC   CVCL_JD95
SY   GM-975
DR   Coriell; GM00975
DR   Wikidata; Q54836574
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00975; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00976
AC   CVCL_CX00
SY   GM-976
DR   Coriell; GM00976
DR   Wikidata; Q54836575
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00976; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00977
AC   CVCL_4J18
SY   GM-977
DR   CLO; CLO_0029503
DR   Coriell; GM00977
DR   Wikidata; Q54836576
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C27725; Porphyria cutanea tarda
DI   ORDO; Orphanet_101330; Porphyria cutanea tarda
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM00978
AC   CVCL_L956
SY   GM-978; GM00188; GM-188
DR   CLO; CLO_0029500
DR   Coriell; GM00188
DR   Coriell; GM00978
DR   Wikidata; Q54836577
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00188; true.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   GM00980
AC   CVCL_X239
SY   GM-980; GM-0980; GM 980
DR   CLO; CLO_0029514
DR   Coriell; GM00980
DR   Wikidata; Q54836578
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM00981
AC   CVCL_V829
SY   GM-981; GM-0981; GM 981
DR   CLO; CLO_0029478
DR   Coriell; GM00981
DR   Wikidata; Q54836579
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=657847;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM00982
AC   CVCL_V788
SY   GM-982
DR   CLO; CLO_0029477
DR   Coriell; GM00982
DR   Wikidata; Q54836580
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=657848;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM00983
AC   CVCL_X240
SY   GM-983; GM-0983; GM0983; GM 983
DR   CLO; CLO_0029476
DR   Coriell; GM00983
DR   Wikidata; Q54836581
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM00984
AC   CVCL_JD77
SY   GM-984; GM00984B
DR   Coriell; GM00984
DR   Wikidata; Q54836582
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00984; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM00988
AC   CVCL_V789
SY   GM-988
DR   CLO; CLO_0029475
DR   Coriell; GM00988
DR   Wikidata; Q54836583
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=872632;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM00988; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   GM00989
AC   CVCL_CV39
AS   CVCL_W837
SY   GM-989; GM00989B; AG00989; AG-989; AG00989B; AG0989B
DR   CLO; CLO_0029474
DR   CLO; CLO_0036917
DR   Coriell; AG00989
DR   Coriell; GM00989
DR   Wikidata; Q54836584
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg644Cys (c.1930C>T); ClinVar=VCV000014527; Zygosity=Heterozygous (Coriell=GM00989).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM00993
AC   CVCL_JD83
SY   GM-993
DR   Coriell; GM00993
DR   Wikidata; Q54836585
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00993; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM00994
AC   CVCL_CX40
SY   GM-994
DR   Coriell; GM00994
DR   Wikidata; Q54836586
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00994; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00995
AC   CVCL_CX41
SY   GM-995
DR   Coriell; GM00995
DR   Wikidata; Q54836587
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM00995; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM00997
AC   CVCL_V206
SY   GM-997; GM 997
DR   CLO; CLO_0029473
DR   Coriell; GM00997
DR   Wikidata; Q54836591
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2445735;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM00997).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM00998
AC   CVCL_V207
SY   GM-998; GM00998A
DR   CLO; CLO_0029472
DR   Coriell; GM00998
DR   Wikidata; Q54836592
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM00998).
CC   Discontinued: Coriell; GM00998; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM00999
AC   CVCL_V208
SY   GM-999; GM00999A
DR   CLO; CLO_0029471
DR   Coriell; GM00999
DR   Wikidata; Q54836594
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.489+1G>T (621+1G>T); ClinVar=VCV000038799; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM00999).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe342Hisfs*28 (c.1019_1020TC[3]) (c.1021_1022dupTC) (1154insTC); ClinVar=VCV000007134; Zygosity=Heterozygous (Coriell=GM00999).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM01000
AC   CVCL_CX07
SY   GM-1000
DR   Coriell; GM01000
DR   Wikidata; Q54836595
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01000; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM01006
AC   CVCL_UA02
SY   GM 1006; GM1006
DR   Coriell; GM01006
DR   Wikidata; Q93568868
RX   PubMed=113895;
RX   PubMed=16465621;
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; c.3435-1G>A (IVS19-1G>A); ClinVar=VCV000038427; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Discontinued: Coriell; GM01006; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   GM01007
AC   CVCL_JB65
SY   GM-1007
DR   Coriell; GM01007
DR   Wikidata; Q54836596
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01007; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85043; Refsum disease
DI   ORDO; Orphanet_773; Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01009
AC   CVCL_JB85
SY   GM-1009
DR   Coriell; GM01009
DR   Wikidata; Q54836597
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01009; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01011
AC   CVCL_L745
SY   GM-1011; GM01011B
DR   CLO; CLO_0029470
DR   BioSample; SAMN00803551
DR   Coriell; GM01011
DR   Wikidata; Q54836598
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from familial inference of GM01012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   GM01012
AC   CVCL_L744
SY   GM-1012; GM1012A
DR   CLO; CLO_0029469
DR   BioSample; SAMN00803553
DR   Coriell; GM01012
DR   Wikidata; Q54836599
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=20715179;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM01012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 20
//
ID   GM01013
AC   CVCL_V209
SY   GM-1013; GM01013A
DR   CLO; CLO_0029496
DR   BioSample; SAMN00803555
DR   Coriell; GM01013
DR   Wikidata; Q54836600
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from familial inference of GM01014).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM01014
AC   CVCL_V210
SY   GM-1014; GM01014A
DR   CLO; CLO_0029498
DR   BioSample; SAMN00803557
DR   Coriell; GM01014
DR   Wikidata; Q54836601
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM01014).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM01016
AC   CVCL_6B40
SY   GM-1016
DR   CLO; CLO_0029497
DR   BioSample; SAMN00803559
DR   Coriell; GM01016
DR   Wikidata; Q54836602
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01017
AC   CVCL_6B41
SY   GM-1017
DR   CLO; CLO_0029493
DR   BioSample; SAMN00803561
DR   Coriell; GM01017
DR   Wikidata; Q54836603
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE08 ! GM01785
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01018
AC   CVCL_M980
SY   GM-1018; GM 1018; GM01018A; GM17072
DR   CLO; CLO_0014601
DR   CLO; CLO_0029492
DR   BioSample; SAMN00803563
DR   Coriell; GM01018
DR   Coriell; GM17072
DR   Wikidata; Q54836604
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM01019
AC   CVCL_U479
SY   GM-1019; GM 1019
DR   CLO; CLO_0029495
DR   BioSample; SAMN00803565
DR   Coriell; GM01019
DR   Wikidata; Q54836605
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (Coriell=GM01019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM01020
AC   CVCL_JE05
SY   GM-1020; GM 1020
DR   Coriell; GM01020
DR   Wikidata; Q54836606
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01020; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01022
AC   CVCL_V790
SY   GM-1022; GM01022A
DR   CLO; CLO_0029494
DR   BioSample; SAMN00803567
DR   Coriell; GM01022
DR   Wikidata; Q54836607
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=806052;
RX   PubMed=826372;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V775 ! GM00519
OI   CVCL_V821 ! GM05358
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM01023
AC   CVCL_V791
SY   GM-1023; GM 1023; GM1023
DR   CLO; CLO_0029490
DR   BioSample; SAMN00803569
DR   Coriell; GM01023
DR   Wikidata; Q54836608
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2803224;
RX   PubMed=3265056;
RX   PubMed=8399358;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln286Arg (c.857A>G) (Q281R); ClinVar=VCV000000691; Zygosity=Heterozygous (PubMed=8399358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V761 ! GM00289
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM01024
AC   CVCL_V792
SY   GM-1024; GM 1024; GM1024
DR   CLO; CLO_0029489
DR   BioSample; SAMN00803571
DR   Coriell; GM01024
DR   Wikidata; Q54836609
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2803224;
RX   PubMed=3265056;
RX   PubMed=8399358;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln82Ter (c.244C>T) (Q77*); ClinVar=VCV000000685; Zygosity=Heterozygous (PubMed=8399358).
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln286Arg (c.857A>G) (Q281R); ClinVar=VCV000000691; Zygosity=Heterozygous (PubMed=8399358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V763 ! GM00291
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM01025
AC   CVCL_V793
SY   GM-1025; GM 1025; GM1025
DR   CLO; CLO_0029491
DR   BioSample; SAMN00803573
DR   Coriell; GM01025
DR   Wikidata; Q54836610
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2803224;
RX   PubMed=3265056;
RX   PubMed=8399358;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln82Ter (c.244C>T) (Q77*); ClinVar=VCV000000685; Zygosity=Heterozygous (PubMed=8399358).
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln286Arg (c.857A>G) (Q281R); ClinVar=VCV000000691; Zygosity=Heterozygous (PubMed=8399358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V764 ! GM00292
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM01026
AC   CVCL_V794
SY   GM-1026; GM 1026; GM1026
DR   CLO; CLO_0030369
DR   BioSample; SAMN00803575
DR   Coriell; GM01026
DR   Wikidata; Q54836611
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2803224;
RX   PubMed=3265056;
RX   PubMed=8399358;
CC   Sequence variation: Mutation; HGNC; HGNC:4006; FUCA1; Simple; p.Gln82Ter (c.244C>T) (Q77*); ClinVar=VCV000000685; Zygosity=Heterozygous (PubMed=8399358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V762 ! GM00290
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM01028
AC   CVCL_V431
SY   GM-1028; GM01028A
DR   CLO; CLO_0030378
DR   BioSample; SAMN00803577
DR   Coriell; GM01028
DR   Wikidata; Q54836612
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*12 (Coriell=GM01028).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM01028).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V430 ! GM00440
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM01029
AC   CVCL_V795
SY   GM-1029; GM01029A
DR   CLO; CLO_0030377
DR   BioSample; SAMN00803579
DR   Coriell; GM01029
DR   Wikidata; Q54836613
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*02,28; B*12,w35 (Coriell=GM01029).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM01029).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V771 ! GM00439
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM01030
AC   CVCL_0R29
SY   GM-1030
DR   CLO; CLO_0030376
DR   BioSample; SAMN00803581
DR   Coriell; GM01030
DR   Wikidata; Q54836614
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (Coriell=GM01030).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   GM01031
AC   CVCL_0R30
SY   GM-1031
DR   CLO; CLO_0030375
DR   BioSample; SAMN00803583
DR   Coriell; GM01031
DR   Wikidata; Q54836615
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19815695;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Gly39Aspfs*3 (c.115+1G>A) (IVS2+1G>A) (IVS2DS,G-A,+1); ClinVar=VCV000093445; Zygosity=Heterozygous; Note=Splice donor mutation that causes skipping of exon 2 (Coriell=GM01031).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01031; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 21
//
ID   GM01032
AC   CVCL_M981
SY   GM-1032; GM01032A; GM17021
DR   CLO; CLO_0014695
DR   CLO; CLO_0030374
DR   BioSample; SAMN00803585
DR   Coriell; GM01032
DR   Coriell; GM17021
DR   Wikidata; Q54836616
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Indo Pakistani.
CC   HLA typing: A*09:10; B*13 (Coriell=GM01032).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM01034
AC   CVCL_1V11
SY   GM-1034; GM01034A
DR   CLO; CLO_0030373
DR   BioSample; SAMN00803586
DR   Coriell; GM01034
DR   Wikidata; Q54836617
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1V12 ! GM01867
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01041
AC   CVCL_4J19
SY   GM-1041
DR   CLO; CLO_0030372
DR   BioSample; SAMN00803588
DR   Coriell; GM01041
DR   Wikidata; Q54836618
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C27725; Porphyria cutanea tarda
DI   ORDO; Orphanet_101330; Porphyria cutanea tarda
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01044
AC   CVCL_U514
SY   GM1044; GM-1044; WG0552; WG552
DR   CLO; CLO_0030371
DR   BioSample; SAMN00803590
DR   Coriell; GM01044
DR   Wikidata; Q54836619
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=891263;
RX   PubMed=7174798;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U515 ! GM01204
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 15
//
ID   GM01053
AC   CVCL_V531
SY   GM-1053; GM01053A
DR   CLO; CLO_0030370
DR   BioSample; SAMN00803592
DR   Coriell; GM01053
DR   Wikidata; Q54836622
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01056
AC   CVCL_D344
SY   GM-1056; GM1056; GM01056A; GM1056-A; GM01056B; GM17211
DR   CLO; CLO_0013890
DR   CLO; CLO_0030349
DR   BioSample; SAMN00803594
DR   Coriell; GM01056
DR   Coriell; GM17211
DR   GEO; GSM569520
DR   GEO; GSM596275
DR   GEO; GSM596636
DR   GEO; GSM924813
DR   Wikidata; Q54836623
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3495441;
RX   PubMed=14583597;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,29:02:01; B*15:01:01,44:03:01; C*03:03:01,16:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,02:01:02; DQA1*01:02:01,05:05:01; DQB1*03:01:01,06:02:01; DRB1*12:01:01G,15:01:01; DRB3*02:02:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7499 ! GM09918
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   GM01057
AC   CVCL_H964
SY   GM-1057
DR   CLO; CLO_0030350
DR   BioSample; SAMN00803596
DR   Coriell; GM01057
DR   Wikidata; Q54836624
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438975;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H965 ! GM01245
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM01058
AC   CVCL_H141
SY   GM1058; GM-1058
DR   CLO; CLO_0030366
DR   BioSample; SAMN00803598
DR   Coriell; GM01058
DR   Wikidata; Q54836625
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H142 ! GM01206
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM01059
AC   CVCL_X079
SY   GM-1059; GM 1059; GM01059A
DR   CLO; CLO_0030365
DR   BioSample; SAMN00803600
DR   Coriell; GM01059
DR   Wikidata; Q54836626
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM01061
AC   CVCL_V036
SY   GM-1061; GM 1061; GM1061; GM01061A
DR   CLO; CLO_0030368
DR   BioSample; SAMN00803602
DR   Coriell; GM01061
DR   Wikidata; Q54836627
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2973075;
RX   PubMed=6220707;
RX   PubMed=6458814;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V042 ! GM03642
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM01063
AC   CVCL_H139
SY   GM-1063; GM01063B
DR   CLO; CLO_0030367
DR   BioSample; SAMN00803604
DR   Coriell; GM01063
DR   Wikidata; Q54836628
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H140 ! GM00972
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM01064
AC   CVCL_V796
SY   GM-1064; GM1064
DR   CLO; CLO_0030362
DR   BioSample; SAMN00803606
DR   Coriell; GM01064
DR   Wikidata; Q54836629
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1017323;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Karyotypic information: 46;XY;t(2;4)(2qter->2p25::4q21->4qter;4pter->4q21::2p25->2pter) (Coriell=GM01064).
CC   Discontinued: Coriell; GM01064; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM01068
AC   CVCL_CX37
SY   GM-1068
DR   Coriell; GM01068
DR   Wikidata; Q54836630
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01068; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM01070
AC   CVCL_CX38
SY   GM-1070
DR   Coriell; GM01070
DR   Wikidata; Q54836631
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01070; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM01078
AC   CVCL_7313
SY   GM-1078; GM 1078; GM01078B; GM18002
DR   CLO; CLO_0015992
DR   CLO; CLO_0030361
DR   BioSample; SAMN00803608
DR   Coriell; GM01078
DR   Coriell; GM18002
DR   Wikidata; Q54836632
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM01082
AC   CVCL_GS53
SY   GM-1082; GM01082A
DR   CLO; CLO_0030364
DR   BioSample; SAMN00803610
DR   Coriell; GM01082
DR   Wikidata; Q54836633
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84697; Erythropoietic porphyria
DI   ORDO; Orphanet_79277; Congenital erythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM01083
AC   CVCL_V037
SY   GM-1083; GM01083A; GM1083A
DR   CLO; CLO_0030363
DR   BioSample; SAMN00803612
DR   Coriell; GM01083
DR   Wikidata; Q54836636
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM01083).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V043 ! GM03643
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM01085
AC   CVCL_V038
SY   GM-1085; GM 1085
DR   CLO; CLO_0030193
DR   BioSample; SAMN00803614
DR   Coriell; GM01085
DR   Wikidata; Q54836637
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=6458814;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V044 ! GM03644
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM01087
AC   CVCL_JD76
SY   GM-1087
DR   Coriell; GM01087
DR   Wikidata; Q54836638
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01087; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01091
AC   CVCL_V797
SY   GM-1091
DR   CLO; CLO_0030198
DR   BioSample; SAMN00803616
DR   Coriell; GM01091
DR   Wikidata; Q54836639
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=446099;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;10)(4pter->4q35::10q24->10qter;10pter->10q24::4q35->4qter) (Coriell=GM01091).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM01093
AC   CVCL_DD66
SY   GM-1093
DR   CLO; CLO_0030195
DR   BioSample; SAMN00803618
DR   Coriell; GM01093
DR   Wikidata; Q54836640
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01094
AC   CVCL_0L98
SY   GM-1094
DR   CLO; CLO_0030180
DR   BioSample; SAMN00803620
DR   Coriell; GM01094
DR   GEO; GSM1266959
DR   Wikidata; Q54836641
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Tyr432_Arg435delTrp432ins (c.1307del9); Zygosity=Heterozygous (Coriell=GM01094).
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M02 ! GM01739
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   GM01095
AC   CVCL_0L99
SY   GM-1095
DR   CLO; CLO_0030181
DR   BioSample; SAMN00803622
DR   Coriell; GM01095
DR   GEO; GSM1257681
DR   GEO; GSM1266958
DR   GEO; GSM1267041
DR   GEO; GSM1288425
DR   Wikidata; Q54836642
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   GM01096
AC   CVCL_0M00
SY   GM-1096
DR   CLO; CLO_0030184
DR   BioSample; SAMN00803624
DR   Coriell; GM01096
DR   GEO; GSM1257682
DR   GEO; GSM1266957
DR   GEO; GSM1267040
DR   GEO; GSM1288426
DR   Wikidata; Q54836643
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   GM01099
AC   CVCL_AD62
SY   GM1099; GM-1099; GM 1099
DR   CLO; CLO_0030187
DR   BioSample; SAMN00803628
DR   Coriell; GM01099
DR   Wikidata; Q54836645
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2241958;
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Tyr438Asn (c.1312T>A) (Y393N); ClinVar=VCV000100009; Zygosity=Homozygous (PubMed=2241958).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM01101
AC   CVCL_0P87
SY   GM-1101
DR   CLO; CLO_0030188
DR   BioSample; SAMN00803630
DR   Coriell; GM01101
DR   Wikidata; Q54836646
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,(4qter->4p16::12p11->12pter;12qter->12p11::4p16->4pter) (Coriell=GM01101).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01108
AC   CVCL_1V04
SY   GM-1108; GM01108A
DR   CLO; CLO_0030189
DR   BioSample; SAMN00803632
DR   Coriell; GM01108
DR   Wikidata; Q54836647
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Glu482Lys (c.1444G>A); ClinVar=VCV000003892; Zygosity=Heterozygous (from familial inference of GM01110).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   GM01109
AC   CVCL_1V05
SY   GM-1109; GM01109A
DR   CLO; CLO_0030177
DR   BioSample; SAMN00803634
DR   Coriell; GM01109
DR   Wikidata; Q54836648
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Glu482Lys (c.1444G>A); ClinVar=VCV000003892; Zygosity=Heterozygous (from familial inference of GM01110).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   GM01110
AC   CVCL_U386
SY   GM-1110; GM 1110; GM1110
DR   CLO; CLO_0030175
DR   BioSample; SAMN00803636
DR   Coriell; GM01110
DR   Wikidata; Q54836649
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=25732146;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Glu482Lys (c.1444G>A); ClinVar=VCV000003892; Zygosity=Homozygous (Coriell=GM01110).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM01116
AC   CVCL_CX46
SY   GM-1116; GM1116
DR   Coriell; GM01116
DR   Wikidata; Q54836650
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Glu408Lys (c.1222G>A) (E387K); ClinVar=VCV000036453; Zygosity=Homozygous (from autologous cell line GM02000).
CC   Discontinued: Coriell; GM01116; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1V08 ! GM02000
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM01118
AC   CVCL_4D80
SY   GM-1118
DR   CLO; CLO_0030174
DR   BioSample; SAMN00803638
DR   Coriell; GM01118
DR   Wikidata; Q54836651
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Mexican.
CC   Karyotypic information: 46,XX,r(18) [39]; 45,XX,-18 [11] (Coriell=GM01118).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01122
AC   CVCL_H970
SY   GM-1122
DR   CLO; CLO_0030172
DR   Coriell; GM01122
DR   Wikidata; Q54836652
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
RX   PubMed=29990710;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H971 ! GM01240
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM01123
AC   CVCL_DF14
AS   CVCL_V556
SY   GM-1123; AG01123; AG-1123; AG 1123; AG1123
DR   CLO; CLO_0030163
DR   BioSample; SAMN00803640
DR   Coriell; AG01123
DR   Coriell; GM01123
DR   Wikidata; Q54836653
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Population: African American.
CC   Donor information: Established from monozygotic twin of GM01131 (Cellosaurus=CVCL_DF16).
CC   Discontinued: Coriell; AG01123; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   GM01125
AC   CVCL_DF15
SY   GM-1125
DR   CLO; CLO_0030166
DR   BioSample; SAMN00803642
DR   Coriell; GM01125
DR   Wikidata; Q54836654
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
DI   NCIt; C168999; Macular dystrophy, retinal, 1
DI   ORDO; Orphanet_75327; North Carolina macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM01126
AC   CVCL_2H10
SY   GM1126; GM-1126
DR   CLO; CLO_0030160
DR   BioSample; SAMN00803644
DR   Coriell; GM01126
DR   Wikidata; Q54836655
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01128
AC   CVCL_2H11
SY   GM1128; GM-1128
DR   CLO; CLO_0030162
DR   BioSample; SAMN00803646
DR   Coriell; GM01128
DR   Wikidata; Q54836656
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Gly307Ser (c.919G>A); ClinVar=VCV000000117; Zygosity=Heterozygous (PubMed=8528202).
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Val454Glu (c.1361T>A); ClinVar=VCV002138391; Zygosity=Heterozygous (PubMed=8528202).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM01129
AC   CVCL_2H12
SY   GM1129; GM-1129
DR   CLO; CLO_0030168
DR   BioSample; SAMN00803648
DR   Coriell; GM01129
DR   Wikidata; Q54836657
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01131
AC   CVCL_DF16
AS   CVCL_V555
SY   GM-1131; AG01131; AG-1131; AG 1131; AG1131
DR   CLO; CLO_0030169
DR   BioSample; SAMN00803650
DR   Coriell; AG01131
DR   Coriell; GM01131
DR   Wikidata; Q54836658
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Population: African American.
CC   Donor information: Established from monozygotic twin of GM01123 (Cellosaurus=CVCL_DF14).
CC   Discontinued: Coriell; AG01131; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   GM01133
AC   CVCL_HF30
SY   GM-1133; GM1133
DR   Coriell; GM01133
DR   Wikidata; Q54836659
RX   PubMed=2973075;
CC   Discontinued: Coriell; GM01133; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM01136
AC   CVCL_JB92
SY   GM-1136
DR   Coriell; GM01136
DR   Wikidata; Q54836660
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01136; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01137
AC   CVCL_V462
SY   GM-1137; GM 1137
DR   CLO; CLO_0030246
DR   BioSample; SAMN00803652
DR   Coriell; GM01137
DR   Wikidata; Q54836661
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Karyotypic information: 48,XXY,t(6;10)(6qter->6p25::10p11->10pter;10qter->10p11::6p25->6pter),+21 (Coriell=GM01137).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM01138
AC   CVCL_V798
SY   GM-1138; GM 1138; GM1138
DR   CLO; CLO_0030239
DR   BioSample; SAMN00803654
DR   Coriell; GM01138
DR   Wikidata; Q54836662
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=862431;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V823 ! GM09216
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM01139
AC   CVCL_0P88
SY   GM-1139
DR   CLO; CLO_0030236
DR   BioSample; SAMN00803656
DR   Coriell; GM01139
DR   Wikidata; Q54836663
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01140
AC   CVCL_CX03
SY   GM1140; GM-1140
DR   CLO; CLO_0030243
DR   BioSample; SAMN00803658
DR   Coriell; GM01140
DR   Wikidata; Q54836664
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01142
AC   CVCL_F129
AS   CVCL_V542
SY   GM-1142; GM1142; GM01142A; AG01142; AG-1142; AG 1142; AG1142
DR   CLO; CLO_0030240
DR   BioSample; SAMN00803660
DR   Coriell; AG01142
DR   Coriell; GM01142
DR   JCRB; KURB2682
DR   Wikidata; Q54836665
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2973075;
RX   PubMed=3762576;
RX   PubMed=6600729;
RX   PubMed=7253718;
RX   PubMed=7329430;
RX   PubMed=7338842;
RX   PubMed=7471105;
RX   PubMed=7471106;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(13)(pter->q14.1::q22.1->qter) (Coriell=GM01142).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; AG01142; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F130 ! GM01484
SX   Female
AG   2Y3M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   GM01150
AC   CVCL_4J20
SY   GM-1150
DR   CLO; CLO_0030226
DR   BioSample; SAMN00803662
DR   Coriell; GM01150
DR   Wikidata; Q54836666
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01151
AC   CVCL_4J21
SY   GM-1151
DR   CLO; CLO_0030228
DR   BioSample; SAMN00803664
DR   Coriell; GM01151
DR   Wikidata; Q54836667
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Sardinian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (Coriell=GM01151).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01152
AC   CVCL_4J22
SY   GM-1152
DR   CLO; CLO_0030232
DR   BioSample; SAMN00803666
DR   Coriell; GM01152
DR   Wikidata; Q54836668
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Sardinian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (Coriell=GM01152).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01153
AC   CVCL_4J23
SY   GM-1153
DR   CLO; CLO_0030234
DR   BioSample; SAMN00803668
DR   Coriell; GM01153
DR   Wikidata; Q54836669
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01154
AC   CVCL_4J24
SY   GM-1154
DR   CLO; CLO_0030219
DR   BioSample; SAMN00803670
DR   Coriell; GM01154
DR   Wikidata; Q54836670
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Heterozygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM01157
AC   CVCL_4J25
SY   GM-1157
DR   CLO; CLO_0030218
DR   BioSample; SAMN00803672
DR   Coriell; GM01157
DR   Wikidata; Q54836671
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Sardinian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01158
AC   CVCL_CX08
SY   GM-1158
DR   Coriell; GM01158
DR   Wikidata; Q54836672
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01158; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM01159
AC   CVCL_CX14
SY   GM-1159
DR   Coriell; GM01159
DR   Wikidata; Q54836673
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01159; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM01161
AC   CVCL_AM62
SY   GM-1161
DR   CLO; CLO_0030217
DR   Coriell; GM01161
DR   Wikidata; Q54836674
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM01162
AC   CVCL_CX04
SY   GM1162; GM-1162
DR   CLO; CLO_0030215
DR   BioSample; SAMN00803674
DR   Coriell; GM01162
DR   Wikidata; Q54836675
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01163
AC   CVCL_4J26
SY   GM-1163
DR   CLO; CLO_0030213
DR   BioSample; SAMN00803676
DR   Coriell; GM01163
DR   Wikidata; Q54836679
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01165
AC   CVCL_4J27
SY   GM-1165
DR   CLO; CLO_0030211
DR   BioSample; SAMN00803678
DR   Coriell; GM01165
DR   Wikidata; Q54836680
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Heterozygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM01166
AC   CVCL_JD88
SY   GM-1166
DR   Coriell; GM01166
DR   Wikidata; Q54836681
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01166; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01168
AC   CVCL_1H37
SY   GM-1168; GM 1168
DR   CLO; CLO_0030210
DR   BioSample; SAMN00803680
DR   Coriell; GM01168
DR   Wikidata; Q54836682
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01169
AC   CVCL_V039
SY   GM-1169; GM 1169
DR   CLO; CLO_0030206
DR   BioSample; SAMN00803682
DR   Coriell; GM01169
DR   Wikidata; Q54836683
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM01170
AC   CVCL_JB93
SY   GM-1170; GM 1170
DR   Coriell; GM01170
DR   Wikidata; Q54836684
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01170; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM01171
AC   CVCL_1H38
SY   GM-1171
DR   CLO; CLO_0030209
DR   BioSample; SAMN00803684
DR   Coriell; GM01171
DR   Wikidata; Q54836685
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM01176
AC   CVCL_X241
SY   GM-1176; GM 1176; GM01176A; TS2 fibroblast
DR   CLO; CLO_0030203
DR   BioSample; SAMN00803686
DR   Coriell; GM01176
DR   Wikidata; Q54836686
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=21949351;
CC   Population: Caucasian.
CC   Karyotypic information: 45,X[18].arr(X)x1 (Coriell=GM01176).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 14
//
ID   GM01177
AC   CVCL_JB60
SY   GM-1177; GM1177; AG01177; AG-1177; AG 1177; AG1177; WG0360; WG360
DR   Coriell; AG01177
DR   Coriell; GM01177
DR   Wikidata; Q54836688
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7176709;
RX   PubMed=7253718;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Discontinued: Coriell; AG01177; probable.
CC   Discontinued: Coriell; GM01177; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM01178
AC   CVCL_CV40
AS   CVCL_X761
SY   GM-1178; GM 1178; GM1178; GM01178B; AG01178; AG-1178; AG1178; AG01178B; WG0380; WG380
DR   CLO; CLO_0030204
DR   CLO; CLO_0036894
DR   Coriell; AG01178
DR   Coriell; GM01178
DR   Wikidata; Q54836689
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM01179
AC   CVCL_4J28
SY   GM-1179
DR   CLO; CLO_0030262
DR   BioSample; SAMN00803688
DR   Coriell; GM01179
DR   Wikidata; Q54836690
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C27725; Porphyria cutanea tarda
DI   ORDO; Orphanet_101330; Porphyria cutanea tarda
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01183
AC   CVCL_X242
SY   GM-1183; GM 1183
DR   CLO; CLO_0030263
DR   BioSample; SAMN00803690
DR   Coriell; GM01183
DR   Wikidata; Q54836691
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM01187
AC   CVCL_8516
SY   GM-1187; GM 1187
DR   CLO; CLO_0030264
DR   BioSample; SAMN00803692
DR   Coriell; GM01187
DR   Wikidata; Q54836692
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM01188
AC   CVCL_4J29
SY   GM-1188
DR   CLO; CLO_0030265
DR   BioSample; SAMN00803694
DR   Coriell; GM01188
DR   Wikidata; Q54836693
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian; Sardinian.
CC   Karyotypic information: 46,XY,inv(9) (Coriell=GM01188).
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Asp282His (c.844G>C); ClinVar=VCV000010372; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01192
AC   CVCL_4J30
SY   GM-1192; GM01192A
DR   CLO; CLO_0030266
DR   BioSample; SAMN00803696
DR   Coriell; GM01192
DR   Wikidata; Q54836694
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Sardinian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Heterozygous (Coriell=GM01192).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM01193
AC   CVCL_4J31
SY   GM-1193
DR   CLO; CLO_0030267
DR   BioSample; SAMN00803698
DR   Coriell; GM01193
DR   Wikidata; Q54836695
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian; Sardinian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Homozygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01201
AC   CVCL_X243
SY   GM-1201; GM 1201; GM01201A
DR   CLO; CLO_0030268
DR   BioSample; SAMN00803700
DR   Coriell; GM01201
DR   Wikidata; Q54836696
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM01202
AC   CVCL_V799
SY   GM-1202; GM 1202; GM1202; GM1202A; GM01202C
DR   CLO; CLO_0030260
DR   BioSample; SAMN00803702
DR   Coriell; GM01202
DR   Wikidata; Q54836697
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 49,XXXXY (Coriell=GM01202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   GM01203
AC   CVCL_0P89
SY   GM-1203; GM01203A
DR   CLO; CLO_0030259
DR   BioSample; SAMN00803704
DR   Coriell; GM01203
DR   Wikidata; Q54836698
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;12)(4pter->4q25::12p13.3->12pter;12qter->12p13.3::4q25->4qter) (Coriell=GM01203).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 12
//
ID   GM01204
AC   CVCL_U515
SY   GM-1204; GM01204A
DR   CLO; CLO_0030261
DR   BioSample; SAMN00803706
DR   Coriell; GM01204
DR   Wikidata; Q54836699
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*02,28; B*12,35 (Coriell=GM01204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U514 ! GM01044
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM01205
AC   CVCL_U512
SY   GM-1205
DR   CLO; CLO_0030253
DR   BioSample; SAMN00803708
DR   Coriell; GM01205
DR   Wikidata; Q54836700
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*01,28; B*13,35 (Coriell=GM01205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM01206
AC   CVCL_H142
SY   GM-1206; GM01206A
DR   CLO; CLO_0030254
DR   BioSample; SAMN00803710
DR   Coriell; GM01206
DR   Wikidata; Q54836701
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*02,11; B*12,15 (Coriell=GM01206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H141 ! GM01058
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM01207
AC   CVCL_F022
SY   GM-1207; GM 1207; GM18003
DR   CLO; CLO_0015993
DR   CLO; CLO_0030251
DR   BioSample; SAMN00803712
DR   Coriell; GM01207
DR   Coriell; GM18003
DR   Wikidata; Q54836702
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*11,28; B*15,35 (Coriell=GM01207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM01208
AC   CVCL_M982
SY   GM-1208; GM17350
DR   CLO; CLO_0013724
DR   CLO; CLO_0030252
DR   BioSample; SAMN00803714
DR   Coriell; GM01208
DR   Coriell; GM17350
DR   Wikidata; Q54836703
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Asp98His (c.292G>C); ClinVar=VCV000025149; Zygosity=Heterozygous (from familial inference of GM01209; GM01210).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GM01209
AC   CVCL_1Y23
SY   GM-1209; GM 1209
DR   CLO; CLO_0030257
DR   BioSample; SAMN00803716
DR   Coriell; GM01209
DR   Wikidata; Q54836704
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1766867;
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Asp98His (c.292G>C); ClinVar=VCV000025149; Zygosity=Homozygous (from familial inference of GM01210).
CC   Donor information: Established from monozygotic twin of GM01210 (Cellosaurus=CVCL_1Y24).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   GM01210
AC   CVCL_1Y24
SY   GM-1210
DR   CLO; CLO_0030258
DR   BioSample; SAMN00803718
DR   Coriell; GM01210
DR   Wikidata; Q54836705
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Asp98His (c.292G>C); ClinVar=VCV000025149; Zygosity=Homozygous (Coriell=GM01210).
CC   Donor information: Established from monozygotic twin of GM01209 (Cellosaurus=CVCL_1Y23).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 17
//
ID   GM01211
AC   CVCL_9R16
SY   GM-1211
DR   CLO; CLO_0030255
DR   BioSample; SAMN00803720
DR   Coriell; GM01211
DR   Wikidata; Q54836707
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Asp98His (c.292G>C); ClinVar=VCV000025149; Zygosity=Heterozygous (from familial inference of GM01209; GM01210).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM01212
AC   CVCL_M983
SY   GM-1212; GM17351
DR   CLO; CLO_0013726
DR   CLO; CLO_0030256
DR   BioSample; SAMN00803722
DR   Coriell; GM01212
DR   Coriell; GM17351
DR   Wikidata; Q54836708
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Asp98His (c.292G>C); ClinVar=VCV000025149; Zygosity=Heterozygous (Coriell=GM01212).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   GM01213
AC   CVCL_1F06
SY   GM-1213; GM1213
DR   CLO; CLO_0030250
DR   BioSample; SAMN00803724
DR   Coriell; GM01213
DR   Wikidata; Q54836709
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7163956;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 12
//
ID   GM01214
AC   CVCL_1B71
SY   GM-1214
DR   CLO; CLO_0030249
DR   BioSample; SAMN00803726
DR   Coriell; GM01214
DR   Wikidata; Q54836710
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01219
AC   CVCL_H967
SY   GM-1219
DR   CLO; CLO_0030288
DR   Coriell; GM01219
DR   Wikidata; Q54836712
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H966 ! GM01246
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM01220
AC   CVCL_V800
SY   GM-1220; GM 1220
DR   CLO; CLO_0030284
DR   Coriell; GM01220
DR   Wikidata; Q54836713
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=891262;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM01221
AC   CVCL_X244
SY   GM-1221; GM 1221; GM1221; GM01221A
DR   CLO; CLO_0030285
DR   BioSample; SAMN00803728
DR   Coriell; GM01221
DR   Wikidata; Q54836715
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6293786;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM01222
AC   CVCL_4D81
SY   GM-1222; GM01222B
DR   CLO; CLO_0030286
DR   BioSample; SAMN00803730
DR   Coriell; GM01222
DR   Wikidata; Q54836716
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Karyotypic information: 46,XX,ins(5;6)(5pter->5q33::6q15->6q25::5q33->5qter;6pter->6q15::6q25->6qter) (Coriell=GM01222).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01224
AC   CVCL_V801
SY   GM-1224; GM 1224
DR   CLO; CLO_0030287
DR   BioSample; SAMN00803732
DR   Coriell; GM01224
DR   Wikidata; Q54836717
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477416;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM01225
AC   CVCL_M984
SY   GM-1225; GM17022
DR   CLO; CLO_0014692
DR   CLO; CLO_0030280
DR   BioSample; SAMN00803734
DR   Coriell; GM01225
DR   Coriell; GM17022
DR   Wikidata; Q54836718
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Indian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   GM01227
AC   CVCL_L459
SY   GM-1227; GM 1227; GM1227
DR   CLO; CLO_0030281
DR   BioSample; SAMN00803736
DR   Coriell; GM01227
DR   JCRB; KURB1268
DR   Wikidata; Q54836719
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7263770;
RX   PubMed=7326997;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 14
//
ID   GM01228
AC   CVCL_L957
SY   GM-1228; GM00642
DR   CLO; CLO_0030282
DR   BioSample; SAMN00803738
DR   Coriell; GM00642
DR   Coriell; GM01228
DR   Wikidata; Q54836720
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00642; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C133729; Intellectual developmental disorder, X-linked 1
DI   ORDO; Orphanet_777; X-linked non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 12
//
ID   GM01229
AC   CVCL_7315
SY   GM-1229; GM 1229; GM17352
DR   CLO; CLO_0003519
DR   CLO; CLO_0013721
DR   CLO; CLO_0030283
DR   CLDB; cl1486
DR   BioSample; SAMN00803740
DR   Coriell; GM01229
DR   Coriell; GM17352
DR   Wikidata; Q54836721
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Cuban.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM01230
AC   CVCL_0P90
SY   GM-1230
DR   CLO; CLO_0030279
DR   BioSample; SAMN00803742
DR   Coriell; GM01230
DR   Wikidata; Q54836722
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Cuban.
CC   Karyotypic information: 46,XY,t(1;2)(1qter->1p36::2q31->2qter;2pter->2q31::1p36->1pter) (Coriell=GM01230).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01236
AC   CVCL_V421
SY   GM-1236
DR   CLO; CLO_0030278
DR   BioSample; SAMN00803746
DR   Coriell; GM01236
DR   Wikidata; Q54836725
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01237
AC   CVCL_H969
SY   GM-1237
DR   CLO; CLO_0030275
DR   Coriell; GM01237
DR   Wikidata; Q54836726
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H968 ! GM01247
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM01240
AC   CVCL_H971
SY   GM-1240; GM 1240; GM01240A
DR   CLO; CLO_0030276
DR   BioSample; SAMN00803748
DR   Coriell; GM01240
DR   Wikidata; Q54836727
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H970 ! GM01122
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM01241
AC   CVCL_H972
SY   GM-1241; GM01241A
DR   CLO; CLO_0030273
DR   BioSample; SAMN00803750
DR   Coriell; GM01241
DR   Wikidata; Q54836728
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H973 ! GM01486
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM01242
AC   CVCL_N344
SY   GM-1242
DR   CLO; CLO_0030274
DR   Coriell; GM01242
DR   Wikidata; Q54836729
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N345 ! GM01435
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   GM01243
AC   CVCL_AI24
SY   GM-1243
DR   CLO; CLO_0030271
DR   Coriell; GM01243
DR   Wikidata; Q54836730
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM01244
AC   CVCL_AI25
SY   GM-1244
DR   CLO; CLO_0030272
DR   Coriell; GM01244
DR   Wikidata; Q54836731
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI27 ! GM01496
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   GM01245
AC   CVCL_H965
SY   GM-1245
DR   CLO; CLO_0030269
DR   BioSample; SAMN00803752
DR   Coriell; GM01245
DR   Wikidata; Q54836733
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H964 ! GM01057
SX   Male
AG   5D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM01246
AC   CVCL_H966
SY   GM-1246; GM 1246; GM01246A
DR   CLO; CLO_0030270
DR   BioSample; SAMN00803754
DR   Coriell; GM01246
DR   Wikidata; Q54836734
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H967 ! GM01219
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM01247
AC   CVCL_H968
SY   GM-1247; GM 1247; GM01247A; GM01247B
DR   CLO; CLO_0030932
DR   BioSample; SAMN00803756
DR   Coriell; GM01247
DR   Wikidata; Q54836735
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H969 ! GM01237
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   GM01250
AC   CVCL_W636
SY   GM-1250; GM 1250
DR   CLO; CLO_0030931
DR   BioSample; SAMN00803758
DR   Coriell; GM01250
DR   Wikidata; Q54836736
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 47,XYY (Coriell=GM01250).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM01251
AC   CVCL_M985
SY   GM-1251; GM17152
DR   CLO; CLO_0013959
DR   CLO; CLO_0030930
DR   BioSample; SAMN00803760
DR   Coriell; GM01251
DR   Coriell; GM17152
DR   GEO; GSM924662
DR   IPD-IMGT/HLA; 23055
DR   Wikidata; Q54836737
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477407;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*03:CVAB,29:02; B*58:02,81:MN; C*06:02,18:AB; DRB1*03:01,08:04 (IPD-IMGT/HLA=23055).
CC   Omics: Genomics; DNA methylation analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM01252
AC   CVCL_V802
SY   GM-1252; GM 1252
DR   CLO; CLO_0030929
DR   BioSample; SAMN00803762
DR   Coriell; GM01252
DR   Wikidata; Q54836738
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477407;
RX   PubMed=6617268;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01253
AC   CVCL_V803
SY   GM-1253; GM 1253
DR   CLO; CLO_0030936
DR   BioSample; SAMN00803764
DR   Coriell; GM01253
DR   Wikidata; Q54836739
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477407;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 46,XY,rec(3)(qter->p25::q25->qter) (Coriell=GM01253).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01254
AC   CVCL_1V23
SY   GM-1254
DR   CLO; CLO_0030935
DR   BioSample; SAMN00803766
DR   Coriell; GM01254
DR   Wikidata; Q54836740
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01255
AC   CVCL_1V24
SY   GM-1255; GM1255
DR   CLO; CLO_0030934
DR   BioSample; SAMN00803768
DR   Coriell; GM01255
DR   Wikidata; Q54836741
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01256
AC   CVCL_1V17
SY   GM-1256
DR   CLO; CLO_0030933
DR   BioSample; SAMN00803770
DR   Coriell; GM01256
DR   Wikidata; Q54836742
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=30052969;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; c.590-7G>A (IVS5AS-7G>A); ClinVar=VCV000222996; Zygosity=Heterozygous (Coriell=GM01256).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (Coriell=GM01256).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61265; Scheie syndrome
DI   ORDO; Orphanet_93474; Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   GM01257
AC   CVCL_V532
SY   GM-1257
DR   CLO; CLO_0030938
DR   BioSample; SAMN00803772
DR   Coriell; GM01257
DR   Wikidata; Q54836744
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 12
//
ID   GM01258
AC   CVCL_W658
SY   GM-1258
DR   CLO; CLO_0030937
DR   BioSample; SAMN00803774
DR   Coriell; GM01258
DR   Wikidata; Q54836745
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01259
AC   CVCL_9W80
SY   GM-1259
DR   CLO; CLO_0030919
DR   BioSample; SAMN00803776
DR   Coriell; GM01259
DR   Wikidata; Q54836746
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8910459;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84901; Mucopolysaccharidosis type IVA
DI   ORDO; Orphanet_309297; Mucopolysaccharidosis type 4A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01260
AC   CVCL_0R31
SY   GM-1260; GM1260
DR   CLO; CLO_0030921
DR   BioSample; SAMN00803778
DR   Coriell; GM01260
DR   Wikidata; Q54836747
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2464926;
RX   PubMed=6593712;
RX   PubMed=30497978;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Pro454Arg (c.1361C>G) (P415R); ClinVar=VCV000004289; Zygosity=Heterozygous (PubMed=30497978).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=30497978).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   GM01261
AC   CVCL_J109
SY   GM-1261; GM 1261
DR   CLO; CLO_0030920
DR   BioSample; SAMN00803780
DR   Coriell; GM01261
DR   Wikidata; Q54836748
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XX,der(13;18)(13qter->13q10::18q10->18qter) (Coriell=GM01261).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 13
//
ID   GM01296
AC   CVCL_0P91
SY   GM-1296; GM1296; GM01296B
DR   CLO; CLO_0030922
DR   BioSample; SAMN00803784
DR   Coriell; GM01296
DR   Wikidata; Q54836750
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XX,der(13;15)(13qter->13q10::15q10->15qter) (Coriell=GM01296).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01297
AC   CVCL_CX05
SY   GM1297; GM-1297
DR   CLO; CLO_0030925
DR   Coriell; GM01297
DR   Wikidata; Q54836751
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01298
AC   CVCL_2N27
SY   GM1298; GM-1298
DR   CLO; CLO_0030924
DR   Coriell; GM01298
DR   Wikidata; Q54836752
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01299
AC   CVCL_2N28
SY   GM1299; GM-1299
DR   CLO; CLO_0030927
DR   Coriell; GM01299
DR   Wikidata; Q54836753
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01300
AC   CVCL_2N29
SY   GM1300; GM-1300
DR   CLO; CLO_0030926
DR   Coriell; GM01300
DR   Wikidata; Q54836754
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01301
AC   CVCL_CX09
SY   GM1301; GM-1301
DR   CLO; CLO_0030928
DR   BioSample; SAMN00803786
DR   Coriell; GM01301
DR   Wikidata; Q54836755
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01302
AC   CVCL_CX10
SY   GM1302; GM-1302
DR   CLO; CLO_0030909
DR   Coriell; GM01302
DR   Wikidata; Q54836756
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01304
AC   CVCL_4F86
SY   GM-1304
DR   CLO; CLO_0030910
DR   Coriell; GM01304
DR   Wikidata; Q54836757
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F87 ! GM01305
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01305
AC   CVCL_4F87
SY   GM-1305
DR   CLO; CLO_0030918
DR   Coriell; GM01305
DR   Wikidata; Q54836758
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F86 ! GM01304
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01306
AC   CVCL_4F88
SY   GM-1306; GM01306A
DR   CLO; CLO_0030917
DR   BioSample; SAMN00803788
DR   Coriell; GM01306
DR   Wikidata; Q54836759
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6401921;
RX   PubMed=6418414;
CC   Population: Caucasian.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
DI   NCIt; C3856; Ovarian dermoid cyst
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F89 ! GM01307
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01307
AC   CVCL_4F89
SY   GM-1307
DR   CLO; CLO_0030916
DR   BioSample; SAMN00803790
DR   Coriell; GM01307
DR   Wikidata; Q54836760
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F88 ! GM01306
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01309
AC   CVCL_F131
SY   GM-1309; GM 1309; GM1309; GM01309B; GM1309B
DR   CLO; CLO_0030915
DR   BioSample; SAMN00803792
DR   Coriell; GM01309
DR   Wikidata; Q54836761
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6442144;
RX   PubMed=7994019;
CC   Population: African American.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 19
//
ID   GM01310
AC   CVCL_7316
SY   GM-1310; GM01310B; GM01310C; GM17212
DR   CLO; CLO_0013895
DR   CLO; CLO_0030914
DR   BioSample; SAMN00803794
DR   Coriell; GM01310
DR   Coriell; GM17212
DR   GEO; GSM569521
DR   GEO; GSM596276
DR   GEO; GSM596637
DR   GEO; GSM924814
DR   Wikidata; Q54836762
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:05:01,11:01:01; B*27:02:01,52:01:01; C*02:02:02,12:02:02; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*01:02:01,01:02:02; DQB1*05:02:01,06:09:01; DRB1*13:02:01,16:01:01; DRB3*03:01:01; DRB5*02:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X802 ! AG16504
OI   CVCL_1M95 ! AG20457
OI   CVCL_1M96 ! AG22339
OI   CVCL_7310 ! GM00967
OI   CVCL_7531 ! GM13335
OI   CVCL_7532 ! GM13336
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM01311
AC   CVCL_J110
SY   GM-1311; GM01311A; AG01311; AG-1311; AG 1311; AG1311
DR   CLO; CLO_0030913
DR   BioSample; SAMN00803796
DR   Coriell; AG01311
DR   Coriell; GM01311
DR   Wikidata; Q54836763
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: African American.
CC   Discontinued: Coriell; AG01311; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE36 ! AG01360
OI   CVCL_JE37 ! AG01485
OI   CVCL_J111 ! GM01312
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM01312
AC   CVCL_J111
SY   GM-1312; GM 1312; GM1312; GM01312A; AG01312; AG-1312; AG 1312; AG1312
DR   CLO; CLO_0030912
DR   BioSample; SAMN00803798
DR   BioSample; SAMN03151629
DR   Coriell; AG01312
DR   Coriell; GM01312
DR   Wikidata; Q54836764
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3893568;
RX   PubMed=7253718;
RX   PubMed=10936422;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00201.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG01312; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE36 ! AG01360
OI   CVCL_JE37 ! AG01485
OI   CVCL_J110 ! GM01311
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 21
//
ID   GM01322
AC   CVCL_AB28
SY   GM-1322; GM 1322
DR   CLO; CLO_0030911
DR   BioSample; SAMN00803800
DR   Coriell; GM01322
DR   Wikidata; Q54836765
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6156493;
CC   Population: African American.
CC   Karyotypic information: 68,XX [1]; 69,XXY [49] (Coriell=GM01322).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   2D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01323
AC   CVCL_1V18
SY   GM-1323
DR   CLO; CLO_0030899
DR   BioSample; SAMN00803802
DR   Coriell; GM01323
DR   Wikidata; Q54836766
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; c.590-7G>A (IVS5AS-7G>A); ClinVar=VCV000222996; Zygosity=Heterozygous (Coriell=GM01323).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (Coriell=GM01323).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61265; Scheie syndrome
DI   ORDO; Orphanet_93474; Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   GM01348
AC   CVCL_V211
SY   GM-1348; GM01348A
DR   CLO; CLO_0030900
DR   BioSample; SAMN00803804
DR   Coriell; GM01348
DR   Wikidata; Q54836772
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM01348).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM01351
AC   CVCL_HQ01
SY   GM-1351
DR   Coriell; GM01351
DR   Wikidata; Q54836773
CC   Population: Caucasian.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129865; Congenital contractural arachnodactyly
DI   ORDO; Orphanet_115; Congenital contractural arachnodactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM01352
AC   CVCL_HQ02
SY   GM-1352
DR   Coriell; GM01352
DR   Wikidata; Q54836774
CC   Population: Caucasian.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129865; Congenital contractural arachnodactyly
DI   ORDO; Orphanet_115; Congenital contractural arachnodactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM01353
AC   CVCL_4N07
SY   GM-1353
DR   CLO; CLO_0030901
DR   BioSample; SAMN00803806
DR   Coriell; GM01353
DR   Wikidata; Q54836775
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM01354
AC   CVCL_4N08
SY   GM-1354
DR   CLO; CLO_0030906
DR   BioSample; SAMN00803808
DR   Coriell; GM01354
DR   Wikidata; Q54836776
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01355
AC   CVCL_4N09
SY   GM-1355; GM01355A
DR   CLO; CLO_0030905
DR   BioSample; SAMN00803810
DR   Coriell; GM01355
DR   Wikidata; Q54836777
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01356
AC   CVCL_V830
SY   GM-1356; GM 1356
DR   CLO; CLO_0030908
DR   BioSample; SAMN00803812
DR   Coriell; GM01356
DR   Wikidata; Q54836778
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=657849;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;7)(1qter->1p34::7p13->7pter;7qter->7p13::1p34->1pter) (Coriell=GM01356).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM01358
AC   CVCL_JB82
SY   GM-1358
DR   Coriell; GM01358
DR   Wikidata; Q54836779
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01358; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01359
AC   CVCL_X080
SY   GM-1359; GM 1359
DR   CLO; CLO_0030907
DR   BioSample; SAMN00803814
DR   Coriell; GM01359
DR   Wikidata; Q54836780
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=7329430;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+18.arr(18)x3 (Coriell=GM01359).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM01361
AC   CVCL_9W81
SY   GM-1361
DR   CLO; CLO_0030903
DR   BioSample; SAMN00803816
DR   Coriell; GM01361
DR   Wikidata; Q54836781
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=30797135;
CC   Sequence variation: Mutation; HGNC; HGNC:4122; GALNS; Simple; p.Arg61Trp (c.181C>T); ClinVar=VCV000381663; Zygosity=Heterozygous (PubMed=30797135).
CC   Sequence variation: Mutation; HGNC; HGNC:4122; GALNS; Simple; p.Trp405_Thr406del (c.1207_1212TGGACC[1]) (c.1213_1218delTGGACC) (p.403_404WT[1]) (WT405del); ClinVar=VCV000566964; Zygosity=Heterozygous (PubMed=30797135).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84901; Mucopolysaccharidosis type IVA
DI   ORDO; Orphanet_309297; Mucopolysaccharidosis type 4A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM01362
AC   CVCL_L486
SY   GM-1362; Gm 1362; GM01362A
DR   CLO; CLO_0030902
DR   BioSample; SAMN00803818
DR   Coriell; GM01362
DR   Wikidata; Q54836782
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   GM01363
AC   CVCL_J112
SY   GM-1363
DR   CLO; CLO_0030904
DR   BioSample; SAMN00803820
DR   Coriell; GM01363
DR   Wikidata; Q54836783
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Ala11Ala (c.33G>C); ClinVar=VCV000640707; Zygosity=Heterozygous; Note=Silent mutation that may affect splicing (Coriell=GM01363).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   GM01364
AC   CVCL_D871
SY   GM1364; GM-1364; GM 1364
DR   CLO; CLO_0030843
DR   BioSample; SAMN00803822
DR   Coriell; GM01364
DR   Wikidata; Q54836784
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2698; DBT; Simple; p.Glu224Ter (c.670G>T) (E163X); ClinVar=VCV000094009; Zygosity=Homozygous (Coriell=GM01364).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D872 ! GM01366
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM01366
AC   CVCL_D872
SY   GM-1366; GM 1366
DR   CLO; CLO_0030842
DR   BioSample; SAMN00803824
DR   Coriell; GM01366
DR   Wikidata; Q54836785
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   HLA typing: A*02,09; B*08,12 (Coriell=GM01366).
CC   Sequence variation: Mutation; HGNC; HGNC:2698; DBT; Simple; p.Glu224Ter (c.670G>T) (E163X); ClinVar=VCV000094009; Zygosity=Homozygous (Coriell=GM01366).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D871 ! GM01364
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   GM01368
AC   CVCL_GY15
SY   GM-1368
DR   CLO; CLO_0030847
DR   BioSample; SAMN00803826
DR   Coriell; GM01368
DR   Wikidata; Q54836786
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4827; HBB; Zygosity=Homozygous (Coriell=GM01368).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4829; HBD; Zygosity=Homozygous (Coriell=GM01368).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129072; Hereditary persistence of fetal hemoglobin
DI   ORDO; Orphanet_46532; Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM01374
AC   CVCL_2H13
SY   GM1374; GM-1374
DR   CLO; CLO_0030845
DR   BioSample; SAMN00803828
DR   Coriell; GM01374
DR   GEO; GSM1266962
DR   Wikidata; Q54836787
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Val168Met (c.502G>A); ClinVar=VCV000000127; Zygosity=Unspecified (PubMed=8528202).
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   GM01375
AC   CVCL_2H14
SY   GM1375; GM-1375
DR   CLO; CLO_0030829
DR   BioSample; SAMN00803830
DR   Coriell; GM01375
DR   GEO; GSM1257683
DR   GEO; GSM1266961
DR   GEO; GSM1267043
DR   GEO; GSM1288427
DR   Wikidata; Q54836788
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   HLA typing: A*02,11; B*22,27 (Coriell=GM01375).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Indicated by Coriell to originate from mother of GM01374 but does not seem to contain any CBS mutation, therefore the pedigree relationship may be incorrect (PubMed=8528202).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM01376
AC   CVCL_2H15
SY   GM1376; GM-1376
DR   CLO; CLO_0030831
DR   BioSample; SAMN00803832
DR   Coriell; GM01376
DR   GEO; GSM1257684
DR   GEO; GSM1266960
DR   GEO; GSM1267042
DR   GEO; GSM1288428
DR   Wikidata; Q54836789
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Gly307Ser (c.919G>A); ClinVar=VCV000000117; Zygosity=Heterozygous (PubMed=8528202).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Indicated by Coriell to originate from father of GM01374 but does not contain the same CBS mutation, therefore the pedigree relationship may be incorrect (PubMed=8528202).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   GM01377
AC   CVCL_4N10
SY   GM-1377
DR   CLO; CLO_0030833
DR   BioSample; SAMN00803834
DR   Coriell; GM01377
DR   Wikidata; Q54836790
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01379
AC   CVCL_7317
SY   GM1379; GM-1379; GM 1379; GM01379A
DR   CLO; CLO_0030835
DR   Coriell; GM01379
DR   Wikidata; Q54836791
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7319 ! GM01381
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM01380
AC   CVCL_7318
SY   GM1380; GM-1380; GM 1380; GM 01380; GM01380A
DR   CLO; CLO_0030836
DR   BioSample; SAMN00803836
DR   Coriell; GM01380
DR   Wikidata; Q54836792
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3374507;
CC   Population: Puerto Rican.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7266 ! GM00010
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM01381
AC   CVCL_7319
SY   GM1381; GM-1381; GM 1381; GM1381A; GM01381B
DR   CLO; CLO_0030837
DR   Coriell; GM01381
DR   Wikidata; Q54836793
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7329430;
RX   PubMed=7471105;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7317 ! GM01379
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 18
//
ID   GM01385
AC   CVCL_4N11
SY   GM-1385
DR   CLO; CLO_0030818
DR   BioSample; SAMN00803838
DR   Coriell; GM01385
DR   Wikidata; Q54836794
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01386
AC   CVCL_4N12
SY   GM-1386
DR   CLO; CLO_0030828
DR   BioSample; SAMN00803840
DR   Coriell; GM01386
DR   Wikidata; Q54836795
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01387
AC   CVCL_J114
SY   GM-1387; GM 1387
DR   CLO; CLO_0030825
DR   BioSample; SAMN00803842
DR   Coriell; GM01387
DR   Wikidata; Q54836796
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,+der(9)(9pter->9q21.2::13q12.1->13qter)mat,-13 (Coriell=GM01387).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J113 ! GM01388
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM01388
AC   CVCL_J113
SY   GM-1388; GM 1388
DR   CLO; CLO_0030823
DR   BioSample; SAMN00803844
DR   Coriell; GM01388
DR   Wikidata; Q54836797
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J114 ! GM01387
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM01389
AC   CVCL_F028
SY   GM-1389; GM01389A; GM01389D; XP408BE
DR   CLO; CLO_0030821
DR   BioSample; SAMN00803846
DR   Coriell; GM01389
DR   Wikidata; Q54836798
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9584159;
RX   PubMed=10655550;
RX   PubMed=10777490;
RX   PubMed=12812979;
RX   PubMed=26184184;
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Asn349del (c.1045_1047delAAC); ClinVar=VCV002137064; Zygosity=Heterozygous (PubMed=10777490; PubMed=12812979; PubMed=26184184).
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Leu350Pro (c.1049T>C); ClinVar=VCV002137065; Zygosity=Heterozygous (PubMed=10777490; PubMed=12812979; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7327 ! GM01646
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM01390
AC   CVCL_8517
SY   GM-1390; GM 1390
DR   CLO; CLO_0030813
DR   BioSample; SAMN00803848
DR   Coriell; GM01390
DR   Wikidata; Q54836799
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
RX   PubMed=18691744;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (PubMed=1346349; PubMed=1680289).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.1050_1054delGAAGA; Zygosity=Heterozygous (Coriell=GM01390).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   GM01391
AC   CVCL_1V13
SY   GM-1391; GM 01391
DR   CLO; CLO_0030816
DR   BioSample; SAMN00803850
DR   Coriell; GM01391
DR   GEO; GSM651172
DR   GEO; GSM651173
DR   GEO; GSM1266965
DR   GEO; GSM1267046
DR   Wikidata; Q54836801
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
RX   PubMed=21418647;
RX   PubMed=25326100;
RX   PubMed=35070079;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM01392
AC   CVCL_1V14
SY   GM-1392
DR   CLO; CLO_0030810
DR   BioSample; SAMN00803852
DR   Coriell; GM01392
DR   GEO; GSM651148
DR   GEO; GSM651149
DR   GEO; GSM1257696
DR   GEO; GSM1266964
DR   GEO; GSM1267045
DR   GEO; GSM1288429
DR   Wikidata; Q54836802
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM01393
AC   CVCL_1V15
SY   GM-1393
DR   CLO; CLO_0030812
DR   BioSample; SAMN00803854
DR   Coriell; GM01393
DR   GEO; GSM651114
DR   GEO; GSM651115
DR   GEO; GSM1257695
DR   GEO; GSM1266963
DR   GEO; GSM1267044
DR   GEO; GSM1288430
DR   Wikidata; Q54836803
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM01396
AC   CVCL_V804
SY   GM-1396; GM 1396
DR   CLO; CLO_0030817
DR   BioSample; SAMN00803856
DR   Coriell; GM01396
DR   Wikidata; Q54836804
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=598254;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM01399
AC   CVCL_X245
SY   GM-1399; GM 1399
DR   CLO; CLO_0030808
DR   BioSample; SAMN00803858
DR   Coriell; GM01399
DR   Wikidata; Q54836805
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM01404
AC   CVCL_JC90
SY   GM-1404
DR   CLO; CLO_0030807
DR   BioSample; SAMN00803860
DR   Coriell; GM01404
DR   Wikidata; Q54836806
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Karyotypic information: 46,XY; but phenotypically female (Coriell=GM01404).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   20Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM01406
AC   CVCL_AV86
SY   GM-1406; GM1406
DR   CLO; CLO_0030801
DR   BioSample; SAMN00803862
DR   Coriell; GM01406
DR   Wikidata; Q54836807
RX   CelloPub=CLPUB00447;
RX   PubMed=2837086;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98944; Hereditary orotic aciduria
DI   ORDO; Orphanet_30; Hereditary orotic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM01408
AC   CVCL_DF17
SY   GM-1408; AG01408; AG-1408; AG 1408; AG1408
DR   CLO; CLO_0030799
DR   BioSample; SAMN00803864
DR   Coriell; AG01408
DR   Coriell; GM01408
DR   Wikidata; Q54836808
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG01408; probable.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM01409
AC   CVCL_J115
SY   GM-1409
DR   CLO; CLO_0030805
DR   Coriell; GM01409
DR   Wikidata; Q54836809
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J116 ! GM01410
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM01410
AC   CVCL_J116
SY   GM-1410; GM 1410
DR   CLO; CLO_0030803
DR   Coriell; GM01410
DR   Wikidata; Q54836810
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J115 ! GM01409
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM01411
AC   CVCL_0P92
SY   GM-1411; GM1411
DR   CLO; CLO_0030790
DR   BioSample; SAMN00803866
DR   Coriell; GM01411
DR   Wikidata; Q54836811
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
CC   Population: African American.
CC   Karyotypic information: 46,X,t(X;21)(q11;p11) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM01413
AC   CVCL_V463
SY   GM-1413; GM 1413; GM01413B
DR   CLO; CLO_0030792
DR   BioSample; SAMN00803868
DR   Coriell; GM01413
DR   Wikidata; Q54836812
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 46,XX,der(10)(10pter->10q26::21q21->21qter)mat (Coriell=GM01413).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM01414
AC   CVCL_X246
SY   GM-1414; GM 1414; GM1414
DR   CLO; CLO_0030794
DR   BioSample; SAMN00803870
DR   Coriell; GM01414
DR   Wikidata; Q54836814
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: African American.
CC   Karyotypic information: 46,X,der(9)t(X;9)(q34;q12) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   GM01415
AC   CVCL_F656
SY   GM-1415; GM 1415; GM01415E
DR   CLO; CLO_0030796
DR   BioSample; SAMN00803872
DR   Coriell; GM01415
DR   Wikidata; Q54836815
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F657 ! GM01416
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM01416
AC   CVCL_F657
SY   GM-1416; GM 1416; GM1416; GM01416B
DR   CLO; CLO_0030788
DR   BioSample; SAMN00803874
DR   Coriell; GM01416
DR   Wikidata; Q54836816
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F656 ! GM01415
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   GM01417
AC   CVCL_1Y25
SY   GM-1417
DR   CLO; CLO_0030787
DR   Coriell; GM01417
DR   Wikidata; Q54836817
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM01417).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01418
AC   CVCL_1Y26
SY   GM-1418
DR   CLO; CLO_0030786
DR   Coriell; GM01418
DR   Wikidata; Q54836818
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM01418).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01419
AC   CVCL_1Y27
SY   GM-1419
DR   CLO; CLO_0030784
DR   Coriell; GM01419
DR   Wikidata; Q54836819
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM01419).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01420
AC   CVCL_JD99
SY   GM-1420
DR   Coriell; GM01420
DR   Wikidata; Q54836820
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01420; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01421
AC   CVCL_V805
SY   GM-1421
DR   CLO; CLO_0030782
DR   BioSample; SAMN00803876
DR   Coriell; GM01421
DR   Wikidata; Q54836821
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=446100;
CC   Population: African American.
CC   Karyotypic information: 46,XY,t(1;6)(1pter->1q42::6q21->6qter;6pter->6q21::1q42->1qter) (Coriell=GM01421).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM01422
AC   CVCL_0P93
SY   GM-1422
DR   CLO; CLO_0030780
DR   BioSample; SAMN00803878
DR   Coriell; GM01422
DR   Wikidata; Q54836822
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Ser371Cys (c.1111A>T); ClinVar=VCV000016333; Zygosity=Heterozygous (Coriell=GM01422).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM01426
AC   CVCL_0M01
SY   GM-1426
DR   CLO; CLO_0030778
DR   BioSample; SAMN00803880
DR   Coriell; GM01426
DR   Wikidata; Q54836823
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=30933722;
RX   PubMed=34411609;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Glu153Lys (c.457G>A); ClinVar=VCV001067431; Zygosity=Homozygous (Coriell=GM01426).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM01429
AC   CVCL_X247
SY   GM-1429; GM 1429; GM1429
DR   CLO; CLO_0030777
DR   BioSample; SAMN00803884
DR   Coriell; GM01429
DR   Wikidata; Q54836825
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=10377420;
CC   Population: African American.
CC   Karyotypic information: 46,X,t(X;9)(q13;q34) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM01430
AC   CVCL_AI26
SY   GM-1430
DR   CLO; CLO_0030772
DR   Coriell; GM01430
DR   Wikidata; Q54836826
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
RX   PubMed=29990710;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI24 ! GM01243
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   GM01435
AC   CVCL_N345
SY   GM-1435
DR   CLO; CLO_0030888
DR   Coriell; GM01435
DR   Wikidata; Q54836827
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N344 ! GM01242
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   GM01436
AC   CVCL_DD67
SY   GM-1436; GM01436A
DR   CLO; CLO_0030889
DR   BioSample; SAMN00803886
DR   Coriell; GM01436
DR   Wikidata; Q54836828
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01441
AC   CVCL_X248
SY   GM-1441; GM 1441
DR   CLO; CLO_0030890
DR   BioSample; SAMN00803888
DR   Coriell; GM01441
DR   Wikidata; Q54836829
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM01442
AC   CVCL_0M09
SY   GM-1442; GM01442A
DR   CLO; CLO_0030891
DR   BioSample; SAMN00803890
DR   Coriell; GM01442
DR   Wikidata; Q54836830
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM01443
AC   CVCL_0M10
SY   GM-1443
DR   CLO; CLO_0030892
DR   BioSample; SAMN00803892
DR   Coriell; GM01443
DR   Wikidata; Q54836831
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM01444
AC   CVCL_0M11
SY   GM-1444
DR   CLO; CLO_0030894
DR   Coriell; GM01444
DR   Wikidata; Q54836832
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM01445
AC   CVCL_V212
SY   GM-1445; GM01445B
DR   CLO; CLO_0030897
DR   BioSample; SAMN00803894
DR   Coriell; GM01445
DR   Wikidata; Q54836833
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM01445).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM01446
AC   CVCL_2H16
SY   GM-1446
DR   CLO; CLO_0030898
DR   BioSample; SAMN00803896
DR   Coriell; GM01446
DR   Wikidata; Q54836834
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01447
AC   CVCL_2H17
SY   GM-1447
DR   CLO; CLO_0030881
DR   BioSample; SAMN00803898
DR   Coriell; GM01447
DR   Wikidata; Q54836835
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01448
AC   CVCL_4N13
SY   GM-1448; GM01448A
DR   CLO; CLO_0030879
DR   BioSample; SAMN00803900
DR   Coriell; GM01448
DR   Wikidata; Q54836837
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=12406975;
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Gly219del (c.651TGG[1]) (c.654_656delTGG) (G197del, c.652delGGT); ClinVar=VCV000226329; Zygosity=Heterozygous (Coriell=GM01448).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 17
//
ID   GM01453
AC   CVCL_AE18
SY   GM-1453
DR   CLO; CLO_0030868
DR   BioSample; SAMN00803902
DR   Coriell; GM01453
DR   Wikidata; Q54836839
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84525; Abetalipoproteinemia
DI   ORDO; Orphanet_14; Abetalipoproteinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE19 ! GM10012
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM01454
AC   CVCL_GY16
SY   GM-1454
DR   CLO; CLO_0030871
DR   BioSample; SAMN00803904
DR   Coriell; GM01454
DR   Wikidata; Q54836840
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Leu262Thrfs*21 (c.784_785delCT) (940_941delCT); ClinVar=VCV000002937; Zygosity=Homozygous (Coriell=GM01454).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129070; Cystathioninuria
DI   ORDO; Orphanet_212; Cystathioninuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 27-11-25; Version: 14
//
ID   GM01455
AC   CVCL_IZ38
SY   GM-1455; GM01455A
DR   CLO; CLO_0030872
DR   Coriell; GM01455
DR   Wikidata; Q54836841
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   HLA typing: A*11,03; B*w22,w40 (Coriell=GM01455).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35637; Hyperlipoproteinemia, type IIb
DI   ORDO; Orphanet_444490; Familial chylomicronemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM01456
AC   CVCL_EJ27
SY   GM-1456; GM01456A
DR   CLO; CLO_0030869
DR   BioSample; SAMN00803906
DR   Coriell; GM01456
DR   Wikidata; Q54836842
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr67Ile (c.200C>T); ClinVar=VCV000002939; Zygosity=Heterozygous (Coriell=GM01456).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM01458
AC   CVCL_4N14
SY   GM-1458; GM01458A
DR   CLO; CLO_0030870
DR   Coriell; GM01458
DR   Wikidata; Q54836843
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM01459
AC   CVCL_4N15
SY   GM-1459; GM01459B
DR   CLO; CLO_0030876
DR   BioSample; SAMN00803908
DR   Coriell; GM01459
DR   Wikidata; Q54836844
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N04 ! GM00486
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM01460
AC   CVCL_4N16
SY   GM-1460; GM01460A
DR   CLO; CLO_0030878
DR   Coriell; GM01460
DR   Wikidata; Q54836845
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=12406975;
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys667Tyr (c.2000G>A) (C646Y); ClinVar=VCV000003689; Zygosity=Heterozygous (Coriell=GM01460).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7288 ! GM00483
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 17
//
ID   GM01461
AC   CVCL_EJ28
SY   GM-1461
DR   CLO; CLO_0030873
DR   BioSample; SAMN00803910
DR   Coriell; GM01461
DR   Wikidata; Q54836846
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   HLA typing: A*02,03; B*w22,w40 (Coriell=GM01461).
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr67Ile (c.200C>T); ClinVar=VCV000002939; Zygosity=Heterozygous (Coriell=GM01461).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM01463
AC   CVCL_2H18
SY   GM-1463
DR   CLO; CLO_0030874
DR   BioSample; SAMN00803912
DR   Coriell; GM01463
DR   Wikidata; Q54836848
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Ala331Val (c.992C>T); ClinVar=VCV000193793; Zygosity=Unspecified (PubMed=8528202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01464
AC   CVCL_1K51
SY   GM-1464; GM 1464
DR   CLO; CLO_0030862
DR   BioSample; SAMN00803914
DR   Coriell; GM01464
DR   Wikidata; Q54836849
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1652892;
RX   PubMed=2112341;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM01464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM01465
AC   CVCL_AA15
SY   GM-1465
DR   CLO; CLO_0031429
DR   BioSample; SAMN00806860
DR   Coriell; GM01465
DR   Wikidata; Q54836850
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01466
AC   CVCL_AA16
SY   GM-1466; GM01466A
DR   CLO; CLO_0031431
DR   BioSample; SAMN00806862
DR   Coriell; GM01466
DR   Wikidata; Q54836851
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01482
AC   CVCL_H974
SY   GM-1482
DR   CLO; CLO_0031430
DR   BioSample; SAMN00806864
DR   Coriell; GM01482
DR   Wikidata; Q54836852
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C27725; Porphyria cutanea tarda
DI   ORDO; Orphanet_101330; Porphyria cutanea tarda
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM01484
AC   CVCL_F130
SY   GM1484; AG01484; AG-1484; AG 1484; AG1484
DR   CLO; CLO_0031433
DR   BioSample; SAMN00806866
DR   Coriell; AG01484
DR   Coriell; GM01484
DR   Wikidata; Q54836853
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; AG01484; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F129 ! GM01142
SX   Female
AG   2Y3M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   GM01486
AC   CVCL_H973
SY   GM-1486
DR   CLO; CLO_0031432
DR   BioSample; SAMN00806868
DR   Coriell; GM01486
DR   Wikidata; Q54836854
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H972 ! GM01241
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM01487
AC   CVCL_T811
SY   GM-1487
DR   CLO; CLO_0031435
DR   BioSample; SAMN00806870
DR   Coriell; GM01487
DR   Wikidata; Q54836855
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   GM01488
AC   CVCL_T809
SY   GM-1488
DR   CLO; CLO_0031434
DR   BioSample; SAMN00806872
DR   Coriell; GM01488
DR   Wikidata; Q54836856
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T810 ! GM02497
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
ID   GM01489
AC   CVCL_T812
SY   GM-1489
DR   CLO; CLO_0031437
DR   BioSample; SAMN00806874
DR   Coriell; GM01489
DR   Wikidata; Q54836865
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
ID   GM01490
AC   CVCL_T813
DR   CLO; CLO_0031436
DR   BioSample; SAMN00806876
DR   Coriell; GM01490
DR   Wikidata; Q54836866
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34387; Anorexia nervosa
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T814 ! GM02503
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
ID   GM01491
AC   CVCL_JD87
SY   GM-1491
DR   Coriell; GM01491
DR   Wikidata; Q54836867
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01491; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   8Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01492
AC   CVCL_7320
SY   GM-1492; GM 1492; GM1492; GM01492B; GM1492B; GM01492C; GM1492C; GM 1492c; GM01492E; BLM1492; HG1232
DR   BTO; BTO_0003590
DR   CLO; CLO_0031438
DR   BioSample; SAMN00806878
DR   Coriell; GM01492
DR   GEO; GSM1316972
DR   GEO; GSM1317009
DR   Wikidata; Q54836868
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=436333;
RX   PubMed=761484;
RX   PubMed=908169;
RX   PubMed=6622549;
RX   PubMed=6667451;
RX   PubMed=6722766;
RX   PubMed=7067035;
RX   PubMed=7471105;
RX   PubMed=7471106;
RX   PubMed=10521302;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155; Coriell=GM01492).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 44(AbRu) (BSR44).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   GM01493
AC   CVCL_1M67
SY   GM-1493; GM 1493; GM1493; GM 1493b; GM1493C
DR   Coriell; GM01493
DR   Wikidata; Q54836869
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=436333;
RX   PubMed=761484;
RX   PubMed=908169;
RX   PubMed=6667451;
CC   Donor information: From Bloom Syndrome Registry patient 57(AmEl) (BSR57).
CC   Discontinued: Coriell; GM01493; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   GM01494
AC   CVCL_9R61
SY   GM-1494
DR   CLO; CLO_0031442
DR   BioSample; SAMN00806880
DR   Coriell; GM01494
DR   Wikidata; Q54836870
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Lys4Gln (c.10A>C); ClinVar=VCV000002774; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   GM01496
AC   CVCL_AI27
SY   GM-1496
DR   CLO; CLO_0031441
DR   Coriell; GM01496
DR   Wikidata; Q54836871
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI25 ! GM01244
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM01497
AC   CVCL_AI28
SY   GM-1497
DR   CLO; CLO_0031440
DR   Coriell; GM01497
DR   Wikidata; Q54836872
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI29 ! GM01498
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM01498
AC   CVCL_AI29
SY   GM-1498; GM 1498
DR   CLO; CLO_0031439
DR   Coriell; GM01498
DR   Wikidata; Q54836873
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI28 ! GM01497
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   GM01500
AC   CVCL_D870
SY   GM-1500; GM 1500; GM1500; GM01500B
DR   CLO; CLO_0031446
DR   Coriell; GM01500
DR   Wikidata; Q54836874
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3495441;
RX   PubMed=3893568;
RX   PubMed=7313555;
RX   PubMed=10936422;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa (Coriell=GM01500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   GM01501
AC   CVCL_9Y81
SY   GM-1501
DR   CLO; CLO_0031445
DR   Coriell; GM01501
DR   Wikidata; Q54836875
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01503
AC   CVCL_8A59
SY   GM-1503; GM1503; GM01503A
DR   CLO; CLO_0031444
DR   BioSample; SAMN00806882
DR   Coriell; GM01503
DR   Wikidata; Q54836876
RX   PubMed=2376596;
RX   PubMed=30471880;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM01506
AC   CVCL_4N17
SY   GM-1506
DR   CLO; CLO_0031443
DR   Coriell; GM01506
DR   Wikidata; Q54836877
CC   Karyotypic information: 46,XY,rec(3)(qter->p25::q21->qter) [46]; 46,XY,rec(3)(qter->p25::q21->qter),+8 [4] (Coriell=GM01506).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM01509
AC   CVCL_1F07
SY   GM-1509
DR   CLO; CLO_0031448
DR   BioSample; SAMN00806884
DR   Coriell; GM01509
DR   Wikidata; Q54836878
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01512
AC   CVCL_0P94
SY   GM-1512
DR   CLO; CLO_0031447
DR   BioSample; SAMN00806886
DR   Coriell; GM01512
DR   Wikidata; Q54836879
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(8;10)(8qter->8p21.1::10p15->10pter;10qter->10p15::8p21.1->8pter) (Coriell=GM01512).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01516
AC   CVCL_AM63
SY   GM-1516
DR   CLO; CLO_0031478
DR   BioSample; SAMN00806888
DR   Coriell; GM01516
DR   GEO; GSM1266976
DR   GEO; GSM1267055
DR   GEO; GSM1288431
DR   Wikidata; Q54836880
RX   CelloPub=CLPUB00447;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   GM01524
AC   CVCL_X249
SY   GM-1524; GM 1524; GM1524
DR   CLO; CLO_0031474
DR   BioSample; SAMN00806890
DR   Coriell; GM01524
DR   GEO; GSM796
DR   Wikidata; Q54836881
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=9150358;
RX   PubMed=11687795;
CC   Population: African American.
CC   Karyotypic information: 46,XY,der(5)(5pter->5q33::6q15->6q25::5q33->5qter)mat (Coriell=GM01524).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 14
//
ID   GM01528
AC   CVCL_2H19
SY   GM-1528
DR   CLO; CLO_0031477
DR   Coriell; GM01528
DR   Wikidata; Q54836884
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; c.1149_1226del (Ex11del); Zygosity=Unspecified (PubMed=8528202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM01529
AC   CVCL_2H20
SY   GM-1529
DR   CLO; CLO_0031470
DR   Coriell; GM01529
DR   Wikidata; Q54836885
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01530
AC   CVCL_V213
SY   GM-1530
DR   CLO; CLO_0031471
DR   Coriell; GM01530
DR   Wikidata; Q54836886
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly542Ter (c.1624G>T); ClinVar=VCV000007115; Zygosity=Heterozygous (Coriell=GM01530).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.His609Arg (c.1826A>G); ClinVar=VCV000053398; Zygosity=Heterozygous (Coriell=GM01530).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM01531
AC   CVCL_V214
SY   GM-1531
DR   CLO; CLO_0031472
DR   BioSample; SAMN00806896
DR   Coriell; GM01531
DR   Wikidata; Q54836887
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM01532
AC   CVCL_2H21
SY   GM-1532
DR   CLO; CLO_0031473
DR   Coriell; GM01532
DR   Wikidata; Q54836888
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01533
AC   CVCL_V806
SY   GM-1533; GM1533; GM1533B
DR   CLO; CLO_0031469
DR   BioSample; SAMN00806898
DR   Coriell; GM01533
DR   Wikidata; Q54836889
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2498246;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;3)(q26;p12) (PubMed=10377420).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM01533).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM01534
AC   CVCL_JD84
SY   GM-1534
DR   Coriell; GM01534
DR   Wikidata; Q54836890
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01534; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01535
AC   CVCL_X250
SY   GM-1535; GM 1535; GM1535
DR   CLO; CLO_0031488
DR   BioSample; SAMN00806900
DR   Coriell; GM01535
DR   GEO; GSM797
DR   Wikidata; Q54836891
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM01536
AC   CVCL_M986
SY   GM-1536; GM17153
DR   CLO; CLO_0013958
DR   CLO; CLO_0031487
DR   BioSample; SAMN00806902
DR   Coriell; GM01536
DR   Coriell; GM17153
DR   GEO; GSM924663
DR   IPD-IMGT/HLA; 16418
DR   Wikidata; Q54836892
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*33:01,74:AB; B*15:BKNX,53:01; C*02:10,04:CVAF; DRB1*08:04,13:02 (IPD-IMGT/HLA=16418).
CC   Karyotypic information: 46,XX,t(5;12)(5pter->5q33::12q24->12qter;12pter->12q24::5q33->5qter) (Coriell=GM01536).
CC   Omics: Genomics; DNA methylation analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM01549
AC   CVCL_X081
SY   GM-1549; GM 1549
DR   CLO; CLO_0031485
DR   Coriell; GM01549
DR   Wikidata; Q54836893
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM01550
AC   CVCL_0P95
SY   GM-1550
DR   CLO; CLO_0031486
DR   BioSample; SAMN00806904
DR   Coriell; GM01550
DR   Wikidata; Q54836894
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01552
AC   CVCL_2Z61
SY   GM-1552
DR   CLO; CLO_0031483
DR   BioSample; SAMN00806906
DR   Coriell; GM01552
DR   Wikidata; Q54836895
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z62 ! GM01553
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01553
AC   CVCL_2Z62
SY   GM-1553
DR   CLO; CLO_0031484
DR   BioSample; SAMN00806908
DR   Coriell; GM01553
DR   Wikidata; Q54836896
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z61 ! GM01552
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01555
AC   CVCL_V807
SY   GM-1555; GM 1555; GM1555
DR   CLO; CLO_0031481
DR   BioSample; SAMN00806910
DR   Coriell; GM01555
DR   Wikidata; Q54836897
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761480;
RX   PubMed=6661932;
RX   PubMed=7329430;
RX   PubMed=7471105;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM01557
AC   CVCL_CX15
SY   GM-1557
DR   Coriell; GM01557
DR   Wikidata; Q54836898
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01557; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM01558
AC   CVCL_2H22
SY   GM-1558
DR   CLO; CLO_0031482
DR   Coriell; GM01558
DR   Wikidata; Q54836900
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01559
AC   CVCL_2H23
SY   GM-1559
DR   CLO; CLO_0031479
DR   Coriell; GM01559
DR   Wikidata; Q54836901
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Arg224His (c.676G>A); Zygosity=Heterozygous (PubMed=8528202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G97 ! GM00585
SX   Male
AG   65-70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01560
AC   CVCL_2H24
SY   GM-1560
DR   CLO; CLO_0031480
DR   Coriell; GM01560
DR   Wikidata; Q54836903
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Arg224His (c.676G>A); Zygosity=Unspecified (from familial inference of GM01559).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2G96 ! GM00584
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01561
AC   CVCL_V808
SY   GM-1561
DR   CLO; CLO_0031456
DR   BioSample; SAMN00806912
DR   Coriell; GM01561
DR   Wikidata; Q54836904
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;11)(4pter->4q23::11q11->11qter;11pter->11q11::4q23->4qter) [8]; 45,X,t(4;11)(4pter->4q23::11q11->11qter;11pter->11q11::4q23->4qter),add(19)(?::p13.3->qter) [2] (Coriell=GM01561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V768 ! GM00380
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM01562
AC   CVCL_EJ29
SY   GM-1562
DR   CLO; CLO_0031458
DR   BioSample; SAMN00806914
DR   Coriell; GM01562
DR   Wikidata; Q54836905
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM01564
AC   CVCL_X251
SY   GM-1564; GM 1564
DR   CLO; CLO_0031457
DR   BioSample; SAMN00806916
DR   Coriell; GM01564
DR   Wikidata; Q54836908
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM01565
AC   CVCL_9R62
SY   GM-1565
DR   CLO; CLO_0031449
DR   BioSample; SAMN00806918
DR   Coriell; GM01565
DR   Wikidata; Q54836913
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=38552357;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr67Ile (c.200C>T); ClinVar=VCV000002939; Zygosity=Homozygous (Coriell=GM01565).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg252Gln (c.755G>A); ClinVar=VCV000102824; Zygosity=Heterozygous (Coriell=GM01565).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.1315+1G>A (IVS12+1G>A); ClinVar=VCV000000576; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM01565).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129070; Cystathioninuria
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_212; Cystathioninuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 17
//
ID   GM01566
AC   CVCL_GY17
SY   GM-1566
DR   CLO; CLO_0031450
DR   BioSample; SAMN00806919
DR   Coriell; GM01566
DR   Wikidata; Q54836914
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*01,28; B*13,w35 (Coriell=GM01566).
CC   Karyotypic information: 47,XX,+12 [66%]; 46,XX,-10,+12 [30%]; 45,XX,-10 [4%] (Coriell=GM01566).
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr67Ile (c.200C>T); ClinVar=VCV000002939; Zygosity=Heterozygous (Coriell=GM01566).
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr355Ilefs*19 (c.1064delC); ClinVar=VCV001033458; Zygosity=Heterozygous (Coriell=GM01566).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129070; Cystathioninuria
DI   ORDO; Orphanet_212; Cystathioninuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   GM01567
AC   CVCL_4N18
SY   GM-1567
DR   CLO; CLO_0031451
DR   BioSample; SAMN00806921
DR   Coriell; GM01567
DR   Wikidata; Q54836915
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM01568
AC   CVCL_1K52
SY   GM-1568
DR   CLO; CLO_0031452
DR   BioSample; SAMN00806923
DR   Coriell; GM01568
DR   Wikidata; Q54836916
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01570
AC   CVCL_V809
SY   GM-1570; GM 1570
DR   CLO; CLO_0031453
DR   Coriell; GM01570
DR   Wikidata; Q54836917
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=446098;
RX   PubMed=6661932;
CC   Karyotypic information: 6,XY,rec(13)(pter->q22::p11->pter)pat (Coriell=GM01570).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM01571
AC   CVCL_W031
SY   GM-1571; GM 1571; GM1571
DR   CLO; CLO_0031454
DR   BioSample; SAMN00806925
DR   Coriell; GM01571
DR   Wikidata; Q54836918
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1409720;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM01575
AC   CVCL_2Z63
SY   GM-1575; GM 1575; GM1575
DR   CLO; CLO_0031455
DR   BioSample; SAMN00806927
DR   Coriell; GM01575
DR   Wikidata; Q54836919
RX   CelloPub=CLPUB00447;
RX   PubMed=2897722;
RX   PubMed=6442144;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z64 ! GM01576
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM01576
AC   CVCL_2Z64
SY   GM-1576
DR   CLO; CLO_0031468
DR   BioSample; SAMN00806929
DR   Coriell; GM01576
DR   Wikidata; Q54836920
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z63 ! GM01575
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01577
AC   CVCL_2Z65
SY   GM-1577; GM01577A
DR   CLO; CLO_0031467
DR   BioSample; SAMN00806931
DR   Coriell; GM01577
DR   Wikidata; Q54836921
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z66 ! GM01578
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01578
AC   CVCL_2Z66
SY   GM-1578
DR   CLO; CLO_0031466
DR   BioSample; SAMN00806933
DR   Coriell; GM01578
DR   Wikidata; Q54836922
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z65 ! GM01577
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01579
AC   CVCL_0P96
SY   GM-1579
DR   CLO; CLO_0031465
DR   BioSample; SAMN00806935
DR   Coriell; GM01579
DR   Wikidata; Q54836923
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   GM01580
AC   CVCL_0P97
SY   GM-1580
DR   CLO; CLO_0031461
DR   BioSample; SAMN00806937
DR   Coriell; GM01580
DR   Wikidata; Q54836924
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Karyotypic information: 46,XX,t(10;21)(10pter->10q26::21q21->21qter;21pter->21q21::10q26->10qter) (Coriell=GM01580).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01581
AC   CVCL_JD78
SY   GM-1581
DR   Coriell; GM01581
DR   Wikidata; Q54836925
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01581; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01582
AC   CVCL_7323
SY   GM1582; GM-1582; GM01582A; GM1582A; GM00240; GM0240; GM-240
DR   CLO; CLO_0031462
DR   BioSample; SAMN00806939
DR   Coriell; GM00240
DR   Coriell; GM01582
DR   GEO; GSM3124639
DR   Wikidata; Q54836927
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=12665480;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; GM00240; true.
CC   Discontinued: Coriell; GM01582; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM01583
AC   CVCL_D511
SY   GM-1583
DR   CLO; CLO_0031459
DR   BioSample; SAMN00806941
DR   Coriell; GM01583
DR   Wikidata; Q54836928
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM01584
AC   CVCL_D512
SY   GM-1584
DR   CLO; CLO_0031460
DR   BioSample; SAMN00806943
DR   Coriell; GM01584
DR   Wikidata; Q54836929
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM01586
AC   CVCL_9Q87
SY   GM-1586; GM01586C
DR   CLO; CLO_0031463
DR   BioSample; SAMN00806945
DR   Coriell; GM01586
DR   Wikidata; Q54836930
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Homozygous (PubMed=16465621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5W
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM01588
AC   CVCL_1L41
SY   GM-1588
DR   CLO; CLO_0031464
DR   BioSample; SAMN00806947
DR   Coriell; GM01588
DR   Wikidata; Q54836931
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg35Ter (c.103C>T); ClinVar=VCV000003025; Zygosity=Homozygous (Coriell=GM01588).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM01589
AC   CVCL_9Q88
SY   GM-1589
DR   CLO; CLO_0031544
DR   BioSample; SAMN00806949
DR   Coriell; GM01589
DR   Wikidata; Q54836932
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM01590
AC   CVCL_9Q89
SY   GM-1590
DR   CLO; CLO_0031540
DR   BioSample; SAMN00806951
DR   Coriell; GM01590
DR   Wikidata; Q54836933
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM01598
AC   CVCL_2Y95
SY   GM-1598; GM1598
DR   CLO; CLO_0031543
DR   BioSample; SAMN00806953
DR   Coriell; GM01598
DR   Wikidata; Q54836934
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=22282976;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01599
AC   CVCL_AK17
SY   GM-1599
DR   CLO; CLO_0031537
DR   BioSample; SAMN00806955
DR   Coriell; GM01599
DR   Wikidata; Q54836935
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM01600
AC   CVCL_AK18
SY   GM-1600
DR   CLO; CLO_0031538
DR   BioSample; SAMN00806957
DR   Coriell; GM01600
DR   Wikidata; Q54836936
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125694; Sitosterolemia
DI   ORDO; Orphanet_2882; Sitosterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM01601
AC   CVCL_AK19
SY   GM-1601
DR   CLO; CLO_0031554
DR   BioSample; SAMN00806959
DR   Coriell; GM01601
DR   Wikidata; Q54836937
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM01602
AC   CVCL_9W82
SY   GM-1602
DR   CLO; CLO_0031553
DR   BioSample; SAMN00806961
DR   Coriell; GM01602
DR   Wikidata; Q54836939
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8910459;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Trp273Leu (c.818G>T); ClinVar=VCV000000931; Zygosity=Heterozygous (Coriell=GM01602).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Arg482His (c.1445G>A); ClinVar=VCV000000932; Zygosity=Heterozygous (Coriell=GM01602).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84902; Mucopolysaccharidosis type IVB
DI   ORDO; Orphanet_309310; Mucopolysaccharidosis type 4B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   GM01603
AC   CVCL_7324
SY   GM1603; GM-1603; GM 1603; GM1603A; GM01603B
DR   CLO; CLO_0031551
DR   BioSample; SAMN00806963
DR   Coriell; GM01603
DR   Wikidata; Q54836940
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7325 ! GM01604
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM01604
AC   CVCL_7325
SY   GM1604; GM-1604; GM 1604; GM01604A
DR   CLO; CLO_0031549
DR   BioSample; SAMN00806965
DR   Coriell; GM01604
DR   Wikidata; Q54836941
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3374507;
RX   PubMed=10655550;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7324 ! GM01603
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 18
//
ID   GM01605
AC   CVCL_0P98
SY   GM-1605
DR   CLO; CLO_0031547
DR   BioSample; SAMN00806967
DR   Coriell; GM01605
DR   Wikidata; Q54836942
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(6;11)(p23;q23) (Coriell=GM01605).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01606
AC   CVCL_F266
SY   GM-1606; GM 1606; GM01606A
DR   CLO; CLO_0003520
DR   CLO; CLO_0031564
DR   CLDB; cl1487
DR   Coriell; GM01606
DR   Wikidata; Q54836943
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6782865;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM01607
AC   CVCL_7326
SY   GM-1607; GM1607
DR   CLO; CLO_0003521
DR   CLO; CLO_0031565
DR   CLDB; cl1488
DR   BioSample; SAMN00806969
DR   Coriell; GM01607
DR   Wikidata; Q54836944
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2464926;
RX   PubMed=6593712;
RX   PubMed=19815695;
RX   PubMed=30497978;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=19815695; PubMed=30497978).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Val433Leu (c.1297G>T) (V394L); ClinVar=VCV000004292; Zygosity=Heterozygous (PubMed=19815695; PubMed=30497978).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   GM01609
AC   CVCL_JB87
SY   GM-1609
DR   Coriell; GM01609
DR   Wikidata; Q54836945
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01609; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D29 ! GM01799
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01610
AC   CVCL_1D23
SY   GM-1610
DR   CLO; CLO_0031557
DR   BioSample; SAMN00806971
DR   Coriell; GM01610
DR   Wikidata; Q54836946
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=32521500;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Arg611His (c.1832G>A); ClinVar=VCV000045442; Zygosity=Heterozygous (PubMed=32521500).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp648Ter (c.1944G>A); ClinVar=VCV000004511; Zygosity=Heterozygous (PubMed=32521500).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Gly695Val (c.2084G>T); ClinVar=VCV000004510; Zygosity=Heterozygous (PubMed=32521500).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D26 ! GM01795
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM01611
AC   CVCL_1D24
SY   GM-1611
DR   CLO; CLO_0031558
DR   BioSample; SAMN00806973
DR   Coriell; GM01611
DR   Wikidata; Q54836947
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01612
AC   CVCL_JB63
SY   GM-1612
DR   Coriell; GM01612
DR   Wikidata; Q54836948
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01612; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61269; Niemann-Pick disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01613
AC   CVCL_JB64
SY   GM-1613
DR   Coriell; GM01613
DR   Wikidata; Q54836949
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01613; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61269; Niemann-Pick disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01617
AC   CVCL_IN55
SY   GM-1617
DR   BTO; BTO_0006472
DR   CLO; CLO_0031561
DR   BioSample; SAMN00806975
DR   Coriell; GM01617
DR   Wikidata; Q54836950
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6176; ITPA; Simple; p.Pro32Thr (c.94C>A); ClinVar=VCV000014746; Zygosity=Homozygous (Coriell=GM01617).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129974; Inosine triphosphatase deficiency
DI   ORDO; Orphanet_457375; ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN47 ! GM01619
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   GM01619
AC   CVCL_IN47
SY   GM-1619
DR   CLO; CLO_0031563
DR   BioSample; SAMN00806977
DR   Coriell; GM01619
DR   Wikidata; Q54836951
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6176; ITPA; Simple; p.Pro32Thr (c.94C>A); ClinVar=VCV000014746; Zygosity=Homozygous (Coriell=GM01619).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129974; Inosine triphosphatase deficiency
DI   ORDO; Orphanet_457375; ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN55 ! GM01617
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   GM01620
AC   CVCL_JD73
SY   GM-1620; GM 1620; GM1620; AG01620; AG1620; HG916
DR   Coriell; AG01620
DR   Coriell; GM01620
DR   Wikidata; Q54836952
RX   CelloPub=CLPUB00387;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=436333;
RX   PubMed=908169;
RX   PubMed=7253718;
RX   PubMed=7471106;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (from autologous cell lines GM02085; HG1947).
CC   Donor information: From Bloom Syndrome Registry patient 53(StAs) (BSR53).
CC   Discontinued: Coriell; AG01620; probable.
CC   Discontinued: Coriell; GM01620; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U703 ! GM02085
OI   CVCL_WX73 ! HG1947
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   GM01621
AC   CVCL_4J32
SY   GM-1621
DR   CLO; CLO_0031570
DR   BioSample; SAMN00806979
DR   Coriell; GM01621
DR   Wikidata; Q54836953
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Thr35Met (c.104C>T); ClinVar=VCV000449465; Zygosity=Heterozygous (Coriell=GM01621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01622
AC   CVCL_4J33
SY   GM-1622
DR   CLO; CLO_0031569
DR   BioSample; SAMN00806981
DR   Coriell; GM01622
DR   Wikidata; Q54836954
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Thr35Met (c.104C>T); ClinVar=VCV000449465; Zygosity=Heterozygous (Coriell=GM01622).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01623
AC   CVCL_4J34
SY   GM-1623
DR   CLO; CLO_0031575
DR   BioSample; SAMN00806983
DR   Coriell; GM01623
DR   Wikidata; Q54836958
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Thr35Met (c.104C>T); ClinVar=VCV000449465; Zygosity=Heterozygous (Coriell=GM01623).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01624
AC   CVCL_4J35
SY   GM-1624
DR   CLO; CLO_0031572
DR   BioSample; SAMN00806985
DR   Coriell; GM01624
DR   Wikidata; Q54836959
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Thr35Met (c.104C>T); ClinVar=VCV000449465; Zygosity=Heterozygous (Coriell=GM01624).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01625
AC   CVCL_4J36
SY   GM-1625
DR   CLO; CLO_0031495
DR   BioSample; SAMN00806987
DR   Coriell; GM01625
DR   Wikidata; Q54836961
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Thr35Met (c.104C>T); ClinVar=VCV000449465; Zygosity=Heterozygous (Coriell=GM01625).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01628
AC   CVCL_DS07
SY   GM-1628
DR   CLO; CLO_0031490
DR   BioSample; SAMN00806989
DR   Coriell; GM01628
DR   Wikidata; Q54836962
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01633
AC   CVCL_9Z54
SY   GM-1633
DR   CLO; CLO_0031498
DR   BioSample; SAMN00806999
DR   Coriell; GM01633
DR   Wikidata; Q54836968
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z57 ! GM01634
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01634
AC   CVCL_9Z57
SY   GM-1634
DR   CLO; CLO_0031512
DR   BioSample; SAMN00807001
DR   Coriell; GM01634
DR   Wikidata; Q54836969
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z54 ! GM01633
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM01635
AC   CVCL_5L39
SY   GM-1635; GM01635B
DR   CLO; CLO_0031508
DR   BioSample; SAMN00807003
DR   Coriell; GM01635
DR   Wikidata; Q54836970
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L40 ! GM01636
OI   CVCL_5L43 ! GM01643
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM01636
AC   CVCL_5L40
SY   GM-1636
DR   CLO; CLO_0031506
DR   BioSample; SAMN00807005
DR   Coriell; GM01636
DR   Wikidata; Q54836971
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L39 ! GM01635
OI   CVCL_5L43 ! GM01643
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   GM01637
AC   CVCL_5L41
SY   GM-1637
DR   CLO; CLO_0031520
DR   BioSample; SAMN00807007
DR   Coriell; GM01637
DR   Wikidata; Q54836972
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L42 ! GM01638
OI   CVCL_5L44 ! GM01644
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM01638
AC   CVCL_5L42
SY   GM-1638
DR   CLO; CLO_0031521
DR   BioSample; SAMN00807009
DR   Coriell; GM01638
DR   Wikidata; Q54836973
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L41 ! GM01637
OI   CVCL_5L44 ! GM01644
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   GM01639
AC   CVCL_5M68
SY   GM-1639
DR   CLO; CLO_0031522
DR   BioSample; SAMN00807011
DR   Coriell; GM01639
DR   Wikidata; Q54836974
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M69 ! GM01641
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01641
AC   CVCL_5M69
SY   GM-1641
DR   CLO; CLO_0031523
DR   BioSample; SAMN00807013
DR   Coriell; GM01641
DR   Wikidata; Q54836975
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M68 ! GM01639
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM01643
AC   CVCL_5L43
SY   GM-1643
DR   CLO; CLO_0031524
DR   BioSample; SAMN00807015
DR   Coriell; GM01643
DR   Wikidata; Q54836976
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L39 ! GM01635
OI   CVCL_5L40 ! GM01636
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM01644
AC   CVCL_5L44
SY   GM-1644
DR   CLO; CLO_0031525
DR   BioSample; SAMN00807017
DR   Coriell; GM01644
DR   Wikidata; Q54836977
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L41 ! GM01637
OI   CVCL_5L42 ! GM01638
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM01646
AC   CVCL_7327
SY   GM-1646; GM1646; GM01646A
DR   CLO; CLO_0031526
DR   BioSample; SAMN00807019
DR   Coriell; GM01646
DR   Wikidata; Q54836978
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9584159;
RX   PubMed=12812979;
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Asn349del (c.1045_1047del); ClinVar=VCV002137064; Zygosity=Heterozygous (from autologous cell line GM01389).
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Leu350Pro (c.1049T>C); ClinVar=VCV002137065; Zygosity=Heterozygous (from autologous cell line GM01389).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F028 ! GM01389
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   GM01647
AC   CVCL_4J37
SY   GM-1647
DR   CLO; CLO_0031527
DR   BioSample; SAMN00807021
DR   Coriell; GM01647
DR   Wikidata; Q54836980
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; c.578T>A; Zygosity=Heterozygous (Coriell=GM01647).
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; c.582_586delGCGCA; Zygosity=Heterozygous (Coriell=GM01647).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM01650
AC   CVCL_7328
SY   GM1650; GM-1650; GM 1650; GM01650A; GM1650A; C1650
DR   CLO; CLO_0031530
DR   BioSample; SAMN00807023
DR   Coriell; GM01650
DR   GEO; GSM1257671
DR   GEO; GSM1266913
DR   GEO; GSM1267007
DR   GEO; GSM1288432
DR   GEO; GSM2794401
DR   GEO; GSM3124658
DR   Wikidata; Q54836981
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3111682;
RX   PubMed=24555846;
RX   PubMed=25326100;
RX   PubMed=29125828;
RX   PubMed=30567591;
RX   PubMed=32291635;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM01651
AC   CVCL_7329
SY   GM1651; GM-1651; GM 01651; GM01651A; GM1651A; GM 1651A; GM01651B
DR   CLO; CLO_0031528
DR   BioSample; SAMN00807025
DR   Coriell; GM01651
DR   GEO; GSM1316973
DR   GEO; GSM1317010
DR   Wikidata; Q54836982
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   Patent=US5773219;
RX   PubMed=8643543;
RX   PubMed=26984941;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM01652
AC   CVCL_7330
SY   GM1652; GM-1652; GM 1652; GM1652A; GM01652B; GM01652C; GMO1652C
DR   CLO; CLO_0030948
DR   BioSample; SAMN00807027
DR   BioSample; SAMN03253066
DR   Coriell; GM01652
DR   GEO; GSM1266914
DR   GEO; GSM3124638
DR   Wikidata; Q54836983
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3111682;
RX   PubMed=3863481;
RX   PubMed=6458814;
RX   PubMed=6726265;
RX   PubMed=8823375;
RX   PubMed=25326100;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM01653
AC   CVCL_7331
SY   GM1653; GM-1653
DR   CLO; CLO_0030947
DR   BioSample; SAMN00807029
DR   Coriell; GM01653
DR   GEO; GSM1257672
DR   GEO; GSM1266912
DR   GEO; GSM1267006
DR   GEO; GSM1288433
DR   GEO; GSM3124659
DR   Wikidata; Q54836984
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=24555846;
RX   PubMed=25326100;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM01654
AC   CVCL_D513
SY   GM1654; GM-1654; GM 1654
DR   CLO; CLO_0030944
DR   BioSample; SAMN00807031
DR   Coriell; GM01654
DR   Wikidata; Q54836985
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Tyr438Asn (c.1312T>A) (Y393N); ClinVar=VCV000100009; Zygosity=Homozygous (from autologous cell line GM01655).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D514 ! GM01655
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM01655
AC   CVCL_D514
SY   GM-1655; GM 1655; GM1655
DR   CLO; CLO_0030943
DR   BioSample; SAMN00807033
DR   Coriell; GM01655
DR   Wikidata; Q54836987
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2241958;
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Tyr438Asn (c.1312T>A) (Y393N); ClinVar=VCV000100009; Zygosity=Homozygous (PubMed=2241958).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D513 ! GM01654
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM01656
AC   CVCL_2Z67
SY   GM-1656; GM01656A
DR   CLO; CLO_0030946
DR   BioSample; SAMN00807035
DR   Coriell; GM01656
DR   Wikidata; Q54836988
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z68 ! GM01657
OI   CVCL_2Z69 ! GM01658
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01657
AC   CVCL_2Z68
SY   GM-1657
DR   CLO; CLO_0030945
DR   BioSample; SAMN00807037
DR   Coriell; GM01657
DR   Wikidata; Q54836989
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z67 ! GM01656
OI   CVCL_2Z69 ! GM01658
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01658
AC   CVCL_2Z69
SY   GM-1658
DR   CLO; CLO_0030940
DR   BioSample; SAMN00807039
DR   Coriell; GM01658
DR   Wikidata; Q54836990
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; Note=From a lesion; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z67 ! GM01656
OI   CVCL_2Z68 ! GM01657
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01659
AC   CVCL_V425
SY   GM-1659; GM 1659
DR   CLO; CLO_0030939
DR   BioSample; SAMN00807041
DR   Coriell; GM01659
DR   Wikidata; Q54836991
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex2-3dup; Zygosity=Heterozygous (from familial inference of GM01662; GM06804).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM01660
AC   CVCL_V426
SY   GM-1660
DR   CLO; CLO_0030942
DR   BioSample; SAMN00807043
DR   Coriell; GM01660
DR   Wikidata; Q54836992
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM01661
AC   CVCL_R905
SY   GM-1661; GM1661
DR   CLO; CLO_0030941
DR   BioSample; SAMN00807045
DR   Coriell; GM01661
DR   Wikidata; Q54836993
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM01662
AC   CVCL_F602
SY   GM-1662; GM 1662; GM1662; GM01662A
DR   CLO; CLO_0030958
DR   BioSample; SAMN00807047
DR   Coriell; GM01662
DR   Wikidata; Q54836994
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3021482;
RX   PubMed=3296189;
RX   PubMed=6087154;
RX   PubMed=14555701;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex2-3dup; Zygosity=Hemizygous (PubMed=3296189).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F609 ! GM06804
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM01663
AC   CVCL_V810
SY   GM-1663; GM 1663; GM1663
DR   CLO; CLO_0030957
DR   BioSample; SAMN00807049
DR   Coriell; GM01663
DR   Wikidata; Q54836995
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761481;
RX   PubMed=6661932;
RX   PubMed=7329430;
RX   PubMed=7471105;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,der(17)(17qter->17p13::13q14->13qter)mat (Coriell=GM01663).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM01664
AC   CVCL_0Q00
SY   GM-1664
DR   CLO; CLO_0030956
DR   BioSample; SAMN00807051
DR   Coriell; GM01664
DR   Wikidata; Q54836997
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(9;13)(9pter->9q13::13q12->13qter;13pter->13q12::9q13->9qter) (Coriell=GM01664).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01665
AC   CVCL_0Q01
SY   GM-1665
DR   CLO; CLO_0030955
DR   BioSample; SAMN00807053
DR   Coriell; GM01665
DR   Wikidata; Q54836998
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(12;21)(12qter->12p11::21p11->21pter;21qter->21p11::12p11->12pter) (Coriell=GM01665).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01667
AC   CVCL_X082
SY   GM-1667; GM 1667
DR   CLO; CLO_0030954
DR   BioSample; SAMN00807055
DR   Coriell; GM01667
DR   Wikidata; Q54836999
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(9)(qter>p22) (Coriell=GM01667).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM01669
AC   CVCL_JB62
SY   GM-1669
DR   Coriell; GM01669
DR   Wikidata; Q54837000
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01669; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01671
AC   CVCL_2Y86
SY   GM-1671
DR   CLO; CLO_0030953
DR   Coriell; GM01671
DR   Wikidata; Q54837001
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01672
AC   CVCL_1R60
SY   GM-1672; GM 1672
DR   CLO; CLO_0030952
DR   BioSample; SAMN00807057
DR   Coriell; GM01672
DR   Wikidata; Q54837002
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6156493;
CC   Population: Caucasian.
CC   Karyotypic information: 69,XXY (Coriell=GM01672).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01673
AC   CVCL_0D84
SY   GM1673; GM-1673
DR   CLO; CLO_0030951
DR   BioSample; SAMN00807059
DR   Coriell; GM01673
DR   Wikidata; Q54837006
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7909321;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 15
//
ID   GM01674
AC   CVCL_AW76
SY   GM1674; GM-1674; Line 245
DR   CLO; CLO_0030950
DR   BioSample; SAMN00807061
DR   Coriell; GM01674
DR   Wikidata; Q54837007
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM01675
AC   CVCL_U387
SY   GM-1675; GM 01675; GM1675
DR   CLO; CLO_0030949
DR   BioSample; SAMN00807063
DR   Coriell; GM01675
DR   Wikidata; Q54837008
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1570834;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4367; GM2A; Simple; p.Cys138Arg (c.412T>C); ClinVar=VCV000000390; Zygosity=Homozygous (PubMed=1570834).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C133084; GM2-gangliosidosis, AB variant
DI   ORDO; Orphanet_309246; GM2 gangliosidosis, AB variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM01676
AC   CVCL_9Q83
SY   GM 01676; GM-1676; GM1676; Lowe 1676
DR   CLO; CLO_0030962
DR   BioSample; SAMN00807065
DR   Coriell; GM01676
DR   Wikidata; Q54837009
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19700499;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple; p.Arg844Ter (c.2530C>T) (R827X, c.2479C>T); ClinVar=VCV000010857; Zygosity=Hemizygous (Coriell=GM01676).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84940; Oculocerebrorenal syndrome
DI   ORDO; Orphanet_534; Oculocerebrorenal syndrome of Lowe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM01678
AC   CVCL_0Q02
SY   GM-1678
DR   CLO; CLO_0030961
DR   Coriell; GM01678
DR   Wikidata; Q54837010
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Karyotypic information: 46,XX,t(5;10)(5qter->5p15::10p13->10pter;10qter->10p13::5p15->5pter) (Coriell=GM01678).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01679
AC   CVCL_U516
SY   GM1679; GM-1679
DR   CLO; CLO_0030964
DR   BioSample; SAMN00807067
DR   Coriell; GM01679
DR   Wikidata; Q54837011
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7174798;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U518 ! GM01685
OI   CVCL_U519 ! GM03056
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM01680
AC   CVCL_7332
SY   GM1680; GM-1680; GM 1680; GM01680A
DR   CLO; CLO_0030963
DR   BioSample; SAMN00807069
DR   Coriell; GM01680
DR   GEO; GSM3124666
DR   Wikidata; Q54837012
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3860870;
RX   PubMed=19896956;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM01681
AC   CVCL_7333
SY   GM1681; GM-1681; GM01681A
DR   CLO; CLO_0030966
DR   BioSample; SAMN00807071
DR   Coriell; GM01681
DR   GEO; GSM3124691
DR   Wikidata; Q54837013
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19896956;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM01683
AC   CVCL_0Q03
SY   GM-1683
DR   CLO; CLO_0030965
DR   BioSample; SAMN00807073
DR   Coriell; GM01683
DR   Wikidata; Q54837014
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;10)(2qter->2p23::10q26->10qter;10pter->10q26::2p23->2pter) (Coriell=GM01683).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM01684
AC   CVCL_U517
SY   GM1684; GM-1684
DR   CLO; CLO_0030968
DR   BioSample; SAMN00807075
DR   Coriell; GM01684
DR   Wikidata; Q54837015
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7174798;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM01685
AC   CVCL_U518
SY   GM-1685
DR   CLO; CLO_0030967
DR   BioSample; SAMN00807077
DR   Coriell; GM01685
DR   Wikidata; Q54837016
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U516 ! GM01679
OI   CVCL_U519 ! GM03056
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM01691
AC   CVCL_AM86
SY   GM-1691
DR   CLO; CLO_0030960
DR   BioSample; SAMN00807079
DR   Coriell; GM01691
DR   Wikidata; Q54837017
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JB89 ! GM02006
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM01695
AC   CVCL_V811
SY   GM-1695; GM1695; GM01695A; GM1695A
DR   CLO; CLO_0030959
DR   BioSample; SAMN00807081
DR   Coriell; GM01695
DR   Wikidata; Q54837018
RX   CelloPub=CLPUB00447;
RX   PubMed=2498246;
RX   PubMed=7438786;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;11)(p21;q13) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM01696
AC   CVCL_1D19
SY   GM-1696; GM 1696; GM1696; GM01696A
DR   CLO; CLO_0030978
DR   BioSample; SAMN00807083
DR   Coriell; GM01696
DR   Wikidata; Q54837019
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;7)(q21;p22) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01700
AC   CVCL_1D22
SY   GM-1700
DR   CLO; CLO_0030973
DR   Coriell; GM01700
DR   Wikidata; Q54837020
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=23665875;
CC   Karyotypic information: 46,XY,t(21;22)(p12;2q11.2).arr(1-22)x2,(XY)x1 (Coriell=GM01700).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM01701
AC   CVCL_1D25
SY   GM-1701
DR   CLO; CLO_0030972
DR   BioSample; SAMN00807085
DR   Coriell; GM01701
DR   Wikidata; Q54837021
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D28 ! GM01797
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM01702
AC   CVCL_1N14
SY   GM-1702
DR   CLO; CLO_0030971
DR   Coriell; GM01702
DR   Wikidata; Q54837022
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01703
AC   CVCL_1Y28
SY   GM-1703
DR   CLO; CLO_0030970
DR   BioSample; SAMN00807087
DR   Coriell; GM01703
DR   Wikidata; Q54837023
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM01703).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01704
AC   CVCL_1Y29
SY   GM-1704
DR   CLO; CLO_0030977
DR   BioSample; SAMN00807089
DR   Coriell; GM01704
DR   Wikidata; Q54837024
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM01704).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM01706
AC   CVCL_7334
SY   GM1706; GM-1706; GM 1706; GM01706A; GM1706A; GM00237; GM0237
DR   CLO; CLO_0030976
DR   BioSample; SAMN00807091
DR   Coriell; GM00237
DR   Coriell; GM01706
DR   GEO; GSM3124688
DR   Wikidata; Q54837025
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; GM00237; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM01707
AC   CVCL_L982
SY   GM-1707; GM01008; GM-1008
DR   CLO; CLO_0030975
DR   BioSample; SAMN00807093
DR   Coriell; GM01008
DR   Coriell; GM01707
DR   Wikidata; Q54837026
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM01707).
CC   Discontinued: Coriell; GM01008; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   GM01708
AC   CVCL_L959
SY   GM-1708; GM-1010; GM01010
DR   CLO; CLO_0030974
DR   BioSample; SAMN00807095
DR   Coriell; GM01010
DR   Coriell; GM01708
DR   Wikidata; Q54837027
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from familial inference of GM01014).
CC   Discontinued: Coriell; GM01010; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   GM01709
AC   CVCL_X252
SY   GM-1709; GM 1709
DR   CLO; CLO_0030969
DR   BioSample; SAMN00807097
DR   Coriell; GM01709
DR   Wikidata; Q54837028
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61420; Gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   11Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM01715
AC   CVCL_GS54
SY   GM-1715; GM 1715
DR   CLO; CLO_0030987
DR   BioSample; SAMN00807101
DR   Coriell; GM01715
DR   Wikidata; Q54837030
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.33+1G>C (IVS1DS,G-C,+1); ClinVar=VCV000001976; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM01715).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg101Gln (c.302G>A); ClinVar=VCV000001956; Zygosity=Heterozygous (Coriell=GM01715).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS57 ! GM02445
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 18
//
ID   GM01717
AC   CVCL_7335
SY   GM1717; GM-1717
DR   CLO; CLO_0030983
DR   BioSample; SAMN00807103
DR   Coriell; GM01717
DR   GEO; GSM3124660
DR   Wikidata; Q54837031
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM01718
AC   CVCL_9R63
SY   GM-1718; GM01718A; GM1718A
DR   CLO; CLO_0030984
DR   BioSample; SAMN00807105
DR   Coriell; GM01718
DR   Wikidata; Q54837032
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9054950;
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Phe260Tyr (c.779T>A); ClinVar=VCV000002446; Zygosity=Heterozygous (PubMed=9054950).
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Leu363Pro (c.1088T>C); ClinVar=VCV000002447; Zygosity=Heterozygous (PubMed=9054950).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_87876; Sialidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM01719
AC   CVCL_9R64
SY   GM-1719; GM1719
DR   CLO; CLO_0030985
DR   BioSample; SAMN00807107
DR   Coriell; GM01719
DR   Wikidata; Q54837033
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9054950;
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Leu363Pro (c.1088T>C); ClinVar=VCV000002447; Zygosity=Heterozygous (PubMed=9054950).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM01720
AC   CVCL_9R65
SY   GM-1720; GM1720
DR   CLO; CLO_0030986
DR   BioSample; SAMN00807109
DR   Coriell; GM01720
DR   Wikidata; Q54837034
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9054950;
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Phe260Tyr (c.779T>A); ClinVar=VCV000002446; Zygosity=Heterozygous (PubMed=9054950).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM01721
AC   CVCL_JC91
SY   GM-1721
DR   CLO; CLO_0030979
DR   BioSample; SAMN00807111
DR   Coriell; GM01721
DR   Wikidata; Q54837035
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC93 ! GM01722
SX   Sex ambiguous
AG   15Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM01722
AC   CVCL_JC93
SY   GM-1722; GM1722
DR   Coriell; GM01722
DR   Wikidata; Q54837036
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM01722; probable.
CC   Derived from site: In situ; Gonad, skin; UBERON=UBERON_8480074.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC91 ! GM01721
SX   Sex ambiguous
AG   15Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 9
//
ID   GM01723
AC   CVCL_X253
SY   GM-1723; GM 1723; GM01723A
DR   CLO; CLO_0030980
DR   BioSample; SAMN00807113
DR   Coriell; GM01723
DR   Wikidata; Q54837037
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X254 ! GM01724
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM01724
AC   CVCL_X254
SY   GM-1724
DR   Coriell; GM01724
DR   Wikidata; Q54837038
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM01724; probable.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X253 ! GM01723
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   GM01725
AC   CVCL_2Z70
SY   GM-1725
DR   CLO; CLO_0030981
DR   BioSample; SAMN00807115
DR   Coriell; GM01725
DR   Wikidata; Q54837039
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z71 ! GM01726
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01726
AC   CVCL_2Z71
SY   GM-1726; GM01726A
DR   CLO; CLO_0030982
DR   BioSample; SAMN00807117
DR   Coriell; GM01726
DR   Wikidata; Q54837040
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z70 ! GM01725
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01727
AC   CVCL_X083
SY   GM-1727; GM 1727
DR   CLO; CLO_0030998
DR   BioSample; SAMN00807119
DR   Coriell; GM01727
DR   Wikidata; Q54837041
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(18)(qter>p11) (Coriell=GM01727).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM01730
AC   CVCL_1R61
SY   GM-1730; GM01730C
DR   CLO; CLO_0030997
DR   BioSample; SAMN00807121
DR   Coriell; GM01730
DR   Wikidata; Q54837042
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Karyotypic information: 46,XX,der(21)(21qter->21p11::Xq11->Xqter)mat (Coriell=GM01730).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01734
AC   CVCL_X255
SY   GM-1734; GM 1734
DR   CLO; CLO_0030996
DR   Coriell; GM01734
DR   Wikidata; Q54837043
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Karyotypic information: 46,XY,+der(9)(9pter->9q12::15q11->15qter)mat,-15 (Coriell=GM01734).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM01736
AC   CVCL_1F09
SY   GM-1736; GM1736
DR   CLO; CLO_0030994
DR   BioSample; SAMN00807123
DR   Coriell; GM01736
DR   Wikidata; Q54837044
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01737
AC   CVCL_2Z43
SY   GM-1737
DR   CLO; CLO_0030995
DR   BioSample; SAMN00807125
DR   Coriell; GM01737
DR   Wikidata; Q54837045
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY; but phenotypically female (Coriell=GM01737).
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   9D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01739
AC   CVCL_0M02
SY   GM-1739
DR   CLO; CLO_0030992
DR   BioSample; SAMN00807127
DR   Coriell; GM01739
DR   Wikidata; Q54837050
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Tyr432_Arg435delTrp432ins (c.1307del9); Zygosity=Heterozygous (from autologous cell line GM01094).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0L98 ! GM01094
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM01740
AC   CVCL_JC92
SY   GM-1740; GM01740A
DR   BioSample; SAMN00807129
DR   Coriell; GM01740
DR   Wikidata; Q54837051
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01740; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM01741
AC   CVCL_H173
SY   GM-1741
DR   CLO; CLO_0030993
DR   BioSample; SAMN00807131
DR   Coriell; GM01741
DR   Wikidata; Q54837053
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4135; GALT; Zygosity=Heterozygous (Coriell=GM01741).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H174 ! GM01743
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM01742
AC   CVCL_CX27
SY   GM-1742
DR   Coriell; GM01742
DR   Wikidata; Q54837054
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01742; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM01743
AC   CVCL_H174
SY   GM-1743
DR   CLO; CLO_0030990
DR   BioSample; SAMN00807133
DR   Coriell; GM01743
DR   Wikidata; Q54837056
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4135; GALT; Zygosity=Heterozygous (from autologous cell line GM01741).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H173 ! GM01741
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM01744
AC   CVCL_AD63
SY   GM1744; GM-1744
DR   CLO; CLO_0030991
DR   BioSample; SAMN00807135
DR   Coriell; GM01744
DR   Wikidata; Q54837057
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM01746
AC   CVCL_1M68
SY   GM-1746; GM 1746
DR   CLO; CLO_0030989
DR   BioSample; SAMN00807137
DR   Coriell; GM01746
DR   Wikidata; Q54837058
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
CC   Population: Arab.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01750
AC   CVCL_X256
SY   GM-1750; GM 1750
DR   CLO; CLO_0031006
DR   BioSample; SAMN00807139
DR   Coriell; GM01750
DR   GEO; GSM798
DR   Wikidata; Q54837059
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM01751
AC   CVCL_0Q58
SY   GM-1751
DR   CLO; CLO_0031005
DR   BioSample; SAMN00807141
DR   Coriell; GM01751
DR   Wikidata; Q54837060
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(9;14)(9qter->9p24::14q21->14qter;14pter->14q21::9p24->9pter) (Coriell=GM01751).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM01759
AC   CVCL_9R66
SY   GM-1759; GM01759B
DR   CLO; CLO_0031008
DR   BioSample; SAMN00807143
DR   Coriell; GM01759
DR   Wikidata; Q54837061
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Asp190Val (c.569A>T) (733A>T) (p.Asp190fs*211); ClinVar=VCV000038431; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM01763
AC   CVCL_L960
SY   GM-1763; GM00249
DR   CLO; CLO_0031007
DR   BioSample; SAMN00807145
DR   Coriell; GM00249
DR   Coriell; GM01763
DR   Wikidata; Q54837062
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2330; CPT2; Simple; p.Ser113Leu (c.439C>T); ClinVar=VCV000008953; Zygosity=Homozygous (Coriell=GM01763).
CC   Discontinued: Coriell; GM00249; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C114766; Carnitine palmitoyltransferase II deficiency
DI   ORDO; Orphanet_157; Carnitine palmitoyltransferase II deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   GM01766
AC   CVCL_L961
SY   GM-1766; GM01449; GM-1449
DR   CLO; CLO_0030999
DR   BioSample; SAMN00807147
DR   Coriell; GM01449
DR   Coriell; GM01766
DR   Wikidata; Q54837063
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01449; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM01767
AC   CVCL_L963
SY   GM-1767; GM01452; GM-1452
DR   CLO; CLO_0031000
DR   Coriell; GM01452
DR   Coriell; GM01767
DR   Wikidata; Q54837064
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01452; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM01769
AC   CVCL_L964
SY   GM01769B; GM01021; GM-1021
DR   CLO; CLO_0031001
DR   BioSample; SAMN00807149
DR   Coriell; GM01021
DR   Coriell; GM01769
DR   Wikidata; Q54837065
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (Coriell=GM01769).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01021; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 22
//
ID   GM01773
AC   CVCL_2Z47
SY   GM-1773
DR   CLO; CLO_0031002
DR   BioSample; SAMN00807151
DR   Coriell; GM01773
DR   Wikidata; Q54837066
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01774
AC   CVCL_7336
SY   GM-1774; GM01774A
DR   CLO; CLO_0031003
DR   BioSample; SAMN00807153
DR   Coriell; GM01774
DR   Wikidata; Q54837067
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=25992652;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Hemizygous (Coriell=GM01774).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D515 ! GM01775
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GM01775
AC   CVCL_D515
SY   GM-1775; GM01775A
DR   CLO; CLO_0031004
DR   BioSample; SAMN00807155
DR   Coriell; GM01775
DR   Wikidata; Q54837068
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Hemizygous (Coriell=GM01775).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7336 ! GM01774
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   GM01777
AC   CVCL_AA17
SY   GM-1777; GM01777A
DR   CLO; CLO_0031014
DR   BioSample; SAMN00807157
DR   Coriell; GM01777
DR   Wikidata; Q54837069
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01778
AC   CVCL_1K53
SY   GM-1778
DR   CLO; CLO_0031018
DR   BioSample; SAMN00807159
DR   Coriell; GM01778
DR   Wikidata; Q54837070
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01780
AC   CVCL_0M03
SY   GM-1780
DR   CLO; CLO_0031017
DR   BioSample; SAMN00807161
DR   Coriell; GM01780
DR   Wikidata; Q54837071
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM01781
AC   CVCL_GY18
SY   GM-1781
DR   CLO; CLO_0031016
DR   BioSample; SAMN00807163
DR   Coriell; GM01781
DR   Wikidata; Q54837072
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr67Ile (c.200C>T); ClinVar=VCV000002939; Zygosity=Heterozygous (Coriell=GM01781).
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Gln240Glu (c.718C>G); ClinVar=VCV000002940; Zygosity=Heterozygous (Coriell=GM01781).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129070; Cystathioninuria
DI   ORDO; Orphanet_212; Cystathioninuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM01783
AC   CVCL_JE07
SY   GM-1783
DR   Coriell; GM01783
DR   Wikidata; Q54837073
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01783; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35637; Hyperlipoproteinemia, type IIb
DI   ORDO; Orphanet_444490; Familial chylomicronemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01784
AC   CVCL_L965
SY   GM-1784; GM01462
DR   CLO; CLO_0031015
DR   Coriell; GM01462
DR   Coriell; GM01784
DR   Wikidata; Q54837074
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01462; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM01785
AC   CVCL_JE08
SY   GM-1785
DR   Coriell; GM01785
DR   Wikidata; Q54837075
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01785; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6B41 ! GM01017
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01786
AC   CVCL_0G94
SY   GM-1786
DR   CLO; CLO_0031011
DR   BioSample; SAMN00807165
DR   Coriell; GM01786
DR   Wikidata; Q54837076
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Heterozygous (from familial inference of GM01774; GM01775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM01787
AC   CVCL_0G95
SY   GM-1787
DR   CLO; CLO_0031012
DR   BioSample; SAMN00807167
DR   Coriell; GM01787
DR   Wikidata; Q54837077
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Heterozygous (from familial inference of GM01774; GM01775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM01788
AC   CVCL_AM87
SY   GM-1788
DR   CLO; CLO_0031009
DR   BioSample; SAMN00807169
DR   Coriell; GM01788
DR   Wikidata; Q54837078
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM01789
AC   CVCL_DD68
SY   GM-1789
DR   CLO; CLO_0031010
DR   BioSample; SAMN00807171
DR   Coriell; GM01789
DR   Wikidata; Q54837079
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01790
AC   CVCL_AN05
SY   GM-1790
DR   CLO; CLO_0031013
DR   BioSample; SAMN00807173
DR   Coriell; GM01790
DR   Wikidata; Q54837080
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125700; Ehlers-Danlos syndrome, type VI
DI   ORDO; Orphanet_536545; Kyphoscoliotic Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM01791
AC   CVCL_AN06
SY   GM-1791
DR   CLO; CLO_0031024
DR   BioSample; SAMN00807175
DR   Coriell; GM01791
DR   Wikidata; Q54837081
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125700; Ehlers-Danlos syndrome, type VI
DI   ORDO; Orphanet_536545; Kyphoscoliotic Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM01792
AC   CVCL_T805
SY   GM-1792
DR   CLO; CLO_0031025
DR   BioSample; SAMN00807177
DR   Coriell; GM01792
DR   Wikidata; Q54837082
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=21490598;
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T806 ! GM01793
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM01793
AC   CVCL_T806
SY   GM-1793
DR   CLO; CLO_0031022
DR   BioSample; SAMN00807179
DR   Coriell; GM01793
DR   Wikidata; Q54837083
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T805 ! GM01792
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
ID   GM01795
AC   CVCL_1D26
SY   GM-1795; GM01795A
DR   CLO; CLO_0031023
DR   BioSample; SAMN00807181
DR   Coriell; GM01795
DR   Wikidata; Q54837084
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Arg611His (c.1832G>A); ClinVar=VCV000045442; Zygosity=Heterozygous (from autologous cell line GM01610).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp648Ter (c.1944G>A); ClinVar=VCV000004511; Zygosity=Heterozygous (from autologous cell line GM01610).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Gly695Val (c.2084G>T); ClinVar=VCV000004510; Zygosity=Heterozygous (from autologous cell line GM01610).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D23 ! GM01610
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM01796
AC   CVCL_1D27
SY   GM-1796
DR   CLO; CLO_0031019
DR   BioSample; SAMN00807183
DR   Coriell; GM01796
DR   Wikidata; Q54837085
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01797
AC   CVCL_1D28
SY   GM-1797
DR   CLO; CLO_0031020
DR   BioSample; SAMN00807185
DR   Coriell; GM01797
DR   Wikidata; Q54837086
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D25 ! GM01701
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM01799
AC   CVCL_1D29
SY   GM-1799
DR   CLO; CLO_0031039
DR   BioSample; SAMN00807187
DR   Coriell; GM01799
DR   Wikidata; Q54837087
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JB87 ! GM01609
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01800
AC   CVCL_1D30
SY   GM-1800
DR   CLO; CLO_0031037
DR   BioSample; SAMN00807189
DR   Coriell; GM01800
DR   Wikidata; Q54837088
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01801
AC   CVCL_1D31
SY   GM-1801
DR   CLO; CLO_0031034
DR   BioSample; SAMN00807191
DR   Coriell; GM01801
DR   Wikidata; Q54837089
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01803
AC   CVCL_1E87
SY   GM-1803
DR   CLO; CLO_0031032
DR   BioSample; SAMN00807193
DR   Coriell; GM01803
DR   Wikidata; Q54837090
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01805
AC   CVCL_7337
SY   GM-1805; GM01805A; GM01073; GM-1073; GM17213
DR   CLO; CLO_0013893
DR   CLO; CLO_0031046
DR   BioSample; SAMN00807195
DR   Coriell; GM01073
DR   Coriell; GM01805
DR   Coriell; GM17213
DR   GEO; GSM569542
DR   GEO; GSM596277
DR   GEO; GSM596638
DR   GEO; GSM924815
DR   Wikidata; Q54837091
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,24:02:01; B*27:05:02,51:01:01; C*01:02:01,15:02:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,03:01:01; DQA1*01:01:01,03:01:01; DQB1*03:02:01,05:01:01; DRB1*01:01:01,04:04:01; DRB4*01:03:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: Coriell; GM01073; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM01806
AC   CVCL_7338
SY   GM-1806; GM01074; GM-1074; GM17214
DR   CLO; CLO_0013886
DR   CLO; CLO_0031047
DR   BioSample; SAMN00807197
DR   Coriell; GM01074
DR   Coriell; GM01806
DR   Coriell; GM17214
DR   GEO; GSM569518
DR   GEO; GSM596278
DR   GEO; GSM596741
DR   GEO; GSM924816
DR   Wikidata; Q54837096
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:05:01; B*37:01:01,58:01:01; C*06:02:01,07:18; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:02:01,01:05:01; DQB1*05:01:01,06:02:01; DRB1*10:01:01,15:01:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: Coriell; GM01074; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM01807
AC   CVCL_9R67
SY   GM-1807
DR   CLO; CLO_0031048
DR   BioSample; SAMN00807199
DR   Coriell; GM01807
DR   Wikidata; Q54837097
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   HLA typing: A*01,02; B*13,w35 (Coriell=GM01807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01808
AC   CVCL_2H25
SY   GM-1808
DR   CLO; CLO_0031040
DR   BioSample; SAMN00807201
DR   Coriell; GM01808
DR   Wikidata; Q54837098
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8528202;
CC   Population: Caucasian.
CC   HLA typing: A*02,10; B*12,27 (Coriell=GM01808).
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Ile278Thr (c.833T>C); ClinVar=VCV000000120; Zygosity=Heterozygous (PubMed=8528202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2H03 ! GM00753
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM01810
AC   CVCL_L966
SY   GM-1810; GM01451
DR   CLO; CLO_0031043
DR   BioSample; SAMN00807203
DR   Coriell; GM01451
DR   Coriell; GM01810
DR   Wikidata; Q54837099
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   HLA typing: A*01,10; B*07,13 (Coriell=GM01810).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01451; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84525; Abetalipoproteinemia
DI   ORDO; Orphanet_14; Abetalipoproteinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM01812
AC   CVCL_AM82
SY   GM-1812
DR   CLO; CLO_0031044
DR   Coriell; GM01812
DR   Wikidata; Q54837100
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM01813
AC   CVCL_1A94
SY   GM-1813; GM1813
DR   CLO; CLO_0031045
DR   BioSample; SAMN00807205
DR   Coriell; GM01813
DR   Wikidata; Q54837101
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;15)(Xqter->Xp11::15q13->15qter;15pter->15q13::Xp11->Xpter),t(1;21)(1pter->1q12::21q22->21qter;21pter->21q22::1q12->1qter)pat (Coriell=GM01813).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01814
AC   CVCL_7339
SY   GM-1814; GM1814; GM01814A; GM01072; GM-1072; GM1072; GM17215
DR   CLO; CLO_0013885
DR   CLO; CLO_0031057
DR   BioSample; SAMN00807207
DR   Coriell; GM01072
DR   Coriell; GM01814
DR   Coriell; GM17215
DR   GEO; GSM569641
DR   GEO; GSM596279
DR   GEO; GSM596639
DR   GEO; GSM924817
DR   Wikidata; Q54837102
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,40:01:02; C*03:04:01,07:01:01; DPA1*01:03:01,02:01:02; DPB1*01:01:01,04:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:04:01; DRB1*03:01:01,13:02:01; DRB3*01:01:02,03:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: Coriell; GM01072; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM01815
AC   CVCL_7340
SY   GM-1815; GM1815; GM01075; GM-1075; GM1075; GM18004
DR   CLO; CLO_0015995
DR   CLO; CLO_0031055
DR   BioSample; SAMN00807209
DR   Coriell; GM01075
DR   Coriell; GM01815
DR   Coriell; GM18004
DR   Wikidata; Q54837103
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01075; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM01817
AC   CVCL_JE11
SY   GM-1817
DR   Coriell; GM01817
DR   Wikidata; Q54837104
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01817; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01824
AC   CVCL_JC84
SY   GM-1824
DR   Coriell; GM01824
DR   Wikidata; Q54837105
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01824; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC85 ! GM01825
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01825
AC   CVCL_JC85
SY   GM-1825
DR   Coriell; GM01825
DR   Wikidata; Q54837106
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01825; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC84 ! GM01824
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01827
AC   CVCL_JE13
SY   GM-1827
DR   Coriell; GM01827
DR   Wikidata; Q54837107
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01827; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01828
AC   CVCL_JB86
SY   GM-1828
DR   Coriell; GM01828
DR   Wikidata; Q54837108
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Thr10Ile (c.29C>T); ClinVar=VCV000066888; Zygosity=Heterozygous (from autologous cell line AG00990).
CC   Discontinued: Coriell; GM01828; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W843 ! AG00990
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM01829
AC   CVCL_1L42
SY   GM-1829; GM01829A
DR   CLO; CLO_0031060
DR   BioSample; SAMN00807211
DR   Coriell; GM01829
DR   Wikidata; Q54837109
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01833
AC   CVCL_JC80
SY   GM-1833
DR   Coriell; GM01833
DR   Wikidata; Q54837110
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01833; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC81 ! GM01834
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01834
AC   CVCL_JC81
SY   GM-1834
DR   Coriell; GM01834
DR   Wikidata; Q54837111
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01834; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC80 ! GM01833
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01835
AC   CVCL_D873
SY   GM-1835
DR   CLO; CLO_0031421
DR   BioSample; SAMN00807213
DR   Coriell; GM01835
DR   Wikidata; Q54837112
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7847674;
RX   PubMed=21490598;
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D874 ! GM01836
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM01836
AC   CVCL_D874
SY   GM-1836
DR   CLO; CLO_0031418
DR   BioSample; SAMN00807215
DR   Coriell; GM01836
DR   Wikidata; Q54837113
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D873 ! GM01835
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM01837
AC   CVCL_AI30
SY   GM-1837
DR   CLO; CLO_0031419
DR   Coriell; GM01837
DR   Wikidata; Q54837114
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI31 ! GM01838
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM01838
AC   CVCL_AI31
SY   GM-1838
DR   CLO; CLO_0031413
DR   Coriell; GM01838
DR   Wikidata; Q54837115
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI30 ! GM01837
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   GM01840
AC   CVCL_M987
SY   GM-1840; GM17311; AG01840; AG-1840; AG 1840; AG1840
DR   CLO; CLO_0013354
DR   CLO; CLO_0031415
DR   BioSample; SAMN00807217
DR   Coriell; AG01840
DR   Coriell; GM01840
DR   Coriell; GM17311
DR   Wikidata; Q54837116
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; AG01840; probable.
CC   Discontinued: Coriell; GM01840; probable.
CC   Discontinued: Coriell; GM17311; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE28 ! AG01839
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM01841
AC   CVCL_1L43
SY   GM-1841; GM01841A
DR   CLO; CLO_0031427
DR   Coriell; GM01841
DR   Wikidata; Q54837117
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01844
AC   CVCL_JC88
SY   GM-1844
DR   Coriell; GM01844
DR   Wikidata; Q54837118
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01844; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC89 ! GM01845
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01845
AC   CVCL_JC89
SY   GM-1845
DR   Coriell; GM01845
DR   Wikidata; Q54837119
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01845; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC88 ! GM01844
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01846
AC   CVCL_JC86
SY   GM-1846
DR   Coriell; GM01846
DR   Wikidata; Q54837120
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01846; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC87 ! GM01847
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01847
AC   CVCL_JC87
SY   GM-1847
DR   Coriell; GM01847
DR   Wikidata; Q54837121
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01847; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC86 ! GM01846
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01848
AC   CVCL_X257
SY   GM-1848; GM 1848
DR   CLO; CLO_0031428
DR   BioSample; SAMN00807219
DR   Coriell; GM01848
DR   Wikidata; Q54837122
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM01849
AC   CVCL_X258
SY   GM-1849; GM 1849
DR   CLO; CLO_0031425
DR   BioSample; SAMN00807221
DR   Coriell; GM01849
DR   Wikidata; Q54837123
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM01850
AC   CVCL_M988
SY   GM-1850; GM17101
DR   CLO; CLO_0014894
DR   CLO; CLO_0031426
DR   BioSample; SAMN00807223
DR   Coriell; GM01850
DR   Coriell; GM17101
DR   GEO; GSM596169
DR   GEO; GSM924611
DR   IPD-IMGT/HLA; 19227
DR   Wikidata; Q54837125
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,26:GAX; B*08:XKT,44:WRJ; C*01:02,03:04; DRB1*01:03,13:04 (IPD-IMGT/HLA=19227).
CC   Sequence variation: Mutation; HGNC; HGNC:4696; GUSB; Simple; p.Trp627Cys (c.1881G>T); ClinVar=VCV000000907; Zygosity=Heterozygous (Coriell=GM01850).
CC   Omics: Genomics; DNA methylation analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM01851
AC   CVCL_CX23
SY   GM-1851
DR   Coriell; GM01851
DR   Wikidata; Q54837126
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01851; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84548; Alpha-mannosidosis
DI   ORDO; Orphanet_61; Alpha-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM01858
AC   CVCL_9Z58
SY   GM-1858; GM01858B
DR   CLO; CLO_0031393
DR   BioSample; SAMN00807233
DR   Coriell; GM01858
DR   Wikidata; Q54837131
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   NCIt; C3272; Neurofibroma
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
DI   ORDO; Orphanet_252183; Neurofibroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z59 ! GM01859
OI   CVCL_JC74 ! GM01860
OI   CVCL_9Z60 ! GM01861
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 8
//
ID   GM01859
AC   CVCL_9Z59
SY   GM-1859
DR   CLO; CLO_0031396
DR   BioSample; SAMN00807236
DR   Coriell; GM01859
DR   Wikidata; Q54837132
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z58 ! GM01858
OI   CVCL_JC74 ! GM01860
OI   CVCL_9Z60 ! GM01861
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01860
AC   CVCL_JC74
SY   GM-1860
DR   Coriell; GM01860
DR   Wikidata; Q54837133
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM01860; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z58 ! GM01858
OI   CVCL_9Z59 ! GM01859
OI   CVCL_9Z60 ! GM01861
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01861
AC   CVCL_9Z60
SY   GM-1861; GM01861A
DR   CLO; CLO_0031397
DR   BioSample; SAMN00807238
DR   Coriell; GM01861
DR   Wikidata; Q54837134
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z58 ! GM01858
OI   CVCL_9Z59 ! GM01859
OI   CVCL_JC74 ! GM01860
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM01862
AC   CVCL_JD89
SY   GM-1862
DR   Coriell; GM01862
DR   Wikidata; Q54837135
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01862; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   37Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01863
AC   CVCL_7341
SY   GM1863; GM-1863
DR   CLO; CLO_0031404
DR   BioSample; SAMN00807240
DR   Coriell; GM01863
DR   Wikidata; Q54837136
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [70%]; 46,XY,t(4;7)(4pter->4q21::7q36->7qter;7pter->7q36::4q21->4qter) [30%] (Coriell=GM01863).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM01864
AC   CVCL_7342
SY   GM1864; GM-1864; GM01864A; GM1864A; GM 1864A
DR   CLO; CLO_0031405
DR   BioSample; SAMN00807242
DR   Coriell; GM01864
DR   Wikidata; Q54837140
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   Patent=US5773219;
RX   PubMed=8643543;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM01865
AC   CVCL_DE31
SY   GM-1865; GM1865
DR   Coriell; GM01865
DR   Wikidata; Q54837141
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7565859;
CC   Discontinued: Coriell; GM01865; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   36Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM01867
AC   CVCL_1V12
SY   GM-1867
DR   Coriell; GM01867
DR   Wikidata; Q54837142
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01867; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1V11 ! GM01034
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM01868
AC   CVCL_EJ30
SY   GM-1868
DR   CLO; CLO_0031406
DR   BioSample; SAMN00807244
DR   Coriell; GM01868
DR   Wikidata; Q54837143
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr355Ilefs (c.1220delC); Zygosity=Heterozygous (Coriell=GM01868).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM01869
AC   CVCL_4J38
SY   GM-1869
DR   CLO; CLO_0031407
DR   BioSample; SAMN00807246
DR   Coriell; GM01869
DR   Wikidata; Q54837144
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01870
AC   CVCL_4J39
SY   GM-1870
DR   CLO; CLO_0032403
DR   BioSample; SAMN00807248
DR   Coriell; GM01870
DR   Wikidata; Q54837145
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM01871
AC   CVCL_4J40
SY   GM-1871
DR   CLO; CLO_0032405
DR   BioSample; SAMN00807250
DR   Coriell; GM01871
DR   Wikidata; Q54837146
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Heterozygous (Coriell=GM01871).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   GM01872
AC   CVCL_GR92
SY   GM-1872; GM1872
DR   CLO; CLO_0032404
DR   BioSample; SAMN00807252
DR   Coriell; GM01872
DR   Wikidata; Q54837147
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS11 ! GM02762
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM01873
AC   CVCL_GR93
SY   GM-1873; GM1873
DR   CLO; CLO_0032400
DR   BioSample; SAMN00807254
DR   Coriell; GM01873
DR   Wikidata; Q54837148
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS12 ! GM02763
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM01874
AC   CVCL_CY02
SY   GM-1874; GM1874
DR   CLO; CLO_0032399
DR   BioSample; SAMN00807256
DR   Coriell; GM01874
DR   Wikidata; Q54837149
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY22 ! GM02766
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 11
//
ID   GM01875
AC   CVCL_CY03
SY   GM-1875; GM1875
DR   CLO; CLO_0032402
DR   BioSample; SAMN00807258
DR   Coriell; GM01875
DR   Wikidata; Q54837150
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY25 ! GM02866
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01876
AC   CVCL_CY04
SY   GM-1876; GM1876
DR   CLO; CLO_0032401
DR   BioSample; SAMN00807260
DR   Coriell; GM01876
DR   Wikidata; Q54837151
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY24 ! GM02812
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01877
AC   CVCL_F076
SY   GM-1877; GM1877
DR   CLO; CLO_0032407
DR   BioSample; SAMN00807264
DR   Coriell; GM01877
DR   GEO; GSM1288434
DR   Wikidata; Q54837152
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=24555846;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F073 ! GM03356
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   GM01878
AC   CVCL_CY05
SY   GM-1878; GM1878
DR   CLO; CLO_0032406
DR   BioSample; SAMN00807266
DR   Coriell; GM01878
DR   GEO; GSM1288435
DR   Wikidata; Q54837153
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438795;
RX   PubMed=24555846;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY19 ! GM02714
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GM01879
AC   CVCL_DF18
AS   CVCL_V557
SY   GM-1879; GM01879A; AG01879; AG-1879; AG 1879; AG1879
DR   CLO; CLO_0032408
DR   BioSample; SAMN00807268
DR   Coriell; AG01879
DR   Coriell; GM01879
DR   Wikidata; Q54837154
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Discontinued: Coriell; AG01879; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM01880
AC   CVCL_DF19
AS   CVCL_V543
SY   GM-1880; GM01880B; AG01880; AG-1880; AG 1880; AG1880
DR   CLO; CLO_0032426
DR   BioSample; SAMN00807270
DR   Coriell; AG01880
DR   Coriell; GM01880
DR   Wikidata; Q54837155
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2973075;
RX   PubMed=6843573;
RX   PubMed=7253718;
RX   PubMed=7471105;
CC   Discontinued: Coriell; AG01880; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM01881
AC   CVCL_V812
SY   GM-1881; GM1881
DR   CLO; CLO_0032425
DR   BioSample; SAMN00807272
DR   Coriell; GM01881
DR   Wikidata; Q54837156
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6777119;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Ser66Trp (c.197C>G); ClinVar=VCV000005111; Zygosity=Heterozygous (Coriell=GM01881).
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Val131Met (c.391G>A); ClinVar=VCV001372507; Zygosity=Heterozygous (Coriell=GM01881).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM01882
AC   CVCL_JC82
SY   GM-1882
DR   Coriell; GM01882
DR   Wikidata; Q54837157
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01882; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC83 ! GM01883
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01883
AC   CVCL_JC83
SY   GM-1883
DR   Coriell; GM01883
DR   Wikidata; Q54837158
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01883; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JC82 ! GM01882
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01886
AC   CVCL_4J41
SY   GM-1886
DR   CLO; CLO_0032424
DR   BioSample; SAMN00807274
DR   Coriell; GM01886
DR   Wikidata; Q54837159
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01887
AC   CVCL_4J42
SY   GM-1887
DR   CLO; CLO_0032423
DR   BioSample; SAMN00807276
DR   Coriell; GM01887
DR   Wikidata; Q54837160
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01888
AC   CVCL_4J43
SY   GM-1888
DR   CLO; CLO_0032422
DR   BioSample; SAMN00807278
DR   Coriell; GM01888
DR   Wikidata; Q54837162
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01889
AC   CVCL_5M70
SY   GM-1889
DR   CLO; CLO_0032421
DR   BioSample; SAMN00807280
DR   Coriell; GM01889
DR   Wikidata; Q54837163
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX (Coriell=GM01889).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C86032; XX male
DI   ORDO; Orphanet_393; 46,XX testicular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   24Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM01891
AC   CVCL_7343
SY   GM1891; GM-1891
DR   CLO; CLO_0032420
DR   BioSample; SAMN00807282
DR   Coriell; GM01891
DR   Wikidata; Q54837164
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM01892
AC   CVCL_F015
SY   GM-1892
DR   CLO; CLO_0032419
DR   BioSample; SAMN00807284
DR   Coriell; GM01892
DR   Wikidata; Q54837165
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(9;18)(9qter->9p24::18q12->18qter;18pter->18q12::9p24->9pter) (Coriell=GM01892).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM01893
AC   CVCL_F016
SY   GM-1893; GM 1893
DR   CLO; CLO_0032428
DR   Coriell; GM01893
DR   Wikidata; Q54837166
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Karyotypic information: 46,XY,del(9)(pter->q11::q21.3->qter) (Coriell=GM01893).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 12
//
ID   GM01896
AC   CVCL_F017
SY   GM-1896
DR   CLO; CLO_0032427
DR   BioSample; SAMN00807286
DR   Coriell; GM01896
DR   Wikidata; Q54837167
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM01897
AC   CVCL_F018
SY   GM-1897
DR   CLO; CLO_0032369
DR   BioSample; SAMN00807288
DR   Coriell; GM01897
DR   Wikidata; Q54837168
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM01898
AC   CVCL_F019
SY   GM-1898; GM 01898
DR   CLO; CLO_0032371
DR   BioSample; SAMN00807290
DR   Coriell; GM01898
DR   Wikidata; Q54837169
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Gly409Arg (c.1225G>C); ClinVar=VCV000092627; Zygosity=Homozygous (PubMed=8328452).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Ter654Cysext*38 (c.1962A>T); ClinVar=VCV000242721; Zygosity=Homozygous (PubMed=8328452).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM01899
AC   CVCL_2448
AS   CVCL_D867
SY   GM-1899; GM 1899; GM1899; GM01899A; GM1899A; GM1899a; GM01899B; RJK 906; RJK906
DR   CLO; CLO_0032370
DR   BioSample; SAMN00807292
DR   Coriell; GM01899
DR   ECACC; 98120701
DR   Wikidata; Q54837170
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   HLA typing: A*02,11; B*18,35 (Coriell=GM01899).
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; c.610-4_610-2delinsTTT (Ex9del partial); ClinVar=VCV000010055; Zygosity=Hemizygous (Coriell=GM01899).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   GM01900
AC   CVCL_L480
SY   GM-1900; GM01900A
DR   CLO; CLO_0032373
DR   BioSample; SAMN00807294
DR   Coriell; GM01900
DR   Wikidata; Q54837171
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; c.610-4_610-2delinsTTT (Ex9del partial); ClinVar=VCV000010055; Zygosity=Heterozygous (from familial inference of GM01899).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   GM01905
AC   CVCL_GR94
SY   GM-1905
DR   CLO; CLO_0032372
DR   Coriell; GM01905
DR   Wikidata; Q54837172
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM01906
AC   CVCL_JB71
SY   GM-1906
DR   Coriell; GM01906
DR   Wikidata; Q54837173
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01906; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01907
AC   CVCL_F026
SY   GM-1907
DR   CLO; CLO_0032375
DR   BioSample; SAMN00807296
DR   Coriell; GM01907
DR   Wikidata; Q54837174
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Val44Met (c.130G>A); ClinVar=VCV000003611; Zygosity=Heterozygous (from autologous cell line GM02795).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Met142Lys (c.425T>A); ClinVar=VCV000003609; Zygosity=Heterozygous (from autologous cell line GM02795).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D342 ! GM00054
OI   CVCL_F027 ! GM02795
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   GM01908
AC   CVCL_F483
SY   GM-1908
DR   CLO; CLO_0032374
DR   BioSample; SAMN00807298
DR   Coriell; GM01908
DR   Wikidata; Q54837175
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Ser135Leu (c.404C>T); ClinVar=VCV000003618; Zygosity=Heterozygous (from autologous cell line GM02796).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Phe171Ser (c.512T>C); ClinVar=VCV000003616; Zygosity=Heterozygous (from autologous cell line GM02796).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2779 ! CHP 4 (W.W.)
OI   CVCL_F484 ! GM02796
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM01909
AC   CVCL_GR95
SY   GM-1909; GM1909
DR   CLO; CLO_0032377
DR   BioSample; SAMN00807300
DR   Coriell; GM01909
DR   Wikidata; Q54837176
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS14 ! GM02765
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM01910
AC   CVCL_CZ03
SY   GM-1910; GM1910
DR   CLO; CLO_0032376
DR   BioSample; SAMN00807302
DR   Coriell; GM01910
DR   Wikidata; Q54837177
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ09 ! GM03354
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM01911
AC   CVCL_GR96
SY   GM-1911
DR   CLO; CLO_0032378
DR   BioSample; SAMN00807304
DR   Coriell; GM01911
DR   Wikidata; Q54837178
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS13 ! GM02764
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM01912
AC   CVCL_4E25
SY   GM-1912
DR   CLO; CLO_0032386
DR   BioSample; SAMN00807306
DR   Coriell; GM01912
DR   Wikidata; Q54837179
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85062; Sea-blue histiocyte syndrome
DI   ORDO; Orphanet_158029; Sea-blue histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4E26 ! GM01913
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM01913
AC   CVCL_4E26
SY   GM-1913
DR   CLO; CLO_0032388
DR   BioSample; SAMN00807308
DR   Coriell; GM01913
DR   Wikidata; Q54837180
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85062; Sea-blue histiocyte syndrome
DI   ORDO; Orphanet_158029; Sea-blue histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4E25 ! GM01912
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM01915
AC   CVCL_4N19
SY   GM-1915; GM 1915; GM1915; GM01915C
DR   CLO; CLO_0032394
DR   BioSample; SAMN00807310
DR   Coriell; GM01915
DR   Wikidata; Q54837183
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3994723;
RX   PubMed=6986448;
RX   PubMed=29308438;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys197Phe (c.590G>T) (C176F); ClinVar=VCV000251309; Zygosity=Heterozygous (PubMed=29308438).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Asp304Asn (c.910G>A) (D283N); ClinVar=VCV000003692; Zygosity=Heterozygous (PubMed=29308438).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM01918
AC   CVCL_JD80
SY   GM-1918
DR   Coriell; GM01918
DR   Wikidata; Q54837184
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01918; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE14 ! GM01919
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01919
AC   CVCL_JE14
SY   GM-1919
DR   Coriell; GM01919
DR   Wikidata; Q54837185
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01919; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JD80 ! GM01918
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01920
AC   CVCL_V464
SY   GM-1920; GM 1920
DR   CLO; CLO_0032393
DR   BioSample; SAMN00807312
DR   Coriell; GM01920
DR   Wikidata; Q54837186
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,t(8;14)(8pter->8q13::14q13->14qter;14pter->14q13::8q13->8qter),inv(9)(p11q13),+21 (Coriell=GM01920).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V465 ! GM01921
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM01921
AC   CVCL_V465
SY   GM-1921; GM 1921; GM01921A
DR   CLO; CLO_0032392
DR   BioSample; SAMN00807314
DR   Coriell; GM01921
DR   Wikidata; Q54837187
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V464 ! GM01920
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM01927
AC   CVCL_W659
SY   GM-1927; GM01927A
DR   CLO; CLO_0032391
DR   BioSample; SAMN00807316
DR   Coriell; GM01927
DR   Wikidata; Q54837188
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01928
AC   CVCL_W660
SY   GM-1928; GM01928A
DR   CLO; CLO_0032398
DR   BioSample; SAMN00807318
DR   Coriell; GM01928
DR   Wikidata; Q54837190
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01929
AC   CVCL_W661
SY   GM-1929; GM01929A
DR   CLO; CLO_0032397
DR   BioSample; SAMN00807319
DR   Coriell; GM01929
DR   Wikidata; Q54837191
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=34990619;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM01930
AC   CVCL_L967
SY   GM-1930; GM01802; GM-1802
DR   CLO; CLO_0032396
DR   BioSample; SAMN00807320
DR   Coriell; GM01802
DR   Coriell; GM01930
DR   Wikidata; Q54837192
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01802; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   GM01931
AC   CVCL_4N20
SY   GM-1931
DR   CLO; CLO_0032395
DR   BioSample; SAMN00807322
DR   Coriell; GM01931
DR   Wikidata; Q54837193
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Swiss.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM01935
AC   CVCL_1K54
SY   GM-1935; GM 1935
DR   CLO; CLO_0032320
DR   BioSample; SAMN00807324
DR   Coriell; GM01935
DR   Wikidata; Q54837194
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6401921;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asp645Glu (c.1935C>A); ClinVar=VCV000004029; Zygosity=Heterozygous (Coriell=GM01935).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Heterozygous (Coriell=GM01935).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM01936
AC   CVCL_1N11
SY   GM-1936
DR   Coriell; GM01936
DR   Wikidata; Q54837195
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
CC   Population: Jewish; Moroccan.
CC   Discontinued: Coriell; GM01936; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM01937
AC   CVCL_1N12
SY   GM-1937; GM01937A
DR   Coriell; GM01937
DR   Wikidata; Q54837196
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
CC   Population: Jewish; Moroccan.
CC   Discontinued: Coriell; GM01937; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM01938
AC   CVCL_AD64
SY   GM1938; GM-1938
DR   CLO; CLO_0032325
DR   BioSample; SAMN00807326
DR   Coriell; GM01938
DR   Wikidata; Q54837197
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM01941
AC   CVCL_X084
SY   GM-1941; GM 1941
DR   CLO; CLO_0032323
DR   BioSample; SAMN00807328
DR   Coriell; GM01941
DR   Wikidata; Q54837198
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM01948
AC   CVCL_9W83
SY   GM-1948; GM 01948
DR   CLO; CLO_0032335
DR   BioSample; SAMN00807330
DR   Coriell; GM01948
DR   GEO; GSM1316974
DR   GEO; GSM1317011
DR   Wikidata; Q54837199
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=26984941;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,15ps+ (Coriell=GM01948).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM01953
AC   CVCL_7344
SY   GM-1953; GM1953; GM01953A; GM01079; GM-1079; GM17216
DR   CLO; CLO_0013888
DR   CLO; CLO_0032336
DR   BioSample; SAMN00807332
DR   Coriell; GM01079
DR   Coriell; GM01953
DR   Coriell; GM17216
DR   GEO; GSM569530
DR   GEO; GSM596280
DR   GEO; GSM596640
DR   GEO; GSM924818
DR   Wikidata; Q54837200
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7519740;
RX   PubMed=7664335;
RX   PubMed=8483505;
RX   PubMed=9025096;
RX   PubMed=14583597;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,03:01:01; B*08:01:01,35:01:01; C*04:01:01,07:01:01; DPA1*01:03:01,02:06; DPB1*04:02:01,05:01:01; DQA1*01:01:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*01:01:01,03:01:01; DRB3*01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: Coriell; GM01079; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   GM01954
AC   CVCL_7345
SY   GM-1954; GM1954; GM01954A; GM01080; GM-1080; GM1080; GM17217
DR   CLO; CLO_0013887
DR   CLO; CLO_0032337
DR   BioSample; SAMN00807334
DR   Coriell; GM01080
DR   Coriell; GM01954
DR   Coriell; GM17217
DR   GEO; GSM569531
DR   GEO; GSM596281
DR   GEO; GSM596641
DR   GEO; GSM924819
DR   Wikidata; Q54837201
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,34:02:01; B*08:01:01,35:01:01; C*07:01:01,15:02:01; DPA1*01:03:01,02:02:02; DPB1*01:01:01,04:02:01; DQA1*01:01:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*01:03:01,03:01:01; DRB3*01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: Coriell; GM01080; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM01955
AC   CVCL_F020
SY   GM-1955
DR   CLO; CLO_0032338
DR   Coriell; GM01955
DR   Wikidata; Q54837202
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F021 ! GM01956
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM01956
AC   CVCL_F021
SY   GM-1956
DR   CLO; CLO_0032332
DR   Coriell; GM01956
DR   Wikidata; Q54837203
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F020 ! GM01955
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   GM01957
AC   CVCL_0M12
SY   GM-1957; GM 1957
DR   CLO; CLO_0032333
DR   BioSample; SAMN00807336
DR   Coriell; GM01957
DR   Wikidata; Q54837204
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2445735;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM01957).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM01958
AC   CVCL_0M13
SY   GM-1958
DR   CLO; CLO_0032334
DR   BioSample; SAMN00807338
DR   Coriell; GM01958
DR   Wikidata; Q54837205
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM01958).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM01959
AC   CVCL_0M14
SY   GM-1959; GM 1959
DR   CLO; CLO_0032346
DR   BioSample; SAMN00807340
DR   Coriell; GM01959
DR   Wikidata; Q54837206
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2445735;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from familial inference of GM01957).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM01960
AC   CVCL_M989
SY   GM-1960; GM 1960; GM17063
DR   CLO; CLO_0014560
DR   CLO; CLO_0032344
DR   BioSample; SAMN00807342
DR   Coriell; GM01960
DR   Coriell; GM17063
DR   Wikidata; Q54837207
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
RX   PubMed=7299037;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:12404; TTPA; Simple; p.Arg221Trp (c.661C>T); ClinVar=VCV000065597; Zygosity=Homozygous (Coriell=GM01960).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155996; Ataxia with isolated vitamin E deficiency
DI   ORDO; Orphanet_96; Ataxia with vitamin E deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM01970
AC   CVCL_JD65
SY   GM-1970
DR   Coriell; GM01970
DR   Wikidata; Q54837208
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01970; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM01972
AC   CVCL_F261
AS   CVCL_F262
SY   GM-1972; GM01972A; AG01972; AG-1972; AG 1972; AG1972; AG01972A; AG01972B
DR   CLO; CLO_0032341
DR   CLO; CLO_0036882
DR   BioSample; SAMN00807344
DR   Coriell; AG01972
DR   Coriell; GM01972
DR   GEO; GSM603044
DR   GEO; GSM603045
DR   Wikidata; Q54837209
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7253718;
RX   PubMed=7471105;
RX   PubMed=12714972;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972; Coriell=GM01972).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y10M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   GM01973
AC   CVCL_JD90
SY   GM-1973
DR   Coriell; GM01973
DR   Wikidata; Q54837210
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01973; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01977
AC   CVCL_JD66
SY   GM-1977
DR   Coriell; GM01977
DR   Wikidata; Q54837211
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01977; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01981
AC   CVCL_F589
SY   GM-1981; GM1981
DR   CLO; CLO_0032339
DR   BioSample; SAMN00807346
DR   Coriell; GM01981
DR   Wikidata; Q54837212
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438975;
RX   PubMed=7977350;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Ile220Serfs*9 (c.659_663delTCTCA) (803_807delATCTC) (p.Leu219fs); Zygosity=Hemizygous (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F590 ! GM01982
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM01982
AC   CVCL_F590
SY   GM-1982
DR   CLO; CLO_0032357
DR   BioSample; SAMN00807348
DR   Coriell; GM01982
DR   Wikidata; Q54837213
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Ile220Serfs*9 (c.659_663delTCTCA) (803_807delATCTC) (p.Leu219fs); Zygosity=Hemizygous (Coriell=GM01982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F589 ! GM01981
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM01983
AC   CVCL_F591
SY   GM-1983
DR   CLO; CLO_0032358
DR   BioSample; SAMN00807350
DR   Coriell; GM01983
DR   Wikidata; Q54837214
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7438975;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Ile220Serfs*9 (c.659_663delTCTCA) (803_807delATCTC) (p.Leu219fs); Zygosity=Hemizygous (from familial inference of GM01981; GM01982).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F592 ! GM01984
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   GM01984
AC   CVCL_F592
SY   GM-1984
DR   CLO; CLO_0032355
DR   BioSample; SAMN00807352
DR   Coriell; GM01984
DR   Wikidata; Q54837215
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Ile220Serfs*9 (c.659_663delTCTCA) (803_807delATCTC) (p.Leu219fs); Zygosity=Hemizygous (from familial inference of GM01981; GM01982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F591 ! GM01983
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM01986
AC   CVCL_JD67
SY   GM-1986
DR   Coriell; GM01986
DR   Wikidata; Q54837216
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM01986; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM01989
AC   CVCL_7346
SY   GM-1989; GM 1989; GM1989; GM01989A; GM01076; GM-1076; GM1076; GM18005
DR   CLO; CLO_0015997
DR   CLO; CLO_0032356
DR   BioSample; SAMN00807354
DR   Coriell; GM01076
DR   Coriell; GM01989
DR   Coriell; GM18005
DR   Wikidata; Q54837217
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01076; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM01990
AC   CVCL_7347
SY   GM-1990; GM 1990; GM1990; GM01077; GM-1077; GM1077; GM17218
DR   CLO; CLO_0013921
DR   CLO; CLO_0032353
DR   BioSample; SAMN00807356
DR   Coriell; GM01077
DR   Coriell; GM01990
DR   Coriell; GM17218
DR   GEO; GSM569532
DR   GEO; GSM596282
DR   GEO; GSM596642
DR   GEO; GSM924820
DR   Wikidata; Q54837218
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=62390;
RX   PubMed=6661932;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,01:01:01; B*07:02:01,08:01:01; C*07:01:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01; DRB3*01:01:02; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: Coriell; GM01077; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM01993
AC   CVCL_F023
SY   GM-1993; GM 1993
DR   CLO; CLO_0032354
DR   BioSample; SAMN00807358
DR   Coriell; GM01993
DR   Wikidata; Q54837219
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM01994
AC   CVCL_UR74
SY   GM01994A
DR   Coriell; GM01994
DR   Wikidata; Q93575202
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM01994; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125694; Sitosterolemia
DI   ORDO; Orphanet_2882; Sitosterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM01995
AC   CVCL_AK20
SY   GM-1995
DR   CLO; CLO_0032281
DR   BioSample; SAMN00807360
DR   Coriell; GM01995
DR   Wikidata; Q54837220
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125694; Sitosterolemia
DI   ORDO; Orphanet_2882; Sitosterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM01996
AC   CVCL_V813
SY   GM-1996; GM 1996; BH-76-506
DR   CLO; CLO_0032286
DR   BioSample; SAMN00807362
DR   Coriell; GM01996
DR   Wikidata; Q54837221
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=891264;
RX   PubMed=1766867;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Asn314Asp (c.940A>G); ClinVar=VCV000003613; Zygosity=Heterozygous (Coriell=GM01996).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM01997
AC   CVCL_CZ12
SY   GM-1997
DR   CLO; CLO_0032285
DR   BioSample; SAMN00807364
DR   Coriell; GM01997
DR   Wikidata; Q54837222
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Ala215Thr (c.643G>A); ClinVar=VCV000001967; Zygosity=Homozygous (Coriell=GM01997).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ84 ! GM02294
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM01998
AC   CVCL_F024
SY   GM-1998
DR   CLO; CLO_0032291
DR   BioSample; SAMN00807366
DR   Coriell; GM01998
DR   Wikidata; Q54837223
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F025 ! GM01999
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM01999
AC   CVCL_F025
SY   GM-1999
DR   CLO; CLO_0032288
DR   BioSample; SAMN00807368
DR   Coriell; GM01999
DR   Wikidata; Q54837227
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F024 ! GM01998
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM02000
AC   CVCL_1V08
SY   GM-2000; GM 2000; GM2000; GM02000F
DR   CLO; CLO_0032294
DR   BioSample; SAMN00807370
DR   Coriell; GM02000
DR   Wikidata; Q54837228
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6089204;
RX   PubMed=6986448;
RX   PubMed=29308438;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Glu408Lys (c.1222G>A) (E387K); ClinVar=VCV000036453; Zygosity=Homozygous (PubMed=29308438).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX46 ! GM01116
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM02003
AC   CVCL_X085
SY   GM-2003; GM 2003
DR   CLO; CLO_0032295
DR   BioSample; SAMN00807372
DR   Coriell; GM02003
DR   Wikidata; Q54837229
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM02006
AC   CVCL_JB89
SY   GM-2006
DR   Coriell; GM02006
DR   Wikidata; Q54837231
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM02006; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM86 ! GM01691
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM02007
AC   CVCL_AM83
SY   GM-2007
DR   CLO; CLO_0032297
DR   BioSample; SAMN00807376
DR   Coriell; GM02007
DR   Wikidata; Q54837232
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM02008
AC   CVCL_X086
SY   GM-2008; GM 2008
DR   CLO; CLO_0032298
DR   BioSample; SAMN00807378
DR   Coriell; GM02008
DR   Wikidata; Q54837233
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM02011
AC   CVCL_V030
SY   GM2011; GM-2011; GM02011A
DR   CLO; CLO_0032312
DR   BioSample; SAMN00807384
DR   Coriell; GM02011
DR   Wikidata; Q54837236
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V029 ! GM00954
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM02013
AC   CVCL_W640
SY   GM-2013; GM02013B; GM02013D
DR   CLO; CLO_0032309
DR   BioSample; SAMN00807386
DR   Coriell; GM02013
DR   Wikidata; Q54837237
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Tyr1079Leufs*3 (c.3231_3234dupCTAC) (3395_3398dupCTAC); ClinVar=VCV000038423; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM02014
AC   CVCL_M990
SY   GM-2014; GM02014A; GM17041; GM17331
DR   CLO; CLO_0013611
DR   CLO; CLO_0014625
DR   CLO; CLO_0032307
DR   BioSample; SAMN00807388
DR   Coriell; GM02014
DR   Coriell; GM17041
DR   Coriell; GM17331
DR   Wikidata; Q54837238
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Part of: Human variation panel.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Tyr1079Leufs*3 (c.3231_3234dupCTAC) (3395_3398dupCTAC); ClinVar=VCV000038423; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   GM02016
AC   CVCL_M991
SY   GM-2016; GM 02016; GM17042; GM17332
DR   CLO; CLO_0013619
DR   CLO; CLO_0014644
DR   CLO; CLO_0032306
DR   BioSample; SAMN00807390
DR   Coriell; GM02016
DR   Coriell; GM17042
DR   Coriell; GM17332
DR   Wikidata; Q54837239
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Arab.
CC   HLA typing: A*02:01:01,30:02:01; B*53:01:01,58:01:01; C*04:01:01,07:18; DPA1*01:03:01,01:03:01; DPB1*02:01:02,03:01:01; DQA1*01:05:01,04:01:02; DQB1*04:02:01,05:01:01; DRB1*08:04:01,14:54:01; DRB3*02:02:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Gly409Arg (c.1225G>C); ClinVar=VCV000092627; Zygosity=Heterozygous (PubMed=8328452).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Ter654Cysext*38 (c.1962A>T); ClinVar=VCV000242721; Zygosity=Heterozygous (PubMed=8328452).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   GM02017
AC   CVCL_M992
SY   GM-2017; GM 02017; GM17333
DR   CLO; CLO_0013617
DR   CLO; CLO_0032316
DR   BioSample; SAMN00807392
DR   Coriell; GM02017
DR   Coriell; GM17333
DR   Wikidata; Q54837240
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8328452;
CC   Part of: Human variation panel.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Gly409Arg (c.1225G>C); ClinVar=VCV000092627; Zygosity=Heterozygous (PubMed=8328452).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Ter654Cysext*38 (c.1962A>T); ClinVar=VCV000242721; Zygosity=Heterozygous (PubMed=8328452).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GM02018
AC   CVCL_V814
SY   GM-2018; GM 2018
DR   CLO; CLO_0032317
DR   BioSample; SAMN00807394
DR   Coriell; GM02018
DR   Wikidata; Q54837241
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=456042;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM02022
AC   CVCL_AM98
SY   GM-2022
DR   CLO; CLO_0032314
DR   BioSample; SAMN00807396
DR   Coriell; GM02022
DR   Wikidata; Q54837242
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM02025
AC   CVCL_V825
SY   GM-2025; GM 2025; GM2025
DR   CLO; CLO_0032577
DR   BioSample; SAMN00807400
DR   Coriell; GM02025
DR   Wikidata; Q54837244
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM02026
AC   CVCL_4J44
SY   GM-2026; GM02026A
DR   CLO; CLO_0032578
DR   BioSample; SAMN00807402
DR   Coriell; GM02026
DR   Wikidata; Q54837245
RX   CelloPub=CLPUB00447;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Heterozygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM02027
AC   CVCL_JB69
SY   GM-2027
DR   Coriell; GM02027
DR   Wikidata; Q54837246
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02027; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM02028
AC   CVCL_CZ13
SY   GM-2028; GM02028A
DR   CLO; CLO_0032575
DR   Coriell; GM02028
DR   Wikidata; Q54837247
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02029
AC   CVCL_JD98
SY   GM-2029
DR   Coriell; GM02029
DR   Wikidata; Q54837248
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02029; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM02030
AC   CVCL_X259
SY   GM-2030; GM 2030
DR   CLO; CLO_0032576
DR   BioSample; SAMN00807404
DR   Coriell; GM02030
DR   Wikidata; Q54837249
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM02036
AC   CVCL_7348
SY   GM2036; GM 02036; GM-02036; GM-2036; GM02036A; GMO2036A; C2036
DR   CLO; CLO_0032573
DR   BioSample; SAMN00807414
DR   BioSample; SAMN03253067
DR   Coriell; GM02036
DR   GEO; GSM2794402
DR   Wikidata; Q54837255
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=17668376;
RX   PubMed=28284873;
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=33038742;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM02037
AC   CVCL_7349
SY   GM2037; GM-2037; GM 2037; GM02037A; GM2037A; GM 2037A; GM02037B; GM 2037B; GM02037C
DR   BTO; BTO_0003842
DR   CLO; CLO_0032574
DR   BioSample; SAMN00807416
DR   Coriell; GM02037
DR   GEO; GSM3124641
DR   Wikidata; Q54837256
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   Patent=US5773219;
RX   PubMed=6223188;
RX   PubMed=8643543;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [45]; 46,XY,t(4;16)(4qter->4p14::16q24->16qter;16pter->16q24::4p14->4pter) [5] (Coriell=GM02037).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM02038
AC   CVCL_CW68
SY   GM-2038
DR   CLO; CLO_0032554
DR   BioSample; SAMN00807418
DR   Coriell; GM02038
DR   Wikidata; Q54837257
RX   CelloPub=CLPUB00447;
RX   PubMed=7847674;
RX   PubMed=21490598;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW69 ! GM02039
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM02039
AC   CVCL_CW69
SY   GM-2039
DR   CLO; CLO_0032555
DR   BioSample; SAMN00807420
DR   Coriell; GM02039
DR   Wikidata; Q54837258
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW68 ! GM02038
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02044
AC   CVCL_1D93
SY   GM-2044; GM2044
DR   CLO; CLO_0032556
DR   Coriell; GM02044
DR   Wikidata; Q54837259
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2095701;
CC   Karyotypic information: 45,XY,-16,t(14;16)(16;18)(14qter->14p12::16p11->16pter;18qter->18p1::16q12->16qter) (Coriell=GM02044).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM02045
AC   CVCL_CX28
SY   GM-2045
DR   Coriell; GM02045
DR   Wikidata; Q54837260
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02045; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM02046
AC   CVCL_L761
SY   GM-2046
DR   CLO; CLO_0032557
DR   BioSample; SAMN00807422
DR   Coriell; GM02046
DR   Wikidata; Q54837261
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu730Lysfs*7 (c.2188delTinsAAA) (2352delTinsAAA); ClinVar=VCV000038418; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   GM02047
AC   CVCL_L762
SY   GM-2047
DR   CLO; CLO_0032558
DR   BioSample; SAMN00807424
DR   Coriell; GM02047
DR   Wikidata; Q54837262
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   GM02048
AC   CVCL_M927
SY   GM-2048
DR   CLO; CLO_0032549
DR   BioSample; SAMN00807426
DR   Coriell; GM02048
DR   Wikidata; Q54837263
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (from autologous cell line GM02533).
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Heterozygous (from autologous cell line GM02533).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M926 ! GM02533
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   GM02049
AC   CVCL_AB44
SY   GM-2049
DR   CLO; CLO_0032550
DR   BioSample; SAMN00807428
DR   Coriell; GM02049
DR   Wikidata; Q54837265
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:6826; MAN2B1; Simple; p.His72Leu (c.215A>T) (H71L); ClinVar=VCV000001684; Zygosity=Heterozygous (Coriell=GM02049).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM02050
AC   CVCL_W641
SY   GM-2050
DR   CLO; CLO_0032551
DR   BioSample; SAMN00807430
DR   Coriell; GM02050
DR   Wikidata; Q54837266
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:6826; MAN2B1; Simple; p.His72Leu (c.215A>T) (H71L); ClinVar=VCV000001684; Zygosity=Homozygous (Coriell=GM02050).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84548; Alpha-mannosidosis
DI   ORDO; Orphanet_61; Alpha-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM02051
AC   CVCL_M993
SY   GM-2051; GM17334
DR   CLO; CLO_0013616
DR   CLO; CLO_0032552
DR   BioSample; SAMN00807432
DR   Coriell; GM02051
DR   Coriell; GM17334
DR   Wikidata; Q54837267
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:6826; MAN2B1; Simple; p.His72Leu (c.215A>T) (H71L); ClinVar=VCV000001684; Zygosity=Homozygous (Coriell=GM02051).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84548; Alpha-mannosidosis
DI   ORDO; Orphanet_61; Alpha-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   GM02052
AC   CVCL_7350
SY   GM-2052; GM 2052; GM2052; GM02052A; AT19IJE-F
DR   CLO; CLO_0032553
DR   BioSample; SAMN00807434
DR   Coriell; GM02052
DR   Wikidata; Q54837268
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=11313956;
RX   PubMed=12446774;
RX   PubMed=19896956;
CC   Population: Jewish; Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg35Ter (c.103C>T); ClinVar=VCV000003025; Zygosity=Homozygous (Coriell=GM02052).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM02052+hTERT
AC   CVCL_VL09
SY   hTERT+ GM02052
DR   Wikidata; Q93575552
RX   PubMed=11313956;
CC   Population: Jewish; Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg35Ter (c.103C>T); ClinVar=VCV000003025; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7350 ! GM02052
SX   Female
AG   15Y
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   GM02052A-hTERT
AC   CVCL_VL04
SY   GM02052A-hTert
DR   Wikidata; Q93575554
RX   PubMed=12446774;
RX   PubMed=21149446;
CC   Population: Jewish; Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg35Ter (c.103C>T); ClinVar=VCV000003025; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7350 ! GM02052
SX   Female
AG   15Y
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   GM02053
AC   CVCL_F593
SY   GM-2053; GM2053
DR   CLO; CLO_0032537
DR   BioSample; SAMN00807436
DR   Coriell; GM02053
DR   Wikidata; Q54837272
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=761484;
RX   PubMed=3030788;
CC   Population: Arab.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 17
//
ID   GM02054
AC   CVCL_X087
SY   GM-2054; GM 2054
DR   CLO; CLO_0032538
DR   BioSample; SAMN00807438
DR   Coriell; GM02054
DR   Wikidata; Q54837273
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM02055
AC   CVCL_H177
SY   GM-2055; GM 2055
DR   CLO; CLO_0032535
DR   Coriell; GM02055
DR   Wikidata; Q54837274
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM02056
AC   CVCL_X447
SY   GM-2056
DR   CLO; CLO_0032536
DR   BioSample; SAMN00807440
DR   Coriell; GM02056
DR   Wikidata; Q54837275
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1904874;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:318; AGA; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000809707; Zygosity=Heterozygous (PubMed=1904874).
CC   Sequence variation: Mutation; HGNC; HGNC:318; AGA; Simple; p.Cys163Ser (c.488G>C); ClinVar=VCV000000219; Zygosity=Heterozygous (PubMed=1904874).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61273; Aspartylglycosaminuria
DI   ORDO; Orphanet_93; Aspartylglucosaminuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   GM02057
AC   CVCL_X448
SY   GM-2057
DR   CLO; CLO_0032533
DR   BioSample; SAMN00807442
DR   Coriell; GM02057
DR   Wikidata; Q54837276
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1904874;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:318; AGA; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000809707; Zygosity=Heterozygous (PubMed=1904874).
CC   Sequence variation: Mutation; HGNC; HGNC:318; AGA; Simple; p.Cys163Ser (c.488G>C); ClinVar=VCV000000219; Zygosity=Homozygous (PubMed=1904874).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61273; Aspartylglycosaminuria
DI   ORDO; Orphanet_93; Aspartylglucosaminuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   GM02058
AC   CVCL_V466
SY   GM-2058
DR   CLO; CLO_0032534
DR   BioSample; SAMN00807444
DR   Coriell; GM02058
DR   Wikidata; Q54837277
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Jewish; Ashkenazi.
CC   Karyotypic information: 46,XX,i(21)(qter->q10::q10->qter) [13]; 46,XX [87] (Coriell=GM02058).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM02060
AC   CVCL_ZP42
SY   GM2060
DR   Coriell; GM02060
DR   Wikidata; Q98126373
RX   PubMed=6492896;
CC   Senescence: Senesces at 22 PDL (PubMed=6492896).
CC   Discontinued: Coriell; GM02060; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   33Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   GM02061
AC   CVCL_AK21
SY   GM-2061
DR   CLO; CLO_0032531
DR   BioSample; SAMN00807446
DR   Coriell; GM02061
DR   Wikidata; Q54837278
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM02063
AC   CVCL_F127
SY   LN; GM-2063; GM 2063; GM-02063; GM00177; GM 177; GM-177; GM177
DR   Coriell; GM00177
DR   Coriell; GM02063
DR   Wikidata; Q54837280
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=180603;
CC   Population: African American.
CC   Discontinued: Coriell; GM00177; probable.
CC   Discontinued: Coriell; GM02063; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y6M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM02064
AC   CVCL_M994
SY   GM-2064; GM 2064; GM2064; GM02064A; GM17342
DR   CLO; CLO_0013747
DR   CLO; CLO_0032529
DR   BioSample; SAMN00807450
DR   Coriell; GM02064
DR   Coriell; GM17342
DR   Wikidata; Q54837281
RX   CelloPub=CLPUB00447;
RX   PubMed=6196781;
RX   PubMed=7313555;
CC   Part of: Human variation panel.
CC   Population: Africans south of the Sahara.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4827; HBB; Zygosity=Homozygous (Coriell=GM02064).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4829; HBD; Zygosity=Homozygous (Coriell=GM02064).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129072; Hereditary persistence of fetal hemoglobin
DI   ORDO; Orphanet_46532; Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM02065
AC   CVCL_9R68
SY   GM-2065
DR   CLO; CLO_0032530
DR   BioSample; SAMN00807452
DR   Coriell; GM02065
DR   Wikidata; Q54837282
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Ser685Lysfs*61 (c.2053_2057delACTCA) (2215_2219delACTCA); ClinVar=VCV000038417; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; c.3335+6T>G (IVS17+6T>G); ClinVar=VCV000002773; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02066
AC   CVCL_CW97
SY   GM2066; GM-2066; GM 2066
DR   CLO; CLO_0032516
DR   BioSample; SAMN00807454
DR   Coriell; GM02066
DR   Wikidata; Q54837283
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9792862;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Pro48Leufs*7 (c.225+5G>A); ClinVar=VCV002924704; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Gly339Arg (c.1015G>A); ClinVar=VCV000004455; Zygosity=Heterozygous (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   GM02067
AC   CVCL_V467
SY   GM-2067; GM 2067; GM02067A
DR   CLO; CLO_0032517
DR   BioSample; SAMN00807456
DR   Coriell; GM02067
DR   Wikidata; Q54837284
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+21 [44]; 47,XY,t(1;16)(q21;p13.3],+21 [4]; 46,XY [2] (Coriell=GM02067).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM02068
AC   CVCL_1N60
SY   GM-2068
DR   CLO; CLO_0032518
DR   BioSample; SAMN00807458
DR   Coriell; GM02068
DR   Wikidata; Q54837285
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(6;7)(6pter->6q27::7q22->7qter;7pter->7q22::6q27->6qter) (Coriell=GM02068).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM02074
AC   CVCL_0P00
SY   GM-2074
DR   CLO; CLO_0032512
DR   BioSample; SAMN00807460
DR   Coriell; GM02074
DR   Wikidata; Q54837287
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4696; GUSB; Simple; p.Arg357Ter (c.1069C>T); ClinVar=VCV000000908; Zygosity=Heterozygous (Coriell=GM02074).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM02075
AC   CVCL_CW70
SY   GM-2075; GM02075A
DR   CLO; CLO_0032513
DR   BioSample; SAMN00807462
DR   Coriell; GM02075
DR   Wikidata; Q54837288
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=8896560;
RX   PubMed=36259166;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Ala40Glyfs*24 (c.118dupG) (c.118_119insG); ClinVar=VCV000003810; Zygosity=Heterozygous (PubMed=8896560).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM02077
AC   CVCL_1H39
SY   GM-2077
DR   CLO; CLO_0032514
DR   BioSample; SAMN00807464
DR   Coriell; GM02077
DR   Wikidata; Q54837289
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H40 ! GM02078
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 16
//
ID   GM02078
AC   CVCL_1H40
SY   GM-2078
DR   CLO; CLO_0032515
DR   BioSample; SAMN00807466
DR   Coriell; GM02078
DR   Wikidata; Q54837290
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H39 ! GM02077
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 17
//
ID   GM02079
AC   CVCL_1H41
SY   GM-2079; GM 2079; GM02079A
DR   CLO; CLO_0032509
DR   BioSample; SAMN00807468
DR   Coriell; GM02079
DR   Wikidata; Q54837291
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H42 ! GM02080
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM02080
AC   CVCL_1H42
SY   GM-2080; GM 2080; GM02080A
DR   CLO; CLO_0032510
DR   BioSample; SAMN00807470
DR   Coriell; GM02080
DR   Wikidata; Q54837292
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H41 ! GM02079
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 13
//
ID   GM02085
AC   CVCL_U703
SY   GM-2085
DR   CLO; CLO_0032511
DR   BioSample; SAMN00807472
DR   Coriell; GM02085
DR   GEO; GSM1316975
DR   GEO; GSM1317012
DR   Wikidata; Q54837293
RX   CelloPub=CLPUB00447;
RX   PubMed=436333;
RX   PubMed=908169;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (Coriell=GM02085).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 53(StAs) (BSR53).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JD73 ! GM01620
OI   CVCL_WX73 ! HG1947
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 21
//
ID   GM02093
AC   CVCL_6B42
SY   GM-2093; GM02093B
DR   CLO; CLO_0031828
DR   BioSample; SAMN00807478
DR   Coriell; GM02093
DR   Wikidata; Q54837297
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM02094
AC   CVCL_1Y44
SY   GM-2094; GM 2094; GM2094A
DR   CLO; CLO_0031827
DR   BioSample; SAMN00807480
DR   Coriell; GM02094
DR   Wikidata; Q54837298
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3017984;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y52 ! GM02144
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM02095
AC   CVCL_H178
SY   GM-2095
DR   CLO; CLO_0031822
DR   BioSample; SAMN00807482
DR   Coriell; GM02095
DR   Wikidata; Q54837299
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM02098
AC   CVCL_2Z72
SY   GM-2098; GM 2098; GM2098; GM02098A
DR   CLO; CLO_0031824
DR   BioSample; SAMN00807486
DR   Coriell; GM02098
DR   Wikidata; Q54837301
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2897722;
RX   PubMed=6442144;
CC   Population: Caucasian.
CC   Characteristics: Hypersensitive to cell killing by ionizing radiation (Coriell=GM02098).
CC   Misspelling: BM 2098; PubMed=2897722; Note=In table 1.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z73 ! GM02099
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 12
//
ID   GM02099
AC   CVCL_2Z73
SY   GM-2099
DR   CLO; CLO_0031823
DR   BioSample; SAMN00807488
DR   Coriell; GM02099
DR   Wikidata; Q54837302
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z72 ! GM02098
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM02103
AC   CVCL_X260
SY   GM-2103; GM 2103; GM2103
DR   CLO; CLO_0031820
DR   BioSample; SAMN00807490
DR   Coriell; GM02103
DR   Wikidata; Q54837303
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;Y)(q11;q11) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM02109
AC   CVCL_W621
SY   GM-2109; GM 2109; GM02109B
DR   CLO; CLO_0031819
DR   BioSample; SAMN00807492
DR   Coriell; GM02109
DR   Wikidata; Q54837304
RX   CelloPub=CLPUB00447;
RX   PubMed=6782865;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Arg65Ter (c.193C>T); ClinVar=VCV000558291; Zygosity=Heterozygous (Coriell=GM02109).
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.His86Tyr (c.256C>T); ClinVar=VCV000555658; Zygosity=Heterozygous (Coriell=GM02109).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM02110
AC   CVCL_L962
SY   GM-2110; GM02110A; GM01450; GM-1450
DR   CLO; CLO_0031830
DR   BioSample; SAMN00807494
DR   Coriell; GM01450
DR   Coriell; GM02110
DR   Wikidata; Q54837305
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01450; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   GM02121
AC   CVCL_JB66
SY   GM-2121
DR   Coriell; GM02121
DR   Wikidata; Q54837306
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02121; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM02123
AC   CVCL_1H43
SY   GM-2123
DR   CLO; CLO_0031848
DR   BioSample; SAMN00807496
DR   Coriell; GM02123
DR   Wikidata; Q54837307
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at 25% risk for disease.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 16
//
ID   GM02124
AC   CVCL_4J45
SY   GM-2124
DR   CLO; CLO_0031847
DR   BioSample; SAMN00807498
DR   Coriell; GM02124
DR   Wikidata; Q54837308
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Val93Phe (c.277G>T); Zygosity=Heterozygous (Coriell=GM02124).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM02133
AC   CVCL_4J46
SY   GM-2133
DR   CLO; CLO_0031844
DR   BioSample; SAMN00807502
DR   Coriell; GM02133
DR   Wikidata; Q54837309
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J16 ! GM00941
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM02134
AC   CVCL_M924
SY   GM-2134; GM17251
DR   CLO; CLO_0014391
DR   CLO; CLO_0031843
DR   BioSample; SAMN00807504
DR   Coriell; GM02134
DR   Coriell; GM17251
DR   GEO; GSM569631
DR   GEO; GSM596315
DR   GEO; GSM596674
DR   GEO; GSM924853
DR   Wikidata; Q54837310
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M925 ! GM00940
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM02135
AC   CVCL_W224
SY   GM-2135
DR   CLO; CLO_0031842
DR   BioSample; SAMN00807506
DR   Coriell; GM02135
DR   Wikidata; Q54837311
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Arg195Cys (c.583C>T); ClinVar=VCV000161251; Zygosity=Heterozygous (Coriell=GM02135).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W223 ! GM00939
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM02137
AC   CVCL_X088
SY   GM-2137; GM 2137
DR   CLO; CLO_0031841
DR   BioSample; SAMN00807508
DR   Coriell; GM02137
DR   Wikidata; Q54837312
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,inv(5)(pter->p13::q13->p13::q13>qter)mat,+mar (Coriell=GM02137).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02138
AC   CVCL_2Z74
SY   GM-2138
DR   CLO; CLO_0031840
DR   BioSample; SAMN00807510
DR   Coriell; GM02138
DR   Wikidata; Q54837313
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z75 ! GM02139
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM02139
AC   CVCL_2Z75
SY   GM-2139; GM02139B
DR   CLO; CLO_0031849
DR   BioSample; SAMN00807512
DR   Coriell; GM02139
DR   Wikidata; Q54837316
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z74 ! GM02138
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM02144
AC   CVCL_1Y52
SY   GM-2144; GM2144
DR   Coriell; GM02144
DR   Wikidata; Q54837317
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM02144; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y44 ! GM02094
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM02145
AC   CVCL_CX29
SY   GM-2145
DR   Coriell; GM02145
DR   Wikidata; Q54837319
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02145; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM02146
AC   CVCL_H755
SY   GM-2146; GM 2146
DR   CLO; CLO_0031850
DR   BioSample; SAMN00807514
DR   Coriell; GM02146
DR   Wikidata; Q54837320
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7313555;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H756 ! GM02147
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 15
//
ID   GM02147
AC   CVCL_H756
SY   GM-2147; GM 2147; GM02147A
DR   CLO; CLO_0031852
DR   BioSample; SAMN00807516
DR   Coriell; GM02147
DR   GEO; GSM1257703
DR   GEO; GSM1266966
DR   GEO; GSM1267047
DR   GEO; GSM1288436
DR   Wikidata; Q54837321
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H755 ! GM02146
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM02148
AC   CVCL_H753
SY   GM-2148
DR   CLO; CLO_0031851
DR   BioSample; SAMN00807518
DR   Coriell; GM02148
DR   Wikidata; Q54837322
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H754 ! GM02149
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM02149
AC   CVCL_H754
SY   GM-2149; GM 2149; GM2149; GM02149A
DR   CLO; CLO_0031854
DR   BioSample; SAMN00807520
DR   Coriell; GM02149
DR   GEO; GSM1257704
DR   GEO; GSM1266967
DR   GEO; GSM1267048
DR   GEO; GSM1288437
DR   Wikidata; Q54837323
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2897722;
RX   PubMed=6220707;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=8643543;
RX   PubMed=19896956;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H753 ! GM02148
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM02150
AC   CVCL_H757
SY   GM-2150
DR   CLO; CLO_0031853
DR   BioSample; SAMN00807522
DR   Coriell; GM02150
DR   Wikidata; Q54837324
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H758 ! GM02151
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM02151
AC   CVCL_H758
SY   GM-2151; GM 2151
DR   CLO; CLO_0031856
DR   BioSample; SAMN00807524
DR   Coriell; GM02151
DR   GEO; GSM1266968
DR   Wikidata; Q54837325
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H757 ! GM02150
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   GM02152
AC   CVCL_F068
SY   GM-2152; GM02152A; GM18006
DR   CLO; CLO_0015998
DR   CLO; CLO_0031855
DR   BioSample; SAMN00807526
DR   Coriell; GM02152
DR   Coriell; GM18006
DR   Wikidata; Q54837326
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F069 ! GM02153
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM02153
AC   CVCL_F069
SY   GM-2153; C2153
DR   CLO; CLO_0031858
DR   BioSample; SAMN00807528
DR   Coriell; GM02153
DR   GEO; GSM2794403
DR   Wikidata; Q54837327
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F068 ! GM02152
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   GM02154
AC   CVCL_1H44
SY   GM-2154; GM02154B
DR   CLO; CLO_0031857
DR   BioSample; SAMN00807530
DR   Coriell; GM02154
DR   Wikidata; Q54837328
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H45 ! GM02155
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 17
//
ID   GM02155
AC   CVCL_1H45
SY   GM-2155
DR   CLO; CLO_0031869
DR   BioSample; SAMN00807532
DR   Coriell; GM02155
DR   Wikidata; Q54837330
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H44 ! GM02154
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM02156
AC   CVCL_1H46
SY   GM-2156
DR   CLO; CLO_0031863
DR   BioSample; SAMN00807534
DR   Coriell; GM02156
DR   Wikidata; Q54837331
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H47 ! GM02157
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 17
//
ID   GM02157
AC   CVCL_1H47
SY   GM-2157
DR   CLO; CLO_0031866
DR   BioSample; SAMN00807536
DR   Coriell; GM02157
DR   Wikidata; Q54837332
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H46 ! GM02156
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM02158
AC   CVCL_1H48
SY   GM-2158
DR   CLO; CLO_0031885
DR   BioSample; SAMN00807538
DR   Coriell; GM02158
DR   Wikidata; Q54837333
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H49 ! GM02159
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 17
//
ID   GM02159
AC   CVCL_1H49
SY   GM-2159
DR   CLO; CLO_0031884
DR   BioSample; SAMN00807540
DR   Coriell; GM02159
DR   Wikidata; Q54837334
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H48 ! GM02158
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM02160
AC   CVCL_1H50
SY   GM-2160
DR   CLO; CLO_0031883
DR   BioSample; SAMN00807542
DR   Coriell; GM02160
DR   Wikidata; Q54837335
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H51 ! GM02161
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 17
//
ID   GM02161
AC   CVCL_1H51
SY   GM-2161
DR   CLO; CLO_0031882
DR   BioSample; SAMN00807544
DR   Coriell; GM02161
DR   Wikidata; Q54837337
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H50 ! GM02160
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM02162
AC   CVCL_1H52
SY   GM-2162
DR   CLO; CLO_0031888
DR   BioSample; SAMN00807546
DR   Coriell; GM02162
DR   Wikidata; Q54837338
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H53 ! GM02163
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 17
//
ID   GM02163
AC   CVCL_1H53
SY   GM-2163
DR   CLO; CLO_0031887
DR   BioSample; SAMN00807548
DR   Coriell; GM02163
DR   Wikidata; Q54837339
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H52 ! GM02162
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM02164
AC   CVCL_F056
SY   GM-2164; GM02164B
DR   CLO; CLO_0031886
DR   BioSample; SAMN00807550
DR   Coriell; GM02164
DR   Wikidata; Q54837340
RX   CelloPub=CLPUB00447;
RX   PubMed=32656337;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=32656337).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[56] (c.52CAG(56)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=32656337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F057 ! GM02165
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   GM02165
AC   CVCL_F057
SY   GM-2165; GM 2165
DR   CLO; CLO_0031757
DR   BioSample; SAMN00807552
DR   Coriell; GM02165
DR   Wikidata; Q54837341
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=6458814;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM02164).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[56] (c.52CAG(56)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM02164).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F056 ! GM02164
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   GM02166
AC   CVCL_F054
SY   GM-2166; GM2166; GM02166B
DR   CLO; CLO_0031755
DR   BioSample; SAMN00807554
DR   Coriell; GM02166
DR   Wikidata; Q54837342
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F055 ! GM02167
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM02167
AC   CVCL_F055
SY   GM-2167; GM02167A; GM2167a
DR   CLO; CLO_0031761
DR   BioSample; SAMN00807556
DR   Coriell; GM02167
DR   Wikidata; Q54837343
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F054 ! GM02166
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM02168
AC   CVCL_F058
SY   GM-2168; GM02168A; GM18007
DR   CLO; CLO_0015999
DR   CLO; CLO_0031758
DR   BioSample; SAMN00807558
DR   Coriell; GM02168
DR   Coriell; GM18007
DR   Wikidata; Q54837344
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F059 ! GM02169
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM02169
AC   CVCL_F059
SY   GM-2169; C2169
DR   CLO; CLO_0031765
DR   BioSample; SAMN00807560
DR   Coriell; GM02169
DR   GEO; GSM2794404
DR   Wikidata; Q54837345
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F058 ! GM02168
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   GM02170
AC   CVCL_1H54
SY   GM-2170
DR   CLO; CLO_0031766
DR   BioSample; SAMN00807562
DR   Coriell; GM02170
DR   Wikidata; Q54837346
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H55 ! GM02171
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 16
//
ID   GM02171
AC   CVCL_1H55
SY   GM-2171; GM 2171
DR   CLO; CLO_0031767
DR   BioSample; SAMN00807564
DR   Coriell; GM02171
DR   GEO; GSM1266971
DR   Wikidata; Q54837347
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H54 ! GM02170
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   GM02172
AC   CVCL_V040
SY   GM-2172; GM02172A
DR   CLO; CLO_0031768
DR   BioSample; SAMN00807566
DR   Coriell; GM02172
DR   Wikidata; Q54837348
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM02173).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V041 ! GM02173
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM02173
AC   CVCL_V041
SY   GM-2173; GM 2173; GM02173A; GM02173B
DR   CLO; CLO_0031763
DR   BioSample; SAMN00807568
DR   Coriell; GM02173
DR   GEO; GSM1257685
DR   GEO; GSM1266970
DR   GEO; GSM1267050
DR   Wikidata; Q54837349
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=6458814;
RX   PubMed=24555846;
RX   PubMed=25326100;
RX   PubMed=25928884;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V040 ! GM02172
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM02174
AC   CVCL_F070
SY   GM-2174; GM18008
DR   CLO; CLO_0015976
DR   CLO; CLO_0031764
DR   BioSample; SAMN00807570
DR   Coriell; GM02174
DR   Coriell; GM18008
DR   Wikidata; Q54837350
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F071 ! GM02175
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM02175
AC   CVCL_F071
SY   GM-2175; GM 2175
DR   CLO; CLO_0031781
DR   BioSample; SAMN00807572
DR   Coriell; GM02175
DR   GEO; GSM1257686
DR   GEO; GSM1266969
DR   GEO; GSM1267049
DR   Wikidata; Q54837351
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F070 ! GM02174
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   GM02176
AC   CVCL_F060
SY   GM-2176
DR   CLO; CLO_0031780
DR   BioSample; SAMN00807574
DR   Coriell; GM02176
DR   Wikidata; Q54837352
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F061 ! GM02177
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM02177
AC   CVCL_F061
SY   GM-2177; GM 2177
DR   CLO; CLO_0031777
DR   BioSample; SAMN00807576
DR   Coriell; GM02177
DR   Wikidata; Q54837353
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington's disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F060 ! GM02176
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM02178
AC   CVCL_1H56
SY   GM-2178
DR   CLO; CLO_0031775
DR   BioSample; SAMN00807578
DR   Coriell; GM02178
DR   Wikidata; Q54837354
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM02180
AC   CVCL_1H57
SY   GM-2180
DR   CLO; CLO_0031774
DR   BioSample; SAMN00807580
DR   Coriell; GM02180
DR   Wikidata; Q54837355
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=32656337;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 13
//
ID   GM02182
AC   CVCL_W556
SY   GM-2182; GM2182
DR   CLO; CLO_0031787
DR   BioSample; SAMN00807582
DR   Coriell; GM02182
DR   Wikidata; Q54837356
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (from autologous cell line GM02183).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM02183
AC   CVCL_W557
SY   GM-2183; GM 2183; GM2183
DR   CLO; CLO_0031788
DR   CLO; CLO_0037414
DR   BioSample; SAMN00807584
DR   Coriell; GM02183
DR   LINCS_LDP; LPC-1015
DR   Wikidata; Q54837357
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6220707;
RX   PubMed=22748968;
RX   PubMed=34746695;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (PubMed=22748968).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W556 ! GM02182
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   GM02184
AC   CVCL_D860
SY   GM-2184; GM 2184; GM2184A; GM02184B; GM02184C; GM2184c; GM02184D; GM17220
DR   CLO; CLO_0014375
DR   CLO; CLO_0031785
DR   EFO; EFO_0022391
DR   BioSample; SAMN00807586
DR   Coriell; GM02184
DR   Coriell; GM17220
DR   GEO; GSM569534
DR   GEO; GSM596284
DR   GEO; GSM596644
DR   GEO; GSM924822
DR   Wikidata; Q54837358
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=9497252;
RX   PubMed=12419185;
RX   PubMed=16260726;
RX   PubMed=18809580;
RX   PubMed=20889555;
RX   PubMed=26651604;
RX   PubMed=29959025;
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=91
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,30:02:01; B*18:01:01,49:01:01; C*05:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,02:02:01; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,11:04:01; DRB3*02:02:01,02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7354 ! GM02185
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   GM02185
AC   CVCL_7354
SY   GM2185; GM-2185; GM 2185; GM 02185; GM02185A; GM02185B
DR   CLO; CLO_0003522
DR   CLO; CLO_0031786
DR   CLDB; cl1489
DR   BioSample; SAMN00807588
DR   Coriell; GM02185
DR   GEO; GSM1317013
DR   Wikidata; Q54837362
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7299037;
RX   PubMed=19896956;
RX   PubMed=26984941;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D860 ! GM02184
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM02186
AC   CVCL_F050
SY   GM-2186
DR   CLO; CLO_0031784
DR   BioSample; SAMN00807590
DR   Coriell; GM02186
DR   Wikidata; Q54837363
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F051 ! GM02187
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM02187
AC   CVCL_F051
SY   GM-2187
DR   CLO; CLO_0032270
DR   BioSample; SAMN00807592
DR   Coriell; GM02187
DR   Wikidata; Q54837364
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F050 ! GM02186
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM02188
AC   CVCL_F052
SY   GM-2188
DR   CLO; CLO_0032269
DR   BioSample; SAMN00807594
DR   Coriell; GM02188
DR   Wikidata; Q54837365
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16874298;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F053 ! GM02189
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM02189
AC   CVCL_F053
SY   GM-2189
DR   CLO; CLO_0032267
DR   BioSample; SAMN00807596
DR   Coriell; GM02189
DR   Wikidata; Q54837366
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F052 ! GM02188
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM02190
AC   CVCL_1H58
SY   GM-2190; GM02190A
DR   CLO; CLO_0032265
DR   BioSample; SAMN00807598
DR   Coriell; GM02190
DR   Wikidata; Q54837367
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H59 ! GM02191
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 17
//
ID   GM02191
AC   CVCL_1H59
SY   GM-2191
DR   CLO; CLO_0032264
DR   BioSample; SAMN00807600
DR   Coriell; GM02191
DR   Wikidata; Q54837368
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H58 ! GM02190
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM02205
AC   CVCL_L968
SY   GM-2205; GM 2205; GM01515
DR   CLO; CLO_0032263
DR   BioSample; SAMN00807602
DR   Coriell; GM01515
DR   Coriell; GM02205
DR   GEO; GSM1266975
DR   GEO; GSM1267054
DR   GEO; GSM1288438
DR   Wikidata; Q54837369
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=23665875;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Coriell; GM01515; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   GM02206
AC   CVCL_L969
SY   GM-2206 GM 2206; GM01514
DR   CLO; CLO_0032262
DR   BioSample; SAMN00807604
DR   Coriell; GM01514
DR   Coriell; GM02206
DR   GEO; GSM1266977
DR   Wikidata; Q54837370
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=23665875;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Coriell; GM01514; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM02207
AC   CVCL_JB90
SY   GM-2207
DR   Coriell; GM02207
DR   Wikidata; Q54837372
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02207; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM02209
AC   CVCL_CZ04
SY   GM2209
DR   CLO; CLO_0032261
DR   BioSample; SAMN00807606
DR   Coriell; GM02209
DR   Wikidata; Q54837373
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02211
AC   CVCL_JB67
SY   GM-2211; GM 2211; GM2211
DR   Coriell; GM02211
DR   Wikidata; Q54837374
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6782865;
CC   Discontinued: Coriell; GM02211; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM02213
AC   CVCL_4J47
SY   GM-2213
DR   CLO; CLO_0032260
DR   BioSample; SAMN00807608
DR   Coriell; GM02213
DR   Wikidata; Q54837375
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Arg167Trp (c.499C>T); ClinVar=VCV000001456; Zygosity=Heterozygous (Coriell=GM02213).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM02214
AC   CVCL_H179
SY   GM-2214
DR   CLO; CLO_0032259
DR   BioSample; SAMN00807610
DR   Coriell; GM02214
DR   Wikidata; Q54837376
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with metachromatic leukodystrophy but at risk for disease.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM02215
AC   CVCL_JB88
SY   GM-2215
DR   Coriell; GM02215
DR   Wikidata; Q54837377
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02215; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U19 ! GM02217
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM02217
AC   CVCL_1U19
SY   GM-2217
DR   CLO; CLO_0032248
DR   BioSample; SAMN00807612
DR   Coriell; GM02217
DR   Wikidata; Q54837378
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JB88 ! GM02215
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM02224
AC   CVCL_CX22
SY   GM-2224
DR   Coriell; GM02224
DR   Wikidata; Q54837379
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02224; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98969; Lactic acidosis
DI   ORDO; Orphanet_17; Fatal infantile lactic acidosis with methylmalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1W
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM02226
AC   CVCL_R906
SY   GM-2226; GM 2226; GM2226
DR   CLO; CLO_0032251
DR   Coriell; GM02226
DR   Wikidata; Q54837380
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=21335555;
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex6-9del/inv; Zygosity=Heterozygous (from familial inference of GM02227).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GM02227
AC   CVCL_L487
SY   GM-2227; GM 2227; GM2227
DR   CLO; CLO_0032249
DR   Coriell; GM02227
DR   Wikidata; Q54837381
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3296189;
RX   PubMed=6087154;
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex6-9del/inv; Zygosity=Hemizygous (PubMed=3296189).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   GM02228
AC   CVCL_U949
SY   GM2228; GM-2228
DR   CLO; CLO_0032242
DR   BioSample; SAMN00807614
DR   Coriell; GM02228
DR   Wikidata; Q54837382
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84546; Alkaptonuria
DI   ORDO; Orphanet_56; Alkaptonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM02229
AC   CVCL_4J48
SY   GM-2229; GM02229A
DR   CLO; CLO_0032241
DR   BioSample; SAMN00807616
DR   Coriell; GM02229
DR   Wikidata; Q54837383
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM02230
AC   CVCL_4J49
SY   GM-2230
DR   CLO; CLO_0032244
DR   BioSample; SAMN00807618
DR   Coriell; GM02230
DR   Wikidata; Q54837384
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM02232
AC   CVCL_BT12
SY   GM-2232; GM02232A
DR   CLO; CLO_0032243
DR   BioSample; SAMN00807620
DR   Coriell; GM02232
DR   Wikidata; Q54837385
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 12
//
ID   GM02241
AC   CVCL_GZ39
SY   GM-2241
DR   CLO; CLO_0032240
DR   BioSample; SAMN00807622
DR   Coriell; GM02241
DR   Wikidata; Q54837386
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Simple; c.293-13A/C>G (IVS2-13A/C>G); Zygosity=Unspecified; Note=Aberrant splice site activation (Coriell=GM02241).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GZ40 ! GM02242
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM02242
AC   CVCL_GZ40
SY   GM-2242
DR   CLO; CLO_0032239
DR   BioSample; SAMN00807624
DR   Coriell; GM02242
DR   Wikidata; Q54837387
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Simple; c.293-13A/C>G (IVS2-13A/C>G); Zygosity=Unspecified; Note=Aberrant splice site activation (Coriell=GM02242).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GZ39 ! GM02241
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM02254
AC   CVCL_7355
SY   GM-2254; GM17221
DR   CLO; CLO_0014377
DR   CLO; CLO_0032160
DR   BioSample; SAMN00807638
DR   Coriell; GM02254
DR   Coriell; GM17221
DR   GEO; GSM569550
DR   GEO; GSM596285
DR   GEO; GSM596645
DR   GEO; GSM924823
DR   Wikidata; Q54837394
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*23:01:01,24:02:01; B*35:02:01,49:01:01; C*04:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:01; DRB1*11:04:01,11:04:01; DRB3*02:02:01,02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM02255
AC   CVCL_4N21
SY   GM-2255
DR   CLO; CLO_0032157
DR   Coriell; GM02255
DR   Wikidata; Q54837395
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123415; Autosomal recessive torsion dystonia 2
DI   ORDO; Orphanet_99657; Primary dystonia, DYT2 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N22 ! GM02256
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02256
AC   CVCL_4N22
SY   GM-2256
DR   CLO; CLO_0032158
DR   Coriell; GM02256
DR   Wikidata; Q54837396
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123415; Autosomal recessive torsion dystonia 2
DI   ORDO; Orphanet_99657; Primary dystonia, DYT2 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N21 ! GM02255
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM02264
AC   CVCL_1U20
SY   GM-2264
DR   CLO; CLO_0032161
DR   BioSample; SAMN00807640
DR   Coriell; GM02264
DR   Wikidata; Q54837397
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM02266
AC   CVCL_BT13
SY   GM-2266; GM02266A
DR   CLO; CLO_0032119
DR   BioSample; SAMN00807642
DR   Coriell; GM02266
DR   Wikidata; Q54837398
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM02267
AC   CVCL_BT14
SY   GM-2267
DR   CLO; CLO_0032120
DR   BioSample; SAMN00807644
DR   Coriell; GM02267
DR   Wikidata; Q54837399
RX   CelloPub=CLPUB00447;
RX   PubMed=6196781;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM02268
AC   CVCL_W662
SY   GM-2268; GM02268A
DR   CLO; CLO_0032121
DR   BioSample; SAMN00807646
DR   Coriell; GM02268
DR   Wikidata; Q54837400
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM02269
AC   CVCL_H180
SY   GM-2269
DR   CLO; CLO_0032123
DR   BioSample; SAMN00807648
DR   Coriell; GM02269
DR   Wikidata; Q54837401
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM02270
AC   CVCL_UR70
SY   GM2270; GM02270A; GM2270A
DR   Coriell; GM02270
DR   Wikidata; Q93576868
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM02270; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM02273
AC   CVCL_9Q90
SY   GM-2273; GM02273F; GM02273G
DR   CLO; CLO_0032126
DR   BioSample; SAMN00807650
DR   Coriell; GM02273
DR   Wikidata; Q54837402
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Arg46Ter (c.136C>T); ClinVar=VCV000039031; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM02274
AC   CVCL_CX30
SY   GM-2274
DR   CLO; CLO_0032128
DR   BioSample; SAMN00807652
DR   Coriell; GM02274
DR   Wikidata; Q54837405
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM02290
AC   CVCL_7356
SY   GM-2290; GM 2290 GM02290A
DR   CLO; CLO_0003523
DR   CLO; CLO_0032129
DR   CLDB; cl1490
DR   BioSample; SAMN00807654
DR   Coriell; GM02290
DR   Wikidata; Q54837406
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477417;
RX   PubMed=6087472;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7357 ! GM02291
OI   CVCL_D868 ! GM02292
OI   CVCL_D869 ! GM02338
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM02291
AC   CVCL_7357
SY   GM-2291
DR   CLO; CLO_0003524
DR   CLO; CLO_0032130
DR   CLDB; cl1491
DR   BioSample; SAMN00807656
DR   Coriell; GM02291
DR   Wikidata; Q54837407
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477417;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7356 ! GM02290
OI   CVCL_D868 ! GM02292
OI   CVCL_D869 ! GM02338
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM02292
AC   CVCL_D868
SY   GM-2292; GM 2292; GM2292A; GM02292B
DR   CLO; CLO_0032131
DR   BioSample; SAMN00807658
DR   Coriell; GM02292
DR   Wikidata; Q54837408
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477417;
RX   PubMed=2762303;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7356 ! GM02290
OI   CVCL_7357 ! GM02291
OI   CVCL_D869 ! GM02338
SX   Male
AG   19FW
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 17
//
ID   GM02293
AC   CVCL_M995
SY   GM-2293; GM17353
DR   CLO; CLO_0013723
DR   CLO; CLO_0032132
DR   BioSample; SAMN00807660
DR   Coriell; GM02293
DR   Coriell; GM17353
DR   Wikidata; Q54837409
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Part of: Human variation panel.
CC   Population: Cuban.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM02294
AC   CVCL_CZ84
SY   GM 2294
DR   CLO; CLO_0032206
DR   BioSample; SAMN00807662
DR   Coriell; GM02294
DR   Wikidata; Q54837410
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Ala215Thr (c.643G>A); ClinVar=VCV000001967; Zygosity=Homozygous (Coriell=GM02294).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ12 ! GM01997
SX   Male
AG   10M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   GM02295
AC   CVCL_4T29
SY   GM-2295
DR   CLO; CLO_0032204
DR   BioSample; SAMN00807665
DR   Coriell; GM02295
DR   Wikidata; Q54837411
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=22922033;
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:7160; MMP14; Simple; p.Thr17Arg (c.50C>G) (n.284C>G); ClinVar=VCV000065463; Zygosity=Homozygous (PubMed=22922033).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C170731; Winchester syndrome
DI   ORDO; Orphanet_371428; Multicentric osteolysis-nodulosis-arthropathy spectrum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM02298
AC   CVCL_5M71
SY   GM-2298; GM2298; GM02298A; HF-B
DR   CLO; CLO_0032205
DR   Coriell; GM02298
DR   Wikidata; Q54837412
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6093571;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; None_reported; -; Zygosity=- (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   GM02299
AC   CVCL_IL08
SY   GM-2299
DR   CLO; CLO_0032202
DR   BioSample; SAMN00807667
DR   Coriell; GM02299
DR   Wikidata; Q54837413
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Genital area, skin; UBERON=UBERON_8480029.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL09 ! GM02300
OI   CVCL_IL10 ! GM02301
SX   Sex ambiguous
AG   8M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   GM02300
AC   CVCL_IL09
SY   GM-2300; GM02300A
DR   CLO; CLO_0032203
DR   BioSample; SAMN00807669
DR   Coriell; GM02300
DR   Wikidata; Q54837414
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL08 ! GM02299
OI   CVCL_IL10 ! GM02301
SX   Sex ambiguous
AG   8M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   GM02301
AC   CVCL_IL10
SY   GM-2301
DR   CLO; CLO_0032199
DR   BioSample; SAMN00807671
DR   Coriell; GM02301
DR   Wikidata; Q54837415
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African American.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL08 ! GM02299
OI   CVCL_IL09 ! GM02300
SX   Sex ambiguous
AG   8M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   GM02302
AC   CVCL_W226
SY   GM-2302
DR   CLO; CLO_0032201
DR   BioSample; SAMN00807673
DR   Coriell; GM02302
DR   Wikidata; Q54837416
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84759; Hereditary coproporphyria
DI   ORDO; Orphanet_79273; Hereditary coproporphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W225 ! GM00962
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM02303
AC   CVCL_BT15
SY   GM-2303
DR   CLO; CLO_0032208
DR   BioSample; SAMN00807675
DR   Coriell; GM02303
DR   Wikidata; Q54837417
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85219; Variegate porphyria
DI   ORDO; Orphanet_79473; Porphyria variegata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM02304
AC   CVCL_1U21
SY   GM-2304
DR   CLO; CLO_0032209
DR   BioSample; SAMN00807677
DR   Coriell; GM02304
DR   Wikidata; Q54837418
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U22 ! GM02305
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM02305
AC   CVCL_1U22
SY   GM-2305
DR   CLO; CLO_0032207
DR   BioSample; SAMN00807679
DR   Coriell; GM02305
DR   Wikidata; Q54837419
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U21 ! GM02304
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 13
//
ID   GM02306
AC   CVCL_4N23
SY   GM-2306
DR   CLO; CLO_0032175
DR   BioSample; SAMN00807681
DR   Coriell; GM02306
DR   Wikidata; Q54837420
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123415; Autosomal recessive torsion dystonia 2
DI   ORDO; Orphanet_99657; Primary dystonia, DYT2 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N24 ! GM02307
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM02307
AC   CVCL_4N24
SY   GM-2307
DR   CLO; CLO_0032176
DR   BioSample; SAMN00807683
DR   Coriell; GM02307
DR   Wikidata; Q54837421
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123415; Autosomal recessive torsion dystonia 2
DI   ORDO; Orphanet_99657; Primary dystonia, DYT2 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N23 ! GM02306
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM02314
AC   CVCL_8A64
SY   GM-2314
DR   CLO; CLO_0032177
DR   BioSample; SAMN00807685
DR   Coriell; GM02314
DR   GEO; GSM651168
DR   GEO; GSM651169
DR   GEO; GSM1266974
DR   GEO; GSM1267053
DR   Wikidata; Q54837422
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=21418647;
RX   PubMed=25326100;
CC   Population: Caucasian; Irish.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM02315
AC   CVCL_8A65
SY   GM-2315; FD-1
DR   BTO; BTO_0004460
DR   CLO; CLO_0032178
DR   BioSample; SAMN00807687
DR   Coriell; GM02315
DR   Wikidata; Q54837423
RX   CelloPub=CLPUB00447;
RX   PubMed=11241842;
RX   PubMed=21335555;
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Glu138Val (c.413A>T) (p.Glu154Val, c.461A>T); ClinVar=VCV000000092; Zygosity=Homozygous (PubMed=11241842).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02316
AC   CVCL_8A66
SY   GM-2316
DR   CLO; CLO_0032169
DR   BioSample; SAMN00807689
DR   Coriell; GM02316
DR   GEO; GSM651150
DR   GEO; GSM651151
DR   GEO; GSM1257697
DR   GEO; GSM1266972
DR   GEO; GSM1267051
DR   GEO; GSM1288439
DR   GEO; GSM1314047
DR   Wikidata; Q54837424
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian; Irish.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM02317
AC   CVCL_8A67
SY   GM-2317
DR   CLO; CLO_0032170
DR   BioSample; SAMN00807691
DR   Coriell; GM02317
DR   GEO; GSM651116
DR   GEO; GSM651117
DR   GEO; GSM1257698
DR   GEO; GSM1266973
DR   GEO; GSM1267052
DR   GEO; GSM1288440
DR   GEO; GSM1314048
DR   Wikidata; Q54837425
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian; Irish.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM02324
AC   CVCL_X261
SY   GM-2324; GM2324; GM02324A
DR   CLO; CLO_0032172
DR   BioSample; SAMN00807693
DR   Coriell; GM02324
DR   Wikidata; Q54837426
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2714795;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,9qh+,t(16;22)(16qter->16p13.11::22q11.21->22qter;22pter->22q11.21::16p13.11->16pter) (Coriell=GM02324).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 13
//
ID   GM02325
AC   CVCL_X262
SY   GM-2325; GM 2325
DR   CLO; CLO_0032174
DR   BioSample; SAMN00807695
DR   Coriell; GM02325
DR   Wikidata; Q54837427
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+der(22)(22pter->22q11.21::16p13.11->16pter)mat (Coriell=GM02325).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM02327
AC   CVCL_AD65
SY   GM2327; GM-2327
DR   CLO; CLO_0032179
DR   BioSample; SAMN00807697
DR   Coriell; GM02327
DR   Wikidata; Q54837428
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Tyr438Asn (c.1312T>A) (Y393N); ClinVar=VCV000100009; Zygosity=Homozygous (from familial inference of GM01099).
CC   Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM02328
AC   CVCL_DD69
SY   GM-2328; IMR-2328
DR   CLO; CLO_0032180
DR   BioSample; SAMN00807699
DR   Coriell; GM02328
DR   Wikidata; Q54837429
RX   CelloPub=CLPUB00447;
RX   PubMed=6689020;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02329
AC   CVCL_X263
SY   GM-2329; GM 2329
DR   CLO; CLO_0033128
DR   BioSample; SAMN00807701
DR   Coriell; GM02329
DR   Wikidata; Q54837430
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+9 [5]; 46,XX [45] (Coriell=GM02329).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM02330
AC   CVCL_L488
SY   GM-2330
DR   CLO; CLO_0033123
DR   BioSample; SAMN00807703
DR   Coriell; GM02330
DR   Wikidata; Q54837431
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   GM02331
AC   CVCL_6B43
SY   GM-2331
DR   CLO; CLO_0033124
DR   BioSample; SAMN00807705
DR   Coriell; GM02331
DR   Wikidata; Q54837432
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM02332
AC   CVCL_5L45
DR   CLO; CLO_0033125
DR   BioSample; SAMN00807707
DR   Coriell; GM02332
DR   Wikidata; Q54837433
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L46 ! GM02333
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM02333
AC   CVCL_5L46
SY   GM-2333
DR   CLO; CLO_0033126
DR   BioSample; SAMN00807709
DR   Coriell; GM02333
DR   Wikidata; Q54837434
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L45 ! GM02332
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 9
//
ID   GM02334
AC   CVCL_4J50
SY   GM-2334
DR   CLO; CLO_0033119
DR   BioSample; SAMN00807711
DR   Coriell; GM02334
DR   Wikidata; Q54837435
RX   CelloPub=CLPUB00447;
RX   PubMed=7803800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Heterozygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM02335
AC   CVCL_X089
SY   GM-2335; GM 2335
DR   CLO; CLO_0033120
DR   BioSample; SAMN00807713
DR   Coriell; GM02335
DR   Wikidata; Q54837436
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM02336
AC   CVCL_4J51
SY   GM-2336
DR   CLO; CLO_0033121
DR   BioSample; SAMN00807715
DR   Coriell; GM02336
DR   Wikidata; Q54837437
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02337
AC   CVCL_X090
SY   GM-2337; GM 2337
DR   CLO; CLO_0033122
DR   BioSample; SAMN00807717
DR   Coriell; GM02337
DR   Wikidata; Q54837438
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(5)(qter->p14) (Coriell=GM02337).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM02338
AC   CVCL_D869
SY   GM-2338
DR   CLO; CLO_0033127
DR   BioSample; SAMN00807719
DR   Coriell; GM02338
DR   Wikidata; Q54837439
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=477417;
CC   Population: Caucasian.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7356 ! GM02290
OI   CVCL_7357 ! GM02291
OI   CVCL_D868 ! GM02292
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM02339
AC   CVCL_5M72
SY   GM-2339; GM2339; HF-D
DR   CLO; CLO_0033118
DR   Coriell; GM02339
DR   Wikidata; Q54837441
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3863481;
RX   PubMed=6093571;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex31-43del; Zygosity=Hemizygous (Coriell=GM02339).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM02340
AC   CVCL_L749
SY   GM-2340; GM02340B
DR   CLO; CLO_0033117
DR   Coriell; GM02340
DR   GEO; GSM860991
DR   GEO; GSM1084803
DR   Wikidata; Q54837442
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=18511599;
RX   PubMed=20715179;
RX   PubMed=22905176;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=18511599).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   GM02340 iPSC clone 1
AC   CVCL_B5QT
DR   GEO; GSM861004
DR   Wikidata; Q111733235
RX   PubMed=22905176;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L749 ! GM02340
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   GM02340 iPSC clone 6
AC   CVCL_B5QU
SY   iPSC clone 6.1
DR   GEO; GSM861005
DR   GEO; GSM1589943
DR   GEO; GSM1589955
DR   Wikidata; Q111733236
RX   PubMed=22905176;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L749 ! GM02340
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   GM02341
AC   CVCL_AA18
SY   GM-2341; GM 2341
DR   CLO; CLO_0033115
DR   BioSample; SAMN00807721
DR   Coriell; GM02341
DR   GEO; GSM3592404
DR   GEO; GSM3592410
DR   Wikidata; Q54837443
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
RX   PubMed=30905397;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30905397).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM02342
AC   CVCL_AA19
SY   GM-2342; GM 2342
DR   CLO; CLO_0033116
DR   BioSample; SAMN00807722
DR   Coriell; GM02342
DR   Wikidata; Q54837444
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (from familial inference of GM02341; GM09826).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02343
AC   CVCL_AA20
SY   GM-2343; GM 2343
DR   CLO; CLO_0033113
DR   BioSample; SAMN00807723
DR   Coriell; GM02343
DR   GEO; GSM3592406
DR   GEO; GSM3592412
DR   Wikidata; Q54837445
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6458814;
RX   PubMed=29762696;
RX   PubMed=30905397;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (Coriell=GM02343).
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30905397).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: GMO2343; PubMed=29762696.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   GM02346
AC   CVCL_X091
SY   GM-2346; GM 2346; GM2346
DR   CLO; CLO_0033112
DR   BioSample; SAMN00807729
DR   Coriell; GM02346
DR   Wikidata; Q54837453
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=2095701;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(4;16)(4pter->4q35::16q22.1->16qter;16pter->16q22.1::4q35->4qter) (Coriell=GM02346).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM02347
AC   CVCL_1U23
SY   GM-2347
DR   CLO; CLO_0033109
DR   BioSample; SAMN00807731
DR   Coriell; GM02347
DR   Wikidata; Q54837454
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM02351
AC   CVCL_B5LN
SY   GM 02351
DR   Coriell; GM02351
DR   Wikidata; Q111733237
RX   PubMed=9458280;
CC   Discontinued: Coriell; GM02351; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   GM02355
AC   CVCL_L945
SY   GM2355
DR   CLO; CLO_0033110
DR   BioSample; SAMN00807733
DR   Coriell; GM02355
DR   Wikidata; Q54837455
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   GM02356
AC   CVCL_X092
SY   GM-2356; GM 2356
DR   CLO; CLO_0033106
DR   Coriell; GM02356
DR   Wikidata; Q54837456
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Karyotypic information: 46,XY,del(9)(9qter->9p22) (Coriell=GM02356).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02361
AC   CVCL_AK22
SY   GM-2361
DR   CLO; CLO_0033107
DR   Coriell; GM02361
DR   Wikidata; Q54837458
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02362
AC   CVCL_AK23
SY   GM-2362; GM02362A
DR   CLO; CLO_0033099
DR   Coriell; GM02362
DR   Wikidata; Q54837459
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02363
AC   CVCL_AK24
SY   GM-2363
DR   CLO; CLO_0033100
DR   Coriell; GM02363
DR   Wikidata; Q54837460
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02364
AC   CVCL_JD75
SY   GM-2364
DR   Coriell; GM02364
DR   Wikidata; Q54837461
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02364; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM02365
AC   CVCL_1R62
SY   GM02365A
DR   CLO; CLO_0033101
DR   BioSample; SAMN00807737
DR   Coriell; GM02365
DR   Wikidata; Q54837463
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84643; Coffin-Lowry syndrome
DI   ORDO; Orphanet_192; Coffin-Lowry syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM02366
AC   CVCL_U388
DR   CLO; CLO_0033102
DR   BioSample; SAMN00807739
DR   Coriell; GM02366
DR   Wikidata; Q54837464
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM02366).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02366; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM02373
AC   CVCL_4N25
SY   GM02373A
DR   CLO; CLO_0033103
DR   BioSample; SAMN00807741
DR   Coriell; GM02373
DR   Wikidata; Q54837465
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM02380
AC   CVCL_H181
SY   GM 2380
DR   CLO; CLO_0033104
DR   Coriell; GM02380
DR   Wikidata; Q54837466
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM02406
AC   CVCL_W148
SY   GM2406; GM-2406
DR   CLO; CLO_0033105
DR   BioSample; SAMN00807743
DR   Coriell; GM02406
DR   Wikidata; Q54837467
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=38555716;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Phe299Cys (c.896T>G); ClinVar=VCV000000613; Zygosity=Heterozygous (Coriell=GM02406).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg408Trp (c.1222C>T); ClinVar=VCV000000577; Zygosity=Heterozygous (Coriell=GM02406).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 21
//
ID   GM02407
AC   CVCL_CX54
SY   GM-2407
DR   Coriell; GM02407
DR   Wikidata; Q54837468
RX   DOI=10.5962/bhl.title.4090;
CC   Discontinued: Coriell; GM02407; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84908; Multiple sulfatase deficiency disease
DI   ORDO; Orphanet_585; Multiple sulfatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM02408
AC   CVCL_F267
SY   GM02408A; GM2408A; GM02408C; GM02408D; JD; J.D.
DR   CLO; CLO_0003525
DR   CLO; CLO_0033098
DR   CLDB; cl1492
DR   Coriell; GM02408
DR   Wikidata; Q54837469
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM02412
AC   CVCL_L972
SY   GM-2412; GM 2412; GM02412B; GM01027; GM-1027
DR   CLO; CLO_0033097
DR   BioSample; SAMN00807745
DR   Coriell; GM01027
DR   Coriell; GM02412
DR   Wikidata; Q54837470
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1766867;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM02412).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM01027; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L973 ! GM00441
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   GM02416
AC   CVCL_8518
DR   CLO; CLO_0033095
DR   BioSample; SAMN00807749
DR   Coriell; GM02416
DR   Wikidata; Q54837472
RX   CelloPub=CLPUB00447;
RX   PubMed=18691744;
CC   Population: Native North American; Alaskan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F066 ! GM02417
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 16
//
ID   GM02417
AC   CVCL_F066
DR   CLO; CLO_0033091
DR   BioSample; SAMN00807751
DR   Coriell; GM02417
DR   Wikidata; Q54837473
RX   CelloPub=CLPUB00447;
CC   Population: Native North American; Alaskan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8518 ! GM02416
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 15
//
ID   GM02419
AC   CVCL_UY61
DR   Coriell; GM02419
DR   Wikidata; Q93577635
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM02419; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM02421
AC   CVCL_H182
SY   GM 2421; GM02421A
DR   CLO; CLO_0033092
DR   BioSample; SAMN00807753
DR   Coriell; GM02421
DR   Wikidata; Q54837475
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM02422
AC   CVCL_H183
SY   GM 2422
DR   CLO; CLO_0033089
DR   BioSample; SAMN00807755
DR   Coriell; GM02422
DR   Wikidata; Q54837476
RX   PubMed=6661932;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM02425
AC   CVCL_9R69
SY   GM-2425
DR   CLO; CLO_0033090
DR   BioSample; SAMN00807757
DR   Coriell; GM02425
DR   Wikidata; Q54837477
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Asp190Val (c.569A>T) (733A>T) (p.Asp190fs*211); ClinVar=VCV000038431; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02426
AC   CVCL_2S82
DR   CLO; CLO_0033093
DR   BioSample; SAMN00807759
DR   Coriell; GM02426
DR   Wikidata; Q54837479
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(5;6)(5qter->5p15::6p21->6pter;6qter->6p21::5p15->5pter) (Coriell=GM02426).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02429
AC   CVCL_L974
SY   GM02375
DR   CLO; CLO_0033094
DR   BioSample; SAMN00807761
DR   Coriell; GM02375
DR   Coriell; GM02429
DR   Wikidata; Q54837480
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02375; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM02430
AC   CVCL_M996
SY   GM17321
DR   CLO; CLO_0013646
DR   CLO; CLO_0033274
DR   BioSample; SAMN00807763
DR   Coriell; GM02430
DR   Coriell; GM17321
DR   Wikidata; Q54837481
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM02431
AC   CVCL_L975
SY   GM02431A; GM02378
DR   CLO; CLO_0033275
DR   BioSample; SAMN00807765
DR   Coriell; GM02378
DR   Coriell; GM02431
DR   Wikidata; Q54837482
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02378; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM02432
AC   CVCL_M997
SY   GM17252
DR   CLO; CLO_0014392
DR   CLO; CLO_0033283
DR   BioSample; SAMN00807767
DR   Coriell; GM02432
DR   Coriell; GM17252
DR   GEO; GSM569642
DR   GEO; GSM596316
DR   GEO; GSM596675
DR   GEO; GSM924854
DR   Wikidata; Q54837483
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM02433
AC   CVCL_CZ14
DR   CLO; CLO_0033284
DR   BioSample; SAMN00807769
DR   Coriell; GM02433
DR   Wikidata; Q54837485
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ15 ! GM02472
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02434
AC   CVCL_GS55
SY   GM-2434; GM 2434; GM02434A
DR   CLO; CLO_0033277
DR   BioSample; SAMN00807771
DR   Coriell; GM02434
DR   Wikidata; Q54837486
RX   CelloPub=CLPUB00447;
RX   PubMed=7380831;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg156Cys (c.466C>T); ClinVar=VCV000001970; Zygosity=Heterozygous (Coriell=GM02434).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Leu304Arg (c.911T>G); ClinVar=VCV000001958; Zygosity=Heterozygous (Coriell=GM02434).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS58 ! GM02471
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   GM02435
AC   CVCL_CZ05
SY   GM 2435
DR   CLO; CLO_0033279
DR   BioSample; SAMN00807773
DR   Coriell; GM02435
DR   Wikidata; Q54837487
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02436
AC   CVCL_GS56
SY   GM-2436; GM 2436
DR   CLO; CLO_0033293
DR   BioSample; SAMN00807775
DR   Coriell; GM02436
DR   Wikidata; Q54837488
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
RX   PubMed=7380831;
CC   Population: Caucasian; Swiss.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (PubMed=1346349; PubMed=1680289).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   GM02437
AC   CVCL_5M73
DR   CLO; CLO_0033298
DR   Coriell; GM02437
DR   Wikidata; Q54837489
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124844; Dyggve-Melchior-Clausen syndrome
DI   ORDO; Orphanet_239; Dyggve-Melchior-Clausen disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM02438
AC   CVCL_IJ35
SY   GM02438A; GM02438a
DR   CLO; CLO_0033286
DR   Coriell; GM02438
DR   Wikidata; Q54837490
RX   CelloPub=CLPUB00447;
RX   PubMed=8910459;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM02439
AC   CVCL_W149
SY   WG0406; WG406
DR   CLO; CLO_0033291
DR   Coriell; GM02439
DR   Wikidata; Q54837491
RX   CelloPub=CLPUB00447;
RX   PubMed=25925601;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Arg201Cys (c.601C>T); ClinVar=VCV000000925; Zygosity=Unspecified (PubMed=25925601).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=25925601
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 12,19
ST   D19S433: 13,14.2
ST   D21S11: 30.2,32.2
ST   D2S1338: 19,22
ST   D3S1358: 13,16
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 19,21
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM02439 GM1-iPSC clone 2
AC   CVCL_VE85
SY   GM1-iPSC-clone 2
DR   SKIP; SKIP001351
DR   Wikidata; Q54837492
RX   PubMed=25925601;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Arg201Cys (c.601C>T); ClinVar=VCV000000925; Zygosity=Unspecified (PubMed=25925601).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=25925601
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 12,19
ST   D19S433: 13,14.2
ST   D21S11: 30.2,32.2
ST   D2S1338: 19,22
ST   D3S1358: 13,16
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 19,21
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W149 ! GM02439
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   GM02439 GM1-iPSC clone 3
AC   CVCL_VE86
SY   GM1-iPSC-clone 3
DR   SKIP; SKIP001350
DR   Wikidata; Q54837493
RX   PubMed=25925601;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Arg201Cys (c.601C>T); ClinVar=VCV000000925; Zygosity=Unspecified (PubMed=25925601).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=25925601
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 12,19
ST   D19S433: 13,14.2
ST   D21S11: 30.2,32.2
ST   D2S1338: 19,22
ST   D3S1358: 13,16
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 19,21
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W149 ! GM02439
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   GM02440
AC   CVCL_GR97
DR   CLO; CLO_0033316
DR   BioSample; SAMN00807777
DR   Coriell; GM02440
DR   Wikidata; Q54837494
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02442
AC   CVCL_GR98
DR   CLO; CLO_0033317
DR   BioSample; SAMN00807779
DR   Coriell; GM02442
DR   Wikidata; Q54837496
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02445
AC   CVCL_GS57
SY   GM-2445; GM 2445
DR   CLO; CLO_0033318
DR   BioSample; SAMN00807781
DR   Coriell; GM02445
DR   Wikidata; Q54837497
RX   CelloPub=CLPUB00447;
RX   PubMed=7380831;
CC   Population: African American.
CC   HLA typing: A*02,30; B*07,39 (Coriell=GM02445).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.33+1G>C (IVS1DS,G-C,+1); ClinVar=VCV000001976; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM02445).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg101Gln (c.302G>A); ClinVar=VCV000001956; Zygosity=Heterozygous (Coriell=GM02445).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS54 ! GM01715
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 16
//
ID   GM02446
AC   CVCL_D862
SY   GM-2446; GM 2446
DR   CLO; CLO_0033319
DR   BioSample; SAMN00807783
DR   Coriell; GM02446
DR   Wikidata; Q54837498
RX   CelloPub=CLPUB00447;
RX   PubMed=7380831;
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg211His (c.632G>A); ClinVar=VCV000001957; Zygosity=Homozygous (Coriell=GM02446).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM02447
AC   CVCL_UR77
SY   GM 2447
DR   Coriell; GM02447
DR   Wikidata; Q93577849
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Discontinued: Coriell; GM02447; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM02448
AC   CVCL_9R19
DR   CLO; CLO_0033322
DR   BioSample; SAMN00807785
DR   Coriell; GM02448
DR   Wikidata; Q54837499
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02451
AC   CVCL_UW16
SY   GMO2451A
DR   Coriell; GM02451
DR   Wikidata; Q93577885
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02451; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM02452
AC   CVCL_GT46
SY   GM2452; GMO2452B
DR   CLO; CLO_0033330
DR   BioSample; SAMN00807791
DR   Coriell; GM02452
DR   Wikidata; Q54837502
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 11
//
ID   GM02453
AC   CVCL_AW77
SY   GM02453A; GM2453A
DR   CLO; CLO_0033331
DR   BioSample; SAMN00807794
DR   Coriell; GM02453
DR   Wikidata; Q54837503
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM02455
AC   CVCL_9W84
DR   CLO; CLO_0033335
DR   BioSample; SAMN00807796
DR   Coriell; GM02455
DR   GEO; GSM651122
DR   GEO; GSM651123
DR   GEO; GSM1266980
DR   GEO; GSM1267058
DR   Wikidata; Q54837504
RX   CelloPub=CLPUB00447;
RX   PubMed=21418647;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Trp273Leu (c.818G>T); ClinVar=VCV000000931; Zygosity=Heterozygous (Coriell=GM02455).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Arg482His (c.1445G>A); ClinVar=VCV000000932; Zygosity=Heterozygous (Coriell=GM02455).
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84902; Mucopolysaccharidosis type IVB
DI   ORDO; Orphanet_309310; Mucopolysaccharidosis type 4B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   GM02456
AC   CVCL_9W85
DR   CLO; CLO_0033193
DR   BioSample; SAMN00807798
DR   Coriell; GM02456
DR   GEO; GSM651118
DR   GEO; GSM651119
DR   GEO; GSM1257699
DR   GEO; GSM1266978
DR   GEO; GSM1267056
DR   GEO; GSM1288441
DR   GEO; GSM1314049
DR   Wikidata; Q54837505
RX   CelloPub=CLPUB00447;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM02469
AC   CVCL_X264
SY   GM 2469
DR   CLO; CLO_0033194
DR   Coriell; GM02469
DR   Wikidata; Q54837506
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Karyotypic information: 46,X,der(X)(Xpter->Xq22::Yq11->Yqter) (Coriell=GM02469).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM02470
AC   CVCL_X059
SY   GM-2470; GM 2470
DR   Coriell; GM02470
DR   Wikidata; Q54837507
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Discontinued: Coriell; GM02470; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   GM02471
AC   CVCL_GS58
SY   GM 2471; GM02471A
DR   CLO; CLO_0033191
DR   Coriell; GM02471
DR   Wikidata; Q54837508
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg156Cys (c.466C>T); ClinVar=VCV000001970; Zygosity=Heterozygous (Coriell=GM02471).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Leu304Arg (c.911T>G); ClinVar=VCV000001958; Zygosity=Heterozygous (PubMed=1346349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS55 ! GM02434
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 18
//
ID   GM02472
AC   CVCL_CZ15
SY   GM 2472
DR   CLO; CLO_0033192
DR   Coriell; GM02472
DR   Wikidata; Q54837509
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ14 ! GM02433
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02473
AC   CVCL_M998
SY   GM17154; GM2473; GM02473A
DR   CLO; CLO_0013961
DR   CLO; CLO_0033212
DR   Coriell; GM02473
DR   Coriell; GM17154
DR   GEO; GSM273421
DR   GEO; GSM569636
DR   GEO; GSM596219
DR   GEO; GSM597019
DR   GEO; GSM924664
DR   Wikidata; Q54837510
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3721 ! HTZ17XP
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM02486
AC   CVCL_L766
SY   GM 2486; GM2486
DR   CLO; CLO_0033202
DR   Coriell; GM02486
DR   Wikidata; Q54837515
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Karyotypic information: 46,XX,dup(3)(pter->q27::q21->qter) (Coriell=GM02486).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   GM02487
AC   CVCL_2S83
DR   CLO; CLO_0033204
DR   Coriell; GM02487
DR   Wikidata; Q54837516
RX   CelloPub=CLPUB00447;
RX   PubMed=8530005;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(5;15)(5qter->5p13::15p11->15pter;15qter->15p11::5p13->5pter) (Coriell=GM02487).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM02488
AC   CVCL_X265
SY   GM 2488
DR   CLO; CLO_0033237
DR   Coriell; GM02488
DR   Wikidata; Q54837517
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=8530005;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02490
AC   CVCL_AM64
DR   CLO; CLO_0033230
DR   Coriell; GM02490
DR   Wikidata; Q54837518
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02492
AC   CVCL_V815
SY   GM2492
DR   CLO; CLO_0033231
DR   Coriell; GM02492
DR   Wikidata; Q54837520
RX   CelloPub=CLPUB00447;
RX   PubMed=7438787;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM02497
AC   CVCL_T810
DR   CLO; CLO_0033232
DR   Coriell; GM02497
DR   Wikidata; Q54837521
RX   CelloPub=CLPUB00447;
RX   PubMed=21490598;
CC   Population: Jewish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T809 ! GM01488
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   GM02503
AC   CVCL_T814
DR   CLO; CLO_0033247
DR   Coriell; GM02503
DR   Wikidata; Q54837523
RX   CelloPub=CLPUB00447;
RX   PubMed=21490598;
CC   Population: Jewish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34387; Anorexia nervosa
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T813 ! GM01490
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM02504
AC   CVCL_L976
SY   GM-2504; GM 2504; GM02504H; GM00258; GM-258; GM258
DR   CLO; CLO_0033251
DR   Coriell; GM00258
DR   Coriell; GM02504
DR   Wikidata; Q54837524
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=291901;
RX   PubMed=694721;
RX   PubMed=6159644;
RX   PubMed=6160588;
RX   PubMed=6179471;
RX   PubMed=7299037;
RX   PubMed=17668376;
RX   PubMed=23716668;
CC   Population: African American.
CC   Discontinued: Coriell; GM00258; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 20
//
ID   GM02520
AC   CVCL_U704
SY   GM-2520; GM 2520; GM2520; GM02520A; HG1289
DR   CLO; CLO_0033253
DR   Coriell; GM02520
DR   GEO; GSM1316976
DR   GEO; GSM1317014
DR   Wikidata; Q54837525
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=436333;
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Val942fs (c.2824-1077_2999+310del1583); Zygosity=Heterozygous (PubMed=17407155; Coriell=GM02520).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln975Lysfs*24 (c.2923delC); ClinVar=VCV000042076; Zygosity=Heterozygous (PubMed=17407155; Coriell=GM02520).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 20(ViSh) (BSR20).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 21
//
ID   GM02521
AC   CVCL_X266
SY   GM-2521; GM 2521
DR   CLO; CLO_0033255
DR   Coriell; GM02521
DR   Wikidata; Q54837526
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Discontinued: Coriell; GM02521; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02522
AC   CVCL_EF91
DR   CLO; CLO_0033239
DR   Coriell; GM02522
DR   Wikidata; Q54837527
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (Coriell=GM02522).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM02523
AC   CVCL_1F10
SY   GM2523
DR   CLO; CLO_0033414
DR   Coriell; GM02523
DR   Wikidata; Q54837528
RX   CelloPub=CLPUB00447;
RX   PubMed=33329388;
CC   Population: African American.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM02524
AC   CVCL_X267
SY   GM 2524
DR   CLO; CLO_0033413
DR   Coriell; GM02524
DR   Wikidata; Q54837529
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+21 [41]; 46,XY,dic(21;21)(pter->q21::p12->qter) [9] (Coriell=GM02524).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M2W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM02525
AC   CVCL_9Q78
DR   CLO; CLO_0033422
DR   Coriell; GM02525
DR   Wikidata; Q54837530
RX   CelloPub=CLPUB00447;
RX   PubMed=11013137;
RX   PubMed=17056595;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Homozygous (PubMed=11013137).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM02526
AC   CVCL_9Q79
DR   CLO; CLO_0033421
DR   Coriell; GM02526
DR   Wikidata; Q54837531
RX   CelloPub=CLPUB00447;
RX   PubMed=11013137;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=11013137).
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Heterozygous (PubMed=11013137).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02527
AC   CVCL_9Q80
DR   CLO; CLO_0033419
DR   Coriell; GM02527
DR   Wikidata; Q54837532
RX   CelloPub=CLPUB00447;
RX   PubMed=11013137;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Homozygous (PubMed=11013137).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM02528
AC   CVCL_9Q81
DR   CLO; CLO_0033417
DR   Coriell; GM02528
DR   Wikidata; Q54837533
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=19815695).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM02529
AC   CVCL_H184
DR   CLO; CLO_0033412
DR   Coriell; GM02529
DR   Wikidata; Q54837534
RX   CelloPub=CLPUB00447;
RX   PubMed=11013137;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=11013137).
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Heterozygous (PubMed=11013137).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM02530
AC   CVCL_F081
SY   AT21IJE-F; GM2530
DR   CLO; CLO_0033411
DR   Coriell; GM02530
DR   Wikidata; Q54837535
RX   CelloPub=CLPUB00447;
CC   Population: Iranian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7364 ! GM02783
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM02531
AC   CVCL_F080
SY   AT20IJE-F; GM2531; GM02531A
DR   CLO; CLO_0033410
DR   Coriell; GM02531
DR   Wikidata; Q54837536
RX   CelloPub=CLPUB00447;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.2251del19; Zygosity=Heterozygous (Coriell=GM02531).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.5675del88; Zygosity=Heterozygous (Coriell=GM02531).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.6573del81; Zygosity=Heterozygous (Coriell=GM02531).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F079 ! GM02782
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   GM02533
AC   CVCL_M926
SY   GM02533A; GM17360
DR   CLO; CLO_0013703
DR   CLO; CLO_0033409
DR   Coriell; GM02533
DR   Coriell; GM17360
DR   Wikidata; Q54837537
RX   CelloPub=CLPUB00447;
RX   PubMed=11013137;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=11013137).
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Heterozygous (PubMed=11013137).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M927 ! GM02048
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   GM02548
AC   CVCL_J657
SY   GM 2548; GM2548; GM2548A; GM02548C; HG1013; HG3002
DR   CLO; CLO_0033446
DR   Coriell; GM02548
DR   GEO; GSM1316977
DR   GEO; GSM1317015
DR   Wikidata; Q54837542
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=436333;
RX   PubMed=908169;
RX   PubMed=3030788;
RX   PubMed=17407155;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Heterozygous (PubMed=17407155; Coriell=GM02548).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln752Ter (c.2328C>T); Zygosity=Heterozygous (PubMed=17407155; Coriell=GM02548).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 71(HaEn) (BSR71).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 27
//
ID   GM02551
AC   CVCL_4N26
DR   CLO; CLO_0033445
DR   Coriell; GM02551
DR   Wikidata; Q54837543
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123415; Autosomal recessive torsion dystonia 2
DI   ORDO; Orphanet_99657; Primary dystonia, DYT2 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM02552
AC   CVCL_0M04
SY   GM 02552
DR   CLO; CLO_0033449
DR   Coriell; GM02552
DR   Wikidata; Q54837544
RX   CelloPub=CLPUB00447;
RX   PubMed=8650226;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg297Ter (c.889C>T); ClinVar=VCV000001562; Zygosity=Heterozygous (Coriell=GM02552).
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg643His (c.1928G>A); ClinVar=VCV000001563; Zygosity=Heterozygous (Coriell=GM02552).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM02555
AC   CVCL_9W86
DR   CLO; CLO_0033447
DR   Coriell; GM02555
DR   GEO; GSM651120
DR   GEO; GSM651121
DR   GEO; GSM1257700
DR   GEO; GSM1266979
DR   GEO; GSM1267057
DR   GEO; GSM1288442
DR   GEO; GSM1314050
DR   Wikidata; Q54837545
RX   CelloPub=CLPUB00447;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM02556
AC   CVCL_GR99
DR   CLO; CLO_0033453
DR   Coriell; GM02556
DR   Wikidata; Q54837546
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM02557
AC   CVCL_GS00
DR   CLO; CLO_0033451
DR   Coriell; GM02557
DR   Wikidata; Q54837547
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM02558
AC   CVCL_9R70
DR   CLO; CLO_0033440
DR   Coriell; GM02558
DR   Wikidata; Q54837548
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Gln278Ter (c.832C>T); ClinVar=VCV000038433; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; c.3335+6T>G (IVS17+6T>G); ClinVar=VCV000002773; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02559
AC   CVCL_9R71
DR   CLO; CLO_0033439
DR   Coriell; GM02559
DR   Wikidata; Q54837549
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Gln278Ter (c.832C>T); ClinVar=VCV000038433; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; c.3335+6T>G (IVS17+6T>G); ClinVar=VCV000002773; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02565
AC   CVCL_X348
DR   CLO; CLO_0033441
DR   Coriell; GM02565
DR   Wikidata; Q54837550
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X349 ! GM02566
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM02566
AC   CVCL_X349
SY   GM02566B
DR   CLO; CLO_0033367
DR   Coriell; GM02566
DR   Wikidata; Q54837551
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X348 ! GM02565
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM02568
AC   CVCL_HM35
DR   CLO; CLO_0033366
DR   Coriell; GM02568
DR   Wikidata; Q54837552
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Gene fusion; HGNC; HGNC:4827; HBB + HGNC; HGNC:4829; HBD; Name(s)=HBD-HBB, Hb Lepore (Coriell=GM02568).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141366; Hemoglobin Lepore syndrome
DI   ORDO; Orphanet_330032; Hemoglobin Lepore-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM02571
AC   CVCL_V468
SY   GM 2571; GM02571A
DR   CLO; CLO_0033364
DR   Coriell; GM02571
DR   Wikidata; Q54837553
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 48,XX,+21,+mar (Coriell=GM02571).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM02572
AC   CVCL_9W87
DR   CLO; CLO_0033362
DR   Coriell; GM02572
DR   Wikidata; Q54837554
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM02573
AC   CVCL_DD70
DR   CLO; CLO_0033360
DR   Coriell; GM02573
DR   Wikidata; Q54837555
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02574
AC   CVCL_J644
DR   CLO; CLO_0033358
DR   Coriell; GM02574
DR   Wikidata; Q54837556
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima/Papago.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J645 ! GM02575
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM02575
AC   CVCL_J645
DR   CLO; CLO_0033356
DR   Coriell; GM02575
DR   Wikidata; Q54837557
RX   CelloPub=CLPUB00447;
CC   Population: Native Central American; Pima/Papago.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J644 ! GM02574
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM02578
AC   CVCL_GS59
SY   GM-2578; GM 2578
DR   CLO; CLO_0033355
DR   Coriell; GM02578
DR   Wikidata; Q54837558
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
RX   PubMed=7380831;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM02580
AC   CVCL_CZ06
DR   CLO; CLO_0033354
DR   Coriell; GM02580
DR   Wikidata; Q54837559
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ07 ! GM02581
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02581
AC   CVCL_CZ07
SY   GM02581A; GM 2581A
DR   CLO; CLO_0033353
DR   Coriell; GM02581
DR   Wikidata; Q54837560
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ06 ! GM02580
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02582
AC   CVCL_DB56
DR   CLO; CLO_0033372
DR   Coriell; GM02582
DR   Wikidata; Q54837561
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB57 ! GM02583
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02583
AC   CVCL_DB57
SY   GM 2583
DR   CLO; CLO_0033393
DR   Coriell; GM02583
DR   Wikidata; Q54837562
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB56 ! GM02582
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02584
AC   CVCL_IM20
SY   GM02584A
DR   CLO; CLO_0033391
DR   Coriell; GM02584
DR   Wikidata; Q54837563
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM02587
AC   CVCL_H185
SY   GM 2587
DR   CLO; CLO_0033397
DR   Coriell; GM02587
DR   Wikidata; Q54837564
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   GM02594
AC   CVCL_1V19
SY   GM2594
DR   CLO; CLO_0033395
DR   Coriell; GM02594
DR   Wikidata; Q54837565
RX   CelloPub=CLPUB00447;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(6;9)(6pter->6q13::9p22->9pter;9qter->9p22::6q13->6qter) (Coriell=GM02594).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM02595
AC   CVCL_X268
SY   GM 2595; GM2595
DR   CLO; CLO_0033385
DR   Coriell; GM02595
DR   Wikidata; Q54837566
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,i(X)(q10) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM02596
AC   CVCL_X269
SY   GM 2596; TRI8 fibroblast
DR   CLO; CLO_0033384
DR   Coriell; GM02596
DR   GEO; GSE123028
DR   Wikidata; Q54837567
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=21949351;
RX   PubMed=28190458;
RX   PubMed=30510006;
RX   PubMed=31582743;
CC   Population: African American.
CC   Karyotypic information: 47,XX,+8 [29]; 46,XX [21]; mosaic (Coriell=GM02596).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 17,18
ST   D21S11: 25.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   Penta D: 11,12
ST   Penta E: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM02598
AC   CVCL_V816
SY   GM-2598
DR   CLO; CLO_0033389
DR   Coriell; GM02598
DR   Wikidata; Q54837568
RX   CelloPub=CLPUB00447;
RX   PubMed=573194;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   GM02600
AC   CVCL_DS08
DR   CLO; CLO_0033387
DR   Coriell; GM02600
DR   Wikidata; Q54837569
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   31Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02601
AC   CVCL_DS09
DR   CLO; CLO_0033382
DR   Coriell; GM02601
DR   Wikidata; Q54837570
RX   CelloPub=CLPUB00447;
CC   Doubling time: Slow growth (Coriell=GM02601).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   28Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02605
AC   CVCL_7360
SY   GM-2605; GM 2605
DR   CLO; CLO_0003526
DR   CLO; CLO_0032688
DR   CLDB; cl1493
DR   Coriell; GM02605
DR   Wikidata; Q54837571
RX   CelloPub=CLPUB00447;
RX   PubMed=7380831;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg101Trp (c.301C>T); ClinVar=VCV000001955; Zygosity=Heterozygous (Coriell=GM02605).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg211His (c.632G>A); ClinVar=VCV000001957; Zygosity=Heterozygous (Coriell=GM02605).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D861 ! GM02606
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   GM02606
AC   CVCL_D861
SY   GM-2606; GM 2606
DR   CLO; CLO_0032687
DR   Coriell; GM02606
DR   Wikidata; Q54837572
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg101Trp (c.301C>T); ClinVar=VCV000001955; Zygosity=Heterozygous (Coriell=GM02606).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg211His (c.632G>A); ClinVar=VCV000001957; Zygosity=Heterozygous (PubMed=1346349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7360 ! GM02605
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   GM02607
AC   CVCL_D863
DR   CLO; CLO_0032683
DR   Coriell; GM02607
DR   Wikidata; Q54837573
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D864 ! GM02608
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   GM02608
AC   CVCL_D864
SY   GM 2608
DR   CLO; CLO_0032684
DR   Coriell; GM02608
DR   Wikidata; Q54837574
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D863 ! GM02607
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM02609
AC   CVCL_DB58
DR   CLO; CLO_0032685
DR   Coriell; GM02609
DR   Wikidata; Q54837575
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB59 ! GM02610
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM02610
AC   CVCL_DB59
SY   GM 2610
DR   CLO; CLO_0032686
DR   Coriell; GM02610
DR   Wikidata; Q54837576
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB58 ! GM02609
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02613
AC   CVCL_GS01
SY   GM2613
DR   CLO; CLO_0032679
DR   Coriell; GM02613
DR   Wikidata; Q54837577
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS07 ! GM02677
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02614
AC   CVCL_GS02
SY   GM2614
DR   CLO; CLO_0032680
DR   Coriell; GM02614
DR   Wikidata; Q54837578
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS08 ! GM02678
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02615
AC   CVCL_CY06
SY   GM2615
DR   CLO; CLO_0032681
DR   Coriell; GM02615
DR   Wikidata; Q54837579
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY13 ! GM02679
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02616
AC   CVCL_CY07
SY   GM2616
DR   CLO; CLO_0032682
DR   Coriell; GM02616
DR   Wikidata; Q54837580
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY14 ! GM02680
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02617
AC   CVCL_CY08
SY   GM2617
DR   CLO; CLO_0032678
DR   Coriell; GM02617
DR   Wikidata; Q54837583
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY23 ! GM02785
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02621
AC   CVCL_1P01
SY   GM2621; GM2621A
DR   CLO; CLO_0032677
DR   Coriell; GM02621
DR   Wikidata; Q54837584
RX   CelloPub=CLPUB00447;
RX   PubMed=2498246;
RX   PubMed=6293786;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;12)(q22;q24) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM02623
AC   CVCL_9W88
SY   GM2623; GM2623B; GM02623C
DR   CLO; CLO_0032676
DR   Coriell; GM02623
DR   Wikidata; Q54837585
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02624
AC   CVCL_5M74
DR   CLO; CLO_0032674
DR   Coriell; GM02624
DR   Wikidata; Q54837586
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM02625
AC   CVCL_5M75
DR   CLO; CLO_0032675
DR   Coriell; GM02625
DR   Wikidata; Q54837587
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM02626
AC   CVCL_5M76
DR   CLO; CLO_0032672
DR   Coriell; GM02626
DR   Wikidata; Q54837588
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C86032; XX male
DI   ORDO; Orphanet_393; 46,XX testicular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM02627
AC   CVCL_0R32
SY   GM2627
DR   CLO; CLO_0032673
DR   Coriell; GM02627
DR   Wikidata; Q54837589
RX   CelloPub=CLPUB00447;
RX   PubMed=2464926;
RX   PubMed=6593712;
RX   PubMed=30497978;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Gly364Arg (c.1090G>A) (G325R); ClinVar=VCV000004318; Zygosity=Heterozygous (PubMed=30497978).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Cys381Gly (c.1141T>G) (C342G); ClinVar=VCV000004319; Zygosity=Heterozygous (PubMed=30497978).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   GM02629
AC   CVCL_9Q82
DR   CLO; CLO_0032670
DR   Coriell; GM02629
DR   Wikidata; Q54837590
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM02630
AC   CVCL_1M69
SY   GM-2630
DR   Coriell; GM02630
DR   Wikidata; Q54837591
RX   PubMed=761484;
CC   Discontinued: Coriell; GM02630; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   GM02631
AC   CVCL_AA21
DR   CLO; CLO_0032671
DR   Coriell; GM02631
DR   Wikidata; Q54837592
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125661; Carnosinemia
DI   ORDO; Orphanet_1361; Carnosinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM02633
AC   CVCL_4N27
DR   CLO; CLO_0032669
DR   Coriell; GM02633
DR   Wikidata; Q54837593
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln215Ter (c.643C>T); ClinVar=VCV000000814; Zygosity=Unspecified (Coriell=GM02633).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3938; Turcot syndrome
DI   ORDO; Orphanet_99818; Turcot syndrome with polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM02635
AC   CVCL_GS03
SY   GM2635
DR   CLO; CLO_0015032
DR   Coriell; GM02635
DR   Wikidata; Q54837595
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*08,15 (Coriell=GM02635).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02637
AC   CVCL_GS04
SY   GM2637
DR   CLO; CLO_0015031
DR   Coriell; GM02637
DR   Wikidata; Q54837596
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS06 ! GM02676
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02638
AC   CVCL_GS05
SY   GM2638
DR   CLO; CLO_0015030
DR   Coriell; GM02638
DR   Wikidata; Q54837597
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS15 ! GM02793
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02639
AC   CVCL_CY09
SY   GM2639
DR   CLO; CLO_0015036
DR   Coriell; GM02639
DR   GEO; GSM651170
DR   GEO; GSM651171
DR   GEO; GSM1266983
DR   GEO; GSM1267061
DR   Wikidata; Q54837598
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=21418647;
RX   PubMed=25326100;
RX   PubMed=35070079;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY12 ! GM02675
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GM02640
AC   CVCL_CY10
SY   GM2640
DR   CLO; CLO_0015037
DR   Coriell; GM02640
DR   GEO; GSM651174
DR   GEO; GSM651175
DR   GEO; GSM1257673
DR   GEO; GSM1266981
DR   GEO; GSM1267059
DR   GEO; GSM1288443
DR   Wikidata; Q54837599
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY21 ! GM02741
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   GM02641
AC   CVCL_CY11
SY   GM2641
DR   CLO; CLO_0015034
DR   Coriell; GM02641
DR   GEO; GSM651152
DR   GEO; GSM651153
DR   GEO; GSM1257674
DR   GEO; GSM1266982
DR   GEO; GSM1267060
DR   GEO; GSM1288444
DR   Wikidata; Q54837600
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY28 ! GM03355
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   GM02642
AC   CVCL_8A00
DR   CLO; CLO_0015035
DR   Coriell; GM02642
DR   Wikidata; Q54837601
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM02644
AC   CVCL_AT01
DR   CLO; CLO_0015038
DR   Coriell; GM02644
DR   Wikidata; Q54837602
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; French.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM02645
AC   CVCL_DD71
DR   CLO; CLO_0015039
DR   Coriell; GM02645
DR   Wikidata; Q54837603
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02658
AC   CVCL_2N07
DR   CLO; CLO_0014975
DR   Coriell; GM02658
DR   Wikidata; Q54837604
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;6)(2pter->2q11::6q15->6qter;6pter->6q15::2q11->2qter) (Coriell=GM02658).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N08 ! GM02699
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM02659
AC   CVCL_N000
SY   GM02659A; GM17073
DR   CLO; CLO_0014604
DR   CLO; CLO_0014971
DR   Coriell; GM02659
DR   Coriell; GM17073
DR   Wikidata; Q54837605
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   HLA typing: A*02:01:01,02:01:01; B*27:05:02,44:02:01; C*01:02:01,05:01:01; DPA1*01:03:01,02:01:01; DPB1*04:01:01,10:01:01; DQA1*01:01:01,05:05:01; DQB1*03:01:01,05:01:01; DRB1*01:01:01,11:01:01; DRB3*02:02:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg176Ter (c.526C>T); ClinVar=VCV000102723; Zygosity=Homozygous (Coriell=GM02659).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   GM02660
AC   CVCL_9Q91
SY   GM02660A
DR   CLO; CLO_0014970
DR   Coriell; GM02660
DR   Wikidata; Q54837606
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM02662
AC   CVCL_H186
DR   CLO; CLO_0014973
DR   Coriell; GM02662
DR   Wikidata; Q54837607
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM02663
AC   CVCL_AW99
SY   GM2663
DR   CLO; CLO_0014972
DR   Coriell; GM02663
DR   Wikidata; Q54837608
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126559; Hard skin syndrome Parana type
DI   ORDO; Orphanet_2812; Parana hard skin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02664
AC   CVCL_L977
SY   GM02643
DR   CLO; CLO_0014990
DR   Coriell; GM02643
DR   Coriell; GM02664
DR   Wikidata; Q54837609
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM02643; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   GM02665
AC   CVCL_9W89
SY   GM2665; GM02665A; GM2665A
DR   CLO; CLO_0014991
DR   Coriell; GM02665
DR   Wikidata; Q54837610
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM02665; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02667
AC   CVCL_AT02
DR   CLO; CLO_0014996
DR   Coriell; GM02667
DR   Wikidata; Q54837611
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM02668
AC   CVCL_X093
SY   GM 2668
DR   CLO; CLO_0014999
DR   Coriell; GM02668
DR   Wikidata; Q54837612
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(Y)(pter->q11.2) [77%]; 45,X [33%] (Coriell=GM02668).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   41Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 11
//
ID   GM02669
AC   CVCL_2S84
DR   CLO; CLO_0014981
DR   Coriell; GM02669
DR   Wikidata; Q54837613
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02670
AC   CVCL_5M77
DR   CLO; CLO_0015007
DR   Coriell; GM02670
DR   Wikidata; Q54837614
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C86032; XX male
DI   ORDO; Orphanet_393; 46,XX testicular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM02671
AC   CVCL_5M78
SY   C2671
DR   CLO; CLO_0015006
DR   Coriell; GM02671
DR   GEO; GSM2794406
DR   Wikidata; Q54837615
RX   CelloPub=CLPUB00447;
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM02672
AC   CVCL_5M79
SY   GM02672A
DR   CLO; CLO_0015005
DR   Coriell; GM02672
DR   Wikidata; Q54837616
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM02673
AC   CVCL_7361
SY   GM2673
DR   CLO; CLO_0015004
DR   Coriell; GM02673
DR   GEO; GSM3124655
DR   Wikidata; Q54837617
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=15450399;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM02674
AC   CVCL_9W90
SY   GM2674; GM 2674; GM 02674; GM02674A; GM2674A; GM 2674A
DR   CLO; CLO_0015003
DR   Coriell; GM02674
DR   GEO; GSM1316978
DR   GEO; GSM1317016
DR   Wikidata; Q54837618
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=1634904;
RX   PubMed=3111682;
RX   PubMed=6220707;
RX   PubMed=26984941;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX [76]; 45,X [24] (Coriell=GM02674).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM02675
AC   CVCL_CY12
SY   GM02675A; GM2675
DR   CLO; CLO_0015001
DR   Coriell; GM02675
DR   Wikidata; Q54837619
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY09 ! GM02639
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02676
AC   CVCL_GS06
SY   GM02676A; GM2676
DR   CLO; CLO_0015024
DR   Coriell; GM02676
DR   Wikidata; Q54837620
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS04 ! GM02637
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM02677
AC   CVCL_GS07
SY   GM2677
DR   CLO; CLO_0015027
DR   Coriell; GM02677
DR   Wikidata; Q54837622
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS01 ! GM02613
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM02678
AC   CVCL_GS08
SY   GM2678
DR   CLO; CLO_0015020
DR   BioSample; SAMN00808000
DR   Coriell; GM02678
DR   Wikidata; Q54837623
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS02 ! GM02614
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM02679
AC   CVCL_CY13
SY   GM2679
DR   CLO; CLO_0015023
DR   BioSample; SAMN00808002
DR   Coriell; GM02679
DR   Wikidata; Q54837626
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY06 ! GM02615
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02680
AC   CVCL_CY14
SY   GM2680
DR   CLO; CLO_0014968
DR   BioSample; SAMN00808004
DR   Coriell; GM02680
DR   Wikidata; Q54837627
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY07 ! GM02616
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02681
AC   CVCL_AM65
DR   CLO; CLO_0014961
DR   BioSample; SAMN00808006
DR   Coriell; GM02681
DR   Wikidata; Q54837628
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02682
AC   CVCL_IL11
DR   CLO; CLO_0014965
DR   BioSample; SAMN00808008
DR   Coriell; GM02682
DR   Wikidata; Q54837629
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL12 ! GM02683
SX   Sex ambiguous
AG   7Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM02683
AC   CVCL_IL12
DR   CLO; CLO_0014957
DR   BioSample; SAMN00808010
DR   Coriell; GM02683
DR   Wikidata; Q54837630
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Genital area, skin; UBERON=UBERON_8480029.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL11 ! GM02682
SX   Sex ambiguous
AG   7Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM02685
AC   CVCL_9R72
DR   CLO; CLO_0014959
DR   BioSample; SAMN00808012
DR   Coriell; GM02685
DR   Wikidata; Q54837631
RX   CelloPub=CLPUB00447;
RX   PubMed=8910459;
RX   PubMed=9054950;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02686
AC   CVCL_VL94
DR   Coriell; GM02686
DR   Wikidata; Q93579395
RX   PubMed=7301938;
CC   Discontinued: Coriell; GM02686; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM02687
AC   CVCL_9Q92
DR   CLO; CLO_0014955
DR   BioSample; SAMN00808014
DR   Coriell; GM02687
DR   Wikidata; Q54837632
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Ser581Ilefs*8 (c.1738TATA[3]) (c.1738_1741[3]) (1902_1905tripTATA); ClinVar=VCV000038415; Zygosity=Heterozygous (PubMed=16465621).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM02688
AC   CVCL_N001
SY   GM02688A; GM17253
DR   CLO; CLO_0014389
DR   CLO; CLO_0014956
DR   BioSample; SAMN00808016
DR   Coriell; GM02688
DR   Coriell; GM17253
DR   GEO; GSM569633
DR   GEO; GSM596317
DR   GEO; GSM596676
DR   GEO; GSM924855
DR   Wikidata; Q54837633
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM02689
AC   CVCL_W736
DR   CLO; CLO_0014938
DR   BioSample; SAMN00808018
DR   Coriell; GM02689
DR   Wikidata; Q54837634
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM02690
AC   CVCL_2H26
DR   CLO; CLO_0014935
DR   BioSample; SAMN00808020
DR   Coriell; GM02690
DR   Wikidata; Q54837635
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM02691
AC   CVCL_AM84
DR   CLO; CLO_0014930
DR   BioSample; SAMN00808022
DR   Coriell; GM02691
DR   Wikidata; Q54837636
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02694
AC   CVCL_4N28
SY   GM02694A
DR   CLO; CLO_0014911
DR   BioSample; SAMN00808024
DR   Coriell; GM02694
DR   Wikidata; Q54837637
RX   CelloPub=CLPUB00447;
RX   PubMed=3374507;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln215Ter (c.643C>T); ClinVar=VCV000000814; Zygosity=Unspecified (Coriell=GM02694).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   NCIt; C3938; Turcot syndrome
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
DI   ORDO; Orphanet_99818; Turcot syndrome with polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM02695
AC   CVCL_DD72
DR   CLO; CLO_0014914
DR   BioSample; SAMN00808026
DR   Coriell; GM02695
DR   Wikidata; Q54837638
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02699
AC   CVCL_2N08
DR   Coriell; GM02699
DR   Wikidata; Q54837639
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM02699; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N07 ! GM02658
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   GM02704
AC   CVCL_M928
SY   GM2704
DR   CLO; CLO_0014916
DR   BioSample; SAMN00808028
DR   Coriell; GM02704
DR   GEO; GSM1257669
DR   GEO; GSM1266984
DR   GEO; GSM1267062
DR   GEO; GSM1288445
DR   Wikidata; Q54837640
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M929 ! GM02705
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   GM02705
AC   CVCL_M929
SY   GM2705; GM17254
DR   CLO; CLO_0014390
DR   CLO; CLO_0014919
DR   BioSample; SAMN00808030
DR   Coriell; GM02705
DR   Coriell; GM17254
DR   GEO; GSM569634
DR   GEO; GSM596318
DR   GEO; GSM596677
DR   GEO; GSM924856
DR   Wikidata; Q54837641
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,35:01:01; C*07:01:01,15:02:01; DPA1*01:03:01,02:01:02; DPB1*01:01:01,04:01:01; DQA1*01:01:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*01:03:01,03:01:01; DRB3*01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M928 ! GM02704
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM02706
AC   CVCL_F067
SY   GM02706A; GM2706
DR   CLO; CLO_0014905
DR   BioSample; SAMN00808032
DR   Coriell; GM02706
DR   GEO; GSM1257670
DR   GEO; GSM1266985
DR   GEO; GSM1267063
DR   GEO; GSM1288446
DR   Wikidata; Q54837642
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7362 ! GM02707
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   GM02707
AC   CVCL_7362
SY   GM18009; GM2707
DR   CLO; CLO_0014906
DR   CLO; CLO_0016001
DR   BioSample; SAMN00808034
DR   Coriell; GM02707
DR   Coriell; GM18009
DR   Wikidata; Q54837643
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F067 ! GM02706
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM02708
AC   CVCL_CY15
SY   GM2708
DR   CLO; CLO_0014908
DR   BioSample; SAMN00808036
DR   Coriell; GM02708
DR   GEO; GSM1266986
DR   Wikidata; Q54837644
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY16 ! GM02709
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GM02709
AC   CVCL_CY16
SY   GM2709
DR   CLO; CLO_0014909
DR   BioSample; SAMN00808038
DR   Coriell; GM02709
DR   Wikidata; Q54837645
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY15 ! GM02708
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02710
AC   CVCL_CY17
SY   GM2710
DR   Coriell; GM02710
DR   Wikidata; Q54837646
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Discontinued: Coriell; GM02710; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY18 ! GM02711
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02711
AC   CVCL_CY18
SY   GM2711
DR   CLO; CLO_0014881
DR   BioSample; SAMN00808040
DR   Coriell; GM02711
DR   Wikidata; Q54837647
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY17 ! GM02710
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02712
AC   CVCL_GS09
SY   GM2712
DR   CLO; CLO_0014877
DR   BioSample; SAMN00808042
DR   Coriell; GM02712
DR   Wikidata; Q54837648
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS10 ! GM02713
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM02713
AC   CVCL_GS10
SY   GM02713A; GM2713
DR   CLO; CLO_0014859
DR   BioSample; SAMN00808044
DR   Coriell; GM02713
DR   Wikidata; Q54837649
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS09 ! GM02712
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM02714
AC   CVCL_CY19
SY   GM2714
DR   CLO; CLO_0014862
DR   BioSample; SAMN00808046
DR   Coriell; GM02714
DR   Wikidata; Q54837650
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY05 ! GM01878
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02715
AC   CVCL_IL13
DR   CLO; CLO_0014864
DR   BioSample; SAMN00808048
DR   Coriell; GM02715
DR   Wikidata; Q54837651
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY (Coriell=GM02715).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL14 ! GM02716
OI   CVCL_IL15 ! GM02717
SX   Sex ambiguous
AG   14Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM02716
AC   CVCL_IL14
DR   CLO; CLO_0014860
DR   BioSample; SAMN00808050
DR   Coriell; GM02716
DR   Wikidata; Q54837652
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY (Coriell=GM02716).
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL13 ! GM02715
OI   CVCL_IL15 ! GM02717
SX   Sex ambiguous
AG   14Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM02717
AC   CVCL_IL15
DR   CLO; CLO_0014861
DR   BioSample; SAMN00808052
DR   Coriell; GM02717
DR   Wikidata; Q54837653
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY (Coriell=GM02717).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IL13 ! GM02715
OI   CVCL_IL14 ! GM02716
SX   Sex ambiguous
AG   14Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM02718
AC   CVCL_5M80
AS   CVCL_V550
SY   AG02718; AG-2718; AG 2718; AG2718
DR   CLO; CLO_0014868
DR   BioSample; SAMN00808054
DR   Coriell; AG02718
DR   Coriell; GM02718
DR   Wikidata; Q54837654
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
RX   PubMed=7329430;
RX   PubMed=7471105;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; AG02718; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM02719
AC   CVCL_V549
AS   CVCL_X049
SY   GM2719; GM02719A; AG02719; AG-2719; AG 2719; AG2719
DR   CLO; CLO_0014869
DR   Coriell; AG02719
DR   Coriell; GM02719
DR   Wikidata; Q54837655
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
RX   PubMed=7329430;
RX   PubMed=7471105;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; AG02719; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM02728
AC   CVCL_CY20
SY   GM2728
DR   CLO; CLO_0014866
DR   Coriell; GM02728
DR   Wikidata; Q54837656
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM02728; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY26 ! GM02869
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM02729
AC   CVCL_X270
SY   GM 2729
DR   CLO; CLO_0014867
DR   BioSample; SAMN00808056
DR   Coriell; GM02729
DR   Wikidata; Q54837658
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+der(15)(15pter->15q13::15p11->15pter) (Coriell=GM02729).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02730
AC   CVCL_X094
SY   GM 2730
DR   CLO; CLO_0014847
DR   BioSample; SAMN00808058
DR   Coriell; GM02730
DR   Wikidata; Q54837659
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(Y)(pter->q11) [67%]; 45,X [33%] (Coriell=GM02730).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   4D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 10
//
ID   GM02732
AC   CVCL_X271
SY   GM 2732
DR   CLO; CLO_0014829
DR   BioSample; SAMN00808060
DR   Coriell; GM02732
DR   Wikidata; Q54837660
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Discontinued: Coriell; GM02732; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM02739
AC   CVCL_4N29
DR   CLO; CLO_0014830
DR   BioSample; SAMN00808062
DR   Coriell; GM02739
DR   Wikidata; Q54837661
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02741
AC   CVCL_CY21
SY   GM02741B; GM2741A
DR   CLO; CLO_0014831
DR   BioSample; SAMN00808064
DR   Coriell; GM02741
DR   Wikidata; Q54837662
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY10 ! GM02640
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02742
AC   CVCL_N002
SY   GM02742A; GM17043; GM17370
DR   CLO; CLO_0013694
DR   CLO; CLO_0014643
DR   CLO; CLO_0014833
DR   BioSample; SAMN00808072
DR   Coriell; GM02742
DR   Coriell; GM17043
DR   Coriell; GM17370
DR   Wikidata; Q54837663
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:1368; CA1; Simple; p.Arg247His (c.740G>A) (R246H); ClinVar=VCV000017606; Zygosity=Heterozygous (from familial inference of GM02744; GM02745).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM02743
AC   CVCL_N003
SY   GM17371
DR   CLO; CLO_0013693
DR   CLO; CLO_0014834
DR   BioSample; SAMN00808074
DR   Coriell; GM02743
DR   Coriell; GM17371
DR   Wikidata; Q54837664
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:1368; CA1; Simple; p.Arg247His (c.740G>A) (R246H); ClinVar=VCV000017606; Zygosity=Heterozygous (from familial inference of GM02744; GM02745).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM02744
AC   CVCL_IX35
DR   CLO; CLO_0014835
DR   BioSample; SAMN00808076
DR   Coriell; GM02744
DR   Wikidata; Q54837665
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00556;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:1368; CA1; Simple; p.Arg247His (c.740G>A) (R246H); ClinVar=VCV000017606; Zygosity=Homozygous (CelloPub=CLPUB00556).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132290; Carbonic anhydrase I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 13
//
ID   GM02745
AC   CVCL_IX36
DR   CLO; CLO_0014836
DR   BioSample; SAMN00808078
DR   Coriell; GM02745
DR   Wikidata; Q54837666
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00556;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:1368; CA1; Simple; p.Arg247His (c.740G>A) (R246H); ClinVar=VCV000017606; Zygosity=Homozygous (CelloPub=CLPUB00556).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132290; Carbonic anhydrase I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 13
//
ID   GM02756
AC   CVCL_F603
SY   GM 2756
DR   CLO; CLO_0014837
DR   BioSample; SAMN00808080
DR   Coriell; GM02756
DR   Wikidata; Q54837669
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg211His (c.632G>A); ClinVar=VCV000001957; Zygosity=Heterozygous (PubMed=1346349).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Ala329Val (c.986C>T); ClinVar=VCV000001959; Zygosity=Heterozygous (PubMed=1346349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM02762
AC   CVCL_GS11
SY   GM2762
DR   CLO; CLO_0014838
DR   BioSample; SAMN00808082
DR   Coriell; GM02762
DR   Wikidata; Q54837670
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR92 ! GM01872
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM02763
AC   CVCL_GS12
SY   GM2763
DR   CLO; CLO_0014839
DR   BioSample; SAMN00808084
DR   Coriell; GM02763
DR   Wikidata; Q54837671
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR93 ! GM01873
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM02764
AC   CVCL_GS13
DR   CLO; CLO_0014809
DR   BioSample; SAMN00808086
DR   Coriell; GM02764
DR   Wikidata; Q54837672
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR96 ! GM01911
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM02765
AC   CVCL_GS14
SY   GM2765
DR   CLO; CLO_0014808
DR   BioSample; SAMN00808088
DR   Coriell; GM02765
DR   Wikidata; Q54837673
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR95 ! GM01909
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM02766
AC   CVCL_CY22
SY   GM2766
DR   CLO; CLO_0014807
DR   BioSample; SAMN00808090
DR   Coriell; GM02766
DR   Wikidata; Q54837674
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY02 ! GM01874
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 11
//
ID   GM02767
AC   CVCL_V469
SY   GM-2767; GM 2767; GM2767; GM02767C; GM 2767C
DR   CLO; CLO_0014806
DR   BioSample; SAMN00808092
DR   Coriell; GM02767
DR   GEO; GSM426281
DR   Wikidata; Q54837675
RX   CelloPub=CLPUB00447;
RX   Patent=US5773219;
RX   PubMed=291901;
RX   PubMed=6661932;
RX   PubMed=7299037;
RX   PubMed=8643543;
RX   PubMed=17668376;
RX   PubMed=19727395;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   GM02768
AC   CVCL_4N30
DR   CLO; CLO_0014804
DR   BioSample; SAMN00808094
DR   Coriell; GM02768
DR   Wikidata; Q54837676
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02769
AC   CVCL_0Q51
DR   CLO; CLO_0014801
DR   BioSample; SAMN00808096
DR   Coriell; GM02769
DR   Wikidata; Q54837677
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000167140; Zygosity=Hemizygous (Coriell=GM02769).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM02770
AC   CVCL_4N31
SY   GM02770B
DR   CLO; CLO_0014800
DR   BioSample; SAMN00808098
DR   Coriell; GM02770
DR   Wikidata; Q54837678
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM02771
AC   CVCL_4N32
DR   CLO; CLO_0014798
DR   BioSample; SAMN00808100
DR   Coriell; GM02771
DR   Wikidata; Q54837679
RX   CelloPub=CLPUB00447;
RX   PubMed=29982630;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000167140; Zygosity=Heterozygous (PubMed=29982630).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM02772
AC   CVCL_4N33
SY   GM 2772; GM02772A
DR   CLO; CLO_0014797
DR   BioSample; SAMN00808102
DR   Coriell; GM02772
DR   Wikidata; Q54837680
RX   CelloPub=CLPUB00447;
RX   PubMed=6303650;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000167140; Zygosity=Heterozygous (from familial inference of GM02769).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   GM02774
AC   CVCL_4N34
SY   GM 2774
DR   CLO; CLO_0014796
DR   BioSample; SAMN00808104
DR   Coriell; GM02774
DR   Wikidata; Q54837681
RX   CelloPub=CLPUB00447;
RX   PubMed=6303650;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000167140; Zygosity=Heterozygous (Coriell=GM02774).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM02775
AC   CVCL_0Q52
DR   CLO; CLO_0014787
DR   BioSample; SAMN00808106
DR   Coriell; GM02775
DR   Wikidata; Q54837682
RX   CelloPub=CLPUB00447;
RX   PubMed=29982630;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000167140; Zygosity=Hemizygous (PubMed=29982630).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM02781
AC   CVCL_7363
SY   GM02781A; GM02781B; GM17044; GM17335
DR   CLO; CLO_0013613
DR   CLO; CLO_0014642
DR   CLO; CLO_0014786
DR   BioSample; SAMN00808108
DR   Coriell; GM02781
DR   Coriell; GM17044
DR   Coriell; GM17335
DR   GEO; GSM1116561
DR   GEO; GSM1116562
DR   GEO; GSM1116601
DR   GEO; GSM1116602
DR   GEO; GSM1116603
DR   GEO; GSM1116604
DR   Wikidata; Q54837683
RX   CelloPub=CLPUB00447;
RX   PubMed=23943852;
CC   Part of: Human variation panel.
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM02782
AC   CVCL_F079
SY   GM-02782; GM-2782; GM2782; GM02782A; GM02782B
DR   CLO; CLO_0014789
DR   BioSample; SAMN00808110
DR   Coriell; GM02782
DR   GEO; GSM1116629
DR   GEO; GSM1116630
DR   GEO; GSM1116631
DR   GEO; GSM1116632
DR   Wikidata; Q54837684
RX   CelloPub=CLPUB00447;
RX   PubMed=761484;
RX   PubMed=8808599;
RX   PubMed=16166284;
RX   PubMed=23943852;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.2251del19; Zygosity=Heterozygous (PubMed=8808599; PubMed=16166284).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.5675del88; Zygosity=Heterozygous (PubMed=8808599; PubMed=16166284).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.6573del81; Zygosity=Heterozygous (PubMed=8808599; PubMed=16166284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F080 ! GM02531
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   GM02783
AC   CVCL_7364
SY   GM-2783; GM2783; GM02783A; GM02783B
DR   CLO; CLO_0014788
DR   BioSample; SAMN00808112
DR   Coriell; GM02783
DR   JCRB; KURB3013
DR   Wikidata; Q54837685
RX   CelloPub=CLPUB00447;
RX   PubMed=761484;
RX   PubMed=2805228;
RX   PubMed=16166284;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F081 ! GM02530
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 21
//
ID   GM02784
AC   CVCL_Z830
SY   GM-2784
DR   BTO; BTO_0006260
DR   CLO; CLO_0014782
DR   BioSample; SAMN00808114
DR   Coriell; GM02784
DR   Wikidata; Q54837686
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84903; Sly syndrome
DI   ORDO; Orphanet_584; Mucopolysaccharidosis type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM02785
AC   CVCL_CY23
SY   GM2785; GM02785A
DR   CLO; CLO_0014779
DR   BioSample; SAMN00808117
DR   Coriell; GM02785
DR   Wikidata; Q54837687
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY08 ! GM02617
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM02790
AC   CVCL_GQ26
DR   CLO; CLO_0014785
DR   Coriell; GM02790
DR   Wikidata; Q54837688
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM02793
AC   CVCL_GS15
SY   GM02793A; GM2793A; GM02793C
DR   CLO; CLO_0014784
DR   BioSample; SAMN00808118
DR   Coriell; GM02793
DR   Wikidata; Q54837689
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS05 ! GM02638
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 11
//
ID   GM02795
AC   CVCL_F027
SY   GM 2795; GM2795; GM02795A
DR   CLO; CLO_0014778
DR   BioSample; SAMN00808119
DR   Coriell; GM02795
DR   Wikidata; Q54837690
RX   CelloPub=CLPUB00447;
RX   PubMed=1766867;
RX   PubMed=2011574;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Val44Met (c.130G>A); ClinVar=VCV000003611; Zygosity=Heterozygous (PubMed=2011574).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Met142Lys (c.425T>A); ClinVar=VCV000003609; Zygosity=Heterozygous (PubMed=2011574).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D342 ! GM00054
OI   CVCL_F026 ! GM01907
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   GM02796
AC   CVCL_F484
SY   GM 2796; GM2796
DR   CLO; CLO_0014777
DR   BioSample; SAMN00808120
DR   Coriell; GM02796
DR   Wikidata; Q54837691
RX   CelloPub=CLPUB00447;
RX   PubMed=1766867;
RX   PubMed=2011574;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Ser135Leu (c.404C>T); ClinVar=VCV000003618; Zygosity=Heterozygous (Coriell=GM02796).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Phe171Ser (c.512T>C); ClinVar=VCV000003616; Zygosity=Heterozygous (Coriell=GM02796).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2779 ! CHP 4 (W.W.)
OI   CVCL_F483 ! GM01908
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM02797
AC   CVCL_1L44
DR   CLO; CLO_0014765
DR   BioSample; SAMN00808121
DR   Coriell; GM02797
DR   Wikidata; Q54837692
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM02800
AC   CVCL_X095
SY   GM 2800
DR   CLO; CLO_0014769
DR   BioSample; SAMN00808122
DR   Coriell; GM02800
DR   Wikidata; Q54837693
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 46,XX,del(5)(qter->p14) (Coriell=GM02800).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02801
AC   CVCL_0M15
DR   CLO; CLO_0014768
DR   BioSample; SAMN00808123
DR   Coriell; GM02801
DR   Wikidata; Q54837694
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM02801).
CC   Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C3256; Nasal cavity polyp
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM02803
AC   CVCL_0M16
DR   CLO; CLO_0014767
DR   BioSample; SAMN00808124
DR   Coriell; GM02803
DR   Wikidata; Q54837695
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from familial inference of GM02827).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   GM02805
AC   CVCL_2N30
SY   GM2805
DR   CLO; CLO_0014766
DR   BioSample; SAMN00808125
DR   Coriell; GM02805
DR   Wikidata; Q54837697
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM02808
AC   CVCL_V817
SY   GM-2808
DR   CLO; CLO_0014760
DR   BioSample; SAMN00808126
DR   Coriell; GM02808
DR   Wikidata; Q54837698
RX   CelloPub=CLPUB00447;
RX   PubMed=509995;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(3;17)(3qter->3p21::17p13->17pter;17qter->17p13::3p21->3pter) (Coriell=GM02808).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM02812
AC   CVCL_CY24
SY   GM02812A; GM2812A
DR   CLO; CLO_0014759
DR   BioSample; SAMN00808127
DR   Coriell; GM02812
DR   Wikidata; Q54837699
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY04 ! GM01876
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM02813
AC   CVCL_X272
SY   GM 2813
DR   CLO; CLO_0014756
DR   BioSample; SAMN00808128
DR   Coriell; GM02813
DR   Wikidata; Q54837700
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,+13,der(13;15)(13qter->q10::q10->15qter)mat (Coriell=GM02813).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02814
AC   CVCL_FA32
SY   GM2814
DR   CLO; CLO_0014754
DR   BioSample; SAMN00808129
DR   Coriell; GM02814
DR   Wikidata; Q54837701
RX   CelloPub=CLPUB00447;
RX   PubMed=8605078;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128802; Acrodermatitis enteropathica
DI   ORDO; Orphanet_37; Acrodermatitis enteropathica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM02815
AC   CVCL_EJ31
DR   CLO; CLO_0014763
DR   BioSample; SAMN00808130
DR   Coriell; GM02815
DR   Wikidata; Q54837702
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM02817
AC   CVCL_AB45
DR   CLO; CLO_0012754
DR   BioSample; SAMN00808131
DR   Coriell; GM02817
DR   Wikidata; Q54837704
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6826; MAN2B1; Simple; p.Arg750Trp (c.2248C>T); ClinVar=VCV000001687; Zygosity=Homozygous (Coriell=GM02817).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84548; Alpha-mannosidosis
DI   ORDO; Orphanet_61; Alpha-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM02819
AC   CVCL_X136
SY   GM 2819
DR   CLO; CLO_0012752
DR   BioSample; SAMN00808132
DR   Coriell; GM02819
DR   Wikidata; Q54837705
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X137 ! GM02820
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM02820
AC   CVCL_X137
SY   GM 2820
DR   CLO; CLO_0012753
DR   BioSample; SAMN00808133
DR   Coriell; GM02820
DR   Wikidata; Q54837706
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X136 ! GM02819
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   GM02821
AC   CVCL_M930
DR   CLO; CLO_0012750
DR   BioSample; SAMN00808134
DR   Coriell; GM02821
DR   Wikidata; Q54837707
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Karyotypic information: 46,XX,t(9;12)(9qter->9p13::12q24->12qter;12pter->12q24::9p13->9pter) (Coriell=GM02821).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M931 ! GM02822
OI   CVCL_N060 ! GM07114
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM02822
AC   CVCL_M931
SY   GM17155
DR   CLO; CLO_0012749
DR   CLO; CLO_0013960
DR   BioSample; SAMN00808135
DR   Coriell; GM02822
DR   Coriell; GM17155
DR   GEO; GSM273422
DR   GEO; GSM569652
DR   GEO; GSM596220
DR   GEO; GSM597020
DR   GEO; GSM924665
DR   IPD-IMGT/HLA; 23056
DR   Wikidata; Q54837708
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*03:CVAB,30:AUX; B*57:02,58:02; C*06:02,18:AB; DRB1*04:05,07:01 (IPD-IMGT/HLA=23056).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M930 ! GM02821
OI   CVCL_N060 ! GM07114
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM02824
AC   CVCL_7365
DR   CLO; CLO_0003527
DR   CLO; CLO_0012748
DR   CLDB; cl1494
DR   BioSample; SAMN00808136
DR   Coriell; GM02824
DR   Wikidata; Q54837709
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.219-2A>G (IVS3-2A>G); ClinVar=VCV000001969; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM02824).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Ala329Val (c.986C>T); ClinVar=VCV000001959; Zygosity=Heterozygous (Coriell=GM02824).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F082 ! GM02825
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM02825
AC   CVCL_F082
SY   GM02825A; GM 2825A
DR   CLO; CLO_0012746
DR   BioSample; SAMN00808137
DR   Coriell; GM02825
DR   Wikidata; Q54837710
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.219-2A>G (IVS3-2A>G); ClinVar=VCV000001969; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM02825).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Ala329Val (c.986C>T); ClinVar=VCV000001959; Zygosity=Heterozygous (PubMed=1346349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7365 ! GM02824
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   GM02826
AC   CVCL_0M17
SY   GM02826A
DR   CLO; CLO_0012744
DR   BioSample; SAMN00808138
DR   Coriell; GM02826
DR   Wikidata; Q54837715
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from familial inference of GM02827).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   GM02827
AC   CVCL_0M18
SY   GM02827C
DR   CLO; CLO_0012741
DR   BioSample; SAMN00808139
DR   Coriell; GM02827
DR   Wikidata; Q54837716
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM02827).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM02828
AC   CVCL_0M19
DR   CLO; CLO_0012740
DR   BioSample; SAMN00808140
DR   Coriell; GM02828
DR   Wikidata; Q54837717
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM02828).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Val520Phe (c.1558G>T); ClinVar=VCV000007150; Zygosity=Heterozygous (Coriell=GM02828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM02830
AC   CVCL_4Z90
SY   GM2830
DR   CLO; CLO_0012772
DR   BioSample; SAMN00808141
DR   Coriell; GM02830
DR   Wikidata; Q54837718
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   GM02831
AC   CVCL_4Z91
SY   GM2831
DR   CLO; CLO_0012771
DR   BioSample; SAMN00808142
DR   Coriell; GM02831
DR   Wikidata; Q54837719
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM02832
AC   CVCL_4Z92
SY   GM2832
DR   CLO; CLO_0012774
DR   BioSample; SAMN00808143
DR   Coriell; GM02832
DR   Wikidata; Q54837720
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM02836
AC   CVCL_X273
SY   GM-2836; GM 2836
DR   CLO; CLO_0012773
DR   BioSample; SAMN00808144
DR   Coriell; GM02836
DR   Wikidata; Q54837721
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02837
AC   CVCL_9R73
DR   CLO; CLO_0012755
DR   BioSample; SAMN00808145
DR   Coriell; GM02837
DR   Wikidata; Q54837722
RX   CelloPub=CLPUB00447;
RX   PubMed=9054950;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02838
AC   CVCL_L470
SY   GM2838
DR   CLO; CLO_0012758
DR   BioSample; SAMN00808146
DR   Coriell; GM02838
DR   JCRB; KURB1920
DR   Wikidata; Q54837723
RX   CelloPub=CLPUB00447;
RX   PubMed=12665480;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   GM02845
AC   CVCL_1V25
DR   CLO; CLO_0012760
DR   BioSample; SAMN00808147
DR   Coriell; GM02845
DR   Wikidata; Q54837724
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02846
AC   CVCL_1V26
DR   CLO; CLO_0012761
DR   BioSample; SAMN00808148
DR   Coriell; GM02846
DR   Wikidata; Q54837725
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02847
AC   CVCL_1V27
DR   CLO; CLO_0012764
DR   BioSample; SAMN00808149
DR   Coriell; GM02847
DR   Wikidata; Q54837727
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM02848
AC   CVCL_7366
SY   GM-2848; GM 2848; GM2848
DR   CLO; CLO_0003528
DR   CLO; CLO_0012765
DR   CLDB; cl1495
DR   BioSample; SAMN00808150
DR   Coriell; GM02848
DR   Wikidata; Q54837728
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,der(2)(qter->q33::p25->qter) (Coriell=GM02848).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM02849
AC   CVCL_9W91
DR   CLO; CLO_0012790
DR   BioSample; SAMN00808151
DR   Coriell; GM02849
DR   Wikidata; Q54837729
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02850
AC   CVCL_9R74
DR   CLO; CLO_0012794
DR   BioSample; SAMN00808152
DR   Coriell; GM02850
DR   Wikidata; Q54837730
RX   CelloPub=CLPUB00447;
CC   Population: Native North American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125591; Dubowitz syndrome
DI   ORDO; Orphanet_235; Dubowitz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02851
AC   CVCL_L489
DR   CLO; CLO_0012793
DR   Coriell; GM02851
DR   Wikidata; Q54837731
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   GM02852
AC   CVCL_L490
DR   CLO; CLO_0012792
DR   Coriell; GM02852
DR   Wikidata; Q54837732
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   GM02857
AC   CVCL_FV43
DR   CLO; CLO_0012791
DR   BioSample; SAMN00808153
DR   Coriell; GM02857
DR   Wikidata; Q54837733
RX   CelloPub=CLPUB00447;
CC   Population: Puerto Rican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM02859
AC   CVCL_M932
SY   GM-2859; GM 2859; GM2859; GM02859A; GM2859A; GM17312
DR   CLO; CLO_0012780
DR   CLO; CLO_0013353
DR   BioSample; SAMN00808154
DR   Coriell; GM02859
DR   Coriell; GM17312
DR   Wikidata; Q54837734
RX   CelloPub=CLPUB00447;
RX   PubMed=2498246;
RX   PubMed=6293786;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=6947233;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Karyotypic information: 46,X,t(X;11)(q11.1;p13) (PubMed=10377420).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM17312).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M933 ! GM03316
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM02860
AC   CVCL_1N31
SY   GM2860
DR   CLO; CLO_0012782
DR   BioSample; SAMN00808155
DR   Coriell; GM02860
DR   Wikidata; Q54837735
RX   CelloPub=CLPUB00447;
RX   PubMed=6293786;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(3;16)(3pter->3q13.2::16q13->16qter;16pter->16q13::3q13.2->3qter) (Coriell=GM02860).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM02866
AC   CVCL_CY25
SY   GM2866; GM02866A
DR   CLO; CLO_0012776
DR   BioSample; SAMN00808156
DR   Coriell; GM02866
DR   Wikidata; Q54837736
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY03 ! GM01875
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM02868
AC   CVCL_GS16
SY   GM2868
DR   CLO; CLO_0012777
DR   BioSample; SAMN00808157
DR   Coriell; GM02868
DR   Wikidata; Q54837737
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP30 ! GM03667
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM02869
AC   CVCL_CY26
SY   GM2869
DR   CLO; CLO_0012783
DR   BioSample; SAMN00808158
DR   Coriell; GM02869
DR   Wikidata; Q54837738
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY20 ! GM02728
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02870
AC   CVCL_CW71
DR   CLO; CLO_0012814
DR   BioSample; SAMN00808159
DR   Coriell; GM02870
DR   Wikidata; Q54837739
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C112116; Eosinophilic fasciitis
DI   ORDO; Orphanet_3165; Eosinophilic fasciitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02881
AC   CVCL_V818
SY   GM2881
DR   CLO; CLO_0012813
DR   BioSample; SAMN00808160
DR   Coriell; GM02881
DR   Wikidata; Q54837740
RX   CelloPub=CLPUB00447;
RX   PubMed=6492896;
RX   PubMed=7059984;
RX   PubMed=7471819;
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (PubMed=6492896).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM02885
AC   CVCL_AX00
DR   CLO; CLO_0012810
DR   BioSample; SAMN00808161
DR   Coriell; GM02885
DR   Wikidata; Q54837741
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; French.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126560; Leri-Weill dyschondrosteosis
DI   ORDO; Orphanet_240; Leri-Weill dyschondrosteosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM02894
AC   CVCL_F604
SY   GM 2894; GM2894
DR   CLO; CLO_0012809
DR   Coriell; GM02894
DR   Wikidata; Q54837742
RX   CelloPub=CLPUB00447;
RX   PubMed=9792862;
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Homozygous (PubMed=9792862).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM02895
AC   CVCL_AX19
DR   CLO; CLO_0012812
DR   BioSample; SAMN00808162
DR   Coriell; GM02895
DR   Wikidata; Q54837743
RX   CelloPub=CLPUB00447;
CC   Population: Puerto Rican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61269; Niemann-Pick disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM02896
AC   CVCL_AX20
DR   CLO; CLO_0012811
DR   BioSample; SAMN00808163
DR   Coriell; GM02896
DR   Wikidata; Q54837745
RX   CelloPub=CLPUB00447;
CC   Population: Puerto Rican.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM02897
AC   CVCL_AX21
DR   CLO; CLO_0012800
DR   BioSample; SAMN00808164
DR   Coriell; GM02897
DR   Wikidata; Q54837746
RX   CelloPub=CLPUB00447;
CC   Population: Puerto Rican.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM02899
AC   CVCL_H962
DR   CLO; CLO_0012802
DR   BioSample; SAMN00808165
DR   Coriell; GM02899
DR   Wikidata; Q54837747
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Finnish.
CC   Karyotypic information: 46,X,t(X;3)(Xpter->Xq28::3q21->3qter;3pter->3q21::Xq28->Xqter) (Coriell=GM02899).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H961 ! GM00194
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM02906
AC   CVCL_X096
SY   GM 2906; GM2906A; GM 2906 A
DR   CLO; CLO_0012804
DR   BioSample; SAMN00808166
DR   Coriell; GM02906
DR   Wikidata; Q54837748
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM02912
AC   CVCL_7367
SY   GM2912; GM02912A; GM 2912A; GM2912A
DR   CLO; CLO_0012806
DR   BioSample; SAMN00808167
DR   Coriell; GM02912
DR   Wikidata; Q54837749
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   Patent=US5773219;
RX   PubMed=3863481;
RX   PubMed=8643543;
RX   PubMed=29762696;
CC   Population: Caucasian.
CC   Misspelling: GMO2912; PubMed=29762696.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM02921
AC   CVCL_9R75
DR   CLO; CLO_0012834
DR   BioSample; SAMN00808168
DR   Coriell; GM02921
DR   Wikidata; Q54837750
RX   CelloPub=CLPUB00447;
RX   PubMed=8910459;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM02922
AC   CVCL_9R76
DR   CLO; CLO_0012833
DR   BioSample; SAMN00808169
DR   Coriell; GM02922
DR   Wikidata; Q54837751
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM02923
AC   CVCL_9R77
DR   CLO; CLO_0012832
DR   BioSample; SAMN00808170
DR   Coriell; GM02923
DR   Wikidata; Q54837752
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM02927
AC   CVCL_2S85
DR   CLO; CLO_0012831
DR   BioSample; SAMN00808171
DR   Coriell; GM02927
DR   Wikidata; Q54837753
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(13;18)(13qter->13p13::18q12.2->18qter;18pter->18q12.2::13p13->13pter) (Coriell=GM02927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 11
//
ID   GM02931
AC   CVCL_0M05
DR   CLO; CLO_0012830
DR   BioSample; SAMN00808172
DR   Coriell; GM02931
DR   Wikidata; Q54837754
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Pro358Leu (c.1073C>T); ClinVar=VCV000631771; Zygosity=Homozygous (Coriell=GM02931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM02932
AC   CVCL_U705
SY   GM2932; GM 2932; HG46
DR   CLO; CLO_0012829
DR   BioSample; SAMN00808173
DR   Coriell; GM02932
DR   GEO; GSM476013
DR   GEO; GSM1316979
DR   GEO; GSM1317017
DR   Wikidata; Q54837755
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=436333;
RX   PubMed=908169;
RX   PubMed=17407155;
RX   PubMed=19966276;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155; Coriell=GM02932).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 3(HoCo) (BSR3).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U702 ! GM00811
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 21
//
ID   GM02935
AC   CVCL_JX70
DR   CLO; CLO_0012828
DR   BioSample; SAMN00808174
DR   Coriell; GM02935
DR   Wikidata; Q54837756
RX   CelloPub=CLPUB00447;
CC   Population: Arab.
CC   Derived from site: In situ; Labioscrotal fold, skin; UBERON=UBERON_8480029.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98699; 5 alpha steroid reductase 2 deficiency
DI   ORDO; Orphanet_753; 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   GM02936
AC   CVCL_7368
SY   GM02936A; GM2936A; GM02936B; GM2936B; GM17064
DR   CLO; CLO_0012822
DR   CLO; CLO_0014568
DR   BioSample; SAMN00808175
DR   Coriell; GM02936
DR   Coriell; GM17064
DR   Wikidata; Q54837761
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM02937
AC   CVCL_7369
SY   GM02937A; GM2937A
DR   CLO; CLO_0012823
DR   BioSample; SAMN00808176
DR   Coriell; GM02937
DR   Wikidata; Q54837762
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=21490598;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM02938
AC   CVCL_U507
SY   GM 2938; GM02938A; GM 2938A; GM2938A; GM2938C; GM02938D
DR   CLO; CLO_0012819
DR   Coriell; GM02938
DR   Wikidata; Q54837763
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   PubMed=2445735;
RX   PubMed=6223188;
RX   PubMed=7176709;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM02938; probable.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM02944
AC   CVCL_X274
SY   GM 2944; GM02944A
DR   CLO; CLO_0012533
DR   BioSample; SAMN00808177
DR   Coriell; GM02944
DR   Wikidata; Q54837765
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM02946
AC   CVCL_X097
SY   GM-2946; GM 2946
DR   CLO; CLO_0012535
DR   BioSample; SAMN00808178
DR   Coriell; GM02946
DR   Wikidata; Q54837766
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,rec(1)dup(q)ins(1)(pter->p22::q32->q31::p22->qter)pat (Coriell=GM02946).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02948
AC   CVCL_X275
SY   GM 2948; GM02948A
DR   CLO; CLO_0012531
DR   BioSample; SAMN00808179
DR   Coriell; GM02948
DR   GEO; GSM799
DR   Wikidata; Q54837767
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=11687795;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM02948; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM02956
AC   CVCL_GS17
SY   GM02956A; GM2956A
DR   CLO; CLO_0012532
DR   BioSample; SAMN00808180
DR   Coriell; GM02956
DR   Wikidata; Q54837768
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS18 ! GM03027
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM02957
AC   CVCL_X098
SY   GM 2957
DR   CLO; CLO_0012529
DR   BioSample; SAMN00808181
DR   Coriell; GM02957
DR   Wikidata; Q54837769
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(6)(pter->p23::q21->p23::q21->qter) (Coriell=GM02957).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02958
AC   CVCL_IN48
DR   CLO; CLO_0012530
DR   BioSample; SAMN00808182
DR   Coriell; GM02958
DR   Wikidata; Q54837770
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM02962
AC   CVCL_DD73
SY   GM 2962; GM2962; IMR-2962
DR   CLO; CLO_0012527
DR   BioSample; SAMN00808183
DR   Coriell; GM02962
DR   Wikidata; Q54837771
RX   CelloPub=CLPUB00447;
RX   PubMed=6689020;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02963
AC   CVCL_1R77
DR   CLO; CLO_0012528
DR   BioSample; SAMN00808184
DR   Coriell; GM02963
DR   Wikidata; Q54837772
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: African American.
CC   Karyotypic information: 46,XY,t(3;17)(p21;q25).arr(1-22)x2,(XY)x1 (Coriell=GM02963).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM02964
AC   CVCL_L755
SY   GM 2964; GM2964; GM02964A
DR   CLO; CLO_0012545
DR   BioSample; SAMN00808185
DR   Coriell; GM02964
DR   Wikidata; Q54837773
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
RX   PubMed=7664335;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L756 ! GM02965
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 16
//
ID   GM02965
AC   CVCL_L756
SY   GM 2965; GM2965
DR   CLO; CLO_0012544
DR   BioSample; SAMN00808186
DR   Coriell; GM02965
DR   Wikidata; Q54837775
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
RX   PubMed=7301938;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L755 ! GM02964
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   GM02968
AC   CVCL_U389
SY   GM2968; GM02968A
DR   CLO; CLO_0012515
DR   BioSample; SAMN00808187
DR   Coriell; GM02968
DR   Wikidata; Q54837776
RX   CelloPub=CLPUB00447;
RX   PubMed=3375249;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM02968).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1421+1G>C (IVS12+1G>C); ClinVar=VCV000003890; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=3375249).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   GM02971
AC   CVCL_5M81
SY   GM2971; AG02971; AG2971
DR   CLO; CLO_0012511
DR   BioSample; SAMN00808188
DR   Coriell; AG02971
DR   Coriell; GM02971
DR   Wikidata; Q54837777
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;13)(p22jq12) (PubMed=10377420).
CC   Discontinued: Coriell; AG02971; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM02972
AC   CVCL_DA22
DR   CLO; CLO_0012512
DR   BioSample; SAMN00808189
DR   Coriell; GM02972
DR   Wikidata; Q54837778
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126877; Epidermodysplasia verruciformis
DI   ORDO; Orphanet_302; Epidermodysplasia verruciformis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DA23 ! GM02973
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02973
AC   CVCL_DA23
DR   CLO; CLO_0012513
DR   BioSample; SAMN00808190
DR   Coriell; GM02973
DR   Wikidata; Q54837780
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126877; Epidermodysplasia verruciformis
DI   ORDO; Orphanet_302; Epidermodysplasia verruciformis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DA22 ! GM02972
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02975
AC   CVCL_AK25
DR   CLO; CLO_0012514
DR   BioSample; SAMN00808191
DR   Coriell; GM02975
DR   Wikidata; Q54837781
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 9
//
ID   GM02976
AC   CVCL_AK26
DR   CLO; CLO_0012507
DR   BioSample; SAMN00808192
DR   Coriell; GM02976
DR   Wikidata; Q54837782
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 9
//
ID   GM02977
AC   CVCL_AK27
SY   C24
DR   CLO; CLO_0012508
DR   BioSample; SAMN00808193
DR   Coriell; GM02977
DR   Wikidata; Q54837784
RX   CelloPub=CLPUB00447;
RX   PubMed=1214005;
CC   Population: Caucasian.
CC   Doubling time: 26.3 +- 1.7 hours (PubMed=1214005).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 9
//
ID   GM02979
AC   CVCL_CZ08
DR   CLO; CLO_0012509
DR   BioSample; SAMN00808194
DR   Coriell; GM02979
DR   Wikidata; Q54837785
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 10
//
ID   GM02980
AC   CVCL_X099
SY   GM 2980
DR   CLO; CLO_0012510
DR   BioSample; SAMN00808195
DR   Coriell; GM02980
DR   Wikidata; Q54837786
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(18)(pter>q21) (Coriell=GM02980).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM02984
AC   CVCL_DA24
DR   CLO; CLO_0012524
DR   BioSample; SAMN00808196
DR   Coriell; GM02984
DR   Wikidata; Q54837787
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; French.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126877; Epidermodysplasia verruciformis
DI   ORDO; Orphanet_302; Epidermodysplasia verruciformis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM02987
AC   CVCL_7370
SY   GM2987; GM 2987; GM 2,987; GM2987A; GM02987C
DR   CLO; CLO_0012588
DR   BioSample; SAMN00808197
DR   Coriell; GM02987
DR   Wikidata; Q54837789
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2445735;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=6773986;
RX   PubMed=6782112;
RX   PubMed=7847674;
RX   PubMed=8823375;
RX   PubMed=9804340;
CC   Population: Caucasian.
CC   Doubling time: Slow growth (Coriell=GM02987).
CC   Karyotypic information: 46,XY [43]; 46,XY,t(7;9)(7pter->7q36::9q12->9qter;9pter->9q12::7q36->qter) [7] (Coriell=GM02987).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM03003
AC   CVCL_4D82
DR   CLO; CLO_0012557
DR   BioSample; SAMN00808207
DR   Coriell; GM03003
DR   Wikidata; Q54837801
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(14) (Coriell=GM03003).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C185638; Ring chromosome 14 syndrome
DI   ORDO; Orphanet_1440; Ring chromosome 14 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03005
AC   CVCL_1N61
SY   GM3005
DR   CLO; CLO_0012558
DR   BioSample; SAMN00808208
DR   Coriell; GM03005
DR   Wikidata; Q54837803
RX   CelloPub=CLPUB00447;
RX   PubMed=2714795;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(11;16)(11pter->11q13::16p11->16pter;16qter->16p11::11q13->11qter) (Coriell=GM03005).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM03010
AC   CVCL_4Z93
DR   CLO; CLO_0012559
DR   Coriell; GM03010
DR   Wikidata; Q54837804
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM03013
AC   CVCL_X100
SY   GM 3013
DR   CLO; CLO_0012548
DR   BioSample; SAMN00808209
DR   Coriell; GM03013
DR   Wikidata; Q54837805
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03015
AC   CVCL_GT47
DR   CLO; CLO_0012551
DR   BioSample; SAMN00808210
DR   Coriell; GM03015
DR   Wikidata; Q54837808
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM03017
AC   CVCL_A2PG
SY   GM3017
DR   Coriell; GM03017
DR   Wikidata; Q105506949
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00600;
CC   Discontinued: Coriell; GM03017; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   GM03022
AC   CVCL_F128
AS   CVCL_JB59
SY   AG03022; AG3022
DR   CLO; CLO_0012553
DR   BioSample; SAMN00808211
DR   Coriell; AG03022
DR   Coriell; GM03022
DR   Wikidata; Q54837810
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Coriell; AG03022; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F129 ! GM01142
SX   Female
AG   2Y3M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 17
//
ID   GM03027
AC   CVCL_GS18
SY   GM3027
DR   CLO; CLO_0012554
DR   BioSample; SAMN00808212
DR   Coriell; GM03027
DR   Wikidata; Q54837821
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS17 ! GM02956
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM03029
AC   CVCL_D866
DR   CLO; CLO_0012555
DR   BioSample; SAMN00808213
DR   Coriell; GM03029
DR   Wikidata; Q54837822
RX   CelloPub=CLPUB00447;
CC   Population: African; !Kung.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Thr233Ile (c.698C>T); ClinVar=VCV000001980; Zygosity=Homozygous (Coriell=GM03029).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D865 ! GM03043
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   GM03030
AC   CVCL_F605
SY   GM3030
DR   CLO; CLO_0012556
DR   BioSample; SAMN00808214
DR   Coriell; GM03030
DR   Wikidata; Q54837823
RX   CelloPub=CLPUB00447;
RX   PubMed=3021482;
RX   PubMed=23665875;
CC   Population: Caucasian; Sardinian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM03031
AC   CVCL_4Z82
DR   CLO; CLO_0012620
DR   BioSample; SAMN00808215
DR   Coriell; GM03031
DR   Wikidata; Q54837824
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM03033
AC   CVCL_4Z83
DR   CLO; CLO_0012619
DR   BioSample; SAMN00808216
DR   Coriell; GM03033
DR   Wikidata; Q54837825
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM03034
AC   CVCL_X428
SY   GM3034
DR   CLO; CLO_0012618
DR   BioSample; SAMN00808217
DR   Coriell; GM03034
DR   Wikidata; Q54837827
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM03035
AC   CVCL_X429
DR   CLO; CLO_0012617
DR   BioSample; SAMN00808218
DR   Coriell; GM03035
DR   Wikidata; Q54837828
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian; Sardinian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 12
//
ID   GM03037
AC   CVCL_M934
SY   GM17082
DR   CLO; CLO_0012630
DR   CLO; CLO_0014481
DR   BioSample; SAMN00808219
DR   Coriell; GM03037
DR   Coriell; GM17082
DR   Wikidata; Q54837829
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Southeast Asian; Vietnamese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M935 ! GM03038
SX   Male
AG   23FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM03038
AC   CVCL_M935
DR   CLO; CLO_0012628
DR   BioSample; SAMN00808220
DR   Coriell; GM03038
DR   Wikidata; Q54837830
RX   CelloPub=CLPUB00447;
CC   Population: Southeast Asian; Vietnamese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M934 ! GM03037
SX   Male
AG   23FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM03039
AC   CVCL_X276
SY   GM 3039
DR   CLO; CLO_0012626
DR   BioSample; SAMN00808221
DR   Coriell; GM03039
DR   Wikidata; Q54837831
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,rec(3)(qter->p25::q21->qter)pat (Coriell=GM03039).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM03040
AC   CVCL_4N35
SY   GM03040B
DR   CLO; CLO_0012624
DR   BioSample; SAMN00808222
DR   Coriell; GM03040
DR   Wikidata; Q54837832
RX   CelloPub=CLPUB00447;
RX   PubMed=29308438;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Gly219del (c.651TGG[1]) (c.654_656delTGG) (G197del, c.652delGGT); ClinVar=VCV000226329; Zygosity=Homozygous (PubMed=29308438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM03043
AC   CVCL_D865
SY   GM-3043; GM 3043; GM17345
DR   CLO; CLO_0012623
DR   CLO; CLO_0013738
DR   BioSample; SAMN00808223
DR   Coriell; GM03043
DR   Coriell; GM17345
DR   Wikidata; Q54837833
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Part of: Human variation panel.
CC   Population: African; !Kung.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Thr233Ile (c.698C>T); ClinVar=VCV000001980; Zygosity=Homozygous (Coriell=GM03043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D866 ! GM03029
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   GM03044
AC   CVCL_7371
DR   CLO; CLO_0012622
DR   BioSample; SAMN00808224
DR   Coriell; GM03044
DR   Wikidata; Q54837834
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XY,der(13;14)(13qter->13q10::14q10->14qter) (Coriell=GM03044).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85071; Smith-Lemli-Opitz syndrome
DI   ORDO; Orphanet_818; Smith-Lemli-Opitz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM03045
AC   CVCL_2Z48
SY   GM 3045; GM3045
DR   CLO; CLO_0013507
DR   Coriell; GM03045
DR   Wikidata; Q54837835
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of GM03046 (Cellosaurus=CVCL_2Z49).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM03046
AC   CVCL_2Z49
SY   GM03046A; GM3046A
DR   CLO; CLO_0013508
DR   Coriell; GM03046
DR   Wikidata; Q54837836
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of GM03045 (Cellosaurus=CVCL_2Z48).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM03047
AC   CVCL_X101
SY   GM 3047
DR   CLO; CLO_0013502
DR   BioSample; SAMN00808225
DR   Coriell; GM03047
DR   Wikidata; Q54837837
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03051
AC   CVCL_4N36
SY   GM3051
DR   CLO; CLO_0013501
DR   BioSample; SAMN00808226
DR   Coriell; GM03051
DR   Wikidata; Q54837838
RX   CelloPub=CLPUB00447;
RX   PubMed=3375249;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1421+1G>C (IVS12+1G>C); ClinVar=VCV000003890; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=3375249).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM03052
AC   CVCL_4N37
SY   GM3052
DR   CLO; CLO_0013500
DR   BioSample; SAMN00808227
DR   Coriell; GM03052
DR   Wikidata; Q54837839
RX   CelloPub=CLPUB00447;
RX   PubMed=3375249;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM03052).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM03056
AC   CVCL_U519
SY   GM3056
DR   CLO; CLO_0013504
DR   BioSample; SAMN00808231
DR   Coriell; GM03056
DR   Wikidata; Q54837844
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=7174798;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U516 ! GM01679
OI   CVCL_U518 ! GM01685
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM03064
AC   CVCL_4N38
DR   CLO; CLO_0013503
DR   BioSample; SAMN00808232
DR   Coriell; GM03064
DR   Wikidata; Q54837845
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Gly219del (c.651TGG[1]) (c.654_656delTGG) (G197del, c.652delGGT); ClinVar=VCV000226329; Zygosity=Heterozygous (from familial inference of GM03040).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM03065
AC   CVCL_4N39
DR   CLO; CLO_0013476
DR   BioSample; SAMN00808233
DR   Coriell; GM03065
DR   Wikidata; Q54837847
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Gly219del (c.651TGG[1]) (c.654_656delTGG) (G197del, c.652delGGT); ClinVar=VCV000226329; Zygosity=Heterozygous (from familial inference of GM03040).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM03066
AC   CVCL_9Q93
SY   GM03066C
DR   CLO; CLO_0013477
DR   BioSample; SAMN00808234
DR   Coriell; GM03066
DR   Wikidata; Q54837848
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Thr284Leufs*5 (c.850delA) (1012delA); ClinVar=VCV000038434; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Cys528Valfs*19 (c.1581delC) (1744delC); ClinVar=VCV000038414; Zygosity=Heterozygous (PubMed=16465621).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM03070
AC   CVCL_EF92
DR   CLO; CLO_0013478
DR   BioSample; SAMN00808235
DR   Coriell; GM03070
DR   Wikidata; Q54837849
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128190; Congenital sucrase-isomaltase deficiency
DI   ORDO; Orphanet_35122; Congenital sucrase-isomaltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03071
AC   CVCL_M936
DR   CLO; CLO_0013465
DR   BioSample; SAMN00808236
DR   Coriell; GM03071
DR   GEO; GSM1266989
DR   Wikidata; Q54837850
RX   CelloPub=CLPUB00447;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157504; Myopathy due to myoadenylate deaminase deficiency
DI   ORDO; Orphanet_45; Adenosine monophosphate deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M937 ! GM03072
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   GM03072
AC   CVCL_M937
DR   CLO; CLO_0013464
DR   BioSample; SAMN00808237
DR   Coriell; GM03072
DR   Wikidata; Q54837851
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C157504; Myopathy due to myoadenylate deaminase deficiency
DI   ORDO; Orphanet_45; Adenosine monophosphate deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M936 ! GM03071
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM03073
AC   CVCL_CW72
DR   CLO; CLO_0013469
DR   BioSample; SAMN00808238
DR   Coriell; GM03073
DR   GEO; GSM1257701
DR   GEO; GSM1266988
DR   GEO; GSM1267065
DR   GEO; GSM1288447
DR   Wikidata; Q54837853
RX   CelloPub=CLPUB00447;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW73 ! GM03074
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   GM03074
AC   CVCL_CW73
DR   CLO; CLO_0013468
DR   BioSample; SAMN00808239
DR   Coriell; GM03074
DR   Wikidata; Q54837854
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW72 ! GM03073
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM03075
AC   CVCL_CW74
DR   CLO; CLO_0013461
DR   BioSample; SAMN00808240
DR   Coriell; GM03075
DR   GEO; GSM1257702
DR   GEO; GSM1266987
DR   GEO; GSM1267064
DR   GEO; GSM1288448
DR   Wikidata; Q54837856
RX   CelloPub=CLPUB00447;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW75 ! GM03076
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   GM03076
AC   CVCL_CW75
DR   CLO; CLO_0013459
DR   BioSample; SAMN00808241
DR   Coriell; GM03076
DR   Wikidata; Q54837857
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW74 ! GM03075
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM03080
AC   CVCL_1F11
DR   CLO; CLO_0013462
DR   BioSample; SAMN00808242
DR   Coriell; GM03080
DR   Wikidata; Q54837859
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM03081
AC   CVCL_UR78
SY   GM03081A
DR   Coriell; GM03081
DR   Wikidata; Q93582195
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM03081; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03083
AC   CVCL_1F12
DR   CLO; CLO_0013497
DR   BioSample; SAMN00808243
DR   Coriell; GM03083
DR   Wikidata; Q54837860
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM03084
AC   CVCL_X277
SY   GM 3084; GM03084A
DR   Coriell; GM03084
DR   Wikidata; Q54837861
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Discontinued: Coriell; GM03084; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM03085
AC   CVCL_X278
SY   GM 3085
DR   CLO; CLO_0013498
DR   BioSample; SAMN00808244
DR   Coriell; GM03085
DR   Wikidata; Q54837862
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian; French Canadian.
CC   Karyotypic information: 46,XY,rec(3)(qter->p25::q21->qter)pat (Coriell=GM03085).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM03089
AC   CVCL_X279
SY   GM 3089
DR   CLO; CLO_0013495
DR   BioSample; SAMN00808245
DR   Coriell; GM03089
DR   Wikidata; Q54837863
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Puerto Rican.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03090
AC   CVCL_H187
DR   CLO; CLO_0013496
DR   BioSample; SAMN00808246
DR   Coriell; GM03090
DR   Wikidata; Q54837864
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM03090; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   GM03091
AC   CVCL_H188
DR   CLO; CLO_0013487
DR   BioSample; SAMN00808247
DR   Coriell; GM03091
DR   Wikidata; Q54837865
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XXY (Coriell=GM03091).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H189 ! GM03102
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM03093
AC   CVCL_UH44
SY   GM 3093; GM3093
DR   CLO; CLO_0013486
DR   BioSample; SAMN00808248
DR   Coriell; GM03093
DR   Wikidata; Q93582268
RX   CelloPub=CLPUB00447;
RX   PubMed=5032527;
RX   PubMed=7299037;
CC   Population: Caucasian.
CC   Donor information: Established from a patient suffering from an unknown defect in the pyruvate dehydrogenase complex.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 9
//
ID   GM03094
AC   CVCL_UT87
DR   Coriell; GM03094
DR   Wikidata; Q93582273
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03094; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03100
AC   CVCL_H190
SY   GM03100A
DR   CLO; CLO_0013480
DR   BioSample; SAMN00808249
DR   Coriell; GM03100
DR   Wikidata; Q54837866
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(9;17)(9qter->9p22::17p11->17pter;17qter->17p11::9p22->9pter)mat (Coriell=GM03100).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM03102
AC   CVCL_H189
DR   CLO; CLO_0013479
DR   BioSample; SAMN00808250
DR   Coriell; GM03102
DR   Wikidata; Q54837874
RX   CelloPub=CLPUB00447;
RX   PubMed=33333453;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XXY (Coriell=GM03102).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H188 ! GM03091
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM03111
AC   CVCL_7373
DR   CLO; CLO_0013553
DR   BioSample; SAMN00808252
DR   Coriell; GM03111
DR   Wikidata; Q54837875
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Gln298Gln (c.894G>A); ClinVar=VCV000203361; Zygosity=Heterozygous; Note=Affects splicing (Coriell=GM03111).
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Ser323Leufs*44 (c.967_968delAG); Zygosity=Heterozygous (Coriell=GM03111).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GM03112
AC   CVCL_L776
SY   GM03112F; GM03112G
DR   CLO; CLO_0013554
DR   BioSample; SAMN00808253
DR   Coriell; GM03112
DR   Wikidata; Q54837876
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu730Lysfs*7 (c.2188delTinsAAA) (2352delTinsAAA); ClinVar=VCV000038418; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   GM03115
AC   CVCL_V745
SY   GM-3115
DR   Coriell; GM03115
DR   Wikidata; Q54837877
RX   PubMed=477417;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM03115; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F064 ! GM03116
OI   CVCL_F065 ! GM03117
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   GM03116
AC   CVCL_F064
SY   GM-3116; GM03116A
DR   CLO; CLO_0013556
DR   BioSample; SAMN00808254
DR   Coriell; GM03116
DR   Wikidata; Q54837878
RX   CelloPub=CLPUB00447;
RX   PubMed=477417;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V745 ! GM03115
OI   CVCL_F065 ! GM03117
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM03117
AC   CVCL_F065
SY   GM-3117
DR   CLO; CLO_0013559
DR   BioSample; SAMN00808255
DR   Coriell; GM03117
DR   Wikidata; Q54837879
RX   CelloPub=CLPUB00447;
RX   PubMed=477417;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V745 ! GM03115
OI   CVCL_F064 ! GM03116
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM03118
AC   CVCL_JE49
SY   GM03118A
DR   CLO; CLO_0013561
DR   Coriell; GM03118
DR   Wikidata; Q54837880
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 9
//
ID   GM03119
AC   CVCL_2S86
DR   CLO; CLO_0013584
DR   BioSample; SAMN00808256
DR   Coriell; GM03119
DR   Wikidata; Q54837881
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(9;17)(9qter->9p22::17p11->17pter;17qter->17p11::9p22->9pter) (Coriell=GM03119).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03120
AC   CVCL_X054
SY   GM 3120
DR   CLO; CLO_0013583
DR   Coriell; GM03120
DR   Wikidata; Q54837882
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
CC   Karyotypic information: 45,X,-Y,inv(9)(p11;q13) [13]; 46,XY,inv(9)(p11;q13) [7] (Coriell=GM03120).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X055 ! GM03121
OI   CVCL_X056 ! GM03122
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM03121
AC   CVCL_X055
DR   Coriell; GM03121
DR   Wikidata; Q54837883
CC   Discontinued: Coriell; GM03121; probable.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X054 ! GM03120
OI   CVCL_X056 ! GM03122
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   GM03122
AC   CVCL_X056
DR   Coriell; GM03122
DR   Wikidata; Q54837884
CC   Discontinued: Coriell; GM03122; probable.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X054 ! GM03120
OI   CVCL_X055 ! GM03121
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   GM03123
AC   CVCL_7374
SY   GM3123; GM03123*A
DR   CLO; CLO_0003529
DR   CLO; CLO_0013588
DR   CLDB; cl1496
DR   BioSample; SAMN00808257
DR   Coriell; GM03123
DR   Wikidata; Q54837885
RX   CelloPub=CLPUB00447;
RX   PubMed=29631617;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (Coriell=GM03123).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM03123).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7375 ! GM03124
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM03124
AC   CVCL_7375
DR   CLO; CLO_0013587
DR   BioSample; SAMN00808258
DR   Coriell; GM03124
DR   Wikidata; Q54837886
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (Coriell=GM03124).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM03124).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM03125
AC   CVCL_5R36
DR   CLO; CLO_0013586
DR   BioSample; SAMN00808259
DR   Coriell; GM03125
DR   Wikidata; Q54837887
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(2)(pter->q23::q32.2->qter) (Coriell=GM03125).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM03126
AC   CVCL_X102
SY   GM 3126
DR   CLO; CLO_0013585
DR   BioSample; SAMN00808260
DR   Coriell; GM03126
DR   Wikidata; Q54837888
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 46,XX,der(1)(pter->p13.1::q21.1->p13.1::q21.1->q42.3) (Coriell=GM03126).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM03127
AC   CVCL_X643
SY   GM3127
DR   CLO; CLO_0013577
DR   Coriell; GM03127
DR   Wikidata; Q54837889
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118635; Pseudoachondroplasia
DI   ORDO; Orphanet_750; Pseudoachondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM03128
AC   CVCL_X061
SY   GM 3128
DR   CLO; CLO_0013579
DR   BioSample; SAMN00808261
DR   Coriell; GM03128
DR   Wikidata; Q54837890
RX   CelloPub=CLPUB00447;
RX   PubMed=6451249;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118437; Glycogen storage disease type VII
DI   ORDO; Orphanet_371; Glycogen storage disease due to muscle phosphofructokinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM03129
AC   CVCL_JM08
DR   CLO; CLO_0013573
DR   BioSample; SAMN00808262
DR   Coriell; GM03129
DR   Wikidata; Q54837891
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133885; Anetoderma
DI   ORDO; Orphanet_228272; Primary anetoderma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM09 ! GM03130
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   GM03130
AC   CVCL_JM09
DR   CLO; CLO_0013575
DR   BioSample; SAMN00808263
DR   Coriell; GM03130
DR   Wikidata; Q54837892
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133885; Anetoderma
DI   ORDO; Orphanet_228272; Primary anetoderma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM08 ! GM03129
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   GM03131
AC   CVCL_EG04
SY   GM3131
DR   CLO; CLO_0013526
DR   Coriell; GM03131
DR   Wikidata; Q54837893
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84907; Multiple acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26791; Multiple acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03132
AC   CVCL_7376
DR   CLO; CLO_0013528
DR   BioSample; SAMN00808264
DR   Coriell; GM03132
DR   Wikidata; Q54837894
RX   CelloPub=CLPUB00447;
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM03132).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GM03133
AC   CVCL_UT32
DR   Coriell; GM03133
DR   Wikidata; Q93582541
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM03133; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03134
AC   CVCL_X103
SY   GM-3134; GM 3134
DR   CLO; CLO_0013527
DR   BioSample; SAMN00808265
DR   Coriell; GM03134
DR   GEO; GSM800
DR   Wikidata; Q54837895
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM03136
AC   CVCL_GS60
SY   GM 3136
DR   CLO; CLO_0013522
DR   BioSample; SAMN00808266
DR   Coriell; GM03136
DR   Wikidata; Q54837896
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Population: Jewish; Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Leu107Pro (c.320T>C); ClinVar=VCV000001965; Zygosity=Heterozygous (PubMed=1346349).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM03137
AC   CVCL_GS61
SY   GM 3137
DR   CLO; CLO_0013521
DR   Coriell; GM03137
DR   Wikidata; Q54837897
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Karyotypic information: 46,XX,t(1;12)(1qter->1p36::12q15->12qter;12pter->12q15::1p36->1pter) [24]; 46,XX [26] (Coriell=GM03137).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM03138
AC   CVCL_DD74
DR   CLO; CLO_0013524
DR   BioSample; SAMN00808267
DR   Coriell; GM03138
DR   Wikidata; Q54837898
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03158
AC   CVCL_F0WT
SY   GM3158
DR   Coriell; GM03158
RX   PubMed=6808075;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of human origin but found to be from marmoset and most probably derived from B95-8 (PubMed=6808075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03158; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
HI   CVCL_1953 ! B95-8
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM03164
AC   CVCL_4N40
SY   AS; GM3164; GM03164B
DR   CLO; CLO_0013547
DR   Coriell; GM03164
DR   Wikidata; Q54837899
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
CC   HLA typing: A*02,24; B*27; C*02 (Coriell=GM03164).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM03165
AC   CVCL_4J52
DR   CLO; CLO_0013546
DR   BioSample; SAMN00808268
DR   Coriell; GM03165
DR   Wikidata; Q54837900
RX   CelloPub=CLPUB00447;
RX   PubMed=7803800;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM03171
AC   CVCL_4J53
DR   CLO; CLO_0013545
DR   BioSample; SAMN00808269
DR   Coriell; GM03171
DR   Wikidata; Q54837901
RX   CelloPub=CLPUB00447;
RX   PubMed=7803800;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM03172
AC   CVCL_N004
SY   GM17372
DR   CLO; CLO_0013544
DR   CLO; CLO_0013697
DR   BioSample; SAMN00808270
DR   Coriell; GM03172
DR   Coriell; GM17372
DR   Wikidata; Q54837902
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Unspecified (Coriell=GM03172).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   GM03173
AC   CVCL_4J54
DR   CLO; CLO_0013543
DR   BioSample; SAMN00808271
DR   Coriell; GM03173
DR   Wikidata; Q54837903
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (Coriell=GM03173).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM03174
AC   CVCL_4J55
DR   CLO; CLO_0013542
DR   BioSample; SAMN00808272
DR   Coriell; GM03174
DR   Wikidata; Q54837904
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Unspecified (Coriell=GM03174).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM03175
AC   CVCL_4J56
DR   CLO; CLO_0013541
DR   BioSample; SAMN00808273
DR   Coriell; GM03175
DR   Wikidata; Q54837905
RX   CelloPub=CLPUB00447;
RX   PubMed=7803800;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser188Phe (c.653C>T); ClinVar=VCV000100057; Zygosity=Hemizygous (PubMed=7803800).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM03177
AC   CVCL_L465
DR   CLO; CLO_0013540
DR   BioSample; SAMN00808275
DR   Coriell; GM03177
DR   Wikidata; Q54837907
RX   CelloPub=CLPUB00447;
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   GM03180
AC   CVCL_4D20
SY   GM03180A
DR   CLO; CLO_0013419
DR   BioSample; SAMN00808278
DR   Coriell; GM03180
DR   Wikidata; Q54837910
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM03181
AC   CVCL_W663
SY   GM03181A
DR   CLO; CLO_0013414
DR   BioSample; SAMN00808279
DR   Coriell; GM03181
DR   Wikidata; Q54837911
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM03184
AC   CVCL_X280
SY   GM 3184
DR   CLO; CLO_0013415
DR   Coriell; GM03184
DR   Wikidata; Q54837912
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM03191
AC   CVCL_EJ32
DR   CLO; CLO_0013428
DR   BioSample; SAMN00808284
DR   Coriell; GM03191
DR   Wikidata; Q54837926
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM03192
AC   CVCL_EJ33
DR   CLO; CLO_0013389
DR   BioSample; SAMN00808285
DR   Coriell; GM03192
DR   Wikidata; Q54837927
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish/Scottish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM03193
AC   CVCL_AB29
DR   CLO; CLO_0013390
DR   BioSample; SAMN00808286
DR   Coriell; GM03193
DR   Wikidata; Q54837928
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Thr66Ala (c.196A>G); ClinVar=VCV000038946; Zygosity=Hemizygous (Coriell=GM03193).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM03194
AC   CVCL_AB30
DR   CLO; CLO_0013395
DR   BioSample; SAMN00808287
DR   Coriell; GM03194
DR   Wikidata; Q54837929
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Thr66Ala (c.196A>G); ClinVar=VCV000038946; Zygosity=Hemizygous (Coriell=GM03194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM03195
AC   CVCL_AB31
DR   CLO; CLO_0013397
DR   BioSample; SAMN00808288
DR   Coriell; GM03195
DR   Wikidata; Q54837930
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Thr66Ala (c.196A>G); ClinVar=VCV000038946; Zygosity=Hemizygous (Coriell=GM03195).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM03196
AC   CVCL_V819
SY   GM-3196; GM 3196; GM3196
DR   CLO; CLO_0013398
DR   BioSample; SAMN00808289
DR   Coriell; GM03196
DR   Wikidata; Q54837931
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=7438788;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(5)(pter->p13::q13->p13::q13->qter),t(17;22)(17qter->17p13::22q11->22qter;22pter->22q11::17p13->17pter) (Coriell=GM03196).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X047 ! GM03197
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM03197
AC   CVCL_X047
SY   GM-3197; GM 3197; GM3197
DR   CLO; CLO_0013399
DR   BioSample; SAMN00808290
DR   Coriell; GM03197
DR   Wikidata; Q54837932
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=7438788;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(5)(pter->p13::q13->p13::q13->qter),t(17;22)(17qter->17p13::22q11->22qter;22pter->22q11::17p13->17pter) (Coriell=GM03197).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V819 ! GM03196
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 13
//
ID   GM03200
AC   CVCL_AX76
SY   GM3200
DR   CLO; CLO_0013391
DR   BioSample; SAMN00808291
DR   Coriell; GM03200
DR   Wikidata; Q54837933
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03201
AC   CVCL_7378
SY   GM 3201
DR   CLO; CLO_0013392
DR   BioSample; SAMN00808292
DR   Coriell; GM03201
DR   Wikidata; Q54837934
RX   CelloPub=CLPUB00447;
RX   PubMed=2112341;
RX   PubMed=6451249;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM03206
AC   CVCL_9W92
DR   CLO; CLO_0013393
DR   BioSample; SAMN00808293
DR   Coriell; GM03206
DR   Wikidata; Q54837935
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98978; Meckel-Gruber syndrome
DI   ORDO; Orphanet_564; Meckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03208
AC   CVCL_4N41
DR   CLO; CLO_0013394
DR   BioSample; SAMN00808294
DR   Coriell; GM03208
DR   Wikidata; Q54837936
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123415; Autosomal recessive torsion dystonia 2
DI   ORDO; Orphanet_99657; Primary dystonia, DYT2 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM03209
AC   CVCL_HQ55
DR   CLO; CLO_0013371
DR   BioSample; SAMN00808295
DR   Coriell; GM03209
DR   Wikidata; Q54837937
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03210
AC   CVCL_HQ56
DR   CLO; CLO_0013369
DR   BioSample; SAMN00808296
DR   Coriell; GM03210
DR   Wikidata; Q54837938
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03211
AC   CVCL_1U24
DR   CLO; CLO_0013370
DR   BioSample; SAMN00808297
DR   Coriell; GM03211
DR   Wikidata; Q54837939
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM03213
AC   CVCL_HQ57
DR   CLO; CLO_0013377
DR   BioSample; SAMN00808298
DR   Coriell; GM03213
DR   Wikidata; Q54837940
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03214
AC   CVCL_HQ58
DR   CLO; CLO_0013378
DR   BioSample; SAMN00808299
DR   Coriell; GM03214
DR   Wikidata; Q54837941
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03215
AC   CVCL_HQ59
DR   CLO; CLO_0013373
DR   BioSample; SAMN00808300
DR   Coriell; GM03215
DR   Wikidata; Q54837942
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03216
AC   CVCL_HQ60
DR   CLO; CLO_0013374
DR   BioSample; SAMN00808301
DR   Coriell; GM03216
DR   Wikidata; Q54837943
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03217
AC   CVCL_HQ61
DR   CLO; CLO_0013381
DR   BioSample; SAMN00808302
DR   Coriell; GM03217
DR   Wikidata; Q54837944
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03218
AC   CVCL_4N42
DR   CLO; CLO_0013382
DR   BioSample; SAMN00808303
DR   Coriell; GM03218
DR   Wikidata; Q54837945
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123415; Autosomal recessive torsion dystonia 2
DI   ORDO; Orphanet_99657; Primary dystonia, DYT2 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03219
AC   CVCL_HQ62
DR   CLO; CLO_0013380
DR   BioSample; SAMN00808304
DR   Coriell; GM03219
DR   Wikidata; Q54837946
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   GM03220
AC   CVCL_HQ63
DR   CLO; CLO_0016478
DR   BioSample; SAMN00808305
DR   Coriell; GM03220
DR   Wikidata; Q54837947
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM03221
AC   CVCL_1U25
DR   CLO; CLO_0016474
DR   BioSample; SAMN00808306
DR   Coriell; GM03221
DR   Wikidata; Q54837948
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM03222
AC   CVCL_HQ64
DR   CLO; CLO_0016473
DR   BioSample; SAMN00808307
DR   Coriell; GM03222
DR   Wikidata; Q54837949
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34564; Idiopathic torsion dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   GM03223
AC   CVCL_CY29
DR   CLO; CLO_0016476
DR   BioSample; SAMN00808308
DR   Coriell; GM03223
DR   Wikidata; Q54837950
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03223).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY30 ! GM03224
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   GM03224
AC   CVCL_CY30
DR   CLO; CLO_0016475
DR   BioSample; SAMN00808309
DR   Coriell; GM03224
DR   Wikidata; Q54837951
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03224).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY29 ! GM03223
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM03225
AC   CVCL_X139
SY   GM 3225; GM03225A
DR   CLO; CLO_0016470
DR   BioSample; SAMN00808310
DR   Coriell; GM03225
DR   Wikidata; Q54837952
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caribbean; Trinidadian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X138 ! GM05066
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   GM03226
AC   CVCL_M938
SY   GM 3226; GM17354
DR   CLO; CLO_0013718
DR   CLO; CLO_0016469
DR   BioSample; SAMN00808311
DR   Coriell; GM03226
DR   Coriell; GM17354
DR   Wikidata; Q54837953
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Caribbean; Trinidadian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M939 ! GM05067
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM03233
AC   CVCL_4D83
DR   CLO; CLO_0016472
DR   BioSample; SAMN00808312
DR   Coriell; GM03233
DR   Wikidata; Q54837954
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM03234
AC   CVCL_9W93
SY   GM3234
DR   CLO; CLO_0016471
DR   BioSample; SAMN00808313
DR   Coriell; GM03234
DR   GEO; GSM3124682
DR   Wikidata; Q54837955
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=3863481;
RX   PubMed=30567591;
CC   Population: Native Central American; Pima.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM03235
AC   CVCL_X441
SY   GM3235
DR   CLO; CLO_0016477
DR   BioSample; SAMN00808314
DR   Coriell; GM03235
DR   Wikidata; Q54837956
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X442 ! GM03358
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 12
//
ID   GM03236
AC   CVCL_X440
SY   GM3236
DR   CLO; CLO_0016732
DR   BioSample; SAMN00808315
DR   Coriell; GM03236
DR   Wikidata; Q54837957
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X439 ! GM03360
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 12
//
ID   GM03237
AC   CVCL_F072
SY   GM3237; GM18010
DR   CLO; CLO_0016000
DR   CLO; CLO_0016730
DR   BioSample; SAMN00808316
DR   Coriell; GM03237
DR   Coriell; GM18010
DR   Wikidata; Q54837958
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X438 ! GM03361
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM03238
AC   CVCL_F074
SY   GM3238; GM03238B
DR   CLO; CLO_0016733
DR   BioSample; SAMN00808317
DR   Coriell; GM03238
DR   Wikidata; Q54837959
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F075 ! GM03362
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM03239
AC   CVCL_H145
SY   GM3239
DR   CLO; CLO_0016735
DR   BioSample; SAMN00808318
DR   Coriell; GM03239
DR   Wikidata; Q54837960
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H146 ! GM03359
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM03240
AC   CVCL_X104
SY   GM 3240
DR   CLO; CLO_0016736
DR   BioSample; SAMN00808319
DR   Coriell; GM03240
DR   Wikidata; Q54837961
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM03241
AC   CVCL_X281
SY   GM 3241; GM03241A
DR   CLO; CLO_0016738
DR   BioSample; SAMN00808320
DR   Coriell; GM03241
DR   Wikidata; Q54837962
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03242
AC   CVCL_JB91
DR   CLO; CLO_0016740
DR   Coriell; GM03242
DR   Wikidata; Q54837963
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM03245
AC   CVCL_AT03
SY   GM3245
DR   CLO; CLO_0016742
DR   BioSample; SAMN00808321
DR   Coriell; GM03245
DR   Wikidata; Q54837970
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84908; Multiple sulfatase deficiency disease
DI   ORDO; Orphanet_585; Multiple sulfatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AT04 ! GM03246
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03246
AC   CVCL_AT04
DR   CLO; CLO_0016745
DR   BioSample; SAMN00808322
DR   Coriell; GM03246
DR   Wikidata; Q54837971
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84908; Multiple sulfatase deficiency disease
DI   ORDO; Orphanet_585; Multiple sulfatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AT03 ! GM03245
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03251
AC   CVCL_9W94
DR   CLO; CLO_0016699
DR   BioSample; SAMN00808325
DR   Coriell; GM03251
DR   Wikidata; Q54837974
RX   CelloPub=CLPUB00447;
RX   PubMed=8910459;
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Trp273Leu (c.818G>T); ClinVar=VCV000000931; Zygosity=Heterozygous (Coriell=GM03251).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Trp509Cys (c.1527G>T); ClinVar=VCV000000933; Zygosity=Heterozygous (Coriell=GM03251).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84902; Mucopolysaccharidosis type IVB
DI   ORDO; Orphanet_309310; Mucopolysaccharidosis type 4B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM03252
AC   CVCL_7379
DR   CLO; CLO_0003530
DR   CLO; CLO_0016698
DR   CLDB; cl1497
DR   BioSample; SAMN00808326
DR   Coriell; GM03252
DR   Wikidata; Q54837975
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Heterozygous (PubMed=19815695).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM03255
AC   CVCL_X282
SY   GM-3255; GM 3255
DR   CLO; CLO_0016709
DR   BioSample; SAMN00808327
DR   Coriell; GM03255
DR   Wikidata; Q54837977
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=8530005;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM03256
AC   CVCL_2S87
DR   CLO; CLO_0016710
DR   BioSample; SAMN00808328
DR   Coriell; GM03256
DR   Wikidata; Q54837979
RX   CelloPub=CLPUB00447;
RX   PubMed=8530005;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03265
AC   CVCL_9Q84
SY   GM 03265; GM3265; Lowe 3265
DR   CLO; CLO_0016705
DR   BioSample; SAMN00808329
DR   Coriell; GM03265
DR   Wikidata; Q54837980
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=19700499;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with oculocerebrorenal syndrome but has a 50% risk.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84940; Oculocerebrorenal syndrome
DI   ORDO; Orphanet_534; Oculocerebrorenal syndrome of Lowe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   GM03268
AC   CVCL_X283
SY   GM 3268
DR   CLO; CLO_0016708
DR   BioSample; SAMN00808330
DR   Coriell; GM03268
DR   Wikidata; Q54837981
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM03273
AC   CVCL_X430
DR   CLO; CLO_0016717
DR   BioSample; SAMN00808331
DR   Coriell; GM03273
DR   Wikidata; Q54837982
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian; Sardinian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 13
//
ID   GM03276
AC   CVCL_X431
DR   CLO; CLO_0016718
DR   BioSample; SAMN00808332
DR   Coriell; GM03276
DR   Wikidata; Q54837983
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian; Sardinian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 13
//
ID   GM03277
AC   CVCL_X432
DR   CLO; CLO_0016713
DR   BioSample; SAMN00808333
DR   Coriell; GM03277
DR   Wikidata; Q54837984
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM03278
AC   CVCL_X433
DR   CLO; CLO_0016781
DR   BioSample; SAMN00808334
DR   Coriell; GM03278
DR   Wikidata; Q54837985
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM03280
AC   CVCL_DS10
DR   CLO; CLO_0016779
DR   BioSample; SAMN00808335
DR   Coriell; GM03280
DR   Wikidata; Q54837986
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS92 ! GM16784
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM03281
AC   CVCL_4Z84
DR   CLO; CLO_0016785
DR   BioSample; SAMN00808336
DR   Coriell; GM03281
DR   Wikidata; Q54837987
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM03283
AC   CVCL_4Z85
DR   CLO; CLO_0016782
DR   BioSample; SAMN00808337
DR   Coriell; GM03283
DR   Wikidata; Q54837988
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM03289
AC   CVCL_X434
DR   CLO; CLO_0016801
DR   BioSample; SAMN00808338
DR   Coriell; GM03289
DR   Wikidata; Q54837989
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM03291
AC   CVCL_X435
DR   CLO; CLO_0016803
DR   BioSample; SAMN00808339
DR   Coriell; GM03291
DR   Wikidata; Q54837990
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian; Sardinian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 13
//
ID   GM03295
AC   CVCL_UR83
SY   GM 3295
DR   Coriell; GM03295
DR   Wikidata; Q93583365
RX   CelloPub=CLPUB00447;
RX   PubMed=6458814;
CC   Discontinued: Coriell; GM03295; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR84 ! GM03959
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   GM03299
AC   CVCL_7380
SY   GM-3299; GM 3299; GM3299; GMO3299; GM03299B
DR   BTO; BTO_0005027
DR   CLO; CLO_0016805
DR   Coriell; GM03299
DR   GEO; GSM1116597
DR   GEO; GSM1116598
DR   GEO; GSM1116599
DR   GEO; GSM1116600
DR   Wikidata; Q54837991
RX   CelloPub=CLPUB00447;
RX   PubMed=6173245;
RX   PubMed=6330733;
RX   PubMed=6667451;
RX   PubMed=23943852;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM03300
AC   CVCL_2Z76
DR   CLO; CLO_0016808
DR   BioSample; SAMN00808340
DR   Coriell; GM03300
DR   Wikidata; Q54837992
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03303
AC   CVCL_9W95
DR   CLO; CLO_0016794
DR   Coriell; GM03303
DR   Wikidata; Q54837993
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84903; Sly syndrome
DI   ORDO; Orphanet_584; Mucopolysaccharidosis type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM03305
AC   CVCL_2S88
DR   CLO; CLO_0016797
DR   BioSample; SAMN00808341
DR   Coriell; GM03305
DR   Wikidata; Q54837994
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(5;9)(5pter->5q33::9p24->9pter;9qter->9p24::5q33->5qter) (Coriell=GM03305).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM03313
AC   CVCL_CY27
SY   AG03313; AG3313
DR   CLO; CLO_0016757
DR   BioSample; SAMN00808342
DR   Coriell; AG03313
DR   Coriell; GM03313
DR   Wikidata; Q54837995
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03313; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM03314
AC   CVCL_L948
SY   GM3314
DR   CLO; CLO_0016755
DR   BioSample; SAMN00808343
DR   Coriell; GM03314
DR   Wikidata; Q54837996
RX   CelloPub=CLPUB00447;
RX   PubMed=3374507;
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03314).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L949 ! GM03315
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   GM03315
AC   CVCL_L949
SY   GM03315A; GM3315A
DR   CLO; CLO_0016753
DR   BioSample; SAMN00808344
DR   Coriell; GM03315
DR   Wikidata; Q54837997
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03315).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L948 ! GM03314
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 20
//
ID   GM03316
AC   CVCL_M933
SY   GM 3316
DR   CLO; CLO_0016750
DR   BioSample; SAMN00808345
DR   Coriell; GM03316
DR   Wikidata; Q54837998
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M932 ! GM02859
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM03317
AC   CVCL_1R63
DR   CLO; CLO_0016748
DR   BioSample; SAMN00808346
DR   Coriell; GM03317
DR   Wikidata; Q54837999
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84643; Coffin-Lowry syndrome
DI   ORDO; Orphanet_192; Coffin-Lowry syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1R64 ! GM03318
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM03318
AC   CVCL_1R64
DR   CLO; CLO_0016774
DR   EFO; EFO_0022390
DR   BioSample; SAMN00808347
DR   Coriell; GM03318
DR   Wikidata; Q54838000
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84643; Coffin-Lowry syndrome
DI   ORDO; Orphanet_192; Coffin-Lowry syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1R63 ! GM03317
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   GM03321
AC   CVCL_N005
SY   GM17373
DR   CLO; CLO_0013698
DR   CLO; CLO_0016771
DR   BioSample; SAMN00808349
DR   Coriell; GM03321
DR   Coriell; GM17373
DR   Wikidata; Q54838001
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM03322
AC   CVCL_Y091
SY   GM3322; GM03322A
DR   CLO; CLO_0016773
DR   BioSample; SAMN00808350
DR   Coriell; GM03322
DR   Wikidata; Q54838002
RX   CelloPub=CLPUB00447;
RX   PubMed=2498246;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;11)(q22;q13) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   GM03323
AC   CVCL_F089
SY   GM17255
DR   CLO; CLO_0014395
DR   CLO; CLO_0016768
DR   BioSample; SAMN00808351
DR   Coriell; GM03323
DR   Coriell; GM17255
DR   GEO; GSM569635
DR   GEO; GSM596319
DR   GEO; GSM596678
DR   GEO; GSM924857
DR   Wikidata; Q54838003
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F088 ! GM03492
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   GM03324
AC   CVCL_F091
DR   CLO; CLO_0016575
DR   BioSample; SAMN00808352
DR   Coriell; GM03324
DR   Wikidata; Q54838004
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F090 ! GM03490
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM03325
AC   CVCL_F093
DR   CLO; CLO_0016580
DR   BioSample; SAMN00808353
DR   Coriell; GM03325
DR   Wikidata; Q54838005
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F092 ! GM03491
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM03327
AC   CVCL_EJ34
DR   CLO; CLO_0016582
DR   BioSample; SAMN00808354
DR   Coriell; GM03327
DR   Wikidata; Q54838006
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM03328
AC   CVCL_EJ35
DR   CLO; CLO_0016585
DR   BioSample; SAMN00808355
DR   Coriell; GM03328
DR   Wikidata; Q54838007
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM03329
AC   CVCL_1K55
SY   GM 3329; GM 03329
DR   CLO; CLO_0016588
DR   BioSample; SAMN00808356
DR   Coriell; GM03329
DR   Wikidata; Q54838008
RX   CelloPub=CLPUB00447;
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=10189220;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.1326+1G>A (IVS8+1G>A); ClinVar=VCV000597944; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10189220).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Met519Val (c.1555A>G); ClinVar=VCV001067893; Zygosity=Heterozygous (PubMed=10189220).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   GM03330
AC   CVCL_X284
SY   GM 3330; TRI13 fibroblast
DR   CLO; CLO_0016591
DR   BioSample; SAMN00808357
DR   Coriell; GM03330
DR   Wikidata; Q54838009
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=21949351;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 12,16
ST   D21S11: 29
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 11,14
ST   FGA: 20.2,25
ST   Penta D: 9,13
ST   Penta E: 12,17
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   GM03332
AC   CVCL_7381
SY   GM03332A
DR   CLO; CLO_0016595
DR   BioSample; SAMN00808358
DR   Coriell; GM03332
DR   GEO; GSM1116571
DR   GEO; GSM1116572
DR   GEO; GSM1116625
DR   GEO; GSM1116626
DR   GEO; GSM1116627
DR   GEO; GSM1116628
DR   Wikidata; Q54838010
RX   CelloPub=CLPUB00447;
RX   PubMed=23943852;
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=92
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2638Ter (c.7913G>A); ClinVar=VCV000141233; Zygosity=Homozygous (Coriell=GM03332).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7385 ! GM03395
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM03333
AC   CVCL_H147
SY   GM03333A
DR   CLO; CLO_0016592
DR   BioSample; SAMN00808359
DR   Coriell; GM03333
DR   Wikidata; Q54838011
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H148 ! GM03400
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM03334
AC   CVCL_F094
SY   GM03334A; GM17156
DR   CLO; CLO_0013963
DR   CLO; CLO_0016598
DR   BioSample; SAMN00808360
DR   Coriell; GM03334
DR   Coriell; GM17156
DR   GEO; GSM273423
DR   GEO; GSM569644
DR   GEO; GSM596221
DR   GEO; GSM597021
DR   GEO; GSM924666
DR   GEO; GSM1116565
DR   GEO; GSM1116566
DR   GEO; GSM1116609
DR   GEO; GSM1116610
DR   GEO; GSM1116611
DR   GEO; GSM1116612
DR   IPD-IMGT/HLA; 20692
DR   Wikidata; Q54838013
RX   CelloPub=CLPUB00447;
RX   PubMed=23943852;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:02,23:DFKR; B*18:RRG,58:02; C*06:02,07:CVAG; DRB1*15:01,15:03 (IPD-IMGT/HLA=20692).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2638Ter (c.7913G>A); ClinVar=VCV000141233; Zygosity=Heterozygous (Coriell=GM03334).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7386 ! GM03396
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   GM03336
AC   CVCL_H191
DR   CLO; CLO_0016596
DR   BioSample; SAMN00808361
DR   Coriell; GM03336
DR   Wikidata; Q54838014
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H192 ! GM03502
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM03347
AC   CVCL_N006
SY   GM17065
DR   CLO; CLO_0014571
DR   CLO; CLO_0016540
DR   BioSample; SAMN00808362
DR   Coriell; GM03347
DR   Coriell; GM17065
DR   Wikidata; Q54838015
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM03348
AC   CVCL_7382
SY   GM3348; GM-03348; GM 03348; GM 3348; GM 3348A; GM3348A; GM03348C; GM03348D; GMO3348E; C3448; IMR-3348
DR   CLO; CLO_0016536
DR   BioSample; SAMN00808363
DR   BioSample; SAMN03253068
DR   Coriell; GM03348
DR   ENCODE; ENCBS285AAA
DR   ENCODE; ENCBS558ENC
DR   ENCODE; ENCBS559ENC
DR   GEO; GSM1008563
DR   GEO; GSM1008564
DR   GEO; GSM1008568
DR   GEO; GSM2794408
DR   Wikidata; Q54838016
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   PubMed=2445735;
RX   PubMed=3745952;
RX   PubMed=6088703;
RX   PubMed=6280044;
RX   PubMed=6574472;
RX   PubMed=6667451;
RX   PubMed=6689020;
RX   PubMed=8650226;
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/FibroblGM03348_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; GM03348; probable.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   GM03349
AC   CVCL_7383
SY   GM3349; GM 3349; GM03349A; GM3349A; GM 3349A; GM03349C; GMO3349C
DR   CLO; CLO_0016537
DR   BioSample; SAMN00808364
DR   Coriell; GM03349
DR   GEO; GSM3124636
DR   Wikidata; Q54838017
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00600;
RX   CelloPub=CLPUB00720;
RX   PubMed=1634904;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=30567591;
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM03354
AC   CVCL_CZ09
SY   GM3354; GM03354A
DR   CLO; CLO_0016548
DR   BioSample; SAMN00808365
DR   Coriell; GM03354
DR   Wikidata; Q54838018
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ03 ! GM01910
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM03355
AC   CVCL_CY28
SY   GM3355
DR   Coriell; GM03355
DR   Wikidata; Q54838019
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03355; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY11 ! GM02641
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03356
AC   CVCL_F073
SY   GM03356A; GM3356A; GM18011
DR   CLO; CLO_0016016
DR   CLO; CLO_0016551
DR   BioSample; SAMN00808366
DR   Coriell; GM03356
DR   Coriell; GM18011
DR   Wikidata; Q54838020
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F076 ! GM01877
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM03358
AC   CVCL_X442
SY   GM3358
DR   CLO; CLO_0016545
DR   BioSample; SAMN00808367
DR   Coriell; GM03358
DR   Wikidata; Q54838021
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X441 ! GM03235
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM03359
AC   CVCL_H146
SY   GM3359
DR   CLO; CLO_0016559
DR   BioSample; SAMN00808368
DR   Coriell; GM03359
DR   Wikidata; Q54838022
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H145 ! GM03239
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM03360
AC   CVCL_X439
SY   GM3360
DR   CLO; CLO_0016557
DR   BioSample; SAMN00808369
DR   Coriell; GM03360
DR   Wikidata; Q54838023
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X440 ! GM03236
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM03361
AC   CVCL_X438
SY   GM3361; GM03361B
DR   Coriell; GM03361
DR   Wikidata; Q54838024
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM03361; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F072 ! GM03237
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM03362
AC   CVCL_F075
SY   GM3362
DR   CLO; CLO_0016556
DR   BioSample; SAMN00808370
DR   Coriell; GM03362
DR   Wikidata; Q54838026
RX   CelloPub=CLPUB00447;
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F074 ! GM03238
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM03365
AC   CVCL_CW76
DR   CLO; CLO_0016664
DR   BioSample; SAMN00808371
DR   Coriell; GM03365
DR   Wikidata; Q54838027
RX   CelloPub=CLPUB00447;
RX   PubMed=8896560;
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Arg1104Ter (c.3310C>T); ClinVar=VCV000003809; Zygosity=Homozygous (PubMed=8896560).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM03367
AC   CVCL_X105
SY   GM 3367
DR   CLO; CLO_0016666
DR   BioSample; SAMN00808372
DR   Coriell; GM03367
DR   Wikidata; Q54838028
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM03368
AC   CVCL_DS11
SY   GM03368-0
DR   CLO; CLO_0016669
DR   BioSample; SAMN00808373
DR   Coriell; GM03368
DR   Wikidata; Q54838029
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS12 ! GM03368-A
SX   Sex ambiguous
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM03368-A
AC   CVCL_DS12
SY   GM03368A
DR   CLO; CLO_0016671
DR   Coriell; GM03368-A
DR   Wikidata; Q54838030
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Discontinued: Coriell; GM03368-A; probable.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS11 ! GM03368
SX   Sex ambiguous
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03369
AC   CVCL_X285
SY   GM 3369
DR   CLO; CLO_0016657
DR   BioSample; SAMN00808374
DR   Coriell; GM03369
DR   Wikidata; Q54838031
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03370
AC   CVCL_2S89
DR   CLO; CLO_0016658
DR   BioSample; SAMN00808375
DR   Coriell; GM03370
DR   Wikidata; Q54838032
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;10)(1pter->1q44::10p11->10pter;10qter->10p11::1q44->1qter) (Coriell=GM03370).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM03371
AC   CVCL_X106
SY   GM 3371
DR   CLO; CLO_0016660
DR   BioSample; SAMN00808376
DR   Coriell; GM03371
DR   Wikidata; Q54838033
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 47,XX,inv(9)(pter->p11::q13->p11::q13->qter)pat,+der(22)(22pter->22q11::11q23->11qter)mat (Coriell=GM03371).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M1W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM03372
AC   CVCL_2S90
DR   CLO; CLO_0016662
DR   BioSample; SAMN00808377
DR   Coriell; GM03372
DR   Wikidata; Q54838034
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
CC   Population: African American.
CC   Karyotypic information: 46,XX,t(11;22)(11pter->11q23::22q11->22qter;22pter->22q11::11q23->11qter) (Coriell=GM03372).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03377
AC   CVCL_7384
SY   GM3377; GM 03377; GM3377A; GM03377B
DR   CLO; CLO_0016681
DR   BioSample; SAMN00808378
DR   Coriell; GM03377
DR   GEO; GSM1316980
DR   GEO; GSM1317018
DR   GEO; GSM3124648
DR   Wikidata; Q54838035
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=3863481;
RX   PubMed=7847674;
RX   PubMed=8823375;
RX   PubMed=12060391;
RX   PubMed=17668376;
RX   PubMed=26984941;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM03380
AC   CVCL_1L45
DR   CLO; CLO_0016610
DR   BioSample; SAMN00808380
DR   Coriell; GM03380
DR   Wikidata; Q54838037
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1L48 ! GM03399
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM03382
AC   CVCL_F107
AS   CVCL_7653
SY   GM17102
DR   CLO; CLO_0014896
DR   CLO; CLO_0016631
DR   BioSample; SAMN00808381
DR   Coriell; GM03382
DR   Coriell; GM17102
DR   GEO; GSM273372
DR   GEO; GSM569494
DR   GEO; GSM596170
DR   GEO; GSM596971
DR   GEO; GSM827331
DR   GEO; GSM924612
DR   IPD-IMGT/HLA; 15334
DR   Wikidata; Q54838038
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=20215515;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:02,74:AB; B*39:10,53:01; C*04:KBG,12:03 (IPD-IMGT/HLA=15334).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2638Ter (c.7913G>A); ClinVar=VCV000141233; Zygosity=Heterozygous (Coriell=GM03382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7387 ! GM03397
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   GM03383
AC   CVCL_J998
DR   CLO; CLO_0016633
DR   BioSample; SAMN00808382
DR   Coriell; GM03383
DR   Wikidata; Q54838039
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J999 ! GM03398
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM03384
AC   CVCL_F289
SY   GM17336
DR   CLO; CLO_0013610
DR   CLO; CLO_0016627
DR   BioSample; SAMN00808383
DR   Coriell; GM03384
DR   Coriell; GM17336
DR   Wikidata; Q54838040
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Middle Eastern.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM03388
AC   CVCL_1F13
DR   CLO; CLO_0016628
DR   BioSample; SAMN00808384
DR   Coriell; GM03388
DR   Wikidata; Q54838041
RX   CelloPub=CLPUB00447;
RX   PubMed=33329388;
CC   Population: Iranian; Arab.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM03390
AC   CVCL_1F14
SY   GM3390
DR   CLO; CLO_0016621
DR   BioSample; SAMN00808385
DR   Coriell; GM03390
DR   Wikidata; Q54838042
RX   CelloPub=CLPUB00447;
RX   PubMed=33329388;
CC   Population: Arab.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM03391
AC   CVCL_IN49
DR   CLO; CLO_0016624
DR   BioSample; SAMN00808386
DR   Coriell; GM03391
DR   Wikidata; Q54838043
RX   CelloPub=CLPUB00447;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:23026; GNPTG; Simple; p.Ala149Profs*13 (c.445delG); ClinVar=VCV000039080; Zygosity=Homozygous (Coriell=GM03391).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129978; Mucolipidosis type III gamma
DI   ORDO; Orphanet_423470; Mucolipidosis type III gamma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   GM03392
AC   CVCL_IN50
DR   CLO; CLO_0016617
DR   BioSample; SAMN00808387
DR   Coriell; GM03392
DR   Wikidata; Q54838044
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:23026; GNPTG; Simple; p.Ala149Profs*13 (c.445delG); ClinVar=VCV000039080; Zygosity=Homozygous (Coriell=GM03392).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129978; Mucolipidosis type III gamma
DI   ORDO; Orphanet_423470; Mucolipidosis type III gamma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   GM03393
AC   CVCL_DA25
DR   CLO; CLO_0016620
DR   BioSample; SAMN00808388
DR   Coriell; GM03393
DR   Wikidata; Q54838045
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03395
AC   CVCL_7385
SY   GM3395; GM 3395; GM03395A
DR   CLO; CLO_0016644
DR   BioSample; SAMN00808389
DR   Coriell; GM03395
DR   Wikidata; Q54838046
RX   CelloPub=CLPUB00447;
RX   PubMed=6409440;
RX   PubMed=6726265;
RX   PubMed=7104995;
RX   PubMed=11080496;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2638Ter (c.7913G>A); ClinVar=VCV000141233; Zygosity=Homozygous (Coriell=GM03395).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7381 ! GM03332
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM03396
AC   CVCL_7386
SY   GM 3396
DR   CLO; CLO_0016342
DR   BioSample; SAMN00808390
DR   Coriell; GM03396
DR   Wikidata; Q54838047
RX   CelloPub=CLPUB00447;
RX   PubMed=7104995;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2638Ter (c.7913G>A); ClinVar=VCV000141233; Zygosity=Heterozygous (Coriell=GM03396).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F094 ! GM03334
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GM03397
AC   CVCL_7387
SY   GM 3397
DR   CLO; CLO_0016340
DR   BioSample; SAMN00808391
DR   Coriell; GM03397
DR   Wikidata; Q54838048
RX   CelloPub=CLPUB00447;
RX   PubMed=7104995;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2638Ter (c.7913G>A); ClinVar=VCV000141233; Zygosity=Heterozygous (Coriell=GM03397).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F107 ! GM03382
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GM03398
AC   CVCL_J999
DR   CLO; CLO_0016338
DR   BioSample; SAMN00808392
DR   Coriell; GM03398
DR   Wikidata; Q54838049
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J998 ! GM03383
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM03399
AC   CVCL_1L48
DR   CLO; CLO_0016337
DR   BioSample; SAMN00808393
DR   Coriell; GM03399
DR   Wikidata; Q54838050
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1L45 ! GM03380
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM03400
AC   CVCL_H148
DR   CLO; CLO_0016336
DR   BioSample; SAMN00808394
DR   Coriell; GM03400
DR   Wikidata; Q54838051
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H147 ! GM03333
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM03401
AC   CVCL_0M20
DR   CLO; CLO_0016335
DR   BioSample; SAMN00808395
DR   Coriell; GM03401
DR   Wikidata; Q54838052
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM03401).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (Coriell=GM03401).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM03402
AC   CVCL_J655
SY   GM 3402; GM3402; GM03402A
DR   CLO; CLO_0016334
DR   BioSample; SAMN00808396
DR   Coriell; GM03402
DR   GEO; GSM476014
DR   GEO; GSM1316981
DR   GEO; GSM1317019
DR   Wikidata; Q54838053
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=908169;
RX   PubMed=3180052;
RX   PubMed=19966276;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (Coriell=GM03402).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 9(EmSh) (BSR9).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J656 ! GM03403
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 23
//
ID   GM03403
AC   CVCL_J656
SY   GM3403; GM03403B; GM3403B; GM03403C; GM3403C; GM03403E; GM03403F; GM 3403F; GM17361
DR   CLO; CLO_0013704
DR   CLO; CLO_0016333
DR   BioSample; SAMN00808397
DR   Coriell; GM03403
DR   Coriell; GM17361
DR   Wikidata; Q54838056
RX   CelloPub=CLPUB00447;
RX   PubMed=908169;
RX   PubMed=1900268;
RX   PubMed=2805228;
RX   PubMed=19815695;
RX   PubMed=22989712;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Doubling time: 48 hours (PubMed=1900268).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (Coriell=GM03403).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 9(EmSh) (BSR9).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J655 ! GM03402
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 27
//
ID   GM03404
AC   CVCL_2S91
DR   CLO; CLO_0016332
DR   Coriell; GM03404
DR   Wikidata; Q54838057
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,XX,t(6;12)(6pter->6q21::12p13->12pter;12qter->12p13::6q21->6qter) (Coriell=GM03404).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM03417
AC   CVCL_V470
DR   CLO; CLO_0016329
DR   BioSample; SAMN00808398
DR   Coriell; GM03417
DR   Wikidata; Q54838058
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,der(14;21)(14qter->14q10::21q10->21qter),+21 [34]; 45,XX,der(14;21)(14qter->14q10::21q10->21qter) [16] (Coriell=GM03417).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM03418
AC   CVCL_GT48
DR   CLO; CLO_0017058
DR   BioSample; SAMN00808399
DR   Coriell; GM03418
DR   Wikidata; Q54838059
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM03419
AC   CVCL_GT49
DR   CLO; CLO_0017057
DR   BioSample; SAMN00808400
DR   Coriell; GM03419
DR   Wikidata; Q54838060
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM03420
AC   CVCL_9Z61
DR   CLO; CLO_0017060
DR   BioSample; SAMN00808401
DR   Coriell; GM03420
DR   Wikidata; Q54838061
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03421
AC   CVCL_9Z62
DR   CLO; CLO_0017059
DR   BioSample; SAMN00808402
DR   Coriell; GM03421
DR   Wikidata; Q54838062
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03423
AC   CVCL_N007
SY   GM17074
DR   CLO; CLO_0014603
DR   CLO; CLO_0017062
DR   BioSample; SAMN00808403
DR   Coriell; GM03423
DR   Coriell; GM17074
DR   Wikidata; Q54838063
RX   CelloPub=CLPUB00447;
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM03429
AC   CVCL_5M82
SY   GM3429; WG0466; WG466; WG 466
DR   CLO; CLO_0017061
DR   BioSample; SAMN00808404
DR   Coriell; GM03429
DR   Wikidata; Q54838064
RX   CelloPub=CLPUB00447;
RX   PubMed=3863481;
RX   PubMed=6093571;
RX   PubMed=6773986;
RX   PubMed=23665875;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (Coriell=GM03429).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   GM03432
AC   CVCL_AY60
SY   GM3432; WG0615; WG615
DR   CLO; CLO_0017065
DR   BioSample; SAMN00808405
DR   Coriell; GM03432
DR   Wikidata; Q54838065
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Pakistani.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84612; Carbamoyl-phosphate synthetase I deficiency
DI   ORDO; Orphanet_147; Carbamoyl-phosphate synthetase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 12
//
ID   GM03433
AC   CVCL_N008
SY   GM3433; GM17012; WG0646; WG646
DR   CLO; CLO_0017064
DR   CLO; CLO_0018026
DR   BioSample; SAMN00808406
DR   Coriell; GM03433
DR   Coriell; GM17012
DR   Wikidata; Q54838066
RX   CelloPub=CLPUB00447;
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   GM03435
AC   CVCL_X286
SY   GM 3435
DR   CLO; CLO_0017049
DR   Coriell; GM03435
DR   Wikidata; Q54838067
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM03440
AC   CVCL_7388
SY   GM3440; GM-3440; GM 3440; GM03440B
DR   BTO; BTO_0005961
DR   CLO; CLO_0017047
DR   BioSample; SAMN00808407
DR   Coriell; GM03440
DR   GEO; GSM1184262
DR   GEO; GSM1184263
DR   GEO; GSM2064581
DR   GEO; GSM3124649
DR   Wikidata; Q54838068
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=7104995;
RX   PubMed=8316623;
RX   PubMed=12665480;
RX   PubMed=17668376;
RX   PubMed=21490598;
RX   PubMed=24749076;
RX   PubMed=27543334;
RX   PubMed=28444186;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM03441
AC   CVCL_U390
SY   GM 03441
DR   CLO; CLO_0017035
DR   BioSample; SAMN00808408
DR   Coriell; GM03441
DR   Wikidata; Q54838069
RX   CelloPub=CLPUB00447;
RX   PubMed=8328452;
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (Coriell=GM03441).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1421+1G>C (IVS12+1G>C); ClinVar=VCV000003890; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM03441).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   GM03442
AC   CVCL_JA44
SY   GM3442
DR   Coriell; GM03442
DR   Wikidata; Q54838070
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM03442; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
OI   CVCL_UY64 ! GM03443
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM03443
AC   CVCL_UY64
DR   Coriell; GM03443
DR   Wikidata; Q93584257
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03443; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
OI   CVCL_JA44 ! GM03442
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03444
AC   CVCL_JA45
SY   GM3444
DR   Coriell; GM03444
DR   Wikidata; Q54838071
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM03444; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM03446
AC   CVCL_JA46
SY   GM3446
DR   Coriell; GM03446
DR   Wikidata; Q54838072
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM03446; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM03448
AC   CVCL_JA47
SY   GM3448; GM03448A; GM03448B
DR   Coriell; GM03448
DR   Wikidata; Q54838073
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM03448; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM03450
AC   CVCL_JA48
SY   GM3450
DR   Coriell; GM03450
DR   Wikidata; Q54838074
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM03450; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM03452
AC   CVCL_JA49
SY   GM3452
DR   Coriell; GM03452
DR   Wikidata; Q54838075
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM03452; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM03459
AC   CVCL_W032
SY   GM 3459; GM3459
DR   CLO; CLO_0017034
DR   BioSample; SAMN00808409
DR   Coriell; GM03459
DR   Wikidata; Q54838076
RX   CelloPub=CLPUB00447;
RX   PubMed=1409720;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM03461
AC   CVCL_U391
DR   CLO; CLO_0017033
DR   BioSample; SAMN00808410
DR   Coriell; GM03461
DR   Wikidata; Q54838077
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (Coriell=GM03461).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1421+1G>C (IVS12+1G>C); ClinVar=VCV000003890; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM03461).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   GM03462
AC   CVCL_X287
SY   GM 3462
DR   CLO; CLO_0017032
DR   BioSample; SAMN00808411
DR   Coriell; GM03462
DR   Wikidata; Q54838078
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03463
AC   CVCL_2S92
DR   CLO; CLO_0017031
DR   BioSample; SAMN00808412
DR   Coriell; GM03463
DR   Wikidata; Q54838079
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(9;14)(9qter->9p22::14q13->14qter;14pter->14q13::9p22->9pter) (Coriell=GM03463).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM03465
AC   CVCL_0M21
DR   CLO; CLO_0017030
DR   BioSample; SAMN00808413
DR   Coriell; GM03465
DR   Wikidata; Q54838080
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM03465).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Coriell=GM03465).
CC   Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M22 ! GM03466
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM03466
AC   CVCL_0M22
SY   GM 3466
DR   CLO; CLO_0017029
DR   BioSample; SAMN00808414
DR   Coriell; GM03466
DR   Wikidata; Q54838081
RX   CelloPub=CLPUB00447;
RX   PubMed=2445735;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM03466).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Coriell=GM03466).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M21 ! GM03465
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM03467
AC   CVCL_L478
SY   GM 3467; GM3467
DR   CLO; CLO_0017028
DR   BioSample; SAMN00808415
DR   Coriell; GM03467
DR   Wikidata; Q54838082
RX   CelloPub=CLPUB00447;
RX   PubMed=3296189;
RX   PubMed=6087154;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex7-9del; Zygosity=Hemizygous (PubMed=3296189; PubMed=6087154).
CC   Misspelling: RJK 3467; PubMed=3296189.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   GM03468
AC   CVCL_7389
SY   GM3468; GM 3468; GM03468A; GM3468A
DR   CLO; CLO_0017027
DR   BioSample; SAMN00808416
DR   Coriell; GM03468
DR   Wikidata; Q54838083
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM03469
AC   CVCL_7390
SY   GM03469A; GM17066
DR   CLO; CLO_0014565
DR   CLO; CLO_0017026
DR   BioSample; SAMN00808417
DR   Coriell; GM03469
DR   Coriell; GM17066
DR   Wikidata; Q54838084
RX   CelloPub=CLPUB00447;
RX   PubMed=16244288;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg170His (c.509G>A); ClinVar=VCV000053983; Zygosity=Heterozygous (Coriell=GM03469).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   GM03470
AC   CVCL_F108
SY   GM 3470
DR   CLO; CLO_0017010
DR   BioSample; SAMN00808418
DR   Coriell; GM03470
DR   Wikidata; Q54838085
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F109 ! GM21877
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   GM03478
AC   CVCL_W110
DR   CLO; CLO_0017012
DR   BioSample; SAMN00808419
DR   Coriell; GM03478
DR   Wikidata; Q54838086
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 92,XXYY [12]; 46,XY [38] (Coriell=GM03478).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM03479
AC   CVCL_2Y96
DR   CLO; CLO_0017004
DR   BioSample; SAMN00808420
DR   Coriell; GM03479
DR   Wikidata; Q54838087
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM03479; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM03485
AC   CVCL_JE06
SY   AG03485; AG3485
DR   CLO; CLO_0017003
DR   BioSample; SAMN00808421
DR   Coriell; AG03485
DR   Coriell; GM03485
DR   Wikidata; Q54838088
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03485; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM03490
AC   CVCL_F090
DR   CLO; CLO_0016996
DR   BioSample; SAMN00808425
DR   Coriell; GM03490
DR   Wikidata; Q54838093
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F091 ! GM03324
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM03491
AC   CVCL_F092
DR   CLO; CLO_0017002
DR   BioSample; SAMN00808426
DR   Coriell; GM03491
DR   Wikidata; Q54838094
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F093 ! GM03325
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM03492
AC   CVCL_F088
DR   CLO; CLO_0017000
DR   BioSample; SAMN00808427
DR   Coriell; GM03492
DR   Wikidata; Q54838095
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F089 ! GM03323
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM03493
AC   CVCL_X288
SY   GM 3493
DR   CLO; CLO_0017327
DR   BioSample; SAMN00808428
DR   Coriell; GM03493
DR   Wikidata; Q54838096
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03494
AC   CVCL_2S93
SY   GM03494A
DR   CLO; CLO_0017332
DR   BioSample; SAMN00808429
DR   Coriell; GM03494
DR   Wikidata; Q54838102
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(5;6)(q35;p22) (Coriell=GM03494).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM03495
AC   CVCL_1V20
SY   GM3495
DR   Coriell; GM03495
DR   Wikidata; Q54838103
RX   PubMed=6293786;
CC   Discontinued: Coriell; GM03495; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   GM03498
AC   CVCL_F114
SY   GM 3498; GM3498; GM3498B; GM03498C; HG1431
DR   CLO; CLO_0017330
DR   BioSample; SAMN00808430
DR   Coriell; GM03498
DR   GEO; GSM1316982
DR   GEO; GSM1317020
DR   Wikidata; Q54838104
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=6648529;
RX   PubMed=6705251;
RX   PubMed=17407155;
CC   Population: Caucasian; English and Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Gly (c.3163T>G); ClinVar=VCV001728339; Zygosity=Heterozygous (PubMed=17407155).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 87(AlFra) (BSR87).
CC   Caution: Coriell has p.Cys1055fs*23 (c.3159delT) (3233delT) as the second mutation for this cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7408 ! GM04408
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   GM03501
AC   CVCL_1N77
SY   GM3501
DR   CLO; CLO_0017334
DR   BioSample; SAMN00808431
DR   Coriell; GM03501
DR   Wikidata; Q54838105
RX   CelloPub=CLPUB00447;
RX   PubMed=2535035;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM03502
AC   CVCL_H192
SY   GM 3502; GM3502
DR   CLO; CLO_0017335
DR   BioSample; SAMN00808432
DR   Coriell; GM03502
DR   Wikidata; Q54838106
RX   CelloPub=CLPUB00447;
RX   PubMed=1409720;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H191 ! GM03336
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM03503
AC   CVCL_5M83
DR   CLO; CLO_0017336
DR   BioSample; SAMN00808433
DR   Coriell; GM03503
DR   Wikidata; Q54838107
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM03509
AC   CVCL_U694
SY   GM3509; GM03509A; HG1219; HG3006
DR   Coriell; GM03509
DR   Wikidata; Q54838109
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=436333;
RX   PubMed=10655550;
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser595Ter (c.1784C>A); ClinVar=VCV000820081; Zygosity=Homozygous (from autologous cell line GM16375).
CC   Donor information: From Bloom Syndrome Registry patient 81(MaGrou) (BSR81).
CC   Discontinued: Coriell; GM03509; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7651 ! GM16375
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM03510
AC   CVCL_J658
SY   GM 3510; GM3510; HG3005; HG1251
DR   Coriell; GM03510
DR   Wikidata; Q54838110
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=908169;
CC   Donor information: From Bloom Syndrome Registry patient 47(ArSmi) (BSR47).
CC   Discontinued: Coriell; GM03510; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   GM03518
AC   CVCL_X289
SY   GM-3518; GM 3518
DR   CLO; CLO_0017339
DR   BioSample; SAMN00808434
DR   Coriell; GM03518
DR   Wikidata; Q54838111
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03519
AC   CVCL_UR75
SY   GM03519B
DR   Coriell; GM03519
DR   Wikidata; Q93584616
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM03519; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61269; Niemann-Pick disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03521
AC   CVCL_AD98
DR   CLO; CLO_0017341
DR   BioSample; SAMN00808435
DR   Coriell; GM03521
DR   Wikidata; Q54838112
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84794; Jeune syndrome
DI   ORDO; Orphanet_474; Jeune syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03522
AC   CVCL_W008
SY   GM3522
DR   CLO; CLO_0017342
DR   BioSample; SAMN00808436
DR   Coriell; GM03522
DR   Wikidata; Q54838113
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98842; Holocarboxylase synthetase deficiency
DI   ORDO; Orphanet_79242; Holocarboxylase synthetase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W009 ! GM21068
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM03523
AC   CVCL_7391
SY   GM3523
DR   CLO; CLO_0017345
DR   BioSample; SAMN00808437
DR   Coriell; GM03523
DR   GEO; GSM3124684
DR   Wikidata; Q54838114
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=15450399;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY [35]; 46,XY,t(3;11)(3pter->3q24::11p15->11pter;11qter->11p15::3q24->3qter) [15] (Coriell=GM03523).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM03524
AC   CVCL_7392
SY   GM3524
DR   CLO; CLO_0017305
DR   BioSample; SAMN00808438
DR   Coriell; GM03524
DR   GEO; GSM3124685
DR   Wikidata; Q54838115
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=7847674;
RX   PubMed=30567591;
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM03525
AC   CVCL_7393
SY   GM3525
DR   CLO; CLO_0017301
DR   BioSample; SAMN00808439
DR   Coriell; GM03525
DR   GEO; GSM3124669
DR   Wikidata; Q54838116
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM03526
AC   CVCL_A2PH
SY   GM3526
DR   Coriell; GM03526
DR   Wikidata; Q105506951
RX   CelloPub=CLPUB00387;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM03526; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   GM03527
AC   CVCL_UR71
SY   GM3527
DR   Coriell; GM03527
DR   Wikidata; Q93584649
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM03527; probable.
CC   Derived from site: In situ; Penis, skin; UBERON=UBERON_0001331.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM03528
AC   CVCL_A2PI
SY   GM3528
DR   Coriell; GM03528
DR   Wikidata; Q105506954
RX   CelloPub=CLPUB00387;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM03528; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   GM03529
AC   CVCL_7394
SY   GM3529
DR   CLO; CLO_0017300
DR   BioSample; SAMN00808440
DR   Coriell; GM03529
DR   GEO; GSM3124689
DR   Wikidata; Q54838118
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=30567591;
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM03534
AC   CVCL_UT34
DR   Coriell; GM03534
DR   Wikidata; Q93584660
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03534; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03535
AC   CVCL_9S88
DR   CLO; CLO_0017298
DR   BioSample; SAMN00808441
DR   Coriell; GM03535
DR   Wikidata; Q54838119
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM03538
AC   CVCL_X290
SY   GM 3538
DR   CLO; CLO_0017309
DR   BioSample; SAMN00808442
DR   Coriell; GM03538
DR   Wikidata; Q54838120
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+18 (Coriell=GM03538).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM03540
AC   CVCL_UT35
DR   Coriell; GM03540
DR   Wikidata; Q93584685
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03540; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03543
AC   CVCL_X291
SY   GM 3543
DR   CLO; CLO_0017306
DR   BioSample; SAMN00808444
DR   Coriell; GM03543
DR   Wikidata; Q54838122
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 12
//
ID   GM03547
AC   CVCL_UR79
DR   CLO; CLO_0017307
DR   BioSample; SAMN00808445
DR   Coriell; GM03547
DR   Wikidata; Q93584700
RX   CelloPub=CLPUB00447;
CC   Population: Arab.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120203; 17-beta-hydroxysteroid dehydrogenase 3 deficiency
DI   ORDO; Orphanet_752; 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   15Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM03549
AC   CVCL_5L47
DR   CLO; CLO_0017314
DR   BioSample; SAMN00808446
DR   Coriell; GM03549
DR   Wikidata; Q54838123
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   GM03550
AC   CVCL_V239
SY   GM3550
DR   CLO; CLO_0017317
DR   Coriell; GM03550
DR   Wikidata; Q54838124
RX   CelloPub=CLPUB00447;
RX   PubMed=15664728;
CC   Senescence: Senesces at 32 PDL (PubMed=15664728).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Southdown; VBO=VBO_0001611.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM03552
AC   CVCL_N009
SY   GM3552; GM 3552; GM03552A; GM3552A; GM17083
DR   CLO; CLO_0014480
DR   CLO; CLO_0017271
DR   BioSample; SAMN00808447
DR   Coriell; GM03552
DR   Coriell; GM17083
DR   Wikidata; Q54838125
RX   CelloPub=CLPUB00447;
RX   PubMed=2498246;
RX   PubMed=6947233;
RX   PubMed=10377420;
CC   Part of: Human variation panel.
CC   Population: Southeast Asian; Vietnamese.
CC   Karyotypic information: 46,X,t(X;11)(q26;q23) (PubMed=10377420).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM03557
AC   CVCL_8B10
DR   CLO; CLO_0017263
DR   BioSample; SAMN00808448
DR   Coriell; GM03557
DR   Wikidata; Q54838126
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.His86Tyr (c.256C>T); ClinVar=VCV000555658; Zygosity=Heterozygous (Coriell=GM03557).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM03558
AC   CVCL_8B11
DR   CLO; CLO_0017261
DR   BioSample; SAMN00808449
DR   Coriell; GM03558
DR   Wikidata; Q54838127
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Arg65Ter (c.193C>T); ClinVar=VCV000558291; Zygosity=Heterozygous (Coriell=GM03558).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM03559
AC   CVCL_X717
SY   GM 3559
DR   CLO; CLO_0017266
DR   BioSample; SAMN00808450
DR   Coriell; GM03559
DR   Wikidata; Q54838129
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM03560
AC   CVCL_F606
DR   CLO; CLO_0017265
DR   BioSample; SAMN00808451
DR   Coriell; GM03560
DR   Wikidata; Q54838130
RX   CelloPub=CLPUB00447;
RX   PubMed=1722323;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:318; AGA; Simple; c.940+1G>T (IVS8DS,G-T,+1) (c.807_940del134); ClinVar=VCV000000227; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=1722323).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61273; Aspartylglycosaminuria
DI   ORDO; Orphanet_93; Aspartylglucosaminuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM03561
AC   CVCL_AX22
DR   CLO; CLO_0017280
DR   BioSample; SAMN00808452
DR   Coriell; GM03561
DR   Wikidata; Q54838131
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[62] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous (Coriell=GM03561).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX23 ! GM03562
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM03562
AC   CVCL_AX23
DR   CLO; CLO_0017282
DR   BioSample; SAMN00808453
DR   Coriell; GM03562
DR   Wikidata; Q54838132
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[62] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous (from autologous cell line GM03561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX22 ! GM03561
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM03563
AC   CVCL_X292
SY   GM 3563
DR   CLO; CLO_0017284
DR   BioSample; SAMN00808454
DR   Coriell; GM03563
DR   GEO; GSM801
DR   Wikidata; Q54838133
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM03566
AC   CVCL_H150
SY   GM3566; D4,37; D4.37.25.24
DR   CLO; CLO_0017285
DR   Coriell; GM03566
DR   Wikidata; Q54838134
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=6768831;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   GM03568
AC   CVCL_H151
SY   GM3568; D4,69; D4,69A; D4.69A
DR   CLO; CLO_0017275
DR   Coriell; GM03568
DR   Wikidata; Q54838135
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=6768831;
CC   Monoclonal antibody isotype: IgG2c, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   GM03575
AC   CVCL_N010
SY   GM17362
DR   CLO; CLO_0013705
DR   CLO; CLO_0017232
DR   BioSample; SAMN00808455
DR   Coriell; GM03575
DR   Coriell; GM17362
DR   Wikidata; Q54838137
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (Coriell=GM03575).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM03575).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   GM03576
AC   CVCL_X293
SY   GM 3576
DR   CLO; CLO_0017254
DR   BioSample; SAMN00808456
DR   Coriell; GM03576
DR   GEO; GSM802
DR   Wikidata; Q54838138
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=11687795;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM03576; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36495; Trisomy 2
DI   NCIt; C43224; Trisomy 21
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM03577
AC   CVCL_X294
SY   GM 3577
DR   CLO; CLO_0017255
DR   BioSample; SAMN00808457
DR   Coriell; GM03577
DR   Wikidata; Q54838139
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XY,der(3)(3pter->3q29::22q11->22qter),-22 (Coriell=GM03577).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM03578
AC   CVCL_EF93
DR   CLO; CLO_0017250
DR   BioSample; SAMN00808458
DR   Coriell; GM03578
DR   Wikidata; Q54838140
RX   CelloPub=CLPUB00447;
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=19767587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM03579
AC   CVCL_N011
SY   GM17355
DR   CLO; CLO_0013720
DR   CLO; CLO_0017252
DR   BioSample; SAMN00808459
DR   Coriell; GM03579
DR   Coriell; GM17355
DR   Wikidata; Q54838141
RX   CelloPub=CLPUB00447;
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Cuban.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=MZ allele (PubMed=19767587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   GM03580
AC   CVCL_F290
SY   GM17045; GM17374
DR   CLO; CLO_0013695
DR   CLO; CLO_0014641
DR   CLO; CLO_0017207
DR   BioSample; SAMN00808460
DR   Coriell; GM03580
DR   Coriell; GM17045
DR   Coriell; GM17374
DR   Wikidata; Q54838142
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=MZ allele (Coriell=GM03580).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM03585
AC   CVCL_U392
DR   CLO; CLO_0017209
DR   BioSample; SAMN00808461
DR   Coriell; GM03585
DR   Wikidata; Q54838143
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM03585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM03586
AC   CVCL_U393
DR   CLO; CLO_0017210
DR   BioSample; SAMN00808462
DR   Coriell; GM03586
DR   Wikidata; Q54838144
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM03586).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM03589
AC   CVCL_W024
SY   GM 3589
DR   CLO; CLO_0017211
DR   BioSample; SAMN00808463
DR   Coriell; GM03589
DR   Wikidata; Q54838146
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Cys127Tyr (c.380G>A); ClinVar=VCV000918041; Zygosity=Heterozygous (from child cell line CHOCi005-A).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Trp161Gly (c.481T>G); ClinVar=VCV000092910; Zygosity=Heterozygous (from child cell line CHOCi005-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM03590
AC   CVCL_2N31
SY   GM3590
DR   CLO; CLO_0017214
DR   BioSample; SAMN00808464
DR   Coriell; GM03590
DR   Wikidata; Q54838150
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM03591
AC   CVCL_AB32
DR   CLO; CLO_0017216
DR   BioSample; SAMN00808465
DR   Coriell; GM03591
DR   Wikidata; Q54838151
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 69,XXY (Coriell=GM03591).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03595
AC   CVCL_X107
SY   GM 3595
DR   CLO; CLO_0017218
DR   BioSample; SAMN00808466
DR   Coriell; GM03595
DR   Wikidata; Q54838152
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(Y)(pter->q11) [42]; 45,X [8] (Coriell=GM03595).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   11Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM03604
AC   CVCL_5M84
SY   GM3604; GM03604A
DR   CLO; CLO_0017225
DR   BioSample; SAMN00808467
DR   Coriell; GM03604
DR   Wikidata; Q54838153
RX   CelloPub=CLPUB00447;
RX   PubMed=3863481;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex18-41del; Zygosity=Hemizygous (Coriell=GM03604).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM03605
AC   CVCL_9R78
SY   GM3605; GM 3605; HPA-1
DR   CLO; CLO_0017224
DR   BioSample; SAMN00808468
DR   Coriell; GM03605
DR   Wikidata; Q54838155
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=1627656;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125593; Hyperpipecolatemia
DI   ORDO; Orphanet_34; Pipecolic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM03606
AC   CVCL_V471
DR   CLO; CLO_0017226
DR   BioSample; SAMN00808469
DR   Coriell; GM03606
DR   Wikidata; Q54838156
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM03614
AC   CVCL_1F15
SY   GM 3614
DR   CLO; CLO_0017189
DR   BioSample; SAMN00808470
DR   Coriell; GM03614
DR   Wikidata; Q54838157
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM03620
AC   CVCL_F062
SY   GM03620A
DR   CLO; CLO_0017198
DR   BioSample; SAMN00808471
DR   Coriell; GM03620
DR   Wikidata; Q54838161
RX   CelloPub=CLPUB00447;
RX   PubMed=32656337;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[70] (c.52CAG(70)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=32656337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F063 ! GM03621
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM03621
AC   CVCL_F063
SY   GM 3621
DR   CLO; CLO_0017192
DR   BioSample; SAMN00808472
DR   Coriell; GM03621
DR   Wikidata; Q54838162
RX   CelloPub=CLPUB00447;
RX   PubMed=6220707;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[70] (c.52CAG(70)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM03620).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F062 ! GM03620
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM03623
AC   CVCL_X295
SY   GM 3623
DR   CLO; CLO_0017193
DR   BioSample; SAMN00808473
DR   Coriell; GM03623
DR   Wikidata; Q54838163
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM03624
AC   CVCL_X108
SY   GM 3624; GM03624A; GM 3624 A
DR   CLO; CLO_0017206
DR   BioSample; SAMN00808474
DR   Coriell; GM03624
DR   Wikidata; Q54838164
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM03625
AC   CVCL_2Y87
SY   GM03625B
DR   CLO; CLO_0017205
DR   BioSample; SAMN00808475
DR   Coriell; GM03625
DR   Wikidata; Q54838165
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM03626
AC   CVCL_2Y88
DR   CLO; CLO_0017166
DR   BioSample; SAMN00808476
DR   Coriell; GM03626
DR   Wikidata; Q54838166
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM03638
AC   CVCL_F187
SY   GM 3638; GM03638B; GM03638C; B cell line 8392; 8392
DR   CLO; CLO_0017157
DR   Coriell; GM03638
DR   Cosmic; 2361360
DR   Wikidata; Q54838167
RX   CelloPub=CLPUB00447;
RX   PubMed=62390;
RX   PubMed=8547074;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F188 ! GM03639
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 17
//
ID   GM03639
AC   CVCL_F188
SY   GM03639A; GM03639C; T cell line 8402; 8402
DR   CLO; CLO_0017159
DR   Coriell; GM03639
DR   Cosmic; 2361363
DR   IARC_TP53; 21652
DR   Wikidata; Q54838168
RX   CelloPub=CLPUB00447;
RX   PubMed=62390;
RX   PubMed=2144611;
RX   PubMed=8547074;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=2144611).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F187 ! GM03638
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   GM03640
AC   CVCL_DF20
SY   AG03640; AG3640
DR   CLO; CLO_0017161
DR   BioSample; SAMN00808477
DR   Coriell; AG03640
DR   Coriell; GM03640
DR   Wikidata; Q54838169
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03640; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03641
AC   CVCL_DF21
SY   AG03641; AG3641
DR   CLO; CLO_0017162
DR   BioSample; SAMN00808478
DR   Coriell; AG03641
DR   Coriell; GM03641
DR   Wikidata; Q54838170
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG03641; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03642
AC   CVCL_V042
DR   CLO; CLO_0017149
DR   BioSample; SAMN00808479
DR   Coriell; GM03642
DR   Wikidata; Q54838171
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V036 ! GM01061
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM03643
AC   CVCL_V043
SY   GM3643
DR   CLO; CLO_0017150
DR   BioSample; SAMN00808480
DR   Coriell; GM03643
DR   Wikidata; Q54838172
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM03643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V037 ! GM01083
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM03644
AC   CVCL_V044
DR   CLO; CLO_0017152
DR   BioSample; SAMN00808481
DR   Coriell; GM03644
DR   Wikidata; Q54838173
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V038 ! GM01085
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM03645
AC   CVCL_V045
DR   CLO; CLO_0017154
DR   BioSample; SAMN00808482
DR   Coriell; GM03645
DR   Wikidata; Q54838174
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM03647
AC   CVCL_X296
SY   GM-3647; GM 3647
DR   CLO; CLO_0017186
DR   BioSample; SAMN00808483
DR   Coriell; GM03647
DR   Wikidata; Q54838175
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,der(6)(6qter->6p25::1q32->1qter)mat (Coriell=GM03647).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM03648
AC   CVCL_X297
SY   GM-3648; GM 3648
DR   CLO; CLO_0015446
DR   BioSample; SAMN00808484
DR   Coriell; GM03648
DR   Wikidata; Q54838176
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM03650
AC   CVCL_AB33
DR   CLO; CLO_0015447
DR   BioSample; SAMN00808485
DR   Coriell; GM03650
DR   Wikidata; Q54838177
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Thr66Ala (c.196A>G); ClinVar=VCV000038946; Zygosity=Heterozygous (Coriell=GM03650).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM03651
AC   CVCL_7396
SY   GM3651; GM 3651; GM 03651; GM03651C; GM3651C; AG03651; AG 3651D
DR   CLO; CLO_0015448
DR   BioSample; SAMN00808486
DR   Coriell; AG03651
DR   Coriell; GM03651
DR   GEO; GSM1317021
DR   GEO; GSM3124679
DR   Wikidata; Q54838178
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   Patent=US5773219;
RX   PubMed=3863481;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=7847674;
RX   PubMed=8643543;
RX   PubMed=8823375;
RX   PubMed=12060391;
RX   PubMed=21490598;
RX   PubMed=26984941;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; AG03651; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM03652
AC   CVCL_7397
SY   GM3652; GM3652A; GM03652C; C3652
DR   CLO; CLO_0015442
DR   BioSample; SAMN00808487
DR   Coriell; GM03652
DR   GEO; GSM2794409
DR   GEO; GSM3124681
DR   Wikidata; Q54838179
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2897722;
RX   PubMed=3863481;
RX   PubMed=7847674;
RX   PubMed=8247227;
RX   PubMed=26184184;
RX   PubMed=29125828;
RX   PubMed=30567591;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: AG03652; PubMed=2897722; Note=In table 1.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM03654
AC   CVCL_F199
DR   CLO; CLO_0015443
DR   BioSample; SAMN00808488
DR   Coriell; GM03654
DR   Wikidata; Q54838180
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y316 ! GM00362
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM03655
AC   CVCL_V250
SY   GM3655
DR   CLO; CLO_0015444
DR   Coriell; GM03655
DR   Wikidata; Q54838181
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 12
//
ID   GM03657
AC   CVCL_7398
SY   GM3657; GM17222
DR   CLO; CLO_0014366
DR   CLO; CLO_0015445
DR   BioSample; SAMN00808489
DR   Coriell; GM03657
DR   Coriell; GM17222
DR   GEO; GSM569548
DR   GEO; GSM596286
DR   GEO; GSM596646
DR   GEO; GSM924824
DR   Wikidata; Q54838182
RX   CelloPub=CLPUB00447;
RX   PubMed=8530025;
RX   PubMed=14583597;
RX   PubMed=14642717;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,68:01:02; B*40:01:02,44:02:01; C*03:04:01,05:01:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:01:01G; DQA1*01:02:01,01:04:01; DQB1*05:03:01,06:04:01; DRB1*13:02:01,14:54:01; DRB3*02:02:01,03:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=14642717
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 18,19
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,20
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 18,22
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 15,16
ST   DXS101: 24
ST   FGA: 18,23
ST   Penta D: 10,13
ST   Penta E: 5
ST   SE33: 22.2,27.2
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7399 ! GM03658
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM03658
AC   CVCL_7399
SY   GM3658
DR   CLO; CLO_0015439
DR   BioSample; SAMN00808490
DR   Coriell; GM03658
DR   GEO; GSM3124690
DR   Wikidata; Q54838183
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=8530025;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7398 ! GM03657
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM03659
AC   CVCL_1L27
SY   GM03659A
DR   CLO; CLO_0015440
DR   BioSample; SAMN00808491
DR   Coriell; GM03659
DR   Wikidata; Q54838184
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM03665
AC   CVCL_U732
SY   GM03665A; F3665; 3665
DR   CLO; CLO_0015441
DR   BioSample; SAMN00808492
DR   Coriell; GM03665
DR   GEO; GSM2794423
DR   Wikidata; Q54838185
RX   CelloPub=CLPUB00447;
RX   PubMed=27002638;
RX   PubMed=29125828;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[816]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1400]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM03666
AC   CVCL_X109
SY   GM 3666
DR   CLO; CLO_0015479
DR   Coriell; GM03666
DR   Wikidata; Q54838186
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Karyotypic information: 47,XY,+idic(15)(pter->q11::q11->pter) [31]; 47,XY,+idic(15)(pter->q11::q11->pter),inv(7)(pter->p22::q32->p22::q32->qter) [19] (Coriell=GM03666).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM03667
AC   CVCL_YP30
SY   GM3667
DR   Coriell; GM03667
DR   Wikidata; Q93585210
RX   PubMed=7438795;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03667; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS16 ! GM02868
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   GM03672
AC   CVCL_8A60
SY   GM3672
DR   CLO; CLO_0015477
DR   BioSample; SAMN00808494
DR   Coriell; GM03672
DR   Wikidata; Q54838187
RX   CelloPub=CLPUB00447;
RX   PubMed=2376596;
RX   PubMed=30471880;
RX   PubMed=34091428;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7427; MT-CYB; Simple; p.Asp171Asn (m.15257G>A); ClinVar=VCV000009674; Zygosity=Heteroplasmic (from child cell line KUCFRi003-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM03673
AC   CVCL_9S89
DR   CLO; CLO_0015476
DR   BioSample; SAMN00808495
DR   Coriell; GM03673
DR   Wikidata; Q54838188
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM03685
AC   CVCL_9R79
DR   CLO; CLO_0015483
DR   BioSample; SAMN00808496
DR   Coriell; GM03685
DR   Wikidata; Q54838189
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; c.3335+6T>G (IVS17+6T>G); ClinVar=VCV000002773; Zygosity=Heterozygous (PubMed=16465621).
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM03689
AC   CVCL_X298
SY   GM-3689; GM 3689
DR   CLO; CLO_0015482
DR   BioSample; SAMN00808497
DR   Coriell; GM03689
DR   Wikidata; Q54838190
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03691
AC   CVCL_U394
DR   CLO; CLO_0015481
DR   BioSample; SAMN00808498
DR   Coriell; GM03691
DR   Wikidata; Q54838193
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   GM03696
AC   CVCL_M944
SY   GM03696B; GM03696C
DR   CLO; CLO_0015480
DR   BioSample; SAMN00808499
DR   Coriell; GM03696
DR   Wikidata; Q54838194
RX   CelloPub=CLPUB00447;
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM03697
AC   CVCL_X122
SY   GM03697A
DR   CLO; CLO_0015485
DR   BioSample; SAMN00808500
DR   Coriell; GM03697
DR   Wikidata; Q54838195
RX   CelloPub=CLPUB00447;
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM03697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM03699
AC   CVCL_UY62
DR   Coriell; GM03699
DR   Wikidata; Q93585329
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM03699; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03700
AC   CVCL_F201
DR   CLO; CLO_0015484
DR   BioSample; SAMN00808501
DR   Coriell; GM03700
DR   Wikidata; Q54838196
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM03704
AC   CVCL_F200
SY   GM3704; PhK2.13.2; K2.13.2
DR   CLO; CLO_0015456
DR   Coriell; GM03704
DR   Wikidata; Q54838197
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=6768831;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   GM03705
AC   CVCL_H149
SY   GM3705; PhN2.11.6; N2.11.6
DR   CLO; CLO_0015458
DR   Coriell; GM03705
DR   Wikidata; Q54838198
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=6768831;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   GM03710
AC   CVCL_JE55
SY   GM3710; PhR9.75.9; R9.75.9
DR   Coriell; GM03710
DR   Wikidata; Q54838199
RX   CelloPub=CLPUB00387;
RX   PubMed=6768831;
CC   Monoclonal antibody isotype: IgG2c.
CC   Misspelling: PhR9.75.2; Coriell=GM03710.
CC   Discontinued: Coriell; GM03710; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   GM03713
AC   CVCL_JE56
SY   GM3713A; PhN2.34.1; N2.34.1
DR   Coriell; GM03713
DR   Wikidata; Q54838200
RX   PubMed=6768831;
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: Coriell; GM03713; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   GM03714
AC   CVCL_7400
SY   GM03714A
DR   CLO; CLO_0015457
DR   BioSample; SAMN00808502
DR   Coriell; GM03714
DR   GEO; GSM1116593
DR   GEO; GSM1116594
DR   GEO; GSM1116595
DR   GEO; GSM1116596
DR   Wikidata; Q54838201
RX   CelloPub=CLPUB00447;
RX   PubMed=17668376;
RX   PubMed=23943852;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM03715
AC   CVCL_7401
SY   GM17001
DR   CLO; CLO_0015460
DR   CLO; CLO_0018044
DR   BioSample; SAMN00808503
DR   Coriell; GM03715
DR   Coriell; GM17001
DR   Wikidata; Q54838202
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 15,18
ST   D21S11: 28,31
ST   D8S1179: 13,15
ST   FGA: 19
ST   TH01: 6,8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
ID   GM03716
AC   CVCL_V472
SY   GM03716A
DR   CLO; CLO_0015459
DR   BioSample; SAMN00808504
DR   Coriell; GM03716
DR   Wikidata; Q54838203
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM03719
AC   CVCL_1M97
DR   CLO; CLO_0015463
DR   BioSample; SAMN00808505
DR   Coriell; GM03719
DR   Wikidata; Q54838204
RX   CelloPub=CLPUB00447;
RX   PubMed=7814621;
RX   PubMed=33329388;
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM03720
AC   CVCL_M940
DR   CLO; CLO_0015462
DR   BioSample; SAMN00808506
DR   Coriell; GM03720
DR   Wikidata; Q54838205
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M941 ! GM03721
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM03721
AC   CVCL_M941
SY   GM17157
DR   CLO; CLO_0013962
DR   CLO; CLO_0015467
DR   BioSample; SAMN00808507
DR   Coriell; GM03721
DR   Coriell; GM17157
DR   GEO; GSM273424
DR   GEO; GSM569659
DR   GEO; GSM596222
DR   GEO; GSM597022
DR   GEO; GSM924667
DR   Wikidata; Q54838206
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M940 ! GM03720
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM03722
AC   CVCL_X452
DR   CLO; CLO_0015465
DR   BioSample; SAMN00808508
DR   Coriell; GM03722
DR   Wikidata; Q54838207
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X453 ! GM03723
SX   Female
AG   3Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM03723
AC   CVCL_X453
DR   CLO; CLO_0015469
DR   BioSample; SAMN00808509
DR   Coriell; GM03723
DR   Wikidata; Q54838208
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X452 ! GM03722
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 12
//
ID   GM03724
AC   CVCL_F221
DR   CLO; CLO_0015508
DR   BioSample; SAMN00808510
DR   Coriell; GM03724
DR   Wikidata; Q54838209
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7654 ! GM03725
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM03725
AC   CVCL_7654
SY   GM17103
DR   CLO; CLO_0014898
DR   CLO; CLO_0015510
DR   BioSample; SAMN00808511
DR   Coriell; GM03725
DR   Coriell; GM17103
DR   GEO; GSM273373
DR   GEO; GSM569500
DR   GEO; GSM596171
DR   GEO; GSM596972
DR   GEO; GSM924613
DR   IPD-IMGT/HLA; 15335
DR   Wikidata; Q54838210
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CRAC,74:AB; B*08:XKT,81:MN; C*07:27,08:04; DRB1*04:05,12:CVT (IPD-IMGT/HLA=15335).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F221 ! GM03724
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM03726
AC   CVCL_9W96
DR   CLO; CLO_0015527
DR   BioSample; SAMN00808512
DR   Coriell; GM03726
DR   Wikidata; Q54838211
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT41 ! GM03727
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03727
AC   CVCL_UT41
DR   Coriell; GM03727
DR   Wikidata; Q93585468
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03727; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9W96 ! GM03726
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM03728
AC   CVCL_BW99
SY   AG03728; AG3728
DR   CLO; CLO_0015526
DR   BioSample; SAMN00808513
DR   Coriell; AG03728
DR   Coriell; GM03728
DR   Wikidata; Q54838212
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=7253718;
CC   Discontinued: Coriell; AG03728; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03733
AC   CVCL_X110
SY   GM-3733; GM 3733
DR   CLO; CLO_0015525
DR   BioSample; SAMN00808514
DR   Coriell; GM03733
DR   Wikidata; Q54838213
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(7)(pter->q34) (Coriell=GM03733).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM03745
AC   CVCL_1H60
DR   CLO; CLO_0015524
DR   BioSample; SAMN00808515
DR   Coriell; GM03745
DR   Wikidata; Q54838214
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM03746
AC   CVCL_1H61
DR   CLO; CLO_0015522
DR   BioSample; SAMN00808516
DR   Coriell; GM03746
DR   Wikidata; Q54838215
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM03747
AC   CVCL_1H62
DR   CLO; CLO_0015521
DR   BioSample; SAMN00808517
DR   Coriell; GM03747
DR   Wikidata; Q54838216
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM03748
AC   CVCL_1H63
DR   CLO; CLO_0015519
DR   BioSample; SAMN00808518
DR   Coriell; GM03748
DR   Wikidata; Q54838218
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 16
//
ID   GM03755
AC   CVCL_X123
DR   Coriell; GM03755
DR   Wikidata; Q54838219
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03755).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM03755).
CC   Discontinued: Coriell; GM03755; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X124 ! GM03756
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM03756
AC   CVCL_X124
DR   CLO; CLO_0015517
DR   BioSample; SAMN00808519
DR   Coriell; GM03756
DR   Wikidata; Q54838220
RX   CelloPub=CLPUB00447;
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03756).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM03756).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X123 ! GM03755
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 19
//
ID   GM03759
AC   CVCL_M945
SY   GM03759A
DR   CLO; CLO_0015488
DR   BioSample; SAMN00808520
DR   Coriell; GM03759
DR   Wikidata; Q54838221
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~2000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03759).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM03767
AC   CVCL_X111
SY   GM 3767
DR   CLO; CLO_0015491
DR   BioSample; SAMN00808521
DR   Coriell; GM03767
DR   Wikidata; Q54838222
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(18)(qter->p11) (Coriell=GM03767).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM03769
AC   CVCL_X299
SY   GM 3769
DR   CLO; CLO_0015492
DR   BioSample; SAMN00808522
DR   Coriell; GM03769
DR   Wikidata; Q54838224
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM03770
AC   CVCL_U395
DR   CLO; CLO_0015504
DR   BioSample; SAMN00808523
DR   Coriell; GM03770
DR   Wikidata; Q54838225
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (Coriell=GM03770).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM03770).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   GM03771
AC   CVCL_U396
DR   CLO; CLO_0015503
DR   BioSample; SAMN00808524
DR   Coriell; GM03771
DR   Wikidata; Q54838226
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   GM03772
AC   CVCL_U397
DR   CLO; CLO_0015506
DR   BioSample; SAMN00808525
DR   Coriell; GM03772
DR   Wikidata; Q54838227
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from twin of GM03773 (Cellosaurus=CVCL_U398).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM03773
AC   CVCL_U398
DR   CLO; CLO_0015505
DR   BioSample; SAMN00808526
DR   Coriell; GM03773
DR   Wikidata; Q54838228
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from twin of GM03772 (Cellosaurus=CVCL_U397).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM03774
AC   CVCL_2M99
DR   CLO; CLO_0015499
DR   BioSample; SAMN00808527
DR   Coriell; GM03774
DR   Wikidata; Q54838229
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM03780
AC   CVCL_M942
SY   GM 3780; GM3780; GM17091
DR   CLO; CLO_0014526
DR   CLO; CLO_0015498
DR   BioSample; SAMN00808528
DR   Coriell; GM03780
DR   Coriell; GM17091
DR   Wikidata; Q54838230
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Iberian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-17del; Zygosity=Hemizygous (Coriell=GM03780).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M943 ! GM03781
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM03781
AC   CVCL_M943
SY   GM 3781; GM3781
DR   CLO; CLO_0015501
DR   BioSample; SAMN00808529
DR   Coriell; GM03781
DR   Wikidata; Q54838231
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00454;
RX   PubMed=3863481;
RX   PubMed=23665875;
CC   Population: Caucasian; Iberian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-17del; Zygosity=Hemizygous (Coriell=GM03781).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M942 ! GM03780
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM03782
AC   CVCL_5M85
SY   GM 3782; GM3782
DR   CLO; CLO_0015601
DR   BioSample; SAMN00808530
DR   Coriell; GM03782
DR   Wikidata; Q54838232
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian; Iberian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-17del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M86 ! GM03783
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   GM03783
AC   CVCL_5M86
SY   GM 3783; GM3783
DR   CLO; CLO_0015596
DR   BioSample; SAMN00808531
DR   Coriell; GM03783
DR   Wikidata; Q54838233
RX   CelloPub=CLPUB00447;
RX   PubMed=6088703;
RX   PubMed=6574472;
CC   Population: Caucasian; Iberian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-17del; Zygosity=Hemizygous (Coriell=GM03783).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M85 ! GM03782
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   GM03784
AC   CVCL_DF22
DR   CLO; CLO_0015604
DR   BioSample; SAMN00808532
DR   Coriell; GM03784
DR   Wikidata; Q54838234
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168999; Macular dystrophy, retinal, 1
DI   ORDO; Orphanet_75327; North Carolina macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DF23 ! GM03785
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03785
AC   CVCL_DF23
DR   CLO; CLO_0015602
DR   BioSample; SAMN00808533
DR   Coriell; GM03785
DR   Wikidata; Q54838237
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168999; Macular dystrophy, retinal, 1
DI   ORDO; Orphanet_75327; North Carolina macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DF22 ! GM03784
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM03786
AC   CVCL_N012
SY   GM17375
DR   CLO; CLO_0013696
DR   CLO; CLO_0015567
DR   BioSample; SAMN00808534
DR   Coriell; GM03786
DR   Coriell; GM17375
DR   Wikidata; Q54838238
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Karyotypic information: 45,XX,dic(13;14)(13qter->13p11::14p11->14qter) (Coriell=GM03786).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM03790
AC   CVCL_1H64
DR   CLO; CLO_0015569
DR   BioSample; SAMN00808535
DR   Coriell; GM03790
DR   Wikidata; Q54838239
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM03791
AC   CVCL_UR85
DR   Coriell; GM03791
DR   Wikidata; Q93585687
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM03791; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM03793
AC   CVCL_F077
DR   CLO; CLO_0015571
DR   BioSample; SAMN00808536
DR   Coriell; GM03793
DR   Wikidata; Q54838240
RX   CelloPub=CLPUB00447;
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F078 ! GM03794
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM03794
AC   CVCL_F078
DR   CLO; CLO_0015574
DR   BioSample; SAMN00808537
DR   Coriell; GM03794
DR   Wikidata; Q54838241
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F077 ! GM03793
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM03797
AC   CVCL_7402
SY   GM18012
DR   CLO; CLO_0015578
DR   CLO; CLO_0016017
DR   BioSample; SAMN00808538
DR   Coriell; GM03797
DR   Coriell; GM18012
DR   Wikidata; Q54838242
RX   CelloPub=CLPUB00447;
RX   PubMed=17668376;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM03798
AC   CVCL_7403
SY   GM03798A
DR   CLO; CLO_0015579
DR   BioSample; SAMN00808539
DR   Coriell; GM03798
DR   Wikidata; Q54838243
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=18485778;
RX   PubMed=19127062;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM03799
AC   CVCL_2S94
DR   CLO; CLO_0015547
DR   BioSample; SAMN00808540
DR   Coriell; GM03799
DR   Wikidata; Q54838244
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM03808
AC   CVCL_JE12
SY   GM3808; 3808
DR   CLO; CLO_0015562
DR   BioSample; SAMN00808541
DR   Coriell; GM03808
DR   Wikidata; Q54838245
RX   CelloPub=CLPUB00447;
RX   PubMed=2559742;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 11
//
ID   GM03809
AC   CVCL_JE58
SY   GM3809
DR   CLO; CLO_0015559
DR   BioSample; SAMN00808542
DR   Coriell; GM03809
DR   Wikidata; Q54838246
RX   CelloPub=CLPUB00447;
RX   PubMed=2570029;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 11
//
ID   GM03810
AC   CVCL_X300
SY   GM 3810
DR   CLO; CLO_0015556
DR   BioSample; SAMN00808543
DR   Coriell; GM03810
DR   Wikidata; Q54838247
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM03811
AC   CVCL_2S95
DR   CLO; CLO_0015553
DR   BioSample; SAMN00808544
DR   Coriell; GM03811
DR   Wikidata; Q54838248
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03813
AC   CVCL_F172
SY   GM 3813; SMA1FABE
DR   CLO; CLO_0015532
DR   BioSample; SAMN00808545
DR   Coriell; GM03813
DR   Wikidata; Q54838249
RX   CelloPub=CLPUB00447;
RX   PubMed=3941662;
RX   PubMed=26190808;
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   Problematic cell line: Misclassified. Originally thought to be a SMA type 1 (SMA1) cell line but shown to be from a SMA type 2 (SMA2) (PubMed=28284873).
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (Coriell=GM03813).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (Coriell=GM03813).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   GM03814
AC   CVCL_F173
SY   GM 3814; SMAM1FABE
DR   CLO; CLO_0015534
DR   CLO; CLO_0037413
DR   BioSample; SAMN00808546
DR   Coriell; GM03814
DR   LINCS_LDP; LPC-1014
DR   Wikidata; Q54838250
RX   CelloPub=CLPUB00447;
RX   PubMed=3941662;
RX   PubMed=26190808;
RX   PubMed=26247043;
RX   PubMed=26651604;
RX   PubMed=28284873;
RX   PubMed=33197628;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (PubMed=28284873; PubMed=33197628).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (PubMed=28284873).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM03815
AC   CVCL_F174
SY   GM 3815; SMAF1FABE
DR   CLO; CLO_0015528
DR   BioSample; SAMN00808547
DR   Coriell; GM03815
DR   Wikidata; Q54838251
RX   CelloPub=CLPUB00447;
RX   PubMed=3941662;
RX   PubMed=26190808;
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (PubMed=26190808; PubMed=28284873).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM03816
AC   CVCL_F193
SY   GM-3816
DR   CLO; CLO_0015531
DR   BioSample; SAMN00808548
DR   Coriell; GM03816
DR   Wikidata; Q54838252
RX   CelloPub=CLPUB00447;
RX   PubMed=28444186;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[330]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM03816).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[380]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM03816).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM03823
AC   CVCL_AK78
SY   GM 3823; GM03823A
DR   CLO; CLO_0015540
DR   BioSample; SAMN00808549
DR   Coriell; GM03823
DR   Wikidata; Q54838253
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK79 ! GM03824
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03824
AC   CVCL_AK79
DR   CLO; CLO_0015683
DR   BioSample; SAMN00808550
DR   Coriell; GM03824
DR   Wikidata; Q54838254
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK78 ! GM03823
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03825
AC   CVCL_AK80
DR   CLO; CLO_0015681
DR   BioSample; SAMN00808551
DR   Coriell; GM03825
DR   Wikidata; Q54838255
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK81 ! GM03826
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03826
AC   CVCL_AK81
DR   CLO; CLO_0015673
DR   BioSample; SAMN00808552
DR   Coriell; GM03826
DR   Wikidata; Q54838256
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK80 ! GM03825
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03827
AC   CVCL_X057
SY   GM 3827
DR   CLO; CLO_0015670
DR   BioSample; SAMN00808553
DR   Coriell; GM03827
DR   Wikidata; Q54838257
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 46,X,del(X)(pter->q21) (Coriell=GM03827).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X058 ! GM03828
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM03828
AC   CVCL_X058
SY   GM 3828
DR   CLO; CLO_0015676
DR   BioSample; SAMN00808554
DR   Coriell; GM03828
DR   Wikidata; Q54838258
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 46,X,del(X)(pter->q21) (Coriell=GM03828).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X057 ! GM03827
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM03831
AC   CVCL_AK82
DR   CLO; CLO_0015674
DR   BioSample; SAMN00808555
DR   Coriell; GM03831
DR   Wikidata; Q54838259
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK83 ! GM03832
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03832
AC   CVCL_AK83
DR   CLO; CLO_0015660
DR   BioSample; SAMN00808556
DR   Coriell; GM03832
DR   Wikidata; Q54838260
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK82 ! GM03831
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03833
AC   CVCL_AK84
DR   CLO; CLO_0015663
DR   BioSample; SAMN00808557
DR   Coriell; GM03833
DR   Wikidata; Q54838261
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK85 ! GM03834
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03834
AC   CVCL_AK85
SY   GM 3834; GM03834A
DR   CLO; CLO_0015666
DR   BioSample; SAMN00808558
DR   Coriell; GM03834
DR   Wikidata; Q54838262
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK84 ! GM03833
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03835
AC   CVCL_AK86
DR   CLO; CLO_0015668
DR   BioSample; SAMN00808559
DR   Coriell; GM03835
DR   Wikidata; Q54838263
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK87 ! GM03836
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03836
AC   CVCL_AK87
SY   GM 3836
DR   CLO; CLO_0015642
DR   BioSample; SAMN00808560
DR   Coriell; GM03836
DR   Wikidata; Q54838264
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK86 ! GM03835
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03837
AC   CVCL_AK88
DR   CLO; CLO_0015639
DR   BioSample; SAMN00808561
DR   Coriell; GM03837
DR   Wikidata; Q54838265
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK89 ! GM03838
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03838
AC   CVCL_AK89
DR   CLO; CLO_0015636
DR   BioSample; SAMN00808562
DR   Coriell; GM03838
DR   Wikidata; Q54838266
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK88 ! GM03837
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03847
AC   CVCL_2S96
DR   CLO; CLO_0015633
DR   BioSample; SAMN00808563
DR   Coriell; GM03847
DR   Wikidata; Q54838267
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(11;22)(11pter->11q23::22q11.2->22qter;22pter->22q11.2::11q23->11qter)mat (Coriell=GM03847).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM03850
AC   CVCL_AM66
SY   GM3850
DR   CLO; CLO_0015631
DR   BioSample; SAMN00808564
DR   Coriell; GM03850
DR   Wikidata; Q54838268
RX   CelloPub=CLPUB00447;
RX   PubMed=7094393;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03851
AC   CVCL_GY19
DR   CLO; CLO_0015629
DR   BioSample; SAMN00808565
DR   Coriell; GM03851
DR   Wikidata; Q54838269
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GY20 ! GM03852
SX   Female
AG   2Y5M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM03852
AC   CVCL_GY20
DR   CLO; CLO_0015628
DR   BioSample; SAMN00808566
DR   Coriell; GM03852
DR   Wikidata; Q54838270
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GY19 ! GM03851
SX   Female
AG   2Y5M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM03853
AC   CVCL_W307
SY   GM 3853
DR   CLO; CLO_0015624
DR   BioSample; SAMN00808567
DR   Coriell; GM03853
DR   Wikidata; Q54838271
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W308 ! GM03854
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM03854
AC   CVCL_W308
SY   GM 3854
DR   CLO; CLO_0015626
DR   BioSample; SAMN00808568
DR   Coriell; GM03854
DR   Wikidata; Q54838272
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W307 ! GM03853
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM03857
AC   CVCL_DD75
SY   GM3857; GM03857A
DR   CLO; CLO_0015618
DR   BioSample; SAMN00808569
DR   Coriell; GM03857
DR   Wikidata; Q54838273
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34864; Hereditary optic atrophy
DI   ORDO; Orphanet_98671; Hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD76 ! GM03858
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM03858
AC   CVCL_DD76
DR   CLO; CLO_0015727
DR   BioSample; SAMN00808570
DR   Coriell; GM03858
DR   Wikidata; Q54838274
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34864; Hereditary optic atrophy
DI   ORDO; Orphanet_98671; Hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD75 ! GM03857
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM03859
AC   CVCL_W028
SY   GM 3859; GM3859
DR   CLO; CLO_0015728
DR   BioSample; SAMN00808571
DR   Coriell; GM03859
DR   Wikidata; Q54838275
RX   CelloPub=CLPUB00447;
RX   PubMed=1409720;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Arg71Pro (c.212G>C) (R54P, 388C); ClinVar=VCV000013665; Zygosity=Heterozygous (PubMed=1409720).
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Gln207Pro (c.620A>C) (Q190P, 796C); ClinVar=VCV000013666; Zygosity=Heterozygous (PubMed=1409720).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM03860
AC   CVCL_1H65
DR   CLO; CLO_0015729
DR   BioSample; SAMN00808572
DR   Coriell; GM03860
DR   Wikidata; Q54838276
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H66 ! GM03861
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM03861
AC   CVCL_1H66
DR   CLO; CLO_0015730
DR   BioSample; SAMN00808573
DR   Coriell; GM03861
DR   Wikidata; Q54838280
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H65 ! GM03860
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM03862
AC   CVCL_1H67
DR   CLO; CLO_0015731
DR   BioSample; SAMN00808574
DR   Coriell; GM03862
DR   Wikidata; Q54838281
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H68 ! GM03863
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
ID   GM03863
AC   CVCL_1H68
DR   CLO; CLO_0015734
DR   BioSample; SAMN00808575
DR   Coriell; GM03863
DR   Wikidata; Q54838282
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H67 ! GM03862
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 16
//
ID   GM03864
AC   CVCL_1H69
SY   GM03864A
DR   CLO; CLO_0015735
DR   BioSample; SAMN00808576
DR   Coriell; GM03864
DR   Wikidata; Q54838283
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H70 ! GM03865
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM03865
AC   CVCL_1H70
DR   CLO; CLO_0015737
DR   BioSample; SAMN00808577
DR   Coriell; GM03865
DR   Wikidata; Q54838284
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H69 ! GM03864
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM03866
AC   CVCL_1H71
DR   CLO; CLO_0015710
DR   BioSample; SAMN00808578
DR   Coriell; GM03866
DR   Wikidata; Q54838285
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H72 ! GM03867
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
ID   GM03867
AC   CVCL_1H72
DR   CLO; CLO_0015709
DR   BioSample; SAMN00808579
DR   Coriell; GM03867
DR   Wikidata; Q54838286
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H71 ! GM03866
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 16
//
ID   GM03868
AC   CVCL_1H73
DR   CLO; CLO_0016025
DR   BioSample; SAMN00808580
DR   Coriell; GM03868
DR   Wikidata; Q54838287
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H74 ! GM03869
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM03869
AC   CVCL_1H74
DR   CLO; CLO_0016026
DR   BioSample; SAMN00808581
DR   Coriell; GM03869
DR   Wikidata; Q54838288
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H73 ! GM03868
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM03870
AC   CVCL_1H75
SY   GM03870A
DR   CLO; CLO_0016028
DR   BioSample; SAMN00808582
DR   Coriell; GM03870
DR   Wikidata; Q54838289
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H76 ! GM03871
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM03871
AC   CVCL_1H76
DR   CLO; CLO_0016030
DR   BioSample; SAMN00808583
DR   Coriell; GM03871
DR   Wikidata; Q54838290
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H75 ! GM03870
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM03872
AC   CVCL_1H77
DR   CLO; CLO_0016031
DR   BioSample; SAMN00808584
DR   Coriell; GM03872
DR   Wikidata; Q54838291
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H78 ! GM03873
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
ID   GM03873
AC   CVCL_1H78
DR   CLO; CLO_0016033
DR   BioSample; SAMN00808585
DR   Coriell; GM03873
DR   Wikidata; Q54838292
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H77 ! GM03872
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 16
//
ID   GM03876
AC   CVCL_1N78
SY   GM3876
DR   CLO; CLO_0016034
DR   BioSample; SAMN00808586
DR   Coriell; GM03876
DR   Wikidata; Q54838293
RX   CelloPub=CLPUB00447;
RX   PubMed=2535035;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;20)(1qter->1p13::20q13.3->20qter;20pter->20q13.3::1p13->1pter) (Coriell=GM03876).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM03877
AC   CVCL_EF94
SY   GM03877A
DR   CLO; CLO_0016037
DR   BioSample; SAMN00808587
DR   Coriell; GM03877
DR   Wikidata; Q54838294
RX   CelloPub=CLPUB00447;
RX   PubMed=8896573;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4624; GSS; Simple; p.Ala2Profs*14 (c.4delG); ClinVar=VCV000338302; Zygosity=Heterozygous (PubMed=8896573).
CC   Sequence variation: Mutation; HGNC; HGNC:4624; GSS; Simple; p.Arg164Gln (c.491G>A); ClinVar=VCV000008525; Zygosity=Heterozygous; Note=Affects splicing (PubMed=8896573).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128193; Glutathione synthetase deficiency
DI   ORDO; Orphanet_32; Glutathione synthetase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   GM03878
AC   CVCL_EF95
SY   GM 3878; GM03878A
DR   CLO; CLO_0016038
DR   BioSample; SAMN00808588
DR   Coriell; GM03878
DR   Wikidata; Q54838295
RX   CelloPub=CLPUB00447;
RX   PubMed=8896573;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4624; GSS; Simple; p.Ala2Profs*14 (c.4delG); ClinVar=VCV000338302; Zygosity=Heterozygous (PubMed=8896573).
CC   Sequence variation: Mutation; HGNC; HGNC:4624; GSS; Simple; p.Arg164Gln (c.491G>A); ClinVar=VCV000008525; Zygosity=Heterozygous; Note=Affects splicing (PubMed=8896573).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128193; Glutathione synthetase deficiency
DI   ORDO; Orphanet_32; Glutathione synthetase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   GM03882
AC   CVCL_2S97
DR   CLO; CLO_0016041
DR   BioSample; SAMN00808589
DR   Coriell; GM03882
DR   Wikidata; Q54838297
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(3;10)(3pter->3q25::10p15->10pter;10qter->10p15::3q25->3qter) (Coriell=GM03882).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM03883
AC   CVCL_X112
SY   GM 3883
DR   CLO; CLO_0016013
DR   BioSample; SAMN00808590
DR   Coriell; GM03883
DR   Wikidata; Q54838298
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(5)(q15;q33)pat.arr(1-22,X)x2 (Coriell=GM03883).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM03884
AC   CVCL_1N62
SY   GM 3884; GM3884
DR   CLO; CLO_0016011
DR   BioSample; SAMN00808591
DR   Coriell; GM03884
DR   Wikidata; Q54838299
RX   CelloPub=CLPUB00447;
RX   PubMed=2498246;
RX   PubMed=3495225;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;16)(q26;q24) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98967; Klippel-Feil syndrome
DI   ORDO; Orphanet_2345; Isolated Klippel-Feil syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM03886
AC   CVCL_2S98
DR   CLO; CLO_0016012
DR   BioSample; SAMN00808592
DR   Coriell; GM03886
DR   Wikidata; Q54838300
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;9)(4pter->4q33::9q12->9qter;9pter->9q12::4q33->4qter) (Coriell=GM03886).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM03887
AC   CVCL_X113
SY   GM 3887
DR   CLO; CLO_0016009
DR   BioSample; SAMN00808593
DR   Coriell; GM03887
DR   Wikidata; Q54838301
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM03889
AC   CVCL_W303
SY   GM 3889
DR   CLO; CLO_0016010
DR   BioSample; SAMN00808594
DR   Coriell; GM03889
DR   Wikidata; Q54838302
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W304 ! GM03890
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM03890
AC   CVCL_W304
SY   GM03890A
DR   CLO; CLO_0016007
DR   BioSample; SAMN00808595
DR   Coriell; GM03890
DR   Wikidata; Q54838303
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W303 ! GM03889
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM03891
AC   CVCL_W305
SY   GM 3891
DR   CLO; CLO_0016008
DR   BioSample; SAMN00808596
DR   Coriell; GM03891
DR   Wikidata; Q54838304
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W306 ! GM03892
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM03892
AC   CVCL_W306
SY   GM 3892; GM03892A
DR   CLO; CLO_0016022
DR   BioSample; SAMN00808597
DR   Coriell; GM03892
DR   Wikidata; Q54838305
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W305 ! GM03891
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM03893
AC   CVCL_AK90
DR   CLO; CLO_0016023
DR   BioSample; SAMN00808598
DR   Coriell; GM03893
DR   Wikidata; Q54838306
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK91 ! GM03894
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM03894
AC   CVCL_AK91
SY   GM 3894
DR   CLO; CLO_0016018
DR   BioSample; SAMN00808599
DR   Coriell; GM03894
DR   Wikidata; Q54838307
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK90 ! GM03893
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03896
AC   CVCL_9Z41
SY   GM3896; GM03896A
DR   CLO; CLO_0015985
DR   Coriell; GM03896
DR   Wikidata; Q54838308
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85043; Refsum disease
DI   ORDO; Orphanet_773; Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z42 ! GM03897
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM03897
AC   CVCL_9Z42
DR   CLO; CLO_0015986
DR   Coriell; GM03897
DR   Wikidata; Q54838309
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85043; Refsum disease
DI   ORDO; Orphanet_773; Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z41 ! GM03896
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03900
AC   CVCL_X050
SY   GM 3900; GM3900
DR   CLO; CLO_0015987
DR   Coriell; GM03900
DR   Wikidata; Q54838310
RX   CelloPub=CLPUB00447;
RX   PubMed=3374507;
RX   PubMed=6617268;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg216Ter (c.646C>T); ClinVar=VCV000127312; Zygosity=Unspecified (Coriell=GM03900).
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X334 ! GM03901
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 17
//
ID   GM03901
AC   CVCL_X334
SY   GM 3901; GM3901
DR   CLO; CLO_0015989
DR   Coriell; GM03901
DR   Wikidata; Q54838311
RX   CelloPub=CLPUB00447;
RX   PubMed=3374507;
RX   PubMed=6617268;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg216Ter (c.646C>T); ClinVar=VCV000127312; Zygosity=Unspecified (Coriell=GM03901).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X050 ! GM03900
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM03903
AC   CVCL_IN20
DR   CLO; CLO_0015978
DR   Coriell; GM03903
DR   Wikidata; Q54838312
RX   CelloPub=CLPUB00447;
CC   Population: Ecuadorian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN23 ! GM08383
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM03904
AC   CVCL_IN21
DR   CLO; CLO_0015979
DR   Coriell; GM03904
DR   Wikidata; Q54838313
RX   CelloPub=CLPUB00447;
CC   Population: Ecuadorian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN22 ! GM08382
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM03905
AC   CVCL_K000
SY   GM 3905; GM03905A; BFA-1c
DR   CLO; CLO_0015981
DR   Coriell; GM03905
DR   Wikidata; Q54838314
RX   CelloPub=CLPUB00447;
RX   PubMed=2112341;
RX   PubMed=6833405;
RX   PubMed=7355268;
CC   Senescence: Estimated life-span is ~80 PDL (PubMed=7355268).
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   GM03906
AC   CVCL_AK92
DR   CLO; CLO_0015983
DR   Coriell; GM03906
DR   Wikidata; Q54838315
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK93 ! GM03907
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM03907
AC   CVCL_AK93
SY   GM 3907; GM03907A
DR   CLO; CLO_0015994
DR   Coriell; GM03907
DR   Wikidata; Q54838316
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK92 ! GM03906
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03910
AC   CVCL_AK94
DR   CLO; CLO_0015996
DR   Coriell; GM03910
DR   Wikidata; Q54838317
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK95 ! GM03911
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM03911
AC   CVCL_AK95
SY   GM 3911; GM03911A
DR   CLO; CLO_0016123
DR   Coriell; GM03911
DR   Wikidata; Q54838318
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK94 ! GM03910
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM03912
AC   CVCL_X114
SY   GM 3912
DR   CLO; CLO_0016130
DR   Coriell; GM03912
DR   Wikidata; Q54838319
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM03913
AC   CVCL_1K35
SY   GM03913A
DR   CLO; CLO_0016129
DR   Coriell; GM03913
DR   Wikidata; Q54838320
RX   CelloPub=CLPUB00447;
RX   PubMed=10655550;
CC   Population: Caucasian; French Canadian.
CC   Karyotypic information: 46,XY [46%]; 47,XY,+7 [54%] (Coriell=GM03913).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4681; Roberts-SC phocomelia syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM03918
AC   CVCL_X115
SY   GM 3918
DR   CLO; CLO_0016128
DR   Coriell; GM03918
DR   Wikidata; Q54838326
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM03923
AC   CVCL_X116
SY   GM 3923; GM3923
DR   CLO; CLO_0016127
DR   Coriell; GM03923
DR   Wikidata; Q54838327
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian; English.
CC   Karyotypic information: 46,X,del(X)(q13;q22) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   GM03928
AC   CVCL_N013
SY   GM18013
DR   CLO; CLO_0016014
DR   CLO; CLO_0016138
DR   Coriell; GM03928
DR   Coriell; GM18013
DR   Wikidata; Q54838328
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM03929
AC   CVCL_5M87
SY   GM03929A; AG03929; AG 3929; AG3929
DR   CLO; CLO_0016136
DR   Coriell; AG03929
DR   Coriell; GM03929
DR   Wikidata; Q54838329
RX   CelloPub=CLPUB00447;
RX   PubMed=6726265;
RX   PubMed=7253718;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex46-50del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; AG03929; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N26 ! GM05162
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM03931
AC   CVCL_9S52
SY   GM03931B
DR   CLO; CLO_0016134
DR   Coriell; GM03931
DR   Wikidata; Q54838330
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S53 ! GM03932
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM03932
AC   CVCL_9S53
DR   CLO; CLO_0016132
DR   Coriell; GM03932
DR   Wikidata; Q54838331
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S52 ! GM03931
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM03933
AC   CVCL_5L48
DR   CLO; CLO_0016126
DR   Coriell; GM03933
DR   Wikidata; Q54838332
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.His522Thrfs*13 (c.1564delC); ClinVar=VCV000049640; Zygosity=Unspecified (Coriell=GM03933).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L49 ! GM03958
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM03935
AC   CVCL_X301
SY   GM 3935
DR   CLO; CLO_0016104
DR   Coriell; GM03935
DR   Wikidata; Q54838333
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,i(X)(q26) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM03940
AC   CVCL_CY31
DR   CLO; CLO_0016105
DR   Coriell; GM03940
DR   Wikidata; Q54838334
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY32 ! GM03941
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM03941
AC   CVCL_CY32
SY   GM03941B
DR   CLO; CLO_0016108
DR   Coriell; GM03941
DR   Wikidata; Q54838336
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY31 ! GM03940
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM03942
AC   CVCL_CY33
DR   CLO; CLO_0016107
DR   Coriell; GM03942
DR   Wikidata; Q54838337
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03942).
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY34 ! GM03943
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   GM03943
AC   CVCL_CY34
DR   CLO; CLO_0016110
DR   Coriell; GM03943
DR   Wikidata; Q54838338
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03943).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY33 ! GM03942
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM03944
AC   CVCL_CY35
DR   CLO; CLO_0016109
DR   Coriell; GM03944
DR   Wikidata; Q54838339
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03944).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY36 ! GM03945
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM03945
AC   CVCL_CY36
DR   CLO; CLO_0016113
DR   Coriell; GM03945
DR   Wikidata; Q54838340
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03945).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY35 ! GM03944
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM03946
AC   CVCL_CY37
DR   CLO; CLO_0016111
DR   Coriell; GM03946
DR   Wikidata; Q54838341
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03946).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY38 ! GM03947
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM03947
AC   CVCL_CY38
DR   CLO; CLO_0016117
DR   Coriell; GM03947
DR   Wikidata; Q54838342
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03947).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY37 ! GM03946
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM03948
AC   CVCL_L946
SY   GM3948
DR   CLO; CLO_0016115
DR   Coriell; GM03948
DR   Wikidata; Q54838343
RX   CelloPub=CLPUB00447;
RX   PubMed=30024920;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03948).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L947 ! GM03949
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   GM03949
AC   CVCL_L947
DR   CLO; CLO_0016082
DR   Coriell; GM03949
DR   Wikidata; Q54838344
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03949).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L946 ! GM03948
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   GM03950
AC   CVCL_CY39
DR   CLO; CLO_0016077
DR   Coriell; GM03950
DR   Wikidata; Q54838345
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03950).
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY40 ! GM03951
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   GM03951
AC   CVCL_CY40
SY   GM03951A; GM03951B
DR   CLO; CLO_0016078
DR   Coriell; GM03951
DR   Wikidata; Q54838346
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03951).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY39 ! GM03950
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM03952
AC   CVCL_CY41
DR   CLO; CLO_0016096
DR   Coriell; GM03952
DR   Wikidata; Q54838347
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY42 ! GM03953
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   GM03953
AC   CVCL_CY42
DR   CLO; CLO_0016095
DR   Coriell; GM03953
DR   Wikidata; Q54838348
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with familial adenomatous polyposis but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY41 ! GM03952
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM03954
AC   CVCL_CY43
DR   CLO; CLO_0016094
DR   Coriell; GM03954
DR   Wikidata; Q54838349
RX   CelloPub=CLPUB00447;
RX   PubMed=30024920;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03954).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY44 ! GM03955
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM03955
AC   CVCL_CY44
DR   CLO; CLO_0016093
DR   Coriell; GM03955
DR   Wikidata; Q54838350
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln541Ter (c.1621C>T); ClinVar=VCV000000806; Zygosity=Heterozygous (Coriell=GM03955).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY43 ! GM03954
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM03956
AC   CVCL_M946
SY   C3956
DR   CLO; CLO_0016092
DR   Coriell; GM03956
DR   GEO; GSM2794410
DR   Wikidata; Q54838351
RX   CelloPub=CLPUB00447;
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M947 ! GM03957
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   GM03957
AC   CVCL_M947
SY   GM18014
DR   CLO; CLO_0016015
DR   CLO; CLO_0016091
DR   Coriell; GM03957
DR   Coriell; GM18014
DR   Wikidata; Q54838352
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M946 ! GM03956
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM03958
AC   CVCL_5L49
DR   CLO; CLO_0016090
DR   Coriell; GM03958
DR   Wikidata; Q54838353
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.His522Thrfs*13 (c.1564delC); ClinVar=VCV000049640; Zygosity=Unspecified (Coriell=GM03958).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L48 ! GM03933
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM03959
AC   CVCL_UR84
SY   GM03959A
DR   Coriell; GM03959
DR   Wikidata; Q93586590
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM03959; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR83 ! GM03295
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM03978
AC   CVCL_V241
DR   CLO; CLO_0016056
DR   Coriell; GM03978
DR   Wikidata; Q54838354
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM03983
AC   CVCL_UY63
DR   Coriell; GM03983
DR   Wikidata; Q93586605
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM03983; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 6
//
ID   GM03986
AC   CVCL_F111
SY   GM03986A
DR   CLO; CLO_0016057
DR   Coriell; GM03986
DR   Wikidata; Q54838355
RX   CelloPub=CLPUB00447;
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03986).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7404 ! GM03987
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   GM03987
AC   CVCL_7404
DR   CLO; CLO_0016059
DR   Coriell; GM03987
DR   Wikidata; Q54838357
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03987).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F111 ! GM03986
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   GM03989
AC   CVCL_X127
DR   CLO; CLO_0016062
DR   Coriell; GM03989
DR   Wikidata; Q54838358
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~2000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03989).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   GM03990
AC   CVCL_X125
SY   GM03990A
DR   CLO; CLO_0016073
DR   Coriell; GM03990
DR   Wikidata; Q54838361
RX   CelloPub=CLPUB00447;
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[50-80] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X126 ! GM03991
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM03991
AC   CVCL_X126
DR   CLO; CLO_0016072
DR   Coriell; GM03991
DR   Wikidata; Q54838362
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[50-80] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (Coriell=GM03991).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X125 ! GM03990
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
ID   GM03997
AC   CVCL_5M88
DR   CLO; CLO_0016075
DR   Coriell; GM03997
DR   Wikidata; Q54838363
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM03998
AC   CVCL_IZ39
DR   CLO; CLO_0016074
DR   Coriell; GM03998
DR   Wikidata; Q54838364
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84771; Hyperlipoproteinemia, type I
DI   ORDO; Orphanet_444490; Familial chylomicronemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM03999
AC   CVCL_X117
SY   GM 3999
DR   CLO; CLO_0016070
DR   Coriell; GM03999
DR   Wikidata; Q54838365
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM04012
AC   CVCL_2S99
DR   CLO; CLO_0016069
DR   Coriell; GM04012
DR   Wikidata; Q54838366
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;5)(2qter->2p25::5q33->5qter;5pter->5q33::2p25->2pter) (Coriell=GM04012).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04017
AC   CVCL_1H79
DR   CLO; CLO_0016239
DR   Coriell; GM04017
DR   Wikidata; Q54838367
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04021
AC   CVCL_1H80
DR   CLO; CLO_0016243
DR   Coriell; GM04021
DR   Wikidata; Q54838368
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM04022
AC   CVCL_1H81
DR   CLO; CLO_0016242
DR   Coriell; GM04022
DR   Wikidata; Q54838369
RX   CelloPub=CLPUB00447;
RX   PubMed=25928884;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H82 ! GM04023
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM04023
AC   CVCL_1H82
DR   CLO; CLO_0016248
DR   Coriell; GM04023
DR   Wikidata; Q54838372
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at 50% risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H81 ! GM04022
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM04024
AC   CVCL_1N27
SY   GM04024B
DR   CLO; CLO_0016245
DR   Coriell; GM04024
DR   Wikidata; Q54838373
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[645]; ClinVar=VCV000009972; Zygosity=Hemizygous (from autologous cell line GM04025).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N28 ! GM04025
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM04025
AC   CVCL_1N28
SY   GM4025B; GM04025C; GM04025E
DR   CLO; CLO_0016229
DR   Coriell; GM04025
DR   Wikidata; Q54838374
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=25776194;
RX   PubMed=33426406;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[645]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N27 ! GM04024
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM04026
AC   CVCL_AX77
DR   CLO; CLO_0016230
DR   Coriell; GM04026
DR   Wikidata; Q54838375
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM04033
AC   CVCL_7405
SY   DMPK CTG1000; DMPK CTG(1000)
DR   CLO; CLO_0016231
DR   Coriell; GM04033
DR   Wikidata; Q54838376
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM04033).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F112 ! GM04034
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   GM04034
AC   CVCL_F112
DR   CLO; CLO_0016232
DR   Coriell; GM04034
DR   Wikidata; Q54838377
RX   CelloPub=CLPUB00447;
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM04034).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7405 ! GM04033
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM04045
AC   CVCL_X118
SY   GM-4045; GM 4045; GM04045B; GM 4045 B
DR   CLO; CLO_0016233
DR   Coriell; GM04045
DR   Wikidata; Q54838379
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian; Greek.
CC   Karyotypic information: 46,XY,t(2;4)(2pter->2q14::4q31.3->4qter;4pter->4q31.1::2q14->2qter) (Coriell=GM04045).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM04053
AC   CVCL_V240
DR   CLO; CLO_0016220
DR   Coriell; GM04053
DR   Wikidata; Q54838380
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM04068
AC   CVCL_1L28
DR   CLO; CLO_0016217
DR   Coriell; GM04068
DR   Wikidata; Q54838381
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04078
AC   CVCL_T820
SY   GM-4078; F4078; 4078
DR   CLO; CLO_0016228
DR   ChEMBL-Cells; CHEMBL4802059
DR   Coriell; GM04078
DR   GEO; GSM2794424
DR   PubChem_Cell_line; CVCL_T820
DR   Wikidata; Q54838382
RX   CelloPub=CLPUB00447;
RX   PubMed=27002638;
RX   PubMed=28444186;
RX   PubMed=29125828;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[341]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[480]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=27002638; PubMed=29125828).
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Indicated by Coriell to have 420 and 541 GAA repeats.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T821 ! GM04079
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   GM04079
AC   CVCL_T821
DR   CLO; CLO_0016225
DR   Coriell; GM04079
DR   Wikidata; Q54838383
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[341]; ClinVar=VCV000561195; Zygosity=Heterozygous (from autologous cell line GM04078).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[480]; ClinVar=VCV000561195; Zygosity=Heterozygous (from autologous cell line GM04078).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Indicated by Coriell to have 420 and 541 GAA repeats.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T820 ! GM04078
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   GM04081
AC   CVCL_0R01
DR   CLO; CLO_0016224
DR   Coriell; GM04081
DR   Wikidata; Q54838384
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98864; Primary carnitine deficiency
DI   ORDO; Orphanet_158; Systemic primary carnitine deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04088
AC   CVCL_2T00
DR   CLO; CLO_0016221
DR   Coriell; GM04088
DR   Wikidata; Q54838385
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;4)(1pter->1q32::4p16->4pter;4qter->4p16::1q32->1qter) (Coriell=GM04088).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04099
AC   CVCL_5M89
DR   CLO; CLO_0016211
DR   Coriell; GM04099
DR   Wikidata; Q54838386
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Heterozygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM04100
AC   CVCL_5M90
SY   RB 4100
DR   CLO; CLO_0016212
DR   Coriell; GM04100
DR   Wikidata; Q54838387
RX   PubMed=6726265;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM04106
AC   CVCL_9Q94
DR   CLO; CLO_0016209
DR   Coriell; GM04106
DR   Wikidata; Q54838388
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q95 ! GM04107
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM04107
AC   CVCL_9Q95
DR   CLO; CLO_0016210
DR   Coriell; GM04107
DR   Wikidata; Q54838389
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q94 ! GM04106
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04111
AC   CVCL_X302
SY   GM 4111
DR   CLO; CLO_0016201
DR   Coriell; GM04111
DR   Wikidata; Q54838390
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;5)(4pter->4q31.1::5p15->5pter;5qter->5p15::4q31.1->4qter),del(21)(qter->p11) (Coriell=GM04111).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM04125
AC   CVCL_1Q58
DR   CLO; CLO_0016208
DR   Coriell; GM04125
DR   Wikidata; Q54838391
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(15;18)(15pter->15q15::18p11.3->18pter;18qter->18p11.3::15q15->15qter) (Coriell=GM04125).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM04126
AC   CVCL_V820
SY   GM 4126
DR   CLO; CLO_0016204
DR   Coriell; GM04126
DR   Wikidata; Q54838392
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35528; Wolf-Hirschhorn syndrome
DI   ORDO; Orphanet_280; Wolf-Hirschhorn syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM04127
AC   CVCL_X303
SY   GM 4127
DR   CLO; CLO_0016194
DR   Coriell; GM04127
DR   Wikidata; Q54838393
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM04128
AC   CVCL_0P44
DR   CLO; CLO_0016192
DR   Coriell; GM04128
DR   Wikidata; Q54838394
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM04139
AC   CVCL_2T01
DR   CLO; CLO_0016199
DR   Coriell; GM04139
DR   Wikidata; Q54838395
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;13)(2pter->2q31::13q32->13qter;13pter->13q32::2q31->2qter) (Coriell=GM04139).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04178
AC   CVCL_DD77
DR   CLO; CLO_0016178
DR   Coriell; GM04178
DR   Wikidata; Q54838396
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM04179
AC   CVCL_9R80
DR   CLO; CLO_0016180
DR   Coriell; GM04179
DR   Wikidata; Q54838397
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125594; Kniest dysplasia
DI   ORDO; Orphanet_485; Kniest dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04180
AC   CVCL_JE59
DR   CLO; CLO_0015924
DR   Coriell; GM04180
DR   Wikidata; Q54838398
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C133744; Pterygium
DI   ORDO; Orphanet_2989; Familial pterygium of the conjunctiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE60 ! GM04181
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM04181
AC   CVCL_JE60
DR   CLO; CLO_0015928
DR   Coriell; GM04181
DR   Wikidata; Q54838399
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133744; Pterygium
DI   ORDO; Orphanet_2989; Familial pterygium of the conjunctiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE59 ! GM04180
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM04188
AC   CVCL_1H83
DR   CLO; CLO_0015927
DR   Coriell; GM04188
DR   Wikidata; Q54838400
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(6;19)(6pter->6q13::19p13.3->19pter;19qter->19p13.3::6q13->6qter) [8]; 46,XX,t(7;22)(7qter->7p15::22q13->22qter;22pter->22q13::7p15>-7pter),del(qter->12)(p13) [4]; 46,XX [38] (Coriell=GM04188).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H84 ! GM04189
SX   Female
AG   77Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04189
AC   CVCL_1H84
DR   CLO; CLO_0015926
DR   Coriell; GM04189
DR   Wikidata; Q54838401
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H83 ! GM04188
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04190
AC   CVCL_1H85
DR   CLO; CLO_0015925
DR   Coriell; GM04190
DR   Wikidata; Q54838403
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,1qh (Coriell=GM04190).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H86 ! GM04191
SX   Female
AG   85Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04191
AC   CVCL_1H86
DR   CLO; CLO_0015922
DR   Coriell; GM04191
DR   Wikidata; Q54838404
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H85 ! GM04190
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04192
AC   CVCL_1H87
DR   CLO; CLO_0015921
DR   Coriell; GM04192
DR   Wikidata; Q54838405
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H88 ! GM04193
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04193
AC   CVCL_1H88
DR   CLO; CLO_0015920
DR   Coriell; GM04193
DR   Wikidata; Q54838406
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H87 ! GM04192
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04194
AC   CVCL_1H89
DR   CLO; CLO_0015919
DR   Coriell; GM04194
DR   Wikidata; Q54838407
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H90 ! GM04195
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04195
AC   CVCL_1H90
DR   CLO; CLO_0015923
DR   Coriell; GM04195
DR   Wikidata; Q54838408
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H89 ! GM04194
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04196
AC   CVCL_1H91
DR   CLO; CLO_0019503
DR   Coriell; GM04196
DR   Wikidata; Q54838409
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H92 ! GM04197
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04197
AC   CVCL_1H92
SY   GM04197A
DR   CLO; CLO_0019502
DR   Coriell; GM04197
DR   Wikidata; Q54838410
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H91 ! GM04196
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04198
AC   CVCL_1H93
DR   CLO; CLO_0019499
DR   Coriell; GM04198
DR   Wikidata; Q54838411
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H94 ! GM04199
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04199
AC   CVCL_1H94
SY   GM04199B
DR   CLO; CLO_0019498
DR   Coriell; GM04199
DR   Wikidata; Q54838412
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H93 ! GM04198
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04200
AC   CVCL_1H95
DR   CLO; CLO_0019501
DR   Coriell; GM04200
DR   Wikidata; Q54838413
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H96 ! GM04201
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04201
AC   CVCL_1H96
SY   GM04201A
DR   CLO; CLO_0019500
DR   Coriell; GM04201
DR   Wikidata; Q54838418
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H95 ! GM04200
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04203
AC   CVCL_1H97
DR   CLO; CLO_0019495
DR   Coriell; GM04203
DR   Wikidata; Q54838419
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM04204
AC   CVCL_M948
DR   CLO; CLO_0019494
DR   Coriell; GM04204
DR   Wikidata; Q54838420
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
RX   PubMed=25928884;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M949 ! GM04205
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM04205
AC   CVCL_M949
SY   GM18015
DR   CLO; CLO_0016021
DR   CLO; CLO_0019497
DR   Coriell; GM04205
DR   Coriell; GM18015
DR   Wikidata; Q54838421
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M948 ! GM04204
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM04206
AC   CVCL_1H98
DR   CLO; CLO_0019496
DR   Coriell; GM04206
DR   Wikidata; Q54838422
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H99 ! GM04207
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04207
AC   CVCL_1H99
DR   CLO; CLO_0019524
DR   Coriell; GM04207
DR   Wikidata; Q54838423
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1H98 ! GM04206
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM04208
AC   CVCL_1I00
DR   CLO; CLO_0019522
DR   Coriell; GM04208
DR   Wikidata; Q54838424
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I01 ! GM04209
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04209
AC   CVCL_1I01
DR   CLO; CLO_0019521
DR   Coriell; GM04209
DR   Wikidata; Q54838425
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I00 ! GM04208
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04210
AC   CVCL_X454
DR   CLO; CLO_0019518
DR   Coriell; GM04210
DR   Wikidata; Q54838426
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X455 ! GM04211
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   GM04211
AC   CVCL_X455
DR   CLO; CLO_0019517
DR   Coriell; GM04211
DR   Wikidata; Q54838427
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X454 ! GM04210
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM04212
AC   CVCL_1I02
DR   CLO; CLO_0019516
DR   Coriell; GM04212
DR   Wikidata; Q54838428
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I03 ! GM04213
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04213
AC   CVCL_1I03
DR   CLO; CLO_0019515
DR   Coriell; GM04213
DR   Wikidata; Q54838429
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I02 ! GM04212
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04217
AC   CVCL_1I04
DR   CLO; CLO_0019514
DR   Coriell; GM04217
DR   Wikidata; Q54838430
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04219
AC   CVCL_1I05
SY   GM04219B
DR   CLO; CLO_0019511
DR   Coriell; GM04219
DR   Wikidata; Q54838431
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04220
AC   CVCL_1I06
DR   CLO; CLO_0019510
DR   Coriell; GM04220
DR   Wikidata; Q54838432
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I07 ! GM04221
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 13
//
ID   GM04221
AC   CVCL_1I07
DR   CLO; CLO_0019457
DR   Coriell; GM04221
DR   Wikidata; Q54838433
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I06 ! GM04220
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM04222
AC   CVCL_1I08
DR   CLO; CLO_0019456
DR   Coriell; GM04222
DR   Wikidata; Q54838434
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I09 ! GM04223
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04223
AC   CVCL_1I09
DR   CLO; CLO_0019459
DR   Coriell; GM04223
DR   Wikidata; Q54838435
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I08 ! GM04222
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04225
AC   CVCL_1I10
DR   CLO; CLO_0019458
DR   Coriell; GM04225
DR   Wikidata; Q54838436
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
ID   GM04226
AC   CVCL_1I11
DR   CLO; CLO_0019461
DR   Coriell; GM04226
DR   Wikidata; Q54838437
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I12 ! GM04227
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04227
AC   CVCL_1I12
DR   CLO; CLO_0019460
DR   Coriell; GM04227
DR   Wikidata; Q54838438
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I11 ! GM04226
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM04229
AC   CVCL_1I13
DR   CLO; CLO_0019463
DR   Coriell; GM04229
DR   Wikidata; Q54838439
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04230
AC   CVCL_1I14
DR   CLO; CLO_0019462
DR   Coriell; GM04230
DR   Wikidata; Q54838440
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I15 ! GM04231
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04231
AC   CVCL_1I15
DR   CLO; CLO_0019455
DR   Coriell; GM04231
DR   Wikidata; Q54838441
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I14 ! GM04230
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04232
AC   CVCL_1I16
DR   CLO; CLO_0019454
DR   Coriell; GM04232
DR   Wikidata; Q54838443
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I17 ! GM04233
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04233
AC   CVCL_1I17
DR   CLO; CLO_0019484
DR   Coriell; GM04233
DR   Wikidata; Q54838444
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I16 ! GM04232
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM04234
AC   CVCL_EJ36
SY   GM4234; GM04234A
DR   CLO; CLO_0019478
DR   Coriell; GM04234
DR   Wikidata; Q54838445
RX   CelloPub=CLPUB00447;
RX   PubMed=1409720;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Arg71Cys (c.211C>T) (R54C, 378T); ClinVar=VCV000013663; Zygosity=Heterozygous (PubMed=1409720).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM04235
AC   CVCL_W029
SY   GM 4235; GM4235
DR   CLO; CLO_0019477
DR   Coriell; GM04235
DR   Wikidata; Q54838446
RX   CelloPub=CLPUB00447;
RX   PubMed=1409720;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Arg71Cys (c.211C>T) (R54C, 378T); ClinVar=VCV000013663; Zygosity=Heterozygous (PubMed=1409720).
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Asp294Ala (c.881A>C) (D277A, 1057C); ClinVar=VCV000013664; Zygosity=Heterozygous (PubMed=1409720).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM04236
AC   CVCL_EJ37
SY   GM4236; GM04236A
DR   CLO; CLO_0019476
DR   Coriell; GM04236
DR   Wikidata; Q54838448
RX   CelloPub=CLPUB00447;
RX   PubMed=1409720;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Asp294Ala (c.881A>C) (D277A, 1057C); ClinVar=VCV000013664; Zygosity=Heterozygous (PubMed=1409720).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM04239
AC   CVCL_N014
SY   GM18016
DR   CLO; CLO_0016024
DR   CLO; CLO_0019481
DR   Coriell; GM04239
DR   Coriell; GM18016
DR   Wikidata; Q54838451
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM04240
AC   CVCL_2T02
DR   CLO; CLO_0019480
DR   Coriell; GM04240
DR   Wikidata; Q54838452
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;6)(4pter->4q25::6p25->6pter;6qter->6p25::4q25->4qter) (Coriell=GM04240).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04250
AC   CVCL_N015
AS   CVCL_4Y27
SY   GM17052; AG04250; AG4250; RB9T
DR   CLO; CLO_0014647
DR   CLO; CLO_0019479
DR   Coriell; AG04250
DR   Coriell; GM04250
DR   Coriell; GM17052
DR   JCRB; KURB2685
DR   Wikidata; Q54838453
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=23665875;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Japanese.
CC   HLA typing: A*02:01:01,33:03:01; B*39:04,44:03:01; C*07:02:01,14:03; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:04:01; DRB1*04:03:01,13:02:01; DRB3*03:01:01; DRB4*01:03:01 (PubMed=29959025).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; AG04250; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM04258
AC   CVCL_GS62
SY   GM04258A; GM 4258A
DR   CLO; CLO_0019474
DR   Coriell; GM04258
DR   Wikidata; Q54838454
RX   CelloPub=CLPUB00447;
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Ser291Leu (c.872C>T); ClinVar=VCV000001971; Zygosity=Heterozygous (Coriell=GM04258).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Ala329Val (c.986C>T); ClinVar=VCV000001959; Zygosity=Heterozygous (PubMed=1346349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   GM04260
AC   CVCL_7406
AS   CVCL_H785
SY   GM4260; GM 04260; GM04260A; AG04260; AG4260
DR   CLO; CLO_0019615
DR   Coriell; AG04260
DR   Coriell; GM04260
DR   GEO; GSM1316983
DR   GEO; GSM1317022
DR   GEO; GSM3124665
DR   Wikidata; Q54838455
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=7847674;
RX   PubMed=8832629;
RX   PubMed=26984941;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; AG04260; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM04263
AC   CVCL_GT50
DR   CLO; CLO_0019612
DR   Coriell; GM04263
DR   Wikidata; Q54838456
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04268
AC   CVCL_0P45
SY   CD#68
DR   CLO; CLO_0019596
DR   Coriell; GM04268
DR   Wikidata; Q54838457
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
RX   PubMed=33304759;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Homozygous (PubMed=19815695; PubMed=33304759).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=33304759
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D21S11: 29,31.2
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04272
AC   CVCL_V236
SY   GM4272
DR   Coriell; GM04272
DR   Wikidata; Q54838458
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM04272; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04279
AC   CVCL_H152
SY   GM04279A; P3B13C2
DR   CLO; CLO_0019600
DR   Coriell; GM04279
DR   Wikidata; Q54838459
RX   CelloPub=CLPUB00447;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   GM04280
AC   CVCL_H153
SY   KE2
DR   CLO; CLO_0019601
DR   Coriell; GM04280
DR   Wikidata; Q54838462
RX   CelloPub=CLPUB00447;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   GM04281
AC   CVCL_8519
DR   CLO; CLO_0019589
DR   Coriell; GM04281
DR   Wikidata; Q54838463
RX   CelloPub=CLPUB00447;
RX   PubMed=18691744;
RX   PubMed=25928884;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=18691744; PubMed=25928884).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F113 ! GM04282
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GM04282
AC   CVCL_F113
SY   GM04282A
DR   CLO; CLO_0019590
DR   Coriell; GM04282
DR   Wikidata; Q54838464
RX   CelloPub=CLPUB00447;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04281).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM04284
AC   CVCL_V565
SY   GM04284B
DR   CLO; CLO_0019591
DR   Coriell; GM04284
DR   Wikidata; Q54838465
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V570 ! GM04807
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04285
AC   CVCL_Y867
DR   CLO; CLO_0019593
DR   Coriell; GM04285
DR   Wikidata; Q54838466
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y868 ! GM04286
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04286
AC   CVCL_Y868
DR   CLO; CLO_0019644
DR   Coriell; GM04286
DR   Wikidata; Q54838468
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y867 ! GM04285
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04287
AC   CVCL_Y859
DR   CLO; CLO_0019641
DR   Coriell; GM04287
DR   Wikidata; Q54838469
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from child cell line ND38551).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y860 ! GM04288
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM04288
AC   CVCL_Y860
DR   CLO; CLO_0019640
DR   Coriell; GM04288
DR   Wikidata; Q54838470
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04287).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y859 ! GM04287
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04289
AC   CVCL_US61
SY   GM04289C
DR   Coriell; GM04289
DR   Wikidata; Q93587500
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM04289; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I19 ! GM04482
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM04290
AC   CVCL_1I18
DR   CLO; CLO_0019631
DR   Coriell; GM04290
DR   Wikidata; Q54838471
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US67 ! GM05551
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
ID   GM04297
AC   CVCL_5M91
DR   CLO; CLO_0019633
DR   Coriell; GM04297
DR   Wikidata; Q54838472
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM04300
AC   CVCL_N016
SY   GM17023
DR   CLO; CLO_0014707
DR   CLO; CLO_0019627
DR   Coriell; GM04300
DR   Coriell; GM17023
DR   Wikidata; Q54838473
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Indian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM04305
AC   CVCL_IJ33
DR   CLO; CLO_0019629
DR   Coriell; GM04305
DR   Wikidata; Q54838474
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX43 ! GM00806
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM04306
AC   CVCL_CZ10
DR   CLO; CLO_0019623
DR   Coriell; GM04306
DR   Wikidata; Q54838475
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ16 ! GM06092
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM04307
AC   CVCL_CZ83
DR   CLO; CLO_0019625
DR   Coriell; GM04307
DR   Wikidata; Q54838476
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ85 ! GM06091
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM04311
AC   CVCL_AY61
SY   GM4311
DR   CLO; CLO_0019620
DR   Coriell; GM04311
DR   Wikidata; Q54838477
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84612; Carbamoyl-phosphate synthetase I deficiency
DI   ORDO; Orphanet_147; Carbamoyl-phosphate synthetase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM04315
AC   CVCL_5M92
DR   CLO; CLO_0019552
DR   Coriell; GM04315
DR   Wikidata; Q54838479
RX   CelloPub=CLPUB00447;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex44del; Zygosity=Heterozygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM04319
AC   CVCL_AX24
DR   CLO; CLO_0019527
DR   Coriell; GM04319
DR   Wikidata; Q54838480
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM04319; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM04320
AC   CVCL_0M23
SY   GM 4320
DR   CLO; CLO_0019529
DR   Coriell; GM04320
DR   Wikidata; Q54838481
RX   CelloPub=CLPUB00447;
RX   PubMed=2445735;
RX   PubMed=25772471;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous (PubMed=25772471).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=25772471).
CC   Caution: Was originally thought to be homozygous for CFTR p.Phe508del and is still described as such in Coriell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM04322
AC   CVCL_0M24
DR   CLO; CLO_0019531
DR   Coriell; GM04322
DR   Wikidata; Q54838482
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM04322).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04323
AC   CVCL_0M25
DR   CLO; CLO_0019534
DR   Coriell; GM04323
DR   Wikidata; Q54838483
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from familial inference of GM04322).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   GM04326
AC   CVCL_0Q83
SY   GM4326
DR   CLO; CLO_0019535
DR   Coriell; GM04326
DR   Wikidata; Q54838484
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04327
AC   CVCL_5M93
SY   GM4327
DR   CLO; CLO_0019536
DR   Coriell; GM04327
DR   Wikidata; Q54838485
RX   CelloPub=CLPUB00447;
RX   PubMed=3863481;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian; Sardinian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex5-7dup; Zygosity=Hemizygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM04329
AC   CVCL_2Z44
DR   CLO; CLO_0019571
DR   Coriell; GM04329
DR   Wikidata; Q54838486
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M2W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM04330
AC   CVCL_0M26
DR   CLO; CLO_0019587
DR   Coriell; GM04330
DR   Wikidata; Q54838488
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile105Serfs*2 (c.313delA) (444delA); ClinVar=VCV000048684; Zygosity=Heterozygous (Coriell=GM04330).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1680-1G>A (IVS11-1G>A) (1812-1G-A); ClinVar=VCV000048681; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM04330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M27 ! GM04331
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM04331
AC   CVCL_0M27
DR   CLO; CLO_0019583
DR   Coriell; GM04331
DR   Wikidata; Q54838489
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile105Serfs*2 (c.313delA) (444delA); ClinVar=VCV000048684; Zygosity=Heterozygous (Coriell=GM04331).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1680-1G>A (IVS11-1G>A) (1812-1G-A); ClinVar=VCV000048681; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM04331).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M26 ! GM04330
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM04337
AC   CVCL_0M28
DR   CLO; CLO_0019580
DR   Coriell; GM04337
DR   Wikidata; Q54838490
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from familial inference of GM04322).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   GM04338
AC   CVCL_0M29
DR   CLO; CLO_0019579
DR   Coriell; GM04338
DR   Wikidata; Q54838492
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM04339
AC   CVCL_0M30
SY   GM 4339
DR   CLO; CLO_0019563
DR   Coriell; GM04339
DR   Wikidata; Q54838493
RX   CelloPub=CLPUB00447;
RX   PubMed=2445735;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly85Glu (c.254G>A); ClinVar=VCV000007143; Zygosity=Heterozygous (Coriell=GM04339).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM04339).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04340
AC   CVCL_N017
SY   GM 04340; GM4340; GM04340A; GM17092
DR   CLO; CLO_0014524
DR   CLO; CLO_0019565
DR   Coriell; GM04340
DR   Coriell; GM17092
DR   Wikidata; Q54838494
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Iberian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM04345
AC   CVCL_0M31
DR   CLO; CLO_0019558
DR   Coriell; GM04345
DR   Wikidata; Q54838495
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM04345).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (Coriell=GM04345).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M32 ! GM04346
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM04346
AC   CVCL_0M32
DR   CLO; CLO_0019560
DR   Coriell; GM04346
DR   Wikidata; Q54838496
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM04346).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (Coriell=GM04346).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M31 ! GM04345
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04347
AC   CVCL_4D84
DR   CLO; CLO_0019567
DR   Coriell; GM04347
DR   Wikidata; Q54838497
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM04363
AC   CVCL_5M94
DR   CLO; CLO_0019311
DR   Coriell; GM04363
DR   Wikidata; Q54838498
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex51-55del; Zygosity=Heterozygous (from familial inference of GM04364).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   GM04364
AC   CVCL_5M95
DR   CLO; CLO_0019314
DR   Coriell; GM04364
DR   Wikidata; Q54838499
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex51-55del; Zygosity=Hemizygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM04368
AC   CVCL_4N43
DR   CLO; CLO_0019307
DR   Coriell; GM04368
DR   Wikidata; Q54838500
CC   Sequence variation: Mutation; HGNC; HGNC:7459; MT-ND4; Simple; p.Arg340His (m.11778G>A); ClinVar=VCV000009708; Zygosity=Unspecified (Coriell=GM04368).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM04370
AC   CVCL_X304
SY   GM 4370; GM04370A
DR   CLO; CLO_0019310
DR   Coriell; GM04370
DR   Wikidata; Q54838501
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=10577914;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+der(22)(22pter->22q11::11q23->11qter)mat (Coriell=GM04370).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 10
//
ID   GM04371
AC   CVCL_X305
SY   GM-4371; GM 4371
DR   CLO; CLO_0019302
DR   Coriell; GM04371
DR   Wikidata; Q54838502
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM04372
AC   CVCL_2Z50
SY   GM 4372
DR   CLO; CLO_0019303
DR   Coriell; GM04372
DR   Wikidata; Q54838503
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Homozygous (Coriell=GM04372).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM04374
AC   CVCL_GS63
DR   CLO; CLO_0019341
DR   Coriell; GM04374
DR   Wikidata; Q54838504
RX   CelloPub=CLPUB00447;
CC   Population: Native North American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129032; Tyrosinemia type II
DI   ORDO; Orphanet_28378; Tyrosinemia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04375
AC   CVCL_W622
SY   GM04375A
DR   CLO; CLO_0019338
DR   Coriell; GM04375
DR   Wikidata; Q54838507
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM04376
AC   CVCL_AB34
SY   GM04376A
DR   CLO; CLO_0019336
DR   Coriell; GM04376
DR   Wikidata; Q54838508
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 69,XXX (Coriell=GM04376).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04390
AC   CVCL_7407
SY   GM4390; GM 04390; GM04390A
DR   CLO; CLO_0019332
DR   Coriell; GM04390
DR   Wikidata; Q54838509
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=7847674;
RX   PubMed=8246632;
RX   PubMed=8650226;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM04391
AC   CVCL_4N44
DR   CLO; CLO_0019701
DR   Coriell; GM04391
DR   Wikidata; Q54838510
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Asn215Ser (c.644A>G); ClinVar=VCV000010730; Zygosity=Hemizygous (Coriell=GM04391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM04394
AC   CVCL_0R33
SY   GM4394
DR   CLO; CLO_0019702
DR   Coriell; GM04394
DR   Wikidata; Q54838511
RX   CelloPub=CLPUB00447;
RX   PubMed=2464926;
RX   PubMed=6593712;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (Coriell=GM04394).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   GM04395
AC   CVCL_GS64
DR   CLO; CLO_0019703
DR   Coriell; GM04395
DR   Wikidata; Q54838512
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Leu107Pro (c.320T>C); ClinVar=VCV000001965; Zygosity=Heterozygous (Coriell=GM04395).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg211Cys (c.631C>T); ClinVar=VCV000001966; Zygosity=Heterozygous (Coriell=GM04395).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS65 ! GM04396
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   GM04396
AC   CVCL_GS65
SY   GM 4396
DR   CLO; CLO_0019704
DR   Coriell; GM04396
DR   Wikidata; Q54838513
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Leu107Pro (c.320T>C); ClinVar=VCV000001965; Zygosity=Heterozygous (Coriell=GM04396).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg211Cys (c.631C>T); ClinVar=VCV000001966; Zygosity=Heterozygous (Coriell=GM04396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GS64 ! GM04395
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   GM04403
AC   CVCL_2T03
DR   CLO; CLO_0019705
DR   Coriell; GM04403
DR   Wikidata; Q54838514
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(11;22)(11pter->11q23::22q11->22qter;22pter->22q11::11q23->11qter) (Coriell=GM04403).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM04408
AC   CVCL_7408
SY   GM4408; GM-4408; GM 4408; GM04408A; HG1440
DR   BTO; BTO_0005028
DR   CLO; CLO_0019706
DR   Coriell; GM04408
DR   Wikidata; Q54838515
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
RX   PubMed=6330733;
RX   PubMed=6667451;
RX   PubMed=6705251;
RX   PubMed=17407155;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian; English and Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Gly (c.3163T>G); ClinVar=VCV001728339; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 87(AlFra) (BSR87).
CC   Caution: Coriell has p.Cys1055fs*23 (c.3159delT) (3233delT) as the second mutation for this cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F114 ! GM03498
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   GM04409
AC   CVCL_F124
SY   GM-4409; GM 4409
DR   CLO; CLO_0019707
DR   Coriell; GM04409
DR   Wikidata; Q54838516
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   GM04410
AC   CVCL_2T04
DR   CLO; CLO_0019708
DR   Coriell; GM04410
DR   Wikidata; Q54838517
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;14)(2qter->2p23::14q32->14qter;14pter->14q32::2p23->2pter) (Coriell=GM04410).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04411
AC   CVCL_9Y77
SY   GM04411A
DR   CLO; CLO_0019709
DR   Coriell; GM04411
DR   Wikidata; Q54838518
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04420
AC   CVCL_AI32
DR   CLO; CLO_0019710
DR   Coriell; GM04420
DR   Wikidata; Q54838519
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 8
//
ID   GM04421
AC   CVCL_AI33
DR   CLO; CLO_0019685
DR   Coriell; GM04421
DR   Wikidata; Q54838520
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI41 ! GM08008
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 8
//
ID   GM04422
AC   CVCL_AI34
DR   CLO; CLO_0019683
DR   Coriell; GM04422
DR   Wikidata; Q54838521
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI91 ! GM08756
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 8
//
ID   GM04425
AC   CVCL_9Y78
DR   CLO; CLO_0019684
DR   Coriell; GM04425
DR   Wikidata; Q54838522
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04426
AC   CVCL_9Y79
DR   CLO; CLO_0019681
DR   Coriell; GM04426
DR   Wikidata; Q54838523
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04427
AC   CVCL_9Y80
DR   CLO; CLO_0019682
DR   Coriell; GM04427
DR   Wikidata; Q54838524
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04428
AC   CVCL_N018
SY   GM17067
DR   CLO; CLO_0014566
DR   CLO; CLO_0019689
DR   Coriell; GM04428
DR   Coriell; GM17067
DR   Wikidata; Q54838525
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM04430
AC   CVCL_X306
SY   GM 4430; GM04430A
DR   CLO; CLO_0019687
DR   Coriell; GM04430
DR   Wikidata; Q54838527
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM04435
AC   CVCL_X307
SY   GM 4435
DR   CLO; CLO_0019688
DR   Coriell; GM04435
DR   GEO; GSM803
DR   Wikidata; Q54838528
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=11687795;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
DI   NCIt; C37866; Trisomy 16
DI   NCIt; C43224; Trisomy 21
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   19FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM04465
AC   CVCL_CV41
DR   CLO; CLO_0019686
DR   Coriell; GM04465
DR   Wikidata; Q54838529
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35008; Schwartz-Jampel syndrome
DI   ORDO; Orphanet_800; Schwartz-Jampel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM04476
AC   CVCL_V339
DR   CLO; CLO_0019665
DR   Coriell; GM04476
DR   Wikidata; Q54838530
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V340 ! GM04477
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04477
AC   CVCL_V340
SY   GM04477A; GM04477B
DR   CLO; CLO_0019666
DR   Coriell; GM04477
DR   Wikidata; Q54838531
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V339 ! GM04476
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM04478
AC   CVCL_V566
DR   CLO; CLO_0019661
DR   Coriell; GM04478
DR   Wikidata; Q54838532
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V567 ! GM04479
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04479
AC   CVCL_V567
SY   GM04479A
DR   CLO; CLO_0019662
DR   Coriell; GM04479
DR   Wikidata; Q54838533
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V566 ! GM04478
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04482
AC   CVCL_1I19
DR   CLO; CLO_0019663
DR   Coriell; GM04482
DR   Wikidata; Q54838534
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US61 ! GM04289
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04488
AC   CVCL_4F50
DR   CLO; CLO_0019664
DR   Coriell; GM04488
DR   Wikidata; Q54838535
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM04488).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM04496
AC   CVCL_9R20
SY   GM 4496
DR   CLO; CLO_0019670
DR   Coriell; GM04496
DR   Wikidata; Q54838539
RX   CelloPub=CLPUB00447;
RX   PubMed=1634904;
RX   PubMed=21721033;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21721033
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 16,19
ST   D19S433: 13,15
ST   D21S11: 30,31.2
ST   D2S1338: 16,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 19,21
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM04500
AC   CVCL_2T05
DR   CLO; CLO_0018817
DR   Coriell; GM04500
DR   Wikidata; Q54838540
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;3)(1qter->1p36::3q13.3->3qter;3pter->3q13.3::1p36->1pter) (Coriell=GM04500).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04501
AC   CVCL_7409
SY   GM04501A; HF20
DR   CLO; CLO_0018819
DR   Coriell; GM04501
DR   GEO; GSM3124646
DR   Wikidata; Q54838541
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Donor information: Established from monozygotic twin of GM04502 (Cellosaurus=CVCL_F135).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM04502
AC   CVCL_F135
SY   GM04502A; HF21
DR   CLO; CLO_0018818
DR   Coriell; GM04502
DR   Wikidata; Q54838542
RX   CelloPub=CLPUB00447;
CC   Donor information: Established from monozygotic twin of GM04501 (Cellosaurus=CVCL_7409).
CC   Discontinued: Coriell; GM04502; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM04503
AC   CVCL_7410
SY   GM04503B; GM04503D; HF22
DR   CLO; CLO_0018813
DR   Coriell; GM04503
DR   ENCODE; ENCBS015ENC
DR   ENCODE; ENCBS290AAA
DR   ENCODE; ENCBS339GFS
DR   GEO; GSE76836
DR   GEO; GSM3124651
DR   Wikidata; Q54838543
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
RX   PubMed=30567591;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM04503D_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Donor information: Established from monozygotic twin of GM04504 (Cellosaurus=CVCL_7411).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM04504
AC   CVCL_7411
SY   GM04504A; HF23
DR   CLO; CLO_0018812
DR   Coriell; GM04504
DR   ENCODE; ENCBS016ENC
DR   ENCODE; ENCBS388KHM
DR   GEO; GSM3124652
DR   Wikidata; Q54838544
RX   CelloPub=CLPUB00447;
RX   PubMed=30567591;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM04504A_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM04503 (Cellosaurus=CVCL_7410).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM04505
AC   CVCL_7412
SY   GM04505A; HF24
DR   CLO; CLO_0018816
DR   Coriell; GM04505
DR   GEO; GSM3124650
DR   Wikidata; Q54838545
RX   CelloPub=CLPUB00447;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM04506 (Cellosaurus=CVCL_7413).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM04506
AC   CVCL_7413
SY   GM04506A; HF25
DR   CLO; CLO_0018815
DR   Coriell; GM04506
DR   Wikidata; Q54838546
RX   CelloPub=CLPUB00447;
RX   PubMed=21490598;
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of GM04505 (Cellosaurus=CVCL_7412).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM04510
AC   CVCL_G039
SY   GM4510; GM04510B; GM4510B; GM04510C
DR   CLO; CLO_0018829
DR   Coriell; GM04510
DR   Wikidata; Q54838550
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
RX   PubMed=3180052;
RX   PubMed=10468606;
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; c.456+4A>T (IVS4+4A>T); ClinVar=VCV000012045; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM04510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM04513
AC   CVCL_X119
SY   GM 4513
DR   CLO; CLO_0018827
DR   Coriell; GM04513
DR   Wikidata; Q54838551
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+del(2)(qter->p23) [38]; 47,XX,+2 [12] (Coriell=GM04513).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM04514
AC   CVCL_X308
SY   GM 4514
DR   CLO; CLO_0018832
DR   Coriell; GM04514
DR   Wikidata; Q54838552
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM04515
AC   CVCL_AW69
DR   CLO; CLO_0018851
DR   Coriell; GM04515
DR   Wikidata; Q54838553
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36078; Sideroblastic anemia
DI   ORDO; Orphanet_1047; Sideroblastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW70 ! GM04516
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM04516
AC   CVCL_AW70
DR   CLO; CLO_0018850
DR   Coriell; GM04516
DR   Wikidata; Q54838554
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36078; Sideroblastic anemia
DI   ORDO; Orphanet_1047; Sideroblastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW69 ! GM04515
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM04517
AC   CVCL_2Z51
SY   GM 4517
DR   CLO; CLO_0018849
DR   Coriell; GM04517
DR   Wikidata; Q54838555
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Homozygous (Coriell=GM04517).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM04518
AC   CVCL_AB46
DR   CLO; CLO_0018848
DR   Coriell; GM04518
DR   Wikidata; Q54838556
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:6826; MAN2B1; Simple; p.Pro356Arg (c.1067C>G); ClinVar=VCV000001688; Zygosity=Homozygous (Coriell=GM04518).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84548; Alpha-mannosidosis
DI   ORDO; Orphanet_61; Alpha-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM04519
AC   CVCL_5L50
DR   CLO; CLO_0018846
DR   Coriell; GM04519
DR   Wikidata; Q54838557
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Unexplicit; Ex1-14del; Zygosity=Unspecified (Coriell=GM04519).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L51 ! GM04520
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM04520
AC   CVCL_5L51
DR   CLO; CLO_0018844
DR   Coriell; GM04520
DR   Wikidata; Q54838558
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Unexplicit; Ex1-14del; Zygosity=Unspecified (Coriell=GM04520).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L50 ! GM04519
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   GM04522
AC   CVCL_7414
SY   GM4522; SK118
DR   CLO; CLO_0018843
DR   Coriell; GM04522
DR   Wikidata; Q54838559
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
RX   PubMed=17668376;
CC   Population: Caucasian.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM04534
AC   CVCL_1I20
DR   CLO; CLO_0018842
DR   Coriell; GM04534
DR   Wikidata; Q54838560
RX   CelloPub=CLPUB00447;
RX   PubMed=6316146;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at low risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04535
AC   CVCL_N019
SY   GM17053
DR   CLO; CLO_0014663
DR   CLO; CLO_0018864
DR   Coriell; GM04535
DR   Coriell; GM17053
DR   Wikidata; Q54838561
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126738; Phosphoglycerate kinase 1 deficiency
DI   ORDO; Orphanet_713; Glycogen storage disease due to phosphoglycerate kinase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM04536
AC   CVCL_X120
SY   GM 4536
DR   CLO; CLO_0018862
DR   Coriell; GM04536
DR   Wikidata; Q54838562
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM04539
AC   CVCL_0M33
DR   CLO; CLO_0018881
DR   Coriell; GM04539
DR   Wikidata; Q54838563
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM04539).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM04540
AC   CVCL_0M34
SY   GM04540A
DR   CLO; CLO_0018873
DR   Coriell; GM04540
DR   Wikidata; Q54838564
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM04540).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M35 ! GM04541
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM04541
AC   CVCL_0M35
DR   CLO; CLO_0018872
DR   Coriell; GM04541
DR   Wikidata; Q54838565
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM04541).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0M34 ! GM04540
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM04543
AC   CVCL_0M36
DR   CLO; CLO_0018875
DR   Coriell; GM04543
DR   Wikidata; Q54838566
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM04543).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM04545
AC   CVCL_0M37
DR   CLO; CLO_0018874
DR   Coriell; GM04545
DR   Wikidata; Q54838567
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM04545).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM04547
AC   CVCL_0M38
DR   CLO; CLO_0018877
DR   Coriell; GM04547
DR   Wikidata; Q54838568
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM04547).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM04562
AC   CVCL_AK96
SY   RB 4562
DR   CLO; CLO_0018876
DR   Coriell; GM04562
DR   Wikidata; Q54838569
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM04567
AC   CVCL_AW53
DR   CLO; CLO_0018879
DR   Coriell; GM04567
DR   Wikidata; Q54838570
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM04567).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM04569
AC   CVCL_8520
DR   CLO; CLO_0018878
DR   Coriell; GM04569
DR   Wikidata; Q54838571
RX   PubMed=18691744;
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; None_reported; -; Zygosity=- (PubMed=21354051).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GM04573
AC   CVCL_AW54
DR   CLO; CLO_0018880
DR   Coriell; GM04573
DR   Wikidata; Q54838572
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM04584
AC   CVCL_1I21
DR   CLO; CLO_0018900
DR   Coriell; GM04584
DR   Wikidata; Q54838573
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
ID   GM04585
AC   CVCL_AA22
DR   CLO; CLO_0018901
DR   Coriell; GM04585
DR   Wikidata; Q54838574
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA23 ! GM04586
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM04586
AC   CVCL_AA23
DR   CLO; CLO_0018885
DR   Coriell; GM04586
DR   Wikidata; Q54838575
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA22 ! GM04585
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM04587
AC   CVCL_AA24
DR   CLO; CLO_0018884
DR   Coriell; GM04587
DR   Wikidata; Q54838576
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM04589
AC   CVCL_AA25
DR   CLO; CLO_0018883
DR   Coriell; GM04589
DR   GEO; GSM3592405
DR   GEO; GSM3592411
DR   Wikidata; Q54838577
RX   PubMed=29762696;
RX   PubMed=30905397;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30905397).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: GMO4589; PubMed=29762696.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM04592
AC   CVCL_V473
SY   GM 4592; GM04592A
DR   CLO; CLO_0018882
DR   Coriell; GM04592
DR   Wikidata; Q54838578
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM04593
AC   CVCL_DB60
DR   CLO; CLO_0018889
DR   Coriell; GM04593
DR   Wikidata; Q54838579
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM04594
AC   CVCL_GY21
DR   CLO; CLO_0018888
DR   Coriell; GM04594
DR   Wikidata; Q54838580
RX   CelloPub=CLPUB00447;
RX   PubMed=28677541;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Val139Met (c.415G>A); ClinVar=VCV000010433; Zygosity=Heterozygous (Coriell=GM04594).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28677541
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 13,16
ST   D21S11: 29,32.2
ST   D2S1338: 19,24
ST   D3S1358: 11,17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,15
ST   Penta E: 7,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 16
//
ID   GM04595
AC   CVCL_GY22
DR   CLO; CLO_0018887
DR   Coriell; GM04595
DR   Wikidata; Q54838581
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Val139Met (c.415G>A); ClinVar=VCV000010433; Zygosity=Heterozygous (Coriell=GM04595).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM04596
AC   CVCL_GY23
DR   CLO; CLO_0018886
DR   Coriell; GM04596
DR   Wikidata; Q54838582
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Val139Met (c.415G>A); ClinVar=VCV000010433; Zygosity=Heterozygous (Coriell=GM04596).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM04597
AC   CVCL_GY24
SY   GM04597A
DR   CLO; CLO_0018914
DR   Coriell; GM04597
DR   Wikidata; Q54838583
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Val139Met (c.415G>A); ClinVar=VCV000010433; Zygosity=Heterozygous (Coriell=GM04597).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM04598
AC   CVCL_GY25
DR   CLO; CLO_0018923
DR   Coriell; GM04598
DR   Wikidata; Q54838585
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Val139Met (c.415G>A); ClinVar=VCV000010433; Zygosity=Hemizygous (Coriell=GM04598).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM04599
AC   CVCL_0L60
SY   GM04599A
DR   Coriell; GM04599
DR   Wikidata; Q54838586
CC   Population: African American.
CC   Discontinued: Coriell; GM04599; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   GM04601
AC   CVCL_Y793
DR   CLO; CLO_0018919
DR   Coriell; GM04601
DR   Wikidata; Q54838587
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM04602
AC   CVCL_Y794
DR   CLO; CLO_0018907
DR   Coriell; GM04602
DR   Wikidata; Q54838588
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (from autologous cell line GM06077).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y800 ! GM06077
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   GM04603
AC   CVCL_Y795
DR   CLO; CLO_0018909
DR   Coriell; GM04603
DR   Wikidata; Q54838589
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y796 ! GM04604
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM04604
AC   CVCL_Y796
DR   CLO; CLO_0018911
DR   Coriell; GM04604
DR   Wikidata; Q54838590
RX   PubMed=32656337;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y795 ! GM04603
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM04608
AC   CVCL_Y797
DR   CLO; CLO_0018912
DR   Coriell; GM04608
DR   Wikidata; Q54838596
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM04610
AC   CVCL_X309
SY   GM 4610
DR   CLO; CLO_0018902
DR   Coriell; GM04610
DR   Wikidata; Q54838597
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Karyotypic information: 47,XX,+8 [75]; 46,XX,+8,dic(14;21)(14qter->14p13::21p13->21qter) [25] (Coriell=GM04610).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM04613
AC   CVCL_1N63
SY   GM4613
DR   CLO; CLO_0018903
DR   Coriell; GM04613
DR   Wikidata; Q54838599
RX   CelloPub=CLPUB00447;
RX   PubMed=2570029;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(2;11)(2qter->2p11.2::11p13->11pter;11qter->11p13::2p11.2->2pter)mat (Coriell=GM04613).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04614
AC   CVCL_V474
SY   GM 4614
DR   CLO; CLO_0018905
DR   Coriell; GM04614
DR   Wikidata; Q54838600
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Discontinued: Coriell; GM04614; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM04616
AC   CVCL_V475
SY   GM 4616; GM04616A
DR   CLO; CLO_0018955
DR   Coriell; GM04616
DR   Wikidata; Q54838601
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=17668376;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM04617
AC   CVCL_V476
SY   GM 4617
DR   CLO; CLO_0018953
DR   Coriell; GM04617
DR   Wikidata; Q54838602
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Puerto Rican.
CC   Karyotypic information: 47,XX,+21[25].arr(21)x3 (Coriell=GM04617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04618
AC   CVCL_N128
SY   GM4618; GM 4618
DR   CLO; CLO_0018950
DR   Coriell; GM04618
DR   Wikidata; Q54838603
RX   CelloPub=CLPUB00447;
RX   PubMed=1679663;
RX   PubMed=2498246;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N129 ! GM10005
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM04619
AC   CVCL_5M96
DR   CLO; CLO_0018945
DR   Coriell; GM04619
DR   Wikidata; Q54838604
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Arg2905Ter (c.8713C>T); ClinVar=VCV000011288; Zygosity=Hemizygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM04621
AC   CVCL_5M97
DR   CLO; CLO_0018941
DR   Coriell; GM04621
DR   Wikidata; Q54838605
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Arg2905Ter (c.8713C>T); ClinVar=VCV000011288; Zygosity=Heterozygous (from familial inference of GM04619).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   GM04623
AC   CVCL_AA26
DR   CLO; CLO_0018944
DR   Coriell; GM04623
DR   Wikidata; Q54838606
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM04624
AC   CVCL_AA27
DR   CLO; CLO_0018938
DR   Coriell; GM04624
DR   Wikidata; Q54838607
RX   CelloPub=CLPUB00447;
CC   Population: Native North American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM04626
AC   CVCL_X310
SY   GM 4626
DR   CLO; CLO_0018940
DR   Coriell; GM04626
DR   GEO; GSM608319
DR   GEO; GSM608320
DR   Wikidata; Q54838608
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=21177337;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM04627
AC   CVCL_X311
SY   GM-4627; GM 4627
DR   CLO; CLO_0018935
DR   Coriell; GM04627
DR   Wikidata; Q54838609
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM04628
AC   CVCL_2T06
SY   GM4628
DR   CLO; CLO_0018936
DR   Coriell; GM04628
DR   Wikidata; Q54838610
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
CC   Population: Caucasian; Swiss.
CC   Karyotypic information: 46,X,t(X;22)(q12;p11) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM04632
AC   CVCL_AA28
DR   CLO; CLO_0018971
DR   Coriell; GM04632
DR   Wikidata; Q54838611
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM02343).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM04634
AC   CVCL_M950
DR   CLO; CLO_0018975
DR   Coriell; GM04634
DR   Wikidata; Q54838612
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM02343).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M951 ! GM04635
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GM04635
AC   CVCL_M951
SY   GM17363
DR   CLO; CLO_0013706
DR   CLO; CLO_0018972
DR   Coriell; GM04635
DR   Coriell; GM17363
DR   Wikidata; Q54838613
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM02343).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M950 ! GM04634
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   GM04637
AC   CVCL_AA29
SY   GM04637A
DR   CLO; CLO_0018979
DR   Coriell; GM04637
DR   Wikidata; Q54838614
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04637).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM04638
AC   CVCL_AA30
DR   CLO; CLO_0018977
DR   Coriell; GM04638
DR   Wikidata; Q54838615
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04638).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (Coriell=GM04638).
CC   Discontinued: Coriell; GM04638; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 17
//
ID   GM04642
AC   CVCL_AA31
DR   CLO; CLO_0018964
DR   BioSample; SAMN00795434
DR   Coriell; GM04642
DR   Wikidata; Q54838616
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA32 ! GM04643
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM04643
AC   CVCL_AA32
DR   CLO; CLO_0018965
DR   BioSample; SAMN00795436
DR   Coriell; GM04643
DR   Wikidata; Q54838617
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA31 ! GM04642
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04647
AC   CVCL_AW55
DR   CLO; CLO_0018966
DR   Coriell; GM04647
DR   Wikidata; Q54838618
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM04647).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW56 ! GM04648
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM04648
AC   CVCL_AW56
DR   CLO; CLO_0018967
DR   Coriell; GM04648
DR   Wikidata; Q54838619
RX   PubMed=23680132;
RX   PubMed=32656337;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=32656337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW55 ! GM04647
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM04663
AC   CVCL_7415
DR   CLO; CLO_0018968
DR   Coriell; GM04663
DR   GEO; GSM3592407
DR   GEO; GSM3592413
DR   Wikidata; Q54838620
RX   CelloPub=CLPUB00447;
RX   PubMed=29762696;
RX   PubMed=30905397;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (Coriell=GM04663).
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30905397).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: GMO4663; PubMed=29762696.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM04664
AC   CVCL_F115
DR   CLO; CLO_0019008
DR   Coriell; GM04664
DR   Wikidata; Q54838621
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM04663).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   GM04665
AC   CVCL_AA33
DR   CLO; CLO_0019010
DR   Coriell; GM04665
DR   Wikidata; Q54838622
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM04663).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   GM04666
AC   CVCL_8A01
DR   CLO; CLO_0019009
DR   Coriell; GM04666
DR   Wikidata; Q54838623
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM04668
AC   CVCL_9W97
DR   CLO; CLO_0019015
DR   Coriell; GM04668
DR   Wikidata; Q54838624
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84903; Sly syndrome
DI   ORDO; Orphanet_584; Mucopolysaccharidosis type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04673
AC   CVCL_9R21
SY   GM04673A; GM04673B
DR   CLO; CLO_0019016
DR   Coriell; GM04673
DR   Wikidata; Q54838625
RX   CelloPub=CLPUB00447;
RX   PubMed=19127062;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R24 ! GM04904
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM04674
AC   CVCL_9R22
SY   GM04674A
DR   CLO; CLO_0019012
DR   Coriell; GM04674
DR   Wikidata; Q54838626
RX   CelloPub=CLPUB00447;
RX   PubMed=19127062;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R23 ! GM04903
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM04681
AC   CVCL_AT05
SY   GM 4681
DR   CLO; CLO_0019037
DR   Coriell; GM04681
DR   Wikidata; Q54838627
RX   CelloPub=CLPUB00447;
RX   PubMed=6132606;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84908; Multiple sulfatase deficiency disease
DI   ORDO; Orphanet_585; Multiple sulfatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM04687
AC   CVCL_Y861
SY   GM04687A
DR   CLO; CLO_0019034
DR   Coriell; GM04687
DR   Wikidata; Q54838629
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[49-50] (c.52CAG(49-50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from child cell line ND38552).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y862 ! GM04688
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04688
AC   CVCL_Y862
SY   GM04688A
DR   CLO; CLO_0019035
DR   Coriell; GM04688
DR   Wikidata; Q54838630
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[49-50] (c.52CAG(49-50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04687).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y861 ! GM04687
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04689
AC   CVCL_M952
DR   CLO; CLO_0019030
DR   Coriell; GM04689
DR   Wikidata; Q54838631
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from child cell line ND38545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M953 ! GM04690
OI   CVCL_W610 ! GM13184
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM04690
AC   CVCL_M953
SY   GM04690B; GM13056; GM17317
DR   CLO; CLO_0013319
DR   CLO; CLO_0013827
DR   CLO; CLO_0019031
DR   BioSample; SAMN00802074
DR   Coriell; GM04690
DR   Coriell; GM13056
DR   Coriell; GM17317
DR   Wikidata; Q54838632
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Part of: Human variation panel.
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Registration: CEPH Families Reference Panel; 10205/10402.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M952 ! GM04689
OI   CVCL_W610 ! GM13184
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM04691
AC   CVCL_1I22
DR   CLO; CLO_0019028
DR   Coriell; GM04691
DR   Wikidata; Q54838633
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I23 ! GM04692
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04692
AC   CVCL_1I23
SY   GM04692A
DR   CLO; CLO_0019029
DR   Coriell; GM04692
DR   Wikidata; Q54838634
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I22 ! GM04691
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04693
AC   CVCL_Y878
DR   CLO; CLO_0019032
DR   Coriell; GM04693
DR   Wikidata; Q54838635
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y879 ! GM04694
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04694
AC   CVCL_Y879
DR   CLO; CLO_0019033
DR   Coriell; GM04694
DR   Wikidata; Q54838636
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y878 ! GM04693
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04704
AC   CVCL_1I24
SY   GM04704A
DR   CLO; CLO_0019023
DR   Coriell; GM04704
DR   Wikidata; Q54838637
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04707
AC   CVCL_1I25
SY   GM04707A
DR   CLO; CLO_0019024
DR   Coriell; GM04707
DR   Wikidata; Q54838641
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I26 ! GM04708
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04708
AC   CVCL_1I26
SY   GM04708A
DR   CLO; CLO_0019025
DR   Coriell; GM04708
DR   Wikidata; Q54838642
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I25 ! GM04707
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04709
AC   CVCL_Y863
DR   CLO; CLO_0019026
DR   Coriell; GM04709
DR   Wikidata; Q54838643
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y864 ! GM04710
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04710
AC   CVCL_Y864
SY   GM04710A
DR   CLO; CLO_0019027
DR   Coriell; GM04710
DR   Wikidata; Q54838644
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y863 ! GM04709
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04711
AC   CVCL_1I27
SY   GM 4711
DR   CLO; CLO_0019018
DR   Coriell; GM04711
DR   Wikidata; Q54838645
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04715
AC   CVCL_Y865
DR   CLO; CLO_0019019
DR   Coriell; GM04715
DR   Wikidata; Q54838646
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y866 ! GM04716
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04716
AC   CVCL_Y866
SY   GM04716A
DR   CLO; CLO_0019020
DR   Coriell; GM04716
DR   Wikidata; Q54838647
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y865 ! GM04715
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04717
AC   CVCL_V568
DR   CLO; CLO_0019021
DR   Coriell; GM04717
DR   Wikidata; Q54838649
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from child cell line ND38548).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V569 ! GM04718
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM04718
AC   CVCL_V569
SY   GM04718A
DR   CLO; CLO_0019022
DR   Coriell; GM04718
DR   Wikidata; Q54838650
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04718).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V568 ! GM04717
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM04719
AC   CVCL_0I32
DR   CLO; CLO_0019076
DR   Coriell; GM04719
DR   Wikidata; Q54838651
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I33 ! GM04720
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04720
AC   CVCL_0I33
SY   GM04720A
DR   CLO; CLO_0019077
DR   Coriell; GM04720
DR   Wikidata; Q54838652
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I32 ! GM04719
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04721
AC   CVCL_Y869
SY   GM 4721
DR   CLO; CLO_0019074
DR   Coriell; GM04721
DR   Wikidata; Q54838653
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y870 ! GM04722
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM04722
AC   CVCL_Y870
SY   GM04722A
DR   CLO; CLO_0019075
DR   Coriell; GM04722
DR   Wikidata; Q54838654
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y869 ! GM04721
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04723
AC   CVCL_Y871
DR   CLO; CLO_0019072
DR   Coriell; GM04723
DR   Wikidata; Q54838655
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y872 ! GM04724
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04724
AC   CVCL_Y872
SY   GM04724A
DR   CLO; CLO_0019073
DR   Coriell; GM04724
DR   Wikidata; Q54838656
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y871 ! GM04723
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04726
AC   CVCL_HJ75
DR   Coriell; GM04726
DR   Wikidata; Q54838657
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM04727
AC   CVCL_Y873
DR   CLO; CLO_0019070
DR   Coriell; GM04727
DR   Wikidata; Q54838658
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04729
AC   CVCL_Y882
SY   GM 4729
DR   CLO; CLO_0019071
DR   Coriell; GM04729
DR   Wikidata; Q54838659
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y883 ! GM04730
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04730
AC   CVCL_Y883
SY   GM04730A
DR   CLO; CLO_0019068
DR   Coriell; GM04730
DR   Wikidata; Q54838660
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y882 ! GM04729
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04734
AC   CVCL_1I28
SY   GM04734A
DR   CLO; CLO_0019069
DR   Coriell; GM04734
DR   Wikidata; Q54838661
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I29 ! GM04745
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04735
AC   CVCL_Y874
DR   CLO; CLO_0019055
DR   Coriell; GM04735
DR   Wikidata; Q54838662
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y875 ! GM04736
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM04736
AC   CVCL_Y875
SY   GM04736A
DR   CLO; CLO_0019056
DR   Coriell; GM04736
DR   Wikidata; Q54838663
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y874 ! GM04735
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04737
AC   CVCL_Y855
DR   CLO; CLO_0019057
DR   Coriell; GM04737
DR   Wikidata; Q54838664
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y856 ! GM04738
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04738
AC   CVCL_Y856
SY   GM04738A
DR   CLO; CLO_0019051
DR   Coriell; GM04738
DR   Wikidata; Q54838665
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y855 ! GM04737
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04745
AC   CVCL_1I29
DR   CLO; CLO_0019052
DR   Coriell; GM04745
DR   Wikidata; Q54838666
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I28 ! GM04734
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04761
AC   CVCL_AA34
SY   GM04761A
DR   CLO; CLO_0019053
DR   Coriell; GM04761
DR   Wikidata; Q54838667
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04763
AC   CVCL_8A02
DR   CLO; CLO_0019054
DR   Coriell; GM04763
DR   Wikidata; Q54838668
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8A03 ! GM04764
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM04764
AC   CVCL_8A03
DR   CLO; CLO_0019048
DR   Coriell; GM04764
DR   Wikidata; Q54838669
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8A02 ! GM04763
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04766
AC   CVCL_1I30
SY   GM04766A
DR   CLO; CLO_0019049
DR   Coriell; GM04766
DR   Wikidata; Q54838670
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I31 ! GM04767
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04767
AC   CVCL_1I31
DR   CLO; CLO_0019050
DR   Coriell; GM04767
DR   Wikidata; Q54838671
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I30 ! GM04766
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04772
AC   CVCL_Y857
SY   GM04772A
DR   CLO; CLO_0018256
DR   Coriell; GM04772
DR   Wikidata; Q54838672
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y858 ! GM04773
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04773
AC   CVCL_Y858
DR   CLO; CLO_0018255
DR   Coriell; GM04773
DR   Wikidata; Q54838673
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y857 ! GM04772
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM04775
AC   CVCL_1I32
SY   GM 4775
DR   CLO; CLO_0018258
DR   Coriell; GM04775
DR   Wikidata; Q54838674
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04776
AC   CVCL_Y853
SY   GM04776A; GM04776B
DR   CLO; CLO_0018257
DR   Coriell; GM04776
DR   Wikidata; Q54838675
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04777).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y854 ! GM04777
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04777
AC   CVCL_Y854
SY   GM 4777
DR   CLO; CLO_0018252
DR   Coriell; GM04777
DR   Wikidata; Q54838676
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
RX   PubMed=7847674;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from child cell line ND38547).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y853 ! GM04776
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM04779
AC   CVCL_1I33
SY   GM 4779
DR   CLO; CLO_0018251
DR   Coriell; GM04779
DR   Wikidata; Q54838677
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04780
AC   CVCL_1I34
SY   GM04780A
DR   CLO; CLO_0018254
DR   Coriell; GM04780
DR   Wikidata; Q54838678
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I35 ! GM04781
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04781
AC   CVCL_1I35
DR   CLO; CLO_0018253
DR   Coriell; GM04781
DR   Wikidata; Q54838679
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I34 ! GM04780
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04786
AC   CVCL_1I36
SY   GM04786A
DR   CLO; CLO_0018250
DR   Coriell; GM04786
DR   Wikidata; Q54838680
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I37 ! GM04787
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04787
AC   CVCL_1I37
DR   CLO; CLO_0018249
DR   Coriell; GM04787
DR   Wikidata; Q54838681
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I36 ! GM04786
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04790
AC   CVCL_Y876
SY   GM04790A
DR   CLO; CLO_0018261
DR   Coriell; GM04790
DR   Wikidata; Q54838684
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y877 ! GM04791
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04791
AC   CVCL_Y877
SY   GM04791A
DR   CLO; CLO_0018278
DR   Coriell; GM04791
DR   Wikidata; Q54838685
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y876 ! GM04790
SX   Female
AG   101Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM04792
AC   CVCL_1I38
SY   GM04792A
DR   CLO; CLO_0018277
DR   Coriell; GM04792
DR   Wikidata; Q54838686
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I39 ! GM04793
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04793
AC   CVCL_1I39
SY   GM 4793
DR   CLO; CLO_0018276
DR   Coriell; GM04793
DR   Wikidata; Q54838687
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I38 ! GM04792
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04794
AC   CVCL_1I40
SY   GM04794A
DR   CLO; CLO_0018275
DR   Coriell; GM04794
DR   Wikidata; Q54838688
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I41 ! GM04795
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04795
AC   CVCL_1I41
DR   CLO; CLO_0018274
DR   Coriell; GM04795
DR   Wikidata; Q54838689
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I40 ! GM04794
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04796
AC   CVCL_Y884
DR   CLO; CLO_0018273
DR   Coriell; GM04796
DR   Wikidata; Q54838690
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y885 ! GM04797
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04797
AC   CVCL_Y885
DR   CLO; CLO_0018272
DR   Coriell; GM04797
DR   Wikidata; Q54838691
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y884 ! GM04796
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM04798
AC   CVCL_Y886
SY   GM04798A
DR   CLO; CLO_0018271
DR   Coriell; GM04798
DR   Wikidata; Q54838692
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y887 ! GM04799
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04799
AC   CVCL_Y887
SY   GM 4799
DR   CLO; CLO_0018270
DR   Coriell; GM04799
DR   Wikidata; Q54838693
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y886 ! GM04798
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM04800
AC   CVCL_1I42
SY   GM04800A
DR   CLO; CLO_0018202
DR   Coriell; GM04800
DR   Wikidata; Q54838694
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I43 ! GM04801
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04801
AC   CVCL_1I43
SY   GM 4801
DR   CLO; CLO_0018204
DR   Coriell; GM04801
DR   Wikidata; Q54838695
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I42 ! GM04800
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04804
AC   CVCL_Y963
SY   GM04804A
DR   CLO; CLO_0018212
DR   Coriell; GM04804
DR   Wikidata; Q54838696
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y964 ! GM04805
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04805
AC   CVCL_Y964
SY   GM 4805
DR   CLO; CLO_0018211
DR   Coriell; GM04805
DR   Wikidata; Q54838697
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y963 ! GM04804
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04807
AC   CVCL_V570
SY   GM04807A
DR   CLO; CLO_0018214
DR   Coriell; GM04807
DR   Wikidata; Q54838698
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V565 ! GM04284
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04808
AC   CVCL_1I44
SY   GM04808A
DR   CLO; CLO_0018213
DR   Coriell; GM04808
DR   Wikidata; Q54838699
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I45 ! GM04809
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04809
AC   CVCL_1I45
DR   CLO; CLO_0018216
DR   Coriell; GM04809
DR   Wikidata; Q54838700
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I44 ! GM04808
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04814
AC   CVCL_M954
SY   GM04814B; GM18017
DR   CLO; CLO_0016019
DR   CLO; CLO_0018215
DR   Coriell; GM04814
DR   Coriell; GM18017
DR   Wikidata; Q54838701
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M955 ! GM04815
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM04815
AC   CVCL_M955
DR   CLO; CLO_0018218
DR   Coriell; GM04815
DR   Wikidata; Q54838702
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M954 ! GM04814
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   GM04818
AC   CVCL_Y880
SY   GM04818B
DR   CLO; CLO_0018217
DR   Coriell; GM04818
DR   Wikidata; Q54838703
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y881 ! GM05562
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM04819
AC   CVCL_1I46
DR   CLO; CLO_0018226
DR   Coriell; GM04819
DR   Wikidata; Q54838704
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J30 ! GM06348
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04820
AC   CVCL_1I47
SY   GM04820A
DR   CLO; CLO_0018221
DR   Coriell; GM04820
DR   Wikidata; Q54838705
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04825
AC   CVCL_8A04
DR   CLO; CLO_0018223
DR   Coriell; GM04825
DR   Wikidata; Q54838706
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM04827
AC   CVCL_8A05
DR   CLO; CLO_0018235
DR   Coriell; GM04827
DR   Wikidata; Q54838707
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM04828
AC   CVCL_1I48
SY   GM04828A
DR   CLO; CLO_0018234
DR   Coriell; GM04828
DR   Wikidata; Q54838708
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I49 ! GM04829
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04829
AC   CVCL_1I49
DR   CLO; CLO_0018233
DR   Coriell; GM04829
DR   Wikidata; Q54838710
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I48 ! GM04828
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04830
AC   CVCL_1I50
SY   GM04830A; GM04830B
DR   CLO; CLO_0018232
DR   Coriell; GM04830
DR   Wikidata; Q54838711
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I51 ! GM04831
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04831
AC   CVCL_1I51
DR   CLO; CLO_0018238
DR   Coriell; GM04831
DR   Wikidata; Q54838712
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I50 ! GM04830
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04837
AC   CVCL_1I52
DR   CLO; CLO_0018237
DR   Coriell; GM04837
DR   Wikidata; Q54838713
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I78 ! GM05376
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04844
AC   CVCL_1I53
SY   GM04844B
DR   CLO; CLO_0018236
DR   Coriell; GM04844
DR   Wikidata; Q54838714
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I54 ! GM04845
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04845
AC   CVCL_1I54
DR   CLO; CLO_0018174
DR   Coriell; GM04845
DR   Wikidata; Q54838715
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I53 ! GM04844
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04846
AC   CVCL_1I55
SY   GM04846A; GM04846C
DR   CLO; CLO_0018173
DR   Coriell; GM04846
DR   Wikidata; Q54838716
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I56 ! GM04847
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04847
AC   CVCL_1I56
DR   CLO; CLO_0018179
DR   Coriell; GM04847
DR   Wikidata; Q54838717
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I55 ! GM04846
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04849
AC   CVCL_1I57
DR   CLO; CLO_0018176
DR   Coriell; GM04849
DR   Wikidata; Q54838718
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I96 ! GM05542
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04852
AC   CVCL_1I58
SY   GM04852A
DR   CLO; CLO_0018185
DR   Coriell; GM04852
DR   Wikidata; Q54838719
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I59 ! GM04853
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04853
AC   CVCL_1I59
DR   CLO; CLO_0018186
DR   Coriell; GM04853
DR   Wikidata; Q54838720
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I58 ! GM04852
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04854
AC   CVCL_1I60
SY   GM04854B
DR   CLO; CLO_0018187
DR   Coriell; GM04854
DR   Wikidata; Q54838721
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[48] (c.52CAG(48)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04855).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I61 ! GM04855
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM04855
AC   CVCL_1I61
DR   CLO; CLO_0018188
DR   Coriell; GM04855
DR   Wikidata; Q54838722
RX   CelloPub=CLPUB00447;
RX   PubMed=25928884;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[48] (c.52CAG(48)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I60 ! GM04854
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM04856
AC   CVCL_1I62
SY   GM04856B
DR   CLO; CLO_0018183
DR   Coriell; GM04856
DR   Wikidata; Q54838723
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04857).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04857).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I63 ! GM04857
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM04857
AC   CVCL_1I63
DR   CLO; CLO_0018184
DR   Coriell; GM04857
DR   Wikidata; Q54838724
RX   CelloPub=CLPUB00447;
RX   PubMed=25928884;
RX   PubMed=30256717;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I62 ! GM04856
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM04858
AC   CVCL_1I64
SY   GM04858A; GM04858B
DR   CLO; CLO_0025784
DR   Coriell; GM04858
DR   Wikidata; Q54838727
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I65 ! GM04859
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04859
AC   CVCL_1I65
DR   CLO; CLO_0025783
DR   Coriell; GM04859
DR   Wikidata; Q54838728
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I64 ! GM04858
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04860
AC   CVCL_1I66
SY   GM04860A
DR   CLO; CLO_0025797
DR   Coriell; GM04860
DR   Wikidata; Q54838729
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I67 ! GM04861
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04861
AC   CVCL_1I67
DR   CLO; CLO_0025796
DR   Coriell; GM04861
DR   Wikidata; Q54838730
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I66 ! GM04860
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04862
AC   CVCL_2T07
DR   CLO; CLO_0025794
DR   Coriell; GM04862
DR   Wikidata; Q54838731
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(7;21)(7pter->7q36::21q21->21qter;21pter->21q21::7q36->7qter) (Coriell=GM04862).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04863
AC   CVCL_4N45
SY   GM 4863
DR   CLO; CLO_0025793
DR   Coriell; GM04863
DR   Wikidata; Q54838732
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (Coriell=GM04863).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg247Trp (c.739C>T); ClinVar=VCV000003922; Zygosity=Heterozygous (PubMed=19815695).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (PubMed=19815695).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 20
//
ID   GM04864
AC   CVCL_1I68
SY   GM04864A
DR   CLO; CLO_0025792
DR   Coriell; GM04864
DR   Wikidata; Q54838733
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I69 ! GM04865
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04865
AC   CVCL_1I69
DR   CLO; CLO_0025789
DR   Coriell; GM04865
DR   Wikidata; Q54838734
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I68 ! GM04864
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM04866
AC   CVCL_1I70
SY   GM04866A; GM04866B
DR   CLO; CLO_0025788
DR   Coriell; GM04866
DR   Wikidata; Q54838735
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I71 ! GM04867
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04867
AC   CVCL_1I71
SY   GM 4867
DR   CLO; CLO_0025785
DR   Coriell; GM04867
DR   Wikidata; Q54838736
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I70 ! GM04866
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04868
AC   CVCL_1I72
SY   GM04868A
DR   CLO; CLO_0025762
DR   Coriell; GM04868
DR   Wikidata; Q54838737
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I73 ! GM04869
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04869
AC   CVCL_1I73
DR   CLO; CLO_0025764
DR   Coriell; GM04869
DR   Wikidata; Q54838738
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I72 ! GM04868
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM04876
AC   CVCL_V571
SY   GM04876A
DR   CLO; CLO_0025763
DR   Coriell; GM04876
DR   Wikidata; Q54838739
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V572 ! GM04877
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04877
AC   CVCL_V572
DR   CLO; CLO_0025775
DR   Coriell; GM04877
DR   Wikidata; Q54838740
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V571 ! GM04876
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04886
AC   CVCL_V573
SY   GM04886A
DR   CLO; CLO_0025773
DR   Coriell; GM04886
DR   Wikidata; Q54838741
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04886).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V574 ! GM04887
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM04887
AC   CVCL_V574
SY   GM 4887
DR   CLO; CLO_0025777
DR   Coriell; GM04887
DR   Wikidata; Q54838742
RX   CelloPub=CLPUB00447;
RX   PubMed=6230415;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from child cell line ND38546).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V573 ! GM04886
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM04890
AC   CVCL_2T08
DR   CLO; CLO_0025776
DR   Coriell; GM04890
DR   Wikidata; Q54838743
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 45,XX,dic(13;14)(13qter->13p11::14p11->14qter) (Coriell=GM04890).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04894
AC   CVCL_1I74
DR   CLO; CLO_0025768
DR   Coriell; GM04894
DR   Wikidata; Q54838744
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I77 ! GM05031
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04895
AC   CVCL_AA35
DR   CLO; CLO_0025765
DR   Coriell; GM04895
DR   Wikidata; Q54838745
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04895).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA36 ! GM04896
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   GM04896
AC   CVCL_AA36
DR   CLO; CLO_0025771
DR   Coriell; GM04896
DR   Wikidata; Q54838746
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA35 ! GM04895
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM04897
AC   CVCL_AA37
DR   CLO; CLO_0025595
DR   Coriell; GM04897
DR   Wikidata; Q54838747
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA38 ! GM04898
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   GM04898
AC   CVCL_AA38
DR   CLO; CLO_0025596
DR   Coriell; GM04898
DR   Wikidata; Q54838748
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM04898).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA37 ! GM04897
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM04899
AC   CVCL_AA39
DR   CLO; CLO_0025597
DR   Coriell; GM04899
DR   GEO; GSM3592408
DR   GEO; GSM3592414
DR   Wikidata; Q54838749
RX   PubMed=29762696;
RX   PubMed=30905397;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30905397).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: GMO4899; PubMed=29762696.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA40 ! GM04900
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM04900
AC   CVCL_AA40
DR   CLO; CLO_0025598
DR   Coriell; GM04900
DR   Wikidata; Q54838750
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (from autologous cell line GM04899).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA39 ! GM04899
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM04901
AC   CVCL_JL90
DR   CLO; CLO_0025591
DR   Coriell; GM04901
DR   Wikidata; Q54838751
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Dutch.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126809; Glucocorticoid resistance
DI   ORDO; Orphanet_786; Generalized glucocorticoid resistance syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM04902
AC   CVCL_JL91
DR   CLO; CLO_0025592
DR   Coriell; GM04902
DR   Wikidata; Q54838752
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Dutch.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126809; Glucocorticoid resistance
DI   ORDO; Orphanet_786; Generalized glucocorticoid resistance syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM04903
AC   CVCL_9R23
DR   CLO; CLO_0025593
DR   Coriell; GM04903
DR   Wikidata; Q54838753
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R22 ! GM04674
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM04904
AC   CVCL_9R24
SY   GM 4904; GM04904B
DR   CLO; CLO_0025594
DR   Coriell; GM04904
DR   Wikidata; Q54838754
RX   CelloPub=CLPUB00447;
RX   PubMed=1634904;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R21 ! GM04673
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04910
AC   CVCL_VH33
DR   CLO; CLO_0025589
DR   Coriell; GM04910
DR   Wikidata; Q54838755
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; French/German.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3939; Bannayan syndrome
DI   ORDO; Orphanet_109; Bannayan-Riley-Ruvalcaba syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   GM04911
AC   CVCL_9R81
DR   CLO; CLO_0025590
DR   Coriell; GM04911
DR   Wikidata; Q54838756
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125594; Kniest dysplasia
DI   ORDO; Orphanet_485; Kniest dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04912
AC   CVCL_F601
SY   GM 4912; GM 04912
DR   CLO; CLO_0025608
DR   Coriell; GM04912
DR   Wikidata; Q54838757
RX   CelloPub=CLPUB00447;
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=10189220;
RX   PubMed=25488666;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp481Glyfs*39 (c.1441delT); ClinVar=VCV000972761; Zygosity=Heterozygous (PubMed=10189220).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp746Ter (c.2237G>A); ClinVar=VCV000280063; Zygosity=Heterozygous (PubMed=10189220).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   GM04912 iPSC
AC   CVCL_UD95
SY   Pompe 2
DR   Wikidata; Q93786874
RX   PubMed=25488666;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp481Glyfs*39 (c.1441delT); ClinVar=VCV000972761; Zygosity=Heterozygous (PubMed=25488666).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp746Ter (c.2237G>A); ClinVar=VCV000280063; Zygosity=Heterozygous (PubMed=25488666).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F601 ! GM04912
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   GM04913
AC   CVCL_2Z52
DR   CLO; CLO_0025606
DR   Coriell; GM04913
DR   Wikidata; Q54838758
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Greek.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Cell type: Fibroblast of spleen; CL=CL_2000051.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z53 ! GM04914
SX   Sex unspecified
AG   21FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM04914
AC   CVCL_2Z53
SY   GM 4914
DR   CLO; CLO_0025607
DR   Coriell; GM04914
DR   Wikidata; Q54838759
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Population: Caucasian; Greek.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z52 ! GM04913
SX   Sex unspecified
AG   21FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   GM04915
AC   CVCL_1I75
SY   GM04915B
DR   CLO; CLO_0025604
DR   Coriell; GM04915
DR   Wikidata; Q54838760
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I76 ! GM05030
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM04916
AC   CVCL_AT06
DR   CLO; CLO_0025605
DR   Coriell; GM04916
DR   Wikidata; Q54838761
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84908; Multiple sulfatase deficiency disease
DI   ORDO; Orphanet_585; Multiple sulfatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM04921
AC   CVCL_2T09
DR   CLO; CLO_0025602
DR   Coriell; GM04921
DR   Wikidata; Q54838762
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;8)(4qter->4p15::8p22->8pter;8qter->8p22::4p15->4pter) (Coriell=GM04921).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM04926
AC   CVCL_X312
DR   CLO; CLO_0025603
DR   Coriell; GM04926
DR   Wikidata; Q54838763
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM04927
AC   CVCL_V477
SY   GM 4927; GM04927C; GM04927D
DR   CLO; CLO_0025600
DR   Coriell; GM04927
DR   Wikidata; Q54838764
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V478 ! GM04928
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM04928
AC   CVCL_V478
SY   GM 4928; GM04928A; GM 4928A
DR   CLO; CLO_0025601
DR   Coriell; GM04928
DR   Wikidata; Q54838765
RX   CelloPub=CLPUB00447;
RX   Patent=US5773219;
RX   PubMed=6661932;
RX   PubMed=8643543;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V477 ! GM04927
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM04930
AC   CVCL_BT16
DR   CLO; CLO_0025599
DR   Coriell; GM04930
DR   Wikidata; Q54838766
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM04931
AC   CVCL_GQ27
SY   GM04931B
DR   CLO; CLO_0025573
DR   Coriell; GM04931
DR   Wikidata; Q54838769
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04932
AC   CVCL_N034
SY   GM17386
DR   CLO; CLO_0012164
DR   CLO; CLO_0025574
DR   Coriell; GM04932
DR   Coriell; GM17386
DR   Wikidata; Q54838770
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Pacific.
CC   Discontinued: Coriell; GM04932; probable.
CC   Discontinued: Coriell; GM17386; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM04933
AC   CVCL_9R25
DR   CLO; CLO_0025575
DR   Coriell; GM04933
DR   Wikidata; Q54838771
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04934
AC   CVCL_9R26
SY   GM 4934
DR   CLO; CLO_0025576
DR   Coriell; GM04934
DR   Wikidata; Q54838772
RX   CelloPub=CLPUB00447;
RX   PubMed=1634904;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04937
AC   CVCL_8A06
DR   CLO; CLO_0025577
DR   Coriell; GM04937
DR   Wikidata; Q54838774
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8A07 ! GM04938
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM04938
AC   CVCL_8A07
DR   CLO; CLO_0025578
DR   Coriell; GM04938
DR   Wikidata; Q54838775
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8A06 ! GM04937
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04939
AC   CVCL_AB35
DR   CLO; CLO_0025569
DR   Coriell; GM04939
DR   Wikidata; Q54838776
CC   Population: Caucasian.
CC   Karyotypic information: 69,XXX (Coriell=GM04939).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM04940
AC   CVCL_X313
SY   GM-4940; GM 4940; GM4940
DR   CLO; CLO_0025570
DR   Coriell; GM04940
DR   Wikidata; Q54838777
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(1)(pter->q25::q32->qter) (Coriell=GM04940).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM04942
AC   CVCL_GQ28
SY   GM04942B
DR   CLO; CLO_0025571
DR   Coriell; GM04942
DR   Wikidata; Q54838778
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04946
AC   CVCL_GQ29
SY   GM04946A
DR   CLO; CLO_0025572
DR   Coriell; GM04946
DR   Wikidata; Q54838779
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ43 ! GM05218
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04948
AC   CVCL_9W98
DR   CLO; CLO_0025584
DR   Coriell; GM04948
DR   Wikidata; Q54838780
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM04949
AC   CVCL_GQ30
SY   GM04949B
DR   CLO; CLO_0025582
DR   Coriell; GM04949
DR   Wikidata; Q54838781
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ45 ! GM05220
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04950
AC   CVCL_GQ31
SY   GM04950A
DR   CLO; CLO_0025583
DR   Coriell; GM04950
DR   Wikidata; Q54838782
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ47 ! GM05222
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04952
AC   CVCL_GQ32
SY   GM04952A
DR   CLO; CLO_0025587
DR   Coriell; GM04952
DR   Wikidata; Q54838783
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ46 ! GM05221
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04956
AC   CVCL_AA41
DR   CLO; CLO_0025588
DR   Coriell; GM04956
DR   Wikidata; Q54838784
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous (Coriell=GM04956).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM04957
AC   CVCL_AA42
DR   CLO; CLO_0025585
DR   Coriell; GM04957
DR   Wikidata; Q54838785
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous (Coriell=GM04957).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   GM04959
AC   CVCL_AA43
DR   CLO; CLO_0025586
DR   Coriell; GM04959
DR   Wikidata; Q54838786
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous (Coriell=GM04959).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA44 ! GM04960
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   GM04960
AC   CVCL_AA44
DR   CLO; CLO_0025580
DR   Coriell; GM04960
DR   Wikidata; Q54838787
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous (Coriell=GM04960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AA43 ! GM04959
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM04965
AC   CVCL_V479
SY   GM 04965
DR   CLO; CLO_0025581
DR   Coriell; GM04965
DR   Wikidata; Q54838788
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM04972
AC   CVCL_GQ33
SY   GM04972A
DR   CLO; CLO_0025579
DR   Coriell; GM04972
DR   Wikidata; Q54838789
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ41 ! GM05216
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04978
AC   CVCL_5M98
SY   GM04978A
DR   CLO; CLO_0025654
DR   Coriell; GM04978
DR   Wikidata; Q54838790
RX   CelloPub=CLPUB00447;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gln1973Ter (c.5917C>T) (p.Gln1965Ter, c.5893C>T); ClinVar=VCV000217206; Zygosity=Hemizygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM04981
AC   CVCL_8521
DR   CLO; CLO_0025653
DR   Coriell; GM04981
DR   Wikidata; Q54838791
RX   CelloPub=CLPUB00447;
RX   PubMed=18691744;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-53del; Zygosity=Hemizygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM04982
AC   CVCL_5M99
SY   GM04982A
DR   CLO; CLO_0025656
DR   Coriell; GM04982
DR   Wikidata; Q54838793
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM04984
AC   CVCL_GQ34
SY   GM04984A; GM04984B
DR   CLO; CLO_0025655
DR   Coriell; GM04984
DR   Wikidata; Q54838794
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ48 ! GM05224
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM04985
AC   CVCL_GQ35
DR   CLO; CLO_0025650
DR   Coriell; GM04985
DR   Wikidata; Q54838795
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ50 ! GM05226
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04986
AC   CVCL_GQ36
SY   GM04986A
DR   CLO; CLO_0025649
DR   Coriell; GM04986
DR   Wikidata; Q54838796
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ49 ! GM05225
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM04993
AC   CVCL_X314
SY   GM 4993
DR   CLO; CLO_0025652
DR   Coriell; GM04993
DR   Wikidata; Q54838797
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM04994
AC   CVCL_Y109
DR   CLO; CLO_0025651
DR   Coriell; GM04994
DR   Wikidata; Q54838798
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:57; ABCC6; Simple; p.Arg1141Ter (c.3421C>T); ClinVar=VCV000006559; Zygosity=Heterozygous (Coriell=GM04994).
CC   Sequence variation: Mutation; HGNC; HGNC:57; ABCC6; Simple; p.Arg1164Ter (c.3490C>T); ClinVar=VCV000006572; Zygosity=Heterozygous (Coriell=GM04994).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   GM04996
AC   CVCL_GQ37
DR   CLO; CLO_0025658
DR   Coriell; GM04996
DR   Wikidata; Q54838799
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ51 ! GM05227
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM04997
AC   CVCL_5N00
DR   CLO; CLO_0025657
DR   Coriell; GM04997
DR   Wikidata; Q54838800
RX   CelloPub=CLPUB00447;
CC   Population: Lebanese.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124844; Dyggve-Melchior-Clausen syndrome
DI   ORDO; Orphanet_239; Dyggve-Melchior-Clausen disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05002
AC   CVCL_AT07
SY   GM5002
DR   CLO; CLO_0025684
DR   Coriell; GM05002
DR   Wikidata; Q54838801
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Cys115Tyr (c.344G>A); ClinVar=VCV000863301; Zygosity=Heterozygous (Coriell=GM05002).
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Pro248Leu (c.743C>T); ClinVar=VCV000370244; Zygosity=Heterozygous (Coriell=GM05002).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM05003
AC   CVCL_AA45
SY   GM5003
DR   CLO; CLO_0025676
DR   Coriell; GM05003
DR   Wikidata; Q54838802
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27960; SLC6A19; Simple; p.Asp173Asn (c.517G>A); ClinVar=VCV000002019; Zygosity=Homozygous (Coriell=GM05003).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84748; Hartnup disease
DI   ORDO; Orphanet_2116; Hartnup disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM05004
AC   CVCL_AA46
SY   GM5004
DR   CLO; CLO_0025675
DR   Coriell; GM05004
DR   Wikidata; Q54838803
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27960; SLC6A19; Simple; p.Asp173Asn (c.517G>A); ClinVar=VCV000002019; Zygosity=Homozygous (Coriell=GM05004).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84748; Hartnup disease
DI   ORDO; Orphanet_2116; Hartnup disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM05005
AC   CVCL_GS66
SY   GM05005A
DR   CLO; CLO_0025674
DR   Coriell; GM05005
DR   Wikidata; Q54838805
RX   CelloPub=CLPUB00447;
RX   PubMed=1376018;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84698; Erythropoietic protoporphyria
DI   ORDO; Orphanet_79278; Autosomal erythropoietic protoporphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05007
AC   CVCL_GS67
SY   GM05007A
DR   CLO; CLO_0025673
DR   Coriell; GM05007
DR   Wikidata; Q54838806
RX   CelloPub=CLPUB00447;
RX   PubMed=1376018;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84698; Erythropoietic protoporphyria
DI   ORDO; Orphanet_79278; Autosomal erythropoietic protoporphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05008
AC   CVCL_GS68
SY   GM05008A
DR   CLO; CLO_0025672
DR   Coriell; GM05008
DR   Wikidata; Q54838807
RX   CelloPub=CLPUB00447;
RX   PubMed=1376018;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3647; FECH; Simple; p.Phe417Ser (c.1250T>C); ClinVar=VCV000000551; Zygosity=Homozygous (PubMed=1376018).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84698; Erythropoietic protoporphyria
DI   ORDO; Orphanet_79278; Autosomal erythropoietic protoporphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   GM05009
AC   CVCL_X315
SY   GM 5009; GM05009B
DR   CLO; CLO_0025671
DR   Coriell; GM05009
DR   Wikidata; Q54838808
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 49,XXXXX [31]; 48,XXXX [15]; 48,XXXX,t(1;18)(1qter->1p36::18q21->18qter;18pter->18q21::1p36->1pter) [2]; 49,XXXXX,t(1;18)(1qter->1p36::18q21->18qter;18pter->18q21::1p36->1pter) [2] (Coriell=GM05009).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89802; Penta X syndrome
DI   ORDO; Orphanet_11; Pentasomy X
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM05010
AC   CVCL_X134
SY   GM-5010; GM 5010
DR   CLO; CLO_0025670
DR   Coriell; GM05010
DR   Wikidata; Q54838809
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;8;2)(Xpter->Xq21.2::2q14.2->2qter;8qter->8p11.1::Xq21.2->Xqter;2pter->2q14.2::8p11.1->8pter) (Coriell=GM05010).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X135 ! GM05011
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM05011
AC   CVCL_X135
SY   GM-5011; GM 5011; GM05011A
DR   CLO; CLO_0025669
DR   Coriell; GM05011
DR   Wikidata; Q54838810
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X134 ! GM05010
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   GM05016
AC   CVCL_5N01
DR   CLO; CLO_0025677
DR   Coriell; GM05016
DR   Wikidata; Q54838812
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (Coriell=GM05016).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N02 ! GM05017
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM05017
AC   CVCL_5N02
DR   CLO; CLO_0025627
DR   Coriell; GM05017
DR   Wikidata; Q54838816
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (Coriell=GM05017).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N01 ! GM05016
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM05022
AC   CVCL_5N03
DR   CLO; CLO_0025628
DR   Coriell; GM05022
DR   Wikidata; Q54838817
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Heterozygous (from familial inference of GM05016; GM05017).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N04 ! GM05023
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM05023
AC   CVCL_5N04
DR   CLO; CLO_0025610
DR   Coriell; GM05023
DR   Wikidata; Q54838819
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Heterozygous (from familial inference of GM05016; GM05017).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N03 ! GM05022
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   GM05030
AC   CVCL_1I76
SY   GM05030B
DR   CLO; CLO_0025609
DR   Coriell; GM05030
DR   Wikidata; Q54838820
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I75 ! GM04915
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM05031
AC   CVCL_1I77
SY   GM05031B
DR   CLO; CLO_0025612
DR   Coriell; GM05031
DR   Wikidata; Q54838821
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I74 ! GM04894
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM05041
AC   CVCL_AA47
SY   GM05041A
DR   CLO; CLO_0025611
DR   Coriell; GM05041
DR   Wikidata; Q54838822
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM05041).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM05042
AC   CVCL_AA48
DR   CLO; CLO_0025614
DR   Coriell; GM05042
DR   Wikidata; Q54838823
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM05042).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM05043
AC   CVCL_AA49
SY   GM05043A
DR   CLO; CLO_0025613
DR   Coriell; GM05043
DR   Wikidata; Q54838824
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05044
AC   CVCL_AA50
DR   CLO; CLO_0025616
DR   Coriell; GM05044
DR   Wikidata; Q54838825
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM05044).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM05045
AC   CVCL_N035
SY   GM05045A; GM17364
DR   CLO; CLO_0013707
DR   CLO; CLO_0025615
DR   Coriell; GM05045
DR   Coriell; GM17364
DR   Wikidata; Q54838826
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM05045).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM05046
AC   CVCL_AA51
SY   GM05046A
DR   CLO; CLO_0025648
DR   Coriell; GM05046
DR   Wikidata; Q54838827
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM05047
AC   CVCL_X316
SY   GM 5047; GM05047A
DR   CLO; CLO_0025646
DR   Coriell; GM05047
DR   Wikidata; Q54838828
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM05048
AC   CVCL_7416
DR   CLO; CLO_0025647
DR   Coriell; GM05048
DR   Wikidata; Q54838829
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM05049
AC   CVCL_CZ11
SY   GM05049B
DR   CLO; CLO_0025632
DR   Coriell; GM05049
DR   Wikidata; Q54838830
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05050
AC   CVCL_HQ65
DR   CLO; CLO_0025631
DR   Coriell; GM05050
DR   Wikidata; Q54838831
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM05051
AC   CVCL_HQ66
SY   GM05051A
DR   CLO; CLO_0025630
DR   Coriell; GM05051
DR   Wikidata; Q54838833
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM05052
AC   CVCL_N036
SY   GM17158
DR   CLO; CLO_0013965
DR   CLO; CLO_0025629
DR   Coriell; GM05052
DR   Coriell; GM17158
DR   GEO; GSM273425
DR   GEO; GSM569647
DR   GEO; GSM596223
DR   GEO; GSM597023
DR   GEO; GSM924668
DR   Wikidata; Q54838834
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM05057
AC   CVCL_AK97
DR   CLO; CLO_0025635
DR   Coriell; GM05057
DR   Wikidata; Q54838835
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK98 ! GM05058
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05058
AC   CVCL_AK98
SY   RB 5058
DR   CLO; CLO_0025634
DR   Coriell; GM05058
DR   Wikidata; Q54838837
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK97 ! GM05057
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM05059
AC   CVCL_AK99
DR   CLO; CLO_0025633
DR   Coriell; GM05059
DR   Wikidata; Q54838838
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL00 ! GM05060
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05060
AC   CVCL_AL00
SY   RB 5060
DR   CLO; CLO_0025342
DR   Coriell; GM05060
DR   Wikidata; Q54838839
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK99 ! GM05059
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM05066
AC   CVCL_X138
SY   GM 5066
DR   CLO; CLO_0025333
DR   Coriell; GM05066
DR   Wikidata; Q54838840
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caribbean; Trinidadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X139 ! GM03225
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM05067
AC   CVCL_M939
SY   GM 5067; GM05067A
DR   CLO; CLO_0025332
DR   Coriell; GM05067
DR   Wikidata; Q54838841
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caribbean; Trinidadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M938 ! GM03226
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM05074
AC   CVCL_AD66
SY   GM5074
DR   CLO; CLO_0025331
DR   Coriell; GM05074
DR   Wikidata; Q54838842
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05076
AC   CVCL_IJ36
DR   CLO; CLO_0025330
DR   Coriell; GM05076
DR   Wikidata; Q54838843
RX   CelloPub=CLPUB00447;
RX   PubMed=8910459;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM05081
AC   CVCL_U480
DR   CLO; CLO_0025341
DR   Coriell; GM05081
DR   Wikidata; Q54838844
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; None_reported; -; Zygosity=- (Coriell=GM05081).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U481 ! GM05082
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM05082
AC   CVCL_U481
DR   CLO; CLO_0025338
DR   Coriell; GM05082
DR   Wikidata; Q54838845
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; None_reported; -; Zygosity=- (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U480 ! GM05081
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   GM05087
AC   CVCL_5N05
DR   CLO; CLO_0025336
DR   Coriell; GM05087
DR   Wikidata; Q54838846
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N06 ! GM05088
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM05088
AC   CVCL_5N06
DR   CLO; CLO_0025335
DR   Coriell; GM05088
DR   Wikidata; Q54838847
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N05 ! GM05087
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05089
AC   CVCL_8522
DR   CLO; CLO_0025323
DR   Coriell; GM05089
DR   Wikidata; Q54838848
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-5del; Zygosity=Hemizygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F116 ! GM05090
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM05090
AC   CVCL_F116
DR   CLO; CLO_0025321
DR   Coriell; GM05090
DR   Wikidata; Q54838849
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-5del; Zygosity=Hemizygous (Coriell=GM05090).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8522 ! GM05089
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   GM05091
AC   CVCL_DS13
DR   CLO; CLO_0025320
DR   Coriell; GM05091
DR   Wikidata; Q54838850
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS93 ! GM16785
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05093
AC   CVCL_AB47
DR   CLO; CLO_0025310
DR   Coriell; GM05093
DR   Wikidata; Q54838851
RX   CelloPub=CLPUB00447;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:4422; GNS; Simple; p.Arg355Ter (c.1063C>T); ClinVar=VCV000002932; Zygosity=Homozygous (Coriell=GM05093).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84900; Mucopolysaccharidosis type IIID
DI   ORDO; Orphanet_79272; Sanfilippo syndrome type D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM05104
AC   CVCL_5N07
DR   CLO; CLO_0025309
DR   Coriell; GM05104
DR   Wikidata; Q54838852
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05105
AC   CVCL_AA52
DR   CLO; CLO_0025312
DR   Coriell; GM05105
DR   Wikidata; Q54838853
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM05105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM05106
AC   CVCL_AA53
DR   CLO; CLO_0025311
DR   Coriell; GM05106
DR   Wikidata; Q54838854
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM05107
AC   CVCL_AA54
DR   CLO; CLO_0025316
DR   Coriell; GM05107
DR   Wikidata; Q54838855
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM05107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM05108
AC   CVCL_AA55
SY   GM05108A
DR   CLO; CLO_0025313
DR   Coriell; GM05108
DR   Wikidata; Q54838856
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM05108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM05109
AC   CVCL_AA56
DR   CLO; CLO_0025319
DR   Coriell; GM05109
DR   Wikidata; Q54838857
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM05109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM05110
AC   CVCL_AA57
DR   CLO; CLO_0025317
DR   Coriell; GM05110
DR   Wikidata; Q54838858
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM05111
AC   CVCL_AA58
DR   CLO; CLO_0025380
DR   Coriell; GM05111
DR   Wikidata; Q54838861
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM05111).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM05112
AC   CVCL_5N08
DR   CLO; CLO_0025379
DR   Coriell; GM05112
DR   Wikidata; Q54838862
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45del; Zygosity=Hemizygous (Coriell=GM05112).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N09 ! GM05113
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM05113
AC   CVCL_5N09
SY   RB 5113
DR   CLO; CLO_0025378
DR   Coriell; GM05113
DR   Wikidata; Q54838863
RX   PubMed=6726265;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45del; Zygosity=Hemizygous (Coriell=GM05113).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N08 ! GM05112
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM05114
AC   CVCL_5N10
DR   CLO; CLO_0025377
DR   Coriell; GM05114
DR   Wikidata; Q54838864
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45del; Zygosity=Hemizygous (Coriell=GM05114).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N11 ! GM05115
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM05115
AC   CVCL_5N11
SY   RB 5115
DR   CLO; CLO_0025376
DR   Coriell; GM05115
DR   Wikidata; Q54838865
RX   PubMed=6726265;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N10 ! GM05114
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM05116
AC   CVCL_5N12
DR   CLO; CLO_0025375
DR   Coriell; GM05116
DR   Wikidata; Q54838866
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45del; Zygosity=Heterozygous (Coriell=GM05116).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N13 ! GM05117
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM05117
AC   CVCL_5N13
DR   CLO; CLO_0025374
DR   Coriell; GM05117
DR   Wikidata; Q54838867
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45del; Zygosity=Heterozygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N12 ! GM05116
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM05118
AC   CVCL_5N14
DR   CLO; CLO_0025373
DR   Coriell; GM05118
DR   Wikidata; Q54838868
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N15 ! GM05119
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM05119
AC   CVCL_5N15
DR   CLO; CLO_0025371
DR   Coriell; GM05119
DR   Wikidata; Q54838869
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N14 ! GM05118
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05123
AC   CVCL_5N16
DR   CLO; CLO_0025369
DR   Coriell; GM05123
DR   Wikidata; Q54838870
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-62del; Zygosity=Hemizygous (Coriell=GM05123).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N17 ! GM05124
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM05124
AC   CVCL_5N17
SY   RB 5124
DR   CLO; CLO_0025357
DR   Coriell; GM05124
DR   Wikidata; Q54838871
RX   PubMed=6726265;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-62del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N16 ! GM05123
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM05125
AC   CVCL_5N18
DR   CLO; CLO_0025356
DR   Coriell; GM05125
DR   Wikidata; Q54838872
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-62del; Zygosity=Hemizygous (Coriell=GM05125).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N19 ! GM05126
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM05126
AC   CVCL_5N19
SY   RB 5126
DR   CLO; CLO_0025359
DR   Coriell; GM05126
DR   Wikidata; Q54838874
RX   PubMed=6726265;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-62del; Zygosity=Hemizygous (Coriell=GM05126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N18 ! GM05125
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM05127
AC   CVCL_5N20
DR   CLO; CLO_0025358
DR   Coriell; GM05127
DR   Wikidata; Q54838875
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Glu1845Ter (c.5533G>T); ClinVar=VCV000545963; Zygosity=Hemizygous (PubMed=21354051).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM05128
AC   CVCL_5N21
DR   CLO; CLO_0025353
DR   Coriell; GM05128
DR   Wikidata; Q54838876
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Glu1845Ter (c.5533G>T); ClinVar=VCV000545963; Zygosity=Hemizygous (from familial inference of GM05127).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   GM05131
AC   CVCL_AX78
DR   CLO; CLO_0025352
DR   Coriell; GM05131
DR   Wikidata; Q54838877
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   GM05132
AC   CVCL_AX79
DR   CLO; CLO_0025355
DR   Coriell; GM05132
DR   Wikidata; Q54838878
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05133
AC   CVCL_X317
SY   GM 5133
DR   CLO; CLO_0025354
DR   Coriell; GM05133
DR   Wikidata; Q54838880
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: African American.
CC   Karyotypic information: 46,XY,der(14)(14qter->14p11.2::20p11.1->20pter)mat (Coriell=GM05133).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM05134
AC   CVCL_GQ38
DR   CLO; CLO_0025351
DR   Coriell; GM05134
DR   Wikidata; Q54838881
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM05135
AC   CVCL_GQ39
SY   GM05135A
DR   CLO; CLO_0025349
DR   Coriell; GM05135
DR   Wikidata; Q54838882
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM05142
AC   CVCL_AW57
DR   CLO; CLO_0025243
DR   Coriell; GM05142
DR   Wikidata; Q54838883
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05146
AC   CVCL_1K22
DR   CLO; CLO_0025239
DR   Coriell; GM05146
DR   Wikidata; Q54838884
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (from familial inference of GM05148; GM05149).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K23 ! GM05147
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM05147
AC   CVCL_1K23
DR   CLO; CLO_0025240
DR   Coriell; GM05147
DR   Wikidata; Q54838886
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (from familial inference of GM05148; GM05149).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K22 ! GM05146
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM05148
AC   CVCL_1K24
DR   CLO; CLO_0025241
DR   Coriell; GM05148
DR   Wikidata; Q54838887
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (Coriell=GM05148).
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; c.448+64T>C (IVS3+64T>C); ClinVar=VCV000683189; Zygosity=Homozygous (Coriell=GM05148).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K25 ! GM05149
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   GM05149
AC   CVCL_1K25
DR   CLO; CLO_0025242
DR   Coriell; GM05149
DR   Wikidata; Q54838888
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (Coriell=GM05149).
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; c.448+64T>C (IVS3+64T>C); ClinVar=VCV000683189; Zygosity=Homozygous (Coriell=GM05149).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K24 ! GM05148
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM05151
AC   CVCL_AW58
DR   CLO; CLO_0025245
DR   Coriell; GM05151
DR   Wikidata; Q54838889
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM05151).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW59 ! GM05152
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM05152
AC   CVCL_AW59
DR   CLO; CLO_0025246
DR   Coriell; GM05152
DR   Wikidata; Q54838890
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM05152).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW58 ! GM05151
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM05156
AC   CVCL_4F91
SY   GM5156; GM05156A
DR   CLO; CLO_0025247
DR   Coriell; GM05156
DR   Wikidata; Q54838891
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F92 ! GM08154
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05157
AC   CVCL_AB48
DR   CLO; CLO_0025248
DR   Coriell; GM05157
DR   Wikidata; Q54838892
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05158
AC   CVCL_5N22
DR   CLO; CLO_0025244
DR   Coriell; GM05158
DR   Wikidata; Q54838893
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex46-50del; Zygosity=Heterozygous (Coriell=GM05158).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N23 ! GM05159
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM05159
AC   CVCL_5N23
DR   CLO; CLO_0025257
DR   Coriell; GM05159
DR   Wikidata; Q54838894
RX   CelloPub=CLPUB00447;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex46-50del; Zygosity=Heterozygous (Coriell=GM05159).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N22 ! GM05158
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM05160
AC   CVCL_F291
DR   CLO; CLO_0025258
DR   Coriell; GM05160
DR   Wikidata; Q54838895
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F292 ! GM05161
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM05161
AC   CVCL_F292
SY   GM05161A; GM17223
DR   CLO; CLO_0014367
DR   CLO; CLO_0025255
DR   Coriell; GM05161
DR   Coriell; GM17223
DR   GEO; GSM569603
DR   GEO; GSM596287
DR   GEO; GSM596647
DR   GEO; GSM924825
DR   Wikidata; Q54838896
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F291 ! GM05160
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM05162
AC   CVCL_5N26
DR   CLO; CLO_0025256
DR   Coriell; GM05162
DR   Wikidata; Q54838897
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex46-50del; Zygosity=Hemizygous (Coriell=GM05162).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M87 ! GM03929
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM05163
AC   CVCL_AW60
DR   CLO; CLO_0025253
DR   Coriell; GM05163
DR   Wikidata; Q54838898
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~340] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM05163).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW61 ! GM05164
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM05164
AC   CVCL_AW61
DR   CLO; CLO_0025254
DR   Coriell; GM05164
DR   Wikidata; Q54838899
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~340] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM05164).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW60 ! GM05163
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM05165
AC   CVCL_1K26
DR   CLO; CLO_0025265
DR   Coriell; GM05165
DR   Wikidata; Q54838900
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K27 ! GM05166
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM05166
AC   CVCL_1K27
DR   CLO; CLO_0025267
DR   Coriell; GM05166
DR   Wikidata; Q54838901
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K26 ! GM05165
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05167
AC   CVCL_1K28
DR   CLO; CLO_0025263
DR   Coriell; GM05167
DR   Wikidata; Q54838902
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K29 ! GM05168
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM05168
AC   CVCL_1K29
DR   CLO; CLO_0025264
DR   Coriell; GM05168
DR   Wikidata; Q54838903
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K28 ! GM05167
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05169
AC   CVCL_L752
DR   CLO; CLO_0025274
DR   Coriell; GM05169
DR   Wikidata; Q54838906
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (Coriell=GM05169).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L753 ! GM05170
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   GM05170
AC   CVCL_L753
DR   CLO; CLO_0025275
DR   Coriell; GM05170
DR   Wikidata; Q54838907
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex4-43del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L752 ! GM05169
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM05171
AC   CVCL_5N27
DR   CLO; CLO_0025276
DR   Coriell; GM05171
DR   Wikidata; Q54838908
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N28 ! GM05172
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM05172
AC   CVCL_5N28
DR   CLO; CLO_0025277
DR   Coriell; GM05172
DR   Wikidata; Q54838909
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N27 ! GM05171
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05173
AC   CVCL_5N29
DR   CLO; CLO_0025278
DR   Coriell; GM05173
DR   Wikidata; Q54838910
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N30 ! GM05174
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05174
AC   CVCL_5N30
DR   CLO; CLO_0025279
DR   Coriell; GM05174
DR   Wikidata; Q54838911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N29 ! GM05173
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05181
AC   CVCL_DD78
DR   CLO; CLO_0025280
DR   Coriell; GM05181
DR   Wikidata; Q54838912
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05182
AC   CVCL_DD79
DR   CLO; CLO_0025281
DR   Coriell; GM05182
DR   Wikidata; Q54838913
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05183
AC   CVCL_1Q24
SY   GM05183A
DR   CLO; CLO_0025283
DR   Coriell; GM05183
DR   Wikidata; Q54838914
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Karyotypic information: 46,XY,t(6;7)(q21;q21.2) (Coriell=GM05183).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q25 ! GM05184
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM05184
AC   CVCL_1Q25
DR   CLO; CLO_0025284
DR   Coriell; GM05184
DR   Wikidata; Q54838915
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Karyotypic information: 46,XY,t(6;7)(6pter->6q21::7q21.2->7qter;7pter->7q21.2::6q21->6qter) (Coriell=GM05184).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q24 ! GM05183
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM05185
AC   CVCL_AX80
DR   CLO; CLO_0025297
DR   Coriell; GM05185
DR   Wikidata; Q54838917
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM05208
AC   CVCL_AW62
DR   CLO; CLO_0025298
DR   Coriell; GM05208
DR   Wikidata; Q54838918
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05209
AC   CVCL_AW63
DR   CLO; CLO_0025295
DR   Coriell; GM05209
DR   Wikidata; Q54838919
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05211
AC   CVCL_AW64
DR   CLO; CLO_0025296
DR   Coriell; GM05211
DR   Wikidata; Q54838920
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05212
AC   CVCL_AW65
DR   CLO; CLO_0025301
DR   Coriell; GM05212
DR   Wikidata; Q54838921
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500-1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM05212).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW66 ! GM05213
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM05213
AC   CVCL_AW66
DR   CLO; CLO_0025302
DR   Coriell; GM05213
DR   Wikidata; Q54838922
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500-1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM05213).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW65 ! GM05212
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM05215
AC   CVCL_GQ40
DR   CLO; CLO_0025299
DR   Coriell; GM05215
DR   Wikidata; Q54838923
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05216
AC   CVCL_GQ41
DR   CLO; CLO_0025300
DR   Coriell; GM05216
DR   Wikidata; Q54838924
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ33 ! GM04972
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05217
AC   CVCL_GQ42
DR   CLO; CLO_0025303
DR   Coriell; GM05217
DR   Wikidata; Q54838925
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05218
AC   CVCL_GQ43
SY   GM05218A
DR   CLO; CLO_0025304
DR   Coriell; GM05218
DR   Wikidata; Q54838926
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ29 ! GM04946
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05219
AC   CVCL_GQ44
DR   CLO; CLO_0025219
DR   Coriell; GM05219
DR   Wikidata; Q54838927
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2878; Anxiety disorder
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM05220
AC   CVCL_GQ45
DR   CLO; CLO_0025226
DR   Coriell; GM05220
DR   Wikidata; Q54838928
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ30 ! GM04949
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05221
AC   CVCL_GQ46
DR   CLO; CLO_0025225
DR   Coriell; GM05221
DR   Wikidata; Q54838929
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ32 ! GM04952
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05222
AC   CVCL_GQ47
DR   CLO; CLO_0025228
DR   Coriell; GM05222
DR   Wikidata; Q54838930
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM05222; probable.
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ31 ! GM04950
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM05224
AC   CVCL_GQ48
DR   CLO; CLO_0025227
DR   Coriell; GM05224
DR   Wikidata; Q54838931
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ34 ! GM04984
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05225
AC   CVCL_GQ49
DR   CLO; CLO_0025222
DR   Coriell; GM05225
DR   Wikidata; Q54838932
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ36 ! GM04986
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05226
AC   CVCL_GQ50
DR   CLO; CLO_0025221
DR   BioSample; SAMN00796005
DR   Coriell; GM05226
DR   Wikidata; Q54838933
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM05226; probable.
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ35 ! GM04985
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05227
AC   CVCL_GQ51
SY   GM05227A
DR   CLO; CLO_0025224
DR   Coriell; GM05227
DR   Wikidata; Q54838934
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ37 ! GM04996
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05228
AC   CVCL_GQ52
DR   CLO; CLO_0025223
DR   Coriell; GM05228
DR   Wikidata; Q54838935
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Posterior iliac crest, skin; UBERON=UBERON_8480026.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34387; Anorexia nervosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05235
AC   CVCL_2T10
DR   CLO; CLO_0025220
DR   Coriell; GM05235
DR   Wikidata; Q54838936
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM05236
AC   CVCL_GQ53
DR   CLO; CLO_0025229
DR   Coriell; GM05236
DR   Wikidata; Q54838937
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05237
AC   CVCL_DB62
SY   GM05237B
DR   CLO; CLO_0025230
DR   Coriell; GM05237
DR   Wikidata; Q54838938
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05239
AC   CVCL_GQ54
DR   CLO; CLO_0025238
DR   Coriell; GM05239
DR   Wikidata; Q54838939
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05240
AC   CVCL_GQ55
DR   CLO; CLO_0025237
DR   Coriell; GM05240
DR   Wikidata; Q54838940
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05241
AC   CVCL_9W99
SY   Minn-1; Minn 1; Minn1
DR   CLO; CLO_0025236
DR   Coriell; GM05241
DR   Wikidata; Q54838941
RX   CelloPub=CLPUB00447;
RX   PubMed=3049675;
RX   PubMed=25059784;
RX   PubMed=26831110;
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Arg924Ter (c.2770C>T) (R897*); ClinVar=VCV000014686; Zygosity=Heterozygous (PubMed=25059784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM05255
AC   CVCL_0P46
DR   CLO; CLO_0025235
DR   Coriell; GM05255
DR   Wikidata; Q54838942
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P47 ! GM05256
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05256
AC   CVCL_0P47
DR   CLO; CLO_0025234
DR   Coriell; GM05256
DR   Wikidata; Q54838943
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P46 ! GM05255
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05257
AC   CVCL_0P48
DR   CLO; CLO_0025233
DR   Coriell; GM05257
DR   Wikidata; Q54838945
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Glu1064Ala (c.3191A>C); ClinVar=VCV000370081; Zygosity=Heterozygous (from autologous cell line GM05258).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (from autologous cell line GM05258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P49 ! GM05258
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM05258
AC   CVCL_0P49
SY   GM05258A
DR   CLO; CLO_0025232
DR   Coriell; GM05258
DR   Wikidata; Q54838946
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Glu1064Ala (c.3191A>C); ClinVar=VCV000370081; Zygosity=Heterozygous (Coriell=GM05258).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (Coriell=GM05258).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P48 ! GM05257
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM05259
AC   CVCL_0P50
DR   CLO; CLO_0025231
DR   Coriell; GM05259
DR   Wikidata; Q54838947
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Glu1064Ala (c.3191A>C); ClinVar=VCV000370081; Zygosity=Heterozygous (from familial inference of GM05257; GM05258).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (from familial inference of GM05257; GM05258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P51 ! GM05260
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM05260
AC   CVCL_0P51
DR   CLO; CLO_0024957
DR   Coriell; GM05260
DR   Wikidata; Q54838951
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Glu1064Ala (c.3191A>C); ClinVar=VCV000370081; Zygosity=Heterozygous (from familial inference of GM05257; GM05258).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (from familial inference of GM05257; GM05258).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P50 ! GM05259
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM05263
AC   CVCL_5N31
DR   CLO; CLO_0024958
DR   Coriell; GM05263
DR   Wikidata; Q54838952
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gln2632Serfs*6 (c.7893delC); Zygosity=Hemizygous (PubMed=21354051).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM05264
AC   CVCL_5N32
DR   CLO; CLO_0024955
DR   Coriell; GM05264
DR   Wikidata; Q54838953
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gln2632Serfs*6 (c.7893delC); Zygosity=Heterozygous (from familial inference of GM05263).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM05267
AC   CVCL_F608
SY   6TGR-SV-tfm
DR   CLO; CLO_0024956
DR   Coriell; GM05267
DR   Wikidata; Q54838954
RX   CelloPub=CLPUB00447;
RX   PubMed=6947233;
CC   Karyotypic information: 84% of cells lack a Y chromosome (Coriell=GM05267).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Tfm.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   GM05281
AC   CVCL_AW67
DR   CLO; CLO_0024953
DR   Coriell; GM05281
DR   Wikidata; Q54838955
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05282
AC   CVCL_AX81
SY   GM05282A
DR   CLO; CLO_0024954
DR   Coriell; GM05282
DR   Wikidata; Q54838956
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM05294
AC   CVCL_9Y65
SY   GM5294
DR   CLO; CLO_0024944
DR   Coriell; GM05294
DR   Wikidata; Q54838959
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: African American.
CC   Karyotypic information: 46,XY [44]; 46,XY,t(3;11)(p21;q23) [6] (Coriell=GM05294).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05296
AC   CVCL_X318
SY   GM 5296
DR   CLO; CLO_0024929
DR   Coriell; GM05296
DR   GEO; GSM804
DR   Wikidata; Q54838960
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=11687795;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,der(11)(11pter->11p13::10q21->10q24::11p13->11qter)mat (Coriell=GM05296).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM05297
AC   CVCL_4D85
SY   GM5297
DR   CLO; CLO_0024925
DR   Coriell; GM05297
DR   Wikidata; Q54838961
RX   CelloPub=CLPUB00447;
RX   PubMed=2570029;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,ins(11;10)(11pter->11p13::10q21->10q24::11p13->11qter;10pter->10q21::10q24->10qter) (Coriell=GM05297).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM05299
AC   CVCL_X121
SY   GM-5299; GM 5299
DR   CLO; CLO_0024926
DR   Coriell; GM05299
DR   Wikidata; Q54838962
RX   CelloPub=CLPUB00447;
RX   PubMed=6617268;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM05300
AC   CVCL_GY26
DR   CLO; CLO_0024927
DR   Coriell; GM05300
DR   Wikidata; Q54838963
CC   Population: Caucasian.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GY27 ! GM05301
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM05301
AC   CVCL_GY27
DR   CLO; CLO_0024928
DR   Coriell; GM05301
DR   Wikidata; Q54838964
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GY26 ! GM05300
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05302
AC   CVCL_X319
SY   GM 5302
DR   CLO; CLO_0024920
DR   Coriell; GM05302
DR   Wikidata; Q54838965
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(1)(pter->q41::q43->qter) (Coriell=GM05302).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM05319
AC   CVCL_X320
SY   GM 5319
DR   CLO; CLO_0024922
DR   Coriell; GM05319
DR   Wikidata; Q54838966
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM05320
AC   CVCL_AL01
DR   CLO; CLO_0024923
DR   Coriell; GM05320
DR   Wikidata; Q54838967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL02 ! GM05321
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05321
AC   CVCL_AL02
DR   CLO; CLO_0024924
DR   Coriell; GM05321
DR   Wikidata; Q54838968
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL01 ! GM05320
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05335
AC   CVCL_W027
DR   CLO; CLO_0024914
DR   Coriell; GM05335
DR   Wikidata; Q54838969
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y7M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM05336
AC   CVCL_X321
SY   GM 5336
DR   CLO; CLO_0024900
DR   Coriell; GM05336
DR   Wikidata; Q54838970
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,der(4)(4qter->4p15::3p21.3->3pter)mat (Coriell=GM05336).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM05339
AC   CVCL_0P52
DR   CLO; CLO_0024899
DR   Coriell; GM05339
DR   Wikidata; Q54838971
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P53 ! GM05340
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05340
AC   CVCL_0P53
DR   CLO; CLO_0024904
DR   Coriell; GM05340
DR   Wikidata; Q54838972
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P52 ! GM05339
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05341
AC   CVCL_0P54
DR   CLO; CLO_0024903
DR   Coriell; GM05341
DR   Wikidata; Q54838973
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P55 ! GM05342
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05342
AC   CVCL_0P55
DR   CLO; CLO_0024902
DR   Coriell; GM05342
DR   Wikidata; Q54838974
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P54 ! GM05341
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05344
AC   CVCL_1K56
SY   GM05344A
DR   CLO; CLO_0024901
DR   Coriell; GM05344
DR   Wikidata; Q54838975
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118437; Glycogen storage disease type VII
DI   ORDO; Orphanet_371; Glycogen storage disease due to muscle phosphofructokinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05345
AC   CVCL_AL03
DR   CLO; CLO_0024910
DR   Coriell; GM05345
DR   Wikidata; Q54838976
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL04 ! GM05346
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05346
AC   CVCL_AL04
DR   CLO; CLO_0024908
DR   Coriell; GM05346
DR   Wikidata; Q54838977
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL03 ! GM05345
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM05347
AC   CVCL_X322
SY   GM 5347
DR   CLO; CLO_0024906
DR   Coriell; GM05347
DR   Wikidata; Q54838978
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM05348
AC   CVCL_2T11
DR   CLO; CLO_0024905
DR   Coriell; GM05348
DR   Wikidata; Q54838979
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05358
AC   CVCL_V821
DR   CLO; CLO_0024869
DR   Coriell; GM05358
DR   Wikidata; Q54838980
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V775 ! GM00519
OI   CVCL_V790 ! GM01022
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM05365
AC   CVCL_DI63
DR   CLO; CLO_0024871
DR   Coriell; GM05365
DR   Wikidata; Q54838981
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84797; Kartagener syndrome
DI   NCIt; C128117; Primary ciliary dyskinesia 1
DI   ORDO; Orphanet_98861; Primary ciliary dyskinesia, Kartagener type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05366
AC   CVCL_0P56
SY   GM05366A
DR   CLO; CLO_0024870
DR   Coriell; GM05366
DR   Wikidata; Q54838982
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P57 ! GM05367
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05367
AC   CVCL_0P57
DR   CLO; CLO_0024873
DR   Coriell; GM05367
DR   Wikidata; Q54838983
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P56 ! GM05366
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05368
AC   CVCL_0Q55
DR   CLO; CLO_0024872
DR   Coriell; GM05368
DR   Wikidata; Q54838984
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM05370
AC   CVCL_0P63
DR   CLO; CLO_0024875
DR   Coriell; GM05370
DR   Wikidata; Q54838985
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P60 ! GM05371
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM05371
AC   CVCL_0P60
DR   CLO; CLO_0024874
DR   Coriell; GM05371
DR   Wikidata; Q54838986
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P63 ! GM05370
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05373
AC   CVCL_F667
DR   CLO; CLO_0024876
DR   Coriell; GM05373
DR   Wikidata; Q54838987
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM05373; probable.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2188 ! SEWA
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   GM05376
AC   CVCL_1I78
SY   GM05376A
DR   CLO; CLO_0024885
DR   Coriell; GM05376
DR   Wikidata; Q54838988
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I52 ! GM04837
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05377
AC   CVCL_7417
SY   GM17256
DR   CLO; CLO_0014396
DR   CLO; CLO_0024842
DR   Coriell; GM05377
DR   Coriell; GM17256
DR   GEO; GSM569660
DR   GEO; GSM596320
DR   GEO; GSM596679
DR   GEO; GSM924858
DR   Wikidata; Q54838989
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,30:01:01; B*13:02:01,40:01:02; C*03:04:01,06:02:01; DPA1*01:03:01,02:01:01; DPB1*02:01:02,17:01:01; DQA1*02:01:01,03:01:01; DQB1*02:02:01,03:02:01; DRB1*04:01:01,07:01:01; DRB4*01:03:01,01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM05378
AC   CVCL_AL05
DR   CLO; CLO_0024841
DR   Coriell; GM05378
DR   Wikidata; Q54838990
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL06 ! GM05379
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05379
AC   CVCL_AL06
DR   CLO; CLO_0024840
DR   Coriell; GM05379
DR   Wikidata; Q54838993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL05 ! GM05378
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05380
AC   CVCL_7418
SY   GM17257
DR   CLO; CLO_0014393
DR   CLO; CLO_0024839
DR   Coriell; GM05380
DR   Coriell; GM17257
DR   GEO; GSM569645
DR   GEO; GSM596321
DR   GEO; GSM596680
DR   GEO; GSM924859
DR   Wikidata; Q54838994
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,11:01:01; B*07:02:01,15:01:01; C*03:03:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:01:01G; DQA1*02:01:01,05:05:01; DQB1*03:01:01,03:03:02; DRB1*07:01:01,11:01:01; DRB3*02:02:01; DRB4*01:03:01:02N (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM05381
AC   CVCL_7419
SY   GM5381; GM 05381
DR   CLO; CLO_0024855
DR   Coriell; GM05381
DR   GEO; GSM3124629
DR   Wikidata; Q54838995
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=30567591;
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical area, skin; UBERON=UBERON_8480053.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   GM05382
AC   CVCL_1Q57
DR   CLO; CLO_0024854
DR   Coriell; GM05382
DR   Wikidata; Q54838996
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(7;18)(7pter->7q36::18q12.2->18qter;18pter->18q12.2::7q36->7qter) (Coriell=GM05382).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM05386
AC   CVCL_7420
SY   GM5386; GM05386A; GM05386B
DR   CLO; CLO_0024852
DR   Coriell; GM05386
DR   Wikidata; Q54838997
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7421 ! GM05387
OI   CVCL_7429 ! GM05421
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM05387
AC   CVCL_7421
SY   GM5387
DR   CLO; CLO_0024850
DR   Coriell; GM05387
DR   Wikidata; Q54838998
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7420 ! GM05386
OI   CVCL_7429 ! GM05421
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM05388
AC   CVCL_7422
SY   GM5388
DR   CLO; CLO_0024848
DR   Coriell; GM05388
DR   Wikidata; Q54838999
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7423 ! GM05389
OI   CVCL_7428 ! GM05420
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM05389
AC   CVCL_7423
SY   GM5389
DR   CLO; CLO_0024813
DR   Coriell; GM05389
DR   Wikidata; Q54839000
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7422 ! GM05388
OI   CVCL_7428 ! GM05420
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM05392
AC   CVCL_F293
SY   GM05392A; GM17258
DR   CLO; CLO_0014394
DR   CLO; CLO_0024810
DR   Coriell; GM05392
DR   Coriell; GM17258
DR   GEO; GSM569653
DR   GEO; GSM596322
DR   GEO; GSM596681
DR   GEO; GSM924860
DR   Wikidata; Q54839001
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM05394
AC   CVCL_2T12
DR   CLO; CLO_0024809
DR   Coriell; GM05394
DR   Wikidata; Q54839002
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM05396
AC   CVCL_X323
SY   GM 5396; GM5396
DR   CLO; CLO_0024812
DR   Coriell; GM05396
DR   Wikidata; Q54839003
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 45,X,dic(X;22)(p11;p12) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 13
//
ID   GM05398
AC   CVCL_7424
SY   GM05398A; GM17259
DR   CLO; CLO_0014388
DR   CLO; CLO_0024811
DR   Coriell; GM05398
DR   Coriell; GM17259
DR   GEO; GSM569654
DR   GEO; GSM596323
DR   GEO; GSM596682
DR   GEO; GSM924861
DR   Wikidata; Q54839004
RX   CelloPub=CLPUB00447;
RX   PubMed=18485778;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM05399
AC   CVCL_7425
SY   GM5399
DR   CLO; CLO_0024823
DR   Coriell; GM05399
DR   Wikidata; Q54839005
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
RX   PubMed=25732146;
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM05400
AC   CVCL_7426
SY   GM5400; C2
DR   CLO; CLO_0024821
DR   CLO; CLO_0037443
DR   Coriell; GM05400
DR   GEO; GSM3124630
DR   LINCS_LDP; LPC-1044
DR   Wikidata; Q54839006
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=25059784;
RX   PubMed=26831110;
RX   PubMed=30567591;
RX   PubMed=34746695;
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X,Y
ST   CSF1PO: 8,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 8,12
ST   D7S820: 8,9
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM05401
AC   CVCL_X324
SY   GM 5401
DR   CLO; CLO_0024825
DR   Coriell; GM05401
DR   Wikidata; Q54839007
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM05404
AC   CVCL_AW68
DR   CLO; CLO_0024824
DR   Coriell; GM05404
DR   Wikidata; Q54839008
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05408
AC   CVCL_7427
SY   GM17260
DR   CLO; CLO_0013182
DR   CLO; CLO_0024816
DR   Coriell; GM05408
DR   Coriell; GM17260
DR   GEO; GSM569646
DR   GEO; GSM596324
DR   GEO; GSM596683
DR   GEO; GSM924862
DR   Wikidata; Q54839010
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,29:02:01; B*08:01:01,44:03:01; C*07:01:01,16:01:01; DPA1*01:03:01,02:01:02; DPB1*01:01:01,02:01:02; DQA1*02:01:01,05:01:01; DQB1*02:01:01,02:02:01; DRB1*03:01:01,07:01:01; DRB3*01:01:02; DRB4*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM05409
AC   CVCL_2T13
DR   CLO; CLO_0024797
DR   Coriell; GM05409
DR   Wikidata; Q54839011
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(5;17)(5pter->5q33::17p12->17pter;17qter->17p12::5q33->5qter) (Coriell=GM05409).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM05420
AC   CVCL_7428
SY   GM5420
DR   CLO; CLO_0024798
DR   Coriell; GM05420
DR   Wikidata; Q54839012
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal eye, conjunctiva; UBERON=UBERON_0010312+UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7422 ! GM05388
OI   CVCL_7423 ! GM05389
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM05421
AC   CVCL_7429
SY   GM5421A; GM05421A
DR   CLO; CLO_0024793
DR   Coriell; GM05421
DR   Wikidata; Q54839013
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal eye, conjunctiva; UBERON=UBERON_0010312+UBERON_0001811.
CC   Cell type: Fibroblast of conjunctiva; CL=CL_0002550.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7420 ! GM05386
OI   CVCL_7421 ! GM05387
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM05422
AC   CVCL_7430
SY   GM17261
DR   CLO; CLO_0013183
DR   CLO; CLO_0024794
DR   Coriell; GM05422
DR   Coriell; GM17261
DR   GEO; GSM569720
DR   GEO; GSM596325
DR   GEO; GSM596747
DR   GEO; GSM924863
DR   Wikidata; Q54839014
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,03:01:01; B*35:08:01,44:02:01; C*04:01:01,06:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:02,03:03:01; DQB1*03:01:01,05:02:01; DRB1*04:01:01,16:07; DRB4*01:03:01; DRB5*02:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM05423
AC   CVCL_7431
SY   GM 05423; GM17262
DR   CLO; CLO_0013173
DR   CLO; CLO_0024795
DR   Coriell; GM05423
DR   Coriell; GM17262
DR   GEO; GSM569752
DR   GEO; GSM596326
DR   GEO; GSM596748
DR   GEO; GSM924864
DR   Wikidata; Q54839015
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,11:01:01; B*27:05:02,39:01:01; C*02:02:02,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*03:01:01,04:01:01; DQB1*03:02:01,04:02:01; DRB1*04:04:01,08:01:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM05425
AC   CVCL_DF24
SY   GM05425A; GM05425B
DR   CLO; CLO_0024789
DR   Coriell; GM05425
DR   Wikidata; Q54839017
RX   CelloPub=CLPUB00447;
RX   PubMed=4025395;
CC   Misspelling: GM5455A; PubMed=4025395.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C13375; Chromosome fragile site
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DF25 ! GM05523
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05426
AC   CVCL_H154
SY   GM05426A
DR   CLO; CLO_0024790
DR   Coriell; GM05426
DR   Wikidata; Q54839018
RX   CelloPub=CLPUB00447;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   GM05427
AC   CVCL_UT11
SY   GM05427Z
DR   Coriell; GM05427
DR   Wikidata; Q93788978
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05427; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I79 ! GM05428
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05428
AC   CVCL_1I79
SY   GM05428B
DR   CLO; CLO_0024791
DR   Coriell; GM05428
DR   Wikidata; Q54839019
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT11 ! GM05427
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05439
AC   CVCL_UR98
SY   GM05439Z
DR   Coriell; GM05439
DR   Wikidata; Q93788985
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05439; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I80 ! GM05440
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05440
AC   CVCL_1I80
SY   GM05440B
DR   CLO; CLO_0024792
DR   Coriell; GM05440
DR   Wikidata; Q54839021
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR98 ! GM05439
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05441
AC   CVCL_UR97
SY   GM05441Z
DR   Coriell; GM05441
DR   Wikidata; Q93788993
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05441; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I81 ! GM05442
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05442
AC   CVCL_1I81
SY   GM05442B
DR   CLO; CLO_0024808
DR   Coriell; GM05442
DR   Wikidata; Q54839022
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR97 ! GM05441
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05447
AC   CVCL_UT22
SY   GM05447Z
DR   Coriell; GM05447
DR   Wikidata; Q93789001
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05447; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I82 ! GM05448
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05448
AC   CVCL_1I82
DR   CLO; CLO_0024806
DR   Coriell; GM05448
DR   Wikidata; Q54839023
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT22 ! GM05447
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05451
AC   CVCL_UT23
SY   GM05451Z
DR   Coriell; GM05451
DR   Wikidata; Q93789008
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05451; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I83 ! GM05452
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05452
AC   CVCL_1I83
SY   GM05452A
DR   CLO; CLO_0024807
DR   Coriell; GM05452
DR   Wikidata; Q54839024
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT23 ! GM05451
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05453
AC   CVCL_UT24
SY   GM05453Z
DR   Coriell; GM05453
DR   Wikidata; Q93789015
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05453; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I84 ! GM05454
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05454
AC   CVCL_1I84
SY   GM05454A
DR   CLO; CLO_0024804
DR   Coriell; GM05454
DR   Wikidata; Q54839025
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT24 ! GM05453
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05485
AC   CVCL_UT20
SY   GM05485Z
DR   Coriell; GM05485
DR   Wikidata; Q93789022
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05485; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I85 ! GM05486
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05486
AC   CVCL_1I85
SY   GM05486A
DR   CLO; CLO_0024805
DR   Coriell; GM05486
DR   Wikidata; Q54839026
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT20 ! GM05485
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05495
AC   CVCL_UR93
SY   GM05495Z
DR   Coriell; GM05495
DR   Wikidata; Q93789030
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05495; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I86 ! GM05496
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05496
AC   CVCL_1I86
SY   GM05496A
DR   CLO; CLO_0024802
DR   Coriell; GM05496
DR   Wikidata; Q54839027
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR93 ! GM05495
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05506
AC   CVCL_1I87
DR   CLO; CLO_0024803
DR   Coriell; GM05506
DR   Wikidata; Q54839028
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05518
AC   CVCL_5N33
SY   GM05518A
DR   CLO; CLO_0024761
DR   Coriell; GM05518
DR   Wikidata; Q54839032
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   GM05519
AC   CVCL_2T14
DR   CLO; CLO_0024762
DR   Coriell; GM05519
DR   Wikidata; Q54839033
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(4;11)(4pter->4q25::11p13->11pter;11qter->11p13::4q25->4qter)mat (Coriell=GM05519).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM05520
AC   CVCL_DS14
DR   CLO; CLO_0024763
DR   Coriell; GM05520
DR   Wikidata; Q54839034
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Yugoslavian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05521
AC   CVCL_DS15
DR   CLO; CLO_0024764
DR   Coriell; GM05521
DR   Wikidata; Q54839036
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Yugoslavian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM05522
AC   CVCL_DS16
DR   CLO; CLO_0024765
DR   Coriell; GM05522
DR   Wikidata; Q54839037
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Yugoslavian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM05523
AC   CVCL_DF25
SY   GM5523; GM05523B
DR   CLO; CLO_0024766
DR   Coriell; GM05523
DR   Wikidata; Q54839038
RX   CelloPub=CLPUB00447;
RX   PubMed=4025395;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C13375; Chromosome fragile site
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DF24 ! GM05425
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05524
AC   CVCL_1I88
SY   GM05524A
DR   CLO; CLO_0024767
DR   Coriell; GM05524
DR   Wikidata; Q54839039
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05526
AC   CVCL_1I89
SY   GM05526A
DR   CLO; CLO_0024768
DR   Coriell; GM05526
DR   Wikidata; Q54839040
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US34 ! GM05527
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05527
AC   CVCL_US34
SY   GM05527Z
DR   Coriell; GM05527
DR   Wikidata; Q93789098
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05527; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I89 ! GM05526
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05528
AC   CVCL_1I90
SY   GM05528A
DR   CLO; CLO_0024759
DR   Coriell; GM05528
DR   Wikidata; Q54839041
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05530
AC   CVCL_1I91
SY   GM05530A
DR   CLO; CLO_0024760
DR   Coriell; GM05530
DR   Wikidata; Q54839042
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05534
AC   CVCL_1I92
SY   GM05534A
DR   CLO; CLO_0024769
DR   Coriell; GM05534
DR   Wikidata; Q54839043
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US33 ! GM05535
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05535
AC   CVCL_US33
SY   GM05535Z
DR   Coriell; GM05535
DR   Wikidata; Q93789114
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05535; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I92 ! GM05534
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05536
AC   CVCL_1I93
SY   GM05536B
DR   CLO; CLO_0024783
DR   Coriell; GM05536
DR   Wikidata; Q54839044
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US66 ! GM06541
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05538
AC   CVCL_1I94
DR   Coriell; GM05538
DR   Wikidata; Q54839045
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[97] (c.52CAG(97)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM05539).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I95 ! GM05539
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM05539
AC   CVCL_1I95
DR   CLO; CLO_0024784
DR   Coriell; GM05539
DR   Wikidata; Q54841861
RX   PubMed=25928884;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[97] (c.52CAG(97)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I94 ! GM05538
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM05542
AC   CVCL_1I96
SY   GM05542D
DR   CLO; CLO_0024781
DR   Coriell; GM05542
DR   Wikidata; Q54841862
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I57 ! GM04849
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05544
AC   CVCL_1I97
SY   GM05544B
DR   CLO; CLO_0024782
DR   Coriell; GM05544
DR   Wikidata; Q54841863
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05546
AC   CVCL_1I98
SY   GM05546B
DR   CLO; CLO_0024787
DR   Coriell; GM05546
DR   Wikidata; Q54841864
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US95 ! GM05547
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05547
AC   CVCL_US95
SY   GM05547Z
DR   Coriell; GM05547
DR   Wikidata; Q93789146
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05547; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I98 ! GM05546
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05551
AC   CVCL_US67
SY   GM05551Z
DR   Coriell; GM05551
DR   Wikidata; Q93789149
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: Coriell; GM05551; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I18 ! GM04290
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   GM05552
AC   CVCL_1I99
DR   CLO; CLO_0024788
DR   Coriell; GM05552
DR   Wikidata; Q54841865
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05554
AC   CVCL_1J00
SY   GM05554B
DR   CLO; CLO_0024785
DR   Coriell; GM05554
DR   Wikidata; Q54841866
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US82 ! GM05555
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05555
AC   CVCL_US82
SY   GM05555Z
DR   Coriell; GM05555
DR   Wikidata; Q93789160
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05555; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J00 ! GM05554
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05557
AC   CVCL_US94
SY   GM05557Z
DR   Coriell; GM05557
DR   Wikidata; Q93789163
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05557; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05558
AC   CVCL_1J01
SY   GM05558A
DR   CLO; CLO_0024786
DR   Coriell; GM05558
DR   Wikidata; Q54841867
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT02 ! GM05559
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05559
AC   CVCL_UT02
SY   GM05559Z
DR   Coriell; GM05559
DR   Wikidata; Q93789172
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05559; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J01 ! GM05558
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05560
AC   CVCL_1J02
SY   GM05560B
DR   CLO; CLO_0024775
DR   Coriell; GM05560
DR   Wikidata; Q54841868
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05562
AC   CVCL_Y881
SY   GM05562Z
DR   Coriell; GM05562
DR   Wikidata; Q54841869
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05562; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y880 ! GM04818
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05563
AC   CVCL_4D86
DR   CLO; CLO_0024547
DR   Coriell; GM05563
DR   Wikidata; Q54841870
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(13) (Coriell=GM05563).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM05564
AC   CVCL_2T15
DR   CLO; CLO_0024545
DR   Coriell; GM05564
DR   Wikidata; Q54841871
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM05565
AC   CVCL_7432
SY   GM5565; GM 05565
DR   CLO; CLO_0024544
DR   Coriell; GM05565
DR   GEO; GSM3124627
DR   Wikidata; Q54841872
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=24119401;
RX   PubMed=30567591;
CC   Population: Latino or Hispanic.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM05566
AC   CVCL_N037
SY   GM5566
DR   CLO; CLO_0024554
DR   Coriell; GM05566
DR   Wikidata; Q54841874
RX   CelloPub=CLPUB00447;
RX   PubMed=9671271;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N038 ! GM05567
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   GM05567
AC   CVCL_N038
SY   GM18018
DR   CLO; CLO_0016020
DR   CLO; CLO_0024553
DR   Coriell; GM05567
DR   Coriell; GM18018
DR   Wikidata; Q54841875
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N037 ! GM05566
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM05571
AC   CVCL_US99
SY   GM05571Z
DR   Coriell; GM05571
DR   Wikidata; Q93789220
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05571; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J03 ! GM05572
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05572
AC   CVCL_1J03
SY   GM05572A
DR   CLO; CLO_0024556
DR   Coriell; GM05572
DR   Wikidata; Q54841878
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US99 ! GM05571
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05579
AC   CVCL_US90
SY   GM05579Z
DR   Coriell; GM05579
DR   Wikidata; Q93789232
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05579; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J04 ! GM05580
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05580
AC   CVCL_1J04
SY   GM05580A
DR   CLO; CLO_0024557
DR   Coriell; GM05580
DR   Wikidata; Q54841879
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US90 ! GM05579
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05583
AC   CVCL_UR89
SY   GM05583Z
DR   Coriell; GM05583
DR   Wikidata; Q93789243
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05583; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J05 ! GM05584
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05584
AC   CVCL_1J05
SY   GM05584A
DR   CLO; CLO_0024558
DR   Coriell; GM05584
DR   Wikidata; Q54841880
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR89 ! GM05583
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05589
AC   CVCL_UR90
SY   GM05589Z
DR   Coriell; GM05589
DR   Wikidata; Q93789255
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05589; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J06 ! GM05590
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05590
AC   CVCL_1J06
SY   GM05590A
DR   CLO; CLO_0024566
DR   Coriell; GM05590
DR   Wikidata; Q54841881
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR90 ! GM05589
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05593
AC   CVCL_US92
SY   GM05593Z
DR   Coriell; GM05593
DR   Wikidata; Q93789267
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05593; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J07 ! GM05594
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05594
AC   CVCL_1J07
SY   GM05594A
DR   CLO; CLO_0024565
DR   Coriell; GM05594
DR   Wikidata; Q54841882
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US92 ! GM05593
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05599
AC   CVCL_US84
SY   GM05599Z
DR   Coriell; GM05599
DR   Wikidata; Q93789280
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05599; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J08 ! GM05600
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05600
AC   CVCL_1J08
SY   GM05600A
DR   CLO; CLO_0024568
DR   Coriell; GM05600
DR   Wikidata; Q54841883
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US84 ! GM05599
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05603
AC   CVCL_US98
SY   GM05603Z
DR   Coriell; GM05603
DR   Wikidata; Q93789291
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05603; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J09 ! GM05604
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05604
AC   CVCL_1J09
SY   GM05604A
DR   CLO; CLO_0024567
DR   Coriell; GM05604
DR   Wikidata; Q54841884
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US98 ! GM05603
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05605
AC   CVCL_US83
SY   GM05605Z
DR   Coriell; GM05605
DR   Wikidata; Q93789303
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05605; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J10 ! GM05606
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05606
AC   CVCL_1J10
SY   GM05606A
DR   CLO; CLO_0024571
DR   Coriell; GM05606
DR   Wikidata; Q54841885
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US83 ! GM05605
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05607
AC   CVCL_US91
SY   GM05607Z
DR   Coriell; GM05607
DR   Wikidata; Q93789316
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05607; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J11 ! GM05608
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05608
AC   CVCL_1J11
SY   GM05608A
DR   CLO; CLO_0024569
DR   Coriell; GM05608
DR   Wikidata; Q54841886
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US91 ! GM05607
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05609
AC   CVCL_US73
SY   GM05609Z
DR   Coriell; GM05609
DR   Wikidata; Q93789328
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05609; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J12 ! GM05610
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05610
AC   CVCL_1J12
SY   GM05610A
DR   CLO; CLO_0024576
DR   Coriell; GM05610
DR   Wikidata; Q54841888
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US73 ! GM05609
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05613
AC   CVCL_Y890
SY   GM05613Z
DR   Coriell; GM05613
DR   Wikidata; Q54841889
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05613; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y891 ! GM05614
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05614
AC   CVCL_Y891
SY   GM05614A
DR   CLO; CLO_0024573
DR   Coriell; GM05614
DR   Wikidata; Q54841890
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y890 ! GM05613
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM05621
AC   CVCL_Y888
SY   GM05621Z
DR   Coriell; GM05621
DR   Wikidata; Q54841891
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05621; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y889 ! GM05622
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05622
AC   CVCL_Y889
SY   GM05622A; GM05622B
DR   CLO; CLO_0024577
DR   Coriell; GM05622
DR   Wikidata; Q54841892
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y888 ! GM05621
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM05625
AC   CVCL_US81
SY   GM05625Z
DR   Coriell; GM05625
DR   Wikidata; Q93789376
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05625; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J13 ! GM05626
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05626
AC   CVCL_1J13
SY   GM05626A
DR   CLO; CLO_0024578
DR   Coriell; GM05626
DR   Wikidata; Q54841893
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US81 ! GM05625
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05627
AC   CVCL_US93
SY   GM05627Z
DR   Coriell; GM05627
DR   Wikidata; Q93789387
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05627; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J14 ! GM05628
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05628
AC   CVCL_1J14
SY   GM05628A
DR   CLO; CLO_0024580
DR   Coriell; GM05628
DR   Wikidata; Q54841894
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US93 ! GM05627
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05637
AC   CVCL_UR96
SY   GM05637Z
DR   Coriell; GM05637
DR   Wikidata; Q93789399
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05637; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J15 ! GM05638
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05638
AC   CVCL_1J15
SY   GM05638A
DR   CLO; CLO_0024597
DR   Coriell; GM05638
DR   Wikidata; Q54841895
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR96 ! GM05637
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05639
AC   CVCL_US87
SY   GM05639Z
DR   Coriell; GM05639
DR   Wikidata; Q93789410
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05639; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J16 ! GM05640
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05640
AC   CVCL_1J16
SY   GM05640A
DR   CLO; CLO_0024596
DR   Coriell; GM05640
DR   Wikidata; Q54841896
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US87 ! GM05639
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05641
AC   CVCL_US80
SY   GM05641Z
DR   Coriell; GM05641
DR   Wikidata; Q93789422
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05641; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J17 ! GM05642
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05642
AC   CVCL_1J17
SY   GM05642A
DR   CLO; CLO_0024595
DR   Coriell; GM05642
DR   Wikidata; Q54841897
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US80 ! GM05641
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05649
AC   CVCL_US71
SY   GM05649Z
DR   Coriell; GM05649
DR   Wikidata; Q93789434
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05649; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05651
AC   CVCL_GQ56
SY   GM05651A
DR   CLO; CLO_0024594
DR   Coriell; GM05651
DR   Wikidata; Q54841898
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05652
AC   CVCL_N039
SY   GM 5652; GM05652A; GM17313
DR   CLO; CLO_0013356
DR   CLO; CLO_0024593
DR   Coriell; GM05652
DR   Coriell; GM17313
DR   Wikidata; Q54841899
RX   CelloPub=CLPUB00447;
RX   PubMed=3926002;
CC   Part of: Human variation panel.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM05653
AC   CVCL_W025
DR   CLO; CLO_0024591
DR   Coriell; GM05653
DR   Wikidata; Q54841900
RX   CelloPub=CLPUB00447;
RX   PubMed=8910459;
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM05654
AC   CVCL_2T16
SY   GM05654A
DR   CLO; CLO_0024590
DR   Coriell; GM05654
DR   Wikidata; Q54841901
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;11)(4pter->4q25::11p13->11pter;11qter->11p13::4q25->4qter) (Coriell=GM05654).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05655
AC   CVCL_X325
SY   GM 5655
DR   CLO; CLO_0024587
DR   Coriell; GM05655
DR   Wikidata; Q54841902
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,der(21)(21qter->21p11.2::6q22.2->6qter)mat (Coriell=GM05655).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   GM05656
AC   CVCL_2T17
DR   CLO; CLO_0024598
DR   Coriell; GM05656
DR   Wikidata; Q54841908
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM05658
AC   CVCL_7433
SY   GM5658; GM-05658
DR   CLO; CLO_0024607
DR   Coriell; GM05658
DR   Wikidata; Q54841909
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
RX   PubMed=17668376;
RX   PubMed=24119401;
CC   Population: African American.
CC   Derived from site: In situ; Umbilical area, skin; UBERON=UBERON_8480053.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM05659
AC   CVCL_7434
SY   GM5659; GM-5659; GM 5659; GM05659B; GM5659B; GM05659C; GM 5659C; GM05659D; GM5659D
DR   CLO; CLO_0024626
DR   EFO; EFO_0006278
DR   Coriell; GM05659
DR   GEO; GSE11919
DR   GEO; GSM3124625
DR   Wikidata; Q54841910
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=1652892;
RX   PubMed=2475503;
RX   PubMed=2705456;
RX   PubMed=2837086;
RX   PubMed=3745952;
RX   PubMed=8605078;
RX   PubMed=17668376;
RX   PubMed=18973801;
RX   PubMed=24119401;
RX   PubMed=25732146;
RX   PubMed=27543334;
RX   PubMed=30220252;
RX   PubMed=30497978;
RX   PubMed=30567591;
RX   PubMed=33038742;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (PubMed=30497978).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   GM05659T
AC   CVCL_ZU51
DR   Wikidata; Q98126374
RX   PubMed=27543334;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   GM05660
AC   CVCL_1J18
SY   GM05660A
DR   CLO; CLO_0024625
DR   Coriell; GM05660
DR   Wikidata; Q54841911
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US77 ! GM05661
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05661
AC   CVCL_US77
SY   GM05661Z
DR   Coriell; GM05661
DR   Wikidata; Q93789516
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05661; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J18 ! GM05660
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05668
AC   CVCL_1J19
SY   GM05668A
DR   CLO; CLO_0024628
DR   Coriell; GM05668
DR   Wikidata; Q54841912
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US78 ! GM05669
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05669
AC   CVCL_US78
SY   GM05669Z
DR   Coriell; GM05669
DR   Wikidata; Q93789530
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05669; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J19 ! GM05668
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05678
AC   CVCL_1J20
SY   GM05678B
DR   CLO; CLO_0024627
DR   Coriell; GM05678
DR   Wikidata; Q54841913
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US72 ! GM05679
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05679
AC   CVCL_US72
SY   GM05679Z
DR   Coriell; GM05679
DR   Wikidata; Q93789543
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05679; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J20 ! GM05678
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05682
AC   CVCL_1J21
SY   GM05682A
DR   CLO; CLO_0024620
DR   Coriell; GM05682
DR   Wikidata; Q54841914
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US76 ! GM05683
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05683
AC   CVCL_US76
SY   GM05683Z
DR   Coriell; GM05683
DR   Wikidata; Q93789554
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05683; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J21 ! GM05682
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05684
AC   CVCL_1J22
SY   GM05684B
DR   CLO; CLO_0024619
DR   Coriell; GM05684
DR   Wikidata; Q54841915
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US75 ! GM05685
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05685
AC   CVCL_US75
SY   GM05685Z
DR   Coriell; GM05685
DR   Wikidata; Q93789566
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05685; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J22 ! GM05684
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05688
AC   CVCL_1J23
SY   GM05688A
DR   CLO; CLO_0024624
DR   Coriell; GM05688
DR   Wikidata; Q54841916
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US96 ! GM05689
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05689
AC   CVCL_US96
SY   GM05689Z
DR   Coriell; GM05689
DR   Wikidata; Q93789579
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05689; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J23 ! GM05688
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM05690
AC   CVCL_1J24
SY   GM05690A
DR   CLO; CLO_0024621
DR   Coriell; GM05690
DR   Wikidata; Q54841917
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US13 ! GM05691
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05691
AC   CVCL_US13
SY   GM05691Z
DR   Coriell; GM05691
DR   Wikidata; Q93789593
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05691; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J24 ! GM05690
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05700
AC   CVCL_1J25
SY   GM05700A
DR   CLO; CLO_0024648
DR   Coriell; GM05700
DR   Wikidata; Q54841918
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05723
AC   CVCL_US85
SY   GM05723Z
DR   Coriell; GM05723
DR   Wikidata; Q93789606
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05723; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J26 ! GM05724
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05724
AC   CVCL_1J26
SY   GM05724A
DR   CLO; CLO_0024646
DR   Coriell; GM05724
DR   Wikidata; Q54841919
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US85 ! GM05723
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05725
AC   CVCL_UR86
SY   GM05725Z
DR   Coriell; GM05725
DR   Wikidata; Q93789618
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05725; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J27 ! GM05726
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05726
AC   CVCL_1J27
SY   GM05726A
DR   CLO; CLO_0024647
DR   Coriell; GM05726
DR   Wikidata; Q54841920
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR86 ! GM05725
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05735
AC   CVCL_UR87
SY   GM05735Z
DR   Coriell; GM05735
DR   Wikidata; Q93789629
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05735; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J28 ! GM05736
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05736
AC   CVCL_1J28
SY   GM05736A
DR   CLO; CLO_0024639
DR   Coriell; GM05736
DR   Wikidata; Q54841921
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR87 ! GM05735
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05739
AC   CVCL_Y892
SY   GM05739Z
DR   Coriell; GM05739
DR   Wikidata; Q54841922
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05739; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y893 ! GM05740
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05740
AC   CVCL_Y893
SY   GM05740A
DR   CLO; CLO_0024640
DR   Coriell; GM05740
DR   Wikidata; Q54841923
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y892 ! GM05739
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM05744
AC   CVCL_US88
SY   GM05744Z
DR   Coriell; GM05744
DR   Wikidata; Q93789658
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM05744; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM05747
AC   CVCL_DD80
SY   GM05747A
DR   CLO; CLO_0024637
DR   Coriell; GM05747
DR   Wikidata; Q54841924
RX   CelloPub=CLPUB00447;
CC   Population: Colombian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M2W
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05748
AC   CVCL_F133
DR   CLO; CLO_0024638
DR   Coriell; GM05748
DR   Wikidata; Q54841925
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7435 ! GM05752
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM05750
AC   CVCL_X326
SY   GM 5750
DR   CLO; CLO_0024642
DR   Coriell; GM05750
DR   Wikidata; Q54841926
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM05751
AC   CVCL_DF26
DR   CLO; CLO_0024644
DR   Coriell; GM05751
DR   Wikidata; Q54841927
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM05752
AC   CVCL_7435
SY   GM 05752
DR   CLO; CLO_0003531
DR   CLO; CLO_0024641
DR   CLDB; cl1498
DR   Coriell; GM05752
DR   Wikidata; Q54841928
RX   CelloPub=CLPUB00447;
RX   PubMed=9458280;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F133 ! GM05748
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM05753
AC   CVCL_5N34
DR   Coriell; GM05753
DR   Wikidata; Q54841929
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM05753; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   GM05754
AC   CVCL_4D87
DR   CLO; CLO_0024665
DR   Coriell; GM05754
DR   Wikidata; Q54841930
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(6) [29]; 45,XY,-6 [21] (Coriell=GM05754).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM05756
AC   CVCL_7436
SY   GM5756; GM 5756; GM5756A
DR   CLO; CLO_0024666
DR   Coriell; GM05756
DR   Wikidata; Q54841931
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
RX   PubMed=3745952;
RX   PubMed=17668376;
RX   PubMed=33038742;
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   GM05757
AC   CVCL_7437
SY   GM5757
DR   CLO; CLO_0024667
DR   Coriell; GM05757
DR   GEO; GSM3124631
DR   Wikidata; Q54841932
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=30567591;
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM05758
AC   CVCL_7438
SY   GM5758
DR   CLO; CLO_0024668
DR   Coriell; GM05758
DR   Wikidata; Q54841933
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
RX   PubMed=17668376;
CC   Population: African American.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM05759
AC   CVCL_U944
DR   CLO; CLO_0024658
DR   Coriell; GM05759
DR   Wikidata; Q54841934
RX   CelloPub=CLPUB00447;
RX   PubMed=34087995;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Arg465Arg (c.1395G>T) (chr20:g.10629709C>A); Zygosity=Heterozygous; Note=Splice site mutation (PubMed=34087995).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM05761
AC   CVCL_0P61
SY   GM05761A
DR   CLO; CLO_0024659
DR   Coriell; GM05761
DR   Wikidata; Q54841935
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Thr977Met (c.2930C>T); ClinVar=VCV000035710; Zygosity=Heterozygous (Coriell=GM05761).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P62 ! GM05762
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM05762
AC   CVCL_0P62
SY   GM05762A
DR   CLO; CLO_0024660
DR   Coriell; GM05762
DR   Wikidata; Q54841936
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Thr977Met (c.2930C>T); ClinVar=VCV000035710; Zygosity=Heterozygous (from autologous cell line GM05761).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P61 ! GM05761
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM05788
AC   CVCL_7439
DR   CLO; CLO_0024661
DR   Coriell; GM05788
DR   Wikidata; Q54841937
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2860; DHCR7; Simple; p.Gly138Val (c.413G>T); Zygosity=Heterozygous (Coriell=GM05788).
CC   Sequence variation: Mutation; HGNC; HGNC:2860; DHCR7; Simple; p.His405Tyr (c.1213C>T); Zygosity=Heterozygous (Coriell=GM05788).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85071; Smith-Lemli-Opitz syndrome
DI   ORDO; Orphanet_818; Smith-Lemli-Opitz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7440 ! GM05789
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   GM05789
AC   CVCL_7440
DR   CLO; CLO_0024662
DR   Coriell; GM05789
DR   Wikidata; Q54841938
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2860; DHCR7; Simple; p.Gly138Val (c.413G>T); Zygosity=Heterozygous (Coriell=GM05789).
CC   Sequence variation: Mutation; HGNC; HGNC:2860; DHCR7; Simple; p.His405Tyr (c.1213C>T); Zygosity=Heterozygous (Coriell=GM05789).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85071; Smith-Lemli-Opitz syndrome
DI   ORDO; Orphanet_818; Smith-Lemli-Opitz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7439 ! GM05788
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   GM05793
AC   CVCL_0Q53
DR   CLO; CLO_0024686
DR   Coriell; GM05793
DR   Wikidata; Q54841941
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q54 ! GM05794
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05794
AC   CVCL_0Q54
DR   CLO; CLO_0024687
DR   Coriell; GM05794
DR   Wikidata; Q54841942
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q53 ! GM05793
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM05795
AC   CVCL_0Q56
DR   CLO; CLO_0024684
DR   Coriell; GM05795
DR   Wikidata; Q54841943
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q57 ! GM05796
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05796
AC   CVCL_0Q57
DR   CLO; CLO_0024685
DR   Coriell; GM05796
DR   Wikidata; Q54841944
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q56 ! GM05795
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM05797
AC   CVCL_0P67
DR   CLO; CLO_0024682
DR   Coriell; GM05797
DR   Wikidata; Q54841945
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P68 ! GM05798
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM05798
AC   CVCL_0P68
DR   CLO; CLO_0024683
DR   Coriell; GM05798
DR   Wikidata; Q54841947
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P67 ! GM05797
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM05816
AC   CVCL_GS69
SY   GM 5816
DR   CLO; CLO_0024680
DR   Coriell; GM05816
DR   Wikidata; Q54841948
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg76Trp (c.226C>T); ClinVar=VCV000001962; Zygosity=Heterozygous (Coriell=GM05816).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Pro274Leu (c.821C>T); ClinVar=VCV000001964; Zygosity=Heterozygous (Coriell=GM05816).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   GM05817
AC   CVCL_N040
SY   GM 5817; GM17159
DR   CLO; CLO_0013964
DR   CLO; CLO_0024681
DR   Coriell; GM05817
DR   Coriell; GM17159
DR   GEO; GSM273426
DR   GEO; GSM569655
DR   GEO; GSM596224
DR   GEO; GSM597024
DR   GEO; GSM924669
DR   IPD-IMGT/HLA; 15817
DR   Wikidata; Q54841955
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*36:01,80:01; B*50:01,53:01; C*04:CVAF,06:02; DRB1*03:01,16:02 (IPD-IMGT/HLA=15817).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg76Trp (c.226C>T); ClinVar=VCV000001962; Zygosity=Heterozygous (Coriell=GM05817).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM05823+hTERT
AC   CVCL_VL10
SY   GM05823-hTert; hTERT+ GM05823
DR   Wikidata; Q93789883
RX   PubMed=11313956;
RX   PubMed=21149446;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu2427_Arg2428del (c.7278_7283delCCTTAG); ClinVar=VCV000003020; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7441 ! AT5BI
SX   Male
AG   18Y
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   GM05832
AC   CVCL_X327
SY   GM 5832
DR   CLO; CLO_0024707
DR   Coriell; GM05832
DR   Wikidata; Q54841956
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM05835
AC   CVCL_5N35
SY   GM5835
DR   CLO; CLO_0024708
DR   Coriell; GM05835
DR   Wikidata; Q54841957
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
CC   Karyotypic information: 46,X,t(X;5)(p21.2;q35.3) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   GM05847
AC   CVCL_AX82
DR   CLO; CLO_0024703
DR   Coriell; GM05847
DR   Wikidata; Q54841958
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[21]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[650]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Discontinued: Coriell; GM05847; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM05848
AC   CVCL_AX83
DR   CLO; CLO_0024704
DR   Coriell; GM05848
DR   Wikidata; Q54841959
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM05852
AC   CVCL_AL07
DR   CLO; CLO_0024706
DR   Coriell; GM05852
DR   Wikidata; Q54841960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL08 ! GM05853
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05853
AC   CVCL_AL08
DR   CLO; CLO_0024699
DR   Coriell; GM05853
DR   Wikidata; Q54841961
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL07 ! GM05852
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM05854
AC   CVCL_AX84
DR   CLO; CLO_0024700
DR   Coriell; GM05854
DR   Wikidata; Q54841962
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM05855
AC   CVCL_AX85
SY   GM05855B
DR   CLO; CLO_0024701
DR   Coriell; GM05855
DR   Wikidata; Q54841963
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM05864
AC   CVCL_V251
DR   CLO; CLO_0024233
DR   Coriell; GM05864
DR   Wikidata; Q54841964
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Limousin; VBO=VBO_0000274.
DI   NCIt; C131472; Bovine protoporphyria
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM05865
AC   CVCL_V252
DR   CLO; CLO_0024235
DR   Coriell; GM05865
DR   Wikidata; Q54841965
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Hereford x Limousin; VBO=VBO_0000232+VBO_0000274.
DI   NCIt; C131472; Bovine protoporphyria
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM05866
AC   CVCL_V253
SY   GM05866B
DR   CLO; CLO_0024234
DR   Coriell; GM05866
DR   Wikidata; Q54841966
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
DI   NCIt; C131470; Bovine congenital erythropoietic porphyria
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM05867
AC   CVCL_V254
DR   CLO; CLO_0024230
DR   Coriell; GM05867
DR   Wikidata; Q54841967
RX   CelloPub=CLPUB00447;
CC   Donor information: Cell line originating from a cow that was a carrier for bovine congenital erythropoietic porphyria.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   GM05868
AC   CVCL_V255
DR   CLO; CLO_0024229
DR   Coriell; GM05868
DR   Wikidata; Q54841968
RX   CelloPub=CLPUB00447;
CC   Donor information: Cell line originating from a cow that was a carrier for bovine protoporphyria.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Hereford x Limousin; VBO=VBO_0000232+VBO_0000274.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   GM05870
AC   CVCL_7443
DR   CLO; CLO_0003532
DR   CLO; CLO_0024232
DR   CLDB; cl1499
DR   Coriell; GM05870
DR   Wikidata; Q54841969
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM05870).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GM05872
AC   CVCL_4F51
DR   CLO; CLO_0024231
DR   Coriell; GM05872
DR   Wikidata; Q54841970
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM05872).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM05875
AC   CVCL_X328
SY   GM 5875; GM05875A; GM5875A
DR   CLO; CLO_0024237
DR   Coriell; GM05875
DR   Wikidata; Q54841971
RX   CelloPub=CLPUB00447;
RX   PubMed=2095701;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM05876
AC   CVCL_2Y97
DR   CLO; CLO_0024236
DR   Coriell; GM05876
DR   Wikidata; Q54841975
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM05877
AC   CVCL_X140
SY   GM 5877
DR   CLO; CLO_0024238
DR   Coriell; GM05877
DR   Wikidata; Q54841976
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X141 ! GM07312
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM05878
AC   CVCL_1Q34
DR   CLO; CLO_0024226
DR   Coriell; GM05878
DR   Wikidata; Q54841977
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM05879
AC   CVCL_7444
SY   GM05879B; GM5879A; C5879
DR   CLO; CLO_0024225
DR   Coriell; GM05879
DR   GEO; GSM2794411
DR   Wikidata; Q54841978
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7445 ! GM05920
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM05880
AC   CVCL_5N36
DR   CLO; CLO_0024224
DR   Coriell; GM05880
DR   Wikidata; Q54841979
CC   Population: Iraqi.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N37 ! GM05881
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM05881
AC   CVCL_5N37
DR   CLO; CLO_0024223
DR   Coriell; GM05881
DR   Wikidata; Q54841980
RX   PubMed=23665875;
CC   Population: Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N36 ! GM05880
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM05882
AC   CVCL_UT31
DR   Coriell; GM05882
DR   Wikidata; Q93790053
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM05882; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F655 ! GM06061
SX   Female
AG   2Y1M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM05883
AC   CVCL_GQ57
DR   CLO; CLO_0024222
DR   Coriell; GM05883
DR   Wikidata; Q54841981
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM05888
AC   CVCL_4F95
SY   GM05888A
DR   CLO; CLO_0024220
DR   Coriell; GM05888
DR   Wikidata; Q54841982
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F96 ! GM05889
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05889
AC   CVCL_4F96
DR   CLO; CLO_0024219
DR   Coriell; GM05889
DR   Wikidata; Q54841983
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F95 ! GM05888
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05890
AC   CVCL_4F97
SY   GM05890A
DR   CLO; CLO_0024228
DR   Coriell; GM05890
DR   Wikidata; Q54841984
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F98 ! GM05891
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05891
AC   CVCL_4F98
DR   CLO; CLO_0024227
DR   Coriell; GM05891
DR   Wikidata; Q54841985
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F97 ! GM05890
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05892
AC   CVCL_4F99
SY   GM05892A
DR   CLO; CLO_0023936
DR   Coriell; GM05892
DR   Wikidata; Q54841986
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G00 ! GM05893
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05893
AC   CVCL_4G00
DR   CLO; CLO_0023937
DR   Coriell; GM05893
DR   Wikidata; Q54841987
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F99 ! GM05892
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05894
AC   CVCL_4G01
SY   GM05894A
DR   CLO; CLO_0023932
DR   Coriell; GM05894
DR   Wikidata; Q54841988
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G02 ! GM05895
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05895
AC   CVCL_4G02
DR   CLO; CLO_0023933
DR   Coriell; GM05895
DR   Wikidata; Q54841989
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G01 ! GM05894
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05896
AC   CVCL_4G03
SY   GM05896A
DR   CLO; CLO_0023934
DR   Coriell; GM05896
DR   Wikidata; Q54841990
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G04 ! GM05897
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05897
AC   CVCL_4G04
DR   CLO; CLO_0023935
DR   Coriell; GM05897
DR   Wikidata; Q54841991
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G03 ! GM05896
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05898
AC   CVCL_4G05
SY   GM05898A
DR   CLO; CLO_0023967
DR   Coriell; GM05898
DR   Wikidata; Q54841992
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G06 ! GM05899
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05899
AC   CVCL_4G06
DR   CLO; CLO_0023966
DR   Coriell; GM05899
DR   Wikidata; Q54841993
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G05 ! GM05898
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05900
AC   CVCL_4G07
DR   CLO; CLO_0023965
DR   Coriell; GM05900
DR   Wikidata; Q54841994
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05901
AC   CVCL_4G08
SY   GM05901A
DR   CLO; CLO_0023964
DR   Coriell; GM05901
DR   Wikidata; Q54841995
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G09 ! GM05902
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05902
AC   CVCL_4G09
DR   CLO; CLO_0023963
DR   Coriell; GM05902
DR   Wikidata; Q54841996
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G08 ! GM05901
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05903
AC   CVCL_4G10
SY   GM05903A
DR   CLO; CLO_0023961
DR   Coriell; GM05903
DR   Wikidata; Q54841997
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G11 ! GM05904
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05904
AC   CVCL_4G11
SY   GM05904A
DR   CLO; CLO_0023962
DR   Coriell; GM05904
DR   Wikidata; Q54842000
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G10 ! GM05903
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05905
AC   CVCL_4G12
SY   GM05905A
DR   CLO; CLO_0023959
DR   Coriell; GM05905
DR   Wikidata; Q54842001
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G13 ! GM05906
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05906
AC   CVCL_4G13
DR   CLO; CLO_0023960
DR   Coriell; GM05906
DR   Wikidata; Q54842002
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G12 ! GM05905
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05907
AC   CVCL_4G14
SY   GM05907A
DR   CLO; CLO_0023957
DR   Coriell; GM05907
DR   Wikidata; Q54842003
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G15 ! GM05908
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05908
AC   CVCL_4G15
DR   CLO; CLO_0023958
DR   Coriell; GM05908
DR   Wikidata; Q54842004
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G14 ! GM05907
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05909
AC   CVCL_4G16
SY   GM05909A
DR   CLO; CLO_0024073
DR   Coriell; GM05909
DR   Wikidata; Q54842005
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05910
AC   CVCL_4G17
DR   CLO; CLO_0024075
DR   Coriell; GM05910
DR   Wikidata; Q54842006
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4J07 ! GM08272
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM05911
AC   CVCL_4G18
DR   CLO; CLO_0024070
DR   Coriell; GM05911
DR   Wikidata; Q54842007
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05912
AC   CVCL_5N38
SY   GM05912A
DR   CLO; CLO_0024083
DR   Coriell; GM05912
DR   Wikidata; Q54842008
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05913
AC   CVCL_5N39
SY   GM05913A
DR   CLO; CLO_0024082
DR   Coriell; GM05913
DR   Wikidata; Q54842009
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM05914
AC   CVCL_4G19
SY   GM05914A
DR   CLO; CLO_0024081
DR   Coriell; GM05914
DR   Wikidata; Q54842010
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G20 ! GM05915
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05915
AC   CVCL_4G20
DR   CLO; CLO_0024080
DR   Coriell; GM05915
DR   Wikidata; Q54842011
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G19 ! GM05914
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05916
AC   CVCL_4G21
DR   CLO; CLO_0024091
DR   Coriell; GM05916
DR   Wikidata; Q54842012
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05918
AC   CVCL_4G22
SY   GM05918A; GM05918B
DR   CLO; CLO_0024089
DR   Coriell; GM05918
DR   Wikidata; Q54842013
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G23 ! GM05919
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   GM05919
AC   CVCL_4G23
DR   CLO; CLO_0024086
DR   Coriell; GM05919
DR   Wikidata; Q54842014
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G22 ! GM05918
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05920
AC   CVCL_7445
SY   GM05920A; GM17224
DR   CLO; CLO_0014369
DR   CLO; CLO_0024084
DR   Coriell; GM05920
DR   Coriell; GM17224
DR   GEO; GSM569551
DR   GEO; GSM596288
DR   GEO; GSM596648
DR   GEO; GSM924826
DR   Wikidata; Q54842016
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,02:01:01; B*15:01:01,15:01:01; C*03:04:01,03:04:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:01:01G; DQA1*03:01:01,03:01:01; DQB1*03:02:01,03:02:01; DRB1*04:01:01,04:01:01; DRB4*01:03:01,01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7444 ! GM05879
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM05921
AC   CVCL_4G24
DR   CLO; CLO_0024104
DR   Coriell; GM05921
DR   Wikidata; Q54842017
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05922
AC   CVCL_4G25
DR   CLO; CLO_0024106
DR   Coriell; GM05922
DR   Wikidata; Q54842018
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05923
AC   CVCL_4G26
DR   CLO; CLO_0024135
DR   Coriell; GM05923
DR   Wikidata; Q54842019
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05926
AC   CVCL_4G27
DR   CLO; CLO_0024113
DR   Coriell; GM05926
DR   Wikidata; Q54842020
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G28 ! GM05927
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05927
AC   CVCL_4G28
SY   GM05927A
DR   CLO; CLO_0024112
DR   Coriell; GM05927
DR   Wikidata; Q54842021
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G27 ! GM05926
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05928
AC   CVCL_4G29
DR   CLO; CLO_0024115
DR   Coriell; GM05928
DR   Wikidata; Q54842022
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G30 ! GM05929
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05929
AC   CVCL_4G30
SY   GM05929A
DR   CLO; CLO_0024114
DR   Coriell; GM05929
DR   Wikidata; Q54842023
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G29 ! GM05928
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05930
AC   CVCL_4G31
DR   CLO; CLO_0024117
DR   Coriell; GM05930
DR   Wikidata; Q54842024
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G32 ! GM05931
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05931
AC   CVCL_4G32
SY   GM05931A
DR   CLO; CLO_0024116
DR   Coriell; GM05931
DR   Wikidata; Q54842025
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G31 ! GM05930
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05932
AC   CVCL_4G33
DR   CLO; CLO_0024121
DR   Coriell; GM05932
DR   Wikidata; Q54842027
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G34 ! GM05933
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05933
AC   CVCL_4G34
SY   GM05933A
DR   CLO; CLO_0024120
DR   Coriell; GM05933
DR   Wikidata; Q54842028
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G33 ! GM05932
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05934
AC   CVCL_4G35
DR   CLO; CLO_0024028
DR   Coriell; GM05934
DR   Wikidata; Q54842029
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G36 ! GM05935
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05935
AC   CVCL_4G36
SY   GM05935A
DR   CLO; CLO_0024040
DR   Coriell; GM05935
DR   Wikidata; Q54842030
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G35 ! GM05934
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05936
AC   CVCL_4G37
DR   CLO; CLO_0024038
DR   Coriell; GM05936
DR   Wikidata; Q54842031
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G38 ! GM05937
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05937
AC   CVCL_4G38
SY   GM05937A
DR   CLO; CLO_0024037
DR   Coriell; GM05937
DR   Wikidata; Q54842032
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G37 ! GM05936
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05938
AC   CVCL_4G39
DR   CLO; CLO_0024036
DR   Coriell; GM05938
DR   Wikidata; Q54842033
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G40 ! GM05939
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05939
AC   CVCL_4G40
SY   GM05939A
DR   CLO; CLO_0024035
DR   Coriell; GM05939
DR   Wikidata; Q54842034
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G39 ! GM05938
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05940
AC   CVCL_4G41
DR   CLO; CLO_0024034
DR   Coriell; GM05940
DR   Wikidata; Q54842035
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G42 ! GM05941
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05941
AC   CVCL_4G42
SY   GM05941A
DR   CLO; CLO_0024033
DR   Coriell; GM05941
DR   Wikidata; Q54842036
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G41 ! GM05940
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05943
AC   CVCL_4G43
DR   CLO; CLO_0024032
DR   Coriell; GM05943
DR   Wikidata; Q54842037
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05945
AC   CVCL_N041
SY   GM18019
DR   CLO; CLO_0015542
DR   CLO; CLO_0024031
DR   Coriell; GM05945
DR   Coriell; GM18019
DR   Wikidata; Q54842038
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N042 ! GM08329
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM05946
AC   CVCL_N043
SY   GM05946A; GM18020
DR   CLO; CLO_0015543
DR   CLO; CLO_0024030
DR   Coriell; GM05946
DR   Coriell; GM18020
DR   Wikidata; Q54842039
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N044 ! GM08330
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM05947
AC   CVCL_4G44
DR   CLO; CLO_0024059
DR   Coriell; GM05947
DR   Wikidata; Q54842040
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2878; Anxiety disorder
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05948
AC   CVCL_9Q64
DR   CLO; CLO_0024062
DR   Coriell; GM05948
DR   Wikidata; Q54842041
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q68 ! GM05952
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05949
AC   CVCL_9Q65
DR   CLO; CLO_0024061
DR   Coriell; GM05949
DR   Wikidata; Q54842044
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q67 ! GM05951
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM05950
AC   CVCL_9Q66
DR   CLO; CLO_0024055
DR   Coriell; GM05950
DR   Wikidata; Q54842045
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q69 ! GM05953
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05951
AC   CVCL_9Q67
DR   CLO; CLO_0024054
DR   Coriell; GM05951
DR   Wikidata; Q54842046
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q65 ! GM05949
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05952
AC   CVCL_9Q68
DR   CLO; CLO_0024057
DR   Coriell; GM05952
DR   Wikidata; Q54842047
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q64 ! GM05948
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05953
AC   CVCL_9Q69
SY   GM05953A
DR   CLO; CLO_0024056
DR   Coriell; GM05953
DR   Wikidata; Q54842048
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q66 ! GM05950
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM05954
AC   CVCL_9Q70
DR   CLO; CLO_0024052
DR   Coriell; GM05954
DR   Wikidata; Q54842049
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM05960
AC   CVCL_4G45
DR   CLO; CLO_0024051
DR   Coriell; GM05960
DR   Wikidata; Q54842050
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G46 ! GM05961
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05961
AC   CVCL_4G46
SY   GM05961A; GM05961B
DR   CLO; CLO_0024053
DR   Coriell; GM05961
DR   Wikidata; Q54842051
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G45 ! GM05960
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05962
AC   CVCL_4G47
SY   GM05962A
DR   CLO; CLO_0024188
DR   Coriell; GM05962
DR   Wikidata; Q54842052
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G48 ! GM05963
SX   Male
AG   86Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05963
AC   CVCL_4G48
SY   GM05963B; GM5963B; GM05963C
DR   CLO; CLO_0024189
DR   Coriell; GM05963
DR   Wikidata; Q54842053
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G47 ! GM05962
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   GM05966
AC   CVCL_4F90
DR   CLO; CLO_0024186
DR   Coriell; GM05966
DR   Wikidata; Q54842054
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM05968
AC   CVCL_4G49
DR   CLO; CLO_0024187
DR   Coriell; GM05968
DR   Wikidata; Q54842055
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G50 ! GM05969
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05969
AC   CVCL_4G50
SY   GM05969A
DR   CLO; CLO_0024192
DR   Coriell; GM05969
DR   Wikidata; Q54842056
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G49 ! GM05968
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05970
AC   CVCL_4G51
DR   CLO; CLO_0024193
DR   Coriell; GM05970
DR   Wikidata; Q54842058
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G52 ! GM05971
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05971
AC   CVCL_4G52
SY   GM05971B
DR   CLO; CLO_0024190
DR   Coriell; GM05971
DR   Wikidata; Q54842059
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G51 ! GM05970
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05972
AC   CVCL_4G53
DR   CLO; CLO_0024191
DR   Coriell; GM05972
DR   Wikidata; Q54842060
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G54 ! GM05973
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05973
AC   CVCL_4G54
SY   GM05973A; GM05973B
DR   CLO; CLO_0024196
DR   Coriell; GM05973
DR   Wikidata; Q54842061
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G53 ! GM05972
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05974
AC   CVCL_4G55
DR   CLO; CLO_0024198
DR   Coriell; GM05974
DR   Wikidata; Q54842062
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G56 ! GM05975
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05975
AC   CVCL_4G56
SY   GM05975A
DR   CLO; CLO_0024207
DR   Coriell; GM05975
DR   Wikidata; Q54842064
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G55 ! GM05974
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05976
AC   CVCL_4G57
DR   CLO; CLO_0024208
DR   Coriell; GM05976
DR   Wikidata; Q54842065
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G58 ! GM05977
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05977
AC   CVCL_4G58
SY   GM05977A
DR   CLO; CLO_0024209
DR   Coriell; GM05977
DR   Wikidata; Q54842066
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G57 ! GM05976
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05978
AC   CVCL_4G59
DR   CLO; CLO_0024210
DR   Coriell; GM05978
DR   Wikidata; Q54842067
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G60 ! GM05979
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05979
AC   CVCL_4G60
SY   GM05979A
DR   CLO; CLO_0024211
DR   Coriell; GM05979
DR   Wikidata; Q54842068
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G59 ! GM05978
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05980
AC   CVCL_4G61
DR   CLO; CLO_0024212
DR   Coriell; GM05980
DR   Wikidata; Q54842069
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G62 ! GM05981
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05981
AC   CVCL_4G62
SY   GM05981A
DR   CLO; CLO_0024213
DR   Coriell; GM05981
DR   Wikidata; Q54842070
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G61 ! GM05980
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05983
AC   CVCL_4G63
SY   GM05983A
DR   CLO; CLO_0024214
DR   Coriell; GM05983
DR   Wikidata; Q54842071
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G64 ! GM05984
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05984
AC   CVCL_4G64
DR   CLO; CLO_0024215
DR   Coriell; GM05984
DR   Wikidata; Q54842072
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G63 ! GM05983
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05985
AC   CVCL_4G65
SY   GM05985A
DR   CLO; CLO_0024217
DR   Coriell; GM05985
DR   Wikidata; Q54842073
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G66 ! GM05986
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05986
AC   CVCL_4G66
DR   CLO; CLO_0024152
DR   Coriell; GM05986
DR   Wikidata; Q54842074
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G65 ! GM05985
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05987
AC   CVCL_4G67
SY   GM05987A; GM05987B
DR   CLO; CLO_0024153
DR   Coriell; GM05987
DR   Wikidata; Q54842075
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G68 ! GM05988
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05988
AC   CVCL_4G68
DR   CLO; CLO_0024150
DR   Coriell; GM05988
DR   Wikidata; Q54842076
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G67 ! GM05987
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05989
AC   CVCL_4G69
SY   GM05989B
DR   CLO; CLO_0024151
DR   Coriell; GM05989
DR   Wikidata; Q54842077
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G70 ! GM05990
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05990
AC   CVCL_4G70
DR   CLO; CLO_0024148
DR   Coriell; GM05990
DR   Wikidata; Q54842078
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G69 ! GM05989
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05991
AC   CVCL_4G71
SY   GM05991A
DR   CLO; CLO_0024149
DR   Coriell; GM05991
DR   Wikidata; Q54842079
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G72 ! GM05992
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05992
AC   CVCL_4G72
DR   CLO; CLO_0024157
DR   Coriell; GM05992
DR   Wikidata; Q54842080
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G71 ! GM05991
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05993
AC   CVCL_4G73
SY   GM05993A
DR   CLO; CLO_0024158
DR   Coriell; GM05993
DR   Wikidata; Q54842081
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G74 ! GM05994
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05994
AC   CVCL_4G74
DR   CLO; CLO_0024155
DR   Coriell; GM05994
DR   Wikidata; Q54842082
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G73 ! GM05993
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM05995
AC   CVCL_4G75
SY   GM05995A; GM05995B
DR   CLO; CLO_0024156
DR   Coriell; GM05995
DR   Wikidata; Q54842083
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G76 ! GM05996
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05996
AC   CVCL_4G76
DR   CLO; CLO_0024173
DR   Coriell; GM05996
DR   Wikidata; Q54842084
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G75 ! GM05995
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM05997
AC   CVCL_4G77
SY   GM05997A
DR   CLO; CLO_0024174
DR   Coriell; GM05997
DR   Wikidata; Q54842085
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM05999
AC   CVCL_4G78
SY   GM05999A
DR   CLO; CLO_0024175
DR   Coriell; GM05999
DR   Wikidata; Q54842092
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G79 ! GM06000
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06000
AC   CVCL_4G79
DR   CLO; CLO_0024169
DR   Coriell; GM06000
DR   Wikidata; Q54842093
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G78 ! GM05999
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06001
AC   CVCL_4G80
SY   GM06001A
DR   CLO; CLO_0024170
DR   Coriell; GM06001
DR   Wikidata; Q54842094
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G81 ! GM06002
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06002
AC   CVCL_4G81
DR   CLO; CLO_0024171
DR   Coriell; GM06002
DR   Wikidata; Q54842095
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G80 ! GM06001
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06003
AC   CVCL_4G82
SY   GM06003A
DR   CLO; CLO_0024172
DR   Coriell; GM06003
DR   Wikidata; Q54842096
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G83 ! GM06004
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06004
AC   CVCL_4G83
DR   CLO; CLO_0024176
DR   Coriell; GM06004
DR   Wikidata; Q54842097
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G82 ! GM06003
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06005
AC   CVCL_4G84
SY   GM06005A
DR   CLO; CLO_0024177
DR   Coriell; GM06005
DR   Wikidata; Q54842098
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G85 ! GM06006
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06006
AC   CVCL_4G85
DR   CLO; CLO_0024178
DR   Coriell; GM06006
DR   Wikidata; Q54842099
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G84 ! GM06005
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06007
AC   CVCL_5N40
SY   GM06007A
DR   CLO; CLO_0023475
DR   Coriell; GM06007
DR   Wikidata; Q54842100
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,X,t(X;9)(Xqter->Xp21.2::9p22->9pter;9qter->9p22::Xp21.2->Xpter) (Coriell=GM06007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM06011
AC   CVCL_4G86
SY   GM06011A
DR   CLO; CLO_0023476
DR   Coriell; GM06011
DR   Wikidata; Q54842101
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G87 ! GM06012
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06012
AC   CVCL_4G87
DR   CLO; CLO_0023477
DR   Coriell; GM06012
DR   Wikidata; Q54842102
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G86 ! GM06011
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06013
AC   CVCL_4G88
SY   GM06013D; GM06013F
DR   CLO; CLO_0023478
DR   Coriell; GM06013
DR   Wikidata; Q54842103
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G89 ! GM06014
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   GM06014
AC   CVCL_4G89
DR   CLO; CLO_0023479
DR   Coriell; GM06014
DR   Wikidata; Q54842104
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G88 ! GM06013
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06015
AC   CVCL_4G90
SY   GM06015B; GM06015C
DR   CLO; CLO_0023494
DR   Coriell; GM06015
DR   Wikidata; Q54842105
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G91 ! GM06016
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06016
AC   CVCL_4G91
DR   CLO; CLO_0023493
DR   Coriell; GM06016
DR   Wikidata; Q54842107
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G90 ! GM06015
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06017
AC   CVCL_4G92
SY   GM06017A
DR   CLO; CLO_0023492
DR   Coriell; GM06017
DR   Wikidata; Q54842108
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G93 ! GM06018
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06018
AC   CVCL_4G93
DR   CLO; CLO_0023491
DR   Coriell; GM06018
DR   Wikidata; Q54842109
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G92 ! GM06017
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06021
AC   CVCL_4G94
DR   CLO; CLO_0023495
DR   Coriell; GM06021
DR   Wikidata; Q54842110
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06022
AC   CVCL_4G95
DR   CLO; CLO_0023496
DR   Coriell; GM06022
DR   Wikidata; Q54842111
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06023
AC   CVCL_4G96
SY   GM06023A
DR   CLO; CLO_0023497
DR   Coriell; GM06023
DR   Wikidata; Q54842112
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G97 ! GM06024
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06024
AC   CVCL_4G97
DR   CLO; CLO_0023500
DR   Coriell; GM06024
DR   Wikidata; Q54842113
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G96 ! GM06023
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM06025
AC   CVCL_4G98
SY   GM06025A
DR   CLO; CLO_0023501
DR   Coriell; GM06025
DR   Wikidata; Q54842114
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G99 ! GM06026
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06026
AC   CVCL_4G99
DR   CLO; CLO_0023498
DR   Coriell; GM06026
DR   Wikidata; Q54842115
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G98 ! GM06025
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06027
AC   CVCL_4H00
SY   GM06027A
DR   CLO; CLO_0023499
DR   Coriell; GM06027
DR   Wikidata; Q54842116
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4H01 ! GM06028
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06028
AC   CVCL_4H01
DR   CLO; CLO_0023514
DR   Coriell; GM06028
DR   Wikidata; Q54842117
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4H00 ! GM06027
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06029
AC   CVCL_4H02
SY   GM06029B
DR   CLO; CLO_0023513
DR   Coriell; GM06029
DR   Wikidata; Q54842118
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4H03 ! GM06030
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM06030
AC   CVCL_4H03
DR   CLO; CLO_0023516
DR   Coriell; GM06030
DR   Wikidata; Q54842119
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4H02 ! GM06029
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06031
AC   CVCL_4H04
DR   CLO; CLO_0023515
DR   Coriell; GM06031
DR   Wikidata; Q54842120
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2878; Anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06032
AC   CVCL_4H05
DR   CLO; CLO_0023521
DR   Coriell; GM06032
DR   Wikidata; Q54842121
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06033
AC   CVCL_X329
SY   GM 6033
DR   CLO; CLO_0023522
DR   Coriell; GM06033
DR   Wikidata; Q54842122
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM06033; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM06034
AC   CVCL_V256
SY   GM06034A
DR   CLO; CLO_0023523
DR   Coriell; GM06034
DR   Wikidata; Q54842123
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM06035
AC   CVCL_V257
SY   GM06035A
DR   CLO; CLO_0023517
DR   Coriell; GM06035
DR   Wikidata; Q54842124
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM06037
AC   CVCL_2T18
DR   CLO; CLO_0023518
DR   Coriell; GM06037
DR   Wikidata; Q54842125
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM06038
AC   CVCL_X330
SY   GM 6038; GM6038
DR   CLO; CLO_0023519
DR   Coriell; GM06038
DR   Wikidata; Q54842126
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   GM06039
AC   CVCL_4H06
DR   CLO; CLO_0023520
DR   Coriell; GM06039
DR   Wikidata; Q54842127
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM06047
AC   CVCL_5U19
SY   MDS1r(17) Fib
DR   CLO; CLO_0023537
DR   Coriell; GM06047
DR   GEO; GSM1274192
DR   Wikidata; Q54842128
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
RX   PubMed=24413397;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   NCIt; C3360; Supernumerary circular chromosome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM06048
AC   CVCL_GQ58
DR   CLO; CLO_0023536
DR   Coriell; GM06048
DR   Wikidata; Q54842129
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM06049
AC   CVCL_GQ59
DR   CLO; CLO_0023535
DR   Coriell; GM06049
DR   Wikidata; Q54842130
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM06051
AC   CVCL_7446
SY   GM17263
DR   CLO; CLO_0013169
DR   CLO; CLO_0023544
DR   Coriell; GM06051
DR   Coriell; GM17263
DR   GEO; GSM569721
DR   GEO; GSM596327
DR   GEO; GSM596749
DR   GEO; GSM924865
DR   Wikidata; Q54842131
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,02:05:01; B*44:02:01,53:01:01; C*05:01:01,06:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,13:01:01G; DQA1*01:02:01,02:01:01; DQB1*02:02:01,06:04:01; DRB1*07:01:01,13:02:01; DRB3*03:01:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM06052
AC   CVCL_N045
SY   GM17160
DR   CLO; CLO_0013984
DR   CLO; CLO_0023545
DR   Coriell; GM06052
DR   Coriell; GM17160
DR   GEO; GSM273427
DR   GEO; GSM569648
DR   GEO; GSM596225
DR   GEO; GSM597025
DR   GEO; GSM924670
DR   IPD-IMGT/HLA; 16419
DR   Wikidata; Q54842132
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:DFKR,36:01; B*53:01,81:MN; C*04:CVAF,18:AB; DRB1*08:04,11:01 (IPD-IMGT/HLA=16419).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM06054
AC   CVCL_GQ60
DR   CLO; CLO_0023542
DR   Coriell; GM06054
DR   Wikidata; Q54842138
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM06055
AC   CVCL_GQ61
DR   CLO; CLO_0023543
DR   Coriell; GM06055
DR   Wikidata; Q54842139
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM06056
AC   CVCL_V822
SY   GM6056
DR   CLO; CLO_0023540
DR   Coriell; GM06056
DR   Wikidata; Q54842140
RX   CelloPub=CLPUB00447;
RX   PubMed=6705569;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85040; Pyruvate carboxylase deficiency
DI   ORDO; Orphanet_3008; Pyruvate carboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM06057
AC   CVCL_ZP70
SY   KR06057
DR   Coriell; GM06057
DR   Wikidata; Q98126375
RX   PubMed=14662655;
RX   PubMed=16081512;
RX   PubMed=18955168;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM06057; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM06058
AC   CVCL_ZP71
SY   KR06058
DR   Coriell; GM06058
DR   Wikidata; Q98126378
RX   PubMed=16081512;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM06058; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM06059
AC   CVCL_ZP72
SY   KR06059
DR   Coriell; GM06059
DR   Wikidata; Q98126379
RX   PubMed=16081512;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM06059; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM06060
AC   CVCL_ZP73
SY   KR06060
DR   Coriell; GM06060
DR   Wikidata; Q98126381
RX   PubMed=16081512;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM06060; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM06061
AC   CVCL_F655
SY   GM6061; GM06061B; GM6061B
DR   CLO; CLO_0023541
DR   Coriell; GM06061
DR   Wikidata; Q54842141
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 49,XXXXX.arr(X)x4 (Coriell=GM06061).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT31 ! GM05882
SX   Female
AG   2Y1M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM06065
AC   CVCL_AW80
DR   CLO; CLO_0023538
DR   Coriell; GM06065
DR   Wikidata; Q54842142
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118438; Osteopetrosis with renal tubular acidosis
DI   ORDO; Orphanet_2785; Osteopetrosis with renal tubular acidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW83 ! GM06071
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM06066
AC   CVCL_AW81
DR   CLO; CLO_0023539
DR   Coriell; GM06066
DR   Wikidata; Q54842143
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118438; Osteopetrosis with renal tubular acidosis
DI   ORDO; Orphanet_2785; Osteopetrosis with renal tubular acidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM06067
AC   CVCL_N046
SY   GM17322
DR   CLO; CLO_0013644
DR   CLO; CLO_0023604
DR   Coriell; GM06067
DR   Coriell; GM17322
DR   Wikidata; Q54842144
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N047 ! GM06072
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM06068
AC   CVCL_AW82
DR   CLO; CLO_0023605
DR   Coriell; GM06068
DR   Wikidata; Q54842145
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW84 ! GM06073
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM06071
AC   CVCL_AW83
DR   CLO; CLO_0023592
DR   Coriell; GM06071
DR   Wikidata; Q54842146
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118438; Osteopetrosis with renal tubular acidosis
DI   ORDO; Orphanet_2785; Osteopetrosis with renal tubular acidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW80 ! GM06065
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM06072
AC   CVCL_N047
DR   CLO; CLO_0023599
DR   Coriell; GM06072
DR   Wikidata; Q54842147
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N046 ! GM06067
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   GM06073
AC   CVCL_AW84
DR   CLO; CLO_0023598
DR   Coriell; GM06073
DR   Wikidata; Q54842148
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AW82 ! GM06068
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM06074
AC   CVCL_CV42
DR   CLO; CLO_0023597
DR   Coriell; GM06074
DR   Wikidata; Q54842149
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,rec(9)(pter->q22.1::q34.3->q34.1::q22.1->qter)mat (Coriell=GM06074).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM06075
AC   CVCL_Y798
DR   CLO; CLO_0023596
DR   Coriell; GM06075
DR   Wikidata; Q54842150
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[66] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM06075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y799 ! GM06076
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM06076
AC   CVCL_Y799
DR   CLO; CLO_0023603
DR   Coriell; GM06076
DR   Wikidata; Q54842151
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[66] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM06076).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y798 ! GM06075
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   GM06077
AC   CVCL_Y800
DR   CLO; CLO_0023602
DR   Coriell; GM06077
DR   Wikidata; Q54842152
RX   PubMed=23680132;
RX   PubMed=32656337;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=32656337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y794 ! GM04602
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM06080
AC   CVCL_9Q71
DR   CLO; CLO_0023601
DR   Coriell; GM06080
DR   Wikidata; Q54842153
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM06081
AC   CVCL_9Q72
DR   CLO; CLO_0023600
DR   Coriell; GM06081
DR   Wikidata; Q54842154
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q73 ! GM06082
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM06082
AC   CVCL_9Q73
DR   CLO; CLO_0023625
DR   Coriell; GM06082
DR   Wikidata; Q54842155
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q72 ! GM06081
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM06087
AC   CVCL_AW85
DR   CLO; CLO_0023616
DR   Coriell; GM06087
DR   Wikidata; Q54842156
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM06091
AC   CVCL_CZ85
DR   CLO; CLO_0023618
DR   Coriell; GM06091
DR   Wikidata; Q54842158
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ83 ! GM04307
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM06092
AC   CVCL_CZ16
SY   GM06092A
DR   CLO; CLO_0023617
DR   Coriell; GM06092
DR   Wikidata; Q54842160
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ10 ! GM04306
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM06094
AC   CVCL_4F52
DR   CLO; CLO_0023620
DR   Coriell; GM06094
DR   Wikidata; Q54842161
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM06097
AC   CVCL_5U20
SY   GM06097A; MDS2 Fib
DR   CLO; CLO_0023619
DR   Coriell; GM06097
DR   Wikidata; Q54842162
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
RX   PubMed=24413397;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM06099
AC   CVCL_5L52
DR   CLO; CLO_0023622
DR   Coriell; GM06099
DR   Wikidata; Q54842163
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; c.2743-1G>A; ClinVar=VCV000049560; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM06099).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L53 ! GM06100
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   GM06100
AC   CVCL_5L53
DR   CLO; CLO_0023621
DR   Coriell; GM06100
DR   Wikidata; Q54842164
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; c.2743-1G>A; ClinVar=VCV000049560; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM06100).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L52 ! GM06099
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM06101
AC   CVCL_1N87
DR   CLO; CLO_0023624
DR   Coriell; GM06101
DR   Wikidata; Q54842165
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg1743Gln (c.5528G>A); ClinVar=VCV000049960; Zygosity=Heterozygous (Coriell=GM06101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N88 ! GM06102
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM06102
AC   CVCL_1N88
DR   CLO; CLO_0023623
DR   Coriell; GM06102
DR   Wikidata; Q54842166
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg1743Gln (c.5528G>A); ClinVar=VCV000049960; Zygosity=Heterozygous (Coriell=GM06102).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N87 ! GM06101
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM06107
AC   CVCL_GQ62
DR   CLO; CLO_0023631
DR   Coriell; GM06107
DR   Wikidata; Q54842167
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM06109
AC   CVCL_4D88
DR   CLO; CLO_0023630
DR   Coriell; GM06109
DR   Wikidata; Q54842168
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,XX,inv(10)(pter->p11.2::q21->p11.2::q21->qter) (Coriell=GM06109).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM06110
AC   CVCL_0M06
DR   CLO; CLO_0023629
DR   Coriell; GM06110
DR   Wikidata; Q54842169
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Arg245His (c.734G>A); ClinVar=VCV000005107; Zygosity=Heterozygous (Coriell=GM06110).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM06111
AC   CVCL_7447
SY   GM6111; GM 06111
DR   CLO; CLO_0023644
DR   Coriell; GM06111
DR   Wikidata; Q54842170
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7448 ! GM06112
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM06112
AC   CVCL_7448
SY   GM6112
DR   CLO; CLO_0023643
DR   Coriell; GM06112
DR   Wikidata; Q54842171
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=17668376;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7447 ! GM06111
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM06113
AC   CVCL_F134
SY   GM6113
DR   CLO; CLO_0023642
DR   Coriell; GM06113
DR   Wikidata; Q54842172
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7449 ! GM06114
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM06114
AC   CVCL_7449
SY   GM6114; GM 06114
DR   CLO; CLO_0023641
DR   Coriell; GM06114
DR   Wikidata; Q54842173
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F134 ! GM06113
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM06119
AC   CVCL_AW86
DR   CLO; CLO_0023640
DR   Coriell; GM06119
DR   Wikidata; Q54842174
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM06120
AC   CVCL_5L54
DR   CLO; CLO_0023639
DR   Coriell; GM06120
DR   Wikidata; Q54842175
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L55 ! GM06121
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM06121
AC   CVCL_5L55
DR   CLO; CLO_0023638
DR   Coriell; GM06121
DR   Wikidata; Q54842176
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L54 ! GM06120
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   GM06122
AC   CVCL_X443
DR   CLO; CLO_0023651
DR   Coriell; GM06122
DR   Wikidata; Q54842177
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Gly266Ter (c.796G>T); ClinVar=VCV000000078; Zygosity=Heterozygous (Coriell=GM06122).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   GM06123
AC   CVCL_X445
DR   CLO; CLO_0023649
DR   Coriell; GM06123
DR   Wikidata; Q54842178
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Ala199Cysfs*13 (c.594dupT); ClinVar=VCV000000080; Zygosity=Heterozygous (Coriell=GM06123).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   GM06124
AC   CVCL_X444
DR   CLO; CLO_0023653
DR   Coriell; GM06124
DR   Wikidata; Q54842183
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   GM06125
AC   CVCL_4F53
DR   CLO; CLO_0023652
DR   Coriell; GM06125
DR   Wikidata; Q54842184
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM06125).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F55 ! GM07523
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM06127
AC   CVCL_7450
DR   CLO; CLO_0003533
DR   CLO; CLO_0023661
DR   CLDB; cl1500
DR   Coriell; GM06127
DR   Wikidata; Q54842185
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:92; ACADVL; Simple; c.1078_1182del105 (c.1182+1G>A); Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM06127).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98647; Very long-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26793; Very long chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GM06128
AC   CVCL_GQ63
DR   CLO; CLO_0023660
DR   Coriell; GM06128
DR   Wikidata; Q54842186
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM06135
AC   CVCL_2T19
DR   CLO; CLO_0023663
DR   Coriell; GM06135
DR   Wikidata; Q54842187
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06136
AC   CVCL_X331
SY   GM 6136
DR   CLO; CLO_0023662
DR   Coriell; GM06136
DR   Wikidata; Q54842188
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM06138
AC   CVCL_N048
SY   GM18021
DR   CLO; CLO_0015536
DR   CLO; CLO_0023659
DR   Coriell; GM06138
DR   Coriell; GM18021
DR   Wikidata; Q54842189
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM06139
AC   CVCL_GQ64
DR   CLO; CLO_0023658
DR   Coriell; GM06139
DR   Wikidata; Q54842190
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM06140
AC   CVCL_CZ17
DR   CLO; CLO_0023562
DR   Coriell; GM06140
DR   Wikidata; Q54842191
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM06142
AC   CVCL_GS70
SY   GM 6142
DR   CLO; CLO_0023566
DR   Coriell; GM06142
DR   Wikidata; Q54842192
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Pro297Gln (c.890C>A); ClinVar=VCV000001961; Zygosity=Homozygous (Coriell=GM06142).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM06143
AC   CVCL_GS71
SY   GM06143A; GM 6143A
DR   CLO; CLO_0023563
DR   Coriell; GM06143
DR   Wikidata; Q54842193
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg149Gln (c.446G>A); ClinVar=VCV000001963; Zygosity=Heterozygous (Coriell=GM06143).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Pro297Gln (c.890C>A); ClinVar=VCV000001961; Zygosity=Heterozygous (Coriell=GM06143).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   GM06144
AC   CVCL_X456
DR   CLO; CLO_0023564
DR   Coriell; GM06144
DR   Wikidata; Q54842194
RX   CelloPub=CLPUB00447;
RX   PubMed=28659158;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Ala199Cysfs*13 (c.594dupT); ClinVar=VCV000000080; Zygosity=Heterozygous (Coriell=GM06144).
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Gly266Ter (c.796G>T); ClinVar=VCV000000078; Zygosity=Heterozygous (Coriell=GM06144).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28659158
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 15,16
ST   D21S11: 30,32.2
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 14
ST   Penta E: 15,16
ST   TH01: 7,9.3
ST   TPOX: 10
ST   vWA: 19
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   GM06146
AC   CVCL_5L56
DR   CLO; CLO_0023559
DR   Coriell; GM06146
DR   Wikidata; Q54842195
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Trp750Ter (c.2249G>A); ClinVar=VCV000048922; Zygosity=Heterozygous (Coriell=GM06146).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L58 ! GM06149
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM06148
AC   CVCL_5L57
DR   CLO; CLO_0023560
DR   Coriell; GM06148
DR   Wikidata; Q54842196
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   GM06149
AC   CVCL_5L58
DR   CLO; CLO_0023557
DR   Coriell; GM06149
DR   Wikidata; Q54842197
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Trp750Ter (c.2249G>A); ClinVar=VCV000048922; Zygosity=Heterozygous (Coriell=GM06149).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5L56 ! GM06146
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM06150
AC   CVCL_5L59
DR   CLO; CLO_0023558
DR   Coriell; GM06150
DR   Wikidata; Q54842198
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   GM06151
AC   CVCL_7451
DR   CLO; CLO_0023561
DR   Coriell; GM06151
DR   Wikidata; Q54842199
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous; Note=The other allele has 24 repeats (Coriell=GM06151).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GM06153
AC   CVCL_7452
DR   CLO; CLO_0023571
DR   Coriell; GM06153
DR   Wikidata; Q54842201
RX   CelloPub=CLPUB00447;
RX   PubMed=25732146;
RX   PubMed=32361312;
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[71]; Zygosity=Heterozygous; Note=The other allele has 23 repeats (Coriell=GM06153).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GM06160
AC   CVCL_7453
SY   GM17264
DR   CLO; CLO_0013168
DR   CLO; CLO_0023572
DR   Coriell; GM06160
DR   Coriell; GM17264
DR   GEO; GSM569722
DR   GEO; GSM596328
DR   GEO; GSM596750
DR   GEO; GSM924866
DR   Wikidata; Q54842202
RX   CelloPub=CLPUB00447;
RX   PubMed=16244288;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,24:02:01; B*08:01:01,35:01:01; C*04:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,06:01:01; DQA1*01:01:01,03:01:01; DQB1*03:02:01,05:01:01; DRB1*01:03:01,04:01:01; DRB4*01:03:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM06160).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM06160).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM06166
AC   CVCL_7454
SY   GM6166
DR   CLO; CLO_0023573
DR   Coriell; GM06166
DR   Wikidata; Q54842203
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=17668376;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7455 ! GM06167
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM06167
AC   CVCL_7455
SY   GM6167; GM 06167
DR   CLO; CLO_0023574
DR   Coriell; GM06167
DR   Wikidata; Q54842204
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7454 ! GM06166
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM06168
AC   CVCL_W040
SY   GM6168
DR   CLO; CLO_0023575
DR   Coriell; GM06168
DR   Wikidata; Q54842205
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W041 ! GM06169
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM06169
AC   CVCL_W041
SY   GM6169
DR   CLO; CLO_0023576
DR   Coriell; GM06169
DR   Wikidata; Q54842206
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W040 ! GM06168
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM06170
AC   CVCL_7456
SY   GM6170
DR   CLO; CLO_0023567
DR   Coriell; GM06170
DR   Wikidata; Q54842207
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F136 ! GM06171
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GM06171
AC   CVCL_F136
SY   GM6171
DR   CLO; CLO_0023568
DR   Coriell; GM06171
DR   Wikidata; Q54842208
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7456 ! GM06170
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM06172
AC   CVCL_GZ41
DR   CLO; CLO_0023569
DR   Coriell; GM06172
DR   Wikidata; Q54842209
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129308; Schinzel-Giedion midface-retraction syndrome
DI   ORDO; Orphanet_798; Schinzel-Giedion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM06174
AC   CVCL_GQ65
DR   CLO; CLO_0023570
DR   Coriell; GM06174
DR   Wikidata; Q54842210
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM06188
AC   CVCL_5L60
DR   CLO; CLO_0023134
DR   Coriell; GM06188
DR   Wikidata; Q54842211
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg611Trp (c.1831C>T); ClinVar=VCV000049643; Zygosity=Heterozygous (Coriell=GM06188).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM06194
AC   CVCL_5L61
DR   CLO; CLO_0023133
DR   Coriell; GM06194
DR   Wikidata; Q54842212
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 9
//
ID   GM06195
AC   CVCL_9Q74
DR   CLO; CLO_0023136
DR   Coriell; GM06195
DR   Wikidata; Q54842213
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q75 ! GM06196
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM06196
AC   CVCL_9Q75
DR   CLO; CLO_0023135
DR   Coriell; GM06196
DR   Wikidata; Q54842214
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q74 ! GM06195
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM06197
AC   CVCL_9Q76
DR   CLO; CLO_0023141
DR   Coriell; GM06197
DR   Wikidata; Q54842215
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 9
//
ID   GM06199
AC   CVCL_4D89
DR   CLO; CLO_0023142
DR   Coriell; GM06199
DR   Wikidata; Q54842216
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Karyotypic information: 46,XY,r(21)(p13->q22) (Coriell=GM06199).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C186278; Ring chromosome 21 syndrome
DI   ORDO; Orphanet_1445; Ring chromosome 21 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM06200
AC   CVCL_GS72
SY   GM 6200
DR   CLO; CLO_0023139
DR   Coriell; GM06200
DR   Wikidata; Q54842217
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg76Trp (c.226C>T); ClinVar=VCV000001962; Zygosity=Homozygous (Coriell=GM06200).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM06201
AC   CVCL_N049
SY   GM 6201; GM06201A; GM17161
DR   CLO; CLO_0013982
DR   CLO; CLO_0023140
DR   Coriell; GM06201
DR   Coriell; GM17161
DR   GEO; GSM273428
DR   GEO; GSM569688
DR   GEO; GSM596226
DR   GEO; GSM597061
DR   GEO; GSM924671
DR   Wikidata; Q54842218
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg76Trp (c.226C>T); ClinVar=VCV000001962; Zygosity=Heterozygous (Coriell=GM06201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM06206
AC   CVCL_V238
DR   CLO; CLO_0023137
DR   Coriell; GM06206
DR   Wikidata; Q54842219
RX   CelloPub=CLPUB00447;
CC   Donor information: Cell line originating from a cat suffering from a Ehlers-Danlos like syndrome.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: American shorthair; VBO=VBO_0100018.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   GM06207
AC   CVCL_V237
DR   CLO; CLO_0023138
DR   Coriell; GM06207
DR   Wikidata; Q54842220
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM06213
AC   CVCL_UY65
DR   Coriell; GM06213
DR   Wikidata; Q93791630
RX   CelloPub=CLPUB00447;
CC   Group: Non-human primate cell line.
CC   Discontinued: Coriell; GM06213; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM06214
AC   CVCL_1V16
SY   GM 06214
DR   CLO; CLO_0023147
DR   Coriell; GM06214
DR   Wikidata; Q54842221
RX   CelloPub=CLPUB00447;
RX   PubMed=8328452;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Homozygous (Coriell=GM06214).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM06221
AC   CVCL_GS73
DR   CLO; CLO_0023146
DR   Coriell; GM06221
DR   Wikidata; Q54842222
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84698; Erythropoietic protoporphyria
DI   ORDO; Orphanet_79278; Autosomal erythropoietic protoporphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 30-01-24; Version: 9
//
ID   GM06222
AC   CVCL_X332
SY   GM 6222
DR   CLO; CLO_0023145
DR   Coriell; GM06222
DR   Wikidata; Q54842223
RX   CelloPub=CLPUB00447;
RX   PubMed=6661932;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   GM06224
AC   CVCL_4N46
SY   GM06224A
DR   CLO; CLO_0023144
DR   Coriell; GM06224
DR   Wikidata; Q54842228
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N47 ! GM06225
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM06225
AC   CVCL_4N47
DR   CLO; CLO_0023143
DR   Coriell; GM06225
DR   Wikidata; Q54842229
RX   CelloPub=CLPUB00447;
RX   PubMed=30471880;
CC   Population: Jewish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4N46 ! GM06224
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06226
AC   CVCL_1P96
DR   CLO; CLO_0023092
DR   Coriell; GM06226
DR   Wikidata; Q54842230
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM06227
AC   CVCL_1P97
SY   GM6227
DR   CLO; CLO_0023091
DR   Coriell; GM06227
DR   Wikidata; Q54842231
RX   CelloPub=CLPUB00447;
RX   PubMed=2714795;
RX   PubMed=3495225;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06228
AC   CVCL_2T20
DR   CLO; CLO_0023094
DR   Coriell; GM06228
DR   Wikidata; Q54842232
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   GM06229
AC   CVCL_F669
SY   GM6229; GM06229A; GM06229B
DR   CLO; CLO_0023093
DR   Coriell; GM06229
DR   Wikidata; Q54842233
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM06230
AC   CVCL_5N41
DR   CLO; CLO_0023095
DR   Coriell; GM06230
DR   Wikidata; Q54842234
RX   PubMed=23665875;
CC   Population: Asian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM06231
AC   CVCL_N050
SY   GM6231; GM17380; PBD061
DR   CLO; CLO_0012204
DR   CLO; CLO_0023106
DR   Coriell; GM06231
DR   Coriell; GM17380
DR   Wikidata; Q54842235
RX   CelloPub=CLPUB00447;
RX   PubMed=9922452;
CC   Part of: Human variation panel.
CC   Population: Africans north of the Sahara.
CC   Sequence variation: Mutation; HGNC; HGNC:8857; PEX16; Simple; p.Arg176Ter (c.526C>T); ClinVar=VCV000006466; Zygosity=Homozygous (PubMed=9922452).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155762; Peroxisome biogenesis disorder 8A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   GM06246
AC   CVCL_9R47
DR   CLO; CLO_0023107
DR   Coriell; GM06246
DR   Wikidata; Q54842236
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM06248
AC   CVCL_5U21
SY   GM6248
DR   CLO; CLO_0023108
DR   Coriell; GM06248
DR   Wikidata; Q54842237
RX   CelloPub=CLPUB00447;
RX   PubMed=3353369;
RX   PubMed=23665875;
CC   Population: Native North American; Salish.
CC   Sequence variation: Mutation; HGNC; HGNC:399; ALB; Simple; c.714-2A>G (IVS6AS,A-G,-2); ClinVar=VCV000018210; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=3353369).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124851; Analbuminemia
DI   ORDO; Orphanet_86816; Congenital analbuminemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM06256
AC   CVCL_4F54
DR   CLO; CLO_0023109
DR   Coriell; GM06256
DR   Wikidata; Q54842238
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(9)(pter->p11::q21->p11::q21->qter)pat (Coriell=GM06256).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM06260
AC   CVCL_DD81
DR   CLO; CLO_0023110
DR   Coriell; GM06260
DR   Wikidata; Q54842239
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM06261
AC   CVCL_AM99
DR   CLO; CLO_0023111
DR   Coriell; GM06261
DR   Wikidata; Q54842240
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM06273
AC   CVCL_1J29
DR   CLO; CLO_0023115
DR   Coriell; GM06273
DR   Wikidata; Q54842241
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM06274
AC   CVCL_V046
DR   CLO; CLO_0023114
DR   Coriell; GM06274
DR   Wikidata; Q54842242
RX   CelloPub=CLPUB00447;
RX   PubMed=7847674;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM06275
AC   CVCL_F670
SY   GM6275; GM06275A
DR   CLO; CLO_0023113
DR   Coriell; GM06275
DR   Wikidata; Q54842244
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM06312
AC   CVCL_5N42
DR   CLO; CLO_0023112
DR   Coriell; GM06312
DR   Wikidata; Q54842245
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM06314
AC   CVCL_H157
SY   GM 6314; GM06314A; GM17323
DR   CLO; CLO_0013649
DR   CLO; CLO_0023128
DR   Coriell; GM06314
DR   Coriell; GM17323
DR   Wikidata; Q54842246
RX   CelloPub=CLPUB00447;
RX   PubMed=1652892;
RX   PubMed=2112341;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM06314).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.1551+1G>C (IVS10+1G>C); ClinVar=VCV000554983; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM06314).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM06315
AC   CVCL_7457
SY   GM06315A; GM17225
DR   CLO; CLO_0014371
DR   CLO; CLO_0023126
DR   Coriell; GM06315
DR   Coriell; GM17225
DR   GEO; GSM569552
DR   GEO; GSM596289
DR   GEO; GSM596649
DR   GEO; GSM924827
DR   Wikidata; Q54842247
RX   CelloPub=CLPUB00447;
RX   PubMed=8327515;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM06316
AC   CVCL_F137
SY   GM06316A; GM6316A
DR   CLO; CLO_0023127
DR   Coriell; GM06316
DR   Wikidata; Q54842248
RX   CelloPub=CLPUB00447;
RX   PubMed=1505951;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM06317
AC   CVCL_1R78
DR   CLO; CLO_0023131
DR   Coriell; GM06317
DR   Wikidata; Q54842249
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome Y mapping. Contains a complete copy of chromosome Y.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1K14 ! CHW-1103
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM06318
AC   CVCL_1R79
SY   GM06318B; GM6318B; GM06318C
DR   CLO; CLO_0023132
DR   Coriell; GM06318
DR   Wikidata; Q54842250
RX   CelloPub=CLPUB00447;
RX   PubMed=8314568;
RX   PubMed=8365721;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping. Contains a complete copy of chromosome X.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM06321
AC   CVCL_2T21
SY   GM06321B
DR   CLO; CLO_0023129
DR   Coriell; GM06321
DR   Wikidata; Q54842251
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM06324
AC   CVCL_Y573
DR   CLO; CLO_0023130
DR   Coriell; GM06324
DR   Wikidata; Q54842252
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Portuguese.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM06325
AC   CVCL_N051
SY   GM17093
DR   CLO; CLO_0014520
DR   CLO; CLO_0023061
DR   Coriell; GM06325
DR   Coriell; GM17093
DR   Wikidata; Q54842253
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Portuguese.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM06326
AC   CVCL_1Q23
DR   CLO; CLO_0023060
DR   Coriell; GM06326
DR   Wikidata; Q54842254
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM06327
AC   CVCL_9X01
DR   CLO; CLO_0023062
DR   Coriell; GM06327
DR   Wikidata; Q54842255
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM06328
AC   CVCL_9X02
DR   CLO; CLO_0023076
DR   Coriell; GM06328
DR   Wikidata; Q54842256
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM06329
AC   CVCL_9X03
DR   CLO; CLO_0023077
DR   Coriell; GM06329
DR   Wikidata; Q54842257
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM06330
AC   CVCL_CY54
SY   GM6330
DR   CLO; CLO_0023078
DR   Coriell; GM06330
DR   Wikidata; Q54842258
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:8091; OAT; Simple; p.Ala226Val (c.677C>T); ClinVar=VCV000000181; Zygosity=Homozygous (Coriell=GM06330).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM06331
AC   CVCL_N052
SY   GM06331A; GM17381
DR   CLO; CLO_0012202
DR   CLO; CLO_0023079
DR   Coriell; GM06331
DR   Coriell; GM17381
DR   Wikidata; Q54842259
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:16002; MPLKIP; Simple; p.Gly46Glufs*13 (c.137_138delGG) (187_188delGG); ClinVar=VCV000001845; Zygosity=Homozygous (Coriell=GM06331).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146899; Trichothiodystrophy 4, nonphotosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM06332
AC   CVCL_W047
DR   CLO; CLO_0023072
DR   Coriell; GM06332
DR   Wikidata; Q54842260
RX   CelloPub=CLPUB00447;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:16002; MPLKIP; Simple; p.Gly46Glufs*13 (c.137_138delGG) (187_188delGG); ClinVar=VCV000001845; Zygosity=Homozygous (Coriell=GM06332).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146899; Trichothiodystrophy 4, nonphotosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM06333
AC   CVCL_W048
DR   CLO; CLO_0023073
DR   Coriell; GM06333
DR   Wikidata; Q54842261
RX   CelloPub=CLPUB00447;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:16002; MPLKIP; Simple; p.Gly46Glufs*13 (c.137_138delGG) (187_188delGG); ClinVar=VCV000001845; Zygosity=Homozygous (Coriell=GM06333).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146899; Trichothiodystrophy 4, nonphotosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM06335
AC   CVCL_CY55
SY   GM6335
DR   CLO; CLO_0023074
DR   Coriell; GM06335
DR   Wikidata; Q54842262
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM06336
AC   CVCL_CY56
SY   GM6336
DR   CLO; CLO_0023075
DR   Coriell; GM06336
DR   Wikidata; Q54842263
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM06342
AC   CVCL_N053
SY   GM17347
DR   CLO; CLO_0013748
DR   CLO; CLO_0023081
DR   Coriell; GM06342
DR   Coriell; GM17347
DR   Wikidata; Q54842264
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African; Kenyan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:4829; HBD + HGNC; HGNC:4831; HBG1; Name(s)=HBG1-HBD, Hb Kenya; Note=In frame fusion of AA 1-81 of HBG1 with AA 84-146 of HBD (Coriell=GM06342).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   GM06343
AC   CVCL_US01
SY   GM06343Z
DR   Coriell; GM06343
DR   Wikidata; Q93791832
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06343; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06348
AC   CVCL_1J30
DR   CLO; CLO_0023080
DR   Coriell; GM06348
DR   Wikidata; Q54842265
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I46 ! GM04819
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06363
AC   CVCL_UT27
SY   GM06363Z
DR   Coriell; GM06363
DR   Wikidata; Q93791840
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06363; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J31 ! GM06364
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06364
AC   CVCL_1J31
DR   CLO; CLO_0023082
DR   Coriell; GM06364
DR   Wikidata; Q54842266
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT27 ! GM06363
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06365
AC   CVCL_UR99
SY   GM06365Z
DR   Coriell; GM06365
DR   Wikidata; Q93791848
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06365; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J32 ! GM06366
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06366
AC   CVCL_1J32
DR   CLO; CLO_0023089
DR   Coriell; GM06366
DR   Wikidata; Q54842267
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR99 ! GM06365
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06369
AC   CVCL_UR91
SY   GM06369Z
DR   Coriell; GM06369
DR   Wikidata; Q93791854
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06369; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J33 ! GM06370
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06370
AC   CVCL_1J33
DR   CLO; CLO_0023090
DR   Coriell; GM06370
DR   Wikidata; Q54842268
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR91 ! GM06369
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06375
AC   CVCL_US79
SY   GM06375Z
DR   Coriell; GM06375
DR   Wikidata; Q93791861
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06375; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J34 ! GM06376
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06376
AC   CVCL_1J34
DR   CLO; CLO_0023087
DR   Coriell; GM06376
DR   Wikidata; Q54842275
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US79 ! GM06375
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06383
AC   CVCL_UR95
SY   GM06383Z
DR   Coriell; GM06383
DR   Wikidata; Q93791868
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06383; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J35 ! GM06384
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06384
AC   CVCL_1J35
SY   GM06384A
DR   CLO; CLO_0023088
DR   Coriell; GM06384
DR   Wikidata; Q54842276
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR95 ! GM06383
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06386
AC   CVCL_US10
SY   GM06386Z
DR   Coriell; GM06386
DR   Wikidata; Q93791876
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06386; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06390
AC   CVCL_US02
SY   GM06390Z
DR   Coriell; GM06390
DR   Wikidata; Q93791879
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06390; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06391
AC   CVCL_US07
SY   GM06391Z
DR   Coriell; GM06391
DR   Wikidata; Q93791882
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06391; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06392
AC   CVCL_US03
SY   GM06392Z
DR   Coriell; GM06392
DR   Wikidata; Q93791884
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06392; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06393
AC   CVCL_US04
SY   GM06393Z
DR   Coriell; GM06393
DR   Wikidata; Q93791887
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06393; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06394
AC   CVCL_US05
SY   GM06394Z
DR   Coriell; GM06394
DR   Wikidata; Q93791888
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06394; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06395
AC   CVCL_US06
SY   GM06395Z
DR   Coriell; GM06395
DR   Wikidata; Q93791891
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06395; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06396
AC   CVCL_US08
SY   GM06396Z
DR   Coriell; GM06396
DR   Wikidata; Q93791893
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06396; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06397
AC   CVCL_US09
SY   GM06397Z
DR   Coriell; GM06397
DR   Wikidata; Q93791895
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06397; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06399
AC   CVCL_US58
SY   GM06399Z
DR   Coriell; GM06399
DR   Wikidata; Q93791898
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06399; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06401
AC   CVCL_US29
SY   GM06401Z
DR   Coriell; GM06401
DR   Wikidata; Q93791900
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06401; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06402
AC   CVCL_US26
SY   GM06402Z
DR   Coriell; GM06402
DR   Wikidata; Q93791902
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06402; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06403
AC   CVCL_US11
SY   GM06403Z
DR   Coriell; GM06403
DR   Wikidata; Q93791904
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06403; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06404
AC   CVCL_US54
SY   GM06404Z
DR   Coriell; GM06404
DR   Wikidata; Q93791907
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06404; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06405
AC   CVCL_US57
SY   GM06405Z
DR   Coriell; GM06405
DR   Wikidata; Q93791910
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06405; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06406
AC   CVCL_US25
SY   GM06406Z
DR   Coriell; GM06406
DR   Wikidata; Q93791911
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06406; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06407
AC   CVCL_US56
SY   GM06407Z
DR   Coriell; GM06407
DR   Wikidata; Q93791914
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06407; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06409
AC   CVCL_US59
SY   GM06409Z
DR   Coriell; GM06409
DR   Wikidata; Q93791916
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06409; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06410
AC   CVCL_US55
SY   GM06410Z
DR   Coriell; GM06410
DR   Wikidata; Q93791918
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06410; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06411
AC   CVCL_US24
SY   GM06411Z
DR   Coriell; GM06411
DR   Wikidata; Q93791921
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06411; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06414
AC   CVCL_US28
SY   GM06414Z
DR   Coriell; GM06414
DR   Wikidata; Q93791924
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06414; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06415
AC   CVCL_N054
SY   GM 6415; GM17356
DR   CLO; CLO_0013713
DR   CLO; CLO_0023085
DR   Coriell; GM06415
DR   Coriell; GM17356
DR   Wikidata; Q54842277
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Part of: Human variation panel.
CC   Population: Latino or Hispanic; Dominican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM06416
AC   CVCL_N055
SY   GM 6416; GM17357
DR   CLO; CLO_0013716
DR   CLO; CLO_0023086
DR   Coriell; GM06416
DR   Coriell; GM17357
DR   Wikidata; Q54842278
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Part of: Human variation panel.
CC   Population: Latino or Hispanic; Dominican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM06417
AC   CVCL_F294
SY   GM17046; GM17337
DR   CLO; CLO_0013609
DR   CLO; CLO_0014640
DR   CLO; CLO_0023083
DR   Coriell; GM06417
DR   Coriell; GM17046
DR   Coriell; GM17337
DR   Wikidata; Q54842279
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
CC   Part of: Human variation panel.
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 13,16
ST   D21S11: 29
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   vWA: 15
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F295 ! GM06418
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 15
//
ID   GM06418
AC   CVCL_F295
DR   CLO; CLO_0023084
DR   Coriell; GM06418
DR   Wikidata; Q54842280
RX   CelloPub=CLPUB00447;
CC   Population: Iranian; Persian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F294 ! GM06417
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM06419
AC   CVCL_H752
DR   CLO; CLO_0023238
DR   Coriell; GM06419
DR   Wikidata; Q54842281
RX   CelloPub=CLPUB00447;
CC   Population: Iranian; Persian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM06420
AC   CVCL_4D90
DR   CLO; CLO_0023232
DR   Coriell; GM06420
DR   Wikidata; Q54842282
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Karyotypic information: 46,XY,r(22) (Coriell=GM06420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C179702; Ring chromosome 22 syndrome
DI   ORDO; Orphanet_1446; Ring chromosome 22 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM06421
AC   CVCL_1J36
DR   CLO; CLO_0023230
DR   Coriell; GM06421
DR   Wikidata; Q54842283
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US69 ! GM06422
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06422
AC   CVCL_US69
SY   GM06422Z
DR   Coriell; GM06422
DR   Wikidata; Q93791961
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06422; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J36 ! GM06421
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06423
AC   CVCL_1J37
DR   CLO; CLO_0023221
DR   Coriell; GM06423
DR   Wikidata; Q54842284
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT17 ! GM06424
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06424
AC   CVCL_UT17
SY   GM06424Z
DR   Coriell; GM06424
DR   Wikidata; Q93791969
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06424; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J37 ! GM06423
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06437
AC   CVCL_1J38
DR   CLO; CLO_0023220
DR   Coriell; GM06437
DR   Wikidata; Q54842285
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US97 ! GM06438
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06438
AC   CVCL_US97
SY   GM06438Z
DR   Coriell; GM06438
DR   Wikidata; Q93791975
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06438; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J38 ! GM06437
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06439
AC   CVCL_1J39
DR   CLO; CLO_0023219
DR   Coriell; GM06439
DR   Wikidata; Q54842286
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT28 ! GM06440
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06440
AC   CVCL_UT28
SY   GM06440Z
DR   Coriell; GM06440
DR   Wikidata; Q93791982
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06440; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J39 ! GM06439
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06443
AC   CVCL_1J40
DR   CLO; CLO_0023218
DR   Coriell; GM06443
DR   Wikidata; Q54842288
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US86 ! GM06444
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06444
AC   CVCL_US86
SY   GM06444Z
DR   Coriell; GM06444
DR   Wikidata; Q93791989
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06444; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J40 ! GM06443
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06445
AC   CVCL_1J41
DR   CLO; CLO_0023225
DR   Coriell; GM06445
DR   Wikidata; Q54842289
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT16 ! GM06446
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06446
AC   CVCL_UT16
SY   GM06446Z
DR   Coriell; GM06446
DR   Wikidata; Q93791996
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06446; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J41 ! GM06445
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06447
AC   CVCL_1J42
SY   GM06447A
DR   CLO; CLO_0023224
DR   Coriell; GM06447
DR   Wikidata; Q54842290
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT14 ! GM06448
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06448
AC   CVCL_UT14
SY   GM06448Z
DR   Coriell; GM06448
DR   Wikidata; Q93792005
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06448; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J42 ! GM06447
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06449
AC   CVCL_1J43
DR   CLO; CLO_0023223
DR   Coriell; GM06449
DR   Wikidata; Q54842291
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT15 ! GM06450
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06450
AC   CVCL_UT15
SY   GM06450Z
DR   Coriell; GM06450
DR   Wikidata; Q93792013
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06450; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J43 ! GM06449
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06456
AC   CVCL_US74
SY   GM06456Z
DR   Coriell; GM06456
DR   Wikidata; Q93792016
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06456; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06457
AC   CVCL_1J44
DR   CLO; CLO_0023222
DR   Coriell; GM06457
DR   Wikidata; Q54842292
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT25 ! GM06458
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06458
AC   CVCL_UT25
SY   GM06458Z
DR   Coriell; GM06458
DR   Wikidata; Q93792022
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06458; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J44 ! GM06457
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06461
AC   CVCL_US50
SY   GM06461Z
DR   Coriell; GM06461
DR   Wikidata; Q93792025
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06461; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06467
AC   CVCL_US51
SY   GM06467Z
DR   Coriell; GM06467
DR   Wikidata; Q93792027
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06467; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06468
AC   CVCL_US52
SY   GM06468Z
DR   Coriell; GM06468
DR   Wikidata; Q93792029
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06468; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06470
AC   CVCL_US12
SY   GM06470Z
DR   Coriell; GM06470
DR   Wikidata; Q93792032
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06470; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06472
AC   CVCL_US53
SY   GM06472Z
DR   Coriell; GM06472
DR   Wikidata; Q93792034
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06472; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06473
AC   CVCL_5N43
DR   CLO; CLO_0023251
DR   Coriell; GM06473
DR   Wikidata; Q54842293
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Hispanic.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM06480
AC   CVCL_UT26
SY   GM06480Z
DR   Coriell; GM06480
DR   Wikidata; Q93792042
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06480; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J45 ! GM06481
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06481
AC   CVCL_1J45
DR   CLO; CLO_0023254
DR   Coriell; GM06481
DR   Wikidata; Q54842294
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT26 ! GM06480
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06498
AC   CVCL_US15
SY   GM06498Z
DR   Coriell; GM06498
DR   Wikidata; Q93792049
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06498; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J46 ! GM06499
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06499
AC   CVCL_1J46
DR   CLO; CLO_0023253
DR   Coriell; GM06499
DR   Wikidata; Q54842295
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US15 ! GM06498
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM0650
AC   CVCL_X919
DR   Wikidata; Q54842296
RX   PubMed=2579038;
RX   PubMed=6093374;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   GM06500
AC   CVCL_US31
SY   GM06500Z
DR   Coriell; GM06500
DR   Wikidata; Q93792061
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06500; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06502
AC   CVCL_US20
SY   GM06502Z
DR   Coriell; GM06502
DR   Wikidata; Q93792064
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06502; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06503
AC   CVCL_US21
SY   GM06503Z
DR   Coriell; GM06503
DR   Wikidata; Q93792065
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06503; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06504
AC   CVCL_US22
SY   GM06504Z
DR   Coriell; GM06504
DR   Wikidata; Q93792067
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06504; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06505
AC   CVCL_US36
SY   GM06505Z
DR   Coriell; GM06505
DR   Wikidata; Q93792070
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06505; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06507
AC   CVCL_US30
SY   GM06507Z
DR   Coriell; GM06507
DR   Wikidata; Q93792072
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06507; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06510
AC   CVCL_US38
SY   GM06510Z
DR   Coriell; GM06510
DR   Wikidata; Q93792075
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06510; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06512
AC   CVCL_US65
SY   GM06512Z
DR   Coriell; GM06512
DR   Wikidata; Q93792077
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06512; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06521
AC   CVCL_US32
SY   GM06521Z
DR   Coriell; GM06521
DR   Wikidata; Q93792079
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06521; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06522
AC   CVCL_US35
SY   GM06522Z
DR   Coriell; GM06522
DR   Wikidata; Q93792082
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06522; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06523
AC   CVCL_US23
SY   GM06523Z
DR   Coriell; GM06523
DR   Wikidata; Q93792083
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06523; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06526
AC   CVCL_2T22
DR   CLO; CLO_0023240
DR   Coriell; GM06526
DR   Wikidata; Q54842297
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM06528
AC   CVCL_1J47
DR   CLO; CLO_0023239
DR   Coriell; GM06528
DR   Wikidata; Q54842298
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US64 ! GM06529
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06529
AC   CVCL_US64
SY   GM06529Z
DR   Coriell; GM06529
DR   Wikidata; Q93792091
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06529; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J47 ! GM06528
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06530
AC   CVCL_1J48
DR   CLO; CLO_0023242
DR   Coriell; GM06530
DR   Wikidata; Q54842299
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US63 ! GM06531
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06531
AC   CVCL_US63
SY   GM06531Z
DR   Coriell; GM06531
DR   Wikidata; Q93792099
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06531; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J48 ! GM06530
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06532
AC   CVCL_1J49
DR   CLO; CLO_0023241
DR   Coriell; GM06532
DR   Wikidata; Q54842300
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06538
AC   CVCL_1J50
DR   CLO; CLO_0023244
DR   Coriell; GM06538
DR   Wikidata; Q54842301
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US62 ! GM06539
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06539
AC   CVCL_US62
SY   GM06539Z
DR   Coriell; GM06539
DR   Wikidata; Q93792109
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06539; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J50 ! GM06538
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06541
AC   CVCL_US66
SY   GM06541Z
DR   Coriell; GM06541
DR   Wikidata; Q93792111
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06541; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1I93 ! GM05536
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06542
AC   CVCL_US39
SY   GM06542Z
DR   Coriell; GM06542
DR   Wikidata; Q93792113
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06542; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06543
AC   CVCL_US44
SY   GM06543Z
DR   Coriell; GM06543
DR   Wikidata; Q93792115
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06543; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06545
AC   CVCL_US47
SY   GM06545Z
DR   Coriell; GM06545
DR   Wikidata; Q93792117
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06545; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06546
AC   CVCL_US48
SY   GM06546Z
DR   Coriell; GM06546
DR   Wikidata; Q93792119
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06546; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06547
AC   CVCL_US46
SY   GM06547Z
DR   Coriell; GM06547
DR   Wikidata; Q93792122
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06547; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06548
AC   CVCL_US40
SY   GM06548Z
DR   Coriell; GM06548
DR   Wikidata; Q93792124
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06548; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06549
AC   CVCL_US41
SY   GM06549Z
DR   Coriell; GM06549
DR   Wikidata; Q93792126
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06549; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06550
AC   CVCL_US42
SY   GM06550Z
DR   Coriell; GM06550
DR   Wikidata; Q93792128
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06550; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06551
AC   CVCL_US43
SY   GM06551Z
DR   Coriell; GM06551
DR   Wikidata; Q93792130
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06551; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06552
AC   CVCL_US37
SY   GM06552Z
DR   Coriell; GM06552
DR   Wikidata; Q93792131
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06552; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06553
AC   CVCL_US45
SY   GM06553Z
DR   Coriell; GM06553
DR   Wikidata; Q93792134
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06553; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06563
AC   CVCL_2T23
DR   CLO; CLO_0023243
DR   Coriell; GM06563
DR   Wikidata; Q54842302
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM06566
AC   CVCL_1J51
DR   CLO; CLO_0023245
DR   Coriell; GM06566
DR   Wikidata; Q54842303
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT13 ! GM06567
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06567
AC   CVCL_UT13
SY   GM06567Z
DR   Coriell; GM06567
DR   Wikidata; Q93792145
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06567; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J51 ! GM06566
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06581
AC   CVCL_1J52
DR   CLO; CLO_0023188
DR   Coriell; GM06581
DR   Wikidata; Q54842304
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT21 ! GM06582
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06582
AC   CVCL_UT21
SY   GM06582Z
DR   Coriell; GM06582
DR   Wikidata; Q93792151
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06582; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J52 ! GM06581
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06585
AC   CVCL_1J53
SY   GM06585A
DR   CLO; CLO_0023186
DR   Coriell; GM06585
DR   Wikidata; Q54842305
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT12 ! GM06586
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06586
AC   CVCL_UT12
SY   GM06586Z
DR   Coriell; GM06586
DR   Wikidata; Q93792158
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06586; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J53 ! GM06585
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06593
AC   CVCL_1J54
SY   GM06593B
DR   CLO; CLO_0023185
DR   Coriell; GM06593
DR   Wikidata; Q54842306
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT10 ! GM06594
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06594
AC   CVCL_UT10
SY   GM06594Z
DR   Coriell; GM06594
DR   Wikidata; Q93792165
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06594; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J54 ! GM06593
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06595
AC   CVCL_1J55
DR   CLO; CLO_0023184
DR   Coriell; GM06595
DR   Wikidata; Q54842307
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT01 ! GM06596
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06596
AC   CVCL_UT01
SY   GM06596Z
DR   Coriell; GM06596
DR   Wikidata; Q93792172
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06596; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J55 ! GM06595
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06601
AC   CVCL_1J56
DR   CLO; CLO_0023183
DR   Coriell; GM06601
DR   Wikidata; Q54842308
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT18 ! GM06602
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06602
AC   CVCL_UT18
SY   GM06602Z
DR   Coriell; GM06602
DR   Wikidata; Q93792181
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06602; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J56 ! GM06601
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06615
AC   CVCL_UT07
SY   GM06615Z
DR   Coriell; GM06615
DR   Wikidata; Q93792183
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06615; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06620
AC   CVCL_US49
SY   GM06620Z
DR   Coriell; GM06620
DR   Wikidata; Q93792185
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06620; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06626
AC   CVCL_4D91
DR   CLO; CLO_0023182
DR   Coriell; GM06626
DR   Wikidata; Q54842309
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM06628
AC   CVCL_US14
SY   GM06628Z
DR   Coriell; GM06628
DR   Wikidata; Q93792193
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06628; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06629
AC   CVCL_1J57
DR   CLO; CLO_0023181
DR   Coriell; GM06629
DR   Wikidata; Q54842310
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US68 ! GM06630
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06630
AC   CVCL_US68
SY   GM06630Z
DR   Coriell; GM06630
DR   Wikidata; Q93792203
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06630; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J57 ! GM06629
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06631
AC   CVCL_1J58
DR   CLO; CLO_0023180
DR   Coriell; GM06631
DR   Wikidata; Q54842311
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT09 ! GM06632
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06632
AC   CVCL_UT09
SY   GM06632Z
DR   Coriell; GM06632
DR   Wikidata; Q93792212
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06632; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J58 ! GM06631
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06633
AC   CVCL_1J59
DR   CLO; CLO_0023179
DR   Coriell; GM06633
DR   Wikidata; Q54842312
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT04 ! GM06634
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06634
AC   CVCL_UT04
SY   GM06634Z
DR   Coriell; GM06634
DR   Wikidata; Q93792222
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06634; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J59 ! GM06633
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06643
AC   CVCL_1J60
DR   CLO; CLO_0023178
DR   Coriell; GM06643
DR   Wikidata; Q54842313
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT19 ! GM06644
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06644
AC   CVCL_UT19
SY   GM06644Z
DR   Coriell; GM06644
DR   Wikidata; Q93792232
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06644; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J60 ! GM06643
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06651
AC   CVCL_1J61
SY   GM06651A
DR   CLO; CLO_0023210
DR   Coriell; GM06651
DR   Wikidata; Q54842314
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT08 ! GM06652
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06652
AC   CVCL_UT08
SY   GM06652Z
DR   Coriell; GM06652
DR   Wikidata; Q93792241
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06652; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J61 ! GM06651
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06655
AC   CVCL_1J62
SY   GM06655A
DR   CLO; CLO_0023204
DR   Coriell; GM06655
DR   Wikidata; Q54842315
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT05 ! GM06656
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06656
AC   CVCL_UT05
SY   GM06656Z
DR   Coriell; GM06656
DR   Wikidata; Q93792249
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06656; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J62 ! GM06655
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06676
AC   CVCL_UT30
SY   GM06676Z
DR   Coriell; GM06676
DR   Wikidata; Q93792251
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06676; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J63 ! GM06677
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06677
AC   CVCL_1J63
DR   CLO; CLO_0023203
DR   Coriell; GM06677
DR   Wikidata; Q54842322
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT30 ! GM06676
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06680
AC   CVCL_US00
SY   GM06680Z
DR   Coriell; GM06680
DR   Wikidata; Q93792260
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06680; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J64 ! GM06681
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06681
AC   CVCL_1J64
DR   CLO; CLO_0023206
DR   Coriell; GM06681
DR   Wikidata; Q54842324
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_US00 ! GM06680
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06682
AC   CVCL_US89
SY   GM06682Z
DR   Coriell; GM06682
DR   Wikidata; Q93792269
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06682; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06684
AC   CVCL_UR88
SY   GM06684Z
DR   Coriell; GM06684
DR   Wikidata; Q93792271
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06684; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J65 ! GM06685
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06685
AC   CVCL_1J65
DR   CLO; CLO_0023205
DR   Coriell; GM06685
DR   Wikidata; Q54842325
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR88 ! GM06684
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06695
AC   CVCL_US27
SY   GM06695Z
DR   Coriell; GM06695
DR   Wikidata; Q93792282
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06695; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06713
AC   CVCL_GQ66
DR   CLO; CLO_0023200
DR   Coriell; GM06713
DR   Wikidata; Q54842326
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM06728
AC   CVCL_US60
SY   GM06728Z
DR   Coriell; GM06728
DR   Wikidata; Q93792293
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06728; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06735
AC   CVCL_US70
SY   GM06735Z
DR   Coriell; GM06735
DR   Wikidata; Q93792295
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06735; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06749
AC   CVCL_US17
SY   GM06749Z
DR   Coriell; GM06749
DR   Wikidata; Q93792298
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06749; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06753
AC   CVCL_US19
SY   GM06753Z
DR   Coriell; GM06753
DR   Wikidata; Q93792301
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06753; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06757
AC   CVCL_US18
SY   GM06757Z
DR   Coriell; GM06757
DR   Wikidata; Q93792303
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06757; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06760
AC   CVCL_US16
SY   GM06760Z
DR   Coriell; GM06760
DR   Wikidata; Q93792305
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06760; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06766
AC   CVCL_UT06
SY   GM06766Z
DR   Coriell; GM06766
DR   Wikidata; Q93792308
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06766; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J66 ! GM06767
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06767
AC   CVCL_1J66
DR   CLO; CLO_0023199
DR   Coriell; GM06767
DR   Wikidata; Q54842327
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT06 ! GM06766
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06768
AC   CVCL_UR94
SY   GM06768Z
DR   Coriell; GM06768
DR   Wikidata; Q93792318
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06768; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J67 ! GM06769
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06769
AC   CVCL_1J67
DR   CLO; CLO_0023202
DR   Coriell; GM06769
DR   Wikidata; Q54842328
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR94 ! GM06768
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06772
AC   CVCL_UT29
SY   GM06772Z
DR   Coriell; GM06772
DR   Wikidata; Q93792327
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06772; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J68 ! GM06773
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06773
AC   CVCL_1J68
DR   CLO; CLO_0023201
DR   Coriell; GM06773
DR   Wikidata; Q54842329
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT29 ! GM06772
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06776
AC   CVCL_UT03
SY   GM06776Z
DR   Coriell; GM06776
DR   Wikidata; Q93792337
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06776; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J69 ! GM06777
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06777
AC   CVCL_1J69
DR   CLO; CLO_0023198
DR   Coriell; GM06777
DR   Wikidata; Q54842330
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT03 ! GM06776
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM06780
AC   CVCL_UT00
SY   GM06780Z
DR   Coriell; GM06780
DR   Wikidata; Q93792346
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06780; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06782
AC   CVCL_UR92
SY   GM06782Z
DR   Coriell; GM06782
DR   Wikidata; Q93792349
RX   CelloPub=CLPUB00447;
CC   Part of: Venezuelan Huntington disease kindreds subcollection.
CC   Discontinued: Coriell; GM06782; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06799
AC   CVCL_AA59
DR   CLO; CLO_0036544
DR   Coriell; GM06799
DR   Wikidata; Q54842331
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,i(13)(qter->q10::q10->qter) [42]; 46,XX,r(13) [8] (Coriell=GM06799).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM06801
AC   CVCL_5N44
DR   Coriell; GM06801
DR   Wikidata; Q54842332
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   GM06802
AC   CVCL_5N45
DR   CLO; CLO_0036542
DR   Coriell; GM06802
DR   Wikidata; Q54842333
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM06803
AC   CVCL_5N46
DR   CLO; CLO_0036543
DR   Coriell; GM06803
DR   Wikidata; Q54842334
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   GM06804
AC   CVCL_F609
SY   GM6804; GM 6804; GM06804A; GM06804B
DR   CLO; CLO_0036539
DR   Coriell; GM06804
DR   Wikidata; Q54842335
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex2-3dup; Zygosity=Hemizygous (Coriell=GM06804).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F602 ! GM01662
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM06805
AC   CVCL_2Z54
DR   CLO; CLO_0036538
DR   Coriell; GM06805
DR   Wikidata; Q54842336
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Homozygous (Coriell=GM06805).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z55 ! GM06806
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM06806
AC   CVCL_2Z55
DR   CLO; CLO_0036541
DR   Coriell; GM06806
DR   Wikidata; Q54842337
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Homozygous (Coriell=GM06806).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z54 ! GM06805
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM06807
AC   CVCL_2Z56
SY   GM06807A
DR   CLO; CLO_0036540
DR   Coriell; GM06807
DR   Wikidata; Q54842338
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Heterozygous (Coriell=GM06807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z59 ! GM06810
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM06808
AC   CVCL_2Z57
DR   CLO; CLO_0036536
DR   Coriell; GM06808
DR   Wikidata; Q54842339
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Heterozygous (Coriell=GM06808).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z58 ! GM06809
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM06809
AC   CVCL_2Z58
DR   CLO; CLO_0036535
DR   Coriell; GM06809
DR   Wikidata; Q54842340
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Heterozygous (Coriell=GM06809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z57 ! GM06808
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM06810
AC   CVCL_2Z59
DR   CLO; CLO_0036537
DR   Coriell; GM06810
DR   Wikidata; Q54842341
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Heterozygous (Coriell=GM06810).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z56 ! GM06807
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM06812
AC   CVCL_8A85
DR   CLO; CLO_0036531
DR   Coriell; GM06812
DR   Wikidata; Q54842342
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125484; Ectopia lentis
DI   ORDO; Orphanet_1885; Isolated ectopia lentis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM06813
AC   CVCL_AD70
SY   GM-06813
DR   CLO; CLO_0036532
DR   Coriell; GM06813
DR   Wikidata; Q54842343
RX   CelloPub=CLPUB00447;
RX   PubMed=9305655;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Simple; p.Tyr198Asnfs*52 (c.592_594delinsAA) (646delT and 648C>A); Zygosity=Hemizygous (PubMed=9305655).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM06830
AC   CVCL_FA33
DR   CLO; CLO_0036516
DR   Coriell; GM06830
DR   Wikidata; Q54842344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_250923; Isolated aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM06832
AC   CVCL_2T24
DR   CLO; CLO_0036515
DR   Coriell; GM06832
DR   Wikidata; Q54842345
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(8;15)(8qter->8p23::15q25->15qter;15pter->15q25::8p23->8pter) (Coriell=GM06832).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 10
//
ID   GM06836
AC   CVCL_UR72
SY   GM6836
DR   Coriell; GM06836
DR   Wikidata; Q93792463
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Discontinued: Coriell; GM06836; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98964; Isovaleric acidemia
DI   ORDO; Orphanet_33; Isovaleric acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM06852
AC   CVCL_AX86
SY   GM6852; GM06852A
DR   CLO; CLO_0036518
DR   Coriell; GM06852
DR   Wikidata; Q54842346
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=25776194;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>200]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM06853
AC   CVCL_0F79
SY   GM06853B
DR   CLO; CLO_0036517
DR   Coriell; GM06853
DR   Wikidata; Q54842347
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0F78 ! 7777-14b-aza
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   GM06855
AC   CVCL_F297
SY   GM6855
DR   CLO; CLO_0036519
DR   Coriell; GM06855
DR   Wikidata; Q54842348
RX   CelloPub=CLPUB00447;
RX   PubMed=3374507;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM06855).
CC   Derived from site: In situ; Skin; Note=From a fibroma; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F309 ! GM07500
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM06856
AC   CVCL_UT46
DR   Coriell; GM06856
DR   Wikidata; Q93792488
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM06856; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM06859
AC   CVCL_F298
SY   GM06859A; GM17265
DR   CLO; CLO_0013163
DR   CLO; CLO_0036509
DR   Coriell; GM06859
DR   Coriell; GM17265
DR   GEO; GSM569723
DR   GEO; GSM596329
DR   GEO; GSM596751
DR   GEO; GSM924867
DR   Wikidata; Q54842349
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,26:01:01; B*07:02:01,51:01:01; C*07:02:01,15:02:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:01:01G; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRB1*04:04:01,11:01:01; DRB3*02:02:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM06861
AC   CVCL_7458
SY   GM17226
DR   CLO; CLO_0014356
DR   CLO; CLO_0036510
DR   Coriell; GM06861
DR   Coriell; GM17226
DR   GEO; GSM569593
DR   GEO; GSM596290
DR   GEO; GSM596650
DR   GEO; GSM924828
DR   Wikidata; Q54842350
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,34:02:01; B*08:01:01,44:02:01; C*05:01:01,07:01:01; DPA1*01:03:01,02:01:01; DPB1*05:01:01,15:01:01; DQA1*01:02:01,02:01:01; DQB1*02:02:01,06:04:01; DRB1*07:01:01,13:02:01; DRB3*03:01:01; DRB4*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM06862
AC   CVCL_7459
SY   GM17266
DR   CLO; CLO_0013181
DR   CLO; CLO_0036511
DR   Coriell; GM06862
DR   Coriell; GM17266
DR   GEO; GSM569724
DR   GEO; GSM596330
DR   GEO; GSM596752
DR   GEO; GSM924868
DR   Wikidata; Q54842352
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM06863
AC   CVCL_X457
SY   GM6863; GM06863A; GM06863B
DR   CLO; CLO_0036512
DR   Coriell; GM06863
DR   Wikidata; Q54842353
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM06864
AC   CVCL_X459
DR   CLO; CLO_0036513
DR   Coriell; GM06864
DR   Wikidata; Q54842354
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM06865
AC   CVCL_N056
SY   GM17104
DR   CLO; CLO_0014900
DR   CLO; CLO_0036514
DR   Coriell; GM06865
DR   Coriell; GM17104
DR   GEO; GSM273374
DR   GEO; GSM569501
DR   GEO; GSM596172
DR   GEO; GSM596973
DR   GEO; GSM924614
DR   Wikidata; Q54842355
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=33426406;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM06867
AC   CVCL_F138
SY   GM17267
DR   CLO; CLO_0013179
DR   CLO; CLO_0036507
DR   Coriell; GM06867
DR   Coriell; GM17267
DR   GEO; GSM569725
DR   GEO; GSM596331
DR   GEO; GSM596753
DR   GEO; GSM924869
DR   Wikidata; Q54842356
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,02:01:01; B*15:17:01,44:02:01; C*05:01:01,07:01:02; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:01:01,01:02:01; DQB1*05:01:01,06:04:01; DRB1*01:01:01,13:02:01; DRB3*03:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM06870
AC   CVCL_5N47
DR   CLO; CLO_0036508
DR   Coriell; GM06870
DR   Wikidata; Q54842357
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N48 ! GM06871
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM06871
AC   CVCL_5N48
DR   CLO; CLO_0036505
DR   Coriell; GM06871
DR   Wikidata; Q54842358
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 47,XX,+i(18)(pter->p10::p10->pter) (Coriell=GM06871).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N47 ! GM06870
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM06873
AC   CVCL_AA60
SY   GM06873A
DR   CLO; CLO_0036506
DR   Coriell; GM06873
DR   Wikidata; Q54842359
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,i(13)(qter->q10::q10->qter) (Coriell=GM06873).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM06875
AC   CVCL_7460
SY   GM17268
DR   CLO; CLO_0013177
DR   CLO; CLO_0036494
DR   Coriell; GM06875
DR   Coriell; GM17268
DR   GEO; GSM569726
DR   GEO; GSM596332
DR   GEO; GSM596754
DR   GEO; GSM924870
DR   Wikidata; Q54842360
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*15:01:01,52:01:01; C*03:03:01,12:02:02; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:03:01,02:01:01; DQB1*03:03:02,06:01:01; DRB1*07:01:01,15:02:01G; DRB4*01:03:01:02N; DRB5*01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM06876
AC   CVCL_GQ67
DR   CLO; CLO_0036493
DR   Coriell; GM06876
DR   Wikidata; Q54842361
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM06888
AC   CVCL_CY45
SY   GM06888A
DR   CLO; CLO_0036492
DR   Coriell; GM06888
DR   Wikidata; Q54842362
RX   CelloPub=CLPUB00447;
RX   PubMed=30024920;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM06888).
CC   Discontinued: Coriell; GM06888; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM06889
AC   CVCL_AX87
DR   CLO; CLO_0036491
DR   Coriell; GM06889
DR   Wikidata; Q54842363
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06890
AC   CVCL_AX88
DR   CLO; CLO_0036490
DR   Coriell; GM06890
DR   Wikidata; Q54842369
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06891
AC   CVCL_AX89
DR   CLO; CLO_0036489
DR   Coriell; GM06891
DR   Wikidata; Q54842370
RX   CelloPub=CLPUB00447;
RX   PubMed=18165276;
RX   PubMed=25776194;
RX   PubMed=33426406;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[100-117]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM06892
AC   CVCL_AX90
SY   GM6892; GM06892A
DR   CLO; CLO_0036488
DR   Coriell; GM06892
DR   Wikidata; Q54842371
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[80-85]; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM06893
AC   CVCL_AX91
DR   CLO; CLO_0036485
DR   Coriell; GM06893
DR   Wikidata; Q54842373
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; Zygosity=Heterozygous (Coriell=GM06893).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; Zygosity=Heterozygous (Coriell=GM06893).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06894
AC   CVCL_AX92
SY   GM6894; GM06894A
DR   CLO; CLO_0036486
DR   Coriell; GM06894
DR   Wikidata; Q54842374
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[78]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06895
AC   CVCL_F299
SY   GM06895A; GM17269
DR   CLO; CLO_0013176
DR   CLO; CLO_0036487
DR   Coriell; GM06895
DR   Coriell; GM17269
DR   GEO; GSM569727
DR   GEO; GSM596333
DR   GEO; GSM596755
DR   GEO; GSM924871
DR   Wikidata; Q54842375
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=25776194;
RX   PubMed=29959025;
RX   PubMed=33426406;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,26:01:01; B*40:01:02,40:02:01; C*02:02:02,03:04:01; DPA1*01:03:01,02:06; DPB1*02:01:02,05:01:01; DQA1*01:02:01,01:03:01; DQB1*06:03:01,06:04:01; DRB1*13:01:01,13:02:01; DRB3*02:02:01,03:01:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 21
//
ID   GM06896
AC   CVCL_AX93
SY   GM06896A
DR   CLO; CLO_0036482
DR   Coriell; GM06896
DR   Wikidata; Q54842376
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[33]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[95-140]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06897
AC   CVCL_AX94
SY   GM6897; GM06897B
DR   CLO; CLO_0036481
DR   Coriell; GM06897
DR   Wikidata; Q54842377
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[477]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM06902
AC   CVCL_Y703
SY   GM6902
DR   CLO; CLO_0036484
DR   Coriell; GM06902
DR   Wikidata; Q54842378
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM06903
AC   CVCL_AX95
SY   GM6903; GM06903A
DR   CLO; CLO_0036483
DR   Coriell; GM06903
DR   Wikidata; Q54842379
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[95]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06904
AC   CVCL_N057
SY   GM06904A; GM18022
DR   CLO; CLO_0015538
DR   CLO; CLO_0036478
DR   Coriell; GM06904
DR   Coriell; GM18022
DR   Wikidata; Q54842380
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   GM06905
AC   CVCL_AX96
DR   CLO; CLO_0036477
DR   Coriell; GM06905
DR   Wikidata; Q54842381
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[70]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06906
AC   CVCL_AX97
SY   GM6906; GM06906A
DR   CLO; CLO_0036480
DR   Coriell; GM06906
DR   Wikidata; Q54842382
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[85-90]; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM06907
AC   CVCL_AX98
SY   GM06907A
DR   CLO; CLO_0036479
DR   Coriell; GM06907
DR   Wikidata; Q54842383
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[85]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06910
AC   CVCL_AX99
DR   CLO; CLO_0036475
DR   Coriell; GM06910
DR   Wikidata; Q54842384
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[75-89]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06911
AC   CVCL_AY00
DR   CLO; CLO_0036476
DR   Coriell; GM06911
DR   Wikidata; Q54842385
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[?]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM06912
AC   CVCL_X458
SY   GM6912; GM 06912
DR   CLO; CLO_0036474
DR   Coriell; GM06912
DR   Wikidata; Q54842386
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=8834039;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM06913
AC   CVCL_AY01
SY   GM6913
DR   CLO; CLO_0036469
DR   Coriell; GM06913
DR   Wikidata; Q54842387
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM06914
AC   CVCL_F132
SY   GM 6914; GM6914; GM06914A; GM6914A; GM06914B
DR   CLO; CLO_0036468
DR   Coriell; GM06914
DR   Wikidata; Q54842388
RX   CelloPub=CLPUB00447;
RX   PubMed=3030788;
RX   PubMed=7994019;
RX   PubMed=11050007;
RX   PubMed=12065746;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F131 ! GM01309
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 21
//
ID   GM06918
AC   CVCL_5N49
DR   CLO; CLO_0036467
DR   Coriell; GM06918
DR   Wikidata; Q54842389
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM06921
AC   CVCL_FA34
DR   CLO; CLO_0036466
DR   Coriell; GM06921
DR   Wikidata; Q54842390
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (Coriell=GM06921).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128801; Hereditary melanoma with CDKN2A mutation
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   GM06923
AC   CVCL_UT67
DR   CLO; CLO_0036473
DR   Coriell; GM06923
DR   Wikidata; Q93792709
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient with diabetes; bone pain and metastatic breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 7
//
ID   GM06924
AC   CVCL_2T25
DR   CLO; CLO_0036472
DR   Coriell; GM06924
DR   Wikidata; Q54842391
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;3)(1pter->1q32.1::3p25.1->3pter;3qter->3p25.1::1q32.1->1qter) (Coriell=GM06924).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 10
//
ID   GM06926
AC   CVCL_T903
DR   CLO; CLO_0036471
DR   Coriell; GM06926
DR   Wikidata; Q54842392
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[52]; Zygosity=Heterozygous; Note=The other allele has 29 repeats (Coriell=GM06926).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T904 ! GM06927
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM06927
AC   CVCL_T904
DR   CLO; CLO_0036470
DR   Coriell; GM06927
DR   Wikidata; Q54842393
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[52]; Zygosity=Heterozygous; Note=The other allele has 29 repeats (Coriell=GM06927).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T903 ! GM06926
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   GM06934
AC   CVCL_JX32
DR   CLO; CLO_0036465
DR   Coriell; GM06934
DR   Wikidata; Q54842394
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a donor suffering from mental retardation, microcephaly, short stature, hypogonadism, photosensitivity, abnormal neurologic exam and typical skin findings. No defects in DNA repair or replication observed in fibroblasts.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   GM06935
AC   CVCL_F594
SY   GM06935A
DR   CLO; CLO_0036464
DR   Coriell; GM06935
DR   Wikidata; Q54842396
RX   CelloPub=CLPUB00447;
CC   Population: Arab.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F593 ! GM02053
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 15
//
ID   GM06936
AC   CVCL_5N50
DR   CLO; CLO_0036463
DR   Coriell; GM06936
DR   Wikidata; Q54842397
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N51 ! GM06937
SX   Female
AG   2Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM06937
AC   CVCL_5N51
DR   CLO; CLO_0036456
DR   Coriell; GM06937
DR   Wikidata; Q54842398
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(10)(p13->qter) (Coriell=GM06937).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N50 ! GM06936
SX   Female
AG   2Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM06938
AC   CVCL_5N52
SY   GM6938; GM06938B; 6938
DR   CLO; CLO_0036455
DR   Coriell; GM06938
DR   Wikidata; Q54842399
RX   CelloPub=CLPUB00447;
RX   PubMed=2559742;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N68 ! GM07736
SX   Male
AG   3W
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   GM06940
AC   CVCL_N058
SY   GM17301
DR   CLO; CLO_0013311
DR   CLO; CLO_0036458
DR   Coriell; GM06940
DR   Coriell; GM17301
DR   Lonza; 1380
DR   Wikidata; Q54842400
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: South American (Andes).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM06943
AC   CVCL_2N09
DR   CLO; CLO_0036457
DR   Coriell; GM06943
DR   Wikidata; Q54842401
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N10 ! GM06944
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM06944
AC   CVCL_2N10
DR   CLO; CLO_0036460
DR   Coriell; GM06944
DR   GEO; GSM426282
DR   Wikidata; Q54842402
RX   CelloPub=CLPUB00447;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(21;22)(21qter->21p12::22q11.1->22qter;22pter->22q11.1::21p12->21pter) (Coriell=GM06944).
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N09 ! GM06943
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM06945
AC   CVCL_AX06
SY   GM06945A
DR   CLO; CLO_0036459
DR   Coriell; GM06945
DR   Wikidata; Q54842403
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126558; Combined lipase deficiency
DI   ORDO; Orphanet_535453; Familial lipase maturation factor 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX07 ! GM06946
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM06946
AC   CVCL_AX07
SY   GM6946
DR   CLO; CLO_0036462
DR   Coriell; GM06946
DR   Wikidata; Q54842404
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126558; Combined lipase deficiency
DI   ORDO; Orphanet_535453; Familial lipase maturation factor 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX06 ! GM06945
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM06960
AC   CVCL_5N53
SY   GM6960
DR   CLO; CLO_0036461
DR   Coriell; GM06960
DR   Wikidata; Q54842405
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: African American.
CC   Karyotypic information: 46,X,i(X)(q22) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM06964
AC   CVCL_CY46
DR   CLO; CLO_0036440
DR   Coriell; GM06964
DR   Wikidata; Q54842406
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM06964).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY47 ! GM07501
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM06965
AC   CVCL_F300
DR   CLO; CLO_0036442
DR   Coriell; GM06965
DR   Wikidata; Q54842407
RX   CelloPub=CLPUB00447;
RX   PubMed=30024920;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM06965).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F308 ! GM07499
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM06966
AC   CVCL_0M39
SY   GM6966; GM 6966
DR   CLO; CLO_0036443
DR   Coriell; GM06966
DR   Wikidata; Q54842408
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=9792862;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Glu92Ter (c.274G>T); ClinVar=VCV000007186; Zygosity=Heterozygous (Coriell=GM06966).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM06966).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_586; Cystic fibrosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM06967
AC   CVCL_9R48
DR   CLO; CLO_0036451
DR   Coriell; GM06967
DR   Wikidata; Q54842409
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM06968
AC   CVCL_AY02
DR   CLO; CLO_0036452
DR   Coriell; GM06968
DR   Wikidata; Q54842410
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[107]; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM06972
AC   CVCL_CW77
SY   GM6972
DR   CLO; CLO_0036453
DR   Coriell; GM06972
DR   Wikidata; Q54842414
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW80 ! GM07398
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM06973
AC   CVCL_CW78
SY   GM6973
DR   CLO; CLO_0036454
DR   Coriell; GM06973
DR   Wikidata; Q54842415
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW79 ! GM07321
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM06974
AC   CVCL_GQ68
SY   GM6974
DR   CLO; CLO_0036448
DR   Coriell; GM06974
DR   Wikidata; Q54842416
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR02 ! GM07320
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM06978
AC   CVCL_IZ40
DR   CLO; CLO_0036449
DR   Coriell; GM06978
DR   Wikidata; Q54842418
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84771; Hyperlipoproteinemia, type I
DI   ORDO; Orphanet_444490; Familial chylomicronemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM06979
AC   CVCL_5N54
DR   CLO; CLO_0036450
DR   Coriell; GM06979
DR   Wikidata; Q54842419
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 92,XXYY.arr(1-22)x2,(XY)x1 (Coriell=GM06979).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM06980
AC   CVCL_5B14
DR   CLO; CLO_0036422
DR   Coriell; GM06980
DR   GEO; GSM420458
DR   Wikidata; Q54842420
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329106.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM06981
AC   CVCL_5B15
DR   CLO; CLO_0036424
DR   Coriell; GM06981
DR   GEO; GSM420459
DR   Wikidata; Q54842421
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329105.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM06982
AC   CVCL_5B16
AS   CVCL_G420
SY   CEPH-1333-NA06982; 1333-8303
DR   CLO; CLO_0036420
DR   Coriell; GM06982
DR   dbMHC; 48568
DR   GEO; GSM25348
DR   GEO; GSM316480
DR   GEO; GSM316481
DR   GEO; GSM316482
DR   GEO; GSM420460
DR   IHW; IHW01048
DR   IPD-IMGT/HLA; 25848
DR   Wikidata; Q54842422
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133305.
CC   HLA typing: A*01:01:01,24:02; B*39:06:01,58:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*04:01,05:01; DQB1*03:01,04:02; DRB1*08:01,13:03; DRB3*02,03:01 (IPD-IMGT/HLA=25848).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM06983
AC   CVCL_5B17
AS   CVCL_G381
SY   CEPH-1331-NA06983; 1331-8238
DR   CLO; CLO_0036421
DR   Coriell; GM06983
DR   dbMHC; 48536
DR   GEO; GSM420461
DR   GEO; GSM659929
DR   GEO; GSM660140
DR   GEO; GSM660346
DR   IHW; IHW01008
DR   IPD-IMGT/HLA; 25809
DR   Wikidata; Q54842424
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133109.
CC   HLA typing: A*02:01,31:01; B*13:02,07:02:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*02:01,03:01; DQB1*02:01,03:02; DRB1*04:04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM06984
AC   CVCL_R687
SY   GM06984A
DR   CLO; CLO_0036433
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM06984
DR   GEO; GSM648926
DR   GEO; GSM1719739
DR   IGSR; NA06984
DR   Wikidata; Q54842425
RX   CelloPub=CLPUB00447;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 132801/1328108/1329312.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F46 ! GM13041
OI   CVCL_5F47 ! GM13042
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM06985
AC   CVCL_9586
AS   CVCL_G428
SY   GM06985A; CEPH-1341-NA06985; 1341-8319
DR   CLO; CLO_0036434
DR   EFO; EFO_0001107
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM06985
DR   dbMHC; 48582
DR   GEO; GSM25349
DR   GEO; GSM25350
DR   GEO; GSM112392
DR   GEO; GSM112759
DR   GEO; GSM188687
DR   GEO; GSM273271
DR   GEO; GSM273272
DR   GEO; GSM314819
DR   GEO; GSM314820
DR   GEO; GSM420462
DR   GEO; GSM420463
DR   GEO; GSM424320
DR   GEO; GSM486735
DR   GEO; GSM486736
DR   GEO; GSM648867
DR   GEO; GSM649847
DR   GEO; GSM659969
DR   GEO; GSM660174
DR   GEO; GSM660379
DR   GEO; GSM905816
DR   GEO; GSM905911
DR   GEO; GSM906006
DR   GEO; GSM957356
DR   GEO; GSM1719740
DR   IGSR; NA06985
DR   IHW; IHW01058
DR   IPD-IMGT/HLA; 25856
DR   Wikidata; Q54842426
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134114.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,03:01; B*07:02:01,57:01; C*07:02,06:02; DPA1*01:03,01:03; DPB1*04:01,04:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,15:01; DRB5*01,01 (IPD-IMGT/HLA=25856).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 28
//
ID   GM06986
AC   CVCL_R578
DR   CLO; CLO_0036431
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   Coriell; GM06986
DR   GEO; GSM314821
DR   GEO; GSM420464
DR   GEO; GSM648902
DR   GEO; GSM906101
DR   GEO; GSM906102
DR   GEO; GSM1719741
DR   IGSR; NA06986
DR   Wikidata; Q54842427
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329112.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM06987
AC   CVCL_5B18
AS   CVCL_G417
SY   GM06987A; GM06987C; CEPH-1333-NA06987; 1333-8281
DR   CLO; CLO_0036432
DR   Coriell; GM06987
DR   dbMHC; 48569
DR   GEO; GSM25351
DR   GEO; GSM25352
DR   GEO; GSM207675
DR   GEO; GSM316429
DR   GEO; GSM316430
DR   GEO; GSM316431
DR   GEO; GSM420465
DR   GEO; GSM420466
DR   IHW; IHW01045
DR   IPD-IMGT/HLA; 25845
DR   Wikidata; Q54842428
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133302.
CC   HLA typing: A*01:01:01,03:01; B*07:02,58:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*04:01,05:01; DQB1*03:01,04:02; DRB1*08:01,13:03 (IPD-IMGT/HLA=25845).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 15,17
ST   D21S11: 31.2,32
ST   D8S1179: 13
ST   FGA: 20,24
ST   TH01: 7,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   GM06988
AC   CVCL_5B19
AS   CVCL_G377
SY   CEPH-1331-NA06988; 1331-8234
DR   CLO; CLO_0036429
DR   Coriell; GM06988
DR   dbMHC; 48537
DR   GEO; GSM420467
DR   GEO; GSM659930
DR   GEO; GSM660141
DR   GEO; GSM660347
DR   IHW; IHW01004
DR   IPD-IMGT/HLA; 25805
DR   Wikidata; Q54842429
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133108.
CC   HLA typing: A*02:01,02:01; B*13:02,51:01; C*15:03,06:02; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:03,02:01; DQB1*02:01,06:03; DRB1*13:01,07:01; DRB3*10:01; DRB4*01 (IPD-IMGT/HLA=25805).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM06989
AC   CVCL_R579
DR   CLO; CLO_0036430
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM06989
DR   GEO; GSM648884
DR   GEO; GSM1719742
DR   IGSR; NA06989
DR   Wikidata; Q54842430
RX   CelloPub=CLPUB00447;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31401124;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 132802/1328109/1329313.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F48 ! GM13043
OI   CVCL_5F49 ! GM13044
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   GM06990
AC   CVCL_9587
AS   CVCL_G376
SY   GM06990A; CEPH-1331-NA06990; 1331-8233
DR   CLO; CLO_0036556
DR   EFO; EFO_0002783
DR   BioSample; SAMN00004982
DR   Coriell; GM06990
DR   dbMHC; 48538
DR   ENCODE; ENCBS057ENC
DR   ENCODE; ENCBS058ENC
DR   ENCODE; ENCBS059ENC
DR   ENCODE; ENCBS060ENC
DR   ENCODE; ENCBS061ENC
DR   ENCODE; ENCBS062ENC
DR   ENCODE; ENCBS063ENC
DR   ENCODE; ENCBS064ENC
DR   ENCODE; ENCBS146QHV
DR   ENCODE; ENCBS177AAA
DR   ENCODE; ENCBS185XLT
DR   ENCODE; ENCBS414HDG
DR   ENCODE; ENCBS875KTK
DR   ENCODE; ENCBS987SKT
DR   GEO; GSE38809
DR   GEO; GSM207754
DR   GEO; GSM420468
DR   GEO; GSM472903
DR   GEO; GSM472904
DR   GEO; GSM660029
DR   GEO; GSM660236
DR   GEO; GSM660440
DR   GEO; GSM736558
DR   GEO; GSM736635
DR   GEO; GSM749705
DR   GEO; GSM749708
DR   GEO; GSM749731
DR   GEO; GSM827333
DR   GEO; GSM905817
DR   GEO; GSM905912
DR   GEO; GSM906007
DR   GEO; GSM923443
DR   GEO; GSM931323
DR   GEO; GSM931324
DR   GEO; GSM945179
DR   GEO; GSM945205
DR   GEO; GSM945213
DR   GEO; GSM945237
DR   IHW; IHW01003
DR   IPD-IMGT/HLA; 25804
DR   Wikidata; Q54842431
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
RX   PubMed=20215515;
RX   PubMed=20856902;
RX   PubMed=23861383;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133102.
CC   HLA typing: A*02:01,24:02; B*51:01,07:02:01; C*15:03,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:03,03:01; DQB1*03:02,06:03; DRB1*13:01,04:04; DRB3*10:01; DRB4*01 (IPD-IMGT/HLA=25804).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM06990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16,17
ST   D21S11: 31,32.2
ST   D8S1179: 14,15
ST   FGA: 19,20
ST   TH01: 6,9.3
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 32
//
ID   GM06991
AC   CVCL_R580
AS   CVCL_G423
SY   CEPH-1341-NA06991; 1341-8314
DR   CLO; CLO_0036555
DR   cancercelllines; CVCL_R580
DR   Coriell; GM06991
DR   dbMHC; 48583
DR   GEO; GSM25353
DR   GEO; GSM25355
DR   GEO; GSM112393
DR   GEO; GSM112760
DR   GEO; GSM188775
DR   GEO; GSM291587
DR   GEO; GSM316432
DR   GEO; GSM316433
DR   GEO; GSM316434
DR   GEO; GSM420469
DR   GEO; GSM420470
DR   GEO; GSM648858
DR   GEO; GSM861984
DR   GEO; GSM861985
DR   GEO; GSM861986
DR   GEO; GSM861987
DR   GEO; GSM861988
DR   GEO; GSM861989
DR   IGSR; NA06991
DR   IHW; IHW01053
DR   IPD-IMGT/HLA; 25851
DR   Progenetix; CVCL_R580
DR   Wikidata; Q54842432
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134102.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,03:01; B*07:02,07:02:01; C*07:02,07:02; DPA1*01:03,01:04; DPB1*04:01,15:01; DQA1*01:02,03:01; DQB1*03:02:01,06:02; DRB1*04:04,15:01; DRB4*01 (IPD-IMGT/HLA=25851).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM06992
AC   CVCL_5B20
AS   CVCL_G382
SY   CEPH-1331-NA06992; 1331-8239
DR   CLO; CLO_0036573
DR   Coriell; GM06992
DR   dbMHC; 48539
DR   GEO; GSM420471
DR   IHW; IHW01009
DR   IPD-IMGT/HLA; 25810
DR   Wikidata; Q54842434
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=21489251;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133111.
CC   HLA typing: A*02:01,31:01; B*40:01,51:01; C*15:03,03:04:01; DPA1*01:03,01:03; DPB1*02:01:02,06:01; DQA1*01:03,03:01; DQB1*03:02,06:03; DRB1*13:01,04:04; DRB3*10:01; DRB4*01 (IPD-IMGT/HLA=25810).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM06993
AC   CVCL_9588
AS   CVCL_G429
SY   CEPH-1341-NA06993; 1341-8320
DR   CLO; CLO_0036574
DR   EFO; EFO_0001108
DR   Coriell; GM06993
DR   dbMHC; 48584
DR   GEO; GSM25356
DR   GEO; GSM25357
DR   GEO; GSM112394
DR   GEO; GSM112761
DR   GEO; GSM188786
DR   GEO; GSM273273
DR   GEO; GSM273274
DR   GEO; GSM291588
DR   GEO; GSM314822
DR   GEO; GSM314823
DR   GEO; GSM420472
DR   GEO; GSM420473
DR   GEO; GSM424321
DR   GEO; GSM486737
DR   GEO; GSM486738
DR   GEO; GSM648840
DR   GEO; GSM659999
DR   GEO; GSM660205
DR   GEO; GSM660409
DR   GEO; GSM905818
DR   GEO; GSM905913
DR   GEO; GSM906008
DR   GEO; GSM957357
DR   IGSR; NA06993
DR   IHW; IHW01059
DR   IPD-IMGT/HLA; 25857
DR   Wikidata; Q54842435
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134113.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:01; B*07:02,50:01; C*07:02,06:02; DPA1*01:04; DPB1*06:01,15:01; DQA1*02:01,03:01; DQB1*02:01,03:02:01; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25857).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   GM06994
AC   CVCL_9589
DR   CLO; CLO_0036571
DR   EFO; EFO_0001109
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   Coriell; GM06994
DR   GEO; GSM25358
DR   GEO; GSM25359
DR   GEO; GSM112395
DR   GEO; GSM112762
DR   GEO; GSM188797
DR   GEO; GSM273275
DR   GEO; GSM273276
DR   GEO; GSM291589
DR   GEO; GSM314824
DR   GEO; GSM314825
DR   GEO; GSM420474
DR   GEO; GSM420475
DR   GEO; GSM424322
DR   GEO; GSM486739
DR   GEO; GSM486740
DR   GEO; GSM648881
DR   GEO; GSM649848
DR   GEO; GSM659967
DR   GEO; GSM660172
DR   GEO; GSM660378
DR   GEO; GSM905819
DR   GEO; GSM905914
DR   GEO; GSM906009
DR   GEO; GSM957358
DR   GEO; GSM1719743
DR   IGSR; NA06994
DR   Wikidata; Q54842436
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134009.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   GM06995
AC   CVCL_R581
DR   CLO; CLO_0036572
DR   Coriell; GM06995
DR   GEO; GSM420476
DR   GEO; GSM648971
DR   IGSR; NA06995
DR   Wikidata; Q54842437
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329101.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM06996
AC   CVCL_5B21
DR   CLO; CLO_0036567
DR   Coriell; GM06996
DR   GEO; GSM420477
DR   Wikidata; Q54842438
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329405.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM06997
AC   CVCL_R582
DR   CLO; CLO_0036569
DR   Coriell; GM06997
DR   GEO; GSM420478
DR   IGSR; NA06997
DR   Wikidata; Q54842439
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329102.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM06998
AC   CVCL_5B22
DR   CLO; CLO_0036565
DR   Coriell; GM06998
DR   GEO; GSM420479
DR   Wikidata; Q54842440
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329206.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM06999
AC   CVCL_5B23
AS   CVCL_G378
SY   CEPH-1331-NA06999; 1331-8235
DR   CLO; CLO_0036566
DR   EFO; EFO_0007077
DR   Coriell; GM06999
DR   dbMHC; 48540
DR   ENCODE; ENCBS340QSD
DR   GEO; GSM420480
DR   GEO; GSM659931
DR   GEO; GSM660142
DR   GEO; GSM660348
DR   IHW; IHW01005
DR   IPD-IMGT/HLA; 25806
DR   Wikidata; Q54842441
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133107.
CC   HLA typing: A*24:02,31:01; B*40:01,07:02:01; C*03:04:01:01,07:02; DPA1*01:03,01:03; DPB1*04:02,06:01; DQA1*03:01,03:01; DQB1*03:02,03:02; DRB1*04:04,04:04; DRB4*01 (IPD-IMGT/HLA=25806).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   GM07000
AC   CVCL_9590
DR   CLO; CLO_0036577
DR   EFO; EFO_0001110
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM07000
DR   GEO; GSM25360
DR   GEO; GSM25361
DR   GEO; GSM30019
DR   GEO; GSM112396
DR   GEO; GSM112763
DR   GEO; GSM188808
DR   GEO; GSM273277
DR   GEO; GSM273278
DR   GEO; GSM291590
DR   GEO; GSM314826
DR   GEO; GSM314827
DR   GEO; GSM420481
DR   GEO; GSM420482
DR   GEO; GSM424323
DR   GEO; GSM486741
DR   GEO; GSM486742
DR   GEO; GSM648847
DR   GEO; GSM649849
DR   GEO; GSM659965
DR   GEO; GSM660169
DR   GEO; GSM660377
DR   GEO; GSM905820
DR   GEO; GSM905915
DR   GEO; GSM906010
DR   GEO; GSM957344
DR   GEO; GSM957359
DR   GEO; GSM1719744
DR   IGSR; NA07000
DR   Wikidata; Q54842443
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134010.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM07001
AC   CVCL_5B24
SY   GM07001A
DR   CLO; CLO_0036576
DR   Coriell; GM07001
DR   GEO; GSM420483
DR   Wikidata; Q54842444
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329208.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07002
AC   CVCL_5B25
AS   CVCL_G410
SY   CEPH-1333-NA07002; 1333-8274
DR   CLO; CLO_0036575
DR   Coriell; GM07002
DR   dbMHC; 48570
DR   GEO; GSM25362
DR   GEO; GSM25363
DR   GEO; GSM314828
DR   GEO; GSM314829
DR   GEO; GSM420484
DR   GEO; GSM420485
DR   GEO; GSM659951
DR   GEO; GSM660155
DR   GEO; GSM660362
DR   GEO; GSM905821
DR   GEO; GSM905916
DR   GEO; GSM906011
DR   IHW; IHW01038
DR   IPD-IMGT/HLA; 25838
DR   Wikidata; Q54842445
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133312.
CC   Doubling time: Slow growth (Coriell=GM07002).
CC   HLA typing: A*03:01:01:01,24:02; B*35:01,51:01; C*04:01,07:04; DPA1*01:03,01:03; DPB1*02:02,16:01; DQA1*01:01,01:02; DQB1*05:02,05:03; DRB1*14:01,16:01; DRB3*02,03:01; DRB4*01:02; DRB5*02:01 (IPD-IMGT/HLA=25838).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   GM07003
AC   CVCL_5B26
DR   CLO; CLO_0036852
DR   Coriell; GM07003
DR   GEO; GSM420486
DR   Wikidata; Q54842446
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329203.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07004
AC   CVCL_5B27
AS   CVCL_G416
SY   CEPH-1333-NA07004; 1333-8280
DR   CLO; CLO_0036851
DR   Coriell; GM07004
DR   dbMHC; 48571
DR   GEO; GSM25364
DR   GEO; GSM316474
DR   GEO; GSM316475
DR   GEO; GSM316476
DR   GEO; GSM420487
DR   IHW; IHW01044
DR   IPD-IMGT/HLA; 25844
DR   Wikidata; Q54842447
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133303.
CC   HLA typing: A*01:01:01,03:01:01:01; B*35:01,58:01; C*04:01,07:01; DPA1*01:03,01:03; DPB1*04:01:01,16:01; DQA1*01:01,05:01; DQB1*03:01,05:03; DRB1*13:03,14:01; DRB3*01 (IPD-IMGT/HLA=25844).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07005
AC   CVCL_5B28
AS   CVCL_G379
SY   CEPH-1331-NA07005; 1331-8236
DR   CLO; CLO_0036850
DR   Coriell; GM07005
DR   dbMHC; 48541
DR   GEO; GSM420488
DR   GEO; GSM659932
DR   GEO; GSM660143
DR   GEO; GSM660349
DR   IHW; IHW01006
DR   IPD-IMGT/HLA; 25807
DR   Wikidata; Q54842448
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133106.
CC   HLA typing: A*24:02,31:01; B*40:01,07:02:01; C*03:04:01:01,07:02; DPA1*01:03,01:03; DPB1*04:02,06:01; DQA1*03:01,03:01; DQB1*03:02,03:02; DRB1*04:04,04:04; DRB4*01 (IPD-IMGT/HLA=25807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07006
AC   CVCL_5B29
AS   CVCL_G421
SY   CEPH-1341-NA07006; 1341-8312
DR   CLO; CLO_0036849
DR   Coriell; GM07006
DR   dbMHC; 48585
DR   GEO; GSM25365
DR   GEO; GSM316201
DR   GEO; GSM316202
DR   GEO; GSM316203
DR   GEO; GSM420489
DR   IHW; IHW01051
DR   IPD-IMGT/HLA; 25849
DR   Wikidata; Q54842449
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134108.
CC   HLA typing: A*02:01,03:01; B*07:02:01,44:02:01:01; C*05:01,07:02; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01 (IPD-IMGT/HLA=25849).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07007
AC   CVCL_G385
SY   CEPH-1331-NA07007; 1331-8242
DR   Coriell; GM07007
DR   dbMHC; 48535
DR   IHW; IHW01012
DR   IPD-IMGT/HLA; 25813
DR   Wikidata; Q54842450
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133112.
CC   HLA typing: A*02:01,31:01; B*18:01,40:01; C*03:04:01:01,07:01; DPA1*01:03,01:03; DPB1*03:01,06:01; DQA1*01:01,03:01; DQB1*03:02,05:03; DRB1*14:01,04:04; DRB3*02,30:01; DRB4*01 (IPD-IMGT/HLA=25813).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM07007; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   GM07008
AC   CVCL_F139
DR   CLO; CLO_0036848
DR   Coriell; GM07008
DR   GEO; GSM25366
DR   GEO; GSM30015
DR   GEO; GSM420490
DR   Wikidata; Q54842451
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134005.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM07009
AC   CVCL_5B30
AS   CVCL_G414
SY   CEPH-1333-NA07009; 1333-8278
DR   CLO; CLO_0036847
DR   Coriell; GM07009
DR   dbMHC; 48572
DR   GEO; GSM25367
DR   GEO; GSM316483
DR   GEO; GSM316484
DR   GEO; GSM316485
DR   GEO; GSM420491
DR   IHW; IHW01042
DR   IPD-IMGT/HLA; 25842
DR   Wikidata; Q54842452
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133307.
CC   HLA typing: A*01:01:01,03:01:01:01; B*35:01,58:01; C*04:01,07:01; DPA1*01:03,01:03; DPB1*04:01:01,16:01; DQA1*01:01,05:01; DQB1*03:01,05:03; DRB1*13:03,14:01; DRB3*02,03:01 (IPD-IMGT/HLA=25842).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07010
AC   CVCL_5B31
AS   CVCL_G424
SY   GM07010A; CEPH-1341-NA07010; 1341-8315
DR   CLO; CLO_0036846
DR   Coriell; GM07010
DR   dbMHC; 48586
DR   GEO; GSM25368
DR   GEO; GSM316204
DR   GEO; GSM316205
DR   GEO; GSM316206
DR   GEO; GSM420492
DR   IHW; IHW01054
DR   IPD-IMGT/HLA; 25852
DR   Wikidata; Q54842453
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134109.
CC   HLA typing: A*02:01,03:01; B*07:02:01,44:02:01:01; C*05:01,07:02; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01; DRB4*01 (IPD-IMGT/HLA=25852).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07011
AC   CVCL_5B32
AS   CVCL_G411
SY   CEPH-1333-NA07011; 1333-8275
DR   CLO; CLO_0036844
DR   Coriell; GM07011
DR   dbMHC; 48573
DR   GEO; GSM25369
DR   GEO; GSM316183
DR   GEO; GSM316184
DR   GEO; GSM316185
DR   GEO; GSM420493
DR   IHW; IHW01039
DR   IPD-IMGT/HLA; 25839
DR   Wikidata; Q54842454
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133306.
CC   HLA typing: A*03:01,03:01:01:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*04:01,16:01; DQA1*01:01,04:01; DQB1*04:02,05:03; DRB1*08:01,14:01; DRB3*02,03:01 (IPD-IMGT/HLA=25839).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07012
AC   CVCL_5B33
DR   CLO; CLO_0036845
DR   Coriell; GM07012
DR   GEO; GSM25370
DR   GEO; GSM316195
DR   GEO; GSM316196
DR   GEO; GSM316197
DR   GEO; GSM420494
DR   Wikidata; Q54842455
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134105.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07013
AC   CVCL_5B34
DR   CLO; CLO_0036842
DR   Coriell; GM07013
DR   GEO; GSM89105
DR   GEO; GSM89106
DR   GEO; GSM420495
DR   GEO; GSM420496
DR   Wikidata; Q54842456
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329401.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07014
AC   CVCL_R583
DR   CLO; CLO_0036843
DR   Coriell; GM07014
DR   GEO; GSM420497
DR   GEO; GSM420498
DR   GEO; GSM648952
DR   IGSR; NA07014
DR   Wikidata; Q54842457
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329202.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM07015
AC   CVCL_5B35
DR   CLO; CLO_0036839
DR   Coriell; GM07015
DR   GEO; GSM420499
DR   Wikidata; Q54842463
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329406.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07016
AC   CVCL_5B36
AS   CVCL_G388
SY   CEPH-1331-NA07016; 1331-8245
DR   CLO; CLO_0036838
DR   Coriell; GM07016
DR   dbMHC; 48542
DR   GEO; GSM314830
DR   GEO; GSM420500
DR   GEO; GSM906103
DR   GEO; GSM906104
DR   IHW; IHW01015
DR   IPD-IMGT/HLA; 25816
DR   Wikidata; Q54842464
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133114.
CC   HLA typing: A*02:01,03:01; B*18:01,51:01; C*15:03,07:01; DPA1*01:03,02:01:01; DPB1*02:01:02,14:01; DQA1*01:02,01:03; DQB1*06:03,06:04; DRB1*13:01,13:02; DRB3*10:01 (IPD-IMGT/HLA=25816).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07017
AC   CVCL_5B37
AS   CVCL_G409
SY   CEPH-1333-NA07017; 1333-8273
DR   CLO; CLO_0036841
DR   Coriell; GM07017
DR   dbMHC; 48574
DR   GEO; GSM25371
DR   GEO; GSM25372
DR   GEO; GSM314831
DR   GEO; GSM314832
DR   GEO; GSM420501
DR   GEO; GSM420502
DR   GEO; GSM906105
DR   GEO; GSM906106
DR   IHW; IHW01037
DR   IPD-IMGT/HLA; 25837
DR   Wikidata; Q54842465
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133313.
CC   HLA typing: A*01:01:01,02:01; B*07:02,58:01; C*07:01,07:02; DPA1*01:03,02:02:02; DPB1*04:01:01,05:01; DQA1*01:02,05:01; DQB1*03:01,06:02; DRB1*13:03,15:01; DRB3*01:01; DRB5*01:01 (IPD-IMGT/HLA=25837).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07018
AC   CVCL_5B38
DR   CLO; CLO_0036840
DR   Coriell; GM07018
DR   GEO; GSM420503
DR   Wikidata; Q54842466
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329103.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07019
AC   CVCL_7461
DR   CLO; CLO_0036837
DR   Coriell; GM07019
DR   GEO; GSM25373
DR   GEO; GSM25374
DR   GEO; GSM30013
DR   GEO; GSM112397
DR   GEO; GSM112764
DR   GEO; GSM188819
DR   GEO; GSM291591
DR   GEO; GSM420504
DR   GEO; GSM420505
DR   GEO; GSM648832
DR   GEO; GSM861990
DR   GEO; GSM861991
DR   GEO; GSM861992
DR   GEO; GSM861993
DR   GEO; GSM861994
DR   GEO; GSM861995
DR   IGSR; NA07019
DR   Wikidata; Q54842467
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134002.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM07020
AC   CVCL_5B39
AS   CVCL_G425
SY   CEPH-1341-NA07020; 1341-8316
DR   CLO; CLO_0036836
DR   Coriell; GM07020
DR   dbMHC; 48587
DR   GEO; GSM25375
DR   GEO; GSM316498
DR   GEO; GSM316499
DR   GEO; GSM316500
DR   GEO; GSM420506
DR   IHW; IHW01055
DR   IPD-IMGT/HLA; 25853
DR   Wikidata; Q54842468
RX   CelloPub=CLPUB00447;
RX   PubMed=17668376;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134110.
CC   HLA typing: A*02:01,03:01; B*07:02,07:02:01; C*07:02,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,15:01; DRB5*01,01 (IPD-IMGT/HLA=25853).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07021
AC   CVCL_5B40
AS   CVCL_G427
SY   CEPH-1341-NA07021; 1341-8318
DR   CLO; CLO_0036835
DR   Coriell; GM07021
DR   dbMHC; 48588
DR   GEO; GSM25376
DR   GEO; GSM316495
DR   GEO; GSM316496
DR   GEO; GSM316497
DR   GEO; GSM420507
DR   IHW; IHW01057
DR   IPD-IMGT/HLA; 25855
DR   Wikidata; Q54842469
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134107.
CC   HLA typing: A*02:01,02:01; B*07:02,44:02:01:01; C*05:01,07:02; DPA1*01:03,01:04; DPB1*04:01:01,15:01; DQA1*03:01,03:01; DQB1*03:01:01,03:02:01; DRB1*04:01,04:04; DRB4*01 (IPD-IMGT/HLA=25855).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07022
AC   CVCL_9591
DR   CLO; CLO_0036831
DR   EFO; EFO_0001111
DR   Coriell; GM07022
DR   GEO; GSM25377
DR   GEO; GSM25378
DR   GEO; GSM30020
DR   GEO; GSM112398
DR   GEO; GSM112765
DR   GEO; GSM188830
DR   GEO; GSM273279
DR   GEO; GSM273280
DR   GEO; GSM291592
DR   GEO; GSM314833
DR   GEO; GSM314834
DR   GEO; GSM420508
DR   GEO; GSM420509
DR   GEO; GSM424324
DR   GEO; GSM486743
DR   GEO; GSM486744
DR   GEO; GSM648943
DR   GEO; GSM659964
DR   GEO; GSM660167
DR   GEO; GSM660373
DR   GEO; GSM905822
DR   GEO; GSM905917
DR   GEO; GSM906012
DR   GEO; GSM957360
DR   IGSR; NA07022
DR   Wikidata; Q54842470
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24057213;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134011.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Virology: Contains a chromosomally integrated human herpesvirus 6B (CI-HHV-6B).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM07023
AC   CVCL_5B41
AS   CVCL_G389
SY   CEPH-1331-NA07023; 1331-8310
DR   CLO; CLO_0036832
DR   Coriell; GM07023
DR   dbMHC; 48543
DR   GEO; GSM420510
DR   GEO; GSM659935
DR   GEO; GSM660146
DR   GEO; GSM660352
DR   IHW; IHW01016
DR   IPD-IMGT/HLA; 25817
DR   Wikidata; Q54842471
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133103.
CC   HLA typing: A*24:02,31:01; B*40:01,07:02:01; C*03:04:01:01,07:02; DPA1*01:03,01:03; DPB1*04:02,06:01; DQA1*03:01,03:01; DQB1*03:02,03:02; DRB1*04:04,04:04; DRB4*01 (IPD-IMGT/HLA=25817).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   GM07024
AC   CVCL_5B42
DR   CLO; CLO_0036833
DR   Coriell; GM07024
DR   GEO; GSM420511
DR   Wikidata; Q54842472
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329407.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07025
AC   CVCL_5B43
DR   CLO; CLO_0036834
DR   Coriell; GM07025
DR   GEO; GSM420512
DR   Wikidata; Q54842473
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329305.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07026
AC   CVCL_5B44
AS   CVCL_G415
SY   CEPH-1333-NA07026; 1333-8279
DR   CLO; CLO_0036873
DR   Coriell; GM07026
DR   dbMHC; 48575
DR   GEO; GSM25379
DR   GEO; GSM316489
DR   GEO; GSM316490
DR   GEO; GSM316491
DR   GEO; GSM420513
DR   IHW; IHW01043
DR   IPD-IMGT/HLA; 25843
DR   Wikidata; Q54842474
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133309.
CC   HLA typing: A*03:01,03:01:01:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*04:01,16:01; DQA1*01:01,04:01; DQB1*04:02,05:03; DRB1*08:01,14:01; DRB3*02,03:01 (IPD-IMGT/HLA=25843).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07027
AC   CVCL_F140
DR   CLO; CLO_0036872
DR   Coriell; GM07027
DR   GEO; GSM25380
DR   GEO; GSM30018
DR   GEO; GSM420514
DR   Wikidata; Q54842475
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134008.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM07028
AC   CVCL_5B45
DR   CLO; CLO_0036871
DR   Coriell; GM07028
DR   GEO; GSM420515
DR   Wikidata; Q54842476
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329303.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07029
AC   CVCL_7462
DR   CLO; CLO_0036870
DR   Coriell; GM07029
DR   GEO; GSM25381
DR   GEO; GSM25382
DR   GEO; GSM112399
DR   GEO; GSM112766
DR   GEO; GSM188841
DR   GEO; GSM291593
DR   GEO; GSM420516
DR   GEO; GSM420517
DR   IGSR; NA07029
DR   Wikidata; Q54842477
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=23676674;
RX   PubMed=24924344;
RX   PubMed=26621101;
RX   PubMed=29474986;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134001.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   GM07030
AC   CVCL_5B46
AS   CVCL_G386
SY   CEPH-1331-NA07030; 1331-8243
DR   CLO; CLO_0036874
DR   Coriell; GM07030
DR   dbMHC; 48544
DR   GEO; GSM420518
DR   GEO; GSM659936
DR   GEO; GSM660147
DR   GEO; GSM660353
DR   IHW; IHW01013
DR   IPD-IMGT/HLA; 25814
DR   Wikidata; Q54842478
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133110.
CC   HLA typing: A*02:01,24:02; B*13:02,07:02:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*02:01,03:01; DQB1*02:01,03:02; DRB1*04:04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25814).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07031
AC   CVCL_R584
SY   GM 7031
DR   CLO; CLO_0036864
DR   Coriell; GM07031
DR   GEO; GSM25383
DR   GEO; GSM25384
DR   GEO; GSM314835
DR   GEO; GSM314836
DR   GEO; GSM420519
DR   GEO; GSM420520
DR   GEO; GSM648873
DR   IGSR; NA07031
DR   Wikidata; Q54842479
RX   CelloPub=CLPUB00447;
RX   PubMed=2112341;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329213/1329410.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F51 ! GM13046
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM07032
AC   CVCL_5B47
DR   CLO; CLO_0036865
DR   Coriell; GM07032
DR   GEO; GSM420521
DR   Wikidata; Q54842480
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329207.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07033
AC   CVCL_5B48
AS   CVCL_G390
SY   CEPH-1331-NA07033; 1331-8549
DR   CLO; CLO_0036868
DR   Coriell; GM07033
DR   dbMHC; 48545
DR   GEO; GSM420522
DR   GEO; GSM659934
DR   GEO; GSM660145
DR   GEO; GSM660351
DR   IHW; IHW01017
DR   IPD-IMGT/HLA; 25818
DR   Wikidata; Q54842481
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133104.
CC   HLA typing: A*02:01,31:01; B*40:01,51:01; C*15:03,03:04:01; DPA1*01:03,01:03; DPB1*02:01:02,06:01; DQA1*01:03,03:01; DQB1*03:02,06:03; DRB1*13:01,04:04; DRB3*01; DRB4*01 (IPD-IMGT/HLA=25818).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07034
AC   CVCL_9592
AS   CVCL_G432
SY   GM07034A; CEPH-1341-NA07034; 1341-8466
DR   CLO; CLO_0036869
DR   EFO; EFO_0001112
DR   Coriell; GM07034
DR   dbMHC; 48589
DR   GEO; GSM25385
DR   GEO; GSM25386
DR   GEO; GSM112400
DR   GEO; GSM112767
DR   GEO; GSM188852
DR   GEO; GSM273281
DR   GEO; GSM273282
DR   GEO; GSM291594
DR   GEO; GSM314837
DR   GEO; GSM314838
DR   GEO; GSM420523
DR   GEO; GSM420524
DR   GEO; GSM424325
DR   GEO; GSM486745
DR   GEO; GSM486746
DR   GEO; GSM648911
DR   GEO; GSM660000
DR   GEO; GSM660207
DR   GEO; GSM660411
DR   GEO; GSM905823
DR   GEO; GSM905918
DR   GEO; GSM906013
DR   GEO; GSM957361
DR   IGSR; NA07034
DR   IHW; IHW01062
DR   IPD-IMGT/HLA; 25860
DR   Wikidata; Q54842482
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134111.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,24:03; B*18:01,44:02:01:01; C*05:01,07:01; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*02:01,03:01; DQB1*02:01,03:01:01; DRB1*04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25860).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   GM07035
AC   CVCL_5B49
DR   CLO; CLO_0036866
DR   Coriell; GM07035
DR   GEO; GSM420525
DR   Wikidata; Q54842483
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329403.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07036
AC   CVCL_5B50
DR   CLO; CLO_0036867
DR   Coriell; GM07036
DR   GEO; GSM420526
DR   Wikidata; Q54842484
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329104.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07037
AC   CVCL_R585
DR   CLO; CLO_0036861
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM07037
DR   GEO; GSM648918
DR   GEO; GSM1719745
DR   IGSR; NA07037
DR   Wikidata; Q54842485
RX   CelloPub=CLPUB00447;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329111/1329211/1329311/1329412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F55 ! GM13050
OI   CVCL_5F56 ! GM13051
OI   CVCL_5F57 ! GM13052
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   GM07038
AC   CVCL_5B51
AS   CVCL_G418
SY   GM07038A; GM07038C; CEPH-1333-NA07038; 1333-8282
DR   CLO; CLO_0036860
DR   Coriell; GM07038
DR   dbMHC; 48576
DR   GEO; GSM25387
DR   GEO; GSM25388
DR   GEO; GSM207755
DR   GEO; GSM316384
DR   GEO; GSM316385
DR   GEO; GSM316386
DR   GEO; GSM420527
DR   GEO; GSM420528
DR   IHW; IHW01046
DR   IPD-IMGT/HLA; 25846
DR   Wikidata; Q54842486
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133301.
CC   HLA typing: A*03:01:01:01,24:02; B*35:01,39:06:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*03:01:01,16:01; DQA1*01:01,04:01; DQB1*04:02,05:03; DRB1*08:01,14:01 (IPD-IMGT/HLA=25846).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM07038).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 13,19
ST   D21S11: 29,32.2
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   TH01: 6,9.3
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 25
//
ID   GM07039
AC   CVCL_5B52
DR   CLO; CLO_0036863
DR   Coriell; GM07039
DR   GEO; GSM420529
DR   Wikidata; Q54842487
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329304.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07040
AC   CVCL_F141
DR   CLO; CLO_0036862
DR   Coriell; GM07040
DR   GEO; GSM25389
DR   GEO; GSM30016
DR   GEO; GSM420530
DR   Wikidata; Q54842488
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134006.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM07041
AC   CVCL_5B53
DR   CLO; CLO_0036853
DR   Coriell; GM07041
DR   Wikidata; Q54842489
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132803.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F58 ! GM13053
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM07042
AC   CVCL_5B54
SY   GM07042A
DR   CLO; CLO_0036854
DR   Coriell; GM07042
DR   GEO; GSM89107
DR   GEO; GSM89108
DR   GEO; GSM420531
DR   GEO; GSM420532
DR   Wikidata; Q54842490
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329201.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07043
AC   CVCL_5B55
SY   GM07043A
DR   CLO; CLO_0036855
DR   Coriell; GM07043
DR   Wikidata; Q54842491
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329408.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM07044
AC   CVCL_5B56
AS   CVCL_G422
SY   CEPH-1341-NA07044; 1341-8313
DR   CLO; CLO_0036856
DR   Coriell; GM07044
DR   dbMHC; 48590
DR   GEO; GSM25390
DR   GEO; GSM316192
DR   GEO; GSM316193
DR   GEO; GSM316194
DR   GEO; GSM420534
DR   IHW; IHW01052
DR   IPD-IMGT/HLA; 25850
DR   Wikidata; Q54842492
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134104.
CC   HLA typing: A*02:01,03:01; B*07:02:01,44:02:01:01; C*05:01,07:02; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01; DRB4*01 (IPD-IMGT/HLA=25850).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07045
AC   CVCL_R586
DR   CLO; CLO_0036857
DR   Coriell; GM07045
DR   GEO; GSM314839
DR   GEO; GSM420535
DR   GEO; GSM906107
DR   GEO; GSM906108
DR   IGSR; NA07045
DR   Wikidata; Q54842493
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329113.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM07046
AC   CVCL_5B57
DR   CLO; CLO_0036858
DR   Coriell; GM07046
DR   GEO; GSM420536
DR   GEO; GSM420537
DR   Wikidata; Q54842494
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329301.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07047
AC   CVCL_5B58
DR   CLO; CLO_0036859
DR   Coriell; GM07047
DR   GEO; GSM420538
DR   Wikidata; Q54842495
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329107.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07048
AC   CVCL_R587
AS   CVCL_G426
SY   CEPH-1341-NA07048; 1341-8317
DR   CLO; CLO_0036808
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   Coriell; GM07048
DR   dbMHC; 48591
DR   GEO; GSM25391
DR   GEO; GSM25392
DR   GEO; GSM112401
DR   GEO; GSM112768
DR   GEO; GSM188688
DR   GEO; GSM291595
DR   GEO; GSM316387
DR   GEO; GSM316388
DR   GEO; GSM316389
DR   GEO; GSM420539
DR   GEO; GSM420540
DR   GEO; GSM648838
DR   GEO; GSM1719746
DR   IGSR; NA07048
DR   IHW; IHW01056
DR   IPD-IMGT/HLA; 25854
DR   Wikidata; Q54842496
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=24924344;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134101.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,02:01; B*07:02,44:02:01:01; C*05:01,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01; DRB4*01 (IPD-IMGT/HLA=25854).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 25
//
ID   GM07049
AC   CVCL_5B59
AS   CVCL_G419
SY   GM07049C; CEPH-1333-NA07049; 1333-8302
DR   CLO; CLO_0036809
DR   Coriell; GM07049
DR   dbMHC; 48577
DR   GEO; GSM25393
DR   GEO; GSM25394
DR   GEO; GSM314840
DR   GEO; GSM314841
DR   GEO; GSM420541
DR   GEO; GSM420542
DR   GEO; GSM659950
DR   GEO; GSM660154
DR   GEO; GSM660361
DR   GEO; GSM905824
DR   GEO; GSM905919
DR   GEO; GSM906014
DR   GEO; GSM906109
DR   GEO; GSM906110
DR   IHW; IHW01047
DR   IPD-IMGT/HLA; 25847
DR   Wikidata; Q54842497
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133311.
CC   HLA typing: A*02:01,24:02; B*15:01,39:06:01; C*03:03,07:02; DPA1*01:03,01:03; DPB1*03:01,03:01:01; DQA1*04:01,05:01; DQB1*03:01,04:02; DRB1*08:01,11:03; DRB3*02,03:01 (IPD-IMGT/HLA=25847).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07050
AC   CVCL_5B60
AS   CVCL_G387
SY   GM07050C; CEPH-1331-NA07050; 1331-8244
DR   CLO; CLO_0036807
DR   Coriell; GM07050
DR   dbMHC; 48546
DR   GEO; GSM314842
DR   GEO; GSM420543
DR   IHW; IHW01014
DR   IPD-IMGT/HLA; 25815
DR   Wikidata; Q54842498
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133115.
CC   HLA typing: A*01:01,24:02; B*57:01,07:02:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*03:01,04:02; DQA1*02:01,03:01; DQB1*03:02,03:03; DRB1*04:04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07051
AC   CVCL_R588
SY   GM07051C
DR   CLO; CLO_0036806
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM07051
DR   GEO; GSM25395
DR   GEO; GSM25396
DR   GEO; GSM314843
DR   GEO; GSM314844
DR   GEO; GSM420544
DR   GEO; GSM420545
DR   GEO; GSM648837
DR   GEO; GSM1719747
DR   IGSR; NA07051
DR   Wikidata; Q54842499
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329212/1329409.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F50 ! GM13045
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM07052
AC   CVCL_5B61
AS   CVCL_G412
SY   CEPH-1333-NA07052; 1333-8276
DR   CLO; CLO_0036805
DR   Coriell; GM07052
DR   dbMHC; 48578
DR   GEO; GSM25397
DR   GEO; GSM316477
DR   GEO; GSM316478
DR   GEO; GSM316479
DR   GEO; GSM420546
DR   IHW; IHW01040
DR   IPD-IMGT/HLA; 25840
DR   Wikidata; Q54842500
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133304.
CC   HLA typing: A*01:01:01,24:02; B*39:06:01,58:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*04:01,05:01; DQB1*03:01,04:02; DRB1*08:01,13:03; DRB3*01,01 (IPD-IMGT/HLA=25840).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07053
AC   CVCL_F142
SY   GM07053A
DR   CLO; CLO_0036804
DR   Coriell; GM07053
DR   GEO; GSM25398
DR   GEO; GSM420547
DR   Wikidata; Q54842501
RX   CelloPub=CLPUB00447;
RX   PubMed=17668376;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134004.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM07054
AC   CVCL_5B62
DR   CLO; CLO_0036803
DR   Coriell; GM07054
DR   GEO; GSM420548
DR   Wikidata; Q54842502
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329404.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07055
AC   CVCL_7463
AS   CVCL_G431
SY   GM07055A; CEPH-1341-NA07055; 1341-8465
DR   CLO; CLO_0036802
DR   EFO; EFO_0001113
DR   Coriell; GM07055
DR   dbMHC; 48592
DR   GEO; GSM25399
DR   GEO; GSM25400
DR   GEO; GSM112402
DR   GEO; GSM112769
DR   GEO; GSM188699
DR   GEO; GSM273283
DR   GEO; GSM273284
DR   GEO; GSM291596
DR   GEO; GSM314845
DR   GEO; GSM314846
DR   GEO; GSM420549
DR   GEO; GSM420550
DR   GEO; GSM424326
DR   GEO; GSM486747
DR   GEO; GSM486748
DR   GEO; GSM648912
DR   GEO; GSM659998
DR   GEO; GSM660206
DR   GEO; GSM660410
DR   GEO; GSM905825
DR   GEO; GSM905920
DR   GEO; GSM906015
DR   GEO; GSM957362
DR   IGSR; NA07055
DR   IHW; IHW01061
DR   IPD-IMGT/HLA; 25859
DR   PRIDE; PXD025499
DR   Wikidata; Q54842508
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134112.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,68:01:02; B*07:02,07:02; C*07:02,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01; DQA1*01:01,01:02; DQB1*05:03,06:02; DRB1*14:01,15:01; DRB3*02; DRB5*01 (IPD-IMGT/HLA=25859).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   GM07056
AC   CVCL_9593
DR   CLO; CLO_0036801
DR   EFO; EFO_0001114
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM07056
DR   GEO; GSM25401
DR   GEO; GSM25402
DR   GEO; GSM30021
DR   GEO; GSM112403
DR   GEO; GSM112770
DR   GEO; GSM188710
DR   GEO; GSM273285
DR   GEO; GSM273286
DR   GEO; GSM291597
DR   GEO; GSM314847
DR   GEO; GSM314848
DR   GEO; GSM420551
DR   GEO; GSM420552
DR   GEO; GSM424327
DR   GEO; GSM486749
DR   GEO; GSM486750
DR   GEO; GSM648915
DR   GEO; GSM659962
DR   GEO; GSM660165
DR   GEO; GSM660371
DR   GEO; GSM905826
DR   GEO; GSM905921
DR   GEO; GSM906016
DR   GEO; GSM957363
DR   GEO; GSM1719748
DR   IGSR; NA07056
DR   Wikidata; Q54842509
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134012.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   GM07057
AC   CVCL_5B63
AS   CVCL_G383
SY   CEPH-1331-NA07057; 1331-8240
DR   CLO; CLO_0036800
DR   Coriell; GM07057
DR   dbMHC; 48547
DR   GEO; GSM207756
DR   GEO; GSM420553
DR   GEO; GSM660030
DR   GEO; GSM660237
DR   GEO; GSM660441
DR   GEO; GSM905827
DR   GEO; GSM905922
DR   GEO; GSM906017
DR   IHW; IHW01010
DR   IPD-IMGT/HLA; 25811
DR   Wikidata; Q54842510
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133101.
CC   HLA typing: A*02:01,31:01; B*13:02,40:01; C*03:04:01:01,06:02:01:01; DPA1*01:03,01:03; DPB1*04:01:01,06:01; DQA1*02:01,03:01; DQB1*02:01,03:02; DRB1*04:04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 10,13
ST   D21S11: 28,30
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 6,9.3
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 20
//
ID   GM07058
AC   CVCL_5B64
SY   GM07058B
DR   CLO; CLO_0036799
DR   Coriell; GM07058
DR   GEO; GSM420554
DR   Wikidata; Q54842511
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329109.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07059
AC   CVCL_5B65
AS   CVCL_G380
SY   GM07059A; CEPH-1331-NA07059; 1331-8237
DR   CLO; CLO_0036797
DR   Coriell; GM07059
DR   dbMHC; 48548
DR   GEO; GSM420555
DR   GEO; GSM659933
DR   GEO; GSM660144
DR   GEO; GSM660350
DR   IHW; IHW01007
DR   IPD-IMGT/HLA; 25808
DR   Wikidata; Q54842512
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133105.
CC   HLA typing: A*24:02,31:01; B*40:01,07:02:01; C*03:04:01:01,07:02; DPA1*01:03,01:03; DPB1*04:02,06:01; DQA1*03:01,03:01; DQB1*03:02,03:02; DRB1*04:04,04:04; DRB4*01 (IPD-IMGT/HLA=25808).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07060
AC   CVCL_5B66
DR   CLO; CLO_0036798
DR   Coriell; GM07060
DR   GEO; GSM420556
DR   Wikidata; Q54842514
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329307.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07061
AC   CVCL_5B67
SY   GM07061A
DR   CLO; CLO_0036788
DR   Coriell; GM07061
DR   GEO; GSM420557
DR   Wikidata; Q54842515
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329308.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07062
AC   CVCL_F143
DR   CLO; CLO_0036794
DR   Coriell; GM07062
DR   GEO; GSM25403
DR   GEO; GSM30014
DR   GEO; GSM420558
DR   Wikidata; Q54842516
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134003.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM07063
AC   CVCL_AY03
DR   CLO; CLO_0036793
DR   Coriell; GM07063
DR   Wikidata; Q54842517
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07064
AC   CVCL_AY04
SY   GM07064A
DR   CLO; CLO_0036796
DR   Coriell; GM07064
DR   Wikidata; Q54842518
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07065
AC   CVCL_DS17
DR   CLO; CLO_0036795
DR   Coriell; GM07065
DR   Wikidata; Q54842519
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98934; Harlequin ichthyosis
DI   ORDO; Orphanet_457; Harlequin ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM07067
AC   CVCL_0R02
DR   CLO; CLO_0036790
DR   Coriell; GM07067
DR   Wikidata; Q54842520
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3160; Letterer-Siwe disease
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 9
//
ID   GM07069
AC   CVCL_2S81
SY   GM07069A
DR   CLO; CLO_0036789
DR   Coriell; GM07069
DR   Wikidata; Q54842521
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(6;10)(6pter->6q25.3::10q26.1->10qter;10pter->10q26.1::6q25.3->6qter) (Coriell=GM07069).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07071
AC   CVCL_AY05
DR   CLO; CLO_0036792
DR   Coriell; GM07071
DR   Wikidata; Q54842522
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AY06 ! GM07072
SX   Male
AG   22FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07072
AC   CVCL_AY06
DR   CLO; CLO_0036791
DR   Coriell; GM07072
DR   Wikidata; Q54842523
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AY05 ! GM07071
SX   Male
AG   22FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07077
AC   CVCL_4J57
DR   CLO; CLO_0036830
DR   Coriell; GM07077
DR   Wikidata; Q54842524
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; p.Arg116Trp (c.346C>T); ClinVar=VCV000001445; Zygosity=Heterozygous (Coriell=GM07077).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM07078
AC   CVCL_F144
SY   GM07078A
DR   CLO; CLO_0036821
DR   Coriell; GM07078
DR   Wikidata; Q54842525
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM07078).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7464 ! GM07166
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM07081
AC   CVCL_0Q59
DR   CLO; CLO_0036820
DR   Coriell; GM07081
DR   GEO; GSM805
DR   Wikidata; Q54842526
RX   CelloPub=CLPUB00447;
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q60 ! GM07082
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   GM07082
AC   CVCL_0Q60
DR   CLO; CLO_0036825
DR   Coriell; GM07082
DR   Wikidata; Q54842527
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,+der(7)(7pter->7q11.2::15q11.2->15qter)mat,-15 (Coriell=GM07082).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q59 ! GM07081
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   GM07087
AC   CVCL_DS03
DR   CLO; CLO_0036824
DR   Coriell; GM07087
DR   Wikidata; Q54842528
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168757; Achromatopsia 2
DI   ORDO; Orphanet_49382; Achromatopsia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM07089
AC   CVCL_AM88
DR   CLO; CLO_0036823
DR   Coriell; GM07089
DR   Wikidata; Q54842529
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07092
AC   CVCL_L479
SY   GM 7092; RJK 888; RJK888
DR   CLO; CLO_0036822
DR   Coriell; GM07092
DR   Wikidata; Q54842530
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; c.609+5G>A (Ex8del); ClinVar=VCV000010054; Zygosity=Hemizygous (Coriell=GM07092).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   GM07093
AC   CVCL_L491
DR   CLO; CLO_0036829
DR   Coriell; GM07093
DR   Wikidata; Q54842531
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish/Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 11
//
ID   GM07094
AC   CVCL_F301
SY   GM17270; GM17324
DR   CLO; CLO_0013212
DR   CLO; CLO_0013647
DR   CLO; CLO_0036828
DR   Coriell; GM07094
DR   Coriell; GM17270
DR   Coriell; GM17324
DR   GEO; GSM569728
DR   GEO; GSM596334
DR   GEO; GSM596756
DR   GEO; GSM924872
DR   Wikidata; Q54842532
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM07097
AC   CVCL_GQ69
DR   CLO; CLO_0036827
DR   Coriell; GM07097
DR   Wikidata; Q54842533
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 02-05-24; Version: 9
//
ID   GM07103
AC   CVCL_X460
SY   GM 7103
DR   CLO; CLO_0036826
DR   Coriell; GM07103
DR   Wikidata; Q54842534
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg76Trp (c.226C>T); ClinVar=VCV000001962; Zygosity=Heterozygous (Coriell=GM07103).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Leu107Pro (c.320T>C); ClinVar=VCV000001965; Zygosity=Heterozygous (Coriell=GM07103).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M2W
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 19
//
ID   GM07104
AC   CVCL_N059
SY   GM 7104; GM17162
DR   CLO; CLO_0013983
DR   CLO; CLO_0036810
DR   Coriell; GM07104
DR   Coriell; GM17162
DR   GEO; GSM273429
DR   GEO; GSM569689
DR   GEO; GSM596227
DR   GEO; GSM597062
DR   GEO; GSM924672
DR   IPD-IMGT/HLA; 20693
DR   Wikidata; Q54842535
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*29:02,68:01; B*15:CWZY,35:BVYT; C*02:10,04:CVAF; DRB1*08:04,11:02 (IPD-IMGT/HLA=20693).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM07106
AC   CVCL_5N55
DR   CLO; CLO_0036812
DR   Coriell; GM07106
DR   Wikidata; Q54842537
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM07114
AC   CVCL_N060
SY   GM17163
DR   CLO; CLO_0013996
DR   CLO; CLO_0036811
DR   Coriell; GM07114
DR   Coriell; GM17163
DR   GEO; GSM273430
DR   GEO; GSM569690
DR   GEO; GSM596228
DR   GEO; GSM597026
DR   Wikidata; Q54842538
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM07114; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M930 ! GM02821
OI   CVCL_M931 ! GM02822
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM07125
AC   CVCL_JF44
DR   CLO; CLO_0036814
DR   Coriell; GM07125
DR   Wikidata; Q54842539
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61276; Familial hemophagocytic lymphohistiocytosis
DI   ORDO; Orphanet_540; Familial hemophagocytic lymphohistiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM07131
AC   CVCL_AY07
SY   GM7131
DR   CLO; CLO_0036813
DR   Coriell; GM07131
DR   Wikidata; Q54842540
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07132
AC   CVCL_AY08
DR   CLO; CLO_0036816
DR   Coriell; GM07132
DR   Wikidata; Q54842541
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07146
AC   CVCL_2T26
SY   GM07146A
DR   CLO; CLO_0036815
DR   Coriell; GM07146
DR   Wikidata; Q54842542
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07147
AC   CVCL_1P23
SY   GM7147
DR   CLO; CLO_0036818
DR   Coriell; GM07147
DR   Wikidata; Q54842543
RX   CelloPub=CLPUB00447;
RX   PubMed=2714795;
CC   Karyotypic information: 46,XX,t(13;16)(13pter->13q12.1::16p13.11->16pter;16qter->16p13.11::13q12.1->13qter) (Coriell=GM07147).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM07148
AC   CVCL_5N56
DR   CLO; CLO_0036817
DR   Coriell; GM07148
DR   Wikidata; Q54842544
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Native North American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM07149
AC   CVCL_9R49
SY   GM7149
DR   CLO; CLO_0036819
DR   Coriell; GM07149
DR   Wikidata; Q54842545
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 45,X,dic(X;22)(p22.1;p11.2) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM07150
AC   CVCL_2T29
DR   CLO; CLO_0036885
DR   Coriell; GM07150
DR   Wikidata; Q54842546
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM07151
AC   CVCL_X048
SY   GM7151
DR   CLO; CLO_0036891
DR   Coriell; GM07151
DR   Wikidata; Q54842547
RX   CelloPub=CLPUB00447;
RX   PubMed=2498246;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;17)(p11.2;p11.2).arr(1-22,X)x2 (Coriell=GM07151).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   GM07152
AC   CVCL_GQ70
SY   GM07152A
DR   CLO; CLO_0036892
DR   Coriell; GM07152
DR   Wikidata; Q54842548
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ71 ! GM07153
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07153
AC   CVCL_GQ71
DR   CLO; CLO_0036886
DR   Coriell; GM07153
DR   Wikidata; Q54842549
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ70 ! GM07152
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07154
AC   CVCL_GQ72
DR   CLO; CLO_0036889
DR   Coriell; GM07154
DR   Wikidata; Q54842556
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ73 ! GM07155
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07155
AC   CVCL_GQ73
DR   CLO; CLO_0036898
DR   Coriell; GM07155
DR   Wikidata; Q54842557
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ72 ! GM07154
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07156
AC   CVCL_5N57
DR   CLO; CLO_0036900
DR   Coriell; GM07156
DR   Wikidata; Q54842558
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 9
//
ID   GM07157
AC   CVCL_W206
DR   CLO; CLO_0036895
DR   Coriell; GM07157
DR   Wikidata; Q54842559
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Trp163Arg (c.487T>C) (W162R); ClinVar=VCV000011074; Zygosity=Hemizygous (Coriell=GM07157).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM07158
AC   CVCL_0L58
DR   CLO; CLO_0036896
DR   Coriell; GM07158
DR   Wikidata; Q54842560
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 13
//
ID   GM07166
AC   CVCL_7464
SY   GM7166; GM07166B
DR   CLO; CLO_0036901
DR   Coriell; GM07166
DR   Wikidata; Q54842561
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00505;
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   PubMed=3337113;
RX   PubMed=12419185;
RX   PubMed=19896956;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM07166).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F144 ! GM07078
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   GM07166VA7
AC   CVCL_WL44
SY   GM07166SV
DR   EFO; EFO_0022347
DR   Wikidata; Q93794124
RX   CelloPub=CLPUB00505;
RX   PubMed=12419185;
RX   PubMed=24830725;
RX   PubMed=27353471;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Could be identical to GM15989 (Cellosaurus=CVCL_F626).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7464 ! GM07166
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   GM07166VA7-NBS1
AC   CVCL_ZW03
DR   Wikidata; Q102113885
RX   PubMed=24830725;
RX   PubMed=27353471;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7652; NBN.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WL44 ! GM07166VA7
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   GM07172
AC   CVCL_AN11
DR   CLO; CLO_0036906
DR   Coriell; GM07172
DR   Wikidata; Q54842562
CC   Population: Puerto Rican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07173
AC   CVCL_2T30
DR   CLO; CLO_0036905
DR   Coriell; GM07173
DR   Wikidata; Q54842563
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM07174
AC   CVCL_AY09
DR   CLO; CLO_0036911
DR   Coriell; GM07174
DR   Wikidata; Q54842565
RX   CelloPub=CLPUB00447;
RX   PubMed=18165276;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; ClinVar=VCV000009972; Zygosity=Hemizygous (Coriell=GM07174).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM07175
AC   CVCL_AY10
DR   CLO; CLO_0036912
DR   Coriell; GM07175
DR   Wikidata; Q54842566
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[23]; ClinVar=VCV000009972; Zygosity=Heterozygous (Coriell=GM07175).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; ClinVar=VCV000009972; Zygosity=Heterozygous (Coriell=GM07175).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM07189
AC   CVCL_9S90
DR   CLO; CLO_0036913
DR   Coriell; GM07189
DR   Wikidata; Q54842567
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+15 (Coriell=GM07189).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM07199
AC   CVCL_GQ74
DR   CLO; CLO_0036914
DR   Coriell; GM07199
DR   Wikidata; Q54842568
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ75 ! GM07200
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07200
AC   CVCL_GQ75
SY   GM07200B
DR   CLO; CLO_0036907
DR   Coriell; GM07200
DR   Wikidata; Q54842569
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ74 ! GM07199
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07201
AC   CVCL_GQ76
DR   CLO; CLO_0036908
DR   Coriell; GM07201
DR   Wikidata; Q54842571
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ77 ! GM07205
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07205
AC   CVCL_GQ77
DR   CLO; CLO_0036909
DR   Coriell; GM07205
DR   Wikidata; Q54842572
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ76 ! GM07201
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07206
AC   CVCL_AN07
DR   CLO; CLO_0036910
DR   Coriell; GM07206
DR   Wikidata; Q54842573
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125700; Ehlers-Danlos syndrome, type VI
DI   ORDO; Orphanet_536545; Kyphoscoliotic Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07207
AC   CVCL_AM85
DR   CLO; CLO_0036918
DR   Coriell; GM07207
DR   Wikidata; Q54842574
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM07208
AC   CVCL_GQ78
SY   GM07208A
DR   CLO; CLO_0036920
DR   Coriell; GM07208
DR   Wikidata; Q54842575
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78349; Hypomania
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ79 ! GM07209
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07209
AC   CVCL_GQ79
DR   CLO; CLO_0036919
DR   Coriell; GM07209
DR   Wikidata; Q54842576
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C78349; Hypomania
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ78 ! GM07208
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07210
AC   CVCL_DB63
DR   CLO; CLO_0036926
DR   Coriell; GM07210
DR   Wikidata; Q54842577
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB64 ! GM07211
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM07211
AC   CVCL_DB64
DR   CLO; CLO_0036927
DR   Coriell; GM07211
DR   Wikidata; Q54842578
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB63 ! GM07210
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM07212
AC   CVCL_5N58
DR   Coriell; GM07212
DR   Wikidata; Q54842579
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM07212; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   GM07213
AC   CVCL_F610
SY   GM7213
DR   CLO; CLO_0036924
DR   Coriell; GM07213
DR   Wikidata; Q54842580
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: African American.
CC   Karyotypic information: 46,X,i(X)(q28) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   GM07214
AC   CVCL_9X04
DR   CLO; CLO_0036925
DR   Coriell; GM07214
DR   Wikidata; Q54842581
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98978; Meckel-Gruber syndrome
DI   ORDO; Orphanet_564; Meckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM07215
AC   CVCL_2Y98
DR   CLO; CLO_0036922
DR   Coriell; GM07215
DR   Wikidata; Q54842582
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM07216
AC   CVCL_5N59
DR   CLO; CLO_0036923
DR   Coriell; GM07216
DR   Wikidata; Q54842583
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM07218
AC   CVCL_GQ80
DR   CLO; CLO_0036921
DR   Coriell; GM07218
DR   Wikidata; Q54842584
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ81 ! GM07219
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07219
AC   CVCL_GQ81
DR   CLO; CLO_0036931
DR   Coriell; GM07219
DR   Wikidata; Q54842585
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ80 ! GM07218
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07220
AC   CVCL_GQ82
DR   CLO; CLO_0036930
DR   Coriell; GM07220
DR   Wikidata; Q54842586
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ83 ! GM07221
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07221
AC   CVCL_GQ83
DR   CLO; CLO_0036929
DR   Coriell; GM07221
DR   Wikidata; Q54842587
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ82 ! GM07220
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07222
AC   CVCL_EJ40
DR   CLO; CLO_0036928
DR   Coriell; GM07222
DR   Wikidata; Q54842588
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ41 ! GM07223
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07223
AC   CVCL_EJ41
SY   GM07223B
DR   CLO; CLO_0035923
DR   Coriell; GM07223
DR   Wikidata; Q54842589
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ40 ! GM07222
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07224
AC   CVCL_0M40
DR   CLO; CLO_0035921
DR   Coriell; GM07224
DR   Wikidata; Q54842590
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07225
AC   CVCL_0M41
DR   CLO; CLO_0035920
DR   Coriell; GM07225
DR   Wikidata; Q54842591
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07225).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM07226
AC   CVCL_0M42
DR   CLO; CLO_0035918
DR   Coriell; GM07226
DR   Wikidata; Q54842592
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Unspecified (from familial inference of GM07224).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM07227
AC   CVCL_0M43
SY   GM07227A
DR   CLO; CLO_0035916
DR   Coriell; GM07227
DR   Wikidata; Q54842593
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Unspecified (from familial inference of GM07224).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM07228
AC   CVCL_0M44
DR   CLO; CLO_0035915
DR   Coriell; GM07228
DR   Wikidata; Q54842594
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07228).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM07231
AC   CVCL_AL09
DR   CLO; CLO_0035932
DR   Coriell; GM07231
DR   Wikidata; Q54842595
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL10 ! GM07232
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07232
AC   CVCL_AL10
DR   CLO; CLO_0035930
DR   Coriell; GM07232
DR   Wikidata; Q54842596
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL09 ! GM07231
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM07233
AC   CVCL_AL11
DR   CLO; CLO_0035931
DR   Coriell; GM07233
DR   Wikidata; Q54842597
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL12 ! GM07234
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07234
AC   CVCL_AL12
DR   CLO; CLO_0035928
DR   Coriell; GM07234
DR   Wikidata; Q54842604
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL11 ! GM07233
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM07235
AC   CVCL_AL13
DR   CLO; CLO_0035929
DR   Coriell; GM07235
DR   Wikidata; Q54842605
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL14 ! GM07236
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07236
AC   CVCL_AL14
DR   CLO; CLO_0035899
DR   Coriell; GM07236
DR   Wikidata; Q54842606
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL13 ! GM07235
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07239
AC   CVCL_GQ84
DR   CLO; CLO_0035897
DR   Coriell; GM07239
DR   Wikidata; Q54842607
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ85 ! GM07240
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07240
AC   CVCL_GQ85
DR   CLO; CLO_0035901
DR   Coriell; GM07240
DR   Wikidata; Q54842608
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ84 ! GM07239
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07241
AC   CVCL_GQ86
DR   CLO; CLO_0035900
DR   Coriell; GM07241
DR   Wikidata; Q54842609
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ87 ! GM07242
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07242
AC   CVCL_GQ87
DR   CLO; CLO_0035892
DR   Coriell; GM07242
DR   Wikidata; Q54842610
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ86 ! GM07241
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07243
AC   CVCL_EJ42
DR   CLO; CLO_0035910
DR   Coriell; GM07243
DR   Wikidata; Q54842611
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ43 ! GM07244
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07244
AC   CVCL_EJ43
DR   CLO; CLO_0035911
DR   Coriell; GM07244
DR   Wikidata; Q54842612
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ42 ! GM07243
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07245
AC   CVCL_GQ88
DR   CLO; CLO_0035906
DR   Coriell; GM07245
DR   Wikidata; Q54842613
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ89 ! GM07246
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07246
AC   CVCL_GQ89
DR   CLO; CLO_0035907
DR   Coriell; GM07246
DR   Wikidata; Q54842614
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ88 ! GM07245
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07247
AC   CVCL_DR44
DR   CLO; CLO_0035908
DR   Coriell; GM07247
DR   Wikidata; Q54842615
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR45 ! GM07248
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM07248
AC   CVCL_DR45
DR   CLO; CLO_0035909
DR   Coriell; GM07248
DR   Wikidata; Q54842616
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR44 ! GM07247
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM07249
AC   CVCL_DR46
DR   CLO; CLO_0035874
DR   Coriell; GM07249
DR   Wikidata; Q54842617
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR47 ! GM07250
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM07250
AC   CVCL_DR47
DR   CLO; CLO_0035873
DR   Coriell; GM07250
DR   Wikidata; Q54842618
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR46 ! GM07249
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM07254
AC   CVCL_V388
SY   GM 7254
DR   CLO; CLO_0035871
DR   Coriell; GM07254
DR   Wikidata; Q54842620
RX   CelloPub=CLPUB00447;
RX   PubMed=6593161;
CC   HLA typing: A*01; B*39; C*w07 (Coriell=GM07254).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a donor that was the offspring of consanguineous parents (brother/sister mating).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM07255
AC   CVCL_9R82
DR   CLO; CLO_0035870
DR   Coriell; GM07255
DR   Wikidata; Q54842621
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Lys4Gln (c.10A>C); ClinVar=VCV000002774; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM07256
AC   CVCL_9R83
DR   CLO; CLO_0035886
DR   Coriell; GM07256
DR   Wikidata; Q54842622
RX   CelloPub=CLPUB00447;
RX   PubMed=16465621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Heterozygous (PubMed=16465621).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM07257
AC   CVCL_GQ90
DR   CLO; CLO_0035884
DR   Coriell; GM07257
DR   Wikidata; Q54842623
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ91 ! GM07258
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07258
AC   CVCL_GQ91
SY   GM7258
DR   CLO; CLO_0035885
DR   Coriell; GM07258
DR   Wikidata; Q54842624
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ90 ! GM07257
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07259
AC   CVCL_GQ92
DR   CLO; CLO_0035889
DR   Coriell; GM07259
DR   Wikidata; Q54842625
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78349; Hypomania
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ93 ! GM07260
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07260
AC   CVCL_GQ93
DR   CLO; CLO_0035890
DR   Coriell; GM07260
DR   Wikidata; Q54842626
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C78349; Hypomania
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ92 ! GM07259
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07261
AC   CVCL_GQ94
DR   CLO; CLO_0035887
DR   Coriell; GM07261
DR   Wikidata; Q54842627
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ95 ! GM07262
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07262
AC   CVCL_GQ95
DR   CLO; CLO_0035888
DR   Coriell; GM07262
DR   Wikidata; Q54842628
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ94 ! GM07261
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07263
AC   CVCL_GQ96
DR   CLO; CLO_0035850
DR   Coriell; GM07263
DR   Wikidata; Q54842629
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ97 ! GM07264
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07264
AC   CVCL_GQ97
DR   CLO; CLO_0035849
DR   Coriell; GM07264
DR   Wikidata; Q54842630
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ96 ! GM07263
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07265
AC   CVCL_GQ98
DR   CLO; CLO_0035851
DR   Coriell; GM07265
DR   Wikidata; Q54842631
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ99 ! GM07266
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07266
AC   CVCL_GQ99
DR   CLO; CLO_0035862
DR   Coriell; GM07266
DR   Wikidata; Q54842632
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ98 ! GM07265
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07267
AC   CVCL_6G90
DR   CLO; CLO_0035863
DR   Coriell; GM07267
DR   Wikidata; Q54842633
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(4)(pter->q31.3) (Coriell=GM07267).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM07268
AC   CVCL_EJ44
DR   CLO; CLO_0035864
DR   Coriell; GM07268
DR   Wikidata; Q54842634
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ45 ! GM07269
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07269
AC   CVCL_EJ45
DR   CLO; CLO_0035865
DR   Coriell; GM07269
DR   Wikidata; Q54842635
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ44 ! GM07268
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07270
AC   CVCL_AW87
DR   CLO; CLO_0035866
DR   Coriell; GM07270
DR   Wikidata; Q54842636
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Belgian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118438; Osteopetrosis with renal tubular acidosis
DI   ORDO; Orphanet_2785; Osteopetrosis with renal tubular acidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07278
AC   CVCL_GR00
DR   CLO; CLO_0035867
DR   Coriell; GM07278
DR   Wikidata; Q54842637
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR01 ! GM07279
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07279
AC   CVCL_GR01
SY   GM07279A
DR   CLO; CLO_0035868
DR   Coriell; GM07279
DR   Wikidata; Q54842638
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR00 ! GM07278
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07280
AC   CVCL_4T30
SY   GM7280
DR   CLO; CLO_0035869
DR   Coriell; GM07280
DR   Wikidata; Q54842640
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123433; Hyperlysinemia
DI   ORDO; Orphanet_2203; Hyperlysinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM07290
AC   CVCL_0R03
DR   CLO; CLO_0035944
DR   Coriell; GM07290
DR   Wikidata; Q54842641
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Leu110Pro (c.329T>C); ClinVar=VCV000018300; Zygosity=Homozygous (Coriell=GM07290).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM07291
AC   CVCL_0R04
DR   CLO; CLO_0035945
DR   Coriell; GM07291
DR   Wikidata; Q54842642
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Leu110Pro (c.329T>C); ClinVar=VCV000018300; Zygosity=Homozygous (Coriell=GM07291).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM07292
AC   CVCL_AY11
DR   CLO; CLO_0035954
DR   Coriell; GM07292
DR   Wikidata; Q54842643
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07294
AC   CVCL_AY12
DR   CLO; CLO_0035953
DR   Coriell; GM07294
DR   Wikidata; Q54842644
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 9
//
ID   GM07297
AC   CVCL_UY67
SY   Line #11.1.2.2
DR   CLO; CLO_0035952
DR   Coriell; GM07297
DR   Wikidata; Q93795083
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM07298
AC   CVCL_UY70
SY   Line #2.12
DR   CLO; CLO_0035951
DR   Coriell; GM07298
DR   Wikidata; Q93795088
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 4
//
ID   GM07299
AC   CVCL_UY66
SY   GM7299; Line #MR 8.2
DR   CLO; CLO_0035950
DR   Coriell; GM07299
DR   Wikidata; Q93795093
RX   CelloPub=CLPUB00447;
RX   PubMed=2740341;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM07300
AC   CVCL_UY68
SY   Line #1.11
DR   CLO; CLO_0035949
DR   Coriell; GM07300
DR   Wikidata; Q93795098
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM07301
AC   CVCL_UY69
SY   Line #16.2
DR   CLO; CLO_0035948
DR   Coriell; GM07301
DR   Wikidata; Q93795106
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM07312
AC   CVCL_X141
SY   GM7312; GM07312A
DR   CLO; CLO_0035947
DR   Coriell; GM07312
DR   Wikidata; Q54842645
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X140 ! GM05877
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   GM07316
AC   CVCL_EJ46
SY   GM7316
DR   CLO; CLO_0035946
DR   Coriell; GM07316
DR   Wikidata; Q54842652
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ47 ! GM07317
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07317
AC   CVCL_EJ47
DR   CLO; CLO_0035933
DR   Coriell; GM07317
DR   Wikidata; Q54842653
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ46 ! GM07316
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07320
AC   CVCL_GR02
DR   CLO; CLO_0035943
DR   Coriell; GM07320
DR   Wikidata; Q54842654
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM07320; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ68 ! GM06974
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM07321
AC   CVCL_CW79
DR   CLO; CLO_0035942
DR   Coriell; GM07321
DR   Wikidata; Q54842655
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW78 ! GM06973
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM07323
AC   CVCL_5N60
DR   CLO; CLO_0035939
DR   Coriell; GM07323
DR   Wikidata; Q54842656
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM07324
AC   CVCL_GR03
SY   GM7324
DR   CLO; CLO_0035938
DR   Coriell; GM07324
DR   Wikidata; Q54842657
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR04 ! GM07325
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07325
AC   CVCL_GR04
SY   GM7325Z
DR   CLO; CLO_0035941
DR   Coriell; GM07325
DR   Wikidata; Q54842658
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR03 ! GM07324
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07326
AC   CVCL_CZ18
DR   CLO; CLO_0035940
DR   Coriell; GM07326
DR   Wikidata; Q54842659
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM07328
AC   CVCL_CZ19
SY   GM7328
DR   CLO; CLO_0035935
DR   Coriell; GM07328
DR   Wikidata; Q54842660
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ20 ! GM07329
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM07329
AC   CVCL_CZ20
DR   CLO; CLO_0035934
DR   Coriell; GM07329
DR   Wikidata; Q54842661
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ19 ! GM07328
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM07330
AC   CVCL_CZ21
SY   GM7330
DR   CLO; CLO_0035937
DR   Coriell; GM07330
DR   Wikidata; Q54842662
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ22 ! GM07331
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM07331
AC   CVCL_CZ22
DR   CLO; CLO_0035936
DR   Coriell; GM07331
DR   Wikidata; Q54842663
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ21 ! GM07330
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM07332
AC   CVCL_2T31
DR   CLO; CLO_0016971
DR   Coriell; GM07332
DR   Wikidata; Q54842664
RX   CelloPub=CLPUB00447;
RX   PubMed=10577914;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(11;22)(11pter->11q23::22q11.2->22qter;22pter->22q11.2::11q23->11qter)mat (Coriell=GM07332).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM07335
AC   CVCL_EJ48
SY   GM7335; GM07335B
DR   CLO; CLO_0016972
DR   Coriell; GM07335
DR   Wikidata; Q54842665
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ49 ! GM07336
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07336
AC   CVCL_EJ49
DR   CLO; CLO_0016973
DR   Coriell; GM07336
DR   Wikidata; Q54842666
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ48 ! GM07335
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07337
AC   CVCL_0M45
DR   CLO; CLO_0016964
DR   Coriell; GM07337
DR   Wikidata; Q54842667
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07338
AC   CVCL_0M46
DR   CLO; CLO_0016965
DR   Coriell; GM07338
DR   Wikidata; Q54842668
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 11
//
ID   GM07339
AC   CVCL_0M47
DR   CLO; CLO_0016968
DR   Coriell; GM07339
DR   Wikidata; Q54842669
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07339).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07340
AC   CVCL_0V35
AS   CVCL_G384
SY   GM07340B; CEPH-1331-NA07340; 1331-8241
DR   CLO; CLO_0016969
DR   Coriell; GM07340
DR   dbMHC; 48549
DR   GEO; GSM314849
DR   GEO; GSM420559
DR   GEO; GSM906111
DR   GEO; GSM906112
DR   IGSR; NA07340
DR   IHW; IHW01011
DR   IPD-IMGT/HLA; 25812
DR   Wikidata; Q54842670
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133113.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,03:01; B*13:02,07:02; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*03:01,04:01:01; DQA1*01:02,02:01; DQB1*02:01,06:02; DRB1*07:01,15:01; DRB4*01; DRB5*01 (IPD-IMGT/HLA=25812).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 22
//
ID   GM07341
AC   CVCL_0V36
AS   CVCL_G408
SY   CEPH-1333-NA07341; 1333-8272
DR   CLO; CLO_0016959
DR   Coriell; GM07341
DR   dbMHC; 48579
DR   GEO; GSM25404
DR   GEO; GSM25405
DR   GEO; GSM314850
DR   GEO; GSM314851
DR   GEO; GSM420560
DR   GEO; GSM420561
DR   GEO; GSM906113
DR   GEO; GSM906114
DR   IHW; IHW01036
DR   IPD-IMGT/HLA; 25836
DR   Wikidata; Q54842671
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133314.
CC   HLA typing: A*02:01,03:01; B*07:02,37:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*02:01,04:01; DQA1*01:01,04:01; DQB1*04:02,05:01; DRB1*08:01,10:01 (IPD-IMGT/HLA=25836).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 19
//
ID   GM07342
AC   CVCL_0V37
DR   CLO; CLO_0016960
DR   Coriell; GM07342
DR   GEO; GSM25406
DR   GEO; GSM30017
DR   GEO; GSM420562
DR   Wikidata; Q54842672
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134007.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   GM07343
AC   CVCL_0V38
AS   CVCL_G430
SY   GM07343A; CEPH-1341-NA07343; 1341-8346
DR   CLO; CLO_0016961
DR   Coriell; GM07343
DR   dbMHC; 48593
DR   GEO; GSM25407
DR   GEO; GSM316189
DR   GEO; GSM316190
DR   GEO; GSM316191
DR   GEO; GSM420563
DR   IHW; IHW01060
DR   IPD-IMGT/HLA; 25858
DR   Wikidata; Q54842673
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134103.
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01; DQA1*01:02,03:01; DQB1*03:02:01,06:02; DRB1*04:04,15:01; DRB4*01 (IPD-IMGT/HLA=25858).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 19
//
ID   GM07344
AC   CVCL_0V39
AS   CVCL_G433
SY   CEPH-1341-NA07344; 1341-8631
DR   CLO; CLO_0016957
DR   Coriell; GM07344
DR   dbMHC; 48594
DR   GEO; GSM25408
DR   GEO; GSM316198
DR   GEO; GSM316199
DR   GEO; GSM316200
DR   GEO; GSM420564
DR   IHW; IHW01063
DR   IPD-IMGT/HLA; 25861
DR   Wikidata; Q54842674
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134106.
CC   HLA typing: A*02:01,03:01; B*07:02:01,44:02:01:01; C*05:01,07:02; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01; DRB4*01; DRB5*01 (IPD-IMGT/HLA=25861).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 19
//
ID   GM07345
AC   CVCL_9594
DR   CLO; CLO_0016958
DR   EFO; EFO_0001115
DR   Coriell; GM07345
DR   GEO; GSM25409
DR   GEO; GSM25410
DR   GEO; GSM30032
DR   GEO; GSM112404
DR   GEO; GSM112771
DR   GEO; GSM188721
DR   GEO; GSM273287
DR   GEO; GSM273288
DR   GEO; GSM291598
DR   GEO; GSM314852
DR   GEO; GSM314853
DR   GEO; GSM420565
DR   GEO; GSM420566
DR   GEO; GSM424328
DR   GEO; GSM486751
DR   GEO; GSM486752
DR   GEO; GSM659957
DR   GEO; GSM660160
DR   GEO; GSM660367
DR   GEO; GSM905828
DR   GEO; GSM905923
DR   GEO; GSM906018
DR   GEO; GSM957364
DR   IGSR; NA07345
DR   Wikidata; Q54842675
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134513.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM07346
AC   CVCL_R589
SY   GM07346A
DR   CLO; CLO_0016955
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   Coriell; GM07346
DR   GEO; GSM25411
DR   GEO; GSM25412
DR   GEO; GSM314854
DR   GEO; GSM314855
DR   GEO; GSM420567
DR   GEO; GSM420568
DR   GEO; GSM648850
DR   GEO; GSM906115
DR   GEO; GSM906116
DR   IGSR; NA07346
DR   Wikidata; Q54842676
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134511.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM07347
AC   CVCL_R590
DR   CLO; CLO_0016956
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM07347
DR   GEO; GSM25413
DR   GEO; GSM25414
DR   GEO; GSM314856
DR   GEO; GSM314857
DR   GEO; GSM420569
DR   GEO; GSM420570
DR   GEO; GSM648919
DR   GEO; GSM906117
DR   GEO; GSM906118
DR   GEO; GSM1719749
DR   IGSR; NA07347
DR   Wikidata; Q54842677
RX   CelloPub=CLPUB00447;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134510.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   GM07348
AC   CVCL_7465
SY   GM07348B
DR   CLO; CLO_0016951
DR   Coriell; GM07348
DR   GEO; GSM25415
DR   GEO; GSM25416
DR   GEO; GSM30024
DR   GEO; GSM112492
DR   GEO; GSM112772
DR   GEO; GSM188732
DR   GEO; GSM207757
DR   GEO; GSM291599
DR   GEO; GSM291600
DR   GEO; GSM420571
DR   GEO; GSM420572
DR   GEO; GSM648877
DR   IGSR; NA07348
DR   Wikidata; Q54842678
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134502.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM07348).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   GM07349
AC   CVCL_R591
DR   CLO; CLO_0016952
DR   Coriell; GM07349
DR   GEO; GSM25417
DR   GEO; GSM25418
DR   GEO; GSM30023
DR   GEO; GSM207758
DR   GEO; GSM420573
DR   GEO; GSM420574
DR   GEO; GSM648973
DR   GEO; GSM827334
DR   IGSR; NA07349
DR   Wikidata; Q54842679
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20215515;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134501.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM07350
AC   CVCL_5B68
DR   CLO; CLO_0016949
DR   Coriell; GM07350
DR   GEO; GSM25419
DR   GEO; GSM420575
DR   Wikidata; Q54842681
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134503.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07351
AC   CVCL_5B69
DR   CLO; CLO_0016950
DR   Coriell; GM07351
DR   GEO; GSM25420
DR   GEO; GSM30025
DR   GEO; GSM420576
DR   Wikidata; Q54842682
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134504.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07352
AC   CVCL_5B70
DR   CLO; CLO_0016953
DR   Coriell; GM07352
DR   GEO; GSM25421
DR   GEO; GSM30026
DR   GEO; GSM420577
DR   Wikidata; Q54842683
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134505.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07353
AC   CVCL_5B71
SY   GM07353A
DR   CLO; CLO_0016954
DR   Coriell; GM07353
DR   GEO; GSM25422
DR   GEO; GSM30027
DR   GEO; GSM420578
DR   Wikidata; Q54842684
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17668376;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134506.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07354
AC   CVCL_5B72
DR   CLO; CLO_0016944
DR   Coriell; GM07354
DR   GEO; GSM25423
DR   GEO; GSM30028
DR   GEO; GSM420579
DR   Wikidata; Q54842685
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134507.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07355
AC   CVCL_5B73
SY   GM07355A
DR   CLO; CLO_0016945
DR   Coriell; GM07355
DR   GEO; GSM25424
DR   GEO; GSM30029
DR   GEO; GSM420580
DR   Wikidata; Q54842686
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134508.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07356
AC   CVCL_5B74
SY   GM07356A
DR   CLO; CLO_0016946
DR   Coriell; GM07356
DR   GEO; GSM25425
DR   GEO; GSM30030
DR   GEO; GSM420581
DR   Wikidata; Q54842687
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134509.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07357
AC   CVCL_9595
DR   CLO; CLO_0016947
DR   EFO; EFO_0001116
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM07357
DR   GEO; GSM25426
DR   GEO; GSM25427
DR   GEO; GSM30031
DR   GEO; GSM112493
DR   GEO; GSM112773
DR   GEO; GSM188743
DR   GEO; GSM273289
DR   GEO; GSM273290
DR   GEO; GSM291601
DR   GEO; GSM291602
DR   GEO; GSM314858
DR   GEO; GSM314859
DR   GEO; GSM420582
DR   GEO; GSM420583
DR   GEO; GSM486753
DR   GEO; GSM486754
DR   GEO; GSM648836
DR   GEO; GSM649850
DR   GEO; GSM659955
DR   GEO; GSM660158
DR   GEO; GSM660365
DR   GEO; GSM905829
DR   GEO; GSM905924
DR   GEO; GSM906019
DR   GEO; GSM1719750
DR   IGSR; NA07357
DR   Wikidata; Q54842688
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=24924344;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 134512.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM07357).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   GM07364
AC   CVCL_4D92
DR   CLO; CLO_0016948
DR   Coriell; GM07364
DR   Wikidata; Q54842689
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C185638; Ring chromosome 14 syndrome
DI   ORDO; Orphanet_1440; Ring chromosome 14 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM07365
AC   CVCL_AY13
DR   CLO; CLO_0016939
DR   Coriell; GM07365
DR   Wikidata; Q54842690
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07368
AC   CVCL_AL15
DR   CLO; CLO_0016940
DR   Coriell; GM07368
DR   Wikidata; Q54842691
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL16 ! GM07369
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07369
AC   CVCL_AL16
DR   CLO; CLO_0016941
DR   Coriell; GM07369
DR   Wikidata; Q54842692
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL15 ! GM07368
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM07370
AC   CVCL_W726
DR   CLO; CLO_0016942
DR   Coriell; GM07370
DR   Wikidata; Q54842697
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Leu12Profs*103 (c.34dupC) (T35insC); ClinVar=VCV000002154; Zygosity=Homozygous (from autologous cell line GM07371).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C155760; Peroxisome biogenesis disorder 7A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W727 ! GM07371
SX   Female
AG   2W
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM07371
AC   CVCL_W727
DR   CLO; CLO_0016943
DR   Coriell; GM07371
DR   Wikidata; Q54842698
RX   PubMed=12851857;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Leu12Profs*103 (c.34dupC) (T35insC); ClinVar=VCV000002154; Zygosity=Homozygous (PubMed=12851857).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155760; Peroxisome biogenesis disorder 7A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W726 ! GM07370
SX   Female
AG   3W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM07372
AC   CVCL_0980
SY   GM7372; GM-7372; GM07372A; BFA-1c 1BPT flat transformant
DR   CLO; CLO_0003536
DR   CLO; CLO_0016934
DR   CLDB; cl1503
DR   BioSamples; SAME42985
DR   Coriell; GM07372
DR   TOKU-E; 4116
DR   Wikidata; Q54842699
RX   CelloPub=CLPUB00447;
RX   PubMed=6833405;
CC   Characteristics: Grows in monolayers.
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_K000 ! GM03905
SX   Male
AG   24FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GM07373
AC   CVCL_2049
SY   GM7373; GM-7373; BFA-1c 1BPT multilayered transformant
DR   CLO; CLO_0003537
DR   CLO; CLO_0016933
DR   CLDB; cl1504
DR   CLDB; cl1505
DR   Coriell; GM07373
DR   DSMZ; ACC-109
DR   DSMZCellDive; ACC-109
DR   Wikidata; Q54842700
RX   CelloPub=CLPUB00447;
RX   PubMed=6833405;
CC   Characteristics: Grows in multilayers.
CC   Doubling time: ~30-60 hours (DSMZ=ACC-109).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Fetal thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_K000 ! GM03905
SX   Male
AG   24FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GM07378
AC   CVCL_GR05
SY   GM7378
DR   CLO; CLO_0016932
DR   Coriell; GM07378
DR   Wikidata; Q54842701
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR06 ! GM07379
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07379
AC   CVCL_GR06
DR   CLO; CLO_0016931
DR   Coriell; GM07379
DR   Wikidata; Q54842702
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR05 ! GM07378
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07380
AC   CVCL_0M48
SY   GM07380A
DR   CLO; CLO_0016930
DR   Coriell; GM07380
DR   Wikidata; Q54842703
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07381
AC   CVCL_0M49
DR   CLO; CLO_0016929
DR   Coriell; GM07381
DR   Wikidata; Q54842704
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07381).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.3718-2477C>T (3849+10KB,C>T); ClinVar=VCV000007166; Zygosity=Heterozygous (Coriell=GM07381).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM07382
AC   CVCL_0M50
DR   CLO; CLO_0016938
DR   Coriell; GM07382
DR   Wikidata; Q54842705
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07383
AC   CVCL_0M51
DR   CLO; CLO_0016937
DR   Coriell; GM07383
DR   Wikidata; Q54842706
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07383).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07384
AC   CVCL_0M52
DR   CLO; CLO_0016936
DR   Coriell; GM07384
DR   Wikidata; Q54842707
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07384).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07385
AC   CVCL_0M53
DR   CLO; CLO_0016935
DR   Coriell; GM07385
DR   Wikidata; Q54842708
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07386
AC   CVCL_0M54
DR   CLO; CLO_0016923
DR   Coriell; GM07386
DR   Wikidata; Q54842709
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07387
AC   CVCL_0M55
SY   GM07387A
DR   CLO; CLO_0016925
DR   Coriell; GM07387
DR   Wikidata; Q54842710
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07392
AC   CVCL_GR07
SY   GM7392
DR   CLO; CLO_0016924
DR   Coriell; GM07392
DR   Wikidata; Q54842711
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR08 ! GM07393
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07393
AC   CVCL_GR08
DR   CLO; CLO_0016920
DR   Coriell; GM07393
DR   Wikidata; Q54842712
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR07 ! GM07392
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07394
AC   CVCL_GR09
SY   GM7394
DR   CLO; CLO_0016919
DR   Coriell; GM07394
DR   Wikidata; Q54842713
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2878; Anxiety disorder
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR10 ! GM07395
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07395
AC   CVCL_GR10
DR   CLO; CLO_0016922
DR   Coriell; GM07395
DR   Wikidata; Q54842714
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2878; Anxiety disorder
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR09 ! GM07394
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM07398
AC   CVCL_CW80
SY   GM07398A
DR   CLO; CLO_0016921
DR   Coriell; GM07398
DR   Wikidata; Q54842715
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW77 ! GM06972
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM07399
AC   CVCL_F302
SY   GM07399B
DR   CLO; CLO_0016927
DR   Coriell; GM07399
DR   Wikidata; Q54842716
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   GM07400
AC   CVCL_F303
DR   CLO; CLO_0016926
DR   Coriell; GM07400
DR   Wikidata; Q54842717
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   GM07401
AC   CVCL_F304
SY   GM18023
DR   CLO; CLO_0015533
DR   CLO; CLO_0016928
DR   Coriell; GM07401
DR   Coriell; GM18023
DR   Wikidata; Q54842718
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM07402
AC   CVCL_F305
SY   GM17271
DR   CLO; CLO_0013213
DR   CLO; CLO_0016912
DR   Coriell; GM07402
DR   Coriell; GM17271
DR   GEO; GSM569753
DR   GEO; GSM596335
DR   GEO; GSM596757
DR   GEO; GSM924873
DR   Wikidata; Q54842719
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM07405
AC   CVCL_BT17
DR   CLO; CLO_0016911
DR   Coriell; GM07405
DR   Wikidata; Q54842720
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.93-21G>A (IVS1,G>A,+110); ClinVar=VCV000015454; Zygosity=Homozygous (Coriell=GM07405).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07406
AC   CVCL_BT18
DR   CLO; CLO_0016910
DR   Coriell; GM07406
DR   Wikidata; Q54842721
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.-137C>G (-87C>G); ClinVar=VCV000015464; Zygosity=Heterozygous (Coriell=GM07406).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.93-21G>A (IVS1,G>A,+110); ClinVar=VCV000015454; Zygosity=Heterozygous (Coriell=GM07406).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   GM07407
AC   CVCL_N061
SY   GM07407A; GM17325
DR   CLO; CLO_0013637
DR   CLO; CLO_0016909
DR   Coriell; GM07407
DR   Coriell; GM17325
DR   Wikidata; Q54842722
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.92+1G>A (IVS1,G>A,+1); ClinVar=VCV000015436; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM07407).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.92+6T>C (IVS1,T>C,+6) (IVS I-6 T>C); ClinVar=VCV000015450; Zygosity=Heterozygous (Coriell=GM07407).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   GM07408
AC   CVCL_5N61
DR   CLO; CLO_0016916
DR   Coriell; GM07408
DR   GEO; GSM806
DR   Wikidata; Q54842723
RX   CelloPub=CLPUB00447;
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Karyotypic information: 47,XX,+20 (Coriell=GM07408).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C36397; Trisomy 20
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM07411
AC   CVCL_CZ23
SY   GM7411
DR   CLO; CLO_0016915
DR   Coriell; GM07411
DR   Wikidata; Q54842724
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ24 ! GM07413
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM07412
AC   CVCL_5N62
DR   CLO; CLO_0016914
DR   Coriell; GM07412
DR   Wikidata; Q54842725
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM07413
AC   CVCL_CZ24
DR   CLO; CLO_0016913
DR   Coriell; GM07413
DR   Wikidata; Q54842726
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM07413; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ23 ! GM07411
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM07414
AC   CVCL_X461
SY   GM07414C
DR   CLO; CLO_0016918
DR   Coriell; GM07414
DR   Wikidata; Q54842727
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Ser332Tyrfs*9 (c.994_995insA); ClinVar=VCV000049136; Zygosity=Heterozygous (Coriell=GM07414).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   GM07415
AC   CVCL_X462
SY   GM07415A
DR   CLO; CLO_0016917
DR   Coriell; GM07415
DR   Wikidata; Q54842728
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Ser332Tyrfs*9 (c.994_995insA); ClinVar=VCV000049136; Zygosity=Heterozygous (Coriell=GM07415).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   GM07416
AC   CVCL_5L62
DR   CLO; CLO_0016908
DR   Coriell; GM07416
DR   Wikidata; Q54842729
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   GM07417
AC   CVCL_5L63
DR   CLO; CLO_0016900
DR   Coriell; GM07417
DR   Wikidata; Q54842730
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Ser332Tyrfs*9 (c.994_995insA); ClinVar=VCV000049136; Zygosity=Heterozygous (Coriell=GM07417).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   GM07418
AC   CVCL_5L64
DR   CLO; CLO_0016899
DR   Coriell; GM07418
DR   Wikidata; Q54842731
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Ser332Tyrfs*9 (c.994_995insA); ClinVar=VCV000049136; Zygosity=Heterozygous (Coriell=GM07418).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   GM07419
AC   CVCL_5L65
DR   CLO; CLO_0016902
DR   Coriell; GM07419
DR   Wikidata; Q54842732
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Ser332Tyrfs*9 (c.994_995insA); ClinVar=VCV000049136; Zygosity=Heterozygous (Coriell=GM07419).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   GM07420
AC   CVCL_5L66
DR   CLO; CLO_0016901
DR   Coriell; GM07420
DR   Wikidata; Q54842733
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Ser332Tyrfs*9 (c.994_995insA); ClinVar=VCV000049136; Zygosity=Heterozygous (Coriell=GM07420).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   GM07421
AC   CVCL_5L67
SY   GM07421A
DR   CLO; CLO_0016904
DR   Coriell; GM07421
DR   Wikidata; Q54842734
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Ser332Tyrfs*9 (c.994_995insA); ClinVar=VCV000049136; Zygosity=Heterozygous (Coriell=GM07421).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   GM07422
AC   CVCL_F306
DR   CLO; CLO_0016903
DR   Coriell; GM07422
DR   Wikidata; Q54842735
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   GM07423
AC   CVCL_EJ50
SY   GM7423
DR   CLO; CLO_0016906
DR   Coriell; GM07423
DR   Wikidata; Q54842736
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ51 ! GM07424
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07424
AC   CVCL_EJ51
SY   GM7424Z
DR   CLO; CLO_0016905
DR   Coriell; GM07424
DR   Wikidata; Q54842745
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ50 ! GM07423
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM07425
AC   CVCL_BT19
DR   CLO; CLO_0016907
DR   Coriell; GM07425
DR   Wikidata; Q54842746
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.93-21G>A (IVS1,G>A,+110); ClinVar=VCV000015454; Zygosity=Heterozygous (Coriell=GM07425).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Gln40Ter (c.118C>T) (Q39*); ClinVar=VCV000015402; Zygosity=Heterozygous (Coriell=GM07425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM07426
AC   CVCL_N062
SY   GM17014
DR   CLO; CLO_0016882
DR   CLO; CLO_0018028
DR   Coriell; GM07426
DR   Coriell; GM17014
DR   Wikidata; Q54842747
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Ser73Lysfs*2 (c.217dupA) (c.216_217insA) (insA codons71/72); ClinVar=VCV000015419; Zygosity=Heterozygous (Coriell=GM07426).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-197C>T (IVS2-654C>T); ClinVar=VCV000015458; Zygosity=Heterozygous (Coriell=GM07426).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   GM07427
AC   CVCL_5N63
SY   GM7427
DR   CLO; CLO_0016881
DR   Coriell; GM07427
DR   Wikidata; Q54842748
RX   CelloPub=CLPUB00447;
RX   PubMed=2570029;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3267; Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM07428
AC   CVCL_F307
SY   GM17047; GM17376
DR   CLO; CLO_0013701
DR   CLO; CLO_0014639
DR   CLO; CLO_0016895
DR   Coriell; GM07428
DR   Coriell; GM17047
DR   Coriell; GM17376
DR   Wikidata; Q54842749
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.92+6T>C (IVS1,T>C,+6) (IVS I-6 T>C); ClinVar=VCV000015450; Zygosity=Heterozygous (Coriell=GM07428).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-106C>G (IVS2,C>G,+745); ClinVar=VCV000015457; Zygosity=Heterozygous (Coriell=GM07428).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM07431
AC   CVCL_5B75
DR   CLO; CLO_0016896
DR   Coriell; GM07431
DR   GEO; GSM420584
DR   Wikidata; Q54842750
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07432
AC   CVCL_5B76
DR   CLO; CLO_0016897
DR   Coriell; GM07432
DR   GEO; GSM420585
DR   Wikidata; Q54842751
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329309.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07433
AC   CVCL_5B77
SY   GM07433A
DR   CLO; CLO_0016898
DR   Coriell; GM07433
DR   GEO; GSM420586
DR   Wikidata; Q54842752
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329108.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07434
AC   CVCL_5B78
DR   CLO; CLO_0016891
DR   Coriell; GM07434
DR   GEO; GSM420587
DR   GEO; GSM420588
DR   Wikidata; Q54842753
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329402.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07435
AC   CVCL_R592
DR   CLO; CLO_0016892
DR   Coriell; GM07435
DR   GEO; GSM648834
DR   IGSR; NA07435
DR   Wikidata; Q54842754
RX   CelloPub=CLPUB00447;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1329110/1329210/1329310/1329411.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F52 ! GM13047
OI   CVCL_5F53 ! GM13048
OI   CVCL_5F54 ! GM13049
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM07436
AC   CVCL_5B79
DR   CLO; CLO_0016893
DR   Coriell; GM07436
DR   GEO; GSM420589
DR   Wikidata; Q54842755
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329204.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07437
AC   CVCL_5B80
DR   CLO; CLO_0016894
DR   Coriell; GM07437
DR   GEO; GSM420590
DR   Wikidata; Q54842756
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329306.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07439
AC   CVCL_N063
SY   GM17164
DR   CLO; CLO_0013994
DR   CLO; CLO_0016861
DR   Coriell; GM07439
DR   Coriell; GM17164
DR   GEO; GSM569691
DR   GEO; GSM596229
DR   GEO; GSM597063
DR   GEO; GSM617121
DR   GEO; GSM924674
DR   IPD-IMGT/HLA; 23057
DR   Wikidata; Q54842757
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=29959025;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*29:02,68:02; B*42:02,53:01; C*04:CVAF,17:MN; DRB1*04:03,15:03 (IPD-IMGT/HLA=23057).
CC   HLA typing: A*29:02:01,68:02:01; B*42:02:01,53:01:01; C*04:01:01,17:01:01; DPA1*02:02:02,03:01; DPB1*01:01:01,105:01:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:02:01; DRB1*04:03:01,15:03:01; DRB4*01:03:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM07440
AC   CVCL_X463
DR   CLO; CLO_0016860
DR   Coriell; GM07440
DR   Wikidata; Q54842759
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.489+1G>T (621+1G>T); ClinVar=VCV000038799; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM07441).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.2988+1G>A (3120+1G>A); ClinVar=VCV000007224; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM07441).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   GM07441
AC   CVCL_7466
SY   GM 07441
DR   CLO; CLO_0016859
DR   Coriell; GM07441
DR   GEO; GSM617122
DR   Wikidata; Q54842760
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=16166172;
RX   PubMed=16244288;
RX   PubMed=19359498;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.489+1G>T (621+1G>T); ClinVar=VCV000038799; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM07441).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.2988+1G>A (3120+1G>A); ClinVar=VCV000007224; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM07441).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   GM07444
AC   CVCL_BT20
DR   CLO; CLO_0016877
DR   Coriell; GM07444
DR   Wikidata; Q54842761
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.315+1G>A (IVS2,G>A,+1); ClinVar=VCV000015438; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM07444).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   GM07445
AC   CVCL_BT21
DR   CLO; CLO_0016878
DR   Coriell; GM07445
DR   Wikidata; Q54842762
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Gln40Ter (c.118C>T) (Q39*); ClinVar=VCV000015402; Zygosity=Heterozygous (Coriell=GM07445).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.315+1G>A (IVS2,G>A,+1); ClinVar=VCV000015438; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM07445).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   GM07446
AC   CVCL_5N64
SY   GM07446B
DR   CLO; CLO_0016875
DR   Coriell; GM07446
DR   Wikidata; Q54842763
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM07447
AC   CVCL_W207
SY   GM07447B
DR   CLO; CLO_0016876
DR   Coriell; GM07447
DR   Wikidata; Q54842764
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM07448
AC   CVCL_5N65
SY   GM07448A
DR   CLO; CLO_0016873
DR   Coriell; GM07448
DR   Wikidata; Q54842765
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM07456
AC   CVCL_2T32
DR   CLO; CLO_0016874
DR   Coriell; GM07456
DR   Wikidata; Q54842767
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM07457
AC   CVCL_2T33
DR   CLO; CLO_0016872
DR   Coriell; GM07457
DR   Wikidata; Q54842768
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;21)(1pter->1q12::21q22.3->21qter;21pter->21q22.3::1q12->1qter) (Coriell=GM07457).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07458
AC   CVCL_0M56
DR   CLO; CLO_0016850
DR   Coriell; GM07458
DR   Wikidata; Q54842769
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07459
AC   CVCL_X465
DR   CLO; CLO_0016849
DR   Coriell; GM07459
DR   Wikidata; Q54842770
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM07460
AC   CVCL_0M57
DR   CLO; CLO_0016852
DR   Coriell; GM07460
DR   Wikidata; Q54842771
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07460).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07461
AC   CVCL_0M58
DR   CLO; CLO_0016851
DR   Coriell; GM07461
DR   Wikidata; Q54842772
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg553Ter (c.1657C>T); ClinVar=VCV000007122; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM07462
AC   CVCL_N064
SY   GM18024
DR   CLO; CLO_0015535
DR   CLO; CLO_0016853
DR   Coriell; GM07462
DR   Coriell; GM18024
DR   Wikidata; Q54842773
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM07464
AC   CVCL_0M59
DR   CLO; CLO_0016854
DR   Coriell; GM07464
DR   Wikidata; Q54842774
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg553Ter (c.1657C>T); ClinVar=VCV000007122; Zygosity=Heterozygous (Coriell=GM07464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM07465
AC   CVCL_0M60
DR   CLO; CLO_0016855
DR   Coriell; GM07465
DR   Wikidata; Q54842775
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07466
AC   CVCL_0M61
DR   CLO; CLO_0016856
DR   Coriell; GM07466
DR   Wikidata; Q54842776
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07467
AC   CVCL_0M62
DR   CLO; CLO_0016857
DR   Coriell; GM07467
DR   Wikidata; Q54842777
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07468
AC   CVCL_0M63
DR   CLO; CLO_0016858
DR   Coriell; GM07468
DR   Wikidata; Q54842778
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07469
AC   CVCL_X466
SY   GM07469A
DR   CLO; CLO_0016488
DR   Coriell; GM07469
DR   Wikidata; Q54842780
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07469).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg553Ter (c.1657C>T); ClinVar=VCV000007122; Zygosity=Heterozygous (Coriell=GM07469).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   GM07480
AC   CVCL_0M64
SY   GM07480B
DR   CLO; CLO_0016487
DR   Coriell; GM07480
DR   Wikidata; Q54842781
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07480).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM07482
AC   CVCL_AL17
DR   CLO; CLO_0016485
DR   Coriell; GM07482
DR   Wikidata; Q54842783
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL18 ! GM07483
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM07483
AC   CVCL_AL18
DR   CLO; CLO_0016484
DR   Coriell; GM07483
DR   Wikidata; Q54842784
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AL17 ! GM07482
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07489
AC   CVCL_F668
DR   CLO; CLO_0016483
DR   Coriell; GM07489
DR   Wikidata; Q54842785
RX   PubMed=23665875;
CC   Population: Southeast Asian; Filipino.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C3110; Hydatidiform mole
DI   ORDO; Orphanet_99927; Hydatidiform mole
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13FW
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   GM07490
AC   CVCL_4W20
SY   GM7490
DR   CLO; CLO_0016482
DR   Coriell; GM07490
DR   Wikidata; Q54842786
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98964; Isovaleric acidemia
DI   ORDO; Orphanet_33; Isovaleric acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   GM07491
AC   CVCL_F145
SY   GM17272
DR   CLO; CLO_0013214
DR   CLO; CLO_0016481
DR   Coriell; GM07491
DR   Coriell; GM17272
DR   GEO; GSM569729
DR   GEO; GSM596336
DR   GEO; GSM596758
DR   GEO; GSM924874
DR   Wikidata; Q54842787
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*32:01:01,33:01:01; B*14:02:01,44:02:01; C*05:01:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:01:01,01:01:02; DQB1*05:01:01,05:01:01; DRB1*01:01:01,01:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7467 ! GM07492
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM07492
AC   CVCL_7467
SY   C7492
DR   CLO; CLO_0016480
DR   Coriell; GM07492
DR   GEO; GSM2794412
DR   GEO; GSM3124644
DR   Wikidata; Q54842796
RX   CelloPub=CLPUB00447;
RX   PubMed=29125828;
RX   PubMed=30567591;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; GM07492; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F145 ! GM07491
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM07492 iPSC
AC   CVCL_E4CL
RX   PubMed=29937144;
RX   PubMed=36202854;
CC   Population: Caucasian.
CC   Caution: Some publication, such as PubMed=36202854, term this cell line just "GM07492" which is wrong as this is the name of the parent cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7467 ! GM07492
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GM07492 iPSC GRIN2B LOF
AC   CVCL_E4CM
SY   GM07492 iPSC GRIN2B Loss Of Function
RX   PubMed=29937144;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4CL ! GM07492 iPSC
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GM07492 iPSC GRIN2B RD
AC   CVCL_E4CN
SY   GM07492 iPSC GRIN2B Reduced Dosage
RX   PubMed=29937144;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B; Note=1 of 2 alleles.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4CL ! GM07492 iPSC
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GM07494
AC   CVCL_AY14
DR   CLO; CLO_0016479
DR   Coriell; GM07494
DR   Wikidata; Q54842797
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07495
AC   CVCL_N065
SY   GM18025
DR   CLO; CLO_0015529
DR   CLO; CLO_0016421
DR   Coriell; GM07495
DR   Coriell; GM18025
DR   Wikidata; Q54842798
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM07496
AC   CVCL_AY15
DR   CLO; CLO_0016419
DR   Coriell; GM07496
DR   Wikidata; Q54842799
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07499
AC   CVCL_F308
DR   CLO; CLO_0016420
DR   Coriell; GM07499
DR   Wikidata; Q54842800
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07499).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F300 ! GM06965
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM07500
AC   CVCL_F309
DR   CLO; CLO_0016427
DR   Coriell; GM07500
DR   Wikidata; Q54842801
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F297 ! GM06855
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM07501
AC   CVCL_CY47
DR   CLO; CLO_0016428
DR   Coriell; GM07501
DR   Wikidata; Q54842802
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07501).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CY46 ! GM06964
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM07503
AC   CVCL_2T34
SY   GM07503A
DR   CLO; CLO_0016425
DR   Coriell; GM07503
DR   Wikidata; Q54842803
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian; Portuguese.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM07504
AC   CVCL_9R11
DR   CLO; CLO_0016426
DR   Coriell; GM07504
DR   Wikidata; Q54842804
RX   PubMed=7847674;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35764; Wernicke-Korsakoff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM07505
AC   CVCL_9R12
DR   CLO; CLO_0016423
DR   Coriell; GM07505
DR   Wikidata; Q54842805
RX   PubMed=7847674;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35764; Wernicke-Korsakoff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM07506
AC   CVCL_9R13
DR   CLO; CLO_0016424
DR   Coriell; GM07506
DR   Wikidata; Q54842806
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35764; Wernicke-Korsakoff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM07507
AC   CVCL_9R14
DR   CLO; CLO_0016422
DR   Coriell; GM07507
DR   Wikidata; Q54842807
RX   PubMed=7847674;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35764; Wernicke-Korsakoff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM07508
AC   CVCL_9R15
DR   CLO; CLO_0016409
DR   Coriell; GM07508
DR   Wikidata; Q54842808
RX   PubMed=7847674;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35764; Wernicke-Korsakoff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM07509
AC   CVCL_F310
DR   CLO; CLO_0016410
DR   Coriell; GM07509
DR   Wikidata; Q54842809
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM07510
AC   CVCL_H158
DR   CLO; CLO_0016411
DR   Coriell; GM07510
DR   Wikidata; Q54842810
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM07511
AC   CVCL_F311
SY   GM07511A; GM07511B
DR   CLO; CLO_0016412
DR   Coriell; GM07511
DR   Wikidata; Q54842812
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07511).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM07512
AC   CVCL_F312
DR   CLO; CLO_0016415
DR   Coriell; GM07512
DR   Wikidata; Q54842813
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM07513
AC   CVCL_F313
SY   GM17273
DR   CLO; CLO_0013197
DR   CLO; CLO_0016416
DR   Coriell; GM07513
DR   Coriell; GM17273
DR   GEO; GSM569754
DR   GEO; GSM596337
DR   GEO; GSM596759
DR   GEO; GSM924875
DR   Wikidata; Q54842814
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM07514
AC   CVCL_F314
DR   CLO; CLO_0016417
DR   Coriell; GM07514
DR   Wikidata; Q54842815
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM07515
AC   CVCL_F315
DR   CLO; CLO_0016418
DR   Coriell; GM07515
DR   Wikidata; Q54842817
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM07516
AC   CVCL_CY48
DR   CLO; CLO_0016413
DR   Coriell; GM07516
DR   Wikidata; Q54842818
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07516).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM07517
AC   CVCL_X467
DR   CLO; CLO_0016414
DR   Coriell; GM07517
DR   Wikidata; Q54842819
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1538Ilefs*5 (c.4612_4613delAG) (P1542X); ClinVar=VCV000000823; Zygosity=Unspecified (Coriell=GM07517).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   GM07518
AC   CVCL_N066
SY   GM18026
DR   CLO; CLO_0015530
DR   CLO; CLO_0016439
DR   Coriell; GM07518
DR   Coriell; GM18026
DR   Wikidata; Q54842820
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM07521
AC   CVCL_7468
SY   GM17274
DR   CLO; CLO_0013193
DR   CLO; CLO_0016442
DR   Coriell; GM07521
DR   Coriell; GM17274
DR   GEO; GSM569730
DR   GEO; GSM596338
DR   GEO; GSM596760
DR   GEO; GSM924876
DR   Wikidata; Q54842821
RX   CelloPub=CLPUB00447;
RX   PubMed=18485778;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:05:01,26:01:01; B*38:01:01,58:01:01; C*07:18,12:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*03:01:01,03:01:01; DQB1*03:02:01,03:02:01; DRB1*04:02:01,04:02:01; DRB4*01:03:01,01:03:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Arg296Cys (c.886C>T); ClinVar=VCV000242771; Zygosity=Heterozygous; Note=CYP2D6*2 allele (Coriell=GM17274).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Ser486Thr (c.1457G>C); ClinVar=VCV000242701; Zygosity=Heterozygous; Note=CYP2D6*2 allele (Coriell=GM17274).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F162 ! GM07522
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM07522
AC   CVCL_F162
SY   C7522
DR   CLO; CLO_0016443
DR   Coriell; GM07522
DR   GEO; GSM2794413
DR   Wikidata; Q54842822
RX   CelloPub=CLPUB00447;
RX   PubMed=29125828;
RX   PubMed=32291635;
RX   PubMed=35850241;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Arg296Cys (c.886C>T); ClinVar=VCV000242771; Zygosity=Heterozygous; Note=CYP2D6*2 allele (from autologous cell line GM07521).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Ser486Thr (c.1457G>C); ClinVar=VCV000242701; Zygosity=Heterozygous; Note=CYP2D6*2 allele (from autologous cell line GM07521).
CC   Omics: Lipidomics.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7468 ! GM07521
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   GM07523
AC   CVCL_4F55
DR   CLO; CLO_0016440
DR   Coriell; GM07523
DR   Wikidata; Q54842823
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM07523).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F53 ! GM06125
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM07524
AC   CVCL_7469
SY   GM17275
DR   CLO; CLO_0013202
DR   CLO; CLO_0016441
DR   Coriell; GM07524
DR   Coriell; GM17275
DR   GEO; GSM569731
DR   GEO; GSM596339
DR   GEO; GSM596761
DR   GEO; GSM924877
DR   Wikidata; Q54842824
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,29:02:01; B*13:02:01,44:03:01; C*06:02:01,16:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*02:01:01,02:01:01; DQB1*02:02:01,02:02:01; DRB1*07:01:01,07:01:01; DRB4*01:01:01,01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7470 ! GM07525
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM07525
AC   CVCL_7470
SY   C7525
DR   CLO; CLO_0016446
DR   Coriell; GM07525
DR   GEO; GSM2794414
DR   Wikidata; Q54842825
RX   CelloPub=CLPUB00447;
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7469 ! GM07524
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   GM07526
AC   CVCL_0M65
DR   CLO; CLO_0016447
DR   Coriell; GM07526
DR   Wikidata; Q54842826
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07527
AC   CVCL_N067
SY   GM18027
DR   CLO; CLO_0015598
DR   CLO; CLO_0016444
DR   Coriell; GM07527
DR   Coriell; GM18027
DR   Wikidata; Q54842827
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM07530
AC   CVCL_9R27
DR   CLO; CLO_0016445
DR   Coriell; GM07530
DR   Wikidata; Q54842829
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM07531
AC   CVCL_9R28
DR   CLO; CLO_0016448
DR   Coriell; GM07531
DR   Wikidata; Q54842830
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM07532
AC   CVCL_7471
SY   GM 07532
DR   CLO; CLO_0016429
DR   Coriell; GM07532
DR   GEO; GSM1316985
DR   GEO; GSM1317024
DR   GEO; GSM3124642
DR   Wikidata; Q54842831
RX   CelloPub=CLPUB00447;
RX   PubMed=26984941;
RX   PubMed=30567591;
CC   Population: Caucasian and Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F163 ! GM07533
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM07533
AC   CVCL_F163
DR   CLO; CLO_0016430
DR   Coriell; GM07533
DR   Wikidata; Q54842832
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian and Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7471 ! GM07532
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 12
//
ID   GM07535
AC   CVCL_7472
SY   GM17276
DR   CLO; CLO_0013199
DR   CLO; CLO_0016431
DR   Coriell; GM07535
DR   Coriell; GM17276
DR   GEO; GSM569732
DR   GEO; GSM596340
DR   GEO; GSM596762
DR   GEO; GSM924878
DR   Wikidata; Q54842833
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,29:02:01; B*08:01:01,44:03:01; C*07:01:01,16:01:01; DPA1*02:01:02,02:01:02; DPB1*01:01:01,01:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01; DRB3*01:01:02; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM07536
AC   CVCL_AY16
DR   CLO; CLO_0016432
DR   Coriell; GM07536
DR   Wikidata; Q54842834
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM07542 (Cellosaurus=CVCL_AY22).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM07537
AC   CVCL_AY17
SY   GM07537A
DR   CLO; CLO_0016433
DR   Coriell; GM07537
DR   Wikidata; Q54842835
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[28-29]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>200]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM07538
AC   CVCL_AY18
DR   CLO; CLO_0016434
DR   Coriell; GM07538
DR   Wikidata; Q54842836
RX   CelloPub=CLPUB00447;
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; ClinVar=VCV000009972; Zygosity=Homozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM07539
AC   CVCL_AY19
DR   CLO; CLO_0016435
DR   Coriell; GM07539
DR   Wikidata; Q54842837
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07540
AC   CVCL_AY20
DR   CLO; CLO_0016436
DR   Coriell; GM07540
DR   Wikidata; Q54842838
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07541
AC   CVCL_AY21
DR   CLO; CLO_0016437
DR   Coriell; GM07541
DR   Wikidata; Q54842844
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07542
AC   CVCL_AY22
DR   CLO; CLO_0016438
DR   Coriell; GM07542
DR   Wikidata; Q54842845
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM07536 (Cellosaurus=CVCL_AY16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   GM07543
AC   CVCL_AY23
DR   CLO; CLO_0016388
DR   Coriell; GM07543
DR   Wikidata; Q54842846
RX   CelloPub=CLPUB00447;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[20]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM07544
AC   CVCL_7473
SY   GM 07544; GM17277
DR   CLO; CLO_0013208
DR   CLO; CLO_0016387
DR   Coriell; GM07544
DR   Coriell; GM17277
DR   GEO; GSM569755
DR   GEO; GSM596341
DR   GEO; GSM596811
DR   GEO; GSM924879
DR   Wikidata; Q54842847
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,31:01:02; B*27:05:02,56:01:01; C*01:02:01,02:02:02; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*04:01:01,05:05:01; DQB1*03:01:01,04:02:01; DRB1*08:01:01,11:01:01; DRB3*02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F165 ! GM07545
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM07545
AC   CVCL_F165
DR   CLO; CLO_0016386
DR   Coriell; GM07545
DR   Wikidata; Q54842848
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7473 ! GM07544
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   GM07546
AC   CVCL_N068
SY   GM17075
DR   CLO; CLO_0014606
DR   CLO; CLO_0016385
DR   Coriell; GM07546
DR   Coriell; GM17075
DR   Wikidata; Q54842849
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   HLA typing: A*11:01:01,32:01:01; B*49:01:01,49:01:01; C*07:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:02:01,05:05:01; DQB1*03:01:01,06:02:01; DRB1*11:01:01,15:01:01; DRB3*02:02:01; DRB5*01:01:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM17075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118438; Osteopetrosis with renal tubular acidosis
DI   ORDO; Orphanet_2785; Osteopetrosis with renal tubular acidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   GM07547
AC   CVCL_AW88
DR   CLO; CLO_0016384
DR   Coriell; GM07547
DR   Wikidata; Q54842850
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07548
AC   CVCL_H159
DR   CLO; CLO_0016383
DR   Coriell; GM07548
DR   Wikidata; Q54842851
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM07548; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM07550
AC   CVCL_EJ52
SY   GM7550
DR   CLO; CLO_0016382
DR   Coriell; GM07550
DR   Wikidata; Q54842852
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ53 ! GM07551
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM07551
AC   CVCL_EJ53
SY   GM07551A
DR   CLO; CLO_0016381
DR   Coriell; GM07551
DR   Wikidata; Q54842853
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ52 ! GM07550
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07552
AC   CVCL_V215
SY   GM07552A
DR   CLO; CLO_0016380
DR   Coriell; GM07552
DR   Wikidata; Q54842854
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg553Ter (c.1657C>T); ClinVar=VCV000007122; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM07553
AC   CVCL_0M66
DR   CLO; CLO_0016379
DR   Coriell; GM07553
DR   Wikidata; Q54842855
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07553).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM07554
AC   CVCL_N069
SY   GM07554B; GM17105
DR   CLO; CLO_0014901
DR   CLO; CLO_0016376
DR   Coriell; GM07554
DR   Coriell; GM17105
DR   GEO; GSM273375
DR   GEO; GSM569495
DR   GEO; GSM596173
DR   GEO; GSM596974
DR   GEO; GSM924615
DR   IPD-IMGT/HLA; 20688
DR   Wikidata; Q54842856
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,66:02; B*53:01,58:VE; C*04:CVAF,07:CVAG; DRB1*15:03 (IPD-IMGT/HLA=20688).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM07555
AC   CVCL_F164
DR   CLO; CLO_0016375
DR   Coriell; GM07555
DR   GEO; GSM617123
DR   Wikidata; Q54842857
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM07556
AC   CVCL_0M67
DR   CLO; CLO_0016378
DR   Coriell; GM07556
DR   Wikidata; Q54842858
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM07557
AC   CVCL_0M68
DR   CLO; CLO_0016377
DR   Coriell; GM07557
DR   Wikidata; Q54842859
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM07674
AC   CVCL_0M69
DR   CLO; CLO_0016372
DR   Coriell; GM07674
DR   Wikidata; Q54842860
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg553Ter (c.1657C>T); ClinVar=VCV000007122; Zygosity=Heterozygous (Coriell=GM07674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM07675
AC   CVCL_9R29
DR   CLO; CLO_0016371
DR   Coriell; GM07675
DR   Wikidata; Q54842861
RX   CelloPub=CLPUB00447;
CC   Population: Hispanic.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM07678
AC   CVCL_5B81
AS   CVCL_G413
SY   GM07678A; CEPH-1333-NA07678; 1333-8277
DR   CLO; CLO_0016374
DR   Coriell; GM07678
DR   dbMHC; 48580
DR   GEO; GSM25428
DR   GEO; GSM316486
DR   GEO; GSM316487
DR   GEO; GSM316488
DR   GEO; GSM420591
DR   IHW; IHW01041
DR   IPD-IMGT/HLA; 25841
DR   Wikidata; Q54842863
RX   CelloPub=CLPUB00447;
RX   PubMed=17668376;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133308.
CC   HLA typing: A*01:01:01,24:02; B*39:06:01,58:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*04:01,05:01; DQB1*03:01,04:02; DRB1*08:01,13:03; DRB3*01:01 (IPD-IMGT/HLA=25841).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM07679
AC   CVCL_5B82
SY   GM07679A
DR   CLO; CLO_0016373
DR   Coriell; GM07679
DR   GEO; GSM25429
DR   GEO; GSM316492
DR   GEO; GSM316493
DR   GEO; GSM316494
DR   GEO; GSM420592
DR   Wikidata; Q54842864
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133310.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM07691
AC   CVCL_5N66
SY   GM07691A
DR   CLO; CLO_0016408
DR   Coriell; GM07691
DR   Wikidata; Q54842867
RX   CelloPub=CLPUB00447;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex1-18del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_379; Chronic granulomatous disease
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM07692
AC   CVCL_5N67
SY   GM07692A
DR   CLO; CLO_0016403
DR   Coriell; GM07692
DR   Wikidata; Q54842868
RX   CelloPub=CLPUB00447;
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex1-18del; Zygosity=Heterozygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM07693
AC   CVCL_2T35
SY   GM7693
DR   CLO; CLO_0016402
DR   Coriell; GM07693
DR   Wikidata; Q54842869
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;10)(p11.2;q24.3) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM07694
AC   CVCL_5B83
DR   CLO; CLO_0016401
DR   Coriell; GM07694
DR   GEO; GSM420593
DR   Wikidata; Q54842870
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329205.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM07711
AC   CVCL_N070
SY   GM07711A; GM17382
DR   CLO; CLO_0012203
DR   CLO; CLO_0016400
DR   Coriell; GM07711
DR   Coriell; GM17382
DR   Wikidata; Q54842871
CC   Part of: Human variation panel.
CC   Population: Egyptian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98969; Lactic acidosis
DI   ORDO; Orphanet_17; Fatal infantile lactic acidosis with methylmalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM07712
AC   CVCL_N071
SY   GM18028
DR   CLO; CLO_0015595
DR   CLO; CLO_0016407
DR   Coriell; GM07712
DR   Coriell; GM18028
DR   Wikidata; Q54842872
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM07713
AC   CVCL_W208
SY   GM07713B
DR   CLO; CLO_0016406
DR   Coriell; GM07713
DR   Wikidata; Q54842873
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W209 ! GM08589
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM07726
AC   CVCL_V049
DR   CLO; CLO_0016405
DR   Coriell; GM07726
DR   Wikidata; Q54842874
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V050 ! GM07727
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM07727
AC   CVCL_V050
SY   GM07727A
DR   CLO; CLO_0016404
DR   Coriell; GM07727
DR   Wikidata; Q54842875
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V049 ! GM07726
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM07730
AC   CVCL_AY24
SY   GM07730A
DR   CLO; CLO_0016399
DR   Coriell; GM07730
DR   Wikidata; Q54842876
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM07731
AC   CVCL_0M70
SY   GM07731A
DR   CLO; CLO_0016397
DR   Coriell; GM07731
DR   Wikidata; Q54842877
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07732
AC   CVCL_0M71
SY   GM07732A
DR   CLO; CLO_0016398
DR   Coriell; GM07732
DR   Wikidata; Q54842878
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Glu60Ter (c.178G>T); ClinVar=VCV000038730; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   GM07733
AC   CVCL_0M72
DR   CLO; CLO_0016390
DR   Coriell; GM07733
DR   Wikidata; Q54842879
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07734
AC   CVCL_0M73
DR   CLO; CLO_0016389
DR   Coriell; GM07734
DR   Wikidata; Q54842880
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM07852 (Cellosaurus=CVCL_OM87).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   GM07735
AC   CVCL_N072
SY   GM18029
DR   CLO; CLO_0015566
DR   CLO; CLO_0016392
DR   Coriell; GM07735
DR   Coriell; GM18029
DR   Wikidata; Q54842881
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM07736
AC   CVCL_5N68
DR   CLO; CLO_0016391
DR   Coriell; GM07736
DR   Wikidata; Q54842882
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N52 ! GM06938
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 12
//
ID   GM07743
AC   CVCL_9X05
DR   CLO; CLO_0016394
DR   Coriell; GM07743
DR   Wikidata; Q54842883
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM07744
AC   CVCL_F254
DR   CLO; CLO_0016393
DR   Coriell; GM07744
DR   Wikidata; Q54842884
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 69,XXX.arr[hg19](1-22,X)x3 (Coriell=GM07744).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM07748
AC   CVCL_4H07
SY   GM7748
DR   CLO; CLO_0016396
DR   Coriell; GM07748
DR   Wikidata; Q54842891
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4H08 ! GM07749
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM07749
AC   CVCL_4H08
DR   CLO; CLO_0016395
DR   Coriell; GM07749
DR   Wikidata; Q54842892
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4H07 ! GM07748
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07752
AC   CVCL_7474
SY   GM17278
DR   CLO; CLO_0013204
DR   CLO; CLO_0016350
DR   Coriell; GM07752
DR   Coriell; GM17278
DR   GEO; GSM569733
DR   GEO; GSM596342
DR   GEO; GSM596763
DR   GEO; GSM924880
DR   Wikidata; Q54842893
RX   CelloPub=CLPUB00447;
RX   PubMed=16244288;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM07752).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7475 ! GM07753
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM07753
AC   CVCL_7475
DR   CLO; CLO_0016352
DR   Coriell; GM07753
DR   GEO; GSM3124643
DR   Wikidata; Q54842894
RX   CelloPub=CLPUB00447;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (from autologous cell line GM07752).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7474 ! GM07752
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM07754
AC   CVCL_1K57
DR   CLO; CLO_0016351
DR   Coriell; GM07754
DR   Wikidata; Q54842895
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118437; Glycogen storage disease type VII
DI   ORDO; Orphanet_371; Glycogen storage disease due to muscle phosphofructokinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM07758
AC   CVCL_X464
SY   GM07758A
DR   CLO; CLO_0016357
DR   Coriell; GM07758
DR   Wikidata; Q54842896
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.489+1G>T (621+1G>T); ClinVar=VCV000038799; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM07441).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.2988+1G>A (3120+1G>A); ClinVar=VCV000007224; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM07441).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   GM07773
AC   CVCL_5N69
DR   CLO; CLO_0016358
DR   Coriell; GM07773
DR   Wikidata; Q54842898
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM07774
AC   CVCL_4H09
SY   GM07774A
DR   CLO; CLO_0016359
DR   Coriell; GM07774
DR   Wikidata; Q54842899
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07775
AC   CVCL_4H10
SY   GM07775B
DR   CLO; CLO_0016360
DR   Coriell; GM07775
DR   Wikidata; Q54842900
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07776
AC   CVCL_4H11
SY   GM07776C
DR   CLO; CLO_0016353
DR   Coriell; GM07776
DR   Wikidata; Q54842901
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07777
AC   CVCL_4H12
DR   CLO; CLO_0016354
DR   Coriell; GM07777
DR   Wikidata; Q54842902
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07778
AC   CVCL_4H13
SY   GM07778C
DR   CLO; CLO_0016355
DR   Coriell; GM07778
DR   Wikidata; Q54842903
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07779
AC   CVCL_4H14
SY   GM07779C
DR   CLO; CLO_0010201
DR   Coriell; GM07779
DR   Wikidata; Q54842904
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07781
AC   CVCL_GR11
DR   CLO; CLO_0010202
DR   Coriell; GM07781
DR   Wikidata; Q54842905
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM07783
AC   CVCL_4H15
DR   CLO; CLO_0010203
DR   Coriell; GM07783
DR   Wikidata; Q54842906
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07784
AC   CVCL_4H16
SY   GM07784B
DR   CLO; CLO_0010204
DR   Coriell; GM07784
DR   Wikidata; Q54842908
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07785
AC   CVCL_4H17
DR   CLO; CLO_0010205
DR   Coriell; GM07785
DR   Wikidata; Q54842909
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07786
AC   CVCL_4H18
DR   CLO; CLO_0010206
DR   Coriell; GM07786
DR   Wikidata; Q54842910
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07787
AC   CVCL_4H19
SY   GM07787A
DR   CLO; CLO_0010207
DR   Coriell; GM07787
DR   Wikidata; Q54842911
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07788
AC   CVCL_4H20
SY   GM07788B
DR   CLO; CLO_0010208
DR   Coriell; GM07788
DR   Wikidata; Q54842912
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07789
AC   CVCL_4H21
SY   GM07789B
DR   CLO; CLO_0010209
DR   Coriell; GM07789
DR   Wikidata; Q54842913
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07790
AC   CVCL_4H22
SY   GM07790A; GM07790C
DR   CLO; CLO_0010230
DR   Coriell; GM07790
DR   Wikidata; Q54842914
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78576; Psychosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07791
AC   CVCL_DF27
DR   CLO; CLO_0010220
DR   Coriell; GM07791
DR   Wikidata; Q54842915
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C13375; Chromosome fragile site
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM07792
AC   CVCL_2T36
SY   GM7792
DR   CLO; CLO_0010221
DR   Coriell; GM07792
DR   Wikidata; Q54842916
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;20)(p10;q10) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 12
//
ID   GM07794
AC   CVCL_4H23
DR   CLO; CLO_0010228
DR   Coriell; GM07794
DR   Wikidata; Q54842917
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07795
AC   CVCL_4H24
DR   CLO; CLO_0010229
DR   Coriell; GM07795
DR   Wikidata; Q54842918
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07796
AC   CVCL_4H25
DR   CLO; CLO_0010226
DR   Coriell; GM07796
DR   Wikidata; Q54842919
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07797
AC   CVCL_4H26
DR   CLO; CLO_0010227
DR   Coriell; GM07797
DR   Wikidata; Q54842920
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07798
AC   CVCL_4H27
DR   CLO; CLO_0010224
DR   Coriell; GM07798
DR   Wikidata; Q54842921
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07800
AC   CVCL_4F93
DR   CLO; CLO_0010225
DR   Coriell; GM07800
DR   Wikidata; Q54842922
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F94 ! GM07924
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM07811
AC   CVCL_4H28
DR   CLO; CLO_0010222
DR   Coriell; GM07811
DR   Wikidata; Q54842923
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07812
AC   CVCL_4H29
SY   GM07812A; GM07812B
DR   CLO; CLO_0010223
DR   Coriell; GM07812
DR   Wikidata; Q54842924
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07813
AC   CVCL_4H30
SY   GM07813A; GM07813B
DR   CLO; CLO_0010210
DR   Coriell; GM07813
DR   Wikidata; Q54842925
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07814
AC   CVCL_4H31
DR   CLO; CLO_0010211
DR   Coriell; GM07814
DR   Wikidata; Q54842926
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07815
AC   CVCL_4H32
SY   GM07815B
DR   CLO; CLO_0010212
DR   Coriell; GM07815
DR   Wikidata; Q54842927
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07816
AC   CVCL_4H33
SY   GM07816A; GM07816B
DR   CLO; CLO_0010216
DR   Coriell; GM07816
DR   Wikidata; Q54842928
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07817
AC   CVCL_9X06
DR   CLO; CLO_0010217
DR   Coriell; GM07817
DR   Wikidata; Q54842929
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98978; Meckel-Gruber syndrome
DI   ORDO; Orphanet_564; Meckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM07819
AC   CVCL_W204
DR   CLO; CLO_0010218
DR   Coriell; GM07819
DR   Wikidata; Q54842930
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98969; Lactic acidosis
DI   ORDO; Orphanet_17; Fatal infantile lactic acidosis with methylmalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM07821
AC   CVCL_0M74
DR   CLO; CLO_0010219
DR   Coriell; GM07821
DR   Wikidata; Q54842931
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 11
//
ID   GM07822
AC   CVCL_0M75
DR   CLO; CLO_0010213
DR   Coriell; GM07822
DR   Wikidata; Q54842932
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07822).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07823
AC   CVCL_0M76
DR   CLO; CLO_0010214
DR   Coriell; GM07823
DR   Wikidata; Q54842940
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07823).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07824
AC   CVCL_0M77
DR   CLO; CLO_0010215
DR   Coriell; GM07824
DR   Wikidata; Q54842941
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM07824).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07825
AC   CVCL_0M78
DR   CLO; CLO_0010241
DR   Coriell; GM07825
DR   Wikidata; Q54842942
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07826
AC   CVCL_0M79
SY   GM07826A
DR   CLO; CLO_0010239
DR   Coriell; GM07826
DR   Wikidata; Q54842943
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM07826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07827
AC   CVCL_0M80
SY   GM07827A
DR   CLO; CLO_0010245
DR   Coriell; GM07827
DR   Wikidata; Q54842945
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07828
AC   CVCL_0M81
DR   CLO; CLO_0010244
DR   Coriell; GM07828
DR   Wikidata; Q54842946
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07828).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07829
AC   CVCL_0M82
SY   GM07829A
DR   CLO; CLO_0010236
DR   Coriell; GM07829
DR   Wikidata; Q54842947
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile142Phefs*11 (c.424delA) (556delA); ClinVar=VCV000007146; Zygosity=Heterozygous (Coriell=GM07829).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM07830
AC   CVCL_0M83
DR   CLO; CLO_0010235
DR   Coriell; GM07830
DR   Wikidata; Q54842948
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile142Phefs*11 (c.424delA) (556delA); ClinVar=VCV000007146; Zygosity=Heterozygous (Coriell=GM07830).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM07830).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM07831
AC   CVCL_0M84
DR   CLO; CLO_0010238
DR   Coriell; GM07831
DR   Wikidata; Q54842949
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07832
AC   CVCL_0M85
DR   CLO; CLO_0010237
DR   Coriell; GM07832
DR   Wikidata; Q54842950
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07835
AC   CVCL_4H34
DR   CLO; CLO_0010233
DR   Coriell; GM07835
DR   Wikidata; Q54842951
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07836
AC   CVCL_4J06
DR   CLO; CLO_0010232
DR   Coriell; GM07836
DR   Wikidata; Q54842952
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07837
AC   CVCL_4H35
DR   CLO; CLO_0010267
DR   Coriell; GM07837
DR   Wikidata; Q54842953
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07840
AC   CVCL_4H36
DR   CLO; CLO_0010265
DR   Coriell; GM07840
DR   Wikidata; Q54842954
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07841
AC   CVCL_9X07
DR   CLO; CLO_0010263
DR   Coriell; GM07841
DR   Wikidata; Q54842955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM07842
AC   CVCL_4F56
SY   GM07842A
DR   CLO; CLO_0010261
DR   Coriell; GM07842
DR   Wikidata; Q54842956
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM07842).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM07843
AC   CVCL_CW81
DR   CLO; CLO_0010258
DR   Coriell; GM07843
DR   Wikidata; Q54842957
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4801; HADHA; Simple; p.Glu510Gln (c.1528G>C); ClinVar=VCV000100085; Zygosity=Homozygous (Coriell=GM07843).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129929; Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_5; Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM07844
AC   CVCL_4F57
DR   CLO; CLO_0010257
DR   Coriell; GM07844
DR   Wikidata; Q54842958
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM07844).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM07845
AC   CVCL_4H37
DR   CLO; CLO_0010256
DR   Coriell; GM07845
DR   Wikidata; Q54842959
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07846
AC   CVCL_4H38
SY   GM07846A
DR   CLO; CLO_0010255
DR   Coriell; GM07846
DR   Wikidata; Q54842960
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07847
AC   CVCL_4H39
SY   GM07847A
DR   CLO; CLO_0010254
DR   Coriell; GM07847
DR   Wikidata; Q54842961
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07848
AC   CVCL_4H40
SY   GM07848A
DR   CLO; CLO_0010253
DR   Coriell; GM07848
DR   Wikidata; Q54842962
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07849
AC   CVCL_4H41
DR   CLO; CLO_0010281
DR   Coriell; GM07849
DR   Wikidata; Q54842963
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07850
AC   CVCL_0M86
DR   CLO; CLO_0010279
DR   Coriell; GM07850
DR   Wikidata; Q54842964
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07852
AC   CVCL_0M87
DR   CLO; CLO_0010286
DR   Coriell; GM07852
DR   Wikidata; Q54842965
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM07734 (Cellosaurus=CVCL_0M73).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   GM07853
AC   CVCL_0M88
DR   CLO; CLO_0010283
DR   Coriell; GM07853
DR   Wikidata; Q54842966
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07854
AC   CVCL_0M89
SY   GM07854B
DR   CLO; CLO_0010289
DR   Coriell; GM07854
DR   Wikidata; Q54842967
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Met1101Lys (c.3302T>A); ClinVar=VCV000039516; Zygosity=Heterozygous (Coriell=GM07854).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM07854; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07855
AC   CVCL_0M90
DR   CLO; CLO_0010287
DR   Coriell; GM07855
DR   Wikidata; Q54842968
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07856
AC   CVCL_0M91
SY   GM07856A
DR   CLO; CLO_0010275
DR   Coriell; GM07856
DR   Wikidata; Q54842969
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07857
AC   CVCL_0M92
DR   CLO; CLO_0010274
DR   Coriell; GM07857
DR   Wikidata; Q54842970
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Met1101Lys (c.3302T>A); ClinVar=VCV000039516; Zygosity=Homozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM07858
AC   CVCL_0M93
DR   CLO; CLO_0010277
DR   Coriell; GM07858
DR   Wikidata; Q54842971
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07859
AC   CVCL_0M94
SY   GM07859C
DR   CLO; CLO_0010276
DR   Coriell; GM07859
DR   Wikidata; Q54842972
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07860
AC   CVCL_0M95
SY   GM07860A
DR   CLO; CLO_0010302
DR   Coriell; GM07860
DR   Wikidata; Q54842973
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Met1101Lys (c.3302T>A); ClinVar=VCV000039516; Zygosity=Homozygous (Coriell=GM07860).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM07861
AC   CVCL_AY25
DR   CLO; CLO_0010301
DR   Coriell; GM07861
DR   Wikidata; Q54842974
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[351-400]; ClinVar=VCV000009972; Zygosity=Hemizygous (Coriell=GM07861).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM07862 (Cellosaurus=CVCL_AY26).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07862
AC   CVCL_AY26
DR   CLO; CLO_0010299
DR   Coriell; GM07862
DR   Wikidata; Q54842975
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[501-550]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM07861 (Cellosaurus=CVCL_AY25).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07863
AC   CVCL_5N70
DR   CLO; CLO_0010309
DR   Coriell; GM07863
DR   Wikidata; Q54842976
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM07873
AC   CVCL_5N71
DR   CLO; CLO_0010307
DR   Coriell; GM07873
DR   Wikidata; Q54842977
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2W
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM07874
AC   CVCL_4H42
DR   CLO; CLO_0010305
DR   Coriell; GM07874
DR   Wikidata; Q54842978
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07875
AC   CVCL_4H43
DR   CLO; CLO_0010303
DR   Coriell; GM07875
DR   Wikidata; Q54842979
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07876
AC   CVCL_4H44
DR   CLO; CLO_0010297
DR   Coriell; GM07876
DR   Wikidata; Q54842980
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07890
AC   CVCL_V283
SY   GM 7890
DR   CLO; CLO_0010296
DR   Coriell; GM07890
DR   Wikidata; Q54842985
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM07891
AC   CVCL_2T37
DR   CLO; CLO_0010295
DR   Coriell; GM07891
DR   Wikidata; Q54842987
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM07892
AC   CVCL_GR12
DR   CLO; CLO_0010315
DR   Coriell; GM07892
DR   Wikidata; Q54842988
RX   CelloPub=CLPUB00447;
RX   PubMed=25187577;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Unexplicit; Exon 41 acceptor site T>C substitution; Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32FW
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM07893
AC   CVCL_0Q61
DR   CLO; CLO_0010316
DR   Coriell; GM07893
DR   Wikidata; Q54842989
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,der(6)(6qter->6p25::4q31.3->4qter)mat (Coriell=GM07893).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q62 ! GM07901
SX   Male
AG   23FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM07895
AC   CVCL_N073
SY   GM17024; GM 7895; GM7895
DR   CLO; CLO_0010317
DR   CLO; CLO_0014704
DR   Coriell; GM07895
DR   Coriell; GM17024
DR   Wikidata; Q54842990
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Indo Pakistani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM07901
AC   CVCL_0Q62
DR   CLO; CLO_0010318
DR   Coriell; GM07901
DR   Wikidata; Q54842991
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q61 ! GM07893
SX   Male
AG   23FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   GM07902
AC   CVCL_0M96
DR   CLO; CLO_0010311
DR   Coriell; GM07902
DR   Wikidata; Q54842992
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from familial inference of GM07904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM07904 (Cellosaurus=CVCL_OM98).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM07903
AC   CVCL_0M97
DR   CLO; CLO_0010312
DR   Coriell; GM07903
DR   Wikidata; Q54842993
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM07904
AC   CVCL_0M98
DR   CLO; CLO_0010313
DR   Coriell; GM07904
DR   Wikidata; Q54842994
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM07904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM07902 (Cellosaurus=CVCL_OM96).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM07905
AC   CVCL_N074
SY   GM17165
DR   CLO; CLO_0010314
DR   CLO; CLO_0013993
DR   Coriell; GM07905
DR   Coriell; GM17165
DR   GEO; GSM569692
DR   GEO; GSM596230
DR   GEO; GSM597064
DR   GEO; GSM924675
DR   IPD-IMGT/HLA; 15809
DR   Wikidata; Q54842995
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:CNJK,30:02; B*37:01,49:01; C*06:02,07:CVAG; DRB1*07:01,11:01 (IPD-IMGT/HLA=15809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM07908
AC   CVCL_2T38
DR   CLO; CLO_0010319
DR   Coriell; GM07908
DR   Wikidata; Q54842996
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07912
AC   CVCL_1Q33
DR   CLO; CLO_0010320
DR   Coriell; GM07912
DR   Wikidata; Q54842997
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM07913
AC   CVCL_1Q32
DR   CLO; CLO_0010321
DR   Coriell; GM07913
DR   Wikidata; Q54842998
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM07924
AC   CVCL_4F94
DR   CLO; CLO_0010328
DR   Coriell; GM07924
DR   Wikidata; Q54842999
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F93 ! GM07800
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07938
AC   CVCL_2N11
DR   CLO; CLO_0010329
DR   Coriell; GM07938
DR   Wikidata; Q54843000
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N12 ! GM07978
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM07939
AC   CVCL_5N72
DR   CLO; CLO_0010326
DR   Coriell; GM07939
DR   Wikidata; Q54843002
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM07941
AC   CVCL_1N64
DR   CLO; CLO_0010327
DR   Coriell; GM07941
DR   Wikidata; Q54843003
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM07942
AC   CVCL_4H45
DR   CLO; CLO_0010324
DR   Coriell; GM07942
DR   Wikidata; Q54843004
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07943
AC   CVCL_4H46
SY   GM07943A
DR   CLO; CLO_0010325
DR   Coriell; GM07943
DR   Wikidata; Q54843005
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07944
AC   CVCL_4H47
SY   GM07944B
DR   CLO; CLO_0010322
DR   Coriell; GM07944
DR   Wikidata; Q54843006
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07945
AC   CVCL_5N73
DR   CLO; CLO_0010323
DR   Coriell; GM07945
DR   Wikidata; Q54843007
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM07947
AC   CVCL_5N74
SY   GM07947B
DR   CLO; CLO_0010330
DR   Coriell; GM07947
DR   Wikidata; Q54843008
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; 5'end-Ex19del; Zygosity=Hemizygous (Coriell=GM07947).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_379; Chronic granulomatous disease
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM07948
AC   CVCL_4H48
SY   GM07948A
DR   CLO; CLO_0010332
DR   Coriell; GM07948
DR   Wikidata; Q54843009
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07949
AC   CVCL_4H49
SY   GM07949B
DR   CLO; CLO_0010331
DR   Coriell; GM07949
DR   Wikidata; Q54843010
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM07964
AC   CVCL_2T39
DR   CLO; CLO_0010333
DR   Coriell; GM07964
DR   Wikidata; Q54843011
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM07965
AC   CVCL_1Q38
DR   CLO; CLO_0010334
DR   Coriell; GM07965
DR   Wikidata; Q54843012
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM07966
AC   CVCL_2T40
DR   CLO; CLO_0010335
DR   Coriell; GM07966
DR   Wikidata; Q54843013
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM07968
AC   CVCL_0R34
SY   GM7968
DR   CLO; CLO_0010336
DR   Coriell; GM07968
DR   Wikidata; Q54843014
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (Coriell=GM07968).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM07970
AC   CVCL_2T41
DR   CLO; CLO_0010337
DR   Coriell; GM07970
DR   Wikidata; Q54843015
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+der(9)(9pter->9q13::Yq12->Yqter)pat (Coriell=GM07970).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07971
AC   CVCL_2T42
DR   CLO; CLO_0010338
DR   Coriell; GM07971
DR   Wikidata; Q54843016
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(Y;9)(Ypter->Yq12::9q13->9qter;9pter->9q13::Yq12->Yqter) (Coriell=GM07971).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07973
AC   CVCL_F316
SY   GM17279
DR   CLO; CLO_0010339
DR   CLO; CLO_0013210
DR   Coriell; GM07973
DR   Coriell; GM17279
DR   GEO; GSM569756
DR   GEO; GSM596343
DR   GEO; GSM596812
DR   GEO; GSM924881
DR   Wikidata; Q54843017
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,39:01:01; C*07:01:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*04:01:01,05:01:01; DQB1*02:01:01,04:02:01; DRB1*03:01:01,08:01:01; DRB3*01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   GM07974
AC   CVCL_AI35
DR   CLO; CLO_0010340
DR   Coriell; GM07974
DR   Wikidata; Q54843018
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07975
AC   CVCL_AI36
DR   CLO; CLO_0010006
DR   Coriell; GM07975
DR   Wikidata; Q54843019
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07976
AC   CVCL_AI37
DR   CLO; CLO_0010005
DR   Coriell; GM07976
DR   Wikidata; Q54843021
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07977
AC   CVCL_AI38
DR   CLO; CLO_0010008
DR   Coriell; GM07977
DR   Wikidata; Q54843023
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07978
AC   CVCL_2N12
DR   CLO; CLO_0010007
DR   Coriell; GM07978
DR   Wikidata; Q54843024
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;6)(4pter->4q31.3::6p25->6pter;6qter->6p25::4q31.3->4qter) (Coriell=GM07978).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N11 ! GM07938
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM07981
AC   CVCL_5N75
SY   GM07981A
DR   CLO; CLO_0010002
DR   Coriell; GM07981
DR   Wikidata; Q54843025
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM07982
AC   CVCL_V341
SY   GM7982
DR   CLO; CLO_0010001
DR   Coriell; GM07982
DR   Wikidata; Q54843026
RX   CelloPub=CLPUB00447;
RX   PubMed=11738860;
RX   PubMed=12418965;
RX   PubMed=21966470;
RX   PubMed=29742391;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (PubMed=11738860).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V342 ! GM07983
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM07983
AC   CVCL_V342
DR   CLO; CLO_0010004
DR   Coriell; GM07983
DR   Wikidata; Q54843027
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (Coriell=GM07983).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V341 ! GM07982
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM07985
AC   CVCL_5N76
DR   CLO; CLO_0010003
DR   Coriell; GM07985
DR   Wikidata; Q54843028
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM07986
AC   CVCL_AI39
DR   CLO; CLO_0010050
DR   Coriell; GM07986
DR   Wikidata; Q54843034
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM07987
AC   CVCL_2T43
DR   CLO; CLO_0010049
DR   Coriell; GM07987
DR   Wikidata; Q54843035
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM07991
AC   CVCL_IZ59
DR   CLO; CLO_0010048
DR   Coriell; GM07991
DR   Wikidata; Q54843036
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C131652; Triosephosphate isomerase deficiency
DI   ORDO; Orphanet_868; Triose phosphate-isomerase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM07992
AC   CVCL_9R50
DR   CLO; CLO_0010042
DR   Coriell; GM07992
DR   Wikidata; Q54843037
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM07993
AC   CVCL_5N77
DR   Coriell; GM07993
DR   Wikidata; Q54843038
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM07993; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM07994
AC   CVCL_2T44
DR   CLO; CLO_0010043
DR   Coriell; GM07994
DR   Wikidata; Q54843039
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM07995
AC   CVCL_5N78
DR   CLO; CLO_0010040
DR   Coriell; GM07995
DR   Wikidata; Q54843040
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM08007
AC   CVCL_AI40
DR   CLO; CLO_0010041
DR   Coriell; GM08007
DR   Wikidata; Q54843042
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08008
AC   CVCL_AI41
DR   CLO; CLO_0010046
DR   Coriell; GM08008
DR   Wikidata; Q54843043
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI33 ! GM04421
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08009
AC   CVCL_2T45
DR   CLO; CLO_0010047
DR   Coriell; GM08009
DR   Wikidata; Q54843044
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM08010
AC   CVCL_5M39
SY   GM0810A
DR   CLO; CLO_0010044
DR   Coriell; GM08010
DR   Wikidata; Q54843046
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3W
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM08012
AC   CVCL_2T46
DR   CLO; CLO_0010039
DR   Coriell; GM08012
DR   Wikidata; Q54843047
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM08014
AC   CVCL_5M40
DR   CLO; CLO_0010037
DR   Coriell; GM08014
DR   Wikidata; Q54843048
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM08015
AC   CVCL_5M41
DR   CLO; CLO_0010038
DR   Coriell; GM08015
DR   Wikidata; Q54843049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM08019
AC   CVCL_0Q05
DR   CLO; CLO_0010029
DR   Coriell; GM08019
DR   Wikidata; Q54843050
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM08024
AC   CVCL_IK46
DR   CLO; CLO_0010030
DR   Coriell; GM08024
DR   Wikidata; Q54843051
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C103144; Perlman syndrome
DI   ORDO; Orphanet_2849; Perlman syndrom
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30FW
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM08035
AC   CVCL_5N79
DR   CLO; CLO_0010031
DR   Coriell; GM08035
DR   Wikidata; Q54843052
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+i(12)(pter->p10::p10->pter) (Coriell=GM08035).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM08036
AC   CVCL_F317
SY   GM17280
DR   CLO; CLO_0010032
DR   CLO; CLO_0013096
DR   Coriell; GM08036
DR   Coriell; GM17280
DR   GEO; GSM89122
DR   GEO; GSM569757
DR   GEO; GSM596344
DR   GEO; GSM596764
DR   GEO; GSM924882
DR   Wikidata; Q54843053
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,11:01:01; B*08:01:01,18:01:01; C*07:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,11:04:01; DRB3*01:01:02,02:02:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM08036).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 22
//
ID   GM08037
AC   CVCL_0Q04
DR   CLO; CLO_0010033
DR   Coriell; GM08037
DR   GEO; GSM89123
DR   Wikidata; Q54843054
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM08037).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   GM08039
AC   CVCL_5N80
DR   CLO; CLO_0010034
DR   Coriell; GM08039
DR   Wikidata; Q54843055
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM08040
AC   CVCL_4F58
DR   CLO; CLO_0010035
DR   Coriell; GM08040
DR   Wikidata; Q54843056
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM08041
AC   CVCL_AI42
DR   CLO; CLO_0010036
DR   Coriell; GM08041
DR   Wikidata; Q54843057
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08070
AC   CVCL_2T47
DR   CLO; CLO_0010024
DR   Coriell; GM08070
DR   Wikidata; Q54843058
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM08071
AC   CVCL_AI43
DR   CLO; CLO_0010025
DR   Coriell; GM08071
DR   Wikidata; Q54843059
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08072
AC   CVCL_AI44
DR   CLO; CLO_0010022
DR   Coriell; GM08072
DR   Wikidata; Q54843060
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08073
AC   CVCL_AI45
DR   CLO; CLO_0010023
DR   Coriell; GM08073
DR   Wikidata; Q54843061
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08079
AC   CVCL_1K58
DR   CLO; CLO_0010020
DR   Coriell; GM08079
DR   Wikidata; Q54843062
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM08083
AC   CVCL_AI46
DR   CLO; CLO_0010021
DR   Coriell; GM08083
DR   Wikidata; Q54843063
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08084
AC   CVCL_AI47
DR   CLO; CLO_0010019
DR   Coriell; GM08084
DR   Wikidata; Q54843064
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08085
AC   CVCL_AI48
SY   GM08085A
DR   CLO; CLO_0010015
DR   Coriell; GM08085
DR   Wikidata; Q54843065
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08086
AC   CVCL_AI49
DR   CLO; CLO_0010016
DR   Coriell; GM08086
DR   Wikidata; Q54843067
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08087
AC   CVCL_AI50
DR   CLO; CLO_0010017
DR   Coriell; GM08087
DR   Wikidata; Q54843068
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08088
AC   CVCL_AI51
DR   CLO; CLO_0010018
DR   Coriell; GM08088
DR   Wikidata; Q54843069
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08089
AC   CVCL_AI52
DR   CLO; CLO_0010011
DR   Coriell; GM08089
DR   Wikidata; Q54843070
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08090
AC   CVCL_AI53
DR   CLO; CLO_0010012
DR   Coriell; GM08090
DR   Wikidata; Q54843071
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08091
AC   CVCL_AI54
SY   GM08091A
DR   CLO; CLO_0010013
DR   Coriell; GM08091
DR   Wikidata; Q54843072
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08092
AC   CVCL_6G91
DR   CLO; CLO_0010014
DR   Coriell; GM08092
DR   Wikidata; Q54843073
CC   Population: Cuban.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5Q73 ! GM16595
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM08093
AC   CVCL_5N81
DR   CLO; CLO_0010009
DR   Coriell; GM08093
DR   Wikidata; Q54843074
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM08100
AC   CVCL_N075
SY   GM8100; GM17383
DR   CLO; CLO_0010010
DR   CLO; CLO_0012174
DR   Coriell; GM08100
DR   Coriell; GM17383
DR   Wikidata; Q54843075
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Egyptian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84523; HMG-CoA lyase deficiency
DI   ORDO; Orphanet_20; 3-hydroxy-3-methylglutaric aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM08106
AC   CVCL_AI55
DR   CLO; CLO_0010103
DR   Coriell; GM08106
DR   Wikidata; Q54843076
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08107
AC   CVCL_AI56
SY   GM08107B
DR   CLO; CLO_0010095
DR   Coriell; GM08107
DR   Wikidata; Q54843084
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08108
AC   CVCL_0Q84
SY   GM8108
DR   CLO; CLO_0010094
DR   Coriell; GM08108
DR   Wikidata; Q54843085
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM08121
AC   CVCL_1K04
DR   CLO; CLO_0010099
DR   Coriell; GM08121
DR   Wikidata; Q54843086
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM08122
AC   CVCL_2T48
DR   CLO; CLO_0010097
DR   Coriell; GM08122
DR   Wikidata; Q54843087
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;11)(2pter->2q14.2::11q25->11qter;11pter->11q25::2q14.2->2qter) (Coriell=GM08122).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM08123
AC   CVCL_2T49
DR   CLO; CLO_0010108
DR   Coriell; GM08123
DR   Wikidata; Q54843088
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM08134
AC   CVCL_2T50
DR   CLO; CLO_0010107
DR   Coriell; GM08134
DR   Wikidata; Q54843089
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM08135
AC   CVCL_2T51
SY   GM8135
DR   CLO; CLO_0010110
DR   Coriell; GM08135
DR   Wikidata; Q54843090
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;21)(q22.3;q11) (PubMed=10377420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM08145
AC   CVCL_6G92
DR   CLO; CLO_0010109
DR   Coriell; GM08145
DR   Wikidata; Q54843091
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G93 ! GM08148
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM08146
AC   CVCL_5N82
DR   CLO; CLO_0010106
DR   Coriell; GM08146
DR   Wikidata; Q54843092
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM08147
AC   CVCL_AT08
DR   CLO; CLO_0010124
DR   Coriell; GM08147
DR   Wikidata; Q54843093
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,9qh- (Coriell=GM08147).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   GM08148
AC   CVCL_6G93
DR   CLO; CLO_0010122
DR   Coriell; GM08148
DR   Wikidata; Q54843094
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G92 ! GM08145
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM08154
AC   CVCL_4F92
DR   CLO; CLO_0010120
DR   Coriell; GM08154
DR   Wikidata; Q54843095
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F91 ! GM05156
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM08177
AC   CVCL_JF45
DR   CLO; CLO_0010118
DR   Coriell; GM08177
DR   Wikidata; Q54843096
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84598; Biotinidase deficiency
DI   ORDO; Orphanet_79241; Biotinidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM08196
AC   CVCL_GR13
DR   CLO; CLO_0010116
DR   Coriell; GM08196
DR   Wikidata; Q54843097
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR14 ! GM08197
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM08197
AC   CVCL_GR14
DR   CLO; CLO_0010114
DR   Coriell; GM08197
DR   Wikidata; Q54843098
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR13 ! GM08196
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM08205
AC   CVCL_4D93
DR   CLO; CLO_0010130
DR   Coriell; GM08205
DR   Wikidata; Q54843099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM08206
AC   CVCL_1N82
DR   CLO; CLO_0010129
DR   Coriell; GM08206
DR   Wikidata; Q54843100
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY.arr(1-22)x2,(XY)x1 (Coriell=GM08206).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM08210
AC   CVCL_1Q56
DR   CLO; CLO_0010127
DR   Coriell; GM08210
DR   Wikidata; Q54843102
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM08211
AC   CVCL_0M99
DR   CLO; CLO_0010055
DR   Coriell; GM08211
DR   Wikidata; Q54843103
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM08228
AC   CVCL_N076
SY   GM17227
DR   CLO; CLO_0010058
DR   CLO; CLO_0014358
DR   Coriell; GM08228
DR   Coriell; GM17227
DR   GEO; GSM569591
DR   GEO; GSM596291
DR   GEO; GSM596651
DR   GEO; GSM924829
DR   Wikidata; Q54843104
RX   PubMed=20889555;
RX   PubMed=26621101;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,40:02:01; C*02:02:02,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:04:01; DRB1*03:01:01,13:02:01; DRB3*01:01:02,03:01:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Lys281del (c.841_843delAAG) (2613_2615delAGA); ClinVar=VCV000039396; Zygosity=Heterozygous; Note=CYP2D6*9 allele (Coriell=GM17227).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM08246
AC   CVCL_IK47
DR   CLO; CLO_0010056
DR   Coriell; GM08246
DR   Wikidata; Q54843105
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C103144; Perlman syndrome
DI   ORDO; Orphanet_2849; Perlman syndrom
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM08247
AC   CVCL_EJ54
DR   CLO; CLO_0010063
DR   Coriell; GM08247
DR   Wikidata; Q54843106
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM08254
AC   CVCL_2T52
DR   CLO; CLO_0010060
DR   Coriell; GM08254
DR   Wikidata; Q54843107
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM08256
AC   CVCL_8A55
DR   CLO; CLO_0010067
DR   Coriell; GM08256
DR   Wikidata; Q54843108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98940; Hereditary factor X deficiency
DI   ORDO; Orphanet_328; Congenital factor X deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM08263
AC   CVCL_2T53
DR   CLO; CLO_0010064
DR   Coriell; GM08263
DR   Wikidata; Q54843109
RX   PubMed=23665875;
CC   Population: Hispanic.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM08271
AC   CVCL_7476
SY   GM18030
DR   CLO; CLO_0010069
DR   CLO; CLO_0015576
DR   Coriell; GM08271
DR   Coriell; GM18030
DR   Wikidata; Q54843110
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM08272
AC   CVCL_4J07
DR   CLO; CLO_0010068
DR   Coriell; GM08272
DR   Wikidata; Q54843111
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4G17 ! GM05910
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM08273
AC   CVCL_AI57
DR   CLO; CLO_0010070
DR   Coriell; GM08273
DR   Wikidata; Q54843112
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08274
AC   CVCL_AI58
DR   CLO; CLO_0010080
DR   Coriell; GM08274
DR   Wikidata; Q54843113
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08275
AC   CVCL_AI59
DR   CLO; CLO_0010079
DR   Coriell; GM08275
DR   Wikidata; Q54843114
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08276
AC   CVCL_AI60
DR   CLO; CLO_0010078
DR   Coriell; GM08276
DR   Wikidata; Q54843115
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08277
AC   CVCL_AI61
DR   CLO; CLO_0010076
DR   Coriell; GM08277
DR   Wikidata; Q54843116
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08278
AC   CVCL_AI62
DR   CLO; CLO_0010087
DR   Coriell; GM08278
DR   Wikidata; Q54843117
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08279
AC   CVCL_AI63
DR   CLO; CLO_0010086
DR   Coriell; GM08279
DR   Wikidata; Q54843118
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08280
AC   CVCL_AI64
DR   CLO; CLO_0010083
DR   Coriell; GM08280
DR   Wikidata; Q54843119
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08281
AC   CVCL_AI65
DR   CLO; CLO_0010082
DR   Coriell; GM08281
DR   Wikidata; Q54843120
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08282
AC   CVCL_AI66
DR   CLO; CLO_0010090
DR   Coriell; GM08282
DR   Wikidata; Q54843122
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08283
AC   CVCL_AI67
DR   CLO; CLO_0010089
DR   Coriell; GM08283
DR   Wikidata; Q54843123
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08284
AC   CVCL_AI68
DR   CLO; CLO_0010151
DR   Coriell; GM08284
DR   Wikidata; Q54843124
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08285
AC   CVCL_AI69
DR   CLO; CLO_0010157
DR   Coriell; GM08285
DR   Wikidata; Q54843131
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08286
AC   CVCL_AI70
DR   CLO; CLO_0010158
DR   Coriell; GM08286
DR   Wikidata; Q54843132
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08287
AC   CVCL_AI71
DR   CLO; CLO_0010159
DR   Coriell; GM08287
DR   Wikidata; Q54843133
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08288
AC   CVCL_N077
SY   GM18031
DR   CLO; CLO_0010160
DR   CLO; CLO_0015581
DR   Coriell; GM08288
DR   Coriell; GM18031
DR   Wikidata; Q54843134
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: Human variation panel.
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 12
//
ID   GM08289
AC   CVCL_AI72
DR   CLO; CLO_0010153
DR   Coriell; GM08289
DR   Wikidata; Q54843135
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08290
AC   CVCL_AI73
DR   CLO; CLO_0010154
DR   Coriell; GM08290
DR   Wikidata; Q54843136
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08291
AC   CVCL_AI74
DR   CLO; CLO_0010155
DR   Coriell; GM08291
DR   Wikidata; Q54843137
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08292
AC   CVCL_AI75
DR   CLO; CLO_0010156
DR   Coriell; GM08292
DR   Wikidata; Q54843138
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08296
AC   CVCL_X469
DR   CLO; CLO_0010152
DR   Coriell; GM08296
DR   Wikidata; Q54843139
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Pro824Alafs*59 (c.2468dupT); ClinVar=VCV000050183; Zygosity=Unspecified (Coriell=GM08296).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   GM08297
AC   CVCL_N078
SY   GM18032
DR   CLO; CLO_0010562
DR   CLO; CLO_0015582
DR   Coriell; GM08297
DR   Coriell; GM18032
DR   Wikidata; Q54843141
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM08298
AC   CVCL_5L68
DR   CLO; CLO_0010564
DR   Coriell; GM08298
DR   Wikidata; Q54843142
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM08299
AC   CVCL_X470
DR   CLO; CLO_0010563
DR   Coriell; GM08299
DR   Wikidata; Q54843143
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Pro824Alafs*59 (c.2468dupT); ClinVar=VCV000050183; Zygosity=Unspecified (Coriell=GM08299).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   GM08300
AC   CVCL_X471
DR   CLO; CLO_0010566
DR   Coriell; GM08300
DR   Wikidata; Q54843144
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Pro824Alafs*59 (c.2468dupT); ClinVar=VCV000050183; Zygosity=Unspecified (Coriell=GM08300).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   GM08304
AC   CVCL_2Z60
DR   CLO; CLO_0010565
DR   Coriell; GM08304
DR   Wikidata; Q54843145
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM08329
AC   CVCL_N042
DR   CLO; CLO_0010568
DR   Coriell; GM08329
DR   Wikidata; Q54843146
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N041 ! GM05945
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   GM08330
AC   CVCL_N044
SY   GM8330
DR   CLO; CLO_0010567
DR   Coriell; GM08330
DR   Wikidata; Q54843147
RX   CelloPub=CLPUB00447;
RX   PubMed=24271013;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N043 ! GM05946
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   GM08331
AC   CVCL_5N83
DR   CLO; CLO_0010581
DR   Coriell; GM08331
DR   Wikidata; Q54843148
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM08333
AC   CVCL_7477
SY   GM8333; GM008333A
DR   CLO; CLO_0010582
DR   Coriell; GM08333
DR   Wikidata; Q54843149
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=17668376;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM08334
AC   CVCL_0N00
DR   CLO; CLO_0010580
DR   BioSample; SAMN00798000
DR   Coriell; GM08334
DR   Wikidata; Q54843150
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM08335
AC   CVCL_0N01
DR   CLO; CLO_0010590
DR   BioSample; SAMN00798002
DR   Coriell; GM08335
DR   Wikidata; Q54843151
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM08336
AC   CVCL_0N02
DR   CLO; CLO_0010589
DR   BioSample; SAMN00798004
DR   Coriell; GM08336
DR   Wikidata; Q54843152
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM08337
AC   CVCL_0N03
DR   CLO; CLO_0010588
DR   BioSample; SAMN00798006
DR   Coriell; GM08337
DR   Wikidata; Q54843153
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM08337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM08338
AC   CVCL_V216
SY   GM08338A
DR   CLO; CLO_0010587
DR   BioSample; SAMN00798008
DR   Coriell; GM08338
DR   Wikidata; Q54843154
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM08339
AC   CVCL_0N04
DR   CLO; CLO_0010586
DR   BioSample; SAMN00798010
DR   Coriell; GM08339
DR   Wikidata; Q54843155
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM08340
AC   CVCL_0N05
DR   CLO; CLO_0010585
DR   BioSample; SAMN00798012
DR   Coriell; GM08340
DR   Wikidata; Q54843156
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM08341
AC   CVCL_0N06
DR   CLO; CLO_0010584
DR   BioSample; SAMN00798014
DR   Coriell; GM08341
DR   Wikidata; Q54843157
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM08342
AC   CVCL_V217
SY   GM08342A
DR   CLO; CLO_0010583
DR   BioSample; SAMN00798016
DR   Coriell; GM08342
DR   Wikidata; Q54843158
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM08342).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Coriell=GM08342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM08343
AC   CVCL_0N07
DR   CLO; CLO_0010569
DR   BioSample; SAMN00798018
DR   Coriell; GM08343
DR   Wikidata; Q54843159
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   GM08344
AC   CVCL_0N08
DR   CLO; CLO_0010570
DR   BioSample; SAMN00798020
DR   Coriell; GM08344
DR   Wikidata; Q54843160
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM08344).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM08345
AC   CVCL_V218
DR   CLO; CLO_0010579
DR   BioSample; SAMN00798022
DR   Coriell; GM08345
DR   Wikidata; Q54843161
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM08352
AC   CVCL_1N65
SY   GM8352
DR   CLO; CLO_0010576
DR   BioSample; SAMN00798024
DR   Coriell; GM08352
DR   Wikidata; Q54843162
RX   CelloPub=CLPUB00447;
RX   PubMed=1505951;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM08353
AC   CVCL_AI76
DR   CLO; CLO_0010575
DR   Coriell; GM08353
DR   Wikidata; Q54843163
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08355
AC   CVCL_EG38
DR   CLO; CLO_0010578
DR   Coriell; GM08355
DR   Wikidata; Q54843164
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26721; Hemophilia B
DI   ORDO; Orphanet_98879; Hemophilia B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM08356
AC   CVCL_EG39
DR   CLO; CLO_0010577
DR   Coriell; GM08356
DR   Wikidata; Q54843165
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26721; Hemophilia B
DI   ORDO; Orphanet_98879; Hemophilia B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM08362
AC   CVCL_AI77
DR   CLO; CLO_0010572
DR   BioSample; SAMN00798026
DR   Coriell; GM08362
DR   Wikidata; Q54843166
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM08363
AC   CVCL_AI78
DR   CLO; CLO_0010571
DR   Coriell; GM08363
DR   Wikidata; Q54843167
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08364
AC   CVCL_AI79
DR   CLO; CLO_0010574
DR   Coriell; GM08364
DR   Wikidata; Q54843168
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08365
AC   CVCL_AI80
DR   CLO; CLO_0010573
DR   BioSample; SAMN00798028
DR   Coriell; GM08365
DR   Wikidata; Q54843169
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM08366
AC   CVCL_AI81
DR   CLO; CLO_0010531
DR   Coriell; GM08366
DR   Wikidata; Q54843170
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08369
AC   CVCL_DA26
DR   CLO; CLO_0010532
DR   BioSample; SAMN00798030
DR   Coriell; GM08369
DR   Wikidata; Q54843171
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM08369).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26721; Hemophilia B
DI   ORDO; Orphanet_98879; Hemophilia B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM08371
AC   CVCL_N079
SY   GM17326
DR   CLO; CLO_0010533
DR   CLO; CLO_0013636
DR   BioSample; SAMN00798032
DR   Coriell; GM08371
DR   Coriell; GM17326
DR   Wikidata; Q54843181
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM08372
AC   CVCL_EJ55
DR   CLO; CLO_0010536
DR   BioSample; SAMN00798034
DR   Coriell; GM08372
DR   Wikidata; Q54843182
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM08373
AC   CVCL_W033
DR   CLO; CLO_0010537
DR   BioSample; SAMN00798036
DR   Coriell; GM08373
DR   Wikidata; Q54843183
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Ala33Val (c.98C>T) (A16V, 274T); ClinVar=VCV000013667; Zygosity=Unspecified (from autologous cell line GM08690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W034 ! GM08435
OI   CVCL_W036 ! GM08690
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM08382
AC   CVCL_IN22
DR   CLO; CLO_0010534
DR   BioSample; SAMN00798038
DR   Coriell; GM08382
DR   Wikidata; Q54843184
RX   CelloPub=CLPUB00447;
CC   Population: Ecuadorian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN21 ! GM03904
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM08383
AC   CVCL_IN23
DR   CLO; CLO_0010535
DR   BioSample; SAMN00798040
DR   Coriell; GM08383
DR   Wikidata; Q54843185
RX   CelloPub=CLPUB00447;
CC   Population: Ecuadorian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN20 ! GM03903
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM08384
AC   CVCL_N080
SY   GM17302
DR   CLO; CLO_0010540
DR   CLO; CLO_0013317
DR   BioSample; SAMN00798042
DR   Coriell; GM08384
DR   Coriell; GM17302
DR   Wikidata; Q54843186
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Ecuadorian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM08385
AC   CVCL_N081
SY   GM08385A; GM17303
DR   CLO; CLO_0010541
DR   CLO; CLO_0013316
DR   BioSample; SAMN00798044
DR   Coriell; GM08385
DR   Coriell; GM17303
DR   Wikidata; Q54843188
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Ecuadorian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM08386
AC   CVCL_2T54
DR   CLO; CLO_0010538
DR   BioSample; SAMN00798046
DR   Coriell; GM08386
DR   Wikidata; Q54843189
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM08387
AC   CVCL_7478
DR   CLO; CLO_0010539
DR   BioSample; SAMN00798048
DR   Coriell; GM08387
DR   Wikidata; Q54843190
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7479 ! GM08388
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GM08388
AC   CVCL_7479
DR   CLO; CLO_0010521
DR   BioSample; SAMN00798050
DR   Coriell; GM08388
DR   Wikidata; Q54843191
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7478 ! GM08387
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM08389
AC   CVCL_F207
DR   CLO; CLO_0010522
DR   BioSample; SAMN00798052
DR   Coriell; GM08389
DR   Wikidata; Q54843192
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7480 ! GM08390
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM08390
AC   CVCL_7480
DR   CLO; CLO_0010523
DR   BioSample; SAMN00798054
DR   Coriell; GM08390
DR   Wikidata; Q54843193
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F207 ! GM08389
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM08391
AC   CVCL_UT47
SY   GM08391A
DR   Coriell; GM08391
DR   Wikidata; Q93798914
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1548Thrfs*14 (c.4638_4641GATA[1]) (c.4642_4645delGATA); ClinVar=VCV000232070; Zygosity=Heterozygous (from autologous cell line GM08436).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1978Ter (c.5932G>T); ClinVar=VCV000127414; Zygosity=Heterozygous (from autologous cell line GM08436).
CC   Discontinued: Coriell; GM08391; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F208 ! GM08436
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   GM08392
AC   CVCL_AI82
DR   CLO; CLO_0010524
DR   Coriell; GM08392
DR   Wikidata; Q54843194
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08393
AC   CVCL_AI83
DR   CLO; CLO_0010525
DR   Coriell; GM08393
DR   Wikidata; Q54843195
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08398
AC   CVCL_7481
SY   GM8398; GM08398C
DR   CLO; CLO_0010526
DR   BioSample; SAMN00798056
DR   Coriell; GM08398
DR   GEO; GSM88295
DR   GEO; GSM88296
DR   GEO; GSM88297
DR   GEO; GSM88313
DR   GEO; GSM88314
DR   GEO; GSM88315
DR   GEO; GSM1316986
DR   GEO; GSM1317025
DR   GEO; GSM3124634
DR   Wikidata; Q54843196
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=15268757;
RX   PubMed=16126733;
RX   PubMed=30567591;
RX   PubMed=33038742;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM08399
AC   CVCL_7482
SY   GM8399; GM 8399; C8399
DR   CLO; CLO_0010527
DR   Coriell; GM08399
DR   GEO; GSM2794415
DR   GEO; GSM3124645
DR   Wikidata; Q54843197
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   Patent=US5773219;
RX   PubMed=1690734;
RX   PubMed=7847674;
RX   PubMed=8643543;
RX   PubMed=22152194;
RX   PubMed=29125828;
RX   PubMed=30567591;
RX   PubMed=32291635;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM08400
AC   CVCL_7483
SY   GM8400; GM-08400
DR   CLO; CLO_0010528
DR   Coriell; GM08400
DR   GEO; GSM3124657
DR   Wikidata; Q54843198
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   GM08401
AC   CVCL_7484
SY   GM8401; GM 08401
DR   CLO; CLO_0010529
DR   Coriell; GM08401
DR   GEO; GSM3124667
DR   Wikidata; Q54843199
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=30497978;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM08402
AC   CVCL_7485
SY   GM 8402; GM-8402; GM 08402
DR   CLO; CLO_0010530
DR   Coriell; GM08402
DR   GEO; GSM1316987
DR   GEO; GSM3124653
DR   Wikidata; Q54843200
RX   CelloPub=CLPUB00447;
RX   PubMed=1690734;
RX   PubMed=26984941;
RX   PubMed=28444186;
RX   PubMed=30567591;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM08403
AC   CVCL_5N84
DR   CLO; CLO_0010554
DR   BioSample; SAMN00798058
DR   Coriell; GM08403
DR   Wikidata; Q54843201
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM08409
AC   CVCL_AI84
DR   CLO; CLO_0010555
DR   Coriell; GM08409
DR   Wikidata; Q54843202
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08410
AC   CVCL_AI85
DR   CLO; CLO_0010552
DR   Coriell; GM08410
DR   Wikidata; Q54843203
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08411
AC   CVCL_AI86
DR   CLO; CLO_0010553
DR   Coriell; GM08411
DR   Wikidata; Q54843204
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08412
AC   CVCL_AI87
DR   CLO; CLO_0010560
DR   Coriell; GM08412
DR   Wikidata; Q54843205
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08413
AC   CVCL_AI88
DR   CLO; CLO_0010561
DR   Coriell; GM08413
DR   Wikidata; Q54843206
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08428
AC   CVCL_N082
SY   GM17228
DR   CLO; CLO_0010558
DR   CLO; CLO_0014359
DR   BioSample; SAMN00798060
DR   Coriell; GM08428
DR   Coriell; GM17228
DR   GEO; GSM569575
DR   GEO; GSM596292
DR   GEO; GSM596652
DR   GEO; GSM924830
DR   Wikidata; Q54843207
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=23665875;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,24:02:01; B*15:01:01,55:01:01; C*03:03:01,03:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:03:01,05:05:01; DQB1*03:01:01,06:03:01; DRB1*12:01:01G,13:01:01; DRB3*01:01:02,02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM08429
AC   CVCL_7486
DR   CLO; CLO_0010559
DR   Coriell; GM08429
DR   Wikidata; Q54843208
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GM08435
AC   CVCL_W034
DR   CLO; CLO_0010556
DR   BioSample; SAMN00798062
DR   Coriell; GM08435
DR   Wikidata; Q54843209
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Ala33Val (c.98C>T) (A16V, 274T); ClinVar=VCV000013667; Zygosity=Unspecified (from autologous cell line GM08690).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W033 ! GM08373
OI   CVCL_W036 ! GM08690
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM08436
AC   CVCL_F208
DR   CLO; CLO_0010557
DR   BioSample; SAMN00798064
DR   Coriell; GM08436
DR   Wikidata; Q54843210
RX   CelloPub=CLPUB00447;
RX   PubMed=8808599;
RX   PubMed=16166284;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1548Thrfs*14 (c.4638_4641GATA[1]) (c.4642_4645delGATA); ClinVar=VCV000232070; Zygosity=Heterozygous (PubMed=8808599).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1978Ter (c.5932G>T); ClinVar=VCV000127414; Zygosity=Heterozygous (Coriell=GM08436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT47 ! GM08391
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   GM08443
AC   CVCL_1K59
SY   GM08443A
DR   CLO; CLO_0010542
DR   BioSample; SAMN00798068
DR   Coriell; GM08443
DR   Wikidata; Q54843211
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118437; Glycogen storage disease type VII
DI   ORDO; Orphanet_371; Glycogen storage disease due to muscle phosphofructokinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM08444
AC   CVCL_JL92
DR   CLO; CLO_0010543
DR   BioSample; SAMN00798070
DR   Coriell; GM08444
DR   Wikidata; Q54843212
CC   Population: Caucasian.
CC   Donor information: Donor had apparent defect in secondary scar formation in muscle, fascia and dermis; possible collagen or ground substance proteoglycan defect.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM08447
AC   CVCL_7487
DR   CLO; CLO_0010544
DR   BioSample; SAMN00798072
DR   Coriell; GM08447
DR   Wikidata; Q54843213
RX   CelloPub=CLPUB00447;
RX   PubMed=17668376;
CC   Population: Caucasian.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM08496
AC   CVCL_DS18
DR   CLO; CLO_0010545
DR   BioSample; SAMN00798074
DR   Coriell; GM08496
DR   Wikidata; Q54843214
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Finnish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM08497
AC   CVCL_DS19
DR   CLO; CLO_0010548
DR   BioSample; SAMN00798076
DR   Coriell; GM08497
DR   Wikidata; Q54843215
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Finnish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM08505
AC   CVCL_7488
SY   GM8505; GM08505B; HG2522
DR   BTO; BTO_0003589
DR   CLO; CLO_0010549
DR   BioSample; SAMN00798078
DR   Coriell; GM08505
DR   Wikidata; Q54843216
RX   CelloPub=CLPUB00447;
RX   PubMed=908169;
RX   PubMed=3180052;
RX   PubMed=7585968;
RX   PubMed=10521302;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=7585968; PubMed=10521302; PubMed=17407155; Coriell=GM08505).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: From Bloom Syndrome Registry patient 42(RaFr) (BSR42).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F288 ! AG06040
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   GM08579
AC   CVCL_AI89
DR   CLO; CLO_0010550
DR   Coriell; GM08579
DR   Wikidata; Q54843217
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08580
AC   CVCL_AI90
DR   CLO; CLO_0010551
DR   BioSample; SAMN00798080
DR   Coriell; GM08580
DR   Wikidata; Q54843218
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM08581
AC   CVCL_W035
DR   CLO; CLO_0010547
DR   BioSample; SAMN00798082
DR   Coriell; GM08581
DR   Wikidata; Q54843219
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 11
//
ID   GM08582
AC   CVCL_VL36
SY   GM8582
DR   Coriell; GM08582
DR   Wikidata; Q93799070
RX   PubMed=2805228;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM08582; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM08583
AC   CVCL_5L69
SY   GM08583A
DR   CLO; CLO_0010600
DR   BioSample; SAMN00798084
DR   Coriell; GM08583
DR   Wikidata; Q54843220
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 11
//
ID   GM08584
AC   CVCL_5L70
SY   GM08584A
DR   CLO; CLO_0010599
DR   BioSample; SAMN00798086
DR   Coriell; GM08584
DR   Wikidata; Q54843221
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   GM08585
AC   CVCL_2T55
SY   GM08585A
DR   CLO; CLO_0010596
DR   BioSample; SAMN00798088
DR   Coriell; GM08585
DR   Wikidata; Q54843229
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   GM08586
AC   CVCL_2T56
SY   GM08586A
DR   CLO; CLO_0010595
DR   BioSample; SAMN00798090
DR   Coriell; GM08586
DR   Wikidata; Q54843231
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM08587
AC   CVCL_N083
SY   GM08587A; GM17229
DR   CLO; CLO_0010598
DR   CLO; CLO_0014362
DR   BioSample; SAMN00798092
DR   Coriell; GM08587
DR   Coriell; GM17229
DR   GEO; GSM569576
DR   GEO; GSM596293
DR   GEO; GSM596653
DR   GEO; GSM924831
DR   Wikidata; Q54843232
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,31:01:02; B*35:01:01,35:20:01; C*03:04:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:02:01G; DQA1*03:01:01,05:03; DQB1*03:01:01,03:02:01; DRB1*04:07:01,14:06:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM08589
AC   CVCL_W209
DR   CLO; CLO_0010597
DR   BioSample; SAMN00798094
DR   Coriell; GM08589
DR   Wikidata; Q54843233
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W208 ! GM07713
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM08618
AC   CVCL_5N85
DR   BioSample; SAMN00798106
DR   Coriell; GM08618
DR   Wikidata; Q54843234
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM08660
AC   CVCL_2Y89
DR   CLO; CLO_0010606
DR   BioSample; SAMN00798108
DR   Coriell; GM08660
DR   Wikidata; Q54843235
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08661
AC   CVCL_2Y90
DR   CLO; CLO_0010605
DR   BioSample; SAMN00798110
DR   Coriell; GM08661
DR   Wikidata; Q54843236
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08662
AC   CVCL_2Y91
DR   CLO; CLO_0010604
DR   BioSample; SAMN00798112
DR   Coriell; GM08662
DR   Wikidata; Q54843237
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08663
AC   CVCL_2Y92
DR   CLO; CLO_0010603
DR   BioSample; SAMN00798114
DR   Coriell; GM08663
DR   Wikidata; Q54843238
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08664
AC   CVCL_2Y93
DR   CLO; CLO_0010602
DR   BioSample; SAMN00798116
DR   Coriell; GM08664
DR   Wikidata; Q54843239
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08665
AC   CVCL_2Y94
DR   CLO; CLO_0010601
DR   BioSample; SAMN00798118
DR   Coriell; GM08665
DR   Wikidata; Q54843240
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08668
AC   CVCL_F152
DR   CLO; CLO_0010614
DR   BioSample; SAMN00798120
DR   Coriell; GM08668
DR   Wikidata; Q54843241
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27725; Porphyria cutanea tarda
DI   ORDO; Orphanet_101330; Porphyria cutanea tarda
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM08669
AC   CVCL_F153
SY   GM17281
DR   CLO; CLO_0010613
DR   CLO; CLO_0013097
DR   BioSample; SAMN00798122
DR   Coriell; GM08669
DR   Coriell; GM17281
DR   GEO; GSM569734
DR   GEO; GSM596345
DR   GEO; GSM596813
DR   GEO; GSM924883
DR   Wikidata; Q54843242
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,31:01:02; B*39:06:02,56:01:01; C*01:02:01,07:612; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*01:01:01,03:01:01; DQB1*03:02:01,05:01:01; DRB1*01:01:01,04:01:01; DRB4*01:03:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Lys281del (c.841_843delAAG) (2613_2615delAGA); ClinVar=VCV000039396; Zygosity=Heterozygous; Note=CYP2D6*9 allele (Coriell=GM17281).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   GM08670
AC   CVCL_F154
DR   CLO; CLO_0010616
DR   BioSample; SAMN00798124
DR   Coriell; GM08670
DR   Wikidata; Q54843243
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM08680
AC   CVCL_7489
SY   GM8680
DR   CLO; CLO_0010615
DR   Coriell; GM08680
DR   Wikidata; Q54843244
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GM08681
AC   CVCL_9S91
DR   CLO; CLO_0010618
DR   BioSample; SAMN00798126
DR   Coriell; GM08681
DR   Wikidata; Q54843245
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+i(18)(pter->p10:p10->pter) (Coriell=GM08681).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM08683
AC   CVCL_1K60
DR   CLO; CLO_0010617
DR   BioSample; SAMN00798128
DR   Coriell; GM08683
DR   Wikidata; Q54843246
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118437; Glycogen storage disease type VII
DI   ORDO; Orphanet_371; Glycogen storage disease due to muscle phosphofructokinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM08684
AC   CVCL_4F59
DR   CLO; CLO_0010620
DR   BioSample; SAMN00798130
DR   Coriell; GM08684
DR   Wikidata; Q54843247
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Cys116Tyr (c.347G>A); ClinVar=VCV000226068; Zygosity=Heterozygous (Coriell=GM08684).
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Heterozygous (Coriell=GM08684).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM08690
AC   CVCL_W036
SY   GM 8690; GM8690
DR   CLO; CLO_0010426
DR   BioSample; SAMN00798140
DR   Coriell; GM08690
DR   Wikidata; Q54843248
RX   CelloPub=CLPUB00447;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Ala33Val (c.98C>T) (A16V, 274T); ClinVar=VCV000013667; Zygosity=Unspecified (PubMed=8675582).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W033 ! GM08373
OI   CVCL_W034 ! GM08435
SX   Female
AG   1Y7M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM08696
AC   CVCL_5N86
DR   CLO; CLO_0010423
DR   BioSample; SAMN00798142
DR   Coriell; GM08696
DR   Wikidata; Q54843249
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetal Achilles tendon; UBERON=UBERON_0003701.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM08697
AC   CVCL_EJ56
DR   CLO; CLO_0010424
DR   Coriell; GM08697
DR   Wikidata; Q54843250
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM08698
AC   CVCL_EJ57
SY   GM08698A
DR   CLO; CLO_0010421
DR   Coriell; GM08698
DR   Wikidata; Q54843251
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM08714
AC   CVCL_E128
DR   CLO; CLO_0010422
DR   EFO; EFO_0005333
DR   BioSample; SAMN00798144
DR   Coriell; GM08714
DR   ENCODE; ENCBS182AAA
DR   ENCODE; ENCBS477AAA
DR   ENCODE; ENCBS478AAA
DR   Wikidata; Q54843253
RX   CelloPub=CLPUB00447;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM08714_Farnham_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Ala603Thr (c.1807G>A); ClinVar=VCV000006740; Zygosity=Heterozygous (Coriell=GM08714).
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Glu806_Arg807insSerThrPro (c.2397-11G>A) (IVS22AS,G>A,-11) (744ins3); ClinVar=VCV000006741; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM08714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156430; Immunodeficiency-centromeric instability-facial anomalies syndrome 1
DI   ORDO; Orphanet_2268; ICF syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E130 ! GM08747
SX   Female
AG   1Y5M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   GM08728
AC   CVCL_E129
DR   CLO; CLO_0010502
DR   BioSample; SAMN00798146
DR   Coriell; GM08728
DR   Wikidata; Q54843254
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Ala603Thr (c.1807G>A); ClinVar=VCV000006740; Zygosity=Heterozygous (Coriell=GM08728).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   GM08729
AC   CVCL_N086
SY   GM17282
DR   CLO; CLO_0010503
DR   CLO; CLO_0013094
DR   BioSample; SAMN00798148
DR   Coriell; GM08729
DR   Coriell; GM17282
DR   GEO; GSM569735
DR   GEO; GSM596346
DR   GEO; GSM596765
DR   GEO; GSM924884
DR   Wikidata; Q54843255
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,11:01:01; B*35:03:01,56:01:01; C*01:02:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:03:01,02:01:01; DQB1*03:03:02,06:03:01; DRB1*07:01:01,13:01:01; DRB3*02:02:01; DRB4*01:03:01:02N (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM08739
AC   CVCL_AW89
DR   CLO; CLO_0010500
DR   BioSample; SAMN00798150
DR   Coriell; GM08739
DR   Wikidata; Q54843256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM08740
AC   CVCL_AW90
DR   CLO; CLO_0010501
DR   BioSample; SAMN00798152
DR   Coriell; GM08740
DR   Wikidata; Q54843257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM08741
AC   CVCL_AW91
DR   CLO; CLO_0010506
DR   BioSample; SAMN00798154
DR   Coriell; GM08741
DR   Wikidata; Q54843258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM08747
AC   CVCL_E130
DR   CLO; CLO_0010505
DR   BioSample; SAMN00798156
DR   Coriell; GM08747
DR   Wikidata; Q54843259
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Ala603Thr (c.1807G>A); ClinVar=VCV000006740; Zygosity=Heterozygous (Coriell=GM08747).
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Glu806_Arg807insSerThrPro (c.2397-11G>A (IVS22AS,G>A,-11) (744ins3); ClinVar=VCV000006741; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM08747).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C156430; Immunodeficiency-centromeric instability-facial anomalies syndrome 1
DI   ORDO; Orphanet_2268; ICF syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E128 ! GM08714
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM08752
AC   CVCL_U476
SY   GM08752A
DR   CLO; CLO_0010504
DR   BioSample; SAMN00798158
DR   Coriell; GM08752
DR   Wikidata; Q54843260
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (from autologous cell line GM08760).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (Coriell=GM08752).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U477 ! GM08760
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 20
//
ID   GM08753
AC   CVCL_N087
SY   GM17068
DR   CLO; CLO_0010510
DR   CLO; CLO_0014572
DR   BioSample; SAMN00798160
DR   Coriell; GM08753
DR   Coriell; GM17068
DR   Wikidata; Q54843261
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (Coriell=GM08753).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM08755
AC   CVCL_2T57
DR   CLO; CLO_0010509
DR   BioSample; SAMN00798162
DR   Coriell; GM08755
DR   Wikidata; Q54843262
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetal Achilles tendon; UBERON=UBERON_0003701.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM08756
AC   CVCL_AI91
DR   CLO; CLO_0010508
DR   Coriell; GM08756
DR   Wikidata; Q54843263
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI34 ! GM04422
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM08757
AC   CVCL_AI92
SY   GM08757A
DR   CLO; CLO_0010507
DR   BioSample; SAMN00798164
DR   Coriell; GM08757
DR   Wikidata; Q54843264
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM08758
AC   CVCL_AI93
DR   CLO; CLO_0010489
DR   Coriell; GM08758
DR   Wikidata; Q54843265
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM08759
AC   CVCL_AI94
DR   CLO; CLO_0010490
DR   Coriell; GM08759
DR   Wikidata; Q54843266
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08760
AC   CVCL_U477
DR   CLO; CLO_0010491
DR   BioSample; SAMN00798166
DR   Coriell; GM08760
DR   Wikidata; Q54843267
RX   CelloPub=CLPUB00447;
RX   PubMed=30497978;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (PubMed=30497978).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=30497978).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U476 ! GM08752
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   GM08761
AC   CVCL_IJ37
DR   CLO; CLO_0010493
DR   BioSample; SAMN00798168
DR   Coriell; GM08761
DR   Wikidata; Q54843268
RX   CelloPub=CLPUB00447;
RX   PubMed=28649545;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Gly197Arg (c.589G>A); ClinVar=VCV000004451; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Heterozygous (PubMed=28649545).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2976; Cystinosis
DI   ORDO; Orphanet_411641; Ocular cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM08762
AC   CVCL_5N87
SY   GM08762A
DR   Coriell; GM08762
DR   Wikidata; Q54843269
CC   Discontinued: Coriell; GM08762; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N88 ! GM08763
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM08763
AC   CVCL_5N88
DR   CLO; CLO_0010492
DR   BioSample; SAMN00798170
DR   Coriell; GM08763
DR   Wikidata; Q54843270
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5N87 ! GM08762
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM08764
AC   CVCL_W728
DR   CLO; CLO_0010495
DR   BioSample; SAMN00798172
DR   Coriell; GM08764
DR   Wikidata; Q54843281
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM08766
AC   CVCL_AA61
DR   CLO; CLO_0010494
DR   BioSample; SAMN00798174
DR   Coriell; GM08766
DR   Wikidata; Q54843282
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08768
AC   CVCL_4F60
DR   CLO; CLO_0010497
DR   BioSample; SAMN00798176
DR   Coriell; GM08768
DR   Wikidata; Q54843283
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM08768).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM08769
AC   CVCL_9Z43
DR   CLO; CLO_0010496
DR   BioSample; SAMN00798178
DR   Coriell; GM08769
DR   Wikidata; Q54843285
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84789; Infantile Refsum disease
DI   ORDO; Orphanet_772; Infantile Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08770
AC   CVCL_9Z44
DR   CLO; CLO_0010499
DR   BioSample; SAMN00798180
DR   Coriell; GM08770
DR   Wikidata; Q54843286
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84789; Infantile Refsum disease
DI   ORDO; Orphanet_772; Infantile Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08771
AC   CVCL_9Z45
DR   CLO; CLO_0010498
DR   BioSample; SAMN00798182
DR   Coriell; GM08771
DR   Wikidata; Q54843287
RX   CelloPub=CLPUB00447;
RX   PubMed=12851857;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000002156; Zygosity=Heterozygous (PubMed=12851857).
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Leu45Pro (c.134T>C); ClinVar=VCV000002157; Zygosity=Heterozygous (PubMed=12851857).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155761; Peroxisome biogenesis disorder 7B
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM08772
AC   CVCL_9Z46
DR   CLO; CLO_0010478
DR   BioSample; SAMN00798184
DR   Coriell; GM08772
DR   Wikidata; Q54843288
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84789; Infantile Refsum disease
DI   ORDO; Orphanet_772; Infantile Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08773
AC   CVCL_2T58
DR   CLO; CLO_0010479
DR   BioSample; SAMN00798186
DR   Coriell; GM08773
DR   Wikidata; Q54843289
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   GM08774
AC   CVCL_DF28
SY   GM08774A
DR   CLO; CLO_0010480
DR   BioSample; SAMN00798188
DR   Coriell; GM08774
DR   Wikidata; Q54843290
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM08775
AC   CVCL_DF29
SY   GM08775A
DR   CLO; CLO_0010488
DR   BioSample; SAMN00798190
DR   Coriell; GM08775
DR   Wikidata; Q54843291
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM08776
AC   CVCL_DF30
DR   CLO; CLO_0010487
DR   BioSample; SAMN00798192
DR   Coriell; GM08776
DR   Wikidata; Q54843292
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM08778
AC   CVCL_5N89
DR   CLO; CLO_0010486
DR   BioSample; SAMN00798194
DR   Coriell; GM08778
DR   Wikidata; Q54843293
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM08779
AC   CVCL_N088
SY   GM08779A; GM17166
DR   CLO; CLO_0010485
DR   CLO; CLO_0013990
DR   BioSample; SAMN00798196
DR   Coriell; GM08779
DR   Coriell; GM17166
DR   GEO; GSM569693
DR   GEO; GSM596231
DR   GEO; GSM597065
DR   GEO; GSM924676
DR   IPD-IMGT/HLA; 20687
DR   Wikidata; Q54843294
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:CNJK,02:DFKP; B*07:CZZS,44:WRJ; C*05:AC,07:CVAG; DRB1*04:01,15:03 (IPD-IMGT/HLA=20687).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM08781
AC   CVCL_DD82
DR   CLO; CLO_0010484
DR   BioSample; SAMN00798198
DR   Coriell; GM08781
DR   Wikidata; Q54843295
RX   CelloPub=CLPUB00447;
RX   PubMed=1953667;
RX   PubMed=6469997;
CC   Population: Caucasian; Swiss.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Gly869Cys (c.2605G>T); ClinVar=VCV00001729; Zygosity=Heterozygous (PubMed=1953667).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM08785
AC   CVCL_5N90
DR   CLO; CLO_0010483
DR   BioSample; SAMN00798200
DR   Coriell; GM08785
DR   Wikidata; Q54843296
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 12
//
ID   GM08786
AC   CVCL_N089
SY   GM17283
DR   CLO; CLO_0010482
DR   CLO; CLO_0013095
DR   BioSample; SAMN00798202
DR   Coriell; GM08786
DR   Coriell; GM17283
DR   GEO; GSM569736
DR   GEO; GSM596347
DR   GEO; GSM596814
DR   GEO; GSM924885
DR   Wikidata; Q54843297
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,03:01:01; B*07:02:01,07:02:01; C*07:02:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:01,01:02:01; DQB1*06:02:01,06:02:01; DRB1*15:01:01,15:01:01; DRB5*01:01:01,01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM08787
AC   CVCL_N090
SY   GM17284
DR   CLO; CLO_0010481
DR   CLO; CLO_0013092
DR   BioSample; SAMN00798204
DR   Coriell; GM08787
DR   Coriell; GM17284
DR   GEO; GSM569737
DR   GEO; GSM596348
DR   GEO; GSM596766
DR   GEO; GSM924886
DR   Wikidata; Q54843298
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM08788
AC   CVCL_EH04
DR   CLO; CLO_0010467
DR   BioSample; SAMN00798206
DR   Coriell; GM08788
DR   Wikidata; Q54843299
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_595337; Adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH06 ! GM10489
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM08794
AC   CVCL_DA27
DR   CLO; CLO_0010469
DR   BioSample; SAMN00798208
DR   Coriell; GM08794
DR   Wikidata; Q54843300
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   GM08799
AC   CVCL_AW92
DR   CLO; CLO_0010468
DR   BioSample; SAMN00798210
DR   Coriell; GM08799
DR   Wikidata; Q54843301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM08800
AC   CVCL_AW93
DR   CLO; CLO_0010475
DR   BioSample; SAMN00798212
DR   Coriell; GM08800
DR   Wikidata; Q54843302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM08801
AC   CVCL_AW94
DR   CLO; CLO_0010474
DR   BioSample; SAMN00798214
DR   Coriell; GM08801
DR   Wikidata; Q54843303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM08808
AC   CVCL_5N91
DR   CLO; CLO_0010477
DR   BioSample; SAMN00798216
DR   Coriell; GM08808
DR   Wikidata; Q54843304
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM08809
AC   CVCL_4H50
SY   GM8809
DR   CLO; CLO_0010476
DR   Coriell; GM08809
DR   Wikidata; Q54843305
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08810
AC   CVCL_4H51
SY   GM08810A
DR   CLO; CLO_0010471
DR   Coriell; GM08810
DR   Wikidata; Q54843306
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08811
AC   CVCL_4H52
DR   CLO; CLO_0010470
DR   Coriell; GM08811
DR   Wikidata; Q54843307
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08812
AC   CVCL_4I97
DR   CLO; CLO_0010473
DR   Coriell; GM08812
DR   Wikidata; Q54843308
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08813
AC   CVCL_4H53
DR   CLO; CLO_0010472
DR   Coriell; GM08813
DR   Wikidata; Q54843309
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08814
AC   CVCL_4H54
DR   CLO; CLO_0010466
DR   Coriell; GM08814
DR   Wikidata; Q54843311
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08820
AC   CVCL_DA28
DR   CLO; CLO_0010464
DR   BioSample; SAMN00798218
DR   Coriell; GM08820
DR   Wikidata; Q54843312
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   GM08821
AC   CVCL_4H55
DR   CLO; CLO_0010465
DR   Coriell; GM08821
DR   Wikidata; Q54843313
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08822
AC   CVCL_4H56
DR   CLO; CLO_0010459
DR   Coriell; GM08822
DR   Wikidata; Q54843314
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08823
AC   CVCL_4H57
SY   GM08823A
DR   CLO; CLO_0010460
DR   Coriell; GM08823
DR   Wikidata; Q54843315
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08824
AC   CVCL_4H58
DR   CLO; CLO_0010457
DR   Coriell; GM08824
DR   Wikidata; Q54843316
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08825
AC   CVCL_4H59
DR   CLO; CLO_0010458
DR   Coriell; GM08825
DR   Wikidata; Q54843317
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08826
AC   CVCL_4H60
DR   CLO; CLO_0010462
DR   Coriell; GM08826
DR   Wikidata; Q54843318
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08827
AC   CVCL_2T59
SY   GM08827A
DR   CLO; CLO_0010463
DR   Coriell; GM08827
DR   Wikidata; Q54843319
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM08828
AC   CVCL_2T60
SY   GM08828A
DR   CLO; CLO_0010461
DR   BioSample; SAMN00798220
DR   Coriell; GM08828
DR   Wikidata; Q54843320
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM08829
AC   CVCL_9Q98
DR   CLO; CLO_0010453
DR   BioSample; SAMN00798222
DR   Coriell; GM08829
DR   Wikidata; Q54843321
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08830
AC   CVCL_9Q99
DR   CLO; CLO_0010454
DR   BioSample; SAMN00798224
DR   Coriell; GM08830
DR   Wikidata; Q54843322
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08831
AC   CVCL_9R00
DR   CLO; CLO_0010455
DR   BioSample; SAMN00798226
DR   Coriell; GM08831
DR   Wikidata; Q54843328
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08832
AC   CVCL_GS74
SY   GM 8832
DR   CLO; CLO_0010456
DR   BioSample; SAMN00798228
DR   Coriell; GM08832
DR   Wikidata; Q54843329
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17D
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM08834
AC   CVCL_EJ58
SY   GM 8834
DR   CLO; CLO_0010447
DR   BioSample; SAMN00798230
DR   Coriell; GM08834
DR   Wikidata; Q54843330
RX   CelloPub=CLPUB00447;
RX   PubMed=2567118;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM08849
AC   CVCL_4H61
SY   GM08849B
DR   CLO; CLO_0010448
DR   Coriell; GM08849
DR   Wikidata; Q54843331
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08850
AC   CVCL_4H62
DR   CLO; CLO_0010449
DR   Coriell; GM08850
DR   Wikidata; Q54843332
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08851
AC   CVCL_4I98
DR   CLO; CLO_0010450
DR   Coriell; GM08851
DR   Wikidata; Q54843333
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08852
AC   CVCL_4H63
DR   CLO; CLO_0010451
DR   Coriell; GM08852
DR   Wikidata; Q54843334
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08853
AC   CVCL_4H64
SY   GM08853C
DR   CLO; CLO_0010452
DR   Coriell; GM08853
DR   Wikidata; Q54843336
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08854
AC   CVCL_1R80
SY   WAV 17; WAV17
DR   CLO; CLO_0010446
DR   Coriell; GM08854
DR   Wikidata; Q54843337
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 21 mapping. Contains a complete copy of chromosome 21.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0579 ! WI-38
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM08855
AC   CVCL_0Q06
DR   CLO; CLO_0010444
DR   BioSample; SAMN00798232
DR   Coriell; GM08855
DR   Wikidata; Q54843338
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM08855).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM08856
AC   CVCL_0Q07
DR   CLO; CLO_0010445
DR   BioSample; SAMN00798234
DR   Coriell; GM08856
DR   Wikidata; Q54843339
RX   CelloPub=CLPUB00447;
CC   Population: Hispanic.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM08857
AC   CVCL_U879
DR   CLO; CLO_0010442
DR   BioSample; SAMN00798236
DR   Coriell; GM08857
DR   Wikidata; Q54843340
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Heterozygous (Coriell=GM08857).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM08858
AC   CVCL_U880
DR   CLO; CLO_0010443
DR   BioSample; SAMN00798238
DR   Coriell; GM08858
DR   Wikidata; Q54843341
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Heterozygous (Coriell=GM08858).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM08859
AC   CVCL_U881
DR   CLO; CLO_0010440
DR   BioSample; SAMN00798240
DR   Coriell; GM08859
DR   Wikidata; Q54843342
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Homozygous (Coriell=GM08859).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM08860
AC   CVCL_4H65
SY   GM08860B
DR   CLO; CLO_0010441
DR   Coriell; GM08860
DR   Wikidata; Q54843343
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08861
AC   CVCL_4H66
SY   GM08861A; GM8861A
DR   CLO; CLO_0010438
DR   Coriell; GM08861
DR   Wikidata; Q54843344
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08862
AC   CVCL_4H67
SY   GM08862B
DR   CLO; CLO_0010439
DR   Coriell; GM08862
DR   Wikidata; Q54843345
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08863
AC   CVCL_4H68
DR   CLO; CLO_0010437
DR   Coriell; GM08863
DR   Wikidata; Q54843346
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08864
AC   CVCL_4H69
DR   CLO; CLO_0010435
DR   Coriell; GM08864
DR   Wikidata; Q54843347
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08865
AC   CVCL_4H70
DR   CLO; CLO_0010436
DR   Coriell; GM08865
DR   Wikidata; Q54843348
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08866
AC   CVCL_JE53
DR   CLO; CLO_0003534
DR   CLDB; cl1501
DR   Coriell; GM08866
DR   Wikidata; Q54843349
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM08866; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84539; Acyl-CoA dehydrogenase, short-chain deficiency
DI   ORDO; Orphanet_26792; Short chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM08867
AC   CVCL_4H71
DR   CLO; CLO_0010431
DR   Coriell; GM08867
DR   Wikidata; Q54843350
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08868
AC   CVCL_4H72
DR   CLO; CLO_0010432
DR   Coriell; GM08868
DR   Wikidata; Q54843351
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08869
AC   CVCL_4I99
SY   GM08869A
DR   CLO; CLO_0010433
DR   Coriell; GM08869
DR   Wikidata; Q54843352
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08870
AC   CVCL_4H73
DR   CLO; CLO_0010434
DR   Coriell; GM08870
DR   Wikidata; Q54843353
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08871
AC   CVCL_4H74
SY   GM08871B
DR   CLO; CLO_0010427
DR   Coriell; GM08871
DR   Wikidata; Q54843354
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08872
AC   CVCL_4H75
DR   CLO; CLO_0010428
DR   Coriell; GM08872
DR   Wikidata; Q54843355
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08873
AC   CVCL_N091
SY   GM17167
DR   CLO; CLO_0010429
DR   CLO; CLO_0013989
DR   BioSample; SAMN00798242
DR   Coriell; GM08873
DR   Coriell; GM17167
DR   GEO; GSM569694
DR   GEO; GSM596232
DR   GEO; GSM597027
DR   GEO; GSM924677
DR   IPD-IMGT/HLA; 16403
DR   Wikidata; Q54843357
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,34:02; B*08:XKT,51:CVAE; C*07:CVAG,16:01; DRB1*13:02,15:01 (IPD-IMGT/HLA=16403).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM08874
AC   CVCL_AA62
DR   CLO; CLO_0010430
DR   BioSample; SAMN00798244
DR   Coriell; GM08874
DR   Wikidata; Q54843358
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM08875
AC   CVCL_4H76
SY   GM08875A
DR   CLO; CLO_0010515
DR   Coriell; GM08875
DR   Wikidata; Q54843359
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08876
AC   CVCL_4H77
DR   CLO; CLO_0010517
DR   Coriell; GM08876
DR   Wikidata; Q54843360
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08877
AC   CVCL_4H78
DR   CLO; CLO_0010516
DR   Coriell; GM08877
DR   Wikidata; Q54843361
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08878
AC   CVCL_HJ76
DR   Coriell; GM08878
DR   Wikidata; Q54843363
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM08879
AC   CVCL_4H79
SY   GM08879C; GM08879D
DR   CLO; CLO_0010512
DR   Coriell; GM08879
DR   Wikidata; Q54843364
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08880
AC   CVCL_4H80
DR   CLO; CLO_0010511
DR   Coriell; GM08880
DR   Wikidata; Q54843365
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08882
AC   CVCL_BD95
DR   CLO; CLO_0010514
DR   BioSample; SAMN00798246
DR   Coriell; GM08882
DR   Wikidata; Q54843366
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu101Gly (c.302A>G) (E100G); ClinVar=VCV000014761; Zygosity=Heterozygous (Coriell=GM08882).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM08883
AC   CVCL_BE98
SY   GM08883A
DR   CLO; CLO_0010513
DR   BioSample; SAMN00798248
DR   Coriell; GM08883
DR   Wikidata; Q54843367
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM08884
AC   CVCL_BE99
SY   GM08884A
DR   CLO; CLO_0010519
DR   BioSample; SAMN00798250
DR   Coriell; GM08884
DR   Wikidata; Q54843368
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM08885
AC   CVCL_BS76
DR   CLO; CLO_0010518
DR   BioSample; SAMN00798252
DR   Coriell; GM08885
DR   Wikidata; Q54843369
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM08886
AC   CVCL_BS77
SY   GM08886A
DR   CLO; CLO_0010520
DR   BioSample; SAMN00798254
DR   Coriell; GM08886
DR   Wikidata; Q54843370
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM08887
AC   CVCL_BS78
DR   CLO; CLO_0011194
DR   BioSample; SAMN00798256
DR   Coriell; GM08887
DR   Wikidata; Q54843385
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM08888
AC   CVCL_BS79
SY   GM08888A; GM08888B
DR   CLO; CLO_0011198
DR   BioSample; SAMN00798258
DR   Coriell; GM08888
DR   Wikidata; Q54843386
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM08889
AC   CVCL_0N09
DR   CLO; CLO_0011197
DR   BioSample; SAMN00798260
DR   Coriell; GM08889
DR   Wikidata; Q54843388
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM08889).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg1162Ter (c.3484C>T); ClinVar=VCV000007137; Zygosity=Heterozygous (Coriell=GM08889).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM08890
AC   CVCL_0N10
SY   GM08890A
DR   CLO; CLO_0011196
DR   BioSample; SAMN00798262
DR   Coriell; GM08890
DR   Wikidata; Q54843389
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM08891
AC   CVCL_AA63
DR   CLO; CLO_0011195
DR   Coriell; GM08891
DR   Wikidata; Q54843390
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM08892
AC   CVCL_AA64
DR   CLO; CLO_0011201
DR   Coriell; GM08892
DR   Wikidata; Q54843391
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM08893
AC   CVCL_AA65
DR   CLO; CLO_0011203
DR   Coriell; GM08893
DR   Wikidata; Q54843392
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM08894
AC   CVCL_AA66
SY   GM08894A
DR   CLO; CLO_0011204
DR   Coriell; GM08894
DR   Wikidata; Q54843393
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM08894).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM08895
AC   CVCL_AA67
DR   CLO; CLO_0011205
DR   Coriell; GM08895
DR   Wikidata; Q54843395
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM08896 (Cellosaurus=CVCL_AA68).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM08896
AC   CVCL_AA68
DR   CLO; CLO_0011199
DR   Coriell; GM08896
DR   Wikidata; Q54843396
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM08895 (Cellosaurus=CVCL_AA67).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM08909
AC   CVCL_0Q08
DR   CLO; CLO_0011219
DR   BioSample; SAMN00798264
DR   Coriell; GM08909
DR   Wikidata; Q54843397
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Ser249Cys (c.746C>G); ClinVar=VCV000016339; Zygosity=Heterozygous (Coriell=GM08909).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM08911
AC   CVCL_4H81
SY   GM08911B
DR   CLO; CLO_0011218
DR   Coriell; GM08911
DR   Wikidata; Q54843398
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08912
AC   CVCL_4H82
DR   CLO; CLO_0011215
DR   Coriell; GM08912
DR   Wikidata; Q54843399
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08913
AC   CVCL_4J00
DR   CLO; CLO_0011214
DR   Coriell; GM08913
DR   Wikidata; Q54843400
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08914
AC   CVCL_4H83
SY   GM08914A
DR   CLO; CLO_0011217
DR   Coriell; GM08914
DR   Wikidata; Q54843401
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08915
AC   CVCL_4H84
DR   CLO; CLO_0011216
DR   Coriell; GM08915
DR   Wikidata; Q54843402
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM08919
AC   CVCL_N092
SY   GM08919B; GM17285
DR   CLO; CLO_0011223
DR   CLO; CLO_0013090
DR   BioSample; SAMN00798266
DR   Coriell; GM08919
DR   Coriell; GM17285
DR   GEO; GSM569738
DR   GEO; GSM596349
DR   GEO; GSM596767
DR   GEO; GSM924887
DR   Wikidata; Q54843403
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:05:01,23:01:01; B*35:02:01,51:08:01; C*04:01:01,16:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,104:01:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:01; DRB1*11:04:01,13:03:01; DRB3*01:01:02,02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM08921
AC   CVCL_9R01
SY   GM08921A
DR   CLO; CLO_0011226
DR   BioSample; SAMN00798268
DR   Coriell; GM08921
DR   Wikidata; Q54843404
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM08922
AC   CVCL_9R02
SY   GM08922A
DR   CLO; CLO_0011220
DR   BioSample; SAMN00798270
DR   Coriell; GM08922
DR   Wikidata; Q54843405
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM08923
AC   CVCL_9R03
DR   CLO; CLO_0011222
DR   BioSample; SAMN00798272
DR   Coriell; GM08923
DR   Wikidata; Q54843406
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08925
AC   CVCL_7490
SY   GM17048; GM17338
DR   CLO; CLO_0011240
DR   CLO; CLO_0013607
DR   CLO; CLO_0014638
DR   BioSample; SAMN00798274
DR   Coriell; GM08925
DR   Coriell; GM17048
DR   Coriell; GM17338
DR   Wikidata; Q54843407
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM08926
AC   CVCL_1L50
DR   CLO; CLO_0011239
DR   BioSample; SAMN00798276
DR   Coriell; GM08926
DR   Wikidata; Q54843408
CC   Population: Caucasian; German/Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM08927
AC   CVCL_N093
SY   GM18033
DR   CLO; CLO_0011238
DR   CLO; CLO_0015586
DR   BioSample; SAMN00798278
DR   Coriell; GM08927
DR   Coriell; GM18033
DR   Wikidata; Q54843409
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM08928
AC   CVCL_7491
DR   CLO; CLO_0011237
DR   BioSample; SAMN00798280
DR   Coriell; GM08928
DR   Wikidata; Q54843410
RX   CelloPub=CLPUB00447;
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM08929
AC   CVCL_1L51
DR   CLO; CLO_0011236
DR   BioSample; SAMN00798282
DR   Coriell; GM08929
DR   Wikidata; Q54843411
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Lithuanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM08930
AC   CVCL_N094
SY   GM17094
DR   CLO; CLO_0011235
DR   CLO; CLO_0014519
DR   BioSample; SAMN00798284
DR   Coriell; GM08930
DR   Coriell; GM17094
DR   Wikidata; Q54843413
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Portuguese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   GM08931
AC   CVCL_1L52
DR   CLO; CLO_0011234
DR   BioSample; SAMN00798286
DR   Coriell; GM08931
DR   Wikidata; Q54843414
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM08932
AC   CVCL_N095
SY   GM17049; GM17377
DR   CLO; CLO_0011051
DR   CLO; CLO_0013702
DR   CLO; CLO_0014637
DR   BioSample; SAMN00798288
DR   Coriell; GM08932
DR   Coriell; GM17049
DR   Coriell; GM17377
DR   Wikidata; Q54843415
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM08935
AC   CVCL_FV44
DR   CLO; CLO_0011050
DR   BioSample; SAMN00798290
DR   Coriell; GM08935
DR   Wikidata; Q54843416
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21576; NHLRC1; Simple; p.Pro129His (c.386C>A); ClinVar=VCV000206187; Zygosity=Homozygous (Coriell=GM08935).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84804; Lafora disease
DI   ORDO; Orphanet_501; Lafora disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM08936
AC   CVCL_FV45
DR   CLO; CLO_0011049
DR   Coriell; GM08936
DR   Wikidata; Q54843417
CC   Sequence variation: Mutation; HGNC; HGNC:21576; NHLRC1; Simple; p.Pro129His (c.386C>A); ClinVar=VCV000206187; Zygosity=Homozygous (Coriell=GM08936).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84804; Lafora disease
DI   ORDO; Orphanet_501; Lafora disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM08939
AC   CVCL_9R04
DR   CLO; CLO_0011043
DR   BioSample; SAMN00798292
DR   Coriell; GM08939
DR   Wikidata; Q54843418
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08940
AC   CVCL_AB49
DR   CLO; CLO_0011044
DR   BioSample; SAMN00798293
DR   Coriell; GM08940
DR   Wikidata; Q54843419
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM08944
AC   CVCL_5N92
SY   GM8944
DR   CLO; CLO_0011041
DR   BioSample; SAMN00798294
DR   Coriell; GM08944
DR   Wikidata; Q54843420
RX   CelloPub=CLPUB00447;
RX   PubMed=10377420;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,i(X)(p11.4) (PubMed=10377420).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM08946
AC   CVCL_5N93
DR   CLO; CLO_0011042
DR   BioSample; SAMN00798296
DR   Coriell; GM08946
DR   Wikidata; Q54843421
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM08947
AC   CVCL_AL19
DR   CLO; CLO_0011047
DR   BioSample; SAMN00798298
DR   Coriell; GM08947
DR   Wikidata; Q54843422
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08947).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08948
AC   CVCL_AL20
SY   GM08948A
DR   CLO; CLO_0011048
DR   BioSample; SAMN00798300
DR   Coriell; GM08948
DR   Wikidata; Q54843423
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08949
AC   CVCL_AL21
DR   CLO; CLO_0011045
DR   BioSample; SAMN00798302
DR   Coriell; GM08949
DR   Wikidata; Q54843424
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08950
AC   CVCL_AL22
DR   CLO; CLO_0011046
DR   BioSample; SAMN00798304
DR   Coriell; GM08950
DR   Wikidata; Q54843425
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08951
AC   CVCL_AL23
DR   CLO; CLO_0011062
DR   BioSample; SAMN00798306
DR   Coriell; GM08951
DR   Wikidata; Q54843426
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08952
AC   CVCL_AL24
DR   CLO; CLO_0011061
DR   BioSample; SAMN00798308
DR   Coriell; GM08952
DR   Wikidata; Q54843427
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08953
AC   CVCL_AL25
SY   GM08953A
DR   CLO; CLO_0011060
DR   BioSample; SAMN00798310
DR   Coriell; GM08953
DR   Wikidata; Q54843436
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08953).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08954
AC   CVCL_AL26
DR   CLO; CLO_0011052
DR   BioSample; SAMN00798312
DR   Coriell; GM08954
DR   Wikidata; Q54843437
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08955
AC   CVCL_AL27
DR   CLO; CLO_0011053
DR   BioSample; SAMN00798314
DR   Coriell; GM08955
DR   Wikidata; Q54843438
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08956
AC   CVCL_AL28
DR   CLO; CLO_0011054
DR   BioSample; SAMN00798316
DR   Coriell; GM08956
DR   Wikidata; Q54843439
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08956).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08957
AC   CVCL_AL29
DR   CLO; CLO_0011055
DR   BioSample; SAMN00798318
DR   Coriell; GM08957
DR   Wikidata; Q54843440
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08958
AC   CVCL_AL30
SY   GM08958A
DR   CLO; CLO_0011056
DR   BioSample; SAMN00798320
DR   Coriell; GM08958
DR   Wikidata; Q54843441
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08958).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08959
AC   CVCL_AL31
DR   CLO; CLO_0011057
DR   BioSample; SAMN00798322
DR   Coriell; GM08959
DR   Wikidata; Q54843442
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08960
AC   CVCL_AL32
SY   GM08960C
DR   CLO; CLO_0011058
DR   BioSample; SAMN00798324
DR   Coriell; GM08960
DR   Wikidata; Q54843443
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08961
AC   CVCL_AL33
DR   CLO; CLO_0011059
DR   BioSample; SAMN00798326
DR   Coriell; GM08961
DR   Wikidata; Q54843444
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08962
AC   CVCL_AL34
DR   CLO; CLO_0011083
DR   BioSample; SAMN00798328
DR   Coriell; GM08962
DR   Wikidata; Q54843445
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM08962).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08963
AC   CVCL_AL35
DR   CLO; CLO_0011077
DR   BioSample; SAMN00798330
DR   Coriell; GM08963
DR   Wikidata; Q54843446
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08964
AC   CVCL_AL36
DR   CLO; CLO_0011078
DR   BioSample; SAMN00798332
DR   Coriell; GM08964
DR   Wikidata; Q54843447
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08965
AC   CVCL_AL37
DR   CLO; CLO_0011073
DR   BioSample; SAMN00798334
DR   Coriell; GM08965
DR   Wikidata; Q54843448
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM08965).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08966
AC   CVCL_AL38
DR   CLO; CLO_0011075
DR   BioSample; SAMN00798336
DR   Coriell; GM08966
DR   Wikidata; Q54843449
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08967
AC   CVCL_AL39
DR   CLO; CLO_0011069
DR   BioSample; SAMN00798338
DR   Coriell; GM08967
DR   Wikidata; Q54843450
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08968
AC   CVCL_AL40
DR   CLO; CLO_0011071
DR   BioSample; SAMN00798340
DR   Coriell; GM08968
DR   Wikidata; Q54843451
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08969
AC   CVCL_AL41
DR   CLO; CLO_0011067
DR   BioSample; SAMN00798342
DR   Coriell; GM08969
DR   Wikidata; Q54843452
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08969).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08970
AC   CVCL_AL42
DR   CLO; CLO_0011068
DR   BioSample; SAMN00798344
DR   Coriell; GM08970
DR   Wikidata; Q54843453
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08971
AC   CVCL_AL43
DR   CLO; CLO_0011063
DR   BioSample; SAMN00798346
DR   Coriell; GM08971
DR   Wikidata; Q54843454
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08971).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08972
AC   CVCL_AL44
DR   CLO; CLO_0011066
DR   BioSample; SAMN00798351
DR   Coriell; GM08972
DR   Wikidata; Q54843455
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08973
AC   CVCL_AL45
DR   CLO; CLO_0011096
DR   BioSample; SAMN00798353
DR   Coriell; GM08973
DR   Wikidata; Q54843456
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08974
AC   CVCL_AL46
DR   CLO; CLO_0011097
DR   BioSample; SAMN00798355
DR   Coriell; GM08974
DR   Wikidata; Q54843457
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08975
AC   CVCL_AL47
DR   CLO; CLO_0011098
DR   BioSample; SAMN00798357
DR   Coriell; GM08975
DR   Wikidata; Q54843458
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08978
AC   CVCL_AL48
DR   CLO; CLO_0011089
DR   BioSample; SAMN00798359
DR   Coriell; GM08978
DR   Wikidata; Q54843459
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08978).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08979
AC   CVCL_AL49
DR   CLO; CLO_0011091
DR   BioSample; SAMN00798361
DR   Coriell; GM08979
DR   Wikidata; Q54843460
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Homozygous (PubMed=10391211; Coriell=GM08979).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08980
AC   CVCL_AL50
SY   GM08980A
DR   CLO; CLO_0011093
DR   BioSample; SAMN00798363
DR   Coriell; GM08980
DR   Wikidata; Q54843461
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08981
AC   CVCL_AL51
SY   GM08981A
DR   CLO; CLO_0011094
DR   BioSample; SAMN00798365
DR   Coriell; GM08981
DR   Wikidata; Q54843462
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08982
AC   CVCL_AL52
DR   CLO; CLO_0011084
DR   BioSample; SAMN00798367
DR   Coriell; GM08982
DR   Wikidata; Q54843463
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08983
AC   CVCL_AL53
DR   CLO; CLO_0011085
DR   BioSample; SAMN00798369
DR   Coriell; GM08983
DR   Wikidata; Q54843464
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08984
AC   CVCL_AL54
SY   GM08984A
DR   CLO; CLO_0011086
DR   BioSample; SAMN00798371
DR   Coriell; GM08984
DR   Wikidata; Q54843465
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08985
AC   CVCL_AL55
DR   CLO; CLO_0011107
DR   BioSample; SAMN00798373
DR   Coriell; GM08985
DR   Wikidata; Q54843466
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08986
AC   CVCL_AL56
DR   CLO; CLO_0011106
DR   BioSample; SAMN00798375
DR   Coriell; GM08986
DR   Wikidata; Q54843467
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM08986).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08987
AC   CVCL_AL57
DR   CLO; CLO_0011105
DR   BioSample; SAMN00798377
DR   Coriell; GM08987
DR   Wikidata; Q54843468
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08988
AC   CVCL_AL58
DR   CLO; CLO_0011104
DR   BioSample; SAMN00798379
DR   Coriell; GM08988
DR   Wikidata; Q54843469
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08988).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08989
AC   CVCL_AL59
DR   CLO; CLO_0011111
DR   BioSample; SAMN00798381
DR   Coriell; GM08989
DR   Wikidata; Q54843470
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08990
AC   CVCL_AL60
SY   GM08990A
DR   CLO; CLO_0011110
DR   BioSample; SAMN00798383
DR   Coriell; GM08990
DR   Wikidata; Q54843471
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08990).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08991
AC   CVCL_AL61
SY   GM08991B
DR   CLO; CLO_0011109
DR   BioSample; SAMN00798385
DR   Coriell; GM08991
DR   Wikidata; Q54843472
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08992
AC   CVCL_AL62
SY   GM08992A
DR   CLO; CLO_0011108
DR   BioSample; SAMN00798387
DR   Coriell; GM08992
DR   Wikidata; Q54843473
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08993
AC   CVCL_AL63
SY   GM08993A
DR   CLO; CLO_0011113
DR   BioSample; SAMN00798389
DR   Coriell; GM08993
DR   Wikidata; Q54843474
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM08993).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM08995
AC   CVCL_AL64
DR   CLO; CLO_0011112
DR   BioSample; SAMN00798391
DR   Coriell; GM08995
DR   Wikidata; Q54843475
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08995).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08996
AC   CVCL_AL65
DR   CLO; CLO_0011114
DR   BioSample; SAMN00798393
DR   Coriell; GM08996
DR   Wikidata; Q54843483
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM08997
AC   CVCL_AL66
DR   CLO; CLO_0011116
DR   BioSample; SAMN00798395
DR   Coriell; GM08997
DR   Wikidata; Q54843484
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM08997).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM08999
AC   CVCL_AL67
DR   CLO; CLO_0011115
DR   BioSample; SAMN00798397
DR   Coriell; GM08999
DR   Wikidata; Q54843485
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09000
AC   CVCL_AL68
SY   GM09000A
DR   CLO; CLO_0011118
DR   BioSample; SAMN00798399
DR   Coriell; GM09000
DR   Wikidata; Q54843486
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09000).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09001
AC   CVCL_AL69
SY   GM09001B
DR   CLO; CLO_0011117
DR   BioSample; SAMN00798401
DR   Coriell; GM09001
DR   Wikidata; Q54843487
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09002
AC   CVCL_AL70
DR   CLO; CLO_0011120
DR   BioSample; SAMN00798403
DR   Coriell; GM09002
DR   Wikidata; Q54843488
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM09002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM09003
AC   CVCL_AL71
DR   CLO; CLO_0011119
DR   BioSample; SAMN00798405
DR   Coriell; GM09003
DR   Wikidata; Q54843489
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09004
AC   CVCL_AL72
DR   CLO; CLO_0011122
DR   BioSample; SAMN00798407
DR   Coriell; GM09004
DR   Wikidata; Q54843490
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09005
AC   CVCL_AL73
DR   CLO; CLO_0011121
DR   BioSample; SAMN00798409
DR   Coriell; GM09005
DR   Wikidata; Q54843491
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09006
AC   CVCL_AL74
DR   CLO; CLO_0011123
DR   BioSample; SAMN00798411
DR   Coriell; GM09006
DR   Wikidata; Q54843492
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09007
AC   CVCL_AL75
SY   GM09007A
DR   CLO; CLO_0011129
DR   BioSample; SAMN00798413
DR   Coriell; GM09007
DR   Wikidata; Q54843493
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09008
AC   CVCL_AL76
SY   GM09008B
DR   CLO; CLO_0011128
DR   BioSample; SAMN00798415
DR   Coriell; GM09008
DR   Wikidata; Q54843494
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09009
AC   CVCL_AL77
SY   GM09009A
DR   CLO; CLO_0011127
DR   BioSample; SAMN00798417
DR   Coriell; GM09009
DR   Wikidata; Q54843496
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09010
AC   CVCL_AL78
SY   GM09010A
DR   CLO; CLO_0011126
DR   BioSample; SAMN00798419
DR   Coriell; GM09010
DR   Wikidata; Q54843497
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09011
AC   CVCL_AL79
SY   GM09011A
DR   CLO; CLO_0011125
DR   BioSample; SAMN00798421
DR   Coriell; GM09011
DR   Wikidata; Q54843498
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09012
AC   CVCL_AL80
SY   GM09012C
DR   CLO; CLO_0011124
DR   BioSample; SAMN00798423
DR   Coriell; GM09012
DR   Wikidata; Q54843499
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM09012).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM09013
AC   CVCL_9R05
DR   CLO; CLO_0011133
DR   BioSample; SAMN00798425
DR   Coriell; GM09013
DR   Wikidata; Q54843500
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09014
AC   CVCL_9R06
SY   GM09014A
DR   CLO; CLO_0011132
DR   BioSample; SAMN00798427
DR   Coriell; GM09014
DR   Wikidata; Q54843501
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09015
AC   CVCL_N096
SY   GM18034
DR   CLO; CLO_0011131
DR   CLO; CLO_0015568
DR   BioSample; SAMN00798429
DR   Coriell; GM09015
DR   Coriell; GM18034
DR   Wikidata; Q54843502
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM09016
AC   CVCL_9R07
DR   CLO; CLO_0011130
DR   BioSample; SAMN00798431
DR   Coriell; GM09016
DR   Wikidata; Q54843503
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09017
AC   CVCL_9R08
DR   CLO; CLO_0010735
DR   BioSample; SAMN00798433
DR   Coriell; GM09017
DR   Wikidata; Q54843504
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09018
AC   CVCL_9R09
DR   CLO; CLO_0010736
DR   BioSample; SAMN00798435
DR   Coriell; GM09018
DR   Wikidata; Q54843505
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09023
AC   CVCL_9R10
DR   CLO; CLO_0010733
DR   BioSample; SAMN00798437
DR   Coriell; GM09023
DR   Wikidata; Q54843506
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09024
AC   CVCL_0L59
DR   CLO; CLO_0010734
DR   BioSample; SAMN00798439
DR   Coriell; GM09024
DR   Wikidata; Q54843507
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   GM09025
AC   CVCL_4D94
DR   CLO; CLO_0010836
DR   BioSample; SAMN00798441
DR   Coriell; GM09025
DR   Wikidata; Q54843508
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   GM09026
AC   CVCL_0L61
DR   CLO; CLO_0010837
DR   BioSample; SAMN00798443
DR   Coriell; GM09026
DR   Wikidata; Q54843509
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0L60 ! GM04599
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   GM09032
AC   CVCL_W037
SY   GM 9032; GM9032
DR   CLO; CLO_0010838
DR   BioSample; SAMN00798445
DR   Coriell; GM09032
DR   Wikidata; Q54843510
RX   CelloPub=CLPUB00447;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Gly334Asp (c.1001G>A) (G317D, 1177A); ClinVar=VCV000013672; Zygosity=Homozygous (PubMed=8675582).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM09033
AC   CVCL_W038
SY   GM 9033; GM9033
DR   CLO; CLO_0010839
DR   BioSample; SAMN00798447
DR   Coriell; GM09033
DR   Wikidata; Q54843511
RX   CelloPub=CLPUB00447;
RX   PubMed=2705456;
RX   PubMed=8675582;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Gly334Asp (c.1001G>A) (G317D, 1177A); ClinVar=VCV000013672; Zygosity=Homozygous (PubMed=8675582).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM09036
AC   CVCL_N097
SY   GM17069
DR   CLO; CLO_0010840
DR   CLO; CLO_0014573
DR   BioSample; SAMN00798449
DR   Coriell; GM09036
DR   Coriell; GM17069
DR   Wikidata; Q54843512
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 16
//
ID   GM09039
AC   CVCL_Y704
DR   CLO; CLO_0010841
DR   BioSample; SAMN00798451
DR   Coriell; GM09039
DR   Wikidata; Q54843513
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM09040
AC   CVCL_Y705
DR   CLO; CLO_0010843
DR   BioSample; SAMN00798453
DR   Coriell; GM09040
DR   Wikidata; Q54843514
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM09041
AC   CVCL_4H85
SY   GM09041A
DR   CLO; CLO_0010845
DR   Coriell; GM09041
DR   Wikidata; Q54843516
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09042
AC   CVCL_4H86
DR   CLO; CLO_0010844
DR   Coriell; GM09042
DR   Wikidata; Q54843517
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09043
AC   CVCL_4H87
DR   CLO; CLO_0010847
DR   Coriell; GM09043
DR   Wikidata; Q54843518
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09044
AC   CVCL_4H88
DR   CLO; CLO_0010846
DR   Coriell; GM09044
DR   Wikidata; Q54843519
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09045
AC   CVCL_4H89
DR   CLO; CLO_0010869
DR   Coriell; GM09045
DR   Wikidata; Q54843520
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09046
AC   CVCL_4H90
DR   CLO; CLO_0010871
DR   Coriell; GM09046
DR   Wikidata; Q54843521
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09047
AC   CVCL_AU22
SY   GM09047A
DR   CLO; CLO_0010866
DR   BioSample; SAMN00798455
DR   Coriell; GM09047
DR   Wikidata; Q54843522
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09048
AC   CVCL_AU23
DR   CLO; CLO_0010867
DR   BioSample; SAMN00798457
DR   Coriell; GM09048
DR   Wikidata; Q54843523
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09049
AC   CVCL_AU24
DR   CLO; CLO_0010872
DR   BioSample; SAMN00798459
DR   Coriell; GM09049
DR   Wikidata; Q54843524
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09050
AC   CVCL_AU25
SY   GM09050B
DR   CLO; CLO_0010874
DR   BioSample; SAMN00798461
DR   Coriell; GM09050
DR   Wikidata; Q54843534
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09051
AC   CVCL_AU26
SY   GM09051A
DR   CLO; CLO_0010873
DR   BioSample; SAMN00798463
DR   Coriell; GM09051
DR   Wikidata; Q54843535
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09052
AC   CVCL_AU27
DR   CLO; CLO_0010878
DR   BioSample; SAMN00798465
DR   Coriell; GM09052
DR   Wikidata; Q54843536
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09053
AC   CVCL_AU28
DR   CLO; CLO_0010877
DR   BioSample; SAMN00798467
DR   Coriell; GM09053
DR   Wikidata; Q54843537
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09054
AC   CVCL_AU29
DR   CLO; CLO_0010876
DR   BioSample; SAMN00798469
DR   Coriell; GM09054
DR   Wikidata; Q54843538
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09055
AC   CVCL_AU30
DR   CLO; CLO_0010875
DR   BioSample; SAMN00798471
DR   Coriell; GM09055
DR   Wikidata; Q54843539
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09056
AC   CVCL_AU31
DR   CLO; CLO_0010784
DR   BioSample; SAMN00798473
DR   Coriell; GM09056
DR   Wikidata; Q54843540
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09057
AC   CVCL_AU32
SY   GM09057A
DR   CLO; CLO_0010787
DR   BioSample; SAMN00798475
DR   Coriell; GM09057
DR   Wikidata; Q54843541
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09058
AC   CVCL_AU33
DR   CLO; CLO_0010789
DR   BioSample; SAMN00798477
DR   Coriell; GM09058
DR   Wikidata; Q54843542
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09059
AC   CVCL_AU34
DR   CLO; CLO_0010790
DR   BioSample; SAMN00798479
DR   Coriell; GM09059
DR   Wikidata; Q54843543
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09060
AC   CVCL_AU35
DR   CLO; CLO_0010795
DR   BioSample; SAMN00798481
DR   Coriell; GM09060
DR   Wikidata; Q54843544
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09061
AC   CVCL_AU36
DR   CLO; CLO_0010797
DR   BioSample; SAMN00798483
DR   Coriell; GM09061
DR   Wikidata; Q54843545
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09062
AC   CVCL_AU37
SY   GM09062A
DR   CLO; CLO_0010796
DR   BioSample; SAMN00798485
DR   Coriell; GM09062
DR   Wikidata; Q54843546
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09063
AC   CVCL_W298
DR   CLO; CLO_0010792
DR   BioSample; SAMN00798487
DR   Coriell; GM09063
DR   Wikidata; Q54843547
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM09065
AC   CVCL_AU38
DR   CLO; CLO_0010791
DR   BioSample; SAMN00798489
DR   Coriell; GM09065
DR   Wikidata; Q54843548
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09066
AC   CVCL_AU39
DR   CLO; CLO_0010794
DR   BioSample; SAMN00798491
DR   Coriell; GM09066
DR   Wikidata; Q54843549
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09067
AC   CVCL_AU40
DR   CLO; CLO_0010793
DR   BioSample; SAMN00798493
DR   Coriell; GM09067
DR   Wikidata; Q54843550
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Homozygous; Note=New splice site creation (from familial inference of GM09070; GM09072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM09068
AC   CVCL_AU41
SY   GM09068B
DR   CLO; CLO_0010807
DR   BioSample; SAMN00798495
DR   Coriell; GM09068
DR   Wikidata; Q54843551
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09069
AC   CVCL_AU42
SY   GM09069A
DR   CLO; CLO_0010809
DR   BioSample; SAMN00798497
DR   Coriell; GM09069
DR   Wikidata; Q54843552
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM09070; GM09072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM09070
AC   CVCL_AU43
DR   CLO; CLO_0010804
DR   BioSample; SAMN00798499
DR   Coriell; GM09070
DR   Wikidata; Q54843553
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Homozygous; Note=New splice site creation (PubMed=15578223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM09071
AC   CVCL_AU44
DR   CLO; CLO_0010818
DR   BioSample; SAMN00798501
DR   Coriell; GM09071
DR   Wikidata; Q54843554
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM09070; GM09072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM09072
AC   CVCL_AU45
DR   CLO; CLO_0010817
DR   BioSample; SAMN00798503
DR   Coriell; GM09072
DR   Wikidata; Q54843555
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (PubMed=15578223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM09073
AC   CVCL_AU46
DR   CLO; CLO_0010816
DR   BioSample; SAMN00798505
DR   Coriell; GM09073
DR   Wikidata; Q54843556
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM09070; GM09072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM09074
AC   CVCL_AU47
DR   CLO; CLO_0010815
DR   BioSample; SAMN00798507
DR   Coriell; GM09074
DR   Wikidata; Q54843557
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Homozygous; Note=New splice site creation (from familial inference of GM09070; GM09072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM09075
AC   CVCL_AU48
SY   GM09075B
DR   CLO; CLO_0010814
DR   BioSample; SAMN00798509
DR   Coriell; GM09075
DR   Wikidata; Q54843558
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09076
AC   CVCL_AU49
DR   CLO; CLO_0010813
DR   BioSample; SAMN00798511
DR   Coriell; GM09076
DR   Wikidata; Q54843559
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM09070; GM09072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM09077
AC   CVCL_AU50
DR   CLO; CLO_0010812
DR   BioSample; SAMN00798513
DR   Coriell; GM09077
DR   Wikidata; Q54843560
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM09070; GM09072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM09078
AC   CVCL_AU51
SY   GM09078A
DR   CLO; CLO_0010811
DR   BioSample; SAMN00798515
DR   Coriell; GM09078
DR   Wikidata; Q54843561
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09079
AC   CVCL_AU52
DR   CLO; CLO_0010651
DR   BioSample; SAMN00798517
DR   Coriell; GM09079
DR   Wikidata; Q54843562
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09080
AC   CVCL_AU53
DR   CLO; CLO_0010650
DR   BioSample; SAMN00798519
DR   Coriell; GM09080
DR   Wikidata; Q54843563
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09081
AC   CVCL_AU54
SY   GM09081B
DR   CLO; CLO_0010641
DR   BioSample; SAMN00798521
DR   Coriell; GM09081
DR   Wikidata; Q54843564
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09082
AC   CVCL_AU55
SY   GM09082A
DR   CLO; CLO_0010644
DR   BioSample; SAMN00798523
DR   Coriell; GM09082
DR   Wikidata; Q54843565
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09083
AC   CVCL_W299
DR   CLO; CLO_0010645
DR   BioSample; SAMN00798525
DR   Coriell; GM09083
DR   Wikidata; Q54843566
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM09084
AC   CVCL_AU56
SY   GM09084C
DR   CLO; CLO_0010642
DR   BioSample; SAMN00798527
DR   Coriell; GM09084
DR   Wikidata; Q54843567
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09085
AC   CVCL_AU57
DR   CLO; CLO_0010643
DR   BioSample; SAMN00798529
DR   Coriell; GM09085
DR   Wikidata; Q54843568
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09086
AC   CVCL_AU58
DR   CLO; CLO_0010648
DR   BioSample; SAMN00798531
DR   Coriell; GM09086
DR   Wikidata; Q54843569
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09087
AC   CVCL_AU59
DR   CLO; CLO_0010649
DR   BioSample; SAMN00798533
DR   Coriell; GM09087
DR   Wikidata; Q54843570
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09089
AC   CVCL_AU60
DR   CLO; CLO_0010646
DR   BioSample; SAMN00798535
DR   Coriell; GM09089
DR   Wikidata; Q54843571
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM09090
AC   CVCL_W300
DR   CLO; CLO_0010647
DR   BioSample; SAMN00798537
DR   Coriell; GM09090
DR   Wikidata; Q54843572
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   GM09091
AC   CVCL_N098
SY   GM17230
DR   CLO; CLO_0010662
DR   CLO; CLO_0014347
DR   BioSample; SAMN00798539
DR   Coriell; GM09091
DR   Coriell; GM17230
DR   GEO; GSM569594
DR   GEO; GSM596294
DR   GEO; GSM596654
DR   GEO; GSM924832
DR   Wikidata; Q54843573
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,32:01:01; B*15:01:01,27:05:02; C*01:02:01,02:02:02; DPA1*01:03:01,02:01:01; DPB1*03:01:01,10:01:01; DQA1*01:01:01,03:01:01; DQB1*03:02:01,05:01:01; DRB1*01:01:01,04:04:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM09093
AC   CVCL_4F61
DR   CLO; CLO_0010652
DR   BioSample; SAMN00798541
DR   Coriell; GM09093
DR   Wikidata; Q54843582
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98647; Very long-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26793; Very long chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM09099
AC   CVCL_N099
SY   GM17286
DR   CLO; CLO_0010653
DR   CLO; CLO_0013086
DR   BioSample; SAMN00798543
DR   Coriell; GM09099
DR   Coriell; GM17286
DR   GEO; GSM569739
DR   GEO; GSM596350
DR   GEO; GSM596768
DR   GEO; GSM924888
DR   Wikidata; Q54843583
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,03:01:01; B*14:02:01,45:01:01; C*06:02:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,04:02:01; DQA1*01:02:01,02:01:01; DQB1*02:02:01,06:09:01; DRB1*07:01:01,13:02:01; DRB3*03:01:01; DRB4*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM09100
AC   CVCL_AA69
DR   CLO; CLO_0010654
DR   BioSample; SAMN00798545
DR   Coriell; GM09100
DR   Wikidata; Q54843584
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09101
AC   CVCL_5N94
DR   CLO; CLO_0010655
DR   BioSample; SAMN00798547
DR   Coriell; GM09101
DR   Wikidata; Q54843585
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM09102
AC   CVCL_5N95
DR   CLO; CLO_0010656
DR   Coriell; GM09102
DR   Wikidata; Q54843587
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM09110
AC   CVCL_CY57
SY   GM09110A
DR   CLO; CLO_0010657
DR   BioSample; SAMN00798549
DR   Coriell; GM09110
DR   Wikidata; Q54843588
RX   CelloPub=CLPUB00447;
RX   PubMed=7395865;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM09112
AC   CVCL_CY58
SY   GM09112A
DR   CLO; CLO_0010658
DR   BioSample; SAMN00798551
DR   Coriell; GM09112
DR   Wikidata; Q54843589
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM09113
AC   CVCL_CY59
DR   CLO; CLO_0010659
DR   BioSample; SAMN00798553
DR   Coriell; GM09113
DR   Wikidata; Q54843590
RX   CelloPub=CLPUB00447;
RX   PubMed=10617919;
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:8091; OAT; Simple; p.Glu318Lys (c.952G>A); ClinVar=VCV000207045; Zygosity=Homozygous (PubMed=10617919).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM09115
AC   CVCL_CY60
DR   CLO; CLO_0010660
DR   BioSample; SAMN00798555
DR   Coriell; GM09115
DR   Wikidata; Q54843591
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM09116
AC   CVCL_CY61
DR   CLO; CLO_0010661
DR   BioSample; SAMN00798557
DR   Coriell; GM09116
DR   Wikidata; Q54843592
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM09117
AC   CVCL_CY62
DR   CLO; CLO_0010623
DR   BioSample; SAMN00798559
DR   Coriell; GM09117
DR   Wikidata; Q54843593
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM09118
AC   CVCL_CY63
SY   GM09118A
DR   CLO; CLO_0010621
DR   BioSample; SAMN00798561
DR   Coriell; GM09118
DR   Wikidata; Q54843594
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84744; Gyrate atrophy
DI   ORDO; Orphanet_414; Gyrate atrophy of choroid and retina
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM09132
AC   CVCL_1P22
SY   GM9132
DR   CLO; CLO_0010622
DR   BioSample; SAMN00798563
DR   Coriell; GM09132
DR   Wikidata; Q54843595
RX   CelloPub=CLPUB00447;
RX   PubMed=1505951;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM09133
AC   CVCL_5N96
DR   CLO; CLO_0010629
DR   BioSample; SAMN00798565
DR   Coriell; GM09133
DR   Wikidata; Q54843596
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM09138
AC   CVCL_4H91
SY   GM9138
DR   CLO; CLO_0010630
DR   Coriell; GM09138
DR   Wikidata; Q54843597
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09142
AC   CVCL_1R81
SY   C2-T10
DR   CLO; CLO_0010627
DR   Coriell; GM09142
DR   Wikidata; Q54843598
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM09145
AC   CVCL_AY27
SY   GM9145
DR   CLO; CLO_0010628
DR   BioSample; SAMN00798567
DR   Coriell; GM09145
DR   Wikidata; Q54843599
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09146
AC   CVCL_AY28
DR   CLO; CLO_0010625
DR   BioSample; SAMN00798569
DR   Coriell; GM09146
DR   Wikidata; Q54843600
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09153
AC   CVCL_BT22
DR   CLO; CLO_0010626
DR   BioSample; SAMN00798571
DR   Coriell; GM09153
DR   Wikidata; Q54843601
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Gln40Ter (c.118C>T) (Q39*); ClinVar=VCV000015402; Zygosity=Homozygous (Coriell=GM09153).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM09154
AC   CVCL_Y574
DR   CLO; CLO_0010624
DR   BioSample; SAMN00798573
DR   Coriell; GM09154
DR   Wikidata; Q54843602
CC   Population: Hispanic.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM09189
AC   CVCL_5N97
DR   CLO; CLO_0010631
DR   BioSample; SAMN00798575
DR   Coriell; GM09189
DR   Wikidata; Q54843603
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM09192
AC   CVCL_2T61
DR   CLO; CLO_0010633
DR   BioSample; SAMN00798577
DR   Coriell; GM09192
DR   Wikidata; Q54843604
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM09193
AC   CVCL_4H92
SY   GM09193A
DR   CLO; CLO_0010634
DR   Coriell; GM09193
DR   Wikidata; Q54843605
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09194
AC   CVCL_1L29
DR   CLO; CLO_0010637
DR   BioSample; SAMN00798579
DR   Coriell; GM09194
DR   Wikidata; Q54843606
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1L31 ! GM09230
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM09195
AC   CVCL_1L30
DR   CLO; CLO_0010638
DR   BioSample; SAMN00798581
DR   Coriell; GM09195
DR   Wikidata; Q54843607
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1L32 ! GM09231
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM09196
AC   CVCL_N100
SY   GM17231
DR   CLO; CLO_0010639
DR   CLO; CLO_0014341
DR   BioSample; SAMN00798583
DR   Coriell; GM09196
DR   Coriell; GM17231
DR   GEO; GSM569606
DR   GEO; GSM596295
DR   GEO; GSM596655
DR   GEO; GSM924833
DR   Wikidata; Q54843608
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*03:01:01,03:01:01; B*07:02:01,40:01:02; C*03:04:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:01:01G; DQA1*01:01:01,01:02:01; DQB1*05:01:01,06:04:01; DRB1*01:01:01,13:02:01; DRB3*03:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N101 ! GM09232
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM09197
AC   CVCL_W576
DR   CLO; CLO_0010640
DR   BioSample; SAMN00798585
DR   Coriell; GM09197
DR   Wikidata; Q54843609
RX   CelloPub=CLPUB00447;
RX   PubMed=25732146;
RX   PubMed=25928884;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=25928884).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM09208
AC   CVCL_5U22
SY   MDS3 Fib
DR   CLO; CLO_0010635
DR   Coriell; GM09208
DR   Wikidata; Q54843610
RX   CelloPub=CLPUB00447;
RX   PubMed=24413397;
CC   Derived from site: In situ; Fetal diaphragm, skeletal muscle; UBERON=UBERON_0010084+UBERON_0004495.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5U23 ! GM09209
OI   CVCL_5U24 ! GM09210
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09209
AC   CVCL_5U23
DR   CLO; CLO_0010636
DR   Coriell; GM09209
DR   Wikidata; Q54843611
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5U22 ! GM09208
OI   CVCL_5U24 ! GM09210
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM09210
AC   CVCL_5U24
DR   CLO; CLO_0010688
DR   Coriell; GM09210
DR   Wikidata; Q54843612
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5U22 ! GM09208
OI   CVCL_5U23 ! GM09209
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09211
AC   CVCL_4H93
DR   CLO; CLO_0010692
DR   Coriell; GM09211
DR   Wikidata; Q54843613
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09212
AC   CVCL_4H94
DR   CLO; CLO_0010691
DR   Coriell; GM09212
DR   Wikidata; Q54843614
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09213
AC   CVCL_4H95
DR   CLO; CLO_0010690
DR   Coriell; GM09213
DR   Wikidata; Q54843615
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09214
AC   CVCL_4H96
DR   CLO; CLO_0010689
DR   Coriell; GM09214
DR   Wikidata; Q54843616
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09215
AC   CVCL_4H97
DR   CLO; CLO_0010686
DR   Coriell; GM09215
DR   Wikidata; Q54843617
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09216
AC   CVCL_V823
DR   CLO; CLO_0010685
DR   BioSample; SAMN00798587
DR   Coriell; GM09216
DR   Wikidata; Q54843618
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V798 ! GM01138
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM09217
AC   CVCL_AA70
DR   CLO; CLO_0010684
DR   BioSample; SAMN00798589
DR   Coriell; GM09217
DR   Wikidata; Q54843619
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Ser375Phe (c.1124C>T) (p.Ser374Phe, c.1121C>T) (S376F); ClinVar=VCV000012267; Zygosity=Homozygous (Coriell=GM09217).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM09218
AC   CVCL_AA71
DR   CLO; CLO_0010683
DR   BioSample; SAMN00798591
DR   Coriell; GM09218
DR   Wikidata; Q54843620
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Ser375Phe (c.1124C>T) (p.Ser374Phe, c.1121C>T) (S376F); ClinVar=VCV000012267; Zygosity=Homozygous (Coriell=GM09218).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM09229
AC   CVCL_4D95
DR   CLO; CLO_0010687
DR   BioSample; SAMN00798593
DR   Coriell; GM09229
DR   Wikidata; Q54843621
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(12)(p13.3;q24.33) [18]; 46,XY,inv(12)(p11.2;q24.33) [13]; 45,X [9]; 45,XY,-12 [2]; 46,XY [8] (Coriell=GM09229).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM09230
AC   CVCL_1L31
DR   CLO; CLO_0012009
DR   BioSample; SAMN00798595
DR   Coriell; GM09230
DR   Wikidata; Q54843622
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1L29 ! GM09194
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM09231
AC   CVCL_1L32
DR   CLO; CLO_0012007
DR   BioSample; SAMN00798597
DR   Coriell; GM09231
DR   Wikidata; Q54843627
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1L30 ! GM09195
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM09232
AC   CVCL_N101
DR   CLO; CLO_0012008
DR   BioSample; SAMN00798599
DR   Coriell; GM09232
DR   Wikidata; Q54843628
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N100 ! GM09196
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   GM09236
AC   CVCL_AY29
SY   GM09236A
DR   CLO; CLO_0012038
DR   Coriell; GM09236
DR   Wikidata; Q54843629
RX   CelloPub=CLPUB00447;
RX   PubMed=32656337;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09237
AC   CVCL_AY30
SY   GM9237
DR   CLO; CLO_0012037
DR   Coriell; GM09237
DR   Wikidata; Q54843630
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
RX   PubMed=25776194;
RX   PubMed=32656337;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[935]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194; PubMed=32656337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM09238
AC   CVCL_AY31
SY   GM9238
DR   CLO; CLO_0012040
DR   Coriell; GM09238
DR   Wikidata; Q54843631
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM09239
AC   CVCL_4J58
DR   CLO; CLO_0012039
DR   Coriell; GM09239
DR   Wikidata; Q54843632
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4982; HMBS; Simple; c.33+1G>A (IVS1+1G>A); ClinVar=VCV000001441; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM09239).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84536; Acute intermittent porphyria
DI   ORDO; Orphanet_79276; Acute intermittent porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM09246
AC   CVCL_1L53
SY   GM09246A; GM09246B
DR   CLO; CLO_0012033
DR   Coriell; GM09246
DR   Wikidata; Q54843633
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German/Swiss.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM09247
AC   CVCL_1L54
SY   GM09247B
DR   CLO; CLO_0012031
DR   Coriell; GM09247
DR   Wikidata; Q54843634
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German/Swiss.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM09252
AC   CVCL_1L55
SY   GM09252A
DR   CLO; CLO_0012036
DR   Coriell; GM09252
DR   Wikidata; Q54843635
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German/Swiss.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM09254
AC   CVCL_1L56
SY   GM09254A; GM09254B
DR   CLO; CLO_0012020
DR   Coriell; GM09254
DR   Wikidata; Q54843636
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German/Swiss.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM09255
AC   CVCL_V134
SY   GM09255A
DR   CLO; CLO_0012021
DR   Coriell; GM09255
DR   GEO; GSM1257725
DR   GEO; GSM1266903
DR   GEO; GSM1266999
DR   Wikidata; Q54843637
RX   CelloPub=CLPUB00447;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian; English/German.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   GM09256
AC   CVCL_V135
SY   GM09256B
DR   CLO; CLO_0012022
DR   Coriell; GM09256
DR   GEO; GSM1257726
DR   GEO; GSM1266904
DR   GEO; GSM1267000
DR   Wikidata; Q54843638
RX   CelloPub=CLPUB00447;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   Population: Caucasian; English/German.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   GM09257
AC   CVCL_V136
SY   GM09257A
DR   CLO; CLO_0012023
DR   Coriell; GM09257
DR   GEO; GSM1266905
DR   Wikidata; Q54843639
RX   CelloPub=CLPUB00447;
RX   PubMed=25326100;
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   GM09276
AC   CVCL_IW08
DR   CLO; CLO_0012061
DR   Coriell; GM09276
DR   Wikidata; Q54843640
RX   CelloPub=CLPUB00447;
RX   PubMed=12560874;
CC   Sequence variation: Mutation; HGNC; HGNC:2312; CPN1; Simple; p.Arg58Glufs (c.173dup) (c.172insG) (385fsinsG); ClinVar=VCV000006622; Zygosity=Heterozygous (Coriell=GM09276).
CC   Sequence variation: Mutation; HGNC; HGNC:2312; CPN1; Simple; p.Gly178Asp (c.533G>A); ClinVar=VCV000006623; Zygosity=Heterozygous (Coriell=GM09276).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132196; Carboxypeptidase N deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   GM09282
AC   CVCL_1K61
SY   GM 9282
DR   CLO; CLO_0012060
DR   Coriell; GM09282
DR   Wikidata; Q54843642
RX   CelloPub=CLPUB00447;
RX   PubMed=1652892;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09283
AC   CVCL_N102
SY   GM17076
DR   CLO; CLO_0012059
DR   CLO; CLO_0014607
DR   Coriell; GM09283
DR   Coriell; GM17076
DR   Wikidata; Q54843643
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09284
AC   CVCL_N103
SY   GM17077
DR   CLO; CLO_0012058
DR   CLO; CLO_0014610
DR   Coriell; GM09284
DR   Coriell; GM17077
DR   Wikidata; Q54843645
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09285
AC   CVCL_2T62
DR   CLO; CLO_0012057
DR   Coriell; GM09285
DR   Wikidata; Q54843646
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM09286
AC   CVCL_9S92
DR   CLO; CLO_0012056
DR   Coriell; GM09286
DR   Wikidata; Q54843647
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Karyotypic information: 47,XY,+9 (Coriell=GM09286).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S93 ! GM09287
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09287
AC   CVCL_9S93
DR   CLO; CLO_0012045
DR   Coriell; GM09287
DR   Wikidata; Q54843648
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Karyotypic information: 47,XY,+9 (Coriell=GM09287).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S92 ! GM09286
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09290
AC   CVCL_2T63
SY   GM09290A
DR   CLO; CLO_0012043
DR   Coriell; GM09290
DR   Wikidata; Q54843649
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;6)(1pter->1q43::6q23->6qter;6pter->6q23::1q43->1qter) (Coriell=GM09290).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM09291
AC   CVCL_9X08
DR   CLO; CLO_0012044
DR   Coriell; GM09291
DR   Wikidata; Q54843650
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X11 ! GM09399
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09292
AC   CVCL_9X09
DR   CLO; CLO_0012041
DR   Coriell; GM09292
DR   Wikidata; Q54843651
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X12 ! GM09400
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09293
AC   CVCL_9X10
DR   CLO; CLO_0012042
DR   Coriell; GM09293
DR   Wikidata; Q54843652
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X13 ! GM09401
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09294
AC   CVCL_AA72
DR   CLO; CLO_0011880
DR   Coriell; GM09294
DR   Wikidata; Q54843653
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09295
AC   CVCL_AA73
DR   CLO; CLO_0011882
DR   Coriell; GM09295
DR   Wikidata; Q54843655
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM09295).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (Coriell=GM09295).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg247Trp (c.739C>T); ClinVar=VCV000003922; Zygosity=Homozygous (Coriell=GM09295).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   GM09296
AC   CVCL_AA74
DR   CLO; CLO_0011883
DR   Coriell; GM09296
DR   Wikidata; Q54843656
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM09296).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09297
AC   CVCL_AA75
DR   CLO; CLO_0011884
DR   Coriell; GM09297
DR   Wikidata; Q54843657
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09298
AC   CVCL_AA76
DR   CLO; CLO_0011885
DR   Coriell; GM09298
DR   Wikidata; Q54843658
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09299
AC   CVCL_AA77
DR   CLO; CLO_0011874
DR   Coriell; GM09299
DR   Wikidata; Q54843659
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09300
AC   CVCL_AA78
DR   CLO; CLO_0011873
DR   Coriell; GM09300
DR   Wikidata; Q54843660
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09301
AC   CVCL_N104
SY   GM17365
DR   CLO; CLO_0011876
DR   CLO; CLO_0013708
DR   Coriell; GM09301
DR   Coriell; GM17365
DR   Wikidata; Q54843661
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   HLA typing: A*23:01:01,30:01:01; B*13:02:01,49:01:01; C*06:02:01,07:01:01; DPA1*01:03:01,02:01:01; DPB1*04:01:01,17:01:01; DQA1*02:01:01,05:05:01; DQB1*02:02:01,03:01:01; DRB1*07:01:01,11:04:01; DRB3*02:02:01; DRB4*01:03:0 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM09302
AC   CVCL_AA79
DR   CLO; CLO_0011875
DR   Coriell; GM09302
DR   Wikidata; Q54843662
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09303
AC   CVCL_8A08
DR   CLO; CLO_0011878
DR   Coriell; GM09303
DR   Wikidata; Q54843663
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09304
AC   CVCL_8A09
DR   CLO; CLO_0011877
DR   Coriell; GM09304
DR   Wikidata; Q54843664
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09305
AC   CVCL_AA03
DR   CLO; CLO_0011915
DR   Coriell; GM09305
DR   Wikidata; Q54843665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09306
AC   CVCL_N105
SY   GM17232
DR   CLO; CLO_0011918
DR   CLO; CLO_0014344
DR   Coriell; GM09306
DR   Coriell; GM17232
DR   GEO; GSM569607
DR   GEO; GSM596296
DR   GEO; GSM596656
DR   GEO; GSM924834
DR   Wikidata; Q54843666
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:02:01,33:01:01; B*14:02:01,18:01:01; C*08:02:01,15:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,23:01:01; DQA1*01:01:02,02:01:01; DQB1*03:03:02,05:01:01; DRB1*01:02:01,07:01:01; DRB4*01:03:01:02N (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM09307
AC   CVCL_AA04
DR   CLO; CLO_0011913
DR   Coriell; GM09307
DR   Wikidata; Q54843667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09310
AC   CVCL_8A10
DR   CLO; CLO_0011914
DR   Coriell; GM09310
DR   Wikidata; Q54843668
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09311
AC   CVCL_8A11
DR   CLO; CLO_0011907
DR   Coriell; GM09311
DR   Wikidata; Q54843669
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09316
AC   CVCL_AY32
SY   GM9316; GM09316A
DR   CLO; CLO_0011906
DR   Coriell; GM09316
DR   Wikidata; Q54843675
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM09317
AC   CVCL_AY33
SY   GM9317
DR   CLO; CLO_0011905
DR   Coriell; GM09317
DR   Wikidata; Q54843676
RX   CelloPub=CLPUB00447;
RX   PubMed=1672039;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM09324
AC   CVCL_CZ25
DR   CLO; CLO_0011911
DR   Coriell; GM09324
DR   Wikidata; Q54843677
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,XX,inv(7)(pter->p13::q22->p13::q22->qter) (Coriell=GM09324).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09325
AC   CVCL_CZ26
DR   CLO; CLO_0011910
DR   Coriell; GM09325
DR   Wikidata; Q54843678
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09326
AC   CVCL_W637
DR   CLO; CLO_0011909
DR   Coriell; GM09326
DR   Wikidata; Q54843679
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English/Irish.
CC   Karyotypic information: 47,XYY (Coriell=GM09326).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM09329
AC   CVCL_8A12
DR   CLO; CLO_0011908
DR   Coriell; GM09329
DR   Wikidata; Q54843680
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09330
AC   CVCL_8A13
DR   CLO; CLO_0011946
DR   Coriell; GM09330
DR   Wikidata; Q54843681
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09331
AC   CVCL_8A14
DR   CLO; CLO_0011947
DR   Coriell; GM09331
DR   Wikidata; Q54843682
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09332
AC   CVCL_5N98
DR   CLO; CLO_0011950
DR   Coriell; GM09332
DR   Wikidata; Q54843683
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM09333
AC   CVCL_JE50
DR   CLO; CLO_0011942
DR   Coriell; GM09333
DR   Wikidata; Q54843684
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3267; Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM09335
AC   CVCL_5L71
DR   CLO; CLO_0011941
DR   Coriell; GM09335
DR   Wikidata; Q54843685
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09335).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09337
AC   CVCL_5L72
DR   CLO; CLO_0011944
DR   Coriell; GM09337
DR   Wikidata; Q54843686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09338
AC   CVCL_5L73
DR   CLO; CLO_0011943
DR   Coriell; GM09338
DR   Wikidata; Q54843687
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09338).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09339
AC   CVCL_5L74
DR   CLO; CLO_0011938
DR   Coriell; GM09339
DR   Wikidata; Q54843688
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09339).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09340
AC   CVCL_5L75
DR   CLO; CLO_0011937
DR   Coriell; GM09340
DR   Wikidata; Q54843689
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09340).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09341
AC   CVCL_5L76
DR   CLO; CLO_0011940
DR   Coriell; GM09341
DR   Wikidata; Q54843690
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09341).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09342
AC   CVCL_5L77
DR   CLO; CLO_0011939
DR   Coriell; GM09342
DR   Wikidata; Q54843691
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09343
AC   CVCL_5L78
DR   CLO; CLO_0011982
DR   Coriell; GM09343
DR   Wikidata; Q54843692
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09343).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09344
AC   CVCL_5L79
DR   CLO; CLO_0011984
DR   Coriell; GM09344
DR   Wikidata; Q54843694
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09344).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09348
AC   CVCL_5L80
DR   CLO; CLO_0011966
DR   Coriell; GM09348
DR   Wikidata; Q54843695
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09348).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09349
AC   CVCL_5L81
DR   CLO; CLO_0011977
DR   Coriell; GM09349
DR   Wikidata; Q54843696
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09351
AC   CVCL_5L82
DR   CLO; CLO_0011976
DR   Coriell; GM09351
DR   Wikidata; Q54843697
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09351).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09353
AC   CVCL_5L83
DR   CLO; CLO_0011975
DR   Coriell; GM09353
DR   Wikidata; Q54843698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09354
AC   CVCL_5L84
DR   CLO; CLO_0011974
DR   Coriell; GM09354
DR   Wikidata; Q54843699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09359
AC   CVCL_5L85
DR   CLO; CLO_0011973
DR   Coriell; GM09359
DR   Wikidata; Q54843700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09366
AC   CVCL_5L86
DR   CLO; CLO_0011972
DR   Coriell; GM09366
DR   Wikidata; Q54843701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09367
AC   CVCL_5N99
DR   CLO; CLO_0011971
DR   Coriell; GM09367
DR   Wikidata; Q54843702
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM09373
AC   CVCL_5L87
DR   CLO; CLO_0011970
DR   Coriell; GM09373
DR   Wikidata; Q54843703
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Ser1232Thrfs*92 (c.3693_3696delGTCT) (Leu1231fs*1323) (c.3693delGTCT); ClinVar=VCV000050013; Zygosity=Unspecified (Coriell=GM09373).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM09374
AC   CVCL_5L88
DR   CLO; CLO_0011842
DR   Coriell; GM09374
DR   Wikidata; Q54843704
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Ser1232Thrfs*92 (c.3693_3696delGTCT) (Leu1231fs*1323) (c.3693delGTCT); ClinVar=VCV000050013; Zygosity=Unspecified (Coriell=GM09374).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM09375
AC   CVCL_5L89
DR   CLO; CLO_0011851
DR   Coriell; GM09375
DR   Wikidata; Q54843705
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM09376
AC   CVCL_5L90
DR   CLO; CLO_0011852
DR   Coriell; GM09376
DR   Wikidata; Q54843706
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Ser1232Thrfs*92 (c.3693_3696delGTCT) (Leu1231fs*1323) (c.3693delGTCT); ClinVar=VCV000050013; Zygosity=Unspecified (Coriell=GM09376).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM09377
AC   CVCL_5L91
DR   CLO; CLO_0011845
DR   Coriell; GM09377
DR   Wikidata; Q54843707
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Ser1232Thrfs*92 (c.3693_3696delGTCT) (Leu1231fs*1323) (c.3693delGTCT); ClinVar=VCV000050013; Zygosity=Unspecified (Coriell=GM09377).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM09378
AC   CVCL_5L92
DR   CLO; CLO_0011846
DR   Coriell; GM09378
DR   Wikidata; Q54843708
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Ser1232Thrfs*92 (c.3693_3696delGTCT) (Leu1231fs*1323) (c.3693delGTCT); ClinVar=VCV000050013; Zygosity=Unspecified (Coriell=GM09378).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM09379
AC   CVCL_5L93
DR   CLO; CLO_0011843
DR   Coriell; GM09379
DR   Wikidata; Q54843710
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Ser1232Thrfs*92 (c.3693_3696delGTCT) (Leu1231fs*1323) (c.3693delGTCT); ClinVar=VCV000050013; Zygosity=Unspecified (Coriell=GM09379).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM09380
AC   CVCL_5L94
DR   CLO; CLO_0011844
DR   Coriell; GM09380
DR   Wikidata; Q54843711
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM09381
AC   CVCL_8A15
DR   CLO; CLO_0011849
DR   Coriell; GM09381
DR   Wikidata; Q54843712
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09382
AC   CVCL_8A16
DR   CLO; CLO_0011850
DR   Coriell; GM09382
DR   Wikidata; Q54843713
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09383
AC   CVCL_8A17
SY   GM09383A
DR   CLO; CLO_0011847
DR   Coriell; GM09383
DR   Wikidata; Q54843714
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09384
AC   CVCL_8A18
DR   CLO; CLO_0011848
DR   Coriell; GM09384
DR   Wikidata; Q54843715
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09385
AC   CVCL_8A19
DR   CLO; CLO_0011860
DR   Coriell; GM09385
DR   Wikidata; Q54843716
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09399
AC   CVCL_9X11
DR   CLO; CLO_0011861
DR   Coriell; GM09399
DR   Wikidata; Q54843725
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X08 ! GM09291
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09400
AC   CVCL_9X12
SY   GM09400A
DR   CLO; CLO_0011862
DR   Coriell; GM09400
DR   Wikidata; Q54843726
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X09 ! GM09292
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09401
AC   CVCL_9X13
DR   CLO; CLO_0011853
DR   Coriell; GM09401
DR   Wikidata; Q54843727
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X10 ! GM09293
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09402
AC   CVCL_9Y62
DR   CLO; CLO_0011854
DR   Coriell; GM09402
DR   Wikidata; Q54843728
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09403
AC   CVCL_2T64
DR   CLO; CLO_0011855
DR   Coriell; GM09403
DR   Wikidata; Q54843729
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM09404
AC   CVCL_DA29
DR   CLO; CLO_0011856
DR   Coriell; GM09404
DR   Wikidata; Q54843730
RX   CelloPub=CLPUB00447;
RX   PubMed=17056595;
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Ile287Asn (c.860T>A); ClinVar=VCV000068750; Zygosity=Heterozygous (Coriell=GM09404).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM09405
AC   CVCL_UR82
DR   Coriell; GM09405
DR   Wikidata; Q93803387
RX   CelloPub=CLPUB00447;
RX   PubMed=9247083;
CC   Discontinued: Coriell; GM09405; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 7
//
ID   GM09407
AC   CVCL_8A20
SY   GM09407A
DR   CLO; CLO_0011857
DR   Coriell; GM09407
DR   Wikidata; Q54843731
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09408
AC   CVCL_8A21
DR   CLO; CLO_0011858
DR   Coriell; GM09408
DR   Wikidata; Q54843732
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09409
AC   CVCL_8A22
DR   CLO; CLO_0011859
DR   Coriell; GM09409
DR   Wikidata; Q54843733
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09410
AC   CVCL_8A23
DR   CLO; CLO_0011871
DR   Coriell; GM09410
DR   Wikidata; Q54843734
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09411
AC   CVCL_8A24
DR   CLO; CLO_0011872
DR   Coriell; GM09411
DR   Wikidata; Q54843735
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09412
AC   CVCL_8A25
DR   CLO; CLO_0011869
DR   Coriell; GM09412
DR   Wikidata; Q54843736
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09413
AC   CVCL_8A26
DR   CLO; CLO_0011870
DR   Coriell; GM09413
DR   Wikidata; Q54843737
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09414
AC   CVCL_8A27
DR   CLO; CLO_0011867
DR   Coriell; GM09414
DR   Wikidata; Q54843738
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09415
AC   CVCL_8A28
DR   CLO; CLO_0011868
DR   Coriell; GM09415
DR   Wikidata; Q54843739
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09425
AC   CVCL_1N29
DR   CLO; CLO_0011865
DR   Coriell; GM09425
DR   Wikidata; Q54843740
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09426
AC   CVCL_N106
SY   GM18035
DR   CLO; CLO_0011866
DR   CLO; CLO_0015570
DR   Coriell; GM09426
DR   Coriell; GM18035
DR   Wikidata; Q54843741
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09427
AC   CVCL_N107
SY   GM18036
DR   CLO; CLO_0011863
DR   CLO; CLO_0015572
DR   Coriell; GM09427
DR   Coriell; GM18036
DR   Wikidata; Q54843742
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09428
AC   CVCL_2T65
DR   CLO; CLO_0011864
DR   Coriell; GM09428
DR   Wikidata; Q54843743
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM09430
AC   CVCL_1F24
DR   CLO; CLO_0012093
DR   Coriell; GM09430
DR   Wikidata; Q54843744
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09431
AC   CVCL_5L95
DR   CLO; CLO_0012092
DR   Coriell; GM09431
DR   Wikidata; Q54843745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09432
AC   CVCL_5L96
DR   CLO; CLO_0011565
DR   Coriell; GM09432
DR   Wikidata; Q54843746
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09432).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09433
AC   CVCL_5L97
DR   CLO; CLO_0011563
DR   Coriell; GM09433
DR   Wikidata; Q54843747
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09433).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09434
AC   CVCL_5L98
DR   CLO; CLO_0011569
DR   Coriell; GM09434
DR   Wikidata; Q54843748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09435
AC   CVCL_5L99
DR   CLO; CLO_0011566
DR   Coriell; GM09435
DR   Wikidata; Q54843749
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09435).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09436
AC   CVCL_5M00
DR   CLO; CLO_0011573
DR   Coriell; GM09436
DR   Wikidata; Q54843750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09437
AC   CVCL_5M01
DR   CLO; CLO_0011570
DR   Coriell; GM09437
DR   Wikidata; Q54843751
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09437).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09438
AC   CVCL_5M02
DR   CLO; CLO_0011576
DR   Coriell; GM09438
DR   Wikidata; Q54843752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09439
AC   CVCL_5M03
DR   CLO; CLO_0011575
DR   Coriell; GM09439
DR   Wikidata; Q54843753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09442
AC   CVCL_W039
SY   GM 9442; GM9442
DR   CLO; CLO_0011560
DR   Coriell; GM09442
DR   Wikidata; Q54843754
RX   CelloPub=CLPUB00447;
RX   PubMed=2705456;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   17FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM09443
AC   CVCL_8A29
DR   CLO; CLO_0011561
DR   Coriell; GM09443
DR   Wikidata; Q54843756
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09444
AC   CVCL_AY34
DR   CLO; CLO_0011562
DR   Coriell; GM09444
DR   Wikidata; Q54843757
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09447
AC   CVCL_5P00
DR   Coriell; GM09447
DR   Wikidata; Q54843758
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM09447; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   GM09448
AC   CVCL_W301
DR   CLO; CLO_0011590
DR   Coriell; GM09448
DR   Wikidata; Q54843759
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM09449
AC   CVCL_W302
DR   CLO; CLO_0011589
DR   Coriell; GM09449
DR   Wikidata; Q54843760
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM09454
AC   CVCL_AU61
DR   CLO; CLO_0011587
DR   Coriell; GM09454
DR   Wikidata; Q54843761
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09455
AC   CVCL_AU62
DR   CLO; CLO_0011585
DR   Coriell; GM09455
DR   Wikidata; Q54843762
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09456
AC   CVCL_AU63
DR   CLO; CLO_0011597
DR   Coriell; GM09456
DR   Wikidata; Q54843763
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (PubMed=15578223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM09457
AC   CVCL_AU64
DR   CLO; CLO_0011595
DR   Coriell; GM09457
DR   Wikidata; Q54843764
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09458
AC   CVCL_W309
DR   CLO; CLO_0011593
DR   Coriell; GM09458
DR   Wikidata; Q54843766
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Homozygous; Note=New splice site creation (PubMed=15578223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM09459
AC   CVCL_AU65
DR   CLO; CLO_0011583
DR   Coriell; GM09459
DR   Wikidata; Q54843771
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (PubMed=15578223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM09461
AC   CVCL_AU66
DR   CLO; CLO_0011584
DR   Coriell; GM09461
DR   Wikidata; Q54843772
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09462
AC   CVCL_AU67
DR   CLO; CLO_0011581
DR   Coriell; GM09462
DR   Wikidata; Q54843774
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09463
AC   CVCL_AU68
DR   CLO; CLO_0011582
DR   Coriell; GM09463
DR   Wikidata; Q54843775
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09464
AC   CVCL_AU69
SY   GM09464A
DR   CLO; CLO_0011530
DR   Coriell; GM09464
DR   Wikidata; Q54843776
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09465
AC   CVCL_AU70
DR   CLO; CLO_0011529
DR   Coriell; GM09465
DR   Wikidata; Q54843777
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09469
AC   CVCL_AU71
DR   CLO; CLO_0011533
DR   Coriell; GM09469
DR   Wikidata; Q54843779
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09470
AC   CVCL_AU72
DR   CLO; CLO_0011531
DR   Coriell; GM09470
DR   Wikidata; Q54843780
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09471
AC   CVCL_AU73
DR   CLO; CLO_0011525
DR   Coriell; GM09471
DR   Wikidata; Q54843781
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09472
AC   CVCL_AU74
DR   CLO; CLO_0011524
DR   Coriell; GM09472
DR   Wikidata; Q54843782
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09473
AC   CVCL_AU75
DR   CLO; CLO_0011522
DR   Coriell; GM09473
DR   Wikidata; Q54843783
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09474
AC   CVCL_AU76
SY   GM09474A
DR   CLO; CLO_0011518
DR   Coriell; GM09474
DR   Wikidata; Q54843784
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09475
AC   CVCL_AU77
DR   CLO; CLO_0011519
DR   Coriell; GM09475
DR   Wikidata; Q54843785
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09476
AC   CVCL_AU78
DR   CLO; CLO_0011520
DR   Coriell; GM09476
DR   Wikidata; Q54843786
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09478
AC   CVCL_8A30
DR   CLO; CLO_0011521
DR   Coriell; GM09478
DR   Wikidata; Q54843787
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09479
AC   CVCL_8A31
DR   CLO; CLO_0011553
DR   Coriell; GM09479
DR   Wikidata; Q54843788
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09480
AC   CVCL_8A32
DR   CLO; CLO_0011552
DR   Coriell; GM09480
DR   Wikidata; Q54843789
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09481
AC   CVCL_8A33
DR   CLO; CLO_0011551
DR   Coriell; GM09481
DR   Wikidata; Q54843791
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09483
AC   CVCL_8A34
DR   CLO; CLO_0011550
DR   Coriell; GM09483
DR   Wikidata; Q54843792
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09484
AC   CVCL_8A35
DR   CLO; CLO_0011549
DR   Coriell; GM09484
DR   Wikidata; Q54843793
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09485
AC   CVCL_8A36
DR   CLO; CLO_0011543
DR   Coriell; GM09485
DR   Wikidata; Q54843794
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09487
AC   CVCL_8A37
DR   CLO; CLO_0011544
DR   Coriell; GM09487
DR   Wikidata; Q54843795
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09488
AC   CVCL_8A38
DR   CLO; CLO_0011541
DR   Coriell; GM09488
DR   Wikidata; Q54843796
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09489
AC   CVCL_8A39
DR   CLO; CLO_0011542
DR   Coriell; GM09489
DR   Wikidata; Q54843797
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09494
AC   CVCL_U716
DR   CLO; CLO_0011539
DR   Coriell; GM09494
DR   Wikidata; Q54843798
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM09495
AC   CVCL_CZ27
DR   CLO; CLO_0011540
DR   Coriell; GM09495
DR   Wikidata; Q54843799
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09496
AC   CVCL_CZ28
DR   CLO; CLO_0011478
DR   Coriell; GM09496
DR   Wikidata; Q54843800
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09497
AC   CVCL_AY35
DR   CLO; CLO_0011480
DR   Coriell; GM09497
DR   Wikidata; Q54843801
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;3)(3pter->3p22::1p32->1qter;1pter->1p32::3p22->3qter) [3]; 46,XY,t(3;12)(3pter->3q12::12q24.1->12qter;12pter->12q24.1:;3q12->3qter) [3]; 46,XY [13] (Coriell=GM09497).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM09498
AC   CVCL_IN24
DR   CLO; CLO_0011481
DR   Coriell; GM09498
DR   Wikidata; Q54843802
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C129980; Neonatal hemochromatosis
DI   ORDO; Orphanet_446; Neonatal hemochromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M3W
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM09499
AC   CVCL_5M45
DR   CLO; CLO_0011483
DR   Coriell; GM09499
DR   Wikidata; Q54843803
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M46 ! GM09500
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   GM09500
AC   CVCL_5M46
DR   CLO; CLO_0011456
DR   Coriell; GM09500
DR   Wikidata; Q54843804
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M45 ! GM09499
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09501
AC   CVCL_N108
SY   GM18037
DR   CLO; CLO_0011458
DR   CLO; CLO_0015573
DR   Coriell; GM09501
DR   Coriell; GM18037
DR   Wikidata; Q54843805
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09502
AC   CVCL_N109
SY   GM18038
DR   CLO; CLO_0011457
DR   CLO; CLO_0015635
DR   Coriell; GM09502
DR   Coriell; GM18038
DR   Wikidata; Q54843806
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09503
AC   CVCL_7492
DR   CLO; CLO_0011460
DR   Coriell; GM09503
DR   Wikidata; Q54843807
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+20 [2]; 46,XY [48] (Coriell=GM09503).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   GM09505
AC   CVCL_8A40
DR   CLO; CLO_0011459
DR   Coriell; GM09505
DR   Wikidata; Q54843808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09507
AC   CVCL_N110
SY   GM18039
DR   CLO; CLO_0015608
DR   Coriell; GM09507
DR   Coriell; GM18039
DR   Wikidata; Q54843809
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM09507; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM09509
AC   CVCL_N111
SY   GM18040
DR   CLO; CLO_0011462
DR   CLO; CLO_0015609
DR   Coriell; GM09509
DR   Coriell; GM18040
DR   Wikidata; Q54843810
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM09512
AC   CVCL_8A41
DR   CLO; CLO_0011461
DR   Coriell; GM09512
DR   Wikidata; Q54843811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09522
AC   CVCL_8A42
DR   CLO; CLO_0011513
DR   Coriell; GM09522
DR   Wikidata; Q54843812
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09523
AC   CVCL_8A43
SY   GM09523A
DR   CLO; CLO_0011514
DR   Coriell; GM09523
DR   Wikidata; Q54843813
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09528
AC   CVCL_1N57
SY   GM09528A
DR   CLO; CLO_0011510
DR   Coriell; GM09528
DR   Wikidata; Q54843825
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09534
AC   CVCL_9Z63
DR   CLO; CLO_0011490
DR   Coriell; GM09534
DR   Wikidata; Q54843826
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English/Irish/Scottish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09535
AC   CVCL_9Z64
SY   GM09535A
DR   CLO; CLO_0011489
DR   Coriell; GM09535
DR   Wikidata; Q54843827
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English/Irish/Scottish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09536
AC   CVCL_9Z65
DR   CLO; CLO_0011488
DR   Coriell; GM09536
DR   Wikidata; Q54843828
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English/Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09539
AC   CVCL_9Z66
DR   CLO; CLO_0011487
DR   Coriell; GM09539
DR   Wikidata; Q54843829
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English/Irish/Scottish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09541
AC   CVCL_8A44
SY   GM09541A
DR   CLO; CLO_0011494
DR   Coriell; GM09541
DR   Wikidata; Q54843831
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09542
AC   CVCL_1N66
DR   CLO; CLO_0011493
DR   Coriell; GM09542
DR   Wikidata; Q54843832
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09543
AC   CVCL_AK28
DR   CLO; CLO_0011492
DR   Coriell; GM09543
DR   Wikidata; Q54843833
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125694; Sitosterolemia
DI   ORDO; Orphanet_2882; Sitosterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM09544
AC   CVCL_8A45
DR   CLO; CLO_0011491
DR   Coriell; GM09544
DR   Wikidata; Q54843835
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09545
AC   CVCL_7493
DR   CLO; CLO_0011433
DR   Coriell; GM09545
DR   Wikidata; Q54843836
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro216Ser (c.646C>T) (P215S); ClinVar=VCV000011073; Zygosity=Hemizygous (Coriell=GM09545).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F209 ! GM09546
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GM09546
AC   CVCL_F209
DR   CLO; CLO_0011434
DR   Coriell; GM09546
DR   Wikidata; Q54843837
RX   CelloPub=CLPUB00447;
RX   PubMed=32446239;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro216Ser (c.646C>T) (P215S); ClinVar=VCV000011073; Zygosity=Hemizygous (Coriell=GM09546).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32446239
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 14,16
ST   D12S391: 15,21
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 11,13
ST   D19S433: 14,15
ST   D1S1656: 11,12
ST   D21S11: 29,31.2
ST   D22S1045: 15,16
ST   D2S1338: 17
ST   D2S441: 14,15
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 21,23
ST   SE33: 18,28.2
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7493 ! GM09545
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   GM09547
AC   CVCL_F210
SY   GM17327
DR   CLO; CLO_0011422
DR   CLO; CLO_0013639
DR   Coriell; GM09547
DR   Coriell; GM17327
DR   Wikidata; Q54843838
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM09548
AC   CVCL_F211
SY   GM09548A
DR   CLO; CLO_0011419
DR   Coriell; GM09548
DR   Wikidata; Q54843839
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro216Ser (c.646C>T) (P215S); ClinVar=VCV000011073; Zygosity=Heterozygous (Coriell=GM09548).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   GM09549
AC   CVCL_F212
SY   GM17287
DR   CLO; CLO_0011418
DR   CLO; CLO_0013082
DR   Coriell; GM09549
DR   Coriell; GM17287
DR   GEO; GSM569758
DR   GEO; GSM596351
DR   GEO; GSM596769
DR   GEO; GSM924889
DR   Wikidata; Q54843840
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,03:02:01; B*15:01:01,35:03:01; C*03:03:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:01; DRB1*11:01:01,11:01:01; DRB3*02:02:01;02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM09550
AC   CVCL_F213
DR   CLO; CLO_0011421
DR   Coriell; GM09550
DR   Wikidata; Q54843841
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM09551
AC   CVCL_AA80
DR   CLO; CLO_0011420
DR   Coriell; GM09551
DR   Wikidata; Q54843842
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Tyr293Metfs*69 (c.877_890delTACATTAATGCTTCinsA) (p.Tyr292Metfs, c.874_887delTACATTAATGCTTCinsA) (879 del 13); ClinVar=VCV000012266; Zygosity=Homozygous (Coriell=GM09551).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM09552
AC   CVCL_2T66
DR   CLO; CLO_0011415
DR   Coriell; GM09552
DR   Wikidata; Q54843843
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM09562
AC   CVCL_6G94
DR   CLO; CLO_0011414
DR   Coriell; GM09562
DR   Wikidata; Q54843844
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09563
AC   CVCL_X473
SY   GM09563A
DR   CLO; CLO_0011417
DR   Coriell; GM09563
DR   Wikidata; Q54843845
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM09564
AC   CVCL_UR76
SY   GM 09564
DR   Coriell; GM09564
DR   Wikidata; Q93804212
RX   CelloPub=CLPUB00447;
RX   PubMed=2916654;
CC   HLA typing: A*01,02; B*51,w57 (PubMed=2916654).
CC   Discontinued: Coriell; GM09564; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129980; Neonatal hemochromatosis
DI   ORDO; Orphanet_446; Neonatal hemochromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20D
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM09566
AC   CVCL_X472
SY   GM09566A
DR   CLO; CLO_0011416
DR   Coriell; GM09566
DR   Wikidata; Q54843846
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM09567
AC   CVCL_N112
SY   GM18041
DR   CLO; CLO_0011455
DR   CLO; CLO_0015614
DR   Coriell; GM09567
DR   Coriell; GM18041
DR   Wikidata; Q54843847
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09569
AC   CVCL_5M04
DR   CLO; CLO_0011444
DR   Coriell; GM09569
DR   Wikidata; Q54843848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09572
AC   CVCL_5M05
DR   CLO; CLO_0011443
DR   Coriell; GM09572
DR   Wikidata; Q54843850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09574
AC   CVCL_5M06
DR   CLO; CLO_0011442
DR   Coriell; GM09574
DR   Wikidata; Q54843851
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09574).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09575
AC   CVCL_5M07
DR   CLO; CLO_0011441
DR   Coriell; GM09575
DR   Wikidata; Q54843852
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09575).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09576
AC   CVCL_5M08
DR   CLO; CLO_0011440
DR   Coriell; GM09576
DR   Wikidata; Q54843853
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09576).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09578
AC   CVCL_DB65
DR   CLO; CLO_0011439
DR   Coriell; GM09578
DR   Wikidata; Q54843854
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09579
AC   CVCL_1L57
DR   CLO; CLO_0011438
DR   Coriell; GM09579
DR   GEO; GSM1116567
DR   GEO; GSM1116568
DR   GEO; GSM1116613
DR   GEO; GSM1116614
DR   GEO; GSM1116615
DR   GEO; GSM1116616
DR   Wikidata; Q54843855
RX   CelloPub=CLPUB00447;
RX   PubMed=23943852;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM09580
AC   CVCL_1L58
DR   CLO; CLO_0011437
DR   Coriell; GM09580
DR   Wikidata; Q54843856
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09581
AC   CVCL_1L59
DR   CLO; CLO_0011436
DR   Coriell; GM09581
DR   Wikidata; Q54843857
RX   CelloPub=CLPUB00447;
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09582
AC   CVCL_7494
DR   CLO; CLO_0011435
DR   Coriell; GM09582
DR   GEO; GSM1116633
DR   GEO; GSM1116634
DR   GEO; GSM1116635
DR   GEO; GSM1116636
DR   Lonza; 973
DR   Wikidata; Q54843858
RX   CelloPub=CLPUB00447;
RX   PubMed=16166284;
RX   PubMed=23943852;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM09583
AC   CVCL_1L60
DR   CLO; CLO_0011394
DR   Coriell; GM09583
DR   Wikidata; Q54843859
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09584
AC   CVCL_1L61
SY   GM09584A
DR   CLO; CLO_0011388
DR   Coriell; GM09584
DR   Wikidata; Q54843860
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09585
AC   CVCL_N315
DR   CLO; CLO_0011391
DR   Coriell; GM09585
DR   Wikidata; Q54843861
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM09586
AC   CVCL_N316
SY   GM09586A
DR   CLO; CLO_0011398
DR   Coriell; GM09586
DR   Wikidata; Q54843862
RX   CelloPub=CLPUB00447;
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09587
AC   CVCL_N317
SY   GM9587; GM09587A
DR   CLO; CLO_0011399
DR   Coriell; GM09587
DR   Wikidata; Q54843863
RX   CelloPub=CLPUB00447;
RX   PubMed=8808599;
RX   PubMed=8845835;
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8269del150; Zygosity=Heterozygous (PubMed=8808599; PubMed=8845835).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg3008Cys (c.9022C>T); ClinVar=VCV000142187; Zygosity=Heterozygous (PubMed=8845835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   GM09588
AC   CVCL_N318
SY   GM09588A
DR   CLO; CLO_0011395
DR   Coriell; GM09588
DR   Wikidata; Q54843864
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM09589
AC   CVCL_GT51
DR   CLO; CLO_0011396
DR   Coriell; GM09589
DR   Wikidata; Q54843865
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26799; Hereditary factor II deficiency
DI   ORDO; Orphanet_325; Congenital factor II deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09590
AC   CVCL_FV46
DR   CLO; CLO_0011401
DR   Coriell; GM09590
DR   Wikidata; Q54843866
RX   CelloPub=CLPUB00447;
CC   Population: Belizean.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV47 ! GM09591
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09591
AC   CVCL_FV47
DR   CLO; CLO_0011402
DR   Coriell; GM09591
DR   Wikidata; Q54843867
RX   CelloPub=CLPUB00447;
CC   Population: Belizean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV46 ! GM09590
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM09592
AC   CVCL_DB66
DR   CLO; CLO_0011400
DR   Coriell; GM09592
DR   Wikidata; Q54843874
RX   CelloPub=CLPUB00447;
CC   Population: Belizean.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB67 ! GM09593
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09593
AC   CVCL_DB67
DR   CLO; CLO_0026605
DR   Coriell; GM09593
DR   Wikidata; Q54843876
RX   CelloPub=CLPUB00447;
CC   Population: Belizean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB66 ! GM09592
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM09595
AC   CVCL_8A46
DR   CLO; CLO_0026607
DR   Coriell; GM09595
DR   Wikidata; Q54843877
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09596
AC   CVCL_5P01
DR   CLO; CLO_0026601
DR   Coriell; GM09596
DR   Wikidata; Q54843878
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM09608
AC   CVCL_8A56
DR   CLO; CLO_0026621
DR   Coriell; GM09608
DR   Wikidata; Q54843880
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98939; Hereditary factor VII deficiency
DI   ORDO; Orphanet_327; Congenital factor VII deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09610
AC   CVCL_8A47
DR   CLO; CLO_0026622
DR   Coriell; GM09610
DR   Wikidata; Q54843881
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09611
AC   CVCL_N113
SY   GM18042
DR   CLO; CLO_0015617
DR   CLO; CLO_0026617
DR   Coriell; GM09611
DR   Coriell; GM18042
DR   Wikidata; Q54843882
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   GM09613
AC   CVCL_AA81
DR   CLO; CLO_0026619
DR   Coriell; GM09613
DR   Wikidata; Q54843883
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,i(18)(qter->q10::q10->qter) (Coriell=GM09613).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09614
AC   CVCL_FV48
DR   CLO; CLO_0026614
DR   Coriell; GM09614
DR   Wikidata; Q54843884
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV49 ! GM09615
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09615
AC   CVCL_FV49
DR   CLO; CLO_0026615
DR   Coriell; GM09615
DR   Wikidata; Q54843885
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV48 ! GM09614
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09616
AC   CVCL_9Z67
DR   CLO; CLO_0026651
DR   Coriell; GM09616
DR   Wikidata; Q54843886
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09617
AC   CVCL_9Z68
DR   CLO; CLO_0026647
DR   Coriell; GM09617
DR   Wikidata; Q54843887
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09618
AC   CVCL_N114
SY   GM17288
DR   CLO; CLO_0013080
DR   CLO; CLO_0026648
DR   Coriell; GM09618
DR   Coriell; GM17288
DR   GEO; GSM569740
DR   GEO; GSM596352
DR   GEO; GSM596770
DR   GEO; GSM924890
DR   Wikidata; Q54843889
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=26621101;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*44:02:01,57:01:01; C*05:01:01,06:02:01; DPA1*01:03:01,02:01:02; DPB1*01:01:01,04:01:01; DQA1*02:01:01,05:01:01; DQB1*02:01:01,03:03:02; DRB1*03:01:01,07:01:01; DRB3*02:02:01; DRB4*01:03:01:02N (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM09619
AC   CVCL_9Z69
DR   CLO; CLO_0026649
DR   Coriell; GM09619
DR   Wikidata; Q54843890
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09620
AC   CVCL_9Z70
DR   CLO; CLO_0026650
DR   Coriell; GM09620
DR   Wikidata; Q54843891
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09621
AC   CVCL_9Z71
DR   CLO; CLO_0026655
DR   Coriell; GM09621
DR   Wikidata; Q54843892
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09622
AC   CVCL_9Z72
DR   CLO; CLO_0026656
DR   Coriell; GM09622
DR   Wikidata; Q54843893
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09623
AC   CVCL_2T67
DR   CLO; CLO_0026657
DR   Coriell; GM09623
DR   Wikidata; Q54843894
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM09625
AC   CVCL_9Z73
DR   CLO; CLO_0026658
DR   Coriell; GM09625
DR   Wikidata; Q54843895
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09626
AC   CVCL_N115
SY   GM18043
DR   CLO; CLO_0015610
DR   CLO; CLO_0026652
DR   Coriell; GM09626
DR   Coriell; GM18043
DR   Wikidata; Q54843896
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09627
AC   CVCL_9Z74
DR   CLO; CLO_0026677
DR   Coriell; GM09627
DR   Wikidata; Q54843897
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09628
AC   CVCL_9Z75
DR   CLO; CLO_0026679
DR   Coriell; GM09628
DR   Wikidata; Q54843898
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09629
AC   CVCL_9Z76
DR   CLO; CLO_0026687
DR   Coriell; GM09629
DR   Wikidata; Q54843899
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09630
AC   CVCL_9Z77
DR   CLO; CLO_0026690
DR   Coriell; GM09630
DR   Wikidata; Q54843900
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09631
AC   CVCL_9Z78
DR   CLO; CLO_0026684
DR   Coriell; GM09631
DR   Wikidata; Q54843902
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09632
AC   CVCL_9Z79
DR   CLO; CLO_0026686
DR   Coriell; GM09632
DR   Wikidata; Q54843903
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09633
AC   CVCL_9Z80
DR   CLO; CLO_0026693
DR   Coriell; GM09633
DR   Wikidata; Q54843904
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09634
AC   CVCL_9Z81
DR   CLO; CLO_0026694
DR   Coriell; GM09634
DR   Wikidata; Q54843905
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09635
AC   CVCL_9Z82
DR   CLO; CLO_0026691
DR   Coriell; GM09635
DR   Wikidata; Q54843906
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09636
AC   CVCL_9Z83
DR   CLO; CLO_0026692
DR   Coriell; GM09636
DR   Wikidata; Q54843907
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09637
AC   CVCL_9Z84
SY   GM09637A
DR   CLO; CLO_0026719
DR   Coriell; GM09637
DR   Wikidata; Q54843908
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09638
AC   CVCL_9Z85
DR   CLO; CLO_0026721
DR   Coriell; GM09638
DR   Wikidata; Q54843910
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09639
AC   CVCL_9Z86
DR   CLO; CLO_0026723
DR   Coriell; GM09639
DR   Wikidata; Q54843911
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09640
AC   CVCL_9Z87
DR   CLO; CLO_0026725
DR   Coriell; GM09640
DR   Wikidata; Q54843912
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09641
AC   CVCL_9Z88
SY   GM09641A
DR   CLO; CLO_0026726
DR   Coriell; GM09641
DR   Wikidata; Q54843913
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09642
AC   CVCL_9Z89
DR   CLO; CLO_0026728
DR   Coriell; GM09642
DR   Wikidata; Q54843914
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09643
AC   CVCL_4D96
DR   CLO; CLO_0026731
DR   Coriell; GM09643
DR   Wikidata; Q54843915
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM09644
AC   CVCL_8A48
DR   CLO; CLO_0026732
DR   Coriell; GM09644
DR   Wikidata; Q54843916
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09645
AC   CVCL_8A49
DR   CLO; CLO_0026733
DR   Coriell; GM09645
DR   Wikidata; Q54843917
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09646
AC   CVCL_8A50
DR   CLO; CLO_0026734
DR   Coriell; GM09646
DR   Wikidata; Q54843923
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09647
AC   CVCL_FV50
DR   CLO; CLO_0026475
DR   Coriell; GM09647
DR   Wikidata; Q54843924
RX   CelloPub=CLPUB00447;
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV51 ! GM09648
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM09648
AC   CVCL_FV51
DR   CLO; CLO_0026473
DR   Coriell; GM09648
DR   Wikidata; Q54843925
RX   CelloPub=CLPUB00447;
CC   Population: Hispanic.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV50 ! GM09647
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09649
AC   CVCL_9Z90
SY   GM09649A
DR   CLO; CLO_0026479
DR   Coriell; GM09649
DR   Wikidata; Q54843926
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09650
AC   CVCL_9Z91
DR   CLO; CLO_0026476
DR   Coriell; GM09650
DR   Wikidata; Q54843927
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09651
AC   CVCL_9Z92
DR   CLO; CLO_0026466
DR   Coriell; GM09651
DR   Wikidata; Q54843928
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09652
AC   CVCL_9Z93
DR   CLO; CLO_0026464
DR   Coriell; GM09652
DR   Wikidata; Q54843929
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09654
AC   CVCL_4D97
DR   CLO; CLO_0026468
DR   Coriell; GM09654
DR   Wikidata; Q54843931
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM09656
AC   CVCL_8A51
DR   CLO; CLO_0026463
DR   Coriell; GM09656
DR   Wikidata; Q54843932
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09659
AC   CVCL_AA82
DR   CLO; CLO_0026462
DR   Coriell; GM09659
DR   Wikidata; Q54843933
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09660
AC   CVCL_AA83
DR   CLO; CLO_0026484
DR   Coriell; GM09660
DR   Wikidata; Q54843934
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09661
AC   CVCL_AA84
DR   CLO; CLO_0026519
DR   Coriell; GM09661
DR   Wikidata; Q54843935
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09662
AC   CVCL_AA85
DR   CLO; CLO_0026516
DR   Coriell; GM09662
DR   Wikidata; Q54843936
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM09662).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09663
AC   CVCL_0Q09
DR   CLO; CLO_0026515
DR   Coriell; GM09663
DR   Wikidata; Q54843937
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; French Canadian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM09666
AC   CVCL_GS75
DR   CLO; CLO_0026512
DR   Coriell; GM09666
DR   Wikidata; Q54843938
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84697; Erythropoietic porphyria
DI   ORDO; Orphanet_79277; Congenital erythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09667
AC   CVCL_GT52
DR   CLO; CLO_0026511
DR   Coriell; GM09667
DR   Wikidata; Q54843939
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C5183; Hereditary multiple exostoses
DI   ORDO; Orphanet_321; Multiple osteochondromas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09668
AC   CVCL_DA30
DR   CLO; CLO_0026509
DR   Coriell; GM09668
DR   Wikidata; Q54843940
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   GM09669
AC   CVCL_DA31
DR   CLO; CLO_0026507
DR   Coriell; GM09669
DR   Wikidata; Q54843941
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   GM09670
AC   CVCL_GS76
DR   CLO; CLO_0026504
DR   Coriell; GM09670
DR   Wikidata; Q54843942
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84697; Erythropoietic porphyria
DI   ORDO; Orphanet_79277; Congenital erythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09673
AC   CVCL_FV52
DR   CLO; CLO_0026503
DR   Coriell; GM09673
DR   Wikidata; Q54843943
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09675
AC   CVCL_DB68
DR   CLO; CLO_0026535
DR   Coriell; GM09675
DR   Wikidata; Q54843944
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09677
AC   CVCL_W562
DR   CLO; CLO_0026536
DR   CLO; CLO_0037422
DR   Coriell; GM09677
DR   LINCS_LDP; LPC-1023
DR   Wikidata; Q54843945
RX   CelloPub=CLPUB00447;
RX   PubMed=26190808;
RX   PubMed=26247043;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (Coriell=GM09677).
CC   Derived from site: In situ; Eye, ocular lens; UBERON=UBERON_0000965.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM09679
AC   CVCL_2T68
DR   CLO; CLO_0026549
DR   Coriell; GM09679
DR   Wikidata; Q54843946
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM09680
AC   CVCL_FV53
DR   CLO; CLO_0026546
DR   Coriell; GM09680
DR   Wikidata; Q54843947
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09682
AC   CVCL_GS77
DR   CLO; CLO_0026553
DR   Coriell; GM09682
DR   Wikidata; Q54843948
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84697; Erythropoietic porphyria
DI   ORDO; Orphanet_79277; Congenital erythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09683
AC   CVCL_5M09
DR   CLO; CLO_0026551
DR   Coriell; GM09683
DR   Wikidata; Q54843949
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09683).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09684
AC   CVCL_5M10
DR   CLO; CLO_0026558
DR   Coriell; GM09684
DR   Wikidata; Q54843950
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Gln1503Pro (c.4508A>C); ClinVar=VCV000012401; Zygosity=Unspecified (Coriell=GM09684).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM09685
AC   CVCL_5M11
DR   CLO; CLO_0026556
DR   Coriell; GM09685
DR   Wikidata; Q54843952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09686
AC   CVCL_5M12
DR   CLO; CLO_0026560
DR   Coriell; GM09686
DR   Wikidata; Q54843953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM09687
AC   CVCL_4D98
DR   CLO; CLO_0026559
DR   Coriell; GM09687
DR   Wikidata; Q54843954
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM09688
AC   CVCL_9Z94
SY   GM09688A
DR   CLO; CLO_0026578
DR   Coriell; GM09688
DR   Wikidata; Q54843955
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09689
AC   CVCL_9Z95
DR   CLO; CLO_0026570
DR   Coriell; GM09689
DR   Wikidata; Q54843956
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09690
AC   CVCL_9Z96
SY   GM09690A
DR   CLO; CLO_0026573
DR   Coriell; GM09690
DR   Wikidata; Q54843957
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09691
AC   CVCL_9Z97
DR   CLO; CLO_0026594
DR   Coriell; GM09691
DR   Wikidata; Q54843958
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09692
AC   CVCL_9Z98
SY   GM09692A
DR   CLO; CLO_0026591
DR   Coriell; GM09692
DR   Wikidata; Q54843959
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09693
AC   CVCL_9Z99
DR   CLO; CLO_0026587
DR   Coriell; GM09693
DR   Wikidata; Q54843960
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09694
AC   CVCL_6F53
DR   CLO; CLO_0026586
DR   Coriell; GM09694
DR   Wikidata; Q54843961
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09703
AC   CVCL_6G78
DR   CLO; CLO_0026600
DR   Coriell; GM09703
DR   Wikidata; Q54843962
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125488; Seckel syndrome
DI   ORDO; Orphanet_808; Seckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G79 ! GM09812
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09704
AC   CVCL_9S94
DR   CLO; CLO_0026597
DR   Coriell; GM09704
DR   Wikidata; Q54843963
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,XX,rec(6)(pter->p12::q26->q16::p12->qter)pat (Coriell=GM09704).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM09705
AC   CVCL_AA86
DR   CLO; CLO_0026596
DR   Coriell; GM09705
DR   Wikidata; Q54843971
RX   CelloPub=CLPUB00447;
RX   PubMed=33485181;
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Tyr293Metfs*69 (c.877_890delTACATTAATGCTTCinsA) (p.Tyr292Metfs, c.874_887delTACATTAATGCTTCinsA) (879 del 13); ClinVar=VCV000012266; Zygosity=Homozygous; Note=Allele UGT1A1*2 (from child cell line HHUUKDi005-A).
CC   Caution: Indicated as originating from a 1 year old female child in Coriell, but seems to contain both male and female cells (PubMed=33485181).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Mixed sex
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM09706
AC   CVCL_4D99
DR   CLO; CLO_0026351
DR   Coriell; GM09706
DR   Wikidata; Q54843972
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM09707
AC   CVCL_AA87
DR   CLO; CLO_0026350
DR   Coriell; GM09707
DR   Wikidata; Q54843973
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09708
AC   CVCL_AA88
DR   CLO; CLO_0026356
DR   Coriell; GM09708
DR   Wikidata; Q54843974
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09709
AC   CVCL_5P02
DR   CLO; CLO_0026353
DR   Coriell; GM09709
DR   Wikidata; Q54843975
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   GM09711
AC   CVCL_5P03
DR   CLO; CLO_0026364
DR   Coriell; GM09711
DR   Wikidata; Q54843976
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM09716
AC   CVCL_AV55
DR   CLO; CLO_0026366
DR   Coriell; GM09716
DR   Wikidata; Q54843977
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM09719
AC   CVCL_AU79
DR   CLO; CLO_0026369
DR   Coriell; GM09719
DR   Wikidata; Q54843978
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09720
AC   CVCL_AU80
DR   CLO; CLO_0026372
DR   Coriell; GM09720
DR   Wikidata; Q54843979
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09721
AC   CVCL_AU81
DR   CLO; CLO_0026360
DR   Coriell; GM09721
DR   Wikidata; Q54843980
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09722
AC   CVCL_AU82
DR   CLO; CLO_0026361
DR   Coriell; GM09722
DR   Wikidata; Q54843981
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09723
AC   CVCL_AU83
DR   CLO; CLO_0026388
DR   Coriell; GM09723
DR   Wikidata; Q54843982
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09726
AC   CVCL_FV54
DR   CLO; CLO_0026386
DR   Coriell; GM09726
DR   Wikidata; Q54843983
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09729
AC   CVCL_4H98
SY   GM09729A
DR   CLO; CLO_0026383
DR   Coriell; GM09729
DR   Wikidata; Q54843984
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09730
AC   CVCL_4H99
SY   GM09730A
DR   CLO; CLO_0026382
DR   Coriell; GM09730
DR   Wikidata; Q54843985
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09731
AC   CVCL_4I00
SY   GM09731A
DR   CLO; CLO_0026379
DR   Coriell; GM09731
DR   Wikidata; Q54843986
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09732
AC   CVCL_7495
DR   CLO; CLO_0026400
DR   Coriell; GM09732
DR   Wikidata; Q54843988
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM09733
AC   CVCL_4I01
DR   CLO; CLO_0026403
DR   Coriell; GM09733
DR   Wikidata; Q54843989
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09734
AC   CVCL_FV55
DR   CLO; CLO_0026393
DR   Coriell; GM09734
DR   Wikidata; Q54843990
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV56 ! GM09735
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09735
AC   CVCL_FV56
DR   CLO; CLO_0026396
DR   Coriell; GM09735
DR   Wikidata; Q54843991
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV55 ! GM09734
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09736
AC   CVCL_N116
SY   GM18044
DR   CLO; CLO_0015613
DR   CLO; CLO_0026390
DR   Coriell; GM09736
DR   Coriell; GM18044
DR   Wikidata; Q54843992
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N117 ! GM09737
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09737
AC   CVCL_N117
DR   CLO; CLO_0030401
DR   Coriell; GM09737
DR   Wikidata; Q54843993
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N116 ! GM09736
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   GM09738
AC   CVCL_FV57
DR   CLO; CLO_0030396
DR   Coriell; GM09738
DR   Wikidata; Q54843994
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV58 ! GM09739
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM09739
AC   CVCL_FV58
DR   CLO; CLO_0030397
DR   Coriell; GM09739
DR   Wikidata; Q54843995
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV57 ! GM09738
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09740
AC   CVCL_F214
SY   GM09740A
DR   CLO; CLO_0030404
DR   Coriell; GM09740
DR   Wikidata; Q54843996
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM09741
AC   CVCL_7496
SY   GM09741A
DR   CLO; CLO_0030405
DR   Coriell; GM09741
DR   Wikidata; Q54843997
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM09742
AC   CVCL_4I02
SY   GM09742A
DR   CLO; CLO_0030402
DR   Coriell; GM09742
DR   Wikidata; Q54843998
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09743
AC   CVCL_4I03
DR   CLO; CLO_0030403
DR   Coriell; GM09743
DR   Wikidata; Q54843999
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09744
AC   CVCL_4I04
SY   GM09744A
DR   CLO; CLO_0030407
DR   Coriell; GM09744
DR   Wikidata; Q54844000
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09745
AC   CVCL_4I05
DR   CLO; CLO_0030408
DR   Coriell; GM09745
DR   Wikidata; Q54844001
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09746
AC   CVCL_4I06
DR   CLO; CLO_0030406
DR   Coriell; GM09746
DR   Wikidata; Q54844002
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09747
AC   CVCL_4I07
DR   CLO; CLO_0030379
DR   Coriell; GM09747
DR   Wikidata; Q54844003
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09748
AC   CVCL_4I08
DR   CLO; CLO_0030380
DR   Coriell; GM09748
DR   Wikidata; Q54844004
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78576; Psychosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM09749
AC   CVCL_AA89
DR   CLO; CLO_0030381
DR   Coriell; GM09749
DR   Wikidata; Q54844005
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09752
AC   CVCL_AA90
DR   CLO; CLO_0030382
DR   Coriell; GM09752
DR   Wikidata; Q54844006
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09753
AC   CVCL_AA91
DR   CLO; CLO_0030383
DR   Coriell; GM09753
DR   Wikidata; Q54844007
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09754
AC   CVCL_AL81
DR   CLO; CLO_0030384
DR   Coriell; GM09754
DR   Wikidata; Q54844008
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09755
AC   CVCL_AL82
DR   CLO; CLO_0030385
DR   Coriell; GM09755
DR   Wikidata; Q54844009
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09756
AC   CVCL_AL83
DR   CLO; CLO_0030386
DR   Coriell; GM09756
DR   Wikidata; Q54844010
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM09756).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM09757
AC   CVCL_AL84
DR   CLO; CLO_0030387
DR   Coriell; GM09757
DR   Wikidata; Q54844011
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM09757).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM09758
AC   CVCL_AL85
DR   CLO; CLO_0030388
DR   Coriell; GM09758
DR   Wikidata; Q54844024
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09759
AC   CVCL_AL86
DR   CLO; CLO_0030548
DR   Coriell; GM09759
DR   Wikidata; Q54844025
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09759).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09760
AC   CVCL_AL87
DR   CLO; CLO_0030547
DR   Coriell; GM09760
DR   Wikidata; Q54844026
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09760).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09761
AC   CVCL_AL88
DR   CLO; CLO_0030546
DR   Coriell; GM09761
DR   Wikidata; Q54844027
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09761).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09762
AC   CVCL_AL89
DR   CLO; CLO_0030545
DR   Coriell; GM09762
DR   Wikidata; Q54844028
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09763
AC   CVCL_AL90
DR   CLO; CLO_0030544
DR   Coriell; GM09763
DR   Wikidata; Q54844029
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM09763).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM09764
AC   CVCL_N118
SY   GM09764A; GM17366
DR   CLO; CLO_0013709
DR   CLO; CLO_0030543
DR   Coriell; GM09764
DR   Coriell; GM17366
DR   Wikidata; Q54844030
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM09765
AC   CVCL_AL91
DR   CLO; CLO_0030542
DR   Coriell; GM09765
DR   Wikidata; Q54844031
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09766
AC   CVCL_AL92
DR   CLO; CLO_0030541
DR   Coriell; GM09766
DR   Wikidata; Q54844032
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09767
AC   CVCL_AL93
DR   CLO; CLO_0030540
DR   Coriell; GM09767
DR   Wikidata; Q54844033
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09768
AC   CVCL_AL94
DR   CLO; CLO_0030539
DR   Coriell; GM09768
DR   Wikidata; Q54844034
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09769
AC   CVCL_AL95
DR   CLO; CLO_0030528
DR   Coriell; GM09769
DR   Wikidata; Q54844035
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09770
AC   CVCL_AL96
DR   CLO; CLO_0030527
DR   Coriell; GM09770
DR   Wikidata; Q54844036
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09770).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09771
AC   CVCL_N119
SY   GM17289
DR   CLO; CLO_0013077
DR   CLO; CLO_0030524
DR   Coriell; GM09771
DR   Coriell; GM17289
DR   GEO; GSM569759
DR   GEO; GSM596353
DR   GEO; GSM596771
DR   GEO; GSM924891
DR   Wikidata; Q54844038
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,23:01:01; B*14:06:02,44:02:01; C*05:01:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:01:02,03:03:01; DQB1*03:01:01,05:01:01; DRB1*01:02:01,04:01:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM09772
AC   CVCL_AL97
SY   GM09772A
DR   CLO; CLO_0030523
DR   Coriell; GM09772
DR   Wikidata; Q54844039
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09773
AC   CVCL_AL98
DR   CLO; CLO_0030526
DR   Coriell; GM09773
DR   Wikidata; Q54844040
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09774
AC   CVCL_AL99
DR   CLO; CLO_0030525
DR   Coriell; GM09774
DR   Wikidata; Q54844041
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09774).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09775
AC   CVCL_AM00
DR   CLO; CLO_0030520
DR   Coriell; GM09775
DR   Wikidata; Q54844042
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09775).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09776
AC   CVCL_AM01
DR   CLO; CLO_0030519
DR   Coriell; GM09776
DR   Wikidata; Q54844043
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09777
AC   CVCL_AM02
DR   CLO; CLO_0030522
DR   Coriell; GM09777
DR   Wikidata; Q54844044
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09777).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09778
AC   CVCL_AM03
DR   CLO; CLO_0030521
DR   Coriell; GM09778
DR   Wikidata; Q54844045
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09779
AC   CVCL_AM04
DR   CLO; CLO_0030494
DR   Coriell; GM09779
DR   Wikidata; Q54844047
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09780
AC   CVCL_AM05
DR   CLO; CLO_0030493
DR   Coriell; GM09780
DR   Wikidata; Q54844048
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (PubMed=10391211; Coriell=GM09780).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM09781
AC   CVCL_AM06
DR   CLO; CLO_0030492
DR   Coriell; GM09781
DR   Wikidata; Q54844049
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09782
AC   CVCL_AM07
DR   CLO; CLO_0030498
DR   Coriell; GM09782
DR   Wikidata; Q54844050
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM09782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM09783
AC   CVCL_AM08
DR   CLO; CLO_0030497
DR   Coriell; GM09783
DR   Wikidata; Q54844051
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09784
AC   CVCL_AM09
DR   CLO; CLO_0030496
DR   Coriell; GM09784
DR   Wikidata; Q54844052
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09785
AC   CVCL_AM10
DR   CLO; CLO_0030495
DR   Coriell; GM09785
DR   Wikidata; Q54844053
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM09786
AC   CVCL_AA92
DR   CLO; CLO_0030491
DR   Coriell; GM09786
DR   Wikidata; Q54844054
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09787
AC   CVCL_U399
DR   CLO; CLO_0030490
DR   Coriell; GM09787
DR   Wikidata; Q54844055
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1073+1G>A (IVS9+1G>A); ClinVar=VCV000003920; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM09787).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM09788
AC   CVCL_AA93
SY   GM09788B
DR   CLO; CLO_0030489
DR   Coriell; GM09788
DR   Wikidata; Q54844057
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09789
AC   CVCL_AA94
DR   CLO; CLO_0030462
DR   Coriell; GM09789
DR   Wikidata; Q54844058
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM09789).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09790
AC   CVCL_AA95
DR   CLO; CLO_0030461
DR   Coriell; GM09790
DR   Wikidata; Q54844059
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM09790).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09791
AC   CVCL_AA96
DR   CLO; CLO_0030464
DR   Coriell; GM09791
DR   Wikidata; Q54844060
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09792
AC   CVCL_AA97
DR   CLO; CLO_0030463
DR   Coriell; GM09792
DR   Wikidata; Q54844061
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09793
AC   CVCL_AA98
SY   GM09793A
DR   CLO; CLO_0030466
DR   Coriell; GM09793
DR   Wikidata; Q54844062
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09794
AC   CVCL_AA99
DR   CLO; CLO_0030465
DR   Coriell; GM09794
DR   Wikidata; Q54844063
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09795
AC   CVCL_AB00
DR   CLO; CLO_0030468
DR   Coriell; GM09795
DR   Wikidata; Q54844064
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09796
AC   CVCL_AB01
SY   GM09796B
DR   CLO; CLO_0030467
DR   Coriell; GM09796
DR   Wikidata; Q54844065
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09811
AC   CVCL_IN25
SY   GM 09811
DR   CLO; CLO_0030458
DR   Coriell; GM09811
DR   Wikidata; Q54844066
RX   CelloPub=CLPUB00447;
RX   PubMed=2916654;
CC   Population: Caucasian; Portuguese.
CC   HLA typing: A*02,03; B*07,44 (PubMed=2916654).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129980; Neonatal hemochromatosis
DI   ORDO; Orphanet_446; Neonatal hemochromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75D
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM09812
AC   CVCL_6G79
DR   CLO; CLO_0030457
DR   Coriell; GM09812
DR   Wikidata; Q54844071
RX   CelloPub=CLPUB00447;
RX   PubMed=19896956;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125488; Seckel syndrome
DI   ORDO; Orphanet_808; Seckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G78 ! GM09703
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09814
AC   CVCL_DB69
DR   CLO; CLO_0030673
DR   Coriell; GM09814
DR   Wikidata; Q54844072
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM09815
AC   CVCL_N120
SY   GM18045
DR   CLO; CLO_0015623
DR   CLO; CLO_0030663
DR   Coriell; GM09815
DR   Coriell; GM18045
DR   Wikidata; Q54844073
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X474 ! GM09816
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM09816
AC   CVCL_X474
DR   CLO; CLO_0030665
DR   Coriell; GM09816
DR   Wikidata; Q54844074
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N120 ! GM09815
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   GM09818
AC   CVCL_F215
SY   GM09818A
DR   CLO; CLO_0030666
DR   Coriell; GM09818
DR   Wikidata; Q54844075
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM09820
AC   CVCL_7497
SY   GM17015
DR   CLO; CLO_0018029
DR   CLO; CLO_0030667
DR   Coriell; GM09820
DR   Coriell; GM17015
DR   Wikidata; Q54844076
RX   CelloPub=CLPUB00447;
RX   PubMed=16244288;
CC   Part of: Human variation panel.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM09822
AC   CVCL_GT53
DR   CLO; CLO_0030659
DR   Coriell; GM09822
DR   Wikidata; Q54844077
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09824
AC   CVCL_2N13
DR   CLO; CLO_0030660
DR   Coriell; GM09824
DR   Wikidata; Q54844078
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N14 ! GM09825
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM09825
AC   CVCL_2N14
DR   CLO; CLO_0030661
DR   Coriell; GM09825
DR   Wikidata; Q54844079
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,X,der(X)(Xpter->Xq21::Yq12->Yqter) (Coriell=GM09825).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2N13 ! GM09824
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM09826
AC   CVCL_AB02
DR   CLO; CLO_0030662
DR   Coriell; GM09826
DR   Wikidata; Q54844080
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (Coriell=GM09826).
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM09826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   GM09827
AC   CVCL_AB03
DR   CLO; CLO_0030668
DR   Coriell; GM09827
DR   Wikidata; Q54844081
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM02341; GM09826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09828
AC   CVCL_AB04
DR   CLO; CLO_0030645
DR   Coriell; GM09828
DR   Wikidata; Q54844082
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM02341; GM09826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09829
AC   CVCL_AB05
DR   CLO; CLO_0030642
DR   Coriell; GM09829
DR   Wikidata; Q54844083
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM02341; GM09826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09830
AC   CVCL_AB06
DR   CLO; CLO_0030635
DR   Coriell; GM09830
DR   Wikidata; Q54844084
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM02341; GM09826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM09832
AC   CVCL_GT54
DR   CLO; CLO_0030636
DR   Coriell; GM09832
DR   Wikidata; Q54844085
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09833
AC   CVCL_2Z77
DR   CLO; CLO_0030633
DR   Coriell; GM09833
DR   Wikidata; Q54844086
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Irish.
CC   Karyotypic information: 46,XX,ins(5;15)(5pter->5q23.2::15q23->15q26.1::5q23.2->5qter;15pter->15q23::15q26.1->15qter) (Coriell=GM09833).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z78 ! GM09834
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM09834
AC   CVCL_2Z78
SY   GM09834A
DR   CLO; CLO_0030634
DR   Coriell; GM09834
DR   Wikidata; Q54844087
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian; Irish.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z77 ! GM09833
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM09838
AC   CVCL_AB07
DR   CLO; CLO_0030631
DR   Coriell; GM09838
DR   Wikidata; Q54844088
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09849
AC   CVCL_GT55
DR   CLO; CLO_0030632
DR   Coriell; GM09849
DR   Wikidata; Q54844089
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09850
AC   CVCL_GT56
DR   CLO; CLO_0030629
DR   Coriell; GM09850
DR   Wikidata; Q54844090
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09852
AC   CVCL_F612
DR   CLO; CLO_0030630
DR   Coriell; GM09852
DR   Wikidata; Q54844091
RX   CelloPub=CLPUB00447;
RX   PubMed=3021482;
CC   Population: Caucasian; Sardinian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F605 ! GM03030
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   GM09853
AC   CVCL_GT57
DR   CLO; CLO_0030619
DR   Coriell; GM09853
DR   Wikidata; Q54844092
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09864
AC   CVCL_GT58
DR   CLO; CLO_0030627
DR   Coriell; GM09864
DR   Wikidata; Q54844093
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09865
AC   CVCL_FV59
DR   CLO; CLO_0030625
DR   Coriell; GM09865
DR   Wikidata; Q54844094
RX   CelloPub=CLPUB00447;
CC   Population: Ecuadorian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV60 ! GM09870
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09867
AC   CVCL_4E00
DR   CLO; CLO_0030589
DR   Coriell; GM09867
DR   Wikidata; Q54844095
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM09867; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM09868
AC   CVCL_F217
DR   CLO; CLO_0030592
DR   Coriell; GM09868
DR   Wikidata; Q54844096
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   GM09869
AC   CVCL_7498
SY   GM18046
DR   CLO; CLO_0015625
DR   CLO; CLO_0030594
DR   Coriell; GM09869
DR   Coriell; GM18046
DR   Wikidata; Q54844097
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM09870
AC   CVCL_FV60
DR   CLO; CLO_0030596
DR   Coriell; GM09870
DR   Wikidata; Q54844098
RX   CelloPub=CLPUB00447;
CC   Population: Ecuadorian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV59 ! GM09865
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM09871
AC   CVCL_N121
SY   GM17304
DR   CLO; CLO_0013315
DR   CLO; CLO_0030597
DR   Coriell; GM09871
DR   Coriell; GM17304
DR   Wikidata; Q54844100
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: South American (Andes).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09884
AC   CVCL_FV61
DR   CLO; CLO_0030599
DR   Coriell; GM09884
DR   Wikidata; Q54844101
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09885
AC   CVCL_DS20
DR   CLO; CLO_0030601
DR   Coriell; GM09885
DR   Wikidata; Q54844102
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM09886
AC   CVCL_9T23
SY   GM09886A
DR   CLO; CLO_0030587
DR   Coriell; GM09886
DR   Wikidata; Q54844103
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09887
AC   CVCL_9X49
SY   GM09887A
DR   CLO; CLO_0030584
DR   Coriell; GM09887
DR   Wikidata; Q54844104
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09888
AC   CVCL_5P04
DR   CLO; CLO_0030582
DR   Coriell; GM09888
DR   Wikidata; Q54844105
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75118; Trichorhinophalangeal syndrome type II
DI   ORDO; Orphanet_502; Trichorhinophalangeal syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM09892
AC   CVCL_5P05
DR   CLO; CLO_0030580
DR   Coriell; GM09892
DR   Wikidata; Q54844106
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM09892; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM09893
AC   CVCL_IN26
DR   CLO; CLO_0030553
DR   Coriell; GM09893
DR   Wikidata; Q54844107
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129980; Neonatal hemochromatosis
DI   ORDO; Orphanet_446; Neonatal hemochromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM09894
AC   CVCL_IN27
SY   GM 09894
DR   CLO; CLO_0030556
DR   Coriell; GM09894
DR   Wikidata; Q54844108
RX   CelloPub=CLPUB00447;
RX   PubMed=2916654;
CC   Population: Caucasian; Portuguese.
CC   HLA typing: A*01,01; B*27,35 (PubMed=2916654).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129980; Neonatal hemochromatosis
DI   ORDO; Orphanet_446; Neonatal hemochromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M2W
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM09899
AC   CVCL_N122
SY   GM17233
DR   CLO; CLO_0014338
DR   CLO; CLO_0030550
DR   Coriell; GM09899
DR   Coriell; GM17233
DR   GEO; GSM569630
DR   GEO; GSM596297
DR   GEO; GSM596657
DR   GEO; GSM924835
DR   Wikidata; Q54844109
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,02:01:01; B*35:03:01,44:02:01; C*04:01:01,05:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:01:02,02:01:01; DQB1*03:03:02,05:01:01; DRB1*01:02:01,07:01:01; DRB4*01:03:01:02N (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM09901
AC   CVCL_N123
SY   GM18047
DR   CLO; CLO_0015620
DR   CLO; CLO_0030552
DR   Coriell; GM09901
DR   Coriell; GM18047
DR   Wikidata; Q54844110
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09909
AC   CVCL_AB08
SY   GM09909A
DR   CLO; CLO_0030560
DR   Coriell; GM09909
DR   Wikidata; Q54844111
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09910
AC   CVCL_AB09
DR   CLO; CLO_0030561
DR   Coriell; GM09910
DR   Wikidata; Q54844120
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09911
AC   CVCL_8A52
DR   CLO; CLO_0029762
DR   Coriell; GM09911
DR   Wikidata; Q54844121
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09912
AC   CVCL_N124
SY   GM17095
DR   CLO; CLO_0014522
DR   CLO; CLO_0029763
DR   Coriell; GM09912
DR   Coriell; GM17095
DR   Wikidata; Q54844122
RX   CelloPub=CLPUB00447;
RX   PubMed=2916654;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Portuguese.
CC   HLA typing: A*01,02; B*07,35; C*w04,w07 (PubMed=2916654).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM09913
AC   CVCL_IN28
DR   CLO; CLO_0029760
DR   Coriell; GM09913
DR   Wikidata; Q54844123
RX   CelloPub=CLPUB00447;
RX   PubMed=2916654;
CC   Population: Caucasian; Portuguese.
CC   HLA typing: A*01,03; B*27,44; C*w02 (PubMed=2916654).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM09914
AC   CVCL_UT44
SY   GM09914A
DR   Coriell; GM09914
DR   Wikidata; Q93806163
RX   CelloPub=CLPUB00447;
RX   PubMed=2916654;
CC   HLA typing: A*02,02; B*35,51; C*w04 (Coriell=GM09914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM09914; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM09915
AC   CVCL_UT45
SY   GM09915A
DR   Coriell; GM09915
DR   Wikidata; Q93806166
RX   CelloPub=CLPUB00447;
RX   PubMed=2916654;
CC   HLA typing: A*01,02; B*44,w57; C*w05,w06 (Coriell=GM09915).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM09915; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM09916
AC   CVCL_N125
SY   GM17290
DR   CLO; CLO_0013140
DR   Coriell; GM09916
DR   Coriell; GM17290
DR   GEO; GSM569741
DR   GEO; GSM596354
DR   GEO; GSM596772
DR   GEO; GSM924892
DR   Wikidata; Q54844124
RX   PubMed=2916654;
RX   PubMed=20889555;
RX   PubMed=26621101;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: B*57:01 (Coriell=GM17290).
CC   HLA typing: A*01,02; B*51,w57 (PubMed=2916654).
CC   HLA typing: A*11:01:01,26:01:01; B*07:02:01,57:01:01; C*06:02:01,12:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:02,01:04:01; DQB1*05:02:01,05:03:01; DRB1*14:54:01,15:01:01; DRB3*02:02:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Caution: Indicated as originating from a female child in Coriell, but seems to be from a male (PubMed=2916654).
CC   Discontinued: Coriell; GM09916; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM09918
AC   CVCL_7499
DR   CLO; CLO_0029761
DR   BioSample; SAMN00799605
DR   Coriell; GM09918
DR   GEO; GSM3124668
DR   Wikidata; Q54844125
RX   CelloPub=CLPUB00447;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D344 ! GM01056
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   GM09919
AC   CVCL_GT59
DR   CLO; CLO_0029758
DR   Coriell; GM09919
DR   Wikidata; Q54844126
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09922
AC   CVCL_6G95
DR   CLO; CLO_0029759
DR   Coriell; GM09922
DR   Wikidata; Q54844127
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G96 ! GM09946
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM09923
AC   CVCL_7500
SY   GM09923B
DR   CLO; CLO_0029756
DR   Coriell; GM09923
DR   Wikidata; Q54844128
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   98Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM09925
AC   CVCL_ZW31
SY   GM 09925; 84-2; 84-2/8; CF84-2/4
DR   Coriell; GM09925
DR   Wikidata; Q102113886
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09925; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09926
AC   CVCL_ZW32
SY   GM 09926; 84-3; 84-3/5; CF84-3/3
DR   Coriell; GM09926
DR   Wikidata; Q102113887
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09926; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09927
AC   CVCL_ZW33
SY   GM 09927; 84-4; 84-4/8
DR   Coriell; GM09927
DR   Wikidata; Q102113889
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09927; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09928
AC   CVCL_ZW34
SY   GM 09927; 84-5; 84-5/8; CF84-5/4
DR   Coriell; GM09928
DR   Wikidata; Q102113890
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09928; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09929
AC   CVCL_ZW35
SY   GM 09929; 84-7; 84-7/8; CF84-7/4
DR   Coriell; GM09929
DR   Wikidata; Q102113892
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09929; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09930
AC   CVCL_ZW36
SY   GM09930A; GM 09930A; 84-20; 84-20/8; CF84-20/4
DR   Coriell; GM09930
DR   Wikidata; Q102113893
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09930; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09931
AC   CVCL_ZW37
SY   GM 09931; 84-21; 84-21/5; CF84-21/4
DR   Coriell; GM09931
DR   Wikidata; Q102113895
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09931; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09932
AC   CVCL_ZW38
SY   GM 09932; 84-25; 84-25/8; CF84-25/4
DR   Coriell; GM09932
DR   Wikidata; Q102113896
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09932; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09933
AC   CVCL_ZW39
SY   GM 09933; 84-26; 84-26/5; CF84-26/8
DR   Coriell; GM09933
DR   Wikidata; Q102113897
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09933; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09934
AC   CVCL_ZW40
SY   GM 09934; 84-27; 84-27/8; CF84-27/3
DR   Coriell; GM09934
DR   Wikidata; Q102113900
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09934; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09935
AC   CVCL_ZW41
SY   GM09935A; GM 09935A; 84-30; 84-30/5; CF84-30/9
DR   Coriell; GM09935
DR   Wikidata; Q102113902
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09935; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09936
AC   CVCL_ZW42
SY   GM 09936; 84-34; 84-34/9; CF84-34/5
DR   Coriell; GM09936
DR   Wikidata; Q102113905
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09936; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09937
AC   CVCL_ZW43
SY   GM 09937; 84-35; CF84-35/11
DR   Coriell; GM09937
DR   Wikidata; Q102113908
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09937; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09938
AC   CVCL_ZW44
SY   GM 09938; 84-37; 84-37/4; CF84-37/8
DR   Coriell; GM09938
DR   Wikidata; Q102113910
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09938; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09940
AC   CVCL_ZW45
SY   GM 09940; 84-39; 84-39/5; CF84-39/8
DR   Coriell; GM09940
DR   Wikidata; Q102113912
RX   PubMed=2005900;
RX   PubMed=3456176;
RX   PubMed=3862130;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM09940; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
HI   CVCL_4114 ! B82
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   GM09944
AC   CVCL_AA00
DR   CLO; CLO_0029755
DR   Coriell; GM09944
DR   Wikidata; Q54844131
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM09946
AC   CVCL_6G96
DR   CLO; CLO_0029741
DR   Coriell; GM09946
DR   Wikidata; Q54844132
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G95 ! GM09922
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09947
AC   CVCL_N126
SY   GM9947; GM09947A; GM09947a; 9947A; GM17234
DR   CLO; CLO_0014340
DR   CLO; CLO_0029743
DR   Coriell; GM09947
DR   Coriell; GM17234
DR   GEO; GSM569608
DR   GEO; GSM596298
DR   GEO; GSM596658
DR   GEO; GSM924836
DR   Wikidata; Q54844133
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00756;
RX   CelloPub=CLPUB00757;
RX   PubMed=8530025;
RX   PubMed=14583597;
RX   PubMed=14642717;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=24266330;
RX   PubMed=26621101;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2391b.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392.
CC   Population: Caucasian.
CC   Biotechnology: Used a source of control genomic and mitochondrial DNA for USA forensic testing.
CC   HLA typing: A*02:01:01,02:01:01; B*44:02:01,51:01:01; C*02:02:02,05:01:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:02:01G; DQA1*04:02,05:01:01; DQB1*02:01:01,04:02:01; DRB1*03:01:01,08:01:01; DRB3*02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): CelloPub=CLPUB00756; CelloPub=CLPUB00757; PubMed=14642717; PubMed=24266330
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 13,15
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D1S1656: 18.3
ST   D21S11: 30
ST   D22S1045: 11,14
ST   D2S1338: 19,23
ST   D2S441: 10,14
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   DXS101: 24,26
ST   F13A01: 6,16
ST   F13B: 8,10
ST   FESFPS: 10,12
ST   FGA: 23,24
ST   LPL: 11,12
ST   Penta D: 12
ST   Penta E: 12,13
ST   SE33: 19,29.2
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   GM09948
AC   CVCL_N127
SY   GM9948; 9948; GM09948A; GM17235
DR   CLO; CLO_0014334
DR   CLO; CLO_0029744
DR   Coriell; GM09948
DR   Coriell; GM17235
DR   GEO; GSM569605
DR   GEO; GSM596299
DR   GEO; GSM596659
DR   GEO; GSM924837
DR   Wikidata; Q54844134
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00756;
RX   CelloPub=CLPUB00757;
RX   PubMed=8530025;
RX   PubMed=14583597;
RX   PubMed=14642717;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=24266330;
RX   PubMed=26621101;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2391b.
CC   Population: Caucasian.
CC   Biotechnology: Used a source of control genomic DNA for USA forensic testing.
CC   HLA typing: A*03:01:01,31:01:02; B*07:02:01,40:01:02; C*03:04:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:02:01; DRB1*04:04:01,15:01:01; DRB4*01:03:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): CelloPub=CLPUB00756; CelloPub=CLPUB00757; PubMed=14642717; PubMed=24266330
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D10S1248: 12,15
ST   D12S391: 18,24
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 13,14
ST   D1S1656: 14,17
ST   D21S11: 29,30
ST   D22S1045: 16,18
ST   D2S1338: 23
ST   D2S441: 11,12
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 12,13
ST   DXS101: 25
ST   DYS391: 10
ST   F13A01: 6
ST   F13B: 8
ST   FESFPS: 11
ST   FGA: 24,26
ST   LPL: 10,12
ST   Penta D: 8,12
ST   Penta E: 11
ST   SE33: 23.2,26.2
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM09958
AC   CVCL_UT53
DR   CLO; CLO_0029736
DR   Coriell; GM09958
DR   Wikidata; Q93806299
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient with type II urogenital sinus with second degree urinary tract obstruction, partial aniridia, mild left hemifacial microsomia, CHD (patent ductus arteriosus) and cerebral vasculitis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM09960
AC   CVCL_U706
DR   CLO; CLO_0029737
DR   Coriell; GM09960
DR   Wikidata; Q54844135
RX   PubMed=908169;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (Coriell=GM09960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 27(LySe) (BSR27).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U707 ! GM16377
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM09963
AC   CVCL_1N30
DR   CLO; CLO_0029738
DR   Coriell; GM09963
DR   Wikidata; Q54844136
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM09964
AC   CVCL_N145
DR   CLO; CLO_0029739
DR   Coriell; GM09964
DR   Wikidata; Q54844137
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_595337; Adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N146 ! GM10490
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM09965
AC   CVCL_EH05
DR   CLO; CLO_0029733
DR   Coriell; GM09965
DR   Wikidata; Q54844138
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM09979
AC   CVCL_FV62
DR   CLO; CLO_0029734
DR   Coriell; GM09979
DR   Wikidata; Q54844139
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3W
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09981
AC   CVCL_5P06
DR   CLO; CLO_0029735
DR   Coriell; GM09981
DR   Wikidata; Q54844140
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex2-4dup; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM09982
AC   CVCL_5P07
DR   CLO; CLO_0029815
DR   Coriell; GM09982
DR   Wikidata; Q54844141
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM09984
AC   CVCL_AB10
DR   CLO; CLO_0029818
DR   Coriell; GM09984
DR   Wikidata; Q54844142
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM09986
AC   CVCL_IZ54
DR   Coriell; GM09986
DR   Wikidata; Q54844143
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM09986; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   GM09987
AC   CVCL_F216
DR   Coriell; GM09987
DR   Wikidata; Q54844144
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   GM09988
AC   CVCL_DC01
DR   Coriell; GM09988
DR   Wikidata; Q54844145
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM09988; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   GM09989
AC   CVCL_FV63
DR   CLO; CLO_0029812
DR   Coriell; GM09989
DR   Wikidata; Q54844146
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09990
AC   CVCL_FV64
DR   CLO; CLO_0029814
DR   Coriell; GM09990
DR   Wikidata; Q54844148
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09991
AC   CVCL_FV65
DR   CLO; CLO_0029804
DR   Coriell; GM09991
DR   Wikidata; Q54844149
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09992
AC   CVCL_FV66
DR   CLO; CLO_0029805
DR   Coriell; GM09992
DR   Wikidata; Q54844150
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM09994
AC   CVCL_0Q63
DR   CLO; CLO_0029802
DR   Coriell; GM09994
DR   Wikidata; Q54844151
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM09996
AC   CVCL_5P08
DR   CLO; CLO_0029803
DR   Coriell; GM09996
DR   Wikidata; Q54844152
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM1 [Drosophila]
AC   CVCL_Z794
DR   FlyBase_Cell_line; FBtc9000032
DR   Wikidata; Q54844153
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=811480;
RX   PubMed=4626439;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage 16
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 10
//
ID   GM1 [Human GM1 gangliosidosis]
AC   CVCL_B6R1
DR   JCRB; JCRB3073
DR   JCRB; KURB1986
DR   Wikidata; Q111733238
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1986; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3073
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 5
//
ID   GM1-1019
AC   CVCL_C0NX
DR   Wikidata; Q112929586
RX   PubMed=2990594;
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   GM1-1019-SV
AC   CVCL_C0NY
SY   GM-1019-SV
DR   Wikidata; Q112929587
RX   PubMed=2990594;
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Doubling time: ~20 hours (PubMed=2990594).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0NX ! GM1-1019
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   GM1-1026
AC   CVCL_C0NZ
DR   Wikidata; Q112929588
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   GM1-1026-SV
AC   CVCL_C0P0
SY   GM-1026-SV
DR   Wikidata; Q112929589
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0NZ ! GM1-1026
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   GM1-22
AC   CVCL_C0NV
DR   Wikidata; Q112929590
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   GM1-22-SV
AC   CVCL_C0NW
SY   GM-22-SV
DR   Wikidata; Q112929591
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0NV ! GM1-22
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   GM10001
AC   CVCL_AU84
DR   CLO; CLO_0029806
DR   BioSample; SAMN00799653
DR   Coriell; GM10001
DR   Wikidata; Q54844154
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10005
AC   CVCL_N129
SY   GM17168
DR   CLO; CLO_0013987
DR   CLO; CLO_0029807
DR   BioSample; SAMN00799655
DR   Coriell; GM10005
DR   Coriell; GM17168
DR   GEO; GSM569695
DR   GEO; GSM596233
DR   GEO; GSM597028
DR   GEO; GSM924678
DR   Wikidata; Q54844156
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:01:01,33:03:01; B*15:03:01,44:02:01; C*02:10:01,05:01:01; DPA1*01:03:01,03:NEW-2; DPB1*04:01:01,350:01; DQA1*01:02:01,03:03:01; DQB1*03:01:01,06:02:01; DRB1*04:01:01,15:03:01; DRB4*01:03:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N128 ! GM04618
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM10006
AC   CVCL_2T69
DR   CLO; CLO_0029789
DR   BioSample; SAMN00799657
DR   Coriell; GM10006
DR   Wikidata; Q54844157
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10011
AC   CVCL_AW78
DR   CLO; CLO_0029792
DR   Coriell; GM10011
DR   Wikidata; Q54844158
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10012
AC   CVCL_AE19
DR   CLO; CLO_0029793
DR   BioSample; SAMN00799659
DR   Coriell; GM10012
DR   Wikidata; Q54844159
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84525; Abetalipoproteinemia
DI   ORDO; Orphanet_14; Abetalipoproteinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE18 ! GM01453
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10013
AC   CVCL_F255
DR   CLO; CLO_0029795
DR   BioSample; SAMN00799661
DR   Coriell; GM10013
DR   Wikidata; Q54844160
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 69,XXX (Coriell=GM10013).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM10014
AC   CVCL_EJ59
DR   CLO; CLO_0029797
DR   Coriell; GM10014
DR   Wikidata; Q54844161
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM10014; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10015
AC   CVCL_H554
SY   GM10015A
DR   CLO; CLO_0029781
DR   BioSample; SAMN00799663
DR   Coriell; GM10015
DR   Wikidata; Q54844171
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM10016
AC   CVCL_EJ60
DR   CLO; CLO_0029782
DR   BioSample; SAMN00799665
DR   Coriell; GM10016
DR   Wikidata; Q54844172
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM10017
AC   CVCL_AI95
SY   GM10017A
DR   CLO; CLO_0029783
DR   BioSample; SAMN00799667
DR   Coriell; GM10017
DR   Wikidata; Q54844173
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10018
AC   CVCL_AI96
DR   CLO; CLO_0029784
DR   Coriell; GM10018
DR   Wikidata; Q54844174
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM10020
AC   CVCL_5P09
DR   CLO; CLO_0029785
DR   Coriell; GM10020
DR   Wikidata; Q54844175
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM10027
AC   CVCL_1R82
SY   EyeF3A6
DR   CLO; CLO_0029881
DR   Coriell; GM10027
DR   Wikidata; Q54844176
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=2395866;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 22 mapping. Contains a complete copy of chromosome 22.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N40 ! CHO Ade-I
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM10036
AC   CVCL_AI97
DR   CLO; CLO_0029878
DR   Coriell; GM10036
DR   Wikidata; Q54844178
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10040
AC   CVCL_2N00
DR   CLO; CLO_0029877
DR   BioSample; SAMN00799669
DR   Coriell; GM10040
DR   Wikidata; Q54844179
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10041
AC   CVCL_AI98
SY   GM10041A
DR   CLO; CLO_0029875
DR   Coriell; GM10041
DR   Wikidata; Q54844180
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10042
AC   CVCL_AI99
DR   CLO; CLO_0029873
DR   Coriell; GM10042
DR   Wikidata; Q54844182
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10043
AC   CVCL_AJ00
SY   GM10043B
DR   CLO; CLO_0029870
DR   BioSample; SAMN00799671
DR   Coriell; GM10043
DR   Wikidata; Q54844183
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10044
AC   CVCL_AJ01
DR   CLO; CLO_0029888
DR   Coriell; GM10044
DR   Wikidata; Q54844184
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10045
AC   CVCL_AJ02
DR   CLO; CLO_0029886
DR   Coriell; GM10045
DR   Wikidata; Q54844185
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10056
AC   CVCL_AJ03
DR   CLO; CLO_0029885
DR   Coriell; GM10056
DR   Wikidata; Q54844186
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10057
AC   CVCL_AJ04
DR   CLO; CLO_0029884
DR   BioSample; SAMN00799673
DR   Coriell; GM10057
DR   Wikidata; Q54844187
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10058
AC   CVCL_AJ05
SY   GM10058A
DR   CLO; CLO_0029843
DR   BioSample; SAMN00799675
DR   Coriell; GM10058
DR   Wikidata; Q54844188
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM10059
AC   CVCL_AJ06
DR   CLO; CLO_0029845
DR   BioSample; SAMN00799677
DR   Coriell; GM10059
DR   Wikidata; Q54844189
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10060
AC   CVCL_AJ07
DR   CLO; CLO_0029844
DR   Coriell; GM10060
DR   Wikidata; Q54844190
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10061
AC   CVCL_9S95
DR   CLO; CLO_0029840
DR   Coriell; GM10061
DR   Wikidata; Q54844191
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 7
//
ID   GM10062
AC   CVCL_1N59
DR   CLO; CLO_0029839
DR   Coriell; GM10062
DR   Wikidata; Q54844192
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,X,t(X;21)(Xqter->Xp21::21p12->21pter;21qter->21p12::Xp21->Xpter) (Coriell=GM10062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM10063
AC   CVCL_1R83
SY   A2-4
DR   CLO; CLO_0029842
DR   Coriell; GM10063
DR   Wikidata; Q54844193
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N59 ! GM10062
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM10064
AC   CVCL_5P10
DR   CLO; CLO_0029841
DR   BioSample; SAMN00799679
DR   Coriell; GM10064
DR   Wikidata; Q54844194
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,der(7)(7pter->7q34::13q12.3->13qter)pat (Coriell=GM10064).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10067
AC   CVCL_2T70
DR   CLO; CLO_0029847
DR   BioSample; SAMN00799681
DR   Coriell; GM10067
DR   Wikidata; Q54844195
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(7;13)(7pter->7q34::13q12.3->13qter;13pter->13q12.3::7q34->7qter) (Coriell=GM10067).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   GM10068
AC   CVCL_2T71
DR   CLO; CLO_0029846
DR   BioSample; SAMN00799683
DR   Coriell; GM10068
DR   Wikidata; Q54844196
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 10
//
ID   GM10069
AC   CVCL_F256
SY   GM10069A
DR   CLO; CLO_0029848
DR   BioSample; SAMN00799685
DR   Coriell; GM10069
DR   Wikidata; Q54844197
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 13
//
ID   GM10070
AC   CVCL_AJ08
DR   CLO; CLO_0029931
DR   Coriell; GM10070
DR   Wikidata; Q54844198
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10071
AC   CVCL_AJ09
SY   GM00171A
DR   CLO; CLO_0029930
DR   Coriell; GM10071
DR   Wikidata; Q54844199
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10072
AC   CVCL_N130
SY   GM18048
DR   CLO; CLO_0015622
DR   CLO; CLO_0029929
DR   BioSample; SAMN00799687
DR   Coriell; GM10072
DR   Coriell; GM18048
DR   Wikidata; Q54844200
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: Human variation panel.
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 12
//
ID   GM10073
AC   CVCL_H956
SY   GM10073A
DR   CLO; CLO_0029928
DR   BioSample; SAMN00799689
DR   Coriell; GM10073
DR   Wikidata; Q54844201
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H955 ! GM00073
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM10074
AC   CVCL_H958
DR   CLO; CLO_0029935
DR   BioSample; SAMN00799691
DR   Coriell; GM10074
DR   Wikidata; Q54844202
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H957 ! GM00074
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM10077
AC   CVCL_UT52
DR   Coriell; GM10077
DR   Wikidata; Q93806916
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10077; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM10078
AC   CVCL_EJ61
DR   CLO; CLO_0029934
DR   BioSample; SAMN00799693
DR   Coriell; GM10078
DR   Wikidata; Q54844203
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10079
AC   CVCL_EJ62
DR   CLO; CLO_0029933
DR   BioSample; SAMN00799695
DR   Coriell; GM10079
DR   Wikidata; Q54844204
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10080
AC   CVCL_AE13
DR   CLO; CLO_0029932
DR   BioSample; SAMN00799697
DR   Coriell; GM10080
DR   Wikidata; Q54844205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3076; Cowden syndrome
DI   ORDO; Orphanet_201; Cowden syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10081
AC   CVCL_AE14
DR   CLO; CLO_0029937
DR   BioSample; SAMN00799699
DR   Coriell; GM10081
DR   Wikidata; Q54844206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3076; Cowden syndrome
DI   ORDO; Orphanet_201; Cowden syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10082
AC   CVCL_9X14
DR   CLO; CLO_0029936
DR   BioSample; SAMN00799701
DR   Coriell; GM10082
DR   Wikidata; Q54844207
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10083
AC   CVCL_AJ10
SY   GM10083A
DR   CLO; CLO_0029897
DR   BioSample; SAMN00799703
DR   Coriell; GM10083
DR   Wikidata; Q54844208
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10084
AC   CVCL_AJ11
DR   CLO; CLO_0029899
DR   BioSample; SAMN00799705
DR   Coriell; GM10084
DR   Wikidata; Q54844209
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10085
AC   CVCL_AJ12
SY   GM10085A
DR   CLO; CLO_0029898
DR   BioSample; SAMN00799707
DR   Coriell; GM10085
DR   Wikidata; Q54844210
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10086
AC   CVCL_AJ13
SY   GM10086A
DR   CLO; CLO_0029901
DR   BioSample; SAMN00799709
DR   Coriell; GM10086
DR   Wikidata; Q54844211
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM10087
AC   CVCL_AJ14
DR   CLO; CLO_0029900
DR   Coriell; GM10087
DR   Wikidata; Q54844212
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10095
AC   CVCL_1R84
SY   CF11-4/5
DR   CLO; CLO_0029903
DR   Coriell; GM10095
DR   Wikidata; Q54844217
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C574 ! CHW-1102
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM10112
AC   CVCL_V422
DR   CLO; CLO_0029902
DR   BioSample; SAMN00799711
DR   Coriell; GM10112
DR   Wikidata; Q54844218
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   GM10113
AC   CVCL_AM67
DR   CLO; CLO_0029905
DR   BioSample; SAMN00799713
DR   Coriell; GM10113
DR   Wikidata; Q54844219
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM10117
AC   CVCL_AJ15
DR   CLO; CLO_0029991
DR   Coriell; GM10117
DR   Wikidata; Q54844220
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10118
AC   CVCL_2T72
DR   CLO; CLO_0029989
DR   BioSample; SAMN00799715
DR   Coriell; GM10118
DR   Wikidata; Q54844221
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM10119
AC   CVCL_AJ16
SY   GM10119A
DR   CLO; CLO_0029979
DR   BioSample; SAMN00799717
DR   Coriell; GM10119
DR   Wikidata; Q54844222
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10121
AC   CVCL_AJ17
SY   GM10121B
DR   CLO; CLO_0029982
DR   BioSample; SAMN00799719
DR   Coriell; GM10121
DR   Wikidata; Q54844223
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 10
//
ID   GM10122
AC   CVCL_AJ18
DR   CLO; CLO_0029984
DR   Coriell; GM10122
DR   Wikidata; Q54844224
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10123
AC   CVCL_AJ19
SY   GM10123A
DR   CLO; CLO_0029985
DR   Coriell; GM10123
DR   Wikidata; Q54844225
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10124
AC   CVCL_AJ20
SY   GM10124A
DR   CLO; CLO_0029973
DR   BioSample; SAMN00799721
DR   Coriell; GM10124
DR   Wikidata; Q54844226
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10125
AC   CVCL_AM11
SY   GM10125B
DR   CLO; CLO_0029974
DR   BioSample; SAMN00799723
DR   Coriell; GM10125
DR   Wikidata; Q54844227
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10125).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10126
AC   CVCL_AM12
DR   CLO; CLO_0029975
DR   BioSample; SAMN00799725
DR   Coriell; GM10126
DR   Wikidata; Q54844228
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10127
AC   CVCL_AM13
SY   GM10127A
DR   CLO; CLO_0029977
DR   BioSample; SAMN00799727
DR   Coriell; GM10127
DR   Wikidata; Q54844229
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10127).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10128
AC   CVCL_AM14
DR   CLO; CLO_0029960
DR   BioSample; SAMN00799729
DR   Coriell; GM10128
DR   Wikidata; Q54844230
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10129
AC   CVCL_N131
SY   GM10129D; GM18049
DR   CLO; CLO_0015649
DR   CLO; CLO_0029958
DR   BioSample; SAMN00799731
DR   Coriell; GM10129
DR   Coriell; GM18049
DR   Wikidata; Q54844231
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10130
AC   CVCL_AM15
DR   CLO; CLO_0029956
DR   BioSample; SAMN00799733
DR   Coriell; GM10130
DR   Wikidata; Q54844232
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10130).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10131
AC   CVCL_AM16
DR   CLO; CLO_0029953
DR   BioSample; SAMN00799735
DR   Coriell; GM10131
DR   Wikidata; Q54844233
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10132
AC   CVCL_AM17
SY   GM10132B
DR   CLO; CLO_0029955
DR   BioSample; SAMN00799737
DR   Coriell; GM10132
DR   Wikidata; Q54844234
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10132).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10133
AC   CVCL_AM18
DR   CLO; CLO_0029949
DR   BioSample; SAMN00799739
DR   Coriell; GM10133
DR   Wikidata; Q54844235
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10133).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10134
AC   CVCL_AM19
DR   CLO; CLO_0029950
DR   BioSample; SAMN00799741
DR   Coriell; GM10134
DR   Wikidata; Q54844236
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10135
AC   CVCL_AM20
DR   CLO; CLO_0029946
DR   BioSample; SAMN00799743
DR   Coriell; GM10135
DR   Wikidata; Q54844237
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10135).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10136
AC   CVCL_AM21
DR   CLO; CLO_0029947
DR   BioSample; SAMN00799744
DR   Coriell; GM10136
DR   Wikidata; Q54844238
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10137
AC   CVCL_AM22
SY   GM10137A
DR   CLO; CLO_0029944
DR   BioSample; SAMN00799746
DR   Coriell; GM10137
DR   Wikidata; Q54844239
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10138
AC   CVCL_AM23
DR   CLO; CLO_0029667
DR   BioSample; SAMN00799748
DR   Coriell; GM10138
DR   Wikidata; Q54844241
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10138).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10139
AC   CVCL_AM24
SY   GM10139B
DR   CLO; CLO_0029664
DR   BioSample; SAMN00799749
DR   Coriell; GM10139
DR   Wikidata; Q54844242
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10139).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10140
AC   CVCL_AM25
SY   GM10140A
DR   CLO; CLO_0029663
DR   BioSample; SAMN00799751
DR   Coriell; GM10140
DR   Wikidata; Q54844243
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10141
AC   CVCL_AM26
DR   CLO; CLO_0029666
DR   BioSample; SAMN00799752
DR   Coriell; GM10141
DR   Wikidata; Q54844244
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10142
AC   CVCL_AM27
DR   CLO; CLO_0029665
DR   BioSample; SAMN00799754
DR   Coriell; GM10142
DR   Wikidata; Q54844245
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10142).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with retinitis pigmentosa but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10143
AC   CVCL_AM28
SY   GM10143B
DR   CLO; CLO_0029660
DR   BioSample; SAMN00799756
DR   Coriell; GM10143
DR   Wikidata; Q54844246
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10144
AC   CVCL_AM29
DR   CLO; CLO_0029659
DR   BioSample; SAMN00799758
DR   Coriell; GM10144
DR   Wikidata; Q54844247
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10145
AC   CVCL_AM30
DR   CLO; CLO_0029662
DR   BioSample; SAMN00799760
DR   Coriell; GM10145
DR   Wikidata; Q54844248
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10146
AC   CVCL_AM31
DR   CLO; CLO_0029661
DR   BioSample; SAMN00799762
DR   Coriell; GM10146
DR   Wikidata; Q54844249
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10146).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10147
AC   CVCL_AM32
DR   CLO; CLO_0029668
DR   BioSample; SAMN00799765
DR   Coriell; GM10147
DR   Wikidata; Q54844250
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Homozygous (PubMed=10391211; Coriell=GM10147).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM10148
AC   CVCL_AM33
DR   CLO; CLO_0029678
DR   BioSample; SAMN00799768
DR   Coriell; GM10148
DR   Wikidata; Q54844251
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10149
AC   CVCL_AM34
DR   CLO; CLO_0029677
DR   BioSample; SAMN00799772
DR   Coriell; GM10149
DR   Wikidata; Q54844253
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10151
AC   CVCL_AJ21
DR   CLO; CLO_0029676
DR   Coriell; GM10151
DR   Wikidata; Q54844254
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10152
AC   CVCL_AJ22
DR   CLO; CLO_0029675
DR   BioSample; SAMN00799775
DR   Coriell; GM10152
DR   Wikidata; Q54844255
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10153
AC   CVCL_AJ23
DR   CLO; CLO_0029674
DR   Coriell; GM10153
DR   Wikidata; Q54844256
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10154
AC   CVCL_AJ24
DR   CLO; CLO_0029673
DR   Coriell; GM10154
DR   Wikidata; Q54844257
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM10155
AC   CVCL_0I31
SY   GM10155B
DR   CLO; CLO_0029672
DR   BioSample; SAMN00799777
DR   Coriell; GM10155
DR   Wikidata; Q54844258
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM10156
AC   CVCL_UH43
SY   GM10156B; GM10156C; 706-B6, clone 17; 706B6, clone 17
DR   CLO; CLO_0029671
DR   Coriell; GM10156
DR   Wikidata; Q93807473
RX   CelloPub=CLPUB00447;
RX   PubMed=7197058;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 8 mapping. Contains a complete copy of chromosome 8.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 5
//
ID   GM10157
AC   CVCL_1R85
SY   72532X
DR   CLO; CLO_0029670
DR   Coriell; GM10157
DR   Wikidata; Q54844262
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N38 ! CHO Ade-G
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM10158
AC   CVCL_FV67
DR   CLO; CLO_0029669
DR   BioSample; SAMN00799780
DR   Coriell; GM10158
DR   Wikidata; Q54844263
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German/Irish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV68 ! GM10159
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10159
AC   CVCL_FV68
DR   CLO; CLO_0029343
DR   BioSample; SAMN00799782
DR   Coriell; GM10159
DR   Wikidata; Q54844264
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German/Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV67 ! GM10158
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10160
AC   CVCL_5P11
DR   CLO; CLO_0029338
DR   BioSample; SAMN00799784
DR   Coriell; GM10160
DR   Wikidata; Q54844265
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10161
AC   CVCL_FV69
DR   CLO; CLO_0029340
DR   BioSample; SAMN00799786
DR   Coriell; GM10161
DR   Wikidata; Q54844266
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; French/Scottish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10162
AC   CVCL_AJ25
DR   CLO; CLO_0029357
DR   BioSample; SAMN00799788
DR   Coriell; GM10162
DR   Wikidata; Q54844267
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10163
AC   CVCL_AJ26
DR   CLO; CLO_0029358
DR   Coriell; GM10163
DR   Wikidata; Q54844268
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10164
AC   CVCL_AJ27
DR   CLO; CLO_0029355
DR   Coriell; GM10164
DR   Wikidata; Q54844269
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10165
AC   CVCL_AJ28
DR   CLO; CLO_0029356
DR   Coriell; GM10165
DR   Wikidata; Q54844270
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM10166
AC   CVCL_AJ29
DR   CLO; CLO_0029353
DR   Coriell; GM10166
DR   Wikidata; Q54844271
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10168
AC   CVCL_AJ30
DR   CLO; CLO_0029354
DR   BioSample; SAMN00799790
DR   Coriell; GM10168
DR   Wikidata; Q54844272
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10169
AC   CVCL_AJ31
DR   CLO; CLO_0029352
DR   Coriell; GM10169
DR   Wikidata; Q54844273
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM10170
AC   CVCL_AJ32
DR   CLO; CLO_0029309
DR   BioSample; SAMN00799793
DR   Coriell; GM10170
DR   Wikidata; Q54844274
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10171
AC   CVCL_AJ33
DR   CLO; CLO_0029311
DR   Coriell; GM10171
DR   Wikidata; Q54844276
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10173
AC   CVCL_4E01
DR   CLO; CLO_0029313
DR   BioSample; SAMN00799795
DR   Coriell; GM10173
DR   Wikidata; Q54844277
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10175
AC   CVCL_2T73
DR   CLO; CLO_0029315
DR   BioSample; SAMN00799797
DR   Coriell; GM10175
DR   Wikidata; Q54844278
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10176
AC   CVCL_N132
SY   GM17025; GM17314
DR   CLO; CLO_0013355
DR   CLO; CLO_0029324
DR   BioSample; SAMN00799800
DR   Coriell; GM10176
DR   Coriell; GM17025
DR   Coriell; GM17314
DR   Wikidata; Q54844279
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM17025; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10177
AC   CVCL_2T74
DR   CLO; CLO_0029325
DR   BioSample; SAMN00799802
DR   Coriell; GM10177
DR   Wikidata; Q54844280
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;7)(Xpter->Xq28::7p11->7pter;7qter->7p11::Xq28->Xqter) (Coriell=GM10177).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM10179
AC   CVCL_2N01
DR   CLO; CLO_0029326
DR   BioSample; SAMN00799803
DR   Coriell; GM10179
DR   Wikidata; Q54844281
CC   Population: African American.
CC   Karyotypic information: 45,X0 (Coriell=GM10179).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM10180
AC   CVCL_DI64
DR   CLO; CLO_0029327
DR   BioSample; SAMN00799806
DR   Coriell; GM10180
DR   Wikidata; Q54844282
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128118; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 1
DI   ORDO; Orphanet_899; Walker-Warburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10181
AC   CVCL_N133
SY   GM17367
DR   CLO; CLO_0013710
DR   CLO; CLO_0029322
DR   BioSample; SAMN00799808
DR   Coriell; GM10181
DR   Coriell; GM17367
DR   Wikidata; Q54844283
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10182
AC   CVCL_DI65
DR   CLO; CLO_0029323
DR   BioSample; SAMN00799810
DR   Coriell; GM10182
DR   Wikidata; Q54844284
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10183
AC   CVCL_9R51
DR   CLO; CLO_0029280
DR   BioSample; SAMN00799812
DR   Coriell; GM10183
DR   Wikidata; Q54844285
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10184
AC   CVCL_5P12
DR   CLO; CLO_0029289
DR   BioSample; SAMN00799814
DR   Coriell; GM10184
DR   Wikidata; Q54844286
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10185
AC   CVCL_AJ34
SY   GM10185B
DR   CLO; CLO_0029292
DR   BioSample; SAMN00799816
DR   Coriell; GM10185
DR   Wikidata; Q54844287
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10186
AC   CVCL_5P13
DR   CLO; CLO_0029285
DR   BioSample; SAMN00799817
DR   Coriell; GM10186
DR   Wikidata; Q54844288
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM10197
AC   CVCL_AU85
DR   CLO; CLO_0029288
DR   BioSample; SAMN00799819
DR   Coriell; GM10197
DR   Wikidata; Q54844289
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10198
AC   CVCL_AU86
DR   CLO; CLO_0029297
DR   BioSample; SAMN00799820
DR   Coriell; GM10198
DR   Wikidata; Q54844290
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10199
AC   CVCL_6B44
DR   CLO; CLO_0029298
DR   BioSample; SAMN00799822
DR   Coriell; GM10199
DR   Wikidata; Q54844291
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10204
AC   CVCL_2T75
DR   CLO; CLO_0029295
DR   BioSample; SAMN00799823
DR   Coriell; GM10204
DR   Wikidata; Q54844292
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM10206
AC   CVCL_2T76
SY   GM10206A
DR   CLO; CLO_0029296
DR   BioSample; SAMN00799825
DR   Coriell; GM10206
DR   Wikidata; Q54844293
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10207
AC   CVCL_5P14
DR   CLO; CLO_0029300
DR   BioSample; SAMN00799827
DR   Coriell; GM10207
DR   Wikidata; Q54844294
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10211
AC   CVCL_AJ35
DR   CLO; CLO_0029249
DR   BioSample; SAMN00799829
DR   Coriell; GM10211
DR   Wikidata; Q54844295
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM10222
AC   CVCL_AJ36
DR   CLO; CLO_0029253
DR   BioSample; SAMN00799831
DR   Coriell; GM10222
DR   Wikidata; Q54844296
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10223
AC   CVCL_AJ37
SY   GM10223B
DR   CLO; CLO_0029255
DR   BioSample; SAMN00799832
DR   Coriell; GM10223
DR   Wikidata; Q54844297
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10224
AC   CVCL_0Q10
DR   CLO; CLO_0029258
DR   BioSample; SAMN00799834
DR   Coriell; GM10224
DR   Wikidata; Q54844298
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM10225
AC   CVCL_DB70
DR   CLO; CLO_0029263
DR   Coriell; GM10225
DR   Wikidata; Q54844300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10227
AC   CVCL_DB71
DR   CLO; CLO_0029264
DR   Coriell; GM10227
DR   Wikidata; Q54844301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10228
AC   CVCL_W903
DR   CLO; CLO_0029266
DR   Coriell; GM10228
DR   Wikidata; Q54844302
CC   Sequence variation: Mutation; HGNC; HGNC:3349; ENG; Simple; p.Arg437Arg (c.1311G>C) (G1311C); ClinVar=VCV000458335; Zygosity=Unspecified; Note=Splice site mutation (Coriell=GM10228).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM10229
AC   CVCL_DB72
DR   CLO; CLO_0029267
DR   Coriell; GM10229
DR   Wikidata; Q54844303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10231
AC   CVCL_W904
DR   CLO; CLO_0029268
DR   Coriell; GM10231
DR   Wikidata; Q54844313
CC   Sequence variation: Mutation; HGNC; HGNC:3349; ENG; Simple; p.Arg437Arg (c.1311G>C) (G1311C); ClinVar=VCV000458335; Zygosity=Unspecified; Note=Splice site mutation (Coriell=GM10231).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM10232
AC   CVCL_GT60
DR   CLO; CLO_0029269
DR   BioSamples; SAME43109
DR   Coriell; GM10232
DR   Wikidata; Q54844314
CC   Sequence variation: Mutation; HGNC; HGNC:3349; ENG; Simple; p.Arg437Arg (c.1311G>C) (G1311C); ClinVar=VCV000458335; Zygosity=Unspecified; Note=Splice site mutation (Coriell=GM10232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM10233
AC   CVCL_FV70
DR   CLO; CLO_0029231
DR   BioSample; SAMN00799835
DR   Coriell; GM10233
DR   Wikidata; Q54844315
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10239
AC   CVCL_2T77
DR   CLO; CLO_0029228
DR   BioSample; SAMN00799837
DR   Coriell; GM10239
DR   Wikidata; Q54844316
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10245
AC   CVCL_FV71
DR   CLO; CLO_0029226
DR   BioSample; SAMN00799839
DR   Coriell; GM10245
DR   Wikidata; Q54844317
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10247
AC   CVCL_DB73
DR   CLO; CLO_0029225
DR   BioSample; SAMN00799841
DR   Coriell; GM10247
DR   Wikidata; Q54844318
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10248
AC   CVCL_L245
DR   CLO; CLO_0029222
DR   EFO; EFO_0005334
DR   BioSample; SAMN00799843
DR   Coriell; GM10248
DR   ENCODE; ENCBS183AAA
DR   GEO; GSM1008589
DR   Wikidata; Q54844319
RX   CelloPub=CLPUB00447;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM10248_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   GM10249
AC   CVCL_W905
DR   CLO; CLO_0029220
DR   Coriell; GM10249
DR   Wikidata; Q54844320
CC   Sequence variation: Mutation; HGNC; HGNC:3349; ENG; Simple; p.Arg437Arg (c.1311G>C) (G1311C); ClinVar=VCV000458335; Zygosity=Unspecified; Note=Splice site mutation (Coriell=GM10249).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM10250
AC   CVCL_DB74
DR   CLO; CLO_0029218
DR   Coriell; GM10250
DR   Wikidata; Q54844321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10251
AC   CVCL_N134
SY   GM17106
DR   CLO; CLO_0014902
DR   CLO; CLO_0029217
DR   BioSample; SAMN00799845
DR   Coriell; GM10251
DR   Coriell; GM17106
DR   GEO; GSM273376
DR   GEO; GSM569511
DR   GEO; GSM596174
DR   GEO; GSM597060
DR   GEO; GSM924616
DR   IPD-IMGT/HLA; 19228
DR   Wikidata; Q54844322
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:AUX,30:02; B*07:CZZS,35:BEZX; C*04:CVAF,07:WCP; DRB1*04:05,09:01 (IPD-IMGT/HLA=19228).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM10253
AC   CVCL_1R86
SY   314-1b; 314-1
DR   CLO; CLO_0029216
DR   Coriell; GM10253
DR   Wikidata; Q54844323
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping. Contains a complete copy of chromosome 3.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N56 ! Urd-C
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM10254
AC   CVCL_5P15
DR   CLO; CLO_0029215
DR   BioSample; SAMN00799847
DR   Coriell; GM10254
DR   Wikidata; Q54844324
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10256
AC   CVCL_FV72
DR   CLO; CLO_0029206
DR   BioSample; SAMN00799849
DR   Coriell; GM10256
DR   Wikidata; Q54844325
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV73 ! GM10257
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10257
AC   CVCL_FV73
DR   CLO; CLO_0029202
DR   BioSample; SAMN00799851
DR   Coriell; GM10257
DR   Wikidata; Q54844326
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV72 ! GM10256
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10258
AC   CVCL_CZ29
DR   CLO; CLO_0029211
DR   BioSample; SAMN00799853
DR   Coriell; GM10258
DR   Wikidata; Q54844327
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10259
AC   CVCL_AD99
DR   CLO; CLO_0029209
DR   BioSample; SAMN00799855
DR   Coriell; GM10259
DR   Wikidata; Q54844328
RX   CelloPub=CLPUB00447;
RX   PubMed=2748491;
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84794; Jeune syndrome
DI   ORDO; Orphanet_474; Jeune syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10260
AC   CVCL_CZ30
SY   GM10260A
DR   CLO; CLO_0029192
DR   BioSample; SAMN00799857
DR   Coriell; GM10260
DR   Wikidata; Q54844330
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ31 ! GM10261
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10261
AC   CVCL_CZ31
SY   GM10261A
DR   CLO; CLO_0029190
DR   BioSample; SAMN00799859
DR   Coriell; GM10261
DR   Wikidata; Q54844331
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ30 ! GM10260
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10262
AC   CVCL_N135
SY   GM17291
DR   CLO; CLO_0013135
DR   CLO; CLO_0029198
DR   BioSample; SAMN00799861
DR   Coriell; GM10262
DR   Coriell; GM17291
DR   GEO; GSM569742
DR   GEO; GSM596355
DR   GEO; GSM596773
DR   GEO; GSM924893
DR   Wikidata; Q54844332
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,02:01:01; B*13:02:01,35:02:01; C*04:01:01,06:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*02:01:01,05:05:01; DQB1*02:02:01,03:01:01; DRB1*07:01:01,11:01:01; DRB3*02:02:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N136 ! GM10263
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM10263
AC   CVCL_N136
DR   CLO; CLO_0029197
DR   BioSample; SAMN00799863
DR   Coriell; GM10263
DR   Wikidata; Q54844333
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N135 ! GM10262
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   GM10266
AC   CVCL_L246
DR   CLO; CLO_0029187
DR   EFO; EFO_0005335
DR   BioSample; SAMN00799865
DR   Coriell; GM10266
DR   ENCODE; ENCBS184AAA
DR   GEO; GSM1008590
DR   Wikidata; Q54844334
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM10266_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   GM10267
AC   CVCL_9X15
DR   CLO; CLO_0029186
DR   BioSample; SAMN00799867
DR   Coriell; GM10267
DR   Wikidata; Q54844335
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Ala2Gly (c.5C>G); ClinVar=VCV000193063; Zygosity=Homozygous (from autologous cell line GM10277).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X16 ! GM10277
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM10268
AC   CVCL_FV74
DR   CLO; CLO_0029183
DR   BioSample; SAMN00799869
DR   Coriell; GM10268
DR   Wikidata; Q54844336
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV75 ! GM10269
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10269
AC   CVCL_FV75
DR   CLO; CLO_0029173
DR   BioSample; SAMN00799871
DR   Coriell; GM10269
DR   Wikidata; Q54844337
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV74 ! GM10268
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10270
AC   CVCL_CZ32
DR   CLO; CLO_0029172
DR   BioSample; SAMN00799872
DR   Coriell; GM10270
DR   Wikidata; Q54844338
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10271
AC   CVCL_CZ33
DR   CLO; CLO_0029170
DR   BioSample; SAMN00799874
DR   Coriell; GM10271
DR   Wikidata; Q54844339
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10272
AC   CVCL_FA35
DR   CLO; CLO_0029168
DR   BioSample; SAMN00799875
DR   Coriell; GM10272
DR   Wikidata; Q54844340
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_250923; Isolated aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10273
AC   CVCL_FA36
DR   CLO; CLO_0029181
DR   BioSample; SAMN00799877
DR   Coriell; GM10273
DR   Wikidata; Q54844341
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_250923; Isolated aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10274
AC   CVCL_FA37
DR   CLO; CLO_0029179
DR   BioSample; SAMN00799879
DR   Coriell; GM10274
DR   Wikidata; Q54844342
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_250923; Isolated aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10275
AC   CVCL_DB75
DR   CLO; CLO_0029177
DR   BioSample; SAMN00799881
DR   Coriell; GM10275
DR   Wikidata; Q54844344
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10276
AC   CVCL_2T78
SY   GM10276A
DR   CLO; CLO_0029176
DR   BioSample; SAMN00799883
DR   Coriell; GM10276
DR   Wikidata; Q54844345
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10277
AC   CVCL_9X16
DR   CLO; CLO_0029166
DR   BioSample; SAMN00799885
DR   Coriell; GM10277
DR   Wikidata; Q54844346
RX   CelloPub=CLPUB00447;
RX   PubMed=25059784;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Ala2Gly (c.5C>G); ClinVar=VCV000193063; Zygosity=Homozygous (PubMed=25059784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9X15 ! GM10267
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM10280
AC   CVCL_FV76
DR   CLO; CLO_0029162
DR   BioSample; SAMN00799886
DR   Coriell; GM10280
DR   Wikidata; Q54844347
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10283
AC   CVCL_5P16
DR   CLO; CLO_0029163
DR   BioSample; SAMN00799887
DR   Coriell; GM10283
DR   Wikidata; Q54844348
RX   CelloPub=CLPUB00447;
RX   PubMed=21354051;
RX   PubMed=23665875;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex73-79del; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM10284
AC   CVCL_4E02
DR   CLO; CLO_0029155
DR   BioSample; SAMN00799889
DR   Coriell; GM10284
DR   Wikidata; Q54844349
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10287
AC   CVCL_V446
DR   CLO; CLO_0029154
DR   BioSample; SAMN00799891
DR   Coriell; GM10287
DR   Wikidata; Q54844350
RX   PubMed=24009235;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM10290
AC   CVCL_AJ38
DR   CLO; CLO_0029157
DR   Coriell; GM10290
DR   Wikidata; Q54844352
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10294
AC   CVCL_FV77
DR   CLO; CLO_0029156
DR   BioSample; SAMN00799893
DR   Coriell; GM10294
DR   Wikidata; Q54844353
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV78 ! GM10295
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10295
AC   CVCL_FV78
DR   CLO; CLO_0029159
DR   BioSample; SAMN00799895
DR   Coriell; GM10295
DR   Wikidata; Q54844354
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV77 ! GM10294
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10296
AC   CVCL_CZ34
DR   CLO; CLO_0029158
DR   BioSample; SAMN00799897
DR   Coriell; GM10296
DR   Wikidata; Q54844356
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ35 ! GM10297
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10297
AC   CVCL_CZ35
DR   CLO; CLO_0029161
DR   BioSample; SAMN00799899
DR   Coriell; GM10297
DR   Wikidata; Q54844365
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CZ34 ! GM10296
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10301
AC   CVCL_FV79
DR   CLO; CLO_0029160
DR   BioSample; SAMN00799901
DR   Coriell; GM10301
DR   Wikidata; Q54844366
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10302
AC   CVCL_AU87
DR   CLO; CLO_0029041
DR   BioSample; SAMN00799902
DR   Coriell; GM10302
DR   Wikidata; Q54844367
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10306
AC   CVCL_FV80
DR   CLO; CLO_0029040
DR   BioSample; SAMN00799904
DR   Coriell; GM10306
DR   Wikidata; Q54844368
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10308
AC   CVCL_2T79
DR   CLO; CLO_0029043
DR   BioSample; SAMN00799906
DR   Coriell; GM10308
DR   Wikidata; Q54844369
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10309
AC   CVCL_W010
SY   GM10309A
DR   CLO; CLO_0029042
DR   BioSample; SAMN00799908
DR   Coriell; GM10309
DR   Wikidata; Q54844370
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4976; HLCS; Simple; p.Val550Met (c.1648G>A); ClinVar=VCV000001911; Zygosity=Heterozygous (Coriell=GM10309).
CC   Sequence variation: Mutation; HGNC; HGNC:4976; HLCS; Simple; p.Arg565Ter (c.1693C>T); ClinVar=VCV000426486; Zygosity=Heterozygous (Coriell=GM10309).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98842; Holocarboxylase synthetase deficiency
DI   ORDO; Orphanet_79242; Holocarboxylase synthetase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM10310
AC   CVCL_W011
DR   CLO; CLO_0029045
DR   BioSample; SAMN00799910
DR   Coriell; GM10310
DR   Wikidata; Q54844371
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM10311
AC   CVCL_W012
DR   CLO; CLO_0029044
DR   BioSample; SAMN00799912
DR   Coriell; GM10311
DR   Wikidata; Q54844372
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM10313
AC   CVCL_2T80
DR   CLO; CLO_0029047
DR   Coriell; GM10313
DR   Wikidata; Q54844373
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   GM10315
AC   CVCL_9S96
DR   CLO; CLO_0029046
DR   BioSample; SAMN00799914
DR   Coriell; GM10315
DR   GEO; GSM807
DR   Wikidata; Q54844374
RX   CelloPub=CLPUB00447;
RX   PubMed=11687795;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10319
AC   CVCL_FV81
DR   CLO; CLO_0029048
DR   BioSample; SAMN00799916
DR   Coriell; GM10319
DR   Wikidata; Q54844375
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10320
AC   CVCL_CZ36
DR   CLO; CLO_0029050
DR   BioSample; SAMN00799918
DR   Coriell; GM10320
DR   Wikidata; Q54844376
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10321
AC   CVCL_1R87
SY   TMS5
DR   CLO; CLO_0029059
DR   Coriell; GM10321
DR   Wikidata; Q54844377
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0058 ! HeLa S3
HI   CVCL_4536 ! L-M(TK-)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM10322
AC   CVCL_1R88
SY   WAVR4dF94a
DR   CLO; CLO_0029065
DR   Coriell; GM10322
DR   Wikidata; Q54844378
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0579 ! WI-38
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM10323
AC   CVCL_1R89
SY   WAVRD4dA19
DR   CLO; CLO_0029064
DR   Coriell; GM10323
DR   Wikidata; Q54844379
RX   CelloPub=CLPUB00447;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 21 mapping. Contains a complete copy of chromosome 21.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_0579 ! WI-38
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM10324
AC   CVCL_1R90
SY   AHA 11a
DR   CLO; CLO_0029063
DR   Coriell; GM10324
DR   Wikidata; Q54844380
RX   CelloPub=CLPUB00447;
RX   PubMed=2005900;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping. Contains a complete copy of chromosome X.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V459 ! GM00144
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM10329
AC   CVCL_2T81
DR   CLO; CLO_0029062
DR   BioSample; SAMN00799920
DR   Coriell; GM10329
DR   Wikidata; Q54844381
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2W
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM10330
AC   CVCL_1R91
SY   4.12
DR   CLO; CLO_0029069
DR   Coriell; GM10330
DR   Wikidata; Q54844382
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping. Contains a complete copy of chromosome X.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N28 ! GM04025
HI   CVCL_2234 ! V79
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 10
//
ID   GM10332
AC   CVCL_4I09
DR   CLO; CLO_0029068
DR   Coriell; GM10332
DR   Wikidata; Q54844383
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10333
AC   CVCL_4I10
DR   CLO; CLO_0029067
DR   Coriell; GM10333
DR   Wikidata; Q54844384
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10334
AC   CVCL_4I11
SY   GM10334A
DR   CLO; CLO_0029066
DR   Coriell; GM10334
DR   Wikidata; Q54844385
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10335
AC   CVCL_4I12
DR   CLO; CLO_0029070
DR   Coriell; GM10335
DR   Wikidata; Q54844386
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10336
AC   CVCL_4I13
SY   GM10336A
DR   CLO; CLO_0029081
DR   Coriell; GM10336
DR   Wikidata; Q54844387
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10337
AC   CVCL_JB54
DR   CLO; CLO_0029080
DR   Coriell; GM10337
DR   Wikidata; Q54844388
RX   PubMed=1598097;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133086; Carnitine-acylcarnitine translocase deficiency
DI   ORDO; Orphanet_159; Carnitine-acylcarnitine translocase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM10338
AC   CVCL_CZ37
DR   CLO; CLO_0029089
DR   Coriell; GM10338
DR   Wikidata; Q54844389
RX   PubMed=1598097;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM10339
AC   CVCL_CZ38
DR   CLO; CLO_0029088
DR   Coriell; GM10339
DR   Wikidata; Q54844390
RX   PubMed=1598097;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   GM10340
AC   CVCL_4I14
DR   CLO; CLO_0029091
DR   Coriell; GM10340
DR   Wikidata; Q54844391
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10341
AC   CVCL_4I15
DR   CLO; CLO_0029090
DR   Coriell; GM10341
DR   Wikidata; Q54844392
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10342
AC   CVCL_4I16
DR   CLO; CLO_0029085
DR   Coriell; GM10342
DR   Wikidata; Q54844393
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10343
AC   CVCL_4I17
DR   CLO; CLO_0029084
DR   Coriell; GM10343
DR   Wikidata; Q54844394
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10344
AC   CVCL_4I18
DR   CLO; CLO_0029087
DR   Coriell; GM10344
DR   Wikidata; Q54844395
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10345
AC   CVCL_N137
SY   GM17169
DR   CLO; CLO_0013985
DR   CLO; CLO_0029086
DR   BioSample; SAMN00799922
DR   Coriell; GM10345
DR   Coriell; GM17169
DR   GEO; GSM924679
DR   Wikidata; Q54844396
RX   CelloPub=CLPUB00447;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Omics: Genomics; DNA methylation analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM10346
AC   CVCL_N138
DR   CLO; CLO_0029104
DR   BioSample; SAMN00799924
DR   Coriell; GM10346
DR   Wikidata; Q54844397
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM10347
AC   CVCL_N139
SY   GM17328
DR   CLO; CLO_0013638
DR   CLO; CLO_0029102
DR   BioSample; SAMN00799926
DR   Coriell; GM10347
DR   Coriell; GM17328
DR   Wikidata; Q54844398
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   GM10349
AC   CVCL_CZ39
DR   CLO; CLO_0029100
DR   BioSample; SAMN00799928
DR   Coriell; GM10349
DR   Wikidata; Q54844399
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10351
AC   CVCL_CZ40
DR   CLO; CLO_0029112
DR   BioSample; SAMN00799930
DR   Coriell; GM10351
DR   Wikidata; Q54844400
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10353
AC   CVCL_AU88
SY   GM10353A
DR   CLO; CLO_0029111
DR   BioSample; SAMN00799932
DR   Coriell; GM10353
DR   Wikidata; Q54844401
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM10354
AC   CVCL_F613
DR   CLO; CLO_0029110
DR   BioSample; SAMN00799934
DR   Coriell; GM10354
DR   Wikidata; Q54844402
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Homozygous; Note=New splice site creation (PubMed=15578223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   GM10355
AC   CVCL_AU89
SY   GM10355A
DR   CLO; CLO_0029109
DR   BioSample; SAMN00799936
DR   Coriell; GM10355
DR   Wikidata; Q54844403
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10356
AC   CVCL_N140
SY   GM17292
DR   CLO; CLO_0013136
DR   CLO; CLO_0029108
DR   BioSample; SAMN00799938
DR   Coriell; GM10356
DR   Coriell; GM17292
DR   GEO; GSM569760
DR   GEO; GSM596356
DR   GEO; GSM596774
DR   GEO; GSM924894
DR   Wikidata; Q54844404
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian; Acadian.
CC   HLA typing: A*02:01:01,02:01:01; B*07:02:01,51:01:01; C*07:02:01,14:02:01; DPA1*01:03:01,02:01:01; DPB1*01:01:02,02:01:02; DQA1*05:05:01,06:01:01; DQB1*03:01:01,03:01:01; DRB1*08:03:02,11:01:01; DRB3*02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM10357
AC   CVCL_AU90
SY   GM10357B
DR   CLO; CLO_0029107
DR   BioSample; SAMN00799940
DR   Coriell; GM10357
DR   Wikidata; Q54844409
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM10354).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM10358
AC   CVCL_AU91
DR   CLO; CLO_0029106
DR   BioSample; SAMN00799942
DR   Coriell; GM10358
DR   Wikidata; Q54844410
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM10354).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM10359
AC   CVCL_AU92
DR   CLO; CLO_0028606
DR   BioSample; SAMN00799944
DR   Coriell; GM10359
DR   Wikidata; Q54844411
RX   CelloPub=CLPUB00447;
RX   PubMed=15578223;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM10354).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM10360
AC   CVCL_CX11
DR   CLO; CLO_0028609
DR   BioSample; SAMN00799946
DR   Coriell; GM10360
DR   Wikidata; Q54844412
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10361
AC   CVCL_AN00
DR   CLO; CLO_0028602
DR   BioSample; SAMN00799948
DR   Coriell; GM10361
DR   Wikidata; Q54844413
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AN01 ! GM10362
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM10362
AC   CVCL_AN01
DR   CLO; CLO_0028604
DR   BioSample; SAMN00799950
DR   Coriell; GM10362
DR   Wikidata; Q54844414
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AN00 ! GM10361
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM10363
AC   CVCL_FV82
DR   CLO; CLO_0028600
DR   BioSample; SAMN00799952
DR   Coriell; GM10363
DR   Wikidata; Q54844415
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV83 ! GM10364
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10364
AC   CVCL_FV83
DR   CLO; CLO_0028601
DR   BioSample; SAMN00799954
DR   Coriell; GM10364
DR   Wikidata; Q54844416
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV82 ! GM10363
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10365
AC   CVCL_FV84
DR   CLO; CLO_0028598
DR   BioSample; SAMN00799957
DR   Coriell; GM10365
DR   Wikidata; Q54844417
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV85 ! GM10366
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10366
AC   CVCL_FV85
DR   CLO; CLO_0028599
DR   BioSample; SAMN00799959
DR   Coriell; GM10366
DR   Wikidata; Q54844418
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FV84 ! GM10365
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10367
AC   CVCL_FV86
DR   CLO; CLO_0028596
DR   BioSample; SAMN00799961
DR   Coriell; GM10367
DR   Wikidata; Q54844419
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10374
AC   CVCL_2T82
DR   CLO; CLO_0028597
DR   BioSample; SAMN00799963
DR   Coriell; GM10374
DR   Wikidata; Q54844420
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM10376
AC   CVCL_UR81
DR   Coriell; GM10376
DR   Wikidata; Q93808884
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM10376; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM10378
AC   CVCL_N141
SY   GM10378A; GM17107
DR   CLO; CLO_0014903
DR   CLO; CLO_0028583
DR   BioSample; SAMN00799965
DR   Coriell; GM10378
DR   Coriell; GM17107
DR   GEO; GSM273377
DR   GEO; GSM569506
DR   GEO; GSM596175
DR   GEO; GSM596975
DR   GEO; GSM924617
DR   IPD-IMGT/HLA; 16404
DR   Wikidata; Q54844421
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:CNJK,02:DFKP; B*08:XKT,49:01; C*07:CVAG; DRB1*03:01,11:01 (IPD-IMGT/HLA=16404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM10379
AC   CVCL_N350
DR   CLO; CLO_0028570
DR   BioSample; SAMN00799967
DR   Coriell; GM10379
DR   Wikidata; Q54844422
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Axilla, skin; UBERON=UBERON_0015474.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118436; Fraser syndrome
DI   ORDO; Orphanet_2052; Fraser syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N351 ! GM10381
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10381
AC   CVCL_N351
DR   CLO; CLO_0028573
DR   BioSample; SAMN00799969
DR   Coriell; GM10381
DR   Wikidata; Q54844423
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118436; Fraser syndrome
DI   ORDO; Orphanet_2052; Fraser syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N350 ! GM10379
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10382
AC   CVCL_0I28
SY   GM10382A
DR   CLO; CLO_0028575
DR   BioSample; SAMN00799971
DR   Coriell; GM10382
DR   Wikidata; Q54844424
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM10383
AC   CVCL_0I29
DR   CLO; CLO_0028577
DR   BioSample; SAMN00799973
DR   Coriell; GM10383
DR   Wikidata; Q54844425
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM10384
AC   CVCL_N142
SY   GM17293
DR   CLO; CLO_0013137
DR   CLO; CLO_0028566
DR   BioSample; SAMN00799975
DR   Coriell; GM10384
DR   Coriell; GM17293
DR   GEO; GSM569761
DR   GEO; GSM596357
DR   GEO; GSM596815
DR   GEO; GSM924895
DR   Wikidata; Q54844426
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=23665875;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,29:02:01; B*07:02:01,44:02:01; C*05:01:01,07:02:01; DPA1*01:03:01,02:06; DPB1*03:01:01G,05:01:01G; DQA1*01:02:01,02:01:01; DQB1*02:02:01,06:02:01; DRB1*07:01:01,15:01:01; DRB4*01:01:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM10386
AC   CVCL_2T83
DR   CLO; CLO_0028567
DR   BioSample; SAMN00799977
DR   Coriell; GM10386
DR   Wikidata; Q54844427
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10388
AC   CVCL_FV87
DR   CLO; CLO_0028568
DR   BioSample; SAMN00799979
DR   Coriell; GM10388
DR   Wikidata; Q54844428
RX   CelloPub=CLPUB00447;
CC   Population: Pakistani.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9D
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10389
AC   CVCL_RB00
DR   CLO; CLO_0028569
DR   BioSample; SAMN00799981
DR   Coriell; GM10389
DR   Wikidata; Q54844429
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126741; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 4
DI   ORDO; Orphanet_272; Congenital muscular dystrophy, Fukuyama type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   GM10392
AC   CVCL_EG70
DR   CLO; CLO_0028565
DR   BioSample; SAMN00799983
DR   Coriell; GM10392
DR   Wikidata; Q54844430
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10393
AC   CVCL_2T84
DR   CLO; CLO_0028664
DR   BioSample; SAMN00799985
DR   Coriell; GM10393
DR   Wikidata; Q54844431
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM10394
AC   CVCL_0Q86
DR   CLO; CLO_0028667
DR   BioSample; SAMN00799987
DR   Coriell; GM10394
DR   Wikidata; Q54844432
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,der(3)(qter->p25::q21->qter) (Coriell=GM10394).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q87 ! GM11428
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM10396
AC   CVCL_0Q85
DR   CLO; CLO_0028676
DR   BioSample; SAMN00799989
DR   Coriell; GM10396
DR   Wikidata; Q54844433
CC   Population: Indian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM10401
AC   CVCL_5P17
DR   CLO; CLO_0028679
DR   BioSample; SAMN00799991
DR   Coriell; GM10401
DR   Wikidata; Q54844434
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+2.arr(2p)x3 (Coriell=GM10401).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM10402
AC   CVCL_1Y30
DR   CLO; CLO_0028672
DR   BioSample; SAMN00799993
DR   Coriell; GM10402
DR   Wikidata; Q54844435
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Arg333Trp (c.997C>T); ClinVar=VCV000003610; Zygosity=Heterozygous (Coriell=GM10402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM10403
AC   CVCL_GT61
DR   CLO; CLO_0028675
DR   BioSample; SAMN00799995
DR   Coriell; GM10403
DR   Wikidata; Q54844436
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10404
AC   CVCL_2T85
DR   CLO; CLO_0028660
DR   BioSample; SAMN00799997
DR   Coriell; GM10404
DR   Wikidata; Q54844437
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10406
AC   CVCL_AJ39
DR   CLO; CLO_0028661
DR   Coriell; GM10406
DR   Wikidata; Q54844438
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10407
AC   CVCL_FA38
DR   CLO; CLO_0028658
DR   BioSample; SAMN00799999
DR   Coriell; GM10407
DR   Wikidata; Q54844439
RX   CelloPub=CLPUB00447;
CC   Population: Hispanic.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98880; Persistent truncus arteriosus
DI   ORDO; Orphanet_3384; Truncus arteriosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M1W
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10408
AC   CVCL_EG71
DR   CLO; CLO_0028659
DR   BioSample; SAMN00800001
DR   Coriell; GM10408
DR   Wikidata; Q54844441
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84742; Transposition of great vessels
DI   ORDO; Orphanet_216675; Transposition of the great arteries
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10417
AC   CVCL_X449
SY   GM10417A
DR   CLO; CLO_0028632
DR   BioSample; SAMN00800003
DR   Coriell; GM10417
DR   Wikidata; Q54844442
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61273; Aspartylglycosaminuria
DI   ORDO; Orphanet_93; Aspartylglucosaminuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM10418
AC   CVCL_X450
SY   GM10418A
DR   CLO; CLO_0028634
DR   BioSample; SAMN00800005
DR   Coriell; GM10418
DR   Wikidata; Q54844443
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Finnish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61273; Aspartylglycosaminuria
DI   ORDO; Orphanet_93; Aspartylglucosaminuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   GM10419
AC   CVCL_DS21
DR   CLO; CLO_0028638
DR   BioSample; SAMN00800007
DR   Coriell; GM10419
DR   Wikidata; Q54844445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10420
AC   CVCL_DS22
DR   CLO; CLO_0028640
DR   BioSample; SAMN00800009
DR   Coriell; GM10420
DR   Wikidata; Q54844446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10423
AC   CVCL_AE20
DR   CLO; CLO_0028645
DR   BioSample; SAMN00800011
DR   Coriell; GM10423
DR   Wikidata; Q54844448
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34983; Reye syndrome
DI   ORDO; Orphanet_3096; Reye syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10431
AC   CVCL_0I30
DR   CLO; CLO_0028627
DR   BioSample; SAMN00800017
DR   Coriell; GM10431
DR   Wikidata; Q54844450
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10432
AC   CVCL_N143
SY   GM17294
DR   CLO; CLO_0013138
DR   CLO; CLO_0028628
DR   BioSample; SAMN00800019
DR   Coriell; GM10432
DR   Coriell; GM17294
DR   GEO; GSM569762
DR   GEO; GSM596358
DR   GEO; GSM596775
DR   GEO; GSM924896
DR   Wikidata; Q54844452
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM10433
AC   CVCL_V051
SY   GM10433A
DR   CLO; CLO_0028629
DR   BioSample; SAMN00800021
DR   Coriell; GM10433
DR   Wikidata; Q54844467
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM10439
AC   CVCL_EG72
DR   CLO; CLO_0028526
DR   BioSample; SAMN00800023
DR   Coriell; GM10439
DR   Wikidata; Q54844469
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3356; ENPP1; Simple; p.Pro305Thr (c.913C>A); ClinVar=VCV000029842; Zygosity=Homozygous (Coriell=GM10439).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128805; Generalized arterial calcification of infancy 1
DI   ORDO; Orphanet_51608; Generalized arterial calcification of infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG73 ! GM10440
SX   Female
AG   29FW
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM10440
AC   CVCL_EG73
DR   CLO; CLO_0028523
DR   BioSample; SAMN00800025
DR   Coriell; GM10440
DR   Wikidata; Q54844470
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3356; ENPP1; Simple; p.Pro305Thr (c.913C>A); ClinVar=VCV000029842; Zygosity=Homozygous (Coriell=GM10440).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128805; Generalized arterial calcification of infancy 1
DI   ORDO; Orphanet_51608; Generalized arterial calcification of infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG72 ! GM10439
SX   Female
AG   29FW
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM10441
AC   CVCL_EG74
DR   CLO; CLO_0028519
DR   BioSample; SAMN00800027
DR   Coriell; GM10441
DR   Wikidata; Q54844471
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10450
AC   CVCL_N144
SY   GM10450A; GM18050
DR   CLO; CLO_0015650
DR   CLO; CLO_0028514
DR   BioSample; SAMN00800029
DR   Coriell; GM10450
DR   Coriell; GM18050
DR   Wikidata; Q54844472
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: Human variation panel.
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 12
//
ID   GM10457
AC   CVCL_4E03
DR   CLO; CLO_0028509
DR   BioSample; SAMN00800031
DR   Coriell; GM10457
DR   Wikidata; Q54844473
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10459
AC   CVCL_4I19
DR   CLO; CLO_0028507
DR   Coriell; GM10459
DR   Wikidata; Q54844474
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10460
AC   CVCL_4I20
DR   CLO; CLO_0028504
DR   Coriell; GM10460
DR   Wikidata; Q54844475
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10461
AC   CVCL_V343
DR   CLO; CLO_0028530
DR   BioSample; SAMN00800033
DR   Coriell; GM10461
DR   Wikidata; Q54844476
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V344 ! GM10462
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM10462
AC   CVCL_V344
DR   CLO; CLO_0028529
DR   BioSample; SAMN00800035
DR   Coriell; GM10462
DR   Wikidata; Q54844477
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V343 ! GM10461
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM10463
AC   CVCL_0Q11
DR   CLO; CLO_0028501
DR   BioSample; SAMN00800037
DR   Coriell; GM10463
DR   Wikidata; Q54844478
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10469
AC   CVCL_N355
SY   GM10469A; JK736
DR   CLO; CLO_0028489
DR   Coriell; GM10469
DR   Wikidata; Q54844479
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM10470
AC   CVCL_N356
SY   JK741
DR   CLO; CLO_0028486
DR   Coriell; GM10470
DR   Wikidata; Q54844482
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM10471
AC   CVCL_N357
SY   JK742
DR   CLO; CLO_0028495
DR   Coriell; GM10471
DR   Wikidata; Q54844483
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM10472
AC   CVCL_N358
SY   GM10472A; JK745
DR   CLO; CLO_0028493
DR   Coriell; GM10472
DR   Wikidata; Q54844484
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM10473
AC   CVCL_N359
SY   GM10473A; JK753
DR   CLO; CLO_0028478
DR   Coriell; GM10473
DR   Wikidata; Q54844485
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM10474
AC   CVCL_GT62
SY   GM10474A
DR   CLO; CLO_0028475
DR   Coriell; GM10474
DR   Wikidata; Q54844486
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24FW
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10482
AC   CVCL_1R92
SY   MCH110.1 C4; MCH110.1C4
DR   CLO; CLO_0028498
DR   Coriell; GM10482
DR   Wikidata; Q54844487
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 11 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_N009 ! GM03552
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM10486
AC   CVCL_V052
DR   CLO; CLO_0024256
DR   BioSample; SAMN00800039
DR   Coriell; GM10486
DR   Wikidata; Q54844488
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM10489
AC   CVCL_EH06
DR   CLO; CLO_0024255
DR   BioSample; SAMN00800041
DR   Coriell; GM10489
DR   Wikidata; Q54844489
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_595337; Adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH04 ! GM08788
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10490
AC   CVCL_N146
SY   GM10490A; GM17170
DR   CLO; CLO_0014022
DR   CLO; CLO_0024254
DR   BioSample; SAMN00800043
DR   Coriell; GM10490
DR   Coriell; GM17170
DR   GEO; GSM569696
DR   GEO; GSM596234
DR   GEO; GSM597029
DR   GEO; GSM924680
DR   IPD-IMGT/HLA; 19225
DR   Wikidata; Q54844490
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*03:CVAB,34:02; B*07:CZZS,42:01; C*07:WCP,17:MN; DRB1*03:02,15:03 (IPD-IMGT/HLA=19225).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_595337; Adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N145 ! GM09964
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM10492
AC   CVCL_7501
SY   JK1029
DR   CLO; CLO_0024253
DR   Coriell; GM10492
DR   Wikidata; Q54844491
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM10493
AC   CVCL_N360
SY   JK1030
DR   CLO; CLO_0024252
DR   Coriell; GM10493
DR   Wikidata; Q54844492
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10494
AC   CVCL_N361
SY   JK1031
DR   CLO; CLO_0024251
DR   Coriell; GM10494
DR   Wikidata; Q54844493
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10495
AC   CVCL_N362
SY   GM10495A; JK1033
DR   CLO; CLO_0024250
DR   Coriell; GM10495
DR   Wikidata; Q54844495
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10496
AC   CVCL_N363
SY   GM10496A; JK1036
DR   CLO; CLO_0024247
DR   Coriell; GM10496
DR   Wikidata; Q54844496
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10497
AC   CVCL_U717
DR   CLO; CLO_0024248
DR   Coriell; GM10497
DR   Wikidata; Q54844497
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM10498
AC   CVCL_1R93
SY   MH-22.6
DR   CLO; CLO_0024249
DR   Coriell; GM10498
DR   Wikidata; Q54844498
RX   CelloPub=CLPUB00447;
RX   PubMed=2005900;
RX   PubMed=2276735;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 17 mapping. Contains a complete copy of chromosome 17.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V760 ! GM00271
HI   CVCL_4536 ! L-M(TK-)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM10500
AC   CVCL_1R94
SY   SP3-10
DR   CLO; CLO_0024244
DR   Coriell; GM10500
DR   Wikidata; Q54844500
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 15 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM10501
AC   CVCL_1R95
SY   88H-5
DR   CLO; CLO_0024243
DR   Coriell; GM10501
DR   Wikidata; Q54844501
RX   CelloPub=CLPUB00447;
RX   PubMed=3130306;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 17 and X mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X048 ! GM07151
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM10502
AC   CVCL_1R96
SY   MH-41
DR   CLO; CLO_0024246
DR   Coriell; GM10502
DR   Wikidata; Q54844502
RX   CelloPub=CLPUB00447;
RX   PubMed=3130306;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 17 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V760 ! GM00271
HI   CVCL_4536 ! L-M(TK-)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM10503
AC   CVCL_DD83
SY   JIMM-69
DR   CLO; CLO_0024245
DR   Coriell; GM10503
DR   Wikidata; Q54844503
RX   CelloPub=CLPUB00447;
RX   PubMed=2914942;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly997Asp (c.2990G>A); Zygosity=Heterozygous (PubMed=2914942).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM10505
AC   CVCL_AU93
DR   CLO; CLO_0024240
DR   BioSample; SAMN00800045
DR   Coriell; GM10505
DR   Wikidata; Q54844504
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Heterozygous; Note=New splice site creation (from familial inference of GM10354).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM10506
AC   CVCL_AU94
DR   CLO; CLO_0024239
DR   BioSample; SAMN00800047
DR   Coriell; GM10506
DR   Wikidata; Q54844505
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Homozygous; Note=New splice site creation (from familial inference of GM10354).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM10507
AC   CVCL_GT63
DR   CLO; CLO_0024242
DR   BioSample; SAMN00800049
DR   Coriell; GM10507
DR   Wikidata; Q54844506
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15FW
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10508
AC   CVCL_HJ77
DR   Coriell; GM10508
DR   Wikidata; Q54844507
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM10509
AC   CVCL_4I21
SY   GM10509C
DR   CLO; CLO_0024241
DR   Coriell; GM10509
DR   Wikidata; Q54844509
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78576; Psychosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10510
AC   CVCL_4I22
DR   CLO; CLO_0024278
DR   Coriell; GM10510
DR   Wikidata; Q54844510
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10511
AC   CVCL_4J01
DR   CLO; CLO_0024277
DR   Coriell; GM10511
DR   Wikidata; Q54844511
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10512
AC   CVCL_4I23
DR   CLO; CLO_0024276
DR   Coriell; GM10512
DR   Wikidata; Q54844512
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10513
AC   CVCL_4I24
DR   CLO; CLO_0024270
DR   Coriell; GM10513
DR   Wikidata; Q54844514
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10514
AC   CVCL_4I25
DR   CLO; CLO_0024271
DR   Coriell; GM10514
DR   Wikidata; Q54844515
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10515
AC   CVCL_AM35
DR   CLO; CLO_0024268
DR   BioSample; SAMN00800051
DR   Coriell; GM10515
DR   Wikidata; Q54844516
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (from familial inference of GM08971).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM10519
AC   CVCL_AM36
DR   CLO; CLO_0024269
DR   BioSample; SAMN00800053
DR   Coriell; GM10519
DR   Wikidata; Q54844517
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10519).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10520
AC   CVCL_AM37
SY   GM10520B
DR   CLO; CLO_0024274
DR   Coriell; GM10520
DR   Wikidata; Q54844518
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10520).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with retinitis pigmentosa but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10521
AC   CVCL_AM38
DR   CLO; CLO_0024275
DR   BioSample; SAMN00800055
DR   Coriell; GM10521
DR   Wikidata; Q54844519
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10523
AC   CVCL_AM39
DR   CLO; CLO_0024272
DR   BioSample; SAMN00800057
DR   Coriell; GM10523
DR   Wikidata; Q54844520
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10524
AC   CVCL_AM40
DR   CLO; CLO_0024273
DR   BioSample; SAMN00800059
DR   Coriell; GM10524
DR   Wikidata; Q54844521
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10525
AC   CVCL_AM41
DR   CLO; CLO_0024267
DR   BioSample; SAMN00800061
DR   Coriell; GM10525
DR   Wikidata; Q54844523
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10525).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10526
AC   CVCL_AM42
DR   CLO; CLO_0024265
DR   BioSample; SAMN00800063
DR   Coriell; GM10526
DR   Wikidata; Q54844524
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10527
AC   CVCL_AM43
SY   GM10527A
DR   CLO; CLO_0024266
DR   BioSample; SAMN00800065
DR   Coriell; GM10527
DR   Wikidata; Q54844525
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10529
AC   CVCL_AM44
DR   CLO; CLO_0024257
DR   BioSample; SAMN00800067
DR   Coriell; GM10529
DR   Wikidata; Q54844526
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10530
AC   CVCL_AM45
SY   GM10530B
DR   CLO; CLO_0024258
DR   BioSample; SAMN00800069
DR   Coriell; GM10530
DR   Wikidata; Q54844527
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10530).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10531
AC   CVCL_AM46
DR   CLO; CLO_0024259
DR   BioSample; SAMN00800071
DR   Coriell; GM10531
DR   Wikidata; Q54844528
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10532
AC   CVCL_AM47
SY   GM10532B
DR   CLO; CLO_0024260
DR   BioSample; SAMN00800072
DR   Coriell; GM10532
DR   Wikidata; Q54844529
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10533
AC   CVCL_AM48
DR   CLO; CLO_0024261
DR   BioSample; SAMN00800074
DR   Coriell; GM10533
DR   Wikidata; Q54844530
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10534
AC   CVCL_AM49
SY   GM10534A
DR   CLO; CLO_0024262
DR   BioSample; SAMN00800075
DR   Coriell; GM10534
DR   Wikidata; Q54844531
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10535
AC   CVCL_AM50
DR   CLO; CLO_0024263
DR   BioSample; SAMN00800077
DR   Coriell; GM10535
DR   Wikidata; Q54844532
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Arg677Ter (c.2029C>T); ClinVar=VCV000005965; Zygosity=Heterozygous (Coriell=GM10535).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10536
AC   CVCL_AM51
SY   GM10536B
DR   CLO; CLO_0024264
DR   BioSample; SAMN00800079
DR   Coriell; GM10536
DR   Wikidata; Q54844533
RX   CelloPub=CLPUB00447;
RX   PubMed=10391211;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10537
AC   CVCL_AM52
DR   CLO; CLO_0024298
DR   BioSample; SAMN00800081
DR   Coriell; GM10537
DR   Wikidata; Q54844534
RX   CelloPub=CLPUB00447;
CC   Part of: Retinitis Pigmentosa Foundation Collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM10539
AC   CVCL_N147
SY   GM17387; JK964
DR   CLO; CLO_0012183
DR   CLO; CLO_0024296
DR   Coriell; GM10539
DR   Coriell; GM17387
DR   Wikidata; Q54844536
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Pacific.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10540
AC   CVCL_7502
SY   GM17388; JK965
DR   CLO; CLO_0012179
DR   CLO; CLO_0024297
DR   Coriell; GM10540
DR   Coriell; GM17388
DR   Wikidata; Q54844537
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Pacific.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   GM10541
AC   CVCL_N148
SY   GM10541A; GM17389; JK971
DR   CLO; CLO_0012177
DR   CLO; CLO_0024294
DR   Coriell; GM10541
DR   Coriell; GM17389
DR   Wikidata; Q54844538
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Pacific.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM10542
AC   CVCL_N149
SY   GM10542A; GM17390; JK972
DR   CLO; CLO_0012243
DR   CLO; CLO_0024295
DR   Coriell; GM10542
DR   Coriell; GM17390
DR   Wikidata; Q54844539
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Pacific.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10543
AC   CVCL_N150
SY   GM10543A; GM17391; JK975
DR   CLO; CLO_0012244
DR   CLO; CLO_0024292
DR   Coriell; GM10543
DR   Coriell; GM17391
DR   Wikidata; Q54844540
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Pacific.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10552
AC   CVCL_V345
DR   CLO; CLO_0024293
DR   BioSample; SAMN00800083
DR   Coriell; GM10552
DR   Wikidata; Q54844541
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84595; Bernard-Soulier syndrome
DI   ORDO; Orphanet_274; Bernard-Soulier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM10557
AC   CVCL_5P18
DR   CLO; CLO_0024290
DR   BioSample; SAMN00800085
DR   Coriell; GM10557
DR   Wikidata; Q54844542
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM10559
AC   CVCL_0Q12
DR   CLO; CLO_0024291
DR   BioSample; SAMN00800087
DR   Coriell; GM10559
DR   Wikidata; Q54844543
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10565
AC   CVCL_5P19
DR   CLO; CLO_0024289
DR   BioSample; SAMN00800089
DR   Coriell; GM10565
DR   Wikidata; Q54844544
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75479; Hypogonadotropic hypogonadism with anosmia
DI   ORDO; Orphanet_478; Kallmann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM10566
AC   CVCL_0Q13
DR   CLO; CLO_0024285
DR   BioSample; SAMN00800091
DR   Coriell; GM10566
DR   Wikidata; Q54844545
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10568
AC   CVCL_5P20
DR   CLO; CLO_0024287
DR   BioSample; SAMN00800093
DR   Coriell; GM10568
DR   Wikidata; Q54844546
CC   Population: Pakistani.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124844; Dyggve-Melchior-Clausen syndrome
DI   ORDO; Orphanet_239; Dyggve-Melchior-Clausen disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10570
AC   CVCL_DA32
DR   CLO; CLO_0024288
DR   BioSample; SAMN00800095
DR   Coriell; GM10570
DR   Wikidata; Q54844547
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   GM10595
AC   CVCL_YP32
SY   GM 10595
DR   Coriell; GM10595
DR   Wikidata; Q93809863
RX   PubMed=1372108;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Coriell; GM10595; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L754 ! XP3NE
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   GM10603
AC   CVCL_F614
DR   CLO; CLO_0024281
DR   BioSample; SAMN00800097
DR   Coriell; GM10603
DR   Wikidata; Q54844548
RX   CelloPub=CLPUB00447;
RX   PubMed=12361951;
CC   Population: Caucasian.
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F600 ! GM00089
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   GM10606
AC   CVCL_5P21
DR   CLO; CLO_0024282
DR   Coriell; GM10606
DR   Wikidata; Q54844549
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Karyotypic information: 69,XXX,dup(20)(pter->q13.2::q11.2->qter).arr 3q21.3(129973405-130112434)x3,8p23.1(7242445-7825360)x1,20q11.21q13.2(29298697-54338231)x3 (Coriell=GM10606).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85204; Triploidy syndrome
DI   ORDO; Orphanet_3376; Triploidy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10607
AC   CVCL_2T86
DR   CLO; CLO_0024283
DR   BioSample; SAMN00800099
DR   Coriell; GM10607
DR   Wikidata; Q54844550
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10608
AC   CVCL_5P22
DR   CLO; CLO_0024284
DR   Coriell; GM10608
DR   Wikidata; Q54844551
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10609
AC   CVCL_0R05
SY   GM10609A
DR   CLO; CLO_0024279
DR   Coriell; GM10609
DR   Wikidata; Q54844552
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35255; Greig syndrome
DI   ORDO; Orphanet_380; Greig cephalopolysyndactyly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM10613
AC   CVCL_2T87
DR   CLO; CLO_0024539
DR   Coriell; GM10613
DR   Wikidata; Q54844553
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,XX,t(20;21)(20pter->20q11.2::21p11.2->21pter;21qter->21p11.2::20q11.2->20qter) (Coriell=GM10613).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM10614
AC   CVCL_0Q14
DR   CLO; CLO_0024542
DR   BioSample; SAMN00800103
DR   Coriell; GM10614
DR   Wikidata; Q54844554
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10618
AC   CVCL_F615
DR   CLO; CLO_0024541
DR   BioSample; SAMN00800105
DR   Coriell; GM10618
DR   Wikidata; Q54844555
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Acadian.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Val72Glufs*65 (c.216G>A) (p.Val72Val); ClinVar=VCV000005143; Zygosity=Homozygous; Note=New splice site creation (from familial inference of GM10354).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM10624
AC   CVCL_DD84
DR   CLO; CLO_0024550
DR   BioSample; SAMN00800107
DR   Coriell; GM10624
DR   Wikidata; Q54844560
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34864; Hereditary optic atrophy
DI   ORDO; Orphanet_98671; Hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD85 ! GM10625
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10625
AC   CVCL_DD85
DR   CLO; CLO_0024548
DR   BioSample; SAMN00800109
DR   Coriell; GM10625
DR   Wikidata; Q54844561
RX   CelloPub=CLPUB00447;
CC   Population: Jewish.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34864; Hereditary optic atrophy
DI   ORDO; Orphanet_98671; Hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD84 ! GM10624
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10627
AC   CVCL_0Q15
SY   GM10627A
DR   CLO; CLO_0024555
DR   BioSample; SAMN00800111
DR   Coriell; GM10627
DR   Wikidata; Q54844562
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10628
AC   CVCL_0Q16
SY   GM10628A
DR   CLO; CLO_0024552
DR   BioSample; SAMN00800114
DR   Coriell; GM10628
DR   Wikidata; Q54844563
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10634
AC   CVCL_FA39
DR   CLO; CLO_0024564
DR   BioSample; SAMN00800116
DR   Coriell; GM10634
DR   Wikidata; Q54844564
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128804; D-glyceric aciduria
DI   ORDO; Orphanet_941; D-glyceric aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM10635
AC   CVCL_2T88
DR   CLO; CLO_0024563
DR   BioSample; SAMN00800118
DR   Coriell; GM10635
DR   Wikidata; Q54844565
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(15;19)(15pter->15q13::19q13.3->19qter;19pter->19q13.3::15q13->15qter) (Coriell=GM10635).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM10636
AC   CVCL_5P23
DR   CLO; CLO_0024562
DR   BioSample; SAMN00800120
DR   Coriell; GM10636
DR   Wikidata; Q54844566
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM10640
AC   CVCL_HQ03
DR   CLO; CLO_0024561
DR   BioSample; SAMN00800122
DR   Coriell; GM10640
DR   Wikidata; Q54844567
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:403; ALDH3A2; Simple; p.Glu433Argfs*3 (c.1293_1294GA[2]) (c.1297_1298delGA); ClinVar=VCV000001641; Zygosity=Heterozygous (Coriell=GM10640).
CC   Sequence variation: Mutation; HGNC; HGNC:403; ALDH3A2; Simple; p.Leu438Thrfs*21 (c.1307_1311dupACAAA); ClinVar=VCV000001642; Zygosity=Heterozygous (Coriell=GM10640).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85070; Sjogren-Larsson syndrome
DI   ORDO; Orphanet_816; Sjogren-Larsson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   GM10641
AC   CVCL_N151
SY   GM17305
DR   CLO; CLO_0013314
DR   CLO; CLO_0024560
DR   BioSample; SAMN00800124
DR   Coriell; GM10641
DR   Coriell; GM17305
DR   Wikidata; Q54844568
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: South American (Andes).
CC   Sequence variation: Mutation; HGNC; HGNC:403; ALDH3A2; Simple; p.Ala314_Pro315delinsGlyAlaLysSerThrValGlyAla (c.941_943delCCCinsGGGCTAAAAGTACTGTTGGGG) (941-943delCCC+ins21bp); Zygosity=Homozygous (Coriell=GM10641).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85070; Sjogren-Larsson syndrome
DI   ORDO; Orphanet_816; Sjogren-Larsson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   GM10642
AC   CVCL_HQ04
DR   CLO; CLO_0024559
DR   BioSample; SAMN00800126
DR   Coriell; GM10642
DR   Wikidata; Q54844569
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:403; ALDH3A2; Simple; p.Glu433Argfs*3 (c.1293_1294GA[2]) (c.1297_1298delGA); ClinVar=VCV000001641; Zygosity=Heterozygous (Coriell=GM10642).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85070; Sjogren-Larsson syndrome
DI   ORDO; Orphanet_816; Sjogren-Larsson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   GM10647
AC   CVCL_N152
SY   GM17295
DR   CLO; CLO_0013127
DR   CLO; CLO_0024575
DR   BioSample; SAMN00800128
DR   Coriell; GM10647
DR   Coriell; GM17295
DR   GEO; GSM569743
DR   GEO; GSM596359
DR   GEO; GSM596816
DR   GEO; GSM924897
DR   Wikidata; Q54844570
RX   CelloPub=CLPUB00447;
RX   PubMed=1897572;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,24:02:01; B*08:01:01,15:01:01; C*03:03:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01G,23:01:01G; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01; DRB3*01:01:02; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM10648
AC   CVCL_DB76
DR   CLO; CLO_0024574
DR   BioSample; SAMN00800130
DR   Coriell; GM10648
DR   Wikidata; Q54844571
RX   CelloPub=CLPUB00447;
RX   PubMed=1897572;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10649
AC   CVCL_UR80
DR   Coriell; GM10649
DR   Wikidata; Q93810070
RX   CelloPub=CLPUB00447;
RX   PubMed=1897572;
CC   Discontinued: Coriell; GM10649; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84978; Osteochondrodysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM10650
AC   CVCL_AT09
DR   CLO; CLO_0024572
DR   BioSample; SAMN00800132
DR   Coriell; GM10650
DR   Wikidata; Q54844572
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; c.127+48T>C; ClinVar=VCV000255394; Zygosity=Heterozygous (Coriell=GM10650).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM10652
AC   CVCL_AT10
DR   CLO; CLO_0024570
DR   BioSample; SAMN00800134
DR   Coriell; GM10652
DR   Wikidata; Q54844573
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Met191Thr (c.572T>C); ClinVar=VCV000198396; Zygosity=Heterozygous (Coriell=GM10652).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM10653
AC   CVCL_AT11
DR   CLO; CLO_0024579
DR   BioSample; SAMN00800136
DR   Coriell; GM10653
DR   Wikidata; Q54844574
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; c.127+48T>C; ClinVar=VCV000255394; Zygosity=Heterozygous (Coriell=GM10653).
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Met191Thr (c.572T>C); ClinVar=VCV000198396; Zygosity=Heterozygous (Coriell=GM10653).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM10657
AC   CVCL_1R97
SY   JW-4
DR   CLO; CLO_0024582
DR   Coriell; GM10657
DR   Wikidata; Q54844575
RX   CelloPub=CLPUB00447;
RX   PubMed=3130306;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 17 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM10659
AC   CVCL_1R98
SY   P12.3B6
DR   CLO; CLO_0024584
DR   Coriell; GM10659
DR   Wikidata; Q54844576
RX   CelloPub=CLPUB00447;
RX   PubMed=3130306;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 15 and 17 mapping (PubMed=9441767).
CC   Misspelling: P12.3B5; PubMed=9441767.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 10
//
ID   GM10660
AC   CVCL_1R99
SY   GM10660A; DCR-1
DR   CLO; CLO_0024583
DR   Coriell; GM10660
DR   Wikidata; Q54844577
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 17 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM10662
AC   CVCL_1S00
SY   8121-A1; GM10662A
DR   CLO; CLO_0024586
DR   Coriell; GM10662
DR   Wikidata; Q54844578
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1K04 ! GM08121
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM10663
AC   CVCL_1S01
SY   2384-A2
DR   CLO; CLO_0024585
DR   Coriell; GM10663
DR   Wikidata; Q54844579
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM10664
AC   CVCL_1S02
SY   94-3
DR   CLO; CLO_0024589
DR   Coriell; GM10664
DR   Wikidata; Q54844580
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 15 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM10665
AC   CVCL_0J44
SY   GM 10665
DR   CLO; CLO_0024588
DR   BioSample; SAMN00800138
DR   Coriell; GM10665
DR   Wikidata; Q54844581
RX   CelloPub=CLPUB00447;
RX   PubMed=10051646;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10969; SLC22A5; Simple; p.Arg282Ter (c.844C>T); ClinVar=VCV000006416; Zygosity=Homozygous (PubMed=10051646).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98864; Primary carnitine deficiency
DI   ORDO; Orphanet_158; Systemic primary carnitine deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM10666
AC   CVCL_N153
SY   GM17026
DR   CLO; CLO_0014702
DR   CLO; CLO_0024592
DR   BioSample; SAMN00800140
DR   Coriell; GM10666
DR   Coriell; GM17026
DR   Wikidata; Q54844582
RX   CelloPub=CLPUB00447;
RX   PubMed=10051646;
CC   Part of: Human variation panel.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10969; SLC22A5; Simple; p.Arg282Ter (c.844C>T); ClinVar=VCV000006416; Zygosity=Heterozygous (PubMed=10051646).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GM10667
AC   CVCL_N154
SY   GM17027
DR   CLO; CLO_0014700
DR   CLO; CLO_0024610
DR   BioSample; SAMN00800142
DR   Coriell; GM10667
DR   Coriell; GM17027
DR   Wikidata; Q54844583
RX   CelloPub=CLPUB00447;
RX   PubMed=10051646;
CC   Part of: Human variation panel.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10969; SLC22A5; Simple; p.Arg282Ter (c.844C>T); ClinVar=VCV000006416; Zygosity=Heterozygous (PubMed=10051646).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GM10668
AC   CVCL_AJ40
DR   CLO; CLO_0024606
DR   Coriell; GM10668
DR   Wikidata; Q54844584
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (Coriell=GM10668).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM10669
AC   CVCL_AE15
DR   CLO; CLO_0024605
DR   BioSample; SAMN00800144
DR   Coriell; GM10669
DR   Wikidata; Q54844585
CC   Population: Caucasian.
CC   Derived from site: In situ; Thyroid gland; Note=From an adenoma nodule; UBERON=UBERON_0002046.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3076; Cowden syndrome
DI   NCIt; C3502; Thyroid gland follicular adenoma
DI   ORDO; Orphanet_201; Cowden syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10672
AC   CVCL_DA33
DR   CLO; CLO_0024603
DR   BioSample; SAMN00800146
DR   Coriell; GM10672
DR   Wikidata; Q54844586
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   GM10679
AC   CVCL_9S97
DR   CLO; CLO_0024618
DR   BioSample; SAMN00800148
DR   Coriell; GM10679
DR   Wikidata; Q54844587
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+i(12)(pter->p10::p10->pter) [37]; 46,XY [13] (Coriell=GM10679).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10680
AC   CVCL_AD71
DR   CLO; CLO_0024615
DR   BioSample; SAMN00800150
DR   Coriell; GM10680
DR   Wikidata; Q54844588
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Simple; p.Asp431Asn (c.1291G>A); ClinVar=VCV000281932; Zygosity=Hemizygous (Coriell=GM10680).
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Simple; p.Asp433Asn (c.1297G>A); ClinVar=VCV000281933; Zygosity=Hemizygous (Coriell=GM10680).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M2W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM10681
AC   CVCL_AD72
DR   CLO; CLO_0024613
DR   BioSample; SAMN00800152
DR   Coriell; GM10681
DR   Wikidata; Q54844589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10684
AC   CVCL_W564
SY   GM10684B
DR   CLO; CLO_0024611
DR   CLO; CLO_0037445
DR   BioSample; SAMN00800154
DR   Coriell; GM10684
DR   LINCS_LDP; LPC-1046
DR   Wikidata; Q54844590
RX   CelloPub=CLPUB00447;
RX   PubMed=28284873;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (Coriell=GM10684).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 7
ST   D7S820: 9,12
ST   TH01: 11,13
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM10688
AC   CVCL_0Q17
DR   CLO; CLO_0024623
DR   BioSample; SAMN00800156
DR   Coriell; GM10688
DR   Wikidata; Q54844591
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(9)(pter->p11::q13->p11::q13->qter) (Coriell=GM10688).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM10688).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM10691
AC   CVCL_V053
SY   GM10691A
DR   CLO; CLO_0024622
DR   BioSample; SAMN00800158
DR   Coriell; GM10691
DR   Wikidata; Q54844592
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   GM10692
AC   CVCL_0Q18
DR   CLO; CLO_0023744
DR   BioSample; SAMN00800160
DR   Coriell; GM10692
DR   Wikidata; Q54844593
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10693
AC   CVCL_0Q19
DR   CLO; CLO_0023743
DR   BioSample; SAMN00800162
DR   Coriell; GM10693
DR   Wikidata; Q54844594
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10694
AC   CVCL_0Q20
DR   CLO; CLO_0023753
DR   BioSample; SAMN00800164
DR   Coriell; GM10694
DR   Wikidata; Q54844595
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10695
AC   CVCL_0Q21
DR   CLO; CLO_0023752
DR   BioSample; SAMN00800166
DR   Coriell; GM10695
DR   Wikidata; Q54844596
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10699
AC   CVCL_4I26
SY   GM01699A
DR   CLO; CLO_0023750
DR   Coriell; GM10699
DR   Wikidata; Q54844597
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10700
AC   CVCL_4I27
SY   GM10700A
DR   CLO; CLO_0023749
DR   Coriell; GM10700
DR   Wikidata; Q54844598
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10701
AC   CVCL_4I28
SY   GM10701A
DR   CLO; CLO_0023734
DR   Coriell; GM10701
DR   Wikidata; Q54844599
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10702
AC   CVCL_HJ78
DR   Coriell; GM10702
DR   Wikidata; Q54844605
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM10703
AC   CVCL_4I29
DR   CLO; CLO_0023735
DR   Coriell; GM10703
DR   Wikidata; Q54844606
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10704
AC   CVCL_4I30
DR   CLO; CLO_0023736
DR   Coriell; GM10704
DR   Wikidata; Q54844608
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10705
AC   CVCL_4I31
DR   CLO; CLO_0023737
DR   Coriell; GM10705
DR   Wikidata; Q54844609
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10706
AC   CVCL_4I32
SY   GM10706A
DR   CLO; CLO_0023721
DR   Coriell; GM10706
DR   Wikidata; Q54844610
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10707
AC   CVCL_4J02
DR   CLO; CLO_0023727
DR   Coriell; GM10707
DR   Wikidata; Q54844611
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10708
AC   CVCL_4I33
DR   CLO; CLO_0023724
DR   Coriell; GM10708
DR   Wikidata; Q54844612
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM10709
AC   CVCL_5P24
DR   BioSample; SAMN00800168
DR   Coriell; GM10709
DR   Wikidata; Q54844613
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10710
AC   CVCL_AD73
DR   CLO; CLO_0023729
DR   BioSample; SAMN00800170
DR   Coriell; GM10710
DR   Wikidata; Q54844614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10711
AC   CVCL_W906
DR   CLO; CLO_0023728
DR   Coriell; GM10711
DR   Wikidata; Q54844615
CC   Sequence variation: Mutation; HGNC; HGNC:3349; ENG; Simple; p.Arg437Arg (c.1311G>C) (G1311C); ClinVar=VCV000458335; Zygosity=Unspecified; Note=Splice site mutation (Coriell=GM10711).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM10712
AC   CVCL_DB77
DR   CLO; CLO_0023732
DR   Coriell; GM10712
DR   Wikidata; Q54844616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10714
AC   CVCL_GT64
DR   CLO; CLO_0023730
DR   Coriell; GM10714
DR   Wikidata; Q54844617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with hereditary hemorrhagic telangiectasia but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM10715
AC   CVCL_W907
DR   CLO; CLO_0023718
DR   Coriell; GM10715
DR   Wikidata; Q54844618
CC   Sequence variation: Mutation; HGNC; HGNC:3349; ENG; Simple; p.Arg437Arg (c.1311G>C) (G1311C); ClinVar=VCV000458335; Zygosity=Unspecified; Note=Splice site mutation (Coriell=GM10715).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM10716
AC   CVCL_2T89
SY   GM10716A
DR   CLO; CLO_0023719
DR   BioSample; SAMN00800172
DR   Coriell; GM10716
DR   Wikidata; Q54844619
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10717
AC   CVCL_2T90
DR   CLO; CLO_0023716
DR   BioSample; SAMN00800174
DR   Coriell; GM10717
DR   Wikidata; Q54844620
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10718
AC   CVCL_1Y45
DR   CLO; CLO_0023711
DR   BioSample; SAMN00800176
DR   Coriell; GM10718
DR   Wikidata; Q54844621
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10719
AC   CVCL_1Y46
DR   CLO; CLO_0023708
DR   BioSample; SAMN00800178
DR   Coriell; GM10719
DR   Wikidata; Q54844622
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10720
AC   CVCL_1Y47
DR   CLO; CLO_0023706
DR   BioSample; SAMN00800180
DR   Coriell; GM10720
DR   Wikidata; Q54844623
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10722
AC   CVCL_6G97
DR   CLO; CLO_0023704
DR   Coriell; GM10722
DR   Wikidata; Q54844624
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,XY,del(4)(qter->p15.2) (Coriell=GM10722).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM10723
AC   CVCL_AJ41
SY   GM10723A
DR   CLO; CLO_0023703
DR   Coriell; GM10723
DR   Wikidata; Q54844625
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10724
AC   CVCL_AJ42
DR   CLO; CLO_0023702
DR   Coriell; GM10724
DR   Wikidata; Q54844626
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM10725
AC   CVCL_AJ43
DR   CLO; CLO_0023701
DR   Coriell; GM10725
DR   Wikidata; Q54844627
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM10729
AC   CVCL_0Q22
SY   GM10729A
DR   CLO; CLO_0023700
DR   BioSample; SAMN00800182
DR   Coriell; GM10729
DR   Wikidata; Q54844628
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM10732
AC   CVCL_DB78
DR   CLO; CLO_0023695
DR   Coriell; GM10732
DR   Wikidata; Q54844629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM10742
AC   CVCL_Y652
SY   GM10742A
DR   CLO; CLO_0023698
DR   BioSample; SAMN00800184
DR   Coriell; GM10742
DR   Wikidata; Q54844630
RX   CelloPub=CLPUB00447;
RX   PubMed=16120335;
CC   Sequence variation: Mutation; HGNC; HGNC:7459; MT-ND4; Simple; p.Arg340His (m.11778G>A); ClinVar=VCV000009708; Zygosity=Unspecified (PubMed=16120335; Coriell=GM10742).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 18
//
ID   GM10744
AC   CVCL_Y653
SY   GM10744A
DR   CLO; CLO_0023683
DR   BioSample; SAMN00800186
DR   Coriell; GM10744
DR   Wikidata; Q54844631
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:7459; MT-ND4; Simple; p.Arg340His (m.11778G>A); ClinVar=VCV000009708; Zygosity=Unspecified (Coriell=GM10744).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM10745
AC   CVCL_UT33
DR   Coriell; GM10745
DR   Wikidata; Q93810682
RX   CelloPub=CLPUB00447;
RX   PubMed=6705251;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (from parent cell line).
CC   Transformant: Ad-SV40 hybrid virus.
CC   Donor information: From Bloom Syndrome Registry patient 86(NoKi) (BSR86).
CC   Discontinued: Coriell; GM10745; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L951 ! BS1KA
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   GM10748
AC   CVCL_V054
DR   CLO; CLO_0023675
DR   BioSample; SAMN00800188
DR   Coriell; GM10748
DR   Wikidata; Q54844632
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM10749
AC   CVCL_0Q23
DR   CLO; CLO_0023674
DR   BioSample; SAMN00800190
DR   Coriell; GM10749
DR   Wikidata; Q54844634
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM10749).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM10763
AC   CVCL_4E04
DR   CLO; CLO_0023679
DR   Coriell; GM10763
DR   Wikidata; Q54844635
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M1W
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM10790
AC   CVCL_1S03
SY   E1
DR   Coriell; GM10790
DR   Wikidata; Q54844636
RX   PubMed=2276735;
RX   PubMed=2395866;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 7 mapping. Contains a complete copy of chromosome 7.
CC   Discontinued: Coriell; GM10790; probable.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM10791
AC   CVCL_1S04
SY   1HL11-G
DR   CLO; CLO_0023677
DR   Coriell; GM10791
DR   Wikidata; Q54844637
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 7 mapping. Contains a complete copy of chromosome 7.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N51 ! irs1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM10793
AC   CVCL_0Q64
DR   CLO; CLO_0023669
DR   BioSample; SAMN00800192
DR   Coriell; GM10793
DR   Wikidata; Q54844638
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,t(4;9)(4pter->4q31.3::9q13->9qter;9pter->9q13::4q31.3->4qter)mat, +der(9)(9pter->9q13::4q31.3->4qter)mat (Coriell=GM10793).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q65 ! GM10794
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM10794
AC   CVCL_0Q65
DR   CLO; CLO_0023672
DR   BioSample; SAMN00800194
DR   Coriell; GM10794
DR   Wikidata; Q54844639
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,t(4;9)(4pter->4q31.3::9q13->9qter;9pter->9q13::4q31.3->4qter)mat, +der(9)(9pter->9q13::4q31.3->4qter)mat (Coriell=GM10794).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q64 ! GM10793
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GM10796
AC   CVCL_N352
DR   CLO; CLO_0023671
DR   BioSample; SAMN00800196
DR   Coriell; GM10796
DR   Wikidata; Q54844640
RX   CelloPub=CLPUB00447;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N353 ! GM10797
SX   Sex ambiguous
AG   22FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   GM10797
AC   CVCL_N353
DR   CLO; CLO_0023808
DR   BioSample; SAMN00800198
DR   Coriell; GM10797
DR   Wikidata; Q54844641
RX   CelloPub=CLPUB00447;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N352 ! GM10796
SX   Sex ambiguous
AG   22FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM10798
AC   CVCL_N155
SY   GM17084
DR   CLO; CLO_0014479
DR   CLO; CLO_0023798
DR   BioSample; SAMN00800200
DR   Coriell; GM10798
DR   Coriell; GM17084
DR   Wikidata; Q54844643
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*11:01:01,80:01:01; B*38:02:02,40:02:01; C*04:01:01,07:02:01; DPA1*01:03:01,02:02:02; DPB1*01:01:01,04:01:01; DQA1*01:02:01,05:05:01; DQB1*03:01:01,05:02:01; DRB1*11:01:01,15:02:01G; DRB3*02:02:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   GM10799
AC   CVCL_N156
SY   GM17085
DR   CLO; CLO_0014478
DR   CLO; CLO_0023799
DR   BioSample; SAMN00800202
DR   Coriell; GM10799
DR   Coriell; GM17085
DR   Wikidata; Q54844644
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM10800
AC   CVCL_5P25
DR   CLO; CLO_0023802
DR   BioSample; SAMN00800204
DR   Coriell; GM10800
DR   Wikidata; Q54844645
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10804
AC   CVCL_2T91
DR   CLO; CLO_0023803
DR   BioSample; SAMN00800206
DR   Coriell; GM10804
DR   Wikidata; Q54844646
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,der(3)(3qter->3p26::2q36->2qter)mat (Coriell=GM10804).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2T92 ! GM10806
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM10806
AC   CVCL_2T92
DR   CLO; CLO_0023800
DR   BioSample; SAMN00800208
DR   Coriell; GM10806
DR   Wikidata; Q54844647
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,der(3)(3qter->3p26::2q36->2qter)mat (Coriell=GM10806).
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2T91 ! GM10804
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM10807
AC   CVCL_0R06
DR   CLO; CLO_0023801
DR   BioSample; SAMN00800210
DR   Coriell; GM10807
DR   Wikidata; Q54844654
RX   CelloPub=CLPUB00447;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (Coriell=GM10807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM10808
AC   CVCL_0R07
DR   CLO; CLO_0023806
DR   BioSample; SAMN00800212
DR   Coriell; GM10808
DR   Wikidata; Q54844655
RX   CelloPub=CLPUB00447;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM10809
AC   CVCL_0R08
DR   CLO; CLO_0023807
DR   BioSample; SAMN00800214
DR   Coriell; GM10809
DR   Wikidata; Q54844656
RX   CelloPub=CLPUB00447;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM10810
AC   CVCL_N157
SY   GM17055
DR   CLO; CLO_0014665
DR   CLO; CLO_0023804
DR   BioSample; SAMN00800216
DR   Coriell; GM10810
DR   Coriell; GM17055
DR   Wikidata; Q54844657
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10811
AC   CVCL_0R09
DR   CLO; CLO_0023805
DR   BioSample; SAMN00800218
DR   Coriell; GM10811
DR   Wikidata; Q54844658
RX   CelloPub=CLPUB00447;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM10812
AC   CVCL_0R10
DR   CLO; CLO_0023788
DR   BioSample; SAMN00800220
DR   Coriell; GM10812
DR   Wikidata; Q54844659
RX   CelloPub=CLPUB00447;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM10816
AC   CVCL_0R11
DR   CLO; CLO_0023789
DR   BioSample; SAMN00800222
DR   Coriell; GM10816
DR   Wikidata; Q54844660
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM10818
AC   CVCL_0R12
SY   GM10818A
DR   CLO; CLO_0023790
DR   BioSample; SAMN00800224
DR   Coriell; GM10818
DR   Wikidata; Q54844661
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM10826
AC   CVCL_1S05
SY   24HL5-4; GM10826B
DR   CLO; CLO_0023791
DR   Coriell; GM10826
DR   Wikidata; Q54844662
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 2 mapping. Contains a complete copy of chromosome 2.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4597 ! UV24
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM10830
AC   CVCL_R593
AS   CVCL_G510
SY   CEPH-1408-NA10830; 1408-1012
DR   CLO; CLO_0023792
DR   BioSample; SAMN00800226
DR   Coriell; GM10830
DR   dbMHC; 48670
DR   GEO; GSM25430
DR   GEO; GSM25431
DR   GEO; GSM112494
DR   GEO; GSM112774
DR   GEO; GSM188754
DR   GEO; GSM291603
DR   GEO; GSM316396
DR   GEO; GSM316397
DR   GEO; GSM316398
DR   GEO; GSM420594
DR   GEO; GSM420595
DR   GEO; GSM648948
DR   IGSR; NA10830
DR   IHW; IHW01141
DR   IPD-IMGT/HLA; 13837
DR   Wikidata; Q54844663
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
RX   PubMed=30844424;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140801.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*05:01,05:01; DQB1*02:01,03:01; DRB1*03:01,12:01; DRB3*01 (IPD-IMGT/HLA=13837).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   GM10831
AC   CVCL_R594
AS   CVCL_G512
SY   CEPH-1408-NA10831; 1408-1014
DR   CLO; CLO_0023793
DR   BioSample; SAMN00800227
DR   Coriell; GM10831
DR   dbMHC; 48671
DR   GEO; GSM25432
DR   GEO; GSM25433
DR   GEO; GSM30116
DR   GEO; GSM112495
DR   GEO; GSM112775
DR   GEO; GSM188765
DR   GEO; GSM207759
DR   GEO; GSM207760
DR   GEO; GSM291604
DR   GEO; GSM316441
DR   GEO; GSM316442
DR   GEO; GSM316443
DR   GEO; GSM420596
DR   GEO; GSM420597
DR   GEO; GSM648846
DR   GEO; GSM861996
DR   GEO; GSM861997
DR   GEO; GSM861998
DR   GEO; GSM861999
DR   GEO; GSM862000
DR   GEO; GSM862001
DR   IGSR; NA10831
DR   IHW; IHW01143
DR   IPD-IMGT/HLA; 13830
DR   Wikidata; Q54844664
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140802.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,01:01; B*08:01,51:01; C*07:01,15:02; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*03:01,05:01; DQB1*02:01,03:01; DRB1*03:01,04:07; DRB3*01; DRB4*01 (IPD-IMGT/HLA=13830).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10832
AC   CVCL_5B84
AS   CVCL_G530
SY   CEPH-1413-NA10832; 1413-1084
DR   CLO; CLO_0023794
DR   BioSample; SAMN00800229
DR   Coriell; GM10832
DR   dbMHC; 48684
DR   GEO; GSM420598
DR   GEO; GSM660012
DR   GEO; GSM660219
DR   GEO; GSM660423
DR   GEO; GSM905830
DR   GEO; GSM905925
DR   GEO; GSM906020
DR   IHW; IHW01161
DR   IPD-IMGT/HLA; 25955
DR   Wikidata; Q54844665
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141301.
CC   HLA typing: A*01:01,68:01:02; B*08:01,13:02; C*03:03,07:01; DPA1*01:03,02:01:01; DPB1*04:01:01,14:01; DQA1*01:02,02:01; DQB1*02:01,06:02; DRB1*07:01,15:01; DRB4*01 (IPD-IMGT/HLA=25955).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM10833
AC   CVCL_5B85
AS   CVCL_G535
SY   CEPH-1413-NA10833; 1413-1089
DR   CLO; CLO_0023795
DR   BioSample; SAMN00800230
DR   Coriell; GM10833
DR   dbMHC; 48685
DR   GEO; GSM207761
DR   GEO; GSM420599
DR   GEO; GSM660011
DR   GEO; GSM660218
DR   GEO; GSM660422
DR   GEO; GSM905831
DR   GEO; GSM905926
DR   GEO; GSM906021
DR   IHW; IHW01166
DR   IPD-IMGT/HLA; 25960
DR   Wikidata; Q54844666
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141302.
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,07:04; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*03:01,05:01; DQB1*03:01:01,03:01:01; DRB1*04:01,11:01; DRB3*01; DRB4*01 (IPD-IMGT/HLA=25960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM10834
AC   CVCL_5B86
AS   CVCL_G544
SY   GM10834A; CEPH-1416-NA10834; 1416-1188
DR   CLO; CLO_0023796
DR   BioSample; SAMN00800232
DR   Coriell; GM10834
DR   dbMHC; 48703
DR   GEO; GSM25434
DR   GEO; GSM25435
DR   GEO; GSM316444
DR   GEO; GSM316445
DR   GEO; GSM316446
DR   GEO; GSM420600
DR   GEO; GSM420601
DR   GEO; GSM905832
DR   GEO; GSM905927
DR   GEO; GSM906022
DR   IHW; IHW01175
DR   IPD-IMGT/HLA; 13832
DR   Wikidata; Q54844667
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=20856902;
RX   PubMed=30844424;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141602.
CC   HLA typing: A*02:01,02:05; B*15:01,49:01; C*03:03,07:01; DPA1*01:03,02:01:01; DPB1*04:01:01,13:01; DQA1*01:02,03:01; DQB1*03:02:01,06:09; DRB1*04:01,13:02; DRB3*01; DRB4*01 (IPD-IMGT/HLA=13832).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   GM10835
AC   CVCL_R595
AS   CVCL_G551
SY   CEPH-1416-NA10835; 1416-1195
DR   CLO; CLO_0023797
DR   BioSample; SAMN00800234
DR   Coriell; GM10835
DR   dbMHC; 48704
DR   GEO; GSM25436
DR   GEO; GSM25437
DR   GEO; GSM112496
DR   GEO; GSM112776
DR   GEO; GSM188773
DR   GEO; GSM291605
DR   GEO; GSM316399
DR   GEO; GSM316400
DR   GEO; GSM316401
DR   GEO; GSM420602
DR   GEO; GSM420603
DR   GEO; GSM648880
DR   IGSR; NA10835
DR   IHW; IHW01182
DR   IPD-IMGT/HLA; 13839
DR   Wikidata; Q54844668
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141601.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,23:01; B*40:01,41:01; C*03:04:01,17:01; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*01:02,02:01; DQB1*02:01,06:04; DRB1*07:01,13:02; DRB3*01; DRB4*01 (IPD-IMGT/HLA=13839).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10836
AC   CVCL_R596
DR   CLO; CLO_0023780
DR   BioSample; SAMN00800236
DR   Coriell; GM10836
DR   GEO; GSM25438
DR   GEO; GSM25439
DR   GEO; GSM30181
DR   GEO; GSM420604
DR   GEO; GSM648955
DR   GEO; GSM660009
DR   GEO; GSM660216
DR   GEO; GSM660420
DR   GEO; GSM905833
DR   GEO; GSM905928
DR   GEO; GSM906023
DR   IGSR; NA10836
DR   Wikidata; Q54844669
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 141802.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10837
AC   CVCL_R597
DR   CLO; CLO_0023781
DR   BioSample; SAMN00800238
DR   Coriell; GM10837
DR   GEO; GSM25440
DR   GEO; GSM25441
DR   GEO; GSM420605
DR   GEO; GSM648970
DR   GEO; GSM660010
DR   GEO; GSM660217
DR   GEO; GSM660421
DR   GEO; GSM905834
DR   GEO; GSM905929
DR   GEO; GSM906024
DR   IGSR; NA10837
DR   Wikidata; Q54844670
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 141801.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10838
AC   CVCL_R598
DR   CLO; CLO_0023778
DR   BioSample; SAMN00800240
DR   Coriell; GM10838
DR   GEO; GSM112497
DR   GEO; GSM112777
DR   GEO; GSM188774
DR   GEO; GSM291606
DR   GEO; GSM316402
DR   GEO; GSM316403
DR   GEO; GSM316404
DR   GEO; GSM420606
DR   GEO; GSM649293
DR   GEO; GSM651077
DR   GEO; GSM651078
DR   GEO; GSM957434
DR   IGSR; NA10838
DR   Wikidata; Q54844671
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=21418647;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142001.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10839
AC   CVCL_R599
DR   CLO; CLO_0023779
DR   BioSample; SAMN00800242
DR   Coriell; GM10839
DR   GEO; GSM112498
DR   GEO; GSM112778
DR   GEO; GSM188776
DR   GEO; GSM291607
DR   GEO; GSM316447
DR   GEO; GSM316448
DR   GEO; GSM316449
DR   GEO; GSM420607
DR   GEO; GSM648898
DR   GEO; GSM651079
DR   GEO; GSM651080
DR   GEO; GSM862002
DR   GEO; GSM862003
DR   GEO; GSM862004
DR   GEO; GSM862005
DR   GEO; GSM862006
DR   GEO; GSM862007
DR   GEO; GSM957345
DR   GEO; GSM957435
DR   IGSR; NA10839
DR   Wikidata; Q54844672
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=21418647;
RX   PubMed=23676674;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142002.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM10839).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 25
//
ID   GM10840
AC   CVCL_R600
DR   CLO; CLO_0023786
DR   BioSample; SAMN00800244
DR   Coriell; GM10840
DR   GEO; GSM25442
DR   GEO; GSM25443
DR   GEO; GSM30193
DR   GEO; GSM316450
DR   GEO; GSM316451
DR   GEO; GSM316452
DR   GEO; GSM420608
DR   GEO; GSM420609
DR   GEO; GSM648960
DR   GEO; GSM905835
DR   GEO; GSM905930
DR   GEO; GSM906025
DR   IGSR; NA10840
DR   Wikidata; Q54844673
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142102.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10841
AC   CVCL_5B87
DR   CLO; CLO_0023787
DR   BioSample; SAMN00800246
DR   Coriell; GM10841
DR   GEO; GSM25444
DR   GEO; GSM25445
DR   GEO; GSM30192
DR   GEO; GSM316405
DR   GEO; GSM316406
DR   GEO; GSM316407
DR   GEO; GSM420610
DR   GEO; GSM420611
DR   GEO; GSM905836
DR   GEO; GSM905931
DR   GEO; GSM906026
DR   Wikidata; Q54844674
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142101.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM10842
AC   CVCL_R601
DR   CLO; CLO_0023784
DR   BioSample; SAMN00800248
DR   Coriell; GM10842
DR   GEO; GSM25446
DR   GEO; GSM25447
DR   GEO; GSM316408
DR   GEO; GSM316409
DR   GEO; GSM316410
DR   GEO; GSM420612
DR   GEO; GSM420613
DR   GEO; GSM905837
DR   GEO; GSM905932
DR   GEO; GSM906027
DR   IGSR; NA10842
DR   Wikidata; Q54844675
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=16809669;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142301.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10843
AC   CVCL_R602
DR   CLO; CLO_0023785
DR   BioSample; SAMN00800250
DR   Coriell; GM10843
DR   GEO; GSM25448
DR   GEO; GSM25449
DR   GEO; GSM316453
DR   GEO; GSM316454
DR   GEO; GSM316455
DR   GEO; GSM420614
DR   GEO; GSM420615
DR   GEO; GSM648969
DR   GEO; GSM905838
DR   GEO; GSM905933
DR   GEO; GSM906028
DR   IGSR; NA10843
DR   Wikidata; Q54844676
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142302.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10844
AC   CVCL_5B88
SY   GM10844A
DR   CLO; CLO_0023782
DR   BioSample; SAMN00800252
DR   Coriell; GM10844
DR   GEO; GSM25450
DR   GEO; GSM25451
DR   GEO; GSM30205
DR   GEO; GSM316456
DR   GEO; GSM316457
DR   GEO; GSM316458
DR   GEO; GSM420616
DR   GEO; GSM420617
DR   GEO; GSM905839
DR   GEO; GSM905934
DR   GEO; GSM906029
DR   Wikidata; Q54844677
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142402.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM10845
AC   CVCL_R603
DR   CLO; CLO_0023783
DR   BioSample; SAMN00800254
DR   Coriell; GM10845
DR   GEO; GSM25452
DR   GEO; GSM25453
DR   GEO; GSM30204
DR   GEO; GSM316411
DR   GEO; GSM316412
DR   GEO; GSM316413
DR   GEO; GSM420618
DR   GEO; GSM420619
DR   GEO; GSM648965
DR   GEO; GSM905840
DR   GEO; GSM905935
DR   GEO; GSM906030
DR   IGSR; NA10845
DR   Wikidata; Q54844678
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142401.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10846
AC   CVCL_R604
DR   CLO; CLO_0023762
DR   BioSample; SAMN00800256
DR   Coriell; GM10846
DR   GEO; GSM30006
DR   GEO; GSM112499
DR   GEO; GSM112779
DR   GEO; GSM188777
DR   GEO; GSM291608
DR   GEO; GSM291609
DR   GEO; GSM420620
DR   GEO; GSM420621
DR   GEO; GSM648839
DR   GEO; GSM905841
DR   GEO; GSM905936
DR   GEO; GSM906031
DR   IGSR; NA10846
DR   Wikidata; Q54844679
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133401.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10847
AC   CVCL_N799
DR   CLO; CLO_0023758
DR   EFO; EFO_0005336
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00800258
DR   Coriell; GM10847
DR   ENCODE; ENCBS185AAA
DR   ENCODE; ENCBS186AAA
DR   GEO; GSM112500
DR   GEO; GSM112780
DR   GEO; GSM188778
DR   GEO; GSM291610
DR   GEO; GSM420622
DR   GEO; GSM420623
DR   GEO; GSM649294
DR   GEO; GSM649851
DR   GEO; GSM1719751
DR   IGSR; NA10847
DR   Wikidata; Q54844680
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=24924344;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=30485824;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133402.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10848
AC   CVCL_5B89
AS   CVCL_G401
SY   CEPH-1332-NA10848; 1332-8260
DR   CLO; CLO_0023759
DR   BioSample; SAMN00800260
DR   Coriell; GM10848
DR   dbMHC; 48553
DR   GEO; GSM420624
DR   GEO; GSM660028
DR   GEO; GSM660235
DR   GEO; GSM660439
DR   IHW; IHW01029
DR   IPD-IMGT/HLA; 25829
DR   Wikidata; Q54844681
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133201.
CC   HLA typing: A*03:01,03:01; B*35:01,56:01; C*01:02,04:01; DPA1*01:03,02:01:01; DPB1*04:01:01,11:01:01; DQA1*04:01,04:01; DQB1*04:02,04:02; DRB1*08:01,08:01 (IPD-IMGT/HLA=25829).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM10849
AC   CVCL_5B90
AS   CVCL_G403
SY   CEPH-1332-NA10849; 1332-8262
DR   CLO; CLO_0023760
DR   BioSample; SAMN00800262
DR   Coriell; GM10849
DR   dbMHC; 48554
DR   GEO; GSM207762
DR   GEO; GSM420625
DR   GEO; GSM660027
DR   GEO; GSM660234
DR   GEO; GSM660438
DR   GEO; GSM905842
DR   GEO; GSM905937
DR   GEO; GSM906032
DR   IHW; IHW01031
DR   IPD-IMGT/HLA; 25831
DR   Wikidata; Q54844682
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133202.
CC   HLA typing: A*03:01,03:01; B*27:05,35:01; C*02:02:02,04:01; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04 (IPD-IMGT/HLA=25831).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM10850
AC   CVCL_R605
AS   CVCL_G444
SY   CEPH-1344-NA10850; 1344-8353
DR   CLO; CLO_0023761
DR   BioSample; SAMN00800264
DR   Coriell; GM10850
DR   dbMHC; 48596
DR   GEO; GSM420626
DR   GEO; GSM648961
DR   GEO; GSM660025
DR   GEO; GSM660232
DR   GEO; GSM660436
DR   GEO; GSM905843
DR   GEO; GSM905938
DR   GEO; GSM906033
DR   IGSR; NA10850
DR   IHW; IHW01074
DR   IPD-IMGT/HLA; 25872
DR   Wikidata; Q54844683
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134402.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,03:01; B*40:01,51:01; C*01:02,03:04:01; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25872).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10851
AC   CVCL_R606
AS   CVCL_G447
SY   CEPH-1344-NA10851; 1344-8356
DR   CLO; CLO_0023767
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00800266
DR   Coriell; GM10851
DR   dbMHC; 48597
DR   GEO; GSM112501
DR   GEO; GSM112781
DR   GEO; GSM188779
DR   GEO; GSM291611
DR   GEO; GSM291612
DR   GEO; GSM397671
DR   GEO; GSM420627
DR   GEO; GSM648906
DR   GEO; GSM649852
DR   GEO; GSM660026
DR   GEO; GSM660233
DR   GEO; GSM660437
DR   GEO; GSM1719752
DR   IGSR; NA10851
DR   IHW; IHW01077
DR   IPD-IMGT/HLA; 25875
DR   Wikidata; Q54844684
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134401.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,24:02; B*08:01,40:01; C*03:04:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*02:01,03:01; DQB1*03:02:01,03:03:02; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25875).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 25
//
ID   GM10852
AC   CVCL_R607
AS   CVCL_G458
SY   CEPH-1346-NA10852; 1346-8365
DR   CLO; CLO_0023770
DR   BioSample; SAMN00800268
DR   Coriell; GM10852
DR   dbMHC; 48610
DR   GEO; GSM25454
DR   GEO; GSM25455
DR   GEO; GSM316435
DR   GEO; GSM316436
DR   GEO; GSM316437
DR   GEO; GSM420628
DR   GEO; GSM420629
DR   GEO; GSM648966
DR   GEO; GSM905844
DR   GEO; GSM905939
DR   GEO; GSM906034
DR   IGSR; NA10852
DR   IHW; IHW01088
DR   IPD-IMGT/HLA; 25886
DR   Wikidata; Q54844685
RX   CelloPub=CLPUB00447;
RX   PubMed=16809669;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134602.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,11:01; B*35:01,57:01; C*04:01,06:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*01:01,05:01; DQB1*02:01,05:03:01; DRB1*03:01,14:01; DRB3*01,02 (IPD-IMGT/HLA=25886).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10853
AC   CVCL_R608
AS   CVCL_G485
SY   CEPH-1349-NA10853; 1349-8398
DR   CLO; CLO_0023771
DR   BioSample; SAMN00800270
DR   Coriell; GM10853
DR   dbMHC; 48640
DR   GEO; GSM30042
DR   GEO; GSM420630
DR   GEO; GSM660022
DR   GEO; GSM660229
DR   GEO; GSM660433
DR   GEO; GSM905845
DR   GEO; GSM905940
DR   GEO; GSM906035
DR   IGSR; NA10853
DR   IHW; IHW01116
DR   IPD-IMGT/HLA; 25913
DR   Wikidata; Q54844686
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134901.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:01; B*15:01,57:01; C*03:04:01,06:02; DPA1*01:03,01:03; DPB1*04:01,20:01; DQA1*02:01,03:01; DQB1*03:01,03:03; DRB1*04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25913).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10854
AC   CVCL_R609
AS   CVCL_G486
SY   CEPH-1349-NA10854; 1349-8399
DR   CLO; CLO_0023773
DR   BioSample; SAMN00800272
DR   Coriell; GM10854
DR   dbMHC; 48641
DR   GEO; GSM30043
DR   GEO; GSM112502
DR   GEO; GSM112782
DR   GEO; GSM188780
DR   GEO; GSM291613
DR   GEO; GSM420631
DR   GEO; GSM660021
DR   GEO; GSM660228
DR   GEO; GSM660432
DR   IGSR; NA10854
DR   IHW; IHW01117
DR   IPD-IMGT/HLA; 25914
DR   Wikidata; Q54844687
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134902.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,02:01; B*27:03,44:02:01:01; C*02:02:02,05:01; DPA1*01:03,01:03; DPB1*04:01,04:01; DQA1*03:01,03:01; DQB1*03:01,03:02; DRB1*04:01,04:04; DRB4*01 (IPD-IMGT/HLA=25914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10855
AC   CVCL_R610
DR   CLO; CLO_0023763
DR   BioSample; SAMN00800274
DR   Coriell; GM10855
DR   GEO; GSM30054
DR   GEO; GSM112503
DR   GEO; GSM112783
DR   GEO; GSM291614
DR   GEO; GSM420632
DR   GEO; GSM648870
DR   IGSR; NA10855
DR   Wikidata; Q54844688
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
RX   PubMed=26621101;
RX   PubMed=31401124;
RX   PubMed=35931342;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135002.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM10855).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 27
//
ID   GM10856
AC   CVCL_R611
DR   CLO; CLO_0024097
DR   BioSample; SAMN00800276
DR   Coriell; GM10856
DR   GEO; GSM112504
DR   GEO; GSM112784
DR   GEO; GSM188781
DR   GEO; GSM291615
DR   GEO; GSM420633
DR   GEO; GSM648856
DR   IGSR; NA10856
DR   Wikidata; Q54844689
RX   CelloPub=CLPUB00447;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24924344;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135001.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM10856).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 26
//
ID   GM10857
AC   CVCL_R612
AS   CVCL_G461
SY   CEPH-1346-NA10857; 1346-8438
DR   CLO; CLO_0024096
DR   BioSample; SAMN00800278
DR   Coriell; GM10857
DR   dbMHC; 48611
DR   GEO; GSM25456
DR   GEO; GSM25457
DR   GEO; GSM30033
DR   GEO; GSM112505
DR   GEO; GSM112785
DR   GEO; GSM188782
DR   GEO; GSM291616
DR   GEO; GSM316390
DR   GEO; GSM316391
DR   GEO; GSM316392
DR   GEO; GSM420634
DR   GEO; GSM420635
DR   GEO; GSM648917
DR   GEO; GSM905846
DR   GEO; GSM905941
DR   GEO; GSM906036
DR   IGSR; NA10857
DR   IHW; IHW01091
DR   IPD-IMGT/HLA; 25889
DR   Wikidata; Q54844690
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134601.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,02:06; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:01,01:03; DQB1*05:01,06:03; DRB1*01:01,13:01; DRB3*01 (IPD-IMGT/HLA=25889).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10858
AC   CVCL_5B91
AS   CVCL_G473
SY   CEPH-1347-NA10858; 1347-8440
DR   CLO; CLO_0024093
DR   BioSample; SAMN00800280
DR   Coriell; GM10858
DR   dbMHC; 48624
DR   GEO; GSM25458
DR   GEO; GSM25459
DR   GEO; GSM207763
DR   GEO; GSM420636
DR   GEO; GSM420637
DR   GEO; GSM660024
DR   GEO; GSM660231
DR   GEO; GSM660435
DR   GEO; GSM905847
DR   GEO; GSM905942
DR   GEO; GSM906037
DR   IHW; IHW01103
DR   IPD-IMGT/HLA; 25901
DR   Wikidata; Q54844691
RX   CelloPub=CLPUB00447;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134701.
CC   HLA typing: A*25:01,68:01:02; B*08:01,44:04; C*07:01,16:01; DPA1*01:03,02:01:02; DPB1*01:01:01,04:01:01; DQA1*05:01,05:01; DQB1*02:01,03:01; DRB1*03:01,11:01; DRB3*01,02 (IPD-IMGT/HLA=25901).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM10858).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 24
//
ID   GM10859
AC   CVCL_R613
AS   CVCL_G478
SY   CEPH-1347-NA10859; 1347-8445
DR   CLO; CLO_0024092
DR   BioSample; SAMN00800282
DR   Coriell; GM10859
DR   dbMHC; 48625
DR   GEO; GSM25460
DR   GEO; GSM25461
DR   GEO; GSM112506
DR   GEO; GSM112786
DR   GEO; GSM188783
DR   GEO; GSM207764
DR   GEO; GSM291617
DR   GEO; GSM420638
DR   GEO; GSM420639
DR   GEO; GSM617124
DR   GEO; GSM648910
DR   GEO; GSM660023
DR   GEO; GSM660230
DR   GEO; GSM660434
DR   IGSR; NA10859
DR   IHW; IHW01108
DR   IPD-IMGT/HLA; 25906
DR   Wikidata; Q54844692
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134702.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,03:01; B*07:02,15:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*04:02,04:02; DQA1*01:02,03:01; DQB1*03:02,06:02; DRB1*04:01,15:01; DRB4*01 (IPD-IMGT/HLA=25906).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 12,20
ST   D21S11: 29,30
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   TH01: 6,7
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10860
AC   CVCL_7503
AS   CVCL_G493
SY   CEPH-1362-NA10860; 1362-8563
DR   CLO; CLO_0024095
DR   BioSample; SAMN00800284
DR   Coriell; GM10860
DR   dbMHC; 48653
DR   GEO; GSM25462
DR   GEO; GSM25463
DR   GEO; GSM30075
DR   GEO; GSM112507
DR   GEO; GSM112787
DR   GEO; GSM188784
DR   GEO; GSM207765
DR   GEO; GSM291618
DR   GEO; GSM316393
DR   GEO; GSM316394
DR   GEO; GSM316395
DR   GEO; GSM420640
DR   GEO; GSM648871
DR   GEO; GSM957417
DR   IGSR; NA10860
DR   IHW; IHW01124
DR   IPD-IMGT/HLA; 25921
DR   Wikidata; Q54844693
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24924344;
RX   PubMed=31401124;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136201.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,29:02; B*35:01,44:03; C*04:01,16:01; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:01,01:01; DQB1*05:01,05:01:01; DRB1*01:01,01:01 (IPD-IMGT/HLA=25921).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   GM10861
AC   CVCL_R614
AS   CVCL_G504
SY   CEPH-1362-NA10861; 1362-8574
DR   CLO; CLO_0024094
DR   BioSample; SAMN00800286
DR   Coriell; GM10861
DR   dbMHC; 48654
DR   GEO; GSM25464
DR   GEO; GSM25465
DR   GEO; GSM30076
DR   GEO; GSM112508
DR   GEO; GSM112788
DR   GEO; GSM188785
DR   GEO; GSM207766
DR   GEO; GSM291619
DR   GEO; GSM316438
DR   GEO; GSM316439
DR   GEO; GSM316440
DR   GEO; GSM420641
DR   GEO; GSM420642
DR   GEO; GSM957418
DR   IGSR; NA10861
DR   IHW; IHW01135
DR   IPD-IMGT/HLA; 25932
DR   Wikidata; Q54844701
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=23676674;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136202.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,01:01; B*07:02,57:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*04:02,15:01; DQA1*01:03,03:01; DQB1*03:02:01,06:03; DRB1*04:04,13:01; DRB3*01; DRB4*01 (IPD-IMGT/HLA=25932).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM10862
AC   CVCL_5B92
DR   CLO; CLO_0024087
DR   BioSample; SAMN00800288
DR   Coriell; GM10862
DR   GEO; GSM30096
DR   GEO; GSM420643
DR   Wikidata; Q54844702
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137501.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM10863
AC   CVCL_R615
SY   GM10863A; CEPH 1375.02; CEPH-137502; 1375-02
DR   CLO; CLO_0024085
DR   BioSample; SAMN00800290
DR   Coriell; GM10863
DR   GEO; GSM30097
DR   GEO; GSM112509
DR   GEO; GSM112789
DR   GEO; GSM188787
DR   GEO; GSM291620
DR   GEO; GSM291621
DR   GEO; GSM420644
DR   GEO; GSM648916
DR   GEO; GSM862008
DR   GEO; GSM862009
DR   GEO; GSM862010
DR   GEO; GSM862011
DR   GEO; GSM862012
DR   GEO; GSM862013
DR   IGSR; NA10863
DR   IPD-IMGT/HLA; 10069
DR   Wikidata; Q54844703
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24057213;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 137502.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Virology: Contains a chromosomally integrated human herpesvirus 6B (CI-HHV-6B).
CC   HLA typing: DPB1*04:01,06:01; DQA1*01:01,03:01; DQB1*03:02,05:03; DRB1*04:04,14:04; DRB3*02 (IPD-IMGT/HLA=10069).
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM10863).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 29
//
ID   GM10864
AC   CVCL_R616
DR   CLO; CLO_0024090
DR   BioSample; SAMN00800292
DR   Coriell; GM10864
DR   GEO; GSM30107
DR   GEO; GSM648963
DR   IGSR; NA10864
DR   Wikidata; Q54844704
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=21397061;
RX   PubMed=26247043;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137702.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM10865
AC   CVCL_R617
DR   CLO; CLO_0024088
DR   BioSample; SAMN00800294
DR   Coriell; GM10865
DR   GEO; GSM30106
DR   IGSR; NA10865
DR   Wikidata; Q54844705
RX   CelloPub=CLPUB00447;
RX   PubMed=15514893;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137701.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM10866
AC   CVCL_W606
DR   CLO; CLO_0024137
DR   BioSample; SAMN00800296
DR   Coriell; GM10866
DR   Wikidata; Q54844706
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.Arg468Pro (c.1403G>C); ClinVar=VCV000092615; Zygosity=Hemizygous (Coriell=GM10866).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM10867
AC   CVCL_W607
DR   CLO; CLO_0024134
DR   BioSample; SAMN00800298
DR   Coriell; GM10867
DR   Wikidata; Q54844707
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM10870
AC   CVCL_0R36
DR   CLO; CLO_0024129
DR   BioSample; SAMN00800300
DR   Coriell; GM10870
DR   Wikidata; Q54844708
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (Coriell=GM10870).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   GM10871
AC   CVCL_0R37
DR   CLO; CLO_0024127
DR   BioSample; SAMN00800302
DR   Coriell; GM10871
DR   Wikidata; Q54844709
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (Coriell=GM10871).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   GM10873
AC   CVCL_N158
SY   GM17368
DR   CLO; CLO_0013711
DR   CLO; CLO_0024125
DR   BioSample; SAMN00800304
DR   Coriell; GM10873
DR   Coriell; GM17368
DR   Wikidata; Q54844710
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (Coriell=GM10873).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   GM10874
AC   CVCL_0R38
DR   CLO; CLO_0024123
DR   BioSample; SAMN00800306
DR   Coriell; GM10874
DR   Wikidata; Q54844711
RX   CelloPub=CLPUB00447;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg159Gln (c.476G>A) (R120Q); ClinVar=VCV000004291; Zygosity=Heterozygous (Coriell=GM10874).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (Coriell=GM10874).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   GM10876
AC   CVCL_F616
DR   CLO; CLO_0024122
DR   Coriell; GM10876
DR   Wikidata; Q54844712
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM10879
AC   CVCL_AD74
DR   CLO; CLO_0024119
DR   BioSample; SAMN00800308
DR   Coriell; GM10879
DR   Wikidata; Q54844713
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98932; Fryns syndrome
DI   ORDO; Orphanet_2059; Fryns syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10880
AC   CVCL_1S06
SY   FUS-8:4-BE1
DR   CLO; CLO_0024118
DR   Coriell; GM10880
DR   Wikidata; Q54844714
RX   CelloPub=CLPUB00447;
RX   PubMed=2535035;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N79 ! SEWA-CL-3
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM10888
AC   CVCL_1S07
SY   KG-1; K1
DR   CLO; CLO_0023414
DR   Coriell; GM10888
DR   Wikidata; Q54844716
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=2395866;
RX   PubMed=8314568;
RX   PubMed=8661140;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 22 mapping. Contains a complete copy of chromosome 22.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM10889
AC   CVCL_1S08
SY   DHA4
DR   CLO; CLO_0023415
DR   Coriell; GM10889
DR   Wikidata; Q54844717
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 17 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM10890
AC   CVCL_1S09
SY   Y17-41
DR   CLO; CLO_0023416
DR   Coriell; GM10890
DR   Wikidata; Q54844718
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1Q23 ! GM06326
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM10892
AC   CVCL_0Q24
DR   CLO; CLO_0023417
DR   BioSample; SAMN00800312
DR   Coriell; GM10892
DR   Wikidata; Q54844719
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM10892).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM10893
AC   CVCL_0Q25
DR   CLO; CLO_0023413
DR   BioSample; SAMN00800314
DR   Coriell; GM10893
DR   Wikidata; Q54844720
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM10894
AC   CVCL_0Q26
DR   CLO; CLO_0023412
DR   BioSample; SAMN00800316
DR   Coriell; GM10894
DR   Wikidata; Q54844721
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   GM10900
AC   CVCL_F147
DR   CLO; CLO_0023409
DR   BioSample; SAMN00800318
DR   Coriell; GM10900
DR   Wikidata; Q54844722
RX   CelloPub=CLPUB00447;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Heterozygous (from familial inference of GM10903; GM10905).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F148 ! GM10901
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   GM10901
AC   CVCL_F148
DR   CLO; CLO_0023397
DR   BioSample; SAMN00800320
DR   Coriell; GM10901
DR   Wikidata; Q54844723
RX   CelloPub=CLPUB00447;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Heterozygous (from familial inference of GM10903; GM10905).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F147 ! GM10900
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM10902
AC   CVCL_7504
DR   CLO; CLO_0023398
DR   BioSample; SAMN00800322
DR   Coriell; GM10902
DR   Wikidata; Q54844724
RX   CelloPub=CLPUB00447;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (Coriell=GM10902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84666; De Sanctis-Cacchione syndrome
DI   ORDO; Orphanet_1569; De Sanctis-Cacchione syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F146 ! GM10903
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM10903
AC   CVCL_F146
DR   CLO; CLO_0023395
DR   BioSample; SAMN00800324
DR   Coriell; GM10903
DR   Wikidata; Q54844725
RX   CelloPub=CLPUB00447;
RX   PubMed=10767341;
RX   PubMed=22661500;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (PubMed=10767341).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=10767341
ST   Amelogenin: X
ST   D21S11: 31.2,32.2
ST   FGA: 23,26
ST   TH01: 7,8
ST   vWA: 18,19
DI   NCIt; C84666; De Sanctis-Cacchione syndrome
DI   ORDO; Orphanet_1569; De Sanctis-Cacchione syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7504 ! GM10902
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM10904
AC   CVCL_F149
DR   CLO; CLO_0023396
DR   BioSample; SAMN00800326
DR   Coriell; GM10904
DR   Wikidata; Q54844726
RX   CelloPub=CLPUB00447;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (Coriell=GM10904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84666; De Sanctis-Cacchione syndrome
DI   ORDO; Orphanet_1569; De Sanctis-Cacchione syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F150 ! GM10905
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   GM10905
AC   CVCL_F150
DR   CLO; CLO_0023393
DR   BioSample; SAMN00800328
DR   Coriell; GM10905
DR   Wikidata; Q54844727
RX   CelloPub=CLPUB00447;
RX   PubMed=7565859;
RX   PubMed=10767341;
RX   PubMed=10771487;
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg735Ter (c.2203C>T) (C2282T); ClinVar=VCV000001701; Zygosity=Homozygous (PubMed=10767341).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=10767341
ST   Amelogenin: X,Y
ST   D21S11: 30,32.2
ST   FGA: 23,26
ST   TH01: 7,8
ST   vWA: 15,18
DI   NCIt; C84666; De Sanctis-Cacchione syndrome
DI   ORDO; Orphanet_1569; De Sanctis-Cacchione syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F149 ! GM10904
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   GM10911
AC   CVCL_AK29
DR   CLO; CLO_0023322
DR   BioSample; SAMN00800330
DR   Coriell; GM10911
DR   Wikidata; Q54844728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM10912
AC   CVCL_AK30
DR   CLO; CLO_0023323
DR   BioSample; SAMN00800332
DR   Coriell; GM10912
DR   Wikidata; Q54844729
CC   Sequence variation: Mutation; HGNC; HGNC:11740; TF; Simple; p.Asp77Asn (c.229G>A); ClinVar=VCV000012621; Zygosity=Heterozygous (Coriell=GM10912).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM10913
AC   CVCL_AK31
DR   CLO; CLO_0023320
DR   BioSample; SAMN00800334
DR   Coriell; GM10913
DR   Wikidata; Q54844730
CC   Sequence variation: Mutation; HGNC; HGNC:11740; TF; Simple; p.Asp77Asn (c.229G>A); ClinVar=VCV000012621; Zygosity=Heterozygous (Coriell=GM10913).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM10914
AC   CVCL_AK32
DR   CLO; CLO_0023321
DR   BioSample; SAMN00800336
DR   Coriell; GM10914
DR   Wikidata; Q54844732
CC   Sequence variation: Mutation; HGNC; HGNC:11740; TF; Simple; p.Asp77Asn (c.229G>A); ClinVar=VCV000012621; Zygosity=Homozygous (Coriell=GM10914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125693; Atransferrinemia
DI   ORDO; Orphanet_1195; Congenital atransferrinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM10915
AC   CVCL_0R39
DR   CLO; CLO_0023326
DR   BioSample; SAMN00800338
DR   Coriell; GM10915
DR   Wikidata; Q54844733
RX   CelloPub=CLPUB00447;
RX   PubMed=30497978;
RX   PubMed=36130205;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=30497978).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM10918
AC   CVCL_5P26
DR   CLO; CLO_0023325
DR   BioSample; SAMN00800340
DR   Coriell; GM10918
DR   Wikidata; Q54844734
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10919
AC   CVCL_W026
DR   CLO; CLO_0023324
DR   BioSample; SAMN00800342
DR   Coriell; GM10919
DR   Wikidata; Q54844735
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM10922
AC   CVCL_5P27
DR   CLO; CLO_0023330
DR   BioSample; SAMN00800344
DR   Coriell; GM10922
DR   Wikidata; Q54844736
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10923
AC   CVCL_7505
SY   GM17003
DR   CLO; CLO_0018042
DR   CLO; CLO_0023329
DR   BioSample; SAMN00800346
DR   Coriell; GM10923
DR   Coriell; GM17003
DR   Wikidata; Q54844737
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM10924
AC   CVCL_7506
SY   GM17004
DR   CLO; CLO_0018041
DR   CLO; CLO_0023328
DR   BioSample; SAMN00800348
DR   Coriell; GM10924
DR   Coriell; GM17004
DR   Wikidata; Q54844738
RX   CelloPub=CLPUB00447;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM10925
AC   CVCL_F151
DR   CLO; CLO_0023327
DR   BioSample; SAMN00800350
DR   Coriell; GM10925
DR   Wikidata; Q54844739
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35255; Greig syndrome
DI   ORDO; Orphanet_380; Greig cephalopolysyndactyly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   GM10926
AC   CVCL_1S10
SY   R342-A4; GM10926B; GM10926C
DR   CLO; CLO_0023299
DR   Coriell; GM10926
DR   Wikidata; Q54844740
RX   CelloPub=CLPUB00447;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 10 mapping. Contains a complete copy of chromosome 10.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0214 ! CHO-K1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM10927
AC   CVCL_1Q54
SY   J1-4; J1Cl4; GM10927A
DR   CLO; CLO_0023300
DR   Coriell; GM10927
DR   Wikidata; Q54844741
RX   CelloPub=CLPUB00447;
RX   PubMed=2595451;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 11 mapping. Contains a complete copy of chromosome 11.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q53 ! 78-5j1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM10929
AC   CVCL_AK33
DR   CLO; CLO_0023301
DR   BioSample; SAMN00800352
DR   Coriell; GM10929
DR   Wikidata; Q54844748
CC   Sequence variation: Mutation; HGNC; HGNC:11740; TF; Simple; p.Asp77Asn (c.229G>A); ClinVar=VCV000012621; Zygosity=Heterozygous (Coriell=GM10929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM10930
AC   CVCL_AD75
DR   CLO; CLO_0023313
DR   BioSample; SAMN00800354
DR   Coriell; GM10930
DR   Wikidata; Q54844749
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM10931
AC   CVCL_AD76
DR   CLO; CLO_0023312
DR   BioSample; SAMN00800357
DR   Coriell; GM10931
DR   Wikidata; Q54844750
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM10932
AC   CVCL_5P28
DR   CLO; CLO_0023315
DR   BioSample; SAMN00800359
DR   Coriell; GM10932
DR   Wikidata; Q54844751
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM10933
AC   CVCL_5P29
DR   CLO; CLO_0023314
DR   BioSample; SAMN00800361
DR   Coriell; GM10933
DR   Wikidata; Q54844752
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM10934
AC   CVCL_4E05
DR   CLO; CLO_0023317
DR   Coriell; GM10934
DR   Wikidata; Q54844753
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM10935
AC   CVCL_2T93
DR   CLO; CLO_0023316
DR   BioSample; SAMN00800363
DR   Coriell; GM10935
DR   Wikidata; Q54844754
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM10946
AC   CVCL_5T65
DR   CLO; CLO_0023319
DR   BioSample; SAMN00800365
DR   Coriell; GM10946
DR   Wikidata; Q54844755
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10947
AC   CVCL_2T94
DR   CLO; CLO_0023318
DR   BioSample; SAMN00800367
DR   Coriell; GM10947
DR   Wikidata; Q54844756
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM10949
AC   CVCL_0Q27
DR   CLO; CLO_0023352
DR   BioSample; SAMN00800369
DR   Coriell; GM10949
DR   Wikidata; Q54844757
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (Coriell=GM10949).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM10951
AC   CVCL_5P30
DR   CLO; CLO_0023353
DR   BioSample; SAMN00800371
DR   Coriell; GM10951
DR   Wikidata; Q54844759
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(7)(pter->p15::p13->qter) (Coriell=GM10951).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM10954
AC   CVCL_5P31
DR   CLO; CLO_0023357
DR   BioSample; SAMN00800373
DR   Coriell; GM10954
DR   Wikidata; Q54844760
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM10954; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10958
AC   CVCL_2T95
DR   CLO; CLO_0023372
DR   BioSample; SAMN00800375
DR   Coriell; GM10958
DR   Wikidata; Q54844761
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM10959
AC   CVCL_N159
SY   GM17236
DR   CLO; CLO_0014336
DR   CLO; CLO_0023371
DR   BioSample; SAMN00800377
DR   Coriell; GM10959
DR   Coriell; GM17236
DR   GEO; GSM569563
DR   GEO; GSM596300
DR   GEO; GSM596660
DR   GEO; GSM924838
DR   Wikidata; Q54844762
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,03:01:01; B*07:02:01,07:02:01; C*07:02:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*01:02:01,01:02:01; DQB1*06:02:01,06:02:01; DRB1*15:01:01,15:01:01; DRB5*01:01:01,01:01:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Arg296Cys (c.886C>T); ClinVar=VCV000242771; Zygosity=Heterozygous; Note=CYP2D6*2 allele (Coriell=GM17236).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Ser486Thr (c.1457G>C); ClinVar=VCV000242701; Zygosity=Heterozygous; Note=CYP2D6*2 allele (Coriell=GM17236).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   GM10960
AC   CVCL_2T96
DR   CLO; CLO_0023370
DR   BioSample; SAMN00800379
DR   Coriell; GM10960
DR   Wikidata; Q54844763
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;11)(1pter->1q31.2::11q25->11qter;11pter->11q25::1q31.2->1qter) (Coriell=GM10960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM10961
AC   CVCL_2T97
DR   CLO; CLO_0023369
DR   BioSample; SAMN00800381
DR   Coriell; GM10961
DR   Wikidata; Q54844764
CC   Population: Southeast Asian; Cambodian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM10962
AC   CVCL_2T98
DR   CLO; CLO_0023368
DR   BioSample; SAMN00800383
DR   Coriell; GM10962
DR   Wikidata; Q54844765
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Karyotypic information: 46,XX,t(5;12)(5pter->5q33::12q24.3->12qter;12pter->12q24.3::5q33->5qter) (Coriell=GM10962).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM10964
AC   CVCL_2T99
SY   10964C; UtLM
DR   CLO; CLO_0023367
DR   Coriell; GM10964
DR   FANTOM5_SSTAR; 10569-108B2
DR   Wikidata; Q54844766
RX   CelloPub=CLPUB00447;
RX   PubMed=12065682;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Uterine smooth muscle cell; CL=CL_0002601.
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM10965
AC   CVCL_N364
SY   JK1388
DR   CLO; CLO_0023366
DR   Coriell; GM10965
DR   Wikidata; Q54844767
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10965; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10966
AC   CVCL_N365
SY   JK1371
DR   CLO; CLO_0023365
DR   Coriell; GM10966
DR   Wikidata; Q54844768
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10966; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10967
AC   CVCL_N366
SY   JK1380
DR   CLO; CLO_0023331
DR   Coriell; GM10967
DR   Wikidata; Q54844769
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10967; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10968
AC   CVCL_N367
SY   JK1364
DR   CLO; CLO_0023339
DR   Coriell; GM10968
DR   Wikidata; Q54844770
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10968; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10969
AC   CVCL_N368
SY   JK1370
DR   CLO; CLO_0023337
DR   Coriell; GM10969
DR   Wikidata; Q54844771
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10969; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10970
AC   CVCL_N369
SY   JK1493
DR   CLO; CLO_0023349
DR   Coriell; GM10970
DR   Wikidata; Q54844772
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10970; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10971
AC   CVCL_N370
SY   JK1498
DR   CLO; CLO_0023348
DR   Coriell; GM10971
DR   Wikidata; Q54844773
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10971; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10972
AC   CVCL_N371
SY   JK1499
DR   CLO; CLO_0023351
DR   Coriell; GM10972
DR   Wikidata; Q54844774
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10972; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10973
AC   CVCL_N372
SY   JK1504
DR   CLO; CLO_0023350
DR   Coriell; GM10973
DR   Wikidata; Q54844775
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10973; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10974
AC   CVCL_N373
SY   JK1505
DR   CLO; CLO_0023345
DR   Coriell; GM10974
DR   Wikidata; Q54844776
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10974; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10975
AC   CVCL_N374
SY   JK1624
DR   CLO; CLO_0023344
DR   Coriell; GM10975
DR   Wikidata; Q54844777
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10976
AC   CVCL_N375
SY   JK1626
DR   CLO; CLO_0023347
DR   Coriell; GM10976
DR   Wikidata; Q54844778
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM10977
AC   CVCL_UG76
SY   JK1632
DR   Coriell; GM10977
DR   Wikidata; Q93812486
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM10977; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   GM10978
AC   CVCL_N376
SY   JK1590
DR   CLO; CLO_0023346
DR   Coriell; GM10978
DR   Wikidata; Q54844779
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10979
AC   CVCL_N377
SY   JK1598
DR   CLO; CLO_0023278
DR   Coriell; GM10979
DR   Wikidata; Q54844780
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM10980
AC   CVCL_DN48
DR   CLO; CLO_0023276
DR   BioSample; SAMN00800385
DR   Coriell; GM10980
DR   Wikidata; Q54844781
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128115; Marshall syndrome
DI   ORDO; Orphanet_560; Marshall syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DN49 ! GM10981
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10981
AC   CVCL_DN49
DR   CLO; CLO_0023277
DR   BioSample; SAMN00800387
DR   Coriell; GM10981
DR   Wikidata; Q54844782
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128115; Marshall syndrome
DI   ORDO; Orphanet_560; Marshall syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DN48 ! GM10980
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM10982
AC   CVCL_DN50
DR   CLO; CLO_0023271
DR   BioSample; SAMN00800389
DR   Coriell; GM10982
DR   Wikidata; Q54844783
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128115; Marshall syndrome
DI   ORDO; Orphanet_560; Marshall syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10983
AC   CVCL_DN51
DR   CLO; CLO_0023272
DR   BioSample; SAMN00800391
DR   Coriell; GM10983
DR   Wikidata; Q54844784
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128115; Marshall syndrome
DI   ORDO; Orphanet_560; Marshall syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM10985
AC   CVCL_5P32
DR   CLO; CLO_0023269
DR   BioSample; SAMN00800393
DR   Coriell; GM10985
DR   Wikidata; Q54844785
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10989
AC   CVCL_N160
SY   GM18051
DR   CLO; CLO_0015651
DR   CLO; CLO_0023270
DR   Coriell; GM10989
DR   Coriell; GM18051
DR   Wikidata; Q54844786
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM10990
AC   CVCL_8A53
DR   CLO; CLO_0023274
DR   Coriell; GM10990
DR   Wikidata; Q54844788
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10991
AC   CVCL_8A54
DR   CLO; CLO_0023275
DR   Coriell; GM10991
DR   Wikidata; Q54844789
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM10994
AC   CVCL_5P33
DR   CLO; CLO_0023273
DR   Coriell; GM10994
DR   Wikidata; Q54844793
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM10995
AC   CVCL_2U00
DR   CLO; CLO_0023265
DR   BioSample; SAMN00800395
DR   Coriell; GM10995
DR   Wikidata; Q54844794
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM11002
AC   CVCL_5P34
DR   CLO; CLO_0023266
DR   Coriell; GM11002
DR   Wikidata; Q54844795
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11003
AC   CVCL_5P35
DR   CLO; CLO_0023267
DR   Coriell; GM11003
DR   Wikidata; Q54844796
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11004
AC   CVCL_5P36
DR   CLO; CLO_0023268
DR   Coriell; GM11004
DR   Wikidata; Q54844797
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11005
AC   CVCL_5P37
DR   CLO; CLO_0023259
DR   Coriell; GM11005
DR   Wikidata; Q54844798
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11006
AC   CVCL_5P38
DR   CLO; CLO_0023260
DR   Coriell; GM11006
DR   Wikidata; Q54844799
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11010
AC   CVCL_1S11
SY   E2B3
DR   CLO; CLO_0023261
DR   Coriell; GM11010
DR   Wikidata; Q54844800
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 18 mapping. Contains a complete copy of chromosome 18.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N28 ! GM04025
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM11012
AC   CVCL_N161
SY   GM17296
DR   CLO; CLO_0013124
DR   CLO; CLO_0023262
DR   Coriell; GM11012
DR   Coriell; GM17296
DR   GEO; GSM569744
DR   GEO; GSM596360
DR   GEO; GSM596776
DR   GEO; GSM925070
DR   Wikidata; Q54844802
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=23665875;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:236,24:02:01; B*14:02:01,44:02:01; C*05:01:01,08:02:01; DPA1*01:03:01,02:01:01; DPB1*04:01:01,05:01:01; DQA1*01:02:01,01:02:01; DQB1*06:02:01,06:09:01; DRB1*13:02:01,15:01:01; DRB3*03:01:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM11022
AC   CVCL_1S12
SY   5E-F9
DR   CLO; CLO_0023263
DR   Coriell; GM11022
DR   Wikidata; Q54844803
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N67 ! GM11024
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11023
AC   CVCL_1S13
SY   IC-C3
DR   CLO; CLO_0023264
DR   Coriell; GM11023
DR   Wikidata; Q54844804
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N68 ! GM11025
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11024
AC   CVCL_1N67
DR   CLO; CLO_0023298
DR   Coriell; GM11024
DR   Wikidata; Q54844805
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;2)(Xqter->Xp21.2::2q37->2qter;2pter->2q37::Xp21.2->Xpter) (Coriell=GM11024).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM11025
AC   CVCL_1N68
DR   CLO; CLO_0023296
DR   Coriell; GM11025
DR   Wikidata; Q54844806
RX   CelloPub=CLPUB00447;
RX   PubMed=8103757;
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;4)(Xqter->Xp21::4q35->4qter;4pter->4q35::Xp21->Xpter) (Coriell=GM11025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM11027
AC   CVCL_UH45
DR   CLO; CLO_0023297
DR   Coriell; GM11027
DR   Wikidata; Q93812777
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Characteristics: Established from tumor tissue passaged in a nude mouse.
CC   Doubling time: Slow growth (Coriell=GM11027).
CC   Karyotypic information: 47,X,-Y,+13,+19p+,9q-,11q-,19p+ (Coriell=GM11027).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UH46 ! GM11028
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   GM11028
AC   CVCL_UH46
DR   CLO; CLO_0023294
DR   Coriell; GM11028
DR   Wikidata; Q93812782
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Characteristics: Established from tumor tissue passaged in a nude mouse.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UH45 ! GM11027
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 6
//
ID   GM11030
AC   CVCL_X468
DR   CLO; CLO_0023295
DR   Coriell; GM11030
DR   Wikidata; Q54844807
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84523; HMG-CoA lyase deficiency
DI   ORDO; Orphanet_20; 3-hydroxy-3-methylglutaric aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   GM11031
AC   CVCL_AM53
DR   CLO; CLO_0023292
DR   Coriell; GM11031
DR   Wikidata; Q54844808
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Pro23His (c.68C>A); ClinVar=VCV000013013; Zygosity=Heterozygous (Coriell=GM11031).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM11032
AC   CVCL_N162
SY   GM17297
DR   CLO; CLO_0013132
DR   CLO; CLO_0023293
DR   Coriell; GM11032
DR   Coriell; GM17297
DR   Wikidata; Q54844809
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM11033
AC   CVCL_U945
DR   CLO; CLO_0023290
DR   Coriell; GM11033
DR   Wikidata; Q54844810
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Cys312Ter (c.936T>A); ClinVar=VCV001358138; Zygosity=Heterozygous (from autologous cell line GM11091).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U946 ! GM11091
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM11034
AC   CVCL_5P39
DR   CLO; CLO_0023291
DR   Coriell; GM11034
DR   Wikidata; Q54844811
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM11035
AC   CVCL_0I34
DR   CLO; CLO_0023289
DR   Coriell; GM11035
DR   Wikidata; Q54844812
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10413.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   GM11036
AC   CVCL_N163
SY   GM11036A; GM17315
DR   CLO; CLO_0013358
DR   CLO; CLO_0023287
DR   Coriell; GM11036
DR   Coriell; GM17315
DR   Wikidata; Q54844813
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Part of: Human variation panel.
CC   Registration: CEPH Families Reference Panel; 10401.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM11037
AC   CVCL_9Z40
DR   CLO; CLO_0023288
DR   Coriell; GM11037
DR   Wikidata; Q54844814
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10403.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM11038
AC   CVCL_0I35
DR   CLO; CLO_0023283
DR   Coriell; GM11038
DR   Wikidata; Q54844815
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10404.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11039
AC   CVCL_0I36
SY   GM11039B
DR   CLO; CLO_0023284
DR   Coriell; GM11039
DR   Wikidata; Q54844816
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10406.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11040
AC   CVCL_0I37
DR   CLO; CLO_0023285
DR   Coriell; GM11040
DR   Wikidata; Q54844817
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10407.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11041
AC   CVCL_0I38
DR   CLO; CLO_0023286
DR   Coriell; GM11041
DR   Wikidata; Q54844818
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10408.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11042
AC   CVCL_0I39
DR   CLO; CLO_0023279
DR   Coriell; GM11042
DR   Wikidata; Q54844819
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10409.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11043
AC   CVCL_0I40
DR   CLO; CLO_0023280
DR   Coriell; GM11043
DR   Wikidata; Q54844820
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10410.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11044
AC   CVCL_0I41
SY   GM11044B
DR   CLO; CLO_0023281
DR   Coriell; GM11044
DR   Wikidata; Q54844821
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10411.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11045
AC   CVCL_0I42
DR   CLO; CLO_0023282
DR   Coriell; GM11045
DR   Wikidata; Q54844822
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10412.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11047
AC   CVCL_4I34
SY   GM11047A
DR   CLO; CLO_0023055
DR   Coriell; GM11047
DR   Wikidata; Q54844823
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11048
AC   CVCL_4I35
DR   CLO; CLO_0023056
DR   Coriell; GM11048
DR   Wikidata; Q54844824
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11049
AC   CVCL_4I36
DR   CLO; CLO_0023057
DR   Coriell; GM11049
DR   Wikidata; Q54844825
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11050
AC   CVCL_4I37
DR   CLO; CLO_0023058
DR   Coriell; GM11050
DR   Wikidata; Q54844826
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11051
AC   CVCL_4I38
SY   GM11051B
DR   CLO; CLO_0023052
DR   Coriell; GM11051
DR   Wikidata; Q54844827
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11052
AC   CVCL_HJ79
DR   Coriell; GM11052
DR   Wikidata; Q54844828
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM11053
AC   CVCL_4I39
SY   GM11053A
DR   CLO; CLO_0023051
DR   Coriell; GM11053
DR   Wikidata; Q54844829
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11054
AC   CVCL_4I40
DR   CLO; CLO_0023050
DR   Coriell; GM11054
DR   Wikidata; Q54844830
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11055
AC   CVCL_4I41
DR   CLO; CLO_0023049
DR   Coriell; GM11055
DR   Wikidata; Q54844831
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11056
AC   CVCL_4I42
SY   GM11056C
DR   CLO; CLO_0023054
DR   Coriell; GM11056
DR   Wikidata; Q54844832
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM11057
AC   CVCL_4I43
SY   GM11057B
DR   CLO; CLO_0023053
DR   Coriell; GM11057
DR   Wikidata; Q54844833
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11058
AC   CVCL_4I44
SY   GM11058B
DR   CLO; CLO_0023044
DR   Coriell; GM11058
DR   Wikidata; Q54844838
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11059
AC   CVCL_4I45
SY   GM11059B
DR   CLO; CLO_0023047
DR   Coriell; GM11059
DR   Wikidata; Q54844839
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM11060
AC   CVCL_4I46
DR   CLO; CLO_0023048
DR   Coriell; GM11060
DR   Wikidata; Q54844840
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11061
AC   CVCL_4I47
DR   CLO; CLO_0023045
DR   Coriell; GM11061
DR   Wikidata; Q54844841
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11062
AC   CVCL_4I48
DR   CLO; CLO_0023046
DR   Coriell; GM11062
DR   Wikidata; Q54844842
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11063
AC   CVCL_4I49
DR   CLO; CLO_0023041
DR   Coriell; GM11063
DR   Wikidata; Q54844843
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11064
AC   CVCL_4I50
DR   CLO; CLO_0023040
DR   Coriell; GM11064
DR   Wikidata; Q54844844
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11065
AC   CVCL_4I51
DR   CLO; CLO_0023043
DR   Coriell; GM11065
DR   Wikidata; Q54844845
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11066
AC   CVCL_2U01
DR   CLO; CLO_0023042
DR   Coriell; GM11066
DR   Wikidata; Q54844846
RX   CelloPub=CLPUB00447;
CC   Karyotypic information: 46,XY,t(4;11)(4pter->4q33::11p13->11pter;11qter->11p13::4q33->4qter) (Coriell=GM11066).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM11067
AC   CVCL_Y319
DR   CLO; CLO_0023039
DR   Coriell; GM11067
DR   Wikidata; Q54844847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   GM11068
AC   CVCL_Y320
DR   CLO; CLO_0023037
DR   Coriell; GM11068
DR   Wikidata; Q54844848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   GM11071
AC   CVCL_BT23
DR   CLO; CLO_0023038
DR   Coriell; GM11071
DR   Wikidata; Q54844849
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99041; Renal agenesis
DI   ORDO; Orphanet_411709; Renal agenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM11083
AC   CVCL_9R84
DR   CLO; CLO_0023033
DR   Coriell; GM11083
DR   Wikidata; Q54844850
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM11085
AC   CVCL_9R85
DR   CLO; CLO_0023034
DR   Coriell; GM11085
DR   Wikidata; Q54844851
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM11087
AC   CVCL_1S14
SY   GM11088A
DR   CLO; CLO_0023035
DR   Coriell; GM11087
DR   Wikidata; Q54844853
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1Q27 ! HDm-18
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11090
AC   CVCL_AJ44
DR   CLO; CLO_0023036
DR   Coriell; GM11090
DR   Wikidata; Q54844854
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (Coriell=GM11090).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM11091
AC   CVCL_U946
DR   CLO; CLO_0023032
DR   Coriell; GM11091
DR   Wikidata; Q54844855
RX   CelloPub=CLPUB00447;
RX   PubMed=34198154;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Cys312Ter (c.936T>A); ClinVar=VCV001358138; Zygosity=Heterozygous (from child cell line TRNDi031-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U945 ! GM11033
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM11094
AC   CVCL_0L62
DR   CLO; CLO_0023031
DR   Coriell; GM11094
DR   Wikidata; Q54844856
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM11095
AC   CVCL_0L63
DR   CLO; CLO_0023030
DR   Coriell; GM11095
DR   Wikidata; Q54844857
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM11097
AC   CVCL_DA34
DR   CLO; CLO_0023029
DR   Coriell; GM11097
DR   Wikidata; Q54844858
RX   CelloPub=CLPUB00447;
RX   PubMed=31009819;
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from child cell line TRNDi004-I).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM11098
AC   CVCL_1Y48
DR   CLO; CLO_0023028
DR   Coriell; GM11098
DR   Wikidata; Q54844859
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11104
AC   CVCL_0I43
SY   GM11104A
DR   CLO; CLO_0023022
DR   Coriell; GM11104
DR   Wikidata; Q54844860
RX   CelloPub=CLPUB00447;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10405.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   GM11105
AC   CVCL_AM54
DR   CLO; CLO_0023023
DR   Coriell; GM11105
DR   Wikidata; Q54844861
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Pro23His (c.68C>A); ClinVar=VCV000013013; Zygosity=Heterozygous (Coriell=GM11105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   GM11108
AC   CVCL_9R86
DR   CLO; CLO_0023012
DR   Coriell; GM11108
DR   Wikidata; Q54844862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM11109
AC   CVCL_9R87
DR   CLO; CLO_0023013
DR   Coriell; GM11109
DR   Wikidata; Q54844863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM11110
AC   CVCL_9R88
DR   CLO; CLO_0023011
DR   Coriell; GM11110
DR   Wikidata; Q54844864
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Tyr414Cys (c.1241A>G); ClinVar=VCV000000593; Zygosity=Heterozygous (Coriell=GM11110).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.1315+1G>A (IVS12+1G>A); ClinVar=VCV000000576; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM11110).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM11111
AC   CVCL_9R89
DR   CLO; CLO_0023017
DR   Coriell; GM11111
DR   Wikidata; Q54844865
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM11115
AC   CVCL_5P40
SY   TRI9 fibroblast
DR   CLO; CLO_0023016
DR   Coriell; GM11115
DR   Wikidata; Q54844866
RX   CelloPub=CLPUB00447;
RX   PubMed=21949351;
RX   PubMed=23665875;
CC   Population: African American.
CC   Karyotypic information: 47,XY,+9.arr(9)x3 (Coriell=GM11115).
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11116
AC   CVCL_4I52
DR   CLO; CLO_0023015
DR   Coriell; GM11116
DR   Wikidata; Q54844867
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11117
AC   CVCL_4J03
DR   CLO; CLO_0023014
DR   Coriell; GM11117
DR   Wikidata; Q54844868
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11119
AC   CVCL_4I53
DR   CLO; CLO_0023021
DR   Coriell; GM11119
DR   Wikidata; Q54844870
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11120
AC   CVCL_4I54
DR   CLO; CLO_0023020
DR   Coriell; GM11120
DR   Wikidata; Q54844871
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11121
AC   CVCL_4I55
DR   CLO; CLO_0023019
DR   Coriell; GM11121
DR   Wikidata; Q54844872
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11122
AC   CVCL_4I56
DR   CLO; CLO_0023018
DR   Coriell; GM11122
DR   Wikidata; Q54844873
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11124
AC   CVCL_4I57
DR   CLO; CLO_0023000
DR   Coriell; GM11124
DR   Wikidata; Q54844874
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11126
AC   CVCL_4I58
DR   CLO; CLO_0023001
DR   Coriell; GM11126
DR   Wikidata; Q54844875
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11127
AC   CVCL_4I59
SY   GM11127A
DR   CLO; CLO_0023010
DR   Coriell; GM11127
DR   Wikidata; Q54844876
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11128
AC   CVCL_4I60
DR   CLO; CLO_0023003
DR   Coriell; GM11128
DR   Wikidata; Q54844877
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11129
AC   CVCL_4I61
SY   GM11129B
DR   CLO; CLO_0023002
DR   Coriell; GM11129
DR   Wikidata; Q54844878
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11130
AC   CVCL_1S15
SY   AHVI-17
DR   CLO; CLO_0023005
DR   Coriell; GM11130
DR   Wikidata; Q54844879
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V812 ! GM01881
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11149
AC   CVCL_0L64
DR   CLO; CLO_0023004
DR   Coriell; GM11149
DR   Wikidata; Q54844887
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;17)(1pter->1q21::17q25->17qter;17pter->17q25::1q21->1qter) (Coriell=GM11149).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM11150
AC   CVCL_AD67
DR   CLO; CLO_0023007
DR   Coriell; GM11150
DR   Wikidata; Q54844888
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Mennonite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM11151
AC   CVCL_AD68
DR   CLO; CLO_0023006
DR   Coriell; GM11151
DR   Wikidata; Q54844889
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11165
AC   CVCL_W114
DR   CLO; CLO_0023009
DR   Coriell; GM11165
DR   Wikidata; Q54844890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM11166
AC   CVCL_W111
DR   CLO; CLO_0023008
DR   Coriell; GM11166
DR   Wikidata; Q54844891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM11167
AC   CVCL_W112
DR   CLO; CLO_0022989
DR   Coriell; GM11167
DR   Wikidata; Q54844892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM11168
AC   CVCL_W113
DR   CLO; CLO_0022999
DR   Coriell; GM11168
DR   Wikidata; Q54844893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM11169
AC   CVCL_5P41
DR   CLO; CLO_0022998
DR   Coriell; GM11169
DR   Wikidata; Q54844894
CC   Population: African American.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
DI   NCIt; C86032; XX male
DI   ORDO; Orphanet_393; 46,XX testicular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM11172
AC   CVCL_1S16
SY   Ben3B
DR   CLO; CLO_0022997
DR   Coriell; GM11172
DR   Wikidata; Q54844895
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM11173
AC   CVCL_1S17
SY   AA-H
DR   CLO; CLO_0022996
DR   Coriell; GM11173
DR   Wikidata; Q54844896
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM11190
AC   CVCL_4I62
DR   CLO; CLO_0022995
DR   Coriell; GM11190
DR   Wikidata; Q54844897
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11191
AC   CVCL_4J04
DR   CLO; CLO_0022994
DR   Coriell; GM11191
DR   Wikidata; Q54844898
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11192
AC   CVCL_4I63
DR   CLO; CLO_0022993
DR   Coriell; GM11192
DR   Wikidata; Q54844899
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11193
AC   CVCL_4I64
DR   CLO; CLO_0022992
DR   Coriell; GM11193
DR   Wikidata; Q54844900
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11194
AC   CVCL_4I65
DR   CLO; CLO_0022991
DR   Coriell; GM11194
DR   Wikidata; Q54844901
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11195
AC   CVCL_9R90
DR   CLO; CLO_0022990
DR   Coriell; GM11195
DR   Wikidata; Q54844902
RX   PubMed=38552357;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Ser196_Leu197insTer (p.Leu197Terfs) (c.590_612del23); ClinVar=VCV000102745; Zygosity=Heterozygous (Coriell=GM11195).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.912+1G>A (IVS8+1G>A); ClinVar=VCV000092752; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM11195).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM11196
AC   CVCL_9R91
DR   CLO; CLO_0022986
DR   Coriell; GM11196
DR   Wikidata; Q54844903
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Ser196_Leu197insTer (p.Leu197Terfs) (c.590_612del23); ClinVar=VCV000102745; Zygosity=Heterozygous (from familial inference of GM11195).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.912+1G>A (IVS8+1G>A); ClinVar=VCV000092752; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of GM11195).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM11197
AC   CVCL_F617
SY   GM17306; JK2643
DR   CLO; CLO_0013284
DR   CLO; CLO_0022988
DR   Coriell; GM11197
DR   Coriell; GM17306
DR   Wikidata; Q54844904
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Quechuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 16
//
ID   GM11198
AC   CVCL_N164
SY   GM17307; JK2644
DR   CLO; CLO_0013285
DR   CLO; CLO_0022987
DR   Coriell; GM11198
DR   Coriell; GM17307
DR   Wikidata; Q54844905
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Quechuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   GM11199
AC   CVCL_N165
SY   GM17308; JK2645
DR   CLO; CLO_0013277
DR   CLO; CLO_0022983
DR   Coriell; GM11199
DR   Coriell; GM17308
DR   Wikidata; Q54844906
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Quechuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   GM11200
AC   CVCL_N166
SY   GM17309; JK2646
DR   CLO; CLO_0013280
DR   CLO; CLO_0022982
DR   Coriell; GM11200
DR   Coriell; GM17309
DR   Wikidata; Q54844907
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Quechuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 15
//
ID   GM11201
AC   CVCL_F618
SY   JK2647
DR   CLO; CLO_0022985
DR   Coriell; GM11201
DR   Wikidata; Q54844908
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Native South American; Quechuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   GM11202
AC   CVCL_4I66
DR   CLO; CLO_0022984
DR   Coriell; GM11202
DR   Wikidata; Q54844909
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11203
AC   CVCL_4I67
DR   CLO; CLO_0022980
DR   Coriell; GM11203
DR   Wikidata; Q54844910
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11204
AC   CVCL_4I68
DR   CLO; CLO_0022979
DR   Coriell; GM11204
DR   Wikidata; Q54844911
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11205
AC   CVCL_4I69
SY   GM11205A
DR   CLO; CLO_0022981
DR   Coriell; GM11205
DR   Wikidata; Q54844912
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11206
AC   CVCL_4E98
DR   CLO; CLO_0022971
DR   Coriell; GM11206
DR   Wikidata; Q54844913
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM11207
AC   CVCL_4E99
SY   GM11207A
DR   CLO; CLO_0022972
DR   Coriell; GM11207
DR   Wikidata; Q54844914
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11208
AC   CVCL_4F00
SY   GM11208A
DR   CLO; CLO_0022969
DR   Coriell; GM11208
DR   Wikidata; Q54844915
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11209
AC   CVCL_4F01
DR   CLO; CLO_0022970
DR   Coriell; GM11209
DR   Wikidata; Q54844916
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM11210
AC   CVCL_4F02
DR   CLO; CLO_0022975
DR   Coriell; GM11210
DR   Wikidata; Q54844917
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM11211
AC   CVCL_4F03
DR   CLO; CLO_0022976
DR   Coriell; GM11211
DR   Wikidata; Q54844918
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM11212
AC   CVCL_4F04
DR   CLO; CLO_0022973
DR   Coriell; GM11212
DR   Wikidata; Q54844919
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM11213
AC   CVCL_N167
SY   GM17028
DR   CLO; CLO_0014684
DR   CLO; CLO_0022974
DR   Coriell; GM11213
DR   Coriell; GM17028
DR   Wikidata; Q54844920
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Indo Pakistani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM11215
AC   CVCL_V390
DR   CLO; CLO_0022977
DR   Coriell; GM11215
DR   Wikidata; Q54844921
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Homozygous (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM11219
AC   CVCL_2U02
DR   CLO; CLO_0022978
DR   Coriell; GM11219
DR   Wikidata; Q54844922
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM11220
AC   CVCL_1S18
SY   X/22 33-TG
DR   Coriell; GM11220
DR   Wikidata; Q54844923
RX   PubMed=8661140;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM11220; probable.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM11221
AC   CVCL_1S19
SY   WESP-2A-TG8
DR   Coriell; GM11221
DR   Wikidata; Q54844924
RX   PubMed=8661140;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM11221; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   GM11222
AC   CVCL_1S20
SY   GM11222C; A3EW2-3B
DR   CLO; CLO_0022959
DR   Coriell; GM11222
DR   Wikidata; Q54844925
RX   CelloPub=CLPUB00447;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 11 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q37 ! Don/a3
HI   CVCL_3446 ! EW-2
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 9
//
ID   GM11223
AC   CVCL_1S21
SY   1/22 AM-27; 1/22AM-27; GM11223C
DR   CLO; CLO_0022960
DR   Coriell; GM11223
DR   Wikidata; Q54844926
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q37 ! Don/a3
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM11224
AC   CVCL_1S22
SY   1/22 AM-6; 1/22AM-6; GM11224C
DR   Coriell; GM11224
DR   Wikidata; Q54844933
RX   PubMed=975865;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM11224; probable.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q37 ! Don/a3
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM11226
AC   CVCL_5P42
DR   CLO; CLO_0022961
DR   Coriell; GM11226
DR   Wikidata; Q54844934
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11235
AC   CVCL_N168
SY   GM17329
DR   CLO; CLO_0013641
DR   CLO; CLO_0022962
DR   Coriell; GM11235
DR   Coriell; GM17329
DR   Wikidata; Q54844935
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM11238
AC   CVCL_1L62
DR   CLO; CLO_0022963
DR   Coriell; GM11238
DR   Wikidata; Q54844936
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.5395-12A>G (IVS32-12A>G); Zygosity=Homozygous (Coriell=GM11238).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM11239
AC   CVCL_H553
DR   CLO; CLO_0022964
DR   Coriell; GM11239
DR   Wikidata; Q54844937
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1:16)(1pter->1q24::16q21->16qter;16pter->16q21::1q24->1qter) (Coriell=GM11239).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM11250
AC   CVCL_1S23
SY   LS-6
DR   CLO; CLO_0022965
DR   Coriell; GM11250
DR   Wikidata; Q54844938
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 15 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM11251
AC   CVCL_2U03
DR   CLO; CLO_0022966
DR   Coriell; GM11251
DR   Wikidata; Q54844939
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(7;17)(7pter->7p10::17p13.3->17pter;17qter->17p13.3::7q10->7qter) (Coriell=GM11251).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11258
AC   CVCL_1L66
DR   CLO; CLO_0025960
DR   Coriell; GM11258
DR   Wikidata; Q54844943
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.5497-2A>C (IVS38-2A>C) (c.5496_5556del61); ClinVar=VCV000449345; Zygosity=Unspecified; Note=Splice acceptor mutation (Coriell=GM11258).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM11264
AC   CVCL_1L68
DR   CLO; CLO_0025972
DR   Coriell; GM11264
DR   Wikidata; Q54844946
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1839Ter (c.5515C>T); ClinVar=VCV000189177; Zygosity=Heterozygous (Coriell=GM11264).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser1905Ilefs*26 (c.5712dupA) (5712insA); ClinVar=VCV000141416; Zygosity=Heterozygous (Coriell=GM11264).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM11269
AC   CVCL_4F12
DR   CLO; CLO_0025966
DR   Coriell; GM11269
DR   Wikidata; Q54844949
RX   PubMed=11738860;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM11270
AC   CVCL_F181
DR   CLO; CLO_0025963
DR   Coriell; GM11270
DR   Wikidata; Q54844950
RX   PubMed=11738860;
RX   PubMed=12418965;
RX   PubMed=21074045;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Heterozygous (PubMed=11738860).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM11271
AC   CVCL_4F13
DR   CLO; CLO_0025962
DR   Coriell; GM11271
DR   Wikidata; Q54844951
RX   PubMed=11738860;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM11272
AC   CVCL_4F14
DR   CLO; CLO_0025981
DR   Coriell; GM11272
DR   GEO; GSM525406
DR   GEO; GSM525407
DR   GEO; GSM525408
DR   Wikidata; Q54844952
RX   PubMed=11738860;
RX   PubMed=12418965;
RX   PubMed=21074045;
RX   PubMed=21840716;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Argfs*8 (c.1157_1188del32) (p.Leu398Argfs*8, c.1193_1224del32) (1155del32); ClinVar=VCV000143366; Zygosity=Unspecified (PubMed=12418965).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   GM11273
AC   CVCL_4F15
DR   CLO; CLO_0025982
DR   Coriell; GM11273
DR   Wikidata; Q54844953
RX   PubMed=11738860;
RX   PubMed=12418965;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg106Trp (c.316C>T) (p.Arg118Trp, c.352C>T); ClinVar=VCV000011814; Zygosity=Unspecified (PubMed=11738860; PubMed=12418965).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM11274
AC   CVCL_V219
DR   CLO; CLO_0025979
DR   Coriell; GM11274
DR   Wikidata; Q54844954
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM11274).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Coriell=GM11274).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM11275
AC   CVCL_V220
DR   CLO; CLO_0025980
DR   Coriell; GM11275
DR   Wikidata; Q54844955
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Thr1220Lysfs*8 (c.3659delC); ClinVar=VCV000007124; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM11277
AC   CVCL_V221
DR   CLO; CLO_0025983
DR   Coriell; GM11277
DR   Wikidata; Q54844956
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM11278
AC   CVCL_V222
DR   CLO; CLO_0025984
DR   Coriell; GM11278
DR   Wikidata; Q54844957
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln493Ter (c.1477C>T); ClinVar=VCV000007107; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM11279
AC   CVCL_V223
DR   CLO; CLO_0025985
DR   Coriell; GM11279
DR   Wikidata; Q54844958
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM11279).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   GM11280
AC   CVCL_V224
DR   CLO; CLO_0025986
DR   Coriell; GM11280
DR   Wikidata; Q54844959
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.489+1G>T (621+1G>T); ClinVar=VCV000038799; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM11280).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.579+1G>T (711+1G>T); ClinVar=VCV000038494; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM11280).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM11281
AC   CVCL_V225
DR   CLO; CLO_0025987
DR   Coriell; GM11281
DR   Wikidata; Q54844961
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.489+1G>T (621+1G>T); ClinVar=VCV000038799; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM11281).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM11281).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM11282
AC   CVCL_V226
DR   CLO; CLO_0025988
DR   Coriell; GM11282
DR   Wikidata; Q54844962
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly85Glu (c.254G>A); ClinVar=VCV000007143; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM11283
AC   CVCL_V227
DR   CLO; CLO_0025989
DR   Coriell; GM11283
DR   Wikidata; Q54844963
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ala455Glu (c.1364C>A); ClinVar=VCV000007111; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM11284
AC   CVCL_V228
SY   GM11284A
DR   CLO; CLO_0025991
DR   Coriell; GM11284
DR   Wikidata; Q54844964
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg560Thr (c.1679G>C); ClinVar=VCV000007113; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM11285
AC   CVCL_V229
DR   CLO; CLO_0025990
DR   Coriell; GM11285
DR   Wikidata; Q54844965
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Tyr1092Ter (c.3276C>A); ClinVar=VCV000007211; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM11286
AC   CVCL_V230
DR   CLO; CLO_0025993
DR   Coriell; GM11286
DR   Wikidata; Q54844966
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM11286).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Coriell=GM11286).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM11287
AC   CVCL_V231
DR   CLO; CLO_0025992
DR   Coriell; GM11287
DR   Wikidata; Q54844967
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Pro574His (c.1721C>A); ClinVar=VCV000007119; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM11288
AC   CVCL_V232
DR   CLO; CLO_0026004
DR   Coriell; GM11288
DR   Wikidata; Q54844968
RX   CelloPub=CLPUB00447;
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly178Arg (c.532G>A); ClinVar=VCV000048692; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM11290
AC   CVCL_V233
DR   CLO; CLO_0026005
DR   Coriell; GM11290
DR   Wikidata; Q54844969
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.489+1G>T (621+1G>T); ClinVar=VCV000038799; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM11290).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ala455Glu (c.1364C>A); ClinVar=VCV000007111; Zygosity=Heterozygous (Coriell=GM11290).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   GM11291
AC   CVCL_1B72
DR   CLO; CLO_0026002
DR   Coriell; GM11291
DR   Wikidata; Q54844970
RX   CelloPub=CLPUB00447;
CC   Population: Puerto Rican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61274; Fucosidosis
DI   ORDO; Orphanet_349; Fucosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM11292
AC   CVCL_AM55
DR   CLO; CLO_0026003
DR   Coriell; GM11292
DR   Wikidata; Q54844971
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Thr373Lys (c.1118C>A); ClinVar=VCV000003774; Zygosity=Heterozygous (Coriell=GM11292).
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Asn382Lys (c.1146C>A); ClinVar=VCV000003786; Zygosity=Heterozygous (Coriell=GM11292).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11293
AC   CVCL_AM56
DR   CLO; CLO_0026006
DR   Coriell; GM11293
DR   Wikidata; Q54844972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84543; Albinism
DI   ORDO; Orphanet_55; Oculocutaneous albinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM11294
AC   CVCL_AM57
DR   CLO; CLO_0026008
DR   Coriell; GM11294
DR   Wikidata; Q54844973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84543; Albinism
DI   ORDO; Orphanet_55; Oculocutaneous albinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM11296
AC   CVCL_AM58
DR   CLO; CLO_0026007
DR   Coriell; GM11296
DR   Wikidata; Q54844980
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Pro81Leu (c.242C>T); ClinVar=VCV000003772; Zygosity=Heterozygous (Coriell=GM11296).
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Arg217Trp (c.649C>T); ClinVar=VCV000003795; Zygosity=Heterozygous (Coriell=GM11296).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11297
AC   CVCL_AM59
DR   CLO; CLO_0026012
DR   Coriell; GM11297
DR   Wikidata; Q54844981
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Asp383Asn (c.1147G>A); ClinVar=VCV000003775; Zygosity=Heterozygous (Coriell=GM11297).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM11298
AC   CVCL_4F16
DR   CLO; CLO_0026011
DR   Coriell; GM11298
DR   Wikidata; Q54844982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11299
AC   CVCL_4F17
DR   CLO; CLO_0026010
DR   Coriell; GM11299
DR   Wikidata; Q54844983
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg106Trp (c.316C>T) (p.Arg118Trp, c.352C>T); ClinVar=VCV000011814; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM11300
AC   CVCL_4F18
DR   CLO; CLO_0026009
DR   Coriell; GM11300
DR   Wikidata; Q54844984
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg106Trp (c.316C>T) (p.Arg118Trp, c.352C>T); ClinVar=VCV000011814; Zygosity=Unspecified (Coriell=GM11300).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM11301
AC   CVCL_4F19
DR   CLO; CLO_0026024
DR   Coriell; GM11301
DR   Wikidata; Q54844985
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Unspecified (Coriell=GM11301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM11302
AC   CVCL_4F20
DR   CLO; CLO_0026025
DR   Coriell; GM11302
DR   Wikidata; Q54844986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11303
AC   CVCL_4F21
DR   CLO; CLO_0026026
DR   Coriell; GM11303
DR   Wikidata; Q54844987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM11303; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM11304
AC   CVCL_4F22
DR   CLO; CLO_0026027
DR   Coriell; GM11304
DR   Wikidata; Q54844988
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Heterozygous (Coriell=GM11304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM11305
AC   CVCL_4F23
DR   CLO; CLO_0026032
DR   Coriell; GM11305
DR   Wikidata; Q54844989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11306
AC   CVCL_4F24
DR   CLO; CLO_0026034
DR   Coriell; GM11306
DR   Wikidata; Q54844990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11307
AC   CVCL_4F25
DR   CLO; CLO_0026033
DR   Coriell; GM11307
DR   Wikidata; Q54844991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM11307; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11308
AC   CVCL_4F26
DR   CLO; CLO_0026029
DR   Coriell; GM11308
DR   Wikidata; Q54844993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM11308; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11310
AC   CVCL_4F27
DR   CLO; CLO_0026028
DR   Coriell; GM11310
DR   Wikidata; Q54844994
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg168Ter (c.502C>T) (p.Arg180Ter, c.538C>T); ClinVar=VCV000011828; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM11311
AC   CVCL_4F28
DR   CLO; CLO_0026031
DR   Coriell; GM11311
DR   Wikidata; Q54844995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11312
AC   CVCL_4F29
DR   CLO; CLO_0026030
DR   Coriell; GM11312
DR   Wikidata; Q54844996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11313
AC   CVCL_4F30
DR   CLO; CLO_0026046
DR   Coriell; GM11313
DR   Wikidata; Q54844997
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Unexplicit; Ex3-4del; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM11314
AC   CVCL_4F31
DR   CLO; CLO_0026047
DR   Coriell; GM11314
DR   Wikidata; Q54844998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11315
AC   CVCL_4F32
DR   CLO; CLO_0026044
DR   Coriell; GM11315
DR   Wikidata; Q54844999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11316
AC   CVCL_U882
DR   CLO; CLO_0026056
DR   Coriell; GM11316
DR   Wikidata; Q54845000
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Homozygous (Coriell=GM11316).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U883 ! GM11317
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM11317
AC   CVCL_U883
DR   CLO; CLO_0026055
DR   Coriell; GM11317
DR   Wikidata; Q54845001
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Homozygous (Coriell=GM11317).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U882 ! GM11316
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM11318
AC   CVCL_N169
SY   GM17330
DR   CLO; CLO_0013612
DR   CLO; CLO_0026054
DR   Coriell; GM11318
DR   Coriell; GM17330
DR   Wikidata; Q54845002
CC   Part of: Human variation panel.
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM11319
AC   CVCL_4F62
DR   CLO; CLO_0026053
DR   Coriell; GM11319
DR   Wikidata; Q54845003
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Ala56Pro (c.166G>C); ClinVar=VCV002733905; Zygosity=Homozygous (Coriell=GM11319).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 15
//
ID   GM11320
AC   CVCL_4F63
DR   CLO; CLO_0026052
DR   Coriell; GM11320
DR   Wikidata; Q54845004
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Ala56Pro (c.166G>C); ClinVar=VCV002733905; Zygosity=Heterozygous (from familial inference of GM11319).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 14
//
ID   GM11321
AC   CVCL_N170
SY   GM11321A; GM17016; CH1
DR   CLO; CLO_0018010
DR   CLO; CLO_0026051
DR   Coriell; GM11321
DR   Coriell; GM17016
DR   Wikidata; Q54845005
RX   CelloPub=CLPUB00447;
RX   PubMed=11416159;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 13,16
ST   D21S11: 30,32.2
ST   D8S1179: 10
ST   FGA: 21,23
ST   TH01: 6
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 15
//
ID   GM11322
AC   CVCL_N171
SY   GM17017; CH5
DR   CLO; CLO_0018012
DR   CLO; CLO_0026050
DR   Coriell; GM11322
DR   Coriell; GM17017
DR   Wikidata; Q54845006
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM11323
AC   CVCL_N172
SY   GM17018; CH28
DR   CLO; CLO_0018014
DR   CLO; CLO_0026049
DR   Coriell; GM11323
DR   Coriell; GM17018
DR   Wikidata; Q54845007
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   GM11324
AC   CVCL_N173
SY   GM17019; CH30
DR   CLO; CLO_0014699
DR   CLO; CLO_0026067
DR   Coriell; GM11324
DR   Coriell; GM17019
DR   Wikidata; Q54845008
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese.
CC   HLA typing: A*02:01:01,11:01:01; B*15:02:01,15:11:01; C*03:03:01,08:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,03:01:01; DQA1*03:02,06:01:01; DQB1*03:01:01,03:03:02; DRB1*09:01:02,12:02:01; DRB3*03:01:03; DRB4*01:03:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM11325
AC   CVCL_N174
SY   GM17020; CH37
DR   CLO; CLO_0014696
DR   CLO; CLO_0026066
DR   Coriell; GM11325
DR   Coriell; GM17020
DR   Wikidata; Q54845009
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese.
CC   HLA typing: A*11:01:01,11:01:01; B*38:02:01,38:02:01; C*07:02:01,07:02:01; DPA1*02:02:02,02:10; DPB1*02:02:01,02:02:01; DQA1*01:03:01,06:01:01; DQB1*03:01:01,06:01:01; DRB1*08:03:02,12:02:01; DRB3*03:01:03 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM11327
AC   CVCL_2U04
DR   CLO; CLO_0026057
DR   Coriell; GM11327
DR   Wikidata; Q54845010
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM11328
AC   CVCL_GY28
DR   CLO; CLO_0026060
DR   Coriell; GM11328
DR   Wikidata; Q54845011
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129071; Fetal akinesia deformation sequence
DI   ORDO; Orphanet_994; Fetal akinesia deformation sequence
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM11329
AC   CVCL_2U05
DR   CLO; CLO_0026061
DR   Coriell; GM11329
DR   Wikidata; Q54845012
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM11330
AC   CVCL_AJ45
DR   CLO; CLO_0026058
DR   Coriell; GM11330
DR   Wikidata; Q54845014
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11331
AC   CVCL_AJ46
DR   CLO; CLO_0026059
DR   Coriell; GM11331
DR   Wikidata; Q54845015
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11332
AC   CVCL_AJ47
SY   GM11332A
DR   CLO; CLO_0026064
DR   Coriell; GM11332
DR   Wikidata; Q54845016
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11333
AC   CVCL_AJ48
DR   CLO; CLO_0026065
DR   Coriell; GM11333
DR   Wikidata; Q54845017
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11335
AC   CVCL_9R30
DR   CLO; CLO_0026062
DR   Coriell; GM11335
DR   Wikidata; Q54845018
RX   CelloPub=CLPUB00447;
RX   PubMed=12851857;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Arg98Trp (c.292C>T); ClinVar=VCV000002152; Zygosity=Homozygous (PubMed=12851857).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155761; Peroxisome biogenesis disorder 7B
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM11337
AC   CVCL_W638
DR   CLO; CLO_0026063
DR   Coriell; GM11337
DR   Wikidata; Q54845019
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XYY (Coriell=GM11337).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM11338
AC   CVCL_4E06
DR   CLO; CLO_0026078
DR   Coriell; GM11338
DR   Wikidata; Q54845020
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX dic,r(21) [36]; 45,XX,-21 [10]; 46,XX,r(21) [4] (Coriell=GM11338).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C186278; Ring chromosome 21 syndrome
DI   ORDO; Orphanet_1445; Ring chromosome 21 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM11345
AC   CVCL_AM60
DR   CLO; CLO_0026068
DR   Coriell; GM11345
DR   Wikidata; Q54845021
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Pro81Leu (c.242C>T); ClinVar=VCV000003772; Zygosity=Heterozygous (Coriell=GM11345).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM11346
AC   CVCL_2U06
DR   CLO; CLO_0026069
DR   Coriell; GM11346
DR   Wikidata; Q54845031
CC   Population: Caucasian.
CC   Karyotypic information: 45,XY,der(14)(14qter->14p12::18q11->18qter),-18 (Coriell=GM11346).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM11347
AC   CVCL_9X17
DR   CLO; CLO_0026070
DR   Coriell; GM11347
DR   Wikidata; Q54845032
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11348
AC   CVCL_9X18
DR   CLO; CLO_0026071
DR   Coriell; GM11348
DR   Wikidata; Q54845033
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1W
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11349
AC   CVCL_9X19
DR   CLO; CLO_0026072
DR   Coriell; GM11349
DR   Wikidata; Q54845034
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11351
AC   CVCL_9X20
DR   CLO; CLO_0026073
DR   Coriell; GM11351
DR   Wikidata; Q54845035
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11370
AC   CVCL_0N11
DR   CLO; CLO_0026074
DR   Coriell; GM11370
DR   Wikidata; Q54845037
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile105Serfs*2 (c.313delA) (444delA); ClinVar=VCV000048684; Zygosity=Heterozygous (Coriell=GM11370).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1680-1G>A (IVS11-1G>A) (1812-1G-A); ClinVar=VCV000048681; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM11370).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM11373
AC   CVCL_N175
SY   GM17086; 86-164
DR   CLO; CLO_0014492
DR   CLO; CLO_0026075
DR   Coriell; GM11373
DR   Coriell; GM17086
DR   Wikidata; Q54845038
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Southeast Asian; Khmer Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM11374
AC   CVCL_UW17
SY   86-171
DR   Coriell; GM11374
DR   Wikidata; Q93815030
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Southeast Asian; Khmer Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM11374; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM11375
AC   CVCL_UW18
SY   86-174
DR   Coriell; GM11375
DR   Wikidata; Q93815034
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Southeast Asian; Khmer Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM11375; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM11376
AC   CVCL_N176
SY   GM17087; 86-192
DR   CLO; CLO_0014494
DR   CLO; CLO_0026076
DR   Coriell; GM11376
DR   Coriell; GM17087
DR   Wikidata; Q54845039
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Southeast Asian; Khmer Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM11377
AC   CVCL_N177
SY   GM17088; 86-194
DR   CLO; CLO_0014488
DR   CLO; CLO_0026077
DR   Coriell; GM11377
DR   Coriell; GM17088
DR   Wikidata; Q54845040
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Southeast Asian; Khmer Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM11380
AC   CVCL_H552
DR   CLO; CLO_0026081
DR   Coriell; GM11380
DR   Wikidata; Q54845041
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   GM11381
AC   CVCL_AD69
DR   CLO; CLO_0026079
DR   Coriell; GM11381
DR   Wikidata; Q54845042
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11382
AC   CVCL_5P43
DR   CLO; CLO_0026080
DR   Coriell; GM11382
DR   Wikidata; Q54845043
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11383
AC   CVCL_5P44
DR   CLO; CLO_0026087
DR   Coriell; GM11383
DR   Wikidata; Q54845044
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11385
AC   CVCL_U532
DR   CLO; CLO_0026088
DR   Coriell; GM11385
DR   Wikidata; Q54845045
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM11386
AC   CVCL_5P45
DR   CLO; CLO_0026085
DR   Coriell; GM11386
DR   Wikidata; Q54845046
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11387
AC   CVCL_5P46
DR   CLO; CLO_0026086
DR   Coriell; GM11387
DR   Wikidata; Q54845047
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11388
AC   CVCL_U533
DR   CLO; CLO_0026083
DR   Coriell; GM11388
DR   Wikidata; Q54845048
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM11389
AC   CVCL_5P47
DR   CLO; CLO_0026084
DR   Coriell; GM11389
DR   Wikidata; Q54845049
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11390
AC   CVCL_5P48
DR   CLO; CLO_0026082
DR   Coriell; GM11390
DR   Wikidata; Q54845050
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11391
AC   CVCL_U534
DR   CLO; CLO_0026089
DR   Coriell; GM11391
DR   Wikidata; Q54845051
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM11392
AC   CVCL_5P49
DR   CLO; CLO_0026090
DR   Coriell; GM11392
DR   Wikidata; Q54845052
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11393
AC   CVCL_5P50
DR   CLO; CLO_0026091
DR   Coriell; GM11393
DR   Wikidata; Q54845053
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11397
AC   CVCL_2U07
DR   CLO; CLO_0026095
DR   Coriell; GM11397
DR   Wikidata; Q54845055
CC   Karyotypic information: 46,XX,t(8;10)(8qter->8p11.2::10q24->10qter;10pter->10q24::8p11.2->8pter) (Coriell=GM11397).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM11401
AC   CVCL_AJ49
SY   GM11401A
DR   CLO; CLO_0026096
DR   Coriell; GM11401
DR   Wikidata; Q54845056
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11402
AC   CVCL_AJ50
DR   CLO; CLO_0026097
DR   Coriell; GM11402
DR   Wikidata; Q54845057
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11403
AC   CVCL_5P51
DR   CLO; CLO_0026098
DR   BioSample; SAMN00800621
DR   Coriell; GM11403
DR   Wikidata; Q54845058
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM11403; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11404
AC   CVCL_5P52
DR   CLO; CLO_0026093
DR   BioSample; SAMN00800623
DR   Coriell; GM11404
DR   Wikidata; Q54845060
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11405
AC   CVCL_N178
SY   GM18052
DR   CLO; CLO_0015652
DR   CLO; CLO_0026094
DR   BioSample; SAMN00800625
DR   Coriell; GM11405
DR   Coriell; GM18052
DR   Wikidata; Q54845061
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM11406
AC   CVCL_9R92
DR   CLO; CLO_0020791
DR   Coriell; GM11406
DR   Wikidata; Q54845062
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125599; Weaver syndrome
DI   ORDO; Orphanet_3447; Weaver syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11407
AC   CVCL_9R93
DR   CLO; CLO_0020790
DR   Coriell; GM11407
DR   Wikidata; Q54845063
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125599; Weaver syndrome
DI   ORDO; Orphanet_3447; Weaver syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM11408
AC   CVCL_4F64
DR   CLO; CLO_0020789
DR   Coriell; GM11408
DR   Wikidata; Q54845064
RX   CelloPub=CLPUB00447;
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98647; Very long-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26793; Very long chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11409
AC   CVCL_N179
SY   GM17369
DR   CLO; CLO_0013712
DR   CLO; CLO_0020788
DR   Coriell; GM11409
DR   Coriell; GM17369
DR   Wikidata; Q54845065
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Gly664Arg (c.1990G>A); ClinVar=VCV000013843; Zygosity=Heterozygous (Coriell=GM11409).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   GM11410
AC   CVCL_N180
SY   GM17078
DR   CLO; CLO_0014612
DR   CLO; CLO_0020787
DR   Coriell; GM11410
DR   Coriell; GM17078
DR   Wikidata; Q54845066
RX   CelloPub=CLPUB00447;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   HLA typing: A*30:04:01,68:02:01; B*44:03:02,57:03:01; C*07:01:02,07:06; DPA1*01:03:01,02:01:01; DPB1*01:01:02,18:01; DQA1*01:05:01,02:01:01; DQB1*02:02:01,05:01:01; DRB1*07:01:01,12:01:01G; DRB3*02:02:01; DRB4*01:01:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala1050Glufs*6 (c.3149delC); ClinVar=VCV000183078; Zygosity=Heterozygous (Coriell=GM11410).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM17078).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N181 ! GM11477
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   GM11411
AC   CVCL_GS78
SY   GM 11411
DR   CLO; CLO_0020796
DR   Coriell; GM11411
DR   Wikidata; Q54845067
RX   PubMed=1346349;
RX   PubMed=1680289;
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Homozygous (PubMed=1346349; PubMed=1680289).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM11412
AC   CVCL_DB79
SY   GM 11412
DR   CLO; CLO_0020795
DR   Coriell; GM11412
DR   Wikidata; Q54845068
RX   PubMed=1680289;
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (PubMed=1680289).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM11413
AC   CVCL_DB80
SY   GM 11413
DR   CLO; CLO_0020794
DR   Coriell; GM11413
DR   Wikidata; Q54845070
RX   PubMed=1680289;
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (PubMed=1680289).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM11416
AC   CVCL_V391
DR   CLO; CLO_0020793
DR   Coriell; GM11416
DR   Wikidata; Q54845071
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Homozygous (Coriell=GM11416).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   GM11418
AC   CVCL_1S24
SY   15A
DR   CLO; CLO_0020792
DR   Coriell; GM11418
DR   Wikidata; Q54845072
RX   CelloPub=CLPUB00447;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 15 mapping. Contains a complete copy of chromosome 15.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0214 ! CHO-K1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 9
//
ID   GM11419
AC   CVCL_N182
SY   GM17316
DR   CLO; CLO_0013357
DR   CLO; CLO_0020867
DR   Coriell; GM11419
DR   Coriell; GM17316
DR   Wikidata; Q54845073
RX   CelloPub=CLPUB00447;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Indian (from Guyana).
CC   Karyotypic information: 49,XYYYY (Coriell=GM11419).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N183 ! GM11420
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM11420
AC   CVCL_N183
DR   CLO; CLO_0020868
DR   Coriell; GM11420
DR   Wikidata; Q54845082
RX   CelloPub=CLPUB00447;
CC   Population: Indian (from Guyana).
CC   Karyotypic information: 49,XYYYY (Coriell=GM11420).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N182 ! GM11419
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   GM11423
AC   CVCL_L746
DR   CLO; CLO_0020874
DR   Coriell; GM11423
DR   Wikidata; Q54845083
RX   CelloPub=CLPUB00447;
RX   PubMed=20715179;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (Coriell=GM11423).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   GM11424
AC   CVCL_L747
DR   CLO; CLO_0020876
DR   Coriell; GM11424
DR   Wikidata; Q54845084
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=MZ allele (Coriell=GM11424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   GM11425
AC   CVCL_L748
DR   CLO; CLO_0020871
DR   Coriell; GM11425
DR   Wikidata; Q54845085
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=MZ allele (Coriell=GM11425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   GM11428
AC   CVCL_0Q87
DR   CLO; CLO_0020872
DR   Coriell; GM11428
DR   Wikidata; Q54845086
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q86 ! GM10394
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM11429
AC   CVCL_AJ51
DR   CLO; CLO_0020862
DR   Coriell; GM11429
DR   Wikidata; Q54845087
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11430
AC   CVCL_AJ52
DR   CLO; CLO_0020865
DR   Coriell; GM11430
DR   Wikidata; Q54845088
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11431
AC   CVCL_6E34
SY   C5807 pSVori- transformed clone 1
DR   CLO; CLO_0020859
DR   Coriell; GM11431
DR   Wikidata; Q54845090
RX   CelloPub=CLPUB00447;
RX   PubMed=1850193;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E35 ! GM11432
OI   CVCL_6E36 ! GM11433
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   GM11432
AC   CVCL_6E35
SY   C5807 pSVori- transformed clone 7
DR   CLO; CLO_0020861
DR   Coriell; GM11432
DR   Wikidata; Q54845091
RX   CelloPub=CLPUB00447;
RX   PubMed=1850193;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E34 ! GM11431
OI   CVCL_6E36 ! GM11433
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   GM11433
AC   CVCL_6E36
SY   C5807 pSVori- transformed clone 15
DR   CLO; CLO_0020835
DR   Coriell; GM11433
DR   Wikidata; Q54845092
RX   CelloPub=CLPUB00447;
RX   PubMed=1850193;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E34 ! GM11431
OI   CVCL_6E35 ! GM11432
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   GM11452
AC   CVCL_AJ53
DR   CLO; CLO_0020927
DR   Coriell; GM11452
DR   Wikidata; Q54845093
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11453
AC   CVCL_AJ54
DR   CLO; CLO_0020922
DR   Coriell; GM11453
DR   Wikidata; Q54845094
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11456
AC   CVCL_AJ55
DR   CLO; CLO_0020923
DR   Coriell; GM11456
DR   Wikidata; Q54845095
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11457
AC   CVCL_AJ56
DR   CLO; CLO_0020881
DR   Coriell; GM11457
DR   Wikidata; Q54845096
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11458
AC   CVCL_AJ57
DR   CLO; CLO_0020901
DR   Coriell; GM11458
DR   Wikidata; Q54845097
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11459
AC   CVCL_2U08
DR   CLO; CLO_0020904
DR   Coriell; GM11459
DR   Wikidata; Q54845098
RX   PubMed=10377420;
CC   Karyotypic information: 46,X,t(X;3)(p22.1;q23) (PubMed=10377420).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM11468
AC   CVCL_V392
DR   CLO; CLO_0020905
DR   Coriell; GM11468
DR   Wikidata; Q54845099
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Arg83Cys (c.247C>T); ClinVar=VCV000011998; Zygosity=Heterozygous (PubMed=19815695).
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Heterozygous (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   GM11470
AC   CVCL_1K62
DR   CLO; CLO_0020908
DR   Coriell; GM11470
DR   Wikidata; Q54845100
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Arg83Cys (c.247C>T); ClinVar=VCV000011998; Zygosity=Heterozygous (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM11471
AC   CVCL_1K63
DR   CLO; CLO_0020894
DR   Coriell; GM11471
DR   Wikidata; Q54845101
RX   CelloPub=CLPUB00447;
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Heterozygous (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM11472
AC   CVCL_0N12
DR   CLO; CLO_0020895
DR   Coriell; GM11472
DR   Wikidata; Q54845102
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asn1303Lys (c.3909C>G); ClinVar=VCV000007136; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly1349Asp (c.4046G>A); ClinVar=VCV000035881; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   GM11473
AC   CVCL_V242
DR   CLO; CLO_0020898
DR   Coriell; GM11473
DR   Wikidata; Q54845103
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Portuguese water dog; VBO=VBO_0201077.
DI   NCIt; C129034; Canine GM1-gangliosidosis
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM11474
AC   CVCL_V243
DR   CLO; CLO_0020899
DR   Coriell; GM11474
DR   Wikidata; Q54845104
RX   CelloPub=CLPUB00447;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Portuguese water dog; VBO=VBO_0201077.
DI   NCIt; C129034; Canine GM1-gangliosidosis
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM11475
AC   CVCL_4I70
DR   CLO; CLO_0020890
DR   Coriell; GM11475
DR   Wikidata; Q54845105
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11477
AC   CVCL_N181
DR   CLO; CLO_0020976
DR   Coriell; GM11477
DR   Wikidata; Q54845106
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala1050Glufs*6 (c.3149delC); ClinVar=VCV000183078; Zygosity=Heterozygous (Coriell=GM11477).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (from autologous cell line GM11410).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N180 ! GM11410
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM11479
AC   CVCL_AJ58
SY   GM11479A
DR   CLO; CLO_0020979
DR   Coriell; GM11479
DR   Wikidata; Q54845107
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11480
AC   CVCL_AJ59
DR   CLO; CLO_0020984
DR   Coriell; GM11480
DR   Wikidata; Q54845108
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11491
AC   CVCL_4I71
DR   CLO; CLO_0020983
DR   Coriell; GM11491
DR   Wikidata; Q54845109
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11492
AC   CVCL_4I72
SY   GM11492A
DR   CLO; CLO_0020982
DR   Coriell; GM11492
DR   Wikidata; Q54845110
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11493
AC   CVCL_AJ60
DR   CLO; CLO_0020981
DR   Coriell; GM11493
DR   Wikidata; Q54845111
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11494
AC   CVCL_AJ61
DR   CLO; CLO_0020988
DR   Coriell; GM11494
DR   Wikidata; Q54845112
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11495
AC   CVCL_1V28
DR   CLO; CLO_0020987
DR   Coriell; GM11495
DR   Wikidata; Q54845113
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11496
AC   CVCL_0N13
SY   GM11496B
DR   CLO; CLO_0020986
DR   Coriell; GM11496
DR   GEO; GSM469000
DR   GEO; GSM469001
DR   GEO; GSM469002
DR   GEO; GSM469003
DR   Wikidata; Q54845114
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly542Ter (c.1624G>T); ClinVar=VCV000007115; Zygosity=Homozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 19
//
ID   GM11497
AC   CVCL_0N14
SY   GM11497B
DR   CLO; CLO_0020985
DR   Coriell; GM11497
DR   Wikidata; Q54845115
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly542Ter (c.1624G>T); ClinVar=VCV000007115; Zygosity=Heterozygous (Coriell=GM11497).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM11499
AC   CVCL_2U09
DR   CLO; CLO_0020947
DR   Coriell; GM11499
DR   Wikidata; Q54845116
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM11500
AC   CVCL_4J05
DR   CLO; CLO_0020949
DR   Coriell; GM11500
DR   Wikidata; Q54845117
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11501
AC   CVCL_4I73
DR   CLO; CLO_0020950
DR   Coriell; GM11501
DR   Wikidata; Q54845118
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11502
AC   CVCL_4I74
DR   CLO; CLO_0020953
DR   Coriell; GM11502
DR   Wikidata; Q54845119
RX   CelloPub=CLPUB00447;
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   GM11503
AC   CVCL_AV56
SY   GM11503A
DR   CLO; CLO_0020952
DR   Coriell; GM11503
DR   Wikidata; Q54845120
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English/German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM11504
AC   CVCL_AV58
DR   CLO; CLO_0020955
DR   Coriell; GM11504
DR   Wikidata; Q54845121
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM11505
AC   CVCL_AV61
DR   CLO; CLO_0020954
DR   Coriell; GM11505
DR   Wikidata; Q54845122
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; English.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   GM11510
AC   CVCL_4E07
DR   CLO; CLO_0020959
DR   Coriell; GM11510
DR   Wikidata; Q54845127
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM11511
AC   CVCL_4E08
DR   CLO; CLO_0020957
DR   Coriell; GM11511
DR   Wikidata; Q54845128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11515
AC   CVCL_5P53
DR   CLO; CLO_0020960
DR   Coriell; GM11515
DR   Wikidata; Q54845129
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11516
AC   CVCL_5P54
DR   CLO; CLO_0021030
DR   Coriell; GM11516
DR   Wikidata; Q54845130
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11517
AC   CVCL_5P55
DR   CLO; CLO_0021031
DR   Coriell; GM11517
DR   Wikidata; Q54845132
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11518
AC   CVCL_5P56
DR   CLO; CLO_0021028
DR   Coriell; GM11518
DR   Wikidata; Q54845133
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11520
AC   CVCL_2U10
DR   CLO; CLO_0021029
DR   Coriell; GM11520
DR   Wikidata; Q54845134
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   GM11521
AC   CVCL_N378
SY   JK1331
DR   CLO; CLO_0021040
DR   Coriell; GM11521
DR   Wikidata; Q54845135
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM11522
AC   CVCL_7507
SY   JK1333
DR   CLO; CLO_0021039
DR   Coriell; GM11522
DR   GEO; GSM207768
DR   Wikidata; Q54845136
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM11523
AC   CVCL_N379
SY   JK1337
DR   CLO; CLO_0021038
DR   Coriell; GM11523
DR   GEO; GSM207780
DR   Wikidata; Q54845137
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM11524
AC   CVCL_N380
SY   JK1342
DR   CLO; CLO_0021037
DR   Coriell; GM11524
DR   GEO; GSM207781
DR   Wikidata; Q54845138
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM11525
AC   CVCL_N381
SY   JK1347
DR   CLO; CLO_0021036
DR   Coriell; GM11525
DR   GEO; GSM207782
DR   Wikidata; Q54845139
RX   CelloPub=CLPUB00447;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Druze.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM11525).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   GM11526
AC   CVCL_DE46
SY   GM11526A; A9/1492-37
DR   CLO; CLO_0021033
DR   Coriell; GM11526
DR   Wikidata; Q54845140
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   GM11529
AC   CVCL_Y575
DR   CLO; CLO_0021003
DR   Coriell; GM11529
DR   Wikidata; Q54845141
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM11530
AC   CVCL_Y576
DR   CLO; CLO_0020997
DR   Coriell; GM11530
DR   Wikidata; Q54845142
CC   Population: Hispanic.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GM11532
AC   CVCL_N184
SY   GM18053
DR   CLO; CLO_0015655
DR   CLO; CLO_0020998
DR   Coriell; GM11532
DR   Coriell; GM18053
DR   Wikidata; Q54845143
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM11536
AC   CVCL_EG40
DR   CLO; CLO_0021010
DR   BioSample; SAMN00800705
DR   Coriell; GM11536
DR   Wikidata; Q54845144
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG41 ! GM11537
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM11537
AC   CVCL_EG41
DR   Coriell; GM11537
DR   Wikidata; Q54845145
CC   Population: Jewish.
CC   Discontinued: Coriell; GM11537; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG40 ! GM11536
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM11538
AC   CVCL_EG42
DR   CLO; CLO_0021009
DR   BioSample; SAMN00800707
DR   Coriell; GM11538
DR   Wikidata; Q54845146
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG43 ! GM11539
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM11539
AC   CVCL_EG43
DR   Coriell; GM11539
DR   Wikidata; Q54845147
CC   Population: Jewish.
CC   Discontinued: Coriell; GM11539; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG42 ! GM11538
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM11540
AC   CVCL_EG44
DR   CLO; CLO_0021012
DR   Coriell; GM11540
DR   Wikidata; Q54845148
CC   Population: Jewish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG45 ! GM11541
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM11541
AC   CVCL_EG45
DR   CLO; CLO_0021011
DR   Coriell; GM11541
DR   Wikidata; Q54845149
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EG44 ! GM11540
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM11543
AC   CVCL_1S25
SY   EDA5
DR   CLO; CLO_0021005
DR   Coriell; GM11543
DR   Wikidata; Q54845150
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11553
AC   CVCL_2U11
DR   CLO; CLO_0021054
DR   Coriell; GM11553
DR   Wikidata; Q54845153
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM11554
AC   CVCL_JF46
DR   CLO; CLO_0021053
DR   Coriell; GM11554
DR   Wikidata; Q54845154
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61276; Familial hemophagocytic lymphohistiocytosis
DI   ORDO; Orphanet_540; Familial hemophagocytic lymphohistiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM11566
AC   CVCL_AJ62
DR   CLO; CLO_0021056
DR   Coriell; GM11566
DR   Wikidata; Q54845155
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11567
AC   CVCL_AJ63
DR   CLO; CLO_0021055
DR   Coriell; GM11567
DR   Wikidata; Q54845156
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11568
AC   CVCL_AJ64
DR   CLO; CLO_0021049
DR   Coriell; GM11568
DR   Wikidata; Q54845157
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11569
AC   CVCL_AJ65
DR   CLO; CLO_0021050
DR   Coriell; GM11569
DR   Wikidata; Q54845158
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11570
AC   CVCL_5P58
DR   CLO; CLO_0021051
DR   Coriell; GM11570
DR   Wikidata; Q54845159
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5Q46 ! GM14238
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM11571
AC   CVCL_5P59
DR   CLO; CLO_0021052
DR   Coriell; GM11571
DR   Wikidata; Q54845160
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5Q45 ! GM14234
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11575
AC   CVCL_1S26
SY   X13-C9
DR   CLO; CLO_0021226
DR   Coriell; GM11575
DR   Wikidata; Q54845161
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N30 ! GM09963
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM11576
AC   CVCL_H551
DR   CLO; CLO_0021225
DR   Coriell; GM11576
DR   Wikidata; Q54845162
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:4976; HLCS; Simple; c.1519+5G>A (IVS10+5G>A); ClinVar=VCV000001912; Zygosity=Heterozygous (Coriell=GM11576).
CC   Sequence variation: Mutation; HGNC; HGNC:4976; HLCS; Simple; p.Leu514Pro; Zygosity=Heterozygous (Coriell=GM11576).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C98842; Holocarboxylase synthetase deficiency
DI   ORDO; Orphanet_79242; Holocarboxylase synthetase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM11577
AC   CVCL_AJ66
DR   CLO; CLO_0021224
DR   Coriell; GM11577
DR   Wikidata; Q54845163
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11578
AC   CVCL_AJ67
SY   GM11578C
DR   CLO; CLO_0021223
DR   Coriell; GM11578
DR   Wikidata; Q54845164
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11579
AC   CVCL_AJ68
DR   CLO; CLO_0021220
DR   Coriell; GM11579
DR   Wikidata; Q54845165
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11585
AC   CVCL_AJ69
DR   CLO; CLO_0021216
DR   Coriell; GM11585
DR   Wikidata; Q54845166
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11586
AC   CVCL_AJ70
DR   CLO; CLO_0021222
DR   Coriell; GM11586
DR   Wikidata; Q54845167
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11587
AC   CVCL_N185
SY   GM17056; J2
DR   CLO; CLO_0014664
DR   CLO; CLO_0021221
DR   Coriell; GM11587
DR   Coriell; GM17056
DR   Wikidata; Q54845174
RX   PubMed=11416159;
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 14,19
ST   D21S11: 30,31.2
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   TH01: 6,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 14
//
ID   GM11589
AC   CVCL_N186
SY   GM17057; J5
DR   CLO; CLO_0014660
DR   CLO; CLO_0021205
DR   Coriell; GM11589
DR   Coriell; GM17057
DR   Wikidata; Q54845175
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Japanese.
CC   HLA typing: A*24:20,33:03:01; B*15:11:01,44:03:01; C*03:04:01,14:03; DPA1*02:02:02,02:02:02; DPB1*05:01:01,05:01:01; DQA1*01:02:01,03:02; DQB1*03:03:02,06:02:01; DRB1*09:01:02,15:01:01; DRB4*01:03:02; DRB5*01:01:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Pro34Ser (c.100C>T); ClinVar=VCV000016893; Zygosity=Heterozygous; Note=CYP2D6*10 allele (Coriell=GM17057).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   GM11590
AC   CVCL_N187
SY   GM17058; J7
DR   CLO; CLO_0014659
DR   CLO; CLO_0021202
DR   Coriell; GM11590
DR   Coriell; GM17058
DR   Wikidata; Q54845176
RX   CelloPub=CLPUB00447;
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01,26:01:01; B*13:01:01,40:01:02; C*03:04:01,08:03:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01G,04:02:01G; DQA1*03:03:01,06:01:01; DQB1*03:01:01,04:01:01; DRB1*04:05:01,12:02:01; DRB3*03:01:03; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   GM11592
AC   CVCL_AV98
DR   CLO; CLO_0021201
DR   Coriell; GM11592
DR   Wikidata; Q54845177
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM11597
AC   CVCL_2U12
DR   CLO; CLO_0021204
DR   Coriell; GM11597
DR   Wikidata; Q54845178
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,der(9)(9qter->9p22::6q23->6qter) (Coriell=GM11597).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM11598
AC   CVCL_AJ71
DR   CLO; CLO_0021203
DR   Coriell; GM11598
DR   Wikidata; Q54845179
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11599
AC   CVCL_AJ72
DR   CLO; CLO_0021198
DR   Coriell; GM11599
DR   Wikidata; Q54845180
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11600
AC   CVCL_AJ73
DR   CLO; CLO_0021197
DR   Coriell; GM11600
DR   Wikidata; Q54845181
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11601
AC   CVCL_AA01
DR   CLO; CLO_0021200
DR   Coriell; GM11601
DR   Wikidata; Q54845182
RX   CelloPub=CLPUB00447;
RX   PubMed=1719426;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Alu Ins; ClinVar=VCV000000332; Zygosity=Heterozygous; Note=De novo Alu repeat insertion in intron between exons 5 and 6 that causes mis-splicing (PubMed=1719426).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM11602
AC   CVCL_AA02
DR   CLO; CLO_0021199
DR   Coriell; GM11602
DR   Wikidata; Q54845184
RX   CelloPub=CLPUB00447;
RX   PubMed=8268926;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys1670Asnfs*7 (c.5010delG); Zygosity=Heterozygous (Coriell=GM11602).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM11603
AC   CVCL_1K64
DR   CLO; CLO_0021196
DR   Coriell; GM11603
DR   Wikidata; Q54845185
RX   CelloPub=CLPUB00447;
CC   Population: African American and Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM11604
AC   CVCL_9R94
DR   CLO; CLO_0021185
DR   Coriell; GM11604
DR   Wikidata; Q54845186
RX   CelloPub=CLPUB00447;
RX   PubMed=9054950;
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Gly3Thrfs*24 (c.4_7dupACTG); Zygosity=Homozygous (PubMed=9054950).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM11605
AC   CVCL_JE93
DR   CLO; CLO_0021184
DR   Coriell; GM11605
DR   Wikidata; Q54845187
CC   Sequence variation: Mutation; HGNC; HGNC:7455; MT-ND1; Simple; p.Ala52Thr (m.3460G>A); ClinVar=VCV000009722; Zygosity=Unspecified (Coriell=GM11605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   GM11610
AC   CVCL_AJ74
DR   CLO; CLO_0021183
DR   Coriell; GM11610
DR   Wikidata; Q54845188
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11611
AC   CVCL_AJ75
SY   GM11611A
DR   CLO; CLO_0021182
DR   Coriell; GM11611
DR   Wikidata; Q54845189
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11616
AC   CVCL_AJ76
SY   GM11616A
DR   CLO; CLO_0021177
DR   Coriell; GM11616
DR   Wikidata; Q54845194
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11617
AC   CVCL_AJ77
SY   GM11617A
DR   CLO; CLO_0021176
DR   Coriell; GM11617
DR   Wikidata; Q54845195
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (PubMed=8945471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM11619
AC   CVCL_DE47
SY   1HL33
DR   CLO; CLO_0021353
DR   Coriell; GM11619
DR   Wikidata; Q54845196
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N51 ! irs1
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM11623
AC   CVCL_DE48
SY   20xP0435-2; 20XP0435-2
DR   CLO; CLO_0021349
DR   Coriell; GM11623
DR   Wikidata; Q54845197
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM11626
AC   CVCL_AJ78
DR   CLO; CLO_0021350
DR   Coriell; GM11626
DR   Wikidata; Q54845198
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11627
AC   CVCL_AJ79
DR   CLO; CLO_0021358
DR   Coriell; GM11627
DR   Wikidata; Q54845199
RX   CelloPub=CLPUB00447;
RX   PubMed=8945471;
CC   Part of: R-W pedigree MODY cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 30-01-24; Version: 9
//
ID   GM11629
AC   CVCL_AB11
DR   CLO; CLO_0021360
DR   Coriell; GM11629
DR   Wikidata; Q54845200
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Met918Thr (c.2753T>C); ClinVar=VCV000013919; Zygosity=Unspecified (Coriell=GM11629).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3227; Multiple endocrine neoplasia type 2B
DI   ORDO; Orphanet_247709; Multiple endocrine neoplasia type 2B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM11630
AC   CVCL_AB12
DR   CLO; CLO_0021354
DR   Coriell; GM11630
DR   Wikidata; Q54845201
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Asp70Profs*51 (c.196_200dupAGCCC) (c.206_207insGCCCC) (317ins5); ClinVar=VCV000403814; Zygosity=Unspecified (Coriell=GM11630).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM11631
AC   CVCL_AE08
DR   CLO; CLO_0021357
DR   BioSample; SAMN00800753
DR   Coriell; GM11631
DR   Wikidata; Q54845202
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM11631; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM11632
AC   CVCL_DS23
DR   CLO; CLO_0021365
DR   Coriell; GM11632
DR   Wikidata; Q54845203
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98934; Harlequin ichthyosis
DI   ORDO; Orphanet_457; Harlequin ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS24 ! GM11633
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM11633
AC   CVCL_DS24
DR   CLO; CLO_0021368
DR   Coriell; GM11633
DR   Wikidata; Q54845204
CC   Population: Caucasian.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98934; Harlequin ichthyosis
DI   ORDO; Orphanet_457; Harlequin ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS23 ! GM11632
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM11634
AC   CVCL_V031
SY   GM11634A
DR   CLO; CLO_0021362
DR   Coriell; GM11634
DR   Wikidata; Q54845205
RX   CelloPub=CLPUB00447;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM11657
AC   CVCL_4F65
DR   Coriell; GM11657
DR   Wikidata; Q54845212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11660
AC   CVCL_UR73
DR   Coriell; GM11660
DR   Wikidata; Q93816696
RX   CelloPub=CLPUB00447;
CC   Discontinued: Coriell; GM11660; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   GM11661
AC   CVCL_0H81
DR   CLO; CLO_0021330
DR   Coriell; GM11661
DR   Wikidata; Q54845213
RX   CelloPub=CLPUB00447;
RX   PubMed=24642446;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM11661).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Heterozygous (Coriell=GM11661).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM11672
AC   CVCL_5P60
DR   CLO; CLO_0021332
DR   Coriell; GM11672
DR   Wikidata; Q54845214
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11675
AC   CVCL_4E09
DR   CLO; CLO_0021335
DR   Coriell; GM11675
DR   Wikidata; Q54845215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11677
AC   CVCL_DD86
DR   CLO; CLO_0021336
DR   Coriell; GM11677
DR   Wikidata; Q54845223
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22FW
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM11678
AC   CVCL_2U13
DR   CLO; CLO_0021285
DR   Coriell; GM11678
DR   Wikidata; Q54845224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11679
AC   CVCL_1S27
SY   DUA1CsAzF
DR   CLO; CLO_0021302
DR   Coriell; GM11679
DR   Wikidata; Q54845225
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM11685
AC   CVCL_1S28
SY   NF13-CL.D3; NF13/D3
DR   CLO; CLO_0021304
DR   Coriell; GM11685
DR   Wikidata; Q54845226
RX   PubMed=8661140;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11686
AC   CVCL_1S29
SY   HA(2)A
DR   CLO; CLO_0021298
DR   Coriell; GM11686
DR   Wikidata; Q54845227
RX   CelloPub=CLPUB00447;
RX   PubMed=1438292;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains a neo-tagged human chromosome 2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   GM11687
AC   CVCL_1S30
SY   HA(4)A
DR   CLO; CLO_0021301
DR   Coriell; GM11687
DR   Wikidata; Q54845228
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains a neo-tagged human chromosome 4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   GM11688
AC   CVCL_1S31
SY   HA(10)A
DR   CLO; CLO_0021295
DR   Coriell; GM11688
DR   Wikidata; Q54845229
RX   CelloPub=CLPUB00447;
RX   PubMed=8104691;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains a neo-tagged human chromosome 10.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   GM11689
AC   CVCL_1S32
SY   HA(13)A
DR   CLO; CLO_0021297
DR   Coriell; GM11689
DR   Wikidata; Q54845230
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Contains a neo-tagged human chromosome 13.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   GM11691
AC   CVCL_1S33
SY   1HL35-8; 1HL35 subclone 8
DR   CLO; CLO_0021290
DR   Coriell; GM11691
DR   Wikidata; Q54845231
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N51 ! irs1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11692
AC   CVCL_1S34
SY   1SHL3-14; 1SHL3 subclone 14
DR   CLO; CLO_0021293
DR   Coriell; GM11692
DR   Wikidata; Q54845232
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N51 ! irs1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11705
AC   CVCL_DD87
DR   CLO; CLO_0021308
DR   Coriell; GM11705
DR   Wikidata; Q54845233
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM11706
AC   CVCL_1K65
DR   CLO; CLO_0021259
DR   Coriell; GM11706
DR   Wikidata; Q54845234
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM11707
AC   CVCL_1Y49
DR   CLO; CLO_0021257
DR   Coriell; GM11707
DR   Wikidata; Q54845235
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11708
AC   CVCL_BW25
DR   CLO; CLO_0021270
DR   Coriell; GM11708
DR   Wikidata; Q54845236
CC   Population: Ecuadorian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7582; Nevus of Ito
DI   ORDO; Orphanet_263432; Nevus of Ito
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW26 ! GM11709
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM11709
AC   CVCL_BW26
DR   CLO; CLO_0021272
DR   Coriell; GM11709
DR   Wikidata; Q54845237
CC   Population: Ecuadorian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C7582; Nevus of Ito
DI   ORDO; Orphanet_263432; Nevus of Ito
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW25 ! GM11708
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM11723
AC   CVCL_0N15
SY   GM11723C
DR   CLO; CLO_0021265
DR   Coriell; GM11723
DR   Wikidata; Q54845238
RX   CelloPub=CLPUB00447;
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM11749
AC   CVCL_1S35
SY   H3-4
DR   CLO; CLO_0021268
DR   Coriell; GM11749
DR   Wikidata; Q54845239
RX   PubMed=2286371;
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N56 ! Urd-C
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM11750
AC   CVCL_1S36
SY   R1-1
DR   CLO; CLO_0021433
DR   Coriell; GM11750
DR   Wikidata; Q54845240
RX   PubMed=2286371;
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM11751
AC   CVCL_1S37
SY   UCH12
DR   CLO; CLO_0021430
DR   Coriell; GM11751
DR   Wikidata; Q54845241
RX   PubMed=2286371;
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N56 ! Urd-C
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM11752
AC   CVCL_1S38
SY   3;21/Q131-91A; 3;21/UC2-1
DR   CLO; CLO_0021431
DR   Coriell; GM11752
DR   Wikidata; Q54845242
RX   PubMed=2286371;
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N58 ! CHO Q131-91A
HI   CVCL_1N57 ! GM09528
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 10
//
ID   GM11753
AC   CVCL_1S39
SY   3;7/UC2E-1; 3;7/UC2-1
DR   CLO; CLO_0021453
DR   Coriell; GM11753
DR   Wikidata; Q54845244
RX   PubMed=2286371;
RX   PubMed=7713507;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N56 ! Urd-C
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11754
AC   CVCL_1S40
SY   R227-3A
DR   CLO; CLO_0021452
DR   Coriell; GM11754
DR   Wikidata; Q54845245
RX   PubMed=2286371;
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R86 ! GM10253
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM11759
AC   CVCL_1K66
DR   Coriell; GM11759
DR   Wikidata; Q54845246
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM11759).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Ser627Phe (c.1880C>T); ClinVar=VCV000597382; Zygosity=Heterozygous (Coriell=GM11759).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM11761
AC   CVCL_0N16
DR   CLO; CLO_0021451
DR   Coriell; GM11761
DR   Wikidata; Q54845247
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (Coriell=GM11761).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg553Ter (c.1657C>T); ClinVar=VCV000007122; Zygosity=Heterozygous (Coriell=GM11761).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM11762
AC   CVCL_0M07
DR   CLO; CLO_0021450
DR   Coriell; GM11762
DR   Wikidata; Q54845248
RX   CelloPub=CLPUB00447;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM11763
AC   CVCL_1Y31
DR   CLO; CLO_0021457
DR   Coriell; GM11763
DR   Wikidata; Q54845249
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM11763).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Arg333Trp (c.997C>T); ClinVar=VCV000003610; Zygosity=Heterozygous (Coriell=GM11763).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 17
//
ID   GM11764
AC   CVCL_1Y32
DR   CLO; CLO_0021456
DR   Coriell; GM11764
DR   Wikidata; Q54845250
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM11764).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM11766
AC   CVCL_1S41
SY   GS89a
DR   CLO; CLO_0021454
DR   Coriell; GM11766
DR   Wikidata; Q54845251
RX   PubMed=8314575;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N64 ! GM07941
HI   CVCL_4595 ! UV135
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11767
AC   CVCL_1S42
SY   PKII90-P5b
DR   CLO; CLO_0021400
DR   Coriell; GM11767
DR   Wikidata; Q54845252
RX   PubMed=8314575;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V283 ! GM07890
HI   CVCL_4595 ! UV135
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11771
AC   CVCL_2U14
DR   CLO; CLO_0021401
DR   Coriell; GM11771
DR   Wikidata; Q54845253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11772
AC   CVCL_UG88
DR   Coriell; GM11772
DR   Wikidata; Q93817007
RX   CelloPub=CLPUB00447;
WW   Info; -; -; https://www.coha.org/biopiracy-the-new-tyrant-of-the-developing-world/
WW   Info; The Scientist; -; https://www.the-scientist.com/bad-blood-1-39751
CC   Population: Native South American; Huaorani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Part of a set of 5 cell lines that were established from blood samples of members of the Huaorani (Waorani) indigenous people. These samples were allegedly taken without the Ecuadorian government's permission during the early 1990s.
CC   Discontinued: Coriell; GM11772; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   GM11773
AC   CVCL_UH04
DR   Coriell; GM11773
DR   Wikidata; Q93817010
RX   CelloPub=CLPUB00447;
WW   Info; -; -; https://www.coha.org/biopiracy-the-new-tyrant-of-the-developing-world/
WW   Info; The Scientist; -; https://www.the-scientist.com/bad-blood-1-39751
CC   Population: Native South American; Huaorani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Part of a set of 5 cell lines that were established from blood samples of members of the Huaorani (Waorani) indigenous people. These samples were allegedly taken without the Ecuadorian government's permission during the early 1990s.
CC   Discontinued: Coriell; GM11773; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   GM11774
AC   CVCL_UH14
DR   Coriell; GM11774
DR   Wikidata; Q93817014
RX   CelloPub=CLPUB00447;
WW   Info; -; -; https://www.coha.org/biopiracy-the-new-tyrant-of-the-developing-world/
WW   Info; The Scientist; -; https://www.the-scientist.com/bad-blood-1-39751
CC   Population: Native South American; Huaorani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Part of a set of 5 cell lines that were established from blood samples of members of the Huaorani (Waorani) indigenous people. These samples were allegedly taken without the Ecuadorian government's permission during the early 1990s.
CC   Discontinued: Coriell; GM11774; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   GM11776
AC   CVCL_HJ74
SY   GM 11776
DR   CLO; CLO_0021402
DR   Coriell; GM11776
DR   Wikidata; Q54845254
RX   CelloPub=CLPUB00447;
WW   Info; -; -; https://www.coha.org/biopiracy-the-new-tyrant-of-the-developing-world/
WW   Info; The Scientist; -; https://www.the-scientist.com/bad-blood-1-39751
CC   Population: Native South American; Huaorani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Part of a set of 5 cell lines that were established from blood samples of members of the Huaorani (Waorani) indigenous people. These samples were allegedly taken without the Ecuadorian government's permission during the early 1990s.
CC   Discontinued: Coriell; GM11776; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   GM11777
AC   CVCL_UH19
DR   Coriell; GM11777
DR   Wikidata; Q93817028
RX   CelloPub=CLPUB00447;
WW   Info; -; -; https://www.coha.org/biopiracy-the-new-tyrant-of-the-developing-world/
WW   Info; The Scientist; -; https://www.the-scientist.com/bad-blood-1-39751
CC   Population: Native South American; Huaorani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Part of a set of 5 cell lines that were established from blood samples of members of the Huaorani (Waorani) indigenous people. These samples were allegedly taken without the Ecuadorian government's permission during the early 1990s.
CC   Discontinued: Coriell; GM11777; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   GM11778
AC   CVCL_0P69
DR   CLO; CLO_0021405
DR   Coriell; GM11778
DR   Wikidata; Q54845255
RX   CelloPub=CLPUB00447;
CC   Population: Arab; Saudi Arabian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   GM11779
AC   CVCL_HM36
SY   XVIII-23H-a
DR   CLO; CLO_0021421
DR   Coriell; GM11779
DR   Wikidata; Q54845256
RX   PubMed=6510024;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HM62 ! V79/380-6
CA   Hybrid cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 3
//
ID   GM11781
AC   CVCL_GZ42
DR   CLO; CLO_0021420
DR   Coriell; GM11781
DR   Wikidata; Q54845257
RX   CelloPub=CLPUB00447;
RX   PubMed=27896104;
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Simple; c.293-13A/C>G (IVS2-13A/C>G); Zygosity=Homozygous; Note=Aberrant splice site activation (PubMed=27896104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM11811
AC   CVCL_N188
SY   GM17050; GM17339
DR   CLO; CLO_0013605
DR   CLO; CLO_0014645
DR   CLO; CLO_0021423
DR   Coriell; GM11811
DR   Coriell; GM17050
DR   Coriell; GM17339
DR   Wikidata; Q54845258
CC   Part of: Human variation panel.
CC   Population: Arab; Saudi Arabian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   GM11813
AC   CVCL_GS79
DR   CLO; CLO_0021422
DR   Coriell; GM11813
DR   Wikidata; Q54845259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129031; Spondyloepimetaphyseal dysplasia, sponastrime type
DI   ORDO; Orphanet_93357; SPONASTRIME dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM11814
AC   CVCL_N189
SY   GM17005
DR   CLO; CLO_0018058
DR   CLO; CLO_0021427
DR   Coriell; GM11814
DR   Coriell; GM17005
DR   Wikidata; Q54845260
CC   Part of: Human variation panel.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM11816
AC   CVCL_DD88
DR   CLO; CLO_0021425
DR   Coriell; GM11816
DR   Wikidata; Q54845261
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM11818
AC   CVCL_5B93
AS   CVCL_G374
SY   CEPH-1331-NA11818; 1331-2426
DR   CLO; CLO_0021383
DR   Coriell; GM11818
DR   dbMHC; 48550
DR   IHW; IHW01001
DR   IPD-IMGT/HLA; 25802
DR   Wikidata; Q54845262
RX   PubMed=11416159;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133116.
CC   HLA typing: A*02:01,24:02; B*13:02,07:02:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*02:01,03:01; DQB1*02:01,03:02; DRB1*04:04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 10,17
ST   D21S11: 30,31
ST   D8S1179: 13,14
ST   FGA: 19
ST   TH01: 6,9.3
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11819
AC   CVCL_5B94
AS   CVCL_G375
SY   CEPH-1331-NA11819; 1331-2427
DR   CLO; CLO_0021381
DR   Coriell; GM11819
DR   dbMHC; 48551
DR   IHW; IHW01002
DR   IPD-IMGT/HLA; 25803
DR   Wikidata; Q54845263
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133117.
CC   HLA typing: A*24:02,31:01; B*40:01,07:02:01; C*03:04:01:01,07:02; DPA1*01:03,01:03; DPB1*04:02,06:01; DQA1*03:01,03:01; DQB1*03:02,03:02; DRB1*04:04,04:04; DRB4*01 (IPD-IMGT/HLA=25803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM11820
AC   CVCL_5B95
AS   CVCL_G407
SY   CEPH-1333-NA11820; 1333-4881
DR   CLO; CLO_0021382
DR   Coriell; GM11820
DR   dbMHC; 48581
DR   GEO; GSM25466
DR   GEO; GSM316186
DR   GEO; GSM316187
DR   GEO; GSM316188
DR   GEO; GSM420645
DR   IHW; IHW01035
DR   IPD-IMGT/HLA; 25835
DR   Wikidata; Q54845268
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133315.
CC   HLA typing: A*03:01,03:01:01:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*04:01,16:01; DQA1*01:01,04:01; DQB1*04:02,05:03; DRB1*08:01,14:01; DRB3*02:02,03:01 (IPD-IMGT/HLA=25835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11821
AC   CVCL_5B96
DR   CLO; CLO_0021379
DR   Coriell; GM11821
DR   GEO; GSM25467
DR   GEO; GSM30022
DR   GEO; GSM420646
DR   Wikidata; Q54845269
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134013.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11822
AC   CVCL_5B97
DR   CLO; CLO_0021380
DR   Coriell; GM11822
DR   GEO; GSM30055
DR   GEO; GSM420647
DR   Wikidata; Q54845270
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135003.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11824
AC   CVCL_5B98
DR   CLO; CLO_0021398
DR   Coriell; GM11824
DR   GEO; GSM30056
DR   GEO; GSM420648
DR   Wikidata; Q54845271
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135005.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11825
AC   CVCL_5B99
DR   CLO; CLO_0021397
DR   Coriell; GM11825
DR   GEO; GSM420649
DR   Wikidata; Q54845272
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135006.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11826
AC   CVCL_5C00
DR   CLO; CLO_0021396
DR   Coriell; GM11826
DR   GEO; GSM30057
DR   GEO; GSM420650
DR   Wikidata; Q54845273
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135007.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11827
AC   CVCL_5C01
DR   CLO; CLO_0021395
DR   Coriell; GM11827
DR   GEO; GSM30058
DR   GEO; GSM420651
DR   Wikidata; Q54845274
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135008.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11828
AC   CVCL_5C02
DR   CLO; CLO_0021394
DR   Coriell; GM11828
DR   GEO; GSM30059
DR   GEO; GSM420652
DR   Wikidata; Q54845276
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135009.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11829
AC   CVCL_7508
DR   CLO; CLO_0020090
DR   EFO; EFO_0001117
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11829
DR   GEO; GSM30060
DR   GEO; GSM112510
DR   GEO; GSM112790
DR   GEO; GSM188788
DR   GEO; GSM273291
DR   GEO; GSM291622
DR   GEO; GSM314860
DR   GEO; GSM420653
DR   GEO; GSM424329
DR   GEO; GSM486755
DR   GEO; GSM486756
DR   GEO; GSM648841
DR   GEO; GSM659956
DR   GEO; GSM660159
DR   GEO; GSM660366
DR   GEO; GSM905848
DR   GEO; GSM905943
DR   GEO; GSM906038
DR   GEO; GSM957365
DR   GEO; GSM1719753
DR   IGSR; NA11829
DR   Wikidata; Q54845277
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135010.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Homozygous; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM11829).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   GM11830
AC   CVCL_9596
DR   CLO; CLO_0020088
DR   EFO; EFO_0001118
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11830
DR   GEO; GSM30061
DR   GEO; GSM112511
DR   GEO; GSM112791
DR   GEO; GSM188789
DR   GEO; GSM273292
DR   GEO; GSM291623
DR   GEO; GSM314861
DR   GEO; GSM420654
DR   GEO; GSM424330
DR   GEO; GSM486757
DR   GEO; GSM486758
DR   GEO; GSM648862
DR   GEO; GSM659946
DR   GEO; GSM660151
DR   GEO; GSM660374
DR   GEO; GSM905849
DR   GEO; GSM905944
DR   GEO; GSM906039
DR   GEO; GSM957366
DR   GEO; GSM1719754
DR   IGSR; NA11830
DR   Wikidata; Q54845278
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135011.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM11831
AC   CVCL_9597
DR   CLO; CLO_0020089
DR   EFO; EFO_0001119
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11831
DR   GEO; GSM30062
DR   GEO; GSM112512
DR   GEO; GSM112792
DR   GEO; GSM188790
DR   GEO; GSM273293
DR   GEO; GSM291624
DR   GEO; GSM314862
DR   GEO; GSM420655
DR   GEO; GSM424331
DR   GEO; GSM486759
DR   GEO; GSM486760
DR   GEO; GSM648879
DR   GEO; GSM659824
DR   GEO; GSM659963
DR   GEO; GSM660150
DR   GEO; GSM905850
DR   GEO; GSM905945
DR   GEO; GSM906040
DR   GEO; GSM957367
DR   GEO; GSM1719755
DR   IGSR; NA11831
DR   Wikidata; Q54845279
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21321133;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135012.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   GM11832
AC   CVCL_9598
DR   CLO; CLO_0020086
DR   EFO; EFO_0001120
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11832
DR   GEO; GSM30063
DR   GEO; GSM112513
DR   GEO; GSM112818
DR   GEO; GSM188791
DR   GEO; GSM273294
DR   GEO; GSM291625
DR   GEO; GSM314863
DR   GEO; GSM420656
DR   GEO; GSM424332
DR   GEO; GSM486761
DR   GEO; GSM486762
DR   GEO; GSM648848
DR   GEO; GSM659945
DR   GEO; GSM660166
DR   GEO; GSM660358
DR   GEO; GSM905851
DR   GEO; GSM905946
DR   GEO; GSM906041
DR   GEO; GSM957368
DR   GEO; GSM1719756
DR   IGSR; NA11832
DR   Wikidata; Q54845281
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
RX   PubMed=31401124;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135013.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   GM11833
AC   CVCL_5C03
AS   CVCL_G480
SY   CEPH-1349-NA11833; 1349-8393
DR   CLO; CLO_0020087
DR   Coriell; GM11833
DR   dbMHC; 48642
DR   GEO; GSM30044
DR   GEO; GSM420657
DR   GEO; GSM659906
DR   GEO; GSM660117
DR   GEO; GSM660324
DR   IHW; IHW01111
DR   IPD-IMGT/HLA; 25908
DR   Wikidata; Q54845282
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134903.
CC   HLA typing: A*02:01,02:01; B*15:01,44:02:01:01; C*03:04:01,05:01; DPA1*01:03,01:03; DPB1*04:01,04:01; DQA1*03:01,03:01; DQB1*03:01,03:01; DRB1*04:01,04:01 (IPD-IMGT/HLA=25908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11834
AC   CVCL_5C04
AS   CVCL_G489
SY   CEPH-1349-NA11834; 1349-8464
DR   CLO; CLO_0020084
DR   Coriell; GM11834
DR   dbMHC; 48643
DR   GEO; GSM30046
DR   GEO; GSM420658
DR   GEO; GSM659904
DR   GEO; GSM660115
DR   GEO; GSM660322
DR   IHW; IHW01120
DR   IPD-IMGT/HLA; 25917
DR   Wikidata; Q54845283
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134905.
CC   HLA typing: A*01:01,02:01; B*27:03,57:01; C*02:02:02,06:02; DPA1*01:03,01:03; DPB1*04:01,20:01; DQA1*02:01,03:01; DQB1*03:02,03:03; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25917).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11835
AC   CVCL_5C05
AS   CVCL_G482
SY   CEPH-1349-NA11835; 1349-8395
DR   CLO; CLO_0020085
DR   Coriell; GM11835
DR   dbMHC; 48644
DR   GEO; GSM30048
DR   GEO; GSM420659
DR   GEO; GSM659903
DR   GEO; GSM660113
DR   GEO; GSM660320
DR   IHW; IHW01113
DR   IPD-IMGT/HLA; 25910
DR   Wikidata; Q54845284
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134907.
CC   HLA typing: A*01:01,02:01; B*44:02:01:01,57:01; C*05:01,06:02; DPA1*01:03,01:03; DPB1*04:01,20:01; DQA1*02:01,03:01; DQB1*03:01,03:03; DRB1*04:01,07:01; DRB4*01 (IPD-IMGT/HLA=25910).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11836
AC   CVCL_5C06
AS   CVCL_G484
SY   CEPH-1349-NA11836; 1349-8397
DR   CLO; CLO_0020082
DR   Coriell; GM11836
DR   dbMHC; 48645
DR   GEO; GSM30049
DR   GEO; GSM420660
DR   GEO; GSM659902
DR   GEO; GSM660112
DR   GEO; GSM660319
DR   IHW; IHW01115
DR   IPD-IMGT/HLA; 25912
DR   Wikidata; Q54845285
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134908.
CC   HLA typing: A*01:01,02:01; B*27:03,57:01; C*02:02:02,06:02; DPA1*01:03,01:03; DPB1*04:01,20:01; DQA1*02:01,03:01; DQB1*03:02,03:03; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25912).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11837
AC   CVCL_5C07
AS   CVCL_G483
SY   CEPH-1349-NA11837; 1349-8396
DR   CLO; CLO_0020083
DR   Coriell; GM11837
DR   dbMHC; 48646
DR   GEO; GSM30050
DR   GEO; GSM420661
DR   GEO; GSM659901
DR   GEO; GSM660111
DR   GEO; GSM660318
DR   IHW; IHW01114
DR   IPD-IMGT/HLA; 25911
DR   Wikidata; Q54845286
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134909.
CC   HLA typing: A*01:01,02:01; B*27:03,57:01; C*02:02:02,06:02; DPA1*01:03,01:03; DPB1*04:01,20:01; DQA1*02:01,03:01; DQB1*03:02,03:03; DRB1*04:04,07:01 (IPD-IMGT/HLA=25911).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11838
AC   CVCL_5C08
AS   CVCL_G490
SY   CEPH-1349-NA11838; 1349-8635
DR   CLO; CLO_0020081
DR   Coriell; GM11838
DR   dbMHC; 48647
DR   GEO; GSM30051
DR   GEO; GSM420662
DR   GEO; GSM659907
DR   GEO; GSM660118
DR   GEO; GSM660325
DR   IHW; IHW01121
DR   IPD-IMGT/HLA; 25918
DR   Wikidata; Q54845287
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134910.
CC   HLA typing: A*01:01,02:01; B*27:03,57:01; C*02:02:02,06:02; DPA1*01:03,01:03; DPB1*04:01,20:01; DQA1*02:01,03:01; DQB1*03:02,03:03; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25918).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11839
AC   CVCL_7509
AS   CVCL_G488
SY   CEPH-1349-NA11839; 1349-8411
DR   CLO; CLO_0020020
DR   EFO; EFO_0001121
DR   Coriell; GM11839
DR   dbMHC; 48648
DR   GEO; GSM112514
DR   GEO; GSM112819
DR   GEO; GSM188792
DR   GEO; GSM273295
DR   GEO; GSM291626
DR   GEO; GSM314864
DR   GEO; GSM420663
DR   GEO; GSM424333
DR   GEO; GSM486763
DR   GEO; GSM486764
DR   GEO; GSM648922
DR   GEO; GSM659825
DR   GEO; GSM659984
DR   GEO; GSM660180
DR   GEO; GSM905852
DR   GEO; GSM905947
DR   GEO; GSM906042
DR   GEO; GSM957369
DR   IGSR; NA11839
DR   IHW; IHW01119
DR   IPD-IMGT/HLA; 25916
DR   Wikidata; Q54845288
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134913.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,25:01; B*44:02:01:01,07:02; C*05:01,07:02; DPA1*01:03,01:03; DPB1*04:01,04:01; DQA1*01:02,03:01; DQB1*03:01,06:02; DRB1*04:01,15:01; DRB4*01; DRB5*01:01 (IPD-IMGT/HLA=25916).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM11839).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   GM11840
AC   CVCL_7510
AS   CVCL_G487
SY   CEPH-1349-NA11840; 1349-8401
DR   CLO; CLO_0020019
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11840
DR   dbMHC; 48649
DR   GEO; GSM30053
DR   GEO; GSM112515
DR   GEO; GSM112820
DR   GEO; GSM188793
DR   GEO; GSM273296
DR   GEO; GSM291627
DR   GEO; GSM291628
DR   GEO; GSM314865
DR   GEO; GSM420664
DR   GEO; GSM486765
DR   GEO; GSM486766
DR   GEO; GSM648859
DR   GEO; GSM659972
DR   GEO; GSM660190
DR   GEO; GSM660383
DR   GEO; GSM905853
DR   GEO; GSM905948
DR   GEO; GSM906043
DR   GEO; GSM1719757
DR   IGSR; NA11840
DR   IHW; IHW01118
DR   IPD-IMGT/HLA; 25915
DR   Wikidata; Q54845289
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134914.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,02:01; B*27:03,57:01; C*02:02:02,06:02; DPA1*01:03,01:03; DPB1*04:01,04:01; DQA1*02:01,03:01; DQB1*03:02,03:03; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25915).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   GM11841
AC   CVCL_5C09
AS   CVCL_G491
SY   CEPH-1349-NA11841; 1349-8636
DR   CLO; CLO_0020022
DR   Coriell; GM11841
DR   dbMHC; 48650
DR   GEO; GSM30045
DR   GEO; GSM420665
DR   GEO; GSM659905
DR   GEO; GSM660116
DR   GEO; GSM660323
DR   IHW; IHW01122
DR   IPD-IMGT/HLA; 25919
DR   Wikidata; Q54845290
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134904.
CC   HLA typing: A*02:01,02:01; B*15:01,44:02:01:01; C*03:04:01,05:01; DPA1*01:03,01:03; DPB1*04:01,04:01; DQA1*03:01,03:01; DQB1*03:01,03:01; DRB1*04:01,04:01 (IPD-IMGT/HLA=25919).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11842
AC   CVCL_5C10
AS   CVCL_G481
SY   CEPH-1349-NA11842; 1349-8394
DR   CLO; CLO_0020021
DR   Coriell; GM11842
DR   dbMHC; 48651
DR   GEO; GSM30047
DR   GEO; GSM420666
DR   GEO; GSM659822
DR   GEO; GSM660114
DR   GEO; GSM660321
DR   IHW; IHW01112
DR   IPD-IMGT/HLA; 25909
DR   Wikidata; Q54845291
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134906.
CC   HLA typing: A*02:01,02:01; B*15:01,44:02:01:01; C*03:04:01,05:01; DPA1*01:03,01:03; DPB1*04:01,20:01; DQA1*02:01,03:01; DQB1*03:01,03:03; DRB1*04:01,07:01 (IPD-IMGT/HLA=25909).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11843
AC   CVCL_R618
AS   CVCL_G479
SY   CEPH-1349-NA11843; 1349-8390
DR   CLO; CLO_0020024
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11843
DR   dbMHC; 48652
DR   GEO; GSM30052
DR   GEO; GSM648886
DR   GEO; GSM906119
DR   GEO; GSM906120
DR   GEO; GSM1719758
DR   IGSR; NA11843
DR   IHW; IHW01109
DR   IPD-IMGT/HLA; 25907
DR   Wikidata; Q54845292
RX   PubMed=15514893;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134911.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,11:01; B*15:01,51:01; C*03:04:01,15:02; DPA1*01:03,01:03; DPB1*03:01,04:01; DQA1*03:01,03:01; DQB1*03:01,03:02; DRB1*04:01,04:04; DRB4*01 (IPD-IMGT/HLA=25907).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM11849
AC   CVCL_1K67
DR   CLO; CLO_0020023
DR   Coriell; GM11849
DR   Wikidata; Q54845293
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM11850
AC   CVCL_DS25
DR   CLO; CLO_0020026
DR   Coriell; GM11850
DR   Wikidata; Q54845294
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM11851
AC   CVCL_8B12
DR   CLO; CLO_0020025
DR   Coriell; GM11851
DR   Wikidata; Q54845295
RX   PubMed=28659158;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28659158
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D21S11: 28,29
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM11852
AC   CVCL_T823
DR   CLO; CLO_0020028
DR   Coriell; GM11852
DR   Wikidata; Q54845296
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM11852).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T824 ! GM11853
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   GM11853
AC   CVCL_T824
DR   CLO; CLO_0020027
DR   Coriell; GM11853
DR   Wikidata; Q54845297
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM11853).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T823 ! GM11852
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   GM11854
AC   CVCL_7511
SY   GM 11854; GM17237
DR   CLO; CLO_0014330
DR   CLO; CLO_0019999
DR   Coriell; GM11854
DR   Coriell; GM17237
DR   GEO; GSM569564
DR   GEO; GSM596301
DR   GEO; GSM596661
DR   GEO; GSM924839
DR   Wikidata; Q54845298
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*26:01:01,30:02:01; B*35:01:01,44:02:01; C*04:01:01,16:04:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:01,05:05:01; DQB1*03:01:01,06:09:01; DRB1*11:04:01,13:02:01; DRB3*02:02:01,03:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM11858
AC   CVCL_BT24
DR   CLO; CLO_0020003
DR   Coriell; GM11858
DR   Wikidata; Q54845299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM11859
AC   CVCL_0N17
DR   CLO; CLO_0020002
DR   Coriell; GM11859
DR   Wikidata; Q54845300
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.2657+5G>A; ClinVar=VCV000038497; Zygosity=Homozygous; Note=Splicing defect (Coriell=GM11859).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM11860
AC   CVCL_N190
SY   GM17029
DR   CLO; CLO_0014681
DR   CLO; CLO_0020001
DR   Coriell; GM11860
DR   Coriell; GM17029
DR   Wikidata; Q54845301
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Part of: Human variation panel.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.3718-2477C>T (3849+10KB,C>T); ClinVar=VCV000007166; Zygosity=Homozygous (Coriell=GM11860).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM17029).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM11870
AC   CVCL_5C11
AS   CVCL_G466
SY   CEPH-1347-NA11870; 1347-8412
DR   CLO; CLO_0020000
DR   Coriell; GM11870
DR   dbMHC; 48626
DR   GEO; GSM25468
DR   GEO; GSM420667
DR   GEO; GSM617125
DR   GEO; GSM659913
DR   GEO; GSM660124
DR   GEO; GSM660330
DR   IHW; IHW01096
DR   IPD-IMGT/HLA; 25894
DR   Wikidata; Q54845302
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134703.
CC   HLA typing: A*01:01,68:01:02; B*15:01,44:04; C*06:02:01:01,16:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*03:01,05:01; DQB1*03:01,03:02; DRB1*04:01,11:01; DRB3*02; DRB4*01 (IPD-IMGT/HLA=25894).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM11871
AC   CVCL_5C12
AS   CVCL_G471
SY   CEPH-1347-NA11871; 1347-8436
DR   CLO; CLO_0020007
DR   Coriell; GM11871
DR   dbMHC; 48627
DR   GEO; GSM25469
DR   GEO; GSM420668
DR   GEO; GSM659912
DR   GEO; GSM660123
DR   GEO; GSM660329
DR   IHW; IHW01101
DR   IPD-IMGT/HLA; 25899
DR   Wikidata; Q54845303
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134704.
CC   HLA typing: A*03:01,25:01; B*07:02,08:01; C*07:01,07:02; DPA1*01:03,02:01:02; DPB1*01:01:01,04:02; DQA1*01:02,05:01; DQB1*02:01,06:02; DRB1*03:01,15:01; DRB3*01 (IPD-IMGT/HLA=25899).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11872
AC   CVCL_5C13
AS   CVCL_G472
SY   CEPH-1347-NA11872; 1347-8437
DR   CLO; CLO_0020006
DR   Coriell; GM11872
DR   dbMHC; 48628
DR   GEO; GSM25470
DR   GEO; GSM420669
DR   GEO; GSM659823
DR   GEO; GSM659911
DR   GEO; GSM660122
DR   IHW; IHW01102
DR   IPD-IMGT/HLA; 25900
DR   Wikidata; Q54845304
RX   PubMed=17668376;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134705.
CC   HLA typing: A*03:01,68:01:02; B*07:02,44:04; C*07:02,16:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:02,05:01; DQB1*03:01,06:02; DRB1*11:01,15:01; DRB3*02; DRB5*01 (IPD-IMGT/HLA=25900).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11873
AC   CVCL_5C14
AS   CVCL_G475
SY   CEPH-1347-NA11873; 1347-8442
DR   CLO; CLO_0020005
DR   Coriell; GM11873
DR   dbMHC; 48629
DR   GEO; GSM659910
DR   GEO; GSM660121
DR   GEO; GSM660328
DR   IHW; IHW01105
DR   IPD-IMGT/HLA; 25903
DR   Wikidata; Q54845305
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134706.
CC   HLA typing: A*01:01,68:01:02; B*15:01,44:04; C*06:02:01:01,16:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*03:01,05:01; DQB1*03:01,03:02; DRB1*04:01,11:01; DRB3*02; DRB4*01 (IPD-IMGT/HLA=25903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM11874
AC   CVCL_G470
SY   CEPH-1347-NA11874; 1347-8435
DR   Coriell; GM11874
DR   dbMHC; 48630
DR   IHW; IHW01100
DR   IPD-IMGT/HLA; 25898
DR   Wikidata; Q54845306
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134707.
CC   HLA typing: A*03:01,68:01:02; B*07:02,44:04; C*07:02,16:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:02,05:01; DQB1*03:01,06:02; DRB1*11:01,15:01; DRB3*02; DRB5*01 (IPD-IMGT/HLA=25898).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM11874; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   GM11875
AC   CVCL_5C15
AS   CVCL_G474
SY   CEPH-1347-NA11875; 1347-8441
DR   CLO; CLO_0020004
DR   Coriell; GM11875
DR   dbMHC; 48631
DR   GEO; GSM25471
DR   GEO; GSM420670
DR   GEO; GSM617126
DR   GEO; GSM659909
DR   GEO; GSM660120
DR   GEO; GSM660327
DR   IHW; IHW01104
DR   IPD-IMGT/HLA; 25902
DR   Wikidata; Q54845307
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134708.
CC   HLA typing: A*03:01,25:01; B*07:02,08:01; C*07:01,07:02; DPA1*01:03,02:01:02; DPB1*01:01:01,04:02; DQA1*01:02,05:01; DQB1*02:01,06:02; DRB1*03:01,15:01; DRB3*01; DRB5*01 (IPD-IMGT/HLA=25902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM11876
AC   CVCL_5C16
AS   CVCL_G477
SY   CEPH-1347-NA11876; 1347-8444
DR   CLO; CLO_0020008
DR   Coriell; GM11876
DR   dbMHC; 48632
DR   GEO; GSM25472
DR   GEO; GSM420671
DR   GEO; GSM659908
DR   GEO; GSM660119
DR   GEO; GSM660326
DR   IHW; IHW01107
DR   IPD-IMGT/HLA; 25905
DR   Wikidata; Q54845308
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134709.
CC   HLA typing: A*03:01,68:01:02; B*07:02,44:04; C*07:02,16:01; DPA1*01:03,01:03; DPB1*04:01,04:02; DQA1*01:02,05:01; DQB1*03:01,06:02; DRB1*11:01,15:01; DRB3*02; DRB5*01 (IPD-IMGT/HLA=25905).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11877
AC   CVCL_5C17
AS   CVCL_G476
SY   CEPH-1347-NA11877; 1347-8443
DR   CLO; CLO_0020044
DR   Coriell; GM11877
DR   dbMHC; 48633
DR   GEO; GSM25473
DR   GEO; GSM420672
DR   IHW; IHW01106
DR   IPD-IMGT/HLA; 25904
DR   Wikidata; Q54845309
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134710.
CC   HLA typing: A*03:01,68:01:02; B*07:02,44:04; C*07:02,16:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:02,05:01; DQB1*03:01,06:02; DRB1*11:01,15:01; DRB3*02; DRB5*01 (IPD-IMGT/HLA=25904).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11878
AC   CVCL_5C18
AS   CVCL_G469
SY   CEPH-1347-NA11878; 1347-8434
DR   CLO; CLO_0020043
DR   Coriell; GM11878
DR   dbMHC; 48634
DR   GEO; GSM25474
DR   GEO; GSM420673
DR   GEO; GSM659914
DR   GEO; GSM660125
DR   GEO; GSM660331
DR   IHW; IHW01099
DR   IPD-IMGT/HLA; 25897
DR   Wikidata; Q54845317
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134711.
CC   HLA typing: A*01:01,25:01; B*08:01,15:01; C*06:02:01:01,07:01; DPA1*01:03,02:01:02; DPB1*01:01:01,04:02; DQA1*03:01,05:01; DQB1*02:01,03:02; DRB1*03:01,04:01; DRB3*01; DRB4*01 (IPD-IMGT/HLA=25897).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11879
AC   CVCL_5C19
AS   CVCL_G468
SY   CEPH-1347-NA11879; 1347-8414
DR   CLO; CLO_0020040
DR   Coriell; GM11879
DR   dbMHC; 48635
DR   GEO; GSM25475
DR   GEO; GSM25476
DR   GEO; GSM314866
DR   GEO; GSM314867
DR   GEO; GSM420674
DR   GEO; GSM420675
DR   GEO; GSM906121
DR   GEO; GSM906122
DR   IHW; IHW01098
DR   IPD-IMGT/HLA; 25896
DR   Wikidata; Q54845318
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134712.
CC   HLA typing: A*01:01,68:01:02; B*44:04,08:01; C*16:01,07:01; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*05:01,05:01; DQB1*02:01,03:01; DRB1*03:01,11:01; DRB3*01,02 (IPD-IMGT/HLA=25896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11880
AC   CVCL_5C20
AS   CVCL_G467
SY   CEPH-1347-NA11880; 1347-8413
DR   CLO; CLO_0020039
DR   Coriell; GM11880
DR   dbMHC; 48636
DR   GEO; GSM25477
DR   GEO; GSM25478
DR   GEO; GSM314868
DR   GEO; GSM314869
DR   GEO; GSM420676
DR   GEO; GSM420677
DR   GEO; GSM906123
DR   GEO; GSM906124
DR   IHW; IHW01097
DR   IPD-IMGT/HLA; 25895
DR   Wikidata; Q54845319
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134713.
CC   HLA typing: A*02:01,25:01; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,02:01:02; DPB1*01:01:01,02:01; DQA1*01:03,05:01; DQB1*02:01,06:03; DRB1*03:01,13:01; DRB3*01,01 (IPD-IMGT/HLA=25895).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11881
AC   CVCL_9599
AS   CVCL_G464
SY   CEPH-1347-NA11881; 1347-8368
DR   CLO; CLO_0020042
DR   EFO; EFO_0001122
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11881
DR   dbMHC; 48637
DR   GEO; GSM25479
DR   GEO; GSM25480
DR   GEO; GSM112516
DR   GEO; GSM112821
DR   GEO; GSM188794
DR   GEO; GSM273297
DR   GEO; GSM273298
DR   GEO; GSM291629
DR   GEO; GSM314870
DR   GEO; GSM314871
DR   GEO; GSM420678
DR   GEO; GSM420679
DR   GEO; GSM424334
DR   GEO; GSM486767
DR   GEO; GSM486768
DR   GEO; GSM648876
DR   GEO; GSM659988
DR   GEO; GSM660184
DR   GEO; GSM660399
DR   GEO; GSM905854
DR   GEO; GSM905949
DR   GEO; GSM906044
DR   GEO; GSM957370
DR   GEO; GSM1719759
DR   IGSR; NA11881
DR   IHW; IHW01094
DR   IPD-IMGT/HLA; 25892
DR   Wikidata; Q54845320
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134714.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*03:01,26:01; B*07:02,07:02; C*07:02,07:02; DPA1*01:03,01:03; DPB1*02:01,04:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,15:01; DRB5*01 (IPD-IMGT/HLA=25892).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   GM11882
AC   CVCL_7512
AS   CVCL_G465
SY   CEPH-1347-NA11882; 1347-8369
DR   CLO; CLO_0020041
DR   EFO; EFO_0001123
DR   Coriell; GM11882
DR   dbMHC; 48638
DR   GEO; GSM25481
DR   GEO; GSM25482
DR   GEO; GSM112517
DR   GEO; GSM112822
DR   GEO; GSM188795
DR   GEO; GSM273299
DR   GEO; GSM273300
DR   GEO; GSM291630
DR   GEO; GSM314872
DR   GEO; GSM314873
DR   GEO; GSM420680
DR   GEO; GSM420681
DR   GEO; GSM424335
DR   GEO; GSM486769
DR   GEO; GSM486770
DR   GEO; GSM648892
DR   GEO; GSM659976
DR   GEO; GSM660193
DR   GEO; GSM660387
DR   GEO; GSM905855
DR   GEO; GSM905950
DR   GEO; GSM906045
DR   GEO; GSM957371
DR   IGSR; NA11882
DR   IHW; IHW01095
DR   IPD-IMGT/HLA; 25893
DR   Wikidata; Q54845322
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134715.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,29:02; B*15:01,44:03; C*06:02:01:01,16:01; DPA1*01:03,01:03; DPB1*03:01,04:02; DQA1*01:02,03:01; DQB1*03:02,06:02; DRB1*04:01,15:01; DRB4*01; DRB5*01 (IPD-IMGT/HLA=25893).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   GM11883
AC   CVCL_7513
AS   CVCL_G463
SY   CEPH-1347-NA11883; 1347-4843
DR   CLO; CLO_0020046
DR   Coriell; GM11883
DR   dbMHC; 48639
DR   GEO; GSM25483
DR   GEO; GSM420682
DR   IHW; IHW01093
DR   IPD-IMGT/HLA; 25891
DR   Wikidata; Q54845323
RX   PubMed=20856902;
RX   PubMed=30844424;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134716.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,68:01:02; B*15:01,44:04; C*06:02:01:01,16:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*03:01,05:01; DQB1*03:01,03:02; DRB1*04:01,11:01; DRB3*02; DRB4*01 (IPD-IMGT/HLA=25891).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   GM11884
AC   CVCL_5C21
DR   CLO; CLO_0020045
DR   Coriell; GM11884
DR   GEO; GSM30108
DR   Wikidata; Q54845324
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137703.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM11885
AC   CVCL_5C22
DR   CLO; CLO_0020048
DR   Coriell; GM11885
DR   GEO; GSM30109
DR   Wikidata; Q54845326
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137704.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM11886
AC   CVCL_5C23
DR   CLO; CLO_0020047
DR   Coriell; GM11886
DR   GEO; GSM30110
DR   Wikidata; Q54845327
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137705.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM11887
AC   CVCL_5C24
DR   CLO; CLO_0020035
DR   Coriell; GM11887
DR   Wikidata; Q54845328
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137706.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM11889
AC   CVCL_5C25
DR   CLO; CLO_0020034
DR   Coriell; GM11889
DR   GEO; GSM30111
DR   Wikidata; Q54845329
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137708.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM11891
AC   CVCL_R619
DR   CLO; CLO_0020033
DR   Coriell; GM11891
DR   GEO; GSM30112
DR   GEO; GSM906125
DR   GEO; GSM906126
DR   IGSR; NA11891
DR   Wikidata; Q54845330
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137710.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM11892
AC   CVCL_R620
DR   CLO; CLO_0020032
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM11892
DR   GEO; GSM30113
DR   GEO; GSM648940
DR   GEO; GSM906127
DR   GEO; GSM906128
DR   GEO; GSM1719760
DR   IGSR; NA11892
DR   Wikidata; Q54845331
RX   PubMed=15514893;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137711.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM11893
AC   CVCL_R621
DR   CLO; CLO_0020031
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11893
DR   GEO; GSM30114
DR   GEO; GSM648978
DR   GEO; GSM906129
DR   GEO; GSM906130
DR   GEO; GSM1719761
DR   IGSR; NA11893
DR   Wikidata; Q54845332
RX   PubMed=15514893;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137712.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM11894
AC   CVCL_R622
DR   CLO; CLO_0020030
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11894
DR   GEO; GSM30115
DR   GEO; GSM648887
DR   GEO; GSM1719762
DR   IGSR; NA11894
DR   Wikidata; Q54845333
RX   PubMed=15514893;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137713.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM11895
AC   CVCL_5C26
DR   CLO; CLO_0020029
DR   Coriell; GM11895
DR   Wikidata; Q54845334
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137714.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM11898
AC   CVCL_N191
SY   GM18054
DR   CLO; CLO_0015657
DR   CLO; CLO_0020038
DR   Coriell; GM11898
DR   Coriell; GM18054
DR   Wikidata; Q54845335
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM11899
AC   CVCL_GR15
DR   CLO; CLO_0020037
DR   BioSample; SAMN00800919
DR   Coriell; GM11899
DR   Wikidata; Q54845336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM11902
AC   CVCL_JX72
DR   CLO; CLO_0020036
DR   Coriell; GM11902
DR   Wikidata; Q54845337
RX   PubMed=25187577;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Lys1447Cysfs*18 (c.4337dupG); Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C135088; Spondyloperipheral dysplasia
DI   ORDO; Orphanet_1856; Spondyloperipheral dysplasia-short ulna syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M2W
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   GM11906
AC   CVCL_IN29
DR   CLO; CLO_0020183
DR   Coriell; GM11906
DR   Wikidata; Q54845338
CC   Sequence variation: Mutation; HGNC; HGNC:7489; MT-TK; Simple; m.8344A>G; ClinVar=VCV000009579; Zygosity=Unspecified (Coriell=GM11906).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84889; Myoclonic epilepsy associated with ragged-red fibers
DI   ORDO; Orphanet_551; MERRF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM11907
AC   CVCL_IN30
DR   CLO; CLO_0020184
DR   Coriell; GM11907
DR   Wikidata; Q54845339
CC   Sequence variation: Mutation; HGNC; HGNC:7489; MT-TK; Simple; m.8344A>G; ClinVar=VCV000009579; Zygosity=Unspecified (Coriell=GM11907).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84889; Myoclonic epilepsy associated with ragged-red fibers
DI   ORDO; Orphanet_551; MERRF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM11908
AC   CVCL_1S43
SY   R148-3
DR   CLO; CLO_0020181
DR   Coriell; GM11908
DR   Wikidata; Q54845341
RX   PubMed=2286371;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R86 ! GM10253
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM11909
AC   CVCL_5C27
DR   CLO; CLO_0020182
DR   Coriell; GM11909
DR   GEO; GSM25484
DR   GEO; GSM316561
DR   GEO; GSM316562
DR   GEO; GSM316563
DR   GEO; GSM420683
DR   Wikidata; Q54845342
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142303.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11910
AC   CVCL_5C28
DR   CLO; CLO_0020187
DR   Coriell; GM11910
DR   GEO; GSM25485
DR   GEO; GSM316300
DR   GEO; GSM316301
DR   GEO; GSM316302
DR   GEO; GSM420684
DR   Wikidata; Q54845343
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142304.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11911
AC   CVCL_5C29
DR   CLO; CLO_0020188
DR   Coriell; GM11911
DR   GEO; GSM25486
DR   GEO; GSM316303
DR   GEO; GSM316304
DR   GEO; GSM316305
DR   GEO; GSM420685
DR   Wikidata; Q54845344
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142305.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11912
AC   CVCL_5C30
DR   CLO; CLO_0020185
DR   Coriell; GM11912
DR   GEO; GSM25487
DR   GEO; GSM316564
DR   GEO; GSM316565
DR   GEO; GSM316566
DR   GEO; GSM420686
DR   Wikidata; Q54845345
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142306.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11913
AC   CVCL_5C31
DR   CLO; CLO_0020186
DR   Coriell; GM11913
DR   GEO; GSM25488
DR   GEO; GSM316567
DR   GEO; GSM316568
DR   GEO; GSM316569
DR   GEO; GSM420687
DR   Wikidata; Q54845346
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142307.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11914
AC   CVCL_5C32
DR   CLO; CLO_0020179
DR   Coriell; GM11914
DR   GEO; GSM25489
DR   GEO; GSM316306
DR   GEO; GSM316307
DR   GEO; GSM316308
DR   GEO; GSM420688
DR   Wikidata; Q54845347
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142308.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11915
AC   CVCL_5C33
DR   CLO; CLO_0020180
DR   Coriell; GM11915
DR   GEO; GSM25490
DR   GEO; GSM316309
DR   GEO; GSM316310
DR   GEO; GSM316311
DR   GEO; GSM420689
DR   Wikidata; Q54845348
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142309.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11916
AC   CVCL_5C34
DR   CLO; CLO_0020173
DR   Coriell; GM11916
DR   GEO; GSM25491
DR   GEO; GSM316570
DR   GEO; GSM316571
DR   GEO; GSM316572
DR   GEO; GSM420690
DR   Wikidata; Q54845349
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142310.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11917
AC   CVCL_R623
DR   CLO; CLO_0020156
DR   Coriell; GM11917
DR   GEO; GSM25492
DR   GEO; GSM25493
DR   GEO; GSM314874
DR   GEO; GSM314875
DR   GEO; GSM420691
DR   GEO; GSM420692
DR   GEO; GSM648928
DR   GEO; GSM906131
DR   GEO; GSM906132
DR   IGSR; NA11917
DR   Wikidata; Q54845350
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142311.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM11918
AC   CVCL_R624
DR   CLO; CLO_0020157
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11918
DR   GEO; GSM25494
DR   GEO; GSM25495
DR   GEO; GSM314876
DR   GEO; GSM314877
DR   GEO; GSM420693
DR   GEO; GSM420694
DR   GEO; GSM648843
DR   GEO; GSM906133
DR   GEO; GSM906134
DR   GEO; GSM1719763
DR   IGSR; NA11918
DR   Wikidata; Q54845351
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142312.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM11919
AC   CVCL_R625
DR   CLO; CLO_0020158
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11919
DR   GEO; GSM25496
DR   GEO; GSM25497
DR   GEO; GSM314878
DR   GEO; GSM314879
DR   GEO; GSM420695
DR   GEO; GSM420696
DR   GEO; GSM648933
DR   GEO; GSM1719764
DR   IGSR; NA11919
DR   Wikidata; Q54845352
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142313.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM11920
AC   CVCL_R626
DR   CLO; CLO_0020159
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11920
DR   GEO; GSM25498
DR   GEO; GSM25499
DR   GEO; GSM314880
DR   GEO; GSM314881
DR   GEO; GSM420697
DR   GEO; GSM420698
DR   GEO; GSM648897
DR   GEO; GSM906135
DR   GEO; GSM906136
DR   GEO; GSM1719765
DR   IGSR; NA11920
DR   Wikidata; Q54845353
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142314.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM11921
AC   CVCL_5C35
DR   CLO; CLO_0020161
DR   Coriell; GM11921
DR   GEO; GSM316312
DR   GEO; GSM316313
DR   GEO; GSM316314
DR   Wikidata; Q54845354
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142315.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM11922
AC   CVCL_5C36
DR   CLO; CLO_0020162
DR   Coriell; GM11922
DR   GEO; GSM25500
DR   GEO; GSM30206
DR   GEO; GSM316573
DR   GEO; GSM316574
DR   GEO; GSM316575
DR   GEO; GSM420699
DR   Wikidata; Q54845355
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142403.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11923
AC   CVCL_5C37
DR   CLO; CLO_0020165
DR   Coriell; GM11923
DR   GEO; GSM25501
DR   GEO; GSM30207
DR   GEO; GSM316576
DR   GEO; GSM316577
DR   GEO; GSM316578
DR   GEO; GSM420700
DR   Wikidata; Q54845356
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142404.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11924
AC   CVCL_5C38
DR   CLO; CLO_0020167
DR   Coriell; GM11924
DR   GEO; GSM25502
DR   GEO; GSM30208
DR   GEO; GSM316315
DR   GEO; GSM316316
DR   GEO; GSM316317
DR   GEO; GSM420701
DR   Wikidata; Q54845357
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142405.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11925
AC   CVCL_5C39
DR   CLO; CLO_0020149
DR   Coriell; GM11925
DR   GEO; GSM25503
DR   GEO; GSM30209
DR   GEO; GSM316579
DR   GEO; GSM316580
DR   GEO; GSM316581
DR   GEO; GSM420702
DR   Wikidata; Q54845358
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142406.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11926
AC   CVCL_5C40
DR   CLO; CLO_0020249
DR   Coriell; GM11926
DR   GEO; GSM25504
DR   GEO; GSM30210
DR   GEO; GSM316318
DR   GEO; GSM316319
DR   GEO; GSM316320
DR   GEO; GSM420703
DR   Wikidata; Q54845359
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142407.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11927
AC   CVCL_5C41
DR   CLO; CLO_0020248
DR   Coriell; GM11927
DR   GEO; GSM25505
DR   GEO; GSM30211
DR   GEO; GSM316582
DR   GEO; GSM316583
DR   GEO; GSM316584
DR   GEO; GSM420704
DR   Wikidata; Q54845365
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142408.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11928
AC   CVCL_5C42
DR   CLO; CLO_0020244
DR   Coriell; GM11928
DR   GEO; GSM25506
DR   GEO; GSM30212
DR   GEO; GSM316585
DR   GEO; GSM316586
DR   GEO; GSM316587
DR   GEO; GSM420705
DR   Wikidata; Q54845366
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142409.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11929
AC   CVCL_5C43
DR   CLO; CLO_0020246
DR   Coriell; GM11929
DR   GEO; GSM25507
DR   GEO; GSM30213
DR   GEO; GSM316588
DR   GEO; GSM316589
DR   GEO; GSM316590
DR   GEO; GSM420706
DR   Wikidata; Q54845367
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142410.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11930
AC   CVCL_R627
DR   CLO; CLO_0020242
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11930
DR   GEO; GSM25508
DR   GEO; GSM25509
DR   GEO; GSM30214
DR   GEO; GSM314882
DR   GEO; GSM314883
DR   GEO; GSM420707
DR   GEO; GSM420708
DR   GEO; GSM648979
DR   GEO; GSM906137
DR   GEO; GSM906138
DR   GEO; GSM1719766
DR   IGSR; NA11930
DR   Wikidata; Q54845368
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142411.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM11931
AC   CVCL_R628
DR   CLO; CLO_0020243
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11931
DR   GEO; GSM25510
DR   GEO; GSM25511
DR   GEO; GSM30215
DR   GEO; GSM314884
DR   GEO; GSM314885
DR   GEO; GSM420709
DR   GEO; GSM420710
DR   GEO; GSM906139
DR   GEO; GSM906140
DR   GEO; GSM1719767
DR   IGSR; NA11931
DR   Wikidata; Q54845369
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM11932
AC   CVCL_0V40
DR   CLO; CLO_0020239
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11932
DR   GEO; GSM25512
DR   GEO; GSM25513
DR   GEO; GSM30216
DR   GEO; GSM314886
DR   GEO; GSM314887
DR   GEO; GSM420711
DR   GEO; GSM420712
DR   GEO; GSM906141
DR   GEO; GSM906142
DR   GEO; GSM1719768
DR   IGSR; NA11932
DR   Wikidata; Q54845371
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142413.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   GM11933
AC   CVCL_0V41
DR   CLO; CLO_0020241
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11933
DR   GEO; GSM25514
DR   GEO; GSM25515
DR   GEO; GSM30217
DR   GEO; GSM314888
DR   GEO; GSM314889
DR   GEO; GSM420713
DR   GEO; GSM420714
DR   GEO; GSM906143
DR   GEO; GSM906144
DR   GEO; GSM1719769
DR   IGSR; NA11933
DR   Wikidata; Q54845372
RX   PubMed=14583597;
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142414.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 18
//
ID   GM11936
AC   CVCL_1S44
SY   CF52-46-6
DR   CLO; CLO_0020235
DR   Coriell; GM11936
DR   Wikidata; Q54845373
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 11 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_1N61 ! GM03005
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM11937
AC   CVCL_1S45
SY   A3RS
DR   CLO; CLO_0020236
DR   Coriell; GM11937
DR   Wikidata; Q54845374
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q37 ! Don/a3
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11939
AC   CVCL_1S46
SY   16TX2
DR   CLO; CLO_0020222
DR   Coriell; GM11939
DR   Wikidata; Q54845375
RX   PubMed=2829363;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F137 ! GM06316
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM11941
AC   CVCL_DE49
SY   1W1LA4.9
DR   CLO; CLO_0020219
DR   Coriell; GM11941
DR   Wikidata; Q54845376
RX   PubMed=4309885;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DD99 ! 1R [Mouse L cells]
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   GM11943
AC   CVCL_1S47
SY   POR4; POR 4
DR   CLO; CLO_0020210
DR   Coriell; GM11943
DR   Wikidata; Q54845377
RX   PubMed=2829363;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 11 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N63 ! GM04613
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM11944
AC   CVCL_1Q55
SY   J1-11; 901-11D
DR   CLO; CLO_0020212
DR   Coriell; GM11944
DR   Wikidata; Q54845378
RX   PubMed=2595451;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 11 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q53 ! 78-5j1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM11947
AC   CVCL_BT25
DR   CLO; CLO_0020214
DR   Coriell; GM11947
DR   Wikidata; Q54845379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM11948
AC   CVCL_5L06
DR   CLO; CLO_0020215
DR   Coriell; GM11948
DR   Wikidata; Q54845380
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11949
AC   CVCL_5P61
DR   CLO; CLO_0020203
DR   Coriell; GM11949
DR   Wikidata; Q54845381
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM11950
AC   CVCL_5L07
DR   CLO; CLO_0020205
DR   Coriell; GM11950
DR   Wikidata; Q54845382
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11951
AC   CVCL_5L08
DR   CLO; CLO_0020208
DR   Coriell; GM11951
DR   Wikidata; Q54845383
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11952
AC   CVCL_5L09
DR   CLO; CLO_0020125
DR   Coriell; GM11952
DR   Wikidata; Q54845385
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11953
AC   CVCL_5L10
DR   CLO; CLO_0020126
DR   Coriell; GM11953
DR   Wikidata; Q54845386
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11954
AC   CVCL_5L11
DR   CLO; CLO_0020123
DR   Coriell; GM11954
DR   Wikidata; Q54845387
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11955
AC   CVCL_5L12
DR   CLO; CLO_0020124
DR   Coriell; GM11955
DR   Wikidata; Q54845388
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11957
AC   CVCL_5L13
DR   CLO; CLO_0020109
DR   Coriell; GM11957
DR   Wikidata; Q54845389
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11958
AC   CVCL_5L14
DR   CLO; CLO_0020108
DR   Coriell; GM11958
DR   Wikidata; Q54845390
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11959
AC   CVCL_5L15
DR   CLO; CLO_0020107
DR   Coriell; GM11959
DR   Wikidata; Q54845391
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11960
AC   CVCL_2U15
DR   CLO; CLO_0020106
DR   Coriell; GM11960
DR   Wikidata; Q54845392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11961
AC   CVCL_2U16
DR   CLO; CLO_0020111
DR   Coriell; GM11961
DR   Wikidata; Q54845393
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM11962
AC   CVCL_2U17
DR   CLO; CLO_0020110
DR   Coriell; GM11962
DR   Wikidata; Q54845394
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM11963
AC   CVCL_5L16
DR   CLO; CLO_0020538
DR   Coriell; GM11963
DR   Wikidata; Q54845395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM11964
AC   CVCL_5L17
DR   CLO; CLO_0020539
DR   Coriell; GM11964
DR   Wikidata; Q54845397
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11965
AC   CVCL_5L18
DR   CLO; CLO_0020544
DR   Coriell; GM11965
DR   Wikidata; Q54845398
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11966
AC   CVCL_2U18
DR   CLO; CLO_0020546
DR   Coriell; GM11966
DR   Wikidata; Q54845399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM11967
AC   CVCL_5L19
DR   CLO; CLO_0020540
DR   Coriell; GM11967
DR   Wikidata; Q54845400
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11968
AC   CVCL_5L20
DR   CLO; CLO_0020543
DR   Coriell; GM11968
DR   Wikidata; Q54845402
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM11970
AC   CVCL_N192
SY   GM17070
DR   CLO; CLO_0014600
DR   CLO; CLO_0020549
DR   Coriell; GM11970
DR   Coriell; GM17070
DR   Wikidata; Q54845403
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N354 ! GM22622
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM11971
AC   CVCL_F155
DR   CLO; CLO_0020550
DR   Coriell; GM11971
DR   Wikidata; Q54845404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM11972
AC   CVCL_F156
DR   CLO; CLO_0020547
DR   Coriell; GM11972
DR   Wikidata; Q54845405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM11973
AC   CVCL_7514
DR   CLO; CLO_0020548
DR   Coriell; GM11973
DR   Wikidata; Q54845406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   GM11978
AC   CVCL_1S48
SY   9542C-5a
DR   CLO; CLO_0020520
DR   Coriell; GM11978
DR   Wikidata; Q54845407
RX   PubMed=3194801;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N34 ! CHO Ade-C
HI   CVCL_1N66 ! GM09542
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM11979
AC   CVCL_1S49
SY   GA9-3
DR   CLO; CLO_0020521
DR   Coriell; GM11979
DR   Wikidata; Q54845408
RX   PubMed=3194801;
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N32 ! CHO Ade-A
HI   CVCL_1Q56 ! GM08210
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM11980
AC   CVCL_1S50
SY   1881C-13b
DR   CLO; CLO_0020522
DR   Coriell; GM11980
DR   Wikidata; Q54845415
RX   PubMed=3194801;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N34 ! CHO Ade-C
HI   CVCL_V812 ! GM01881
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM11982
AC   CVCL_5C44
AS   CVCL_G498
SY   CEPH-1362-NA11982; 1362-8568
DR   CLO; CLO_0020526
DR   Coriell; GM11982
DR   dbMHC; 48655
DR   GEO; GSM25516
DR   GEO; GSM30077
DR   GEO; GSM316216
DR   GEO; GSM316217
DR   GEO; GSM316218
DR   GEO; GSM420715
DR   GEO; GSM957419
DR   IHW; IHW01129
DR   IPD-IMGT/HLA; 25926
DR   Wikidata; Q54845416
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136203.
CC   HLA typing: A*01:01,29:02; B*44:03,57:01; C*06:02:01:01,16:01; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:01,01:03; DQB1*05:01,06:03; DRB1*01:01,13:01 (IPD-IMGT/HLA=25926).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11983
AC   CVCL_5C45
AS   CVCL_G496
SY   CEPH-1362-NA11983; 1362-8566
DR   CLO; CLO_0020527
DR   Coriell; GM11983
DR   dbMHC; 48656
DR   GEO; GSM25517
DR   GEO; GSM30078
DR   GEO; GSM316219
DR   GEO; GSM316220
DR   GEO; GSM316221
DR   GEO; GSM420716
DR   GEO; GSM957420
DR   IHW; IHW01127
DR   IPD-IMGT/HLA; 25924
DR   Wikidata; Q54845417
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136204.
CC   HLA typing: A*01:01,29:02; B*07:02,44:03; C*07:02,16:01; DPA1*01:03,01:03; DPB1*02:01:02,15:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01; DRB1*01:01,04:04 (IPD-IMGT/HLA=25924).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11984
AC   CVCL_5C46
AS   CVCL_G494
SY   CEPH-1362-NA11984; 1362-8564
DR   CLO; CLO_0020528
DR   Coriell; GM11984
DR   dbMHC; 48657
DR   GEO; GSM25518
DR   GEO; GSM30079
DR   GEO; GSM316516
DR   GEO; GSM316517
DR   GEO; GSM316518
DR   GEO; GSM420717
DR   GEO; GSM957421
DR   IHW; IHW01125
DR   IPD-IMGT/HLA; 25922
DR   Wikidata; Q54845418
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136205.
CC   HLA typing: A*01:01,29:02; B*44:03,57:01; C*06:02:01:01,16:01; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:01,01:03; DQB1*05:01,06:03; DRB1*01:01,13:01 (IPD-IMGT/HLA=25922).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11985
AC   CVCL_5C47
AS   CVCL_G507
SY   CEPH-1362-NA11985; 1362-8594
DR   CLO; CLO_0020529
DR   Coriell; GM11985
DR   dbMHC; 48658
DR   GEO; GSM25519
DR   GEO; GSM30080
DR   GEO; GSM316222
DR   GEO; GSM316223
DR   GEO; GSM316224
DR   GEO; GSM420718
DR   GEO; GSM957422
DR   IHW; IHW01138
DR   IPD-IMGT/HLA; 25935
DR   Wikidata; Q54845420
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136206.
CC   HLA typing: A*01:01,02:01; B*35:01,57:01; C*04:01,06:02; DPA1*01:03,01:03; DPB1*04:02,04:02; DQA1*01:01,01:03; DQB1*05:01:01,06:03; DRB1*01:01,13:01 (IPD-IMGT/HLA=25935).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11986
AC   CVCL_5C48
AS   CVCL_G492
SY   CEPH-1362-NA11986; 1362-8215
DR   CLO; CLO_0020523
DR   Coriell; GM11986
DR   dbMHC; 48659
DR   GEO; GSM25520
DR   GEO; GSM30081
DR   GEO; GSM316225
DR   GEO; GSM316226
DR   GEO; GSM316227
DR   GEO; GSM420719
DR   GEO; GSM957423
DR   IHW; IHW01123
DR   IPD-IMGT/HLA; 25920
DR   Wikidata; Q54845421
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136207.
CC   HLA typing: A*01:01,29:02; B*07:02,44:03; C*07:02,16:01; DPA1*01:03,01:03; DPB1*02:01:02,15:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01; DRB1*01:01,04:04 (IPD-IMGT/HLA=25920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM11987
AC   CVCL_5C49
AS   CVCL_G495
SY   CEPH-1362-NA11987; 1362-8565
DR   CLO; CLO_0020524
DR   Coriell; GM11987
DR   dbMHC; 48660
DR   GEO; GSM25521
DR   GEO; GSM30086
DR   GEO; GSM316519
DR   GEO; GSM316520
DR   GEO; GSM316521
DR   GEO; GSM420720
DR   GEO; GSM957424
DR   IHW; IHW01126
DR   IPD-IMGT/HLA; 25923
DR   Wikidata; Q54845422
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136208.
CC   HLA typing: A*01:01,02:01; B*35:01,57:01; C*04:01,06:02; DPA1*01:03,01:03; DPB1*04:02,04:02; DQA1*01:01,01:03; DQB1*05:01:01,06:03; DRB1*01:01,13:01 (IPD-IMGT/HLA=25923).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11988
AC   CVCL_5C50
AS   CVCL_G497
SY   CEPH-1362-NA11988; 1362-8567
DR   CLO; CLO_0020525
DR   Coriell; GM11988
DR   dbMHC; 48661
DR   GEO; GSM25522
DR   GEO; GSM30087
DR   GEO; GSM316228
DR   GEO; GSM316229
DR   GEO; GSM316230
DR   GEO; GSM420721
DR   GEO; GSM957425
DR   IHW; IHW01128
DR   IPD-IMGT/HLA; 25925
DR   Wikidata; Q54845423
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136209.
CC   HLA typing: A*01:01,02:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*04:02,15:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04 (IPD-IMGT/HLA=25925).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11989
AC   CVCL_5C51
AS   CVCL_G499
SY   CEPH-1362-NA11989; 1362-8569
DR   CLO; CLO_0020501
DR   Coriell; GM11989
DR   dbMHC; 48662
DR   GEO; GSM25523
DR   GEO; GSM30088
DR   GEO; GSM316231
DR   GEO; GSM316232
DR   GEO; GSM316233
DR   GEO; GSM420722
DR   GEO; GSM957426
DR   IHW; IHW01130
DR   IPD-IMGT/HLA; 25927
DR   Wikidata; Q54845424
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136210.
CC   HLA typing: A*01:01,02:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*04:02,15:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04 (IPD-IMGT/HLA=25927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM11990
AC   CVCL_5C52
AS   CVCL_G500
SY   CEPH-1362-NA11990; 1362-8570
DR   CLO; CLO_0020502
DR   Coriell; GM11990
DR   dbMHC; 48663
DR   GEO; GSM30089
DR   GEO; GSM316522
DR   GEO; GSM316523
DR   GEO; GSM316524
DR   GEO; GSM957427
DR   IHW; IHW01131
DR   IPD-IMGT/HLA; 25928
DR   Wikidata; Q54845425
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136211.
CC   HLA typing: A*01:01,02:01; B*35:01,57:01; C*04:01,06:02; DPA1*01:03,01:03; DPB1*04:02,04:02; DQA1*01:01,01:03; DQB1*05:01:01,06:03; DRB1*01:01,13:01 (IPD-IMGT/HLA=25928).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM11991
AC   CVCL_5C53
AS   CVCL_G501
SY   CEPH-1362-NA11991; 1362-8571
DR   CLO; CLO_0020499
DR   Coriell; GM11991
DR   dbMHC; 48664
DR   GEO; GSM30090
DR   GEO; GSM316234
DR   GEO; GSM316235
DR   GEO; GSM316236
DR   GEO; GSM957428
DR   IHW; IHW01132
DR   IPD-IMGT/HLA; 25929
DR   Wikidata; Q54845426
RX   PubMed=15514893;
RX   PubMed=17668376;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136212.
CC   HLA typing: A*01:01,02:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*04:02,15:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04 (IPD-IMGT/HLA=25929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM11992
AC   CVCL_7515
AS   CVCL_G503
SY   CEPH-1362-NA11992; 1362-8573
DR   CLO; CLO_0020500
DR   EFO; EFO_0001124
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11992
DR   dbMHC; 48665
DR   GEO; GSM25524
DR   GEO; GSM25525
DR   GEO; GSM30091
DR   GEO; GSM112518
DR   GEO; GSM112823
DR   GEO; GSM188796
DR   GEO; GSM273301
DR   GEO; GSM273302
DR   GEO; GSM291631
DR   GEO; GSM314890
DR   GEO; GSM314891
DR   GEO; GSM420723
DR   GEO; GSM420724
DR   GEO; GSM424336
DR   GEO; GSM486771
DR   GEO; GSM486772
DR   GEO; GSM648942
DR   GEO; GSM659997
DR   GEO; GSM660204
DR   GEO; GSM660408
DR   GEO; GSM905856
DR   GEO; GSM905951
DR   GEO; GSM906046
DR   GEO; GSM957346
DR   GEO; GSM957372
DR   GEO; GSM957429
DR   GEO; GSM1719770
DR   IGSR; NA11992
DR   IHW; IHW01134
DR   IPD-IMGT/HLA; 25931
DR   Wikidata; Q54845427
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136213.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:01; B*35:01,08:01; C*04:01,07:01; DPA1*01:03,01:03; DPB1*04:01,04:02; DQA1*01:01,05:01; DQB1*02:01,05:01:01; DRB1*01:01,03:01 (IPD-IMGT/HLA=25931).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   GM11993
AC   CVCL_7516
AS   CVCL_G502
SY   CEPH-1362-NA11993; 1362-8572
DR   CLO; CLO_0020508
DR   EFO; EFO_0001125
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   Coriell; GM11993
DR   dbMHC; 48666
DR   GEO; GSM25526
DR   GEO; GSM25527
DR   GEO; GSM30092
DR   GEO; GSM112519
DR   GEO; GSM112824
DR   GEO; GSM188798
DR   GEO; GSM207783
DR   GEO; GSM273303
DR   GEO; GSM273304
DR   GEO; GSM314892
DR   GEO; GSM314893
DR   GEO; GSM420725
DR   GEO; GSM420726
DR   GEO; GSM424337
DR   GEO; GSM486773
DR   GEO; GSM486774
DR   GEO; GSM648866
DR   GEO; GSM659995
DR   GEO; GSM660201
DR   GEO; GSM660406
DR   GEO; GSM905857
DR   GEO; GSM905952
DR   GEO; GSM906047
DR   GEO; GSM957347
DR   GEO; GSM957373
DR   GEO; GSM957430
DR   IGSR; NA11993
DR   IHW; IHW01133
DR   IPD-IMGT/HLA; 25930
DR   Wikidata; Q54845428
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136214.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*26:01,29:02; B*44:02,44:03; C*16:01,05:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01; DQA1*01:01,01:02; DQB1*05:01,06:02; DRB1*01:01,15:01 (IPD-IMGT/HLA=25930).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   GM11994
AC   CVCL_7517
AS   CVCL_G505
SY   CEPH-1362-NA11994; 1362-8575
DR   CLO; CLO_0020509
DR   EFO; EFO_0001126
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11994
DR   dbMHC; 48667
DR   GEO; GSM25528
DR   GEO; GSM25529
DR   GEO; GSM30093
DR   GEO; GSM112520
DR   GEO; GSM112825
DR   GEO; GSM188799
DR   GEO; GSM273305
DR   GEO; GSM273306
DR   GEO; GSM291632
DR   GEO; GSM291633
DR   GEO; GSM314894
DR   GEO; GSM314895
DR   GEO; GSM420727
DR   GEO; GSM420728
DR   GEO; GSM424338
DR   GEO; GSM486775
DR   GEO; GSM486776
DR   GEO; GSM648883
DR   GEO; GSM659993
DR   GEO; GSM660200
DR   GEO; GSM660404
DR   GEO; GSM905858
DR   GEO; GSM905953
DR   GEO; GSM906048
DR   GEO; GSM957348
DR   GEO; GSM957374
DR   GEO; GSM957431
DR   GEO; GSM1719771
DR   IGSR; NA11994
DR   IHW; IHW01136
DR   IPD-IMGT/HLA; 25933
DR   Wikidata; Q54845429
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136215.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,11:01; B*07:02,51:01; C*07:02,15:02; DPA1*01:03,01:03; DPB1*04:01,15:01; DQA1*03:01,03:01; DQB1*03:02,03:02:01; DRB1*04:02,04:04 (IPD-IMGT/HLA=25933).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   GM11995
AC   CVCL_9600
AS   CVCL_G506
SY   CEPH-1362-NA11995; 1362-8589
DR   CLO; CLO_0020506
DR   EFO; EFO_0001127
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   Coriell; GM11995
DR   dbMHC; 48668
DR   GEO; GSM25530
DR   GEO; GSM25531
DR   GEO; GSM30094
DR   GEO; GSM112521
DR   GEO; GSM112826
DR   GEO; GSM188800
DR   GEO; GSM273307
DR   GEO; GSM273308
DR   GEO; GSM291634
DR   GEO; GSM291635
DR   GEO; GSM314896
DR   GEO; GSM314897
DR   GEO; GSM420729
DR   GEO; GSM420730
DR   GEO; GSM486777
DR   GEO; GSM486778
DR   GEO; GSM648882
DR   GEO; GSM659991
DR   GEO; GSM660197
DR   GEO; GSM660402
DR   GEO; GSM905859
DR   GEO; GSM905954
DR   GEO; GSM906049
DR   GEO; GSM957349
DR   GEO; GSM957432
DR   GEO; GSM1719772
DR   IGSR; NA11995
DR   IHW; IHW01137
DR   IPD-IMGT/HLA; 25934
DR   Wikidata; Q54845430
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136216.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,01:01; B*57:01,08:01; C*06:02:01:01,07:01; DPA1*01:03,01:03; DPB1*04:01,04:02; DQA1*01:02,01:03; DQB1*06:02,06:03; DRB1*13:01,15:01 (IPD-IMGT/HLA=25934).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM11995).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   GM11996
AC   CVCL_5C54
AS   CVCL_G508
SY   CEPH-1362-NA11996; 1362-8929
DR   CLO; CLO_0020507
DR   Coriell; GM11996
DR   dbMHC; 48669
DR   GEO; GSM30095
DR   GEO; GSM316525
DR   GEO; GSM316526
DR   GEO; GSM316527
DR   GEO; GSM957433
DR   IHW; IHW01139
DR   IPD-IMGT/HLA; 25936
DR   Wikidata; Q54845431
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 136217.
CC   HLA typing: A*01:01,29:02; B*44:03,57:01; C*06:02,06:02; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*01:01,01:03; DQB1*05:01,06:03; DRB1*01:01,13:01 (IPD-IMGT/HLA=25936).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM11997
AC   CVCL_5C55
DR   CLO; CLO_0020503
DR   Coriell; GM11997
DR   GEO; GSM316267
DR   GEO; GSM316268
DR   GEO; GSM316269
DR   GEO; GSM420731
DR   GEO; GSM651081
DR   GEO; GSM651082
DR   GEO; GSM957436
DR   Wikidata; Q54845432
RX   PubMed=14583597;
RX   PubMed=20856902;
RX   PubMed=21418647;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142003.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11998
AC   CVCL_5C56
DR   CLO; CLO_0020504
DR   Coriell; GM11998
DR   GEO; GSM316270
DR   GEO; GSM316271
DR   GEO; GSM316272
DR   GEO; GSM420732
DR   GEO; GSM651083
DR   GEO; GSM651084
DR   GEO; GSM957437
DR   Wikidata; Q54845433
RX   PubMed=14583597;
RX   PubMed=20856902;
RX   PubMed=21418647;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142004.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM11999
AC   CVCL_5C57
DR   CLO; CLO_0020484
DR   Coriell; GM11999
DR   GEO; GSM316273
DR   GEO; GSM316274
DR   GEO; GSM316275
DR   GEO; GSM420733
DR   GEO; GSM651085
DR   GEO; GSM651086
DR   GEO; GSM957438
DR   Wikidata; Q54845434
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142005.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12000
AC   CVCL_5C58
DR   CLO; CLO_0020486
DR   Coriell; GM12000
DR   GEO; GSM316276
DR   GEO; GSM316277
DR   GEO; GSM316278
DR   GEO; GSM420734
DR   GEO; GSM651087
DR   GEO; GSM651088
DR   GEO; GSM957439
DR   Wikidata; Q54845435
RX   PubMed=20856902;
RX   PubMed=21418647;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142006.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12001
AC   CVCL_5C59
DR   CLO; CLO_0020485
DR   Coriell; GM12001
DR   GEO; GSM316279
DR   GEO; GSM316280
DR   GEO; GSM316281
DR   GEO; GSM420735
DR   GEO; GSM651089
DR   GEO; GSM651090
DR   GEO; GSM957440
DR   Wikidata; Q54845436
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142007.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12002
AC   CVCL_5C60
DR   CLO; CLO_0020488
DR   Coriell; GM12002
DR   GEO; GSM316282
DR   GEO; GSM316283
DR   GEO; GSM316284
DR   GEO; GSM420736
DR   GEO; GSM651091
DR   GEO; GSM651092
DR   GEO; GSM957441
DR   Wikidata; Q54845437
RX   PubMed=14583597;
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142008.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12003
AC   CVCL_9601
DR   CLO; CLO_0020487
DR   EFO; EFO_0001128
DR   BioSample; SAMN00801049
DR   Coriell; GM12003
DR   GEO; GSM112522
DR   GEO; GSM112827
DR   GEO; GSM188801
DR   GEO; GSM273309
DR   GEO; GSM291636
DR   GEO; GSM314898
DR   GEO; GSM420737
DR   GEO; GSM424339
DR   GEO; GSM486779
DR   GEO; GSM486780
DR   GEO; GSM651097
DR   GEO; GSM651098
DR   GEO; GSM659983
DR   GEO; GSM660191
DR   GEO; GSM660395
DR   GEO; GSM905860
DR   GEO; GSM905955
DR   GEO; GSM906050
DR   GEO; GSM957375
DR   GEO; GSM957442
DR   GEO; GSM1719773
DR   IGSR; NA12003
DR   Wikidata; Q54845438
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142009.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   GM12004
AC   CVCL_9602
DR   CLO; CLO_0020480
DR   EFO; EFO_0001129
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00801051
DR   Coriell; GM12004
DR   GEO; GSM112523
DR   GEO; GSM112828
DR   GEO; GSM188802
DR   GEO; GSM273310
DR   GEO; GSM291637
DR   GEO; GSM314899
DR   GEO; GSM420738
DR   GEO; GSM424340
DR   GEO; GSM486781
DR   GEO; GSM486782
DR   GEO; GSM649295
DR   GEO; GSM651099
DR   GEO; GSM651100
DR   GEO; GSM659948
DR   GEO; GSM660168
DR   GEO; GSM660376
DR   GEO; GSM905861
DR   GEO; GSM905956
DR   GEO; GSM906051
DR   GEO; GSM957342
DR   GEO; GSM957350
DR   GEO; GSM957376
DR   GEO; GSM957443
DR   GEO; GSM980644
DR   GEO; GSM980646
DR   GEO; GSM1261036
DR   GEO; GSM1719774
DR   IGSR; NA12004
DR   Wikidata; Q54845439
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=21418647;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142010.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   GM12005
AC   CVCL_9603
DR   CLO; CLO_0020479
DR   EFO; EFO_0001130
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801053
DR   Coriell; GM12005
DR   GEO; GSM112524
DR   GEO; GSM112829
DR   GEO; GSM188803
DR   GEO; GSM273311
DR   GEO; GSM291638
DR   GEO; GSM291639
DR   GEO; GSM314900
DR   GEO; GSM420739
DR   GEO; GSM424341
DR   GEO; GSM486783
DR   GEO; GSM486784
DR   GEO; GSM649296
DR   GEO; GSM651101
DR   GEO; GSM651102
DR   GEO; GSM659982
DR   GEO; GSM660189
DR   GEO; GSM660394
DR   GEO; GSM905862
DR   GEO; GSM905957
DR   GEO; GSM906052
DR   GEO; GSM957377
DR   GEO; GSM957444
DR   GEO; GSM1719775
DR   IGSR; NA12005
DR   Wikidata; Q54845440
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=21418647;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142011/147712.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM12005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F17 ! GM12908
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   GM12006
AC   CVCL_7518
DR   CLO; CLO_0020482
DR   EFO; EFO_0001131
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801055
DR   Coriell; GM12006
DR   GEO; GSM112525
DR   GEO; GSM112830
DR   GEO; GSM188804
DR   GEO; GSM273312
DR   GEO; GSM291640
DR   GEO; GSM314901
DR   GEO; GSM420740
DR   GEO; GSM424342
DR   GEO; GSM486785
DR   GEO; GSM486786
DR   GEO; GSM651103
DR   GEO; GSM651104
DR   GEO; GSM659980
DR   GEO; GSM660187
DR   GEO; GSM660391
DR   GEO; GSM905863
DR   GEO; GSM905958
DR   GEO; GSM906053
DR   GEO; GSM957378
DR   GEO; GSM957445
DR   GEO; GSM1719776
DR   IGSR; NA12006
DR   Wikidata; Q54845441
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142012/147713.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F18 ! GM12909
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   GM12007
AC   CVCL_5C61
DR   CLO; CLO_0020481
DR   Coriell; GM12007
DR   GEO; GSM316549
DR   GEO; GSM316550
DR   GEO; GSM316551
DR   GEO; GSM420741
DR   GEO; GSM651093
DR   GEO; GSM651094
DR   GEO; GSM957446
DR   Wikidata; Q54845443
RX   PubMed=14583597;
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142013.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12010
AC   CVCL_L492
SY   RJK 2163; RJK2163
DR   CLO; CLO_0020483
DR   Coriell; GM12010
DR   Wikidata; Q54845444
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg45Lys (c.134G>A); ClinVar=VCV000010048; Zygosity=Hemizygous (Coriell=GM12010).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   GM12011
AC   CVCL_L493
SY   RJK 2256; RJK2256
DR   CLO; CLO_0020464
DR   Coriell; GM12011
DR   Wikidata; Q54845445
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.His204Arg (c.611A>G); Zygosity=Hemizygous (Coriell=GM12011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   GM12012
AC   CVCL_L494
SY   RJK 2397; RJK2397
DR   CLO; CLO_0020463
DR   Coriell; GM12012
DR   Wikidata; Q54845446
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Gly40Glu (c.119G>A) (G39E); Zygosity=Hemizygous (Coriell=GM12012).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   GM12013
AC   CVCL_5P62
DR   CLO; CLO_0020468
DR   Coriell; GM12013
DR   Wikidata; Q54845448
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM12014
AC   CVCL_X346
DR   CLO; CLO_0020467
DR   Coriell; GM12014
DR   Wikidata; Q54845449
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84890; Mevalonate kinase deficiency
DI   ORDO; Orphanet_29; Mevalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X347 ! GM12015
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM12015
AC   CVCL_X347
DR   CLO; CLO_0020466
DR   Coriell; GM12015
DR   Wikidata; Q54845451
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84890; Mevalonate kinase deficiency
DI   ORDO; Orphanet_29; Mevalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X346 ! GM12014
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM12016
AC   CVCL_5J55
DR   CLO; CLO_0020465
DR   BioSample; SAMN00801071
DR   Coriell; GM12016
DR   Wikidata; Q54845452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM12017
AC   CVCL_5J56
DR   CLO; CLO_0020462
DR   Coriell; GM12017
DR   Wikidata; Q54845453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12018
AC   CVCL_5J57
DR   CLO; CLO_0020461
DR   Coriell; GM12018
DR   Wikidata; Q54845454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12019
AC   CVCL_2U19
DR   CLO; CLO_0020460
DR   Coriell; GM12019
DR   Wikidata; Q54845455
CC   Derived from site: In situ; Fetal diaphragm, skeletal muscle; UBERON=UBERON_0010084+UBERON_0004495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM12023
AC   CVCL_BT26
DR   CLO; CLO_0020459
DR   Coriell; GM12023
DR   Wikidata; Q54845456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12025
AC   CVCL_5L21
DR   CLO; CLO_0020446
DR   Coriell; GM12025
DR   Wikidata; Q54845457
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM12027
AC   CVCL_BT27
DR   CLO; CLO_0020448
DR   Coriell; GM12027
DR   Wikidata; Q54845458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12028
AC   CVCL_AT12
DR   CLO; CLO_0020447
DR   Coriell; GM12028
DR   Wikidata; Q54845466
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg402Trp (c.1204C>T); ClinVar=VCV000002085; Zygosity=Homozygous (Coriell=GM12028).
CC   Discontinued: Coriell; GM12028; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM12029
AC   CVCL_AT13
DR   CLO; CLO_0020443
DR   Coriell; GM12029
DR   Wikidata; Q54845467
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg402Trp (c.1204C>T); ClinVar=VCV000002085; Zygosity=Homozygous (Coriell=GM12029).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM12035
AC   CVCL_5C62
AS   CVCL_G455
SY   CEPH-1346-NA12035; 1346-8362
DR   CLO; CLO_0020442
DR   Coriell; GM12035
DR   dbMHC; 48612
DR   GEO; GSM25532
DR   GEO; GSM316501
DR   GEO; GSM316502
DR   GEO; GSM316503
DR   GEO; GSM420742
DR   IHW; IHW01085
DR   IPD-IMGT/HLA; 25883
DR   Wikidata; Q54845468
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134603.
CC   HLA typing: A*02:01,11:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:01,01:03; DQB1*05:03:01,06:03; DRB1*13:01,14:01; DRB3*02 (IPD-IMGT/HLA=25883).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12036
AC   CVCL_5C63
AS   CVCL_G450
SY   CEPH-1346-NA12036; 1346-8357
DR   CLO; CLO_0020445
DR   Coriell; GM12036
DR   dbMHC; 48613
DR   GEO; GSM25533
DR   GEO; GSM30034
DR   GEO; GSM316504
DR   GEO; GSM316505
DR   GEO; GSM316506
DR   GEO; GSM420743
DR   IHW; IHW01080
DR   IPD-IMGT/HLA; 25878
DR   Wikidata; Q54845469
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134604.
CC   HLA typing: A*01:01,02:06; B*35:01,57:01; C*04:01,06:02; DPA1*01:03,01:03; DPB1*03:01:01,04:02; DQA1*01:01,05:01; DQB1*02:01,05:01; DRB1*01:01,03:01; DRB3*01 (IPD-IMGT/HLA=25878).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12037
AC   CVCL_5C64
AS   CVCL_G462
SY   CEPH-1346-NA12037; 1346-8603
DR   CLO; CLO_0020444
DR   Coriell; GM12037
DR   dbMHC; 48614
DR   GEO; GSM25534
DR   GEO; GSM30035
DR   GEO; GSM316507
DR   GEO; GSM316508
DR   GEO; GSM316509
DR   GEO; GSM420744
DR   IHW; IHW01092
DR   IPD-IMGT/HLA; 25890
DR   Wikidata; Q54845470
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134605.
CC   HLA typing: A*02:01,11:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:01,01:03; DQB1*05:03:01,06:03; DRB1*13:01,14:01; DRB3*01,02 (IPD-IMGT/HLA=25890).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12038
AC   CVCL_5C65
AS   CVCL_G452
SY   CEPH-1346-NA12038; 1346-8359
DR   CLO; CLO_0020440
DR   Coriell; GM12038
DR   dbMHC; 48615
DR   GEO; GSM25535
DR   GEO; GSM316510
DR   GEO; GSM316511
DR   GEO; GSM316512
DR   GEO; GSM420745
DR   IHW; IHW01082
DR   IPD-IMGT/HLA; 25880
DR   Wikidata; Q54845471
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134606.
CC   HLA typing: A*02:01,11:01; B*07:02,35:01; C*04:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:01,01:03; DQB1*05:03:01,06:03; DRB1*13:01,14:01; DRB3*01,02 (IPD-IMGT/HLA=25880).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12039
AC   CVCL_5C66
AS   CVCL_G449
SY   CEPH-1346-NA12039; 1346-1370
DR   CLO; CLO_0020439
DR   Coriell; GM12039
DR   dbMHC; 48616
DR   GEO; GSM25536
DR   GEO; GSM30036
DR   GEO; GSM316513
DR   GEO; GSM316514
DR   GEO; GSM316515
DR   GEO; GSM420746
DR   IHW; IHW01079
DR   IPD-IMGT/HLA; 25877
DR   Wikidata; Q54845472
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134607.
CC   HLA typing: A*02:06,11:01; B*35:01,35:01; C*04:01,04:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:01,01:01; DQB1*05:01,05:03:01; DRB1*01:01,14:01; DRB3*02 (IPD-IMGT/HLA=25877).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12040
AC   CVCL_5C67
AS   CVCL_G457
SY   CEPH-1346-NA12040; 1346-8364
DR   CLO; CLO_0020441
DR   Coriell; GM12040
DR   dbMHC; 48617
DR   GEO; GSM25537
DR   GEO; GSM30037
DR   GEO; GSM316207
DR   GEO; GSM316208
DR   GEO; GSM316209
DR   GEO; GSM420747
DR   IHW; IHW01087
DR   IPD-IMGT/HLA; 25885
DR   Wikidata; Q54845473
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134608.
CC   HLA typing: A*02:06,11:01; B*35:01,35:01; C*04:01,04:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:01,01:01; DQB1*05:01,05:03:01; DRB1*01:01,14:01; DRB3*02 (IPD-IMGT/HLA=25885).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12041
AC   CVCL_5C68
AS   CVCL_G453
SY   CEPH-1346-NA12041; 1346-8360
DR   CLO; CLO_0020428
DR   Coriell; GM12041
DR   dbMHC; 48618
DR   GEO; GSM25538
DR   GEO; GSM316210
DR   GEO; GSM316211
DR   GEO; GSM316212
DR   GEO; GSM420748
DR   IHW; IHW01083
DR   IPD-IMGT/HLA; 25881
DR   Wikidata; Q54845474
RX   PubMed=17668376;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134609.
CC   HLA typing: A*01:01,02:01; B*07:02,57:01; C*06:02:01:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*01:03,05:01; DQB1*02:01,06:03; DRB1*03:01,13:01; DRB3*01,01 (IPD-IMGT/HLA=25881).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12042
AC   CVCL_5C69
AS   CVCL_G454
SY   CEPH-1346-NA12042; 1346-8361
DR   CLO; CLO_0020427
DR   Coriell; GM12042
DR   dbMHC; 48619
DR   GEO; GSM25539
DR   GEO; GSM30038
DR   GEO; GSM316213
DR   GEO; GSM316214
DR   GEO; GSM316215
DR   GEO; GSM420749
DR   IHW; IHW01084
DR   IPD-IMGT/HLA; 25882
DR   Wikidata; Q54845475
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134610.
CC   HLA typing: A*01:01,02:06; B*35:01,57:01; C*04:01,06:02; DPA1*01:03,01:03; DPB1*03:01:01,04:02; DQA1*01:01,05:01; DQB1*02:01,05:01; DRB1*01:01,03:01; DRB3*01 (IPD-IMGT/HLA=25882).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12043
AC   CVCL_9604
AS   CVCL_G451
SY   CEPH-1346-NA12043; 1346-8358
DR   CLO; CLO_0020426
DR   EFO; EFO_0001132
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801099
DR   Coriell; GM12043
DR   dbMHC; 48620
DR   GEO; GSM25540
DR   GEO; GSM25541
DR   GEO; GSM30039
DR   GEO; GSM112526
DR   GEO; GSM112831
DR   GEO; GSM188805
DR   GEO; GSM273313
DR   GEO; GSM273314
DR   GEO; GSM291641
DR   GEO; GSM314902
DR   GEO; GSM314903
DR   GEO; GSM420750
DR   GEO; GSM420751
DR   GEO; GSM424343
DR   GEO; GSM486787
DR   GEO; GSM486788
DR   GEO; GSM648904
DR   GEO; GSM659942
DR   GEO; GSM660199
DR   GEO; GSM660356
DR   GEO; GSM957379
DR   GEO; GSM1719777
DR   IGSR; NA12043
DR   IHW; IHW01081
DR   IPD-IMGT/HLA; 25879
DR   Wikidata; Q54845476
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134611.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:06,26:01; B*35:01,38:01; C*04:01,12:03; DPA1*01:03,01:03; DPB1*04:01,04:02; DQA1*01:01,03:01; DQB1*03:02,05:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25879).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM12043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   GM12044
AC   CVCL_9605
AS   CVCL_G456
SY   CEPH-1346-NA12044; 1346-8363
DR   CLO; CLO_0020425
DR   EFO; EFO_0001133
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801101
DR   Coriell; GM12044
DR   dbMHC; 48621
DR   GEO; GSM25542
DR   GEO; GSM25543
DR   GEO; GSM30040
DR   GEO; GSM112527
DR   GEO; GSM112832
DR   GEO; GSM188806
DR   GEO; GSM273315
DR   GEO; GSM273316
DR   GEO; GSM291642
DR   GEO; GSM314904
DR   GEO; GSM314905
DR   GEO; GSM420752
DR   GEO; GSM420753
DR   GEO; GSM424344
DR   GEO; GSM486789
DR   GEO; GSM486790
DR   GEO; GSM648941
DR   GEO; GSM957380
DR   GEO; GSM1719778
DR   IGSR; NA12044
DR   IHW; IHW01086
DR   IPD-IMGT/HLA; 25884
DR   Wikidata; Q54845477
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=35931342;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134612.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:01; B*07:02,07:02; C*07:02,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:01; DQA1*01:02,01:03; DQB1*06:02,06:03; DRB1*13:01,15:01; DRB3*01; DRB5*01 (IPD-IMGT/HLA=25884).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   GM12045
AC   CVCL_R629
AS   CVCL_G460
SY   CEPH-1346-NA12045; 1346-8367
DR   CLO; CLO_0020424
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801103
DR   Coriell; GM12045
DR   dbMHC; 48622
DR   GEO; GSM25544
DR   GEO; GSM25545
DR   GEO; GSM30041
DR   GEO; GSM314906
DR   GEO; GSM314907
DR   GEO; GSM420754
DR   GEO; GSM420755
DR   GEO; GSM648869
DR   GEO; GSM906145
DR   GEO; GSM906146
DR   GEO; GSM1719779
DR   IGSR; NA12045
DR   IHW; IHW01090
DR   IPD-IMGT/HLA; 25888
DR   Wikidata; Q54845479
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134613.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,11:01; B*35:01,44:02; C*04:01,05:01; DPA1*01:03,01:03; DPB1*03:01,04:01:01; DQA1*01:01,01:03; DQB1*05:03:01,06:03; DRB1*13:01,14:01; DRB3*01,02 (IPD-IMGT/HLA=25888).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   GM12046
AC   CVCL_0V42
AS   CVCL_G459
SY   CEPH-1346-NA12046; 1346-8366
DR   CLO; CLO_0020423
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801105
DR   Coriell; GM12046
DR   dbMHC; 48623
DR   GEO; GSM25546
DR   GEO; GSM25547
DR   GEO; GSM314908
DR   GEO; GSM314909
DR   GEO; GSM420756
DR   GEO; GSM420757
DR   GEO; GSM1719780
DR   IGSR; NA12046
DR   IHW; IHW01089
DR   IPD-IMGT/HLA; 25887
DR   Wikidata; Q54845481
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134614.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:05; B*50:01,57:01; C*06:02,06:02; DPA1*01:03,02:01:01; DPB1*03:01:01,11:01; DQA1*02:01,05:01; DQB1*02:01,02:01; DRB1*03:01,07:01; DRB3*01; DRB4*01 (IPD-IMGT/HLA=25887).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 21
//
ID   GM12047
AC   CVCL_5C70
AS   CVCL_G439
SY   CEPH-1344-NA12047; 1344-8348
DR   CLO; CLO_0020422
DR   Coriell; GM12047
DR   dbMHC; 48598
DR   GEO; GSM420758
DR   GEO; GSM659921
DR   GEO; GSM660132
DR   GEO; GSM660338
DR   IHW; IHW01069
DR   IPD-IMGT/HLA; 25867
DR   Wikidata; Q54845482
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134403.
CC   HLA typing: A*03:01,24:02; B*40:01,51:01; C*01:02,03:04:01; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25867).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12048
AC   CVCL_5C71
AS   CVCL_G448
SY   CEPH-1344-NA12048; 1344-8370
DR   CLO; CLO_0020421
DR   Coriell; GM12048
DR   dbMHC; 48599
DR   GEO; GSM420759
DR   GEO; GSM659920
DR   GEO; GSM660131
DR   GEO; GSM660337
DR   IHW; IHW01078
DR   IPD-IMGT/HLA; 25876
DR   Wikidata; Q54845483
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134404.
CC   HLA typing: A*01:01,03:01; B*08:01,51:01; C*01:02,07:01; DPA1*01:03,01:03; DPB1*03:01:01,04:02; DQA1*01:01,02:01; DQB1*03:03:02,05:01:01; DRB1*01:01,07:01; DRB4*01 (IPD-IMGT/HLA=25876).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12049
AC   CVCL_5C72
AS   CVCL_G438
SY   CEPH-1344-NA12049; 1344-8347
DR   CLO; CLO_0020420
DR   Coriell; GM12049
DR   dbMHC; 48600
DR   GEO; GSM420760
DR   GEO; GSM659919
DR   GEO; GSM660130
DR   GEO; GSM660336
DR   IHW; IHW01068
DR   IPD-IMGT/HLA; 25866
DR   Wikidata; Q54845484
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134405.
CC   HLA typing: A*03:01,24:02; B*40:01,51:01; C*01:02,03:04:01; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25866).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12050
AC   CVCL_5C73
AS   CVCL_G440
SY   CEPH-1344-NA12050; 1344-8349
DR   CLO; CLO_0020419
DR   Coriell; GM12050
DR   dbMHC; 48601
DR   GEO; GSM420761
DR   GEO; GSM659918
DR   GEO; GSM660129
DR   GEO; GSM660335
DR   IHW; IHW01070
DR   IPD-IMGT/HLA; 25868
DR   PRIDE; PXD025499
DR   Wikidata; Q54845485
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134406.
CC   HLA typing: A*01:01,02:01; B*08:01,40:01; C*03:04:01,07:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*02:01,03:01; DQB1*03:02:01,03:03:02; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25868).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM12051
AC   CVCL_5C74
AS   CVCL_G441
SY   CEPH-1344-NA12051; 1344-8350
DR   CLO; CLO_0020658
DR   Coriell; GM12051
DR   dbMHC; 48602
DR   GEO; GSM420762
DR   GEO; GSM659917
DR   GEO; GSM660128
DR   GEO; GSM660334
DR   IHW; IHW01071
DR   IPD-IMGT/HLA; 25869
DR   Wikidata; Q54845486
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134407.
CC   HLA typing: A*02:01,24:02; B*40:01,40:01; C*03:04:01,03:04:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*03:01,03:01; DQB1*03:02:01,03:02:01; DRB1*04:04,04:04; DRB4*01 (IPD-IMGT/HLA=25869).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12052
AC   CVCL_5C75
AS   CVCL_G443
SY   CEPH-1344-NA12052; 1344-8352
DR   CLO; CLO_0020641
DR   Coriell; GM12052
DR   dbMHC; 48603
DR   GEO; GSM420763
DR   GEO; GSM659916
DR   GEO; GSM660127
DR   GEO; GSM660333
DR   IHW; IHW01073
DR   IPD-IMGT/HLA; 25871
DR   Wikidata; Q54845487
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134408.
CC   HLA typing: A*01:01,03:01; B*08:01,51:01; C*01:02,07:01; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25871).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12053
AC   CVCL_5C76
AS   CVCL_G442
SY   CEPH-1344-NA12053; 1344-8351
DR   CLO; CLO_0020642
DR   Coriell; GM12053
DR   dbMHC; 48604
DR   GEO; GSM420764
DR   GEO; GSM659915
DR   GEO; GSM660126
DR   GEO; GSM660332
DR   IHW; IHW01072
DR   IPD-IMGT/HLA; 25870
DR   Wikidata; Q54845488
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134409.
CC   HLA typing: A*03:01,24:02; B*40:01,51:01; C*01:02,03:04:01; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25870).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12054
AC   CVCL_5C77
AS   CVCL_G445
SY   CEPH-1344-NA12054; 1344-8354
DR   CLO; CLO_0020639
DR   Coriell; GM12054
DR   dbMHC; 48605
DR   GEO; GSM420765
DR   IHW; IHW01075
DR   IPD-IMGT/HLA; 25873
DR   Wikidata; Q54845489
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134410.
CC   HLA typing: A*03:01,24:02; B*40:01,51:01; C*01:02,03:04:01; DPA1*01:03,01:03; DPB1*02:01:02,03:01:01; DQA1*01:01,03:01; DQB1*03:02:01,05:01:01; DRB1*01:01,04:04; DRB4*01 (IPD-IMGT/HLA=25873).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12055
AC   CVCL_5C78
AS   CVCL_G446
SY   CEPH-1344-NA12055; 1344-8355
DR   CLO; CLO_0020640
DR   Coriell; GM12055
DR   dbMHC; 48606
DR   IHW; IHW01076
DR   IPD-IMGT/HLA; 25874
DR   Wikidata; Q54845490
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134411.
CC   HLA typing: A*01:01,02:01; B*08:01,40:01; C*03:04:01,07:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*02:01,03:01; DQB1*03:02:01,03:03:02; DRB1*04:04,07:01; DRB4*01 (IPD-IMGT/HLA=25874).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12056
AC   CVCL_7519
AS   CVCL_G435
SY   CEPH-1344-NA12056; 1344-8322
DR   CLO; CLO_0020648
DR   EFO; EFO_0001134
DR   Coriell; GM12056
DR   dbMHC; 48607
DR   GEO; GSM112528
DR   GEO; GSM112833
DR   GEO; GSM188807
DR   GEO; GSM273317
DR   GEO; GSM291643
DR   GEO; GSM314910
DR   GEO; GSM420766
DR   GEO; GSM424345
DR   GEO; GSM486791
DR   GEO; GSM486792
DR   GEO; GSM649297
DR   GEO; GSM659961
DR   GEO; GSM660163
DR   GEO; GSM660370
DR   GEO; GSM905864
DR   GEO; GSM905959
DR   GEO; GSM906054
DR   GEO; GSM957381
DR   IGSR; NA12056
DR   IHW; IHW01065
DR   IPD-IMGT/HLA; 25863
DR   Wikidata; Q54845491
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,24:02; B*15:01,40:01; C*03:03,03:04:01; DPA1*01:03; DPB1*02:01:02,03:01; DQA1*01:02,03:01; DQB1*03:02:01,06:02; DRB1*04:04,15:01; DRB4*01; DRB5*01 (IPD-IMGT/HLA=25863).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   GM12057
AC   CVCL_7520
AS   CVCL_G434
SY   CEPH-1344-NA12057; 1344-8321
DR   CLO; CLO_0020650
DR   EFO; EFO_0001135
DR   Coriell; GM12057
DR   dbMHC; 48608
DR   GEO; GSM112529
DR   GEO; GSM112834
DR   GEO; GSM188809
DR   GEO; GSM273318
DR   GEO; GSM291644
DR   GEO; GSM314911
DR   GEO; GSM420767
DR   GEO; GSM424346
DR   GEO; GSM486793
DR   GEO; GSM486794
DR   GEO; GSM659959
DR   GEO; GSM660161
DR   GEO; GSM660368
DR   GEO; GSM905865
DR   GEO; GSM905960
DR   GEO; GSM906055
DR   GEO; GSM957382
DR   IGSR; NA12057
DR   IHW; IHW01064
DR   IPD-IMGT/HLA; 25862
DR   Wikidata; Q54845492
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134413.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:01; B*08:01,15:01; C*04:01,07:01; DPA1*01:03; DPB1*04:01,04:02; DQA1*01:03,02:01; DQB1*03:03:02,06:03; DRB1*07:01,13:01; DRB3*01; DRB4*01 (IPD-IMGT/HLA=25862).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   GM12058
AC   CVCL_R630
AS   CVCL_G437
SY   CEPH-1344-NA12058; 1344-8324
DR   CLO; CLO_0020643
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00801126
DR   Coriell; GM12058
DR   dbMHC; 48609
DR   GEO; GSM314912
DR   GEO; GSM420768
DR   GEO; GSM648885
DR   GEO; GSM906147
DR   GEO; GSM906148
DR   GEO; GSM1719781
DR   IGSR; NA12058
DR   IHW; IHW01067
DR   IPD-IMGT/HLA; 25865
DR   Wikidata; Q54845493
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 134415/137509.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,03:01; B*40:01; C*03:04:01; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*03:01,04:01; DQB1*03:02:01,04:02; DRB1*04:04,08:01 (IPD-IMGT/HLA=25865).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F60 ! GM13060
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   GM12059
AC   CVCL_4Z86
DR   CLO; CLO_0020646
DR   Coriell; GM12059
DR   Wikidata; Q54845494
CC   Discontinued: Coriell; GM12059; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84779; X-linked ichthyosis
DI   ORDO; Orphanet_281210; X-linked ichthyosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-60Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12072
AC   CVCL_1S51
SY   E4E
DR   CLO; CLO_0020653
DR   Coriell; GM12072
DR   Wikidata; Q54845495
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U406 ! CHO-glyA
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12074
AC   CVCL_5P63
DR   CLO; CLO_0020638
DR   Coriell; GM12074
DR   Wikidata; Q54845496
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM12079
AC   CVCL_U947
SY   GM12079A
DR   CLO; CLO_0020637
DR   Coriell; GM12079
DR   Wikidata; Q54845497
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM12081
AC   CVCL_N193
SY   GM17171
DR   CLO; CLO_0014024
DR   CLO; CLO_0020619
DR   Coriell; GM12081
DR   Coriell; GM17171
DR   GEO; GSM569697
DR   GEO; GSM596235
DR   GEO; GSM597030
DR   GEO; GSM924681
DR   IPD-IMGT/HLA; 20694
DR   Wikidata; Q54845498
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:CNJK,29:02; B*08:XKT,35:BEZX; C*07:CVAG,07:19; DRB1*03:01,13:02 (IPD-IMGT/HLA=20694).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM12082
AC   CVCL_DE50
SY   DL18ts
DR   CLO; CLO_0020620
DR   Coriell; GM12082
DR   Wikidata; Q54845499
RX   PubMed=2045101;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F81 ! CHO-tsH1
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM12083
AC   CVCL_1S52
SY   A1261-35-5
DR   CLO; CLO_0020622
DR   Coriell; GM12083
DR   Wikidata; Q54845500
RX   PubMed=1427858;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 18 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
HI   CVCL_J109 ! GM01261
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM12084
AC   CVCL_1S53
SY   A2054-5-1
DR   CLO; CLO_0020623
DR   Coriell; GM12084
DR   Wikidata; Q54845501
RX   PubMed=1427858;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 18 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
HI   CVCL_X087 ! GM02054
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM12085
AC   CVCL_1S54
SY   A5832-14-11
DR   CLO; CLO_0020625
DR   Coriell; GM12085
DR   Wikidata; Q54845502
RX   PubMed=1427858;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 18 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
HI   CVCL_1Q57 ! GM05382
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM12086
AC   CVCL_1S55
SY   ABCL2-43-12
DR   CLO; CLO_0020627
DR   Coriell; GM12086
DR   Wikidata; Q54845503
RX   PubMed=1427858;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
HI   CVCL_1179 ! DoHH2
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12087
AC   CVCL_1S56
SY   A4125-30-2
DR   CLO; CLO_0020629
DR   Coriell; GM12087
DR   Wikidata; Q54845504
RX   PubMed=1427858;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
HI   CVCL_1Q58 ! GM04125
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12088
AC   CVCL_1S57
SY   ADJ-40-32
DR   CLO; CLO_0020630
DR   Coriell; GM12088
DR   Wikidata; Q54845505
RX   PubMed=1427858;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12089
AC   CVCL_5C79
AS   CVCL_G394
SY   CEPH-1332-NA12089; 1332-8252
DR   CLO; CLO_0020618
DR   Coriell; GM12089
DR   dbMHC; 48555
DR   GEO; GSM420769
DR   GEO; GSM659928
DR   GEO; GSM660139
DR   GEO; GSM660345
DR   IHW; IHW01021
DR   IPD-IMGT/HLA; 25822
DR   Wikidata; Q54845506
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133203.
CC   HLA typing: A*03:01,03:01; B*35:01,35:01; C*04:01,04:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25822).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12090
AC   CVCL_5C80
AS   CVCL_G391
SY   CEPH-1332-NA12090; 1332-1133
DR   CLO; CLO_0020617
DR   Coriell; GM12090
DR   dbMHC; 48556
DR   IHW; IHW01018
DR   IPD-IMGT/HLA; 25819
DR   Wikidata; Q54845507
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133204.
CC   HLA typing: A*03:01,03:01; B*35:01,56:01; C*01:02,04:01; DPA1*01:03,02:01:01; DPB1*04:02,11:01:01; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12091
AC   CVCL_5C81
AS   CVCL_G402
SY   CEPH-1332-NA12091; 1332-8261
DR   CLO; CLO_0020616
DR   Coriell; GM12091
DR   dbMHC; 48557
DR   IHW; IHW01030
DR   IPD-IMGT/HLA; 25830
DR   Wikidata; Q54845516
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133206.
CC   HLA typing: A*03:01,03:01; B*35:01,56:01; C*01:02,04:01; DPA1*01:03,02:01:01; DPB1*04:02,11:01:01; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25830).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12092
AC   CVCL_5C82
AS   CVCL_G398
SY   CEPH-1332-NA12092; 1332-8256
DR   CLO; CLO_0020609
DR   Coriell; GM12092
DR   dbMHC; 48558
DR   GEO; GSM420770
DR   GEO; GSM659925
DR   GEO; GSM660136
DR   GEO; GSM660342
DR   IHW; IHW01025
DR   IPD-IMGT/HLA; 25826
DR   Wikidata; Q54845517
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133207.
CC   HLA typing: A*03:01,03:01; B*27:05,56:01; C*01:02,02:02:02; DPA1*01:03,02:01:01; DPB1*02:01:02,11:01:01; DQA1*03:01,04:01; DQB1*03:02:01,04:02; DRB1*04:04,08:01; DRB4*01 (IPD-IMGT/HLA=25826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12093
AC   CVCL_5C83
AS   CVCL_G397
SY   CEPH-1332-NA12093; 1332-8255
DR   CLO; CLO_0020611
DR   Coriell; GM12093
DR   dbMHC; 48559
DR   GEO; GSM420771
DR   GEO; GSM659924
DR   GEO; GSM660135
DR   GEO; GSM660341
DR   IHW; IHW01024
DR   IPD-IMGT/HLA; 25825
DR   Wikidata; Q54845518
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133208.
CC   HLA typing: A*03:01,03:01; B*35:01,35:01; C*04:01,04:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25825).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12094
AC   CVCL_5C84
AS   CVCL_G395
SY   CEPH-1332-NA12094; 1332-8253
DR   CLO; CLO_0020606
DR   Coriell; GM12094
DR   dbMHC; 48560
DR   GEO; GSM420772
DR   GEO; GSM659923
DR   GEO; GSM660134
DR   GEO; GSM660340
DR   IHW; IHW01022
DR   IPD-IMGT/HLA; 25823
DR   Wikidata; Q54845519
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133211.
CC   HLA typing: A*03:01,03:01; B*35:01,56:01; C*01:02,04:01; DPA1*01:03,02:01:01; DPB1*04:02,11:01:01; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25823).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12095
AC   CVCL_5C85
AS   CVCL_G396
SY   CEPH-1332-NA12095; 1332-8254
DR   CLO; CLO_0020607
DR   Coriell; GM12095
DR   dbMHC; 48561
DR   GEO; GSM420773
DR   GEO; GSM659922
DR   GEO; GSM660133
DR   GEO; GSM660339
DR   IHW; IHW01023
DR   IPD-IMGT/HLA; 25824
DR   Wikidata; Q54845520
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133212.
CC   HLA typing: A*03:01,03:01; B*35:01,35:01; C*04:01,04:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25824).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12096
AC   CVCL_0V43
AS   CVCL_G404
SY   CEPH-1332-NA12096; 1332-8263
DR   CLO; CLO_0020602
DR   Coriell; GM12096
DR   dbMHC; 48562
DR   GEO; GSM314913
DR   GEO; GSM420774
DR   IHW; IHW01032
DR   IPD-IMGT/HLA; 25832
DR   Wikidata; Q54845521
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133213.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,03:01; B*35:01,08:01; C*04:01,07:01; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*04:01,05:01; DQB1*02:01,04:02; DRB1*03:01,08:01; DRB3*10:01 (IPD-IMGT/HLA=25832).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 19
//
ID   GM12097
AC   CVCL_0V44
AS   CVCL_G405
SY   CEPH-1332-NA12097; 1332-8264
DR   CLO; CLO_0020605
DR   Coriell; GM12097
DR   dbMHC; 48563
DR   GEO; GSM314914
DR   GEO; GSM420775
DR   GEO; GSM906149
DR   GEO; GSM906150
DR   IHW; IHW01033
DR   IPD-IMGT/HLA; 25833
DR   Wikidata; Q54845522
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133214.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,03:01; B*56:01,07:02; C*01:02,07:02; DPA1*01:03,02:01:01; DPB1*04:01,11:01:01; DQA1*01:02,04:01; DQB1*04:02,06:02; DRB1*08:01,15:01; DRB5*01:01 (IPD-IMGT/HLA=25833).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 21
//
ID   GM12099
AC   CVCL_5C86
AS   CVCL_G399
SY   CEPH-1332-NA12099; 1332-8257
DR   CLO; CLO_0020600
DR   Coriell; GM12099
DR   dbMHC; 48564
DR   GEO; GSM314915
DR   GEO; GSM420776
DR   IHW; IHW01026
DR   IPD-IMGT/HLA; 25827
DR   Wikidata; Q54845523
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133216.
CC   HLA typing: A*03:01,30:01; B*35:01,07:02; C*04:01,07:02; DPA1*01:03,01:03; DPB1*03:01,04:02; DQA1*01:01,01:02; DQB1*05:01:01,06:02; DRB1*01:01,15:01; DRB5*01:01 (IPD-IMGT/HLA=25827).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12100
AC   CVCL_5C87
AS   CVCL_G392
SY   CEPH-1332-NA12100; 1332-4889
DR   CLO; CLO_0018763
DR   Coriell; GM12100
DR   dbMHC; 48565
DR   GEO; GSM420777
DR   GEO; GSM659926
DR   GEO; GSM660137
DR   GEO; GSM660343
DR   IHW; IHW01019
DR   IPD-IMGT/HLA; 25820
DR   Wikidata; Q54845524
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133217.
CC   HLA typing: A*03:01,03:01; B*35:01,35:01; C*04:01,04:01; DPA1*01:03,01:03; DPB1*04:01:01,04:02; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25820).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12101
AC   CVCL_5C88
AS   CVCL_G531
SY   CEPH-1413-NA12101; 1413-1085
DR   CLO; CLO_0018764
DR   Coriell; GM12101
DR   dbMHC; 48686
DR   GEO; GSM420778
DR   GEO; GSM659867
DR   GEO; GSM660077
DR   GEO; GSM660284
DR   IHW; IHW01162
DR   IPD-IMGT/HLA; 25956
DR   Wikidata; Q54845525
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141303.
CC   HLA typing: A*02:01,68:01:02; B*13:02,44:02; C*03:03,07:04; DPA1*01:03,02:01:01; DPB1*04:01:01,14:01; DQA1*02:01,05:01; DQB1*02:01,03:01:01; DRB1*07:01,11:01 (IPD-IMGT/HLA=25956).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12102
AC   CVCL_5C89
AS   CVCL_G529
SY   CEPH-1413-NA12102; 1413-1083
DR   CLO; CLO_0018765
DR   Coriell; GM12102
DR   dbMHC; 48687
DR   GEO; GSM420779
DR   GEO; GSM659866
DR   GEO; GSM660076
DR   GEO; GSM660283
DR   IHW; IHW01160
DR   IPD-IMGT/HLA; 25954
DR   Wikidata; Q54845526
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141304.
CC   HLA typing: A*02:01,68:01:02; B*13:02,44:02; C*03:03,05:01; DPA1*01:03,02:01:01; DPB1*02:01:02,14:01; DQA1*02:01,03:01; DQB1*02:01,03:01:01; DRB1*04:01,07:01 (IPD-IMGT/HLA=25954).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12103
AC   CVCL_5C90
AS   CVCL_G528
SY   CEPH-1413-NA12103; 1413-1082
DR   CLO; CLO_0018768
DR   Coriell; GM12103
DR   dbMHC; 48688
DR   GEO; GSM659865
DR   GEO; GSM660075
DR   GEO; GSM660282
DR   IHW; IHW01159
DR   IPD-IMGT/HLA; 25953
DR   Wikidata; Q54845527
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141305.
CC   HLA typing: A*02:01,68:01:02; B*13:02,44:02; C*03:03,05:01; DPA1*01:03,02:01:01; DPB1*02:01:02,14:01; DQA1*02:01,03:01; DQB1*02:01,03:01:01; DRB1*04:01,07:01 (IPD-IMGT/HLA=25953).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12104
AC   CVCL_5C91
AS   CVCL_G538
SY   CEPH-1413-NA12104; 1413-1092
DR   CLO; CLO_0018770
DR   Coriell; GM12104
DR   dbMHC; 48689
DR   GEO; GSM659864
DR   GEO; GSM660074
DR   GEO; GSM660281
DR   IHW; IHW01169
DR   IPD-IMGT/HLA; 25963
DR   Wikidata; Q54845528
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141306.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01 (IPD-IMGT/HLA=25963).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12105
AC   CVCL_5C92
AS   CVCL_G541
SY   CEPH-1413-NA12105; 1413-1280
DR   CLO; CLO_0018773
DR   Coriell; GM12105
DR   dbMHC; 48690
DR   GEO; GSM659863
DR   GEO; GSM660073
DR   GEO; GSM660280
DR   IHW; IHW01172
DR   IPD-IMGT/HLA; 25966
DR   Wikidata; Q54845529
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141307.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*07:01,07:04; DPA1*01:03,01:03; DPB1*04:01:01,04:01:01; DQA1*01:02,05:01; DQB1*03:01:01,06:02; DRB1*11:01,15:01 (IPD-IMGT/HLA=25966).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12106
AC   CVCL_5C93
AS   CVCL_G537
SY   CEPH-1413-NA12106; 1413-1091
DR   CLO; CLO_0018774
DR   Coriell; GM12106
DR   dbMHC; 48691
DR   GEO; GSM420780
DR   GEO; GSM659862
DR   GEO; GSM660072
DR   GEO; GSM660279
DR   IHW; IHW01168
DR   IPD-IMGT/HLA; 25962
DR   Wikidata; Q54845530
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141308.
CC   HLA typing: A*02:01,68:01:02; B*13:02,44:02; C*03:03,07:04; DPA1*01:03,02:01:01; DPB1*04:01:01,14:01; DQA1*02:01,05:01; DQB1*02:01,03:01:01; DRB1*07:01,11:01 (IPD-IMGT/HLA=25962).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12107
AC   CVCL_5C94
AS   CVCL_G540
SY   CEPH-1413-NA12107; 1413-1279
DR   CLO; CLO_0018776
DR   Coriell; GM12107
DR   dbMHC; 48692
DR   GEO; GSM420781
DR   GEO; GSM659861
DR   GEO; GSM660071
DR   GEO; GSM660278
DR   IHW; IHW01171
DR   IPD-IMGT/HLA; 25965
DR   Wikidata; Q54845531
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141309.
CC   HLA typing: A*02:01,68:01:02; B*13:02,44:02; C*03:03,07:04; DPA1*01:03,02:01:01; DPB1*04:01:01,14:01; DQA1*02:01,05:01; DQB1*02:01,03:01:01; DRB1*07:01,11:01 (IPD-IMGT/HLA=25965).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12108
AC   CVCL_5C95
AS   CVCL_G527
SY   CEPH-1413-NA12108; 1413-1081
DR   CLO; CLO_0018780
DR   Coriell; GM12108
DR   dbMHC; 48693
DR   GEO; GSM420782
DR   GEO; GSM659868
DR   GEO; GSM660078
DR   GEO; GSM660285
DR   IHW; IHW01158
DR   IPD-IMGT/HLA; 25952
DR   Wikidata; Q54845532
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141310.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01 (IPD-IMGT/HLA=25952).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12109
AC   CVCL_5C96
AS   CVCL_G524
SY   CEPH-1413-NA12109; 1413-1078
DR   CLO; CLO_0019092
DR   Coriell; GM12109
DR   dbMHC; 48694
DR   IHW; IHW01155
DR   IPD-IMGT/HLA; 25949
DR   Wikidata; Q54845533
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141311.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01 (IPD-IMGT/HLA=25949).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12110
AC   CVCL_5C97
AS   CVCL_G525
SY   CEPH-1413-NA12110; 1413-1079
DR   CLO; CLO_0019087
DR   Coriell; GM12110
DR   dbMHC; 48695
DR   IHW; IHW01156
DR   IPD-IMGT/HLA; 25950
DR   Wikidata; Q54845534
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141312.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*07:01,07:04; DPA1*01:03,01:03; DPB1*04:01:01,04:01:01; DQA1*01:02,05:01; DQB1*03:01:01,06:02; DRB1*11:01,15:01 (IPD-IMGT/HLA=25950).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12111
AC   CVCL_5C98
AS   CVCL_G526
SY   CEPH-1413-NA12111; 1413-1080
DR   CLO; CLO_0019086
DR   Coriell; GM12111
DR   dbMHC; 48696
DR   GEO; GSM420783
DR   IHW; IHW01157
DR   IPD-IMGT/HLA; 25951
DR   Wikidata; Q54845535
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141313.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*07:01,07:04; DPA1*01:03,01:03; DPB1*04:01:01,04:01:01; DQA1*01:02,05:01; DQB1*03:01:01,06:02; DRB1*11:01,15:01 (IPD-IMGT/HLA=25951).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12112
AC   CVCL_5C99
AS   CVCL_G532
SY   CEPH-1413-NA12112; 1413-1086
DR   CLO; CLO_0019079
DR   Coriell; GM12112
DR   dbMHC; 48697
DR   GEO; GSM420784
DR   IHW; IHW01163
DR   IPD-IMGT/HLA; 25957
DR   Wikidata; Q54845536
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141314.
CC   HLA typing: A*02:01,68:01:02; B*13:02,44:02; C*03:03,07:04; DPA1*01:03,02:01:01; DPB1*04:01:01,14:01; DQA1*02:01,05:01; DQB1*02:01,03:01:01; DRB1*07:01,11:01 (IPD-IMGT/HLA=25957).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12113
AC   CVCL_5D00
AS   CVCL_G533
SY   CEPH-1413-NA12113; 1413-1087
DR   CLO; CLO_0019078
DR   Coriell; GM12113
DR   dbMHC; 48698
DR   IHW; IHW01164
DR   IPD-IMGT/HLA; 25958
DR   Wikidata; Q54845537
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141315.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01 (IPD-IMGT/HLA=25958).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12114
AC   CVCL_5D01
AS   CVCL_G534
SY   CEPH-1413-NA12114; 1413-1088
DR   CLO; CLO_0019081
DR   Coriell; GM12114
DR   dbMHC; 48699
DR   IHW; IHW01165
DR   IPD-IMGT/HLA; 25959
DR   Wikidata; Q54845538
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141316.
CC   HLA typing: A*01:01,02:01; B*13:02,44:02; C*05:01,07:01; DPA1*01:03,02:01:01; DPB1*02:01:02,14:01; DQA1*02:01,03:01; DQB1*02:01,03:01:01; DRB1*04:01,07:01 (IPD-IMGT/HLA=25959).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12115
AC   CVCL_5D02
AS   CVCL_G536
SY   CEPH-1413-NA12115; 1413-1090
DR   CLO; CLO_0019080
DR   Coriell; GM12115
DR   dbMHC; 48700
DR   GEO; GSM420785
DR   IHW; IHW01167
DR   IPD-IMGT/HLA; 25961
DR   Wikidata; Q54845539
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141317.
CC   HLA typing: A*02:01,68:01:02; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*01:02,03:01; DQB1*03:01:01,06:02; DRB1*04:01,15:01 (IPD-IMGT/HLA=25961).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12116
AC   CVCL_5D03
AS   CVCL_G539
SY   CEPH-1413-NA12116; 1413-1218
DR   CLO; CLO_0019083
DR   Coriell; GM12116
DR   dbMHC; 48701
DR   GEO; GSM314916
DR   GEO; GSM420786
DR   IHW; IHW01170
DR   IPD-IMGT/HLA; 25964
DR   Wikidata; Q54845540
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141318.
CC   HLA typing: A*11:01,68:01:02; B*07:02,13:02; C*03:03,07:02; DPA1*01:03,02:01:01; DPB1*04:01,14:01; DQA1*01:02,02:01; DQB1*02:01,06:02; DRB1*07:01,15:01 (IPD-IMGT/HLA=25964).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12117
AC   CVCL_5D04
AS   CVCL_G523
SY   CEPH-1413-NA12117; 1413-1077
DR   CLO; CLO_0019082
DR   Coriell; GM12117
DR   dbMHC; 48702
DR   GEO; GSM314917
DR   GEO; GSM420787
DR   IHW; IHW01154
DR   IPD-IMGT/HLA; 25948
DR   Wikidata; Q54845541
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141319.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01; DQA1*03:01,05:01; DQB1*02:01,03:01:01; DRB1*03:01,04:01 (IPD-IMGT/HLA=25948).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12123
AC   CVCL_JL93
DR   CLO; CLO_0019085
DR   Coriell; GM12123
DR   Wikidata; Q54845542
RX   PubMed=12730363;
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:13666; AAAS; Simple; c.1331+1G>A (IVS14+1G>A); ClinVar=VCV000264994; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=12730363).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C35710; Triple A syndrome
DI   ORDO; Orphanet_869; Triple A syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM12125
AC   CVCL_EH07
DR   CLO; CLO_0019084
DR   Coriell; GM12125
DR   Wikidata; Q54845543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM12126
AC   CVCL_GS80
DR   CLO; CLO_0019108
DR   Coriell; GM12126
DR   Wikidata; Q54845545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129031; Spondyloepimetaphyseal dysplasia, sponastrime type
DI   ORDO; Orphanet_93357; SPONASTRIME dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM12127
AC   CVCL_GR16
DR   CLO; CLO_0019107
DR   Coriell; GM12127
DR   Wikidata; Q54845546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM12129
AC   CVCL_BT28
DR   CLO; CLO_0019106
DR   Coriell; GM12129
DR   Wikidata; Q54845547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12131
AC   CVCL_1K68
DR   CLO; CLO_0019102
DR   Coriell; GM12131
DR   Wikidata; Q54845548
RX   PubMed=1333075;
CC   Population: Caucasian.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84737; Glycogen storage disease type IV
DI   ORDO; Orphanet_367; Glycogen storage disease due to glycogen branching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM12132
AC   CVCL_5J58
DR   CLO; CLO_0019101
DR   Coriell; GM12132
DR   Wikidata; Q54845549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12133
AC   CVCL_5J59
DR   CLO; CLO_0019100
DR   Coriell; GM12133
DR   Wikidata; Q54845550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12134
AC   CVCL_U535
DR   CLO; CLO_0019099
DR   BioSample; SAMN00801199
DR   Coriell; GM12134
DR   Wikidata; Q54845551
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U537 ! GM13553
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM12135
AC   CVCL_U536
DR   CLO; CLO_0019105
DR   Coriell; GM12135
DR   Wikidata; Q54845553
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM12136
AC   CVCL_N194
SY   GM17006
DR   CLO; CLO_0018055
DR   CLO; CLO_0019104
DR   Coriell; GM12136
DR   Coriell; GM17006
DR   Wikidata; Q54845554
RX   PubMed=1333075;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM12137
AC   CVCL_N195
SY   GM17007
DR   CLO; CLO_0018053
DR   CLO; CLO_0019103
DR   Coriell; GM12137
DR   Coriell; GM17007
DR   Wikidata; Q54845555
RX   PubMed=1333075;
CC   Part of: Human variation panel.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM12138
AC   CVCL_5D05
DR   CLO; CLO_0019127
DR   Coriell; GM12138
DR   GEO; GSM30007
DR   GEO; GSM420788
DR   Wikidata; Q54845556
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133403.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12139
AC   CVCL_5D06
DR   CLO; CLO_0019126
DR   Coriell; GM12139
DR   GEO; GSM420789
DR   Wikidata; Q54845557
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133404.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12141
AC   CVCL_5D07
DR   CLO; CLO_0019129
DR   Coriell; GM12141
DR   GEO; GSM420790
DR   Wikidata; Q54845566
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133406.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12142
AC   CVCL_5D08
DR   CLO; CLO_0019128
DR   Coriell; GM12142
DR   GEO; GSM420791
DR   Wikidata; Q54845567
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133407.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12143
AC   CVCL_5D09
DR   CLO; CLO_0019123
DR   Coriell; GM12143
DR   GEO; GSM30009
DR   GEO; GSM420792
DR   Wikidata; Q54845568
RX   PubMed=15514893;
RX   PubMed=17668376;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133409.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12144
AC   CVCL_9606
DR   CLO; CLO_0019121
DR   EFO; EFO_0001136
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM12144
DR   GEO; GSM25548
DR   GEO; GSM25549
DR   GEO; GSM112530
DR   GEO; GSM112835
DR   GEO; GSM188810
DR   GEO; GSM273319
DR   GEO; GSM273320
DR   GEO; GSM291645
DR   GEO; GSM291646
DR   GEO; GSM314918
DR   GEO; GSM314919
DR   GEO; GSM420793
DR   GEO; GSM420794
DR   GEO; GSM424347
DR   GEO; GSM486795
DR   GEO; GSM486796
DR   GEO; GSM648908
DR   GEO; GSM649853
DR   GEO; GSM659941
DR   GEO; GSM660152
DR   GEO; GSM660392
DR   GEO; GSM905866
DR   GEO; GSM905961
DR   GEO; GSM906056
DR   GEO; GSM957383
DR   GEO; GSM1719782
DR   IGSR; NA12144
DR   Wikidata; Q54845569
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133410.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   GM12145
AC   CVCL_7521
DR   CLO; CLO_0019125
DR   EFO; EFO_0001137
DR   Coriell; GM12145
DR   GEO; GSM25550
DR   GEO; GSM25551
DR   GEO; GSM30010
DR   GEO; GSM112531
DR   GEO; GSM112836
DR   GEO; GSM188811
DR   GEO; GSM273321
DR   GEO; GSM273322
DR   GEO; GSM291647
DR   GEO; GSM291648
DR   GEO; GSM291649
DR   GEO; GSM291650
DR   GEO; GSM291651
DR   GEO; GSM291652
DR   GEO; GSM291653
DR   GEO; GSM291654
DR   GEO; GSM291655
DR   GEO; GSM291656
DR   GEO; GSM291657
DR   GEO; GSM314920
DR   GEO; GSM314921
DR   GEO; GSM420795
DR   GEO; GSM420796
DR   GEO; GSM424348
DR   GEO; GSM486797
DR   GEO; GSM486798
DR   GEO; GSM649298
DR   GEO; GSM659978
DR   GEO; GSM660183
DR   GEO; GSM660389
DR   GEO; GSM905867
DR   GEO; GSM905962
DR   GEO; GSM906057
DR   GEO; GSM957384
DR   IGSR; NA12145
DR   Wikidata; Q54845570
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133411.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12145).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   GM12146
AC   CVCL_9607
DR   CLO; CLO_0019124
DR   EFO; EFO_0001138
DR   Coriell; GM12146
DR   GEO; GSM25552
DR   GEO; GSM25553
DR   GEO; GSM30011
DR   GEO; GSM112532
DR   GEO; GSM112837
DR   GEO; GSM188812
DR   GEO; GSM273323
DR   GEO; GSM273324
DR   GEO; GSM291658
DR   GEO; GSM314922
DR   GEO; GSM314923
DR   GEO; GSM420797
DR   GEO; GSM420798
DR   GEO; GSM486799
DR   GEO; GSM486800
DR   GEO; GSM648842
DR   GEO; GSM659974
DR   GEO; GSM660179
DR   GEO; GSM660385
DR   GEO; GSM905868
DR   GEO; GSM905963
DR   GEO; GSM906058
DR   IGSR; NA12146
DR   Wikidata; Q54845571
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   GM12147
AC   CVCL_5D10
AS   CVCL_G509
SY   CEPH-1408-NA12147; 1408-1011
DR   CLO; CLO_0019120
DR   Coriell; GM12147
DR   dbMHC; 48672
DR   GEO; GSM25554
DR   GEO; GSM30117
DR   GEO; GSM316237
DR   GEO; GSM316238
DR   GEO; GSM316239
DR   GEO; GSM420799
DR   IHW; IHW01140
DR   IPD-IMGT/HLA; 25937
DR   Wikidata; Q54845572
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140803.
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*05:01,05:01; DQB1*02:01,03:01; DRB1*03:01,12:01 (IPD-IMGT/HLA=25937).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12148
AC   CVCL_5D11
AS   CVCL_G514
SY   CEPH-1408-NA12148; 1408-1016
DR   CLO; CLO_0019119
DR   Coriell; GM12148
DR   dbMHC; 48673
DR   GEO; GSM25555
DR   GEO; GSM30118
DR   GEO; GSM316528
DR   GEO; GSM316529
DR   GEO; GSM316530
DR   GEO; GSM420800
DR   IHW; IHW01145
DR   IPD-IMGT/HLA; 25940
DR   Wikidata; Q54845573
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140804.
CC   HLA typing: A*01:01,02:01; B*07:02,51:01; C*07:02,15:02; DPA1*01:03,01:03; DPB1*03:01:01,04:02; DQA1*03:01,05:01; DQB1*03:01,03:01; DRB1*04:07,12:01 (IPD-IMGT/HLA=25940).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12149
AC   CVCL_5D12
AS   CVCL_G520
SY   CEPH-1408-NA12149; 1408-1025
DR   CLO; CLO_0019148
DR   Coriell; GM12149
DR   dbMHC; 48674
DR   GEO; GSM25556
DR   GEO; GSM30119
DR   GEO; GSM316240
DR   GEO; GSM316241
DR   GEO; GSM316242
DR   GEO; GSM420801
DR   IHW; IHW01151
DR   IPD-IMGT/HLA; 25946
DR   Wikidata; Q54845574
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140805.
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*05:01,05:01; DQB1*02:01,03:01; DRB1*03:01,12:01 (IPD-IMGT/HLA=25946).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12150
AC   CVCL_5D13
AS   CVCL_G519
SY   CEPH-1408-NA12150; 1408-1022
DR   CLO; CLO_0019147
DR   Coriell; GM12150
DR   dbMHC; 48675
DR   GEO; GSM25557
DR   GEO; GSM30120
DR   GEO; GSM316243
DR   GEO; GSM316244
DR   GEO; GSM316245
DR   GEO; GSM420802
DR   IHW; IHW01150
DR   IPD-IMGT/HLA; 25945
DR   Wikidata; Q54845575
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140806.
CC   HLA typing: A*01:01,02:01; B*07:02,51:01; C*07:02,15:02; DPA1*01:03,01:03; DPB1*03:01:01,04:02; DQA1*03:01,05:01; DQB1*03:01,03:01; DRB1*04:07,12:01 (IPD-IMGT/HLA=25945).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12151
AC   CVCL_5D14
AS   CVCL_G521
SY   CEPH-1408-NA12151; 1408-1038
DR   CLO; CLO_0019146
DR   Coriell; GM12151
DR   dbMHC; 48676
DR   GEO; GSM25558
DR   GEO; GSM30121
DR   GEO; GSM316246
DR   GEO; GSM316247
DR   GEO; GSM316248
DR   GEO; GSM420803
DR   IHW; IHW01152
DR   IPD-IMGT/HLA; 13836
DR   Wikidata; Q54845576
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140807.
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*05:01,05:01; DQB1*02:01,02:01; DRB1*03:01,03:01 (IPD-IMGT/HLA=13836).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12152
AC   CVCL_5D15
AS   CVCL_G513
SY   CEPH-1408-NA12152; 1408-1015
DR   CLO; CLO_0019145
DR   Coriell; GM12152
DR   dbMHC; 48677
DR   GEO; GSM25559
DR   GEO; GSM30122
DR   GEO; GSM316531
DR   GEO; GSM316532
DR   GEO; GSM316533
DR   GEO; GSM420804
DR   IHW; IHW01144
DR   IPD-IMGT/HLA; 25939
DR   Wikidata; Q54845577
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140808.
CC   HLA typing: A*01:01,02:01; B*07:02,51:01; C*07:02,15:02; DPA1*01:03,01:03; DPB1*03:01:01,04:02; DQA1*03:01,05:01; DQB1*03:01,03:01; DRB1*04:07,12:01 (IPD-IMGT/HLA=25939).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12153
AC   CVCL_5D16
AS   CVCL_G511
SY   CEPH-1408-NA12153; 1408-1013
DR   CLO; CLO_0019144
DR   Coriell; GM12153
DR   dbMHC; 48678
DR   GEO; GSM25560
DR   GEO; GSM30123
DR   GEO; GSM316534
DR   GEO; GSM316535
DR   GEO; GSM316536
DR   GEO; GSM420805
DR   IHW; IHW01142
DR   IPD-IMGT/HLA; 25938
DR   Wikidata; Q54845578
RX   PubMed=15514893;
RX   PubMed=17668376;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140809.
CC   HLA typing: A*01:01,01:01; B*08:01,51:01; C*07:01,15:02; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*03:01,05:01; DQB1*02:01,03:01; DRB1*03:01,04:07 (IPD-IMGT/HLA=25938).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12154
AC   CVCL_9608
AS   CVCL_G518
SY   CEPH-1408-NA12154; 1408-1020
DR   CLO; CLO_0019143
DR   EFO; EFO_0001139
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801237
DR   Coriell; GM12154
DR   dbMHC; 48679
DR   GEO; GSM25561
DR   GEO; GSM25562
DR   GEO; GSM30177
DR   GEO; GSM112533
DR   GEO; GSM112838
DR   GEO; GSM188813
DR   GEO; GSM273325
DR   GEO; GSM273326
DR   GEO; GSM291659
DR   GEO; GSM291660
DR   GEO; GSM314924
DR   GEO; GSM314925
DR   GEO; GSM420806
DR   GEO; GSM420807
DR   GEO; GSM486801
DR   GEO; GSM486802
DR   GEO; GSM648947
DR   GEO; GSM659958
DR   GEO; GSM660171
DR   GEO; GSM660355
DR   GEO; GSM905869
DR   GEO; GSM905964
DR   GEO; GSM906059
DR   GEO; GSM1719783
DR   IGSR; NA12154
DR   IHW; IHW01149
DR   IPD-IMGT/HLA; 25944
DR   Wikidata; Q54845579
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
RX   PubMed=31401124;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140810.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,31:01; B*08:01,40:01; C*03:04:01,07:01; DPA1*01:03,01:03; DPB1*04:01,04:01:01; DQA1*03:01,05:01; DQB1*02:01,03:02; DRB1*03:01,04:04 (IPD-IMGT/HLA=25944).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 28
//
ID   GM12155
AC   CVCL_7522
AS   CVCL_G516
SY   CEPH-1408-NA12155; 1408-1018
DR   CLO; CLO_0019142
DR   EFO; EFO_0001140
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801239
DR   Coriell; GM12155
DR   dbMHC; 48680
DR   GEO; GSM25563
DR   GEO; GSM25564
DR   GEO; GSM30178
DR   GEO; GSM112534
DR   GEO; GSM112839
DR   GEO; GSM188814
DR   GEO; GSM273327
DR   GEO; GSM291661
DR   GEO; GSM314926
DR   GEO; GSM420808
DR   GEO; GSM424349
DR   GEO; GSM486803
DR   GEO; GSM486804
DR   GEO; GSM648854
DR   GEO; GSM659989
DR   GEO; GSM660196
DR   GEO; GSM660400
DR   GEO; GSM905870
DR   GEO; GSM905965
DR   GEO; GSM906060
DR   GEO; GSM957385
DR   GEO; GSM1719784
DR   IGSR; NA12155
DR   IHW; IHW01147
DR   IPD-IMGT/HLA; 25942
DR   Wikidata; Q54845580
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140812.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01; DQA1*03:01,05:01; DQB1*02:01,03:01; DRB1*03:01,04:01 (IPD-IMGT/HLA=25942).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   GM12156
AC   CVCL_9609
AS   CVCL_G515
SY   CEPH-1408-NA12156; 1408-1017
DR   CLO; CLO_0019141
DR   EFO; EFO_0001141
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801241
DR   Coriell; GM12156
DR   dbMHC; 48681
DR   GEO; GSM25565
DR   GEO; GSM25566
DR   GEO; GSM30179
DR   GEO; GSM112535
DR   GEO; GSM112840
DR   GEO; GSM188815
DR   GEO; GSM273328
DR   GEO; GSM273329
DR   GEO; GSM291662
DR   GEO; GSM314927
DR   GEO; GSM314928
DR   GEO; GSM420809
DR   GEO; GSM420810
DR   GEO; GSM486805
DR   GEO; GSM486806
DR   GEO; GSM648951
DR   GEO; GSM649854
DR   GEO; GSM659987
DR   GEO; GSM660194
DR   GEO; GSM660398
DR   GEO; GSM905871
DR   GEO; GSM905966
DR   GEO; GSM906061
DR   GEO; GSM1719785
DR   IGSR; NA12156
DR   IHW; IHW01146
DR   IPD-IMGT/HLA; 25941
DR   Wikidata; Q54845581
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140813.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01:01,11:01; B*50:01,51:01; C*06:02,15:02; DPA1*01:03,01:03; DPB1*02:01,03:01:01; DQA1*02:01,03:01; DQB1*02:01,03:01; DRB1*04:07,07:01 (IPD-IMGT/HLA=25941).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   GM12157
AC   CVCL_5D17
AS   CVCL_G522
SY   CEPH-1408-NA12157; 1408-1694
DR   CLO; CLO_0019140
DR   Coriell; GM12157
DR   dbMHC; 48682
DR   GEO; GSM25567
DR   GEO; GSM30180
DR   GEO; GSM316249
DR   GEO; GSM316250
DR   GEO; GSM316251
DR   GEO; GSM420811
DR   IHW; IHW01153
DR   IPD-IMGT/HLA; 25947
DR   Wikidata; Q54845582
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140814.
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02; DPA1*01:03,01:03; DPB1*02:01:02,04:02; DQA1*05:01,05:01; DQB1*02:01,03:01; DRB1*03:01,12:01 (IPD-IMGT/HLA=25947).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12158
AC   CVCL_0P70
DR   CLO; CLO_0019139
DR   Coriell; GM12158
DR   Wikidata; Q54845584
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM12160
AC   CVCL_6G98
DR   CLO; CLO_0019159
DR   Coriell; GM12160
DR   Wikidata; Q54845585
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(4)(qter->p15.1) (Coriell=GM12160).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM12198
AC   CVCL_0P71
DR   CLO; CLO_0019160
DR   Coriell; GM12198
DR   Wikidata; Q54845586
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM12199
AC   CVCL_0P72
DR   CLO; CLO_0019161
DR   Coriell; GM12199
DR   Wikidata; Q54845587
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM12200
AC   CVCL_5M51
DR   CLO; CLO_0019162
DR   Coriell; GM12200
DR   Wikidata; Q54845588
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM12201
AC   CVCL_5M52
DR   CLO; CLO_0019163
DR   Coriell; GM12201
DR   Wikidata; Q54845589
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM12202
AC   CVCL_5M53
DR   CLO; CLO_0019164
DR   Coriell; GM12202
DR   Wikidata; Q54845590
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM12203
AC   CVCL_5M54
DR   CLO; CLO_0019166
DR   Coriell; GM12203
DR   Wikidata; Q54845591
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85032; Proteus syndrome
DI   ORDO; Orphanet_744; Proteus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M55 ! GM12260
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM12212
AC   CVCL_5M50
DR   CLO; CLO_0019168
DR   Coriell; GM12212
DR   Wikidata; Q54845592
CC   Sequence variation: Mutation; HGNC; HGNC:8806; PDHA1; Simple; p.Arg263Gly (c.787C>G); ClinVar=VCV000010878; Zygosity=Hemizygous (Coriell=GM12212).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103968; Pyruvate dehydrogenase deficiency
DI   ORDO; Orphanet_79243; Pyruvate dehydrogenase E1-alpha deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM12214
AC   CVCL_1K30
DR   CLO; CLO_0019169
DR   Coriell; GM12214
DR   Wikidata; Q54845593
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM12215
AC   CVCL_1S58
SY   Hy484-2D
DR   CLO; CLO_0019170
DR   Coriell; GM12215
DR   Wikidata; Q54845594
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12217
AC   CVCL_GZ43
DR   CLO; CLO_0019181
DR   Coriell; GM12217
DR   Wikidata; Q54845595
RX   PubMed=27896104;
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Simple; p.Ile173Asn (c.518T>A) (p.Ile172Asn, c.515T>A); ClinVar=VCV000012150; Zygosity=Homozygous (PubMed=27896104).
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; CH-3 30kb del (CH-3 type CYP21A1P/CYP21A2 chimer); Zygosity=Homozygous (PubMed=27896104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM12218
AC   CVCL_5P64
DR   Coriell; GM12218
DR   Wikidata; Q54845596
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM12220
AC   CVCL_DB81
DR   CLO; CLO_0019179
DR   Coriell; GM12220
DR   Wikidata; Q54845597
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM12221
AC   CVCL_DB82
DR   CLO; CLO_0019180
DR   Coriell; GM12221
DR   Wikidata; Q54845598
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM12222
AC   CVCL_AY62
DR   CLO; CLO_0019184
DR   Coriell; GM12222
DR   Wikidata; Q54845599
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM12223
AC   CVCL_AY63
DR   CLO; CLO_0019185
DR   Coriell; GM12223
DR   Wikidata; Q54845600
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM12224
AC   CVCL_AY64
DR   CLO; CLO_0019182
DR   Coriell; GM12224
DR   Wikidata; Q54845601
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84612; Carbamoyl-phosphate synthetase I deficiency
DI   ORDO; Orphanet_147; Carbamoyl-phosphate synthetase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM12225
AC   CVCL_V423
DR   CLO; CLO_0019183
DR   Coriell; GM12225
DR   Wikidata; Q54845602
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM12226
AC   CVCL_V424
DR   CLO; CLO_0019187
DR   Coriell; GM12226
DR   Wikidata; Q54845603
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM12227
AC   CVCL_5J60
DR   CLO; CLO_0019189
DR   Coriell; GM12227
DR   Wikidata; Q54845604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12228
AC   CVCL_5J61
DR   CLO; CLO_0019186
DR   Coriell; GM12228
DR   Wikidata; Q54845605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12229
AC   CVCL_5D18
DR   CLO; CLO_0019203
DR   Coriell; GM12229
DR   GEO; GSM30098
DR   GEO; GSM420812
DR   Wikidata; Q54845606
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137503.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12230
AC   CVCL_5D19
DR   CLO; CLO_0019204
DR   Coriell; GM12230
DR   GEO; GSM420813
DR   Wikidata; Q54845614
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137504.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12231
AC   CVCL_5D20
DR   CLO; CLO_0019205
DR   Coriell; GM12231
DR   GEO; GSM30099
DR   GEO; GSM420814
DR   Wikidata; Q54845615
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137505.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12232
AC   CVCL_5D21
DR   CLO; CLO_0019206
DR   Coriell; GM12232
DR   GEO; GSM30100
DR   GEO; GSM420815
DR   Wikidata; Q54845616
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137506.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12233
AC   CVCL_5D22
DR   CLO; CLO_0019199
DR   Coriell; GM12233
DR   GEO; GSM30101
DR   GEO; GSM420816
DR   Wikidata; Q54845617
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137507.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12234
AC   CVCL_9610
DR   CLO; CLO_0019200
DR   EFO; EFO_0001142
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801290
DR   Coriell; GM12234
DR   GEO; GSM30104
DR   GEO; GSM112536
DR   GEO; GSM112841
DR   GEO; GSM188816
DR   GEO; GSM273330
DR   GEO; GSM291663
DR   GEO; GSM314929
DR   GEO; GSM420817
DR   GEO; GSM486807
DR   GEO; GSM486808
DR   GEO; GSM649299
DR   GEO; GSM659981
DR   GEO; GSM660176
DR   GEO; GSM660393
DR   GEO; GSM905872
DR   GEO; GSM905967
DR   GEO; GSM906062
DR   GEO; GSM1719786
DR   IGSR; NA12234
DR   Wikidata; Q54845618
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137512.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM12235
AC   CVCL_5D23
DR   CLO; CLO_0019201
DR   Coriell; GM12235
DR   GEO; GSM30105
DR   GEO; GSM420818
DR   Wikidata; Q54845619
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137513.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12236
AC   CVCL_9611
AS   CVCL_G517
SY   CEPH-1408-NA12236; 1408-1019
DR   CLO; CLO_0019202
DR   EFO; EFO_0001143
DR   Coriell; GM12236
DR   dbMHC; 48683
DR   GEO; GSM25568
DR   GEO; GSM25569
DR   GEO; GSM112537
DR   GEO; GSM112842
DR   GEO; GSM273331
DR   GEO; GSM273332
DR   GEO; GSM314930
DR   GEO; GSM314931
DR   GEO; GSM420819
DR   GEO; GSM420820
DR   GEO; GSM486809
DR   GEO; GSM486810
DR   GEO; GSM648891
DR   GEO; GSM659966
DR   GEO; GSM660153
DR   GEO; GSM660360
DR   GEO; GSM905873
DR   GEO; GSM905968
DR   GEO; GSM906063
DR   IHW; IHW01148
DR   IPD-IMGT/HLA; 25943
DR   Wikidata; Q54845620
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=29474986;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 140811.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,02:01; B*07:02,44:02; C*05:01,07:02; DPA1*01:03,02:01:01; DPB1*04:02,14:01; DQA1*03:01,05:01; DQB1*03:01,03:02; DRB1*04:03,12:01 (IPD-IMGT/HLA=25943).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM12236; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   GM12237
AC   CVCL_5D24
AS   CVCL_G400
SY   CEPH-1332-NA12237; 1332-8259
DR   CLO; CLO_0019208
DR   Coriell; GM12237
DR   dbMHC; 48566
DR   GEO; GSM420821
DR   IHW; IHW01028
DR   IPD-IMGT/HLA; 25828
DR   Wikidata; Q54845621
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133210.
CC   HLA typing: A*03:01,03:01; B*27:05,35:01; C*02:02:02,04:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*03:01,04:01; DQB1*03:02:01,04:02; DRB1*04:04,08:01; DRB4*01 (IPD-IMGT/HLA=25828).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM12238
AC   CVCL_5D25
DR   CLO; CLO_0019210
DR   Coriell; GM12238
DR   GEO; GSM30008
DR   GEO; GSM420822
DR   Wikidata; Q54845622
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133408.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12239
AC   CVCL_9612
DR   CLO; CLO_0019238
DR   EFO; EFO_0001144
DR   Coriell; GM12239
DR   GEO; GSM25570
DR   GEO; GSM25571
DR   GEO; GSM30012
DR   GEO; GSM112538
DR   GEO; GSM112843
DR   GEO; GSM188817
DR   GEO; GSM273333
DR   GEO; GSM273334
DR   GEO; GSM291664
DR   GEO; GSM314932
DR   GEO; GSM314933
DR   GEO; GSM420823
DR   GEO; GSM420824
DR   GEO; GSM486811
DR   GEO; GSM486812
DR   GEO; GSM648946
DR   GEO; GSM659970
DR   GEO; GSM660175
DR   GEO; GSM660381
DR   GEO; GSM905874
DR   GEO; GSM905969
DR   GEO; GSM906064
DR   IGSR; NA12239
DR   Wikidata; Q54845623
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133413.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   GM12240
AC   CVCL_5D26
AS   CVCL_G550
SY   CEPH-1416-NA12240; 1416-1194
DR   CLO; CLO_0019225
DR   Coriell; GM12240
DR   dbMHC; 48705
DR   GEO; GSM25572
DR   GEO; GSM316537
DR   GEO; GSM316538
DR   GEO; GSM316539
DR   GEO; GSM420825
DR   IHW; IHW01181
DR   IPD-IMGT/HLA; 13841
DR   Wikidata; Q54845624
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141603.
CC   HLA typing: A*02:01,02:05; B*40:01,49:01; C*03:04:01,07:01; DPA1*01:03,02:01:01; DPB1*03:01:01,13:01; DQA1*01:02,01:02; DQB1*06:04:01,06:09; DRB1*13:02,13:02 (IPD-IMGT/HLA=13841).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12241
AC   CVCL_5D27
AS   CVCL_G553
SY   CEPH-1416-NA12241; 1416-1197
DR   CLO; CLO_0019226
DR   Coriell; GM12241
DR   dbMHC; 48706
DR   GEO; GSM25573
DR   GEO; GSM316540
DR   GEO; GSM316541
DR   GEO; GSM316542
DR   GEO; GSM420826
DR   IHW; IHW01184
DR   IPD-IMGT/HLA; 13833
DR   Wikidata; Q54845625
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141604.
CC   HLA typing: A*02:01,23:01; B*15:01,41:01; C*03:03,17:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*02:01,03:01; DQB1*02:01,03:02:01; DRB1*04:01,07:01 (IPD-IMGT/HLA=13833).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12242
AC   CVCL_G545
SY   CEPH-1416-NA12242; 1416-1189
DR   Coriell; GM12242
DR   dbMHC; 48707
DR   IHW; IHW01176
DR   IPD-IMGT/HLA; 25968
DR   Wikidata; Q54845626
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141605.
CC   HLA typing: A*02:05,23:01; B*41:01,49:01; C*07:01,17:01; DPA1*01:03,02:01:01; DPB1*02:01:02,13:01; DQA1*01:02,02:01; DQB1*02:01,06:09; DRB1*07:01,13:02 (IPD-IMGT/HLA=25968).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM12243
AC   CVCL_5D28
AS   CVCL_G549
SY   CEPH-1416-NA12243; 1416-1193
DR   CLO; CLO_0019223
DR   Coriell; GM12243
DR   dbMHC; 48708
DR   GEO; GSM25574
DR   GEO; GSM316543
DR   GEO; GSM316544
DR   GEO; GSM316545
DR   GEO; GSM420827
DR   IHW; IHW01180
DR   IPD-IMGT/HLA; 25972
DR   Wikidata; Q54845627
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141606.
CC   HLA typing: A*02:01,02:01; B*15:01,40:01; C*03:03,03:04:01; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*01:02,03:01; DQB1*03:02:01,06:04; DRB1*04:01,13:02 (IPD-IMGT/HLA=25972).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12244
AC   CVCL_5D29
AS   CVCL_G547
SY   CEPH-1416-NA12244; 1416-1191
DR   CLO; CLO_0019224
DR   Coriell; GM12244
DR   dbMHC; 48709
DR   GEO; GSM660031
DR   GEO; GSM660238
DR   GEO; GSM660442
DR   IHW; IHW01178
DR   IPD-IMGT/HLA; 25970
DR   Wikidata; Q54845628
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141607.
CC   HLA typing: A*02:01,23:01; B*15:01,41:01; C*03:03,17:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01:01; DQA1*02:01,03:01; DQB1*02:01,03:02:01; DRB1*04:01,07:01 (IPD-IMGT/HLA=25970).
CC   HLA typing: A*02:01:01,23:01:01; B*15:01:01,41:01:01; C*03:03:01,17:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*02:01:01,03:01:01; DQB1*02:02:01,03:02:01; DRB1*04:01:01,07:01:01; DRB4*01:03:01,01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   GM12245
AC   CVCL_5D30
AS   CVCL_G548
SY   CEPH-1416-NA12245; 1416-1192
DR   CLO; CLO_0019221
DR   Coriell; GM12245
DR   dbMHC; 48710
DR   GEO; GSM25575
DR   GEO; GSM316546
DR   GEO; GSM316547
DR   GEO; GSM316548
DR   GEO; GSM420828
DR   IHW; IHW01179
DR   IPD-IMGT/HLA; 25971
DR   Wikidata; Q54845629
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141608.
CC   HLA typing: A*02:01,02:01; B*15:01,40:01; C*03:03,03:04:01; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*01:02,03:01; DQB1*03:02:01,06:04; DRB1*04:01,13:02 (IPD-IMGT/HLA=25971).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12246
AC   CVCL_5D31
AS   CVCL_G546
SY   CEPH-1416-NA12246; 1416-1190
DR   CLO; CLO_0019222
DR   Coriell; GM12246
DR   dbMHC; 48711
DR   GEO; GSM25576
DR   GEO; GSM316255
DR   GEO; GSM316256
DR   GEO; GSM316257
DR   GEO; GSM420829
DR   IHW; IHW01177
DR   IPD-IMGT/HLA; 25969
DR   Wikidata; Q54845630
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141609.
CC   HLA typing: A*02:01,02:01; B*15:01,40:01; C*03:03,03:04:01; DPA1*01:03,01:03; DPB1*03:01:01,04:01:01; DQA1*01:02,03:01; DQB1*03:02:01,06:04; DRB1*04:01,13:02 (IPD-IMGT/HLA=25969).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12247
AC   CVCL_5D32
AS   CVCL_G552
SY   CEPH-1416-NA12247; 1416-1196
DR   CLO; CLO_0019219
DR   Coriell; GM12247
DR   dbMHC; 48712
DR   GEO; GSM25577
DR   GEO; GSM316258
DR   GEO; GSM316259
DR   GEO; GSM316260
DR   GEO; GSM420830
DR   IHW; IHW01183
DR   IPD-IMGT/HLA; 25973
DR   Wikidata; Q54845631
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141610.
CC   HLA typing: A*02:01,23:01; B*41:01,49:01; C*07:01,17:01; DPA1*01:03,02:01:01; DPB1*02:01:02,13:01; DQA1*01:02,02:01; DQB1*02:01,06:09; DRB1*07:01,13:02 (IPD-IMGT/HLA=25973).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12248
AC   CVCL_9613
AS   CVCL_G542
SY   CEPH-1416-NA12248; 1416-1186
DR   CLO; CLO_0019220
DR   EFO; EFO_0001145
DR   Coriell; GM12248
DR   dbMHC; 48713
DR   GEO; GSM25578
DR   GEO; GSM25579
DR   GEO; GSM112539
DR   GEO; GSM112844
DR   GEO; GSM188818
DR   GEO; GSM273335
DR   GEO; GSM273336
DR   GEO; GSM291665
DR   GEO; GSM314934
DR   GEO; GSM314935
DR   GEO; GSM420831
DR   GEO; GSM420832
DR   GEO; GSM486813
DR   GEO; GSM486814
DR   GEO; GSM648909
DR   GEO; GSM659949
DR   GEO; GSM660170
DR   GEO; GSM660359
DR   GEO; GSM905875
DR   GEO; GSM905970
DR   GEO; GSM906065
DR   IGSR; NA12248
DR   IHW; IHW01173
DR   IPD-IMGT/HLA; 13827
DR   Wikidata; Q54845632
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141611.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*23:01,23:01; B*41:01,51:01; C*15:02,17:01; DPA1*01:03,01:03; DPB1*02:01:02,04:01; DQA1*01:02,02:01; DQB1*02:01,06:02; DRB1*07:01,15:01 (IPD-IMGT/HLA=13827).
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12248).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   GM12249
AC   CVCL_9614
AS   CVCL_G543
SY   CEPH-1416-NA12249; 1416-1187
DR   CLO; CLO_0019229
DR   EFO; EFO_0001146
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801317
DR   Coriell; GM12249
DR   dbMHC; 48714
DR   GEO; GSM25580
DR   GEO; GSM25581
DR   GEO; GSM112542
DR   GEO; GSM112845
DR   GEO; GSM188820
DR   GEO; GSM273337
DR   GEO; GSM273338
DR   GEO; GSM291666
DR   GEO; GSM291667
DR   GEO; GSM314936
DR   GEO; GSM314937
DR   GEO; GSM420833
DR   GEO; GSM420834
DR   GEO; GSM486815
DR   GEO; GSM486816
DR   GEO; GSM648863
DR   GEO; GSM659986
DR   GEO; GSM660192
DR   GEO; GSM660397
DR   GEO; GSM905876
DR   GEO; GSM905971
DR   GEO; GSM906066
DR   GEO; GSM1719787
DR   IGSR; NA12249
DR   IHW; IHW01174
DR   IPD-IMGT/HLA; 25967
DR   Wikidata; Q54845633
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141612.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,25:01; B*40:01,44:02:/03; C*03:04:01,05:01; DPA1*01:03,01:03; DPB1*03:01:01,04:01; DQA1*01:02,03:01; DQB1*03:02,06:04; DRB1*04:01,13:02 (IPD-IMGT/HLA=25967).
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12249).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 32
//
ID   GM12250
AC   CVCL_5D33
AS   CVCL_G554
SY   CEPH-1416-NA12250; 1416-1337
DR   CLO; CLO_0018998
DR   Coriell; GM12250
DR   dbMHC; 48715
DR   GEO; GSM25582
DR   GEO; GSM25583
DR   GEO; GSM314938
DR   GEO; GSM314939
DR   GEO; GSM420835
DR   GEO; GSM420836
DR   GEO; GSM906151
DR   GEO; GSM906152
DR   IHW; IHW01185
DR   IPD-IMGT/HLA; 25974
DR   Wikidata; Q54845634
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141613.
CC   HLA typing: A*02:05,25:01; B*44:02,49:01; C*05:01,07:01; DPA1*01:03,02:01:01; DPB1*04:01,13:01; DQA1*01:02,05:01; DQB1*03:01,06:09; DRB1*11:01,13:02 (IPD-IMGT/HLA=25974).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12251
AC   CVCL_5D34
AS   CVCL_G555
SY   CEPH-1416-NA12251; 1416-1338
DR   CLO; CLO_0018999
DR   Coriell; GM12251
DR   dbMHC; 48716
DR   GEO; GSM25584
DR   GEO; GSM25585
DR   GEO; GSM314940
DR   GEO; GSM314941
DR   GEO; GSM420837
DR   GEO; GSM420838
DR   GEO; GSM906153
DR   GEO; GSM906154
DR   IHW; IHW01186
DR   IPD-IMGT/HLA; 25975
DR   Wikidata; Q54845635
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141614.
CC   HLA typing: A*01:01,02:01; B*08:01,15:01; C*03:03,07:01; DPA1*01:03,01:03; DPB1*04:01:01; DQA1*02:01,03:01; DQB1*03:02:01,03:03; DRB1*04:01,07:01 (IPD-IMGT/HLA=25975).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12252
AC   CVCL_5D35
AS   CVCL_G556
SY   CEPH-1416-NA12252; 1416-2387
DR   CLO; CLO_0019003
DR   Coriell; GM12252
DR   dbMHC; 48717
DR   GEO; GSM25586
DR   GEO; GSM316261
DR   GEO; GSM316262
DR   GEO; GSM316263
DR   GEO; GSM420839
DR   IHW; IHW01187
DR   IPD-IMGT/HLA; 25976
DR   Wikidata; Q54845636
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141615.
CC   HLA typing: A*02:05,23:01; B*41:01,49:01; C*07:01,17:01; DPA1*01:03,02:01:01; DPB1*02:01:02,13:01; DQA1*01:02,02:01; DQB1*02:01,06:09; DRB1*07:01,13:02 (IPD-IMGT/HLA=25976).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12253
AC   CVCL_5D36
AS   CVCL_G557
SY   CEPH-1416-NA12253; 1416-4899
DR   CLO; CLO_0019002
DR   Coriell; GM12253
DR   dbMHC; 48718
DR   GEO; GSM25587
DR   GEO; GSM316264
DR   GEO; GSM316265
DR   GEO; GSM316266
DR   GEO; GSM420840
DR   IHW; IHW01188
DR   IPD-IMGT/HLA; 25977
DR   Wikidata; Q54845637
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 141616.
CC   HLA typing: A*02:01,02:05; B*40:01,49:01; C*03:04:01,07:01; DPA1*01:03,02:01:01; DPB1*03:01:01,13:01; DQA1*01:02,01:02; DQB1*06:04,06:09; DRB1*13:02,13:02 (IPD-IMGT/HLA=25977).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM12254
AC   CVCL_U948
DR   CLO; CLO_0019001
DR   Coriell; GM12254
DR   Wikidata; Q54845638
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM12260
AC   CVCL_5M55
DR   CLO; CLO_0019000
DR   Coriell; GM12260
DR   Wikidata; Q54845639
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85032; Proteus syndrome
DI   ORDO; Orphanet_744; Proteus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5M54 ! GM12203
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   GM12261
AC   CVCL_JL94
DR   CLO; CLO_0019007
DR   Coriell; GM12261
DR   Wikidata; Q54845640
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133887; Acute hepatic porphyria
DI   ORDO; Orphanet_100924; Porphyria due to ALA dehydratase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM12262
AC   CVCL_JL95
DR   CLO; CLO_0019006
DR   Coriell; GM12262
DR   Wikidata; Q54845641
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM12263
AC   CVCL_5D37
DR   CLO; CLO_0019005
DR   Coriell; GM12263
DR   GEO; GSM30102
DR   GEO; GSM420841
DR   Wikidata; Q54845642
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 137508.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12264
AC   CVCL_R631
DR   CLO; CLO_0019004
DR   Coriell; GM12264
DR   GEO; GSM30103
DR   GEO; GSM112543
DR   GEO; GSM112846
DR   GEO; GSM188821
DR   GEO; GSM273339
DR   GEO; GSM291668
DR   GEO; GSM291669
DR   GEO; GSM314942
DR   GEO; GSM420842
DR   GEO; GSM424350
DR   GEO; GSM486817
DR   GEO; GSM486818
DR   GEO; GSM648905
DR   GEO; GSM957386
DR   IGSR; NA12264
DR   Wikidata; Q54845643
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21321133;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 137511.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12264).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 26
//
ID   GM12265
AC   CVCL_5D38
DR   CLO; CLO_0019434
DR   Coriell; GM12265
DR   GEO; GSM25588
DR   GEO; GSM30182
DR   GEO; GSM420843
DR   GEO; GSM659858
DR   GEO; GSM660068
DR   GEO; GSM660275
DR   Wikidata; Q54845644
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141804.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12266
AC   CVCL_5D39
DR   CLO; CLO_0019435
DR   Coriell; GM12266
DR   GEO; GSM25589
DR   GEO; GSM30183
DR   GEO; GSM420844
DR   GEO; GSM659857
DR   GEO; GSM660067
DR   GEO; GSM660274
DR   Wikidata; Q54845645
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141805.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12267
AC   CVCL_5D40
DR   CLO; CLO_0019436
DR   Coriell; GM12267
DR   GEO; GSM25590
DR   GEO; GSM30184
DR   GEO; GSM420845
DR   GEO; GSM659856
DR   GEO; GSM660066
DR   GEO; GSM660273
DR   Wikidata; Q54845646
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141806.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12268
AC   CVCL_5D41
DR   CLO; CLO_0019437
DR   Coriell; GM12268
DR   GEO; GSM25591
DR   GEO; GSM30185
DR   GEO; GSM420846
DR   GEO; GSM659855
DR   GEO; GSM660065
DR   GEO; GSM660272
DR   Wikidata; Q54845647
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141807.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12269
AC   CVCL_5D42
DR   CLO; CLO_0019427
DR   Coriell; GM12269
DR   GEO; GSM25592
DR   GEO; GSM30186
DR   Wikidata; Q54845648
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141808.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; GM12269; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12270
AC   CVCL_5D43
DR   CLO; CLO_0019428
DR   Coriell; GM12270
DR   GEO; GSM25593
DR   GEO; GSM30187
DR   GEO; GSM420847
DR   GEO; GSM659854
DR   GEO; GSM660064
DR   GEO; GSM660271
DR   Wikidata; Q54845649
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141809.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12271
AC   CVCL_5D44
DR   CLO; CLO_0019430
DR   Coriell; GM12271
DR   GEO; GSM25594
DR   GEO; GSM30188
DR   GEO; GSM420848
DR   GEO; GSM659860
DR   GEO; GSM660070
DR   GEO; GSM660277
DR   Wikidata; Q54845650
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141810.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12272
AC   CVCL_R632
DR   CLO; CLO_0019432
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801350
DR   Coriell; GM12272
DR   GEO; GSM25595
DR   GEO; GSM25596
DR   GEO; GSM30189
DR   GEO; GSM314943
DR   GEO; GSM314944
DR   GEO; GSM420849
DR   GEO; GSM420850
DR   GEO; GSM648864
DR   GEO; GSM1719788
DR   IGSR; NA12272
DR   Wikidata; Q54845651
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 141811.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12273
AC   CVCL_R633
DR   CLO; CLO_0019406
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00801352
DR   Coriell; GM12273
DR   GEO; GSM25597
DR   GEO; GSM25598
DR   GEO; GSM30190
DR   GEO; GSM207784
DR   GEO; GSM314945
DR   GEO; GSM314946
DR   GEO; GSM420851
DR   GEO; GSM420852
DR   GEO; GSM648939
DR   GEO; GSM906155
DR   GEO; GSM906156
DR   GEO; GSM1719789
DR   IGSR; NA12273
DR   Wikidata; Q54845652
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=20889555;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29959025;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 141812.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01:01,32:01:01; B*35:01:01,44:02:01; C*04:01:01,07:04:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:01; DRB1*11:01:01,13:05:01; DRB3*02:02:01,02:02:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM12273).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 26
//
ID   GM12274
AC   CVCL_R634
DR   CLO; CLO_0019405
DR   Coriell; GM12274
DR   GEO; GSM25599
DR   GEO; GSM25600
DR   GEO; GSM314947
DR   GEO; GSM314948
DR   GEO; GSM420853
DR   GEO; GSM420854
DR   GEO; GSM648874
DR   GEO; GSM906157
DR   GEO; GSM906158
DR   IGSR; NA12274
DR   Wikidata; Q54845653
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 141813.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12275
AC   CVCL_R635
DR   CLO; CLO_0019423
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801356
DR   Coriell; GM12275
DR   GEO; GSM25601
DR   GEO; GSM25602
DR   GEO; GSM30191
DR   GEO; GSM314949
DR   GEO; GSM314950
DR   GEO; GSM420855
DR   GEO; GSM420856
DR   GEO; GSM648851
DR   GEO; GSM1719790
DR   IGSR; NA12275
DR   Wikidata; Q54845660
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 141814.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM12276
AC   CVCL_5D45
DR   CLO; CLO_0019409
DR   Coriell; GM12276
DR   GEO; GSM25603
DR   GEO; GSM316285
DR   GEO; GSM316286
DR   GEO; GSM316287
DR   GEO; GSM420857
DR   Wikidata; Q54845661
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142103.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12277
AC   CVCL_5D46
DR   CLO; CLO_0019410
DR   Coriell; GM12277
DR   GEO; GSM25604
DR   GEO; GSM30194
DR   GEO; GSM316288
DR   GEO; GSM316289
DR   GEO; GSM316290
DR   GEO; GSM420858
DR   Wikidata; Q54845662
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142104.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12278
AC   CVCL_5D47
DR   CLO; CLO_0019407
DR   Coriell; GM12278
DR   GEO; GSM25605
DR   GEO; GSM30195
DR   GEO; GSM316291
DR   GEO; GSM316292
DR   GEO; GSM316293
DR   GEO; GSM420859
DR   Wikidata; Q54845663
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142105.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12279
AC   CVCL_5D48
DR   CLO; CLO_0019408
DR   Coriell; GM12279
DR   GEO; GSM25606
DR   GEO; GSM316294
DR   GEO; GSM316295
DR   GEO; GSM316296
DR   GEO; GSM420860
DR   Wikidata; Q54845664
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142106.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12280
AC   CVCL_5D49
DR   CLO; CLO_0019416
DR   Coriell; GM12280
DR   GEO; GSM25607
DR   GEO; GSM30196
DR   GEO; GSM316297
DR   GEO; GSM316298
DR   GEO; GSM316299
DR   GEO; GSM420861
DR   Wikidata; Q54845665
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142107.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12281
AC   CVCL_5D50
DR   CLO; CLO_0019417
DR   Coriell; GM12281
DR   GEO; GSM25608
DR   GEO; GSM30197
DR   GEO; GSM316552
DR   GEO; GSM316553
DR   GEO; GSM316554
DR   GEO; GSM420862
DR   Wikidata; Q54845666
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142108.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12282
AC   CVCL_R636
DR   CLO; CLO_0019412
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801370
DR   Coriell; GM12282
DR   GEO; GSM25609
DR   GEO; GSM25610
DR   GEO; GSM30198
DR   GEO; GSM314951
DR   GEO; GSM314952
DR   GEO; GSM420863
DR   GEO; GSM420864
DR   GEO; GSM648930
DR   GEO; GSM906159
DR   GEO; GSM906160
DR   GEO; GSM1719791
DR   IGSR; NA12282
DR   Wikidata; Q54845667
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142109.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM12283
AC   CVCL_R637
DR   CLO; CLO_0019413
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801372
DR   Coriell; GM12283
DR   GEO; GSM25611
DR   GEO; GSM25612
DR   GEO; GSM30199
DR   GEO; GSM314953
DR   GEO; GSM314954
DR   GEO; GSM420865
DR   GEO; GSM420866
DR   GEO; GSM648833
DR   GEO; GSM906161
DR   GEO; GSM906162
DR   GEO; GSM1719792
DR   IGSR; NA12283
DR   Wikidata; Q54845668
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142110.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12284
AC   CVCL_5D51
DR   CLO; CLO_0019374
DR   Coriell; GM12284
DR   GEO; GSM25613
DR   GEO; GSM30200
DR   GEO; GSM316555
DR   GEO; GSM316556
DR   GEO; GSM316557
DR   GEO; GSM420867
DR   Wikidata; Q54845669
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142111.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12285
AC   CVCL_5D52
DR   CLO; CLO_0019402
DR   Coriell; GM12285
DR   GEO; GSM25614
DR   GEO; GSM30201
DR   GEO; GSM316558
DR   GEO; GSM316559
DR   GEO; GSM316560
DR   GEO; GSM420868
DR   Wikidata; Q54845670
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142112.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12286
AC   CVCL_R638
DR   CLO; CLO_0019403
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801378
DR   Coriell; GM12286
DR   GEO; GSM25615
DR   GEO; GSM25616
DR   GEO; GSM30202
DR   GEO; GSM314955
DR   GEO; GSM314956
DR   GEO; GSM420869
DR   GEO; GSM420870
DR   GEO; GSM648888
DR   GEO; GSM906163
DR   GEO; GSM906164
DR   GEO; GSM1719793
DR   IGSR; NA12286
DR   Wikidata; Q54845671
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142113.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM12287
AC   CVCL_R639
DR   CLO; CLO_0019375
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801380
DR   Coriell; GM12287
DR   GEO; GSM25617
DR   GEO; GSM25618
DR   GEO; GSM30203
DR   GEO; GSM314957
DR   GEO; GSM314958
DR   GEO; GSM420871
DR   GEO; GSM420872
DR   GEO; GSM648875
DR   GEO; GSM1719794
DR   IGSR; NA12287
DR   Wikidata; Q54845672
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 142114.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM12315
AC   CVCL_5M56
DR   CLO; CLO_0019376
DR   Coriell; GM12315
DR   Wikidata; Q54845673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12316
AC   CVCL_5M57
DR   CLO; CLO_0019378
DR   Coriell; GM12316
DR   Wikidata; Q54845674
RX   PubMed=9143918;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM12318
AC   CVCL_5M58
DR   CLO; CLO_0019380
DR   Coriell; GM12318
DR   Wikidata; Q54845675
RX   PubMed=9143918;
CC   Sequence variation: Mutation; HGNC; HGNC:7678; NDP; Simple; p.Leu61Phe (c.181C>T); ClinVar=VCV000010690; Zygosity=Hemizygous (PubMed=9143918).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118634; Norrie syndrome
DI   ORDO; Orphanet_649; Norrie disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM12323
AC   CVCL_AT14
DR   CLO; CLO_0019382
DR   Coriell; GM12323
DR   Wikidata; Q54845676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12324
AC   CVCL_6G99
DR   CLO; CLO_0019383
DR   Coriell; GM12324
DR   Wikidata; Q54845677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM12325
AC   CVCL_U884
DR   CLO; CLO_0019387
DR   Coriell; GM12325
DR   Wikidata; Q54845678
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Heterozygous (from familial inference of GM11316; GM11317).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM12326
AC   CVCL_U885
DR   CLO; CLO_0019388
DR   Coriell; GM12326
DR   Wikidata; Q54845680
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Heterozygous (from familial inference of GM11316; GM11317).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM12328
AC   CVCL_5D53
DR   CLO; CLO_0019761
DR   Coriell; GM12328
DR   GEO; GSM25619
DR   GEO; GSM420873
DR   GEO; GSM659859
DR   GEO; GSM660069
DR   GEO; GSM660276
DR   Wikidata; Q54845681
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 141803.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12329
AC   CVCL_R640
DR   CLO; CLO_0019763
DR   Coriell; GM12329
DR   GEO; GSM420874
DR   GEO; GSM648964
DR   IGSR; NA12329
DR   Wikidata; Q54845682
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 132804/1328102.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5F59 ! GM13054
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12330
AC   CVCL_5D54
DR   CLO; CLO_0019762
DR   Coriell; GM12330
DR   GEO; GSM420875
DR   Wikidata; Q54845683
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132805.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12331
AC   CVCL_5D55
DR   CLO; CLO_0019765
DR   Coriell; GM12331
DR   GEO; GSM420876
DR   Wikidata; Q54845684
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132806.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12332
AC   CVCL_5D56
DR   CLO; CLO_0019764
DR   Coriell; GM12332
DR   Wikidata; Q54845685
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132809.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12333
AC   CVCL_5D57
DR   CLO; CLO_0019767
DR   Coriell; GM12333
DR   GEO; GSM420877
DR   Wikidata; Q54845686
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132810.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12334
AC   CVCL_5D58
DR   CLO; CLO_0019766
DR   Coriell; GM12334
DR   GEO; GSM420878
DR   Wikidata; Q54845687
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132811.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12335
AC   CVCL_R641
DR   CLO; CLO_0019769
DR   Coriell; GM12335
DR   GEO; GSM420879
DR   GEO; GSM648934
DR   IGSR; NA12335
DR   Wikidata; Q54845688
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133001.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM12336
AC   CVCL_R642
DR   CLO; CLO_0019768
DR   Coriell; GM12336
DR   GEO; GSM420880
DR   GEO; GSM648972
DR   IGSR; NA12336
DR   Wikidata; Q54845689
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133002.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM12337
AC   CVCL_5D59
DR   CLO; CLO_0019770
DR   Coriell; GM12337
DR   GEO; GSM420881
DR   Wikidata; Q54845690
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133004.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12338
AC   CVCL_5D60
DR   CLO; CLO_0019784
DR   Coriell; GM12338
DR   GEO; GSM420882
DR   Wikidata; Q54845691
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133005.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12339
AC   CVCL_5D61
DR   CLO; CLO_0019783
DR   Coriell; GM12339
DR   GEO; GSM420883
DR   Wikidata; Q54845692
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133006.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12340
AC   CVCL_R643
DR   CLO; CLO_0019782
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801418
DR   Coriell; GM12340
DR   GEO; GSM314959
DR   GEO; GSM420884
DR   GEO; GSM648937
DR   GEO; GSM906165
DR   GEO; GSM906166
DR   GEO; GSM1719795
DR   IGSR; NA12340
DR   Wikidata; Q54845693
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133008.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12341
AC   CVCL_R644
DR   CLO; CLO_0019781
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801420
DR   Coriell; GM12341
DR   GEO; GSM314960
DR   GEO; GSM420885
DR   GEO; GSM648920
DR   GEO; GSM906167
DR   GEO; GSM906168
DR   GEO; GSM1719796
DR   IGSR; NA12341
DR   Wikidata; Q54845694
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133009.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12342
AC   CVCL_R645
DR   CLO; CLO_0019788
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00801422
DR   Coriell; GM12342
DR   GEO; GSM314961
DR   GEO; GSM420886
DR   GEO; GSM1719797
DR   IGSR; NA12342
DR   Wikidata; Q54845695
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133010.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12343
AC   CVCL_R646
DR   CLO; CLO_0019787
DR   Coriell; GM12343
DR   GEO; GSM648956
DR   IGSR; NA12343
DR   Wikidata; Q54845696
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 133011.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM12344
AC   CVCL_R647
DR   CLO; CLO_0019786
DR   Coriell; GM12344
DR   GEO; GSM420887
DR   GEO; GSM648967
DR   IGSR; NA12344
DR   Wikidata; Q54845697
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1328101.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM12345
AC   CVCL_5D62
DR   CLO; CLO_0019785
DR   Coriell; GM12345
DR   GEO; GSM420888
DR   Wikidata; Q54845698
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1328103.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12346
AC   CVCL_5D63
DR   CLO; CLO_0019790
DR   Coriell; GM12346
DR   GEO; GSM420889
DR   Wikidata; Q54845699
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1328105.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12347
AC   CVCL_R648
DR   CLO; CLO_0019789
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801432
DR   Coriell; GM12347
DR   GEO; GSM314962
DR   GEO; GSM420890
DR   GEO; GSM648925
DR   GEO; GSM1719798
DR   IGSR; NA12347
DR   Wikidata; Q54845700
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1328106.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12348
AC   CVCL_R649
DR   CLO; CLO_0019725
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801434
DR   Coriell; GM12348
DR   GEO; GSM314963
DR   GEO; GSM420891
DR   GEO; GSM648895
DR   GEO; GSM1719799
DR   IGSR; NA12348
DR   Wikidata; Q54845705
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 1328107.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12349
AC   CVCL_5D64
DR   CLO; CLO_0019722
DR   Coriell; GM12349
DR   GEO; GSM420892
DR   Wikidata; Q54845706
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1328110.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12351
AC   CVCL_5D65
DR   CLO; CLO_0019721
DR   Coriell; GM12351
DR   GEO; GSM420893
DR   Wikidata; Q54845707
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1328114.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12355
AC   CVCL_BT29
DR   CLO; CLO_0019724
DR   Coriell; GM12355
DR   Wikidata; Q54845708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12365
AC   CVCL_JF47
DR   CLO; CLO_0019723
DR   Coriell; GM12365
DR   Wikidata; Q54845709
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61276; Familial hemophagocytic lymphohistiocytosis
DI   ORDO; Orphanet_540; Familial hemophagocytic lymphohistiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM12366
AC   CVCL_4D21
DR   CLO; CLO_0019729
DR   Coriell; GM12366
DR   Wikidata; Q54845710
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM12367
AC   CVCL_IJ38
DR   CLO; CLO_0019728
DR   Coriell; GM12367
DR   Wikidata; Q54845711
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM12368
AC   CVCL_U400
DR   CLO; CLO_0019732
DR   Coriell; GM12368
DR   Wikidata; Q54845712
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   GM12369
AC   CVCL_CX45
DR   CLO; CLO_0019731
DR   Coriell; GM12369
DR   Wikidata; Q54845713
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM12370
AC   CVCL_9X21
DR   CLO; CLO_0019726
DR   Coriell; GM12370
DR   Wikidata; Q54845715
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM12375
AC   CVCL_R650
DR   CLO; CLO_0019746
DR   Coriell; GM12375
DR   GEO; GSM648977
DR   IGSR; NA12375
DR   Wikidata; Q54845716
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135301.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM12376
AC   CVCL_R651
DR   CLO; CLO_0019745
DR   Coriell; GM12376
DR   GEO; GSM420894
DR   GEO; GSM648974
DR   IGSR; NA12376
DR   Wikidata; Q54845717
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135302.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM12377
AC   CVCL_5D66
DR   CLO; CLO_0019744
DR   Coriell; GM12377
DR   GEO; GSM420895
DR   Wikidata; Q54845718
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135304.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12378
AC   CVCL_5D67
DR   CLO; CLO_0019743
DR   Coriell; GM12378
DR   Wikidata; Q54845719
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135305.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12379
AC   CVCL_5D68
DR   CLO; CLO_0019742
DR   Coriell; GM12379
DR   GEO; GSM420896
DR   Wikidata; Q54845720
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135306.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12380
AC   CVCL_5D69
DR   CLO; CLO_0019741
DR   Coriell; GM12380
DR   GEO; GSM420897
DR   Wikidata; Q54845721
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135307.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12381
AC   CVCL_5D70
DR   CLO; CLO_0019751
DR   Coriell; GM12381
DR   GEO; GSM420898
DR   Wikidata; Q54845722
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135308.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12382
AC   CVCL_5D71
DR   CLO; CLO_0019750
DR   Coriell; GM12382
DR   GEO; GSM420899
DR   Wikidata; Q54845723
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135309.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12383
AC   CVCL_R652
DR   CLO; CLO_0019748
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801457
DR   Coriell; GM12383
DR   GEO; GSM314964
DR   GEO; GSM420900
DR   GEO; GSM648936
DR   GEO; GSM906169
DR   GEO; GSM906170
DR   GEO; GSM1719800
DR   IGSR; NA12383
DR   Wikidata; Q54845725
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135312.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM12385
AC   CVCL_5D72
DR   CLO; CLO_0019747
DR   Coriell; GM12385
DR   GEO; GSM420901
DR   GEO; GSM660020
DR   GEO; GSM660227
DR   GEO; GSM660431
DR   GEO; GSM905877
DR   GEO; GSM905972
DR   GEO; GSM906067
DR   Wikidata; Q54845726
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135401.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12386
AC   CVCL_R653
DR   CLO; CLO_0019826
DR   Coriell; GM12386
DR   GEO; GSM420902
DR   GEO; GSM648968
DR   GEO; GSM660019
DR   GEO; GSM660226
DR   GEO; GSM660430
DR   GEO; GSM905878
DR   GEO; GSM905973
DR   GEO; GSM906068
DR   IGSR; NA12386
DR   Wikidata; Q54845727
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135402.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12387
AC   CVCL_5D73
DR   CLO; CLO_0019827
DR   Coriell; GM12387
DR   GEO; GSM420903
DR   GEO; GSM659899
DR   GEO; GSM660109
DR   GEO; GSM660316
DR   Wikidata; Q54845728
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135403.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12388
AC   CVCL_5D74
DR   CLO; CLO_0019828
DR   Coriell; GM12388
DR   GEO; GSM659898
DR   GEO; GSM660108
DR   GEO; GSM660315
DR   Wikidata; Q54845729
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135404.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12389
AC   CVCL_5D75
DR   CLO; CLO_0019829
DR   Coriell; GM12389
DR   GEO; GSM420904
DR   GEO; GSM659897
DR   GEO; GSM660107
DR   GEO; GSM660314
DR   Wikidata; Q54845730
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135405.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12390
AC   CVCL_5D76
DR   CLO; CLO_0019830
DR   Coriell; GM12390
DR   GEO; GSM420905
DR   GEO; GSM659896
DR   GEO; GSM660106
DR   GEO; GSM660313
DR   Wikidata; Q54845731
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135406.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12391
AC   CVCL_5D77
DR   CLO; CLO_0019831
DR   Coriell; GM12391
DR   GEO; GSM420906
DR   GEO; GSM659895
DR   GEO; GSM660105
DR   GEO; GSM660312
DR   Wikidata; Q54845732
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135407.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12392
AC   CVCL_5D78
DR   CLO; CLO_0019832
DR   Coriell; GM12392
DR   GEO; GSM420907
DR   GEO; GSM659894
DR   GEO; GSM660104
DR   GEO; GSM660311
DR   Wikidata; Q54845733
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135408.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12393
AC   CVCL_5D79
DR   CLO; CLO_0019819
DR   Coriell; GM12393
DR   GEO; GSM420908
DR   GEO; GSM659893
DR   GEO; GSM660103
DR   GEO; GSM660310
DR   Wikidata; Q54845734
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135409.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12394
AC   CVCL_5D80
DR   CLO; CLO_0019822
DR   Coriell; GM12394
DR   Wikidata; Q54845735
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135410.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12395
AC   CVCL_5D81
DR   CLO; CLO_0019824
DR   Coriell; GM12395
DR   GEO; GSM420909
DR   Wikidata; Q54845736
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135411.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12396
AC   CVCL_5D82
DR   CLO; CLO_0019846
DR   Coriell; GM12396
DR   GEO; GSM659900
DR   GEO; GSM660110
DR   GEO; GSM660317
DR   Wikidata; Q54845737
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135412.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12397
AC   CVCL_5D83
DR   CLO; CLO_0019847
DR   Coriell; GM12397
DR   GEO; GSM420910
DR   Wikidata; Q54845738
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135413.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12398
AC   CVCL_5D84
DR   CLO; CLO_0019844
DR   Coriell; GM12398
DR   GEO; GSM314965
DR   GEO; GSM420911
DR   GEO; GSM906171
DR   GEO; GSM906172
DR   Wikidata; Q54845740
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135414.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12399
AC   CVCL_R654
DR   CLO; CLO_0019845
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801485
DR   Coriell; GM12399
DR   GEO; GSM314966
DR   GEO; GSM420912
DR   GEO; GSM648944
DR   GEO; GSM1719801
DR   IGSR; NA12399
DR   Wikidata; Q54845741
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135415.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12400
AC   CVCL_R655
DR   CLO; CLO_0019850
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801487
DR   Coriell; GM12400
DR   GEO; GSM314967
DR   GEO; GSM420913
DR   GEO; GSM648924
DR   GEO; GSM906173
DR   GEO; GSM906174
DR   GEO; GSM1719802
DR   IGSR; NA12400
DR   Wikidata; Q54845742
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135416.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12401
AC   CVCL_5D85
DR   CLO; CLO_0019851
DR   Coriell; GM12401
DR   Wikidata; Q54845743
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135502.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12403
AC   CVCL_5D86
DR   CLO; CLO_0019848
DR   Coriell; GM12403
DR   Wikidata; Q54845744
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135504.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12404
AC   CVCL_5D87
DR   CLO; CLO_0019849
DR   Coriell; GM12404
DR   Wikidata; Q54845745
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135506.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12405
AC   CVCL_5D88
DR   CLO; CLO_0019841
DR   Coriell; GM12405
DR   Wikidata; Q54845746
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135507.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12406
AC   CVCL_5D89
DR   CLO; CLO_0019842
DR   Coriell; GM12406
DR   Wikidata; Q54845747
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135508.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12407
AC   CVCL_5D90
DR   CLO; CLO_0019810
DR   Coriell; GM12407
DR   Wikidata; Q54845750
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135509.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12408
AC   CVCL_5D91
DR   CLO; CLO_0019806
DR   BioSample; SAMN00801499
DR   Coriell; GM12408
DR   Wikidata; Q54845751
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135510.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM12408; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12409
AC   CVCL_5D92
DR   CLO; CLO_0019807
DR   BioSample; SAMN00801501
DR   Coriell; GM12409
DR   Wikidata; Q54845752
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135511.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12410
AC   CVCL_5D93
DR   CLO; CLO_0019808
DR   Coriell; GM12410
DR   Wikidata; Q54845753
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135512.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12411
AC   CVCL_5D94
DR   CLO; CLO_0019809
DR   Coriell; GM12411
DR   Wikidata; Q54845754
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135513.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12413
AC   CVCL_R656
DR   CLO; CLO_0019802
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801507
DR   Coriell; GM12413
DR   GEO; GSM906175
DR   GEO; GSM906176
DR   GEO; GSM1719803
DR   IGSR; NA12413
DR   Wikidata; Q54845755
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135515.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12414
AC   CVCL_R657
DR   CLO; CLO_0019803
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801509
DR   Coriell; GM12414
DR   GEO; GSM648975
DR   GEO; GSM1719804
DR   IGSR; NA12414
DR   Wikidata; Q54845756
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135516.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM12415
AC   CVCL_5D95
DR   CLO; CLO_0019804
DR   Coriell; GM12415
DR   Wikidata; Q54845757
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135517.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12444
AC   CVCL_0N18
SY   GM12444A
DR   CLO; CLO_0019805
DR   Coriell; GM12444
DR   Wikidata; Q54845758
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1585-1G>A (IVS10AS,G>A,-1) (1717-1G>A); ClinVar=VCV000007112; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM12444).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM12445
AC   CVCL_EF96
DR   CLO; CLO_0019801
DR   Coriell; GM12445
DR   Wikidata; Q54845759
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (Coriell=GM12445).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM12446
AC   CVCL_2U20
DR   CLO; CLO_0017543
DR   Coriell; GM12446
DR   Wikidata; Q54845760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM12448
AC   CVCL_1S59
SY   UMHG-17/2
DR   CLO; CLO_0017546
DR   Coriell; GM12448
DR   Wikidata; Q54845761
RX   PubMed=8404043;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12449
AC   CVCL_1S60
SY   UMHG-17/3
DR   CLO; CLO_0017544
DR   Coriell; GM12449
DR   Wikidata; Q54845762
RX   PubMed=8404043;
RX   PubMed=9186513;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12451
AC   CVCL_V003
DR   CLO; CLO_0017550
DR   Coriell; GM12451
DR   Wikidata; Q54845763
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99099; Type I acrocephalosyndactyly
DI   ORDO; Orphanet_87; Apert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM12452
AC   CVCL_H550
DR   CLO; CLO_0017547
DR   Coriell; GM12452
DR   Wikidata; Q54845764
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   GM12455
AC   CVCL_5D96
DR   CLO; CLO_0017553
DR   Coriell; GM12455
DR   GEO; GSM420914
DR   GEO; GSM660018
DR   GEO; GSM660225
DR   GEO; GSM660429
DR   Wikidata; Q54845765
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135601.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12456
AC   CVCL_5D97
DR   CLO; CLO_0017551
DR   Coriell; GM12456
DR   GEO; GSM420915
DR   GEO; GSM660017
DR   GEO; GSM660224
DR   GEO; GSM660428
DR   GEO; GSM905879
DR   GEO; GSM905974
DR   GEO; GSM906069
DR   Wikidata; Q54845766
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135602.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12457
AC   CVCL_5D98
DR   CLO; CLO_0017418
DR   Coriell; GM12457
DR   GEO; GSM420916
DR   GEO; GSM659890
DR   GEO; GSM660100
DR   GEO; GSM660307
DR   Wikidata; Q54845767
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135604.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12458
AC   CVCL_5D99
DR   CLO; CLO_0017416
DR   Coriell; GM12458
DR   GEO; GSM420917
DR   GEO; GSM659889
DR   GEO; GSM660099
DR   GEO; GSM660306
DR   Wikidata; Q54845768
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135605.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12459
AC   CVCL_5E00
DR   CLO; CLO_0017414
DR   Coriell; GM12459
DR   GEO; GSM420918
DR   GEO; GSM659888
DR   GEO; GSM660098
DR   GEO; GSM660305
DR   Wikidata; Q54845769
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135606.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12460
AC   CVCL_5E01
DR   CLO; CLO_0017408
DR   Coriell; GM12460
DR   GEO; GSM420919
DR   GEO; GSM659887
DR   GEO; GSM660097
DR   GEO; GSM660304
DR   Wikidata; Q54845770
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135607.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12461
AC   CVCL_5E02
DR   CLO; CLO_0017409
DR   Coriell; GM12461
DR   GEO; GSM420920
DR   GEO; GSM659886
DR   GEO; GSM660096
DR   GEO; GSM660303
DR   Wikidata; Q54845771
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135608.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12462
AC   CVCL_5E03
DR   CLO; CLO_0017406
DR   Coriell; GM12462
DR   GEO; GSM420921
DR   GEO; GSM659885
DR   GEO; GSM660095
DR   GEO; GSM660302
DR   Wikidata; Q54845772
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135609.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12463
AC   CVCL_5E04
DR   CLO; CLO_0017407
DR   Coriell; GM12463
DR   GEO; GSM659892
DR   GEO; GSM660102
DR   GEO; GSM660309
DR   Wikidata; Q54845773
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135610.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12464
AC   CVCL_5E05
DR   CLO; CLO_0017402
DR   Coriell; GM12464
DR   GEO; GSM659891
DR   GEO; GSM660101
DR   GEO; GSM660308
DR   Wikidata; Q54845774
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135611.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12465
AC   CVCL_5E06
DR   CLO; CLO_0017404
DR   Coriell; GM12465
DR   GEO; GSM314968
DR   Wikidata; Q54845775
RX   PubMed=19797678;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135613.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12466
AC   CVCL_5E07
DR   CLO; CLO_0017399
DR   Coriell; GM12466
DR   GEO; GSM314969
DR   GEO; GSM420922
DR   GEO; GSM906177
DR   GEO; GSM906178
DR   Wikidata; Q54845776
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135614.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12467
AC   CVCL_5E08
DR   CLO; CLO_0017401
DR   Coriell; GM12467
DR   GEO; GSM420923
DR   Wikidata; Q54845777
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135615.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12470
AC   CVCL_5E09
DR   CLO; CLO_0017376
DR   Coriell; GM12470
DR   GEO; GSM420924
DR   GEO; GSM660016
DR   GEO; GSM660223
DR   GEO; GSM660427
DR   GEO; GSM905880
DR   GEO; GSM905975
DR   GEO; GSM906070
DR   Wikidata; Q54845778
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135701.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12471
AC   CVCL_5E10
DR   CLO; CLO_0017374
DR   Coriell; GM12471
DR   GEO; GSM420925
DR   GEO; GSM660015
DR   GEO; GSM660222
DR   GEO; GSM660426
DR   GEO; GSM905881
DR   GEO; GSM905976
DR   GEO; GSM906071
DR   Wikidata; Q54845779
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135702.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12472
AC   CVCL_5E11
DR   CLO; CLO_0017353
DR   Coriell; GM12472
DR   GEO; GSM659883
DR   GEO; GSM660093
DR   GEO; GSM660300
DR   Wikidata; Q54845780
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135703.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12473
AC   CVCL_5E12
DR   CLO; CLO_0017365
DR   Coriell; GM12473
DR   GEO; GSM659882
DR   GEO; GSM660092
DR   GEO; GSM660299
DR   Wikidata; Q54845781
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135704.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12474
AC   CVCL_5E13
DR   CLO; CLO_0017366
DR   Coriell; GM12474
DR   GEO; GSM420926
DR   GEO; GSM659881
DR   GEO; GSM660091
DR   GEO; GSM660298
DR   Wikidata; Q54845782
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135705.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12475
AC   CVCL_5E14
DR   CLO; CLO_0017367
DR   Coriell; GM12475
DR   GEO; GSM420927
DR   GEO; GSM659880
DR   GEO; GSM660090
DR   GEO; GSM660297
DR   Wikidata; Q54845783
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135706.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12476
AC   CVCL_5E15
DR   CLO; CLO_0017368
DR   Coriell; GM12476
DR   GEO; GSM659879
DR   GEO; GSM660089
DR   GEO; GSM660296
DR   Wikidata; Q54845784
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135707.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12477
AC   CVCL_5E16
DR   CLO; CLO_0017358
DR   Coriell; GM12477
DR   GEO; GSM420928
DR   GEO; GSM659878
DR   GEO; GSM660088
DR   GEO; GSM660295
DR   Wikidata; Q54845785
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135708.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12478
AC   CVCL_5E17
DR   CLO; CLO_0017360
DR   Coriell; GM12478
DR   GEO; GSM659877
DR   GEO; GSM660087
DR   GEO; GSM660294
DR   Wikidata; Q54845786
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135709.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12479
AC   CVCL_5E18
DR   CLO; CLO_0017361
DR   Coriell; GM12479
DR   GEO; GSM420929
DR   Wikidata; Q54845787
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135711.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12480
AC   CVCL_5E19
DR   CLO; CLO_0017364
DR   Coriell; GM12480
DR   GEO; GSM420930
DR   Wikidata; Q54845788
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135712.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12481
AC   CVCL_5E20
DR   CLO; CLO_0017471
DR   Coriell; GM12481
DR   GEO; GSM314970
DR   GEO; GSM420931
DR   GEO; GSM906179
DR   GEO; GSM906180
DR   Wikidata; Q54845789
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135715.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12482
AC   CVCL_5E21
DR   CLO; CLO_0017456
DR   Coriell; GM12482
DR   GEO; GSM314971
DR   GEO; GSM906181
DR   GEO; GSM906182
DR   Wikidata; Q54845796
RX   PubMed=19797678;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135716.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12483
AC   CVCL_5E22
DR   CLO; CLO_0017457
DR   Coriell; GM12483
DR   Wikidata; Q54845797
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135717.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12484
AC   CVCL_5E23
DR   CLO; CLO_0017463
DR   Coriell; GM12484
DR   GEO; GSM420932
DR   Wikidata; Q54845798
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135718.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12485
AC   CVCL_R658
DR   CLO; CLO_0017464
DR   Coriell; GM12485
DR   GEO; GSM648953
DR   IGSR; NA12485
DR   Wikidata; Q54845799
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135501.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM12486
AC   CVCL_5E24
DR   CLO; CLO_0017461
DR   Coriell; GM12486
DR   Wikidata; Q54845800
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135505.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12487
AC   CVCL_5E25
DR   CLO; CLO_0017462
DR   Coriell; GM12487
DR   Wikidata; Q54845801
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135518.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12488
AC   CVCL_5E26
DR   CLO; CLO_0017469
DR   Coriell; GM12488
DR   GEO; GSM420933
DR   Wikidata; Q54845802
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135303.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12489
AC   CVCL_R659
DR   CLO; CLO_0017470
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801582
DR   Coriell; GM12489
DR   GEO; GSM314972
DR   GEO; GSM420934
DR   GEO; GSM648938
DR   GEO; GSM906183
DR   GEO; GSM906184
DR   GEO; GSM1719805
DR   IGSR; NA12489
DR   Wikidata; Q54845803
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135314.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM12490
AC   CVCL_5E27
DR   CLO; CLO_0017465
DR   Coriell; GM12490
DR   Wikidata; Q54845804
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132808.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12491
AC   CVCL_5E28
DR   CLO; CLO_0017467
DR   Coriell; GM12491
DR   GEO; GSM420935
DR   Wikidata; Q54845805
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 133003.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12492
AC   CVCL_BT30
DR   CLO; CLO_0017431
DR   Coriell; GM12492
DR   Wikidata; Q54845806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12494
AC   CVCL_F158
DR   CLO; CLO_0017432
DR   Coriell; GM12494
DR   Wikidata; Q54845807
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM12495
AC   CVCL_F159
DR   CLO; CLO_0017433
DR   Coriell; GM12495
DR   Wikidata; Q54845808
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM12496
AC   CVCL_F160
DR   CLO; CLO_0017434
DR   Coriell; GM12496
DR   Wikidata; Q54845809
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM12497
AC   CVCL_7523
DR   CLO; CLO_0017435
DR   Coriell; GM12497
DR   Wikidata; Q54845810
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F157 ! GM12583
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM12498
AC   CVCL_EH08
SY   GM12498A
DR   CLO; CLO_0017436
DR   BioSample; SAMN00801598
DR   Coriell; GM12498
DR   Wikidata; Q54845811
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM12499
AC   CVCL_EH09
DR   CLO; CLO_0017437
DR   BioSample; SAMN00801600
DR   Coriell; GM12499
DR   Wikidata; Q54845812
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM12506
AC   CVCL_1S61
SY   Ag-2
DR   CLO; CLO_0017438
DR   Coriell; GM12506
DR   Wikidata; Q54845813
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12507
AC   CVCL_5U25
DR   CLO; CLO_0017439
DR   Coriell; GM12507
DR   Wikidata; Q54845814
CC   Discontinued: Coriell; GM12507; probable.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   GM12508
AC   CVCL_1S62
SY   Br-8
DR   CLO; CLO_0017440
DR   Coriell; GM12508
DR   Wikidata; Q54845815
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12510
AC   CVCL_1K00
SY   CAIA2
DR   CLO; CLO_0017856
DR   Coriell; GM12510
DR   Wikidata; Q54845816
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM12511
AC   CVCL_1S63
SY   RBCD1
DR   CLO; CLO_0017855
DR   Coriell; GM12511
DR   Wikidata; Q54845817
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12513
AC   CVCL_1S64
SY   KCB4
DR   CLO; CLO_0017858
DR   Coriell; GM12513
DR   Wikidata; Q54845818
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12514
AC   CVCL_2U21
DR   CLO; CLO_0017857
DR   Coriell; GM12514
DR   Wikidata; Q54845819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM12515
AC   CVCL_1S65
SY   JFA6
DR   CLO; CLO_0017850
DR   Coriell; GM12515
DR   Wikidata; Q54845821
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12517
AC   CVCL_1S66
SY   LS-1
DR   CLO; CLO_0017852
DR   Coriell; GM12517
DR   Wikidata; Q54845823
RX   PubMed=3130306;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM12519
AC   CVCL_H549
DR   CLO; CLO_0017851
DR   Coriell; GM12519
DR   Wikidata; Q54845824
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   GM12521
AC   CVCL_5J62
DR   CLO; CLO_0017854
DR   Coriell; GM12521
DR   Wikidata; Q54845825
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12522
AC   CVCL_5J63
DR   CLO; CLO_0017853
DR   Coriell; GM12522
DR   Wikidata; Q54845827
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12523
AC   CVCL_5J64
DR   CLO; CLO_0017884
DR   Coriell; GM12523
DR   Wikidata; Q54845828
RX   PubMed=1746558;
RX   PubMed=23756445;
CC   Sequence variation: Mutation; HGNC; HGNC:560; AP1S2; Simple; c.426+1G>T (p.Val97_Glu142del); ClinVar=VCV000140457; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=23756445).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124839; Pettigrew syndrome
DI   ORDO; Orphanet_1568; X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM12524
AC   CVCL_5J65
DR   CLO; CLO_0017888
DR   Coriell; GM12524
DR   Wikidata; Q54845829
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12525
AC   CVCL_5J66
DR   CLO; CLO_0017887
DR   Coriell; GM12525
DR   Wikidata; Q54845830
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12526
AC   CVCL_5J67
DR   CLO; CLO_0017886
DR   Coriell; GM12526
DR   Wikidata; Q54845831
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12527
AC   CVCL_5J68
DR   CLO; CLO_0017885
DR   Coriell; GM12527
DR   Wikidata; Q54845832
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12528
AC   CVCL_5J69
DR   CLO; CLO_0017882
DR   Coriell; GM12528
DR   Wikidata; Q54845833
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12529
AC   CVCL_5J70
DR   CLO; CLO_0017881
DR   Coriell; GM12529
DR   Wikidata; Q54845834
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12530
AC   CVCL_5J71
DR   CLO; CLO_0017880
DR   Coriell; GM12530
DR   Wikidata; Q54845835
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12531
AC   CVCL_5J72
DR   CLO; CLO_0017879
DR   Coriell; GM12531
DR   Wikidata; Q54845836
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12532
AC   CVCL_5J73
DR   CLO; CLO_0017883
DR   Coriell; GM12532
DR   Wikidata; Q54845837
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12533
AC   CVCL_5J74
DR   CLO; CLO_0017917
DR   Coriell; GM12533
DR   Wikidata; Q54845838
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12534
AC   CVCL_5J75
DR   CLO; CLO_0017915
DR   Coriell; GM12534
DR   Wikidata; Q54845843
RX   PubMed=1746558;
RX   PubMed=23756445;
CC   Sequence variation: Mutation; HGNC; HGNC:560; AP1S2; Simple; c.426+1G>T (p.Val97_Glu142del); ClinVar=VCV000140457; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=23756445).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124839; Pettigrew syndrome
DI   ORDO; Orphanet_1568; X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM12536
AC   CVCL_5J76
DR   CLO; CLO_0017912
DR   Coriell; GM12536
DR   Wikidata; Q54845844
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12537
AC   CVCL_5J77
DR   CLO; CLO_0017911
DR   Coriell; GM12537
DR   Wikidata; Q54845845
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12538
AC   CVCL_5J78
DR   CLO; CLO_0017914
DR   Coriell; GM12538
DR   Wikidata; Q54845846
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12539
AC   CVCL_5J79
DR   CLO; CLO_0017913
DR   Coriell; GM12539
DR   Wikidata; Q54845847
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12541
AC   CVCL_5J80
DR   CLO; CLO_0017906
DR   Coriell; GM12541
DR   Wikidata; Q54845848
RX   PubMed=1746558;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12542
AC   CVCL_5J81
DR   CLO; CLO_0017904
DR   Coriell; GM12542
DR   Wikidata; Q54845849
RX   PubMed=1746558;
RX   PubMed=23756445;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM12543
AC   CVCL_5J82
DR   CLO; CLO_0017910
DR   Coriell; GM12543
DR   Wikidata; Q54845850
RX   PubMed=1746558;
RX   PubMed=23756445;
CC   Sequence variation: Mutation; HGNC; HGNC:560; AP1S2; Simple; c.426+1G>T (p.Val97_Glu142del); ClinVar=VCV000140457; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=23756445).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM12546
AC   CVCL_R660
DR   CLO; CLO_0017909
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801602
DR   Coriell; GM12546
DR   GEO; GSM648932
DR   GEO; GSM1719806
DR   IGSR; NA12546
DR   Wikidata; Q54845851
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135313.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12547
AC   CVCL_N196
SY   GM17008
DR   CLO; CLO_0017948
DR   CLO; CLO_0018052
DR   Coriell; GM12547
DR   Coriell; GM17008
DR   Wikidata; Q54845852
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Part of: Human variation panel.
CC   Registration: CEPH Families Reference Panel; 6601.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM12548
AC   CVCL_N197
SY   GM17009
DR   CLO; CLO_0017947
DR   CLO; CLO_0018022
DR   Coriell; GM12548
DR   Coriell; GM17009
DR   Wikidata; Q54845853
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Part of: Human variation panel.
CC   Registration: CEPH Families Reference Panel; 6602.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM12549
AC   CVCL_9X22
DR   CLO; CLO_0017945
DR   Coriell; GM12549
DR   Wikidata; Q54845854
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6603.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12550
AC   CVCL_9X23
DR   CLO; CLO_0017944
DR   Coriell; GM12550
DR   Wikidata; Q54845855
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6604.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12551
AC   CVCL_9X24
DR   CLO; CLO_0017943
DR   Coriell; GM12551
DR   Wikidata; Q54845856
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6605.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12552
AC   CVCL_9X25
DR   CLO; CLO_0017942
DR   Coriell; GM12552
DR   Wikidata; Q54845857
RX   PubMed=33197628;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6606.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Triplication; Zygosity=Unspecified (PubMed=33197628).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM12553
AC   CVCL_9X26
DR   CLO; CLO_0017941
DR   Coriell; GM12553
DR   Wikidata; Q54845858
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6607.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12554
AC   CVCL_9X27
DR   CLO; CLO_0017940
DR   Coriell; GM12554
DR   Wikidata; Q54845860
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6608.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12555
AC   CVCL_9X28
DR   CLO; CLO_0017937
DR   Coriell; GM12555
DR   Wikidata; Q54845862
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6609.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12556
AC   CVCL_9X29
DR   CLO; CLO_0017936
DR   Coriell; GM12556
DR   Wikidata; Q54845863
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6610.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12557
AC   CVCL_9X30
DR   CLO; CLO_0017760
DR   Coriell; GM12557
DR   Wikidata; Q54845864
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6611.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12558
AC   CVCL_9X31
DR   CLO; CLO_0017761
DR   Coriell; GM12558
DR   GEO; GSM906185
DR   GEO; GSM906186
DR   Wikidata; Q54845865
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6612.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12559
AC   CVCL_9X32
DR   CLO; CLO_0017762
DR   Coriell; GM12559
DR   Wikidata; Q54845866
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 6613.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12560
AC   CVCL_9X33
DR   CLO; CLO_0017763
DR   Coriell; GM12560
DR   Wikidata; Q54845867
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1201.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12561
AC   CVCL_9X34
DR   CLO; CLO_0017764
DR   Coriell; GM12561
DR   Wikidata; Q54845868
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1202.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12562
AC   CVCL_9X35
DR   CLO; CLO_0017765
DR   Coriell; GM12562
DR   Wikidata; Q54845869
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1203.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12563
AC   CVCL_9X36
DR   CLO; CLO_0017766
DR   Coriell; GM12563
DR   Wikidata; Q54845870
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1204.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12564
AC   CVCL_9X37
DR   CLO; CLO_0017767
DR   Coriell; GM12564
DR   Wikidata; Q54845871
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1205.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12565
AC   CVCL_9X38
DR   CLO; CLO_0017768
DR   Coriell; GM12565
DR   Wikidata; Q54845872
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1206.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12566
AC   CVCL_9X39
DR   CLO; CLO_0017769
DR   Coriell; GM12566
DR   Wikidata; Q54845873
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1207.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12567
AC   CVCL_9X40
DR   CLO; CLO_0018118
DR   Coriell; GM12567
DR   Wikidata; Q54845874
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1208.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12568
AC   CVCL_9X41
DR   CLO; CLO_0018116
DR   Coriell; GM12568
DR   Wikidata; Q54845875
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12569
AC   CVCL_9X42
DR   CLO; CLO_0018109
DR   Coriell; GM12569
DR   GEO; GSM906187
DR   GEO; GSM906188
DR   Wikidata; Q54845876
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1210.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12570
AC   CVCL_9X43
DR   CLO; CLO_0018107
DR   Coriell; GM12570
DR   Wikidata; Q54845877
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1211.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12571
AC   CVCL_9X44
DR   CLO; CLO_0018114
DR   Coriell; GM12571
DR   Wikidata; Q54845878
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1212.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12572
AC   CVCL_9X45
DR   CLO; CLO_0018111
DR   Coriell; GM12572
DR   Wikidata; Q54845879
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1213.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12573
AC   CVCL_2U22
DR   CLO; CLO_0018094
DR   Coriell; GM12573
DR   Wikidata; Q54845880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM12583
AC   CVCL_F157
DR   CLO; CLO_0018095
DR   Coriell; GM12583
DR   Wikidata; Q54845881
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7523 ! GM12497
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   GM12585
AC   CVCL_0N19
DR   CLO; CLO_0018090
DR   Coriell; GM12585
DR   Wikidata; Q54845882
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg1162Ter (c.3484C>T); ClinVar=VCV000007137; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM12590
AC   CVCL_5P65
DR   Coriell; GM12590
DR   Wikidata; Q54845883
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM12592
AC   CVCL_2U23
DR   CLO; CLO_0018092
DR   Coriell; GM12592
DR   Wikidata; Q54845884
CC   Karyotypic information: 46,XX,t(3;7)(3qter->3p26::7p12->7pter;7qter->7p12::3p26->3pter) (Coriell=GM12592).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM12593
AC   CVCL_7524
SY   GM17238
DR   CLO; CLO_0014332
DR   CLO; CLO_0018080
DR   Coriell; GM12593
DR   Coriell; GM17238
DR   GEO; GSM569565
DR   GEO; GSM596302
DR   GEO; GSM596662
DR   GEO; GSM924840
DR   Wikidata; Q54845892
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM12601
AC   CVCL_BW63
DR   CLO; CLO_0018079
DR   Coriell; GM12601
DR   Wikidata; Q54845893
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM12604
AC   CVCL_Y706
DR   CLO; CLO_0018077
DR   Coriell; GM12604
DR   Wikidata; Q54845894
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Asp175Val (c.524A>T); ClinVar=VCV000097233; Zygosity=Heterozygous (Coriell=GM12604).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM12606
AC   CVCL_5P66
DR   CLO; CLO_0018088
DR   Coriell; GM12606
DR   Wikidata; Q54845895
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM12607
AC   CVCL_V447
DR   CLO; CLO_0018086
DR   Coriell; GM12607
DR   Wikidata; Q54845896
RX   PubMed=24009235;
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Thr36Met (c.107C>T); ClinVar=VCV000004108; Zygosity=Unspecified (PubMed=24009235).
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Trp2736Gly (c.8206T>G); ClinVar=VCV000496527; Zygosity=Unspecified (PubMed=24009235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V448 ! GM12609
SX   Female
AG   6D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM12609
AC   CVCL_V448
DR   CLO; CLO_0018084
DR   Coriell; GM12609
DR   Wikidata; Q54845897
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Thr36Met (c.107C>T); ClinVar=VCV000004108; Zygosity=Unspecified (from autologous cell line GM12607).
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Trp2736Gly (c.8206T>G); ClinVar=VCV000496527; Zygosity=Unspecified (from autologous cell line GM12607).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V447 ! GM12607
SX   Female
AG   6D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM12610
AC   CVCL_JF48
DR   CLO; CLO_0018081
DR   Coriell; GM12610
DR   Wikidata; Q54845898
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C61276; Familial hemophagocytic lymphohistiocytosis
DI   ORDO; Orphanet_540; Familial hemophagocytic lymphohistiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM12615
AC   CVCL_9X46
DR   CLO; CLO_0018059
DR   Coriell; GM12615
DR   Wikidata; Q54845899
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3501.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12616
AC   CVCL_9X47
DR   CLO; CLO_0018061
DR   Coriell; GM12616
DR   Wikidata; Q54845900
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3502.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12617
AC   CVCL_9X48
DR   CLO; CLO_0018064
DR   Coriell; GM12617
DR   Wikidata; Q54845901
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3503.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12618
AC   CVCL_9Y64
DR   CLO; CLO_0018048
DR   Coriell; GM12618
DR   Wikidata; Q54845902
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3504.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12619
AC   CVCL_9X50
DR   CLO; CLO_0018047
DR   Coriell; GM12619
DR   Wikidata; Q54845903
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3505.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12620
AC   CVCL_9X51
DR   CLO; CLO_0018050
DR   Coriell; GM12620
DR   Wikidata; Q54845904
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3506.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12621
AC   CVCL_9X52
DR   CLO; CLO_0018049
DR   Coriell; GM12621
DR   Wikidata; Q54845905
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3507.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12622
AC   CVCL_9X53
DR   CLO; CLO_0018054
DR   Coriell; GM12622
DR   Wikidata; Q54845906
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3508.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12623
AC   CVCL_9X54
DR   CLO; CLO_0018051
DR   Coriell; GM12623
DR   Wikidata; Q54845907
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3509.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12624
AC   CVCL_9X55
DR   CLO; CLO_0018057
DR   Coriell; GM12624
DR   Wikidata; Q54845908
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3510.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12625
AC   CVCL_9X56
DR   CLO; CLO_0018056
DR   Coriell; GM12625
DR   Wikidata; Q54845909
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3701.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12626
AC   CVCL_9X57
DR   CLO; CLO_0018040
DR   Coriell; GM12626
DR   Wikidata; Q54845910
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3702.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12627
AC   CVCL_9X58
DR   CLO; CLO_0018039
DR   Coriell; GM12627
DR   Wikidata; Q54845911
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3703.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12628
AC   CVCL_9X59
DR   CLO; CLO_0018021
DR   Coriell; GM12628
DR   Wikidata; Q54845912
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3704.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12629
AC   CVCL_9X60
DR   CLO; CLO_0018019
DR   Coriell; GM12629
DR   Wikidata; Q54845913
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3705.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12630
AC   CVCL_9X61
DR   CLO; CLO_0018020
DR   Coriell; GM12630
DR   Wikidata; Q54845914
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3706.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12631
AC   CVCL_9X62
DR   CLO; CLO_0018017
DR   Coriell; GM12631
DR   Wikidata; Q54845915
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3707.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12632
AC   CVCL_9X63
DR   CLO; CLO_0018018
DR   Coriell; GM12632
DR   Wikidata; Q54845916
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3708.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12633
AC   CVCL_9X64
DR   CLO; CLO_0018015
DR   Coriell; GM12633
DR   Wikidata; Q54845917
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 3709.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12634
AC   CVCL_9X65
DR   CLO; CLO_0018016
DR   Coriell; GM12634
DR   Wikidata; Q54845919
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2801.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12635
AC   CVCL_9X66
DR   CLO; CLO_0018011
DR   Coriell; GM12635
DR   Wikidata; Q54845920
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2802.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12636
AC   CVCL_9X67
DR   CLO; CLO_0018013
DR   Coriell; GM12636
DR   Wikidata; Q54845921
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2803.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12637
AC   CVCL_9X68
DR   CLO; CLO_0018007
DR   Coriell; GM12637
DR   Wikidata; Q54845922
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2804.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12638
AC   CVCL_9X69
DR   CLO; CLO_0017997
DR   Coriell; GM12638
DR   Wikidata; Q54845923
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2805.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12639
AC   CVCL_9X70
DR   CLO; CLO_0017998
DR   Coriell; GM12639
DR   Wikidata; Q54845924
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2806.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12642
AC   CVCL_9X71
DR   CLO; CLO_0017993
DR   Coriell; GM12642
DR   Wikidata; Q54845925
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2809.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12644
AC   CVCL_JA67
DR   CLO; CLO_0017994
DR   Coriell; GM12644
DR   Wikidata; Q54845926
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C90598; Junctional epidermolysis bullosa
DI   ORDO; Orphanet_305; Junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM12645
AC   CVCL_AM68
DR   CLO; CLO_0017995
DR   Coriell; GM12645
DR   Wikidata; Q54845927
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12646
AC   CVCL_AM69
DR   CLO; CLO_0017996
DR   Coriell; GM12646
DR   Wikidata; Q54845928
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12655
AC   CVCL_AM70
DR   CLO; CLO_0017989
DR   Coriell; GM12655
DR   Wikidata; Q54845929
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12659
AC   CVCL_AT15
DR   CLO; CLO_0017990
DR   Coriell; GM12659
DR   Wikidata; Q54845930
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84908; Multiple sulfatase deficiency disease
DI   ORDO; Orphanet_585; Multiple sulfatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM12662
AC   CVCL_5P67
DR   Coriell; GM12662
DR   Wikidata; Q54845931
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM12663
AC   CVCL_9X72
DR   CLO; CLO_0017991
DR   Coriell; GM12663
DR   Wikidata; Q54845932
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2301.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12664
AC   CVCL_9X73
DR   CLO; CLO_0017992
DR   Coriell; GM12664
DR   Wikidata; Q54845938
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2302.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12665
AC   CVCL_9X74
DR   CLO; CLO_0017981
DR   Coriell; GM12665
DR   Wikidata; Q54845939
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2303.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12666
AC   CVCL_9X75
DR   CLO; CLO_0017976
DR   Coriell; GM12666
DR   Wikidata; Q54845940
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2304.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12667
AC   CVCL_9X76
DR   CLO; CLO_0017977
DR   Coriell; GM12667
DR   Wikidata; Q54845941
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2305.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12668
AC   CVCL_9X77
DR   CLO; CLO_0017971
DR   Coriell; GM12668
DR   Wikidata; Q54845942
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2306.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12669
AC   CVCL_9X78
DR   CLO; CLO_0017972
DR   Coriell; GM12669
DR   Wikidata; Q54845943
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2307.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12670
AC   CVCL_9X79
DR   CLO; CLO_0017969
DR   Coriell; GM12670
DR   Wikidata; Q54845944
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2308.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12671
AC   CVCL_9X80
DR   CLO; CLO_0017970
DR   Coriell; GM12671
DR   Wikidata; Q54845945
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 201.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12672
AC   CVCL_9X81
DR   CLO; CLO_0017974
DR   Coriell; GM12672
DR   Wikidata; Q54845946
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 202.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12673
AC   CVCL_9X82
DR   CLO; CLO_0017975
DR   Coriell; GM12673
DR   Wikidata; Q54845947
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 203.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12674
AC   CVCL_9X83
DR   CLO; CLO_0017973
DR   Coriell; GM12674
DR   Wikidata; Q54845948
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 204.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12675
AC   CVCL_9X84
DR   CLO; CLO_0017955
DR   Coriell; GM12675
DR   Wikidata; Q54845950
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 205.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12676
AC   CVCL_9X85
DR   CLO; CLO_0017957
DR   Coriell; GM12676
DR   Wikidata; Q54845951
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 206.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12677
AC   CVCL_9X86
DR   CLO; CLO_0017959
DR   Coriell; GM12677
DR   Wikidata; Q54845952
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 207.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12678
AC   CVCL_9X87
DR   CLO; CLO_0017960
DR   Coriell; GM12678
DR   Wikidata; Q54845953
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 208.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12679
AC   CVCL_9X88
DR   CLO; CLO_0017949
DR   Coriell; GM12679
DR   Wikidata; Q54845954
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1701.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12680
AC   CVCL_9X89
DR   CLO; CLO_0017950
DR   Coriell; GM12680
DR   Wikidata; Q54845955
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1702.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12681
AC   CVCL_9X90
DR   CLO; CLO_0017951
DR   Coriell; GM12681
DR   Wikidata; Q54845956
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1703.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12682
AC   CVCL_9X91
DR   CLO; CLO_0017952
DR   Coriell; GM12682
DR   Wikidata; Q54845957
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1704.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12684
AC   CVCL_9X92
DR   CLO; CLO_0017953
DR   Coriell; GM12684
DR   Wikidata; Q54845959
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1706.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12685
AC   CVCL_9X93
DR   CLO; CLO_0017954
DR   Coriell; GM12685
DR   Wikidata; Q54845960
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1707.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12686
AC   CVCL_9X00
DR   CLO; CLO_0018467
DR   Coriell; GM12686
DR   Wikidata; Q54845961
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1708.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12687
AC   CVCL_9X94
DR   CLO; CLO_0018469
DR   Coriell; GM12687
DR   Wikidata; Q54845962
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1709.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12688
AC   CVCL_9X95
DR   CLO; CLO_0018468
DR   Coriell; GM12688
DR   Wikidata; Q54845963
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1710.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12690
AC   CVCL_GZ44
DR   CLO; CLO_0018471
DR   Coriell; GM12690
DR   Wikidata; Q54845964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129304; Congenital myasthenic syndrome 5
DI   ORDO; Orphanet_98915; Synaptic congenital myasthenic syndromes
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM12691
AC   CVCL_9X96
DR   CLO; CLO_0018470
DR   Coriell; GM12691
DR   Wikidata; Q54845965
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2101.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12692
AC   CVCL_9X97
DR   CLO; CLO_0018475
DR   Coriell; GM12692
DR   Wikidata; Q54845966
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2102.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12693
AC   CVCL_9X98
DR   CLO; CLO_0018473
DR   Coriell; GM12693
DR   Wikidata; Q54845967
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2103.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12694
AC   CVCL_9X99
DR   CLO; CLO_0018477
DR   Coriell; GM12694
DR   Wikidata; Q54845968
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2104.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12695
AC   CVCL_9Y00
DR   CLO; CLO_0018476
DR   Coriell; GM12695
DR   Wikidata; Q54845969
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2105.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12696
AC   CVCL_9Y01
DR   CLO; CLO_0018478
DR   Coriell; GM12696
DR   Wikidata; Q54845970
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2106.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12697
AC   CVCL_9Y02
DR   CLO; CLO_0018489
DR   Coriell; GM12697
DR   Wikidata; Q54845971
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2107.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12698
AC   CVCL_9Y03
DR   CLO; CLO_0018488
DR   Coriell; GM12698
DR   Wikidata; Q54845972
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4501.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12699
AC   CVCL_9Y04
DR   CLO; CLO_0018493
DR   Coriell; GM12699
DR   Wikidata; Q54845973
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4502.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12700
AC   CVCL_9Y05
DR   CLO; CLO_0018492
DR   Coriell; GM12700
DR   Wikidata; Q54845974
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4503.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12701
AC   CVCL_9Y06
DR   CLO; CLO_0018491
DR   Coriell; GM12701
DR   Wikidata; Q54845975
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4505.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12702
AC   CVCL_9Y07
DR   CLO; CLO_0018490
DR   Coriell; GM12702
DR   Wikidata; Q54845976
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4506.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12703
AC   CVCL_9Y08
DR   CLO; CLO_0018498
DR   Coriell; GM12703
DR   Wikidata; Q54845977
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4507.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12704
AC   CVCL_9Y09
DR   CLO; CLO_0018497
DR   Coriell; GM12704
DR   Wikidata; Q54845978
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4508.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12705
AC   CVCL_9Y10
DR   CLO; CLO_0018495
DR   Coriell; GM12705
DR   Wikidata; Q54845979
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4509.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12706
AC   CVCL_9Y11
DR   CLO; CLO_0018494
DR   Coriell; GM12706
DR   Wikidata; Q54845986
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4510.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12707
AC   CVCL_R661
DR   CLO; CLO_0018447
DR   Coriell; GM12707
DR   GEO; GSM30064
DR   GEO; GSM112544
DR   GEO; GSM112847
DR   GEO; GSM188822
DR   GEO; GSM291670
DR   GEO; GSM420936
DR   GEO; GSM660014
DR   GEO; GSM660221
DR   GEO; GSM660425
DR   IGSR; NA12707
DR   Wikidata; Q54845987
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135801.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12707).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 25
//
ID   GM12708
AC   CVCL_R662
DR   CLO; CLO_0018449
DR   Coriell; GM12708
DR   GEO; GSM30065
DR   GEO; GSM420937
DR   GEO; GSM648980
DR   GEO; GSM660013
DR   GEO; GSM660220
DR   GEO; GSM660424
DR   GEO; GSM905882
DR   GEO; GSM905977
DR   GEO; GSM906072
DR   IGSR; NA12708
DR   Wikidata; Q54845988
RX   PubMed=15514893;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135802.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12709
AC   CVCL_5E29
DR   CLO; CLO_0018448
DR   Coriell; GM12709
DR   GEO; GSM30066
DR   GEO; GSM420938
DR   GEO; GSM659875
DR   GEO; GSM660085
DR   GEO; GSM660292
DR   Wikidata; Q54845989
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135803.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12710
AC   CVCL_5E30
DR   CLO; CLO_0018444
DR   Coriell; GM12710
DR   GEO; GSM420939
DR   GEO; GSM659874
DR   GEO; GSM660084
DR   GEO; GSM660291
DR   Wikidata; Q54845991
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135804.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12711
AC   CVCL_5E31
DR   CLO; CLO_0018443
DR   Coriell; GM12711
DR   GEO; GSM420940
DR   GEO; GSM659873
DR   GEO; GSM660083
DR   GEO; GSM660290
DR   Wikidata; Q54845992
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135805.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12712
AC   CVCL_5E32
DR   CLO; CLO_0018446
DR   Coriell; GM12712
DR   GEO; GSM30067
DR   GEO; GSM420941
DR   GEO; GSM659872
DR   GEO; GSM660082
DR   GEO; GSM660289
DR   Wikidata; Q54845993
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135806.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12713
AC   CVCL_5E33
DR   CLO; CLO_0018445
DR   Coriell; GM12713
DR   GEO; GSM30068
DR   GEO; GSM420942
DR   GEO; GSM659871
DR   GEO; GSM660081
DR   GEO; GSM660288
DR   Wikidata; Q54845994
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135807.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12714
AC   CVCL_5E34
DR   CLO; CLO_0018451
DR   Coriell; GM12714
DR   GEO; GSM30069
DR   GEO; GSM420943
DR   GEO; GSM659870
DR   GEO; GSM660080
DR   GEO; GSM660287
DR   Wikidata; Q54845995
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135808.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12715
AC   CVCL_5E35
DR   CLO; CLO_0018450
DR   Coriell; GM12715
DR   GEO; GSM30070
DR   GEO; GSM659869
DR   GEO; GSM660079
DR   GEO; GSM660286
DR   Wikidata; Q54845996
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135809.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12716
AC   CVCL_9615
DR   CLO; CLO_0018452
DR   EFO; EFO_0001147
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801646
DR   Coriell; GM12716
DR   GEO; GSM30071
DR   GEO; GSM112545
DR   GEO; GSM112848
DR   GEO; GSM273340
DR   GEO; GSM314973
DR   GEO; GSM420944
DR   GEO; GSM424351
DR   GEO; GSM486819
DR   GEO; GSM486821
DR   GEO; GSM648855
DR   GEO; GSM659954
DR   GEO; GSM660157
DR   GEO; GSM660364
DR   GEO; GSM957351
DR   GEO; GSM957387
DR   GEO; GSM1719807
DR   IGSR; NA12716
DR   Wikidata; Q54845997
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135811.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12716).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   GM12717
AC   CVCL_9616
DR   CLO; CLO_0022519
DR   EFO; EFO_0001148
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801648
DR   Coriell; GM12717
DR   GEO; GSM30072
DR   GEO; GSM112546
DR   GEO; GSM112849
DR   GEO; GSM188823
DR   GEO; GSM273341
DR   GEO; GSM291671
DR   GEO; GSM314974
DR   GEO; GSM420945
DR   GEO; GSM424352
DR   GEO; GSM486822
DR   GEO; GSM486823
DR   GEO; GSM648899
DR   GEO; GSM659944
DR   GEO; GSM660149
DR   GEO; GSM660372
DR   GEO; GSM905883
DR   GEO; GSM905978
DR   GEO; GSM906073
DR   GEO; GSM957352
DR   GEO; GSM957388
DR   GEO; GSM1719808
DR   IGSR; NA12717
DR   Wikidata; Q54845998
RX   PubMed=15514893;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135812.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Homozygous; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12717).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   GM12718
AC   CVCL_R663
DR   CLO; CLO_0022521
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801650
DR   Coriell; GM12718
DR   GEO; GSM30073
DR   GEO; GSM314975
DR   GEO; GSM420946
DR   GEO; GSM648929
DR   GEO; GSM906189
DR   GEO; GSM906190
DR   GEO; GSM1719809
DR   IGSR; NA12718
DR   Wikidata; Q54845999
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 135814.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12719
AC   CVCL_5E36
DR   CLO; CLO_0022520
DR   Coriell; GM12719
DR   GEO; GSM30074
DR   GEO; GSM420947
DR   GEO; GSM659876
DR   GEO; GSM660086
DR   GEO; GSM660293
DR   Wikidata; Q54846000
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135815.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12720
AC   CVCL_W205
DR   CLO; CLO_0022523
DR   Coriell; GM12720
DR   Wikidata; Q54846001
CC   Population: Jewish; Ashkenazi.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98969; Lactic acidosis
DI   ORDO; Orphanet_17; Fatal infantile lactic acidosis with methylmalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM12721
AC   CVCL_5P68
DR   CLO; CLO_0022522
DR   Coriell; GM12721
DR   Wikidata; Q54846002
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5P70 ! GM12929
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12722
AC   CVCL_5P69
DR   CLO; CLO_0022568
DR   Coriell; GM12722
DR   Wikidata; Q54846003
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM12739
AC   CVCL_R664
DR   CLO; CLO_0022567
DR   Coriell; GM12739
DR   GEO; GSM316414
DR   GEO; GSM316415
DR   GEO; GSM316416
DR   GEO; GSM420948
DR   GEO; GSM420949
DR   GEO; GSM905884
DR   GEO; GSM905979
DR   GEO; GSM906074
DR   IGSR; NA12739
DR   Wikidata; Q54846004
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144401.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12740
AC   CVCL_R665
DR   CLO; CLO_0022570
DR   Coriell; GM12740
DR   GEO; GSM89109
DR   GEO; GSM89110
DR   GEO; GSM112547
DR   GEO; GSM112850
DR   GEO; GSM188824
DR   GEO; GSM316459
DR   GEO; GSM316460
DR   GEO; GSM316461
DR   GEO; GSM420950
DR   GEO; GSM648900
DR   GEO; GSM862014
DR   GEO; GSM862015
DR   GEO; GSM862016
DR   GEO; GSM862017
DR   GEO; GSM862018
DR   GEO; GSM862019
DR   IGSR; NA12740
DR   Wikidata; Q54846005
RX   PubMed=14583597;
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144402.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 26
//
ID   GM12741
AC   CVCL_5E37
DR   CLO; CLO_0022569
DR   Coriell; GM12741
DR   GEO; GSM316321
DR   GEO; GSM316322
DR   GEO; GSM316323
DR   GEO; GSM420951
DR   Wikidata; Q54846006
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144403.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12742
AC   CVCL_5E38
DR   CLO; CLO_0022566
DR   Coriell; GM12742
DR   GEO; GSM316591
DR   GEO; GSM316592
DR   GEO; GSM316593
DR   GEO; GSM420952
DR   Wikidata; Q54846007
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144404.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12743
AC   CVCL_5E39
DR   CLO; CLO_0022575
DR   Coriell; GM12743
DR   GEO; GSM316324
DR   GEO; GSM316325
DR   GEO; GSM316326
DR   GEO; GSM420953
DR   Wikidata; Q54846008
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144405.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12744
AC   CVCL_5E40
DR   CLO; CLO_0022576
DR   Coriell; GM12744
DR   GEO; GSM316327
DR   GEO; GSM316328
DR   GEO; GSM316329
DR   GEO; GSM420954
DR   Wikidata; Q54846009
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144406.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12745
AC   CVCL_5E41
DR   CLO; CLO_0022571
DR   Coriell; GM12745
DR   GEO; GSM316330
DR   GEO; GSM316331
DR   GEO; GSM316332
DR   GEO; GSM420955
DR   Wikidata; Q54846010
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144407.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12746
AC   CVCL_5E42
DR   CLO; CLO_0022572
DR   Coriell; GM12746
DR   GEO; GSM316594
DR   GEO; GSM316595
DR   GEO; GSM316596
DR   GEO; GSM420956
DR   Wikidata; Q54846011
RX   PubMed=14583597;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144408.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12747
AC   CVCL_5E43
DR   CLO; CLO_0022573
DR   Coriell; GM12747
DR   GEO; GSM316600
DR   GEO; GSM316601
DR   GEO; GSM316602
DR   GEO; GSM420957
DR   Wikidata; Q54846012
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144410.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12748
AC   CVCL_R666
DR   CLO; CLO_0022574
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801678
DR   Coriell; GM12748
DR   GEO; GSM25620
DR   GEO; GSM25621
DR   GEO; GSM314976
DR   GEO; GSM314977
DR   GEO; GSM420958
DR   GEO; GSM420959
DR   GEO; GSM648852
DR   GEO; GSM1719810
DR   IGSR; NA12748
DR   Wikidata; Q54846013
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144411.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12749
AC   CVCL_R667
DR   CLO; CLO_0022580
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801680
DR   Coriell; GM12749
DR   GEO; GSM25622
DR   GEO; GSM25623
DR   GEO; GSM207785
DR   GEO; GSM314978
DR   GEO; GSM314979
DR   GEO; GSM420960
DR   GEO; GSM420961
DR   GEO; GSM648896
DR   GEO; GSM906191
DR   GEO; GSM906192
DR   GEO; GSM1719811
DR   IGSR; NA12749
DR   Wikidata; Q54846014
RX   PubMed=14583597;
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12750
AC   CVCL_9617
DR   CLO; CLO_0022579
DR   EFO; EFO_0001149
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801682
DR   Coriell; GM12750
DR   GEO; GSM25624
DR   GEO; GSM25625
DR   GEO; GSM112548
DR   GEO; GSM112851
DR   GEO; GSM188825
DR   GEO; GSM273342
DR   GEO; GSM273343
DR   GEO; GSM291672
DR   GEO; GSM314980
DR   GEO; GSM314981
DR   GEO; GSM420962
DR   GEO; GSM420963
DR   GEO; GSM424353
DR   GEO; GSM486824
DR   GEO; GSM486826
DR   GEO; GSM648878
DR   GEO; GSM659979
DR   GEO; GSM660185
DR   GEO; GSM660390
DR   GEO; GSM905885
DR   GEO; GSM905980
DR   GEO; GSM906075
DR   GEO; GSM957343
DR   GEO; GSM957353
DR   GEO; GSM957389
DR   GEO; GSM980645
DR   GEO; GSM1261037
DR   GEO; GSM1719812
DR   IGSR; NA12750
DR   Wikidata; Q54846015
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144413.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM12751
AC   CVCL_7525
DR   CLO; CLO_0022578
DR   EFO; EFO_0001150
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801684
DR   Coriell; GM12751
DR   GEO; GSM25626
DR   GEO; GSM25627
DR   GEO; GSM112549
DR   GEO; GSM112852
DR   GEO; GSM188826
DR   GEO; GSM273344
DR   GEO; GSM273345
DR   GEO; GSM291673
DR   GEO; GSM291674
DR   GEO; GSM314982
DR   GEO; GSM314983
DR   GEO; GSM420964
DR   GEO; GSM420965
DR   GEO; GSM486828
DR   GEO; GSM486830
DR   GEO; GSM648894
DR   GEO; GSM659977
DR   GEO; GSM660182
DR   GEO; GSM660388
DR   GEO; GSM905886
DR   GEO; GSM905981
DR   GEO; GSM906076
DR   GEO; GSM1719813
DR   IGSR; NA12751
DR   Wikidata; Q54846016
RX   PubMed=14583597;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=35931342;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144414.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12751).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   GM12752
AC   CVCL_R668
DR   CLO; CLO_0022577
DR   Coriell; GM12752
DR   GEO; GSM112550
DR   GEO; GSM112853
DR   GEO; GSM188827
DR   GEO; GSM291675
DR   GEO; GSM291676
DR   GEO; GSM316417
DR   GEO; GSM316418
DR   GEO; GSM316419
DR   GEO; GSM420966
DR   GEO; GSM420967
DR   GEO; GSM648901
DR   IGSR; NA12752
DR   Wikidata; Q54846017
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144701.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12752).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 25
//
ID   GM12753
AC   CVCL_R669
DR   CLO; CLO_0022587
DR   Coriell; GM12753
DR   GEO; GSM112551
DR   GEO; GSM112854
DR   GEO; GSM188828
DR   GEO; GSM291677
DR   GEO; GSM291678
DR   GEO; GSM316462
DR   GEO; GSM316463
DR   GEO; GSM316464
DR   GEO; GSM420968
DR   GEO; GSM420969
DR   GEO; GSM648921
DR   IGSR; NA12753
DR   Wikidata; Q54846018
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24924344;
RX   PubMed=26621101;
RX   PubMed=35931342;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144702.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12753).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 26
//
ID   GM12754
AC   CVCL_5E44
DR   CLO; CLO_0022585
DR   Coriell; GM12754
DR   GEO; GSM316333
DR   GEO; GSM316334
DR   GEO; GSM316335
DR   GEO; GSM420970
DR   Wikidata; Q54846019
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144703.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12755
AC   CVCL_5E45
DR   CLO; CLO_0022586
DR   Coriell; GM12755
DR   GEO; GSM316603
DR   GEO; GSM316604
DR   GEO; GSM316605
DR   GEO; GSM420971
DR   Wikidata; Q54846020
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144704.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12756
AC   CVCL_5E46
DR   CLO; CLO_0022583
DR   Coriell; GM12756
DR   GEO; GSM316606
DR   GEO; GSM316607
DR   GEO; GSM316608
DR   GEO; GSM420972
DR   Wikidata; Q54846021
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144705.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12757
AC   CVCL_5E47
DR   CLO; CLO_0022584
DR   Coriell; GM12757
DR   GEO; GSM316336
DR   GEO; GSM316337
DR   GEO; GSM316338
DR   GEO; GSM420973
DR   Wikidata; Q54846022
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144706.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12758
AC   CVCL_5E48
DR   CLO; CLO_0022581
DR   Coriell; GM12758
DR   GEO; GSM316339
DR   GEO; GSM316340
DR   GEO; GSM316341
DR   GEO; GSM420974
DR   Wikidata; Q54846023
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144707.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12759
AC   CVCL_5E49
DR   CLO; CLO_0022582
DR   Coriell; GM12759
DR   GEO; GSM316342
DR   GEO; GSM316343
DR   GEO; GSM316344
DR   Wikidata; Q54846024
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144708.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12760
AC   CVCL_9618
DR   CLO; CLO_0022545
DR   EFO; EFO_0001151
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801702
DR   Coriell; GM12760
DR   GEO; GSM25628
DR   GEO; GSM25629
DR   GEO; GSM112552
DR   GEO; GSM112855
DR   GEO; GSM188829
DR   GEO; GSM273346
DR   GEO; GSM273347
DR   GEO; GSM291679
DR   GEO; GSM314984
DR   GEO; GSM314985
DR   GEO; GSM420975
DR   GEO; GSM420976
DR   GEO; GSM486831
DR   GEO; GSM486832
DR   GEO; GSM648865
DR   GEO; GSM659975
DR   GEO; GSM660181
DR   GEO; GSM660386
DR   GEO; GSM905887
DR   GEO; GSM905982
DR   GEO; GSM906077
DR   GEO; GSM1719814
DR   IGSR; NA12760
DR   Wikidata; Q54846025
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144709.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM12761
AC   CVCL_9619
DR   CLO; CLO_0022544
DR   EFO; EFO_0001152
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801704
DR   Coriell; GM12761
DR   GEO; GSM25630
DR   GEO; GSM25631
DR   GEO; GSM112553
DR   GEO; GSM112856
DR   GEO; GSM188831
DR   GEO; GSM273348
DR   GEO; GSM273349
DR   GEO; GSM291680
DR   GEO; GSM314986
DR   GEO; GSM314987
DR   GEO; GSM420977
DR   GEO; GSM420978
DR   GEO; GSM486833
DR   GEO; GSM486834
DR   GEO; GSM648868
DR   GEO; GSM659973
DR   GEO; GSM660178
DR   GEO; GSM660384
DR   GEO; GSM905888
DR   GEO; GSM905983
DR   GEO; GSM906078
DR   GEO; GSM1719815
DR   IGSR; NA12761
DR   Wikidata; Q54846026
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144710.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12761).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   GM12762
AC   CVCL_9620
DR   CLO; CLO_0022546
DR   EFO; EFO_0001153
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801706
DR   Coriell; GM12762
DR   GEO; GSM25632
DR   GEO; GSM25633
DR   GEO; GSM112554
DR   GEO; GSM112857
DR   GEO; GSM188832
DR   GEO; GSM273350
DR   GEO; GSM273351
DR   GEO; GSM291681
DR   GEO; GSM291682
DR   GEO; GSM314988
DR   GEO; GSM314989
DR   GEO; GSM420979
DR   GEO; GSM420980
DR   GEO; GSM424354
DR   GEO; GSM486835
DR   GEO; GSM486836
DR   GEO; GSM659947
DR   GEO; GSM660148
DR   GEO; GSM660375
DR   GEO; GSM905889
DR   GEO; GSM905984
DR   GEO; GSM906079
DR   GEO; GSM957390
DR   GEO; GSM1719816
DR   IGSR; NA12762
DR   Wikidata; Q54846033
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144711.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM12763
AC   CVCL_9621
DR   CLO; CLO_0022547
DR   EFO; EFO_0001154
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801708
DR   Coriell; GM12763
DR   GEO; GSM25634
DR   GEO; GSM25635
DR   GEO; GSM112555
DR   GEO; GSM112858
DR   GEO; GSM188833
DR   GEO; GSM273352
DR   GEO; GSM273353
DR   GEO; GSM291683
DR   GEO; GSM314990
DR   GEO; GSM314991
DR   GEO; GSM420981
DR   GEO; GSM420982
DR   GEO; GSM486837
DR   GEO; GSM486838
DR   GEO; GSM648907
DR   GEO; GSM659971
DR   GEO; GSM660177
DR   GEO; GSM660382
DR   GEO; GSM905890
DR   GEO; GSM905985
DR   GEO; GSM906080
DR   GEO; GSM1719817
DR   IGSR; NA12763
DR   Wikidata; Q54846034
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 144712.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12763).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   GM12764
AC   CVCL_5E50
DR   CLO; CLO_0022548
DR   Coriell; GM12764
DR   GEO; GSM316609
DR   GEO; GSM316610
DR   GEO; GSM316611
DR   GEO; GSM420983
DR   Wikidata; Q54846035
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144713.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12765
AC   CVCL_5E51
DR   CLO; CLO_0022549
DR   Coriell; GM12765
DR   GEO; GSM316612
DR   GEO; GSM316613
DR   GEO; GSM316614
DR   GEO; GSM420984
DR   Wikidata; Q54846036
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144714.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12766
AC   CVCL_R670
DR   CLO; CLO_0022550
DR   Coriell; GM12766
DR   GEO; GSM316420
DR   GEO; GSM316421
DR   GEO; GSM316422
DR   GEO; GSM420985
DR   GEO; GSM420986
DR   GEO; GSM648954
DR   GEO; GSM905891
DR   GEO; GSM905986
DR   GEO; GSM906081
DR   IGSR; NA12766
DR   Wikidata; Q54846037
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145101.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12767
AC   CVCL_R671
DR   CLO; CLO_0022551
DR   Coriell; GM12767
DR   GEO; GSM89111
DR   GEO; GSM89112
DR   GEO; GSM316465
DR   GEO; GSM316466
DR   GEO; GSM316467
DR   GEO; GSM420987
DR   GEO; GSM420988
DR   GEO; GSM648958
DR   GEO; GSM905892
DR   GEO; GSM905987
DR   GEO; GSM906082
DR   IGSR; NA12767
DR   Wikidata; Q54846038
RX   PubMed=16809669;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145102.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12768
AC   CVCL_5E52
DR   CLO; CLO_0022552
DR   Coriell; GM12768
DR   GEO; GSM316615
DR   GEO; GSM316616
DR   GEO; GSM316617
DR   GEO; GSM420989
DR   Wikidata; Q54846039
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145103.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12769
AC   CVCL_5E53
DR   CLO; CLO_0022553
DR   Coriell; GM12769
DR   GEO; GSM316345
DR   GEO; GSM316346
DR   GEO; GSM316347
DR   GEO; GSM420990
DR   Wikidata; Q54846040
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145104.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12770
AC   CVCL_5E54
DR   CLO; CLO_0022554
DR   Coriell; GM12770
DR   GEO; GSM316348
DR   GEO; GSM316349
DR   GEO; GSM316350
DR   GEO; GSM420991
DR   Wikidata; Q54846041
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145105.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12771
AC   CVCL_5E55
DR   CLO; CLO_0022556
DR   Coriell; GM12771
DR   GEO; GSM316618
DR   GEO; GSM316619
DR   GEO; GSM316620
DR   GEO; GSM420992
DR   Wikidata; Q54846042
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145106.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12772
AC   CVCL_5E56
DR   CLO; CLO_0022555
DR   Coriell; GM12772
DR   GEO; GSM316351
DR   GEO; GSM316352
DR   GEO; GSM316353
DR   GEO; GSM420993
DR   Wikidata; Q54846043
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145107.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12773
AC   CVCL_5E57
DR   CLO; CLO_0022565
DR   Coriell; GM12773
DR   GEO; GSM316354
DR   GEO; GSM316355
DR   GEO; GSM316356
DR   GEO; GSM420994
DR   Wikidata; Q54846044
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145108.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12774
AC   CVCL_5E58
DR   CLO; CLO_0022559
DR   Coriell; GM12774
DR   GEO; GSM316621
DR   GEO; GSM316622
DR   GEO; GSM316623
DR   GEO; GSM420995
DR   Wikidata; Q54846045
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145110.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12775
AC   CVCL_R672
DR   CLO; CLO_0022560
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801732
DR   Coriell; GM12775
DR   GEO; GSM25636
DR   GEO; GSM25637
DR   GEO; GSM314992
DR   GEO; GSM314993
DR   GEO; GSM420996
DR   GEO; GSM420997
DR   GEO; GSM648844
DR   GEO; GSM906193
DR   GEO; GSM906194
DR   GEO; GSM1719818
DR   IGSR; NA12775
DR   Wikidata; Q54846046
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145111.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12776
AC   CVCL_R673
DR   CLO; CLO_0022557
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801734
DR   Coriell; GM12776
DR   GEO; GSM25638
DR   GEO; GSM25639
DR   GEO; GSM314994
DR   GEO; GSM314995
DR   GEO; GSM420998
DR   GEO; GSM420999
DR   GEO; GSM648927
DR   GEO; GSM906195
DR   GEO; GSM906196
DR   GEO; GSM1719819
DR   IGSR; NA12776
DR   Wikidata; Q54846047
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145112.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM12777
AC   CVCL_R674
DR   CLO; CLO_0022558
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801736
DR   Coriell; GM12777
DR   GEO; GSM25640
DR   GEO; GSM25641
DR   GEO; GSM314996
DR   GEO; GSM314997
DR   GEO; GSM421000
DR   GEO; GSM421001
DR   GEO; GSM648903
DR   GEO; GSM906197
DR   GEO; GSM906198
DR   GEO; GSM1719820
DR   IGSR; NA12777
DR   Wikidata; Q54846048
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145113.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12778
AC   CVCL_R675
DR   CLO; CLO_0022563
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801738
DR   Coriell; GM12778
DR   GEO; GSM25642
DR   GEO; GSM25643
DR   GEO; GSM314998
DR   GEO; GSM421002
DR   GEO; GSM648959
DR   GEO; GSM906199
DR   GEO; GSM906200
DR   GEO; GSM1719821
DR   IGSR; NA12778
DR   Wikidata; Q54846049
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145114.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12779
AC   CVCL_9Y12
DR   CLO; CLO_0022564
DR   Coriell; GM12779
DR   Wikidata; Q54846050
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 2108.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM12780
AC   CVCL_4I75
DR   CLO; CLO_0022561
DR   Coriell; GM12780
DR   Wikidata; Q54846051
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12781
AC   CVCL_4I76
DR   CLO; CLO_0022562
DR   Coriell; GM12781
DR   Wikidata; Q54846052
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12782
AC   CVCL_4I77
DR   CLO; CLO_0022617
DR   Coriell; GM12782
DR   Wikidata; Q54846053
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12783
AC   CVCL_4I78
DR   CLO; CLO_0022619
DR   Coriell; GM12783
DR   Wikidata; Q54846054
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12784
AC   CVCL_4I79
DR   CLO; CLO_0022618
DR   Coriell; GM12784
DR   Wikidata; Q54846055
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12785
AC   CVCL_0N20
DR   CLO; CLO_0022632
DR   Coriell; GM12785
DR   Wikidata; Q54846056
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg347Pro (c.1040G>C); ClinVar=VCV000007110; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly551Asp (c.1652G>A); ClinVar=VCV000007120; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM12787
AC   CVCL_5M42
DR   CLO; CLO_0022631
DR   Coriell; GM12787
DR   Wikidata; Q54846057
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(2)(pter->q35) (Coriell=GM12787).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75012; Dandy-Walker malformation
DI   ORDO; Orphanet_1538; Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   GM12790
AC   CVCL_4I80
DR   CLO; CLO_0022636
DR   Coriell; GM12790
DR   Wikidata; Q54846058
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12791
AC   CVCL_4I81
DR   CLO; CLO_0022635
DR   Coriell; GM12791
DR   Wikidata; Q54846059
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12792
AC   CVCL_4I82
DR   CLO; CLO_0022624
DR   Coriell; GM12792
DR   Wikidata; Q54846061
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12793
AC   CVCL_4I83
DR   CLO; CLO_0022623
DR   Coriell; GM12793
DR   Wikidata; Q54846062
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM12794
AC   CVCL_AK34
SY   GM 12794
DR   CLO; CLO_0022628
DR   Coriell; GM12794
DR   Wikidata; Q54846063
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Asp23Ilefs*23 (c.67delG) (322delG); ClinVar=VCV000012049; Zygosity=Unspecified (Coriell=GM12794).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM12801
AC   CVCL_L247
DR   CLO; CLO_0022626
DR   EFO; EFO_0005353
DR   Coriell; GM12801
DR   ENCODE; ENCBS187AAA
DR   ENCODE; ENCBS188AAA
DR   ENCODE; ENCBS189AAA
DR   ENCODE; ENCBS190AAA
DR   ENCODE; ENCBS191AAA
DR   ENCODE; ENCBS192AAA
DR   ENCODE; ENCBS193AAA
DR   GEO; GSM25644
DR   GEO; GSM25645
DR   GEO; GSM112556
DR   GEO; GSM112859
DR   GEO; GSM188834
DR   GEO; GSM291684
DR   GEO; GSM291685
DR   GEO; GSM316423
DR   GEO; GSM316424
DR   GEO; GSM316425
DR   GEO; GSM421003
DR   GEO; GSM421004
DR   GEO; GSM648849
DR   GEO; GSM749701
DR   GEO; GSM749711
DR   GEO; GSM923440
DR   IGSR; NA12801
DR   Wikidata; Q54846064
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12801_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145401.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 22
//
ID   GM12802
AC   CVCL_L248
DR   CLO; CLO_0022642
DR   Coriell; GM12802
DR   GEO; GSM25646
DR   GEO; GSM25647
DR   GEO; GSM112557
DR   GEO; GSM112860
DR   GEO; GSM188835
DR   GEO; GSM291686
DR   GEO; GSM316468
DR   GEO; GSM316469
DR   GEO; GSM316470
DR   GEO; GSM421005
DR   GEO; GSM421006
DR   GEO; GSM648860
DR   GEO; GSM862020
DR   GEO; GSM862021
DR   GEO; GSM862022
DR   GEO; GSM862023
DR   GEO; GSM862024
DR   GEO; GSM862025
DR   IGSR; NA12802
DR   Wikidata; Q54846065
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145402.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 21
//
ID   GM12803
AC   CVCL_L249
DR   CLO; CLO_0022641
DR   Coriell; GM12803
DR   GEO; GSM25648
DR   GEO; GSM316360
DR   GEO; GSM316361
DR   GEO; GSM316362
DR   GEO; GSM421007
DR   Wikidata; Q54846066
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145403.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12804
AC   CVCL_L250
DR   CLO; CLO_0022640
DR   Coriell; GM12804
DR   GEO; GSM25649
DR   GEO; GSM316363
DR   GEO; GSM316364
DR   GEO; GSM316365
DR   GEO; GSM421008
DR   Wikidata; Q54846067
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145404.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12805
AC   CVCL_L251
DR   CLO; CLO_0022658
DR   Coriell; GM12805
DR   GEO; GSM25650
DR   GEO; GSM316624
DR   GEO; GSM316625
DR   GEO; GSM316626
DR   GEO; GSM421009
DR   Wikidata; Q54846068
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145405.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12806
AC   CVCL_L252
DR   CLO; CLO_0022656
DR   Coriell; GM12806
DR   GEO; GSM25651
DR   GEO; GSM316627
DR   GEO; GSM316628
DR   GEO; GSM316629
DR   GEO; GSM421010
DR   Wikidata; Q54846069
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145406.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12807
AC   CVCL_L253
DR   CLO; CLO_0022653
DR   Coriell; GM12807
DR   GEO; GSM25652
DR   GEO; GSM316366
DR   GEO; GSM316367
DR   GEO; GSM316368
DR   GEO; GSM421011
DR   Wikidata; Q54846070
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145407.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12808
AC   CVCL_L254
DR   CLO; CLO_0022651
DR   Coriell; GM12808
DR   GEO; GSM25653
DR   GEO; GSM316369
DR   GEO; GSM316370
DR   GEO; GSM316371
DR   GEO; GSM421012
DR   Wikidata; Q54846071
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145408.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12809
AC   CVCL_L255
DR   CLO; CLO_0022649
DR   Coriell; GM12809
DR   GEO; GSM25654
DR   GEO; GSM316372
DR   GEO; GSM316373
DR   GEO; GSM316374
DR   GEO; GSM421013
DR   Wikidata; Q54846072
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145409.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12810
AC   CVCL_5E59
DR   CLO; CLO_0022648
DR   Coriell; GM12810
DR   GEO; GSM25655
DR   GEO; GSM316630
DR   GEO; GSM316631
DR   GEO; GSM316632
DR   GEO; GSM421014
DR   Wikidata; Q54846073
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145410.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12811
AC   CVCL_5E60
DR   CLO; CLO_0022646
DR   Coriell; GM12811
DR   GEO; GSM316633
DR   GEO; GSM316634
DR   GEO; GSM316635
DR   Wikidata; Q54846081
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145411.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12812
AC   CVCL_9622
DR   CLO; CLO_0022589
DR   EFO; EFO_0001155
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00801768
DR   Coriell; GM12812
DR   ENCODE; ENCBS194AAA
DR   ENCODE; ENCBS195AAA
DR   ENCODE; ENCBS196AAA
DR   ENCODE; ENCBS197AAA
DR   ENCODE; ENCBS198AAA
DR   ENCODE; ENCBS199AAA
DR   ENCODE; ENCBS200AAA
DR   GEO; GSM25656
DR   GEO; GSM25657
DR   GEO; GSM112558
DR   GEO; GSM112861
DR   GEO; GSM188836
DR   GEO; GSM273354
DR   GEO; GSM273355
DR   GEO; GSM291687
DR   GEO; GSM314999
DR   GEO; GSM315000
DR   GEO; GSM421015
DR   GEO; GSM421016
DR   GEO; GSM486839
DR   GEO; GSM486840
DR   GEO; GSM648872
DR   GEO; GSM659996
DR   GEO; GSM660202
DR   GEO; GSM660407
DR   GEO; GSM905893
DR   GEO; GSM905988
DR   GEO; GSM906083
DR   GEO; GSM923439
DR   GEO; GSM1719822
DR   IGSR; NA12812
DR   Wikidata; Q54846082
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12812_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   GM12813
AC   CVCL_9623
DR   CLO; CLO_0022588
DR   EFO; EFO_0001156
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801770
DR   Coriell; GM12813
DR   ENCODE; ENCBS201AAA
DR   ENCODE; ENCBS202AAA
DR   ENCODE; ENCBS203AAA
DR   ENCODE; ENCBS204AAA
DR   ENCODE; ENCBS205AAA
DR   ENCODE; ENCBS206AAA
DR   ENCODE; ENCBS207AAA
DR   GEO; GSM25658
DR   GEO; GSM25659
DR   GEO; GSM112559
DR   GEO; GSM112862
DR   GEO; GSM188837
DR   GEO; GSM207786
DR   GEO; GSM273356
DR   GEO; GSM273357
DR   GEO; GSM291688
DR   GEO; GSM315001
DR   GEO; GSM315002
DR   GEO; GSM421017
DR   GEO; GSM421018
DR   GEO; GSM424355
DR   GEO; GSM486841
DR   GEO; GSM486842
DR   GEO; GSM648861
DR   GEO; GSM659992
DR   GEO; GSM660198
DR   GEO; GSM660403
DR   GEO; GSM905894
DR   GEO; GSM905989
DR   GEO; GSM906084
DR   GEO; GSM923450
DR   GEO; GSM957391
DR   GEO; GSM1719823
DR   IGSR; NA12813
DR   Wikidata; Q54846083
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12813_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145413.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM12813).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   GM12814
AC   CVCL_9624
DR   CLO; CLO_0022591
DR   EFO; EFO_0001157
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801772
DR   Coriell; GM12814
DR   GEO; GSM25660
DR   GEO; GSM25661
DR   GEO; GSM112560
DR   GEO; GSM112863
DR   GEO; GSM188838
DR   GEO; GSM273358
DR   GEO; GSM273359
DR   GEO; GSM291689
DR   GEO; GSM315003
DR   GEO; GSM315004
DR   GEO; GSM421019
DR   GEO; GSM421020
DR   GEO; GSM424356
DR   GEO; GSM486843
DR   GEO; GSM486844
DR   GEO; GSM648913
DR   GEO; GSM659953
DR   GEO; GSM660188
DR   GEO; GSM660396
DR   GEO; GSM905895
DR   GEO; GSM905990
DR   GEO; GSM906085
DR   GEO; GSM957392
DR   GEO; GSM1719824
DR   IGSR; NA12814
DR   Wikidata; Q54846084
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21321133;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145414.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   GM12815
AC   CVCL_9625
DR   CLO; CLO_0022590
DR   EFO; EFO_0001158
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801774
DR   Coriell; GM12815
DR   GEO; GSM25662
DR   GEO; GSM25663
DR   GEO; GSM112561
DR   GEO; GSM112864
DR   GEO; GSM188839
DR   GEO; GSM273360
DR   GEO; GSM273361
DR   GEO; GSM291690
DR   GEO; GSM315005
DR   GEO; GSM315006
DR   GEO; GSM421021
DR   GEO; GSM421022
DR   GEO; GSM424357
DR   GEO; GSM486845
DR   GEO; GSM486846
DR   GEO; GSM648890
DR   GEO; GSM659985
DR   GEO; GSM660195
DR   GEO; GSM660354
DR   GEO; GSM905896
DR   GEO; GSM905991
DR   GEO; GSM906086
DR   GEO; GSM957393
DR   GEO; GSM1719825
DR   IGSR; NA12815
DR   Wikidata; Q54846087
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145415.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   GM12816
AC   CVCL_5E61
DR   CLO; CLO_0022594
DR   Coriell; GM12816
DR   GEO; GSM316636
DR   GEO; GSM316637
DR   GEO; GSM316638
DR   Wikidata; Q54846088
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145416.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12817
AC   CVCL_R676
DR   CLO; CLO_0022592
DR   Coriell; GM12817
DR   GEO; GSM89113
DR   GEO; GSM89114
DR   GEO; GSM421023
DR   GEO; GSM421024
DR   GEO; GSM648957
DR   GEO; GSM660008
DR   GEO; GSM660215
DR   GEO; GSM660419
DR   GEO; GSM905897
DR   GEO; GSM905992
DR   GEO; GSM906087
DR   IGSR; NA12817
DR   Wikidata; Q54846089
RX   PubMed=16809669;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145601.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12818
AC   CVCL_R677
DR   CLO; CLO_0022599
DR   Coriell; GM12818
DR   GEO; GSM421025
DR   GEO; GSM421026
DR   GEO; GSM648976
DR   GEO; GSM660007
DR   GEO; GSM660214
DR   GEO; GSM660418
DR   GEO; GSM905898
DR   GEO; GSM905993
DR   GEO; GSM906088
DR   IGSR; NA12818
DR   Wikidata; Q54846091
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145602.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12819
AC   CVCL_5E62
DR   CLO; CLO_0022597
DR   Coriell; GM12819
DR   GEO; GSM421027
DR   GEO; GSM659852
DR   GEO; GSM660062
DR   GEO; GSM660269
DR   Wikidata; Q54846092
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145603.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12820
AC   CVCL_5E63
DR   CLO; CLO_0022602
DR   Coriell; GM12820
DR   GEO; GSM421028
DR   GEO; GSM659851
DR   GEO; GSM660061
DR   GEO; GSM660268
DR   Wikidata; Q54846093
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145604.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12821
AC   CVCL_5E64
DR   CLO; CLO_0022601
DR   Coriell; GM12821
DR   GEO; GSM421029
DR   GEO; GSM659850
DR   GEO; GSM660060
DR   GEO; GSM660267
DR   Wikidata; Q54846094
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145605.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12822
AC   CVCL_5E65
DR   CLO; CLO_0022606
DR   Coriell; GM12822
DR   GEO; GSM421030
DR   GEO; GSM659849
DR   GEO; GSM660059
DR   GEO; GSM660266
DR   Wikidata; Q54846095
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145606.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12823
AC   CVCL_5E66
DR   CLO; CLO_0022610
DR   Coriell; GM12823
DR   GEO; GSM421031
DR   GEO; GSM659848
DR   GEO; GSM660058
DR   GEO; GSM660265
DR   Wikidata; Q54846096
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145607.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12824
AC   CVCL_5E67
DR   CLO; CLO_0022609
DR   Coriell; GM12824
DR   GEO; GSM421032
DR   GEO; GSM659847
DR   GEO; GSM660057
DR   GEO; GSM660264
DR   Wikidata; Q54846097
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145608.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12825
AC   CVCL_5E68
DR   CLO; CLO_0022608
DR   Coriell; GM12825
DR   GEO; GSM421033
DR   GEO; GSM659846
DR   GEO; GSM660056
DR   GEO; GSM660263
DR   Wikidata; Q54846098
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145609.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12826
AC   CVCL_5E69
DR   CLO; CLO_0022607
DR   Coriell; GM12826
DR   GEO; GSM421034
DR   GEO; GSM659853
DR   GEO; GSM660063
DR   GEO; GSM660270
DR   Wikidata; Q54846099
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145610.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12827
AC   CVCL_R678
DR   CLO; CLO_0022614
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801798
DR   Coriell; GM12827
DR   GEO; GSM25664
DR   GEO; GSM25665
DR   GEO; GSM315007
DR   GEO; GSM315008
DR   GEO; GSM421035
DR   GEO; GSM421036
DR   GEO; GSM648981
DR   GEO; GSM906201
DR   GEO; GSM906202
DR   GEO; GSM1719826
DR   IGSR; NA12827
DR   Wikidata; Q54846100
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145611.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12828
AC   CVCL_R679
DR   CLO; CLO_0022613
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801800
DR   Coriell; GM12828
DR   GEO; GSM25666
DR   GEO; GSM25667
DR   GEO; GSM315009
DR   GEO; GSM315010
DR   GEO; GSM421037
DR   GEO; GSM421038
DR   GEO; GSM648931
DR   GEO; GSM906203
DR   GEO; GSM906204
DR   GEO; GSM1719827
DR   IGSR; NA12828
DR   Wikidata; Q54846101
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145612.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12829
AC   CVCL_R680
DR   CLO; CLO_0022612
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00801802
DR   Coriell; GM12829
DR   GEO; GSM25668
DR   GEO; GSM25669
DR   GEO; GSM315011
DR   GEO; GSM315012
DR   GEO; GSM421039
DR   GEO; GSM421040
DR   GEO; GSM648845
DR   GEO; GSM906205
DR   GEO; GSM906206
DR   GEO; GSM1719828
DR   IGSR; NA12829
DR   Wikidata; Q54846105
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145613.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12830
AC   CVCL_R681
DR   CLO; CLO_0022611
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801804
DR   Coriell; GM12830
DR   GEO; GSM25670
DR   GEO; GSM25671
DR   GEO; GSM315013
DR   GEO; GSM315014
DR   GEO; GSM421041
DR   GEO; GSM421042
DR   GEO; GSM648835
DR   GEO; GSM906207
DR   GEO; GSM906208
DR   GEO; GSM1719829
DR   IGSR; NA12830
DR   Wikidata; Q54846108
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145614.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12831
AC   CVCL_5E70
DR   CLO; CLO_0022615
DR   Coriell; GM12831
DR   GEO; GSM421043
DR   GEO; GSM421044
DR   GEO; GSM660006
DR   GEO; GSM660213
DR   GEO; GSM660413
DR   GEO; GSM905899
DR   GEO; GSM905994
DR   GEO; GSM906089
DR   Wikidata; Q54846111
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145801.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12832
AC   CVCL_R682
DR   CLO; CLO_0022397
DR   Coriell; GM12832
DR   GEO; GSM421045
DR   GEO; GSM421046
DR   GEO; GSM648949
DR   GEO; GSM660005
DR   GEO; GSM660212
DR   GEO; GSM660412
DR   GEO; GSM905900
DR   GEO; GSM905995
DR   GEO; GSM906090
DR   IGSR; NA12832
DR   Wikidata; Q54846115
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145802.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM12833
AC   CVCL_5E71
DR   CLO; CLO_0022400
DR   Coriell; GM12833
DR   GEO; GSM421047
DR   GEO; GSM659844
DR   GEO; GSM660054
DR   GEO; GSM660261
DR   Wikidata; Q54846116
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145803.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12834
AC   CVCL_5E72
DR   CLO; CLO_0022406
DR   Coriell; GM12834
DR   GEO; GSM421048
DR   GEO; GSM659843
DR   GEO; GSM660053
DR   GEO; GSM660260
DR   Wikidata; Q54846118
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145804.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12835
AC   CVCL_5E73
DR   CLO; CLO_0022407
DR   Coriell; GM12835
DR   GEO; GSM421049
DR   GEO; GSM659842
DR   GEO; GSM660052
DR   GEO; GSM660259
DR   Wikidata; Q54846119
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145805.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12836
AC   CVCL_5E74
DR   CLO; CLO_0022403
DR   Coriell; GM12836
DR   GEO; GSM421050
DR   GEO; GSM659841
DR   GEO; GSM660051
DR   GEO; GSM660258
DR   Wikidata; Q54846120
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145806.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12837
AC   CVCL_5E75
DR   CLO; CLO_0022404
DR   Coriell; GM12837
DR   GEO; GSM421051
DR   GEO; GSM659840
DR   GEO; GSM660050
DR   GEO; GSM660257
DR   Wikidata; Q54846121
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145807.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12838
AC   CVCL_5E76
DR   CLO; CLO_0022391
DR   Coriell; GM12838
DR   GEO; GSM421052
DR   GEO; GSM659839
DR   GEO; GSM660049
DR   GEO; GSM660256
DR   Wikidata; Q54846123
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145808.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12839
AC   CVCL_5E77
DR   CLO; CLO_0022392
DR   Coriell; GM12839
DR   GEO; GSM421053
DR   GEO; GSM659838
DR   GEO; GSM660048
DR   GEO; GSM660255
DR   Wikidata; Q54846124
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145809.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12840
AC   CVCL_5E78
DR   CLO; CLO_0022389
DR   Coriell; GM12840
DR   GEO; GSM25672
DR   GEO; GSM25673
DR   GEO; GSM315015
DR   GEO; GSM315016
DR   GEO; GSM421054
DR   GEO; GSM421055
DR   GEO; GSM906209
DR   GEO; GSM906210
DR   Wikidata; Q54846125
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145810/145911.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (from autologous cell line GM12874).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9628 ! GM12874
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 22
//
ID   GM12841
AC   CVCL_5E79
DR   CLO; CLO_0022390
DR   Coriell; GM12841
DR   GEO; GSM25674
DR   GEO; GSM25675
DR   GEO; GSM207787
DR   GEO; GSM315017
DR   GEO; GSM315018
DR   GEO; GSM421056
DR   GEO; GSM421057
DR   GEO; GSM906211
DR   GEO; GSM906212
DR   Wikidata; Q54846126
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145811/145912.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (from autologous cell line GM12875).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9629 ! GM12875
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 21
//
ID   GM12842
AC   CVCL_R683
DR   CLO; CLO_0022810
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801828
DR   Coriell; GM12842
DR   GEO; GSM25676
DR   GEO; GSM25677
DR   GEO; GSM315019
DR   GEO; GSM315020
DR   GEO; GSM421058
DR   GEO; GSM421059
DR   GEO; GSM648935
DR   GEO; GSM906213
DR   GEO; GSM906214
DR   GEO; GSM1719830
DR   IGSR; NA12842
DR   Wikidata; Q54846127
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145812.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12843
AC   CVCL_R684
DR   CLO; CLO_0022809
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801830
DR   Coriell; GM12843
DR   GEO; GSM25678
DR   GEO; GSM25679
DR   GEO; GSM315021
DR   GEO; GSM315022
DR   GEO; GSM421060
DR   GEO; GSM421061
DR   GEO; GSM648945
DR   GEO; GSM906215
DR   GEO; GSM906216
DR   GEO; GSM1719831
DR   IGSR; NA12843
DR   Wikidata; Q54846128
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145813.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12844
AC   CVCL_5E80
DR   CLO; CLO_0022812
DR   Coriell; GM12844
DR   GEO; GSM421062
DR   GEO; GSM659845
DR   GEO; GSM660055
DR   GEO; GSM660262
DR   Wikidata; Q54846129
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145814.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12847
AC   CVCL_5E81
DR   CLO; CLO_0022811
DR   Coriell; GM12847
DR   GEO; GSM316597
DR   GEO; GSM316598
DR   GEO; GSM316599
DR   GEO; GSM421063
DR   Wikidata; Q54846130
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 144409.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12848
AC   CVCL_5E82
DR   CLO; CLO_0022820
DR   Coriell; GM12848
DR   GEO; GSM316357
DR   GEO; GSM316358
DR   GEO; GSM316359
DR   GEO; GSM421064
DR   Wikidata; Q54846134
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145109.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12849
AC   CVCL_9Y13
DR   CLO; CLO_0022821
DR   Coriell; GM12849
DR   Wikidata; Q54846138
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 4504.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM12852
AC   CVCL_5E83
DR   CLO; CLO_0022818
DR   Coriell; GM12852
DR   GEO; GSM421065
DR   Wikidata; Q54846141
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140001.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12853
AC   CVCL_5E84
DR   CLO; CLO_0022819
DR   Coriell; GM12853
DR   GEO; GSM421066
DR   Wikidata; Q54846144
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140002.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12854
AC   CVCL_5E85
DR   CLO; CLO_0022822
DR   Coriell; GM12854
DR   GEO; GSM421067
DR   Wikidata; Q54846146
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140003.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12855
AC   CVCL_5E86
DR   CLO; CLO_0022823
DR   Coriell; GM12855
DR   Wikidata; Q54846152
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140004.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12856
AC   CVCL_5E87
DR   CLO; CLO_0022813
DR   Coriell; GM12856
DR   GEO; GSM421068
DR   Wikidata; Q54846153
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140005.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12857
AC   CVCL_5E88
DR   CLO; CLO_0022817
DR   Coriell; GM12857
DR   GEO; GSM421069
DR   Wikidata; Q54846154
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140006.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12858
AC   CVCL_5E89
DR   CLO; CLO_0022816
DR   Coriell; GM12858
DR   Wikidata; Q54846155
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140007.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12859
AC   CVCL_5E90
DR   CLO; CLO_0022815
DR   Coriell; GM12859
DR   GEO; GSM421070
DR   Wikidata; Q54846156
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140008.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12860
AC   CVCL_5E91
DR   CLO; CLO_0022814
DR   Coriell; GM12860
DR   GEO; GSM315023
DR   GEO; GSM421071
DR   GEO; GSM906217
DR   GEO; GSM906218
DR   Wikidata; Q54846157
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140009.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12861
AC   CVCL_5E92
DR   CLO; CLO_0022830
DR   Coriell; GM12861
DR   GEO; GSM315024
DR   GEO; GSM421072
DR   GEO; GSM906219
DR   GEO; GSM906220
DR   Wikidata; Q54846158
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140010.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12862
AC   CVCL_5E93
DR   CLO; CLO_0022831
DR   Coriell; GM12862
DR   GEO; GSM315025
DR   GEO; GSM421073
DR   GEO; GSM906221
DR   GEO; GSM906222
DR   Wikidata; Q54846159
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140011.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12863
AC   CVCL_5E94
DR   CLO; CLO_0022832
DR   Coriell; GM12863
DR   GEO; GSM207788
DR   GEO; GSM315026
DR   GEO; GSM421074
DR   GEO; GSM906223
DR   GEO; GSM906224
DR   Wikidata; Q54846160
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 140012.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM12863).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; GM12863; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 20
//
ID   GM12864
AC   CVCL_L256
DR   CLO; CLO_0022833
DR   EFO; EFO_0005337
DR   Coriell; GM12864
DR   ENCODE; ENCBS208AAA
DR   ENCODE; ENCBS315VRM
DR   ENCODE; ENCBS388ZNW
DR   ENCODE; ENCBS395VNK
DR   ENCODE; ENCBS605TTN
DR   ENCODE; ENCBS845FQR
DR   ENCODE; ENCBS892LHC
DR   GEO; GSM112562
DR   GEO; GSM112865
DR   GEO; GSM188840
DR   GEO; GSM291691
DR   GEO; GSM421075
DR   GEO; GSM421076
DR   GEO; GSM648893
DR   GEO; GSM749676
DR   GEO; GSM749754
DR   GEO; GSM749762
DR   GEO; GSM824872
DR   GEO; GSM824873
DR   GEO; GSM945238
DR   GEO; GSM945296
DR   GEO; GSM1022664
DR   IGSR; NA12864
DR   Wikidata; Q54846161
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12864_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145901.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 21
//
ID   GM12865
AC   CVCL_L257
DR   CLO; CLO_0022834
DR   EFO; EFO_0005338
DR   Coriell; GM12865
DR   ENCODE; ENCBS073XSW
DR   ENCODE; ENCBS159QLB
DR   ENCODE; ENCBS209AAA
DR   ENCODE; ENCBS239KGS
DR   ENCODE; ENCBS332CTQ
DR   ENCODE; ENCBS356ARP
DR   ENCODE; ENCBS710IXP
DR   ENCODE; ENCBS885AEZ
DR   GEO; GSM89115
DR   GEO; GSM89116
DR   GEO; GSM112563
DR   GEO; GSM112866
DR   GEO; GSM188842
DR   GEO; GSM291692
DR   GEO; GSM421077
DR   GEO; GSM749725
DR   GEO; GSM749740
DR   GEO; GSM749777
DR   GEO; GSM824874
DR   GEO; GSM945234
DR   GEO; GSM945295
DR   GEO; GSM1022636
DR   IGSR; NA12865
DR   Wikidata; Q54846162
RX   PubMed=16809669;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12865_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145902.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12865).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 28
//
ID   GM12866
AC   CVCL_L258
DR   CLO; CLO_0022825
DR   EFO; EFO_0005339
DR   Coriell; GM12866
DR   ENCODE; ENCBS133HLD
DR   ENCODE; ENCBS210AAA
DR   GEO; GSM421078
DR   GEO; GSM849305
DR   GEO; GSM945220
DR   Wikidata; Q54846163
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12866_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: CEPH Families Reference Panel; 145903.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   GM12867
AC   CVCL_L259
DR   CLO; CLO_0022824
DR   EFO; EFO_0005340
DR   Coriell; GM12867
DR   ENCODE; ENCBS211AAA
DR   ENCODE; ENCBS795QWU
DR   GEO; GSM421079
DR   GEO; GSM849301
DR   Wikidata; Q54846164
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12867_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: CEPH Families Reference Panel; 145904.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   GM12868
AC   CVCL_L260
DR   CLO; CLO_0022827
DR   EFO; EFO_0005341
DR   Coriell; GM12868
DR   ENCODE; ENCBS212AAA
DR   ENCODE; ENCBS480ERX
DR   GEO; GSM421080
DR   GEO; GSM849300
DR   Wikidata; Q54846165
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12868_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: CEPH Families Reference Panel; 145905.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   GM12869
AC   CVCL_L261
DR   CLO; CLO_0022826
DR   EFO; EFO_0005342
DR   Coriell; GM12869
DR   ENCODE; ENCBS146ETE
DR   ENCODE; ENCBS213AAA
DR   GEO; GSM421081
DR   GEO; GSM849303
DR   Wikidata; Q54846166
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12869_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: CEPH Families Reference Panel; 145906.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   GM12870
AC   CVCL_L262
DR   CLO; CLO_0022829
DR   EFO; EFO_0005343
DR   Coriell; GM12870
DR   ENCODE; ENCBS214AAA
DR   ENCODE; ENCBS300LOH
DR   GEO; GSM421082
DR   GEO; GSM849302
DR   Wikidata; Q54846167
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12870_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: CEPH Families Reference Panel; 145907.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   GM12871
AC   CVCL_L263
DR   CLO; CLO_0022828
DR   EFO; EFO_0005344
DR   Coriell; GM12871
DR   ENCODE; ENCBS215AAA
DR   ENCODE; ENCBS723JLA
DR   GEO; GSM421083
DR   GEO; GSM849304
DR   Wikidata; Q54846168
RX   PubMed=20856902;
RX   PubMed=24924344;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12871_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: CEPH Families Reference Panel; 145908.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   GM12872
AC   CVCL_9626
DR   CLO; CLO_0022836
DR   EFO; EFO_0001159
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801876
DR   Coriell; GM12872
DR   ENCODE; ENCBS216AAA
DR   ENCODE; ENCBS265RII
DR   ENCODE; ENCBS477BBE
DR   ENCODE; ENCBS883JTO
DR   GEO; GSM25680
DR   GEO; GSM25681
DR   GEO; GSM112564
DR   GEO; GSM112867
DR   GEO; GSM188843
DR   GEO; GSM273362
DR   GEO; GSM273363
DR   GEO; GSM291693
DR   GEO; GSM315027
DR   GEO; GSM315028
DR   GEO; GSM421084
DR   GEO; GSM421085
DR   GEO; GSM424358
DR   GEO; GSM486847
DR   GEO; GSM486848
DR   GEO; GSM648853
DR   GEO; GSM659968
DR   GEO; GSM660203
DR   GEO; GSM660380
DR   GEO; GSM749692
DR   GEO; GSM749694
DR   GEO; GSM749765
DR   GEO; GSM905901
DR   GEO; GSM905996
DR   GEO; GSM906091
DR   GEO; GSM957394
DR   GEO; GSM1022633
DR   GEO; GSM1719832
DR   IGSR; NA12872
DR   Wikidata; Q54846169
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12872_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145909.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   GM12873
AC   CVCL_9627
DR   CLO; CLO_0022835
DR   EFO; EFO_0001160
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801878
DR   Coriell; GM12873
DR   ENCODE; ENCBS217AAA
DR   ENCODE; ENCBS502JSQ
DR   ENCODE; ENCBS738YMX
DR   ENCODE; ENCBS800BFZ
DR   GEO; GSM25682
DR   GEO; GSM25683
DR   GEO; GSM112565
DR   GEO; GSM112868
DR   GEO; GSM188844
DR   GEO; GSM273364
DR   GEO; GSM273365
DR   GEO; GSM291694
DR   GEO; GSM291695
DR   GEO; GSM315029
DR   GEO; GSM315030
DR   GEO; GSM421086
DR   GEO; GSM421087
DR   GEO; GSM486849
DR   GEO; GSM486850
DR   GEO; GSM648889
DR   GEO; GSM659943
DR   GEO; GSM660164
DR   GEO; GSM660357
DR   GEO; GSM749685
DR   GEO; GSM749686
DR   GEO; GSM749730
DR   GEO; GSM905902
DR   GEO; GSM905997
DR   GEO; GSM906092
DR   GEO; GSM1022629
DR   GEO; GSM1719833
DR   IGSR; NA12873
DR   Wikidata; Q54846170
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29116076;
RX   PubMed=31048460;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12873_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145910.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; RPB2.
CC   Omics: Genomics; ChIP-seq; SPI1.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   GM12874
AC   CVCL_9628
DR   CLO; CLO_0022838
DR   EFO; EFO_0001161
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801880
DR   Coriell; GM12874
DR   ENCODE; ENCBS018FUP
DR   ENCODE; ENCBS218AAA
DR   ENCODE; ENCBS790RFB
DR   GEO; GSM25684
DR   GEO; GSM25685
DR   GEO; GSM112566
DR   GEO; GSM112869
DR   GEO; GSM188845
DR   GEO; GSM273366
DR   GEO; GSM273367
DR   GEO; GSM291696
DR   GEO; GSM315031
DR   GEO; GSM315032
DR   GEO; GSM421088
DR   GEO; GSM421089
DR   GEO; GSM424359
DR   GEO; GSM486851
DR   GEO; GSM486852
DR   GEO; GSM648857
DR   GEO; GSM659994
DR   GEO; GSM660173
DR   GEO; GSM660405
DR   GEO; GSM749741
DR   GEO; GSM749742
DR   GEO; GSM749757
DR   GEO; GSM905903
DR   GEO; GSM905998
DR   GEO; GSM906093
DR   GEO; GSM957395
DR   GEO; GSM1719834
DR   IGSR; NA12874
DR   Wikidata; Q54846171
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12874_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145810/145911.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12874).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5E78 ! GM12840
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   GM12875
AC   CVCL_9629
DR   CLO; CLO_0022837
DR   EFO; EFO_0001162
DR   Coriell; GM12875
DR   ENCODE; ENCBS219AAA
DR   ENCODE; ENCBS364XYO
DR   ENCODE; ENCBS525QYH
DR   ENCODE; ENCBS823YEP
DR   GEO; GSM25686
DR   GEO; GSM25687
DR   GEO; GSM112567
DR   GEO; GSM112870
DR   GEO; GSM188846
DR   GEO; GSM273368
DR   GEO; GSM273369
DR   GEO; GSM291697
DR   GEO; GSM315033
DR   GEO; GSM315034
DR   GEO; GSM421090
DR   GEO; GSM421091
DR   GEO; GSM486853
DR   GEO; GSM486854
DR   GEO; GSM648914
DR   GEO; GSM659952
DR   GEO; GSM660156
DR   GEO; GSM660363
DR   GEO; GSM749670
DR   GEO; GSM749724
DR   GEO; GSM749764
DR   GEO; GSM945221
DR   GEO; GSM945260
DR   IGSR; NA12875
DR   Wikidata; Q54846172
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12875_Stam_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 145811/145912.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM12875).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5E79 ! GM12841
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   GM12876
AC   CVCL_L264
DR   CLO; CLO_0022848
DR   Coriell; GM12876
DR   GEO; GSM421092
DR   Wikidata; Q54846173
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 145913.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   GM12877
AC   CVCL_L265
DR   CLO; CLO_0022850
DR   Coriell; GM12877
DR   GEO; GSM648962
DR   GEO; GSM660004
DR   GEO; GSM660211
DR   GEO; GSM660417
DR   GEO; GSM905904
DR   GEO; GSM905999
DR   GEO; GSM906094
DR   GEO; GSM957354
DR   IGSR; NA12877
DR   Wikidata; Q54846174
RX   PubMed=21397061;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146301.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   GM12878
AC   CVCL_7526
SY   GM-12878; HG001
DR   BTO; BTO_0006353
DR   CLO; CLO_0022851
DR   EFO; EFO_0002784
DR   4DN; 4DNSRH17RFKR
DR   4DN; 4DNSRVWZS4XO
DR   ArrayExpress; E-MTAB-1511
DR   ArrayExpress; E-MTAB-5835
DR   BioGRID_ORCS_Cell_line; 203
DR   BioSample; SAMN00000339
DR   BioSample; SAMN00801888
DR   BioSample; SAMN03492678
DR   Coriell; GM12878
DR   ENCODE; ENCBS004QBB
DR   ENCODE; ENCBS011ZCV
DR   ENCODE; ENCBS036HXX
DR   ENCODE; ENCBS057BBL
DR   ENCODE; ENCBS058GRO
DR   ENCODE; ENCBS068RRP
DR   ENCODE; ENCBS083XJQ
DR   ENCODE; ENCBS089RNA
DR   ENCODE; ENCBS090RNA
DR   ENCODE; ENCBS095RNA
DR   ENCODE; ENCBS096RNA
DR   ENCODE; ENCBS101KOX
DR   ENCODE; ENCBS105ILZ
DR   ENCODE; ENCBS110ENC
DR   ENCODE; ENCBS112GEV
DR   ENCODE; ENCBS127ZRH
DR   ENCODE; ENCBS135VMF
DR   ENCODE; ENCBS155GIM
DR   ENCODE; ENCBS158BMT
DR   ENCODE; ENCBS158FOT
DR   ENCODE; ENCBS160DJZ
DR   ENCODE; ENCBS162RYJ
DR   ENCODE; ENCBS165XVU
DR   ENCODE; ENCBS166BUX
DR   ENCODE; ENCBS175OMJ
DR   ENCODE; ENCBS176TMN
DR   ENCODE; ENCBS178ZIG
DR   ENCODE; ENCBS195IGI
DR   ENCODE; ENCBS195XMM
DR   ENCODE; ENCBS197KWD
DR   ENCODE; ENCBS202PFA
DR   ENCODE; ENCBS217CXJ
DR   ENCODE; ENCBS229YYL
DR   ENCODE; ENCBS232JAP
DR   ENCODE; ENCBS236ZAD
DR   ENCODE; ENCBS237JOI
DR   ENCODE; ENCBS241TQO
DR   ENCODE; ENCBS256VGP
DR   ENCODE; ENCBS260WJQ
DR   ENCODE; ENCBS263DSS
DR   ENCODE; ENCBS268UXF
DR   ENCODE; ENCBS272IWA
DR   ENCODE; ENCBS276RPG
DR   ENCODE; ENCBS280SII
DR   ENCODE; ENCBS330WEW
DR   ENCODE; ENCBS332CFX
DR   ENCODE; ENCBS337LQM
DR   ENCODE; ENCBS338MMX
DR   ENCODE; ENCBS339VHO
DR   ENCODE; ENCBS348KQK
DR   ENCODE; ENCBS350HSZ
DR   ENCODE; ENCBS356XKT
DR   ENCODE; ENCBS360VGQ
DR   ENCODE; ENCBS361VFY
DR   ENCODE; ENCBS381VEV
DR   ENCODE; ENCBS383ZNJ
DR   ENCODE; ENCBS386THJ
DR   ENCODE; ENCBS389LEA
DR   ENCODE; ENCBS397JTN
DR   ENCODE; ENCBS411YBT
DR   ENCODE; ENCBS421UOG
DR   ENCODE; ENCBS434ZBE
DR   ENCODE; ENCBS436SAI
DR   ENCODE; ENCBS443JGY
DR   ENCODE; ENCBS446GJK
DR   ENCODE; ENCBS446LSH
DR   ENCODE; ENCBS460NBS
DR   ENCODE; ENCBS482WRI
DR   ENCODE; ENCBS487GLA
DR   ENCODE; ENCBS488GLI
DR   ENCODE; ENCBS492CVI
DR   ENCODE; ENCBS494ENC
DR   ENCODE; ENCBS495ENC
DR   ENCODE; ENCBS495SKR
DR   ENCODE; ENCBS496ENC
DR   ENCODE; ENCBS501RRP
DR   ENCODE; ENCBS502UVH
DR   ENCODE; ENCBS504ZJS
DR   ENCODE; ENCBS506MRD
DR   ENCODE; ENCBS519VWT
DR   ENCODE; ENCBS538MCC
DR   ENCODE; ENCBS540DKD
DR   ENCODE; ENCBS543LGX
DR   ENCODE; ENCBS571ZAL
DR   ENCODE; ENCBS579VBW
DR   ENCODE; ENCBS584ZED
DR   ENCODE; ENCBS588GPN
DR   ENCODE; ENCBS594YOH
DR   ENCODE; ENCBS595CWJ
DR   ENCODE; ENCBS603ZPO
DR   ENCODE; ENCBS607NAA
DR   ENCODE; ENCBS608PGT
DR   ENCODE; ENCBS609AMN
DR   ENCODE; ENCBS621MYU
DR   ENCODE; ENCBS630AAA
DR   ENCODE; ENCBS631AAA
DR   ENCODE; ENCBS632AAA
DR   ENCODE; ENCBS638AZC
DR   ENCODE; ENCBS644QQI
DR   ENCODE; ENCBS657BPX
DR   ENCODE; ENCBS657FSS
DR   ENCODE; ENCBS664ZGZ
DR   ENCODE; ENCBS676TGQ
DR   ENCODE; ENCBS681NDP
DR   ENCODE; ENCBS685XZU
DR   ENCODE; ENCBS692APS
DR   ENCODE; ENCBS694MFZ
DR   ENCODE; ENCBS705AAA
DR   ENCODE; ENCBS706AAA
DR   ENCODE; ENCBS707AAA
DR   ENCODE; ENCBS708AAA
DR   ENCODE; ENCBS709AAA
DR   ENCODE; ENCBS710AAA
DR   ENCODE; ENCBS715VCP
DR   ENCODE; ENCBS727AAA
DR   ENCODE; ENCBS728AAA
DR   ENCODE; ENCBS729AAA
DR   ENCODE; ENCBS730AAA
DR   ENCODE; ENCBS734TTU
DR   ENCODE; ENCBS755AAA
DR   ENCODE; ENCBS756AAA
DR   ENCODE; ENCBS757AAA
DR   ENCODE; ENCBS758AAA
DR   ENCODE; ENCBS759AAA
DR   ENCODE; ENCBS760AAA
DR   ENCODE; ENCBS761AAA
DR   ENCODE; ENCBS762AAA
DR   ENCODE; ENCBS763AAA
DR   ENCODE; ENCBS771XJW
DR   ENCODE; ENCBS772FMA
DR   ENCODE; ENCBS773HZT
DR   ENCODE; ENCBS778MKB
DR   ENCODE; ENCBS779LIK
DR   ENCODE; ENCBS791FEH
DR   ENCODE; ENCBS792AAA
DR   ENCODE; ENCBS793AAA
DR   ENCODE; ENCBS794AAA
DR   ENCODE; ENCBS795AAA
DR   ENCODE; ENCBS796AAA
DR   ENCODE; ENCBS798AAA
DR   ENCODE; ENCBS799AAA
DR   ENCODE; ENCBS800AAA
DR   ENCODE; ENCBS801AAA
DR   ENCODE; ENCBS801TVI
DR   ENCODE; ENCBS802BKO
DR   ENCODE; ENCBS802GDX
DR   ENCODE; ENCBS803QIM
DR   ENCODE; ENCBS812YDO
DR   ENCODE; ENCBS813RJD
DR   ENCODE; ENCBS817AAA
DR   ENCODE; ENCBS818AAA
DR   ENCODE; ENCBS819AAA
DR   ENCODE; ENCBS826OYW
DR   ENCODE; ENCBS830CIQ
DR   ENCODE; ENCBS830FPU
DR   ENCODE; ENCBS831YAX
DR   ENCODE; ENCBS837QOG
DR   ENCODE; ENCBS839NNF
DR   ENCODE; ENCBS842EZN
DR   ENCODE; ENCBS844IZD
DR   ENCODE; ENCBS845AAA
DR   ENCODE; ENCBS845TXY
DR   ENCODE; ENCBS846AAA
DR   ENCODE; ENCBS849IVF
DR   ENCODE; ENCBS853AAA
DR   ENCODE; ENCBS857VGC
DR   ENCODE; ENCBS859QLM
DR   ENCODE; ENCBS866OKF
DR   ENCODE; ENCBS878MAF
DR   ENCODE; ENCBS879WMA
DR   ENCODE; ENCBS882WSF
DR   ENCODE; ENCBS886YKM
DR   ENCODE; ENCBS890IXM
DR   ENCODE; ENCBS891HAO
DR   ENCODE; ENCBS892YZW
DR   ENCODE; ENCBS900QPF
DR   ENCODE; ENCBS901DKW
DR   ENCODE; ENCBS907LID
DR   ENCODE; ENCBS913AHD
DR   ENCODE; ENCBS913NDQ
DR   ENCODE; ENCBS917LTR
DR   ENCODE; ENCBS926QYK
DR   ENCODE; ENCBS934CYZ
DR   ENCODE; ENCBS937MAM
DR   ENCODE; ENCBS950FXN
DR   ENCODE; ENCBS965YSG
DR   ENCODE; ENCBS976FSZ
DR   ENCODE; ENCBS978YID
DR   ENCODE; ENCBS981DLH
DR   ENCODE; ENCBS985PRF
DR   FANTOM5_SSTAR; 10821-111C2
DR   FANTOM5_SSTAR; 10822-111C3
DR   FANTOM5_SSTAR; 10823-111C4
DR   GEO; GSM112568
DR   GEO; GSM112871
DR   GEO; GSM188847
DR   GEO; GSM291698
DR   GEO; GSM421093
DR   GEO; GSM472901
DR   GEO; GSM472902
DR   GEO; GSM472931
DR   GEO; GSM489277
DR   GEO; GSM489278
DR   GEO; GSM489279
DR   GEO; GSM489290
DR   GEO; GSM489291
DR   GEO; GSM489292
DR   GEO; GSM651106
DR   GEO; GSM651107
DR   GEO; GSM660003
DR   GEO; GSM660210
DR   GEO; GSM660416
DR   GEO; GSM733642
DR   GEO; GSM733664
DR   GEO; GSM733677
DR   GEO; GSM733679
DR   GEO; GSM733708
DR   GEO; GSM733736
DR   GEO; GSM733752
DR   GEO; GSM733758
DR   GEO; GSM733767
DR   GEO; GSM733769
DR   GEO; GSM733771
DR   GEO; GSM733772
DR   GEO; GSM736496
DR   GEO; GSM736620
DR   GEO; GSM749669
DR   GEO; GSM749704
DR   GEO; GSM749706
DR   GEO; GSM803338
DR   GEO; GSM803341
DR   GEO; GSM803342
DR   GEO; GSM803347
DR   GEO; GSM803349
DR   GEO; GSM803350
DR   GEO; GSM803355
DR   GEO; GSM803356
DR   GEO; GSM803362
DR   GEO; GSM803363
DR   GEO; GSM803386
DR   GEO; GSM803387
DR   GEO; GSM803388
DR   GEO; GSM803389
DR   GEO; GSM803390
DR   GEO; GSM803391
DR   GEO; GSM803392
DR   GEO; GSM803406
DR   GEO; GSM803411
DR   GEO; GSM803416
DR   GEO; GSM803420
DR   GEO; GSM803434
DR   GEO; GSM803477
DR   GEO; GSM803485
DR   GEO; GSM803496
DR   GEO; GSM803508
DR   GEO; GSM803509
DR   GEO; GSM803510
DR   GEO; GSM803511
DR   GEO; GSM803531
DR   GEO; GSM803532
DR   GEO; GSM803534
DR   GEO; GSM803537
DR   GEO; GSM803538
DR   GEO; GSM816665
DR   GEO; GSM822270
DR   GEO; GSM822290
DR   GEO; GSM822312
DR   GEO; GSM862026
DR   GEO; GSM862027
DR   GEO; GSM862028
DR   GEO; GSM862029
DR   GEO; GSM862030
DR   GEO; GSM862031
DR   GEO; GSM923451
DR   GEO; GSM935277
DR   GEO; GSM935283
DR   GEO; GSM935294
DR   GEO; GSM935301
DR   GEO; GSM935309
DR   GEO; GSM935316
DR   GEO; GSM935330
DR   GEO; GSM935331
DR   GEO; GSM935332
DR   GEO; GSM935345
DR   GEO; GSM935349
DR   GEO; GSM935375
DR   GEO; GSM935376
DR   GEO; GSM935377
DR   GEO; GSM935378
DR   GEO; GSM935386
DR   GEO; GSM935409
DR   GEO; GSM935412
DR   GEO; GSM935415
DR   GEO; GSM935417
DR   GEO; GSM935430
DR   GEO; GSM935431
DR   GEO; GSM935442
DR   GEO; GSM935480
DR   GEO; GSM935482
DR   GEO; GSM935483
DR   GEO; GSM935492
DR   GEO; GSM935506
DR   GEO; GSM935507
DR   GEO; GSM935518
DR   GEO; GSM935541
DR   GEO; GSM935556
DR   GEO; GSM935557
DR   GEO; GSM935558
DR   GEO; GSM935559
DR   GEO; GSM935562
DR   GEO; GSM935583
DR   GEO; GSM935608
DR   GEO; GSM935611
DR   GEO; GSM935612
DR   GEO; GSM935613
DR   GEO; GSM935651
DR   GEO; GSM935652
DR   GEO; GSM935653
DR   GEO; GSM945188
DR   GEO; GSM945196
DR   GEO; GSM945212
DR   GEO; GSM945259
DR   GEO; GSM957355
DR   GEO; GSM1003498
DR   GEO; GSM1003602
DR   GEO; GSM1003603
DR   GEO; GSM1003604
DR   GEO; GSM1003605
DR   GEO; GSM1003616
DR   GEO; GSM1003617
DR   GEO; GSM1003634
DR   GEO; GSM1010721
DR   GEO; GSM1010729
DR   GEO; GSM1010730
DR   GEO; GSM1010731
DR   GEO; GSM1010744
DR   GEO; GSM1010745
DR   GEO; GSM1010760
DR   GEO; GSM1010771
DR   GEO; GSM1010779
DR   GEO; GSM1010780
DR   GEO; GSM1010850
DR   GEO; GSM1010881
DR   GEO; GSM1010893
DR   GEO; GSM1719835
DR   GEO; GSM2071261
DR   GEO; GSM2071262
DR   GEO; GSM2071297
DR   GEO; GSM2071298
DR   GEO; GSM2071299
DR   GEO; GSM2071300
DR   GEO; GSM2071301
DR   GEO; GSM2071302
DR   GEO; GSM2071303
DR   GEO; GSM2071344
DR   GEO; GSM2071564
DR   GEO; GSM4338386
DR   GEO; GSM4338387
DR   IGSR; NA12878
DR   Wikidata; Q54846175
RX   CelloPub=CLPUB00604;
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=23325432;
RX   PubMed=23676674;
RX   PubMed=24185094;
RX   PubMed=24380390;
RX   PubMed=26621101;
RX   PubMed=26719794;
RX   PubMed=27271295;
RX   PubMed=27792722;
RX   PubMed=29116076;
RX   PubMed=29431738;
RX   PubMed=30485824;
RX   PubMed=31273215;
RX   PubMed=31401124;
RX   PubMed=36094314;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12878_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 1.
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Genome in a Bottle (GIAB) consortium samples.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146302.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; HG001.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01,11; B*08,56; C*01,07; DPA1*01:03:01,02:01:01; DPB1*04:01:01,14:01; DQA1*01,05; DQB1*02,05; DRB1*01,03:01 (PubMed=27792722).
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Unspecified; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12878).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   GM12878-XiMat clone 16
AC   CVCL_N800
DR   Wikidata; Q54846176
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12878-XiMat_Myers_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7526 ! GM12878
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   GM12878-XiMat clone 56
AC   CVCL_N801
DR   Wikidata; Q54846177
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12878-XiMat_Myers_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7526 ! GM12878
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   GM12879
AC   CVCL_5E95
DR   CLO; CLO_0022840
DR   Coriell; GM12879
DR   GEO; GSM659836
DR   GEO; GSM660046
DR   GEO; GSM660253
DR   IGSR; NA12879
DR   Wikidata; Q54846178
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146303.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12880
AC   CVCL_5E96
DR   CLO; CLO_0022842
DR   Coriell; GM12880
DR   GEO; GSM421094
DR   GEO; GSM659835
DR   GEO; GSM660045
DR   GEO; GSM660252
DR   IGSR; NA12880
DR   Wikidata; Q54846179
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146304.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12881
AC   CVCL_5E97
DR   CLO; CLO_0022843
DR   Coriell; GM12881
DR   GEO; GSM421095
DR   GEO; GSM659834
DR   GEO; GSM660044
DR   GEO; GSM660251
DR   IGSR; NA12881
DR   Wikidata; Q54846180
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146305.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12882
AC   CVCL_5E98
DR   CLO; CLO_0022845
DR   Coriell; GM12882
DR   GEO; GSM421096
DR   GEO; GSM659833
DR   GEO; GSM660043
DR   GEO; GSM660250
DR   IGSR; NA12882
DR   Wikidata; Q54846181
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146306.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12883
AC   CVCL_5E99
DR   CLO; CLO_0022855
DR   Coriell; GM12883
DR   GEO; GSM421097
DR   GEO; GSM659832
DR   GEO; GSM660042
DR   GEO; GSM660249
DR   IGSR; NA12883
DR   Wikidata; Q54846182
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146307.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12884
AC   CVCL_5F00
DR   CLO; CLO_0022854
DR   Coriell; GM12884
DR   GEO; GSM659831
DR   GEO; GSM660041
DR   GEO; GSM660248
DR   IGSR; NA12884
DR   Wikidata; Q54846183
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146308.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12885
AC   CVCL_5F01
DR   CLO; CLO_0022853
DR   Coriell; GM12885
DR   GEO; GSM421098
DR   GEO; GSM659830
DR   GEO; GSM660040
DR   GEO; GSM660247
DR   IGSR; NA12885
DR   Wikidata; Q54846184
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146309.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12886
AC   CVCL_5F02
DR   CLO; CLO_0022862
DR   Coriell; GM12886
DR   GEO; GSM421099
DR   GEO; GSM659837
DR   GEO; GSM660047
DR   GEO; GSM660254
DR   IGSR; NA12886
DR   Wikidata; Q54846185
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146310.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12887
AC   CVCL_5F03
DR   CLO; CLO_0022863
DR   Coriell; GM12887
DR   GEO; GSM421100
DR   IGSR; NA12887
DR   Wikidata; Q54846186
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146311.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12888
AC   CVCL_5F04
DR   CLO; CLO_0022860
DR   Coriell; GM12888
DR   IGSR; NA12888
DR   Wikidata; Q54846187
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146312.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12889
AC   CVCL_R685
DR   CLO; CLO_0022861
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801908
DR   Coriell; GM12889
DR   GEO; GSM315035
DR   GEO; GSM421101
DR   GEO; GSM648923
DR   GEO; GSM906225
DR   GEO; GSM906226
DR   GEO; GSM1719836
DR   IGSR; NA12889
DR   Wikidata; Q54846188
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146313.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12890
AC   CVCL_R686
DR   CLO; CLO_0022858
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-5835
DR   BioSample; SAMN00801910
DR   Coriell; GM12890
DR   GEO; GSM315036
DR   GEO; GSM315037
DR   GEO; GSM421102
DR   GEO; GSM421103
DR   GEO; GSM648950
DR   GEO; GSM906227
DR   GEO; GSM906228
DR   GEO; GSM1719837
DR   IGSR; NA12890
DR   Wikidata; Q54846190
RX   PubMed=19797678;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=29116076;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146314.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM12891
AC   CVCL_9630
DR   CLO; CLO_0022859
DR   EFO; EFO_0002785
DR   BioSample; SAMN00801912
DR   Coriell; GM12891
DR   ENCODE; ENCBS041WYJ
DR   ENCODE; ENCBS270GPL
DR   ENCODE; ENCBS377ENC
DR   ENCODE; ENCBS384ENC
DR   ENCODE; ENCBS388ENC
DR   ENCODE; ENCBS430ENC
DR   ENCODE; ENCBS507TOT
DR   ENCODE; ENCBS606OMD
DR   ENCODE; ENCBS653UMX
DR   GEO; GSM112569
DR   GEO; GSM112872
DR   GEO; GSM188848
DR   GEO; GSM273370
DR   GEO; GSM273371
DR   GEO; GSM291699
DR   GEO; GSM315038
DR   GEO; GSM421104
DR   GEO; GSM424360
DR   GEO; GSM486855
DR   GEO; GSM486856
DR   GEO; GSM489280
DR   GEO; GSM489281
DR   GEO; GSM489293
DR   GEO; GSM489294
DR   GEO; GSM649300
DR   GEO; GSM649855
DR   GEO; GSM659960
DR   GEO; GSM660162
DR   GEO; GSM660369
DR   GEO; GSM816656
DR   GEO; GSM905905
DR   GEO; GSM906000
DR   GEO; GSM906095
DR   GEO; GSM957396
DR   IGSR; NA12891
DR   Wikidata; Q54846191
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21397061;
RX   PubMed=23325432;
RX   PubMed=23676674;
RX   PubMed=27792722;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12891_Crawford_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146315.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*01,24; B*07,08; C*07,07; DPA1*01:03:01,01:03:01; DPB1*03,04:01:01; DQA1*01,05; DQB1*02,06; DRB1*03:01,15:01 (PubMed=27792722).
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Homozygous; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (Coriell=GM12891).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   GM12892
AC   CVCL_9631
DR   CLO; CLO_0022856
DR   EFO; EFO_0002786
DR   BioSample; SAMN00801914
DR   Coriell; GM12892
DR   ENCODE; ENCBS055ENC
DR   ENCODE; ENCBS255UYZ
DR   ENCODE; ENCBS287ATY
DR   ENCODE; ENCBS564VMX
DR   ENCODE; ENCBS633AAA
DR   ENCODE; ENCBS698HPL
DR   ENCODE; ENCBS726USL
DR   ENCODE; ENCBS781AAA
DR   ENCODE; ENCBS813EMP
DR   ENCODE; ENCBS850AAA
DR   GEO; GSM112570
DR   GEO; GSM112873
DR   GEO; GSM188849
DR   GEO; GSM291700
DR   GEO; GSM315039
DR   GEO; GSM421105
DR   GEO; GSM486857
DR   GEO; GSM486858
DR   GEO; GSM489282
DR   GEO; GSM489283
DR   GEO; GSM489295
DR   GEO; GSM489296
DR   GEO; GSM649301
DR   GEO; GSM649856
DR   GEO; GSM651140
DR   GEO; GSM651141
DR   GEO; GSM651142
DR   GEO; GSM651143
DR   GEO; GSM651144
DR   GEO; GSM651145
DR   GEO; GSM651146
DR   GEO; GSM651147
DR   GEO; GSM651156
DR   GEO; GSM651157
DR   GEO; GSM651158
DR   GEO; GSM651159
DR   GEO; GSM659990
DR   GEO; GSM660186
DR   GEO; GSM660401
DR   GEO; GSM816657
DR   GEO; GSM905906
DR   GEO; GSM906001
DR   GEO; GSM906096
DR   IGSR; NA12892
DR   Wikidata; Q54846193
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20398888;
RX   PubMed=20856902;
RX   PubMed=21418647;
RX   PubMed=23325432;
RX   PubMed=23676674;
RX   PubMed=26621101;
RX   PubMed=27792722;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM12892_Crawford_protocol.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146316.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   HLA typing: A*02:01,11; B*15:01,56; C*01,04:01; DPA1*01:03,02:01:01; DPB1*06:01,14:01; DQA1*01,01; DQB1*05,05; DRB1*01,01 (PubMed=27792722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   GM12893
AC   CVCL_5F05
DR   CLO; CLO_0022857
DR   Coriell; GM12893
DR   IGSR; NA12893
DR   Wikidata; Q54846200
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Registration: CEPH Families Reference Panel; 146317.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12894
AC   CVCL_DB83
DR   CLO; CLO_0022865
DR   BioSample; SAMN00801917
DR   Coriell; GM12894
DR   Wikidata; Q54846201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM12895
AC   CVCL_GZ45
DR   CLO; CLO_0022864
DR   Coriell; GM12895
DR   Wikidata; Q54846202
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM12895).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129303; Congenital bilateral aplasia of the vas deferens
DI   ORDO; Orphanet_48; Congenital bilateral absence of vas deferens
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM12896
AC   CVCL_IX37
DR   CLO; CLO_0022866
DR   Coriell; GM12896
DR   Wikidata; Q54846203
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,-9,+der(9)t(2;9)(p21;p24) (Coriell=GM12896).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C132270; 46,XY sex reversal 4
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM12897
AC   CVCL_5F06
DR   CLO; CLO_0022867
DR   Coriell; GM12897
DR   GEO; GSM30218
DR   GEO; GSM421106
DR   GEO; GSM660002
DR   GEO; GSM660209
DR   GEO; GSM660415
DR   GEO; GSM905907
DR   GEO; GSM906002
DR   GEO; GSM906097
DR   Wikidata; Q54846204
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147701.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12898
AC   CVCL_5F07
DR   CLO; CLO_0022868
DR   Coriell; GM12898
DR   GEO; GSM30219
DR   GEO; GSM421107
DR   GEO; GSM660001
DR   GEO; GSM660208
DR   GEO; GSM660414
DR   GEO; GSM905908
DR   GEO; GSM906003
DR   GEO; GSM906098
DR   Wikidata; Q54846205
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147702.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12899
AC   CVCL_5F08
DR   CLO; CLO_0022869
DR   Coriell; GM12899
DR   GEO; GSM30220
DR   GEO; GSM421108
DR   GEO; GSM659828
DR   GEO; GSM660038
DR   GEO; GSM660245
DR   Wikidata; Q54846206
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147703.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12900
AC   CVCL_5F09
DR   CLO; CLO_0022870
DR   Coriell; GM12900
DR   GEO; GSM30221
DR   GEO; GSM421109
DR   GEO; GSM659827
DR   GEO; GSM660037
DR   GEO; GSM660244
DR   Wikidata; Q54846207
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147704.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12901
AC   CVCL_5F10
DR   CLO; CLO_0022871
DR   Coriell; GM12901
DR   GEO; GSM30222
DR   GEO; GSM421110
DR   GEO; GSM659826
DR   GEO; GSM660036
DR   GEO; GSM660243
DR   Wikidata; Q54846208
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147705.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12902
AC   CVCL_5F11
DR   CLO; CLO_0022872
DR   Coriell; GM12902
DR   GEO; GSM421111
DR   GEO; GSM659940
DR   GEO; GSM660035
DR   GEO; GSM660242
DR   Wikidata; Q54846209
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147706.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12903
AC   CVCL_5F12
DR   CLO; CLO_0022873
DR   Coriell; GM12903
DR   GEO; GSM30223
DR   GEO; GSM421112
DR   GEO; GSM659939
DR   GEO; GSM660034
DR   GEO; GSM660241
DR   Wikidata; Q54846210
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147707.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12904
AC   CVCL_5F13
DR   CLO; CLO_0022874
DR   Coriell; GM12904
DR   GEO; GSM30224
DR   GEO; GSM659938
DR   GEO; GSM660033
DR   GEO; GSM660240
DR   Wikidata; Q54846211
RX   PubMed=15514893;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147708.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12905
AC   CVCL_5F14
DR   CLO; CLO_0022875
DR   Coriell; GM12905
DR   GEO; GSM30225
DR   GEO; GSM421113
DR   Wikidata; Q54846212
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147709.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12906
AC   CVCL_5F15
DR   CLO; CLO_0022876
DR   Coriell; GM12906
DR   GEO; GSM421114
DR   GEO; GSM659829
DR   GEO; GSM660039
DR   GEO; GSM660246
DR   Wikidata; Q54846213
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147710.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12907
AC   CVCL_5F16
DR   CLO; CLO_0022877
DR   Coriell; GM12907
DR   GEO; GSM30226
DR   GEO; GSM421115
DR   GEO; GSM659937
DR   GEO; GSM660032
DR   GEO; GSM660239
DR   Wikidata; Q54846214
RX   PubMed=15514893;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147711.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12908
AC   CVCL_5F17
DR   CLO; CLO_0022880
DR   Coriell; GM12908
DR   GEO; GSM30227
DR   GEO; GSM315040
DR   GEO; GSM421116
DR   GEO; GSM906229
DR   GEO; GSM906230
DR   Wikidata; Q54846215
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142011/147712.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9603 ! GM12005
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12909
AC   CVCL_5F18
DR   CLO; CLO_0022881
DR   Coriell; GM12909
DR   GEO; GSM30228
DR   GEO; GSM207789
DR   GEO; GSM315041
DR   GEO; GSM421117
DR   Wikidata; Q54846216
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142012/147713.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7518 ! GM12006
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12910
AC   CVCL_5F19
DR   CLO; CLO_0022878
DR   Coriell; GM12910
DR   GEO; GSM30229
DR   GEO; GSM315042
DR   GEO; GSM421118
DR   Wikidata; Q54846217
RX   PubMed=15514893;
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 147714.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12911
AC   CVCL_5F20
DR   CLO; CLO_0022879
DR   Coriell; GM12911
DR   GEO; GSM89117
DR   GEO; GSM89118
DR   GEO; GSM207790
DR   GEO; GSM316426
DR   GEO; GSM316427
DR   GEO; GSM316428
DR   GEO; GSM421119
DR   GEO; GSM421120
DR   GEO; GSM905909
DR   GEO; GSM906004
DR   GEO; GSM906099
DR   Wikidata; Q54846219
RX   PubMed=16809669;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158201.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM12912
AC   CVCL_5F21
DR   CLO; CLO_0022884
DR   Coriell; GM12912
DR   GEO; GSM89119
DR   GEO; GSM89120
DR   GEO; GSM207791
DR   GEO; GSM316471
DR   GEO; GSM316472
DR   GEO; GSM316473
DR   GEO; GSM421121
DR   GEO; GSM421122
DR   GEO; GSM905910
DR   GEO; GSM906005
DR   GEO; GSM906100
DR   Wikidata; Q54846221
RX   PubMed=16809669;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158202.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM12912).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 21
//
ID   GM12913
AC   CVCL_5F22
DR   CLO; CLO_0022885
DR   Coriell; GM12913
DR   GEO; GSM316375
DR   GEO; GSM316376
DR   GEO; GSM316377
DR   GEO; GSM421123
DR   Wikidata; Q54846222
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158203.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12914
AC   CVCL_5F23
DR   CLO; CLO_0022882
DR   Coriell; GM12914
DR   GEO; GSM316639
DR   GEO; GSM316640
DR   GEO; GSM316641
DR   GEO; GSM421124
DR   Wikidata; Q54846223
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158204.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12915
AC   CVCL_5F24
DR   CLO; CLO_0022883
DR   Coriell; GM12915
DR   GEO; GSM316642
DR   GEO; GSM316643
DR   GEO; GSM316644
DR   GEO; GSM421125
DR   Wikidata; Q54846224
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158205.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12916
AC   CVCL_5F25
DR   CLO; CLO_0022900
DR   Coriell; GM12916
DR   GEO; GSM316645
DR   GEO; GSM316646
DR   GEO; GSM316647
DR   GEO; GSM421126
DR   Wikidata; Q54846225
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158206.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12917
AC   CVCL_5F26
DR   CLO; CLO_0022902
DR   Coriell; GM12917
DR   GEO; GSM316648
DR   GEO; GSM316649
DR   GEO; GSM316650
DR   GEO; GSM421127
DR   Wikidata; Q54846226
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158207.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12918
AC   CVCL_5F27
DR   CLO; CLO_0022901
DR   Coriell; GM12918
DR   GEO; GSM316378
DR   GEO; GSM316379
DR   GEO; GSM316380
DR   Wikidata; Q54846227
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158208.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12919
AC   CVCL_5F28
DR   CLO; CLO_0022895
DR   Coriell; GM12919
DR   GEO; GSM421128
DR   Wikidata; Q54846228
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM12920
AC   CVCL_5F29
DR   CLO; CLO_0022894
DR   Coriell; GM12920
DR   GEO; GSM316381
DR   GEO; GSM316382
DR   GEO; GSM316383
DR   GEO; GSM421129
DR   Wikidata; Q54846229
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158210.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12921
AC   CVCL_5F30
DR   CLO; CLO_0022898
DR   Coriell; GM12921
DR   GEO; GSM25688
DR   GEO; GSM25689
DR   GEO; GSM315043
DR   GEO; GSM315044
DR   GEO; GSM421130
DR   GEO; GSM421131
DR   GEO; GSM906231
DR   GEO; GSM906232
DR   Wikidata; Q54846230
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158211.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12922
AC   CVCL_5F31
DR   CLO; CLO_0022896
DR   Coriell; GM12922
DR   GEO; GSM25690
DR   GEO; GSM25691
DR   GEO; GSM315045
DR   GEO; GSM315046
DR   GEO; GSM421132
DR   GEO; GSM421133
DR   Wikidata; Q54846231
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158212.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12923
AC   CVCL_5F32
DR   CLO; CLO_0022889
DR   Coriell; GM12923
DR   GEO; GSM25692
DR   GEO; GSM25693
DR   GEO; GSM315047
DR   GEO; GSM315048
DR   GEO; GSM421134
DR   GEO; GSM421135
DR   Wikidata; Q54846232
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158213.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12924
AC   CVCL_5F33
DR   CLO; CLO_0022887
DR   Coriell; GM12924
DR   GEO; GSM25694
DR   GEO; GSM25695
DR   GEO; GSM315049
DR   GEO; GSM315050
DR   GEO; GSM421136
DR   GEO; GSM421137
DR   Wikidata; Q54846233
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 158214.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM12926
AC   CVCL_0N21
DR   CLO; CLO_0022891
DR   Coriell; GM12926
DR   Wikidata; Q54846234
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln493Ter (c.1477C>T); ClinVar=VCV000007107; Zygosity=Heterozygous (Coriell=GM12926).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM12928
AC   CVCL_N198
SY   GM17079
DR   CLO; CLO_0014613
DR   CLO; CLO_0022924
DR   Coriell; GM12928
DR   Coriell; GM17079
DR   Wikidata; Q54846235
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.His497Glnfs*90 (c.1472_1487dup16); ClinVar=VCV000005277; Zygosity=Homozygous (Coriell=GM12928).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   GM12929
AC   CVCL_5P70
DR   CLO; CLO_0022923
DR   Coriell; GM12929
DR   Wikidata; Q54846236
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5P68 ! GM12721
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM12930
AC   CVCL_N199
SY   GM17172
DR   CLO; CLO_0014025
DR   CLO; CLO_0022922
DR   Coriell; GM12930
DR   Coriell; GM17172
DR   GEO; GSM569698
DR   GEO; GSM596236
DR   GEO; GSM597031
DR   GEO; GSM924682
DR   IPD-IMGT/HLA; 20207
DR   Wikidata; Q54846237
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:DFKR; B*07:CZZS,53:01; C*06:02,07:WCP; DRB1*13:02,15:03 (IPD-IMGT/HLA=20207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM12931
AC   CVCL_N200
SY   GM17108
DR   CLO; CLO_0014889
DR   CLO; CLO_0022921
DR   Coriell; GM12931
DR   Coriell; GM17108
DR   GEO; GSM273378
DR   GEO; GSM569512
DR   GEO; GSM596176
DR   GEO; GSM596976
DR   GEO; GSM924618
DR   IPD-IMGT/HLA; 16405
DR   Wikidata; Q54846238
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*68:02; B*45:AH,78:01; C*16:01; DRB1*13:02,13:04 (IPD-IMGT/HLA=16405).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM12932
AC   CVCL_1K69
SY   GM 12932
DR   CLO; CLO_0022920
DR   Coriell; GM12932
DR   Wikidata; Q54846239
RX   PubMed=10189220;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.1326+1G>A (IVS8+1G>A); ClinVar=VCV000597944; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10189220).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp481Arg (c.1441T>C); ClinVar=VCV000189007; Zygosity=Heterozygous (PubMed=10189220).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   GM12959
AC   CVCL_5P71
DR   CLO; CLO_0022918
DR   Coriell; GM12959
DR   Wikidata; Q54846240
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM12960
AC   CVCL_0N22
DR   CLO; CLO_0022915
DR   Coriell; GM12960
DR   Wikidata; Q54846242
RX   PubMed=14709668;
RX   PubMed=19359498;
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg334Trp (c.1000C>T); ClinVar=VCV000007139; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.3368-2A>T; ClinVar=VCV000371331; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM12960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM12961
AC   CVCL_0N23
DR   CLO; CLO_0022913
DR   Coriell; GM12961
DR   Wikidata; Q54846250
RX   PubMed=19359498;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Val520Phe (c.1558G>T); ClinVar=VCV000007150; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM12966
AC   CVCL_8B06
DR   CLO; CLO_0022911
DR   Coriell; GM12966
DR   Wikidata; Q54846251
CC   Karyotypic information: 46,XY,del(11)(pter->q23.1::q24->qter) (Coriell=GM12966).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM12968
AC   CVCL_5F34
DR   CLO; CLO_0022910
DR   Coriell; GM12968
DR   Wikidata; Q54846252
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142701.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12969
AC   CVCL_5F35
DR   CLO; CLO_0022943
DR   Coriell; GM12969
DR   Wikidata; Q54846253
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142702.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12971
AC   CVCL_5F36
DR   CLO; CLO_0022945
DR   Coriell; GM12971
DR   Wikidata; Q54846254
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142704.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12972
AC   CVCL_5F37
DR   CLO; CLO_0022944
DR   Coriell; GM12972
DR   Wikidata; Q54846255
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142705.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12973
AC   CVCL_5F38
DR   CLO; CLO_0022947
DR   Coriell; GM12973
DR   Wikidata; Q54846256
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142706.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM12973; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12974
AC   CVCL_5F39
DR   CLO; CLO_0022946
DR   Coriell; GM12974
DR   Wikidata; Q54846257
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142707.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12975
AC   CVCL_5F40
DR   CLO; CLO_0022932
DR   Coriell; GM12975
DR   Wikidata; Q54846258
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142708.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12976
AC   CVCL_5F41
DR   CLO; CLO_0022929
DR   Coriell; GM12976
DR   Wikidata; Q54846259
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142709.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM12977
AC   CVCL_5F42
DR   CLO; CLO_0022936
DR   Coriell; GM12977
DR   GEO; GSM906233
DR   GEO; GSM906234
DR   Wikidata; Q54846261
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142710.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12978
AC   CVCL_5F43
DR   CLO; CLO_0022934
DR   Coriell; GM12978
DR   GEO; GSM906235
DR   GEO; GSM906236
DR   Wikidata; Q54846262
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142711.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12979
AC   CVCL_5F44
DR   CLO; CLO_0022938
DR   Coriell; GM12979
DR   GEO; GSM906237
DR   GEO; GSM906238
DR   Wikidata; Q54846263
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142712.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM12980
AC   CVCL_5F45
DR   CLO; CLO_0013988
DR   Coriell; GM12980
DR   Wikidata; Q54846264
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 142713.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM13019
AC   CVCL_2N02
DR   CLO; CLO_0013986
DR   Coriell; GM13019
DR   Wikidata; Q54846265
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM13031
AC   CVCL_5P72
DR   CLO; CLO_0014030
DR   Coriell; GM13031
DR   GEO; GSM808
DR   Wikidata; Q54846273
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13032
AC   CVCL_UH42
DR   Coriell; GM13032
DR   Wikidata; Q93828198
RX   PubMed=14709668;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile506Val (c.1516A>G); ClinVar=VCV000007131; Zygosity=Heterozygous (Coriell=GM13032).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM13032; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   GM13033
AC   CVCL_N201
SY   GM17298
DR   CLO; CLO_0013130
DR   CLO; CLO_0014027
DR   BioSample; SAMN00802032
DR   Coriell; GM13033
DR   Coriell; GM17298
DR   Wikidata; Q54846274
RX   PubMed=14709668;
RX   PubMed=19359498;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,11:01:01; B*07:02:01,08:01:01; C*07:01:01,07:02:01; DPA1*01:03:01,02:01:02; DPB1*01:01:01,04:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01; DRB3*01:01:02; DRB5*01:01:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508Cys (c.1523T>G); ClinVar=VCV000007126; Zygosity=Heterozygous; Note=Benign (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   GM13034
AC   CVCL_Y605
DR   CLO; CLO_0014038
DR   BioSample; SAMN00802034
DR   Coriell; GM13034
DR   Wikidata; Q54846275
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4451; GPC3; Simple; c.1292+1G>T (IVS5+1G>T); ClinVar=VCV000011688; Zygosity=Unspecified; Note=Splice donor mutation (Coriell=GM13034).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118787; Simpson Golabi Behmel syndrome type 1
DI   ORDO; Orphanet_373; Simpson-Golabi-Behmel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM13041
AC   CVCL_5F46
DR   CLO; CLO_0014041
DR   BioSample; SAMN00802044
DR   Coriell; GM13041
DR   Wikidata; Q54846280
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132801/1328108/1329312.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R687 ! GM06984
OI   CVCL_5F47 ! GM13042
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13042
AC   CVCL_5F47
DR   CLO; CLO_0014040
DR   BioSample; SAMN00802046
DR   Coriell; GM13042
DR   GEO; GSM25696
DR   GEO; GSM25697
DR   GEO; GSM315051
DR   GEO; GSM315052
DR   GEO; GSM421138
DR   GEO; GSM421139
DR   GEO; GSM906239
DR   GEO; GSM906240
DR   Wikidata; Q54846281
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132801/1328108/1329312.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R687 ! GM06984
OI   CVCL_5F46 ! GM13041
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM13043
AC   CVCL_5F48
DR   CLO; CLO_0013786
DR   BioSample; SAMN00802048
DR   Coriell; GM13043
DR   Wikidata; Q54846282
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132802/1328109/1329313.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R579 ! GM06989
OI   CVCL_5F49 ! GM13044
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13044
AC   CVCL_5F49
DR   CLO; CLO_0013788
DR   BioSample; SAMN00802050
DR   Coriell; GM13044
DR   GEO; GSM25698
DR   GEO; GSM25699
DR   GEO; GSM315053
DR   GEO; GSM315054
DR   GEO; GSM421140
DR   GEO; GSM421141
DR   Wikidata; Q54846283
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132802/1328109/1329313.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R579 ! GM06989
OI   CVCL_5F48 ! GM13043
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM13045
AC   CVCL_5F50
DR   CLO; CLO_0013789
DR   BioSample; SAMN00802052
DR   Coriell; GM13045
DR   Wikidata; Q54846284
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329212/1329409.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R588 ! GM07051
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13046
AC   CVCL_5F51
DR   CLO; CLO_0013791
DR   BioSample; SAMN00802054
DR   Coriell; GM13046
DR   Wikidata; Q54846285
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329213/1329410.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R584 ! GM07031
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13047
AC   CVCL_5F52
DR   CLO; CLO_0013774
DR   BioSample; SAMN00802056
DR   Coriell; GM13047
DR   GEO; GSM25700
DR   GEO; GSM25701
DR   GEO; GSM315055
DR   GEO; GSM315056
DR   GEO; GSM421142
DR   GEO; GSM421143
DR   Wikidata; Q54846286
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329110/1329210/1329310/1329411.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R592 ! GM07435
OI   CVCL_5F53 ! GM13048
OI   CVCL_5F54 ! GM13049
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM13048
AC   CVCL_5F53
DR   CLO; CLO_0013778
DR   BioSample; SAMN00802058
DR   Coriell; GM13048
DR   Wikidata; Q54846288
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329110/1329210/1329310/1329411.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R592 ! GM07435
OI   CVCL_5F52 ! GM13047
OI   CVCL_5F54 ! GM13049
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM13049
AC   CVCL_5F54
DR   CLO; CLO_0013782
DR   BioSample; SAMN00802060
DR   Coriell; GM13049
DR   Wikidata; Q54846289
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329110/1329210/1329310/1329411.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R592 ! GM07435
OI   CVCL_5F52 ! GM13047
OI   CVCL_5F53 ! GM13048
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13050
AC   CVCL_5F55
DR   CLO; CLO_0013785
DR   BioSample; SAMN00802062
DR   Coriell; GM13050
DR   Wikidata; Q54846290
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329111/1329211/1329311/1329412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R585 ! GM07037
OI   CVCL_5F56 ! GM13051
OI   CVCL_5F57 ! GM13052
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13051
AC   CVCL_5F56
DR   CLO; CLO_0013765
DR   BioSample; SAMN00802064
DR   Coriell; GM13051
DR   GEO; GSM25702
DR   GEO; GSM25703
DR   GEO; GSM315057
DR   GEO; GSM315058
DR   GEO; GSM421144
DR   GEO; GSM421145
DR   Wikidata; Q54846291
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329111/1329211/1329311/1329412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R585 ! GM07037
OI   CVCL_5F55 ! GM13050
OI   CVCL_5F57 ! GM13052
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM13052
AC   CVCL_5F57
DR   CLO; CLO_0013767
DR   BioSample; SAMN00802066
DR   Coriell; GM13052
DR   Wikidata; Q54846292
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329111/1329211/1329311/1329412.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R585 ! GM07037
OI   CVCL_5F55 ! GM13050
OI   CVCL_5F56 ! GM13051
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13053
AC   CVCL_5F58
DR   CLO; CLO_0013792
DR   BioSample; SAMN00802068
DR   Coriell; GM13053
DR   GEO; GSM421146
DR   GEO; GSM421147
DR   Wikidata; Q54846299
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 1329302.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5B53 ! GM07041
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM13054
AC   CVCL_5F59
DR   CLO; CLO_0013830
DR   BioSample; SAMN00802070
DR   Coriell; GM13054
DR   GEO; GSM421148
DR   Wikidata; Q54846300
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 132804/1328102.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R640 ! GM12329
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM13055
AC   CVCL_0I44
DR   CLO; CLO_0013832
DR   BioSample; SAMN00802072
DR   Coriell; GM13055
DR   Wikidata; Q54846301
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10201/10415.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N203 ! GM13180
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   GM13057
AC   CVCL_0I45
DR   CLO; CLO_0013828
DR   BioSample; SAMN00802076
DR   Coriell; GM13057
DR   Wikidata; Q54846302
RX   PubMed=14583597;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10202/10416.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N204 ! GM13181
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   GM13059
AC   CVCL_DE51
SY   ML5-12 #3
DR   CLO; CLO_0013822
DR   Coriell; GM13059
DR   Wikidata; Q54846303
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM13060
AC   CVCL_5F60
DR   CLO; CLO_0013824
DR   BioSample; SAMN00802077
DR   Coriell; GM13060
DR   Wikidata; Q54846304
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 134415/137509.
CC   Population: Caucasian; Utah residents with ancestry from Northern and Western Europe.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R630 ! GM12058
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   GM13068
AC   CVCL_7527
SY   GM18055
DR   CLO; CLO_0013817
DR   CLO; CLO_0015658
DR   BioSample; SAMN00802079
DR   Coriell; GM13068
DR   Coriell; GM18055
DR   Wikidata; Q54846305
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM13069
AC   CVCL_7528
SY   GM17239
DR   CLO; CLO_0013820
DR   CLO; CLO_0014327
DR   BioSample; SAMN00802081
DR   Coriell; GM13069
DR   Coriell; GM17239
DR   GEO; GSM569566
DR   GEO; GSM596303
DR   GEO; GSM596663
DR   GEO; GSM924841
DR   Wikidata; Q54846306
RX   PubMed=14583597;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM13070
AC   CVCL_F318
SY   GM17240
DR   CLO; CLO_0013810
DR   CLO; CLO_0014410
DR   BioSample; SAMN00802083
DR   Coriell; GM13070
DR   Coriell; GM17240
DR   GEO; GSM569567
DR   GEO; GSM596304
DR   GEO; GSM596742
DR   GEO; GSM924842
DR   Wikidata; Q54846307
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,30:02:01; B*07:02:01,57:01:01; C*06:02:01,07:02:01; DPA1*01:03:01,02:01:01; DPB1*02:01:02,13:01:01G; DQA1*01:03:01,02:01:01; DQB1*03:03:02,05:03:01; DRB1*07:01:01,13:01:01; DRB3*02:02:01; DRB4*01:03:01:02N (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM13072
AC   CVCL_7529
SY   GM18056
DR   CLO; CLO_0013841
DR   CLO; CLO_0015661
DR   BioSample; SAMN00802087
DR   Coriell; GM13072
DR   Coriell; GM18056
DR   Wikidata; Q54846309
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM13073
AC   CVCL_V393
DR   CLO; CLO_0013867
DR   BioSample; SAMN00802089
DR   Coriell; GM13073
DR   Wikidata; Q54846310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM13078
AC   CVCL_GS81
DR   CLO; CLO_0013870
DR   BioSample; SAMN00802091
DR   Coriell; GM13078
DR   Wikidata; Q54846311
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13079
AC   CVCL_7530
SY   GM18057
DR   CLO; CLO_0013871
DR   CLO; CLO_0015664
DR   BioSample; SAMN00802093
DR   Coriell; GM13079
DR   Coriell; GM18057
DR   Wikidata; Q54846312
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM13080
AC   CVCL_0H21
SY   JH226
DR   CLO; CLO_0013873
DR   Coriell; GM13080
DR   Wikidata; Q54846313
RX   PubMed=1577474;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 18 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   GM13081
AC   CVCL_0H22
SY   JH281
DR   CLO; CLO_0013876
DR   Coriell; GM13081
DR   Wikidata; Q54846314
RX   PubMed=7713507;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM13082
AC   CVCL_0F86
SY   JH295
DR   CLO; CLO_0013878
DR   Coriell; GM13082
DR   Wikidata; Q54846315
RX   PubMed=8488839;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM13083
AC   CVCL_0G25
SY   JH341
DR   CLO; CLO_0013880
DR   Coriell; GM13083
DR   Wikidata; Q54846316
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 18 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1U18 ! GM50323
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   GM13085
AC   CVCL_JX71
DR   CLO; CLO_0013883
DR   BioSample; SAMN00802095
DR   Coriell; GM13085
DR   Wikidata; Q54846317
CC   Population: Caucasian; English.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C135087; Schimke immunoosseous dysplasia
DI   ORDO; Orphanet_1830; Schimke immuno-osseous dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 8
//
ID   GM13111
AC   CVCL_9Y14
DR   CLO; CLO_0013894
DR   BioSample; SAMN00802097
DR   Coriell; GM13111
DR   Wikidata; Q54846318
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88415.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13112
AC   CVCL_9Y15
DR   CLO; CLO_0013892
DR   BioSample; SAMN00802099
DR   Coriell; GM13112
DR   Wikidata; Q54846319
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88416.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13113
AC   CVCL_9Y16
DR   CLO; CLO_0013889
DR   BioSample; SAMN00802101
DR   Coriell; GM13113
DR   Wikidata; Q54846320
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88401.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13114
AC   CVCL_9Y17
DR   CLO; CLO_0013916
DR   BioSample; SAMN00802103
DR   Coriell; GM13114
DR   GEO; GSM617127
DR   Wikidata; Q54846321
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88402.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM13115
AC   CVCL_9Y18
DR   CLO; CLO_0013918
DR   BioSample; SAMN00802105
DR   Coriell; GM13115
DR   Wikidata; Q54846322
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88417.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13116
AC   CVCL_9Y19
DR   CLO; CLO_0013913
DR   BioSample; SAMN00802107
DR   Coriell; GM13116
DR   Wikidata; Q54846323
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88418.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13117
AC   CVCL_9Y20
DR   CLO; CLO_0013914
DR   BioSample; SAMN00802109
DR   Coriell; GM13117
DR   Wikidata; Q54846324
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88403.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13118
AC   CVCL_9Y21
DR   CLO; CLO_0013925
DR   BioSample; SAMN00802111
DR   Coriell; GM13118
DR   GEO; GSM617128
DR   Wikidata; Q54846325
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88404.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM13119
AC   CVCL_9Y22
DR   CLO; CLO_0013927
DR   BioSample; SAMN00802113
DR   Coriell; GM13119
DR   GEO; GSM617129
DR   Wikidata; Q54846326
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88405.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM13120
AC   CVCL_9Y23
DR   CLO; CLO_0013920
DR   BioSample; SAMN00802115
DR   Coriell; GM13120
DR   Wikidata; Q54846327
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88406.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13121
AC   CVCL_9Y24
DR   CLO; CLO_0013674
DR   BioSample; SAMN00802117
DR   Coriell; GM13121
DR   Wikidata; Q54846328
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88407.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13122
AC   CVCL_9Y25
DR   CLO; CLO_0013675
DR   BioSample; SAMN00802119
DR   Coriell; GM13122
DR   Wikidata; Q54846329
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88408.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13123
AC   CVCL_9Y26
DR   CLO; CLO_0013672
DR   BioSample; SAMN00802121
DR   Coriell; GM13123
DR   Wikidata; Q54846330
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88409.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13124
AC   CVCL_9Y27
DR   CLO; CLO_0013673
DR   BioSample; SAMN00802123
DR   Coriell; GM13124
DR   Wikidata; Q54846331
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88410.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13125
AC   CVCL_9Y28
DR   CLO; CLO_0013690
DR   BioSample; SAMN00802125
DR   Coriell; GM13125
DR   Wikidata; Q54846332
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88411.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13126
AC   CVCL_9Y29
DR   CLO; CLO_0013689
DR   BioSample; SAMN00802127
DR   Coriell; GM13126
DR   Wikidata; Q54846333
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88412.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13127
AC   CVCL_9Y30
DR   CLO; CLO_0013688
DR   BioSample; SAMN00802129
DR   Coriell; GM13127
DR   Wikidata; Q54846334
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88413.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13128
AC   CVCL_9Y31
DR   CLO; CLO_0013687
DR   BioSample; SAMN00802131
DR   Coriell; GM13128
DR   Wikidata; Q54846335
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Amish pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 88414.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM13130
AC   CVCL_5F61
AS   CVCL_G406
SY   CEPH-1332-NA13130; 1332-8265
DR   CLO; CLO_0013692
DR   BioSample; SAMN00802132
DR   Coriell; GM13130
DR   dbMHC; 48567
DR   GEO; GSM421149
DR   GEO; GSM659927
DR   GEO; GSM660138
DR   GEO; GSM660344
DR   IHW; IHW01034
DR   IPD-IMGT/HLA; 25834
DR   Wikidata; Q54846336
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Registration: CEPH Families Reference Panel; 133205.
CC   HLA typing: A*03:01,03:01; B*35:01,56:01; C*01:02,04:01; DPA1*01:03,02:01:01; DPB1*04:02,11:01:01; DQA1*01:01,04:01; DQB1*04:02,05:01:01; DRB1*01:01,08:01 (IPD-IMGT/HLA=25834).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM13131
AC   CVCL_5F62
DR   CLO; CLO_0013691
DR   BioSample; SAMN00802134
DR   Coriell; GM13131
DR   GEO; GSM421150
DR   GEO; GSM659884
DR   GEO; GSM660094
DR   GEO; GSM660301
DR   Wikidata; Q54846337
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135710.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM13132
AC   CVCL_5F63
DR   CLO; CLO_0013651
DR   BioSample; SAMN00802135
DR   Coriell; GM13132
DR   GEO; GSM421151
DR   Wikidata; Q54846338
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135713.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM13133
AC   CVCL_5F64
DR   CLO; CLO_0013652
DR   BioSample; SAMN00802137
DR   Coriell; GM13133
DR   GEO; GSM315059
DR   GEO; GSM421152
DR   GEO; GSM906241
DR   GEO; GSM906242
DR   Wikidata; Q54846344
RX   PubMed=19797678;
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135612.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM13134
AC   CVCL_9Y32
DR   CLO; CLO_0013653
DR   Coriell; GM13134
DR   Wikidata; Q54846345
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/French pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM13136
AC   CVCL_F126
DR   CLO; CLO_0013654
DR   BioSample; SAMN00802139
DR   Coriell; GM13136
DR   Wikidata; Q54846346
RX   PubMed=7994019;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; c.456+4A>T (IVS4+4A>T); ClinVar=VCV000012045; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM13136).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F125 ! GM00449
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   GM13138
AC   CVCL_N202
SY   GM17089
DR   CLO; CLO_0013655
DR   CLO; CLO_0014491
DR   BioSample; SAMN00802141
DR   Coriell; GM13138
DR   Coriell; GM17089
DR   Wikidata; Q54846347
CC   Part of: Human variation panel.
CC   Population: Southeast Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM13147
AC   CVCL_DB84
DR   CLO; CLO_0013671
DR   BioSample; SAMN00802147
DR   Coriell; GM13147
DR   Wikidata; Q54846350
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM13148
AC   CVCL_DB85
DR   CLO; CLO_0013625
DR   BioSample; SAMN00802149
DR   Coriell; GM13148
DR   Wikidata; Q54846351
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM13164
AC   CVCL_4W21
DR   CLO; CLO_0013645
DR   BioSample; SAMN00802155
DR   Coriell; GM13164
DR   Wikidata; Q54846354
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75466; Rubinstein-Taybi syndrome
DI   ORDO; Orphanet_783; Rubinstein-Taybi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GM13166
AC   CVCL_2Q71
DR   CLO; CLO_0013643
DR   Coriell; GM13166
DR   Wikidata; Q54846355
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM13175
AC   CVCL_DE52
SY   GS901c-531
DR   CLO; CLO_0013593
DR   Coriell; GM13175
DR   Wikidata; Q54846357
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM13180
AC   CVCL_N203
SY   GM17318; 104-15
DR   CLO; CLO_0013320
DR   CLO; CLO_0013594
DR   BioSample; SAMN00802157
DR   Coriell; GM13180
DR   Coriell; GM17318
DR   Wikidata; Q54846358
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Part of: Human variation panel.
CC   Registration: CEPH Families Reference Panel; 10201/10415.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I44 ! GM13055
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM13181
AC   CVCL_N204
SY   GM17319; 104-16
DR   CLO; CLO_0013323
DR   CLO; CLO_0013596
DR   BioSample; SAMN00802159
DR   Coriell; GM13181
DR   Coriell; GM17319
DR   Wikidata; Q54846359
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Part of: Human variation panel.
CC   Registration: CEPH Families Reference Panel; 10202/10416.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0I45 ! GM13057
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM13182
AC   CVCL_W608
DR   CLO; CLO_0013589
DR   BioSample; SAMN00802161
DR   Coriell; GM13182
DR   Wikidata; Q54846361
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10203.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13183
AC   CVCL_W609
DR   CLO; CLO_0013590
DR   BioSample; SAMN00802163
DR   Coriell; GM13183
DR   Wikidata; Q54846362
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10204.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13184
AC   CVCL_W610
DR   CLO; CLO_0013591
DR   BioSample; SAMN00802165
DR   Coriell; GM13184
DR   Wikidata; Q54846363
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10205/10402.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM04689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M952 ! GM04689
OI   CVCL_M953 ! GM04690
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   GM13185
AC   CVCL_W611
DR   CLO; CLO_0013592
DR   BioSample; SAMN00802166
DR   Coriell; GM13185
DR   Wikidata; Q54846364
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10206.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13187
AC   CVCL_W612
DR   CLO; CLO_0013615
DR   BioSample; SAMN00802168
DR   Coriell; GM13187
DR   Wikidata; Q54846365
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10208.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13188
AC   CVCL_W613
DR   CLO; CLO_0013614
DR   BioSample; SAMN00802169
DR   Coriell; GM13188
DR   Wikidata; Q54846366
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13189
AC   CVCL_W614
DR   CLO; CLO_0013618
DR   BioSample; SAMN00802171
DR   Coriell; GM13189
DR   Wikidata; Q54846367
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10210.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13190
AC   CVCL_W615
DR   CLO; CLO_0013180
DR   BioSample; SAMN00802173
DR   Coriell; GM13190
DR   Wikidata; Q54846368
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10211.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13191
AC   CVCL_W616
DR   CLO; CLO_0013167
DR   BioSample; SAMN00802175
DR   Coriell; GM13191
DR   Wikidata; Q54846369
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10212.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13192
AC   CVCL_W617
DR   CLO; CLO_0013162
DR   BioSample; SAMN00802177
DR   Coriell; GM13192
DR   Wikidata; Q54846370
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10213.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13193
AC   CVCL_W618
DR   CLO; CLO_0013174
DR   BioSample; SAMN00802180
DR   Coriell; GM13193
DR   Wikidata; Q54846371
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10214.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13194
AC   CVCL_W619
DR   CLO; CLO_0013170
DR   BioSample; SAMN00802183
DR   Coriell; GM13194
DR   Wikidata; Q54846372
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10215.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13195
AC   CVCL_W620
DR   CLO; CLO_0013153
DR   BioSample; SAMN00802185
DR   Coriell; GM13195
DR   Wikidata; Q54846373
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10216.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM13199
AC   CVCL_FV88
DR   CLO; CLO_0013151
DR   BioSample; SAMN00802187
DR   Coriell; GM13199
DR   Wikidata; Q54846374
CC   Population: Caucasian; Amish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM13200
AC   CVCL_H548
DR   CLO; CLO_0013160
DR   BioSample; SAMN00802190
DR   Coriell; GM13200
DR   Wikidata; Q54846375
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM13201
AC   CVCL_X451
DR   CLO; CLO_0013155
DR   BioSample; SAMN00802193
DR   Coriell; GM13201
DR   Wikidata; Q54846377
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61273; Aspartylglycosaminuria
DI   ORDO; Orphanet_93; Aspartylglucosaminuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   GM13202
AC   CVCL_9Z47
DR   CLO; CLO_0013145
DR   Coriell; GM13202
DR   Wikidata; Q54846378
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85043; Refsum disease
DI   ORDO; Orphanet_773; Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM13203
AC   CVCL_N205
SY   GM17358
DR   CLO; CLO_0013207
DR   CLO; CLO_0013728
DR   BioSample; SAMN00802196
DR   Coriell; GM13203
DR   Coriell; GM17358
DR   Wikidata; Q54846379
RX   PubMed=34990619;
CC   Part of: Human variation panel.
CC   Population: Caribbean; Haitian.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.His70Profs*29 (c.208dupC) (c.208insC); ClinVar=VCV000195037; Zygosity=Hemizygous (Coriell=GM13203).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   GM13204
AC   CVCL_U401
DR   CLO; CLO_0013206
DR   Coriell; GM13204
DR   Wikidata; Q54846380
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (Coriell=GM13204).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM13204).
CC   Discontinued: Coriell; GM13204; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   GM13205
AC   CVCL_AX25
SY   NPD-1
DR   BTO; BTO_0004931
DR   CLO; CLO_0013203
DR   Coriell; GM13205
DR   Wikidata; Q54846381
RX   PubMed=19815695;
RX   PubMed=21335555;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Phe333Serfs*52 (c.996delC) (P330fs, 990delC); ClinVar=VCV000002990; Zygosity=Heterozygous (Coriell=GM13205).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM13206
AC   CVCL_IJ39
DR   CLO; CLO_0013198
DR   Coriell; GM13206
DR   Wikidata; Q54846382
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM13238
AC   CVCL_2U24
DR   CLO; CLO_0013196
DR   Coriell; GM13238
DR   Wikidata; Q54846383
CC   Karyotypic information: 46,XX,t(1;13)(1pter->1q25::13q22->13qter;13pter->13q22::1q25->1qter) (Coriell=GM13238).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM13239
AC   CVCL_9Y33
DR   CLO; CLO_0013192
DR   BioSample; SAMN00802198
DR   Coriell; GM13239
DR   Wikidata; Q54846385
CC   Population: Mexican.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84903; Sly syndrome
DI   ORDO; Orphanet_584; Mucopolysaccharidosis type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13241
AC   CVCL_GS82
DR   CLO; CLO_0013190
DR   BioSample; SAMN00802200
DR   Coriell; GM13241
DR   Wikidata; Q54846386
CC   Population: Caucasian; German.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84829; Lipoid proteinosis of Urbach and Wiethe
DI   ORDO; Orphanet_530; Lipoid proteinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13242
AC   CVCL_GZ46
DR   CLO; CLO_0013189
DR   BioSample; SAMN00802202
DR   Coriell; GM13242
DR   Wikidata; Q54846387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129303; Congenital bilateral aplasia of the vas deferens
DI   ORDO; Orphanet_48; Congenital bilateral absence of vas deferens
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13243
AC   CVCL_V394
DR   CLO; CLO_0013187
DR   BioSample; SAMN00802204
DR   Coriell; GM13243
DR   Wikidata; Q54846392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM13247
AC   CVCL_V395
DR   CLO; CLO_0013186
DR   BioSample; SAMN00802206
DR   Coriell; GM13247
DR   Wikidata; Q54846393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM13248
AC   CVCL_V137
DR   CLO; CLO_0013074
DR   BioSample; SAMN00802208
DR   Coriell; GM13248
DR   Wikidata; Q54846394
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asn150Ilefs*9 (c.449delA); ClinVar=VCV000195093; Zygosity=Unspecified (Coriell=GM13248).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM13249
AC   CVCL_V138
DR   CLO; CLO_0013079
DR   Coriell; GM13249
DR   Wikidata; Q54846395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM13250
AC   CVCL_V139
DR   CLO; CLO_0013078
DR   BioSample; SAMN00802210
DR   Coriell; GM13250
DR   Wikidata; Q54846396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM13251
AC   CVCL_V140
DR   CLO; CLO_0013085
DR   Coriell; GM13251
DR   Wikidata; Q54846397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM13252
AC   CVCL_V141
DR   CLO; CLO_0013084
DR   BioSample; SAMN00802212
DR   Coriell; GM13252
DR   Wikidata; Q54846398
RX   PubMed=8493574;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser168Cysfs*3 (c.501_502insTTGTCCGT) (8-nt insertion at nt 714); ClinVar=VCV000093329; Zygosity=Unspecified (PubMed=8493574).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM13254
AC   CVCL_V142
DR   CLO; CLO_0013093
DR   BioSample; SAMN00802214
DR   Coriell; GM13254
DR   Wikidata; Q54846399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM13255
AC   CVCL_V143
DR   CLO; CLO_0013088
DR   BioSample; SAMN00802216
DR   Coriell; GM13255
DR   Wikidata; Q54846400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM13256
AC   CVCL_V144
DR   CLO; CLO_0013063
DR   BioSample; SAMN00802218
DR   Coriell; GM13256
DR   Wikidata; Q54846402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM13257
AC   CVCL_V145
DR   CLO; CLO_0013060
DR   BioSample; SAMN00802220
DR   Coriell; GM13257
DR   Wikidata; Q54846403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM13262
AC   CVCL_BW64
DR   CLO; CLO_0013116
DR   BioSample; SAMN00802222
DR   Coriell; GM13262
DR   Wikidata; Q54846404
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C119676; D-bifunctional protein deficiency
DI   ORDO; Orphanet_300; Bifunctional enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13263
AC   CVCL_BW65
DR   CLO; CLO_0013114
DR   BioSample; SAMN00802224
DR   Coriell; GM13263
DR   Wikidata; Q54846405
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:5213; HSD17B4; Simple; p.Lys142Valfs*23 (c.423_424delGA) (c.422_423delAG); ClinVar=VCV000007659; Zygosity=Homozygous (Coriell=GM13263).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C119676; D-bifunctional protein deficiency
DI   ORDO; Orphanet_300; Bifunctional enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM13264
AC   CVCL_BW66
DR   CLO; CLO_0013134
DR   BioSample; SAMN00802226
DR   Coriell; GM13264
DR   Wikidata; Q54846406
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5213; HSD17B4; Simple; p.Lys142Valfs*23 (c.423_424delGA) (c.422_423delAG); ClinVar=VCV000007659; Zygosity=Homozygous (Coriell=GM13264).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C119676; D-bifunctional protein deficiency
DI   ORDO; Orphanet_300; Bifunctional enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM13265
AC   CVCL_BW67
DR   CLO; CLO_0013129
DR   BioSample; SAMN00802228
DR   Coriell; GM13265
DR   Wikidata; Q54846407
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C119676; D-bifunctional protein deficiency
DI   ORDO; Orphanet_300; Bifunctional enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13266
AC   CVCL_4F66
DR   CLO; CLO_0013126
DR   BioSample; SAMN00802230
DR   Coriell; GM13266
DR   Wikidata; Q54846408
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM13267
AC   CVCL_4F67
DR   CLO; CLO_0013123
DR   BioSample; SAMN00802232
DR   Coriell; GM13267
DR   Wikidata; Q54846409
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM13268
AC   CVCL_9R31
DR   CLO; CLO_0013108
DR   BioSample; SAMN00802234
DR   Coriell; GM13268
DR   Wikidata; Q54846410
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99251; Neonatal adrenoleukodystrophy
DI   ORDO; Orphanet_44; Neonatal adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13269
AC   CVCL_4F68
DR   CLO; CLO_0013105
DR   BioSample; SAMN00802236
DR   Coriell; GM13269
DR   Wikidata; Q54846411
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM13272
AC   CVCL_4F69
DR   CLO; CLO_0013313
DR   BioSample; SAMN00802238
DR   Coriell; GM13272
DR   Wikidata; Q54846412
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM13273
AC   CVCL_4F70
DR   CLO; CLO_0013287
DR   BioSample; SAMN00802240
DR   Coriell; GM13273
DR   Wikidata; Q54846413
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM13275
AC   CVCL_4F71
DR   CLO; CLO_0013288
DR   BioSample; SAMN00802242
DR   Coriell; GM13275
DR   Wikidata; Q54846414
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM13275).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM13276
AC   CVCL_GZ47
DR   CLO; CLO_0013289
DR   BioSample; SAMN00802244
DR   Coriell; GM13276
DR   Wikidata; Q54846415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129303; Congenital bilateral aplasia of the vas deferens
DI   ORDO; Orphanet_48; Congenital bilateral absence of vas deferens
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13277
AC   CVCL_5P73
DR   CLO; CLO_0013290
DR   BioSample; SAMN00802246
DR   Coriell; GM13277
DR   Wikidata; Q54846416
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM13278
AC   CVCL_GS83
DR   CLO; CLO_0013279
DR   BioSample; SAMN00802248
DR   Coriell; GM13278
DR   Wikidata; Q54846417
RX   PubMed=11393534;
CC   Sequence variation: Mutation; HGNC; HGNC:9155; PNLIP; Simple; p.Asn162Asn (c.486C>T) (486C/T); ClinVar=VCV000769789; Zygosity=Heterozygous (PubMed=11393534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129030; Pancreatic lipase deficiency
DI   ORDO; Orphanet_309031; Pancreatic triacylglycerol lipase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM13280
AC   CVCL_GT65
DR   CLO; CLO_0013282
DR   BioSample; SAMN00802250
DR   Coriell; GM13280
DR   Wikidata; Q54846418
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13281
AC   CVCL_N206
SY   GM17320
DR   CLO; CLO_0013283
DR   CLO; CLO_0013642
DR   BioSample; SAMN00802252
DR   Coriell; GM13281
DR   Coriell; GM17320
DR   Wikidata; Q54846419
CC   Part of: Human variation panel.
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13284
AC   CVCL_2U25
DR   CLO; CLO_0013286
DR   BioSample; SAMN00802254
DR   Coriell; GM13284
DR   Wikidata; Q54846420
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM13286
AC   CVCL_4Z70
SY   GM13286A
DR   CLO; CLO_0013300
DR   BioSample; SAMN00802256
DR   Coriell; GM13286
DR   Wikidata; Q54846421
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z71 ! GM13287
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   GM13287
AC   CVCL_4Z71
DR   CLO; CLO_0013352
DR   BioSample; SAMN00802258
DR   Coriell; GM13287
DR   Wikidata; Q54846422
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z70 ! GM13286
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM13289
AC   CVCL_V396
DR   CLO; CLO_0013350
DR   BioSample; SAMN00802260
DR   Coriell; GM13289
DR   Wikidata; Q54846423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM13290
AC   CVCL_V397
DR   CLO; CLO_0013330
DR   BioSample; SAMN00802262
DR   Coriell; GM13290
DR   Wikidata; Q54846424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   GM13291
AC   CVCL_1K70
DR   BioSample; SAMN00802263
DR   Coriell; GM13291
DR   Wikidata; Q54846425
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM13291).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.1195-8G>A; ClinVar=VCV000570655; Zygosity=Heterozygous (Coriell=GM13291).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13293
AC   CVCL_L931
SY   GM17173
DR   CLO; CLO_0013331
DR   CLO; CLO_0014026
DR   BioSample; SAMN00802265
DR   Coriell; GM13293
DR   Coriell; GM17173
DR   GEO; GSM569745
DR   GEO; GSM596237
DR   GEO; GSM597032
DR   GEO; GSM924683
DR   IPD-IMGT/HLA; 17383
DR   Wikidata; Q54846426
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,30:AUX; B*40:AZAY,42:01; C*03:04,17:MN; DRB1*03:02,04:04 (IPD-IMGT/HLA=17383).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   GM13294
AC   CVCL_L932
SY   GM17109
DR   CLO; CLO_0013328
DR   CLO; CLO_0014887
DR   BioSample; SAMN00802266
DR   Coriell; GM13294
DR   Coriell; GM17109
DR   GEO; GSM273379
DR   GEO; GSM569513
DR   GEO; GSM596177
DR   GEO; GSM596977
DR   GEO; GSM924619
DR   IPD-IMGT/HLA; 15331
DR   Wikidata; Q54846427
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:01,33:03; B*15:10,42:02; C*03:04,17:MN; DRB1*08:04,12:CVT (IPD-IMGT/HLA=15331).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   GM13298
AC   CVCL_9R32
DR   CLO; CLO_0013327
DR   BioSample; SAMN00802271
DR   Coriell; GM13298
DR   Wikidata; Q54846430
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C99251; Neonatal adrenoleukodystrophy
DI   ORDO; Orphanet_44; Neonatal adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM133
AC   CVCL_B4FS
DR   cancercelllines; CVCL_B4FS
DR   IARC_TP53; 20808
DR   Wikidata; Q110432814
RX   PubMed=14961077;
RX   PubMed=23541792;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   GM13301
AC   CVCL_FV89
DR   CLO; CLO_0013318
DR   BioSample; SAMN00802273
DR   Coriell; GM13301
DR   Wikidata; Q54846431
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   GM13302
AC   CVCL_1S67
SY   UMHG-17/1A
DR   CLO; CLO_0013321
DR   Coriell; GM13302
DR   Wikidata; Q54846432
RX   PubMed=8404043;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K265 ! Don/a23
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13304
AC   CVCL_HJ80
DR   BioSample; SAMN00802275
DR   Coriell; GM13304
DR   Wikidata; Q54846444
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM13304).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp516Ter (c.1548G>A); ClinVar=VCV000189025; Zygosity=Heterozygous (Coriell=GM13304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM13305
AC   CVCL_1K71
DR   BioSample; SAMN00802277
DR   Coriell; GM13305
DR   Wikidata; Q54846445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM13306
AC   CVCL_1K72
DR   BioSample; SAMN00802279
DR   Coriell; GM13306
DR   Wikidata; Q54846447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM13307
AC   CVCL_9R95
DR   CLO; CLO_0013243
DR   BioSample; SAMN00802281
DR   Coriell; GM13307
DR   Wikidata; Q54846448
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13309
AC   CVCL_4F05
DR   CLO; CLO_0013245
DR   BioSample; SAMN00802283
DR   Coriell; GM13309
DR   Wikidata; Q54846449
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13310
AC   CVCL_4F06
DR   CLO; CLO_0013244
DR   BioSample; SAMN00802285
DR   Coriell; GM13310
DR   Wikidata; Q54846450
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13311
AC   CVCL_4F07
DR   CLO; CLO_0013215
DR   BioSample; SAMN00802287
DR   Coriell; GM13311
DR   Wikidata; Q54846451
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13312
AC   CVCL_4F08
DR   CLO; CLO_0013216
DR   BioSample; SAMN00802289
DR   Coriell; GM13312
DR   Wikidata; Q54846452
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13313
AC   CVCL_4F09
DR   CLO; CLO_0013217
DR   BioSample; SAMN00802291
DR   Coriell; GM13313
DR   Wikidata; Q54846453
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13314
AC   CVCL_4F10
DR   CLO; CLO_0013218
DR   BioSample; SAMN00802293
DR   Coriell; GM13314
DR   Wikidata; Q54846454
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13315
AC   CVCL_4F11
DR   CLO; CLO_0013219
DR   BioSample; SAMN00802295
DR   Coriell; GM13315
DR   Wikidata; Q54846456
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84684; Ellis-Van Creveld syndrome
DI   ORDO; Orphanet_289; Ellis Van Creveld syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13316
AC   CVCL_4I84
DR   CLO; CLO_0013222
DR   Coriell; GM13316
DR   Wikidata; Q54846457
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13321
AC   CVCL_N207
SY   GM17174
DR   CLO; CLO_0013224
DR   CLO; CLO_0014034
DR   BioSample; SAMN00802297
DR   Coriell; GM13321
DR   Coriell; GM17174
DR   GEO; GSM569746
DR   GEO; GSM596238
DR   GEO; GSM597033
DR   GEO; GSM924684
DR   Wikidata; Q54846458
RX   PubMed=16260726;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM13322
AC   CVCL_GS84
DR   CLO; CLO_0013276
DR   BioSample; SAMN00802299
DR   Coriell; GM13322
DR   Wikidata; Q54846459
RX   PubMed=11393534;
CC   Sequence variation: Mutation; HGNC; HGNC:9155; PNLIP; Simple; p.Pro32Pro (c.96A>C) (96A/C); ClinVar=VCV000768391; Zygosity=Homozygous (PubMed=11393534).
CC   Sequence variation: Mutation; HGNC; HGNC:9155; PNLIP; Simple; p.Thr453Thr (c.1359C>T) (1359C/T); ClinVar=VCV000768392; Zygosity=Homozygous (PubMed=11393534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129030; Pancreatic lipase deficiency
DI   ORDO; Orphanet_309031; Pancreatic triacylglycerol lipase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM13323
AC   CVCL_2N04
DR   CLO; CLO_0013275
DR   Coriell; GM13323
DR   Wikidata; Q54846460
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Donor information: Established from monozygotic twin of GM13324 (Cellosaurus=CVCL_2N05).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   GM13324
AC   CVCL_2N05
DR   CLO; CLO_0013274
DR   Coriell; GM13324
DR   Wikidata; Q54846461
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Donor information: Established from monozygotic twin of GM13323 (Cellosaurus=CVCL_2N04).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   GM13325
AC   CVCL_2Y99
DR   CLO; CLO_0013273
DR   BioSample; SAMN00802301
DR   Coriell; GM13325
DR   Wikidata; Q54846462
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM13330
AC   CVCL_2U26
DR   CLO; CLO_0013247
DR   BioSample; SAMN00802309
DR   Coriell; GM13330
DR   GEO; GSM809
DR   Wikidata; Q54846466
RX   PubMed=11687795;
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM13331
AC   CVCL_1K73
DR   CLO; CLO_0013253
DR   BioSample; SAMN00802311
DR   Coriell; GM13331
DR   Wikidata; Q54846467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13335
AC   CVCL_7531
SY   GM00967B
DR   CLO; CLO_0012883
DR   BioSample; SAMN00802313
DR   Coriell; GM13335
DR   GEO; GSM3124664
DR   Wikidata; Q54846468
RX   CelloPub=CLPUB00447;
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X802 ! AG16504
OI   CVCL_1M95 ! AG20457
OI   CVCL_1M96 ! AG22339
OI   CVCL_7310 ! GM00967
OI   CVCL_7316 ! GM01310
OI   CVCL_7532 ! GM13336
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM13336
AC   CVCL_7532
DR   CLO; CLO_0012886
DR   BioSample; SAMN00802316
DR   Coriell; GM13336
DR   Wikidata; Q54846469
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X802 ! AG16504
OI   CVCL_1M95 ! AG20457
OI   CVCL_1M96 ! AG22339
OI   CVCL_7310 ! GM00967
OI   CVCL_7316 ! GM01310
OI   CVCL_7531 ! GM13335
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM13339
AC   CVCL_1S68
SY   G1A10; G1A-10
DR   CLO; CLO_0012887
DR   Coriell; GM13339
DR   Wikidata; Q54846470
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 3 and X mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_H961 ! GM00194
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM13340
AC   CVCL_1S69
SY   G4A2; GM13340B
DR   Coriell; GM13340
DR   Wikidata; Q54846471
RX   PubMed=7713507;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM13340; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V771 ! GM00439
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   GM13341
AC   CVCL_1S70
SY   GL5; GL-5
DR   CLO; CLO_0012884
DR   Coriell; GM13341
DR   Wikidata; Q54846472
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V817 ! GM02808
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM13342
AC   CVCL_1S71
SY   LG63-13; LG-63-13
DR   CLO; CLO_0012885
DR   Coriell; GM13342
DR   Wikidata; Q54846473
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1R77 ! GM02963
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   GM13343
AC   CVCL_GS85
DR   CLO; CLO_0012899
DR   BioSample; SAMN00802318
DR   Coriell; GM13343
DR   Wikidata; Q54846474
RX   PubMed=11393534;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129030; Pancreatic lipase deficiency
DI   ORDO; Orphanet_309031; Pancreatic triacylglycerol lipase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13344
AC   CVCL_GS86
DR   CLO; CLO_0012895
DR   BioSample; SAMN00802320
DR   Coriell; GM13344
DR   Wikidata; Q54846475
RX   PubMed=11393534;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129030; Pancreatic lipase deficiency
DI   ORDO; Orphanet_309031; Pancreatic triacylglycerol lipase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13347
AC   CVCL_4W22
DR   CLO; CLO_0012891
DR   BioSample; SAMN00802322
DR   Coriell; GM13347
DR   Wikidata; Q54846476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75466; Rubinstein-Taybi syndrome
DI   ORDO; Orphanet_783; Rubinstein-Taybi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM13350
AC   CVCL_GZ48
DR   CLO; CLO_0012888
DR   BioSample; SAMN00802324
DR   Coriell; GM13350
DR   Wikidata; Q54846477
CC   Population: Arab; Saudi Arabian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129301; Adrenal gland hyperplasia II
DI   ORDO; Orphanet_90791; Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GZ49 ! GM13365
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   GM13352
AC   CVCL_1K74
DR   CLO; CLO_0012903
DR   BioSample; SAMN00802326
DR   Coriell; GM13352
DR   Wikidata; Q54846478
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu521Lys (c.1561G>A); ClinVar=VCV000004022; Zygosity=Homozygous (Coriell=GM13352).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13355
AC   CVCL_5F65
DR   CLO; CLO_0012841
DR   BioSample; SAMN00802328
DR   Coriell; GM13355
DR   GEO; GSM421153
DR   Wikidata; Q54846479
RX   PubMed=20856902;
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Utah pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 135603.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM13356
AC   CVCL_0I46
DR   CLO; CLO_0012842
DR   Coriell; GM13356
DR   Wikidata; Q54846480
WW   Info; CEPH; -; https://www.cephb.fr/en/familles_CEPH.php
CC   Part of: CEPH/Venezuelan pedigree cell line collection.
CC   Registration: CEPH Families Reference Panel; 10414.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM13360
AC   CVCL_AD77
DR   CLO; CLO_0012843
DR   BioSample; SAMN00802330
DR   Coriell; GM13360
DR   Wikidata; Q54846481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M3W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13363
AC   CVCL_Y602
DR   CLO; CLO_0012844
DR   BioSample; SAMN00802332
DR   Coriell; GM13363
DR   Wikidata; Q54846482
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Asp90Glu (c.270C>A); ClinVar=VCV000014167; Zygosity=Heterozygous (Coriell=GM13363).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM13365
AC   CVCL_GZ49
DR   CLO; CLO_0012845
DR   BioSample; SAMN00802334
DR   Coriell; GM13365
DR   Wikidata; Q54846483
CC   Population: Arab; Saudi Arabian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129301; Adrenal gland hyperplasia II
DI   ORDO; Orphanet_90791; Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GZ48 ! GM13350
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   GM13395
AC   CVCL_JF49
SY   WG2255; 2255
DR   CLO; CLO_0012849
DR   BioSample; SAMN00802340
DR   Coriell; GM13395
DR   Wikidata; Q54846505
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Arab; Saudi Arabian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   GM13408
AC   CVCL_1K75
DR   BioSample; SAMN00802342
DR   Coriell; GM13408
DR   Wikidata; Q54846506
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-3C>A; ClinVar=VCV000371622; Zygosity=Heterozygous (Coriell=GM13408).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM13408).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13409
AC   CVCL_1K76
DR   BioSample; SAMN00802344
DR   Coriell; GM13409
DR   Wikidata; Q54846507
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-3C>A; ClinVar=VCV000371622; Zygosity=Heterozygous (Coriell=GM13409).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM13409).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13410
AC   CVCL_2U27
DR   CLO; CLO_0012856
DR   BioSample; SAMN00802346
DR   Coriell; GM13410
DR   Wikidata; Q54846508
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   25D
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13411
AC   CVCL_8A61
DR   CLO; CLO_0012853
DR   BioSample; SAMN00802348
DR   Coriell; GM13411
DR   Wikidata; Q54846509
RX   PubMed=8042671;
RX   PubMed=30471880;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Unspecified (PubMed=8042671).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM13412
AC   CVCL_1S72
SY   1HL35-5; 1HL35 subclone 5
DR   CLO; CLO_0012655
DR   Coriell; GM13412
DR   Wikidata; Q54846510
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N51 ! irs1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13413
AC   CVCL_1S73
SY   9HL10-2; 9HL10 subclone 2
DR   CLO; CLO_0012656
DR   Coriell; GM13413
DR   Wikidata; Q54846511
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13415
AC   CVCL_1N83
DR   CLO; CLO_0012653
DR   BioSample; SAMN00802350
DR   Coriell; GM13415
DR   Wikidata; Q54846512
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM13416
AC   CVCL_1N84
DR   CLO; CLO_0012654
DR   BioSample; SAMN00802352
DR   Coriell; GM13416
DR   Wikidata; Q54846513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13418
AC   CVCL_N208
SY   GM17299
DR   CLO; CLO_0012645
DR   CLO; CLO_0013115
DR   BioSample; SAMN00802354
DR   Coriell; GM13418
DR   Coriell; GM17299
DR   Wikidata; Q54846514
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13419
AC   CVCL_1N85
DR   CLO; CLO_0012646
DR   BioSample; SAMN00802356
DR   Coriell; GM13419
DR   Wikidata; Q54846515
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34415; Beckwith-Wiedemann syndrome
DI   ORDO; Orphanet_116; Beckwith-Wiedemann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM13423
AC   CVCL_0N24
DR   CLO; CLO_0012643
DR   BioSample; SAMN00802358
DR   Coriell; GM13423
DR   Wikidata; Q54846516
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly85Glu (c.254G>A); ClinVar=VCV000007143; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asp1152His (c.3454G>C); ClinVar=VCV000035867; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM13425
AC   CVCL_AN08
DR   CLO; CLO_0012644
DR   BioSample; SAMN00802360
DR   Coriell; GM13425
DR   Wikidata; Q54846517
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9081; PLOD1; Simple; p.Glu532del (c.1594_1596delGAG); ClinVar=VCV000014367; Zygosity=Heterozygous (Coriell=GM13425).
CC   Sequence variation: Mutation; HGNC; HGNC:9081; PLOD1; Simple; p.Gly678Arg (c.2032G>A); ClinVar=VCV000014366; Zygosity=Heterozygous (Coriell=GM13425).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125700; Ehlers-Danlos syndrome, type VI
DI   ORDO; Orphanet_1900; Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   GM13426
AC   CVCL_AN09
DR   CLO; CLO_0012650
DR   BioSample; SAMN00802362
DR   Coriell; GM13426
DR   Wikidata; Q54846518
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9081; PLOD1; Simple; p.Glu532del (c.1594_1596delGAG); ClinVar=VCV000014367; Zygosity=Heterozygous (Coriell=GM13426).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM13427
AC   CVCL_AN10
DR   CLO; CLO_0012651
DR   BioSample; SAMN00802364
DR   Coriell; GM13427
DR   Wikidata; Q54846519
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9081; PLOD1; Simple; p.Gly678Arg (c.2032G>A); ClinVar=VCV000014366; Zygosity=Heterozygous (Coriell=GM13427).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM13428
AC   CVCL_IJ40
DR   CLO; CLO_0012672
DR   BioSample; SAMN00802366
DR   Coriell; GM13428
DR   Wikidata; Q54846520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129930; MASA syndrome
DI   ORDO; Orphanet_2466; MASA syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM13430
AC   CVCL_2U28
DR   CLO; CLO_0012673
DR   BioSample; SAMN00802368
DR   Coriell; GM13430
DR   Wikidata; Q54846522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM13433
AC   CVCL_5P74
DR   CLO; CLO_0012674
DR   BioSample; SAMN00802370
DR   Coriell; GM13433
DR   Wikidata; Q54846523
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro15Leu (c.44C>T) (P14L); ClinVar=VCV000011075; Zygosity=Hemizygous (Coriell=GM13433).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM13434
AC   CVCL_5P75
DR   CLO; CLO_0012675
DR   Coriell; GM13434
DR   Wikidata; Q54846524
RX   PubMed=7539213;
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Thr118_Val166del (c.352_499del); Zygosity=Hemizygous (PubMed=7539213).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM13435
AC   CVCL_5P76
DR   CLO; CLO_0012676
DR   BioSample; SAMN00802372
DR   Coriell; GM13435
DR   Wikidata; Q54846526
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Gly128Gly (c.384C>G) (G127G); Zygosity=Hemizygous (Coriell=GM13435).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM13436
AC   CVCL_5P77
DR   CLO; CLO_0012664
DR   BioSample; SAMN00802374
DR   Coriell; GM13436
DR   Wikidata; Q54846527
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Thr43Ile (c.128C>T) (T42I); ClinVar=VCV000011086; Zygosity=Hemizygous (Coriell=GM13436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM13437
AC   CVCL_5P78
DR   CLO; CLO_0012665
DR   Coriell; GM13437
DR   Wikidata; Q54846528
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Thr116Lys (c.347C>A) (T115K); Zygosity=Hemizygous (Coriell=GM13437).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM13439
AC   CVCL_CX12
DR   CLO; CLO_0012666
DR   BioSample; SAMN00802376
DR   Coriell; GM13439
DR   Wikidata; Q54846529
CC   Population: Jordanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX13 ! GM13440
SX   Female
AG   10D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM13440
AC   CVCL_CX13
DR   CLO; CLO_0012667
DR   BioSample; SAMN00802378
DR   Coriell; GM13440
DR   Wikidata; Q54846530
CC   Population: Jordanian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX12 ! GM13439
SX   Female
AG   10D
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM13441
AC   CVCL_5P79
DR   CLO; CLO_0012669
DR   BioSample; SAMN00802380
DR   Coriell; GM13441
DR   Wikidata; Q54846531
RX   PubMed=22639450;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Ser1481Gly (c.4441A>G); ClinVar=VCV000036074; Zygosity=Unspecified; Note=VUS (PubMed=22639450).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124840; Shprintzen-Goldberg craniosynostosis syndrome
DI   ORDO; Orphanet_2462; Shprintzen-Goldberg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM13445
AC   CVCL_1S74
SY   5184-4
DR   CLO; CLO_0012182
DR   Coriell; GM13445
DR   Wikidata; Q54846532
RX   PubMed=1559705;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1Q25 ! GM05184
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13446
AC   CVCL_DE53
SY   640-5A
DR   CLO; CLO_0012181
DR   Coriell; GM13446
DR   Wikidata; Q54846533
RX   PubMed=1559705;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM13448
AC   CVCL_1S75
SY   HAL26-12
DR   CLO; CLO_0012167
DR   Coriell; GM13448
DR   Wikidata; Q54846534
RX   PubMed=1559705;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13449
AC   CVCL_1K77
DR   Coriell; GM13449
DR   Wikidata; Q54846535
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM13449).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Tyr609Ter (c.1827delC) (p.Arg608_Tyr609insTer); ClinVar=VCV000188936; Zygosity=Heterozygous (Coriell=GM13449).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13450
AC   CVCL_1K78
DR   CLO; CLO_0012166
DR   BioSample; SAMN00802382
DR   Coriell; GM13450
DR   Wikidata; Q54846536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13451
AC   CVCL_5P80
DR   Coriell; GM13451
DR   Wikidata; Q54846537
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM13460
AC   CVCL_5P81
DR   CLO; CLO_0012173
DR   BioSample; SAMN00802384
DR   Coriell; GM13460
DR   Wikidata; Q54846538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13461
AC   CVCL_5P82
DR   CLO; CLO_0012170
DR   BioSample; SAMN00802386
DR   Coriell; GM13461
DR   Wikidata; Q54846540
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13463
AC   CVCL_5P83
DR   CLO; CLO_0012190
DR   BioSample; SAMN00802388
DR   Coriell; GM13463
DR   Wikidata; Q54846541
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13464
AC   CVCL_5P84
DR   CLO; CLO_0012187
DR   BioSample; SAMN00802390
DR   Coriell; GM13464
DR   Wikidata; Q54846542
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13465
AC   CVCL_5P85
DR   CLO; CLO_0012195
DR   BioSample; SAMN00802392
DR   Coriell; GM13465
DR   Wikidata; Q54846543
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13466
AC   CVCL_5P86
DR   CLO; CLO_0012193
DR   BioSample; SAMN00802394
DR   Coriell; GM13466
DR   Wikidata; Q54846545
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13467
AC   CVCL_5P87
DR   CLO; CLO_0012223
DR   BioSample; SAMN00802396
DR   Coriell; GM13467
DR   Wikidata; Q54846547
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13468
AC   CVCL_5P88
DR   CLO; CLO_0012222
DR   BioSample; SAMN00802398
DR   Coriell; GM13468
DR   Wikidata; Q54846548
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13470
AC   CVCL_5P89
DR   CLO; CLO_0012219
DR   BioSample; SAMN00802400
DR   Coriell; GM13470
DR   Wikidata; Q54846550
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13471
AC   CVCL_5P90
DR   CLO; CLO_0012214
DR   BioSample; SAMN00802402
DR   Coriell; GM13471
DR   Wikidata; Q54846558
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13472
AC   CVCL_5P91
DR   CLO; CLO_0012212
DR   BioSample; SAMN00802404
DR   Coriell; GM13472
DR   Wikidata; Q54846559
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13473
AC   CVCL_5P92
DR   CLO; CLO_0012210
DR   BioSample; SAMN00802406
DR   Coriell; GM13473
DR   Wikidata; Q54846560
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13474
AC   CVCL_5P93
DR   CLO; CLO_0012206
DR   BioSample; SAMN00802408
DR   Coriell; GM13474
DR   Wikidata; Q54846561
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13475
AC   CVCL_5P94
DR   CLO; CLO_0012237
DR   BioSample; SAMN00802410
DR   Coriell; GM13475
DR   Wikidata; Q54846562
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13476
AC   CVCL_5K11
DR   CLO; CLO_0012235
DR   BioSample; SAMN00802412
DR   Coriell; GM13476
DR   Wikidata; Q54846563
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   GM13477
AC   CVCL_5P95
DR   CLO; CLO_0012232
DR   BioSample; SAMN00802414
DR   Coriell; GM13477
DR   Wikidata; Q54846564
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13478
AC   CVCL_5P96
DR   CLO; CLO_0012250
DR   BioSample; SAMN00802416
DR   Coriell; GM13478
DR   Wikidata; Q54846565
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13479
AC   CVCL_5P97
DR   CLO; CLO_0012248
DR   BioSample; SAMN00802418
DR   Coriell; GM13479
DR   Wikidata; Q54846566
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13480
AC   CVCL_5P98
DR   CLO; CLO_0012253
DR   BioSample; SAMN00802420
DR   Coriell; GM13480
DR   Wikidata; Q54846567
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13481
AC   CVCL_5P99
DR   CLO; CLO_0012252
DR   BioSample; SAMN00802422
DR   Coriell; GM13481
DR   Wikidata; Q54846568
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13482
AC   CVCL_5Q00
DR   CLO; CLO_0012259
DR   BioSample; SAMN00802424
DR   Coriell; GM13482
DR   Wikidata; Q54846569
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13483
AC   CVCL_5Q01
DR   CLO; CLO_0012258
DR   BioSample; SAMN00802426
DR   Coriell; GM13483
DR   Wikidata; Q54846570
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13484
AC   CVCL_5Q02
DR   CLO; CLO_0012268
DR   BioSample; SAMN00802428
DR   Coriell; GM13484
DR   Wikidata; Q54846571
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13485
AC   CVCL_5Q03
DR   CLO; CLO_0012265
DR   BioSample; SAMN00802430
DR   Coriell; GM13485
DR   Wikidata; Q54846574
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM13486
AC   CVCL_AW49
DR   CLO; CLO_0012274
DR   BioSample; SAMN00802432
DR   Coriell; GM13486
DR   Wikidata; Q54846575
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM13487
AC   CVCL_5Q04
DR   CLO; CLO_0012271
DR   BioSample; SAMN00802434
DR   Coriell; GM13487
DR   Wikidata; Q54846576
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13488
AC   CVCL_5Q05
DR   CLO; CLO_0012337
DR   BioSample; SAMN00802436
DR   Coriell; GM13488
DR   Wikidata; Q54846577
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13489
AC   CVCL_5Q06
DR   CLO; CLO_0012307
DR   BioSample; SAMN00802438
DR   Coriell; GM13489
DR   Wikidata; Q54846578
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13491
AC   CVCL_1K01
SY   HC7; HCG7
DR   CLO; CLO_0012305
DR   Coriell; GM13491
DR   Wikidata; Q54846579
RX   PubMed=2035533;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13492
AC   CVCL_1K02
SY   HC10; HCG10
DR   CLO; CLO_0012302
DR   Coriell; GM13492
DR   Wikidata; Q54846580
RX   PubMed=2035533;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 8
//
ID   GM13495
AC   CVCL_QX33
DR   CLO; CLO_0012301
DR   BioSample; SAMN00802440
DR   Coriell; GM13495
DR   Wikidata; Q54846581
RX   PubMed=35667217;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg394Leu (c.181G>T); Zygosity=Heterozygous (PubMed=35667217).
CC   Derived from site: In situ; Testis, tunica albuginea; UBERON=UBERON_0006610.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84668; Denys-Drash syndrome
DI   ORDO; Orphanet_220; Denys-Drash syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   GM13496
AC   CVCL_9R33
DR   CLO; CLO_0012318
DR   BioSample; SAMN00802442
DR   Coriell; GM13496
DR   Wikidata; Q54846582
RX   PubMed=19127062;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13497
AC   CVCL_9R34
DR   CLO; CLO_0012314
DR   BioSample; SAMN00802444
DR   Coriell; GM13497
DR   Wikidata; Q54846583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13498
AC   CVCL_1S76
SY   Cl 15-1/PB; Cl.15-1
DR   CLO; CLO_0012313
DR   Coriell; GM13498
DR   Wikidata; Q54846584
RX   PubMed=8661140;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13499
AC   CVCL_1S77
SY   Cl 21-2/PB; Cl.21-2
DR   CLO; CLO_0012310
DR   Coriell; GM13499
DR   Wikidata; Q54846585
RX   PubMed=8661140;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13500
AC   CVCL_1S78
SY   Cl 8-1/AMB6; Cl.8-1
DR   CLO; CLO_0012324
DR   Coriell; GM13500
DR   Wikidata; Q54846586
RX   PubMed=8661140;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM13501
AC   CVCL_DE54
SY   Cl-2/DIBA
DR   CLO; CLO_0012369
DR   Coriell; GM13501
DR   Wikidata; Q54846587
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM13502
AC   CVCL_DE55
SY   D6S5
DR   CLO; CLO_0012368
DR   Coriell; GM13502
DR   Wikidata; Q54846588
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM13503
AC   CVCL_1J70
DR   CLO; CLO_0012363
DR   Coriell; GM13503
DR   Wikidata; Q54846589
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13503).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13504
AC   CVCL_1J71
DR   CLO; CLO_0012364
DR   Coriell; GM13504
DR   Wikidata; Q54846590
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13504).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13505
AC   CVCL_1J72
DR   CLO; CLO_0012365
DR   Coriell; GM13505
DR   Wikidata; Q54846591
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13506
AC   CVCL_1J73
DR   CLO; CLO_0012366
DR   Coriell; GM13506
DR   Wikidata; Q54846592
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[48] (c.52CAG(48)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13506).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13507
AC   CVCL_1J74
DR   CLO; CLO_0012357
DR   Coriell; GM13507
DR   Wikidata; Q54846593
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[55] (c.52CAG(55)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13507).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13508
AC   CVCL_1J75
DR   CLO; CLO_0012359
DR   Coriell; GM13508
DR   Wikidata; Q54846594
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[58] (c.52CAG(58)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13508).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13509
AC   CVCL_1J76
DR   CLO; CLO_0012360
DR   Coriell; GM13509
DR   Wikidata; Q54846595
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[70] (c.52CAG(70)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13509).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J84 ! GM21756
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM13510
AC   CVCL_1J77
DR   CLO; CLO_0012362
DR   Coriell; GM13510
DR   Wikidata; Q54846596
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13511
AC   CVCL_1J78
DR   CLO; CLO_0012412
DR   Coriell; GM13511
DR   Wikidata; Q54846597
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13511).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[47] (c.52CAG(47)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13511).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13512
AC   CVCL_1J79
DR   CLO; CLO_0012411
DR   Coriell; GM13512
DR   Wikidata; Q54846598
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13513
AC   CVCL_1J80
DR   CLO; CLO_0012410
DR   Coriell; GM13513
DR   Wikidata; Q54846599
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[49] (c.52CAG(49)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13513).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13514
AC   CVCL_1J81
DR   CLO; CLO_0012408
DR   Coriell; GM13514
DR   Wikidata; Q54846606
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[52] (c.52CAG(52)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13514).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13515
AC   CVCL_1J82
DR   CLO; CLO_0012409
DR   Coriell; GM13515
DR   Wikidata; Q54846607
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[66] (c.52CAG(66)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=GM13515).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J85 ! GM21757
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM13522
AC   CVCL_1K79
DR   BioSample; SAMN00802446
DR   Coriell; GM13522
DR   Wikidata; Q54846608
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg660His (c.1979G>A); ClinVar=VCV000189172; Zygosity=Heterozygous (Coriell=GM13522).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Heterozygous (Coriell=GM13522).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13523
AC   CVCL_4I85
DR   CLO; CLO_0012406
DR   Coriell; GM13523
DR   Wikidata; Q54846609
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13524
AC   CVCL_4I86
DR   CLO; CLO_0012407
DR   Coriell; GM13524
DR   Wikidata; Q54846610
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13525
AC   CVCL_4I87
DR   CLO; CLO_0012402
DR   Coriell; GM13525
DR   Wikidata; Q54846612
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13526
AC   CVCL_4I88
DR   CLO; CLO_0012405
DR   Coriell; GM13526
DR   Wikidata; Q54846613
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13527
AC   CVCL_1K80
DR   CLO; CLO_0012400
DR   BioSample; SAMN00802448
DR   Coriell; GM13527
DR   Wikidata; Q54846614
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13531
AC   CVCL_BT31
DR   CLO; CLO_0012448
DR   BioSample; SAMN00802450
DR   Coriell; GM13531
DR   Wikidata; Q54846615
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; None_reported; -; Zygosity=- (Coriell=GM13531).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM13532
AC   CVCL_AJ80
DR   CLO; CLO_0012445
DR   BioSample; SAMN00802452
DR   Coriell; GM13532
DR   Wikidata; Q54846616
CC   Sequence variation: Mutation; HGNC; HGNC:4195; GCK; Simple; p.Glu279Gln (c.835G>C); ClinVar=VCV000211076; Zygosity=Heterozygous (Coriell=GM13532).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129741; Glucokinase-associated diabetes mellitus
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM13533
AC   CVCL_1S79
SY   GAT57
DR   CLO; CLO_0012451
DR   Coriell; GM13533
DR   Wikidata; Q54846618
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N80 ! CHO-GAT
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM13534
AC   CVCL_1S80
SY   GATKY10
DR   CLO; CLO_0012450
DR   Coriell; GM13534
DR   Wikidata; Q54846619
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N80 ! CHO-GAT
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM13535
AC   CVCL_1S81
SY   GAT2806B1
DR   CLO; CLO_0012434
DR   Coriell; GM13535
DR   Wikidata; Q54846620
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N80 ! CHO-GAT
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM13536
AC   CVCL_IN31
DR   CLO; CLO_0012435
DR   BioSample; SAMN00802454
DR   Coriell; GM13536
DR   Wikidata; Q54846621
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[43]; Zygosity=Heterozygous; Note=The other allele has 31 repeats (Coriell=GM13536).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM13537
AC   CVCL_IN32
DR   CLO; CLO_0012437
DR   BioSample; SAMN00802456
DR   Coriell; GM13537
DR   Wikidata; Q54846622
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[60]; Zygosity=Heterozygous; Note=The other allele has 32 repeats (Coriell=GM13537).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM13539
AC   CVCL_AV99
DR   CLO; CLO_0012438
DR   BioSample; SAMN00802458
DR   Coriell; GM13539
DR   Wikidata; Q54846623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM13540
AC   CVCL_5Q07
DR   CLO; CLO_0012440
DR   BioSample; SAMN00802460
DR   Coriell; GM13540
DR   Wikidata; Q54846624
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM13542
AC   CVCL_VS75
DR   CLO; CLO_0012442
DR   Coriell; GM13542
DR   Wikidata; Q93831453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient affected with villus adenomas, tubular adenomas and hyperplastic polyps.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM13543
AC   CVCL_VS76
DR   CLO; CLO_0012487
DR   Coriell; GM13543
DR   Wikidata; Q93831459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient affected with cancer of the rectum, hyperplastic polyps and sessile villous adenomas.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM13544
AC   CVCL_1K81
DR   BioSample; SAMN00802462
DR   Coriell; GM13544
DR   Wikidata; Q54846625
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp516Ter (c.1548G>A); ClinVar=VCV000189025; Zygosity=Heterozygous (Coriell=GM13544).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asn520Ser (c.1559A>G); ClinVar=VCV000849167; Zygosity=Heterozygous (Coriell=GM13544).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13546
AC   CVCL_1S82
SY   GAT2806A2
DR   CLO; CLO_0012493
DR   Coriell; GM13546
DR   Wikidata; Q54846626
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N80 ! CHO-GAT
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM13550
AC   CVCL_FV90
DR   CLO; CLO_0012490
DR   BioSample; SAMN00802464
DR   Coriell; GM13550
DR   Wikidata; Q54846628
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM13551
AC   CVCL_EH10
DR   CLO; CLO_0012489
DR   BioSample; SAMN00802466
DR   Coriell; GM13551
DR   Wikidata; Q54846629
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM13552
AC   CVCL_EH11
DR   CLO; CLO_0012488
DR   BioSample; SAMN00802468
DR   Coriell; GM13552
DR   Wikidata; Q54846630
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM13553
AC   CVCL_U537
DR   CLO; CLO_0012479
DR   BioSample; SAMN00802470
DR   Coriell; GM13553
DR   Wikidata; Q54846631
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U535 ! GM12134
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM13554
AC   CVCL_5Q08
DR   CLO; CLO_0012480
DR   BioSample; SAMN00802472
DR   Coriell; GM13554
DR   Wikidata; Q54846632
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM13555
AC   CVCL_U538
DR   CLO; CLO_0012476
DR   BioSample; SAMN00802474
DR   Coriell; GM13555
DR   Wikidata; Q54846633
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM13556
AC   CVCL_U539
DR   CLO; CLO_0012477
DR   BioSample; SAMN00802476
DR   Coriell; GM13556
DR   Wikidata; Q54846634
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM13557
AC   CVCL_DS26
DR   CLO; CLO_0012485
DR   Coriell; GM13557
DR   Wikidata; Q54846635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM13558
AC   CVCL_VS77
DR   CLO; CLO_0032942
DR   Coriell; GM13558
DR   Wikidata; Q93831572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient affected with hyperplastic polyps, tubular adenomas and villous adenomas.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM13561
AC   CVCL_1K82
DR   BioSample; SAMN00802478
DR   Coriell; GM13561
DR   Wikidata; Q54846636
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM13561).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Pro482Arg (c.1445C>G); ClinVar=VCV001067574; Zygosity=Heterozygous (Coriell=GM13561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   GM13563
AC   CVCL_VS78
DR   CLO; CLO_0032946
DR   Coriell; GM13563
DR   Wikidata; Q93831591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient affected with hyperplastic polyps, tubular adenomas and colon cancer.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM13567
AC   CVCL_IN33
DR   CLO; CLO_0032944
DR   BioSample; SAMN00802480
DR   Coriell; GM13567
DR   Wikidata; Q54846637
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129980; Neonatal hemochromatosis
DI   ORDO; Orphanet_446; Neonatal hemochromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM13568
AC   CVCL_FV91
DR   CLO; CLO_0032931
DR   BioSample; SAMN00802482
DR   Coriell; GM13568
DR   Wikidata; Q54846638
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM13569
AC   CVCL_FV40
DR   BioSample; SAMN00802484
DR   Coriell; GM13569
DR   Wikidata; Q54846639
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28D
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM13570
AC   CVCL_FV92
DR   CLO; CLO_0032929
DR   BioSample; SAMN00802486
DR   Coriell; GM13570
DR   Wikidata; Q54846641
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM13571
AC   CVCL_FV93
DR   CLO; CLO_0032935
DR   BioSample; SAMN00802488
DR   Coriell; GM13571
DR   Wikidata; Q54846642
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM13574
AC   CVCL_FV41
DR   BioSample; SAMN00802490
DR   Coriell; GM13574
DR   Wikidata; Q54846643
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM13578
AC   CVCL_FV42
DR   BioSample; SAMN00802492
DR   Coriell; GM13578
DR   Wikidata; Q54846644
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM13585
AC   CVCL_VS79
DR   CLO; CLO_0032933
DR   Coriell; GM13585
DR   Wikidata; Q93831680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient affected with hyperplastic polyps, tubular adenomas and villous adenomas.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   GM13588
AC   CVCL_EH12
DR   CLO; CLO_0032938
DR   BioSample; SAMN00802494
DR   Coriell; GM13588
DR   Wikidata; Q54846645
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM13589
AC   CVCL_EH13
DR   CLO; CLO_0032937
DR   BioSample; SAMN00802496
DR   Coriell; GM13589
DR   Wikidata; Q54846646
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM13590
AC   CVCL_5Q09
DR   CLO; CLO_0032939
DR   Coriell; GM13590
DR   Wikidata; Q54846647
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM13591
AC   CVCL_7533
SY   GM 13591
DR   CLO; CLO_0032917
DR   BioSample; SAMN00802498
DR   Coriell; GM13591
DR   Wikidata; Q54846648
RX   PubMed=14709668;
RX   PubMed=16166172;
RX   PubMed=16244288;
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg117His (c.350G>A); ClinVar=VCV000007109; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM13591).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 24
//
ID   GM13597
AC   CVCL_N382
SY   JK2931A
DR   CLO; CLO_0032915
DR   Coriell; GM13597
DR   Wikidata; Q54846649
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13598
AC   CVCL_N383
SY   JK2932A
DR   CLO; CLO_0032913
DR   Coriell; GM13598
DR   Wikidata; Q54846655
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13599
AC   CVCL_N384
SY   JK2934A
DR   CLO; CLO_0032910
DR   Coriell; GM13599
DR   Wikidata; Q54846656
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13600
AC   CVCL_N385
SY   JK2935A; JK2935
DR   CLO; CLO_0032904
DR   Coriell; GM13600
DR   Wikidata; Q54846657
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13601
AC   CVCL_N386
SY   JK2936A
DR   CLO; CLO_0032902
DR   Coriell; GM13601
DR   Wikidata; Q54846658
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13602
AC   CVCL_N387
SY   JK2937A
DR   CLO; CLO_0032900
DR   Coriell; GM13602
DR   Wikidata; Q54846659
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13603
AC   CVCL_N388
SY   JK2938A
DR   CLO; CLO_0032898
DR   Coriell; GM13603
DR   Wikidata; Q54846660
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13604
AC   CVCL_N389
SY   JK2939A
DR   CLO; CLO_0032909
DR   Coriell; GM13604
DR   Wikidata; Q54846661
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13605
AC   CVCL_N390
SY   JK2940A
DR   CLO; CLO_0032906
DR   Coriell; GM13605
DR   Wikidata; Q54846662
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13606
AC   CVCL_N391
SY   JK2941A
DR   CLO; CLO_0033008
DR   Coriell; GM13606
DR   Wikidata; Q54846663
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Atayal.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13607
AC   CVCL_N392
SY   JK2994A
DR   CLO; CLO_0033002
DR   Coriell; GM13607
DR   Wikidata; Q54846664
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13608
AC   CVCL_N393
SY   JK2995A
DR   CLO; CLO_0033001
DR   Coriell; GM13608
DR   Wikidata; Q54846665
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13609
AC   CVCL_N394
SY   JK2996A
DR   CLO; CLO_0033007
DR   Coriell; GM13609
DR   Wikidata; Q54846666
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13610
AC   CVCL_N395
SY   JK2997A
DR   CLO; CLO_0033004
DR   Coriell; GM13610
DR   Wikidata; Q54846667
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13611
AC   CVCL_N396
SY   JK2998A
DR   CLO; CLO_0032995
DR   Coriell; GM13611
DR   Wikidata; Q54846668
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13612
AC   CVCL_N397
SY   JK2999A
DR   CLO; CLO_0032993
DR   Coriell; GM13612
DR   Wikidata; Q54846669
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13613
AC   CVCL_N398
SY   JK3000A
DR   CLO; CLO_0033000
DR   Coriell; GM13613
DR   Wikidata; Q54846670
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13614
AC   CVCL_N399
SY   JK3001A
DR   CLO; CLO_0032997
DR   Coriell; GM13614
DR   Wikidata; Q54846671
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13615
AC   CVCL_N400
SY   JK3002A
DR   CLO; CLO_0032990
DR   Coriell; GM13615
DR   Wikidata; Q54846672
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13616
AC   CVCL_N401
SY   JK3003A
DR   CLO; CLO_0032977
DR   Coriell; GM13616
DR   Wikidata; Q54846673
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Chinese/Asian ethnic group: Ami.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13617
AC   CVCL_N402
SY   JK3156A
DR   CLO; CLO_0032976
DR   Coriell; GM13617
DR   GEO; GSM207792
DR   Wikidata; Q54846674
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   GM13618
AC   CVCL_N403
SY   JK3157A
DR   CLO; CLO_0032975
DR   Coriell; GM13618
DR   GEO; GSM207793
DR   Wikidata; Q54846675
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   GM13619
AC   CVCL_N404
SY   JK3158A
DR   CLO; CLO_0032974
DR   Coriell; GM13619
DR   GEO; GSM207794
DR   Wikidata; Q54846676
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   GM13620
AC   CVCL_N405
SY   JK3159A; JK3159
DR   CLO; CLO_0032973
DR   Coriell; GM13620
DR   Wikidata; Q54846677
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13622
AC   CVCL_N406
SY   JK3161A
DR   CLO; CLO_0032971
DR   Coriell; GM13622
DR   Wikidata; Q54846678
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13623
AC   CVCL_N407
SY   JK3162A
DR   CLO; CLO_0032969
DR   Coriell; GM13623
DR   Wikidata; Q54846679
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13624
AC   CVCL_N408
SY   JK3163A
DR   CLO; CLO_0032967
DR   Coriell; GM13624
DR   Wikidata; Q54846680
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13625
AC   CVCL_N409
SY   JK3164A
DR   CLO; CLO_0032964
DR   Coriell; GM13625
DR   Wikidata; Q54846681
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13626
AC   CVCL_N410
SY   JK3168A; JK3168
DR   CLO; CLO_0032963
DR   Coriell; GM13626
DR   Wikidata; Q54846682
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13628
AC   CVCL_UY73
DR   CLO; CLO_0032711
DR   BioSample; SAMN00802500
DR   Coriell; GM13628
DR   Wikidata; Q93832019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Donor and sister have tubular adenomas; brother with lymphoma; mother with breast cancer.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   GM13629
AC   CVCL_UY74
DR   CLO; CLO_0032709
DR   BioSample; SAMN00802502
DR   Coriell; GM13629
DR   Wikidata; Q93832022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   GM13635
AC   CVCL_JE39
DR   CLO; CLO_0032710
DR   BioSample; SAMN00802504
DR   Coriell; GM13635
DR   Wikidata; Q54846683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3060; Glomus tumor
DI   ORDO; Orphanet_391651; Glomus tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM13636
AC   CVCL_AN02
DR   CLO; CLO_0032714
DR   BioSample; SAMN00802506
DR   Coriell; GM13636
DR   Wikidata; Q54846684
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM13639
AC   CVCL_DS27
DR   CLO; CLO_0032715
DR   BioSample; SAMN00802508
DR   Coriell; GM13639
DR   Wikidata; Q54846685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13643
AC   CVCL_DS28
DR   CLO; CLO_0032712
DR   BioSample; SAMN00802510
DR   Coriell; GM13643
DR   Wikidata; Q54846686
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13649
AC   CVCL_N209
SY   GM17175
DR   CLO; CLO_0014033
DR   CLO; CLO_0032713
DR   BioSample; SAMN00802512
DR   Coriell; GM13649
DR   Coriell; GM17175
DR   GEO; GSM569747
DR   GEO; GSM596239
DR   GEO; GSM597034
DR   GEO; GSM924685
DR   Wikidata; Q54846687
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM13652
AC   CVCL_1L73
SY   AT128AIV3
DR   CLO; CLO_0032717
DR   BioSample; SAMN00802514
DR   Coriell; GM13652
DR   Wikidata; Q54846688
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp57Ter (c.170G>A); ClinVar=VCV000127341; Zygosity=Heterozygous (Coriell=GM13652).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Heterozygous (Coriell=GM13652).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13653
AC   CVCL_1K83
DR   BioSample; SAMN00802516
DR   Coriell; GM13653
DR   Wikidata; Q54846689
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM13653).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly309Arg (c.925G>A); ClinVar=VCV000188797; Zygosity=Heterozygous (Coriell=GM13653).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13661
AC   CVCL_1L74
SY   AT399AIV2
DR   CLO; CLO_0032718
DR   BioSample; SAMN00802518
DR   Coriell; GM13661
DR   Wikidata; Q54846690
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2993Ter (c.8977C>T); ClinVar=VCV000186330; Zygosity=Heterozygous (Coriell=GM13661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13664
AC   CVCL_AY36
DR   CLO; CLO_0032716
DR   Coriell; GM13664
DR   Wikidata; Q54846691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM13666
AC   CVCL_JF00
DR   CLO; CLO_0032689
DR   BioSample; SAMN00802520
DR   Coriell; GM13666
DR   Wikidata; Q54846692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM13667
AC   CVCL_1L33
SY   S1095
DR   CLO; CLO_0032690
DR   Coriell; GM13667
DR   Wikidata; Q54846694
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Ile582fs (c.1748_1749delAG) (1893_1894delAG); Zygosity=Hemizygous (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13668
AC   CVCL_1L34
SY   S1401
DR   CLO; CLO_0032691
DR   Coriell; GM13668
DR   Wikidata; Q54846695
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.His218fs (c.657_661delTATCT) (798_802delATCTT); Zygosity=Hemizygous (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13669
AC   CVCL_1L35
SY   S1190
DR   CLO; CLO_0032692
DR   Coriell; GM13669
DR   Wikidata; Q54846704
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; IVS8DS+2,T>C; Zygosity=Hemizygous; Note=Exon skipping mutation (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM13670
AC   CVCL_1L36
SY   S1407
DR   CLO; CLO_0032693
DR   Coriell; GM13670
DR   Wikidata; Q54846705
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Gly727Arg (c.2179G>A); ClinVar=VCV000210418; Zygosity=Hemizygous (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13671
AC   CVCL_1L37
SY   S1286
DR   CLO; CLO_0032694
DR   Coriell; GM13671
DR   Wikidata; Q54846706
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Arg645Ter (c.1933C>T); ClinVar=VCV000210404; Zygosity=Hemizygous (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13672
AC   CVCL_7534
SY   S1433
DR   CLO; CLO_0032695
DR   Coriell; GM13672
DR   Wikidata; Q54846707
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; c.1948_1949insAAGAT (ataagAT>ataagATAAGAT junction 2091/2092); Zygosity=Hemizygous (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   GM13674
AC   CVCL_1L38
SY   S1560
DR   CLO; CLO_0032696
DR   Coriell; GM13674
DR   Wikidata; Q54846708
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; p.Gln167Ter (c.499C>T); ClinVar=VCV002138615; Zygosity=Hemizygous (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM13675
AC   CVCL_1L39
SY   S1488
DR   CLO; CLO_0032697
DR   Coriell; GM13675
DR   Wikidata; Q54846709
RX   PubMed=7977350;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Simple; c.4006-2A>G (IVS20AS-2,A>G); Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=7977350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13678
AC   CVCL_JF01
DR   CLO; CLO_0032698
DR   BioSample; SAMN00802522
DR   Coriell; GM13678
DR   Wikidata; Q54846710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM13681
AC   CVCL_9R96
DR   CLO; CLO_0032743
DR   BioSample; SAMN00802524
DR   Coriell; GM13681
DR   Wikidata; Q54846711
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM13683
AC   CVCL_1L75
SY   AT400AIV3
DR   CLO; CLO_0032756
DR   BioSample; SAMN00802526
DR   Coriell; GM13683
DR   Wikidata; Q54846712
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1267_Val1268insTer (c.3802delG) (p.Val1268Terfs); ClinVar=VCV000127374; Zygosity=Unspecified (Coriell=GM13683).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13685
AC   CVCL_2U29
DR   CLO; CLO_0032757
DR   BioSample; SAMN00802528
DR   Coriell; GM13685
DR   Wikidata; Q54846713
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13686
AC   CVCL_2U30
DR   CLO; CLO_0032754
DR   BioSample; SAMN00802530
DR   Coriell; GM13686
DR   Wikidata; Q54846714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM13687
AC   CVCL_2U31
DR   CLO; CLO_0032755
DR   BioSample; SAMN00802532
DR   Coriell; GM13687
DR   Wikidata; Q54846715
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13688
AC   CVCL_2U32
DR   CLO; CLO_0032752
DR   BioSample; SAMN00802534
DR   Coriell; GM13688
DR   Wikidata; Q54846717
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13689
AC   CVCL_2U33
DR   CLO; CLO_0032753
DR   BioSample; SAMN00802536
DR   Coriell; GM13689
DR   Wikidata; Q54846718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM13691
AC   CVCL_1L76
SY   AT380AIV2
DR   CLO; CLO_0032750
DR   BioSample; SAMN00802538
DR   Coriell; GM13691
DR   Wikidata; Q54846719
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.901+1G>A (IVS9+1G>A); ClinVar=VCV000186761; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM13691).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8988-2A>G (IVS64-2A>G); ClinVar=VCV000185326; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM13691).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   GM13692
AC   CVCL_1L77
SY   AT380AIV1
DR   CLO; CLO_0032751
DR   BioSample; SAMN00802540
DR   Coriell; GM13692
DR   Wikidata; Q54846720
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.901+1G>A (IVS9+1G>A); ClinVar=VCV000186761; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM13692).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8988-2A>G (IVS64-2A>G); ClinVar=VCV000185326; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM13692).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   GM13693
AC   CVCL_DB86
DR   CLO; CLO_0032758
DR   BioSample; SAMN00802542
DR   Coriell; GM13693
DR   Wikidata; Q54846721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13694
AC   CVCL_FG75
DR   CLO; CLO_0032726
DR   BioSample; SAMN00802544
DR   Coriell; GM13694
DR   Wikidata; Q54846722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13695
AC   CVCL_FV94
DR   CLO; CLO_0032724
DR   BioSample; SAMN00802546
DR   Coriell; GM13695
DR   Wikidata; Q54846723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13696
AC   CVCL_0H23
SY   JH262
DR   CLO; CLO_0032735
DR   Coriell; GM13696
DR   Wikidata; Q54846724
RX   PubMed=7713507;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 3 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   GM13697
AC   CVCL_0G26
SY   JH142.I
DR   CLO; CLO_0032736
DR   Coriell; GM13697
DR   Wikidata; Q54846725
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM13698
AC   CVCL_JE94
DR   CLO; CLO_0032737
DR   BioSample; SAMN00802548
DR   Coriell; GM13698
DR   Wikidata; Q54846726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM13703
AC   CVCL_JE95
DR   CLO; CLO_0032738
DR   BioSample; SAMN00802550
DR   Coriell; GM13703
DR   Wikidata; Q54846728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient affected with infiltrating ductal carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   GM13705
AC   CVCL_7535
DR   CLO; CLO_0032731
DR   BioSample; SAMN00802552
DR   Coriell; GM13705
DR   Wikidata; Q54846730
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ser1253Argfs*10 (c.3752_3755GTCT[1]) (c.3756_3759delGTCT); ClinVar=VCV000017673; Zygosity=Unspecified (Coriell=GM13705).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM13706
AC   CVCL_5A79
SY   GM13706A
DR   Coriell; GM13706
DR   Wikidata; Q54846732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM13706; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   GM13707
AC   CVCL_5A71
DR   CLO; CLO_0032732
DR   BioSample; SAMN00802554
DR   Coriell; GM13707
DR   Wikidata; Q54846733
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Leu392Glnfs (c.1175_1214del40); Zygosity=Unspecified (Coriell=GM13707).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM13708
AC   CVCL_7536
DR   CLO; CLO_0032733
DR   Coriell; GM13708
DR   Wikidata; Q54846735
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Tyr1563Ter (c.4689C>G); ClinVar=VCV000037607; Zygosity=Unspecified (Coriell=GM13708).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM13709
AC   CVCL_7537
DR   CLO; CLO_0032734
DR   BioSample; SAMN00802556
DR   Coriell; GM13709
DR   Wikidata; Q54846737
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Arg691Aspfs*10 (c.2071delA); ClinVar=VCV000037444; Zygosity=Unspecified (Coriell=GM13709).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM13710
AC   CVCL_5A72
DR   CLO; CLO_0032784
DR   BioSample; SAMN00802558
DR   Coriell; GM13710
DR   Wikidata; Q54846739
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Arg1443Gly (c.4327C>G); ClinVar=VCV000017676; Zygosity=Unspecified (Coriell=GM13710).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM13711
AC   CVCL_5A73
DR   CLO; CLO_0032780
DR   BioSample; SAMN00802560
DR   Coriell; GM13711
DR   Wikidata; Q54846742
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ser1040Asn (c.3119G>A); ClinVar=VCV000017670; Zygosity=Unspecified (Coriell=GM13711).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM13712
AC   CVCL_7538
DR   CLO; CLO_0032782
DR   BioSample; SAMN00802562
DR   Coriell; GM13712
DR   Wikidata; Q54846744
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu720Argfs*6 (c.2157dupA); ClinVar=VCV000054478; Zygosity=Unspecified (Coriell=GM13712).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM13713
AC   CVCL_5A74
DR   CLO; CLO_0032795
DR   BioSample; SAMN00802564
DR   Coriell; GM13713
DR   Wikidata; Q54846746
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu1250Ter (c.3748G>T); ClinVar=VCV000017672; Zygosity=Unspecified (Coriell=GM13713).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   GM13714
AC   CVCL_5A75
SY   GM13714A
DR   CLO; CLO_0032794
DR   BioSample; SAMN00802566
DR   Coriell; GM13714
DR   Wikidata; Q54846747
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Asn1774Glnfs*56 (c.5319dupC); ClinVar=VCV000055523; Zygosity=Unspecified (Coriell=GM13714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM13715
AC   CVCL_W413
DR   CLO; CLO_0032793
DR   BioSample; SAMN00802568
DR   Coriell; GM13715
DR   Wikidata; Q54846748
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Unspecified (Coriell=GM13715).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 20
//
ID   GM13716
AC   CVCL_T902
DR   CLO; CLO_0032792
DR   BioSample; SAMN00802570
DR   Coriell; GM13716
DR   Wikidata; Q54846749
RX   PubMed=23364790;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3033; ATN1; Repeat_expansion; CAG[68] (g.17267CAG[(54-68)]); ClinVar=VCV000590267; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[16] (Coriell=GM13716).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   GM13717
AC   CVCL_T905
DR   CLO; CLO_0032798
DR   BioSample; SAMN00802572
DR   Coriell; GM13717
DR   Wikidata; Q54846750
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3033; ATN1; Repeat_expansion; CAG[65] (g.17267CAG[(54-68)]); ClinVar=VCV000590267; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[15] (Coriell=GM13717).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   GM13720
AC   CVCL_UI20
DR   Coriell; GM13720
DR   Wikidata; Q93832361
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2547_Ser2549del (c.7638_7646delTAGAATTTC) (7636del9); ClinVar=VCV000003019; Zygosity=Unspecified (PubMed=16166284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM13720; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   GM13721
AC   CVCL_5Q10
DR   CLO; CLO_0032797
DR   BioSample; SAMN00802574
DR   Coriell; GM13721
DR   Wikidata; Q54846751
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM13730
AC   CVCL_FV95
DR   CLO; CLO_0032796
DR   BioSample; SAMN00802576
DR   Coriell; GM13730
DR   Wikidata; Q54846752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13732
AC   CVCL_2U34
DR   CLO; CLO_0032761
DR   BioSample; SAMN00802578
DR   Coriell; GM13732
DR   Wikidata; Q54846753
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13733
AC   CVCL_2U35
DR   CLO; CLO_0032762
DR   BioSample; SAMN00802580
DR   Coriell; GM13733
DR   Wikidata; Q54846754
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13734
AC   CVCL_2U36
DR   CLO; CLO_0032764
DR   BioSample; SAMN00802582
DR   Coriell; GM13734
DR   Wikidata; Q54846767
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13740
AC   CVCL_8A62
DR   CLO; CLO_0032767
DR   BioSample; SAMN00802584
DR   Coriell; GM13740
DR   Wikidata; Q54846768
RX   PubMed=8078883;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Homoplasmic (Coriell=GM13740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM13741
AC   CVCL_8A63
DR   CLO; CLO_0032774
DR   BioSample; SAMN00802586
DR   Coriell; GM13741
DR   Wikidata; Q54846769
RX   PubMed=8078883;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Heteroplasmic (Coriell=GM13741).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM13743
AC   CVCL_2U37
DR   CLO; CLO_0032773
DR   BioSample; SAMN00802588
DR   Coriell; GM13743
DR   Wikidata; Q54846770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM13744
AC   CVCL_2U38
DR   CLO; CLO_0032776
DR   BioSample; SAMN00802590
DR   Coriell; GM13744
DR   Wikidata; Q54846771
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13750
AC   CVCL_FG76
DR   CLO; CLO_0032775
DR   BioSample; SAMN00802592
DR   Coriell; GM13750
DR   Wikidata; Q54846772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13762
AC   CVCL_1L78
SY   AT401AIV2
DR   CLO; CLO_0032778
DR   BioSample; SAMN00802594
DR   Coriell; GM13762
DR   Wikidata; Q54846773
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr2333Asnfs*40 (c.6997dupA) (6997insA); ClinVar=VCV000140818; Zygosity=Heterozygous (Coriell=GM13762).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser2855_Val2856delinsArgIle (c.8565_8566delTGinsAA) (8565TG>AA); ClinVar=VCV000140897; Zygosity=Heterozygous (Coriell=GM13762).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   GM13764
AC   CVCL_JF50
DR   CLO; CLO_0032777
DR   BioSample; SAMN00802596
DR   Coriell; GM13764
DR   Wikidata; Q54846775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM13764; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM13765
AC   CVCL_1L79
SY   AT403AIV3
DR   CLO; CLO_0033492
DR   BioSample; SAMN00802598
DR   Coriell; GM13765
DR   Wikidata; Q54846776
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2136Ter (c.6404_6405insTT) (p.Leu2135_Arg2136insTer) (6404insTT); ClinVar=VCV000220763; Zygosity=Heterozygous (Coriell=GM13765).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8786+1G>A (IVS62+1G>A) (c.8672del115) (G2891fsX); ClinVar=VCV000127463; Zygosity=Heterozygous; Note=Splice donor mutation. Causes in-frame skipping of exon 62 (Coriell=GM13765).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   GM13767
AC   CVCL_DS29
DR   CLO; CLO_0033493
DR   BioSample; SAMN00802600
DR   Coriell; GM13767
DR   Wikidata; Q54846777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13768
AC   CVCL_F319
SY   GM17241
DR   CLO; CLO_0014411
DR   CLO; CLO_0033485
DR   BioSample; SAMN00802602
DR   Coriell; GM13768
DR   Coriell; GM17241
DR   GEO; GSM569582
DR   GEO; GSM596305
DR   GEO; GSM596664
DR   GEO; GSM924843
DR   Wikidata; Q54846778
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM13774
AC   CVCL_1L80
DR   CLO; CLO_0033487
DR   BioSample; SAMN00802604
DR   Coriell; GM13774
DR   Wikidata; Q54846779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13780
AC   CVCL_CZ41
DR   CLO; CLO_0033488
DR   BioSample; SAMN00802606
DR   Coriell; GM13780
DR   Wikidata; Q54846780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13783
AC   CVCL_V480
DR   CLO; CLO_0033491
DR   BioSample; SAMN00802608
DR   Coriell; GM13783
DR   Wikidata; Q54846781
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM13783; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM13785
AC   CVCL_1L81
SY   AT314AIV2
DR   CLO; CLO_0033476
DR   BioSample; SAMN00802610
DR   Coriell; GM13785
DR   Wikidata; Q54846782
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1839Ter (c.5515C>T); ClinVar=VCV000189177; Zygosity=Heterozygous (Coriell=GM13785).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser1905Ilefs*26 (c.5712dupA) (5712insA); ClinVar=VCV000141416; Zygosity=Heterozygous (Coriell=GM13785).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13786
AC   CVCL_DS30
DR   CLO; CLO_0033478
DR   BioSample; SAMN00802612
DR   Coriell; GM13786
DR   Wikidata; Q54846783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13787
AC   CVCL_N210
SY   GM17059
DR   CLO; CLO_0014661
DR   CLO; CLO_0033481
DR   BioSample; SAMN00802614
DR   Coriell; GM13787
DR   Coriell; GM17059
DR   Wikidata; Q54846784
CC   Part of: Human variation panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM13789
AC   CVCL_DS31
DR   CLO; CLO_0033482
DR   BioSample; SAMN00802616
DR   Coriell; GM13789
DR   Wikidata; Q54846785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13790
AC   CVCL_DS32
DR   CLO; CLO_0033471
DR   BioSample; SAMN00802618
DR   Coriell; GM13790
DR   Wikidata; Q54846786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13791
AC   CVCL_1L82
SY   AT322AIV5
DR   CLO; CLO_0033469
DR   BioSample; SAMN00802620
DR   Coriell; GM13791
DR   Wikidata; Q54846787
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile1581Asnfs*5 (c.4741dupA) (4742insA); ClinVar=VCV000453535; Zygosity=Heterozygous (Coriell=GM13791).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13792
AC   CVCL_1L83
DR   CLO; CLO_0033470
DR   BioSample; SAMN00802622
DR   Coriell; GM13792
DR   Wikidata; Q54846788
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.3993+1G>A (IVS28+1G>A) (IVS26+1G>A); ClinVar=VCV000141447; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM13792).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   GM13793
AC   CVCL_1K84
DR   BioSample; SAMN00802624
DR   Coriell; GM13793
DR   Wikidata; Q54846789
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-2A>G; ClinVar=VCV000972817; Zygosity=Heterozygous (Coriell=GM13793).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly293Arg (c.877G>A); ClinVar=VCV000004036; Zygosity=Heterozygous (Coriell=GM13793).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13794
AC   CVCL_4I89
DR   CLO; CLO_0033467
DR   Coriell; GM13794
DR   Wikidata; Q54846790
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13795
AC   CVCL_4I90
DR   CLO; CLO_0033468
DR   Coriell; GM13795
DR   Wikidata; Q54846791
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13796
AC   CVCL_4I91
DR   CLO; CLO_0033462
DR   Coriell; GM13796
DR   Wikidata; Q54846792
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13797
AC   CVCL_4I92
DR   CLO; CLO_0033465
DR   Coriell; GM13797
DR   Wikidata; Q54846793
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13798
AC   CVCL_4I93
DR   CLO; CLO_0033458
DR   Coriell; GM13798
DR   Wikidata; Q54846794
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13799
AC   CVCL_4I94
DR   CLO; CLO_0033460
DR   Coriell; GM13799
DR   Wikidata; Q54846795
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13800
AC   CVCL_4I95
DR   CLO; CLO_0033456
DR   Coriell; GM13800
DR   Wikidata; Q54846796
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13801
AC   CVCL_1L84
DR   CLO; CLO_0033613
DR   BioSample; SAMN00802626
DR   Coriell; GM13801
DR   Wikidata; Q54846797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13802
AC   CVCL_1L85
DR   CLO; CLO_0033612
DR   BioSample; SAMN00802628
DR   Coriell; GM13802
DR   Wikidata; Q54846798
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu762Valfs*2 (c.2282_2283CT[1]) (c.2284_2285delCT); ClinVar=VCV000141325; Zygosity=Heterozygous (Coriell=GM13802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13803
AC   CVCL_1L86
DR   CLO; CLO_0033618
DR   BioSample; SAMN00802630
DR   Coriell; GM13803
DR   Wikidata; Q54846799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13804
AC   CVCL_1L87
DR   CLO; CLO_0033616
DR   BioSample; SAMN00802632
DR   Coriell; GM13804
DR   Wikidata; Q54846800
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13805
AC   CVCL_1L88
SY   AT394AIV1
DR   CLO; CLO_0033621
DR   BioSample; SAMN00802634
DR   Coriell; GM13805
DR   Wikidata; Q54846802
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Val410Ala (c.1229T>C); ClinVar=VCV000127332; Zygosity=Heterozygous (Coriell=GM13805).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.6736del20ins2; Zygosity=Heterozygous (Coriell=GM13805).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13806
AC   CVCL_DS33
DR   CLO; CLO_0033620
DR   BioSample; SAMN00802636
DR   Coriell; GM13806
DR   Wikidata; Q54846803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13808
AC   CVCL_DB87
DR   CLO; CLO_0033626
DR   Coriell; GM13808
DR   Wikidata; Q54846804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM13810
AC   CVCL_1L89
DR   CLO; CLO_0033623
DR   BioSample; SAMN00802638
DR   Coriell; GM13810
DR   Wikidata; Q54846805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13811
AC   CVCL_1L90
SY   GM13811A
DR   CLO; CLO_0033628
DR   BioSample; SAMN00802640
DR   Coriell; GM13811
DR   Wikidata; Q54846807
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13812
AC   CVCL_1L91
DR   CLO; CLO_0033627
DR   BioSample; SAMN00802642
DR   Coriell; GM13812
DR   Wikidata; Q54846808
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13813
AC   CVCL_1L92
DR   CLO; CLO_0033589
DR   BioSample; SAMN00802644
DR   Coriell; GM13813
DR   Wikidata; Q54846809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13814
AC   CVCL_1L93
DR   CLO; CLO_0033597
DR   BioSample; SAMN00802646
DR   Coriell; GM13814
DR   Wikidata; Q54846813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13815
AC   CVCL_1L94
DR   CLO; CLO_0033595
DR   BioSample; SAMN00802648
DR   Coriell; GM13815
DR   Wikidata; Q54846814
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13816
AC   CVCL_1L95
DR   CLO; CLO_0033594
DR   BioSample; SAMN00802650
DR   Coriell; GM13816
DR   Wikidata; Q54846815
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13818
AC   CVCL_UH47
DR   CLO; CLO_0033605
DR   BioSample; SAMN00802654
DR   Coriell; GM13818
DR   Wikidata; Q93832686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from an infant with primary hyperoxaluria and oxalosis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   GM13819
AC   CVCL_1L96
DR   CLO; CLO_0033604
DR   BioSample; SAMN00802656
DR   Coriell; GM13819
DR   Wikidata; Q54846817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13820
AC   CVCL_N411
SY   JK3489
DR   CLO; CLO_0033601
DR   Coriell; GM13820
DR   Wikidata; Q54846818
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 13
//
ID   GM13821
AC   CVCL_N412
SY   JK3490
DR   CLO; CLO_0033600
DR   Coriell; GM13821
DR   Wikidata; Q54846819
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 13
//
ID   GM13822
AC   CVCL_N413
SY   JK3493
DR   CLO; CLO_0033608
DR   Coriell; GM13822
DR   Wikidata; Q54846820
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 13
//
ID   GM13823
AC   CVCL_N414
SY   JK3494
DR   CLO; CLO_0033568
DR   Coriell; GM13823
DR   Wikidata; Q54846821
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 13
//
ID   GM13824
AC   CVCL_N415
SY   JK3495
DR   CLO; CLO_0033567
DR   Coriell; GM13824
DR   Wikidata; Q54846822
RX   PubMed=14583597;
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 13
//
ID   GM13825
AC   CVCL_N416
SY   JK3496
DR   CLO; CLO_0033562
DR   Coriell; GM13825
DR   Wikidata; Q54846823
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13826
AC   CVCL_N417
SY   JK3497
DR   CLO; CLO_0033560
DR   Coriell; GM13826
DR   Wikidata; Q54846824
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13827
AC   CVCL_N418
SY   JK3498
DR   CLO; CLO_0033565
DR   Coriell; GM13827
DR   Wikidata; Q54846825
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13828
AC   CVCL_N419
SY   JK3499
DR   CLO; CLO_0033563
DR   Coriell; GM13828
DR   Wikidata; Q54846826
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13829
AC   CVCL_N420
SY   JK3500
DR   CLO; CLO_0033574
DR   Coriell; GM13829
DR   Wikidata; Q54846827
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13830
AC   CVCL_N421
SY   JK3502
DR   CLO; CLO_0033572
DR   Coriell; GM13830
DR   Wikidata; Q54846828
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13831
AC   CVCL_N422
SY   JK3503
DR   CLO; CLO_0033578
DR   Coriell; GM13831
DR   Wikidata; Q54846829
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13832
AC   CVCL_N423
SY   JK3504
DR   CLO; CLO_0033576
DR   Coriell; GM13832
DR   Wikidata; Q54846830
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13833
AC   CVCL_N424
SY   JK3505
DR   CLO; CLO_0033538
DR   Coriell; GM13833
DR   Wikidata; Q54846831
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13834
AC   CVCL_N425
SY   JK3506
DR   CLO; CLO_0033537
DR   Coriell; GM13834
DR   Wikidata; Q54846832
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13835
AC   CVCL_N426
SY   JK3507
DR   CLO; CLO_0033536
DR   Coriell; GM13835
DR   Wikidata; Q54846833
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13836
AC   CVCL_N427
SY   JK3508
DR   CLO; CLO_0033535
DR   Coriell; GM13836
DR   Wikidata; Q54846834
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13837
AC   CVCL_N428
SY   JK3509
DR   CLO; CLO_0033533
DR   Coriell; GM13837
DR   Wikidata; Q54846835
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13838
AC   CVCL_N429
SY   JK3510
DR   CLO; CLO_0033532
DR   Coriell; GM13838
DR   Wikidata; Q54846836
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13839
AC   CVCL_N430
SY   JK3511
DR   CLO; CLO_0033529
DR   Coriell; GM13839
DR   Wikidata; Q54846837
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13840
AC   CVCL_N431
SY   JK3512
DR   CLO; CLO_0033548
DR   Coriell; GM13840
DR   Wikidata; Q54846838
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13841
AC   CVCL_N432
SY   JK3513
DR   CLO; CLO_0033546
DR   Coriell; GM13841
DR   Wikidata; Q54846839
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13842
AC   CVCL_N433
SY   JK3514
DR   CLO; CLO_0033543
DR   Coriell; GM13842
DR   Wikidata; Q54846840
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13843
AC   CVCL_N434
SY   JK3515
DR   CLO; CLO_0033323
DR   Coriell; GM13843
DR   Wikidata; Q54846841
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13844
AC   CVCL_N435
SY   JK3516
DR   CLO; CLO_0033326
DR   Coriell; GM13844
DR   Wikidata; Q54846842
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13845
AC   CVCL_N436
SY   JK3517
DR   CLO; CLO_0033320
DR   Coriell; GM13845
DR   Wikidata; Q54846843
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13846
AC   CVCL_N437
SY   JK3518
DR   CLO; CLO_0033321
DR   Coriell; GM13846
DR   Wikidata; Q54846844
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13847
AC   CVCL_N438
SY   JK3521
DR   CLO; CLO_0033334
DR   Coriell; GM13847
DR   Wikidata; Q54846845
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13848
AC   CVCL_N439
SY   JK3523
DR   CLO; CLO_0033337
DR   Coriell; GM13848
DR   Wikidata; Q54846846
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13849
AC   CVCL_N440
SY   JK3524
DR   CLO; CLO_0033328
DR   Coriell; GM13849
DR   Wikidata; Q54846847
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13850
AC   CVCL_N441
SY   JK3525
DR   CLO; CLO_0033333
DR   Coriell; GM13850
DR   Wikidata; Q54846849
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13851
AC   CVCL_N442
SY   JK3526
DR   CLO; CLO_0033312
DR   Coriell; GM13851
DR   Wikidata; Q54846850
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13852
AC   CVCL_N443
SY   JK3527
DR   CLO; CLO_0033314
DR   Coriell; GM13852
DR   Wikidata; Q54846851
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13853
AC   CVCL_N444
SY   JK3528
DR   CLO; CLO_0033265
DR   Coriell; GM13853
DR   Wikidata; Q54846852
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13854
AC   CVCL_N445
SY   JK3529
DR   CLO; CLO_0033278
DR   Coriell; GM13854
DR   Wikidata; Q54846853
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13855
AC   CVCL_N446
SY   JK3530
DR   CLO; CLO_0033280
DR   Coriell; GM13855
DR   Wikidata; Q54846864
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13856
AC   CVCL_N447
SY   JK3531
DR   CLO; CLO_0033282
DR   Coriell; GM13856
DR   Wikidata; Q54846865
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13857
AC   CVCL_N448
SY   JK3532
DR   CLO; CLO_0033285
DR   Coriell; GM13857
DR   Wikidata; Q54846866
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13858
AC   CVCL_N449
SY   JK3533
DR   CLO; CLO_0033288
DR   Coriell; GM13858
DR   Wikidata; Q54846867
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13859
AC   CVCL_1L97
DR   CLO; CLO_0033290
DR   BioSample; SAMN00802658
DR   Coriell; GM13859
DR   Wikidata; Q54846869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13860
AC   CVCL_1L98
DR   CLO; CLO_0033295
DR   BioSample; SAMN00802660
DR   Coriell; GM13860
DR   Wikidata; Q54846870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13861
AC   CVCL_1L99
DR   CLO; CLO_0033296
DR   BioSample; SAMN00802662
DR   Coriell; GM13861
DR   Wikidata; Q54846871
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8418+5_8418+8delGTGA (IVS59+5_IVS59+8delGTGA) (IVS59+1del4); ClinVar=VCV000181866; Zygosity=Unspecified (Coriell=GM13861).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13862
AC   CVCL_1M00
DR   CLO; CLO_0033269
DR   BioSample; SAMN00802664
DR   Coriell; GM13862
DR   Wikidata; Q54846872
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Unexplicit; IVS19-21del3; Zygosity=Unspecified (Coriell=GM13862).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13863
AC   CVCL_DS34
DR   CLO; CLO_0033220
DR   BioSample; SAMN00802666
DR   Coriell; GM13863
DR   Wikidata; Q54846873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13864
AC   CVCL_IP53
DR   CLO; CLO_0033219
DR   BioSample; SAMN00802668
DR   Coriell; GM13864
DR   Wikidata; Q54846874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   GM13866
AC   CVCL_1M01
DR   CLO; CLO_0033252
DR   BioSample; SAMN00802670
DR   Coriell; GM13866
DR   Wikidata; Q54846875
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13867
AC   CVCL_1M02
DR   CLO; CLO_0033257
DR   BioSample; SAMN00802672
DR   Coriell; GM13867
DR   Wikidata; Q54846876
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM13868
AC   CVCL_1M03
DR   CLO; CLO_0033248
DR   BioSample; SAMN00802674
DR   Coriell; GM13868
DR   Wikidata; Q54846877
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1017Ter (c.3049C>T); ClinVar=VCV000181992; Zygosity=Heterozygous (Coriell=GM13868).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13869
AC   CVCL_DS35
DR   CLO; CLO_0033250
DR   BioSample; SAMN00802676
DR   Coriell; GM13869
DR   Wikidata; Q54846878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13870
AC   CVCL_DS36
DR   CLO; CLO_0033244
DR   BioSample; SAMN00802678
DR   Coriell; GM13870
DR   Wikidata; Q54846879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13871
AC   CVCL_1M04
DR   CLO; CLO_0033245
DR   BioSample; SAMN00802680
DR   Coriell; GM13871
DR   Wikidata; Q54846880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13872
AC   CVCL_1M05
DR   CLO; CLO_0033238
DR   BioSample; SAMN00802682
DR   Coriell; GM13872
DR   Wikidata; Q54846881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13873
AC   CVCL_1M06
DR   CLO; CLO_0033241
DR   BioSample; SAMN00802684
DR   Coriell; GM13873
DR   GEO; GSM1116573
DR   GEO; GSM1116574
DR   GEO; GSM1116617
DR   GEO; GSM1116618
DR   GEO; GSM1116619
DR   GEO; GSM1116620
DR   Wikidata; Q54846882
RX   PubMed=23943852;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM13874
AC   CVCL_N450
SY   JK3501
DR   CLO; CLO_0033179
DR   Coriell; GM13874
DR   Wikidata; Q54846883
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13875
AC   CVCL_N451
SY   JK3519
DR   CLO; CLO_0033184
DR   Coriell; GM13875
DR   Wikidata; Q54846884
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13876
AC   CVCL_N452
SY   JK3534
DR   CLO; CLO_0033182
DR   Coriell; GM13876
DR   Wikidata; Q54846885
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13877
AC   CVCL_N453
SY   JK3535
DR   CLO; CLO_0033208
DR   Coriell; GM13877
DR   Wikidata; Q54846886
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13878
AC   CVCL_1M07
DR   CLO; CLO_0033210
DR   BioSample; SAMN00802686
DR   Coriell; GM13878
DR   Wikidata; Q54846887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13879
AC   CVCL_1M08
DR   CLO; CLO_0033214
DR   BioSample; SAMN00802688
DR   Coriell; GM13879
DR   Wikidata; Q54846888
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8418+5_8418+8delGTGA (IVS59+5_IVS59+8delGTGA) (IVS59+1del4); ClinVar=VCV000181866; Zygosity=Homozygous (Coriell=GM13879).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13880
AC   CVCL_5Q11
DR   CLO; CLO_0033217
DR   BioSample; SAMN00802690
DR   Coriell; GM13880
DR   Wikidata; Q54846889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13882
AC   CVCL_1M09
DR   CLO; CLO_0033197
DR   BioSample; SAMN00802692
DR   Coriell; GM13882
DR   Wikidata; Q54846890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13883
AC   CVCL_1M10
DR   CLO; CLO_0033199
DR   BioSample; SAMN00802694
DR   Coriell; GM13883
DR   Wikidata; Q54846891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13885
AC   CVCL_HL79
DR   BioSample; SAMN00802696
DR   Coriell; GM13885
DR   Wikidata; Q54846892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM13886
AC   CVCL_HL90
DR   BioSample; SAMN00802698
DR   Coriell; GM13886
DR   Wikidata; Q54846893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM13887
AC   CVCL_HL91
DR   BioSample; SAMN00802700
DR   Coriell; GM13887
DR   Wikidata; Q54846894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM13890
AC   CVCL_4I96
DR   CLO; CLO_0033203
DR   Coriell; GM13890
DR   Wikidata; Q54846895
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   GM13891
AC   CVCL_HJ81
DR   Coriell; GM13891
DR   Wikidata; Q54846896
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM13893
AC   CVCL_5Q12
DR   CLO; CLO_0033957
DR   BioSample; SAMN00802702
DR   Coriell; GM13893
DR   Wikidata; Q54846897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13894
AC   CVCL_EG48
DR   CLO; CLO_0033959
DR   BioSample; SAMN00802704
DR   Coriell; GM13894
DR   Wikidata; Q54846898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C87069; Cleft palate
DI   ORDO; Orphanet_2014; Cleft palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13895
AC   CVCL_5Q13
DR   CLO; CLO_0033961
DR   BioSample; SAMN00802706
DR   Coriell; GM13895
DR   Wikidata; Q54846899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13896
AC   CVCL_EG49
DR   CLO; CLO_0033964
DR   BioSample; SAMN00802708
DR   Coriell; GM13896
DR   Wikidata; Q54846900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C87069; Cleft palate
DI   ORDO; Orphanet_2014; Cleft palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM13897
AC   CVCL_5Q14
DR   CLO; CLO_0033967
DR   BioSample; SAMN00802710
DR   Coriell; GM13897
DR   Wikidata; Q54846901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13898
AC   CVCL_1M11
DR   CLO; CLO_0033970
DR   BioSample; SAMN00802712
DR   Coriell; GM13898
DR   Wikidata; Q54846902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13899
AC   CVCL_1M12
DR   CLO; CLO_0033971
DR   BioSample; SAMN00802714
DR   Coriell; GM13899
DR   Wikidata; Q54846903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM139
AC   CVCL_B4FT
DR   IARC_TP53; 21045
DR   Wikidata; Q110432815
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM13906
AC   CVCL_1M13
DR   CLO; CLO_0033973
DR   BioSample; SAMN00802716
DR   Coriell; GM13906
DR   Wikidata; Q54846904
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1331His (c.3993G>C); ClinVar=VCV000221142; Zygosity=Heterozygous; Note=Causes in-frame skipping of exon 28 (Coriell=GM13906).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13907
AC   CVCL_1M14
DR   CLO; CLO_0033974
DR   BioSample; SAMN00802720
DR   Coriell; GM13907
DR   Wikidata; Q54846910
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys750Lys (c.2250G>A); ClinVar=VCV000003044; Zygosity=Heterozygous; Note=Causes skipping of exon 14 (p.Ile709_Lys750del, c.2125_2250del) (Coriell=GM13907).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Unexplicit; IVS49-2A>G; Zygosity=Heterozygous; Note=Causes in-frame skipping of exon 50 (Met2315del38) (Coriell=GM13907).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13909
AC   CVCL_1M15
DR   CLO; CLO_0033917
DR   BioSample; SAMN00802722
DR   Coriell; GM13909
DR   Wikidata; Q54846911
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1978Ter (c.5932G>T); ClinVar=VCV000127414; Zygosity=Heterozygous (Coriell=GM13909).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13910
AC   CVCL_1M16
DR   CLO; CLO_0033924
DR   BioSample; SAMN00802724
DR   Coriell; GM13910
DR   Wikidata; Q54846912
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1978Ter (c.5932G>T); ClinVar=VCV000127414; Zygosity=Heterozygous (Coriell=GM13910).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM13911
AC   CVCL_N454
SY   JK3491
DR   CLO; CLO_0033926
DR   Coriell; GM13911
DR   Wikidata; Q54846914
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13912
AC   CVCL_N455
SY   JK3492
DR   CLO; CLO_0033935
DR   Coriell; GM13912
DR   Wikidata; Q54846915
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13913
AC   CVCL_N456
SY   JK3520
DR   CLO; CLO_0033937
DR   Coriell; GM13913
DR   Wikidata; Q54846916
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13914
AC   CVCL_N457
SY   JK3522
DR   CLO; CLO_0033928
DR   Coriell; GM13914
DR   Wikidata; Q54846917
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13915
AC   CVCL_N458
SY   JK3536
DR   CLO; CLO_0033932
DR   Coriell; GM13915
DR   Wikidata; Q54846918
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 12
//
ID   GM13919
AC   CVCL_5Q15
DR   CLO; CLO_0033943
DR   BioSample; SAMN00802726
DR   Coriell; GM13919
DR   Wikidata; Q54846919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13920
AC   CVCL_1M17
SY   AT306AIV5
DR   CLO; CLO_0033944
DR   BioSample; SAMN00802728
DR   Coriell; GM13920
DR   Wikidata; Q54846920
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp57Ter (c.170G>A); ClinVar=VCV000127341; Zygosity=Heterozygous (Coriell=GM13920).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1466Ter (c.4396C>T); ClinVar=VCV000236716; Zygosity=Heterozygous (Coriell=GM13920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13921
AC   CVCL_1M18
DR   CLO; CLO_0033938
DR   BioSample; SAMN00802730
DR   Coriell; GM13921
DR   Wikidata; Q54846921
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1921Ter (IVS40+1126A>G); Zygosity=Heterozygous (Coriell=GM13921).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13922
AC   CVCL_1M19
DR   CLO; CLO_0033940
DR   BioSample; SAMN00802732
DR   Coriell; GM13922
DR   Wikidata; Q54846922
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg1921Ter (IVS40+1126A>G); Zygosity=Heterozygous (Coriell=GM13922).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13924
AC   CVCL_1M20
DR   CLO; CLO_0034020
DR   BioSample; SAMN00802734
DR   Coriell; GM13924
DR   Wikidata; Q54846923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13925
AC   CVCL_1M21
DR   CLO; CLO_0034022
DR   BioSample; SAMN00802736
DR   Coriell; GM13925
DR   Wikidata; Q54846924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13933
AC   CVCL_FV96
DR   CLO; CLO_0034023
DR   BioSample; SAMN00802738
DR   Coriell; GM13933
DR   Wikidata; Q54846925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13934
AC   CVCL_FV97
DR   CLO; CLO_0034031
DR   BioSample; SAMN00802740
DR   Coriell; GM13934
DR   Wikidata; Q54846926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13935
AC   CVCL_1M22
DR   CLO; CLO_0034034
DR   BioSample; SAMN00802742
DR   Coriell; GM13935
DR   Wikidata; Q54846927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13936
AC   CVCL_AT16
DR   CLO; CLO_0034036
DR   BioSample; SAMN00802744
DR   Coriell; GM13936
DR   Wikidata; Q54846928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM13937
AC   CVCL_GT66
DR   CLO; CLO_0034037
DR   BioSample; SAMN00802746
DR   Coriell; GM13937
DR   Wikidata; Q54846929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13939
AC   CVCL_DS37
DR   CLO; CLO_0034024
DR   Coriell; GM13939
DR   Wikidata; Q54846930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM13940
AC   CVCL_5Q16
DR   CLO; CLO_0034026
DR   BioSample; SAMN00802748
DR   Coriell; GM13940
DR   Wikidata; Q54846931
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM13941
AC   CVCL_1M23
DR   CLO; CLO_0034028
DR   BioSample; SAMN00802750
DR   Coriell; GM13941
DR   Wikidata; Q54846932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13942
AC   CVCL_1M24
DR   CLO; CLO_0033991
DR   BioSample; SAMN00802752
DR   Coriell; GM13942
DR   Wikidata; Q54846933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13943
AC   CVCL_5Q17
DR   CLO; CLO_0033992
DR   BioSample; SAMN00802754
DR   Coriell; GM13943
DR   Wikidata; Q54846934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13944
AC   CVCL_5Q18
DR   CLO; CLO_0033989
DR   BioSample; SAMN00802756
DR   Coriell; GM13944
DR   Wikidata; Q54846935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13945
AC   CVCL_5Q19
DR   CLO; CLO_0033990
DR   BioSample; SAMN00802758
DR   Coriell; GM13945
DR   Wikidata; Q54846936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13946
AC   CVCL_5Q20
DR   CLO; CLO_0034004
DR   BioSample; SAMN00802760
DR   Coriell; GM13946
DR   Wikidata; Q54846937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13947
AC   CVCL_5Q21
DR   CLO; CLO_0034006
DR   BioSample; SAMN00802762
DR   Coriell; GM13947
DR   Wikidata; Q54846938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13948
AC   CVCL_5Q22
DR   CLO; CLO_0034001
DR   BioSample; SAMN00802764
DR   Coriell; GM13948
DR   Wikidata; Q54846939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13949
AC   CVCL_5Q23
DR   CLO; CLO_0034003
DR   BioSample; SAMN00802766
DR   Coriell; GM13949
DR   Wikidata; Q54846940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13950
AC   CVCL_5Q24
DR   CLO; CLO_0033995
DR   BioSample; SAMN00802768
DR   Coriell; GM13950
DR   Wikidata; Q54846941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13951
AC   CVCL_5Q25
DR   CLO; CLO_0033998
DR   BioSample; SAMN00802770
DR   Coriell; GM13951
DR   Wikidata; Q54846942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13952
AC   CVCL_5Q26
DR   CLO; CLO_0033848
DR   BioSample; SAMN00802772
DR   Coriell; GM13952
DR   Wikidata; Q54846943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13954
AC   CVCL_1M25
DR   CLO; CLO_0033850
DR   BioSample; SAMN00802774
DR   Coriell; GM13954
DR   Wikidata; Q54846944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13955
AC   CVCL_FV98
DR   CLO; CLO_0033849
DR   BioSample; SAMN00802776
DR   Coriell; GM13955
DR   Wikidata; Q54846946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13956
AC   CVCL_FV99
DR   CLO; CLO_0033852
DR   BioSample; SAMN00802778
DR   Coriell; GM13956
DR   Wikidata; Q54846947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM13957
AC   CVCL_1M26
DR   CLO; CLO_0033851
DR   BioSample; SAMN00802780
DR   Coriell; GM13957
DR   Wikidata; Q54846948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13958
AC   CVCL_0R43
DR   CLO; CLO_0033844
DR   Coriell; GM13958
DR   Wikidata; Q54846949
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.Gln397Serfs*2 (c.1189delC); ClinVar=VCV000021091; Zygosity=Homozygous (Coriell=GM13958).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM13959
AC   CVCL_5Q27
DR   CLO; CLO_0033843
DR   BioSample; SAMN00802782
DR   Coriell; GM13959
DR   Wikidata; Q54846950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13961
AC   CVCL_1M27
DR   CLO; CLO_0033846
DR   BioSample; SAMN00802784
DR   Coriell; GM13961
DR   Wikidata; Q54846951
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.7630-2A>C (IVS53-2A>C) (IVS51-2A>C) (L2544del53); ClinVar=VCV000127447; Zygosity=Heterozygous; Note=Causes in-frame skipping of exon 54 (Leu2544del53) (Coriell=GM13961).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   GM13963
AC   CVCL_1K85
DR   CLO; CLO_0033845
DR   BioSample; SAMN00802786
DR   Coriell; GM13963
DR   Wikidata; Q54846960
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (Coriell=GM13963).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13964
AC   CVCL_V346
DR   CLO; CLO_0033847
DR   BioSample; SAMN00802788
DR   Coriell; GM13964
DR   Wikidata; Q54846961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84595; Bernard-Soulier syndrome
DI   ORDO; Orphanet_274; Bernard-Soulier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   GM13969
AC   CVCL_1M28
DR   CLO; CLO_0033828
DR   BioSample; SAMN00802789
DR   Coriell; GM13969
DR   Wikidata; Q54846962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13970
AC   CVCL_1M29
DR   CLO; CLO_0033827
DR   BioSample; SAMN00802791
DR   Coriell; GM13970
DR   Wikidata; Q54846963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13972
AC   CVCL_1M30
DR   CLO; CLO_0033832
DR   BioSample; SAMN00802793
DR   Coriell; GM13972
DR   Wikidata; Q54846964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13973
AC   CVCL_1M31
SY   AT406AIV11
DR   CLO; CLO_0033831
DR   BioSample; SAMN00802794
DR   Coriell; GM13973
DR   Wikidata; Q54846965
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1978Ter (c.5932G>T); ClinVar=VCV000127414; Zygosity=Heterozygous (Coriell=GM13973).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp2959Glyfs*3 (c.8876_8879delACTG) (8876del4); ClinVar=VCV000189140; Zygosity=Heterozygous (Coriell=GM13973).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM13976
AC   CVCL_L266
DR   CLO; CLO_0033830
DR   EFO; EFO_0005345
DR   BioSample; SAMN00802796
DR   Coriell; GM13976
DR   ENCODE; ENCBS220AAA
DR   GEO; GSM1008591
DR   Wikidata; Q54846966
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM13976_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM13977 (Cellosaurus=CVCL_L267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   GM13977
AC   CVCL_L267
DR   CLO; CLO_0033829
DR   EFO; EFO_0005346
DR   BioSample; SAMN00802797
DR   Coriell; GM13977
DR   ENCODE; ENCBS221AAA
DR   GEO; GSM1008556
DR   Wikidata; Q54846967
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM13977_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM13976 (Cellosaurus=CVCL_L266).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   GM13984
AC   CVCL_1M32
DR   CLO; CLO_0033826
DR   BioSample; SAMN00802799
DR   Coriell; GM13984
DR   Wikidata; Q54846968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13988
AC   CVCL_5Q28
DR   CLO; CLO_0033825
DR   BioSample; SAMN00802801
DR   Coriell; GM13988
DR   Wikidata; Q54846970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM13989
AC   CVCL_N211
SY   GM17340
DR   CLO; CLO_0013743
DR   CLO; CLO_0033824
DR   BioSample; SAMN00802803
DR   Coriell; GM13989
DR   Coriell; GM17340
DR   GEO; GSM1116575
DR   GEO; GSM1116576
DR   GEO; GSM1116621
DR   GEO; GSM1116622
DR   GEO; GSM1116623
DR   GEO; GSM1116624
DR   Wikidata; Q54846971
RX   PubMed=23943852;
CC   Part of: Human variation panel.
CC   Population: Middle Eastern.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM13992
AC   CVCL_2U39
DR   CLO; CLO_0033823
DR   BioSample; SAMN00802805
DR   Coriell; GM13992
DR   Wikidata; Q54846972
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM13995
AC   CVCL_1M33
DR   CLO; CLO_0033909
DR   BioSample; SAMN00802807
DR   Coriell; GM13995
DR   Wikidata; Q54846973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13996
AC   CVCL_1M34
DR   CLO; CLO_0033912
DR   BioSample; SAMN00802809
DR   Coriell; GM13996
DR   Wikidata; Q54846974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM13997
AC   CVCL_1M35
DR   CLO; CLO_0033910
DR   BioSample; SAMN00802811
DR   Coriell; GM13997
DR   Wikidata; Q54846975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM14000
AC   CVCL_1M36
DR   CLO; CLO_0033904
DR   Coriell; GM14000
DR   Wikidata; Q54846976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14001
AC   CVCL_FW01
DR   CLO; CLO_0033901
DR   Coriell; GM14001
DR   Wikidata; Q54846977
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M1W
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   GM14002
AC   CVCL_CZ42
DR   CLO; CLO_0033907
DR   Coriell; GM14002
DR   Wikidata; Q54846978
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM14003
AC   CVCL_CZ43
DR   CLO; CLO_0033905
DR   Coriell; GM14003
DR   Wikidata; Q54846980
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM14005
AC   CVCL_5Q29
DR   CLO; CLO_0033896
DR   Coriell; GM14005
DR   Wikidata; Q54846981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14006
AC   CVCL_UY71
DR   CLO; CLO_0033894
DR   Coriell; GM14006
DR   Wikidata; Q93833903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C87069; Cleft palate
DI   ORDO; Orphanet_2014; Cleft palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM14007
AC   CVCL_5Q30
DR   CLO; CLO_0033900
DR   Coriell; GM14007
DR   Wikidata; Q54846982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14008
AC   CVCL_1M37
DR   CLO; CLO_0033882
DR   Coriell; GM14008
DR   Wikidata; Q54846983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14010
AC   CVCL_1M38
DR   CLO; CLO_0033881
DR   Coriell; GM14010
DR   Wikidata; Q54846984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14011
AC   CVCL_1K86
DR   Coriell; GM14011
DR   Wikidata; Q54846985
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asn87Glnfs*9 (c.258dupC) (c.251insC); ClinVar=VCV000282842; Zygosity=Heterozygous (Coriell=GM14011).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.1195-8G>A; ClinVar=VCV000570655; Zygosity=Heterozygous (Coriell=GM14011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1L06 ! GM14510
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14013
AC   CVCL_1M39
DR   CLO; CLO_0033880
DR   Coriell; GM14013
DR   Wikidata; Q54846986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14014
AC   CVCL_1M40
DR   CLO; CLO_0033879
DR   Coriell; GM14014
DR   Wikidata; Q54846987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14015
AC   CVCL_1K87
DR   Coriell; GM14015
DR   Wikidata; Q54846988
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-2A>G; ClinVar=VCV000972817; Zygosity=Heterozygous (Coriell=GM14015).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM14016
AC   CVCL_1K88
DR   Coriell; GM14016
DR   Wikidata; Q54846989
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Tyr609Ter (c.1827delC) (p.Arg608_Tyr609insTer); ClinVar=VCV000188936; Zygosity=Heterozygous (Coriell=GM14016).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM14018
AC   CVCL_EH14
DR   CLO; CLO_0033878
DR   Coriell; GM14018
DR   Wikidata; Q54846990
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:11948; TNNT1; Simple; p.Glu180Ter (c.538G>T); ClinVar=VCV000012440; Zygosity=Heterozygous (Coriell=GM14018).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM14023
AC   CVCL_EH15
DR   CLO; CLO_0033876
DR   Coriell; GM14023
DR   Wikidata; Q54846991
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:11948; TNNT1; Simple; p.Glu180Ter (c.538G>T); ClinVar=VCV000012440; Zygosity=Heterozygous (Coriell=GM14023).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM14025
AC   CVCL_EH16
DR   CLO; CLO_0033873
DR   Coriell; GM14025
DR   Wikidata; Q54846992
CC   Sequence variation: Mutation; HGNC; HGNC:11948; TNNT1; Simple; p.Glu180Ter (c.538G>T); ClinVar=VCV000012440; Zygosity=Heterozygous (Coriell=GM14025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM14026
AC   CVCL_EH17
DR   CLO; CLO_0033872
DR   Coriell; GM14026
DR   Wikidata; Q54846993
CC   Sequence variation: Mutation; HGNC; HGNC:11948; TNNT1; Simple; p.Glu180Ter (c.538G>T); ClinVar=VCV000012440; Zygosity=Heterozygous (Coriell=GM14026).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM14031
AC   CVCL_1M41
DR   CLO; CLO_0033870
DR   Coriell; GM14031
DR   Wikidata; Q54846994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14033
AC   CVCL_5Q31
DR   CLO; CLO_0033867
DR   Coriell; GM14033
DR   Wikidata; Q54846995
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14038
AC   CVCL_1M42
DR   CLO; CLO_0033788
DR   Coriell; GM14038
DR   Wikidata; Q54846996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14039
AC   CVCL_1K89
DR   Coriell; GM14039
DR   Wikidata; Q54846997
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg190His (c.569G>A); ClinVar=VCV000188809; Zygosity=Heterozygous (Coriell=GM14039).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly828_Asn882del (c.2481+102_2646+31del) (c.2482_2646del165); Zygosity=Heterozygous (Coriell=GM14039).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14043
AC   CVCL_5Q32
DR   Coriell; GM14043
DR   Wikidata; Q54846998
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14044
AC   CVCL_1J83
DR   CLO; CLO_0033775
DR   Coriell; GM14044
DR   Wikidata; Q54846999
RX   PubMed=32656337;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[750] (c.52CAG(750)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=32656337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   GM14045
AC   CVCL_1K90
DR   Coriell; GM14045
DR   Wikidata; Q54847000
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Met318Thr (c.953T>C); ClinVar=VCV000004021; Zygosity=Heterozygous (Coriell=GM14045).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp746Ser (c.2237G>C); ClinVar=VCV000188484; Zygosity=Heterozygous (Coriell=GM14045).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14046
AC   CVCL_1K91
DR   Coriell; GM14046
DR   Wikidata; Q54847001
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp746Ser (c.2237G>C); ClinVar=VCV000188484; Zygosity=Heterozygous (Coriell=GM14046).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM14047
AC   CVCL_1K92
DR   Coriell; GM14047
DR   Wikidata; Q54847009
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Met318Thr (c.953T>C); ClinVar=VCV000004021; Zygosity=Heterozygous (Coriell=GM14047).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM14049
AC   CVCL_5Q33
DR   CLO; CLO_0033776
DR   Coriell; GM14049
DR   Wikidata; Q54847011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14050
AC   CVCL_1S83
SY   CF25
DR   CLO; CLO_0033773
DR   Coriell; GM14050
DR   Wikidata; Q54847012
RX   PubMed=8314575;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM14051
AC   CVCL_1M43
DR   CLO; CLO_0033774
DR   Coriell; GM14051
DR   Wikidata; Q54847013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14053
AC   CVCL_1M44
DR   CLO; CLO_0033780
DR   Coriell; GM14053
DR   Wikidata; Q54847014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14055
AC   CVCL_5Q34
DR   CLO; CLO_0033777
DR   Coriell; GM14055
DR   Wikidata; Q54847015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14057
AC   CVCL_1K93
DR   Coriell; GM14057
DR   Wikidata; Q54847016
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-2A>G; ClinVar=VCV000972817; Zygosity=Heterozygous (Coriell=GM14057).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Tyr609Ter (c.1827delC) (p.Arg608_Tyr609insTer); ClinVar=VCV000188936; Zygosity=Heterozygous (Coriell=GM14057).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM14058
AC   CVCL_1M45
DR   CLO; CLO_0033778
DR   Coriell; GM14058
DR   Wikidata; Q54847017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14059
AC   CVCL_CZ44
DR   CLO; CLO_0033781
DR   BioSample; SAMN00802870
DR   Coriell; GM14059
DR   Wikidata; Q54847018
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM14060
AC   CVCL_CZ45
DR   CLO; CLO_0033772
DR   BioSample; SAMN00802872
DR   Coriell; GM14060
DR   Wikidata; Q54847019
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM14064
AC   CVCL_1S84
SY   8q-a
DR   CLO; CLO_0033770
DR   Coriell; GM14064
DR   Wikidata; Q54847020
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N34 ! CHO Ade-C
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM14065
AC   CVCL_1S85
SY   21q+
DR   CLO; CLO_0033753
DR   Coriell; GM14065
DR   Wikidata; Q54847021
RX   PubMed=2045096;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U407 ! CHO-glyB
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM14066
AC   CVCL_1M46
DR   CLO; CLO_0033754
DR   Coriell; GM14066
DR   Wikidata; Q54847022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14067
AC   CVCL_1M47
DR   CLO; CLO_0033755
DR   Coriell; GM14067
DR   Wikidata; Q54847023
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu1267_Val1268insTer (c.3802delG) (p.Val1268Terfs); ClinVar=VCV000127374; Zygosity=Unspecified (Coriell=GM14067).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14070
AC   CVCL_1M48
SY   AT340AIB8
DR   CLO; CLO_0033756
DR   Coriell; GM14070
DR   Wikidata; Q54847024
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser1924Ter (c.5771C>A); ClinVar=VCV000429078; Zygosity=Heterozygous (Coriell=GM14070).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp2625_Ala2626delinsGluPro (c.7875_7876delTGinsGC); ClinVar=VCV000003030; Zygosity=Heterozygous (Coriell=GM14070).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM14075
AC   CVCL_EH18
DR   CLO; CLO_0033757
DR   Coriell; GM14075
DR   Wikidata; Q54847025
CC   Sequence variation: Mutation; HGNC; HGNC:11948; TNNT1; Simple; p.Glu180Ter (c.538G>T); ClinVar=VCV000012440; Zygosity=Heterozygous (Coriell=GM14075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM14076
AC   CVCL_EH19
DR   CLO; CLO_0033758
DR   Coriell; GM14076
DR   Wikidata; Q54847026
CC   Sequence variation: Mutation; HGNC; HGNC:11948; TNNT1; Simple; p.Glu180Ter (c.538G>T); ClinVar=VCV000012440; Zygosity=Heterozygous (Coriell=GM14076).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM14080
AC   CVCL_9R52
DR   CLO; CLO_0033759
DR   Coriell; GM14080
DR   Wikidata; Q54847027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101214; Spina bifida
DI   ORDO; Orphanet_268357; Neural tube closure defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14081
AC   CVCL_1K19
DR   CLO; CLO_0033760
DR   Coriell; GM14081
DR   Wikidata; Q54847028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14082
AC   CVCL_9R53
DR   CLO; CLO_0034042
DR   Coriell; GM14082
DR   Wikidata; Q54847029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101214; Spina bifida
DI   ORDO; Orphanet_268357; Neural tube closure defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14083
AC   CVCL_1M49
DR   CLO; CLO_0034041
DR   Coriell; GM14083
DR   Wikidata; Q54847030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14084
AC   CVCL_EF97
DR   CLO; CLO_0034040
DR   Coriell; GM14084
DR   Wikidata; Q54847031
CC   Population: Jewish.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128192; Mosaic variegated aneuploidy syndrome 1
DI   ORDO; Orphanet_1052; Mosaic variegated aneuploidy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14085
AC   CVCL_1M50
DR   CLO; CLO_0034039
DR   Coriell; GM14085
DR   Wikidata; Q54847032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14087
AC   CVCL_1M51
SY   AT409AIV2
DR   CLO; CLO_0034046
DR   Coriell; GM14087
DR   Wikidata; Q54847033
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys750Lys (c.2250G>A); ClinVar=VCV000003044; Zygosity=Heterozygous; Note=Causes skipping of exon 14 (p.Ile709_Lys750del, c.2125_2250del) (Coriell=GM14087).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM14088
AC   CVCL_0Q28
DR   CLO; CLO_0034045
DR   Coriell; GM14088
DR   Wikidata; Q54847034
CC   Population: Caucasian; Russian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q29 ! GM14089
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   GM14089
AC   CVCL_0Q29
DR   CLO; CLO_0034044
DR   Coriell; GM14089
DR   Wikidata; Q54847035
CC   Population: Caucasian; Russian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q28 ! GM14088
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 10
//
ID   GM14090
AC   CVCL_7539
DR   CLO; CLO_0034043
DR   Coriell; GM14090
DR   Wikidata; Q54847036
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu23Valfs*17 (c.68_69delAG) (c.66_67AG[1]) (185delAG); ClinVar=VCV000017662; Zygosity=Unspecified (Coriell=GM14090).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   GM14091
AC   CVCL_5A76
DR   CLO; CLO_0034056
DR   Coriell; GM14091
DR   Wikidata; Q54847037
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Unspecified (Coriell=GM14091).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM14092
AC   CVCL_5A77
DR   CLO; CLO_0034057
DR   Coriell; GM14092
DR   Wikidata; Q54847038
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Val1713Ala (c.5138T>C); ClinVar=VCV000055412; Zygosity=Unspecified (Coriell=GM14092).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM14093
AC   CVCL_5A78
DR   CLO; CLO_0034047
DR   Coriell; GM14093
DR   Wikidata; Q54847039
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu402Serfs*8 (c.1204delG); ClinVar=VCV000054162; Zygosity=Unspecified (Coriell=GM14093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM14094
AC   CVCL_W414
DR   CLO; CLO_0034049
DR   Coriell; GM14094
DR   Wikidata; Q54847040
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Leu392Glnfs (c.1175_1214del40); Zygosity=Unspecified (Coriell=GM14094).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   GM14095
AC   CVCL_W415
DR   CLO; CLO_0034048
DR   Coriell; GM14095
DR   Wikidata; Q54847041
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Val1713Terfs (c.5137delG) (p.Trp1712_Val1713insTer); ClinVar=VCV000055411; Zygosity=Unspecified (Coriell=GM14095).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM14096
AC   CVCL_W416
DR   CLO; CLO_0034051
DR   Coriell; GM14096
DR   Wikidata; Q54847042
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu1161Phefs*3 (c.3481_3491delGAAGATACTAG); ClinVar=VCV000017684; Zygosity=Unspecified (Coriell=GM14096).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   GM14097
AC   CVCL_W417
DR   CLO; CLO_0034050
DR   Coriell; GM14097
DR   Wikidata; Q54847043
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Cys61Gly (c.181T>G); ClinVar=VCV000017661; Zygosity=Unspecified (Coriell=GM14097).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM14100
AC   CVCL_1M52
DR   CLO; CLO_0034053
DR   Coriell; GM14100
DR   Wikidata; Q54847044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14101
AC   CVCL_1M53
DR   CLO; CLO_0034052
DR   Coriell; GM14101
DR   Wikidata; Q54847045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14106
AC   CVCL_5Q35
DR   CLO; CLO_0034055
DR   Coriell; GM14106
DR   Wikidata; Q54847046
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75479; Hypogonadotropic hypogonadism with anosmia
DI   ORDO; Orphanet_478; Kallmann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM14108
AC   CVCL_1K94
DR   Coriell; GM14108
DR   Wikidata; Q54847047
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14108).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM14108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14109
AC   CVCL_BT32
DR   CLO; CLO_0034054
DR   Coriell; GM14109
DR   Wikidata; Q54847048
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; None_reported; -; Zygosity=- (Coriell=GM14109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM14111
AC   CVCL_0G27
SY   JH148
DR   CLO; CLO_0034412
DR   Coriell; GM14111
DR   Wikidata; Q54847049
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V995 ! GM14119
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14113
AC   CVCL_0G28
SY   JH199
DR   CLO; CLO_0034435
DR   Coriell; GM14113
DR   Wikidata; Q54847056
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W001 ! GM14125
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14114
AC   CVCL_V990
SY   JL16
DR   CLO; CLO_0034437
DR   Coriell; GM14114
DR   Wikidata; Q54847057
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM14115
AC   CVCL_V991
SY   JL18
DR   Coriell; GM14115
DR   Wikidata; Q54847058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM14116
AC   CVCL_V992
SY   JL27
DR   CLO; CLO_0034419
DR   Coriell; GM14116
DR   Wikidata; Q54847059
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14117
AC   CVCL_V993
SY   JL30
DR   CLO; CLO_0034422
DR   Coriell; GM14117
DR   Wikidata; Q54847060
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14118
AC   CVCL_V994
SY   JL32
DR   CLO; CLO_0034424
DR   Coriell; GM14118
DR   Wikidata; Q54847061
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14119
AC   CVCL_V995
SY   JL47
DR   CLO; CLO_0034425
DR   Coriell; GM14119
DR   Wikidata; Q54847062
RX   PubMed=8004090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM14120
AC   CVCL_V996
SY   JL54
DR   CLO; CLO_0034427
DR   Coriell; GM14120
DR   Wikidata; Q54847063
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14121
AC   CVCL_V997
SY   JL63
DR   CLO; CLO_0034429
DR   Coriell; GM14121
DR   Wikidata; Q54847064
RX   PubMed=8004090;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM14122
AC   CVCL_V998
SY   JL65
DR   CLO; CLO_0034431
DR   Coriell; GM14122
DR   Wikidata; Q54847065
RX   PubMed=8004090;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM14123
AC   CVCL_V999
SY   JL70
DR   CLO; CLO_0034432
DR   Coriell; GM14123
DR   Wikidata; Q54847066
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14124
AC   CVCL_W000
SY   JL72
DR   CLO; CLO_0034409
DR   Coriell; GM14124
DR   Wikidata; Q54847067
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14125
AC   CVCL_W001
SY   JL106
DR   CLO; CLO_0034405
DR   Coriell; GM14125
DR   Wikidata; Q54847068
RX   PubMed=8004090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM14126
AC   CVCL_W002
SY   JL135
DR   CLO; CLO_0034407
DR   Coriell; GM14126
DR   Wikidata; Q54847069
RX   PubMed=8004090;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM14127
AC   CVCL_W003
SY   JL136
DR   CLO; CLO_0034395
DR   Coriell; GM14127
DR   Wikidata; Q54847071
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14128
AC   CVCL_W004
SY   JL138
DR   CLO; CLO_0034397
DR   Coriell; GM14128
DR   Wikidata; Q54847072
RX   PubMed=8004090;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM14129
AC   CVCL_W005
SY   JL139
DR   CLO; CLO_0034390
DR   Coriell; GM14129
DR   Wikidata; Q54847073
RX   PubMed=8004090;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM14130
AC   CVCL_W006
SY   JL140
DR   CLO; CLO_0034392
DR   Coriell; GM14130
DR   Wikidata; Q54847074
RX   PubMed=8004090;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   GM14131
AC   CVCL_W007
SY   JL142
DR   CLO; CLO_0034401
DR   Coriell; GM14131
DR   Wikidata; Q54847075
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM14134
AC   CVCL_1M54
DR   CLO; CLO_0034402
DR   Coriell; GM14134
DR   Wikidata; Q54847076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14137
AC   CVCL_AW50
DR   CLO; CLO_0034398
DR   Coriell; GM14137
DR   Wikidata; Q54847077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM14138
AC   CVCL_1M55
SY   AT311AIV1
DR   CLO; CLO_0034384
DR   Coriell; GM14138
DR   Wikidata; Q54847078
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1765Ter (c.5293C>T); ClinVar=VCV001073216; Zygosity=Heterozygous (Coriell=GM14138).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14140
AC   CVCL_5Q36
DR   CLO; CLO_0034385
DR   Coriell; GM14140
DR   Wikidata; Q54847079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14142
AC   CVCL_1M56
DR   CLO; CLO_0034387
DR   Coriell; GM14142
DR   Wikidata; Q54847080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14152
AC   CVCL_1M57
DR   CLO; CLO_0034389
DR   Coriell; GM14152
DR   Wikidata; Q54847081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14153
AC   CVCL_1M58
DR   CLO; CLO_0034375
DR   Coriell; GM14153
DR   Wikidata; Q54847082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14155
AC   CVCL_2Z79
DR   CLO; CLO_0034377
DR   Coriell; GM14155
DR   Wikidata; Q54847083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM14157
AC   CVCL_4E10
DR   CLO; CLO_0034379
DR   Coriell; GM14157
DR   Wikidata; Q54847084
CC   Population: Hispanic.
CC   Karyotypic information: 47,XX,+r(16).ish r(16)(D16Z1+) [27]; 48,XX,+r(1).ish r(1)(D1Z5+),+r(16).ish r(16)(D16Z1+) [15]; 47,XX,+r(1).ish r(1)(D1Z5+) [2]; 46,XX [6] (Coriell=GM14157).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM14158
AC   CVCL_1M59
SY   AT414AIV2
DR   CLO; CLO_0034383
DR   Coriell; GM14158
DR   Wikidata; Q54847085
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser1905Ilefs*26 (c.5712dupA) (5712insA); ClinVar=VCV000141416; Zygosity=Heterozygous (Coriell=GM14158).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14162
AC   CVCL_5Q37
DR   CLO; CLO_0034370
DR   Coriell; GM14162
DR   Wikidata; Q54847086
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14163
AC   CVCL_5Q38
DR   CLO; CLO_0034371
DR   Coriell; GM14163
DR   Wikidata; Q54847087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14164
AC   CVCL_5M47
DR   CLO; CLO_0034357
DR   Coriell; GM14164
DR   Wikidata; Q54847088
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM14165
AC   CVCL_JF02
DR   CLO; CLO_0034355
DR   Coriell; GM14165
DR   Wikidata; Q54847089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C87069; Cleft palate
DI   ORDO; Orphanet_2014; Cleft palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM14169
AC   CVCL_1M60
DR   CLO; CLO_0034356
DR   Coriell; GM14169
DR   Wikidata; Q54847090
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr2333Asnfs*40 (c.6997dupA) (6997insA); ClinVar=VCV000140818; Zygosity=Heterozygous (Coriell=GM14169).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8786+1G>A (IVS62+1G>A) (c.8672del115) (G2891fsX); ClinVar=VCV000127463; Zygosity=Heterozygous; Note=Splice donor mutation. Causes in-frame skipping of exon 62 (Coriell=GM14169).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   GM14170
AC   CVCL_7540
DR   CLO; CLO_0034353
DR   Coriell; GM14170
DR   Wikidata; Q54847091
RX   PubMed=19767587;
RX   PubMed=22152194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14171
AC   CVCL_5Q39
DR   CLO; CLO_0034354
DR   Coriell; GM14171
DR   Wikidata; Q54847092
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14172
AC   CVCL_AW51
DR   CLO; CLO_0034348
DR   Coriell; GM14172
DR   Wikidata; Q54847093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM14173
AC   CVCL_AW52
DR   CLO; CLO_0034351
DR   Coriell; GM14173
DR   Wikidata; Q54847094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM14174
AC   CVCL_9R54
DR   CLO; CLO_0034344
DR   Coriell; GM14174
DR   Wikidata; Q54847095
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R55 ! GM14175
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM14175
AC   CVCL_9R55
DR   CLO; CLO_0034345
DR   Coriell; GM14175
DR   Wikidata; Q54847096
CC   Population: Hispanic.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R54 ! GM14174
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM14179
AC   CVCL_AW00
DR   CLO; CLO_0034339
DR   Coriell; GM14179
DR   Wikidata; Q54847102
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   GM14182
AC   CVCL_5Q40
DR   CLO; CLO_0034317
DR   Coriell; GM14182
DR   Wikidata; Q54847103
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14183
AC   CVCL_5Q41
DR   CLO; CLO_0034316
DR   Coriell; GM14183
DR   Wikidata; Q54847104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14184
AC   CVCL_5Q42
DR   CLO; CLO_0034319
DR   Coriell; GM14184
DR   Wikidata; Q54847105
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14213
AC   CVCL_5U18
SY   Line 928
DR   CLO; CLO_0034304
DR   Coriell; GM14213
DR   Wikidata; Q54847107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14217
AC   CVCL_4E11
SY   Line 1111
DR   CLO; CLO_0034283
DR   Coriell; GM14217
DR   Wikidata; Q54847108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM14222
AC   CVCL_5Q43
SY   Line #1328
DR   CLO; CLO_0034276
DR   Coriell; GM14222
DR   Wikidata; Q54847109
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14228
AC   CVCL_0H46
SY   Line #771
DR   CLO; CLO_0034252
DR   Coriell; GM14228
DR   Wikidata; Q54847110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM14230
AC   CVCL_5Q44
SY   Line 1110
DR   CLO; CLO_0034263
DR   Coriell; GM14230
DR   Wikidata; Q54847111
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14234
AC   CVCL_5Q45
SY   Line 1419
DR   CLO; CLO_0034260
DR   Coriell; GM14234
DR   Wikidata; Q54847112
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5P59 ! GM11571
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14236
AC   CVCL_2U40
SY   Line 1594
DR   CLO; CLO_0034258
DR   Coriell; GM14236
DR   Wikidata; Q54847113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM14238
AC   CVCL_5Q46
SY   Line 1418
DR   CLO; CLO_0034265
DR   Coriell; GM14238
DR   Wikidata; Q54847114
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5P58 ! GM11570
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM14239
AC   CVCL_2U41
DR   CLO; CLO_0031113
DR   Coriell; GM14239
DR   Wikidata; Q54847115
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM14242
AC   CVCL_1K95
DR   Coriell; GM14242
DR   Wikidata; Q54847116
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14242).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM14242).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14243
AC   CVCL_5Q47
DR   CLO; CLO_0031110
DR   Coriell; GM14243
DR   Wikidata; Q54847117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14258
AC   CVCL_5Q48
DR   CLO; CLO_0031107
DR   Coriell; GM14258
DR   Wikidata; Q54847118
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14259
AC   CVCL_1K96
DR   Coriell; GM14259
DR   Wikidata; Q54847119
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg594Pro (c.1781G>C); ClinVar=VCV000289361; Zygosity=Heterozygous (Coriell=GM14259).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly828_Asn882del (c.2481+102_2646+31del) (c.2482_2646del165); Zygosity=Heterozygous (Coriell=GM14259).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM14260
AC   CVCL_UI19
DR   Coriell; GM14260
DR   Wikidata; Q93834971
RX   PubMed=16166284;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM14260; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM14266
AC   CVCL_4E12
DR   CLO; CLO_0031108
DR   Coriell; GM14266
DR   Wikidata; Q54847120
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM14267
AC   CVCL_5Q49
DR   CLO; CLO_0031103
DR   Coriell; GM14267
DR   Wikidata; Q54847121
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14268
AC   CVCL_5Q50
DR   CLO; CLO_0031104
DR   Coriell; GM14268
DR   Wikidata; Q54847122
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14274
AC   CVCL_DS38
DR   CLO; CLO_0031082
DR   Coriell; GM14274
DR   Wikidata; Q54847123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14275
AC   CVCL_DS39
DR   CLO; CLO_0031081
DR   Coriell; GM14275
DR   Wikidata; Q54847124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14277
AC   CVCL_DS40
DR   CLO; CLO_0031083
DR   Coriell; GM14277
DR   Wikidata; Q54847125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14278
AC   CVCL_DS41
DR   CLO; CLO_0031092
DR   Coriell; GM14278
DR   Wikidata; Q54847126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14279
AC   CVCL_DS42
DR   CLO; CLO_0031093
DR   Coriell; GM14279
DR   Wikidata; Q54847127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14280
AC   CVCL_DS43
DR   CLO; CLO_0031094
DR   Coriell; GM14280
DR   Wikidata; Q54847128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14281
AC   CVCL_DS44
DR   CLO; CLO_0031095
DR   Coriell; GM14281
DR   Wikidata; Q54847129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14282
AC   CVCL_DS45
DR   CLO; CLO_0031085
DR   Coriell; GM14282
DR   Wikidata; Q54847130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14283
AC   CVCL_DS46
DR   CLO; CLO_0031086
DR   Coriell; GM14283
DR   Wikidata; Q54847131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14286
AC   CVCL_DS47
DR   CLO; CLO_0031089
DR   Coriell; GM14286
DR   Wikidata; Q54847132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14287
AC   CVCL_DS48
DR   CLO; CLO_0031091
DR   Coriell; GM14287
DR   Wikidata; Q54847133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14288
AC   CVCL_DS49
DR   CLO; CLO_0031141
DR   Coriell; GM14288
DR   Wikidata; Q54847134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14289
AC   CVCL_DS50
DR   CLO; CLO_0031140
DR   Coriell; GM14289
DR   Wikidata; Q54847135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14290
AC   CVCL_DS51
DR   CLO; CLO_0031157
DR   Coriell; GM14290
DR   Wikidata; Q54847136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14291
AC   CVCL_5Q51
DR   CLO; CLO_0031144
DR   Coriell; GM14291
DR   Wikidata; Q54847137
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14292
AC   CVCL_5Q52
DR   CLO; CLO_0031145
DR   Coriell; GM14292
DR   Wikidata; Q54847138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14293
AC   CVCL_DS52
DR   CLO; CLO_0031142
DR   Coriell; GM14293
DR   Wikidata; Q54847139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14294
AC   CVCL_DS53
DR   CLO; CLO_0031143
DR   Coriell; GM14294
DR   Wikidata; Q54847140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14295
AC   CVCL_5Q53
DR   CLO; CLO_0031150
DR   Coriell; GM14295
DR   Wikidata; Q54847141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14296
AC   CVCL_5Q54
DR   CLO; CLO_0031152
DR   Coriell; GM14296
DR   Wikidata; Q54847142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14297
AC   CVCL_5Q55
DR   CLO; CLO_0031146
DR   Coriell; GM14297
DR   Wikidata; Q54847149
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14299
AC   CVCL_DS54
DR   CLO; CLO_0031149
DR   Coriell; GM14299
DR   Wikidata; Q54847150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14300
AC   CVCL_DS55
DR   CLO; CLO_0031119
DR   Coriell; GM14300
DR   Wikidata; Q54847151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14301
AC   CVCL_DS56
DR   CLO; CLO_0031136
DR   Coriell; GM14301
DR   Wikidata; Q54847152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14302
AC   CVCL_DS57
DR   CLO; CLO_0031139
DR   Coriell; GM14302
DR   Wikidata; Q54847153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14303
AC   CVCL_DS58
DR   CLO; CLO_0031120
DR   Coriell; GM14303
DR   Wikidata; Q54847154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14304
AC   CVCL_DS59
DR   CLO; CLO_0031121
DR   Coriell; GM14304
DR   Wikidata; Q54847155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14308
AC   CVCL_N212
SY   GM17392; JK3753A
DR   CLO; CLO_0012245
DR   CLO; CLO_0031122
DR   Coriell; GM14308
DR   Coriell; GM17392
DR   Wikidata; Q54847156
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Mexican Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14309
AC   CVCL_N213
SY   GM17393; JK3754A
DR   CLO; CLO_0012246
DR   CLO; CLO_0031123
DR   Coriell; GM14309
DR   Coriell; GM17393
DR   Wikidata; Q54847157
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Mexican Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14310
AC   CVCL_N214
SY   GM17394; JK3755A
DR   CLO; CLO_0012209
DR   CLO; CLO_0031124
DR   Coriell; GM14310
DR   Coriell; GM17394
DR   Wikidata; Q54847158
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Mexican Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14311
AC   CVCL_N215
SY   GM17395; JK3758A
DR   CLO; CLO_0012207
DR   CLO; CLO_0031125
DR   Coriell; GM14311
DR   Coriell; GM17395
DR   Wikidata; Q54847159
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Mexican Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   GM14313
AC   CVCL_N216
SY   GM17396; JK3761A
DR   CLO; CLO_0012216
DR   CLO; CLO_0031126
DR   Coriell; GM14313
DR   Coriell; GM17396
DR   Wikidata; Q54847160
RX   PubMed=11416159;
CC   Part of: Human variation panel.
CC   Part of: Yale-Stanford Collection from NIGMS Human Genetic Cell Repository.
CC   Population: Mexican Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 13
ST   D21S11: 28
ST   D8S1179: 11,14
ST   FGA: 20,26
ST   TH01: 7
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14347
AC   CVCL_DS60
DR   CLO; CLO_0031128
DR   Coriell; GM14347
DR   Wikidata; Q54847161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14348
AC   CVCL_DS61
DR   CLO; CLO_0031161
DR   Coriell; GM14348
DR   Wikidata; Q54847162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14349
AC   CVCL_DS62
DR   CLO; CLO_0031163
DR   Coriell; GM14349
DR   Wikidata; Q54847163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14350
AC   CVCL_DS63
DR   CLO; CLO_0031162
DR   Coriell; GM14350
DR   Wikidata; Q54847164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14351
AC   CVCL_DS64
DR   CLO; CLO_0031165
DR   Coriell; GM14351
DR   Wikidata; Q54847165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14352
AC   CVCL_DS65
DR   CLO; CLO_0031164
DR   Coriell; GM14352
DR   Wikidata; Q54847166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14353
AC   CVCL_DS66
DR   CLO; CLO_0031167
DR   Coriell; GM14353
DR   Wikidata; Q54847167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14354
AC   CVCL_DS67
DR   CLO; CLO_0031166
DR   Coriell; GM14354
DR   Wikidata; Q54847168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14358
AC   CVCL_DS68
DR   CLO; CLO_0031169
DR   Coriell; GM14358
DR   Wikidata; Q54847169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14359
AC   CVCL_DS69
DR   CLO; CLO_0031168
DR   Coriell; GM14359
DR   Wikidata; Q54847170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14360
AC   CVCL_DS70
DR   CLO; CLO_0031170
DR   Coriell; GM14360
DR   Wikidata; Q54847171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14361
AC   CVCL_DS71
DR   CLO; CLO_0031184
DR   Coriell; GM14361
DR   Wikidata; Q54847172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14362
AC   CVCL_DS72
DR   CLO; CLO_0031183
DR   Coriell; GM14362
DR   Wikidata; Q54847173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14363
AC   CVCL_DS73
DR   CLO; CLO_0031182
DR   Coriell; GM14363
DR   Wikidata; Q54847174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14364
AC   CVCL_DS74
DR   CLO; CLO_0031181
DR   Coriell; GM14364
DR   Wikidata; Q54847175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14371
AC   CVCL_DS75
DR   CLO; CLO_0031188
DR   Coriell; GM14371
DR   Wikidata; Q54847176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14372
AC   CVCL_DS76
DR   CLO; CLO_0031187
DR   Coriell; GM14372
DR   Wikidata; Q54847177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14373
AC   CVCL_DS77
DR   CLO; CLO_0031186
DR   Coriell; GM14373
DR   Wikidata; Q54847178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14374
AC   CVCL_DS78
DR   CLO; CLO_0031185
DR   Coriell; GM14374
DR   Wikidata; Q54847179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14375
AC   CVCL_DS79
DR   CLO; CLO_0031190
DR   Coriell; GM14375
DR   Wikidata; Q54847180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14381
AC   CVCL_7541
DR   CLO; CLO_0031189
DR   Coriell; GM14381
DR   GEO; GSM494500
DR   GEO; GSM494501
DR   GEO; GSM957397
DR   Wikidata; Q54847181
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14382 (Cellosaurus=CVCL_7542).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14382
AC   CVCL_7542
DR   CLO; CLO_0031198
DR   Coriell; GM14382
DR   GEO; GSM494502
DR   GEO; GSM494503
DR   GEO; GSM957398
DR   Wikidata; Q54847182
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14381 (Cellosaurus=CVCL_7541).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14383
AC   CVCL_DS80
DR   CLO; CLO_0031193
DR   Coriell; GM14383
DR   Wikidata; Q54847183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14384
AC   CVCL_DS81
DR   CLO; CLO_0031191
DR   Coriell; GM14384
DR   Wikidata; Q54847184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14385
AC   CVCL_DS82
DR   CLO; CLO_0031197
DR   Coriell; GM14385
DR   Wikidata; Q54847185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14386
AC   CVCL_DS83
DR   CLO; CLO_0031194
DR   Coriell; GM14386
DR   Wikidata; Q54847186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14387
AC   CVCL_DS84
DR   CLO; CLO_0031206
DR   Coriell; GM14387
DR   Wikidata; Q54847187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14388
AC   CVCL_DS85
DR   CLO; CLO_0031203
DR   Coriell; GM14388
DR   Wikidata; Q54847188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14389
AC   CVCL_DS86
DR   CLO; CLO_0031209
DR   Coriell; GM14389
DR   Wikidata; Q54847192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14393
AC   CVCL_1K97
DR   Coriell; GM14393
DR   Wikidata; Q54847193
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14393).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly309Arg (c.925G>A); ClinVar=VCV000188797; Zygosity=Heterozygous (Coriell=GM14393).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14396
AC   CVCL_4E13
DR   CLO; CLO_0031207
DR   Coriell; GM14396
DR   Wikidata; Q54847194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM14405
AC   CVCL_7543
DR   CLO; CLO_0031201
DR   Coriell; GM14405
DR   GEO; GSM494504
DR   GEO; GSM494505
DR   Wikidata; Q54847195
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14406 (Cellosaurus=CVCL_7544).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14406
AC   CVCL_7544
DR   CLO; CLO_0031228
DR   Coriell; GM14406
DR   GEO; GSM494506
DR   GEO; GSM494507
DR   Wikidata; Q54847196
RX   PubMed=18485778;
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14405 (Cellosaurus=CVCL_7543).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14407
AC   CVCL_1K98
DR   Coriell; GM14407
DR   Wikidata; Q54847197
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Leu291Phe (c.871C>T); ClinVar=VCV000956209; Zygosity=Heterozygous (Coriell=GM14407).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp481Arg (c.1441T>C); ClinVar=VCV000189007; Zygosity=Heterozygous (Coriell=GM14407).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM14408
AC   CVCL_7545
DR   CLO; CLO_0031227
DR   Coriell; GM14408
DR   GEO; GSM494508
DR   GEO; GSM494509
DR   GEO; GSM957399
DR   Wikidata; Q54847198
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14409 (Cellosaurus=CVCL_7546).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14409
AC   CVCL_7546
DR   CLO; CLO_0031226
DR   Coriell; GM14409
DR   GEO; GSM494510
DR   GEO; GSM494511
DR   GEO; GSM957400
DR   Wikidata; Q54847199
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14408 (Cellosaurus=CVCL_7545).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14411
AC   CVCL_1K99
DR   Coriell; GM14411
DR   Wikidata; Q54847200
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14411).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly309Arg (c.925G>A); ClinVar=VCV000188797; Zygosity=Heterozygous (Coriell=GM14411).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14414
AC   CVCL_7547
DR   CLO; CLO_0031225
DR   Coriell; GM14414
DR   GEO; GSM494512
DR   GEO; GSM494513
DR   Wikidata; Q54847201
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14417 (Cellosaurus=CVCL_7548).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14415
AC   CVCL_1S86
SY   RAJ5B; Raj5
DR   CLO; CLO_0031223
DR   Coriell; GM14415
DR   Wikidata; Q54847202
RX   PubMed=3194801;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N34 ! CHO Ade-C
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   GM14416
AC   CVCL_UY75
SY   R50-3
DR   CLO; CLO_0031222
DR   Coriell; GM14416
DR   Wikidata; Q93835485
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ04 ! CHO Ade-PcG
HI   CVCL_V459 ! GM00144
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM14417
AC   CVCL_7548
DR   CLO; CLO_0031239
DR   Coriell; GM14417
DR   GEO; GSM494514
DR   GEO; GSM494515
DR   Wikidata; Q54847203
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14414 (Cellosaurus=CVCL_7547).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14423
AC   CVCL_1L00
DR   Coriell; GM14423
DR   Wikidata; Q54847204
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14423).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.His308Pro (c.923A>C); ClinVar=VCV001493530; Zygosity=Heterozygous (Coriell=GM14423).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM14427
AC   CVCL_HQ05
DR   Coriell; GM14427
DR   Wikidata; Q54847205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129869; Multiple vascular disruption syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM14428
AC   CVCL_1L01
DR   Coriell; GM14428
DR   Wikidata; Q54847206
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14428).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly638Trp (c.1912G>T); ClinVar=VCV000280954; Zygosity=Heterozygous (Coriell=GM14428).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14432
AC   CVCL_7549
DR   CLO; CLO_0031238
DR   Coriell; GM14432
DR   GEO; GSM494516
DR   GEO; GSM494517
DR   GEO; GSM957401
DR   Wikidata; Q54847207
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14433 (Cellosaurus=CVCL_7550).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14433
AC   CVCL_7550
DR   CLO; CLO_0031236
DR   Coriell; GM14433
DR   GEO; GSM494518
DR   GEO; GSM494519
DR   GEO; GSM957402
DR   Wikidata; Q54847208
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14432 (Cellosaurus=CVCL_7549).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14434
AC   CVCL_1L02
DR   Coriell; GM14434
DR   Wikidata; Q54847209
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14434).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly293Arg (c.877G>A); ClinVar=VCV000004036; Zygosity=Heterozygous (Coriell=GM14434).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14439
AC   CVCL_7551
SY   GM17110
DR   CLO; CLO_0014964
DR   CLO; CLO_0031234
DR   Coriell; GM14439
DR   Coriell; GM17110
DR   GEO; GSM273380
DR   GEO; GSM494452
DR   GEO; GSM494453
DR   GEO; GSM569544
DR   GEO; GSM596178
DR   GEO; GSM596978
DR   GEO; GSM827332
DR   GEO; GSM924620
DR   IPD-IMGT/HLA; 20689
DR   Wikidata; Q54847210
RX   PubMed=16260726;
RX   PubMed=20215515;
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,30:02; B*15:10,35:BEZX; C*03:04,16:01; DRB1*13:03,14:01 (IPD-IMGT/HLA=20689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from monozygotic twin of GM14440 (Cellosaurus=CVCL_7552).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14440
AC   CVCL_7552
DR   CLO; CLO_0031257
DR   Coriell; GM14440
DR   GEO; GSM494454
DR   GEO; GSM494455
DR   Wikidata; Q54847211
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14439 (Cellosaurus=CVCL_7551).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14441
AC   CVCL_F320
SY   GM17111
DR   CLO; CLO_0014947
DR   CLO; CLO_0031258
DR   Coriell; GM14441
DR   Coriell; GM17111
DR   GEO; GSM273381
DR   GEO; GSM569522
DR   GEO; GSM596179
DR   GEO; GSM596979
DR   GEO; GSM924621
DR   IPD-IMGT/HLA; 20684
DR   Wikidata; Q54847212
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:AUX,34:02; B*42:02,58:02; C*06:02,17:MN; DRB1*08:04,11:02 (IPD-IMGT/HLA=20684).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from dizygotic twin of GM14442 (Cellosaurus=CVCL_9Y34).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM14442
AC   CVCL_9Y34
DR   CLO; CLO_0031259
DR   Coriell; GM14442
DR   Wikidata; Q54847213
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM14441 (Cellosaurus=CVCL_F320).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM14445
AC   CVCL_1L03
DR   Coriell; GM14445
DR   Wikidata; Q54847214
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14445).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly638Trp (c.1912G>T); ClinVar=VCV000280954; Zygosity=Heterozygous (Coriell=GM14445).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14447
AC   CVCL_F161
DR   CLO; CLO_0031260
DR   Coriell; GM14447
DR   GEO; GSM494520
DR   GEO; GSM494521
DR   GEO; GSM957403
DR   Wikidata; Q54847215
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14448 (Cellosaurus=CVCL_7553).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   GM14448
AC   CVCL_7553
AS   CVCL_7656
SY   GM17242
DR   CLO; CLO_0014412
DR   CLO; CLO_0031261
DR   Coriell; GM14448
DR   Coriell; GM17242
DR   GEO; GSM494522
DR   GEO; GSM494523
DR   GEO; GSM569583
DR   GEO; GSM596306
DR   GEO; GSM596665
DR   GEO; GSM924844
DR   GEO; GSM957404
DR   Wikidata; Q54847216
RX   PubMed=16260726;
RX   PubMed=20398888;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,32:01:01; B*35:01:01,40:01:02; C*03:04:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:01:01,01:02:01; DQB1*05:01:01,06:04:01; DRB1*01:01:01,13:02:01; DRB3*03:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14447 (Cellosaurus=CVCL_F161).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM14451
AC   CVCL_1M61
DR   CLO; CLO_0031262
DR   Coriell; GM14451
DR   Wikidata; Q54847217
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp2569Ter (c.7703_7704GA[1]) (c.7705_7706delGA) (p.Arg2568_Asp2569insTer); ClinVar=VCV000220550; Zygosity=Heterozygous (Coriell=GM14451).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM14452
AC   CVCL_7554
SY   GM18058
DR   CLO; CLO_0015667
DR   CLO; CLO_0031263
DR   Coriell; GM14452
DR   Coriell; GM18058
DR   GEO; GSM494524
DR   GEO; GSM494525
DR   GEO; GSM957405
DR   Wikidata; Q54847218
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14453 (Cellosaurus=CVCL_7555).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14453
AC   CVCL_7555
DR   CLO; CLO_0031253
DR   Coriell; GM14453
DR   GEO; GSM494526
DR   GEO; GSM494527
DR   GEO; GSM957406
DR   Wikidata; Q54847219
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14452 (Cellosaurus=CVCL_7554).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14454
AC   CVCL_7556
SY   GM17112
DR   CLO; CLO_0014948
DR   CLO; CLO_0031254
DR   Coriell; GM14454
DR   Coriell; GM17112
DR   GEO; GSM273382
DR   GEO; GSM494456
DR   GEO; GSM494457
DR   GEO; GSM569523
DR   GEO; GSM596180
DR   GEO; GSM596980
DR   GEO; GSM924622
DR   IPD-IMGT/HLA; 20679
DR   Wikidata; Q54847220
RX   PubMed=16260726;
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,24:CWFP; B*18:RRG,27:EKN; C*02:02,05:AC; DRB1*04:05,15:01 (IPD-IMGT/HLA=20679).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14455 (Cellosaurus=CVCL_F218).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14455
AC   CVCL_F218
DR   CLO; CLO_0031256
DR   Coriell; GM14455
DR   GEO; GSM494458
DR   GEO; GSM494459
DR   Wikidata; Q54847221
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14454 (Cellosaurus=CVCL_7556).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   GM14463
AC   CVCL_1L04
DR   Coriell; GM14463
DR   Wikidata; Q54847222
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14463).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gln124Serfs*18 (c.366delT); Zygosity=Heterozygous (Coriell=GM14463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14464
AC   CVCL_7557
SY   GM14464A; GM17113
DR   CLO; CLO_0014943
DR   CLO; CLO_0031278
DR   Coriell; GM14464
DR   Coriell; GM17113
DR   GEO; GSM273383
DR   GEO; GSM494460
DR   GEO; GSM494461
DR   GEO; GSM569524
DR   GEO; GSM596181
DR   GEO; GSM596981
DR   GEO; GSM924623
DR   IPD-IMGT/HLA; 15330
DR   Wikidata; Q54847223
RX   PubMed=16260726;
RX   PubMed=20398888;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:01,33:03; B*08:XKT,49:01; C*07:CVAG,07:WTR; DRB1*01:02,10:01 (IPD-IMGT/HLA=15330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14465 (Cellosaurus=CVCL_7558).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM14465
AC   CVCL_7558
DR   CLO; CLO_0031275
DR   Coriell; GM14465
DR   GEO; GSM494462
DR   GEO; GSM494463
DR   Wikidata; Q54847224
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14464 (Cellosaurus=CVCL_7557).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14467
AC   CVCL_7559
SY   GM18059
DR   CLO; CLO_0015698
DR   CLO; CLO_0031276
DR   Coriell; GM14467
DR   Coriell; GM18059
DR   GEO; GSM494528
DR   GEO; GSM494529
DR   GEO; GSM957407
DR   Wikidata; Q54847225
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14468 (Cellosaurus=CVCL_7560).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14468
AC   CVCL_7560
DR   CLO; CLO_0031281
DR   Coriell; GM14468
DR   GEO; GSM494530
DR   GEO; GSM494531
DR   GEO; GSM957408
DR   Wikidata; Q54847226
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14467 (Cellosaurus=CVCL_7559).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14471
AC   CVCL_1M62
DR   CLO; CLO_0031282
DR   Coriell; GM14471
DR   Wikidata; Q54847227
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.7630-2A>C (IVS53-2A>C) (IVS51-2A>C) (L2544del53); ClinVar=VCV000127447; Zygosity=Heterozygous; Note=Splice acceptor mutation. Causes in-frame skipping of exon 54 (Leu2544del53) (Coriell=GM14471).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8786+1G>A (IVS62+1G>A) (c.8672del115) (G2891fsX); ClinVar=VCV000127463; Zygosity=Heterozygous; Note=Splice donor mutation. Causes in-frame skipping of exon 62 (Coriell=GM14471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   GM14472
AC   CVCL_1M63
DR   CLO; CLO_0031279
DR   Coriell; GM14472
DR   Wikidata; Q54847228
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.7630-2A>C (IVS53-2A>C) (IVS51-2A>C) (L2544del53); ClinVar=VCV000127447; Zygosity=Heterozygous; Note=Splice acceptor mutation. Causes in-frame skipping of exon 54 (Leu2544del53) (Coriell=GM14472).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.8786+1G>A (IVS62+1G>A) (c.8672del115) (G2891fsX); ClinVar=VCV000127463; Zygosity=Heterozygous; Note=Splice donor mutation. Causes in-frame skipping of exon 62 (Coriell=GM14472).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   GM14474
AC   CVCL_7561
SY   GM17176
DR   CLO; CLO_0014039
DR   CLO; CLO_0031280
DR   Coriell; GM14474
DR   Coriell; GM17176
DR   GEO; GSM273431
DR   GEO; GSM494464
DR   GEO; GSM494465
DR   GEO; GSM569699
DR   GEO; GSM596240
DR   GEO; GSM597035
DR   GEO; GSM924686
DR   IPD-IMGT/HLA; 23058
DR   Wikidata; Q54847229
RX   PubMed=16260726;
RX   PubMed=17668376;
RX   PubMed=20398888;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,03:DBVX; B*07:CZZS,57:01; C*06:02,07:WCP; DRB1*07:01,15:01 (IPD-IMGT/HLA=23058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14475 (Cellosaurus=CVCL_7562).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM14475
AC   CVCL_7562
SY   GM14475A
DR   CLO; CLO_0031272
DR   Coriell; GM14475
DR   GEO; GSM494466
DR   GEO; GSM494467
DR   Wikidata; Q54847230
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14474 (Cellosaurus=CVCL_7561).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14476
AC   CVCL_7563
SY   GM17177
DR   CLO; CLO_0014037
DR   CLO; CLO_0031274
DR   Coriell; GM14476
DR   Coriell; GM17177
DR   GEO; GSM273432
DR   GEO; GSM494468
DR   GEO; GSM494469
DR   GEO; GSM569700
DR   GEO; GSM596241
DR   GEO; GSM597036
DR   GEO; GSM924687
DR   IPD-IMGT/HLA; 17384
DR   Wikidata; Q54847231
RX   PubMed=16260726;
RX   PubMed=20210923;
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*03:CVAB,33:BEKE; B*42:02,44:03; C*17:MN,18:AB; DRB1*11:01,15:03 (IPD-IMGT/HLA=17384).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14477 (Cellosaurus=CVCL_7564).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14477
AC   CVCL_7564
DR   CLO; CLO_0031531
DR   Coriell; GM14477
DR   GEO; GSM494470
DR   GEO; GSM494471
DR   Wikidata; Q54847239
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14476 (Cellosaurus=CVCL_7563).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14478
AC   CVCL_7565
AS   CVCL_7596
SY   GM18060
DR   CLO; CLO_0015697
DR   CLO; CLO_0031529
DR   Coriell; GM14478
DR   Coriell; GM18060
DR   GEO; GSM494532
DR   GEO; GSM494533
DR   Wikidata; Q54847240
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14479 (Cellosaurus=CVCL_7566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14479
AC   CVCL_7566
AS   CVCL_7597
DR   CLO; CLO_0031535
DR   Coriell; GM14479
DR   GEO; GSM494534
DR   GEO; GSM494535
DR   Wikidata; Q54847241
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14478 (Cellosaurus=CVCL_7565).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14480
AC   CVCL_7567
SY   GM17178
DR   CLO; CLO_0014029
DR   CLO; CLO_0031534
DR   Coriell; GM14480
DR   Coriell; GM17178
DR   GEO; GSM273433
DR   GEO; GSM494472
DR   GEO; GSM494473
DR   GEO; GSM569748
DR   GEO; GSM596242
DR   GEO; GSM597037
DR   GEO; GSM924688
DR   IPD-IMGT/HLA; 17386
DR   Wikidata; Q54847242
RX   PubMed=16260726;
RX   PubMed=20210923;
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*11:BDFZ,74:AB; B*45:AH,52:01; C*16:01; DRB1*13:01,03:01 (IPD-IMGT/HLA=17386).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14481 (Cellosaurus=CVCL_7568).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14481
AC   CVCL_7568
DR   CLO; CLO_0031533
DR   Coriell; GM14481
DR   GEO; GSM494474
DR   GEO; GSM494475
DR   Wikidata; Q54847243
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14480 (Cellosaurus=CVCL_7567).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14483
AC   CVCL_DS87
DR   CLO; CLO_0031532
DR   Coriell; GM14483
DR   Wikidata; Q54847244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14484
AC   CVCL_1L05
DR   Coriell; GM14484
DR   Wikidata; Q54847245
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14484).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gln58Ter (c.172C>T); ClinVar=VCV000188903; Zygosity=Heterozygous (Coriell=GM14484).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14485
AC   CVCL_5Q56
DR   CLO; CLO_0031489
DR   Coriell; GM14485
DR   Wikidata; Q54847246
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14489
AC   CVCL_5Q57
DR   CLO; CLO_0031491
DR   Coriell; GM14489
DR   Wikidata; Q54847248
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM14490
AC   CVCL_F321
DR   CLO; CLO_0031493
DR   Coriell; GM14490
DR   Wikidata; Q54847249
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   GM14492
AC   CVCL_F322
SY   GM17243
DR   CLO; CLO_0014413
DR   CLO; CLO_0031494
DR   Coriell; GM14492
DR   Coriell; GM17243
DR   GEO; GSM569584
DR   GEO; GSM596307
DR   GEO; GSM596666
DR   GEO; GSM924845
DR   Wikidata; Q54847250
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,29:02:01; B*40:01:02,44:03:01; C*03:04:01,16:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,06:01:01; DQA1*01:02:01,02:01:01; DQB1*02:02:01,06:04:01; DRB1*07:01:01,13:02:01; DRB3*03:01:01; DRB4*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM14495
AC   CVCL_7569
DR   Coriell; GM14495
DR   Wikidata; Q54847251
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM14496 (Cellosaurus=CVCL_7570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14496
AC   CVCL_7570
SY   GM14496A
DR   Coriell; GM14496
DR   GEO; GSM924705
DR   Wikidata; Q54847252
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from monozygotic twin of GM14495 (Cellosaurus=CVCL_7569).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14501
AC   CVCL_7571
SY   GM17179
DR   CLO; CLO_0014028
DR   CLO; CLO_0031504
DR   Coriell; GM14501
DR   Coriell; GM17179
DR   GEO; GSM273434
DR   GEO; GSM494476
DR   GEO; GSM494477
DR   GEO; GSM569701
DR   GEO; GSM596243
DR   GEO; GSM597038
DR   GEO; GSM924689
DR   IPD-IMGT/HLA; 20681
DR   Wikidata; Q54847253
RX   PubMed=16260726;
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,02:02; B*15:10,35:BEZX; C*08:04,16:01; DRB1*03:02,11:04 (IPD-IMGT/HLA=20681).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14502 (Cellosaurus=CVCL_7572).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14502
AC   CVCL_F219
DR   CLO; CLO_0031510
DR   Coriell; GM14502
DR   GEO; GSM494478
DR   GEO; GSM494479
DR   Wikidata; Q54847254
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14501 (Cellosaurus=CVCL_7571).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   GM14503
AC   CVCL_7572
SY   GM17180
DR   CLO; CLO_0013751
DR   CLO; CLO_0031509
DR   Coriell; GM14503
DR   Coriell; GM17180
DR   GEO; GSM273435
DR   GEO; GSM494480
DR   GEO; GSM494481
DR   GEO; GSM569702
DR   GEO; GSM596244
DR   GEO; GSM597039
DR   GEO; GSM924690
DR   IPD-IMGT/HLA; 15807
DR   Wikidata; Q54847255
RX   PubMed=16260726;
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,33:BEKE; B*07:CZZS,37:01; C*02:10,07:WCP; DRB1*03:01,07:01 (IPD-IMGT/HLA=15807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14504 (Cellosaurus=CVCL_7573).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14504
AC   CVCL_7573
DR   CLO; CLO_0031516
DR   Coriell; GM14504
DR   GEO; GSM494482
DR   GEO; GSM494483
DR   Wikidata; Q54847256
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14503 (Cellosaurus=CVCL_7572).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14505
AC   CVCL_F220
DR   CLO; CLO_0031514
DR   Coriell; GM14505
DR   Wikidata; Q54847257
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   GM14506
AC   CVCL_7574
SY   GM18061
DR   CLO; CLO_0015696
DR   CLO; CLO_0031519
DR   Coriell; GM14506
DR   Coriell; GM18061
DR   GEO; GSM494536
DR   GEO; GSM494537
DR   GEO; GSM957409
DR   Wikidata; Q54847258
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14507 (Cellosaurus=CVCL_7575).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14507
AC   CVCL_7575
DR   CLO; CLO_0031517
DR   Coriell; GM14507
DR   GEO; GSM494538
DR   GEO; GSM494539
DR   GEO; GSM957410
DR   Wikidata; Q54847259
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14506 (Cellosaurus=CVCL_7574).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14508
AC   CVCL_7576
SY   GM17181
DR   CLO; CLO_0013755
DR   CLO; CLO_0031610
DR   Coriell; GM14508
DR   Coriell; GM17181
DR   GEO; GSM273436
DR   GEO; GSM494484
DR   GEO; GSM494485
DR   GEO; GSM569703
DR   GEO; GSM596245
DR   GEO; GSM597040
DR   GEO; GSM924691
DR   Wikidata; Q54847260
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14509 (Cellosaurus=CVCL_7577).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM14509
AC   CVCL_7577
DR   CLO; CLO_0031609
DR   Coriell; GM14509
DR   GEO; GSM494486
DR   GEO; GSM494487
DR   Wikidata; Q54847262
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14508 (Cellosaurus=CVCL_7576).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14510
AC   CVCL_1L06
DR   Coriell; GM14510
DR   Wikidata; Q54847263
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asn87Glnfs*9 (c.258dupC) (c.251insC); ClinVar=VCV000282842; Zygosity=Heterozygous (Coriell=GM14510).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.1195-8G>A; ClinVar=VCV000570655; Zygosity=Heterozygous (Coriell=GM14510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K86 ! GM14011
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14511
AC   CVCL_7578
SY   GM17182
DR   CLO; CLO_0013754
DR   CLO; CLO_0031608
DR   Coriell; GM14511
DR   Coriell; GM17182
DR   GEO; GSM273437
DR   GEO; GSM569704
DR   GEO; GSM596246
DR   GEO; GSM597041
DR   GEO; GSM924692
DR   Wikidata; Q54847264
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from dizygotic twin of GM14512 (Cellosaurus=CVCL_7579).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14512
AC   CVCL_7579
DR   CLO; CLO_0031617
DR   Coriell; GM14512
DR   Wikidata; Q54847265
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM14511 (Cellosaurus=CVCL_7578).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14513
AC   CVCL_0Q66
DR   CLO; CLO_0031618
DR   Coriell; GM14513
DR   Wikidata; Q54847266
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q67 ! GM14514
SX   Male
AG   10D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GM14514
AC   CVCL_0Q67
DR   CLO; CLO_0031615
DR   Coriell; GM14514
DR   Wikidata; Q54847267
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,rec(3)(qter->p25::q21->qter) (Coriell=GM14514).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0Q66 ! GM14513
SX   Male
AG   10D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   GM14517
AC   CVCL_7580
SY   GM 14517; GM18062
DR   CLO; CLO_0015695
DR   CLO; CLO_0031616
DR   Coriell; GM14517
DR   Coriell; GM18062
DR   Wikidata; Q54847268
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14518
AC   CVCL_U733
DR   CLO; CLO_0031613
DR   Coriell; GM14518
DR   Wikidata; Q54847269
RX   PubMed=18485778;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~925]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM14518).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~1122]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM14518).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM14519
AC   CVCL_0U91
DR   CLO; CLO_0031614
DR   Coriell; GM14519
DR   Wikidata; Q54847270
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[9]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM14519).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~1285]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM14519).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM14520
AC   CVCL_7581
SY   GM18063
DR   CLO; CLO_0015694
DR   CLO; CLO_0031611
DR   Coriell; GM14520
DR   Coriell; GM18063
DR   GEO; GSM494540
DR   GEO; GSM494541
DR   GEO; GSM957411
DR   Wikidata; Q54847271
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14521 (Cellosaurus=CVCL_7582).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14521
AC   CVCL_7582
DR   CLO; CLO_0031612
DR   Coriell; GM14521
DR   GEO; GSM494542
DR   GEO; GSM494543
DR   GEO; GSM957412
DR   Wikidata; Q54847272
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14520 (Cellosaurus=CVCL_7581).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14523
AC   CVCL_2U42
DR   CLO; CLO_0031598
DR   Coriell; GM14523
DR   Wikidata; Q54847273
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM14524
AC   CVCL_2U43
DR   CLO; CLO_0031597
DR   Coriell; GM14524
DR   FANTOM5_SSTAR; 10570-108B3
DR   Wikidata; Q54847274
CC   Misspelling: 15242A; FANTOM5_SSTAR=10570-108B3.
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Uterine smooth muscle cell; CL=CL_0002601.
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   GM14525
AC   CVCL_2U44
DR   CLO; CLO_0031599
DR   Coriell; GM14525
DR   FANTOM5_SSTAR; 10571-108B4
DR   Wikidata; Q54847275
RX   PubMed=23665875;
CC   Karyotypic information: 46,XX,t(12;14)(q?14;q?24).arr(1-22,X)x2 (Coriell=GM14525).
CC   Omics: Variations; CNV analysis.
CC   Misspelling: 15425; FANTOM5_SSTAR=10571-108B4.
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Uterine smooth muscle cell; CL=CL_0002601.
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   GM14526
AC   CVCL_1L07
DR   Coriell; GM14526
DR   Wikidata; Q54847276
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (Coriell=GM14526).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Val939Leufs*78 (c.2815_2816delGT); ClinVar=VCV000371481; Zygosity=Heterozygous (Coriell=GM14526).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14528
AC   CVCL_1L08
DR   Coriell; GM14528
DR   Wikidata; Q54847277
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Val939Leufs*78 (c.2815_2816delGT); ClinVar=VCV000371481; Zygosity=Heterozygous (Coriell=GM14528).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM14529
AC   CVCL_7583
SY   GM17183
DR   CLO; CLO_0013753
DR   CLO; CLO_0031604
DR   Coriell; GM14529
DR   Coriell; GM17183
DR   GEO; GSM273438
DR   GEO; GSM569705
DR   GEO; GSM596247
DR   GEO; GSM597042
DR   GEO; GSM924693
DR   IPD-IMGT/HLA; 16402
DR   Wikidata; Q54847278
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,29:02; B*07:CZZS,44:03; C*07:WCP,16:01; DRB1*07:01,15:01 (IPD-IMGT/HLA=16402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from dizygotic twin of GM14530 (Cellosaurus=CVCL_7584).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14530
AC   CVCL_7584
DR   CLO; CLO_0031605
DR   Coriell; GM14530
DR   Wikidata; Q54847279
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM14529 (Cellosaurus=CVCL_7583).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14532
AC   CVCL_7585
SY   GM17184
DR   CLO; CLO_0013752
DR   CLO; CLO_0031606
DR   Coriell; GM14532
DR   Coriell; GM17184
DR   GEO; GSM273439
DR   GEO; GSM494488
DR   GEO; GSM494489
DR   GEO; GSM569706
DR   GEO; GSM596248
DR   GEO; GSM597043
DR   GEO; GSM924694
DR   Wikidata; Q54847280
RX   PubMed=16260726;
RX   PubMed=20398888;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14533 (Cellosaurus=CVCL_7586).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14533
AC   CVCL_7586
DR   CLO; CLO_0031607
DR   Coriell; GM14533
DR   GEO; GSM494490
DR   GEO; GSM494491
DR   Wikidata; Q54847290
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14532 (Cellosaurus=CVCL_7585).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14535
AC   CVCL_7587
SY   GM17185
DR   CLO; CLO_0013781
DR   CLO; CLO_0031600
DR   Coriell; GM14535
DR   Coriell; GM17185
DR   GEO; GSM273440
DR   GEO; GSM494492
DR   GEO; GSM494493
DR   GEO; GSM569707
DR   GEO; GSM596249
DR   GEO; GSM597044
DR   GEO; GSM924695
DR   Wikidata; Q54847291
RX   PubMed=16260726;
RX   PubMed=20398888;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14536 (Cellosaurus=CVCL_7588).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GM14536
AC   CVCL_7588
DR   CLO; CLO_0031601
DR   Coriell; GM14536
DR   GEO; GSM494494
DR   GEO; GSM494495
DR   Wikidata; Q54847293
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14535 (Cellosaurus=CVCL_7587).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14537
AC   CVCL_7589
SY   GM17114
DR   CLO; CLO_0014945
DR   CLO; CLO_0031602
DR   Coriell; GM14537
DR   Coriell; GM17114
DR   GEO; GSM273384
DR   GEO; GSM569519
DR   GEO; GSM596182
DR   GEO; GSM596982
DR   GEO; GSM924624
DR   IPD-IMGT/HLA; 15332
DR   Wikidata; Q54847294
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:02,11:BDFZ; B*15:17; C*05:AC,07:WTR (IPD-IMGT/HLA=15332).
CC   HLA typing: A*02:02:01,11:01:01; B*15:17:01,15:17:01; C*05:01:01,07:01:02; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:19:01; DRB1*03:01:01,11:02:01; DRB3*02:02:01,02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from dizygotic twin of GM14538 (Cellosaurus=CVCL_7590).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM14538
AC   CVCL_7590
DR   CLO; CLO_0031603
DR   Coriell; GM14538
DR   Wikidata; Q54847295
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM14537 (Cellosaurus=CVCL_7589).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14544
AC   CVCL_DR25
DR   Coriell; GM14544
DR   GEO; GSM924673
DR   Wikidata; Q54847296
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   GM14547
AC   CVCL_7591
SY   GM17244
DR   CLO; CLO_0014414
DR   CLO; CLO_0031586
DR   Coriell; GM14547
DR   Coriell; GM17244
DR   GEO; GSM569585
DR   GEO; GSM596308
DR   GEO; GSM596667
DR   GEO; GSM924846
DR   Wikidata; Q54847297
RX   PubMed=20889555;
RX   PubMed=26621101;
RX   PubMed=29959025;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,30:02:01; B*13:02:01,51:01:01; C*06:02:01,14:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:01,01:03:01; DQB1*06:02:01,06:03:01; DRB1*13:01:01,15:01:01; DRB3*01:01:02; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14548
AC   CVCL_7592
SY   GM17245
DR   CLO; CLO_0014415
DR   CLO; CLO_0031587
DR   Coriell; GM14548
DR   Coriell; GM17245
DR   GEO; GSM569586
DR   GEO; GSM596309
DR   GEO; GSM596668
DR   GEO; GSM924847
DR   Wikidata; Q54847298
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:05:01,68:02:01; B*44:02:01,53:01:01; C*04:01:01,16:04:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:01:02,05:05:01; DQB1*03:01:01,05:01:01; DRB1*01:02:01,11:04:01; DRB3*02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from dizygotic twin of GM14549 (Cellosaurus=CVCL_7593).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM14549
AC   CVCL_7593
DR   CLO; CLO_0031588
DR   Coriell; GM14549
DR   Wikidata; Q54847299
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM14548 (Cellosaurus=CVCL_7592).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14550
AC   CVCL_1L09
DR   Coriell; GM14550
DR   Wikidata; Q54847300
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM14550).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Thr737Asn (c.2210C>A); ClinVar=VCV000972796; Zygosity=Heterozygous (Coriell=GM14550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM14551
AC   CVCL_1L10
DR   Coriell; GM14551
DR   Wikidata; Q54847301
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Thr737Asn (c.2210C>A); ClinVar=VCV000972796; Zygosity=Heterozygous (Coriell=GM14551).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14552
AC   CVCL_1L11
DR   Coriell; GM14552
DR   Wikidata; Q54847302
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM14552).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14553
AC   CVCL_FA40
DR   CLO; CLO_0031591
DR   Coriell; GM14553
DR   Wikidata; Q54847303
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3356; ENPP1; Simple; p.Tyr312Ter (c.936T>G); Zygosity=Heterozygous (Coriell=GM14553).
CC   Sequence variation: Mutation; HGNC; HGNC:3356; ENPP1; Simple; p.Asn792Ser (c.2375A>G); Zygosity=Heterozygous (Coriell=GM14553).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C128805; Generalized arterial calcification of infancy 1
DI   ORDO; Orphanet_51608; Generalized arterial calcification of infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1W
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM14554
AC   CVCL_FA41
DR   CLO; CLO_0031592
DR   Coriell; GM14554
DR   Wikidata; Q54847304
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3356; ENPP1; Simple; p.Asn792Ser (c.2375A>G); Zygosity=Heterozygous (Coriell=GM14554).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM14556
AC   CVCL_EJ63
DR   CLO; CLO_0031589
DR   Coriell; GM14556
DR   Wikidata; Q54847305
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3356; ENPP1; Simple; p.Tyr312Ter (c.936T>G); Zygosity=Heterozygous (Coriell=GM14556).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM14558
AC   CVCL_0F89
SY   JH237
DR   CLO; CLO_0031590
DR   Coriell; GM14558
DR   Wikidata; Q54847306
RX   PubMed=1577474;
RX   PubMed=8488839;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F90 ! GM50113
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14559
AC   CVCL_0H24
SY   JH251
DR   CLO; CLO_0031595
DR   Coriell; GM14559
DR   Wikidata; Q54847307
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14560
AC   CVCL_0H25
SY   JH252
DR   CLO; CLO_0031596
DR   Coriell; GM14560
DR   Wikidata; Q54847308
RX   PubMed=1577474;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1U17 ! GM50322
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14561
AC   CVCL_0F95
SY   JH254
DR   CLO; CLO_0031593
DR   Coriell; GM14561
DR   Wikidata; Q54847309
RX   PubMed=8488839;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F96 ! GM50116
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14562
AC   CVCL_0F87
SY   JH282
DR   CLO; CLO_0031594
DR   Coriell; GM14562
DR   Wikidata; Q54847310
RX   PubMed=8488839;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F88 ! GM50120
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14563
AC   CVCL_0F91
SY   JH306
DR   CLO; CLO_0031576
DR   Coriell; GM14563
DR   Wikidata; Q54847311
RX   PubMed=8488839;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F92 ! GM50122
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14564
AC   CVCL_0F93
SY   JH333
DR   CLO; CLO_0031577
DR   Coriell; GM14564
DR   Wikidata; Q54847312
RX   PubMed=8488839;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F94 ! GM50125
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14565
AC   CVCL_0H26
SY   JH253
DR   CLO; CLO_0031578
DR   Coriell; GM14565
DR   Wikidata; Q54847313
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1U16 ! GM50124
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM14566
AC   CVCL_UY76
SY   HySynSarc
DR   CLO; CLO_0031579
DR   Coriell; GM14566
DR   Wikidata; Q93836214
RX   PubMed=2165233;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR93 ! CHO-CH3S
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM14568
AC   CVCL_7594
DR   CLO; CLO_0031580
DR   Coriell; GM14568
DR   GEO; GSM494544
DR   GEO; GSM494545
DR   GEO; GSM957413
DR   Wikidata; Q54847314
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14569 (Cellosaurus=CVCL_7595).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14569
AC   CVCL_7595
DR   CLO; CLO_0031581
DR   Coriell; GM14569
DR   GEO; GSM494546
DR   GEO; GSM494547
DR   GEO; GSM957414
DR   Wikidata; Q54847315
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14568 (Cellosaurus=CVCL_7594).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14574
AC   CVCL_1L12
DR   Coriell; GM14574
DR   Wikidata; Q54847316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM14579
AC   CVCL_4Z74
DR   CLO; CLO_0031584
DR   Coriell; GM14579
DR   Wikidata; Q54847319
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV002136487; Zygosity=Heterozygous (from familial inference of TTD13PV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   GM14581
AC   CVCL_7598
DR   CLO; CLO_0031585
DR   Coriell; GM14581
DR   GEO; GSM494548
DR   GEO; GSM494549
DR   GEO; GSM957415
DR   Wikidata; Q54847320
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14582 (Cellosaurus=CVCL_7599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14582
AC   CVCL_7599
DR   CLO; CLO_0031666
DR   Coriell; GM14582
DR   GEO; GSM494550
DR   GEO; GSM494551
DR   GEO; GSM957416
DR   Wikidata; Q54847321
RX   PubMed=20398888;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from monozygotic twin of GM14581 (Cellosaurus=CVCL_7598).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14583
AC   CVCL_7600
SY   GM17115
DR   CLO; CLO_0014952
DR   CLO; CLO_0031665
DR   Coriell; GM14583
DR   Coriell; GM17115
DR   GEO; GSM273385
DR   GEO; GSM494496
DR   GEO; GSM494497
DR   GEO; GSM569525
DR   GEO; GSM596183
DR   GEO; GSM596983
DR   GEO; GSM924625
DR   IPD-IMGT/HLA; 15814
DR   Wikidata; Q54847322
RX   PubMed=16260726;
RX   PubMed=20398888;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:02,68:02; B*15:10,57:03; C*03:04,08:02 (IPD-IMGT/HLA=15814).
CC   HLA typing: A*30:02:01,68:02:01; B*15:10:01,57:03:01; C*03:04:02,08:02:01; DPA1*01:03:01,03:NEW-1; DPB1*02:01:19,584:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:04; DRB1*08:04:01,13:03:01; DRB3*01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14584 (Cellosaurus=CVCL_7601).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   GM14584
AC   CVCL_7601
DR   CLO; CLO_0031668
DR   Coriell; GM14584
DR   GEO; GSM494498
DR   GEO; GSM494499
DR   Wikidata; Q54847323
RX   PubMed=20398888;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from monozygotic twin of GM14583 (Cellosaurus=CVCL_7600).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14589
AC   CVCL_EG50
DR   CLO; CLO_0031667
DR   Coriell; GM14589
DR   Wikidata; Q54847324
CC   Population: Peruvian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM14590
AC   CVCL_N217
SY   GM17310
DR   CLO; CLO_0013351
DR   CLO; CLO_0031660
DR   Coriell; GM14590
DR   Coriell; GM17310
DR   Wikidata; Q54847325
CC   Part of: Human variation panel.
CC   Population: Peruvian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM14592
AC   CVCL_7602
DR   CLO; CLO_0031659
DR   Coriell; GM14592
DR   Wikidata; Q54847326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM14593 (Cellosaurus=CVCL_7603).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14593
AC   CVCL_7603
DR   CLO; CLO_0031662
DR   Coriell; GM14593
DR   Wikidata; Q54847327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM14592 (Cellosaurus=CVCL_7602).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14599
AC   CVCL_UY77
DR   CLO; CLO_0031661
DR   Coriell; GM14599
DR   Wikidata; Q93836274
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ05 ! R21-1B
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM14603
AC   CVCL_1L13
DR   Coriell; GM14603
DR   Wikidata; Q54847328
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg224Trp (c.670C>T); ClinVar=VCV000189188; Zygosity=Heterozygous (Coriell=GM14603).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gly828_Asn882del (c.2481+102_2646+31del) (c.2482_2646del165); Zygosity=Heterozygous (Coriell=GM14603).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14604
AC   CVCL_1L14
DR   Coriell; GM14604
DR   Wikidata; Q54847329
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg224Trp (c.670C>T); ClinVar=VCV000189188; Zygosity=Heterozygous (Coriell=GM14604).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM14606
AC   CVCL_0R44
DR   CLO; CLO_0031664
DR   Coriell; GM14606
DR   Wikidata; Q54847330
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.His497Glnfs*90 (c.1472_1487dup16); ClinVar=VCV000005277; Zygosity=Homozygous (Coriell=GM14606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0R45 ! GM14609
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14609
AC   CVCL_0R45
DR   CLO; CLO_0031663
DR   Coriell; GM14609
DR   Wikidata; Q54847338
RX   PubMed=27345974;
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.His497Glnfs*90 (c.1472_1487dup16); ClinVar=VCV000005277; Zygosity=Homozygous (Coriell=GM14609).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0R44 ! GM14606
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM14611
AC   CVCL_7604
SY   GM17030
DR   CLO; CLO_0014708
DR   CLO; CLO_0031684
DR   Coriell; GM14611
DR   Coriell; GM17030
DR   Wikidata; Q54847339
RX   PubMed=11416159;
CC   Part of: Human variation panel.
CC   Population: Indo Pakistani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 11,14
ST   D21S11: 30
ST   D8S1179: 12,13
ST   FGA: 23.2,24
ST   TH01: 6
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   GM14620
AC   CVCL_5A96
DR   CLO; CLO_0031688
DR   Coriell; GM14620
DR   Wikidata; Q54847340
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14620).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14621
AC   CVCL_5A97
DR   CLO; CLO_0031687
DR   Coriell; GM14621
DR   Wikidata; Q54847341
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14621).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14622
AC   CVCL_7605
DR   CLO; CLO_0031686
DR   Coriell; GM14622
DR   Wikidata; Q54847342
RX   PubMed=22152194;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Leu2092Profs*7 (c.6275_6276delTT); ClinVar=VCV000009318; Zygosity=Unspecified (Coriell=GM14622).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   GM14623
AC   CVCL_CW82
DR   CLO; CLO_0031685
DR   Coriell; GM14623
DR   Wikidata; Q54847343
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr42Cys (c.125A>G); ClinVar=VCV000037734; Zygosity=Unspecified; Note=Predicted to be non-pathogenic (Coriell=GM14623).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   GM14624
AC   CVCL_CW83
DR   CLO; CLO_0031682
DR   Coriell; GM14624
DR   Wikidata; Q54847344
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Leu1908Argfs*2 (c.5718_5719CT[2]) (c.5722_5723delCT); ClinVar=VCV000009320; Zygosity=Unspecified (Coriell=GM14624).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   GM14626
AC   CVCL_CW84
DR   CLO; CLO_0031681
DR   Coriell; GM14626
DR   Wikidata; Q54847345
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys3326Ter (c.9976A>T) (10204A>T); ClinVar=VCV000038266; Zygosity=Unspecified (Coriell=GM14626).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   GM14628
AC   CVCL_5A98
DR   CLO; CLO_0031680
DR   Coriell; GM14628
DR   Wikidata; Q54847346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM14631
AC   CVCL_5A99
DR   CLO; CLO_0031679
DR   Coriell; GM14631
DR   Wikidata; Q54847347
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14631).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14632
AC   CVCL_7606
SY   GM17186
DR   CLO; CLO_0013784
DR   CLO; CLO_0031683
DR   Coriell; GM14632
DR   Coriell; GM17186
DR   GEO; GSM569708
DR   GEO; GSM596250
DR   GEO; GSM597045
DR   GEO; GSM924696
DR   IPD-IMGT/HLA; 23059
DR   Wikidata; Q54847348
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*03:CVAB,36:03; B*35:BEZX,53:01; C*04:CVAF,04:CVAF; DRB1*03:02,12:CVT (IPD-IMGT/HLA=23059).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from dizygotic twin of GM14633 (Cellosaurus=CVCL_7607).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM14633
AC   CVCL_7607
DR   CLO; CLO_0031629
DR   Coriell; GM14633
DR   Wikidata; Q54847349
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of GM14632 (Cellosaurus=CVCL_7606).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14634
AC   CVCL_5A80
DR   CLO; CLO_0031628
DR   Coriell; GM14634
DR   Wikidata; Q54847350
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Asn1355Lysfs*10 (c.4065_4068delTCAA) (4184del4); ClinVar=VCV000017674; Zygosity=Unspecified (Coriell=GM14634).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM14636
AC   CVCL_5A81
DR   CLO; CLO_0031625
DR   Coriell; GM14636
DR   Wikidata; Q54847351
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Tyr1853Terfs (c.5558dupA) (p.Tyr1853Ter) (5677insA); ClinVar=VCV000055628; Zygosity=Unspecified (Coriell=GM14636).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM14637
AC   CVCL_5A82
DR   CLO; CLO_0031624
DR   Coriell; GM14637
DR   Wikidata; Q54847352
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Arg1443Ter (c.4327C>T); ClinVar=VCV000017675; Zygosity=Unspecified (Coriell=GM14637).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM14638
AC   CVCL_5A83
DR   CLO; CLO_0031627
DR   Coriell; GM14638
DR   Wikidata; Q54847353
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.213-11T>G (332-11T>G); ClinVar=VCV000037449; Zygosity=Unspecified (Coriell=GM14638).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM14639
AC   CVCL_CW85
DR   CLO; CLO_0031626
DR   Coriell; GM14639
DR   Wikidata; Q54847354
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2067Hisfs*10 (c.6198_6199delTT); ClinVar=VCV000052027; Zygosity=Unspecified (Coriell=GM14639).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM14640
AC   CVCL_5B00
DR   CLO; CLO_0031621
DR   Coriell; GM14640
DR   Wikidata; Q54847355
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14640).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14641
AC   CVCL_N218
SY   GM 14641; GM18064
DR   CLO; CLO_0015693
DR   CLO; CLO_0031620
DR   Coriell; GM14641
DR   Coriell; GM18064
DR   Wikidata; Q54847356
RX   PubMed=16166172;
RX   PubMed=16244288;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Heterozygous; Note=Factor V Leiden (PubMed=16166172).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (Coriell=GM18064).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM18064).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 21
//
ID   GM14643
AC   CVCL_7608
SY   GM18065
DR   CLO; CLO_0015692
DR   CLO; CLO_0031623
DR   Coriell; GM14643
DR   Coriell; GM18065
DR   Wikidata; Q54847357
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM18065; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14646
AC   CVCL_W240
DR   CLO; CLO_0031622
DR   Coriell; GM14646
DR   Wikidata; Q54847358
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14646).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM14648
AC   CVCL_7609
SY   GM18066
DR   CLO; CLO_0015691
DR   CLO; CLO_0031648
DR   Coriell; GM14648
DR   Coriell; GM18066
DR   Wikidata; Q54847359
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14649
AC   CVCL_7610
SY   GM17187
DR   CLO; CLO_0013775
DR   CLO; CLO_0031647
DR   Coriell; GM14649
DR   Coriell; GM17187
DR   GEO; GSM273441
DR   GEO; GSM569709
DR   GEO; GSM596251
DR   GEO; GSM597046
DR   GEO; GSM924697
DR   IPD-IMGT/HLA; 15811
DR   Wikidata; Q54847360
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,66:02; B*13:02,58:VE; C*06:02,07:CVAG; DRB1*15:01,15:03 (IPD-IMGT/HLA=15811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14650
AC   CVCL_5B01
DR   CLO; CLO_0031646
DR   Coriell; GM14650
DR   Wikidata; Q54847361
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Heterozygous; Note=Factor V Leiden (Coriell=GM14650).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (Coriell=GM14650).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM14650).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM14651
AC   CVCL_5B02
DR   CLO; CLO_0031645
DR   Coriell; GM14651
DR   Wikidata; Q54847362
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14651).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14652
AC   CVCL_5B03
DR   CLO; CLO_0031644
DR   Coriell; GM14652
DR   Wikidata; Q54847363
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (Coriell=GM14652).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM14652).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   GM14654
AC   CVCL_N219
SY   GM18067
DR   CLO; CLO_0015690
DR   CLO; CLO_0031643
DR   Coriell; GM14654
DR   Coriell; GM18067
DR   Wikidata; Q54847364
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM18067).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   GM14655
AC   CVCL_N220
SY   GM17300
DR   CLO; CLO_0013312
DR   CLO; CLO_0031642
DR   Coriell; GM14655
DR   Coriell; GM17300
DR   Wikidata; Q54847365
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,03:01:01; B*07:02:01,53:01:01; C*04:01:01,07:02:01; DPA1*01:03:01,02:01:01; DPB1*04:01:01,17:01:01; DQA1*02:01:01,03:01:01; DQB1*02:02:01,03:02:01; DRB1*04:04:01,07:01:01; DRB4*01:01:01,01:03:01 (PubMed=29959025).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Trp152Glyfs*2 (c.454delT) (1707delT) (1795delT); ClinVar=VCV000016891; Zygosity=Heterozygous; Note=CYP2D6*6 allele (Coriell=GM17300).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM14655).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   GM14657
AC   CVCL_5B04
DR   CLO; CLO_0031641
DR   Coriell; GM14657
DR   Wikidata; Q54847366
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14657).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM14660
AC   CVCL_7611
SY   GM17031; GM17188
DR   CLO; CLO_0013777
DR   CLO; CLO_0014727
DR   CLO; CLO_0031640
DR   Coriell; GM14660
DR   Coriell; GM17031
DR   Coriell; GM17188
DR   GEO; GSM273442
DR   GEO; GSM569710
DR   GEO; GSM596252
DR   GEO; GSM597047
DR   GEO; GSM924698
DR   IPD-IMGT/HLA; 19230
DR   Wikidata; Q54847367
RX   PubMed=11416159;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:DFKR,34:02; B*49:01,53:01; C*06:02,07:CVAG; DRB1*12:CVT,15:03 (IPD-IMGT/HLA=19230).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Thr107Ile (c.320C>T); ClinVar=VCV000039379; Zygosity=Heterozygous; Note=CYP2D6*17 allele (Coriell=GM17188).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Arg296Cys (c.886C>T); ClinVar=VCV000242771; Zygosity=Heterozygous; Note=CYP2D6*17 allele (Coriell=GM17188).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Ser486Thr (c.1457G>C); ClinVar=VCV000242701; Zygosity=Heterozygous; Note=CYP2D6*17 allele (Coriell=GM17188).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 14,15
ST   D21S11: 31,35
ST   D8S1179: 14,15
ST   FGA: 22,24
ST   TH01: 7,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   GM14661
AC   CVCL_7612
SY   GM17032
DR   CLO; CLO_0014724
DR   CLO; CLO_0031639
DR   Coriell; GM14661
DR   Coriell; GM17032
DR   Wikidata; Q54847368
RX   PubMed=14583597;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14662
AC   CVCL_7613
SY   GM17189
DR   CLO; CLO_0013790
DR   CLO; CLO_0031978
DR   Coriell; GM14662
DR   Coriell; GM17189
DR   GEO; GSM273443
DR   GEO; GSM569711
DR   GEO; GSM596253
DR   GEO; GSM597048
DR   GEO; GSM924699
DR   Wikidata; Q54847370
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14663
AC   CVCL_7614
SY   GM17033; GM17190
DR   CLO; CLO_0013794
DR   CLO; CLO_0014731
DR   CLO; CLO_0031977
DR   Coriell; GM14663
DR   Coriell; GM17033
DR   Coriell; GM17190
DR   GEO; GSM273444
DR   GEO; GSM569712
DR   GEO; GSM596254
DR   GEO; GSM597049
DR   GEO; GSM924700
DR   IPD-IMGT/HLA; 19249
DR   Wikidata; Q54847371
RX   PubMed=14583597;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:DFKR,74:AB; B*07:CZZS,45:AH; C*06:02,07:WCP; DRB1*13:02,15:03 (IPD-IMGT/HLA=19249).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM14664
AC   CVCL_7615
SY   GM18068
DR   CLO; CLO_0015689
DR   CLO; CLO_0031976
DR   Coriell; GM14664
DR   Coriell; GM18068
DR   Wikidata; Q54847372
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14665
AC   CVCL_7616
SY   GM17034; GM17191
DR   CLO; CLO_0013793
DR   CLO; CLO_0014728
DR   CLO; CLO_0031974
DR   Coriell; GM14665
DR   Coriell; GM17034
DR   Coriell; GM17191
DR   GEO; GSM273445
DR   GEO; GSM569749
DR   GEO; GSM596255
DR   GEO; GSM597050
DR   GEO; GSM924701
DR   Wikidata; Q54847373
RX   PubMed=14583597;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM14666
AC   CVCL_7617
SY   GM17192
DR   CLO; CLO_0013796
DR   CLO; CLO_0031972
DR   Coriell; GM14666
DR   Coriell; GM17192
DR   GEO; GSM273446
DR   GEO; GSM569713
DR   GEO; GSM596256
DR   GEO; GSM597051
DR   GEO; GSM924702
DR   IPD-IMGT/HLA; 20682
DR   Wikidata; Q54847374
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:06,33:01; B*42:01,57:03; C*07:CVAG,17:MN; DRB1*03:02 (IPD-IMGT/HLA=20682).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14667
AC   CVCL_7618
SY   GM17010
DR   CLO; CLO_0018023
DR   CLO; CLO_0031963
DR   Coriell; GM14667
DR   Coriell; GM17010
DR   Wikidata; Q54847375
CC   Part of: Human variation panel.
CC   Population: Caucasian; Northern European.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM14671
AC   CVCL_N221
SY   GM18069
DR   CLO; CLO_0015720
DR   CLO; CLO_0031965
DR   Coriell; GM14671
DR   Coriell; GM18069
DR   Wikidata; Q54847376
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM14672
AC   CVCL_7619
SY   GM17035
DR   CLO; CLO_0014735
DR   CLO; CLO_0031968
DR   Coriell; GM14672
DR   Coriell; GM17035
DR   IPD-IMGT/HLA; 12108
DR   Wikidata; Q54847378
RX   PubMed=14583597;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:06 (IPD-IMGT/HLA=12108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM14673
AC   CVCL_N222
SY   GM17246
DR   CLO; CLO_0014416
DR   CLO; CLO_0031969
DR   Coriell; GM14673
DR   Coriell; GM17246
DR   GEO; GSM569662
DR   GEO; GSM596310
DR   GEO; GSM596669
DR   GEO; GSM924848
DR   Wikidata; Q54847379
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,25:01:01; B*08:01:01,18:01:01; C*07:01:01,07:01:01; DPA1*01:03:01,02:01:02; DPB1*01:01:01,04:01:01; DQA1*01:03:01,05:01:01; DQB1*02:01:01,06:03:01; DRB1*03:01:01,13:01:01; DRB3*01:01:02,01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM14676
AC   CVCL_N223
SY   GM18070
DR   CLO; CLO_0015717
DR   CLO; CLO_0031956
DR   Coriell; GM14676
DR   Coriell; GM18070
DR   Wikidata; Q54847392
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM14679
AC   CVCL_7620
AS   CVCL_7655
SY   GM17193
DR   CLO; CLO_0013795
DR   CLO; CLO_0031953
DR   Coriell; GM14679
DR   Coriell; GM17193
DR   GEO; GSM273447
DR   GEO; GSM569750
DR   GEO; GSM596257
DR   GEO; GSM597052
DR   GEO; GSM924703
DR   IPD-IMGT/HLA; 19226
DR   Wikidata; Q54847393
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,23:DFKR; B*18:RRG,57:03; C*02:02,07:CVAG; DRB1*07:01,13:02 (IPD-IMGT/HLA=19226).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14680
AC   CVCL_7621
SY   GM 14680; GM17194
DR   CLO; CLO_0013798
DR   CLO; CLO_0031951
DR   Coriell; GM14680
DR   Coriell; GM17194
DR   GEO; GSM273448
DR   GEO; GSM569714
DR   GEO; GSM596258
DR   GEO; GSM597053
DR   GEO; GSM924704
DR   Wikidata; Q54847394
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   GM14681
AC   CVCL_7622
SY   GM17116
DR   CLO; CLO_0014953
DR   CLO; CLO_0031943
DR   Coriell; GM14681
DR   Coriell; GM17116
DR   GEO; GSM273386
DR   GEO; GSM569535
DR   GEO; GSM596184
DR   GEO; GSM596984
DR   GEO; GSM924626
DR   IPD-IMGT/HLA; 19241
DR   Wikidata; Q54847395
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:CNJK,32:01; B*08:XKT,27:09; C*01:02,07:CVAG; DRB1*03:01,11:01 (IPD-IMGT/HLA=19241).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14682
AC   CVCL_7623
SY   GM17036
DR   CLO; CLO_0014733
DR   CLO; CLO_0031941
DR   Coriell; GM14682
DR   Coriell; GM17036
DR   Wikidata; Q54847396
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM14683
AC   CVCL_7624
SY   GM17037; GM17195
DR   CLO; CLO_0013797
DR   CLO; CLO_0014738
DR   CLO; CLO_0031947
DR   Coriell; GM14683
DR   Coriell; GM17037
DR   Coriell; GM17195
DR   GEO; GSM273449
DR   GEO; GSM569715
DR   GEO; GSM596259
DR   GEO; GSM597054
DR   Wikidata; Q54847397
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM14684
AC   CVCL_5A84
DR   CLO; CLO_0031945
DR   Coriell; GM14684
DR   Wikidata; Q54847398
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ser267Lysfs*19 (c.798_799delTT) (916delTT); ClinVar=VCV000037698; Zygosity=Unspecified (Coriell=GM14684).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM14685
AC   CVCL_5B05
DR   CLO; CLO_0032024
DR   Coriell; GM14685
DR   Wikidata; Q54847399
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14685).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14686
AC   CVCL_5B06
DR   CLO; CLO_0032026
DR   Coriell; GM14686
DR   Wikidata; Q54847401
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (Coriell=GM14686).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14687
AC   CVCL_7625
SY   GM17117
DR   CLO; CLO_0014950
DR   CLO; CLO_0032020
DR   Coriell; GM14687
DR   Coriell; GM17117
DR   GEO; GSM273387
DR   GEO; GSM569536
DR   GEO; GSM596185
DR   GEO; GSM596985
DR   GEO; GSM924627
DR   IPD-IMGT/HLA; 20690
DR   Wikidata; Q54847402
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:CNJK,03:CVAB; B*07:CZZS,08:XKT; C*07:CVAG,07:WCP; DRB1*03:01,13:02 (IPD-IMGT/HLA=20690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14688
AC   CVCL_5B07
DR   CLO; CLO_0032021
DR   Coriell; GM14688
DR   Wikidata; Q54847403
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14688).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM14689
AC   CVCL_5B08
DR   CLO; CLO_0032010
DR   Coriell; GM14689
DR   Wikidata; Q54847404
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM14690
AC   CVCL_N224
SY   GM18071
DR   CLO; CLO_0015716
DR   CLO; CLO_0032009
DR   Coriell; GM14690
DR   Coriell; GM18071
DR   Wikidata; Q54847405
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM18071).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   GM14691
AC   CVCL_5B09
DR   CLO; CLO_0032008
DR   Coriell; GM14691
DR   Wikidata; Q54847406
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (Coriell=GM14691).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM14691).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   GM14693
AC   CVCL_N225
SY   GM17247
DR   CLO; CLO_0014417
DR   CLO; CLO_0032018
DR   Coriell; GM14693
DR   Coriell; GM17247
DR   GEO; GSM569617
DR   GEO; GSM596311
DR   GEO; GSM596670
DR   GEO; GSM924849
DR   Wikidata; Q54847407
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,24:03:01; B*44:03:01,57:01:01; C*04:01:01,06:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:01:01,05:05:01; DQB1*03:01:01,05:01:01; DRB1*01:01:01,13:05:01; DRB3*02:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM14694
AC   CVCL_N226
SY   GM18072
DR   CLO; CLO_0015719
DR   CLO; CLO_0032016
DR   Coriell; GM14694
DR   Coriell; GM18072
DR   Wikidata; Q54847408
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM14696
AC   CVCL_F323
SY   GM17038; GM17196
DR   CLO; CLO_0013816
DR   CLO; CLO_0014736
DR   CLO; CLO_0032014
DR   Coriell; GM14696
DR   Coriell; GM17038
DR   Coriell; GM17196
DR   GEO; GSM273450
DR   GEO; GSM569716
DR   GEO; GSM596260
DR   GEO; GSM597055
DR   GEO; GSM924706
DR   IPD-IMGT/HLA; 20695
DR   Wikidata; Q54847409
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*68:02,74:AB; B*15:BKNX,52:01; C*02:10,16:01; DRB1*03:01,07:01 (IPD-IMGT/HLA=20695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM14697
AC   CVCL_F324
SY   GM17118
DR   CLO; CLO_0014951
DR   CLO; CLO_0032012
DR   Coriell; GM14697
DR   Coriell; GM17118
DR   GEO; GSM273388
DR   GEO; GSM569537
DR   GEO; GSM596186
DR   GEO; GSM596986
DR   GEO; GSM924628
DR   IPD-IMGT/HLA; 20206
DR   Wikidata; Q54847410
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,23:DFKR; B*49:01,58:VE; C*03:02,07:CVAG; DRB1*07:01,09:01 (IPD-IMGT/HLA=20206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM14698
AC   CVCL_7626
SY   GM17039; GM17197
DR   CLO; CLO_0013818
DR   CLO; CLO_0014720
DR   CLO; CLO_0031999
DR   Coriell; GM14698
DR   Coriell; GM17039
DR   Coriell; GM17197
DR   GEO; GSM273451
DR   GEO; GSM569717
DR   GEO; GSM596261
DR   GEO; GSM597056
DR   IPD-IMGT/HLA; 20683
DR   Wikidata; Q54847411
RX   PubMed=14583597;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:AUX,31:CGAJ; B*35:08,42:02; C*04:CVAF,17:MN; DRB1*04:03,08:04 (IPD-IMGT/HLA=20683).
CC   HLA typing: A*30:01:01,31:01:02; B*35:08:01,42:02:01; C*04:01:01,17:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,104:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01:04,03:02:01; DRB1*04:03:01,08:04:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   GM14699
AC   CVCL_F325
SY   GM17119
DR   CLO; CLO_0014942
DR   CLO; CLO_0032001
DR   Coriell; GM14699
DR   Coriell; GM17119
DR   GEO; GSM273389
DR   GEO; GSM569538
DR   GEO; GSM596187
DR   GEO; GSM596987
DR   GEO; GSM924629
DR   IPD-IMGT/HLA; 15818
DR   Wikidata; Q54847413
RX   PubMed=16260726;
RX   PubMed=20210923;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*03:CVAB,74:AB; B*35:BEZX,42:02; C*07:CVAG,17:MN; DRB1*08:04,08:06 (IPD-IMGT/HLA=15818).
CC   HLA typing: A*03:01:01,74:01:01; B*35:01:01,42:02:01; C*07:18,17:01:01; DPA1*02:01:01,03:NEW-1; DPB1*131:01,584:01; DQA1*01:02:01,05:05:01; DQB1*03:01:04,06:02:01; DRB1*08:04:01,08:06 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM14700
AC   CVCL_7627
SY   GM17040; GM17198
DR   CLO; CLO_0013823
DR   CLO; CLO_0014624
DR   CLO; CLO_0032003
DR   Coriell; GM14700
DR   Coriell; GM17040
DR   Coriell; GM17198
DR   GEO; GSM273452
DR   GEO; GSM569718
DR   GEO; GSM596262
DR   GEO; GSM597057
DR   Wikidata; Q54847414
RX   PubMed=14583597;
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM14702
AC   CVCL_5B10
DR   CLO; CLO_0031987
DR   Coriell; GM14702
DR   Wikidata; Q54847416
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (Coriell=GM14702).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM14703
AC   CVCL_5B11
DR   CLO; CLO_0031990
DR   Coriell; GM14703
DR   Wikidata; Q54847417
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (Coriell=GM14703).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Heterozygous (Coriell=GM14703).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   GM14704
AC   CVCL_7628
SY   GM17199
DR   CLO; CLO_0013826
DR   CLO; CLO_0031989
DR   Coriell; GM14704
DR   Coriell; GM17199
DR   GEO; GSM273453
DR   GEO; GSM569719
DR   GEO; GSM596263
DR   GEO; GSM597058
DR   IPD-IMGT/HLA; 15812
DR   Wikidata; Q54847418
RX   PubMed=14583597;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:AUX,68:01; B*35:BEZX,42:02; C*04:CVAF,17:MN; DRB1*03:02,13:02 (IPD-IMGT/HLA=15812).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   GM14706
AC   CVCL_JF51
DR   CLO; CLO_0031993
DR   Coriell; GM14706
DR   Wikidata; Q54847419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM14707
AC   CVCL_JF52
DR   CLO; CLO_0031991
DR   Coriell; GM14707
DR   Wikidata; Q54847420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM14712
AC   CVCL_5B12
DR   CLO; CLO_0031996
DR   Coriell; GM14712
DR   Wikidata; Q54847421
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14712).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14715
AC   CVCL_5B13
DR   CLO; CLO_0031994
DR   Coriell; GM14715
DR   Wikidata; Q54847422
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14715).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM14717
AC   CVCL_1K20
DR   CLO; CLO_0031920
DR   Coriell; GM14717
DR   Wikidata; Q54847423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122655; Neuronal intranuclear inclusion disease
DI   ORDO; Orphanet_2289; Neuronal intranuclear inclusion disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM14720
AC   CVCL_7629
SY   GM17120
DR   CLO; CLO_0015112
DR   CLO; CLO_0031919
DR   Coriell; GM14720
DR   Coriell; GM17120
DR   GEO; GSM273390
DR   GEO; GSM569539
DR   GEO; GSM596188
DR   GEO; GSM596988
DR   GEO; GSM924630
DR   IPD-IMGT/HLA; 15819
DR   Wikidata; Q54847424
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:AUX,30:02; B*07:CZZS,44:03; C*04:CVAF,17:MN; DRB1*03:02,08:04 (IPD-IMGT/HLA=15819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14728
AC   CVCL_9Q96
DR   CLO; CLO_0031918
DR   Coriell; GM14728
DR   Wikidata; Q54847425
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q97 ! GM14729
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM14729
AC   CVCL_9Q97
DR   CLO; CLO_0031916
DR   Coriell; GM14729
DR   Wikidata; Q54847426
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Q96 ! GM14728
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14732
AC   CVCL_EJ64
DR   CLO; CLO_0031917
DR   Coriell; GM14732
DR   Wikidata; Q54847427
RX   PubMed=27896104;
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; Ex1-8del; Zygosity=Heterozygous (PubMed=27896104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   GM14733
AC   CVCL_EJ65
DR   CLO; CLO_0031914
DR   Coriell; GM14733
DR   Wikidata; Q54847429
RX   PubMed=27896104;
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; CH-5 30kb del (CH-5 type CYP21A1P/CYP21A2 chimer); Zygosity=Heterozygous (PubMed=27896104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   GM14734
AC   CVCL_GZ50
DR   CLO; CLO_0031915
DR   Coriell; GM14734
DR   Wikidata; Q54847430
RX   PubMed=27896104;
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; CH-5 30kb del (CH-5 type CYP21A1P/CYP21A2 chimer); Zygosity=Heterozygous (PubMed=27896104).
CC   Sequence variation: Mutation; HGNC; HGNC:2600; CYP21A2; Unexplicit; Ex1-8del; Zygosity=Heterozygous (PubMed=27896104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   GM14746
AC   CVCL_7630
SY   GM17121
DR   CLO; CLO_0015115
DR   CLO; CLO_0031912
DR   Coriell; GM14746
DR   Coriell; GM17121
DR   GEO; GSM273391
DR   GEO; GSM569604
DR   GEO; GSM596189
DR   GEO; GSM596989
DR   GEO; GSM924631
DR   IPD-IMGT/HLA; 23052
DR   Wikidata; Q54847431
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:02,32:01; B*35:BEZX,44:03; C*16:01,16:01; DRB1*01:02,07:01 (IPD-IMGT/HLA=23052).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14753
AC   CVCL_H558
SY   GM17248
DR   CLO; CLO_0014408
DR   CLO; CLO_0031913
DR   Coriell; GM14753
DR   Coriell; GM17248
DR   GEO; GSM569625
DR   GEO; GSM596312
DR   GEO; GSM596671
DR   GEO; GSM924850
DR   Wikidata; Q54847432
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,30:01:01; B*13:02:01,38:01:01; C*06:02:01,12:03:01; DPA1*01:03:01,02:01:01; DPB1*04:02:01,09:01:01; DQA1*02:01:01,05:05:01; DQB1*02:02:01,03:01:01; DRB1*07:01:01,11:04:01; DRB3*02:02:01; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM14754
AC   CVCL_H559
SY   GM17122
DR   CLO; CLO_0015117
DR   CLO; CLO_0031910
DR   Coriell; GM14754
DR   Coriell; GM17122
DR   GEO; GSM273392
DR   GEO; GSM569553
DR   GEO; GSM596190
DR   GEO; GSM596990
DR   GEO; GSM924632
DR   IPD-IMGT/HLA; 20685
DR   Wikidata; Q54847433
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,29:02; B*13:02,49:01; C*06:02,07:CVAG; DRB1*09:01,13:02 (IPD-IMGT/HLA=20685).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM14755
AC   CVCL_H560
SY   GM17123
DR   CLO; CLO_0015119
DR   CLO; CLO_0031911
DR   Coriell; GM14755
DR   Coriell; GM17123
DR   GEO; GSM273393
DR   GEO; GSM569554
DR   GEO; GSM596191
DR   GEO; GSM596991
DR   GEO; GSM924633
DR   IPD-IMGT/HLA; 15333
DR   Wikidata; Q54847434
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:02,33:03; B*18:RRG,49:01; C*05:AC,07:WTR (IPD-IMGT/HLA=15333).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM14758
AC   CVCL_H546
DR   CLO; CLO_0031907
DR   Coriell; GM14758
DR   Wikidata; Q54847454
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
DI   NCIt; C122654; Short-rib thoracic dysplasia 6 with or without polydactyly
DI   ORDO; Orphanet_93269; Short rib-polydactyly syndrome, Majewski type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H547 ! GM14760
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM14760
AC   CVCL_H547
DR   CLO; CLO_0031902
DR   Coriell; GM14760
DR   Wikidata; Q54847455
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
DI   NCIt; C122654; Short-rib thoracic dysplasia 6 with or without polydactyly
DI   ORDO; Orphanet_93269; Short rib-polydactyly syndrome, Majewski type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H546 ! GM14758
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM14771
AC   CVCL_H561
SY   GM17124
DR   CLO; CLO_0015121
DR   CLO; CLO_0031903
DR   Coriell; GM14771
DR   Coriell; GM17124
DR   GEO; GSM273394
DR   GEO; GSM569555
DR   GEO; GSM596192
DR   GEO; GSM596992
DR   GEO; GSM924634
DR   IPD-IMGT/HLA; 15820
DR   Wikidata; Q54847456
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,31:CGAJ; B*35:BEZX,35:08; C*04:CVAF; DRB1*11:02,16:01 (IPD-IMGT/HLA=15820).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM14772
AC   CVCL_H562
SY   GM17125
DR   CLO; CLO_0015123
DR   CLO; CLO_0031897
DR   Coriell; GM14772
DR   Coriell; GM17125
DR   GEO; GSM273395
DR   GEO; GSM569549
DR   GEO; GSM596193
DR   GEO; GSM596993
DR   GEO; GSM924635
DR   Wikidata; Q54847458
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM14779
AC   CVCL_H563
DR   CLO; CLO_0031898
DR   Coriell; GM14779
DR   Wikidata; Q54847459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM14780
AC   CVCL_H564
SY   GM18073
DR   CLO; CLO_0015718
DR   CLO; CLO_0031899
DR   Coriell; GM14780
DR   Coriell; GM18073
DR   Wikidata; Q54847460
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM14781
AC   CVCL_H565
DR   CLO; CLO_0031900
DR   Coriell; GM14781
DR   Wikidata; Q54847461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122655; Neuronal intranuclear inclusion disease
DI   ORDO; Orphanet_2289; Neuronal intranuclear inclusion disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM14782
AC   CVCL_7631
SY   GM17249
DR   CLO; CLO_0014409
DR   CLO; CLO_0031890
DR   Coriell; GM14782
DR   Coriell; GM17249
DR   GEO; GSM569626
DR   GEO; GSM596313
DR   GEO; GSM596672
DR   GEO; GSM924851
DR   Wikidata; Q54847462
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,32:01:01; B*08:01:01,44:02:01; C*05:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01G,04:02:01G; DQA1*01:03:01,05:01:01; DQB1*02:01:01,06:03:01; DRB1*03:01:01,13:01:01; DRB3*01:01:02,01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM14783
AC   CVCL_7632
SY   GM17126
DR   CLO; CLO_0015124
DR   CLO; CLO_0031892
DR   Coriell; GM14783
DR   Coriell; GM17126
DR   GEO; GSM273396
DR   GEO; GSM569595
DR   GEO; GSM596194
DR   GEO; GSM596994
DR   GEO; GSM924636
DR   IPD-IMGT/HLA; 16416
DR   Wikidata; Q54847463
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*26:GAX,68:AKR; B*08:XKT,44:WRJ; C*03:04,07:ET; DRB1*04:07,13:04 (IPD-IMGT/HLA=16416).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   GM14788
AC   CVCL_H566
DR   CLO; CLO_0031893
DR   Coriell; GM14788
DR   Wikidata; Q54847464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   GM14805
AC   CVCL_7633
DR   CLO; CLO_0031895
DR   Coriell; GM14805
DR   Wikidata; Q54847465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   GM14807
AC   CVCL_H567
SY   GM17250
DR   CLO; CLO_0014397
DR   CLO; CLO_0031940
DR   Coriell; GM14807
DR   Coriell; GM17250
DR   GEO; GSM569618
DR   GEO; GSM596314
DR   GEO; GSM596673
DR   GEO; GSM924852
DR   Wikidata; Q54847466
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   GM14811
AC   CVCL_7634
SY   GM18074
DR   CLO; CLO_0015713
DR   CLO; CLO_0031938
DR   Coriell; GM14811
DR   Coriell; GM18074
DR   Wikidata; Q54847467
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14817
AC   CVCL_H568
DR   CLO; CLO_0031939
DR   Coriell; GM14817
DR   Wikidata; Q54847469
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:9706; NECTIN1; Simple; p.Trp185Ter (c.554G>A); ClinVar=VCV000008969; Zygosity=Homozygous (Coriell=GM14817).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122656; Cleft lip/palate-ectodermal dysplasia syndrome
DI   ORDO; Orphanet_3253; Zlotogora-Ogur syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H569 ! GM14818
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM14818
AC   CVCL_H569
DR   CLO; CLO_0031933
DR   Coriell; GM14818
DR   Wikidata; Q54847470
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:9706; NECTIN1; Simple; p.Trp185Ter (c.554G>A); ClinVar=VCV000008969; Zygosity=Homozygous (Coriell=GM14818).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122656; Cleft lip/palate-ectodermal dysplasia syndrome
DI   ORDO; Orphanet_3253; Zlotogora-Ogur syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H568 ! GM14817
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   GM14819
AC   CVCL_7635
SY   GM17060
DR   CLO; CLO_0014563
DR   CLO; CLO_0031934
DR   Coriell; GM14819
DR   Coriell; GM17060
DR   Wikidata; Q54847471
CC   Part of: Human variation panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14820
AC   CVCL_7636
SY   GM17080
DR   CLO; CLO_0014484
DR   CLO; CLO_0031931
DR   Coriell; GM14820
DR   Coriell; GM17080
DR   Wikidata; Q54847472
RX   PubMed=11416159;
CC   Part of: Human variation panel.
CC   Population: Puerto Rican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 11,15
ST   D21S11: 30,32.2
ST   D8S1179: 15
ST   FGA: 23,27
ST   TH01: 9,9.3
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   GM14826
AC   CVCL_H570
SY   GM17127
DR   CLO; CLO_0015126
DR   CLO; CLO_0031932
DR   Coriell; GM14826
DR   Coriell; GM17127
DR   GEO; GSM273397
DR   GEO; GSM569596
DR   GEO; GSM596195
DR   GEO; GSM596995
DR   GEO; GSM924637
DR   IPD-IMGT/HLA; 15815
DR   Wikidata; Q54847473
RX   PubMed=16260726;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,30:AUX; B*42:01,45:AH; C*16:01,17:MN; DRB1*03:02,12:CVT (IPD-IMGT/HLA=15815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM14837
AC   CVCL_H571
SY   GM17128
DR   CLO; CLO_0015128
DR   CLO; CLO_0031936
DR   Coriell; GM14837
DR   Coriell; GM17128
DR   GEO; GSM273398
DR   GEO; GSM569597
DR   GEO; GSM596196
DR   GEO; GSM596996
DR   GEO; GSM924638
DR   IPD-IMGT/HLA; 15336
DR   Wikidata; Q54847474
RX   PubMed=16260726;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,29:03; B*37:01,53:01; C*06:02; DRB1*10:01,11:01 (IPD-IMGT/HLA=15336).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GM14849
AC   CVCL_1S87
SY   XOL-6
DR   CLO; CLO_0031937
DR   Coriell; GM14849
DR   Wikidata; Q54847475
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V747 ! GM00097
HI   CVCL_4536 ! L-M(TK-)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM14853
AC   CVCL_1S88
SY   20L-17
DR   CLO; CLO_0031935
DR   Coriell; GM14853
DR   Wikidata; Q54847476
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V460 ! GM00201
HI   CVCL_4536 ! L-M(TK-)
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM14855
AC   CVCL_1S90
SY   PBR-3
DR   CLO; CLO_0031928
DR   Coriell; GM14855
DR   Wikidata; Q54847478
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM14857
AC   CVCL_H572
DR   CLO; CLO_0031929
DR   Coriell; GM14857
DR   Wikidata; Q54847479
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous (Coriell=GM14857).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84764; HFE-associated hereditary hemochromatosis
DI   ORDO; Orphanet_465508; Symptomatic form of hemochromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM14862
AC   CVCL_H573
SY   GM17129
DR   CLO; CLO_0015130
DR   CLO; CLO_0031930
DR   Coriell; GM14862
DR   Coriell; GM17129
DR   GEO; GSM273399
DR   GEO; GSM569598
DR   GEO; GSM596197
DR   GEO; GSM596997
DR   GEO; GSM924639
DR   IPD-IMGT/HLA; 19248
DR   Wikidata; Q54847480
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*33:01,74:AB; B*50:01,53:01; C*06:02,07:CVAG; DRB1*01:02,13:01 (IPD-IMGT/HLA=19248).
CC   HLA typing: A*33:01:01,74:01:01; B*50:01:01,53:01:01; C*06:02:01,07:18; DPA1*02:01:01,02:01:08; DPB1*01:01:01,11:01:01; DQA1*01:01:02,01:03:01; DQB1*05:01:01,06:03:01; DRB1*01:02:01,13:01:01; DRB3*01:01:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM14863
AC   CVCL_H574
SY   GM17130
DR   CLO; CLO_0015085
DR   CLO; CLO_0031921
DR   Coriell; GM14863
DR   Coriell; GM17130
DR   GEO; GSM273400
DR   GEO; GSM569599
DR   GEO; GSM596198
DR   GEO; GSM596998
DR   GEO; GSM924640
DR   Wikidata; Q54847481
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,14:02:01; C*07:01:01,08:02:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,04:01:01; DQA1*01:02:01,04:01:01; DQB1*04:02:01,06:02:01; DRB1*08:01:01,15:03:01; DRB5*01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   GM14864
AC   CVCL_H575
SY   GM17131
DR   CLO; CLO_0015087
DR   CLO; CLO_0031922
DR   Coriell; GM14864
DR   Coriell; GM17131
DR   GEO; GSM273401
DR   GEO; GSM569609
DR   GEO; GSM596199
DR   GEO; GSM596999
DR   GEO; GSM924641
DR   IPD-IMGT/HLA; 16417
DR   Wikidata; Q54847482
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,03:DDKG; B*27:EKN,57:04; C*01:WG,18:AB; DRB1*01:03,07:01 (IPD-IMGT/HLA=16417).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   GM14889
AC   CVCL_BX00
DR   CLO; CLO_0032076
DR   Coriell; GM14889
DR   Wikidata; Q54847495
CC   Sequence variation: Mutation; HGNC; HGNC:8896; PGK1; Simple; p.Asp164Val (c.491A>T) (D163V); ClinVar=VCV000009954; Zygosity=Hemizygous (Coriell=GM14889).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126738; Phosphoglycerate kinase 1 deficiency
DI   ORDO; Orphanet_713; Glycogen storage disease due to phosphoglycerate kinase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM14890
AC   CVCL_4J59
DR   CLO; CLO_0032078
DR   Coriell; GM14890
DR   Wikidata; Q54847506
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Ser106Cys (c.317C>G); ClinVar=VCV000242797; Zygosity=Hemizygous (Coriell=GM14890).
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Arg182Trp (c.544C>T); ClinVar=VCV000242750; Zygosity=Hemizygous (Coriell=GM14890).
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple; p.Arg198Cys (c.592C>T); ClinVar=VCV000010391; Zygosity=Hemizygous (Coriell=GM14890).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98933; Glucose-6-phosphate dehydrogenase deficiency
DI   ORDO; Orphanet_466026; Class I glucose-6-phosphate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM14892
AC   CVCL_N227
SY   GM17132
DR   CLO; CLO_0015081
DR   CLO; CLO_0032090
DR   Coriell; GM14892
DR   Coriell; GM17132
DR   GEO; GSM273402
DR   GEO; GSM569610
DR   GEO; GSM596200
DR   GEO; GSM597000
DR   GEO; GSM924642
DR   IPD-IMGT/HLA; 17388
DR   Wikidata; Q54847507
RX   PubMed=16260726;
RX   PubMed=20210923;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,30:02; B*07:CZZS,08:XKT; C*07:CVAG,07:WCP; DRB1*03:01,13:01 (IPD-IMGT/HLA=17388).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14893
AC   CVCL_N228
SY   GM17133
DR   CLO; CLO_0015082
DR   CLO; CLO_0032089
DR   Coriell; GM14893
DR   Coriell; GM17133
DR   GEO; GSM273403
DR   GEO; GSM569611
DR   GEO; GSM596201
DR   GEO; GSM597001
DR   GEO; GSM924643
DR   IPD-IMGT/HLA; 20691
DR   Wikidata; Q54847508
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:02,33:BEKE; B*42:01,58:VE; C*03:02,04:CVAF; DRB1*03:01,04:02 (IPD-IMGT/HLA=20691).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14894
AC   CVCL_N229
SY   GM17134
DR   CLO; CLO_0015093
DR   CLO; CLO_0032094
DR   Coriell; GM14894
DR   Coriell; GM17134
DR   GEO; GSM273404
DR   GEO; GSM569612
DR   GEO; GSM596202
DR   GEO; GSM597002
DR   GEO; GSM924644
DR   IPD-IMGT/HLA; 15816
DR   Wikidata; Q54847509
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*68:02,74:AB; B*35:BEZX,44:03; C*04:CVAF; DRB1*09:01,13:02 (IPD-IMGT/HLA=15816).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14895
AC   CVCL_N230
SY   GM17135
DR   CLO; CLO_0015094
DR   CLO; CLO_0032093
DR   Coriell; GM14895
DR   Coriell; GM17135
DR   GEO; GSM273405
DR   GEO; GSM569613
DR   GEO; GSM596203
DR   GEO; GSM597003
DR   GEO; GSM924645
DR   IPD-IMGT/HLA; 23051
DR   Wikidata; Q54847510
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*34:02,34:02; B*35:BEZX,44:03; C*04:CVAF,04:CVAF; DRB1*13:01,15:03 (IPD-IMGT/HLA=23051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14897
AC   CVCL_N231
SY   GM17136
DR   CLO; CLO_0015088
DR   CLO; CLO_0032092
DR   Coriell; GM14897
DR   Coriell; GM17136
DR   GEO; GSM273406
DR   GEO; GSM569568
DR   GEO; GSM596204
DR   GEO; GSM597004
DR   GEO; GSM924646
DR   IPD-IMGT/HLA; 17382
DR   Wikidata; Q54847511
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*32:01,68:02; B*53:01,81:MN; C*04:CVAF,08:02; DRB1*10:01,12:CVT (IPD-IMGT/HLA=17382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14899
AC   CVCL_8A57
DR   CLO; CLO_0032091
DR   Coriell; GM14899
DR   Wikidata; Q54847512
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Homozygous; Note=Factor V Leiden (Coriell=GM14899).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98938; Hereditary factor V deficiency
DI   ORDO; Orphanet_326; Congenital factor V deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM14900
AC   CVCL_N232
SY   GM17137
DR   CLO; CLO_0015090
DR   CLO; CLO_0032098
DR   Coriell; GM14900
DR   Coriell; GM17137
DR   GEO; GSM273407
DR   GEO; GSM569561
DR   GEO; GSM596205
DR   GEO; GSM597005
DR   GEO; GSM924647
DR   IPD-IMGT/HLA; 20680
DR   Wikidata; Q54847513
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:05,29:02; B*27:03,57:03; C*02:02,15:05; DRB1*07:01,08:04 (IPD-IMGT/HLA=20680).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM14901
AC   CVCL_N233
SY   GM17138
DR   CLO; CLO_0015097
DR   CLO; CLO_0032097
DR   Coriell; GM14901
DR   Coriell; GM17138
DR   GEO; GSM273408
DR   GEO; GSM569569
DR   GEO; GSM596206
DR   GEO; GSM597006
DR   GEO; GSM924648
DR   IPD-IMGT/HLA; 23053
DR   Wikidata; Q54847514
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,29:02; B*51:CVAE,58:02; C*02:02,06:02; DRB1*13:01,13:02 (IPD-IMGT/HLA=23053).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14903
AC   CVCL_N234
SY   GM17139
DR   CLO; CLO_0015098
DR   CLO; CLO_0032096
DR   Coriell; GM14903
DR   Coriell; GM17139
DR   GEO; GSM273409
DR   GEO; GSM569570
DR   GEO; GSM596207
DR   GEO; GSM597007
DR   GEO; GSM924649
DR   Wikidata; Q54847515
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14904
AC   CVCL_N235
SY   GM17140
DR   CLO; CLO_0013935
DR   CLO; CLO_0032095
DR   Coriell; GM14904
DR   Coriell; GM17140
DR   GEO; GSM273410
DR   GEO; GSM569571
DR   GEO; GSM596208
DR   GEO; GSM597008
DR   GEO; GSM924650
DR   IPD-IMGT/HLA; 15813
DR   Wikidata; Q54847516
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*29:02,74:AB; B*14:01,53:01; C*04:CVAF,14:03 (IPD-IMGT/HLA=15813).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14905
AC   CVCL_N236
SY   GM17141
DR   CLO; CLO_0013939
DR   CLO; CLO_0030517
DR   Coriell; GM14905
DR   Coriell; GM17141
DR   GEO; GSM273411
DR   GEO; GSM569587
DR   GEO; GSM596209
DR   GEO; GSM597009
DR   GEO; GSM924651
DR   IPD-IMGT/HLA; 16401
DR   Wikidata; Q54847517
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,23:DFKR; B*15:BKNX,51:CVAE; C*02:10,16:01; DRB1*07:01,13:03 (IPD-IMGT/HLA=16401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14907
AC   CVCL_7637
SY   GM18075
DR   CLO; CLO_0015712
DR   CLO; CLO_0030515
DR   Coriell; GM14907
DR   Coriell; GM18075
DR   Wikidata; Q54847518
RX   PubMed=18485778;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14922
AC   CVCL_N237
SY   GM17142
DR   CLO; CLO_0013938
DR   CLO; CLO_0030514
DR   Coriell; GM14922
DR   Coriell; GM17142
DR   GEO; GSM273412
DR   GEO; GSM569588
DR   GEO; GSM596210
DR   GEO; GSM597010
DR   GEO; GSM924652
DR   IPD-IMGT/HLA; 20686
DR   Wikidata; Q54847519
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:DFKR,32:01; B*07:CZZS,39:10; C*07:WCP,12:03; DRB1*03:02,1:401 (IPD-IMGT/HLA=20686).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14923
AC   CVCL_N238
SY   GM17143
DR   CLO; CLO_0013937
DR   CLO; CLO_0030512
DR   Coriell; GM14923
DR   Coriell; GM17143
DR   GEO; GSM273413
DR   GEO; GSM569589
DR   GEO; GSM596211
DR   GEO; GSM597011
DR   GEO; GSM924653
DR   IPD-IMGT/HLA; 23054
DR   Wikidata; Q54847520
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*29:02,66:01; B*58:02,78:01; C*06:02,16:01; DRB1*13:01,13:01 (IPD-IMGT/HLA=23054).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14924
AC   CVCL_N239
SY   GM17144
DR   CLO; CLO_0013936
DR   CLO; CLO_0030510
DR   Coriell; GM14924
DR   Coriell; GM17144
DR   GEO; GSM273414
DR   GEO; GSM569590
DR   GEO; GSM596212
DR   GEO; GSM597012
DR   GEO; GSM924654
DR   Wikidata; Q54847521
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14925
AC   CVCL_N240
SY   GM17145
DR   CLO; CLO_0013943
DR   CLO; CLO_0030509
DR   Coriell; GM14925
DR   Coriell; GM17145
DR   GEO; GSM273415
DR   GEO; GSM569658
DR   GEO; GSM596213
DR   GEO; GSM597013
DR   GEO; GSM924655
DR   Wikidata; Q54847522
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14926
AC   CVCL_7638
SY   GM18076
DR   CLO; CLO_0015715
DR   CLO; CLO_0030507
DR   Coriell; GM14926
DR   Coriell; GM18076
DR   Wikidata; Q54847523
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM14932
AC   CVCL_N241
SY   GM17146
DR   CLO; CLO_0013942
DR   CLO; CLO_0030501
DR   Coriell; GM14932
DR   Coriell; GM17146
DR   GEO; GSM273416
DR   GEO; GSM569619
DR   GEO; GSM596214
DR   GEO; GSM597014
DR   GEO; GSM924656
DR   IPD-IMGT/HLA; 19229
DR   Wikidata; Q54847526
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*30:02,31:CGAJ; B*57:03,78:01; C*08:02,16:01; DRB1*13:02,13:03 (IPD-IMGT/HLA=19229).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14933
AC   CVCL_N242
SY   GM17147
DR   CLO; CLO_0013941
DR   CLO; CLO_0030477
DR   Coriell; GM14933
DR   Coriell; GM17147
DR   GEO; GSM273417
DR   GEO; GSM569627
DR   GEO; GSM596215
DR   GEO; GSM597015
DR   GEO; GSM924657
DR   Wikidata; Q54847527
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14934
AC   CVCL_N243
SY   GM17148
DR   CLO; CLO_0013940
DR   CLO; CLO_0030474
DR   Coriell; GM14934
DR   Coriell; GM17148
DR   GEO; GSM273418
DR   GEO; GSM569615
DR   GEO; GSM596216
DR   GEO; GSM597016
DR   GEO; GSM924658
DR   IPD-IMGT/HLA; 15808
DR   Wikidata; Q54847528
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*23:DFKR,02:02; B*15:16,53:01; C*04:CVAF,14:02 (IPD-IMGT/HLA=15808).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM14935
AC   CVCL_N244
SY   GM17149
DR   CLO; CLO_0013947
DR   CLO; CLO_0030480
DR   Coriell; GM14935
DR   Coriell; GM17149
DR   GEO; GSM273419
DR   GEO; GSM569620
DR   GEO; GSM596217
DR   GEO; GSM597017
DR   GEO; GSM924659
DR   Wikidata; Q54847529
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14936
AC   CVCL_N245
SY   GM17150
DR   CLO; CLO_0013956
DR   CLO; CLO_0030478
DR   Coriell; GM14936
DR   Coriell; GM17150
DR   GEO; GSM273420
DR   GEO; GSM569640
DR   GEO; GSM596218
DR   GEO; GSM597018
DR   GEO; GSM924660
DR   Wikidata; Q54847530
CC   Part of: Human variation panel.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14940
AC   CVCL_5V18
DR   CLO; CLO_0030483
DR   Coriell; GM14940
DR   Wikidata; Q54847531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14941
AC   CVCL_N246
SY   GM18077
DR   CLO; CLO_0015714
DR   CLO; CLO_0030482
DR   Coriell; GM14941
DR   Coriell; GM18077
DR   Wikidata; Q54847532
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM14942
AC   CVCL_5V19
DR   CLO; CLO_0030487
DR   Coriell; GM14942
DR   Wikidata; Q54847533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14943
AC   CVCL_5V20
DR   CLO; CLO_0030486
DR   Coriell; GM14943
DR   Wikidata; Q54847535
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM14944
AC   CVCL_5V21
DR   CLO; CLO_0030470
DR   Coriell; GM14944
DR   Wikidata; Q54847536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14945
AC   CVCL_5V22
DR   CLO; CLO_0030469
DR   Coriell; GM14945
DR   Wikidata; Q54847537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM14946
AC   CVCL_H545
DR   CLO; CLO_0030459
DR   Coriell; GM14946
DR   Wikidata; Q54847538
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   GM14950
AC   CVCL_CZ46
DR   CLO; CLO_0030448
DR   Coriell; GM14950
DR   Wikidata; Q54847539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM14951
AC   CVCL_GA13
DR   CLO; CLO_0030445
DR   Coriell; GM14951
DR   Wikidata; Q54847540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM14952
AC   CVCL_GS87
DR   CLO; CLO_0030443
DR   Coriell; GM14952
DR   Wikidata; Q54847541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from acute lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   GM14978
AC   CVCL_9T92
DR   CLO; CLO_0030292
DR   Coriell; GM14978
DR   Wikidata; Q54847542
CC   Population: Caucasian; Sicilian.
CC   Sequence variation: Mutation; HGNC; HGNC:6998; MEFV; Simple; p.Glu148Gln (c.442G>C); ClinVar=VCV000002542; Zygosity=Heterozygous (Coriell=GM14978).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM14979
AC   CVCL_9T93
DR   CLO; CLO_0030297
DR   Coriell; GM14979
DR   Wikidata; Q54847543
CC   Population: Caucasian; Sicilian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM14982
AC   CVCL_F189
DR   CLO; CLO_0030298
DR   Coriell; GM14982
DR   Wikidata; Q54847544
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   GM1500-6TG-A11
AC   CVCL_H615
AS   CVCL_F607
SY   GM1500 6TG-A11; GM 1500 6TG-A11; GM 1500 6TG A11; GM1500 6TG A-11; GM 1500 6TG-A1 1; 6TG-A11; GM04672; GM 4672; GM4672; GM04672B
DR   CLO; CLO_0019017
DR   Coriell; GM04672
DR   Wikidata; Q54847545
RX   CelloPub=CLPUB00447;
RX   Patent=US4608337;
RX   PubMed=6350451;
RX   PubMed=6864164;
RX   PubMed=6969366;
RX   PubMed=7085884;
RX   PubMed=7689347;
RX   PubMed=8357959;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8032.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa (Coriell=GM04672).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Misspelling: GM1500-GTG-A11; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D870 ! GM01500
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM1500-6TG-A12
AC   CVCL_H616
SY   GM1500 6TG-A12; GM 1500 6TG-A12; GM 1500 6TG-A1 2; GM 1500 6 TG-A12; GM1500TG-A12
DR   Wikidata; Q54847546
RX   Patent=US4608337;
RX   PubMed=6969366;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8038.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Misspelling: GM1500-GTG-A12; Note=Occasionally.
CC   Misspelling: GTG-A12(GM1500); Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D870 ! GM01500
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   GM1500-6TG-OUB
AC   CVCL_H617
SY   GM1500 OUB/6TG; KR-4; KR4
DR   BTO; BTO_0005031
DR   Wikidata; Q54847562
RX   PubMed=6292911;
RX   PubMed=6328505;
CC   Group: Hybridoma fusion partner cell line.
CC   Problematic cell line: Misclassified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H615 ! GM1500-6TG-A11
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   GM15006
AC   CVCL_4E14
DR   CLO; CLO_0030295
DR   Coriell; GM15006
DR   Wikidata; Q54847563
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM15009
AC   CVCL_HE86
DR   CLO; CLO_0030296
DR   Coriell; GM15009
DR   Wikidata; Q54847564
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (Coriell=GM15009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HE88 ! ND00196
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM15010
AC   CVCL_HE87
DR   CLO; CLO_0030299
DR   Coriell; GM15010
DR   Wikidata; Q54847565
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (Coriell=GM15010).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM15012
AC   CVCL_5V23
DR   Coriell; GM15012
DR   Wikidata; Q54847566
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM15012; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM15024
AC   CVCL_5V25
DR   CLO; CLO_0030301
DR   Coriell; GM15024
DR   Wikidata; Q54847567
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15025
AC   CVCL_5V26
DR   CLO; CLO_0030300
DR   Coriell; GM15025
DR   Wikidata; Q54847568
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15026
AC   CVCL_5V27
DR   CLO; CLO_0030302
DR   Coriell; GM15026
DR   Wikidata; Q54847569
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15027
AC   CVCL_5V28
DR   CLO; CLO_0030303
DR   Coriell; GM15027
DR   Wikidata; Q54847570
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15028
AC   CVCL_5V29
DR   CLO; CLO_0030304
DR   Coriell; GM15028
DR   Wikidata; Q54847571
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15029
AC   CVCL_5V30
DR   CLO; CLO_0030305
DR   Coriell; GM15029
DR   GEO; GSM260553
DR   GEO; GSM260554
DR   GEO; GSM260555
DR   GEO; GSM260556
DR   Wikidata; Q54847572
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15029).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM15030
AC   CVCL_5V31
DR   CLO; CLO_0030306
DR   Coriell; GM15030
DR   Wikidata; Q54847573
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15031
AC   CVCL_5V32
DR   CLO; CLO_0030307
DR   Coriell; GM15031
DR   Wikidata; Q54847574
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15034
AC   CVCL_5V33
DR   CLO; CLO_0030308
DR   Coriell; GM15034
DR   Wikidata; Q54847576
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15035
AC   CVCL_5V34
DR   CLO; CLO_0030312
DR   Coriell; GM15035
DR   Wikidata; Q54847577
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15036
AC   CVCL_5V35
DR   CLO; CLO_0030311
DR   Coriell; GM15036
DR   GEO; GSM260557
DR   GEO; GSM260558
DR   GEO; GSM260559
DR   GEO; GSM260560
DR   GEO; GSM561295
DR   GEO; GSM561296
DR   GEO; GSM561297
DR   GEO; GSM561298
DR   GEO; GSM561299
DR   GEO; GSM561300
DR   GEO; GSM561301
DR   GEO; GSM561302
DR   GEO; GSM561303
DR   GEO; GSM561304
DR   GEO; GSM561305
DR   GEO; GSM561306
DR   GEO; GSM561307
DR   GEO; GSM561308
DR   GEO; GSM561309
DR   Wikidata; Q54847578
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=16187739;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM15037
AC   CVCL_5V36
DR   CLO; CLO_0030310
DR   Coriell; GM15037
DR   Wikidata; Q54847579
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15038
AC   CVCL_5V37
DR   CLO; CLO_0030309
DR   Coriell; GM15038
DR   GEO; GSM260605
DR   GEO; GSM260606
DR   GEO; GSM260607
DR   GEO; GSM260608
DR   Wikidata; Q54847580
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15039
AC   CVCL_5V38
DR   CLO; CLO_0030317
DR   Coriell; GM15039
DR   Wikidata; Q54847581
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15040
AC   CVCL_5V39
DR   CLO; CLO_0030318
DR   Coriell; GM15040
DR   Wikidata; Q54847582
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15041
AC   CVCL_5V40
DR   CLO; CLO_0030315
DR   Coriell; GM15041
DR   Wikidata; Q54847583
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15042
AC   CVCL_5V41
DR   CLO; CLO_0030316
DR   Coriell; GM15042
DR   Wikidata; Q54847584
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15043
AC   CVCL_5V42
DR   CLO; CLO_0030313
DR   Coriell; GM15043
DR   Wikidata; Q54847585
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15047
AC   CVCL_5V43
DR   CLO; CLO_0030314
DR   Coriell; GM15047
DR   Wikidata; Q54847586
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15048
AC   CVCL_5V44
DR   CLO; CLO_0030323
DR   Coriell; GM15048
DR   Wikidata; Q54847587
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15049
AC   CVCL_5V45
DR   CLO; CLO_0030320
DR   Coriell; GM15049
DR   Wikidata; Q54847588
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15050
AC   CVCL_5V46
DR   CLO; CLO_0030319
DR   Coriell; GM15050
DR   Wikidata; Q54847589
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM15050).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15051
AC   CVCL_5V47
DR   CLO; CLO_0030322
DR   Coriell; GM15051
DR   Wikidata; Q54847590
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15052
AC   CVCL_5V48
DR   CLO; CLO_0030321
DR   Coriell; GM15052
DR   Wikidata; Q54847591
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15053
AC   CVCL_5V49
DR   CLO; CLO_0030325
DR   Coriell; GM15053
DR   Wikidata; Q54847592
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15054
AC   CVCL_5V50
DR   CLO; CLO_0030326
DR   Coriell; GM15054
DR   Wikidata; Q54847593
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15055
AC   CVCL_5V51
DR   CLO; CLO_0030327
DR   Coriell; GM15055
DR   Wikidata; Q54847594
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15056
AC   CVCL_5V52
DR   CLO; CLO_0030328
DR   Coriell; GM15056
DR   GEO; GSM260609
DR   GEO; GSM260610
DR   GEO; GSM260611
DR   GEO; GSM260612
DR   Wikidata; Q54847595
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15061
AC   CVCL_5V53
DR   CLO; CLO_0030324
DR   Coriell; GM15061
DR   GEO; GSM260645
DR   GEO; GSM260646
DR   GEO; GSM260647
DR   GEO; GSM260648
DR   Wikidata; Q54847596
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15062
AC   CVCL_5V54
DR   CLO; CLO_0030329
DR   Coriell; GM15062
DR   Wikidata; Q54847597
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15063
AC   CVCL_5V55
DR   CLO; CLO_0030330
DR   Coriell; GM15063
DR   Wikidata; Q54847598
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15064
AC   CVCL_5V56
DR   CLO; CLO_0030333
DR   Coriell; GM15064
DR   Wikidata; Q54847599
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15065
AC   CVCL_5V57
DR   CLO; CLO_0030334
DR   Coriell; GM15065
DR   Wikidata; Q54847600
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15066
AC   CVCL_5V58
DR   CLO; CLO_0030331
DR   Coriell; GM15066
DR   Wikidata; Q54847601
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15067
AC   CVCL_5V59
DR   CLO; CLO_0030332
DR   Coriell; GM15067
DR   Wikidata; Q54847602
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15070
AC   CVCL_5V60
DR   CLO; CLO_0030338
DR   Coriell; GM15070
DR   Wikidata; Q54847613
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15072
AC   CVCL_5V61
DR   CLO; CLO_0030337
DR   Coriell; GM15072
DR   GEO; GSM260613
DR   GEO; GSM260614
DR   GEO; GSM260615
DR   GEO; GSM260616
DR   Wikidata; Q54847614
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15073
AC   CVCL_5V62
DR   CLO; CLO_0030336
DR   Coriell; GM15073
DR   Wikidata; Q54847615
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15075
AC   CVCL_5V63
DR   CLO; CLO_0030335
DR   Coriell; GM15075
DR   Wikidata; Q54847616
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15076
AC   CVCL_5V64
DR   CLO; CLO_0030339
DR   Coriell; GM15076
DR   Wikidata; Q54847617
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15077
AC   CVCL_5V65
DR   CLO; CLO_0030340
DR   Coriell; GM15077
DR   Wikidata; Q54847618
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15078
AC   CVCL_5V66
DR   CLO; CLO_0030341
DR   Coriell; GM15078
DR   Wikidata; Q54847619
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15079
AC   CVCL_5V67
DR   CLO; CLO_0030342
DR   Coriell; GM15079
DR   Wikidata; Q54847620
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15080
AC   CVCL_5V68
DR   CLO; CLO_0030343
DR   Coriell; GM15080
DR   Wikidata; Q54847621
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15081
AC   CVCL_5V69
DR   CLO; CLO_0030344
DR   Coriell; GM15081
DR   Wikidata; Q54847622
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15082
AC   CVCL_5V70
DR   CLO; CLO_0030345
DR   Coriell; GM15082
DR   Wikidata; Q54847623
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15083
AC   CVCL_5V71
DR   CLO; CLO_0030347
DR   Coriell; GM15083
DR   Wikidata; Q54847624
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15084
AC   CVCL_5V72
DR   CLO; CLO_0030346
DR   Coriell; GM15084
DR   Wikidata; Q54847625
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15085
AC   CVCL_5V73
DR   CLO; CLO_0030348
DR   Coriell; GM15085
DR   Wikidata; Q54847626
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15086
AC   CVCL_5V74
DR   CLO; CLO_0030357
DR   Coriell; GM15086
DR   Wikidata; Q54847628
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15087
AC   CVCL_5V75
DR   CLO; CLO_0030358
DR   Coriell; GM15087
DR   Wikidata; Q54847629
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15088
AC   CVCL_5V76
DR   CLO; CLO_0030355
DR   Coriell; GM15088
DR   Wikidata; Q54847630
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15089
AC   CVCL_5V77
DR   CLO; CLO_0030356
DR   Coriell; GM15089
DR   Wikidata; Q54847632
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15092
AC   CVCL_5V78
DR   CLO; CLO_0030353
DR   Coriell; GM15092
DR   Wikidata; Q54847633
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15093
AC   CVCL_5V79
DR   CLO; CLO_0030354
DR   Coriell; GM15093
DR   Wikidata; Q54847634
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15094
AC   CVCL_5V80
DR   CLO; CLO_0030351
DR   Coriell; GM15094
DR   Wikidata; Q54847635
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15095
AC   CVCL_5V81
DR   CLO; CLO_0030352
DR   Coriell; GM15095
DR   Wikidata; Q54847636
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15096
AC   CVCL_5V82
DR   CLO; CLO_0030360
DR   Coriell; GM15096
DR   Wikidata; Q54847637
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15097
AC   CVCL_5V83
DR   CLO; CLO_0030359
DR   Coriell; GM15097
DR   Wikidata; Q54847638
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15098
AC   CVCL_5V84
DR   CLO; CLO_0029775
DR   Coriell; GM15098
DR   Wikidata; Q54847639
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15099
AC   CVCL_5Q58
DR   CLO; CLO_0029776
DR   Coriell; GM15099
DR   Wikidata; Q54847640
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15100
AC   CVCL_5V85
DR   CLO; CLO_0029779
DR   Coriell; GM15100
DR   Wikidata; Q54847641
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15101
AC   CVCL_5V86
DR   CLO; CLO_0029780
DR   Coriell; GM15101
DR   Wikidata; Q54847642
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15102
AC   CVCL_5V87
DR   CLO; CLO_0029777
DR   Coriell; GM15102
DR   Wikidata; Q54847643
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15103
AC   CVCL_5V88
DR   CLO; CLO_0029778
DR   Coriell; GM15103
DR   Wikidata; Q54847644
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15104
AC   CVCL_5V89
DR   CLO; CLO_0029771
DR   Coriell; GM15104
DR   Wikidata; Q54847645
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15105
AC   CVCL_5V90
DR   CLO; CLO_0029772
DR   Coriell; GM15105
DR   Wikidata; Q54847647
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15106
AC   CVCL_5V91
DR   CLO; CLO_0029769
DR   Coriell; GM15106
DR   Wikidata; Q54847648
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15113
AC   CVCL_1S91
SY   WTR-14
DR   CLO; CLO_0029770
DR   Coriell; GM15113
DR   Wikidata; Q54847649
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM15118
AC   CVCL_5V92
DR   CLO; CLO_0029857
DR   Coriell; GM15118
DR   Wikidata; Q54847650
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15119
AC   CVCL_5V93
DR   CLO; CLO_0029861
DR   Coriell; GM15119
DR   Wikidata; Q54847651
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15120
AC   CVCL_5V94
DR   CLO; CLO_0029860
DR   Coriell; GM15120
DR   Wikidata; Q54847652
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15121
AC   CVCL_5V95
DR   CLO; CLO_0029851
DR   Coriell; GM15121
DR   Wikidata; Q54847653
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15122
AC   CVCL_5V96
DR   CLO; CLO_0029850
DR   Coriell; GM15122
DR   Wikidata; Q54847654
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15123
AC   CVCL_5V97
DR   CLO; CLO_0029856
DR   Coriell; GM15123
DR   Wikidata; Q54847655
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15125
AC   CVCL_5V98
DR   CLO; CLO_0029854
DR   Coriell; GM15125
DR   Wikidata; Q54847663
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15126
AC   CVCL_5V99
DR   CLO; CLO_0029866
DR   Coriell; GM15126
DR   Wikidata; Q54847664
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15127
AC   CVCL_5W00
DR   CLO; CLO_0029863
DR   Coriell; GM15127
DR   Wikidata; Q54847665
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15128
AC   CVCL_5W01
DR   CLO; CLO_0029869
DR   Coriell; GM15128
DR   Wikidata; Q54847666
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15129
AC   CVCL_5W02
DR   CLO; CLO_0029833
DR   Coriell; GM15129
DR   Wikidata; Q54847667
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15130
AC   CVCL_5W03
DR   CLO; CLO_0029831
DR   Coriell; GM15130
DR   Wikidata; Q54847668
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15131
AC   CVCL_5W04
DR   CLO; CLO_0029829
DR   Coriell; GM15131
DR   Wikidata; Q54847669
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15132
AC   CVCL_5W05
DR   CLO; CLO_0029828
DR   Coriell; GM15132
DR   Wikidata; Q54847670
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15133
AC   CVCL_5W06
DR   CLO; CLO_0029825
DR   Coriell; GM15133
DR   Wikidata; Q54847671
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15134
AC   CVCL_5W07
DR   CLO; CLO_0029823
DR   Coriell; GM15134
DR   Wikidata; Q54847674
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15135
AC   CVCL_5W08
DR   CLO; CLO_0029822
DR   Coriell; GM15135
DR   Wikidata; Q54847675
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15136
AC   CVCL_5W09
DR   CLO; CLO_0029820
DR   Coriell; GM15136
DR   Wikidata; Q54847676
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15137
AC   CVCL_5W10
DR   CLO; CLO_0029838
DR   Coriell; GM15137
DR   Wikidata; Q54847677
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15138
AC   CVCL_5W11
DR   CLO; CLO_0029836
DR   Coriell; GM15138
DR   Wikidata; Q54847678
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15140
AC   CVCL_5W12
DR   CLO; CLO_0029938
DR   Coriell; GM15140
DR   Wikidata; Q54847679
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15141
AC   CVCL_5W13
DR   CLO; CLO_0029912
DR   Coriell; GM15141
DR   Wikidata; Q54847680
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15142
AC   CVCL_5W14
DR   CLO; CLO_0029910
DR   Coriell; GM15142
DR   Wikidata; Q54847681
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15144
AC   CVCL_5W15
DR   CLO; CLO_0029916
DR   Coriell; GM15144
DR   GEO; GSM260617
DR   GEO; GSM260618
DR   GEO; GSM260619
DR   GEO; GSM260620
DR   Wikidata; Q54847682
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15146
AC   CVCL_5W16
DR   CLO; CLO_0029913
DR   Coriell; GM15146
DR   Wikidata; Q54847683
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15151
AC   CVCL_5W17
DR   CLO; CLO_0029919
DR   Coriell; GM15151
DR   Wikidata; Q54847684
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15153
AC   CVCL_5W18
DR   CLO; CLO_0029917
DR   Coriell; GM15153
DR   Wikidata; Q54847685
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15154
AC   CVCL_5W19
DR   CLO; CLO_0029924
DR   Coriell; GM15154
DR   Wikidata; Q54847686
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15155
AC   CVCL_5W20
DR   CLO; CLO_0029922
DR   Coriell; GM15155
DR   Wikidata; Q54847687
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15156
AC   CVCL_5W21
DR   CLO; CLO_0029925
DR   Coriell; GM15156
DR   Wikidata; Q54847688
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15158
AC   CVCL_5W22
DR   CLO; CLO_0029907
DR   Coriell; GM15158
DR   Wikidata; Q54847689
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15159
AC   CVCL_5W23
DR   CLO; CLO_0029908
DR   Coriell; GM15159
DR   Wikidata; Q54847691
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15160
AC   CVCL_5W24
DR   CLO; CLO_0029892
DR   Coriell; GM15160
DR   Wikidata; Q54847692
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15161
AC   CVCL_5W25
DR   CLO; CLO_0029891
DR   Coriell; GM15161
DR   Wikidata; Q54847693
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15162
AC   CVCL_5W26
DR   CLO; CLO_0029890
DR   Coriell; GM15162
DR   Wikidata; Q54847694
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15163
AC   CVCL_5W27
DR   CLO; CLO_0029889
DR   Coriell; GM15163
DR   Wikidata; Q54847695
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15164
AC   CVCL_5W28
DR   CLO; CLO_0029896
DR   Coriell; GM15164
DR   Wikidata; Q54847696
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15165
AC   CVCL_5W29
DR   CLO; CLO_0029895
DR   Coriell; GM15165
DR   Wikidata; Q54847697
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15166
AC   CVCL_5W30
DR   CLO; CLO_0029894
DR   Coriell; GM15166
DR   Wikidata; Q54847698
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15170
AC   CVCL_5W31
DR   CLO; CLO_0029893
DR   Coriell; GM15170
DR   Wikidata; Q54847699
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15176
AC   CVCL_5W32
DR   CLO; CLO_0027518
DR   Coriell; GM15176
DR   Wikidata; Q54847700
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15177
AC   CVCL_5W33
DR   CLO; CLO_0027516
DR   Coriell; GM15177
DR   Wikidata; Q54847701
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15178
AC   CVCL_5W34
DR   CLO; CLO_0027517
DR   Coriell; GM15178
DR   Wikidata; Q54847702
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15179
AC   CVCL_5W35
DR   CLO; CLO_0027512
DR   Coriell; GM15179
DR   Wikidata; Q54847703
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15181
AC   CVCL_5W36
DR   CLO; CLO_0027511
DR   Coriell; GM15181
DR   Wikidata; Q54847704
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15183
AC   CVCL_5W37
DR   CLO; CLO_0027510
DR   Coriell; GM15183
DR   Wikidata; Q54847705
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15184
AC   CVCL_5W38
DR   CLO; CLO_0027509
DR   Coriell; GM15184
DR   Wikidata; Q54847712
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15185
AC   CVCL_5W39
DR   CLO; CLO_0027515
DR   Coriell; GM15185
DR   Wikidata; Q54847713
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15186
AC   CVCL_N247
SY   GM17200
DR   CLO; CLO_0013840
DR   CLO; CLO_0027514
DR   Coriell; GM15186
DR   Coriell; GM17200
DR   GEO; GSM273454
DR   GEO; GSM569751
DR   GEO; GSM596264
DR   GEO; GSM597059
DR   IPD-IMGT/HLA; 15810
DR   Wikidata; Q54847714
RX   PubMed=16260726;
RX   PubMed=20210923;
RX   PubMed=23665875;
CC   Part of: Human variation panel.
CC   Population: African American.
CC   HLA typing: A*03:02,31:CGAJ; B*14:02,57:03; C*07:CVAG,08:02; DRB1*15:01,15:03 (IPD-IMGT/HLA=15810).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM15187
AC   CVCL_5W40
DR   CLO; CLO_0027513
DR   Coriell; GM15187
DR   Wikidata; Q54847715
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15191
AC   CVCL_5W41
DR   CLO; CLO_0027505
DR   Coriell; GM15191
DR   Wikidata; Q54847717
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15192
AC   CVCL_5W42
DR   CLO; CLO_0027506
DR   Coriell; GM15192
DR   Wikidata; Q54847718
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15193
AC   CVCL_5W43
DR   CLO; CLO_0027507
DR   Coriell; GM15193
DR   Wikidata; Q54847719
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15194
AC   CVCL_5W44
DR   CLO; CLO_0027508
DR   Coriell; GM15194
DR   Wikidata; Q54847722
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15199
AC   CVCL_0R55
DR   CLO; CLO_0027500
DR   Coriell; GM15199
DR   Wikidata; Q54847723
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15200
AC   CVCL_0R56
DR   CLO; CLO_0027499
DR   Coriell; GM15200
DR   Wikidata; Q54847724
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15201
AC   CVCL_0R57
DR   CLO; CLO_0027502
DR   Coriell; GM15201
DR   Wikidata; Q54847726
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15202
AC   CVCL_0R58
DR   CLO; CLO_0027501
DR   Coriell; GM15202
DR   Wikidata; Q54847727
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15203
AC   CVCL_0R59
DR   CLO; CLO_0027504
DR   Coriell; GM15203
DR   Wikidata; Q54847728
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15204
AC   CVCL_0R60
DR   CLO; CLO_0027503
DR   Coriell; GM15204
DR   Wikidata; Q54847729
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15205
AC   CVCL_0R61
DR   CLO; CLO_0027498
DR   Coriell; GM15205
DR   Wikidata; Q54847730
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15206
AC   CVCL_0R62
DR   CLO; CLO_0027496
DR   Coriell; GM15206
DR   Wikidata; Q54847731
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15207
AC   CVCL_0R63
DR   CLO; CLO_0027497
DR   Coriell; GM15207
DR   Wikidata; Q54847732
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15208
AC   CVCL_0R64
DR   CLO; CLO_0027494
DR   Coriell; GM15208
DR   Wikidata; Q54847733
CC   Part of: Human variation panel.
CC   Population: Caucasian; Hungarian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM15212
AC   CVCL_5W45
DR   CLO; CLO_0027495
DR   Coriell; GM15212
DR   Wikidata; Q54847735
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15213
AC   CVCL_5W46
DR   CLO; CLO_0027493
DR   Coriell; GM15213
DR   GEO; GSM260585
DR   GEO; GSM260586
DR   GEO; GSM260587
DR   GEO; GSM260588
DR   Wikidata; Q54847736
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15215
AC   CVCL_5W47
DR   CLO; CLO_0027492
DR   Coriell; GM15215
DR   GEO; GSM260561
DR   GEO; GSM260562
DR   GEO; GSM260563
DR   GEO; GSM260564
DR   Wikidata; Q54847737
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15216
AC   CVCL_5W48
DR   CLO; CLO_0027491
DR   Coriell; GM15216
DR   GEO; GSM260621
DR   GEO; GSM260622
DR   GEO; GSM260623
DR   GEO; GSM260624
DR   Wikidata; Q54847738
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM15216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM15217
AC   CVCL_5W49
DR   CLO; CLO_0027490
DR   Coriell; GM15217
DR   Wikidata; Q54847739
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15219
AC   CVCL_5W50
DR   CLO; CLO_0027489
DR   Coriell; GM15219
DR   Wikidata; Q54847740
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15221
AC   CVCL_5W51
DR   CLO; CLO_0027487
DR   Coriell; GM15221
DR   GEO; GSM260589
DR   GEO; GSM260590
DR   GEO; GSM260591
DR   GEO; GSM260592
DR   Wikidata; Q54847741
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15222
AC   CVCL_5W52
DR   CLO; CLO_0027488
DR   Coriell; GM15222
DR   Wikidata; Q54847742
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15223
AC   CVCL_5W53
DR   CLO; CLO_0027483
DR   Coriell; GM15223
DR   GEO; GSM260565
DR   GEO; GSM260566
DR   GEO; GSM260567
DR   GEO; GSM260568
DR   Wikidata; Q54847743
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15224
AC   CVCL_5W54
DR   CLO; CLO_0027484
DR   Coriell; GM15224
DR   GEO; GSM260573
DR   GEO; GSM260574
DR   GEO; GSM260575
DR   GEO; GSM260576
DR   Wikidata; Q54847744
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15225
AC   CVCL_5W55
DR   CLO; CLO_0027485
DR   Coriell; GM15225
DR   Wikidata; Q54847745
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15226
AC   CVCL_5W56
DR   CLO; CLO_0027486
DR   Coriell; GM15226
DR   GEO; GSM260625
DR   GEO; GSM260626
DR   GEO; GSM260627
DR   GEO; GSM260628
DR   Wikidata; Q54847746
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15227
AC   CVCL_5W57
DR   CLO; CLO_0027473
DR   Coriell; GM15227
DR   GEO; GSM260593
DR   GEO; GSM260594
DR   GEO; GSM260595
DR   GEO; GSM260596
DR   Wikidata; Q54847747
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15228
AC   CVCL_5W58
DR   CLO; CLO_0027470
DR   Coriell; GM15228
DR   Wikidata; Q54847748
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15228).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15229
AC   CVCL_5W59
DR   CLO; CLO_0027477
DR   Coriell; GM15229
DR   Wikidata; Q54847749
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15230
AC   CVCL_5W60
DR   CLO; CLO_0027474
DR   Coriell; GM15230
DR   Wikidata; Q54847750
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15232
AC   CVCL_2U45
DR   CLO; CLO_0027464
DR   Coriell; GM15232
DR   Wikidata; Q54847751
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM15233
AC   CVCL_5V24
DR   CLO; CLO_0027463
DR   Coriell; GM15233
DR   Wikidata; Q54847752
CC   Population: Caucasian; Northern European.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98978; Meckel-Gruber syndrome
DI   ORDO; Orphanet_564; Meckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM15234
AC   CVCL_5W61
DR   CLO; CLO_0027462
DR   Coriell; GM15234
DR   Wikidata; Q54847753
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15235
AC   CVCL_5W62
DR   CLO; CLO_0027468
DR   Coriell; GM15235
DR   Wikidata; Q54847754
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15236
AC   CVCL_5W63
DR   CLO; CLO_0027467
DR   Coriell; GM15236
DR   GEO; GSM260577
DR   GEO; GSM260578
DR   GEO; GSM260579
DR   GEO; GSM260580
DR   Wikidata; Q54847755
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15237
AC   CVCL_5W64
DR   CLO; CLO_0027466
DR   Coriell; GM15237
DR   Wikidata; Q54847756
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15238
AC   CVCL_5W65
DR   CLO; CLO_0027465
DR   Coriell; GM15238
DR   Wikidata; Q54847760
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15239
AC   CVCL_5W66
DR   CLO; CLO_0027453
DR   Coriell; GM15239
DR   Wikidata; Q54847761
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15241
AC   CVCL_5W67
DR   CLO; CLO_0027454
DR   Coriell; GM15241
DR   Wikidata; Q54847762
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15242
AC   CVCL_5W68
DR   CLO; CLO_0027447
DR   Coriell; GM15242
DR   GEO; GSM260629
DR   GEO; GSM260630
DR   GEO; GSM260631
DR   GEO; GSM260632
DR   Wikidata; Q54847763
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM15242).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM15243
AC   CVCL_5W69
DR   CLO; CLO_0027397
DR   Coriell; GM15243
DR   Wikidata; Q54847764
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15244
AC   CVCL_5W70
DR   CLO; CLO_0027393
DR   Coriell; GM15244
DR   Wikidata; Q54847765
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM15244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15245
AC   CVCL_5W71
DR   CLO; CLO_0027391
DR   Coriell; GM15245
DR   GEO; GSM260569
DR   GEO; GSM260570
DR   GEO; GSM260571
DR   GEO; GSM260572
DR   Wikidata; Q54847766
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=18805990;
RX   PubMed=31401124;
RX   PubMed=35931342;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM15247
AC   CVCL_5W72
DR   CLO; CLO_0027388
DR   Coriell; GM15247
DR   Wikidata; Q54847767
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15248
AC   CVCL_5W73
DR   CLO; CLO_0027384
DR   Coriell; GM15248
DR   Wikidata; Q54847768
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15249
AC   CVCL_5W74
DR   CLO; CLO_0027411
DR   Coriell; GM15249
DR   Wikidata; Q54847769
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15250
AC   CVCL_5W75
DR   CLO; CLO_0027410
DR   Coriell; GM15250
DR   Wikidata; Q54847770
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15251
AC   CVCL_5W76
DR   CLO; CLO_0027408
DR   Coriell; GM15251
DR   Wikidata; Q54847771
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15252
AC   CVCL_5W77
DR   CLO; CLO_0027406
DR   Coriell; GM15252
DR   Wikidata; Q54847772
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15256
AC   CVCL_5W78
DR   CLO; CLO_0027405
DR   Coriell; GM15256
DR   Wikidata; Q54847773
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15257
AC   CVCL_5W79
DR   CLO; CLO_0027310
DR   Coriell; GM15257
DR   Wikidata; Q54847774
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15259
AC   CVCL_5W80
DR   CLO; CLO_0027308
DR   Coriell; GM15259
DR   Wikidata; Q54847776
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15260
AC   CVCL_5W81
DR   CLO; CLO_0027318
DR   Coriell; GM15260
DR   Wikidata; Q54847777
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15261
AC   CVCL_5W82
DR   CLO; CLO_0027313
DR   Coriell; GM15261
DR   Wikidata; Q54847778
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15263
AC   CVCL_5W83
DR   CLO; CLO_0027324
DR   Coriell; GM15263
DR   Wikidata; Q54847779
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15264
AC   CVCL_5W84
DR   CLO; CLO_0027320
DR   Coriell; GM15264
DR   Wikidata; Q54847780
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15265
AC   CVCL_5W85
DR   CLO; CLO_0027326
DR   Coriell; GM15265
DR   Wikidata; Q54847781
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15266
AC   CVCL_GZ14
DR   Coriell; GM15266
DR   Wikidata; Q54847782
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM15266; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM15267
AC   CVCL_5W86
DR   CLO; CLO_0027325
DR   Coriell; GM15267
DR   Wikidata; Q54847783
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15268
AC   CVCL_5W87
DR   CLO; CLO_0027328
DR   Coriell; GM15268
DR   GEO; GSM260633
DR   GEO; GSM260634
DR   GEO; GSM260635
DR   GEO; GSM260636
DR   Wikidata; Q54847784
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=16187739;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15269
AC   CVCL_5W88
DR   CLO; CLO_0027327
DR   Coriell; GM15269
DR   Wikidata; Q54847785
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15270
AC   CVCL_5W89
DR   CLO; CLO_0027344
DR   Coriell; GM15270
DR   Wikidata; Q54847786
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15271
AC   CVCL_5W90
DR   CLO; CLO_0027340
DR   Coriell; GM15271
DR   Wikidata; Q54847787
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15272
AC   CVCL_5W91
DR   CLO; CLO_0027337
DR   Coriell; GM15272
DR   Wikidata; Q54847788
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15273
AC   CVCL_5W92
DR   CLO; CLO_0027355
DR   Coriell; GM15273
DR   Wikidata; Q54847789
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15274
AC   CVCL_5W93
DR   CLO; CLO_0027353
DR   Coriell; GM15274
DR   Wikidata; Q54847790
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15276
AC   CVCL_5W94
DR   CLO; CLO_0027351
DR   Coriell; GM15276
DR   Wikidata; Q54847791
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15277
AC   CVCL_5W95
DR   CLO; CLO_0027348
DR   Coriell; GM15277
DR   Wikidata; Q54847792
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15278
AC   CVCL_5W96
DR   CLO; CLO_0027360
DR   Coriell; GM15278
DR   Wikidata; Q54847793
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15279
AC   CVCL_5W97
DR   CLO; CLO_0027359
DR   Coriell; GM15279
DR   Wikidata; Q54847794
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15280
AC   CVCL_5W98
DR   CLO; CLO_0027358
DR   Coriell; GM15280
DR   Wikidata; Q54847795
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15281
AC   CVCL_5W99
DR   CLO; CLO_0027248
DR   Coriell; GM15281
DR   Wikidata; Q54847796
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15282
AC   CVCL_5Y00
DR   CLO; CLO_0027249
DR   Coriell; GM15282
DR   Wikidata; Q54847797
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15283
AC   CVCL_5Y01
DR   CLO; CLO_0027251
DR   Coriell; GM15283
DR   Wikidata; Q54847798
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15284
AC   CVCL_5Y02
DR   CLO; CLO_0027252
DR   Coriell; GM15284
DR   Wikidata; Q54847799
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15285
AC   CVCL_5Y03
DR   CLO; CLO_0027238
DR   Coriell; GM15285
DR   Wikidata; Q54847800
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15286
AC   CVCL_5Y04
DR   CLO; CLO_0027240
DR   Coriell; GM15286
DR   Wikidata; Q54847804
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15286).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15287
AC   CVCL_5Y05
DR   CLO; CLO_0027244
DR   Coriell; GM15287
DR   Wikidata; Q54847805
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15288
AC   CVCL_5Y06
DR   CLO; CLO_0027246
DR   Coriell; GM15288
DR   Wikidata; Q54847806
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15289
AC   CVCL_5Y07
DR   CLO; CLO_0027227
DR   Coriell; GM15289
DR   Wikidata; Q54847807
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15292
AC   CVCL_1S92
SY   0044 Rag 1-15; GM0044RAG1-15
DR   CLO; CLO_0027232
DR   Coriell; GM15292
DR   Wikidata; Q54847808
RX   PubMed=1663489;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H953 ! GM00044
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM15296
AC   CVCL_1S93
SY   2068RAG22-2
DR   CLO; CLO_0027253
DR   Coriell; GM15296
DR   Wikidata; Q54847809
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N60 ! GM02068
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM15297
AC   CVCL_1S94
DR   CLO; CLO_0027292
DR   Coriell; GM15297
DR   Wikidata; Q54847810
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM15301
AC   CVCL_1S95
DR   CLO; CLO_0027293
DR   Coriell; GM15301
DR   Wikidata; Q54847811
RX   PubMed=1663489;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM15302
AC   CVCL_1S96
DR   CLO; CLO_0027290
DR   Coriell; GM15302
DR   Wikidata; Q54847812
RX   PubMed=1663489;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM15307
AC   CVCL_5Y08
DR   CLO; CLO_0027291
DR   Coriell; GM15307
DR   Wikidata; Q54847813
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15308
AC   CVCL_5Y09
DR   CLO; CLO_0027284
DR   Coriell; GM15308
DR   Wikidata; Q54847814
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15309
AC   CVCL_5Y10
DR   CLO; CLO_0027288
DR   Coriell; GM15309
DR   Wikidata; Q54847815
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15310
AC   CVCL_5Y11
DR   CLO; CLO_0027278
DR   Coriell; GM15310
DR   Wikidata; Q54847816
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15311
AC   CVCL_5Y12
DR   CLO; CLO_0027282
DR   Coriell; GM15311
DR   Wikidata; Q54847817
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15312
AC   CVCL_5Y13
DR   CLO; CLO_0027274
DR   Coriell; GM15312
DR   Wikidata; Q54847818
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15313
AC   CVCL_5Y14
DR   CLO; CLO_0027149
DR   Coriell; GM15313
DR   Wikidata; Q54847819
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15314
AC   CVCL_5Y15
DR   CLO; CLO_0027147
DR   Coriell; GM15314
DR   Wikidata; Q54847820
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15315
AC   CVCL_5Y16
DR   CLO; CLO_0027165
DR   Coriell; GM15315
DR   Wikidata; Q54847821
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15316
AC   CVCL_5Y17
DR   CLO; CLO_0027167
DR   Coriell; GM15316
DR   Wikidata; Q54847822
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15317
AC   CVCL_5Y18
DR   CLO; CLO_0027168
DR   Coriell; GM15317
DR   Wikidata; Q54847823
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15318
AC   CVCL_5Y19
DR   CLO; CLO_0027169
DR   Coriell; GM15318
DR   Wikidata; Q54847824
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15319
AC   CVCL_5Y20
DR   CLO; CLO_0027170
DR   Coriell; GM15319
DR   Wikidata; Q54847825
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15320
AC   CVCL_5Y21
DR   CLO; CLO_0027173
DR   Coriell; GM15320
DR   Wikidata; Q54847826
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15321
AC   CVCL_5Y22
DR   CLO; CLO_0027175
DR   Coriell; GM15321
DR   Wikidata; Q54847827
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15322
AC   CVCL_5Y23
DR   CLO; CLO_0027178
DR   Coriell; GM15322
DR   Wikidata; Q54847828
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15323
AC   CVCL_5Y24
DR   CLO; CLO_0027183
DR   Coriell; GM15323
DR   Wikidata; Q54847829
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15324
AC   CVCL_5Y25
DR   CLO; CLO_0027182
DR   Coriell; GM15324
DR   GEO; GSM260637
DR   GEO; GSM260638
DR   GEO; GSM260639
DR   GEO; GSM260640
DR   Wikidata; Q54847830
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15325
AC   CVCL_5Y26
DR   CLO; CLO_0027181
DR   Coriell; GM15325
DR   Wikidata; Q54847831
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15326
AC   CVCL_5Y27
DR   CLO; CLO_0027201
DR   Coriell; GM15326
DR   Wikidata; Q54847832
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15327
AC   CVCL_5Y28
DR   CLO; CLO_0027204
DR   Coriell; GM15327
DR   Wikidata; Q54847833
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15328
AC   CVCL_5Y29
DR   CLO; CLO_0027199
DR   Coriell; GM15328
DR   Wikidata; Q54847834
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15330
AC   CVCL_5Y30
DR   CLO; CLO_0027200
DR   Coriell; GM15330
DR   Wikidata; Q54847835
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM15330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15331
AC   CVCL_5Y31
DR   CLO; CLO_0027209
DR   Coriell; GM15331
DR   Wikidata; Q54847836
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15332
AC   CVCL_5Y32
DR   CLO; CLO_0027210
DR   Coriell; GM15332
DR   Wikidata; Q54847837
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15333
AC   CVCL_5Y33
DR   CLO; CLO_0027206
DR   Coriell; GM15333
DR   Wikidata; Q54847838
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15333).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15334
AC   CVCL_5Y34
DR   CLO; CLO_0026947
DR   Coriell; GM15334
DR   Wikidata; Q54847839
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15334).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15335
AC   CVCL_5Y35
DR   CLO; CLO_0026948
DR   Coriell; GM15335
DR   Wikidata; Q54847840
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15336
AC   CVCL_5Y36
DR   CLO; CLO_0026945
DR   Coriell; GM15336
DR   Wikidata; Q54847841
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15337
AC   CVCL_5Y37
DR   CLO; CLO_0026946
DR   Coriell; GM15337
DR   Wikidata; Q54847842
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15339
AC   CVCL_5Y38
DR   CLO; CLO_0026942
DR   Coriell; GM15339
DR   Wikidata; Q54847843
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15340
AC   CVCL_5Y39
DR   CLO; CLO_0026941
DR   Coriell; GM15340
DR   Wikidata; Q54847849
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15341
AC   CVCL_5Y40
DR   CLO; CLO_0026940
DR   Coriell; GM15341
DR   Wikidata; Q54847850
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15342
AC   CVCL_5Y41
DR   CLO; CLO_0026939
DR   Coriell; GM15342
DR   Wikidata; Q54847851
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15343
AC   CVCL_5Y42
DR   CLO; CLO_0026944
DR   Coriell; GM15343
DR   Wikidata; Q54847852
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15344
AC   CVCL_5Y43
DR   CLO; CLO_0026943
DR   Coriell; GM15344
DR   Wikidata; Q54847853
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15346
AC   CVCL_5Y44
DR   CLO; CLO_0026934
DR   Coriell; GM15346
DR   Wikidata; Q54847854
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15348
AC   CVCL_5Y45
DR   CLO; CLO_0026935
DR   Coriell; GM15348
DR   Wikidata; Q54847855
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15348).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15349
AC   CVCL_5Y46
DR   CLO; CLO_0026936
DR   Coriell; GM15349
DR   Wikidata; Q54847856
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM15349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15351
AC   CVCL_5Y47
DR   CLO; CLO_0026937
DR   Coriell; GM15351
DR   Wikidata; Q54847857
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15352
AC   CVCL_5Y48
DR   CLO; CLO_0026938
DR   Coriell; GM15352
DR   Wikidata; Q54847858
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15354
AC   CVCL_5Y49
DR   CLO; CLO_0026928
DR   Coriell; GM15354
DR   Wikidata; Q54847859
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15355
AC   CVCL_5Y50
DR   CLO; CLO_0026925
DR   Coriell; GM15355
DR   Wikidata; Q54847861
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15356
AC   CVCL_5Y51
DR   CLO; CLO_0026932
DR   Coriell; GM15356
DR   Wikidata; Q54847862
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15357
AC   CVCL_5Y52
DR   CLO; CLO_0026930
DR   Coriell; GM15357
DR   Wikidata; Q54847863
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15359
AC   CVCL_5Y53
DR   CLO; CLO_0026933
DR   Coriell; GM15359
DR   Wikidata; Q54847864
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15360
AC   CVCL_5Y54
DR   CLO; CLO_0026977
DR   Coriell; GM15360
DR   Wikidata; Q54847865
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15361
AC   CVCL_5Y55
DR   CLO; CLO_0026978
DR   Coriell; GM15361
DR   Wikidata; Q54847866
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15362
AC   CVCL_5Y56
DR   CLO; CLO_0026975
DR   Coriell; GM15362
DR   Wikidata; Q54847867
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15363
AC   CVCL_5Y57
DR   CLO; CLO_0026976
DR   Coriell; GM15363
DR   Wikidata; Q54847868
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15364
AC   CVCL_5Y58
DR   CLO; CLO_0026973
DR   Coriell; GM15364
DR   Wikidata; Q54847869
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15365
AC   CVCL_5Y59
DR   CLO; CLO_0026974
DR   Coriell; GM15365
DR   Wikidata; Q54847870
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15366
AC   CVCL_5Y60
DR   CLO; CLO_0026971
DR   Coriell; GM15366
DR   Wikidata; Q54847871
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15367
AC   CVCL_5Y61
DR   CLO; CLO_0026969
DR   Coriell; GM15367
DR   Wikidata; Q54847872
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15367).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15368
AC   CVCL_5Y62
DR   CLO; CLO_0026968
DR   Coriell; GM15368
DR   Wikidata; Q54847873
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15369
AC   CVCL_5Y63
DR   CLO; CLO_0026965
DR   Coriell; GM15369
DR   Wikidata; Q54847874
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15370
AC   CVCL_5Y64
DR   CLO; CLO_0026419
DR   Coriell; GM15370
DR   Wikidata; Q54847875
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15371
AC   CVCL_5Y65
DR   CLO; CLO_0026420
DR   Coriell; GM15371
DR   Wikidata; Q54847876
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15372
AC   CVCL_5Y66
DR   CLO; CLO_0026421
DR   Coriell; GM15372
DR   Wikidata; Q54847877
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15373
AC   CVCL_5Y67
DR   CLO; CLO_0026422
DR   Coriell; GM15373
DR   Wikidata; Q54847878
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15374
AC   CVCL_5Y68
DR   CLO; CLO_0026423
DR   Coriell; GM15374
DR   Wikidata; Q54847879
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15375
AC   CVCL_5Y69
DR   CLO; CLO_0026424
DR   Coriell; GM15375
DR   Wikidata; Q54847880
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15376
AC   CVCL_5Y70
DR   CLO; CLO_0026425
DR   Coriell; GM15376
DR   Wikidata; Q54847881
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15377
AC   CVCL_5Y71
DR   CLO; CLO_0026426
DR   Coriell; GM15377
DR   Wikidata; Q54847882
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15379
AC   CVCL_5Y72
DR   CLO; CLO_0026428
DR   Coriell; GM15379
DR   Wikidata; Q54847883
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15380
AC   CVCL_5Y73
DR   CLO; CLO_0026430
DR   Coriell; GM15380
DR   Wikidata; Q54847884
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15381
AC   CVCL_5Y74
DR   CLO; CLO_0026797
DR   Coriell; GM15381
DR   Wikidata; Q54847885
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15382
AC   CVCL_5Y75
DR   CLO; CLO_0026784
DR   Coriell; GM15382
DR   Wikidata; Q54847886
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15383
AC   CVCL_5Y76
DR   CLO; CLO_0026780
DR   Coriell; GM15383
DR   Wikidata; Q54847888
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15385
AC   CVCL_5Y77
DR   CLO; CLO_0026789
DR   Coriell; GM15385
DR   GEO; GSM260597
DR   GEO; GSM260598
DR   GEO; GSM260599
DR   GEO; GSM260600
DR   Wikidata; Q54847889
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15386
AC   CVCL_5Y78
DR   CLO; CLO_0026786
DR   Coriell; GM15386
DR   GEO; GSM260641
DR   GEO; GSM260642
DR   GEO; GSM260643
DR   GEO; GSM260644
DR   Wikidata; Q54847890
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15386).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM15388
AC   CVCL_5Y79
DR   CLO; CLO_0026774
DR   Coriell; GM15388
DR   Wikidata; Q54847899
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15389
AC   CVCL_5Y80
DR   CLO; CLO_0026773
DR   Coriell; GM15389
DR   Wikidata; Q54847900
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15391
AC   CVCL_5Y81
DR   CLO; CLO_0026777
DR   Coriell; GM15391
DR   Wikidata; Q54847901
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15392
AC   CVCL_5Y82
DR   CLO; CLO_0026776
DR   Coriell; GM15392
DR   Wikidata; Q54847902
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15393
AC   CVCL_5Y83
DR   CLO; CLO_0026771
DR   Coriell; GM15393
DR   Wikidata; Q54847903
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15394
AC   CVCL_5Y84
DR   CLO; CLO_0026827
DR   Coriell; GM15394
DR   Wikidata; Q54847904
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15397
AC   CVCL_5Y85
DR   CLO; CLO_0026822
DR   Coriell; GM15397
DR   Wikidata; Q54847905
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15398
AC   CVCL_5Y86
DR   CLO; CLO_0026819
DR   Coriell; GM15398
DR   Wikidata; Q54847906
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15399
AC   CVCL_5Y87
DR   CLO; CLO_0026816
DR   Coriell; GM15399
DR   Wikidata; Q54847907
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15400
AC   CVCL_5Y88
DR   CLO; CLO_0026813
DR   Coriell; GM15400
DR   Wikidata; Q54847908
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15401
AC   CVCL_5Y89
DR   CLO; CLO_0026812
DR   Coriell; GM15401
DR   Wikidata; Q54847909
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15402
AC   CVCL_5Y90
DR   CLO; CLO_0026809
DR   Coriell; GM15402
DR   Wikidata; Q54847910
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15403
AC   CVCL_5Y91
DR   CLO; CLO_0026808
DR   Coriell; GM15403
DR   Wikidata; Q54847911
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15405
AC   CVCL_5Y92
DR   CLO; CLO_0026807
DR   Coriell; GM15405
DR   Wikidata; Q54847912
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15406
AC   CVCL_5Y93
DR   CLO; CLO_0026805
DR   Coriell; GM15406
DR   Wikidata; Q54847913
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15407
AC   CVCL_5Y94
DR   CLO; CLO_0026838
DR   Coriell; GM15407
DR   Wikidata; Q54847914
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15409
AC   CVCL_5Y95
DR   CLO; CLO_0026844
DR   Coriell; GM15409
DR   Wikidata; Q54847915
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15412
AC   CVCL_5Y96
DR   CLO; CLO_0026841
DR   Coriell; GM15412
DR   Wikidata; Q54847916
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15414
AC   CVCL_5Y97
DR   CLO; CLO_0026850
DR   Coriell; GM15414
DR   Wikidata; Q54847917
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15416
AC   CVCL_5Y98
DR   CLO; CLO_0026849
DR   Coriell; GM15416
DR   Wikidata; Q54847918
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15417
AC   CVCL_5Y99
DR   CLO; CLO_0026858
DR   Coriell; GM15417
DR   Wikidata; Q54847919
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15418
AC   CVCL_5Z00
DR   CLO; CLO_0026855
DR   Coriell; GM15418
DR   Wikidata; Q54847920
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15419
AC   CVCL_5Z01
DR   CLO; CLO_0026836
DR   Coriell; GM15419
DR   Wikidata; Q54847921
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15420
AC   CVCL_5Z02
DR   CLO; CLO_0026835
DR   Coriell; GM15420
DR   Wikidata; Q54847922
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15421
AC   CVCL_5Z03
DR   CLO; CLO_0026837
DR   Coriell; GM15421
DR   Wikidata; Q54847923
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15422
AC   CVCL_5Z04
DR   CLO; CLO_0026870
DR   Coriell; GM15422
DR   Wikidata; Q54847925
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15423
AC   CVCL_5Z05
DR   CLO; CLO_0026869
DR   Coriell; GM15423
DR   Wikidata; Q54847926
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15426
AC   CVCL_5Z06
DR   CLO; CLO_0026868
DR   Coriell; GM15426
DR   Wikidata; Q54847927
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15427
AC   CVCL_5Z07
DR   CLO; CLO_0026866
DR   Coriell; GM15427
DR   Wikidata; Q54847928
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15428
AC   CVCL_5Z08
DR   CLO; CLO_0026878
DR   Coriell; GM15428
DR   Wikidata; Q54847929
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15429
AC   CVCL_5Z09
DR   CLO; CLO_0026876
DR   Coriell; GM15429
DR   Wikidata; Q54847930
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15431
AC   CVCL_5Z10
DR   CLO; CLO_0026873
DR   Coriell; GM15431
DR   Wikidata; Q54847931
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15432
AC   CVCL_5Z11
DR   CLO; CLO_0026872
DR   Coriell; GM15432
DR   Wikidata; Q54847932
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15433
AC   CVCL_5Z12
DR   CLO; CLO_0026865
DR   Coriell; GM15433
DR   Wikidata; Q54847933
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15434
AC   CVCL_5Z13
DR   CLO; CLO_0026864
DR   Coriell; GM15434
DR   Wikidata; Q54847934
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15435
AC   CVCL_5Z14
DR   CLO; CLO_0026613
DR   Coriell; GM15435
DR   Wikidata; Q54847935
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15436
AC   CVCL_5Z15
DR   CLO; CLO_0026636
DR   Coriell; GM15436
DR   Wikidata; Q54847936
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15437
AC   CVCL_5Z16
DR   CLO; CLO_0026637
DR   Coriell; GM15437
DR   Wikidata; Q54847937
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15438
AC   CVCL_5Z17
DR   CLO; CLO_0026638
DR   Coriell; GM15438
DR   Wikidata; Q54847938
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15439
AC   CVCL_5Z18
DR   CLO; CLO_0026639
DR   Coriell; GM15439
DR   Wikidata; Q54847939
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15440
AC   CVCL_5Z19
DR   CLO; CLO_0026624
DR   Coriell; GM15440
DR   Wikidata; Q54847949
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15441
AC   CVCL_5Z20
DR   CLO; CLO_0026629
DR   Coriell; GM15441
DR   Wikidata; Q54847950
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15442
AC   CVCL_5Z21
DR   CLO; CLO_0026630
DR   Coriell; GM15442
DR   Wikidata; Q54847951
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15443
AC   CVCL_5Z22
DR   CLO; CLO_0026635
DR   Coriell; GM15443
DR   Wikidata; Q54847952
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15444
AC   CVCL_5Z23
DR   CLO; CLO_0026643
DR   Coriell; GM15444
DR   Wikidata; Q54847953
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15445
AC   CVCL_5Z24
DR   CLO; CLO_0026654
DR   Coriell; GM15445
DR   Wikidata; Q54847954
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15447
AC   CVCL_5Z25
DR   CLO; CLO_0026653
DR   Coriell; GM15447
DR   Wikidata; Q54847955
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15453
AC   CVCL_7639
SY   GM17359
DR   CLO; CLO_0013729
DR   CLO; CLO_0026670
DR   Coriell; GM15453
DR   Coriell; GM17359
DR   Wikidata; Q54847957
CC   Part of: Human variation panel.
CC   Population: Cuban.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM15455
AC   CVCL_5Z26
DR   CLO; CLO_0026667
DR   Coriell; GM15455
DR   Wikidata; Q54847958
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15457
AC   CVCL_5Z27
DR   CLO; CLO_0026668
DR   Coriell; GM15457
DR   Wikidata; Q54847959
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15458
AC   CVCL_5Z28
DR   CLO; CLO_0026664
DR   Coriell; GM15458
DR   Wikidata; Q54847960
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15459
AC   CVCL_5Z29
DR   CLO; CLO_0026665
DR   Coriell; GM15459
DR   Wikidata; Q54847961
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15461
AC   CVCL_5Z30
DR   CLO; CLO_0026660
DR   Coriell; GM15461
DR   Wikidata; Q54847962
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15463
AC   CVCL_5Z31
DR   CLO; CLO_0026661
DR   Coriell; GM15463
DR   Wikidata; Q54847963
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15464
AC   CVCL_5Z32
DR   CLO; CLO_0026695
DR   Coriell; GM15464
DR   Wikidata; Q54847964
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15465
AC   CVCL_5Z33
DR   CLO; CLO_0026697
DR   Coriell; GM15465
DR   Wikidata; Q54847965
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15466
AC   CVCL_5Z34
DR   CLO; CLO_0026696
DR   Coriell; GM15466
DR   Wikidata; Q54847966
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15467
AC   CVCL_5Z35
DR   CLO; CLO_0026699
DR   Coriell; GM15467
DR   Wikidata; Q54847967
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15468
AC   CVCL_5Z36
DR   CLO; CLO_0026700
DR   Coriell; GM15468
DR   Wikidata; Q54847968
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15469
AC   CVCL_5Z37
DR   CLO; CLO_0026702
DR   Coriell; GM15469
DR   Wikidata; Q54847970
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15470
AC   CVCL_5Z38
DR   CLO; CLO_0026703
DR   Coriell; GM15470
DR   Wikidata; Q54847971
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15471
AC   CVCL_5Z39
DR   CLO; CLO_0026704
DR   Coriell; GM15471
DR   Wikidata; Q54847972
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15472
AC   CVCL_5Z40
DR   CLO; CLO_0026707
DR   Coriell; GM15472
DR   Wikidata; Q54847973
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15474
AC   CVCL_5Z41
DR   CLO; CLO_0026708
DR   Coriell; GM15474
DR   Wikidata; Q54847974
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15475
AC   CVCL_5Z42
DR   CLO; CLO_0026738
DR   Coriell; GM15475
DR   Wikidata; Q54847975
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15476
AC   CVCL_5Z43
DR   CLO; CLO_0026737
DR   Coriell; GM15476
DR   Wikidata; Q54847976
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15477
AC   CVCL_5Z44
DR   CLO; CLO_0026736
DR   Coriell; GM15477
DR   Wikidata; Q54847977
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15478
AC   CVCL_5Z45
DR   CLO; CLO_0026735
DR   Coriell; GM15478
DR   Wikidata; Q54847978
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15479
AC   CVCL_5Z46
DR   CLO; CLO_0026743
DR   Coriell; GM15479
DR   Wikidata; Q54847979
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15480
AC   CVCL_5Z47
DR   CLO; CLO_0026745
DR   Coriell; GM15480
DR   Wikidata; Q54847980
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15482
AC   CVCL_5Z48
DR   CLO; CLO_0026739
DR   Coriell; GM15482
DR   Wikidata; Q54847981
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15483
AC   CVCL_5Z49
DR   CLO; CLO_0026741
DR   Coriell; GM15483
DR   Wikidata; Q54847982
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15485
AC   CVCL_5Z50
DR   CLO; CLO_0026748
DR   Coriell; GM15485
DR   Wikidata; Q54847983
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15486
AC   CVCL_5Z51
DR   CLO; CLO_0026750
DR   Coriell; GM15486
DR   Wikidata; Q54847984
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15487
AC   CVCL_5Z52
DR   CLO; CLO_0028289
DR   Coriell; GM15487
DR   Wikidata; Q54847985
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15489
AC   CVCL_5Z53
DR   CLO; CLO_0028292
DR   Coriell; GM15489
DR   Wikidata; Q54847986
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15490
AC   CVCL_5Z54
DR   CLO; CLO_0028293
DR   Coriell; GM15490
DR   Wikidata; Q54847987
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15491
AC   CVCL_5Z55
DR   CLO; CLO_0028290
DR   Coriell; GM15491
DR   Wikidata; Q54847988
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15492
AC   CVCL_5Z56
DR   CLO; CLO_0028291
DR   Coriell; GM15492
DR   Wikidata; Q54847989
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15493
AC   CVCL_5Z57
DR   CLO; CLO_0028300
DR   Coriell; GM15493
DR   Wikidata; Q54847997
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15494
AC   CVCL_5Z58
DR   CLO; CLO_0028299
DR   Coriell; GM15494
DR   Wikidata; Q54847998
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15495
AC   CVCL_5Z59
DR   CLO; CLO_0028297
DR   Coriell; GM15495
DR   Wikidata; Q54847999
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15496
AC   CVCL_5Z60
DR   CLO; CLO_0028294
DR   Coriell; GM15496
DR   Wikidata; Q54848000
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15499
AC   CVCL_5Z61
DR   CLO; CLO_0028302
DR   Coriell; GM15499
DR   Wikidata; Q54848001
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15500
AC   CVCL_5Z62
DR   CLO; CLO_0028069
DR   Coriell; GM15500
DR   Wikidata; Q54848002
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15501
AC   CVCL_5Z63
DR   CLO; CLO_0028070
DR   Coriell; GM15501
DR   Wikidata; Q54848003
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15503
AC   CVCL_5Z64
DR   CLO; CLO_0028071
DR   Coriell; GM15503
DR   Wikidata; Q54848005
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15504
AC   CVCL_5Z65
DR   CLO; CLO_0028065
DR   Coriell; GM15504
DR   Wikidata; Q54848006
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15506
AC   CVCL_5Z66
DR   CLO; CLO_0028066
DR   Coriell; GM15506
DR   Wikidata; Q54848007
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15506).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15509
AC   CVCL_5Z67
DR   CLO; CLO_0028067
DR   Coriell; GM15509
DR   Wikidata; Q54848008
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15510
AC   CVCL_N802
DR   CLO; CLO_0028068
DR   EFO; EFO_0005347
DR   Coriell; GM15510
DR   ENCODE; ENCBS497ENC
DR   ENCODE; ENCBS498ENC
DR   GEO; GSM260581
DR   GEO; GSM260582
DR   GEO; GSM260583
DR   GEO; GSM260584
DR   GEO; GSM397672
DR   GEO; GSM561310
DR   GEO; GSM561311
DR   GEO; GSM561312
DR   GEO; GSM561313
DR   GEO; GSM561314
DR   GEO; GSM561315
DR   GEO; GSM561316
DR   GEO; GSM561317
DR   GEO; GSM561318
DR   GEO; GSM561319
DR   GEO; GSM561320
DR   GEO; GSM561321
DR   GEO; GSM561322
DR   GEO; GSM561323
DR   GEO; GSM561324
DR   Wikidata; Q54848009
RX   PubMed=9872978;
RX   PubMed=12160888;
RX   PubMed=16187739;
RX   PubMed=18292219;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Arg144Cys (c.430C>T) (416C>T); ClinVar=VCV000008409; Zygosity=Heterozygous; Note=CYP2C9*2 allele (Coriell=GM15510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM15511
AC   CVCL_0G29
SY   JH243
DR   CLO; CLO_0028062
DR   Coriell; GM15511
DR   Wikidata; Q54848010
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W005 ! GM14129
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM15512
AC   CVCL_5Z68
DR   CLO; CLO_0028063
DR   Coriell; GM15512
DR   Wikidata; Q54848011
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15513
AC   CVCL_5Z69
DR   CLO; CLO_0028064
DR   Coriell; GM15513
DR   Wikidata; Q54848012
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15514
AC   CVCL_5Z70
DR   CLO; CLO_0028050
DR   Coriell; GM15514
DR   Wikidata; Q54848013
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15515
AC   CVCL_5Z71
DR   CLO; CLO_0028051
DR   Coriell; GM15515
DR   Wikidata; Q54848014
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15516
AC   CVCL_5Z72
DR   CLO; CLO_0028048
DR   Coriell; GM15516
DR   Wikidata; Q54848015
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15517
AC   CVCL_5Z73
DR   CLO; CLO_0028049
DR   Coriell; GM15517
DR   Wikidata; Q54848016
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15518
AC   CVCL_5Z74
DR   CLO; CLO_0028044
DR   Coriell; GM15518
DR   Wikidata; Q54848017
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15519
AC   CVCL_5Z75
DR   CLO; CLO_0028045
DR   Coriell; GM15519
DR   Wikidata; Q54848018
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15520
AC   CVCL_5Z76
DR   CLO; CLO_0028042
DR   Coriell; GM15520
DR   Wikidata; Q54848020
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15521
AC   CVCL_5Z77
DR   CLO; CLO_0028043
DR   Coriell; GM15521
DR   Wikidata; Q54848021
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15522
AC   CVCL_5Z78
DR   CLO; CLO_0028046
DR   Coriell; GM15522
DR   Wikidata; Q54848022
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15523
AC   CVCL_5Z79
DR   CLO; CLO_0028047
DR   Coriell; GM15523
DR   Wikidata; Q54848023
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15524
AC   CVCL_5Z80
DR   CLO; CLO_0028057
DR   Coriell; GM15524
DR   Wikidata; Q54848024
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15525
AC   CVCL_5Z81
DR   CLO; CLO_0028058
DR   Coriell; GM15525
DR   Wikidata; Q54848025
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15526
AC   CVCL_5Z82
DR   CLO; CLO_0028059
DR   Coriell; GM15526
DR   Wikidata; Q54848026
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15527
AC   CVCL_5Z83
DR   CLO; CLO_0028060
DR   Coriell; GM15527
DR   Wikidata; Q54848027
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15528
AC   CVCL_5Z84
DR   CLO; CLO_0028061
DR   Coriell; GM15528
DR   Wikidata; Q54848028
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15529
AC   CVCL_5Z85
DR   CLO; CLO_0028052
DR   Coriell; GM15529
DR   Wikidata; Q54848029
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15530
AC   CVCL_5Z86
DR   CLO; CLO_0028053
DR   Coriell; GM15530
DR   Wikidata; Q54848030
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15531
AC   CVCL_5Z87
DR   CLO; CLO_0028054
DR   Coriell; GM15531
DR   Wikidata; Q54848031
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15533
AC   CVCL_5Z88
DR   CLO; CLO_0028055
DR   Coriell; GM15533
DR   Wikidata; Q54848032
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15534
AC   CVCL_5Z89
DR   CLO; CLO_0028056
DR   Coriell; GM15534
DR   Wikidata; Q54848033
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15535
AC   CVCL_5Z90
DR   CLO; CLO_0028135
DR   Coriell; GM15535
DR   Wikidata; Q54848035
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15536
AC   CVCL_5Z91
DR   CLO; CLO_0028133
DR   Coriell; GM15536
DR   Wikidata; Q54848036
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15537
AC   CVCL_5Z92
DR   CLO; CLO_0028126
DR   Coriell; GM15537
DR   Wikidata; Q54848037
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15538
AC   CVCL_5Z93
DR   CLO; CLO_0028125
DR   Coriell; GM15538
DR   Wikidata; Q54848038
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15539
AC   CVCL_5Z94
DR   CLO; CLO_0028131
DR   Coriell; GM15539
DR   Wikidata; Q54848039
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15540
AC   CVCL_5Z95
DR   CLO; CLO_0028128
DR   Coriell; GM15540
DR   Wikidata; Q54848048
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15541
AC   CVCL_5Z96
DR   CLO; CLO_0028142
DR   Coriell; GM15541
DR   Wikidata; Q54848049
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15548
AC   CVCL_5Z97
DR   CLO; CLO_0028139
DR   Coriell; GM15548
DR   Wikidata; Q54848050
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15550
AC   CVCL_5Z98
DR   CLO; CLO_0028145
DR   Coriell; GM15550
DR   Wikidata; Q54848052
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15551
AC   CVCL_5Z99
DR   CLO; CLO_0028144
DR   Coriell; GM15551
DR   Wikidata; Q54848053
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15552
AC   CVCL_6A00
DR   CLO; CLO_0028167
DR   Coriell; GM15552
DR   Wikidata; Q54848054
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15553
AC   CVCL_6A01
DR   CLO; CLO_0028166
DR   Coriell; GM15553
DR   Wikidata; Q54848055
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15554
AC   CVCL_6A02
DR   CLO; CLO_0028164
DR   Coriell; GM15554
DR   Wikidata; Q54848056
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15556
AC   CVCL_6A03
DR   CLO; CLO_0028161
DR   Coriell; GM15556
DR   Wikidata; Q54848057
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15557
AC   CVCL_6A04
DR   CLO; CLO_0028160
DR   Coriell; GM15557
DR   Wikidata; Q54848058
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15558
AC   CVCL_6A05
DR   CLO; CLO_0028158
DR   Coriell; GM15558
DR   Wikidata; Q54848059
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15560
AC   CVCL_6A06
DR   CLO; CLO_0028156
DR   Coriell; GM15560
DR   Wikidata; Q54848060
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15562
AC   CVCL_6A07
DR   CLO; CLO_0028177
DR   Coriell; GM15562
DR   Wikidata; Q54848061
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15563
AC   CVCL_6A08
DR   CLO; CLO_0028174
DR   Coriell; GM15563
DR   Wikidata; Q54848062
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15564
AC   CVCL_6A09
DR   CLO; CLO_0028172
DR   Coriell; GM15564
DR   Wikidata; Q54848063
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15566
AC   CVCL_6A10
DR   CLO; CLO_0028073
DR   Coriell; GM15566
DR   Wikidata; Q54848064
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15567
AC   CVCL_6A11
DR   CLO; CLO_0028072
DR   Coriell; GM15567
DR   Wikidata; Q54848065
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15569
AC   CVCL_6A12
DR   CLO; CLO_0028075
DR   Coriell; GM15569
DR   Wikidata; Q54848066
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15573
AC   CVCL_6A13
DR   CLO; CLO_0028074
DR   Coriell; GM15573
DR   Wikidata; Q54848067
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15576
AC   CVCL_6A14
DR   CLO; CLO_0028080
DR   Coriell; GM15576
DR   Wikidata; Q54848068
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15577
AC   CVCL_6A15
DR   CLO; CLO_0028078
DR   Coriell; GM15577
DR   Wikidata; Q54848069
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15578
AC   CVCL_6A16
DR   CLO; CLO_0028084
DR   Coriell; GM15578
DR   Wikidata; Q54848070
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15579
AC   CVCL_6A17
DR   CLO; CLO_0028082
DR   Coriell; GM15579
DR   Wikidata; Q54848071
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15580
AC   CVCL_6A18
DR   CLO; CLO_0028088
DR   Coriell; GM15580
DR   Wikidata; Q54848072
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15581
AC   CVCL_6A19
DR   CLO; CLO_0028086
DR   Coriell; GM15581
DR   Wikidata; Q54848073
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15583
AC   CVCL_6A20
DR   CLO; CLO_0028123
DR   Coriell; GM15583
DR   Wikidata; Q54848074
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15584
AC   CVCL_6A21
DR   CLO; CLO_0028106
DR   Coriell; GM15584
DR   Wikidata; Q54848075
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15585
AC   CVCL_6A22
DR   CLO; CLO_0028105
DR   Coriell; GM15585
DR   Wikidata; Q54848076
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15589
AC   CVCL_6A23
DR   CLO; CLO_0028104
DR   Coriell; GM15589
DR   Wikidata; Q54848077
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15590
AC   CVCL_6A24
DR   CLO; CLO_0028103
DR   Coriell; GM15590
DR   GEO; GSM260601
DR   GEO; GSM260602
DR   GEO; GSM260603
DR   GEO; GSM260604
DR   Wikidata; Q54848078
RX   PubMed=9872978;
RX   PubMed=18805990;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15591
AC   CVCL_6A25
DR   CLO; CLO_0028110
DR   Coriell; GM15591
DR   Wikidata; Q54848079
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15593
AC   CVCL_6A26
DR   CLO; CLO_0028109
DR   Coriell; GM15593
DR   Wikidata; Q54848080
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15594
AC   CVCL_6A27
DR   CLO; CLO_0028108
DR   Coriell; GM15594
DR   Wikidata; Q54848081
RX   PubMed=9872978;
RX   PubMed=12160888;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15595
AC   CVCL_6A28
DR   CLO; CLO_0028107
DR   Coriell; GM15595
DR   Wikidata; Q54848082
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15596
AC   CVCL_6A29
DR   CLO; CLO_0028114
DR   Coriell; GM15596
DR   Wikidata; Q54848083
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15597
AC   CVCL_6A30
DR   CLO; CLO_0028229
DR   Coriell; GM15597
DR   Wikidata; Q54848084
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Sequence variation: Mutation; HGNC; HGNC:2623; CYP2C9; Simple; p.Ile359Leu (c.1075A>C); ClinVar=VCV000008408; Zygosity=Heterozygous; Note=CYP2C9*3 allele (Coriell=GM15597).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM15603
AC   CVCL_5Q59
DR   CLO; CLO_0028228
DR   Coriell; GM15603
DR   GEO; GSM469004
DR   GEO; GSM469005
DR   GEO; GSM469006
DR   GEO; GSM469007
DR   Wikidata; Q54848085
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM15609
AC   CVCL_6A31
DR   CLO; CLO_0028223
DR   Coriell; GM15609
DR   Wikidata; Q54848086
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15610
AC   CVCL_6A32
DR   CLO; CLO_0028224
DR   Coriell; GM15610
DR   Wikidata; Q54848087
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15613
AC   CVCL_6A33
DR   CLO; CLO_0028225
DR   Coriell; GM15613
DR   Wikidata; Q54848088
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15614
AC   CVCL_6A34
DR   CLO; CLO_0028226
DR   Coriell; GM15614
DR   Wikidata; Q54848093
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15616
AC   CVCL_6A35
DR   CLO; CLO_0028219
DR   Coriell; GM15616
DR   Wikidata; Q54848094
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15617
AC   CVCL_6A36
DR   CLO; CLO_0028220
DR   Coriell; GM15617
DR   Wikidata; Q54848095
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15618
AC   CVCL_6A37
DR   CLO; CLO_0028221
DR   Coriell; GM15618
DR   Wikidata; Q54848097
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15619
AC   CVCL_6A38
DR   CLO; CLO_0028222
DR   Coriell; GM15619
DR   Wikidata; Q54848098
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15620
AC   CVCL_6A39
DR   CLO; CLO_0028250
DR   Coriell; GM15620
DR   Wikidata; Q54848099
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15622
AC   CVCL_6A40
DR   CLO; CLO_0028249
DR   Coriell; GM15622
DR   Wikidata; Q54848100
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15623
AC   CVCL_6A41
DR   CLO; CLO_0028248
DR   Coriell; GM15623
DR   Wikidata; Q54848102
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15624
AC   CVCL_6A42
DR   CLO; CLO_0028246
DR   Coriell; GM15624
DR   Wikidata; Q54848103
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15625
AC   CVCL_6A43
DR   CLO; CLO_0028247
DR   Coriell; GM15625
DR   Wikidata; Q54848104
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15626
AC   CVCL_6A44
DR   CLO; CLO_0028244
DR   Coriell; GM15626
DR   Wikidata; Q54848105
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15630
AC   CVCL_6A45
DR   CLO; CLO_0028245
DR   Coriell; GM15630
DR   Wikidata; Q54848106
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15633
AC   CVCL_6A46
DR   CLO; CLO_0028242
DR   Coriell; GM15633
DR   Wikidata; Q54848107
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15634
AC   CVCL_6A47
DR   CLO; CLO_0028243
DR   Coriell; GM15634
DR   Wikidata; Q54848108
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15636
AC   CVCL_6A48
DR   CLO; CLO_0028241
DR   Coriell; GM15636
DR   Wikidata; Q54848109
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15638
AC   CVCL_6A49
DR   CLO; CLO_0028194
DR   Coriell; GM15638
DR   Wikidata; Q54848110
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15639
AC   CVCL_6A50
DR   CLO; CLO_0028193
DR   Coriell; GM15639
DR   Wikidata; Q54848111
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15640
AC   CVCL_6A51
DR   CLO; CLO_0028198
DR   Coriell; GM15640
DR   Wikidata; Q54848112
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15642
AC   CVCL_6A52
DR   CLO; CLO_0028196
DR   Coriell; GM15642
DR   Wikidata; Q54848113
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15643
AC   CVCL_6A53
DR   CLO; CLO_0028186
DR   Coriell; GM15643
DR   Wikidata; Q54848114
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15644
AC   CVCL_6A54
DR   CLO; CLO_0028187
DR   Coriell; GM15644
DR   Wikidata; Q54848115
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15647
AC   CVCL_6A55
DR   CLO; CLO_0028188
DR   Coriell; GM15647
DR   Wikidata; Q54848116
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15664
AC   CVCL_6A56
DR   CLO; CLO_0028189
DR   Coriell; GM15664
DR   Wikidata; Q54848117
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15666
AC   CVCL_6A57
DR   CLO; CLO_0028190
DR   Coriell; GM15666
DR   Wikidata; Q54848118
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15667
AC   CVCL_6A58
DR   CLO; CLO_0028191
DR   Coriell; GM15667
DR   Wikidata; Q54848119
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15679
AC   CVCL_6A59
DR   CLO; CLO_0027648
DR   Coriell; GM15679
DR   Wikidata; Q54848120
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15681
AC   CVCL_6A60
DR   CLO; CLO_0027647
DR   Coriell; GM15681
DR   Wikidata; Q54848121
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15682
AC   CVCL_6A61
DR   CLO; CLO_0027635
DR   Coriell; GM15682
DR   Wikidata; Q54848122
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15683
AC   CVCL_6A62
DR   CLO; CLO_0027633
DR   Coriell; GM15683
DR   Wikidata; Q54848123
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15684
AC   CVCL_6A63
DR   CLO; CLO_0027638
DR   Coriell; GM15684
DR   Wikidata; Q54848124
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15685
AC   CVCL_6A64
DR   CLO; CLO_0027637
DR   Coriell; GM15685
DR   Wikidata; Q54848125
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15686
AC   CVCL_6A65
DR   CLO; CLO_0027641
DR   Coriell; GM15686
DR   Wikidata; Q54848126
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15689
AC   CVCL_6A66
DR   CLO; CLO_0027640
DR   Coriell; GM15689
DR   Wikidata; Q54848127
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15690
AC   CVCL_6A67
DR   CLO; CLO_0027645
DR   Coriell; GM15690
DR   Wikidata; Q54848129
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15691
AC   CVCL_6A68
DR   CLO; CLO_0027644
DR   Coriell; GM15691
DR   Wikidata; Q54848130
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15692
AC   CVCL_6A69
DR   CLO; CLO_0027656
DR   Coriell; GM15692
DR   Wikidata; Q54848131
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15696
AC   CVCL_F623
DR   CLO; CLO_0027654
DR   Coriell; GM15696
DR   Wikidata; Q54848132
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15696).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7464 ! GM07166
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   GM15724
AC   CVCL_CZ47
DR   CLO; CLO_0027682
DR   Coriell; GM15724
DR   GEO; GSE5373
DR   Wikidata; Q54848160
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM15725
AC   CVCL_CZ48
DR   CLO; CLO_0027683
DR   Coriell; GM15725
DR   Wikidata; Q54848161
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15726
AC   CVCL_CZ49
DR   CLO; CLO_0027680
DR   Coriell; GM15726
DR   Wikidata; Q54848162
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15727
AC   CVCL_CZ50
DR   CLO; CLO_0027681
DR   Coriell; GM15727
DR   Wikidata; Q54848163
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15728
AC   CVCL_CZ51
DR   CLO; CLO_0027686
DR   Coriell; GM15728
DR   Wikidata; Q54848164
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15729
AC   CVCL_CZ52
DR   CLO; CLO_0027687
DR   Coriell; GM15729
DR   Wikidata; Q54848165
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15730
AC   CVCL_CZ53
DR   CLO; CLO_0027684
DR   Coriell; GM15730
DR   Wikidata; Q54848166
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15731
AC   CVCL_CZ54
DR   CLO; CLO_0027685
DR   Coriell; GM15731
DR   Wikidata; Q54848167
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15732
AC   CVCL_CZ55
DR   CLO; CLO_0027688
DR   Coriell; GM15732
DR   Wikidata; Q54848168
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15733
AC   CVCL_CZ56
DR   CLO; CLO_0027689
DR   Coriell; GM15733
DR   Wikidata; Q54848169
CC   Part of: Human variation panel.
CC   Population: Caucasian; Czechoslovakian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15740
AC   CVCL_6A70
DR   CLO; CLO_0027690
DR   Coriell; GM15740
DR   Wikidata; Q54848170
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15742
AC   CVCL_6A71
DR   CLO; CLO_0027691
DR   Coriell; GM15742
DR   Wikidata; Q54848171
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15747
AC   CVCL_6A72
DR   CLO; CLO_0027692
DR   Coriell; GM15747
DR   Wikidata; Q54848172
RX   PubMed=9872978;
CC   Part of: DNA polymorphism discovery resource collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM15751
AC   CVCL_4Z75
DR   CLO; CLO_0027693
DR   Coriell; GM15751
DR   Wikidata; Q54848173
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   GM15755
AC   CVCL_AT17
DR   CLO; CLO_0027697
DR   Coriell; GM15755
DR   Wikidata; Q54848177
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15756
AC   CVCL_AT18
DR   CLO; CLO_0027698
DR   Coriell; GM15756
DR   Wikidata; Q54848178
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15757
AC   CVCL_AT19
DR   CLO; CLO_0027710
DR   Coriell; GM15757
DR   Wikidata; Q54848179
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15758
AC   CVCL_AT20
DR   CLO; CLO_0027713
DR   Coriell; GM15758
DR   Wikidata; Q54848180
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15759
AC   CVCL_AT21
DR   CLO; CLO_0027711
DR   Coriell; GM15759
DR   Wikidata; Q54848181
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15760
AC   CVCL_AT22
DR   CLO; CLO_0027704
DR   Coriell; GM15760
DR   Wikidata; Q54848182
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15761
AC   CVCL_AT23
DR   CLO; CLO_0027702
DR   Coriell; GM15761
DR   Wikidata; Q54848183
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15762
AC   CVCL_AT24
DR   CLO; CLO_0027709
DR   Coriell; GM15762
DR   Wikidata; Q54848191
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15763
AC   CVCL_AT25
DR   CLO; CLO_0027707
DR   Coriell; GM15763
DR   Wikidata; Q54848192
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15764
AC   CVCL_AT26
DR   CLO; CLO_0027700
DR   Coriell; GM15764
DR   Wikidata; Q54848193
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15765
AC   CVCL_AT27
DR   CLO; CLO_0027699
DR   Coriell; GM15765
DR   Wikidata; Q54848194
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15766
AC   CVCL_AT28
DR   CLO; CLO_0027701
DR   Coriell; GM15766
DR   Wikidata; Q54848195
CC   Part of: Human variation panel.
CC   Population: Caucasian; Icelandic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15776
AC   CVCL_1S97
DR   Coriell; GM15776
DR   Wikidata; Q54848196
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: Coriell; GM15776; probable.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q37 ! Don/a3
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   GM1578
AC   CVCL_B4FU
DR   IARC_TP53; 21046
DR   Wikidata; Q110432816
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM15780
AC   CVCL_CX64
SY   RL-III
DR   CLO; CLO_0027732
DR   Coriell; GM15780
DR   Wikidata; Q54848197
RX   PubMed=9186513;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q37 ! Don/a3
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM15786
AC   CVCL_W151
DR   CLO; CLO_0027730
DR   Coriell; GM15786
DR   Wikidata; Q54848199
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Lys1192Lys (c.3576G>A) (3403del174) (Ex26del); ClinVar=VCV000003035; Zygosity=Homozygous (Coriell=GM15786).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM15788
AC   CVCL_0Q30
DR   CLO; CLO_0027729
DR   BioSample; SAMN00804132
DR   Coriell; GM15788
DR   Wikidata; Q54848200
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15788).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM15789
AC   CVCL_0Q31
DR   Coriell; GM15789
DR   Wikidata; Q54848201
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15789).
CC   Discontinued: Coriell; GM15789; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM15790
AC   CVCL_0Q32
DR   CLO; CLO_0027728
DR   BioSample; SAMN00804134
DR   Coriell; GM15790
DR   Wikidata; Q54848202
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15790).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM15805
AC   CVCL_F228
DR   CLO; CLO_0027727
DR   BioSample; SAMN00804136
DR   Coriell; GM15805
DR   GEO; GSM89124
DR   Wikidata; Q54848203
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15805).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; GM15805; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   GM15806
AC   CVCL_F227
DR   CLO; CLO_0027726
DR   BioSample; SAMN00804138
DR   Coriell; GM15806
DR   GEO; GSM89125
DR   Wikidata; Q54848204
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15806).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; GM15806; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   GM15807
AC   CVCL_7640
DR   CLO; CLO_0027725
DR   BioSample; SAMN00804140
DR   Coriell; GM15807
DR   Wikidata; Q54848205
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   GM15808
AC   CVCL_7641
DR   CLO; CLO_0027724
DR   BioSample; SAMN00804142
DR   Coriell; GM15808
DR   Wikidata; Q54848206
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15808).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM15808; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM15809
AC   CVCL_7642
DR   CLO; CLO_0027723
DR   BioSample; SAMN00804144
DR   Coriell; GM15809
DR   Wikidata; Q54848207
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM15809; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   GM15810
AC   CVCL_0Q33
DR   CLO; CLO_0027747
DR   Coriell; GM15810
DR   GEO; GSM89126
DR   Wikidata; Q54848208
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15810).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   GM15811
AC   CVCL_0Q34
DR   CLO; CLO_0027740
DR   Coriell; GM15811
DR   GEO; GSM89127
DR   Wikidata; Q54848209
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   GM15812
AC   CVCL_U632
SY   GM15812A
DR   CLO; CLO_0027739
DR   Coriell; GM15812
DR   Wikidata; Q54848210
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15812).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM15813
AC   CVCL_0Q35
DR   CLO; CLO_0027742
DR   Coriell; GM15813
DR   Wikidata; Q54848211
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15813).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM15814
AC   CVCL_U633
DR   CLO; CLO_0027741
DR   Coriell; GM15814
DR   Wikidata; Q54848212
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15814).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM15815
AC   CVCL_0Q36
DR   CLO; CLO_0027744
DR   Coriell; GM15815
DR   GEO; GSM89128
DR   Wikidata; Q54848213
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15815).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   GM15816
AC   CVCL_0Q37
DR   CLO; CLO_0027743
DR   Coriell; GM15816
DR   GEO; GSM89131
DR   Wikidata; Q54848214
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15816).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   GM15817
AC   CVCL_0Q38
DR   CLO; CLO_0027746
DR   Coriell; GM15817
DR   Wikidata; Q54848215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM15818
AC   CVCL_U634
DR   CLO; CLO_0027745
DR   Coriell; GM15818
DR   Wikidata; Q54848216
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15818).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM15819
AC   CVCL_U635
DR   CLO; CLO_0027734
DR   Coriell; GM15819
DR   Wikidata; Q54848217
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM15820
AC   CVCL_0Q39
DR   CLO; CLO_0027768
DR   Coriell; GM15820
DR   GEO; GSM89129
DR   Wikidata; Q54848218
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15820).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   GM15821
AC   CVCL_0Q40
DR   CLO; CLO_0027769
DR   Coriell; GM15821
DR   GEO; GSM89130
DR   Wikidata; Q54848219
RX   PubMed=16809669;
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15821).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   GM15822
AC   CVCL_0Q41
DR   CLO; CLO_0027763
DR   Coriell; GM15822
DR   Wikidata; Q54848221
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15822).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM15823
AC   CVCL_0Q42
DR   CLO; CLO_0027762
DR   Coriell; GM15823
DR   Wikidata; Q54848222
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15823).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM15825
AC   CVCL_0Q43
DR   CLO; CLO_0027761
DR   Coriell; GM15825
DR   Wikidata; Q54848223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM15836
AC   CVCL_D343
DR   CLO; CLO_0027767
DR   Coriell; GM15836
DR   Wikidata; Q54848224
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7908 ! GM00847
SX   Male
AG   5Y6M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   GM15840
AC   CVCL_UY78
DR   CLO; CLO_0027766
DR   Coriell; GM15840
DR   Wikidata; Q93841130
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UZ87 ! XTR-3 BSAgB
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   GM15841
AC   CVCL_0Q44
DR   CLO; CLO_0027765
DR   BioSample; SAMN00804178
DR   Coriell; GM15841
DR   GEO; GSM89121
DR   Wikidata; Q54848225
RX   PubMed=16809669;
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15841).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 18
//
ID   GM15842
AC   CVCL_0Q45
DR   CLO; CLO_0027764
DR   Coriell; GM15842
DR   Wikidata; Q54848226
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (Coriell=GM15842).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM15844
AC   CVCL_L024
DR   CLO; CLO_0027793
DR   Coriell; GM15844
DR   Wikidata; Q54848227
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (Coriell=GM15844).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F203 ! ND00139
OI   CVCL_F204 ! ND27760
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   GM15845
AC   CVCL_HE90
DR   CLO; CLO_0027795
DR   Coriell; GM15845
DR   Wikidata; Q54848228
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM15847
AC   CVCL_0U92
DR   CLO; CLO_0027794
DR   Coriell; GM15847
DR   Wikidata; Q54848229
RX   PubMed=18485778;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[760]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15847).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15847).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   GM15848
AC   CVCL_0U93
DR   CLO; CLO_0027778
DR   Coriell; GM15848
DR   Wikidata; Q54848230
RX   PubMed=18485778;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15848).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15848).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   GM15849
AC   CVCL_0U94
DR   CLO; CLO_0027779
DR   Coriell; GM15849
DR   Wikidata; Q54848231
RX   PubMed=18485778;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[920]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15849).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15849).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   GM15850
AC   CVCL_U734
DR   CLO; CLO_0027780
DR   EFO; EFO_0006276
DR   ChEMBL-Cells; CHEMBL4295474
DR   ChEMBL-Targets; CHEMBL4296416
DR   Coriell; GM15850
DR   GEO; GSM113813
DR   GEO; GSM113814
DR   GEO; GSM113815
DR   GEO; GSM113816
DR   GEO; GSM113817
DR   GEO; GSM113818
DR   GEO; GSM113819
DR   GEO; GSM113820
DR   GEO; GSM113821
DR   GEO; GSM113822
DR   GEO; GSM113823
DR   GEO; GSM113824
DR   PubChem_Cell_line; CVCL_U734
DR   Wikidata; Q54848235
RX   PubMed=18485778;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[650]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15850).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1030]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM15850).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 20
//
ID   GM15851
AC   CVCL_N248
SY   GM18078
DR   CLO; CLO_0015711
DR   CLO; CLO_0027781
DR   EFO; EFO_0006277
DR   Coriell; GM15851
DR   Coriell; GM18078
DR   GEO; GSM113678
DR   GEO; GSM113802
DR   GEO; GSM113803
DR   GEO; GSM113804
DR   GEO; GSM113805
DR   GEO; GSM113806
DR   GEO; GSM113807
DR   GEO; GSM113808
DR   GEO; GSM113809
DR   GEO; GSM113810
DR   GEO; GSM113811
DR   GEO; GSM113812
DR   Wikidata; Q54848236
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Homozygous (Coriell=GM18078).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM15859
AC   CVCL_F624
DR   CLO; CLO_0027775
DR   Coriell; GM15859
DR   Wikidata; Q54848237
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F610 ! GM07213
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM15860
AC   CVCL_N249
SY   GM18079
DR   CLO; CLO_0015744
DR   CLO; CLO_0027776
DR   Coriell; GM15860
DR   Coriell; GM18079
DR   Wikidata; Q54848238
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N250 ! GM15869
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM15861
AC   CVCL_AM71
DR   CLO; CLO_0027777
DR   Coriell; GM15861
DR   Wikidata; Q54848239
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM75 ! GM15870
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15862
AC   CVCL_AM72
DR   CLO; CLO_0018547
DR   Coriell; GM15862
DR   Wikidata; Q54848240
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM76 ! GM15871
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15863
AC   CVCL_AM73
DR   CLO; CLO_0018533
DR   Coriell; GM15863
DR   Wikidata; Q54848241
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM77 ! GM15872
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15864
AC   CVCL_AM74
DR   CLO; CLO_0018532
DR   Coriell; GM15864
DR   Wikidata; Q54848242
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM78 ! GM15873
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15869
AC   CVCL_N250
DR   CLO; CLO_0018529
DR   Coriell; GM15869
DR   Wikidata; Q54848243
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N249 ! GM15860
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   GM15870
AC   CVCL_AM75
DR   CLO; CLO_0018527
DR   Coriell; GM15870
DR   Wikidata; Q54848244
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM71 ! GM15861
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM15871
AC   CVCL_AM76
DR   CLO; CLO_0018546
DR   Coriell; GM15871
DR   Wikidata; Q54848245
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM72 ! GM15862
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   GM15872
AC   CVCL_AM77
DR   CLO; CLO_0018543
DR   Coriell; GM15872
DR   Wikidata; Q54848246
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM73 ! GM15863
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM15873
AC   CVCL_AM78
DR   CLO; CLO_0018538
DR   Coriell; GM15873
DR   Wikidata; Q54848247
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM74 ! GM15864
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM15876
AC   CVCL_F509
SY   XP2OS-pCAH19WS; XP20S-pCAH19WS; XP20S(pCAH19WS); GM15876A
DR   CLO; CLO_0018536
DR   Coriell; GM15876
DR   Wikidata; Q54848248
CC   Population: Japanese.
CC   Characteristics: Transfection of wild type XPA corrects the c.390-1G>C mutation of this gene in the cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12814; XPA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZN80 ! XP2OS SV40-transformed
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   GM15877
AC   CVCL_F508
SY   D6BE-ER2-9; XP6BE-ER2-9; XP6BE ER2-9
DR   CLO; CLO_0018646
DR   Coriell; GM15877
DR   Wikidata; Q54848249
RX   PubMed=8033104;
RX   PubMed=18470933;
CC   Population: Caucasian.
CC   Characteristics: Transfection of wild type ERCC2 corrects the defects of this gene in the cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly36_Arg61del; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3434; ERCC2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F505 ! XP6BE(SV)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   GM15879
AC   CVCL_LH35
DR   CLO; CLO_0018672
DR   Coriell; GM15879
DR   Wikidata; Q54848250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84562; Anhidrotic ectodermal dysplasia 1
DI   ORDO; Orphanet_238468; Hypohidrotic ectodermal dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM15880
AC   CVCL_DS88
DR   CLO; CLO_0018671
DR   Coriell; GM15880
DR   Wikidata; Q54848251
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM15883
AC   CVCL_AT29
DR   CLO; CLO_0018664
DR   Coriell; GM15883
DR   Wikidata; Q54848252
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15884
AC   CVCL_AT30
DR   CLO; CLO_0018662
DR   Coriell; GM15884
DR   Wikidata; Q54848253
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15885
AC   CVCL_AT31
DR   CLO; CLO_0018669
DR   Coriell; GM15885
DR   Wikidata; Q54848254
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15886
AC   CVCL_AT32
DR   CLO; CLO_0018667
DR   Coriell; GM15886
DR   Wikidata; Q54848255
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15887
AC   CVCL_AT33
DR   CLO; CLO_0018654
DR   Coriell; GM15887
DR   Wikidata; Q54848256
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM15888
AC   CVCL_N251
SY   GM17096
DR   CLO; CLO_0014521
DR   CLO; CLO_0018652
DR   Coriell; GM15888
DR   Coriell; GM17096
DR   Wikidata; Q54848257
CC   Part of: Human variation panel.
CC   Population: Caucasian; Iberian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM15889
AC   CVCL_N252
SY   GM17097
DR   CLO; CLO_0014531
DR   CLO; CLO_0018658
DR   Coriell; GM15889
DR   Coriell; GM17097
DR   Wikidata; Q54848258
CC   Part of: Human variation panel.
CC   Population: Caucasian; Iberian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM15890
AC   CVCL_N253
SY   GM17098
DR   CLO; CLO_0014533
DR   CLO; CLO_0018656
DR   Coriell; GM15890
DR   Coriell; GM17098
DR   Wikidata; Q54848259
CC   Part of: Human variation panel.
CC   Population: Caucasian; Iberian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM15891
AC   CVCL_N254
SY   GM17099
DR   CLO; CLO_0014535
DR   CLO; CLO_0018630
DR   Coriell; GM15891
DR   Coriell; GM17099
DR   Wikidata; Q54848260
CC   Part of: Human variation panel.
CC   Population: Caucasian; Iberian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM15892
AC   CVCL_N255
SY   GM17100
DR   CLO; CLO_0014893
DR   CLO; CLO_0018629
DR   Coriell; GM15892
DR   Coriell; GM17100
DR   Wikidata; Q54848261
CC   Part of: Human variation panel.
CC   Population: Caucasian; Iberian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM15893
AC   CVCL_FW02
DR   CLO; CLO_0018628
DR   BioSample; SAMN00804244
DR   Coriell; GM15893
DR   Wikidata; Q54848263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   GM15900
AC   CVCL_FW03
DR   CLO; CLO_0018626
DR   BioSample; SAMN00804246
DR   Coriell; GM15900
DR   Wikidata; Q54848264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   GM15901
AC   CVCL_5Q60
DR   CLO; CLO_0018623
DR   Coriell; GM15901
DR   Wikidata; Q54848265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM15903
AC   CVCL_FW04
DR   CLO; CLO_0018622
DR   Coriell; GM15903
DR   Wikidata; Q54848266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   GM15904
AC   CVCL_FW05
DR   CLO; CLO_0018620
DR   BioSample; SAMN00804252
DR   Coriell; GM15904
DR   Wikidata; Q54848267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   GM15909
AC   CVCL_CZ57
DR   CLO; CLO_0018613
DR   Coriell; GM15909
DR   Wikidata; Q54848270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM15910
AC   CVCL_CZ58
DR   CLO; CLO_0018728
DR   Coriell; GM15910
DR   Wikidata; Q54848271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM15911
AC   CVCL_DR48
DR   CLO; CLO_0018729
DR   Coriell; GM15911
DR   Wikidata; Q54848272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM15912 (Cellosaurus=CVCL_DR49).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM15912
AC   CVCL_DR49
DR   CLO; CLO_0018730
DR   Coriell; GM15912
DR   Wikidata; Q54848274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM15911 (Cellosaurus=CVCL_DR48).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128189; Childhood absence epilepsy
DI   ORDO; Orphanet_64280; Childhood absence epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM15913
AC   CVCL_5Q61
DR   Coriell; GM15913
DR   Wikidata; Q54848276
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124842; Waardenburg syndrome type 4
DI   ORDO; Orphanet_897; Waardenburg-Shah syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM15916
AC   CVCL_9S82
DR   CLO; CLO_0018731
DR   Coriell; GM15916
DR   Wikidata; Q54848277
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   GM15917
AC   CVCL_9S83
DR   CLO; CLO_0018733
DR   Coriell; GM15917
DR   Wikidata; Q54848282
CC   Karyotypic information: Monosomic for 1pter->1p32, 4p12->4qter, 10pter->10p11 and 13q12->13q12 (Coriell=GM15917).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S82 ! GM15916
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   GM15918
AC   CVCL_9S84
DR   CLO; CLO_0018735
DR   Coriell; GM15918
DR   Wikidata; Q54848283
CC   Karyotypic information: Monosomic for 4q33->4qter and 10p (Coriell=GM15918).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S82 ! GM15916
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   GM15919
AC   CVCL_9S85
DR   CLO; CLO_0018736
DR   Coriell; GM15919
DR   Wikidata; Q54848284
CC   Karyotypic information: Partially monosomic for 4q3(qter) (Coriell=GM15919).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S82 ! GM15916
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   GM1592
AC   CVCL_B4FV
DR   IARC_TP53; 21047
DR   Wikidata; Q110432817
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM15920
AC   CVCL_9S86
DR   CLO; CLO_0018739
DR   Coriell; GM15920
DR   Wikidata; Q54848285
CC   Karyotypic information: Monosomic for 6pter->6q21 and 18p (Coriell=GM15920).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S82 ! GM15916
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   GM1596
AC   CVCL_B4FW
DR   cancercelllines; CVCL_B4FW
DR   IARC_TP53; 20807
DR   Wikidata; Q110432818
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220His (c.658T>C); ClinVar=VCV000376687; Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   GM15989
AC   CVCL_F626
DR   CLO; CLO_0018690
DR   Coriell; GM15989
DR   Wikidata; Q54848287
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (Coriell=GM15989).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Could be identical to GM07166VA7 (Cellosaurus=CVCL_WL44).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7464 ! GM07166
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   GM15992
AC   CVCL_EH20
DR   CLO; CLO_0018695
DR   Coriell; GM15992
DR   Wikidata; Q54848288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM15993
AC   CVCL_2U46
DR   CLO; CLO_0018697
DR   Coriell; GM15993
DR   Wikidata; Q54848289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM15996
AC   CVCL_FW06
DR   CLO; CLO_0018692
DR   BioSample; SAMN00804266
DR   Coriell; GM15996
DR   Wikidata; Q54848290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   GM15998
AC   CVCL_FW07
DR   CLO; CLO_0018693
DR   BioSample; SAMN00804268
DR   Coriell; GM15998
DR   Wikidata; Q54848291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   GM15999
AC   CVCL_FW08
DR   CLO; CLO_0018706
DR   BioSample; SAMN00804270
DR   Coriell; GM15999
DR   Wikidata; Q54848292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   GM1600
AC   CVCL_B4FX
DR   IARC_TP53; 21048
DR   Wikidata; Q110432819
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM16000
AC   CVCL_W239
SY   GM 16000
DR   CLO; CLO_0018708
DR   BCRJ; 0327
DR   Coriell; GM16000
DR   Wikidata; Q54848293
RX   PubMed=16166172;
RX   PubMed=16244288;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3535; F2; Simple; c.*97G>A (20210G>A); ClinVar=VCV000013310; Zygosity=Heterozygous (PubMed=16166172).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.His63Asp (c.187C>G); ClinVar=VCV000000010; Zygosity=Heterozygous (Coriell=GM16000).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM16000).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26799; Hereditary factor II deficiency
DI   ORDO; Orphanet_325; Congenital factor II deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 17
//
ID   GM16002
AC   CVCL_DS89
DR   CLO; CLO_0018699
DR   Coriell; GM16002
DR   Wikidata; Q54848294
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16003
AC   CVCL_DS90
DR   CLO; CLO_0018703
DR   Coriell; GM16003
DR   Wikidata; Q54848295
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16004
AC   CVCL_N256
SY   GM18080
DR   CLO; CLO_0015743
DR   CLO; CLO_0018711
DR   Coriell; GM16004
DR   Coriell; GM18080
DR   Wikidata; Q54848296
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16005
AC   CVCL_CZ59
DR   CLO; CLO_0018799
DR   Coriell; GM16005
DR   Wikidata; Q54848297
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16006
AC   CVCL_CZ60
DR   CLO; CLO_0018801
DR   Coriell; GM16006
DR   Wikidata; Q54848298
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16007
AC   CVCL_CZ61
DR   CLO; CLO_0018791
DR   Coriell; GM16007
DR   Wikidata; Q54848299
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16008
AC   CVCL_CZ62
DR   CLO; CLO_0018792
DR   Coriell; GM16008
DR   Wikidata; Q54848300
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16009
AC   CVCL_CZ63
DR   CLO; CLO_0018794
DR   Coriell; GM16009
DR   Wikidata; Q54848301
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16010
AC   CVCL_CZ64
DR   CLO; CLO_0018797
DR   Coriell; GM16010
DR   Wikidata; Q54848302
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16011
AC   CVCL_CZ65
DR   CLO; CLO_0018805
DR   Coriell; GM16011
DR   Wikidata; Q54848303
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16019
AC   CVCL_CZ66
DR   CLO; CLO_0018806
DR   Coriell; GM16019
DR   Wikidata; Q54848304
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM16020
AC   CVCL_CZ67
DR   CLO; CLO_0018808
DR   Coriell; GM16020
DR   Wikidata; Q54848305
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16027
AC   CVCL_2U47
DR   CLO; CLO_0018759
DR   Coriell; GM16027
DR   Wikidata; Q54848308
CC   Karyotypic information: 46,XX,der(15)(15qter->15p11.1::7q11.2->7qter).ish der(15)(D7Z1-,D15Z+) (Coriell=GM16027).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM16028
AC   CVCL_4W10
DR   CLO; CLO_0018760
DR   BCRJ; 0328
DR   Coriell; GM16028
DR   Wikidata; Q54848309
RX   PubMed=16166172;
RX   PubMed=16244288;
CC   Sequence variation: Mutation; HGNC; HGNC:3535; F2; Simple; c.*97G>A (20210G>A); ClinVar=VCV000013310; Zygosity=Heterozygous (Coriell=GM16028).
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Heterozygous; Note=Factor V Leiden (Coriell=GM16028).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple; p.Ser65Cys (c.193A>T); ClinVar=VCV000000011; Zygosity=Heterozygous (Coriell=GM16028).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (PubMed=16166172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C49343; Deep vein thrombosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 16
//
ID   GM16080
AC   CVCL_DA35
DR   CLO; CLO_0018757
DR   Coriell; GM16080
DR   Wikidata; Q54848310
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Thr75Pro (c.223A>C); ClinVar=VCV000008900; Zygosity=Heterozygous (Coriell=GM16080).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg151Ter (c.451C>T); ClinVar=VCV000008904; Zygosity=Heterozygous (Coriell=GM16080).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM16081
AC   CVCL_DA36
DR   CLO; CLO_0018758
DR   Coriell; GM16081
DR   Wikidata; Q54848311
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Asp79Gly (c.236A>G); ClinVar=VCV000008901; Zygosity=Heterozygous (Coriell=GM16081).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg151Ter (c.451C>T); ClinVar=VCV000008904; Zygosity=Heterozygous (Coriell=GM16081).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM16082
AC   CVCL_DA37
DR   CLO; CLO_0018753
DR   Coriell; GM16082
DR   Wikidata; Q54848312
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Gln177Glu (c.529C>G); ClinVar=VCV000056198; Zygosity=Heterozygous (Coriell=GM16082).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Trp296Ter (c.888G>A); ClinVar=VCV000056219; Zygosity=Heterozygous (Coriell=GM16082).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM16083
AC   CVCL_DA38
DR   CLO; CLO_0018755
DR   Coriell; GM16083
DR   Wikidata; Q54848313
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg151Ter (c.451C>T); ClinVar=VCV000008904; Zygosity=Homozygous (Coriell=GM16083).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM16084
AC   CVCL_DA39
DR   CLO; CLO_0018777
DR   Coriell; GM16084
DR   Wikidata; Q54848314
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.His39Gln (c.117T>A); ClinVar=VCV000056175; Zygosity=Heterozygous (Coriell=GM16084).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg151Ter (c.451C>T); ClinVar=VCV000008904; Zygosity=Heterozygous (Coriell=GM16084).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM16085
AC   CVCL_DA40
DR   CLO; CLO_0018781
DR   Coriell; GM16085
DR   Wikidata; Q54848315
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Thr75Pro (c.223A>C); ClinVar=VCV000008900; Zygosity=Homozygous (Coriell=GM16085).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM16098
AC   CVCL_5Q62
DR   Coriell; GM16098
DR   Wikidata; Q54848320
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM16098; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   GM16100
AC   CVCL_UD02
DR   Coriell; GM16100
DR   Wikidata; Q93842062
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16101
AC   CVCL_A5WN
DR   Coriell; GM16101
DR   Wikidata; Q107115128
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16101; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   GM16105
AC   CVCL_5A85
DR   CLO; CLO_0018861
DR   Coriell; GM16105
DR   Wikidata; Q54848321
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.547+2T>A (IVS8+2T>A); ClinVar=VCV000037674; Zygosity=Unspecified; Note=Splice donor mutation (Coriell=GM16105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM16106
AC   CVCL_DA41
DR   CLO; CLO_0018860
DR   Coriell; GM16106
DR   Wikidata; Q54848322
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Phe85del (c.249CTT[2]) (c.255_257delCTT); ClinVar=VCV000056185; Zygosity=Heterozygous (Coriell=GM16106).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Gln177Glu (c.529C>G); ClinVar=VCV000056198; Zygosity=Heterozygous (Coriell=GM16106).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 16
//
ID   GM16107
AC   CVCL_DA42
DR   CLO; CLO_0018847
DR   Coriell; GM16107
DR   Wikidata; Q54848328
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg164Ter (c.490C>T) (p.Arg61Ter, c.181C>T); ClinVar=VCV000056197; Zygosity=Heterozygous (Coriell=GM16107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM16108
AC   CVCL_DA43
DR   CLO; CLO_0018845
DR   Coriell; GM16108
DR   Wikidata; Q54848329
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000520610; Zygosity=Heterozygous (Coriell=GM16108).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg151Ter (c.451C>T); ClinVar=VCV000008904; Zygosity=Heterozygous (Coriell=GM16108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM16109
AC   CVCL_DA44
DR   CLO; CLO_0018841
DR   Coriell; GM16109
DR   Wikidata; Q54848330
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg164Ter (c.490C>T) (p.Arg61Ter, c.181C>T); ClinVar=VCV000056197; Zygosity=Heterozygous (Coriell=GM16109).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Gln291Ter (c.871C>T); ClinVar=VCV000056217; Zygosity=Heterozygous (Coriell=GM16109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM16111
AC   CVCL_7645
SY   GM18081
DR   CLO; CLO_0015748
DR   CLO; CLO_0018822
DR   Coriell; GM16111
DR   Coriell; GM18081
DR   Wikidata; Q54848331
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM16113
AC   CVCL_7646
SY   GM18082
DR   CLO; CLO_0015747
DR   CLO; CLO_0018821
DR   Coriell; GM16113
DR   Coriell; GM18082
DR   Wikidata; Q54848332
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM16115
AC   CVCL_7647
SY   GM18083
DR   CLO; CLO_0015746
DR   CLO; CLO_0018825
DR   Coriell; GM16115
DR   Coriell; GM18083
DR   Wikidata; Q54848333
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM16117
AC   CVCL_7648
SY   GM18084
DR   CLO; CLO_0015745
DR   CLO; CLO_0018824
DR   Coriell; GM16117
DR   Coriell; GM18084
DR   Wikidata; Q54848334
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM16118
AC   CVCL_7649
SY   GM18085
DR   CLO; CLO_0015742
DR   CLO; CLO_0018830
DR   Coriell; GM16118
DR   Coriell; GM18085
DR   Wikidata; Q54848335
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM16119
AC   CVCL_7650
SY   GM18086
DR   CLO; CLO_0015741
DR   CLO; CLO_0018828
DR   Coriell; GM16119
DR   Coriell; GM18086
DR   Wikidata; Q54848336
RX   PubMed=17668376;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   GM16126
AC   CVCL_A5WP
DR   Coriell; GM16126
DR   Wikidata; Q107115130
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 9 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16126; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16130
AC   CVCL_LN42
DR   Coriell; GM16130
DR   Wikidata; Q54848337
RX   PubMed=28161093;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16131
AC   CVCL_A5WQ
DR   Coriell; GM16131
DR   Wikidata; Q107115132
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16131; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16151
AC   CVCL_CZ68
DR   CLO; CLO_0019812
DR   Coriell; GM16151
DR   Wikidata; Q54848338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM16152
AC   CVCL_V032
DR   CLO; CLO_0019813
DR   Coriell; GM16152
DR   Wikidata; Q54848339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM16154
AC   CVCL_UT68
DR   Coriell; GM16154
DR   Wikidata; Q93842332
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 8
//
ID   GM16156
AC   CVCL_5Q63
DR   Coriell; GM16156
DR   Wikidata; Q54848341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16158
AC   CVCL_5Q64
DR   Coriell; GM16158
DR   Wikidata; Q54848342
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124838; Orofacial cleft 1
DI   ORDO; Orphanet_199306; Cleft lip/palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16184
AC   CVCL_AB13
DR   CLO; CLO_0019816
DR   Coriell; GM16184
DR   Wikidata; Q54848346
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM16184).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM16185
AC   CVCL_AT34
DR   CLO; CLO_0019817
DR   Coriell; GM16185
DR   Wikidata; Q54848347
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM16186
AC   CVCL_AT35
DR   CLO; CLO_0019818
DR   Coriell; GM16186
DR   Wikidata; Q54848348
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM16188
AC   CVCL_AT36
DR   CLO; CLO_0019343
DR   Coriell; GM16188
DR   Wikidata; Q54848349
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM16189
AC   CVCL_AT37
DR   CLO; CLO_0019346
DR   Coriell; GM16189
DR   Wikidata; Q54848350
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM16190
AC   CVCL_AT38
DR   CLO; CLO_0019354
DR   Coriell; GM16190
DR   Wikidata; Q54848351
CC   Part of: Human variation panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM16192
AC   CVCL_CV43
DR   CLO; CLO_0019360
DR   Coriell; GM16192
DR   Wikidata; Q54848352
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3622; FKTN; Simple; p.Ile129Ter (c.385delA) (p.Ile129fs*1); Zygosity=Heterozygous (Coriell=GM16192).
CC   Sequence variation: Mutation; HGNC; HGNC:3622; FKTN; Simple; p.Tyr392Ter (c.1176C>A); ClinVar=VCV000969988; Zygosity=Heterozygous (Coriell=GM16192).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126741; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 4
DI   ORDO; Orphanet_272; Congenital muscular dystrophy, Fukuyama type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM16193
AC   CVCL_DA45
DR   CLO; CLO_0019358
DR   Coriell; GM16193
DR   Wikidata; Q54848353
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (Coriell=GM16193).
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Arg498Leu (c.1493G>T) (R496L); ClinVar=VCV000002980; Zygosity=Heterozygous (Coriell=GM16193).
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Arg610del (c.1826_1828GCC[1]) (c.1829_1831delGCC) (R608del); ClinVar=VCV000198093; Zygosity=Heterozygous (Coriell=GM16193).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   GM16195
AC   CVCL_AX26
SY   NPD-2
DR   BTO; BTO_0005285
DR   CLO; CLO_0019366
DR   Coriell; GM16195
DR   Wikidata; Q54848354
RX   PubMed=21335555;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Homozygous (Coriell=GM16195).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM16197
AC   CVCL_U735
DR   CLO; CLO_0019363
DR   Coriell; GM16197
DR   Wikidata; Q54848355
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[760]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16197).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16197).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16198
AC   CVCL_N257
SY   GM18087
DR   CLO; CLO_0015740
DR   CLO; CLO_0019369
DR   Coriell; GM16198
DR   Coriell; GM18087
DR   Wikidata; Q54848356
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16200
AC   CVCL_N258
SY   GM18088
DR   CLO; CLO_0015739
DR   CLO; CLO_0019368
DR   Coriell; GM16200
DR   Coriell; GM18088
DR   Wikidata; Q54848357
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18088).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18088).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM16201
AC   CVCL_0U95
DR   CLO; CLO_0019373
DR   Coriell; GM16201
DR   Wikidata; Q54848358
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[450]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16201).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[640]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM16202
AC   CVCL_N259
SY   GM18089
DR   CLO; CLO_0015752
DR   CLO; CLO_0019372
DR   Coriell; GM16202
DR   Coriell; GM18089
DR   Wikidata; Q54848359
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18089).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18089).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM16203
AC   CVCL_U736
DR   CLO; CLO_0019306
DR   Coriell; GM16203
DR   Wikidata; Q54848360
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[670]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16203).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16203).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16204
AC   CVCL_0U97
DR   CLO; CLO_0019321
DR   Coriell; GM16204
DR   Wikidata; Q54848361
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[350]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16204).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM16205
AC   CVCL_0U98
DR   CLO; CLO_0019319
DR   Coriell; GM16205
DR   Wikidata; Q54848362
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~530]; ClinVar=VCV000561195; Zygosity=Homozygous (Coriell=GM16205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM16206
AC   CVCL_U737
DR   CLO; CLO_0019330
DR   Coriell; GM16206
DR   Wikidata; Q54848363
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[640]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16206).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[670]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16207
AC   CVCL_U738
DR   CLO; CLO_0019326
DR   Coriell; GM16207
DR   Wikidata; Q54848364
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[280]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16207).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16209
AC   CVCL_U739
DR   CLO; CLO_0019325
DR   Coriell; GM16209
DR   Wikidata; Q54848365
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~800]; ClinVar=VCV000561195; Zygosity=Homozygous (Coriell=GM16209).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM16210
AC   CVCL_U740
DR   CLO; CLO_0019322
DR   Coriell; GM16210
DR   Wikidata; Q54848366
RX   PubMed=18485778;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~580]; ClinVar=VCV000561195; Zygosity=Homozygous (Coriell=GM16210).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM16211
AC   CVCL_U741
DR   CLO; CLO_0019340
DR   Coriell; GM16211
DR   Wikidata; Q54848367
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16211).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16211).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   GM16212
AC   CVCL_N260
SY   GM18090
DR   CLO; CLO_0015754
DR   CLO; CLO_0019337
DR   Coriell; GM16212
DR   Coriell; GM18090
DR   Wikidata; Q54848368
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[500]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18090).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18090).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM16213
AC   CVCL_N261
SY   GM18091
DR   CLO; CLO_0015753
DR   CLO; CLO_0019335
DR   Coriell; GM16213
DR   Coriell; GM18091
DR   Wikidata; Q54848369
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[420]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18091).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18091).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM16214
AC   CVCL_U742
DR   CLO; CLO_0019333
DR   Coriell; GM16214
DR   Wikidata; Q54848377
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~600]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16214).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~700]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16214).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16215
AC   CVCL_N262
SY   GM18092
DR   CLO; CLO_0015756
DR   CLO; CLO_0019278
DR   Coriell; GM16215
DR   Coriell; GM18092
DR   Wikidata; Q54848378
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18092).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM18092).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM16216
AC   CVCL_U743
DR   CLO; CLO_0019280
DR   ChEMBL-Cells; CHEMBL4295479
DR   ChEMBL-Targets; CHEMBL4296417
DR   Coriell; GM16216
DR   PubChem_Cell_line; CVCL_U743
DR   Wikidata; Q54848379
RX   PubMed=18485778;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~200]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16216).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~500]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM16218
AC   CVCL_0U99
DR   CLO; CLO_0019279
DR   Coriell; GM16218
DR   Wikidata; Q54848380
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16218).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16218).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16219
AC   CVCL_0V00
DR   CLO; CLO_0019292
DR   Coriell; GM16219
DR   Wikidata; Q54848381
RX   PubMed=18485778;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[570]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16219).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16219).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16220
AC   CVCL_U744
DR   CLO; CLO_0019291
DR   Coriell; GM16220
DR   Wikidata; Q54848382
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~460]; ClinVar=VCV000561195; Zygosity=Homozygous (Coriell=GM16220).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM16222
AC   CVCL_0V01
DR   CLO; CLO_0019298
DR   Coriell; GM16222
DR   Wikidata; Q54848383
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16222).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16222).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16223
AC   CVCL_U745
DR   CLO; CLO_0019297
DR   Coriell; GM16223
DR   Wikidata; Q54848384
RX   PubMed=18485778;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[400]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16223).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[630]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16225
AC   CVCL_0V02
DR   CLO; CLO_0019285
DR   Coriell; GM16225
DR   Wikidata; Q54848385
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16225).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16225).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16226
AC   CVCL_0V03
DR   CLO; CLO_0019283
DR   Coriell; GM16226
DR   Wikidata; Q54848386
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[670]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16226).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16226).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16227
AC   CVCL_U746
DR   CLO; CLO_0019287
DR   Coriell; GM16227
DR   Wikidata; Q54848387
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[630]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16227).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16227).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16228
AC   CVCL_U747
DR   CLO; CLO_0019252
DR   Coriell; GM16228
DR   Wikidata; Q54848388
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[670]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16228).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16228).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16229
AC   CVCL_0V04
DR   CLO; CLO_0019251
DR   Coriell; GM16229
DR   Wikidata; Q54848389
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[670]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16229).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16229).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16230
AC   CVCL_U748
DR   CLO; CLO_0019250
DR   Coriell; GM16230
DR   Wikidata; Q54848390
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[380]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16230).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[950]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16230).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16231
AC   CVCL_0V05
DR   CLO; CLO_0019249
DR   Coriell; GM16231
DR   Wikidata; Q54848391
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[380]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16231).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16231).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16232
AC   CVCL_0V06
DR   CLO; CLO_0019269
DR   Coriell; GM16232
DR   Wikidata; Q54848392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM16234
AC   CVCL_U749
DR   CLO; CLO_0019265
DR   Coriell; GM16234
DR   Wikidata; Q54848393
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[580]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16234).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1030]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16234).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16236
AC   CVCL_0V07
DR   CLO; CLO_0019263
DR   Coriell; GM16236
DR   Wikidata; Q54848395
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1070]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16236).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16236).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16237
AC   CVCL_0V08
DR   CLO; CLO_0019259
DR   Coriell; GM16237
DR   Wikidata; Q54848396
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[700]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16237).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16238
AC   CVCL_U750
DR   CLO; CLO_0019258
DR   Coriell; GM16238
DR   Wikidata; Q54848397
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~550]; ClinVar=VCV000561195; Zygosity=Homozygous (Coriell=GM16238).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM16239
AC   CVCL_0V09
DR   CLO; CLO_0019256
DR   Coriell; GM16239
DR   Wikidata; Q54848398
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[800]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16239).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16239).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16240
AC   CVCL_0V10
DR   CLO; CLO_0019449
DR   Coriell; GM16240
DR   Wikidata; Q54848399
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16240).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16240).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16241
AC   CVCL_0V11
DR   CLO; CLO_0019450
DR   Coriell; GM16241
DR   Wikidata; Q54848400
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[830]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16241).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[<30]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16241).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM16242
AC   CVCL_U751
DR   CLO; CLO_0019451
DR   Coriell; GM16242
DR   Wikidata; Q54848401
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~630]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16242).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~730]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16242).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16243
AC   CVCL_U752
DR   CLO; CLO_0019452
DR   Coriell; GM16243
DR   Wikidata; Q54848402
RX   PubMed=18485778;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~670]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16243).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~1170]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16243).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16244
AC   CVCL_U753
DR   CLO; CLO_0019453
DR   Coriell; GM16244
DR   Wikidata; Q54848403
RX   PubMed=18485778;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~550]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16244).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~920]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16245
AC   CVCL_1S98
DR   CLO; CLO_0019444
DR   Coriell; GM16245
DR   Wikidata; Q54848404
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1S97 ! GM15776
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   GM16250
AC   CVCL_LN43
DR   Coriell; GM16250
DR   Wikidata; Q54848405
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16251
AC   CVCL_LN44
DR   Coriell; GM16251
DR   Wikidata; Q54848406
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16253
AC   CVCL_UC85
DR   Coriell; GM16253
DR   Wikidata; Q93843485
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16254
AC   CVCL_UT69
DR   Coriell; GM16254
DR   Wikidata; Q93843497
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 9 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 9
//
ID   GM16257
AC   CVCL_UC86
DR   Coriell; GM16257
DR   Wikidata; Q93843499
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16258
AC   CVCL_UD01
DR   Coriell; GM16258
DR   Wikidata; Q93843502
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16259
AC   CVCL_UT70
DR   Coriell; GM16259
DR   Wikidata; Q93843506
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 8
//
ID   GM16262
AC   CVCL_9S87
DR   CLO; CLO_0019448
DR   Coriell; GM16262
DR   Wikidata; Q54848407
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S82 ! GM15916
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   GM16265
AC   CVCL_BT33
DR   CLO; CLO_0019438
DR   Coriell; GM16265
DR   Wikidata; Q54848408
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (Coriell=GM16265).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM16266
AC   CVCL_W238
SY   GM 16266
DR   CLO; CLO_0019439
DR   Coriell; GM16266
DR   Wikidata; Q54848409
RX   PubMed=16166172;
RX   PubMed=16244288;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Lys (c.19G>A) (E6K); ClinVar=VCV000015126; Zygosity=Heterozygous (Coriell=GM16266).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Heterozygous (Coriell=GM16266).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 20
//
ID   GM16267
AC   CVCL_BT34
DR   CLO; CLO_0019442
DR   Coriell; GM16267
DR   Wikidata; Q54848410
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (Coriell=GM16267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_232; Sickle cell anemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM16268
AC   CVCL_5Q65
DR   Coriell; GM16268
DR   Wikidata; Q54848411
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16269
AC   CVCL_N263
SY   GM18093
DR   CLO; CLO_0015755
DR   CLO; CLO_0019443
DR   Coriell; GM16269
DR   Coriell; GM18093
DR   Wikidata; Q54848412
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16270
AC   CVCL_4F33
DR   CLO; CLO_0019440
DR   Coriell; GM16270
DR   Wikidata; Q54848413
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg255Ter (c.763C>T) (p.Arg267Ter, c.799C>T); ClinVar=VCV000011829; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM16271
AC   CVCL_4F34
DR   CLO; CLO_0019441
DR   Coriell; GM16271
DR   Wikidata; Q54848414
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Thr158Met (c.473C>T) (p.Thr170Met, c.509C>T); ClinVar=VCV000011811; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM16272
AC   CVCL_AB14
DR   CLO; CLO_0019431
DR   Coriell; GM16272
DR   Wikidata; Q54848415
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM16275
AC   CVCL_LN45
DR   Coriell; GM16275
DR   Wikidata; Q54848416
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16276
AC   CVCL_LN46
DR   Coriell; GM16276
DR   Wikidata; Q54848417
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16277
AC   CVCL_LN47
DR   Coriell; GM16277
DR   Wikidata; Q54848432
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16278
AC   CVCL_LN48
DR   Coriell; GM16278
DR   Wikidata; Q54848433
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16279
AC   CVCL_LN49
DR   Coriell; GM16279
DR   Wikidata; Q54848434
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16280
AC   CVCL_LN50
DR   Coriell; GM16280
DR   Wikidata; Q54848435
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16281
AC   CVCL_LN51
DR   Coriell; GM16281
DR   Wikidata; Q54848436
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16282
AC   CVCL_LN52
DR   Coriell; GM16282
DR   Wikidata; Q54848437
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16283
AC   CVCL_LN53
DR   Coriell; GM16283
DR   Wikidata; Q54848438
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16284
AC   CVCL_LN54
DR   Coriell; GM16284
DR   Wikidata; Q54848439
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16285
AC   CVCL_A5WB
DR   Coriell; GM16285
DR   Wikidata; Q107115136
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16285; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16286
AC   CVCL_A5WC
DR   Coriell; GM16286
DR   Wikidata; Q107115138
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16286; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16287
AC   CVCL_A5WD
DR   Coriell; GM16287
DR   Wikidata; Q107115140
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16287; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16288
AC   CVCL_A5WE
DR   Coriell; GM16288
DR   Wikidata; Q107115143
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16288; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16289
AC   CVCL_A5WF
DR   Coriell; GM16289
DR   Wikidata; Q107115145
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16289; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   GM1629(SV)
AC   CVCL_4Y26
SY   GM1629SV
DR   GEO; GSM3048746
DR   GEO; GSM3048747
DR   GEO; GSM3048748
DR   GEO; GSM3048749
DR   JCRB; KURB1919
DR   Wikidata; Q54848440
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg670Trp (c.2008C>T) (C2087T); ClinVar=VCV000190158; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Tyr1179Leufs*22 (c.3536delA) (3615delA); ClinVar=VCV000190167; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L473 ! CS1BE
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM16290
AC   CVCL_A5WG
DR   Coriell; GM16290
DR   Wikidata; Q107115147
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16290; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   GM16291
AC   CVCL_A5WH
DR   Coriell; GM16291
DR   Wikidata; Q107115150
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16291; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16292
AC   CVCL_A5WI
DR   Coriell; GM16292
DR   Wikidata; Q107115152
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16292; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   GM16293
AC   CVCL_A5WJ
DR   Coriell; GM16293
DR   Wikidata; Q107115154
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16293; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   GM16294
AC   CVCL_A5WK
DR   Coriell; GM16294
DR   Wikidata; Q107115156
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16294; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16295
AC   CVCL_A5WL
DR   Coriell; GM16295
DR   Wikidata; Q107115158
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16295; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   GM16296
AC   CVCL_UC87
DR   Coriell; GM16296
DR   Wikidata; Q93843939
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16297
AC   CVCL_UC88
DR   Coriell; GM16297
DR   Wikidata; Q93843942
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16298
AC   CVCL_UC89
DR   Coriell; GM16298
DR   Wikidata; Q93843954
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16299
AC   CVCL_UC90
DR   Coriell; GM16299
DR   Wikidata; Q93843957
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16300
AC   CVCL_UC91
DR   Coriell; GM16300
DR   Wikidata; Q93843960
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16301
AC   CVCL_UC92
DR   Coriell; GM16301
DR   Wikidata; Q93843963
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16302
AC   CVCL_UC93
DR   Coriell; GM16302
DR   Wikidata; Q93843972
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16303
AC   CVCL_UC94
DR   Coriell; GM16303
DR   Wikidata; Q93843978
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16304
AC   CVCL_UC95
DR   Coriell; GM16304
DR   Wikidata; Q93843981
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16305
AC   CVCL_UC96
DR   Coriell; GM16305
DR   Wikidata; Q93843985
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16306
AC   CVCL_UC97
DR   Coriell; GM16306
DR   Wikidata; Q93843989
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16307
AC   CVCL_UC98
DR   Coriell; GM16307
DR   Wikidata; Q93844001
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16308
AC   CVCL_UC99
DR   Coriell; GM16308
DR   Wikidata; Q93844004
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 10
//
ID   GM16309
AC   CVCL_UD00
DR   Coriell; GM16309
DR   Wikidata; Q93844007
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16310
AC   CVCL_LN55
DR   Coriell; GM16310
DR   Wikidata; Q54848441
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16311
AC   CVCL_LN56
DR   Coriell; GM16311
DR   Wikidata; Q54848442
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16312
AC   CVCL_LN57
DR   Coriell; GM16312
DR   Wikidata; Q54848443
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16313
AC   CVCL_LN58
DR   Coriell; GM16313
DR   Wikidata; Q54848444
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16314
AC   CVCL_LN59
DR   Coriell; GM16314
DR   Wikidata; Q54848445
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16315
AC   CVCL_LN60
DR   Coriell; GM16315
DR   Wikidata; Q54848446
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16316
AC   CVCL_LN61
DR   Coriell; GM16316
DR   Wikidata; Q54848447
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16317
AC   CVCL_LN62
DR   Coriell; GM16317
DR   Wikidata; Q54848448
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16318
AC   CVCL_LN63
DR   Coriell; GM16318
DR   Wikidata; Q54848449
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16319
AC   CVCL_LN64
DR   Coriell; GM16319
DR   Wikidata; Q54848450
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16320
AC   CVCL_LN65
DR   Coriell; GM16320
DR   Wikidata; Q54848451
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16321
AC   CVCL_LN66
DR   Coriell; GM16321
DR   Wikidata; Q54848452
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16322
AC   CVCL_LN67
DR   Coriell; GM16322
DR   Wikidata; Q54848453
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 8
//
ID   GM16324
AC   CVCL_LN68
DR   Coriell; GM16324
DR   Wikidata; Q54848454
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 8
//
ID   GM16325
AC   CVCL_LN69
DR   Coriell; GM16325
DR   Wikidata; Q54848456
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16326
AC   CVCL_LN70
DR   Coriell; GM16326
DR   Wikidata; Q54848458
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16327
AC   CVCL_LN71
DR   Coriell; GM16327
DR   Wikidata; Q54848459
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16328
AC   CVCL_LN72
DR   Coriell; GM16328
DR   Wikidata; Q54848460
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16329
AC   CVCL_LN73
DR   Coriell; GM16329
DR   Wikidata; Q54848461
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to <=4 repeats) (Coriell=GM16329).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 11
//
ID   GM16330
AC   CVCL_A5WR
DR   Coriell; GM16330
DR   Wikidata; Q107115159
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16330; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   GM16331
AC   CVCL_LN74
DR   Coriell; GM16331
DR   Wikidata; Q54848462
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16332
AC   CVCL_LN75
DR   Coriell; GM16332
DR   Wikidata; Q54848463
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16333
AC   CVCL_A5WM
DR   Coriell; GM16333
DR   Wikidata; Q107115161
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16333; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16334
AC   CVCL_UD06
DR   Coriell; GM16334
DR   Wikidata; Q93844457
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 5 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16335
AC   CVCL_UD07
DR   Coriell; GM16335
DR   Wikidata; Q93844460
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16336
AC   CVCL_UD08
DR   Coriell; GM16336
DR   Wikidata; Q93844464
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 5 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16337
AC   CVCL_UD09
DR   Coriell; GM16337
DR   Wikidata; Q93844475
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 5 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16338
AC   CVCL_UD10
DR   Coriell; GM16338
DR   Wikidata; Q93844477
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16339
AC   CVCL_UD11
DR   Coriell; GM16339
DR   Wikidata; Q93844480
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 10
//
ID   GM16340
AC   CVCL_UD12
DR   Coriell; GM16340
DR   Wikidata; Q93844482
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16341
AC   CVCL_UD13
DR   Coriell; GM16341
DR   Wikidata; Q93844490
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16342
AC   CVCL_UD03
DR   Coriell; GM16342
DR   Wikidata; Q93844496
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16343
AC   CVCL_UD04
DR   Coriell; GM16343
DR   Wikidata; Q93844500
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 8
//
ID   GM16344
AC   CVCL_UT71
DR   Coriell; GM16344
DR   Wikidata; Q93844504
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 6
//
ID   GM16345
AC   CVCL_A5WU
DR   Coriell; GM16345
DR   Wikidata; Q107115162
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16345; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM16347
AC   CVCL_DB88
DR   CLO; CLO_0019433
DR   Coriell; GM16347
DR   Wikidata; Q54848464
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   GM16348
AC   CVCL_HQ06
DR   CLO; CLO_0019426
DR   Coriell; GM16348
DR   Wikidata; Q54848465
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 4 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 11
//
ID   GM16349
AC   CVCL_DB89
DR   CLO; CLO_0019429
DR   Coriell; GM16349
DR   Wikidata; Q54848466
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   GM16350
AC   CVCL_DB90
DR   CLO; CLO_0019422
DR   Coriell; GM16350
DR   Wikidata; Q54848467
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   GM16351
AC   CVCL_HQ07
DR   CLO; CLO_0019424
DR   Coriell; GM16351
DR   Wikidata; Q54848468
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 4 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 11
//
ID   GM16352
AC   CVCL_CZ69
DR   CLO; CLO_0019425
DR   Coriell; GM16352
DR   Wikidata; Q54848469
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   GM16353
AC   CVCL_UT72
DR   Coriell; GM16353
DR   Wikidata; Q93844603
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 6
//
ID   GM16354
AC   CVCL_UT73
DR   Coriell; GM16354
DR   Wikidata; Q93844609
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 9 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 8
//
ID   GM16355
AC   CVCL_UT74
DR   Coriell; GM16355
DR   Wikidata; Q93844613
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 6
//
ID   GM16356
AC   CVCL_UT75
DR   Coriell; GM16356
DR   Wikidata; Q93844615
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 6
//
ID   GM16357
AC   CVCL_UT76
DR   Coriell; GM16357
DR   Wikidata; Q93844625
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 6
//
ID   GM16361
AC   CVCL_LN76
DR   Coriell; GM16361
DR   Wikidata; Q54848470
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16362
AC   CVCL_5Q66
DR   Coriell; GM16362
DR   Wikidata; Q54848471
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Donor information: Established from monozygotic twin of GM16363 (Cellosaurus=CVCL_5Q67).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   GM16363
AC   CVCL_5Q67
DR   Coriell; GM16363
DR   Wikidata; Q54848472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM16362 (Cellosaurus=CVCL_5Q66).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM16368
AC   CVCL_4F35
DR   CLO; CLO_0019418
DR   Coriell; GM16368
DR   Wikidata; Q54848473
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Thr158Met (c.473C>T) (p.Thr170Met, c.509C>T); ClinVar=VCV000011811; Zygosity=Unspecified (Coriell=GM16368).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM16372
AC   CVCL_JF23
DR   CLO; CLO_0019420
DR   Coriell; GM16372
DR   Wikidata; Q54848483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133727; Hypoparathyroidism-intellectual developmental disorder-dysmorphism syndrome
DI   ORDO; Orphanet_2323; Sanjad-Sakati syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 7
//
ID   GM16375
AC   CVCL_7651
SY   HG1525
DR   CLO; CLO_0019421
DR   Coriell; GM16375
DR   Wikidata; Q54848484
RX   PubMed=436333;
RX   PubMed=10521302;
RX   PubMed=11325959;
RX   PubMed=17407155;
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser595Ter (c.1784C>A); ClinVar=VCV000820081; Zygosity=Homozygous (PubMed=10521302; Coriell=GM16375).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 81(MaGrou) (BSR81).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U694 ! GM03509
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   GM16377
AC   CVCL_U707
SY   HG1619
DR   CLO; CLO_0019411
DR   Coriell; GM16377
DR   Wikidata; Q54848485
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155; Coriell=GM16377).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 27(LySe) (BSR27).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U706 ! GM09960
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM16378
AC   CVCL_9Y35
DR   CLO; CLO_0019414
DR   Coriell; GM16378
DR   Wikidata; Q54848486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16382
AC   CVCL_4F36
DR   CLO; CLO_0019399
DR   Coriell; GM16382
DR   Wikidata; Q54848490
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Pro387Leufs*9 (c.1160_1185del) (c.1160del26); Zygosity=Unspecified (Coriell=GM16382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16387
AC   CVCL_0E66
DR   CLO; CLO_0019394
DR   Coriell; GM16387
DR   Wikidata; Q54848498
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11025; SLC3A1; Simple; p.Met467Thr (c.1400T>C); ClinVar=VCV000018115; Zygosity=Heterozygous (Coriell=GM16387).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM16389
AC   CVCL_Y604
DR   CLO; CLO_0019385
DR   Coriell; GM16389
DR   Wikidata; Q54848499
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168990; Bartsocas-Papas syndrome
DI   ORDO; Orphanet_1234; Bartsocas-Papas syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM16390
AC   CVCL_V269
DR   CLO; CLO_0019389
DR   Coriell; GM16390
DR   Wikidata; Q54848500
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM16391
AC   CVCL_4Z81
DR   CLO; CLO_0019526
DR   Coriell; GM16391
DR   Wikidata; Q54848501
CC   Population: Caucasian; Welsh.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM16392
AC   CVCL_AT39
DR   CLO; CLO_0019507
DR   Coriell; GM16392
DR   Wikidata; Q54848502
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg257Trp (c.769C>T); ClinVar=VCV000188872; Zygosity=Homozygous (Coriell=GM16392).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM16393
AC   CVCL_AT40
DR   CLO; CLO_0019506
DR   Coriell; GM16393
DR   Wikidata; Q54848503
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg227Pro (c.680G>C); ClinVar=VCV000002089; Zygosity=Heterozygous (Coriell=GM16393).
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Val400Met (c.1198G>A); ClinVar=VCV000002088; Zygosity=Heterozygous (Coriell=GM16393).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM16394
AC   CVCL_AT41
DR   CLO; CLO_0019505
DR   Coriell; GM16394
DR   Wikidata; Q54848505
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg88Ser (c.262C>A); ClinVar=VCV000529444; Zygosity=Heterozygous (Coriell=GM16394).
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg402Trp (c.1204C>T); ClinVar=VCV000002085; Zygosity=Heterozygous (Coriell=GM16394).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM16395
AC   CVCL_AT42
DR   CLO; CLO_0019504
DR   Coriell; GM16395
DR   Wikidata; Q54848506
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg257Trp (c.769C>T); ClinVar=VCV000188872; Zygosity=Heterozygous (Coriell=GM16395).
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Arg294Gln (c.881G>A); ClinVar=VCV000859875; Zygosity=Heterozygous (Coriell=GM16395).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM16396
AC   CVCL_AT43
DR   CLO; CLO_0019513
DR   Coriell; GM16396
DR   Wikidata; Q54848507
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Ile67Serfs*75 (c.198delC); ClinVar=VCV000371205; Zygosity=Heterozygous (Coriell=GM16396).
CC   Sequence variation: Mutation; HGNC; HGNC:4189; GCDH; Simple; p.Tyr74Cys (c.221A>G); Zygosity=Heterozygous (Coriell=GM16396).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM16400
AC   CVCL_N264
SY   GM18094
DR   CLO; CLO_0015758
DR   CLO; CLO_0019509
DR   Coriell; GM16400
DR   Coriell; GM18094
DR   Wikidata; Q54848509
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16401
AC   CVCL_DS04
DR   CLO; CLO_0019508
DR   Coriell; GM16401
DR   Wikidata; Q54848510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101029; Atrioventricular septal defect
DI   ORDO; Orphanet_98722; Atrioventricular canal defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM16402
AC   CVCL_DS05
DR   CLO; CLO_0019519
DR   Coriell; GM16402
DR   Wikidata; Q54848511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101029; Atrioventricular septal defect
DI   ORDO; Orphanet_98722; Atrioventricular canal defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM16405
AC   CVCL_4F37
DR   CLO; CLO_0017784
DR   Coriell; GM16405
DR   Wikidata; Q54848512
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly161Val (c.482G>T) (p.Gly173Val, c.518G>T); ClinVar=VCV000143598; Zygosity=Unspecified (Coriell=GM16405).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16406
AC   CVCL_N265
SY   GM18095
DR   CLO; CLO_0015757
DR   CLO; CLO_0017785
DR   Coriell; GM16406
DR   Coriell; GM18095
DR   Wikidata; Q54848513
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16407
AC   CVCL_DB91
DR   CLO; CLO_0017786
DR   Coriell; GM16407
DR   Wikidata; Q54848514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM16412
AC   CVCL_LN77
DR   Coriell; GM16412
DR   Wikidata; Q54848515
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16413
AC   CVCL_LN78
DR   Coriell; GM16413
DR   Wikidata; Q54848516
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16414
AC   CVCL_LN79
DR   Coriell; GM16414
DR   Wikidata; Q54848517
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16415
AC   CVCL_LN80
DR   Coriell; GM16415
DR   Wikidata; Q54848518
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16416
AC   CVCL_LN81
DR   Coriell; GM16416
DR   Wikidata; Q54848519
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 12
//
ID   GM16417
AC   CVCL_LN82
DR   Coriell; GM16417
DR   Wikidata; Q54848520
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16418
AC   CVCL_LN83
DR   Coriell; GM16418
DR   Wikidata; Q54848521
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16419
AC   CVCL_LN84
DR   Coriell; GM16419
DR   Wikidata; Q54848522
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16420
AC   CVCL_LN85
DR   Coriell; GM16420
DR   Wikidata; Q54848523
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16421
AC   CVCL_LN91
DR   Coriell; GM16421
DR   Wikidata; Q54848525
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16422
AC   CVCL_LN86
DR   Coriell; GM16422
DR   Wikidata; Q54848526
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16423
AC   CVCL_UT77
DR   Coriell; GM16423
DR   Wikidata; Q93845575
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 8
//
ID   GM16424
AC   CVCL_UT78
DR   Coriell; GM16424
DR   Wikidata; Q93845578
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 9 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 9
//
ID   GM16425
AC   CVCL_UT79
DR   Coriell; GM16425
DR   Wikidata; Q93845581
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 9 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 9
//
ID   GM16426
AC   CVCL_UT80
DR   Coriell; GM16426
DR   Wikidata; Q93845590
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 6
//
ID   GM16427
AC   CVCL_LN87
DR   Coriell; GM16427
DR   Wikidata; Q54848551
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 10
//
ID   GM16428
AC   CVCL_LN88
DR   Coriell; GM16428
DR   Wikidata; Q54848552
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM16429
AC   CVCL_LN89
DR   Coriell; GM16429
DR   Wikidata; Q54848553
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 12
//
ID   GM16430
AC   CVCL_LN90
DR   Coriell; GM16430
DR   Wikidata; Q54848554
RX   PubMed=28161093;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with facioscapulohumeral muscular dystrophy but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 12
//
ID   GM16431
AC   CVCL_UD05
DR   Coriell; GM16431
DR   Wikidata; Q93845634
RX   PubMed=28161093;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 6
//
ID   GM16434
AC   CVCL_0H57
SY   JL203
DR   Coriell; GM16434
DR   Wikidata; Q54848556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16434; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GM16435
AC   CVCL_0G30
SY   JH374
DR   CLO; CLO_0017780
DR   Coriell; GM16435
DR   Wikidata; Q54848557
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16436
AC   CVCL_0H58
SY   JL281
DR   Coriell; GM16436
DR   Wikidata; Q54848558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16436; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GM16437
AC   CVCL_0H27
SY   JH429
DR   CLO; CLO_0017781
DR   Coriell; GM16437
DR   Wikidata; Q54848559
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H58 ! GM16436
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16438
AC   CVCL_0H47
SY   JL480
DR   CLO; CLO_0017782
DR   Coriell; GM16438
DR   Wikidata; Q54848560
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16439
AC   CVCL_0H28
SY   JH556
DR   CLO; CLO_0017783
DR   Coriell; GM16439
DR   Wikidata; Q54848561
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H47 ! GM16438
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   GM16440
AC   CVCL_0H53
SY   JL481
DR   CLO; CLO_0017791
DR   Coriell; GM16440
DR   Wikidata; Q54848562
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16442
AC   CVCL_2U48
SY   JL482
DR   CLO; CLO_0017788
DR   Coriell; GM16442
DR   Wikidata; Q54848563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM16443
AC   CVCL_0H59
SY   JL320
DR   Coriell; GM16443
DR   Wikidata; Q54848564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16443; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GM16444
AC   CVCL_0H29
SY   JH478
DR   CLO; CLO_0017787
DR   Coriell; GM16444
DR   Wikidata; Q54848565
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H59 ! GM16443
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16445
AC   CVCL_5L22
SY   JL439
DR   CLO; CLO_0017802
DR   Coriell; GM16445
DR   Wikidata; Q54848566
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM16447
AC   CVCL_5L23
SY   JL288
DR   CLO; CLO_0017803
DR   Coriell; GM16447
DR   Wikidata; Q54848567
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM16449
AC   CVCL_0H48
SY   JL314
DR   CLO; CLO_0017800
DR   Coriell; GM16449
DR   Wikidata; Q54848569
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16450
AC   CVCL_0H30
SY   JH466
DR   CLO; CLO_0017801
DR   Coriell; GM16450
DR   Wikidata; Q54848570
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H48 ! GM16449
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16451
AC   CVCL_0H49
SY   JL359
DR   CLO; CLO_0017806
DR   Coriell; GM16451
DR   Wikidata; Q54848571
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16452
AC   CVCL_0H31
SY   JH458
DR   CLO; CLO_0017807
DR   Coriell; GM16452
DR   Wikidata; Q54848572
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H49 ! GM16451
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16453
AC   CVCL_0H50
SY   JL360
DR   CLO; CLO_0017804
DR   Coriell; GM16453
DR   Wikidata; Q54848573
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16454
AC   CVCL_0H32
SY   JH459
DR   CLO; CLO_0017805
DR   Coriell; GM16454
DR   Wikidata; Q54848574
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H50 ! GM16453
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16455
AC   CVCL_0H51
SY   JL401
DR   CLO; CLO_0017811
DR   Coriell; GM16455
DR   Wikidata; Q54848575
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16456
AC   CVCL_0H33
SY   JH468
DR   CLO; CLO_0017808
DR   Coriell; GM16456
DR   Wikidata; Q54848576
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H51 ! GM16455
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16457
AC   CVCL_5L24
SY   JL404
DR   CLO; CLO_0017820
DR   Coriell; GM16457
DR   Wikidata; Q54848577
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM16459
AC   CVCL_0H52
SY   JL421
DR   CLO; CLO_0017821
DR   Coriell; GM16459
DR   Wikidata; Q54848578
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16460
AC   CVCL_0H34
SY   JH406
DR   CLO; CLO_0017822
DR   Coriell; GM16460
DR   Wikidata; Q54848579
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H52 ! GM16459
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16465
AC   CVCL_0H35
SY   JH497
DR   CLO; CLO_0017824
DR   Coriell; GM16465
DR   Wikidata; Q54848581
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H58 ! GM16436
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16466
AC   CVCL_0H36
SY   JH551
DR   CLO; CLO_0017825
DR   Coriell; GM16466
DR   Wikidata; Q54848582
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H53 ! GM16440
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16479
AC   CVCL_9T94
DR   CLO; CLO_0017531
DR   Coriell; GM16479
DR   Wikidata; Q54848586
CC   Population: Caucasian; Sicilian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16480
AC   CVCL_4F38
DR   CLO; CLO_0017524
DR   Coriell; GM16480
DR   Wikidata; Q54848587
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM16481
AC   CVCL_0E67
DR   CLO; CLO_0017523
DR   Coriell; GM16481
DR   Wikidata; Q54848588
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11025; SLC3A1; Simple; p.Met467Thr (c.1400T>C); ClinVar=VCV000018115; Zygosity=Heterozygous (Coriell=GM16481).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84664; Cystinuria
DI   ORDO; Orphanet_214; Cystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM16482
AC   CVCL_0E68
DR   CLO; CLO_0017515
DR   Coriell; GM16482
DR   Wikidata; Q54848589
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   GM16483
AC   CVCL_0E69
DR   CLO; CLO_0017513
DR   Coriell; GM16483
DR   Wikidata; Q54848590
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11025; SLC3A1; Simple; p.Met467Thr (c.1400T>C); ClinVar=VCV000018115; Zygosity=Heterozygous (Coriell=GM16483).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM16485
AC   CVCL_DA46
SY   CABM011
DR   CLO; CLO_0017518
DR   Coriell; GM16485
DR   Wikidata; Q54848591
RX   PubMed=29631617;
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg127Ter (c.379C>T); ClinVar=VCV000207569; Zygosity=Heterozygous (Coriell=GM16485).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (Coriell=GM16485).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM16486
AC   CVCL_DA47
SY   CABM020
DR   CLO; CLO_0017517
DR   Coriell; GM16486
DR   Wikidata; Q54848592
RX   PubMed=29631617;
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg127Gln (c.380G>A); ClinVar=VCV000068746; Zygosity=Heterozygous (Coriell=GM16486).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM16486).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM16490
AC   CVCL_0H37
SY   JH347
DR   CLO; CLO_0017520
DR   Coriell; GM16490
DR   Wikidata; Q54848604
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H57 ! GM16434
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16491
AC   CVCL_9Z48
DR   CLO; CLO_0017519
DR   Coriell; GM16491
DR   Wikidata; Q54848605
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85043; Refsum disease
DI   ORDO; Orphanet_773; Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM16492
AC   CVCL_9Z49
DR   CLO; CLO_0017522
DR   Coriell; GM16492
DR   Wikidata; Q54848606
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85043; Refsum disease
DI   ORDO; Orphanet_773; Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM16493
AC   CVCL_9Z50
DR   CLO; CLO_0017521
DR   Coriell; GM16493
DR   Wikidata; Q54848608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84789; Infantile Refsum disease
DI   ORDO; Orphanet_772; Infantile Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16494
AC   CVCL_9Z51
DR   CLO; CLO_0017493
DR   Coriell; GM16494
DR   Wikidata; Q54848609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84789; Infantile Refsum disease
DI   ORDO; Orphanet_772; Infantile Refsum disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16495
AC   CVCL_4F72
DR   CLO; CLO_0017492
DR   Coriell; GM16495
DR   Wikidata; Q54848610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM16497
AC   CVCL_4F39
DR   CLO; CLO_0017491
DR   Coriell; GM16497
DR   Wikidata; Q54848611
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg255Ter (c.763C>T) (p.Arg267Ter, c.799C>T); ClinVar=VCV000011829; Zygosity=Unspecified (Coriell=GM16497).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16499
AC   CVCL_JE96
DR   CLO; CLO_0017487
DR   Coriell; GM16499
DR   Wikidata; Q54848612
CC   Population: Caucasian.
CC   Donor information: Established from a donor with cleft hand and absent tibia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6D
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM16500
AC   CVCL_0E70
DR   CLO; CLO_0017485
DR   Coriell; GM16500
DR   Wikidata; Q54848613
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11025; SLC3A1; Simple; p.Met467Thr (c.1400T>C); ClinVar=VCV000018115; Zygosity=Heterozygous (Coriell=GM16500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84664; Cystinuria
DI   ORDO; Orphanet_214; Cystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM16510
AC   CVCL_9R35
DR   CLO; CLO_0017483
DR   Coriell; GM16510
DR   Wikidata; Q54848614
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99251; Neonatal adrenoleukodystrophy
DI   ORDO; Orphanet_44; Neonatal adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16512
AC   CVCL_9R36
DR   CLO; CLO_0017482
DR   Coriell; GM16512
DR   Wikidata; Q54848615
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99251; Neonatal adrenoleukodystrophy
DI   ORDO; Orphanet_44; Neonatal adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16513
AC   CVCL_4F73
DR   CLO; CLO_0017490
DR   Coriell; GM16513
DR   Wikidata; Q54848616
CC   Sequence variation: Mutation; HGNC; HGNC:8850; PEX1; Simple; p.Ile700Tyrfs*42 (c.2097dupT); ClinVar=VCV000007519; Zygosity=Heterozygous (Coriell=GM16513).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155748; Peroxisome biogenesis disorder 1A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM16514
AC   CVCL_4F74
DR   CLO; CLO_0017489
DR   Coriell; GM16514
DR   Wikidata; Q54848617
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM16521
AC   CVCL_9R37
DR   CLO; CLO_0017488
DR   Coriell; GM16521
DR   Wikidata; Q54848619
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99251; Neonatal adrenoleukodystrophy
DI   ORDO; Orphanet_44; Neonatal adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16523
AC   CVCL_9R38
DR   CLO; CLO_0017587
DR   Coriell; GM16523
DR   Wikidata; Q54848620
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99251; Neonatal adrenoleukodystrophy
DI   ORDO; Orphanet_44; Neonatal adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16524
AC   CVCL_9R39
DR   CLO; CLO_0017586
DR   Coriell; GM16524
DR   Wikidata; Q54848622
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99251; Neonatal adrenoleukodystrophy
DI   ORDO; Orphanet_44; Neonatal adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16527
AC   CVCL_BT35
DR   CLO; CLO_0017589
DR   Coriell; GM16527
DR   Wikidata; Q54848623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM16528
AC   CVCL_BT36
DR   CLO; CLO_0017588
DR   Coriell; GM16528
DR   Wikidata; Q54848624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM16529
AC   CVCL_BT37
DR   CLO; CLO_0017582
DR   Coriell; GM16529
DR   Wikidata; Q54848625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM16530
AC   CVCL_IW03
DR   CLO; CLO_0017581
DR   Coriell; GM16530
DR   Wikidata; Q54848626
RX   PubMed=8078883;
CC   Characteristics: Cytoplasmic transfer (cybrid) produced by the fusion of Leigh syndrome enucleated cells GM13740 (Cellosaurus=CVCL_8A62) with cell line devoid of mitochondrial DNA (rho0) derived from 143B (Cellosaurus=CVCL_2270).
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
HI   CVCL_8A62 ! GM13740
CA   Hybrid cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   GM16532
AC   CVCL_FA42
DR   CLO; CLO_0017584
DR   Coriell; GM16532
DR   Wikidata; Q54848627
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ile49Thr (c.146T>C); ClinVar=VCV000127523; Zygosity=Unspecified (Coriell=GM16532).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128801; Hereditary melanoma with CDKN2A mutation
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   GM16533
AC   CVCL_FA43
DR   CLO; CLO_0017583
DR   Coriell; GM16533
DR   Wikidata; Q54848628
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala76Cysfs*64 (c.225_243del19) (p.Arg90Valfs*76, c.268_286del19) (p16-Leiden); ClinVar=VCV000182411; Zygosity=Unspecified (Coriell=GM16533).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128801; Hereditary melanoma with CDKN2A mutation
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   GM16534
AC   CVCL_FA44
DR   CLO; CLO_0017580
DR   Coriell; GM16534
DR   Wikidata; Q54848629
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala76Cysfs*64 (c.225_243del19) (p.Arg90Valfs*76, c.268_286del19) (p16-Leiden); ClinVar=VCV000182411; Zygosity=Unspecified (Coriell=GM16534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128801; Hereditary melanoma with CDKN2A mutation
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   GM16535
AC   CVCL_DB92
DR   CLO; CLO_0017579
DR   Coriell; GM16535
DR   Wikidata; Q54848630
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro11_Ser12insAlaAlaGlySerSerMetGluPro (c.9_32dupGGCGGCGGGGAGCAGCATGGAGCC); Zygosity=Unspecified (Coriell=GM16535).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with cutaneous malignant melanoma 2 but at risk for disease (mutation in CDKN2A start site).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128801; Hereditary melanoma with CDKN2A mutation
DI   ORDO; Orphanet_618; Familial melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   GM16546
AC   CVCL_4F40
DR   CLO; CLO_0017559
DR   Coriell; GM16546
DR   Wikidata; Q54848632
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM16547
AC   CVCL_4F41
DR   CLO; CLO_0017558
DR   Coriell; GM16547
DR   Wikidata; Q54848633
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gln244Ter (c.730C>T) (p.Gln256Ter, c.766C>T); ClinVar=VCV000095200; Zygosity=Heterozygous (Coriell=GM16547).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F42 ! GM16548
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM16548
AC   CVCL_4F42
DR   CLO; CLO_0017557
DR   Coriell; GM16548
DR   Wikidata; Q54848634
RX   PubMed=21074045;
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gln244Ter (c.730C>T) (p.Gln256Ter, c.766C>T); ClinVar=VCV000095200; Zygosity=Heterozygous (Coriell=GM16548).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F41 ! GM16547
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM16549
AC   CVCL_X436
DR   Coriell; GM16549
DR   Wikidata; Q54848637
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85071; Smith-Lemli-Opitz syndrome
DI   ORDO; Orphanet_818; Smith-Lemli-Opitz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   GM16555
AC   CVCL_JX69
DR   CLO; CLO_0017556
DR   Coriell; GM16555
DR   Wikidata; Q54848638
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85033; Prune belly syndrome
DI   ORDO; Orphanet_2970; Prune belly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   GM16560
AC   CVCL_H527
DR   CLO; CLO_0017555
DR   Coriell; GM16560
DR   Wikidata; Q54848639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H528 ! GM16563
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   GM16563
AC   CVCL_H528
DR   CLO; CLO_0017554
DR   Coriell; GM16563
DR   Wikidata; Q54848640
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H527 ! GM16560
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM16580
AC   CVCL_5Q68
SY   JL462
DR   Coriell; GM16580
DR   Wikidata; Q54848641
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   NCIt; C3360; Supernumerary circular chromosome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16582
AC   CVCL_0G73
SY   JL376
DR   CLO; CLO_0017552
DR   Coriell; GM16582
DR   Wikidata; Q54848642
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   NCIt; C3360; Supernumerary circular chromosome
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16583
AC   CVCL_0H38
SY   JH499
DR   CLO; CLO_0017549
DR   Coriell; GM16583
DR   Wikidata; Q54848643
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G73 ! GM16582
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16584
AC   CVCL_0G74
SY   JL257
DR   CLO; CLO_0017548
DR   Coriell; GM16584
DR   Wikidata; Q54848644
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16585
AC   CVCL_0H39
SY   JH407
DR   CLO; CLO_0017545
DR   Coriell; GM16585
DR   Wikidata; Q54848645
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G74 ! GM16584
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16586
AC   CVCL_0G75
SY   JL218
DR   CLO; CLO_0017390
DR   Coriell; GM16586
DR   Wikidata; Q54848646
RX   PubMed=7485158;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM16587
AC   CVCL_0G76
SY   JH360
DR   CLO; CLO_0017393
DR   Coriell; GM16587
DR   Wikidata; Q54848648
RX   PubMed=7485158;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G75 ! GM16586
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM16588
AC   CVCL_5Q69
SY   JL442
DR   CLO; CLO_0017394
DR   Coriell; GM16588
DR   Wikidata; Q54848649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16589
AC   CVCL_5Q70
SY   JH508
DR   CLO; CLO_0017395
DR   Coriell; GM16589
DR   Wikidata; Q54848650
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5Q69 ! GM16588
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   GM16593
AC   CVCL_5Q71
SY   JL444
DR   CLO; CLO_0017398
DR   Coriell; GM16593
DR   Wikidata; Q54848668
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16594
AC   CVCL_5Q72
SY   JH517
DR   CLO; CLO_0017400
DR   Coriell; GM16594
DR   Wikidata; Q54848669
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5Q71 ! GM16593
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   GM16595
AC   CVCL_5Q73
SY   JL163
DR   CLO; CLO_0017403
DR   Coriell; GM16595
DR   Wikidata; Q54848670
RX   PubMed=23665875;
CC   Population: Cuban.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G91 ! GM08092
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM16598
AC   CVCL_5Q74
SY   JL88
DR   CLO; CLO_0017405
DR   Coriell; GM16598
DR   Wikidata; Q54848671
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16599
AC   CVCL_5Q75
SY   JH164
DR   CLO; CLO_0017352
DR   Coriell; GM16599
DR   Wikidata; Q54848672
RX   PubMed=7896290;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5Q74 ! GM16598
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   GM16627
AC   CVCL_DS91
DR   CLO; CLO_0017349
DR   Coriell; GM16627
DR   Wikidata; Q54848673
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35337; Congenital nephrotic syndrome
DI   ORDO; Orphanet_564127; Genetic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16631
AC   CVCL_AK40
SY   PD720.F; PD720.f; PD.720.F
DR   CLO; CLO_0017351
DR   Coriell; GM16631
DR   Wikidata; Q54848674
RX   PubMed=12361951;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM16632
AC   CVCL_AK41
SY   PD720.F RV:FANCA; 720-Retro
DR   CLO; CLO_0017356
DR   Coriell; GM16632
DR   Wikidata; Q54848675
RX   PubMed=12361951;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3582; FANCA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AK40 ! GM16631
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   GM16633
AC   CVCL_G042
SY   PD20 hygro; PD.20hygro; PD-20; PD20
DR   CLO; CLO_0017357
DR   EFO; EFO_0022708
DR   Coriell; GM16633
DR   Wikidata; Q54848676
RX   PubMed=7581463;
RX   PubMed=12361951;
CC   Sequence variation: Mutation; HGNC; HGNC:3585; FANCD2; Simple; p.Ser126Gly (c.376A>G); ClinVar=VCV000012039; Zygosity=Heterozygous; Note=Also causes abnormal splicing (Coriell=GM16633).
CC   Sequence variation: Mutation; HGNC; HGNC:3585; FANCD2; Simple; p.Arg1236His (c.3707G>A); ClinVar=VCV000012038; Zygosity=Heterozygous (Coriell=GM16633).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125706; Fanconi anemia, complementation group D2
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G041 ! GM16756
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   GM16634
AC   CVCL_V456
SY   PD20-3-15
DR   CLO; CLO_0017354
DR   Coriell; GM16634
DR   Wikidata; Q54848677
RX   PubMed=7581463;
CC   Group: Human/rodent somatic cell hybrid.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1P16 ! A9+15
HI   CVCL_G042 ! GM16633
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   GM16635
AC   CVCL_F634
SY   PD352.T
DR   CLO; CLO_0017355
DR   Coriell; GM16635
DR   Wikidata; Q54848678
RX   PubMed=8782494;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV7).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AK48 ! PD352.F
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 15
//
ID   GM16643
AC   CVCL_BT38
DR   CLO; CLO_0017362
DR   Coriell; GM16643
DR   Wikidata; Q54848679
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Heterozygous; Note=Factor V Leiden (Coriell=GM16643).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu102Asp (c.306G>C) (E101D); ClinVar=VCV000015317; Zygosity=Unspecified; Note=Hb Potomac (Coriell=GM16643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98938; Hereditary factor V deficiency
DI   ORDO; Orphanet_326; Congenital factor V deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM16645
AC   CVCL_HJ86
DR   Coriell; GM16645
DR   Wikidata; Q54848680
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM16646
AC   CVCL_HJ87
DR   Coriell; GM16646
DR   Wikidata; Q54848681
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM16647
AC   CVCL_HJ88
DR   Coriell; GM16647
DR   Wikidata; Q54848682
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HJ89 ! GM16648
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM16648
AC   CVCL_HJ89
DR   Coriell; GM16648
DR   Wikidata; Q54848683
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HJ88 ! GM16647
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM16649
AC   CVCL_HJ90
DR   Coriell; GM16649
DR   Wikidata; Q54848684
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HJ91 ! GM16650
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM16650
AC   CVCL_HJ91
DR   Coriell; GM16650
DR   Wikidata; Q54848685
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HJ90 ! GM16649
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM16651
AC   CVCL_HJ92
DR   Coriell; GM16651
DR   Wikidata; Q54848686
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HJ93 ! GM16652
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM16652
AC   CVCL_HJ93
DR   Coriell; GM16652
DR   Wikidata; Q54848687
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HJ92 ! GM16651
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM16654
AC   CVCL_AB36
DR   CLO; CLO_0017363
DR   Coriell; GM16654
DR   Wikidata; Q54848688
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Chinese.
CC   HLA typing: A*24:02:01,26:01:01; B*15:01:01,51:01:01; C*04:01:01,15:02:01; DPA1*01:03:01,02:02:02; DPB1*02:01:02,05:01:01; DQA1*01:03:01,06:01:01; DQB1*03:01:01,06:01:01; DRB1*08:03:02,12:02:01; DRB3*03:01:03 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM16658
AC   CVCL_AB15
DR   CLO; CLO_0017359
DR   Coriell; GM16658
DR   Wikidata; Q54848689
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys620Phe (c.1859G>T); ClinVar=VCV000013928; Zygosity=Heterozygous (PubMed=19767587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM16659
AC   CVCL_AB16
DR   CLO; CLO_0017455
DR   Coriell; GM16659
DR   Wikidata; Q54848690
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys620Phe (c.1859G>T); ClinVar=VCV000013928; Zygosity=Heterozygous (Coriell=GM16659).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM16660
AC   CVCL_AB17
DR   CLO; CLO_0017458
DR   Coriell; GM16660
DR   Wikidata; Q54848691
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys618Ser (c.1853G>C); ClinVar=VCV000013914; Zygosity=Heterozygous (PubMed=19767587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM16678
AC   CVCL_9Y36
DR   CLO; CLO_0017451
DR   Coriell; GM16678
DR   Wikidata; Q54848695
CC   Population: Lebanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM16688
AC   CVCL_AB37
DR   CLO; CLO_0017468
DR   Coriell; GM16688
DR   Wikidata; Q54848701
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Chinese.
CC   HLA typing: A*24:02:01,26:01:01; B*15:07:01,35:01:01; C*03:03:01,03:03:01; DPA1*01:03:01,02:02:02; DPB1*04:02:01,05:01:01; DQA1*03:03:01,05:05:01; DQB1*03:01:01,04:01:01; DRB1*04:05:01,12:01:01G; DRB3*01:01:02; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM16689
AC   CVCL_AB38
DR   CLO; CLO_0018454
DR   Coriell; GM16689
DR   Wikidata; Q54848703
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Chinese.
CC   HLA typing: A*24:02:01,30:01:01; B*13:02:01,51:01:01; C*06:02:01,14:02:01; DPA1*01:03:01,02:01:01; DPB1*04:02:01G,17:01:01G; DQA1*02:01:01,05:07; DQB1*02:02:01,03:01:01; DRB1*07:01:01,14:03:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM16717
AC   CVCL_2U49
DR   CLO; CLO_0018457
DR   Coriell; GM16717
DR   Wikidata; Q54848710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM16718
AC   CVCL_5Q76
DR   CLO; CLO_0018424
DR   Coriell; GM16718
DR   Wikidata; Q54848711
RX   PubMed=23665875;
CC   Population: Southeast Asian; Vietnamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM16728
AC   CVCL_9Y37
DR   CLO; CLO_0018421
DR   Coriell; GM16728
DR   Wikidata; Q54848712
CC   Population: Caucasian; French Canadian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Y38 ! GM16776
SX   Female
AG   2Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM16732
AC   CVCL_N266
SY   GM16732A; GM18096
DR   CLO; CLO_0015750
DR   CLO; CLO_0018431
DR   Coriell; GM16732
DR   Coriell; GM18096
DR   Wikidata; Q54848718
RX   PubMed=23661601;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP91 ! GM16733
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16733
AC   CVCL_YP91
DR   Coriell; GM16733
DR   Wikidata; Q93847995
RX   PubMed=23661601;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM16733; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N266 ! GM16732
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   GM16734
AC   CVCL_N267
SY   GM16734A; GM18097
DR   CLO; CLO_0015749
DR   CLO; CLO_0018429
DR   Coriell; GM16734
DR   Coriell; GM18097
DR   Wikidata; Q54848719
RX   PubMed=23661601;
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP92 ! GM16735
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16735
AC   CVCL_YP92
DR   Coriell; GM16735
DR   Wikidata; Q93848015
RX   PubMed=23661601;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM16735; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N267 ! GM16734
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   GM16736
AC   CVCL_5Q77
DR   Coriell; GM16736
DR   Wikidata; Q54848720
RX   PubMed=23661601;
RX   PubMed=23665875;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1787; CDKN2A + HGNC; HGNC:45045; FAM230A; Name(s)=CDKN2A-FAM230A (PubMed=23661601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27644; Deafness
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5Q78 ! GM16792
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   GM16753
AC   CVCL_0E71
DR   CLO; CLO_0018427
DR   Coriell; GM16753
DR   Wikidata; Q54848722
CC   Sequence variation: Mutation; HGNC; HGNC:11067; SLC7A9; Simple; c.604+2T>C (789+2T-C); ClinVar=VCV000938724; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM16753).
CC   Sequence variation: Mutation; HGNC; HGNC:11067; SLC7A9; Simple; p.Thr389Met (c.1166C>T); ClinVar=VCV002138267; Zygosity=Heterozygous (Coriell=GM16753).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84664; Cystinuria
DI   ORDO; Orphanet_214; Cystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM16754
AC   CVCL_AK43
SY   PD331.F; PD331.f; PD331
DR   CLO; CLO_0018428
DR   Coriell; GM16754
DR   Wikidata; Q54848723
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM16755
AC   CVCL_AK44
SY   PD331.F RV:FANCC puro
DR   CLO; CLO_0018425
DR   Coriell; GM16755
DR   Wikidata; Q54848726
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3584; FANCC.
CC   Misspelling: PD331.F RV:FANNC puro; Coriell=GM16755.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AK43 ! GM16754
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM16756
AC   CVCL_G041
SY   PD20.L; PD.20i; PD20
DR   CLO; CLO_0018426
DR   Coriell; GM16756
DR   Wikidata; Q54848727
RX   PubMed=12361951;
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:3585; FANCD2; Simple; p.Ser126Gly (c.376A>G); ClinVar=VCV000012039; Zygosity=Heterozygous; Note=Also causes abnormal splicing (Coriell=GM16756).
CC   Sequence variation: Mutation; HGNC; HGNC:3585; FANCD2; Simple; p.Arg1236His (c.3707G>A); ClinVar=VCV000012038; Zygosity=Heterozygous (Coriell=GM16756).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125706; Fanconi anemia, complementation group D2
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G042 ! GM16633
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   GM16768
AC   CVCL_AB18
DR   CLO; CLO_0018432
DR   Coriell; GM16768
DR   Wikidata; Q54848728
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM16768).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM16769
AC   CVCL_AB19
DR   CLO; CLO_0018434
DR   Coriell; GM16769
DR   Wikidata; Q54848729
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM16769).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM16770
AC   CVCL_AB20
DR   CLO; CLO_0018439
DR   Coriell; GM16770
DR   Wikidata; Q54848730
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM16770).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM16771
AC   CVCL_AB21
DR   CLO; CLO_0018440
DR   Coriell; GM16771
DR   Wikidata; Q54848731
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM16771).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM16772 (Cellosaurus=CVCL_AB22).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 17
//
ID   GM16772
AC   CVCL_AB22
DR   CLO; CLO_0018441
DR   Coriell; GM16772
DR   Wikidata; Q54848732
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM16772).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM16771 (Cellosaurus=CVCL_AB21).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 17
//
ID   GM16774
AC   CVCL_N268
SY   GM18098
DR   CLO; CLO_0015751
DR   CLO; CLO_0018442
DR   Coriell; GM16774
DR   Coriell; GM18098
DR   Wikidata; Q54848733
CC   Part of: Human variation panel.
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM16775
AC   CVCL_N269
SY   GM18099
DR   CLO; CLO_0015423
DR   CLO; CLO_0018435
DR   Coriell; GM16775
DR   Coriell; GM18099
DR   Wikidata; Q54848734
CC   Part of: Human variation panel.
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   GM16776
AC   CVCL_9Y38
DR   CLO; CLO_0018436
DR   Coriell; GM16776
DR   Wikidata; Q54848735
CC   Population: Caucasian; French Canadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Y37 ! GM16728
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM16784
AC   CVCL_DS92
DR   CLO; CLO_0018437
DR   BioSample; SAMN00804679
DR   Coriell; GM16784
DR   Wikidata; Q54848736
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS10 ! GM03280
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM16785
AC   CVCL_DS93
DR   CLO; CLO_0018438
DR   Coriell; GM16785
DR   Wikidata; Q54848738
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DS13 ! GM05091
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16786
AC   CVCL_CZ70
DR   CLO; CLO_0018385
DR   Coriell; GM16786
DR   Wikidata; Q54848739
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16787
AC   CVCL_CZ71
DR   CLO; CLO_0018383
DR   Coriell; GM16787
DR   Wikidata; Q54848740
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16788
AC   CVCL_DS94
DR   CLO; CLO_0018399
DR   Coriell; GM16788
DR   Wikidata; Q54848741
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16789
AC   CVCL_DS95
DR   CLO; CLO_0018393
DR   Coriell; GM16789
DR   Wikidata; Q54848742
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16790
AC   CVCL_CZ72
DR   CLO; CLO_0018394
DR   Coriell; GM16790
DR   Wikidata; Q54848743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM16791
AC   CVCL_CZ73
DR   CLO; CLO_0018391
DR   Coriell; GM16791
DR   Wikidata; Q54848744
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM16792
AC   CVCL_5Q78
SY   DD129BE
DR   Coriell; GM16792
DR   Wikidata; Q54848745
RX   PubMed=23661601;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1787; CDKN2A + HGNC; HGNC:45045; FAM230A; Name(s)=CDKN2A-FAM230A (PubMed=23661601).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27644; Deafness
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5Q77 ! GM16736
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM16794
AC   CVCL_V435
DR   CLO; CLO_0018392
DR   Coriell; GM16794
DR   Wikidata; Q54848746
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16794).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM16798
AC   CVCL_U754
DR   CLO; CLO_0018397
DR   Coriell; GM16798
DR   Wikidata; Q54848747
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~750]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16798).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~1000]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM16798).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM16799
AC   CVCL_1F67
DR   CLO; CLO_0018398
DR   Coriell; GM16799
DR   Wikidata; Q54848749
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F68 ! GM16800
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM16800
AC   CVCL_1F68
DR   CLO; CLO_0018395
DR   Coriell; GM16800
DR   Wikidata; Q54848750
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F67 ! GM16799
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   GM16807
AC   CVCL_N270
SY   GM18100
DR   CLO; CLO_0018419
DR   Coriell; GM16807
DR   Coriell; GM18100
DR   Wikidata; Q54848754
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM16808
AC   CVCL_5Q79
DR   Coriell; GM16808
DR   Wikidata; Q54848755
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16809
AC   CVCL_5Q80
DR   Coriell; GM16809
DR   Wikidata; Q54848756
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16810
AC   CVCL_5Q81
DR   Coriell; GM16810
DR   Wikidata; Q54848757
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM16824
AC   CVCL_U889
SY   ALX-1
DR   CLO; CLO_0018420
DR   Coriell; GM16824
DR   Wikidata; Q54848759
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg239Cys (c.729C>T); ClinVar=VCV000016167; Zygosity=Heterozygous (Coriell=GM16824).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM16825
AC   CVCL_U890
SY   ALX-2
DR   CLO; CLO_0018411
DR   Coriell; GM16825
DR   Wikidata; Q54848761
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg239Cys (c.729C>T); ClinVar=VCV000016167; Zygosity=Heterozygous (Coriell=GM16825).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM16826
AC   CVCL_U891
SY   ALX-3
DR   CLO; CLO_0018412
DR   Coriell; GM16826
DR   Wikidata; Q54848762
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg79Cys (c.235C>T); ClinVar=VCV000016171; Zygosity=Heterozygous (Coriell=GM16826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM16834
AC   CVCL_V436
DR   Coriell; GM16834
DR   Wikidata; Q54848763
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16834).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16834; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V437 ! GM16835
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM16835
AC   CVCL_V437
DR   CLO; CLO_0018413
DR   BioSample; SAMN00804720
DR   Coriell; GM16835
DR   Wikidata; Q54848764
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16835).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V436 ! GM16834
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM16851
AC   CVCL_J697
DR   CLO; CLO_0018414
DR   Coriell; GM16851
DR   Wikidata; Q54848783
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16851).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J698 ! GM16852
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM16852
AC   CVCL_J698
DR   CLO; CLO_0018415
DR   Coriell; GM16852
DR   Wikidata; Q54848784
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16852).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J697 ! GM16851
SX   Female
AG   87Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   GM16853
AC   CVCL_4D22
DR   CLO; CLO_0018416
DR   Coriell; GM16853
DR   Wikidata; Q54848785
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16853).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D23 ! GM16854
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM16854
AC   CVCL_4D23
DR   CLO; CLO_0018417
DR   Coriell; GM16854
DR   Wikidata; Q54848786
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16854).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D22 ! GM16853
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16859
AC   CVCL_U708
DR   CLO; CLO_0018418
DR   Coriell; GM16859
DR   GEO; GSM1316988
DR   GEO; GSM1317026
DR   Wikidata; Q54848787
RX   PubMed=2647324;
CC   Population: Jewish; Ashkenazi/Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (Coriell=GM16859).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 107(MyAsa) (BSR107).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX89 ! HG1742
OI   CVCL_WX72 ! HG2654
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   GM16860
AC   CVCL_U709
SY   HG2896
DR   CLO; CLO_0018129
DR   Coriell; GM16860
DR   Wikidata; Q54848788
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Arg899Ter (c.2695C>T); ClinVar=VCV000127491; Zygosity=Homozygous (PubMed=17407155; Coriell=GM16860).
CC   Donor information: From Bloom Syndrome Registry patient 191 (BSR191).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM16864
AC   CVCL_6B22
DR   CLO; CLO_0018131
DR   Coriell; GM16864
DR   Wikidata; Q54848791
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Gln219Trpfs*20 (c.650_654dupTGGGC) (1712-1713insTGGGC); ClinVar=VCV000179133; Zygosity=Hemizygous (Coriell=GM16864).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168730; Emery-Dreifuss muscular dystrophy 1, X-linked
DI   ORDO; Orphanet_98863; X-linked Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM16865
AC   CVCL_9Z52
DR   CLO; CLO_0018130
DR   Coriell; GM16865
DR   Wikidata; Q54848792
RX   PubMed=12851857;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Cys86Valfs*29 (c.254dupT); ClinVar=VCV000002158; Zygosity=Heterozygous (PubMed=12851857).
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Arg98Trp (c.292C>T); ClinVar=VCV000002152; Zygosity=Heterozygous (PubMed=12851857).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155761; Peroxisome biogenesis disorder 7B
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM16866
AC   CVCL_4F75
DR   CLO; CLO_0018133
DR   Coriell; GM16866
DR   Wikidata; Q54848793
RX   PubMed=12851857;
RX   PubMed=16257970;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155760; Peroxisome biogenesis disorder 7A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM16877
AC   CVCL_RG79
SY   XPTTD268BE
DR   Coriell; GM16877
DR   Wikidata; Q54848794
RX   PubMed=18470933;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=18470933).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Cys663Arg (c.1987T>C); dbSNP=rs770367713; Zygosity=Heterozygous (PubMed=18470933).
CC   Discontinued: Coriell; GM16877; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_33364; Trichothiodystrophy
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   GM16878
AC   CVCL_4D24
DR   CLO; CLO_0018132
DR   BioSample; SAMN00804737
DR   Coriell; GM16878
DR   Wikidata; Q54848795
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D25 ! GM16879
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM16879
AC   CVCL_4D25
DR   CLO; CLO_0018135
DR   Coriell; GM16879
DR   Wikidata; Q54848797
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D24 ! GM16878
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM16881
AC   CVCL_U710
SY   HG1179
DR   CLO; CLO_0018134
DR   Coriell; GM16881
DR   GEO; GSM1316989
DR   GEO; GSM1317027
DR   Wikidata; Q54848798
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln975Lysfs*24 (c.2923delC); ClinVar=VCV000042076; Zygosity=Homozygous (PubMed=17407155; Coriell=GM16881).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 6(DeSou) (BSR6).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM16882
AC   CVCL_U711
SY   HG369
DR   CLO; CLO_0018137
DR   Coriell; GM16882
DR   GEO; GSM1316990
DR   GEO; GSM1317028
DR   Wikidata; Q54848799
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155; Coriell=GM16882).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Phe1087Leufs*11 (c.3261delT); ClinVar=VCV000454132; Zygosity=Heterozygous (PubMed=17407155; Coriell=GM16882).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 26(SaTi) (BSR26).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX75 ! HG2166
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   GM16883
AC   CVCL_U712
SY   HG1348
DR   CLO; CLO_0018136
DR   Coriell; GM16883
DR   GEO; GSM1316991
DR   GEO; GSM1317029
DR   Wikidata; Q54848800
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian; Belgian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ala363fs (c.1088-2A>G) (IVS5-2A>G); Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=17407155; Coriell=GM16883).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln672Arg (c.2015A>G) (2089A>G); ClinVar=VCV000188963; Zygosity=Heterozygous (PubMed=17407155; Coriell=GM16883).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 31(CaDe) (BSR31).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 20
//
ID   GM16886
AC   CVCL_U713
SY   HG1304
DR   CLO; CLO_0018138
DR   Coriell; GM16886
DR   GEO; GSM1316992
DR   GEO; GSM1317030
DR   Wikidata; Q54848802
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln700Ter (c.2098C>T); ClinVar=VCV000042067; Zygosity=Heterozygous (PubMed=17407155; Coriell=GM16886).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 59(FrFi) (BSR59).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX85 ! HG1321
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM16890
AC   CVCL_U714
SY   HG1992
DR   CLO; CLO_0018106
DR   Coriell; GM16890
DR   GEO; GSM1317031
DR   Wikidata; Q54848803
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Homozygous (PubMed=17407155; Coriell=GM16890).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 133 (BSR133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM16891
AC   CVCL_U715
SY   HG1824
DR   CLO; CLO_0018105
DR   Coriell; GM16891
DR   GEO; GSM476015
DR   GEO; GSM1316993
DR   GEO; GSM1317032
DR   Wikidata; Q54848804
RX   PubMed=17407155;
RX   PubMed=19966276;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Homozygous (PubMed=17407155; Coriell=GM16891).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Donor information: From Bloom Syndrome Registry patient 169 (BSR169).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   GM16923
AC   CVCL_4D26
DR   CLO; CLO_0018104
DR   Coriell; GM16923
DR   Wikidata; Q54848805
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16923).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16924
AC   CVCL_4D27
DR   CLO; CLO_0018103
DR   Coriell; GM16924
DR   Wikidata; Q54848806
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16924).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D28 ! GM16925
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM16925
AC   CVCL_4D28
DR   CLO; CLO_0018113
DR   Coriell; GM16925
DR   Wikidata; Q54848807
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16925).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D27 ! GM16924
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16952
AC   CVCL_1F71
DR   CLO; CLO_0018108
DR   Coriell; GM16952
DR   Wikidata; Q54848810
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F72 ! GM16953
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM16953
AC   CVCL_1F72
DR   CLO; CLO_0018117
DR   Coriell; GM16953
DR   Wikidata; Q54848812
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F71 ! GM16952
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   GM16963
AC   CVCL_4D29
DR   CLO; CLO_0018075
DR   Coriell; GM16963
DR   Wikidata; Q54848817
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16963).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D30 ! GM16964
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM16964
AC   CVCL_4D30
DR   CLO; CLO_0018074
DR   Coriell; GM16964
DR   Wikidata; Q54848818
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16964).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D29 ! GM16963
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16965
AC   CVCL_4D31
DR   CLO; CLO_0018083
DR   Coriell; GM16965
DR   Wikidata; Q54848820
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D32 ! GM16966
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM16966
AC   CVCL_4D32
DR   CLO; CLO_0018082
DR   Coriell; GM16966
DR   Wikidata; Q54848821
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D31 ! GM16965
SX   Female
AG   80Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM16967
AC   CVCL_4D33
DR   CLO; CLO_0018087
DR   Coriell; GM16967
DR   Wikidata; Q54848822
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D34 ! GM16968
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM16968
AC   CVCL_4D34
DR   CLO; CLO_0018085
DR   Coriell; GM16968
DR   Wikidata; Q54848823
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D33 ! GM16967
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM16969
AC   CVCL_V438
DR   CLO; CLO_0018078
DR   Coriell; GM16969
DR   Wikidata; Q54848824
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16969).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V439 ! GM16970
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   GM16970
AC   CVCL_V439
DR   CLO; CLO_0018046
DR   Coriell; GM16970
DR   Wikidata; Q54848825
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16970).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V438 ! GM16969
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM16972
AC   CVCL_4D35
DR   CLO; CLO_0018045
DR   Coriell; GM16972
DR   Wikidata; Q54848826
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM16972).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM16994
AC   CVCL_2N34
DR   Coriell; GM16994
DR   Wikidata; Q54848827
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM17397
AC   CVCL_9Z53
DR   Coriell; GM17397
DR   Wikidata; Q54848828
RX   PubMed=16257970;
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Pro117Leu (c.350C>T); ClinVar=VCV002138415; Zygosity=Heterozygous (PubMed=16257970).
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Leu153Val (c.457G>C); Zygosity=Heterozygous (PubMed=16257970).
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Arg288fs (c.862delC) (c.861delC); dbSNP=rs267608192; Zygosity=Heterozygous (PubMed=16257970).
CC   Discontinued: Coriell; GM17397; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155761; Peroxisome biogenesis disorder 7B
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM17398
AC   CVCL_4F76
DR   CLO; CLO_0012211
DR   Coriell; GM17398
DR   Wikidata; Q54848843
RX   PubMed=16257970;
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Thr77fs*139 (c.230+1G>T) (IVS2+1G>T); ClinVar=VCV000002159; Zygosity=Homozygous (PubMed=16257970).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155760; Peroxisome biogenesis disorder 7A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM17399
AC   CVCL_9Z55
DR   Coriell; GM17399
DR   Wikidata; Q54848844
RX   PubMed=16257970;
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Leu44Pro (c.131T>C); Zygosity=Heterozygous (PubMed=16257970).
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Arg98Trp (c.292C>T); ClinVar=VCV000002152; Zygosity=Heterozygous (PubMed=16257970).
CC   Discontinued: Coriell; GM17399; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155761; Peroxisome biogenesis disorder 7B
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM17400
AC   CVCL_9Z56
DR   CLO; CLO_0012221
DR   BioSample; SAMN00804789
DR   Coriell; GM17400
DR   Wikidata; Q54848845
RX   PubMed=16257970;
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Leu44Pro (c.131T>C); Zygosity=Heterozygous (PubMed=16257970).
CC   Sequence variation: Mutation; HGNC; HGNC:22965; PEX26; Simple; p.Arg98Trp (c.292C>T); ClinVar=VCV000002152; Zygosity=Heterozygous (PubMed=16257970).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155761; Peroxisome biogenesis disorder 7B
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM17410
AC   CVCL_V715
DR   CLO; CLO_0012217
DR   Coriell; GM17410
DR   Wikidata; Q54848846
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17410).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 15
//
ID   GM17411
AC   CVCL_4D36
DR   CLO; CLO_0012299
DR   Coriell; GM17411
DR   Wikidata; Q54848847
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D37 ! GM17412
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17412
AC   CVCL_4D37
DR   CLO; CLO_0012295
DR   Coriell; GM17412
DR   Wikidata; Q54848848
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D36 ! GM17411
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17413
AC   CVCL_V713
DR   CLO; CLO_0012296
DR   Coriell; GM17413
DR   Wikidata; Q54848849
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17413).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V714 ! GM17414
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM17414
AC   CVCL_V714
DR   CLO; CLO_0012293
DR   Coriell; GM17414
DR   Wikidata; Q54848850
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17414).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V713 ! GM17413
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 15
//
ID   GM17415
AC   CVCL_4D38
DR   CLO; CLO_0012294
DR   Coriell; GM17415
DR   Wikidata; Q54848852
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D39 ! GM17416
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17416
AC   CVCL_4D39
DR   CLO; CLO_0012266
DR   Coriell; GM17416
DR   Wikidata; Q54848853
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D38 ! GM17415
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17417
AC   CVCL_W155
DR   CLO; CLO_0012263
DR   Coriell; GM17417
DR   Wikidata; Q54848854
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS2+1G>A; Zygosity=Homozygous; Note=Splice donor mutation (from familial inference of XP86BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W156 ! GM17418
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM17418
AC   CVCL_W156
DR   CLO; CLO_0012262
DR   Coriell; GM17418
DR   Wikidata; Q54848855
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS2+1G>A; Zygosity=Homozygous; Note=Splice donor mutation (from familial inference of XP86BE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W155 ! GM17417
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM17419
AC   CVCL_1F73
DR   CLO; CLO_0012256
DR   Coriell; GM17419
DR   Wikidata; Q54848856
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS2+1G>A; Zygosity=Homozygous; Note=Splice donor mutation (from familial inference of XP86BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F74 ! GM17420
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM17420
AC   CVCL_1F74
DR   CLO; CLO_0012254
DR   Coriell; GM17420
DR   Wikidata; Q54848857
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS2+1G>A; Zygosity=Homozygous; Note=Splice donor mutation (from familial inference of XP86BE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F73 ! GM17419
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM17421
AC   CVCL_1F75
DR   CLO; CLO_0012338
DR   Coriell; GM17421
DR   Wikidata; Q54848858
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS2+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (from familial inference of XP86BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM17425
AC   CVCL_V716
DR   CLO; CLO_0012334
DR   Coriell; GM17425
DR   Wikidata; Q54848862
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V717 ! GM17426
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM17426
AC   CVCL_V717
DR   CLO; CLO_0012335
DR   Coriell; GM17426
DR   Wikidata; Q54848863
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17426).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V716 ! GM17425
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 15
//
ID   GM17427
AC   CVCL_V711
DR   CLO; CLO_0012336
DR   Coriell; GM17427
DR   Wikidata; Q54848864
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17427).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V712 ! GM17428
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   GM17428
AC   CVCL_V712
DR   CLO; CLO_0012312
DR   Coriell; GM17428
DR   Wikidata; Q54848865
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17428).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V711 ! GM17427
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 15
//
ID   GM17429
AC   CVCL_HJ83
DR   Coriell; GM17429
DR   Wikidata; Q54848866
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM17429).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_352; Galactosemia
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM17430
AC   CVCL_1Y33
DR   CLO; CLO_0012309
DR   Coriell; GM17430
DR   Wikidata; Q54848867
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM17430).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Arg333Trp (c.997C>T); ClinVar=VCV000003610; Zygosity=Heterozygous (Coriell=GM17430).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17431
AC   CVCL_1Y34
DR   CLO; CLO_0012317
DR   Coriell; GM17431
DR   Wikidata; Q54848868
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM17431).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Leu195Pro (c.584T>C); ClinVar=VCV000025222; Zygosity=Heterozygous (Coriell=GM17431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17432
AC   CVCL_1Y35
DR   CLO; CLO_0012316
DR   Coriell; GM17432
DR   Wikidata; Q54848869
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM17432).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17433
AC   CVCL_1Y36
DR   CLO; CLO_0012893
DR   Coriell; GM17433
DR   Wikidata; Q54848870
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Leu74Pro (c.221T>C); ClinVar=VCV000003615; Zygosity=Heterozygous (Coriell=GM17433).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM17433).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17434
AC   CVCL_1Y37
DR   CLO; CLO_0012889
DR   Coriell; GM17434
DR   Wikidata; Q54848871
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Homozygous (Coriell=GM17434).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17435
AC   CVCL_1Y38
DR   CLO; CLO_0012898
DR   Coriell; GM17435
DR   Wikidata; Q54848872
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM17435).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Asn314Asp (c.940A>G); ClinVar=VCV000003613; Zygosity=Heterozygous (Coriell=GM17435).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17436
AC   CVCL_1Y39
DR   CLO; CLO_0012894
DR   Coriell; GM17436
DR   Wikidata; Q54848873
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Leu74Pro (c.221T>C); ClinVar=VCV000003615; Zygosity=Heterozygous (Coriell=GM17436).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Gln188Arg (c.563A>G); ClinVar=VCV000003614; Zygosity=Heterozygous (Coriell=GM17436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17437
AC   CVCL_4E15
DR   CLO; CLO_0012909
DR   Coriell; GM17437
DR   Wikidata; Q54848874
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM17438
AC   CVCL_0R65
DR   CLO; CLO_0012907
DR   Coriell; GM17438
DR   Wikidata; Q54848875
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   HLA typing: A*24:02:01,68:03:01; B*35:01:01,52:01:02; C*03:03:01,04:01:01; DPA1*01:03:01,02:01:01; DPB1*04:02:01,14:01:01; DQA1*03:01:01,05:03; DQB1*03:01:01,03:02:01; DRB1*04:07:01,14:06:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17439
AC   CVCL_0R66
DR   CLO; CLO_0012913
DR   Coriell; GM17439
DR   Wikidata; Q54848876
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17440
AC   CVCL_0R67
DR   CLO; CLO_0012912
DR   Coriell; GM17440
DR   Wikidata; Q54848877
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   HLA typing: A*02:01:01,02:06:01; B*15:15,35:23; C*01:02:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*04:01:01,04:01:01; DQB1*04:02:01,04:02:01; DRB1*08:02:01,08:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17441
AC   CVCL_0R68
DR   CLO; CLO_0012906
DR   Coriell; GM17441
DR   Wikidata; Q54848878
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17442
AC   CVCL_0R69
DR   CLO; CLO_0012905
DR   Coriell; GM17442
DR   Wikidata; Q54848879
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17443
AC   CVCL_0R70
DR   CLO; CLO_0012860
DR   Coriell; GM17443
DR   Wikidata; Q54848880
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17444
AC   CVCL_0R71
DR   CLO; CLO_0012857
DR   Coriell; GM17444
DR   Wikidata; Q54848881
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17445
AC   CVCL_0R72
DR   CLO; CLO_0012855
DR   Coriell; GM17445
DR   Wikidata; Q54848882
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17446
AC   CVCL_0R73
DR   CLO; CLO_0012852
DR   Coriell; GM17446
DR   Wikidata; Q54848883
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17448
AC   CVCL_0R74
DR   CLO; CLO_0012848
DR   Coriell; GM17448
DR   Wikidata; Q54848884
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17449
AC   CVCL_0R75
DR   CLO; CLO_0012872
DR   Coriell; GM17449
DR   Wikidata; Q54848887
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17450
AC   CVCL_0R76
DR   CLO; CLO_0012870
DR   Coriell; GM17450
DR   Wikidata; Q54848888
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17451
AC   CVCL_0R77
DR   CLO; CLO_0012868
DR   Coriell; GM17451
DR   Wikidata; Q54848889
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17452
AC   CVCL_0R78
DR   CLO; CLO_0012866
DR   Coriell; GM17452
DR   Wikidata; Q54848890
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17453
AC   CVCL_0R79
DR   CLO; CLO_0012865
DR   Coriell; GM17453
DR   Wikidata; Q54848891
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17454
AC   CVCL_0R80
DR   CLO; CLO_0012947
DR   Coriell; GM17454
DR   Wikidata; Q54848892
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17456
AC   CVCL_0R81
DR   CLO; CLO_0012946
DR   Coriell; GM17456
DR   Wikidata; Q54848893
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17457
AC   CVCL_0R82
DR   CLO; CLO_0012949
DR   Coriell; GM17457
DR   Wikidata; Q54848894
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17458
AC   CVCL_0R83
DR   CLO; CLO_0012948
DR   Coriell; GM17458
DR   Wikidata; Q54848895
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17459
AC   CVCL_0R84
DR   CLO; CLO_0012951
DR   Coriell; GM17459
DR   Wikidata; Q54848896
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17460
AC   CVCL_0R85
DR   CLO; CLO_0012950
DR   Coriell; GM17460
DR   Wikidata; Q54848897
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17461
AC   CVCL_0R86
DR   CLO; CLO_0012953
DR   Coriell; GM17461
DR   Wikidata; Q54848899
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17462
AC   CVCL_0R87
DR   CLO; CLO_0012952
DR   Coriell; GM17462
DR   Wikidata; Q54848900
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17463
AC   CVCL_0R88
DR   CLO; CLO_0012956
DR   Coriell; GM17463
DR   Wikidata; Q54848901
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17464
AC   CVCL_HJ84
DR   Coriell; GM17464
DR   Wikidata; Q54848902
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM17465
AC   CVCL_0R89
DR   CLO; CLO_0012955
DR   Coriell; GM17465
DR   Wikidata; Q54848903
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17466
AC   CVCL_0R90
DR   CLO; CLO_0012926
DR   Coriell; GM17466
DR   Wikidata; Q54848904
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   HLA typing: A*11:01:01,23:01:01; B*44:03:01,44:03:01; C*04:01:01,04:01:01; DPA1*01:03:01,02:01:01; DPB1*04:01:01,14:01:01; DQA1*02:01:01,02:01:01; DQB1*02:02:01,02:02:01; DRB1*07:01:01,07:01:01; DRB4*01:01:01,01:01:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17467
AC   CVCL_0R91
DR   CLO; CLO_0012925
DR   Coriell; GM17467
DR   Wikidata; Q54848905
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17468
AC   CVCL_HJ85
DR   Coriell; GM17468
DR   Wikidata; Q54848906
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM17470
AC   CVCL_4F77
DR   CLO; CLO_0012924
DR   Coriell; GM17470
DR   Wikidata; Q54848907
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:90; ACADS; Simple; p.Arg107Cys (c.319C>T); ClinVar=VCV000003826; Zygosity=Homozygous (Coriell=GM17470).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84539; Acyl-CoA dehydrogenase, short-chain deficiency
DI   ORDO; Orphanet_26792; Short chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17471
AC   CVCL_4F78
DR   CLO; CLO_0012930
DR   Coriell; GM17471
DR   Wikidata; Q54848908
CC   Sequence variation: Mutation; HGNC; HGNC:90; ACADS; Simple; p.Arg171Trp (c.511C>T) (R147W); ClinVar=VCV000003830; Zygosity=Homozygous (Coriell=GM17471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84539; Acyl-CoA dehydrogenase, short-chain deficiency
DI   ORDO; Orphanet_26792; Short chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17472
AC   CVCL_4F79
DR   CLO; CLO_0012929
DR   Coriell; GM17472
DR   Wikidata; Q54848909
CC   Sequence variation: Mutation; HGNC; HGNC:90; ACADS; Simple; p.Arg171Trp (c.511C>T) (R147W); ClinVar=VCV000003830; Zygosity=Heterozygous (Coriell=GM17472).
CC   Sequence variation: Mutation; HGNC; HGNC:90; ACADS; Simple; p.Gly209Ser (c.625G>A) (G185S); ClinVar=VCV000003831; Zygosity=Heterozygous (Coriell=GM17472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84539; Acyl-CoA dehydrogenase, short-chain deficiency
DI   ORDO; Orphanet_26792; Short chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17473
AC   CVCL_4F80
DR   CLO; CLO_0012928
DR   Coriell; GM17473
DR   Wikidata; Q54848910
CC   Sequence variation: Mutation; HGNC; HGNC:90; ACADS; Simple; p.Gly209Ser (c.625G>A) (G185S); ClinVar=VCV000003831; Zygosity=Homozygous (Coriell=GM17473).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84539; Acyl-CoA dehydrogenase, short-chain deficiency
DI   ORDO; Orphanet_26792; Short chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17475
AC   CVCL_4F81
DR   CLO; CLO_0012927
DR   Coriell; GM17475
DR   Wikidata; Q54848911
CC   Sequence variation: Mutation; HGNC; HGNC:92; ACADVL; Simple; p.Asn122Asp (c.364A>G); ClinVar=VCV000376917; Zygosity=Homozygous (Coriell=GM17475).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98647; Very long-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26793; Very long chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17476
AC   CVCL_IN34
DR   CLO; CLO_0012935
DR   Coriell; GM17476
DR   Wikidata; Q54848912
CC   Sequence variation: Mutation; HGNC; HGNC:87; ACAD8; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV000005359; Zygosity=Homozygous (Coriell=GM17476).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129975; Isobutyryl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_79159; Isobutyryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM17477
AC   CVCL_IM21
DR   CLO; CLO_0012934
DR   Coriell; GM17477
DR   Wikidata; Q54848913
CC   Population: Chinese/Asian ethnic group; Hmong.
CC   Sequence variation: Mutation; HGNC; HGNC:91; ACADSB; Simple; p.Met389Val (c.1165A>G); ClinVar=VCV000664690; Zygosity=Homozygous (Coriell=GM17477).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98863; Butyryl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_79157; 2-methylbutyryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3W
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM17478
AC   CVCL_4W23
DR   CLO; CLO_0012932
DR   Coriell; GM17478
DR   Wikidata; Q54848914
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98964; Isovaleric acidemia
DI   ORDO; Orphanet_33; Isovaleric acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM17479
AC   CVCL_CZ74
DR   CLO; CLO_0013014
DR   Coriell; GM17479
DR   Wikidata; Q54848915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM17482
AC   CVCL_CV44
DR   CLO; CLO_0013015
DR   Coriell; GM17482
DR   Wikidata; Q54848916
CC   Sequence variation: Mutation; HGNC; HGNC:4803; HADHB; Simple; p.Arg61His (c.182G>A) (R28H); ClinVar=VCV000014845; Zygosity=Heterozygous (Coriell=GM17482).
CC   Sequence variation: Mutation; HGNC; HGNC:4803; HADHB; Simple; p.Arg247His (c.740G>A); ClinVar=VCV000014846; Zygosity=Heterozygous (Coriell=GM17482).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98991; Mitochondrial trifunctional protein deficiency
DI   ORDO; Orphanet_746; Mitochondrial trifunctional protein deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM17488
AC   CVCL_DS96
DR   CLO; CLO_0013017
DR   Coriell; GM17488
DR   Wikidata; Q54848917
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM17489
AC   CVCL_AB50
DR   CLO; CLO_0013018
DR   Coriell; GM17489
DR   Wikidata; Q54848918
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84548; Alpha-mannosidosis
DI   ORDO; Orphanet_61; Alpha-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM17491
AC   CVCL_0M08
DR   CLO; CLO_0013006
DR   Coriell; GM17491
DR   Wikidata; Q54848919
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM17493
AC   CVCL_DS97
DR   CLO; CLO_0013009
DR   Coriell; GM17493
DR   Wikidata; Q54848920
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM17494
AC   CVCL_GY29
DR   CLO; CLO_0013010
DR   Coriell; GM17494
DR   Wikidata; Q54848921
RX   PubMed=10339581;
CC   Sequence variation: Mutation; HGNC; HGNC:5320; HYAL1; Simple; p.Val251Phefs*20 (c.751_787delinsTTCCGTGTGGCCCG) (1361del37ins14); ClinVar=VCV000003531; Zygosity=Heterozygous (PubMed=10339581).
CC   Sequence variation: Mutation; HGNC; HGNC:5320; HYAL1; Simple; p.Glu268Lys (c.802G>A); ClinVar=VCV000003530; Zygosity=Heterozygous (PubMed=10339581).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129073; Mucopolysaccharidosis type IX
DI   ORDO; Orphanet_67041; Hyaluronidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM17495
AC   CVCL_AB51
DR   CLO; CLO_0013012
DR   Coriell; GM17495
DR   Wikidata; Q54848922
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84900; Mucopolysaccharidosis type IIID
DI   ORDO; Orphanet_79272; Sanfilippo syndrome type D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM17501
AC   CVCL_4D40
DR   CLO; CLO_0013001
DR   Coriell; GM17501
DR   Wikidata; Q54848923
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D41 ! GM17502
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17502
AC   CVCL_4D41
DR   CLO; CLO_0013003
DR   Coriell; GM17502
DR   Wikidata; Q54848924
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D40 ! GM17501
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17503
AC   CVCL_4D42
DR   CLO; CLO_0012958
DR   Coriell; GM17503
DR   Wikidata; Q54848925
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D43 ! GM17504
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17504
AC   CVCL_4D43
DR   CLO; CLO_0012985
DR   Coriell; GM17504
DR   Wikidata; Q54848927
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D42 ! GM17503
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17505
AC   CVCL_1J93
DR   CLO; CLO_0012988
DR   Coriell; GM17505
DR   Wikidata; Q54848928
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17505).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J94 ! GM17506
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM17506
AC   CVCL_1J94
DR   CLO; CLO_0012983
DR   Coriell; GM17506
DR   Wikidata; Q54848946
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17506).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J93 ! GM17505
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM17507
AC   CVCL_7657
DR   CLO; CLO_0012984
DR   BioSample; SAMN00804918
DR   Coriell; GM17507
DR   Wikidata; Q54848947
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7658 ! GM17508
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   GM17508
AC   CVCL_7658
DR   CLO; CLO_0012979
DR   BioSample; SAMN00804920
DR   Coriell; GM17508
DR   Wikidata; Q54848948
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM17508; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7657 ! GM17507
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   GM17509
AC   CVCL_5A86
DR   CLO; CLO_0012982
DR   BioSample; SAMN00804922
DR   Coriell; GM17509
DR   Wikidata; Q54848949
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.81-2delA (IVS2-2delA); ClinVar=VCV000055717; Zygosity=Unspecified; Note=Splice acceptor mutation (Coriell=GM17509).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gly890Arg (c.2668G>A); ClinVar=VCV000054634; Zygosity=Unspecified (Coriell=GM17509).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Val2739Ile (c.8215G>A); ClinVar=VCV000052529; Zygosity=Unspecified (Coriell=GM17509).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   GM17513
AC   CVCL_V710
DR   CLO; CLO_0012976
DR   Coriell; GM17513
DR   Wikidata; Q54848950
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114766; Carnitine palmitoyltransferase II deficiency
DI   ORDO; Orphanet_157; Carnitine palmitoyltransferase II deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM17515
AC   CVCL_DB93
DR   CLO; CLO_0012977
DR   Coriell; GM17515
DR   Wikidata; Q54848951
CC   Population: Pakistani.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM17516
AC   CVCL_DB94
DR   CLO; CLO_0012972
DR   Coriell; GM17516
DR   Wikidata; Q54848952
CC   Population: Pakistani.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM17517
AC   CVCL_J693
DR   CLO; CLO_0013041
DR   Coriell; GM17517
DR   Wikidata; Q54848953
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17517).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J694 ! GM17518
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM17518
AC   CVCL_J694
DR   CLO; CLO_0013040
DR   Coriell; GM17518
DR   Wikidata; Q54848954
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17518).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J693 ! GM17517
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM17519
AC   CVCL_J699
DR   CLO; CLO_0013045
DR   Coriell; GM17519
DR   Wikidata; Q54848955
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J700 ! GM17520
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM17520
AC   CVCL_J700
DR   CLO; CLO_0013047
DR   Coriell; GM17520
DR   Wikidata; Q54848956
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J699 ! GM17519
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   GM17521
AC   CVCL_J701
DR   CLO; CLO_0013049
DR   Coriell; GM17521
DR   Wikidata; Q54848957
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17521).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J702 ! GM17522
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM17522
AC   CVCL_J702
DR   CLO; CLO_0013051
DR   Coriell; GM17522
DR   Wikidata; Q54848958
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17522).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J701 ! GM17521
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM17523
AC   CVCL_1K21
SY   99P0149
DR   CLO; CLO_0013052
DR   Coriell; GM17523
DR   Wikidata; Q54848959
RX   PubMed=11779494;
RX   PubMed=19896956;
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Gly469Glu (c.1406G>A); ClinVar=VCV000007674; Zygosity=Heterozygous (PubMed=11779494).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg814Ter (c.2440C>T); ClinVar=VCV000007673; Zygosity=Heterozygous (PubMed=11779494).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM17527
AC   CVCL_IZ52
DR   CLO; CLO_0013054
DR   Coriell; GM17527
DR   Wikidata; Q54848960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132827; Autosomal recessive congenital ichthyosis 2
DI   ORDO; Orphanet_79394; Congenital non-bullous ichthyosiform erythroderma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM17538
AC   CVCL_4F43
DR   CLO; CLO_0013059
DR   Coriell; GM17538
DR   Wikidata; Q54848962
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Ser134Cys (c.401C>G) (p.Ser146Cys, c.437C>G); ClinVar=VCV000143562; Zygosity=Hemizygous (Coriell=GM17538).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM17539
AC   CVCL_4F44
DR   CLO; CLO_0013022
DR   Coriell; GM17539
DR   Wikidata; Q54848963
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Ser134Cys (c.401C>G) (p.Ser146Cys, c.437C>G); ClinVar=VCV000143562; Zygosity=Heterozygous (Coriell=GM17539).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM17540
AC   CVCL_4F45
DR   CLO; CLO_0013020
DR   Coriell; GM17540
DR   Wikidata; Q54848964
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Ser134Cys (c.401C>G) (p.Ser146Cys, c.437C>G); ClinVar=VCV000143562; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM17542
AC   CVCL_RG80
SY   XPTTD306BE
DR   Coriell; GM17542
DR   Wikidata; Q54848965
RX   PubMed=18470933;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ser51Phe (c.152C>T); Zygosity=Heterozygous (PubMed=18470933).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=18470933).
CC   Discontinued: Coriell; GM17542; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_33364; Trichothiodystrophy
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM17547
AC   CVCL_Y317
DR   CLO; CLO_0013019
DR   Coriell; GM17547
DR   Wikidata; Q54848966
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple; p.Cys506Arg (c.1516T>C); ClinVar=VCV000011376; Zygosity=Hemizygous (Coriell=GM17547).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   GM17566
AC   CVCL_Y318
DR   CLO; CLO_0013025
DR   Coriell; GM17566
DR   Wikidata; Q54848967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   GM17567
AC   CVCL_4F46
DR   CLO; CLO_0013028
DR   Coriell; GM17567
DR   Wikidata; Q54848968
RX   PubMed=29742391;
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Ter487Trp (c.1461A>G) (p.Ter499Trp, c.1497A>G); ClinVar=VCV000143490; Zygosity=Unspecified (Coriell=GM17567).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17569
AC   CVCL_1F76
DR   CLO; CLO_0013037
DR   Coriell; GM17569
DR   Wikidata; Q54848969
CC   Population: African American.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F77 ! GM17570
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM17570
AC   CVCL_1F77
DR   CLO; CLO_0013039
DR   Coriell; GM17570
DR   Wikidata; Q54848970
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F76 ! GM17569
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17572
AC   CVCL_1F78
DR   CLO; CLO_0016982
DR   Coriell; GM17572
DR   Wikidata; Q54848972
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17575
AC   CVCL_0E72
DR   CLO; CLO_0016981
DR   Coriell; GM17575
DR   Wikidata; Q54848973
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11025; SLC3A1; Simple; p.Met467Thr (c.1400T>C); ClinVar=VCV000018115; Zygosity=Heterozygous (Coriell=GM17575).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM17576
AC   CVCL_4D44
DR   CLO; CLO_0016980
DR   Coriell; GM17576
DR   Wikidata; Q54848974
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D45 ! GM17577
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17577
AC   CVCL_4D45
DR   CLO; CLO_0016979
DR   Coriell; GM17577
DR   Wikidata; Q54848975
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D44 ! GM17576
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17578
AC   CVCL_4D46
DR   CLO; CLO_0016985
DR   Coriell; GM17578
DR   Wikidata; Q54848976
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17578).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D47 ! GM17579
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17579
AC   CVCL_4D47
DR   CLO; CLO_0016986
DR   Coriell; GM17579
DR   Wikidata; Q54848977
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17579).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D46 ! GM17578
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17583
AC   CVCL_4F47
DR   CLO; CLO_0016983
DR   Coriell; GM17583
DR   Wikidata; Q54848978
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu100Val (c.298C>G) (p.Leu112Val, c.334C>G); ClinVar=VCV000011835; Zygosity=Heterozygous (Coriell=GM17583).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129718; 47,XXX syndrome
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_3375; Trisomy X
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17586
AC   CVCL_1J97
DR   CLO; CLO_0016984
DR   Coriell; GM17586
DR   Wikidata; Q54848979
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J98 ! GM17587
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM17587
AC   CVCL_1J98
DR   CLO; CLO_0016987
DR   Coriell; GM17587
DR   Wikidata; Q54848980
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J97 ! GM17586
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM17588
AC   CVCL_1J95
DR   CLO; CLO_0016988
DR   Coriell; GM17588
DR   Wikidata; Q54848981
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J96 ! GM17589
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM17589
AC   CVCL_1J96
DR   CLO; CLO_0016962
DR   Coriell; GM17589
DR   Wikidata; Q54848982
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17589).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J95 ! GM17588
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM17590
AC   CVCL_4D48
DR   CLO; CLO_0016966
DR   Coriell; GM17590
DR   Wikidata; Q54848983
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D49 ! GM17591
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17591
AC   CVCL_4D49
DR   CLO; CLO_0016963
DR   Coriell; GM17591
DR   Wikidata; Q54848984
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D48 ! GM17590
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17592
AC   CVCL_V718
DR   CLO; CLO_0016970
DR   Coriell; GM17592
DR   Wikidata; Q54848985
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W735 ! GM17593
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   GM17593
AC   CVCL_W735
DR   CLO; CLO_0016967
DR   Coriell; GM17593
DR   Wikidata; Q54848992
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V718 ! GM17592
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM17594
AC   CVCL_4D50
DR   CLO; CLO_0016974
DR   Coriell; GM17594
DR   Wikidata; Q54848993
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D51 ! GM17595
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17595
AC   CVCL_4D51
DR   CLO; CLO_0016975
DR   Coriell; GM17595
DR   Wikidata; Q54848994
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D50 ! GM17594
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17596
AC   CVCL_4D52
DR   CLO; CLO_0016976
DR   Coriell; GM17596
DR   Wikidata; Q54848995
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17596).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D53 ! GM17597
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17597
AC   CVCL_4D53
DR   CLO; CLO_0016977
DR   Coriell; GM17597
DR   Wikidata; Q54848996
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17597).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D52 ! GM17596
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17598
AC   CVCL_4D54
DR   CLO; CLO_0016978
DR   Coriell; GM17598
DR   Wikidata; Q54848997
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17598).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D55 ! GM17599
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17599
AC   CVCL_4D55
DR   CLO; CLO_0017136
DR   Coriell; GM17599
DR   Wikidata; Q54848998
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17599).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D54 ! GM17598
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17600
AC   CVCL_4D56
DR   CLO; CLO_0017135
DR   Coriell; GM17600
DR   Wikidata; Q54848999
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17602
AC   CVCL_4D57
DR   CLO; CLO_0017134
DR   Coriell; GM17602
DR   Wikidata; Q54849001
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17602).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D58 ! GM17603
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17603
AC   CVCL_4D58
DR   CLO; CLO_0017143
DR   Coriell; GM17603
DR   Wikidata; Q54849002
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17603).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D57 ! GM17602
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17604
AC   CVCL_4D59
DR   CLO; CLO_0017142
DR   Coriell; GM17604
DR   Wikidata; Q54849003
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17604).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D60 ! GM17605
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17605
AC   CVCL_4D60
DR   CLO; CLO_0017139
DR   Coriell; GM17605
DR   Wikidata; Q54849004
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D59 ! GM17604
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17614
AC   CVCL_0R92
DR   CLO; CLO_0017138
DR   Coriell; GM17614
DR   Wikidata; Q54849005
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17615
AC   CVCL_0R93
DR   CLO; CLO_0017146
DR   Coriell; GM17615
DR   Wikidata; Q54849006
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17616
AC   CVCL_0R94
DR   CLO; CLO_0017145
DR   Coriell; GM17616
DR   Wikidata; Q54849007
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17617
AC   CVCL_0R95
DR   CLO; CLO_0017144
DR   Coriell; GM17617
DR   Wikidata; Q54849009
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17618
AC   CVCL_0R96
DR   CLO; CLO_0017173
DR   Coriell; GM17618
DR   Wikidata; Q54849010
RX   PubMed=20889555;
RX   PubMed=29959025;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   HLA typing: A*02:01:01,02:01:01; B*15:16:01,35:12:01; C*04:01:01,14:02:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,104:01:01; DQA1*01:01:02,04:01:01; DQB1*04:02:01,05:01:01; DRB1*01:02:01,08:02:01 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17619
AC   CVCL_0R97
DR   CLO; CLO_0017172
DR   Coriell; GM17619
DR   Wikidata; Q54849011
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17622
AC   CVCL_0R98
DR   CLO; CLO_0017175
DR   Coriell; GM17622
DR   Wikidata; Q54849012
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17624
AC   CVCL_0R99
DR   CLO; CLO_0017174
DR   Coriell; GM17624
DR   Wikidata; Q54849013
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17626
AC   CVCL_0S00
DR   CLO; CLO_0017179
DR   Coriell; GM17626
DR   Wikidata; Q54849014
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17629
AC   CVCL_0U78
DR   CLO; CLO_0017176
DR   Coriell; GM17629
DR   Wikidata; Q54849015
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17630
AC   CVCL_0S01
DR   CLO; CLO_0017183
DR   Coriell; GM17630
DR   Wikidata; Q54849016
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17631
AC   CVCL_0S02
DR   CLO; CLO_0017180
DR   Coriell; GM17631
DR   Wikidata; Q54849017
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17632
AC   CVCL_0S03
DR   CLO; CLO_0017185
DR   Coriell; GM17632
DR   Wikidata; Q54849018
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17633
AC   CVCL_0S04
DR   CLO; CLO_0017184
DR   Coriell; GM17633
DR   Wikidata; Q54849019
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17634
AC   CVCL_0S05
DR   CLO; CLO_0017106
DR   Coriell; GM17634
DR   Wikidata; Q54849021
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17636
AC   CVCL_0S06
DR   CLO; CLO_0017102
DR   Coriell; GM17636
DR   Wikidata; Q54849022
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17637
AC   CVCL_0S07
DR   CLO; CLO_0017103
DR   Coriell; GM17637
DR   Wikidata; Q54849023
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17639
AC   CVCL_0S08
DR   CLO; CLO_0017104
DR   Coriell; GM17639
DR   Wikidata; Q54849024
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17640
AC   CVCL_0S09
DR   CLO; CLO_0017105
DR   Coriell; GM17640
DR   Wikidata; Q54849025
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17641
AC   CVCL_0S10
DR   CLO; CLO_0017098
DR   Coriell; GM17641
DR   Wikidata; Q54849026
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17642
AC   CVCL_0S11
DR   CLO; CLO_0017099
DR   Coriell; GM17642
DR   Wikidata; Q54849027
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17644
AC   CVCL_0S12
DR   CLO; CLO_0017100
DR   Coriell; GM17644
DR   Wikidata; Q54849028
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17645
AC   CVCL_0S13
DR   CLO; CLO_0017101
DR   Coriell; GM17645
DR   Wikidata; Q54849030
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17646
AC   CVCL_0S14
DR   CLO; CLO_0017097
DR   Coriell; GM17646
DR   Wikidata; Q54849031
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17648
AC   CVCL_0S15
DR   CLO; CLO_0017115
DR   Coriell; GM17648
DR   Wikidata; Q54849032
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17650
AC   CVCL_0S16
DR   CLO; CLO_0017116
DR   Coriell; GM17650
DR   Wikidata; Q54849033
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17651
AC   CVCL_0S17
DR   CLO; CLO_0017113
DR   Coriell; GM17651
DR   Wikidata; Q54849034
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17652
AC   CVCL_HJ94
DR   Coriell; GM17652
DR   Wikidata; Q54849035
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM17653
AC   CVCL_0S18
DR   CLO; CLO_0017114
DR   Coriell; GM17653
DR   Wikidata; Q54849049
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17654
AC   CVCL_0S19
DR   CLO; CLO_0017111
DR   Coriell; GM17654
DR   Wikidata; Q54849050
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17655
AC   CVCL_0S20
DR   CLO; CLO_0017112
DR   Coriell; GM17655
DR   Wikidata; Q54849051
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17656
AC   CVCL_0S21
DR   CLO; CLO_0017109
DR   Coriell; GM17656
DR   Wikidata; Q54849052
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17657
AC   CVCL_0S22
DR   CLO; CLO_0017110
DR   Coriell; GM17657
DR   Wikidata; Q54849053
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17658
AC   CVCL_0S23
DR   CLO; CLO_0017107
DR   Coriell; GM17658
DR   Wikidata; Q54849054
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17659
AC   CVCL_0S24
DR   CLO; CLO_0017108
DR   Coriell; GM17659
DR   Wikidata; Q54849056
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17660
AC   CVCL_0S25
DR   CLO; CLO_0017080
DR   Coriell; GM17660
DR   Wikidata; Q54849057
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17661
AC   CVCL_0S26
DR   CLO; CLO_0017081
DR   Coriell; GM17661
DR   Wikidata; Q54849058
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17667
AC   CVCL_0S27
DR   CLO; CLO_0017082
DR   Coriell; GM17667
DR   Wikidata; Q54849059
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17668
AC   CVCL_0S28
DR   CLO; CLO_0017083
DR   Coriell; GM17668
DR   Wikidata; Q54849060
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17670
AC   CVCL_0S29
DR   CLO; CLO_0017084
DR   Coriell; GM17670
DR   Wikidata; Q54849061
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17671
AC   CVCL_0S30
DR   CLO; CLO_0017085
DR   Coriell; GM17671
DR   Wikidata; Q54849062
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17672
AC   CVCL_0S31
DR   CLO; CLO_0017086
DR   Coriell; GM17672
DR   Wikidata; Q54849063
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17673
AC   CVCL_0S32
DR   CLO; CLO_0017077
DR   Coriell; GM17673
DR   Wikidata; Q54849064
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17674
AC   CVCL_0S33
DR   CLO; CLO_0017078
DR   Coriell; GM17674
DR   Wikidata; Q54849065
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17675
AC   CVCL_HJ95
DR   Coriell; GM17675
DR   Wikidata; Q54849066
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM17676
AC   CVCL_0S34
DR   CLO; CLO_0017079
DR   Coriell; GM17676
DR   Wikidata; Q54849067
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17677
AC   CVCL_0S35
DR   CLO; CLO_0017091
DR   Coriell; GM17677
DR   Wikidata; Q54849068
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17678
AC   CVCL_0S36
DR   CLO; CLO_0017092
DR   Coriell; GM17678
DR   Wikidata; Q54849069
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17679
AC   CVCL_0S37
DR   CLO; CLO_0017089
DR   Coriell; GM17679
DR   Wikidata; Q54849071
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17680
AC   CVCL_0S38
DR   CLO; CLO_0017090
DR   Coriell; GM17680
DR   Wikidata; Q54849072
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17682
AC   CVCL_0S39
DR   CLO; CLO_0017095
DR   Coriell; GM17682
DR   Wikidata; Q54849073
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17683
AC   CVCL_0S40
DR   CLO; CLO_0017096
DR   Coriell; GM17683
DR   Wikidata; Q54849074
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17684
AC   CVCL_0S41
DR   CLO; CLO_0017093
DR   Coriell; GM17684
DR   Wikidata; Q54849075
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17685
AC   CVCL_0S42
DR   CLO; CLO_0017094
DR   Coriell; GM17685
DR   Wikidata; Q54849076
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17686
AC   CVCL_0S43
DR   CLO; CLO_0017087
DR   Coriell; GM17686
DR   Wikidata; Q54849077
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17687
AC   CVCL_0S44
DR   CLO; CLO_0017088
DR   Coriell; GM17687
DR   Wikidata; Q54849078
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17689
AC   CVCL_0S45
DR   CLO; CLO_0017066
DR   Coriell; GM17689
DR   Wikidata; Q54849079
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17692
AC   CVCL_0S46
DR   CLO; CLO_0017054
DR   Coriell; GM17692
DR   Wikidata; Q54849080
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17694
AC   CVCL_HJ96
DR   Coriell; GM17694
DR   Wikidata; Q54849081
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM17695
AC   CVCL_0S47
DR   CLO; CLO_0017053
DR   Coriell; GM17695
DR   Wikidata; Q54849082
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17698
AC   CVCL_0S48
DR   CLO; CLO_0017056
DR   Coriell; GM17698
DR   Wikidata; Q54849084
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17699
AC   CVCL_0S49
DR   CLO; CLO_0017055
DR   Coriell; GM17699
DR   Wikidata; Q54849085
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17700
AC   CVCL_0S50
DR   CLO; CLO_0017050
DR   Coriell; GM17700
DR   Wikidata; Q54849087
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17701
AC   CVCL_0S51
DR   CLO; CLO_0017048
DR   Coriell; GM17701
DR   Wikidata; Q54849088
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17702
AC   CVCL_0S52
DR   CLO; CLO_0017052
DR   Coriell; GM17702
DR   Wikidata; Q54849089
RX   PubMed=26621101;
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17703
AC   CVCL_0S53
DR   CLO; CLO_0017051
DR   Coriell; GM17703
DR   Wikidata; Q54849090
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17704
AC   CVCL_0S54
DR   CLO; CLO_0017063
DR   Coriell; GM17704
DR   Wikidata; Q54849091
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17705
AC   CVCL_0S55
DR   CLO; CLO_0017075
DR   Coriell; GM17705
DR   Wikidata; Q54849092
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17706
AC   CVCL_0S56
DR   CLO; CLO_0017076
DR   Coriell; GM17706
DR   Wikidata; Q54849105
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17707
AC   CVCL_0S57
DR   CLO; CLO_0017074
DR   Coriell; GM17707
DR   Wikidata; Q54849106
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17708
AC   CVCL_0S58
DR   CLO; CLO_0017073
DR   Coriell; GM17708
DR   Wikidata; Q54849107
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17709
AC   CVCL_0S59
DR   CLO; CLO_0017072
DR   Coriell; GM17709
DR   Wikidata; Q54849108
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17710
AC   CVCL_0S60
DR   CLO; CLO_0017071
DR   Coriell; GM17710
DR   Wikidata; Q54849110
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17711
AC   CVCL_0S61
DR   CLO; CLO_0017070
DR   Coriell; GM17711
DR   Wikidata; Q54849113
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17712
AC   CVCL_0S62
DR   CLO; CLO_0017069
DR   Coriell; GM17712
DR   Wikidata; Q54849114
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17713
AC   CVCL_0S63
DR   CLO; CLO_0017068
DR   Coriell; GM17713
DR   Wikidata; Q54849115
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM17714
AC   CVCL_HJ97
DR   Coriell; GM17714
DR   Wikidata; Q54849116
CC   Part of: Human variation panel.
CC   Population: Mexican-American (from Los Angeles).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM17719
AC   CVCL_V440
DR   CLO; CLO_0017067
DR   Coriell; GM17719
DR   Wikidata; Q54849117
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17719).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V441 ! GM17720
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   GM17720
AC   CVCL_V441
DR   CLO; CLO_0017017
DR   Coriell; GM17720
DR   Wikidata; Q54849118
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17720).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V440 ! GM17719
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM17721
AC   CVCL_AB39
DR   CLO; CLO_0017018
DR   Coriell; GM17721
DR   Wikidata; Q54849119
CC   Sequence variation: Mutation; HGNC; HGNC:10933; SLC17A5; Simple; p.Arg39Cys (c.115C>T); ClinVar=VCV000005615; Zygosity=Homozygous (Coriell=GM17721).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM17722
AC   CVCL_AB40
DR   CLO; CLO_0017019
DR   Coriell; GM17722
DR   Wikidata; Q54849120
CC   Sequence variation: Mutation; HGNC; HGNC:10933; SLC17A5; Simple; p.Arg39Cys (c.115C>T); ClinVar=VCV000005615; Zygosity=Homozygous (Coriell=GM17722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM17723
AC   CVCL_AB41
DR   CLO; CLO_0016990
DR   Coriell; GM17723
DR   Wikidata; Q54849121
CC   Sequence variation: Mutation; HGNC; HGNC:10933; SLC17A5; Simple; p.Arg39Cys (c.115C>T); ClinVar=VCV000005615; Zygosity=Homozygous (Coriell=GM17723).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85067; Sialic acid storage disease
DI   ORDO; Orphanet_834; Free sialic acid storage disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM17724
AC   CVCL_HQ08
DR   CLO; CLO_0016989
DR   Coriell; GM17724
DR   Wikidata; Q54849122
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 6 repeats) (Coriell=GM17724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM17726
AC   CVCL_BT39
DR   CLO; CLO_0016992
DR   Coriell; GM17726
DR   Wikidata; Q54849123
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Thr184Argfs*36 (c.550delA); ClinVar=VCV000017621; Zygosity=Heterozygous (Coriell=GM17726).
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Arg490Gln (c.1469G>A); ClinVar=VCV000017622; Zygosity=Heterozygous (Coriell=GM17726).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM17729
AC   CVCL_W963
DR   CLO; CLO_0016991
DR   Coriell; GM17729
DR   Wikidata; Q54849124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM17730
AC   CVCL_2U50
DR   CLO; CLO_0016994
DR   Coriell; GM17730
DR   Wikidata; Q54849125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17731
AC   CVCL_H530
DR   CLO; CLO_0016993
DR   Coriell; GM17731
DR   Wikidata; Q54849126
RX   CelloPub=CLPUB00573;
CC   Senescence: Capable of at least 32 PDL (Coriell=GM17731).
CC   Discontinued: Coriell; GM17731; probable.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   GM17733
AC   CVCL_0S64
DR   CLO; CLO_0016995
DR   Coriell; GM17733
DR   GEO; GSM569502
DR   GEO; GSM596361
DR   GEO; GSM596684
DR   GEO; GSM827335
DR   GEO; GSM924707
DR   Wikidata; Q54849127
RX   PubMed=20215515;
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17734
AC   CVCL_0S65
DR   CLO; CLO_0017045
DR   Coriell; GM17734
DR   GEO; GSM569496
DR   GEO; GSM596362
DR   GEO; GSM596685
DR   GEO; GSM924708
DR   Wikidata; Q54849130
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17735
AC   CVCL_0S66
DR   CLO; CLO_0017046
DR   Coriell; GM17735
DR   GEO; GSM569503
DR   GEO; GSM596363
DR   GEO; GSM596686
DR   GEO; GSM924709
DR   Wikidata; Q54849131
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17736
AC   CVCL_0S67
DR   CLO; CLO_0017043
DR   Coriell; GM17736
DR   GEO; GSM569497
DR   GEO; GSM596364
DR   GEO; GSM596687
DR   GEO; GSM924710
DR   Wikidata; Q54849132
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17737
AC   CVCL_0S68
DR   CLO; CLO_0017044
DR   Coriell; GM17737
DR   GEO; GSM569504
DR   GEO; GSM596365
DR   GEO; GSM596688
DR   GEO; GSM827336
DR   GEO; GSM924711
DR   Wikidata; Q54849133
RX   PubMed=20215515;
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17738
AC   CVCL_0S69
DR   CLO; CLO_0017023
DR   Coriell; GM17738
DR   GEO; GSM569514
DR   GEO; GSM596366
DR   GEO; GSM596689
DR   GEO; GSM924712
DR   Wikidata; Q54849134
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17739
AC   CVCL_0S70
DR   CLO; CLO_0017022
DR   Coriell; GM17739
DR   GEO; GSM569507
DR   GEO; GSM596367
DR   GEO; GSM596690
DR   GEO; GSM924713
DR   Wikidata; Q54849135
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17740
AC   CVCL_0S71
DR   CLO; CLO_0017021
DR   Coriell; GM17740
DR   GEO; GSM569515
DR   GEO; GSM596368
DR   GEO; GSM596691
DR   GEO; GSM924714
DR   Wikidata; Q54849136
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17741
AC   CVCL_0S72
DR   CLO; CLO_0017020
DR   Coriell; GM17741
DR   GEO; GSM569516
DR   GEO; GSM596369
DR   GEO; GSM596692
DR   GEO; GSM924715
DR   Wikidata; Q54849137
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17742
AC   CVCL_0S73
DR   CLO; CLO_0017025
DR   Coriell; GM17742
DR   GEO; GSM569517
DR   GEO; GSM596370
DR   GEO; GSM596693
DR   GEO; GSM924716
DR   Wikidata; Q54849138
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17743
AC   CVCL_0S74
DR   CLO; CLO_0017024
DR   Coriell; GM17743
DR   GEO; GSM569526
DR   GEO; GSM596371
DR   GEO; GSM596694
DR   GEO; GSM924717
DR   Wikidata; Q54849139
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17744
AC   CVCL_0S75
DR   CLO; CLO_0016568
DR   Coriell; GM17744
DR   GEO; GSM569527
DR   GEO; GSM596372
DR   GEO; GSM596695
DR   GEO; GSM924718
DR   Wikidata; Q54849140
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17745
AC   CVCL_0S76
DR   CLO; CLO_0016567
DR   Coriell; GM17745
DR   GEO; GSM569528
DR   GEO; GSM596373
DR   GEO; GSM596696
DR   GEO; GSM924719
DR   Wikidata; Q54849141
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17746
AC   CVCL_0S77
DR   CLO; CLO_0016566
DR   Coriell; GM17746
DR   GEO; GSM569543
DR   GEO; GSM596374
DR   GEO; GSM596743
DR   GEO; GSM924720
DR   Wikidata; Q54849142
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17747
AC   CVCL_0S78
DR   CLO; CLO_0016565
DR   Coriell; GM17747
DR   GEO; GSM569529
DR   GEO; GSM596375
DR   GEO; GSM596744
DR   GEO; GSM924721
DR   Wikidata; Q54849143
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17749
AC   CVCL_0S79
DR   CLO; CLO_0016564
DR   Coriell; GM17749
DR   GEO; GSM569540
DR   GEO; GSM596376
DR   GEO; GSM596697
DR   GEO; GSM924722
DR   Wikidata; Q54849145
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17752
AC   CVCL_0S80
DR   CLO; CLO_0016561
DR   Coriell; GM17752
DR   GEO; GSM569546
DR   GEO; GSM596377
DR   GEO; GSM596698
DR   GEO; GSM924723
DR   Wikidata; Q54849146
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17753
AC   CVCL_0S81
DR   CLO; CLO_0016560
DR   Coriell; GM17753
DR   GEO; GSM569545
DR   GEO; GSM596378
DR   GEO; GSM596699
DR   GEO; GSM924724
DR   Wikidata; Q54849147
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17754
AC   CVCL_0S82
DR   CLO; CLO_0016558
DR   Coriell; GM17754
DR   GEO; GSM569541
DR   GEO; GSM596379
DR   GEO; GSM596700
DR   GEO; GSM924725
DR   Wikidata; Q54849148
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17755
AC   CVCL_0S83
DR   CLO; CLO_0016555
DR   Coriell; GM17755
DR   GEO; GSM569547
DR   GEO; GSM596380
DR   GEO; GSM596701
DR   GEO; GSM924726
DR   Wikidata; Q54849149
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17756
AC   CVCL_0S84
DR   CLO; CLO_0016554
DR   Coriell; GM17756
DR   GEO; GSM569556
DR   GEO; GSM596381
DR   GEO; GSM596702
DR   GEO; GSM924727
DR   Wikidata; Q54849150
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17757
AC   CVCL_0S85
DR   CLO; CLO_0016606
DR   Coriell; GM17757
DR   GEO; GSM569557
DR   GEO; GSM596382
DR   GEO; GSM596703
DR   GEO; GSM924728
DR   Wikidata; Q54849166
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17758
AC   CVCL_0S86
DR   CLO; CLO_0016608
DR   Coriell; GM17758
DR   GEO; GSM569558
DR   GEO; GSM596383
DR   GEO; GSM596704
DR   GEO; GSM924729
DR   Wikidata; Q54849167
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17759
AC   CVCL_0S87
DR   CLO; CLO_0016607
DR   Coriell; GM17759
DR   GEO; GSM569559
DR   GEO; GSM596384
DR   GEO; GSM596705
DR   GEO; GSM924730
DR   Wikidata; Q54849168
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17761
AC   CVCL_0S88
DR   CLO; CLO_0016601
DR   Coriell; GM17761
DR   GEO; GSM569560
DR   GEO; GSM596385
DR   GEO; GSM596706
DR   GEO; GSM924731
DR   Wikidata; Q54849169
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17762
AC   CVCL_0S89
DR   CLO; CLO_0016600
DR   Coriell; GM17762
DR   GEO; GSM569592
DR   GEO; GSM596386
DR   GEO; GSM596707
DR   GEO; GSM924732
DR   Wikidata; Q54849171
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17764
AC   CVCL_0S90
DR   CLO; CLO_0016604
DR   Coriell; GM17764
DR   GEO; GSM569600
DR   GEO; GSM596387
DR   GEO; GSM596708
DR   GEO; GSM924733
DR   Wikidata; Q54849172
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17765
AC   CVCL_0S91
DR   CLO; CLO_0016602
DR   Coriell; GM17765
DR   GEO; GSM569601
DR   GEO; GSM596388
DR   GEO; GSM596709
DR   GEO; GSM924734
DR   Wikidata; Q54849173
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17766
AC   CVCL_0S92
DR   CLO; CLO_0016594
DR   Coriell; GM17766
DR   GEO; GSM569577
DR   GEO; GSM596389
DR   GEO; GSM596710
DR   GEO; GSM924735
DR   Wikidata; Q54849174
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17767
AC   CVCL_0S93
DR   CLO; CLO_0016593
DR   Coriell; GM17767
DR   GEO; GSM569602
DR   GEO; GSM596390
DR   GEO; GSM596711
DR   GEO; GSM924736
DR   Wikidata; Q54849175
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17768
AC   CVCL_0S94
DR   CLO; CLO_0016597
DR   Coriell; GM17768
DR   GEO; GSM569614
DR   GEO; GSM596391
DR   GEO; GSM596712
DR   GEO; GSM924737
DR   Wikidata; Q54849176
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17769
AC   CVCL_0S95
DR   CLO; CLO_0016648
DR   Coriell; GM17769
DR   GEO; GSM569578
DR   GEO; GSM596392
DR   GEO; GSM596713
DR   GEO; GSM924738
DR   Wikidata; Q54849177
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17770
AC   CVCL_0S96
DR   CLO; CLO_0016647
DR   Coriell; GM17770
DR   GEO; GSM569579
DR   GEO; GSM596393
DR   GEO; GSM596714
DR   GEO; GSM924739
DR   Wikidata; Q54849178
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17771
AC   CVCL_0S97
DR   CLO; CLO_0016646
DR   Coriell; GM17771
DR   GEO; GSM569580
DR   GEO; GSM596394
DR   GEO; GSM596715
DR   GEO; GSM924740
DR   Wikidata; Q54849179
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17773
AC   CVCL_0S98
DR   CLO; CLO_0016645
DR   Coriell; GM17773
DR   GEO; GSM569581
DR   GEO; GSM596395
DR   GEO; GSM596716
DR   GEO; GSM924741
DR   Wikidata; Q54849180
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17774
AC   CVCL_0S99
DR   CLO; CLO_0016641
DR   Coriell; GM17774
DR   GEO; GSM569663
DR   GEO; GSM596396
DR   GEO; GSM596717
DR   GEO; GSM924742
DR   Wikidata; Q54849181
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17775
AC   CVCL_0T00
DR   CLO; CLO_0016638
DR   Coriell; GM17775
DR   GEO; GSM569572
DR   GEO; GSM596397
DR   GEO; GSM596718
DR   GEO; GSM924743
DR   Wikidata; Q54849182
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17776
AC   CVCL_0T01
DR   CLO; CLO_0016636
DR   Coriell; GM17776
DR   GEO; GSM569562
DR   GEO; GSM596398
DR   GEO; GSM596719
DR   GEO; GSM924744
DR   Wikidata; Q54849183
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17779
AC   CVCL_0T02
DR   CLO; CLO_0016635
DR   Coriell; GM17779
DR   GEO; GSM569573
DR   GEO; GSM596399
DR   GEO; GSM596720
DR   GEO; GSM924745
DR   Wikidata; Q54849184
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17780
AC   CVCL_0T03
DR   CLO; CLO_0016643
DR   Coriell; GM17780
DR   GEO; GSM569574
DR   GEO; GSM596400
DR   GEO; GSM596721
DR   GEO; GSM924746
DR   Wikidata; Q54849186
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17782
AC   CVCL_0T04
DR   CLO; CLO_0016642
DR   Coriell; GM17782
DR   GEO; GSM569664
DR   GEO; GSM596401
DR   GEO; GSM596722
DR   GEO; GSM924747
DR   Wikidata; Q54849188
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17783
AC   CVCL_0T05
DR   CLO; CLO_0016684
DR   Coriell; GM17783
DR   GEO; GSM569665
DR   GEO; GSM596402
DR   GEO; GSM596723
DR   GEO; GSM924748
DR   Wikidata; Q54849189
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17784
AC   CVCL_HJ98
DR   Coriell; GM17784
DR   GEO; GSM924799
DR   Wikidata; Q54849190
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   GM17785
AC   CVCL_0T06
DR   CLO; CLO_0016686
DR   Coriell; GM17785
DR   GEO; GSM569666
DR   GEO; GSM596403
DR   GEO; GSM596724
DR   GEO; GSM924749
DR   Wikidata; Q54849191
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17787
AC   CVCL_0T07
DR   CLO; CLO_0016685
DR   Coriell; GM17787
DR   GEO; GSM569667
DR   GEO; GSM596404
DR   GEO; GSM596725
DR   GEO; GSM924750
DR   Wikidata; Q54849192
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17789
AC   CVCL_0T08
DR   CLO; CLO_0016688
DR   Coriell; GM17789
DR   GEO; GSM569661
DR   GEO; GSM596405
DR   GEO; GSM596726
DR   GEO; GSM924751
DR   Wikidata; Q54849193
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17790
AC   CVCL_0T09
DR   CLO; CLO_0016687
DR   Coriell; GM17790
DR   GEO; GSM569621
DR   GEO; GSM596406
DR   GEO; GSM596727
DR   GEO; GSM924752
DR   Wikidata; Q54849194
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17791
AC   CVCL_0T10
DR   CLO; CLO_0016675
DR   Coriell; GM17791
DR   GEO; GSM569622
DR   GEO; GSM596407
DR   GEO; GSM596728
DR   GEO; GSM924753
DR   Wikidata; Q54849195
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17792
AC   CVCL_0T11
DR   CLO; CLO_0016672
DR   Coriell; GM17792
DR   GEO; GSM569623
DR   GEO; GSM596408
DR   GEO; GSM596729
DR   GEO; GSM924754
DR   Wikidata; Q54849196
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17793
AC   CVCL_0T12
DR   CLO; CLO_0016678
DR   Coriell; GM17793
DR   GEO; GSM569624
DR   GEO; GSM596409
DR   GEO; GSM596730
DR   GEO; GSM924755
DR   Wikidata; Q54849197
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17794
AC   CVCL_0T13
DR   CLO; CLO_0016676
DR   Coriell; GM17794
DR   GEO; GSM569616
DR   GEO; GSM596410
DR   GEO; GSM596731
DR   GEO; GSM924756
DR   Wikidata; Q54849198
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17795
AC   CVCL_0T14
DR   CLO; CLO_0016682
DR   Coriell; GM17795
DR   GEO; GSM569632
DR   GEO; GSM596411
DR   GEO; GSM596732
DR   GEO; GSM924757
DR   Wikidata; Q54849199
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17796
AC   CVCL_0T15
DR   CLO; CLO_0016493
DR   Coriell; GM17796
DR   GEO; GSM569637
DR   GEO; GSM596412
DR   GEO; GSM596733
DR   GEO; GSM924758
DR   Wikidata; Q54849200
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17797
AC   CVCL_0T16
DR   CLO; CLO_0016494
DR   Coriell; GM17797
DR   GEO; GSM569638
DR   GEO; GSM596413
DR   GEO; GSM596745
DR   GEO; GSM924759
DR   Wikidata; Q54849201
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17798
AC   CVCL_0T17
DR   CLO; CLO_0016489
DR   Coriell; GM17798
DR   GEO; GSM569643
DR   GEO; GSM596414
DR   GEO; GSM596746
DR   GEO; GSM924760
DR   Wikidata; Q54849203
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17799
AC   CVCL_0T18
DR   CLO; CLO_0016490
DR   Coriell; GM17799
DR   GEO; GSM569639
DR   GEO; GSM596415
DR   GEO; GSM596734
DR   GEO; GSM924761
DR   Wikidata; Q54849204
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17800
AC   CVCL_0T19
DR   CLO; CLO_0016491
DR   Coriell; GM17800
DR   GEO; GSM569649
DR   GEO; GSM596416
DR   GEO; GSM596735
DR   GEO; GSM924762
DR   Wikidata; Q54849205
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17801
AC   CVCL_0T20
DR   CLO; CLO_0016492
DR   Coriell; GM17801
DR   GEO; GSM569656
DR   GEO; GSM596417
DR   GEO; GSM596736
DR   GEO; GSM924763
DR   Wikidata; Q54849206
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17802
AC   CVCL_0T21
DR   CLO; CLO_0016495
DR   Coriell; GM17802
DR   GEO; GSM569650
DR   GEO; GSM596418
DR   GEO; GSM596737
DR   GEO; GSM924764
DR   Wikidata; Q54849207
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17803
AC   CVCL_0T22
DR   CLO; CLO_0016496
DR   Coriell; GM17803
DR   GEO; GSM569657
DR   GEO; GSM596419
DR   GEO; GSM596738
DR   GEO; GSM924765
DR   Wikidata; Q54849208
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17804
AC   CVCL_0T23
DR   CLO; CLO_0016497
DR   Coriell; GM17804
DR   GEO; GSM569651
DR   GEO; GSM596420
DR   GEO; GSM596739
DR   GEO; GSM924766
DR   Wikidata; Q54849209
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17805
AC   CVCL_0T24
DR   CLO; CLO_0016498
DR   Coriell; GM17805
DR   GEO; GSM569668
DR   GEO; GSM596421
DR   GEO; GSM596817
DR   GEO; GSM924767
DR   Wikidata; Q54849228
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17806
AC   CVCL_0T25
DR   CLO; CLO_0016505
DR   Coriell; GM17806
DR   GEO; GSM569669
DR   GEO; GSM596422
DR   GEO; GSM596777
DR   GEO; GSM924768
DR   Wikidata; Q54849230
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17807
AC   CVCL_0T26
DR   CLO; CLO_0016503
DR   Coriell; GM17807
DR   GEO; GSM569670
DR   GEO; GSM596423
DR   GEO; GSM596818
DR   GEO; GSM924769
DR   Wikidata; Q54849231
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17808
AC   CVCL_0T27
DR   CLO; CLO_0016504
DR   Coriell; GM17808
DR   GEO; GSM569671
DR   GEO; GSM596424
DR   GEO; GSM596778
DR   GEO; GSM924770
DR   Wikidata; Q54849232
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17809
AC   CVCL_0T28
DR   CLO; CLO_0016501
DR   Coriell; GM17809
DR   GEO; GSM569672
DR   GEO; GSM596425
DR   GEO; GSM596779
DR   GEO; GSM924771
DR   Wikidata; Q54849233
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17810
AC   CVCL_0T29
DR   CLO; CLO_0016502
DR   Coriell; GM17810
DR   GEO; GSM569673
DR   GEO; GSM596426
DR   GEO; GSM596780
DR   GEO; GSM924772
DR   Wikidata; Q54849234
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17811
AC   CVCL_0T30
DR   CLO; CLO_0016499
DR   Coriell; GM17811
DR   GEO; GSM569674
DR   GEO; GSM596427
DR   GEO; GSM596781
DR   GEO; GSM924773
DR   Wikidata; Q54849235
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17812
AC   CVCL_0T31
DR   CLO; CLO_0016500
DR   Coriell; GM17812
DR   GEO; GSM569675
DR   GEO; GSM596428
DR   GEO; GSM596782
DR   GEO; GSM924774
DR   Wikidata; Q54849237
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17813
AC   CVCL_0T32
DR   CLO; CLO_0016507
DR   Coriell; GM17813
DR   GEO; GSM569763
DR   GEO; GSM596429
DR   GEO; GSM596783
DR   GEO; GSM924775
DR   Wikidata; Q54849238
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17814
AC   CVCL_0T33
DR   CLO; CLO_0016508
DR   Coriell; GM17814
DR   GEO; GSM569676
DR   GEO; GSM596430
DR   GEO; GSM596784
DR   GEO; GSM924776
DR   Wikidata; Q54849239
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17815
AC   CVCL_0T34
DR   CLO; CLO_0016506
DR   Coriell; GM17815
DR   GEO; GSM569677
DR   GEO; GSM596431
DR   GEO; GSM596785
DR   GEO; GSM924777
DR   Wikidata; Q54849240
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17816
AC   CVCL_0T35
DR   CLO; CLO_0016509
DR   Coriell; GM17816
DR   GEO; GSM569678
DR   GEO; GSM596432
DR   GEO; GSM596786
DR   GEO; GSM924778
DR   Wikidata; Q54849241
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17817
AC   CVCL_0T36
DR   CLO; CLO_0016510
DR   Coriell; GM17817
DR   GEO; GSM569679
DR   GEO; GSM596433
DR   GEO; GSM596787
DR   GEO; GSM924779
DR   Wikidata; Q54849242
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17818
AC   CVCL_0T37
DR   CLO; CLO_0016511
DR   Coriell; GM17818
DR   GEO; GSM569680
DR   GEO; GSM596434
DR   GEO; GSM596788
DR   GEO; GSM924780
DR   Wikidata; Q54849243
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17819
AC   CVCL_W059
DR   CLO; CLO_0016512
DR   Coriell; GM17819
DR   Wikidata; Q54849244
RX   PubMed=21721033;
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Unexplicit; Ex8-10del; Zygosity=Hemizygous (Coriell=GM17819).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21721033
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 12,18
ST   D19S433: 12,14
ST   D21S11: 30,32.2
ST   D2S1338: 25,26
ST   D3S1358: 14,16
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   D8S1179: 10,11
ST   FGA: 20,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM17821
AC   CVCL_0P73
DR   CLO; CLO_0016513
DR   Coriell; GM17821
DR   Wikidata; Q54849245
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Heterozygous (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM17822
AC   CVCL_IL04
DR   CLO; CLO_0016514
DR   Coriell; GM17822
DR   Wikidata; Q54849247
CC   Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple; p.Phe311Profs*16 (c.927_933delTGTCTTT) (7-BP del); Zygosity=Homozygous (Coriell=GM17822).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8967; Brain iron accumulation type I syndrome
DI   ORDO; Orphanet_216873; Atypical pantothenate kinase-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   GM17823
AC   CVCL_0T38
DR   CLO; CLO_0016515
DR   Coriell; GM17823
DR   GEO; GSM569681
DR   GEO; GSM596435
DR   GEO; GSM596789
DR   GEO; GSM924781
DR   Wikidata; Q54849248
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17824
AC   CVCL_0T39
DR   CLO; CLO_0016516
DR   Coriell; GM17824
DR   GEO; GSM569764
DR   GEO; GSM596436
DR   GEO; GSM596790
DR   GEO; GSM924782
DR   Wikidata; Q54849249
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17825
AC   CVCL_0T40
DR   CLO; CLO_0016517
DR   Coriell; GM17825
DR   GEO; GSM569682
DR   GEO; GSM596437
DR   GEO; GSM596791
DR   GEO; GSM924783
DR   Wikidata; Q54849250
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17826
AC   CVCL_0T41
DR   CLO; CLO_0016518
DR   Coriell; GM17826
DR   GEO; GSM569683
DR   GEO; GSM596438
DR   GEO; GSM596792
DR   GEO; GSM924784
DR   Wikidata; Q54849251
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17827
AC   CVCL_0T42
DR   CLO; CLO_0016528
DR   Coriell; GM17827
DR   GEO; GSM569765
DR   GEO; GSM596439
DR   GEO; GSM596793
DR   GEO; GSM924785
DR   Wikidata; Q54849253
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17828
AC   CVCL_0T43
DR   CLO; CLO_0016521
DR   Coriell; GM17828
DR   GEO; GSM569684
DR   GEO; GSM596440
DR   GEO; GSM596794
DR   GEO; GSM924786
DR   Wikidata; Q54849254
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17831
AC   CVCL_0T44
DR   CLO; CLO_0016522
DR   Coriell; GM17831
DR   GEO; GSM569766
DR   GEO; GSM596441
DR   GEO; GSM596795
DR   GEO; GSM924787
DR   Wikidata; Q54849255
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17833
AC   CVCL_0T45
DR   CLO; CLO_0016519
DR   Coriell; GM17833
DR   GEO; GSM569685
DR   GEO; GSM596442
DR   GEO; GSM596796
DR   GEO; GSM924788
DR   Wikidata; Q54849256
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17835
AC   CVCL_0T46
DR   CLO; CLO_0016520
DR   Coriell; GM17835
DR   GEO; GSM569686
DR   GEO; GSM596443
DR   GEO; GSM596797
DR   GEO; GSM924789
DR   Wikidata; Q54849257
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17837
AC   CVCL_0T47
DR   CLO; CLO_0016525
DR   Coriell; GM17837
DR   GEO; GSM569767
DR   GEO; GSM596444
DR   GEO; GSM596798
DR   GEO; GSM924790
DR   Wikidata; Q54849258
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17838
AC   CVCL_0T48
DR   CLO; CLO_0016526
DR   Coriell; GM17838
DR   GEO; GSM569687
DR   GEO; GSM596445
DR   GEO; GSM596799
DR   GEO; GSM924791
DR   Wikidata; Q54849259
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17839
AC   CVCL_0T49
DR   CLO; CLO_0016523
DR   Coriell; GM17839
DR   GEO; GSM569768
DR   GEO; GSM596446
DR   GEO; GSM596800
DR   GEO; GSM924792
DR   Wikidata; Q54849260
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17840
AC   CVCL_0T50
DR   CLO; CLO_0016524
DR   Coriell; GM17840
DR   GEO; GSM569769
DR   GEO; GSM596447
DR   GEO; GSM596801
DR   GEO; GSM924793
DR   Wikidata; Q54849261
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17841
AC   CVCL_0T51
DR   CLO; CLO_0016527
DR   Coriell; GM17841
DR   GEO; GSM569770
DR   GEO; GSM596448
DR   GEO; GSM596802
DR   GEO; GSM924794
DR   Wikidata; Q54849263
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17842
AC   CVCL_0T52
DR   CLO; CLO_0016457
DR   Coriell; GM17842
DR   GEO; GSM569771
DR   GEO; GSM596449
DR   GEO; GSM596803
DR   GEO; GSM924795
DR   Wikidata; Q54849264
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17843
AC   CVCL_0T53
DR   CLO; CLO_0016458
DR   Coriell; GM17843
DR   GEO; GSM569772
DR   GEO; GSM596450
DR   GEO; GSM596804
DR   GEO; GSM924796
DR   Wikidata; Q54849266
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17844
AC   CVCL_0T54
DR   CLO; CLO_0016454
DR   Coriell; GM17844
DR   GEO; GSM569773
DR   GEO; GSM596451
DR   GEO; GSM596805
DR   GEO; GSM924797
DR   Wikidata; Q54849267
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17845
AC   CVCL_0T55
DR   CLO; CLO_0016453
DR   Coriell; GM17845
DR   GEO; GSM569774
DR   GEO; GSM596452
DR   GEO; GSM596806
DR   GEO; GSM924798
DR   Wikidata; Q54849268
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17846
AC   CVCL_0T56
DR   CLO; CLO_0016456
DR   Coriell; GM17846
DR   GEO; GSM569775
DR   GEO; GSM596453
DR   GEO; GSM596807
DR   Wikidata; Q54849269
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17847
AC   CVCL_0T57
DR   CLO; CLO_0016455
DR   Coriell; GM17847
DR   GEO; GSM569776
DR   GEO; GSM596454
DR   GEO; GSM596808
DR   GEO; GSM924800
DR   Wikidata; Q54849270
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17850
AC   CVCL_0T58
DR   CLO; CLO_0016450
DR   Coriell; GM17850
DR   GEO; GSM569777
DR   GEO; GSM596455
DR   GEO; GSM596809
DR   GEO; GSM924801
DR   Wikidata; Q54849271
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17852
AC   CVCL_0T59
DR   CLO; CLO_0016449
DR   Coriell; GM17852
DR   GEO; GSM569778
DR   GEO; GSM596456
DR   GEO; GSM596810
DR   GEO; GSM924802
DR   Wikidata; Q54849272
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17853
AC   CVCL_0T60
DR   CLO; CLO_0016452
DR   Coriell; GM17853
DR   Wikidata; Q54849273
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17854
AC   CVCL_0T61
DR   CLO; CLO_0016451
DR   Coriell; GM17854
DR   Wikidata; Q54849284
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17855
AC   CVCL_0T62
DR   CLO; CLO_0016468
DR   Coriell; GM17855
DR   Wikidata; Q54849285
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17856
AC   CVCL_0T63
DR   CLO; CLO_0016466
DR   Coriell; GM17856
DR   Wikidata; Q54849286
CC   Part of: Human variation panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17857
AC   CVCL_W964
DR   CLO; CLO_0016467
DR   Coriell; GM17857
DR   Wikidata; Q54849287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM17867
AC   CVCL_W965
DR   CLO; CLO_0016462
DR   Coriell; GM17867
DR   Wikidata; Q54849292
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   GM17868
AC   CVCL_H160
DR   CLO; CLO_0016461
DR   Coriell; GM17868
DR   Wikidata; Q54849293
RX   CelloPub=CLPUB00573;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 5 repeats) (Coriell=GM17868).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H161 ! GM17869
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   GM17869
AC   CVCL_H161
DR   CLO; CLO_0016460
DR   Coriell; GM17869
DR   Wikidata; Q54849294
RX   CelloPub=CLPUB00573;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 5 repeats) (Coriell=GM17869).
CC   Discontinued: Coriell; GM17869; probable.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H160 ! GM17868
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   GM17879
AC   CVCL_W966
DR   CLO; CLO_0016459
DR   Coriell; GM17879
DR   Wikidata; Q54849295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
DI   NCIt; C97160; Attention deficit hyperactivity disorder
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM17880
AC   CVCL_4F48
DR   CLO; CLO_0016152
DR   Coriell; GM17880
DR   Wikidata; Q54849296
RX   PubMed=21074045;
CC   Senescence: Senesces at 56 PDL (Coriell=GM17880).
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Thr158Met (c.473C>T) (p.Thr170Met, c.509C>T); ClinVar=VCV000011811; Zygosity=Heterozygous (Coriell=GM17880).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17881
AC   CVCL_0R46
DR   CLO; CLO_0016143
DR   Coriell; GM17881
DR   Wikidata; Q54849297
CC   Population: Caucasian; Flemish.
CC   Sequence variation: Mutation; HGNC; HGNC:18817; HPS6; Simple; p.Leu572Alafs*40 (c.1714_1717delCTGT); ClinVar=VCV000003151; Zygosity=Homozygous (Coriell=GM17881).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150369; Hermansky-Pudlak syndrome 6
DI   ORDO; Orphanet_231512; Hermansky-Pudlak syndrome without pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM17883
AC   CVCL_W967
DR   CLO; CLO_0016145
DR   Coriell; GM17883
DR   Wikidata; Q54849298
CC   Karyotypic information: 47,XXY [49]; 46,XY [1] (Coriell=GM17883).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM17885
AC   CVCL_IJ34
DR   CLO; CLO_0016139
DR   Coriell; GM17885
DR   Wikidata; Q54849299
RX   PubMed=28649545;
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Gly308Arg (c.922G>A); ClinVar=VCV000267310; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Unexplicit; Ex1-10del (nsv1067862) (57-KB DEL); ClinVar=VCV000004445; Zygosity=Heterozygous (PubMed=28649545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM17886
AC   CVCL_W237
DR   CLO; CLO_0016142
DR   Coriell; GM17886
DR   Wikidata; Q54849300
RX   PubMed=28649545;
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Thr7Phefs*7 (c.18_21delGACT); ClinVar=VCV000188834; Zygosity=Homozygous (PubMed=28649545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM17888
AC   CVCL_IJ41
DR   CLO; CLO_0016150
DR   Coriell; GM17888
DR   Wikidata; Q54849302
RX   PubMed=28649545;
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; p.Ile69Argfs*5 (c.206_210delTCCTT); ClinVar=VCV000455787; Zygosity=Heterozygous (PubMed=28649545).
CC   Sequence variation: Mutation; HGNC; HGNC:2518; CTNS; Simple; c.853-3C>G (IVS11-3C>G); ClinVar=VCV000004449; Zygosity=Heterozygous (PubMed=28649545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2976; Cystinosis
DI   ORDO; Orphanet_411641; Ocular cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM17890
AC   CVCL_0R47
DR   CLO; CLO_0016151
DR   Coriell; GM17890
DR   Wikidata; Q54849303
CC   Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; p.Arg509Ter (c.1525C>T); ClinVar=VCV000006377; Zygosity=Heterozygous (Coriell=GM17890).
CC   Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; p.Glu659Ter (c.1975G>T); ClinVar=VCV000006378; Zygosity=Heterozygous (Coriell=GM17890).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150368; Hermansky-Pudlak syndrome 2
DI   ORDO; Orphanet_183678; Hermansky-Pudlak syndrome with neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM17894
AC   CVCL_CZ75
DR   CLO; CLO_0016147
DR   Coriell; GM17894
DR   Wikidata; Q54849304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM17895
AC   CVCL_GS88
DR   CLO; CLO_0016149
DR   Coriell; GM17895
DR   Wikidata; Q54849305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129028; Frontonasal dysplasia
DI   ORDO; Orphanet_391474; Frontorhiny
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM17896
AC   CVCL_8B07
DR   CLO; CLO_0016195
DR   Coriell; GM17896
DR   Wikidata; Q54849306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM17897
AC   CVCL_8B08
DR   CLO; CLO_0016185
DR   Coriell; GM17897
DR   Wikidata; Q54849307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM17898
AC   CVCL_HQ09
DR   CLO; CLO_0016186
DR   Coriell; GM17898
DR   Wikidata; Q54849308
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 4 repeats) (Coriell=GM17898).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM17903
AC   CVCL_V004
DR   CLO; CLO_0016168
DR   Coriell; GM17903
DR   Wikidata; Q54849309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99099; Type I acrocephalosyndactyly
DI   ORDO; Orphanet_87; Apert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   GM17906
AC   CVCL_W968
DR   CLO; CLO_0016170
DR   Coriell; GM17906
DR   Wikidata; Q54849311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM17908
AC   CVCL_W969
DR   CLO; CLO_0016172
DR   Coriell; GM17908
DR   Wikidata; Q54849313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
DI   NCIt; C97160; Attention deficit hyperactivity disorder
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   GM17910
AC   CVCL_DA48
DR   CLO; CLO_0016174
DR   Coriell; GM17910
DR   Wikidata; Q54849314
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; p.Cys93Phe (c.278G>T); ClinVar=VCV001210442; Zygosity=Homozygous (Coriell=GM17910).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126865; Niemann-Pick disease, type C2
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 12
//
ID   GM17911
AC   CVCL_DA49
DR   CLO; CLO_0016176
DR   Coriell; GM17911
DR   Wikidata; Q54849315
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Thr1036Met (c.3107C>T); ClinVar=VCV000002958; Zygosity=Heterozygous (Coriell=GM17911).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17911).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17912
AC   CVCL_DA50
DR   CLO; CLO_0016179
DR   Coriell; GM17912
DR   Wikidata; Q54849316
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro1007Ala (c.3019C>G); ClinVar=VCV000002966; Zygosity=Heterozygous (Coriell=GM17912).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Thr1036Met (c.3107C>T); ClinVar=VCV000002958; Zygosity=Heterozygous (Coriell=GM17912).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17913
AC   CVCL_DA51
DR   CLO; CLO_0016182
DR   Coriell; GM17913
DR   Wikidata; Q54849317
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17913).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Val1165Met (c.3493G>A); ClinVar=VCV000195723; Zygosity=Heterozygous (Coriell=GM17913).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM17914
AC   CVCL_DA52
DR   CLO; CLO_0016184
DR   Coriell; GM17914
DR   Wikidata; Q54849318
RX   PubMed=12955717;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Lys142Argfs*80 (c.423_424dupGA) (c.424_425insGA); ClinVar=VCV000503633; Zygosity=Heterozygous (Coriell=GM17914).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17914).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17918
AC   CVCL_DA53
DR   CLO; CLO_0016271
DR   Coriell; GM17918
DR   Wikidata; Q54849319
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Thr137Met (c.410C>T); ClinVar=VCV000449504; Zygosity=Heterozygous (Coriell=GM17918).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Val780Argfs*9 (c.2336dupT) (c.2336insT); Zygosity=Heterozygous (Coriell=GM17918).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM17919
AC   CVCL_DA54
DR   CLO; CLO_0016270
DR   Coriell; GM17919
DR   Wikidata; Q54849320
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Arg404Trp (c.1210C>T); ClinVar=VCV000499939; Zygosity=Heterozygous (Coriell=GM17919).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17919).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17920
AC   CVCL_DA55
DR   CLO; CLO_0016269
DR   Coriell; GM17920
DR   Wikidata; Q54849321
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro401Thr (c.1201C>A); ClinVar=VCV002138137; Zygosity=Heterozygous (Coriell=GM17920).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17920).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17921
AC   CVCL_DA56
DR   CLO; CLO_0016278
DR   Coriell; GM17921
DR   Wikidata; Q54849323
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro433Leu (c.1298C>T); ClinVar=VCV000419321; Zygosity=Heterozygous (Coriell=GM17921).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17921).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17922
AC   CVCL_DA57
DR   CLO; CLO_0016277
DR   Coriell; GM17922
DR   Wikidata; Q54849324
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Lys142Argfs*80 (c.423_424dupGA) (c.424_425insGA); ClinVar=VCV000503633; Zygosity=Heterozygous (Coriell=GM17922).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Gln991Argfs*15 (c.2972_2973delAG); ClinVar=VCV000188932; Zygosity=Heterozygous (Coriell=GM17922).
CC   Discontinued: Coriell; GM17922; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17923
AC   CVCL_DA58
DR   CLO; CLO_0016276
DR   Coriell; GM17923
DR   Wikidata; Q54849325
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro543Leu (c.1628C>T); ClinVar=VCV000181455; Zygosity=Heterozygous (Coriell=GM17923).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17923).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM17924
AC   CVCL_DA59
DR   CLO; CLO_0016275
DR   Coriell; GM17924
DR   Wikidata; Q54849326
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ser151Phefs*18 (c.449_450AG[1]) (c.451_452delAG); ClinVar=VCV000558159; Zygosity=Heterozygous (Coriell=GM17924).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Tyr825Cys (c.2474A>G); ClinVar=VCV000370184; Zygosity=Heterozygous (Coriell=GM17924).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17926
AC   CVCL_DA60
DR   CLO; CLO_0016274
DR   Coriell; GM17926
DR   Wikidata; Q54849327
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Tyr509Ser (c.1526A>C); ClinVar=VCV000554002; Zygosity=Heterozygous (Coriell=GM17926).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM17926).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM17931
AC   CVCL_W970
DR   CLO; CLO_0016273
DR   Coriell; GM17931
DR   Wikidata; Q54849328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   GM17932
AC   CVCL_EH21
DR   CLO; CLO_0016272
DR   Coriell; GM17932
DR   Wikidata; Q54849335
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98890; Congenital cerebellar hypoplasia
DI   ORDO; Orphanet_35656; Coenzyme Q10 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM17933
AC   CVCL_8B09
DR   CLO; CLO_0016280
DR   Coriell; GM17933
DR   Wikidata; Q54849336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM17934
AC   CVCL_UY72
DR   CLO; CLO_0016279
DR   Coriell; GM17934
DR   Wikidata; Q93856360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157576; Ankyloblepharon-ectodermal defects-cleft lip/palate
DI   ORDO; Orphanet_1071; Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   GM17938
AC   CVCL_5Q82
DR   CLO; CLO_0016282
DR   Coriell; GM17938
DR   Wikidata; Q54849337
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM17939
AC   CVCL_F205
DR   CLO; CLO_0016281
DR   Coriell; GM17939
DR   Wikidata; Q54849339
RX   CelloPub=CLPUB00573;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (Coriell=GM17939).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F206 ! GM17940
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   GM17940
AC   CVCL_F206
DR   CLO; CLO_0016286
DR   Coriell; GM17940
DR   Wikidata; Q54849340
RX   CelloPub=CLPUB00573;
WW   Provider; Beyotime; C6269; https://www.beyotime.com/Manual/C6269%20GM17940%20(Human%20Skeletal%20Muscle%20Myoblast%20Cells).pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (Coriell=GM17940).
CC   Discontinued: Coriell; GM17940; probable.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
ST   Source(s): Beyotime
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F205 ! GM17939
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   GM17941
AC   CVCL_5Q83
DR   Coriell; GM17941
DR   Wikidata; Q54849341
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM17941; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM17942
AC   CVCL_2Z00
DR   CLO; CLO_0016285
DR   Coriell; GM17942
DR   Wikidata; Q54849342
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM17944
AC   CVCL_4D61
DR   CLO; CLO_0016288
DR   Coriell; GM17944
DR   Wikidata; Q54849344
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17944).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D68 ! GM17953
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17945
AC   CVCL_4D62
DR   CLO; CLO_0016287
DR   Coriell; GM17945
DR   Wikidata; Q54849345
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D69 ! GM17954
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM17947
AC   CVCL_4D63
DR   CLO; CLO_0016284
DR   BioSample; SAMN00805446
DR   Coriell; GM17947
DR   Wikidata; Q54849346
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17947).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D70 ! GM17955
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17948
AC   CVCL_4D64
DR   CLO; CLO_0016283
DR   BioSample; SAMN00805448
DR   Coriell; GM17948
DR   Wikidata; Q54849347
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17948).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D71 ! GM17956
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   GM17949
AC   CVCL_4D65
DR   CLO; CLO_0016249
DR   BioSample; SAMN00805450
DR   Coriell; GM17949
DR   Wikidata; Q54849348
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D72 ! GM17957
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM17951
AC   CVCL_4D66
DR   CLO; CLO_0016253
DR   BioSample; SAMN00805452
DR   Coriell; GM17951
DR   Wikidata; Q54849349
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D73 ! GM17959
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   GM17952
AC   CVCL_4D67
DR   CLO; CLO_0016252
DR   Coriell; GM17952
DR   Wikidata; Q54849350
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17952).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D74 ! GM17960
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM17953
AC   CVCL_4D68
DR   CLO; CLO_0016251
DR   Coriell; GM17953
DR   Wikidata; Q54849351
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17953).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D61 ! GM17944
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17954
AC   CVCL_4D69
DR   CLO; CLO_0016250
DR   Coriell; GM17954
DR   Wikidata; Q54849353
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D62 ! GM17945
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17955
AC   CVCL_4D70
DR   Coriell; GM17955
DR   Wikidata; Q54849354
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17955).
CC   Discontinued: Coriell; GM17955; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D63 ! GM17947
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17956
AC   CVCL_4D71
DR   CLO; CLO_0016257
DR   BioSample; SAMN00805460
DR   Coriell; GM17956
DR   Wikidata; Q54849355
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17956).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D64 ! GM17948
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM17957
AC   CVCL_4D72
DR   Coriell; GM17957
DR   Wikidata; Q54849356
CC   Population: Caucasian; Amish.
CC   Discontinued: Coriell; GM17957; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D65 ! GM17949
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   GM17959
AC   CVCL_4D73
DR   CLO; CLO_0016256
DR   BioSample; SAMN00805462
DR   Coriell; GM17959
DR   Wikidata; Q54849357
CC   Population: Caucasian; Amish.
CC   Discontinued: Coriell; GM17959; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D66 ! GM17951
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM17960
AC   CVCL_4D74
DR   CLO; CLO_0016255
DR   Coriell; GM17960
DR   Wikidata; Q54849358
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM17960).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4D67 ! GM17952
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM17962
AC   CVCL_0V45
DR   CLO; CLO_0016254
DR   Coriell; GM17962
DR   Wikidata; Q54849359
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17963
AC   CVCL_0V46
DR   CLO; CLO_0016258
DR   Coriell; GM17963
DR   Wikidata; Q54849360
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17965
AC   CVCL_0V47
DR   CLO; CLO_0016260
DR   Coriell; GM17965
DR   Wikidata; Q54849361
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17966
AC   CVCL_0V48
DR   CLO; CLO_0016259
DR   Coriell; GM17966
DR   Wikidata; Q54849362
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17967
AC   CVCL_0V49
DR   CLO; CLO_0016262
DR   Coriell; GM17967
DR   Wikidata; Q54849363
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17968
AC   CVCL_0V50
DR   CLO; CLO_0016261
DR   Coriell; GM17968
DR   Wikidata; Q54849364
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17969
AC   CVCL_0V51
DR   CLO; CLO_0016264
DR   Coriell; GM17969
DR   Wikidata; Q54849365
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17970
AC   CVCL_0V52
DR   CLO; CLO_0016263
DR   Coriell; GM17970
DR   Wikidata; Q54849366
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17971
AC   CVCL_0V53
DR   CLO; CLO_0016266
DR   Coriell; GM17971
DR   Wikidata; Q54849367
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17972
AC   CVCL_0V54
DR   CLO; CLO_0016265
DR   Coriell; GM17972
DR   Wikidata; Q54849368
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17973
AC   CVCL_0V55
DR   CLO; CLO_0016268
DR   Coriell; GM17973
DR   Wikidata; Q54849369
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17974
AC   CVCL_0V56
DR   CLO; CLO_0016267
DR   Coriell; GM17974
DR   Wikidata; Q54849370
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17975
AC   CVCL_0V57
DR   CLO; CLO_0016042
DR   Coriell; GM17975
DR   Wikidata; Q54849371
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17976
AC   CVCL_0V58
DR   CLO; CLO_0016043
DR   Coriell; GM17976
DR   Wikidata; Q54849372
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17977
AC   CVCL_0V59
DR   CLO; CLO_0016044
DR   Coriell; GM17977
DR   Wikidata; Q54849373
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17978
AC   CVCL_0V60
DR   Coriell; GM17978
DR   Wikidata; Q54849374
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM17979
AC   CVCL_0V61
DR   CLO; CLO_0016035
DR   Coriell; GM17979
DR   Wikidata; Q54849375
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17980
AC   CVCL_0V62
DR   CLO; CLO_0016036
DR   Coriell; GM17980
DR   Wikidata; Q54849376
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17981
AC   CVCL_0V63
DR   CLO; CLO_0016039
DR   Coriell; GM17981
DR   Wikidata; Q54849377
RX   PubMed=30485824;
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17982
AC   CVCL_0V64
DR   CLO; CLO_0016040
DR   Coriell; GM17982
DR   Wikidata; Q54849385
RX   PubMed=30485824;
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM17983
AC   CVCL_0V65
DR   CLO; CLO_0016027
DR   Coriell; GM17983
DR   Wikidata; Q54849386
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17986
AC   CVCL_0V66
DR   CLO; CLO_0016029
DR   Coriell; GM17986
DR   Wikidata; Q54849387
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17987
AC   CVCL_0V67
DR   CLO; CLO_0016032
DR   Coriell; GM17987
DR   Wikidata; Q54849388
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17988
AC   CVCL_0V68
DR   CLO; CLO_0016053
DR   Coriell; GM17988
DR   Wikidata; Q54849389
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17989
AC   CVCL_0V69
DR   CLO; CLO_0016054
DR   Coriell; GM17989
DR   Wikidata; Q54849391
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17990
AC   CVCL_0V70
DR   CLO; CLO_0016051
DR   Coriell; GM17990
DR   Wikidata; Q54849392
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17991
AC   CVCL_0V71
DR   CLO; CLO_0016052
DR   Coriell; GM17991
DR   Wikidata; Q54849393
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17992
AC   CVCL_0V72
DR   CLO; CLO_0016049
DR   Coriell; GM17992
DR   Wikidata; Q54849394
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17993
AC   CVCL_0V73
DR   CLO; CLO_0016050
DR   Coriell; GM17993
DR   Wikidata; Q54849395
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17994
AC   CVCL_0V74
DR   CLO; CLO_0016047
DR   Coriell; GM17994
DR   Wikidata; Q54849396
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17995
AC   CVCL_0V75
DR   CLO; CLO_0016048
DR   Coriell; GM17995
DR   Wikidata; Q54849397
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17996
AC   CVCL_0V76
DR   CLO; CLO_0016045
DR   Coriell; GM17996
DR   Wikidata; Q54849398
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17997
AC   CVCL_0V77
DR   CLO; CLO_0016046
DR   Coriell; GM17997
DR   Wikidata; Q54849399
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17998
AC   CVCL_0V78
DR   CLO; CLO_0015969
DR   Coriell; GM17998
DR   Wikidata; Q54849400
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM17999
AC   CVCL_0V79
DR   CLO; CLO_0015990
DR   Coriell; GM17999
DR   Wikidata; Q54849401
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18000
AC   CVCL_0V80
DR   CLO; CLO_0015424
DR   Coriell; GM18000
DR   Wikidata; Q54849402
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18101
AC   CVCL_0V81
DR   CLO; CLO_0015425
DR   Coriell; GM18101
DR   Wikidata; Q54849403
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18102
AC   CVCL_0V82
DR   CLO; CLO_0015426
DR   Coriell; GM18102
DR   Wikidata; Q54849404
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18103
AC   CVCL_0V83
DR   CLO; CLO_0015419
DR   Coriell; GM18103
DR   Wikidata; Q54849406
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18104
AC   CVCL_0V84
DR   Coriell; GM18104
DR   Wikidata; Q54849407
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18105
AC   CVCL_0V85
DR   CLO; CLO_0015420
DR   Coriell; GM18105
DR   Wikidata; Q54849408
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18106
AC   CVCL_0V86
DR   CLO; CLO_0015421
DR   Coriell; GM18106
DR   Wikidata; Q54849409
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18107
AC   CVCL_0V87
DR   CLO; CLO_0015422
DR   Coriell; GM18107
DR   Wikidata; Q54849410
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18108
AC   CVCL_0V88
DR   CLO; CLO_0015427
DR   Coriell; GM18108
DR   Wikidata; Q54849411
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18109
AC   CVCL_0V89
DR   CLO; CLO_0015428
DR   Coriell; GM18109
DR   Wikidata; Q54849412
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18110
AC   CVCL_0V90
DR   CLO; CLO_0015429
DR   Coriell; GM18110
DR   Wikidata; Q54849413
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18111
AC   CVCL_0V91
DR   CLO; CLO_0015436
DR   Coriell; GM18111
DR   Wikidata; Q54849414
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18112
AC   CVCL_0V92
DR   CLO; CLO_0015437
DR   Coriell; GM18112
DR   Wikidata; Q54849415
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18113
AC   CVCL_0V93
DR   Coriell; GM18113
DR   Wikidata; Q54849416
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18114
AC   CVCL_0V94
DR   CLO; CLO_0015434
DR   Coriell; GM18114
DR   Wikidata; Q54849417
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18115
AC   CVCL_0V95
DR   CLO; CLO_0015435
DR   Coriell; GM18115
DR   Wikidata; Q54849418
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18116
AC   CVCL_0V96
DR   Coriell; GM18116
DR   Wikidata; Q54849419
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18117
AC   CVCL_0V97
DR   CLO; CLO_0015432
DR   Coriell; GM18117
DR   Wikidata; Q54849421
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18118
AC   CVCL_0V98
DR   CLO; CLO_0015433
DR   Coriell; GM18118
DR   Wikidata; Q54849422
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18119
AC   CVCL_0V99
DR   Coriell; GM18119
DR   Wikidata; Q54849423
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18120
AC   CVCL_0W00
DR   CLO; CLO_0015430
DR   Coriell; GM18120
DR   Wikidata; Q54849424
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18122
AC   CVCL_0W01
DR   CLO; CLO_0015431
DR   Coriell; GM18122
DR   Wikidata; Q54849425
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18123
AC   CVCL_0W02
DR   Coriell; GM18123
DR   Wikidata; Q54849426
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18124
AC   CVCL_0W03
DR   CLO; CLO_0015438
DR   Coriell; GM18124
DR   Wikidata; Q54849427
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18125
AC   CVCL_0W04
DR   CLO; CLO_0031294
DR   Coriell; GM18125
DR   Wikidata; Q54849438
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18126
AC   CVCL_0W05
DR   Coriell; GM18126
DR   Wikidata; Q54849439
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18127
AC   CVCL_0W06
DR   CLO; CLO_0031292
DR   Coriell; GM18127
DR   Wikidata; Q54849440
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18128
AC   CVCL_0W07
DR   CLO; CLO_0031293
DR   Coriell; GM18128
DR   Wikidata; Q54849441
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18129
AC   CVCL_0W08
DR   CLO; CLO_0031300
DR   Coriell; GM18129
DR   Wikidata; Q54849442
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18130
AC   CVCL_0W09
DR   CLO; CLO_0031302
DR   Coriell; GM18130
DR   Wikidata; Q54849443
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18131
AC   CVCL_0W10
DR   CLO; CLO_0031295
DR   Coriell; GM18131
DR   Wikidata; Q54849444
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18132
AC   CVCL_0W11
DR   CLO; CLO_0031298
DR   Coriell; GM18132
DR   Wikidata; Q54849445
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18133
AC   CVCL_0W12
DR   CLO; CLO_0031322
DR   Coriell; GM18133
DR   Wikidata; Q54849446
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18134
AC   CVCL_0W13
DR   CLO; CLO_0031321
DR   Coriell; GM18134
DR   Wikidata; Q54849447
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18135
AC   CVCL_0W14
DR   CLO; CLO_0031325
DR   Coriell; GM18135
DR   Wikidata; Q54849448
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18136
AC   CVCL_0W15
DR   CLO; CLO_0031309
DR   Coriell; GM18136
DR   Wikidata; Q54849449
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18138
AC   CVCL_0W16
DR   CLO; CLO_0031310
DR   Coriell; GM18138
DR   Wikidata; Q54849450
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18139
AC   CVCL_0W17
DR   CLO; CLO_0031311
DR   Coriell; GM18139
DR   Wikidata; Q54849451
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18140
AC   CVCL_0W18
DR   CLO; CLO_0031312
DR   Coriell; GM18140
DR   Wikidata; Q54849452
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18141
AC   CVCL_0W19
DR   CLO; CLO_0031313
DR   Coriell; GM18141
DR   Wikidata; Q54849453
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18143
AC   CVCL_0W20
DR   CLO; CLO_0031314
DR   Coriell; GM18143
DR   Wikidata; Q54849454
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18144
AC   CVCL_0W21
DR   CLO; CLO_0031317
DR   Coriell; GM18144
DR   Wikidata; Q54849455
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18145
AC   CVCL_0W22
DR   Coriell; GM18145
DR   Wikidata; Q54849456
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18146
AC   CVCL_0W23
DR   CLO; CLO_0031319
DR   Coriell; GM18146
DR   Wikidata; Q54849457
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18147
AC   CVCL_0W24
DR   CLO; CLO_0031041
DR   Coriell; GM18147
DR   Wikidata; Q54849458
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18148
AC   CVCL_0W25
DR   CLO; CLO_0031042
DR   Coriell; GM18148
DR   Wikidata; Q54849459
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18149
AC   CVCL_0W26
DR   CLO; CLO_0031049
DR   Coriell; GM18149
DR   Wikidata; Q54849460
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18150
AC   CVCL_0W27
DR   CLO; CLO_0031051
DR   Coriell; GM18150
DR   Wikidata; Q54849461
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18151
AC   CVCL_0W28
DR   CLO; CLO_0031050
DR   Coriell; GM18151
DR   Wikidata; Q54849462
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18152
AC   CVCL_0W29
DR   CLO; CLO_0031053
DR   Coriell; GM18152
DR   Wikidata; Q54849463
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18153
AC   CVCL_0W30
DR   CLO; CLO_0031052
DR   Coriell; GM18153
DR   Wikidata; Q54849464
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18154
AC   CVCL_0W31
DR   CLO; CLO_0031056
DR   Coriell; GM18154
DR   Wikidata; Q54849465
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18155
AC   CVCL_0W32
DR   CLO; CLO_0031054
DR   Coriell; GM18155
DR   Wikidata; Q54849466
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18156
AC   CVCL_0W33
DR   CLO; CLO_0031059
DR   Coriell; GM18156
DR   Wikidata; Q54849467
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18157
AC   CVCL_0W34
DR   CLO; CLO_0031058
DR   Coriell; GM18157
DR   Wikidata; Q54849468
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18158
AC   CVCL_0W35
DR   CLO; CLO_0031021
DR   Coriell; GM18158
DR   Wikidata; Q54849469
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18159
AC   CVCL_0W36
DR   CLO; CLO_0031027
DR   Coriell; GM18159
DR   Wikidata; Q54849470
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18160
AC   CVCL_0W37
DR   CLO; CLO_0031026
DR   Coriell; GM18160
DR   Wikidata; Q54849471
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18161
AC   CVCL_0W38
DR   CLO; CLO_0031031
DR   Coriell; GM18161
DR   Wikidata; Q54849472
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18162
AC   CVCL_0W39
DR   CLO; CLO_0031030
DR   Coriell; GM18162
DR   Wikidata; Q54849473
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18163
AC   CVCL_0W40
DR   CLO; CLO_0031029
DR   Coriell; GM18163
DR   Wikidata; Q54849474
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18164
AC   CVCL_0W41
DR   Coriell; GM18164
DR   Wikidata; Q54849475
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18166
AC   CVCL_0W42
DR   CLO; CLO_0031028
DR   Coriell; GM18166
DR   Wikidata; Q54849476
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18180
AC   CVCL_5Q84
DR   Coriell; GM18180
DR   Wikidata; Q54849477
RX   PubMed=22639450;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124840; Shprintzen-Goldberg craniosynostosis syndrome
DI   ORDO; Orphanet_2462; Shprintzen-Goldberg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18207
AC   CVCL_HQ10
DR   CLO; CLO_0031038
DR   Coriell; GM18207
DR   Wikidata; Q54849483
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 3 repeats) (Coriell=GM18207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM18241
AC   CVCL_W639
DR   CLO; CLO_0031036
DR   Coriell; GM18241
DR   Wikidata; Q54849484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM18260
AC   CVCL_JX68
DR   CLO; CLO_0031035
DR   Coriell; GM18260
DR   Wikidata; Q54849485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133724; Brown-Vialetto-van Laere syndrome 1
DI   ORDO; Orphanet_572550; RFVT3-related riboflavin transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   GM18308
AC   CVCL_5Q85
DR   CLO; CLO_0031033
DR   Coriell; GM18308
DR   Wikidata; Q54849486
CC   Sequence variation: Mutation; HGNC; HGNC:21317; DYM; Simple; p.Tyr16Ter (c.48C>G); ClinVar=VCV000003184; Zygosity=Homozygous (Coriell=GM18308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124844; Dyggve-Melchior-Clausen syndrome
DI   ORDO; Orphanet_239; Dyggve-Melchior-Clausen disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM18310
AC   CVCL_FW09
DR   CLO; CLO_0031071
DR   Coriell; GM18310
DR   Wikidata; Q54849487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM18311
AC   CVCL_5Q86
DR   CLO; CLO_0031073
DR   Coriell; GM18311
DR   Wikidata; Q54849489
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18313
AC   CVCL_8A68
DR   CLO; CLO_0031072
DR   Coriell; GM18313
DR   Wikidata; Q54849490
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM18319
AC   CVCL_5K12
DR   CLO; CLO_0031078
DR   Coriell; GM18319
DR   Wikidata; Q54849491
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM18320
AC   CVCL_5K13
DR   CLO; CLO_0031077
DR   Coriell; GM18320
DR   Wikidata; Q54849492
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM18321
AC   CVCL_5K14
DR   CLO; CLO_0031080
DR   Coriell; GM18321
DR   Wikidata; Q54849493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM18322
AC   CVCL_5K15
DR   CLO; CLO_0031079
DR   Coriell; GM18322
DR   Wikidata; Q54849494
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM18323
AC   CVCL_5K16
DR   CLO; CLO_0031075
DR   Coriell; GM18323
DR   Wikidata; Q54849495
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM18324
AC   CVCL_5K17
DR   CLO; CLO_0031074
DR   Coriell; GM18324
DR   Wikidata; Q54849496
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM18325
AC   CVCL_5K18
DR   CLO; CLO_0031076
DR   Coriell; GM18325
DR   Wikidata; Q54849497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM18326
AC   CVCL_5K19
DR   CLO; CLO_0031064
DR   Coriell; GM18326
DR   Wikidata; Q54849498
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM18331
AC   CVCL_5Q87
DR   CLO; CLO_0031063
DR   Coriell; GM18331
DR   Wikidata; Q54849499
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18332
AC   CVCL_5Q88
DR   CLO; CLO_0031062
DR   Coriell; GM18332
DR   Wikidata; Q54849500
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18333
AC   CVCL_5Q89
DR   CLO; CLO_0031061
DR   Coriell; GM18333
DR   Wikidata; Q54849501
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18334
AC   CVCL_5Q90
DR   CLO; CLO_0031070
DR   Coriell; GM18334
DR   Wikidata; Q54849502
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18335
AC   CVCL_5Q91
DR   CLO; CLO_0031069
DR   Coriell; GM18335
DR   Wikidata; Q54849503
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18336
AC   CVCL_5Q92
DR   CLO; CLO_0031068
DR   Coriell; GM18336
DR   Wikidata; Q54849504
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18337
AC   CVCL_5Q93
DR   CLO; CLO_0031067
DR   Coriell; GM18337
DR   Wikidata; Q54849505
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18338
AC   CVCL_5Q94
DR   CLO; CLO_0031066
DR   Coriell; GM18338
DR   Wikidata; Q54849506
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18339
AC   CVCL_5Q95
DR   CLO; CLO_0031065
DR   Coriell; GM18339
DR   Wikidata; Q54849507
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18340
AC   CVCL_5Q96
DR   CLO; CLO_0031114
DR   Coriell; GM18340
DR   Wikidata; Q54849508
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18346
AC   CVCL_9R40
DR   CLO; CLO_0031115
DR   Coriell; GM18346
DR   Wikidata; Q54849509
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C170437; Peroxisomal acyl-CoA oxidase deficiency
DI   ORDO; Orphanet_2971; Peroxisomal acyl-CoA oxidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18347
AC   CVCL_9R41
DR   CLO; CLO_0031116
DR   Coriell; GM18347
DR   Wikidata; Q54849510
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM18362
AC   CVCL_9R42
DR   CLO; CLO_0031117
DR   Coriell; GM18362
DR   Wikidata; Q54849511
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C170437; Peroxisomal acyl-CoA oxidase deficiency
DI   ORDO; Orphanet_2971; Peroxisomal acyl-CoA oxidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R43 ! GM18363
SX   Male
AG   1Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM18363
AC   CVCL_9R43
DR   CLO; CLO_0031118
DR   Coriell; GM18363
DR   Wikidata; Q54849512
CC   Population: Palestinian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C170437; Peroxisomal acyl-CoA oxidase deficiency
DI   ORDO; Orphanet_2971; Peroxisomal acyl-CoA oxidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9R42 ! GM18362
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM18364
AC   CVCL_9R44
DR   CLO; CLO_0031102
DR   Coriell; GM18364
DR   Wikidata; Q54849513
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C170437; Peroxisomal acyl-CoA oxidase deficiency
DI   ORDO; Orphanet_2971; Peroxisomal acyl-CoA oxidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18365
AC   CVCL_9R45
DR   CLO; CLO_0031105
DR   Coriell; GM18365
DR   Wikidata; Q54849514
CC   Sequence variation: Mutation; HGNC; HGNC:119; ACOX1; Unexplicit; Ex7del; Zygosity=Unspecified (Coriell=GM18365).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C170437; Peroxisomal acyl-CoA oxidase deficiency
DI   ORDO; Orphanet_2971; Peroxisomal acyl-CoA oxidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM18366
AC   CVCL_6G80
AS   CVCL_ZV76
SY   F02/98; F02-98
DR   CLO; CLO_0031106
DR   BioSample; SAMN00805492
DR   Coriell; GM18366
DR   Wikidata; Q54849515
RX   PubMed=12640452;
RX   PubMed=18077418;
RX   PubMed=19896956;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly674Gly (c.2022A>G) (2101A>G); ClinVar=VCV000008307; Zygosity=Homozygous; Note=Silent mutation that causes increased levels of skipping exon 9 and activation of two cryptic splicing events from sites in exon 9 leading to termination in exon 10 (PubMed=12640452).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125488; Seckel syndrome
DI   ORDO; Orphanet_808; Seckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R778 ! DK0064
OI   CVCL_6G81 ! GM18367
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM18367
AC   CVCL_6G81
DR   CLO; CLO_0031109
DR   Coriell; GM18367
DR   Wikidata; Q54849516
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly674Gly (c.2022A>G) (2101A>G); ClinVar=VCV000008307; Zygosity=Homozygous; Note=Silent mutation that causes increased levels of skipping exon 9 and activation of two cryptic splicing events from sites in exon 9 leading to termination in exon 10 (Coriell=GM18367).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Could be identical to DK0064 (Cellosaurus=CVCL_R778).
CC   Discontinued: Coriell; GM18367; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125488; Seckel syndrome
DI   ORDO; Orphanet_808; Seckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R778 ! DK0064
OI   CVCL_6G80 ! GM18366
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   GM18378
AC   CVCL_5Q97
DR   Coriell; GM18378
DR   Wikidata; Q54849517
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18379
AC   CVCL_5Q98
DR   CLO; CLO_0031111
DR   Coriell; GM18379
DR   Wikidata; Q54849518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124841; Orofaciodigital syndrome type 6
DI   ORDO; Orphanet_2754; Orofaciodigital syndrome type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18381
AC   CVCL_5Q99
DR   CLO; CLO_0031096
DR   Coriell; GM18381
DR   Wikidata; Q54849519
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125418; Pseudotrisomy 13 syndrome
DI   ORDO; Orphanet_2166; Holoprosencephaly-postaxial polydactyly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM18382
AC   CVCL_DA61
DR   CLO; CLO_0031097
DR   Coriell; GM18382
DR   Wikidata; Q54849520
CC   Sequence variation: Mutation; HGNC; HGNC:10825; SH3BP2; Simple; p.Gly420Arg (c.1258G>C); ClinVar=VCV000007552; Zygosity=Heterozygous (Coriell=GM18382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84630; Cherubism
DI   ORDO; Orphanet_184; Cherubism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18387
AC   CVCL_DA62
DR   CLO; CLO_0031100
DR   Coriell; GM18387
DR   Wikidata; Q54849521
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Asp874Val (c.2621A>T); ClinVar=VCV000194810; Zygosity=Heterozygous (Coriell=GM18387).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Tyr890Ter (c.2670C>G); ClinVar=VCV000495788; Zygosity=Heterozygous (Coriell=GM18387).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM18388
AC   CVCL_DA63
DR   CLO; CLO_0031101
DR   Coriell; GM18388
DR   Wikidata; Q54849522
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Arg404Gln (c.1211G>A); ClinVar=VCV000188794; Zygosity=Heterozygous (Coriell=GM18388).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM18390
AC   CVCL_DA64
DR   CLO; CLO_0031098
DR   Coriell; GM18390
DR   Wikidata; Q54849523
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Asp242His (c.724G>C); Zygosity=Heterozygous (Coriell=GM18390).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ser940Leu (c.2819C>T); ClinVar=VCV000188716; Zygosity=Heterozygous (Coriell=GM18390).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18393
AC   CVCL_DA65
DR   CLO; CLO_0031099
DR   Coriell; GM18393
DR   Wikidata; Q54849529
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Gly248Val (c.743G>T); ClinVar=VCV000995578; Zygosity=Heterozygous (Coriell=GM18393).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Met1142Thr (c.3425T>C); ClinVar=VCV000372435; Zygosity=Heterozygous (Coriell=GM18393).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM18397
AC   CVCL_DA66
DR   CLO; CLO_0031088
DR   Coriell; GM18397
DR   Wikidata; Q54849530
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Asn1156Ser (c.3467A>G); ClinVar=VCV000002959; Zygosity=Heterozygous (Coriell=GM18397).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Arg1186His (c.3557G>A); ClinVar=VCV000189174; Zygosity=Heterozygous (Coriell=GM18397).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM18398
AC   CVCL_DA67
DR   CLO; CLO_0031090
DR   Coriell; GM18398
DR   Wikidata; Q54849531
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Gly673Val (c.2018G>T); ClinVar=VCV000554148; Zygosity=Heterozygous (Coriell=GM18398).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM18398).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18402
AC   CVCL_DA68
DR   CLO; CLO_0031084
DR   Coriell; GM18402
DR   Wikidata; Q54849532
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Asp700Asn (c.2098G>A); Zygosity=Heterozygous (Coriell=GM18402).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Phe1221Serfs*21 (c.3662delT); ClinVar=VCV000002977; Zygosity=Heterozygous (Coriell=GM18402).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18407
AC   CVCL_DA69
DR   CLO; CLO_0031087
DR   Coriell; GM18407
DR   Wikidata; Q54849533
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Arg404Gln (c.1211G>A); ClinVar=VCV000188794; Zygosity=Heterozygous (Coriell=GM18407).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Met1142Thr (c.3425T>C); ClinVar=VCV000372435; Zygosity=Heterozygous (Coriell=GM18407).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM18411
AC   CVCL_DA70
DR   CLO; CLO_0031158
DR   Coriell; GM18411
DR   Wikidata; Q54849534
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Trp833Ter (c.2498G>A); Zygosity=Heterozygous (Coriell=GM18411).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM18411).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18414
AC   CVCL_DA71
DR   CLO; CLO_0031159
DR   Coriell; GM18414
DR   Wikidata; Q54849535
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Thr1036Met (c.3107C>T); ClinVar=VCV000002958; Zygosity=Homozygous (Coriell=GM18414).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM18415
AC   CVCL_DA72
DR   CLO; CLO_0031160
DR   Coriell; GM18415
DR   Wikidata; Q54849536
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Cys74Tyr (c.221G>A); Zygosity=Heterozygous (Coriell=GM18415).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM18417
AC   CVCL_DA73
DR   CLO; CLO_0031153
DR   Coriell; GM18417
DR   Wikidata; Q54849537
RX   PubMed=12955717;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (Coriell=GM18417).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM18420
AC   CVCL_DA74
DR   CLO; CLO_0031154
DR   Coriell; GM18420
DR   Wikidata; Q54849538
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro1007Ala (c.3019C>G); ClinVar=VCV000002966; Zygosity=Heterozygous (Coriell=GM18420).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Unexplicit; IVS23+4delA; Zygosity=Heterozygous (Coriell=GM18420).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18422
AC   CVCL_DA75
DR   CLO; CLO_0031155
DR   Coriell; GM18422
DR   Wikidata; Q54849539
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile271del (c.810_812CAT[1]) (c.813_815delCAT); ClinVar=VCV000449503; Zygosity=Heterozygous (Coriell=GM18422).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Asp874Val (c.2621A>T); ClinVar=VCV000194810; Zygosity=Heterozygous (Coriell=GM18422).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18424
AC   CVCL_DA76
DR   CLO; CLO_0031156
DR   Coriell; GM18424
DR   Wikidata; Q54849540
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; p.Val30Met (c.88G>A); ClinVar=VCV000183281; Zygosity=Heterozygous (Coriell=GM18424).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126865; Niemann-Pick disease, type C2
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM18429
AC   CVCL_DA77
DR   CLO; CLO_0031147
DR   Coriell; GM18429
DR   Wikidata; Q54849541
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; c.82+2T>C (IVS1+2T>C); ClinVar=VCV000242903; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM18429).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126865; Niemann-Pick disease, type C2
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM18436
AC   CVCL_W152
DR   CLO; CLO_0031148
DR   Coriell; GM18436
DR   Wikidata; Q54849542
RX   PubMed=12955717;
CC   Population: Caucasian; Canadian/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro543Argfs*20 (c.1628delC) (p.Phe542fs); ClinVar=VCV000556403; Zygosity=Heterozygous (Coriell=GM18436).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Glu612Asp (c.1836A>C); ClinVar=VCV000555407; Zygosity=Heterozygous (Coriell=GM18436).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   GM18445
AC   CVCL_W153
DR   CLO; CLO_0031151
DR   Coriell; GM18445
DR   Wikidata; Q54849543
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; p.Val39Met (c.115G>A); ClinVar=VCV000008483; Zygosity=Homozygous (Coriell=GM18445).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126865; Niemann-Pick disease, type C2
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM18453
AC   CVCL_DA78
DR   CLO; CLO_0031137
DR   Coriell; GM18453
DR   Wikidata; Q54849544
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (Coriell=GM18453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM18455
AC   CVCL_DA79
DR   CLO; CLO_0031138
DR   Coriell; GM18455
DR   Wikidata; Q54849545
RX   PubMed=12955717;
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; p.Glu20Ter (c.58G>T); ClinVar=VCV000008477; Zygosity=Heterozygous (Coriell=GM18455).
CC   Sequence variation: Mutation; HGNC; HGNC:14537; NPC2; Simple; p.Cys47Phe (c.140G>T); ClinVar=VCV000549984; Zygosity=Heterozygous (Coriell=GM18455).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126865; Niemann-Pick disease, type C2
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM18456
AC   CVCL_9Y39
DR   CLO; CLO_0031134
DR   Coriell; GM18456
DR   Wikidata; Q54849546
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.10560del4400; Zygosity=Heteroplasmic (Coriell=GM18456).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM18473
AC   CVCL_9Y40
DR   CLO; CLO_0031135
DR   Coriell; GM18473
DR   Wikidata; Q54849547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18474
AC   CVCL_9Y41
DR   CLO; CLO_0031132
DR   Coriell; GM18474
DR   Wikidata; Q54849548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18475
AC   CVCL_9Y42
DR   CLO; CLO_0031133
DR   Coriell; GM18475
DR   Wikidata; Q54849549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18476
AC   CVCL_9Y43
DR   CLO; CLO_0031130
DR   Coriell; GM18476
DR   Wikidata; Q54849550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18477
AC   CVCL_9Y44
DR   CLO; CLO_0031131
DR   Coriell; GM18477
DR   Wikidata; Q54849551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18478
AC   CVCL_9Y45
DR   CLO; CLO_0031127
DR   Coriell; GM18478
DR   Wikidata; Q54849552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18479
AC   CVCL_9Y46
DR   CLO; CLO_0031129
DR   Coriell; GM18479
DR   Wikidata; Q54849553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM18481
AC   CVCL_5M59
DR   CLO; CLO_0024921
DR   Coriell; GM18481
DR   Wikidata; Q54849554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84893; Mobius syndrome
DI   ORDO; Orphanet_570; Moebius syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM18484
AC   CVCL_0V19
DR   CLO; CLO_0024949
DR   Coriell; GM18484
DR   GEO; GSM649284
DR   IGSR; NA18484
DR   Wikidata; Q54849555
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18485
AC   CVCL_0V20
DR   CLO; CLO_0024950
DR   Coriell; GM18485
DR   GEO; GSM649258
DR   IGSR; NA18485
DR   Wikidata; Q54849556
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18486
AC   CVCL_P452
DR   CLO; CLO_0024943
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18486
DR   GEO; GSM485470
DR   GEO; GSM485491
DR   GEO; GSM649181
DR   GEO; GSM1719838
DR   IGSR; NA18486
DR   PRIDE; PXD001406
DR   Wikidata; Q54849557
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18487
AC   CVCL_P453
DR   CLO; CLO_0024947
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18487
DR   GEO; GSM649140
DR   IGSR; NA18487
DR   Wikidata; Q54849558
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18488
AC   CVCL_P454
DR   CLO; CLO_0024940
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18488
DR   GEO; GSM649150
DR   GEO; GSM1719839
DR   IGSR; NA18488
DR   Wikidata; Q54849559
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18489
AC   CVCL_P455
SY   H18489_LCL
DR   CLO; CLO_0024941
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18489
DR   GEO; GSM649144
DR   GEO; GSM1495416
DR   GEO; GSM1502718
DR   GEO; GSM1719840
DR   IGSR; NA18489
DR   Wikidata; Q54849560
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=26102527;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18497
AC   CVCL_0V21
DR   CLO; CLO_0024935
DR   Coriell; GM18497
DR   GEO; GSM649249
DR   IGSR; NA18497
DR   Wikidata; Q54849561
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18498
AC   CVCL_P456
DR   CLO; CLO_0024937
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18498
DR   GEO; GSM485374
DR   GEO; GSM485434
DR   GEO; GSM485451
DR   GEO; GSM485486
DR   GEO; GSM649183
DR   GEO; GSM1719841
DR   IGSR; NA18498
DR   PRIDE; PXD001406
DR   Wikidata; Q54849562
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18499
AC   CVCL_P457
DR   CLO; CLO_0024933
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18499
DR   GEO; GSM485375
DR   GEO; GSM485387
DR   GEO; GSM649182
DR   GEO; GSM1719842
DR   IGSR; NA18499
DR   PRIDE; PXD001406
DR   Wikidata; Q54849563
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18500
AC   CVCL_0V22
DR   CLO; CLO_0024907
DR   Coriell; GM18500
DR   GEO; GSM112571
DR   GEO; GSM112874
DR   GEO; GSM188850
DR   GEO; GSM291701
DR   GEO; GSM649155
DR   IGSR; NA18500
DR   Wikidata; Q54849564
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18501
AC   CVCL_P458
DR   CLO; CLO_0024909
DR   Coriell; GM18501
DR   GEO; GSM112572
DR   GEO; GSM112875
DR   GEO; GSM188851
DR   GEO; GSM273455
DR   GEO; GSM291702
DR   GEO; GSM291703
DR   GEO; GSM291704
DR   GEO; GSM315142
DR   GEO; GSM485403
DR   GEO; GSM485503
DR   GEO; GSM485518
DR   GEO; GSM649138
DR   GEO; GSM649857
DR   GEO; GSM1719843
DR   IGSR; NA18501
DR   PRIDE; PXD001406
DR   Wikidata; Q54849565
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18502
AC   CVCL_P459
DR   CLO; CLO_0024912
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18502
DR   GEO; GSM112573
DR   GEO; GSM112876
DR   GEO; GSM188853
DR   GEO; GSM273456
DR   GEO; GSM291705
DR   GEO; GSM315143
DR   GEO; GSM485426
DR   GEO; GSM485456
DR   GEO; GSM485506
DR   GEO; GSM485515
DR   GEO; GSM649858
DR   GEO; GSM1719844
DR   IGSR; NA18502
DR   PRIDE; PXD001406
DR   Wikidata; Q54849566
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=22797897;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31273215;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM18503
AC   CVCL_0V23
DR   CLO; CLO_0024911
DR   Coriell; GM18503
DR   GEO; GSM112574
DR   GEO; GSM112877
DR   GEO; GSM188854
DR   GEO; GSM291706
DR   GEO; GSM649173
DR   IGSR; NA18503
DR   Wikidata; Q54849567
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18504
AC   CVCL_P460
DR   CLO; CLO_0024915
DR   Coriell; GM18504
DR   GEO; GSM112575
DR   GEO; GSM112878
DR   GEO; GSM188855
DR   GEO; GSM273457
DR   GEO; GSM291707
DR   GEO; GSM291708
DR   GEO; GSM291709
DR   GEO; GSM315144
DR   GEO; GSM485415
DR   GEO; GSM485429
DR   GEO; GSM485462
DR   GEO; GSM485481
DR   GEO; GSM649187
DR   GEO; GSM649859
DR   GEO; GSM1719845
DR   IGSR; NA18504
DR   PRIDE; PXD001406
DR   Wikidata; Q54849568
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18505
AC   CVCL_N803
DR   CLO; CLO_0024913
DR   EFO; EFO_0005332
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18505
DR   ENCODE; ENCBS499ENC
DR   ENCODE; ENCBS500ENC
DR   GEO; GSM112576
DR   GEO; GSM112880
DR   GEO; GSM188856
DR   GEO; GSM273458
DR   GEO; GSM291710
DR   GEO; GSM291711
DR   GEO; GSM291712
DR   GEO; GSM315145
DR   GEO; GSM485424
DR   GEO; GSM485455
DR   GEO; GSM485505
DR   GEO; GSM485517
DR   GEO; GSM649860
DR   GEO; GSM1164203
DR   GEO; GSM1164213
DR   GEO; GSM1164223
DR   GEO; GSM1164233
DR   GEO; GSM1164243
DR   GEO; GSM1204876
DR   GEO; GSM1719846
DR   IGSR; NA18505
DR   PRIDE; PXD000419
DR   PRIDE; PXD001406
DR   Wikidata; Q54849583
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=24136357;
RX   PubMed=24136359;
RX   PubMed=25468404;
RX   PubMed=27617755;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   GM18506
AC   CVCL_F278
DR   CLO; CLO_0024917
DR   Coriell; GM18506
DR   GEO; GSM112577
DR   GEO; GSM112881
DR   GEO; GSM188857
DR   GEO; GSM291713
DR   GEO; GSM649147
DR   IGSR; NA18506
DR   Wikidata; Q54849584
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   GM18507
AC   CVCL_9632
DR   CLO; CLO_0024916
DR   EFO; EFO_0002787
DR   Coriell; GM18507
DR   ENCODE; ENCBS222AAA
DR   GEO; GSM112578
DR   GEO; GSM112882
DR   GEO; GSM188858
DR   GEO; GSM273459
DR   GEO; GSM291714
DR   GEO; GSM315146
DR   GEO; GSM485428
DR   GEO; GSM485464
DR   GEO; GSM649268
DR   GEO; GSM816653
DR   GEO; GSM1164204
DR   GEO; GSM1164214
DR   GEO; GSM1164224
DR   GEO; GSM1164234
DR   GEO; GSM1164244
DR   GEO; GSM1204877
DR   GEO; GSM1618715
DR   GEO; GSM1719847
DR   IGSR; NA18507
DR   PRIDE; PXD000419
DR   PRIDE; PXD001406
DR   Wikidata; Q54849585
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=22797897;
RX   PubMed=23676674;
RX   PubMed=24136357;
RX   PubMed=24136359;
RX   PubMed=25468404;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM18507_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM18508
AC   CVCL_F279
DR   CLO; CLO_0024919
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18508
DR   GEO; GSM112579
DR   GEO; GSM112883
DR   GEO; GSM188859
DR   GEO; GSM273460
DR   GEO; GSM315147
DR   GEO; GSM485421
DR   GEO; GSM485457
DR   GEO; GSM649254
DR   GEO; GSM1164205
DR   GEO; GSM1164215
DR   GEO; GSM1164225
DR   GEO; GSM1164235
DR   GEO; GSM1164245
DR   GEO; GSM1719848
DR   IGSR; NA18508
DR   PRIDE; PXD001406
DR   Wikidata; Q54849587
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=24136359;
RX   PubMed=25468404;
RX   PubMed=27617755;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   GM18509
AC   CVCL_0V24
DR   CLO; CLO_0024918
DR   Coriell; GM18509
DR   GEO; GSM649275
DR   IGSR; NA18509
DR   Wikidata; Q54849588
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18510
AC   CVCL_P461
DR   CLO; CLO_0024884
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18510
DR   GEO; GSM485468
DR   GEO; GSM485500
DR   GEO; GSM649185
DR   GEO; GSM1719849
DR   IGSR; NA18510
DR   PRIDE; PXD001406
DR   Wikidata; Q54849589
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=22797897;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18511
AC   CVCL_P462
DR   CLO; CLO_0024877
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18511
DR   GEO; GSM485372
DR   GEO; GSM485432
DR   GEO; GSM649189
DR   GEO; GSM1719850
DR   IGSR; NA18511
DR   PRIDE; PXD001406
DR   Wikidata; Q54849590
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18515
AC   CVCL_0V25
DR   CLO; CLO_0024881
DR   Coriell; GM18515
DR   GEO; GSM112580
DR   GEO; GSM112884
DR   GEO; GSM188860
DR   GEO; GSM291715
DR   GEO; GSM291716
DR   GEO; GSM291717
DR   IGSR; NA18515
DR   Wikidata; Q54849591
RX   PubMed=17122850;
RX   PubMed=19043577;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18516
AC   CVCL_P463
DR   CLO; CLO_0024892
DR   Coriell; GM18516
DR   GEO; GSM112581
DR   GEO; GSM112885
DR   GEO; GSM188861
DR   GEO; GSM273461
DR   GEO; GSM291718
DR   GEO; GSM315148
DR   GEO; GSM485416
DR   GEO; GSM485431
DR   GEO; GSM485466
DR   GEO; GSM485482
DR   GEO; GSM649225
DR   GEO; GSM649861
DR   GEO; GSM1164206
DR   GEO; GSM1164216
DR   GEO; GSM1164226
DR   GEO; GSM1164236
DR   GEO; GSM1164246
DR   GEO; GSM1204878
DR   GEO; GSM1719851
DR   IGSR; NA18516
DR   PRIDE; PXD000419
DR   PRIDE; PXD001406
DR   Wikidata; Q54849592
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24136357;
RX   PubMed=24136359;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18517
AC   CVCL_P464
DR   CLO; CLO_0024890
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18517
DR   GEO; GSM112582
DR   GEO; GSM112886
DR   GEO; GSM188862
DR   GEO; GSM273462
DR   GEO; GSM291719
DR   GEO; GSM315149
DR   GEO; GSM485410
DR   GEO; GSM485450
DR   GEO; GSM485478
DR   GEO; GSM485479
DR   GEO; GSM649267
DR   GEO; GSM1719852
DR   IGSR; NA18517
DR   PRIDE; PXD001406
DR   Wikidata; Q54849593
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=22797897;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18518
AC   CVCL_0V26
DR   CLO; CLO_0024889
DR   Coriell; GM18518
DR   GEO; GSM649276
DR   IGSR; NA18518
DR   Wikidata; Q54849594
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18519
AC   CVCL_P465
DR   CLO; CLO_0024886
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18519
DR   GEO; GSM485422
DR   GEO; GSM485459
DR   GEO; GSM649151
DR   GEO; GSM1719853
DR   IGSR; NA18519
DR   PRIDE; PXD001406
DR   Wikidata; Q54849595
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18520
AC   CVCL_P466
DR   CLO; CLO_0024898
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18520
DR   GEO; GSM485376
DR   GEO; GSM485433
DR   GEO; GSM1719854
DR   IGSR; NA18520
DR   PRIDE; PXD001406
DR   Wikidata; Q54849596
RX   PubMed=20220758;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18521
AC   CVCL_0V27
DR   CLO; CLO_0024895
DR   Coriell; GM18521
DR   GEO; GSM112583
DR   GEO; GSM112887
DR   GEO; GSM188689
DR   GEO; GSM291720
DR   IGSR; NA18521
DR   Wikidata; Q54849597
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18522
AC   CVCL_P467
DR   CLO; CLO_0024894
DR   Coriell; GM18522
DR   GEO; GSM112584
DR   GEO; GSM112888
DR   GEO; GSM188690
DR   GEO; GSM273463
DR   GEO; GSM291721
DR   GEO; GSM315150
DR   GEO; GSM485417
DR   GEO; GSM485483
DR   GEO; GSM649256
DR   GEO; GSM1164207
DR   GEO; GSM1164217
DR   GEO; GSM1164227
DR   GEO; GSM1164237
DR   GEO; GSM1164247
DR   GEO; GSM1719855
DR   IGSR; NA18522
DR   PRIDE; PXD001406
DR   Wikidata; Q54849598
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24136359;
RX   PubMed=25468404;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18523
AC   CVCL_P468
DR   CLO; CLO_0024843
DR   Coriell; GM18523
DR   GEO; GSM112585
DR   GEO; GSM112889
DR   GEO; GSM188691
DR   GEO; GSM273464
DR   GEO; GSM291722
DR   GEO; GSM291723
DR   GEO; GSM291724
DR   GEO; GSM315151
DR   GEO; GSM485494
DR   GEO; GSM485512
DR   GEO; GSM649192
DR   GEO; GSM649862
DR   GEO; GSM1719856
DR   IGSR; NA18523
DR   PRIDE; PXD001406
DR   Wikidata; Q54849599
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18524
AC   CVCL_P144
DR   CLO; CLO_0024845
DR   Coriell; GM18524
DR   GEO; GSM112586
DR   GEO; GSM112890
DR   GEO; GSM291725
DR   GEO; GSM315060
DR   GEO; GSM649302
DR   Wikidata; Q54849600
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18525
AC   CVCL_P145
DR   Coriell; GM18525
DR   GEO; GSM649863
DR   GEO; GSM1719857
DR   IGSR; NA18525
DR   Wikidata; Q54849601
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18526
AC   CVCL_E124
DR   CLO; CLO_0024847
DR   EFO; EFO_0005348
DR   Coriell; GM18526
DR   ENCODE; ENCBS501ENC
DR   ENCODE; ENCBS502ENC
DR   GEO; GSM112587
DR   GEO; GSM112891
DR   GEO; GSM291726
DR   GEO; GSM291727
DR   GEO; GSM315061
DR   GEO; GSM649864
DR   GEO; GSM1719858
DR   IGSR; NA18526
DR   Wikidata; Q54849602
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   GM18527
AC   CVCL_P036
DR   Coriell; GM18527
DR   GEO; GSM649865
DR   IGSR; NA18527
DR   Wikidata; Q54849603
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18528
AC   CVCL_P146
DR   Coriell; GM18528
DR   GEO; GSM649866
DR   GEO; GSM1719859
DR   IGSR; NA18528
DR   Wikidata; Q54849604
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18529
AC   CVCL_P147
DR   CLO; CLO_0024851
DR   Coriell; GM18529
DR   GEO; GSM112588
DR   GEO; GSM112892
DR   GEO; GSM291728
DR   GEO; GSM315062
DR   Wikidata; Q54849605
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18530
AC   CVCL_P148
DR   CLO; CLO_0024863
DR   Coriell; GM18530
DR   GEO; GSM649867
DR   GEO; GSM1719860
DR   IGSR; NA18530
DR   Wikidata; Q54849606
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18531
AC   CVCL_P149
DR   Coriell; GM18531
DR   GEO; GSM649868
DR   GEO; GSM1719861
DR   IGSR; NA18531
DR   Wikidata; Q54849607
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18532
AC   CVCL_P150
DR   CLO; CLO_0024862
DR   Coriell; GM18532
DR   GEO; GSM112589
DR   GEO; GSM112893
DR   GEO; GSM315063
DR   GEO; GSM649303
DR   GEO; GSM649869
DR   GEO; GSM1719862
DR   IGSR; NA18532
DR   Wikidata; Q54849608
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18533
AC   CVCL_P151
DR   Coriell; GM18533
DR   GEO; GSM649870
DR   GEO; GSM1719863
DR   IGSR; NA18533
DR   Wikidata; Q54849609
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18534
AC   CVCL_P152
DR   CLO; CLO_0024867
DR   Coriell; GM18534
DR   GEO; GSM649871
DR   GEO; GSM1719864
DR   IGSR; NA18534
DR   Wikidata; Q54849610
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18535
AC   CVCL_P153
DR   Coriell; GM18535
DR   GEO; GSM649872
DR   GEO; GSM1719865
DR   IGSR; NA18535
DR   Wikidata; Q54849611
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18536
AC   CVCL_P154
DR   CLO; CLO_0024866
DR   Coriell; GM18536
DR   GEO; GSM1719866
DR   IGSR; NA18536
DR   Wikidata; Q54849612
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18537
AC   CVCL_P155
DR   CLO; CLO_0024859
DR   Coriell; GM18537
DR   GEO; GSM112590
DR   GEO; GSM112894
DR   GEO; GSM291729
DR   GEO; GSM315064
DR   GEO; GSM649004
DR   GEO; GSM1719867
DR   IGSR; NA18537
DR   Wikidata; Q54849613
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18538
AC   CVCL_P156
DR   Coriell; GM18538
DR   GEO; GSM649873
DR   GEO; GSM1719868
DR   IGSR; NA18538
DR   Wikidata; Q54849614
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18539
AC   CVCL_P157
DR   Coriell; GM18539
DR   GEO; GSM649874
DR   GEO; GSM1719869
DR   IGSR; NA18539
DR   Wikidata; Q54849615
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18540
AC   CVCL_P158
DR   CLO; CLO_0024856
DR   Coriell; GM18540
DR   GEO; GSM112591
DR   GEO; GSM112895
DR   GEO; GSM291730
DR   GEO; GSM291731
DR   GEO; GSM315065
DR   Wikidata; Q54849616
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18541
AC   CVCL_P159
DR   Coriell; GM18541
DR   GEO; GSM649875
DR   GEO; GSM1719870
DR   IGSR; NA18541
DR   Wikidata; Q54849617
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18542
AC   CVCL_P160
DR   CLO; CLO_0024822
DR   Coriell; GM18542
DR   GEO; GSM112592
DR   GEO; GSM112896
DR   GEO; GSM291732
DR   GEO; GSM315066
DR   GEO; GSM649007
DR   GEO; GSM649876
DR   GEO; GSM1719871
DR   IGSR; NA18542
DR   Wikidata; Q54849618
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18543
AC   CVCL_P161
DR   CLO; CLO_0024819
DR   Coriell; GM18543
DR   GEO; GSM649877
DR   GEO; GSM1719872
DR   IGSR; NA18543
DR   Wikidata; Q54849619
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18544
AC   CVCL_P162
DR   CLO; CLO_0024820
DR   Coriell; GM18544
DR   GEO; GSM649878
DR   GEO; GSM1719873
DR   IGSR; NA18544
DR   Wikidata; Q54849620
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18545
AC   CVCL_P163
DR   CLO; CLO_0024814
DR   Coriell; GM18545
DR   GEO; GSM112593
DR   GEO; GSM112897
DR   GEO; GSM291733
DR   GEO; GSM291734
DR   GEO; GSM315067
DR   GEO; GSM649015
DR   GEO; GSM649879
DR   GEO; GSM1719874
DR   IGSR; NA18545
DR   Wikidata; Q54849622
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18546
AC   CVCL_P164
DR   CLO; CLO_0024818
DR   Coriell; GM18546
DR   GEO; GSM649880
DR   GEO; GSM1719875
DR   IGSR; NA18546
DR   Wikidata; Q54849623
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18547
AC   CVCL_P165
DR   CLO; CLO_0024838
DR   Coriell; GM18547
DR   GEO; GSM112594
DR   GEO; GSM112898
DR   GEO; GSM291735
DR   GEO; GSM315068
DR   GEO; GSM649016
DR   GEO; GSM649881
DR   GEO; GSM1719876
DR   IGSR; NA18547
DR   Wikidata; Q54849624
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18548
AC   CVCL_P166
DR   CLO; CLO_0024835
DR   Coriell; GM18548
DR   GEO; GSM649882
DR   GEO; GSM1719877
DR   IGSR; NA18548
DR   Wikidata; Q54849639
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18549
AC   CVCL_P167
DR   CLO; CLO_0024834
DR   Coriell; GM18549
DR   GEO; GSM649883
DR   GEO; GSM1719878
DR   IGSR; NA18549
DR   Wikidata; Q54849640
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18550
AC   CVCL_P168
DR   CLO; CLO_0024832
DR   Coriell; GM18550
DR   GEO; GSM112595
DR   GEO; GSM112899
DR   GEO; GSM291736
DR   GEO; GSM315069
DR   GEO; GSM648982
DR   GEO; GSM1719879
DR   IGSR; NA18550
DR   Wikidata; Q54849641
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18552
AC   CVCL_P169
DR   CLO; CLO_0024830
DR   Coriell; GM18552
DR   GEO; GSM112596
DR   GEO; GSM112900
DR   GEO; GSM291737
DR   GEO; GSM291738
DR   GEO; GSM315070
DR   GEO; GSM648983
DR   GEO; GSM1719880
DR   IGSR; NA18552
DR   Wikidata; Q54849642
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18553
AC   CVCL_P170
DR   Coriell; GM18553
DR   GEO; GSM649884
DR   GEO; GSM1719881
DR   IGSR; NA18553
DR   Wikidata; Q54849643
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18555
AC   CVCL_P171
DR   CLO; CLO_0025138
DR   Coriell; GM18555
DR   GEO; GSM112597
DR   GEO; GSM112901
DR   GEO; GSM291739
DR   GEO; GSM291740
DR   GEO; GSM315071
DR   GEO; GSM649017
DR   GEO; GSM1719882
DR   IGSR; NA18555
DR   Wikidata; Q54849644
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18557
AC   CVCL_P172
DR   CLO; CLO_0025137
DR   Coriell; GM18557
DR   GEO; GSM649885
DR   GEO; GSM1719883
DR   IGSR; NA18557
DR   Wikidata; Q54849645
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18558
AC   CVCL_P173
DR   CLO; CLO_0025142
DR   Coriell; GM18558
DR   GEO; GSM112598
DR   GEO; GSM112974
DR   GEO; GSM291741
DR   GEO; GSM291742
DR   GEO; GSM315072
DR   GEO; GSM649304
DR   GEO; GSM1719884
DR   IGSR; NA18558
DR   Wikidata; Q54849646
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=23676674;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18559
AC   CVCL_P174
DR   CLO; CLO_0025141
DR   Coriell; GM18559
DR   GEO; GSM649886
DR   GEO; GSM1719885
DR   IGSR; NA18559
DR   Wikidata; Q54849647
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18560
AC   CVCL_P175
DR   Coriell; GM18560
DR   GEO; GSM649887
DR   GEO; GSM1719886
DR   IGSR; NA18560
DR   Wikidata; Q54849648
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18561
AC   CVCL_P176
DR   CLO; CLO_0025140
DR   Coriell; GM18561
DR   GEO; GSM112599
DR   GEO; GSM112975
DR   GEO; GSM291743
DR   GEO; GSM315073
DR   GEO; GSM1719887
DR   IGSR; NA18561
DR   Wikidata; Q54849649
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18562
AC   CVCL_P177
DR   CLO; CLO_0025139
DR   Coriell; GM18562
DR   GEO; GSM112600
DR   GEO; GSM112976
DR   GEO; GSM291744
DR   GEO; GSM315074
DR   GEO; GSM649001
DR   GEO; GSM1719888
DR   IGSR; NA18562
DR   Wikidata; Q54849650
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18563
AC   CVCL_P178
DR   CLO; CLO_0025135
DR   Coriell; GM18563
DR   GEO; GSM112601
DR   GEO; GSM112977
DR   GEO; GSM291745
DR   GEO; GSM315075
DR   GEO; GSM648986
DR   GEO; GSM1719889
DR   IGSR; NA18563
DR   Wikidata; Q54849651
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18564
AC   CVCL_P179
DR   CLO; CLO_0025136
DR   Coriell; GM18564
DR   GEO; GSM112602
DR   GEO; GSM112978
DR   GEO; GSM291746
DR   GEO; GSM315076
DR   GEO; GSM649000
DR   GEO; GSM1719890
DR   IGSR; NA18564
DR   Wikidata; Q54849652
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18565
AC   CVCL_P180
DR   Coriell; GM18565
DR   GEO; GSM649888
DR   GEO; GSM1719891
DR   IGSR; NA18565
DR   Wikidata; Q54849653
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18566
AC   CVCL_P181
DR   CLO; CLO_0025133
DR   Coriell; GM18566
DR   GEO; GSM112603
DR   GEO; GSM112979
DR   GEO; GSM291747
DR   GEO; GSM315077
DR   GEO; GSM648985
DR   GEO; GSM1719892
DR   IGSR; NA18566
DR   Wikidata; Q54849654
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18567
AC   CVCL_P182
DR   Coriell; GM18567
DR   GEO; GSM649889
DR   GEO; GSM1719893
DR   IGSR; NA18567
DR   Wikidata; Q54849655
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18568
AC   CVCL_0V28
DR   Coriell; GM18568
DR   Wikidata; Q54849656
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18569
AC   CVCL_P183
DR   Coriell; GM18569
DR   Wikidata; Q54849657
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18570
AC   CVCL_P184
DR   CLO; CLO_0025134
DR   Coriell; GM18570
DR   GEO; GSM112604
DR   GEO; GSM112980
DR   GEO; GSM291748
DR   GEO; GSM315078
DR   GEO; GSM648987
DR   GEO; GSM1719894
DR   IGSR; NA18570
DR   Wikidata; Q54849658
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18571
AC   CVCL_P185
DR   CLO; CLO_0025110
DR   Coriell; GM18571
DR   GEO; GSM112605
DR   GEO; GSM112981
DR   GEO; GSM291749
DR   GEO; GSM416945
DR   GEO; GSM648989
DR   GEO; GSM1719895
DR   IGSR; NA18571
DR   Wikidata; Q54849659
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18572
AC   CVCL_P186
DR   CLO; CLO_0025112
DR   Coriell; GM18572
DR   GEO; GSM112606
DR   GEO; GSM112982
DR   GEO; GSM291750
DR   GEO; GSM291751
DR   GEO; GSM416946
DR   GEO; GSM649014
DR   GEO; GSM1719896
DR   IGSR; NA18572
DR   Wikidata; Q54849660
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18573
AC   CVCL_P187
DR   CLO; CLO_0025111
DR   Coriell; GM18573
DR   GEO; GSM112607
DR   GEO; GSM112983
DR   GEO; GSM291752
DR   GEO; GSM315079
DR   GEO; GSM648994
DR   GEO; GSM1719897
DR   IGSR; NA18573
DR   Wikidata; Q54849661
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18574
AC   CVCL_P188
DR   Coriell; GM18574
DR   GEO; GSM649890
DR   GEO; GSM1719898
DR   IGSR; NA18574
DR   Wikidata; Q54849662
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18575
AC   CVCL_0V29
DR   Coriell; GM18575
DR   Wikidata; Q54849663
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18576
AC   CVCL_P189
DR   CLO; CLO_0025114
DR   Coriell; GM18576
DR   GEO; GSM112608
DR   GEO; GSM112984
DR   GEO; GSM291753
DR   GEO; GSM315080
DR   GEO; GSM649305
DR   IGSR; NA18576
DR   Wikidata; Q54849664
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18577
AC   CVCL_P190
DR   CLO; CLO_0025113
DR   Coriell; GM18577
DR   GEO; GSM112609
DR   GEO; GSM112985
DR   GEO; GSM315081
DR   GEO; GSM649003
DR   GEO; GSM1719899
DR   IGSR; NA18577
DR   Wikidata; Q54849665
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18579
AC   CVCL_P191
DR   CLO; CLO_0025116
DR   Coriell; GM18579
DR   GEO; GSM112610
DR   GEO; GSM112986
DR   GEO; GSM291754
DR   GEO; GSM315082
DR   GEO; GSM648996
DR   GEO; GSM1719900
DR   IGSR; NA18579
DR   Wikidata; Q54849666
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18580
AC   CVCL_P192
DR   Coriell; GM18580
DR   Wikidata; Q54849667
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18581
AC   CVCL_0V30
DR   Coriell; GM18581
DR   Wikidata; Q54849668
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18582
AC   CVCL_P193
DR   CLO; CLO_0025115
DR   Coriell; GM18582
DR   GEO; GSM112611
DR   GEO; GSM112987
DR   GEO; GSM291755
DR   GEO; GSM291756
DR   GEO; GSM315083
DR   GEO; GSM648998
DR   GEO; GSM1719901
DR   IGSR; NA18582
DR   Wikidata; Q54849669
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18583
AC   CVCL_0V31
DR   Coriell; GM18583
DR   Wikidata; Q54849670
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18591
AC   CVCL_P194
DR   Coriell; GM18591
DR   GEO; GSM1719902
DR   IGSR; NA18591
DR   Wikidata; Q54849671
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18592
AC   CVCL_P195
DR   CLO; CLO_0025107
DR   Coriell; GM18592
DR   GEO; GSM112612
DR   GEO; GSM112988
DR   GEO; GSM291757
DR   GEO; GSM315084
DR   GEO; GSM649009
DR   GEO; GSM1719903
DR   IGSR; NA18592
DR   Wikidata; Q54849672
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18593
AC   CVCL_P196
DR   CLO; CLO_0025108
DR   Coriell; GM18593
DR   GEO; GSM112613
DR   GEO; GSM112989
DR   GEO; GSM291758
DR   GEO; GSM291759
DR   GEO; GSM315085
DR   GEO; GSM649011
DR   GEO; GSM1719904
DR   IGSR; NA18593
DR   Wikidata; Q54849673
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18594
AC   CVCL_P197
DR   CLO; CLO_0025109
DR   Coriell; GM18594
DR   GEO; GSM112614
DR   GEO; GSM112990
DR   GEO; GSM291760
DR   GEO; GSM315086
DR   GEO; GSM648992
DR   Wikidata; Q54849674
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18595
AC   CVCL_P198
DR   CLO; CLO_0025097
DR   Coriell; GM18595
DR   GEO; GSM649891
DR   GEO; GSM1719905
DR   IGSR; NA18595
DR   Wikidata; Q54849675
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18596
AC   CVCL_P199
DR   CLO; CLO_0025096
DR   Coriell; GM18596
DR   GEO; GSM649892
DR   GEO; GSM1719906
DR   IGSR; NA18596
DR   Wikidata; Q54849676
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18597
AC   CVCL_P200
DR   CLO; CLO_0025095
DR   Coriell; GM18597
DR   GEO; GSM649893
DR   GEO; GSM1719907
DR   IGSR; NA18597
DR   Wikidata; Q54849677
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18598
AC   CVCL_0V32
DR   Coriell; GM18598
DR   Wikidata; Q54849678
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18599
AC   CVCL_P201
DR   CLO; CLO_0025094
DR   Coriell; GM18599
DR   GEO; GSM649894
DR   GEO; GSM1719908
DR   IGSR; NA18599
DR   Wikidata; Q54849691
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18602
AC   CVCL_P202
DR   CLO; CLO_0025093
DR   Coriell; GM18602
DR   GEO; GSM649895
DR   GEO; GSM1719909
DR   IGSR; NA18602
DR   Wikidata; Q54849692
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18603
AC   CVCL_P203
DR   CLO; CLO_0025092
DR   Coriell; GM18603
DR   GEO; GSM112615
DR   GEO; GSM112991
DR   GEO; GSM291761
DR   GEO; GSM315087
DR   GEO; GSM649005
DR   GEO; GSM1719910
DR   IGSR; NA18603
DR   Wikidata; Q54849693
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18605
AC   CVCL_P204
DR   CLO; CLO_0025091
DR   Coriell; GM18605
DR   GEO; GSM112616
DR   GEO; GSM112992
DR   GEO; GSM291762
DR   GEO; GSM315088
DR   GEO; GSM649006
DR   GEO; GSM1719911
DR   IGSR; NA18605
DR   Wikidata; Q54849694
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18606
AC   CVCL_P205
DR   CLO; CLO_0025090
DR   Coriell; GM18606
DR   GEO; GSM291763
DR   GEO; GSM649896
DR   GEO; GSM1719912
DR   IGSR; NA18606
DR   Wikidata; Q54849695
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18608
AC   CVCL_P206
DR   CLO; CLO_0025088
DR   Coriell; GM18608
DR   GEO; GSM112617
DR   GEO; GSM112993
DR   GEO; GSM291764
DR   GEO; GSM291765
DR   GEO; GSM315089
DR   GEO; GSM649002
DR   GEO; GSM1719913
DR   IGSR; NA18608
DR   Wikidata; Q54849696
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18609
AC   CVCL_P207
DR   CLO; CLO_0025089
DR   Coriell; GM18609
DR   GEO; GSM112618
DR   GEO; GSM112994
DR   GEO; GSM291766
DR   GEO; GSM649013
DR   GEO; GSM1719914
DR   IGSR; NA18609
DR   Wikidata; Q54849697
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18610
AC   CVCL_P208
DR   CLO; CLO_0025078
DR   Coriell; GM18610
DR   GEO; GSM649897
DR   GEO; GSM1719915
DR   IGSR; NA18610
DR   Wikidata; Q54849698
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18611
AC   CVCL_P209
DR   CLO; CLO_0025075
DR   Coriell; GM18611
DR   GEO; GSM112619
DR   GEO; GSM112995
DR   GEO; GSM291767
DR   GEO; GSM315090
DR   GEO; GSM648984
DR   GEO; GSM1719916
DR   IGSR; NA18611
DR   Wikidata; Q54849699
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18612
AC   CVCL_P210
DR   CLO; CLO_0025074
DR   Coriell; GM18612
DR   GEO; GSM112620
DR   GEO; GSM112996
DR   GEO; GSM291768
DR   GEO; GSM315091
DR   GEO; GSM648988
DR   GEO; GSM1719917
DR   IGSR; NA18612
DR   Wikidata; Q54849700
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18613
AC   CVCL_P211
DR   CLO; CLO_0025077
DR   Coriell; GM18613
DR   GEO; GSM649898
DR   GEO; GSM1719918
DR   IGSR; NA18613
DR   Wikidata; Q54849701
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18614
AC   CVCL_P212
DR   CLO; CLO_0025076
DR   Coriell; GM18614
DR   GEO; GSM649899
DR   GEO; GSM1719919
DR   IGSR; NA18614
DR   Wikidata; Q54849702
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18615
AC   CVCL_P213
DR   CLO; CLO_0025071
DR   Coriell; GM18615
DR   GEO; GSM649900
DR   GEO; GSM1719920
DR   IGSR; NA18615
DR   Wikidata; Q54849703
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18616
AC   CVCL_P214
DR   CLO; CLO_0025070
DR   Coriell; GM18616
DR   GEO; GSM649901
DR   GEO; GSM1719921
DR   IGSR; NA18616
DR   Wikidata; Q54849704
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18617
AC   CVCL_P215
DR   CLO; CLO_0025073
DR   Coriell; GM18617
DR   GEO; GSM649902
DR   GEO; GSM1719922
DR   IGSR; NA18617
DR   Wikidata; Q54849705
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18618
AC   CVCL_P216
DR   CLO; CLO_0025072
DR   Coriell; GM18618
DR   GEO; GSM649903
DR   GEO; GSM1719923
DR   IGSR; NA18618
DR   Wikidata; Q54849706
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18619
AC   CVCL_P217
DR   CLO; CLO_0025069
DR   Coriell; GM18619
DR   GEO; GSM649904
DR   GEO; GSM1719924
DR   IGSR; NA18619
DR   Wikidata; Q54849707
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18620
AC   CVCL_P218
DR   CLO; CLO_0025049
DR   Coriell; GM18620
DR   GEO; GSM112621
DR   GEO; GSM112997
DR   GEO; GSM291769
DR   GEO; GSM291770
DR   GEO; GSM315092
DR   GEO; GSM648990
DR   GEO; GSM1719925
DR   IGSR; NA18620
DR   Wikidata; Q54849708
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18621
AC   CVCL_P219
DR   CLO; CLO_0025050
DR   Coriell; GM18621
DR   GEO; GSM112622
DR   GEO; GSM112998
DR   GEO; GSM291771
DR   GEO; GSM315093
DR   GEO; GSM648991
DR   GEO; GSM1719926
DR   IGSR; NA18621
DR   Wikidata; Q54849709
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18622
AC   CVCL_P220
DR   CLO; CLO_0025053
DR   Coriell; GM18622
DR   GEO; GSM112623
DR   GEO; GSM112999
DR   GEO; GSM291772
DR   GEO; GSM315094
DR   GEO; GSM648993
DR   GEO; GSM1719927
DR   IGSR; NA18622
DR   Wikidata; Q54849710
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18623
AC   CVCL_P221
DR   CLO; CLO_0025054
DR   Coriell; GM18623
DR   GEO; GSM112624
DR   GEO; GSM113000
DR   GEO; GSM291773
DR   GEO; GSM291774
DR   GEO; GSM315095
DR   GEO; GSM1719928
DR   IGSR; NA18623
DR   Wikidata; Q54849711
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18624
AC   CVCL_P222
DR   CLO; CLO_0025051
DR   Coriell; GM18624
DR   GEO; GSM112625
DR   GEO; GSM113001
DR   GEO; GSM291775
DR   GEO; GSM315096
DR   GEO; GSM648995
DR   GEO; GSM1719929
DR   IGSR; NA18624
DR   Wikidata; Q54849712
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18625
AC   CVCL_P223
DR   CLO; CLO_0025052
DR   Coriell; GM18625
DR   GEO; GSM649905
DR   GEO; GSM1719930
DR   IGSR; NA18625
DR   Wikidata; Q54849713
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18626
AC   CVCL_P224
DR   CLO; CLO_0025057
DR   Coriell; GM18626
DR   GEO; GSM649906
DR   GEO; GSM1719931
DR   IGSR; NA18626
DR   Wikidata; Q54849714
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18627
AC   CVCL_P225
DR   CLO; CLO_0025058
DR   Coriell; GM18627
DR   GEO; GSM649907
DR   GEO; GSM1719932
DR   IGSR; NA18627
DR   Wikidata; Q54849715
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18628
AC   CVCL_P226
DR   CLO; CLO_0025055
DR   Coriell; GM18628
DR   GEO; GSM649908
DR   GEO; GSM1719933
DR   IGSR; NA18628
DR   Wikidata; Q54849716
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18629
AC   CVCL_P227
DR   Coriell; GM18629
DR   GEO; GSM1719934
DR   IGSR; NA18629
DR   Wikidata; Q54849717
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18630
AC   CVCL_P228
DR   CLO; CLO_0025056
DR   Coriell; GM18630
DR   GEO; GSM1719935
DR   IGSR; NA18630
DR   Wikidata; Q54849718
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18631
AC   CVCL_P229
DR   CLO; CLO_0026143
DR   Coriell; GM18631
DR   GEO; GSM649909
DR   GEO; GSM1719936
DR   IGSR; NA18631
DR   Wikidata; Q54849719
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18632
AC   CVCL_P230
DR   CLO; CLO_0026145
DR   Coriell; GM18632
DR   GEO; GSM112626
DR   GEO; GSM113002
DR   GEO; GSM291776
DR   GEO; GSM315097
DR   GEO; GSM648997
DR   GEO; GSM1719937
DR   IGSR; NA18632
DR   Wikidata; Q54849720
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18633
AC   CVCL_P231
DR   CLO; CLO_0026140
DR   Coriell; GM18633
DR   GEO; GSM112627
DR   GEO; GSM113003
DR   GEO; GSM291777
DR   GEO; GSM291778
DR   GEO; GSM648999
DR   GEO; GSM1719938
DR   IGSR; NA18633
DR   Wikidata; Q54849721
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18634
AC   CVCL_P232
DR   CLO; CLO_0026141
DR   Coriell; GM18634
DR   GEO; GSM649910
DR   GEO; GSM1719939
DR   IGSR; NA18634
DR   Wikidata; Q54849722
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18635
AC   CVCL_P233
DR   CLO; CLO_0026152
DR   Coriell; GM18635
DR   GEO; GSM112628
DR   GEO; GSM113004
DR   GEO; GSM291779
DR   GEO; GSM315098
DR   GEO; GSM649008
DR   GEO; GSM1719940
DR   IGSR; NA18635
DR   Wikidata; Q54849723
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18636
AC   CVCL_P234
DR   CLO; CLO_0026154
DR   Coriell; GM18636
DR   GEO; GSM112629
DR   GEO; GSM113005
DR   GEO; GSM291780
DR   GEO; GSM315099
DR   GEO; GSM649010
DR   GEO; GSM1719941
DR   IGSR; NA18636
DR   Wikidata; Q54849724
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18637
AC   CVCL_P235
DR   CLO; CLO_0026147
DR   Coriell; GM18637
DR   GEO; GSM112630
DR   GEO; GSM113006
DR   GEO; GSM291781
DR   GEO; GSM315100
DR   GEO; GSM649012
DR   GEO; GSM1719942
DR   IGSR; NA18637
DR   Wikidata; Q54849725
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18638
AC   CVCL_P236
DR   CLO; CLO_0026149
DR   Coriell; GM18638
DR   GEO; GSM1719943
DR   IGSR; NA18638
DR   Wikidata; Q54849726
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18639
AC   CVCL_P237
DR   CLO; CLO_0026155
DR   Coriell; GM18639
DR   GEO; GSM649911
DR   GEO; GSM1719944
DR   IGSR; NA18639
DR   Wikidata; Q54849727
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18640
AC   CVCL_P238
DR   CLO; CLO_0026156
DR   Coriell; GM18640
DR   GEO; GSM649912
DR   GEO; GSM1719945
DR   IGSR; NA18640
DR   Wikidata; Q54849728
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18641
AC   CVCL_P239
DR   CLO; CLO_0026208
DR   Coriell; GM18641
DR   GEO; GSM649913
DR   GEO; GSM1719946
DR   IGSR; NA18641
DR   Wikidata; Q54849729
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18642
AC   CVCL_P240
DR   CLO; CLO_0026198
DR   Coriell; GM18642
DR   GEO; GSM649914
DR   GEO; GSM1719947
DR   IGSR; NA18642
DR   Wikidata; Q54849730
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18643
AC   CVCL_P241
DR   CLO; CLO_0026199
DR   Coriell; GM18643
DR   GEO; GSM649915
DR   GEO; GSM1719948
DR   IGSR; NA18643
DR   Wikidata; Q54849744
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18644
AC   CVCL_0V33
DR   Coriell; GM18644
DR   GEO; GSM1719949
DR   IGSR; NA18644
DR   Wikidata; Q54849745
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18645
AC   CVCL_P242
DR   CLO; CLO_0026201
DR   Coriell; GM18645
DR   GEO; GSM649916
DR   GEO; GSM1719950
DR   IGSR; NA18645
DR   Wikidata; Q54849746
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18646
AC   CVCL_0V34
DR   Coriell; GM18646
DR   GEO; GSM1719951
DR   IGSR; NA18646
DR   Wikidata; Q54849747
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18647
AC   CVCL_P243
DR   CLO; CLO_0026204
DR   Coriell; GM18647
DR   GEO; GSM649917
DR   GEO; GSM1719952
DR   IGSR; NA18647
DR   Wikidata; Q54849748
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18648
AC   CVCL_P244
DR   Coriell; GM18648
DR   GEO; GSM1719953
DR   IGSR; NA18648
DR   Wikidata; Q54849749
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18649
AC   CVCL_P245
DR   Coriell; GM18649
DR   Wikidata; Q54849750
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18666
AC   CVCL_AB23
DR   CLO; CLO_0026190
DR   Coriell; GM18666
DR   Wikidata; Q54849751
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Asn540Lys (c.1620C>A); ClinVar=VCV000016337; Zygosity=Heterozygous (Coriell=GM18666).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118697; Hypochondroplasia
DI   ORDO; Orphanet_429; Hypochondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM18668
AC   CVCL_0N25
DR   CLO; CLO_0026192
DR   Coriell; GM18668
DR   Wikidata; Q54849752
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM18668).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Unexplicit; Ex2-3del; Zygosity=Heterozygous (Coriell=GM18668).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM18669
AC   CVCL_0W43
DR   Coriell; GM18669
DR   Wikidata; Q54849753
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18670
AC   CVCL_0W44
DR   CLO; CLO_0026193
DR   Coriell; GM18670
DR   Wikidata; Q54849754
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18671
AC   CVCL_0W45
DR   Coriell; GM18671
DR   Wikidata; Q54849755
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18673
AC   CVCL_0W46
DR   CLO; CLO_0026196
DR   Coriell; GM18673
DR   Wikidata; Q54849756
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18674
AC   CVCL_0W47
DR   CLO; CLO_0026205
DR   Coriell; GM18674
DR   Wikidata; Q54849757
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18675
AC   CVCL_0W48
DR   Coriell; GM18675
DR   Wikidata; Q54849758
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18677
AC   CVCL_0W49
DR   Coriell; GM18677
DR   Wikidata; Q54849759
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18679
AC   CVCL_0W50
DR   Coriell; GM18679
DR   Wikidata; Q54849760
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18682
AC   CVCL_0W51
DR   CLO; CLO_0026188
DR   Coriell; GM18682
DR   Wikidata; Q54849761
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18683
AC   CVCL_0W52
DR   Coriell; GM18683
DR   Wikidata; Q54849762
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18684
AC   CVCL_0W53
DR   Coriell; GM18684
DR   Wikidata; Q54849763
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18685
AC   CVCL_0W54
DR   CLO; CLO_0026187
DR   Coriell; GM18685
DR   Wikidata; Q54849764
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18686
AC   CVCL_0W55
DR   Coriell; GM18686
DR   Wikidata; Q54849765
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18687
AC   CVCL_0W56
DR   Coriell; GM18687
DR   Wikidata; Q54849766
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18689
AC   CVCL_0W57
DR   CLO; CLO_0026182
DR   Coriell; GM18689
DR   Wikidata; Q54849767
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18690
AC   CVCL_0W58
DR   Coriell; GM18690
DR   Wikidata; Q54849768
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18691
AC   CVCL_0W59
DR   CLO; CLO_0026183
DR   Coriell; GM18691
DR   Wikidata; Q54849769
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18692
AC   CVCL_0W60
DR   Coriell; GM18692
DR   Wikidata; Q54849770
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18693
AC   CVCL_0W61
DR   CLO; CLO_0026178
DR   Coriell; GM18693
DR   Wikidata; Q54849771
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18694
AC   CVCL_0W62
DR   CLO; CLO_0026180
DR   Coriell; GM18694
DR   Wikidata; Q54849772
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18695
AC   CVCL_0W63
DR   Coriell; GM18695
DR   Wikidata; Q54849773
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18696
AC   CVCL_0W64
DR   CLO; CLO_0026173
DR   Coriell; GM18696
DR   Wikidata; Q54849774
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18697
AC   CVCL_0W65
DR   Coriell; GM18697
DR   Wikidata; Q54849775
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18698
AC   CVCL_0W66
DR   Coriell; GM18698
DR   Wikidata; Q54849776
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18699
AC   CVCL_0W67
DR   Coriell; GM18699
DR   Wikidata; Q54849777
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18701
AC   CVCL_0W68
DR   Coriell; GM18701
DR   Wikidata; Q54849778
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18702
AC   CVCL_0W69
DR   CLO; CLO_0026175
DR   Coriell; GM18702
DR   Wikidata; Q54849779
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18704
AC   CVCL_0W70
DR   CLO; CLO_0026170
DR   Coriell; GM18704
DR   Wikidata; Q54849780
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM18706
AC   CVCL_0W71
DR   Coriell; GM18706
DR   Wikidata; Q54849781
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18707
AC   CVCL_0W72
DR   Coriell; GM18707
DR   Wikidata; Q54849782
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18708
AC   CVCL_0W73
DR   Coriell; GM18708
DR   Wikidata; Q54849783
CC   Population: Chinese (from Denver).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM18739
AC   CVCL_P246
DR   Coriell; GM18739
DR   Wikidata; Q54849791
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18740
AC   CVCL_P247
DR   CLO; CLO_0026171
DR   Coriell; GM18740
DR   GEO; GSM1719954
DR   IGSR; NA18740
DR   Wikidata; Q54849792
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18741
AC   CVCL_P248
DR   Coriell; GM18741
DR   Wikidata; Q54849793
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18742
AC   CVCL_P249
DR   Coriell; GM18742
DR   Wikidata; Q54849794
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18743
AC   CVCL_0W74
DR   Coriell; GM18743
DR   Wikidata; Q54849795
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18744
AC   CVCL_0W75
DR   Coriell; GM18744
DR   Wikidata; Q54849796
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18745
AC   CVCL_P250
DR   CLO; CLO_0026226
DR   Coriell; GM18745
DR   GEO; GSM649918
DR   GEO; GSM1719955
DR   IGSR; NA18745
DR   Wikidata; Q54849797
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18747
AC   CVCL_P251
DR   CLO; CLO_0026227
DR   Coriell; GM18747
DR   GEO; GSM649919
DR   GEO; GSM1719956
DR   IGSR; NA18747
DR   Wikidata; Q54849798
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18748
AC   CVCL_P252
DR   CLO; CLO_0026228
DR   Coriell; GM18748
DR   GEO; GSM649920
DR   GEO; GSM1719957
DR   IGSR; NA18748
DR   Wikidata; Q54849799
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18749
AC   CVCL_P253
DR   CLO; CLO_0026220
DR   Coriell; GM18749
DR   GEO; GSM649921
DR   GEO; GSM1719958
DR   IGSR; NA18749
DR   Wikidata; Q54849800
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18750
AC   CVCL_0W76
DR   Coriell; GM18750
DR   Wikidata; Q54849801
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18751
AC   CVCL_0W77
DR   Coriell; GM18751
DR   Wikidata; Q54849802
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18752
AC   CVCL_0W78
DR   Coriell; GM18752
DR   Wikidata; Q54849803
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18753
AC   CVCL_0W79
DR   Coriell; GM18753
DR   Wikidata; Q54849804
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18755
AC   CVCL_0W80
DR   Coriell; GM18755
DR   Wikidata; Q54849805
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18756
AC   CVCL_0W81
DR   Coriell; GM18756
DR   Wikidata; Q54849806
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18757
AC   CVCL_P254
DR   CLO; CLO_0026219
DR   Coriell; GM18757
DR   GEO; GSM649922
DR   GEO; GSM1719959
DR   IGSR; NA18757
DR   Wikidata; Q54849807
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18758
AC   CVCL_0W82
DR   Coriell; GM18758
DR   Wikidata; Q54849808
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18759
AC   CVCL_0W83
DR   Coriell; GM18759
DR   Wikidata; Q54849809
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18760
AC   CVCL_0W84
DR   Coriell; GM18760
DR   Wikidata; Q54849810
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18761
AC   CVCL_0W85
DR   Coriell; GM18761
DR   Wikidata; Q54849811
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18762
AC   CVCL_0W86
DR   Coriell; GM18762
DR   Wikidata; Q54849812
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18763
AC   CVCL_0W87
DR   Coriell; GM18763
DR   Wikidata; Q54849813
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18764
AC   CVCL_0W88
DR   Coriell; GM18764
DR   Wikidata; Q54849815
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18765
AC   CVCL_0W89
DR   Coriell; GM18765
DR   Wikidata; Q54849816
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18767
AC   CVCL_0W90
DR   Coriell; GM18767
DR   Wikidata; Q54849817
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18768
AC   CVCL_0W91
DR   Coriell; GM18768
DR   Wikidata; Q54849818
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18769
AC   CVCL_P255
DR   Coriell; GM18769
DR   Wikidata; Q54849819
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18770
AC   CVCL_0W92
DR   Coriell; GM18770
DR   Wikidata; Q54849820
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18771
AC   CVCL_P256
DR   Coriell; GM18771
DR   Wikidata; Q54849821
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18772
AC   CVCL_0W93
DR   Coriell; GM18772
DR   Wikidata; Q54849822
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18773
AC   CVCL_0W94
DR   Coriell; GM18773
DR   Wikidata; Q54849823
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18774
AC   CVCL_0W95
DR   Coriell; GM18774
DR   Wikidata; Q54849824
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18775
AC   CVCL_0W96
DR   Coriell; GM18775
DR   Wikidata; Q54849825
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18777
AC   CVCL_0W97
DR   Coriell; GM18777
DR   Wikidata; Q54849826
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18778
AC   CVCL_0W98
DR   Coriell; GM18778
DR   Wikidata; Q54849827
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18779
AC   CVCL_0W99
DR   Coriell; GM18779
DR   Wikidata; Q54849828
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18780
AC   CVCL_0X00
DR   Coriell; GM18780
DR   Wikidata; Q54849829
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18781
AC   CVCL_0X01
DR   Coriell; GM18781
DR   Wikidata; Q54849830
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18783
AC   CVCL_0X02
DR   Coriell; GM18783
DR   Wikidata; Q54849831
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18784
AC   CVCL_0X03
DR   Coriell; GM18784
DR   Wikidata; Q54849842
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18785
AC   CVCL_P257
DR   Coriell; GM18785
DR   Wikidata; Q54849843
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18787
AC   CVCL_HJ99
DR   Coriell; GM18787
DR   Wikidata; Q54849844
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM18789
AC   CVCL_0X04
DR   Coriell; GM18789
DR   Wikidata; Q54849845
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18790
AC   CVCL_P258
DR   Coriell; GM18790
DR   Wikidata; Q54849846
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18791
AC   CVCL_0X05
DR   Coriell; GM18791
DR   IGSR; NA18791
DR   Wikidata; Q54849847
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18792
AC   CVCL_0X06
DR   Coriell; GM18792
DR   Wikidata; Q54849848
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18794
AC   CVCL_P259
DR   Coriell; GM18794
DR   IGSR; NA18794
DR   Wikidata; Q54849849
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18795
AC   CVCL_0X07
DR   Coriell; GM18795
DR   IGSR; NA18795
DR   Wikidata; Q54849850
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18796
AC   CVCL_0X08
DR   Coriell; GM18796
DR   Wikidata; Q54849851
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18797
AC   CVCL_0X09
DR   Coriell; GM18797
DR   Wikidata; Q54849852
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM18797; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18798
AC   CVCL_P260
DR   Coriell; GM18798
DR   Wikidata; Q54849853
CC   Population: Chinese; Han in Beijing (CHB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM18799
AC   CVCL_0N26
DR   CLO; CLO_0026222
DR   Coriell; GM18799
DR   Wikidata; Q54849854
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Lys684Asnfs*38 (c.2052delA) (2184delA); ClinVar=VCV000038493; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM18800
AC   CVCL_0N27
DR   CLO; CLO_0026221
DR   Coriell; GM18800
DR   Wikidata; Q54849855
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM18800).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1766+1G>A (1898+1G>A); ClinVar=VCV000007168; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM18800).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM18801
AC   CVCL_0N28
DR   CLO; CLO_0026224
DR   Coriell; GM18801
DR   Wikidata; Q54849856
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.3140-26A>G (3272-26A>G); ClinVar=VCV000035864; Zygosity=Heterozygous (Coriell=GM18801).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.3468+2dupT (3600+2insT); ClinVar=VCV000487380; Zygosity=Heterozygous (Coriell=GM18801).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM18802
AC   CVCL_0N29
DR   CLO; CLO_0026223
DR   Coriell; GM18802
DR   Wikidata; Q54849857
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Tyr122Ter (c.366T>A); ClinVar=VCV000038833; Zygosity=Heterozygous (Coriell=GM18802).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg1158Ter (c.3472C>T); ClinVar=VCV000007144; Zygosity=Heterozygous (Coriell=GM18802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM18803
AC   CVCL_0N30
DR   CLO; CLO_0026225
DR   Coriell; GM18803
DR   Wikidata; Q54849858
CC   Population: Caucasian; Czechoslovakian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM18803).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Lys684Serfs*38 (c.2051_2052delAAinsG) (2183AA>G); ClinVar=VCV000035837; Zygosity=Heterozygous (Coriell=GM18803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM18825
AC   CVCL_2U51
DR   CLO; CLO_0026217
DR   Coriell; GM18825
DR   Wikidata; Q54849859
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM18826
AC   CVCL_2U52
DR   CLO; CLO_0026218
DR   Coriell; GM18826
DR   Wikidata; Q54849860
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM18827
AC   CVCL_2U53
DR   CLO; CLO_0026215
DR   Coriell; GM18827
DR   Wikidata; Q54849861
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM18828
AC   CVCL_2U54
DR   CLO; CLO_0026216
DR   Coriell; GM18828
DR   Wikidata; Q54849862
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM18852
AC   CVCL_P469
DR   CLO; CLO_0026212
DR   Coriell; GM18852
DR   GEO; GSM112631
DR   GEO; GSM113007
DR   GEO; GSM188692
DR   GEO; GSM273465
DR   GEO; GSM291782
DR   GEO; GSM291783
DR   GEO; GSM291784
DR   GEO; GSM315152
DR   GEO; GSM485497
DR   GEO; GSM485508
DR   GEO; GSM649161
DR   IGSR; NA18852
DR   PRIDE; PXD001406
DR   Wikidata; Q54849864
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18853
AC   CVCL_P470
DR   CLO; CLO_0026211
DR   Coriell; GM18853
DR   GEO; GSM112632
DR   GEO; GSM113008
DR   GEO; GSM188693
DR   GEO; GSM273466
DR   GEO; GSM291785
DR   GEO; GSM315153
DR   GEO; GSM485398
DR   GEO; GSM485444
DR   GEO; GSM649198
DR   GEO; GSM1719960
DR   IGSR; NA18853
DR   Wikidata; Q54849866
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18854
AC   CVCL_0X10
DR   CLO; CLO_0026210
DR   Coriell; GM18854
DR   GEO; GSM112633
DR   GEO; GSM113009
DR   GEO; GSM188694
DR   GEO; GSM291786
DR   GEO; GSM291787
DR   GEO; GSM291788
DR   GEO; GSM649139
DR   IGSR; NA18854
DR   Wikidata; Q54849867
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18855
AC   CVCL_P471
DR   CLO; CLO_0026209
DR   Coriell; GM18855
DR   GEO; GSM112634
DR   GEO; GSM113010
DR   GEO; GSM188695
DR   GEO; GSM273467
DR   GEO; GSM291789
DR   GEO; GSM315154
DR   GEO; GSM485498
DR   GEO; GSM485507
DR   GEO; GSM649218
DR   IGSR; NA18855
DR   PRIDE; PXD001406
DR   Wikidata; Q54849868
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18856
AC   CVCL_P472
DR   CLO; CLO_0026214
DR   Coriell; GM18856
DR   GEO; GSM112635
DR   GEO; GSM113011
DR   GEO; GSM188696
DR   GEO; GSM273468
DR   GEO; GSM291790
DR   GEO; GSM291791
DR   GEO; GSM291792
DR   GEO; GSM315155
DR   GEO; GSM485404
DR   GEO; GSM485504
DR   GEO; GSM485516
DR   GEO; GSM485519
DR   GEO; GSM649306
DR   GEO; GSM1719961
DR   IGSR; NA18856
DR   Wikidata; Q54849869
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18857
AC   CVCL_0X11
DR   CLO; CLO_0026213
DR   Coriell; GM18857
DR   GEO; GSM112636
DR   GEO; GSM113012
DR   GEO; GSM188697
DR   GEO; GSM291793
DR   GEO; GSM649226
DR   IGSR; NA18857
DR   Wikidata; Q54849870
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18858
AC   CVCL_P473
DR   CLO; CLO_0026258
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18858
DR   GEO; GSM112637
DR   GEO; GSM113017
DR   GEO; GSM188698
DR   GEO; GSM273469
DR   GEO; GSM291794
DR   GEO; GSM315156
DR   GEO; GSM485460
DR   GEO; GSM485509
DR   GEO; GSM649923
DR   GEO; GSM1719962
DR   IGSR; NA18858
DR   PRIDE; PXD001406
DR   Wikidata; Q54849871
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18859
AC   CVCL_P474
DR   CLO; CLO_0026254
DR   Coriell; GM18859
DR   GEO; GSM112638
DR   GEO; GSM113018
DR   GEO; GSM188700
DR   GEO; GSM273470
DR   GEO; GSM291795
DR   GEO; GSM315157
DR   GEO; GSM649178
DR   IGSR; NA18859
DR   Wikidata; Q54849872
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18860
AC   CVCL_0X12
DR   CLO; CLO_0026255
DR   Coriell; GM18860
DR   GEO; GSM112639
DR   GEO; GSM113019
DR   GEO; GSM188701
DR   GEO; GSM291796
DR   GEO; GSM649220
DR   IGSR; NA18860
DR   Wikidata; Q54849873
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18861
AC   CVCL_P475
DR   CLO; CLO_0026256
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18861
DR   GEO; GSM112640
DR   GEO; GSM113020
DR   GEO; GSM188702
DR   GEO; GSM273471
DR   GEO; GSM291797
DR   GEO; GSM315158
DR   GEO; GSM485391
DR   GEO; GSM485438
DR   GEO; GSM649158
DR   GEO; GSM1719963
DR   IGSR; NA18861
DR   PRIDE; PXD001406
DR   Wikidata; Q54849874
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18862
AC   CVCL_P476
DR   CLO; CLO_0026257
DR   Coriell; GM18862
DR   GEO; GSM112641
DR   GEO; GSM113021
DR   GEO; GSM188703
DR   GEO; GSM273472
DR   GEO; GSM291798
DR   GEO; GSM291799
DR   GEO; GSM291800
DR   GEO; GSM315159
DR   GEO; GSM485399
DR   GEO; GSM485443
DR   GEO; GSM649205
DR   IGSR; NA18862
DR   PRIDE; PXD001406
DR   Wikidata; Q54849875
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18863
AC   CVCL_0X13
DR   CLO; CLO_0026251
DR   Coriell; GM18863
DR   GEO; GSM112642
DR   GEO; GSM113023
DR   GEO; GSM188704
DR   GEO; GSM291801
DR   GEO; GSM291802
DR   GEO; GSM291803
DR   GEO; GSM649217
DR   IGSR; NA18863
DR   Wikidata; Q54849876
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18864
AC   CVCL_0X14
DR   Coriell; GM18864
DR   GEO; GSM1719964
DR   IGSR; NA18864
DR   Wikidata; Q54849877
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18865
AC   CVCL_0X15
DR   Coriell; GM18865
DR   GEO; GSM1719965
DR   IGSR; NA18865
DR   Wikidata; Q54849878
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18867
AC   CVCL_P477
DR   CLO; CLO_0026250
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18867
DR   GEO; GSM649242
DR   GEO; GSM1719966
DR   IGSR; NA18867
DR   Wikidata; Q54849879
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18868
AC   CVCL_P478
DR   CLO; CLO_0026253
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18868
DR   GEO; GSM649213
DR   GEO; GSM1719967
DR   IGSR; NA18868
DR   Wikidata; Q54849880
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18869
AC   CVCL_0X16
DR   CLO; CLO_0026252
DR   Coriell; GM18869
DR   GEO; GSM649273
DR   IGSR; NA18869
DR   Wikidata; Q54849881
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18870
AC   CVCL_P479
DR   CLO; CLO_0026249
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18870
DR   GEO; GSM112643
DR   GEO; GSM113024
DR   GEO; GSM188705
DR   GEO; GSM273473
DR   GEO; GSM291804
DR   GEO; GSM291805
DR   GEO; GSM315160
DR   GEO; GSM485471
DR   GEO; GSM485499
DR   GEO; GSM649202
DR   GEO; GSM1719968
DR   IGSR; NA18870
DR   PRIDE; PXD001406
DR   Wikidata; Q54849882
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18871
AC   CVCL_P480
DR   CLO; CLO_0026247
DR   Coriell; GM18871
DR   GEO; GSM112644
DR   GEO; GSM113025
DR   GEO; GSM273474
DR   GEO; GSM291806
DR   GEO; GSM315161
DR   GEO; GSM485469
DR   GEO; GSM485488
DR   GEO; GSM649190
DR   GEO; GSM1719969
DR   IGSR; NA18871
DR   PRIDE; PXD001406
DR   Wikidata; Q54849883
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18872
AC   CVCL_0X17
DR   CLO; CLO_0026248
DR   Coriell; GM18872
DR   GEO; GSM112645
DR   GEO; GSM113026
DR   GEO; GSM188706
DR   GEO; GSM291807
DR   GEO; GSM291808
DR   GEO; GSM291809
DR   GEO; GSM649264
DR   IGSR; NA18872
DR   Wikidata; Q54849894
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18873
AC   CVCL_P481
DR   CLO; CLO_0026245
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18873
DR   GEO; GSM649149
DR   GEO; GSM1719970
DR   IGSR; NA18873
DR   Wikidata; Q54849895
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18874
AC   CVCL_P482
DR   CLO; CLO_0026246
DR   Coriell; GM18874
DR   GEO; GSM649234
DR   GEO; GSM1719971
DR   IGSR; NA18874
DR   Wikidata; Q54849896
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18875
AC   CVCL_0X18
DR   CLO; CLO_0026241
DR   Coriell; GM18875
DR   GEO; GSM649250
DR   IGSR; NA18875
DR   Wikidata; Q54849897
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18876
AC   CVCL_0X19
DR   Coriell; GM18876
DR   GEO; GSM1719972
DR   IGSR; NA18876
DR   Wikidata; Q54849898
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18877
AC   CVCL_P483
DR   Coriell; GM18877
DR   GEO; GSM1719973
DR   IGSR; NA18877
DR   Wikidata; Q54849899
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18878
AC   CVCL_0X20
DR   Coriell; GM18878
DR   GEO; GSM1719974
DR   IGSR; NA18878
DR   Wikidata; Q54849900
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18879
AC   CVCL_0X21
DR   Coriell; GM18879
DR   GEO; GSM1719975
DR   IGSR; NA18879
DR   Wikidata; Q54849901
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18881
AC   CVCL_P484
DR   Coriell; GM18881
DR   GEO; GSM1719976
DR   IGSR; NA18881
DR   Wikidata; Q54849902
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18886
AC   CVCL_0N31
DR   CLO; CLO_0026242
DR   Coriell; GM18886
DR   Wikidata; Q54849903
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM18886).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser670_Leu671insTer (c.2012delT) (p.Leu671Terfs) (2143delT); ClinVar=VCV000035836; Zygosity=Heterozygous (Coriell=GM18886).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM18906
AC   CVCL_0X22
DR   Coriell; GM18906
DR   IGSR; NA18906
DR   Wikidata; Q54849904
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM18907
AC   CVCL_P485
DR   CLO; CLO_0026238
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18907
DR   GEO; GSM649142
DR   GEO; GSM1719977
DR   IGSR; NA18907
DR   PRIDE; PXD001406
DR   Wikidata; Q54849905
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM18908
AC   CVCL_P486
DR   CLO; CLO_0026236
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18908
DR   GEO; GSM649195
DR   GEO; GSM1719978
DR   IGSR; NA18908
DR   Wikidata; Q54849906
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18909
AC   CVCL_P487
DR   CLO; CLO_0026235
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18909
DR   GEO; GSM485370
DR   GEO; GSM485384
DR   GEO; GSM649214
DR   GEO; GSM1719979
DR   IGSR; NA18909
DR   PRIDE; PXD001406
DR   Wikidata; Q54849907
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18910
AC   CVCL_P488
DR   CLO; CLO_0026233
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18910
DR   GEO; GSM649200
DR   GEO; GSM1719980
DR   IGSR; NA18910
DR   Wikidata; Q54849908
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18911
AC   CVCL_0X23
DR   CLO; CLO_0026271
DR   Coriell; GM18911
DR   GEO; GSM649262
DR   IGSR; NA18911
DR   Wikidata; Q54849909
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18912
AC   CVCL_P489
DR   CLO; CLO_0026270
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18912
DR   GEO; GSM112646
DR   GEO; GSM113027
DR   GEO; GSM188707
DR   GEO; GSM273475
DR   GEO; GSM291810
DR   GEO; GSM315162
DR   GEO; GSM485405
DR   GEO; GSM485493
DR   GEO; GSM485502
DR   GEO; GSM485520
DR   GEO; GSM1719981
DR   IGSR; NA18912
DR   PRIDE; PXD001406
DR   Wikidata; Q54849910
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM18913
AC   CVCL_P490
DR   CLO; CLO_0026269
DR   Coriell; GM18913
DR   GEO; GSM112647
DR   GEO; GSM113028
DR   GEO; GSM188708
DR   GEO; GSM273476
DR   GEO; GSM291811
DR   GEO; GSM315163
DR   GEO; GSM485397
DR   GEO; GSM485445
DR   IGSR; NA18913
DR   PRIDE; PXD001406
DR   Wikidata; Q54849911
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18914
AC   CVCL_0X24
DR   CLO; CLO_0026275
DR   Coriell; GM18914
DR   GEO; GSM112648
DR   GEO; GSM113029
DR   GEO; GSM188709
DR   GEO; GSM291812
DR   IGSR; NA18914
DR   Wikidata; Q54849912
RX   PubMed=17122850;
RX   PubMed=19043577;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM18915
AC   CVCL_P491
DR   Coriell; GM18915
DR   GEO; GSM1719982
DR   IGSR; NA18915
DR   Wikidata; Q54849913
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18916
AC   CVCL_P492
DR   CLO; CLO_0026274
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18916
DR   GEO; GSM485394
DR   GEO; GSM485442
DR   GEO; GSM649141
DR   GEO; GSM1719983
DR   IGSR; NA18916
DR   PRIDE; PXD001406
DR   Wikidata; Q54849914
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18917
AC   CVCL_P493
DR   CLO; CLO_0026273
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18917
DR   GEO; GSM649143
DR   GEO; GSM1719984
DR   IGSR; NA18917
DR   Wikidata; Q54849916
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18921
AC   CVCL_0X25
DR   Coriell; GM18921
DR   Wikidata; Q54849917
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18923
AC   CVCL_P494
DR   CLO; CLO_0026272
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18923
DR   GEO; GSM649215
DR   GEO; GSM1719985
DR   IGSR; NA18923
DR   Wikidata; Q54849918
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18924
AC   CVCL_P495
DR   CLO; CLO_0026277
DR   Coriell; GM18924
DR   GEO; GSM649201
DR   GEO; GSM1719986
DR   IGSR; NA18924
DR   Wikidata; Q54849919
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18925
AC   CVCL_0X26
DR   CLO; CLO_0026278
DR   Coriell; GM18925
DR   GEO; GSM649283
DR   IGSR; NA18925
DR   Wikidata; Q54849920
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18929
AC   CVCL_0P74
DR   CLO; CLO_0026276
DR   Coriell; GM18929
DR   Wikidata; Q54849921
RX   PubMed=19815695;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Ter (c.693C>A); ClinVar=VCV000002609; Zygosity=Heterozygous (PubMed=19815695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM18930
AC   CVCL_0X27
DR   CLO; CLO_0026260
DR   Coriell; GM18930
DR   GEO; GSM649280
DR   IGSR; NA18930
DR   Wikidata; Q54849922
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18931
AC   CVCL_0X28
DR   Coriell; GM18931
DR   Wikidata; Q54849923
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18932
AC   CVCL_0X29
DR   Coriell; GM18932
DR   Wikidata; Q54849924
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM18933
AC   CVCL_P496
DR   CLO; CLO_0026259
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18933
DR   GEO; GSM649236
DR   GEO; GSM1719987
DR   IGSR; NA18933
DR   Wikidata; Q54849926
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18934
AC   CVCL_P497
DR   CLO; CLO_0026262
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM18934
DR   GEO; GSM649167
DR   GEO; GSM1719988
DR   IGSR; NA18934
DR   Wikidata; Q54849927
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18935
AC   CVCL_0X30
DR   CLO; CLO_0026261
DR   Coriell; GM18935
DR   GEO; GSM649248
DR   IGSR; NA18935
DR   Wikidata; Q54849928
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM18939
AC   CVCL_P024
DR   CLO; CLO_0026264
DR   Coriell; GM18939
DR   GEO; GSM649924
DR   GEO; GSM1719989
DR   IGSR; NA18939
DR   Wikidata; Q54849929
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18940
AC   CVCL_P025
DR   CLO; CLO_0026263
DR   Coriell; GM18940
DR   GEO; GSM112649
DR   GEO; GSM113030
DR   GEO; GSM291813
DR   GEO; GSM315101
DR   GEO; GSM649047
DR   GEO; GSM649925
DR   GEO; GSM1719990
DR   IGSR; NA18940
DR   Wikidata; Q54849931
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18941
AC   CVCL_P026
DR   CLO; CLO_0026266
DR   Coriell; GM18941
DR   GEO; GSM649926
DR   GEO; GSM1719991
DR   IGSR; NA18941
DR   Wikidata; Q54849932
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18942
AC   CVCL_P027
DR   CLO; CLO_0026265
DR   Coriell; GM18942
DR   GEO; GSM112650
DR   GEO; GSM113031
DR   GEO; GSM291814
DR   GEO; GSM291815
DR   GEO; GSM315102
DR   GEO; GSM649048
DR   GEO; GSM649927
DR   GEO; GSM1719992
DR   IGSR; NA18942
DR   Wikidata; Q54849933
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18943
AC   CVCL_P028
DR   CLO; CLO_0026267
DR   Coriell; GM18943
DR   GEO; GSM112651
DR   GEO; GSM113032
DR   GEO; GSM291816
DR   GEO; GSM291817
DR   GEO; GSM315103
DR   GEO; GSM649928
DR   GEO; GSM1719993
DR   IGSR; NA18943
DR   Wikidata; Q54849934
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18944
AC   CVCL_P029
DR   CLO; CLO_0026268
DR   Coriell; GM18944
DR   GEO; GSM112652
DR   GEO; GSM113033
DR   GEO; GSM291818
DR   GEO; GSM315104
DR   GEO; GSM649929
DR   GEO; GSM1719994
DR   IGSR; NA18944
DR   Wikidata; Q54849935
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18945
AC   CVCL_P030
DR   CLO; CLO_0026299
DR   Coriell; GM18945
DR   GEO; GSM112653
DR   GEO; GSM113034
DR   GEO; GSM291819
DR   GEO; GSM291820
DR   GEO; GSM315105
DR   GEO; GSM649051
DR   GEO; GSM1719995
DR   IGSR; NA18945
DR   Wikidata; Q54849936
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18946
AC   CVCL_P031
DR   CLO; CLO_0026307
DR   Coriell; GM18946
DR   GEO; GSM649930
DR   GEO; GSM1719996
DR   IGSR; NA18946
DR   Wikidata; Q54849955
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18947
AC   CVCL_P032
DR   CLO; CLO_0026306
DR   Coriell; GM18947
DR   GEO; GSM112654
DR   GEO; GSM113035
DR   GEO; GSM291821
DR   GEO; GSM315106
DR   GEO; GSM649307
DR   GEO; GSM649931
DR   GEO; GSM1719997
DR   IGSR; NA18947
DR   Wikidata; Q54849956
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18948
AC   CVCL_P033
DR   CLO; CLO_0026305
DR   Coriell; GM18948
DR   GEO; GSM112655
DR   GEO; GSM113036
DR   GEO; GSM291822
DR   GEO; GSM291823
DR   GEO; GSM315107
DR   GEO; GSM649308
DR   GEO; GSM1719998
DR   IGSR; NA18948
DR   Wikidata; Q54849957
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18949
AC   CVCL_P034
DR   CLO; CLO_0026304
DR   Coriell; GM18949
DR   GEO; GSM112656
DR   GEO; GSM113037
DR   GEO; GSM291824
DR   GEO; GSM291825
DR   GEO; GSM315108
DR   GEO; GSM649052
DR   GEO; GSM1719999
DR   IGSR; NA18949
DR   Wikidata; Q54849958
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18950
AC   CVCL_P035
DR   Coriell; GM18950
DR   GEO; GSM649932
DR   GEO; GSM1720000
DR   IGSR; NA18950
DR   Wikidata; Q54849959
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18951
AC   CVCL_N804
DR   CLO; CLO_0026303
DR   EFO; EFO_0005349
DR   Coriell; GM18951
DR   ENCODE; ENCBS503ENC
DR   ENCODE; ENCBS504ENC
DR   GEO; GSM112657
DR   GEO; GSM113038
DR   GEO; GSM291826
DR   GEO; GSM416947
DR   GEO; GSM1720001
DR   IGSR; NA18951
DR   Wikidata; Q54849960
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=23676674;
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM18952
AC   CVCL_P037
DR   CLO; CLO_0026302
DR   Coriell; GM18952
DR   GEO; GSM112658
DR   GEO; GSM113039
DR   GEO; GSM291827
DR   GEO; GSM315109
DR   GEO; GSM649054
DR   GEO; GSM1720002
DR   IGSR; NA18952
DR   Wikidata; Q54849962
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18953
AC   CVCL_P038
DR   CLO; CLO_0026301
DR   Coriell; GM18953
DR   GEO; GSM112659
DR   GEO; GSM113040
DR   GEO; GSM291828
DR   GEO; GSM315110
DR   GEO; GSM649050
DR   GEO; GSM1720003
DR   IGSR; NA18953
DR   Wikidata; Q54849963
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18954
AC   CVCL_P039
DR   CLO; CLO_0026300
DR   Coriell; GM18954
DR   GEO; GSM649933
DR   GEO; GSM1720004
DR   IGSR; NA18954
DR   Wikidata; Q54849964
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18955
AC   CVCL_P040
DR   CLO; CLO_0026308
DR   Coriell; GM18955
DR   GEO; GSM649934
DR   IGSR; NA18955
DR   Wikidata; Q54849965
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18956
AC   CVCL_P041
DR   CLO; CLO_0026132
DR   Coriell; GM18956
DR   GEO; GSM112660
DR   GEO; GSM113041
DR   GEO; GSM291829
DR   GEO; GSM315111
DR   GEO; GSM649056
DR   GEO; GSM1720005
DR   IGSR; NA18956
DR   Wikidata; Q54849966
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18957
AC   CVCL_P042
DR   CLO; CLO_0026134
DR   Coriell; GM18957
DR   GEO; GSM1720006
DR   IGSR; NA18957
DR   Wikidata; Q54849967
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18959
AC   CVCL_P043
DR   CLO; CLO_0026133
DR   Coriell; GM18959
DR   GEO; GSM112662
DR   GEO; GSM113042
DR   GEO; GSM291830
DR   GEO; GSM315112
DR   GEO; GSM649020
DR   GEO; GSM1720007
DR   IGSR; NA18959
DR   Wikidata; Q54849968
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18960
AC   CVCL_P044
DR   CLO; CLO_0026136
DR   Coriell; GM18960
DR   GEO; GSM112663
DR   GEO; GSM113043
DR   GEO; GSM291831
DR   GEO; GSM315113
DR   GEO; GSM649022
DR   GEO; GSM1720008
DR   IGSR; NA18960
DR   Wikidata; Q54849969
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18961
AC   CVCL_P045
DR   CLO; CLO_0026135
DR   Coriell; GM18961
DR   GEO; GSM112671
DR   GEO; GSM113044
DR   GEO; GSM291832
DR   GEO; GSM315114
DR   GEO; GSM649018
DR   GEO; GSM1720009
DR   IGSR; NA18961
DR   Wikidata; Q54849970
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18962
AC   CVCL_P046
DR   CLO; CLO_0026138
DR   Coriell; GM18962
DR   GEO; GSM649935
DR   GEO; GSM1720010
DR   IGSR; NA18962
DR   Wikidata; Q54849973
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18963
AC   CVCL_P047
DR   CLO; CLO_0026137
DR   Coriell; GM18963
DR   GEO; GSM649936
DR   GEO; GSM1720011
DR   IGSR; NA18963
DR   Wikidata; Q54849974
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18964
AC   CVCL_P048
DR   CLO; CLO_0026130
DR   Coriell; GM18964
DR   GEO; GSM112672
DR   GEO; GSM113045
DR   GEO; GSM291833
DR   GEO; GSM315115
DR   GEO; GSM649049
DR   GEO; GSM1720012
DR   IGSR; NA18964
DR   Wikidata; Q54849975
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18965
AC   CVCL_P049
DR   CLO; CLO_0026129
DR   Coriell; GM18965
DR   GEO; GSM112673
DR   GEO; GSM113046
DR   GEO; GSM291834
DR   GEO; GSM315116
DR   GEO; GSM649055
DR   GEO; GSM1720013
DR   IGSR; NA18965
DR   Wikidata; Q54849976
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18966
AC   CVCL_P050
DR   CLO; CLO_0026131
DR   Coriell; GM18966
DR   GEO; GSM112674
DR   GEO; GSM113047
DR   GEO; GSM291835
DR   GEO; GSM315117
DR   GEO; GSM649024
DR   GEO; GSM1720014
DR   IGSR; NA18966
DR   Wikidata; Q54849977
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18967
AC   CVCL_P051
DR   CLO; CLO_0025751
DR   Coriell; GM18967
DR   GEO; GSM112675
DR   GEO; GSM113048
DR   GEO; GSM291836
DR   GEO; GSM315118
DR   GEO; GSM649026
DR   GEO; GSM1720015
DR   IGSR; NA18967
DR   Wikidata; Q54849978
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18968
AC   CVCL_P052
DR   CLO; CLO_0025752
DR   Coriell; GM18968
DR   GEO; GSM112676
DR   GEO; GSM113049
DR   GEO; GSM291837
DR   GEO; GSM315119
DR   GEO; GSM649019
DR   GEO; GSM1720016
DR   IGSR; NA18968
DR   Wikidata; Q54849979
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18969
AC   CVCL_P053
DR   CLO; CLO_0025753
DR   Coriell; GM18969
DR   GEO; GSM112677
DR   GEO; GSM113050
DR   GEO; GSM291838
DR   GEO; GSM315120
DR   GEO; GSM649021
DR   GEO; GSM1720017
DR   IGSR; NA18969
DR   Wikidata; Q54849980
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18970
AC   CVCL_P054
DR   CLO; CLO_0025754
DR   Coriell; GM18970
DR   GEO; GSM112678
DR   GEO; GSM113051
DR   GEO; GSM315121
DR   GEO; GSM649028
DR   GEO; GSM1720018
DR   IGSR; NA18970
DR   Wikidata; Q54849981
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18971
AC   CVCL_P055
DR   CLO; CLO_0025755
DR   Coriell; GM18971
DR   GEO; GSM112679
DR   GEO; GSM113052
DR   GEO; GSM291839
DR   GEO; GSM315122
DR   GEO; GSM649032
DR   GEO; GSM1720019
DR   IGSR; NA18971
DR   Wikidata; Q54849983
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18972
AC   CVCL_P056
DR   CLO; CLO_0025756
DR   Coriell; GM18972
DR   GEO; GSM112680
DR   GEO; GSM113053
DR   GEO; GSM291840
DR   GEO; GSM315123
DR   GEO; GSM649040
DR   GEO; GSM1720020
DR   IGSR; NA18972
DR   Wikidata; Q54849984
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18973
AC   CVCL_P057
DR   CLO; CLO_0025757
DR   Coriell; GM18973
DR   GEO; GSM112681
DR   GEO; GSM113054
DR   GEO; GSM291841
DR   GEO; GSM315124
DR   GEO; GSM649023
DR   GEO; GSM1720021
DR   IGSR; NA18973
DR   Wikidata; Q54849985
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18974
AC   CVCL_P058
DR   CLO; CLO_0025758
DR   Coriell; GM18974
DR   GEO; GSM112682
DR   GEO; GSM113055
DR   GEO; GSM291842
DR   GEO; GSM315125
DR   GEO; GSM649033
DR   GEO; GSM1720022
DR   IGSR; NA18974
DR   Wikidata; Q54849986
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18975
AC   CVCL_P059
DR   CLO; CLO_0025749
DR   Coriell; GM18975
DR   GEO; GSM112683
DR   GEO; GSM113056
DR   GEO; GSM291843
DR   GEO; GSM315126
DR   GEO; GSM649025
DR   GEO; GSM1720023
DR   IGSR; NA18975
DR   Wikidata; Q54849987
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18976
AC   CVCL_P060
DR   CLO; CLO_0025750
DR   Coriell; GM18976
DR   GEO; GSM112684
DR   GEO; GSM113057
DR   GEO; GSM291844
DR   GEO; GSM315127
DR   GEO; GSM1720024
DR   IGSR; NA18976
DR   Wikidata; Q54849988
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18977
AC   CVCL_P061
DR   CLO; CLO_0025746
DR   Coriell; GM18977
DR   GEO; GSM649937
DR   GEO; GSM1720025
DR   IGSR; NA18977
DR   Wikidata; Q54849990
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18978
AC   CVCL_P062
DR   CLO; CLO_0025735
DR   Coriell; GM18978
DR   GEO; GSM112685
DR   GEO; GSM113058
DR   GEO; GSM291845
DR   GEO; GSM315128
DR   GEO; GSM649027
DR   GEO; GSM1720026
DR   IGSR; NA18978
DR   Wikidata; Q54849991
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18979
AC   CVCL_P063
DR   CLO; CLO_0025736
DR   Coriell; GM18979
DR   GEO; GSM649938
DR   GEO; GSM1720027
DR   IGSR; NA18979
DR   Wikidata; Q54849992
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18980
AC   CVCL_P064
DR   CLO; CLO_0025731
DR   Coriell; GM18980
DR   GEO; GSM112686
DR   GEO; GSM113059
DR   GEO; GSM291846
DR   GEO; GSM315129
DR   GEO; GSM649029
DR   GEO; GSM1720028
DR   IGSR; NA18980
DR   Wikidata; Q54849995
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18981
AC   CVCL_P065
DR   CLO; CLO_0025733
DR   Coriell; GM18981
DR   GEO; GSM112687
DR   GEO; GSM113060
DR   GEO; GSM291847
DR   GEO; GSM315130
DR   GEO; GSM649031
DR   GEO; GSM1720029
DR   IGSR; NA18981
DR   Wikidata; Q54849996
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18982
AC   CVCL_P066
DR   Coriell; GM18982
DR   GEO; GSM649939
DR   GEO; GSM1720030
DR   IGSR; NA18982
DR   Wikidata; Q54849997
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18983
AC   CVCL_P067
DR   Coriell; GM18983
DR   GEO; GSM649940
DR   GEO; GSM1720031
DR   IGSR; NA18983
DR   Wikidata; Q54849999
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18984
AC   CVCL_P068
DR   Coriell; GM18984
DR   GEO; GSM649941
DR   GEO; GSM1720032
DR   IGSR; NA18984
DR   Wikidata; Q54850000
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18985
AC   CVCL_P069
DR   Coriell; GM18985
DR   GEO; GSM649942
DR   GEO; GSM1720033
DR   IGSR; NA18985
DR   Wikidata; Q54850001
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18986
AC   CVCL_P070
DR   Coriell; GM18986
DR   GEO; GSM649943
DR   GEO; GSM1720034
DR   IGSR; NA18986
DR   Wikidata; Q54850003
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18987
AC   CVCL_P071
DR   CLO; CLO_0025743
DR   Coriell; GM18987
DR   GEO; GSM112688
DR   GEO; GSM113061
DR   GEO; GSM291848
DR   GEO; GSM315131
DR   GEO; GSM649034
DR   GEO; GSM1720035
DR   IGSR; NA18987
DR   Wikidata; Q54850022
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18988
AC   CVCL_P072
DR   Coriell; GM18988
DR   GEO; GSM649944
DR   GEO; GSM1720036
DR   IGSR; NA18988
DR   Wikidata; Q54850023
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18989
AC   CVCL_P073
DR   Coriell; GM18989
DR   GEO; GSM649945
DR   GEO; GSM1720037
DR   IGSR; NA18989
DR   Wikidata; Q54850024
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM18990
AC   CVCL_P074
DR   CLO; CLO_0025745
DR   Coriell; GM18990
DR   GEO; GSM112689
DR   GEO; GSM113062
DR   GEO; GSM291849
DR   GEO; GSM291850
DR   GEO; GSM315132
DR   GEO; GSM649035
DR   GEO; GSM1720038
DR   IGSR; NA18990
DR   Wikidata; Q54850025
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18991
AC   CVCL_P075
DR   CLO; CLO_0025738
DR   Coriell; GM18991
DR   GEO; GSM112690
DR   GEO; GSM113063
DR   GEO; GSM291851
DR   GEO; GSM315133
DR   GEO; GSM649036
DR   GEO; GSM1720039
DR   IGSR; NA18991
DR   Wikidata; Q54850026
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18992
AC   CVCL_P076
DR   CLO; CLO_0025740
DR   Coriell; GM18992
DR   GEO; GSM112691
DR   GEO; GSM113064
DR   GEO; GSM291852
DR   GEO; GSM315134
DR   GEO; GSM649038
DR   GEO; GSM1720040
DR   IGSR; NA18992
DR   Wikidata; Q54850027
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18993
AC   CVCL_P077
DR   CLO; CLO_0025729
DR   Coriell; GM18993
DR   GEO; GSM649946
DR   GEO; GSM1720041
DR   IGSR; NA18993
DR   Wikidata; Q54850028
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM18994
AC   CVCL_P078
DR   CLO; CLO_0025727
DR   Coriell; GM18994
DR   GEO; GSM112692
DR   GEO; GSM113065
DR   GEO; GSM291853
DR   GEO; GSM315135
DR   GEO; GSM649037
DR   GEO; GSM1720042
DR   IGSR; NA18994
DR   Wikidata; Q54850029
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18995
AC   CVCL_P079
DR   CLO; CLO_0025726
DR   Coriell; GM18995
DR   GEO; GSM112693
DR   GEO; GSM113066
DR   GEO; GSM291854
DR   GEO; GSM315136
DR   GEO; GSM649030
DR   GEO; GSM1720043
DR   IGSR; NA18995
DR   Wikidata; Q54850030
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18997
AC   CVCL_P080
DR   CLO; CLO_0025718
DR   Coriell; GM18997
DR   GEO; GSM112694
DR   GEO; GSM113067
DR   GEO; GSM291855
DR   GEO; GSM416948
DR   GEO; GSM649039
DR   GEO; GSM1720044
DR   IGSR; NA18997
DR   Wikidata; Q54850033
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18998
AC   CVCL_P081
DR   CLO; CLO_0025720
DR   Coriell; GM18998
DR   GEO; GSM112695
DR   GEO; GSM113068
DR   GEO; GSM291856
DR   GEO; GSM416949
DR   GEO; GSM649041
DR   GEO; GSM1720045
DR   IGSR; NA18998
DR   Wikidata; Q54850034
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM18999
AC   CVCL_P082
DR   CLO; CLO_0025723
DR   Coriell; GM18999
DR   GEO; GSM112696
DR   GEO; GSM113069
DR   GEO; GSM291857
DR   GEO; GSM315137
DR   GEO; GSM649044
DR   GEO; GSM1720046
DR   IGSR; NA18999
DR   Wikidata; Q54850035
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=24057213;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Virology: Contains a chromosomally integrated human herpesvirus 6A (CI-HHV-6A).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19000
AC   CVCL_P083
DR   CLO; CLO_0025724
DR   Coriell; GM19000
DR   GEO; GSM112697
DR   GEO; GSM113070
DR   GEO; GSM291858
DR   GEO; GSM315138
DR   GEO; GSM649042
DR   GEO; GSM1720047
DR   IGSR; NA19000
DR   Wikidata; Q54850036
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19001
AC   CVCL_P084
DR   CLO; CLO_0025711
DR   Coriell; GM19001
DR   GEO; GSM649947
DR   GEO; GSM1720048
DR   IGSR; NA19001
DR   Wikidata; Q54850037
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19002
AC   CVCL_P085
DR   CLO; CLO_0025713
DR   Coriell; GM19002
DR   GEO; GSM649948
DR   GEO; GSM1720049
DR   IGSR; NA19002
DR   Wikidata; Q54850038
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19003
AC   CVCL_P086
DR   CLO; CLO_0025714
DR   Coriell; GM19003
DR   GEO; GSM112698
DR   GEO; GSM113071
DR   GEO; GSM291859
DR   GEO; GSM291860
DR   GEO; GSM315139
DR   GEO; GSM649046
DR   GEO; GSM1720050
DR   IGSR; NA19003
DR   Wikidata; Q54850039
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19004
AC   CVCL_P087
DR   Coriell; GM19004
DR   GEO; GSM649949
DR   GEO; GSM1720051
DR   IGSR; NA19004
DR   Wikidata; Q54850040
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19005
AC   CVCL_P088
DR   CLO; CLO_0025716
DR   Coriell; GM19005
DR   GEO; GSM112699
DR   GEO; GSM113072
DR   GEO; GSM291861
DR   GEO; GSM315140
DR   GEO; GSM649043
DR   GEO; GSM1720052
DR   IGSR; NA19005
DR   Wikidata; Q54850042
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19006
AC   CVCL_P089
DR   Coriell; GM19006
DR   GEO; GSM1720053
DR   IGSR; NA19006
DR   Wikidata; Q54850043
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19007
AC   CVCL_P090
DR   CLO; CLO_0025708
DR   Coriell; GM19007
DR   GEO; GSM112700
DR   GEO; GSM113073
DR   GEO; GSM291862
DR   GEO; GSM315141
DR   GEO; GSM649045
DR   GEO; GSM1720054
DR   IGSR; NA19007
DR   Wikidata; Q54850044
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19009
AC   CVCL_P091
DR   CLO; CLO_0025707
DR   Coriell; GM19009
DR   GEO; GSM649950
DR   GEO; GSM1720055
DR   IGSR; NA19009
DR   Wikidata; Q54850045
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19010
AC   CVCL_P092
DR   CLO; CLO_0025706
DR   Coriell; GM19010
DR   GEO; GSM649053
DR   GEO; GSM1720056
DR   IGSR; NA19010
DR   Wikidata; Q54850047
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19011
AC   CVCL_P093
DR   Coriell; GM19011
DR   GEO; GSM1720057
DR   IGSR; NA19011
DR   Wikidata; Q54850048
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19012
AC   CVCL_P094
DR   CLO; CLO_0025702
DR   Coriell; GM19012
DR   GEO; GSM112701
DR   GEO; GSM113074
DR   GEO; GSM291863
DR   GEO; GSM1720058
DR   IGSR; NA19012
DR   Wikidata; Q54850049
RX   PubMed=17122850;
RX   PubMed=19043577;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19014
AC   CVCL_IV98
DR   CLO; CLO_0025704
DR   Coriell; GM19014
DR   Wikidata; Q54850050
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131851; Hyperphosphatemic familial tumoral calcinosis
DI   ORDO; Orphanet_306661; Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   GM19015
AC   CVCL_IV99
DR   CLO; CLO_0025698
DR   Coriell; GM19015
DR   Wikidata; Q54850051
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131851; Hyperphosphatemic familial tumoral calcinosis
DI   ORDO; Orphanet_306661; Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   GM19016
AC   CVCL_IW00
DR   CLO; CLO_0025701
DR   Coriell; GM19016
DR   Wikidata; Q54850053
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131851; Hyperphosphatemic familial tumoral calcinosis
DI   ORDO; Orphanet_306661; Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   GM19017
AC   CVCL_P261
DR   Coriell; GM19017
DR   GEO; GSM1720059
DR   IGSR; NA19017
DR   Wikidata; Q54850054
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19019
AC   CVCL_P262
DR   Coriell; GM19019
DR   GEO; GSM1720060
DR   IGSR; NA19019
DR   Wikidata; Q54850055
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19020
AC   CVCL_P263
DR   CLO; CLO_0025694
DR   Coriell; GM19020
DR   GEO; GSM649952
DR   GEO; GSM1720061
DR   IGSR; NA19020
DR   Wikidata; Q54850056
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19022
AC   CVCL_P264
DR   Coriell; GM19022
DR   Wikidata; Q54850057
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19023
AC   CVCL_P265
DR   EFO; EFO_0010835
DR   Coriell; GM19023
DR   GEO; GSM1720062
DR   IGSR; NA19023
DR   Wikidata; Q54850058
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19024
AC   CVCL_P266
DR   Coriell; GM19024
DR   GEO; GSM1720063
DR   IGSR; NA19024
DR   Wikidata; Q54850059
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19025
AC   CVCL_P267
DR   EFO; EFO_0010836
DR   Coriell; GM19025
DR   GEO; GSM1720064
DR   IGSR; NA19025
DR   Wikidata; Q54850060
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19026
AC   CVCL_P268
DR   Coriell; GM19026
DR   GEO; GSM1720065
DR   IGSR; NA19026
DR   Wikidata; Q54850061
RX   PubMed=35931342;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19027
AC   CVCL_P269
DR   CLO; CLO_0025697
DR   Coriell; GM19027
DR   GEO; GSM649953
DR   GEO; GSM1720066
DR   IGSR; NA19027
DR   Wikidata; Q54850062
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19028
AC   CVCL_P270
DR   CLO; CLO_0025692
DR   Coriell; GM19028
DR   GEO; GSM649954
DR   GEO; GSM1720067
DR   IGSR; NA19028
DR   Wikidata; Q54850064
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19030
AC   CVCL_P271
DR   Coriell; GM19030
DR   GEO; GSM1720068
DR   IGSR; NA19030
DR   Wikidata; Q54850065
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19031
AC   CVCL_P272
DR   CLO; CLO_0025815
DR   Coriell; GM19031
DR   GEO; GSM649955
DR   GEO; GSM1720069
DR   IGSR; NA19031
DR   Wikidata; Q54850066
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19035
AC   CVCL_P273
DR   CLO; CLO_0025816
DR   Coriell; GM19035
DR   GEO; GSM649956
DR   GEO; GSM1720070
DR   IGSR; NA19035
DR   Wikidata; Q54850067
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19036
AC   CVCL_P274
DR   CLO; CLO_0025817
DR   Coriell; GM19036
DR   GEO; GSM649957
DR   GEO; GSM1720071
DR   IGSR; NA19036
DR   Wikidata; Q54850088
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19037
AC   CVCL_P275
DR   Coriell; GM19037
DR   GEO; GSM1720072
DR   IGSR; NA19037
DR   Wikidata; Q54850089
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19038
AC   CVCL_P276
DR   CLO; CLO_0025818
DR   Coriell; GM19038
DR   GEO; GSM649958
DR   GEO; GSM1720073
DR   IGSR; NA19038
DR   Wikidata; Q54850090
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19039
AC   CVCL_P277
DR   Coriell; GM19039
DR   Wikidata; Q54850091
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19041
AC   CVCL_P278
DR   CLO; CLO_0025810
DR   Coriell; GM19041
DR   GEO; GSM649959
DR   GEO; GSM1720074
DR   IGSR; NA19041
DR   Wikidata; Q54850092
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19042
AC   CVCL_0X31
DR   Coriell; GM19042
DR   GEO; GSM1720075
DR   IGSR; NA19042
DR   Wikidata; Q54850093
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19043
AC   CVCL_P279
DR   EFO; EFO_0010837
DR   Coriell; GM19043
DR   GEO; GSM1720076
DR   IGSR; NA19043
DR   Wikidata; Q54850094
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19044
AC   CVCL_P280
DR   CLO; CLO_0025809
DR   Coriell; GM19044
DR   GEO; GSM649960
DR   IGSR; NA19044
DR   Wikidata; Q54850095
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19045
AC   CVCL_P281
DR   Coriell; GM19045
DR   Wikidata; Q54850096
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19046
AC   CVCL_P282
DR   CLO; CLO_0025812
DR   Coriell; GM19046
DR   GEO; GSM649961
DR   IGSR; NA19046
DR   Wikidata; Q54850097
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19054
AC   CVCL_P095
DR   CLO; CLO_0025811
DR   Coriell; GM19054
DR   GEO; GSM649962
DR   GEO; GSM1720077
DR   IGSR; NA19054
DR   Wikidata; Q54850099
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19055
AC   CVCL_P096
DR   CLO; CLO_0025814
DR   Coriell; GM19055
DR   GEO; GSM649963
DR   GEO; GSM1720078
DR   IGSR; NA19055
DR   Wikidata; Q54850100
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19056
AC   CVCL_P097
DR   CLO; CLO_0025813
DR   Coriell; GM19056
DR   GEO; GSM649964
DR   GEO; GSM1720079
DR   IGSR; NA19056
DR   Wikidata; Q54850101
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19057
AC   CVCL_P098
DR   CLO; CLO_0025804
DR   Coriell; GM19057
DR   GEO; GSM1720080
DR   IGSR; NA19057
DR   Wikidata; Q54850102
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19058
AC   CVCL_P099
DR   CLO; CLO_0025807
DR   Coriell; GM19058
DR   GEO; GSM649965
DR   GEO; GSM1720081
DR   IGSR; NA19058
DR   Wikidata; Q54850103
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19059
AC   CVCL_P100
DR   CLO; CLO_0025808
DR   Coriell; GM19059
DR   GEO; GSM649966
DR   GEO; GSM1720082
DR   IGSR; NA19059
DR   Wikidata; Q54850104
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19060
AC   CVCL_P101
DR   CLO; CLO_0025805
DR   Coriell; GM19060
DR   GEO; GSM649967
DR   GEO; GSM1720083
DR   IGSR; NA19060
DR   Wikidata; Q54850105
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19062
AC   CVCL_P102
DR   CLO; CLO_0025806
DR   Coriell; GM19062
DR   GEO; GSM649968
DR   GEO; GSM1720084
DR   IGSR; NA19062
DR   Wikidata; Q54850106
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19063
AC   CVCL_P103
DR   CLO; CLO_0025802
DR   Coriell; GM19063
DR   GEO; GSM649969
DR   GEO; GSM1720085
DR   IGSR; NA19063
DR   Wikidata; Q54850107
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19064
AC   CVCL_P104
DR   CLO; CLO_0025801
DR   Coriell; GM19064
DR   GEO; GSM649970
DR   GEO; GSM1720086
DR   IGSR; NA19064
DR   Wikidata; Q54850108
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19065
AC   CVCL_P105
DR   CLO; CLO_0025800
DR   Coriell; GM19065
DR   GEO; GSM649971
DR   GEO; GSM1720087
DR   IGSR; NA19065
DR   Wikidata; Q54850109
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19066
AC   CVCL_P106
DR   CLO; CLO_0025799
DR   Coriell; GM19066
DR   GEO; GSM649972
DR   GEO; GSM1720088
DR   IGSR; NA19066
DR   Wikidata; Q54850110
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19067
AC   CVCL_P107
DR   CLO; CLO_0025803
DR   Coriell; GM19067
DR   GEO; GSM649973
DR   GEO; GSM1720089
DR   IGSR; NA19067
DR   Wikidata; Q54850111
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19068
AC   CVCL_P108
DR   CLO; CLO_0025795
DR   Coriell; GM19068
DR   GEO; GSM649974
DR   GEO; GSM1720090
DR   IGSR; NA19068
DR   Wikidata; Q54850112
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19070
AC   CVCL_P109
DR   CLO; CLO_0025798
DR   Coriell; GM19070
DR   GEO; GSM649975
DR   GEO; GSM1720091
DR   IGSR; NA19070
DR   Wikidata; Q54850113
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19072
AC   CVCL_P110
DR   CLO; CLO_0025786
DR   Coriell; GM19072
DR   GEO; GSM649976
DR   GEO; GSM1720092
DR   IGSR; NA19072
DR   Wikidata; Q54850114
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19074
AC   CVCL_P111
DR   CLO; CLO_0025787
DR   Coriell; GM19074
DR   GEO; GSM649977
DR   GEO; GSM1720093
DR   IGSR; NA19074
DR   Wikidata; Q54850116
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19075
AC   CVCL_P112
DR   CLO; CLO_0025790
DR   Coriell; GM19075
DR   GEO; GSM649978
DR   GEO; GSM1720094
DR   IGSR; NA19075
DR   Wikidata; Q54850117
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19076
AC   CVCL_P113
DR   CLO; CLO_0025791
DR   Coriell; GM19076
DR   GEO; GSM649979
DR   GEO; GSM1720095
DR   IGSR; NA19076
DR   Wikidata; Q54850118
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19077
AC   CVCL_P114
DR   CLO; CLO_0025780
DR   Coriell; GM19077
DR   GEO; GSM649980
DR   GEO; GSM1720096
DR   IGSR; NA19077
DR   Wikidata; Q54850119
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19078
AC   CVCL_P115
DR   CLO; CLO_0025779
DR   Coriell; GM19078
DR   GEO; GSM649981
DR   GEO; GSM1720097
DR   IGSR; NA19078
DR   Wikidata; Q54850120
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19079
AC   CVCL_P116
DR   CLO; CLO_0025782
DR   BioSample; SAMN03471031
DR   Coriell; GM19079
DR   GEO; GSM649982
DR   GEO; GSM1720098
DR   IGSR; NA19079
DR   Wikidata; Q54850121
RX   PubMed=21397061;
RX   PubMed=25877200;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 30,31
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9.1,11
ST   D8S1179: 14,15
ST   FGA: 18,22
ST   Penta D: 9,13
ST   Penta E: 15,16
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19080
AC   CVCL_P117
DR   CLO; CLO_0025781
DR   Coriell; GM19080
DR   GEO; GSM649983
DR   GEO; GSM1720099
DR   IGSR; NA19080
DR   Wikidata; Q54850122
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19081
AC   CVCL_P118
DR   CLO; CLO_0025778
DR   Coriell; GM19081
DR   GEO; GSM649984
DR   GEO; GSM1720100
DR   IGSR; NA19081
DR   Wikidata; Q54850123
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19082
AC   CVCL_P119
DR   CLO; CLO_0025772
DR   BioSample; SAMN03470972
DR   Coriell; GM19082
DR   GEO; GSM649985
DR   GEO; GSM1720101
DR   IGSR; NA19082
DR   Wikidata; Q54850124
RX   PubMed=21397061;
RX   PubMed=25877200;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D19S433: 13,14.2
ST   D21S11: 32.2,33.2
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 10,12
ST   Penta E: 12,17
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19083
AC   CVCL_P120
DR   CLO; CLO_0025774
DR   Coriell; GM19083
DR   GEO; GSM649986
DR   GEO; GSM1720102
DR   IGSR; NA19083
DR   Wikidata; Q54850125
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19084
AC   CVCL_P121
DR   CLO; CLO_0025769
DR   Coriell; GM19084
DR   GEO; GSM649987
DR   GEO; GSM1720103
DR   IGSR; NA19084
DR   Wikidata; Q54850126
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19085
AC   CVCL_P122
DR   CLO; CLO_0025770
DR   BioSample; SAMN03470973
DR   Coriell; GM19085
DR   GEO; GSM649988
DR   GEO; GSM1720104
DR   IGSR; NA19085
DR   Wikidata; Q54850127
RX   PubMed=21397061;
RX   PubMed=25877200;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 13,14
ST   D19S433: 14,15.2
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 20
ST   Penta D: 10,12
ST   Penta E: 5,13
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19086
AC   CVCL_P123
DR   CLO; CLO_0025766
DR   Coriell; GM19086
DR   GEO; GSM649989
DR   GEO; GSM1720105
DR   IGSR; NA19086
DR   Wikidata; Q54850128
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19087
AC   CVCL_P124
DR   CLO; CLO_0025767
DR   Coriell; GM19087
DR   GEO; GSM649990
DR   GEO; GSM1720106
DR   IGSR; NA19087
DR   Wikidata; Q54850129
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19088
AC   CVCL_P125
DR   CLO; CLO_0025761
DR   Coriell; GM19088
DR   GEO; GSM649991
DR   GEO; GSM1720107
DR   IGSR; NA19088
DR   Wikidata; Q54850142
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19089
AC   CVCL_P126
DR   Coriell; GM19089
DR   GEO; GSM1720108
DR   IGSR; NA19089
DR   Wikidata; Q54850144
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19090
AC   CVCL_P127
DR   Coriell; GM19090
DR   GEO; GSM1720109
DR   IGSR; NA19090
DR   Wikidata; Q54850145
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19091
AC   CVCL_P128
DR   Coriell; GM19091
DR   GEO; GSM1720110
DR   IGSR; NA19091
DR   Wikidata; Q54850146
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19092
AC   CVCL_P498
DR   CLO; CLO_0025760
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19092
DR   GEO; GSM112702
DR   GEO; GSM113075
DR   GEO; GSM188711
DR   GEO; GSM273477
DR   GEO; GSM291864
DR   GEO; GSM315164
DR   GEO; GSM649219
DR   GEO; GSM1720111
DR   IGSR; NA19092
DR   PRIDE; PXD001406
DR   Wikidata; Q54850147
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19093
AC   CVCL_P499
DR   CLO; CLO_0025759
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19093
DR   GEO; GSM112703
DR   GEO; GSM113076
DR   GEO; GSM188712
DR   GEO; GSM273478
DR   GEO; GSM291865
DR   GEO; GSM315165
DR   GEO; GSM485418
DR   GEO; GSM485484
DR   GEO; GSM649224
DR   GEO; GSM1720112
DR   IGSR; NA19093
DR   PRIDE; PXD001406
DR   Wikidata; Q54850148
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19094
AC   CVCL_0X32
DR   CLO; CLO_0025872
DR   Coriell; GM19094
DR   GEO; GSM112704
DR   GEO; GSM113077
DR   GEO; GSM188713
DR   GEO; GSM291866
DR   GEO; GSM291867
DR   GEO; GSM291868
DR   GEO; GSM649196
DR   IGSR; NA19094
DR   Wikidata; Q54850149
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19095
AC   CVCL_P500
DR   CLO; CLO_0025871
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19095
DR   GEO; GSM649169
DR   GEO; GSM1720113
DR   IGSR; NA19095
DR   Wikidata; Q54850150
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19096
AC   CVCL_P501
DR   CLO; CLO_0025870
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19096
DR   GEO; GSM649179
DR   GEO; GSM1720114
DR   IGSR; NA19096
DR   Wikidata; Q54850151
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19097
AC   CVCL_0X33
DR   CLO; CLO_0025869
DR   Coriell; GM19097
DR   GEO; GSM649272
DR   IGSR; NA19097
DR   Wikidata; Q54850152
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19098
AC   CVCL_P502
DR   CLO; CLO_0025876
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19098
DR   GEO; GSM112705
DR   GEO; GSM113078
DR   GEO; GSM188714
DR   GEO; GSM273479
DR   GEO; GSM291869
DR   GEO; GSM315166
DR   GEO; GSM485366
DR   GEO; GSM485379
DR   GEO; GSM649152
DR   GEO; GSM1720115
DR   IGSR; NA19098
DR   PRIDE; PXD001406
DR   Wikidata; Q54850153
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19099
AC   CVCL_E125
DR   CLO; CLO_0025875
DR   EFO; EFO_0005350
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19099
DR   ENCODE; ENCBS505ENC
DR   ENCODE; ENCBS506ENC
DR   GEO; GSM112706
DR   GEO; GSM113086
DR   GEO; GSM188715
DR   GEO; GSM273480
DR   GEO; GSM291870
DR   GEO; GSM315167
DR   GEO; GSM485449
DR   GEO; GSM485480
DR   GEO; GSM649232
DR   GEO; GSM651176
DR   GEO; GSM651177
DR   GEO; GSM651178
DR   GEO; GSM651179
DR   GEO; GSM651180
DR   GEO; GSM651181
DR   GEO; GSM1720116
DR   IGSR; NA19099
DR   PRIDE; PXD001406
DR   Wikidata; Q54850154
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=21418647;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   GM19100
AC   CVCL_0X34
DR   CLO; CLO_0025874
DR   Coriell; GM19100
DR   GEO; GSM112707
DR   GEO; GSM113090
DR   GEO; GSM188716
DR   GEO; GSM291871
DR   GEO; GSM649222
DR   IGSR; NA19100
DR   Wikidata; Q54850155
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19101
AC   CVCL_P503
SY   H19101_LCL
DR   CLO; CLO_0025873
DR   Coriell; GM19101
DR   GEO; GSM112708
DR   GEO; GSM113095
DR   GEO; GSM188717
DR   GEO; GSM273481
DR   GEO; GSM291872
DR   GEO; GSM315168
DR   GEO; GSM485447
DR   GEO; GSM485474
DR   GEO; GSM649207
DR   GEO; GSM1495417
DR   GEO; GSM1502719
DR   IGSR; NA19101
DR   PRIDE; PXD001406
DR   Wikidata; Q54850156
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=26102527;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19102
AC   CVCL_P504
DR   CLO; CLO_0025884
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19102
DR   GEO; GSM112709
DR   GEO; GSM113098
DR   GEO; GSM188718
DR   GEO; GSM273482
DR   GEO; GSM291873
DR   GEO; GSM315169
DR   GEO; GSM485406
DR   GEO; GSM485521
DR   GEO; GSM649208
DR   GEO; GSM1720117
DR   IGSR; NA19102
DR   PRIDE; PXD001406
DR   Wikidata; Q54850157
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19103
AC   CVCL_0X35
DR   CLO; CLO_0025885
DR   Coriell; GM19103
DR   GEO; GSM112710
DR   GEO; GSM113099
DR   GEO; GSM188719
DR   GEO; GSM291874
DR   GEO; GSM649223
DR   IGSR; NA19103
DR   Wikidata; Q54850158
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19104
AC   CVCL_0X36
DR   Coriell; GM19104
DR   IGSR; NA19104
DR   Wikidata; Q54850160
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19105
AC   CVCL_P505
DR   Coriell; GM19105
DR   IGSR; NA19105
DR   Wikidata; Q54850161
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19107
AC   CVCL_P506
DR   CLO; CLO_0025683
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19107
DR   GEO; GSM649188
DR   GEO; GSM1720118
DR   IGSR; NA19107
DR   Wikidata; Q54850162
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19108
AC   CVCL_P507
DR   CLO; CLO_0025682
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19108
DR   GEO; GSM485373
DR   GEO; GSM485436
DR   GEO; GSM649164
DR   GEO; GSM1720119
DR   IGSR; NA19108
DR   PRIDE; PXD001406
DR   Wikidata; Q54850163
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19109
AC   CVCL_0X37
DR   CLO; CLO_0025679
DR   Coriell; GM19109
DR   GEO; GSM649278
DR   IGSR; NA19109
DR   Wikidata; Q54850164
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19110
AC   CVCL_0X38
DR   Coriell; GM19110
DR   Wikidata; Q54850165
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19113
AC   CVCL_P508
DR   CLO; CLO_0025678
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19113
DR   GEO; GSM649162
DR   GEO; GSM1720120
DR   IGSR; NA19113
DR   Wikidata; Q54850166
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19114
AC   CVCL_P509
SY   H19114_LCL
DR   CLO; CLO_0025681
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19114
DR   GEO; GSM485427
DR   GEO; GSM485465
DR   GEO; GSM649309
DR   GEO; GSM1495418
DR   GEO; GSM1502720
DR   GEO; GSM1720121
DR   IGSR; NA19114
DR   PRIDE; PXD001406
DR   Wikidata; Q54850167
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26102527;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19115
AC   CVCL_0X39
DR   CLO; CLO_0025680
DR   Coriell; GM19115
DR   GEO; GSM649238
DR   IGSR; NA19115
DR   Wikidata; Q54850168
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19116
AC   CVCL_P510
DR   CLO; CLO_0025686
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19116
DR   GEO; GSM112711
DR   GEO; GSM113100
DR   GEO; GSM188720
DR   GEO; GSM273483
DR   GEO; GSM291875
DR   GEO; GSM315170
DR   GEO; GSM485448
DR   GEO; GSM485487
DR   GEO; GSM649186
DR   GEO; GSM1720122
DR   IGSR; NA19116
DR   PRIDE; PXD001406
DR   Wikidata; Q54850169
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19117
AC   CVCL_P511
DR   CLO; CLO_0025685
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19117
DR   GEO; GSM649193
DR   GEO; GSM1720123
DR   IGSR; NA19117
DR   Wikidata; Q54850170
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19118
AC   CVCL_P512
DR   CLO; CLO_0025688
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19118
DR   GEO; GSM649184
DR   GEO; GSM1720124
DR   IGSR; NA19118
DR   Wikidata; Q54850171
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19119
AC   CVCL_P513
DR   CLO; CLO_0025687
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19119
DR   GEO; GSM112712
DR   GEO; GSM113101
DR   GEO; GSM188722
DR   GEO; GSM273484
DR   GEO; GSM291876
DR   GEO; GSM315171
DR   GEO; GSM485407
DR   GEO; GSM485522
DR   GEO; GSM649216
DR   GEO; GSM1720125
DR   IGSR; NA19119
DR   PRIDE; PXD001406
DR   Wikidata; Q54850172
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19120
AC   CVCL_0X40
DR   CLO; CLO_0025619
DR   Coriell; GM19120
DR   GEO; GSM112713
DR   GEO; GSM113102
DR   GEO; GSM188723
DR   GEO; GSM291877
DR   GEO; GSM649255
DR   IGSR; NA19120
DR   Wikidata; Q54850173
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19121
AC   CVCL_P514
DR   CLO; CLO_0025618
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19121
DR   GEO; GSM649194
DR   GEO; GSM1720126
DR   IGSR; NA19121
DR   Wikidata; Q54850174
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19122
AC   CVCL_P515
DR   CLO; CLO_0025617
DR   Coriell; GM19122
DR   GEO; GSM649163
DR   IGSR; NA19122
DR   Wikidata; Q54850175
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Homozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19123
AC   CVCL_0X41
DR   CLO; CLO_0025623
DR   Coriell; GM19123
DR   GEO; GSM649286
DR   IGSR; NA19123
DR   Wikidata; Q54850176
RX   PubMed=21397061;
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Triplication; Zygosity=Unspecified; Note=Has 2 copies on one chromosome and 1 on the other (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Homozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   GM19124
AC   CVCL_0X42
DR   Coriell; GM19124
DR   Wikidata; Q54850177
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19125
AC   CVCL_0X43
DR   Coriell; GM19125
DR   Wikidata; Q54850178
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19127
AC   CVCL_P516
DR   CLO; CLO_0025622
DR   Coriell; GM19127
DR   GEO; GSM112714
DR   GEO; GSM113103
DR   GEO; GSM188724
DR   GEO; GSM273485
DR   GEO; GSM291878
DR   GEO; GSM315172
DR   GEO; GSM485423
DR   GEO; GSM485454
DR   GEO; GSM649210
DR   IGSR; NA19127
DR   PRIDE; PXD001406
DR   Wikidata; Q54850179
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19128
AC   CVCL_0X44
DR   CLO; CLO_0025621
DR   Coriell; GM19128
DR   GEO; GSM112715
DR   GEO; GSM113104
DR   GEO; GSM188725
DR   GEO; GSM273486
DR   GEO; GSM291879
DR   GEO; GSM315173
DR   GEO; GSM485411
DR   GEO; GSM485475
DR   GEO; GSM649310
DR   IGSR; NA19128
DR   PRIDE; PXD001406
DR   Wikidata; Q54850180
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   GM19129
AC   CVCL_P517
DR   CLO; CLO_0025620
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19129
DR   GEO; GSM112716
DR   GEO; GSM113106
DR   GEO; GSM188726
DR   GEO; GSM291880
DR   GEO; GSM649270
DR   GEO; GSM1720127
DR   IGSR; NA19129
DR   Wikidata; Q54850181
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19130
AC   CVCL_P518
DR   CLO; CLO_0025626
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19130
DR   GEO; GSM112717
DR   GEO; GSM113107
DR   GEO; GSM188727
DR   GEO; GSM273487
DR   GEO; GSM291881
DR   GEO; GSM315174
DR   GEO; GSM485412
DR   GEO; GSM485476
DR   GEO; GSM649153
DR   GEO; GSM1720128
DR   IGSR; NA19130
DR   PRIDE; PXD001406
DR   Wikidata; Q54850182
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19131
AC   CVCL_P519
DR   CLO; CLO_0025625
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19131
DR   GEO; GSM112718
DR   GEO; GSM113108
DR   GEO; GSM188728
DR   GEO; GSM273488
DR   GEO; GSM291882
DR   GEO; GSM315175
DR   GEO; GSM485392
DR   GEO; GSM485435
DR   GEO; GSM649165
DR   GEO; GSM1720129
DR   IGSR; NA19131
DR   PRIDE; PXD001406
DR   Wikidata; Q54850183
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19132
AC   CVCL_0X45
DR   CLO; CLO_0025624
DR   Coriell; GM19132
DR   GEO; GSM112719
DR   GEO; GSM188729
DR   GEO; GSM291883
DR   GEO; GSM649311
DR   IGSR; NA19132
DR   Wikidata; Q54850197
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19133
AC   CVCL_0X46
DR   Coriell; GM19133
DR   Wikidata; Q54850199
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19135
AC   CVCL_0X47
DR   Coriell; GM19135
DR   Wikidata; Q54850200
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19136
AC   CVCL_0X48
DR   Coriell; GM19136
DR   Wikidata; Q54850201
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19137
AC   CVCL_P520
DR   CLO; CLO_0025637
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19137
DR   GEO; GSM112720
DR   GEO; GSM188730
DR   GEO; GSM273489
DR   GEO; GSM291884
DR   GEO; GSM291885
DR   GEO; GSM291886
DR   GEO; GSM315176
DR   GEO; GSM485511
DR   GEO; GSM485513
DR   GEO; GSM649229
DR   GEO; GSM1720130
DR   IGSR; NA19137
DR   PRIDE; PXD001406
DR   Wikidata; Q54850202
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19138
AC   CVCL_P521
DR   CLO; CLO_0025636
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19138
DR   GEO; GSM112721
DR   GEO; GSM188731
DR   GEO; GSM273490
DR   GEO; GSM291887
DR   GEO; GSM291888
DR   GEO; GSM291889
DR   GEO; GSM315177
DR   GEO; GSM485425
DR   GEO; GSM485458
DR   GEO; GSM649160
DR   GEO; GSM1720131
DR   IGSR; NA19138
DR   PRIDE; PXD001406
DR   Wikidata; Q54850203
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19139
AC   CVCL_0X49
DR   CLO; CLO_0025639
DR   Coriell; GM19139
DR   GEO; GSM112722
DR   GEO; GSM188733
DR   GEO; GSM291890
DR   GEO; GSM649260
DR   IGSR; NA19139
DR   Wikidata; Q54850204
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19140
AC   CVCL_P522
DR   CLO; CLO_0025638
DR   Coriell; GM19140
DR   GEO; GSM112723
DR   GEO; GSM188734
DR   GEO; GSM273491
DR   GEO; GSM291891
DR   GEO; GSM315178
DR   GEO; GSM485420
DR   GEO; GSM485453
DR   GEO; GSM649312
DR   IGSR; NA19140
DR   PRIDE; PXD001406
DR   Wikidata; Q54850205
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19141
AC   CVCL_P523
DR   CLO; CLO_0025641
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19141
DR   GEO; GSM112724
DR   GEO; GSM188735
DR   GEO; GSM273492
DR   GEO; GSM291892
DR   GEO; GSM315179
DR   GEO; GSM651182
DR   GEO; GSM651183
DR   GEO; GSM651184
DR   GEO; GSM651185
DR   GEO; GSM651186
DR   GEO; GSM651187
DR   GEO; GSM1164208
DR   GEO; GSM1164218
DR   GEO; GSM1164228
DR   GEO; GSM1164238
DR   GEO; GSM1164248
DR   GEO; GSM1720132
DR   IGSR; NA19141
DR   Wikidata; Q54850206
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21418647;
RX   PubMed=24037378;
RX   PubMed=24136359;
RX   PubMed=25468404;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM19142
AC   CVCL_0X50
DR   CLO; CLO_0025640
DR   Coriell; GM19142
DR   GEO; GSM112725
DR   GEO; GSM188736
DR   GEO; GSM291893
DR   GEO; GSM649145
DR   IGSR; NA19142
DR   Wikidata; Q54850207
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19143
AC   CVCL_P524
DR   CLO; CLO_0025643
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19143
DR   GEO; GSM112726
DR   GEO; GSM188737
DR   GEO; GSM273493
DR   GEO; GSM315180
DR   GEO; GSM485389
DR   GEO; GSM485401
DR   GEO; GSM649233
DR   GEO; GSM1720133
DR   IGSR; NA19143
DR   PRIDE; PXD001406
DR   Wikidata; Q54850208
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM19144
AC   CVCL_P525
DR   CLO; CLO_0025642
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19144
DR   GEO; GSM112727
DR   GEO; GSM188738
DR   GEO; GSM273494
DR   GEO; GSM291894
DR   GEO; GSM291895
DR   GEO; GSM291896
DR   GEO; GSM315181
DR   GEO; GSM485369
DR   GEO; GSM485380
DR   GEO; GSM649171
DR   GEO; GSM1720134
DR   IGSR; NA19144
DR   PRIDE; PXD001406
DR   Wikidata; Q54850209
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19145
AC   CVCL_0X51
DR   CLO; CLO_0025645
DR   Coriell; GM19145
DR   GEO; GSM112728
DR   GEO; GSM188739
DR   GEO; GSM291897
DR   GEO; GSM649235
DR   IGSR; NA19145
DR   Wikidata; Q54850210
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19146
AC   CVCL_P526
DR   CLO; CLO_0025644
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19146
DR   GEO; GSM649156
DR   GEO; GSM1720135
DR   IGSR; NA19146
DR   Wikidata; Q54850212
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19147
AC   CVCL_P527
DR   CLO; CLO_0027361
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19147
DR   GEO; GSM485385
DR   GEO; GSM485400
DR   GEO; GSM649180
DR   GEO; GSM1720136
DR   IGSR; NA19147
DR   PRIDE; PXD001406
DR   Wikidata; Q54850213
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19148
AC   CVCL_0X52
DR   CLO; CLO_0027368
DR   Coriell; GM19148
DR   GEO; GSM649253
DR   IGSR; NA19148
DR   Wikidata; Q54850214
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19149
AC   CVCL_P528
DR   CLO; CLO_0027367
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19149
DR   GEO; GSM649157
DR   GEO; GSM1720137
DR   IGSR; NA19149
DR   Wikidata; Q54850215
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19150
AC   CVCL_P529
DR   CLO; CLO_0027364
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19150
DR   GEO; GSM649246
DR   IGSR; NA19150
DR   Wikidata; Q54850216
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19151
AC   CVCL_0X53
DR   CLO; CLO_0027363
DR   Coriell; GM19151
DR   GEO; GSM649289
DR   IGSR; NA19151
DR   Wikidata; Q54850217
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19152
AC   CVCL_P530
DR   CLO; CLO_0027376
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19152
DR   GEO; GSM112729
DR   GEO; GSM188740
DR   GEO; GSM273495
DR   GEO; GSM291898
DR   GEO; GSM315182
DR   GEO; GSM485371
DR   GEO; GSM485386
DR   GEO; GSM649313
DR   GEO; GSM1720138
DR   IGSR; NA19152
DR   PRIDE; PXD001406
DR   Wikidata; Q54850218
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19153
AC   CVCL_P531
DR   CLO; CLO_0027375
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19153
DR   GEO; GSM112730
DR   GEO; GSM188741
DR   GEO; GSM273496
DR   GEO; GSM291899
DR   GEO; GSM315183
DR   GEO; GSM485368
DR   GEO; GSM485383
DR   GEO; GSM649228
DR   GEO; GSM1720139
DR   IGSR; NA19153
DR   PRIDE; PXD001406
DR   Wikidata; Q54850219
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19154
AC   CVCL_0X54
DR   CLO; CLO_0027373
DR   Coriell; GM19154
DR   GEO; GSM112731
DR   GEO; GSM188742
DR   GEO; GSM291900
DR   GEO; GSM291901
DR   GEO; GSM291902
DR   GEO; GSM649159
DR   IGSR; NA19154
DR   Wikidata; Q54850220
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19155
AC   CVCL_0X57
DR   CLO; CLO_0027370
DR   Coriell; GM19155
DR   Wikidata; Q54850221
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19156
AC   CVCL_0X55
DR   Coriell; GM19156
DR   Wikidata; Q54850222
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19157
AC   CVCL_0X56
DR   Coriell; GM19157
DR   Wikidata; Q54850223
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19159
AC   CVCL_P532
DR   CLO; CLO_0027377
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19159
DR   GEO; GSM112732
DR   GEO; GSM188744
DR   GEO; GSM273497
DR   GEO; GSM291903
DR   GEO; GSM291904
DR   GEO; GSM291905
DR   GEO; GSM315184
DR   GEO; GSM485472
DR   GEO; GSM485490
DR   GEO; GSM649177
DR   GEO; GSM1720140
DR   IGSR; NA19159
DR   Wikidata; Q54850224
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19160
AC   CVCL_P533
DR   CLO; CLO_0027382
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19160
DR   GEO; GSM112733
DR   GEO; GSM188745
DR   GEO; GSM273498
DR   GEO; GSM291906
DR   GEO; GSM315185
DR   GEO; GSM485452
DR   GEO; GSM485463
DR   GEO; GSM485473
DR   GEO; GSM485496
DR   GEO; GSM649314
DR   GEO; GSM1720141
DR   IGSR; NA19160
DR   PRIDE; PXD001406
DR   Wikidata; Q54850225
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19161
AC   CVCL_0X58
DR   CLO; CLO_0027383
DR   Coriell; GM19161
DR   GEO; GSM112734
DR   GEO; GSM188746
DR   GEO; GSM291907
DR   GEO; GSM649197
DR   IGSR; NA19161
DR   Wikidata; Q54850227
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19162
AC   CVCL_0X59
DR   Coriell; GM19162
DR   Wikidata; Q54850228
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19163
AC   CVCL_0X60
DR   Coriell; GM19163
DR   Wikidata; Q54850229
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19166
AC   CVCL_0X61
DR   Coriell; GM19166
DR   IGSR; NA19166
DR   Wikidata; Q54850230
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19167
AC   CVCL_0X62
DR   Coriell; GM19167
DR   Wikidata; Q54850231
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19168
AC   CVCL_0X63
DR   Coriell; GM19168
DR   Wikidata; Q54850232
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19170
AC   CVCL_0X64
DR   Coriell; GM19170
DR   Wikidata; Q54850233
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19171
AC   CVCL_P534
DR   CLO; CLO_0027389
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19171
DR   GEO; GSM112735
DR   GEO; GSM188747
DR   GEO; GSM273499
DR   GEO; GSM291908
DR   GEO; GSM291909
DR   GEO; GSM291910
DR   GEO; GSM315186
DR   GEO; GSM485408
DR   GEO; GSM485492
DR   GEO; GSM485510
DR   GEO; GSM485523
DR   GEO; GSM649209
DR   GEO; GSM1720142
DR   IGSR; NA19171
DR   Wikidata; Q54850234
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19172
AC   CVCL_P535
DR   CLO; CLO_0027386
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19172
DR   GEO; GSM112736
DR   GEO; GSM188748
DR   GEO; GSM273500
DR   GEO; GSM291911
DR   GEO; GSM291912
DR   GEO; GSM291913
DR   GEO; GSM315187
DR   GEO; GSM485419
DR   GEO; GSM485485
DR   GEO; GSM649266
DR   GEO; GSM1720143
DR   IGSR; NA19172
DR   PRIDE; PXD001406
DR   Wikidata; Q54850235
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19173
AC   CVCL_0X65
DR   CLO; CLO_0027395
DR   Coriell; GM19173
DR   GEO; GSM112737
DR   GEO; GSM188749
DR   GEO; GSM649199
DR   IGSR; NA19173
DR   Wikidata; Q54850237
RX   PubMed=17122850;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19174
AC   CVCL_0X66
DR   CLO; CLO_0027390
DR   Coriell; GM19174
DR   GEO; GSM649292
DR   IGSR; NA19174
DR   Wikidata; Q54850238
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19175
AC   CVCL_P536
DR   CLO; CLO_0027399
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19175
DR   GEO; GSM649212
DR   GEO; GSM1720144
DR   IGSR; NA19175
DR   Wikidata; Q54850239
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19176
AC   CVCL_0X67
DR   CLO; CLO_0027396
DR   Coriell; GM19176
DR   IGSR; NA19176
DR   Wikidata; Q54850241
RX   PubMed=26621101;
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19177
AC   CVCL_0X68
DR   CLO; CLO_0027403
DR   Coriell; GM19177
DR   GEO; GSM649251
DR   IGSR; NA19177
DR   Wikidata; Q54850252
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19178
AC   CVCL_0X69
DR   CLO; CLO_0027401
DR   Coriell; GM19178
DR   GEO; GSM649174
DR   Wikidata; Q54850253
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19179
AC   CVCL_0X70
DR   CLO; CLO_0027301
DR   Coriell; GM19179
DR   GEO; GSM649168
DR   Wikidata; Q54850254
RX   PubMed=21397061;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19180
AC   CVCL_0X71
DR   CLO; CLO_0027299
DR   Coriell; GM19180
DR   GEO; GSM649252
DR   Wikidata; Q54850255
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19181
AC   CVCL_0X72
DR   CLO; CLO_0027300
DR   Coriell; GM19181
DR   GEO; GSM649237
DR   Wikidata; Q54850256
RX   PubMed=21397061;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19182
AC   CVCL_0X73
DR   CLO; CLO_0027322
DR   Coriell; GM19182
DR   GEO; GSM649211
DR   Wikidata; Q54850257
RX   PubMed=21397061;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19183
AC   CVCL_0X74
DR   CLO; CLO_0027319
DR   Coriell; GM19183
DR   GEO; GSM649241
DR   Wikidata; Q54850258
RX   PubMed=21397061;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19184
AC   CVCL_P537
DR   CLO; CLO_0027316
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19184
DR   GEO; GSM649148
DR   GEO; GSM1720145
DR   IGSR; NA19184
DR   Wikidata; Q54850259
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19185
AC   CVCL_P538
DR   CLO; CLO_0027314
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19185
DR   GEO; GSM649271
DR   GEO; GSM1720146
DR   IGSR; NA19185
DR   Wikidata; Q54850260
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19186
AC   CVCL_0X75
DR   CLO; CLO_0027312
DR   Coriell; GM19186
DR   GEO; GSM649281
DR   IGSR; NA19186
DR   Wikidata; Q54850261
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19187
AC   CVCL_0X76
DR   Coriell; GM19187
DR   Wikidata; Q54850262
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19189
AC   CVCL_P539
DR   CLO; CLO_0027309
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19189
DR   GEO; GSM649245
DR   GEO; GSM1720147
DR   IGSR; NA19189
DR   Wikidata; Q54850263
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19190
AC   CVCL_P540
DR   CLO; CLO_0027306
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19190
DR   GEO; GSM485402
DR   GEO; GSM485437
DR   GEO; GSM649287
DR   GEO; GSM1720148
DR   IGSR; NA19190
DR   Wikidata; Q54850264
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19191
AC   CVCL_0X77
DR   CLO; CLO_0027330
DR   Coriell; GM19191
DR   GEO; GSM649261
DR   IGSR; NA19191
DR   Wikidata; Q54850265
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19192
AC   CVCL_F106
DR   CLO; CLO_0027331
DR   Coriell; GM19192
DR   GEO; GSM112738
DR   GEO; GSM188750
DR   GEO; GSM273501
DR   GEO; GSM291914
DR   GEO; GSM315188
DR   GEO; GSM485393
DR   GEO; GSM485440
DR   GEO; GSM649265
DR   PRIDE; PXD001406
DR   Wikidata; Q54850266
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   GM19193
AC   CVCL_E126
DR   CLO; CLO_0027332
DR   EFO; EFO_0005351
DR   Coriell; GM19193
DR   ENCODE; ENCBS507ENC
DR   ENCODE; ENCBS508ENC
DR   GEO; GSM112739
DR   GEO; GSM188751
DR   GEO; GSM273502
DR   GEO; GSM291915
DR   GEO; GSM315189
DR   GEO; GSM485430
DR   GEO; GSM485495
DR   GEO; GSM649172
DR   GEO; GSM1164209
DR   GEO; GSM1164219
DR   GEO; GSM1164229
DR   GEO; GSM1164239
DR   GEO; GSM1164249
DR   GEO; GSM1204879
DR   PRIDE; PXD000419
DR   PRIDE; PXD001406
DR   Wikidata; Q54850267
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24136357;
RX   PubMed=24136359;
RX   PubMed=25468404;
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   GM19194
AC   CVCL_0X78
DR   CLO; CLO_0027333
DR   Coriell; GM19194
DR   GEO; GSM112740
DR   GEO; GSM188752
DR   GEO; GSM291916
DR   GEO; GSM291917
DR   GEO; GSM291918
DR   GEO; GSM649227
DR   Wikidata; Q54850268
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19195
AC   CVCL_0X79
DR   Coriell; GM19195
DR   IGSR; NA19195
DR   Wikidata; Q54850269
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19196
AC   CVCL_0X80
DR   Coriell; GM19196
DR   IGSR; NA19196
DR   Wikidata; Q54850270
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19197
AC   CVCL_P541
DR   CLO; CLO_0027350
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19197
DR   GEO; GSM649240
DR   GEO; GSM1720149
DR   IGSR; NA19197
DR   Wikidata; Q54850271
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19198
AC   CVCL_P542
DR   CLO; CLO_0027346
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19198
DR   GEO; GSM649277
DR   GEO; GSM1720150
DR   IGSR; NA19198
DR   Wikidata; Q54850272
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19199
AC   CVCL_0X81
DR   CLO; CLO_0027356
DR   Coriell; GM19199
DR   GEO; GSM649247
DR   IGSR; NA19199
DR   Wikidata; Q54850273
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19200
AC   CVCL_P543
DR   CLO; CLO_0027352
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19200
DR   GEO; GSM112741
DR   GEO; GSM188753
DR   GEO; GSM273503
DR   GEO; GSM291919
DR   GEO; GSM291920
DR   GEO; GSM291921
DR   GEO; GSM315190
DR   GEO; GSM485409
DR   GEO; GSM485501
DR   GEO; GSM485514
DR   GEO; GSM485524
DR   GEO; GSM649203
DR   GEO; GSM1720151
DR   IGSR; NA19200
DR   PRIDE; PXD001406
DR   Wikidata; Q54850274
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19201
AC   CVCL_P544
DR   CLO; CLO_0027341
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19201
DR   GEO; GSM112742
DR   GEO; GSM188755
DR   GEO; GSM273504
DR   GEO; GSM291922
DR   GEO; GSM315191
DR   GEO; GSM485367
DR   GEO; GSM485381
DR   GEO; GSM649170
DR   GEO; GSM1720152
DR   IGSR; NA19201
DR   Wikidata; Q54850275
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=23676674;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19202
AC   CVCL_0X82
DR   CLO; CLO_0027339
DR   Coriell; GM19202
DR   GEO; GSM112743
DR   GEO; GSM188756
DR   GEO; GSM291923
DR   GEO; GSM291924
DR   GEO; GSM291925
DR   GEO; GSM649230
DR   IGSR; NA19202
DR   Wikidata; Q54850276
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=23676674;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19203
AC   CVCL_0X83
DR   CLO; CLO_0027212
DR   Coriell; GM19203
DR   GEO; GSM112744
DR   GEO; GSM188757
DR   GEO; GSM273505
DR   GEO; GSM291926
DR   GEO; GSM315192
DR   GEO; GSM485446
DR   GEO; GSM485477
DR   IGSR; NA19203
DR   PRIDE; PXD001406
DR   Wikidata; Q54850278
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   GM19204
AC   CVCL_P545
DR   CLO; CLO_0027216
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19204
DR   GEO; GSM112745
DR   GEO; GSM188758
DR   GEO; GSM273506
DR   GEO; GSM291927
DR   GEO; GSM315193
DR   GEO; GSM485467
DR   GEO; GSM485489
DR   GEO; GSM649176
DR   GEO; GSM1164210
DR   GEO; GSM1164220
DR   GEO; GSM1164230
DR   GEO; GSM1164240
DR   GEO; GSM1164250
DR   GEO; GSM1720153
DR   IGSR; NA19204
DR   PRIDE; PXD000419
DR   PRIDE; PXD001406
DR   Wikidata; Q54850279
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=24136357;
RX   PubMed=24136359;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   GM19205
AC   CVCL_0X84
DR   CLO; CLO_0027215
DR   Coriell; GM19205
DR   GEO; GSM112746
DR   GEO; GSM188759
DR   GEO; GSM291928
DR   GEO; GSM649206
DR   IGSR; NA19205
DR   Wikidata; Q54850280
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19206
AC   CVCL_P546
DR   CLO; CLO_0027214
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19206
DR   GEO; GSM112747
DR   GEO; GSM188760
DR   GEO; GSM273507
DR   GEO; GSM315194
DR   GEO; GSM649146
DR   GEO; GSM1720154
DR   IGSR; NA19206
DR   Wikidata; Q54850281
RX   PubMed=17122850;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19207
AC   CVCL_P547
DR   CLO; CLO_0027213
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19207
DR   GEO; GSM112748
DR   GEO; GSM188761
DR   GEO; GSM273508
DR   GEO; GSM291929
DR   GEO; GSM291930
DR   GEO; GSM315195
DR   GEO; GSM649221
DR   GEO; GSM1720155
DR   IGSR; NA19207
DR   PRIDE; PXD001406
DR   Wikidata; Q54850282
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19208
AC   CVCL_0X85
DR   CLO; CLO_0027243
DR   Coriell; GM19208
DR   GEO; GSM112749
DR   GEO; GSM188762
DR   GEO; GSM291931
DR   GEO; GSM649166
DR   IGSR; NA19208
DR   Wikidata; Q54850283
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19209
AC   CVCL_P548
DR   CLO; CLO_0027245
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19209
DR   GEO; GSM112750
DR   GEO; GSM188763
DR   GEO; GSM273509
DR   GEO; GSM291932
DR   GEO; GSM315196
DR   GEO; GSM485365
DR   GEO; GSM485388
DR   GEO; GSM649263
DR   GEO; GSM1720156
DR   IGSR; NA19209
DR   PRIDE; PXD001406
DR   Wikidata; Q54850285
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19210
AC   CVCL_P549
DR   CLO; CLO_0027239
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19210
DR   GEO; GSM112751
DR   GEO; GSM188764
DR   GEO; GSM273510
DR   GEO; GSM291933
DR   GEO; GSM315197
DR   GEO; GSM485364
DR   GEO; GSM485382
DR   GEO; GSM649175
DR   GEO; GSM1720157
DR   IGSR; NA19210
DR   Wikidata; Q54850286
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19211
AC   CVCL_0X86
DR   CLO; CLO_0027242
DR   Coriell; GM19211
DR   GEO; GSM112752
DR   GEO; GSM188766
DR   GEO; GSM291934
DR   GEO; GSM649191
DR   IGSR; NA19211
DR   Wikidata; Q54850287
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19213
AC   CVCL_P550
DR   CLO; CLO_0027250
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19213
DR   GEO; GSM1720158
DR   IGSR; NA19213
DR   Wikidata; Q54850288
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19214
AC   CVCL_P551
DR   CLO; CLO_0027255
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19214
DR   GEO; GSM649290
DR   GEO; GSM1720159
DR   IGSR; NA19214
DR   Wikidata; Q54850289
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19215
AC   CVCL_0X87
DR   CLO; CLO_0027254
DR   Coriell; GM19215
DR   IGSR; NA19215
DR   Wikidata; Q54850290
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19216
AC   CVCL_0X88
DR   Coriell; GM19216
DR   Wikidata; Q54850291
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19217
AC   CVCL_0X89
DR   Coriell; GM19217
DR   Wikidata; Q54850292
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19218
AC   CVCL_0X90
DR   Coriell; GM19218
DR   Wikidata; Q54850293
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19220
AC   CVCL_0X91
DR   Coriell; GM19220
DR   Wikidata; Q54850307
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19221
AC   CVCL_0X92
DR   CLO; CLO_0027257
DR   Coriell; GM19221
DR   GEO; GSM112753
DR   GEO; GSM188767
DR   GEO; GSM291935
DR   GEO; GSM649204
DR   IGSR; NA19221
DR   Wikidata; Q54850308
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM19222
AC   CVCL_P552
DR   CLO; CLO_0027256
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19222
DR   GEO; GSM112754
DR   GEO; GSM188768
DR   GEO; GSM273511
DR   GEO; GSM291936
DR   GEO; GSM315198
DR   GEO; GSM485395
DR   GEO; GSM485441
DR   GEO; GSM649231
DR   GEO; GSM1720160
DR   IGSR; NA19222
DR   PRIDE; PXD001406
DR   Wikidata; Q54850309
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM19223
AC   CVCL_P553
DR   CLO; CLO_0027259
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19223
DR   GEO; GSM112755
DR   GEO; GSM188769
DR   GEO; GSM273512
DR   GEO; GSM291937
DR   GEO; GSM315199
DR   GEO; GSM649154
DR   GEO; GSM1720161
DR   IGSR; NA19223
DR   Wikidata; Q54850311
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19224
AC   CVCL_0U53
DR   CLO; CLO_0027258
DR   Coriell; GM19224
DR   GEO; GSM649239
DR   IGSR; NA19224
DR   Wikidata; Q54850312
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19225
AC   CVCL_P554
DR   CLO; CLO_0027280
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19225
DR   GEO; GSM485396
DR   GEO; GSM485461
DR   GEO; GSM649243
DR   GEO; GSM1720162
DR   IGSR; NA19225
DR   Wikidata; Q54850313
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19226
AC   CVCL_0U54
DR   CLO; CLO_0027283
DR   BioSample; SAMN03470974
DR   Coriell; GM19226
DR   IGSR; NA19226
DR   Wikidata; Q54850315
RX   PubMed=25877200;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 15,20
ST   D19S433: 14,15
ST   D21S11: 28,32.2
ST   D2S1338: 21,22
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 8
ST   TH01: 7
ST   TPOX: 6
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   GM19228
AC   CVCL_0X93
DR   Coriell; GM19228
DR   Wikidata; Q54850316
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19229
AC   CVCL_0X94
DR   Coriell; GM19229
DR   Wikidata; Q54850317
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19230
AC   CVCL_0X95
DR   Coriell; GM19230
DR   Wikidata; Q54850319
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19235
AC   CVCL_P555
DR   CLO; CLO_0027286
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19235
DR   GEO; GSM649274
DR   GEO; GSM1720163
DR   IGSR; NA19235
DR   Wikidata; Q54850320
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Quadruplication; Zygosity=Unspecified (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Homozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19236
AC   CVCL_P556
DR   CLO; CLO_0027287
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19236
DR   GEO; GSM649279
DR   GEO; GSM1720164
DR   IGSR; NA19236
DR   Wikidata; Q54850321
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19237
AC   CVCL_0X96
DR   CLO; CLO_0027148
DR   Coriell; GM19237
DR   GEO; GSM649259
DR   IGSR; NA19237
DR   Wikidata; Q54850322
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19238
AC   CVCL_9633
DR   CLO; CLO_0027146
DR   EFO; EFO_0002788
DR   4DN; 4DNSRE31VFYQ
DR   Coriell; GM19238
DR   ENCODE; ENCBS332FBI
DR   ENCODE; ENCBS509ENC
DR   ENCODE; ENCBS594JOC
DR   GEO; GSM112756
DR   GEO; GSM188770
DR   GEO; GSM273513
DR   GEO; GSM291938
DR   GEO; GSM315200
DR   GEO; GSM485377
DR   GEO; GSM485413
DR   GEO; GSM489286
DR   GEO; GSM489287
DR   GEO; GSM489299
DR   GEO; GSM489300
DR   GEO; GSM651190
DR   GEO; GSM651191
DR   GEO; GSM816658
DR   GEO; GSM1164211
DR   GEO; GSM1164221
DR   GEO; GSM1164231
DR   GEO; GSM1164241
DR   GEO; GSM1164251
DR   GEO; GSM1204881
DR   GEO; GSM1720165
DR   IGSR; NA19238
DR   Wikidata; Q54850323
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21418647;
RX   PubMed=22797897;
RX   PubMed=23676674;
RX   PubMed=24136359;
RX   PubMed=25468404;
RX   PubMed=26621101;
RX   PubMed=27792722;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM19238_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   HLA typing: A*30:01,36:01; B*53:01:01,57:03:01; C*04:01,18; DPA1*01:03:01,02:01:01; DPB1*01:01:01,02:01:02; DQA1*01:02:01,01:02:01; DQB1*05,06; DRB1*11:01:02,16 (PubMed=27792722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   GM19239
AC   CVCL_9634
DR   CLO; CLO_0027144
DR   EFO; EFO_0002789
DR   4DN; 4DNSRKH549U5
DR   Coriell; GM19239
DR   ENCODE; ENCBS385ENC
DR   ENCODE; ENCBS513JGI
DR   ENCODE; ENCBS657HMS
DR   GEO; GSM112757
DR   GEO; GSM188771
DR   GEO; GSM273514
DR   GEO; GSM291939
DR   GEO; GSM315201
DR   GEO; GSM485378
DR   GEO; GSM485414
DR   GEO; GSM489288
DR   GEO; GSM489289
DR   GEO; GSM489301
DR   GEO; GSM489302
DR   GEO; GSM649315
DR   GEO; GSM651188
DR   GEO; GSM651189
DR   GEO; GSM816659
DR   GEO; GSM1164212
DR   GEO; GSM1164222
DR   GEO; GSM1164232
DR   GEO; GSM1164242
DR   GEO; GSM1164252
DR   GEO; GSM1720166
DR   IGSR; NA19239
DR   Wikidata; Q54850324
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=19797678;
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=21418647;
RX   PubMed=22797897;
RX   PubMed=23325432;
RX   PubMed=23676674;
RX   PubMed=24136359;
RX   PubMed=25468404;
RX   PubMed=26621101;
RX   PubMed=27792722;
RX   PubMed=29474986;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM19239_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   HLA typing: A*02:01,68:02:01; B*35:01,52:01:02; C*04:01,16; DPA1*02:01:01,02:02:02; DPB1*01:01:01; DQA1*01:03:01,05; DQB1*03:01,05; DRB1*12,13 (PubMed=27792722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   GM19240
AC   CVCL_9635
DR   CLO; CLO_0027143
DR   EFO; EFO_0002790
DR   4DN; 4DNSRWYYID1N
DR   Coriell; GM19240
DR   ENCODE; ENCBS338PQB
DR   ENCODE; ENCBS510ENC
DR   ENCODE; ENCBS760NLE
DR   GEO; GSM112758
DR   GEO; GSM188772
DR   GEO; GSM291940
DR   GEO; GSM489284
DR   GEO; GSM489285
DR   GEO; GSM489297
DR   GEO; GSM489298
DR   GEO; GSM649269
DR   GEO; GSM651108
DR   GEO; GSM651109
DR   GEO; GSM816648
DR   GEO; GSM1720167
DR   IGSR; NA19240
DR   Wikidata; Q54850325
RX   PubMed=17122850;
RX   PubMed=19043577;
RX   PubMed=21397061;
RX   PubMed=21418647;
RX   PubMed=23325432;
RX   PubMed=23676674;
RX   PubMed=27792722;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM19240_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   HLA typing: A*30:01,68:02:01; B*35:01,57:03:01; C*04:01,18; DPA1*02:01:01,02:02:02; DPB1*01:01:01,01:01:01; DQA1*01:02,05; DQB1*03:01,05; DRB1*12,16 (PubMed=27792722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GM19242
AC   CVCL_0X97
DR   Coriell; GM19242
DR   Wikidata; Q54850327
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19244
AC   CVCL_0X98
DR   Coriell; GM19244
DR   Wikidata; Q54850328
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19246
AC   CVCL_0X99
DR   Coriell; GM19246
DR   Wikidata; Q54850329
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19247
AC   CVCL_P557
DR   CLO; CLO_0027142
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19247
DR   GEO; GSM649285
DR   GEO; GSM1720168
DR   IGSR; NA19247
DR   Wikidata; Q54850330
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19248
AC   CVCL_P558
DR   CLO; CLO_0027141
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19248
DR   GEO; GSM649288
DR   GEO; GSM1720169
DR   IGSR; NA19248
DR   Wikidata; Q54850331
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19249
AC   CVCL_1A16
DR   CLO; CLO_0027140
DR   Coriell; GM19249
DR   GEO; GSM649257
DR   IGSR; NA19249
DR   Wikidata; Q54850332
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19250
AC   CVCL_1A17
DR   Coriell; GM19250
DR   Wikidata; Q54850333
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19252
AC   CVCL_1A18
DR   CLO; CLO_0027177
DR   Coriell; GM19252
DR   GEO; GSM649282
DR   IGSR; NA19252
DR   Wikidata; Q54850334
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19253
AC   CVCL_1A19
DR   Coriell; GM19253
DR   Wikidata; Q54850335
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19254
AC   CVCL_1A20
DR   Coriell; GM19254
DR   IGSR; NA19254
DR   Wikidata; Q54850336
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19256
AC   CVCL_P559
DR   CLO; CLO_0027180
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19256
DR   GEO; GSM649291
DR   GEO; GSM1720170
DR   IGSR; NA19256
DR   Wikidata; Q54850339
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19257
AC   CVCL_P560
DR   CLO; CLO_0027171
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   Coriell; GM19257
DR   GEO; GSM485390
DR   GEO; GSM485439
DR   GEO; GSM649137
DR   GEO; GSM1720171
DR   IGSR; NA19257
DR   PRIDE; PXD001406
DR   Wikidata; Q54850340
RX   PubMed=20220758;
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM19258
AC   CVCL_1A21
DR   CLO; CLO_0027469
DR   Coriell; GM19258
DR   GEO; GSM649244
DR   IGSR; NA19258
DR   Wikidata; Q54850341
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19259
AC   CVCL_1A22
DR   Coriell; GM19259
DR   Wikidata; Q54850342
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19260
AC   CVCL_1A23
DR   Coriell; GM19260
DR   Wikidata; Q54850343
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19262
AC   CVCL_1A24
DR   Coriell; GM19262
DR   Wikidata; Q54850344
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19264
AC   CVCL_1A25
DR   Coriell; GM19264
DR   Wikidata; Q54850345
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19266
AC   CVCL_1A26
DR   Coriell; GM19266
DR   Wikidata; Q54850346
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19291
AC   CVCL_5M43
DR   CLO; CLO_0027476
DR   Coriell; GM19291
DR   Wikidata; Q54850347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27191; Hashimoto thyroiditis
DI   NCIt; C26915; Vitiligo
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM19292
AC   CVCL_5M44
DR   CLO; CLO_0027475
DR   Coriell; GM19292
DR   Wikidata; Q54850349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27191; Hashimoto thyroiditis
DI   NCIt; C26915; Vitiligo
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM19307
AC   CVCL_P283
DR   CLO; CLO_0027472
DR   Coriell; GM19307
DR   GEO; GSM649992
DR   GEO; GSM1720172
DR   IGSR; NA19307
DR   Wikidata; Q54850350
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19308
AC   CVCL_P284
DR   CLO; CLO_0027471
DR   Coriell; GM19308
DR   GEO; GSM649993
DR   GEO; GSM1720173
DR   IGSR; NA19308
DR   Wikidata; Q54850352
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19309
AC   CVCL_P285
DR   CLO; CLO_0027481
DR   Coriell; GM19309
DR   GEO; GSM649994
DR   GEO; GSM1720174
DR   IGSR; NA19309
DR   Wikidata; Q54850353
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19310
AC   CVCL_P286
DR   CLO; CLO_0027480
DR   Coriell; GM19310
DR   GEO; GSM649995
DR   GEO; GSM1720175
DR   IGSR; NA19310
DR   Wikidata; Q54850354
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19311
AC   CVCL_P287
DR   CLO; CLO_0027479
DR   Coriell; GM19311
DR   GEO; GSM649996
DR   GEO; GSM1720176
DR   IGSR; NA19311
DR   Wikidata; Q54850371
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19312
AC   CVCL_P288
DR   CLO; CLO_0027478
DR   Coriell; GM19312
DR   GEO; GSM649997
DR   GEO; GSM1720177
DR   IGSR; NA19312
DR   Wikidata; Q54850372
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19313
AC   CVCL_P289
DR   CLO; CLO_0027482
DR   Coriell; GM19313
DR   GEO; GSM649998
DR   GEO; GSM1720178
DR   IGSR; NA19313
DR   Wikidata; Q54850373
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19314
AC   CVCL_P290
DR   CLO; CLO_0027459
DR   Coriell; GM19314
DR   GEO; GSM649999
DR   GEO; GSM1720179
DR   IGSR; NA19314
DR   Wikidata; Q54850374
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19315
AC   CVCL_P291
DR   CLO; CLO_0027461
DR   Coriell; GM19315
DR   GEO; GSM650000
DR   GEO; GSM1720180
DR   IGSR; NA19315
DR   Wikidata; Q54850375
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19316
AC   CVCL_P292
DR   CLO; CLO_0027448
DR   Coriell; GM19316
DR   GEO; GSM650001
DR   GEO; GSM1720181
DR   IGSR; NA19316
DR   Wikidata; Q54850376
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19317
AC   CVCL_P293
DR   CLO; CLO_0027449
DR   Coriell; GM19317
DR   GEO; GSM650002
DR   GEO; GSM1720182
DR   IGSR; NA19317
DR   Wikidata; Q54850377
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19318
AC   CVCL_P294
DR   CLO; CLO_0027451
DR   Coriell; GM19318
DR   GEO; GSM650003
DR   GEO; GSM1720183
DR   IGSR; NA19318
DR   Wikidata; Q54850378
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19319
AC   CVCL_P295
DR   CLO; CLO_0027456
DR   Coriell; GM19319
DR   GEO; GSM650004
DR   GEO; GSM1720184
DR   IGSR; NA19319
DR   Wikidata; Q54850379
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19320
AC   CVCL_1A27
DR   Coriell; GM19320
DR   GEO; GSM1720185
DR   IGSR; NA19320
DR   Wikidata; Q54850380
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19321
AC   CVCL_P296
DR   CLO; CLO_0027442
DR   Coriell; GM19321
DR   GEO; GSM650005
DR   GEO; GSM1720186
DR   IGSR; NA19321
DR   Wikidata; Q54850381
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19323
AC   CVCL_P297
DR   Coriell; GM19323
DR   GEO; GSM1720187
DR   IGSR; NA19323
DR   Wikidata; Q54850382
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19324
AC   CVCL_P298
DR   CLO; CLO_0027443
DR   Coriell; GM19324
DR   GEO; GSM650006
DR   GEO; GSM1720188
DR   IGSR; NA19324
DR   Wikidata; Q54850383
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19327
AC   CVCL_P299
DR   CLO; CLO_0027444
DR   Coriell; GM19327
DR   GEO; GSM650007
DR   GEO; GSM1720189
DR   IGSR; NA19327
DR   Wikidata; Q54850384
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19328
AC   CVCL_P300
DR   CLO; CLO_0027445
DR   Coriell; GM19328
DR   GEO; GSM650008
DR   GEO; GSM1720190
DR   IGSR; NA19328
DR   Wikidata; Q54850385
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19331
AC   CVCL_P301
DR   CLO; CLO_0027441
DR   Coriell; GM19331
DR   GEO; GSM650009
DR   GEO; GSM1720191
DR   IGSR; NA19331
DR   Wikidata; Q54850386
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19332
AC   CVCL_P302
DR   CLO; CLO_0027439
DR   Coriell; GM19332
DR   GEO; GSM650010
DR   GEO; GSM1720192
DR   IGSR; NA19332
DR   Wikidata; Q54850387
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19334
AC   CVCL_P303
DR   CLO; CLO_0027440
DR   Coriell; GM19334
DR   GEO; GSM650011
DR   GEO; GSM1720193
DR   IGSR; NA19334
DR   Wikidata; Q54850388
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19338
AC   CVCL_P304
DR   CLO; CLO_0027437
DR   Coriell; GM19338
DR   GEO; GSM650012
DR   GEO; GSM1720194
DR   IGSR; NA19338
DR   Wikidata; Q54850389
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19344
AC   CVCL_2U55
DR   CLO; CLO_0027438
DR   Coriell; GM19344
DR   Wikidata; Q54850390
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM19345
AC   CVCL_2U56
DR   CLO; CLO_0027435
DR   Coriell; GM19345
DR   Wikidata; Q54850391
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM19346
AC   CVCL_P305
DR   CLO; CLO_0027436
DR   Coriell; GM19346
DR   GEO; GSM650013
DR   GEO; GSM1720195
DR   IGSR; NA19346
DR   Wikidata; Q54850392
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19347
AC   CVCL_P306
DR   CLO; CLO_0027433
DR   Coriell; GM19347
DR   GEO; GSM650014
DR   GEO; GSM1720196
DR   IGSR; NA19347
DR   Wikidata; Q54850393
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19350
AC   CVCL_P307
DR   CLO; CLO_0027434
DR   Coriell; GM19350
DR   GEO; GSM650015
DR   GEO; GSM1720197
DR   IGSR; NA19350
DR   Wikidata; Q54850394
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19351
AC   CVCL_P308
DR   CLO; CLO_0027432
DR   Coriell; GM19351
DR   GEO; GSM650016
DR   GEO; GSM1720198
DR   IGSR; NA19351
DR   Wikidata; Q54850395
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19352
AC   CVCL_P309
DR   CLO; CLO_0027424
DR   Coriell; GM19352
DR   GEO; GSM650017
DR   IGSR; NA19352
DR   Wikidata; Q54850396
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19355
AC   CVCL_P310
DR   CLO; CLO_0027425
DR   Coriell; GM19355
DR   GEO; GSM650018
DR   GEO; GSM1720199
DR   IGSR; NA19355
DR   Wikidata; Q54850397
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19359
AC   CVCL_P311
DR   CLO; CLO_0027426
DR   Coriell; GM19359
DR   GEO; GSM650019
DR   IGSR; NA19359
DR   Wikidata; Q54850398
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19360
AC   CVCL_P312
DR   CLO; CLO_0027427
DR   Coriell; GM19360
DR   GEO; GSM650020
DR   GEO; GSM1720200
DR   IGSR; NA19360
DR   Wikidata; Q54850399
RX   PubMed=21397061;
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Quadruplication; Zygosity=Unspecified (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Homozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19371
AC   CVCL_P313
DR   CLO; CLO_0027428
DR   Coriell; GM19371
DR   GEO; GSM650021
DR   IGSR; NA19371
DR   Wikidata; Q54850400
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19372
AC   CVCL_P314
DR   CLO; CLO_0027429
DR   Coriell; GM19372
DR   GEO; GSM650022
DR   GEO; GSM1720201
DR   IGSR; NA19372
DR   Wikidata; Q54850402
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19373
AC   CVCL_P315
DR   CLO; CLO_0027430
DR   Coriell; GM19373
DR   GEO; GSM650023
DR   IGSR; NA19373
DR   Wikidata; Q54850403
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19374
AC   CVCL_P316
DR   CLO; CLO_0027431
DR   Coriell; GM19374
DR   GEO; GSM650024
DR   GEO; GSM1720202
DR   IGSR; NA19374
DR   Wikidata; Q54850404
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19375
AC   CVCL_P317
DR   CLO; CLO_0027422
DR   Coriell; GM19375
DR   GEO; GSM650025
DR   GEO; GSM1720203
DR   IGSR; NA19375
DR   Wikidata; Q54850405
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19376
AC   CVCL_P318
DR   CLO; CLO_0027423
DR   Coriell; GM19376
DR   GEO; GSM650026
DR   GEO; GSM1720204
DR   IGSR; NA19376
DR   Wikidata; Q54850406
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19377
AC   CVCL_P319
DR   CLO; CLO_0027421
DR   Coriell; GM19377
DR   GEO; GSM650027
DR   GEO; GSM1720205
DR   IGSR; NA19377
DR   Wikidata; Q54850407
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19378
AC   CVCL_P320
DR   Coriell; GM19378
DR   GEO; GSM1720206
DR   IGSR; NA19378
DR   Wikidata; Q54850408
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19379
AC   CVCL_P321
DR   CLO; CLO_0027415
DR   Coriell; GM19379
DR   GEO; GSM650028
DR   GEO; GSM1720207
DR   IGSR; NA19379
DR   Wikidata; Q54850409
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19380
AC   CVCL_P322
DR   CLO; CLO_0027416
DR   Coriell; GM19380
DR   GEO; GSM650029
DR   GEO; GSM1720208
DR   IGSR; NA19380
DR   Wikidata; Q54850410
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19381
AC   CVCL_P323
DR   CLO; CLO_0027413
DR   Coriell; GM19381
DR   GEO; GSM650030
DR   IGSR; NA19381
DR   Wikidata; Q54850411
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19382
AC   CVCL_P324
DR   CLO; CLO_0027414
DR   Coriell; GM19382
DR   GEO; GSM650031
DR   IGSR; NA19382
DR   Wikidata; Q54850440
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19383
AC   CVCL_P325
DR   CLO; CLO_0027419
DR   Coriell; GM19383
DR   GEO; GSM650032
DR   GEO; GSM1720209
DR   IGSR; NA19383
DR   Wikidata; Q54850441
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19384
AC   CVCL_P326
DR   CLO; CLO_0027420
DR   Coriell; GM19384
DR   GEO; GSM650033
DR   GEO; GSM1720210
DR   IGSR; NA19384
DR   Wikidata; Q54850443
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19385
AC   CVCL_P327
DR   CLO; CLO_0027417
DR   Coriell; GM19385
DR   GEO; GSM650034
DR   GEO; GSM1720211
DR   IGSR; NA19385
DR   Wikidata; Q54850444
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19390
AC   CVCL_P328
DR   CLO; CLO_0027418
DR   Coriell; GM19390
DR   GEO; GSM650035
DR   GEO; GSM1720212
DR   IGSR; NA19390
DR   Wikidata; Q54850445
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19391
AC   CVCL_P329
DR   CLO; CLO_0027412
DR   Coriell; GM19391
DR   GEO; GSM650036
DR   GEO; GSM1720213
DR   IGSR; NA19391
DR   Wikidata; Q54850446
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19392
AC   CVCL_P330
DR   Coriell; GM19392
DR   Wikidata; Q54850448
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19393
AC   CVCL_P331
DR   CLO; CLO_0026760
DR   Coriell; GM19393
DR   GEO; GSM650037
DR   GEO; GSM1720214
DR   IGSR; NA19393
DR   Wikidata; Q54850449
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19394
AC   CVCL_P332
DR   CLO; CLO_0026761
DR   Coriell; GM19394
DR   GEO; GSM650038
DR   GEO; GSM1720215
DR   IGSR; NA19394
DR   Wikidata; Q54850450
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19395
AC   CVCL_P333
DR   CLO; CLO_0026790
DR   Coriell; GM19395
DR   GEO; GSM650039
DR   GEO; GSM1720216
DR   IGSR; NA19395
DR   Wikidata; Q54850451
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19396
AC   CVCL_P334
DR   CLO; CLO_0026787
DR   Coriell; GM19396
DR   GEO; GSM650040
DR   IGSR; NA19396
DR   Wikidata; Q54850452
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19397
AC   CVCL_P335
DR   CLO; CLO_0026782
DR   Coriell; GM19397
DR   GEO; GSM650041
DR   GEO; GSM1720217
DR   IGSR; NA19397
DR   Wikidata; Q54850453
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19398
AC   CVCL_P336
DR   CLO; CLO_0026779
DR   Coriell; GM19398
DR   GEO; GSM650042
DR   IGSR; NA19398
DR   Wikidata; Q54850454
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19399
AC   CVCL_P337
DR   CLO; CLO_0026798
DR   Coriell; GM19399
DR   GEO; GSM650043
DR   GEO; GSM1720218
DR   IGSR; NA19399
DR   Wikidata; Q54850455
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19401
AC   CVCL_P338
DR   CLO; CLO_0026795
DR   Coriell; GM19401
DR   GEO; GSM650044
DR   GEO; GSM1720219
DR   IGSR; NA19401
DR   Wikidata; Q54850456
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19402
AC   CVCL_P339
DR   Coriell; GM19402
DR   Wikidata; Q54850457
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19403
AC   CVCL_P340
DR   CLO; CLO_0026794
DR   Coriell; GM19403
DR   GEO; GSM650045
DR   GEO; GSM1720220
DR   IGSR; NA19403
DR   Wikidata; Q54850458
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19404
AC   CVCL_P341
DR   CLO; CLO_0026792
DR   Coriell; GM19404
DR   GEO; GSM650046
DR   GEO; GSM1720221
DR   IGSR; NA19404
DR   Wikidata; Q54850459
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19428
AC   CVCL_P342
DR   CLO; CLO_0026802
DR   Coriell; GM19428
DR   GEO; GSM650047
DR   GEO; GSM1720222
DR   IGSR; NA19428
DR   Wikidata; Q54850460
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19429
AC   CVCL_P343
DR   CLO; CLO_0026803
DR   Coriell; GM19429
DR   GEO; GSM650048
DR   GEO; GSM1720223
DR   IGSR; NA19429
DR   Wikidata; Q54850461
RX   PubMed=21397061;
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Quadruplication; Zygosity=Unspecified (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Heterozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM19430
AC   CVCL_P344
DR   CLO; CLO_0026804
DR   Coriell; GM19430
DR   GEO; GSM650049
DR   GEO; GSM1720224
DR   IGSR; NA19430
DR   Wikidata; Q54850462
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19431
AC   CVCL_P345
DR   CLO; CLO_0026815
DR   Coriell; GM19431
DR   GEO; GSM650050
DR   GEO; GSM1720225
DR   IGSR; NA19431
DR   Wikidata; Q54850463
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19432
AC   CVCL_P346
DR   Coriell; GM19432
DR   IGSR; NA19432
DR   Wikidata; Q54850464
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19434
AC   CVCL_P347
DR   CLO; CLO_0026810
DR   Coriell; GM19434
DR   GEO; GSM650051
DR   GEO; GSM1720226
DR   IGSR; NA19434
DR   Wikidata; Q54850465
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19435
AC   CVCL_P348
DR   CLO; CLO_0026821
DR   Coriell; GM19435
DR   GEO; GSM650052
DR   GEO; GSM1720227
DR   IGSR; NA19435
DR   Wikidata; Q54850466
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19436
AC   CVCL_P349
DR   CLO; CLO_0026817
DR   Coriell; GM19436
DR   GEO; GSM650053
DR   GEO; GSM1720228
DR   IGSR; NA19436
DR   Wikidata; Q54850467
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19437
AC   CVCL_P350
DR   CLO; CLO_0026826
DR   Coriell; GM19437
DR   GEO; GSM650054
DR   GEO; GSM1720229
DR   IGSR; NA19437
DR   Wikidata; Q54850468
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19438
AC   CVCL_P351
DR   CLO; CLO_0026824
DR   Coriell; GM19438
DR   GEO; GSM650055
DR   GEO; GSM1720230
DR   IGSR; NA19438
DR   Wikidata; Q54850469
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19439
AC   CVCL_P352
DR   CLO; CLO_0026829
DR   Coriell; GM19439
DR   GEO; GSM650056
DR   GEO; GSM1720231
DR   IGSR; NA19439
DR   Wikidata; Q54850470
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19440
AC   CVCL_P353
DR   CLO; CLO_0026833
DR   Coriell; GM19440
DR   GEO; GSM650057
DR   GEO; GSM1720232
DR   IGSR; NA19440
DR   Wikidata; Q54850471
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19441
AC   CVCL_P354
DR   Coriell; GM19441
DR   Wikidata; Q54850472
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19443
AC   CVCL_P355
DR   CLO; CLO_0026834
DR   Coriell; GM19443
DR   GEO; GSM650058
DR   GEO; GSM1720233
DR   IGSR; NA19443
DR   Wikidata; Q54850473
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19444
AC   CVCL_P356
DR   CLO; CLO_0026831
DR   Coriell; GM19444
DR   GEO; GSM650059
DR   IGSR; NA19444
DR   Wikidata; Q54850474
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19445
AC   CVCL_P357
DR   CLO; CLO_0026832
DR   Coriell; GM19445
DR   GEO; GSM650060
DR   GEO; GSM1720234
DR   IGSR; NA19445
DR   Wikidata; Q54850475
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19446
AC   CVCL_P358
DR   CLO; CLO_0026856
DR   Coriell; GM19446
DR   GEO; GSM650061
DR   GEO; GSM1720235
DR   IGSR; NA19446
DR   Wikidata; Q54850476
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19448
AC   CVCL_P359
DR   CLO; CLO_0026853
DR   Coriell; GM19448
DR   GEO; GSM650062
DR   GEO; GSM1720236
DR   IGSR; NA19448
DR   Wikidata; Q54850477
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19449
AC   CVCL_P360
DR   CLO; CLO_0026851
DR   Coriell; GM19449
DR   GEO; GSM650063
DR   GEO; GSM1720237
DR   IGSR; NA19449
DR   Wikidata; Q54850478
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19451
AC   CVCL_P361
DR   CLO; CLO_0026848
DR   Coriell; GM19451
DR   GEO; GSM650064
DR   GEO; GSM1720238
DR   IGSR; NA19451
DR   Wikidata; Q54850479
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19452
AC   CVCL_P362
DR   CLO; CLO_0026846
DR   Coriell; GM19452
DR   GEO; GSM650065
DR   GEO; GSM1720239
DR   IGSR; NA19452
DR   Wikidata; Q54850480
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19453
AC   CVCL_P363
DR   CLO; CLO_0026842
DR   Coriell; GM19453
DR   IGSR; NA19453
DR   Wikidata; Q54850481
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19454
AC   CVCL_P364
DR   Coriell; GM19454
DR   GEO; GSM1720240
DR   IGSR; NA19454
DR   Wikidata; Q54850488
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19455
AC   CVCL_P365
DR   CLO; CLO_0026863
DR   Coriell; GM19455
DR   GEO; GSM650066
DR   GEO; GSM1720241
DR   IGSR; NA19455
DR   Wikidata; Q54850489
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19456
AC   CVCL_P366
DR   CLO; CLO_0026859
DR   Coriell; GM19456
DR   GEO; GSM650067
DR   GEO; GSM1720242
DR   IGSR; NA19456
DR   Wikidata; Q54850490
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Doubling time: Slow growth (Coriell=GM19456).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM19457
AC   CVCL_P367
DR   CLO; CLO_0026860
DR   Coriell; GM19457
DR   GEO; GSM650068
DR   GEO; GSM1720243
DR   IGSR; NA19457
DR   Wikidata; Q54850491
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19461
AC   CVCL_P368
DR   CLO; CLO_0026861
DR   Coriell; GM19461
DR   GEO; GSM1720244
DR   IGSR; NA19461
DR   Wikidata; Q54850493
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19462
AC   CVCL_P369
DR   CLO; CLO_0026862
DR   Coriell; GM19462
DR   GEO; GSM650069
DR   GEO; GSM1720245
DR   IGSR; NA19462
DR   Wikidata; Q54850494
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19463
AC   CVCL_P370
DR   CLO; CLO_0026874
DR   Coriell; GM19463
DR   GEO; GSM650070
DR   GEO; GSM1720246
DR   IGSR; NA19463
DR   Wikidata; Q54850495
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19466
AC   CVCL_P371
DR   CLO; CLO_0026871
DR   Coriell; GM19466
DR   GEO; GSM650071
DR   GEO; GSM1720247
DR   IGSR; NA19466
DR   Wikidata; Q54850496
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19467
AC   CVCL_P372
DR   CLO; CLO_0026877
DR   Coriell; GM19467
DR   GEO; GSM650072
DR   GEO; GSM1720248
DR   IGSR; NA19467
DR   Wikidata; Q54850497
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19468
AC   CVCL_P373
DR   CLO; CLO_0026875
DR   Coriell; GM19468
DR   GEO; GSM650073
DR   GEO; GSM1720249
DR   IGSR; NA19468
DR   Wikidata; Q54850498
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19469
AC   CVCL_P374
DR   CLO; CLO_0026867
DR   Coriell; GM19469
DR   GEO; GSM650074
DR   IGSR; NA19469
DR   Wikidata; Q54850499
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19470
AC   CVCL_P375
DR   CLO; CLO_0026612
DR   Coriell; GM19470
DR   GEO; GSM650075
DR   IGSR; NA19470
DR   Wikidata; Q54850500
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19471
AC   CVCL_P376
DR   CLO; CLO_0026611
DR   Coriell; GM19471
DR   GEO; GSM650076
DR   GEO; GSM1720250
DR   IGSR; NA19471
DR   Wikidata; Q54850501
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19472
AC   CVCL_P377
DR   CLO; CLO_0026623
DR   Coriell; GM19472
DR   GEO; GSM650077
DR   GEO; GSM1720251
DR   IGSR; NA19472
DR   Wikidata; Q54850502
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19473
AC   CVCL_P378
DR   CLO; CLO_0026620
DR   Coriell; GM19473
DR   GEO; GSM650078
DR   GEO; GSM1720252
DR   IGSR; NA19473
DR   Wikidata; Q54850503
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19474
AC   CVCL_P379
DR   CLO; CLO_0026618
DR   Coriell; GM19474
DR   GEO; GSM650079
DR   GEO; GSM1720253
DR   IGSR; NA19474
DR   Wikidata; Q54850504
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19475
AC   CVCL_P380
DR   Coriell; GM19475
DR   GEO; GSM1720254
DR   IGSR; NA19475
DR   Wikidata; Q54850505
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Luhya in Webuye, Kenya (LWK).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19476
AC   CVCL_AM79
DR   CLO; CLO_0026616
DR   Coriell; GM19476
DR   Wikidata; Q54850506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM19480
AC   CVCL_AM89
DR   CLO; CLO_0026632
DR   Coriell; GM19480
DR   Wikidata; Q54850507
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM90 ! GM19481
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM19481
AC   CVCL_AM90
DR   CLO; CLO_0026633
DR   Coriell; GM19481
DR   Wikidata; Q54850508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM89 ! GM19480
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM19482
AC   CVCL_AM91
DR   CLO; CLO_0026625
DR   Coriell; GM19482
DR   Wikidata; Q54850509
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM92 ! GM19483
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM19483
AC   CVCL_AM92
DR   CLO; CLO_0026628
DR   Coriell; GM19483
DR   Wikidata; Q54850510
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM91 ! GM19482
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM19484
AC   CVCL_AM93
DR   CLO; CLO_0026931
DR   Coriell; GM19484
DR   Wikidata; Q54850511
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM94 ! GM19485
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM19485
AC   CVCL_AM94
DR   CLO; CLO_0026929
DR   Coriell; GM19485
DR   Wikidata; Q54850512
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM93 ! GM19484
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM19490
AC   CVCL_AM95
DR   CLO; CLO_0026927
DR   Coriell; GM19490
DR   Wikidata; Q54850513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM96 ! GM19491
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM19491
AC   CVCL_AM96
DR   CLO; CLO_0026926
DR   Coriell; GM19491
DR   Wikidata; Q54850514
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM95 ! GM19490
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM19542
AC   CVCL_AM80
DR   CLO; CLO_0026924
DR   Coriell; GM19542
DR   Wikidata; Q54850515
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM81 ! GM19543
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM19543
AC   CVCL_AM81
DR   CLO; CLO_0026923
DR   Coriell; GM19543
DR   Wikidata; Q54850516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AM80 ! GM19542
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM19545
AC   CVCL_P129
DR   Coriell; GM19545
DR   Wikidata; Q54850517
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19546
AC   CVCL_P130
DR   Coriell; GM19546
DR   Wikidata; Q54850518
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19548
AC   CVCL_P131
DR   Coriell; GM19548
DR   Wikidata; Q54850519
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19550
AC   CVCL_P132
DR   Coriell; GM19550
DR   Wikidata; Q54850520
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19551
AC   CVCL_1A28
DR   Coriell; GM19551
DR   Wikidata; Q54850521
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19552
AC   CVCL_1A29
DR   Coriell; GM19552
DR   Wikidata; Q54850522
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19553
AC   CVCL_1A30
DR   Coriell; GM19553
DR   Wikidata; Q54850523
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19554
AC   CVCL_1A31
DR   Coriell; GM19554
DR   Wikidata; Q54850524
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19555
AC   CVCL_1A32
DR   Coriell; GM19555
DR   Wikidata; Q54850525
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19556
AC   CVCL_P133
DR   Coriell; GM19556
DR   Wikidata; Q54850526
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19557
AC   CVCL_P134
DR   Coriell; GM19557
DR   Wikidata; Q54850527
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19558
AC   CVCL_P135
DR   Coriell; GM19558
DR   Wikidata; Q54850528
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19559
AC   CVCL_P136
DR   Coriell; GM19559
DR   Wikidata; Q54850534
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19560
AC   CVCL_1A33
DR   Coriell; GM19560
DR   Wikidata; Q54850535
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19561
AC   CVCL_1A34
DR   Coriell; GM19561
DR   Wikidata; Q54850536
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19562
AC   CVCL_P137
DR   Coriell; GM19562
DR   Wikidata; Q54850537
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19563
AC   CVCL_P138
DR   Coriell; GM19563
DR   Wikidata; Q54850538
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19564
AC   CVCL_P139
DR   Coriell; GM19564
DR   Wikidata; Q54850539
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19565
AC   CVCL_1A35
DR   Coriell; GM19565
DR   Wikidata; Q54850540
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19566
AC   CVCL_P140
DR   Coriell; GM19566
DR   Wikidata; Q54850541
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19568
AC   CVCL_1A36
DR   Coriell; GM19568
DR   Wikidata; Q54850543
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19569
AC   CVCL_P141
DR   Coriell; GM19569
DR   Wikidata; Q54850544
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19570
AC   CVCL_P142
DR   Coriell; GM19570
DR   Wikidata; Q54850545
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM19572
AC   CVCL_1A37
DR   Coriell; GM19572
DR   Wikidata; Q54850546
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM19573
AC   CVCL_P143
DR   Coriell; GM19573
DR   Wikidata; Q54850547
RX   PubMed=30485824;
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19574
AC   CVCL_1A38
DR   Coriell; GM19574
DR   Wikidata; Q54850549
RX   PubMed=30485824;
CC   Population: Japanese in Tokyo (JPT).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19625
AC   CVCL_N854
DR   CLO; CLO_0026922
DR   Coriell; GM19625
DR   GEO; GSM650080
DR   GEO; GSM1720255
DR   IGSR; NA19625
DR   Wikidata; Q54850550
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19632
AC   CVCL_AN03
DR   CLO; CLO_0026921
DR   Coriell; GM19632
DR   Wikidata; Q54850551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AN04 ! GM19633
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM19633
AC   CVCL_AN04
DR   CLO; CLO_0026920
DR   Coriell; GM19633
DR   Wikidata; Q54850552
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AN03 ! GM19632
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM19634
AC   CVCL_1N15
DR   CLO; CLO_0026919
DR   Coriell; GM19634
DR   Wikidata; Q54850553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N16 ! GM19647
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19647
AC   CVCL_1N16
DR   CLO; CLO_0026964
DR   Coriell; GM19647
DR   Wikidata; Q54850554
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N15 ! GM19634
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19648
AC   CVCL_P381
DR   CLO; CLO_0026967
DR   Coriell; GM19648
DR   GEO; GSM650081
DR   GEO; GSM1720256
DR   IGSR; NA19648
DR   Wikidata; Q54850555
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19649
AC   CVCL_P382
DR   CLO; CLO_0026966
DR   Coriell; GM19649
DR   GEO; GSM650082
DR   GEO; GSM1720257
DR   IGSR; NA19649
DR   Wikidata; Q54850556
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19650
AC   CVCL_1A39
DR   CLO; CLO_0026972
DR   Coriell; GM19650
DR   GEO; GSM650083
DR   IGSR; NA19650
DR   Wikidata; Q54850557
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19651
AC   CVCL_P383
DR   CLO; CLO_0026970
DR   Coriell; GM19651
DR   GEO; GSM650084
DR   GEO; GSM1720258
DR   IGSR; NA19651
DR   Wikidata; Q54850558
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19652
AC   CVCL_P384
DR   CLO; CLO_0026960
DR   Coriell; GM19652
DR   GEO; GSM650085
DR   GEO; GSM1720259
DR   IGSR; NA19652
DR   Wikidata; Q54850559
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19653
AC   CVCL_1A40
DR   CLO; CLO_0026959
DR   Coriell; GM19653
DR   GEO; GSM650086
DR   IGSR; NA19653
DR   Wikidata; Q54850560
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19654
AC   CVCL_P385
DR   CLO; CLO_0026962
DR   Coriell; GM19654
DR   GEO; GSM650087
DR   GEO; GSM1720260
DR   IGSR; NA19654
DR   Wikidata; Q54850561
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19655
AC   CVCL_P386
DR   CLO; CLO_0026961
DR   Coriell; GM19655
DR   GEO; GSM650088
DR   GEO; GSM1720261
DR   IGSR; NA19655
DR   Wikidata; Q54850562
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19656
AC   CVCL_1A41
DR   CLO; CLO_0026963
DR   Coriell; GM19656
DR   GEO; GSM650089
DR   IGSR; NA19656
DR   Wikidata; Q54850563
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19657
AC   CVCL_P387
DR   CLO; CLO_0026954
DR   Coriell; GM19657
DR   GEO; GSM650090
DR   GEO; GSM1720262
DR   IGSR; NA19657
DR   Wikidata; Q54850564
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19658
AC   CVCL_P388
DR   CLO; CLO_0026953
DR   Coriell; GM19658
DR   GEO; GSM650091
DR   GEO; GSM1720263
DR   IGSR; NA19658
DR   Wikidata; Q54850565
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19659
AC   CVCL_1A42
DR   CLO; CLO_0026958
DR   Coriell; GM19659
DR   GEO; GSM650092
DR   IGSR; NA19659
DR   Wikidata; Q54850566
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19660
AC   CVCL_P389
DR   CLO; CLO_0026957
DR   Coriell; GM19660
DR   GEO; GSM650093
DR   GEO; GSM1720264
DR   IGSR; NA19660
DR   Wikidata; Q54850567
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19661
AC   CVCL_P390
DR   CLO; CLO_0026956
DR   Coriell; GM19661
DR   GEO; GSM650094
DR   GEO; GSM1720265
DR   IGSR; NA19661
DR   Wikidata; Q54850568
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19662
AC   CVCL_1A43
DR   CLO; CLO_0026955
DR   Coriell; GM19662
DR   GEO; GSM650095
DR   IGSR; NA19662
DR   Wikidata; Q54850569
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19663
AC   CVCL_P391
DR   CLO; CLO_0026952
DR   Coriell; GM19663
DR   GEO; GSM650096
DR   GEO; GSM1720266
DR   IGSR; NA19663
DR   Wikidata; Q54850570
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19664
AC   CVCL_P392
DR   CLO; CLO_0026951
DR   Coriell; GM19664
DR   GEO; GSM650097
DR   GEO; GSM1720267
DR   IGSR; NA19664
DR   Wikidata; Q54850571
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19665
AC   CVCL_1A44
DR   CLO; CLO_0026950
DR   Coriell; GM19665
DR   GEO; GSM650098
DR   IGSR; NA19665
DR   Wikidata; Q54850572
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19669
AC   CVCL_P393
DR   CLO; CLO_0026949
DR   Coriell; GM19669
DR   GEO; GSM650099
DR   GEO; GSM1720268
DR   IGSR; NA19669
DR   Wikidata; Q54850573
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19670
AC   CVCL_P394
DR   CLO; CLO_0026893
DR   Coriell; GM19670
DR   GEO; GSM650100
DR   GEO; GSM1720269
DR   IGSR; NA19670
DR   Wikidata; Q54850574
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19671
AC   CVCL_1A45
DR   CLO; CLO_0026894
DR   Coriell; GM19671
DR   GEO; GSM650101
DR   IGSR; NA19671
DR   Wikidata; Q54850575
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19672
AC   CVCL_P395
DR   Coriell; GM19672
DR   GEO; GSM650102
DR   IGSR; NA19672
DR   Wikidata; Q54850583
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19674
AC   CVCL_1A46
DR   Coriell; GM19674
DR   IGSR; NA19674
DR   Wikidata; Q54850584
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM19674; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19675
AC   CVCL_P396
DR   CLO; CLO_0026895
DR   Coriell; GM19675
DR   GEO; GSM650103
DR   GEO; GSM1720270
DR   IGSR; NA19675
DR   Wikidata; Q54850585
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19676
AC   CVCL_P397
DR   CLO; CLO_0026889
DR   Coriell; GM19676
DR   GEO; GSM650104
DR   GEO; GSM1720271
DR   IGSR; NA19676
DR   Wikidata; Q54850586
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19677
AC   CVCL_1A47
DR   CLO; CLO_0026890
DR   Coriell; GM19677
DR   GEO; GSM650105
DR   IGSR; NA19677
DR   Wikidata; Q54850587
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19678
AC   CVCL_P398
DR   CLO; CLO_0026891
DR   Coriell; GM19678
DR   GEO; GSM650106
DR   GEO; GSM1720272
DR   IGSR; NA19678
DR   Wikidata; Q54850588
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19679
AC   CVCL_P399
DR   CLO; CLO_0026892
DR   Coriell; GM19679
DR   GEO; GSM650107
DR   GEO; GSM1720273
DR   IGSR; NA19679
DR   Wikidata; Q54850589
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19680
AC   CVCL_1A48
DR   CLO; CLO_0026896
DR   Coriell; GM19680
DR   GEO; GSM650108
DR   IGSR; NA19680
DR   Wikidata; Q54850590
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19681
AC   CVCL_P400
DR   CLO; CLO_0026897
DR   Coriell; GM19681
DR   GEO; GSM650109
DR   GEO; GSM1720274
DR   IGSR; NA19681
DR   Wikidata; Q54850592
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19682
AC   CVCL_P401
DR   CLO; CLO_0026898
DR   Coriell; GM19682
DR   GEO; GSM650110
DR   GEO; GSM1720275
DR   IGSR; NA19682
DR   Wikidata; Q54850593
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19683
AC   CVCL_1A49
DR   CLO; CLO_0026885
DR   Coriell; GM19683
DR   GEO; GSM650111
DR   IGSR; NA19683
DR   Wikidata; Q54850594
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19684
AC   CVCL_P402
DR   CLO; CLO_0026886
DR   Coriell; GM19684
DR   GEO; GSM650112
DR   GEO; GSM1720276
DR   IGSR; NA19684
DR   Wikidata; Q54850595
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19685
AC   CVCL_P403
DR   CLO; CLO_0026883
DR   Coriell; GM19685
DR   GEO; GSM650113
DR   GEO; GSM1720277
DR   IGSR; NA19685
DR   Wikidata; Q54850596
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19686
AC   CVCL_1A50
DR   CLO; CLO_0026884
DR   Coriell; GM19686
DR   GEO; GSM650114
DR   IGSR; NA19686
DR   Wikidata; Q54850598
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19687
AC   CVCL_1N17
DR   CLO; CLO_0026881
DR   Coriell; GM19687
DR   Wikidata; Q54850599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N18 ! GM19688
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19688
AC   CVCL_1N18
DR   CLO; CLO_0026882
DR   Coriell; GM19688
DR   Wikidata; Q54850600
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N17 ! GM19687
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM19693
AC   CVCL_1N19
DR   CLO; CLO_0026879
DR   Coriell; GM19693
DR   Wikidata; Q54850601
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N20 ! GM19694
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19694
AC   CVCL_1N20
DR   CLO; CLO_0026880
DR   Coriell; GM19694
DR   Wikidata; Q54850602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N19 ! GM19693
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19695
AC   CVCL_1N21
DR   CLO; CLO_0026887
DR   Coriell; GM19695
DR   Wikidata; Q54850603
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N22 ! GM19696
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19696
AC   CVCL_1N22
DR   CLO; CLO_0026888
DR   Coriell; GM19696
DR   Wikidata; Q54850604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N21 ! GM19695
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19698
AC   CVCL_1N23
DR   CLO; CLO_0026918
DR   Coriell; GM19698
DR   Wikidata; Q54850605
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM19700
AC   CVCL_N855
DR   CLO; CLO_0026909
DR   Coriell; GM19700
DR   GEO; GSM650115
DR   GEO; GSM1720278
DR   IGSR; NA19700
DR   Wikidata; Q54850606
RX   PubMed=21397061;
RX   PubMed=26621101;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19701
AC   CVCL_N856
DR   CLO; CLO_0026910
DR   Coriell; GM19701
DR   GEO; GSM650116
DR   GEO; GSM1720279
DR   IGSR; NA19701
DR   Wikidata; Q54850607
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19702
AC   CVCL_1A51
DR   CLO; CLO_0026911
DR   Coriell; GM19702
DR   GEO; GSM650117
DR   IGSR; NA19702
DR   Wikidata; Q54850608
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19703
AC   CVCL_N857
DR   CLO; CLO_0026912
DR   Coriell; GM19703
DR   GEO; GSM650118
DR   GEO; GSM1720280
DR   IGSR; NA19703
DR   Wikidata; Q54850609
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19704
AC   CVCL_N858
DR   CLO; CLO_0026913
DR   Coriell; GM19704
DR   GEO; GSM650119
DR   GEO; GSM1720281
DR   IGSR; NA19704
DR   Wikidata; Q54850610
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19705
AC   CVCL_1A52
DR   CLO; CLO_0026914
DR   Coriell; GM19705
DR   GEO; GSM650120
DR   IGSR; NA19705
DR   Wikidata; Q54850611
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19707
AC   CVCL_N859
DR   CLO; CLO_0026915
DR   Coriell; GM19707
DR   GEO; GSM650121
DR   GEO; GSM1720282
DR   IGSR; NA19707
DR   Wikidata; Q54850612
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19708
AC   CVCL_1A53
DR   CLO; CLO_0026916
DR   Coriell; GM19708
DR   GEO; GSM650122
DR   IGSR; NA19708
DR   Wikidata; Q54850613
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19711
AC   CVCL_N860
DR   CLO; CLO_0026917
DR   Coriell; GM19711
DR   GEO; GSM650123
DR   GEO; GSM1720283
DR   IGSR; NA19711
DR   Wikidata; Q54850614
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19712
AC   CVCL_N861
DR   CLO; CLO_0026908
DR   Coriell; GM19712
DR   GEO; GSM650124
DR   GEO; GSM1720284
DR   IGSR; NA19712
DR   Wikidata; Q54850617
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19713
AC   CVCL_N862
DR   CLO; CLO_0026907
DR   Coriell; GM19713
DR   GEO; GSM650125
DR   GEO; GSM1720285
DR   IGSR; NA19713
DR   Wikidata; Q54850618
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19714
AC   CVCL_1A54
DR   CLO; CLO_0026901
DR   Coriell; GM19714
DR   GEO; GSM650126
DR   IGSR; NA19714
DR   Wikidata; Q54850619
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19715
AC   CVCL_5R00
DR   Coriell; GM19715
DR   Wikidata; Q54850620
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124840; Shprintzen-Goldberg craniosynostosis syndrome
DI   ORDO; Orphanet_2462; Shprintzen-Goldberg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM19716
AC   CVCL_P404
DR   CLO; CLO_0026902
DR   Coriell; GM19716
DR   GEO; GSM650127
DR   GEO; GSM1720286
DR   IGSR; NA19716
DR   Wikidata; Q54850621
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19717
AC   CVCL_P405
DR   CLO; CLO_0026899
DR   Coriell; GM19717
DR   GEO; GSM650128
DR   GEO; GSM1720287
DR   IGSR; NA19717
DR   Wikidata; Q54850622
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19718
AC   CVCL_1A55
DR   CLO; CLO_0026900
DR   Coriell; GM19718
DR   GEO; GSM650129
DR   IGSR; NA19718
DR   Wikidata; Q54850623
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19719
AC   CVCL_P406
DR   CLO; CLO_0026905
DR   Coriell; GM19719
DR   GEO; GSM650130
DR   GEO; GSM1720288
DR   IGSR; NA19719
DR   Wikidata; Q54850624
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19720
AC   CVCL_P407
DR   CLO; CLO_0026906
DR   Coriell; GM19720
DR   GEO; GSM650131
DR   GEO; GSM1720289
DR   IGSR; NA19720
DR   Wikidata; Q54850626
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19721
AC   CVCL_1A56
DR   CLO; CLO_0026903
DR   Coriell; GM19721
DR   GEO; GSM650132
DR   IGSR; NA19721
DR   Wikidata; Q54850627
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19722
AC   CVCL_P408
DR   CLO; CLO_0026904
DR   Coriell; GM19722
DR   GEO; GSM650133
DR   GEO; GSM1720290
DR   IGSR; NA19722
DR   Wikidata; Q54850635
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19723
AC   CVCL_P409
DR   CLO; CLO_0028154
DR   Coriell; GM19723
DR   GEO; GSM650134
DR   GEO; GSM1720291
DR   IGSR; NA19723
DR   Wikidata; Q54850636
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19724
AC   CVCL_1A57
DR   CLO; CLO_0028152
DR   Coriell; GM19724
DR   GEO; GSM650135
DR   IGSR; NA19724
DR   Wikidata; Q54850637
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19725
AC   CVCL_P410
DR   CLO; CLO_0028153
DR   Coriell; GM19725
DR   GEO; GSM650136
DR   GEO; GSM1720292
DR   IGSR; NA19725
DR   Wikidata; Q54850638
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19726
AC   CVCL_P411
DR   CLO; CLO_0028130
DR   Coriell; GM19726
DR   GEO; GSM650137
DR   GEO; GSM1720293
DR   IGSR; NA19726
DR   Wikidata; Q54850640
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19727
AC   CVCL_1A58
DR   CLO; CLO_0028129
DR   Coriell; GM19727
DR   GEO; GSM650138
DR   IGSR; NA19727
DR   Wikidata; Q54850641
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19728
AC   CVCL_P412
DR   CLO; CLO_0028127
DR   Coriell; GM19728
DR   GEO; GSM650139
DR   GEO; GSM1720294
DR   IGSR; NA19728
DR   Wikidata; Q54850642
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19729
AC   CVCL_P413
DR   CLO; CLO_0028124
DR   Coriell; GM19729
DR   GEO; GSM650140
DR   GEO; GSM1720295
DR   IGSR; NA19729
DR   Wikidata; Q54850644
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19730
AC   CVCL_1A59
DR   CLO; CLO_0028136
DR   Coriell; GM19730
DR   GEO; GSM650141
DR   IGSR; NA19730
DR   Wikidata; Q54850646
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19731
AC   CVCL_P414
DR   CLO; CLO_0028134
DR   Coriell; GM19731
DR   GEO; GSM650142
DR   GEO; GSM1720296
DR   IGSR; NA19731
DR   Wikidata; Q54850647
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19732
AC   CVCL_P415
DR   CLO; CLO_0028132
DR   Coriell; GM19732
DR   GEO; GSM650143
DR   GEO; GSM1720297
DR   IGSR; NA19732
DR   Wikidata; Q54850648
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19733
AC   CVCL_1A60
DR   CLO; CLO_0028182
DR   Coriell; GM19733
DR   GEO; GSM650144
DR   IGSR; NA19733
DR   Wikidata; Q54850649
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19734
AC   CVCL_P416
DR   Coriell; GM19734
DR   GEO; GSM650145
DR   GEO; GSM1720298
DR   IGSR; NA19734
DR   Wikidata; Q54850650
RX   PubMed=21397061;
RX   PubMed=30485824;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19735
AC   CVCL_P417
DR   Coriell; GM19735
DR   GEO; GSM650146
DR   GEO; GSM1720299
DR   IGSR; NA19735
DR   Wikidata; Q54850651
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19737
AC   CVCL_P418
DR   Coriell; GM19737
DR   GEO; GSM650147
DR   IGSR; NA19737
DR   Wikidata; Q54850652
RX   PubMed=21397061;
RX   PubMed=30485824;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19738
AC   CVCL_P419
DR   Coriell; GM19738
DR   GEO; GSM650148
DR   IGSR; NA19738
DR   Wikidata; Q54850653
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19740
AC   CVCL_P420
DR   Coriell; GM19740
DR   GEO; GSM650149
DR   GEO; GSM1720300
DR   IGSR; NA19740
DR   Wikidata; Q54850655
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19741
AC   CVCL_P421
DR   Coriell; GM19741
DR   GEO; GSM650150
DR   GEO; GSM1720301
DR   IGSR; NA19741
DR   Wikidata; Q54850656
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19742
AC   CVCL_1A61
DR   Coriell; GM19742
DR   IGSR; NA19742
DR   Wikidata; Q54850657
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM19742; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19743
AC   CVCL_1N24
DR   CLO; CLO_0028183
DR   Coriell; GM19743
DR   Wikidata; Q54850658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19744
AC   CVCL_1N25
DR   CLO; CLO_0028184
DR   Coriell; GM19744
DR   Wikidata; Q54850659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19745
AC   CVCL_1N26
DR   CLO; CLO_0028185
DR   Coriell; GM19745
DR   Wikidata; Q54850660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM19746
AC   CVCL_P422
DR   CLO; CLO_0028157
DR   Coriell; GM19746
DR   GEO; GSM650151
DR   GEO; GSM1720302
DR   IGSR; NA19746
DR   Wikidata; Q54850661
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19747
AC   CVCL_P423
DR   CLO; CLO_0028155
DR   Coriell; GM19747
DR   GEO; GSM650152
DR   GEO; GSM1720303
DR   IGSR; NA19747
DR   Wikidata; Q54850662
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19748
AC   CVCL_1A62
DR   CLO; CLO_0028162
DR   Coriell; GM19748
DR   GEO; GSM650153
DR   IGSR; NA19748
DR   Wikidata; Q54850663
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19749
AC   CVCL_P424
DR   CLO; CLO_0028159
DR   Coriell; GM19749
DR   GEO; GSM650154
DR   GEO; GSM1720304
DR   IGSR; NA19749
DR   Wikidata; Q54850665
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19750
AC   CVCL_P425
DR   CLO; CLO_0028165
DR   Coriell; GM19750
DR   GEO; GSM650155
DR   GEO; GSM1720305
DR   IGSR; NA19750
DR   Wikidata; Q54850666
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19751
AC   CVCL_1A63
DR   CLO; CLO_0028163
DR   Coriell; GM19751
DR   GEO; GSM650156
DR   IGSR; NA19751
DR   Wikidata; Q54850667
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19752
AC   CVCL_P426
DR   Coriell; GM19752
DR   GEO; GSM650157
DR   GEO; GSM1720306
DR   IGSR; NA19752
DR   Wikidata; Q54850668
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19753
AC   CVCL_P427
DR   Coriell; GM19753
DR   IGSR; NA19753
DR   Wikidata; Q54850669
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19754
AC   CVCL_1A64
DR   Coriell; GM19754
DR   IGSR; NA19754
DR   Wikidata; Q54850670
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM19754; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19755
AC   CVCL_P428
DR   CLO; CLO_0028102
DR   Coriell; GM19755
DR   GEO; GSM650158
DR   GEO; GSM1720307
DR   IGSR; NA19755
DR   Wikidata; Q54850671
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19756
AC   CVCL_P429
DR   CLO; CLO_0028100
DR   Coriell; GM19756
DR   GEO; GSM650159
DR   GEO; GSM1720308
DR   IGSR; NA19756
DR   Wikidata; Q54850672
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19757
AC   CVCL_1A65
DR   CLO; CLO_0028101
DR   Coriell; GM19757
DR   GEO; GSM650160
DR   IGSR; NA19757
DR   Wikidata; Q54850673
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19758
AC   CVCL_P430
DR   CLO; CLO_0028098
DR   Coriell; GM19758
DR   GEO; GSM650161
DR   GEO; GSM1720309
DR   IGSR; NA19758
DR   Wikidata; Q54850674
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19759
AC   CVCL_P431
DR   CLO; CLO_0028099
DR   Coriell; GM19759
DR   GEO; GSM650162
DR   GEO; GSM1720310
DR   IGSR; NA19759
DR   Wikidata; Q54850675
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19760
AC   CVCL_1A66
DR   CLO; CLO_0028083
DR   Coriell; GM19760
DR   GEO; GSM650163
DR   IGSR; NA19760
DR   Wikidata; Q54850676
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19761
AC   CVCL_P432
DR   CLO; CLO_0028081
DR   Coriell; GM19761
DR   GEO; GSM650164
DR   GEO; GSM1720311
DR   IGSR; NA19761
DR   Wikidata; Q54850677
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19762
AC   CVCL_P433
DR   CLO; CLO_0028079
DR   Coriell; GM19762
DR   GEO; GSM650165
DR   GEO; GSM1720312
DR   IGSR; NA19762
DR   Wikidata; Q54850678
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19763
AC   CVCL_1A67
DR   CLO; CLO_0028077
DR   Coriell; GM19763
DR   GEO; GSM650166
DR   IGSR; NA19763
DR   Wikidata; Q54850679
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19764
AC   CVCL_P434
DR   Coriell; GM19764
DR   GEO; GSM1720313
DR   IGSR; NA19764
DR   Wikidata; Q54850688
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19766
AC   CVCL_1A68
DR   Coriell; GM19766
DR   IGSR; NA19766
DR   Wikidata; Q54850689
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM19766; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19768
AC   CVCL_1A69
DR   Coriell; GM19768
DR   Wikidata; Q54850690
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM19770
AC   CVCL_P435
DR   CLO; CLO_0028076
DR   Coriell; GM19770
DR   GEO; GSM650167
DR   GEO; GSM1720314
DR   IGSR; NA19770
DR   Wikidata; Q54850691
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19771
AC   CVCL_P436
DR   CLO; CLO_0028438
DR   Coriell; GM19771
DR   GEO; GSM650168
DR   GEO; GSM1720315
DR   IGSR; NA19771
DR   Wikidata; Q54850692
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19772
AC   CVCL_1A70
DR   CLO; CLO_0028439
DR   Coriell; GM19772
DR   GEO; GSM650169
DR   IGSR; NA19772
DR   Wikidata; Q54850694
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19773
AC   CVCL_P437
DR   CLO; CLO_0028440
DR   Coriell; GM19773
DR   GEO; GSM650170
DR   GEO; GSM1720316
DR   IGSR; NA19773
DR   Wikidata; Q54850695
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19774
AC   CVCL_P438
DR   CLO; CLO_0028423
DR   Coriell; GM19774
DR   GEO; GSM650171
DR   GEO; GSM1720317
DR   IGSR; NA19774
DR   Wikidata; Q54850696
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19775
AC   CVCL_1A71
DR   CLO; CLO_0028425
DR   Coriell; GM19775
DR   GEO; GSM650172
DR   IGSR; NA19775
DR   Wikidata; Q54850697
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19776
AC   CVCL_P439
DR   CLO; CLO_0028428
DR   Coriell; GM19776
DR   GEO; GSM650173
DR   GEO; GSM1720318
DR   IGSR; NA19776
DR   Wikidata; Q54850698
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19777
AC   CVCL_P440
DR   CLO; CLO_0028430
DR   Coriell; GM19777
DR   GEO; GSM650174
DR   GEO; GSM1720319
DR   IGSR; NA19777
DR   Wikidata; Q54850699
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19778
AC   CVCL_1A72
DR   CLO; CLO_0028432
DR   Coriell; GM19778
DR   GEO; GSM650175
DR   IGSR; NA19778
DR   Wikidata; Q54850700
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19779
AC   CVCL_P441
DR   CLO; CLO_0028434
DR   Coriell; GM19779
DR   GEO; GSM650176
DR   GEO; GSM1720320
DR   IGSR; NA19779
DR   Wikidata; Q54850701
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19780
AC   CVCL_P442
DR   CLO; CLO_0028436
DR   Coriell; GM19780
DR   GEO; GSM650177
DR   GEO; GSM1720321
DR   IGSR; NA19780
DR   Wikidata; Q54850702
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19781
AC   CVCL_1A73
DR   CLO; CLO_0028296
DR   Coriell; GM19781
DR   GEO; GSM650178
DR   IGSR; NA19781
DR   Wikidata; Q54850703
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19782
AC   CVCL_P443
DR   CLO; CLO_0028295
DR   Coriell; GM19782
DR   GEO; GSM650179
DR   GEO; GSM1720322
DR   IGSR; NA19782
DR   Wikidata; Q54850704
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19783
AC   CVCL_P444
DR   CLO; CLO_0028301
DR   Coriell; GM19783
DR   GEO; GSM650180
DR   GEO; GSM1720323
DR   IGSR; NA19783
DR   Wikidata; Q54850705
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19784
AC   CVCL_1A74
DR   CLO; CLO_0028298
DR   Coriell; GM19784
DR   GEO; GSM650181
DR   IGSR; NA19784
DR   Wikidata; Q54850706
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19785
AC   CVCL_P445
DR   CLO; CLO_0028306
DR   Coriell; GM19785
DR   GEO; GSM650182
DR   GEO; GSM1720324
DR   IGSR; NA19785
DR   Wikidata; Q54850707
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19786
AC   CVCL_P446
DR   CLO; CLO_0028305
DR   Coriell; GM19786
DR   GEO; GSM650183
DR   GEO; GSM1720325
DR   IGSR; NA19786
DR   Wikidata; Q54850708
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19787
AC   CVCL_1A75
DR   CLO; CLO_0028308
DR   Coriell; GM19787
DR   GEO; GSM650184
DR   IGSR; NA19787
DR   Wikidata; Q54850709
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19788
AC   CVCL_P447
DR   CLO; CLO_0028307
DR   Coriell; GM19788
DR   GEO; GSM650185
DR   GEO; GSM1720326
DR   IGSR; NA19788
DR   Wikidata; Q54850710
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19789
AC   CVCL_P448
DR   CLO; CLO_0028304
DR   Coriell; GM19789
DR   GEO; GSM650186
DR   GEO; GSM1720327
DR   IGSR; NA19789
DR   Wikidata; Q54850712
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19790
AC   CVCL_1A76
DR   CLO; CLO_0028303
DR   Coriell; GM19790
DR   GEO; GSM650187
DR   IGSR; NA19790
DR   Wikidata; Q54850713
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19792
AC   CVCL_P449
DR   Coriell; GM19792
DR   GEO; GSM1720328
DR   IGSR; NA19792
DR   Wikidata; Q54850714
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19794
AC   CVCL_P450
DR   CLO; CLO_0028283
DR   Coriell; GM19794
DR   GEO; GSM650188
DR   GEO; GSM1720329
DR   IGSR; NA19794
DR   Wikidata; Q54850715
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19795
AC   CVCL_P451
DR   CLO; CLO_0028282
DR   Coriell; GM19795
DR   GEO; GSM650189
DR   GEO; GSM1720330
DR   IGSR; NA19795
DR   Wikidata; Q54850716
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19796
AC   CVCL_1A77
DR   CLO; CLO_0028281
DR   Coriell; GM19796
DR   GEO; GSM650190
DR   IGSR; NA19796
DR   Wikidata; Q54850717
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19797
AC   CVCL_1A78
DR   Coriell; GM19797
DR   IGSR; NA19797
DR   Wikidata; Q54850718
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19798
AC   CVCL_1A79
DR   Coriell; GM19798
DR   IGSR; NA19798
DR   Wikidata; Q54850719
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Mexican ancestry in Los Angeles, USA (MXL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19800
AC   CVCL_AA05
DR   CLO; CLO_0028280
DR   Coriell; GM19800
DR   Wikidata; Q54850720
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Met514Val (c.1540A>G) (1539A>G); ClinVar=VCV000201125; Zygosity=Unspecified (Coriell=GM19800).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM19801
AC   CVCL_AA06
DR   CLO; CLO_0028279
DR   Coriell; GM19801
DR   Wikidata; Q54850721
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Phe96del (c.286_288delTTC) (c.285CTT[1]); ClinVar=VCV000003288; Zygosity=Unspecified (Coriell=GM19801).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM19802
AC   CVCL_AA07
DR   CLO; CLO_0028288
DR   Coriell; GM19802
DR   Wikidata; Q54850722
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Leu542His (c.1625T>A); ClinVar=VCV002138435; Zygosity=Unspecified (Coriell=GM19802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM19808
AC   CVCL_H529
DR   CLO; CLO_0028287
DR   Coriell; GM19808
DR   Wikidata; Q54850723
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   GM19809
AC   CVCL_9Y47
DR   CLO; CLO_0028286
DR   Coriell; GM19809
DR   Wikidata; Q54850724
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM19813
AC   CVCL_9Y48
DR   CLO; CLO_0028285
DR   Coriell; GM19813
DR   Wikidata; Q54850725
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM19814
AC   CVCL_2U57
DR   CLO; CLO_0028284
DR   Coriell; GM19814
DR   Wikidata; Q54850726
CC   Karyotypic information: 46,XY,t(4;9)(4qter->4p15.2::9p13->9pter;9qter->9p13::4p15.2->4pter) (Coriell=GM19814).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM19815
AC   CVCL_F095
DR   CLO; CLO_0028270
DR   Coriell; GM19815
DR   Wikidata; Q54850727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM19818
AC   CVCL_N863
DR   CLO; CLO_0028269
DR   Coriell; GM19818
DR   GEO; GSM650191
DR   GEO; GSM1720331
DR   IGSR; NA19818
DR   Wikidata; Q54850728
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19819
AC   CVCL_N864
DR   CLO; CLO_0028272
DR   Coriell; GM19819
DR   GEO; GSM650192
DR   GEO; GSM1720332
DR   IGSR; NA19819
DR   Wikidata; Q54850729
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19828
AC   CVCL_1A80
DR   CLO; CLO_0028271
DR   Coriell; GM19828
DR   GEO; GSM650193
DR   IGSR; NA19828
DR   Wikidata; Q54850732
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19829
AC   CVCL_F096
DR   CLO; CLO_0028274
DR   Coriell; GM19829
DR   Wikidata; Q54850733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM19834
AC   CVCL_N865
DR   CLO; CLO_0028273
DR   Coriell; GM19834
DR   GEO; GSM650194
DR   GEO; GSM1720333
DR   IGSR; NA19834
DR   Wikidata; Q54850734
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19835
AC   CVCL_N866
DR   CLO; CLO_0028276
DR   Coriell; GM19835
DR   GEO; GSM650195
DR   GEO; GSM1720334
DR   IGSR; NA19835
DR   Wikidata; Q54850735
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19836
AC   CVCL_1A81
DR   CLO; CLO_0028275
DR   Coriell; GM19836
DR   GEO; GSM650196
DR   IGSR; NA19836
DR   Wikidata; Q54850736
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19900
AC   CVCL_N867
DR   CLO; CLO_0028278
DR   Coriell; GM19900
DR   GEO; GSM650197
DR   GEO; GSM1720335
DR   IGSR; NA19900
DR   Wikidata; Q54850737
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19901
AC   CVCL_N868
DR   CLO; CLO_0028277
DR   Coriell; GM19901
DR   GEO; GSM650198
DR   GEO; GSM1720336
DR   IGSR; NA19901
DR   Wikidata; Q54850738
RX   PubMed=21397061;
RX   PubMed=30485824;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19902
AC   CVCL_1A82
DR   CLO; CLO_0028261
DR   Coriell; GM19902
DR   GEO; GSM650199
DR   IGSR; NA19902
DR   Wikidata; Q54850739
RX   PubMed=21397061;
RX   PubMed=30485824;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM19903
AC   CVCL_F097
DR   CLO; CLO_0028260
DR   Coriell; GM19903
DR   Wikidata; Q54850740
CC   Sequence variation: Mutation; HGNC; HGNC:4162; GARS1; Simple; p.Gly294Arg (c.880G>C) (G240R); ClinVar=VCV000009204; Zygosity=Heterozygous (Coriell=GM19903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122659; Charcot-Marie-Tooth disease type 2D
DI   ORDO; Orphanet_99938; Autosomal dominant Charcot-Marie-Tooth disease type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   GM19904
AC   CVCL_N869
DR   CLO; CLO_0028259
DR   Coriell; GM19904
DR   GEO; GSM650200
DR   GEO; GSM1720337
DR   IGSR; NA19904
DR   Wikidata; Q54850741
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19905
AC   CVCL_1A83
DR   Coriell; GM19905
DR   IGSR; NA19905
DR   Wikidata; Q54850742
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM19905; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19908
AC   CVCL_N870
DR   CLO; CLO_0028265
DR   Coriell; GM19908
DR   GEO; GSM650201
DR   GEO; GSM1720338
DR   IGSR; NA19908
DR   Wikidata; Q54850743
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19909
AC   CVCL_N871
DR   CLO; CLO_0028264
DR   Coriell; GM19909
DR   GEO; GSM650202
DR   GEO; GSM1720339
DR   IGSR; NA19909
DR   Wikidata; Q54850744
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19913
AC   CVCL_1A84
DR   Coriell; GM19913
DR   GEO; GSM1720340
DR   IGSR; NA19913
DR   Wikidata; Q54850745
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19914
AC   CVCL_N872
DR   CLO; CLO_0028263
DR   Coriell; GM19914
DR   GEO; GSM650203
DR   GEO; GSM1720341
DR   IGSR; NA19914
DR   Wikidata; Q54850746
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19915
AC   CVCL_1A85
DR   CLO; CLO_0028262
DR   Coriell; GM19915
DR   GEO; GSM650204
DR   IGSR; NA19915
DR   Wikidata; Q54850747
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19916
AC   CVCL_N873
DR   CLO; CLO_0028268
DR   Coriell; GM19916
DR   GEO; GSM650205
DR   GEO; GSM1720342
DR   IGSR; NA19916
DR   Wikidata; Q54850748
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19917
AC   CVCL_N874
DR   CLO; CLO_0028267
DR   Coriell; GM19917
DR   GEO; GSM650206
DR   GEO; GSM1720343
DR   IGSR; NA19917
DR   Wikidata; Q54850749
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19918
AC   CVCL_1A86
DR   CLO; CLO_0028266
DR   Coriell; GM19918
DR   GEO; GSM650207
DR   IGSR; NA19918
DR   Wikidata; Q54850750
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19919
AC   CVCL_1A87
DR   CLO; CLO_0028379
DR   Coriell; GM19919
DR   GEO; GSM650208
DR   IGSR; NA19919
DR   Wikidata; Q54850751
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19920
AC   CVCL_N875
DR   CLO; CLO_0028380
DR   Coriell; GM19920
DR   GEO; GSM650209
DR   GEO; GSM1720344
DR   IGSR; NA19920
DR   Wikidata; Q54850752
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM19921
AC   CVCL_N876
DR   CLO; CLO_0028381
DR   Coriell; GM19921
DR   GEO; GSM650210
DR   GEO; GSM1720345
DR   IGSR; NA19921
DR   Wikidata; Q54850754
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19922
AC   CVCL_N877
DR   Coriell; GM19922
DR   GEO; GSM650211
DR   GEO; GSM1720346
DR   IGSR; NA19922
DR   Wikidata; Q54850755
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19923
AC   CVCL_N878
DR   Coriell; GM19923
DR   GEO; GSM650212
DR   GEO; GSM1720347
DR   IGSR; NA19923
DR   Wikidata; Q54850756
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19924
AC   CVCL_1A88
DR   Coriell; GM19924
DR   IGSR; NA19924
DR   Wikidata; Q54850757
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM19924; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM19926
AC   CVCL_F098
DR   CLO; CLO_0028382
DR   Coriell; GM19926
DR   Wikidata; Q54850758
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   GM19974
AC   CVCL_F099
DR   CLO; CLO_0028375
DR   Coriell; GM19974
DR   Wikidata; Q54850759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM19975
AC   CVCL_F100
DR   CLO; CLO_0028376
DR   Coriell; GM19975
DR   Wikidata; Q54850760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM19976
AC   CVCL_F101
DR   CLO; CLO_0028377
DR   Coriell; GM19976
DR   Wikidata; Q54850761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   GM19977
AC   CVCL_F102
DR   CLO; CLO_0028378
DR   Coriell; GM19977
DR   Wikidata; Q54850762
CC   Sequence variation: Mutation; HGNC; HGNC:14234; NSD1; Simple; p.Lys2151Glnfs*15 (c.6450dupC) (c.6450-1insC); ClinVar=VCV000004141; Zygosity=Unspecified (Coriell=GM19977).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM19978
AC   CVCL_F103
DR   CLO; CLO_0028373
DR   Coriell; GM19978
DR   Wikidata; Q54850763
CC   Sequence variation: Mutation; HGNC; HGNC:14234; NSD1; Simple; p.Arg2005Gln (c.6014G>A); ClinVar=VCV000159395; Zygosity=Unspecified (Coriell=GM19978).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   GM19982
AC   CVCL_N879
DR   CLO; CLO_0028374
DR   Coriell; GM19982
DR   GEO; GSM650213
DR   GEO; GSM1720348
DR   IGSR; NA19982
DR   Wikidata; Q54850764
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19983
AC   CVCL_1A89
DR   CLO; CLO_0028361
DR   Coriell; GM19983
DR   GEO; GSM650214
DR   IGSR; NA19983
DR   Wikidata; Q54850765
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM19984
AC   CVCL_N880
DR   Coriell; GM19984
DR   GEO; GSM650215
DR   GEO; GSM1720349
DR   IGSR; NA19984
DR   Wikidata; Q54850766
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM19985
AC   CVCL_N881
DR   CLO; CLO_0028369
DR   Coriell; GM19985
DR   GEO; GSM650216
DR   GEO; GSM1720350
DR   IGSR; NA19985
DR   Wikidata; Q54850767
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM19988
AC   CVCL_F104
DR   CLO; CLO_0028370
DR   Coriell; GM19988
DR   Wikidata; Q54850768
CC   Sequence variation: Mutation; HGNC; HGNC:3258; EIF2B2; Simple; p.Ser171Phe (c.512C>T); ClinVar=VCV000004339; Zygosity=Heterozygous (Coriell=GM19988).
CC   Sequence variation: Mutation; HGNC; HGNC:3258; EIF2B2; Simple; p.Met203Trpfs*2 (c.607_612delATGGCTinsTG); ClinVar=VCV000004340; Zygosity=Heterozygous (Coriell=GM19988).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GM19999
AC   CVCL_F105
DR   CLO; CLO_0028367
DR   Coriell; GM19999
DR   Wikidata; Q54850769
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   GM1H11
AC   CVCL_KT05
DR   Wikidata; Q54850770
RX   PubMed=16186162;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12544; Human GZMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   GM1T#17
AC   CVCL_A3YY
DR   SKIP; SKIP005471
DR   Wikidata; Q105506957
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132195; Galloway-Mowat syndrome
DI   ORDO; Orphanet_2065; Galloway-Mowat syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3YZ ! GM1T#26
OI   CVCL_A3ZA ! GM1T#27
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM1T#26
AC   CVCL_A3YZ
DR   SKIP; SKIP005472
DR   Wikidata; Q105506959
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132195; Galloway-Mowat syndrome
DI   ORDO; Orphanet_2065; Galloway-Mowat syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3YY ! GM1T#17
OI   CVCL_A3ZA ! GM1T#27
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM1T#27
AC   CVCL_A3ZA
DR   SKIP; SKIP005470
DR   Wikidata; Q105506961
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132195; Galloway-Mowat syndrome
DI   ORDO; Orphanet_2065; Galloway-Mowat syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3YY ! GM1T#17
OI   CVCL_A3YZ ! GM1T#26
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM2
AC   CVCL_Z795
DR   CLO; CLO_0003535
DR   EFO; EFO_0005747
DR   CLDB; cl1502
DR   DGRC; 39
DR   ENCODE; ENCBS405IST
DR   FlyBase_Cell_line; FBtc0000039
DR   Wikidata; Q54850771
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=811480;
RX   PubMed=4626439;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 72 hours (DGRC=39).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   GM2-1TKB
AC   CVCL_K263
DR   CLO; CLO_0050679
DR   BioSample; SAMN03472218
DR   RCB; RCB0697
DR   Wikidata; Q54850772
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0697
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 13
//
ID   GM20000
AC   CVCL_E127
DR   CLO; CLO_0028368
DR   EFO; EFO_0005352
DR   Coriell; GM20000
DR   ENCODE; ENCBS223AAA
DR   GEO; GSM1008587
DR   Wikidata; Q54850776
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/GM20000_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Sequence variation: Mutation; HGNC; HGNC:28862; NIPBL; Simple; p.Glu1908Ilefs*13 (c.5721_5725delTGAAA) (5721del5); Zygosity=Heterozygous (Coriell=GM20000).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   GM20005
AC   CVCL_F637
DR   CLO; CLO_0028365
DR   BioSample; SAMN00805638
DR   Coriell; GM20005
DR   Wikidata; Q54850777
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp481Glyfs*39 (c.1441delT); ClinVar=VCV000972761; Zygosity=Heterozygous (Coriell=GM20005).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Trp746Ter (c.2237G>A); ClinVar=VCV000280063; Zygosity=Heterozygous (Coriell=GM20005).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Coriell; GM20005; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F601 ! GM04912
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   GM20015
AC   CVCL_8A69
DR   CLO; CLO_0028366
DR   Coriell; GM20015
DR   Wikidata; Q54850778
RX   PubMed=34088014;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Tyr36Cys (c.107A>G) (p.Tyr52Cys, c.155A>G); ClinVar=VCV000000093; Zygosity=Homozygous (Coriell=GM20015).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM20016
AC   CVCL_8A70
DR   CLO; CLO_0028363
DR   Coriell; GM20016
DR   Wikidata; Q54850780
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Asn320Asp (c.958A>G) (p.Asn336Asp, c.1006A>G); ClinVar=VCV000000094; Zygosity=Homozygous (Coriell=GM20016).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM20017
AC   CVCL_8A71
SY   FD-2
DR   BTO; BTO_0004640
DR   CLO; CLO_0028364
DR   Coriell; GM20017
DR   Wikidata; Q54850781
RX   PubMed=21335555;
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; c.1098+1G>T (IVS13+1G>T) (p.Asn348_Lys366del); ClinVar=VCV000812507; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM20017).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM20018
AC   CVCL_8A72
DR   CLO; CLO_0028362
DR   Coriell; GM20018
DR   Wikidata; Q54850782
CC   Population: Caucasian; Belgian.
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Thr222Lys (c.665C>A) (p.Thr238Lys, c.713C>A); ClinVar=VCV000000091; Zygosity=Homozygous (Coriell=GM20018).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM20019
AC   CVCL_8A73
DR   CLO; CLO_0028341
DR   Coriell; GM20019
DR   Wikidata; Q54850783
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Gly128_Lys152del (c.412G>T); Zygosity=Heterozygous (Coriell=GM20019).
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Asp331Asn (c.991G>A) (p.Asp347Asn, c.1039G>A); ClinVar=VCV000812495; Zygosity=Heterozygous (Coriell=GM20019).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM20022
AC   CVCL_5R01
DR   CLO; CLO_0028340
DR   Coriell; GM20022
DR   Wikidata; Q54850784
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20027
AC   CVCL_2N06
DR   CLO; CLO_0028353
DR   Coriell; GM20027
DR   Wikidata; Q54850785
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM20031
AC   CVCL_9Y49
DR   CLO; CLO_0028354
DR   Coriell; GM20031
DR   Wikidata; Q54850786
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Asn458Asp (c.1372A>G) (N431D); ClinVar=VCV000014714; Zygosity=Homozygous (Coriell=GM20031).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM20032
AC   CVCL_9Y50
DR   CLO; CLO_0028355
DR   Coriell; GM20032
DR   Wikidata; Q54850787
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Leu120Gln (c.359T>A) (L93Q); Zygosity=Heterozygous (Coriell=GM20032).
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Tyr1149Ter (c.3447C>A) (Y1122*); Zygosity=Heterozygous (Coriell=GM20032).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM20033
AC   CVCL_9Y51
DR   CLO; CLO_0028356
DR   Coriell; GM20033
DR   Wikidata; Q54850788
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Ser350Leu (c.1049C>T) (S323L); Zygosity=Homozygous (Coriell=GM20033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM20034
AC   CVCL_9Y52
DR   CLO; CLO_0028357
DR   Coriell; GM20034
DR   Wikidata; Q54850789
RX   PubMed=25059784;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Leu260Pro (c.779T>C) (L233P); ClinVar=VCV000014689; Zygosity=Homozygous (Coriell=GM20034).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM20035
AC   CVCL_9Y53
DR   CLO; CLO_0028358
DR   Coriell; GM20035
DR   Wikidata; Q54850790
CC   Population: Kurdistani.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Arg924Ter (c.2770C>T) (R897*); ClinVar=VCV000014686; Zygosity=Heterozygous (Coriell=GM20035).
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Arg1119Trp (c.3355C>T) (R1092W); Zygosity=Heterozygous (Coriell=GM20035).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-9M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM20071
AC   CVCL_AM97
DR   CLO; CLO_0028359
DR   Coriell; GM20071
DR   Wikidata; Q54850791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM20073
AC   CVCL_1M98
DR   CLO; CLO_0028360
DR   Coriell; GM20073
DR   Wikidata; Q54850792
CC   Sequence variation: Mutation; HGNC; HGNC:3258; EIF2B2; Simple; p.Glu213Gly (c.638A>G); ClinVar=VCV000004336; Zygosity=Heterozygous (Coriell=GM20073).
CC   Sequence variation: Mutation; HGNC; HGNC:3258; EIF2B2; Simple; p.Glu304Ter (c.910G>T); ClinVar=VCV000977721; Zygosity=Heterozygous (Coriell=GM20073).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM20074
AC   CVCL_1M99
DR   CLO; CLO_0028311
DR   Coriell; GM20074
DR   Wikidata; Q54850793
CC   Sequence variation: Mutation; HGNC; HGNC:3258; EIF2B2; Simple; p.Glu213Gly (c.638A>G); ClinVar=VCV000004336; Zygosity=Heterozygous (Coriell=GM20074).
CC   Sequence variation: Mutation; HGNC; HGNC:3258; EIF2B2; Simple; p.Glu304Ter (c.910G>T); ClinVar=VCV000977721; Zygosity=Heterozygous (Coriell=GM20074).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM20087
AC   CVCL_5T66
DR   CLO; CLO_0028310
DR   Coriell; GM20087
DR   Wikidata; Q54850794
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20088
AC   CVCL_1L15
DR   CLO; CLO_0028309
DR   BioSample; SAMN00805672
DR   Coriell; GM20088
DR   Wikidata; Q54850795
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.2646+2T>A (IVS18+2T>A); ClinVar=VCV000188924; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM20088).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; IVS7-IVS15del; Zygosity=Heterozygous (Coriell=GM20088).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM20089
AC   CVCL_1L16
DR   CLO; CLO_0028329
DR   BioSample; SAMN00805674
DR   Coriell; GM20089
DR   Wikidata; Q54850796
RX   PubMed=25488666;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Homozygous (Coriell=GM20089).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM20089 iPSC
AC   CVCL_UD93
SY   Pompe 1
DR   Wikidata; Q93864397
RX   PubMed=25488666;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Homozygous (PubMed=25488666).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1L16 ! GM20089
SX   Female
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   GM20090
AC   CVCL_1L17
DR   CLO; CLO_0028332
DR   Coriell; GM20090
DR   Wikidata; Q54850797
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asp645Asn (c.1933G>A); ClinVar=VCV000188728; Zygosity=Heterozygous (Coriell=GM20090).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu748Glyfs*48 (c.2242dupG) (2243insG); ClinVar=VCV000370651; Zygosity=Heterozygous (Coriell=GM20090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM20091
AC   CVCL_1L18
DR   CLO; CLO_0028325
DR   Coriell; GM20091
DR   Wikidata; Q54850798
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Gln58Ter (c.172C>T); ClinVar=VCV000188903; Zygosity=Heterozygous (Coriell=GM20091).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM20091).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM20092
AC   CVCL_1L19
DR   CLO; CLO_0028328
DR   Coriell; GM20092
DR   Wikidata; Q54850799
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Ala486Serfs*30 (c.1456_1468del); Zygosity=Heterozygous (Coriell=GM20092).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Cys647Trp (c.1941C>G); ClinVar=VCV000550327; Zygosity=Heterozygous (Coriell=GM20092).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-2Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM20100
AC   CVCL_DA80
DR   CLO; CLO_0028337
DR   Coriell; GM20100
DR   Wikidata; Q54850801
CC   Sequence variation: Mutation; HGNC; HGNC:19358; ALG12; Simple; p.Tyr230Asp (c.688T>G); Zygosity=Heterozygous (Coriell=GM20100).
CC   Sequence variation: Mutation; HGNC; HGNC:19358; ALG12; Simple; p.Arg311Cys (c.931C>T); ClinVar=VCV000377465; Zygosity=Heterozygous (Coriell=GM20100).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126873; Congenital disorder of glycosylation type Ig
DI   ORDO; Orphanet_79324; ALG12-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM20101
AC   CVCL_DA81
DR   CLO; CLO_0028338
DR   Coriell; GM20101
DR   Wikidata; Q54850802
CC   Sequence variation: Mutation; HGNC; HGNC:19358; ALG12; Simple; p.Leu12Serfs*8 (c.29delG); Zygosity=Heterozygous (Coriell=GM20101).
CC   Sequence variation: Mutation; HGNC; HGNC:19358; ALG12; Simple; p.Ser275Asn (c.824G>A); Zygosity=Heterozygous (Coriell=GM20101).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126873; Congenital disorder of glycosylation type Ig
DI   ORDO; Orphanet_79324; ALG12-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20118
AC   CVCL_5R02
DR   CLO; CLO_0028333
DR   Coriell; GM20118
DR   Wikidata; Q54850803
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20122
AC   CVCL_1L20
DR   CLO; CLO_0027717
DR   Coriell; GM20122
DR   Wikidata; Q54850805
RX   PubMed=33375166;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (Coriell=GM20122).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM20123
AC   CVCL_1L21
DR   CLO; CLO_0027718
DR   Coriell; GM20123
DR   Wikidata; Q54850806
RX   PubMed=25488666;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Heterozygous (Coriell=GM20123).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM20123 iPSC
AC   CVCL_UD94
SY   Control 1
DR   Wikidata; Q93864425
RX   PubMed=25488666;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Heterozygous (PubMed=25488666).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1L21 ! GM20123
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   GM20124
AC   CVCL_0H82
DR   CLO; CLO_0027715
DR   Coriell; GM20124
DR   Wikidata; Q54850807
RX   PubMed=24642446;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (Coriell=GM20124).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Heterozygous (Coriell=GM20124).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20125
AC   CVCL_5R03
DR   CLO; CLO_0027716
DR   Coriell; GM20125
DR   Wikidata; Q54850808
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20126
AC   CVCL_N882
DR   CLO; CLO_0027708
DR   BioSample; SAMN00007827
DR   Coriell; GM20126
DR   GEO; GSM650217
DR   GEO; GSM1720351
DR   IGSR; NA20126
DR   Wikidata; Q54850809
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20127
AC   CVCL_N883
DR   CLO; CLO_0027706
DR   Coriell; GM20127
DR   GEO; GSM650218
DR   GEO; GSM1720352
DR   IGSR; NA20127
DR   Wikidata; Q54850810
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM20128
AC   CVCL_1A90
DR   CLO; CLO_0027705
DR   Coriell; GM20128
DR   GEO; GSM650219
DR   IGSR; NA20128
DR   Wikidata; Q54850812
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20129
AC   CVCL_1A91
DR   CLO; CLO_0027703
DR   Coriell; GM20129
DR   GEO; GSM650220
DR   IGSR; NA20129
DR   Wikidata; Q54850813
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20136
AC   CVCL_9R97
DR   CLO; CLO_0027714
DR   Coriell; GM20136
DR   Wikidata; Q54850814
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu257Leu (c.771G>A) (G-A,EX7); ClinVar=VCV000002761; Zygosity=Homozygous; Note=Causes skipping of exon 7 (Coriell=GM20136).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM20161
AC   CVCL_1L22
DR   CLO; CLO_0027712
DR   Coriell; GM20161
DR   Wikidata; Q54850815
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Cys647Trp (c.1941C>G); ClinVar=VCV000550327; Zygosity=Homozygous (Coriell=GM20161).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM20170
AC   CVCL_HL80
DR   Coriell; GM20170
DR   Wikidata; Q54850816
CC   Sequence variation: Mutation; HGNC; HGNC:4893; HGF; Simple; c.482+1986_1988delTGA; Zygosity=Heterozygous (Coriell=GM20170).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM20171
AC   CVCL_HQ11
DR   Coriell; GM20171
DR   Wikidata; Q54850817
CC   Sequence variation: Mutation; HGNC; HGNC:4893; HGF; Simple; c.482+1986_1988delTGA; Zygosity=Homozygous (Coriell=GM20171).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129874; Deafness, autosomal recessive 39
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM20172
AC   CVCL_GS89
DR   CLO; CLO_0027932
DR   Coriell; GM20172
DR   Wikidata; Q54850818
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1331+4_1331+7delAGTG (IVS4+2delTGAG) (p.Lys445fs*461); ClinVar=VCV000001196; Zygosity=Homozygous (Coriell=GM20172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129024; Deafness, autosomal recessive 49
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM20173
AC   CVCL_CZ76
DR   CLO; CLO_0027933
DR   Coriell; GM20173
DR   Wikidata; Q54850819
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1331+4_1331+7delAGTG (IVS4+2delTGAG) (p.Lys445fs*461); ClinVar=VCV000001196; Zygosity=Heterozygous (Coriell=GM20173).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20174
AC   CVCL_HL81
DR   Coriell; GM20174
DR   Wikidata; Q54850825
CC   Sequence variation: Mutation; HGNC; HGNC:4893; HGF; Simple; c.482+1986_1988delTGA; Zygosity=Heterozygous (Coriell=GM20174).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM20175
AC   CVCL_HQ12
DR   Coriell; GM20175
DR   Wikidata; Q54850826
CC   Sequence variation: Mutation; HGNC; HGNC:4893; HGF; Simple; c.482+1986_1988delTGA; Zygosity=Homozygous (Coriell=GM20175).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129874; Deafness, autosomal recessive 39
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM20182
AC   CVCL_GS90
DR   CLO; CLO_0027945
DR   Coriell; GM20182
DR   Wikidata; Q54850827
CC   Sequence variation: Mutation; HGNC; HGNC:17009; TRIOBP; Simple; p.Arg1068Ter (c.3202C>T); ClinVar=VCV000001494; Zygosity=Homozygous (Coriell=GM20182).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129023; Deafness, autosomal recessive 28
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM20184
AC   CVCL_DB95
DR   CLO; CLO_0027948
DR   Coriell; GM20184
DR   Wikidata; Q54850828
CC   Sequence variation: Mutation; HGNC; HGNC:17009; TRIOBP; Simple; p.Arg788Ter (c.2362C>T); ClinVar=VCV000001493; Zygosity=Heterozygous (Coriell=GM20184).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20185
AC   CVCL_GS91
DR   CLO; CLO_0027949
DR   Coriell; GM20185
DR   Wikidata; Q54850829
CC   Sequence variation: Mutation; HGNC; HGNC:17009; TRIOBP; Simple; p.Arg788Ter (c.2362C>T); ClinVar=VCV000001493; Zygosity=Homozygous (Coriell=GM20185).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129023; Deafness, autosomal recessive 28
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM20188
AC   CVCL_DB96
DR   CLO; CLO_0027950
DR   Coriell; GM20188
DR   Wikidata; Q54850830
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; p.Arg500Ter (c.1498C>T); ClinVar=VCV000001198; Zygosity=Heterozygous (Coriell=GM20188).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20189
AC   CVCL_GS92
DR   CLO; CLO_0027938
DR   Coriell; GM20189
DR   Wikidata; Q54850831
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; p.Arg500Ter (c.1498C>T); ClinVar=VCV000001198; Zygosity=Homozygous (Coriell=GM20189).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129024; Deafness, autosomal recessive 49
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM20190
AC   CVCL_GS93
DR   CLO; CLO_0027940
DR   Coriell; GM20190
DR   Wikidata; Q54850832
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1183-1G>A (IVS3-1G>A) (p.Cys395fs*396); ClinVar=VCV000001195; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=GM20190).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129024; Deafness, autosomal recessive 49
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM20191
AC   CVCL_CZ77
DR   CLO; CLO_0027941
DR   Coriell; GM20191
DR   Wikidata; Q54850833
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1183-1G>A (IVS3-1G>A) (p.Cys395fs*396); ClinVar=VCV000001195; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM20191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20192
AC   CVCL_DB97
DR   CLO; CLO_0027944
DR   Coriell; GM20192
DR   Wikidata; Q54850834
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1331+2T>C (IVS4+2T>C) (p.Cys395fs*403); ClinVar=VCV000001197; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM20192).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20193
AC   CVCL_GS94
DR   CLO; CLO_0027986
DR   Coriell; GM20193
DR   Wikidata; Q54850835
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1331+2T>C (IVS4+2T>C) (p.Cys395fs*403); ClinVar=VCV000001197; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM20193).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129024; Deafness, autosomal recessive 49
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM20196
AC   CVCL_DB98
DR   CLO; CLO_0027984
DR   Coriell; GM20196
DR   Wikidata; Q54850836
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1331+2T>C (IVS4+2T>C) (p.Cys395fs*403); ClinVar=VCV000001197; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM20196).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20197
AC   CVCL_GS95
DR   CLO; CLO_0027985
DR   Coriell; GM20197
DR   Wikidata; Q54850837
RX   PubMed=17186462;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:26401; MARVELD2; Simple; c.1331+2T>C (IVS4+2T>C) (p.Cys395fs*403); ClinVar=VCV000001197; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM20197).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129024; Deafness, autosomal recessive 49
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM20198
AC   CVCL_HQ13
DR   Coriell; GM20198
DR   Wikidata; Q54850838
CC   Sequence variation: Mutation; HGNC; HGNC:4893; HGF; Simple; c.482+1986_1988delTGA; Zygosity=Homozygous (Coriell=GM20198).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129874; Deafness, autosomal recessive 39
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM20199
AC   CVCL_HL82
DR   Coriell; GM20199
DR   Wikidata; Q54850839
CC   Sequence variation: Mutation; HGNC; HGNC:4893; HGF; Simple; c.482+1986_1988delTGA; Zygosity=Heterozygous (Coriell=GM20199).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM20200
AC   CVCL_5R04
DR   CLO; CLO_0027992
DR   Coriell; GM20200
DR   Wikidata; Q54850841
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20201
AC   CVCL_5R05
DR   CLO; CLO_0027994
DR   Coriell; GM20201
DR   Wikidata; Q54850842
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20202
AC   CVCL_9R56
DR   CLO; CLO_0027987
DR   Coriell; GM20202
DR   Wikidata; Q54850843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM20212
AC   CVCL_DA82
DR   CLO; CLO_0027990
DR   Coriell; GM20212
DR   Wikidata; Q54850844
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:10853; SHOX; Zygosity=Heterozygous (Coriell=GM20212).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126876; Langer mesomelic dysplasia
DI   ORDO; Orphanet_2632; Langer mesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM20213
AC   CVCL_DA83
DR   CLO; CLO_0027999
DR   Coriell; GM20213
DR   Wikidata; Q54850845
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:10853; SHOX; Zygosity=Heterozygous (Coriell=GM20213).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126876; Langer mesomelic dysplasia
DI   ORDO; Orphanet_2632; Langer mesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM20214
AC   CVCL_DA84
DR   CLO; CLO_0028000
DR   Coriell; GM20214
DR   Wikidata; Q54850846
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10853; SHOX; Simple; p.Arg153Cys (c.457C>T); Zygosity=Heterozygous (Coriell=GM20214).
CC   Sequence variation: Mutation; HGNC; HGNC:10853; SHOX; Simple; p.Val163Phe (c.487G>T); Zygosity=Heterozygous (Coriell=GM20214).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126876; Langer mesomelic dysplasia
DI   ORDO; Orphanet_2632; Langer mesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20215
AC   CVCL_DA85
DR   CLO; CLO_0027996
DR   Coriell; GM20215
DR   Wikidata; Q54850847
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10853; SHOX; Simple; p.Pro244Alafs*147 (c.728dupC) (ins723C); ClinVar=VCV000009880; Zygosity=Hemizygous or homozygous (Coriell=GM20215).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126876; Langer mesomelic dysplasia
DI   ORDO; Orphanet_2632; Langer mesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20216
AC   CVCL_DA86
DR   CLO; CLO_0027963
DR   Coriell; GM20216
DR   Wikidata; Q54850848
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:10853; SHOX; Zygosity=Heterozygous (Coriell=GM20216).
CC   Sequence variation: Mutation; HGNC; HGNC:10853; SHOX; Simple; p.Arg119Alafs*10 (c.350_351AG[3]) (c.352_353dupAG) (ins350AG); ClinVar=VCV000009881; Zygosity=Heterozygous (Coriell=GM20216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126876; Langer mesomelic dysplasia
DI   ORDO; Orphanet_2632; Langer mesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM20217
AC   CVCL_DA87
DR   CLO; CLO_0027964
DR   Coriell; GM20217
DR   Wikidata; Q54850849
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:10853; SHOX; Zygosity=Heterozygous (Coriell=GM20217).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126876; Langer mesomelic dysplasia
DI   ORDO; Orphanet_2632; Langer mesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM20218
AC   CVCL_DA88
DR   CLO; CLO_0027965
DR   Coriell; GM20218
DR   Wikidata; Q54850850
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:10853; SHOX; Zygosity=Homozygous (Coriell=GM20218).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126876; Langer mesomelic dysplasia
DI   ORDO; Orphanet_2632; Langer mesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20220
AC   CVCL_5R06
DR   CLO; CLO_0027966
DR   Coriell; GM20220
DR   Wikidata; Q54850851
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20230
AC   CVCL_AY37
DR   CLO; CLO_0027968
DR   Coriell; GM20230
DR   Wikidata; Q54850852
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[53]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20231
AC   CVCL_AY38
DR   CLO; CLO_0027969
DR   Coriell; GM20231
DR   Wikidata; Q54850853
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[76]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20232
AC   CVCL_AY39
DR   CLO; CLO_0027972
DR   Coriell; GM20232
DR   Wikidata; Q54850854
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[46]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20233
AC   CVCL_AY40
DR   CLO; CLO_0027974
DR   Coriell; GM20233
DR   Wikidata; Q54850855
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[117]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126566; Fragile X tremor/ataxia syndrome
DI   ORDO; Orphanet_93256; Fragile X-associated tremor/ataxia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20234
AC   CVCL_AY41
DR   CLO; CLO_0027975
DR   Coriell; GM20234
DR   Wikidata; Q54850856
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[31]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[46]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20235
AC   CVCL_AY42
DR   CLO; CLO_0027978
DR   Coriell; GM20235
DR   Wikidata; Q54850857
RX   PubMed=18165276;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; ClinVar=VCV000009972; Zygosity=Heterozygous (Coriell=GM20235).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[45]; ClinVar=VCV000009972; Zygosity=Heterozygous (Coriell=GM20235).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20236
AC   CVCL_AY43
DR   CLO; CLO_0027848
DR   Coriell; GM20236
DR   Wikidata; Q54850858
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[31]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[53]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20237
AC   CVCL_AY44
DR   CLO; CLO_0027845
DR   Coriell; GM20237
DR   Wikidata; Q54850859
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[100-104]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20238
AC   CVCL_AY45
DR   CLO; CLO_0027844
DR   Coriell; GM20238
DR   Wikidata; Q54850860
RX   PubMed=18165276;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; ClinVar=VCV000009972; Zygosity=Heterozygous (Coriell=GM20238).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; ClinVar=VCV000009972; Zygosity=Heterozygous (Coriell=GM20238).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20239
AC   CVCL_AY46
DR   CLO; CLO_0027847
DR   Coriell; GM20239
DR   Wikidata; Q54850861
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[20]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[183-193]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20240
AC   CVCL_AY47
DR   CLO; CLO_0027846
DR   Coriell; GM20240
DR   Wikidata; Q54850862
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[20]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[80]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20241
AC   CVCL_AY48
DR   CLO; CLO_0027841
DR   Coriell; GM20241
DR   Wikidata; Q54850863
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[93-110]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20242
AC   CVCL_AY49
DR   CLO; CLO_0027840
DR   Coriell; GM20242
DR   Wikidata; Q54850864
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[30]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[73]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20243
AC   CVCL_AY50
DR   CLO; CLO_0027843
DR   Coriell; GM20243
DR   Wikidata; Q54850865
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[29]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[41]; ClinVar=VCV000009972; Zygosity=Heterozygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20244
AC   CVCL_AY51
DR   CLO; CLO_0027842
DR   Coriell; GM20244
DR   Wikidata; Q54850871
RX   PubMed=18165276;
RX   PubMed=25776194;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[41]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=25776194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM20254
AC   CVCL_CV45
DR   CLO; CLO_0027839
DR   Coriell; GM20254
DR   Wikidata; Q54850872
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:8918; PHEX; Simple; p.Leu650Arg (c.1949T>G); Zygosity=Heterozygous (from familial inference of GM20255).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85234; X-linked dominant hypophosphatemic rickets
DI   ORDO; Orphanet_89936; X-linked hypophosphatemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM20255
AC   CVCL_CV46
DR   CLO; CLO_0027838
DR   Coriell; GM20255
DR   Wikidata; Q54850873
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:8918; PHEX; Simple; p.Leu650Arg (c.1949T>G); Zygosity=Hemizygous (Coriell=GM20255).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85234; X-linked dominant hypophosphatemic rickets
DI   ORDO; Orphanet_89936; X-linked hypophosphatemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM20263
AC   CVCL_2U58
DR   CLO; CLO_0027836
DR   Coriell; GM20263
DR   Wikidata; Q54850874
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM20264
AC   CVCL_2U59
DR   CLO; CLO_0027835
DR   Coriell; GM20264
DR   Wikidata; Q54850875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM20265
AC   CVCL_CV47
DR   CLO; CLO_0027834
DR   Coriell; GM20265
DR   Wikidata; Q54850876
CC   Sequence variation: Mutation; HGNC; HGNC:4803; HADHB; Simple; p.Arg61His (c.182G>A) (R28H); ClinVar=VCV000014845; Zygosity=Homozygous (Coriell=GM20265).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98991; Mitochondrial trifunctional protein deficiency
DI   ORDO; Orphanet_746; Mitochondrial trifunctional protein deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4W
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20266
AC   CVCL_IJ42
DR   CLO; CLO_0027833
DR   Coriell; GM20266
DR   Wikidata; Q54850877
CC   Sequence variation: Mutation; HGNC; HGNC:4801; HADHA; Simple; p.Glu510Gln (c.1528G>C); ClinVar=VCV000100085; Zygosity=Homozygous (Coriell=GM20266).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129929; Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_5; Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM20269
AC   CVCL_0R40
DR   CLO; CLO_0027832
DR   Coriell; GM20269
DR   Wikidata; Q54850878
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.His294Gln (c.882T>G) (H255Q); ClinVar=VCV000242810; Zygosity=Heterozygous (Coriell=GM20269).
CC   Discontinued: Coriell; GM20269; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM20270
AC   CVCL_0R41
DR   CLO; CLO_0027831
DR   Coriell; GM20270
DR   Wikidata; Q54850879
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Gly39Aspfs*3 (c.115+1G>A) (IVS2+1G>A) (IVS2DS,G-A,+1); ClinVar=VCV000093445; Zygosity=Heterozygous; Note=Splice donor mutation that causes skipping of exon 2 (Coriell=GM20270).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (Coriell=GM20270).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   GM20272
AC   CVCL_0R42
DR   CLO; CLO_0027830
DR   Coriell; GM20272
DR   Wikidata; Q54850880
RX   PubMed=36130205;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (Coriell=GM20272).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   GM20273
AC   CVCL_0R35
DR   CLO; CLO_0027829
DR   Coriell; GM20273
DR   Wikidata; Q54850881
CC   Population: Lebanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM20274
AC   CVCL_1A92
DR   BioSample; SAMN00006620
DR   Coriell; GM20274
DR   GEO; GSM1720353
DR   IGSR; NA20274
DR   Wikidata; Q54850883
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20276
AC   CVCL_N884
DR   CLO; CLO_0027862
DR   BioSample; SAMN00007830
DR   Coriell; GM20276
DR   GEO; GSM650221
DR   GEO; GSM1720354
DR   IGSR; NA20276
DR   Wikidata; Q54850884
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20277
AC   CVCL_1A93
DR   CLO; CLO_0027864
DR   Coriell; GM20277
DR   GEO; GSM650222
DR   IGSR; NA20277
DR   Wikidata; Q54850885
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20278
AC   CVCL_N885
DR   CLO; CLO_0027863
DR   BioSample; SAMN00007832
DR   Coriell; GM20278
DR   GEO; GSM650223
DR   GEO; GSM1720355
DR   IGSR; NA20278
DR   Wikidata; Q54850886
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20279
AC   CVCL_1A95
DR   CLO; CLO_0027866
DR   Coriell; GM20279
DR   GEO; GSM650224
DR   IGSR; NA20279
DR   Wikidata; Q54850887
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20281
AC   CVCL_N886
DR   CLO; CLO_0027865
DR   BioSample; SAMN00007834
DR   Coriell; GM20281
DR   GEO; GSM650225
DR   GEO; GSM1720356
DR   IGSR; NA20281
DR   Wikidata; Q54850888
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20282
AC   CVCL_N887
DR   CLO; CLO_0027868
DR   BioSample; SAMN00007835
DR   Coriell; GM20282
DR   GEO; GSM650226
DR   GEO; GSM1720357
DR   IGSR; NA20282
DR   Wikidata; Q54850889
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20284
AC   CVCL_1B27
DR   CLO; CLO_0027867
DR   Coriell; GM20284
DR   GEO; GSM650227
DR   IGSR; NA20284
DR   Wikidata; Q54850890
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20285
AC   CVCL_1A96
DR   Coriell; GM20285
DR   IGSR; NA20285
DR   Wikidata; Q54850891
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM20285; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM20287
AC   CVCL_N888
DR   CLO; CLO_0027860
DR   BioSample; SAMN00007837
DR   Coriell; GM20287
DR   GEO; GSM650228
DR   GEO; GSM1720358
DR   IGSR; NA20287
DR   Wikidata; Q54850893
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20288
AC   CVCL_1A97
DR   CLO; CLO_0027859
DR   Coriell; GM20288
DR   GEO; GSM650229
DR   IGSR; NA20288
DR   Wikidata; Q54850894
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20289
AC   CVCL_N889
DR   CLO; CLO_0027861
DR   BioSample; SAMN00007839
DR   Coriell; GM20289
DR   GEO; GSM650230
DR   GEO; GSM1720359
DR   IGSR; NA20289
DR   Wikidata; Q54850895
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20290
AC   CVCL_1A98
DR   CLO; CLO_0027854
DR   Coriell; GM20290
DR   GEO; GSM650231
DR   IGSR; NA20290
DR   Wikidata; Q54850896
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20291
AC   CVCL_N890
DR   CLO; CLO_0027853
DR   BioSample; SAMN00007841
DR   Coriell; GM20291
DR   GEO; GSM650232
DR   GEO; GSM1720360
DR   IGSR; NA20291
DR   Wikidata; Q54850897
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20292
AC   CVCL_1A99
DR   CLO; CLO_0027852
DR   Coriell; GM20292
DR   GEO; GSM650233
DR   IGSR; NA20292
DR   Wikidata; Q54850898
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20293
AC   CVCL_AW79
DR   CLO; CLO_0027851
DR   Coriell; GM20293
DR   Wikidata; Q54850899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM20294
AC   CVCL_N891
DR   CLO; CLO_0027858
DR   BioSample; SAMN00007843
DR   Coriell; GM20294
DR   GEO; GSM650234
DR   GEO; GSM1720361
DR   IGSR; NA20294
DR   Wikidata; Q54850900
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20295
AC   CVCL_1B00
DR   CLO; CLO_0027857
DR   Coriell; GM20295
DR   GEO; GSM650235
DR   IGSR; NA20295
DR   Wikidata; Q54850901
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20296
AC   CVCL_N892
DR   CLO; CLO_0027856
DR   BioSample; SAMN00007845
DR   Coriell; GM20296
DR   GEO; GSM650236
DR   GEO; GSM1720362
DR   IGSR; NA20296
DR   Wikidata; Q54850902
RX   PubMed=21397061;
RX   PubMed=26621101;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20297
AC   CVCL_1B01
DR   CLO; CLO_0027855
DR   Coriell; GM20297
DR   GEO; GSM650237
DR   IGSR; NA20297
DR   Wikidata; Q54850903
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20298
AC   CVCL_N893
DR   BioSample; SAMN00004483
DR   Coriell; GM20298
DR   GEO; GSM650238
DR   GEO; GSM1720363
DR   IGSR; NA20298
DR   Wikidata; Q54850904
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM20299
AC   CVCL_N894
DR   CLO; CLO_0027850
DR   BioSample; SAMN00007847
DR   Coriell; GM20299
DR   GEO; GSM650239
DR   GEO; GSM1720364
DR   IGSR; NA20299
DR   Wikidata; Q54850905
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20300
AC   CVCL_1B02
DR   CLO; CLO_0027849
DR   Coriell; GM20300
DR   GEO; GSM650240
DR   IGSR; NA20300
DR   Wikidata; Q54850906
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20301
AC   CVCL_1B03
DR   CLO; CLO_0027879
DR   Coriell; GM20301
DR   GEO; GSM650241
DR   IGSR; NA20301
DR   Wikidata; Q54850907
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20302
AC   CVCL_1B04
DR   CLO; CLO_0027884
DR   Coriell; GM20302
DR   GEO; GSM650242
DR   IGSR; NA20302
DR   Wikidata; Q54850908
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20304
AC   CVCL_5R07
DR   CLO; CLO_0027885
DR   Coriell; GM20304
DR   Wikidata; Q54850910
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20305
AC   CVCL_5R08
DR   CLO; CLO_0027886
DR   Coriell; GM20305
DR   Wikidata; Q54850911
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20310
AC   CVCL_1L23
DR   CLO; CLO_0027887
DR   Coriell; GM20310
DR   Wikidata; Q54850913
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex16-20del (IVS15>3' of exon 20 9-kb del); Zygosity=Homozygous (Coriell=GM20310).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM20311
AC   CVCL_2U60
DR   CLO; CLO_0027880
DR   Coriell; GM20311
DR   Wikidata; Q54850914
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM20312
AC   CVCL_1B05
DR   Coriell; GM20312
DR   IGSR; NA20312
DR   Wikidata; Q54850925
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM20312; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM20313
AC   CVCL_1B06
DR   Coriell; GM20313
DR   IGSR; NA20313
DR   Wikidata; Q54850926
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM20314
AC   CVCL_N895
DR   CLO; CLO_0027881
DR   BioSample; SAMN00007851
DR   Coriell; GM20314
DR   GEO; GSM650243
DR   GEO; GSM1720365
DR   IGSR; NA20314
DR   Wikidata; Q54850928
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20316
AC   CVCL_1B07
DR   CLO; CLO_0027882
DR   Coriell; GM20316
DR   GEO; GSM650244
DR   IGSR; NA20316
DR   Wikidata; Q54850929
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20317
AC   CVCL_N896
DR   CLO; CLO_0027883
DR   BioSample; SAMN00007853
DR   Coriell; GM20317
DR   GEO; GSM650245
DR   GEO; GSM1720366
DR   IGSR; NA20317
DR   Wikidata; Q54850931
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20318
AC   CVCL_1B08
DR   BioSample; SAMN00006624
DR   Coriell; GM20318
DR   GEO; GSM1720367
DR   IGSR; NA20318
DR   Wikidata; Q54850932
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20319
AC   CVCL_1B09
DR   CLO; CLO_0027888
DR   Coriell; GM20319
DR   GEO; GSM650246
DR   IGSR; NA20319
DR   Wikidata; Q54850933
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20320
AC   CVCL_1B10
DR   BioSample; SAMN00006625
DR   Coriell; GM20320
DR   GEO; GSM1720368
DR   IGSR; NA20320
DR   Wikidata; Q54850935
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20321
AC   CVCL_1B11
DR   BioSample; SAMN00006626
DR   Coriell; GM20321
DR   GEO; GSM1720369
DR   IGSR; NA20321
DR   Wikidata; Q54850936
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20322
AC   CVCL_N897
DR   CLO; CLO_0027870
DR   BioSample; SAMN00007855
DR   Coriell; GM20322
DR   GEO; GSM650247
DR   GEO; GSM1720370
DR   IGSR; NA20322
DR   Wikidata; Q54850937
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20327
AC   CVCL_9Y54
DR   CLO; CLO_0027869
DR   Coriell; GM20327
DR   Wikidata; Q54850939
RX   PubMed=26831110;
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Glu151Ter (c.451G>T) (E124X); Zygosity=Homozygous (Coriell=GM20327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM20328
AC   CVCL_9Y55
DR   CLO; CLO_0027877
DR   Coriell; GM20328
DR   Wikidata; Q54850940
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Asn308del (c.922_924del) (N281del); Zygosity=Heterozygous (Coriell=GM20328).
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Unexplicit; IVS13+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM20328).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   GM20332
AC   CVCL_N898
DR   CLO; CLO_0027878
DR   BioSample; SAMN00007856
DR   Coriell; GM20332
DR   GEO; GSM650248
DR   GEO; GSM1720371
DR   IGSR; NA20332
DR   Wikidata; Q54850941
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20333
AC   CVCL_1B12
DR   CLO; CLO_0027875
DR   Coriell; GM20333
DR   GEO; GSM650249
DR   IGSR; NA20333
DR   Wikidata; Q54850942
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20334
AC   CVCL_N899
DR   CLO; CLO_0027876
DR   BioSample; SAMN00007858
DR   Coriell; GM20334
DR   GEO; GSM650250
DR   GEO; GSM1720372
DR   IGSR; NA20334
DR   Wikidata; Q54850943
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20335
AC   CVCL_1B13
DR   CLO; CLO_0027873
DR   Coriell; GM20335
DR   GEO; GSM650251
DR   IGSR; NA20335
DR   Wikidata; Q54850945
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20336
AC   CVCL_N900
DR   CLO; CLO_0027874
DR   BioSample; SAMN00007860
DR   Coriell; GM20336
DR   GEO; GSM650252
DR   GEO; GSM1720373
DR   IGSR; NA20336
DR   Wikidata; Q54850947
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20337
AC   CVCL_1B14
DR   CLO; CLO_0027871
DR   Coriell; GM20337
DR   GEO; GSM650253
DR   IGSR; NA20337
DR   Wikidata; Q54850948
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20339
AC   CVCL_N901
DR   BioSample; SAMN00004484
DR   Coriell; GM20339
DR   GEO; GSM650254
DR   GEO; GSM1720374
DR   IGSR; NA20339
DR   Wikidata; Q54850949
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM20340
AC   CVCL_N902
DR   CLO; CLO_0027872
DR   BioSample; SAMN00007862
DR   Coriell; GM20340
DR   GEO; GSM650255
DR   GEO; GSM1720375
DR   IGSR; NA20340
DR   Wikidata; Q54850950
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20341
AC   CVCL_N903
DR   CLO; CLO_0027892
DR   BioSample; SAMN00007863
DR   Coriell; GM20341
DR   GEO; GSM650256
DR   GEO; GSM1720376
DR   IGSR; NA20341
DR   Wikidata; Q54850952
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20342
AC   CVCL_N904
DR   CLO; CLO_0027894
DR   BioSample; SAMN00007864
DR   Coriell; GM20342
DR   GEO; GSM650257
DR   GEO; GSM1720377
DR   IGSR; NA20342
DR   Wikidata; Q54850953
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20343
AC   CVCL_1B15
DR   CLO; CLO_0027893
DR   Coriell; GM20343
DR   GEO; GSM650258
DR   IGSR; NA20343
DR   Wikidata; Q54850954
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20344
AC   CVCL_N905
DR   CLO; CLO_0027895
DR   BioSample; SAMN00007866
DR   Coriell; GM20344
DR   GEO; GSM650259
DR   GEO; GSM1720378
DR   IGSR; NA20344
DR   Wikidata; Q54850956
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20345
AC   CVCL_1B16
DR   CLO; CLO_0027896
DR   Coriell; GM20345
DR   GEO; GSM650260
DR   IGSR; NA20345
DR   Wikidata; Q54850957
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20346
AC   CVCL_N906
DR   CLO; CLO_0027897
DR   BioSample; SAMN00007868
DR   Coriell; GM20346
DR   GEO; GSM650261
DR   GEO; GSM1720379
DR   IGSR; NA20346
DR   Wikidata; Q54850958
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20347
AC   CVCL_1B17
DR   CLO; CLO_0027898
DR   Coriell; GM20347
DR   GEO; GSM650262
DR   IGSR; NA20347
DR   Wikidata; Q54850959
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20348
AC   CVCL_N907
DR   CLO; CLO_0027899
DR   BioSample; SAMN00007870
DR   Coriell; GM20348
DR   GEO; GSM650263
DR   GEO; GSM1720380
DR   IGSR; NA20348
DR   Wikidata; Q54850960
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20349
AC   CVCL_1B18
DR   CLO; CLO_0027900
DR   Coriell; GM20349
DR   GEO; GSM650264
DR   IGSR; NA20349
DR   Wikidata; Q54850961
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20350
AC   CVCL_1B19
DR   CLO; CLO_0027901
DR   Coriell; GM20350
DR   GEO; GSM650265
DR   IGSR; NA20350
DR   Wikidata; Q54850962
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20351
AC   CVCL_N908
DR   BioSample; SAMN00004485
DR   Coriell; GM20351
DR   GEO; GSM650266
DR   GEO; GSM1720381
DR   IGSR; NA20351
DR   Wikidata; Q54850963
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM20355
AC   CVCL_1B20
DR   BioSample; SAMN00006627
DR   Coriell; GM20355
DR   GEO; GSM1720382
DR   IGSR; NA20355
DR   Wikidata; Q54850964
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20356
AC   CVCL_N909
DR   CLO; CLO_0029607
DR   BioSample; SAMN00007873
DR   Coriell; GM20356
DR   GEO; GSM650267
DR   GEO; GSM1720383
DR   IGSR; NA20356
DR   Wikidata; Q54850965
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20357
AC   CVCL_N910
DR   CLO; CLO_0029608
DR   BioSample; SAMN00007874
DR   Coriell; GM20357
DR   GEO; GSM650268
DR   GEO; GSM1720384
DR   IGSR; NA20357
DR   Wikidata; Q54850966
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20358
AC   CVCL_1B21
DR   CLO; CLO_0029613
DR   Coriell; GM20358
DR   GEO; GSM650269
DR   IGSR; NA20358
DR   Wikidata; Q54850967
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20359
AC   CVCL_N911
DR   CLO; CLO_0029614
DR   BioSample; SAMN00007876
DR   Coriell; GM20359
DR   GEO; GSM650270
DR   GEO; GSM1720385
DR   IGSR; NA20359
DR   Wikidata; Q54850968
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20360
AC   CVCL_1B22
DR   CLO; CLO_0029616
DR   Coriell; GM20360
DR   GEO; GSM650271
DR   IGSR; NA20360
DR   Wikidata; Q54850969
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20361
AC   CVCL_1B23
DR   Coriell; GM20361
DR   IGSR; NA20361
DR   Wikidata; Q54850970
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM20361; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM20362
AC   CVCL_1B24
DR   BioSample; SAMN00006629
DR   Coriell; GM20362
DR   GEO; GSM1720386
DR   IGSR; NA20362
DR   Wikidata; Q54850971
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20363
AC   CVCL_N912
DR   CLO; CLO_0029619
DR   BioSample; SAMN00007878
DR   Coriell; GM20363
DR   GEO; GSM650272
DR   IGSR; NA20363
DR   Wikidata; Q54850972
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20364
AC   CVCL_1B25
DR   CLO; CLO_0029622
DR   Coriell; GM20364
DR   GEO; GSM650273
DR   IGSR; NA20364
DR   Wikidata; Q54850984
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20366
AC   CVCL_5R09
DR   CLO; CLO_0029625
DR   Coriell; GM20366
DR   Wikidata; Q54850985
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20375
AC   CVCL_5R10
DR   CLO; CLO_0029626
DR   Coriell; GM20375
DR   Wikidata; Q54850986
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20377
AC   CVCL_DA89
DR   CLO; CLO_0029544
DR   Coriell; GM20377
DR   Wikidata; Q54850987
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (Coriell=GM20377).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Gly473Arg (c.1417G>A); ClinVar=VCV000068740; Zygosity=Heterozygous (Coriell=GM20377).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM20378
AC   CVCL_DA90
DR   CLO; CLO_0029559
DR   Coriell; GM20378
DR   Wikidata; Q54850988
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>A (IVS5-1G>A); ClinVar=VCV000207574; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM20378).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.887-10A>G (IVS7-10A>G); ClinVar=VCV000002649; Zygosity=Heterozygous (Coriell=GM20378).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20379
AC   CVCL_DA91
DR   CLO; CLO_0029558
DR   Coriell; GM20379
DR   Wikidata; Q54850989
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Gly42Glu (c.125G>A); ClinVar=VCV000056179; Zygosity=Heterozygous (Coriell=GM20379).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg122Trp (c.364A>T); ClinVar=VCV000008899; Zygosity=Heterozygous (Coriell=GM20379).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM20380
AC   CVCL_DA92
DR   CLO; CLO_0029557
DR   Coriell; GM20380
DR   Wikidata; Q54850990
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Arg151Ter (c.451C>T); ClinVar=VCV000008904; Zygosity=Heterozygous (Coriell=GM20380).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Val181Met (c.541G>A); ClinVar=VCV000188857; Zygosity=Heterozygous (Coriell=GM20380).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM20381
AC   CVCL_DA93
DR   CLO; CLO_0029556
DR   Coriell; GM20381
DR   Wikidata; Q54850991
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (Coriell=GM20381).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Unexplicit; IVS11+6G>A; Zygosity=Heterozygous (Coriell=GM20381).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20382
AC   CVCL_DA94
DR   CLO; CLO_0029555
DR   Coriell; GM20382
DR   Wikidata; Q54850992
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Val142Leufs*39 (c.424delG); ClinVar=VCV000056269; Zygosity=Heterozygous (Coriell=GM20382).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (Coriell=GM20382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM20383
AC   CVCL_DA95
DR   CLO; CLO_0029554
DR   Coriell; GM20383
DR   Wikidata; Q54850993
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (Coriell=GM20383).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Glu295Lys (c.883G>A); ClinVar=VCV000003556; Zygosity=Heterozygous (Coriell=GM20383).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   GM20384
AC   CVCL_DA96
DR   CLO; CLO_0029553
DR   Coriell; GM20384
DR   Wikidata; Q54850994
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (Coriell=GM20384).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.1198-1G>T (IVS14-1G>T); ClinVar=VCV000056251; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM20384).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM20385
AC   CVCL_DA97
DR   CLO; CLO_0029551
DR   Coriell; GM20385
DR   Wikidata; Q54850995
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>A (IVS5-1G>A); ClinVar=VCV000207574; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM20385).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM20385).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   GM20387
AC   CVCL_DA98
DR   CLO; CLO_0029548
DR   Coriell; GM20387
DR   Wikidata; Q54850996
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM20387).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (Coriell=GM20387).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20389
AC   CVCL_DA99
DR   CLO; CLO_0029547
DR   Coriell; GM20389
DR   Wikidata; Q54850997
RX   PubMed=29631617;
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000056193; Zygosity=Heterozygous (Coriell=GM20389).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Tyr247His (c.739T>C); ClinVar=VCV000056214; Zygosity=Heterozygous (Coriell=GM20389).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20390
AC   CVCL_F190
DR   CLO; CLO_0029577
DR   Coriell; GM20390
DR   Wikidata; Q54850998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GM20392
AC   CVCL_U305
DR   CLO; CLO_0029579
DR   Coriell; GM20392
DR   Wikidata; Q54850999
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Val8Gly (c.23T>G); ClinVar=VCV001410753; Zygosity=Hemizygous (Coriell=GM20392).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   GM20393
AC   CVCL_U302
DR   CLO; CLO_0029578
DR   Coriell; GM20393
DR   Wikidata; Q54851000
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Glu47Gly (c.140A>G); Zygosity=Hemizygous (Coriell=GM20393).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   GM20394
AC   CVCL_U301
DR   CLO; CLO_0029574
DR   Coriell; GM20394
DR   Wikidata; Q54851002
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex1del; Zygosity=Hemizygous (Coriell=GM20394).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   GM20395
AC   CVCL_U299
DR   CLO; CLO_0029573
DR   Coriell; GM20395
DR   Wikidata; Q54851003
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Met143Lys (c.428T>A); ClinVar=VCV000010062; Zygosity=Hemizygous (Coriell=GM20395).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   GM20396
AC   CVCL_U300
DR   CLO; CLO_0029576
DR   Coriell; GM20396
DR   Wikidata; Q54851004
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Asp201Asn (c.601G>A); Zygosity=Hemizygous (Coriell=GM20396).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   GM20397
AC   CVCL_U303
DR   CLO; CLO_0029575
DR   Coriell; GM20397
DR   Wikidata; Q54851005
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg48His (c.143G>A); ClinVar=VCV000029985; Zygosity=Hemizygous (Coriell=GM20397).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   GM20398
AC   CVCL_U304
DR   CLO; CLO_0029569
DR   Coriell; GM20398
DR   Wikidata; Q54851006
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Asp194His (c.580G>C); ClinVar=VCV000284173; Zygosity=Hemizygous (Coriell=GM20398).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   GM20399
AC   CVCL_EJ66
DR   CLO; CLO_0029566
DR   Coriell; GM20399
DR   Wikidata; Q54851007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM20400
AC   CVCL_EJ38
DR   CLO; CLO_0029572
DR   Coriell; GM20400
DR   Wikidata; Q54851008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM20406
AC   CVCL_U540
DR   CLO; CLO_0029518
DR   Coriell; GM20406
DR   Wikidata; Q54851009
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM20408
AC   CVCL_U541
DR   CLO; CLO_0029517
DR   Coriell; GM20408
DR   Wikidata; Q54851010
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   GM20409
AC   CVCL_5R11
DR   CLO; CLO_0029516
DR   Coriell; GM20409
DR   Wikidata; Q54851011
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20410
AC   CVCL_5R12
DR   CLO; CLO_0029515
DR   Coriell; GM20410
DR   Wikidata; Q54851012
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20411
AC   CVCL_5R13
DR   CLO; CLO_0029511
DR   Coriell; GM20411
DR   Wikidata; Q54851013
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20412
AC   CVCL_N913
DR   BioSample; SAMN00004486
DR   Coriell; GM20412
DR   GEO; GSM650274
DR   GEO; GSM1720387
DR   IGSR; NA20412
DR   Wikidata; Q54851014
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM20413
AC   CVCL_1B26
DR   Coriell; GM20413
DR   IGSR; NA20413
DR   Wikidata; Q54851015
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: Coriell; GM20413; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM20414
AC   CVCL_N914
DR   BioSample; SAMN00004487
DR   Coriell; GM20414
DR   GEO; GSM650275
DR   IGSR; NA20414
DR   Wikidata; Q54851016
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African ancestry in Southwest USA (ASW).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM20415
AC   CVCL_GY30
DR   CLO; CLO_0029510
DR   Coriell; GM20415
DR   Wikidata; Q54851017
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129076; Molybdenum cofactor deficiency
DI   ORDO; Orphanet_99732; Sulfite oxidase deficiency due to molybdenum cofactor deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM20418
AC   CVCL_5R14
DR   CLO; CLO_0029509
DR   Coriell; GM20418
DR   Wikidata; Q54851019
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20419
AC   CVCL_5R15
DR   CLO; CLO_0029508
DR   Coriell; GM20419
DR   Wikidata; Q54851020
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM20421
AC   CVCL_HM37
DR   Coriell; GM20421
DR   Wikidata; Q54851021
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   NCIt; C35069; Thalassemia
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM20431
AC   CVCL_7659
DR   EFO; EFO_0009317
DR   Coriell; GM20431
DR   ENCODE; ENCBS686DBH
DR   Wikidata; Q54851022
RX   PubMed=37751688;
WW   Info; PGP; hu43860C; https://my.pgp-hms.org/profile_public?hex=hu43860C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: Established from George Church blood.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F183 ! GM23248
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GM20432
AC   CVCL_HM38
DR   Coriell; GM20432
DR   Wikidata; Q54851023
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   NCIt; C35069; Thalassemia
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM20434
AC   CVCL_5R16
DR   CLO; CLO_0029513
DR   Coriell; GM20434
DR   Wikidata; Q54851024
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20435
AC   CVCL_5R17
DR   Coriell; GM20435
DR   Wikidata; Q54851025
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20437
AC   CVCL_5R18
DR   Coriell; GM20437
DR   Wikidata; Q54851032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM20458
AC   CVCL_HM45
DR   Coriell; GM20458
DR   Wikidata; Q54851033
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Lys83Asn (c.249G>Y); ClinVar=VCV000015319; Zygosity=Unspecified; Note=Hb Providence (Coriell=GM20458).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM20459
AC   CVCL_HM46
DR   Coriell; GM20459
DR   Wikidata; Q54851034
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Lys83Asn (c.249G>Y); ClinVar=VCV000015319; Zygosity=Unspecified; Note=Hb Providence (Coriell=GM20459).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM20460
AC   CVCL_HM47
DR   Coriell; GM20460
DR   Wikidata; Q54851035
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Lys83Asn (c.249G>Y); ClinVar=VCV000015319; Zygosity=Unspecified; Note=Hb Providence (Coriell=GM20460).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM20461
AC   CVCL_HM48
DR   Coriell; GM20461
DR   Wikidata; Q54851036
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Lys83Asn (c.249G>Y); ClinVar=VCV000015319; Zygosity=Unspecified; Note=Hb Providence (Coriell=GM20461).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM20462
AC   CVCL_HM49
DR   Coriell; GM20462
DR   Wikidata; Q54851037
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Lys83Asn (c.249G>Y); ClinVar=VCV000015319; Zygosity=Unspecified; Note=Hb Providence (Coriell=GM20462).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM20463
AC   CVCL_HM50
DR   Coriell; GM20463
DR   Wikidata; Q54851038
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Lys83Asn (c.249G>Y); ClinVar=VCV000015319; Zygosity=Unspecified; Note=Hb Providence (Coriell=GM20463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM20466
AC   CVCL_7660
SY   AG04344; AG4344
DR   CLO; CLO_0029512
DR   BioSample; SAMN00805846
DR   Coriell; AG04344
DR   Coriell; GM20466
DR   Wikidata; Q54851039
RX   PubMed=16380922;
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Gln202Ter (c.604C>T); ClinVar=VCV000001740; Zygosity=Heterozygous (PubMed=16380922).
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Lys253fs*12 (c.752delA); Zygosity=Heterozygous (PubMed=16380922).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG04344; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4681; Roberts-SC phocomelia syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7661 ! GM20467
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   GM20467
AC   CVCL_7661
SY   AG03970
DR   CLO; CLO_0029534
DR   BioSample; SAMN00805848
DR   Coriell; AG03970
DR   Coriell; GM20467
DR   Wikidata; Q54851040
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Gln202Ter (c.604C>T); ClinVar=VCV000001740; Zygosity=Heterozygous (Coriell=GM20467).
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Lys253fs*12 (c.752delA); Zygosity=Heterozygous (Coriell=GM20467).
CC   Discontinued: Coriell; AG03970; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4681; Roberts-SC phocomelia syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7660 ! GM20466
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   GM20479
AC   CVCL_BT40
DR   CLO; CLO_0029536
DR   Coriell; GM20479
DR   Wikidata; Q54851041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM20480
AC   CVCL_BT41
DR   Coriell; GM20480
DR   Wikidata; Q54851042
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:4827; HBB + HGNC; HGNC:4829; HBD; Name(s)=HBD-HBB, HBD50/HBB86, Hb Lepore-Baltimore; Note=ClinVar VCV000015060 (Coriell=GM20480).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141366; Hemoglobin Lepore syndrome
DI   ORDO; Orphanet_330032; Hemoglobin Lepore-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20481
AC   CVCL_BT42
DR   CLO; CLO_0029535
DR   Coriell; GM20481
DR   Wikidata; Q54851043
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:4827; HBB + HGNC; HGNC:4829; HBD; Name(s)=HBD-HBB, HBD50/HBB86, Hb Lepore-Baltimore; Note=ClinVar VCV000015060 (Coriell=GM20481).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141366; Hemoglobin Lepore syndrome
DI   ORDO; Orphanet_330032; Hemoglobin Lepore-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20482
AC   CVCL_BT43
DR   CLO; CLO_0029538
DR   Coriell; GM20482
DR   Wikidata; Q54851044
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM20483
AC   CVCL_BT44
DR   Coriell; GM20483
DR   Wikidata; Q54851045
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM20486
AC   CVCL_IM22
DR   CLO; CLO_0029537
DR   Coriell; GM20486
DR   Wikidata; Q54851046
RX   PubMed=15966046;
CC   Population: Chinese; Taiwan.
CC   Karyotypic information: Chimera 46,XX/46,XY.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   <1Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM20498
AC   CVCL_HM51
DR   Coriell; GM20498
DR   Wikidata; Q54851047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM20501
AC   CVCL_5R19
DR   CLO; CLO_0029528
DR   Coriell; GM20501
DR   Wikidata; Q54851048
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20502
AC   CVCL_P561
DR   CLO; CLO_0029527
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001222
DR   Coriell; GM20502
DR   GEO; GSM650276
DR   GEO; GSM1720388
DR   IGSR; NA20502
DR   Wikidata; Q54851049
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20503
AC   CVCL_P562
DR   CLO; CLO_0029530
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001223
DR   Coriell; GM20503
DR   GEO; GSM650277
DR   GEO; GSM1720389
DR   IGSR; NA20503
DR   Wikidata; Q54851050
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20504
AC   CVCL_P563
DR   CLO; CLO_0029529
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001224
DR   Coriell; GM20504
DR   GEO; GSM650278
DR   GEO; GSM1720390
DR   IGSR; NA20504
DR   Wikidata; Q54851051
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20505
AC   CVCL_P564
DR   CLO; CLO_0029533
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001225
DR   Coriell; GM20505
DR   GEO; GSM650279
DR   GEO; GSM1720391
DR   IGSR; NA20505
DR   Wikidata; Q54851052
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20506
AC   CVCL_P565
DR   CLO; CLO_0029713
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001226
DR   Coriell; GM20506
DR   GEO; GSM650280
DR   GEO; GSM1720392
DR   IGSR; NA20506
DR   Wikidata; Q54851053
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20507
AC   CVCL_P566
DR   CLO; CLO_0029714
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001227
DR   Coriell; GM20507
DR   GEO; GSM650281
DR   GEO; GSM1720393
DR   IGSR; NA20507
DR   Wikidata; Q54851054
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20508
AC   CVCL_P567
DR   CLO; CLO_0029709
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001228
DR   Coriell; GM20508
DR   GEO; GSM650282
DR   GEO; GSM1720394
DR   IGSR; NA20508
DR   Wikidata; Q54851055
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20509
AC   CVCL_P568
DR   CLO; CLO_0029710
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001229
DR   Coriell; GM20509
DR   GEO; GSM650283
DR   GEO; GSM1720395
DR   IGSR; NA20509
DR   Wikidata; Q54851056
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=29474986;
RX   PubMed=31048460;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   GM20510
AC   CVCL_P569
DR   CLO; CLO_0029711
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001230
DR   Coriell; GM20510
DR   GEO; GSM650284
DR   GEO; GSM1720396
DR   IGSR; NA20510
DR   Wikidata; Q54851057
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20511
AC   CVCL_1A15
DR   BioSample; SAMN00001231
DR   Coriell; GM20511
DR   GEO; GSM1720397
DR   IGSR; NA20511
DR   Wikidata; Q54851058
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM20512
AC   CVCL_P570
DR   CLO; CLO_0029712
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001232
DR   Coriell; GM20512
DR   GEO; GSM650285
DR   GEO; GSM1720398
DR   IGSR; NA20512
DR   Wikidata; Q54851059
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20513
AC   CVCL_P571
DR   CLO; CLO_0029715
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001233
DR   Coriell; GM20513
DR   GEO; GSM650286
DR   GEO; GSM1720399
DR   IGSR; NA20513
DR   Wikidata; Q54851060
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20514
AC   CVCL_P572
DR   CLO; CLO_0029716
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001234
DR   Coriell; GM20514
DR   GEO; GSM650287
DR   GEO; GSM1720400
DR   IGSR; NA20514
DR   Wikidata; Q54851061
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20515
AC   CVCL_P573
DR   CLO; CLO_0029717
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001235
DR   Coriell; GM20515
DR   GEO; GSM650288
DR   GEO; GSM1720401
DR   IGSR; NA20515
DR   Wikidata; Q54851062
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20516
AC   CVCL_P574
DR   CLO; CLO_0029718
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001236
DR   Coriell; GM20516
DR   GEO; GSM650289
DR   GEO; GSM1720402
DR   IGSR; NA20516
DR   Wikidata; Q54851063
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20517
AC   CVCL_P575
DR   CLO; CLO_0029725
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001237
DR   Coriell; GM20517
DR   GEO; GSM650290
DR   GEO; GSM1720403
DR   IGSR; NA20517
DR   Wikidata; Q54851064
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20518
AC   CVCL_P576
DR   CLO; CLO_0029723
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001238
DR   Coriell; GM20518
DR   GEO; GSM650291
DR   GEO; GSM1720404
DR   IGSR; NA20518
DR   Wikidata; Q54851065
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20519
AC   CVCL_P577
DR   CLO; CLO_0029724
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001239
DR   Coriell; GM20519
DR   GEO; GSM650292
DR   GEO; GSM1720405
DR   IGSR; NA20519
DR   Wikidata; Q54851066
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20520
AC   CVCL_P578
DR   CLO; CLO_0029721
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001240
DR   Coriell; GM20520
DR   GEO; GSM650293
DR   GEO; GSM1720406
DR   IGSR; NA20520
DR   Wikidata; Q54851067
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20521
AC   CVCL_P579
DR   CLO; CLO_0029722
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001241
DR   Coriell; GM20521
DR   GEO; GSM650294
DR   GEO; GSM1720407
DR   IGSR; NA20521
DR   Wikidata; Q54851068
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20522
AC   CVCL_P580
DR   CLO; CLO_0029719
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001242
DR   Coriell; GM20522
DR   GEO; GSM650295
DR   GEO; GSM1720408
DR   IGSR; NA20522
DR   Wikidata; Q54851069
RX   PubMed=21397061;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20524
AC   CVCL_P581
DR   CLO; CLO_0029720
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001243
DR   Coriell; GM20524
DR   GEO; GSM650296
DR   GEO; GSM1720409
DR   IGSR; NA20524
DR   Wikidata; Q54851070
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20525
AC   CVCL_P582
DR   CLO; CLO_0029727
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001244
DR   Coriell; GM20525
DR   GEO; GSM650297
DR   GEO; GSM1720410
DR   IGSR; NA20525
DR   Wikidata; Q54851071
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20526
AC   CVCL_P583
DR   CLO; CLO_0029728
DR   BioSample; SAMN00001245
DR   Coriell; GM20526
DR   GEO; GSM650298
DR   GEO; GSM1720411
DR   IGSR; NA20526
DR   Wikidata; Q54851080
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20527
AC   CVCL_P584
DR   CLO; CLO_0029726
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001246
DR   Coriell; GM20527
DR   GEO; GSM650299
DR   GEO; GSM1720412
DR   IGSR; NA20527
DR   Wikidata; Q54851081
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20528
AC   CVCL_P585
DR   CLO; CLO_0029689
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001247
DR   Coriell; GM20528
DR   GEO; GSM650300
DR   GEO; GSM1720413
DR   IGSR; NA20528
DR   Wikidata; Q54851082
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20529
AC   CVCL_P586
DR   CLO; CLO_0029690
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001248
DR   Coriell; GM20529
DR   GEO; GSM650301
DR   GEO; GSM1720414
DR   IGSR; NA20529
DR   Wikidata; Q54851083
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20530
AC   CVCL_P587
DR   CLO; CLO_0029691
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001249
DR   Coriell; GM20530
DR   GEO; GSM650302
DR   GEO; GSM1720415
DR   IGSR; NA20530
DR   Wikidata; Q54851084
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20531
AC   CVCL_P588
DR   CLO; CLO_0029692
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001250
DR   Coriell; GM20531
DR   GEO; GSM650303
DR   GEO; GSM1720416
DR   IGSR; NA20531
DR   Wikidata; Q54851085
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20532
AC   CVCL_P589
DR   CLO; CLO_0029693
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001251
DR   Coriell; GM20532
DR   GEO; GSM650304
DR   GEO; GSM1720417
DR   IGSR; NA20532
DR   Wikidata; Q54851086
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20533
AC   CVCL_P590
DR   CLO; CLO_0029694
DR   BioSample; SAMN00001252
DR   Coriell; GM20533
DR   GEO; GSM650305
DR   GEO; GSM1720418
DR   IGSR; NA20533
DR   Wikidata; Q54851087
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20534
AC   CVCL_P591
DR   CLO; CLO_0029695
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001253
DR   Coriell; GM20534
DR   GEO; GSM650306
DR   GEO; GSM1720419
DR   IGSR; NA20534
DR   Wikidata; Q54851089
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20535
AC   CVCL_P592
DR   CLO; CLO_0029696
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001254
DR   Coriell; GM20535
DR   GEO; GSM650307
DR   GEO; GSM1720420
DR   IGSR; NA20535
DR   Wikidata; Q54851090
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20536
AC   CVCL_P593
DR   CLO; CLO_0029697
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001255
DR   Coriell; GM20536
DR   GEO; GSM650308
DR   GEO; GSM1720421
DR   IGSR; NA20536
DR   Wikidata; Q54851091
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20537
AC   CVCL_P594
DR   CLO; CLO_0029698
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001256
DR   Coriell; GM20537
DR   IGSR; NA20537
DR   Wikidata; Q54851092
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20538
AC   CVCL_P595
DR   CLO; CLO_0029708
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001257
DR   Coriell; GM20538
DR   GEO; GSM650309
DR   GEO; GSM1720422
DR   IGSR; NA20538
DR   Wikidata; Q54851093
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20539
AC   CVCL_P596
DR   CLO; CLO_0029701
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001258
DR   Coriell; GM20539
DR   GEO; GSM650310
DR   GEO; GSM1720423
DR   IGSR; NA20539
DR   Wikidata; Q54851094
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20540
AC   CVCL_P597
DR   CLO; CLO_0029702
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001259
DR   Coriell; GM20540
DR   GEO; GSM650311
DR   GEO; GSM1720424
DR   IGSR; NA20540
DR   Wikidata; Q54851095
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20541
AC   CVCL_P598
DR   CLO; CLO_0029699
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001260
DR   Coriell; GM20541
DR   GEO; GSM650312
DR   GEO; GSM1720425
DR   IGSR; NA20541
DR   Wikidata; Q54851096
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20542
AC   CVCL_P599
DR   CLO; CLO_0029700
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001261
DR   Coriell; GM20542
DR   GEO; GSM650313
DR   GEO; GSM1720426
DR   IGSR; NA20542
DR   Wikidata; Q54851097
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20543
AC   CVCL_P600
DR   CLO; CLO_0029705
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001262
DR   Coriell; GM20543
DR   GEO; GSM650314
DR   GEO; GSM1720427
DR   IGSR; NA20543
DR   Wikidata; Q54851098
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20544
AC   CVCL_P601
DR   CLO; CLO_0029706
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001263
DR   Coriell; GM20544
DR   GEO; GSM650315
DR   GEO; GSM1720428
DR   IGSR; NA20544
DR   Wikidata; Q54851099
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20545
AC   CVCL_5R20
DR   CLO; CLO_0029703
DR   Coriell; GM20545
DR   Wikidata; Q54851101
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20546
AC   CVCL_5R21
DR   CLO; CLO_0029704
DR   Coriell; GM20546
DR   Wikidata; Q54851102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM20547
AC   CVCL_5R22
DR   CLO; CLO_0029707
DR   Coriell; GM20547
DR   Wikidata; Q54851103
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20548
AC   CVCL_5R23
DR   CLO; CLO_0029687
DR   Coriell; GM20548
DR   Wikidata; Q54851104
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20550
AC   CVCL_5R24
DR   CLO; CLO_0029688
DR   Coriell; GM20550
DR   Wikidata; Q54851105
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20551
AC   CVCL_5R25
DR   CLO; CLO_0029684
DR   Coriell; GM20551
DR   Wikidata; Q54851106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM20555
AC   CVCL_5R26
DR   CLO; CLO_0029683
DR   Coriell; GM20555
DR   Wikidata; Q54851107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM20556
AC   CVCL_5R27
DR   CLO; CLO_0029686
DR   Coriell; GM20556
DR   Wikidata; Q54851108
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20560
AC   CVCL_5R28
DR   Coriell; GM20560
DR   Wikidata; Q54851109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM20562
AC   CVCL_5R29
DR   CLO; CLO_0029685
DR   Coriell; GM20562
DR   Wikidata; Q54851110
RX   PubMed=23665875;
RX   PubMed=39059105;
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+idic(15)(pter>q13::q13>pter).ish idic(15)(D15Z1++,D15S11++,GABRB3++) (Coriell=GM20562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   GM20567
AC   CVCL_4E16
DR   CLO; CLO_0029680
DR   Coriell; GM20567
DR   Wikidata; Q54851111
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM20568
AC   CVCL_X437
DR   Coriell; GM20568
DR   Wikidata; Q54851112
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 11
//
ID   GM20569
AC   CVCL_5R30
DR   Coriell; GM20569
DR   Wikidata; Q54851113
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20570
AC   CVCL_5R31
DR   CLO; CLO_0029679
DR   Coriell; GM20570
DR   Wikidata; Q54851114
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20571
AC   CVCL_2U61
DR   CLO; CLO_0029682
DR   Coriell; GM20571
DR   Wikidata; Q54851115
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM20572
AC   CVCL_2U62
DR   CLO; CLO_0029681
DR   Coriell; GM20572
DR   Wikidata; Q54851116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM20574
AC   CVCL_HK00
DR   Coriell; GM20574
DR   Wikidata; Q54851117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20575
AC   CVCL_BT45
DR   Coriell; GM20575
DR   Wikidata; Q54851118
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34825; Kawasaki disease
DI   ORDO; Orphanet_2331; Kawasaki disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM20576
AC   CVCL_BT46
DR   Coriell; GM20576
DR   Wikidata; Q54851119
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM20577
AC   CVCL_HM52
DR   Coriell; GM20577
DR   Wikidata; Q54851120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM20581
AC   CVCL_P602
DR   CLO; CLO_0028959
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001264
DR   Coriell; GM20581
DR   GEO; GSM650316
DR   GEO; GSM1720429
DR   IGSR; NA20581
DR   Wikidata; Q54851121
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20582
AC   CVCL_P603
DR   CLO; CLO_0028961
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001265
DR   Coriell; GM20582
DR   GEO; GSM650317
DR   GEO; GSM1720430
DR   IGSR; NA20582
DR   Wikidata; Q54851128
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20585
AC   CVCL_P604
DR   CLO; CLO_0028963
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001266
DR   Coriell; GM20585
DR   GEO; GSM650318
DR   GEO; GSM1720431
DR   IGSR; NA20585
DR   Wikidata; Q54851129
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20586
AC   CVCL_P605
DR   CLO; CLO_0028966
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001267
DR   Coriell; GM20586
DR   GEO; GSM650319
DR   GEO; GSM1720432
DR   IGSR; NA20586
DR   Wikidata; Q54851130
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20587
AC   CVCL_P606
DR   BioSample; SAMN00001268
DR   Coriell; GM20587
DR   GEO; GSM1720433
DR   IGSR; NA20587
DR   Wikidata; Q54851131
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20588
AC   CVCL_P607
DR   CLO; CLO_0028953
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001269
DR   Coriell; GM20588
DR   GEO; GSM650320
DR   GEO; GSM1720434
DR   IGSR; NA20588
DR   Wikidata; Q54851132
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20589
AC   CVCL_P608
DR   CLO; CLO_0028954
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001270
DR   Coriell; GM20589
DR   GEO; GSM650321
DR   GEO; GSM1720435
DR   IGSR; NA20589
DR   Wikidata; Q54851133
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20613
AC   CVCL_DS98
DR   CLO; CLO_0028956
DR   Coriell; GM20613
DR   Wikidata; Q54851134
CC   Derived from site: In situ; Fetal umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122795; Nephrotic syndrome - NPHS1 associated
DI   ORDO; Orphanet_839; Congenital nephrotic syndrome, Finnish type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM20614
AC   CVCL_CZ78
DR   CLO; CLO_0028957
DR   Coriell; GM20614
DR   Wikidata; Q54851135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM20615
AC   CVCL_CZ79
DR   CLO; CLO_0028971
DR   Coriell; GM20615
DR   Wikidata; Q54851136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM20616
AC   CVCL_2N32
DR   CLO; CLO_0028970
DR   Coriell; GM20616
DR   Wikidata; Q54851137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM20630
AC   CVCL_HM63
DR   Coriell; GM20630
DR   Wikidata; Q54851138
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20631
AC   CVCL_HM64
DR   Coriell; GM20631
DR   Wikidata; Q54851139
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20632
AC   CVCL_HM65
DR   Coriell; GM20632
DR   Wikidata; Q54851140
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20633
AC   CVCL_HM66
DR   Coriell; GM20633
DR   Wikidata; Q54851141
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20634
AC   CVCL_HM67
DR   Coriell; GM20634
DR   Wikidata; Q54851142
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20635
AC   CVCL_HM68
DR   Coriell; GM20635
DR   Wikidata; Q54851143
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2878; Anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20636
AC   CVCL_HM69
DR   Coriell; GM20636
DR   Wikidata; Q54851144
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20637
AC   CVCL_HM70
DR   Coriell; GM20637
DR   Wikidata; Q54851145
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20638
AC   CVCL_HM71
DR   Coriell; GM20638
DR   Wikidata; Q54851146
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20639
AC   CVCL_HM72
DR   Coriell; GM20639
DR   Wikidata; Q54851147
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20640
AC   CVCL_HM73
DR   Coriell; GM20640
DR   Wikidata; Q54851148
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20641
AC   CVCL_HM74
DR   Coriell; GM20641
DR   Wikidata; Q54851149
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20642
AC   CVCL_HM75
DR   Coriell; GM20642
DR   Wikidata; Q54851150
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20643
AC   CVCL_HM76
DR   Coriell; GM20643
DR   Wikidata; Q54851151
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20644
AC   CVCL_HM77
DR   Coriell; GM20644
DR   Wikidata; Q54851152
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20645
AC   CVCL_HM78
DR   Coriell; GM20645
DR   Wikidata; Q54851153
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20646
AC   CVCL_HM79
DR   Coriell; GM20646
DR   Wikidata; Q54851154
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20647
AC   CVCL_HM80
DR   Coriell; GM20647
DR   Wikidata; Q54851155
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20648
AC   CVCL_HM81
DR   Coriell; GM20648
DR   Wikidata; Q54851156
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20649
AC   CVCL_HM82
DR   Coriell; GM20649
DR   Wikidata; Q54851157
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20650
AC   CVCL_HM83
DR   Coriell; GM20650
DR   Wikidata; Q54851158
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20651
AC   CVCL_HM84
DR   Coriell; GM20651
DR   Wikidata; Q54851159
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20652
AC   CVCL_HM85
DR   Coriell; GM20652
DR   Wikidata; Q54851160
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20653
AC   CVCL_HM86
DR   Coriell; GM20653
DR   Wikidata; Q54851161
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20654
AC   CVCL_HM87
DR   Coriell; GM20654
DR   Wikidata; Q54851162
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20655
AC   CVCL_HM88
DR   Coriell; GM20655
DR   Wikidata; Q54851163
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20656
AC   CVCL_HM89
DR   Coriell; GM20656
DR   Wikidata; Q54851164
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20657
AC   CVCL_HM90
DR   Coriell; GM20657
DR   Wikidata; Q54851165
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20658
AC   CVCL_HM91
DR   Coriell; GM20658
DR   Wikidata; Q54851166
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20659
AC   CVCL_HM92
DR   Coriell; GM20659
DR   Wikidata; Q54851167
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20660
AC   CVCL_HM93
DR   Coriell; GM20660
DR   Wikidata; Q54851189
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20661
AC   CVCL_HM94
DR   Coriell; GM20661
DR   Wikidata; Q54851190
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20662
AC   CVCL_HM95
DR   Coriell; GM20662
DR   Wikidata; Q54851191
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20664
AC   CVCL_HM96
DR   Coriell; GM20664
DR   Wikidata; Q54851193
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20666
AC   CVCL_HM97
DR   Coriell; GM20666
DR   Wikidata; Q54851194
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20668
AC   CVCL_HM98
DR   Coriell; GM20668
DR   Wikidata; Q54851195
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20669
AC   CVCL_HM99
DR   Coriell; GM20669
DR   Wikidata; Q54851196
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20670
AC   CVCL_HN00
DR   Coriell; GM20670
DR   Wikidata; Q54851197
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20671
AC   CVCL_HN01
DR   Coriell; GM20671
DR   Wikidata; Q54851198
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20672
AC   CVCL_HN02
DR   Coriell; GM20672
DR   Wikidata; Q54851199
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20673
AC   CVCL_HN03
DR   Coriell; GM20673
DR   Wikidata; Q54851200
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20674
AC   CVCL_HN04
DR   Coriell; GM20674
DR   Wikidata; Q54851201
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20675
AC   CVCL_HN05
DR   Coriell; GM20675
DR   Wikidata; Q54851202
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20677
AC   CVCL_HN06
DR   Coriell; GM20677
DR   Wikidata; Q54851203
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20678
AC   CVCL_HN07
DR   Coriell; GM20678
DR   Wikidata; Q54851204
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20679
AC   CVCL_HN08
DR   Coriell; GM20679
DR   Wikidata; Q54851205
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20680
AC   CVCL_HN09
DR   Coriell; GM20680
DR   Wikidata; Q54851206
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20681
AC   CVCL_HN10
DR   Coriell; GM20681
DR   Wikidata; Q54851207
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20682
AC   CVCL_HN11
DR   Coriell; GM20682
DR   Wikidata; Q54851208
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20683
AC   CVCL_HN12
DR   Coriell; GM20683
DR   Wikidata; Q54851209
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20684
AC   CVCL_HN13
DR   Coriell; GM20684
DR   Wikidata; Q54851210
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20685
AC   CVCL_HN14
DR   Coriell; GM20685
DR   Wikidata; Q54851211
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20686
AC   CVCL_HN15
DR   Coriell; GM20686
DR   Wikidata; Q54851212
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20687
AC   CVCL_HN16
DR   Coriell; GM20687
DR   Wikidata; Q54851213
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20688
AC   CVCL_HN17
DR   Coriell; GM20688
DR   Wikidata; Q54851214
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20689
AC   CVCL_HN18
DR   Coriell; GM20689
DR   Wikidata; Q54851215
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20690
AC   CVCL_HN19
DR   Coriell; GM20690
DR   Wikidata; Q54851216
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20691
AC   CVCL_HN20
DR   Coriell; GM20691
DR   Wikidata; Q54851217
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20694
AC   CVCL_HN21
DR   Coriell; GM20694
DR   Wikidata; Q54851218
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20695
AC   CVCL_HN22
DR   Coriell; GM20695
DR   Wikidata; Q54851219
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20696
AC   CVCL_HN23
DR   Coriell; GM20696
DR   Wikidata; Q54851220
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20697
AC   CVCL_HN24
DR   Coriell; GM20697
DR   Wikidata; Q54851221
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20722
AC   CVCL_4T31
DR   CLO; CLO_0028997
DR   Coriell; GM20722
DR   Wikidata; Q54851222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123436; Peters-plus syndrome
DI   ORDO; Orphanet_709; Peters plus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM20729
AC   CVCL_HL71
DR   Coriell; GM20729
DR   Wikidata; Q54851223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20730
AC   CVCL_DB00
DR   CLO; CLO_0028982
DR   Coriell; GM20730
DR   Wikidata; Q54851224
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM20730).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Glu429Ala (c.1286A>C) (1298A>C); ClinVar=VCV000003521; Zygosity=Homozygous (Coriell=GM20730).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20731
AC   CVCL_AK45
DR   CLO; CLO_0028983
DR   Coriell; GM20731
DR   Wikidata; Q54851225
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; c.456+4A>T (IVS4+4A>T); ClinVar=VCV000012045; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM20731).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20732
AC   CVCL_AK46
DR   CLO; CLO_0028977
DR   Coriell; GM20732
DR   Wikidata; Q54851226
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; c.456+4A>T (IVS4+4A>T); ClinVar=VCV000012045; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM20732).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM20734
AC   CVCL_5K20
DR   CLO; CLO_0028979
DR   Coriell; GM20734
DR   Wikidata; Q54851228
CC   Sequence variation: Mutation; HGNC; HGNC:9834; RAI1; Simple; p.Leu85fs*60 (c.253del19); Zygosity=Unspecified (Coriell=GM20734).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   GM20735
AC   CVCL_5K21
DR   CLO; CLO_0028993
DR   Coriell; GM20735
DR   Wikidata; Q54851229
CC   Sequence variation: Mutation; HGNC; HGNC:9834; RAI1; Simple; p.Gln1562Arg (c.4685A>G); ClinVar=VCV000002950; Zygosity=Unspecified (Coriell=GM20735).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM20736
AC   CVCL_HL72
DR   Coriell; GM20736
DR   Wikidata; Q54851231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20737
AC   CVCL_0N32
DR   CLO; CLO_0028996
DR   Coriell; GM20737
DR   Wikidata; Q54851242
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg347His (c.1040G>A); ClinVar=VCV000007182; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20738
AC   CVCL_5R32
DR   CLO; CLO_0028988
DR   Coriell; GM20738
DR   Wikidata; Q54851243
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125419; Spondyloepimetaphyseal dysplasia with joint laxity type 2
DI   ORDO; Orphanet_93360; Spondyloepimetaphyseal dysplasia with multiple dislocations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM20741
AC   CVCL_0N33
DR   CLO; CLO_0028989
DR   Coriell; GM20741
DR   Wikidata; Q54851244
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Lys1250Argfs*9 (c.3744delA) (3876delA); ClinVar=VCV000007231; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM20742
AC   CVCL_5K22
DR   CLO; CLO_0028999
DR   Coriell; GM20742
DR   Wikidata; Q54851245
CC   Sequence variation: Mutation; HGNC; HGNC:9834; RAI1; Simple; p.Val925fs*8 (c.2773del29); Zygosity=Unspecified (Coriell=GM20742).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM20743
AC   CVCL_5K23
DR   CLO; CLO_0029027
DR   Coriell; GM20743
DR   Wikidata; Q54851246
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM20744
AC   CVCL_HM53
DR   Coriell; GM20744
DR   Wikidata; Q54851247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20745
AC   CVCL_0N34
DR   CLO; CLO_0029028
DR   Coriell; GM20745
DR   Wikidata; Q54851248
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser549Asn (c.1646G>A); ClinVar=VCV000007116; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20746
AC   CVCL_DB01
DR   CLO; CLO_0029005
DR   Coriell; GM20746
DR   Wikidata; Q54851249
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Heterozygous (Coriell=GM20746).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Glu429Ala (c.1286A>C) (1298A>C); ClinVar=VCV000003521; Zygosity=Homozygous (Coriell=GM20746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM20747
AC   CVCL_HM39
DR   Coriell; GM20747
DR   Wikidata; Q54851250
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129072; Hereditary persistence of fetal hemoglobin
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_251380; Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20748
AC   CVCL_HL73
DR   Coriell; GM20748
DR   Wikidata; Q54851251
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20752
AC   CVCL_P609
DR   CLO; CLO_0029009
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSample; SAMN00001271
DR   Coriell; GM20752
DR   GEO; GSM650322
DR   GEO; GSM1720436
DR   IGSR; NA20752
DR   Wikidata; Q54851252
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20753
AC   CVCL_P610
DR   CLO; CLO_0029011
DR   BioSample; SAMN00001272
DR   Coriell; GM20753
DR   GEO; GSM650323
DR   GEO; GSM1720437
DR   IGSR; NA20753
DR   Wikidata; Q54851253
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20754
AC   CVCL_P611
DR   CLO; CLO_0029013
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001273
DR   Coriell; GM20754
DR   GEO; GSM650324
DR   GEO; GSM1720438
DR   IGSR; NA20754
DR   Wikidata; Q54851254
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20755
AC   CVCL_P612
DR   CLO; CLO_0029015
DR   BioSample; SAMN00001274
DR   Coriell; GM20755
DR   GEO; GSM1720439
DR   IGSR; NA20755
DR   Wikidata; Q54851255
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20756
AC   CVCL_P613
DR   CLO; CLO_0029020
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001275
DR   Coriell; GM20756
DR   GEO; GSM650325
DR   GEO; GSM1720440
DR   IGSR; NA20756
DR   Wikidata; Q54851256
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20757
AC   CVCL_P614
DR   CLO; CLO_0029021
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001276
DR   Coriell; GM20757
DR   GEO; GSM650326
DR   GEO; GSM1720441
DR   IGSR; NA20757
DR   Wikidata; Q54851257
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20758
AC   CVCL_P615
DR   CLO; CLO_0029026
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001277
DR   Coriell; GM20758
DR   GEO; GSM650327
DR   GEO; GSM1720442
DR   IGSR; NA20758
DR   Wikidata; Q54851258
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20759
AC   CVCL_P616
DR   CLO; CLO_0028857
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001278
DR   Coriell; GM20759
DR   GEO; GSM650328
DR   GEO; GSM1720443
DR   IGSR; NA20759
DR   Wikidata; Q54851259
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20760
AC   CVCL_P617
DR   CLO; CLO_0028856
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001279
DR   Coriell; GM20760
DR   GEO; GSM650329
DR   GEO; GSM1720444
DR   IGSR; NA20760
DR   Wikidata; Q54851260
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Heterozygous (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Heterozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20761
AC   CVCL_P618
DR   CLO; CLO_0028855
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001280
DR   Coriell; GM20761
DR   GEO; GSM650330
DR   GEO; GSM1720445
DR   IGSR; NA20761
DR   Wikidata; Q54851262
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20762
AC   CVCL_P619
DR   BioSample; SAMN00001281
DR   Coriell; GM20762
DR   GEO; GSM1720446
DR   IGSR; NA20762
DR   Wikidata; Q54851263
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20763
AC   CVCL_P620
DR   BioSample; SAMN00001282
DR   Coriell; GM20763
DR   GEO; GSM1720447
DR   IGSR; NA20763
DR   Wikidata; Q54851264
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20764
AC   CVCL_P621
DR   BioSample; SAMN00001283
DR   Coriell; GM20764
DR   GEO; GSM1720448
DR   IGSR; NA20764
DR   Wikidata; Q54851265
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20765
AC   CVCL_P622
DR   CLO; CLO_0028868
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001284
DR   Coriell; GM20765
DR   GEO; GSM650331
DR   GEO; GSM1720449
DR   IGSR; NA20765
DR   Wikidata; Q54851266
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20766
AC   CVCL_P623
DR   CLO; CLO_0028867
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001285
DR   Coriell; GM20766
DR   GEO; GSM650332
DR   GEO; GSM1720450
DR   IGSR; NA20766
DR   Wikidata; Q54851267
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20767
AC   CVCL_P624
DR   BioSample; SAMN00001286
DR   Coriell; GM20767
DR   GEO; GSM1720451
DR   IGSR; NA20767
DR   Wikidata; Q54851268
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20768
AC   CVCL_P625
DR   CLO; CLO_0028866
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001287
DR   Coriell; GM20768
DR   GEO; GSM650333
DR   GEO; GSM1720452
DR   IGSR; NA20768
DR   Wikidata; Q54851269
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20769
AC   CVCL_P626
DR   CLO; CLO_0028865
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001288
DR   Coriell; GM20769
DR   GEO; GSM650334
DR   GEO; GSM1720453
DR   IGSR; NA20769
DR   Wikidata; Q54851270
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20770
AC   CVCL_P627
DR   CLO; CLO_0028864
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001289
DR   Coriell; GM20770
DR   GEO; GSM650335
DR   GEO; GSM1720454
DR   IGSR; NA20770
DR   Wikidata; Q54851271
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20771
AC   CVCL_P628
DR   CLO; CLO_0028862
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001290
DR   Coriell; GM20771
DR   GEO; GSM650336
DR   GEO; GSM1720455
DR   IGSR; NA20771
DR   Wikidata; Q54851272
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20772
AC   CVCL_P629
DR   CLO; CLO_0028859
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001291
DR   Coriell; GM20772
DR   GEO; GSM650337
DR   GEO; GSM1720456
DR   IGSR; NA20772
DR   Wikidata; Q54851274
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20773
AC   CVCL_P630
DR   CLO; CLO_0028875
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001292
DR   Coriell; GM20773
DR   GEO; GSM650338
DR   GEO; GSM1720457
DR   IGSR; NA20773
DR   Wikidata; Q54851275
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20774
AC   CVCL_P631
DR   CLO; CLO_0028874
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001293
DR   Coriell; GM20774
DR   GEO; GSM650339
DR   GEO; GSM1720458
DR   IGSR; NA20774
DR   Wikidata; Q54851276
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20775
AC   CVCL_P632
DR   CLO; CLO_0028877
DR   BioSample; SAMN00001294
DR   Coriell; GM20775
DR   GEO; GSM650340
DR   GEO; GSM1720459
DR   IGSR; NA20775
DR   Wikidata; Q54851277
RX   PubMed=21397061;
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11117; SMN1; Triplication; Zygosity=Unspecified (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11118; SMN2; Zygosity=Heterozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   GM20778
AC   CVCL_P633
DR   CLO; CLO_0028876
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001295
DR   Coriell; GM20778
DR   GEO; GSM650341
DR   GEO; GSM1720460
DR   IGSR; NA20778
DR   Wikidata; Q54851278
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20780
AC   CVCL_P634
DR   Coriell; GM20780
DR   Wikidata; Q54851279
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM20783
AC   CVCL_P635
DR   CLO; CLO_0028886
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001297
DR   Coriell; GM20783
DR   GEO; GSM650342
DR   GEO; GSM1720461
DR   IGSR; NA20783
DR   Wikidata; Q54851280
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20785
AC   CVCL_P636
DR   CLO; CLO_0028884
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001298
DR   Coriell; GM20785
DR   GEO; GSM650343
DR   GEO; GSM1720462
DR   IGSR; NA20785
DR   Wikidata; Q54851281
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20786
AC   CVCL_P637
DR   CLO; CLO_0028888
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001299
DR   Coriell; GM20786
DR   GEO; GSM650344
DR   GEO; GSM1720463
DR   IGSR; NA20786
DR   Wikidata; Q54851282
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20787
AC   CVCL_P638
DR   CLO; CLO_0028887
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001300
DR   Coriell; GM20787
DR   GEO; GSM650345
DR   GEO; GSM1720464
DR   IGSR; NA20787
DR   Wikidata; Q54851283
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20790
AC   CVCL_P639
DR   CLO; CLO_0028880
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001301
DR   Coriell; GM20790
DR   GEO; GSM1720465
DR   IGSR; NA20790
DR   Wikidata; Q54851299
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20791
AC   CVCL_P640
DR   Coriell; GM20791
DR   Wikidata; Q54851301
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM20792
AC   CVCL_P641
DR   CLO; CLO_0028879
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001303
DR   Coriell; GM20792
DR   GEO; GSM650346
DR   GEO; GSM1720466
DR   IGSR; NA20792
DR   Wikidata; Q54851302
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20795
AC   CVCL_P642
DR   CLO; CLO_0028897
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001304
DR   Coriell; GM20795
DR   GEO; GSM650347
DR   GEO; GSM1720467
DR   IGSR; NA20795
DR   Wikidata; Q54851304
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20796
AC   CVCL_P643
DR   CLO; CLO_0028901
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001305
DR   Coriell; GM20796
DR   GEO; GSM650348
DR   GEO; GSM1720468
DR   IGSR; NA20796
DR   Wikidata; Q54851305
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20797
AC   CVCL_P644
DR   CLO; CLO_0028900
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001306
DR   Coriell; GM20797
DR   GEO; GSM650349
DR   GEO; GSM1720469
DR   IGSR; NA20797
DR   Wikidata; Q54851306
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20798
AC   CVCL_P645
DR   CLO; CLO_0028899
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001307
DR   Coriell; GM20798
DR   GEO; GSM650350
DR   GEO; GSM1720470
DR   IGSR; NA20798
DR   Wikidata; Q54851307
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20799
AC   CVCL_P646
DR   CLO; CLO_0028898
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001308
DR   Coriell; GM20799
DR   GEO; GSM650351
DR   GEO; GSM1720471
DR   IGSR; NA20799
DR   Wikidata; Q54851308
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20800
AC   CVCL_P647
DR   CLO; CLO_0028905
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001309
DR   Coriell; GM20800
DR   GEO; GSM650352
DR   GEO; GSM1720472
DR   IGSR; NA20800
DR   Wikidata; Q54851309
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20801
AC   CVCL_P648
DR   CLO; CLO_0028904
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001310
DR   Coriell; GM20801
DR   GEO; GSM650353
DR   GEO; GSM1720473
DR   IGSR; NA20801
DR   Wikidata; Q54851310
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20802
AC   CVCL_P649
DR   CLO; CLO_0028903
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001311
DR   Coriell; GM20802
DR   GEO; GSM650354
DR   GEO; GSM1720474
DR   IGSR; NA20802
DR   Wikidata; Q54851311
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20803
AC   CVCL_P650
DR   CLO; CLO_0028902
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001312
DR   Coriell; GM20803
DR   GEO; GSM1720475
DR   IGSR; NA20803
DR   Wikidata; Q54851312
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM20804
AC   CVCL_P651
DR   CLO; CLO_0028908
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001313
DR   Coriell; GM20804
DR   GEO; GSM650355
DR   GEO; GSM1720476
DR   IGSR; NA20804
DR   Wikidata; Q54851313
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20805
AC   CVCL_P652
DR   CLO; CLO_0028923
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001314
DR   Coriell; GM20805
DR   GEO; GSM650356
DR   GEO; GSM1720477
DR   IGSR; NA20805
DR   Wikidata; Q54851314
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20806
AC   CVCL_P653
DR   CLO; CLO_0028922
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001315
DR   Coriell; GM20806
DR   GEO; GSM650357
DR   GEO; GSM1720478
DR   IGSR; NA20806
DR   Wikidata; Q54851315
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20807
AC   CVCL_P654
DR   CLO; CLO_0028925
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001316
DR   Coriell; GM20807
DR   GEO; GSM650358
DR   GEO; GSM1720479
DR   IGSR; NA20807
DR   Wikidata; Q54851316
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20808
AC   CVCL_P655
DR   CLO; CLO_0028924
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001317
DR   Coriell; GM20808
DR   GEO; GSM650359
DR   GEO; GSM1720480
DR   IGSR; NA20808
DR   Wikidata; Q54851317
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20809
AC   CVCL_P656
DR   CLO; CLO_0028927
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001318
DR   Coriell; GM20809
DR   GEO; GSM650360
DR   GEO; GSM1720481
DR   IGSR; NA20809
DR   Wikidata; Q54851318
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20810
AC   CVCL_P657
DR   CLO; CLO_0028926
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001319
DR   Coriell; GM20810
DR   GEO; GSM650361
DR   GEO; GSM1720482
DR   IGSR; NA20810
DR   Wikidata; Q54851319
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20811
AC   CVCL_P658
DR   CLO; CLO_0028930
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001320
DR   Coriell; GM20811
DR   GEO; GSM650362
DR   GEO; GSM1720483
DR   IGSR; NA20811
DR   Wikidata; Q54851320
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20812
AC   CVCL_P659
DR   CLO; CLO_0028929
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001321
DR   Coriell; GM20812
DR   GEO; GSM650363
DR   GEO; GSM1720484
DR   IGSR; NA20812
DR   Wikidata; Q54851321
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20813
AC   CVCL_P660
DR   CLO; CLO_0028934
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001322
DR   Coriell; GM20813
DR   GEO; GSM650364
DR   GEO; GSM1720485
DR   IGSR; NA20813
DR   Wikidata; Q54851322
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20814
AC   CVCL_P661
DR   CLO; CLO_0028932
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001323
DR   Coriell; GM20814
DR   GEO; GSM1720486
DR   IGSR; NA20814
DR   Wikidata; Q54851323
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20815
AC   CVCL_P662
DR   CLO; CLO_0029120
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001324
DR   Coriell; GM20815
DR   GEO; GSM650365
DR   GEO; GSM1720487
DR   IGSR; NA20815
DR   Wikidata; Q54851324
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20816
AC   CVCL_P663
DR   CLO; CLO_0029121
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001325
DR   Coriell; GM20816
DR   GEO; GSM650366
DR   IGSR; NA20816
DR   Wikidata; Q54851325
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20817
AC   CVCL_P664
DR   Coriell; GM20817
DR   Wikidata; Q54851326
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM20818
AC   CVCL_P665
DR   CLO; CLO_0029122
DR   BioSample; SAMN00001327
DR   Coriell; GM20818
DR   GEO; GSM650367
DR   GEO; GSM1720488
DR   IGSR; NA20818
DR   Wikidata; Q54851327
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20819
AC   CVCL_P666
DR   CLO; CLO_0029116
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001328
DR   Coriell; GM20819
DR   GEO; GSM650368
DR   GEO; GSM1720489
DR   IGSR; NA20819
DR   Wikidata; Q54851328
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20820
AC   CVCL_P667
DR   Coriell; GM20820
DR   Wikidata; Q54851329
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   GM20821
AC   CVCL_P668
DR   BioSample; SAMN00001330
DR   Coriell; GM20821
DR   GEO; GSM1720490
DR   IGSR; NA20821
DR   Wikidata; Q54851330
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20822
AC   CVCL_P669
DR   BioSample; SAMN00001331
DR   Coriell; GM20822
DR   GEO; GSM1720491
DR   IGSR; NA20822
DR   Wikidata; Q54851331
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20825
AC   CVCL_1A05
DR   Coriell; GM20825
DR   Wikidata; Q54851332
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM20826
AC   CVCL_P670
DR   CLO; CLO_0029117
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001333
DR   Coriell; GM20826
DR   GEO; GSM650369
DR   GEO; GSM1720492
DR   IGSR; NA20826
DR   Wikidata; Q54851333
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20827
AC   CVCL_P671
DR   BioSample; SAMN00001334
DR   Coriell; GM20827
DR   GEO; GSM1720493
DR   IGSR; NA20827
DR   Wikidata; Q54851334
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20828
AC   CVCL_P672
DR   CLO; CLO_0029118
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSample; SAMN00001335
DR   Coriell; GM20828
DR   GEO; GSM650370
DR   GEO; GSM1720494
DR   IGSR; NA20828
DR   Wikidata; Q54851335
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20829
AC   CVCL_1A06
DR   Coriell; GM20829
DR   IGSR; NA20829
DR   Wikidata; Q54851336
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM20831
AC   CVCL_P673
DR   Coriell; GM20831
DR   IGSR; NA20831
DR   Wikidata; Q54851337
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM20832
AC   CVCL_P674
DR   BioSample; SAMN00001338
DR   Coriell; GM20832
DR   GEO; GSM1720495
DR   IGSR; NA20832
DR   Wikidata; Q54851338
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Toscani in Italia (TSI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20833
AC   CVCL_8A58
DR   CLO; CLO_0029119
DR   Coriell; GM20833
DR   Wikidata; Q54851339
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.His1327Arg (c.3980A>G) (H1299R); ClinVar=VCV000037345; Zygosity=Heterozygous (Coriell=GM20833).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM20834
AC   CVCL_0N35
DR   CLO; CLO_0029113
DR   Coriell; GM20834
DR   Wikidata; Q54851340
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg347His (c.1040G>A); ClinVar=VCV000007182; Zygosity=Heterozygous (Coriell=GM20834).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20835
AC   CVCL_CZ80
DR   CLO; CLO_0029114
DR   Coriell; GM20835
DR   Wikidata; Q54851344
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu288Val (c.863A>T); ClinVar=VCV000017969; Zygosity=Heterozygous; Note=S allele (PubMed=19767587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM20836
AC   CVCL_0N36
DR   CLO; CLO_0029115
DR   Coriell; GM20836
DR   Wikidata; Q54851345
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Leu1258Phefs*7 (c.3773dupT) (3905insT); ClinVar=VCV000038726; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM20837
AC   CVCL_0N37
DR   CLO; CLO_0029141
DR   Coriell; GM20837
DR   Wikidata; Q54851346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM20838
AC   CVCL_HL74
DR   Coriell; GM20838
DR   Wikidata; Q54851347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20839
AC   CVCL_HM54
DR   Coriell; GM20839
DR   Wikidata; Q54851348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM20841
AC   CVCL_4W24
DR   CLO; CLO_0029142
DR   Coriell; GM20841
DR   Wikidata; Q54851349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123814; Jackson-Weiss syndrome
DI   ORDO; Orphanet_1540; Jackson-Weiss syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM20845
AC   CVCL_N915
DR   CLO; CLO_0029139
DR   BioSample; SAMN00007880
DR   Coriell; GM20845
DR   GEO; GSM1720496
DR   IGSR; NA20845
DR   Wikidata; Q54851350
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20846
AC   CVCL_N916
DR   CLO; CLO_0029140
DR   BioSample; SAMN00007881
DR   Coriell; GM20846
DR   GEO; GSM1720497
DR   IGSR; NA20846
DR   Wikidata; Q54851351
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20847
AC   CVCL_N917
DR   CLO; CLO_0029137
DR   BioSample; SAMN00007882
DR   Coriell; GM20847
DR   GEO; GSM1720498
DR   IGSR; NA20847
DR   Wikidata; Q54851352
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20849
AC   CVCL_N918
DR   CLO; CLO_0029138
DR   BioSample; SAMN00007883
DR   Coriell; GM20849
DR   GEO; GSM1720499
DR   IGSR; NA20849
DR   Wikidata; Q54851353
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20850
AC   CVCL_N919
DR   CLO; CLO_0029135
DR   BioSample; SAMN00007884
DR   Coriell; GM20850
DR   GEO; GSM1720500
DR   IGSR; NA20850
DR   Wikidata; Q54851354
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20851
AC   CVCL_N920
DR   CLO; CLO_0029136
DR   BioSample; SAMN00007885
DR   Coriell; GM20851
DR   GEO; GSM1720501
DR   IGSR; NA20851
DR   Wikidata; Q54851355
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20852
AC   CVCL_N921
DR   CLO; CLO_0029133
DR   BioSample; SAMN00007886
DR   Coriell; GM20852
DR   GEO; GSM1720502
DR   IGSR; NA20852
DR   Wikidata; Q54851356
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20853
AC   CVCL_N922
DR   CLO; CLO_0029134
DR   BioSample; SAMN00007887
DR   Coriell; GM20853
DR   GEO; GSM1720503
DR   IGSR; NA20853
DR   Wikidata; Q54851357
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20854
AC   CVCL_N923
DR   CLO; CLO_0029152
DR   BioSample; SAMN00007888
DR   Coriell; GM20854
DR   GEO; GSM1720504
DR   IGSR; NA20854
DR   Wikidata; Q54851358
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20856
AC   CVCL_N924
DR   CLO; CLO_0029144
DR   BioSample; SAMN00007889
DR   Coriell; GM20856
DR   GEO; GSM1720505
DR   IGSR; NA20856
DR   Wikidata; Q54851359
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20858
AC   CVCL_N925
DR   CLO; CLO_0029145
DR   BioSample; SAMN00007890
DR   Coriell; GM20858
DR   GEO; GSM1720506
DR   IGSR; NA20858
DR   Wikidata; Q54851361
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20859
AC   CVCL_N926
DR   CLO; CLO_0029146
DR   BioSample; SAMN00007891
DR   Coriell; GM20859
DR   GEO; GSM1720507
DR   IGSR; NA20859
DR   Wikidata; Q54851362
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20861
AC   CVCL_N927
DR   CLO; CLO_0029147
DR   BioSample; SAMN00007892
DR   Coriell; GM20861
DR   GEO; GSM1720508
DR   IGSR; NA20861
DR   Wikidata; Q54851363
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20862
AC   CVCL_N928
DR   CLO; CLO_0029148
DR   BioSample; SAMN00007893
DR   Coriell; GM20862
DR   GEO; GSM1720509
DR   IGSR; NA20862
DR   Wikidata; Q54851364
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20863
AC   CVCL_N929
DR   BioSample; SAMN00004488
DR   Coriell; GM20863
DR   GEO; GSM1720510
DR   IGSR; NA20863
DR   Wikidata; Q54851365
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20864
AC   CVCL_N930
DR   BioSample; SAMN00004489
DR   Coriell; GM20864
DR   GEO; GSM1720511
DR   IGSR; NA20864
DR   Wikidata; Q54851366
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20866
AC   CVCL_N931
DR   CLO; CLO_0029149
DR   BioSample; SAMN00007894
DR   Coriell; GM20866
DR   GEO; GSM1720512
DR   IGSR; NA20866
DR   Wikidata; Q54851367
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20867
AC   CVCL_N932
DR   BioSample; SAMN00004490
DR   Coriell; GM20867
DR   GEO; GSM1720513
DR   IGSR; NA20867
DR   Wikidata; Q54851368
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20868
AC   CVCL_N933
DR   BioSample; SAMN00004491
DR   Coriell; GM20868
DR   GEO; GSM1720514
DR   IGSR; NA20868
DR   Wikidata; Q54851370
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20869
AC   CVCL_N934
DR   CLO; CLO_0029150
DR   BioSample; SAMN00007895
DR   Coriell; GM20869
DR   GEO; GSM1720515
DR   IGSR; NA20869
DR   Wikidata; Q54851371
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20870
AC   CVCL_N935
DR   CLO; CLO_0029151
DR   BioSample; SAMN00007896
DR   Coriell; GM20870
DR   GEO; GSM1720516
DR   IGSR; NA20870
DR   Wikidata; Q54851372
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20871
AC   CVCL_N936
DR   CLO; CLO_0029143
DR   BioSample; SAMN00007897
DR   Coriell; GM20871
DR   GEO; GSM1720517
DR   IGSR; NA20871
DR   Wikidata; Q54851374
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20872
AC   CVCL_N937
DR   CLO; CLO_0015319
DR   BioSample; SAMN00007898
DR   Coriell; GM20872
DR   GEO; GSM1720518
DR   IGSR; NA20872
DR   Wikidata; Q54851375
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20873
AC   CVCL_N938
DR   CLO; CLO_0015321
DR   Coriell; GM20873
DR   IGSR; NA20873
DR   Wikidata; Q54851377
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20874
AC   CVCL_N939
DR   CLO; CLO_0015337
DR   BioSample; SAMN00007900
DR   Coriell; GM20874
DR   GEO; GSM1720519
DR   IGSR; NA20874
DR   Wikidata; Q54851378
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20875
AC   CVCL_N940
DR   CLO; CLO_0015334
DR   BioSample; SAMN00007901
DR   Coriell; GM20875
DR   GEO; GSM1720520
DR   IGSR; NA20875
DR   Wikidata; Q54851379
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   GM20876
AC   CVCL_N941
DR   CLO; CLO_0015333
DR   BioSample; SAMN00007902
DR   Coriell; GM20876
DR   GEO; GSM1720521
DR   IGSR; NA20876
DR   Wikidata; Q54851381
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20877
AC   CVCL_N942
DR   CLO; CLO_0015330
DR   BioSample; SAMN00007903
DR   Coriell; GM20877
DR   GEO; GSM1720522
DR   IGSR; NA20877
DR   Wikidata; Q54851382
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20878
AC   CVCL_N943
DR   CLO; CLO_0015328
DR   BioSample; SAMN00007904
DR   Coriell; GM20878
DR   GEO; GSM1720523
DR   IGSR; NA20878
DR   Wikidata; Q54851383
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20879
AC   CVCL_1A07
DR   CLO; CLO_0015327
DR   Coriell; GM20879
DR   IGSR; NA20879
DR   Wikidata; Q54851385
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM20881
AC   CVCL_N944
DR   CLO; CLO_0015324
DR   BioSample; SAMN00007906
DR   Coriell; GM20881
DR   GEO; GSM1720524
DR   IGSR; NA20881
DR   Wikidata; Q54851387
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20882
AC   CVCL_N945
DR   CLO; CLO_0015323
DR   BioSample; SAMN00007907
DR   Coriell; GM20882
DR   GEO; GSM1720525
DR   IGSR; NA20882
DR   Wikidata; Q54851388
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20883
AC   CVCL_N946
DR   CLO; CLO_0015299
DR   Coriell; GM20883
DR   IGSR; NA20883
DR   Wikidata; Q54851390
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20884
AC   CVCL_N947
DR   CLO; CLO_0015300
DR   BioSample; SAMN00007909
DR   Coriell; GM20884
DR   GEO; GSM1720526
DR   IGSR; NA20884
DR   Wikidata; Q54851391
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20885
AC   CVCL_N948
DR   CLO; CLO_0015301
DR   BioSample; SAMN00007910
DR   Coriell; GM20885
DR   GEO; GSM1720527
DR   IGSR; NA20885
DR   Wikidata; Q54851411
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20886
AC   CVCL_N949
DR   CLO; CLO_0015312
DR   BioSample; SAMN00007911
DR   Coriell; GM20886
DR   GEO; GSM1720528
DR   IGSR; NA20886
DR   Wikidata; Q54851412
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20887
AC   CVCL_N950
DR   CLO; CLO_0015309
DR   BioSample; SAMN00007912
DR   Coriell; GM20887
DR   GEO; GSM1720529
DR   IGSR; NA20887
DR   Wikidata; Q54851414
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20888
AC   CVCL_N951
DR   CLO; CLO_0015316
DR   BioSample; SAMN00007913
DR   Coriell; GM20888
DR   GEO; GSM1720530
DR   IGSR; NA20888
DR   Wikidata; Q54851415
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20889
AC   CVCL_N952
DR   CLO; CLO_0015314
DR   BioSample; SAMN00007914
DR   Coriell; GM20889
DR   GEO; GSM1720531
DR   IGSR; NA20889
DR   Wikidata; Q54851417
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20890
AC   CVCL_N953
DR   CLO; CLO_0015304
DR   BioSample; SAMN00007915
DR   Coriell; GM20890
DR   GEO; GSM1720532
DR   IGSR; NA20890
DR   Wikidata; Q54851418
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20891
AC   CVCL_N954
DR   CLO; CLO_0015303
DR   BioSample; SAMN00007916
DR   Coriell; GM20891
DR   GEO; GSM1720533
DR   IGSR; NA20891
DR   Wikidata; Q54851419
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20892
AC   CVCL_N955
DR   CLO; CLO_0015307
DR   BioSample; SAMN00007917
DR   Coriell; GM20892
DR   GEO; GSM1720534
DR   IGSR; NA20892
DR   Wikidata; Q54851421
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20893
AC   CVCL_N956
DR   CLO; CLO_0015356
DR   BioSample; SAMN00007918
DR   Coriell; GM20893
DR   GEO; GSM1720535
DR   IGSR; NA20893
DR   Wikidata; Q54851422
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20894
AC   CVCL_N957
DR   CLO; CLO_0015355
DR   BioSample; SAMN00007919
DR   Coriell; GM20894
DR   GEO; GSM1720536
DR   IGSR; NA20894
DR   Wikidata; Q54851423
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20895
AC   CVCL_N958
DR   CLO; CLO_0015358
DR   BioSample; SAMN00007920
DR   Coriell; GM20895
DR   GEO; GSM1720537
DR   IGSR; NA20895
DR   Wikidata; Q54851425
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20896
AC   CVCL_N959
DR   CLO; CLO_0015357
DR   BioSample; SAMN00007921
DR   Coriell; GM20896
DR   GEO; GSM1720538
DR   IGSR; NA20896
DR   Wikidata; Q54851427
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20897
AC   CVCL_N960
DR   CLO; CLO_0015349
DR   BioSample; SAMN00007922
DR   Coriell; GM20897
DR   GEO; GSM1720539
DR   IGSR; NA20897
DR   Wikidata; Q54851428
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20898
AC   CVCL_N961
DR   CLO; CLO_0015350
DR   BioSample; SAMN00007923
DR   Coriell; GM20898
DR   GEO; GSM1720540
DR   IGSR; NA20898
DR   Wikidata; Q54851429
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20899
AC   CVCL_N962
DR   CLO; CLO_0015351
DR   BioSample; SAMN00007924
DR   Coriell; GM20899
DR   GEO; GSM1720541
DR   IGSR; NA20899
DR   Wikidata; Q54851430
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20900
AC   CVCL_N963
DR   CLO; CLO_0015352
DR   BioSample; SAMN00007925
DR   Coriell; GM20900
DR   GEO; GSM1720542
DR   IGSR; NA20900
DR   Wikidata; Q54851431
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20901
AC   CVCL_N964
DR   CLO; CLO_0015353
DR   BioSample; SAMN00007926
DR   Coriell; GM20901
DR   GEO; GSM1720543
DR   IGSR; NA20901
DR   Wikidata; Q54851432
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20902
AC   CVCL_N965
DR   CLO; CLO_0015354
DR   BioSample; SAMN00007927
DR   Coriell; GM20902
DR   GEO; GSM1720545
DR   IGSR; NA20902
DR   Wikidata; Q54851433
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20903
AC   CVCL_N966
DR   CLO; CLO_0015344
DR   BioSample; SAMN00007928
DR   Coriell; GM20903
DR   GEO; GSM1720547
DR   IGSR; NA20903
DR   Wikidata; Q54851434
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20904
AC   CVCL_N967
DR   CLO; CLO_0015348
DR   BioSample; SAMN00007929
DR   Coriell; GM20904
DR   GEO; GSM1720548
DR   IGSR; NA20904
DR   Wikidata; Q54851435
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20905
AC   CVCL_N968
DR   BioSample; SAMN00004492
DR   Coriell; GM20905
DR   GEO; GSM1720551
DR   IGSR; NA20905
DR   Wikidata; Q54851436
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM20906
AC   CVCL_N969
DR   CLO; CLO_0015347
DR   BioSample; SAMN00007930
DR   Coriell; GM20906
DR   GEO; GSM1720553
DR   IGSR; NA20906
DR   Wikidata; Q54851438
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20907
AC   CVCL_1A08
DR   CLO; CLO_0015346
DR   Coriell; GM20907
DR   IGSR; NA20907
DR   Wikidata; Q54851439
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM20908
AC   CVCL_N970
DR   CLO; CLO_0015345
DR   BioSample; SAMN00007932
DR   Coriell; GM20908
DR   GEO; GSM1720555
DR   IGSR; NA20908
DR   Wikidata; Q54851440
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20909
AC   CVCL_1A09
DR   CLO; CLO_0015341
DR   Coriell; GM20909
DR   IGSR; NA20909
DR   Wikidata; Q54851441
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM20910
AC   CVCL_N971
DR   CLO; CLO_0015342
DR   BioSample; SAMN00007934
DR   Coriell; GM20910
DR   GEO; GSM1720557
DR   IGSR; NA20910
DR   Wikidata; Q54851442
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20911
AC   CVCL_N972
DR   CLO; CLO_0015339
DR   BioSample; SAMN00007935
DR   Coriell; GM20911
DR   GEO; GSM1720559
DR   IGSR; NA20911
DR   Wikidata; Q54851444
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM20912
AC   CVCL_9S51
DR   CLO; CLO_0015340
DR   Coriell; GM20912
DR   Wikidata; Q54851445
CC   Derived from site: In situ; Fetal umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   GM20913
AC   CVCL_HL75
DR   Coriell; GM20913
DR   Wikidata; Q54851447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20914
AC   CVCL_HL76
DR   Coriell; GM20914
DR   Wikidata; Q54851448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20915
AC   CVCL_0N38
DR   CLO; CLO_0015343
DR   Coriell; GM20915
DR   Wikidata; Q54851449
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser549Arg (c.1647T>G); ClinVar=VCV000040190; Zygosity=Heterozygous (Coriell=GM20915).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20916
AC   CVCL_5R33
DR   Coriell; GM20916
DR   Wikidata; Q54851450
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM20917
AC   CVCL_HM59
DR   Coriell; GM20917
DR   Wikidata; Q54851451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM20918
AC   CVCL_EF98
DR   CLO; CLO_0015378
DR   Coriell; GM20918
DR   Wikidata; Q54851452
RX   PubMed=19767587;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM20919
AC   CVCL_HM55
DR   Coriell; GM20919
DR   Wikidata; Q54851453
CC   Population: Caucasian; Greek/Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM20920
AC   CVCL_HL77
DR   Coriell; GM20920
DR   Wikidata; Q54851454
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Unspecified (from child cell line WISC012i-SCA).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM20924
AC   CVCL_0N39
DR   CLO; CLO_0015377
DR   Coriell; GM20924
DR   Wikidata; Q54851455
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg75Ter (c.223C>T); ClinVar=VCV000048672; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20925
AC   CVCL_0N40
DR   CLO; CLO_0015374
DR   Coriell; GM20925
DR   Wikidata; Q54851456
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser549Arg (c.1645A>C); ClinVar=VCV000038733; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20926
AC   CVCL_HM40
DR   CLO; CLO_0015373
DR   Coriell; GM20926
DR   Wikidata; Q54851458
CC   Population: Caucasian; Lithuanian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (Coriell=GM20926).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM20928
AC   CVCL_0N41
DR   CLO; CLO_0015376
DR   Coriell; GM20928
DR   Wikidata; Q54851459
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM20929
AC   CVCL_0N42
DR   CLO; CLO_0015375
DR   Coriell; GM20929
DR   Wikidata; Q54851478
RX   PubMed=19359498;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM20932
AC   CVCL_0N43
DR   CLO; CLO_0015369
DR   Coriell; GM20932
DR   Wikidata; Q54851479
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser549Asn (c.1646G>A); ClinVar=VCV000007116; Zygosity=Heterozygous (Coriell=GM20932).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM20935
AC   CVCL_DB61
DR   CLO; CLO_0015370
DR   Coriell; GM20935
DR   Wikidata; Q54851480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM20936
AC   CVCL_GY31
DR   CLO; CLO_0015371
DR   Coriell; GM20936
DR   Wikidata; Q54851481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM20937
AC   CVCL_EJ39
DR   CLO; CLO_0015372
DR   Coriell; GM20937
DR   Wikidata; Q54851482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM20941
AC   CVCL_DB02
DR   CLO; CLO_0015368
DR   Coriell; GM20941
DR   Wikidata; Q54851483
CC   Sequence variation: Mutation; HGNC; HGNC:2995; DPAGT1; Simple; p.Tyr170Cys (c.509A>G) (660A>G); ClinVar=VCV000012296; Zygosity=Heterozygous (Coriell=GM20941).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126874; Congenital disorder of glycosylation type Ij
DI   ORDO; Orphanet_86309; DPAGT1-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20942
AC   CVCL_DB03
DR   CLO; CLO_0015367
DR   Coriell; GM20942
DR   Wikidata; Q54851484
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Phe119Leu (c.357C>A); ClinVar=VCV000007711; Zygosity=Heterozygous (Coriell=GM20942).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (Coriell=GM20942).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20944
AC   CVCL_DB04
DR   CLO; CLO_0015366
DR   Coriell; GM20944
DR   Wikidata; Q54851485
CC   Sequence variation: Mutation; HGNC; HGNC:3005; DPM1; Simple; p.Arg92Gly (c.274C>G); ClinVar=VCV000006296; Zygosity=Homozygous (Coriell=GM20944).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126871; Congenital disorder of glycosylation type Ie
DI   ORDO; Orphanet_79322; DPM1-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20945
AC   CVCL_DB05
DR   CLO; CLO_0015365
DR   Coriell; GM20945
DR   Wikidata; Q54851486
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Leu32Arg (c.95_96delinsGC) (c.95TA>GC); ClinVar=VCV000092807; Zygosity=Heterozygous (Coriell=GM20945).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Phe157Ser (c.470T>C); ClinVar=VCV000188763; Zygosity=Heterozygous (Coriell=GM20945).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20947
AC   CVCL_DB06
DR   CLO; CLO_0015364
DR   Coriell; GM20947
DR   Wikidata; Q54851487
CC   Sequence variation: Mutation; HGNC; HGNC:23056; ALG3; Simple; p.Trp71Arg (c.211T>C); ClinVar=VCV000002130; Zygosity=Heterozygous (Coriell=GM20947).
CC   Sequence variation: Mutation; HGNC; HGNC:23056; ALG3; Simple; p.Met157Lys (c.470T>A); ClinVar=VCV000002131; Zygosity=Heterozygous (Coriell=GM20947).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126870; Congenital disorder of glycosylation type Id
DI   ORDO; Orphanet_79321; ALG3-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM20948
AC   CVCL_DB07
DR   CLO; CLO_0015363
DR   Coriell; GM20948
DR   Wikidata; Q54851488
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM20949
AC   CVCL_DB08
DR   CLO; CLO_0015362
DR   Coriell; GM20949
DR   Wikidata; Q54851489
CC   Sequence variation: Mutation; HGNC; HGNC:23157; ALG6; Simple; c.680+2T>G (IVS7+2T>G); ClinVar=VCV000030421; Zygosity=Heterozygous; Note=Causes skipping of exons 7-12 plus 22 bases of exon 13 (Coriell=GM20949).
CC   Sequence variation: Mutation; HGNC; HGNC:23157; ALG6; Simple; p.Ile299del (c.897_899delAAT) (c.894_896AAT[1]); ClinVar=VCV000030420; Zygosity=Heterozygous (Coriell=GM20949).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126869; Congenital disorder of glycosylation type Ic
DI   ORDO; Orphanet_79320; ALG6-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   GM20950
AC   CVCL_DB09
DR   CLO; CLO_0015360
DR   Coriell; GM20950
DR   Wikidata; Q54851490
CC   Sequence variation: Mutation; HGNC; HGNC:23056; ALG3; Simple; p.Arg171Gln (c.512G>A); ClinVar=VCV000002129; Zygosity=Homozygous (Coriell=GM20950).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126870; Congenital disorder of glycosylation type Id
DI   ORDO; Orphanet_79321; ALG3-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2W
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20951
AC   CVCL_DB10
DR   CLO; CLO_0015361
DR   Coriell; GM20951
DR   Wikidata; Q54851491
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM20956
AC   CVCL_DB11
DR   CLO; CLO_0015359
DR   Coriell; GM20956
DR   Wikidata; Q54851492
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Pro113Thr (c.337C>A); ClinVar=VCV000420784; Zygosity=Heterozygous (Coriell=GM20956).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (Coriell=GM20956).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM20958
AC   CVCL_DB12
DR   CLO; CLO_0015391
DR   Coriell; GM20958
DR   Wikidata; Q54851493
CC   Sequence variation: Mutation; HGNC; HGNC:7207; MPDU1; Simple; p.Leu119Pro (c.356T>C); ClinVar=VCV000005868; Zygosity=Homozygous (Coriell=GM20958).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126872; Congenital disorder of glycosylation type If
DI   ORDO; Orphanet_79323; MPDU1-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM2096-SV3
AC   CVCL_AD96
DR   Wikidata; Q54851495
RX   PubMed=3003928;
RX   PubMed=3480511;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro334His (c.1001C>A); ClinVar=VCV000000253; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7351 ! XP1MI 2
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM2096-SV9
AC   CVCL_AD97
SY   GM2096SV9
DR   Wikidata; Q54851496
RX   PubMed=3003928;
RX   PubMed=3413074;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro334His (c.1001C>A); ClinVar=VCV000000253; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7351 ! XP1MI 2
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM20969
AC   CVCL_HN25
DR   Coriell; GM20969
DR   Wikidata; Q54851497
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20970
AC   CVCL_HN26
DR   Coriell; GM20970
DR   Wikidata; Q54851498
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20971
AC   CVCL_HN27
DR   Coriell; GM20971
DR   Wikidata; Q54851499
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20972
AC   CVCL_HN28
DR   Coriell; GM20972
DR   Wikidata; Q54851500
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20973
AC   CVCL_HN29
DR   Coriell; GM20973
DR   Wikidata; Q54851501
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20974
AC   CVCL_HN30
DR   Coriell; GM20974
DR   Wikidata; Q54851502
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20977
AC   CVCL_HN31
DR   Coriell; GM20977
DR   Wikidata; Q54851503
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20978
AC   CVCL_HN32
DR   Coriell; GM20978
DR   Wikidata; Q54851504
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20979
AC   CVCL_HN33
DR   Coriell; GM20979
DR   Wikidata; Q54851505
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20980
AC   CVCL_HN34
DR   Coriell; GM20980
DR   Wikidata; Q54851506
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20981
AC   CVCL_HN35
DR   Coriell; GM20981
DR   Wikidata; Q54851507
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20982
AC   CVCL_HN36
DR   Coriell; GM20982
DR   Wikidata; Q54851508
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20983
AC   CVCL_HN37
DR   Coriell; GM20983
DR   Wikidata; Q54851509
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2878; Anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20984
AC   CVCL_HN38
DR   Coriell; GM20984
DR   Wikidata; Q54851510
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20985
AC   CVCL_HN39
DR   Coriell; GM20985
DR   Wikidata; Q54851511
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20986
AC   CVCL_HN40
DR   Coriell; GM20986
DR   Wikidata; Q54851512
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20987
AC   CVCL_DR52
DR   Coriell; GM20987
DR   Wikidata; Q54851513
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM20988
AC   CVCL_DR26
DR   Coriell; GM20988
DR   Wikidata; Q54851514
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM20989
AC   CVCL_HN43
DR   Coriell; GM20989
DR   Wikidata; Q54851515
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20990
AC   CVCL_DR29
DR   Coriell; GM20990
DR   Wikidata; Q54851516
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM20991 (Cellosaurus=CVCL_DR30).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   GM20991
AC   CVCL_DR30
DR   Coriell; GM20991
DR   Wikidata; Q54851517
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM20990 (Cellosaurus=CVCL_DR29).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 12
//
ID   GM20992
AC   CVCL_HN46
DR   Coriell; GM20992
DR   Wikidata; Q54851518
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20993
AC   CVCL_HN47
DR   Coriell; GM20993
DR   Wikidata; Q54851533
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20994
AC   CVCL_HN48
DR   Coriell; GM20994
DR   Wikidata; Q54851534
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20995
AC   CVCL_HN49
DR   Coriell; GM20995
DR   Wikidata; Q54851535
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20996
AC   CVCL_HN50
DR   Coriell; GM20996
DR   Wikidata; Q54851536
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20997
AC   CVCL_HN51
DR   Coriell; GM20997
DR   Wikidata; Q54851537
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20998
AC   CVCL_HN52
DR   Coriell; GM20998
DR   Wikidata; Q54851538
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM20999
AC   CVCL_HN53
DR   Coriell; GM20999
DR   Wikidata; Q54851539
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21000
AC   CVCL_HN54
DR   Coriell; GM21000
DR   Wikidata; Q54851540
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21001
AC   CVCL_HN55
DR   Coriell; GM21001
DR   Wikidata; Q54851541
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21002
AC   CVCL_HN56
DR   Coriell; GM21002
DR   Wikidata; Q54851542
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21003
AC   CVCL_HN57
DR   Coriell; GM21003
DR   Wikidata; Q54851543
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21004
AC   CVCL_HN58
DR   Coriell; GM21004
DR   Wikidata; Q54851544
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21005
AC   CVCL_HN59
DR   Coriell; GM21005
DR   Wikidata; Q54851545
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21006
AC   CVCL_HN60
DR   Coriell; GM21006
DR   Wikidata; Q54851546
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21007
AC   CVCL_HN61
DR   Coriell; GM21007
DR   Wikidata; Q54851547
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21008
AC   CVCL_HN62
DR   Coriell; GM21008
DR   Wikidata; Q54851548
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21010
AC   CVCL_HN63
DR   Coriell; GM21010
DR   Wikidata; Q54851549
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21011
AC   CVCL_HN64
DR   Coriell; GM21011
DR   Wikidata; Q54851550
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21012
AC   CVCL_HN65
DR   Coriell; GM21012
DR   Wikidata; Q54851551
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21013
AC   CVCL_HN66
DR   Coriell; GM21013
DR   Wikidata; Q54851552
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21014
AC   CVCL_HN67
DR   Coriell; GM21014
DR   Wikidata; Q54851553
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21015
AC   CVCL_HN68
DR   Coriell; GM21015
DR   Wikidata; Q54851554
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21016
AC   CVCL_HN69
DR   Coriell; GM21016
DR   Wikidata; Q54851555
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21017
AC   CVCL_HN70
DR   Coriell; GM21017
DR   Wikidata; Q54851556
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21018
AC   CVCL_HN71
DR   Coriell; GM21018
DR   Wikidata; Q54851557
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21019
AC   CVCL_HN72
DR   Coriell; GM21019
DR   Wikidata; Q54851558
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21020
AC   CVCL_HN73
DR   Coriell; GM21020
DR   Wikidata; Q54851559
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21021
AC   CVCL_HN74
DR   Coriell; GM21021
DR   Wikidata; Q54851560
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21022
AC   CVCL_HN75
DR   Coriell; GM21022
DR   Wikidata; Q54851561
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21023
AC   CVCL_HN76
DR   Coriell; GM21023
DR   Wikidata; Q54851562
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21024
AC   CVCL_HN77
DR   Coriell; GM21024
DR   Wikidata; Q54851564
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21025
AC   CVCL_HN78
DR   Coriell; GM21025
DR   Wikidata; Q54851566
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21026
AC   CVCL_HN79
DR   Coriell; GM21026
DR   Wikidata; Q54851567
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21027
AC   CVCL_HN80
DR   Coriell; GM21027
DR   Wikidata; Q54851570
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21028
AC   CVCL_HN81
DR   Coriell; GM21028
DR   Wikidata; Q54851571
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21029
AC   CVCL_HN82
DR   Coriell; GM21029
DR   Wikidata; Q54851572
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21030
AC   CVCL_HN83
DR   Coriell; GM21030
DR   Wikidata; Q54851573
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21031
AC   CVCL_HN84
DR   Coriell; GM21031
DR   Wikidata; Q54851575
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21032
AC   CVCL_HN85
DR   Coriell; GM21032
DR   Wikidata; Q54851576
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21033
AC   CVCL_HN86
DR   Coriell; GM21033
DR   Wikidata; Q54851578
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21034
AC   CVCL_HN87
DR   Coriell; GM21034
DR   Wikidata; Q54851584
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21035
AC   CVCL_HN88
DR   Coriell; GM21035
DR   Wikidata; Q54851585
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21037
AC   CVCL_HN89
DR   Coriell; GM21037
DR   Wikidata; Q54851586
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21038
AC   CVCL_HN90
DR   Coriell; GM21038
DR   Wikidata; Q54851587
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21039
AC   CVCL_HN91
DR   Coriell; GM21039
DR   Wikidata; Q54851588
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21040
AC   CVCL_HN92
DR   Coriell; GM21040
DR   Wikidata; Q54851589
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21041
AC   CVCL_HN93
DR   Coriell; GM21041
DR   Wikidata; Q54851590
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21042
AC   CVCL_HN94
DR   Coriell; GM21042
DR   Wikidata; Q54851591
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21043
AC   CVCL_HN95
DR   Coriell; GM21043
DR   Wikidata; Q54851592
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21044
AC   CVCL_HN96
DR   Coriell; GM21044
DR   Wikidata; Q54851593
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21045
AC   CVCL_HN97
DR   Coriell; GM21045
DR   Wikidata; Q54851595
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21046
AC   CVCL_HN98
DR   Coriell; GM21046
DR   Wikidata; Q54851596
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21048
AC   CVCL_HN99
DR   Coriell; GM21048
DR   Wikidata; Q54851597
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21049
AC   CVCL_HP88
DR   Coriell; GM21049
DR   Wikidata; Q54851598
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21050
AC   CVCL_HP00
DR   Coriell; GM21050
DR   Wikidata; Q54851599
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21051
AC   CVCL_HP01
DR   Coriell; GM21051
DR   Wikidata; Q54851600
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21052
AC   CVCL_HP02
DR   Coriell; GM21052
DR   Wikidata; Q54851601
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21053
AC   CVCL_HP03
DR   Coriell; GM21053
DR   Wikidata; Q54851602
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21054
AC   CVCL_HP04
DR   Coriell; GM21054
DR   Wikidata; Q54851603
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21055
AC   CVCL_HP05
DR   Coriell; GM21055
DR   Wikidata; Q54851604
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21056
AC   CVCL_HP06
DR   Coriell; GM21056
DR   Wikidata; Q54851606
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21057
AC   CVCL_HP07
DR   Coriell; GM21057
DR   Wikidata; Q54851607
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21058
AC   CVCL_HP08
DR   Coriell; GM21058
DR   Wikidata; Q54851609
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21059
AC   CVCL_HP09
DR   Coriell; GM21059
DR   Wikidata; Q54851610
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21060
AC   CVCL_HP10
DR   Coriell; GM21060
DR   Wikidata; Q54851611
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21061
AC   CVCL_HP11
DR   Coriell; GM21061
DR   Wikidata; Q54851612
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21062
AC   CVCL_HP12
DR   Coriell; GM21062
DR   Wikidata; Q54851613
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21063
AC   CVCL_HP13
DR   Coriell; GM21063
DR   Wikidata; Q54851614
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21064
AC   CVCL_HP14
DR   Coriell; GM21064
DR   Wikidata; Q54851615
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21065
AC   CVCL_HP15
DR   Coriell; GM21065
DR   Wikidata; Q54851616
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21066
AC   CVCL_HP16
DR   Coriell; GM21066
DR   Wikidata; Q54851617
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21067
AC   CVCL_HP17
DR   Coriell; GM21067
DR   Wikidata; Q54851618
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21068
AC   CVCL_W009
DR   Coriell; GM21068
DR   Wikidata; Q54851619
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98842; Holocarboxylase synthetase deficiency
DI   ORDO; Orphanet_79242; Holocarboxylase synthetase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W008 ! GM03522
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   GM21069
AC   CVCL_0N44
DR   CLO; CLO_0015392
DR   Coriell; GM21069
DR   Wikidata; Q54851620
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Lys1250Argfs*9 (c.3744delA) (3876delA); ClinVar=VCV000007231; Zygosity=Heterozygous (Coriell=GM21069).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM21070
AC   CVCL_0U96
DR   Coriell; GM21070
DR   Wikidata; Q54851621
RX   PubMed=37751688;
WW   Info; PGP; huC30901; https://my.pgp-hms.org/profile_public?hex=huC30901
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM21073
AC   CVCL_2U63
DR   CLO; CLO_0015395
DR   Coriell; GM21073
DR   Wikidata; Q54851624
RX   PubMed=23665875;
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM21074
AC   CVCL_4E17
DR   CLO; CLO_0015396
DR   Coriell; GM21074
DR   Wikidata; Q54851625
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(2)(p23;q31).arr(1-22,X)x2 (Coriell=GM21074).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM21075
AC   CVCL_4E18
DR   CLO; CLO_0015397
DR   Coriell; GM21075
DR   Wikidata; Q54851627
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   GM21076
AC   CVCL_HK01
DR   Coriell; GM21076
DR   Wikidata; Q54851634
CC   Karyotypic information: 46,XY,t(5;7)(q14;q21) (Coriell=GM21076).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 7
//
ID   GM21077
AC   CVCL_4E19
DR   CLO; CLO_0015398
DR   Coriell; GM21077
DR   Wikidata; Q54851635
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM21078
AC   CVCL_2U64
DR   CLO; CLO_0015390
DR   Coriell; GM21078
DR   Wikidata; Q54851636
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM21079
AC   CVCL_2U65
DR   CLO; CLO_0015389
DR   Coriell; GM21079
DR   Wikidata; Q54851637
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM21080
AC   CVCL_0N45
DR   CLO; CLO_0015380
DR   Coriell; GM21080
DR   Wikidata; Q54851638
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Leu88Ilefs*22 (c.262_263delTT) (394delTT); ClinVar=VCV000007232; Zygosity=Heterozygous (Coriell=GM21080).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM21081
AC   CVCL_HM56
DR   Coriell; GM21081
DR   Wikidata; Q54851639
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu27Lys (c.79G>A) (E26K); ClinVar=VCV000015161; Zygosity=Homozygous; Note=Hb E (Coriell=GM21081).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21082
AC   CVCL_HM57
DR   Coriell; GM21082
DR   Wikidata; Q54851640
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu27Lys (c.79G>A) (E26K); ClinVar=VCV000015161; Zygosity=Homozygous; Note=Hb E (Coriell=GM21082).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21086
AC   CVCL_N973
DR   CLO; CLO_0015383
DR   Coriell; GM21086
DR   GEO; GSM1720561
DR   IGSR; NA21086
DR   Wikidata; Q54851641
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21087
AC   CVCL_N974
DR   Coriell; GM21087
DR   GEO; GSM1720563
DR   IGSR; NA21087
DR   Wikidata; Q54851642
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM21088
AC   CVCL_N975
DR   CLO; CLO_0015384
DR   Coriell; GM21088
DR   GEO; GSM1720565
DR   IGSR; NA21088
DR   Wikidata; Q54851643
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21089
AC   CVCL_N976
DR   CLO; CLO_0015381
DR   Coriell; GM21089
DR   GEO; GSM1720566
DR   IGSR; NA21089
DR   Wikidata; Q54851644
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21090
AC   CVCL_N977
DR   CLO; CLO_0015382
DR   Coriell; GM21090
DR   GEO; GSM1720567
DR   IGSR; NA21090
DR   Wikidata; Q54851645
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21091
AC   CVCL_N978
DR   CLO; CLO_0015387
DR   Coriell; GM21091
DR   GEO; GSM1720568
DR   IGSR; NA21091
DR   Wikidata; Q54851646
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21092
AC   CVCL_N979
DR   CLO; CLO_0015388
DR   Coriell; GM21092
DR   GEO; GSM1720569
DR   IGSR; NA21092
DR   Wikidata; Q54851647
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21093
AC   CVCL_N980
DR   Coriell; GM21093
DR   GEO; GSM1720570
DR   IGSR; NA21093
DR   Wikidata; Q54851648
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM21094
AC   CVCL_N981
DR   CLO; CLO_0015385
DR   Coriell; GM21094
DR   GEO; GSM1720571
DR   IGSR; NA21094
DR   Wikidata; Q54851649
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21095
AC   CVCL_N982
DR   Coriell; GM21095
DR   GEO; GSM1720572
DR   IGSR; NA21095
DR   Wikidata; Q54851650
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM21097
AC   CVCL_N983
DR   CLO; CLO_0015386
DR   Coriell; GM21097
DR   GEO; GSM1720573
DR   IGSR; NA21097
DR   Wikidata; Q54851651
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21098
AC   CVCL_N984
DR   CLO; CLO_0015379
DR   Coriell; GM21098
DR   GEO; GSM1720574
DR   IGSR; NA21098
DR   Wikidata; Q54851652
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21099
AC   CVCL_N985
DR   CLO; CLO_0015409
DR   Coriell; GM21099
DR   GEO; GSM1720575
DR   IGSR; NA21099
DR   Wikidata; Q54851653
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21100
AC   CVCL_N986
DR   CLO; CLO_0015410
DR   Coriell; GM21100
DR   GEO; GSM1720576
DR   IGSR; NA21100
DR   Wikidata; Q54851654
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21101
AC   CVCL_N987
DR   CLO; CLO_0015415
DR   Coriell; GM21101
DR   GEO; GSM1720577
DR   IGSR; NA21101
DR   Wikidata; Q54851655
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21102
AC   CVCL_N988
DR   CLO; CLO_0015416
DR   Coriell; GM21102
DR   GEO; GSM1720578
DR   IGSR; NA21102
DR   Wikidata; Q54851656
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21103
AC   CVCL_N989
DR   CLO; CLO_0015417
DR   Coriell; GM21103
DR   GEO; GSM1720579
DR   IGSR; NA21103
DR   Wikidata; Q54851657
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21104
AC   CVCL_N990
DR   CLO; CLO_0015418
DR   Coriell; GM21104
DR   GEO; GSM1720580
DR   IGSR; NA21104
DR   Wikidata; Q54851658
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21105
AC   CVCL_N991
DR   CLO; CLO_0015411
DR   Coriell; GM21105
DR   GEO; GSM1720581
DR   IGSR; NA21105
DR   Wikidata; Q54851659
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   GM21106
AC   CVCL_N992
DR   CLO; CLO_0015412
DR   Coriell; GM21106
DR   GEO; GSM1720582
DR   IGSR; NA21106
DR   Wikidata; Q54851660
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21107
AC   CVCL_N993
DR   CLO; CLO_0015413
DR   Coriell; GM21107
DR   GEO; GSM1720583
DR   IGSR; NA21107
DR   Wikidata; Q54851661
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21108
AC   CVCL_N994
DR   CLO; CLO_0015414
DR   Coriell; GM21108
DR   GEO; GSM1720584
DR   IGSR; NA21108
DR   Wikidata; Q54851662
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21109
AC   CVCL_N995
DR   CLO; CLO_0015401
DR   Coriell; GM21109
DR   GEO; GSM1720585
DR   IGSR; NA21109
DR   Wikidata; Q54851663
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21110
AC   CVCL_N996
DR   CLO; CLO_0015399
DR   Coriell; GM21110
DR   GEO; GSM1720586
DR   IGSR; NA21110
DR   Wikidata; Q54851664
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21111
AC   CVCL_N997
DR   CLO; CLO_0015400
DR   Coriell; GM21111
DR   GEO; GSM1720587
DR   IGSR; NA21111
DR   Wikidata; Q54851665
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21112
AC   CVCL_N998
DR   CLO; CLO_0015407
DR   Coriell; GM21112
DR   GEO; GSM1720588
DR   IGSR; NA21112
DR   Wikidata; Q54851666
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21113
AC   CVCL_N999
DR   CLO; CLO_0015408
DR   Coriell; GM21113
DR   GEO; GSM1720589
DR   IGSR; NA21113
DR   Wikidata; Q54851667
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21114
AC   CVCL_P000
DR   Coriell; GM21114
DR   GEO; GSM1720590
DR   IGSR; NA21114
DR   Wikidata; Q54851668
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM21115
AC   CVCL_P001
DR   CLO; CLO_0015405
DR   Coriell; GM21115
DR   GEO; GSM1720591
DR   IGSR; NA21115
DR   Wikidata; Q54851669
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21116
AC   CVCL_P002
DR   CLO; CLO_0015406
DR   Coriell; GM21116
DR   GEO; GSM1720592
DR   IGSR; NA21116
DR   Wikidata; Q54851670
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21117
AC   CVCL_P003
DR   CLO; CLO_0015403
DR   Coriell; GM21117
DR   GEO; GSM1720593
DR   IGSR; NA21117
DR   Wikidata; Q54851671
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21118
AC   CVCL_P004
DR   CLO; CLO_0015404
DR   Coriell; GM21118
DR   GEO; GSM1720594
DR   IGSR; NA21118
DR   Wikidata; Q54851672
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21119
AC   CVCL_P005
DR   CLO; CLO_0015402
DR   Coriell; GM21119
DR   GEO; GSM1720595
DR   IGSR; NA21119
DR   Wikidata; Q54851673
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21120
AC   CVCL_P006
DR   CLO; CLO_0015861
DR   Coriell; GM21120
DR   GEO; GSM1720596
DR   IGSR; NA21120
DR   Wikidata; Q54851678
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21121
AC   CVCL_P007
DR   CLO; CLO_0015871
DR   Coriell; GM21121
DR   IGSR; NA21121
DR   Wikidata; Q54851679
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21122
AC   CVCL_P008
DR   CLO; CLO_0015870
DR   Coriell; GM21122
DR   GEO; GSM1720597
DR   IGSR; NA21122
DR   Wikidata; Q54851680
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21123
AC   CVCL_P009
DR   CLO; CLO_0015868
DR   Coriell; GM21123
DR   GEO; GSM1720598
DR   IGSR; NA21123
DR   Wikidata; Q54851681
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21124
AC   CVCL_P010
DR   Coriell; GM21124
DR   GEO; GSM1720599
DR   IGSR; NA21124
DR   Wikidata; Q54851682
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM21125
AC   CVCL_P011
DR   CLO; CLO_0015865
DR   Coriell; GM21125
DR   GEO; GSM1720600
DR   IGSR; NA21125
DR   Wikidata; Q54851683
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21126
AC   CVCL_P012
DR   Coriell; GM21126
DR   GEO; GSM1720601
DR   IGSR; NA21126
DR   Wikidata; Q54851684
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM21127
AC   CVCL_P013
DR   CLO; CLO_0015877
DR   Coriell; GM21127
DR   GEO; GSM1720602
DR   IGSR; NA21127
DR   Wikidata; Q54851685
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21128
AC   CVCL_P014
DR   CLO; CLO_0015875
DR   Coriell; GM21128
DR   GEO; GSM1720603
DR   IGSR; NA21128
DR   Wikidata; Q54851686
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21129
AC   CVCL_P015
DR   Coriell; GM21129
DR   GEO; GSM1720604
DR   IGSR; NA21129
DR   Wikidata; Q54851687
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GM21130
AC   CVCL_P016
DR   CLO; CLO_0015874
DR   Coriell; GM21130
DR   GEO; GSM1720605
DR   IGSR; NA21130
DR   Wikidata; Q54851688
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21131
AC   CVCL_1A10
DR   Coriell; GM21131
DR   Wikidata; Q54851689
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21132
AC   CVCL_1A11
DR   Coriell; GM21132
DR   Wikidata; Q54851690
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21133
AC   CVCL_P017
DR   CLO; CLO_0015873
DR   Coriell; GM21133
DR   GEO; GSM1720606
DR   IGSR; NA21133
DR   Wikidata; Q54851691
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21134
AC   CVCL_1A12
DR   Coriell; GM21134
DR   IGSR; NA21134
DR   Wikidata; Q54851692
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM21135
AC   CVCL_P018
DR   CLO; CLO_0015864
DR   Coriell; GM21135
DR   GEO; GSM1720607
DR   IGSR; NA21135
DR   Wikidata; Q54851693
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21136
AC   CVCL_1A13
DR   Coriell; GM21136
DR   Wikidata; Q54851694
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM21137
AC   CVCL_P019
DR   CLO; CLO_0015841
DR   Coriell; GM21137
DR   GEO; GSM1720608
DR   IGSR; NA21137
DR   Wikidata; Q54851695
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21141
AC   CVCL_P020
DR   CLO; CLO_0015842
DR   Coriell; GM21141
DR   GEO; GSM1720609
DR   IGSR; NA21141
DR   Wikidata; Q54851696
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21142
AC   CVCL_P021
DR   CLO; CLO_0015846
DR   Coriell; GM21142
DR   GEO; GSM1720610
DR   IGSR; NA21142
DR   Wikidata; Q54851697
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21143
AC   CVCL_P022
DR   CLO; CLO_0015844
DR   Coriell; GM21143
DR   GEO; GSM1720611
DR   IGSR; NA21143
DR   Wikidata; Q54851698
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21144
AC   CVCL_P023
DR   CLO; CLO_0015850
DR   Coriell; GM21144
DR   GEO; GSM1720612
DR   IGSR; NA21144
DR   Wikidata; Q54851699
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   GM21145
AC   CVCL_1A14
DR   Coriell; GM21145
DR   Wikidata; Q54851700
CC   Population: Indian; Gujarati in Houston, Texas, USA (GIH).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21149
AC   CVCL_1F81
DR   CLO; CLO_0015854
DR   Coriell; GM21149
DR   Wikidata; Q54851702
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (Coriell=GM21149).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM21150
AC   CVCL_1F82
DR   CLO; CLO_0015853
DR   Coriell; GM21150
DR   Wikidata; Q54851703
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Arg425Ter (c.1273C>T); ClinVar=VCV000016585; Zygosity=Heterozygous (Coriell=GM21150).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM21154
AC   CVCL_HM58
DR   Coriell; GM21154
DR   Wikidata; Q54851705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21160
AC   CVCL_HP18
DR   Coriell; GM21160
DR   Wikidata; Q54851706
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21161
AC   CVCL_HP19
DR   Coriell; GM21161
DR   Wikidata; Q54851707
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21162
AC   CVCL_HP20
DR   Coriell; GM21162
DR   Wikidata; Q54851708
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21163
AC   CVCL_HP21
DR   Coriell; GM21163
DR   Wikidata; Q54851709
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21164
AC   CVCL_HP22
DR   Coriell; GM21164
DR   Wikidata; Q54851710
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21165
AC   CVCL_HP23
DR   Coriell; GM21165
DR   Wikidata; Q54851711
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21166
AC   CVCL_HP24
DR   Coriell; GM21166
DR   Wikidata; Q54851712
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21167
AC   CVCL_HP25
DR   Coriell; GM21167
DR   Wikidata; Q54851713
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21168
AC   CVCL_HP26
DR   Coriell; GM21168
DR   Wikidata; Q54851714
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21169
AC   CVCL_HP27
DR   Coriell; GM21169
DR   Wikidata; Q54851715
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21170
AC   CVCL_HP28
DR   Coriell; GM21170
DR   Wikidata; Q54851716
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21171
AC   CVCL_HP29
DR   Coriell; GM21171
DR   Wikidata; Q54851717
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21172
AC   CVCL_HP30
DR   Coriell; GM21172
DR   Wikidata; Q54851724
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21173
AC   CVCL_HP31
DR   Coriell; GM21173
DR   Wikidata; Q54851725
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21174
AC   CVCL_HP32
DR   Coriell; GM21174
DR   Wikidata; Q54851726
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21175
AC   CVCL_HP33
DR   Coriell; GM21175
DR   Wikidata; Q54851727
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21179
AC   CVCL_HP34
DR   Coriell; GM21179
DR   Wikidata; Q54851728
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21180
AC   CVCL_HP35
DR   Coriell; GM21180
DR   Wikidata; Q54851729
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21181
AC   CVCL_HP36
DR   Coriell; GM21181
DR   Wikidata; Q54851730
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21182
AC   CVCL_HP37
DR   Coriell; GM21182
DR   Wikidata; Q54851731
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21183
AC   CVCL_HP38
DR   Coriell; GM21183
DR   Wikidata; Q54851732
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21184
AC   CVCL_HP39
DR   Coriell; GM21184
DR   Wikidata; Q54851733
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21185
AC   CVCL_HP40
DR   Coriell; GM21185
DR   Wikidata; Q54851734
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21186
AC   CVCL_HP41
DR   Coriell; GM21186
DR   Wikidata; Q54851735
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21187
AC   CVCL_HP42
DR   Coriell; GM21187
DR   Wikidata; Q54851736
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21192
AC   CVCL_4F82
DR   CLO; CLO_0015857
DR   Coriell; GM21192
DR   Wikidata; Q54851737
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM21192).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM21215
AC   CVCL_HP43
DR   Coriell; GM21215
DR   Wikidata; Q54851738
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21216
AC   CVCL_HP44
DR   Coriell; GM21216
DR   Wikidata; Q54851739
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21217
AC   CVCL_HP45
DR   Coriell; GM21217
DR   Wikidata; Q54851740
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21218
AC   CVCL_HP46
DR   Coriell; GM21218
DR   Wikidata; Q54851741
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21219
AC   CVCL_HP47
DR   Coriell; GM21219
DR   Wikidata; Q54851742
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21220
AC   CVCL_DR27
DR   Coriell; GM21220
DR   Wikidata; Q54851743
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM21221
AC   CVCL_HP49
DR   Coriell; GM21221
DR   Wikidata; Q54851744
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21250
AC   CVCL_HP50
DR   Coriell; GM21250
DR   Wikidata; Q54851745
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21251
AC   CVCL_HP51
DR   Coriell; GM21251
DR   Wikidata; Q54851746
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21252
AC   CVCL_HP52
DR   Coriell; GM21252
DR   Wikidata; Q54851747
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21253
AC   CVCL_HP53
DR   Coriell; GM21253
DR   Wikidata; Q54851748
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21254
AC   CVCL_HP54
DR   Coriell; GM21254
DR   Wikidata; Q54851749
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21255
AC   CVCL_HP55
DR   Coriell; GM21255
DR   Wikidata; Q54851750
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21256
AC   CVCL_HP56
DR   Coriell; GM21256
DR   Wikidata; Q54851751
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21257
AC   CVCL_HP57
DR   Coriell; GM21257
DR   Wikidata; Q54851752
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21258
AC   CVCL_HP58
DR   Coriell; GM21258
DR   Wikidata; Q54851753
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21259
AC   CVCL_HP59
DR   Coriell; GM21259
DR   Wikidata; Q54851754
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21260
AC   CVCL_HP60
DR   Coriell; GM21260
DR   Wikidata; Q54851755
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21261
AC   CVCL_5U26
DR   CLO; CLO_0015823
DR   Coriell; GM21261
DR   Wikidata; Q54851757
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124853; Mayer-Rokitansky-Kuster-Hauser syndrome
DI   ORDO; Orphanet_3109; Mayer-Rokitansky-Kuster-Hauser syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21262
AC   CVCL_IJ43
DR   CLO; CLO_0015819
DR   Coriell; GM21262
DR   Wikidata; Q54851758
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-2M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21284
AC   CVCL_EF99
DR   Coriell; GM21284
DR   Wikidata; Q54851759
CC   Sequence variation: Mutation; HGNC; HGNC:1149; BUB1B; Simple; p.Ser738Valfs*16 (c.2208_2211dupGTTA) (2212insGTTA); ClinVar=VCV000006763; Zygosity=Heterozygous (Coriell=GM21284).
CC   Sequence variation: Mutation; HGNC; HGNC:1149; BUB1B; Simple; p.Arg814His (c.2441G>A); ClinVar=VCV000006764; Zygosity=Heterozygous (Coriell=GM21284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128192; Mosaic variegated aneuploidy syndrome 1
DI   ORDO; Orphanet_1052; Mosaic variegated aneuploidy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM21285
AC   CVCL_1M64
DR   CLO; CLO_0015821
DR   Coriell; GM21285
DR   Wikidata; Q54851760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM21295
AC   CVCL_0Y00
DR   CLO; CLO_0015838
DR   Coriell; GM21295
DR   GEO; GSM650371
DR   Wikidata; Q54851761
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21297
AC   CVCL_0Y01
DR   CLO; CLO_0015835
DR   Coriell; GM21297
DR   GEO; GSM650372
DR   Wikidata; Q54851762
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21298
AC   CVCL_0Y02
DR   Coriell; GM21298
DR   Wikidata; Q54851763
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21300
AC   CVCL_0Y03
DR   CLO; CLO_0015834
DR   Coriell; GM21300
DR   GEO; GSM650373
DR   Wikidata; Q54851764
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21301
AC   CVCL_0Y04
DR   CLO; CLO_0015831
DR   Coriell; GM21301
DR   GEO; GSM649079
DR   Wikidata; Q54851770
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21302
AC   CVCL_0Y05
DR   CLO; CLO_0015830
DR   Coriell; GM21302
DR   GEO; GSM649121
DR   Wikidata; Q54851772
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21303
AC   CVCL_0Y06
DR   CLO; CLO_0015828
DR   Coriell; GM21303
DR   GEO; GSM649098
DR   Wikidata; Q54851773
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21304
AC   CVCL_0Y07
DR   Coriell; GM21304
DR   Wikidata; Q54851774
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21306
AC   CVCL_0Y08
DR   CLO; CLO_0015826
DR   Coriell; GM21306
DR   GEO; GSM650374
DR   Wikidata; Q54851775
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21307
AC   CVCL_0Y09
DR   CLO; CLO_0015799
DR   Coriell; GM21307
DR   GEO; GSM649097
DR   Wikidata; Q54851776
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21308
AC   CVCL_0Y10
DR   CLO; CLO_0015800
DR   Coriell; GM21308
DR   Wikidata; Q54851777
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM21309
AC   CVCL_0Y11
DR   CLO; CLO_0015802
DR   Coriell; GM21309
DR   GEO; GSM649135
DR   Wikidata; Q54851778
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21310
AC   CVCL_0Y12
DR   CLO; CLO_0015803
DR   Coriell; GM21310
DR   GEO; GSM649124
DR   Wikidata; Q54851779
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21311
AC   CVCL_0Y13
DR   CLO; CLO_0015814
DR   Coriell; GM21311
DR   Wikidata; Q54851780
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM21312
AC   CVCL_0Y14
DR   CLO; CLO_0015811
DR   Coriell; GM21312
DR   GEO; GSM649059
DR   Wikidata; Q54851781
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21313
AC   CVCL_0Y15
DR   CLO; CLO_0015817
DR   Coriell; GM21313
DR   GEO; GSM649127
DR   Wikidata; Q54851783
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21314
AC   CVCL_0Y16
DR   CLO; CLO_0015816
DR   Coriell; GM21314
DR   GEO; GSM650375
DR   Wikidata; Q54851784
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21316
AC   CVCL_0Y17
DR   CLO; CLO_0015808
DR   Coriell; GM21316
DR   GEO; GSM649086
DR   Wikidata; Q54851785
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21317
AC   CVCL_0Y18
DR   CLO; CLO_0015806
DR   Coriell; GM21317
DR   GEO; GSM649113
DR   Wikidata; Q54851786
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21318
AC   CVCL_0Y19
DR   CLO; CLO_0015914
DR   Coriell; GM21318
DR   GEO; GSM650376
DR   Wikidata; Q54851787
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21320
AC   CVCL_0Y20
DR   CLO; CLO_0015916
DR   Coriell; GM21320
DR   GEO; GSM650377
DR   Wikidata; Q54851788
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21322
AC   CVCL_HP61
DR   Coriell; GM21322
DR   Wikidata; Q54851789
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21323
AC   CVCL_HP62
DR   Coriell; GM21323
DR   Wikidata; Q54851790
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21324
AC   CVCL_HP63
DR   Coriell; GM21324
DR   Wikidata; Q54851791
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21325
AC   CVCL_HP64
DR   Coriell; GM21325
DR   Wikidata; Q54851792
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21333
AC   CVCL_0Y21
DR   CLO; CLO_0015915
DR   Coriell; GM21333
DR   GEO; GSM650378
DR   Wikidata; Q54851793
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21335
AC   CVCL_0Y22
DR   Coriell; GM21335
DR   Wikidata; Q54851794
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21336
AC   CVCL_0Y23
DR   CLO; CLO_0015918
DR   Coriell; GM21336
DR   GEO; GSM650379
DR   Wikidata; Q54851795
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21338
AC   CVCL_0Y24
DR   Coriell; GM21338
DR   Wikidata; Q54851796
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21339
AC   CVCL_0Y25
DR   CLO; CLO_0015917
DR   Coriell; GM21339
DR   GEO; GSM650380
DR   Wikidata; Q54851797
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21341
AC   CVCL_0Y26
DR   Coriell; GM21341
DR   Wikidata; Q54851798
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21344
AC   CVCL_0Y27
DR   CLO; CLO_0015909
DR   Coriell; GM21344
DR   GEO; GSM649104
DR   Wikidata; Q54851799
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21345
AC   CVCL_HP65
DR   Coriell; GM21345
DR   Wikidata; Q54851800
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21346
AC   CVCL_HP66
DR   Coriell; GM21346
DR   Wikidata; Q54851801
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21347
AC   CVCL_HP67
DR   Coriell; GM21347
DR   Wikidata; Q54851802
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21348
AC   CVCL_HP68
DR   Coriell; GM21348
DR   Wikidata; Q54851803
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21349
AC   CVCL_HP69
DR   Coriell; GM21349
DR   Wikidata; Q54851804
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21350
AC   CVCL_HP70
DR   Coriell; GM21350
DR   Wikidata; Q54851805
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21351
AC   CVCL_0Y28
DR   Coriell; GM21351
DR   Wikidata; Q54851806
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21352
AC   CVCL_0Y29
DR   CLO; CLO_0015910
DR   Coriell; GM21352
DR   GEO; GSM650381
DR   Wikidata; Q54851807
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21353
AC   CVCL_0Y30
DR   CLO; CLO_0015911
DR   Coriell; GM21353
DR   GEO; GSM650382
DR   Wikidata; Q54851808
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21355
AC   CVCL_0Y31
DR   CLO; CLO_0015912
DR   Coriell; GM21355
DR   GEO; GSM650383
DR   Wikidata; Q54851809
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21356
AC   CVCL_0Y32
DR   CLO; CLO_0015913
DR   Coriell; GM21356
DR   GEO; GSM650384
DR   Wikidata; Q54851810
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21357
AC   CVCL_0Y33
DR   CLO; CLO_0015904
DR   Coriell; GM21357
DR   GEO; GSM650385
DR   Wikidata; Q54851811
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21359
AC   CVCL_0Y34
DR   CLO; CLO_0015903
DR   Coriell; GM21359
DR   GEO; GSM649120
DR   Wikidata; Q54851814
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21360
AC   CVCL_0Y35
DR   CLO; CLO_0015908
DR   Coriell; GM21360
DR   GEO; GSM649061
DR   Wikidata; Q54851815
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21361
AC   CVCL_0Y36
DR   CLO; CLO_0015907
DR   Coriell; GM21361
DR   GEO; GSM649057
DR   Wikidata; Q54851816
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21362
AC   CVCL_0Y37
DR   CLO; CLO_0015906
DR   Coriell; GM21362
DR   GEO; GSM649116
DR   Wikidata; Q54851817
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21363
AC   CVCL_0Y38
DR   CLO; CLO_0015905
DR   Coriell; GM21363
DR   GEO; GSM649109
DR   Wikidata; Q54851818
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21364
AC   CVCL_0Y39
DR   CLO; CLO_0015901
DR   Coriell; GM21364
DR   GEO; GSM650386
DR   Wikidata; Q54851820
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21365
AC   CVCL_0Y40
DR   CLO; CLO_0015902
DR   Coriell; GM21365
DR   GEO; GSM649064
DR   Wikidata; Q54851821
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21366
AC   CVCL_0Y41
DR   CLO; CLO_0015899
DR   Coriell; GM21366
DR   GEO; GSM649107
DR   Wikidata; Q54851823
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21367
AC   CVCL_0Y42
DR   CLO; CLO_0015900
DR   Coriell; GM21367
DR   GEO; GSM650387
DR   Wikidata; Q54851824
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21368
AC   CVCL_0Y43
DR   CLO; CLO_0015896
DR   Coriell; GM21368
DR   GEO; GSM650388
DR   Wikidata; Q54851825
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21370
AC   CVCL_0Y44
DR   CLO; CLO_0015898
DR   Coriell; GM21370
DR   GEO; GSM650389
DR   Wikidata; Q54851826
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21371
AC   CVCL_0Y45
DR   CLO; CLO_0015897
DR   Coriell; GM21371
DR   GEO; GSM650390
DR   Wikidata; Q54851828
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21374
AC   CVCL_HP71
DR   Coriell; GM21374
DR   Wikidata; Q54851830
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21375
AC   CVCL_HP72
DR   Coriell; GM21375
DR   Wikidata; Q54851831
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21376
AC   CVCL_HP73
DR   Coriell; GM21376
DR   Wikidata; Q54851833
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21377
AC   CVCL_HP74
DR   Coriell; GM21377
DR   Wikidata; Q54851834
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21378
AC   CVCL_0Y46
DR   CLO; CLO_0015893
DR   Coriell; GM21378
DR   GEO; GSM650391
DR   Wikidata; Q54851836
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21379
AC   CVCL_0Y47
DR   CLO; CLO_0015892
DR   Coriell; GM21379
DR   GEO; GSM650392
DR   Wikidata; Q54851838
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21381
AC   CVCL_0Y48
DR   CLO; CLO_0015895
DR   Coriell; GM21381
DR   GEO; GSM649076
DR   Wikidata; Q54851839
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21382
AC   CVCL_0Y49
DR   CLO; CLO_0015894
DR   Coriell; GM21382
DR   GEO; GSM649077
DR   Wikidata; Q54851841
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21383
AC   CVCL_0Y50
DR   CLO; CLO_0015889
DR   Coriell; GM21383
DR   GEO; GSM649134
DR   Wikidata; Q54851842
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21384
AC   CVCL_0Y51
DR   CLO; CLO_0015890
DR   Coriell; GM21384
DR   GEO; GSM649083
DR   Wikidata; Q54851843
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21385
AC   CVCL_0Y52
DR   CLO; CLO_0015891
DR   Coriell; GM21385
DR   Wikidata; Q54851844
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM21386
AC   CVCL_0Y53
DR   CLO; CLO_0015888
DR   Coriell; GM21386
DR   GEO; GSM649128
DR   Wikidata; Q54851845
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21387
AC   CVCL_0Y54
DR   CLO; CLO_0015887
DR   Coriell; GM21387
DR   GEO; GSM649100
DR   Wikidata; Q54851846
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21388
AC   CVCL_0Y55
DR   CLO; CLO_0015886
DR   Coriell; GM21388
DR   GEO; GSM649063
DR   Wikidata; Q54851847
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21389
AC   CVCL_0Y56
DR   CLO; CLO_0015885
DR   Coriell; GM21389
DR   GEO; GSM649119
DR   Wikidata; Q54851848
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21390
AC   CVCL_0Y57
DR   CLO; CLO_0015884
DR   Coriell; GM21390
DR   GEO; GSM649095
DR   Wikidata; Q54851849
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21391
AC   CVCL_0Y58
DR   CLO; CLO_0015883
DR   Coriell; GM21391
DR   GEO; GSM649069
DR   Wikidata; Q54851850
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21393
AC   CVCL_HL39
DR   Coriell; GM21393
DR   Wikidata; Q54851851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL40 ! GM21394
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21394
AC   CVCL_HL40
DR   Coriell; GM21394
DR   Wikidata; Q54851852
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL39 ! GM21393
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21399
AC   CVCL_0Y59
DR   CLO; CLO_0015882
DR   Coriell; GM21399
DR   GEO; GSM649070
DR   Wikidata; Q54851853
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21400
AC   CVCL_0Y60
DR   CLO; CLO_0015881
DR   Coriell; GM21400
DR   GEO; GSM649090
DR   Wikidata; Q54851854
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21401
AC   CVCL_0Y61
DR   CLO; CLO_0015879
DR   Coriell; GM21401
DR   GEO; GSM649118
DR   Wikidata; Q54851855
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21402
AC   CVCL_0Y62
DR   CLO; CLO_0015880
DR   Coriell; GM21402
DR   Wikidata; Q54851856
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM21403
AC   CVCL_0Y63
DR   CLO; CLO_0015968
DR   Coriell; GM21403
DR   GEO; GSM649103
DR   Wikidata; Q54851857
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21404
AC   CVCL_0Y64
DR   CLO; CLO_0015960
DR   Coriell; GM21404
DR   GEO; GSM649133
DR   Wikidata; Q54851858
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21405
AC   CVCL_0Y65
DR   CLO; CLO_0015961
DR   Coriell; GM21405
DR   GEO; GSM650393
DR   Wikidata; Q54851859
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21408
AC   CVCL_0Y66
DR   CLO; CLO_0015962
DR   Coriell; GM21408
DR   GEO; GSM650394
DR   Wikidata; Q54851860
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21409
AC   CVCL_0Y67
DR   Coriell; GM21409
DR   Wikidata; Q54851861
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21410
AC   CVCL_0Y68
DR   Coriell; GM21410
DR   Wikidata; Q54851868
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21414
AC   CVCL_0Y69
DR   CLO; CLO_0015963
DR   Coriell; GM21414
DR   GEO; GSM650395
DR   Wikidata; Q54851869
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21415
AC   CVCL_0Y70
DR   CLO; CLO_0015964
DR   Coriell; GM21415
DR   GEO; GSM650396
DR   Wikidata; Q54851870
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21417
AC   CVCL_0Y71
DR   CLO; CLO_0015965
DR   Coriell; GM21417
DR   GEO; GSM650397
DR   Wikidata; Q54851871
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21418
AC   CVCL_0Y72
DR   CLO; CLO_0015966
DR   Coriell; GM21418
DR   GEO; GSM650398
DR   Wikidata; Q54851872
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21420
AC   CVCL_0Y73
DR   CLO; CLO_0015967
DR   Coriell; GM21420
DR   GEO; GSM650399
DR   Wikidata; Q54851873
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21421
AC   CVCL_0Y74
DR   CLO; CLO_0015955
DR   Coriell; GM21421
DR   GEO; GSM650400
DR   Wikidata; Q54851874
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21423
AC   CVCL_0Y75
DR   CLO; CLO_0015947
DR   Coriell; GM21423
DR   GEO; GSM649066
DR   Wikidata; Q54851875
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21424
AC   CVCL_0Y76
DR   CLO; CLO_0015948
DR   Coriell; GM21424
DR   Wikidata; Q54851876
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM21425
AC   CVCL_0Y77
DR   CLO; CLO_0015941
DR   Coriell; GM21425
DR   GEO; GSM649316
DR   Wikidata; Q54851877
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21426
AC   CVCL_4F49
DR   CLO; CLO_0015942
DR   Coriell; GM21426
DR   Wikidata; Q54851879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM21428
AC   CVCL_HL41
DR   Coriell; GM21428
DR   Wikidata; Q54851881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21430
AC   CVCL_HK84
DR   Coriell; GM21430
DR   Wikidata; Q54851882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21431
AC   CVCL_HL42
DR   Coriell; GM21431
DR   Wikidata; Q54851883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL43 ! GM21432
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21432
AC   CVCL_HL43
DR   Coriell; GM21432
DR   Wikidata; Q54851885
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL42 ! GM21431
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21434
AC   CVCL_0Y78
DR   CLO; CLO_0015939
DR   Coriell; GM21434
DR   GEO; GSM650401
DR   Wikidata; Q54851886
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21435
AC   CVCL_0Y79
DR   CLO; CLO_0015940
DR   Coriell; GM21435
DR   GEO; GSM650402
DR   Wikidata; Q54851887
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21436
AC   CVCL_0Y80
DR   CLO; CLO_0015945
DR   Coriell; GM21436
DR   GEO; GSM650403
DR   Wikidata; Q54851888
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21438
AC   CVCL_0Y81
DR   CLO; CLO_0015946
DR   Coriell; GM21438
DR   GEO; GSM649115
DR   Wikidata; Q54851889
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21439
AC   CVCL_0Y82
DR   CLO; CLO_0015943
DR   Coriell; GM21439
DR   GEO; GSM649058
DR   Wikidata; Q54851890
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21440
AC   CVCL_0Y83
DR   CLO; CLO_0015944
DR   Coriell; GM21440
DR   GEO; GSM649099
DR   Wikidata; Q54851891
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21441
AC   CVCL_0Y84
DR   CLO; CLO_0014169
DR   Coriell; GM21441
DR   GEO; GSM649074
DR   Wikidata; Q54851892
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21442
AC   CVCL_0Y85
DR   CLO; CLO_0014168
DR   Coriell; GM21442
DR   GEO; GSM649112
DR   Wikidata; Q54851893
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21443
AC   CVCL_0Y86
DR   CLO; CLO_0014165
DR   Coriell; GM21443
DR   GEO; GSM650404
DR   Wikidata; Q54851894
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21447
AC   CVCL_0Y87
DR   CLO; CLO_0014163
DR   Coriell; GM21447
DR   GEO; GSM649075
DR   Wikidata; Q54851895
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21448
AC   CVCL_0Y88
DR   CLO; CLO_0014160
DR   Coriell; GM21448
DR   GEO; GSM650405
DR   Wikidata; Q54851896
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21449
AC   CVCL_0Y89
DR   Coriell; GM21449
DR   Wikidata; Q54851897
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21450
AC   CVCL_0Y90
DR   Coriell; GM21450
DR   Wikidata; Q54851898
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21451
AC   CVCL_0Y91
DR   CLO; CLO_0014158
DR   Coriell; GM21451
DR   GEO; GSM650406
DR   Wikidata; Q54851899
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21453
AC   CVCL_0Y92
DR   CLO; CLO_0014154
DR   Coriell; GM21453
DR   GEO; GSM649062
DR   Wikidata; Q54851900
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21454
AC   CVCL_0Y93
DR   CLO; CLO_0014150
DR   Coriell; GM21454
DR   GEO; GSM649094
DR   Wikidata; Q54851901
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21455
AC   CVCL_0Y94
DR   CLO; CLO_0014149
DR   Coriell; GM21455
DR   GEO; GSM649108
DR   Wikidata; Q54851902
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21456
AC   CVCL_0Y95
DR   Coriell; GM21456
DR   Wikidata; Q54851903
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21457
AC   CVCL_0Y96
DR   CLO; CLO_0014147
DR   Coriell; GM21457
DR   GEO; GSM650407
DR   Wikidata; Q54851904
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21458
AC   CVCL_0Y97
DR   Coriell; GM21458
DR   Wikidata; Q54851905
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21459
AC   CVCL_HK85
DR   Coriell; GM21459
DR   Wikidata; Q54851906
CC   Sequence variation: Mutation; HGNC; HGNC:2209; COL5A1; Simple; p.Gly721Argfs*5 (c.2159dupC) (c.2160insC); ClinVar=VCV000213029; Zygosity=Unspecified (Coriell=GM21459).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21461
AC   CVCL_HP75
DR   Coriell; GM21461
DR   Wikidata; Q54851907
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21462
AC   CVCL_HP76
DR   Coriell; GM21462
DR   Wikidata; Q54851908
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21463
AC   CVCL_HP77
DR   Coriell; GM21463
DR   Wikidata; Q54851909
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21464
AC   CVCL_HP78
DR   Coriell; GM21464
DR   Wikidata; Q54851910
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21465
AC   CVCL_HP79
DR   Coriell; GM21465
DR   Wikidata; Q54851916
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21466
AC   CVCL_HL44
DR   Coriell; GM21466
DR   Wikidata; Q54851917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL45 ! GM21467
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21467
AC   CVCL_HL45
DR   Coriell; GM21467
DR   Wikidata; Q54851918
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL44 ! GM21466
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21468
AC   CVCL_HL46
DR   Coriell; GM21468
DR   Wikidata; Q54851919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL47 ! GM21469
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21469
AC   CVCL_HL47
DR   Coriell; GM21469
DR   Wikidata; Q54851922
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL46 ! GM21468
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21473
AC   CVCL_0Y98
DR   CLO; CLO_0014214
DR   Coriell; GM21473
DR   GEO; GSM650408
DR   Wikidata; Q54851923
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21475
AC   CVCL_0Y99
DR   CLO; CLO_0014204
DR   Coriell; GM21475
DR   GEO; GSM649073
DR   Wikidata; Q54851924
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21476
AC   CVCL_0Z00
DR   CLO; CLO_0014203
DR   Coriell; GM21476
DR   GEO; GSM649068
DR   Wikidata; Q54851926
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21477
AC   CVCL_0Z01
DR   CLO; CLO_0014210
DR   Coriell; GM21477
DR   GEO; GSM649123
DR   Wikidata; Q54851927
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21478
AC   CVCL_0Z02
DR   CLO; CLO_0014207
DR   Coriell; GM21478
DR   GEO; GSM649102
DR   Wikidata; Q54851928
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21479
AC   CVCL_0Z03
DR   CLO; CLO_0014193
DR   Coriell; GM21479
DR   GEO; GSM649117
DR   Wikidata; Q54851929
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21480
AC   CVCL_0Z04
DR   CLO; CLO_0014190
DR   Coriell; GM21480
DR   GEO; GSM649130
DR   Wikidata; Q54851930
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21481
AC   CVCL_HL48
DR   Coriell; GM21481
DR   Wikidata; Q54851931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL49 ! GM21482
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21482
AC   CVCL_HL49
DR   Coriell; GM21482
DR   Wikidata; Q54851932
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL48 ! GM21481
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21483
AC   CVCL_HK86
DR   Coriell; GM21483
DR   Wikidata; Q54851933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK87 ! GM21484
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21484
AC   CVCL_HK87
DR   Coriell; GM21484
DR   Wikidata; Q54851934
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK86 ! GM21483
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21485
AC   CVCL_0Z05
DR   CLO; CLO_0014199
DR   Coriell; GM21485
DR   GEO; GSM649093
DR   Wikidata; Q54851935
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21486
AC   CVCL_0Z06
DR   CLO; CLO_0014197
DR   Coriell; GM21486
DR   GEO; GSM649088
DR   Wikidata; Q54851936
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21487
AC   CVCL_0Z07
DR   CLO; CLO_0014187
DR   Coriell; GM21487
DR   GEO; GSM649129
DR   Wikidata; Q54851937
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21488
AC   CVCL_0Z08
DR   CLO; CLO_0014053
DR   Coriell; GM21488
DR   GEO; GSM649078
DR   Wikidata; Q54851938
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21489
AC   CVCL_0Z09
DR   CLO; CLO_0014052
DR   Coriell; GM21489
DR   GEO; GSM649092
DR   Wikidata; Q54851939
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21490
AC   CVCL_0Z10
DR   CLO; CLO_0014046
DR   Coriell; GM21490
DR   GEO; GSM649132
DR   Wikidata; Q54851940
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21491
AC   CVCL_0Z11
DR   CLO; CLO_0014047
DR   Coriell; GM21491
DR   GEO; GSM650409
DR   Wikidata; Q54851941
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21493
AC   CVCL_0Z12
DR   CLO; CLO_0014044
DR   Coriell; GM21493
DR   GEO; GSM649106
DR   Wikidata; Q54851942
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21494
AC   CVCL_0Z13
DR   CLO; CLO_0014045
DR   Coriell; GM21494
DR   GEO; GSM649114
DR   Wikidata; Q54851943
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21496
AC   CVCL_5U27
DR   CLO; CLO_0014050
DR   Coriell; GM21496
DR   Wikidata; Q54851944
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124853; Mayer-Rokitansky-Kuster-Hauser syndrome
DI   ORDO; Orphanet_3109; Mayer-Rokitansky-Kuster-Hauser syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21498
AC   CVCL_HK06
DR   Coriell; GM21498
DR   Wikidata; Q54851945
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Asn28Ser (c.83A>G); ClinVar=VCV000036130; Zygosity=Heterozygous (Coriell=GM21498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK07 ! GM21499
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21499
AC   CVCL_HK07
DR   Coriell; GM21499
DR   Wikidata; Q54851946
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Asn28Ser (c.83A>G); ClinVar=VCV000036130; Zygosity=Heterozygous (Coriell=GM21499).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK06 ! GM21498
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21500
AC   CVCL_HK88
DR   Coriell; GM21500
DR   Wikidata; Q54851947
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.997-2A>G (IVS15-2A>G) (p.Gly333_Lys350del+); ClinVar=VCV000101317; Zygosity=Unspecified; Note=Splice acceptor mutation (Coriell=GM21500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK89 ! GM21501
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21501
AC   CVCL_HK89
DR   Coriell; GM21501
DR   Wikidata; Q54851948
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.997-2A>G (IVS15-2A>G) (p.Gly333_Lys350del+); ClinVar=VCV000101317; Zygosity=Unspecified; Note=Splice acceptor mutation (Coriell=GM21501).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK88 ! GM21500
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM21503
AC   CVCL_HL50
DR   Coriell; GM21503
DR   Wikidata; Q54851949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL51 ! GM21504
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21504
AC   CVCL_HL51
DR   Coriell; GM21504
DR   Wikidata; Q54851950
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL50 ! GM21503
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21505
AC   CVCL_HL52
DR   Coriell; GM21505
DR   Wikidata; Q54851951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL53 ! GM21506
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21506
AC   CVCL_HL53
DR   Coriell; GM21506
DR   Wikidata; Q54851952
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL52 ! GM21505
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21507
AC   CVCL_HK90
DR   Coriell; GM21507
DR   Wikidata; Q54851953
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly252Val (c.755G>T); ClinVar=VCV000101156; Zygosity=Unspecified (Coriell=GM21507).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK91 ! GM21508
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21508
AC   CVCL_HK91
DR   Coriell; GM21508
DR   Wikidata; Q54851954
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly252Val (c.755G>T); ClinVar=VCV000101156; Zygosity=Unspecified (Coriell=GM21508).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK90 ! GM21507
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21509
AC   CVCL_0Z14
DR   CLO; CLO_0014051
DR   Coriell; GM21509
DR   GEO; GSM650410
DR   Wikidata; Q54851955
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21510
AC   CVCL_0Z15
DR   CLO; CLO_0014048
DR   Coriell; GM21510
DR   GEO; GSM650411
DR   Wikidata; Q54851956
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21512
AC   CVCL_0Z16
DR   CLO; CLO_0014049
DR   Coriell; GM21512
DR   GEO; GSM649105
DR   Wikidata; Q54851957
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21513
AC   CVCL_0Z17
DR   CLO; CLO_0014061
DR   Coriell; GM21513
DR   GEO; GSM649089
DR   Wikidata; Q54851958
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21514
AC   CVCL_0Z18
DR   CLO; CLO_0014063
DR   Coriell; GM21514
DR   GEO; GSM649136
DR   Wikidata; Q54851964
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21515
AC   CVCL_0Z19
DR   EFO; EFO_0010838
DR   Coriell; GM21515
DR   Wikidata; Q54851965
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   GM21517
AC   CVCL_0Z20
DR   CLO; CLO_0014062
DR   Coriell; GM21517
DR   GEO; GSM650412
DR   Wikidata; Q54851966
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21519
AC   CVCL_0Z21
DR   CLO; CLO_0014054
DR   Coriell; GM21519
DR   GEO; GSM650413
DR   Wikidata; Q54851967
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21520
AC   CVCL_0Z22
DR   CLO; CLO_0014055
DR   Coriell; GM21520
DR   GEO; GSM650414
DR   Wikidata; Q54851968
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21521
AC   CVCL_0Z23
DR   CLO; CLO_0014056
DR   Coriell; GM21521
DR   GEO; GSM650415
DR   Wikidata; Q54851969
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21522
AC   CVCL_0Z24
DR   CLO; CLO_0014057
DR   Coriell; GM21522
DR   GEO; GSM649110
DR   Wikidata; Q54851970
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21523
AC   CVCL_0Z25
DR   CLO; CLO_0014058
DR   Coriell; GM21523
DR   GEO; GSM649087
DR   Wikidata; Q54851971
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21524
AC   CVCL_0Z26
DR   CLO; CLO_0014059
DR   Coriell; GM21524
DR   GEO; GSM649060
DR   Wikidata; Q54851972
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21525
AC   CVCL_0Z27
DR   CLO; CLO_0014060
DR   Coriell; GM21525
DR   GEO; GSM649111
DR   Wikidata; Q54851973
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21526
AC   CVCL_0Z28
DR   CLO; CLO_0014083
DR   Coriell; GM21526
DR   GEO; GSM649081
DR   Wikidata; Q54851974
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21527
AC   CVCL_0Z29
DR   CLO; CLO_0014081
DR   Coriell; GM21527
DR   Wikidata; Q54851975
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM21528
AC   CVCL_0Z30
DR   CLO; CLO_0014080
DR   Coriell; GM21528
DR   GEO; GSM650416
DR   Wikidata; Q54851976
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21529
AC   CVCL_0Z31
DR   CLO; CLO_0014078
DR   Coriell; GM21529
DR   GEO; GSM650417
DR   Wikidata; Q54851977
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21542
AC   CVCL_U755
DR   CLO; CLO_0014073
DR   Coriell; GM21542
DR   Wikidata; Q54851978
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Simple; p.Gly130Val (c.389G>T); ClinVar=VCV000003982; Zygosity=Heterozygous (Coriell=GM21542).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   GM21545
AC   CVCL_Y606
DR   CLO; CLO_0014075
DR   Coriell; GM21545
DR   Wikidata; Q54851979
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118845; Otopalatodigital syndrome type 1
DI   ORDO; Orphanet_90650; Otopalatodigital syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM21546
AC   CVCL_5R34
DR   Coriell; GM21546
DR   Wikidata; Q54851980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM21548
AC   CVCL_HL54
DR   Coriell; GM21548
DR   Wikidata; Q54851981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL55 ! GM21549
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21549
AC   CVCL_HL55
DR   Coriell; GM21549
DR   Wikidata; Q54851982
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL54 ! GM21548
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21551
AC   CVCL_0N46
DR   CLO; CLO_0014069
DR   Coriell; GM21551
DR   Wikidata; Q54851983
RX   PubMed=19359498;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507Val (c.1519A>G); ClinVar=VCV000188863; Zygosity=Heterozygous; Note=Benign (PubMed=19359498).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19359498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   GM21554
AC   CVCL_HK92
DR   Coriell; GM21554
DR   Wikidata; Q54851984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK93 ! GM21555
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21555
AC   CVCL_HK93
DR   Coriell; GM21555
DR   Wikidata; Q54851985
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK92 ! GM21554
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21556
AC   CVCL_HK94
DR   Coriell; GM21556
DR   Wikidata; Q54851986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21558
AC   CVCL_HK95
DR   Coriell; GM21558
DR   Wikidata; Q54851987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21560
AC   CVCL_HK96
DR   Coriell; GM21560
DR   Wikidata; Q54851988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21561
AC   CVCL_HL56
DR   Coriell; GM21561
DR   Wikidata; Q54851989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21566
AC   CVCL_BT47
DR   Coriell; GM21566
DR   Wikidata; Q54851990
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Arg1024Ter (c.3070C>T); ClinVar=VCV000101174; Zygosity=Heterozygous (Coriell=GM21566).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT48 ! GM21567
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM21567
AC   CVCL_BT48
DR   Coriell; GM21567
DR   Wikidata; Q54851991
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Arg1024Ter (c.3070C>T); ClinVar=VCV000101174; Zygosity=Heterozygous (Coriell=GM21567).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT47 ! GM21566
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM21568
AC   CVCL_9R57
DR   CLO; CLO_0014071
DR   Coriell; GM21568
DR   Wikidata; Q54851992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM21569
AC   CVCL_HK97
DR   Coriell; GM21569
DR   Wikidata; Q54851993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21570
AC   CVCL_HK98
DR   Coriell; GM21570
DR   Wikidata; Q54851994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21572
AC   CVCL_0N47
DR   CLO; CLO_0014065
DR   Coriell; GM21572
DR   Wikidata; Q54851995
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Leu1258Phefs*7 (c.3773dupT) (3905insT); ClinVar=VCV000038726; Zygosity=Heterozygous (Coriell=GM21572).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM21573
AC   CVCL_0Z32
DR   CLO; CLO_0014067
DR   Coriell; GM21573
DR   GEO; GSM650418
DR   Wikidata; Q54851996
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21574
AC   CVCL_0Z33
DR   CLO; CLO_0014103
DR   Coriell; GM21574
DR   GEO; GSM650419
DR   Wikidata; Q54851997
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21575
AC   CVCL_0Z34
DR   CLO; CLO_0014098
DR   Coriell; GM21575
DR   GEO; GSM650420
DR   Wikidata; Q54851998
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21576
AC   CVCL_0Z35
DR   CLO; CLO_0014097
DR   Coriell; GM21576
DR   GEO; GSM650421
DR   Wikidata; Q54851999
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21577
AC   CVCL_0Z36
DR   CLO; CLO_0014102
DR   Coriell; GM21577
DR   GEO; GSM650422
DR   Wikidata; Q54852000
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21578
AC   CVCL_0Z37
DR   CLO; CLO_0014099
DR   Coriell; GM21578
DR   GEO; GSM650423
DR   Wikidata; Q54852001
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21580
AC   CVCL_0Z38
DR   CLO; CLO_0014089
DR   Coriell; GM21580
DR   GEO; GSM649085
DR   Wikidata; Q54852002
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21581
AC   CVCL_0Z39
DR   CLO; CLO_0014092
DR   Coriell; GM21581
DR   GEO; GSM649317
DR   Wikidata; Q54852003
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21582
AC   CVCL_0Z40
DR   CLO; CLO_0014094
DR   Coriell; GM21582
DR   GEO; GSM650424
DR   Wikidata; Q54852011
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21583
AC   CVCL_0Z41
DR   CLO; CLO_0014096
DR   Coriell; GM21583
DR   GEO; GSM649096
DR   Wikidata; Q54852012
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21584
AC   CVCL_0Z42
DR   Coriell; GM21584
DR   Wikidata; Q54852013
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21587
AC   CVCL_0Z43
DR   CLO; CLO_0014085
DR   Coriell; GM21587
DR   GEO; GSM650425
DR   Wikidata; Q54852014
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21590
AC   CVCL_HK99
DR   Coriell; GM21590
DR   Wikidata; Q54852015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21594
AC   CVCL_HL00
DR   Coriell; GM21594
DR   Wikidata; Q54852016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL01 ! GM21595
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21595
AC   CVCL_HL01
DR   Coriell; GM21595
DR   Wikidata; Q54852017
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL00 ! GM21594
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21596
AC   CVCL_0Z44
DR   CLO; CLO_0013929
DR   Coriell; GM21596
DR   GEO; GSM650426
DR   Wikidata; Q54852018
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21597
AC   CVCL_0Z45
DR   CLO; CLO_0013930
DR   Coriell; GM21597
DR   GEO; GSM650427
DR   Wikidata; Q54852020
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21599
AC   CVCL_0Z46
DR   CLO; CLO_0013931
DR   Coriell; GM21599
DR   GEO; GSM649072
DR   Wikidata; Q54852021
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21600
AC   CVCL_0Z47
DR   CLO; CLO_0013932
DR   Coriell; GM21600
DR   GEO; GSM649082
DR   Wikidata; Q54852022
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21601
AC   CVCL_0Z48
DR   CLO; CLO_0013933
DR   Coriell; GM21601
DR   GEO; GSM649122
DR   Wikidata; Q54852023
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21603
AC   CVCL_HL02
DR   Coriell; GM21603
DR   Wikidata; Q54852024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL03 ! GM21604
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21604
AC   CVCL_HL03
DR   Coriell; GM21604
DR   Wikidata; Q54852025
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL02 ! GM21603
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21605
AC   CVCL_HL04
DR   Coriell; GM21605
DR   Wikidata; Q54852026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21608
AC   CVCL_0Z49
DR   CLO; CLO_0013934
DR   Coriell; GM21608
DR   GEO; GSM649131
DR   Wikidata; Q54852027
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21611
AC   CVCL_0Z50
DR   CLO; CLO_0013945
DR   Coriell; GM21611
DR   GEO; GSM650428
DR   Wikidata; Q54852028
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21613
AC   CVCL_0Z51
DR   CLO; CLO_0013944
DR   Coriell; GM21613
DR   GEO; GSM650429
DR   Wikidata; Q54852029
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21614
AC   CVCL_0Z52
DR   CLO; CLO_0013948
DR   Coriell; GM21614
DR   GEO; GSM649091
DR   Wikidata; Q54852030
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21615
AC   CVCL_0Z53
DR   CLO; CLO_0013946
DR   Coriell; GM21615
DR   GEO; GSM649084
DR   Wikidata; Q54852031
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21616
AC   CVCL_0Z54
DR   CLO; CLO_0013951
DR   Coriell; GM21616
DR   GEO; GSM650430
DR   Wikidata; Q54852032
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21617
AC   CVCL_0Z55
DR   CLO; CLO_0013949
DR   Coriell; GM21617
DR   GEO; GSM650431
DR   Wikidata; Q54852033
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21619
AC   CVCL_0Z56
DR   CLO; CLO_0013950
DR   Coriell; GM21619
DR   GEO; GSM650432
DR   Wikidata; Q54852034
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21620
AC   CVCL_0Z57
DR   CLO; CLO_0013954
DR   Coriell; GM21620
DR   GEO; GSM650433
DR   Wikidata; Q54852035
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21622
AC   CVCL_0Z58
DR   Coriell; GM21622
DR   Wikidata; Q54852036
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21627
AC   CVCL_HL57
DR   Coriell; GM21627
DR   Wikidata; Q54852038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21629
AC   CVCL_HL58
DR   Coriell; GM21629
DR   Wikidata; Q54852039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21631
AC   CVCL_0Z59
DR   CLO; CLO_0013955
DR   Coriell; GM21631
DR   GEO; GSM650434
DR   Wikidata; Q54852040
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21632
AC   CVCL_0Z60
DR   CLO; CLO_0013952
DR   Coriell; GM21632
DR   GEO; GSM650435
DR   Wikidata; Q54852041
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21634
AC   CVCL_0Z61
DR   CLO; CLO_0013953
DR   Coriell; GM21634
DR   GEO; GSM649080
DR   Wikidata; Q54852042
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21635
AC   CVCL_0Z62
DR   CLO; CLO_0013968
DR   Coriell; GM21635
DR   GEO; GSM649065
DR   Wikidata; Q54852043
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21636
AC   CVCL_0Z63
DR   CLO; CLO_0013967
DR   Coriell; GM21636
DR   GEO; GSM649318
DR   Wikidata; Q54852044
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21637
AC   CVCL_HL59
DR   Coriell; GM21637
DR   Wikidata; Q54852045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21639
AC   CVCL_BA05
DR   Coriell; GM21639
DR   Wikidata; Q54852046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA06 ! GM21640
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM21640
AC   CVCL_BA06
DR   Coriell; GM21640
DR   Wikidata; Q54852047
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA05 ! GM21639
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM21647
AC   CVCL_0Z64
DR   CLO; CLO_0013975
DR   Coriell; GM21647
DR   Wikidata; Q54852049
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   GM21648
AC   CVCL_0Z65
DR   CLO; CLO_0013977
DR   Coriell; GM21648
DR   GEO; GSM649126
DR   Wikidata; Q54852050
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21649
AC   CVCL_0Z66
DR   CLO; CLO_0013979
DR   Coriell; GM21649
DR   GEO; GSM650436
DR   Wikidata; Q54852051
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21650
AC   CVCL_0Z67
DR   CLO; CLO_0013981
DR   Coriell; GM21650
DR   GEO; GSM650437
DR   Wikidata; Q54852052
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21652
AC   CVCL_9Q77
DR   CLO; CLO_0013969
DR   Coriell; GM21652
DR   Wikidata; Q54852056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM21654
AC   CVCL_EG00
DR   CLO; CLO_0013970
DR   Coriell; GM21654
DR   Wikidata; Q54852057
RX   PubMed=30804344;
CC   Sequence variation: Mutation; HGNC; HGNC:30794; CEP57; Simple; p.Glu174Thrfs*4 (c.518_519GA[1]) (c.520_521delGA); ClinVar=VCV000030690; Zygosity=Heterozygous (PubMed=30804344).
CC   Sequence variation: Mutation; HGNC; HGNC:30794; CEP57; Simple; p.Leu309Profs*9 (c.915_925dup11) (p.His317fs); ClinVar=VCV000030691; Zygosity=Heterozygous (PubMed=30804344).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168989; Mosaic variegated aneuploidy syndrome 2
DI   ORDO; Orphanet_1052; Mosaic variegated aneuploidy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM21655
AC   CVCL_EG01
DR   CLO; CLO_0013972
DR   Coriell; GM21655
DR   Wikidata; Q54852058
RX   PubMed=30804344;
CC   Sequence variation: Mutation; HGNC; HGNC:30794; CEP57; Simple; p.Glu174Thrfs*4 (c.518_519GA[1]) (c.520_521delGA); ClinVar=VCV000030690; Zygosity=Heterozygous (PubMed=30804344).
CC   Sequence variation: Mutation; HGNC; HGNC:30794; CEP57; Simple; p.Leu309Profs*9 (c.915_925dup11) (p.His317fs); ClinVar=VCV000030691; Zygosity=Heterozygous (PubMed=30804344).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168989; Mosaic variegated aneuploidy syndrome 2
DI   ORDO; Orphanet_1052; Mosaic variegated aneuploidy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM21656
AC   CVCL_CZ81
DR   CLO; CLO_0013973
DR   Coriell; GM21656
DR   Wikidata; Q54852059
RX   PubMed=30804344;
CC   Sequence variation: Mutation; HGNC; HGNC:30794; CEP57; Simple; p.Leu309Profs*9 (c.915_925dup11) (p.His317fs); ClinVar=VCV000030691; Zygosity=Heterozygous (PubMed=30804344).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM21657
AC   CVCL_CZ82
DR   CLO; CLO_0014007
DR   Coriell; GM21657
DR   Wikidata; Q54852060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM21658
AC   CVCL_HL05
DR   Coriell; GM21658
DR   Wikidata; Q54852061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL06 ! GM21659
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21659
AC   CVCL_HL06
DR   Coriell; GM21659
DR   Wikidata; Q54852062
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL05 ! GM21658
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21660
AC   CVCL_1B75
DR   Coriell; GM21660
DR   Wikidata; Q54852063
RX   PubMed=37751688;
WW   Info; PGP; huBEDA0B; https://my.pgp-hms.org/profile_public?hex=huBEDA0B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM21662
AC   CVCL_HL07
DR   Coriell; GM21662
DR   Wikidata; Q54852064
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly540Arg (c.1618G>A); ClinVar=VCV000101297; Zygosity=Heterozygous (Coriell=GM21662).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL08 ! GM21663
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21663
AC   CVCL_HL08
DR   Coriell; GM21663
DR   Wikidata; Q54852065
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly540Arg (c.1618G>A); ClinVar=VCV000101297; Zygosity=Heterozygous (Coriell=GM21663).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL07 ! GM21662
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21664
AC   CVCL_HL60
DR   Coriell; GM21664
DR   Wikidata; Q54852066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL61 ! GM21665
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21665
AC   CVCL_HL61
DR   Coriell; GM21665
DR   Wikidata; Q54852067
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL60 ! GM21664
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21668
AC   CVCL_HL62
DR   Coriell; GM21668
DR   Wikidata; Q54852068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL63 ! GM21669
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21669
AC   CVCL_HL63
DR   Coriell; GM21669
DR   Wikidata; Q54852069
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL62 ! GM21668
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21670
AC   CVCL_HL64
DR   Coriell; GM21670
DR   Wikidata; Q54852070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL65 ! GM21671
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21671
AC   CVCL_HL65
DR   Coriell; GM21671
DR   Wikidata; Q54852071
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL64 ! GM21670
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21672
AC   CVCL_HL09
DR   Coriell; GM21672
DR   Wikidata; Q54852072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL10 ! GM21673
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21673
AC   CVCL_HL10
DR   Coriell; GM21673
DR   Wikidata; Q54852074
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL09 ! GM21672
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21674
AC   CVCL_HL11
DR   Coriell; GM21674
DR   Wikidata; Q54852075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL12 ! GM21675
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21675
AC   CVCL_HL12
DR   Coriell; GM21675
DR   Wikidata; Q54852076
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL11 ! GM21674
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21677
AC   CVCL_F186
DR   Coriell; GM21677
DR   Wikidata; Q54852077
RX   PubMed=37751688;
WW   Info; PGP; huE80E3D; https://my.pgp-hms.org/profile_public?hex=huE80E3D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F185 ! GM23249
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   GM21678
AC   CVCL_0Z68
DR   CLO; CLO_0014006
DR   Coriell; GM21678
DR   GEO; GSM650438
DR   Wikidata; Q54852078
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21679
AC   CVCL_0Z69
DR   Coriell; GM21679
DR   Wikidata; Q54852079
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21681
AC   CVCL_5R35
DR   Coriell; GM21681
DR   Wikidata; Q54852080
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21682
AC   CVCL_0Z70
DR   CLO; CLO_0014023
DR   Coriell; GM21682
DR   GEO; GSM650439
DR   Wikidata; Q54852081
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21683
AC   CVCL_0Z71
DR   CLO; CLO_0014018
DR   Coriell; GM21683
DR   GEO; GSM650440
DR   Wikidata; Q54852082
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21685
AC   CVCL_0Z72
DR   CLO; CLO_0014021
DR   Coriell; GM21685
DR   GEO; GSM650441
DR   Wikidata; Q54852083
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21686
AC   CVCL_0Z73
DR   CLO; CLO_0014014
DR   Coriell; GM21686
DR   GEO; GSM649071
DR   Wikidata; Q54852084
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21687
AC   CVCL_0U57
DR   Coriell; GM21687
DR   Wikidata; Q54852085
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu9385BA; https://my.pgp-hms.org/profile_public?hex=hu9385BA
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U56 ! GM23250
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21689
AC   CVCL_0Z74
DR   CLO; CLO_0014017
DR   Coriell; GM21689
DR   GEO; GSM650442
DR   Wikidata; Q54852086
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21693
AC   CVCL_0Z75
DR   CLO; CLO_0014012
DR   Coriell; GM21693
DR   GEO; GSM650443
DR   Wikidata; Q54852087
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21698
AC   CVCL_4J60
DR   CLO; CLO_0014013
DR   Coriell; GM21698
DR   Wikidata; Q54852088
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM21699
AC   CVCL_4J61
DR   CLO; CLO_0014010
DR   Coriell; GM21699
DR   Wikidata; Q54852089
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   GM21715
AC   CVCL_5R37
SY   801-002 LCL
DR   Coriell; GM21715
DR   Wikidata; Q54852090
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM21716
AC   CVCL_0Z76
DR   CLO; CLO_0014011
DR   Coriell; GM21716
DR   GEO; GSM649101
DR   Wikidata; Q54852091
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21717
AC   CVCL_0Z77
DR   CLO; CLO_0014043
DR   Coriell; GM21717
DR   GEO; GSM649067
DR   Wikidata; Q54852092
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21718
AC   CVCL_0Z78
DR   CLO; CLO_0014874
DR   Coriell; GM21718
DR   GEO; GSM649125
DR   Wikidata; Q54852093
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21719
AC   CVCL_0Z79
DR   CLO; CLO_0014872
DR   Coriell; GM21719
DR   GEO; GSM650444
DR   Wikidata; Q54852094
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21722
AC   CVCL_0Z80
DR   CLO; CLO_0014871
DR   Coriell; GM21722
DR   GEO; GSM650445
DR   Wikidata; Q54852095
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21723
AC   CVCL_0Z81
DR   CLO; CLO_0014886
DR   Coriell; GM21723
DR   GEO; GSM650446
DR   Wikidata; Q54852096
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21729
AC   CVCL_5R38
DR   Coriell; GM21729
DR   Wikidata; Q54852104
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21730
AC   CVCL_1B76
DR   Coriell; GM21730
DR   Wikidata; Q54852105
RX   PubMed=37751688;
WW   Info; PGP; hu04FD18; https://my.pgp-hms.org/profile_public?hex=hu04FD18
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM21731
AC   CVCL_1B77
DR   Coriell; GM21731
DR   Wikidata; Q54852106
RX   PubMed=37751688;
WW   Info; PGP; hu0D879F; https://my.pgp-hms.org/profile_public?hex=hu0D879F
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM21732
AC   CVCL_0Z82
DR   Coriell; GM21732
DR   Wikidata; Q54852107
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM21733
AC   CVCL_0Z83
DR   CLO; CLO_0014884
DR   Coriell; GM21733
DR   GEO; GSM650447
DR   Wikidata; Q54852108
RX   PubMed=21397061;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21737
AC   CVCL_0Z84
DR   EFO; EFO_0010839
DR   Coriell; GM21737
DR   Wikidata; Q54852109
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21738
AC   CVCL_0Z85
DR   CLO; CLO_0014880
DR   Coriell; GM21738
DR   GEO; GSM650448
DR   Wikidata; Q54852110
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21739
AC   CVCL_0Z86
DR   CLO; CLO_0014878
DR   Coriell; GM21739
DR   GEO; GSM650449
DR   Wikidata; Q54852111
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21740
AC   CVCL_0Z87
DR   CLO; CLO_0014891
DR   Coriell; GM21740
DR   GEO; GSM650450
DR   Wikidata; Q54852112
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21741
AC   CVCL_0Z88
DR   CLO; CLO_0014890
DR   Coriell; GM21741
DR   GEO; GSM650451
DR   Wikidata; Q54852113
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21742
AC   CVCL_0Z89
DR   CLO; CLO_0014888
DR   Coriell; GM21742
DR   GEO; GSM650452
DR   Wikidata; Q54852114
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21743
AC   CVCL_0Z90
DR   CLO; CLO_0014922
DR   Coriell; GM21743
DR   GEO; GSM650453
DR   Wikidata; Q54852115
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21744
AC   CVCL_0Z91
DR   CLO; CLO_0014921
DR   Coriell; GM21744
DR   GEO; GSM650454
DR   Wikidata; Q54852116
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21745
AC   CVCL_DR35
DR   Coriell; GM21745
DR   Wikidata; Q54852117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR36 ! GM21746
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM21746
AC   CVCL_DR36
DR   Coriell; GM21746
DR   Wikidata; Q54852118
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR35 ! GM21745
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM21747
AC   CVCL_DR37
DR   Coriell; GM21747
DR   Wikidata; Q54852119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM21749
AC   CVCL_HL66
DR   Coriell; GM21749
DR   Wikidata; Q54852120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL67 ! GM21750
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21750
AC   CVCL_HL67
DR   Coriell; GM21750
DR   Wikidata; Q54852121
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84714; Fibromuscular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL66 ! GM21749
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21751
AC   CVCL_HL30
DR   Coriell; GM21751
DR   Wikidata; Q54852122
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21751).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL31 ! GM21752
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21752
AC   CVCL_HL31
DR   Coriell; GM21752
DR   Wikidata; Q54852123
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21752).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL30 ! GM21751
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21756
AC   CVCL_1J84
DR   CLO; CLO_0014927
DR   Coriell; GM21756
DR   Wikidata; Q54852124
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[70] (c.52CAG(70)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM13509).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J76 ! GM13509
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM21757
AC   CVCL_1J85
DR   CLO; CLO_0014924
DR   Coriell; GM21757
DR   Wikidata; Q54852125
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[66] (c.52CAG(66)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line GM13515).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1J82 ! GM13515
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM21762
AC   CVCL_BT49
DR   Coriell; GM21762
DR   Wikidata; Q54852126
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Arg1024Ter (c.3070C>T); ClinVar=VCV000101174; Zygosity=Heterozygous (Coriell=GM21762).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM21767
AC   CVCL_0Z92
DR   Coriell; GM21767
DR   Wikidata; Q54852127
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM21768
AC   CVCL_0Z93
DR   CLO; CLO_0014932
DR   Coriell; GM21768
DR   GEO; GSM650455
DR   Wikidata; Q54852129
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21769
AC   CVCL_0Z94
DR   Coriell; GM21769
DR   Wikidata; Q54852130
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21770
AC   CVCL_0Z95
DR   Coriell; GM21770
DR   Wikidata; Q54852131
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21774
AC   CVCL_0Z96
DR   CLO; CLO_0014928
DR   Coriell; GM21774
DR   GEO; GSM650456
DR   Wikidata; Q54852132
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21775
AC   CVCL_0Z97
DR   Coriell; GM21775
DR   Wikidata; Q54852133
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21776
AC   CVCL_0Z98
DR   CLO; CLO_0014937
DR   Coriell; GM21776
DR   GEO; GSM650457
DR   Wikidata; Q54852134
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21781
AC   CVCL_1B78
DR   Coriell; GM21781
DR   Wikidata; Q54852135
RX   PubMed=26621101;
RX   PubMed=31401124;
RX   PubMed=37751688;
WW   Info; PGP; huAE6220; https://my.pgp-hms.org/profile_public?hex=huAE6220
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21782
AC   CVCL_0Z99
DR   Coriell; GM21782
DR   Wikidata; Q54852137
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21784
AC   CVCL_1A00
DR   CLO; CLO_0014934
DR   Coriell; GM21784
DR   GEO; GSM650458
DR   Wikidata; Q54852138
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21785
AC   CVCL_1A01
DR   Coriell; GM21785
DR   Wikidata; Q54852139
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GM21786
AC   CVCL_1A02
DR   EFO; EFO_0010840
DR   Coriell; GM21786
DR   Wikidata; Q54852140
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   GM21787
AC   CVCL_DR34
DR   Coriell; GM21787
DR   Wikidata; Q54852142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR33 ! GM21788
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM21788
AC   CVCL_DR33
DR   Coriell; GM21788
DR   Wikidata; Q54852143
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR34 ! GM21787
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM21790
AC   CVCL_HP80
DR   Coriell; GM21790
DR   Wikidata; Q54852145
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34805; Manic bipolar affective disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21791
AC   CVCL_DR28
DR   Coriell; GM21791
DR   Wikidata; Q54852146
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM21792
AC   CVCL_HP82
DR   Coriell; GM21792
DR   Wikidata; Q54852147
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21793
AC   CVCL_DR31
DR   Coriell; GM21793
DR   Wikidata; Q54852158
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM21794
AC   CVCL_DR32
DR   Coriell; GM21794
DR   Wikidata; Q54852159
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   GM21795
AC   CVCL_HP85
DR   Coriell; GM21795
DR   Wikidata; Q54852160
CC   Part of: Old Order Amish Major Affective Disorder cell line collection.
CC   Population: Caucasian; Amish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   GM21806
AC   CVCL_H990
DR   Coriell; GM21806
DR   Wikidata; Q54852161
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 18 PDL (Coriell=GM21806).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H991 ! GM21808
OI   CVCL_H992 ! GM21810
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM21807
AC   CVCL_H988
DR   Coriell; GM21807
DR   Wikidata; Q54852162
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=GM21807).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H989 ! GM21811
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM21808
AC   CVCL_H991
SY   C21808
DR   Coriell; GM21808
DR   GEO; GSM2794405
DR   Wikidata; Q54852164
RX   PubMed=29125828;
RX   PubMed=32291635;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H990 ! GM21806
OI   CVCL_H992 ! GM21810
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   GM21810
AC   CVCL_H992
DR   Coriell; GM21810
DR   Wikidata; Q54852165
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=GM21810).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H990 ! GM21806
OI   CVCL_H991 ! GM21808
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM21811
AC   CVCL_H989
DR   Coriell; GM21811
DR   Wikidata; Q54852166
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=GM21811).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H988 ! GM21807
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM21814
AC   CVCL_HL13
DR   Coriell; GM21814
DR   Wikidata; Q54852167
CC   Sequence variation: Mutation; HGNC; HGNC:2209; COL5A1; Simple; p.Gly530Ser (c.1588G>A); ClinVar=VCV000038863; Zygosity=Unspecified (Coriell=GM21814).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL14 ! GM21815
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21815
AC   CVCL_HL14
DR   Coriell; GM21815
DR   Wikidata; Q54852168
CC   Sequence variation: Mutation; HGNC; HGNC:2209; COL5A1; Simple; p.Gly530Ser (c.1588G>A); ClinVar=VCV000038863; Zygosity=Unspecified (Coriell=GM21815).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL13 ! GM21814
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21816
AC   CVCL_HL78
DR   Coriell; GM21816
DR   Wikidata; Q54852169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM21819
AC   CVCL_HL15
DR   Coriell; GM21819
DR   Wikidata; Q54852170
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21825
AC   CVCL_1A03
DR   CLO; CLO_0014941
DR   Coriell; GM21825
DR   GEO; GSM650459
DR   Wikidata; Q54852171
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21826
AC   CVCL_1A04
DR   CLO; CLO_0014939
DR   Coriell; GM21826
DR   GEO; GSM650460
DR   Wikidata; Q54852172
RX   PubMed=21397061;
CC   Population: African; Maasai in Kinyawa, Kenya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM21827
AC   CVCL_BT50
DR   Coriell; GM21827
DR   Wikidata; Q54852173
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21827).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT52 ! GM21829
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21828
AC   CVCL_BT51
DR   Coriell; GM21828
DR   Wikidata; Q54852174
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21828).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT53 ! GM21830
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21829
AC   CVCL_BT52
DR   Coriell; GM21829
DR   Wikidata; Q54852175
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21829).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT50 ! GM21827
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21830
AC   CVCL_BT53
DR   Coriell; GM21830
DR   Wikidata; Q54852176
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21830).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT51 ! GM21828
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21833
AC   CVCL_7662
DR   Coriell; GM21833
DR   Wikidata; Q54852177
RX   PubMed=37751688;
WW   Info; PGP; hu034DB1; https://my.pgp-hms.org/profile_public?hex=hu034DB1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F110 ! GM23251
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   GM21843
AC   CVCL_BA07
DR   Coriell; GM21843
DR   Wikidata; Q54852178
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM21844
AC   CVCL_BA08
DR   Coriell; GM21844
DR   Wikidata; Q54852179
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM21845
AC   CVCL_BA09
DR   Coriell; GM21845
DR   Wikidata; Q54852180
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM21846
AC   CVCL_0U55
DR   Coriell; GM21846
DR   Wikidata; Q54852181
WW   Info; PGP; hu604D39; https://my.pgp-hms.org/profile_public?hex=hu604D39
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 14
//
ID   GM21847
AC   CVCL_HL16
DR   Coriell; GM21847
DR   Wikidata; Q54852182
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM21847).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21849
AC   CVCL_1M65
DR   CLO; CLO_0014832
DR   Coriell; GM21849
DR   Wikidata; Q54852183
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.His1082Leufs*14 (c.3245_3247delATCinsTGAT) (c.3245ATC>TGAT) (H1082X); ClinVar=VCV000003033; Zygosity=Heterozygous (Coriell=GM21849).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM21850
AC   CVCL_BT54
DR   Coriell; GM21850
DR   Wikidata; Q54852184
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21850).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT55 ! GM21851
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21851
AC   CVCL_BT55
DR   Coriell; GM21851
DR   Wikidata; Q54852185
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21851).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT54 ! GM21850
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21852
AC   CVCL_BT56
DR   Coriell; GM21852
DR   Wikidata; Q54852186
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21852).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT57 ! GM21853
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21853
AC   CVCL_BT57
DR   Coriell; GM21853
DR   Wikidata; Q54852187
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM21853).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT56 ! GM21852
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21865
AC   CVCL_BA10
DR   Coriell; GM21865
DR   Wikidata; Q54852188
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA11 ! GM22279
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM21867
AC   CVCL_HL32
DR   Coriell; GM21867
DR   Wikidata; Q54852189
CC   Sequence variation: Mutation; HGNC; HGNC:12731; WAS; Simple; c.449+5G>A (IVS6+5G>A); Zygosity=Unspecified; Note=Activates a cryptic splice site (Coriell=GM21867).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21868
AC   CVCL_HL33
DR   Coriell; GM21868
DR   Wikidata; Q54852190
CC   Sequence variation: Mutation; HGNC; HGNC:12731; WAS; Simple; p.Val75Met (c.223G>A); ClinVar=VCV000265289; Zygosity=Unspecified (Coriell=GM21868).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21871
AC   CVCL_5R39
DR   Coriell; GM21871
DR   Wikidata; Q54852191
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Lys103Glufs*2 (c.307_311delAAAGA) (I102fs*1); ClinVar=VCV000021243; Zygosity=Homozygous (Coriell=GM21871).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM21871; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4681; Roberts-SC phocomelia syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7663 ! GM21872
SX   Female
AG   25FW
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM21872
AC   CVCL_7663
DR   Coriell; GM21872
DR   Wikidata; Q54852192
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Lys103Glufs*2 (c.307_311delAAAGA) (I102fs*1); ClinVar=VCV000021243; Zygosity=Homozygous (Coriell=GM21872).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4681; Roberts-SC phocomelia syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5R39 ! GM21871
SX   Female
AG   25FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   GM21873
AC   CVCL_D339
DR   Coriell; GM21873
DR   Wikidata; Q54852193
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Lys253fs*12 (c.752delA); Zygosity=Heterozygous (Coriell=GM21873).
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; c.1132-7A>G (IVS6-7A>G) (p.I377_378insLX); ClinVar=VCV000021234; Zygosity=Heterozygous (Coriell=GM21873).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C4681; Roberts-SC phocomelia syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM21874
AC   CVCL_5R40
DR   Coriell; GM21874
DR   Wikidata; Q54852194
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM21877
AC   CVCL_F109
DR   Coriell; GM21877
DR   Wikidata; Q54852195
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F108 ! GM03470
SX   Female
AG   1M2W
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   GM21878
AC   CVCL_5R41
DR   Coriell; GM21878
DR   Wikidata; Q54852196
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM21879
AC   CVCL_HK02
DR   Coriell; GM21879
DR   Wikidata; Q54852197
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21880
AC   CVCL_HK03
DR   Coriell; GM21880
DR   Wikidata; Q54852198
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21881
AC   CVCL_HK04
DR   Coriell; GM21881
DR   Wikidata; Q54852204
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM21883
AC   CVCL_5R42
DR   Coriell; GM21883
DR   Wikidata; Q54852205
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21884
AC   CVCL_5R43
DR   Coriell; GM21884
DR   Wikidata; Q54852206
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21885
AC   CVCL_5R44
DR   Coriell; GM21885
DR   Wikidata; Q54852207
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21886
AC   CVCL_5R45
DR   Coriell; GM21886
DR   Wikidata; Q54852208
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21887
AC   CVCL_5R46
DR   Coriell; GM21887
DR   Wikidata; Q54852209
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21889
AC   CVCL_U542
DR   Coriell; GM21889
DR   Wikidata; Q54852210
RX   PubMed=23665875;
RX   PubMed=24816254;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   GM21890
AC   CVCL_U543
DR   Coriell; GM21890
DR   Wikidata; Q54852211
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U544 ! GM21891
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   GM21891
AC   CVCL_U544
DR   Coriell; GM21891
DR   Wikidata; Q54852212
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U543 ! GM21890
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM21892
AC   CVCL_5R47
DR   Coriell; GM21892
DR   Wikidata; Q54852213
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21893
AC   CVCL_5R48
DR   Coriell; GM21893
DR   Wikidata; Q54852214
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM21894
AC   CVCL_HL17
DR   Coriell; GM21894
DR   Wikidata; Q54852215
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84609; Campomelic dysplasia
DI   ORDO; Orphanet_140; Campomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   <1D
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM21902
AC   CVCL_HQ14
DR   Coriell; GM21902
DR   Wikidata; Q54852216
CC   Sequence variation: Mutation; HGNC; HGNC:4263; GHR; Simple; p.Val230fs*4 (c.689_690delTA) (fs234Ter); Zygosity=Homozygous (Coriell=GM21902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129867; Growth hormone insensitivity syndrome
DI   ORDO; Orphanet_633; Laron syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21911
AC   CVCL_BT58
DR   Coriell; GM21911
DR   Wikidata; Q54852217
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Glu137Aspfs*1 (c.411delG) (p.Glu149Aspfs*1, c.447delG) (L138X); ClinVar=VCV000143565; Zygosity=Unspecified (Coriell=GM21911).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM21912
AC   CVCL_BT59
DR   Coriell; GM21912
DR   Wikidata; Q54852218
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg270Ter (c.808C>T) (p.Arg282Ter, c.844C>T); ClinVar=VCV000011815; Zygosity=Unspecified (Coriell=GM21912).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM21913
AC   CVCL_BT60
DR   Coriell; GM21913
DR   Wikidata; Q54852219
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Unspecified (Coriell=GM21913).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM21916
AC   CVCL_BT61
DR   Coriell; GM21916
DR   Wikidata; Q54852220
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Unspecified (Coriell=GM21916).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM21920
AC   CVCL_BT62
DR   Coriell; GM21920
DR   Wikidata; Q54852221
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Unexplicit; Ex4del; Zygosity=Unspecified (Coriell=GM21920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM21921
AC   CVCL_IX38
DR   Coriell; GM21921
DR   Wikidata; Q54852222
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Ile125fs*11 (r.378_384delTCCCCAG); Zygosity=Hemizygous (Coriell=GM21921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C132293; Severe neonatal encephalopathy due to MECP2 mutations
DI   ORDO; Orphanet_209370; Severe neonatal-onset encephalopathy with microcephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   GM21931
AC   CVCL_HK08
DR   Coriell; GM21931
DR   Wikidata; Q54852223
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3464del17; Zygosity=Unspecified (Coriell=GM21931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21932
AC   CVCL_HK09
DR   Coriell; GM21932
DR   Wikidata; Q54852224
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1589Phe (c.4766G>T); ClinVar=VCV000549246; Zygosity=Unspecified (Coriell=GM21932).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21934
AC   CVCL_HK10
DR   Coriell; GM21934
DR   Wikidata; Q54852225
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.5788+5G>A (IVS46+5G-A) (Ex46del); ClinVar=VCV000042394; Zygosity=Unspecified (Coriell=GM21934).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21935
AC   CVCL_HK11
DR   Coriell; GM21935
DR   Wikidata; Q54852226
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.6163+2del6 (IVS49+2del6) (Ex49del); Zygosity=Unspecified (Coriell=GM21935).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21936
AC   CVCL_HK12
DR   Coriell; GM21936
DR   Wikidata; Q54852227
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3839-1G>A (IVS30-1G>A) (Ex31del); Zygosity=Unspecified; Note=Splice acceptor mutation (Coriell=GM21936).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM21937
AC   CVCL_HK13
DR   Coriell; GM21937
DR   Wikidata; Q54852228
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.7205-2A>G (IVS57-2A>G) (Ex58del); ClinVar=VCV000982349; Zygosity=Unspecified; Note=Splice acceptor mutation (Coriell=GM21937).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM21938
AC   CVCL_HK14
DR   Coriell; GM21938
DR   Wikidata; Q54852230
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Gly1127Ser (c.3379G>A); ClinVar=VCV000016443; Zygosity=Unspecified (Coriell=GM21938).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21939
AC   CVCL_HK15
DR   Coriell; GM21939
DR   Wikidata; Q54852231
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Unexplicit; Ex42-43del; Zygosity=Unspecified (Coriell=GM21939).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21940
AC   CVCL_HK16
DR   Coriell; GM21940
DR   Wikidata; Q54852232
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Unexplicit; Ex44-46del; Zygosity=Unspecified (Coriell=GM21940).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21941
AC   CVCL_HK17
DR   Coriell; GM21941
DR   Wikidata; Q54852233
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Ile2118Ile (c.6354C>T); ClinVar=VCV000016449; Zygosity=Unspecified; Note=Causes in-frame skipping of exon 51 (Coriell=GM21941).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   GM21942
AC   CVCL_HK18
DR   Coriell; GM21942
DR   Wikidata; Q54852234
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1153Tyr (c.3458G>A); ClinVar=VCV000457194; Zygosity=Unspecified (Coriell=GM21942).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21943
AC   CVCL_HK19
DR   Coriell; GM21943
DR   Wikidata; Q54852235
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1242Tyr (c.3725G>A); ClinVar=VCV000016429; Zygosity=Unspecified (Coriell=GM21943).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21944
AC   CVCL_HK20
DR   Coriell; GM21944
DR   Wikidata; Q54852236
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1326Arg (c.3976T>C); ClinVar=VCV002137695; Zygosity=Heterozygous (Coriell=GM21944).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21945
AC   CVCL_HK21
DR   Coriell; GM21945
DR   Wikidata; Q54852237
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2017Arg (c.6049T>C); ClinVar=VCV000457240; Zygosity=Unspecified (Coriell=GM21945).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21946
AC   CVCL_HK22
DR   Coriell; GM21946
DR   Wikidata; Q54852238
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2686Phe (c.8057G>T); ClinVar=VCV001071312; Zygosity=Unspecified (Coriell=GM21946).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21947
AC   CVCL_HK23
DR   Coriell; GM21947
DR   Wikidata; Q54852239
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys499Arg (c.1495T>C); Zygosity=Unspecified (Coriell=GM21947).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21948
AC   CVCL_HK24
DR   Coriell; GM21948
DR   Wikidata; Q54852240
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1039Tyr (c.3116G>A); ClinVar=VCV001069719; Zygosity=Unspecified (Coriell=GM21948).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21950
AC   CVCL_HK25
DR   Coriell; GM21950
DR   Wikidata; Q54852241
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1171Arg (c.3511T>C); ClinVar=VCV001069718; Zygosity=Unspecified (Coriell=GM21950).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21951
AC   CVCL_HK26
DR   Coriell; GM21951
DR   Wikidata; Q54852242
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2221Arg (c.6661T>C); ClinVar=VCV000439708; Zygosity=Unspecified (Coriell=GM21951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21952
AC   CVCL_HK27
DR   Coriell; GM21952
DR   Wikidata; Q54852243
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2111Arg (c.6331T>C); ClinVar=VCV000549340; Zygosity=Unspecified (Coriell=GM21952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21953
AC   CVCL_HK28
DR   Coriell; GM21953
DR   Wikidata; Q54852244
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2170Phe (c.6509G>T); Zygosity=Unspecified (Coriell=GM21953).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21954
AC   CVCL_HK29
DR   Coriell; GM21954
DR   Wikidata; Q54852251
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys637Arg (c.1909T>C); ClinVar=VCV000222601; Zygosity=Unspecified (Coriell=GM21954).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21956
AC   CVCL_HK30
DR   Coriell; GM21956
DR   Wikidata; Q54852252
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1672Phe (c.5015G>T); ClinVar=VCV000640108; Zygosity=Unspecified (Coriell=GM21956).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21957
AC   CVCL_HK31
DR   Coriell; GM21957
DR   Wikidata; Q54852253
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys832Tyr (c.2495G>A); ClinVar=VCV000042311; Zygosity=Unspecified (Coriell=GM21957).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21958
AC   CVCL_HK32
DR   Coriell; GM21958
DR   Wikidata; Q54852254
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys570Arg (c.1708T>C); ClinVar=VCV000956400; Zygosity=Unspecified (Coriell=GM21958).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21960
AC   CVCL_HK33
DR   Coriell; GM21960
DR   Wikidata; Q54852255
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1361Tyr (c.4082G>A); ClinVar=VCV000519726; Zygosity=Heterozygous (Coriell=GM21960).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21966
AC   CVCL_HK34
DR   Coriell; GM21966
DR   Wikidata; Q54852256
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu249Ter (c.745G>T); Zygosity=Unspecified (Coriell=GM21966).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21967
AC   CVCL_HK35
DR   Coriell; GM21967
DR   Wikidata; Q54852257
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Asn264Ter (755del8); Zygosity=Unspecified (Coriell=GM21967).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21968
AC   CVCL_HK36
DR   Coriell; GM21968
DR   Wikidata; Q54852258
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Tyr434Ter (c.1302T>G); Zygosity=Unspecified (Coriell=GM21968).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21969
AC   CVCL_HK37
DR   Coriell; GM21969
DR   Wikidata; Q54852259
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Ile578Ter (c.1642del3ins20); Zygosity=Unspecified (Coriell=GM21969).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21970
AC   CVCL_HK38
DR   Coriell; GM21970
DR   Wikidata; Q54852260
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys628Ter (c.1884C>A); Zygosity=Unspecified (Coriell=GM21970).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21971
AC   CVCL_HK39
DR   Coriell; GM21971
DR   Wikidata; Q54852261
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Met717Ter (c.1888delAAinsC); Zygosity=Unspecified (Coriell=GM21971).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21972
AC   CVCL_HK40
DR   Coriell; GM21972
DR   Wikidata; Q54852262
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Leu802Ter (c.2399delC); Zygosity=Unspecified (Coriell=GM21972).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21974
AC   CVCL_HK41
DR   Coriell; GM21974
DR   Wikidata; Q54852263
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Arg861Ter (c.2581C>T); ClinVar=VCV000265401; Zygosity=Unspecified (Coriell=GM21974).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21976
AC   CVCL_HK42
DR   Coriell; GM21976
DR   Wikidata; Q54852264
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1158Ter (c.3474insC); Zygosity=Unspecified (Coriell=GM21976).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21978
AC   CVCL_HK43
DR   Coriell; GM21978
DR   Wikidata; Q54852265
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Met1275Ter (c.3823delA); Zygosity=Unspecified (Coriell=GM21978).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21979
AC   CVCL_HK44
DR   Coriell; GM21979
DR   Wikidata; Q54852266
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1260Ter (c.3778G>T); ClinVar=VCV000527164; Zygosity=Unspecified (Coriell=GM21979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21982
AC   CVCL_HK45
DR   Coriell; GM21982
DR   Wikidata; Q54852267
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Arg1523Ter (c.4567C>T); ClinVar=VCV000042365; Zygosity=Unspecified (Coriell=GM21982).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21983
AC   CVCL_HK46
DR   Coriell; GM21983
DR   Wikidata; Q54852268
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Arg1644Ter (c.4930C>T); ClinVar=VCV000200186; Zygosity=Unspecified (Coriell=GM21983).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21984
AC   CVCL_HK47
DR   Coriell; GM21984
DR   Wikidata; Q54852269
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Ile1892Ter (c.5240insACACT); Zygosity=Unspecified (Coriell=GM21984).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21987
AC   CVCL_HK48
DR   Coriell; GM21987
DR   Wikidata; Q54852270
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Arg2057Ter (c.6169C>T); ClinVar=VCV000200076; Zygosity=Unspecified (Coriell=GM21987).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21988
AC   CVCL_HK49
DR   Coriell; GM21988
DR   Wikidata; Q54852271
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Tyr2062Ter (c.6185dupA) (c.6185insA); Zygosity=Unspecified (Coriell=GM21988).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21989
AC   CVCL_HK50
DR   Coriell; GM21989
DR   Wikidata; Q54852272
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Asp2104Ter (c.6309dupC) (c.6283insC); ClinVar=VCV001426876; Zygosity=Unspecified (Coriell=GM21989).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21990
AC   CVCL_HK51
DR   Coriell; GM21990
DR   Wikidata; Q54852273
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Leu2159Ter (c.6423delG); Zygosity=Unspecified (Coriell=GM21990).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM21992
AC   CVCL_HK52
DR   Coriell; GM21992
DR   Wikidata; Q54852274
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Arg2414Ter (c.7240C>T); ClinVar=VCV000519729; Zygosity=Unspecified (Coriell=GM21992).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM21994
AC   CVCL_HK53
DR   Coriell; GM21994
DR   Wikidata; Q54852275
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.8051+1G>A (IVS63+1G>A); ClinVar=VCV000042394; Zygosity=Unspecified; Note=Splice donor mutation (p.Val2751Ter) (Coriell=GM21994).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM21995
AC   CVCL_HQ15
DR   Coriell; GM21995
DR   Wikidata; Q54852277
CC   Sequence variation: Mutation; HGNC; HGNC:3604; FBN2; Simple; p.Asp1115His (c.3343G>C) (D1114H, 3340G>C); ClinVar=VCV000000525; Zygosity=Unspecified (Coriell=GM21995).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129865; Congenital contractural arachnodactyly
DI   ORDO; Orphanet_115; Congenital contractural arachnodactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM22004
AC   CVCL_CX67
DR   Coriell; GM22004
DR   Wikidata; Q54852278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM22005
AC   CVCL_CX68
DR   Coriell; GM22005
DR   Wikidata; Q54852279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM22006
AC   CVCL_EG02
DR   Coriell; GM22006
DR   Wikidata; Q54852280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128192; Mosaic variegated aneuploidy syndrome 1
DI   ORDO; Orphanet_1052; Mosaic variegated aneuploidy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM22010
AC   CVCL_BT63
DR   Coriell; GM22010
DR   Wikidata; Q54852281
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Gly241Valfs*19 (c.722delG) (G216fs); ClinVar=VCV000551231; Zygosity=Homozygous (Coriell=GM22010).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22011
AC   CVCL_BT64
DR   Coriell; GM22011
DR   Wikidata; Q54852282
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Gly241Valfs*19 (c.722delG) (G216fs); ClinVar=VCV000551231; Zygosity=Heterozygous (Coriell=GM22011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22012
AC   CVCL_BT65
DR   Coriell; GM22012
DR   Wikidata; Q54852283
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Gly241Valfs*19 (c.722delG) (G216fs); ClinVar=VCV000551231; Zygosity=Heterozygous (Coriell=GM22012).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22013
AC   CVCL_BT66
DR   Coriell; GM22013
DR   Wikidata; Q54852284
CC   Population: Caucasian; German/Lithuanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM22014
AC   CVCL_BT67
DR   Coriell; GM22014
DR   Wikidata; Q54852285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22015
AC   CVCL_BT68
DR   Coriell; GM22015
DR   Wikidata; Q54852286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22016
AC   CVCL_BT69
DR   Coriell; GM22016
DR   Wikidata; Q54852287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22017
AC   CVCL_BT70
DR   Coriell; GM22017
DR   Wikidata; Q54852288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22018
AC   CVCL_BT71
DR   Coriell; GM22018
DR   Wikidata; Q54852290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22019
AC   CVCL_BT72
DR   Coriell; GM22019
DR   Wikidata; Q54852291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22020
AC   CVCL_BT73
DR   Coriell; GM22020
DR   Wikidata; Q54852292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22021
AC   CVCL_BT74
DR   Coriell; GM22021
DR   Wikidata; Q54852302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22022
AC   CVCL_BT75
DR   Coriell; GM22022
DR   Wikidata; Q54852304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22025
AC   CVCL_BT76
DR   Coriell; GM22025
DR   Wikidata; Q54852305
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Gly112Asp (c.335G>A); ClinVar=VCV000038883; Zygosity=Heterozygous (Coriell=GM22025).
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Ala402Hisfs*41 (c.1204delG); Zygosity=Heterozygous (Coriell=GM22025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22028
AC   CVCL_BT77
DR   Coriell; GM22028
DR   Wikidata; Q54852306
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22028).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT78 ! GM22029
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22029
AC   CVCL_BT78
DR   Coriell; GM22029
DR   Wikidata; Q54852307
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22029).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT77 ! GM22028
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22030
AC   CVCL_BT79
DR   Coriell; GM22030
DR   Wikidata; Q54852308
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Phe391Cysfs*2 (c.1172_1173delTT); ClinVar=VCV000659170; Zygosity=Homozygous (Coriell=GM22030).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM22031
AC   CVCL_5R49
DR   Coriell; GM22031
DR   Wikidata; Q54852309
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22032
AC   CVCL_5R50
DR   CLO; CLO_0014824
DR   Coriell; GM22032
DR   Wikidata; Q54852310
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22034
AC   CVCL_BT80
DR   Coriell; GM22034
DR   Wikidata; Q54852311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22040
AC   CVCL_BT81
DR   Coriell; GM22040
DR   Wikidata; Q54852312
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Coriell=GM22040).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT82 ! GM22041
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22041
AC   CVCL_BT82
DR   Coriell; GM22041
DR   Wikidata; Q54852313
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Coriell=GM22041).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT81 ! GM22040
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22049
AC   CVCL_5R51
DR   Coriell; GM22049
DR   Wikidata; Q54852314
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22051
AC   CVCL_BT83
DR   Coriell; GM22051
DR   Wikidata; Q54852315
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly708Asp (c.2123G>A); ClinVar=VCV001786274; Zygosity=Unspecified (Coriell=GM22051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22052
AC   CVCL_BT84
DR   Coriell; GM22052
DR   Wikidata; Q54852316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT85 ! GM22053
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22053
AC   CVCL_BT85
DR   Coriell; GM22053
DR   Wikidata; Q54852317
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT84 ! GM22052
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22060
AC   CVCL_JF03
DR   Coriell; GM22060
DR   Wikidata; Q54852318
CC   Population: Jewish; Ashkenazi.
CC   Donor information: Established from a donor suffering from Pelizaeus-Merzbacher-like symptoms.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   ORDO; Orphanet_280270; Pelizaeus-Merzbacher-like disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 10
//
ID   GM22062
AC   CVCL_1M66
DR   CLO; CLO_0014822
DR   Coriell; GM22062
DR   Wikidata; Q54852319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM22063
AC   CVCL_BA12
DR   Coriell; GM22063
DR   Wikidata; Q54852320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22068
AC   CVCL_BT86
DR   Coriell; GM22068
DR   Wikidata; Q54852321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT87 ! GM22069
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22069
AC   CVCL_BT87
DR   Coriell; GM22069
DR   Wikidata; Q54852322
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT86 ! GM22068
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22070
AC   CVCL_BT88
DR   Coriell; GM22070
DR   Wikidata; Q54852323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT89 ! GM22071
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22071
AC   CVCL_BT89
DR   Coriell; GM22071
DR   Wikidata; Q54852324
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT88 ! GM22070
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22078
AC   CVCL_BT90
DR   Coriell; GM22078
DR   Wikidata; Q54852325
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22078).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT91 ! GM22079
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22079
AC   CVCL_BT91
DR   Coriell; GM22079
DR   Wikidata; Q54852326
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22079).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT90 ! GM22078
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22080
AC   CVCL_BT92
DR   Coriell; GM22080
DR   Wikidata; Q54852327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22081
AC   CVCL_BT93
DR   Coriell; GM22081
DR   Wikidata; Q54852328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22082
AC   CVCL_BT94
DR   Coriell; GM22082
DR   Wikidata; Q54852329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22083
AC   CVCL_BT95
DR   Coriell; GM22083
DR   Wikidata; Q54852330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22084
AC   CVCL_BT96
DR   Coriell; GM22084
DR   Wikidata; Q54852331
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22084).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT97 ! GM22085
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22085
AC   CVCL_BT97
DR   Coriell; GM22085
DR   Wikidata; Q54852332
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22085).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT96 ! GM22084
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22086
AC   CVCL_CX69
DR   Coriell; GM22086
DR   Wikidata; Q54852333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   GM22087
AC   CVCL_CX70
DR   Coriell; GM22087
DR   Wikidata; Q54852335
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM22090
AC   CVCL_JF04
DR   Coriell; GM22090
DR   Wikidata; Q54852336
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   ORDO; Orphanet_280270; Pelizaeus-Merzbacher-like disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   GM22100
AC   CVCL_BT98
DR   Coriell; GM22100
DR   Wikidata; Q54852338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT99 ! GM22101
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22101
AC   CVCL_BT99
DR   Coriell; GM22101
DR   Wikidata; Q54852339
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT98 ! GM22100
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22102
AC   CVCL_BU00
DR   Coriell; GM22102
DR   Wikidata; Q54852341
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22103
AC   CVCL_BU01
DR   Coriell; GM22103
DR   Wikidata; Q54852342
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM22110
AC   CVCL_BU02
DR   Coriell; GM22110
DR   Wikidata; Q54852343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22111
AC   CVCL_BU03
DR   Coriell; GM22111
DR   Wikidata; Q54852346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22112
AC   CVCL_BU04
DR   Coriell; GM22112
DR   Wikidata; Q54852347
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Gly407Argfs*14 (c.1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA) (c.1218_1231del14ins12); ClinVar=VCV000038875; Zygosity=Homozygous (Coriell=GM22112).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22113
AC   CVCL_BU05
DR   Coriell; GM22113
DR   Wikidata; Q54852356
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Gly407Argfs*14 (c.1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA) (c.1218_1231del14ins12); ClinVar=VCV000038875; Zygosity=Homozygous (Coriell=GM22113).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22114
AC   CVCL_BU06
DR   Coriell; GM22114
DR   Wikidata; Q54852357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU07 ! GM22115
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22115
AC   CVCL_BU07
DR   Coriell; GM22115
DR   Wikidata; Q54852358
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU06 ! GM22114
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM22121
AC   CVCL_5R52
DR   Coriell; GM22121
DR   Wikidata; Q54852359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5R53 ! GM22122
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22122
AC   CVCL_5R53
DR   Coriell; GM22122
DR   Wikidata; Q54852360
RX   PubMed=23665875;
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5R52 ! GM22121
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM22123
AC   CVCL_BU08
DR   Coriell; GM22123
DR   Wikidata; Q54852361
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Arg113Ter (c.377C>T); ClinVar=VCV000265422; Zygosity=Heterozygous (Coriell=GM22123).
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Phe391Ser (c.1172T>C); ClinVar=VCV001942487; Zygosity=Heterozygous (Coriell=GM22123).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22124
AC   CVCL_BU09
DR   Coriell; GM22124
DR   Wikidata; Q54852362
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Arg113Ter (c.377C>T); ClinVar=VCV000265422; Zygosity=Heterozygous (from familial inference of GM22123).
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Phe391Ser (c.1172T>C); ClinVar=VCV001942487; Zygosity=Heterozygous (from familial inference of GM22123).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   GM22125
AC   CVCL_BU10
DR   Coriell; GM22125
DR   Wikidata; Q54852363
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22126
AC   CVCL_BU11
DR   Coriell; GM22126
DR   Wikidata; Q54852364
CC   Population: Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22128
AC   CVCL_BU12
DR   Coriell; GM22128
DR   Wikidata; Q54852365
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Leu212Pro (c.635T>C); ClinVar=VCV002506888; Zygosity=Hemizygous (Coriell=GM22128).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   GM22129
AC   CVCL_BU13
DR   Coriell; GM22129
DR   Wikidata; Q54852366
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; c.109+5G>A (IVS1+5G>A); ClinVar=VCV001073013; Zygosity=Hemizygous; Note=Splicing mutation (Coriell=GM22129).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM22130
AC   CVCL_BU14
DR   Coriell; GM22130
DR   Wikidata; Q54852367
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.His69Gln (c.207C>G); ClinVar=VCV000559335; Zygosity=Hemizygous (Coriell=GM22130).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22131
AC   CVCL_V261
DR   Coriell; GM22131
DR   Wikidata; Q54852368
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22131).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V262 ! GM22133
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM22133
AC   CVCL_V262
DR   Coriell; GM22133
DR   Wikidata; Q54852369
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 33 PDL (Coriell=GM22133).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V261 ! GM22131
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM22134
AC   CVCL_V263
DR   Coriell; GM22134
DR   Wikidata; Q54852370
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22134).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V264 ! GM22135
OI   CVCL_V265 ! GM22136
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM22135
AC   CVCL_V264
DR   Coriell; GM22135
DR   Wikidata; Q54852371
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 38 PDL (Coriell=GM22135).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V263 ! GM22134
OI   CVCL_V265 ! GM22136
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM22136
AC   CVCL_V265
DR   Coriell; GM22136
DR   Wikidata; Q54852372
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 29 PDL (Coriell=GM22136).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V263 ! GM22134
OI   CVCL_V264 ! GM22135
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM22137
AC   CVCL_BU15
DR   Coriell; GM22137
DR   Wikidata; Q54852373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU16 ! GM22138
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22138
AC   CVCL_BU16
DR   Coriell; GM22138
DR   Wikidata; Q54852374
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU15 ! GM22137
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22141
AC   CVCL_1P24
DR   Coriell; GM22141
DR   Wikidata; Q54852375
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22141).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P25 ! GM22143
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22143
AC   CVCL_1P25
DR   Coriell; GM22143
DR   Wikidata; Q54852376
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=GM22143).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P24 ! GM22141
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22147
AC   CVCL_BU17
DR   Coriell; GM22147
DR   Wikidata; Q54852377
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Lys37Ser_Tyr38ins18 (c.109+5G>C) (IVS1+5G>C); ClinVar=VCV000011106; Zygosity=Hemizygous (Coriell=GM22147).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22148
AC   CVCL_BU18
DR   Coriell; GM22148
DR   Wikidata; Q54852378
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Leu42Ter (c.124delC); Zygosity=Hemizygous (Coriell=GM22148).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22149
AC   CVCL_BU19
DR   Coriell; GM22149
DR   Wikidata; Q54852379
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Arg123Ter (c.367C>T); ClinVar=VCV000560626; Zygosity=Hemizygous (Coriell=GM22149).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22150
AC   CVCL_BU20
DR   Coriell; GM22150
DR   Wikidata; Q54852380
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Trp79Ter (c.236G>A); ClinVar=VCV002506921; Zygosity=Hemizygous (Coriell=GM22150).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 12
//
ID   GM22157
AC   CVCL_1P26
DR   Coriell; GM22157
DR   Wikidata; Q54852381
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Asian.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22157).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P27 ! GM22159
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22159
AC   CVCL_1P27
DR   Coriell; GM22159
DR   Wikidata; Q54852382
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Asian.
CC   Senescence: Senesces at 28 PDL (Coriell=GM22159).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P26 ! GM22157
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22162
AC   CVCL_BA13
DR   Coriell; GM22162
DR   Wikidata; Q54852383
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous (Coriell=GM22162).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM22162).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM22163
AC   CVCL_BU21
DR   Coriell; GM22163
DR   Wikidata; Q54852384
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Gly58Alafs*25 (c.171delA); ClinVar=VCV002506914; Zygosity=Hemizygous (Coriell=GM22163).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   GM22164
AC   CVCL_BU22
DR   Coriell; GM22164
DR   Wikidata; Q54852385
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Gln233Ter (c.697C>T); ClinVar=VCV000662186; Zygosity=Hemizygous (Coriell=GM22164).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22165
AC   CVCL_BU23
DR   Coriell; GM22165
DR   Wikidata; Q54852386
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; c.110-2A>G (IVS1-2A>G); ClinVar=VCV000011109; Zygosity=Hemizygous; Note=Splice acceptor mutation (Coriell=GM22165).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM22167
AC   CVCL_1P28
DR   Coriell; GM22167
DR   Wikidata; Q54852387
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Discontinued: Coriell; GM22167; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P29 ! GM22168
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22168
AC   CVCL_1P29
DR   Coriell; GM22168
DR   Wikidata; Q54852388
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Discontinued: Coriell; GM22168; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P28 ! GM22167
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM2217
AC   CVCL_B4FY
DR   IARC_TP53; 20804
DR   Wikidata; Q110432820
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Ser (c.488A>C); Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   GM22170
AC   CVCL_1P30
DR   Coriell; GM22170
DR   Wikidata; Q54852389
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Discontinued: Coriell; GM22170; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P31 ! GM22171
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22171
AC   CVCL_1P31
DR   Coriell; GM22171
DR   Wikidata; Q54852390
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Discontinued: Coriell; GM22171; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P30 ! GM22170
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22182
AC   CVCL_1P32
DR   Coriell; GM22182
DR   Wikidata; Q54852391
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 25 PDL (Coriell=GM22182).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P33 ! GM22183
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22183
AC   CVCL_1P33
DR   Coriell; GM22183
DR   Wikidata; Q54852392
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 27 PDL (Coriell=GM22183).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P32 ! GM22182
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22185
AC   CVCL_1P34
DR   Coriell; GM22185
DR   Wikidata; Q54852393
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 21 PDL (Coriell=GM22185).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P35 ! GM22186
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22186
AC   CVCL_1P35
SY   H3
DR   BioSample; SAMN04469530
DR   Coriell; GM22186
DR   Wikidata; Q54852394
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 27 PDL (Coriell=GM22186).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P34 ! GM22185
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22189
AC   CVCL_1P36
DR   Coriell; GM22189
DR   Wikidata; Q54852395
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22189).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P37 ! GM22191
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22191
AC   CVCL_1P37
DR   Coriell; GM22191
DR   Wikidata; Q54852414
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 28 PDL (Coriell=GM22191).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P36 ! GM22189
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22192
AC   CVCL_BU24
DR   Coriell; GM22192
DR   Wikidata; Q54852415
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Arg94Cys (c.280C>T); ClinVar=VCV000202092; Zygosity=Hemizygous (Coriell=GM22192).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22193
AC   CVCL_BU25
DR   Coriell; GM22193
DR   Wikidata; Q54852416
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Leu166Ter (c.498T>A); ClinVar=VCV002506891; Zygosity=Hemizygous (Coriell=GM22193).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   GM22194
AC   CVCL_BU26
DR   Coriell; GM22194
DR   Wikidata; Q54852417
CC   Sequence variation: Gene deletion; HGNC; HGNC:11577; TAFAZZIN; Zygosity=Hemizygous (Coriell=GM22194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22200
AC   CVCL_1P38
DR   Coriell; GM22200
DR   Wikidata; Q54852418
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22200).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P39 ! GM22201
OI   CVCL_1P40 ! GM22202
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22201
AC   CVCL_1P39
DR   Coriell; GM22201
DR   Wikidata; Q54852419
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 43 PDL (Coriell=GM22201).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P38 ! GM22200
OI   CVCL_1P40 ! GM22202
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22202
AC   CVCL_1P40
DR   Coriell; GM22202
DR   Wikidata; Q54852420
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=GM22202).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P38 ! GM22200
OI   CVCL_1P39 ! GM22201
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22203
AC   CVCL_1P41
DR   Coriell; GM22203
DR   Wikidata; Q54852421
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22203).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P42 ! GM22204
OI   CVCL_1P43 ! GM22205
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22204
AC   CVCL_1P42
DR   Coriell; GM22204
DR   Wikidata; Q54852422
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 37 PDL (Coriell=GM22204).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P41 ! GM22203
OI   CVCL_1P43 ! GM22205
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22205
AC   CVCL_1P43
DR   Coriell; GM22205
DR   Wikidata; Q54852425
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 27 PDL (Coriell=GM22205).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P41 ! GM22203
OI   CVCL_1P42 ! GM22204
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22206
AC   CVCL_AA08
DR   Coriell; GM22206
DR   Wikidata; Q54852426
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Lys159Serfs*15 (c.476delA); ClinVar=VCV001803112; Zygosity=Heterozygous (Coriell=GM22206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM22208
AC   CVCL_BU27
DR   Coriell; GM22208
DR   Wikidata; Q54852427
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Lys298Arg (c.893A>G); ClinVar=VCV000449078; Zygosity=Heterozygous (Coriell=GM22208).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Unexplicit; Ex13-20del; Zygosity=Heterozygous (Coriell=GM22208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22211
AC   CVCL_BU28
DR   Coriell; GM22211
DR   Wikidata; Q54852429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU29 ! GM22212
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22212
AC   CVCL_BU29
DR   Coriell; GM22212
DR   Wikidata; Q54852430
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU28 ! GM22211
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22213
AC   CVCL_BU30
DR   Coriell; GM22213
DR   Wikidata; Q54852432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   NCIt; C84714; Fibromuscular dysplasia
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU31 ! GM22214
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22214
AC   CVCL_BU31
DR   Coriell; GM22214
DR   Wikidata; Q54852433
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   NCIt; C84714; Fibromuscular dysplasia
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU30 ! GM22213
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22215
AC   CVCL_BU32
DR   Coriell; GM22215
DR   Wikidata; Q54852434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU33 ! GM22216
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22216
AC   CVCL_BU33
DR   Coriell; GM22216
DR   Wikidata; Q54852435
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU32 ! GM22215
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22219
AC   CVCL_5R54
DR   Coriell; GM22219
DR   Wikidata; Q54852436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22221
AC   CVCL_1P44
DR   Coriell; GM22221
DR   Wikidata; Q54852437
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Asian.
CC   Senescence: Senesces at 41 PDL (Coriell=GM22221).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P45 ! GM22222
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22222
AC   CVCL_1P45
DR   Coriell; GM22222
DR   Wikidata; Q54852438
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Asian.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22222).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P44 ! GM22221
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22227
AC   CVCL_DB13
DR   Coriell; GM22227
DR   Wikidata; Q54852439
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (Coriell=GM22227).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM22227).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM22256 (Cellosaurus=CVCL_DB16) and GM22871 (Cellosaurus=CVCL_DB18).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB17 ! GM22870
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM22229
AC   CVCL_DB14
DR   Coriell; GM22229
DR   Wikidata; Q54852440
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Arg978Cys (c.2932C>T); ClinVar=VCV000002976; Zygosity=Heterozygous (Coriell=GM22229).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Unexplicit; IVS21-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM22229).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM22230
AC   CVCL_DB15
DR   Coriell; GM22230
DR   Wikidata; Q54852441
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Arg978Cys (c.2932C>T); ClinVar=VCV000002976; Zygosity=Heterozygous (Coriell=GM22230).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Unexplicit; IVS21-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM22230).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM22232
AC   CVCL_1U26
SY   NLGIP-6630; NLGIP6630
DR   CLO; CLO_0014821
DR   Coriell; GM22232
DR   Wikidata; Q54852442
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM22232; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 16
//
ID   GM22233
AC   CVCL_1U27
SY   NLGIP-6638; NLGIP6638
DR   CLO; CLO_0014818
DR   Coriell; GM22233
DR   Wikidata; Q54852443
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Syrian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM22233; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 16
//
ID   GM22234
AC   CVCL_1U28
SY   NLGIP-6642; NLGIP6642
DR   CLO; CLO_0014817
DR   Coriell; GM22234
DR   Wikidata; Q54852445
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 16
//
ID   GM22235
AC   CVCL_1U29
SY   NLGIP-6647; NLGIP6647
DR   CLO; CLO_0014814
DR   Coriell; GM22235
DR   Wikidata; Q54852446
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 16
//
ID   GM22236
AC   CVCL_1U30
SY   NLGIP-6659; NLGIP6659
DR   CLO; CLO_0014813
DR   Coriell; GM22236
DR   Wikidata; Q54852447
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Lybian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 16
//
ID   GM22237
AC   CVCL_BU34
DR   Coriell; GM22237
DR   Wikidata; Q54852448
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU35 ! GM22238
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22238
AC   CVCL_BU35
DR   Coriell; GM22238
DR   Wikidata; Q54852449
CC   Population: Caucasian.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU34 ! GM22237
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22239
AC   CVCL_BU36
DR   Coriell; GM22239
DR   Wikidata; Q54852450
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22239).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with myopathy but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU37 ! GM22240
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22240
AC   CVCL_BU37
DR   Coriell; GM22240
DR   Wikidata; Q54852451
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22240).
CC   Donor information: At sampling donor was not affected with myopathy but at significant risk for disease.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU36 ! GM22239
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22241
AC   CVCL_8A74
DR   Coriell; GM22241
DR   Wikidata; Q54852452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22242
AC   CVCL_5R55
DR   Coriell; GM22242
DR   Wikidata; Q54852453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22243
AC   CVCL_8A75
DR   Coriell; GM22243
DR   Wikidata; Q54852454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22244
AC   CVCL_BU38
DR   Coriell; GM22244
DR   Wikidata; Q54852455
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Asp1067Thrfs*4 (c.3198delA); ClinVar=VCV002417452; Zygosity=Homozygous (Coriell=GM22244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   GM22245
AC   CVCL_BU39
DR   Coriell; GM22245
DR   Wikidata; Q54852456
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU40 ! GM22246
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22246
AC   CVCL_BU40
DR   Coriell; GM22246
DR   Wikidata; Q54852457
CC   Population: Caucasian.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU39 ! GM22245
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22247
AC   CVCL_BU41
DR   Coriell; GM22247
DR   Wikidata; Q54852458
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU42 ! GM22248
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22248
AC   CVCL_BU42
DR   Coriell; GM22248
DR   Wikidata; Q54852463
CC   Population: Caucasian.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU41 ! GM22247
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22249
AC   CVCL_5R56
DR   Coriell; GM22249
DR   Wikidata; Q54852464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22250
AC   CVCL_1P46
DR   Coriell; GM22250
DR   Wikidata; Q54852465
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P47 ! GM22251
OI   CVCL_1P48 ! GM22252
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22251
AC   CVCL_1P47
DR   Coriell; GM22251
DR   Wikidata; Q54852466
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P46 ! GM22250
OI   CVCL_1P48 ! GM22252
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22252
AC   CVCL_1P48
DR   Coriell; GM22252
DR   Wikidata; Q54852467
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P46 ! GM22250
OI   CVCL_1P47 ! GM22251
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22253
AC   CVCL_1P49
DR   Coriell; GM22253
DR   Wikidata; Q54852468
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22253).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P50 ! GM22254
OI   CVCL_1P51 ! GM22255
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22254
AC   CVCL_1P50
DR   Coriell; GM22254
DR   Wikidata; Q54852469
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22254).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P49 ! GM22253
OI   CVCL_1P51 ! GM22255
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22255
AC   CVCL_1P51
DR   Coriell; GM22255
DR   Wikidata; Q54852470
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22255).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P49 ! GM22253
OI   CVCL_1P50 ! GM22254
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22256
AC   CVCL_DB16
DR   Coriell; GM22256
DR   Wikidata; Q54852471
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (Coriell=GM22256).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM22256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM22227 (Cellosaurus=CVCL_DB13) and GM22871 (Cellosaurus=CVCL_DB17).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB18 ! GM22871
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM22258
AC   CVCL_1P52
DR   Coriell; GM22258
DR   Wikidata; Q54852472
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 31 PDL (Coriell=GM22258).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P53 ! GM22259
OI   CVCL_1P54 ! GM22260
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22259
AC   CVCL_1P53
DR   Coriell; GM22259
DR   Wikidata; Q54852473
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 27 PDL (Coriell=GM22259).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P52 ! GM22258
OI   CVCL_1P54 ! GM22260
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22260
AC   CVCL_1P54
DR   Coriell; GM22260
DR   Wikidata; Q54852474
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 28 PDL (Coriell=GM22260).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P52 ! GM22258
OI   CVCL_1P53 ! GM22259
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22261
AC   CVCL_1P55
DR   Coriell; GM22261
DR   Wikidata; Q54852475
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 25 PDL (Coriell=GM22261).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P56 ! GM22262
OI   CVCL_1P57 ! GM22263
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22262
AC   CVCL_1P56
DR   Coriell; GM22262
DR   Wikidata; Q54852476
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22262).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P55 ! GM22261
OI   CVCL_1P57 ! GM22263
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22263
AC   CVCL_1P57
DR   Coriell; GM22263
DR   Wikidata; Q54852477
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Latino or Hispanic.
CC   Senescence: Senesces at 29 PDL (Coriell=GM22263).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P55 ! GM22261
OI   CVCL_1P56 ! GM22262
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22264
AC   CVCL_8A76
DR   Coriell; GM22264
DR   Wikidata; Q54852478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22265
AC   CVCL_BU43
DR   Coriell; GM22265
DR   Wikidata; Q54852479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34639; Angle closure glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM22266
AC   CVCL_1P58
DR   Coriell; GM22266
DR   Wikidata; Q54852480
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 27 PDL (Coriell=GM22266).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P59 ! GM22267
OI   CVCL_1P60 ! GM22268
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22267
AC   CVCL_1P59
DR   Coriell; GM22267
DR   Wikidata; Q54852481
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 46 PDL (Coriell=GM22267).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P58 ! GM22266
OI   CVCL_1P60 ! GM22268
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22268
AC   CVCL_1P60
SY   F3
DR   BioSample; SAMN04469529
DR   Coriell; GM22268
DR   Wikidata; Q54852482
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 27 PDL (Coriell=GM22268).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P58 ! GM22266
OI   CVCL_1P59 ! GM22267
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22269
AC   CVCL_5R57
DR   Coriell; GM22269
DR   Wikidata; Q54852483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22270
AC   CVCL_BU44
DR   Coriell; GM22270
DR   Wikidata; Q54852484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22272
AC   CVCL_BU45
DR   Coriell; GM22272
DR   Wikidata; Q54852485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22275
AC   CVCL_1P61
DR   Coriell; GM22275
DR   Wikidata; Q54852486
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (Coriell=GM22275).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P62 ! GM22276
OI   CVCL_1P63 ! GM22277
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22276
AC   CVCL_1P62
DR   Coriell; GM22276
DR   Wikidata; Q54852487
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 44 PDL (Coriell=GM22276).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P61 ! GM22275
OI   CVCL_1P63 ! GM22277
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22277
AC   CVCL_1P63
DR   Coriell; GM22277
DR   Wikidata; Q54852488
RX   PubMed=22374857;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: Caucasian.
CC   Senescence: Senesces at 28 PDL (Coriell=GM22277).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P61 ! GM22275
OI   CVCL_1P62 ! GM22276
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22279
AC   CVCL_BA11
DR   Coriell; GM22279
DR   Wikidata; Q54852489
CC   Population: Caucasian.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA10 ! GM21865
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   GM22281
AC   CVCL_5R58
DR   Coriell; GM22281
DR   Wikidata; Q54852490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22285
AC   CVCL_5R59
DR   Coriell; GM22285
DR   Wikidata; Q54852491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22295
AC   CVCL_5R60
DR   Coriell; GM22295
DR   Wikidata; Q54852492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22296
AC   CVCL_8A77
DR   Coriell; GM22296
DR   Wikidata; Q54852493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22299
AC   CVCL_1U41
SY   NLGIP-1106; NLGIP1106
DR   Coriell; GM22299
DR   Wikidata; Q54852494
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22300
AC   CVCL_1U42
SY   NLGIP-1113; NLGIP1113
DR   Coriell; GM22300
DR   Wikidata; Q54852495
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22301
AC   CVCL_1U43
SY   NLGIP-1119; NLGIP1119
DR   Coriell; GM22301
DR   Wikidata; Q54852496
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22302
AC   CVCL_1U44
SY   NLGIP-1131; NLGIP1131
DR   Coriell; GM22302
DR   Wikidata; Q54852498
RX   CelloPub=CLPUB00389;
RX   PubMed=24129413;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22303
AC   CVCL_1U45
SY   NLGIP-1267; NLGIP1267
DR   Coriell; GM22303
DR   Wikidata; Q54852499
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22304
AC   CVCL_1U46
SY   NLGIP-1115; NLGIP1115
DR   Coriell; GM22304
DR   Wikidata; Q54852500
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22305
AC   CVCL_1U47
SY   NLGIP-1121; NLGIP1121
DR   Coriell; GM22305
DR   Wikidata; Q54852501
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22306
AC   CVCL_1U48
SY   NLGIP-1123; NLGIP1123
DR   Coriell; GM22306
DR   Wikidata; Q54852502
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22307
AC   CVCL_1U49
SY   NLGIP-1129; NLGIP1129
DR   Coriell; GM22307
DR   Wikidata; Q54852503
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22308
AC   CVCL_1U50
SY   NLGIP-1133; NLGIP1133
DR   Coriell; GM22308
DR   Wikidata; Q54852512
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22309
AC   CVCL_1U51
SY   NLGIP-1166; NLGIP1166
DR   Coriell; GM22309
DR   Wikidata; Q54852513
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22310
AC   CVCL_1U52
SY   NLGIP-1372; NLGIP1372
DR   Coriell; GM22310
DR   Wikidata; Q54852514
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22311
AC   CVCL_1U53
SY   NLGIP-1378; NLGIP1378
DR   Coriell; GM22311
DR   Wikidata; Q54852515
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22312
AC   CVCL_1U54
SY   NLGIP-1379; NLGIP1379
DR   Coriell; GM22312
DR   Wikidata; Q54852516
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22313
AC   CVCL_1U55
SY   NLGIP-1436; NLGIP1436
DR   Coriell; GM22313
DR   Wikidata; Q54852517
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22314
AC   CVCL_1U56
SY   NLGIP-1107; NLGIP1107
DR   Coriell; GM22314
DR   Wikidata; Q54852518
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22315
AC   CVCL_1U57
SY   NLGIP-1114; NLGIP1114
DR   Coriell; GM22315
DR   Wikidata; Q54852519
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22316
AC   CVCL_1U58
SY   NLGIP-1136; NLGIP1136
DR   Coriell; GM22316
DR   Wikidata; Q54852520
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22317
AC   CVCL_1U59
SY   NLGIP-1380; NLGIP1380
DR   Coriell; GM22317
DR   Wikidata; Q54852521
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22318
AC   CVCL_1U60
SY   NLGIP-1403; NLGIP1403
DR   Coriell; GM22318
DR   Wikidata; Q54852522
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22319
AC   CVCL_1U61
SY   NLGIP-1143; NLGIP1143
DR   Coriell; GM22319
DR   Wikidata; Q54852523
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22320
AC   CVCL_1U62
SY   NLGIP-1159; NLGIP1159
DR   Coriell; GM22320
DR   Wikidata; Q54852524
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22321
AC   CVCL_1U63
SY   NLGIP-1173; NLGIP1173
DR   Coriell; GM22321
DR   Wikidata; Q54852525
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22322
AC   CVCL_1U64
SY   NLGIP-1383; NLGIP1383
DR   Coriell; GM22322
DR   Wikidata; Q54852526
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22323
AC   CVCL_1U65
SY   NLGIP-1404; NLGIP1404
DR   Coriell; GM22323
DR   Wikidata; Q54852527
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22324
AC   CVCL_1U66
SY   NLGIP-1132; NLGIP1132
DR   Coriell; GM22324
DR   Wikidata; Q54852528
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22325
AC   CVCL_1U67
SY   NLGIP-1161; NLGIP1161
DR   Coriell; GM22325
DR   Wikidata; Q54852529
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22326
AC   CVCL_1U68
SY   NLGIP-1284; NLGIP1284
DR   Coriell; GM22326
DR   Wikidata; Q54852530
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22327
AC   CVCL_1U69
SY   NLGIP-1409; NLGIP1409
DR   Coriell; GM22327
DR   Wikidata; Q54852531
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22328
AC   CVCL_1U70
SY   NLGIP-1419; NLGIP1419
DR   Coriell; GM22328
DR   Wikidata; Q54852532
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22329
AC   CVCL_1U71
SY   NLGIP-1141; NLGIP1141
DR   Coriell; GM22329
DR   Wikidata; Q54852533
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: NLGIP1171; Note=In Cellosaurus releases 13 to 24.
CC   Misspelling: NLGIP-1171; Note=In Cellosaurus releases 22 to 24.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22330
AC   CVCL_1U72
SY   NLGIP-1145; NLGIP1145
DR   Coriell; GM22330
DR   Wikidata; Q54852534
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22332
AC   CVCL_1U73
SY   NLGIP-1384; NLGIP1384
DR   Coriell; GM22332
DR   Wikidata; Q54852535
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22333
AC   CVCL_1U74
SY   NLGIP-1402; NLGIP1402
DR   Coriell; GM22333
DR   Wikidata; Q54852536
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22334
AC   CVCL_1U75
SY   NLGIP-1101; NLGIP1101
DR   Coriell; GM22334
DR   Wikidata; Q54852537
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22335
AC   CVCL_1U76
SY   NLGIP-1111; NLGIP1111
DR   Coriell; GM22335
DR   Wikidata; Q54852538
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22336
AC   CVCL_1U77
SY   NLGIP-1125; NLGIP1125
DR   Coriell; GM22336
DR   Wikidata; Q54852539
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22337
AC   CVCL_1U78
SY   NLGIP-1127; NLGIP1127
DR   Coriell; GM22337
DR   Wikidata; Q54852540
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22338
AC   CVCL_1U79
SY   NLGIP-1165; NLGIP1165
DR   Coriell; GM22338
DR   Wikidata; Q54852541
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   GM22364
AC   CVCL_5R61
SY   801-005 LCL
DR   Coriell; GM22364
DR   Wikidata; Q54852542
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22366
AC   CVCL_BU46
DR   Coriell; GM22366
DR   Wikidata; Q54852543
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Glu248Lys (c.742G>A) (E233K); ClinVar=VCV000418400; Zygosity=Heterozygous (Coriell=GM22366).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Gly477Val (c.1430G>T) (G452V); ClinVar=VCV000550273; Zygosity=Heterozygous (Coriell=GM22366).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22367
AC   CVCL_BU47
DR   Coriell; GM22367
DR   Wikidata; Q54852544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22368
AC   CVCL_BU48
DR   Coriell; GM22368
DR   Wikidata; Q54852545
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22368).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU49 ! GM22369
OI   CVCL_BV25 ! GM23260
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22369
AC   CVCL_BU49
DR   Coriell; GM22369
DR   Wikidata; Q54852546
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22369).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU48 ! GM22368
OI   CVCL_BV25 ! GM23260
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22370
AC   CVCL_BU50
DR   Coriell; GM22370
DR   Wikidata; Q54852547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22371
AC   CVCL_BU51
DR   Coriell; GM22371
DR   Wikidata; Q54852548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22376
AC   CVCL_BU52
DR   Coriell; GM22376
DR   Wikidata; Q54852549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22382
AC   CVCL_BU53
DR   Coriell; GM22382
DR   Wikidata; Q54852550
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Phe128Ser (c.383T>C); ClinVar=VCV000042259; Zygosity=Hemizygous (Coriell=GM22382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   NCIt; C62798; Restrictive cardiomyopathy
DI   ORDO; Orphanet_111; Barth syndrome
DI   ORDO; Orphanet_217632; Restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22389
AC   CVCL_5R62
DR   Coriell; GM22389
DR   Wikidata; Q54852551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22390
AC   CVCL_5R63
DR   Coriell; GM22390
DR   Wikidata; Q54852557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22391
AC   CVCL_5R64
DR   Coriell; GM22391
DR   Wikidata; Q54852558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22392
AC   CVCL_5R65
DR   Coriell; GM22392
DR   Wikidata; Q54852559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22393
AC   CVCL_T893
DR   Coriell; GM22393
DR   Wikidata; Q54852560
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (Coriell=GM22393).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T894 ! GM22394
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   GM22394
AC   CVCL_T894
DR   Coriell; GM22394
DR   Wikidata; Q54852561
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (Coriell=GM22394).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T893 ! GM22393
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   GM22395
AC   CVCL_T895
DR   Coriell; GM22395
DR   Wikidata; Q54852562
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (Coriell=GM22395).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T896 ! GM22396
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   GM22396
AC   CVCL_T896
DR   Coriell; GM22396
DR   Wikidata; Q54852563
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (Coriell=GM22396).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T895 ! GM22395
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   GM22397
AC   CVCL_5R66
DR   Coriell; GM22397
DR   Wikidata; Q54852564
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22421
AC   CVCL_5M60
DR   Coriell; GM22421
DR   Wikidata; Q54852566
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75457; Jacobsen syndrome
DI   ORDO; Orphanet_2308; Jacobsen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM22439
AC   CVCL_5M61
DR   Coriell; GM22439
DR   Wikidata; Q54852567
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75457; Jacobsen syndrome
DI   ORDO; Orphanet_2308; Jacobsen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM22475
AC   CVCL_5M62
DR   Coriell; GM22475
DR   Wikidata; Q54852568
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75457; Jacobsen syndrome
DI   ORDO; Orphanet_2308; Jacobsen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM22478
AC   CVCL_5M63
DR   Coriell; GM22478
DR   Wikidata; Q54852569
RX   PubMed=23665875;
CC   Karyotypic information: 46,XX,del(11)(pter->q24.1) (Coriell=GM22478).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75457; Jacobsen syndrome
DI   ORDO; Orphanet_2308; Jacobsen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM22495
AC   CVCL_8A78
DR   Coriell; GM22495
DR   Wikidata; Q54852570
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22496
AC   CVCL_BU54
DR   Coriell; GM22496
DR   Wikidata; Q54852571
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Gly407Argfs*14 (c.1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA) (c.1218_1231del14ins12); ClinVar=VCV000038875; Zygosity=Homozygous (Coriell=GM22496).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22497
AC   CVCL_BU55
DR   Coriell; GM22497
DR   Wikidata; Q54852572
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Gly407Argfs*14 (c.1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA) (c.1218_1231del14ins12); ClinVar=VCV000038875; Zygosity=Heterozygous (from familial inference of GM22496).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   GM22498
AC   CVCL_BU56
DR   Coriell; GM22498
DR   Wikidata; Q54852573
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Gly407Argfs*14 (c.1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA) (c.1218_1231del14ins12); ClinVar=VCV000038875; Zygosity=Heterozygous (from familial inference of GM22496).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   GM22500
AC   CVCL_5R67
DR   Coriell; GM22500
DR   Wikidata; Q54852574
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22501
AC   CVCL_8A79
DR   Coriell; GM22501
DR   Wikidata; Q54852575
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22502
AC   CVCL_5R68
DR   Coriell; GM22502
DR   Wikidata; Q54852576
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22503
AC   CVCL_BU57
DR   Coriell; GM22503
DR   Wikidata; Q54852577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22509
AC   CVCL_BU58
DR   Coriell; GM22509
DR   Wikidata; Q54852578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22510
AC   CVCL_BU59
DR   Coriell; GM22510
DR   Wikidata; Q54852579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22511
AC   CVCL_5R69
DR   Coriell; GM22511
DR   Wikidata; Q54852580
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22513
AC   CVCL_5R70
DR   Coriell; GM22513
DR   Wikidata; Q54852581
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22516
AC   CVCL_5R71
DR   Coriell; GM22516
DR   Wikidata; Q54852582
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22517
AC   CVCL_5R72
DR   Coriell; GM22517
DR   Wikidata; Q54852583
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22519
AC   CVCL_GZ51
DR   Coriell; GM22519
DR   Wikidata; Q54852584
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129305; Cranioectodermal dysplasia
DI   ORDO; Orphanet_1515; Cranioectodermal dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM22520
AC   CVCL_CX71
DR   Coriell; GM22520
DR   Wikidata; Q54852585
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM22521
AC   CVCL_8A80
DR   Coriell; GM22521
DR   Wikidata; Q54852586
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22522
AC   CVCL_8A81
DR   Coriell; GM22522
DR   Wikidata; Q54852587
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22523
AC   CVCL_5R73
DR   Coriell; GM22523
DR   Wikidata; Q54852588
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22524
AC   CVCL_5R74
DR   Coriell; GM22524
DR   Wikidata; Q54852589
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22525
AC   CVCL_8A82
DR   Coriell; GM22525
DR   Wikidata; Q54852590
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22526
AC   CVCL_5R75
DR   Coriell; GM22526
DR   Wikidata; Q54852591
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22527
AC   CVCL_5R76
DR   Coriell; GM22527
DR   Wikidata; Q54852592
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22528
AC   CVCL_5R77
DR   Coriell; GM22528
DR   Wikidata; Q54852593
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22542
AC   CVCL_8A83
DR   Coriell; GM22542
DR   Wikidata; Q54852594
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22543
AC   CVCL_5R78
DR   Coriell; GM22543
DR   Wikidata; Q54852595
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22544
AC   CVCL_5R79
DR   Coriell; GM22544
DR   Wikidata; Q54852596
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22549
AC   CVCL_BU60
DR   Coriell; GM22549
DR   Wikidata; Q54852597
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Coriell=GM22549).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with myopathy but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU61 ! GM22550
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22550
AC   CVCL_BU61
DR   Coriell; GM22550
DR   Wikidata; Q54852612
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Coriell=GM22550).
CC   Donor information: At sampling donor was not affected with myopathy but at significant risk for disease.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU60 ! GM22549
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22551
AC   CVCL_BU62
DR   Coriell; GM22551
DR   Wikidata; Q54852613
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Coriell=GM22551).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22553
AC   CVCL_BU63
DR   Coriell; GM22553
DR   Wikidata; Q54852614
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Coriell=GM22553).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU64 ! GM22554
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22554
AC   CVCL_BU64
DR   Coriell; GM22554
DR   Wikidata; Q54852615
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (Coriell=GM22554).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU63 ! GM22553
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22555
AC   CVCL_BU65
DR   Coriell; GM22555
DR   Wikidata; Q54852616
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; c.1209+2delT; Zygosity=Heterozygous (Coriell=GM22555).
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Asn536Asp (c.1606A>G); ClinVar=VCV000038881; Zygosity=Heterozygous (Coriell=GM22555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22556
AC   CVCL_BU66
DR   Coriell; GM22556
DR   Wikidata; Q54852617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22557
AC   CVCL_BU67
DR   Coriell; GM22557
DR   Wikidata; Q54852618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22558
AC   CVCL_5R80
DR   Coriell; GM22558
DR   Wikidata; Q54852619
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22559
AC   CVCL_5R81
DR   Coriell; GM22559
DR   Wikidata; Q54852620
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22562
AC   CVCL_BU68
DR   Coriell; GM22562
DR   Wikidata; Q54852621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU69 ! GM22563
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22563
AC   CVCL_BU69
DR   Coriell; GM22563
DR   Wikidata; Q54852622
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU68 ! GM22562
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22564
AC   CVCL_BU70
DR   Coriell; GM22564
DR   Wikidata; Q54852623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU71 ! GM22565
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22565
AC   CVCL_BU71
DR   Coriell; GM22565
DR   Wikidata; Q54852624
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU70 ! GM22564
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM22566
AC   CVCL_CX72
DR   Coriell; GM22566
DR   Wikidata; Q54852625
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM22566).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX75 ! GM23151
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM22567
AC   CVCL_CX73
DR   Coriell; GM22567
DR   Wikidata; Q54852626
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (Coriell=GM22567).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX76 ! GM23152
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM22568
AC   CVCL_CX74
DR   Coriell; GM22568
DR   Wikidata; Q54852627
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM22568).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX82 ! GM23945
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM22569
AC   CVCL_5R82
DR   Coriell; GM22569
DR   Wikidata; Q54852629
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22570
AC   CVCL_5R83
DR   Coriell; GM22570
DR   Wikidata; Q54852630
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22571
AC   CVCL_5R84
SY   801-007 LCL
DR   Coriell; GM22571
DR   Wikidata; Q54852631
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22574
AC   CVCL_BU72
DR   Coriell; GM22574
DR   Wikidata; Q54852632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22575
AC   CVCL_1P64
DR   Coriell; GM22575
DR   Wikidata; Q54852633
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 30 PDL (Coriell=GM22575).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P65 ! GM22577
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22577
AC   CVCL_1P65
DR   Coriell; GM22577
DR   Wikidata; Q54852634
CC   Part of: NIGMS collection of multiple cell lines from the same individual; cell lines from neonatal foreskins.
CC   Population: African American.
CC   Senescence: Senesces at 27 PDL (Coriell=GM22577).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P64 ! GM22575
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22578
AC   CVCL_BU73
DR   Coriell; GM22578
DR   Wikidata; Q54852635
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22578).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22580
AC   CVCL_BU74
DR   Coriell; GM22580
DR   Wikidata; Q54852636
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22581
AC   CVCL_BU75
DR   Coriell; GM22581
DR   Wikidata; Q54852637
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.His140fs (c.418delC); Zygosity=Heterozygous (Coriell=GM22581).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Leu532del (c.1593_1595delATT); ClinVar=VCV000554477; Zygosity=Heterozygous (Coriell=GM22581).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22582
AC   CVCL_BU76
DR   Coriell; GM22582
DR   Wikidata; Q54852638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22587
AC   CVCL_8A84
DR   Coriell; GM22587
DR   Wikidata; Q54852639
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22588
AC   CVCL_5R85
DR   Coriell; GM22588
DR   Wikidata; Q54852640
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22592
AC   CVCL_BU77
DR   Coriell; GM22592
DR   Wikidata; Q54852641
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (Coriell=GM22592).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (Coriell=GM22592).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 8,10
ST   D13S317: 8,14
ST   D16S539: 12,13
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22593
AC   CVCL_5R86
SY   801-009 LCL
DR   Coriell; GM22593
DR   Wikidata; Q54852642
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22594
AC   CVCL_5R87
DR   Coriell; GM22594
DR   Wikidata; Q54852643
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22595
AC   CVCL_GS96
DR   Coriell; GM22595
DR   Wikidata; Q54852644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129025; Exfoliation syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM22596
AC   CVCL_5R88
DR   Coriell; GM22596
DR   Wikidata; Q54852645
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22597
AC   CVCL_5R89
DR   Coriell; GM22597
DR   Wikidata; Q54852646
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22598
AC   CVCL_5R90
DR   Coriell; GM22598
DR   Wikidata; Q54852647
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22599
AC   CVCL_BU78
DR   Coriell; GM22599
DR   Wikidata; Q54852648
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22599).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU79 ! GM22600
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22600
AC   CVCL_BU79
DR   Coriell; GM22600
DR   Wikidata; Q54852649
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM22600).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU78 ! GM22599
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22601
AC   CVCL_V824
DR   Coriell; GM22601
DR   Wikidata; Q54852650
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35528; Wolf-Hirschhorn syndrome
DI   ORDO; Orphanet_280; Wolf-Hirschhorn syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM22602
AC   CVCL_5R91
DR   Coriell; GM22602
DR   Wikidata; Q54852651
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22603
AC   CVCL_8A86
DR   Coriell; GM22603
DR   Wikidata; Q54852652
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22604
AC   CVCL_EG52
DR   Coriell; GM22604
DR   Wikidata; Q54852657
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C87069; Cleft palate
DI   ORDO; Orphanet_2014; Cleft palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM22605
AC   CVCL_5R92
DR   Coriell; GM22605
DR   Wikidata; Q54852658
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22606
AC   CVCL_BU80
DR   Coriell; GM22606
DR   Wikidata; Q54852659
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Ile256Tyrfs*7 (c.766delA); ClinVar=VCV000101146; Zygosity=Unspecified (Coriell=GM22606).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU81 ! GM22607
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22607
AC   CVCL_BU81
DR   Coriell; GM22607
DR   Wikidata; Q54852660
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Ile256Tyrfs*7 (c.766delA); ClinVar=VCV000101146; Zygosity=Unspecified (Coriell=GM22607).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU80 ! GM22606
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22608
AC   CVCL_BU82
DR   Coriell; GM22608
DR   Wikidata; Q54852661
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Ile256Tyrfs*7 (c.766delA); ClinVar=VCV000101146; Zygosity=Unspecified (Coriell=GM22608).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU83 ! GM22609
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22609
AC   CVCL_BU83
DR   Coriell; GM22609
DR   Wikidata; Q54852662
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Ile256Tyrfs*7 (c.766delA); ClinVar=VCV000101146; Zygosity=Unspecified (Coriell=GM22609).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU82 ! GM22608
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22622
AC   CVCL_N354
DR   Coriell; GM22622
DR   Wikidata; Q54852663
RX   PubMed=23665875;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N192 ! GM11970
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   GM22623
AC   CVCL_1K36
DR   Coriell; GM22623
DR   Wikidata; Q54852664
RX   PubMed=23665875;
CC   Karyotypic information: 46,XX,ins(13;11)(q14.1;p11.2p12).ish ins(13;11)(q14.1;p11.2p12)(wcp11+).arr(1-22,X)x2 (Coriell=GM22623).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22624
AC   CVCL_1K37
DR   Coriell; GM22624
DR   Wikidata; Q54852665
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22625
AC   CVCL_1K38
DR   Coriell; GM22625
DR   Wikidata; Q54852666
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22626
AC   CVCL_1K39
DR   Coriell; GM22626
DR   Wikidata; Q54852667
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22627
AC   CVCL_1K40
DR   Coriell; GM22627
DR   Wikidata; Q54852668
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22628
AC   CVCL_1K41
DR   Coriell; GM22628
DR   Wikidata; Q54852669
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22629
AC   CVCL_1K42
DR   Coriell; GM22629
DR   Wikidata; Q54852670
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22630
AC   CVCL_1K43
DR   Coriell; GM22630
DR   Wikidata; Q54852671
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22631
AC   CVCL_1K44
DR   Coriell; GM22631
DR   Wikidata; Q54852672
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22632
AC   CVCL_1K45
DR   Coriell; GM22632
DR   Wikidata; Q54852674
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22633
AC   CVCL_1P95
DR   Coriell; GM22633
DR   Wikidata; Q54852675
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75456; Potocki-Shaffer syndrome
DI   ORDO; Orphanet_52022; Potocki-Shaffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22634
AC   CVCL_5R93
DR   Coriell; GM22634
DR   Wikidata; Q54852677
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22635
AC   CVCL_8A87
DR   Coriell; GM22635
DR   Wikidata; Q54852678
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22637
AC   CVCL_5R94
DR   Coriell; GM22637
DR   Wikidata; Q54852679
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22639
AC   CVCL_5R95
DR   Coriell; GM22639
DR   Wikidata; Q54852680
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22641
AC   CVCL_1P66
DR   Coriell; GM22641
DR   Wikidata; Q54852682
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P67 ! GM22642
OI   CVCL_1P68 ! GM22643
OI   CVCL_1P69 ! GM22644
OI   CVCL_1P70 ! GM22645
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22642
AC   CVCL_1P67
DR   Coriell; GM22642
DR   Wikidata; Q54852684
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P66 ! GM22641
OI   CVCL_1P68 ! GM22643
OI   CVCL_1P69 ! GM22644
OI   CVCL_1P70 ! GM22645
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22643
AC   CVCL_1P68
DR   Coriell; GM22643
DR   Wikidata; Q54852685
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P66 ! GM22641
OI   CVCL_1P67 ! GM22642
OI   CVCL_1P69 ! GM22644
OI   CVCL_1P70 ! GM22645
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22644
AC   CVCL_1P69
DR   Coriell; GM22644
DR   Wikidata; Q54852686
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P66 ! GM22641
OI   CVCL_1P67 ! GM22642
OI   CVCL_1P68 ! GM22643
OI   CVCL_1P70 ! GM22645
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22645
AC   CVCL_1P70
DR   Coriell; GM22645
DR   Wikidata; Q54852687
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P66 ! GM22641
OI   CVCL_1P67 ! GM22642
OI   CVCL_1P68 ! GM22643
OI   CVCL_1P69 ! GM22644
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22647
AC   CVCL_1P71
DR   Coriell; GM22647
DR   Wikidata; Q54852688
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P72 ! GM22648
OI   CVCL_1P73 ! GM22649
OI   CVCL_1P74 ! GM22650
OI   CVCL_1P75 ! GM22651
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22648
AC   CVCL_1P72
DR   Coriell; GM22648
DR   Wikidata; Q54852689
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P71 ! GM22647
OI   CVCL_1P73 ! GM22649
OI   CVCL_1P74 ! GM22650
OI   CVCL_1P75 ! GM22651
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22649
AC   CVCL_1P73
DR   Coriell; GM22649
DR   Wikidata; Q54852690
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P71 ! GM22647
OI   CVCL_1P72 ! GM22648
OI   CVCL_1P74 ! GM22650
OI   CVCL_1P75 ! GM22651
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22650
AC   CVCL_1P74
DR   Coriell; GM22650
DR   Wikidata; Q54852691
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P71 ! GM22647
OI   CVCL_1P72 ! GM22648
OI   CVCL_1P73 ! GM22649
OI   CVCL_1P75 ! GM22651
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22651
AC   CVCL_1P75
DR   Coriell; GM22651
DR   Wikidata; Q54852693
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P71 ! GM22647
OI   CVCL_1P72 ! GM22648
OI   CVCL_1P73 ! GM22649
OI   CVCL_1P74 ! GM22650
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22652
AC   CVCL_8A88
DR   Coriell; GM22652
DR   Wikidata; Q54852694
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22653
AC   CVCL_8A89
DR   Coriell; GM22653
DR   Wikidata; Q54852695
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22654
AC   CVCL_5R96
DR   Coriell; GM22654
DR   Wikidata; Q54852696
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22655
AC   CVCL_5R97
DR   Coriell; GM22655
DR   Wikidata; Q54852697
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22656
AC   CVCL_5R98
DR   Coriell; GM22656
DR   Wikidata; Q54852698
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22657
AC   CVCL_8A90
DR   Coriell; GM22657
DR   Wikidata; Q54852699
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22658
AC   CVCL_5R99
DR   Coriell; GM22658
DR   Wikidata; Q54852700
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22659
AC   CVCL_DN52
DR   Coriell; GM22659
DR   Wikidata; Q54852701
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2186; COL11A1; Simple; c.3816+1G>A (IVS50+1G>A); ClinVar=VCV000039776; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM22659).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128115; Marshall syndrome
DI   ORDO; Orphanet_560; Marshall syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM22660
AC   CVCL_1N07
DR   Coriell; GM22660
DR   Wikidata; Q54852710
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (Coriell=GM22660).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with myopathy but at significant risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N08 ! GM22661
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   GM22661
AC   CVCL_1N08
DR   Coriell; GM22661
DR   Wikidata; Q54852711
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (Coriell=GM22661).
CC   Donor information: At sampling donor was not affected with myopathy but at significant risk for disease.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N07 ! GM22660
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   GM22663
AC   CVCL_5S00
DR   Coriell; GM22663
DR   Wikidata; Q54852712
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22664
AC   CVCL_5S01
DR   Coriell; GM22664
DR   Wikidata; Q54852713
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22665
AC   CVCL_8A91
DR   Coriell; GM22665
DR   Wikidata; Q54852714
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22666
AC   CVCL_5S02
DR   Coriell; GM22666
DR   Wikidata; Q54852715
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22667
AC   CVCL_5S03
DR   Coriell; GM22667
DR   Wikidata; Q54852716
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22668
AC   CVCL_5S04
DR   Coriell; GM22668
DR   Wikidata; Q54852717
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22669
AC   CVCL_5S05
DR   Coriell; GM22669
DR   Wikidata; Q54852718
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22671
AC   CVCL_1P76
DR   Coriell; GM22671
DR   Wikidata; Q54852719
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P77 ! GM22672
OI   CVCL_1P78 ! GM22673
OI   CVCL_1P79 ! GM22674
OI   CVCL_1P80 ! GM22675
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22672
AC   CVCL_1P77
DR   Coriell; GM22672
DR   Wikidata; Q54852721
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P76 ! GM22671
OI   CVCL_1P78 ! GM22673
OI   CVCL_1P79 ! GM22674
OI   CVCL_1P80 ! GM22675
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22673
AC   CVCL_1P78
DR   Coriell; GM22673
DR   Wikidata; Q54852722
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P76 ! GM22671
OI   CVCL_1P77 ! GM22672
OI   CVCL_1P79 ! GM22674
OI   CVCL_1P80 ! GM22675
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22674
AC   CVCL_1P79
DR   Coriell; GM22674
DR   Wikidata; Q54852723
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P76 ! GM22671
OI   CVCL_1P77 ! GM22672
OI   CVCL_1P78 ! GM22673
OI   CVCL_1P80 ! GM22675
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22675
AC   CVCL_1P80
DR   Coriell; GM22675
DR   Wikidata; Q54852724
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P76 ! GM22671
OI   CVCL_1P77 ! GM22672
OI   CVCL_1P78 ! GM22673
OI   CVCL_1P79 ! GM22674
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22677
AC   CVCL_1P81
DR   Coriell; GM22677
DR   Wikidata; Q54852725
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX.arr(1-22,X)x2 (Coriell=GM22677).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P82 ! GM22678
OI   CVCL_1P83 ! GM22679
OI   CVCL_1P84 ! GM22680
OI   CVCL_1P85 ! GM22681
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22678
AC   CVCL_1P82
DR   Coriell; GM22678
DR   Wikidata; Q54852726
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P81 ! GM22677
OI   CVCL_1P83 ! GM22679
OI   CVCL_1P84 ! GM22680
OI   CVCL_1P85 ! GM22681
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22679
AC   CVCL_1P83
DR   Coriell; GM22679
DR   Wikidata; Q54852727
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P81 ! GM22677
OI   CVCL_1P82 ! GM22678
OI   CVCL_1P84 ! GM22680
OI   CVCL_1P85 ! GM22681
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22680
AC   CVCL_1P84
DR   Coriell; GM22680
DR   Wikidata; Q54852728
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P81 ! GM22677
OI   CVCL_1P82 ! GM22678
OI   CVCL_1P83 ! GM22679
OI   CVCL_1P85 ! GM22681
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22681
AC   CVCL_1P85
DR   Coriell; GM22681
DR   Wikidata; Q54852729
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P81 ! GM22677
OI   CVCL_1P82 ! GM22678
OI   CVCL_1P83 ! GM22679
OI   CVCL_1P84 ! GM22680
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM22682
AC   CVCL_5S06
DR   Coriell; GM22682
DR   Wikidata; Q54852730
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22683
AC   CVCL_8A92
DR   Coriell; GM22683
DR   Wikidata; Q54852731
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22684
AC   CVCL_5S07
DR   Coriell; GM22684
DR   Wikidata; Q54852732
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22688
AC   CVCL_8A93
DR   Coriell; GM22688
DR   Wikidata; Q54852733
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22690
AC   CVCL_HL18
SY   F-2111
DR   Coriell; GM22690
DR   Wikidata; Q54852734
RX   PubMed=17632790;
CC   Population: Caucasian; Circassian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr1885Profs*32 (c.5653delA); ClinVar=VCV003721088; Zygosity=Homozygous (PubMed=17632790).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL20 ! GM22692
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 12
//
ID   GM22691
AC   CVCL_HL19
SY   F-2112
DR   Coriell; GM22691
DR   Wikidata; Q54852735
RX   PubMed=17632790;
CC   Population: Caucasian; Circassian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr1885Profs*32 (c.5653delA); ClinVar=VCV003721088; Zygosity=Homozygous (PubMed=17632790).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL21 ! GM22693
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 12
//
ID   GM22692
AC   CVCL_HL20
SY   YS4
DR   Coriell; GM22692
DR   Wikidata; Q54852736
RX   PubMed=17632790;
CC   Population: Caucasian; Circassian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr1885Profs*32 (c.5653delA); ClinVar=VCV003721088; Zygosity=Homozygous (PubMed=17632790).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL18 ! GM22690
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 10
//
ID   GM22693
AC   CVCL_HL21
SY   YS3
DR   Coriell; GM22693
DR   Wikidata; Q54852737
RX   PubMed=17632790;
CC   Population: Caucasian; Circassian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr1885Profs*32 (c.5653delA); ClinVar=VCV003721088; Zygosity=Homozygous (PubMed=17632790).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HL19 ! GM22691
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 10
//
ID   GM22699
AC   CVCL_8A94
DR   Coriell; GM22699
DR   Wikidata; Q54852738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22700
AC   CVCL_8A95
DR   Coriell; GM22700
DR   Wikidata; Q54852739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22703
AC   CVCL_BU84
DR   Coriell; GM22703
DR   Wikidata; Q54852740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22704
AC   CVCL_BU85
DR   Coriell; GM22704
DR   Wikidata; Q54852741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22705
AC   CVCL_BU86
DR   Coriell; GM22705
DR   Wikidata; Q54852742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22708
AC   CVCL_8A96
DR   Coriell; GM22708
DR   Wikidata; Q54852743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22709
AC   CVCL_5S08
DR   Coriell; GM22709
DR   Wikidata; Q54852745
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22710
AC   CVCL_5S09
DR   Coriell; GM22710
DR   Wikidata; Q54852746
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22711
AC   CVCL_5S10
DR   Coriell; GM22711
DR   Wikidata; Q54852747
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22712
AC   CVCL_5S11
DR   Coriell; GM22712
DR   Wikidata; Q54852748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22713
AC   CVCL_BU87
DR   Coriell; GM22713
DR   Wikidata; Q54852749
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg168Ter (c.502C>T) (p.Arg180Ter, c.538C>T); ClinVar=VCV000011828; Zygosity=Heterozygous (Coriell=GM22713).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM22714
AC   CVCL_BU88
DR   Coriell; GM22714
DR   Wikidata; Q54852750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22715
AC   CVCL_BU89
DR   Coriell; GM22715
DR   Wikidata; Q54852751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22731
AC   CVCL_1P86
DR   Coriell; GM22731
DR   Wikidata; Q54852762
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P87 ! GM22732
OI   CVCL_1P88 ! GM22733
OI   CVCL_1P89 ! GM22734
OI   CVCL_1P90 ! GM22735
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22732
AC   CVCL_1P87
DR   Coriell; GM22732
DR   Wikidata; Q54852763
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P86 ! GM22731
OI   CVCL_1P88 ! GM22733
OI   CVCL_1P89 ! GM22734
OI   CVCL_1P90 ! GM22735
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22733
AC   CVCL_1P88
DR   Coriell; GM22733
DR   Wikidata; Q54852764
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P86 ! GM22731
OI   CVCL_1P87 ! GM22732
OI   CVCL_1P89 ! GM22734
OI   CVCL_1P90 ! GM22735
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22734
AC   CVCL_1P89
DR   Coriell; GM22734
DR   Wikidata; Q54852765
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P86 ! GM22731
OI   CVCL_1P87 ! GM22732
OI   CVCL_1P88 ! GM22733
OI   CVCL_1P90 ! GM22735
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22735
AC   CVCL_1P90
DR   Coriell; GM22735
DR   Wikidata; Q54852766
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P86 ! GM22731
OI   CVCL_1P87 ! GM22732
OI   CVCL_1P88 ! GM22733
OI   CVCL_1P89 ! GM22734
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22737
AC   CVCL_1P91
DR   Coriell; GM22737
DR   Wikidata; Q54852767
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P92 ! GM22738
OI   CVCL_1P93 ! GM22739
OI   CVCL_1P94 ! GM22741
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22738
AC   CVCL_1P92
DR   Coriell; GM22738
DR   Wikidata; Q54852768
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P91 ! GM22737
OI   CVCL_1P93 ! GM22739
OI   CVCL_1P94 ! GM22741
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22739
AC   CVCL_1P93
DR   Coriell; GM22739
DR   Wikidata; Q54852769
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P91 ! GM22737
OI   CVCL_1P92 ! GM22738
OI   CVCL_1P94 ! GM22741
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22741
AC   CVCL_1P94
DR   Coriell; GM22741
DR   Wikidata; Q54852770
RX   PubMed=22374857;
RX   PubMed=30075799;
CC   Part of: NIGMS collection of multiple cell lines from the same individual; EBV-transformed lymphoblasts.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1P91 ! GM22737
OI   CVCL_1P92 ! GM22738
OI   CVCL_1P93 ! GM22739
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM22744
AC   CVCL_BU90
DR   Coriell; GM22744
DR   Wikidata; Q54852771
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22745
AC   CVCL_HL22
DR   Coriell; GM22745
DR   Wikidata; Q54852772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM22746
AC   CVCL_BU91
DR   Coriell; GM22746
DR   Wikidata; Q54852773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22749
AC   CVCL_HL34
DR   Coriell; GM22749
DR   Wikidata; Q54852774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 7
//
ID   GM22750
AC   CVCL_BU92
DR   Coriell; GM22750
DR   Wikidata; Q54852775
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly177_Pro194del (c.582+5G>A) (IVS8+5G>A); ClinVar=VCV000101425; Zygosity=Unspecified (Coriell=GM22750).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU93 ! GM22751
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22751
AC   CVCL_BU93
DR   Coriell; GM22751
DR   Wikidata; Q54852776
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly177_Pro194del (c.582+5G>A) (IVS8+5G>A); ClinVar=VCV000101425; Zygosity=Unspecified (Coriell=GM22751).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU92 ! GM22750
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22752
AC   CVCL_BU94
DR   Coriell; GM22752
DR   Wikidata; Q54852777
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly177_Pro194del (c.582+5G>A) (IVS8+5G>A); ClinVar=VCV000101425; Zygosity=Unspecified (Coriell=GM22752).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU95 ! GM22753
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22753
AC   CVCL_BU95
DR   Coriell; GM22753
DR   Wikidata; Q54852778
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly177_Pro194del (c.582+5G>A) (IVS8+5G>A); ClinVar=VCV000101425; Zygosity=Unspecified (Coriell=GM22753).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU94 ! GM22752
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22756
AC   CVCL_1N09
DR   Coriell; GM22756
DR   Wikidata; Q54852779
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N10 ! GM22757
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM22757
AC   CVCL_1N10
DR   Coriell; GM22757
DR   Wikidata; Q54852780
CC   Population: Caucasian.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N09 ! GM22756
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   GM22762
AC   CVCL_BU96
DR   Coriell; GM22762
DR   Wikidata; Q54852781
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg159Cys (c.475C>T) (c.864C>T); ClinVar=VCV000280123; Zygosity=Heterozygous (Coriell=GM22762).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22763
AC   CVCL_BU97
DR   Coriell; GM22763
DR   Wikidata; Q54852782
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg159Cys (c.475C>T) (c.864C>T); ClinVar=VCV000280123; Zygosity=Heterozygous (Coriell=GM22763).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU98 ! GM22764
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22764
AC   CVCL_BU98
DR   Coriell; GM22764
DR   Wikidata; Q54852783
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg159Cys (c.475C>T) (c.864C>T); ClinVar=VCV000280123; Zygosity=Heterozygous (Coriell=GM22764).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU97 ! GM22763
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM22765
AC   CVCL_5S12
DR   Coriell; GM22765
DR   Wikidata; Q54852784
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22766
AC   CVCL_5K24
DR   Coriell; GM22766
DR   Wikidata; Q54852785
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:9834; RAI1; Simple; p.Ala75Ser (c.223G>T); ClinVar=VCV000588756; Zygosity=Unspecified (Coriell=GM22766).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   GM22767
AC   CVCL_5K25
DR   Coriell; GM22767
DR   Wikidata; Q54852786
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:9834; RAI1; Simple; p.Ala75Ser (c.223G>T); ClinVar=VCV000588756; Zygosity=Unspecified (Coriell=GM22767).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   GM22768
AC   CVCL_HL23
DR   Coriell; GM22768
DR   Wikidata; Q54852787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM22770
AC   CVCL_5S13
DR   Coriell; GM22770
DR   Wikidata; Q54852789
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22771
AC   CVCL_5S14
DR   Coriell; GM22771
DR   Wikidata; Q54852790
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22772
AC   CVCL_BU99
DR   Coriell; GM22772
DR   Wikidata; Q54852791
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly762Asp (c.2285G>A); ClinVar=VCV000101377; Zygosity=Unspecified (Coriell=GM22772).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV00 ! GM22773
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22773
AC   CVCL_BV00
DR   Coriell; GM22773
DR   Wikidata; Q54852793
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly762Asp (c.2285G>A); ClinVar=VCV000101377; Zygosity=Unspecified (Coriell=GM22773).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU99 ! GM22772
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM22774
AC   CVCL_8A97
DR   Coriell; GM22774
DR   Wikidata; Q54852794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22775
AC   CVCL_5S15
DR   Coriell; GM22775
DR   Wikidata; Q54852795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22777
AC   CVCL_5S16
DR   Coriell; GM22777
DR   Wikidata; Q54852797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22778
AC   CVCL_BV01
DR   Coriell; GM22778
DR   Wikidata; Q54852798
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly939Asp (c.2816G>A); Zygosity=Heterozygous (Coriell=GM22778).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV02 ! GM22779
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22779
AC   CVCL_BV02
DR   Coriell; GM22779
DR   Wikidata; Q54852799
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly939Asp (c.2816G>A); Zygosity=Heterozygous (Coriell=GM22779).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV01 ! GM22778
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM22780
AC   CVCL_BV03
DR   Coriell; GM22780
DR   Wikidata; Q54852800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV04 ! GM22781
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22781
AC   CVCL_BV04
DR   Coriell; GM22781
DR   Wikidata; Q54852801
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV03 ! GM22780
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM22782
AC   CVCL_5S17
DR   Coriell; GM22782
DR   Wikidata; Q54852802
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM22783
AC   CVCL_BV05
DR   Coriell; GM22783
DR   Wikidata; Q54852803
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg133Cys (c.397C>T) (p.Arg145Cys, c.433C>T); ClinVar=VCV000011809; Zygosity=Heterozygous (Coriell=GM22783).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM22784
AC   CVCL_BV06
DR   Coriell; GM22784
DR   Wikidata; Q54852804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22785
AC   CVCL_BV07
DR   Coriell; GM22785
DR   Wikidata; Q54852808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22786
AC   CVCL_DN53
DR   Coriell; GM22786
DR   Wikidata; Q54852809
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2186; COL11A1; Simple; c.3816+1G>A (IVS50+1G>A); ClinVar=VCV000039776; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM22786).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C128115; Marshall syndrome
DI   ORDO; Orphanet_560; Marshall syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM22807
AC   CVCL_8A98
DR   Coriell; GM22807
DR   Wikidata; Q54852810
RX   PubMed=33197628;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM22828
AC   CVCL_BV08
DR   Coriell; GM22828
DR   Wikidata; Q54852811
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; c.3892delT; Zygosity=Heterozygous (Coriell=GM22828).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168733; Stickler syndrome type 1
DI   ORDO; Orphanet_90653; Stickler syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV09 ! GM22829
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM22829
AC   CVCL_BV09
DR   Coriell; GM22829
DR   Wikidata; Q54852812
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; c.3892delT; Zygosity=Heterozygous (Coriell=GM22829).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168733; Stickler syndrome type 1
DI   ORDO; Orphanet_90653; Stickler syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV08 ! GM22828
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM22870
AC   CVCL_DB17
DR   Coriell; GM22870
DR   Wikidata; Q54852813
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (Coriell=GM22870).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM22870).
CC   Donor information: Established from monozygotic twin of GM22256 (Cellosaurus=CVCL_DB16) and GM22871 (Cellosaurus=CVCL_DB18).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB13 ! GM22227
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM22871
AC   CVCL_DB18
DR   Coriell; GM22871
DR   Wikidata; Q54852814
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (Coriell=GM22871).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM22871).
CC   Donor information: Established from monozygotic twin of GM22227 (Cellosaurus=CVCL_DB13) and GM22871 (Cellosaurus=CVCL_DB17).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DB16 ! GM22256
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM22873
AC   CVCL_8A99
DR   Coriell; GM22873
DR   Wikidata; Q54852815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22894
AC   CVCL_5S18
SY   801-008 LCL
DR   Coriell; GM22894
DR   Wikidata; Q54852816
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22899
AC   CVCL_5S19
DR   Coriell; GM22899
DR   Wikidata; Q54852817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22902
AC   CVCL_5S20
DR   Coriell; GM22902
DR   Wikidata; Q54852818
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22903
AC   CVCL_5S21
DR   Coriell; GM22903
DR   Wikidata; Q54852819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22904
AC   CVCL_5S22
DR   Coriell; GM22904
DR   Wikidata; Q54852820
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22905
AC   CVCL_5S23
DR   Coriell; GM22905
DR   Wikidata; Q54852821
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22908
AC   CVCL_5S24
DR   Coriell; GM22908
DR   Wikidata; Q54852822
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22909
AC   CVCL_5S25
DR   Coriell; GM22909
DR   Wikidata; Q54852823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22910
AC   CVCL_5S26
DR   Coriell; GM22910
DR   Wikidata; Q54852824
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22916
AC   CVCL_5S27
DR   Coriell; GM22916
DR   Wikidata; Q54852825
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22918
AC   CVCL_BV10
DR   Coriell; GM22918
DR   Wikidata; Q54852826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22919
AC   CVCL_BV11
DR   Coriell; GM22919
DR   Wikidata; Q54852827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22920
AC   CVCL_BV12
DR   Coriell; GM22920
DR   Wikidata; Q54852828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM22923
AC   CVCL_5S28
DR   Coriell; GM22923
DR   Wikidata; Q54852829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22925
AC   CVCL_5S29
DR   Coriell; GM22925
DR   Wikidata; Q54852830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22926
AC   CVCL_5S30
DR   Coriell; GM22926
DR   Wikidata; Q54852831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22927
AC   CVCL_5S31
DR   Coriell; GM22927
DR   Wikidata; Q54852832
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22929
AC   CVCL_5S32
DR   Coriell; GM22929
DR   Wikidata; Q54852833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22930
AC   CVCL_5S33
DR   Coriell; GM22930
DR   Wikidata; Q54852835
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22931
AC   CVCL_5S34
DR   Coriell; GM22931
DR   Wikidata; Q54852836
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM22931; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22932
AC   CVCL_5S35
DR   Coriell; GM22932
DR   Wikidata; Q54852837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22936
AC   CVCL_5S36
DR   Coriell; GM22936
DR   Wikidata; Q54852838
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22937
AC   CVCL_5S37
DR   Coriell; GM22937
DR   Wikidata; Q54852839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22944
AC   CVCL_5S38
DR   Coriell; GM22944
DR   Wikidata; Q54852840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22948
AC   CVCL_5S39
DR   Coriell; GM22948
DR   Wikidata; Q54852841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22951
AC   CVCL_5S40
DR   Coriell; GM22951
DR   Wikidata; Q54852842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22952
AC   CVCL_5S41
DR   Coriell; GM22952
DR   Wikidata; Q54852843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22953
AC   CVCL_5S42
DR   Coriell; GM22953
DR   Wikidata; Q54852844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22963
AC   CVCL_5S43
DR   Coriell; GM22963
DR   Wikidata; Q54852845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22972
AC   CVCL_5S44
DR   Coriell; GM22972
DR   Wikidata; Q54852846
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22976
AC   CVCL_5S45
DR   Coriell; GM22976
DR   Wikidata; Q54852847
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22977
AC   CVCL_5S46
DR   Coriell; GM22977
DR   Wikidata; Q54852848
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22979
AC   CVCL_5S47
DR   Coriell; GM22979
DR   Wikidata; Q54852855
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22991
AC   CVCL_5S48
DR   Coriell; GM22991
DR   Wikidata; Q54852856
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22992
AC   CVCL_5S49
DR   Coriell; GM22992
DR   Wikidata; Q54852857
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22993
AC   CVCL_5S50
DR   Coriell; GM22993
DR   Wikidata; Q54852858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22994
AC   CVCL_5S51
DR   Coriell; GM22994
DR   Wikidata; Q54852859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22995
AC   CVCL_5S52
DR   Coriell; GM22995
DR   Wikidata; Q54852860
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM22996
AC   CVCL_5S53
DR   Coriell; GM22996
DR   Wikidata; Q54852861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM22998
AC   CVCL_5S54
DR   Coriell; GM22998
DR   Wikidata; Q54852862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM2300
AC   CVCL_B4FZ
DR   IARC_TP53; 21049
DR   Wikidata; Q110432821
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM23001
AC   CVCL_5S55
DR   Coriell; GM23001
DR   Wikidata; Q54852863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23002
AC   CVCL_5S56
DR   Coriell; GM23002
DR   Wikidata; Q54852864
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23003
AC   CVCL_5S57
DR   Coriell; GM23003
DR   Wikidata; Q54852865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23004
AC   CVCL_5S58
DR   Coriell; GM23004
DR   Wikidata; Q54852866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23005
AC   CVCL_5S59
DR   Coriell; GM23005
DR   Wikidata; Q54852867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23006
AC   CVCL_5S60
DR   Coriell; GM23006
DR   Wikidata; Q54852868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23007
AC   CVCL_5S61
DR   Coriell; GM23007
DR   Wikidata; Q54852869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23008
AC   CVCL_5S62
DR   Coriell; GM23008
DR   Wikidata; Q54852870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23010
AC   CVCL_5S63
DR   Coriell; GM23010
DR   Wikidata; Q54852871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23011
AC   CVCL_5S64
DR   Coriell; GM23011
DR   Wikidata; Q54852872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23053
AC   CVCL_5S65
DR   Coriell; GM23053
DR   Wikidata; Q54852874
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23054
AC   CVCL_5S66
DR   Coriell; GM23054
DR   Wikidata; Q54852875
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23055
AC   CVCL_5S67
DR   Coriell; GM23055
DR   Wikidata; Q54852877
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23056
AC   CVCL_8B00
DR   Coriell; GM23056
DR   Wikidata; Q54852878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23057
AC   CVCL_BV13
DR   Coriell; GM23057
DR   Wikidata; Q54852880
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly222Val (c.665G>T) (G55V); ClinVar=VCV000101218; Zygosity=Heterozygous (Coriell=GM23057).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23058
AC   CVCL_BV14
DR   Coriell; GM23058
DR   Wikidata; Q54852881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23079
AC   CVCL_Y321
DR   Coriell; GM23079
DR   Wikidata; Q54852882
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly588_Pro590delinsValSer (c.1763_1769delGTGCTCCinsTAAG); ClinVar=VCV000101208; Zygosity=Unspecified (Coriell=GM23079).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BT11 ! GM23080
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   GM23080
AC   CVCL_BT11
DR   Coriell; GM23080
DR   Wikidata; Q54852885
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly588_Pro590delinsValSer (c.1763_1769delGTGCTCCinsTAAG); ClinVar=VCV000101208; Zygosity=Unspecified (Coriell=GM23080).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y321 ! GM23079
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23081
AC   CVCL_5S68
SY   801-010 LCL
DR   Coriell; GM23081
DR   Wikidata; Q54852886
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23086
AC   CVCL_5S69
DR   Coriell; GM23086
DR   Wikidata; Q54852887
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex2-30dup; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23087
AC   CVCL_5S70
DR   Coriell; GM23087
DR   Wikidata; Q54852888
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex2-30dup; Zygosity=Heterozygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23090
AC   CVCL_BV15
DR   Coriell; GM23090
DR   Wikidata; Q54852889
RX   PubMed=26621101;
RX   PubMed=29959025;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   HLA typing: A*11:01:01,11:01:01; B*15:02:01,51:01:01; C*08:01:01,14:02:01; DPA1*01:03:01,02:02:02; DPB1*02:01:02,05:01:01; DQA1*03:02,03:03:01; DQB1*03:03:02,04:01:01; DRB1*04:05:01,09:01:02; DRB4*01:03:01,01:03:02 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM23091
AC   CVCL_8B01
DR   Coriell; GM23091
DR   Wikidata; Q54852890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23092
AC   CVCL_8B02
DR   Coriell; GM23092
DR   Wikidata; Q54852891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23093
AC   CVCL_BV16
DR   Coriell; GM23093
DR   Wikidata; Q54852892
RX   PubMed=26621101;
RX   PubMed=29959025;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   HLA typing: A*11:01:01,11:01:01; B*15:02:01,15:02:01; C*08:01:01,08:01:01; DPA1*01:03:01,02:02:02; DPB1*05:01:01,21:01; DQA1*06:01:01,06:01:01; DQB1*03:01:01,03:01:01; DRB1*12:02:01,12:02:01; DRB3*03:01:03,03:01:03 (PubMed=29959025).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM23094
AC   CVCL_5S71
DR   Coriell; GM23094
DR   Wikidata; Q54852893
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex35-43del; Zygosity=Heterozygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23095
AC   CVCL_5S72
DR   Coriell; GM23095
DR   Wikidata; Q54852894
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex35-43del; Zygosity=Hemizygous (Coriell=GM23095).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM23096
AC   CVCL_5S73
DR   Coriell; GM23096
DR   Wikidata; Q54852895
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex35-43del; Zygosity=Hemizygous (Coriell=GM23096).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM23097
AC   CVCL_6B45
DR   Coriell; GM23097
DR   Wikidata; Q54852896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23099
AC   CVCL_5S74
DR   Coriell; GM23099
DR   Wikidata; Q54852897
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex8-17dup; Zygosity=Heterozygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23104
AC   CVCL_8B03
DR   Coriell; GM23104
DR   Wikidata; Q54852898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23125
AC   CVCL_5S75
SY   801-011 LCL
DR   Coriell; GM23125
DR   Wikidata; Q54852899
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23127
AC   CVCL_U482
DR   Coriell; GM23127
DR   Wikidata; Q54852906
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex27-28dup; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM2313
AC   CVCL_B4G0
DR   cancercelllines; CVCL_B4G0
DR   IARC_TP53; 20803
DR   Wikidata; Q110432822
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   GM23150
AC   CVCL_DB19
DR   Coriell; GM23150
DR   Wikidata; Q54852907
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Unexplicit; IVS2+1G>T; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM23150).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM23151
AC   CVCL_CX75
DR   Coriell; GM23151
DR   Wikidata; Q54852908
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM23151).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX72 ! GM22566
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM23152
AC   CVCL_CX76
DR   Coriell; GM23152
DR   Wikidata; Q54852909
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (Coriell=GM23152).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX73 ! GM22567
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23154
AC   CVCL_DB20
DR   Coriell; GM23154
DR   Wikidata; Q54852910
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[196]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM23154).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Arg404Gln (c.1211G>A); ClinVar=VCV000188794; Zygosity=Heterozygous (Coriell=GM23154).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro1007Ala (c.3019C>G); ClinVar=VCV000002966; Zygosity=Heterozygous (Coriell=GM23154).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_95; Friedreich ataxia
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23159
AC   CVCL_5S76
DR   Coriell; GM23159
DR   Wikidata; Q54852911
RX   PubMed=21354051;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex17dup; Zygosity=Hemizygous (PubMed=21354051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23160
AC   CVCL_5S77
DR   Coriell; GM23160
DR   Wikidata; Q54852912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23161
AC   CVCL_5S78
DR   Coriell; GM23161
DR   Wikidata; Q54852913
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   NCIt; C6831; Isodicentric chromosome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23162
AC   CVCL_DB21
DR   Coriell; GM23162
DR   Wikidata; Q54852914
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Cys42Tyr (c.125G>A); Zygosity=Heterozygous (Coriell=GM23162).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Asp948Asn (c.2842G>A); ClinVar=VCV000552987; Zygosity=Heterozygous (Coriell=GM23162).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23163
AC   CVCL_AA09
DR   BioSample; SAMN00806669
DR   Coriell; GM23163
DR   Wikidata; Q54852915
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; c.1026_1027delAG; Zygosity=Hemizygous (Coriell=GM23163).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23164
AC   CVCL_8B04
DR   Coriell; GM23164
DR   Wikidata; Q54852916
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23165
AC   CVCL_8B05
DR   Coriell; GM23165
DR   Wikidata; Q54852917
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23221
AC   CVCL_BV17
DR   Coriell; GM23221
DR   Wikidata; Q54852919
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Arg268Cys (c.802C>T) (R243C); ClinVar=VCV000289402; Zygosity=Heterozygous (Coriell=GM23221).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Cys616_Val633del (c.1899+4_1899+7delAGTA) (1824IVS+3del4) (IVS21+3del4); Zygosity=Heterozygous (Coriell=GM23221).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23225
AC   CVCL_F169
SY   GM23225*B
DR   Coriell; GM23225
DR   SKIP; SKIP000181
DR   SKIP; SKIP004345
DR   Wikidata; Q54852920
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   GM23226
AC   CVCL_F170
SY   GM23226*A
DR   Coriell; GM23226
DR   SKIP; SKIP000182
DR   SKIP; SKIP004346
DR   Wikidata; Q54852921
RX   PubMed=23665875;
CC   Population: Native North American; Alaskan.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8518 ! GM02416
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   GM23228
AC   CVCL_JE51
DR   Coriell; GM23228
DR   Wikidata; Q54852922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3267; Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM23230
AC   CVCL_F176
DR   Coriell; GM23230
DR   SKIP; SKIP000183
DR   SKIP; SKIP004347
DR   Wikidata; Q54852923
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8520 ! GM04569
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 15
//
ID   GM23232
AC   CVCL_F191
SY   GM23232*A
DR   BioSample; SAMN00806683
DR   Coriell; GM23232
DR   SKIP; SKIP000184
DR   SKIP; SKIP004348
DR   Wikidata; Q54852925
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (Coriell=GM23232).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.1050_1054delGAAGA; Zygosity=Heterozygous (Coriell=GM23232).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8517 ! GM01390
SX   Male
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   GM23235
AC   CVCL_5S79
SY   801-013 LCL
DR   Coriell; GM23235
DR   Wikidata; Q54852926
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23237
AC   CVCL_JE52
DR   Coriell; GM23237
DR   Wikidata; Q54852927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3267; Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM23242
AC   CVCL_5S80
DR   Coriell; GM23242
DR   Wikidata; Q54852929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23243
AC   CVCL_5S81
DR   Coriell; GM23243
DR   Wikidata; Q54852930
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-44dup; Zygosity=Hemizygous (Coriell=GM23243).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM23244
AC   CVCL_5S82
DR   Coriell; GM23244
DR   Wikidata; Q54852931
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-44dup; Zygosity=Hemizygous (Coriell=GM23244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   GM23246
AC   CVCL_BV19
DR   Coriell; GM23246
DR   Wikidata; Q54852932
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23248
AC   CVCL_F183
DR   EFO; EFO_0005723
DR   Coriell; GM23248
DR   ENCODE; ENCBS367AAA
DR   ENCODE; ENCBS372AAA
DR   GEO; GSM2072585
DR   GEO; GSM2072586
DR   GEO; GSM3124663
DR   Wikidata; Q54852933
RX   PubMed=30567591;
WW   Info; PGP; hu43860C; https://my.pgp-hms.org/profile_public?hex=hu43860C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from George Church fibroblasts.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7659 ! GM20431
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   GM23249
AC   CVCL_F185
DR   Coriell; GM23249
DR   Wikidata; Q54852934
WW   Info; PGP; huE80E3D; https://my.pgp-hms.org/profile_public?hex=huE80E3D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F186 ! GM21677
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   GM23250
AC   CVCL_0U56
DR   Coriell; GM23250
DR   Wikidata; Q54852935
WW   Info; PGP; hu9385BA; https://my.pgp-hms.org/profile_public?hex=hu9385BA
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U57 ! GM21687
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM23251
AC   CVCL_F110
SY   Fibro 009-A
DR   Coriell; GM23251
DR   Wikidata; Q54852936
WW   Info; PGP; hu034DB1; https://my.pgp-hms.org/profile_public?hex=hu034DB1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7662 ! GM21833
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   GM23252
AC   CVCL_BV20
DR   Coriell; GM23252
DR   Wikidata; Q54852937
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg159Cys (c.475C>T) (c.864C>T); ClinVar=VCV000280123; Zygosity=Heterozygous (Coriell=GM23252).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV21 ! GM23253
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23253
AC   CVCL_BV21
DR   Coriell; GM23253
DR   Wikidata; Q54852938
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg159Cys (c.475C>T) (c.864C>T); ClinVar=VCV000280123; Zygosity=Heterozygous (Coriell=GM23253).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV20 ! GM23252
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23254
AC   CVCL_BA14
DR   Coriell; GM23254
DR   Wikidata; Q54852939
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ile507del (c.1516_1518ATC[1]) (c.1519_1521delATC); ClinVar=VCV000007106; Zygosity=Heterozygous (Coriell=GM23254).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM23254).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM23255
AC   CVCL_5S83
DR   Coriell; GM23255
DR   Wikidata; Q54852940
RX   PubMed=23665875;
RX   PubMed=26247043;
RX   PubMed=28284873;
RX   PubMed=33197628;
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   GM23256
AC   CVCL_BV22
DR   Coriell; GM23256
DR   Wikidata; Q54852941
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM23258
AC   CVCL_BV23
DR   Coriell; GM23258
DR   Wikidata; Q54852942
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM23259
AC   CVCL_BV24
DR   Coriell; GM23259
DR   Wikidata; Q54852943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84680; Dystrophia myotonica 2
DI   ORDO; Orphanet_606; Proximal myotonic myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23260
AC   CVCL_BV25
DR   Coriell; GM23260
DR   Wikidata; Q54852944
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23260).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BU48 ! GM22368
OI   CVCL_BU49 ! GM22369
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23262
AC   CVCL_F177
SY   GM23262*A
DR   Coriell; GM23262
DR   SKIP; SKIP000187
DR   SKIP; SKIP004351
DR   Wikidata; Q54852945
RX   PubMed=23665875;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-53del; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8521 ! GM04981
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   GM23263
AC   CVCL_5S84
SY   801-014 LCL
DR   Coriell; GM23263
DR   Wikidata; Q54852946
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23264
AC   CVCL_5S85
SY   801-015 LCL
DR   Coriell; GM23264
DR   Wikidata; Q54852947
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23265
AC   CVCL_BV26
DR   Coriell; GM23265
DR   Wikidata; Q54852948
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian; English/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[60] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23265).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23266
AC   CVCL_BA15
DR   Coriell; GM23266
DR   Wikidata; Q54852954
CC   Population: Asian and Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23267
AC   CVCL_BV27
DR   Coriell; GM23267
DR   Wikidata; Q54852955
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV28 ! GM23268
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23268
AC   CVCL_BV28
DR   Coriell; GM23268
DR   Wikidata; Q54852956
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23268).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV27 ! GM23267
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23270
AC   CVCL_5S86
DR   Coriell; GM23270
DR   Wikidata; Q54852957
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23275
AC   CVCL_BV29
DR   Coriell; GM23275
DR   Wikidata; Q54852958
RX   PubMed=26621101;
RX   PubMed=31401124;
RX   PubMed=35931342;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM23276
AC   CVCL_IJ31
DR   Coriell; GM23276
DR   Wikidata; Q54852960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98674; Methylcrotonyl-CoA carboxylase deficiency
DI   ORDO; Orphanet_6; 3-methylcrotonyl-CoA carboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM23277
AC   CVCL_GS97
DR   Coriell; GM23277
DR   Wikidata; Q54852961
CC   Sequence variation: Mutation; HGNC; HGNC:14063; HDAC4; Simple; c.490+56_121del65; Zygosity=Heterozygous (Coriell=GM23277).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129021; Chromosome 2q37 deletion syndrome
DI   ORDO; Orphanet_1001; 2q37 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   GM23278
AC   CVCL_BV30
DR   Coriell; GM23278
DR   Wikidata; Q54852962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84680; Dystrophia myotonica 2
DI   ORDO; Orphanet_606; Proximal myotonic myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23279
AC   CVCL_F178
SY   GM23279A; GM23279*A; GM23279*E
DR   Coriell; GM23279
DR   SKIP; SKIP000396
DR   SKIP; SKIP004352
DR   Wikidata; Q54852963
RX   PubMed=27264186;
CC   Population: Caucasian.
CC   Caution: May be identical to one of the many iPSC cell lines produced from HDF1388 by the Center for iPS Cell Research and Application (CiRA).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM2328
AC   CVCL_B4G1
DR   IARC_TP53; 20802
DR   Wikidata; Q110432824
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Ser (c.481G>T); Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   GM23280
AC   CVCL_F179
SY   GM23280A; GM23280*A
DR   Coriell; GM23280
DR   SKIP; SKIP000387
DR   SKIP; SKIP004353
DR   Wikidata; Q54852964
RX   PubMed=27264186;
CC   Population: Caucasian.
CC   Caution: May be identical to one of the many iPSC cell lines produced from HDF1388 by the Center for iPS Cell Research and Application (CiRA).
CC   Discontinued: Coriell; GM23280; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   GM23283
AC   CVCL_BV31
DR   Coriell; GM23283
DR   Wikidata; Q54852965
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23283).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV32 ! GM23284
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23284
AC   CVCL_BV32
DR   Coriell; GM23284
DR   Wikidata; Q54852966
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23284).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV31 ! GM23283
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23285
AC   CVCL_BV33
DR   Coriell; GM23285
DR   Wikidata; Q54852967
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23285).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23286
AC   CVCL_BV34
DR   Coriell; GM23286
DR   Wikidata; Q54852968
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23286).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23287
AC   CVCL_BV35
DR   Coriell; GM23287
DR   Wikidata; Q54852969
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23287).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23289
AC   CVCL_BV36
DR   Coriell; GM23289
DR   Wikidata; Q54852970
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23289).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV37 ! GM23290
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23290
AC   CVCL_BV37
DR   Coriell; GM23290
DR   Wikidata; Q54852971
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155His (c.464G>A); ClinVar=VCV000008468; Zygosity=Heterozygous (Coriell=GM23290).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV36 ! GM23289
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23292
AC   CVCL_U545
DR   Coriell; GM23292
DR   Wikidata; Q54852972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM23295
AC   CVCL_EG03
DR   Coriell; GM23295
DR   Wikidata; Q54852973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128187; 2-hydroxyglutaric aciduria
DI   ORDO; Orphanet_19; 2-hydroxyglutaric aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23296
AC   CVCL_BV38
DR   Coriell; GM23296
DR   Wikidata; Q54852974
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23297
AC   CVCL_BV39
DR   Coriell; GM23297
DR   Wikidata; Q54852975
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23298
AC   CVCL_F180
SY   GM23298*A; R306C-iPS
DR   BioSample; SAMN00806719
DR   Coriell; GM23298
DR   SKIP; SKIP000188
DR   SKIP; SKIP000704
DR   SKIP; SKIP004354
DR   Wikidata; Q54852977
RX   PubMed=19404254;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Heterozygous (Coriell=GM23298).
CC   Discontinued: Coriell; GM23298; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F181 ! GM11270
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   GM23299
AC   CVCL_BV40
DR   Coriell; GM23299
DR   Wikidata; Q54852978
RX   PubMed=23680132;
CC   Population: Caucasian; Dutch/English.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[90-100] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23299).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23300
AC   CVCL_BV41
DR   Coriell; GM23300
DR   Wikidata; Q54852979
RX   PubMed=23680132;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~150-160] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23300).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23301
AC   CVCL_AZ45
SY   801-017 LCL
DR   Coriell; GM23301
DR   Wikidata; Q54852980
RX   PubMed=23495136;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23302
AC   CVCL_5S87
DR   Coriell; GM23302
DR   Wikidata; Q54852981
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23304
AC   CVCL_AY65
DR   Coriell; GM23304
DR   Wikidata; Q54852982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23305
AC   CVCL_4T43
DR   Coriell; GM23305
DR   Wikidata; Q54852983
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM23306
AC   CVCL_4T44
DR   Coriell; GM23306
DR   Wikidata; Q54852984
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T45 ! GM23307
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   GM23307
AC   CVCL_4T45
DR   Coriell; GM23307
DR   Wikidata; Q54852985
CC   Population: Korean.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T44 ! GM23306
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   GM23308
AC   CVCL_4T46
DR   Coriell; GM23308
DR   Wikidata; Q54852986
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; c.856-3C>G (IVS6-3C>G); Zygosity=Heterozygous (Coriell=GM23308).
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Lys796Ter (c.2386A>T); Zygosity=Heterozygous (Coriell=GM23308).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T61 ! GM24232
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM23309
AC   CVCL_F197
DR   Coriell; GM23309
DR   Wikidata; Q54852987
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg683Serfs*21 (c.2045_2046AG[2]) (c.2049_2050delAG); ClinVar=VCV000038340; Zygosity=Heterozygous (Coriell=GM23309).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   GM23310
AC   CVCL_F198
DR   Coriell; GM23310
DR   Wikidata; Q54852988
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg2578Ter (c.7732C>T); ClinVar=VCV000014296; Zygosity=Heterozygous (Coriell=GM23310).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   GM23311
AC   CVCL_F196
DR   Coriell; GM23311
DR   Wikidata; Q54852989
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg683Serfs*21 (c.2045_2046AG[2]) (c.2049_2050delAG); ClinVar=VCV000038340; Zygosity=Heterozygous (Coriell=GM23311).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg2578Ter (c.7732C>T); ClinVar=VCV000014296; Zygosity=Heterozygous (Coriell=GM23311).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   GM23312
AC   CVCL_CW86
DR   Coriell; GM23312
DR   Wikidata; Q54852990
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   GM23313
AC   CVCL_BV42
DR   Coriell; GM23313
DR   Wikidata; Q54852991
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23316
AC   CVCL_AY66
DR   Coriell; GM23316
DR   Wikidata; Q54852992
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Ser2099_Val2117dup (c.6295_6351dup57); ClinVar=VCV000478252; Zygosity=Heterozygous (Coriell=GM23316).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23320
AC   CVCL_CX77
DR   Coriell; GM23320
DR   Wikidata; Q54852993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23321
AC   CVCL_BX01
DR   Coriell; GM23321
DR   Wikidata; Q54852994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23324
AC   CVCL_AZ46
DR   Coriell; GM23324
DR   Wikidata; Q54852995
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23325
AC   CVCL_AY67
DR   Coriell; GM23325
DR   Wikidata; Q54853004
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23326
AC   CVCL_AY68
DR   Coriell; GM23326
DR   Wikidata; Q54853005
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23327
AC   CVCL_AY69
DR   Coriell; GM23327
DR   Wikidata; Q54853006
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000477459; Zygosity=Heterozygous (Coriell=GM23327).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Gly16Alafs*29 (c.47delG); Zygosity=Heterozygous (Coriell=GM23327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23328
AC   CVCL_CX78
DR   Coriell; GM23328
DR   Wikidata; Q54853007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX79 ! GM23373
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23330
AC   CVCL_4T47
DR   Coriell; GM23330
DR   Wikidata; Q54853008
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; c.1823-8G>A; ClinVar=VCV000093837; Zygosity=Unspecified (Coriell=GM23330).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 11
//
ID   GM23336
AC   CVCL_U546
DR   Coriell; GM23336
DR   Wikidata; Q54853009
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23337
AC   CVCL_BV43
DR   Coriell; GM23337
DR   Wikidata; Q54853010
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   GM23338
AC   CVCL_F182
AS   CVCL_A0ZT
SY   GM23338*B; PGP1 iPSC; PGP1-iPS; PGP1 hiPSC; PGP1-1; PGP1; HVRDi004-B; UMi031-A
DR   EFO; EFO_0007950
DR   BioSample; SAMN00211020
DR   BioSample; SAMN03485859
DR   Coriell; GM23338
DR   ENCODE; ENCBS368AAA
DR   ENCODE; ENCBS373AAA
DR   GEO; GSM1019346
DR   GEO; GSM1019347
DR   GEO; GSM1658378
DR   GEO; GSM2072609
DR   GEO; GSM2072610
DR   hPSCreg; HVRDi004-B
DR   SKIP; SKIP000178
DR   SKIP; SKIP004355
DR   Wikidata; Q54853011
RX   PubMed=19911041;
RX   PubMed=26004630;
RX   PubMed=34352618;
RX   PubMed=36459969;
WW   Info; PGP; hu43860C; https://my.pgp-hms.org/profile_public?hex=hu43860C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F183 ! GM23248
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   GM23340
AC   CVCL_F184
SY   GM23340*A
DR   Coriell; GM23340
DR   SKIP; SKIP000179
DR   SKIP; SKIP004356
DR   Wikidata; Q54853012
WW   Info; PGP; huE80E3D; https://my.pgp-hms.org/profile_public?hex=huE80E3D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM23340; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F185 ! GM23249
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   GM23348
AC   CVCL_BV44
DR   Coriell; GM23348
DR   Wikidata; Q54853013
RX   PubMed=26621101;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23349
AC   CVCL_BV45
DR   Coriell; GM23349
DR   Wikidata; Q54853014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23352
AC   CVCL_BV46
DR   Coriell; GM23352
DR   Wikidata; Q54853015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23354
AC   CVCL_HK74
DR   Coriell; GM23354
DR   Wikidata; Q54853016
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   GM23355
AC   CVCL_BV47
DR   Coriell; GM23355
DR   Wikidata; Q54853017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84680; Dystrophia myotonica 2
DI   ORDO; Orphanet_606; Proximal myotonic myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23356
AC   CVCL_HK75
DR   Coriell; GM23356
DR   Wikidata; Q54853018
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   GM23357
AC   CVCL_BV48
DR   Coriell; GM23357
DR   Wikidata; Q54853019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23358
AC   CVCL_BV49
DR   Coriell; GM23358
DR   Wikidata; Q54853020
RX   PubMed=23680132;
CC   Population: Iraqi.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~800-900] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23361
AC   CVCL_U547
DR   Coriell; GM23361
DR   Wikidata; Q54853021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM23363
AC   CVCL_JF24
DR   Coriell; GM23363
DR   Wikidata; Q54853022
CC   Sequence variation: Mutation; HGNC; HGNC:9202; POMT1; Simple; p.Ser29Arg (c.85A>C); Zygosity=Heterozygous (Coriell=GM23363).
CC   Sequence variation: Mutation; HGNC; HGNC:9202; POMT1; Simple; p.Arg622Ter (c.1864C>T); Zygosity=Heterozygous (Coriell=GM23363).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133730; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 1
DI   ORDO; Orphanet_86812; POMT1-related limb-girdle muscular dystrophy R11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM23365
AC   CVCL_BV50
DR   Coriell; GM23365
DR   Wikidata; Q54853023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23366
AC   CVCL_BV51
DR   Coriell; GM23366
DR   Wikidata; Q54853024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23367
AC   CVCL_BV52
DR   Coriell; GM23367
DR   Wikidata; Q54853025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23370
AC   CVCL_BV53
DR   Coriell; GM23370
DR   Wikidata; Q54853026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23372
AC   CVCL_BV54
DR   Coriell; GM23372
DR   Wikidata; Q54853027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84680; Dystrophia myotonica 2
DI   ORDO; Orphanet_606; Proximal myotonic myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23373
AC   CVCL_CX79
DR   Coriell; GM23373
DR   Wikidata; Q54853028
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX78 ! GM23328
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23374
AC   CVCL_BV55
DR   Coriell; GM23374
DR   Wikidata; Q54853029
RX   PubMed=23680132;
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~130-140] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23374).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23375
AC   CVCL_BV56
DR   Coriell; GM23375
DR   Wikidata; Q54853030
CC   Population: Iraqi.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700-1800] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23375).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23376
AC   CVCL_BV57
DR   Coriell; GM23376
DR   Wikidata; Q54853031
CC   Population: Caucasian; Austrian/German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84680; Dystrophia myotonica 2
DI   ORDO; Orphanet_606; Proximal myotonic myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23377
AC   CVCL_BV58
DR   Coriell; GM23377
DR   Wikidata; Q54853032
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99041; Renal agenesis
DI   ORDO; Orphanet_411709; Renal agenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   19FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23378
AC   CVCL_BV59
DR   Coriell; GM23378
DR   Wikidata; Q54853033
RX   PubMed=23680132;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Caucasian; French/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~80-90] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23378).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23382
AC   CVCL_BV60
DR   Coriell; GM23382
DR   Wikidata; Q54853034
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Pro (c.464G>C); ClinVar=VCV000008472; Zygosity=Unspecified (Coriell=GM23382).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23384
AC   CVCL_BV61
DR   Coriell; GM23384
DR   Wikidata; Q54853035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84680; Dystrophia myotonica 2
DI   ORDO; Orphanet_606; Proximal myotonic myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23385
AC   CVCL_BV62
DR   Coriell; GM23385
DR   Wikidata; Q54853036
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Unexplicit; Large deletion; Zygosity=Unspecified (Coriell=GM23385).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23386
AC   CVCL_DS06
DR   Coriell; GM23386
DR   Wikidata; Q54853037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84721; Fuchs endothelial dystrophy
DI   ORDO; Orphanet_98974; Fuchs endothelial corneal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23387
AC   CVCL_Y707
DR   Coriell; GM23387
DR   Wikidata; Q54853038
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg277Trp (c.829C>T); ClinVar=VCV000010999; Zygosity=Heterozygous (Coriell=GM23387).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23388
AC   CVCL_Y708
DR   Coriell; GM23388
DR   Wikidata; Q54853039
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg277Trp (c.829C>T); ClinVar=VCV000010999; Zygosity=Hemizygous (Coriell=GM23388).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23389
AC   CVCL_Y709
DR   Coriell; GM23389
DR   Wikidata; Q54853040
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg277Trp (c.829C>T); ClinVar=VCV000010999; Zygosity=Heterozygous (Coriell=GM23389).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23390
AC   CVCL_Y710
DR   Coriell; GM23390
DR   Wikidata; Q54853041
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg277Trp (c.829C>T); ClinVar=VCV000010999; Zygosity=Heterozygous (Coriell=GM23390).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23391
AC   CVCL_F168
DR   Coriell; GM23391
DR   Wikidata; Q54853042
RX   PubMed=23680132;
CC   Population: Caucasian; English/German.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~170-180] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   GM23392
AC   CVCL_F167
SY   GM23392*B
DR   Coriell; GM23392
DR   SKIP; SKIP000175
DR   SKIP; SKIP004358
DR   Wikidata; Q54853043
RX   PubMed=23665875;
CC   Population: African American.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7449 ! GM06114
SX   Male
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   GM23394
AC   CVCL_F166
SY   GM23394*B
DR   Coriell; GM23394
DR   SKIP; SKIP000180
DR   SKIP; SKIP004359
DR   Wikidata; Q54853048
CC   Population: African American.
CC   Discontinued: Coriell; GM23394; probable.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7477 ! GM08333
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM23396
AC   CVCL_T815
SY   GM23396*D
DR   Coriell; GM23396
DR   SKIP; SKIP000256
DR   SKIP; SKIP004360
DR   Wikidata; Q54853049
CC   Population: African American.
CC   Karyotypic information: 46,XX [23]; 47,XXX [2] (Coriell=GM23396).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7447 ! GM06111
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   GM23404
AC   CVCL_F192
SY   GM23404*C
DR   Coriell; GM23404
DR   SKIP; SKIP000189
DR   SKIP; SKIP004363
DR   Wikidata; Q54853050
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[330]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM23404).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[380]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM23404).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F193 ! GM03816
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   GM23405
AC   CVCL_BV63
DR   Coriell; GM23405
DR   Wikidata; Q54853051
RX   PubMed=26621101;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23406
AC   CVCL_BV64
DR   Coriell; GM23406
DR   Wikidata; Q54853052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23407
AC   CVCL_V033
DR   Coriell; GM23407
DR   Wikidata; Q54853053
CC   Sequence variation: Mutation; HGNC; HGNC:663; ARG1; Simple; p.Gly142Glu (c.425G>A); ClinVar=VCV000556022; Zygosity=Unspecified (Coriell=GM23407).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM23409
AC   CVCL_V034
DR   Coriell; GM23409
DR   Wikidata; Q54853054
CC   Sequence variation: Mutation; HGNC; HGNC:663; ARG1; Simple; p.Trp122Ter (c.365G>A); ClinVar=VCV000002390; Zygosity=Unspecified (Coriell=GM23409).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   GM23410
AC   CVCL_Y711
DR   Coriell; GM23410
DR   Wikidata; Q54853055
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg23Ter (c.67C>T); ClinVar=VCV000097292; Zygosity=Heterozygous (Coriell=GM23410).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23411
AC   CVCL_T816
SY   GM23411*B
DR   Coriell; GM23411
DR   SKIP; SKIP000257
DR   SKIP; SKIP004364
DR   Wikidata; Q54853056
CC   Population: Puerto Rican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7272 ! GM00041
SX   Female
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   GM23413
AC   CVCL_F194
SY   GM23413*B
DR   Coriell; GM23413
DR   SKIP; SKIP000176
DR   SKIP; SKIP004362
DR   Wikidata; Q54853057
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7448 ! GM06112
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   GM23415
AC   CVCL_BV65
DR   Coriell; GM23415
DR   Wikidata; Q54853058
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.1494-1G>A (c.1398-1G>A); ClinVar=VCV000094272; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM23415).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Gln691Ter (c.2071C>T) (p.Gln709Ter, c.2125C>T); ClinVar=VCV000963357; Zygosity=Heterozygous (Coriell=GM23415).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23416
AC   CVCL_Y712
DR   Coriell; GM23416
DR   Wikidata; Q54853059
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Asp196Val (c.587A>T); ClinVar=VCV000097259; Zygosity=Heterozygous (Coriell=GM23416).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was asymptomatic for ornithine carbamoyltransferase deficiency.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23417
AC   CVCL_BV66
DR   Coriell; GM23417
DR   Wikidata; Q54853060
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly12Valfs*2 (c.35delG); ClinVar=VCV000017004; Zygosity=Heterozygous (Coriell=GM23417).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Met34Thr (c.101T>C); ClinVar=VCV000017000; Zygosity=Heterozygous (Coriell=GM23417).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Val10952Leu (c.32854G>C) (p.Val13520Leu, c.40558G>C); ClinVar=VCV000130666; Zygosity=Heterozygous (Coriell=GM23417).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; c.39893-1G>A (IVS192-1G>A) (c.37112-1G>A, IVS191-1G>A); ClinVar=VCV000202368; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM23417).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK83 ! GM25936
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM23418
AC   CVCL_BV67
DR   Coriell; GM23418
DR   Wikidata; Q54853061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23419
AC   CVCL_Y713
DR   Coriell; GM23419
DR   Wikidata; Q54853062
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Thr178Met (c.533C>T); ClinVar=VCV000097237; Zygosity=Heterozygous (Coriell=GM23419).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23420
AC   CVCL_GS98
DR   Coriell; GM23420
DR   Wikidata; Q54853064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129029; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
DI   ORDO; Orphanet_415; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23421
AC   CVCL_BX02
DR   Coriell; GM23421
DR   Wikidata; Q54853065
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg249Gln (c.746G>A); ClinVar=VCV000066931; Zygosity=Unspecified (Coriell=GM23421).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126745; Emery-Dreifuss muscular dystrophy 2, autosomal dominant
DI   ORDO; Orphanet_98853; Autosomal dominant Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM23423
AC   CVCL_Y714
DR   Coriell; GM23423
DR   Wikidata; Q54853066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23424
AC   CVCL_JF43
DR   Coriell; GM23424
DR   Wikidata; Q54853067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_64746; Autosomal dominant Charcot-Marie-Tooth disease type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM23425
AC   CVCL_U548
DR   Coriell; GM23425
DR   Wikidata; Q54853068
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23426
AC   CVCL_BV68
DR   Coriell; GM23426
DR   Wikidata; Q54853069
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Ile113Thr (c.338T>C); ClinVar=VCV000283107; Zygosity=Heterozygous (Coriell=GM23426).
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Phe200_Leu204del (c.598_612del15); ClinVar=VCV000166786; Zygosity=Heterozygous (Coriell=GM23426).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23427
AC   CVCL_Y715
DR   Coriell; GM23427
DR   Wikidata; Q54853070
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Unexplicit; Ex5del; Zygosity=Heterozygous (Coriell=GM23427).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was asymptomatic for ornithine carbamoyltransferase deficiency.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23428
AC   CVCL_JA56
DR   Coriell; GM23428
DR   Wikidata; Q54853071
CC   Sequence variation: Mutation; HGNC; HGNC:9118; PMP22; Simple; p.His12Arg (c.35A>G); ClinVar=VCV000835185; Zygosity=Heterozygous (Coriell=GM23428).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133087; Charcot-Marie-Tooth disease, type 3
DI   ORDO; Orphanet_64748; Dejerine-Sottas syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   GM23429
AC   CVCL_Y716
DR   Coriell; GM23429
DR   Wikidata; Q54853072
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000097371; Zygosity=Heterozygous (Coriell=GM23429).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was asymptomatic for ornithine carbamoyltransferase deficiency.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23430
AC   CVCL_5M30
DR   Coriell; GM23430
DR   Wikidata; Q54853073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23431
AC   CVCL_Y717
DR   Coriell; GM23431
DR   Wikidata; Q54853074
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Unexplicit; IVS6+1delG; Zygosity=Heterozygous (Coriell=GM23431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23432
AC   CVCL_5S88
DR   Coriell; GM23432
DR   Wikidata; Q54853075
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23433
AC   CVCL_5S89
DR   Coriell; GM23433
DR   Wikidata; Q54853076
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23436
AC   CVCL_AY70
DR   Coriell; GM23436
DR   Wikidata; Q54853077
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Arg12Gln (c.35G>A); ClinVar=VCV000092360; Zygosity=Heterozygous (Coriell=GM23436).
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Gly280Glufs*4 (c.839delG); Zygosity=Heterozygous (Coriell=GM23436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23437
AC   CVCL_AY71
DR   Coriell; GM23437
DR   Wikidata; Q54853078
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Arg12Gln (c.35G>A); ClinVar=VCV000092360; Zygosity=Heterozygous (Coriell=GM23437).
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Gly280Glufs*4 (c.839delG); Zygosity=Heterozygous (Coriell=GM23437).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23438
AC   CVCL_AY72
DR   Coriell; GM23438
DR   Wikidata; Q54853079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23439
AC   CVCL_Y718
DR   Coriell; GM23439
DR   Wikidata; Q54853081
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Gln279Ter (c.835C>T); ClinVar=VCV000097341; Zygosity=Heterozygous (Coriell=GM23439).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was asymptomatic for ornithine carbamoyltransferase deficiency.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM23441
AC   CVCL_Y719
DR   Coriell; GM23441
DR   Wikidata; Q54853082
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Met213Thr (c.638T>C); Zygosity=Heterozygous (Coriell=GM23441).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23443
AC   CVCL_BV69
DR   Coriell; GM23443
DR   Wikidata; Q54853083
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~160]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM23443).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[~947]; ClinVar=VCV000561195; Zygosity=Heterozygous (Coriell=GM23443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23444
AC   CVCL_BV70
DR   Coriell; GM23444
DR   Wikidata; Q54853084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23445
AC   CVCL_BV71
DR   Coriell; GM23445
DR   Wikidata; Q54853085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23446
AC   CVCL_T817
SY   GM23446*B
DR   Coriell; GM23446
DR   SKIP; SKIP000258
DR   SKIP; SKIP004365
DR   Wikidata; Q54853087
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7271 ! GM00038
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   GM2345
AC   CVCL_B4G2
DR   cancercelllines; CVCL_B4G2
DR   IARC_TP53; 20805
DR   Wikidata; Q110432825
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   GM23450
AC   CVCL_T802
SY   GM23450*B
DR   Coriell; GM23450
DR   SKIP; SKIP000177
DR   SKIP; SKIP004357
DR   Wikidata; Q54853089
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F134 ! GM06113
SX   Male
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   GM23455
AC   CVCL_Y720
DR   Coriell; GM23455
DR   Wikidata; Q54853090
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Pro347Ser (c.1039C>T); ClinVar=VCV002138547; Zygosity=Hemizygous (Coriell=GM23455).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23457
AC   CVCL_Y721
DR   Coriell; GM23457
DR   Wikidata; Q54853091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23459
AC   CVCL_BV72
DR   Coriell; GM23459
DR   Wikidata; Q54853095
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; c.1226_1337del (Ex4del); Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM23461
AC   CVCL_BV73
DR   Coriell; GM23461
DR   Wikidata; Q54853096
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Pro152Arg (c.455C>G) (p.Pro164Arg, c.491C>G); ClinVar=VCV000143579; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23462
AC   CVCL_BV74
DR   Coriell; GM23462
DR   Wikidata; Q54853097
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg270Ter (c.808C>T) (p.Arg282Ter, c.844C>T); ClinVar=VCV000011815; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23463
AC   CVCL_BV75
DR   Coriell; GM23463
DR   Wikidata; Q54853098
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Glu392Ter (c.1173_1207del); Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23464
AC   CVCL_Y722
DR   Coriell; GM23464
DR   Wikidata; Q54853100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23465
AC   CVCL_Y723
DR   Coriell; GM23465
DR   Wikidata; Q54853101
CC   Sequence variation: Gene deletion; HGNC; HGNC:8512; OTC; Zygosity=Homozygous (Coriell=GM23465).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM23466
AC   CVCL_U549
DR   Coriell; GM23466
DR   Wikidata; Q54853102
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23468
AC   CVCL_1N00
DR   Coriell; GM23468
DR   Wikidata; Q54853103
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23476
AC   CVCL_T841
SY   GM23476*C
DR   Coriell; GM23476
DR   SKIP; SKIP000391
DR   SKIP; SKIP004366
DR   Wikidata; Q54853104
RX   PubMed=21490598;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7413 ! GM04506
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM23485
AC   CVCL_BV76
DR   Coriell; GM23485
DR   Wikidata; Q54853105
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM23486
AC   CVCL_Y724
DR   Coriell; GM23486
DR   Wikidata; Q54853106
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu95Ser (c.284T>C); ClinVar=VCV000097156; Zygosity=Heterozygous (Coriell=GM23486).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23487
AC   CVCL_Y725
DR   Coriell; GM23487
DR   Wikidata; Q54853107
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu95Ser (c.284T>C); ClinVar=VCV000097156; Zygosity=Heterozygous (Coriell=GM23487).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23488
AC   CVCL_5S90
DR   Coriell; GM23488
DR   Wikidata; Q54853108
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23489
AC   CVCL_5S91
DR   Coriell; GM23489
DR   Wikidata; Q54853109
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23490
AC   CVCL_1K32
DR   Coriell; GM23490
DR   Wikidata; Q54853110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23491
AC   CVCL_1K33
DR   Coriell; GM23491
DR   Wikidata; Q54853111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23492
AC   CVCL_5S92
SY   801-018 LCL
DR   Coriell; GM23492
DR   Wikidata; Q54853112
RX   PubMed=23495136;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23493
AC   CVCL_5S93
DR   Coriell; GM23493
DR   Wikidata; Q54853113
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23494
AC   CVCL_AY73
DR   Coriell; GM23494
DR   Wikidata; Q54853114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23495
AC   CVCL_4F83
DR   Coriell; GM23495
DR   Wikidata; Q54853115
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM23495).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F84 ! GM23496
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM23496
AC   CVCL_4F84
DR   Coriell; GM23496
DR   Wikidata; Q54853116
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM23496).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4F83 ! GM23495
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM23497
AC   CVCL_BV77
DR   Coriell; GM23497
DR   Wikidata; Q54853118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23498
AC   CVCL_5S94
DR   Coriell; GM23498
DR   Wikidata; Q54853119
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23499
AC   CVCL_CX80
DR   Coriell; GM23499
DR   Wikidata; Q54853120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23500
AC   CVCL_Y726
DR   Coriell; GM23500
DR   Wikidata; Q54853121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23501
AC   CVCL_Y727
DR   Coriell; GM23501
DR   Wikidata; Q54853122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23502
AC   CVCL_Y728
DR   Coriell; GM23502
DR   Wikidata; Q54853123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23503
AC   CVCL_BV78
DR   Coriell; GM23503
DR   Wikidata; Q54853124
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM23504
AC   CVCL_5S95
DR   Coriell; GM23504
DR   Wikidata; Q54853125
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23505
AC   CVCL_1L24
DR   Coriell; GM23505
DR   Wikidata; Q54853127
CC   Sequence variation: Mutation; HGNC; HGNC:9726; PYGM; Simple; p.Arg50Ter (c.148C>T); ClinVar=VCV000002298; Zygosity=Homozygous (Coriell=GM23505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM23506
AC   CVCL_AY74
DR   Coriell; GM23506
DR   Wikidata; Q54853128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23507
AC   CVCL_AY75
DR   Coriell; GM23507
DR   Wikidata; Q54853129
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Cys967Ter (c.2901C>A); ClinVar=VCV000014301; Zygosity=Heterozygous (Coriell=GM23507).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; c.6429+1G>T; ClinVar=VCV000556858; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM23507).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23508
AC   CVCL_AY76
DR   Coriell; GM23508
DR   Wikidata; Q54853130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23509
AC   CVCL_Y729
DR   Coriell; GM23509
DR   Wikidata; Q54853131
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ala135Glu (c.404C>A); ClinVar=VCV000097191; Zygosity=Hemizygous (Coriell=GM23509).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23510
AC   CVCL_BV79
DR   Coriell; GM23510
DR   Wikidata; Q54853132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23597
AC   CVCL_HK81
DR   Coriell; GM23597
DR   Wikidata; Q54853133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM23598
AC   CVCL_BV80
DR   Coriell; GM23598
DR   Wikidata; Q54853134
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg270Ter (c.808C>T) (p.Arg282Ter, c.844C>T); ClinVar=VCV000011815; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23599
AC   CVCL_BV81
DR   Coriell; GM23599
DR   Wikidata; Q54853135
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Unexplicit; Ex3-4del; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM23600
AC   CVCL_JA66
DR   Coriell; GM23600
DR   Wikidata; Q54853136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26965; Selective IgM immunodeficiency
DI   ORDO; Orphanet_331235; Selective IgM deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM23601
AC   CVCL_BV82
DR   Coriell; GM23601
DR   Wikidata; Q54853137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23602
AC   CVCL_BV83
DR   Coriell; GM23602
DR   Wikidata; Q54853142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   NCIt; C68677; von Willebrand disease
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_903; Von Willebrand disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23603
AC   CVCL_IZ53
DR   Coriell; GM23603
DR   Wikidata; Q54853143
RX   PubMed=26247043;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132826; Charcot-Marie-Tooth disease, spinal, type I
DI   ORDO; Orphanet_139518; Distal hereditary motor neuropathy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   GM23605
AC   CVCL_BV84
DR   Coriell; GM23605
DR   Wikidata; Q54853144
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Tyr141Ter (c.423C>G) (p.Tyr153Ter, c.459C>G); ClinVar=VCV000011833; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23606
AC   CVCL_BV85
DR   Coriell; GM23606
DR   Wikidata; Q54853145
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; c.27-8C>G (IVS2-8C>G); ClinVar=VCV000156049; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23607
AC   CVCL_BV86
DR   Coriell; GM23607
DR   Wikidata; Q54853146
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Glyfs*4 (c.1157_1200del44) (p.Leu398Glyfs*4, c.1193_1236del44); ClinVar=VCV000143372; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23608
AC   CVCL_V035
DR   Coriell; GM23608
DR   Wikidata; Q54853147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM23609
AC   CVCL_5M26
DR   Coriell; GM23609
DR   Wikidata; Q54853148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2W
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23610
AC   CVCL_1N01
DR   Coriell; GM23610
DR   Wikidata; Q54853149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N02 ! GM23611
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM23611
AC   CVCL_1N02
DR   Coriell; GM23611
DR   Wikidata; Q54853150
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N01 ! GM23610
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23612
AC   CVCL_M918
DR   Coriell; GM23612
DR   Wikidata; Q54853151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M919 ! GM23613
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM23613
AC   CVCL_M919
DR   Coriell; GM23613
DR   Wikidata; Q54853152
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M918 ! GM23612
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   GM23614
AC   CVCL_M917
DR   Coriell; GM23614
DR   Wikidata; Q54853153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GM23616
AC   CVCL_5S96
DR   Coriell; GM23616
DR   Wikidata; Q54853154
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23617
AC   CVCL_BV87
DR   Coriell; GM23617
DR   Wikidata; Q54853155
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~750] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23617).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23618
AC   CVCL_BV88
DR   Coriell; GM23618
DR   Wikidata; Q54853156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23620
AC   CVCL_1N03
DR   Coriell; GM23620
DR   Wikidata; Q54853157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N04 ! GM23621
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23621
AC   CVCL_1N04
DR   Coriell; GM23621
DR   Wikidata; Q54853158
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N03 ! GM23620
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   GM23622
AC   CVCL_1N05
DR   Coriell; GM23622
DR   Wikidata; Q54853159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N06 ! GM23623
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM23623
AC   CVCL_1N06
DR   Coriell; GM23623
DR   Wikidata; Q54853160
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122660; Hardcastle's syndrome
DI   ORDO; Orphanet_85182; Diaphyseal medullary stenosis-bone malignancy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N05 ! GM23622
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23624
AC   CVCL_BV89
DR   Coriell; GM23624
DR   Wikidata; Q54853161
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg133Pro (c.398G>C) (p.Arg145Pro, c.434G>C); ClinVar=VCV001679147; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23625
AC   CVCL_BV90
DR   Coriell; GM23625
DR   Wikidata; Q54853162
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg270Ter (c.808C>T) (p.Arg282Ter, c.844C>T); ClinVar=VCV000011815; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23626
AC   CVCL_BV91
DR   Coriell; GM23626
DR   Wikidata; Q54853163
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Pro152Arg (c.455C>G) (p.Pro164Arg, c.491C>G); ClinVar=VCV000143579; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23627
AC   CVCL_Y730
DR   Coriell; GM23627
DR   Wikidata; Q54853164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23628
AC   CVCL_IN35
DR   Coriell; GM23628
DR   Wikidata; Q54853165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM23629
AC   CVCL_GS99
DR   Coriell; GM23629
DR   Wikidata; Q54853166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84942; Oculopharyngeal muscular dystrophy
DI   ORDO; Orphanet_270; Oculopharyngeal muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23630
AC   CVCL_BX03
DR   Coriell; GM23630
DR   Wikidata; Q54853167
CC   Sequence variation: Mutation; HGNC; HGNC:17997; FKRP; Simple; p.Leu276Ile (c.826C>A); ClinVar=VCV000004221; Zygosity=Homozygous (Coriell=GM23630).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126739; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 5
DI   ORDO; Orphanet_34515; FKRP-related limb-girdle muscular dystrophy R9
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX13 ! GM23868
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM23631
AC   CVCL_Y731
DR   Coriell; GM23631
DR   Wikidata; Q54853168
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Met335Ile (c.1005G>A); ClinVar=VCV000097091; Zygosity=Hemizygous (Coriell=GM23631).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23632
AC   CVCL_Y732
DR   Coriell; GM23632
DR   Wikidata; Q54853169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23633
AC   CVCL_CX81
DR   Coriell; GM23633
DR   Wikidata; Q54853170
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly12Valfs*2 (c.35delG); ClinVar=VCV000017004; Zygosity=Heterozygous (Coriell=GM23633).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23634
AC   CVCL_BV92
DR   Coriell; GM23634
DR   Wikidata; Q54853171
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg133Cys (c.397C>T) (p.Arg145Cys, c.433C>T); ClinVar=VCV000011809; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23635
AC   CVCL_BV93
DR   Coriell; GM23635
DR   Wikidata; Q54853172
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Unexplicit; Ex3-4del; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM23636
AC   CVCL_Y733
DR   Coriell; GM23636
DR   Wikidata; Q54853173
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Gln180Pro (c.539_540AG>CC); Zygosity=Unspecified (Coriell=GM23636).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23637
AC   CVCL_HK82
DR   Coriell; GM23637
DR   Wikidata; Q54853175
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg277Trp (c.829C>T); ClinVar=VCV000010999; Zygosity=Heterozygous (Coriell=GM23637).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with OTC deficiency but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM23638
AC   CVCL_Y734
DR   Coriell; GM23638
DR   Wikidata; Q54853176
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg277Trp (c.829C>T); ClinVar=VCV000010999; Zygosity=Heterozygous (Coriell=GM23638).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with OTC deficiency but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM23640
AC   CVCL_AY77
DR   Coriell; GM23640
DR   Wikidata; Q54853177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23641
AC   CVCL_AY78
DR   Coriell; GM23641
DR   Wikidata; Q54853178
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Val178Met (c.532G>A); ClinVar=VCV000002402; Zygosity=Heterozygous (Coriell=GM23641).
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Met256Thr (c.767T>C); ClinVar=VCV002066939; Zygosity=Heterozygous (Coriell=GM23641).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23642
AC   CVCL_BV94
DR   Coriell; GM23642
DR   Wikidata; Q54853179
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84704; Facioscapulohumeral muscular dystrophy
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23643
AC   CVCL_Y735
DR   Coriell; GM23643
DR   Wikidata; Q54853180
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg141Gln (c.422G>A); ClinVar=VCV000010987; Zygosity=Heterozygous (Coriell=GM23643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23645
AC   CVCL_BV95
DR   Coriell; GM23645
DR   Wikidata; Q54853181
CC   Population: Caucasian; German/Norwegian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~333] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (Coriell=GM23645).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23646
AC   CVCL_BV96
DR   Coriell; GM23646
DR   Wikidata; Q54853182
CC   Population: Caucasian; Norwegian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23647
AC   CVCL_BV97
DR   Coriell; GM23647
DR   Wikidata; Q54853190
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; c.378-3C>G (IVS3-3C>G); ClinVar=VCV000156068; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23648
AC   CVCL_BV98
DR   Coriell; GM23648
DR   Wikidata; Q54853192
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Unexplicit; Ex4del; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM23649
AC   CVCL_BV99
DR   Coriell; GM23649
DR   Wikidata; Q54853193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23650
AC   CVCL_BX04
DR   Coriell; GM23650
DR   Wikidata; Q54853194
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg401Cys (c.1201C>T); ClinVar=VCV000133029; Zygosity=Heterozygous (Coriell=GM23650).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Pro2488Hisfs*39 (c.7463_7475delCAAAGATGTCAGC); ClinVar=VCV000197559; Zygosity=Heterozygous (Coriell=GM23650).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23651
AC   CVCL_AZ47
DR   Coriell; GM23651
DR   Wikidata; Q54853196
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Asn238Lysfs*63 (c.713dupA) (c.713_714insA); ClinVar=VCV000004494; Zygosity=Homozygous (Coriell=GM23651).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ51 ! GM24369
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23652
AC   CVCL_BX05
DR   Coriell; GM23652
DR   Wikidata; Q54853197
CC   Sequence variation: Mutation; HGNC; HGNC:6511; LARGE1; Simple; p.Glu509Lys (c.1525G>A); ClinVar=VCV000006216; Zygosity=Heterozygous (Coriell=GM23652).
CC   Sequence variation: Mutation; HGNC; HGNC:6511; LARGE1; Unexplicit; Large deletion; Zygosity=Heterozygous (Coriell=GM23652).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126743; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 6
DI   ORDO; Orphanet_370968; Congenital muscular dystrophy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23653
AC   CVCL_5M27
DR   Coriell; GM23653
DR   Wikidata; Q54853199
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Arg304Trp (c.910C>T); ClinVar=VCV000006330; Zygosity=Homozygous (Coriell=GM23653).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   GM23654
AC   CVCL_BW00
DR   Coriell; GM23654
DR   Wikidata; Q54853201
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Unexplicit; Ex3-4del; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM23656
AC   CVCL_Y736
DR   Coriell; GM23656
DR   Wikidata; Q54853202
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg92Gln (c.275G>A); ClinVar=VCV000097152; Zygosity=Heterozygous (Coriell=GM23656).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23657
AC   CVCL_Y737
DR   Coriell; GM23657
DR   Wikidata; Q54853203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23658
AC   CVCL_AY79
DR   Coriell; GM23658
DR   Wikidata; Q54853205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23659
AC   CVCL_BW01
DR   Coriell; GM23659
DR   Wikidata; Q54853206
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg133Cys (c.397C>T) (p.Arg145Cys, c.433C>T); ClinVar=VCV000011809; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23661
AC   CVCL_5M31
DR   Coriell; GM23661
DR   Wikidata; Q54853207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23663
AC   CVCL_BW02
DR   Coriell; GM23663
DR   Wikidata; Q54853208
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg133Cys (c.397C>T) (p.Arg145Cys, c.433C>T); ClinVar=VCV000011809; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23665
AC   CVCL_GT00
DR   Coriell; GM23665
DR   Wikidata; Q54853209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129029; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
DI   ORDO; Orphanet_415; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23666
AC   CVCL_4T48
DR   Coriell; GM23666
DR   Wikidata; Q54853210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM23667
AC   CVCL_Y738
DR   Coriell; GM23667
DR   Wikidata; Q54853211
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; c.216+1G>T (IVS2+1G>T); ClinVar=VCV000097135; Zygosity=Hemizygous; Note=Splice donor mutation (Coriell=GM23667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   GM23668
AC   CVCL_Y739
DR   Coriell; GM23668
DR   Wikidata; Q54853212
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ala208Thr (c.622G>A); ClinVar=VCV000097274; Zygosity=Hemizygous (Coriell=GM23668).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23670
AC   CVCL_AY80
DR   Coriell; GM23670
DR   Wikidata; Q54853213
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Asp2498Ilefs*49 (c.7491delA); Zygosity=Heterozygous (Coriell=GM23670).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; c.8244+3_8244+6delAAGT (c.8244+3_+6delAAGT); ClinVar=VCV000447695; Zygosity=Heterozygous (Coriell=GM23670).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23671
AC   CVCL_Y740
DR   Coriell; GM23671
DR   Wikidata; Q54853214
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg141Ter (c.421C>T); ClinVar=VCV000010988; Zygosity=Heterozygous (Coriell=GM23671).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23672
AC   CVCL_5M32
DR   Coriell; GM23672
DR   Wikidata; Q54853215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23673
AC   CVCL_AY81
DR   Coriell; GM23673
DR   Wikidata; Q54853216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23674
AC   CVCL_BW03
DR   Coriell; GM23674
DR   Wikidata; Q54853217
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Asn238Lysfs*63 (c.713dupA) (c.713_714insA); ClinVar=VCV000004494; Zygosity=Unspecified (Coriell=GM23674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23675
AC   CVCL_5S97
DR   Coriell; GM23675
DR   Wikidata; Q54853218
RX   PubMed=23665875;
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Hemizygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 14
//
ID   GM23676
AC   CVCL_5S98
DR   Coriell; GM23676
DR   Wikidata; Q54853219
RX   PubMed=23665875;
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 14
//
ID   GM23677
AC   CVCL_5M33
DR   Coriell; GM23677
DR   Wikidata; Q54853220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23678
AC   CVCL_BW04
DR   Coriell; GM23678
DR   Wikidata; Q54853221
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23681
AC   CVCL_4T49
DR   Coriell; GM23681
DR   Wikidata; Q54853222
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Gly301Ser (c.901G>A); ClinVar=VCV000283758; Zygosity=Heterozygous (Coriell=GM23681).
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Pro518Ser (c.1552C>T); ClinVar=VCV000093911; Zygosity=Heterozygous (Coriell=GM23681).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM23682
AC   CVCL_BW05
DR   Coriell; GM23682
DR   Wikidata; Q54853223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23683
AC   CVCL_Y741
DR   Coriell; GM23683
DR   Wikidata; Q54853224
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg92Ter (c.274C>T); ClinVar=VCV000097151; Zygosity=Heterozygous (Coriell=GM23683).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23684
AC   CVCL_AY82
DR   Coriell; GM23684
DR   Wikidata; Q54853225
CC   Sequence variation: Mutation; HGNC; HGNC:2323; CPS1; Simple; p.Glu1034Gly (c.3101A>G); Zygosity=Unspecified (Coriell=GM23684).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84612; Carbamoyl-phosphate synthetase I deficiency
DI   ORDO; Orphanet_147; Carbamoyl-phosphate synthetase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   GM23685
AC   CVCL_Y742
DR   Coriell; GM23685
DR   Wikidata; Q54853227
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ile160Thr (c.479T>C); ClinVar=VCV000097213; Zygosity=Hemizygous (Coriell=GM23685).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23686
AC   CVCL_Y966
DR   Coriell; GM23686
DR   Wikidata; Q54853228
RX   PubMed=26247043;
RX   PubMed=28284873;
RX   PubMed=33197628;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,14
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   GM23687
AC   CVCL_Y937
DR   Coriell; GM23687
DR   Wikidata; Q54853229
RX   PubMed=26247043;
RX   PubMed=28284873;
RX   PubMed=33197628;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Heterozygous (PubMed=28284873; PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   GM23688
AC   CVCL_Y938
DR   Coriell; GM23688
DR   Wikidata; Q54853230
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Heterozygous (PubMed=28284873).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 7,11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   GM23689
AC   CVCL_Y939
DR   Coriell; GM23689
DR   Wikidata; Q54853231
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: GM23389; PubMed=28284873.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 9
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11,12
ST   vWA: 14,15
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   GM23692
AC   CVCL_1L25
DR   Coriell; GM23692
DR   Wikidata; Q54853233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23693
AC   CVCL_5S99
DR   Coriell; GM23693
DR   Wikidata; Q54853234
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23694
AC   CVCL_5T00
DR   Coriell; GM23694
DR   Wikidata; Q54853235
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23695
AC   CVCL_5T01
DR   Coriell; GM23695
DR   Wikidata; Q54853236
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23696
AC   CVCL_5T02
DR   Coriell; GM23696
DR   Wikidata; Q54853241
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23697
AC   CVCL_5T03
DR   Coriell; GM23697
DR   Wikidata; Q54853242
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23698
AC   CVCL_5T04
DR   Coriell; GM23698
DR   Wikidata; Q54853243
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23699
AC   CVCL_5T05
DR   Coriell; GM23699
DR   Wikidata; Q54853244
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23700
AC   CVCL_5T06
DR   Coriell; GM23700
DR   Wikidata; Q54853245
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23701
AC   CVCL_5T07
DR   Coriell; GM23701
DR   Wikidata; Q54853246
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23702
AC   CVCL_5T08
DR   Coriell; GM23702
DR   Wikidata; Q54853247
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23703
AC   CVCL_5T09
DR   Coriell; GM23703
DR   Wikidata; Q54853248
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23704
AC   CVCL_5T10
DR   Coriell; GM23704
DR   Wikidata; Q54853249
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23705
AC   CVCL_5M34
DR   Coriell; GM23705
DR   Wikidata; Q54853250
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Gly390Arg (c.1168G>A); ClinVar=VCV000006329; Zygosity=Unspecified (Coriell=GM23705).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   GM23706
AC   CVCL_5M35
DR   Coriell; GM23706
DR   Wikidata; Q54853251
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM23707
AC   CVCL_6B21
DR   Coriell; GM23707
DR   Wikidata; Q54853252
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Gln119Argfs*2 (c.356delA); Zygosity=Hemizygous (Coriell=GM23707).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84685; Emery-Dreifuss muscular dystrophy
DI   ORDO; Orphanet_261; Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23708
AC   CVCL_5T11
DR   Coriell; GM23708
DR   Wikidata; Q54853253
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23709
AC   CVCL_BT10
DR   Coriell; GM23709
DR   Wikidata; Q54853254
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)51 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (Coriell=GM23709).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23710
AC   CVCL_IW01
DR   Coriell; GM23710
DR   Wikidata; Q54853255
CC   Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Unexplicit; Ex17-18del; Zygosity=Unspecified (Coriell=GM23710).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   GM23711
AC   CVCL_5T12
DR   Coriell; GM23711
DR   Wikidata; Q54853256
RX   PubMed=23665875;
CC   Sequence variation: Gene deletion; HGNC; HGNC:20444; MBD5; Zygosity=Heterozygous (Coriell=GM23711).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141424; Intellectual developmental disorder, autosomal dominant 1
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ37 ! GM24585
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 15
//
ID   GM23712
AC   CVCL_5T13
DR   Coriell; GM23712
DR   Wikidata; Q54853257
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5T41 ! GM24586
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23713
AC   CVCL_5T14
DR   Coriell; GM23713
DR   Wikidata; Q54853258
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5T42 ! GM24587
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23714
AC   CVCL_BW06
DR   Coriell; GM23714
DR   Wikidata; Q54853259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23715
AC   CVCL_5T15
DR   Coriell; GM23715
DR   Wikidata; Q54853260
CC   Discontinued: Coriell; GM23715; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM23716
AC   CVCL_T803
SY   GM23716*B
DR   Coriell; GM23716
DR   SKIP; SKIP000252
DR   SKIP; SKIP004361
DR   Wikidata; Q54853262
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7447 ! GM06111
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   GM23717
AC   CVCL_F195
SY   GM23717*B; GM23717-iPSC
DR   Coriell; GM23717
DR   SKIP; SKIP000190
DR   SKIP; SKIP004367
DR   Wikidata; Q54853263
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg683Serfs*21 (c.2045_2046AG[2]) (c.2049_2050delAG); ClinVar=VCV000038340; Zygosity=Heterozygous (Coriell=GM23717).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg2578Ter (c.7732C>T); ClinVar=VCV000014296; Zygosity=Heterozygous (Coriell=GM23717).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F196 ! GM23311
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GM23720
AC   CVCL_T818
SY   GM23720*B
DR   Coriell; GM23720
DR   SKIP; SKIP000259
DR   SKIP; SKIP004368
DR   Wikidata; Q54853264
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7355 ! GM02254
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   GM23721
AC   CVCL_M916
DR   Coriell; GM23721
DR   Wikidata; Q54853265
RX   PubMed=29034895;
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Ser140Thr (c.418T>A); ClinVar=VCV000447730; Zygosity=Heterozygous (Coriell=GM23721).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034895
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 22,25
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 7,15
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 14,15
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   GM23722
AC   CVCL_5T16
DR   Coriell; GM23722
DR   Wikidata; Q54853266
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23723
AC   CVCL_5T17
DR   Coriell; GM23723
DR   Wikidata; Q54853267
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23724
AC   CVCL_Y743
DR   Coriell; GM23724
DR   Wikidata; Q54853268
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu301Ser (c.901T>C); Zygosity=Unspecified (Coriell=GM23724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23725
AC   CVCL_Y744
DR   Coriell; GM23725
DR   Wikidata; Q54853269
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu301Ser (c.901T>C); Zygosity=Unspecified (Coriell=GM23725).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23726
AC   CVCL_Y745
DR   Coriell; GM23726
DR   Wikidata; Q54853270
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM23728
AC   CVCL_4T50
DR   Coriell; GM23728
DR   Wikidata; Q54853271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM23730
AC   CVCL_Y746
DR   Coriell; GM23730
DR   Wikidata; Q54853272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23731
AC   CVCL_GT01
DR   Coriell; GM23731
DR   Wikidata; Q54853273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129029; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
DI   ORDO; Orphanet_415; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23732
AC   CVCL_Y747
DR   Coriell; GM23732
DR   Wikidata; Q54853274
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; c.472dupT; Zygosity=Unspecified (Coriell=GM23732).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23733
AC   CVCL_BX06
DR   Coriell; GM23733
DR   Wikidata; Q54853275
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   GM23734
AC   CVCL_BX07
DR   Coriell; GM23734
DR   Wikidata; Q54853276
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Gene amplification; HGNC; HGNC:6990; MECP2; Duplication; Zygosity=Hemizygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126747; Lubs X-linked intellectual disability syndrome
DI   ORDO; Orphanet_1762; Proximal Xq28 duplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   GM23735
AC   CVCL_4T51
DR   Coriell; GM23735
DR   Wikidata; Q54853277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM23742
AC   CVCL_BW07
DR   Coriell; GM23742
DR   Wikidata; Q54853278
CC   Population: Caucasian and Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23743
AC   CVCL_Y748
DR   Coriell; GM23743
DR   Wikidata; Q54853279
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg26Gln (c.77G>A); ClinVar=VCV000010993; Zygosity=Hemizygous (Coriell=GM23743).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23744
AC   CVCL_Y749
DR   Coriell; GM23744
DR   Wikidata; Q54853280
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg26Gln (c.77G>A); ClinVar=VCV000010993; Zygosity=Heterozygous (Coriell=GM23744).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23747
AC   CVCL_BW08
DR   Coriell; GM23747
DR   Wikidata; Q54853281
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23748
AC   CVCL_BW09
DR   Coriell; GM23748
DR   Wikidata; Q54853286
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Population: Asian and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM23749
AC   CVCL_BW10
DR   Coriell; GM23749
DR   Wikidata; Q54853287
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23750
AC   CVCL_BW11
DR   Coriell; GM23750
DR   Wikidata; Q54853288
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23751
AC   CVCL_BW12
DR   Coriell; GM23751
DR   Wikidata; Q54853289
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23752
AC   CVCL_Y750
DR   Coriell; GM23752
DR   Wikidata; Q54853290
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM23760
AC   CVCL_T804
SY   GM23760*B
DR   Coriell; GM23760
DR   SKIP; SKIP000253
DR   SKIP; SKIP004369
DR   Wikidata; Q54853291
RX   PubMed=21490598;
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T805 ! GM01792
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM23761
AC   CVCL_T807
SY   GM23761*B
DR   Coriell; GM23761
DR   SKIP; SKIP000260
DR   SKIP; SKIP004370
DR   Wikidata; Q54853292
RX   PubMed=21490598;
CC   Population: Jewish and Caucasian; Scandinavian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D873 ! GM01835
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM23762
AC   CVCL_T808
SY   GM23762*B
DR   Coriell; GM23762
DR   SKIP; SKIP000261
DR   SKIP; SKIP004371
DR   Wikidata; Q54853293
RX   PubMed=21490598;
CC   Population: Jewish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T810 ! GM02497
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   GM23764
AC   CVCL_U111
SY   GM23764*C
DR   Coriell; GM23764
DR   SKIP; SKIP000390
DR   SKIP; SKIP004372
DR   Wikidata; Q54853294
RX   PubMed=21490598;
CC   Population: Jewish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34387; Anorexia nervosa
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T814 ! GM02503
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 15
//
ID   GM23767
AC   CVCL_Y751
DR   Coriell; GM23767
DR   Wikidata; Q54853295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23768
AC   CVCL_AY83
DR   Coriell; GM23768
DR   Wikidata; Q54853296
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23769
AC   CVCL_Y752
DR   Coriell; GM23769
DR   Wikidata; Q54853297
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu349Pro (c.1046T>C); Zygosity=Mosaic (Coriell=GM23769).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with ornithine carbamoyltransferase deficiency disease but at risk.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23770
AC   CVCL_Y753
DR   Coriell; GM23770
DR   Wikidata; Q54853298
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu349Pro (c.1046T>C); Zygosity=Unspecified (Coriell=GM23770).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23771
AC   CVCL_BW13
DR   Coriell; GM23771
DR   Wikidata; Q54853299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84786; Inclusion body myositis
DI   ORDO; Orphanet_611; Inclusion body myositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23772
AC   CVCL_1L26
DR   Coriell; GM23772
DR   Wikidata; Q54853300
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GM23773
AC   CVCL_BX08
DR   Coriell; GM23773
DR   Wikidata; Q54853301
CC   Population: Caucasian; British/French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM23774
AC   CVCL_BX09
DR   Coriell; GM23774
DR   Wikidata; Q54853302
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM23778
AC   CVCL_4T52
DR   Coriell; GM23778
DR   Wikidata; Q54853303
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; c.1053+1G>T (IVS11+1G>T); Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM23778).
CC   Discontinued: Coriell; GM23778; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM23780
AC   CVCL_BX10
DR   Coriell; GM23780
DR   Wikidata; Q54853304
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Leu35Pro (c.104T>C); ClinVar=VCV000066765; Zygosity=Heterozygous (Coriell=GM23780).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126745; Emery-Dreifuss muscular dystrophy 2, autosomal dominant
DI   ORDO; Orphanet_98853; Autosomal dominant Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM23781
AC   CVCL_AY84
DR   Coriell; GM23781
DR   Wikidata; Q54853305
CC   Population: Caucasian; German/Irish and Native North American; Cherokee.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Tyr3921Ter (c.11763C>A); ClinVar=VCV000161361; Zygosity=Heterozygous (Coriell=GM23781).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23782
AC   CVCL_4T53
DR   Coriell; GM23782
DR   Wikidata; Q54853306
CC   Population: Caucasian; British/German.
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Gly319_Lys333del (c.955-2A>G); ClinVar=VCV000520800; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM23782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM23784
AC   CVCL_BW14
DR   Coriell; GM23784
DR   Wikidata; Q54853307
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; c.532+5G>A (IVS7+5G>A); ClinVar=VCV000010056; Zygosity=Hemizygous (Coriell=GM23784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23785
AC   CVCL_BW15
DR   Coriell; GM23785
DR   Wikidata; Q54853308
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; c.532+5G>A (IVS7+5G>A); ClinVar=VCV000010056; Zygosity=Hemizygous (Coriell=GM23785).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23786
AC   CVCL_5K26
DR   Coriell; GM23786
DR   Wikidata; Q54853309
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K60 ! GM24308
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   GM23788
AC   CVCL_Y754
DR   Coriell; GM23788
DR   Wikidata; Q54853310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23793
AC   CVCL_AY85
DR   Coriell; GM23793
DR   Wikidata; Q54853311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23794
AC   CVCL_AY86
DR   Coriell; GM23794
DR   Wikidata; Q54853312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23795
AC   CVCL_AY87
DR   Coriell; GM23795
DR   Wikidata; Q54853313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23796
AC   CVCL_AD78
DR   Coriell; GM23796
DR   Wikidata; Q54853314
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg109Trp (c.325C>T); ClinVar=VCV000012988; Zygosity=Heterozygous (from familial inference of GM23800).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg2241Ter (c.6721C>T); Zygosity=Heterozygous (from familial inference of GM23800).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150608; Minicore myopathy with external ophthalmoplegia
DI   ORDO; Orphanet_98905; Congenital multicore myopathy with external ophthalmoplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23797
AC   CVCL_AD79
DR   Coriell; GM23797
DR   Wikidata; Q54853315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23798
AC   CVCL_AD80
DR   Coriell; GM23798
DR   Wikidata; Q54853316
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg109Trp (c.325C>T); ClinVar=VCV000012988; Zygosity=Heterozygous (Coriell=GM23798).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23799
AC   CVCL_AD81
DR   Coriell; GM23799
DR   Wikidata; Q54853317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23800
AC   CVCL_AD82
DR   Coriell; GM23800
DR   Wikidata; Q54853319
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg109Trp (c.325C>T); ClinVar=VCV000012988; Zygosity=Heterozygous (Coriell=GM23800).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg2241Ter (c.6721C>T); Zygosity=Heterozygous (Coriell=GM23800).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150608; Minicore myopathy with external ophthalmoplegia
DI   ORDO; Orphanet_98905; Congenital multicore myopathy with external ophthalmoplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VI97 ! GM25516
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM23803
AC   CVCL_AD83
DR   Coriell; GM23803
DR   Wikidata; Q54853320
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM23806
AC   CVCL_AD84
DR   Coriell; GM23806
DR   Wikidata; Q54853321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM23808
AC   CVCL_Y755
DR   Coriell; GM23808
DR   Wikidata; Q54853322
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000097371; Zygosity=Unspecified (Coriell=GM23808).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23809
AC   CVCL_5M36
DR   Coriell; GM23809
DR   Wikidata; Q54853323
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Arg344Ter (c.1030C>T); ClinVar=VCV000188885; Zygosity=Heterozygous (Coriell=GM23809).
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Arg363Trp (c.1087C>T); ClinVar=VCV000006328; Zygosity=Heterozygous (Coriell=GM23809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM23811
AC   CVCL_Y756
DR   Coriell; GM23811
DR   Wikidata; Q54853324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23813
AC   CVCL_5T18
DR   Coriell; GM23813
DR   Wikidata; Q54853325
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23814
AC   CVCL_BW16
DR   Coriell; GM23814
DR   Wikidata; Q54853326
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg48His (c.143G>A); ClinVar=VCV000029985; Zygosity=Hemizygous (Coriell=GM23814).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23815
AC   CVCL_BW17
DR   Coriell; GM23815
DR   GEO; GSM3124678
DR   Wikidata; Q54853342
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   GM23817
AC   CVCL_BX11
DR   Coriell; GM23817
DR   Wikidata; Q54853343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126738; Phosphoglycerate kinase 1 deficiency
DI   ORDO; Orphanet_713; Glycogen storage disease due to phosphoglycerate kinase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23818
AC   CVCL_5T19
DR   Coriell; GM23818
DR   Wikidata; Q54853344
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23819
AC   CVCL_1K34
DR   Coriell; GM23819
DR   Wikidata; Q54853345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GM23820
AC   CVCL_BW18
DR   Coriell; GM23820
DR   Wikidata; Q54853346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23822
AC   CVCL_5T20
DR   Coriell; GM23822
DR   Wikidata; Q54853347
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34858; Morbid obesity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23823
AC   CVCL_AY88
DR   Coriell; GM23823
DR   Wikidata; Q54853348
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Gln286Arg (c.857A>G); ClinVar=VCV000002399; Zygosity=Unspecified (Coriell=GM23823).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23824
AC   CVCL_BX12
DR   Coriell; GM23824
DR   Wikidata; Q54853350
CC   Sequence variation: Mutation; HGNC; HGNC:19743; POMT2; Simple; p.Phe221Ile (c.661T>A); ClinVar=VCV000807153; Zygosity=Homozygous (Coriell=GM23824).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126742; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 2
DI   ORDO; Orphanet_899; Walker-Warburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23825
AC   CVCL_5M37
DR   Coriell; GM23825
DR   Wikidata; Q54853352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23826
AC   CVCL_Y757
DR   Coriell; GM23826
DR   Wikidata; Q54853353
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg141Ter (c.421C>T); ClinVar=VCV000010988; Zygosity=Unspecified (Coriell=GM23826).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23827
AC   CVCL_Y758
DR   Coriell; GM23827
DR   Wikidata; Q54853355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM23828
AC   CVCL_Y759
DR   Coriell; GM23828
DR   Wikidata; Q54853356
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg141Ter (c.421C>T); ClinVar=VCV000010988; Zygosity=Unspecified (Coriell=GM23828).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23829
AC   CVCL_Y760
DR   Coriell; GM23829
DR   Wikidata; Q54853357
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg141Ter (c.421C>T); ClinVar=VCV000010988; Zygosity=Unspecified (Coriell=GM23829).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23830
AC   CVCL_5T21
DR   Coriell; GM23830
DR   Wikidata; Q54853358
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6831; Isodicentric chromosome
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23831
AC   CVCL_HQ54
DR   Coriell; GM23831
DR   Wikidata; Q54853359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35132; Wolff-Parkinson-White syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM23832
AC   CVCL_U550
DR   Coriell; GM23832
DR   Wikidata; Q54853361
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23834
AC   CVCL_U551
DR   Coriell; GM23834
DR   Wikidata; Q54853362
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23835
AC   CVCL_GT02
DR   Coriell; GM23835
DR   Wikidata; Q54853363
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly12Valfs*2 (c.35delG); ClinVar=VCV000017004; Zygosity=Heterozygous (Coriell=GM23835).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Met34Thr (c.101T>C); ClinVar=VCV000017000; Zygosity=Heterozygous (Coriell=GM23835).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   GM23836
AC   CVCL_BW19
DR   Coriell; GM23836
DR   Wikidata; Q54853364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23837
AC   CVCL_BW20
DR   Coriell; GM23837
DR   Wikidata; Q54853365
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg167Met (c.500G>T); Zygosity=Hemizygous (Coriell=GM23837).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM23840
AC   CVCL_Y761
DR   Coriell; GM23840
DR   Wikidata; Q54853366
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Pro225Leu (c.674C>T); ClinVar=VCV000011000; Zygosity=Unspecified (Coriell=GM23840).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23841
AC   CVCL_BW21
DR   Coriell; GM23841
DR   Wikidata; Q54853367
CC   Population: Caucasian; Irish.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=30kb deletion in the D4Z4 microsatellite region (Coriell=GM23841).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 10
//
ID   GM23842
AC   CVCL_IX39
DR   Coriell; GM23842
DR   Wikidata; Q54853368
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132292; Presynaptic congenital myasthenic syndrome 6
DI   ORDO; Orphanet_98914; Presynaptic congenital myasthenic syndromes
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM23843
AC   CVCL_1B79
DR   Coriell; GM23843
DR   Wikidata; Q54853369
RX   PubMed=23665875;
RX   PubMed=37751688;
WW   Info; PGP; huA90CE6; https://my.pgp-hms.org/profile_public?hex=huA90CE6
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM23845
AC   CVCL_AY89
DR   Coriell; GM23845
DR   Wikidata; Q54853371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23846
AC   CVCL_BW22
DR   Coriell; GM23846
DR   Wikidata; Q54853372
RX   PubMed=24508304;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Pro388Argfs*7 (c.1163_1188del26); Zygosity=Heterozygous (PubMed=24508304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23847
AC   CVCL_Y762
DR   Coriell; GM23847
DR   Wikidata; Q54853373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23850
AC   CVCL_Y763
DR   Coriell; GM23850
DR   Wikidata; Q54853374
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg40His (c.119G>A); ClinVar=VCV000011014; Zygosity=Hemizygous (Coriell=GM23850).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM23851
AC   CVCL_5M25
DR   Coriell; GM23851
DR   Wikidata; Q54853375
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Val269Met (c.805G>A); ClinVar=VCV000193968; Zygosity=Heterozygous (Coriell=GM23851).
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Arg272Cys (c.814C>T); ClinVar=VCV000371132; Zygosity=Heterozygous (Coriell=GM23851).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM23852
AC   CVCL_5T22
DR   Coriell; GM23852
DR   Wikidata; Q54853376
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23853
AC   CVCL_Y764
DR   Coriell; GM23853
DR   Wikidata; Q54853377
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg92Ter (c.274C>T); ClinVar=VCV000097151; Zygosity=Unspecified (Coriell=GM23853).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23854
AC   CVCL_5T23
DR   Coriell; GM23854
DR   Wikidata; Q54853378
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23855
AC   CVCL_AY90
DR   Coriell; GM23855
DR   Wikidata; Q54853379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23857
AC   CVCL_U552
DR   Coriell; GM23857
DR   Wikidata; Q54853380
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23858
AC   CVCL_GZ52
DR   Coriell; GM23858
DR   Wikidata; Q54853383
CC   Sequence variation: Mutation; HGNC; HGNC:17996; NAGS; Simple; c.-3063C>A; Zygosity=Unspecified; Note=In enhancer region (Coriell=GM23858).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129307; N-acetylglutamate synthase deficiency
DI   ORDO; Orphanet_927; Hyperammonemia due to N-acetylglutamate synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM23862
AC   CVCL_U553
DR   Coriell; GM23862
DR   Wikidata; Q54853384
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23863
AC   CVCL_U554
DR   Coriell; GM23863
DR   Wikidata; Q54853385
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23864
AC   CVCL_Y765
DR   Coriell; GM23864
DR   Wikidata; Q54853386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23865
AC   CVCL_5M24
DR   Coriell; GM23865
DR   Wikidata; Q54853387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23866
AC   CVCL_Y766
DR   Coriell; GM23866
DR   Wikidata; Q54853388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23867
AC   CVCL_5M28
DR   Coriell; GM23867
DR   Wikidata; Q54853405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23868
AC   CVCL_BX13
DR   Coriell; GM23868
DR   Wikidata; Q54853406
CC   Sequence variation: Mutation; HGNC; HGNC:17997; FKRP; Simple; p.Leu276Ile (c.826C>A); ClinVar=VCV000004221; Zygosity=Homozygous (Coriell=GM23868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126739; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 5
DI   ORDO; Orphanet_34515; FKRP-related limb-girdle muscular dystrophy R9
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX03 ! GM23630
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23872
AC   CVCL_5T24
DR   Coriell; GM23872
DR   Wikidata; Q54853408
RX   PubMed=23665875;
RX   PubMed=26621101;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23873
AC   CVCL_5T25
DR   Coriell; GM23873
DR   Wikidata; Q54853409
RX   PubMed=23665875;
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM23874
AC   CVCL_5T26
DR   Coriell; GM23874
DR   Wikidata; Q54853410
RX   PubMed=23665875;
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM23875
AC   CVCL_Y767
DR   Coriell; GM23875
DR   Wikidata; Q54853411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23877
AC   CVCL_5T27
DR   Coriell; GM23877
DR   Wikidata; Q54853412
RX   PubMed=23665875;
RX   PubMed=26621101;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23878
AC   CVCL_5T28
DR   Coriell; GM23878
DR   Wikidata; Q54853413
RX   PubMed=23665875;
RX   PubMed=26621101;
RX   PubMed=29474986;
RX   PubMed=31401124;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   GM23879
AC   CVCL_5M38
DR   Coriell; GM23879
DR   Wikidata; Q54853414
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Thr389Ile (c.1166C>T); ClinVar=VCV000645842; Zygosity=Heterozygous (Coriell=GM23879).
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Gly390Arg (c.1168G>A); ClinVar=VCV000006329; Zygosity=Heterozygous (Coriell=GM23879).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   GM23881
AC   CVCL_5T29
DR   Coriell; GM23881
DR   Wikidata; Q54853415
RX   PubMed=23665875;
RX   PubMed=26621101;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23882
AC   CVCL_AY91
DR   Coriell; GM23882
DR   Wikidata; Q54853416
CC   Sequence variation: Mutation; HGNC; HGNC:2323; CPS1; Simple; c.3337-1G>T; ClinVar=VCV001343551; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM23882).
CC   Sequence variation: Mutation; HGNC; HGNC:2323; CPS1; Simple; p.Ala1155Val (c.3464C>T); ClinVar=VCV000477855; Zygosity=Heterozygous (Coriell=GM23882).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84612; Carbamoyl-phosphate synthetase I deficiency
DI   ORDO; Orphanet_147; Carbamoyl-phosphate synthetase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   GM23883
AC   CVCL_GY32
DR   Coriell; GM23883
DR   Wikidata; Q54853417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129072; Hereditary persistence of fetal hemoglobin
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_251380; Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23884
AC   CVCL_GY33
DR   Coriell; GM23884
DR   Wikidata; Q54853418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23885
AC   CVCL_GY34
DR   Coriell; GM23885
DR   Wikidata; Q54853419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23886
AC   CVCL_GY35
DR   Coriell; GM23886
DR   Wikidata; Q54853420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23890
AC   CVCL_Y768
DR   Coriell; GM23890
DR   Wikidata; Q54853421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23891
AC   CVCL_Y769
DR   Coriell; GM23891
DR   Wikidata; Q54853422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23892
AC   CVCL_4T54
DR   Coriell; GM23892
DR   Wikidata; Q54853423
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM23893
AC   CVCL_BW23
DR   Coriell; GM23893
DR   Wikidata; Q54853424
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23894
AC   CVCL_JF25
DR   Coriell; GM23894
DR   Wikidata; Q54853425
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C133730; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 1
DI   ORDO; Orphanet_86812; POMT1-related limb-girdle muscular dystrophy R11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   GM23895
AC   CVCL_BW24
DR   Coriell; GM23895
DR   Wikidata; Q54853426
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120046; Congenital fiber-type disproportion
DI   ORDO; Orphanet_2020; Congenital fiber-type disproportion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23896
AC   CVCL_GZ53
DR   Coriell; GM23896
DR   Wikidata; Q54853427
RX   PubMed=11748852;
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Ser153Glnfs*111 (c.457delT); Zygosity=Hemizygous (Coriell=GM23896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM23899
AC   CVCL_U555
DR   Coriell; GM23899
DR   Wikidata; Q54853428
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GM23900
AC   CVCL_5T30
DR   Coriell; GM23900
DR   Wikidata; Q54853429
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23904
AC   CVCL_5T31
DR   Coriell; GM23904
DR   Wikidata; Q54853430
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23905
AC   CVCL_5T32
DR   Coriell; GM23905
DR   Wikidata; Q54853431
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23906
AC   CVCL_5T33
DR   Coriell; GM23906
DR   Wikidata; Q54853432
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM23906; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23907
AC   CVCL_5T34
DR   Coriell; GM23907
DR   Wikidata; Q54853433
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120197; 46,XX gonadal dysgenesis
DI   ORDO; Orphanet_243; 46,XX gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM23908
AC   CVCL_5T35
DR   Coriell; GM23908
DR   Wikidata; Q54853434
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Gln252Argfs*12 (c.754delC); ClinVar=VCV000492852; Zygosity=Hemizygous (Coriell=GM23908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM23909
AC   CVCL_5T36
DR   Coriell; GM23909
DR   Wikidata; Q54853435
RX   PubMed=11748852;
RX   PubMed=23665875;
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Val115Trpfs*149 (c.343delG); ClinVar=VCV001208006; Zygosity=Hemizygous (Coriell=GM23909).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   GM23910
AC   CVCL_EH22
DR   Coriell; GM23910
DR   Wikidata; Q54853436
RX   PubMed=11748852;
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Leu295Pro (c.884T>C); Zygosity=Hemizygous (Coriell=GM23910).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM23913
AC   CVCL_T819
SY   GM23913*D
DR   Coriell; GM23913
DR   SKIP; SKIP000262
DR   SKIP; SKIP004373
DR   Wikidata; Q54853437
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[341]; ClinVar=VCV000561195; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[480]; ClinVar=VCV000561195; Zygosity=Heterozygous (from parent cell line).
CC   Caution: Indicated by Coriell to have 420 and 541 GAA repeats.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T820 ! GM04078
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   GM23916
AC   CVCL_BW27
DR   Coriell; GM23916
DR   Wikidata; Q54853438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23917
AC   CVCL_BX14
DR   Coriell; GM23917
DR   Wikidata; Q54853439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126741; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 4
DI   ORDO; Orphanet_272; Congenital muscular dystrophy, Fukuyama type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23919
AC   CVCL_4F85
DR   Coriell; GM23919
DR   Wikidata; Q54853440
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM23919).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM23920
AC   CVCL_5T37
DR   Coriell; GM23920
DR   Wikidata; Q54853441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM23922
AC   CVCL_5T38
DR   Coriell; GM23922
DR   Wikidata; Q54853442
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM23923
AC   CVCL_Y770
DR   Coriell; GM23923
DR   Wikidata; Q54853443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23924
AC   CVCL_Y771
DR   Coriell; GM23924
DR   Wikidata; Q54853444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM23925
AC   CVCL_GT03
DR   Coriell; GM23925
DR   Wikidata; Q54853445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129029; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
DI   ORDO; Orphanet_415; Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   GM23926
AC   CVCL_BX15
DR   Coriell; GM23926
DR   Wikidata; Q54853452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM23929
AC   CVCL_Y603
DR   Coriell; GM23929
DR   Wikidata; Q54853453
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Trp5885Ter (c.17654G>A) (p.Trp4184Ter, c.12551G>A); ClinVar=VCV001076162; Zygosity=Heterozygous (Coriell=GM23929).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Phe8257Leufs*10 (c.24771delT) (p.Phe6366Leufs*10, c.19098delT); ClinVar=VCV000279999; Zygosity=Heterozygous (Coriell=GM23929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   GM23937
AC   CVCL_T822
SY   GM23937*B
DR   Coriell; GM23937
DR   SKIP; SKIP000263
DR   SKIP; SKIP004374
DR   Wikidata; Q54853454
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM23937).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T824 ! GM11853
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   GM23941
AC   CVCL_BW28
DR   Coriell; GM23941
DR   Wikidata; Q54853455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23942
AC   CVCL_5M29
DR   Coriell; GM23942
DR   Wikidata; Q54853456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM23943
AC   CVCL_U556
DR   Coriell; GM23943
DR   Wikidata; Q54853457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM23944
AC   CVCL_BW29
DR   Coriell; GM23944
DR   Wikidata; Q54853458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23945
AC   CVCL_CX82
DR   Coriell; GM23945
DR   Wikidata; Q54853459
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (Coriell=GM23945).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX74 ! GM22568
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM23958
AC   CVCL_BW30
DR   Coriell; GM23958
DR   Wikidata; Q54853460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM23960
AC   CVCL_EH23
DR   Coriell; GM23960
DR   Wikidata; Q54853461
RX   PubMed=11748852;
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Gly210Alafs*54 (c.629delG); Zygosity=Hemizygous (Coriell=GM23960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM23962
AC   CVCL_BW31
DR   Coriell; GM23962
DR   Wikidata; Q54853462
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23963
AC   CVCL_BW32
DR   Coriell; GM23963
DR   Wikidata; Q54853463
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23964
AC   CVCL_BW33
DR   Coriell; GM23964
DR   Wikidata; Q54853464
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 8
//
ID   GM23965
AC   CVCL_BW34
DR   Coriell; GM23965
DR   Wikidata; Q54853465
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23966
AC   CVCL_BW35
DR   Coriell; GM23966
DR   Wikidata; Q54853466
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23967
AC   CVCL_BW36
DR   Coriell; GM23967
DR   GEO; GSM3124662
DR   Wikidata; Q54853467
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   GM23968
AC   CVCL_BW37
DR   Coriell; GM23968
DR   Wikidata; Q54853468
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23969
AC   CVCL_BW38
DR   Coriell; GM23969
DR   Wikidata; Q54853469
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23970
AC   CVCL_BW39
DR   Coriell; GM23970
DR   Wikidata; Q54853470
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23971
AC   CVCL_BW40
DR   Coriell; GM23971
DR   GEO; GSM3124656
DR   Wikidata; Q54853471
RX   PubMed=30567591;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   GM23972
AC   CVCL_BW41
DR   Coriell; GM23972
DR   Wikidata; Q54853472
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23973
AC   CVCL_BW42
DR   Coriell; GM23973
DR   GEO; GSM3124647
DR   Wikidata; Q54853473
RX   PubMed=30567591;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   GM23974
AC   CVCL_BW43
DR   Coriell; GM23974
DR   Wikidata; Q54853474
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23975
AC   CVCL_BW44
DR   Coriell; GM23975
DR   Wikidata; Q54853475
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23976
AC   CVCL_BW45
DR   Coriell; GM23976
DR   Wikidata; Q54853476
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM23977
AC   CVCL_U557
DR   Coriell; GM23977
DR   Wikidata; Q54853477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM23981
AC   CVCL_Y772
DR   Coriell; GM23981
DR   Wikidata; Q54853478
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg92Gln (c.275G>A); ClinVar=VCV000097152; Zygosity=Unspecified (Coriell=GM23981).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23982
AC   CVCL_Y773
DR   Coriell; GM23982
DR   Wikidata; Q54853479
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg92Gln (c.275G>A); ClinVar=VCV000097152; Zygosity=Unspecified (Coriell=GM23982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM23984
AC   CVCL_AD85
DR   Coriell; GM23984
DR   Wikidata; Q54853480
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Simple; p.Lys363Serfs*14 (c.1088_1089delAA); ClinVar=VCV000158894; Zygosity=Hemizygous (Coriell=GM23984).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   GM23986
AC   CVCL_BW46
DR   Coriell; GM23986
DR   Wikidata; Q54853481
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Met185Val (c.553A>G); ClinVar=VCV002138792; Zygosity=Hemizygous (Coriell=GM23986).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM23988
AC   CVCL_U558
DR   Coriell; GM23988
DR   Wikidata; Q54853482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM23989
AC   CVCL_BW47
DR   Coriell; GM23989
DR   Wikidata; Q54853483
CC   Sequence variation: Mutation; HGNC; HGNC:10983; SLC25A13; Simple; c.615+5G>A; ClinVar=VCV000021517; Zygosity=Heterozygous (Coriell=GM23989).
CC   Sequence variation: Mutation; HGNC; HGNC:10983; SLC25A13; Simple; p.Ala554Glyfs*16 (c.1638_1660dup23); ClinVar=VCV000006003; Zygosity=Heterozygous (Coriell=GM23989).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150603; Citrullinemia type II
DI   ORDO; Orphanet_247585; Citrullinemia type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24007
AC   CVCL_Y774
DR   Coriell; GM24007
DR   Wikidata; Q54853484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24008
AC   CVCL_AY92
DR   Coriell; GM24008
DR   Wikidata; Q54853485
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM24009
AC   CVCL_AY93
DR   Coriell; GM24009
DR   Wikidata; Q54853486
RX   PubMed=26621101;
RX   PubMed=29474986;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM2401
AC   CVCL_B4G3
DR   IARC_TP53; 21050
DR   Wikidata; Q110432826
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM24010
AC   CVCL_Y775
DR   Coriell; GM24010
DR   Wikidata; Q54853487
CC   Population: Caucasian; Greek/Portuguese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM24011
AC   CVCL_Y776
DR   Coriell; GM24011
DR   Wikidata; Q54853488
CC   Population: Caucasian; Portuguese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   GM24017
AC   CVCL_Y777
DR   Coriell; GM24017
DR   Wikidata; Q54853489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24018
AC   CVCL_Y778
DR   Coriell; GM24018
DR   Wikidata; Q54853490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24019
AC   CVCL_Y779
DR   Coriell; GM24019
DR   Wikidata; Q54853491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24023
AC   CVCL_AE09
DR   Coriell; GM24023
DR   Wikidata; Q54853494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84568; Argininemia
DI   ORDO; Orphanet_90; Argininemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM24027
AC   CVCL_AE10
DR   Coriell; GM24027
DR   Wikidata; Q54853495
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   GM24028
AC   CVCL_AE11
DR   Coriell; GM24028
DR   Wikidata; Q54853496
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Asp120Glu (c.360C>A); Zygosity=Heterozygous (Coriell=GM24028).
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Arg217Ter (c.649C>T); ClinVar=VCV000203615; Zygosity=Heterozygous (Coriell=GM24028).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM24029
AC   CVCL_AE12
DR   Coriell; GM24029
DR   Wikidata; Q54853497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM24045
AC   CVCL_AY94
DR   Coriell; GM24045
DR   Wikidata; Q54853498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24046
AC   CVCL_AY95
DR   Coriell; GM24046
DR   Wikidata; Q54853499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24047
AC   CVCL_Y780
DR   Coriell; GM24047
DR   Wikidata; Q54853500
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Glu273Glyfs*16 (c.818delA); ClinVar=VCV000097338; Zygosity=Unspecified (Coriell=GM24047).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM24048
AC   CVCL_Y781
DR   Coriell; GM24048
DR   Wikidata; Q54853501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24049
AC   CVCL_1B80
DR   Coriell; GM24049
DR   Wikidata; Q54853502
RX   PubMed=37751688;
WW   Info; PGP; hu0A4518; https://my.pgp-hms.org/profile_public?hex=hu0A4518
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24050
AC   CVCL_1B81
DR   Coriell; GM24050
DR   Wikidata; Q54853503
RX   PubMed=37751688;
WW   Info; PGP; hu04F220; https://my.pgp-hms.org/profile_public?hex=hu04F220
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2878; Anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW88 ! NYSCF-051121-01-MR
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24053
AC   CVCL_Y782
DR   Coriell; GM24053
DR   Wikidata; Q54853504
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg129His (c.386G>A); ClinVar=VCV000011010; Zygosity=Unspecified (Coriell=GM24053).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM24054
AC   CVCL_Y783
DR   Coriell; GM24054
DR   Wikidata; Q54853505
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg129His (c.386G>A); ClinVar=VCV000011010; Zygosity=Hemizygous (Coriell=GM24054).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   GM24059
AC   CVCL_AY96
DR   Coriell; GM24059
DR   Wikidata; Q54853506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24061
AC   CVCL_AY97
DR   Coriell; GM24061
DR   Wikidata; Q54853507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24065
AC   CVCL_U559
DR   Coriell; GM24065
DR   Wikidata; Q54853508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM24067
AC   CVCL_1B82
DR   Coriell; GM24067
DR   Wikidata; Q54853509
RX   PubMed=37751688;
WW   Info; PGP; hu88A079; https://my.pgp-hms.org/profile_public?hex=hu88A079
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24068
AC   CVCL_1B83
DR   Coriell; GM24068
DR   Wikidata; Q54853510
RX   PubMed=37751688;
WW   Info; PGP; huCA14D2; https://my.pgp-hms.org/profile_public?hex=huCA14D2
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24070
AC   CVCL_1B84
DR   Coriell; GM24070
DR   Wikidata; Q54853511
RX   PubMed=37751688;
WW   Info; PGP; hu661AD0; https://my.pgp-hms.org/profile_public?hex=hu661AD0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW95 ! NYSCF-051015-01-MR
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24071
AC   CVCL_1B85
DR   Coriell; GM24071
DR   Wikidata; Q54853512
RX   PubMed=37751688;
WW   Info; PGP; hu132B5C; https://my.pgp-hms.org/profile_public?hex=hu132B5C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW85 ! NYSCF-051088-01-MR
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24072
AC   CVCL_1B86
DR   Coriell; GM24072
DR   Wikidata; Q54853513
RX   PubMed=37751688;
WW   Info; PGP; hu8E2A35; https://my.pgp-hms.org/profile_public?hex=hu8E2A35
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24073
AC   CVCL_1B87
DR   Coriell; GM24073
DR   Wikidata; Q54853514
RX   PubMed=37751688;
WW   Info; PGP; hu57A769; https://my.pgp-hms.org/profile_public?hex=hu57A769
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; Armenian/Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24074
AC   CVCL_1B88
DR   Coriell; GM24074
DR   Wikidata; Q54853515
RX   PubMed=37751688;
WW   Info; PGP; huCCD063; https://my.pgp-hms.org/profile_public?hex=huCCD063
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24075
AC   CVCL_1B89
DR   Coriell; GM24075
DR   Wikidata; Q54853516
RX   PubMed=37751688;
WW   Info; PGP; hu79F922; https://my.pgp-hms.org/profile_public?hex=hu79F922
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24076
AC   CVCL_1B90
DR   Coriell; GM24076
DR   Wikidata; Q54853517
RX   PubMed=37751688;
WW   Info; PGP; hu52B7E5; https://my.pgp-hms.org/profile_public?hex=hu52B7E5
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: Donor has a family history of breast cancer but negative for BRCA1 and BRCA2 mutations.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24077
AC   CVCL_1B91
DR   Coriell; GM24077
DR   Wikidata; Q54853518
RX   PubMed=37751688;
WW   Info; PGP; hu72C17A; https://my.pgp-hms.org/profile_public?hex=hu72C17A
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW77 ! NYSCF-050974-01-MR
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24078
AC   CVCL_1B92
DR   Coriell; GM24078
DR   Wikidata; Q54853519
RX   PubMed=37751688;
WW   Info; PGP; huA0E089; https://my.pgp-hms.org/profile_public?hex=huA0E089
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; German/Polish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24079
AC   CVCL_1B93
DR   Coriell; GM24079
DR   Wikidata; Q54853520
RX   PubMed=37751688;
WW   Info; PGP; hu7A2F1D; https://my.pgp-hms.org/profile_public?hex=hu7A2F1D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24080
AC   CVCL_1B94
DR   Coriell; GM24080
DR   Wikidata; Q54853521
RX   PubMed=37751688;
WW   Info; PGP; hu5CD2C6; https://my.pgp-hms.org/profile_public?hex=hu5CD2C6
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24081
AC   CVCL_1B95
DR   Coriell; GM24081
DR   Wikidata; Q54853522
RX   PubMed=37751688;
WW   Info; PGP; hu67EBB3; https://my.pgp-hms.org/profile_public?hex=hu67EBB3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24083
AC   CVCL_1B96
DR   Coriell; GM24083
DR   Wikidata; Q54853523
RX   PubMed=37751688;
WW   Info; PGP; huEA4EE5; https://my.pgp-hms.org/profile_public?hex=huEA4EE5
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24084
AC   CVCL_1B97
DR   Coriell; GM24084
DR   Wikidata; Q54853524
RX   PubMed=37751688;
WW   Info; PGP; hu3C0611; https://my.pgp-hms.org/profile_public?hex=hu3C0611
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24085
AC   CVCL_1B98
DR   Coriell; GM24085
DR   Wikidata; Q54853525
RX   PubMed=37751688;
WW   Info; PGP; huED0F40; https://my.pgp-hms.org/profile_public?hex=huED0F40
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24086
AC   CVCL_1B99
DR   Coriell; GM24086
DR   Wikidata; Q54853526
RX   PubMed=37751688;
WW   Info; PGP; hu032C04; https://my.pgp-hms.org/profile_public?hex=hu032C04
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW86 ! NYSCF-051094-01-MR
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24087
AC   CVCL_1C00
DR   Coriell; GM24087
DR   Wikidata; Q54853527
RX   PubMed=37751688;
WW   Info; PGP; hu60AB7C; https://my.pgp-hms.org/profile_public?hex=hu60AB7C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24088
AC   CVCL_1C01
DR   Coriell; GM24088
DR   Wikidata; Q54853528
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu9D3638; https://my.pgp-hms.org/profile_public?hex=hu9D3638
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24090
AC   CVCL_1C02
DR   Coriell; GM24090
DR   Wikidata; Q54853529
RX   PubMed=37751688;
WW   Info; PGP; huF1DC30; https://my.pgp-hms.org/profile_public?hex=huF1DC30
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24091
AC   CVCL_1C03
DR   Coriell; GM24091
DR   Wikidata; Q54853530
RX   PubMed=37751688;
WW   Info; PGP; hu4B0812; https://my.pgp-hms.org/profile_public?hex=hu4B0812
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24093
AC   CVCL_1C04
DR   Coriell; GM24093
DR   Wikidata; Q54853531
RX   PubMed=37751688;
WW   Info; PGP; hu939B7C; https://my.pgp-hms.org/profile_public?hex=hu939B7C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24094
AC   CVCL_1C05
DR   Coriell; GM24094
DR   Wikidata; Q54853532
RX   PubMed=37751688;
WW   Info; PGP; huFFAD87; https://my.pgp-hms.org/profile_public?hex=huFFAD87
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24095
AC   CVCL_1C06
DR   Coriell; GM24095
DR   Wikidata; Q54853533
WW   Info; PGP; huAE4A11; https://my.pgp-hms.org/profile_public?hex=huAE4A11
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; British and Indian; Tanzania.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: Established from Leila Jamal blood.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   GM24096
AC   CVCL_1C07
DR   Coriell; GM24096
DR   Wikidata; Q54853539
WW   Info; PGP; hu92FD55; https://my.pgp-hms.org/profile_public?hex=hu92FD55
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   GM24097
AC   CVCL_1C08
DR   Coriell; GM24097
DR   Wikidata; Q54853540
RX   PubMed=37751688;
WW   Info; PGP; huC3160A; https://my.pgp-hms.org/profile_public?hex=huC3160A
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24098
AC   CVCL_1C09
DR   Coriell; GM24098
DR   Wikidata; Q54853541
RX   PubMed=37751688;
WW   Info; PGP; huA4F281; https://my.pgp-hms.org/profile_public?hex=huA4F281
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24099
AC   CVCL_1C10
DR   Coriell; GM24099
DR   Wikidata; Q54853542
RX   PubMed=37751688;
WW   Info; PGP; hu8F918A; https://my.pgp-hms.org/profile_public?hex=hu8F918A
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24101
AC   CVCL_1C11
DR   Coriell; GM24101
DR   Wikidata; Q54853543
RX   PubMed=37751688;
WW   Info; PGP; hu7A4AD1; https://my.pgp-hms.org/profile_public?hex=hu7A4AD1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24102
AC   CVCL_1C12
DR   Coriell; GM24102
DR   Wikidata; Q54853544
RX   PubMed=37751688;
WW   Info; PGP; huC434ED; https://my.pgp-hms.org/profile_public?hex=huC434ED
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; Dutch/Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24103
AC   CVCL_1C13
DR   Coriell; GM24103
DR   Wikidata; Q54853545
RX   PubMed=37751688;
WW   Info; PGP; huAFA81C; https://my.pgp-hms.org/profile_public?hex=huAFA81C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian and Native North American; Alaskan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   GM24104
AC   CVCL_1C14
DR   Coriell; GM24104
DR   Wikidata; Q54853546
RX   PubMed=37751688;
WW   Info; PGP; hu687B6B; https://my.pgp-hms.org/profile_public?hex=hu687B6B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24105
AC   CVCL_1C15
DR   Coriell; GM24105
DR   Wikidata; Q54853547
RX   PubMed=37751688;
WW   Info; PGP; huD52556; https://my.pgp-hms.org/profile_public?hex=huD52556
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24106
AC   CVCL_1C16
DR   Coriell; GM24106
DR   Wikidata; Q54853548
RX   PubMed=37751688;
WW   Info; PGP; hu42D651; https://my.pgp-hms.org/profile_public?hex=hu42D651
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24107
AC   CVCL_1C17
DR   Coriell; GM24107
DR   Wikidata; Q54853549
RX   PubMed=37751688;
WW   Info; PGP; hu0D1FA1; https://my.pgp-hms.org/profile_public?hex=hu0D1FA1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24108
AC   CVCL_1C18
DR   Coriell; GM24108
DR   Wikidata; Q54853550
RX   PubMed=37751688;
WW   Info; PGP; hu6C733E; https://my.pgp-hms.org/profile_public?hex=hu6C733E
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW79 ! NYSCF-051001-01-MR
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24109
AC   CVCL_1C19
DR   Coriell; GM24109
DR   Wikidata; Q54853551
RX   PubMed=37751688;
WW   Info; PGP; hu5FA322; https://my.pgp-hms.org/profile_public?hex=hu5FA322
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24110
AC   CVCL_1C20
DR   Coriell; GM24110
DR   Wikidata; Q54853552
RX   PubMed=37751688;
WW   Info; PGP; huEDEA65; https://my.pgp-hms.org/profile_public?hex=huEDEA65
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24111
AC   CVCL_1C21
DR   Coriell; GM24111
DR   Wikidata; Q54853553
RX   PubMed=37751688;
WW   Info; PGP; huC92BC9; https://my.pgp-hms.org/profile_public?hex=huC92BC9
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24112
AC   CVCL_1C22
DR   Coriell; GM24112
DR   Wikidata; Q54853554
RX   PubMed=37751688;
WW   Info; PGP; hu3F864B; https://my.pgp-hms.org/profile_public?hex=hu3F864B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24114
AC   CVCL_1C23
DR   Coriell; GM24114
DR   Wikidata; Q54853555
RX   PubMed=37751688;
WW   Info; PGP; hu68929D; https://my.pgp-hms.org/profile_public?hex=hu68929D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24115
AC   CVCL_1C24
DR   Coriell; GM24115
DR   Wikidata; Q54853556
RX   PubMed=37751688;
WW   Info; PGP; huE58004; https://my.pgp-hms.org/profile_public?hex=huE58004
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24116
AC   CVCL_1C25
DR   Coriell; GM24116
DR   Wikidata; Q54853557
RX   PubMed=37751688;
WW   Info; PGP; hu5FCE15; https://my.pgp-hms.org/profile_public?hex=hu5FCE15
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2878; Anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW93 ! NYSCF-050921-01-MR
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24117
AC   CVCL_1C26
DR   Coriell; GM24117
DR   Wikidata; Q54853558
RX   PubMed=37751688;
WW   Info; PGP; hu448C4B; https://my.pgp-hms.org/profile_public?hex=hu448C4B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24118
AC   CVCL_1C27
DR   Coriell; GM24118
DR   Wikidata; Q54853559
RX   PubMed=37751688;
WW   Info; PGP; hu4CA5B9; https://my.pgp-hms.org/profile_public?hex=hu4CA5B9
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24119
AC   CVCL_1C28
DR   Coriell; GM24119
DR   Wikidata; Q54853560
RX   PubMed=37751688;
WW   Info; PGP; hu34D5B9; https://my.pgp-hms.org/profile_public?hex=hu34D5B9
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; Ukrainian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24120
AC   CVCL_1C29
DR   Coriell; GM24120
DR   Wikidata; Q54853561
RX   PubMed=37751688;
WW   Info; PGP; hu619F51; https://my.pgp-hms.org/profile_public?hex=hu619F51
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24121
AC   CVCL_1C30
DR   Coriell; GM24121
DR   Wikidata; Q54853562
WW   Info; PGP; hu575C62; https://my.pgp-hms.org/profile_public?hex=hu575C62
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM24122
AC   CVCL_1C31
DR   Coriell; GM24122
DR   Wikidata; Q54853563
RX   PubMed=37751688;
WW   Info; PGP; hu90B053; https://my.pgp-hms.org/profile_public?hex=hu90B053
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24123
AC   CVCL_1C32
DR   Coriell; GM24123
DR   Wikidata; Q54853564
RX   PubMed=37751688;
WW   Info; PGP; huD09534; https://my.pgp-hms.org/profile_public?hex=huD09534
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24124
AC   CVCL_1C33
DR   Coriell; GM24124
DR   Wikidata; Q54853565
RX   PubMed=37751688;
WW   Info; PGP; huDBF9DD; https://my.pgp-hms.org/profile_public?hex=huDBF9DD
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24125
AC   CVCL_1C34
DR   Coriell; GM24125
DR   Wikidata; Q54853566
RX   PubMed=37751688;
WW   Info; PGP; hu025CEA; https://my.pgp-hms.org/profile_public?hex=hu025CEA
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24126
AC   CVCL_1C35
DR   Coriell; GM24126
DR   Wikidata; Q54853567
RX   PubMed=37751688;
WW   Info; PGP; hu553620; https://my.pgp-hms.org/profile_public?hex=hu553620
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24129
AC   CVCL_1C36
DR   Coriell; GM24129
DR   Wikidata; Q54853568
RX   PubMed=37751688;
WW   Info; PGP; hu627574; https://my.pgp-hms.org/profile_public?hex=hu627574
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24130
AC   CVCL_1C37
DR   Coriell; GM24130
DR   Wikidata; Q54853569
RX   PubMed=37751688;
WW   Info; PGP; hu7123C1; https://my.pgp-hms.org/profile_public?hex=hu7123C1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24131
AC   CVCL_1C38
DR   Coriell; GM24131
DR   Wikidata; Q54853570
RX   PubMed=37751688;
WW   Info; PGP; hu4BE6F2; https://my.pgp-hms.org/profile_public?hex=hu4BE6F2
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24132
AC   CVCL_1C39
DR   Coriell; GM24132
DR   Wikidata; Q54853571
RX   PubMed=37751688;
WW   Info; PGP; hu52F345; https://my.pgp-hms.org/profile_public?hex=hu52F345
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24133
AC   CVCL_1C40
DR   Coriell; GM24133
DR   Wikidata; Q54853572
RX   PubMed=37751688;
WW   Info; PGP; huC5733C; https://my.pgp-hms.org/profile_public?hex=huC5733C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24134
AC   CVCL_1C41
DR   Coriell; GM24134
DR   Wikidata; Q54853573
RX   PubMed=37751688;
WW   Info; PGP; huA49E22; https://my.pgp-hms.org/profile_public?hex=huA49E22
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24135
AC   CVCL_1C42
DR   Coriell; GM24135
DR   Wikidata; Q54853574
RX   PubMed=37751688;
WW   Info; PGP; hu016B28; https://my.pgp-hms.org/profile_public?hex=hu016B28
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW83 ! NYSCF-051045-01-MR
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24136
AC   CVCL_1C43
DR   Coriell; GM24136
DR   Wikidata; Q54853575
RX   PubMed=37751688;
WW   Info; PGP; huF80F84; https://my.pgp-hms.org/profile_public?hex=huF80F84
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24137
AC   CVCL_1C44
DR   Coriell; GM24137
DR   Wikidata; Q54853576
RX   PubMed=37751688;
WW   Info; PGP; huB4D223; https://my.pgp-hms.org/profile_public?hex=huB4D223
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24139
AC   CVCL_1C45
DR   Coriell; GM24139
DR   Wikidata; Q54853578
RX   PubMed=37751688;
WW   Info; PGP; huD103CC; https://my.pgp-hms.org/profile_public?hex=huD103CC
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24141
AC   CVCL_1C46
DR   Coriell; GM24141
DR   Wikidata; Q54853579
RX   PubMed=37751688;
WW   Info; PGP; hu64DBF7; https://my.pgp-hms.org/profile_public?hex=hu64DBF7
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24142
AC   CVCL_1C47
DR   Coriell; GM24142
DR   Wikidata; Q54853584
WW   Info; PGP; huBEDA0B; https://my.pgp-hms.org/profile_public?hex=huBEDA0B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24143
AC   CVCL_1C48
SY   GM24143*C; HG004
DR   BioSample; SAMN03283346
DR   Coriell; GM24143
DR   Wikidata; Q54853585
RX   PubMed=27271295;
RX   PubMed=37751688;
WW   Info; PGP; hu8E87A9; https://my.pgp-hms.org/profile_public?hex=hu8E87A9
CC   Part of: Genome in a Bottle (GIAB) consortium samples.
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; HG004.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24144
AC   CVCL_1C49
DR   Coriell; GM24144
DR   Wikidata; Q54853586
RX   PubMed=37751688;
WW   Info; PGP; huE9B698; https://my.pgp-hms.org/profile_public?hex=huE9B698
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24145
AC   CVCL_1C50
DR   Coriell; GM24145
DR   Wikidata; Q54853587
RX   PubMed=37751688;
WW   Info; PGP; huA05317; https://my.pgp-hms.org/profile_public?hex=huA05317
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24146
AC   CVCL_1C51
DR   Coriell; GM24146
DR   Wikidata; Q54853588
RX   PubMed=37751688;
WW   Info; PGP; hu7B594C; https://my.pgp-hms.org/profile_public?hex=hu7B594C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24147
AC   CVCL_1C52
DR   Coriell; GM24147
DR   Wikidata; Q54853591
RX   PubMed=37751688;
WW   Info; PGP; huFE71F3; https://my.pgp-hms.org/profile_public?hex=huFE71F3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24148
AC   CVCL_1C53
DR   Coriell; GM24148
DR   Wikidata; Q54853592
RX   PubMed=37751688;
WW   Info; PGP; hu589D0B; https://my.pgp-hms.org/profile_public?hex=hu589D0B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24149
AC   CVCL_1C54
SY   HG003
DR   BioSample; SAMN03283345
DR   Coriell; GM24149
DR   Wikidata; Q54853593
RX   PubMed=27271295;
RX   PubMed=37751688;
WW   Info; PGP; hu6E4515; https://my.pgp-hms.org/profile_public?hex=hu6E4515
CC   Part of: Genome in a Bottle (GIAB) consortium samples.
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; HG003.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24150
AC   CVCL_1C55
DR   Coriell; GM24150
DR   Wikidata; Q54853595
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; huF06AD0; https://my.pgp-hms.org/profile_public?hex=huF06AD0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24151
AC   CVCL_1C56
DR   Coriell; GM24151
DR   Wikidata; Q54853596
RX   PubMed=37751688;
WW   Info; PGP; hu297562; https://my.pgp-hms.org/profile_public?hex=hu297562
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24152
AC   CVCL_1C57
DR   Coriell; GM24152
DR   Wikidata; Q54853597
WW   Info; PGP; hu57C9FD; https://my.pgp-hms.org/profile_public?hex=hu57C9FD
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   GM24153
AC   CVCL_1C58
DR   Coriell; GM24153
DR   Wikidata; Q54853598
RX   PubMed=37751688;
WW   Info; PGP; huFA70A3; https://my.pgp-hms.org/profile_public?hex=huFA70A3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24154
AC   CVCL_1C59
DR   Coriell; GM24154
DR   Wikidata; Q54853599
RX   PubMed=37751688;
WW   Info; PGP; hu432EB5; https://my.pgp-hms.org/profile_public?hex=hu432EB5
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24155
AC   CVCL_1C60
DR   Coriell; GM24155
DR   Wikidata; Q54853600
RX   PubMed=37751688;
WW   Info; PGP; hu19C09F; https://my.pgp-hms.org/profile_public?hex=hu19C09F
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24157
AC   CVCL_1C61
DR   Coriell; GM24157
DR   Wikidata; Q54853601
RX   PubMed=37751688;
WW   Info; PGP; hu4FE0D1; https://my.pgp-hms.org/profile_public?hex=hu4FE0D1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24158
AC   CVCL_1C62
DR   Coriell; GM24158
DR   Wikidata; Q54853602
RX   PubMed=37751688;
WW   Info; PGP; huFCC1C1; https://my.pgp-hms.org/profile_public?hex=huFCC1C1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24159
AC   CVCL_1C63
DR   Coriell; GM24159
DR   Wikidata; Q54853603
RX   PubMed=37751688;
WW   Info; PGP; hu67EBB3; https://my.pgp-hms.org/profile_public?hex=hu67EBB3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24160
AC   CVCL_1C64
DR   Coriell; GM24160
DR   Wikidata; Q54853604
RX   PubMed=37751688;
WW   Info; PGP; huCCAFD0; https://my.pgp-hms.org/profile_public?hex=huCCAFD0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24161
AC   CVCL_1C65
DR   Coriell; GM24161
DR   Wikidata; Q54853605
RX   PubMed=37751688;
WW   Info; PGP; hu1F73AB; https://my.pgp-hms.org/profile_public?hex=hu1F73AB
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24162
AC   CVCL_1C66
DR   Coriell; GM24162
DR   Wikidata; Q54853606
RX   PubMed=37751688;
WW   Info; PGP; hu44DCFF; https://my.pgp-hms.org/profile_public?hex=hu44DCFF
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24164
AC   CVCL_1C67
DR   Coriell; GM24164
DR   Wikidata; Q54853607
RX   PubMed=37751688;
WW   Info; PGP; huEBD467; https://my.pgp-hms.org/profile_public?hex=huEBD467
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Honduran.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   GM24165
AC   CVCL_1C68
DR   Coriell; GM24165
DR   Wikidata; Q54853609
RX   PubMed=37751688;
WW   Info; PGP; hu011C57; https://my.pgp-hms.org/profile_public?hex=hu011C57
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24166
AC   CVCL_1C69
DR   Coriell; GM24166
DR   Wikidata; Q54853610
WW   Info; PGP; hu0D879F; https://my.pgp-hms.org/profile_public?hex=hu0D879F
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24167
AC   CVCL_1C70
DR   Coriell; GM24167
DR   Wikidata; Q54853611
RX   PubMed=37751688;
WW   Info; PGP; hu5FB1B9; https://my.pgp-hms.org/profile_public?hex=hu5FB1B9
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24168
AC   CVCL_1C71
DR   Coriell; GM24168
DR   Wikidata; Q54853612
RX   PubMed=37751688;
WW   Info; PGP; huC93106; https://my.pgp-hms.org/profile_public?hex=huC93106
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24169
AC   CVCL_1C72
DR   Coriell; GM24169
DR   Wikidata; Q54853613
RX   PubMed=37751688;
WW   Info; PGP; hu599905; https://my.pgp-hms.org/profile_public?hex=hu599905
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24170
AC   CVCL_1C73
DR   Coriell; GM24170
DR   Wikidata; Q54853614
RX   PubMed=37751688;
WW   Info; PGP; huBE0B25; https://my.pgp-hms.org/profile_public?hex=huBE0B25
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24171
AC   CVCL_1C74
DR   Coriell; GM24171
DR   Wikidata; Q54853618
RX   PubMed=37751688;
WW   Info; PGP; hu33E2D9; https://my.pgp-hms.org/profile_public?hex=hu33E2D9
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24172
AC   CVCL_1C75
DR   Coriell; GM24172
DR   Wikidata; Q54853619
RX   PubMed=37751688;
WW   Info; PGP; huD10E53; https://my.pgp-hms.org/profile_public?hex=huD10E53
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24173
AC   CVCL_1C76
DR   Coriell; GM24173
DR   Wikidata; Q54853621
RX   PubMed=37751688;
WW   Info; PGP; hu1378E3; https://my.pgp-hms.org/profile_public?hex=hu1378E3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24176
AC   CVCL_1C77
DR   Coriell; GM24176
DR   Wikidata; Q54853622
RX   PubMed=37751688;
WW   Info; PGP; hu04DF3C; https://my.pgp-hms.org/profile_public?hex=hu04DF3C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24202
AC   CVCL_BX16
DR   Coriell; GM24202
DR   Wikidata; Q54853623
CC   Sequence variation: Mutation; HGNC; HGNC:19139; POMGNT1; Simple; c.1895+1G>T; ClinVar=VCV000056593; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM24202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126740; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 3
DI   ORDO; Orphanet_899; Walker-Warburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM24204
AC   CVCL_5K27
DR   Coriell; GM24204
DR   Wikidata; Q54853624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24206
AC   CVCL_AY98
DR   Coriell; GM24206
DR   Wikidata; Q54853625
CC   Population: Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:12496; UBE3A; Simple; p.Thr126Lys (c.377C>A) (p.Thr106Lys, c.317C>A); ClinVar=VCV000155994; Zygosity=Unspecified (Coriell=GM24206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_411511; Angelman syndrome due to a point mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24207
AC   CVCL_AY99
DR   Coriell; GM24207
DR   Wikidata; Q54853626
CC   Population: Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:12496; UBE3A; Simple; p.Thr126Lys (c.377C>A) (p.Thr106Lys, c.317C>A); ClinVar=VCV000155994; Zygosity=Unspecified (Coriell=GM24207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24213
AC   CVCL_BX17
DR   Coriell; GM24213
DR   Wikidata; Q54853627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126739; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 5
DI   ORDO; Orphanet_34515; FKRP-related limb-girdle muscular dystrophy R9
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM24214
AC   CVCL_Y784
DR   Coriell; GM24214
DR   Wikidata; Q54853628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24215
AC   CVCL_Y785
DR   Coriell; GM24215
DR   Wikidata; Q54853630
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg141Gln (c.422G>A); ClinVar=VCV000010987; Zygosity=Unspecified (Coriell=GM24215).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM24217
AC   CVCL_AZ00
DR   Coriell; GM24217
DR   Wikidata; Q54853631
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM24218
AC   CVCL_AZ01
DR   Coriell; GM24218
DR   Wikidata; Q54853632
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ07 ! GM24241
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24219
AC   CVCL_AZ02
DR   Coriell; GM24219
DR   Wikidata; Q54853636
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Cys314Trpfs*3 (c.939_940delAT); ClinVar=VCV000477529; Zygosity=Unspecified (Coriell=GM24219).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg1326Ter (c.3976C>T); ClinVar=VCV000092956; Zygosity=Unspecified (Coriell=GM24219).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24220
AC   CVCL_4T55
DR   Coriell; GM24220
DR   Wikidata; Q54853637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24221
AC   CVCL_4T56
DR   Coriell; GM24221
DR   Wikidata; Q54853638
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; p.Gly293Arg (c.877G>A); ClinVar=VCV000093895; Zygosity=Unspecified (Coriell=GM24221).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM24222
AC   CVCL_4T57
DR   Coriell; GM24222
DR   Wikidata; Q54853639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T58 ! GM24223
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24223
AC   CVCL_4T58
DR   Coriell; GM24223
DR   Wikidata; Q54853640
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T57 ! GM24222
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24224
AC   CVCL_4T59
DR   Coriell; GM24224
DR   Wikidata; Q54853641
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; c.1770+1delG; ClinVar=VCV000289581; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM24224).
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Arg784His (c.2351G>A); ClinVar=VCV000093938; Zygosity=Heterozygous (Coriell=GM24224).
CC   Discontinued: Coriell; GM24224; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T60 ! GM24231
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   GM24228
AC   CVCL_AZ03
DR   Coriell; GM24228
DR   Wikidata; Q54853642
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24230
AC   CVCL_AZ04
DR   Coriell; GM24230
DR   Wikidata; Q54853643
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Leu12Arg (c.35T>G); Zygosity=Heterozygous (Coriell=GM24230).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Gln2433Ter (c.7297C>T); ClinVar=VCV002152018; Zygosity=Heterozygous (Coriell=GM24230).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ14 ! GM24249
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM24231
AC   CVCL_4T60
DR   Coriell; GM24231
DR   Wikidata; Q54853644
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; c.1770+1delG; ClinVar=VCV000289581; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM24231).
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Arg784His (c.2351G>A); ClinVar=VCV000093938; Zygosity=Heterozygous (Coriell=GM24231).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T59 ! GM24224
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM24232
AC   CVCL_4T61
DR   Coriell; GM24232
DR   Wikidata; Q54853645
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; c.856-3C>G (IVS6-3C>G); Zygosity=Heterozygous (Coriell=GM24232).
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Lys796Ter (c.2386A>T); Zygosity=Heterozygous (Coriell=GM24232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4T46 ! GM23308
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   GM24233
AC   CVCL_AZ05
DR   Coriell; GM24233
DR   Wikidata; Q54853646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ19 ! GM24258
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24234
AC   CVCL_AZ48
DR   Coriell; GM24234
DR   Wikidata; Q54853647
CC   Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; p.Asp563Gly (c.1688A>G); ClinVar=VCV000094910; Zygosity=Unspecified (Coriell=GM24234).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM24235
AC   CVCL_AZ06
DR   Coriell; GM24235
DR   Wikidata; Q54853648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24236
AC   CVCL_4T62
DR   Coriell; GM24236
DR   Wikidata; Q54853649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24237
AC   CVCL_4T63
DR   Coriell; GM24237
DR   Wikidata; Q54853650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24238
AC   CVCL_4T64
DR   Coriell; GM24238
DR   Wikidata; Q54853651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24239
AC   CVCL_4T65
DR   Coriell; GM24239
DR   Wikidata; Q54853652
CC   Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; c.6310-2A>G; ClinVar=VCV000571080; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM24239).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   GM24240
AC   CVCL_4T66
DR   Coriell; GM24240
DR   Wikidata; Q54853653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24241
AC   CVCL_AZ07
DR   Coriell; GM24241
DR   Wikidata; Q54853654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ01 ! GM24218
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24243
AC   CVCL_AZ08
DR   Coriell; GM24243
DR   Wikidata; Q54853655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24244
AC   CVCL_AZ09
DR   Coriell; GM24244
DR   Wikidata; Q54853656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24245
AC   CVCL_AZ10
DR   Coriell; GM24245
DR   Wikidata; Q54853657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24246
AC   CVCL_AZ11
DR   Coriell; GM24246
DR   Wikidata; Q54853658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24247
AC   CVCL_AZ12
DR   Coriell; GM24247
DR   Wikidata; Q54853659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24248
AC   CVCL_AZ13
DR   Coriell; GM24248
DR   Wikidata; Q54853660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24249
AC   CVCL_AZ14
DR   Coriell; GM24249
DR   Wikidata; Q54853661
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Leu12Arg (c.35T>G); Zygosity=Heterozygous (Coriell=GM24249).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Gln2433Ter (c.7297C>T); ClinVar=VCV002152018; Zygosity=Heterozygous (Coriell=GM24249).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ04 ! GM24230
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM24250
AC   CVCL_4T67
DR   Coriell; GM24250
DR   Wikidata; Q54853663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24251
AC   CVCL_4T68
DR   Coriell; GM24251
DR   Wikidata; Q54853664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24252
AC   CVCL_4T69
DR   Coriell; GM24252
DR   Wikidata; Q54853665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24253
AC   CVCL_AZ15
DR   Coriell; GM24253
DR   Wikidata; Q54853666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ18 ! GM24256
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24254
AC   CVCL_AZ16
DR   Coriell; GM24254
DR   Wikidata; Q54853667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ20 ! GM24260
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24255
AC   CVCL_AZ17
DR   Coriell; GM24255
DR   Wikidata; Q54853668
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Trp166Ter (c.498G>A); ClinVar=VCV000551094; Zygosity=Unspecified (Coriell=GM24255).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Val1138Met (c.3412G>A); ClinVar=VCV000092952; Zygosity=Unspecified (Coriell=GM24255).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ21 ! GM24261
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24256
AC   CVCL_AZ18
DR   Coriell; GM24256
DR   Wikidata; Q54853669
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ15 ! GM24253
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24258
AC   CVCL_AZ19
DR   Coriell; GM24258
DR   Wikidata; Q54853671
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ05 ! GM24233
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24259
AC   CVCL_4T70
DR   Coriell; GM24259
DR   Wikidata; Q54853672
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; c.1002+1G>A; ClinVar=VCV000287971; Zygosity=Unspecified; Note=Splice donor mutation (Coriell=GM24259).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM24260
AC   CVCL_AZ20
DR   Coriell; GM24260
DR   Wikidata; Q54853673
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ16 ! GM24254
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24261
AC   CVCL_AZ21
DR   Coriell; GM24261
DR   Wikidata; Q54853674
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Trp166Ter (c.498G>A); ClinVar=VCV000551094; Zygosity=Unspecified (Coriell=GM24261).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Val1138Met (c.3412G>A); ClinVar=VCV000092952; Zygosity=Unspecified (Coriell=GM24261).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ17 ! GM24255
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24263
AC   CVCL_Y786
DR   Coriell; GM24263
DR   Wikidata; Q54853675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24264
AC   CVCL_AZ22
DR   Coriell; GM24264
DR   Wikidata; Q54853676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24265
AC   CVCL_HK05
DR   Coriell; GM24265
DR   Wikidata; Q54853677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM24268
AC   CVCL_AZ49
DR   Coriell; GM24268
DR   Wikidata; Q54853681
CC   Sequence variation: Mutation; HGNC; HGNC:2974; DNM2; Simple; p.Glu368Lys (c.1102G>A); ClinVar=VCV000007282; Zygosity=Heterozygous (Coriell=GM24268).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24271
AC   CVCL_5K28
DR   Coriell; GM24271
DR   Wikidata; Q54853682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24273
AC   CVCL_5K29
DR   Coriell; GM24273
DR   Wikidata; Q54853683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K61 ! GM24309
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24274
AC   CVCL_5K30
DR   Coriell; GM24274
DR   Wikidata; Q54853684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24276
AC   CVCL_5K31
DR   Coriell; GM24276
DR   Wikidata; Q54853685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24277
AC   CVCL_5K32
DR   Coriell; GM24277
DR   Wikidata; Q54853686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24278
AC   CVCL_5K33
DR   Coriell; GM24278
DR   Wikidata; Q54853687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K63 ! GM24311
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24279
AC   CVCL_5K34
DR   Coriell; GM24279
DR   Wikidata; Q54853688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24280
AC   CVCL_5K35
DR   Coriell; GM24280
DR   Wikidata; Q54853689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24281
AC   CVCL_5K36
DR   Coriell; GM24281
DR   Wikidata; Q54853690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24283
AC   CVCL_5K37
DR   Coriell; GM24283
DR   Wikidata; Q54853691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K64 ! GM24312
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24284
AC   CVCL_5K38
DR   Coriell; GM24284
DR   Wikidata; Q54853692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24286
AC   CVCL_5K39
DR   Coriell; GM24286
DR   Wikidata; Q54853693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K65 ! GM24313
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24287
AC   CVCL_5K40
DR   Coriell; GM24287
DR   Wikidata; Q54853694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24288
AC   CVCL_5K41
DR   Coriell; GM24288
DR   Wikidata; Q54853695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K67 ! GM24315
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24289
AC   CVCL_5K42
DR   Coriell; GM24289
DR   Wikidata; Q54853696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24290
AC   CVCL_5K43
DR   Coriell; GM24290
DR   Wikidata; Q54853697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24291
AC   CVCL_5K44
DR   Coriell; GM24291
DR   Wikidata; Q54853698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24292
AC   CVCL_5K45
DR   Coriell; GM24292
DR   Wikidata; Q54853699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24293
AC   CVCL_5K46
DR   Coriell; GM24293
DR   Wikidata; Q54853700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24294
AC   CVCL_5K47
DR   Coriell; GM24294
DR   Wikidata; Q54853701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24295
AC   CVCL_5K48
DR   Coriell; GM24295
DR   Wikidata; Q54853703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24296
AC   CVCL_5K49
DR   Coriell; GM24296
DR   Wikidata; Q54853704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K87 ! GM25372
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24297
AC   CVCL_5K50
DR   Coriell; GM24297
DR   Wikidata; Q54853705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24298
AC   CVCL_5K51
DR   Coriell; GM24298
DR   Wikidata; Q54853706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24299
AC   CVCL_5K52
DR   Coriell; GM24299
DR   Wikidata; Q54853707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24300
AC   CVCL_5K53
DR   Coriell; GM24300
DR   Wikidata; Q54853708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K66 ! GM24314
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24301
AC   CVCL_5K54
DR   Coriell; GM24301
DR   Wikidata; Q54853709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24302
AC   CVCL_5K55
DR   Coriell; GM24302
DR   Wikidata; Q54853710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24303
AC   CVCL_5K56
DR   Coriell; GM24303
DR   Wikidata; Q54853711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24304
AC   CVCL_5K57
DR   Coriell; GM24304
DR   Wikidata; Q54853712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24305
AC   CVCL_5K58
DR   Coriell; GM24305
DR   Wikidata; Q54853713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24306
AC   CVCL_5K59
DR   Coriell; GM24306
DR   Wikidata; Q54853714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24308
AC   CVCL_5K60
DR   Coriell; GM24308
DR   Wikidata; Q54853715
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K26 ! GM23786
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24309
AC   CVCL_5K61
DR   Coriell; GM24309
DR   Wikidata; Q54853716
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K29 ! GM24273
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   GM24310
AC   CVCL_5K62
DR   Coriell; GM24310
DR   Wikidata; Q54853717
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24311
AC   CVCL_5K63
DR   Coriell; GM24311
DR   Wikidata; Q54853718
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K33 ! GM24278
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24312
AC   CVCL_5K64
DR   Coriell; GM24312
DR   Wikidata; Q54853719
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K37 ! GM24283
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24313
AC   CVCL_5K65
DR   Coriell; GM24313
DR   Wikidata; Q54853720
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K39 ! GM24286
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24314
AC   CVCL_5K66
DR   Coriell; GM24314
DR   Wikidata; Q54853721
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K53 ! GM24300
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24315
AC   CVCL_5K67
DR   Coriell; GM24315
DR   Wikidata; Q54853725
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K41 ! GM24288
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24319
AC   CVCL_HK76
DR   Coriell; GM24319
DR   Wikidata; Q54853726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM24322
AC   CVCL_5K68
DR   Coriell; GM24322
DR   Wikidata; Q54853727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24341
AC   CVCL_U560
DR   Coriell; GM24341
DR   Wikidata; Q54853728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM24342
AC   CVCL_HK77
DR   Coriell; GM24342
DR   Wikidata; Q54853729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM24343
AC   CVCL_AZ50
DR   Coriell; GM24343
DR   Wikidata; Q54853730
CC   Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; p.Asp563Gly (c.1688A>G); ClinVar=VCV000094910; Zygosity=Heterozygous (Coriell=GM24343).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM24346
AC   CVCL_AD86
DR   Coriell; GM24346
DR   Wikidata; Q54853731
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Simple; c.1261-10A>G (IVS11-10A>G); ClinVar=VCV000011058; Zygosity=Hemizygous (Coriell=GM24346).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM24352
AC   CVCL_HK78
DR   Coriell; GM24352
DR   Wikidata; Q54853732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM24353
AC   CVCL_AZ23
DR   Coriell; GM24353
DR   Wikidata; Q54853733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24354
AC   CVCL_AZ24
DR   Coriell; GM24354
DR   Wikidata; Q54853734
CC   Sequence variation: Mutation; HGNC; HGNC:2323; CPS1; Simple; p.Arg1262Ter (c.3784C>T); ClinVar=VCV000552571; Zygosity=Heterozygous (Coriell=GM24354).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84612; Carbamoyl-phosphate synthetase I deficiency
DI   ORDO; Orphanet_147; Carbamoyl-phosphate synthetase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24356
AC   CVCL_BX18
DR   Coriell; GM24356
DR   Wikidata; Q54853735
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Lys4534del (c.13597AAG[1]) (c.13600_13602delAAG); ClinVar=VCV000590434; Zygosity=Heterozygous (Coriell=GM24356).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM24357
AC   CVCL_5K69
DR   Coriell; GM24357
DR   Wikidata; Q54853736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24365
AC   CVCL_AZ25
DR   Coriell; GM24365
DR   Wikidata; Q54853737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24366
AC   CVCL_AZ26
DR   Coriell; GM24366
DR   Wikidata; Q54853738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24367
AC   CVCL_AZ27
DR   Coriell; GM24367
DR   Wikidata; Q54853739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24369
AC   CVCL_AZ51
DR   Coriell; GM24369
DR   Wikidata; Q54853740
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Asn238Lysfs*63 (c.713dupA) (c.713_714insA); ClinVar=VCV000004494; Zygosity=Homozygous (Coriell=GM24369).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AZ47 ! GM23651
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24373
AC   CVCL_AZ28
DR   Coriell; GM24373
DR   Wikidata; Q54853741
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84560; Anencephaly
DI   ORDO; Orphanet_1048; Isolated anencephaly/exencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37FW
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   GM24374
AC   CVCL_AZ52
DR   Coriell; GM24374
DR   Wikidata; Q54853742
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:19743; POMT2; Simple; p.Gly353Ser (c.1057G>A); ClinVar=VCV000003231; Zygosity=Homozygous (Coriell=GM24374).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126690; Congenital muscular dystrophy-dystroglycanopathy with intellectual developmental disorder type B2
DI   ORDO; Orphanet_370968; Congenital muscular dystrophy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   GM24375
AC   CVCL_AZ53
DR   Coriell; GM24375
DR   Wikidata; Q54853743
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:19743; POMT2; Simple; p.Gly353Ser (c.1057G>A); ClinVar=VCV000003231; Zygosity=Homozygous (Coriell=GM24375).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126690; Congenital muscular dystrophy-dystroglycanopathy with intellectual developmental disorder type B2
DI   ORDO; Orphanet_370968; Congenital muscular dystrophy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 14
//
ID   GM24383
AC   CVCL_4Q36
DR   Coriell; GM24383
DR   Wikidata; Q54853744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99100; Type V acrocephalosyndactyly
DI   ORDO; Orphanet_710; Pfeiffer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM24384
AC   CVCL_4T71
DR   Coriell; GM24384
DR   Wikidata; Q54853745
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; p.Gly284Arg (c.850G>A); ClinVar=VCV000017180; Zygosity=Heterozygous (Coriell=GM24384).
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; c.1182+3G>A; ClinVar=VCV000162526; Zygosity=Heterozygous (Coriell=GM24384).
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; c.1814-6C>G; ClinVar=VCV000093830; Zygosity=Heterozygous (Coriell=GM24384).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM24385
AC   CVCL_1C78
SY   GM24385*B; HG002
DR   BioSample; SAMN03283347
DR   Coriell; GM24385
DR   Wikidata; Q54853746
RX   PubMed=27271295;
RX   PubMed=35819189;
RX   PubMed=37751688;
WW   Info; PGP; huAA53E0; https://my.pgp-hms.org/profile_public?hex=huAA53E0
CC   Part of: Genome in a Bottle (GIAB) consortium samples.
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; HG002.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZH94 ! GM27730
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   GM24389
AC   CVCL_Y787
DR   Coriell; GM24389
DR   Wikidata; Q54853747
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu82Ter (c.245T>A); Zygosity=Hemizygous (Coriell=GM24389).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   GM24391
AC   CVCL_4T72
DR   Coriell; GM24391
DR   Wikidata; Q54853748
CC   Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; p.Gln1682Serfs*12 (c.5044delC); Zygosity=Heterozygous (Coriell=GM24391).
CC   Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; p.Gly2356Ter (c.7066G>T); Zygosity=Heterozygous (Coriell=GM24391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM24392
AC   CVCL_AD87
DR   Coriell; GM24392
DR   Wikidata; Q54853749
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM24396
AC   CVCL_AZ29
DR   Coriell; GM24396
DR   Wikidata; Q54853751
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM24405
AC   CVCL_4T73
DR   Coriell; GM24405
DR   Wikidata; Q54853752
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; c.957+1G>A; ClinVar=VCV000290695; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM24405).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM24406
AC   CVCL_AZ54
DR   Coriell; GM24406
DR   Wikidata; Q54853753
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24407
AC   CVCL_U561
DR   Coriell; GM24407
DR   Wikidata; Q54853755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM24411
AC   CVCL_VJ08
DR   Coriell; GM24411
DR   Wikidata; Q93930046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM24415
AC   CVCL_4T74
DR   Coriell; GM24415
DR   Wikidata; Q54853756
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; p.Gly311Asp (c.932G>A); ClinVar=VCV000289651; Zygosity=Heterozygous (Coriell=GM24415).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   GM24417
AC   CVCL_AD88
DR   Coriell; GM24417
DR   Wikidata; Q54853757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM24418
AC   CVCL_AD89
DR   Coriell; GM24418
DR   Wikidata; Q54853758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM24422
AC   CVCL_Y788
DR   Coriell; GM24422
DR   Wikidata; Q54853759
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ala208Thr (c.622G>A); ClinVar=VCV000097274; Zygosity=Hemizygous (Coriell=GM24422).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM24463
AC   CVCL_AZ30
DR   Coriell; GM24463
DR   Wikidata; Q54853760
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg1400Ter (c.4198C>T); ClinVar=VCV000557566; Zygosity=Heterozygous (Coriell=GM24463).
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg2236Arg (c.6706A>C); ClinVar=VCV000256082; Zygosity=Heterozygous (Coriell=GM24463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24465
AC   CVCL_5T39
DR   Coriell; GM24465
DR   Wikidata; Q54853761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM24467
AC   CVCL_AZ55
DR   Coriell; GM24467
DR   Wikidata; Q54853762
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Val48Serfs*18 (c.142delG); ClinVar=VCV002419559; Zygosity=Heterozygous (Coriell=GM24467).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Gly315Ser (c.943G>A); ClinVar=VCV000004496; Zygosity=Heterozygous (Coriell=GM24467).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24468
AC   CVCL_T825
SY   GM24468*D
DR   Coriell; GM24468
DR   SKIP; SKIP000254
DR   SKIP; SKIP004349
DR   Wikidata; Q54853763
CC   Problematic cell line: Misclassified. Parent cell line originally thought to be a SMA type 1 (SMA1) cell line but shown to be from a SMA type 2 (SMA2).
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (Coriell=GM24468).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F172 ! GM03813
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   GM24474
AC   CVCL_T826
SY   GM24474*D
DR   Coriell; GM24474
DR   SKIP; SKIP000255
DR   SKIP; SKIP004375
DR   Wikidata; Q54853764
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   GM24482
AC   CVCL_U562
DR   Coriell; GM24482
DR   Wikidata; Q54853765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   GM24509
AC   CVCL_AD90
DR   Coriell; GM24509
DR   Wikidata; Q54853766
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Simple; p.Asp394His (c.1180G>C); ClinVar=VCV000158902; Zygosity=Hemizygous (Coriell=GM24509).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   GM24510
AC   CVCL_AZ31
DR   Coriell; GM24510
DR   Wikidata; Q54853770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24511
AC   CVCL_AZ32
DR   Coriell; GM24511
DR   Wikidata; Q54853771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM24513
AC   CVCL_AZ33
DR   Coriell; GM24513
DR   Wikidata; Q54853772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24518
AC   CVCL_5T40
DR   Coriell; GM24518
DR   Wikidata; Q54853773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GM24519
AC   CVCL_AZ34
DR   Coriell; GM24519
DR   Wikidata; Q54853774
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Arg425Gly (c.1273A>G); ClinVar=VCV002629746; Zygosity=Hemizygous (Coriell=GM24519).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24520
AC   CVCL_AZ35
DR   Coriell; GM24520
DR   Wikidata; Q54853775
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Arg425Gly (c.1273A>G); ClinVar=VCV002629746; Zygosity=Hemizygous (Coriell=GM24520).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM24521
AC   CVCL_AZ36
DR   Coriell; GM24521
DR   Wikidata; Q54853776
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; p.Arg425Gly (c.1273A>G); ClinVar=VCV002629746; Zygosity=Heterozygous (Coriell=GM24521).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM24523
AC   CVCL_HK54
DR   Coriell; GM24523
DR   Wikidata; Q54853777
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.12018+1G>A; ClinVar=VCV000265494; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM24523).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Met8154Ilefs*13 (c.24458_24461dupAGAT); ClinVar=VCV000551882; Zygosity=Heterozygous (Coriell=GM24523).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM24527
AC   CVCL_5K70
DR   Coriell; GM24527
DR   Wikidata; Q54853778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24528
AC   CVCL_YP31
DR   Coriell; GM24528
DR   Wikidata; Q93930128
CC   Population: Caucasian; Macedonian.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Arg2578Ter (c.7732C>T); ClinVar=VCV000014296; Zygosity=Unspecified (Coriell=GM24528).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   GM24529
AC   CVCL_BX19
DR   Coriell; GM24529
DR   Wikidata; Q54853779
RX   PubMed=30471880;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20278; NUBPL; Simple; p.Leu104Pro (c.311T>C); ClinVar=VCV000209179; Zygosity=Heterozygous (Coriell=GM24529).
CC   Sequence variation: Mutation; HGNC; HGNC:20278; NUBPL; Simple; c.815-27T>C; ClinVar=VCV000050317; Zygosity=Heterozygous (Coriell=GM24529).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 14
//
ID   GM24530
AC   CVCL_AZ56
DR   Coriell; GM24530
DR   Wikidata; Q54853780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24531
AC   CVCL_AZ57
DR   Coriell; GM24531
DR   Wikidata; Q54853781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24538
AC   CVCL_5K71
DR   Coriell; GM24538
DR   Wikidata; Q54853782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM24539
AC   CVCL_AZ58
DR   Coriell; GM24539
DR   Wikidata; Q54853783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM2455
AC   CVCL_B4G4
DR   IARC_TP53; 21051
DR   Wikidata; Q110432827
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GM24559
AC   CVCL_Y801
SY   GM24559*B
DR   Coriell; GM24559
DR   SKIP; SKIP000705
DR   Wikidata; Q54853784
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y794 ! GM04602
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   GM24581
AC   CVCL_1N90
SY   GM24581*B
DR   Coriell; GM24581
DR   SKIP; SKIP000664
DR   Wikidata; Q54853785
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM24581; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7348 ! GM02036
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   GM24585
AC   CVCL_AZ37
DR   Coriell; GM24585
DR   Wikidata; Q54853786
CC   Sequence variation: Gene deletion; HGNC; HGNC:20444; MBD5; Zygosity=Heterozygous (Coriell=GM24585).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141424; Intellectual developmental disorder, autosomal dominant 1
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5T12 ! GM23711
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 12
//
ID   GM24586
AC   CVCL_5T41
DR   Coriell; GM24586
DR   Wikidata; Q54853787
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5T13 ! GM23712
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM24587
AC   CVCL_5T42
DR   Coriell; GM24587
DR   Wikidata; Q54853788
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5T14 ! GM23713
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM24588
AC   CVCL_BX20
DR   Coriell; GM24588
DR   Wikidata; Q54853789
CC   Sequence variation: Mutation; HGNC; HGNC:17997; FKRP; Simple; p.Leu276Ile (c.826C>A); ClinVar=VCV000004221; Zygosity=Heterozygous (Coriell=GM24588).
CC   Sequence variation: Mutation; HGNC; HGNC:17997; FKRP; Simple; p.Lys291Argfs*137 (c.872delA); Zygosity=Heterozygous (Coriell=GM24588).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126739; Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 5
DI   ORDO; Orphanet_34515; FKRP-related limb-girdle muscular dystrophy R9
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM24589
AC   CVCL_AZ38
DR   Coriell; GM24589
DR   Wikidata; Q54853790
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:17416; ADGRV1; Simple; p.Ser2934Ter (c.8801C>A); ClinVar=VCV003376959; Zygosity=Heterozygous (Coriell=GM24589).
CC   Sequence variation: Mutation; HGNC; HGNC:17416; ADGRV1; Simple; c.14973-2A>G; ClinVar=VCV000046275; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM24589).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153174; Usher syndrome type 2C
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 14
//
ID   GM24590
AC   CVCL_AZ39
DR   Coriell; GM24590
DR   Wikidata; Q54853791
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:17416; ADGRV1; Simple; p.Ser2934Ter (c.8801C>A); ClinVar=VCV003376959; Zygosity=Heterozygous (Coriell=GM24590).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   GM24591
AC   CVCL_AZ40
DR   Coriell; GM24591
DR   Wikidata; Q54853792
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:17416; ADGRV1; Simple; c.14973-2A>G; ClinVar=VCV000046275; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM24591).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM24592
AC   CVCL_HL24
DR   Coriell; GM24592
DR   Wikidata; Q54853793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM24593
AC   CVCL_AZ41
DR   Coriell; GM24593
DR   Wikidata; Q54853794
CC   Population: Bangladeshi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM24594
AC   CVCL_1C79
DR   Coriell; GM24594
DR   Wikidata; Q54853795
RX   PubMed=27724973;
WW   Info; PGP; hu6CC83D; https://my.pgp-hms.org/profile_public?hex=hu6CC83D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24595
AC   CVCL_1C80
DR   Coriell; GM24595
DR   Wikidata; Q54853796
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu3A0860; https://my.pgp-hms.org/profile_public?hex=hu3A0860
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24598
AC   CVCL_1C81
DR   Coriell; GM24598
DR   Wikidata; Q54853797
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu66D0AA; https://my.pgp-hms.org/profile_public?hex=hu66D0AA
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24599
AC   CVCL_1C82
DR   Coriell; GM24599
DR   Wikidata; Q54853798
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu2B8562; https://my.pgp-hms.org/profile_public?hex=hu2B8562
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24601
AC   CVCL_1C83
DR   Coriell; GM24601
DR   Wikidata; Q54853799
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu9E6329; https://my.pgp-hms.org/profile_public?hex=hu9E6329
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24602
AC   CVCL_1C84
DR   Coriell; GM24602
DR   Wikidata; Q54853800
RX   PubMed=37751688;
WW   Info; PGP; hu4BF398; https://my.pgp-hms.org/profile_public?hex=hu4BF398
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24603
AC   CVCL_1C85
DR   Coriell; GM24603
DR   Wikidata; Q54853801
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; huDAA62E; https://my.pgp-hms.org/profile_public?hex=huDAA62E
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24604
AC   CVCL_1C86
DR   Coriell; GM24604
DR   Wikidata; Q54853802
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; huADA07D; https://my.pgp-hms.org/profile_public?hex=huADA07D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24605
AC   CVCL_1C87
DR   Coriell; GM24605
DR   Wikidata; Q54853804
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu84082F; https://my.pgp-hms.org/profile_public?hex=hu84082F
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24606
AC   CVCL_1C88
DR   Coriell; GM24606
DR   Wikidata; Q54853805
RX   PubMed=27724973;
WW   Info; PGP; hu973BAC; https://my.pgp-hms.org/profile_public?hex=hu973BAC
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Chinese and Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 12
//
ID   GM24607
AC   CVCL_1C89
DR   Coriell; GM24607
DR   Wikidata; Q54853806
RX   PubMed=27724973;
WW   Info; PGP; hu384E20; https://my.pgp-hms.org/profile_public?hex=hu384E20
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24608
AC   CVCL_1C90
DR   Coriell; GM24608
DR   Wikidata; Q54853807
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; huE9B080; https://my.pgp-hms.org/profile_public?hex=huE9B080
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24609
AC   CVCL_A2YK
DR   Coriell; GM24609
DR   Wikidata; Q105506963
RX   PubMed=27724973;
WW   Info; PGP; hu87C6A9; https://my.pgp-hms.org/profile_public?hex=hu87C6A9
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   GM24610
AC   CVCL_A2YL
DR   Coriell; GM24610
DR   Wikidata; Q105506967
RX   PubMed=27724973;
WW   Info; PGP; huD44B2B; https://my.pgp-hms.org/profile_public?hex=huD44B2B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   GM24611
AC   CVCL_1C91
DR   Coriell; GM24611
DR   Wikidata; Q54853808
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; huEAE6C8; https://my.pgp-hms.org/profile_public?hex=huEAE6C8
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian and Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24612
AC   CVCL_1C92
DR   Coriell; GM24612
DR   Wikidata; Q54853809
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu02C8E3; https://my.pgp-hms.org/profile_public?hex=hu02C8E3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JW75 ! NYSCF-050882-01-MR
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GM24613
AC   CVCL_1C93
DR   Coriell; GM24613
DR   Wikidata; Q54853810
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu269E6C; https://my.pgp-hms.org/profile_public?hex=hu269E6C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24614
AC   CVCL_1C94
DR   Coriell; GM24614
DR   Wikidata; Q54853815
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu7C3A81; https://my.pgp-hms.org/profile_public?hex=hu7C3A81
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24615
AC   CVCL_1C95
DR   Coriell; GM24615
DR   Wikidata; Q54853816
RX   PubMed=27724973;
WW   Info; PGP; huFAC582; https://my.pgp-hms.org/profile_public?hex=huFAC582
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   GM24617
AC   CVCL_1C96
DR   Coriell; GM24617
DR   Wikidata; Q54853817
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu904B18; https://my.pgp-hms.org/profile_public?hex=hu904B18
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM24631
AC   CVCL_1C97
SY   GM24631*B; HG005
DR   BioSample; SAMN03283350
DR   Coriell; GM24631
DR   Wikidata; Q54853818
RX   PubMed=27271295;
RX   PubMed=27724973;
RX   PubMed=37751688;
WW   Info; PGP; hu91BD69; https://my.pgp-hms.org/profile_public?hex=hu91BD69
CC   Part of: Genome in a Bottle (GIAB) consortium samples.
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; HG005.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24645
AC   CVCL_A2YM
DR   Coriell; GM24645
DR   Wikidata; Q105506970
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84655; Craniosynostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM24646
AC   CVCL_AZ42
DR   Coriell; GM24646
DR   Wikidata; Q54853819
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12597; USH1C; Simple; p.Arg80Profs*69 (c.238dupC) (c.238_239insC); ClinVar=VCV000005141; Zygosity=Homozygous (Coriell=GM24646).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126327; Usher syndrome type 1
DI   ORDO; Orphanet_231169; Usher syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   GM24676
AC   CVCL_D2YF
DR   Coriell; GM24676
DR   Wikidata; Q127380872
CC   Population: Caucasian; German/Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101328; Mitochondrial myopathy
DI   ORDO; Orphanet_206966; Mitochondrial myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM24681
AC   CVCL_Y789
DR   Coriell; GM24681
DR   Wikidata; Q54853820
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Leu301Phe (c.903A>T); ClinVar=VCV000097350; Zygosity=Hemizygous (Coriell=GM24681).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   GM24683
AC   CVCL_Y802
SY   GM24683*C; CIMRi003-A
DR   Coriell; GM24683
DR   hPSCreg; CIMRi003-A
DR   SKIP; SKIP000735
DR   Wikidata; Q54853821
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (Coriell=GM24683).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V210 ! GM01014
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   GM24694
AC   CVCL_1C98
DR   BioSample; SAMN03283348
DR   Coriell; GM24694
DR   Wikidata; Q54853822
RX   PubMed=27271295;
RX   PubMed=37751688;
WW   Info; PGP; huCA017E; https://my.pgp-hms.org/profile_public?hex=huCA017E
CC   Part of: Genome in a Bottle (GIAB) consortium samples.
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24695
AC   CVCL_1C99
DR   BioSample; SAMN03283349
DR   Coriell; GM24695
DR   Wikidata; Q54853823
RX   PubMed=27271295;
RX   PubMed=37751688;
WW   Info; PGP; hu38168C; https://my.pgp-hms.org/profile_public?hex=hu38168C
CC   Part of: Genome in a Bottle (GIAB) consortium samples.
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   GM24696
AC   CVCL_AZ43
DR   Coriell; GM24696
DR   Wikidata; Q54853824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM24720
AC   CVCL_Y790
DR   Coriell; GM24720
DR   Wikidata; Q54853825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24721
AC   CVCL_Y791
DR   Coriell; GM24721
DR   Wikidata; Q54853826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM24722
AC   CVCL_D2YG
DR   Coriell; GM24722
DR   Wikidata; Q127380873
CC   Population: Caucasian; Armenian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM24723
AC   CVCL_D2YH
DR   Coriell; GM24723
DR   Wikidata; Q127380874
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM24729
AC   CVCL_D2YI
DR   Coriell; GM24729
DR   Wikidata; Q127380875
CC   Population: Caucasian; English/German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM2493
AC   CVCL_B4G5
DR   cancercelllines; CVCL_B4G5
DR   IARC_TP53; 20806
DR   Wikidata; Q110432828
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   GM24C3
AC   CVCL_KT06
SY   GM-24C3
DR   Wikidata; Q54853827
RX   PubMed=16186162;
WW   Info; -; -; https://cdn2.hubspot.net/hubfs/1769030/files/genovac/GM0202.pdf
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P49863; Human GZMK (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   GM25134
AC   CVCL_A5PB
DR   Coriell; GM25134
DR   Wikidata; Q107115163
CC   Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Gly156Asp (c.467G>A); Zygosity=Homozygous (Coriell=GM25134).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   GM25144
AC   CVCL_LP15
DR   Coriell; GM25144
DR   Wikidata; Q54853828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25146
AC   CVCL_HK55
DR   Coriell; GM25146
DR   Wikidata; Q54853830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25151
AC   CVCL_HK56
DR   Coriell; GM25151
DR   Wikidata; Q54853831
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.3252_3255+3delTGACGTA; ClinVar=VCV000632922; Zygosity=Heterozygous; Note=Splicing mutation (Coriell=GM25151).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25153
AC   CVCL_A5PC
DR   Coriell; GM25153
DR   Wikidata; Q107115165
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ter355Aspext*48 (c.1063delT) (X355D); Zygosity=Unspecified (Coriell=GM25153).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   GM25154
AC   CVCL_A5PD
DR   Coriell; GM25154
DR   Wikidata; Q107115166
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ter355Aspext*48 (c.1063delT) (X355D); Zygosity=Unspecified (Coriell=GM25154).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   GM25155
AC   CVCL_A5PE
DR   Coriell; GM25155
DR   Wikidata; Q107115167
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25160
AC   CVCL_HK57
DR   Coriell; GM25160
DR   Wikidata; Q54853832
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Ser8073Ter (c.24218C>A); ClinVar=VCV000496134; Zygosity=Heterozygous (Coriell=GM25160).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM25161
AC   CVCL_HK58
DR   Coriell; GM25161
DR   Wikidata; Q54853833
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.13059+5G>A; ClinVar=VCV002154406; Zygosity=Heterozygous (Coriell=GM25161).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Ser8073Ter (c.24218C>A); ClinVar=VCV000496134; Zygosity=Heterozygous (Coriell=GM25161).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   GM25162
AC   CVCL_HL35
DR   Coriell; GM25162
DR   Wikidata; Q54853834
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Gln444Arg (c.1313A>G); Zygosity=Hemizygous (Coriell=GM25162).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25163
AC   CVCL_HL36
DR   Coriell; GM25163
DR   Wikidata; Q54853835
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Trp52Tyrfs*29 (c.259+1G>A) (IVS3+1G>A) (Ex3del); Zygosity=Hemizygous (Coriell=GM25163).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM25166
AC   CVCL_A5PF
DR   Coriell; GM25166
DR   Wikidata; Q107115168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25168
AC   CVCL_A5PG
DR   Coriell; GM25168
DR   Wikidata; Q107115169
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Trp114Glnfs*7 (c.338-1G>A) (IVS4-1G>A) (Ex5del); Zygosity=Hemizygous; Note=Splice acceptor mutation (Coriell=GM25168).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   GM25169
AC   CVCL_HL37
DR   Coriell; GM25169
DR   Wikidata; Q54853836
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Unexplicit; IVS7-2A>G (Ex8del); Zygosity=Hemizygous; Note=Splice acceptor mutation (Coriell=GM25169).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25170
AC   CVCL_A5PH
DR   Coriell; GM25170
DR   Wikidata; Q107115170
CC   Sequence variation: Gene deletion; HGNC; HGNC:2928; DMD; Zygosity=Hemizygous (Coriell=GM25170).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   GM25172
AC   CVCL_HK59
DR   Coriell; GM25172
DR   Wikidata; Q54853837
CC   Population: Chinese and Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.9619-2A>G; ClinVar=VCV000379231; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM25172).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.His8159Glnfs*8 (c.24473_24476dupAACA); Zygosity=Heterozygous (Coriell=GM25172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IU32 ! GM26093
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25173
AC   CVCL_HK60
DR   Coriell; GM25173
DR   Wikidata; Q54853838
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.3255+1G>A; ClinVar=VCV000449502; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM25173).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Arg8218Serfs*9 (c.24650_24651AG[2]) (c.24654_24655delAG) (p.Arg6327Serfs*9, c.18977_18978AG[2]); ClinVar=VCV000552108; Zygosity=Heterozygous (Coriell=GM25173).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25184
AC   CVCL_HL25
DR   Coriell; GM25184
DR   Wikidata; Q54853839
CC   Sequence variation: Mutation; HGNC; HGNC:89; ACADM; Simple; p.Lys329Glu (c.985A>G); ClinVar=VCV000003586; Zygosity=Homozygous (Coriell=GM25184).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84538; Medium-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_42; Medium chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM25185
AC   CVCL_HL70
DR   Coriell; GM25185
DR   Wikidata; Q54853840
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4827; HBB; Zygosity=Unspecified (Coriell=GM25185).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129072; Hereditary persistence of fetal hemoglobin
DI   ORDO; Orphanet_46532; Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM25186
AC   CVCL_HL26
DR   Coriell; GM25186
DR   Wikidata; Q54853841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128119; Fructose-1,6-bisphosphatase deficiency
DI   ORDO; Orphanet_348; Fructose-1,6-bisphosphatase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25195
AC   CVCL_VJ09
DR   Coriell; GM25195
DR   Wikidata; Q93930337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM25196
AC   CVCL_VJ10
DR   Coriell; GM25196
DR   Wikidata; Q93930340
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Asp198Gly (c.593A>G); Zygosity=Hemizygous (Coriell=GM25196).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   GM25198
AC   CVCL_VJ11
DR   Coriell; GM25198
DR   Wikidata; Q93930342
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Glu459Lys (c.1357G>A); Zygosity=Hemizygous (Coriell=GM25198).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   GM25201
AC   CVCL_D2YL
DR   Coriell; GM25201
DR   Wikidata; Q127380876
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Gly264Arg (c.790G>A) (p.Gly258Arg, c.772G>A); Zygosity=Hemizygous (Coriell=GM25201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25202
AC   CVCL_D2YM
DR   Coriell; GM25202
DR   Wikidata; Q127380877
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7960; NR0B1; Zygosity=Hemizygous (Coriell=GM25202).
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex20-79del; Zygosity=Hemizygous (Coriell=GM25202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   GM25204
AC   CVCL_GT04
DR   Coriell; GM25204
DR   Wikidata; Q54853842
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly59Alafs*18 (c.176_191del16); ClinVar=VCV000284906; Zygosity=Heterozygous (Coriell=GM25204).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Heterozygous (Coriell=GM25204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   GM25205
AC   CVCL_D2YP
DR   Coriell; GM25205
DR   Wikidata; Q127380878
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; c.1398insC; Zygosity=Hemizygous (Coriell=GM25205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25206
AC   CVCL_D2YQ
DR   Coriell; GM25206
DR   Wikidata; Q127380879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202543; 46,XY sex reversal 2
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25207
AC   CVCL_D2YR
DR   Coriell; GM25207
DR   Wikidata; Q127380880
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; c.749_759del; Zygosity=Hemizygous (Coriell=GM25207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   GM25221
AC   CVCL_D2YS
DR   Coriell; GM25221
DR   Wikidata; Q127380882
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; c.375_376insGCCC; Zygosity=Hemizygous (Coriell=GM25221).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25222
AC   CVCL_D2YT
DR   Coriell; GM25222
DR   Wikidata; Q127380884
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; c.673-4161inv3488; Zygosity=Hemizygous (Coriell=GM25222).
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; c.4162_4164delCTT; Zygosity=Hemizygous (Coriell=GM25222).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   GM25223
AC   CVCL_D2YU
DR   Coriell; GM25223
DR   Wikidata; Q127380885
CC   Sequence variation: Mutation; HGNC; HGNC:7960; NR0B1; Simple; c.626insG; Zygosity=Hemizygous (Coriell=GM25223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_95702; X-linked adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25234
AC   CVCL_HL38
DR   Coriell; GM25234
DR   Wikidata; Q54853843
CC   Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Asn294Asp (c.880A>G) (p.Asn288Asp, c.862A>G); ClinVar=VCV000010948; Zygosity=Hemizygous (Coriell=GM25234).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124845; Hyperglycerolemia
DI   ORDO; Orphanet_408; Isolated glycerol kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25243
AC   CVCL_HK79
DR   Coriell; GM25243
DR   Wikidata; Q54853844
CC   Population: Southeast Asian; Vietnamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25245
AC   CVCL_IW09
DR   Coriell; GM25245
DR   Wikidata; Q54853845
RX   PubMed=26070982;
CC   Sequence variation: Mutation; HGNC; HGNC:25928; WDR73; Simple; p.Phe296Leufs*26 (c.888delT); ClinVar=VCV000225244; Zygosity=Homozygous (PubMed=26070982).
CC   Sequence variation: Mutation; HGNC; HGNC:30493; WHAMM; Simple; p.Ile422Lysfs*35 (c.1264_1270delATAAAAG); Zygosity=Heterozygous (PubMed=26070982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C132195; Galloway-Mowat syndrome
DI   ORDO; Orphanet_2065; Galloway-Mowat syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JF29 ! GM25246
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   GM25246
AC   CVCL_JF29
DR   Coriell; GM25246
DR   Wikidata; Q54853846
RX   PubMed=26070982;
CC   Sequence variation: Mutation; HGNC; HGNC:25928; WDR73; Simple; p.Phe296Leufs*26 (c.888delT); ClinVar=VCV000225244; Zygosity=Homozygous (PubMed=26070982).
CC   Sequence variation: Mutation; HGNC; HGNC:30493; WHAMM; Simple; p.Ile422Lysfs*35 (c.1264_1270delATAAAAG); Zygosity=Heterozygous (PubMed=26070982).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C132195; Galloway-Mowat syndrome
DI   ORDO; Orphanet_2065; Galloway-Mowat syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW09 ! GM25245
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   GM25247
AC   CVCL_CX83
DR   Coriell; GM25247
DR   Wikidata; Q54853847
RX   PubMed=26070982;
CC   Sequence variation: Mutation; HGNC; HGNC:25928; WDR73; Simple; p.Phe296Leufs*26 (c.888delT); ClinVar=VCV000225244; Zygosity=Heterozygous (PubMed=26070982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX84 ! GM25248
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM25248
AC   CVCL_CX84
DR   Coriell; GM25248
DR   Wikidata; Q54853848
RX   PubMed=26070982;
CC   Sequence variation: Mutation; HGNC; HGNC:25928; WDR73; Simple; p.Phe296Leufs*26 (c.888delT); ClinVar=VCV000225244; Zygosity=Heterozygous (PubMed=26070982).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX83 ! GM25247
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM25249
AC   CVCL_CX85
DR   Coriell; GM25249
DR   Wikidata; Q54853849
RX   PubMed=26070982;
CC   Sequence variation: Mutation; HGNC; HGNC:25928; WDR73; Simple; p.Phe296Leufs*26 (c.888delT); ClinVar=VCV000225244; Zygosity=Heterozygous (PubMed=26070982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM25250
AC   CVCL_HK61
DR   Coriell; GM25250
DR   Wikidata; Q54853850
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Arg2809Ter (c.8425C>T); ClinVar=VCV001213189; Zygosity=Heterozygous (Coriell=GM25250).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Leu8106Ter (c.24317T>A); ClinVar=VCV000551889; Zygosity=Heterozygous (Coriell=GM25250).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK62 ! GM25251
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25251
AC   CVCL_HK62
DR   Coriell; GM25251
DR   Wikidata; Q54853851
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Arg2809Ter (c.8425C>T); ClinVar=VCV001213189; Zygosity=Heterozygous (Coriell=GM25251).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Leu8106Ter (c.24317T>A); ClinVar=VCV000551889; Zygosity=Heterozygous (Coriell=GM25251).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK61 ! GM25250
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   GM25252
AC   CVCL_LN92
DR   Coriell; GM25252
DR   Wikidata; Q54853852
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:17380; ANAPC7; Unexplicit; Ex4-6del (8054bp del); Zygosity=Homozygous (Coriell=GM25252).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   GM25253
AC   CVCL_LN93
DR   Coriell; GM25253
DR   Wikidata; Q54853853
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:17380; ANAPC7; Unexplicit; Ex4-6del (8054bp del); Zygosity=Heterozygous (Coriell=GM25253).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   GM25255
AC   CVCL_LN94
DR   Coriell; GM25255
DR   Wikidata; Q54853854
CC   Population: Mexican; native South American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84560; Anencephaly
DI   ORDO; Orphanet_1048; Isolated anencephaly/exencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   GM25256
AC   CVCL_Y803
SY   GM25256*B; GM25256*E; GM25256*G; WTC-11; WTC11; WTC; iPS-4; WTC/AICS-0; CIMRi002-A; UCSFi001-A
DR   EFO; EFO_0009747
DR   4DN; 4DNSR7GFFYBK
DR   BioSamples; SAMEA6260505
DR   Coriell; GM25256
DR   hPSCreg; UCSFi001-A
DR   PRIDE; PXD014031
DR   SKIP; SKIP000736
DR   Wikidata; Q54853855
RX   PubMed=23862100;
RX   PubMed=28814507;
RX   PubMed=30199041;
RX   PubMed=34019794;
RX   PubMed=34536661;
RX   PubMed=36965406;
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Population: Japanese.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): Allen Institute; PubMed=34536661; PubMed=36965406
ST   Amelogenin: X (Allen Institute)
ST   Amelogenin: X,Y (PubMed=34536661; PubMed=36965406)
ST   CSF1PO: 10,12
ST   D13S317: 8,11 (Allen Institute)
ST   D13S317: 8,12 (PubMed=34536661; PubMed=36965406)
ST   D16S539: 9,10
ST   D18S51: 12,21
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 9,10 (Allen Institute)
ST   D5S818: 10 (PubMed=34536661; PubMed=36965406)
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 21
//
ID   GM25262
AC   CVCL_HK80
DR   Coriell; GM25262
DR   Wikidata; Q54853860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25267
AC   CVCL_1N93
SY   GM25267*D; LQT3 iPS
DR   Coriell; GM25267
DR   SKIP; SKIP000737
DR   Wikidata; Q54853861
RX   PubMed=24268663;
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Asn406Lys (c.1218C>A); ClinVar=VCV000067648; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM25267).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   GM25268
AC   CVCL_IN36
DR   Coriell; GM25268
DR   Wikidata; Q54853862
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:10990; SLC25A4; Simple; p.Gln175Argfs*38 (c.523delC); ClinVar=VCV000215174; Zygosity=Homozygous (Coriell=GM25268).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129977; Mitochondrial DNA depletion syndrome 12
DI   ORDO; Orphanet_1369; Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25270
AC   CVCL_AZ59
DR   Coriell; GM25270
DR   Wikidata; Q54853863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   NCIt; C6831; Isodicentric chromosome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM25285
AC   CVCL_BX21
DR   Coriell; GM25285
DR   Wikidata; Q54853864
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Heterozygous; Note=Factor V Leiden (Coriell=GM25285).
CC   Sequence variation: Mutation; HGNC; HGNC:9479; LONP1; Simple; p.Arg721Gly (c.2161C>G); ClinVar=VCV000180657; Zygosity=Homozygous (Coriell=GM25285).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126744; CODAS syndrome
DI   ORDO; Orphanet_1458; CODAS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM25288
AC   CVCL_HL68
DR   Coriell; GM25288
DR   Wikidata; Q54853865
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:18127; TUBGCP6; Simple; p.Ter1820Glyext*16 (c.5458T>G); ClinVar=VCV000030809; Zygosity=Homozygous (Coriell=GM25288).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129306; Microcephaly and chorioretinopathy, autosomal recessive, type 1
DI   ORDO; Orphanet_2518; Autosomal recessive chorioretinopathy-microcephaly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25291
AC   CVCL_HQ16
DR   Coriell; GM25291
DR   Wikidata; Q54853866
CC   Sequence variation: Mutation; HGNC; HGNC:11049; SLC6A3; Simple; p.Tyr470Ser (c.1408_1409delinsAG); ClinVar=VCV001404765; Zygosity=Homozygous (Coriell=GM25291).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129866; Dopamine transporter deficiency syndrome
DI   ORDO; Orphanet_238455; Infantile dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM25294
AC   CVCL_BW48
DR   Coriell; GM25294
DR   Wikidata; Q54853867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM25305
AC   CVCL_1N94
SY   GM25305*C
DR   Coriell; GM25305
DR   SKIP; SKIP000738
DR   Wikidata; Q54853868
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Ala422Thr (c.1264G>A); ClinVar=VCV000067174; Zygosity=Heterozygous (Coriell=GM25305).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZG16 ! GM27173
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   GM25308
AC   CVCL_HK63
DR   Coriell; GM25308
DR   Wikidata; Q54853869
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Gln7398Ter (c.22192C>T) (p.Gln5662Ter, c.16984C>T); ClinVar=VCV000556628; Zygosity=Heterozygous (Coriell=GM25308).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Leu8414Ter (c.25241T>G) (p.Leu6523Ter, c.19568T>G); ClinVar=VCV000633334; Zygosity=Heterozygous (Coriell=GM25308).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25309
AC   CVCL_BW49
DR   Coriell; GM25309
DR   Wikidata; Q54853870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM25313
AC   CVCL_5T43
SY   GM25313*D
DR   Coriell; GM25313
DR   SKIP; SKIP001196
DR   Wikidata; Q54853871
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45del; Zygosity=Hemizygous (Coriell=GM25313).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5N08 ! GM05112
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM25318
AC   CVCL_1N89
SY   GM25318*B
DR   Coriell; GM25318
DR   SKIP; SKIP000739
DR   Wikidata; Q54853872
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg1743Gln (c.5528G>A); ClinVar=VCV000049960; Zygosity=Heterozygous (Coriell=GM25318).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N88 ! GM06102
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   GM25330
AC   CVCL_BX22
DR   Coriell; GM25330
DR   Wikidata; Q54853873
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM25330).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (Coriell=GM25330).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM25330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX28 ! GM25344
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM25331
AC   CVCL_BX23
DR   Coriell; GM25331
DR   Wikidata; Q54853874
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM25331).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (Coriell=GM25331).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM25331).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX27 ! GM25343
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM25334
AC   CVCL_BW50
DR   Coriell; GM25334
DR   Wikidata; Q54853875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM25335
AC   CVCL_HQ17
DR   Coriell; GM25335
DR   Wikidata; Q54853876
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Gly253Asp (c.758G>A); Zygosity=Heterozygous (Coriell=GM25335).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HQ18 ! GM25336
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM25336
AC   CVCL_HQ18
DR   Coriell; GM25336
DR   Wikidata; Q54853877
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Gly253Asp (c.758G>A); Zygosity=Heterozygous (Coriell=GM25336).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HQ17 ! GM25335
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25340
AC   CVCL_BX24
DR   Coriell; GM25340
DR   Wikidata; Q54853878
CC   Population: Caucasian; German/Polish and Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM25340).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln631Serfs*7 (c.1891delC); ClinVar=VCV000050961; Zygosity=Heterozygous (Coriell=GM25340).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   GM25341
AC   CVCL_BX25
DR   Coriell; GM25341
DR   Wikidata; Q54853879
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln631Serfs*7 (c.1891delC); ClinVar=VCV000050961; Zygosity=Heterozygous (Coriell=GM25341).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT70 ! GM26583
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   GM25342
AC   CVCL_BX26
DR   Coriell; GM25342
DR   Wikidata; Q54853880
CC   Population: Caucasian; German/Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM25342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT69 ! GM26582
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 13
//
ID   GM25343
AC   CVCL_BX27
DR   Coriell; GM25343
DR   Wikidata; Q54853881
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM25343).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (Coriell=GM25343).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM25343).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX23 ! GM25331
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM25344
AC   CVCL_BX28
DR   Coriell; GM25344
DR   Wikidata; Q54853882
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM25344).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (Coriell=GM25344).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM25344).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX22 ! GM25330
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   GM25347
AC   CVCL_BX29
DR   Coriell; GM25347
DR   Wikidata; Q54853883
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (Coriell=GM25347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT64 ! GM26607
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM25348
AC   CVCL_BX30
DR   Coriell; GM25348
DR   Wikidata; Q54853884
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM25348).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT65 ! GM26608
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM25350
AC   CVCL_5K72
DR   Coriell; GM25350
DR   Wikidata; Q54853885
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25351
AC   CVCL_5K73
DR   Coriell; GM25351
DR   Wikidata; Q54853886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25352
AC   CVCL_5K74
DR   Coriell; GM25352
DR   Wikidata; Q54853887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25353
AC   CVCL_5K75
DR   Coriell; GM25353
DR   Wikidata; Q54853888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25354
AC   CVCL_5K76
DR   Coriell; GM25354
DR   Wikidata; Q54853889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25355
AC   CVCL_5K77
DR   Coriell; GM25355
DR   Wikidata; Q54853890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25357
AC   CVCL_5K78
DR   Coriell; GM25357
DR   Wikidata; Q54853891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25361
AC   CVCL_5K79
DR   Coriell; GM25361
DR   Wikidata; Q54853892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25362
AC   CVCL_5K80
DR   Coriell; GM25362
DR   Wikidata; Q54853893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25363
AC   CVCL_5K81
DR   Coriell; GM25363
DR   Wikidata; Q54853894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25364
AC   CVCL_5K82
DR   Coriell; GM25364
DR   Wikidata; Q54853895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25365
AC   CVCL_5K83
DR   Coriell; GM25365
DR   Wikidata; Q54853896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25367
AC   CVCL_5K84
DR   Coriell; GM25367
DR   Wikidata; Q54853897
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25368
AC   CVCL_5K85
DR   Coriell; GM25368
DR   Wikidata; Q54853898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25369
AC   CVCL_5K86
DR   Coriell; GM25369
DR   Wikidata; Q54853899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25370
AC   CVCL_BA18
DR   Coriell; GM25370
DR   Wikidata; Q54853903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA19 ! GM25371
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM25371
AC   CVCL_BA19
DR   Coriell; GM25371
DR   Wikidata; Q54853904
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA18 ! GM25370
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   GM25372
AC   CVCL_5K87
DR   Coriell; GM25372
DR   Wikidata; Q54853905
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K49 ! GM24296
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25373
AC   CVCL_5K88
DR   Coriell; GM25373
DR   Wikidata; Q54853906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K89 ! GM25374
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25374
AC   CVCL_5K89
DR   Coriell; GM25374
DR   Wikidata; Q54853907
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K88 ! GM25373
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25375
AC   CVCL_5K90
DR   Coriell; GM25375
DR   Wikidata; Q54853908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25377
AC   CVCL_5K91
DR   Coriell; GM25377
DR   Wikidata; Q54853909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K92 ! GM25378
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25378
AC   CVCL_5K92
DR   Coriell; GM25378
DR   Wikidata; Q54853910
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5K91 ! GM25377
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25379
AC   CVCL_5K93
DR   Coriell; GM25379
DR   Wikidata; Q54853911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25380
AC   CVCL_5K94
DR   Coriell; GM25380
DR   Wikidata; Q54853912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM25382
AC   CVCL_BW51
DR   Coriell; GM25382
DR   Wikidata; Q54853913
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM25382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW52 ! GM25383
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM25383
AC   CVCL_BW52
DR   Coriell; GM25383
DR   Wikidata; Q54853914
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM25383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW51 ! GM25382
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM25384
AC   CVCL_D2YJ
DR   Coriell; GM25384
DR   Wikidata; Q127380886
CC   Population: Arab; Yemeni.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25385
AC   CVCL_BW53
DR   Coriell; GM25385
DR   Wikidata; Q54853915
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM25385).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW54 ! GM25386
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM25386
AC   CVCL_BW54
DR   Coriell; GM25386
DR   Wikidata; Q54853917
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM25386).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW53 ! GM25385
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM25389
AC   CVCL_BX31
DR   Coriell; GM25389
DR   Wikidata; Q54853918
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg458Lysfs*14 (c.1370dupG); ClinVar=VCV000126422; Zygosity=Homozygous (Coriell=GM25389).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT76 ! GM26590
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM25390
AC   CVCL_BX32
DR   Coriell; GM25390
DR   Wikidata; Q54853919
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg458Lysfs*14 (c.1370dupG); ClinVar=VCV000126422; Zygosity=Heterozygous (Coriell=GM25390).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM25391
AC   CVCL_BX33
DR   Coriell; GM25391
DR   Wikidata; Q54853920
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg458Lysfs*14 (c.1370dupG); ClinVar=VCV000126422; Zygosity=Heterozygous (Coriell=GM25391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM25392
AC   CVCL_BW55
DR   Coriell; GM25392
DR   Wikidata; Q54853921
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; c.189+1G>T (IVS3+1G>T); ClinVar=VCV002780474; Zygosity=Hemizygous; Note=Splice donor mutation (Coriell=GM25392).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW56 ! GM25393
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   GM25393
AC   CVCL_BW56
DR   Coriell; GM25393
DR   Wikidata; Q54853922
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; c.189+1G>T (IVS3+1G>T); ClinVar=VCV002780474; Zygosity=Hemizygous; Note=Splice donor mutation (Coriell=GM25393).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW55 ! GM25392
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   GM25394
AC   CVCL_HK68
DR   Coriell; GM25394
DR   Wikidata; Q54853923
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg293Ter (c.877C>T); ClinVar=VCV000011154; Zygosity=Hemizygous (Coriell=GM25394).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM25395
AC   CVCL_JF30
DR   Coriell; GM25395
DR   Wikidata; Q54853924
CC   Sequence variation: Mutation; HGNC; HGNC:13830; CNTNAP2; Simple; p.Asp1237Ilefs*17 (c.3709delG); ClinVar=VCV000005490; Zygosity=Homozygous (Coriell=GM25395).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133743; Cortical dysplasia-focal epilepsy syndrome
DI   ORDO; Orphanet_163681; Cortical dysplasia-focal epilepsy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 13
//
ID   GM25396
AC   CVCL_JF31
DR   Coriell; GM25396
DR   Wikidata; Q54853925
CC   Sequence variation: Mutation; HGNC; HGNC:13830; CNTNAP2; Simple; p.Asp1237Ilefs*17 (c.3709delG); ClinVar=VCV000005490; Zygosity=Heterozygous (Coriell=GM25396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM25397
AC   CVCL_JF32
DR   Coriell; GM25397
DR   Wikidata; Q54853926
CC   Sequence variation: Mutation; HGNC; HGNC:13830; CNTNAP2; Simple; p.Asp1237Ilefs*17 (c.3709delG); ClinVar=VCV000005490; Zygosity=Heterozygous (Coriell=GM25397).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM25399
AC   CVCL_EH24
DR   Coriell; GM25399
DR   Wikidata; Q54853927
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM25399).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH25 ! GM25400
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM25400
AC   CVCL_EH25
DR   Coriell; GM25400
DR   Wikidata; Q54853928
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM25400).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH24 ! GM25399
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM25401
AC   CVCL_VJ12
DR   Coriell; GM25401
DR   Wikidata; Q93931132
CC   Sequence variation: Mutation; HGNC; HGNC:9834; RAI1; Simple; p.Lys1753Ter (c.5257A>T); Zygosity=Unspecified (Coriell=GM25401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   GM25402
AC   CVCL_HQ19
DR   Coriell; GM25402
DR   Wikidata; Q54853929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25403
AC   CVCL_HQ20
DR   Coriell; GM25403
DR   Wikidata; Q54853930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25404
AC   CVCL_HL83
DR   Coriell; GM25404
DR   Wikidata; Q54853931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25405
AC   CVCL_HQ21
DR   Coriell; GM25405
DR   Wikidata; Q54853932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25406
AC   CVCL_HQ22
DR   Coriell; GM25406
DR   Wikidata; Q54853933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25407
AC   CVCL_HQ23
DR   Coriell; GM25407
DR   Wikidata; Q54853934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25408
AC   CVCL_HL84
DR   Coriell; GM25408
DR   Wikidata; Q54853935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25409
AC   CVCL_HL85
DR   Coriell; GM25409
DR   Wikidata; Q54853936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25410
AC   CVCL_HQ24
DR   Coriell; GM25410
DR   Wikidata; Q54853937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25411
AC   CVCL_HQ25
DR   Coriell; GM25411
DR   Wikidata; Q54853938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25412
AC   CVCL_HL86
DR   Coriell; GM25412
DR   Wikidata; Q54853939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25413
AC   CVCL_HQ26
DR   Coriell; GM25413
DR   Wikidata; Q54853940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25415
AC   CVCL_HQ27
DR   Coriell; GM25415
DR   Wikidata; Q54853941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25416
AC   CVCL_HQ28
DR   Coriell; GM25416
DR   Wikidata; Q54853942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25417
AC   CVCL_HQ29
DR   Coriell; GM25417
DR   Wikidata; Q54853943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25418
AC   CVCL_HQ30
DR   Coriell; GM25418
DR   Wikidata; Q54853947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25419
AC   CVCL_HQ31
DR   Coriell; GM25419
DR   Wikidata; Q54853948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25420
AC   CVCL_EH26
DR   Coriell; GM25420
DR   Wikidata; Q54853949
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Ser190Ter (c.569C>T); Zygosity=Hemizygous (Coriell=GM25420).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH27 ! GM25421
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM25421
AC   CVCL_EH27
DR   Coriell; GM25421
DR   Wikidata; Q54853951
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Ser190Ter (c.569C>T); Zygosity=Hemizygous (Coriell=GM25421).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH26 ! GM25420
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM25422
AC   CVCL_HK69
DR   Coriell; GM25422
DR   Wikidata; Q54853952
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Glu177Lysfs*6 (c.525_526delAG); ClinVar=VCV000279773; Zygosity=Hemizygous (Coriell=GM25422).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM25427
AC   CVCL_HL87
DR   Coriell; GM25427
DR   Wikidata; Q54853953
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25428
AC   CVCL_LN95
DR   Coriell; GM25428
DR   Wikidata; Q54853954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141424; Intellectual developmental disorder, autosomal dominant 1
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   GM25429
AC   CVCL_AY59
DR   Coriell; GM25429
DR   Wikidata; Q54853955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM25431
AC   CVCL_AY57
DR   Coriell; GM25431
DR   Wikidata; Q54853957
CC   Sequence variation: Mutation; HGNC; HGNC:4087; GABRG2; Simple; p.Pro282Ser (c.844C>T) (p.Pro322Ser, c.964C>T); ClinVar=VCV000625863; Zygosity=Heterozygous (Coriell=GM25431).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   GM25432
AC   CVCL_AY58
DR   Coriell; GM25432
DR   Wikidata; Q54853958
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GM25433
AC   CVCL_HQ32
DR   Coriell; GM25433
DR   Wikidata; Q54853959
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25434
AC   CVCL_HQ33
DR   Coriell; GM25434
DR   Wikidata; Q54853960
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25435
AC   CVCL_HQ34
DR   Coriell; GM25435
DR   Wikidata; Q54853961
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25436
AC   CVCL_HQ35
DR   Coriell; GM25436
DR   Wikidata; Q54853962
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25437
AC   CVCL_HQ36
DR   Coriell; GM25437
DR   Wikidata; Q54853963
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25438
AC   CVCL_CX86
DR   Coriell; GM25438
DR   Wikidata; Q54853964
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ser738Ter (c.2213C>A); ClinVar=VCV000242482; Zygosity=Heterozygous (Coriell=GM25438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM25439
AC   CVCL_DB22
DR   Coriell; GM25439
DR   Wikidata; Q54853965
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ser738Ter (c.2213C>A); ClinVar=VCV000242482; Zygosity=Heterozygous (Coriell=GM25439).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro1080Ilefs*18 (c.3234_3237dupATTT); ClinVar=VCV000242483; Zygosity=Heterozygous (Coriell=GM25439).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   GM25440
AC   CVCL_CX87
DR   Coriell; GM25440
DR   Wikidata; Q54853966
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM25441
AC   CVCL_CX88
DR   Coriell; GM25441
DR   Wikidata; Q54853967
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM25442
AC   CVCL_CX89
DR   Coriell; GM25442
DR   Wikidata; Q54853968
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro1080Ilefs*18 (c.3234_3237_dupATTT); Zygosity=Heterozygous (Coriell=GM25442).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM25444
AC   CVCL_CX90
DR   Coriell; GM25444
DR   Wikidata; Q54853969
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   GM25445
AC   CVCL_CX91
DR   Coriell; GM25445
DR   Wikidata; Q54853971
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro1080Ilefs*18 (c.3234_3237_dupATTT); Zygosity=Heterozygous (Coriell=GM25445).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   GM25448
AC   CVCL_HQ37
DR   Coriell; GM25448
DR   Wikidata; Q54853972
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25449
AC   CVCL_HQ38
DR   Coriell; GM25449
DR   Wikidata; Q54853973
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25450
AC   CVCL_HQ39
DR   Coriell; GM25450
DR   Wikidata; Q54853974
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25451
AC   CVCL_HQ40
DR   Coriell; GM25451
DR   Wikidata; Q54853975
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25452
AC   CVCL_HQ41
DR   Coriell; GM25452
DR   Wikidata; Q54853976
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25453
AC   CVCL_HQ42
DR   Coriell; GM25453
DR   Wikidata; Q54853977
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25454
AC   CVCL_HQ43
DR   Coriell; GM25454
DR   Wikidata; Q54853978
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25455
AC   CVCL_BA16
DR   Coriell; GM25455
DR   Wikidata; Q54853979
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; c.62+1delGT; Zygosity=Unspecified; Note=De novo mutation (Coriell=GM25455).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA17 ! GM25456
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM25456
AC   CVCL_BA17
DR   Coriell; GM25456
DR   Wikidata; Q54853980
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; c.62+1delGT; Zygosity=Unspecified; Note=De novo mutation (Coriell=GM25456).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA16 ! GM25455
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   GM25471
AC   CVCL_D2YV
DR   Coriell; GM25471
DR   Wikidata; Q127380887
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25472
AC   CVCL_D2YW
DR   Coriell; GM25472
DR   Wikidata; Q127380888
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25473
AC   CVCL_D2YX
DR   Coriell; GM25473
DR   Wikidata; Q127380889
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25474
AC   CVCL_D2YY
DR   Coriell; GM25474
DR   Wikidata; Q127380890
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25475
AC   CVCL_D2YZ
DR   Coriell; GM25475
DR   Wikidata; Q127380891
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Arg92Pro (c.275G>C); ClinVar=VCV000097153; Zygosity=Hemizygous (Coriell=GM25475).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25477
AC   CVCL_D2Z0
DR   Coriell; GM25477
DR   Wikidata; Q127380892
CC   Population: Caucasian and Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:8565; PABPN1; Simple; p.Ala11_Gly12insAlaAla (c.21_26dup) (c.18_23dupGGCGGC) ((GCG)9); ClinVar=VCV002437738; Zygosity=Heterozygous (Coriell=GM25477).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84942; Oculopharyngeal muscular dystrophy
DI   ORDO; Orphanet_270; Oculopharyngeal muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25482
AC   CVCL_HQ44
DR   Coriell; GM25482
DR   Wikidata; Q54853981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25483
AC   CVCL_HQ45
DR   Coriell; GM25483
DR   Wikidata; Q54853982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25484
AC   CVCL_HQ46
DR   Coriell; GM25484
DR   Wikidata; Q54853983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25485
AC   CVCL_HQ47
DR   Coriell; GM25485
DR   Wikidata; Q54853984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25486
AC   CVCL_D2Z1
DR   Coriell; GM25486
DR   Wikidata; Q127380893
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25487
AC   CVCL_D2Z2
DR   Coriell; GM25487
DR   Wikidata; Q127380894
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25488
AC   CVCL_D2Z3
DR   Coriell; GM25488
DR   Wikidata; Q127380895
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25489
AC   CVCL_D2Z4
DR   Coriell; GM25489
DR   Wikidata; Q127380896
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25490
AC   CVCL_D2Z5
DR   Coriell; GM25490
DR   Wikidata; Q127380897
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25491
AC   CVCL_D2Z6
DR   Coriell; GM25491
DR   Wikidata; Q127380898
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25492
AC   CVCL_D2Z7
DR   Coriell; GM25492
DR   Wikidata; Q127380899
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Glu120del (c.355GAG[1]) (c.358_360delGAG); ClinVar=VCV000017006; Zygosity=Heterozygous (Coriell=GM25492).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Met195Ile (c.585G>A); ClinVar=VCV000438621; Zygosity=Heterozygous (Coriell=GM25492).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25493
AC   CVCL_D2YN
DR   Coriell; GM25493
DR   Wikidata; Q127380900
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly4Asp (c.11G>A); ClinVar=VCV000044724; Zygosity=Homozygous (Coriell=GM25493).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM25494
AC   CVCL_HQ48
DR   Coriell; GM25494
DR   Wikidata; Q54853985
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:30372; KLHL40; Simple; p.Arg547His (c.1640G>A); ClinVar=VCV000566161; Zygosity=Heterozygous (Coriell=GM25494).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129871; Nemaline myopathy 8
DI   ORDO; Orphanet_171430; Severe congenital nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 12
//
ID   GM25495
AC   CVCL_HK70
DR   Coriell; GM25495
DR   Wikidata; Q54853986
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Unexplicit; Ex6-8del; Zygosity=Hemizygous (Coriell=GM25495).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM25496
AC   CVCL_HK71
DR   Coriell; GM25496
DR   Wikidata; Q54853987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25497
AC   CVCL_HK64
DR   Coriell; GM25497
DR   Wikidata; Q54853988
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Leu8168Phefs*13 (c.24502_24503dupAA) (p.Leu6277Phefs*13, c.18829_18830dupAA); ClinVar=VCV000855559; Zygosity=Heterozygous (Coriell=GM25497).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 12
//
ID   GM25498
AC   CVCL_HK65
DR   Coriell; GM25498
DR   Wikidata; Q54853995
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Leu8168Phefs*13 (c.24502_24503dupAA) (p.Leu6277Phefs*13, c.18829_18830dupAA); ClinVar=VCV000855559; Zygosity=Heterozygous (Coriell=GM25498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM25500
AC   CVCL_AZ44
DR   Coriell; GM25500
DR   Wikidata; Q54853996
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   GM25502
AC   CVCL_GZ54
DR   Coriell; GM25502
DR   Wikidata; Q54853997
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:18127; TUBGCP6; Simple; p.Ter1820Glyext*16 (c.5458T>G); ClinVar=VCV000030809; Zygosity=Homozygous (Coriell=GM25502).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129306; Microcephaly and chorioretinopathy, autosomal recessive, type 1
DI   ORDO; Orphanet_2518; Autosomal recessive chorioretinopathy-microcephaly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM25503
AC   CVCL_GZ60
DR   Coriell; GM25503
DR   Wikidata; Q54853998
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:18127; TUBGCP6; Simple; p.Ter1820Glyext*16 (c.5458T>G); ClinVar=VCV000030809; Zygosity=Homozygous (Coriell=GM25503).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129306; Microcephaly and chorioretinopathy, autosomal recessive, type 1
DI   ORDO; Orphanet_2518; Autosomal recessive chorioretinopathy-microcephaly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   GM25504
AC   CVCL_CX92
DR   Coriell; GM25504
DR   Wikidata; Q54853999
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:18127; TUBGCP6; Simple; p.Ter1820Glyext*16 (c.5458T>G); ClinVar=VCV000030809; Zygosity=Heterozygous (Coriell=GM25504).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM25515
AC   CVCL_HQ49
DR   Coriell; GM25515
DR   Wikidata; Q54854000
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:29427; SH3TC2; Simple; p.Arg954Ter (c.2860C>T); ClinVar=VCV000002482; Zygosity=Unspecified (Coriell=GM25515).
CC   Sequence variation: Mutation; HGNC; HGNC:10994; SLC26A2; Simple; p.Arg279Trp (c.835C>T); ClinVar=VCV000004089; Zygosity=Unspecified (Coriell=GM25515).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129864; Charcot-Marie-Tooth disease type 4C
DI   NCIt; C156311; Diastrophic dysplasia
DI   ORDO; Orphanet_99949; Charcot-Marie-Tooth disease type 4C
DI   ORDO; Orphanet_628; Diastrophic dwarfism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25516
AC   CVCL_VI97
DR   Coriell; GM25516
DR   Wikidata; Q93931854
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg109Trp (c.325C>T); ClinVar=VCV000012988; Zygosity=Heterozygous (Coriell=GM25516).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg2241Ter (c.6721C>T); Zygosity=Heterozygous (Coriell=GM25516).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150608; Minicore myopathy with external ophthalmoplegia
DI   ORDO; Orphanet_98905; Congenital multicore myopathy with external ophthalmoplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD82 ! GM23800
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   GM25517
AC   CVCL_HK72
DR   Coriell; GM25517
DR   Wikidata; Q54854001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25522
AC   CVCL_JF33
DR   Coriell; GM25522
DR   Wikidata; Q54854003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM25541
AC   CVCL_5T44
SY   GM25541*B
DR   Coriell; GM25541
DR   SKIP; SKIP001195
DR   Wikidata; Q54854004
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex2-3dup; Zygosity=Hemizygous (Coriell=GM25541).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F602 ! GM01662
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   GM25544
AC   CVCL_HQ50
DR   Coriell; GM25544
DR   Wikidata; Q54854005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25571
AC   CVCL_EH28
DR   Coriell; GM25571
DR   Wikidata; Q54854006
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg253Ter (c.757C>T); ClinVar=VCV000279774; Zygosity=Hemizygous (Coriell=GM25571).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM25576
AC   CVCL_5T45
DR   Coriell; GM25576
DR   Wikidata; Q54854007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM25577
AC   CVCL_LN96
DR   Coriell; GM25577
DR   Wikidata; Q54854008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25578
AC   CVCL_LN97
DR   Coriell; GM25578
DR   Wikidata; Q54854009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25579
AC   CVCL_LN98
DR   Coriell; GM25579
DR   Wikidata; Q54854011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25580
AC   CVCL_LN99
DR   Coriell; GM25580
DR   Wikidata; Q54854012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25581
AC   CVCL_VJ13
DR   Coriell; GM25581
DR   Wikidata; Q93931969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM25582
AC   CVCL_VJ14
DR   Coriell; GM25582
DR   Wikidata; Q93931976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM25583
AC   CVCL_VJ15
DR   Coriell; GM25583
DR   Wikidata; Q93931979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM25584
AC   CVCL_LP01
DR   Coriell; GM25584
DR   Wikidata; Q54854013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25585
AC   CVCL_JF34
DR   Coriell; GM25585
DR   Wikidata; Q54854014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM25586
AC   CVCL_JF35
DR   Coriell; GM25586
DR   Wikidata; Q54854015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM25587
AC   CVCL_LP02
DR   Coriell; GM25587
DR   Wikidata; Q54854016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   NCIt; C35078; Tourette syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25588
AC   CVCL_LP03
DR   Coriell; GM25588
DR   Wikidata; Q54854017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25589
AC   CVCL_VJ16
DR   Coriell; GM25589
DR   Wikidata; Q93932035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM25590
AC   CVCL_LP04
DR   Coriell; GM25590
DR   Wikidata; Q54854018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25591
AC   CVCL_LP05
DR   Coriell; GM25591
DR   Wikidata; Q54854019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25592
AC   CVCL_LP06
DR   Coriell; GM25592
DR   Wikidata; Q54854020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25593
AC   CVCL_JF36
DR   Coriell; GM25593
DR   Wikidata; Q54854021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM25594
AC   CVCL_JF37
DR   Coriell; GM25594
DR   Wikidata; Q54854022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM25595
AC   CVCL_VJ17
DR   Coriell; GM25595
DR   Wikidata; Q93932076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   GM25596
AC   CVCL_EH31
DR   Coriell; GM25596
DR   Wikidata; Q54854023
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Ser116Ter (c.347C>G); ClinVar=VCV000221579; Zygosity=Heterozygous (Coriell=GM25596).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; c.881+5G>T (IVS5+5G>T); ClinVar=VCV000221584; Zygosity=Heterozygous (Coriell=GM25596).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT66 ! GM26598
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM25597
AC   CVCL_EH32
DR   Coriell; GM25597
DR   Wikidata; Q54854024
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Ser116Ter (c.347C>G); ClinVar=VCV000221579; Zygosity=Heterozygous (Coriell=GM25597).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT67 ! GM26599
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM25598
AC   CVCL_EH33
DR   Coriell; GM25598
DR   Wikidata; Q54854026
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; c.881+5G>T (IVS5+5G>T); ClinVar=VCV000221584; Zygosity=Heterozygous (Coriell=GM25598).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT68 ! GM26600
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM25853
AC   CVCL_HK66
DR   Coriell; GM25853
DR   Wikidata; Q54854027
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.1152+1G>A; ClinVar=VCV000095104; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM25853).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.17013+1G>T; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM25853).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK67 ! GM25854
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25854
AC   CVCL_HK67
DR   Coriell; GM25854
DR   Wikidata; Q54854028
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.1152+1G>A; ClinVar=VCV000095104; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM25854).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.17013+1G>T; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM25854).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK66 ! GM25853
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   GM25856
AC   CVCL_A5NM
DR   Coriell; GM25856
DR   Wikidata; Q107115171
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25857
AC   CVCL_A5NN
DR   Coriell; GM25857
DR   Wikidata; Q107115172
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25858
AC   CVCL_A5NP
DR   Coriell; GM25858
DR   Wikidata; Q107115173
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25860
AC   CVCL_A5NQ
DR   Coriell; GM25860
DR   Wikidata; Q107115174
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25861
AC   CVCL_A5NR
DR   Coriell; GM25861
DR   Wikidata; Q107115175
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129875; Chromosome 16p12.1 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25864
AC   CVCL_VJ19
SY   GM25864*B
DR   Coriell; GM25864
DR   Wikidata; Q93932121
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (Coriell=GM25864).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (Coriell=GM25864).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   GM25872
AC   CVCL_A5NS
DR   Coriell; GM25872
DR   Wikidata; Q107115176
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25873
AC   CVCL_A5NT
DR   Coriell; GM25873
DR   Wikidata; Q107115177
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25886
AC   CVCL_A5NU
DR   Coriell; GM25886
DR   Wikidata; Q107115179
CC   Population: Caucasian; English/German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25929
AC   CVCL_A5NV
DR   Coriell; GM25929
DR   Wikidata; Q107115180
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LP07 ! GM25930
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25930
AC   CVCL_LP07
DR   Coriell; GM25930
DR   Wikidata; Q54854029
CC   Population: Caucasian.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5NV ! GM25929
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   GM25931
AC   CVCL_VJ18
DR   Coriell; GM25931
DR   Wikidata; Q93932133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5NW ! GM25932
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   GM25932
AC   CVCL_A5NW
DR   Coriell; GM25932
DR   Wikidata; Q107115181
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ18 ! GM25931
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   GM25933
AC   CVCL_A5NX
DR   Coriell; GM25933
DR   Wikidata; Q107115182
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25936
AC   CVCL_HK83
DR   Coriell; GM25936
DR   Wikidata; Q54854030
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly12Valfs*2 (c.35delG); ClinVar=VCV000017004; Zygosity=Heterozygous (Coriell=GM25936).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Met34Thr (c.101T>C); ClinVar=VCV000017000; Zygosity=Heterozygous (Coriell=GM25936).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Val10952Leu (c.32854G>C) (p.Val13520Leu, c.40558G>C); ClinVar=VCV000130666; Zygosity=Heterozygous (Coriell=GM25936).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; c.39893-1G>A (IVS192-1G>A) (c.37112-1G>A, IVS191-1G>A); ClinVar=VCV000202368; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM25936).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BV66 ! GM23417
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   GM25944
AC   CVCL_A5NY
DR   Coriell; GM25944
DR   Wikidata; Q107115184
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   GM25945
AC   CVCL_D2YK
DR   Coriell; GM25945
DR   Wikidata; Q127380901
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM25948
AC   CVCL_HL27
DR   Coriell; GM25948
DR   Wikidata; Q54854031
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly12Valfs*2 (c.35delG); ClinVar=VCV000017004; Zygosity=Heterozygous (Coriell=GM25948).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Val10952Leu (c.32854G>C) (p.Val13520Leu, c.40558G>C); ClinVar=VCV000130666; Zygosity=Heterozygous (Coriell=GM25948).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   GM25951
AC   CVCL_HL28
DR   Coriell; GM25951
DR   Wikidata; Q54854032
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Met34Thr (c.101T>C); ClinVar=VCV000017000; Zygosity=Heterozygous (Coriell=GM25951).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; c.39893-1G>A (IVS192-1G>A) (c.37112-1G>A, IVS191-1G>A); ClinVar=VCV000202368; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM25951).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25952
AC   CVCL_IJ32
DR   Coriell; GM25952
DR   Wikidata; Q54854033
CC   Sequence variation: Mutation; HGNC; HGNC:2745; DDX3X; Simple; p.Gln417Pro (c.1250A>C); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM25952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129931; Intellectual developmental disorder, X-linked 102
DI   ORDO; Orphanet_457260; X-linked intellectual disability-hypotonia-movement disorder syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 12
//
ID   GM25953
AC   CVCL_HL88
DR   Coriell; GM25953
DR   Wikidata; Q54854034
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   GM25965
AC   CVCL_EH29
DR   Coriell; GM25965
DR   Wikidata; Q54854035
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Tyr315Ilefs*1 (c.941dupG); Zygosity=Hemizygous (Coriell=GM25965).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   GM25974
AC   CVCL_JF38
DR   Coriell; GM25974
DR   Wikidata; Q54854036
CC   Sequence variation: Mutation; HGNC; HGNC:2745; DDX3X; Simple; p.Tyr462Ilefs*3 (c.1383dupA); dbSNP=rs796052228; Zygosity=Homozygous (Coriell=GM25974).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129931; Intellectual developmental disorder, X-linked 102
DI   ORDO; Orphanet_457260; X-linked intellectual disability-hypotonia-movement disorder syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 13
//
ID   GM25975
AC   CVCL_JF39
DR   Coriell; GM25975
DR   Wikidata; Q54854037
CC   Sequence variation: Mutation; HGNC; HGNC:2745; DDX3X; Simple; p.Tyr462Ilefs*3 (c.1383dupA); dbSNP=rs796052228; Zygosity=Heterozygous (Coriell=GM25975).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM25976
AC   CVCL_JF40
DR   Coriell; GM25976
DR   Wikidata; Q54854051
CC   Sequence variation: Mutation; HGNC; HGNC:2745; DDX3X; Simple; p.Tyr462Ilefs*3 (c.1383dupA); dbSNP=rs796052228; Zygosity=Heterozygous (Coriell=GM25976).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM25977
AC   CVCL_VJ20
DR   Coriell; GM25977
DR   Wikidata; Q93932203
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:2340; CRADD; Simple; p.Gly128Arg (c.382G>C); ClinVar=VCV000030360; Zygosity=Heterozygous (Coriell=GM25977).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   GM25978
AC   CVCL_VJ21
DR   Coriell; GM25978
DR   Wikidata; Q93932205
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:2340; CRADD; Simple; p.Gly128Arg (c.382G>C); ClinVar=VCV000030360; Zygosity=Homozygous (Coriell=GM25978).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153179; Intellectual developmental disorder, autosomal recessive 34
DI   ORDO; Orphanet_88616; Autosomal recessive non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 11
//
ID   GM25979
AC   CVCL_VJ22
DR   Coriell; GM25979
DR   Wikidata; Q93932206
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:2340; CRADD; Simple; p.Gly128Arg (c.382G>C); ClinVar=VCV000030360; Zygosity=Heterozygous (Coriell=GM25979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   GM25980
AC   CVCL_VJ23
DR   Coriell; GM25980
DR   Wikidata; Q93932209
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:2340; CRADD; Simple; p.Gly128Arg (c.382G>C); ClinVar=VCV000030360; Zygosity=Homozygous (Coriell=GM25980).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153179; Intellectual developmental disorder, autosomal recessive 34
DI   ORDO; Orphanet_88616; Autosomal recessive non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 11
//
ID   GM25981
AC   CVCL_VJ24
DR   Coriell; GM25981
DR   Wikidata; Q93932212
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:2340; CRADD; Simple; p.Gly128Arg (c.382G>C); ClinVar=VCV000030360; Zygosity=Heterozygous (Coriell=GM25981).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   GM25982
AC   CVCL_JF41
DR   Coriell; GM25982
DR   Wikidata; Q54854052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM25987
AC   CVCL_HQ51
DR   Coriell; GM25987
DR   Wikidata; Q54854053
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg580Trp (c.1738C>T) (p.Arg576Trp, c.1726C>T); ClinVar=VCV000007370; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM25987).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM25988
AC   CVCL_HL89
DR   Coriell; GM25988
DR   Wikidata; Q54854054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   GM25990
AC   CVCL_EH30
DR   Coriell; GM25990
DR   Wikidata; Q54854056
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg402del (c.1202_1204GAA[1]) (c.1205_1207delTTC); ClinVar=VCV000126423; Zygosity=Heterozygous (Coriell=GM25990).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg542Ter (c.1624C>T); ClinVar=VCV000126424; Zygosity=Heterozygous (Coriell=GM25990).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   GM25991
AC   CVCL_A5NZ
DR   Coriell; GM25991
DR   Wikidata; Q107115185
CC   Population: Asian.
CC   Characteristics: No OTC mutation found.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM25992
AC   CVCL_LP08
DR   Coriell; GM25992
DR   Wikidata; Q54854057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM25993
AC   CVCL_HL29
DR   Coriell; GM25993
DR   Wikidata; Q54854058
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; c.39893-1G>A (IVS192-1G>A) (c.37112-1G>A, IVS191-1G>A); ClinVar=VCV000202368; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM25993).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM25994
AC   CVCL_JF42
DR   Coriell; GM25994
DR   Wikidata; Q54854059
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Gly484Ser (c.1450G>A); ClinVar=VCV000245898; Zygosity=Heterozygous (Coriell=GM25994).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 13
//
ID   GM25995
AC   CVCL_A5PA
DR   Coriell; GM25995
DR   Wikidata; Q107115186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GM26017
AC   CVCL_IU31
SY   GM26017*B
DR   Coriell; GM26017
DR   Wikidata; Q54854060
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_FV75 ! GM10269
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
ID   GM26023
AC   CVCL_A2VA
DR   Coriell; GM26023
DR   Wikidata; Q105506974
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Ala614Val (c.1841C>T) (p.Ala610Val, c.1829C>T); ClinVar=VCV000581714; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM26023).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2Z8 ! GM26068
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM26025
AC   CVCL_IU33
SY   GM26025*B
DR   Coriell; GM26025
DR   Wikidata; Q54854061
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U20 ! GM06097
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 10
//
ID   GM26029
AC   CVCL_IU30
SY   GM26029*B
DR   Coriell; GM26029
DR   Wikidata; Q54854062
CC   Population: Jewish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4N47 ! GM06225
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   GM26035
AC   CVCL_D2ZC
DR   Coriell; GM26035
DR   Wikidata; Q127380902
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:27302; IBA57; Simple; p.Arg197Trp (c.589C>T); ClinVar=VCV000521722; Zygosity=Heterozygous (Coriell=GM26035).
CC   Sequence variation: Mutation; HGNC; HGNC:27302; IBA57; Simple; p.Pro236Ala (c.706C>G); ClinVar=VCV000521723; Zygosity=Heterozygous (Coriell=GM26035).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202608; Multiple mitochondrial dysfunctions syndrome type 3
DI   ORDO; Orphanet_363424; Multiple mitochondrial dysfunctions syndrome type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM26036
AC   CVCL_HK73
DR   Coriell; GM26036
DR   Wikidata; Q54854063
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg253Ter (c.757C>T); ClinVar=VCV000279774; Zygosity=Hemizygous (Coriell=GM26036).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   GM26037
AC   CVCL_HQ52
DR   Coriell; GM26037
DR   Wikidata; Q54854064
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg174Ter (c.520C>T); ClinVar=VCV000235853; Zygosity=Heterozygous (Coriell=GM26037).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HQ53 ! GM26038
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   GM26038
AC   CVCL_HQ53
DR   Coriell; GM26038
DR   Wikidata; Q54854065
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg174Ter (c.520C>T); ClinVar=VCV000235853; Zygosity=Heterozygous (Coriell=GM26038).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HQ52 ! GM26037
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   GM26045
AC   CVCL_VP81
DR   Coriell; GM26045
DR   Wikidata; Q93932334
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:21701; BRAT1; Simple; p.Val214Glyfs*189 (c.638dupA) (c.638_639insA); ClinVar=VCV000031199; Zygosity=Homozygous (Coriell=GM26045).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C154618; Lethal neonatal rigidity and multifocal seizure syndrome
DI   ORDO; Orphanet_435845; Lethal neonatal spasticity-epileptic encephalopathy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24D
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   GM26046
AC   CVCL_VP82
DR   Coriell; GM26046
DR   Wikidata; Q93932339
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:21701; BRAT1; Simple; p.Val214Glyfs*189 (c.638dupA) (c.638_639insA); ClinVar=VCV000031199; Zygosity=Heterozygous (Coriell=GM26046).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   GM26063
AC   CVCL_JF26
DR   Coriell; GM26063
DR   Wikidata; Q54854066
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg262Profs*3 (c.784_785insCA); ClinVar=VCV002499608; Zygosity=Heterozygous (Coriell=GM26063).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   GM26068
AC   CVCL_D2Z8
DR   Coriell; GM26068
DR   Wikidata; Q127380903
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Ala614Val (c.1841C>T) (p.Ala610Val, c.1829C>T); ClinVar=VCV000581714; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM26068).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2VA ! GM26023
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM26069
AC   CVCL_D2Z9
DR   Coriell; GM26069
DR   Wikidata; Q127380904
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Ex5-9del; Zygosity=Heterozygous (Coriell=GM26069).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM26070
AC   CVCL_D2ZA
DR   Coriell; GM26070
DR   Wikidata; Q127380905
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM26071
AC   CVCL_D2ZB
DR   Coriell; GM26071
DR   Wikidata; Q127380906
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM26073
AC   CVCL_RT99
DR   Coriell; GM26073
DR   Wikidata; Q54854067
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; c.1297-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation. De novo mutation (Coriell=GM26073).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26074
AC   CVCL_HL69
DR   Coriell; GM26074
DR   Wikidata; Q54854068
CC   Population: Caucasian; Mennonite.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3424; Tuberous sclerosis
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   GM26075
AC   CVCL_LH22
DR   Coriell; GM26075
DR   Wikidata; Q54854069
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; c.1182_1197delAGGTGATGTTTGGGTC; Zygosity=Heterozygous (Coriell=GM26075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123815; Myhre syndrome
DI   ORDO; Orphanet_2588; Myhre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   GM26076
AC   CVCL_LH23
DR   Coriell; GM26076
DR   Wikidata; Q54854070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM26077
AC   CVCL_LP09
SY   GM26077*C
DR   Coriell; GM26077
DR   Wikidata; Q54854071
WW   Info; PGP; hu8E87A9; https://my.pgp-hms.org/profile_public?hex=hu8E87A9
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C48 ! GM24143
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   GM26087
AC   CVCL_YP66
DR   Coriell; GM26087
DR   Wikidata; Q93932406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM26091
AC   CVCL_A2VB
DR   Coriell; GM26091
DR   Wikidata; Q105506977
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   GM26093
AC   CVCL_IU32
DR   Coriell; GM26093
DR   Wikidata; Q54854072
CC   Population: Chinese and Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.9619-2A>G; ClinVar=VCV000379231; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM26093).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.His8159Glnfs*8 (c.24473_24476dupAACA); Zygosity=Heterozygous (Coriell=GM26093).
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HK59 ! GM25172
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   GM26094
AC   CVCL_A2VC
DR   Coriell; GM26094
DR   Wikidata; Q105506980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26095
AC   CVCL_LH24
DR   Coriell; GM26095
DR   Wikidata; Q54854074
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM26095).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_206662; Inclusion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH25 ! GM26096
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   GM26096
AC   CVCL_LH25
DR   Coriell; GM26096
DR   Wikidata; Q54854075
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM26096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_206662; Inclusion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH24 ! GM26095
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   GM26097
AC   CVCL_LH26
DR   Coriell; GM26097
DR   Wikidata; Q54854076
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM26097).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_206662; Inclusion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH27 ! GM26098
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   GM26098
AC   CVCL_LH27
DR   Coriell; GM26098
DR   Wikidata; Q54854077
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM26098).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_206662; Inclusion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH26 ! GM26097
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   GM26099
AC   CVCL_LH28
DR   Coriell; GM26099
DR   Wikidata; Q54854078
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM26099).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with inclusion myopathy but possess the mutation affecting his brother, mother and uncle.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_206662; Inclusion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5LG ! GM28283
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   GM26100
AC   CVCL_LH29
DR   Coriell; GM26100
DR   Wikidata; Q54854079
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   GM26105
AC   CVCL_LP11
SY   GM26105*C
DR   Coriell; GM26105
DR   Wikidata; Q54854080
WW   Info; PGP; huAA53E0; https://my.pgp-hms.org/profile_public?hex=huAA53E0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C78 ! GM24385
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   GM26107
AC   CVCL_LP12
SY   GM26107*C
DR   Coriell; GM26107
DR   Wikidata; Q54854081
WW   Info; PGP; hu91BD69; https://my.pgp-hms.org/profile_public?hex=hu91BD69
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C97 ! GM24631
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   GM26112
AC   CVCL_A2VD
DR   Coriell; GM26112
DR   Wikidata; Q105506982
CC   Population: Caucasian; Irish/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Gly48Cys (c.142C>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM26112).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120046; Congenital fiber-type disproportion
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_2020; Congenital fiber-type disproportion myopathy
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM26113
AC   CVCL_A2VE
DR   Coriell; GM26113
DR   Wikidata; Q105506984
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:8967; PIGN; Simple; c.1434_c.1434+1delGGinsAA; ClinVar=VCV000280280; Zygosity=Homozygous; Note=Causes abnormal splicing (Coriell=GM26113).
CC   Sequence variation: Mutation; HGNC; HGNC:10485; RYR3; Simple; p.Arg1521Ser (c.4562G>C); Zygosity=Heterozygous (Coriell=GM26113).
CC   Sequence variation: Mutation; HGNC; HGNC:10485; RYR3; Simple; p.Glu4130Ala (c.12389A>C); Zygosity=Heterozygous (Coriell=GM26113).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176896; Multiple congenital anomalies-hypotonia-seizures syndrome 1
DI   ORDO; Orphanet_280633; Multiple congenital anomalies-hypotonia-seizures syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM26114
AC   CVCL_A2VF
DR   Coriell; GM26114
DR   Wikidata; Q105506986
CC   Population: Caucasian; Lithuanian.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Asp27Asn (c.79G>A); ClinVar=VCV003068434; Zygosity=Heterozygous (Coriell=GM26114).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Arg1894Gly (c.5680A>G); ClinVar=VCV000465617; Zygosity=Heterozygous (Coriell=GM26114).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Pro4678Arg (c.14033C>G) (p.Pro3751Arg, c.11252C>G) (p.Pro4995Arg, c.14984C>G); ClinVar=VCV000046595; Zygosity=Heterozygous (Coriell=GM26114).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Val5118Met (c.15352G>A) (p.Val4191Met, c.12571G>A) (p.Val5435Met, c.16303G>A); ClinVar=VCV000046614; Zygosity=Heterozygous (Coriell=GM26114).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 7
//
ID   GM26115
AC   CVCL_A2VG
DR   Coriell; GM26115
DR   Wikidata; Q105506990
CC   Population: Caucasian; Lithuanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26116
AC   CVCL_A2VH
DR   Coriell; GM26116
DR   Wikidata; Q105506994
CC   Population: Caucasian; Lithuanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26117
AC   CVCL_A2VI
DR   Coriell; GM26117
DR   Wikidata; Q105506997
CC   Population: Caucasian; Lithuanian.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Asn94Lys (c.282C>A); ClinVar=VCV000948238; Zygosity=Heterozygous (Coriell=GM26117).
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Ile382Met (c.1146A>G); ClinVar=VCV000050866; Zygosity=Heterozygous (Coriell=GM26117).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Glu3212Gly (c.9635A>G); ClinVar=VCV000329090; Zygosity=Heterozygous (Coriell=GM26117).
CC   Sequence variation: Mutation; HGNC; HGNC:11831; TK2; Simple; p.Arg183Trp (c.547C>T); ClinVar=VCV000038992; Zygosity=Heterozygous (Coriell=GM26117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120046; Congenital fiber-type disproportion
DI   ORDO; Orphanet_2020; Congenital fiber-type disproportion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM26118
AC   CVCL_RU00
DR   Coriell; GM26118
DR   Wikidata; Q54854082
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg975Trp (c.2923C>T); ClinVar=VCV000451566; Zygosity=Unspecified (Coriell=GM26118).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26119
AC   CVCL_RU01
DR   Coriell; GM26119
DR   Wikidata; Q54854083
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg975Trp (c.2923C>T); ClinVar=VCV000451566; Zygosity=Unspecified (Coriell=GM26119).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26120
AC   CVCL_RU02
DR   Coriell; GM26120
DR   Wikidata; Q54854084
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg975Trp (c.2923C>T); ClinVar=VCV000451566; Zygosity=Unspecified (Coriell=GM26120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26124
AC   CVCL_D2ZD
DR   Coriell; GM26124
DR   Wikidata; Q127380908
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Ser868Gly (c.2602A>G); ClinVar=VCV000649876; Zygosity=Heterozygous (Coriell=GM26124).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Pro2195Leu (c.6584C>T); ClinVar=VCV000590572; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM26124).
CC   Sequence variation: Mutation; HGNC; HGNC:3148; TYMP; Simple; c.929-6_929-3delCCGC; ClinVar=VCV000215324; Zygosity=Heterozygous (Coriell=GM26124).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202545; Autosomal dominant congenital myopathy-1A
DI   ORDO; Orphanet_598; Multiminicore myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM26125
AC   CVCL_D2ZE
DR   Coriell; GM26125
DR   Wikidata; Q127380909
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM26126
AC   CVCL_D2ZF
DR   Coriell; GM26126
DR   Wikidata; Q127380910
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM26130
AC   CVCL_A2VL
DR   Coriell; GM26130
DR   Wikidata; Q105507000
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; c.3337-4dupC (c.3337-3dupC); ClinVar=VCV000042956; Zygosity=Heterozygous (Coriell=GM26130).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Gly334Val (c.1001G>T); ClinVar=VCV000159825; Zygosity=Heterozygous (Coriell=GM26130).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; c.1186_1187delinsTC; Zygosity=Heterozygous (Coriell=GM26130).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Pro2496Arg (c.7487C>G); ClinVar=VCV000159859; Zygosity=Heterozygous (Coriell=GM26130).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Arg3113His (c.9338G>A); ClinVar=VCV000130688; Zygosity=Heterozygous (Coriell=GM26130).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26131
AC   CVCL_A2VM
DR   Coriell; GM26131
DR   Wikidata; Q105507004
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26132
AC   CVCL_A2VN
DR   Coriell; GM26132
DR   Wikidata; Q105507007
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26135
AC   CVCL_A2VP
DR   Coriell; GM26135
DR   Wikidata; Q105507010
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Asn4575Thr (c.13724A>C); ClinVar=VCV000590436; Zygosity=Heterozygous (Coriell=GM26135).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26136
AC   CVCL_A2VQ
DR   Coriell; GM26136
DR   Wikidata; Q105507012
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Asn4575Thr (c.13724A>C); ClinVar=VCV000590436; Zygosity=Heterozygous (Coriell=GM26136).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26137
AC   CVCL_A2VR
DR   Coriell; GM26137
DR   Wikidata; Q105507015
CC   Population: Caucasian; Dutch/German.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Asn4575Thr (c.13724A>C); ClinVar=VCV000590436; Zygosity=Heterozygous (Coriell=GM26137).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26147
AC   CVCL_A2VS
DR   Coriell; GM26147
DR   Wikidata; Q105507017
CC   Population: Caucasian; British/Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:3754; FLNA; Simple; p.Pro680Leu (c.2039C>T); Zygosity=Hemizygous (Coriell=GM26147).
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Val1360Ile (c.4078G>A); ClinVar=VCV000042991; Zygosity=Heterozygous (Coriell=GM26147).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Gln1589Pro (c.4766A>C); ClinVar=VCV000544377; Zygosity=Heterozygous (Coriell=GM26147).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26153
AC   CVCL_A2VT
DR   Coriell; GM26153
DR   Wikidata; Q105507021
CC   Population: Caucasian; British/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:90; ACADS; Simple; p.Arg171Trp (c.511C>T) (R147W); ClinVar=VCV000003830; Zygosity=Homozygous (Coriell=GM26153).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Lys3867Thr (c.11600A>C); ClinVar=VCV000544409; Zygosity=Heterozygous (Coriell=GM26153).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26154
AC   CVCL_A2VU
DR   Coriell; GM26154
DR   Wikidata; Q105507024
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26155
AC   CVCL_A2VV
DR   Coriell; GM26155
DR   Wikidata; Q105507026
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Gly4444_Gly4450dup (c.13331_13351dup); ClinVar=VCV000478183; Zygosity=Heterozygous (Coriell=GM26155).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg4861His (c.14582G>A); ClinVar=VCV000012982; Zygosity=Heterozygous (Coriell=GM26155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26156
AC   CVCL_A2VW
DR   Coriell; GM26156
DR   Wikidata; Q105507030
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26163
AC   CVCL_A2VX
DR   Coriell; GM26163
DR   Wikidata; Q105507032
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26164
AC   CVCL_A2VY
DR   Coriell; GM26164
DR   Wikidata; Q105507035
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26165
AC   CVCL_A2VZ
DR   Coriell; GM26165
DR   Wikidata; Q105507037
CC   Population: Caucasian; Hungarian/Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26179
AC   CVCL_A2WA
DR   Coriell; GM26179
DR   Wikidata; Q105507039
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Val178Met (c.532G>A); ClinVar=VCV000002402; Zygosity=Heterozygous (Coriell=GM26179).
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Arg193Gln (c.578G>A); ClinVar=VCV000372306; Zygosity=Heterozygous (Coriell=GM26179).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26181
AC   CVCL_A2WB
DR   Coriell; GM26181
DR   Wikidata; Q105507044
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.5238+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM26181).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Tyr8107Cysfs*75 (c.24313_24317dupGTGTT); ClinVar=VCV000553170; Zygosity=Heterozygous (Coriell=GM26181).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26182
AC   CVCL_A2WC
DR   Coriell; GM26182
DR   Wikidata; Q105507046
CC   Population: Caucasian; Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26183
AC   CVCL_A2WD
DR   Coriell; GM26183
DR   Wikidata; Q105507049
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26184
AC   CVCL_A2WE
DR   Coriell; GM26184
DR   Wikidata; Q105507053
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12340; TRPS1; Simple; c.-9dupT; ClinVar=VCV000260329; Zygosity=Heterozygous (Coriell=GM26184).
CC   Sequence variation: Mutation; HGNC; HGNC:12340; TRPS1; Simple; p.Ser1067Argfs*3 (c.3198_3199delAT); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM26184).
CC   Derived from site: In situ; Nose, cartilage; UBERON=UBERON_0001823.
DI   NCIt; C75109; Trichorhinophalangeal syndrome type I
DI   ORDO; Orphanet_77258; Trichorhinophalangeal syndrome type 1 and 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26185
AC   CVCL_RU03
DR   Coriell; GM26185
DR   Wikidata; Q54854085
CC   Sequence variation: Mutation; HGNC; HGNC:10983; SLC25A13; Simple; p.Met285Profs*2 (c.852_855delTATG) (c.851_854delGTAT); ClinVar=VCV000225472; Zygosity=Heterozygous (Coriell=GM26185).
CC   Sequence variation: Mutation; HGNC; HGNC:10983; SLC25A13; Simple; p.Ala554Glyfs*16 (c.1638_1660dup23); ClinVar=VCV000006003; Zygosity=Heterozygous (Coriell=GM26185).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150603; Citrullinemia type II
DI   ORDO; Orphanet_247585; Citrullinemia type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26186
AC   CVCL_A2WF
DR   Coriell; GM26186
DR   Wikidata; Q105507056
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Ile4898Thr (c.14693T>C); ClinVar=VCV000012975; Zygosity=Heterozygous (Coriell=GM26186).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26188
AC   CVCL_YP67
DR   Coriell; GM26188
DR   Wikidata; Q93932530
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM26190
AC   CVCL_LP13
DR   Coriell; GM26190
DR   Wikidata; Q54854086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM26191
AC   CVCL_LP14
DR   Coriell; GM26191
DR   Wikidata; Q54854087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   GM26193
AC   CVCL_A2VJ
DR   Coriell; GM26193
DR   Wikidata; Q105507061
CC   Sequence variation: Mutation; HGNC; HGNC:92; ACADVL; Simple; p.Val283Ala (c.848T>C); ClinVar=VCV000021025; Zygosity=Heterozygous (Coriell=GM26193).
CC   Sequence variation: Mutation; HGNC; HGNC:92; ACADVL; Simple; p.Ile420Leu (c.1258A>C); Zygosity=Heterozygous (Coriell=GM26193).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98647; Very long-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26793; Very long chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM26194
AC   CVCL_A2VK
DR   Coriell; GM26194
DR   Wikidata; Q105507064
CC   Sequence variation: Mutation; HGNC; HGNC:92; ACADVL; Simple; p.Ile373Thr (c.1118T>C); Zygosity=Heterozygous (Coriell=GM26194).
CC   Sequence variation: Mutation; HGNC; HGNC:92; ACADVL; Simple; p.Arg453Gln (c.1358G>A); ClinVar=VCV000374123; Zygosity=Heterozygous (Coriell=GM26194).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98647; Very long-chain acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26793; Very long chain acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM26197
AC   CVCL_JF27
DR   Coriell; GM26197
DR   Wikidata; Q54854088
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln73Ter (c.217C>T); ClinVar=VCV000205480; Zygosity=Heterozygous (Coriell=GM26197).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   GM26198
AC   CVCL_JF28
DR   Coriell; GM26198
DR   Wikidata; Q54854089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   GM26199
AC   CVCL_A2WG
DR   Coriell; GM26199
DR   Wikidata; Q105507067
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Ile4898Thr (c.14693T>C); ClinVar=VCV000012975; Zygosity=Heterozygous (Coriell=GM26199).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26200
AC   CVCL_RU04
DR   Coriell; GM26200
DR   Wikidata; Q54854090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   GM26201
AC   CVCL_YP68
DR   Coriell; GM26201
DR   Wikidata; Q93932595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM26216
AC   CVCL_A2WH
DR   Coriell; GM26216
DR   Wikidata; Q105507070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26227
AC   CVCL_A2UY
DR   Coriell; GM26227
DR   Wikidata; Q105507072
WW   Info; -; -; https://eu.delawareonline.com/in-depth/news/health/2018/12/13/how-delaware-amish-nemours-doctors-harness-genetics-save-grace/2130218002/
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:12840; YARS1; Simple; p.Pro167Thr (c.499C>A); ClinVar=VCV000662296; Zygosity=Homozygous (Coriell=GM26227).
CC   Donor information: Established from the skin fibroblast of Grace Miller, the seventh member of a Dover Amish family to be diagnosed with what is known now as YARSopathy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176704; YARSopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   GM26228
AC   CVCL_A2UZ
DR   Coriell; GM26228
DR   Wikidata; Q105507073
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:12840; YARS1; Simple; p.Pro167Thr (c.499C>A); ClinVar=VCV000662296; Zygosity=Heterozygous (Coriell=GM26228).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM26234
AC   CVCL_YP69
DR   Coriell; GM26234
DR   Wikidata; Q93932599
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Phe354Ile (c.1060T>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM26234).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   GM26249
AC   CVCL_LH30
DR   Coriell; GM26249
DR   Wikidata; Q54854091
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Homozygous (Coriell=GM26249).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C138174; Vici syndrome
DI   ORDO; Orphanet_1493; Vici syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH34 ! GM26636
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   GM26250
AC   CVCL_LH31
DR   Coriell; GM26250
DR   Wikidata; Q54854092
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Heterozygous (Coriell=GM26250).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW57 ! GM27894
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   GM26251
AC   CVCL_LH32
DR   Coriell; GM26251
DR   Wikidata; Q54854097
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Heterozygous (Coriell=GM26251).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   GM26258
AC   CVCL_YP70
DR   Coriell; GM26258
DR   Wikidata; Q93932636
CC   Population: Caucasian and Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg576Ter (c.1726C>T) (p.Arg572Ter, c.1714C>T); ClinVar=VCV000488988; Zygosity=Heterozygous (Coriell=GM26258).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VI95 ! GM26580
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM26259
AC   CVCL_YP71
DR   Coriell; GM26259
DR   Wikidata; Q93932640
CC   Population: Caucasian and Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   GM26260
AC   CVCL_YP72
DR   Coriell; GM26260
DR   Wikidata; Q93932643
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Heterozygous (Coriell=GM26260).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Trp5754Ter (c.17262G>A) (p.Trp4053Ter, c.12159G>A); ClinVar=VCV000373081; Zygosity=Heterozygous (Coriell=GM26260).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Tyr8107Asnfs*74 (c.24318_24319insAA); ClinVar=VCV000422612; Zygosity=Heterozygous (Coriell=GM26260).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP73 ! GM26261
SX   Male
AG   1Y9M
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM26261
AC   CVCL_YP73
DR   Coriell; GM26261
DR   Wikidata; Q93932647
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Heterozygous (Coriell=GM26261).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Trp5754Ter (c.17262G>A) (p.Trp4053Ter, c.12159G>A); ClinVar=VCV000373081; Zygosity=Heterozygous (Coriell=GM26261).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Tyr8107Asnfs*74 (c.24318_24319insAA); ClinVar=VCV000422612; Zygosity=Heterozygous (Coriell=GM26261).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP72 ! GM26260
SX   Male
AG   1Y9M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   GM26262
AC   CVCL_RU05
DR   Coriell; GM26262
DR   Wikidata; Q54854098
CC   Population: Caucasian; German/Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Tyr8107Asnfs*74 (c.24318_24319insAA); ClinVar=VCV000422612; Zygosity=Heterozygous (Coriell=GM26262).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26263
AC   CVCL_YP74
DR   Coriell; GM26263
DR   Wikidata; Q93932660
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Heterozygous (Coriell=GM26263).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Trp5754Ter (c.17262G>A) (p.Trp4053Ter, c.12159G>A); ClinVar=VCV000373081; Zygosity=Heterozygous (Coriell=GM26263).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM26264
AC   CVCL_A2WI
DR   Coriell; GM26264
DR   Wikidata; Q105507076
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Ser8228Ser (c.24684G>A) (p.Ser8193Ser, c.24579G>A) (p.Ser6337Ser, c.19011G>A); ClinVar=VCV000521691; Zygosity=Unspecified (Coriell=GM26264).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26267
AC   CVCL_LP10
DR   Coriell; GM26267
DR   Wikidata; Q54854099
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Glu95Aspfs*32 (c.285_286delGC); Zygosity=Heterozygous (Coriell=GM26267).
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Lys215Met (c.644A>T); Zygosity=Heterozygous (Coriell=GM26267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 12
//
ID   GM26577
AC   CVCL_A2WJ
DR   Coriell; GM26577
DR   Wikidata; Q105507080
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9118; PMP22; Unexplicit; Ex1-5del; Zygosity=Heterozygous (Coriell=GM26577).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176898; Neuropathy, recurrent, with pressure palsies
DI   ORDO; Orphanet_640; Hereditary neuropathy with liability to pressure palsies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26579
AC   CVCL_LH33
DR   Coriell; GM26579
DR   Wikidata; Q54854100
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM26579).
CC   Derived from site: In situ; Flank, skin; UBERON=UBERON_8480023.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_206662; Inclusion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   GM26580
AC   CVCL_VI95
DR   Coriell; GM26580
DR   Wikidata; Q93932688
CC   Population: Caucasian and Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg576Ter (c.1726C>T) (p.Arg572Ter, c.1714C>T); ClinVar=VCV000488988; Zygosity=Heterozygous (Coriell=GM26580).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP70 ! GM26258
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 12
//
ID   GM26582
AC   CVCL_RT69
DR   Coriell; GM26582
DR   Wikidata; Q54854101
CC   Population: Caucasian; German/Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26582).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX26 ! GM25342
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   GM26583
AC   CVCL_RT70
DR   Coriell; GM26583
DR   Wikidata; Q54854102
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln631Serfs*7 (c.1891delC); ClinVar=VCV000050961; Zygosity=Heterozygous (Coriell=GM26583).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX25 ! GM25341
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   GM26584
AC   CVCL_RT71
DR   Coriell; GM26584
DR   Wikidata; Q54854103
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (Coriell=GM26584).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26585
AC   CVCL_RT72
DR   Coriell; GM26585
DR   Wikidata; Q54854104
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (Coriell=GM26585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT73 ! GM26586
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26586
AC   CVCL_RT73
DR   Coriell; GM26586
DR   Wikidata; Q54854105
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (Coriell=GM26586).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT72 ! GM26585
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26587
AC   CVCL_RT74
DR   Coriell; GM26587
DR   Wikidata; Q54854106
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26588
AC   CVCL_RT75
DR   Coriell; GM26588
DR   Wikidata; Q54854107
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26588).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26590
AC   CVCL_RT76
DR   Coriell; GM26590
DR   Wikidata; Q54854108
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg458Lysfs*14 (c.1370dupG); ClinVar=VCV000126422; Zygosity=Homozygous (Coriell=GM26590).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX31 ! GM25389
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26591
AC   CVCL_RT77
DR   Coriell; GM26591
DR   Wikidata; Q54854109
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (Coriell=GM26591).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT78 ! GM26592
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   GM26592
AC   CVCL_RT78
DR   Coriell; GM26592
DR   Wikidata; Q54854110
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (Coriell=GM26592).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT77 ! GM26591
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26593
AC   CVCL_RT79
DR   Coriell; GM26593
DR   Wikidata; Q54854111
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM26593).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM26593).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT80 ! GM26594
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   GM26594
AC   CVCL_RT80
DR   Coriell; GM26594
DR   Wikidata; Q54854112
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM26594).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM26594).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT79 ! GM26593
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   GM26595
AC   CVCL_RT81
DR   Coriell; GM26595
DR   Wikidata; Q54854113
CC   Sequence variation: Mutation; HGNC; HGNC:3157; EDA; Simple; p.Arg69Leu (c.206G>T); ClinVar=VCV000011032; Zygosity=Hemizygous (Coriell=GM26595).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Trp535Ter (c.1604G>A); ClinVar=VCV000221577; Zygosity=Heterozygous (Coriell=GM26595).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Ser636_Leu637insTer (c.1910delT) (p.Leu637Ter); ClinVar=VCV000221582; Zygosity=Heterozygous (Coriell=GM26595).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Arg813Gln (c.2438G>A); ClinVar=VCV000643114; Zygosity=Heterozygous (Coriell=GM26595).
CC   Sequence variation: Mutation; HGNC; HGNC:10891; SIX5; Simple; p.Thr552Met (c.1655C>T); ClinVar=VCV000008601; Zygosity=Heterozygous (Coriell=GM26595).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT82 ! GM26596
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26596
AC   CVCL_RT82
DR   Coriell; GM26596
DR   Wikidata; Q54854114
CC   Sequence variation: Mutation; HGNC; HGNC:3157; EDA; Simple; p.Arg69Leu (c.206G>T); ClinVar=VCV000011032; Zygosity=Hemizygous (Coriell=GM26596).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Trp535Ter (c.1604G>A); ClinVar=VCV000221577; Zygosity=Heterozygous (Coriell=GM26596).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Ser636_Leu637insTer (c.1910delT) (p.Leu637Ter); ClinVar=VCV000221582; Zygosity=Heterozygous (Coriell=GM26596).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Arg813Gln (c.2438G>A); ClinVar=VCV000643114; Zygosity=Heterozygous (Coriell=GM26596).
CC   Sequence variation: Mutation; HGNC; HGNC:10891; SIX5; Simple; p.Thr552Met (c.1655C>T); ClinVar=VCV000008601; Zygosity=Heterozygous (Coriell=GM26596).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT81 ! GM26595
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   GM26597
AC   CVCL_RT83
DR   Coriell; GM26597
DR   Wikidata; Q54854115
CC   Sequence variation: Mutation; HGNC; HGNC:3157; EDA; Simple; p.Arg69Leu (c.206G>T); ClinVar=VCV000011032; Zygosity=Unspecified (Coriell=GM26597).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Trp535Ter (c.1604G>A); ClinVar=VCV000221577; Zygosity=Heterozygous (Coriell=GM26597).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   GM26598
AC   CVCL_RT66
DR   Coriell; GM26598
DR   Wikidata; Q54854116
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Ser116Ter (c.347C>G); ClinVar=VCV000221579; Zygosity=Heterozygous (Coriell=GM26598).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; c.881+5G>T (IVS5+5G>T); ClinVar=VCV000221584; Zygosity=Heterozygous (Coriell=GM26598).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH31 ! GM25596
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26599
AC   CVCL_RT67
DR   Coriell; GM26599
DR   Wikidata; Q54854117
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Ser116Ter (c.347C>G); ClinVar=VCV000221579; Zygosity=Heterozygous (Coriell=GM26599).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH32 ! GM25597
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GM26600
AC   CVCL_RT68
DR   Coriell; GM26600
DR   Wikidata; Q54854118
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; c.881+5G>T (IVS5+5G>T); ClinVar=VCV000221584; Zygosity=Heterozygous (Coriell=GM26600).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EH33 ! GM25598
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   GM26601
AC   CVCL_RT84
DR   Coriell; GM26601
DR   Wikidata; Q54854119
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (Coriell=GM26601).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (Coriell=GM26601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT85 ! GM26602
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   GM26602
AC   CVCL_RT85
DR   Coriell; GM26602
DR   Wikidata; Q54854120
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (Coriell=GM26602).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (Coriell=GM26602).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT84 ! GM26601
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   GM26603
AC   CVCL_RT86
DR   Coriell; GM26603
DR   Wikidata; Q54854121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT87 ! GM26604
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   GM26604
AC   CVCL_RT87
DR   Coriell; GM26604
DR   Wikidata; Q54854122
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT86 ! GM26603
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   GM26605
AC   CVCL_RT88
DR   Coriell; GM26605
DR   Wikidata; Q54854123
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT89 ! GM26606
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
//
ID   GM26606
AC   CVCL_RT89
DR   Coriell; GM26606
DR   Wikidata; Q54854124
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT88 ! GM26605
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 7
//
ID   GM26607
AC   CVCL_RT64
DR   Coriell; GM26607
DR   Wikidata; Q54854125
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (Coriell=GM26607).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX29 ! GM25347
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   GM26608
AC   CVCL_RT65
DR   Coriell; GM26608
DR   Wikidata; Q54854126
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26608).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BX30 ! GM25348
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26609
AC   CVCL_RT90
DR   Coriell; GM26609
DR   Wikidata; Q54854128
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26609).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT91 ! GM26610
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26610
AC   CVCL_RT91
DR   Coriell; GM26610
DR   Wikidata; Q54854129
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26610).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT90 ! GM26609
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26611
AC   CVCL_RT92
DR   Coriell; GM26611
DR   Wikidata; Q54854130
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (Coriell=GM26611).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT93 ! GM26612
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26612
AC   CVCL_RT93
DR   Coriell; GM26612
DR   Wikidata; Q54854131
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (Coriell=GM26612).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT92 ! GM26611
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26613
AC   CVCL_RT94
DR   Coriell; GM26613
DR   Wikidata; Q54854132
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26613).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT95 ! GM26614
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26614
AC   CVCL_RT95
DR   Coriell; GM26614
DR   Wikidata; Q54854134
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26614).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT94 ! GM26613
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26615
AC   CVCL_RT96
DR   Coriell; GM26615
DR   Wikidata; Q54854135
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26615).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT97 ! GM26616
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   GM26616
AC   CVCL_RT97
DR   Coriell; GM26616
DR   Wikidata; Q54854136
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (Coriell=GM26616).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RT96 ! GM26615
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26636
AC   CVCL_LH34
DR   Coriell; GM26636
DR   Wikidata; Q54854137
RX   PubMed=35700637;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Homozygous (PubMed=35700637).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C138174; Vici syndrome
DI   ORDO; Orphanet_1493; Vici syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH30 ! GM26249
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   GM26642
AC   CVCL_A2WK
DR   Coriell; GM26642
DR   Wikidata; Q105507082
CC   Sequence variation: Mutation; HGNC; HGNC:2209; COL5A1; Simple; p.Thr1008Met (c.3023C>T); ClinVar=VCV000213047; Zygosity=Heterozygous (Coriell=GM26642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM26643
AC   CVCL_A2WL
DR   Coriell; GM26643
DR   Wikidata; Q105507085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM26644
AC   CVCL_RU06
SY   GM26644*B
DR   Coriell; GM26644
DR   Wikidata; Q54854138
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Unexplicit; Ex11-17del (30-KB DEL,IVS10); ClinVar=VCV000003819; Zygosity=Homozygous (Coriell=GM26644).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2Z55 ! GM06806
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26650
AC   CVCL_VI87
SY   GM26650*B
DR   Coriell; GM26650
DR   Wikidata; Q93932979
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; c.189+1G>T (IVS3+1G>T); ClinVar=VCV002780474; Zygosity=Hemizygous; Note=Splice donor mutation (Coriell=GM26650).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW56 ! GM25393
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 13
//
ID   GM26656
AC   CVCL_RU07
SY   GM26656*B
DR   Coriell; GM26656
DR   Wikidata; Q54854143
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Homozygous (Coriell=GM26656).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V528 ! GM00798
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26663
AC   CVCL_RT98
SY   GM26663*B
DR   Coriell; GM26663
DR   Wikidata; Q54854144
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg270Ter (c.808C>T); ClinVar=VCV000143078; Zygosity=Hemizygous (Coriell=GM26663).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW52 ! GM25383
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   GM26E7
AC   CVCL_KT07
SY   GM-26E7
DR   Wikidata; Q54854145
RX   PubMed=16208762;
WW   Info; -; -; https://cdn2.hubspot.net/hubfs/1769030/files/genovac/GM0203.pdf
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49863; Human GZMK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   GM27102
AC   CVCL_ZG15
SY   GM27102*B
DR   Coriell; GM27102
DR   Wikidata; Q98126382
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM27102).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V210 ! GM01014
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   GM27104
AC   CVCL_WP05
DR   Coriell; GM27104
DR   Wikidata; Q93933002
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000004491; Zygosity=Heterozygous (Coriell=GM27104).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Gly315Ser (c.943G>A); ClinVar=VCV000004496; Zygosity=Heterozygous (Coriell=GM27104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   GM27105
AC   CVCL_WP06
DR   Coriell; GM27105
DR   Wikidata; Q93933005
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000004491; Zygosity=Heterozygous (Coriell=GM27105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   GM27106
AC   CVCL_WP07
DR   Coriell; GM27106
DR   Wikidata; Q93933007
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000004491; Zygosity=Heterozygous (Coriell=GM27106).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   GM27108
AC   CVCL_WP08
DR   Coriell; GM27108
DR   Wikidata; Q93933011
CC   Population: Caucasian; Danish/English/Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; p.Gly290Trp (c.868G>T); ClinVar=VCV000476441; Zygosity=Heterozygous (Coriell=GM27108).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 27-11-25; Version: 10
//
ID   GM27115
AC   CVCL_WP09
DR   Coriell; GM27115
DR   Wikidata; Q93933012
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Met1fs (c.-11_c.81del92); ClinVar=VCV000373075; Zygosity=Heterozygous (Coriell=GM27115).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Gly315Ser (c.943G>A); ClinVar=VCV000004496; Zygosity=Heterozygous (Coriell=GM27115).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   GM27120
AC   CVCL_A2PW
DR   Coriell; GM27120
DR   Wikidata; Q105507088
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Asn238Lysfs*63 (c.713dupA) (c.713_714insA); ClinVar=VCV000004494; Zygosity=Heterozygous (Coriell=GM27120).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Arg466Gln (c.1397G>A); ClinVar=VCV000004492; Zygosity=Heterozygous (Coriell=GM27120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27122
AC   CVCL_WP10
DR   Coriell; GM27122
DR   Wikidata; Q93933015
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Asn238Lysfs*63 (c.713dupA) (c.713_714insA); ClinVar=VCV000004494; Zygosity=Homozygous (Coriell=GM27122).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   GM27123
AC   CVCL_A2PX
DR   Coriell; GM27123
DR   Wikidata; Q105507089
CC   Population: Caucasian; Swiss.
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; c.1003-1G>A; ClinVar=VCV000286179; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM27123).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27125
AC   CVCL_A2PY
DR   Coriell; GM27125
DR   Wikidata; Q105507093
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; c.39893-1G>A (IVS192-1G>A) (c.37112-1G>A, IVS191-1G>A); ClinVar=VCV000202368; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM27125).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27126
AC   CVCL_WP11
DR   Coriell; GM27126
DR   Wikidata; Q93933018
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000014524; Zygosity=Heterozygous (Coriell=GM27126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126745; Emery-Dreifuss muscular dystrophy 2, autosomal dominant
DI   ORDO; Orphanet_98853; Autosomal dominant Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   GM27127
AC   CVCL_WP12
DR   Coriell; GM27127
DR   Wikidata; Q93933019
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Arg268Cys (c.802C>T); ClinVar=VCV000657794; Zygosity=Heterozygous (Coriell=GM27127).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Arg469Gln (c.1406G>A); ClinVar=VCV000461629; Zygosity=Heterozygous (Coriell=GM27127).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   GM27131
AC   CVCL_A2PZ
DR   Coriell; GM27131
DR   Wikidata; Q105507097
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Cys528Thrfs*4 (c.1577_1580dupCACT); ClinVar=VCV000181148; Zygosity=Heterozygous (Coriell=GM27131).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27134
AC   CVCL_YN21
DR   Coriell; GM27134
DR   Wikidata; Q93933021
CC   Population: Caucasian; English/German/Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   GM27135
AC   CVCL_YN22
DR   Coriell; GM27135
DR   Wikidata; Q93933022
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   GM27137
AC   CVCL_YN23
DR   Coriell; GM27137
DR   Wikidata; Q93933024
CC   Population: Caucasian; English/German/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Thr295Lys (c.884C>A); ClinVar=VCV001298419; Zygosity=Heterozygous (Coriell=GM27137).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27138
AC   CVCL_YN24
DR   Coriell; GM27138
DR   Wikidata; Q93933025
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   GM27139
AC   CVCL_YN25
DR   Coriell; GM27139
DR   Wikidata; Q93933027
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Trp453Cys (c.1359G>C); ClinVar=VCV000372502; Zygosity=Heterozygous (Coriell=GM27139).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Glu474Aspfs*93 (c.1421_1422insC); ClinVar=VCV002100000; Zygosity=Heterozygous (Coriell=GM27139).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   GM27140
AC   CVCL_YN26
DR   Coriell; GM27140
DR   Wikidata; Q93933029
CC   Population: Caucasian; Norwegian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   GM27141
AC   CVCL_YN27
DR   Coriell; GM27141
DR   Wikidata; Q93933031
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   GM27142
AC   CVCL_YN28
DR   Coriell; GM27142
DR   Wikidata; Q93933033
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Trp453Cys (c.1359G>C); ClinVar=VCV000372502; Zygosity=Heterozygous (Coriell=GM27142).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Glu474Aspfs*93 (c.1421_1422insC); ClinVar=VCV002100000; Zygosity=Heterozygous (Coriell=GM27142).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   GM27144
AC   CVCL_XC53
DR   Coriell; GM27144
DR   Wikidata; Q93933035
CC   Population: Caucasian; English/German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000974929; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27144).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC54 ! GM27145
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   GM27145
AC   CVCL_XC54
DR   Coriell; GM27145
DR   Wikidata; Q93933036
CC   Population: Caucasian; English/German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000974929; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27145).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC53 ! GM27144
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   GM27153
AC   CVCL_D6ZB
DR   Coriell; GM27153
CC   Population: Caucasian; English/German/Irish.
CC   Karyotypic information: 46,XY,inv(5)(q15;q35.1) [19] (Coriell=GM27153).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM27154 (Cellosaurus=CVCL_D6ZC).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM27154
AC   CVCL_D6ZC
DR   Coriell; GM27154
CC   Population: Caucasian; English/German/Irish.
CC   Karyotypic information: 46,XY,inv(5)(q15;q35.1) [20] (Coriell=GM27154).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of GM27153 (Cellosaurus=CVCL_D6ZB).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM27158
AC   CVCL_VP79
DR   Coriell; GM27158
DR   Wikidata; Q93933038
CC   Population: Caucasian; English/German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg141Cys (c.421C>T); ClinVar=VCV000447846; Zygosity=Heterozygous (Coriell=GM27158).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   GM27159
AC   CVCL_VI93
DR   Coriell; GM27159
DR   Wikidata; Q93933040
CC   Population: Caucasian and Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27159).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   GM27160
AC   CVCL_VH43
DR   Coriell; GM27160
DR   Wikidata; Q54854146
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   GM27161
AC   CVCL_VI94
DR   Coriell; GM27161
DR   Wikidata; Q93933044
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27161).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   GM27162
AC   CVCL_VH44
SY   GM27162*B
DR   Coriell; GM27162
DR   Wikidata; Q54854147
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Arg245His (c.734G>A); ClinVar=VCV000005107; Zygosity=Heterozygous (Coriell=GM27162).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0M06 ! GM06110
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   GM27171
AC   CVCL_VP80
DR   Coriell; GM27171
DR   Wikidata; Q93933051
CC   Population: Caucasian; English/German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Unspecified (Coriell=GM27171).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Glu429Ala (c.1286A>C) (1298A>C); ClinVar=VCV000003521; Zygosity=Unspecified (Coriell=GM27171).
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg141Cys (c.421C>T); ClinVar=VCV000447846; Zygosity=Heterozygous (Coriell=GM27171).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84606; CADASIL syndrome
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_136; CADASIL
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN20 ! GM27393
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 13
//
ID   GM27172
AC   CVCL_UF17
DR   Coriell; GM27172
DR   Wikidata; Q93933053
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg141Cys (c.421C>T); ClinVar=VCV000447846; Zygosity=Heterozygous (Coriell=GM27172).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   GM27173
AC   CVCL_ZG16
SY   GM27173*B
DR   Coriell; GM27173
DR   Wikidata; Q98126383
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple_corrected; p.Ala422Thr (c.1264G>A); ClinVar=VCV000067174; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Coriell=GM27173).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N94 ! GM25305
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   GM27177
AC   CVCL_VH45
SY   GM27177*B
DR   Coriell; GM27177
DR   Wikidata; Q54854148
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>A (IVS5-1G>A); ClinVar=VCV000207574; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM27177).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM27177).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA97 ! GM20385
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   GM27186
AC   CVCL_A2QA
DR   Coriell; GM27186
DR   Wikidata; Q105507098
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Lys171Argfs*63 (c.512delA); Zygosity=Heterozygous (Coriell=GM27186).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27190
AC   CVCL_UT81
DR   Coriell; GM27190
DR   Wikidata; Q93933062
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Trp308Ter (c.924G>A); ClinVar=VCV000013871; Zygosity=Unspecified; Note=De novo mutation (Coriell=GM27190).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV51 ! GM27227
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   GM27192
AC   CVCL_YN29
DR   Coriell; GM27192
DR   Wikidata; Q93933065
CC   Sequence variation: Mutation; HGNC; HGNC:2745; DDX3X; Simple; p.Lys208Serfs*13 (c.623delA); ClinVar=VCV000432784; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27192).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129931; Intellectual developmental disorder, X-linked 102
DI   ORDO; Orphanet_457260; X-linked intellectual disability-hypotonia-movement disorder syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 10
//
ID   GM27195
AC   CVCL_ZG17
DR   Coriell; GM27195
DR   Wikidata; Q98126384
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   GM27199
AC   CVCL_UT82
DR   Coriell; GM27199
DR   Wikidata; Q93933068
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; p.Gly281Arg (c.841G>A); ClinVar=VCV000017182; Zygosity=Heterozygous (Coriell=GM27199).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   GM27200
AC   CVCL_UF18
DR   Coriell; GM27200
DR   Wikidata; Q93933071
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg133Cys (c.397C>T); ClinVar=VCV000009225; Zygosity=Heterozygous (Coriell=GM27200).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   GM27203
AC   CVCL_YN30
DR   Coriell; GM27203
DR   Wikidata; Q93933074
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg157Glufs*77 (c.469delC); ClinVar=VCV000589268; Zygosity=Heterozygous (Coriell=GM27203).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27205
AC   CVCL_YN31
DR   Coriell; GM27205
DR   Wikidata; Q93933078
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN32 ! GM27206
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   GM27206
AC   CVCL_YN32
DR   Coriell; GM27206
DR   Wikidata; Q93933081
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN31 ! GM27205
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   GM27207
AC   CVCL_YN33
DR   Coriell; GM27207
DR   Wikidata; Q93933084
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN34 ! GM27208
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   GM27208
AC   CVCL_YN34
DR   Coriell; GM27208
DR   Wikidata; Q93933087
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN33 ! GM27207
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   GM27226
AC   CVCL_YN35
DR   Coriell; GM27226
DR   Wikidata; Q93933090
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (Coriell=GM27226).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Asn216Ile (c.647A>T); ClinVar=VCV000007707; Zygosity=Heterozygous (Coriell=GM27226).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   GM27227
AC   CVCL_VV51
DR   Coriell; GM27227
DR   Wikidata; Q93933094
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Trp308Ter (c.924G>A); ClinVar=VCV000013871; Zygosity=Unspecified; Note=De novo mutation (Coriell=GM27227).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT81 ! GM27190
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   GM27239
AC   CVCL_A2QB
DR   Coriell; GM27239
DR   Wikidata; Q105507102
CC   Population: Caucasian and Pacific; Hawaiian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; c.922+1G>A; ClinVar=VCV001711453; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM27239).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27240
AC   CVCL_VV52
DR   Coriell; GM27240
DR   Wikidata; Q93933097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GM27241
AC   CVCL_UT83
DR   Coriell; GM27241
DR   Wikidata; Q93933100
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Arg230Cys (c.688C>T); ClinVar=VCV000803013; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27241).
CC   Sequence variation: Mutation; HGNC; HGNC:6111; IQGAP2; Simple; p.Gln953Ter (c.2857C>T); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27241).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE54 ! GM27461
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   GM27242
AC   CVCL_VV53
DR   Coriell; GM27242
DR   Wikidata; Q93933103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GM27243
AC   CVCL_YN36
DR   Coriell; GM27243
DR   Wikidata; Q93933106
CC   Population: Caucasian; Scottish/Ukranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   GM27244
AC   CVCL_VV54
DR   Coriell; GM27244
DR   Wikidata; Q93933109
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV56 ! GM27251
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GM27245
AC   CVCL_VV55
DR   Coriell; GM27245
DR   Wikidata; Q93933112
CC   Population: Caucasian; French.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV57 ! GM27249
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GM27246
AC   CVCL_UT84
DR   Coriell; GM27246
DR   Wikidata; Q93933116
CC   Population: Caucasian; French and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM27246).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT85 ! GM27248
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   GM27248
AC   CVCL_UT85
DR   Coriell; GM27248
DR   Wikidata; Q93933118
CC   Population: Caucasian; French and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM27248).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT84 ! GM27246
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   GM27249
AC   CVCL_VV57
DR   Coriell; GM27249
DR   Wikidata; Q93933123
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV55 ! GM27245
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   GM27250
AC   CVCL_VV58
DR   Coriell; GM27250
DR   Wikidata; Q93933125
CC   Population: Caucasian; French and Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   GM27251
AC   CVCL_VV56
DR   Coriell; GM27251
DR   Wikidata; Q93933129
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV54 ! GM27244
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   GM27255
AC   CVCL_UT86
DR   Coriell; GM27255
DR   Wikidata; Q93933132
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Tyr208Cys (c.623A>G); Zygosity=Heterozygous (Coriell=GM27255).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1UW ! GM27379
SX   Male
AG   2Y2M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   GM27256
AC   CVCL_VV59
DR   Coriell; GM27256
DR   Wikidata; Q93933136
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   GM27257
AC   CVCL_VV60
DR   Coriell; GM27257
DR   Wikidata; Q93933138
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   GM27260
AC   CVCL_A2QC
DR   Coriell; GM27260
DR   Wikidata; Q105507105
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2QD ! GM27261
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27261
AC   CVCL_A2QD
DR   Coriell; GM27261
DR   Wikidata; Q105507108
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2QC ! GM27260
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   GM27262
AC   CVCL_A2QE
DR   Coriell; GM27262
DR   Wikidata; Q105507111
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27264
AC   CVCL_A2QF
DR   Coriell; GM27264
DR   Wikidata; Q105507115
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2QG ! GM27265
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27265
AC   CVCL_A2QG
DR   Coriell; GM27265
DR   Wikidata; Q105507119
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2QF ! GM27264
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   GM27267
AC   CVCL_VV61
DR   Coriell; GM27267
DR   Wikidata; Q93933142
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Asn187Lys (c.561C>G); ClinVar=VCV000265363; Zygosity=Unspecified (Coriell=GM27267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   GM27270
AC   CVCL_XC52
SY   GM27270*B
DR   Coriell; GM27270
DR   Wikidata; Q93933146
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg174Ter (c.520C>T); ClinVar=VCV000235853; Zygosity=Heterozygous (Coriell=GM27270).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HQ53 ! GM26038
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   GM27288
AC   CVCL_YN37
DR   Coriell; GM27288
DR   Wikidata; Q93933148
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Gly219Arg (c.655G>A); ClinVar=VCV000140752; Zygosity=Heterozygous (Coriell=GM27288).
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Leu492Pro (c.1475T>C); ClinVar=VCV000375390; Zygosity=Heterozygous (Coriell=GM27288).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168597; Developmental and epileptic encephalopathy 25
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 11
//
ID   GM27289
AC   CVCL_YN38
DR   Coriell; GM27289
DR   Wikidata; Q93933150
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Gly219Arg (c.655G>A); ClinVar=VCV000140752; Zygosity=Heterozygous (Coriell=GM27289).
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Leu492Pro (c.1475T>C); ClinVar=VCV000375390; Zygosity=Heterozygous (Coriell=GM27289).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168597; Developmental and epileptic encephalopathy 25
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 11
//
ID   GM27290
AC   CVCL_YN39
DR   Coriell; GM27290
DR   Wikidata; Q93933151
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Leu492Pro (c.1475T>C); ClinVar=VCV000375390; Zygosity=Heterozygous (Coriell=GM27290).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27291
AC   CVCL_VV62
SY   GM27291*B; CIMRi001-A
DR   BioSamples; SAMEA10457755
DR   Coriell; GM27291
DR   hPSCreg; CIMRi001-A
DR   Wikidata; Q93933153
RX   PubMed=35700637;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Homozygous (PubMed=35700637).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C138174; Vici syndrome
DI   ORDO; Orphanet_1493; Vici syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LH34 ! GM26636
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 13
//
ID   GM27299
AC   CVCL_YN40
DR   Coriell; GM27299
DR   Wikidata; Q93933155
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Gly219Arg (c.655G>A); ClinVar=VCV000140752; Zygosity=Heterozygous (Coriell=GM27299).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27300
AC   CVCL_WP04
DR   Coriell; GM27300
DR   Wikidata; Q93933158
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:13830; CNTNAP2; Simple; p.Ser269Asn (c.806G>A); ClinVar=VCV000373714; Zygosity=Heterozygous (from autologous cell line GM27325).
CC   Sequence variation: Mutation; HGNC; HGNC:3791; FOLR1; Simple; c.493+2T>C (IVS4+2T>C); ClinVar=VCV000095750; Zygosity=Heterozygous (from autologous cell line GM27325).
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gly224Ser (c.670G>A); ClinVar=VCV000167092; Zygosity=Heterozygous (Coriell=GM27300).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Pro8Thr (c.22C>A); ClinVar=VCV000205598; Zygosity=Heterozygous (from autologous cell line GM27325).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN13 ! GM27325
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   GM27308
AC   CVCL_A1UK
DR   Coriell; GM27308
DR   Wikidata; Q105507122
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27315
AC   CVCL_A1UJ
DR   Coriell; GM27315
DR   Wikidata; Q105507125
CC   Population: Southeast Asian; Thai and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Phe215Ser (c.644T>C); Zygosity=Heterozygous (Coriell=GM27315).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27318
AC   CVCL_A1UL
DR   Coriell; GM27318
DR   Wikidata; Q105507128
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27319
AC   CVCL_A1UM
DR   Coriell; GM27319
DR   Wikidata; Q105507133
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27320
AC   CVCL_A1UN
DR   Coriell; GM27320
DR   Wikidata; Q105507136
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27321
AC   CVCL_A1UP
DR   Coriell; GM27321
DR   Wikidata; Q105507140
CC   Population: Caucasian; Hungarian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Arg230Leu (c.689G>T); ClinVar=VCV000288531; Zygosity=Heterozygous (Coriell=GM27321).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27322
AC   CVCL_A1UQ
DR   Coriell; GM27322
DR   Wikidata; Q105507145
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln29Argfs*90 (c.85_90delCAGAACinsA); Zygosity=Heterozygous (Coriell=GM27322).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27323
AC   CVCL_A1US
DR   Coriell; GM27323
DR   Wikidata; Q105507149
CC   Population: Caucasian; Italian/Portuguese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   GM27324
AC   CVCL_A1UR
DR   Coriell; GM27324
DR   Wikidata; Q105507153
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27325
AC   CVCL_YN13
DR   Coriell; GM27325
DR   Wikidata; Q93933160
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:13830; CNTNAP2; Simple; p.Ser269Asn (c.806G>A); ClinVar=VCV000373714; Zygosity=Heterozygous (Coriell=GM27325).
CC   Sequence variation: Mutation; HGNC; HGNC:3791; FOLR1; Simple; c.493+2T>C (IVS4+2T>C); ClinVar=VCV000095750; Zygosity=Heterozygous (Coriell=GM27325).
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gly224Ser (c.670G>A); ClinVar=VCV000167092; Zygosity=Heterozygous (Coriell=GM27325).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Pro8Thr (c.22C>A); ClinVar=VCV000205598; Zygosity=Heterozygous (Coriell=GM27325).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP04 ! GM27300
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27326
AC   CVCL_YN41
DR   Coriell; GM27326
DR   Wikidata; Q93933161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27327
AC   CVCL_VV71
SY   GM27327*B
DR   Coriell; GM27327
DR   Wikidata; Q93933163
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN47 ! GM16277
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   GM27335
AC   CVCL_VV63
DR   Coriell; GM27335
DR   Wikidata; Q93933165
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Ser326Glufs*129 (c.974_975insA); Zygosity=Heterozygous (Coriell=GM27335).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE51 ! GM27462
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   GM27336
AC   CVCL_XC51
DR   Coriell; GM27336
DR   Wikidata; Q93933169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   GM27337
AC   CVCL_VV64
DR   Coriell; GM27337
DR   Wikidata; Q93933173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GM27353
AC   CVCL_XC49
DR   Coriell; GM27353
DR   Wikidata; Q93933176
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Arg497Ter (c.1489C>T); ClinVar=VCV000210050; Zygosity=Heterozygous (Coriell=GM27353).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC48 ! GM27412
SX   Male
AG   1Y11M
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 12
//
ID   GM27357
AC   CVCL_D6YY
DR   Coriell; GM27357
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11634; TCF4; Zygosity=Heterozygous (Coriell=GM27357).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   GM27367
AC   CVCL_VV65
DR   Coriell; GM27367
DR   Wikidata; Q93933179
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:11544; TAF11; Simple; p.Ser155Phe (c.464C>T); Zygosity=Homozygous (Coriell=GM27367).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   GM27368
AC   CVCL_VV66
DR   Coriell; GM27368
DR   Wikidata; Q93933183
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:11544; TAF11; Simple; p.Ser155Phe (c.464C>T); Zygosity=Heterozygous (Coriell=GM27368).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   GM27369
AC   CVCL_VV67
DR   Coriell; GM27369
DR   Wikidata; Q93933186
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:11544; TAF11; Simple; p.Ser155Phe (c.464C>T); Zygosity=Homozygous (Coriell=GM27369).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   GM27370
AC   CVCL_VV68
DR   Coriell; GM27370
DR   Wikidata; Q93933189
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:11544; TAF11; Simple; p.Ser155Phe (c.464C>T); Zygosity=Homozygous (Coriell=GM27370).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   GM27371
AC   CVCL_VV69
DR   Coriell; GM27371
DR   Wikidata; Q93933194
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:11544; TAF11; Simple; p.Ser155Phe (c.464C>T); Zygosity=Homozygous (Coriell=GM27371).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   GM27373
AC   CVCL_A1UT
DR   Coriell; GM27373
DR   Wikidata; Q105507157
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Asn232Ser (c.695A>G); ClinVar=VCV001698021; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27373).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9QY ! GM27616
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27374
AC   CVCL_A1UU
DR   Coriell; GM27374
DR   Wikidata; Q105507161
CC   Population: Caucasian; British.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27376
AC   CVCL_A1UV
DR   Coriell; GM27376
DR   Wikidata; Q105507164
CC   Population: Caucasian; British.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27379
AC   CVCL_A1UW
DR   Coriell; GM27379
DR   Wikidata; Q105507168
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Tyr208Cys (c.623A>G); Zygosity=Heterozygous (Coriell=GM27379).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT86 ! GM27255
SX   Male
AG   2Y5M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27381
AC   CVCL_XC50
SY   GM27381*B
DR   Coriell; GM27381
DR   Wikidata; Q93933196
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (Coriell=GM27381).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (Coriell=GM27381).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (Coriell=GM27381).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BX28 ! GM25344
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   GM27386
AC   CVCL_VV70
DR   Coriell; GM27386
DR   Wikidata; Q93933200
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Glu139Lys (c.415G>A); ClinVar=VCV000021143; Zygosity=Heterozygous (Coriell=GM27386).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (Coriell=GM27386).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   GM27387
AC   CVCL_YE58
DR   Coriell; GM27387
DR   Wikidata; Q93933205
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Glu1979Ala (c.5936A>C); ClinVar=VCV002505064; Zygosity=Heterozygous (Coriell=GM27387).
CC   Sequence variation: Mutation; HGNC; HGNC:11042; SLC6A1; Simple; p.Ser295Leu (c.884C>T); ClinVar=VCV000684489; Zygosity=Heterozygous (Coriell=GM27387).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C191771; SLC6A1-associated myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE59 ! GM27388
SX   Male
AG   1Y7M
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 12
//
ID   GM27388
AC   CVCL_YE59
DR   Coriell; GM27388
DR   Wikidata; Q93933208
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Glu1979Ala (c.5936A>C); ClinVar=VCV002505064; Zygosity=Heterozygous (Coriell=GM27388).
CC   Sequence variation: Mutation; HGNC; HGNC:11042; SLC6A1; Simple; p.Ser295Leu (c.884C>T); ClinVar=VCV000684489; Zygosity=Heterozygous (Coriell=GM27388).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C191771; SLC6A1-associated myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE58 ! GM27387
SX   Male
AG   1Y7M
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 13
//
ID   GM27389
AC   CVCL_YN42
DR   Coriell; GM27389
DR   Wikidata; Q93933211
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Arg141His (c.422G>A); ClinVar=VCV000007706; Zygosity=Heterozygous (Coriell=GM27389).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27393
AC   CVCL_YN20
DR   Coriell; GM27393
DR   Wikidata; Q93933216
CC   Population: Caucasian; English/German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Unspecified (Coriell=GM27393).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Glu429Ala (c.1286A>C) (1298A>C); ClinVar=VCV000003521; Zygosity=Unspecified (Coriell=GM27393).
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg141Cys (c.421C>T); ClinVar=VCV000447846; Zygosity=Heterozygous (Coriell=GM27393).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84606; CADASIL syndrome
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_136; CADASIL
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP80 ! GM27171
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 11
//
ID   GM27407
AC   CVCL_XC46
DR   Coriell; GM27407
DR   Wikidata; Q93933220
CC   Population: Caucasian.
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
//
ID   GM27408
AC   CVCL_XC44
DR   Coriell; GM27408
DR   Wikidata; Q93933222
CC   Population: Caucasian and Native North American; Alaskan.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous (Coriell=GM27408).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC45 ! GM27458
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 11
//
ID   GM27409
AC   CVCL_XC47
DR   Coriell; GM27409
DR   Wikidata; Q93933224
CC   Population: Native North American; Alaskan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   GM27411
AC   CVCL_YN43
DR   Coriell; GM27411
DR   Wikidata; Q93933226
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Glu154Glyfs*301 (c.460dupG); ClinVar=VCV000095268; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27411).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   GM27412
AC   CVCL_XC48
DR   Coriell; GM27412
DR   Wikidata; Q93933228
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Arg497Ter (c.1489C>T); ClinVar=VCV000210050; Zygosity=Heterozygous (Coriell=GM27412).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC49 ! GM27353
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 11
//
ID   GM27434
AC   CVCL_A2QH
DR   Coriell; GM27434
DR   Wikidata; Q105507171
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM27434).
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Leu257Arg (c.770T>G); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27434).
CC   Sequence variation: Mutation; HGNC; HGNC:8656; PCDH11X; Simple; p.Asp1111Asn (c.3331G>A); Zygosity=Hemizygous (Coriell=GM27434).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27435
AC   CVCL_A2QI
DR   Coriell; GM27435
DR   Wikidata; Q105507174
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:8656; PCDH11X; Simple; p.Asp1111Asn (c.3331G>A); Zygosity=Heterozygous (Coriell=GM27435).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27436
AC   CVCL_A2QJ
DR   Coriell; GM27436
DR   Wikidata; Q105507177
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (Coriell=GM27436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27437
AC   CVCL_WP03
SY   GM27437*B
DR   Coriell; GM27437
DR   Wikidata; Q93933230
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Argfs*8 (c.1157_1188del32) (p.Leu398Argfs*8, c.1193_1224del32) (1155del32); ClinVar=VCV000143366; Zygosity=Unspecified (Coriell=GM27437).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F14 ! GM11272
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   GM27443
AC   CVCL_ZG18
DR   Coriell; GM27443
DR   Wikidata; Q98126385
CC   Population: Southeast Asian; Thai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27448
AC   CVCL_YE57
DR   Coriell; GM27448
DR   Wikidata; Q93933234
CC   Population: Caucasian; Romanian and Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Unexplicit; Ex10-11del; Zygosity=Hemizygous (Coriell=GM27448).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   GM27452
AC   CVCL_YE55
DR   Coriell; GM27452
DR   Wikidata; Q93933236
CC   Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple; p.Ser867Arg (c.2601C>A); ClinVar=VCV001878636; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27452).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129308; Schinzel-Giedion midface-retraction syndrome
DI   ORDO; Orphanet_798; Schinzel-Giedion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE56 ! GM27453
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   GM27453
AC   CVCL_YE56
DR   Coriell; GM27453
DR   Wikidata; Q93933240
CC   Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple; p.Ser867Arg (c.2601C>A); ClinVar=VCV001878636; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129308; Schinzel-Giedion midface-retraction syndrome
DI   ORDO; Orphanet_798; Schinzel-Giedion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YE55 ! GM27452
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   GM27458
AC   CVCL_XC45
DR   Coriell; GM27458
DR   Wikidata; Q93933242
CC   Population: Caucasian and Native North American; Alaskan.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous (Coriell=GM27458).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC44 ! GM27408
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 9
//
ID   GM27461
AC   CVCL_YE54
DR   Coriell; GM27461
DR   Wikidata; Q93933246
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Arg230Cys (c.688C>T); ClinVar=VCV000803013; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27461).
CC   Sequence variation: Mutation; HGNC; HGNC:6111; IQGAP2; Simple; p.Gln953Ter (c.2857C>T); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27461).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT83 ! GM27241
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   GM27462
AC   CVCL_YE51
DR   Coriell; GM27462
DR   Wikidata; Q93933249
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Ser326Glufs*129 (c.974_975insA); Zygosity=Heterozygous (Coriell=GM27462).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV63 ! GM27335
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   GM27463
AC   CVCL_A8QQ
SY   GM27463*A; HT139B
DR   Coriell; GM27463
DR   Wikidata; Q108820295
RX   PubMed=27484861;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Homozygous (Coriell=GM27463).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AX26 ! GM16195
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM27464
AC   CVCL_YE52
SY   GM27464*C; HT138C
DR   Coriell; GM27464
DR   Wikidata; Q93933252
RX   PubMed=27484861;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Phe333Serfs*52 (c.996delC) (P330fs, 990delC); ClinVar=VCV000002990; Zygosity=Heterozygous (Coriell=GM27464).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AX25 ! GM13205
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   GM27468
AC   CVCL_ZG38
DR   Coriell; GM27468
DR   Wikidata; Q98126386
CC   Population: Indian; Gujarati.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27469
AC   CVCL_ZG39
DR   Coriell; GM27469
DR   Wikidata; Q98126387
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27470
AC   CVCL_ZG40
DR   Coriell; GM27470
DR   Wikidata; Q98126388
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27471
AC   CVCL_ZG41
DR   Coriell; GM27471
DR   Wikidata; Q98126390
CC   Population: Indian; Bengali.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27472
AC   CVCL_ZG42
DR   Coriell; GM27472
DR   Wikidata; Q98126392
CC   Population: Indian; Gujarati.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27473
AC   CVCL_ZG43
DR   Coriell; GM27473
DR   Wikidata; Q98126393
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27474
AC   CVCL_ZG44
DR   Coriell; GM27474
DR   Wikidata; Q98126394
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27475
AC   CVCL_ZG45
DR   Coriell; GM27475
DR   Wikidata; Q98126395
CC   Population: Indian; Bengali.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27476
AC   CVCL_ZG46
DR   Coriell; GM27476
DR   Wikidata; Q98126396
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27477
AC   CVCL_ZG47
DR   Coriell; GM27477
DR   Wikidata; Q98126397
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27478
AC   CVCL_ZG48
DR   Coriell; GM27478
DR   Wikidata; Q98126398
CC   Population: Indian; Marathi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27479
AC   CVCL_ZG49
DR   Coriell; GM27479
DR   Wikidata; Q98126399
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27480
AC   CVCL_ZG50
DR   Coriell; GM27480
DR   Wikidata; Q98126401
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27481
AC   CVCL_ZG51
DR   Coriell; GM27481
DR   Wikidata; Q98126403
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27482
AC   CVCL_ZG52
DR   Coriell; GM27482
DR   Wikidata; Q98126404
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27483
AC   CVCL_ZG53
DR   Coriell; GM27483
DR   Wikidata; Q98126405
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27484
AC   CVCL_ZG54
DR   Coriell; GM27484
DR   Wikidata; Q98126406
CC   Population: Indian; Bengali.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27485
AC   CVCL_ZG55
DR   Coriell; GM27485
DR   Wikidata; Q98126407
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27486
AC   CVCL_ZG56
DR   Coriell; GM27486
DR   Wikidata; Q98126408
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27487
AC   CVCL_ZG57
DR   Coriell; GM27487
DR   Wikidata; Q98126409
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27488
AC   CVCL_ZG58
DR   Coriell; GM27488
DR   Wikidata; Q98126411
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27489
AC   CVCL_ZG59
DR   Coriell; GM27489
DR   Wikidata; Q98126412
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27490
AC   CVCL_ZG60
DR   Coriell; GM27490
DR   Wikidata; Q98126414
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27491
AC   CVCL_ZG61
DR   Coriell; GM27491
DR   Wikidata; Q98126416
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27492
AC   CVCL_ZG62
DR   Coriell; GM27492
DR   Wikidata; Q98126418
CC   Population: Indian; Kashmiri.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27493
AC   CVCL_ZG63
DR   Coriell; GM27493
DR   Wikidata; Q98126419
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27494
AC   CVCL_ZG64
DR   Coriell; GM27494
DR   Wikidata; Q98126420
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27495
AC   CVCL_ZG65
DR   Coriell; GM27495
DR   Wikidata; Q98126421
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27496
AC   CVCL_ZG66
DR   Coriell; GM27496
DR   Wikidata; Q98126422
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27497
AC   CVCL_ZG67
DR   Coriell; GM27497
DR   Wikidata; Q98126423
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27498
AC   CVCL_ZG68
DR   Coriell; GM27498
DR   Wikidata; Q98126424
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27499
AC   CVCL_ZG69
DR   Coriell; GM27499
DR   Wikidata; Q98126425
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27500
AC   CVCL_ZG70
DR   Coriell; GM27500
DR   Wikidata; Q98126428
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27501
AC   CVCL_ZG71
DR   Coriell; GM27501
DR   Wikidata; Q98126429
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27502
AC   CVCL_ZG72
DR   Coriell; GM27502
DR   Wikidata; Q98126431
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27503
AC   CVCL_ZG73
DR   Coriell; GM27503
DR   Wikidata; Q98126432
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27504
AC   CVCL_ZG74
DR   Coriell; GM27504
DR   Wikidata; Q98126433
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27505
AC   CVCL_ZG75
DR   Coriell; GM27505
DR   Wikidata; Q98126434
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27506
AC   CVCL_ZG76
DR   Coriell; GM27506
DR   Wikidata; Q98126435
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27507
AC   CVCL_ZG77
DR   Coriell; GM27507
DR   Wikidata; Q98126436
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27508
AC   CVCL_ZG78
DR   Coriell; GM27508
DR   Wikidata; Q98126438
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27509
AC   CVCL_ZG79
DR   Coriell; GM27509
DR   Wikidata; Q98126439
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27510
AC   CVCL_ZG80
DR   Coriell; GM27510
DR   Wikidata; Q98126442
CC   Population: Indian; Marathi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27511
AC   CVCL_ZG81
DR   Coriell; GM27511
DR   Wikidata; Q98126443
CC   Population: Indian; Marathi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27512
AC   CVCL_ZG82
DR   Coriell; GM27512
DR   Wikidata; Q98126444
CC   Population: Indian; Marathi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27513
AC   CVCL_ZG83
DR   Coriell; GM27513
DR   Wikidata; Q98126445
CC   Population: Indian; Marathi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27514
AC   CVCL_ZG84
DR   Coriell; GM27514
DR   Wikidata; Q98126446
CC   Population: Indian; Marathi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27515
AC   CVCL_ZG85
DR   Coriell; GM27515
DR   Wikidata; Q98126448
CC   Population: Indian; Marathi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27516
AC   CVCL_ZG86
DR   Coriell; GM27516
DR   Wikidata; Q98126449
CC   Population: Indian; Marwari.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27517
AC   CVCL_ZG87
DR   Coriell; GM27517
DR   Wikidata; Q98126450
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27518
AC   CVCL_ZG88
DR   Coriell; GM27518
DR   Wikidata; Q98126452
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27519
AC   CVCL_ZG89
DR   Coriell; GM27519
DR   Wikidata; Q98126454
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27520
AC   CVCL_ZG90
DR   Coriell; GM27520
DR   Wikidata; Q98126455
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27521
AC   CVCL_ZG91
DR   Coriell; GM27521
DR   Wikidata; Q98126456
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27522
AC   CVCL_ZG92
DR   Coriell; GM27522
DR   Wikidata; Q98126457
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27523
AC   CVCL_ZG93
DR   Coriell; GM27523
DR   Wikidata; Q98126458
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27524
AC   CVCL_ZG94
DR   Coriell; GM27524
DR   Wikidata; Q98126459
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27525
AC   CVCL_ZG95
DR   Coriell; GM27525
DR   Wikidata; Q98126460
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27526
AC   CVCL_ZG96
DR   Coriell; GM27526
DR   Wikidata; Q98126461
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27527
AC   CVCL_ZG97
DR   Coriell; GM27527
DR   Wikidata; Q98126462
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27528
AC   CVCL_ZG98
DR   Coriell; GM27528
DR   Wikidata; Q98126464
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27529
AC   CVCL_ZG99
DR   Coriell; GM27529
DR   Wikidata; Q98126466
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27530
AC   CVCL_ZH00
DR   Coriell; GM27530
DR   Wikidata; Q98126467
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27531
AC   CVCL_ZH01
DR   Coriell; GM27531
DR   Wikidata; Q98126468
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27532
AC   CVCL_ZH02
DR   Coriell; GM27532
DR   Wikidata; Q98126469
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27533
AC   CVCL_ZH03
DR   Coriell; GM27533
DR   Wikidata; Q98126470
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27534
AC   CVCL_ZH04
DR   Coriell; GM27534
DR   Wikidata; Q98126471
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27535
AC   CVCL_ZH05
DR   Coriell; GM27535
DR   Wikidata; Q98126472
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27536
AC   CVCL_ZH06
DR   Coriell; GM27536
DR   Wikidata; Q98126473
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27537
AC   CVCL_ZH07
DR   Coriell; GM27537
DR   Wikidata; Q98126474
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27538
AC   CVCL_ZH08
DR   Coriell; GM27538
DR   Wikidata; Q98126475
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27539
AC   CVCL_ZH09
DR   Coriell; GM27539
DR   Wikidata; Q98126478
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27540
AC   CVCL_ZJ02
DR   Coriell; GM27540
DR   Wikidata; Q98126479
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27541
AC   CVCL_ZH10
DR   Coriell; GM27541
DR   Wikidata; Q98126480
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27543
AC   CVCL_ZH11
DR   Coriell; GM27543
DR   Wikidata; Q98126481
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27544
AC   CVCL_ZH12
DR   Coriell; GM27544
DR   Wikidata; Q98126482
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27545
AC   CVCL_ZH13
DR   Coriell; GM27545
DR   Wikidata; Q98126483
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27546
AC   CVCL_ZH14
DR   Coriell; GM27546
DR   Wikidata; Q98126484
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27547
AC   CVCL_ZH15
DR   Coriell; GM27547
DR   Wikidata; Q98126485
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27548
AC   CVCL_ZH16
DR   Coriell; GM27548
DR   Wikidata; Q98126486
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27549
AC   CVCL_ZH17
DR   Coriell; GM27549
DR   Wikidata; Q98126487
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27550
AC   CVCL_ZH18
DR   Coriell; GM27550
DR   Wikidata; Q98126490
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27551
AC   CVCL_ZH19
DR   Coriell; GM27551
DR   Wikidata; Q98126491
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27552
AC   CVCL_ZH20
DR   Coriell; GM27552
DR   Wikidata; Q98126492
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27553
AC   CVCL_ZH21
DR   Coriell; GM27553
DR   Wikidata; Q98126493
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27554
AC   CVCL_ZH22
DR   Coriell; GM27554
DR   Wikidata; Q98126494
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27555
AC   CVCL_ZH23
DR   Coriell; GM27555
DR   Wikidata; Q98126495
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27556
AC   CVCL_ZH24
DR   Coriell; GM27556
DR   Wikidata; Q98126496
CC   Population: Indian; Telugu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27557
AC   CVCL_ZH25
DR   Coriell; GM27557
DR   Wikidata; Q98126497
CC   Population: Indian; Tulu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27558
AC   CVCL_ZH26
DR   Coriell; GM27558
DR   Wikidata; Q98126498
CC   Population: Indian; Tulu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27559
AC   CVCL_ZH27
DR   Coriell; GM27559
DR   Wikidata; Q98126499
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27560
AC   CVCL_ZH28
DR   Coriell; GM27560
DR   Wikidata; Q98126502
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27561
AC   CVCL_ZH29
DR   Coriell; GM27561
DR   Wikidata; Q98126503
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27562
AC   CVCL_ZH30
DR   Coriell; GM27562
DR   Wikidata; Q98126504
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27563
AC   CVCL_ZH31
DR   Coriell; GM27563
DR   Wikidata; Q98126505
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27564
AC   CVCL_ZH32
DR   Coriell; GM27564
DR   Wikidata; Q98126506
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27565
AC   CVCL_ZH33
DR   Coriell; GM27565
DR   Wikidata; Q98126507
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27566
AC   CVCL_ZH34
DR   Coriell; GM27566
DR   Wikidata; Q98126508
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27567
AC   CVCL_ZH35
DR   Coriell; GM27567
DR   Wikidata; Q98126509
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27572
AC   CVCL_A2QK
DR   Coriell; GM27572
DR   Wikidata; Q105507180
CC   Population: Caucasian and Pacific; Hawaiian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27573
AC   CVCL_A2QL
DR   Coriell; GM27573
DR   Wikidata; Q105507184
CC   Population: Caucasian and Pacific; Hawaiian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; c.922+1G>A; ClinVar=VCV001711453; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM27573).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27574
AC   CVCL_A2QM
DR   Coriell; GM27574
DR   Wikidata; Q105507187
CC   Population: Caucasian and Pacific; Hawaiian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; c.922+1G>A; ClinVar=VCV001711453; Zygosity=Mosaic; Note=Splice donor mutation. Mutation found in 3% of the cells (Coriell=GM27574).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27575
AC   CVCL_A2QN
DR   Coriell; GM27575
DR   Wikidata; Q105507191
CC   Population: Caucasian and Pacific; Hawaiian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27576
AC   CVCL_A2QP
DR   Coriell; GM27576
DR   Wikidata; Q105507194
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27578
AC   CVCL_YE53
SY   GM27578*B
DR   Coriell; GM27578
DR   Wikidata; Q93933254
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Phe299Cys (c.896T>G); ClinVar=VCV000000613; Zygosity=Heterozygous (Coriell=GM27578).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg408Trp (c.1222C>T); ClinVar=VCV000000577; Zygosity=Heterozygous (Coriell=GM27578).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W148 ! GM02406
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   GM27600
AC   CVCL_YN44
DR   Coriell; GM27600
DR   Wikidata; Q93933258
CC   Population: Caucasian; Spanish (Chilean).
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Ile190Asn (c.569T>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27600).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2SQ ! GM27871
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27612
AC   CVCL_A2QQ
DR   Coriell; GM27612
DR   Wikidata; Q105507197
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Glu154Glyfs*301 (c.460dupG); ClinVar=VCV000095268; Zygosity=Heterozygous (Coriell=GM27612).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27613
AC   CVCL_A2QR
DR   Coriell; GM27613
DR   Wikidata; Q105507200
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Glu154Glyfs*301 (c.460dupG); ClinVar=VCV000095268; Zygosity=Heterozygous (Coriell=GM27613).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27614
AC   CVCL_YN45
DR   Coriell; GM27614
DR   Wikidata; Q93933262
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM27614).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 11
//
ID   GM27615
AC   CVCL_A2QS
DR   Coriell; GM27615
DR   Wikidata; Q105507203
CC   Sequence variation: Gene deletion; HGNC; HGNC:3811; FOXG1; Zygosity=Heterozygous (Coriell=GM27615).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27616
AC   CVCL_A9QY
DR   Coriell; GM27616
DR   Wikidata; Q102113914
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Asn232Ser (c.695A>G); ClinVar=VCV001698021; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27616).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1UT ! GM27373
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   GM27620
AC   CVCL_C7L3
SY   GM27620*A
DR   Coriell; GM27620
DR   Wikidata; Q117704346
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Glu154Glyfs*301 (c.460dupG); ClinVar=VCV000095268; Zygosity=Heterozygous (Coriell=GM27620).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2QR ! GM27613
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27622
AC   CVCL_YN46
SY   GM27622*A
DR   Coriell; GM27622
DR   Wikidata; Q93933265
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM27622).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN45 ! GM27614
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   GM27624
AC   CVCL_C7KW
SY   GM27624*A
DR   Coriell; GM27624
DR   Wikidata; Q117704347
CC   Sequence variation: Gene deletion; HGNC; HGNC:3811; FOXG1; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2QS ! GM27615
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   GM27629
AC   CVCL_YN47
SY   GM27629*A
DR   Coriell; GM27629
DR   Wikidata; Q93933267
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Asn232Ser (c.695A>G); ClinVar=VCV001698021; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27629).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9QY ! GM27616
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 11
//
ID   GM27630
AC   CVCL_ZH90
DR   Coriell; GM27630
DR   Wikidata; Q98126510
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Tyr709Ter (c.2127T>G); ClinVar=VCV000523879; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27630).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 9
//
ID   GM27631
AC   CVCL_ZW58
DR   Coriell; GM27631
DR   Wikidata; Q102113915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GM27632
AC   CVCL_ZW59
DR   Coriell; GM27632
DR   Wikidata; Q102113916
CC   Population: El Salvadoran.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   GM27633
AC   CVCL_ZW60
DR   Coriell; GM27633
DR   Wikidata; Q102113917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GM27638
AC   CVCL_ZH91
DR   Coriell; GM27638
DR   Wikidata; Q98126512
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Tyr709Ter (c.2127T>G); ClinVar=VCV000523879; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27638).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 9
//
ID   GM27639
AC   CVCL_ZH92
DR   Coriell; GM27639
DR   Wikidata; Q98126514
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27640
AC   CVCL_ZH93
DR   Coriell; GM27640
DR   Wikidata; Q98126515
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27641
AC   CVCL_ZW61
DR   Coriell; GM27641
DR   Wikidata; Q102113918
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Arg398Ter (c.1192C>T); ClinVar=VCV000208415; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27641).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   GM27642
AC   CVCL_ZW62
DR   Coriell; GM27642
DR   Wikidata; Q102113921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GM27643
AC   CVCL_YN48
DR   Coriell; GM27643
DR   Wikidata; Q93933270
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Gln649Ter (c.1945C>T); ClinVar=VCV000217910; Zygosity=Heterozygous (Coriell=GM27643).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Val91Serfs*11 (c.269dupT); ClinVar=VCV000177737; Zygosity=Heterozygous (Coriell=GM27643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 9
//
ID   GM27644
AC   CVCL_YN49
DR   Coriell; GM27644
DR   Wikidata; Q93933275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27648
AC   CVCL_ZW63
DR   Coriell; GM27648
DR   Wikidata; Q102113923
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Lys618Glufs*13 (c.1850dupA); ClinVar=VCV000280855; Zygosity=Heterozygous (Coriell=GM27648).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   GM27650
AC   CVCL_YN50
DR   Coriell; GM27650
DR   Wikidata; Q93933279
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27650).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27651
AC   CVCL_YN51
DR   Coriell; GM27651
DR   Wikidata; Q93933283
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   GM27659
AC   CVCL_YN52
DR   Coriell; GM27659
DR   Wikidata; Q93933285
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Trp65Ter (c.195G>A); Zygosity=Heterozygous (Coriell=GM27659).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   GM27660
AC   CVCL_YN53
DR   Coriell; GM27660
DR   Wikidata; Q93933287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27661
AC   CVCL_YN54
DR   Coriell; GM27661
DR   Wikidata; Q93933290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27664
AC   CVCL_ZW64
DR   Coriell; GM27664
DR   Wikidata; Q102113925
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Arg212Leufs*24 (c.628_629delAG); Zygosity=Heterozygous (Coriell=GM27664).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GM27665
AC   CVCL_ZW65
DR   Coriell; GM27665
DR   Wikidata; Q102113926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GM27666
AC   CVCL_ZW66
DR   Coriell; GM27666
DR   Wikidata; Q102113927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GM27667
AC   CVCL_YN55
DR   Coriell; GM27667
DR   Wikidata; Q93933293
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; c.680-11G>A; ClinVar=VCV000521457; Zygosity=Heterozygous (Coriell=GM27667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   GM27668
AC   CVCL_YN56
DR   Coriell; GM27668
DR   Wikidata; Q93933294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27669
AC   CVCL_YN57
DR   Coriell; GM27669
DR   Wikidata; Q93933296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27682
AC   CVCL_ZW67
DR   Coriell; GM27682
DR   Wikidata; Q102113928
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Arg212His (c.635G>A); ClinVar=VCV000265386; Zygosity=Heterozygous (Coriell=GM27682).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GM27683
AC   CVCL_ZW68
DR   Coriell; GM27683
DR   Wikidata; Q102113929
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GM27698
AC   CVCL_YN58
DR   Coriell; GM27698
DR   Wikidata; Q93933297
CC   Population: Caucasian; Spanish (Chilean).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   GM27699
AC   CVCL_YN59
DR   Coriell; GM27699
DR   Wikidata; Q93933298
CC   Population: Caucasian; Spanish (Chilean).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   GM27717
AC   CVCL_ZJ01
SY   GM27717*B
DR   Coriell; GM27717
DR   Wikidata; Q98126516
CC   Population: African American.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7392 ! GM03524
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   GM27723
AC   CVCL_YN60
DR   Coriell; GM27723
DR   Wikidata; Q93933300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27724
AC   CVCL_YN61
DR   Coriell; GM27724
DR   Wikidata; Q93933301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   GM27730
AC   CVCL_ZH94
SY   GM27730*B
DR   Coriell; GM27730
DR   Wikidata; Q98126517
WW   Info; PGP; huAA53E0; https://my.pgp-hms.org/profile_public?hex=huAA53E0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1C78 ! GM24385
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   GM27743
AC   CVCL_YN62
DR   Coriell; GM27743
DR   Wikidata; Q93933304
CC   Population: Caucasian; French/Polish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 5
//
ID   GM27748
AC   CVCL_ZH36
DR   Coriell; GM27748
DR   Wikidata; Q98126518
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27749
AC   CVCL_ZH37
DR   Coriell; GM27749
DR   Wikidata; Q98126521
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27750
AC   CVCL_ZH38
DR   Coriell; GM27750
DR   Wikidata; Q98126524
CC   Population: Indian; Konkani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27751
AC   CVCL_ZH39
DR   Coriell; GM27751
DR   Wikidata; Q98126526
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27752
AC   CVCL_ZH40
DR   Coriell; GM27752
DR   Wikidata; Q98126528
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27753
AC   CVCL_A2QT
DR   Coriell; GM27753
DR   Wikidata; Q105507206
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27754
AC   CVCL_ZH41
DR   Coriell; GM27754
DR   Wikidata; Q98126533
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27755
AC   CVCL_ZH42
DR   Coriell; GM27755
DR   Wikidata; Q98126534
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27756
AC   CVCL_ZH43
DR   Coriell; GM27756
DR   Wikidata; Q98126536
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27757
AC   CVCL_ZH44
DR   Coriell; GM27757
DR   Wikidata; Q98126539
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27758
AC   CVCL_ZH45
DR   Coriell; GM27758
DR   Wikidata; Q98126540
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27759
AC   CVCL_ZH46
DR   Coriell; GM27759
DR   Wikidata; Q98126542
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27760
AC   CVCL_ZH47
DR   Coriell; GM27760
DR   Wikidata; Q98126544
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27761
AC   CVCL_ZH48
DR   Coriell; GM27761
DR   Wikidata; Q98126547
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27762
AC   CVCL_ZH49
DR   Coriell; GM27762
DR   Wikidata; Q98126549
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27763
AC   CVCL_ZH50
DR   Coriell; GM27763
DR   Wikidata; Q98126552
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27764
AC   CVCL_ZH51
DR   Coriell; GM27764
DR   Wikidata; Q98126553
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27765
AC   CVCL_ZH52
DR   Coriell; GM27765
DR   Wikidata; Q98126554
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27766
AC   CVCL_ZH53
DR   Coriell; GM27766
DR   Wikidata; Q98126555
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27767
AC   CVCL_ZH54
DR   Coriell; GM27767
DR   Wikidata; Q98126556
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27768
AC   CVCL_ZH55
DR   Coriell; GM27768
DR   Wikidata; Q98126558
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27769
AC   CVCL_A2QU
DR   Coriell; GM27769
DR   Wikidata; Q105507209
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27770
AC   CVCL_ZH56
DR   Coriell; GM27770
DR   Wikidata; Q98126561
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27771
AC   CVCL_ZH57
DR   Coriell; GM27771
DR   Wikidata; Q98126563
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27772
AC   CVCL_A2QV
DR   Coriell; GM27772
DR   Wikidata; Q105507211
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27773
AC   CVCL_ZH58
DR   Coriell; GM27773
DR   Wikidata; Q98126566
CC   Population: Indian; Bengali.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27774
AC   CVCL_A2QW
DR   Coriell; GM27774
DR   Wikidata; Q105507214
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27775
AC   CVCL_ZH59
DR   Coriell; GM27775
DR   Wikidata; Q98126568
CC   Population: Indian; Bengali.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27776
AC   CVCL_ZH60
DR   Coriell; GM27776
DR   Wikidata; Q98126572
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27777
AC   CVCL_ZH61
DR   Coriell; GM27777
DR   Wikidata; Q98126574
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27778
AC   CVCL_ZH62
DR   Coriell; GM27778
DR   Wikidata; Q98126576
CC   Population: Indian; Bengali.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27779
AC   CVCL_ZH63
DR   Coriell; GM27779
DR   Wikidata; Q98126578
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27780
AC   CVCL_ZH64
DR   Coriell; GM27780
DR   Wikidata; Q98126580
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27781
AC   CVCL_ZH65
DR   Coriell; GM27781
DR   Wikidata; Q98126583
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27782
AC   CVCL_ZH66
DR   Coriell; GM27782
DR   Wikidata; Q98126586
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27783
AC   CVCL_ZH67
DR   Coriell; GM27783
DR   Wikidata; Q98126588
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27784
AC   CVCL_ZH68
DR   Coriell; GM27784
DR   Wikidata; Q98126590
CC   Population: Indian; Kashmiri.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27785
AC   CVCL_ZH69
DR   Coriell; GM27785
DR   Wikidata; Q98126593
CC   Population: Indian; Kashmiri.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27786
AC   CVCL_ZH70
DR   Coriell; GM27786
DR   Wikidata; Q98126594
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27787
AC   CVCL_ZH71
DR   Coriell; GM27787
DR   Wikidata; Q98126597
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27788
AC   CVCL_ZH72
DR   Coriell; GM27788
DR   Wikidata; Q98126598
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27789
AC   CVCL_ZH73
DR   Coriell; GM27789
DR   Wikidata; Q98126601
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27790
AC   CVCL_ZH74
DR   Coriell; GM27790
DR   Wikidata; Q98126602
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27791
AC   CVCL_ZH75
DR   Coriell; GM27791
DR   Wikidata; Q98126603
CC   Population: Indian; Tulu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27792
AC   CVCL_ZH76
DR   Coriell; GM27792
DR   Wikidata; Q98126604
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27793
AC   CVCL_ZH77
DR   Coriell; GM27793
DR   Wikidata; Q98126605
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27794
AC   CVCL_ZH78
DR   Coriell; GM27794
DR   Wikidata; Q98126607
CC   Population: Indian; Dogri.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27795
AC   CVCL_ZH79
DR   Coriell; GM27795
DR   Wikidata; Q98126609
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27796
AC   CVCL_ZH80
DR   Coriell; GM27796
DR   Wikidata; Q98126611
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27797
AC   CVCL_ZH81
DR   Coriell; GM27797
DR   Wikidata; Q98126614
CC   Population: Indian; Kashmiri.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27798
AC   CVCL_ZH82
DR   Coriell; GM27798
DR   Wikidata; Q98126616
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27799
AC   CVCL_ZH83
DR   Coriell; GM27799
DR   Wikidata; Q98126617
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27800
AC   CVCL_ZH84
DR   Coriell; GM27800
DR   Wikidata; Q98126620
CC   Population: Indian; Kashmiri.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27801
AC   CVCL_ZH85
DR   Coriell; GM27801
DR   Wikidata; Q98126621
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27802
AC   CVCL_ZH86
DR   Coriell; GM27802
DR   Wikidata; Q98126622
CC   Population: Indian; Oriya.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27803
AC   CVCL_A2QX
DR   Coriell; GM27803
DR   Wikidata; Q105507217
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27804
AC   CVCL_A2QY
DR   Coriell; GM27804
DR   Wikidata; Q105507222
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27805
AC   CVCL_ZH87
DR   Coriell; GM27805
DR   Wikidata; Q98126625
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27806
AC   CVCL_ZH88
DR   Coriell; GM27806
DR   Wikidata; Q98126626
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27807
AC   CVCL_ZH89
DR   Coriell; GM27807
DR   Wikidata; Q98126628
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27808
AC   CVCL_A2QZ
DR   Coriell; GM27808
DR   Wikidata; Q105507225
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27809
AC   CVCL_A2RA
DR   Coriell; GM27809
DR   Wikidata; Q105507229
CC   Population: Indian; Malayalam.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27810
AC   CVCL_A2RB
DR   Coriell; GM27810
DR   Wikidata; Q105507232
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27811
AC   CVCL_A2RC
DR   Coriell; GM27811
DR   Wikidata; Q105507235
CC   Population: Indian; Punjabi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27812
AC   CVCL_A2RD
DR   Coriell; GM27812
DR   Wikidata; Q105507238
CC   Population: Indian; Hindi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27813
AC   CVCL_A2RE
DR   Coriell; GM27813
DR   Wikidata; Q105507241
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27815
AC   CVCL_A2RF
DR   Coriell; GM27815
DR   Wikidata; Q105507245
CC   Population: Indian; Marwari.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27816
AC   CVCL_A2RG
DR   Coriell; GM27816
DR   Wikidata; Q105507248
CC   Population: Indian; Marwari.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27817
AC   CVCL_A2RH
DR   Coriell; GM27817
DR   Wikidata; Q105507251
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27818
AC   CVCL_A2RI
DR   Coriell; GM27818
DR   Wikidata; Q105507254
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27819
AC   CVCL_A2RJ
DR   Coriell; GM27819
DR   Wikidata; Q105507257
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27820
AC   CVCL_A2RK
DR   Coriell; GM27820
DR   Wikidata; Q105507262
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27821
AC   CVCL_A2RL
DR   Coriell; GM27821
DR   Wikidata; Q105507265
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27822
AC   CVCL_A2RM
DR   Coriell; GM27822
DR   Wikidata; Q105507271
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27823
AC   CVCL_A2RN
DR   Coriell; GM27823
DR   Wikidata; Q105507274
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27824
AC   CVCL_A2RP
DR   Coriell; GM27824
DR   Wikidata; Q105507278
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27825
AC   CVCL_A2RQ
DR   Coriell; GM27825
DR   Wikidata; Q105507280
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27826
AC   CVCL_A2RR
DR   Coriell; GM27826
DR   Wikidata; Q105507284
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27827
AC   CVCL_A2RS
DR   Coriell; GM27827
DR   Wikidata; Q105507286
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27828
AC   CVCL_A2RT
DR   Coriell; GM27828
DR   Wikidata; Q105507289
CC   Population: Indian; Kannada.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27829
AC   CVCL_A2RU
DR   Coriell; GM27829
DR   Wikidata; Q105507294
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27830
AC   CVCL_A2RV
DR   Coriell; GM27830
DR   Wikidata; Q105507296
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27831
AC   CVCL_A2RW
DR   Coriell; GM27831
DR   Wikidata; Q105507300
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27832
AC   CVCL_A2RX
DR   Coriell; GM27832
DR   Wikidata; Q105507303
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27833
AC   CVCL_A2RY
DR   Coriell; GM27833
DR   Wikidata; Q105507306
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27834
AC   CVCL_A2RZ
DR   Coriell; GM27834
DR   Wikidata; Q105507310
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27835
AC   CVCL_A2SA
DR   Coriell; GM27835
DR   Wikidata; Q105507313
CC   Population: Indian; Assamese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27836
AC   CVCL_A2SB
DR   Coriell; GM27836
DR   Wikidata; Q105507316
CC   Population: Indian; Marwari.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27837
AC   CVCL_A2SC
DR   Coriell; GM27837
DR   Wikidata; Q105507320
CC   Population: Indian; Marwari.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27838
AC   CVCL_A2SM
DR   Coriell; GM27838
DR   Wikidata; Q105507324
CC   Population: Indian; Marwari.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27839
AC   CVCL_A2SD
DR   Coriell; GM27839
DR   Wikidata; Q105507327
CC   Population: Indian; Marwari.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27840
AC   CVCL_A2SE
DR   Coriell; GM27840
DR   Wikidata; Q105507330
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   29Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27841
AC   CVCL_A2SF
DR   Coriell; GM27841
DR   Wikidata; Q105507333
CC   Population: Indian; Kashmiri.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27842
AC   CVCL_A2SG
DR   Coriell; GM27842
DR   Wikidata; Q105507337
CC   Population: Indian; Tamil.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27843
AC   CVCL_A2SH
DR   Coriell; GM27843
DR   Wikidata; Q105507340
CC   Population: Indian; Parsi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27844
AC   CVCL_A2SI
DR   Coriell; GM27844
DR   Wikidata; Q105507343
CC   Population: Indian; Parsi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27845
AC   CVCL_A2SJ
DR   Coriell; GM27845
DR   Wikidata; Q105507347
CC   Population: Indian; Parsi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27846
AC   CVCL_A2SK
DR   Coriell; GM27846
DR   Wikidata; Q105507351
CC   Population: Indian; Parsi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27847
AC   CVCL_A2SL
DR   Coriell; GM27847
DR   Wikidata; Q105507354
CC   Population: Indian; Parsi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27848
AC   CVCL_YN63
DR   Coriell; GM27848
DR   Wikidata; Q93933305
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM27848).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 11
//
ID   GM27849
AC   CVCL_YN64
DR   Coriell; GM27849
DR   Wikidata; Q93933307
CC   Population: Jewish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   GM27850
AC   CVCL_YN65
DR   Coriell; GM27850
DR   Wikidata; Q93933308
CC   Population: Jewish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   GM27851
AC   CVCL_YN66
DR   Coriell; GM27851
DR   Wikidata; Q93933310
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gly169Alafs*23 (c.506delG); ClinVar=VCV000471470; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27851).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZH95 ! GM27852
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   GM27852
AC   CVCL_ZH95
DR   Coriell; GM27852
DR   Wikidata; Q98126629
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gly169Alafs*23 (c.506delG); ClinVar=VCV000471470; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27852).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN66 ! GM27851
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   GM27853
AC   CVCL_ZH96
DR   Coriell; GM27853
DR   Wikidata; Q98126630
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27854
AC   CVCL_ZH97
DR   Coriell; GM27854
DR   Wikidata; Q98126631
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Thr221Asnfs*3 (c.661dupA); ClinVar=VCV000827777; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27854).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 9
//
ID   GM27857
AC   CVCL_A2SN
SY   GM27857*B
DR   Coriell; GM27857
DR   Wikidata; Q105507359
CC   Population: Caucasian; Romanian and Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Unexplicit; Ex10-11del; Zygosity=Hemizygous (Coriell=GM27857).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE57 ! GM27448
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27860
AC   CVCL_ZH98
SY   GM27860*B
DR   Coriell; GM27860
DR   Wikidata; Q98126632
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Arg497Ter (c.1489C>T); ClinVar=VCV000210050; Zygosity=Heterozygous (Coriell=GM27860).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XC49 ! GM27353
SX   Male
AG   1Y11M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   GM27863
AC   CVCL_ZW48
DR   Coriell; GM27863
DR   Wikidata; Q102113930
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe408del (c.1216_1218TTC[2]) (c.1222_1224delTTC); ClinVar=VCV000011698; Zygosity=Hemizygous (Coriell=GM27863).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW49 ! GM27874
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GM27864
AC   CVCL_ZH99
DR   Coriell; GM27864
DR   Wikidata; Q98126634
CC   Population: Caucasian; Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   GM27865
AC   CVCL_ZW50
DR   Coriell; GM27865
DR   Wikidata; Q102113932
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Trp556Ter (c.1667G>A); ClinVar=VCV000546017; Zygosity=Hemizygous (Coriell=GM27865).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW51 ! GM27866
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   GM27866
AC   CVCL_ZW51
DR   Coriell; GM27866
DR   Wikidata; Q102113934
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Trp556Ter (c.1667G>A); ClinVar=VCV000546017; Zygosity=Hemizygous (Coriell=GM27866).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW50 ! GM27865
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GM27867
AC   CVCL_ZW52
DR   Coriell; GM27867
DR   Wikidata; Q102113935
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Trp556Ter (c.1667G>A); ClinVar=VCV000546017; Zygosity=Heterozygous (Coriell=GM27867).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW53 ! GM27868
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   GM27868
AC   CVCL_ZW53
DR   Coriell; GM27868
DR   Wikidata; Q102113936
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Trp556Ter (c.1667G>A); ClinVar=VCV000546017; Zygosity=Heterozygous (Coriell=GM27868).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW52 ! GM27867
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GM27869
AC   CVCL_A2SP
DR   Coriell; GM27869
DR   Wikidata; Q105507362
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; c.726-1G>A (c.729-1G>A) (IVS9-1G>A); ClinVar=VCV001803675; Zygosity=Heterozygous; Note=De novo mutation. Splice acceptor mutation (Coriell=GM27869).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27871
AC   CVCL_A2SQ
DR   Coriell; GM27871
DR   Wikidata; Q105507366
CC   Population: Caucasian; Spanish (Chilean).
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Ile190Asn (c.569T>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27871).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN44 ! GM27600
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27872
AC   CVCL_A2SR
DR   Coriell; GM27872
DR   Wikidata; Q105507370
CC   Population: Caucasian; Spanish (Chilean).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27873
AC   CVCL_A2SS
DR   Coriell; GM27873
DR   Wikidata; Q105507373
CC   Population: Caucasian; Spanish (Chilean).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27874
AC   CVCL_ZW49
DR   Coriell; GM27874
DR   Wikidata; Q102113937
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe408del (c.1216_1218TTC[2]) (c.1222_1224delTTC); ClinVar=VCV000011698; Zygosity=Hemizygous (Coriell=GM27874).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW48 ! GM27863
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   GM27880
AC   CVCL_A2TB
SY   GM27880*C; 1123-FOXG1-LOF-Hom#A8
DR   Coriell; GM27880
DR   Wikidata; Q105507379
RX   PubMed=37071670;
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple_edited; p.Ser19Glnfs*120 (c.53_54insT); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM27880).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TY ! S1123-01 iPS #3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27881
AC   CVCL_A2TC
SY   GM27881*C; 1123-FOXG1-LOF-Hom#B7
DR   Coriell; GM27881
DR   Wikidata; Q105507384
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple_edited; p.Phe18Thrfs*188 (c.49_58delTCGTTCAGCA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM27881).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TY ! S1123-01 iPS #3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27882
AC   CVCL_A2TD
SY   GM27882*C; 1123-FOXG1-LOF-Het#A4
DR   Coriell; GM27882
DR   Wikidata; Q105507389
RX   PubMed=37071670;
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple_edited; p.Ser19Glnfs*120 (c.53_54insT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Coriell=GM27882).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TY ! S1123-01 iPS #3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27885
AC   CVCL_A2TE
SY   GM27885*C; 1123-FOXG1-LOF-Isogenic Control#A12
DR   Coriell; GM27885
DR   Wikidata; Q105507393
CC   Characteristics: Control cell line for the edited cell lines GM27880 (Cellosaurus=CVCL_A2TB), GM27881 (Cellosaurus=CVCL_A2TC) and GM27882 (Cellosaurus=CVCL_A2TD).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TY ! S1123-01 iPS #3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 30-01-24; Version: 6
//
ID   GM27888
AC   CVCL_ZW54
DR   Coriell; GM27888
DR   Wikidata; Q102113938
CC   Discontinued: Coriell; GM27888; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   GM27889
AC   CVCL_ZW55
DR   Coriell; GM27889
DR   Wikidata; Q102113939
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   GM27890
AC   CVCL_A2TF
DR   Coriell; GM27890
DR   Wikidata; Q105507397
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Thr150Ala (c.448A>G); Zygosity=Heterozygous (Coriell=GM27890).
CC   Sequence variation: Mutation; HGNC; HGNC:14888; DNAJB6; Simple; c.899-3T>G; Zygosity=Heterozygous (Coriell=GM27890).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27891
AC   CVCL_C7L4
DR   Coriell; GM27891
DR   Wikidata; Q117704348
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11164; SNRPN; Simple; p.Arg25Ter (c.73C>T); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27891).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27892
AC   CVCL_ZW56
DR   Coriell; GM27892
DR   Wikidata; Q102113940
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Glu142del (c.421GAG[1]) (c.424_426delGAG); ClinVar=VCV002689111; dbSNP=rs1736323141; Zygosity=Homozygous (Coriell=GM27892).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   GM27894
AC   CVCL_ZW57
DR   Coriell; GM27894
DR   Wikidata; Q102113941
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Heterozygous (Coriell=GM27894).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH31 ! GM26250
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   GM27895
AC   CVCL_ZI00
DR   Coriell; GM27895
DR   Wikidata; Q98126635
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   GM27897
AC   CVCL_ZI02
SY   S17-1455
DR   Coriell; GM27897
DR   Wikidata; Q98126638
RX   PubMed=30197081;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple; p.Pro485Leu (c.1454C>T); ClinVar=VCV000871442; Zygosity=Heterozygous (Coriell=GM27897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   GM27898
AC   CVCL_ZI03
DR   Coriell; GM27898
DR   Wikidata; Q98126640
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Trp865Ter (c.2595G>A); Zygosity=Heterozygous (Coriell=GM27898).
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Leu1067Tyrfs*10 (c.3200delT); Zygosity=Heterozygous (Coriell=GM27898).
CC   Sequence variation: Mutation; HGNC; HGNC:13890; ITCH; Simple; c.337+2T>C; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM27898).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C138174; Vici syndrome
DI   ORDO; Orphanet_1493; Vici syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI04 ! GM27900
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   GM27899
AC   CVCL_A2TV
DR   Coriell; GM27899
DR   Wikidata; Q105507400
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11042; SLC6A1; Simple; p.Ala288Val (c.863C>T); ClinVar=VCV000192372; Zygosity=Heterozygous (Coriell=GM27899).
CC   Sequence variation: Mutation; HGNC; HGNC:12303; TRIO; Simple; p.Arg2707Ter (c.8119C>T); ClinVar=VCV000936994; Zygosity=Heterozygous (Coriell=GM27899).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C191771; SLC6A1-associated myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   GM27900
AC   CVCL_ZI04
DR   Coriell; GM27900
DR   Wikidata; Q98126641
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Trp865Ter (c.2595G>A); Zygosity=Heterozygous (Coriell=GM27900).
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple; p.Leu1067Tyrfs*10 (c.3200delT); Zygosity=Heterozygous (Coriell=GM27900).
CC   Sequence variation: Mutation; HGNC; HGNC:13890; ITCH; Simple; c.337+2T>C; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM27900).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C138174; Vici syndrome
DI   ORDO; Orphanet_1493; Vici syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI03 ! GM27898
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   GM27901
AC   CVCL_A5MK
DR   Coriell; GM27901
DR   Wikidata; Q107115187
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11497; SYNGAP1; Simple; p.Arg1240Ter (c.3718C>T); ClinVar=VCV000225077; Zygosity=Heterozygous (Coriell=GM27901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178414; Intellectual developmental disorder, autosomal dominant 5
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   GM27903
AC   CVCL_A2TU
DR   Coriell; GM27903
DR   Wikidata; Q105507403
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe365Leufs*105 (c.1094_1095insGGAGCGTGGGCTTCTC); Zygosity=Hemizygous (Coriell=GM27903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   GM27904
AC   CVCL_A2TT
DR   Coriell; GM27904
DR   Wikidata; Q105507405
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GM27909
AC   CVCL_ZW46
DR   Coriell; GM27909
DR   Wikidata; Q102113942
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Val277_Leu281dup (c.829_843dup15); ClinVar=VCV000810773; Zygosity=Hemizygous (Coriell=GM27909).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   GM27910
AC   CVCL_ZW47
DR   Coriell; GM27910
DR   Wikidata; Q102113944
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Asn125Tyr (c.373A>T); Zygosity=Hemizygous (Coriell=GM27910).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GM27912
AC   CVCL_A9ZJ
DR   Coriell; GM27912
DR   Wikidata; Q102113945
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Gln657Ter (c.1969C>T); ClinVar=VCV000217916; Zygosity=Heterozygous (Coriell=GM27912).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   GM27913
AC   CVCL_A9ZI
DR   Coriell; GM27913
DR   Wikidata; Q102113946
CC   Population: Jewish; Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Arg468Ter (c.1402C>T); ClinVar=VCV000565700; Zygosity=Homozygous (Coriell=GM27913).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   GM27914
AC   CVCL_C7L5
DR   Coriell; GM27914
DR   Wikidata; Q117704349
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Phe221Leufs*67 (c.660delC); Zygosity=Heterozygous (Coriell=GM27914).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27918
AC   CVCL_A5MM
SY   GM27918*B
DR   Coriell; GM27918
DR   Wikidata; Q107115188
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5K92 ! GM25378
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   GM27925
AC   CVCL_A5MN
SY   GM27925*B
DR   Coriell; GM27925
DR   Wikidata; Q107115189
CC   Population: Caucasian; Amish.
CC   Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM27925).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V714 ! GM17414
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM27930
AC   CVCL_A9ZH
SY   GM27930*B
DR   Coriell; GM27930
DR   Wikidata; Q102113947
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; c.726-1G>A (c.729-1G>A) (IVS9-1G>A); ClinVar=VCV001803675; Zygosity=Heterozygous; Note=De novo mutation. Splice acceptor mutation (Coriell=GM27930).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2SP ! GM27869
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   GM27933
AC   CVCL_A2TN
SY   GM27933*B
DR   Coriell; GM27933
DR   Wikidata; Q105507409
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Pro305Leu (c.914C>T); ClinVar=VCV000428604; Zygosity=Heterozygous (Coriell=GM27933).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   GM27934
AC   CVCL_A2TP
SY   GM27934*B
DR   Coriell; GM27934
DR   Wikidata; Q105507412
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Glu253Lys (c.757G>A); ClinVar=VCV000162059; Zygosity=Heterozygous (Coriell=GM27934).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   GM27935
AC   CVCL_A2TQ
SY   GM27935*B
DR   Coriell; GM27935
DR   Wikidata; Q105507417
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Cys151Tyr (c.452G>A); ClinVar=VCV000451648; Zygosity=Heterozygous (Coriell=GM27935).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   GM27936
AC   CVCL_A2TR
SY   GM27936*B
DR   Coriell; GM27936
DR   Wikidata; Q105507421
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Arg316Trp (c.946C>T); ClinVar=VCV000162060; Zygosity=Heterozygous (Coriell=GM27936).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   GM27937
AC   CVCL_A5MP
SY   GM27937*B
DR   Coriell; GM27937
DR   Wikidata; Q107115190
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Arg203Ser (c.609G>T); Zygosity=Mosaic (Coriell=GM27937).
CC   Donor information: The donor is mosaic for the disease causing KIF1A mutation, this cell line originate from a diseased cell (Coriell=GM27937).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5MQ ! GM27938
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   GM27938
AC   CVCL_A5MQ
SY   GM27938*B
DR   Coriell; GM27938
DR   Wikidata; Q107115191
CC   Population: Caucasian.
CC   Donor information: The donor is mosaic for the disease causing KIF1A mutation, this cell line originate from a wild-type cell (Coriell=GM27938).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5MP ! GM27937
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   GM27939
AC   CVCL_C7L6
SY   GM27939*B; CIMRi004-A
DR   BioSamples; SAMEA112941191
DR   Coriell; GM27939
DR   hPSCreg; CIMRi004-A
DR   Wikidata; Q117704350
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:19743; POMT2; Simple; p.Gly353Ser (c.1057G>A); ClinVar=VCV000003231; Zygosity=Homozygous (Coriell=GM27939).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126690; Congenital muscular dystrophy-dystroglycanopathy with intellectual developmental disorder type B2
DI   ORDO; Orphanet_370968; Congenital muscular dystrophy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AZ52 ! GM24374
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 7
//
ID   GM27948
AC   CVCL_C7L7
DR   Coriell; GM27948
DR   Wikidata; Q117704351
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Glu64Lys (c.190G>A); ClinVar=VCV000128068; Zygosity=Heterozygous (Coriell=GM27948).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7L8 ! GM27953
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27949
AC   CVCL_C7LA
DR   Coriell; GM27949
DR   Wikidata; Q117704352
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84832; Macroglossia
DI   ORDO; Orphanet_2430; Congenital macroglossia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM27953
AC   CVCL_C7L8
DR   Coriell; GM27953
DR   Wikidata; Q117704353
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Glu64Lys (c.190G>A); ClinVar=VCV000128068; Zygosity=Heterozygous (Coriell=GM27953).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7L7 ! GM27948
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27954
AC   CVCL_C7LB
DR   Coriell; GM27954
DR   Wikidata; Q117704354
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Tyr335Cysfs*5 (c.1004_1005delAT (p.Tyr336Cysfs*5, c.1007_1008delAT); ClinVar=VCV000041911; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27954).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27955
AC   CVCL_C7LC
DR   Coriell; GM27955
DR   Wikidata; Q117704355
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:4175; GATM; Simple; p.Ala97Valfs*11 (c.484+1G>T); ClinVar=VCV000021299; Zygosity=Homozygous (Coriell=GM27955).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198575; Cerebral creatine deficiency syndrome 3
DI   ORDO; Orphanet_35704; L-arginine:glycine amidinotransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27957
AC   CVCL_A5ML
SY   GM27957*B
DR   Coriell; GM27957
DR   Wikidata; Q107115192
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11497; SYNGAP1; Simple; p.Arg1240Ter (c.3718C>T); ClinVar=VCV000225077; Zygosity=Heterozygous (Coriell=GM27957).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178414; Intellectual developmental disorder, autosomal dominant 5
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5MK ! GM27901
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   GM27961
AC   CVCL_C7LE
DR   Coriell; GM27961
DR   Wikidata; Q117704356
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LF ! GM27962
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM27962
AC   CVCL_C7LF
DR   Coriell; GM27962
DR   Wikidata; Q117704357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LE ! GM27961
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM27963
AC   CVCL_C7LG
DR   Coriell; GM27963
DR   Wikidata; Q117704358
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27963).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LH ! GM27967
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM27967
AC   CVCL_C7LH
DR   Coriell; GM27967
DR   Wikidata; Q117704359
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27967).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LG ! GM27963
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM27968
AC   CVCL_C7LI
DR   Coriell; GM27968
DR   Wikidata; Q117704360
CC   Population: Caucasian; Bosnian.
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Unspecified; Note=Factor V Leiden (Coriell=GM27968).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LJ ! GM27980
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27973
AC   CVCL_A2TS
DR   Coriell; GM27973
DR   Wikidata; Q105507424
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gly169Glyfs*23 (c.507del); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM27973).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Arg303His (c.908G>A); ClinVar=VCV000284411; Zygosity=Heterozygous (Coriell=GM27973).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM27978
AC   CVCL_A5MR
SY   GM27978*B
DR   Coriell; GM27978
DR   Wikidata; Q107115193
CC   Population: Caucasian and Native North American; Alaskan.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous (Coriell=GM27978).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XC44 ! GM27408
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   GM27980
AC   CVCL_C7LJ
DR   Coriell; GM27980
DR   Wikidata; Q117704361
CC   Population: Caucasian; Bosnian.
CC   Sequence variation: Mutation; HGNC; HGNC:3542; F5; Simple; p.Arg534Gln (c.1601G>A) (R506Q); ClinVar=VCV000000642; Zygosity=Unspecified; Note=Factor V Leiden (Coriell=GM27980).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LI ! GM27968
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27987
AC   CVCL_C7LK
DR   Coriell; GM27987
DR   Wikidata; Q117704362
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:7027; MERTK; Simple; p.Ala258Glu (c.773C>A); ClinVar=VCV000330747; Zygosity=Heterozygous (Coriell=GM27987).
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Gln389Ter (c.1165C>T); ClinVar=VCV001297104; Zygosity=Heterozygous (Coriell=GM27987).
CC   Sequence variation: Mutation; HGNC; HGNC:28396; TMEM67; Simple; p.Gly195Ilefs*13 (c.579_580delAG); ClinVar=VCV000056783; Zygosity=Heterozygous (Coriell=GM27987).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27988
AC   CVCL_C7LL
DR   Coriell; GM27988
DR   Wikidata; Q117704363
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Glu105Asnfs*2 (c.312delA); Zygosity=Heterozygous (Coriell=GM27988).
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Pro277Thr (c.829C>A); Zygosity=Heterozygous (Coriell=GM27988).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LM ! GM27990
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27990
AC   CVCL_C7LM
DR   Coriell; GM27990
DR   Wikidata; Q117704364
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Glu105Asnfs*2 (c.312delA); Zygosity=Heterozygous (Coriell=GM27990).
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Pro277Thr (c.829C>A); Zygosity=Heterozygous (Coriell=GM27990).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LL ! GM27988
SX   Female
AG   1Y10M
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27991
AC   CVCL_C7LN
DR   Coriell; GM27991
DR   Wikidata; Q117704366
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Glu105Asnfs*2 (c.312delA); Zygosity=Heterozygous (Coriell=GM27991).
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Pro277Thr (c.829C>A); Zygosity=Heterozygous (Coriell=GM27991).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LP ! GM27993
SX   Female
AG   3Y10M
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27993
AC   CVCL_C7LP
DR   Coriell; GM27993
DR   Wikidata; Q117704367
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Glu105Asnfs*2 (c.312delA); Zygosity=Heterozygous (Coriell=GM27993).
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Pro277Thr (c.829C>A); Zygosity=Heterozygous (Coriell=GM27993).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LN ! GM27991
SX   Female
AG   3Y10M
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27994
AC   CVCL_C7LQ
DR   Coriell; GM27994
DR   Wikidata; Q117704368
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Glu105Asnfs*2 (c.312delA); Zygosity=Heterozygous (Coriell=GM27994).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LR ! GM27995
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27995
AC   CVCL_C7LR
DR   Coriell; GM27995
DR   Wikidata; Q117704369
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Glu105Asnfs*2 (c.312delA); Zygosity=Heterozygous (Coriell=GM27995).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LQ ! GM27994
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27996
AC   CVCL_C7LS
DR   Coriell; GM27996
DR   Wikidata; Q117704370
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Pro277Thr (c.829C>A); Zygosity=Heterozygous (Coriell=GM27996).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LT ! GM27997
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM27997
AC   CVCL_C7LT
DR   Coriell; GM27997
DR   Wikidata; Q117704371
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9440; THAP12; Simple; p.Pro277Thr (c.829C>A); Zygosity=Heterozygous (Coriell=GM27997).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7LS ! GM27996
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28007
AC   CVCL_B3SD
DR   Coriell; GM28007
DR   Wikidata; Q110432829
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ile486Tyrfs*2 (c.1455dup); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28007).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 7
//
ID   GM28009
AC   CVCL_A2YN
DR   Coriell; GM28009
DR   Wikidata; Q105507428
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   GM28010
AC   CVCL_A2YP
DR   Coriell; GM28010
DR   Wikidata; Q105507431
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28010).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg192Trp (c.574C>T); ClinVar=VCV000215235; Zygosity=Heterozygous (Coriell=GM28010).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM28011
AC   CVCL_A2YQ
DR   Coriell; GM28011
DR   Wikidata; Q105507435
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28011).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM28012
AC   CVCL_A2YR
DR   Coriell; GM28012
DR   Wikidata; Q105507438
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28012).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg192Profs*8 (c.574_575insCTGC); ClinVar=VCV000419973; Zygosity=Heterozygous (Coriell=GM28012).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM28013
AC   CVCL_A2YS
DR   Coriell; GM28013
DR   Wikidata; Q105507442
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Ile143Val (m.8953A>G); ClinVar=VCV000693034; Zygosity=Homoplasmic (Coriell=GM28013).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Gln251Ter (c.751C>T); ClinVar=VCV000012762; Zygosity=Heterozygous (Coriell=GM28013).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Thr266Asnfs*26 (c.796dupA); ClinVar=VCV000524066; Zygosity=Heterozygous (Coriell=GM28013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM28014
AC   CVCL_A2YT
DR   Coriell; GM28014
DR   Wikidata; Q105507447
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Ile143Val (m.8953A>G); ClinVar=VCV000693034; Zygosity=Unspecified (Coriell=GM28014).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Thr266Asnfs*26 (c.796dupA); ClinVar=VCV000524066; Zygosity=Heterozygous (Coriell=GM28014).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM28016
AC   CVCL_A2YU
DR   Coriell; GM28016
DR   Wikidata; Q105507450
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Gly124Arg (c.370G>A); dbSNP=rs782033035; Zygosity=Heterozygous (Coriell=GM28016).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; c.751+1G>A; ClinVar=VCV002081237; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28016).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM28017
AC   CVCL_A2YV
DR   Coriell; GM28017
DR   Wikidata; Q105507453
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; c.751+1G>A; ClinVar=VCV002081237; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28017).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   GM28019
AC   CVCL_A5MA
DR   Coriell; GM28019
DR   Wikidata; Q107115195
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28019).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28019).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28019).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C34807; Marfan syndrome
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28020
AC   CVCL_A5MB
DR   Coriell; GM28020
DR   Wikidata; Q107115196
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28020).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28020).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28020).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C34807; Marfan syndrome
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28021
AC   CVCL_A5MC
DR   Coriell; GM28021
DR   Wikidata; Q107115198
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28021).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28021).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28022
AC   CVCL_A5MD
DR   Coriell; GM28022
DR   Wikidata; Q107115199
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28022).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28023
AC   CVCL_A5ME
DR   Coriell; GM28023
DR   Wikidata; Q107115200
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28023).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28023).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28024
AC   CVCL_B0I0
DR   Coriell; GM28024
DR   Wikidata; Q108820296
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21308; ELOVL5; Simple; c.246+3891C>T (p.Gln102Ter, c.304C>T); ClinVar=VCV000691282; Zygosity=Heterozygous (Coriell=GM28024).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Met1_Ala5del (c-11_13delGGCCGGGTGCGATGGCGGCGGTGG) (c.-13_11del24); ClinVar=VCV000215241; Zygosity=Heterozygous (Coriell=GM28024).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28024).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28025
AC   CVCL_B0I1
DR   Coriell; GM28025
DR   Wikidata; Q108820297
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GM28026
AC   CVCL_A5MF
DR   Coriell; GM28026
DR   Wikidata; Q107115201
CC   Sequence variation: Mutation; HGNC; HGNC:6408; MAFB; Simple; p.Pro71Arg (c.212C>G); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28026).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178416; Multicentric carpotarsal osteolysis syndrome
DI   ORDO; Orphanet_2774; Multicentric carpo-tarsal osteolysis with or without nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   GM28028
AC   CVCL_C7M1
DR   Coriell; GM28028
DR   Wikidata; Q117704372
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe107del (c.318CTT[1]) (c.321_323delCTT); ClinVar=VCV000021448; Zygosity=Hemizygous (Coriell=GM28028).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28029
AC   CVCL_A5MG
DR   Coriell; GM28029
DR   Wikidata; Q107115202
CC   Population: Native North American; Cherokee, Caucasian and Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28029).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg230Ter (c.688C>T); ClinVar=VCV000280010; Zygosity=Heterozygous (Coriell=GM28029).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28030
AC   CVCL_A5MH
DR   Coriell; GM28030
DR   Wikidata; Q107115203
CC   Population: Caucasian; Polish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   GM28031
AC   CVCL_A5MI
DR   Coriell; GM28031
DR   Wikidata; Q107115204
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28031).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28031).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28032
AC   CVCL_A5MJ
DR   Coriell; GM28032
DR   Wikidata; Q107115205
CC   Population: Caucasian; Polish.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   GM28033
AC   CVCL_B0I2
DR   Coriell; GM28033
DR   Wikidata; Q108820298
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Trp278Ter (c.834G>A); ClinVar=VCV000928763; Zygosity=Heterozygous (Coriell=GM28033).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28033).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28034
AC   CVCL_B0I3
DR   Coriell; GM28034
DR   Wikidata; Q108820299
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Trp278Ter (c.834G>A); ClinVar=VCV000928763; Zygosity=Heterozygous (Coriell=GM28034).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28034).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28035
AC   CVCL_B0I4
DR   Coriell; GM28035
DR   Wikidata; Q108820300
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GM28036
AC   CVCL_B0I5
DR   Coriell; GM28036
DR   Wikidata; Q108820301
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GM28037
AC   CVCL_A7ND
DR   Coriell; GM28037
DR   Wikidata; Q107115206
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28037).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Tyr117Ter (c.351T>G); Zygosity=Heterozygous (Coriell=GM28037).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   GM28047
AC   CVCL_B5LB
DR   Coriell; GM28047
DR   Wikidata; Q111733239
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe107del (c.318CTT[1]) (c.321_323delCTT); ClinVar=VCV000021448; Zygosity=Hemizygous (Coriell=GM28047).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   GM28048
AC   CVCL_C7M2
DR   Coriell; GM28048
DR   Wikidata; Q117704373
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe107del (c.318CTT[1]) (c.321_323delCTT); ClinVar=VCV000021448; Zygosity=Heterozygous (Coriell=GM28048).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28053
AC   CVCL_B0II
DR   Coriell; GM28053
DR   Wikidata; Q108820302
CC   Population: Caucasian; Russian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28053).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 9
//
ID   GM28054
AC   CVCL_B0IJ
DR   Coriell; GM28054
DR   Wikidata; Q108820303
CC   Population: Caucasian; Russian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Gly195Asp (c.584G>A); ClinVar=VCV002413125; Zygosity=Heterozygous (Coriell=GM28054).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28054).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 9
//
ID   GM28061
AC   CVCL_C7M3
DR   Coriell; GM28061
DR   Wikidata; Q117704374
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe107del (c.318CTT[1]) (c.321_323delCTT); ClinVar=VCV000021448; Zygosity=Hemizygous (Coriell=GM28061).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28063
AC   CVCL_B3SE
DR   Coriell; GM28063
DR   Wikidata; Q110432830
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Asn178Glufs*9 (c.532_535delAATA); ClinVar=VCV000372719; Zygosity=Heterozygous (Coriell=GM28063).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   GM28070
AC   CVCL_C7M4
DR   Coriell; GM28070
DR   Wikidata; Q117704375
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Lys109Lys (c.327G>A); ClinVar=VCV000021065; Zygosity=Heterozygous; Note=Affects splicing (Coriell=GM28070).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Trp174Ter (c.522G>A); ClinVar=VCV000205584; Zygosity=Heterozygous (Coriell=GM28070).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7M5 ! GM28096
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28072
AC   CVCL_D6X2
DR   Coriell; GM28072
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Homozygous (Coriell=GM28072).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28073
AC   CVCL_D6X3
DR   Coriell; GM28073
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28073).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28074
AC   CVCL_D2ZZ
DR   Coriell; GM28074
DR   Wikidata; Q127380911
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14631; ADAMTSL2; Simple; p.Arg61His (c.182G>A); ClinVar=VCV003767152; Zygosity=Heterozygous (Coriell=GM28074).
CC   Sequence variation: Mutation; HGNC; HGNC:14631; ADAMTSL2; Simple; p.Ala165Thr (c.493G>A); ClinVar=VCV000524194; Zygosity=Heterozygous (Coriell=GM28074).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202607; Geleophysic dysplasia 1
DI   ORDO; Orphanet_2623; Geleophysic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM28075
AC   CVCL_C0LF
DR   Coriell; GM28075
DR   Wikidata; Q112929592
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18060; ARX; Simple; p.Ala151_Ala155dup (c.441_455dup15); ClinVar=VCV000818170; Zygosity=Hemizygous (Coriell=GM28075).
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Asn336del (c.1000AAC[2]) (c.1006_1008delAAC); ClinVar=VCV000265402; Zygosity=Hemizygous (Coriell=GM28075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28076
AC   CVCL_C0LG
DR   Coriell; GM28076
DR   Wikidata; Q112929594
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28077
AC   CVCL_B0IK
DR   Coriell; GM28077
DR   Wikidata; Q108820304
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Tyr133Asp (c.397T>G); Zygosity=Heterozygous (Coriell=GM28077).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28079
AC   CVCL_B0IM
DR   Coriell; GM28079
DR   Wikidata; Q108820305
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg192Profs*8 (c.574_575insCTGC); ClinVar=VCV000419973; Zygosity=Heterozygous (Coriell=GM28079).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28090
AC   CVCL_B0IN
DR   Coriell; GM28090
DR   Wikidata; Q108820306
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Homozygous (Coriell=GM28090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28091
AC   CVCL_B0IP
DR   Coriell; GM28091
DR   Wikidata; Q108820307
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28091).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28092
AC   CVCL_B0IQ
DR   Coriell; GM28092
DR   Wikidata; Q108820308
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28092).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28095
AC   CVCL_B0IR
DR   Coriell; GM28095
DR   Wikidata; Q108820309
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Tyr133Asp (c.397T>G); Zygosity=Heterozygous (Coriell=GM28095).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg192Profs*8 (c.574_575insCTGC); ClinVar=VCV000419973; Zygosity=Heterozygous (Coriell=GM28095).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28096
AC   CVCL_C7M5
DR   Coriell; GM28096
DR   Wikidata; Q117704376
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Lys109Lys (c.327G>A); ClinVar=VCV000021065; Zygosity=Heterozygous; Note=Affects splicing (Coriell=GM28096).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Trp174Ter (c.522G>A); ClinVar=VCV000205584; Zygosity=Heterozygous (Coriell=GM28096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7M4 ! GM28070
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28098
AC   CVCL_C7M6
DR   Coriell; GM28098
DR   Wikidata; Q117704377
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Unexplicit; Ex4-13del; Zygosity=Hemizygous (Coriell=GM28098).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7M7 ! GM28099
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28099
AC   CVCL_C7M7
DR   Coriell; GM28099
DR   Wikidata; Q117704379
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Unexplicit; Ex4-13del; Zygosity=Hemizygous (Coriell=GM28099).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7M6 ! GM28098
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28102
AC   CVCL_B0IL
DR   Coriell; GM28102
DR   Wikidata; Q108820310
CC   Population: Caucasian; Norwegian.
CC   Sequence variation: Mutation; HGNC; HGNC:11042; SLC6A1; Simple; p.Asp52Asn (c.154G>A); ClinVar=VCV001804228; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28102).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C191771; SLC6A1-associated myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   GM28206
AC   CVCL_B0IA
DR   Coriell; GM28206
DR   Wikidata; Q108820311
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous (Coriell=GM28206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0IB ! GM28210
OI   CVCL_D6Y3 ! GM28584
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28208
AC   CVCL_B0I8
DR   Coriell; GM28208
DR   Wikidata; Q108820312
CC   Population: Bangladeshi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0I9 ! GM28211
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   GM28209
AC   CVCL_B0I6
DR   Coriell; GM28209
DR   Wikidata; Q108820313
CC   Population: Bangladeshi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0I7 ! GM28212
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   GM28210
AC   CVCL_B0IB
DR   Coriell; GM28210
DR   Wikidata; Q108820314
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous (Coriell=GM28210).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0IA ! GM28206
OI   CVCL_D6Y3 ! GM28584
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   GM28211
AC   CVCL_B0I9
DR   Coriell; GM28211
DR   Wikidata; Q108820315
CC   Population: Bangladeshi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0I8 ! GM28208
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GM28212
AC   CVCL_B0I7
DR   Coriell; GM28212
DR   Wikidata; Q108820316
CC   Population: Bangladeshi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0I6 ! GM28209
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GM28213
AC   CVCL_B0IC
DR   Coriell; GM28213
DR   Wikidata; Q108820317
CC   Population: Caucasian; Romanian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Unexplicit; Ex10-11del; Zygosity=Mosaic (Coriell=GM28213).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28214
AC   CVCL_B0ID
DR   Coriell; GM28214
DR   Wikidata; Q108820318
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg75Ter (c.223C>T); ClinVar=VCV000048672; Zygosity=Heterozygous (Coriell=GM28214).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   GM28217
AC   CVCL_D3AC
DR   Coriell; GM28217
DR   Wikidata; Q127380912
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ala1643Glu (c.4928C>A) (p.Ala1632Glu, c.4895C>A); ClinVar=VCV000245903; Zygosity=Heterozygous (Coriell=GM28217).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125385; Paroxysmal extreme pain disorder
DI   ORDO; Orphanet_46348; Paroxysmal extreme pain disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28219
AC   CVCL_D6X4
DR   Coriell; GM28219
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Ser251del (c.746CCT[1]) (c.752_754delCCT); ClinVar=VCV000418542; Zygosity=Hemizygous (Coriell=GM28219).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6X5 ! GM28231
SX   Male
AG   2Y8M
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28221
AC   CVCL_D6X6
DR   Coriell; GM28221
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Ser251del (c.746CCT[1]) (c.752_754delCCT); ClinVar=VCV000418542; Zygosity=Heterozygous (Coriell=GM28221).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6X7 ! GM28232
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28225
AC   CVCL_D3AA
DR   Coriell; GM28225
DR   Wikidata; Q127380913
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30778; GATAD2B; Simple; p.Ser135Argfs*17 (c.405_406delTCinsG); Zygosity=Heterozygous (Coriell=GM28225).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202606; Intellectual developmental disorder, autosomal dominant 18
DI   ORDO; Orphanet_363686; Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM28231
AC   CVCL_D6X5
DR   Coriell; GM28231
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Ser251del (c.746CCT[1]) (c.752_754delCCT); ClinVar=VCV000418542; Zygosity=Hemizygous (Coriell=GM28231).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6X4 ! GM28219
SX   Male
AG   2Y9M
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28232
AC   CVCL_D6X7
DR   Coriell; GM28232
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Ser251del (c.746CCT[1]) (c.752_754delCCT); ClinVar=VCV000418542; Zygosity=Heterozygous (Coriell=GM28232).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6X6 ! GM28221
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28233
AC   CVCL_D6X8
DR   Coriell; GM28233
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28234
AC   CVCL_B0IE
DR   Coriell; GM28234
DR   Wikidata; Q108820319
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Arg468Ter (c.1402C>T); ClinVar=VCV000565700; Zygosity=Homozygous (Coriell=GM28234).
CC   Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; p.Arg625Thr (c.1874G>C); ClinVar=VCV000964423; Zygosity=Heterozygous (Coriell=GM28234).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 8
//
ID   GM28249
AC   CVCL_B0IF
SY   GM28249*B
DR   Coriell; GM28249
DR   Wikidata; Q108820320
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000126510; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P14 ! GM00059
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   GM28252
AC   CVCL_B0IG
SY   GM28252*B
DR   Coriell; GM28252
DR   Wikidata; Q108820321
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; c.448+64T>C (IVS3+64T>C); ClinVar=VCV000683189; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1K24 ! GM05148
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   GM28257
AC   CVCL_B0IH
DR   Coriell; GM28257
DR   Wikidata; Q108820322
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Heterozygous (Coriell=GM28257).
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; c.173+1G>A; ClinVar=VCV000554440; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28257).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   GM28259
AC   CVCL_C0MD
SY   GM28259*B
DR   Coriell; GM28259
DR   Wikidata; Q112929595
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (Coriell=GM28259).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (Coriell=GM28259).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U401 ! GM13204
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28267
AC   CVCL_D3A9
DR   Coriell; GM28267
DR   Wikidata; Q127380914
CC   Population: Caucasian; Danish/German.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple; p.Arg334Trp (c.1000C>T) (p.Arg307Trp, c.919C>T); ClinVar=VCV000004696; Zygosity=Heterozygous (Coriell=GM28267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28268
AC   CVCL_D6X9
DR   Coriell; GM28268
CC   Population: Caucasian; Danish/German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28283
AC   CVCL_B5LG
DR   Coriell; GM28283
DR   Wikidata; Q111733240
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM28283).
CC   Donor information: At sampling donor was not affected with inclusion myopathy but possess the mutation affecting his brother, mother and uncle.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_206662; Inclusion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH28 ! GM26099
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   GM28284
AC   CVCL_C0LH
DR   Coriell; GM28284
DR   Wikidata; Q112929596
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Gly163Ter (c.487G>T); ClinVar=VCV000504345; Zygosity=Heterozygous (Coriell=GM28284).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28285
AC   CVCL_C0LI
DR   Coriell; GM28285
DR   Wikidata; Q112929597
CC   Population: Asian and Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Gln18Ter (c.52C>T); ClinVar=VCV000620358; Zygosity=Heterozygous (Coriell=GM28285).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LJ ! GM28286
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28286
AC   CVCL_C0LJ
DR   Coriell; GM28286
DR   Wikidata; Q112929598
CC   Population: Asian and Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Gln18Ter (c.52C>T); ClinVar=VCV000620358; Zygosity=Heterozygous (Coriell=GM28286).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LI ! GM28285
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28288
AC   CVCL_D2ZQ
DR   Coriell; GM28288
DR   Wikidata; Q127380915
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gln114His (c.342G>C); ClinVar=VCV000940774; Zygosity=Hemizygous (Coriell=GM28288).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZR ! GM28309
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28289
AC   CVCL_D3AB
DR   Coriell; GM28289
DR   Wikidata; Q127380916
CC   Population: Caucasian; Danish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM28293
AC   CVCL_D6XA
DR   Coriell; GM28293
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gly421Alafs*35 (c.1260_1281del); ClinVar=VCV000987004; Zygosity=Mosaic; Note=Less than 10% of the cells (Coriell=GM28293).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XB ! GM28295
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28294
AC   CVCL_D6XC
DR   Coriell; GM28294
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gly421Alafs*35 (c.1260_1281del); ClinVar=VCV000987004; Zygosity=Hemizygous (Coriell=GM28294).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28295
AC   CVCL_D6XB
DR   Coriell; GM28295
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gly421Alafs*35 (c.1260_1281del); ClinVar=VCV000987004; Zygosity=Mosaic; Note=Less than 10% of the cells (Coriell=GM28295).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XA ! GM28293
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28299
AC   CVCL_B5LC
DR   Coriell; GM28299
DR   Wikidata; Q111733241
CC   Population: Jewish; Ashkenazi and Jewish; Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly237Valfs*11 (c.710delG) (p.Gly249Valfs*11, c.746delG); ClinVar=VCV000011846; Zygosity=Heterozygous (Coriell=GM28299).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5LD ! GM28300
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   GM28300
AC   CVCL_B5LD
DR   Coriell; GM28300
DR   Wikidata; Q111733242
CC   Population: Jewish; Ashkenazi and Jewish; Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly237Valfs*11 (c.710delG) (p.Gly249Valfs*11, c.746delG); ClinVar=VCV000011846; Zygosity=Heterozygous (Coriell=GM28300).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5LC ! GM28299
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   GM28301
AC   CVCL_B5LE
DR   Coriell; GM28301
DR   Wikidata; Q111733243
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   GM28302
AC   CVCL_B5LF
DR   Coriell; GM28302
DR   Wikidata; Q111733244
CC   Population: Jewish; Ashkenazi and Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   GM28303
AC   CVCL_D6XD
DR   Coriell; GM28303
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple; p.Glu383Gly (c.1148A>G) (p.Glu356Gly, c.1067A>G); ClinVar=VCV000097822; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XE ! GM28304
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28304
AC   CVCL_D6XE
DR   Coriell; GM28304
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:5331; NOD2; Simple; p.Glu383Gly (c.1148A>G) (p.Glu356Gly, c.1067A>G); ClinVar=VCV000097822; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28304).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116794; Blau syndrome
DI   ORDO; Orphanet_90340; Blau syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XD ! GM28303
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28305
AC   CVCL_D6XF
DR   Coriell; GM28305
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XG ! GM28306
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28306
AC   CVCL_D6XG
DR   Coriell; GM28306
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XF ! GM28305
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28307
AC   CVCL_D6XH
DR   Coriell; GM28307
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XI ! GM28308
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28308
AC   CVCL_D6XI
DR   Coriell; GM28308
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XH ! GM28307
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28309
AC   CVCL_D2ZR
DR   Coriell; GM28309
DR   Wikidata; Q127380917
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gln114His (c.342G>C); ClinVar=VCV000940774; Zygosity=Hemizygous (Coriell=GM28309).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZQ ! GM28288
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28311
AC   CVCL_C0LP
DR   Coriell; GM28311
DR   Wikidata; Q112929599
CC   Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Leu573Phe (c.1719A>T); ClinVar=VCV000811288; Zygosity=Heterozygous (Coriell=GM28311).
CC   Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Glu3077Lys (c.9229G>A); ClinVar=VCV002730303; Zygosity=Heterozygous (Coriell=GM28311).
CC   Sequence variation: Mutation; HGNC; HGNC:19440; SBDS; Simple; p.Asn14Ser (c.41A>G); ClinVar=VCV000427147; Zygosity=Heterozygous (Coriell=GM28311).
CC   Sequence variation: Mutation; HGNC; HGNC:19440; SBDS; Simple; c.258+2T>C (IVS2+2T>C); ClinVar=VCV000003196; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28311).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61235; Shwachman-Diamond syndrome
DI   ORDO; Orphanet_811; Shwachman-Diamond syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   GM28322
AC   CVCL_C7LU
DR   Coriell; GM28322
DR   Wikidata; Q117704380
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28328
AC   CVCL_D6XJ
DR   Coriell; GM28328
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:19088; ASH1L; Simple; p.Ser1635Cysfs*18 (c.4902_4903del); ClinVar=VCV000962517; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28328).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206522; Intellectual developmental disorder, autosomal dominant 52
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28329
AC   CVCL_D6XK
DR   Coriell; GM28329
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28330
AC   CVCL_D6XL
DR   Coriell; GM28330
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28332
AC   CVCL_C0LM
DR   Coriell; GM28332
DR   Wikidata; Q112929600
CC   Population: Caucasian; Finnish/German.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Ala79Thr (c.235G>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28332).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LN ! GM28333
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28333
AC   CVCL_C0LN
DR   Coriell; GM28333
DR   Wikidata; Q112929601
CC   Population: Caucasian; Finnish/German.
CC   Sequence variation: Mutation; HGNC; HGNC:28912; WDR45; Simple; p.Ala79Thr (c.235G>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28333).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LM ! GM28332
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28344
AC   CVCL_C7M8
DR   Coriell; GM28344
DR   Wikidata; Q117704381
CC   Population: Caucasian; Dutch/Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7M9 ! GM28345
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28345
AC   CVCL_C7M9
DR   Coriell; GM28345
DR   Wikidata; Q117704382
CC   Population: Caucasian; Dutch/Spanish.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7M8 ! GM28344
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28350
AC   CVCL_C0LQ
DR   Coriell; GM28350
DR   Wikidata; Q112929602
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:17300; TAF8; Simple; p.Thr240Argfs*7 (c.719_720delAC); ClinVar=VCV001686246; Zygosity=Heterozygous (Coriell=GM28350).
CC   Sequence variation: Mutation; HGNC; HGNC:17300; TAF8; Simple; p.Asn269Thrfs*29 (c.806_809delACAC); ClinVar=VCV001686247; Zygosity=Heterozygous (Coriell=GM28350).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192636; Neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   GM28358
AC   CVCL_C7MD
DR   Coriell; GM28358
DR   Wikidata; Q117704383
CC   Population: Caucasian; Dutch.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7ME ! GM28359
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28359
AC   CVCL_C7ME
DR   Coriell; GM28359
DR   Wikidata; Q117704384
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7MD ! GM28358
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28360
AC   CVCL_C7MF
DR   Coriell; GM28360
DR   Wikidata; Q117704386
CC   Population: Caucasian; Dutch/Spanish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7MG ! GM28361
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28361
AC   CVCL_C7MG
DR   Coriell; GM28361
DR   Wikidata; Q117704387
CC   Population: Caucasian; Dutch/Spanish.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7MF ! GM28360
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28362
AC   CVCL_C7MA
DR   Coriell; GM28362
DR   Wikidata; Q117704388
CC   Population: Caucasian; Dutch/Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:24931; ZC4H2; Unexplicit; 244kb microdeletion; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28362).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198578; Female-restricted Wieacker-Wolff syndrome
DI   ORDO; Orphanet_3454; Wieacker-Wolff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7MB ! GM28363
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28363
AC   CVCL_C7MB
DR   Coriell; GM28363
DR   Wikidata; Q117704389
CC   Population: Caucasian; Dutch/Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:24931; ZC4H2; Unexplicit; 244kb microdeletion; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28363).
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198578; Female-restricted Wieacker-Wolff syndrome
DI   ORDO; Orphanet_3454; Wieacker-Wolff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7MA ! GM28362
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28364
AC   CVCL_C0LR
DR   Coriell; GM28364
DR   Wikidata; Q112929603
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Arg1666Pro (c.4997G>C); ClinVar=VCV000638582; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28364).
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Asn578Ilefs*47 (c.1733delT); ClinVar=VCV002888527; Zygosity=Heterozygous (Coriell=GM28364).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 7
//
ID   GM28365
AC   CVCL_C0LS
DR   Coriell; GM28365
DR   Wikidata; Q112929604
CC   Population: Caucasian; Hungarian/Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28366
AC   CVCL_C0LT
DR   Coriell; GM28366
DR   Wikidata; Q112929605
CC   Population: Caucasian; English/Scottish.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28368
AC   CVCL_C0LU
DR   Coriell; GM28368
DR   Wikidata; Q112929606
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1349; SAMD9L; Simple; p.Arg986His (c.2957G>A); ClinVar=VCV001190635; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28368).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176909; Ataxia-pancytopenia syndrome
DI   ORDO; Orphanet_2585; Ataxia-pancytopenia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28374
AC   CVCL_C0LV
SY   GM28374*B
DR   Coriell; GM28374
DR   Wikidata; Q112929607
CC   Population: Hispanic.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y574 ! GM09154
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28378
AC   CVCL_C7MH
DR   Coriell; GM28378
DR   Wikidata; Q117704390
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Gln1673Serfs*43 (c.5015dupG) (p.Gln1674Serfs*43, c.5018dupG); ClinVar=VCV001679533; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28378).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28379
AC   CVCL_D6XM
DR   Coriell; GM28379
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Val78Glu (c.233T>A); ClinVar=VCV002683728; Zygosity=Heterozygous (Coriell=GM28379).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Arg105Glyfs*26 (c.299_311dup13); ClinVar=VCV000008302; Zygosity=Heterozygous (Coriell=GM28379).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3A1 ! GM28756
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28386
AC   CVCL_C0LW
DR   Coriell; GM28386
DR   Wikidata; Q112929608
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg576Ter (c.1726C>T) (p.Arg572Ter, c.1714C>T); ClinVar=VCV000488988; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28386).
CC   Derived from site: In situ; Labioscrotal fold, skin; UBERON=UBERON_8480029.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LX ! GM28387
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28387
AC   CVCL_C0LX
DR   Coriell; GM28387
DR   Wikidata; Q112929609
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg576Ter (c.1726C>T) (p.Arg572Ter, c.1714C>T); ClinVar=VCV000488988; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28387).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LW ! GM28386
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28388
AC   CVCL_C0LY
DR   Coriell; GM28388
DR   Wikidata; Q112929610
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LZ ! GM28389
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28389
AC   CVCL_C0LZ
DR   Coriell; GM28389
DR   Wikidata; Q112929611
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LY ! GM28388
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28390
AC   CVCL_C0M0
DR   Coriell; GM28390
DR   Wikidata; Q112929612
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0M1 ! GM28391
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28391
AC   CVCL_C0M1
DR   Coriell; GM28391
DR   Wikidata; Q112929613
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0M0 ! GM28390
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28392
AC   CVCL_C0M2
DR   Coriell; GM28392
DR   Wikidata; Q112929614
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg2085Cys (c.6253C>T); ClinVar=VCV001180765; Zygosity=Hemizygous (Coriell=GM28392).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 7
//
ID   GM28395
AC   CVCL_C0M3
DR   Coriell; GM28395
DR   Wikidata; Q112929615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28396
AC   CVCL_D6X0
DR   Coriell; GM28396
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Trp390Ter (c.1169C>G); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28396).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Lys285Asn (c.855G>T); ClinVar=VCV000003621; Zygosity=Heterozygous (Coriell=GM28396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_352; Galactosemia
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28399
AC   CVCL_C7MI
SY   GM28399*B
DR   Coriell; GM28399
DR   Wikidata; Q117704391
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous (Coriell=GM28399).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AA43 ! GM04959
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28404
AC   CVCL_C0M4
SY   GM28404*B
DR   Coriell; GM28404
DR   Wikidata; Q112929616
CC   Population: Native Central American; Pima.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W93 ! GM03234
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28411
AC   CVCL_D6XN
DR   Coriell; GM28411
CC   Population: Caucasian; English/German.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A); ClinVar=VCV000008505; Zygosity=Heterozygous (Coriell=GM28411).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28466
AC   CVCL_C0LK
DR   Coriell; GM28466
DR   Wikidata; Q112929617
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gly67Asp (c.200G>A); Zygosity=Hemizygous (Coriell=GM28466).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LL ! GM28467
SX   Male
AG   2Y10M
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28467
AC   CVCL_C0LL
DR   Coriell; GM28467
DR   Wikidata; Q112929618
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Gly67Asp (c.200G>A); Zygosity=Hemizygous (Coriell=GM28467).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0LK ! GM28466
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28469
AC   CVCL_C0M5
DR   Coriell; GM28469
DR   Wikidata; Q112929619
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28471
AC   CVCL_C0M6
DR   Coriell; GM28471
DR   Wikidata; Q112929620
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   GM28472
AC   CVCL_D6XP
DR   Coriell; GM28472
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Cys225Arg (c.673T>C); ClinVar=VCV001691714; Zygosity=Homozygous (Coriell=GM28472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174218; Mitochondrial short-chain enoyl-CoA hydratase-1 deficiency
DI   ORDO; Orphanet_255241; Leigh syndrome with leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28473
AC   CVCL_D6XQ
DR   Coriell; GM28473
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Cys225Arg (c.673T>C); ClinVar=VCV001691714; Zygosity=Heterozygous (Coriell=GM28473).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28474
AC   CVCL_D6XR
DR   Coriell; GM28474
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Cys225Arg (c.673T>C); ClinVar=VCV001691714; Zygosity=Heterozygous (Coriell=GM28474).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28475
AC   CVCL_C7MJ
DR   Coriell; GM28475
DR   Wikidata; Q117704392
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:9081; PLOD1; Simple; p.Gly159Valfs*68 (c.476delG); Zygosity=Homozygous (Coriell=GM28475).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125700; Ehlers-Danlos syndrome, type VI
DI   ORDO; Orphanet_1900; Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28476
AC   CVCL_C7MK
DR   Coriell; GM28476
DR   Wikidata; Q117704393
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:9081; PLOD1; Simple; p.Gly159Valfs*68 (c.476delG); Zygosity=Heterozygous (from familial inference of GM28475).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   GM28477
AC   CVCL_C7ML
DR   Coriell; GM28477
DR   Wikidata; Q117704394
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:9081; PLOD1; Simple; p.Gly159Valfs*68 (c.476delG); Zygosity=Heterozygous (from familial inference of GM28475).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   GM28478
AC   CVCL_D3AD
DR   Coriell; GM28478
DR   Wikidata; Q127380918
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:11581; TBCD; Simple; p.Arg323Ter (c.967C>T); ClinVar=VCV000692021; Zygosity=Heterozygous (Coriell=GM28478).
CC   Sequence variation: Mutation; HGNC; HGNC:11581; TBCD; Simple; p.Thr1046Lys (c.3137C>A); ClinVar=VCV002504395; Zygosity=Heterozygous (Coriell=GM28478).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202602; Early-onset progressive encephalopathy with brain atrophy and thin corpus callosum
DI   ORDO; Orphanet_496641; Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28480
AC   CVCL_C7MM
SY   NLGIP-4001; NLGIP4001
DR   Coriell; GM28480
DR   Wikidata; Q117704395
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28481
AC   CVCL_C7MN
SY   NLGIP-4002; NLGIP4002
DR   Coriell; GM28481
DR   Wikidata; Q117704396
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28482
AC   CVCL_C7MP
SY   NLGIP-4004; NLGIP4004
DR   Coriell; GM28482
DR   Wikidata; Q117704397
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28483
AC   CVCL_C7MQ
SY   NLGIP-4005; NLGIP4005
DR   Coriell; GM28483
DR   Wikidata; Q117704398
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28484
AC   CVCL_C7MR
SY   NLGIP-4006; NLGIP4006
DR   Coriell; GM28484
DR   Wikidata; Q117704399
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28485
AC   CVCL_C7MS
SY   NLGIP-4007; NLGIP4007
DR   Coriell; GM28485
DR   Wikidata; Q117704400
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28487
AC   CVCL_C7MT
SY   NLGIP-4012; NLGIP4012
DR   Coriell; GM28487
DR   Wikidata; Q117704401
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28488
AC   CVCL_C7MU
SY   NLGIP-4014; NLGIP4014
DR   Coriell; GM28488
DR   Wikidata; Q117704402
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28489
AC   CVCL_C7MV
SY   NLGIP-4015; NLGIP4015
DR   Coriell; GM28489
DR   Wikidata; Q117704403
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28490
AC   CVCL_C7MW
SY   NLGIP-4016; NLGIP4016
DR   Coriell; GM28490
DR   Wikidata; Q117704404
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28492
AC   CVCL_C7MX
SY   NLGIP-4018; NLGIP4018
DR   Coriell; GM28492
DR   Wikidata; Q117704405
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28493
AC   CVCL_C7MY
SY   NLGIP-4019; NLGIP4019
DR   Coriell; GM28493
DR   Wikidata; Q117704406
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28494
AC   CVCL_C7MZ
SY   NLGIP-1620; NLGIP1620
DR   Coriell; GM28494
DR   Wikidata; Q117704407
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28495
AC   CVCL_C7N0
SY   NLGIP-1626; NLGIP1626
DR   Coriell; GM28495
DR   Wikidata; Q117704409
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28496
AC   CVCL_C7N1
SY   NLGIP-1627; NLGIP1627
DR   Coriell; GM28496
DR   Wikidata; Q117704410
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28497
AC   CVCL_C7N2
SY   NLGIP-4542; NLGIP4542
DR   Coriell; GM28497
DR   Wikidata; Q117704411
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28498
AC   CVCL_C7N3
SY   NLGIP-4610; NLGIP4610
DR   Coriell; GM28498
DR   Wikidata; Q117704412
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28499
AC   CVCL_C7N4
SY   NLGIP-4842; NLGIP4842
DR   Coriell; GM28499
DR   Wikidata; Q117704413
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28500
AC   CVCL_C7N5
SY   NLGIP-4844; NLGIP4844
DR   Coriell; GM28500
DR   Wikidata; Q117704414
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28501
AC   CVCL_C7N6
SY   NLGIP-4901; NLGIP4901
DR   Coriell; GM28501
DR   Wikidata; Q117704415
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28502
AC   CVCL_JB06
SY   NLGIP-4902; NLGIP4902
DR   Coriell; GM28502
DR   Wikidata; Q54930749
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   GM28503
AC   CVCL_C7N7
SY   NLGIP-4903; NLGIP4903
DR   Coriell; GM28503
DR   Wikidata; Q117704416
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28504
AC   CVCL_JB07
SY   NLGIP-4904; NLGIP4904
DR   Coriell; GM28504
DR   Wikidata; Q54930750
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   GM28505
AC   CVCL_C7N8
SY   NLGIP-4905; NLGIP4905
DR   Coriell; GM28505
DR   Wikidata; Q117704417
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28506
AC   CVCL_C7N9
SY   NLGIP-4907; NLGIP4907
DR   Coriell; GM28506
DR   Wikidata; Q117704418
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28507
AC   CVCL_C7NA
SY   NLGIP-4908; NLGIP4908
DR   Coriell; GM28507
DR   Wikidata; Q117704419
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28508
AC   CVCL_JB08
SY   NLGIP-4911; NLGIP4911
DR   Coriell; GM28508
DR   Wikidata; Q54930751
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   GM28509
AC   CVCL_JB09
SY   NLGIP-4912; NLGIP4912
DR   Coriell; GM28509
DR   Wikidata; Q54930752
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   GM28510
AC   CVCL_C7NM
SY   NLGIP-4917; NLGIP4917
DR   Coriell; GM28510
DR   Wikidata; Q117704420
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28511
AC   CVCL_JB10
SY   NLGIP-4918; NLGIP4918
DR   Coriell; GM28511
DR   Wikidata; Q54930753
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   GM28512
AC   CVCL_JB11
SY   NLGIP-4919; NLGIP4919
DR   Coriell; GM28512
DR   Wikidata; Q54930754
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   GM28513
AC   CVCL_C7NN
SY   NLGIP-4920; NLGIP4920
DR   Coriell; GM28513
DR   Wikidata; Q117704421
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28514
AC   CVCL_C7NP
SY   NLGIP-4273; NLGIP4273
DR   Coriell; GM28514
DR   Wikidata; Q117704423
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28515
AC   CVCL_C7NQ
SY   NLGIP-4312; NLGIP4312
DR   Coriell; GM28515
DR   Wikidata; Q117704424
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28517
AC   CVCL_C7NR
SY   NLGIP-4640; NLGIP4640
DR   Coriell; GM28517
DR   Wikidata; Q117704425
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28518
AC   CVCL_C7NS
SY   NLGIP-4811; NLGIP4811
DR   Coriell; GM28518
DR   Wikidata; Q117704426
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28519
AC   CVCL_C7NT
SY   NLGIP-5172; NLGIP5172
DR   Coriell; GM28519
DR   Wikidata; Q117704427
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28520
AC   CVCL_C7NU
SY   NLGIP-5173; NLGIP5173
DR   Coriell; GM28520
DR   Wikidata; Q117704428
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28521
AC   CVCL_C7NV
SY   NLGIP-5203; NLGIP5203
DR   Coriell; GM28521
DR   Wikidata; Q117704429
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28524
AC   CVCL_C7NW
SY   NLGIP-5536; NLGIP5536
DR   Coriell; GM28524
DR   Wikidata; Q117704431
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28525
AC   CVCL_C7NX
SY   NLGIP-1476; NLGIP1476
DR   Coriell; GM28525
DR   Wikidata; Q117704432
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28526
AC   CVCL_C7NY
SY   NLGIP-1478; NLGIP1478
DR   Coriell; GM28526
DR   Wikidata; Q117704433
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28527
AC   CVCL_C7NZ
SY   NLGIP-1479; NLGIP1479
DR   Coriell; GM28527
DR   Wikidata; Q117704434
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28528
AC   CVCL_C7P0
SY   NLGIP-1480; NLGIP1480
DR   Coriell; GM28528
DR   Wikidata; Q117704435
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28529
AC   CVCL_C7P1
SY   NLGIP-1481; NLGIP1481
DR   Coriell; GM28529
DR   Wikidata; Q117704436
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28531
AC   CVCL_D6XS
DR   Coriell; GM28531
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11752; TFE3; Simple; p.Val114Asp (c.341T>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28531).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206529; X-linked syndromic intellectual developmental disorder with pigmentary mosaicism and coarse facies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28532
AC   CVCL_C0M7
DR   Coriell; GM28532
DR   Wikidata; Q112929621
CC   Population: African American and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ile256Asn (c.767T>A); ClinVar=VCV000187883; Zygosity=Heterozygous (Coriell=GM28532).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Trp583Ter (c.1748G>A); ClinVar=VCV000998376; Zygosity=Heterozygous (Coriell=GM28532).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28543
AC   CVCL_D3AE
DR   Coriell; GM28543
DR   Wikidata; Q127380919
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11581; TBCD; Simple; p.Arg323Ter (c.967C>T); ClinVar=VCV000692021; Zygosity=Heterozygous (Coriell=GM28543).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28544
AC   CVCL_C0M8
DR   Coriell; GM28544
DR   Wikidata; Q112929622
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Val1392Met (c.4174G>A); ClinVar=VCV000195935; Zygosity=Mosaic (Coriell=GM28544).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28545
AC   CVCL_C0M9
DR   Coriell; GM28545
DR   Wikidata; Q112929623
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Val1392Met (c.4174G>A); ClinVar=VCV000195935; Zygosity=Heterozygous (Coriell=GM28545).
CC   Sequence variation: Mutation; HGNC; HGNC:7470; MT-RNR1; Simple; m.963C>T; Zygosity=Homoplasmic (Coriell=GM28545).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188142; Developmental and epileptic encephalopathy 42
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28546
AC   CVCL_C0MA
DR   Coriell; GM28546
DR   Wikidata; Q112929624
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7470; MT-RNR1; Simple; m.963C>T; Zygosity=Homoplasmic (Coriell=GM28546).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GM28550
AC   CVCL_D6XT
DR   Coriell; GM28550
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; c.3951+2T>C; ClinVar=VCV000537819; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28550).
CC   Sequence variation: Mutation; HGNC; HGNC:24931; ZC4H2; Simple; p.Glu42Ter (c.124G>T); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28550).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198578; Female-restricted Wieacker-Wolff syndrome
DI   ORDO; Orphanet_3454; Wieacker-Wolff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XU ! GM28551
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28551
AC   CVCL_D6XU
DR   Coriell; GM28551
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; c.3951+2T>C; ClinVar=VCV000537819; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28551).
CC   Sequence variation: Mutation; HGNC; HGNC:24931; ZC4H2; Simple; p.Glu42Ter (c.124G>T); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28551).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198578; Female-restricted Wieacker-Wolff syndrome
DI   ORDO; Orphanet_3454; Wieacker-Wolff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XT ! GM28550
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28562
AC   CVCL_D6XV
DR   Coriell; GM28562
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28569
AC   CVCL_D6XX
DR   Coriell; GM28569
CC   Population: Indian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28570
AC   CVCL_D6XY
DR   Coriell; GM28570
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:15766; ADNP; Simple; p.Ser738Phefs*6 (c.2212dupT); ClinVar=VCV001804918; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28570).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C160662; Intellectual developmental disorder, autosomal dominant 28
DI   ORDO; Orphanet_404448; ADNP syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XZ ! GM28572
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28572
AC   CVCL_D6XZ
DR   Coriell; GM28572
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:15766; ADNP; Simple; p.Ser738Phefs*6 (c.2212dupT); ClinVar=VCV001804918; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28572).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C160662; Intellectual developmental disorder, autosomal dominant 28
DI   ORDO; Orphanet_404448; ADNP syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XY ! GM28570
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28573
AC   CVCL_D6Y0
DR   Coriell; GM28573
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:20093; ADSS1; Simple; p.Asp261Asn (c.781G>A) (p.Asp304Asn, c.910G>A); ClinVar=VCV000243025; Zygosity=Homozygous (Coriell=GM28573).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206521; Distal myopathy-5
DI   ORDO; Orphanet_482601; Adenylosuccinate synthetase-like 1-related distal myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28574
AC   CVCL_D2ZG
SY   GM28574*E
DR   Coriell; GM28574
DR   Wikidata; Q127380920
CC   Population: Caucasian; French and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gln86Profs*35 (c.256dupC); ClinVar=VCV000189613; Zygosity=Heterozygous (Coriell=GM28574).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT84 ! GM27246
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28575
AC   CVCL_C7LV
SY   GM28575*C
DR   Coriell; GM28575
DR   Wikidata; Q117704437
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gly169Glyfs*23 (c.507del); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28575).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Arg303His (c.908G>A); ClinVar=VCV000284411; Zygosity=Heterozygous (Coriell=GM28575).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TS ! GM27973
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   GM28576
AC   CVCL_C7LW
SY   GM28576*C
DR   Coriell; GM28576
DR   Wikidata; Q117704438
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Trp308Ter (c.924G>A); ClinVar=VCV000013871; Zygosity=Unspecified; Note=De novo mutation (Coriell=GM28576).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT81 ! GM27190
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28577
AC   CVCL_C7LX
SY   GM28577*C
DR   Coriell; GM28577
DR   Wikidata; Q117704439
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:13830; CNTNAP2; Simple; p.Ser269Asn (c.806G>A); ClinVar=VCV000373714; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3791; FOLR1; Simple; c.493+2T>C (IVS4+2T>C); ClinVar=VCV000095750; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Gly224Ser (c.670G>A); ClinVar=VCV000167092; Zygosity=Heterozygous (Coriell=GM28577).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Pro8Thr (c.22C>A); ClinVar=VCV000205598; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WP04 ! GM27300
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28578
AC   CVCL_C7LY
SY   GM28578*C
DR   Coriell; GM28578
DR   Wikidata; Q117704440
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Ser326Glufs*129 (c.974_975insA); Zygosity=Heterozygous (Coriell=GM28578).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE51 ! GM27462
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28581
AC   CVCL_D6Y1
DR   Coriell; GM28581
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:20093; ADSS1; Simple; p.Asp261Asn (c.781G>A) (p.Asp304Asn, c.910G>A); ClinVar=VCV000243025; Zygosity=Heterozygous (Coriell=GM28581).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28582
AC   CVCL_D6Y2
DR   Coriell; GM28582
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:20093; ADSS1; Simple; p.Asp261Asn (c.781G>A) (p.Asp304Asn, c.910G>A); ClinVar=VCV000243025; Zygosity=Heterozygous (Coriell=GM28582).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6Z8 ! GM28895
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28584
AC   CVCL_D6Y3
DR   Coriell; GM28584
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous (Coriell=GM28584).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0IA ! GM28206
OI   CVCL_B0IB ! GM28210
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28589
AC   CVCL_C7LD
SY   GM28589*B
DR   Coriell; GM28589
DR   Wikidata; Q117704441
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:4175; GATM; Simple; p.Ala97Valfs*11 (c.484+1G>T); ClinVar=VCV000021299; Zygosity=Homozygous (Coriell=GM28589).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198575; Cerebral creatine deficiency syndrome 3
DI   ORDO; Orphanet_35704; L-arginine:glycine amidinotransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7LC ! GM27955
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28603
AC   CVCL_C7MC
SY   GM28603*B
DR   Coriell; GM28603
DR   Wikidata; Q117704442
CC   Population: Caucasian; Dutch/Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:24931; ZC4H2; Unexplicit; 244kb microdeletion; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28603).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198578; Female-restricted Wieacker-Wolff syndrome
DI   ORDO; Orphanet_3454; Wieacker-Wolff syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7MA ! GM28362
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28610
AC   CVCL_C7P2
DR   Coriell; GM28610
DR   Wikidata; Q117704443
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:23794; PACS2; Simple; p.Glu209Lys (c.625G>A); ClinVar=VCV000495141; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28610).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198576; Developmental and epileptic encephalopathy 66
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7P6 ! GM28627
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28611
AC   CVCL_C7P3
DR   Coriell; GM28611
DR   Wikidata; Q117704444
CC   Population: Caucasian; Polish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3A8 ! GM28625
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   GM28623
AC   CVCL_C7P4
DR   Coriell; GM28623
DR   Wikidata; Q117704445
CC   Population: Caucasian; Polish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7P5 ! GM28624
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28624
AC   CVCL_C7P5
DR   Coriell; GM28624
DR   Wikidata; Q117704446
CC   Population: Caucasian; Polish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7P4 ! GM28623
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28625
AC   CVCL_D3A8
DR   Coriell; GM28625
DR   Wikidata; Q127380921
CC   Population: Caucasian; Polish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7P3 ! GM28611
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM28627
AC   CVCL_C7P6
DR   Coriell; GM28627
DR   Wikidata; Q117704448
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:23794; PACS2; Simple; p.Glu209Lys (c.625G>A); ClinVar=VCV000495141; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28627).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198576; Developmental and epileptic encephalopathy 66
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7P2 ! GM28610
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 5
//
ID   GM28628
AC   CVCL_C7P7
DR   Coriell; GM28628
DR   Wikidata; Q117704449
CC   Population: Caucasian; Polish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7P8 ! GM28629
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28629
AC   CVCL_C7P8
DR   Coriell; GM28629
DR   Wikidata; Q117704450
CC   Population: Caucasian; Polish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7P7 ! GM28628
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   GM28726
AC   CVCL_D6Y6
DR   Coriell; GM28726
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Arg121Cys (c.361C>T); ClinVar=VCV000212842; Zygosity=Heterozygous (Coriell=GM28726).
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Asn149Glufs*39 (c.444dup); ClinVar=VCV001456891; Zygosity=Heterozygous (Coriell=GM28726).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28727
AC   CVCL_D6Y4
DR   Coriell; GM28727
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Arg121Cys (c.361C>T); ClinVar=VCV000212842; Zygosity=Heterozygous (Coriell=GM28726).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28728
AC   CVCL_D6Y5
DR   Coriell; GM28728
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Asn149Glufs*39 (c.444dup); ClinVar=VCV001456891; Zygosity=Heterozygous (Coriell=GM28726).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28735
AC   CVCL_D3A0
DR   Coriell; GM28735
DR   Wikidata; Q127380922
CC   Population: Caucasian; English/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.Gly307Ser (c.919G>A); ClinVar=VCV000000117; Zygosity=Homozygous (Coriell=GM28735).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28741
AC   CVCL_D6Y7
DR   Coriell; GM28741
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (Coriell=GM28741).
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Simple; p.Pro1173Leu (c.3518C>T); ClinVar=VCV000014278; Zygosity=Heterozygous (Coriell=GM28741).
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Unexplicit; Ex29-30del; Zygosity=Heterozygous (Coriell=GM28741).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28742
AC   CVCL_D6Y8
DR   Coriell; GM28742
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28743
AC   CVCL_D6Y9
DR   Coriell; GM28743
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28746
AC   CVCL_D6YA
DR   Coriell; GM28746
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Arg339Gln (c.1196G>A); Zygosity=Heterozygous (Coriell=GM28746).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (Coriell=GM28746).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala324Thr (c.970G>A); ClinVar=VCV000550893; Zygosity=Heterozygous (Coriell=GM28746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28747
AC   CVCL_D6YB
DR   Coriell; GM28747
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28748
AC   CVCL_D6YC
DR   Coriell; GM28748
CC   Population: Chinese and Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28749
AC   CVCL_D6YD
DR   Coriell; GM28749
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28755
AC   CVCL_D6YE
DR   Coriell; GM28755
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28756
AC   CVCL_D3A1
DR   Coriell; GM28756
DR   Wikidata; Q127380923
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Val78Glu (c.233T>A); ClinVar=VCV002683728; Zygosity=Heterozygous (Coriell=GM28756).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Arg105Glyfs*26 (c.299_311dup13); ClinVar=VCV000008302; Zygosity=Heterozygous (Coriell=GM28756).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6XM ! GM28379
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM28757
AC   CVCL_D3A2
DR   Coriell; GM28757
DR   Wikidata; Q127380924
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Val78Glu (c.233T>A); ClinVar=VCV002683728; Zygosity=Heterozygous (Coriell=GM28757).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Arg105Glyfs*26 (c.299_311dup13); ClinVar=VCV000008302; Zygosity=Heterozygous (Coriell=GM28757).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM28758
AC   CVCL_D3A3
DR   Coriell; GM28758
DR   Wikidata; Q127380926
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM28759
AC   CVCL_D3A4
DR   Coriell; GM28759
DR   Wikidata; Q127380927
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM28764
AC   CVCL_D6YF
DR   Coriell; GM28764
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19954; SLC25A22; Simple; p.Arg44Cys (c.130C>T); ClinVar=VCV000207160; Zygosity=Heterozygous (Coriell=GM28764).
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Arg514Ter (c.1540C>T); ClinVar=VCV000011696; Zygosity=Hemizygous (Coriell=GM28764).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   GM28768
AC   CVCL_D6YG
DR   Coriell; GM28768
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28769
AC   CVCL_D6YH
DR   Coriell; GM28769
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28774
AC   CVCL_D6YI
DR   Coriell; GM28774
CC   Population: Caucasian; Ukrainian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.His22Arg (c.65A>G); ClinVar=VCV000212870; Zygosity=Heterozygous (Coriell=GM28774).
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Pro382Leu (c.1145C>T); ClinVar=VCV000533700; Zygosity=Hemizygous (Coriell=GM28774).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6YJ ! GM28876
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28779
AC   CVCL_D6YK
DR   Coriell; GM28779
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Asp431Leufs*27 (c.1290_1309del20); ClinVar=VCV000280650; Zygosity=Hemizygous; Note=De novo mutation (Coriell=GM28779).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28780
AC   CVCL_D6YL
DR   Coriell; GM28780
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28781
AC   CVCL_D6YM
DR   Coriell; GM28781
CC   Population: Caucasian; English/French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28782
AC   CVCL_D6YP
DR   Coriell; GM28782
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000205591; Zygosity=Heterozygous (Coriell=GM28782).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Val110Phe (c.328G>T); ClinVar=VCV000205580; Zygosity=Heterozygous (Coriell=GM28782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28783
AC   CVCL_D6YN
DR   Coriell; GM28783
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28784
AC   CVCL_D6YQ
DR   Coriell; GM28784
CC   Population: Asian and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; c.1016+2T>C; ClinVar=VCV000520792; Zygosity=Hemizygous; Note=Splice donor mutation (Coriell=GM28784).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28785
AC   CVCL_D6YR
DR   Coriell; GM28785
CC   Population: Asian and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; c.1016+2T>C; ClinVar=VCV000520792; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28785).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28786
AC   CVCL_D6YS
DR   Coriell; GM28786
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28787
AC   CVCL_D6YT
DR   Coriell; GM28787
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; c.1016+2T>C; ClinVar=VCV000520792; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28787).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28788
AC   CVCL_D6YU
DR   Coriell; GM28788
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Tyr356Ter (c.1068C>A); ClinVar=VCV000092729; Zygosity=Heterozygous (Coriell=GM28788).
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Asn336del (c.1000AAC[2]) (c.1006_1008delAAC); ClinVar=VCV000265402; Zygosity=Hemizygous (Coriell=GM28788).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0YH ! GM29687
SX   Male
AG   2Y6M
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28789
AC   CVCL_D6YV
DR   Coriell; GM28789
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Asn336del (c.1000AAC[2]) (c.1006_1008delAAC); ClinVar=VCV000265402; Zygosity=Heterozygous (from familial inference of GM28788).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28790
AC   CVCL_D6YW
DR   Coriell; GM28790
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM28820
AC   CVCL_D6YX
DR   Coriell; GM28820
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple; p.Trp204Ter (c.612G>A); ClinVar=VCV000001357; Zygosity=Heterozygous (Coriell=GM28820).
CC   Sequence variation: Mutation; HGNC; HGNC:408; ALDH5A1; Simple; p.Arg412Ter (c.1234C>T); ClinVar=VCV000001358; Zygosity=Heterozygous (Coriell=GM28820).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206527; Succinic semialdehyde dehydrogenase deficiency
DI   ORDO; Orphanet_22; Succinic semialdehyde dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28854
AC   CVCL_D3AF
DR   Coriell; GM28854
DR   Wikidata; Q127380928
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Arg1345Ter (c.4033C>T) (p.Arg1346Ter, c.4036C>T) (R1346*); ClinVar=VCV000585570; Zygosity=Heterozygous (Coriell=GM28854).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202603; Episodic ataxia type 2
DI   ORDO; Orphanet_97; Familial paroxysmal ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28856
AC   CVCL_D2ZS
DR   Coriell; GM28856
DR   Wikidata; Q127380929
CC   Population: Southeast Asian; Vietnamese.
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Met57Val (c.169A>G); ClinVar=VCV000265755; Zygosity=Heterozygous (Coriell=GM28856).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZT ! GM28954
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28857
AC   CVCL_D2ZW
DR   Coriell; GM28857
DR   Wikidata; Q127380930
CC   Population: Southeast Asian; Vietnamese.
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Met57Val (c.169A>G); ClinVar=VCV000265755; Zygosity=Heterozygous (Coriell=GM28857).
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Gln312Leu (c.935A>T); Zygosity=Heterozygous (Coriell=GM28857).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202547; Developmental and epileptic encephalopathy 44
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZX ! GM28942
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28858
AC   CVCL_D2ZU
DR   Coriell; GM28858
DR   Wikidata; Q127380931
CC   Population: Southeast Asian; Vietnamese.
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Gln312Leu (c.935A>T); Zygosity=Heterozygous (Coriell=GM28858).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZV ! GM28953
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28861
AC   CVCL_D6YZ
SY   GM28861*D
DR   Coriell; GM28861
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11634; TCF4; Zygosity=Heterozygous (Coriell=GM28861).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6YY ! GM27357
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   GM28862
AC   CVCL_C7P9
SY   GM28862*B
DR   Coriell; GM28862
DR   Wikidata; Q117704451
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28862).
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg192Trp (c.574C>T); ClinVar=VCV000215235; Zygosity=Heterozygous (Coriell=GM28862).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2YP ! GM28010
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28873
AC   CVCL_D6XW
DR   Coriell; GM28873
CC   Population: Latino or Hispanic and Caribbean; Haitian.
CC   Sequence variation: Mutation; HGNC; HGNC:11497; SYNGAP1; Simple; p.Arg687Ter (c.2059C>T); ClinVar=VCV000411584; Zygosity=Heterozygous (Coriell=GM28873).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178414; Intellectual developmental disorder, autosomal dominant 5
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28876
AC   CVCL_D6YJ
DR   Coriell; GM28876
CC   Population: Caucasian; Ukrainian.
CC   Sequence variation: Mutation; HGNC; HGNC:1550; CBS; Simple; p.His22Arg (c.65A>G); ClinVar=VCV000212870; Zygosity=Heterozygous (Coriell=GM28876).
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Pro382Leu (c.1145C>T); ClinVar=VCV000533700; Zygosity=Hemizygous (Coriell=GM28876).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6YI ! GM28774
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28877
AC   CVCL_D3A5
DR   Coriell; GM28877
DR   Wikidata; Q127380932
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:22923; GMPPA; Simple; p.Thr292Pro (c.874A>C); ClinVar=VCV001684137; Zygosity=Heterozygous (Coriell=GM28877).
CC   Sequence variation: Mutation; HGNC; HGNC:22923; GMPPA; Simple; p.Arg318Trp (c.952C>T); ClinVar=VCV003685821; Zygosity=Heterozygous (Coriell=GM28877).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202544; Alacrima, achalasia, and impaired intellectual development syndrome
DI   ORDO; Orphanet_869; Triple A syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM28879
AC   CVCL_D6Z0
DR   Coriell; GM28879
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:22923; GMPPA; Simple; p.Thr292Pro (c.874A>C); ClinVar=VCV001684137; Zygosity=Heterozygous (Coriell=GM28879).
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3A6 ! GM28880
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28880
AC   CVCL_D3A6
DR   Coriell; GM28880
DR   Wikidata; Q127380933
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:22923; GMPPA; Simple; p.Thr292Pro (c.874A>C); ClinVar=VCV001684137; Zygosity=Heterozygous (Coriell=GM28880).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6Z0 ! GM28879
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28881
AC   CVCL_D6Z1
DR   Coriell; GM28881
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:22923; GMPPA; Simple; p.Arg318Trp (c.952C>T); ClinVar=VCV003685821; Zygosity=Heterozygous (Coriell=GM28881).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3A7 ! GM28882
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28882
AC   CVCL_D3A7
DR   Coriell; GM28882
DR   Wikidata; Q127380934
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:22923; GMPPA; Simple; p.Arg318Trp (c.952C>T); ClinVar=VCV003685821; Zygosity=Heterozygous (Coriell=GM28882).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6Z1 ! GM28881
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM28888
AC   CVCL_D6Z2
SY   GM28888*B
DR   Coriell; GM28888
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:19998; TNPO2; Simple; p.Asp156Asn (c.466G>A); ClinVar=VCV001299679; Zygosity=Heterozygous (Coriell=GM28888).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C210890; Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28891
AC   CVCL_D2ZH
SY   GM28891*B
DR   Coriell; GM28891
DR   Wikidata; Q127380935
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous (Coriell=GM28891).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0IB ! GM28210
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28895
AC   CVCL_D6Z8
DR   Coriell; GM28895
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:20093; ADSS1; Simple; p.Asp261Asn (c.781G>A) (p.Asp304Asn, c.910G>A); ClinVar=VCV000243025; Zygosity=Heterozygous (Coriell=GM28895).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM28895; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6Y2 ! GM28582
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28907
AC   CVCL_D2ZI
SY   GM28907*B
DR   Coriell; GM28907
DR   Wikidata; Q127380936
CC   Population: Caucasian and Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7471 ! GM07532
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM28910
AC   CVCL_C7LZ
SY   GM28910*B
DR   Coriell; GM28910
DR   Wikidata; Q117704452
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Thr150Ala (c.448A>G); Zygosity=Heterozygous (Coriell=GM28910).
CC   Sequence variation: Mutation; HGNC; HGNC:14888; DNAJB6; Simple; c.899-3T>G; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TF ! GM27890
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28915
AC   CVCL_C7L9
SY   GM28915*B
DR   Coriell; GM28915
DR   Wikidata; Q117704453
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Glu64Lys (c.190G>A); ClinVar=VCV000128068; Zygosity=Heterozygous (Coriell=GM28915).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36107; Hereditary female breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7L8 ! GM27953
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28920
AC   CVCL_D6Z3
SY   GM28920*C
DR   Coriell; GM28920
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Gly219Arg (c.655G>A); ClinVar=VCV000140752; Zygosity=Heterozygous (Coriell=GM28920).
CC   Sequence variation: Mutation; HGNC; HGNC:23089; SLC13A5; Simple; p.Leu492Pro (c.1475T>C); ClinVar=VCV000375390; Zygosity=Heterozygous (Coriell=GM28920).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168597; Developmental and epileptic encephalopathy 25
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN37 ! GM27288
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28930
AC   CVCL_D2ZJ
SY   GM28930*B
DR   Coriell; GM28930
DR   Wikidata; Q127380937
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:29331; EPG5; Simple_corrected; p.Gln336Arg (c.1007A>G); ClinVar=VCV000192333; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM28930).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C138174; Vici syndrome
DI   ORDO; Orphanet_1493; Vici syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV62 ! GM27291
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28936
AC   CVCL_D6Z4
SY   GM28936*B
DR   Coriell; GM28936
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Val78Glu (c.233T>A); ClinVar=VCV002683728; Zygosity=Heterozygous (Coriell=GM28936).
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Arg105Glyfs*26 (c.299_311dup13); ClinVar=VCV000008302; Zygosity=Heterozygous (Coriell=GM28936).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3A1 ! GM28756
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28937
AC   CVCL_C7M0
SY   GM28937*B
DR   Coriell; GM28937
DR   Wikidata; Q117704454
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe408del (c.1216_1218TTC[2]) (c.1222_1224delTTC); ClinVar=VCV000011698; Zygosity=Hemizygous (Coriell=GM28937).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZW48 ! GM27863
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   GM28942
AC   CVCL_D2ZX
DR   Coriell; GM28942
DR   Wikidata; Q127380939
CC   Population: Southeast Asian; Vietnamese.
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Met57Val (c.169A>G); ClinVar=VCV000265755; Zygosity=Heterozygous (Coriell=GM28942).
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Gln312Leu (c.935A>T); Zygosity=Heterozygous (Coriell=GM28942).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202547; Developmental and epileptic encephalopathy 44
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZW ! GM28857
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28947
AC   CVCL_D6Z5
SY   GM28947*B
DR   Coriell; GM28947
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:15766; ADNP; Simple; p.Ser738Phefs*6 (c.2212dupT); ClinVar=VCV001804918; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28947).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C160662; Intellectual developmental disorder, autosomal dominant 28
DI   ORDO; Orphanet_404448; ADNP syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6XY ! GM28570
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM28952
AC   CVCL_D6Z6
DR   Coriell; GM28952
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14280; CIAO1; Simple; p.His302Pro (c.905G>A); Zygosity=Heterozygous (Coriell=GM28952).
CC   Sequence variation: Mutation; HGNC; HGNC:14280; CIAO1; Unexplicit; Ex7del; Zygosity=Heterozygous (Coriell=GM28952).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28953
AC   CVCL_D2ZV
DR   Coriell; GM28953
DR   Wikidata; Q127380940
CC   Population: Southeast Asian; Vietnamese.
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Gln312Leu (c.935A>T); Zygosity=Heterozygous (Coriell=GM28953).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZU ! GM28858
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28954
AC   CVCL_D2ZT
DR   Coriell; GM28954
DR   Wikidata; Q127380941
CC   Population: Southeast Asian; Vietnamese.
CC   Sequence variation: Mutation; HGNC; HGNC:23230; UBA5; Simple; p.Met57Val (c.169A>G); ClinVar=VCV000265755; Zygosity=Heterozygous (Coriell=GM28954).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2ZS ! GM28856
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28955
AC   CVCL_D2ZK
SY   GM28955*B
DR   Coriell; GM28955
DR   Wikidata; Q127380942
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.His522Thrfs*13 (c.1564delC); ClinVar=VCV000049640; Zygosity=Unspecified (Coriell=GM28955).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5L49 ! GM03958
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28959
AC   CVCL_D2ZL
SY   GM28959*B
DR   Coriell; GM28959
DR   Wikidata; Q127380943
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Trp750Ter (c.2249G>A); ClinVar=VCV000048922; Zygosity=Heterozygous (Coriell=GM28959).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5L58 ! GM06149
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28966
AC   CVCL_D2ZM
SY   GM28966*B
DR   Coriell; GM28966
DR   Wikidata; Q127380944
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple_corrected; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Coriell=GM28966).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T822 ! GM23937
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28967
AC   CVCL_D2ZN
SY   GM28967*B
DR   Coriell; GM28967
DR   Wikidata; Q127380945
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple_corrected; p.Pro305Leu (c.914C>T); ClinVar=VCV000428604; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Coriell=GM28967).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133742; Intellectual developmental disorder, autosomal dominant 9
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TN ! GM27933
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM28975
AC   CVCL_D6Z7
SY   GM28975*B
DR   Coriell; GM28975
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:20093; ADSS1; Simple; p.Asp261Asn (c.781G>A) (p.Asp304Asn, c.910G>A); ClinVar=VCV000243025; Zygosity=Homozygous (Coriell=GM28975).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206521; Distal myopathy-5
DI   ORDO; Orphanet_482601; Adenylosuccinate synthetase-like 1-related distal myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28977
AC   CVCL_D2ZY
DR   Coriell; GM28977
DR   Wikidata; Q127380946
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11233; SPAST; Simple; p.Arg499His (c.1496G>A); ClinVar=VCV000240950; Zygosity=Heterozygous (Coriell=GM28977).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129981; Spastic paraplegia 4
DI   ORDO; Orphanet_100985; Autosomal dominant spastic paraplegia type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM28978
AC   CVCL_D2ZP
SY   GM28978*B
DR   Coriell; GM28978
DR   Wikidata; Q127380947
CC   Population: Korean.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M979 ! GM00726
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GM28982
AC   CVCL_D6Z9
SY   GM28982*B
DR   Coriell; GM28982
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:20093; ADSS1; Simple; p.Asp261Asn (c.781G>A) (p.Asp304Asn, c.910G>A); ClinVar=VCV000243025; Zygosity=Heterozygous (Coriell=GM28982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6Z8 ! GM28895
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM28994
AC   CVCL_D6ZA
DR   Coriell; GM28994
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Ser435Ser (c.1359C>T); ClinVar=VCV001303896; Zygosity=Hemizygous (Coriell=GM28994).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29010
AC   CVCL_F0TZ
SY   NLGIP-1509; NLGIP1509
DR   Coriell; GM29010
WW   Provider; NLGIP; -; https://en-med.tau.ac.il/nlgip
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Moroccan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29051
AC   CVCL_D3AG
DR   Coriell; GM29051
DR   Wikidata; Q127380948
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Asp191_Trp192insTer (c.563_572dup) (p.Trp192Ter); ClinVar=VCV000001677; Zygosity=Heterozygous (Coriell=GM29051).
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Arg500His (c.1499G>A); ClinVar=VCV001515408; Zygosity=Heterozygous (Coriell=GM29051).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84596; Beta-mannosidosis
DI   ORDO; Orphanet_118; Beta-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM29052
AC   CVCL_D6WG
DR   Coriell; GM29052
CC   Population: Caucasian; Italian and Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Arg182Gly (c.545G>A); Zygosity=Homozygous (Coriell=GM29052).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84596; Beta-mannosidosis
DI   ORDO; Orphanet_118; Beta-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29054
AC   CVCL_D6WH
SY   GM29054*B
DR   Coriell; GM29054
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11005; SLC2A1; Simple_corrected; p.Pro485Leu (c.1454C>T); ClinVar=VCV000871442; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Coriell=GM29054).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168599; GLUT1 deficiency syndrome 1
DI   ORDO; Orphanet_71277; Classic glucose transporter type 1 deficiency syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI05 ! BIHi037-A
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29071
AC   CVCL_D3AH
DR   Coriell; GM29071
DR   Wikidata; Q127380949
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Asp191_Trp192insTer (c.563_572dup) (p.Trp192Ter); ClinVar=VCV000001677; Zygosity=Heterozygous (Coriell=GM29071).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM29085
AC   CVCL_D6WI
SY   GM29085*B
DR   Coriell; GM29085
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C98 ! GM24694
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM29087
AC   CVCL_D6WJ
SY   GM29087*B
DR   Coriell; GM29087
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F110 ! GM23251
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM29090
AC   CVCL_D6WK
SY   GM29090*B
DR   Coriell; GM29090
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F185 ! GM23249
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM29095
AC   CVCL_F0U0
DR   Coriell; GM29095
CC   Population: Caucasian; Hungarian.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Lys273Glu (c.817A>G); ClinVar=VCV000372596; Zygosity=Heterozygous (Coriell=GM29095).
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Gln159Arg (C.476A>G); ClinVar=VCV000379794; Zygosity=Heterozygous (Coriell=GM29095).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174218; Mitochondrial short-chain enoyl-CoA hydratase-1 deficiency
DI   ORDO; Orphanet_255241; Leigh syndrome with leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29104
AC   CVCL_D3AI
SY   GM29104*B
DR   Coriell; GM29104
DR   Wikidata; Q127380950
CC   Sequence variation: Mutation; HGNC; HGNC:603; APOB; Simple; p.Arg3527Gln (C.10580G>A); ClinVar=VCV000017890; Zygosity=Heterozygous (Coriell=GM29104).
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ile698Metfs*5 (c.2094delT); ClinVar=VCV002672076; Zygosity=Heterozygous (Coriell=GM29104).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   NCIt; C176014; Hypercholesterolemia, familial, 2
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   GM29106
AC   CVCL_D6WL
SY   GM29106*B
DR   Coriell; GM29106
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Arg268Cys (c.802C>T); ClinVar=VCV000657794; Zygosity=Heterozygous (Coriell=GM29106).
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Arg469Gln (c.1406G>A); ClinVar=VCV000461629; Zygosity=Heterozygous (Coriell=GM29106).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WP12 ! GM27127
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29109
AC   CVCL_D6WM
SY   GM29109*B
DR   Coriell; GM29109
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Ile4898Thr (c.14693T>C); ClinVar=VCV000012975; Zygosity=Heterozygous (Coriell=GM29109).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2WF ! GM26186
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29112
AC   CVCL_D3AJ
SY   GM29112*B
DR   Coriell; GM29112
DR   Wikidata; Q127380951
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Heterozygous (Coriell=GM29112).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Trp5754Ter (c.17262G>A) (p.Trp4053Ter, c.12159G>A); ClinVar=VCV000373081; Zygosity=Heterozygous (Coriell=GM29112).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Tyr8107Asnfs*74 (c.24318_24319insAA); ClinVar=VCV000422612; Zygosity=Heterozygous (Coriell=GM29112).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP72 ! GM26260
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM29115
AC   CVCL_D6WN
SY   GM29115*B
DR   Coriell; GM29115
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:4136; GAMT; Simple; p.Glu142del (c.421GAG[1]) (c.424_426delGAG); ClinVar=VCV002689111; dbSNP=rs1736323141; Zygosity=Homozygous (Coriell=GM29115).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173468; Cerebral creatine deficiency syndrome 2
DI   ORDO; Orphanet_382; Guanidinoacetate methyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZW56 ! GM27892
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM29118
AC   CVCL_D3AK
DR   Coriell; GM29118
DR   Wikidata; Q127380952
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Arg500His (c.1499G>A); ClinVar=VCV001515408; Zygosity=Heterozygous (Coriell=GM29118).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM29122
AC   CVCL_D3AL
DR   Coriell; GM29122
DR   Wikidata; Q127380954
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11111; SMC1A; Simple; p.Ile1185Glyfs*23 (c.3549_3552dupGGCC); ClinVar=VCV000208627; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM29122).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202548; Developmental and epileptic encephalopathy 85 with or without midline brain defects
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   GM29125
AC   CVCL_D6WP
DR   Coriell; GM29125
CC   Population: Caucasian; Italian and Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM29126
AC   CVCL_D6WQ
DR   Coriell; GM29126
CC   Population: Caucasian; British/Italian and Jewish; Ashkenazi.
CC   Karyotypic information: Hemizygous deletion at Xp11.3 and also a deletion at 17p11.2 (Coriell=GM29126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   GM29132
AC   CVCL_D6WS
SY   GM29132*B
DR   Coriell; GM29132
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Asn178Glufs*9 (c.532_535delAATA); ClinVar=VCV000372719; Zygosity=Heterozygous (Coriell=GM29132).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C176895; Mitochondrial complex IV deficiency, nuclear type 1
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SE ! GM28063
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29194
AC   CVCL_F0YG
SY   GM29194*B
DR   Coriell; GM29194
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Glu95Aspfs*32 (c.285_286delGC); Zygosity=Heterozygous (Coriell=GM29194).
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Lys215Met (c.644A>T); Zygosity=Heterozygous (Coriell=GM29194).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LP10 ! GM26267
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29205
AC   CVCL_F0YK
DR   Coriell; GM29205
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11603; TBX4; Simple; p.Phe97Leu (c.291C>G); Zygosity=Heterozygous (Coriell=GM29205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C222354; Ischiocoxopodopatellar syndrome
DI   ORDO; Orphanet_1509; Coxopodopatellar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29206
AC   CVCL_F0YL
SY   GM29206*B
DR   Coriell; GM29206
CC   Population: Puerto Rican.
CC   Sequence variation: Mutation; HGNC; HGNC:30372; KLHL40; Simple; p.Arg547His (c.1640G>A); ClinVar=VCV000566161; Zygosity=Heterozygous (Coriell=GM29206).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129871; Nemaline myopathy 8
DI   ORDO; Orphanet_171430; Severe congenital nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HQ48 ! GM25494
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29212
AC   CVCL_F0YM
SY   GM29212*B
DR   Coriell; GM29212
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; c.3337-4dupC (c.3337-3dupC); ClinVar=VCV000042956; Zygosity=Heterozygous (Coriell=GM29212).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Gly334Val (c.1001G>T); ClinVar=VCV000159825; Zygosity=Heterozygous (Coriell=GM29212).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; c.1186_1187delinsTC; Zygosity=Heterozygous (Coriell=GM29212).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Pro2496Arg (c.7487C>G); ClinVar=VCV000159859; Zygosity=Heterozygous (Coriell=GM29212).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Arg3113His (c.9338G>A); ClinVar=VCV000130688; Zygosity=Heterozygous (Coriell=GM29212).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126689; Centronuclear myopathy 1
DI   ORDO; Orphanet_169189; Autosomal dominant centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2VL ! GM26130
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29216
AC   CVCL_F0YN
SY   GM29216*C
DR   Coriell; GM29216
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Ex5-9del; Zygosity=Heterozygous (Coriell=GM29216).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2Z9 ! GM26069
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29241
AC   CVCL_F0YP
DR   Coriell; GM29241
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84596; Beta-mannosidosis
DI   ORDO; Orphanet_118; Beta-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29256
AC   CVCL_D6WT
SY   GM29256*B
DR   Coriell; GM29256
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6884; MAPK8IP3; Simple; c.2451+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (Coriell=GM29256).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206532; Neurodevelopmental disorder with or without variable brain abnormalities
DI   ORDO; Orphanet_528084; Non-specific syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29257
AC   CVCL_D6WU
SY   GM29257*B
DR   Coriell; GM29257
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6884; MAPK8IP3; Simple; p.Tyr37Ter (c.111C>G); ClinVar=VCV000598741; Zygosity=Unspecified (Coriell=GM29257).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206532; Neurodevelopmental disorder with or without variable brain abnormalities
DI   ORDO; Orphanet_528084; Non-specific syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29259
AC   CVCL_D6WX
DR   Coriell; GM29259
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8514; CLDN11; Simple; p.Gly172fs (c.515del); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM29259).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C201587; Hypomyelinating leukodystrophy-22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29270
AC   CVCL_D6WV
SY   GM29270*C
DR   Coriell; GM29270
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6884; MAPK8IP3; Simple; p.Met537del (c.1609_1611delATG); Zygosity=Unspecified (Coriell=GM29270).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206532; Neurodevelopmental disorder with or without variable brain abnormalities
DI   ORDO; Orphanet_528084; Non-specific syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29271
AC   CVCL_D6WW
SY   GM29271*C
DR   Coriell; GM29271
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6884; MAPK8IP3; Simple; p.Arg578Cys (c.1732C>T) (p.Arg579Cys, c.1735C>T); ClinVar=VCV000632564; Zygosity=Unspecified (Coriell=GM29270).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206532; Neurodevelopmental disorder with or without variable brain abnormalities
DI   ORDO; Orphanet_528084; Non-specific syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29277
AC   CVCL_D6WR
SY   GM29277*B
DR   Coriell; GM29277
CC   Population: Caucasian; British/Italian and Jewish; Ashkenazi.
CC   Karyotypic information: Hemizygous deletion at Xp11.3 and also a deletion at 17p11.2 (Coriell=GM29277).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6WQ ! GM29126
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   GM29309
AC   CVCL_D6WY
SY   GM29309*C
DR   Coriell; GM29309
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3811; FOXG1; Simple; p.Arg230Cys (c.688C>T); ClinVar=VCV000803013; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM29309).
CC   Sequence variation: Mutation; HGNC; HGNC:6111; IQGAP2; Simple; p.Gln953Ter (c.2857C>T); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM29309).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176903; Rett syndrome, congenital variant
DI   ORDO; Orphanet_3095; Atypical Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE54 ! GM27461
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GM29310
AC   CVCL_D6WZ
SY   GM29310*B
DR   Coriell; GM29310
CC   Population: Caucasian; Italian and Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6WP ! GM29125
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GM29325
AC   CVCL_D6X1
SY   GM29325*B
DR   Coriell; GM29325
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Trp390Ter (c.1169C>G); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM29325).
CC   Sequence variation: Mutation; HGNC; HGNC:4135; GALT; Simple; p.Lys285Asn (c.855G>T); ClinVar=VCV000003621; Zygosity=Heterozygous (Coriell=GM29325).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84723; Galactosemia
DI   NCIt; C163754; Intellectual developmental disorder, autosomal dominant 40
DI   ORDO; Orphanet_352; Galactosemia
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6X0 ! GM28396
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   GM29333
AC   CVCL_F0YQ
DR   Coriell; GM29333
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:11603; TBX4; Simple; p.Phe97Leu (c.291C>G); Zygosity=Heterozygous (Coriell=GM29333).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C222354; Ischiocoxopodopatellar syndrome
DI   ORDO; Orphanet_1509; Coxopodopatellar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29334
AC   CVCL_F0YR
DR   Coriell; GM29334
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29336
AC   CVCL_F0YS
DR   Coriell; GM29336
CC   Population: Caucasian; German/Irish/Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29337
AC   CVCL_F0YT
DR   Coriell; GM29337
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Ala222Thr (c.664G>A); ClinVar=VCV000427193; Zygosity=Heterozygous (Coriell=GM29337).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0ZB ! GM29405
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29339
AC   CVCL_F0YU
DR   Coriell; GM29339
CC   Population: Caucasian; German/Irish/Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29340
AC   CVCL_F0YV
DR   Coriell; GM29340
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Gly175Ser (c.523G>A); ClinVar=VCV001300726; Zygosity=Heterozygous (Coriell=GM29340).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29342
AC   CVCL_F0YW
DR   Coriell; GM29342
CC   Population: Caucasian; German/Irish/Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Gly175Ser (c.523G>A); ClinVar=VCV001300726; Zygosity=Heterozygous (Coriell=GM29342).
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Ala222Thr (c.664G>A); ClinVar=VCV000427193; Zygosity=Heterozygous (Coriell=GM29342).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174218; Mitochondrial short-chain enoyl-CoA hydratase-1 deficiency
DI   ORDO; Orphanet_255241; Leigh syndrome with leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29343
AC   CVCL_F0YX
DR   Coriell; GM29343
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20278; NUBPL; Simple; p.Leu104Pro (c.311T>C); ClinVar=VCV000209179; Zygosity=Heterozygous (Coriell=GM29343).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29344
AC   CVCL_F0YY
DR   Coriell; GM29344
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20278; NUBPL; Simple; c.815-27T>C; ClinVar=VCV000050317; Zygosity=Heterozygous (Coriell=GM29344).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29345
AC   CVCL_F0YZ
DR   Coriell; GM29345
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Ala173Val (c.518C>T); ClinVar=VCV000377257; Zygosity=Heterozygous (Coriell=GM29345).
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Gly175Ser (c.523G>A); ClinVar=VCV001300726; Zygosity=Heterozygous (Coriell=GM29345).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174218; Mitochondrial short-chain enoyl-CoA hydratase-1 deficiency
DI   ORDO; Orphanet_255241; Leigh syndrome with leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29359
AC   CVCL_F0Z0
DR   Coriell; GM29359
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Val514Cysfs*10 (c.1540_1541del); ClinVar=VCV000542166; Zygosity=Heterozygous (Coriell=GM29359).
CC   Sequence variation: Mutation; HGNC; HGNC:6831; MANBA; Simple; p.Thr785Leufs*27 (c.2352_2356del); ClinVar=VCV000542165; Zygosity=Heterozygous (Coriell=GM29359).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84596; Beta-mannosidosis
DI   ORDO; Orphanet_118; Beta-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0Z2 ! GM29361
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29360
AC   CVCL_F0Z1
DR   Coriell; GM29360
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29361
AC   CVCL_F0Z2
DR   Coriell; GM29361
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Ala173Val (c.518C>T); ClinVar=VCV000377257; Zygosity=Heterozygous (Coriell=GM29361).
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Gly175Ser (c.523G>A); ClinVar=VCV001300726; Zygosity=Heterozygous (Coriell=GM29361).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84596; Beta-mannosidosis
DI   ORDO; Orphanet_118; Beta-mannosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0Z0 ! GM29359
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29367
AC   CVCL_F0Z3
DR   Coriell; GM29367
CC   Population: Caucasian; English/Italian/Lithuanian/Norwegian.
CC   Sequence variation: Mutation; HGNC; HGNC:11233; SPAST; Simple; c.1413+1G>A; ClinVar=VCV000805511; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM29367).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129981; Spastic paraplegia 4
DI   ORDO; Orphanet_100985; Autosomal dominant spastic paraplegia type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29368
AC   CVCL_F0Z4
DR   Coriell; GM29368
CC   Population: Caucasian; Italian/Lithuanian/Norwegian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29369
AC   CVCL_F0Z5
SY   GM29369*B
DR   Coriell; GM29369
CC   Characteristics: Using TALEN a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus and a CAG-dCas9-TagBFP-KRAB at the CLYBL locus (Coriell=GM29369).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29370
AC   CVCL_F0Z6
SY   GM29370*B
DR   Coriell; GM29370
CC   Characteristics: Using TALEN a Tet-on driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (Coriell=GM29370).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29372
AC   CVCL_F0Z7
SY   GM29372*B
DR   Coriell; GM29372
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:15999; SELENON; Simple; p.Asn238Lysfs*63 (c.713dupA) (c.713_714insA); ClinVar=VCV000004494; Zygosity=Homozygous (Coriell=GM29372).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126691; Rigid spine muscular dystrophy 1
DI   ORDO; Orphanet_97244; Rigid spine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WP10 ! GM27122
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29375
AC   CVCL_F0Z8
SY   GM29375*B
DR   Coriell; GM29375
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; p.Leu8168Phefs*13 (c.24502_24503dupAA) (p.Leu6277Phefs*13, c.18829_18830dupAA); ClinVar=VCV000855559; Zygosity=Heterozygous (Coriell=GM29375).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HK64 ! GM25497
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29378
AC   CVCL_F0Z9
SY   GM29378*C
DR   Coriell; GM29378
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:11164; SNRPN; Simple; p.Arg25Ter (c.73C>T); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM29378).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7L4 ! GM27891
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29388
AC   CVCL_F0ZA
SY   GM29388*B
DR   Coriell; GM29388
CC   Population: Caucasian; German/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Cys528Thrfs*4 (c.1577_1580dupCACT); ClinVar=VCV000181148; Zygosity=Heterozygous (Coriell=GM29388).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2PZ ! GM27131
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29405
AC   CVCL_F0ZB
DR   Coriell; GM29405
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Ala222Thr (c.664G>A); ClinVar=VCV000427193; Zygosity=Heterozygous (Coriell=GM29405).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0YT ! GM29337
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29449
AC   CVCL_F0ZC
SY   GM29449*B
DR   Coriell; GM29449
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AZ44 ! GM25500
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29471
AC   CVCL_F0ZD
SY   GM29471*B
DR   Coriell; GM29471
CC   Sequence variation: Mutation; HGNC; HGNC:19743; POMT2; Simple; p.Phe221Ile (c.661T>A); ClinVar=VCV000807153; Zygosity=Homozygous (Coriell=GM29471).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126742; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 2
DI   ORDO; Orphanet_899; Walker-Warburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BX12 ! GM23824
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29475
AC   CVCL_F0ZE
DR   Coriell; GM29475
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Val178Met (c.532G>A); ClinVar=VCV000002402; Zygosity=Heterozygous (Coriell=GM29475).
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Arg193Gln (c.578G>A); ClinVar=VCV000372306; Zygosity=Heterozygous (Coriell=GM29475).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2WA ! GM26179
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29484
AC   CVCL_F0ZF
SY   GM29484*B
DR   Coriell; GM29484
CC   Population: Caucasian; Danish/English/Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; p.Gly290Trp (c.868G>T); ClinVar=VCV000476441; Zygosity=Heterozygous (Coriell=GM29484).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WP08 ! GM27108
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29488
AC   CVCL_F0ZG
SY   GM29488*B
DR   Coriell; GM29488
CC   Population: Caucasian; Swiss.
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; c.1003-1G>A; ClinVar=VCV000286179; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM29488).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2PX ! GM27123
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29496
AC   CVCL_F0ZH
SY   GM29496*B
DR   Coriell; GM29496
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN24 ! GM27138
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29515
AC   CVCL_F0ZI
SY   GM29515*B
DR   Coriell; GM29515
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Simple; p.Gly281Arg (c.841G>A); ClinVar=VCV000017182; Zygosity=Heterozygous (Coriell=GM29515).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT82 ! GM27199
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29518
AC   CVCL_F0ZJ
SY   GM29518*B
DR   Coriell; GM29518
CC   Population: Caucasian; French/Polish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN62 ! GM27743
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29523
AC   CVCL_F0ZK
SY   GM29523*B
DR   Coriell; GM29523
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:8967; PIGN; Simple; c.1434_c.1434+1delGGinsAA; ClinVar=VCV000280280; Zygosity=Homozygous; Note=Causes abnormal splicing (Coriell=GM29523).
CC   Sequence variation: Mutation; HGNC; HGNC:10485; RYR3; Simple; p.Arg1521Ser (c.4562G>C); Zygosity=Heterozygous (Coriell=GM29523).
CC   Sequence variation: Mutation; HGNC; HGNC:10485; RYR3; Simple; p.Glu4130Ala (c.12389A>C); Zygosity=Heterozygous (Coriell=GM29523).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176896; Multiple congenital anomalies-hypotonia-seizures syndrome 1
DI   ORDO; Orphanet_280633; Multiple congenital anomalies-hypotonia-seizures syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2VE ! GM26113
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29603
AC   CVCL_F0ZL
SY   GM29603*B
DR   Coriell; GM29603
WW   Info; PGP; huEA4EE5; https://my.pgp-hms.org/profile_public?hex=huEA4EE5
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1B96 ! GM24083
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29607
AC   CVCL_F0ZM
SY   GM29607*C
DR   Coriell; GM29607
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29608
AC   CVCL_F0ZN
SY   GM29608*B
DR   Coriell; GM29608
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14214; CIC; Simple; p.Arg1262Ter (c.3784C>T) (p.Arg353Ter, c.1057C>T); ClinVar=VCV000431168; Zygosity=Heterozygous (Coriell=GM29608).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C222355; Intellectual developmental disorder, autosomal dominant 45
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29612
AC   CVCL_F0ZP
SY   GM29612*B
DR   Coriell; GM29612
WW   Info; PGP; huAE4A11; https://my.pgp-hms.org/profile_public?hex=huAE4A11
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian; British and Indian; Tanzania.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C06 ! GM24095
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29616
AC   CVCL_F0ZQ
SY   GM29616*B
DR   Coriell; GM29616
WW   Info; PGP; hu3F864B; https://my.pgp-hms.org/profile_public?hex=hu3F864B
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C22 ! GM24112
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29620
AC   CVCL_F0ZR
SY   GM29620*B
DR   Coriell; GM29620
WW   Info; PGP; hu604D39; https://my.pgp-hms.org/profile_public?hex=hu604D39
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0U55 ! GM21846
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29625
AC   CVCL_F0ZS
SY   GM29625*B
DR   Coriell; GM29625
WW   Info; PGP; hu92FD55; https://my.pgp-hms.org/profile_public?hex=hu92FD55
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C07 ! GM24096
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29629
AC   CVCL_F0ZT
SY   GM29629*B
DR   Coriell; GM29629
WW   Info; PGP; huADA07D; https://my.pgp-hms.org/profile_public?hex=huADA07D
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C86 ! GM24604
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29633
AC   CVCL_F0ZU
SY   GM29633*B
DR   Coriell; GM29633
WW   Info; PGP; huAFA81C; https://my.pgp-hms.org/profile_public?hex=huAFA81C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian and Native North American; Alaskan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C13 ! GM24103
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29645
AC   CVCL_F0ZV
SY   GM29645*B
DR   Coriell; GM29645
WW   Info; PGP; hu661AD0; https://my.pgp-hms.org/profile_public?hex=hu661AD0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1B84 ! GM24070
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29646
AC   CVCL_F0ZW
SY   GM29646*B
DR   Coriell; GM29646
WW   Info; PGP; huEAE6C8; https://my.pgp-hms.org/profile_public?hex=huEAE6C8
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian and Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C91 ! GM24611
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29650
AC   CVCL_F0ZX
SY   GM29650*B
DR   Coriell; GM29650
WW   Info; PGP; hu973BAC; https://my.pgp-hms.org/profile_public?hex=hu973BAC
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Chinese and Southeast Asian; Filipino.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C88 ! GM24606
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29668
AC   CVCL_F0ZY
SY   GM29668*B
DR   Coriell; GM29668
WW   Info; PGP; hu7123C1; https://my.pgp-hms.org/profile_public?hex=hu7123C1
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C37 ! GM24130
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29687
AC   CVCL_F0YH
DR   Coriell; GM29687
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Tyr356Ter (c.1068C>A); ClinVar=VCV000092729; Zygosity=Heterozygous (Coriell=GM29687).
CC   Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Asn336del (c.1000AAC[2]) (c.1006_1008delAAC); ClinVar=VCV000265402; Zygosity=Hemizygous (Coriell=GM29687).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125665; Cerebral creatine deficiency syndrome 1
DI   ORDO; Orphanet_52503; X-linked creatine transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6YU ! GM28788
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29739
AC   CVCL_F0ZZ
DR   Coriell; GM29739
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29739).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29740
AC   CVCL_F1A0
DR   Coriell; GM29740
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29741
AC   CVCL_F1A1
DR   Coriell; GM29741
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29742
AC   CVCL_F1A2
DR   Coriell; GM29742
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29742).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29743
AC   CVCL_F1A3
DR   Coriell; GM29743
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29743).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29744
AC   CVCL_F1A4
DR   Coriell; GM29744
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29745
AC   CVCL_F1A5
DR   Coriell; GM29745
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29745).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29746
AC   CVCL_F1A6
DR   Coriell; GM29746
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29746).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29747
AC   CVCL_F1A7
DR   Coriell; GM29747
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29748
AC   CVCL_F1A8
DR   Coriell; GM29748
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29749
AC   CVCL_F1A9
DR   Coriell; GM29749
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29749).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29750
AC   CVCL_F1AA
DR   Coriell; GM29750
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29750).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29751
AC   CVCL_F1AB
DR   Coriell; GM29751
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (Coriell=GM29751).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29787
AC   CVCL_F0YI
SY   GM29787*B
DR   Coriell; GM29787
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19082; NALCN; Simple; p.Asp600His (c.1798G>C); Zygosity=Heterozygous (Coriell=GM29787).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C222353; CLIFAHDD syndrome
DI   ORDO; Orphanet_562528; Congenital limbs-face contractures-hypotonia-developmental delay syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0YJ ! GM29788
SX   Female
AG   10M
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29788
AC   CVCL_F0YJ
DR   Coriell; GM29788
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19082; NALCN; Simple; p.Asp600His (c.1798G>C); Zygosity=Heterozygous (Coriell=GM29788).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C222353; CLIFAHDD syndrome
DI   ORDO; Orphanet_562528; Congenital limbs-face contractures-hypotonia-developmental delay syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29798
AC   CVCL_F1AC
SY   GM29798*B
DR   Coriell; GM29798
WW   Info; PGP; huEBD467; https://my.pgp-hms.org/profile_public?hex=huEBD467
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Honduran.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1C67 ! GM24164
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29843
AC   CVCL_F1AD
SY   GM29843*B
DR   Coriell; GM29843
CC   Population: Caucasian; Irish/Italian.
CC   Karyotypic information: 46,XX,inv(9)(p11->q13) (Coriell=GM29843).
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Gly48Cys (c.142C>A); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM29843).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120046; Congenital fiber-type disproportion
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_2020; Congenital fiber-type disproportion myopathy
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2VD ! GM26112
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29847
AC   CVCL_F1AE
SY   GM29847*B
DR   Coriell; GM29847
CC   Population: Jewish; Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Arg468Ter (c.1402C>T); ClinVar=VCV000565700; Zygosity=Homozygous (Coriell=GM29847).
CC   Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; p.Arg625Thr (c.1874G>C); ClinVar=VCV000964423; Zygosity=Heterozygous (Coriell=GM29847).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123438; Ullrich congenital muscular dystrophy
DI   ORDO; Orphanet_75840; Congenital muscular dystrophy, Ullrich type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0IE ! GM28234
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29866
AC   CVCL_F1AF
DR   Coriell; GM29866
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:6842; MAP2K2; Simple; p.Glu207Lys (c.619G>A); ClinVar=VCV000040813; Zygosity=Heterozygous (Coriell=GM29866).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C222348; Cardiofaciocutaneous syndrome 4
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM29867
AC   CVCL_F1AG
DR   Coriell; GM29867
CC   Population: Caucasian; Polish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM2B4
AC   CVCL_KT08
DR   Wikidata; Q54854149
RX   PubMed=16186162;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51124; Human GZMM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   GM3
AC   CVCL_Z796
DR   DGRC; 11
DR   FlyBase_Cell_line; FBtc0000011
DR   Wikidata; Q54854150
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=811480;
RX   PubMed=4626439;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 25-28 hours (Note=Depending on growth medium) (DGRC=11).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   GM3498B-HV1
AC   CVCL_B7BK
DR   Wikidata; Q111733245
RX   PubMed=6648529;
CC   Population: Caucasian; English and Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Gly (c.3163T>G); ClinVar=VCV001728339; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F114 ! GM03498
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   GM3498B-HV2
AC   CVCL_B7BL
DR   Wikidata; Q111733246
RX   PubMed=6648529;
CC   Population: Caucasian; English and Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Gly (c.3163T>G); ClinVar=VCV001728339; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F114 ! GM03498
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   GM3501-V5
AC   CVCL_D7DS
RX   PubMed=2535035;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N77 ! GM03501
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   GM50050
AC   CVCL_0G31
SY   JH101
DR   CLO; CLO_0014863
DR   Coriell; GM50050
DR   Wikidata; Q54854152
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50051
AC   CVCL_0G32
SY   JH115
DR   CLO; CLO_0014865
DR   Coriell; GM50051
DR   Wikidata; Q54854153
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50052
AC   CVCL_0G33
SY   JH121
DR   CLO; CLO_0014851
DR   Coriell; GM50052
DR   Wikidata; Q54854154
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V997 ! GM14121
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50053
AC   CVCL_0G34
SY   JH123
DR   CLO; CLO_0014849
DR   Coriell; GM50053
DR   Wikidata; Q54854155
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50056
AC   CVCL_0G35
SY   JH132
DR   CLO; CLO_0014855
DR   Coriell; GM50056
DR   Wikidata; Q54854156
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50057
AC   CVCL_0G36
SY   JH133
DR   CLO; CLO_0014853
DR   Coriell; GM50057
DR   Wikidata; Q54854157
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50058
AC   CVCL_0G37
SY   JH134
DR   CLO; CLO_0014843
DR   Coriell; GM50058
DR   Wikidata; Q54854158
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50059
AC   CVCL_0G38
SY   JH135
DR   CLO; CLO_0014840
DR   Coriell; GM50059
DR   Wikidata; Q54854159
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V998 ! GM14122
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50060
AC   CVCL_0G39
SY   JH141
DR   CLO; CLO_0014848
DR   Coriell; GM50060
DR   Wikidata; Q54854160
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50061
AC   CVCL_0G40
SY   JH143
DR   CLO; CLO_0014845
DR   Coriell; GM50061
DR   Wikidata; Q54854161
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50063
AC   CVCL_0G41
SY   JH161
DR   CLO; CLO_0014783
DR   Coriell; GM50063
DR   Wikidata; Q54854162
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50065
AC   CVCL_0G42
SY   JH169
DR   CLO; CLO_0014781
DR   Coriell; GM50065
DR   Wikidata; Q54854163
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   GM50068
AC   CVCL_0G43
SY   JH196
DR   CLO; CLO_0014780
DR   BioSamples; SAME44488
DR   Coriell; GM50068
DR   Wikidata; Q54854164
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G44 ! GM50127
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   GM50069
AC   CVCL_0G45
SY   JH211
DR   CLO; CLO_0014772
DR   Coriell; GM50069
DR   Wikidata; Q54854165
RX   PubMed=1577474;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50070
AC   CVCL_0G46
SY   JH217
DR   CLO; CLO_0014773
DR   Coriell; GM50070
DR   Wikidata; Q54854166
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50071
AC   CVCL_0G47
SY   JH240
DR   CLO; CLO_0014770
DR   Coriell; GM50071
DR   Wikidata; Q54854167
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G48 ! GM50112
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50072
AC   CVCL_0G49
SY   JH246
DR   CLO; CLO_0014771
DR   Coriell; GM50072
DR   Wikidata; Q54854168
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W002 ! GM14126
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50073
AC   CVCL_0G50
SY   JH250
DR   CLO; CLO_0014775
DR   Coriell; GM50073
DR   Wikidata; Q54854169
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W004 ! GM14128
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50074
AC   CVCL_0F97
SY   JH269
DR   CLO; CLO_0014776
DR   Coriell; GM50074
DR   Wikidata; Q54854170
RX   PubMed=8488839;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F98 ! GM50118
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50076
AC   CVCL_0G51
SY   JH290
DR   CLO; CLO_0014774
DR   Coriell; GM50076
DR   Wikidata; Q54854171
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50077
AC   CVCL_0G52
SY   JH292
DR   CLO; CLO_0014802
DR   Coriell; GM50077
DR   Wikidata; Q54854172
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W006 ! GM14130
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50079
AC   CVCL_0G77
SY   JH312
DR   CLO; CLO_0014799
DR   Coriell; GM50079
DR   Wikidata; Q54854173
RX   PubMed=7485158;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G78 ! GM50121
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50081
AC   CVCL_0G79
SY   JH357
DR   CLO; CLO_0014805
DR   Coriell; GM50081
DR   Wikidata; Q54854174
RX   PubMed=7485158;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G80 ! GM50126
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50082
AC   CVCL_CW94
SY   JH385
DR   CLO; CLO_0014803
DR   Coriell; GM50082
DR   Wikidata; Q54854175
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5T48 ! GM50136
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM50084
AC   CVCL_0G53
SY   JH397
DR   CLO; CLO_0014790
DR   Coriell; GM50084
DR   Wikidata; Q54854176
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50085
AC   CVCL_0G54
SY   JH409
DR   CLO; CLO_0014791
DR   Coriell; GM50085
DR   Wikidata; Q54854177
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G55 ! GM50139
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50086
AC   CVCL_CW67
SY   JH410
DR   CLO; CLO_0014792
DR   Coriell; GM50086
DR   Wikidata; Q54854178
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   GM50088
AC   CVCL_0G56
SY   JH421
DR   CLO; CLO_0014793
DR   Coriell; GM50088
DR   Wikidata; Q54854179
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50089
AC   CVCL_0G57
SY   JH423
DR   CLO; CLO_0014794
DR   Coriell; GM50089
DR   Wikidata; Q54854180
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50090
AC   CVCL_0H40
SY   JH432
DR   CLO; CLO_0014795
DR   Coriell; GM50090
DR   Wikidata; Q54854181
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H54 ! GM50143
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50091
AC   CVCL_0H41
SY   JH439
DR   CLO; CLO_0014749
DR   Coriell; GM50091
DR   Wikidata; Q54854182
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H56 ! GM50163
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50092
AC   CVCL_0G58
SY   JH440
DR   CLO; CLO_0014748
DR   Coriell; GM50092
DR   Wikidata; Q54854183
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G59 ! GM50154
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50093
AC   CVCL_0G60
SY   JH444
DR   CLO; CLO_0014747
DR   Coriell; GM50093
DR   Wikidata; Q54854190
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G61 ! GM50167
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50095
AC   CVCL_0G62
SY   JH462
DR   CLO; CLO_0014746
DR   Coriell; GM50095
DR   Wikidata; Q54854191
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G63 ! GM50173
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50096
AC   CVCL_0G64
SY   JH463
DR   CLO; CLO_0014745
DR   Coriell; GM50096
DR   Wikidata; Q54854192
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50097
AC   CVCL_0G65
SY   JH464
DR   CLO; CLO_0014743
DR   Coriell; GM50097
DR   Wikidata; Q54854193
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50098
AC   CVCL_0G66
SY   JH465
DR   CLO; CLO_0014744
DR   Coriell; GM50098
DR   Wikidata; Q54854194
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G67 ! GM50178
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50099
AC   CVCL_0H42
SY   JH486
DR   CLO; CLO_0014741
DR   Coriell; GM50099
DR   Wikidata; Q54854195
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H55 ! GM50186
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50100
AC   CVCL_0G68
SY   JH494
DR   CLO; CLO_0014742
DR   Coriell; GM50100
DR   Wikidata; Q54854196
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50101
AC   CVCL_0G69
SY   JH515
DR   CLO; CLO_0014740
DR   Coriell; GM50101
DR   Wikidata; Q54854197
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50103
AC   CVCL_0G70
SY   JH519
DR   CLO; CLO_0014764
DR   Coriell; GM50103
DR   Wikidata; Q54854198
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50106
AC   CVCL_0G71
SY   JH540
DR   CLO; CLO_0014762
DR   Coriell; GM50106
DR   Wikidata; Q54854199
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G72 ! GM50194
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   GM50112
AC   CVCL_0G48
SY   JL137
DR   CLO; CLO_0014757
DR   Coriell; GM50112
DR   Wikidata; Q54854200
RX   PubMed=8004090;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50113
AC   CVCL_0F90
SY   JL143
DR   CLO; CLO_0014755
DR   Coriell; GM50113
DR   Wikidata; Q54854201
RX   PubMed=8488839;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50114
AC   CVCL_5T46
DR   Coriell; GM50114
DR   Wikidata; Q54854202
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50115
AC   CVCL_5T47
DR   Coriell; GM50115
DR   Wikidata; Q54854203
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50116
AC   CVCL_0F96
SY   JL156
DR   CLO; CLO_0014761
DR   Coriell; GM50116
DR   Wikidata; Q54854204
RX   PubMed=8488839;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50118
AC   CVCL_0F98
SY   JL172
DR   CLO; CLO_0014758
DR   Coriell; GM50118
DR   Wikidata; Q54854205
RX   PubMed=8488839;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50120
AC   CVCL_0F88
SY   JL181
DR   CLO; CLO_0014750
DR   Coriell; GM50120
DR   Wikidata; Q54854206
RX   PubMed=8488839;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50121
AC   CVCL_0G78
SY   JL182
DR   CLO; CLO_0014751
DR   Coriell; GM50121
DR   Wikidata; Q54854207
RX   PubMed=7485158;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32FW
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50122
AC   CVCL_0F92
SY   JL184
DR   CLO; CLO_0014752
DR   Coriell; GM50122
DR   Wikidata; Q54854208
RX   PubMed=8488839;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50124
AC   CVCL_1U16
SY   JL208
DR   CLO; CLO_0014753
DR   Coriell; GM50124
DR   Wikidata; Q54854209
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM50125
AC   CVCL_0F94
SY   JL209
DR   CLO; CLO_0014669
DR   Coriell; GM50125
DR   Wikidata; Q54854210
RX   PubMed=8488839;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50126
AC   CVCL_0G80
SY   JL219
DR   CLO; CLO_0014670
DR   Coriell; GM50126
DR   Wikidata; Q54854211
RX   PubMed=7485158;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50127
AC   CVCL_0G44
DR   Coriell; GM50127
DR   Wikidata; Q54854212
RX   PubMed=8004090;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM50127; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM50128
AC   CVCL_2U66
SY   JL237
DR   CLO; CLO_0014672
DR   Coriell; GM50128
DR   Wikidata; Q54854213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM50129
AC   CVCL_2U67
SY   JL240
DR   CLO; CLO_0014674
DR   Coriell; GM50129
DR   Wikidata; Q54854214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM50136
AC   CVCL_5T48
SY   JL255
DR   Coriell; GM50136
DR   Wikidata; Q54854215
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50139
AC   CVCL_0G55
SY   JL259
DR   CLO; CLO_0014675
DR   Coriell; GM50139
DR   Wikidata; Q54854216
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50142
AC   CVCL_5T49
SY   JL263
DR   CLO; CLO_0014676
DR   Coriell; GM50142
DR   Wikidata; Q54854217
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50143
AC   CVCL_0H54
SY   JL266
DR   CLO; CLO_0014677
DR   Coriell; GM50143
DR   Wikidata; Q54854218
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50145
AC   CVCL_5L25
SY   JL268
DR   CLO; CLO_0014679
DR   Coriell; GM50145
DR   Wikidata; Q54854219
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50146
AC   CVCL_4E20
SY   JL272
DR   CLO; CLO_0014678
DR   Coriell; GM50146
DR   Wikidata; Q54854220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM50147
AC   CVCL_5T50
SY   JL273
DR   CLO; CLO_0014683
DR   Coriell; GM50147
DR   Wikidata; Q54854221
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50148
AC   CVCL_5T51
DR   Coriell; GM50148
DR   Wikidata; Q54854222
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM50148; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM50149
AC   CVCL_AB24
SY   JL277
DR   CLO; CLO_0014713
DR   Coriell; GM50149
DR   Wikidata; Q54854223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM50150
AC   CVCL_5T52
SY   JL278
DR   CLO; CLO_0014715
DR   Coriell; GM50150
DR   Wikidata; Q54854224
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50152
AC   CVCL_5L26
SY   JL280
DR   CLO; CLO_0014709
DR   Coriell; GM50152
DR   Wikidata; Q54854225
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50153
AC   CVCL_5L27
SY   JL284
DR   CLO; CLO_0014710
DR   Coriell; GM50153
DR   Wikidata; Q54854226
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50154
AC   CVCL_0G59
SY   JL285
DR   CLO; CLO_0014718
DR   Coriell; GM50154
DR   Wikidata; Q54854227
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50158
AC   CVCL_9Y56
SY   JL293
DR   CLO; CLO_0014719
DR   Coriell; GM50158
DR   Wikidata; Q54854228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GM50159
AC   CVCL_5T53
SY   JL298
DR   CLO; CLO_0014716
DR   Coriell; GM50159
DR   Wikidata; Q54854229
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50160
AC   CVCL_5L28
SY   JL305
DR   CLO; CLO_0014717
DR   Coriell; GM50160
DR   Wikidata; Q54854234
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50163
AC   CVCL_0H56
SY   JL317
DR   CLO; CLO_0014722
DR   Coriell; GM50163
DR   Wikidata; Q54854235
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50164
AC   CVCL_5L29
SY   JL325
DR   CLO; CLO_0014721
DR   Coriell; GM50164
DR   Wikidata; Q54854236
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50165
AC   CVCL_5L30
SY   JL330
DR   CLO; CLO_0015015
DR   Coriell; GM50165
DR   Wikidata; Q54854238
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50166
AC   CVCL_5T54
DR   Coriell; GM50166
DR   Wikidata; Q54854239
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50167
AC   CVCL_0G61
SY   JL333
DR   CLO; CLO_0015017
DR   Coriell; GM50167
DR   Wikidata; Q54854240
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   GM50168
AC   CVCL_5L31
SY   JL339
DR   CLO; CLO_0015018
DR   Coriell; GM50168
DR   Wikidata; Q54854241
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50170
AC   CVCL_4E21
SY   JL346
DR   CLO; CLO_0015021
DR   Coriell; GM50170
DR   Wikidata; Q54854242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM50171
AC   CVCL_AB25
SY   JL347
DR   CLO; CLO_0015026
DR   Coriell; GM50171
DR   Wikidata; Q54854243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM50172
AC   CVCL_5L32
SY   JL351
DR   CLO; CLO_0015028
DR   Coriell; GM50172
DR   Wikidata; Q54854244
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50173
AC   CVCL_0G63
SY   JL361
DR   CLO; CLO_0015008
DR   Coriell; GM50173
DR   Wikidata; Q54854245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GM50174
AC   CVCL_AB26
SY   JL362
DR   CLO; CLO_0015009
DR   Coriell; GM50174
DR   Wikidata; Q54854246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM50175
AC   CVCL_5L33
SY   JL366
DR   CLO; CLO_0015010
DR   Coriell; GM50175
DR   Wikidata; Q54854247
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50176
AC   CVCL_5L34
SY   JL369
DR   CLO; CLO_0015011
DR   Coriell; GM50176
DR   Wikidata; Q54854248
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50178
AC   CVCL_0G67
SY   JL378
DR   CLO; CLO_0014986
DR   Coriell; GM50178
DR   Wikidata; Q54854249
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   GM50180
AC   CVCL_5L35
SY   JL393
DR   CLO; CLO_0014980
DR   Coriell; GM50180
DR   Wikidata; Q54854250
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50182
AC   CVCL_5T55
DR   Coriell; GM50182
DR   Wikidata; Q54854251
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM50182; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   GM50186
AC   CVCL_0H55
SY   JL430
DR   CLO; CLO_0014983
DR   Coriell; GM50186
DR   Wikidata; Q54854252
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84522; Deletion 18q syndrome
DI   ORDO; Orphanet_1600; Monosomy 18q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   GM50188
AC   CVCL_5T56
DR   Coriell; GM50188
DR   Wikidata; Q54854253
RX   PubMed=23665875;
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM50189
AC   CVCL_4E22
SY   JL438
DR   CLO; CLO_0014994
DR   Coriell; GM50189
DR   Wikidata; Q54854254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM50192
AC   CVCL_AB27
SY   JL446
DR   CLO; CLO_0014998
DR   Coriell; GM50192
DR   Wikidata; Q54854255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GM50193
AC   CVCL_5L36
SY   JL451
DR   CLO; CLO_0014989
DR   Coriell; GM50193
DR   Wikidata; Q54854256
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   GM50194
AC   CVCL_0G72
SY   JL453
DR   CLO; CLO_0014993
DR   Coriell; GM50194
DR   Wikidata; Q54854257
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   GM50204
AC   CVCL_5T57
DR   Coriell; GM50204
DR   Wikidata; Q54854258
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50205
AC   CVCL_5T58
DR   BioSample; SAMN00806847
DR   Coriell; GM50205
DR   Wikidata; Q54854259
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM50215
AC   CVCL_5T59
DR   BioSample; SAMN00806849
DR   Coriell; GM50215
DR   Wikidata; Q54854260
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   GM50248
AC   CVCL_5T60
DR   Coriell; GM50248
DR   Wikidata; Q54854261
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50275
AC   CVCL_5T61
DR   Coriell; GM50275
DR   Wikidata; Q54854262
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50276
AC   CVCL_5T62
DR   Coriell; GM50276
DR   Wikidata; Q54854263
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50284
AC   CVCL_5T63
DR   Coriell; GM50284
DR   Wikidata; Q54854264
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50291
AC   CVCL_2U68
SY   JL612
DR   CLO; CLO_0014977
DR   Coriell; GM50291
DR   Wikidata; Q54854265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   GM50292
AC   CVCL_5L37
SY   JL614
DR   CLO; CLO_0014978
DR   Coriell; GM50292
DR   Wikidata; Q54854266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM50321
AC   CVCL_5L38
SY   JL84
DR   CLO; CLO_0014976
DR   Coriell; GM50321
DR   Wikidata; Q54854267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   GM50322
AC   CVCL_1U17
SY   JL91
DR   CLO; CLO_0012521
DR   Coriell; GM50322
DR   Wikidata; Q54854268
RX   PubMed=1577474;
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84521; Deletion 18p syndrome
DI   ORDO; Orphanet_1598; Monosomy 18p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM50323
AC   CVCL_1U18
SY   JL92
DR   CLO; CLO_0012520
DR   Coriell; GM50323
DR   Wikidata; Q54854269
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   GM50324
AC   CVCL_5T64
DR   Coriell; GM50324
DR   Wikidata; Q54854270
RX   PubMed=23665875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   GM50332
AC   CVCL_EG53
DR   CLO; CLO_0012519
DR   BioSample; SAMN00806851
DR   Coriell; GM50332
DR   Wikidata; Q54854271
CC   Population: Caucasian; Amish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   GM50333
AC   CVCL_EG54
DR   CLO; CLO_0012518
DR   BioSample; SAMN00806853
DR   Coriell; GM50333
DR   Wikidata; Q54854272
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   GM50334
AC   CVCL_H996
DR   CLO; CLO_0012526
DR   BioSample; SAMN00806855
DR   Coriell; GM50334
DR   Wikidata; Q54854273
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   GM50336
AC   CVCL_H995
DR   CLO; CLO_0012525
DR   Coriell; GM50336
DR   Wikidata; Q54854274
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM50345
AC   CVCL_H993
DR   CLO; CLO_0012523
DR   Coriell; GM50345
DR   Wikidata; Q54854279
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3817; Cerebrooculofacioskeletal syndrome
DI   ORDO; Orphanet_1466; COFS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM50346
AC   CVCL_H994
DR   CLO; CLO_0012522
DR   Coriell; GM50346
DR   Wikidata; Q54854280
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3817; Cerebrooculofacioskeletal syndrome
DI   ORDO; Orphanet_1466; COFS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   GM5756-T
AC   CVCL_VQ75
SY   GM5756T; 5756T
DR   Lonza; 1146
DR   Wikidata; Q93933917
RX   PubMed=9922452;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Incorrectly stated in Lonza=1146 to originate from a 18 year old male patient with ataxia telangiectasia.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7436 ! GM05756
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 9
//
ID   GM6C3
AC   CVCL_KT09
SY   GM-6C3
DR   Wikidata; Q54854281
RX   PubMed=16208762;
WW   Info; -; -; https://cdn2.hubspot.net/hubfs/1769030/files/genovac/GM0205.pdf
CC   Monoclonal antibody isotype: IgG2b, kappa (Santa Cruz); IgG1 (Aldevron).
CC   Monoclonal antibody target: UniProtKB; P49863; Human GZMK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   GM7
AC   CVCL_IR55
DR   Wikidata; Q54854282
RX   PubMed=19082452;
RX   PubMed=24270553;
CC   Doubling time: ~18 hours (PubMed=19082452).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   GM7S
AC   CVCL_RG46
DR   Wikidata; Q54854283
RX   PubMed=688393;
RX   PubMed=1170022;
RX   PubMed=4359990;
CC   Doubling time: 12 hours (Note=At 34 Celsius) (PubMed=1170022).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2886 ! Dede
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 8
//
ID   GM7S-TRAC
AC   CVCL_F0V2
RX   PubMed=4359990;
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG46 ! GM7S
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GM847/ATRkd
AC   CVCL_7947
SY   GM847 ATR kinase dead; ATRkd
DR   Wikidata; Q54751292
RX   PubMed=9427750;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:882; ATR (Note=With p.Asp2494Glu = ATRkd).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7908 ! GM00847
SX   Male
AG   5Y6M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   GM847/hTERT-3
AC   CVCL_C1HE
DR   Wikidata; Q114311535
RX   PubMed=11359895;
RX   PubMed=19935656;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7908 ! GM00847
SX   Male
AG   5Y6M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   GM847/hTERT-3 subclone 9
AC   CVCL_C1HG
DR   Wikidata; Q114311536
RX   PubMed=11359895;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1HE ! GM847/hTERT-3
SX   Male
AG   5Y6M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   GM847/hTERT-6
AC   CVCL_C1HF
DR   Wikidata; Q114311537
RX   PubMed=11359895;
RX   PubMed=19935656;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7908 ! GM00847
SX   Male
AG   5Y6M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   GM847/hTERT-6 subclone 11
AC   CVCL_C1HH
DR   Wikidata; Q114311538
RX   PubMed=11359895;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1HF ! GM847/hTERT-6
SX   Male
AG   5Y6M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   GM86.fl
AC   CVCL_I000
DR   CLO; CLO_0050780
DR   RCB; RCB0570
DR   Wikidata; Q54854284
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   GM9573M
AC   CVCL_LM89
SY   GM95
DR   CLO; CLO_0003541
DR   CLDB; cl1508
DR   Wikidata; Q54854285
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   GM97
AC   CVCL_B4G6
DR   cancercelllines; CVCL_B4G6
DR   IARC_TP53; 20801
DR   Wikidata; Q110432831
RX   PubMed=14961077;
CC   Characteristics: Early passage culture.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=14961077).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   GMA/LULS61
AC   CVCL_E1HK
RX   PubMed=38760668;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Characteristics: Supports infection and replication of a panel of Wolbachia strains (wAlbB, wBol1-b, wCfeJ, wMelPop-CLA, wPap and wStr1). Does not support infection by strain WPip (PubMed=38760668).
CC   Virology: Persistently infected with the iflavirus GmmIV and the negevirus GmmNegeV (PubMed=38760668).
CC   Breed/subspecies: Liverpool School of Tropical Medicine colony.
OX   NCBI_TaxID=37546; ! Glossina morsitans morsitans (Savannah tsetse fly)
SX   Female
AG   10W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   GMA32
AC   CVCL_RG47
DR   Wikidata; Q54854286
RX   PubMed=3785179;
RX   PubMed=4359990;
RX   PubMed=6526013;
RX   PubMed=7162515;
CC   Characteristics: Deoxycytidine kinase (dCK)-deficient.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2886 ! Dede
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   GMab-r1
AC   CVCL_D3DZ
DR   Wikidata; Q127380955
RX   PubMed=23750482;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132Gly).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   GMB28
AC   CVCL_U844
DR   Wikidata; Q54854287
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60327; Ganglioside GM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   GMB7
AC   CVCL_U835
DR   CLO; CLO_0050336
DR   RCB; RCB2014
DR   Wikidata; Q54854288
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 7
//
ID   GMCL
AC   CVCL_6F80
SY   Goldfish Macrophage Cell Line
DR   Wikidata; Q54854289
RX   DOI=10.1006/fsim.1995.0032;
RX   PubMed=8617403;
RX   PubMed=9699487;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   gMDCKI
AC   CVCL_VR38
SY   Genentech MDCKI
DR   Wikidata; Q93933959
RX   PubMed=30222362;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:37431; ABCB1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0592 ! MDCK-I
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   gMDCKI-MDR1
AC   CVCL_VR39
DR   Wikidata; Q93933962
RX   PubMed=30222362;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:37431; ABCB1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_VR38 ! gMDCKI
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   gMEC
AC   CVCL_ZV96
SY   goat Mammary Epithelial Cells
DR   Wikidata; Q102113948
RX   DOI=10.5539/ijb.v11n4p36;
CC   Doubling time: ~3 days (Direct_author_submission).
CC   Miscellaneous: Doubling time from personal communication of Singh, Mahipal.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Saanen; VBO=VBO_0000827.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   GMGE-3
AC   CVCL_IQ59
SY   Goat Mammary Glandular Epithelial-3
DR   Wikidata; Q54854290
RX   PubMed=17570337;
CC   Doubling time: 38-51 hours (PubMed=17570337).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Glandular epithelial cell; CL=CL_0000150.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   GMI-R1
AC   CVCL_W175
SY   GMIR1
DR   Wikidata; Q54854291
RX   Patent=US6673605;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7062.
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1W
CA   Factor-dependent cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   GMK-2
AC   CVCL_L499
AS   CVCL_L500
SY   OKIBA
DR   Wikidata; Q54854292
RX   PubMed=14662023;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   GMK-5
AC   CVCL_F643
AS   CVCL_L501
SY   AOTO
DR   Wikidata; Q54750172
RX   PubMed=14662023;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   GMK-AH-1
AC   CVCL_L878
SY   GMK-AH 1; GMK AH-1; GMK-AH1; GMK AH1; GMK,AH-1; AH-1; AH-I; Green Monkey Kidney-Ann Holloway-1
DR   CLO; CLO_0003544
DR   CLDB; cl1509
DR   Wikidata; Q54854294
RX   PubMed=7104376;
RX   PubMed=14254593;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   GML-5
AC   CVCL_KR30
SY   Gadus Morhua Larvae-5
DR   Wikidata; Q54854295
RX   CelloPub=CLPUB00403;
RX   PubMed=29882595;
CC   Group: Fish cell line.
CC   Doubling time: ~3 days (CelloPub=CLPUB00403).
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
OX   NCBI_TaxID=8049; ! Gadus morhua (Atlantic cod)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   GML-HE-12
AC   CVCL_Z841
DR   Wikidata; Q54854296
RX   PubMed=6143720;
RX   PubMed=7636489;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by a variety of arboviruses (PubMed=6143720).
CC   Virology: Infected by Haemagogus equinus densovirus (HeDNV) (PubMed=7636489).
OX   NCBI_TaxID=53526; ! Haemagogus equinus (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   GMM-1
AC   CVCL_X711
DR   Wikidata; Q54854297
RX   PubMed=2388531;
RX   PubMed=8339071;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Erythrophore; CL=CL_0000574.
CC   Breed/subspecies: Wakin; VBO=VBO_0017501.
DI   NCIt; C134562; Goldfish erythrophoroma
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
HI   CVCL_4206 ! GEM-81
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 12
//
ID   GMMe
AC   CVCL_6397
SY   GMme1; EPI
DR   CLO; CLO_0003545
DR   ABM; T0734
DR   ATCC; CRL-2674
DR   Wikidata; Q54854298
RX   PubMed=7578673;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/gmme/gmmecells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell of uterus; CL=CL_0002149.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   GMMs
AC   CVCL_6398
SY   GMms1; STR
DR   CLO; CLO_0003546
DR   ABM; T0751
DR   ATCC; CRL-2675
DR   Wikidata; Q54854299
RX   PubMed=7578673;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   GMP-iPSCs-1
AC   CVCL_VD84
DR   Wikidata; Q54854300
RX   PubMed=26564165;
CC   From: Institute of Zoology, Chinese Academy of Sciences; Beijing; China.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD85 ! GMP-iPSCs-2
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   GMP-iPSCs-2
AC   CVCL_VD85
DR   Wikidata; Q54854301
RX   PubMed=26564165;
CC   From: Institute of Zoology, Chinese Academy of Sciences; Beijing; China.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD84 ! GMP-iPSCs-1
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   GMR11
AC   CVCL_U842
DR   Wikidata; Q54854302
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27691; Ganglioside GT1a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   GMR19
AC   CVCL_U843
DR   Wikidata; Q54854303
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   GMR2
AC   CVCL_U841
DR   Wikidata; Q54854304
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: O-acetylated-disialogangliosides.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   GMR3
AC   CVCL_U836
DR   CLO; CLO_0050335
DR   RCB; RCB2013
DR   Wikidata; Q54854305
RX   PubMed=1567198;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: N-glycolylneuraminic acid-containing gangliosides.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   GMR6
AC   CVCL_U839
DR   Wikidata; Q54854306
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_84118; Ganglioside GM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   GMR7
AC   CVCL_U840
DR   Wikidata; Q54854307
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 6
//
ID   GMR8
AC   CVCL_U837
DR   CLO; CLO_0050387
DR   RCB; RCB2015
DR   Wikidata; Q54854308
RX   PubMed=1567198;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: N-glycolylneuraminic acid-containing gangliosides.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   GMS-10
AC   CVCL_1233
SY   GMS10
DR   CLO; CLO_0003547
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473583
DR   BioSample; SAMN10988272
DR   cancercelllines; CVCL_1233
DR   Cell_Model_Passport; SIDM01074
DR   ChEMBL-Cells; CHEMBL3308105
DR   ChEMBL-Targets; CHEMBL1075449
DR   Cosmic; 687570
DR   Cosmic; 906873
DR   Cosmic; 1746948
DR   Cosmic; 2302331
DR   Cosmic; 2367528
DR   Cosmic; 2516018
DR   Cosmic-CLP; 906873
DR   DepMap; ACH-000102
DR   DSMZ; ACC-405
DR   DSMZCellDive; ACC-405
DR   EGA; EGAS00001000978
DR   GDSC; 906873
DR   GEO; GSM326239
DR   GEO; GSM887025
DR   GEO; GSM888095
DR   GEO; GSM1669812
DR   IARC_TP53; 21346
DR   LiGeA; CCLE_764
DR   LINCS_LDP; LCL-1352
DR   PharmacoDB; GMS10_407_2019
DR   Progenetix; CVCL_1233
DR   PubChem_Cell_line; CVCL_1233
DR   Wikidata; Q54854309
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=25984343); ~50-70 hours (DSMZ=ACC-405).
CC   HLA typing: A*02:01,02:01; B*38:01,44:02; C*12:03,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Homozygous (Cosmic-CLP=906873; DepMap=ACH-000102).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Homozygous (Cosmic-CLP=906873; DepMap=ACH-000102).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.11%; Native American=0%; East Asian, North=3.91%; East Asian, South=0%; South Asian=0.08%; European, North=70.41%; European, South=25.49% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=906873; DSMZ=ACC-405
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 13,17,18
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 19,24
ST   D3S1358: 14,18
ST   D5S818: 11,14
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 17
ST   Penta D: 13
ST   Penta E: 10,16
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   GMSM-K
AC   CVCL_6A82
SY   GMSMK
DR   Wikidata; Q54854310
RX   PubMed=10982956;
CC   Doubling time: ~90 hours (PubMed=10982956).
CC   Karyotypic information: 46,XY [21%]; 89-92,XXYY [79%], hypotetraploid (PubMed=10982956).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal oral cavity, mouth, labial vestibule; UBERON=UBERON_0034767.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30FW
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GMSM-K4.1
AC   CVCL_C4LL
SY   GMSM-K clone 4.1; GMSM-K (4.1); GMSMK 4.1
DR   Wikidata; Q116049081
RX   PubMed=10982956;
CC   Doubling time: ~55 hours (PubMed=10982956).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal oral cavity, mouth, labial vestibule; UBERON=UBERON_0034767.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6A82 ! GMSM-K
SX   Male
AG   30FW
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GMSM-K4.2
AC   CVCL_C4LM
SY   GMSM-K clone 4.2; GMSM-K (4.2)
DR   Wikidata; Q116049082
RX   PubMed=10982956;
CC   Doubling time: ~38 hours (PubMed=10982956).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal oral cavity, mouth, labial vestibule; UBERON=UBERON_0034767.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6A82 ! GMSM-K
SX   Male
AG   30FW
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GN
AC   CVCL_ZL19
DR   Wikidata; Q98126642
RX   PubMed=2014260;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: Transgenic with human GNRH1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   GN-1
AC   CVCL_M793
DR   Wikidata; Q54854311
RX   PubMed=11435180;
CC   Population: Japanese.
CC   Characteristics: Established from a 85th generation xenograft (MFH-R) established in nude BALB/cAJcl-nu mice.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   GN-3
AC   CVCL_M794
DR   Wikidata; Q54854312
RX   PubMed=11435180;
CC   Population: Japanese.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M793 ! GN-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   GN-CL-1
AC   CVCL_M795
DR   Wikidata; Q54854313
RX   PubMed=11435180;
CC   Population: Japanese.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M793 ! GN-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   GN-CL-2
AC   CVCL_M796
DR   Wikidata; Q54854314
RX   PubMed=11435180;
CC   Population: Japanese.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M793 ! GN-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   GN-R
AC   CVCL_XH18
DR   CCLV; CCLV-RIE 0059
DR   Wikidata; Q93934066
CC   Group: Bird cell line.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8844; ! Anser anser anser (Western greylag goose)
SX   Sex unspecified
AG   6FW
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   GN00001
AC   CVCL_JC45
SY   GN001
DR   Wikidata; Q54854315
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00016
AC   CVCL_JC46
SY   GN016
DR   Wikidata; Q54854316
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00017
AC   CVCL_JC47
SY   GN017
DR   IPD-IMGT/HLA; 10666
DR   Wikidata; Q54854317
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQA1*01,02:01; DQB1*02:02,05:03:01; DRB1*07:01,14:01; DRB3*02:01; DRB4*03:01N (IPD-IMGT/HLA=10666).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00020
AC   CVCL_JC48
SY   GN020
DR   Wikidata; Q54871585
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00027
AC   CVCL_JC49
SY   GN027
DR   Wikidata; Q54871586
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00045
AC   CVCL_JC50
SY   GN045
DR   IPD-IMGT/HLA; 10672
DR   Wikidata; Q54871588
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQA1*01:02,02:01; DQB1*06:02,02:02; DRB1*15:03,13:03; DRB3*02:02; DRB5*01:04; DRB6*02:01 (IPD-IMGT/HLA=10672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00049
AC   CVCL_JC51
SY   GN049
DR   Wikidata; Q54871589
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00053
AC   CVCL_JC52
SY   GN053
DR   Wikidata; Q54871590
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00068
AC   CVCL_JC53
SY   GN068
DR   IPD-IMGT/HLA; 10674
DR   Wikidata; Q54871591
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQA1*01,02:01; DQB1*02:02,05:03:01; DRB1*07:01,14:01; DRB3*02:05; DRB4*01:01:01 (IPD-IMGT/HLA=10674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00076
AC   CVCL_JC54
SY   GN076
DR   Wikidata; Q54871592
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00080
AC   CVCL_JC55
SY   GN080
DR   Wikidata; Q54871593
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00087
AC   CVCL_JC56
SY   GN087
DR   Wikidata; Q54871594
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00092
AC   CVCL_JC57
SY   GN092
DR   Wikidata; Q54871595
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00098
AC   CVCL_JC58
SY   GN098
DR   Wikidata; Q54871596
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00105
AC   CVCL_JD64
DR   IPD-IMGT/HLA; 10619
DR   Wikidata; Q54871597
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*07:02:01:01,15:34 (IPD-IMGT/HLA=10619).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00151
AC   CVCL_JC59
DR   IPD-IMGT/HLA; 10629
DR   Wikidata; Q54871598
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*30:02,68:01:01; B*44:02; C*05:ASHR,07; DQA1*01:02,05:03; DQB1*05:02,03:01; DRB1*16:01,11:01; DRB3*02:02; DRB5*02:04 (IPD-IMGT/HLA=10629).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   GN00218
AC   CVCL_E674
DR   dbMHC; 48868
DR   IHW; IHW09392
DR   IPD-IMGT/HLA; 10658
DR   Wikidata; Q54871599
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*03:01:01,29:02; B*58:02,47:03; C*06:02,07; DPB1*13:01,30:01; DQB1*02,04:02; DRB1*07:01:01,08:04:01; DRB4*01:01:01 (IPD-IMGT/HLA=10658).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   GN00350
AC   CVCL_6G67
DR   IPD-IMGT/HLA; 12148
DR   Wikidata; Q54871600
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24,26; B*44:02:02,55:01; DRB1*15/16,13 (IPD-IMGT/HLA=12148).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   GN1
AC   CVCL_DN35
DR   Wikidata; Q54871601
RX   PubMed=2862991;
RX   PubMed=2862992;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GN10
AC   CVCL_ZL24
SY   Gn10; Gn-10
DR   Wikidata; Q98126643
RX   PubMed=18406727;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: Transgenic with human GNRH1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZL19 ! GN
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   GN11
AC   CVCL_ZL25
SY   Gn11; Gn-11
DR   Millipore; SCC188
DR   Wikidata; Q98126644
RX   PubMed=9139717;
RX   PubMed=10830297;
RX   PubMed=15471890;
RX   PubMed=16207762;
RX   PubMed=18406727;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: Transgenic with human GNRH1 promoter-Tg(SV40).
ST   Source(s): Millipore=SCC188
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 28
ST   Mouse STR 8-1: 15
ST   Mouse STR 11-2: 15,16
ST   Mouse STR 12-1: 20
ST   Mouse STR 13-1: 15.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZL19 ! GN
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   GN11-EGFP
AC   CVCL_ZL26
SY   GN11-GFP
DR   Wikidata; Q98126645
RX   PubMed=15471890;
RX   PubMed=16207762;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: Transgenic with human GNRH1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZL25 ! GN11
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   GN2
AC   CVCL_DN36
DR   Wikidata; Q54871602
RX   PubMed=2862991;
RX   PubMed=2862992;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GN3
AC   CVCL_A284
DR   Wikidata; Q54871603
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   GN4
AC   CVCL_DN37
DR   Wikidata; Q54871604
RX   PubMed=2862991;
RX   PubMed=2862992;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GN5
AC   CVCL_A285
DR   BTO; BTO_0004338
DR   Wikidata; Q54871605
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GN6
AC   CVCL_A286
DR   Wikidata; Q54871606
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   GN7
AC   CVCL_DN38
DR   Wikidata; Q54871607
RX   PubMed=2862991;
RX   PubMed=2862992;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GNB1 FiPS1-Ep6F-1
AC   CVCL_E7SV
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+GNB1+FiPS1-Ep6F-1+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/GNB1%2520FiPS1-Ep6F-1%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4396; GNB1; Simple; p.Ile80Thr (c.239T>C); ClinVar=VCV000208722; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C215154; Intellectual developmental disorder, autosomal dominant 42
DI   ORDO; Orphanet_488613; Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GNB1 FiPS2-Ep6F-6
AC   CVCL_E7SW
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+GNB1+FiPS2-Ep6F-6+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/GNB1%2520FiPS2-Ep6F-6%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4396; GNB1; Simple; p.Ile80Thr (c.239T>C); ClinVar=VCV000208722; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D21S11: 30,32.2
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GNB1 FiPS3-Ep6F-2
AC   CVCL_E7SX
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+GNB1+FiPS3-Ep6F-2+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+GNB1+FiPS3-Ep6F-2+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4396; GNB1; Simple; p.Leu95Pro (c.284T>C); ClinVar=VCV000224716; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 6,10
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C215154; Intellectual developmental disorder, autosomal dominant 42
DI   ORDO; Orphanet_488613; Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GNB1 FiPS4-Ep6F-12
AC   CVCL_E7SY
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+GNB1+FiP4-Ep6F-12+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/GNB1%2520FiP4-Ep6F-12%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4396; GNB1; Simple; p.Leu95Pro (c.284T>C); ClinVar=VCV000224716; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 28
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GNC92H2
AC   CVCL_B0SN
DR   ABCD; ABCD_AD508
DR   Wikidata; Q108820323
RX   PubMed=10823960;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma as well as a humanized version are used in immunotherapeutical neutralization studies in rodents and human.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   GNE-587170
AC   CVCL_AT69
SY   OCI-Ly-3 Boston variant
DR   BioSample; SAMN03470848
DR   Wikidata; Q54871608
RX   PubMed=25877200;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. This cell line was mistakenly distributed by OCI to a number of groups as being OCI-Ly-3 (Cellosaurus=CVCL_8800). The real identity of this cell line is not known. From personal communication of Neve, Richard M.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00517.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 10
ST   D18S51: 18,19
ST   D21S11: 28,30
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 2.2,8
ST   Penta E: 5,8
ST   TH01: 7
ST   TPOX: 6,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Undefined cell line type
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   GNE01.23B12.H8.A4
AC   CVCL_1F97
SY   23B12
DR   Wikidata; Q54871609
RX   Patent=US8512705;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7951.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q969D9; Human TSLP.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 6
//
ID   GNM
AC   CVCL_WL58
SY   Gingival carcinoma Neck Metastasis
DR   CCTCC; GDC0185
DR   Wikidata; Q93934197
RX   PubMed=10779629;
RX   PubMed=15929393;
RX   PubMed=26116706;
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a patient with a gingival carcinoma neck metastasis.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   Go Je
AC   CVCL_3314
DR   CLO; CLO_0003548
DR   ATCC; CRL-1381
DR   BioSample; SAMN03471360
DR   Wikidata; Q54871610
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1381
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 16,24
ST   D3S1358: 13,14
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Go01
AC   CVCL_VZ56
DR   IBRC; C10032
DR   Wikidata; Q93934207
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GoBo-1
AC   CVCL_VX00
DR   IBRC; C10831
DR   Wikidata; Q93934210
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-10
AC   CVCL_VX09
DR   IBRC; C10859
DR   Wikidata; Q93934212
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   1-2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-11
AC   CVCL_VX10
DR   IBRC; C10860
DR   Wikidata; Q93934215
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-12
AC   CVCL_VX11
DR   IBRC; C10861
DR   Wikidata; Q93934217
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-13
AC   CVCL_VX12
DR   IBRC; C10862
DR   Wikidata; Q93934220
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-14
AC   CVCL_VX13
DR   IBRC; C10863
DR   Wikidata; Q93934223
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-15
AC   CVCL_VX14
DR   IBRC; C10864
DR   Wikidata; Q93934225
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-16
AC   CVCL_VX15
DR   IBRC; C10865
DR   Wikidata; Q93934228
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-17
AC   CVCL_VX16
DR   IBRC; C10866
DR   Wikidata; Q93934230
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-18
AC   CVCL_VX17
DR   IBRC; C10867
DR   Wikidata; Q93934234
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-19
AC   CVCL_VX18
DR   IBRC; C10868
DR   Wikidata; Q93934237
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-2
AC   CVCL_VX01
DR   IBRC; C10832
DR   Wikidata; Q93934240
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-20
AC   CVCL_VX19
DR   IBRC; C10869
DR   Wikidata; Q93934243
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-21
AC   CVCL_VX20
DR   IBRC; C11056
DR   Wikidata; Q93934246
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-22
AC   CVCL_VX21
DR   IBRC; C11057
DR   Wikidata; Q93934250
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-23
AC   CVCL_VX22
DR   IBRC; C11058
DR   Wikidata; Q93934253
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-24
AC   CVCL_VX23
DR   IBRC; C11059
DR   Wikidata; Q93934256
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-25
AC   CVCL_VX24
DR   IBRC; C11060
DR   Wikidata; Q93934259
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-26
AC   CVCL_VX25
DR   IBRC; C11061
DR   Wikidata; Q93934263
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-3
AC   CVCL_VX02
DR   IBRC; C10833
DR   Wikidata; Q93934267
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-4
AC   CVCL_VX03
DR   IBRC; C10835
DR   Wikidata; Q93934269
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-5
AC   CVCL_VX04
DR   IBRC; C10836
DR   Wikidata; Q93934273
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-6
AC   CVCL_VX05
DR   IBRC; C10837
DR   Wikidata; Q93934276
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-7
AC   CVCL_VX06
DR   IBRC; C10838
DR   Wikidata; Q93934279
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-8
AC   CVCL_VX07
SY   GoBo-08
DR   IBRC; C10857
DR   Wikidata; Q93934282
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1-2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoBo-9
AC   CVCL_VX08
SY   GoBo-09
DR   IBRC; C10858
DR   Wikidata; Q93934285
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Golpayegani; VBO=VBO_0004944.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   GoH3
AC   CVCL_E4RB
RX   PubMed=2426332;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P23229; Human ITGA6/CD49f.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   GOL1
AC   CVCL_YE05
DR   Wikidata; Q93934288
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=4333769;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   GOM-1
AC   CVCL_D5DE
DR   Wikidata; Q127380956
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown carbohydrate antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GOM-2
AC   CVCL_D5DF
DR   Wikidata; Q127380957
RX   PubMed=1344715;
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59045; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc (Lewis Y).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   GOM-3
AC   CVCL_D5DG
DR   Wikidata; Q127380958
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   GOM-4
AC   CVCL_D5DH
DR   Wikidata; Q127380959
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown carbohydrate antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GOM-5
AC   CVCL_D5DI
DR   Wikidata; Q127380960
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53481; Beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   GOM-6
AC   CVCL_D5DJ
DR   Wikidata; Q127380961
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown carbohydrate antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GOM-7
AC   CVCL_D5DK
DR   Wikidata; Q127380962
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown carbohydrate antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GOM-8
AC   CVCL_D5DL
DR   Wikidata; Q127380963
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown carbohydrate antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GOM-9
AC   CVCL_D5DM
DR   Wikidata; Q127380964
RX   PubMed=1398682;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Human unknown carbohydrate antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GON
AC   CVCL_WY78
SY   Gonad
DR   Wikidata; Q93934292
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   Gor
AC   CVCL_V740
DR   Wikidata; Q54871611
RX   PubMed=22552293;
RX   PubMed=22893632;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   GOS-1
AC   CVCL_A3BD
SY   GOS 1; GOS1
DR   Wikidata; Q105507457
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=9760066;
CC   Doubling time: 25 hours (PubMed=9760066).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GOS-2
AC   CVCL_A3BE
SY   GOS 2; GOS2
DR   Wikidata; Q105507460
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=9760066;
CC   Doubling time: 30 hours (PubMed=9760066).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   GOS-3
AC   CVCL_2050
SY   GOS 3; GOS3
DR   CLO; CLO_0003550
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03151979
DR   BioSample; SAMN03470943
DR   BioSample; SAMN10987798
DR   cancercelllines; CVCL_2050
DR   CCRID; 1101HUM-PUMC000467
DR   Cell_Model_Passport; SIDM01635
DR   DepMap; ACH-000027
DR   DSMZ; ACC-408
DR   DSMZCellDive; ACC-408
DR   GEO; GSM887026
DR   GEO; GSM888096
DR   IARC_TP53; 21347
DR   LiGeA; CCLE_213
DR   LINCS_LDP; LCL-1406
DR   PharmacoDB; GOS3_408_2019
DR   Progenetix; CVCL_2050
DR   Wikidata; Q54871613
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=9760066;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-343MGa derivative (PubMed=22570425). Originally thought to originate from the brain of a 55 year old patient with a mixed astro-oligodendroglioma (grade II/III).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00449.
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=9760066); ~50 hours (DSMZ=ACC-408).
CC   HLA typing: A*02:01,03:01; B*07:02,47:01; C*06:02,07:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.06%; Native American=0%; East Asian, North=2.96%; East Asian, South=0%; South Asian=0%; European, North=75.07%; European, South=20.9% (PubMed=30894373).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): DSMZ=ACC-408; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D18S51: 23
ST   D19S433: 13,14
ST   D21S11: 31 (DSMZ=ACC-408)
ST   D21S11: 31,33.2 (PubMed=25877200)
ST   D2S1338: 22,24
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,20
ST   Penta D: 9,10
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4773 ! U-343MGa
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   GOT1
AC   CVCL_L306
SY   GOTeborg 1
DR   Wikidata; Q54871614
RX   PubMed=11159212;
RX   PubMed=22538498;
RX   PubMed=29444910;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Heterozygous (PubMed=29444910).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=29444910
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   GOT3
AC   CVCL_M819
SY   GOT-3; GOTeborg 3
DR   Cosmic; 2800521
DR   Wikidata; Q54871615
RX   PubMed=18160213;
RX   PubMed=22911243;
RX   PubMed=26643872;
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   GOTO
AC   CVCL_1234
DR   BTO; BTO_0002253
DR   CLO; CLO_0037078
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471632
DR   cancercelllines; CVCL_1234
DR   Cell_Model_Passport; SIDM00544
DR   CGH-DB; 79-1
DR   CGH-DB; 9101-4
DR   ChEMBL-Cells; CHEMBL3308168
DR   ChEMBL-Targets; CHEMBL2366179
DR   Cosmic; 801735
DR   Cosmic; 906875
DR   Cosmic; 920255
DR   Cosmic; 947701
DR   Cosmic; 1037351
DR   Cosmic; 1099148
DR   Cosmic; 1153780
DR   Cosmic; 2131591
DR   Cosmic-CLP; 906875
DR   DepMap; ACH-001716
DR   EGA; EGAS00001000978
DR   GDSC; 906875
DR   GEO; GSM313801
DR   GEO; GSM333796
DR   GEO; GSM827274
DR   GEO; GSM1669813
DR   IARC_TP53; 21052
DR   JCRB; JCRB0612
DR   LINCS_LDP; LCL-1974
DR   PharmacoDB; GOTO_409_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1234
DR   PubChem_Cell_line; CVCL_1234
DR   Wikidata; Q54871616
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=201151;
RX   PubMed=470188;
RX   PubMed=9290701;
RX   PubMed=12702577;
RX   PubMed=18082704;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-564.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=470188).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (Cosmic-CLP=906875; DepMap=ACH-001716).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=74.22%; East Asian, South=25.78%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Cosmic-CLP=906875; DepMap=ACH-001716; JCRB=JCRB0612
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 15
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D21S11: 31,32,33
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18,19 (DepMap=ACH-001716)
ST   vWA: 17,19 (Cosmic-CLP=906875)
ST   vWA: 18,19 (JCRB=JCRB0612)
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   GOTO.P3
AC   CVCL_2911
SY   Goto-P3; GOTO-P3; GOTO/P3
DR   CLO; CLO_0050269
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03470916
DR   BioSample; SAMN03472373
DR   cancercelllines; CVCL_2911
DR   Cosmic; 724827
DR   Cosmic; 906876
DR   IARC_TP53; 27694
DR   JCRB; JCRB0612.1
DR   JCRB; NIHS0370
DR   RCB; RCB0721
DR   Wikidata; Q54871617
RX   PubMed=12068308;
RX   PubMed=15892104;
RX   PubMed=25877200;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=12068308).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Misspelling: GOTO?P3; BioSample=SAMN03470916; PubMed=25877200.
CC   Discontinued: JCRB; NIHS0370; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): JCRB=JCRB0612.1; PubMed=25877200; RCB=RCB0721
ST   Amelogenin: X
ST   CSF1PO: 10 (JCRB=JCRB0612.1; PubMed=25877200)
ST   CSF1PO: 10,12 (RCB=RCB0721)
ST   D13S317: 15
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 31,32
ST   D2S1338: 22,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19 (JCRB=JCRB0612.1)
ST   vWA: 18,19 (PubMed=25877200; RCB=RCB0721)
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1234 ! GOTO
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   GP+E-86
AC   CVCL_8956
AS   CVCL_3372
SY   GP+E86; GP/E-86; GP-E-86; GP-E86; GP#E86; GP E86; GPE 86
DR   CLO; CLO_0003551
DR   CLDB; cl7177
DR   ATCC; CRL-3620
DR   ATCC; CRL-9642
DR   ICLC; HTL06007
DR   TOKU-E; 1339
DR   Wikidata; Q54871620
RX   Patent=US5278056;
RX   PubMed=2831375;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9642.
CC   Discontinued: ATCC; CRL-9642; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 16
//
ID   GP+envAM-12
AC   CVCL_8957
SY   GP+envAm12; GP-envAm12; GP/envAm12
DR   CLO; CLO_0003552
DR   ATCC; CRL-9641
DR   TOKU-E; 1340
DR   Wikidata; Q54871621
RX   Patent=US5278056;
RX   PubMed=2462307;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9641.
CC   Discontinued: ATCC; CRL-9641; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   GP-1
AC   CVCL_2449
DR   JCRB; JCRB1366
DR   Wikidata; Q54871618
RX   PubMed=10195239;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   GP-H1
AC   CVCL_BT09
SY   GPH4; KB-CPO; CPO-KCB
DR   CCRID; 5301MAM-KCB03001ZJ
DR   KCB; KCB 200301ZJ
DR   Wikidata; Q54871643
RX   PubMed=26010445;
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   GP-H2
AC   CVCL_A9GB
DR   CCRID; 5301MAM-KCB110104H
DR   KCB; KCB 2011104H
DR   Wikidata; Q108820324
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
OI   CVCL_A9GC ! GP-K1
OI   CVCL_A9GE ! GP-L2
OI   CVCL_A9GF ! GP-M2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-K1
AC   CVCL_A9GC
DR   CCRID; 5301MAM-KCB110104K
DR   KCB; KCB 2011104K
DR   Wikidata; Q108820325
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
OI   CVCL_A9GB ! GP-H2
OI   CVCL_A9GE ! GP-L2
OI   CVCL_A9GF ! GP-M2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-L1
AC   CVCL_A9GD
SY   GPL1
DR   CCRID; 5301MAM-KCB84004ZJ
DR   KCB; KCB 84004ZL
DR   Wikidata; Q108820326
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-L2
AC   CVCL_A9GE
DR   CCRID; 5301MAM-KCB110104L
DR   KCB; KCB 2011104L
DR   Wikidata; Q108820327
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
OI   CVCL_A9GB ! GP-H2
OI   CVCL_A9GC ! GP-K1
OI   CVCL_A9GF ! GP-M2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-M2
AC   CVCL_A9GF
DR   CCRID; 5301MAM-KCB110104R
DR   KCB; KCB 2011104R
DR   Wikidata; Q108820328
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
OI   CVCL_A9GB ! GP-H2
OI   CVCL_A9GC ! GP-K1
OI   CVCL_A9GE ! GP-L2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-S2
AC   CVCL_A9GG
DR   CCRID; 5301MAM-KCB01006ZJ
DR   KCB; KCB 200106ZJ
DR   Wikidata; Q108820329
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-S3
AC   CVCL_A9GH
SY   GPS5
DR   CCRID; 5301MAM-KCB03002ZJ
DR   KCB; KCB 200302ZJ
DR   Wikidata; Q108820330
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-S4
AC   CVCL_A9GI
DR   CCRID; 5301MAM-KCB110104S
DR   KCB; KCB 2011104S
DR   Wikidata; Q108820331
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GP-SMDCL
AC   CVCL_1F98
SY   Giant Panda-Skeletal Muscle-Derived Cell Line
DR   Wikidata; Q54871619
RX   PubMed=26035009;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: ~33.8 hours (PubMed=26035009).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9646; ! Ailuropoda melanoleuca (Giant panda)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   GP1
AC   CVCL_DN39
DR   Wikidata; Q54871623
RX   PubMed=2862991;
RX   PubMed=2862992;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GP10
AC   CVCL_A291
DR   Wikidata; Q54871624
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   GP101
AC   CVCL_1J87
SY   GP 101
DR   Wikidata; Q54871625
RX   Patent=US7015035;
RX   PubMed=14599814;
CC   Group: Retrovirus packaging cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8957 ! GP+envAM-12
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GP11
AC   CVCL_A2FK
DR   ABM; T0865
DR   Wikidata; Q105507463
RX   PubMed=32432378;
CC   Characteristics: Expresses GNRH1, GPR54 and ESR2, but not ESR1. Secretes GnRH peptides and responds to kisspeptin (PubMed=32432378).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain, hypothalamus, preoptic area; UBERON=UBERON_0006238+UBERON_0001928.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: Shiba; VBO=VBO_0017514.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_A2FJ ! GA28
OI   CVCL_A2FL ! GP31
OI   CVCL_A2FM ! GP64
SX   Female
AG   118FD
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   GP2
AC   CVCL_A287
DR   Wikidata; Q54871626
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   GP2-293
AC   CVCL_WI48
DR   Lonza; 1435
DR   Wikidata; Q93934414
WW   Provider; Takara Bio; 631458; https://www.takarabio.com/documents/Certificate%20of%20Analysis/631458/631458.pdf
WW   Provider; Takara Bio; 631458; https://www.takarabio.com/products/gene-function/viral-transduction/retrovirus/packaging-systems-and-cells
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   GP202
AC   CVCL_S967
SY   GP-202
DR   BTO; BTO_0005459
DR   cancercelllines; CVCL_S967
DR   Cosmic; 887258
DR   Cosmic; 2036666
DR   GEO; GSM322176
DR   Progenetix; CVCL_S967
DR   Wikidata; Q54871630
RX   PubMed=8925130;
RX   PubMed=19563644;
CC   Characteristics: Established from a fourth passage nude mice xenograft.
CC   Doubling time: 35 hours (PubMed=8925130).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   GP220
AC   CVCL_S968
SY   IPA220; IPA-220; IPA220A
DR   BTO; BTO_0005466
DR   cancercelllines; CVCL_S968
DR   Cosmic; 887257
DR   Cosmic; 1460706
DR   Cosmic; 2036665
DR   GEO; GSM322179
DR   Progenetix; CVCL_S968
DR   Wikidata; Q54871631
RX   PubMed=8925130;
RX   PubMed=19563644;
CC   Characteristics: Established from a second passage nude mice xenograft.
CC   Doubling time: 22 hours (PubMed=8925130).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   GP2d
AC   CVCL_2450
SY   Gp2d; Gp2D; GP2D
DR   CLO; CLO_0003554
DR   CLO; CLO_0009961
DR   EFO; EFO_0006575
DR   CLDB; cl1511
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472980
DR   BioSample; SAMN10988004
DR   cancercelllines; CVCL_2450
DR   Cell_Model_Passport; SIDM00536
DR   ColonAtlas; GP2d
DR   Cosmic; 907292
DR   Cosmic; 948863
DR   Cosmic; 995380
DR   Cosmic; 1223138
DR   Cosmic; 1609504
DR   Cosmic; 2301973
DR   DepMap; ACH-000982
DR   ECACC; 95090714
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM887027
DR   GEO; GSM888097
DR   GEO; GSM1346870
DR   GEO; GSM1374483
DR   GEO; GSM1448105
DR   IARC_TP53; 21352
DR   LiGeA; CCLE_010
DR   LINCS_LDP; LCL-1188
DR   PharmacoDB; Gp2D_410_2019
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Progenetix; CVCL_2450
DR   Wikidata; Q54871632
RX   PubMed=7601566;
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/GP2d.html
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30-32 hours (PubMed=7601566); 27 hours (PubMed=25984343).
CC   HLA typing: A*24:02,24:02; B*44:02,44:02; C*05:01,05:01; DQA1*03:02,05:02; DQB1*06:13,06:13; DRB1*04:05,15:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=24755471; PubMed=25926053; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7601566; DepMap=ACH-000982).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.09%; East Asian, South=0%; South Asian=0%; European, North=74.93%; European, South=24.97% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=95090714; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1235 ! GP5d
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   GP31
AC   CVCL_A2FL
DR   ABM; T0866
DR   Wikidata; Q105507467
RX   PubMed=32432378;
CC   Characteristics: Expresses GNRH1, GPR54 and ESR2, but not ESR1. Secretes GnRH peptides and responds to kisspeptin (PubMed=32432378).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain, hypothalamus, preoptic area; UBERON=UBERON_0006238+UBERON_0001928.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: Shiba; VBO=VBO_0017514.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_A2FJ ! GA28
OI   CVCL_A2FK ! GP11
OI   CVCL_A2FM ! GP64
SX   Female
AG   118FD
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   GP4
AC   CVCL_A288
DR   Wikidata; Q54871633
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   GP5d
AC   CVCL_1235
SY   Gp5d; Gp5D; GP5D
DR   CLO; CLO_0003555
DR   EFO; EFO_0006576
DR   CLDB; cl1512
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 877
DR   BioSample; SAMN03472981
DR   cancercelllines; CVCL_1235
DR   Cell_Model_Passport; SIDM00537
DR   ChEMBL-Cells; CHEMBL3308735
DR   ChEMBL-Targets; CHEMBL1075450
DR   ColonAtlas; GP5d
DR   Cosmic; 907291
DR   Cosmic; 995384
DR   Cosmic; 1043811
DR   Cosmic; 1479572
DR   Cosmic; 1609497
DR   Cosmic; 1803941
DR   Cosmic; 2301974
DR   Cosmic; 2800587
DR   Cosmic-CLP; 907291
DR   DepMap; ACH-001345
DR   ECACC; 95090715
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907291
DR   GEO; GSM827313
DR   GEO; GSM1346871
DR   GEO; GSM1448106
DR   GEO; GSM1669814
DR   IARC_TP53; 21348
DR   LINCS_LDP; LCL-1176
DR   PharmacoDB; GP5d_411_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1235
DR   PubChem_Cell_line; CVCL_1235
DR   Wikidata; Q54871634
RX   PubMed=7601566;
RX   PubMed=10051639;
RX   PubMed=10737795;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 30-32 hours (PubMed=7601566); 60.06 hours (PubMed=25944804).
CC   HLA typing: A*24:02,24:02; B*44:02,44:02; C*05:01,05:01; DQB1*06:02,06:02; DRB1*04:05,15:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=24755471; PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7601566; PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=20570890).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.21%; East Asian, South=0%; South Asian=0%; European, North=75.24%; European, South=24.54% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=907291; DepMap=ACH-001345; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2450 ! GP2d
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   GP6
AC   CVCL_A289
DR   BTO; BTO_0004335
DR   Wikidata; Q54871635
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   GP64
AC   CVCL_A2FM
DR   ABM; T0867
DR   Wikidata; Q105507470
RX   PubMed=33100283;
CC   Characteristics: Expresses kisspeptin and ER-alpha both at the mRNA and protein levels and responds to estrogen, similar to endogenous preoptic area kisspeptin neurons, which mediate estrogen positive feedback and regulate GnRH/LH surge (PubMed=33100283).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain, hypothalamus, preoptic area; UBERON=UBERON_0006238+UBERON_0001928.
CC   Cell type: Kisspeptin neuron; CL=CL_4023130.
CC   Breed/subspecies: Shiba; VBO=VBO_0017514.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_A2FJ ! GA28
OI   CVCL_A2FK ! GP11
OI   CVCL_A2FL ! GP31
SX   Female
AG   118FD
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   GP8 [Mouse]
AC   CVCL_5510
DR   JCRB; JCRB1198
DR   JCRB; JCRB1198.01
DR   Wikidata; Q54871636
RX   PubMed=11504597;
RX   PubMed=27844419;
CC   Problematic cell line: Contaminated/misidentified. Not from strain C57BL/6 as originally assigned but from a C57BL/6 x CBA cross (PubMed=27844419).
CC   Knockout cell: Method=KO mouse; MGI; MGI:88151; Glb1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4298; GLB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E938 ! SV
AG   4D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   GP8 [Rat brain]
AC   CVCL_0280
SY   IO/GP8
DR   MCCL; MCC:0000171
DR   Wikidata; Q54871637
RX   DOI=10.1007/978-1-4757-9489-2_46;
RX   PubMed=8982103;
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Endothelial cell of cerebral cortex; CL=CL_1001602.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   4-6W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   GP8 [Rat liver transformed]
AC   CVCL_DN34
DR   Wikidata; Q54871638
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   GP8.3
AC   CVCL_T959
SY   GP8/3; IO/GP8/3
DR   Wikidata; Q54871639
RX   DOI=10.1007/978-1-4757-9489-2_46;
RX   PubMed=8982103;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Endothelial cell of cerebral cortex; CL=CL_1001602.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0280 ! GP8 [Rat brain]
SX   Female
AG   4-6W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   GP8/3.9
AC   CVCL_XG70
DR   Wikidata; Q93934495
RX   PubMed=10734001;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Endothelial cell of cerebral cortex; CL=CL_1001602.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T959 ! GP8.3
SX   Female
AG   4-6W
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   GP9
AC   CVCL_A290
DR   Wikidata; Q54871640
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=2880659;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_DN33 ! WB-5-11
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   GPASE
AC   CVCL_A8RX
SY   Guinea pig Placental Amniotic Sac Epithelial
DR   Wikidata; Q108820332
RX   PubMed=32068527;
CC   Virology: Susceptible to infection by guinea pig cytomegalovirus (GPCMV) (PubMed=32068527).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   GPC-16
AC   CVCL_3463
DR   CLO; CLO_0003556
DR   ATCC; CCL-242
DR   Wikidata; Q54871641
RX   PubMed=7237435;
RX   PubMed=32226606;
CC   Virology: Susceptible to infection and early propagation by guinea pig adenovirus (GPAdV) (PubMed=32226606).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C134563; Guinea pig colon adenocarcinoma
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   GPC3-7C8
AC   CVCL_A0PN
SY   7C8
DR   CCRID; 4201PAT-CCTCC00332
DR   Wikidata; Q108820333
RX   Patent=CN102276721B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201009.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   GPCCi001-A
AC   CVCL_QX39
DR   hPSCreg; GPCCi001-A
DR   Wikidata; Q54871642
RX   PubMed=28395738;
CC   From: Greater Poland Cancer Centre (GPCC), Poznan University of Medical Sciences; Poznan; Poland.
CC   Donor information: Established from a patient suffering from breast cancer.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   GPF
AC   CVCL_E7B7
SY   Golden Pompano Fin
RX   PubMed=38636741;
CC   Group: Fish cell line.
CC   Characteristics: Cadmium (Cd), copper (Cu) and iron (Fe) are toxic to this cell line with Cd the most toxic (PubMed=38636741).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GPF-1
AC   CVCL_C0XK
SY   Giant Panda Fibroblast-1
DR   Wikidata; Q114311539
RX   PubMed=35362864;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: ~26 hours (PubMed=35362864).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9646; ! Ailuropoda melanoleuca (Giant panda)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   GPG
AC   CVCL_C3MH
SY   Gymnocypris Przewalskii Gill
DR   Wikidata; Q116049083
RX   PubMed=36373002;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 28 Celsius (PubMed=36373002).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=75348; ! Gymnocypris przewalskii (Przewalski's naked carp)
SX   Sex unspecified
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GPK
AC   CVCL_E9XB
SY   Guinea Pig Keratocyte
RX   Patent=US4780412;
RX   PubMed=3920046;
RX   PubMed=6123842;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-221.
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GPK-AI_D1
AC   CVCL_C7F6
SY   Guinea-Pig Kidney-Artifically Immortalized clone D1
DR   Wikidata; Q117704455
RX   PubMed=36631081;
CC   Virology: Susceptible to infection by classical swine fever virus (CSFV) strain GPE- (PubMed=36631081).
CC   Doubling time: 50.87 +- 5.24 hours (PubMed=36631081).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
OI   CVCL_C7F7 ! GPK-AI_F5
OI   CVCL_C7F8 ! GPK-SI
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   GPK-AI_F5
AC   CVCL_C7F7
SY   Guinea-Pig Kidney-Artifically Immortalized clone F5
DR   Wikidata; Q117704456
RX   PubMed=36631081;
CC   Virology: Susceptible to infection by classical swine fever virus (CSFV) strain GPE- (PubMed=36631081).
CC   Doubling time: 61.28 +- 9.55 hours (PubMed=36631081).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
OI   CVCL_C7F6 ! GPK-AI_D1
OI   CVCL_C7F8 ! GPK-SI
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   GPK-SI
AC   CVCL_C7F8
SY   Guinea-Pig Kidney-Spontaneously Immortalized
DR   Wikidata; Q117704457
RX   PubMed=36631081;
CC   Virology: Susceptible to infection by classical swine fever virus (CSFV) strain GPE- (PubMed=36631081).
CC   Doubling time: 87.82 +- 12.49 hours (Note=At 27th passage) (PubMed=36631081).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
OI   CVCL_C7F6 ! GPK-AI_D1
OI   CVCL_C7F7 ! GPK-AI_F5
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   GPM
AC   CVCL_E7B6
SY   Golden Pompano Muscle
RX   DOI=10.1016/j.aquaculture.2023.740286;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by red-spotted grouper nervous necrosis virus (RGNNV) (DOI=10.1016/j.aquaculture.2023.740286).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=173339; ! Trachinotus ovatus (Derbio)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GPM-1
AC   CVCL_S833
DR   Wikidata; Q54871644
RX   PubMed=22450770;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   GPM-2
AC   CVCL_S834
DR   Wikidata; Q54871645
RX   PubMed=22450770;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GPNT
AC   CVCL_T962
SY   GP8 NeuroTech
DR   ABM; T0685
DR   ECACC; 09061601
DR   Wikidata; Q54871646
RX   PubMed=10537053;
CC   Doubling time: ~10 hours (ECACC=09061601).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Endothelial cell of cerebral cortex; CL=CL_1001602.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T959 ! GP8.3
SX   Female
AG   4-6W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   GPS
AC   CVCL_DF53
SY   Golden Pompano Snout
DR   Wikidata; Q54871647
RX   PubMed=27146361;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=173339; ! Trachinotus ovatus (Derbio)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
ID   GPS-M
AC   CVCL_1R31
SY   Guinea Pig Spleen-Michigan
DR   BioSample; SAMN03151927
DR   Wikidata; Q54871648
RX   PubMed=4943055;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of guinea pig origin but found to be from mouse (PubMed=4943055; PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00049.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4535 ! L-M
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GPS-PD
AC   CVCL_1R32
SY   Guinea Pig Spleen-Parke Davies
DR   BioSample; SAMN03151928
DR   Wikidata; Q54871649
RX   PubMed=4943055;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of guinea pig origin but found to be from mouse (PubMed=4943055; PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00050.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4535 ! L-M
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   GPSM4
AC   CVCL_RB21
DR   Wikidata; Q54871650
RX   PubMed=7585498;
CC   From: Pulido-Cejudo, Gabriel; Health Canada; Ottawa; Canada.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 6
//
ID   GPSM5
AC   CVCL_RB22
DR   Wikidata; Q54871651
RX   PubMed=7585498;
CC   From: Pulido-Cejudo, Gabriel; Health Canada; Ottawa; Canada.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 6
//
ID   GPTEC-T
AC   CVCL_XI43
SY   Guinea Pig Tracheal Epithelial Cells-T antigen transformed
DR   Wikidata; Q93934594
RX   PubMed=32226606;
CC   Virology: Susceptible to infection and early propagation by guinea pig adenovirus (GPAdV) (PubMed=32226606).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSVneoT).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   GQPC2.27
AC   CVCL_LC03
SY   PC2.27
DR   Wikidata; Q54871652
RX   Patent=WO1997036930A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 93113040.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse cytoskeleton 51 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   GR [Human LCL]
AC   CVCL_C5VZ
DR   PRIDE; PXD004233
DR   Wikidata; Q116049084
RX   PubMed=24616531;
RX   PubMed=26280087;
RX   PubMed=34925382;
CC   HLA typing: A*01:01,03:01; B*07:02,27:05; C*02:02,07:02 (PubMed=34925382).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GR [Mouse liver]
AC   CVCL_HA25
DR   BCRJ; 0093
DR   Wikidata; Q54871707
RX   PubMed=2126187;
CC   Characteristics: Established from fibrotic granulomas induced in C3H/HeN mice liver by experimental infection with Schistosoma mansoni (PubMed=2126187).
CC   Derived from site: In situ; Liver; Note=From a granulomatous inflammation; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   GR [Mouse mammary tumor]
AC   CVCL_WL69
SY   GR-3A; GR-M
DR   CCRID; 4201MOU-CCTCC00026
DR   CCTCC; GDC0026
DR   Wikidata; Q93934613
RX   PubMed=49975;
RX   PubMed=189932;
RX   PubMed=212202;
CC   Characteristics: Secretes MMTV.
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 6
//
ID   GR-20
AC   CVCL_9177
DR   CLO; CLO_0003557
DR   ATCC; CRL-2024
DR   Wikidata; Q54871654
RX   PubMed=2477471;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01580; Mouse Ifng.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   GR-34
AC   CVCL_VU52
SY   GR 34
DR   Cosmic; 2759414
DR   Wikidata; Q93934627
RX   PubMed=10395107;
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.45_48delTTCT); Zygosity=Hemizygous (PubMed=10395107).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU53 ! GR-34-EBV
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   GR-34-EBV
AC   CVCL_VU53
SY   GR 34 EBV
DR   Wikidata; Q93934630
RX   PubMed=10395107;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU52 ! GR-34
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   GR-96
AC   CVCL_9178
DR   CLO; CLO_0003560
DR   ATCC; CRL-2013
DR   Wikidata; Q54871655
RX   PubMed=1376354;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; P15261; Mouse Ifngr1/Cd119.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   GR-M
AC   CVCL_2451
SY   GRM
DR   CLO; CLO_0003564
DR   EFO; EFO_0006577
DR   CLDB; cl1513
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472907
DR   BioSample; SAMN10988055
DR   cancercelllines; CVCL_2451
DR   Cell_Model_Passport; SIDM00468
DR   Cosmic; 2163785
DR   DepMap; ACH-001072
DR   ECACC; 95032301
DR   EGA; EGAS00001000610
DR   ESTDAB; ESTDAB-036
DR   IARC_TP53; 21349
DR   PharmacoDB; GRM_412_2019
DR   Progenetix; CVCL_2451
DR   Wikidata; Q54871656
RX   PubMed=7780963;
RX   PubMed=15592718;
RX   PubMed=23851445;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PSN1 derivative (PubMed=25877200). Originally thought to originate from the chest of a 36 year old male melanoma patient with skin metastases.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00538.
CC   Population: Japanese.
CC   HLA typing: A*24:02,24:02; B*52:01:01,52:01:01; C*12:02,12:02; DPB1*09:01; DQB1*06:02,06:01:01; DRB1*15:01 (PubMed=15592718).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (DepMap=ACH-001072).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (PubMed=23851445; DepMap=ACH-001072).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.55%; East Asian, South=15.04%; South Asian=1.41%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: ESTDAB; ESTDAB-036; probable.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D18S51: 21
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 14,15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1644 ! PSN1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   GR-Mel
AC   CVCL_7045
DR   Cosmic; 1109806
DR   Cosmic; 1295327
DR   Wikidata; Q54871657
RX   PubMed=11121133;
RX   PubMed=11851879;
RX   PubMed=18384130;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Microsatellite instability: Stable (MSS) (PubMed=11851879).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   GR-Mel-3
AC   CVCL_C497
DR   cancercelllines; CVCL_C497
DR   Cosmic; 2163844
DR   ESTDAB; ESTDAB-157
DR   Wikidata; Q54871658
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-157
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 9,12
ST   FGA: 20
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   GR-Mel-8
AC   CVCL_C498
DR   cancercelllines; CVCL_C498
DR   Cosmic; 2163845
DR   ESTDAB; ESTDAB-158
DR   Wikidata; Q54871659
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-158
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D3S1358: 16,17
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   FGA: 23.2,24
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   GR-Mel-9
AC   CVCL_C499
DR   Cosmic; 2163846
DR   ESTDAB; ESTDAB-159
DR   Wikidata; Q54871660
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Ser (c.404G>C); Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-159
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   GR-OH1
AC   CVCL_S864
SY   GR-OH-1; GROH1
DR   Wikidata; Q54871661
RX   PubMed=9393981;
RX   PubMed=12904596;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=9393981).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   GR-ST
AC   CVCL_1236
SY   GRST
DR   CLO; CLO_0050981
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472171
DR   cancercelllines; CVCL_1236
DR   Cell_Model_Passport; SIDM01259
DR   ChEMBL-Cells; CHEMBL3308529
DR   ChEMBL-Targets; CHEMBL2366111
DR   Cosmic; 906877
DR   Cosmic-CLP; 906877
DR   DepMap; ACH-002238
DR   EGA; EGAS00001000978
DR   GDSC; 906877
DR   GEO; GSM1669816
DR   IARC_TP53; 21350
DR   LINCS_LDP; LCL-1045
DR   PharmacoDB; GRST_413_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1236
DR   RCB; RCB1182
DR   Wikidata; Q54871662
RX   PubMed=7538617;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asp361Gly (c.1082A>G); Zygosity=Heterozygous (Cosmic-CLP=906877; DepMap=ACH-002238).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Lys193fs*30 (c.576_580delCAAGT); Zygosity=Heterozygous (Cosmic-CLP=906877; DepMap=ACH-002238).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Thr (c.737T>C); ClinVar=VCV000428886; Zygosity=Heterozygous (Cosmic-CLP=906877; DepMap=ACH-002238).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2439; CSF3R.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=74.6%; East Asian, South=25.39%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=906877; RCB=RCB1182
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 11,12
ST   D16S539: 12,13 (Cosmic-CLP=906877)
ST   D16S539: 12,13,14 (RCB=RCB1182)
ST   D5S818: 10,11,12 (RCB=RCB1182)
ST   D5S818: 10,12 (Cosmic-CLP=906877)
ST   D7S820: 10,11
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 14,18,19 (RCB=RCB1182)
ST   vWA: 14,19 (Cosmic-CLP=906877)
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U347 ! ST [Human leukemia]
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   GR1202
AC   CVCL_F553
SY   Extract 285; Extract 327
DR   IPD-IMGT/HLA; 13137
DR   Wikidata; Q54871663
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02,26:01; B*15:80,51:01; C*07:04,14:BE; DQB1*04:02; DRB1*08:01:01 (IPD-IMGT/HLA=13137).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   Gr431
AC   CVCL_8958
SY   Gr-431
DR   CLO; CLO_0003558
DR   ATCC; HB-8575
DR   Wikidata; Q54871664
RX   Patent=US4695538;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8575.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   GR7A4
AC   CVCL_D5GI
DR   Wikidata; Q127380965
RX   PubMed=3036690;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   GRA
AC   CVCL_UD51
DR   Wikidata; Q93934708
RX   PubMed=1997098;
RX   PubMed=2789934;
RX   PubMed=3182331;
CC   Doubling time: 48 hours (PubMed=3182331).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   Grace-HSA
AC   CVCL_0D04
DR   Kerafast; EMN016-FP
DR   Wikidata; Q54871665
CC   Doubling time: ~1 week (Kerafast=EMN016-FP).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Portuguese water dog; VBO=VBO_0201077.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   Gracie
AC   CVCL_L353
DR   GEO; GSM1974789
DR   Wikidata; Q54871668
RX   PubMed=21908323;
RX   PubMed=22916246;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
RX   PubMed=36099278;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 19.2 hours (PubMed=22916246); 19 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:46802; SRGAP3; Simple; p.Val850fs (c.2548dupG); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231,235
ST   Dog FHC2054: 156,172
ST   Dog FHC2079: 275,279
ST   Dog PEZ1: 115
ST   Dog PEZ3: 124,127
ST   Dog PEZ5: 111
ST   Dog PEZ6: 179,183
ST   Dog PEZ8: 240
ST   Dog PEZ12: 270,274
ST   Dog PEZ20: 180
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   Granta-380
AC   CVCL_DH42
SY   Granta 380
DR   Cosmic; 2297015
DR   Wikidata; Q54871669
RX   PubMed=16960149;
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   Granta-452
AC   CVCL_1817
SY   GRANTA-452; Granta 452; GRANTA 452
DR   BioSample; SAMN03473396
DR   cancercelllines; CVCL_1817
DR   Cosmic; 2297014
DR   DSMZ; ACC-713
DR   DSMZCellDive; ACC-713
DR   GEO; GSM119556
DR   Progenetix; CVCL_1817
DR   Wikidata; Q54871670
RX   PubMed=7849311;
RX   PubMed=16960149;
RX   PubMed=26727417;
CC   Doubling time: ~48 hours (DSMZ=ACC-713).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): DSMZ=ACC-713
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 15
ST   D21S11: 28,31
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 11
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 12,17
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   Granta-519
AC   CVCL_1818
SY   GRANTA-519; Granta 519; Granta519; GRANTA519; G-519; G519
DR   CLO; CLO_0003561
DR   EFO; EFO_0005369
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03472258
DR   BioSample; SAMN10988429
DR   cancercelllines; CVCL_1818
DR   Cell_Model_Passport; SIDM01058
DR   ChEMBL-Cells; CHEMBL4483170
DR   ChEMBL-Targets; CHEMBL4483240
DR   Cosmic; 1037808
DR   Cosmic; 1047113
DR   Cosmic; 1291032
DR   Cosmic; 1881780
DR   Cosmic; 2296989
DR   Cosmic; 2756233
DR   Cosmic-CLP; 1303897
DR   DepMap; ACH-000073
DR   DSMZ; ACC-342
DR   DSMZCellDive; ACC-342
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1303897
DR   GEO; GSM95562
DR   GEO; GSM95567
DR   GEO; GSM104459
DR   GEO; GSM115802
DR   GEO; GSM155069
DR   GEO; GSM155070
DR   GEO; GSM155071
DR   GEO; GSM274840
DR   GEO; GSM629484
DR   GEO; GSM629485
DR   GEO; GSM827167
DR   GEO; GSM887028
DR   GEO; GSM888098
DR   GEO; GSM907517
DR   GEO; GSM1266777
DR   GEO; GSM1266778
DR   GEO; GSM1374484
DR   GEO; GSM1669815
DR   GEO; GSM2322618
DR   GEO; GSM3150245
DR   IARC_TP53; 25016
DR   LiGeA; CCLE_863
DR   LINCS_LDP; LCL-1126
DR   Lonza; 257
DR   PharmacoDB; GRANTA519_414_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD020750
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1818
DR   PubChem_Cell_line; CVCL_1818
DR   Wikidata; Q54871671
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7849311;
RX   PubMed=8036001;
RX   PubMed=9001420;
RX   PubMed=12169673;
RX   PubMed=12683869;
RX   PubMed=15350304;
RX   PubMed=16448697;
RX   PubMed=16960149;
RX   PubMed=17332242;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=21746927;
RX   PubMed=22460905;
RX   PubMed=24362935;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26194763;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-25.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/granta519-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (DSMZ=ACC-342).
CC   HLA typing: A*02:05,02:05; B*07:02,50:01; C*06:02,07:02; DQA1*05:01,01:02; DQB1*06:02,03:01; DRB1*11:03,15:01 (PubMed=25960936).
CC   HLA typing: A*02,02; B*07,50; C*06,07 (PubMed=25688540).
CC   HLA typing: A*02:05,02:05; B*07:02,50:01; C*06:02,07:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,02:05:01; B*07:02:01,50:01:01; C*06:02:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:01,05:05:01; DQB1*03:01:01,06:02:01; DRA*01:01:01,01:02:03; DRB1*11:03:01,15:01:01 (DSMZCellDive=ACC-342).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16448697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.28%; Native American=0%; East Asian, North=1.9%; East Asian, South=0%; South Asian=0%; European, North=66.14%; European, South=30.67% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1303897; DSMZ=ACC-342; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11,12 (Cosmic-CLP=1303897)
ST   D16S539: 12 (DSMZ=ACC-342; PubMed=25877200)
ST   D18S51: 17,18
ST   D19S433: 12,13
ST   D21S11: 28,30
ST   D2S1338: 16,17
ST   D3S1358: 15,16
ST   D5S818: 9,13
ST   D7S820: 10,14
ST   D8S1179: 14,15
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   Granta-519/Cas9-hyg
AC   CVCL_C9EY
SY   Granta-519-Cas9-hyg
DR   GeneCopoeia; SL583
DR   Wikidata; Q123031371
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL583).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1818 ! Granta-519
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   Granta-56
AC   CVCL_0T64
SY   Granta 56
DR   Wikidata; Q54871672
RX   PubMed=7849311;
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 6
//
ID   Gratch
AC   CVCL_X046
SY   GRATCH
DR   Cosmic; 844344
DR   Wikidata; Q54871674
RX   PubMed=9698466;
CC   From: Wang, Nancy; University of Rochester; New York; USA.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 6
//
ID   GrB
AC   CVCL_B6Y1
SY   Gobiocypris rarus Brain
DR   Wikidata; Q111733247
RX   DOI=10.1111/are.15702;
CC   Group: Fish cell line.
CC   Characteristics: Can grow between 22 to 27 Celsius, with an optimal growth temperature of 27 Celsius (DOI=10.1111/are.15702).
CC   Virology: Susceptible to infection by tilapia lake virus 2017A (TiLV-2017A) (DOI=10.1111/are.15702).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=143606; ! Gobiocypris rarus (Chinese rare minnow)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   GRB-PAP1
AC   CVCL_9702
DR   Wikidata; Q54871675
RX   PubMed=2493741;
RX   PubMed=3303963;
CC   Derived from site: In situ; Kidney, renal papilla; UBERON=UBERON_0001228.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   GRB-S1
AC   CVCL_A9IF
SY   GRBS1
DR   CCRID; 5301MAM-KCB04046ZJ
DR   KCB; KCB 200446ZJ
DR   Wikidata; Q108820334
CC   Group: Bat cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=186990; ! Hipposideros armiger (Great Himalayan leaf-nosed bat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GRC-138
AC   CVCL_E675
SY   GRC 138; GRC138; TER262; TER-262; Ter 262; TER314; TER-314; Ter 314; TER326; TER-326; Ter 326; TER447; TER-447; Ter 447; Extract 130; Extract 239; Extract 362
DR   dbMHC; 48870
DR   ECACC; 94071442
DR   IHW; IHW09365
DR   IPD-IMGT/HLA; 10682
DR   Wikidata; Q54871676
RX   PubMed=9331945;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/354cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Guarani.
CC   HLA typing: A*02:01:01:01,02:11:01; B*15:04:01,40:03; C*03:03:01,03:04:01:02; DPA1*01:03:01:05; DPB1*04:02:01:02; DQA1*05:03,05:05:01:06; DQB1*03:01:01:01; DRB1*14:13,16:02:01; DRB3*01:01:02; DRB5*02:02 (IPD-IMGT/HLA=10682).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   GRC-150
AC   CVCL_E676
SY   GRC 150; GRC150
DR   dbMHC; 48871
DR   IHW; IHW09362
DR   IPD-IMGT/HLA; 10683
DR   Wikidata; Q54871677
RX   PubMed=9331945;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Guarani.
CC   HLA typing: A*02:01:01:01,31:01:02; B*51:04,15:04; C*03:03:01,15:03; DPA1*01:03; DPB1*04:01,04:02 (IPD-IMGT/HLA=10683).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   GRC-181
AC   CVCL_LN21
SY   GRC181
DR   Wikidata; Q54871678
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Guarani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   GRC-187
AC   CVCL_E677
SY   GRC 187; GRC187
DR   dbMHC; 48872
DR   ECACC; 94071443
DR   IHW; IHW09363
DR   IPD-IMGT/HLA; 10684
DR   Wikidata; Q54871679
RX   PubMed=9331945;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Guarani.
CC   HLA typing: A*68:01:02,31:01:02; B*35:11,15:04; C*03:03:01,03:04:01; DPA1*01:03; DPB1*04:01,04:02 (IPD-IMGT/HLA=10684).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   GRC-191
AC   CVCL_LN22
SY   GRC191
DR   Wikidata; Q54871680
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Guarani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   GRC-192
AC   CVCL_LN23
SY   GRC192
DR   Wikidata; Q54871681
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Guarani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   GRC-212
AC   CVCL_E678
SY   GRC 212; GRC212
DR   dbMHC; 48873
DR   ECACC; 94071444
DR   IHW; IHW09364
DR   IPD-IMGT/HLA; 10685
DR   Wikidata; Q54871683
RX   PubMed=9331945;
RX   PubMed=29171935;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Guarani.
CC   HLA typing: A*68:01:02:01,02:11:01; B*35:05:01:02,40:04; C*04:01:01:01,03:04:01:02; DPA1*02:01:01; DPB1*27:01; DQA1*03:01:01,03:02; DQB1*03:02:01,03:03:02; DRB1*04:11:01,09:01:02/09:21; DRB4*01:03:01:01,01:03:02 (IPD-IMGT/HLA=10685).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   GRCHJUi001-A
AC   CVCL_D6N3
SY   LYJ-iPS-C2
DR   BioSamples; SAMEA115049286
DR   hPSCreg; GRCHJUi001-A
RX   PubMed=38341987;
CC   From: Guangzhou Red Cross Hospital of Jinan University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser209Pro (c.625T>C); ClinVar=VCV000067094; Zygosity=Heterozygous (PubMed=38341987).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6N4 ! GRCHJUi001-B
OI   CVCL_D6N5 ! GRCHJUi001-C
OI   CVCL_D6N6 ! GRCHJUi001-D
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GRCHJUi001-B
AC   CVCL_D6N4
SY   LYJ-iPS-C4
RX   PubMed=38341987;
CC   From: Guangzhou Red Cross Hospital of Jinan University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser209Pro (c.625T>C); ClinVar=VCV000067094; Zygosity=Heterozygous (PubMed=38341987).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6N3 ! GRCHJUi001-A
OI   CVCL_D6N5 ! GRCHJUi001-C
OI   CVCL_D6N6 ! GRCHJUi001-D
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GRCHJUi001-C
AC   CVCL_D6N5
SY   LYJ-iPS-C6
RX   PubMed=38341987;
CC   From: Guangzhou Red Cross Hospital of Jinan University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser209Pro (c.625T>C); ClinVar=VCV000067094; Zygosity=Heterozygous (PubMed=38341987).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6N3 ! GRCHJUi001-A
OI   CVCL_D6N4 ! GRCHJUi001-B
OI   CVCL_D6N6 ! GRCHJUi001-D
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GRCHJUi001-D
AC   CVCL_D6N6
SY   LYJ-iPS-C7
RX   PubMed=38341987;
CC   From: Guangzhou Red Cross Hospital of Jinan University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser209Pro (c.625T>C); ClinVar=VCV000067094; Zygosity=Heterozygous (PubMed=38341987).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6N3 ! GRCHJUi001-A
OI   CVCL_D6N4 ! GRCHJUi001-B
OI   CVCL_D6N5 ! GRCHJUi001-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   GRD
AC   CVCL_JC96
SY   TER204; TER-204; Ter 204; TER453; TER-453; Ter 453
DR   IPD-IMGT/HLA; 10686
DR   Wikidata; Q54871684
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/357cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*03:04,04; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=10686).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   GrE
AC   CVCL_XH44
SY   Gobiocypris rarus Egg
DR   Wikidata; Q93934813
RX   PubMed=31491550;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by grass carp reovirus (GCRV) genotypes 1 and 2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=143606; ! Gobiocypris rarus (Chinese rare minnow)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   GRE-R
AC   CVCL_A3AD
DR   CCLV; CCLV-RIE 0458
DR   Wikidata; Q105507473
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   GRE,G
AC   CVCL_E679
SY   GRE, G
DR   dbMHC; 48874
DR   ECACC; 94082261
DR   IHW; IHW09161
DR   IPD-IMGT/HLA; 11704
DR   Wikidata; Q54871685
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,11; B*07:02,27:05; DPB1*04:01,04:02; DQA1*01:02,03; DQB1*03:01,06:02; DRB1*04:01,15:01; DRB4*01:01; DRB5*01:01 (IPD-IMGT/HLA=11704).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   GREC
AC   CVCL_C0MH
SY   Goose Retinal Epithelial Cell line
DR   CCRID; 4201PAT-CCTCC01799
DR   Wikidata; Q112929625
RX   Patent=CN114107171B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021238.
CC   Derived from site: In situ; Embryonic eye, optic cup, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=8844; ! Anser anser anser (Western greylag goose)
SX   Sex unspecified
AG   11FD
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   GREF-X
AC   CVCL_7667
DR   BTO; BTO_0003518
DR   BioSample; SAMN03152009
DR   Wikidata; Q54871686
RX   PubMed=9251679;
RX   PubMed=10508494;
RX   PubMed=17760834;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00123.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   GREG
AC   CVCL_AS31
DR   Wikidata; Q54871687
RX   PubMed=22020321;
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Characteristics: Dysferlin-deficient myogenic cell line (PubMed=22020321).
CC   Doubling time: 34.5 +- 1.2 hours (Note=At 20th passage), 18.6 +- 0.2 hours (Note=At 40th passage) (PubMed=22020321).
CC   Sequence variation: Mutation; MGI; MGI:1349385; Dysf; Unexplicit; retrotransposon insertion in intron 4; Zygosity=Homozygous (PubMed=22020321).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9D
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 6
//
ID   GreenTad-gill
AC   CVCL_A0WG
DR   Wikidata; Q108820335
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=145282; ! Lithobates clamitans (Green frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   GreenTad-HE4
AC   CVCL_A0WF
DR   Wikidata; Q108820336
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=145282; ! Lithobates clamitans (Green frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   GreenTad-HF1
AC   CVCL_A0WC
DR   Wikidata; Q108820337
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=145282; ! Lithobates clamitans (Green frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   GreenTad-HF2
AC   CVCL_A0WD
DR   Wikidata; Q108820338
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=145282; ! Lithobates clamitans (Green frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   GreenTad-HF3
AC   CVCL_A0WE
DR   Wikidata; Q108820339
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=145282; ! Lithobates clamitans (Green frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   Grey
AC   CVCL_L354
DR   BTO; BTO_0005355
DR   Wikidata; Q54871688
RX   PubMed=21552385;
RX   PubMed=22916246;
CC   Doubling time: 18.1 hours (PubMed=22916246).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   GRINCH
AC   CVCL_WH61
SY   Glucose-Responsive INsulin-secreting C-peptide-modified Human-proinsulin
DR   Wikidata; Q93934841
RX   CelloPub=CLPUB00488;
RX   PubMed=23223446;
CC   Characteristics: Transfected with the hPro-CpepSfGFP construct containing human insulin with a C-peptide modified with a C-terminal Superfolder GFP insert.
CC   Genetic integration: Method=Transfection; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   GRIP-1
AC   CVCL_V169
SY   Glial-Restricted Immortalized Precursor-1
DR   ATCC; CRL-2727
DR   Wikidata; Q54871689
RX   PubMed=11921204;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Discontinued: ATCC; CRL-2727; true.
CC   Derived from site: In situ; Spinal cord neural tube; UBERON=UBERON_2007042.
CC   Cell type: Glial restricted tripotential precursor cell; CL=CL_4040000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   GRIP-1-GFP
AC   CVCL_V170
DR   ATCC; CRL-2728
DR   Wikidata; Q54871690
RX   PubMed=11921204;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Discontinued: ATCC; CRL-2728; true.
CC   Derived from site: In situ; Spinal cord neural tube; UBERON=UBERON_2007042.
CC   Cell type: Glial restricted tripotential precursor cell; CL=CL_4040000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_V169 ! GRIP-1
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   GRiPS
AC   CVCL_0H63
DR   SKIP; SKIP000588
DR   Wikidata; Q54871691
RX   PubMed=25479750;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   GripTite 293 MSR
AC   CVCL_U428
SY   GripTite HEK293; 293-H MSR; MSR 293; HEK293MSR
DR   CLO; CLO_0037228
DR   EFO; EFO_0022448
DR   Wikidata; Q54871692
RX   DOI=10.13005/bpj/1414;
RX   Patent=US7217566;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-601.html
WW   Provider; Thermo Fisher; R79507; https://www.thermofisher.com/order/catalog/product/R79507
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5078.
CC   Characteristics: This cell line has a superior adherence compared to normal HEK293 cells. These cells adhere to standard tissue culture treated plastic.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   GRL101 (KC7)
AC   CVCL_4208
DR   CLO; CLO_0003562
DR   CLDB; cl1516
DR   ECACC; 94071259
DR   Wikidata; Q54871693
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P46023; Lymnaea stagnalis GRL101.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   GRL101 (MIX)
AC   CVCL_4209
DR   CLO; CLO_0003563
DR   CLDB; cl1517
DR   ECACC; 94071258
DR   Wikidata; Q54871694
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P46023; Lymnaea stagnalis GRL101.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   GRM01
AC   CVCL_6637
DR   Wikidata; Q54871695
RX   PubMed=8025176;
RX   PubMed=8167900;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   GRM01L
AC   CVCL_6638
DR   Wikidata; Q54871696
RX   PubMed=8025176;
RX   PubMed=8167900;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6637 ! GRM01
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   GRM02
AC   CVCL_6639
DR   Wikidata; Q54871697
RX   PubMed=8025176;
RX   PubMed=8167900;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   GRmel8
AC   CVCL_E2TV
RX   PubMed=18820372;
CC   Population: Caucasian; Greek.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   GRmel8 clone UDCCS-1
AC   CVCL_E2TW
SY   UDCCS-1
RX   PubMed=18820372;
CC   Population: Caucasian; Greek.
CC   Characteristics: Established after one passage of the parent cell line in immunocompromised mice (PubMed=18820372).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2TV ! GRmel8
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   GRmel8 clone WDCCS-1
AC   CVCL_E2TX
SY   WDCCS-1
RX   PubMed=18820372;
CC   Population: Caucasian; Greek.
CC   Characteristics: Established after one passage of the parent cell line in immunocompromised mice (PubMed=18820372).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2TV ! GRmel8
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Gro2C
AC   CVCL_D241
SY   gro2C
DR   CCLV; CCLV-RIE 0288
DR   Wikidata; Q54871698
RX   PubMed=8380101;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   GRS-IV
AC   CVCL_M785
SY   GRS IV
DR   Wikidata; Q54871699
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=15126569;
RX   PubMed=17786610;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M786 ! GRS-V
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   GRS-V
AC   CVCL_M786
SY   GRS V
DR   Wikidata; Q54871700
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=15126569;
RX   PubMed=17786610;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M785 ! GRS-IV
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   GRSL
AC   CVCL_5509
DR   JCRB; IFO50111
DR   Wikidata; Q54871701
RX   PubMed=232176;
CC   Breed/subspecies: GRS/A.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   GRTE
AC   CVCL_E7BS
SY   Goose Renal Tubular Epithelial cell
RX   PubMed=38669820;
CC   Group: Bird cell line.
CC   Virology: Susceptible to infection by goose astrovirus genotype 2 (GAstV-2) (PubMed=38669820).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Embryonic kidney, renal tubule; UBERON=UBERON_0009773.
CC   Cell type: Kidney cortex tubule cell; CL=CL_1000615.
OX   NCBI_TaxID=8844; ! Anser anser anser (Western greylag goose)
SX   Sex unspecified
AG   26FD
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GRU-1
AC   CVCL_N845
SY   GRU-I
DR   Wikidata; Q54871702
RX   PubMed=1688830;
RX   PubMed=7525493;
CC   Doubling time: 29 hours (PubMed=1688830); 17 hours (PubMed=7525493).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   GRU-1A
AC   CVCL_N846
SY   GRU-IA
DR   Wikidata; Q54871703
RX   CelloPub=CLPUB00411;
RX   PubMed=7525493;
RX   PubMed=9935182;
CC   Doubling time: 19 hours (PubMed=7525493).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N845 ! GRU-1
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   GRU-1B
AC   CVCL_N847
SY   GRU-IB
DR   Wikidata; Q54871704
RX   CelloPub=CLPUB00411;
RX   PubMed=7525493;
RX   PubMed=9935182;
CC   Doubling time: 16 hours (PubMed=7525493).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N845 ! GRU-1
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   GRU-1C
AC   CVCL_N848
SY   GRU-IC
DR   Wikidata; Q54871705
RX   CelloPub=CLPUB00411;
RX   PubMed=7525493;
RX   PubMed=9935182;
CC   Doubling time: 13 hours (PubMed=7525493).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N845 ! GRU-1
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   Grunt Fin
AC   CVCL_8875
SY   GF; Grunt Fin (GF)
DR   CLO; CLO_0003565
DR   CLDB; cl1518
DR   ATCC; CCL-58
DR   BCRJ; 0417
DR   ECACC; 88010601
DR   Wikidata; Q54871706
RX   DOI=10.1007/BF02618370;
RX   DOI=10.2307/1444537;
RX   PubMed=13879872;
CC   Group: Fish cell line.
CC   Discontinued: ATCC; CCL-58; true.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=119718; ! Haemulon sciurus (Bluestriped grunt)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   GRX
AC   CVCL_M115
DR   BTO; BTO_0003528
DR   BCRJ; 0094
DR   Wikidata; Q54871708
RX   PubMed=2126187;
RX   PubMed=4030623;
RX   PubMed=17760834;
RX   PubMed=35563813;
CC   Characteristics: Established from fibrotic granulomas induced in C3H/HeN mice liver by experimental infection with Schistosoma mansoni (PubMed=2126187).
CC   Derived from site: In situ; Liver; Note=From a granulomatous inflammation; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C3H/HeN.
ST   Source(s): PubMed=35563813
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 25.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26,27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HA25 ! GR [Mouse liver]
SX   Sex unspecified
AG   4M
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   GS
AC   CVCL_S933
SY   Grouper Spleen
DR   Wikidata; Q54871710
RX   PubMed=16137774;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Singapore grouper iridovirus (SGIV) and Epinephelus tauvina nervous necrosis virus (ETNNV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 11
//
ID   GS-1
AC   CVCL_VM37
SY   Grouper Spleen-1
DR   Wikidata; Q93935015
RX   PubMed=30224575;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 6
//
ID   GS-109-IV-8
AC   CVCL_2452
DR   CLO; CLO_0003566
DR   ATCC; CRL-1672
DR   BioSample; SAMN03471414
DR   Wikidata; Q54871712
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1672
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 14,16.2
ST   D21S11: 32.2
ST   D2S1338: 16,22
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 11,12
ST   FGA: 20,24
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   GS-109-V-20
AC   CVCL_2453
DR   CLO; CLO_0003567
DR   CLDB; cl1519
DR   ATCC; CRL-1610
DR   BioSample; SAMN03471404
DR   ECACC; 90110505
DR   Wikidata; Q54871713
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-1610; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1610
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2883 ! D422T
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   GS-109-V-21
AC   CVCL_2454
DR   CLO; CLO_0003568
DR   ATCC; CRL-1643
DR   BioSample; SAMN03471411
DR   Wikidata; Q54871714
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,-2,2q+ (ATCC=CRL-1643).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1643
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D19S433: 14.2,16.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 11,14
ST   FGA: 20,22
ST   Penta D: 10
ST   Penta E: 12,15
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   GS-109-V-34
AC   CVCL_2455
DR   CLO; CLO_0003569
DR   CLDB; cl1520
DR   ATCC; CRL-1613
DR   BioSample; SAMN03471405
DR   ECACC; 90110504
DR   Wikidata; Q54871715
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1613; ECACC=90110504
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 8,11
ST   FGA: 21,22
ST   Penta D: 10,12
ST   Penta E: 5,10
ST   TH01: 6,9.3
ST   TPOX: 10,12
ST   vWA: 14,16
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   GS-109-V-63
AC   CVCL_2456
SY   G96
DR   CLO; CLO_0003570
DR   CLDB; cl1521
DR   ATCC; CRL-1614
DR   BioSample; SAMN03471406
DR   ECACC; 90110503
DR   Wikidata; Q54871733
CC   Population: Caucasian.
CC   Karyotypic information: Diploid karyotype (ATCC=CRL-1614).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1614; ECACC=90110503
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,17
ST   D19S433: 13,13.2
ST   D21S11: 29,33.2
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   GS-DG1
AC   CVCL_E268
SY   GSDG1
DR   RCB; AES0002
DR   RCB; RCB1968
DR   SKIP; SKIP001636
DR   Wikidata; Q54871734
RX   PubMed=12700182;
CC   Discontinued: RCB; RCB1968; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1FD
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   GS-iPSC1
AC   CVCL_A2WQ
SY   Ground Squirrel-iPSC1
DR   Wikidata; Q105507476
RX   PubMed=29576452;
WW   Provider; NCI TTC; TAB-4119/E-059-2017-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4119
WW   Provider; NEI; -; https://www.nei.nih.gov/grants-and-training/resources-researchers/technology-transfer-nei/induced-pluripotent-stem-cells-ipsc-thirteen-lined-ground-squirrel
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=43179; ! Ictidomys tridecemlineatus (Thirteen-lined ground squirrel)
SX   Female
AG   0-2D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   GS-iPSC3
AC   CVCL_A2WR
SY   Ground Squirrel-iPSC3
DR   Wikidata; Q105507479
RX   PubMed=29576452;
WW   Provider; NCI TTC; TAB-4119/E-059-2017-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4119
WW   Provider; NEI; -; https://www.nei.nih.gov/grants-and-training/resources-researchers/technology-transfer-nei/induced-pluripotent-stem-cells-ipsc-thirteen-lined-ground-squirrel
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=43179; ! Ictidomys tridecemlineatus (Thirteen-lined ground squirrel)
SX   Female
AG   0-2D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   GS1
AC   CVCL_0H90
DR   Wikidata; Q54871735
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   GS17F1C4
AC   CVCL_B0JU
SY   GS1
DR   Wikidata; Q108820340
RX   PubMed=9832699;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01032; Pig C5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   GS1.K
AC   CVCL_S391
SY   GS1K
DR   ATCC; CRL-6561
DR   Wikidata; Q54871736
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6561; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=38241; ! Globicephala macrorhynchus (Short-finned pilot whale)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   GS33JTO
AC   CVCL_2912
SY   Gardner Syndrome 33 Japan TOkyo
DR   JCRB; JCRB0322
DR   Wikidata; Q54871738
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0322
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   GS33JTO(SVT)
AC   CVCL_0I82
DR   JCRB; KURB2746
DR   Wikidata; Q54871739
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2912 ! GS33JTO
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   GS70JTO
AC   CVCL_2913
SY   GS7OJTO; Gardner Syndrome 70 Japan TOkyo
DR   JCRB; JCRB0323
DR   Wikidata; Q54871740
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0323
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   GS70JTO(SVT)-1
AC   CVCL_A2JR
DR   JCRB; KURB2747
DR   Wikidata; Q105507483
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2913 ! GS70JTO
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   GS70JTO(SVT)-2
AC   CVCL_A2JS
DR   JCRB; KURB2748
DR   Wikidata; Q105507488
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C6728; Gardner syndrome
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2913 ! GS70JTO
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   GSB
AC   CVCL_S934
SY   Grouper Swim Bladder
DR   Wikidata; Q54871742
RX   PubMed=12962209;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=152218; ! Epinephelus awoara (Yellow grouper)
OI   CVCL_S930 ! GE
OI   CVCL_S931 ! GF
OI   CVCL_S932 ! GH [Epinephelus]
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 12
//
ID   GSC
AC   CVCL_M752
SY   Grouper Snout Cell line
DR   Wikidata; Q54871743
RX   PubMed=17342554;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=215347; ! Epinephelus akaara (Hong Kong grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   GSC-0131
AC   CVCL_C9EE
SY   GSC0131; 0131
DR   BioGRID_ORCS_Cell_line; 297
DR   GEO; GSM1715941
DR   GEO; GSM1715942
DR   GEO; GSM1715943
DR   GEO; GSM1715944
DR   Wikidata; Q123031372
RX   PubMed=19427293;
RX   PubMed=26673326;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val147Asp (c.440T>A); ClinVar=VCV001351017; Zygosity=Homozygous (PubMed=26673326).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   GSC-0827
AC   CVCL_C9EF
SY   GSC0827; 0827
DR   BioGRID_ORCS_Cell_line; 295
DR   GEO; GSM1715945
DR   GEO; GSM1715946
DR   GEO; GSM1715947
DR   GEO; GSM1715948
DR   Wikidata; Q123031373
RX   PubMed=19427293;
RX   PubMed=26673326;
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   GSC-1123
AC   CVCL_C6IM
DR   GEO; GSM1638621
DR   GEO; GSM1638622
DR   GEO; GSM1638623
DR   Wikidata; Q116049085
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left occipital lobe; UBERON=UBERON_0002806.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC-157
AC   CVCL_C6IN
SY   157
DR   GEO; GSM1638624
DR   GEO; GSM1638625
DR   GEO; GSM1638626
DR   Wikidata; Q116049086
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC-1406
AC   CVCL_C9GT
SY   GSC1406; 1406
DR   Wikidata; Q123031374
RX   CelloPub=CLPUB00794;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   GSC-1502
AC   CVCL_C9EG
SY   GSC1502; 1502
DR   Wikidata; Q123031375
RX   CelloPub=CLPUB00794;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   GSC-1600
AC   CVCL_C6IP
DR   Wikidata; Q116049087
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-19
AC   CVCL_C6IQ
DR   Wikidata; Q116049088
RX   PubMed=23650391;
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-326
AC   CVCL_C6IR
DR   PRIDE; PXD028125
DR   Wikidata; Q116049089
RX   PubMed=23650391;
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-326/ALDH1A3-KO.1.1
AC   CVCL_C6J4
DR   Wikidata; Q116049090
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IR ! GSC-326
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GSC-326/ALDH1A3-KO.2.3
AC   CVCL_C6J5
DR   Wikidata; Q116049091
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IR ! GSC-326
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GSC-326/ALDH1A3-KO.2.4
AC   CVCL_C6J6
DR   Wikidata; Q116049092
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IR ! GSC-326
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GSC-326/ALDH1A3-KO.3.1
AC   CVCL_C6J7
DR   Wikidata; Q116049093
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IR ! GSC-326
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GSC-326/ALDH1A3-KO.3.4
AC   CVCL_C6J8
DR   Wikidata; Q116049094
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IR ! GSC-326
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GSC-326/ALDH1A3-KO.3.5
AC   CVCL_C6J9
DR   Wikidata; Q116049095
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IR ! GSC-326
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GSC-345
AC   CVCL_C6IS
DR   Wikidata; Q116049096
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-347
AC   CVCL_C6IT
DR   Wikidata; Q116049097
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-524
AC   CVCL_C6IU
DR   Wikidata; Q116049098
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-528
AC   CVCL_C6IV
SY   528
DR   GEO; GSM1638630
DR   GEO; GSM1638631
DR   GEO; GSM1638632
DR   Wikidata; Q116049100
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6IW ! GSC-528rec
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC-528rec
AC   CVCL_C6IW
SY   GSC-528REC
DR   Wikidata; Q116049101
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6IV ! GSC-528
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-718
AC   CVCL_C6IX
DR   Wikidata; Q116049102
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   GSC-816
AC   CVCL_C6IY
SY   816
DR   GEO; GSM1638633
DR   GEO; GSM1638634
DR   GEO; GSM1638635
DR   Wikidata; Q116049103
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC-83
AC   CVCL_C6IZ
SY   83
DR   GEO; GSM1638636
DR   GEO; GSM1638637
DR   GEO; GSM1638638
DR   Wikidata; Q116049104
RX   PubMed=23650391;
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC-83/ALDH1A3-KO.1.2
AC   CVCL_C6J3
DR   Wikidata; Q116049105
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IZ ! GSC-83
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   GSC-84
AC   CVCL_C6J0
SY   84
DR   GEO; GSM1638639
DR   GEO; GSM1638640
DR   GEO; GSM1638641
DR   Wikidata; Q116049106
RX   PubMed=23650391;
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC-ac17
AC   CVCL_C6J1
SY   AC17
DR   GEO; GSM1638642
DR   GEO; GSM1638643
DR   GEO; GSM1638644
DR   Wikidata; Q116049107
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC-ac20
AC   CVCL_C6J2
SY   AC20
DR   GEO; GSM1638645
DR   GEO; GSM1638646
DR   GEO; GSM1638647
DR   Wikidata; Q116049108
RX   PubMed=23650391;
CC   Group: Cancer stem cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
CC   Cell type: Neural stem cell; CL=CL_0000047.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   GSC11
AC   CVCL_DR55
DR   BTO; BTO_0006537
DR   PRIDE; PXD000563
DR   Wikidata; Q54871744
RX   PubMed=24266786;
CC   Group: Cancer stem cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   GSC13
AC   CVCL_DR56
DR   PRIDE; PXD000563
DR   Wikidata; Q54871745
RX   PubMed=24266786;
CC   Group: Cancer stem cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   GSC17
AC   CVCL_DR57
DR   PRIDE; PXD000563
DR   Wikidata; Q54871748
RX   PubMed=24266786;
CC   Group: Cancer stem cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   GSC2
AC   CVCL_DR58
DR   PRIDE; PXD000563
DR   Wikidata; Q54871749
RX   PubMed=24266786;
CC   Group: Cancer stem cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   GSC23
AC   CVCL_DR59
SY   GSC-23
DR   BTO; BTO_0006538
DR   PRIDE; PXD000563
DR   Wikidata; Q54871750
RX   PubMed=24266786;
RX   PubMed=29887596;
CC   Group: Cancer stem cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   GSC8-11
AC   CVCL_DR60
DR   PRIDE; PXD000563
DR   Wikidata; Q54871751
RX   PubMed=24266786;
CC   Group: Cancer stem cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   GSC#1
AC   CVCL_A9T7
SY   GSC #1; GSC 1; GSC1
DR   Wikidata; Q102113949
RX   PubMed=21102434;
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=32290386;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11,14
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#10
AC   CVCL_A9T8
DR   Wikidata; Q102113950
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#112
AC   CVCL_A9TN
DR   Wikidata; Q102113951
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#120
AC   CVCL_A9TP
DR   Wikidata; Q102113953
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,21
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#142
AC   CVCL_A9TQ
DR   Wikidata; Q102113955
RX   PubMed=21102434;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#147
AC   CVCL_A9TR
DR   Wikidata; Q102113956
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#148
AC   CVCL_A9TS
DR   Wikidata; Q102113957
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 10
ST   D16S539: 12,13
ST   D5S818: 9
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#151
AC   CVCL_A9TT
DR   Wikidata; Q102113958
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#163
AC   CVCL_A9TU
SY   GSC #163
DR   Wikidata; Q102113960
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=32290386;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#169
AC   CVCL_A9TV
DR   Wikidata; Q102113961
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 10
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#170
AC   CVCL_A9TW
DR   Wikidata; Q102113962
RX   PubMed=28204560;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#171
AC   CVCL_A9TX
DR   Wikidata; Q102113963
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#172
AC   CVCL_A9TY
DR   Wikidata; Q102113964
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#181
AC   CVCL_A9TZ
DR   Wikidata; Q102113965
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#184
AC   CVCL_A9U0
DR   Wikidata; Q102113966
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#188
AC   CVCL_A9U1
DR   Wikidata; Q102113967
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#191
AC   CVCL_A9U2
DR   Wikidata; Q102113968
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#195
AC   CVCL_A9U3
DR   Wikidata; Q102113969
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 7,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9U4 ! GSC#195V
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#195V
AC   CVCL_A9U4
DR   Wikidata; Q102113970
RX   PubMed=28204560;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 7,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9U3 ! GSC#195
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#196
AC   CVCL_A9U5
DR   Wikidata; Q102113972
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#204
AC   CVCL_A9U6
DR   Wikidata; Q102113975
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#206
AC   CVCL_A9U7
DR   Wikidata; Q102113976
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 9,12
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#208
AC   CVCL_A9U8
DR   Wikidata; Q102113977
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#209
AC   CVCL_A9U9
DR   Wikidata; Q102113978
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 13,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#210
AC   CVCL_A9UA
DR   Wikidata; Q102113979
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#213
AC   CVCL_A9UB
DR   Wikidata; Q102113980
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#220C
AC   CVCL_A9UC
DR   Wikidata; Q102113981
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#221
AC   CVCL_A9UD
DR   Wikidata; Q102113982
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 8,13
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#23C
AC   CVCL_A9T9
DR   Wikidata; Q102113983
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9TA ! GSC#23P
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#23P
AC   CVCL_A9TA
DR   Wikidata; Q102113984
RX   PubMed=28204560;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9T9 ! GSC#23C
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#242
AC   CVCL_A9UE
DR   Wikidata; Q102113985
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 10,14
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#257
AC   CVCL_A9UF
DR   Wikidata; Q102113986
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12,14
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#262
AC   CVCL_A9UG
DR   Wikidata; Q102113987
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#275
AC   CVCL_A9UH
DR   Wikidata; Q102113989
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9UI ! GSC#275bis
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#275bis
AC   CVCL_A9UI
DR   Wikidata; Q102113990
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9UH ! GSC#275
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#277
AC   CVCL_A9UJ
DR   Wikidata; Q102113991
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#28
AC   CVCL_A9TB
DR   Wikidata; Q102113992
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 10,14
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#284
AC   CVCL_A9UK
DR   Wikidata; Q102113994
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#290
AC   CVCL_A9UL
DR   Wikidata; Q102113995
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 9,13
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#291
AC   CVCL_A9UM
DR   Wikidata; Q102113996
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,14
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,14
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#298
AC   CVCL_A9UN
DR   Wikidata; Q102113997
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 7,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#309S
AC   CVCL_A9UP
DR   Wikidata; Q102113998
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 14
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#30P
AC   CVCL_A9TC
DR   Wikidata; Q102113999
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9TD ! GSC#30PT
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#30PT
AC   CVCL_A9TD
SY   GSC#30pt
DR   Wikidata; Q102114000
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9TC ! GSC#30P
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#314C
AC   CVCL_A9UQ
DR   Wikidata; Q102114002
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9UR ! GSC#314P
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#314P
AC   CVCL_A9UR
DR   Wikidata; Q102114003
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9UQ ! GSC#314C
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#315
AC   CVCL_A9US
DR   Wikidata; Q102114004
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 9
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#318
AC   CVCL_A9UT
DR   Wikidata; Q102114005
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 16,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#323
AC   CVCL_A9UU
DR   Wikidata; Q102114007
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#326
AC   CVCL_A9UV
DR   Wikidata; Q102114008
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#327
AC   CVCL_A9UW
DR   Wikidata; Q102114009
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#329
AC   CVCL_A9UX
DR   Wikidata; Q102114010
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#352
AC   CVCL_A9UY
DR   Wikidata; Q102114011
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 8,11
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#361
AC   CVCL_A9UZ
DR   Wikidata; Q102114012
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#365
AC   CVCL_A9V0
DR   Wikidata; Q102114014
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#366
AC   CVCL_A9V1
DR   Wikidata; Q102114015
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#369
AC   CVCL_A9V2
DR   Wikidata; Q102114016
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#381
AC   CVCL_A9V3
DR   Wikidata; Q102114017
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#384
AC   CVCL_A9V4
DR   Wikidata; Q102114018
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#389
AC   CVCL_A9V5
DR   Wikidata; Q102114019
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#391
AC   CVCL_A9V6
DR   Wikidata; Q102114020
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   TH01: 9,9.3
ST   TPOX: 9,10
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#393
AC   CVCL_A9V7
DR   Wikidata; Q102114022
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,14
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#394
AC   CVCL_A9V8
DR   Wikidata; Q102114024
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9.3,10
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9V9 ! GSC#394bis
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#394bis
AC   CVCL_A9V9
DR   Wikidata; Q102114025
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9.3,10
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9V8 ! GSC#394
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#395
AC   CVCL_A9VA
DR   Wikidata; Q102114026
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#397
AC   CVCL_A9VB
DR   Wikidata; Q102114027
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#399
AC   CVCL_A9VC
DR   Wikidata; Q102114028
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#401
AC   CVCL_A9VD
DR   Wikidata; Q102114029
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#403
AC   CVCL_A9VE
DR   Wikidata; Q102114030
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 14,15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#406
AC   CVCL_A9VF
DR   Wikidata; Q102114031
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#407
AC   CVCL_A9VG
DR   Wikidata; Q102114032
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#411
AC   CVCL_A9VH
DR   Wikidata; Q102114033
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 8,11
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#413
AC   CVCL_A9VI
DR   Wikidata; Q102114034
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,14
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#415
AC   CVCL_A9VJ
DR   Wikidata; Q102114035
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 8,11
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 9,10
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#416
AC   CVCL_A9VK
DR   Wikidata; Q102114036
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 10
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#420
AC   CVCL_A9VL
DR   Wikidata; Q102114037
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 10
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#421
AC   CVCL_A9VM
DR   Wikidata; Q102114038
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#426
AC   CVCL_A9VN
DR   Wikidata; Q102114039
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#429
AC   CVCL_A9VP
DR   Wikidata; Q102114041
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 13,15
ST   D7S820: 9,10
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#431
AC   CVCL_A9VQ
DR   Wikidata; Q102114042
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 8,10
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#432
AC   CVCL_A9VR
DR   Wikidata; Q102114043
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#433
AC   CVCL_A9VS
DR   Wikidata; Q102114045
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#440
AC   CVCL_A9VT
DR   Wikidata; Q102114046
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,10
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#441
AC   CVCL_A9VU
DR   Wikidata; Q102114048
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#442
AC   CVCL_A9VV
DR   Wikidata; Q102114050
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 8,12
ST   D5S818: 11
ST   D7S820: 7,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#445
AC   CVCL_A9VW
DR   Wikidata; Q102114051
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#447P
AC   CVCL_A9VX
DR   Wikidata; Q102114052
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#448
AC   CVCL_A9VY
DR   Wikidata; Q102114053
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#449
AC   CVCL_A9VZ
DR   Wikidata; Q102114054
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 13,14
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#450
AC   CVCL_A9W0
DR   Wikidata; Q102114055
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#452C
AC   CVCL_A9W1
DR   Wikidata; Q102114056
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9W2 ! GSC#452P
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#452P
AC   CVCL_A9W2
DR   Wikidata; Q102114057
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9W1 ! GSC#452C
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#454
AC   CVCL_A9W3
DR   Wikidata; Q102114059
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#455
AC   CVCL_A9W4
DR   Wikidata; Q102114060
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#61
AC   CVCL_A9TE
SY   GSC #61; GSC61
DR   Wikidata; Q102114061
RX   PubMed=21102434;
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=32290386;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#62
AC   CVCL_A9TF
DR   Wikidata; Q102114062
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 9
ST   D7S820: 7,11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#67
AC   CVCL_A9TG
DR   Wikidata; Q102114063
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D5S818: 10,13
ST   D7S820: 8
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#68
AC   CVCL_A9TH
DR   Wikidata; Q102114065
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#70
AC   CVCL_A9TI
SY   GSC70
DR   Wikidata; Q102114066
RX   PubMed=21102434;
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#74
AC   CVCL_A9TJ
DR   Wikidata; Q102114067
RX   PubMed=21102434;
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#76
AC   CVCL_A9TK
DR   Wikidata; Q102114068
RX   PubMed=21102434;
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#83
AC   CVCL_A9TL
SY   GSC #83; GSC 83; GSC83
DR   Wikidata; Q102114069
RX   PubMed=21102434;
RX   PubMed=28204560;
RX   PubMed=28248456;
RX   PubMed=29531533;
RX   PubMed=32290386;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9TM ! GSC#83.2
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSC#83.2
AC   CVCL_A9TM
DR   Wikidata; Q102114070
RX   PubMed=28204560;
RX   PubMed=29531533;
RX   PubMed=33128777;
CC   Group: Cancer stem cell line.
CC   From: Institute of Neurosurgery, Catholic University School of Medicine; Rome; Italy.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=33128777
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 12,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9TL ! GSC#83
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GSD1-hiPSC1
AC   CVCL_C870
SY   GSD.1.H.iPSC.1
DR   RSCB; RSCB0054
DR   Wikidata; Q54871753
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.1124-2A>G; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C871 ! GSD1-hiPSC2
OI   CVCL_C872 ! GSD1-hiPSC3
OI   CVCL_C873 ! GSD1-hiPSC5
OI   CVCL_C874 ! GSD1-hiPSC6
OI   CVCL_C875 ! GSD1-hiPSC7
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   GSD1-hiPSC2
AC   CVCL_C871
SY   GSD.1.H.iPSC.2
DR   RSCB; RSCB0055
DR   Wikidata; Q54871755
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.1124-2A>G; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C870 ! GSD1-hiPSC1
OI   CVCL_C872 ! GSD1-hiPSC3
OI   CVCL_C873 ! GSD1-hiPSC5
OI   CVCL_C874 ! GSD1-hiPSC6
OI   CVCL_C875 ! GSD1-hiPSC7
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   GSD1-hiPSC3
AC   CVCL_C872
SY   GSD.1.H.iPSC.3
DR   RSCB; RSCB0056
DR   Wikidata; Q54871756
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.1124-2A>G; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C870 ! GSD1-hiPSC1
OI   CVCL_C871 ! GSD1-hiPSC2
OI   CVCL_C873 ! GSD1-hiPSC5
OI   CVCL_C874 ! GSD1-hiPSC6
OI   CVCL_C875 ! GSD1-hiPSC7
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   GSD1-hiPSC5
AC   CVCL_C873
SY   GSD.1.H.iPSC.5
DR   RSCB; RSCB0057
DR   Wikidata; Q54871758
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.1124-2A>G; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C870 ! GSD1-hiPSC1
OI   CVCL_C871 ! GSD1-hiPSC2
OI   CVCL_C872 ! GSD1-hiPSC3
OI   CVCL_C874 ! GSD1-hiPSC6
OI   CVCL_C875 ! GSD1-hiPSC7
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   GSD1-hiPSC6
AC   CVCL_C874
SY   GSD.1.H.iPSC.6
DR   RSCB; RSCB0058
DR   Wikidata; Q54871759
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.1124-2A>G; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C870 ! GSD1-hiPSC1
OI   CVCL_C871 ! GSD1-hiPSC2
OI   CVCL_C872 ! GSD1-hiPSC3
OI   CVCL_C873 ! GSD1-hiPSC5
OI   CVCL_C875 ! GSD1-hiPSC7
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   GSD1-hiPSC7
AC   CVCL_C875
SY   GSD.1.H.iPSC.7; GSD1hiPSC7; GSD-hiPSC7; RIi004-A
DR   hPSCreg; RIi004-A
DR   RSCB; RSCB0059
DR   SKIP; SKIP002399
DR   SKIP; SKIP005841
DR   Wikidata; Q54871760
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.1124-2A>G; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C870 ! GSD1-hiPSC1
OI   CVCL_C871 ! GSD1-hiPSC2
OI   CVCL_C872 ! GSD1-hiPSC3
OI   CVCL_C873 ! GSD1-hiPSC5
OI   CVCL_C874 ! GSD1-hiPSC6
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   GSD1a patient 1 line 1
AC   CVCL_WV74
SY   GSD patient 1 line 1
DR   Wikidata; Q93935212
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gly222Arg (c.666G>C) (G743C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Heterozygous (from parent cell line).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM00574, the patient description is identical.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V389 ! GM00574
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   GSD1a patient 1 line 2
AC   CVCL_WV75
SY   GSD patient 1 line 2
DR   Wikidata; Q93935214
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gly222Arg (c.666G>C) (G743C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Heterozygous (from parent cell line).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM00574, the patient description is identical.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V389 ! GM00574
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   GSD1a patient 1 line 3
AC   CVCL_WV76
SY   GSD patient 1 line 3
DR   Wikidata; Q93935215
RX   PubMed=20739751;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gly222Arg (c.666G>C) (G743C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Gln347Ter (c.1039C>T) (C1118T); ClinVar=VCV000012000; Zygosity=Heterozygous (from parent cell line).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM00574, the patient description is identical.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V389 ! GM00574
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   GSDIb-iPSCs F#1
AC   CVCL_E5YZ
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5Z0 ! GSDIb-iPSCs F#2
OI   CVCL_E5Z1 ! GSDIb-iPSCs F#3
OI   CVCL_E5Z2 ! GSDIb-iPSCs H#1
OI   CVCL_E5Z3 ! GSDIb-iPSCs H#2
OI   CVCL_E5Z4 ! GSDIb-iPSCs H#3
OI   CVCL_E5Z5 ! GSDIb-iPSCs H#4
OI   CVCL_E5Z6 ! GSDIb-iPSCs H#5
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSDIb-iPSCs F#2
AC   CVCL_E5Z0
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5YZ ! GSDIb-iPSCs F#1
OI   CVCL_E5Z1 ! GSDIb-iPSCs F#3
OI   CVCL_E5Z2 ! GSDIb-iPSCs H#1
OI   CVCL_E5Z3 ! GSDIb-iPSCs H#2
OI   CVCL_E5Z4 ! GSDIb-iPSCs H#3
OI   CVCL_E5Z5 ! GSDIb-iPSCs H#4
OI   CVCL_E5Z6 ! GSDIb-iPSCs H#5
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSDIb-iPSCs F#3
AC   CVCL_E5Z1
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5YZ ! GSDIb-iPSCs F#1
OI   CVCL_E5Z0 ! GSDIb-iPSCs F#2
OI   CVCL_E5Z2 ! GSDIb-iPSCs H#1
OI   CVCL_E5Z3 ! GSDIb-iPSCs H#2
OI   CVCL_E5Z4 ! GSDIb-iPSCs H#3
OI   CVCL_E5Z5 ! GSDIb-iPSCs H#4
OI   CVCL_E5Z6 ! GSDIb-iPSCs H#5
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSDIb-iPSCs H#1
AC   CVCL_E5Z2
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5YZ ! GSDIb-iPSCs F#1
OI   CVCL_E5Z0 ! GSDIb-iPSCs F#2
OI   CVCL_E5Z1 ! GSDIb-iPSCs F#3
OI   CVCL_E5Z3 ! GSDIb-iPSCs H#2
OI   CVCL_E5Z4 ! GSDIb-iPSCs H#3
OI   CVCL_E5Z5 ! GSDIb-iPSCs H#4
OI   CVCL_E5Z6 ! GSDIb-iPSCs H#5
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSDIb-iPSCs H#2
AC   CVCL_E5Z3
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5YZ ! GSDIb-iPSCs F#1
OI   CVCL_E5Z0 ! GSDIb-iPSCs F#2
OI   CVCL_E5Z1 ! GSDIb-iPSCs F#3
OI   CVCL_E5Z2 ! GSDIb-iPSCs H#1
OI   CVCL_E5Z4 ! GSDIb-iPSCs H#3
OI   CVCL_E5Z5 ! GSDIb-iPSCs H#4
OI   CVCL_E5Z6 ! GSDIb-iPSCs H#5
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSDIb-iPSCs H#3
AC   CVCL_E5Z4
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5YZ ! GSDIb-iPSCs F#1
OI   CVCL_E5Z0 ! GSDIb-iPSCs F#2
OI   CVCL_E5Z1 ! GSDIb-iPSCs F#3
OI   CVCL_E5Z2 ! GSDIb-iPSCs H#1
OI   CVCL_E5Z3 ! GSDIb-iPSCs H#2
OI   CVCL_E5Z5 ! GSDIb-iPSCs H#4
OI   CVCL_E5Z6 ! GSDIb-iPSCs H#5
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSDIb-iPSCs H#4
AC   CVCL_E5Z5
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5YZ ! GSDIb-iPSCs F#1
OI   CVCL_E5Z0 ! GSDIb-iPSCs F#2
OI   CVCL_E5Z1 ! GSDIb-iPSCs F#3
OI   CVCL_E5Z2 ! GSDIb-iPSCs H#1
OI   CVCL_E5Z3 ! GSDIb-iPSCs H#2
OI   CVCL_E5Z4 ! GSDIb-iPSCs H#3
OI   CVCL_E5Z6 ! GSDIb-iPSCs H#5
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSDIb-iPSCs H#5
AC   CVCL_E5Z6
RX   PubMed=24581426;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; c.148+1G>A (IVS1,G-A,+1); ClinVar=VCV000006932; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=24581426).
CC   Sequence variation: Mutation; HGNC; HGNC:4061; SLC37A4; Simple; p.Trp118Arg (c.352T>C); ClinVar=VCV000006923; Zygosity=Heterozygous (PubMed=24581426).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5YZ ! GSDIb-iPSCs F#1
OI   CVCL_E5Z0 ! GSDIb-iPSCs F#2
OI   CVCL_E5Z1 ! GSDIb-iPSCs F#3
OI   CVCL_E5Z2 ! GSDIb-iPSCs H#1
OI   CVCL_E5Z3 ! GSDIb-iPSCs H#2
OI   CVCL_E5Z4 ! GSDIb-iPSCs H#3
OI   CVCL_E5Z5 ! GSDIb-iPSCs H#4
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   GSE
AC   CVCL_6F81
SY   Gizzard Shad Embryo
DR   Wikidata; Q54871762
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=365056; ! Konosirus punctatus (Dotted gizzard shad)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   GSF2010
AC   CVCL_W829
SY   Goat Skin Fibroblast cell line 2010
DR   Wikidata; Q54871764
RX   PubMed=21108049;
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Kiko; VBO=VBO_0000787.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   6-8M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   GSF289
AC   CVCL_W830
SY   Goat Skin Fibroblast cell line 289
DR   Wikidata; Q54871765
RX   CelloPub=CLPUB00140;
RX   PubMed=21108049;
CC   Doubling time: 25 hours (Note=At 5th passage) (PubMed=21108049).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Breed/subspecies: Saanen; VBO=VBO_0000827.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   6-8M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   GSF737
AC   CVCL_W831
SY   Goat Skin Fibroblast cell line 737
DR   Wikidata; Q54871766
RX   PubMed=21108049;
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Kiko; VBO=VBO_0000787.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   6-8M
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   GSI-1
AC   CVCL_A0GG
SY   Gsi-1; Genome Systems Inc-1
DR   Wikidata; Q108820341
RX   PubMed=17701442;
RX   PubMed=17828574;
RX   PubMed=25277546;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GSJO
AC   CVCL_M780
DR   cancercelllines; CVCL_M780
DR   Wikidata; Q54871768
RX   PubMed=15126569;
RX   PubMed=17786610;
RX   PubMed=19424640;
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Val804Met (c.2410G>A); ClinVar=VCV000037102; Zygosity=Unspecified (PubMed=15126569).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C46099; Hereditary thyroid gland medullary carcinoma
DI   ORDO; Orphanet_99361; Familial medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   GSK6F05
AC   CVCL_A3CN
SY   Anti-Rev-Erb alpha; REVERBa
DR   ECACC; 19061801
DR   Wikidata; Q105507490
RX   PubMed=29533925;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20393; Human NR1D1 (Note=AA 281-614).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   GSKC
AC   CVCL_1G56
SY   Giant Salamander Kidney Cell line
DR   Wikidata; Q54871769
RX   PubMed=26070783;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=141262; ! Andrias davidianus (Chinese giant salamander)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   GSM06
AC   CVCL_E134
SY   GSM 06
DR   RCB; RCB1779
DR   Wikidata; Q54871770
RX   PubMed=8262157;
RX   PubMed=9224657;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Characteristics: At the permissive temperature (33 Celsius) grow until confluent monolayer are formed (PubMed=8262157).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Discontinued: RCB; RCB1779; true.
CC   Derived from site: In situ; Stomach, fundus, mucosa; UBERON=UBERON_0004994.
CC   Cell type: Surface mucosal cell of stomach; CL=CL_0002179.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-12W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   GSM10
AC   CVCL_E135
SY   GSM 10
DR   RCB; RCB1780
DR   Wikidata; Q54871772
RX   PubMed=8262157;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Characteristics: At the permissive temperature (33 Celsius) grow until confluent monolayer are formed (PubMed=8262157).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Discontinued: RCB; RCB1780; true.
CC   Derived from site: In situ; Stomach, fundus, mucosa; UBERON=UBERON_0004994.
CC   Cell type: Surface mucosal cell of stomach; CL=CL_0002179.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-12W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   GSML
AC   CVCL_3691
SY   Guyanese Squirrel Monkey Lymphoblastic cell line
DR   CLO; CLO_0003575
DR   ATCC; CRL-2699
DR   Wikidata; Q54871774
RX   PubMed=11528123;
RX   PubMed=11703081;
WW   Info; KCCMR; -; https://web.archive.org/web/20110829112150/http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9521; ! Saimiri sciureus (Common squirrel monkey)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Gsn-1
AC   CVCL_F707
DR   Wikidata; Q54871775
RX   PubMed=19947933;
CC   Group: Reptilian cell line.
CC   Doubling time: ~21 hours (PubMed=19947933).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
OX   NCBI_TaxID=146911; ! Gekko japonicus (Schlegel's Japanese gecko)
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   Gsn-3
AC   CVCL_F708
DR   Wikidata; Q54871777
RX   PubMed=19947933;
CC   Group: Reptilian cell line.
CC   Doubling time: ~33 hours (PubMed=19947933).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
OX   NCBI_TaxID=146911; ! Gekko japonicus (Schlegel's Japanese gecko)
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   GSnFB-L2
AC   CVCL_A9IK
SY   GSnFBL2
DR   CCRID; 5301MAM-KCB0502LZJ
DR   KCB; KCB 200502LZJ
DR   Wikidata; Q108820342
CC   Group: Bat cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9400; ! Cynopterus sphinx (Indian short-nosed fruit bat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GSnFB-S1
AC   CVCL_A9IL
SY   GSnFBS1
DR   CCRID; 5301MAM-KCB0501SZJ
DR   KCB; KCB 200501SZJ
DR   Wikidata; Q108820343
CC   Group: Bat cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9400; ! Cynopterus sphinx (Indian short-nosed fruit bat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GSNM-F
AC   CVCL_A2XM
SY   Golden Snub-Nosed Monkey Fibroblast
DR   Wikidata; Q105507496
RX   PubMed=33211213;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=61622; ! Rhinopithecus roxellana (Golden snub-nosed monkey)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   GSPHi001-A
AC   CVCL_WU86
SY   iPS-19
DR   hPSCreg; GSPHi001-A
DR   SKIP; SKIP005647
DR   Wikidata; Q93935246
RX   PubMed=31759290;
CC   From: Gansu Provincial Hospital; Lanzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34845; Nephrotic syndrome
DI   ORDO; Orphanet_564127; Genetic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   GSQ-S1
AC   CVCL_A9JE
SY   GSQS1
DR   CCRID; 5301MAM-KCB04030YJ
DR   KCB; KCB 200430YJ
DR   Wikidata; Q108820344
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30640; ! Sciurus carolinensis (Eastern gray squirrel)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   GSS
AC   CVCL_8876
DR   CLO; CLO_0050795
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 669
DR   BioSample; SAMN03471947
DR   BioSample; SAMN10987754
DR   cancercelllines; CVCL_8876
DR   Cell_Model_Passport; SIDM01511
DR   DepMap; ACH-000746
DR   FANTOM5_SSTAR; 10560-108A2
DR   GEO; GSM887029
DR   GEO; GSM888099
DR   IARC_TP53; 28346
DR   LiGeA; CCLE_070
DR   PharmacoDB; GSS_415_2019
DR   Progenetix; CVCL_8876
DR   RCB; RCB2277
DR   Wikidata; Q54871779
RX   PubMed=22460905;
RX   PubMed=24587255;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Asn (c.250G>A) (p.Arg98Gln, c.293G>A); ClinVar=VCV000229806; Zygosity=Homozygous (DepMap=ACH-000746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Homozygous (DepMap=ACH-000746).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=6.73%; Native American=0%; East Asian, North=81.61%; East Asian, South=6.93%; South Asian=0%; European, North=0%; European, South=4.73% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): RCB=RCB2277
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   GSS-Y218N-iPS
AC   CVCL_VL24
SY   FH10
DR   Wikidata; Q93935250
RX   PubMed=28466265;
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Tyr218Asn (c.652T>A); Zygosity=Unspecified (PubMed=28466265).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84727; Gerstmann-Straussler-Scheinker disease
DI   ORDO; Orphanet_356; Gerstmann-Straussler-Scheinker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >54Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   GSSC
AC   CVCL_1G57
SY   Giant Salamander Spleen Cell line
DR   Wikidata; Q54871780
RX   PubMed=26070783;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=141262; ! Andrias davidianus (Chinese giant salamander)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GSTC
AC   CVCL_1G58
SY   Giant Salamander Thymus Cell line
DR   Wikidata; Q54871781
RX   PubMed=26070783;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=141262; ! Andrias davidianus (Chinese giant salamander)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   GSU
AC   CVCL_8877
DR   CLO; CLO_0050794
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03471948
DR   BioSample; SAMN10987761
DR   cancercelllines; CVCL_8877
DR   Cell_Model_Passport; SIDM01551
DR   DepMap; ACH-000485
DR   GEO; GSM887030
DR   GEO; GSM888100
DR   IARC_TP53; 28289
DR   LiGeA; CCLE_054
DR   PharmacoDB; GSU_416_2019
DR   Progenetix; CVCL_8877
DR   RCB; RCB2278
DR   Wikidata; Q54871783
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000485).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Heterozygous (DepMap=ACH-000485).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=0.03%; East Asian, North=77.2%; East Asian, South=22.13%; South Asian=0%; European, North=0.34%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB2278
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14,16
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   GSW001
AC   CVCL_G030
DR   IPD-IMGT/HLA; 10687
DR   Wikidata; Q54871784
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*18:05; DRB1*13,16 (IPD-IMGT/HLA=10687).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GSW002
AC   CVCL_G031
DR   IPD-IMGT/HLA; 10688
DR   Wikidata; Q54871786
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*18:03; DRB1*03,11 (IPD-IMGT/HLA=10688).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GT-1
AC   CVCL_UI25
SY   GT1
DR   Wikidata; Q93935266
RX   PubMed=15250834;
RX   PubMed=19029086;
RX   PubMed=23278752;
RX   PubMed=25359319;
CC   Population: Japanese.
CC   Doubling time: 38.4 hours (PubMed=15250834).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   GT-13A
AC   CVCL_U125
DR   CLO; CLO_0050326
DR   RCB; RCB1858
DR   Wikidata; Q54871787
RX   PubMed=12182484;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_80769; Gonyautoxin 2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 8
//
ID   GT-BR
AC   CVCL_T703
SY   Green Turtle-BRain
DR   Wikidata; Q54871789
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-EYE
AC   CVCL_T704
SY   Green Turtle-Eye
DR   Wikidata; Q54871810
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-GB
AC   CVCL_T705
SY   Green Turtle-Gall Bladder
DR   Wikidata; Q54871811
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   GT-HT
AC   CVCL_T706
SY   Green Turtle-HearT
DR   Wikidata; Q54871812
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-KD
AC   CVCL_T707
SY   Green Turtle-KiDney
DR   Wikidata; Q54871813
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-LG
AC   CVCL_T708
SY   Green Turtle-LunG
DR   Wikidata; Q54871814
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-LV
AC   CVCL_T709
SY   Green Turtle-LiVer
DR   Wikidata; Q54871815
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-PS
AC   CVCL_T710
SY   Green Turtle-PancreaS
DR   Wikidata; Q54871816
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-SK
AC   CVCL_T711
SY   Green Turtle-SKin
DR   Wikidata; Q54871817
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-SP
AC   CVCL_T712
SY   Green Turtle-SPleen
DR   Wikidata; Q54871818
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-TM
AC   CVCL_T713
SY   Green Turtle-TuMor
DR   Wikidata; Q54871819
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
DI   NCIt; C135001; Turtle neoplasm
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T714 ! GT-TS
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   GT-TS
AC   CVCL_T714
SY   Green Turtle-TeStis
DR   Wikidata; Q54871820
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T715 ! GT-UB
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT-UB
AC   CVCL_T715
SY   Green Turtle-Urinary Bladder
DR   Wikidata; Q54871821
RX   PubMed=10462202;
CC   Group: Reptilian cell line.
CC   Doubling time: 30-36 hours (PubMed=10462202).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_T703 ! GT-BR
OI   CVCL_T704 ! GT-EYE
OI   CVCL_T705 ! GT-GB
OI   CVCL_T706 ! GT-HT
OI   CVCL_T707 ! GT-KD
OI   CVCL_T708 ! GT-LG
OI   CVCL_T709 ! GT-LV
OI   CVCL_T710 ! GT-PS
OI   CVCL_T711 ! GT-SK
OI   CVCL_T712 ! GT-SP
OI   CVCL_T713 ! GT-TM
OI   CVCL_T714 ! GT-TS
SX   Male
AG   Immature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GT0001
AC   CVCL_8W53
DR   ECACC; 96011125
DR   Wikidata; Q54871822
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Karyotypic information: 46,XY,inv(13)(q31.3;q32.3) (ECACC=96011125).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   GT0002
AC   CVCL_8W54
DR   ECACC; 96011126
DR   Wikidata; Q54871823
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Karyotypic information: 46,XY,inv(13)(q31.3;q32.3) (ECACC=96011126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96011126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74988; Holoprosencephaly
DI   ORDO; Orphanet_2162; Holoprosencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   GT0013
AC   CVCL_8W55
DR   ECACC; 07082302
DR   Wikidata; Q54871824
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   GT01s-p
AC   CVCL_F1GI
WW   Provider; ARI-TOX MWCB; GT01s-p; https://aritox.com/mwcb/mwcb-gt01s-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT04s-p
AC   CVCL_F1GJ
WW   Provider; ARI-TOX MWCB; GT04s-p; https://aritox.com/mwcb/mwcb-gt04s-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
SX   Sex ambiguous
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT06s-p
AC   CVCL_F1GK
WW   Provider; ARI-TOX MWCB; GT06s-p; https://aritox.com/mwcb/mwcb-gt06s-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
SX   Sex ambiguous
AG   Subadult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT07s-p
AC   CVCL_F1GL
WW   Provider; ARI-TOX MWCB; GT07s-p; https://aritox.com/mwcb/mwcb-gt07s-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
SX   Sex ambiguous
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT08h-p
AC   CVCL_F1GM
WW   Provider; ARI-TOX MWCB; GT08h-p; https://aritox.com/mwcb/mwcb-gt08h-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GN ! GT08i-p
OI   CVCL_F1GP ! GT08k-p
SX   Sex ambiguous
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT08i-p
AC   CVCL_F1GN
WW   Provider; ARI-TOX MWCB; GT08i-p; https://aritox.com/mwcb/mwcb-gt08i-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GM ! GT08h-p
OI   CVCL_F1GP ! GT08k-p
SX   Sex ambiguous
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT08k-p
AC   CVCL_F1GP
WW   Provider; ARI-TOX MWCB; GT08k-p; https://aritox.com/mwcb/mwcb-gt08k-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GM ! GT08h-p
OI   CVCL_F1GN ! GT08i-p
SX   Sex ambiguous
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT1
AC   CVCL_6235
SY   GT-1
DR   BTO; BTO_0003898
DR   Wikidata; Q54871825
RX   PubMed=2196069;
RX   PubMed=18406727;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 transgenic with rat Gnrh1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   GT1-1
AC   CVCL_6236
AS   CVCL_8219
DR   BTO; BTO_0003899
DR   CCRID; 1101MOU-PUMC000009
DR   Wikidata; Q54871826
RX   PubMed=1542682;
RX   PubMed=1714837;
RX   PubMed=2196069;
RX   PubMed=18406727;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: GTI-1; Note=Occasionally.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 transgenic with rat Gnrh1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6235 ! GT1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   GT1-3
AC   CVCL_6237
AS   CVCL_8220
DR   Wikidata; Q54871827
RX   PubMed=1714837;
RX   PubMed=2196069;
RX   PubMed=18406727;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: GTI-3; Note=Occasionally.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 transgenic with rat Gnrh1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6235 ! GT1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   GT1-7
AC   CVCL_0281
AS   CVCL_8221
DR   BTO; BTO_0002708
DR   MCCL; MCC:0000172
DR   BCRJ; 0095
DR   Lonza; 687
DR   Millipore; SCC116
DR   TOKU-E; 4052
DR   Wikidata; Q54871828
RX   PubMed=1714837;
RX   PubMed=2196069;
RX   PubMed=10830297;
RX   PubMed=18406727;
CC   Characteristics: Exhibits high levels of Gnrh1 expression and secretes GnRH in response to depolarization.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: GTI-7; Note=Occasionally.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 transgenic with rat Gnrh1 promoter-Tg(SV40).
ST   Source(s): Millipore=SCC116
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 13,17
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 13,16
ST   Mouse STR 11-2: 16,18
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2,17
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 25,28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6235 ! GT1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   GT1-7-OX1
AC   CVCL_RL73
DR   Wikidata; Q54871829
RX   PubMed=29145494;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4848; HCRTR1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 transgenic with rat Gnrh1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0281 ! GT1-7
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   GT1.Lu
AC   CVCL_S372
DR   ATCC; CRL-6268
DR   Wikidata; Q54871830
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6268; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=69308; ! Eudorcas thomsonii (Thomson's gazelle)
OI   CVCL_Y445 ! GT1.Thy
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   GT1.Thy
AC   CVCL_Y445
DR   ATCC; CRL-6269
DR   Wikidata; Q54871831
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6269; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=69308; ! Eudorcas thomsonii (Thomson's gazelle)
OI   CVCL_S372 ! GT1.Lu
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 8
//
ID   GT10i-p
AC   CVCL_F1GQ
WW   Provider; ARI-TOX MWCB; GT10i-p; https://aritox.com/mwcb/mwcb-gt10i-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GR ! GT10l-p
OI   CVCL_F1GS ! GT10o-p
SX   Female
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT10l-p
AC   CVCL_F1GR
WW   Provider; ARI-TOX MWCB; GT10l-p; https://aritox.com/mwcb/mwcb-gt10l-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GQ ! GT10i-p
OI   CVCL_F1GS ! GT10o-p
SX   Female
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT10o-p
AC   CVCL_F1GS
WW   Provider; ARI-TOX MWCB; GT10o-p; https://aritox.com/mwcb/mwcb-gt10o-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GQ ! GT10i-p
OI   CVCL_F1GR ! GT10l-p
SX   Female
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT12h-p
AC   CVCL_F1GT
WW   Provider; ARI-TOX MWCB; GT12h-p; https://aritox.com/mwcb/mwcb-gt12h-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GU ! GT12o-p
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT12o-p
AC   CVCL_F1GU
WW   Provider; ARI-TOX MWCB; GT12o-p; https://aritox.com/mwcb/mwcb-gt12o-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GT ! GT12h-p
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT14k-p
AC   CVCL_F1GV
WW   Provider; ARI-TOX MWCB; GT14k-p; https://aritox.com/mwcb/mwcb-gt14k-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GW ! GT14t-p
SX   Male
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT14t-p
AC   CVCL_F1GW
WW   Provider; ARI-TOX MWCB; GT14t-p; https://aritox.com/mwcb/mwcb-gt14t-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
OI   CVCL_F1GV ! GT14k-p
SX   Male
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   GT38
AC   CVCL_C8NH
SY   GT-38
DR   BTO; BTO_0006490
DR   Wikidata; Q123031376
RX   PubMed=9600119;
RX   PubMed=11543663;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=9600119).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   GT39
AC   CVCL_C8NI
SY   GT-39
DR   BTO; BTO_0006491
DR   Wikidata; Q123031378
RX   PubMed=9600119;
RX   PubMed=11543663;
CC   Population: Japanese.
CC   Doubling time: ~22 hours (PubMed=9600119).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   GT3TKB
AC   CVCL_1237
DR   CLO; CLO_0037139
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03151908
DR   cancercelllines; CVCL_1237
DR   Cell_Model_Passport; SIDM01231
DR   ChEMBL-Cells; CHEMBL3308840
DR   ChEMBL-Targets; CHEMBL2366148
DR   Cosmic; 907041
DR   Cosmic; 983730
DR   Cosmic; 1001654
DR   Cosmic-CLP; 907041
DR   DepMap; ACH-002122
DR   EGA; EGAS00001000978
DR   GEO; GSM1669817
DR   IARC_TP53; 21351
DR   LINCS_LDP; LCL-1895
DR   PharmacoDB; GT3TKB_417_2019
DR   PubChem_Cell_line; CVCL_1237
DR   RCB; RCB0885
DR   Wikidata; Q54871832
RX   PubMed=15767549;
RX   PubMed=16643607;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RERF-LC-A1 derivative (PubMed=16643607; PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00202.
CC   Population: Chinese; Taiwan.
CC   Microsatellite instability: Stable (MSS) (PubMed=31068700).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Homozygous (DepMap=ACH-002122).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=89.7%; East Asian, South=9.37%; South Asian=0.05%; European, North=0.87%; European, South=0% (PubMed=30894373).
CC   Misspelling: CT3TKB; Cosmic=1001654.
CC   Discontinued: Cosmic-CLP; 907041; true.
CC   Discontinued: RCB; RCB0885; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=907041
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4402 ! RERF-LC-A1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   GT512muMAB 55A
AC   CVCL_B7CV
SY   55A
DR   Wikidata; Q112929626
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3089.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 59A
AC   CVCL_B7CW
SY   59A
DR   Wikidata; Q112929627
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3067.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 60A
AC   CVCL_B7CX
SY   60A
DR   Wikidata; Q112929628
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3068.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 61D
AC   CVCL_B7CY
SY   61D
DR   Wikidata; Q112929629
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3069.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 64A
AC   CVCL_B7CZ
SY   64A
DR   Wikidata; Q112929630
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3070.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 65A
AC   CVCL_B7D0
SY   65A
DR   Wikidata; Q112929631
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3071.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 66B
AC   CVCL_B7D1
SY   66B
DR   Wikidata; Q112929632
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3072.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 67A
AC   CVCL_B7D2
SY   67A
DR   Wikidata; Q112929633
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3073.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT512muMAB 89A
AC   CVCL_B7D3
SY   89A
DR   Wikidata; Q112929634
RX   Patent=US10919974;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3090.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   GT9
AC   CVCL_IR53
DR   IARC_TP53; 4530
DR   Wikidata; Q54871833
RX   Patent=WO1995007105A1;
RX   PubMed=7757303;
CC   Group: Patented cell line.
CC   Doubling time: 36 hours (PubMed=7757303).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249_Pro250delinsSerAla (c.747_748delGCinsTG); Zygosity=Homozygous (PubMed=7757303).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   GTE
AC   CVCL_C8J7
SY   TEPI; Guinea pig Trophoblast Epithelial
DR   Wikidata; Q123031379
RX   PubMed=28651121;
CC   Virology: Susceptible to infection by guinea pig cytomegalovirus (GPCMV) (PubMed=28651121).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Hartley; VBO=VBO_0017521.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   GTI
AC   CVCL_9W63
DR   Wikidata; Q54871834
RX   PubMed=11930168;
RX   PubMed=16646156;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic dorsal root ganglion; UBERON=UBERON_0000044.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
DI   NCIt; C125660; Mouse trisomy 16
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-16FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   GTL-16
AC   CVCL_7668
SY   GTL 16; GTL16
DR   EFO; EFO_0006578
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_7668
DR   ChEMBL-Cells; CHEMBL3308698
DR   ChEMBL-Targets; CHEMBL612708
DR   Cosmic; 755306
DR   Cosmic; 755613
DR   Cosmic; 887246
DR   Cosmic; 1945868
DR   Cosmic; 2069777
DR   Cosmic; 2484973
DR   Cosmic; 2807624
DR   EGA; EGAS00001000610
DR   GEO; GSM685812
DR   GEO; GSM686033
DR   GEO; GSM686034
DR   GEO; GSM843505
DR   GEO; GSM1178098
DR   GEO; GSM1178099
DR   GEO; GSM1374485
DR   GEO; GSM1374486
DR   PharmacoDB; GTL16_418_2019
DR   Progenetix; CVCL_7668
DR   PubChem_Cell_line; CVCL_7668
DR   Wikidata; Q54871835
RX   PubMed=1486568;
RX   PubMed=1674365;
RX   PubMed=2541345;
RX   PubMed=22745804;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=26589293;
CC   Population: Japanese.
CC   Characteristics: MET is amplified and overexpressed in this cell line.
CC   HLA typing: A*24:02,24:02; B*52:01,67:02; C*12:02,12:02; DRB1*14:01,14:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   GTL16R1
AC   CVCL_VS67
SY   GTL16 R1
DR   cancercelllines; CVCL_VS67
DR   GEO; GSM686016
DR   GEO; GSM686035
DR   GEO; GSM686036
DR   Progenetix; CVCL_VS67
DR   Wikidata; Q93935412
RX   PubMed=22745804;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_91425; 2-[4-[3-(6-quinolinylmethyl)-5-triazolo[4,5-b]pyrazinyl]-1-pyrazolyl]ethanol (PF-04217903).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1097; BRAF + HGNC; HGNC:30646; SND1; Name(s)=SND1-BRAF (PubMed=22745804).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7668 ! GTL-16
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   GTL16R3
AC   CVCL_VS68
SY   GTL16 R3
DR   cancercelllines; CVCL_VS68
DR   GEO; GSM686017
DR   GEO; GSM686037
DR   GEO; GSM686038
DR   Progenetix; CVCL_VS68
DR   Wikidata; Q93935415
RX   PubMed=22745804;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_91425; 2-[4-[3-(6-quinolinylmethyl)-5-triazolo[4,5-b]pyrazinyl]-1-pyrazolyl]ethanol (PF-04217903).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1097; BRAF + HGNC; HGNC:30646; SND1; Name(s)=SND1-BRAF (PubMed=22745804).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7668 ! GTL-16
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   GTL16S5
AC   CVCL_VS69
SY   GTL16 S5
DR   cancercelllines; CVCL_VS69
DR   Wikidata; Q93935419
RX   PubMed=22745804;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_91425; 2-[4-[3-(6-quinolinylmethyl)-5-triazolo[4,5-b]pyrazinyl]-1-pyrazolyl]ethanol (PF-04217903).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7668 ! GTL-16
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   GTM-3
AC   CVCL_5G33
SY   GTM3; Glaucomatous Trabecular Meshwork-3; HTM-3; Human Trabecular Meshwork-3
DR   Wikidata; Q54871836
RX   PubMed=8156826;
RX   PubMed=16303956;
RX   PubMed=16636656;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
DI   NCIt; C26782; Glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G31 ! HTM-2
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   GTO
AC   CVCL_T064
DR   Wikidata; Q54871837
RX   PubMed=23605439;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   GTS
AC   CVCL_T682
SY   Green Turtle Skin
DR   Wikidata; Q54871838
RX   PubMed=7129477;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=8469; ! Chelonia mydas (Green sea-turtle)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   GTT
AC   CVCL_YP03
SY   Goat Testis Transformed
DR   Wikidata; Q93935442
RX   PubMed=31805146;
CC   Virology: Susceptible to infection by ORFV.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: Anglo-Nubian; VBO=VBO_0000722.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_YP02 ! FBT [Goat]
SX   Male
AG   2W
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   GTX-006
AC   CVCL_C1HW
DR   Wikidata; Q114311540
RX   DOI=10.15616/BSL.2017.23.3.238;
CC   Population: Korean.
CC   Characteristics: Highly tumorigenic. Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, body; UBERON=UBERON_0001161.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 10,11
ST   D18S51: 18,19
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 23,25
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GTX-007
AC   CVCL_C1HX
DR   Wikidata; Q114311541
RX   DOI=10.15616/BSL.2017.23.3.238;
CC   Population: Korean.
CC   Characteristics: Highly tumorigenic. Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 8,11
ST   D18S51: 13,14
ST   D19S433: 13,14.2
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GTX-085
AC   CVCL_C1HY
DR   Wikidata; Q114311542
RX   DOI=10.15616/BSL.2017.23.3.238;
RX   PubMed=35641282;
CC   Population: Korean.
CC   Characteristics: Highly tumorigenic. Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, cardia; UBERON=UBERON_0001162.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 9,14
ST   D16S539: 10,13
ST   D18S51: 12,13
ST   D19S433: 11,14.2
ST   D21S11: 29,34
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 8,11
ST   D7S820: 10,12
ST   D8S1179: 15,17
ST   FGA: 20,21
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 18,20
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GTX-086
AC   CVCL_C1HZ
DR   Wikidata; Q114311543
RX   DOI=10.15616/BSL.2017.23.3.238;
CC   Population: Korean.
CC   Characteristics: Highly tumorigenic. Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, body; UBERON=UBERON_0001161.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 29,31
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 7,10
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 23,26
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GTX-087
AC   CVCL_C1I0
DR   Wikidata; Q114311544
RX   DOI=10.15616/BSL.2017.23.3.238;
RX   PubMed=35641282;
CC   Population: Korean.
CC   Characteristics: Highly tumorigenic. Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GTX-103
AC   CVCL_C1I1
DR   Wikidata; Q114311545
RX   DOI=10.15616/BSL.2017.23.3.238;
RX   PubMed=35641282;
CC   Population: Korean.
CC   Characteristics: Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 23,24
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 8,13
ST   D8S1179: 15
ST   FGA: 20
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GTX-116
AC   CVCL_C1I2
DR   Wikidata; Q114311546
RX   DOI=10.15616/BSL.2017.23.3.238;
RX   PubMed=35641282;
CC   Population: Korean.
CC   Characteristics: Highly tumorigenic. Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X
ST   CSF1PO: 8,9
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 16,17
ST   D19S433: 11,12
ST   D21S11: 28,33.2
ST   D2S1338: 20
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,12
ST   FGA: 19,21
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GTX-139
AC   CVCL_C1I3
DR   Wikidata; Q114311549
RX   DOI=10.15616/BSL.2017.23.3.238;
RX   PubMed=35641282;
CC   Population: Korean.
CC   Characteristics: Highly tumorigenic. Established from a xenograft after serial heterotransplantation of the original gastric tumor in nude mice.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach, pyloric antrum; UBERON=UBERON_0001165.
ST   Source(s): DOI=10.15616/BSL.2017.23.3.238
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 15,17
ST   D19S433: 12,14
ST   D21S11: 31.2
ST   D2S1338: 17,25
ST   D3S1358: 13,14
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 10,11
ST   FGA: 21,22
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 19,22
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   GU-4
AC   CVCL_D7E9
RX   CelloPub=CLPUB00770;
RX   PubMed=1612780;
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   GU-4/2
AC   CVCL_D7EA
RX   PubMed=1612780;
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7E9 ! GU-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   GU-4/4
AC   CVCL_D7EB
RX   PubMed=1612780;
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7E9 ! GU-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   GU2037
AC   CVCL_F554
DR   IPD-IMGT/HLA; 10689
DR   Wikidata; Q54871839
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*74:01; B*15:10,50:01 (IPD-IMGT/HLA=10689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GU2040
AC   CVCL_F555
DR   IPD-IMGT/HLA; 10690
DR   Wikidata; Q54871840
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*74:01:01:01 (IPD-IMGT/HLA=10690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GU2092
AC   CVCL_F556
DR   IPD-IMGT/HLA; 10691
DR   Wikidata; Q54871841
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*15:10,49:01 (IPD-IMGT/HLA=10691).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GU2739
AC   CVCL_F557
DR   IPD-IMGT/HLA; 10692
DR   Wikidata; Q54871842
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*15:18,35:01:01 (IPD-IMGT/HLA=10692).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GU2760
AC   CVCL_F558
DR   IPD-IMGT/HLA; 10693
DR   Wikidata; Q54871843
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*15:18,37:01:01 (IPD-IMGT/HLA=10693).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GU373
AC   CVCL_E680
SY   CRGE
DR   dbMHC; 48875
DR   ECACC; 94071410
DR   IHW; IHW09275
DR   IPD-IMGT/HLA; 10694
DR   Wikidata; Q54871845
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*30:01; B*15:10,53:01; C*03:04,04:01; DPB1*04:02,17:01; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*02:02 (IPD-IMGT/HLA=10694).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   GU5175
AC   CVCL_F559
SY   TER178
DR   IPD-IMGT/HLA; 10695
DR   Wikidata; Q54871846
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:01,66:01; B*15:10,41:02; C*16:01,17 (IPD-IMGT/HLA=10695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   GUGU-A32
AC   CVCL_E8W0
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9CRA0; Mouse Art4/Cd297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GUGU-A53
AC   CVCL_E8W1
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9CRA0; Mouse Art4/Cd297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   GUCASe001-A
AC   CVCL_B529
SY   hPES-1; HPES-1
DR   hPSCreg; GUCASe001-A
DR   SKIP; SKIP002276
DR   Wikidata; Q54871847
RX   PubMed=18071366;
CC   From: Graduate University of Chinese Academy of Sciences Institute of Zoology; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=18071366
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10
ST   D18S51: 14,15
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 9,12
ST   D8S1179: 15
ST   FGA: 14,15
ST   Penta D: 11
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   GUCASe002-A
AC   CVCL_B530
SY   hPES-2; HPES-2
DR   hPSCreg; GUCASe002-A
DR   SKIP; SKIP002277
DR   Wikidata; Q54871848
RX   PubMed=18071366;
CC   From: Graduate University of Chinese Academy of Sciences Institute of Zoology; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   GUMBUS
AC   CVCL_2051
SY   Gumbus
DR   BioSample; SAMN03473510
DR   Cosmic; 2814539
DR   DSMZ; ACC-630
DR   DSMZCellDive; ACC-630
DR   Wikidata; Q54871849
RX   PubMed=17562080;
RX   PubMed=22885699;
RX   PubMed=25960936;
CC   Virology: EBV-negative.
CC   Doubling time: ~48 hours (DSMZ=ACC-630).
CC   HLA typing: A*02:01,23:01; B*07:02,44:03; C*04:01,07:02; DQA1*01:01,02:01; DQB1*02:01,05:03; DRB1*14:01,07:01 (PubMed=25960936).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-630
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,19
ST   D3S1358: 14,15
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   D8S1179: 13,16
ST   FGA: 19,20
ST   Penta D: 10,12
ST   Penta E: 10,14
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   GUMC-29
AC   CVCL_E3DN
RX   PubMed=28009986;
CC   Characteristics: Established by conditional reprogramming (CR), a cell culture method in which epithelial cells are seeded onto an irradiated 3T3-J2 mouse fibroblast feeder layer in a specialized medium that contains Y-276321 an inhibitor of ROCK1 and ROCK2 (PubMed=28009986).
CC   Characteristics: Obtained from the non-malignant tissue of the prostate cancer patient (PubMed=28009986).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from autologous cell line RC-123T/E).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): PubMed=28009986
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 14,17.2
ST   D21S11: 29,30
ST   D2S1338: 18,25
ST   D3S1358: 17,18
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 18,26
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3DP ! GUMC-30
OI   CVCL_VV24 ! RC-123T/E
SX   Male
AG   57Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   GUMC-30
AC   CVCL_E3DP
RX   PubMed=28009986;
CC   Characteristics: Established by conditional reprogramming (CR), a cell culture method in which epithelial cells are seeded onto an irradiated 3T3-J2 mouse fibroblast feeder layer in a specialized medium that contains Y-276321 an inhibitor of ROCK1 and ROCK2 (PubMed=28009986).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from autologous cell line RC-123T/E).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): PubMed=28009986
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 14,17.2
ST   D21S11: 29,30
ST   D2S1338: 18,25
ST   D3S1358: 17,18
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 18,26
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3DN ! GUMC-29
OI   CVCL_VV24 ! RC-123T/E
SX   Male
AG   57Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Guo-1
AC   CVCL_C4SN
DR   ABCD; ABCD_AE899
DR   Wikidata; Q116049109
RX   PubMed=7508080;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16750; Guanosine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   Guo-2
AC   CVCL_C4SP
DR   ABCD; ABCD_AE900
DR   Wikidata; Q116049110
RX   PubMed=7508080;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16750; Guanosine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   GuRt05
AC   CVCL_C1KL
DR   Wikidata; Q114311550
RX   CelloPub=CLPUB00714;
CC   Characteristics: Proliferates at the permissive temperature of 33 Celsius. Differentiates at the non-permissive temperature of 37 Celsius.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1KK ! GuRt09
SX   Sex unspecified
AG   10-12FW
CA   Conditionally immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   GuRt09
AC   CVCL_C1KK
DR   Wikidata; Q114311551
RX   CelloPub=CLPUB00714;
RX   PubMed=20447347;
CC   Characteristics: Proliferates at the permissive temperature of 33 Celsius. Differentiates at the non-permissive temperature of 37 Celsius.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1KL ! GuRt05
SX   Sex unspecified
AG   10-12FW
CA   Conditionally immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   GUSS-1
AC   CVCL_N589
SY   Georgetown University Synovial Sarcoma-1
DR   Wikidata; Q54871850
RX   PubMed=23716114;
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=23716114).
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GUSS-2
AC   CVCL_N590
SY   Georgetown University Synovial Sarcoma-2
DR   Wikidata; Q54871854
RX   PubMed=23716114;
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=23716114).
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GUSS-3
AC   CVCL_N591
SY   Georgetown University Synovial Sarcoma-3
DR   Wikidata; Q54871855
RX   PubMed=23716114;
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=23716114).
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LG31 ! GUSS-3b
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   GUSS-3b
AC   CVCL_LG31
SY   Georgetown University Synovial Sarcoma-3b
DR   Wikidata; Q54871856
RX   PubMed=23716114;
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=23716114).
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N591 ! GUSS-3
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   GV39M
AC   CVCL_KR34
DR   Wikidata; Q54871857
RX   PubMed=9581838;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P26617; Cavia porcellus VEGFA (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   GW0011
AC   CVCL_8W56
DR   ECACC; 96080816
DR   Wikidata; Q54871858
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Mexican.
CC   Discontinued: ECACC; 96080816; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 5
//
ID   GW0012
AC   CVCL_8W57
DR   ECACC; 96080817
DR   Wikidata; Q54871859
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Mexican.
CC   Discontinued: ECACC; 96080817; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 5
//
ID   GW0013
AC   CVCL_8W58
DR   ECACC; 96080818
DR   Wikidata; Q54871860
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Mexican.
CC   Discontinued: ECACC; 96080818; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 5
//
ID   GWCMCi001-A
AC   CVCL_A1CY
SY   iPS-57
DR   BioSamples; SAMEA7485353
DR   hPSCreg; GWCMCi001-A
DR   Wikidata; Q102114072
RX   PubMed=33359895;
CC   From: Guangzhou Women and Children's Medical Center; Guangzhou; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   GWCMCi002-A
AC   CVCL_A4VC
SY   IPS79-1; iPS79
DR   BioSamples; SAMEA8050982
DR   hPSCreg; GWCMCi002-A
DR   Wikidata; Q107115207
RX   PubMed=34088015;
CC   From: Guangzhou Women and Children's Medical Center; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; c.1517-1G>T; ClinVar=VCV000024421; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=34088015).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   GWCMCi003-A
AC   CVCL_A4XF
DR   hPSCreg; GWCMCi003-A
DR   Wikidata; Q107115208
CC   From: Guangzhou Women and Children's Medical Center; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   GWCMCi004-A
AC   CVCL_A1CZ
DR   BioSamples; SAMEA7484348
DR   hPSCreg; GWCMCi004-A
DR   Wikidata; Q102114073
CC   From: Guangzhou Women and Children's Medical Center; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 4
//
ID   GWCMCi005-A
AC   CVCL_C0F0
SY   GWCMCi-TANC2
DR   BioSamples; SAMEA12075250
DR   hPSCreg; GWCMCi005-A
DR   Wikidata; Q112929635
RX   PubMed=35066241;
CC   From: Guangzhou Women and Children's Medical Center; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:30212; TANC2; Simple; p.Gln1441Ter (c.4321C>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=35066241).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   GWCMCi006-A
AC   CVCL_D0F4
SY   GWCMCi-GRIN1
DR   BioSamples; SAMEA114293122
DR   hPSCreg; GWCMCi006-A
DR   Wikidata; Q123031380
RX   PubMed=38452705;
CC   From: Guangzhou Women and Children's Medical Center; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4584; GRIN1; Simple; p.Asp130Gly (c.389A>G); Zygosity=Heterozygous; Note=De novo mutation (PubMed=38452705).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206518; Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   GWH04
AC   CVCL_C0W3
SY   GWH 04; Fu
DR   cancercelllines; CVCL_C0W3
DR   CCRID; 4201PAT-CCTCC01832
DR   Wikidata; Q114311552
RX   Patent=CN114214281B;
RX   PubMed=36169178;
WW   Provider; BRICS; BRICS0010; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3825
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202163.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu1038Gly (c.3113A>G); ClinVar=VCV000041815; Zygosity=Unspecified (PubMed=36169178).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Ser423Gly (c.1267A>G); ClinVar=VCV001398791; Zygosity=Unspecified (PubMed=36169178).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Val384Asp (c.1151T>A); ClinVar=VCV000041632; Zygosity=Unspecified (PubMed=36169178).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Ter640Argext (c.1918T>C); Zygosity=Unspecified (PubMed=36169178).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Unspecified (PubMed=36169178).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr315Ter (c.945T>A); ClinVar=VCV000234509; Zygosity=Unspecified (PubMed=36169178).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=36169178).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Unspecified (PubMed=36169178).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=36169178
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,23
ST   D13S317: 9
ST   D16S539: 10,12
ST   D19S433: 14
ST   D1S1656: 15
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D6S1043: 11,19
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 9,15
ST   Penta E: 12,18
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   GWSS-G3
AC   CVCL_Z888
SY   GWSS Z10 subline G3
DR   ICLDB; gwss-g3
DR   Wikidata; Q54871861
RX   PubMed=16153147;
CC   Group: Insect cell line.
CC   Doubling time: 100.3 +- 6.8 hours (PubMed=16153147).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=197043; ! Homalodisca vitripennis (Glassy-winged sharpshooter)
HI   CVCL_Z890 ! GWSS-Z10
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GWSS-LH
AC   CVCL_Z889
DR   ICLDB; gwss-lh
DR   Wikidata; Q54871862
RX   PubMed=16153147;
CC   Group: Insect cell line.
CC   Doubling time: 60.2 +- 4.9 hours (PubMed=16153147).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=197043; ! Homalodisca vitripennis (Glassy-winged sharpshooter)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GWSS-Z10
AC   CVCL_Z890
DR   ICLDB; gwss-z10
DR   Wikidata; Q54871863
RX   PubMed=16153147;
RX   PubMed=17113099;
CC   Group: Insect cell line.
CC   Doubling time: 46.2 +- 1.6 hours (PubMed=16153147).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=197043; ! Homalodisca vitripennis (Glassy-winged sharpshooter)
OI   CVCL_Z891 ! GWSS-Z15
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GWSS-Z15
AC   CVCL_Z891
DR   ICLDB; gwss-z15
DR   Wikidata; Q54871864
RX   PubMed=16153147;
CC   Group: Insect cell line.
CC   Doubling time: 90.9 +- 14.0 hours (PubMed=16153147).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=197043; ! Homalodisca vitripennis (Glassy-winged sharpshooter)
OI   CVCL_Z890 ! GWSS-Z10
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   GX
AC   CVCL_ZV99
DR   Wikidata; Q102114074
RX   PubMed=8325953;
RX   PubMed=31728905;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
DI   NCIt; C4536; Pituitary gland carcinoma
DI   ORDO; Orphanet_300385; Pituitary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   GXF 251L
AC   CVCL_D243
SY   GXF521; GXF 251; GXF251L
DR   Wikidata; Q54871865
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   GXRCas9
AC   CVCL_C8ZC
DR   BioGRID_ORCS_Cell_line; 1226
DR   Wikidata; Q123031381
RX   PubMed=27992415;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZB ! CEM-GXR25
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   GZ-13
AC   CVCL_C4QU
DR   Wikidata; Q116049111
RX   PubMed=36045061;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08857; Mouse Cd36 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   GZ-143
AC   CVCL_C4QV
DR   Wikidata; Q116049112
RX   PubMed=36045061;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08857; Mouse Cd36 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   GZ-3
AC   CVCL_C4QW
DR   Wikidata; Q116049113
RX   PubMed=36045061;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08857; Mouse Cd36 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   GZ-413
AC   CVCL_C4QX
DR   Wikidata; Q116049114
RX   PubMed=36045061;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08857; Mouse Cd36 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   GZ-507
AC   CVCL_C4QY
DR   Wikidata; Q116049115
RX   PubMed=36045061;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08857; Mouse Cd36 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   GZ-608
AC   CVCL_C4QZ
DR   Wikidata; Q116049116
RX   PubMed=36045061;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08857; Mouse Cd36 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   GZ-70
AC   CVCL_C4R0
DR   Wikidata; Q116049117
RX   PubMed=36045061;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08857; Mouse Cd36 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   GZHMCe003-A-1
AC   CVCL_D0QL
DR   Wikidata; Q123031382
RX   PubMed=37182381;
CC   From: Wuyi University; Jiangmen; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4585; GRIN2A.
CC   Caution: Incorrectly called GZHMCe003-A in PubMed=37182381.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9929 ! FY-hES-10
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   GZHMCi001-A
AC   CVCL_ZX47
SY   MEAK-iPS 1
DR   BioSamples; SAMEA6992761
DR   hPSCreg; GZHMCi001-A
DR   SKIP; SKIP005889
DR   Wikidata; Q102114075
RX   PubMed=32712483;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6233; KCNC1; Simple; p.Arg320His (c.959G>A); ClinVar=VCV000162519; Zygosity=Heterozygous (PubMed=32712483).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142804; Epilepsy, progressive myoclonic 7
DI   ORDO; Orphanet_435438; Progressive myoclonic epilepsy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX48 ! GZHMCi001-B
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   GZHMCi001-B
AC   CVCL_ZX48
SY   MEAK-iPS 2
DR   hPSCreg; GZHMCi001-B
DR   SKIP; SKIP005890
DR   Wikidata; Q102114076
RX   PubMed=32712483;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6233; KCNC1; Simple; p.Arg320His (c.959G>A); ClinVar=VCV000162519; Zygosity=Heterozygous (PubMed=32712483).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142804; Epilepsy, progressive myoclonic 7
DI   ORDO; Orphanet_435438; Progressive myoclonic epilepsy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX47 ! GZHMCi001-A
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   GZHMCi002-A
AC   CVCL_A1WB
SY   APOB-iPSC
DR   hPSCreg; GZHMCi002-A
DR   Wikidata; Q105507498
RX   PubMed=33128957;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:603; APOB; Simple; p.Arg3527Trp (c.10579C>T); ClinVar=VCV000040223; Zygosity=Heterozygous (PubMed=33128957).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176014; Hypercholesterolemia, familial, 2
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   GZHMCi003-A
AC   CVCL_A1WC
SY   iPS-63; IPS63
DR   hPSCreg; GZHMCi003-A
DR   Wikidata; Q105507501
RX   PubMed=33477036;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Unexplicit; Ex3del; Zygosity=Heterozygous (PubMed=33477036).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   GZHMCi004-A
AC   CVCL_A1WD
SY   iPS80-1; IPS80-1
DR   BioSamples; SAMEA8268546
DR   hPSCreg; GZHMCi004-A
DR   Wikidata; Q105507504
RX   PubMed=33848795;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Gly380Arg (c.1138G>A); ClinVar=VCV000016327; Zygosity=Heterozygous (PubMed=33848795).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   GZHMCi005-A
AC   CVCL_A5EZ
SY   dup 8p-iPSC
DR   hPSCreg; GZHMCi005-A
DR   Wikidata; Q107115209
RX   PubMed=33588214;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36455; Gain of chromosome 8
DI   ORDO; Orphanet_262758; Partial duplication of the short arm of chromosome 8
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GZHMCi006-A
AC   CVCL_A7GB
SY   del 14q-iPSC
DR   hPSCreg; GZHMCi006-A
DR   Wikidata; Q107115211
RX   PubMed=33894549;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C39795; Loss of chromosome 14q
DI   ORDO; Orphanet_96150; Distal monosomy 14q
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   GZHMCi007-A
AC   CVCL_A7GC
DR   hPSCreg; GZHMCi007-A
DR   Wikidata; Q107115212
RX   PubMed=34403853;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18078; ZBTB7A.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=Hb Constant Spring (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34403853
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 19,21
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 11,14
ST   D19S433: 12,15.2
ST   D1S1656: 15,16
ST   D21S11: 29,32.2
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D6S1043: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,15
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4G8 ! SU-iPS-1
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   GZHMCi008-A
AC   CVCL_B3T6
SY   TDSD-iPSC
DR   hPSCreg; GZHMCi008-A
DR   Wikidata; Q110432832
RX   PubMed=34710837;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C86032; XX male
DI   ORDO; Orphanet_393; 46,XX testicular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   GZHMCi009-A
AC   CVCL_C0IB
SY   SCA3-iPSC1; SCA3-CJY
DR   BioSamples; SAMEA14093699
DR   hPSCreg; GZHMCi009-A
DR   Wikidata; Q112929636
RX   PubMed=35421843;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=35421843).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   GZHMCi010-A
AC   CVCL_C0IC
SY   SCA3-iPSC2; SCA3-HJY
DR   hPSCreg; GZHMCi010-A
DR   Wikidata; Q112929637
RX   PubMed=35421843;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=35421843).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   GZHMCi011-A
AC   CVCL_D0F5
SY   SCA3-LXM
DR   BioSamples; SAMEA114245588
DR   hPSCreg; GZHMCi011-A
DR   Wikidata; Q123031383
RX   PubMed=37866221;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[63]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=37866221).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   GZHMD1F10
AC   CVCL_XA33
DR   CCRID; 4201PAT-CCTCC00209
DR   Wikidata; Q93935513
RX   Patent=CN100482643C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200640.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_28306; Semicarbazide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   GZHMUi001-A
AC   CVCL_QX44
SY   TripleX-iPSC1; LWM-iPSC1
DR   hPSCreg; GZHMUi001-A
DR   Wikidata; Q54871866
RX   PubMed=28925367;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129718; 47,XXX syndrome
DI   ORDO; Orphanet_3375; Trisomy X
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   GZHMUi002-A
AC   CVCL_C1T7
DR   hPSCreg; GZHMUi002-A
DR   Wikidata; Q114311554
CC   From: Guangzhou Medical University; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   GZKHQi001-A
AC   CVCL_RV20
SY   DMD-iPS1
DR   Wikidata; Q54871867
RX   PubMed=29414414;
CC   From: The Third Affiliated Hospital of Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex51del; Zygosity=Hemizygous (PubMed=29414414).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   GZLSL-i001-A
AC   CVCL_A4EK
SY   HA-LSL-iPSC
DR   Wikidata; Q105507507
RX   PubMed=33212352;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3546; F8; Unexplicit; Inv22 (IVS22 INV); ClinVar=VCV000010150; Zygosity=Hemizygous (PubMed=33212352).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   GZMU3Hi001-A
AC   CVCL_VE34
SY   TS-male-iPS
DR   SKIP; SKIP002982
DR   Wikidata; Q54871868
RX   PubMed=29320756;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   GZWTZi001-A
AC   CVCL_YM91
SY   ASD2-iPSC
DR   SKIP; SKIP005595
DR   Wikidata; Q93935523
RX   PubMed=31698190;
CC   From: The Third Affiliated Hospital of Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Ala267Val (c.800C>T) (c.551C>T); Zygosity=Heterozygous (PubMed=31698190).
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Tyr398Ser (c.1193A>C) (c.944A>C); ClinVar=VCV001456043; Zygosity=Heterozygous (PubMed=31698190).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168586; Asparagine synthetase deficiency
DI   ORDO; Orphanet_391376; Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   GZWWTi001-A [2018]
AC   CVCL_RV21
SY   DMD-iPS2
DR   Wikidata; Q54871869
RX   PubMed=29414414;
CC   From: The Third Affiliated Hospital of Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50dup; Zygosity=Hemizygous (PubMed=29414414).
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex56-60dup; Zygosity=Hemizygous (PubMed=29414414).
CC   Caution: This group has named GZWWTi001-A two different iPSC cell lines.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   GZWWTi001-A [2019]
AC   CVCL_YM90
SY   ASD1-iPSC
DR   SKIP; SKIP005594
DR   Wikidata; Q93935535
RX   PubMed=31698190;
CC   From: The Third Affiliated Hospital of Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Ala267Val (c.800C>T) (c.551C>T); Zygosity=Heterozygous (PubMed=31698190).
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Tyr398Ser (c.1193A>C) (c.944A>C); ClinVar=VCV001456043; Zygosity=Heterozygous (PubMed=31698190).
CC   Caution: This group has named GZWWTi001-A two different iPSC cell lines.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168586; Asparagine synthetase deficiency
DI   ORDO; Orphanet_391376; Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   GZWXDi001-A
AC   CVCL_YM92
SY   ASD4-iPSC
DR   SKIP; SKIP005597
DR   Wikidata; Q93935539
RX   PubMed=31698190;
CC   From: The Third Affiliated Hospital of Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Ala267Val (c.800C>T) (c.551C>T); Zygosity=Heterozygous (PubMed=31698190).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   GZWXYi001-A
AC   CVCL_YM93
SY   ASD3-iPSC
DR   SKIP; SKIP005596
DR   Wikidata; Q93935542
RX   PubMed=31698190;
CC   From: The Third Affiliated Hospital of Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Tyr398Ser (c.1193A>C) (c.944A>C); ClinVar=VCV001456043; Zygosity=Heterozygous (PubMed=31698190).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   H-1
AC   CVCL_N541
SY   H1; 2nH1
DR   RCB; AES0001
DR   RCB; RCB1778
DR   SKIP; SKIP001637
DR   Wikidata; Q54871870
RX   PubMed=9107142;
RX   PubMed=17531078;
CC   Discontinued: RCB; RCB1778; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   H-1 [Human gingival squamous cell carcinoma]
AC   CVCL_W471
DR   Wikidata; Q54871871
RX   PubMed=8343447;
RX   PubMed=16211297;
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=8343447).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C8171; Lower gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   H-111-TC
AC   CVCL_5511
SY   H-111
DR   CLO; CLO_0050791
DR   BioSample; SAMN03472083
DR   Cosmic; 1187273
DR   RCB; RCB1884
DR   TKG; TKG 0342
DR   TKG; TKG 0411
DR   Wikidata; Q54871872
CC   Characteristics: Established from a nude mouse xenograft.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): RCB=RCB1884; TKG=TKG 0411
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   H-148
AC   CVCL_E2VT
RX   PubMed=7756584;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_EY25 ! CLB-Hu-TT-1
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   H-15
AC   CVCL_1E31
DR   Wikidata; Q54871873
RX   PubMed=7507797;
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   H-1A(H123)
AC   CVCL_4W36
DR   JCRB; JCRB1548
DR   Wikidata; Q54871874
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
ID   H-1D(H162)
AC   CVCL_JE61
DR   JCRB; JCRB1570
DR   Wikidata; Q54871875
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   H-1R
AC   CVCL_GZ06
DR   Wikidata; Q54871876
RX   PubMed=16211297;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C8171; Lower gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W471 ! H-1 [Human gingival squamous cell carcinoma]
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   H-2
AC   CVCL_N542
DR   Wikidata; Q54871877
RX   PubMed=9107142;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   H-22
AC   CVCL_1E32
DR   Wikidata; Q54871878
RX   PubMed=7507797;
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   H-3
AC   CVCL_N543
DR   Wikidata; Q54871879
RX   PubMed=9107142;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   H-3LL
AC   CVCL_M063
DR   Wikidata; Q54871880
RX   PubMed=3697987;
CC   Characteristics: Developed from a spontaneous hepatic metastasis of the parent cell line. Metastatic primarily to the liver (PubMed=3697987).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   H-4
AC   CVCL_6C19
SY   H4
DR   Wikidata; Q54871882
RX   PubMed=8755542;
RX   PubMed=10823949;
RX   PubMed=20444515;
RX   PubMed=28239090;
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-22FW
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   H-494
AC   CVCL_7669
SY   H 494; H494
DR   BTO; BTO_0002970
DR   BioSample; SAMN03151698
DR   Wikidata; Q54871883
RX   PubMed=87387;
RX   PubMed=6244232;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6244232; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00051.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   H-59 [Human liver]
AC   CVCL_C4S5
DR   Wikidata; Q116049118
RX   PubMed=8023938;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   H-59 [Mouse lung]
AC   CVCL_M066
SY   H59
DR   BTO; BTO_0004429
DR   Wikidata; Q54871884
RX   PubMed=3697987;
CC   Characteristics: Metastatic primarily to the liver but also to the lung (PubMed=3697987).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M063 ! H-3LL
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   H-69
AC   CVCL_8121
SY   H69
DR   Lonza; 712
DR   Wikidata; Q54872199
RX   PubMed=8023938;
RX   PubMed=10094943;
CC   Doubling time: 118 hours (PubMed=8023938).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   H-7
AC   CVCL_HG38
DR   Wikidata; Q54871885
RX   PubMed=12418925;
CC   Derived from site: In situ; Mammary gland, udder; UBERON=UBERON_0013216.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_HG39 ! L-1 [Bovine mammary gland]
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
ID   H-75
AC   CVCL_C4S6
DR   Wikidata; Q116049119
RX   PubMed=8023938;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   H-825
AC   CVCL_1E33
DR   Wikidata; Q54871886
RX   PubMed=7507797;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   H-AE-IV
AC   CVCL_K099
DR   BioSample; SAMN03472200
DR   RCB; RCB1011
DR   Wikidata; Q54871887
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB1011
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 9
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   H-bc
AC   CVCL_BT00
DR   KCB; KCB 89022YJ
DR   Wikidata; Q54871888
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 4
//
ID   H-BL-Ig kappa
AC   CVCL_B0LY
DR   Wikidata; Q108820345
RX   Patent=DD230880B1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0049.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-BL-IgE/1
AC   CVCL_B0LZ
SY   BL-IgE/1
DR   Wikidata; Q108820346
RX   Patent=DD230878B1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0052.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-BL-IgE/2
AC   CVCL_B0M0
SY   BL-IgE/2
DR   Wikidata; Q108820347
RX   Patent=DD230878B1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0053.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human IgE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-BL-IgE/3
AC   CVCL_B0M1
SY   BL-IgE/3
DR   Wikidata; Q108820348
RX   Patent=DD230878B1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0094.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human IgE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-BL-IgE/4
AC   CVCL_B0M2
SY   BL-IgE/4
DR   Wikidata; Q108820349
RX   Patent=DD230878B1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0095.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-BL-IgG/1
AC   CVCL_B0M4
SY   BL-IgG/1
DR   Wikidata; Q108820350
RX   Patent=DD230884A1;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-BL-IgM/1
AC   CVCL_B0M3
SY   BL-IgM/1
DR   Wikidata; Q108820351
RX   Patent=DD230879B1;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0056.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-CB-P1
AC   CVCL_B0MU
DR   Wikidata; Q108820352
RX   Patent=DD295985B5;
RX   Patent=WO2004031383A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2104.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0517.
CC   Monoclonal antibody isotype: IgM, lambda.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-CB-P2
AC   CVCL_B0MV
DR   Wikidata; Q108820353
RX   Patent=DD295985B5;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0518.
CC   Monoclonal antibody isotype: IgM, lambda.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-CB-P3
AC   CVCL_B0MW
DR   Wikidata; Q108820354
RX   Patent=DD295985B5;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0519.
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H-EMC-SS
AC   CVCL_1238
SY   HEMCSS; HEMC-SS
DR   CLO; CLO_0003701
DR   CLO; CLO_0051381
DR   CLDB; cl1625
DR   CLDB; cl4965
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMD00005690
DR   BioSample; SAMN03472276
DR   cancercelllines; CVCL_1238
DR   Cell_Model_Passport; SIDM00535
DR   ChEMBL-Cells; CHEMBL3308736
DR   ChEMBL-Targets; CHEMBL1075451
DR   Cosmic; 907290
DR   Cosmic-CLP; 907290
DR   DepMap; ACH-001519
DR   ECACC; 94042258
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10410-106B5
DR   GDSC; 907290
DR   GEO; GSM827448
DR   GEO; GSM1669877
DR   IARC_TP53; 21353
DR   ICLC; HTL99016
DR   LINCS_LDP; LCL-1458
DR   PharmacoDB; HEMCSS_419_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1238
DR   PubChem_Cell_line; CVCL_1238
DR   RCB; RCB0508
DR   Wikidata; Q54871889
RX   CelloPub=CLPUB00044;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=34413129;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 17.3-42.8 hours (CelloPub=CLPUB00044).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.61%; Native American=0.67%; East Asian, North=77.11%; East Asian, South=20.07%; South Asian=0.1%; European, North=0.01%; European, South=1.42% (PubMed=30894373).
CC   Caution: Does not harbor a gene fusion involving EWSR1 which is a hallmark of extraskeletal myxoid chondrosarcoma (PubMed=34413129).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
ST   Source(s): Cosmic-CLP=907290; DepMap=ACH-001519; RCB=RCB0508
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9 (RCB=RCB0508)
ST   D13S317: 9,13 (Cosmic-CLP=907290; DepMap=ACH-001519)
ST   D16S539: 9,13
ST   D18S51: 16,24
ST   D21S11: 30,32.2
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 14,17
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 10,14
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C27502; Extraskeletal myxoid chondrosarcoma
DI   ORDO; Orphanet_209916; Extraskeletal myxoid chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   H-MESO-1
AC   CVCL_5759
SY   H-Meso-1; HMESO-1; HMeso-1; HMeso1; HMESO1; H-Meso; HMESO; HMeso; Hmeso; MM-E1
DR   BTO; BTO_0005907
DR   BioSamples; SAMEA100968
DR   cancercelllines; CVCL_5759
DR   CLS; 300186
DR   Cosmic; 922059
DR   Cosmic; 1522785
DR   Cosmic; 1541215
DR   GEO; GSM726268
DR   NCI-DTP; H-MESO-1
DR   Progenetix; CVCL_5759
DR   Wikidata; Q54871890
RX   PubMed=3496960;
RX   PubMed=3555770;
RX   PubMed=10373640;
RX   PubMed=21454801;
RX   PubMed=21642991;
RX   PubMed=28159921;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Indicated as originating from a 35 year old male patient in PubMed=3555770 and from a 42 year old male patient in PubMed=3496960.
CC   Caution: It seems that PubMed=10373640 has renamed this cell line as MM-E1 because they thought it has a have an epithelial morphology.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): CLS=300186
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,20
ST   D21S11: 30,33.2
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   H-MESO-1A
AC   CVCL_5760
SY   H-Meso-1A; H-Meso 1A; H-Meso1A; HMeso01A; HMESO1A; HMeso1A
DR   BioSamples; SAMEA100945
DR   cancercelllines; CVCL_5760
DR   CLS; 300187
DR   Cosmic; 1522768
DR   Cosmic; 1541205
DR   GEO; GSM726269
DR   Progenetix; CVCL_5760
DR   Wikidata; Q54871891
RX   PubMed=21642991;
CC   Sequence variation: Gene deletion; HGNC; HGNC:950; BAP1; Zygosity=Heterozygous (PubMed=21642991).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Glu685Val (c.2054A>T); Zygosity=Heterozygous (PubMed=21642991).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: H-Messo-1A; Note=Occasionally.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): CLS=300187
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,20
ST   D21S11: 30,33.2
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5759 ! H-MESO-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   h-pES10
AC   CVCL_AX68
SY   pES10
DR   BioGRID_ORCS_Cell_line; 762
DR   Wikidata; Q54871892
RX   PubMed=26982723;
RX   PubMed=29662178;
CC   Group: Haploid karyotype cell line.
CC   Omics: Phenotyping; CRISPR screening.
CC   Anecdotal: First human haploid embryonic stem cell line (with h-PES12 (Cellosaurus=CVCL_AX69)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   h-pES12
AC   CVCL_AX69
DR   Wikidata; Q54871893
RX   PubMed=26982723;
CC   Group: Haploid karyotype cell line.
CC   Anecdotal: First human haploid embryonic stem cell line (with h-PES10 (Cellosaurus=CVCL_AX68)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   H-STS
AC   CVCL_L296
SY   HSTS
DR   cancercelllines; CVCL_L296
DR   GEO; GSM966943
DR   PharmacoDB; HSTS_623_2019
DR   Progenetix; CVCL_L296
DR   Wikidata; Q54871894
RX   PubMed=19528452;
RX   PubMed=29444910;
RX   PubMed=31548718;
RX   PubMed=31548719;
CC   Problematic cell line: Misclassified. Originally thought to arise from a metastatic carcinoid of the terminal ileum but shown to be an EBV-transformed lymphoblastoid cell line (PubMed=29444910; PubMed=31548718). Although misidentified, it has been argued that transcriptional regulation of the cells enough resemble gastroenteropancreatic neuroendocrine tumors to be used in studies (PubMed=31548719).
CC   Doubling time: ~3 days (PubMed=19528452).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=29444910
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 13
ST   D21S11: 28,30
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L297 ! L-STS
OI   CVCL_L298 ! P-STS
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   h-TREK-1/HEK
AC   CVCL_JQ47
SY   human-TREK-1/HEK293
DR   Wikidata; Q54871899
RX   PubMed=22022421;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6277; KCNK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   H. K.
AC   CVCL_C8NR
DR   Wikidata; Q123031384
RX   PubMed=1374683;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   H.Emb.Rh. #1
AC   CVCL_JB74
SY   H.Emb.Rh. 1; H. Emb. Rh. #1; HEmbRh1; Human Embryonal Rhabdomyosarcoma #1
DR   Wikidata; Q54871903
RX   PubMed=13209540;
RX   PubMed=13261081;
RX   PubMed=14287274;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   H.S. #1
AC   CVCL_JB75
SY   HS1; H. S. #1; Human sarcoma #1
DR   Wikidata; Q54871904
RX   PubMed=13209540;
RX   PubMed=14287274;
DI   NCIt; C9306; Soft tissue sarcoma
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   H/Rb-CL2
AC   CVCL_JE91
SY   H/RB-CL2
DR   cancercelllines; CVCL_JE91
DR   CCRID; 4201PAT-CCTCC00098
DR   Wikidata; Q54871901
RX   Patent=WO1992022640A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10708.
CC   Characteristics: Corrects the lack of expression of RB1 in the parent cell line which is due to an homozygous mutation p.Tyr325Ter (c.975T>A).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   H/Rb-M
AC   CVCL_JE92
SY   H/RB-M; H/Rb-M-CL5
DR   cancercelllines; CVCL_JE92
DR   CCRID; 4201PAT-CCTCC00099
DR   Wikidata; Q54871902
RX   Patent=WO1992022640A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10707.
CC   Characteristics: Corrects the lack of expression of RB1 in the parent cell line which is due to an homozygous mutation p.Tyr325Ter (c.975T>A).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   H0287
AC   CVCL_D048
SY   HCM287
DR   EFO; EFO_0002776
DR   GEO; GSM472945
DR   Wikidata; Q54871905
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/H0287_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   H1
AC   CVCL_D4YF
DR   Wikidata; Q127380966
RX   DOI=10.22092/ari.2017.111601;
CC   Doubling time: 21 hours (Note=When cultured in flasks), 17 hours (Note=In cellspin culture) (DOI=10.22092/ari.2017.111601).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   H1 EFNB2-tdTomato clone 14
AC   CVCL_A1HA
DR   Wikidata; Q127380967
RX   PubMed=28696312;
CC   Characteristics: Using CRISPR/Cas9 a tdTomato-Neo cassette was integrated in front of the stop codon of one allele of EFNB2 (PubMed=28696312).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   H1 EFNB2-tdTomato/EPHB4-EGFP clone 29
AC   CVCL_A1HB
SY   EFNB2-tdTomato/EPHB4-EGFP dual reporter
DR   WiCell; efnb2-tdtomato-ephb4-egfp
DR   Wikidata; Q127380968
RX   PubMed=28696312;
CC   Characteristics: Using CRISPR/Cas9 a tdTomato-Neo cassette was integrated in front of the stop codon of one allele of EFNB2 (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 a 2A-eGFP-PuroR cassette was integrated in front of the stop codon of one allele of EPHB4 (PubMed=28696312).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1HA ! H1 EFNB2-tdTomato clone 14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   H1-F11
AC   CVCL_F1WU
RX   Patent=US7494650;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7261 ! EcR-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   H1-iCas9
AC   CVCL_WS14
SY   H1 iCas9
DR   Wikidata; Q93935734
RX   PubMed=28196600;
RX   PubMed=31110351;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9. Can be used for rapid and highly efficient generation of biallelic knockout hPSCs for loss-of-function studies. Using TALEN two constructs SA-2A-Hygro-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Miscellaneous: STR profile from personal communication of Huangfu, Dan-Wei.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 11
//
ID   H1 NANOG
AC   CVCL_F0SJ
RX   PubMed=19139263;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20857; NANOG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C122923; Persistent hyperinsulinemic hypoglycemia of infancy
DI   ORDO; Orphanet_276575; Autosomal dominant hyperinsulinism due to SUR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   H1 Oct4-EGFP
AC   CVCL_U159
SY   H1 OCT4-EGFP; WA01 Oct4-eGFP Knock In; H1-OGN
DR   WiCell; h1-oct4-egfp
DR   Wikidata; Q54871906
RX   PubMed=12577066;
RX   PubMed=18157115;
CC   Characteristics: A eGFP-neo construct was added to the C-terminal of the POU5F1/OCT4 gene by homologous recombination.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=h1-oct4-egfp
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C813 ! H1.1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   H1-HeLa+CHDR3
AC   CVCL_C8ZH
DR   BioGRID_ORCS_Cell_line; 1180
DR   Wikidata; Q123031385
RX   PubMed=31527793;
CC   Population: African American.
CC   Virology: Supports replication of rhinovirus C15 (RV-C15) and Enterovirus D68 (EV-D68) (PubMed=31527793).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:26308; CDHR3 (Note=With p.Cys529Tyr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3334 ! H1HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   H1-HeLa+CDHR3 SETD3KO
AC   CVCL_C8ZI
DR   Wikidata; Q123031386
RX   PubMed=31527793;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20493; SETD3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:26308; CDHR3 (Note=With p.Cys529Tyr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZH ! H1-HeLa+CHDR3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   H1.1
AC   CVCL_C813
SY   WA01.1; WAe001-A-1; WICELLe001-A-1
DR   hPSCreg; WAe001-A-1
DR   SKIP; SKIP001997
DR   Wikidata; Q54871907
CC   From: University of Wisconsin; Madison; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   H1.6
AC   CVCL_J545
DR   CLO; CLO_0003582
DR   ATCC; CRL-2567
DR   Wikidata; Q54871908
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P60852; Human ZP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   H1.NPC-i1
AC   CVCL_DE08
DR   Wikidata; Q54871909
RX   PubMed=24374290;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
ST   Source(s): PubMed=24374290
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   H1.NPC-i2
AC   CVCL_DE09
DR   Wikidata; Q54871910
RX   PubMed=24374290;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
ST   Source(s): PubMed=24374290
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   H1.NPC-i3
AC   CVCL_DE10
DR   Wikidata; Q54871911
RX   PubMed=24374290;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
ST   Source(s): PubMed=24374290
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   H10 [Mouse hybridoma against human SIPA1]
AC   CVCL_C7XF
DR   Wikidata; Q123031387
RX   Patent=US5998585;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4840.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96FS4; Human SIPA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   H10 [Rat cardiomyocyte]
AC   CVCL_W080
SY   H-10
DR   BTO; BTO_0004266
DR   Wikidata; Q54871912
RX   PubMed=8838663;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   H101.1
AC   CVCL_C4YU
DR   Wikidata; Q116049120
RX   PubMed=11604109;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96T60; Human PNKP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H101.2
AC   CVCL_C4YV
DR   Wikidata; Q116049121
RX   PubMed=11604109;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q96T60; Human PNKP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H101.3
AC   CVCL_C4YW
DR   Wikidata; Q116049123
RX   PubMed=11604109;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q96T60; Human PNKP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H101.4
AC   CVCL_C4YX
DR   Wikidata; Q116049124
RX   PubMed=11604109;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q96T60; Human PNKP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H101.5
AC   CVCL_C4YY
DR   Wikidata; Q116049125
RX   PubMed=11604109;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q96T60; Human PNKP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H101.6
AC   CVCL_C4YZ
DR   Wikidata; Q116049126
RX   PubMed=11604109;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q96T60; Human PNKP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H101.7
AC   CVCL_C4Z0
DR   Wikidata; Q116049127
RX   PubMed=11604109;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96T60; Human PNKP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H103
AC   CVCL_2457
DR   CancerTools; 153419
DR   Cell_Model_Passport; SIDM01568
DR   ChEMBL-Cells; CHEMBL4483157
DR   ChEMBL-Targets; CHEMBL4483241
DR   Cosmic; 716673
DR   Cosmic; 916367
DR   Cosmic; 928234
DR   DepMap; ACH-001346
DR   ECACC; 06092001
DR   PubChem_Cell_line; CVCL_2457
DR   Wikidata; Q54871913
DR   Ximbio; 153419
RX   PubMed=1692339;
RX   PubMed=1744799;
RX   PubMed=7633286;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Cys (c.730G>T); ClinVar=VCV000376599; Zygosity=Homozygous (PubMed=7633286; DepMap=ACH-001346).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: ECACC; 06092001; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DepMap=ACH-001346; ECACC=06092001
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 9,11
ST   Penta E: 20
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   H103D8.1D11
AC   CVCL_A2HU
SY   AI-11
DR   Wikidata; Q105507509
RX   Patent=US4828986;
RX   Patent=US5126240;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9201.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   H105C7.1C10
AC   CVCL_A2HV
SY   AI-12
DR   Wikidata; Q105507514
RX   Patent=US5126240;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9202.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   H105F4.1B4
AC   CVCL_A2HW
SY   AI-13
DR   Wikidata; Q105507517
RX   Patent=US5126240;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9203.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   H107
AC   CVCL_C6MS
DR   ABCD; ABCD_AE896
DR   Wikidata; Q116049128
RX   PubMed=3089283;
RX   PubMed=7476997;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02794; Human FTH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H114D12.2D8
AC   CVCL_A2HX
SY   AI-14
DR   Wikidata; Q105507520
RX   Patent=US5126240;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9204.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   H11C130
AC   CVCL_A9RA
SY   HCV H11C130
DR   ATCC; HB-10589
DR   Wikidata; Q102114077
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10589.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1191-1457 = Serine protease NS3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   H12
AC   CVCL_C4FT
DR   ABCD; ABCD_AE300
DR   Wikidata; Q116049129
RX   PubMed=3081356;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   H120-2
AC   CVCL_C5K4
DR   Wikidata; Q116049130
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H1215L
AC   CVCL_U109
DR   Wikidata; Q54871914
RX   PubMed=16651449;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   H1224EBV-B
AC   CVCL_TZ83
SY   H1224 EBV-B
DR   Wikidata; Q54871915
RX   PubMed=19799608;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: H1124EBV-B; Note=In Cellosaurus releases 26 to 32.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U107 ! H1224L
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   H1224L
AC   CVCL_U107
DR   Wikidata; Q54871916
RX   PubMed=16651449;
RX   PubMed=17725806;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_TZ83 ! H1224EBV-B
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   H129-1
AC   CVCL_5G05
DR   ECACC; 14040203
DR   Wikidata; Q54871917
RX   Patent=US11085020;
RX   PubMed=21900896;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   H129-121.6.8
AC   CVCL_L836
SY   H129.121
DR   ECACC; 85103103
DR   Wikidata; Q54871918
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q62351; Mouse Tfrc/Cd71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   H129-19.6.8
AC   CVCL_L837
SY   H129-19.6; H129-19
DR   ECACC; 85103101
DR   Wikidata; Q54871920
RX   PubMed=6202760;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   H129-2
AC   CVCL_5G06
DR   ECACC; 14040205
DR   Wikidata; Q54871921
RX   Patent=US11085020;
RX   PubMed=21900896;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   H1299/LKB1shRNA
AC   CVCL_E7UV
RX   PubMed=18794113;
WW   Provider; Emory OTT; 11191; https://emoryott.technologypublisher.com/techcase/11191
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H1299/pLKO.1
AC   CVCL_E7UW
RX   PubMed=18794113;
WW   Provider; Emory OTT; 11191; https://emoryott.technologypublisher.com/techcase/11191
CC   Population: Caucasian.
CC   Characteristics: Control cell line for H1299/LKB1shRNA (Cellosaurus=CVCL_E7UV) (PubMed=18794113).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H1299/TS1
AC   CVCL_B7N7
DR   cancercelllines; CVCL_B7N7
DR   Wikidata; Q112929638
RX   PubMed=21487406;
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   H1299/TS2
AC   CVCL_B7N8
DR   cancercelllines; CVCL_B7N8
DR   Wikidata; Q112929639
RX   PubMed=21487406;
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   H13.11F10
AC   CVCL_N307
SY   H13.11F.sub.10; 11F10
DR   ATCC; HB-8425
DR   Wikidata; Q54871922
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8425.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae lipid antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   H13.17D4
AC   CVCL_N308
SY   H13.17D.sub.4; 17D4
DR   ATCC; HB-8973
DR   Wikidata; Q54871923
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8973.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae lipid antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   H13.1D11
AC   CVCL_N309
SY   H13.1D.sub.11; 1D11
DR   ATCC; HB-8422
DR   Wikidata; Q54871925
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8422.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae 200 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   H13.2G2
AC   CVCL_N310
SY   H13.2G.sub.2; 2G2
DR   ATCC; HB-8424
DR   Wikidata; Q54871926
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8424.
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   H13.3B3
AC   CVCL_N311
SY   H13.3B.sub.3; 3B3
DR   ATCC; HB-8972
DR   Wikidata; Q54871927
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8972.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae lipid antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   H13.4F4
AC   CVCL_N312
SY   H13.4F.sub.4; 4F4
DR   ATCC; HB-8974
DR   Wikidata; Q54871928
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8974.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae 32 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 8
//
ID   H13.9G4
AC   CVCL_N313
SY   H13.9G.sub.4; 9G4
DR   ATCC; HB-8421
DR   Wikidata; Q54871929
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8421.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   H130-5
AC   CVCL_C5K5
DR   ABCD; ABCD_AE215
DR   Wikidata; Q116049131
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H130-6
AC   CVCL_C5K6
DR   Wikidata; Q116049132
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H135D3
AC   CVCL_A2HY
SY   AI-18; AI-18 (SCRF 131.0); SCRF 131.0
DR   ATCC; HB-9570
DR   Wikidata; Q105507524
RX   Patent=US5055396;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9570.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   H139-52
AC   CVCL_L838
DR   ECACC; 85103111
DR   Wikidata; Q54871930
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mouse Ig kappa light chains.
CC   Discontinued: ECACC; 85103111; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   H13a
AC   CVCL_Z931
DR   Wikidata; Q54871931
RX   PubMed=8459104;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Gray seal IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   H13C113
AC   CVCL_A1TK
SY   HCV E146-H13-C113
DR   ATCC; HB-10857
DR   Wikidata; Q105507527
RX   Patent=US5308750;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10857.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 643-683 = Envelope glycoprotein E2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   H14-H2B-RFP
AC   CVCL_A5NK
DR   Wikidata; Q107115215
CC   Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Miscellaneous: Cell line information from personal communication of Price, Christopher John.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   H14-YAP1
AC   CVCL_A5LM
SY   H14-YAP
DR   Wikidata; Q107115216
RX   PubMed=34407428;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   H14.BJ1
AC   CVCL_A5KU
SY   H14BJ1
DR   Wikidata; Q107115217
RX   PubMed=27829140;
CC   Characteristics: Aneuploid WA14 subline with gain of chromosome 12 and chromosome 17 that incorporates an hsr comprising amplification of chromosomal region 17p13.3.
CC   Karyotypic information: 48,XY,+12,+der(17)hsr(17)(p11.2) del(17)(p13.3).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   H14.BJ1-GFP
AC   CVCL_A5KX
SY   H14BJ1-GFP
DR   Wikidata; Q107115218
RX   PubMed=27829140;
RX   PubMed=34407428;
CC   Characteristics: Aneuploid WA14 subline with gain of chromosome 12 and chromosome 17 that incorporates an hsr comprising amplification of chromosomal region 17p13.3.
CC   Karyotypic information: 48,XY,+12,+der(17)hsr(17)(p11.2) del(17)(p13.3).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5KU ! H14.BJ1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   H14.s3
AC   CVCL_C3IU
DR   GEO; GSM151739
DR   GEO; GSM151741
DR   Wikidata; Q114311555
RX   PubMed=17287758;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   H14.s9
AC   CVCL_A5KV
DR   Wikidata; Q107115219
RX   PubMed=27829140;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   H14-A11
AC   CVCL_5J83
SY   H14 A11-5; WC00013
DR   CLO; CLO_0012693
DR   BioSamples; SAME17697
DR   Coriell; WC00013
DR   Wikidata; Q54871934
RX   PubMed=6182104;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03449; Influenza A virus (strain A/Memphis/1/1971 H3N2) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00013; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H14-A2
AC   CVCL_KR61
SY   H14/A2; H14 A2-19
DR   Wikidata; Q54871932
RX   PubMed=90425;
RX   PubMed=6182104;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03449; Influenza A virus (strain A/Memphis/1/1971 H3N2) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 4
//
ID   H14-A20
AC   CVCL_5J84
SY   H14/A20; H14 A20-14; WC00024
DR   CLO; CLO_0012696
DR   BioSamples; SAME17825
DR   Coriell; WC00024
DR   Wikidata; Q54871935
RX   PubMed=90425;
RX   PubMed=6182104;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03449; Influenza A virus (strain A/Memphis/1/1971 H3N2) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00024; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H14-A21
AC   CVCL_5J85
SY   H14/A21; H14 A21-3; WC00010
DR   CLO; CLO_0012682
DR   BioSamples; SAME17701
DR   Coriell; WC00010
DR   Wikidata; Q54871936
RX   PubMed=90425;
RX   PubMed=6182104;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03449; Influenza A virus (strain A/Memphis/1/1971 H3N2) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00010; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H14-B18
AC   CVCL_5J86
SY   H14 B18-12; WC00042
DR   CLO; CLO_0012733
DR   BioSamples; SAME17833
DR   Coriell; WC00042
DR   Wikidata; Q54871937
RX   PubMed=6182104;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03449; Influenza A virus (strain A/Memphis/1/1971 H3N2) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00042; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H140
AC   CVCL_S697
DR   Wikidata; Q54871938
RX   PubMed=1692339;
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   H140-1E6
AC   CVCL_C5K7
DR   ABCD; ABCD_AE159
DR   Wikidata; Q116049133
RX   PubMed=1908510;
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H142-3H5
AC   CVCL_C5K8
DR   ABCD; ABCD_AE158
DR   Wikidata; Q116049134
RX   PubMed=1908510;
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H144-17B7
AC   CVCL_C5K9
DR   Wikidata; Q116049135
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H144-17C5
AC   CVCL_C5KA
DR   ABCD; ABCD_AE157
DR   Wikidata; Q116049136
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H146-24B1
AC   CVCL_C5KB
DR   Wikidata; Q116049137
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H146-24B3
AC   CVCL_C5KC
DR   ABCD; ABCD_AE258
DR   Wikidata; Q116049138
RX   PubMed=1908510;
RX   PubMed=2427335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H146-24E9
AC   CVCL_C5KD
DR   ABCD; ABCD_AE156
DR   Wikidata; Q116049139
RX   PubMed=1908510;
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H147-25H1
AC   CVCL_C5KE
DR   Wikidata; Q116049140
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H15-A13
AC   CVCL_5K09
SY   WC00050
DR   Coriell; WC00050
DR   Wikidata; Q54871939
RX   PubMed=2414912;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03454; Influenza A virus (strain A/Wilson-Smith/1933 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00050; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 6
//
ID   H15-B9-22
AC   CVCL_KR86
SY   H15-B9
DR   Wikidata; Q54871940
RX   PubMed=2414912;
WW   Info; Wistar; -; https://www.wistar.org/technology-transfer/monoclonal-antibodies-influenza-research
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03454; Influenza A virus (strain A/Wilson-Smith/1933 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 5
//
ID   H152-43B2
AC   CVCL_C5LS
DR   Wikidata; Q116049141
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H153-70A12
AC   CVCL_C5KF
DR   ABCD; ABCD_AE152
DR   Wikidata; Q116049142
RX   PubMed=1908510;
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H156H2
AC   CVCL_6G68
DR   IPD-IMGT/HLA; 12649
DR   Wikidata; Q54871941
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*27,37:04; DRB1*15/16,11; DRB3*02; DRB5*01 (IPD-IMGT/HLA=12649).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   H157
AC   CVCL_2458
DR   EFO; EFO_0022634
DR   cancercelllines; CVCL_2458
DR   CancerTools; 153420
DR   CCRID; 5301HUM-KCB15028YJ
DR   Cell_Model_Passport; SIDM01808
DR   Cosmic; 716674
DR   Cosmic; 916368
DR   Cosmic; 928235
DR   DepMap; ACH-001347
DR   ECACC; 07030901
DR   KCB; KCB 2015028YJ
DR   Wikidata; Q54871942
DR   Ximbio; 153420
RX   PubMed=1692339;
RX   PubMed=1744799;
RX   PubMed=7633286;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (DepMap=ACH-001347).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (PubMed=7633286; DepMap=ACH-001347).
CC   Discontinued: ECACC; 07030901; true.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): CCRID=5301HUM-KCB15028YJ; DepMap=ACH-001347; ECACC=07030901
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 20,22
ST   D21S11: 28,29
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 9
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 12
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   H157R
AC   CVCL_VD88
SY   NCI H157R
DR   cancercelllines; CVCL_VD88
DR   Wikidata; Q54871951
RX   PubMed=8557774;
CC   Problematic cell line: Contaminated. Parent cell line (NCI-H157) has been shown to be identical to NCI-H1264.
CC   Characteristics: Resistant to the polyamine analog N(1),N(12)-diethylspermine.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:10540; SAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Phefs*8 (c.102_103insT) (c.103_104insT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0463 ! NCI-H157
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 15
//
ID   H158-89H4
AC   CVCL_C5KG
DR   ABCD; ABCD_AE257
DR   Wikidata; Q116049143
RX   PubMed=1908510;
RX   PubMed=2427335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H16-1.93
AC   CVCL_W160
DR   Wikidata; Q54871952
RX   Patent=US8236310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7449.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14638; Human ENPP3/CD203c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   H16-9.69
AC   CVCL_W161
DR   Wikidata; Q54871953
RX   Patent=US8236310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7451.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14638; Human ENPP3/CD203c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   H16-L10-4R5
AC   CVCL_4524
SY   H 16-L10-4R 5; H16-L10-4; H16-L10; WC00007
DR   CLO; CLO_0003580
DR   CLO; CLO_0003583
DR   CLO; CLO_0013431
DR   CLDB; cl5192
DR   ATCC; HB-65
DR   BioSamples; SAME17765
DR   Coriell; WC00007
DR   IZSLER; BS Hy 41
DR   Wikidata; Q54871954
RX   PubMed=7217668;
WW   Info; Wistar; -; https://www.wistar.org/technology-transfer/monoclonal-antibodies-influenza-research
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Influenza A virus nucleoprotein (NP).
CC   Discontinued: Coriell; WC00007; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   H161
AC   CVCL_XX73
DR   ABCD; ABCD_AJ154
DR   DSHB; H161
DR   Wikidata; Q93935868
RX   DOI=10.24450/journals/abrep.2019.e23;
RX   DOI=10.24450/journals/abrep.2019.e24;
RX   PubMed=11831389;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7YXD4; Dictyostelium discoideum p80.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 5
//
ID   H163-130F2
AC   CVCL_C5KH
DR   Wikidata; Q116049144
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H163-130H9
AC   CVCL_C5KI
DR   ABCD; ABCD_AE211
DR   Wikidata; Q116049145
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H165-156A2
AC   CVCL_C5KJ
DR   ABCD; ABCD_AE155
DR   Wikidata; Q116049146
RX   PubMed=1908510;
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H1650-ER1
AC   CVCL_4V01
DR   cancercelllines; CVCL_4V01
DR   Wikidata; Q54871955
RX   PubMed=22433462;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1483 ! NCI-H1650
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   H1650/LKB1shRNA
AC   CVCL_E7UX
RX   PubMed=18794113;
WW   Provider; Emory OTT; 11191; https://emoryott.technologypublisher.com/techcase/11191
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1483 ! NCI-H1650
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H1650/pLKO.1
AC   CVCL_E7UY
RX   PubMed=18794113;
WW   Provider; Emory OTT; 11191; https://emoryott.technologypublisher.com/techcase/11191
CC   Population: Caucasian.
CC   Characteristics: Control cell line for H1650/LKB1shRNA (Cellosaurus=CVCL_E7UX) (PubMed=18794113).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1483 ! NCI-H1650
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H16C08
AC   CVCL_C5MJ
DR   Wikidata; Q116049147
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H16E07
AC   CVCL_C5MK
DR   Wikidata; Q116049148
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H16F1
AC   CVCL_IP81
DR   Wikidata; Q54871956
RX   DOI=10.1007/978-1-4612-0411-4_18;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7931 ! 21MT-1
OI   CVCL_7932 ! 21MT-2
OI   CVCL_7933 ! 21NT
OI   CVCL_7934 ! 21PT
OI   CVCL_IP82 ! H16N-2
OI   CVCL_IP83 ! H16N-3
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   H16N-2
AC   CVCL_IP82
SY   H16N2
DR   Cell_Model_Passport; SIDM01809
DR   Wikidata; Q54871957
RX   DOI=10.1007/978-1-4612-0411-4_18;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7931 ! 21MT-1
OI   CVCL_7932 ! 21MT-2
OI   CVCL_7933 ! 21NT
OI   CVCL_7934 ! 21PT
OI   CVCL_IP81 ! H16F1
OI   CVCL_IP83 ! H16N-3
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 12
//
ID   H16N-3
AC   CVCL_IP83
DR   Wikidata; Q54871958
RX   DOI=10.1007/978-1-4612-0411-4_18;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7931 ! 21MT-1
OI   CVCL_7932 ! 21MT-2
OI   CVCL_7933 ! 21NT
OI   CVCL_7934 ! 21PT
OI   CVCL_IP81 ! H16F1
OI   CVCL_IP82 ! H16N-2
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   H16N2-erbB-2
AC   CVCL_IP84
SY   H16N2erbB-2
DR   Wikidata; Q54871959
RX   PubMed=10433219;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IP82 ! H16N-2
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   H17-L10
AC   CVCL_C5KK
SY   Ca-6; Ca6
DR   Wikidata; Q116049149
RX   PubMed=6163993;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H17-L19
AC   CVCL_C5KL
SY   Ca-1; Ca1
DR   Wikidata; Q116049150
RX   PubMed=6163993;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H17-L2
AC   CVCL_C5KM
SY   Ca-8; Ca8
DR   Wikidata; Q116049151
RX   PubMed=6163993;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H17-L8
AC   CVCL_5K00
SY   WC00011
DR   CLO; CLO_0012692
DR   BioSamples; SAME17705
DR   Coriell; WC00011
DR   Wikidata; Q54871961
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00011; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H17.8A5
AC   CVCL_N314
SY   H17.8A.sub.5; 8A5
DR   ATCC; HB-8423
DR   Wikidata; Q54871963
RX   Patent=US4945041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8423.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   H1703/LKB1shRNA
AC   CVCL_E7UZ
RX   PubMed=18794113;
WW   Provider; Emory OTT; 11191; https://emoryott.technologypublisher.com/techcase/11191
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Val (c.251A>T); ClinVar=VCV002136746; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>T (IVS8+1G>T); ClinVar=VCV000495326; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1490 ! NCI-H1703
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H1703/pLKO.1
AC   CVCL_E7V0
RX   PubMed=18794113;
WW   Provider; Emory OTT; 11191; https://emoryott.technologypublisher.com/techcase/11191
CC   Population: Caucasian.
CC   Characteristics: Control cell line for H1703/LKB1shRNA (Cellosaurus=CVCL_E7UZ) (PubMed=18794113).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Val (c.251A>T); ClinVar=VCV002136746; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>T (IVS8+1G>T); ClinVar=VCV000495326; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1490 ! NCI-H1703
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H17B11
AC   CVCL_C5ML
DR   Wikidata; Q116049152
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H17D09
AC   CVCL_C5MM
SY   17/9
DR   ABCD; ABCD_AE392
DR   Wikidata; Q116049153
RX   PubMed=3182835;
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
CC   Monoclonal antibody target: ChEBI; CHEBI_80171; HA tag.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   H17D12
AC   CVCL_C5MN
DR   Wikidata; Q116049154
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H18-S210
AC   CVCL_5K02
SY   WC00029
DR   CLO; CLO_0012713
DR   BioSamples; SAME17793
DR   Coriell; WC00029
DR   Wikidata; Q54871964
RX   PubMed=2414912;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Monoclonal antibody target: UniProtKB; P03454; Influenza A virus (strain A/Wilson-Smith/1933 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00029; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H18-S415
AC   CVCL_5K03
SY   WC00038
DR   CLO; CLO_0012726
DR   BioSamples; SAME17721
DR   Coriell; WC00038
DR   Wikidata; Q54871965
RX   PubMed=1908881;
RX   PubMed=2414912;
RX   PubMed=2427335;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Monoclonal antibody target: UniProtKB; P03454; Influenza A virus (strain A/Wilson-Smith/1933 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00038; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   H18/7
AC   CVCL_L517
DR   CLO; CLO_0003584
DR   ATCC; HB-11684
DR   Wikidata; Q54871966
RX   PubMed=2827173;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11684.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   H18489
AC   CVCL_HA50
SY   H5; H5.iPSC; H18489_iPSC
DR   GEO; GSM1495400
DR   GEO; GSM1502702
DR   Wikidata; Q54871967
RX   PubMed=26102527;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_P455 ! GM18489
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   H184B5-F5
AC   CVCL_IP80
SY   H184B5 F5
DR   Wikidata; Q54871968
RX   DOI=10.1007/978-1-4612-0411-4_10;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4688 ! 184B5
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   H184B5F5/M10
AC   CVCL_Y093
SY   184B5F5M10; B5F5M10
DR   BCRC; 60197
DR   Wikidata; Q54871969
RX   PubMed=9303071;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): BCRC=60197
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IP80 ! H184B5-F5
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   H19-5
AC   CVCL_H782
DR   Wikidata; Q54871970
RX   PubMed=1316607;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsa).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   H19-7
AC   CVCL_H781
DR   EFO; EFO_0022832
DR   ABM; T0359
DR   Wikidata; Q54871971
RX   PubMed=1316607;
RX   PubMed=10786694;
RX   PubMed=22863662;
CC   Characteristics: Grows at the permissive temperature (34 Celsius). Differentiate to a neuronal phenotype at the nonpermissive temperature (39 Celsius) when induced by FGF2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   H19-7/IGF-IR
AC   CVCL_6493
DR   CLO; CLO_0003585
DR   ATCC; CRL-2526
DR   IZSLER; BS CL 203
DR   Wikidata; Q54871972
RX   PubMed=10786694;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-516.html
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5465; IGF1R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_H781 ! H19-7
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   H19-S24-4
AC   CVCL_5K01
SY   H19-S24; WC00018
DR   CLO; CLO_0012688
DR   BioSamples; SAME17717
DR   Coriell; WC00018
DR   Wikidata; Q54871973
WW   Info; Wistar; -; https://www.wistar.org/technology-transfer/monoclonal-antibodies-influenza-research
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Influenza A virus nucleoprotein (NP).
CC   Discontinued: Coriell; WC00018; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   H191 [Human tongue SCC]
AC   CVCL_S696
DR   Wikidata; Q54871974
RX   PubMed=1692339;
RX   PubMed=1744799;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   H191 [Mouse hybridoma against D.discoideum p80]
AC   CVCL_A9H6
DR   ABCD; ABCD_AN702
DR   Wikidata; Q102114078
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q7YXD4; Dictyostelium discoideum p80.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   H19101
AC   CVCL_HA51
SY   H6; H6.iPSC; H19101_iPSC
DR   GEO; GSM1495401
DR   GEO; GSM1502703
DR   Wikidata; Q54871975
RX   PubMed=26102527;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_P503 ! GM19101
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   H19114
AC   CVCL_HA52
SY   H7; H7.iPSC; H19114_iPSC
DR   GEO; GSM1495402
DR   GEO; GSM1502704
DR   Wikidata; Q54871976
RX   PubMed=26102527;
CC   Population: African; Yoruba in Ibadan, Nigeria (YRI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_P509 ! GM19114
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   H194
AC   CVCL_XX74
DR   ABCD; ABCD_AJ155
DR   Wikidata; Q93935946
RX   DOI=10.24450/journals/abrep.2019.e43;
RX   PubMed=11831389;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Dictyostelium discoideum 23 kDa antigen at plasma membrane and intracellular compartments.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   H196 C7
AC   CVCL_AB81
SY   H196 c7; H196 clone 7
DR   Wikidata; Q54871978
RX   PubMed=27345814;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[36] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=27345814).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   H196 C7 GC
AC   CVCL_DQ63
SY   H196 c7 GC; H196 clone7 GC; H196 clone 7 GC
DR   Wikidata; Q54871979
RX   PubMed=27345804;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion_corrected; p.Gln166[36] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=By CRISPR/Cas9. The original 36 CAG repeat has been replaced with a 22 CAG repeat (PubMed=27345804).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AB81 ! H196 C7
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   H1975 BIR
AC   CVCL_E4DI
SY   H1975BIR
RX   PubMed=39061985;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_232716; (20R)-10,15,20-trimethyl-2-[(4-methylpiperazin-1-yl)methyl]-18,19,20,21-tetrahydro-15H,17H-12,8-(metheno)pyrazolo[3',4':2,3][1,5,10,12]oxatriazacycloheptadecino[12,11-a]benzimidazol-7(6H)-one (BI-4020).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   H1975/Cas9-hyg
AC   CVCL_C9BL
DR   GeneCopoeia; SL529
DR   Wikidata; Q123031388
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL529).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   H1975/OR [China Dongguan]
AC   CVCL_B0JT
DR   cancercelllines; CVCL_B0JT
DR   Wikidata; Q108820355
RX   PubMed=33992097;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   H1975/OR [China Guangzhou]
AC   CVCL_B0JS
DR   cancercelllines; CVCL_B0JS
DR   CCRID; 4201PAT-CCTCC01545
DR   Wikidata; Q108820356
RX   Patent=CN111793604B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019300.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   H1975/WR
AC   CVCL_DG25
DR   cancercelllines; CVCL_DG25
DR   Wikidata; Q54871980
RX   PubMed=26980747;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   H19B10
AC   CVCL_C5MP
DR   Wikidata; Q116049155
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H19D03
AC   CVCL_C5MQ
DR   Wikidata; Q116049156
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H1a
AC   CVCL_L839
DR   ECACC; 93031701
DR   Wikidata; Q54871981
RX   PubMed=8459104;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Gray seal IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   H1b
AC   CVCL_9W64
DR   Wikidata; Q54871982
RX   PubMed=12429219;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-16FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   H1B
AC   CVCL_ZD50
DR   Wikidata; Q98126646
RX   PubMed=8105609;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   h1c
AC   CVCL_U126
DR   CLO; CLO_0050351
DR   RCB; RCB1924
DR   Wikidata; Q54871983
RX   DOI=10.1508/cytologia.68.271;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Lygodium japonicum strain an-1 basal apparatus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   H1C46
AC   CVCL_A9RB
SY   HCV H1C46
DR   ATCC; HB-10594
DR   Wikidata; Q102114079
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10594.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1191-1457 = Serine protease NS3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   H1G1.1c3
AC   CVCL_DC19
DR   Wikidata; Q54871984
RX   PubMed=11812924;
RX   PubMed=15096657;
RX   PubMed=21394221;
CC   Biotechnology: Cell line developed for CAFLUX (Chemically Activated FLUorescence eXpression) bioassay. CAFLUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a EGFP gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   H1H
AC   CVCL_ZD51
DR   Wikidata; Q98126647
RX   PubMed=8105609;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   H1H8
AC   CVCL_WZ72
DR   CCRID; 4201PAT-CCTCC00303
DR   Wikidata; Q93935983
RX   Patent=CN101948808A;
RX   PubMed=20815254;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200949.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16793; Mercury(2+).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   H1HeLa
AC   CVCL_3334
SY   H1-HeLa; H1 HeLa; H-Hela; HeLa H1
DR   CLO; CLO_0003586
DR   ATCC; CRL-1958
DR   BioGRID_ORCS_Cell_line; 1185
DR   CCRID; 1101HUM-PUMC000344
DR   ChEMBL-Cells; CHEMBL3833201
DR   ChEMBL-Targets; CHEMBL4296418
DR   PubChem_Cell_line; CVCL_3334
DR   Wikidata; Q54871985
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-1958; CCRID=1101HUM-PUMC000344
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17,18
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   H1L1.1c2
AC   CVCL_DC20
SY   H1L1.1
DR   Wikidata; Q54871986
RX   Patent=US5854010;
RX   PubMed=8812265;
RX   PubMed=15096657;
RX   PubMed=18969542;
RX   PubMed=21394221;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12286.
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 14
//
ID   H1L1.1c7
AC   CVCL_DC21
SY   Hepa.Luc
DR   Wikidata; Q54871987
RX   PubMed=8812260;
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   H1L6.1c2
AC   CVCL_DC22
DR   Wikidata; Q54871988
RX   PubMed=15096657;
RX   PubMed=21394221;
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   H1L6.1c3
AC   CVCL_DC23
DR   Wikidata; Q54871989
RX   PubMed=18969542;
RX   PubMed=21872055;
RX   PubMed=26366531;
WW   Info; EPA; -; https://www.epa.gov/hw-sw846/sw-846-test-method-4435-screening-dioxin-chemical-activity-soils-and-sediments-using-calux
WW   Provider; XDSI; -; http://www.dioxins.com/products/
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Biotechnology: Used in US Environmental Protection Agency (EPA) hazardous waste test method 4435 (SW-846).
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 14
//
ID   H1L7.5c1
AC   CVCL_DC24
DR   Wikidata; Q54871990
RX   PubMed=21872055;
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   H1L7.5c3
AC   CVCL_DC25
DR   Wikidata; Q54871991
RX   PubMed=26366531;
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 13
//
ID   H1R8
AC   CVCL_B6DT
DR   Wikidata; Q111733248
RX   DOI=10.1007/BF01051776;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_62485; Blood group A antigen type 1 (Alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc).
CC   Monoclonal antibody target: ChEBI; CHEBI_62486; Blood group A antigen type 2 (Alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   h1RPE116
AC   CVCL_9W31
SY   h1RPE-116
DR   Wikidata; Q54871992
RX   PubMed=11818403;
RX   PubMed=25177495;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2459 ! h1RPE7
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   h1RPE7
AC   CVCL_2459
SY   h1RPE-7
DR   ECACC; 09061602
DR   Wikidata; Q54871994
RX   PubMed=11504951;
RX   PubMed=11818403;
RX   PubMed=25177495;
CC   Doubling time: ~24 hours (ECACC=09061602).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
ST   Source(s): ECACC=09061602
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9W31 ! h1RPE116
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   H2-4B3
AC   CVCL_5K06
SY   WC00041
DR   CLO; CLO_0012732
DR   BioSamples; SAME17785
DR   Coriell; WC00041
DR   Wikidata; Q54872004
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00041; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H2-4C2
AC   CVCL_5K07
SY   WC00034
DR   CLO; CLO_0012708
DR   ABCD; ABCD_AE208
DR   BioSamples; SAME17741
DR   Coriell; WC00034
DR   Wikidata; Q54872005
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00034; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H2-6A1
AC   CVCL_5K08
SY   WC00022
DR   CLO; CLO_0012690
DR   BioSamples; SAME17805
DR   Coriell; WC00022
DR   Wikidata; Q54872006
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00022; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H2-6C4
AC   CVCL_C5KN
DR   Wikidata; Q116049157
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H2.35
AC   CVCL_4210
DR   BTO; BTO_0003277
DR   CLO; CLO_0003587
DR   EFO; EFO_0022758
DR   CLDB; cl1539
DR   ATCC; CRL-1995
DR   ECACC; 94050407
DR   Wikidata; Q54872008
RX   PubMed=3194409;
CC   Characteristics: At the permissive temperature (33 Celsius) exhibits low level of albumin transcription while at the restrictive temperature (39 Celsius) albumin mRNA increase 100-fold.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   H2.8
AC   CVCL_L518
DR   CLO; CLO_0003588
DR   ATCC; CRL-2568
DR   Wikidata; Q54872009
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q05996; Human ZP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   H20-A15
AC   CVCL_C5KP
DR   ABCD; ABCD_AE154
DR   Wikidata; Q116049158
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H200
AC   CVCL_GS36
DR   Wikidata; Q54872010
RX   PubMed=9241248;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   H2030-BrM3
AC   CVCL_XA22
DR   cancercelllines; CVCL_XA22
DR   GEO; GSM354021
DR   GEO; GSM354022
DR   Wikidata; Q93936089
RX   PubMed=19576624;
CC   Population: Caucasian.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262Val (c.785G>T); ClinVar=VCV000428889; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA21 ! H2030-TGL
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   H2030-TGL
AC   CVCL_XA21
DR   cancercelllines; CVCL_XA21
DR   GEO; GSM354017
DR   GEO; GSM354018
DR   Wikidata; Q93936092
RX   PubMed=19576624;
CC   Population: Caucasian.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262Val (c.785G>T); ClinVar=VCV000428889; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: In PubMed=19576624 and the associated GEO data sets H2030-TGL is termed H2030 Parental.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1517 ! NCI-H2030
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   H2087-LCC1-1
AC   CVCL_VR28
SY   H2087-LCC1; H2087 LCC1; H2087-Latency Competent Cancer 1
DR   cancercelllines; CVCL_VR28
DR   GEO; GSM1875323
DR   GEO; GSM1875332
DR   Wikidata; Q93936095
RX   PubMed=27015306;
CC   Population: Caucasian.
CC   Characteristics: After 3 months was recovered from the lung of healthy FOXN1nu mice that had been intracardially injected with the parent cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu848Gln (c.2542G>C); ClinVar=VCV001686474; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Val (c.1789C>G); ClinVar=VCV000013969; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Glu54Lys (c.160G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 10
ST   FGA: 20
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR27 ! H2087-TGL
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   H2087-LCC1-2
AC   CVCL_VR29
SY   H2087-LCC2; H2087 LCC2; H2087-Latency Competent Cancer 2
DR   cancercelllines; CVCL_VR29
DR   GEO; GSM1875324
DR   GEO; GSM1875333
DR   GEO; GSM2066430
DR   GEO; GSM2066434
DR   GEO; GSM2066438
DR   Wikidata; Q93936100
RX   PubMed=27015306;
CC   Population: Caucasian.
CC   Characteristics: After 3 months was recovered from the kidney of healthy FOXN1nu mice that had been intracardially injected with the parent cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu848Gln (c.2542G>C); ClinVar=VCV001686474; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Val (c.1789C>G); ClinVar=VCV000013969; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Glu54Lys (c.160G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 10
ST   FGA: 20
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR27 ! H2087-TGL
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   H2087-TGL
AC   CVCL_VR27
SY   H2087-HSV1-TK/GFP/Fluc
DR   cancercelllines; CVCL_VR27
DR   GEO; GSM1875321
DR   GEO; GSM1875322
DR   GEO; GSM1875329
DR   GEO; GSM1875330
DR   GEO; GSM1875331
DR   GEO; GSM2066429
DR   GEO; GSM2066433
DR   GEO; GSM2066437
DR   Wikidata; Q93936103
RX   PubMed=27015306;
CC   Population: Caucasian.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL) and with bsr; parent cell line for the H2087-LCC1 and H2087-LCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu848Gln (c.2542G>C); ClinVar=VCV001686474; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Val (c.1789C>G); ClinVar=VCV000013969; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Glu54Lys (c.160G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Caution: In PubMed=27015306 and the associated GEO data sets H2087-TGL is termed H2087 Parental.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 10
ST   FGA: 20
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1524 ! NCI-H2087
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 13
//
ID   H209/CP
AC   CVCL_9V41
DR   cancercelllines; CVCL_9V41
DR   Wikidata; Q54872011
RX   PubMed=8646677;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Cys706Phe (c.2117G>T); ClinVar=VCV000376330; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1525 ! NCI-H209
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   H209/VP
AC   CVCL_9V42
DR   cancercelllines; CVCL_9V42
DR   Wikidata; Q54872012
RX   PubMed=8646677;
RX   PubMed=10699927;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Cys706Phe (c.2117G>T); ClinVar=VCV000376330; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1525 ! NCI-H209
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   H20961
AC   CVCL_HA53
SY   H1; H1.iPSC; H20961_iPSC
DR   GEO; GSM1495403
DR   GEO; GSM1502705
DR   Wikidata; Q54872014
RX   PubMed=26102527;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   H20C01
AC   CVCL_C5MR
DR   Wikidata; Q116049159
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H20E03
AC   CVCL_C5MS
DR   Wikidata; Q116049160
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H20F04
AC   CVCL_C5MT
DR   Wikidata; Q116049161
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H210-56
AC   CVCL_C5KQ
DR   ABCD; ABCD_AE194
DR   Wikidata; Q116049162
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H21C08
AC   CVCL_C5MU
DR   Wikidata; Q116049163
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H21F8-1
AC   CVCL_L519
SY   1F8
DR   CLO; CLO_0003589
DR   ATCC; CRL-8018
DR   BCRC; 60234
DR   Wikidata; Q54872016
RX   Patent=US4271145;
RX   Patent=US4870026;
RX   PubMed=6940137;
RX   PubMed=18600747;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8018.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
CC   Discontinued: ATCC; CRL-8018; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 9
//
ID   H22
AC   CVCL_H613
SY   Hepatoma-22; Hepatoma 22
DR   CCRID; 1101MOU-PUMC000309
DR   CCRID; 4201MOU-CCTCC00091
DR   CCTCC; GDC0091
DR   ChEMBL-Cells; CHEMBL3307751
DR   ChEMBL-Targets; CHEMBL614998
DR   CLS; 305163
DR   PubChem_Cell_line; CVCL_H613
DR   Ubigene; YC-C053
DR   Wikidata; Q54872017
RX   CelloPub=CLPUB00792;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/h22-xenograft-model/
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
ST   Source(s): CLS=305163; Ubigene=YC-C053
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 18,19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 15.3,16.3
ST   Mouse STR 6-7: 13
ST   Mouse STR 7-1: 24.2
ST   Mouse STR 8-1: 17,18
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 19.3,20.3
ST   Mouse STR 17-2: 13
ST   Mouse STR 18-3: 11,17 (Ubigene=YC-C053)
ST   Mouse STR 18-3: 17 (CLS=305163)
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E7BW ! H22-F25/L
OI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   H22-F25/L
AC   CVCL_E7BW
RX   DOI=10.1007/BF02954998;
RX   PubMed=1889333;
CC   Doubling time: 20.7 hours (DOI=10.1007/BF02954998; PubMed=1889333).
CC   Karyotypic information: 43,XY,-2,+M1,+M2,+M3,+M4 (DOI=10.1007/BF02954998; PubMed=1889333).
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_H613 ! H22
OI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   H22-H8D8
AC   CVCL_IR42
DR   CCRID; 4201MOU-CCTCC00132
DR   CCTCC; GDC0132
DR   Wikidata; Q54872018
RX   CelloPub=CLPUB00371;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H613 ! H22
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   H22-Luc
AC   CVCL_C8Y4
DR   Ubigene; YC-C053-Luc-P
DR   Wikidata; Q123031389
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H613 ! H22
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   H220-1
AC   CVCL_C5KR
DR   ABCD; ABCD_AE218
DR   Wikidata; Q116049164
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-10
AC   CVCL_C5KS
DR   Wikidata; Q116049165
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-11
AC   CVCL_C5KT
DR   ABCD; ABCD_AE153
DR   Wikidata; Q116049166
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-17
AC   CVCL_C5KU
DR   Wikidata; Q116049167
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-19
AC   CVCL_C5LT
DR   Wikidata; Q116049168
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-20
AC   CVCL_C5KV
DR   Wikidata; Q116049169
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-22
AC   CVCL_C5KW
DR   ABCD; ABCD_AE203
DR   Wikidata; Q116049170
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-23
AC   CVCL_C5KX
DR   ABCD; ABCD_AE213
DR   Wikidata; Q116049171
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-25
AC   CVCL_C5KY
DR   ABCD; ABCD_AE259
DR   Wikidata; Q116049172
RX   PubMed=1908510;
RX   PubMed=2427335;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-3
AC   CVCL_C5KZ
DR   ABCD; ABCD_AE196
DR   Wikidata; Q116049173
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-5
AC   CVCL_C5L0
DR   ABCD; ABCD_AE210
DR   Wikidata; Q116049174
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H220-7
AC   CVCL_C5L1
DR   ABCD; ABCD_AE202
DR   Wikidata; Q116049175
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H224 C2
AC   CVCL_IK96
SY   H224 clone 2
DR   SKIP; SKIP003202
DR   Wikidata; Q54872019
RX   PubMed=27789411;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ser305Ile (c.914G>T) (S622I, c.1865G>T or S640I, c.1919G>T); ClinVar=VCV001256161; Zygosity=Heterozygous (PubMed=27789411).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   H22F02
AC   CVCL_C5MV
DR   Wikidata; Q116049176
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H22F05
AC   CVCL_C5MW
DR   Wikidata; Q116049177
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H230-2
AC   CVCL_C5L2
DR   ABCD; ABCD_AE205
DR   Wikidata; Q116049178
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H230-5
AC   CVCL_C5L3
DR   Wikidata; Q116049179
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H230-7
AC   CVCL_C5L4
DR   ABCD; ABCD_AE195
DR   Wikidata; Q116049180
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H234 C2
AC   CVCL_DQ59
SY   H234 clone 2; L150P-hiPSC
DR   SKIP; SKIP001287
DR   Wikidata; Q54872020
RX   PubMed=27345792;
RX   PubMed=27789395;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu150Pro (c.449T>C); Zygosity=Heterozygous (PubMed=27345792).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   H234 C2 GC
AC   CVCL_IK98
SY   L150P-GC-hiPSC
DR   Wikidata; Q54900977
RX   PubMed=27789395;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_corrected; p.Leu150Pro (c.449T>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=27789395).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ59 ! H234 C2
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   H236 C6
AC   CVCL_DQ58
SY   H236 clone 6
DR   SKIP; SKIP003199
DR   Wikidata; Q54872022
RX   PubMed=27345791;
RX   PubMed=27934590;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (PubMed=27345791).
CC   Donor information: At sampling donor was pre-symptomatic for frontotemporal dementia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 17
//
ID   H236 C6 GC
AC   CVCL_A4GA
SY   H236 clone 6 GC
DR   SKIP; SKIP003203
DR   Wikidata; Q105507530
RX   PubMed=27934590;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=27934590).
CC   Donor information: At sampling donor was pre-symptomatic for frontotemporal dementia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ58 ! H236 C6
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 8
//
ID   H237 C3
AC   CVCL_DQ57
SY   H237 clone 3
DR   SKIP; SKIP003198
DR   Wikidata; Q54872023
RX   PubMed=27345789;
RX   PubMed=27934586;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous (PubMed=27345789).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 17
//
ID   H237 C3 GC
AC   CVCL_UM05
SY   H237 clone 3 GC
DR   SKIP; SKIP003201
DR   Wikidata; Q93936185
RX   PubMed=27934586;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=27934586).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ57 ! H237 C3
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 11
//
ID   H23B05
AC   CVCL_C5MX
DR   Wikidata; Q116049181
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H23C163
AC   CVCL_A1TL
SY   HCV E146-H23-C163
DR   ATCC; HB-10856
DR   Wikidata; Q105507533
RX   Patent=US5308750;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10856.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 643-683 = Envelope glycoprotein E2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   H23D02
AC   CVCL_C5MY
DR   Wikidata; Q116049182
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H23F10
AC   CVCL_C5MZ
DR   Wikidata; Q116049183
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H241
AC   CVCL_E6K3
DR   ABCD; ABCD_BD781
RX   PubMed=2424026;
RX   PubMed=8626460;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4705; Double-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   H24b
AC   CVCL_L840
DR   ECACC; 93031702
DR   Wikidata; Q54872024
RX   PubMed=8459104;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Gray seal IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   H24E07
AC   CVCL_C5N0
DR   Wikidata; Q116049184
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H250
AC   CVCL_F0WI
RX   PubMed=2559442;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Epstein-Barr virus (strain B95-8) 75 kDa capsid protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   H250-6
AC   CVCL_C5L5
DR   ABCD; ABCD_AE206
DR   Wikidata; Q116049185
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H251 C3
AC   CVCL_DQ56
SY   H251 clone 3
DR   SKIP; SKIP003200
DR   Wikidata; Q54872025
RX   PubMed=27345788;
RX   PubMed=27789409;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Heterozygous (PubMed=27345788).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   H251 C3 GC
AC   CVCL_IK97
SY   H251 clone 3 GC
DR   Wikidata; Q54872026
RX   PubMed=27789409;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=27789409).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ56 ! H251 C3
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   H256 C6
AC   CVCL_ZG14
SY   H256 clone 6
DR   Wikidata; Q98126648
RX   PubMed=27558613;
RX   PubMed=27558614;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   H256 C6 CHMP2B IVS5AS GG-CC
AC   CVCL_GP82
SY   H256 clone 6 CHMP2B IVS5AS GG-CC; CHMP2B IVS5AS GG-CC
DR   Wikidata; Q54872027
RX   PubMed=27558614;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZG14 ! H256 C6
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   H256 C6 CHMP2B IVS5AS GG-GC
AC   CVCL_GP83
SY   H256 clone 6 CHMP2B IVS5AS GG-GC; CHMP2B IVS5AS GG-GC
DR   Wikidata; Q54872028
RX   PubMed=27558613;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZG14 ! H256 C6
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   H25B10
AC   CVCL_2053
DR   CLO; CLO_0003590
DR   CLO; CLO_0003591
DR   CLDB; cl1541
DR   ATCC; CRL-8017
DR   ATCC; CRL-8017A
DR   BCRC; 60233
DR   DSMZ; ACC-98
DR   DSMZCellDive; ACC-98
DR   ECACC; 90120615
DR   Wikidata; Q54872030
RX   Patent=US4271145;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8017.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8017A.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   H26
AC   CVCL_C4FD
DR   ABCD; ABCD_AE289
DR   Wikidata; Q116049186
RX   PubMed=2767052;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   H266 C10
AC   CVCL_AB82
SY   H266 c10; H266 clone 10
DR   Wikidata; Q54872032
RX   PubMed=27345805;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[44] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=27345805).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   H266 C10 GC
AC   CVCL_DQ64
SY   H266 c10 GC; H266 clone10 GC; H266 clone 10 GC
DR   Wikidata; Q54872033
RX   PubMed=27345815;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion_corrected; p.Gln166[44] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=By CRISPR/Cas9. The original 44 CAG repeat has been replaced with a 22 CAG repeat (PubMed=27345815).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AB82 ! H266 C10
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   H2669
AC   CVCL_D345
SY   2669
DR   Wikidata; Q54872034
RX   PubMed=1690595;
RX   PubMed=8179825;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   H26A09
AC   CVCL_C5N1
SY   26/09
DR   ABCD; ABCD_AE391
DR   Wikidata; Q116049187
RX   PubMed=6192445;
RX   PubMed=7520084;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
CC   Monoclonal antibody target: ChEBI; CHEBI_80171; HA tag.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   H26D02
AC   CVCL_C5N2
DR   Wikidata; Q116049188
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H26D08
AC   CVCL_C5N3
DR   Wikidata; Q116049189
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H26F02
AC   CVCL_C5N4
DR   Wikidata; Q116049190
RX   PubMed=6192445;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I6SHA6; Influenza A virus (strain A/X-47 H3N2) hemagglutinin (HA) (Note=Immunized with AA 93-127).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   H271 C1
AC   CVCL_9U78
SY   H271 clone 1; H271 c 1; H271
DR   Wikidata; Q54872035
RX   PubMed=27345803;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[44] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=27345803).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   H271 C1 GC
AC   CVCL_DQ65
SY   H271 c1 GC; H271 clone1 GC; H271 clone 1 GC
DR   Wikidata; Q54872037
RX   PubMed=27345809;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion_corrected; p.Gln166[44] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=By CRISPR/Cas9. The original 44 CAG repeat has been replaced with a 22 CAG repeat (PubMed=27345809).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U78 ! H271 C1
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   H273
AC   CVCL_Y296
DR   BTO; BTO_0005140
DR   cancercelllines; CVCL_Y296
DR   Wikidata; Q54872038
RX   PubMed=19382257;
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   H28-A2
AC   CVCL_C5L6
DR   ABCD; ABCD_AE256
DR   Wikidata; Q116049191
RX   PubMed=2427335;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H28-D14
AC   CVCL_C5L7
DR   Wikidata; Q116049192
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H28-E23
AC   CVCL_C5IE
SY   H28 E23; Sb-9; Sb9
DR   Wikidata; Q116049193
RX   PubMed=6163993;
RX   PubMed=6600489;
RX   PubMed=9712021;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H280-10
AC   CVCL_C5L8
DR   Wikidata; Q116049194
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H280-15
AC   CVCL_C5L9
DR   ABCD; ABCD_AE214
DR   Wikidata; Q116049195
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H280-4
AC   CVCL_C5LU
DR   Wikidata; Q116049196
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H28834
AC   CVCL_HA54
SY   H2; H2.iPSC; H28834_iPSC
DR   GEO; GSM1495404
DR   GEO; GSM1502706
DR   Wikidata; Q54872039
RX   PubMed=26102527;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   H28C110
AC   CVCL_A9R8
SY   HCV H28C110
DR   ATCC; HB-10587
DR   Wikidata; Q102114080
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10587.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1569-1930 = Non-structural protein 4A/4B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   H2964
AC   CVCL_LG10
SY   2964
DR   Wikidata; Q54872041
RX   PubMed=1690595;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H2981
AC   CVCL_D346
DR   ChEMBL-Cells; CHEMBL3308656
DR   ChEMBL-Targets; CHEMBL614802
DR   PubChem_Cell_line; CVCL_D346
DR   Wikidata; Q54872042
RX   PubMed=1565644;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   H2987
AC   CVCL_D347
SY   2987
DR   ChEMBL-Cells; CHEMBL3308612
DR   ChEMBL-Targets; CHEMBL614669
DR   PubChem_Cell_line; CVCL_D347
DR   Wikidata; Q54872043
RX   PubMed=1690595;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   H2A
AC   CVCL_ZD52
DR   Wikidata; Q98126649
RX   PubMed=8105609;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   H2E
AC   CVCL_ZD53
DR   Wikidata; Q98126651
RX   PubMed=8105609;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   H2H5
AC   CVCL_WZ73
DR   CCRID; 4201PAT-CCTCC00302
DR   Wikidata; Q93936300
RX   Patent=CN101948807B;
RX   PubMed=20815254;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200948.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16793; Mercury(2+).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   H2K 2B4
AC   CVCL_0P22
DR   Wikidata; Q54872044
RX   PubMed=21935475;
CC   Characteristics: Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotube (PubMed=21935475).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Muscle, extensor digitorum longus; UBERON=UBERON_0001386.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   3W
CA   Conditionally immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   H2K mdx
AC   CVCL_8120
SY   H2K-mdx; H2K/mdx
DR   Lonza; 1505
DR   Wikidata; Q54872046
RX   PubMed=8150209;
CC   Sequence variation: Mutation; MGI; MGI:94909; Dmd; Simple; p.Gln995Ter (c.2983C>T); Zygosity=Hemizygous; Note=mdx mutation (from inference of mdx mice mutation).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Limb, muscle; UBERON=UBERON_0003661.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x mdx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1-2D
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   H2M
AC   CVCL_M189
SY   H2-M; H-2M
DR   Cosmic; 2773186
DR   Wikidata; Q54872047
RX   CelloPub=CLPUB00254;
RX   PubMed=14697646;
CC   Population: Chinese.
CC   Karyotypic information: Hypertetraploid karyotype (PubMed=14697646).
CC   Derived from site: Metastatic; Portal vein; Note=From a tumor thrombus; UBERON=UBERON_0002017.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M190 ! H2P
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   H2Mab-119
AC   CVCL_D2T5
DR   Wikidata; Q127380969
RX   PubMed=29172998;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-139
AC   CVCL_D2T6
DR   Wikidata; Q127380970
RX   PubMed=29315012;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-181
AC   CVCL_D2T7
DR   Wikidata; Q127380971
RX   PubMed=34424764;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-19
AC   CVCL_D2T9
DR   Wikidata; Q127380972
RX   PubMed=32765652;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-214
AC   CVCL_D2TA
DR   Wikidata; Q127380973
RX   DOI=10.2139/ssrn.4565236;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-250
AC   CVCL_D3EH
DR   Wikidata; Q127380974
RX   PubMed=38563783;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   H2Mab-300
AC   CVCL_D2SP
DR   Wikidata; Q127380975
RX   DOI=10.3390/ijtm3030022;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P70424; Mouse Erbb2/Cd340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-304
AC   CVCL_D2SS
DR   Wikidata; Q127380976
RX   DOI=10.3390/ijtm3030022;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P70424; Mouse Erbb2/Cd340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-41
AC   CVCL_D2T8
DR   Wikidata; Q127380977
RX   PubMed=31199696;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 (Note=Also react with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2Mab-77
AC   CVCL_D2T2
DR   Wikidata; Q127380978
RX   PubMed=28700270;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H2P
AC   CVCL_M190
SY   H2-P; H-2P
DR   Cosmic; 2773185
DR   Wikidata; Q54872048
RX   PubMed=14697646;
CC   Population: Chinese.
CC   Karyotypic information: Hypertriploid karyotype (PubMed=14697646).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M189 ! H2M
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   H2T
AC   CVCL_S971
DR   Wikidata; Q54872049
RX   PubMed=1499946;
RX   PubMed=7089870;
RX   PubMed=7809021;
RX   PubMed=7809022;
RX   PubMed=8863680;
CC   Doubling time: 24-28 hours (PubMed=7089870).
CC   Sequence variation: Mutation; UniProtKB; A0A1U7QTX5; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (PubMed=7809022).
CC   Transformant: ChEBI; CHEBI_140063; N-nitrobis(2-hydroxypropyl)amine (BHP).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   H3-4C5
AC   CVCL_C5LA
SY   Ca-2; Ca2
DR   Wikidata; Q116049197
RX   PubMed=6163993;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H3.1
AC   CVCL_L520
DR   CLO; CLO_0003592
DR   ATCC; CRL-2569
DR   Wikidata; Q54872051
RX   PubMed=9609824;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P21754; Human ZP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   H305.G8G1
AC   CVCL_C5GE
SY   MAb-3
DR   Wikidata; Q116049198
RX   PubMed=1382325;
RX   PubMed=3140427;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20474; Bothrops asper basic phospholipase A2 myotoxin I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H305.G9F4
AC   CVCL_C5GF
SY   MAb-4
DR   Wikidata; Q116049199
RX   PubMed=1382325;
RX   PubMed=3140427;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20474; Bothrops asper basic phospholipase A2 myotoxin I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H314
AC   CVCL_2460
DR   cancercelllines; CVCL_2460
DR   CancerTools; 153421
DR   Cosmic; 716675
DR   Cosmic; 916369
DR   Cosmic; 928236
DR   ECACC; 06092003
DR   Wikidata; Q54872065
DR   Ximbio; 153421
RX   PubMed=1692339;
RX   PubMed=1744799;
RX   PubMed=7633286;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Homozygous (PubMed=7633286).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys373Glu (c.1117A>G); Zygosity=Homozygous (PubMed=7633286).
CC   Discontinued: ECACC; 06092003; true.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   H32
AC   CVCL_E3Z2
RX   Patent=US10239941;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P81172; Human HAMP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   H33-48
AC   CVCL_5J99
SY   WC00036
DR   CLO; CLO_0012725
DR   BioSamples; SAME17749
DR   Coriell; WC00036
DR   Wikidata; Q54872067
RX   PubMed=1908881;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00036; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H3347
AC   CVCL_LG07
SY   3347
DR   Wikidata; Q54872068
RX   PubMed=1565644;
RX   PubMed=1690595;
RX   PubMed=8179825;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3396
AC   CVCL_D348
SY   3396
DR   ChEMBL-Cells; CHEMBL3308066
DR   ChEMBL-Targets; CHEMBL613839
DR   PubChem_Cell_line; CVCL_D348
DR   Wikidata; Q54872069
RX   PubMed=1690595;
RX   PubMed=7535774;
RX   PubMed=8179825;
RX   PubMed=9186000;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   H33HJ-JA1
AC   CVCL_2461
DR   CLO; CLO_0003593
DR   CLDB; cl1542
DR   ATCC; CRL-8163
DR   BioSample; SAMN03471197
DR   cancercelllines; CVCL_2461
DR   CCRID; 5301HUM-KCB16015YJ
DR   Cosmic; 683537
DR   ECACC; 90112119
DR   GEO; GSM827363
DR   IARC_TP53; 21354
DR   KCB; KCB 2016015YJ
DR   LINCS_LDP; LCL-2037
DR   Progenetix; CVCL_2461
DR   Wikidata; Q54872070
RX   Patent=US5597901;
RX   PubMed=7592872;
RX   PubMed=20215515;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8163.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: H33Hj-A1; KCB=KCB 2016015YJ.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8163
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,10,11
ST   D16S539: 11,12
ST   D5S818: 9
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   H3464
AC   CVCL_D349
DR   Wikidata; Q54872072
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   H3477
AC   CVCL_D350
AS   CVCL_JY55
SY   HBT 3477; HBT-3477; HBT3477
DR   Wikidata; Q54872073
RX   PubMed=9108094;
RX   PubMed=9186000;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   H35-C10
AC   CVCL_C5LB
DR   Wikidata; Q116049200
RX   PubMed=1908881;
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H35-C2
AC   CVCL_5J98
SY   WC00037
DR   CLO; CLO_0012728
DR   BioSamples; SAME17753
DR   Coriell; WC00037
DR   Wikidata; Q54872074
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00037; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H35-C4
AC   CVCL_C5LC
DR   Wikidata; Q116049201
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H35-C6
AC   CVCL_C5LD
DR   ABCD; ABCD_AE263
DR   Wikidata; Q116049202
RX   PubMed=1908510;
RX   PubMed=1908881;
RX   PubMed=2427335;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H35-C7
AC   CVCL_C5LE
DR   Wikidata; Q116049203
RX   PubMed=1908881;
RX   PubMed=2118933;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H35-C9
AC   CVCL_C5LF
DR   Wikidata; Q116049204
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H35-D1
AC   CVCL_C5LG
DR   ABCD; ABCD_AE192
DR   Wikidata; Q116049205
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H357
AC   CVCL_2462
DR   CancerTools; 153422
DR   Cell_Model_Passport; SIDM01810
DR   Cosmic; 716676
DR   Cosmic; 916370
DR   Cosmic; 928237
DR   DepMap; ACH-001509
DR   ECACC; 06092004
DR   Wikidata; Q54872075
DR   Ximbio; 153422
RX   PubMed=1692339;
RX   PubMed=7633286;
RX   PubMed=8552382;
RX   PubMed=17944752;
RX   PubMed=20426848;
RX   PubMed=27846777;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Ser (c.37G>A); ClinVar=VCV000376323; Zygosity=Unspecified (DepMap=ACH-001509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Homozygous (PubMed=7633286).
CC   Discontinued: ECACC; 06092004; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DepMap=ACH-001509
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 29,31.2
ST   D3S1358: 17,18
ST   D5S818: 12,14
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23,26
ST   Penta D: 6,12
ST   Penta E: 11,13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   H357-V3
AC   CVCL_JY67
SY   V3
DR   Wikidata; Q54992480
RX   PubMed=8552382;
RX   PubMed=11442751;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Ser (c.37G>A); ClinVar=VCV000376323; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2462 ! H357
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   H357-VB6
AC   CVCL_JY68
SY   VB6
DR   Wikidata; Q54992947
RX   PubMed=11340566;
RX   PubMed=11442751;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Ser (c.37G>A); ClinVar=VCV000376323; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6161; ITGB6.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JY67 ! H357-V3
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   H35C54
AC   CVCL_A9R7
SY   HCV H35C54
DR   ATCC; HB-10592
DR   Wikidata; Q102114082
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10592.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1-150 = Core protein p21).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   H35R0.3
AC   CVCL_1B44
DR   ChEMBL-Cells; CHEMBL3307550
DR   ChEMBL-Targets; CHEMBL614160
DR   PubChem_Cell_line; CVCL_1B44
DR   Wikidata; Q54872076
RX   PubMed=3965926;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0285 ! H4-II-E-C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 12
//
ID   H36 [Mouse hybridoma against D.discoideum cprG]
AC   CVCL_YB01
DR   ABCD; ABCD_AN701
DR   DSHB; H36
DR   Wikidata; Q93936459
RX   PubMed=16968738;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q94504; Dictyostelium discoideum cprG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 6
//
ID   H36 [Mouse hybridoma against rat Itga7]
AC   CVCL_C4L7
DR   Wikidata; Q116049206
RX   PubMed=1315319;
RX   PubMed=3889014;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q63258; Rat Itga7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H36-1
AC   CVCL_C5IF
DR   Wikidata; Q116049207
RX   PubMed=3920342;
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-101
AC   CVCL_C5IQ
DR   Wikidata; Q116049208
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-11
AC   CVCL_C5IG
DR   Wikidata; Q116049209
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-12
AC   CVCL_C5IH
DR   Wikidata; Q116049210
RX   PubMed=2108213;
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-15
AC   CVCL_C5II
DR   Wikidata; Q116049211
RX   PubMed=3920342;
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-17
AC   CVCL_C5IJ
DR   Wikidata; Q116049212
RX   PubMed=3920342;
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-18
AC   CVCL_C5IK
DR   Wikidata; Q116049213
RX   PubMed=3920342;
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-2
AC   CVCL_5J87
SY   WC00030
DR   CLO; CLO_0012714
DR   ABCD; ABCD_AE255
DR   BioSamples; SAME17729
DR   Coriell; WC00030
DR   Wikidata; Q54872078
RX   PubMed=1908510;
RX   PubMed=1908881;
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00030; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H36-4-5.2
AC   CVCL_2Z38
SY   H36-4; WC00005
DR   CLO; CLO_0013429
DR   BioSamples; SAME17757
DR   Coriell; WC00005
DR   Wikidata; Q54872080
RX   PubMed=3920342;
RX   PubMed=6203114;
RX   PubMed=6600489;
WW   Info; Wistar; -; https://www.wistar.org/technology-transfer/monoclonal-antibodies-influenza-research
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00005; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 9
//
ID   H36-5
AC   CVCL_C5IL
DR   Wikidata; Q116049214
RX   PubMed=3920342;
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-6
AC   CVCL_C5IM
DR   Wikidata; Q116049215
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-7
AC   CVCL_C5IN
DR   Wikidata; Q116049216
RX   PubMed=3920342;
RX   PubMed=6203114;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36-8
AC   CVCL_C5IP
DR   Wikidata; Q116049217
RX   PubMed=2108213;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H36.12a
AC   CVCL_B955
SY   Pixie 12a
DR   CLO; CLO_0003594
DR   ATCC; CRL-2445
DR   Wikidata; Q54872081
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   H36.12b
AC   CVCL_B956
SY   Pixie 12b
DR   CLO; CLO_0003595
DR   ATCC; CRL-2446
DR   Wikidata; Q54872082
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   H36.12d
AC   CVCL_B957
SY   Pixie 12d
DR   CLO; CLO_0003596
DR   ATCC; CRL-2447
DR   Wikidata; Q54872083
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   H36.12e
AC   CVCL_B958
SY   Pixie 12e
DR   CLO; CLO_0003597
DR   ATCC; CRL-2448
DR   Wikidata; Q54872084
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   H36.12j
AC   CVCL_B959
SY   Pixie 12j
DR   CLO; CLO_0003598
DR   ATCC; CRL-2449
DR   Wikidata; Q54872085
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   H3600
AC   CVCL_LG11
SY   3600
DR   Wikidata; Q54872087
RX   PubMed=1690595;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3606
AC   CVCL_LG03
SY   3606
DR   Wikidata; Q54872088
RX   PubMed=1565644;
RX   PubMed=1690595;
RX   PubMed=8179825;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   H3614
AC   CVCL_LG04
DR   Wikidata; Q54872089
RX   PubMed=8179825;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   H3619
AC   CVCL_LG09
SY   3619
DR   Wikidata; Q54872090
RX   PubMed=1690595;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3620
AC   CVCL_LG05
SY   3620
DR   Wikidata; Q54872091
RX   PubMed=1690595;
RX   PubMed=8179825;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3630
AC   CVCL_LF99
SY   3630
DR   Wikidata; Q54872094
RX   PubMed=1690595;
RX   PubMed=9186000;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3639
AC   CVCL_D351
DR   Wikidata; Q54872095
RX   PubMed=1565644;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   H3650
AC   CVCL_LG06
DR   Wikidata; Q54872097
RX   PubMed=8179825;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3677
AC   CVCL_H603
SY   3677
DR   ChEMBL-Cells; CHEMBL3307809
DR   ChEMBL-Targets; CHEMBL612820
DR   PubChem_Cell_line; CVCL_H603
DR   Wikidata; Q54585138
RX   PubMed=7627964;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   H3680B
AC   CVCL_LG00
DR   Wikidata; Q54872098
RX   PubMed=9186000;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H37-104
AC   CVCL_C5IR
DR   Wikidata; Q116049218
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-109
AC   CVCL_C5IS
DR   Wikidata; Q116049219
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-112
AC   CVCL_C5IT
DR   Wikidata; Q116049220
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-22
AC   CVCL_5J88
SY   WC00035
DR   CLO; CLO_0012709
DR   BioSamples; SAME17745
DR   Coriell; WC00035
DR   Wikidata; Q54872099
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00035; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H37-23
AC   CVCL_C5IU
DR   Wikidata; Q116049221
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-24
AC   CVCL_C5IV
DR   Wikidata; Q116049222
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-26
AC   CVCL_C5IX
DR   Wikidata; Q116049224
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-29
AC   CVCL_C5IY
DR   Wikidata; Q116049225
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-311
AC   CVCL_C5IZ
DR   ABCD; ABCD_AE254
DR   Wikidata; Q116049226
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-312
AC   CVCL_C5J0
DR   Wikidata; Q116049227
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-36
AC   CVCL_C5J1
DR   Wikidata; Q116049228
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-37
AC   CVCL_C5J2
DR   Wikidata; Q116049229
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-38
AC   CVCL_C5J3
DR   Wikidata; Q116049230
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-40
AC   CVCL_C5J4
DR   ABCD; ABCD_AE253
DR   Wikidata; Q116049231
RX   PubMed=1908510;
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-41
AC   CVCL_C5J5
DR   Wikidata; Q116049232
RX   PubMed=2108213;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-42
AC   CVCL_C5J6
DR   Wikidata; Q116049233
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-43
AC   CVCL_C5J7
DR   ABCD; ABCD_AE252
DR   Wikidata; Q116049234
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-45
AC   CVCL_C5J8
DR   ABCD; ABCD_AE251
DR   Wikidata; Q116049235
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-50
AC   CVCL_C5J9
DR   Wikidata; Q116049236
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-52
AC   CVCL_C5JA
DR   Wikidata; Q116049237
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-543
AC   CVCL_C5JB
DR   Wikidata; Q116049238
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-545
AC   CVCL_C5JC
DR   Wikidata; Q116049239
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-55
AC   CVCL_C5JD
DR   Wikidata; Q116049240
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-59
AC   CVCL_5J89
SY   WC00021
DR   CLO; CLO_0012689
DR   BioSamples; SAME17809
DR   Coriell; WC00021
DR   Wikidata; Q54872100
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00021; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H37-60
AC   CVCL_C5JF
DR   ABCD; ABCD_AE250
DR   Wikidata; Q116049241
RX   PubMed=1908510;
RX   PubMed=1908881;
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-61
AC   CVCL_C5JG
DR   Wikidata; Q116049242
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-62
AC   CVCL_C5JH
DR   ABCD; ABCD_AE249
DR   Wikidata; Q116049243
RX   PubMed=1908510;
RX   PubMed=1908881;
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-63
AC   CVCL_5J90
SY   WC00027
DR   CLO; CLO_0012715
DR   BioSamples; SAME17813
DR   Coriell; WC00027
DR   Wikidata; Q54872101
RX   PubMed=3920342;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00027; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H37-64
AC   CVCL_C5JJ
DR   Wikidata; Q116049244
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-65
AC   CVCL_5J91
SY   WC00025
DR   CLO; CLO_0012700
DR   BioSamples; SAME17821
DR   Coriell; WC00025
DR   Wikidata; Q54872103
RX   PubMed=2398280;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00025; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H37-66
AC   CVCL_5J92
SY   WC00026
DR   CLO; CLO_0012698
DR   BioSamples; SAME17817
DR   Coriell; WC00026
DR   Wikidata; Q54872104
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgA.
CC   Discontinued: Coriell; WC00026; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   H37-67
AC   CVCL_C5JL
DR   Wikidata; Q116049245
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-68
AC   CVCL_C5JM
DR   Wikidata; Q116049246
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-69
AC   CVCL_C5JN
DR   Wikidata; Q116049247
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-70
AC   CVCL_C5JP
DR   Wikidata; Q116049248
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-72
AC   CVCL_C5JQ
DR   Wikidata; Q116049250
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-76
AC   CVCL_C5JR
DR   Wikidata; Q116049251
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-77
AC   CVCL_C5JS
DR   ABCD; ABCD_AE329
DR   Wikidata; Q116049253
RX   PubMed=3920342;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-78
AC   CVCL_C5JT
DR   Wikidata; Q116049254
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-79
AC   CVCL_C5JU
DR   Wikidata; Q116049255
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-80
AC   CVCL_5J93
SY   WC00032
DR   CLO; CLO_0012710
DR   ABCD; ABCD_AE248
DR   BioSamples; SAME17733
DR   Coriell; WC00032
DR   Wikidata; Q54872106
RX   PubMed=1908510;
RX   PubMed=1908881;
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00032; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   H37-82
AC   CVCL_5J94
SY   WC00033
DR   CLO; CLO_0012711
DR   ABCD; ABCD_AE261
DR   BioSamples; SAME17737
DR   Coriell; WC00033
DR   Wikidata; Q54872107
RX   PubMed=1908510;
RX   PubMed=1908881;
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00033; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H37-83
AC   CVCL_C5JX
DR   Wikidata; Q116049256
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-84
AC   CVCL_C5JY
DR   ABCD; ABCD_AE260
DR   Wikidata; Q116049258
RX   PubMed=2427335;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-85
AC   CVCL_C5JZ
DR   ABCD; ABCD_AE328
DR   Wikidata; Q116049259
RX   PubMed=3920342;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-86
AC   CVCL_C5K0
DR   Wikidata; Q116049260
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-87
AC   CVCL_C5K1
DR   Wikidata; Q116049261
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-88
AC   CVCL_5J95
SY   WC00023
DR   CLO; CLO_0012691
DR   BioSamples; SAME17801
DR   Coriell; WC00023
DR   Wikidata; Q54872108
RX   PubMed=2398280;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00023; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H37-89
AC   CVCL_C5K3
DR   Wikidata; Q116049262
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-90
AC   CVCL_C5JE
DR   Wikidata; Q116049263
RX   PubMed=1908510;
RX   PubMed=1908881;
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-91
AC   CVCL_C5JI
DR   Wikidata; Q116049264
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-92
AC   CVCL_C5JK
DR   Wikidata; Q116049265
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-93
AC   CVCL_C5JV
DR   Wikidata; Q116049266
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-94
AC   CVCL_C5JW
DR   Wikidata; Q116049267
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H37-96
AC   CVCL_C5K2
DR   Wikidata; Q116049268
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H3719
AC   CVCL_LG23
DR   Wikidata; Q54872109
RX   PubMed=1565644;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3723
AC   CVCL_D352
DR   Wikidata; Q54872110
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   H3730
AC   CVCL_LG01
DR   Wikidata; Q54872111
RX   PubMed=9186000;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3737
AC   CVCL_LG25
DR   Wikidata; Q54872113
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H376
AC   CVCL_2463
DR   cancercelllines; CVCL_2463
DR   CancerTools; 153423
DR   Cell_Model_Passport; SIDM01857
DR   Cosmic; 716677
DR   Cosmic; 916371
DR   Cosmic; 928238
DR   DepMap; ACH-001510
DR   ECACC; 06092005
DR   Wikidata; Q54872114
DR   Ximbio; 153423
RX   PubMed=1692339;
RX   PubMed=7633286;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Ter (c.796G>T); ClinVar=VCV000954591; Zygosity=Homozygous (PubMed=7633286; DepMap=ACH-001510).
CC   Discontinued: ECACC; 06092005; true.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DepMap=ACH-001510; ECACC=06092005
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 12,14
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 13,17
ST   FGA: 19,22
ST   Penta D: 12,14
ST   Penta E: 7,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   H3774
AC   CVCL_D353
DR   Wikidata; Q54872115
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   H3802
AC   CVCL_LG08
DR   Wikidata; Q54872122
RX   PubMed=8179825;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   H3914
AC   CVCL_LG02
DR   Wikidata; Q54872123
RX   PubMed=9186000;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   H3922
AC   CVCL_0283
DR   MCCL; MCC:0000174
DR   Wikidata; Q54872124
RX   PubMed=9186000;
RX   PubMed=11839257;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   H3L
AC   CVCL_6D70
DR   Wikidata; Q54872125
RX   PubMed=2414007;
RX   PubMed=3597519;
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   H3Mab-17
AC   CVCL_D2TB
DR   Wikidata; Q127380979
RX   PubMed=34184091;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   H4
AC   CVCL_1239
SY   H-4
DR   BTO; BTO_0003704
DR   CLO; CLO_0003599
DR   EFO; EFO_0002184
DR   CLDB; cl5193
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-148
DR   BCRJ; 0263
DR   BioGRID_ORCS_Cell_line; 430
DR   BioSample; SAMN03472722
DR   BioSample; SAMN10987915
DR   cancercelllines; CVCL_1239
DR   CCRID; 1101HUM-PUMC000372
DR   CCRID; 4201HUM-CCTCC00128
DR   CCTCC; GDC0128
DR   Cell_Model_Passport; SIDM00852
DR   ChEMBL-Cells; CHEMBL3308507
DR   ChEMBL-Targets; CHEMBL1075452
DR   CLS; 300184
DR   Cosmic; 687571
DR   Cosmic; 849856
DR   Cosmic; 907042
DR   Cosmic; 1610749
DR   Cosmic; 1746955
DR   Cosmic; 2060805
DR   Cosmic; 2302320
DR   Cosmic; 2367529
DR   Cosmic-CLP; 907042
DR   DepMap; ACH-000389
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS381KGR
DR   ENCODE; ENCBS836LDB
DR   ENCODE; ENCBS902ISQ
DR   GDSC; 907042
DR   GEO; GSM326236
DR   GEO; GSM887031
DR   GEO; GSM888101
DR   GEO; GSM1669834
DR   IARC_TP53; 21355
DR   IGRhCellID; H4
DR   IZSLER; BS TCL 102
DR   KCB; KCB 2012027YJ
DR   LiGeA; CCLE_383
DR   LINCS_LDP; LCL-1401
DR   Lonza; 285
DR   PharmacoDB; H4_437_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1239
DR   PubChem_Cell_line; CVCL_1239
DR   TOKU-E; 1367
DR   Wikidata; Q54872126
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=4544026;
RX   PubMed=6256643;
RX   PubMed=6500159;
RX   PubMed=10074188;
RX   PubMed=10560660;
RX   PubMed=11414198;
RX   PubMed=11508811;
RX   PubMed=19435942;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-293.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,30:02; B*08:01,18:01; C*05:01,07:01; DQB1*02:02,02:02; DRB1*03:01,03:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=10560660).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=907042; DepMap=ACH-000389).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.32%; East Asian, North=0.97%; East Asian, South=0%; South Asian=0%; European, North=68.05%; European, South=29.66% (PubMed=30894373).
CC   Miscellaneous: Originally classified as originating from a neuroglioma, an obsolete classification. This cell line has been reclassified as an astrocytoma.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=HTB-148; CCRID; CLS=300184; Cosmic-CLP=907042
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 30,31
ST   D2S1338: 18,25
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 9,12 (ATCC=HTB-148; CCRID)
ST   D8S1179: 14 (CLS=300184)
ST   FGA: 19,25
ST   Penta D: 10,12
ST   Penta E: 5,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   H4 [Hamster hybridoma against mouse Cfp]
AC   CVCL_D6UN
RX   PubMed=25723276;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P11680; Mouse Cfp.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   H4 [Mouse chondrocyte]
AC   CVCL_W634
DR   Wikidata; Q54872128
RX   PubMed=12464558;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Articular cartilage; UBERON=UBERON_0010996.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   H4 [Mouse hybridoma against human MHC class II]
AC   CVCL_D5Y6
DR   Wikidata; Q127380980
RX   PubMed=6765322;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human MHC class II (Ia) antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   H4 [Mouse hybridoma against human TERT]
AC   CVCL_C4YT
DR   Wikidata; Q116049269
RX   PubMed=11604111;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   H4-1 [Human bone marrow]
AC   CVCL_6F32
DR   Wikidata; Q54872129
RX   PubMed=15293342;
RX   PubMed=15923633;
CC   Population: Japanese and Korean.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   H4-1 [Human small intestinal epithelial]
AC   CVCL_6C20
DR   Wikidata; Q54872130
RX   PubMed=20444515;
RX   PubMed=24454965;
RX   PubMed=28239090;
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6C19 ! H-4
SX   Male
AG   20-22FW
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   H4-APP751
AC   CVCL_D601
DR   BTO; BTO_0005186
DR   Wikidata; Q54872131
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:620; APP.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1239 ! H4
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   H4-C99
AC   CVCL_U993
SY   H4-APP-C99
DR   BTO; BTO_0005095
DR   Wikidata; Q54872132
RX   PubMed=20143425;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:620; APP (Note=With p.Met1_Met671del = C99).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1239 ! H4
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   H4-II
AC   CVCL_4623
SY   H4II; H-35tc2; Reuber-H-35 hepatoma tissue culture 2; Reuber H-35 tc2; Reuber H35 tc2; H-35 Reuber tc2; H35 Reuber tc2; RH-35 tc2; RH35 tc2; H-35 tc2; H35 tc2
DR   CLO; CLO_0003602
DR   CLDB; cl1549
DR   CLS; 305210
DR   ECACC; 89042702
DR   Wikidata; Q54872157
RX   PubMed=115836;
RX   PubMed=194696;
CC   Characteristics: Directly derived from the Reuber hepatoma.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_X358 ! H4AzC2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   H4-II-E
AC   CVCL_0284
SY   H-4-II-E; H4IIE
DR   CLO; CLO_0003603
DR   EFO; EFO_0022768
DR   MCCL; MCC:0000173
DR   CLDB; cl1533
DR   CLDB; cl5191
DR   ATCC; CRL-1548
DR   BCRC; 60209
DR   CCRID; 1101RAT-PUMC000183
DR   CCRID; 4201RAT-CCTCC00104
DR   CCTCC; GDC0104
DR   CLS; 305204
DR   ECACC; 87031301
DR   IZSLER; BS TCL 136
DR   KCB; KCB 200819YJ
DR   KCLB; 21548
DR   Lonza; 273
DR   PRIDE; PXD011458
DR   TOKU-E; 3590
DR   Wikidata; Q54872133
RX   PubMed=115836;
RX   PubMed=194696;
RX   PubMed=14143233;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-295.html
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9185.
CC   Doubling time: 49.2 hours (PubMed=194696).
CC   Misspelling: H411-E; Note=Occasionally.
CC   Discontinued: CLS; 305204; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4623 ! H4-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   H4-II-E-C3
AC   CVCL_0285
SY   H4IIEC3; H4-IIE-C3; H4-II-EC3; H-II-E-C3
DR   BTO; BTO_0004428
DR   CLO; CLO_0003604
DR   MCCL; MCC:0000175
DR   CLDB; cl1544
DR   CLDB; cl1545
DR   CLDB; cl1546
DR   CLDB; cl5194
DR   ATCC; CRL-1600
DR   BCRC; 60211
DR   CCRID; 1101RAT-PUMC000184
DR   ChEMBL-Cells; CHEMBL3307707
DR   ChEMBL-Targets; CHEMBL614784
DR   ECACC; 85061112
DR   GEO; GSM1240502
DR   GEO; GSM1240503
DR   GEO; GSM1240504
DR   GEO; GSM1240505
DR   GEO; GSM1240506
DR   GEO; GSM1240507
DR   GEO; GSM1240508
DR   GEO; GSM1240509
DR   GEO; GSM1240510
DR   GEO; GSM1240511
DR   GEO; GSM1240512
DR   GEO; GSM1240513
DR   IZSLER; BS TCL 127
DR   KCB; KCB 92022YJ
DR   PubChem_Cell_line; CVCL_0285
DR   TOKU-E; 4024
DR   Wikidata; Q54872134
RX   PubMed=3431441;
RX   PubMed=4404256;
RX   PubMed=24386269;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-292.html
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: H4-I-E-C3; Note=Occasionally.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0284 ! H4-II-E
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   H4-M
AC   CVCL_HE79
AS   CVCL_M188
SY   H4M
DR   Wikidata; Q54872135
RX   CelloPub=CLPUB00254;
RX   PubMed=12072206;
RX   PubMed=12526216;
CC   Population: Chinese.
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: Metastatic; Portal vein; UBERON=UBERON_0002017.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   H4/18
AC   CVCL_L521
DR   Wikidata; Q54872136
RX   PubMed=2827173;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   H400
AC   CVCL_2464
DR   cancercelllines; CVCL_2464
DR   CancerTools; 153424
DR   Cosmic; 716678
DR   Cosmic; 916372
DR   Cosmic; 928239
DR   ECACC; 06092006
DR   Wikidata; Q54872137
DR   Ximbio; 153424
RX   PubMed=1692339;
RX   PubMed=7633286;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283Gly (c.847C>G); ClinVar=VCV000580186; Zygosity=Homozygous (PubMed=7633286).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ECACC; 06092006; true.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   H413
AC   CVCL_2465
DR   cancercelllines; CVCL_2465
DR   CancerTools; 153425
DR   Cell_Model_Passport; SIDM01811
DR   Cosmic; 716679
DR   Cosmic; 928240
DR   DepMap; ACH-001511
DR   ECACC; 06092007
DR   Wikidata; Q54872138
DR   Ximbio; 153425
RX   PubMed=1692339;
RX   PubMed=7633286;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu68Gly (c.203A>G); Zygosity=Heterozygous (PubMed=7633286).
CC   Discontinued: ECACC; 06092007; true.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): DepMap=ACH-001511; ECACC=06092007
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 18
ST   D21S11: 29,33.2
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 23,24
ST   Penta D: 13
ST   Penta E: 5,7
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   H414
AC   CVCL_1Q94
SY   H-414
DR   BTO; BTO_0006439
DR   cancercelllines; CVCL_1Q94
DR   RCB; RCB2997
DR   Wikidata; Q54872139
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   H414-LIG4(+/-)
AC   CVCL_1Q95
DR   cancercelllines; CVCL_1Q95
DR   RCB; RCB3002
DR   Wikidata; Q54872140
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6601; LIG4 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q94 ! H414
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   H414-MDC1(+/-)
AC   CVCL_1Q96
DR   cancercelllines; CVCL_1Q96
DR   RCB; RCB3000
DR   Wikidata; Q54872141
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:21163; MDC1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q94 ! H414
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   H414-MDC1(-/-)
AC   CVCL_1Q97
DR   cancercelllines; CVCL_1Q97
DR   RCB; RCB3001
DR   Wikidata; Q54872142
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:21163; MDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q94 ! H414
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   H414-RAD18(+/-)
AC   CVCL_1Q98
DR   cancercelllines; CVCL_1Q98
DR   RCB; RCB2998
DR   Wikidata; Q54872143
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:18278; RAD18 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q94 ! H414
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   H414-RAD18(-/-)
AC   CVCL_1Q99
DR   cancercelllines; CVCL_1Q99
DR   RCB; RCB2999
DR   Wikidata; Q54872144
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:18278; RAD18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q94 ! H414
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   H446/CDDP
AC   CVCL_RT21
SY   H446/DDP
DR   cancercelllines; CVCL_RT21
DR   Wikidata; Q54872145
RX   PubMed=16677475;
RX   PubMed=19360300;
RX   PubMed=26676926;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6728; LY6H + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-LY6H (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1562 ! NCI-H446
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   H446/EP
AC   CVCL_RT18
DR   cancercelllines; CVCL_RT18
DR   Wikidata; Q54872146
RX   PubMed=28599409;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6728; LY6H + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-LY6H (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1562 ! NCI-H446
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   H446/VP
AC   CVCL_C1MD
DR   cancercelllines; CVCL_C1MD
DR   Wikidata; Q114311556
RX   CelloPub=CLPUB00716;
RX   PubMed=21163134;
CC   Population: Caucasian.
CC   Doubling time: 35.7 hours (CelloPub=CLPUB00716).
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6728; LY6H + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-LY6H (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1562 ! NCI-H446
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   H454
AC   CVCL_F269
DR   CLO; CLO_0003600
DR   CLDB; cl1547
DR   Wikidata; Q54872147
RX   PubMed=8912708;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   H460-16-2
AC   CVCL_LC15
DR   Wikidata; Q54872148
RX   Patent=US7420039;
RX   Patent=US8071072;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4621.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   H460-22-1
AC   CVCL_LC16
DR   Wikidata; Q54872149
RX   Patent=US7420039;
RX   Patent=US7431923;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4622.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   H460-23
AC   CVCL_LC17
DR   Wikidata; Q54872150
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2700.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   H460-27
AC   CVCL_LC18
DR   Wikidata; Q54872151
RX   Patent=US7420039;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2699.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   H460/CIS
AC   CVCL_A9CH
DR   cancercelllines; CVCL_A9CH
DR   Wikidata; Q108820357
RX   PubMed=11551417;
CC   Population: Caucasian.
CC   Doubling time: 1.9 days (PubMed=11551417).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   H460/CisR
AC   CVCL_C5S1
DR   Wikidata; Q116049270
RX   PubMed=26498137;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   H460/TR
AC   CVCL_C5ST
DR   Wikidata; Q116049271
RX   PubMed=26498137;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   H460R
AC   CVCL_UW76
DR   cancercelllines; CVCL_UW76
DR   Wikidata; Q93936856
RX   PubMed=20510196;
RX   PubMed=24465237;
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line after 40 repetitive irradiation dose of 2 Gy each.
CC   Selected for resistance to: NCIt; C44386; Gamma radiation.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   H48N
AC   CVCL_D554
SY   H-48N
DR   cancercelllines; CVCL_D554
DR   Cosmic; 918058
DR   Wikidata; Q54872153
RX   PubMed=21607521;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=21607521).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   H49a
AC   CVCL_L841
DR   ECACC; 93031703
DR   Wikidata; Q54872154
RX   PubMed=8459104;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Gray seal IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   H4A3
AC   CVCL_B7B9
AS   CVCL_B7BD
DR   DSHB; H4A3
DR   Wikidata; Q111733249
RX   PubMed=1984792;
RX   PubMed=2912382;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11279; Human LAMP1/CD107a (Note=Also reacts with rat and hamster).
CC   Misspelling: H4H3; PubMed=1984792.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   H4AzC2
AC   CVCL_X358
DR   Wikidata; Q54872155
RX   PubMed=28957;
RX   PubMed=203590;
RX   PubMed=9745712;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4623 ! H4-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 11
//
ID   H4B4
AC   CVCL_B7BA
DR   DSHB; H4B4
DR   Wikidata; Q111733250
RX   PubMed=2912382;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13473; Human LAMP2/CD107b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   H4C20
AC   CVCL_A9R9
SY   HCV H4C20
DR   ATCC; HB-10593
DR   Wikidata; Q102114084
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10593.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1569-1930 = Non-structural protein 4A/4B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   H4C4
AC   CVCL_B7BB
DR   DSHB; H4C4
DR   Wikidata; Q111733251
RX   PubMed=1689752;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   H4F8
AC   CVCL_B7BC
DR   Wikidata; Q111733252
RX   PubMed=1984792;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   H4G1.1c2
AC   CVCL_DC26
DR   Wikidata; Q54872156
RX   PubMed=21394221;
CC   Biotechnology: Cell line developed for CAFLUX (Chemically Activated FLUorescence eXpression) bioassay. CAFLUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a EGFP gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0284 ! H4-II-E
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 11
//
ID   H4L1.1c4
AC   CVCL_DC27
SY   H4IIE.Luc
DR   Wikidata; Q54872158
RX   Patent=US5854010;
RX   PubMed=8812260;
RX   PubMed=8812265;
RX   PubMed=18969542;
RX   PubMed=21394221;
RX   PubMed=26366531;
WW   Provider; XDSI; -; http://www.dioxins.com/products/
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0284 ! H4-II-E
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 11
//
ID   H4L7.5c2
AC   CVCL_DC28
DR   Wikidata; Q54872159
RX   PubMed=26366531;
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0284 ! H4-II-E
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 12
//
ID   H4S
AC   CVCL_4211
DR   CLO; CLO_0003605
DR   CLDB; cl1550
DR   ECACC; 89102001
DR   Wikidata; Q54872161
RX   PubMed=6257395;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0285 ! H4-II-E-C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 10
//
ID   H4TG
AC   CVCL_3512
DR   BTO; BTO_0005193
DR   CLO; CLO_0003606
DR   CLDB; cl5195
DR   ATCC; CRL-1578
DR   IZSLER; BS TCL 155
DR   Wikidata; Q54872162
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0285 ! H4-II-E-C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   H5
AC   CVCL_4212
DR   CLO; CLO_0003607
DR   CLDB; cl1551
DR   ECACC; 94101905
DR   Wikidata; Q54872163
RX   PubMed=6932027;
CC   Doubling time: 16 hours (PubMed=6932027); 12 hours (ECACC=94101905).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0285 ! H4-II-E-C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   H5-GFP
AC   CVCL_B6BW
DR   Wikidata; Q111733255
RX   PubMed=28365799;
CC   Group: Insect cell line.
CC   Characteristics: Expresses GFP at the cell surface. Transfected with a vector containing a fused AcMNPV gp64-GFP construct (PubMed=28365799).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17501; Autographa californica nuclear polyhedrosis virus (AcMNPV) GP64.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   h5.1.1
AC   CVCL_KB85
SY   IL5.1
DR   Wikidata; Q54872169
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12637.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.1.2
AC   CVCL_KB86
SY   IL5.2
DR   Wikidata; Q54872170
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12627.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.1.3
AC   CVCL_KB87
SY   IL5.3
DR   Wikidata; Q54872171
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12640.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.2.1
AC   CVCL_KB88
SY   IL5.4
DR   Wikidata; Q54872172
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12626.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.2.2
AC   CVCL_KB89
SY   IL5.5
DR   Wikidata; Q54872173
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12634.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.2.3
AC   CVCL_KB90
SY   IL5.6
DR   Wikidata; Q54872174
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12636.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.2.4
AC   CVCL_KB91
SY   IL5.7
DR   Wikidata; Q54872175
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12638.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.3.1
AC   CVCL_KB92
SY   IL5.8
DR   Wikidata; Q54872176
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12633.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.3.2
AC   CVCL_KB93
SY   IL5.9
DR   Wikidata; Q54872178
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12628.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.4
AC   CVCL_KB94
SY   IL5.10
DR   Wikidata; Q54872179
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12630.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   H5.46
AC   CVCL_U874
SY   546
DR   ATCC; CRL-2546
DR   Wikidata; Q54872180
RX   DOI=10.1007/978-3-7091-9091-3_17;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P06935; West Nile virus envelope protein E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   h5.5
AC   CVCL_KB95
SY   IL5.11
DR   Wikidata; Q54872181
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12635.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.6
AC   CVCL_KB96
SY   IL5.12
DR   Wikidata; Q54872182
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12639.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.7.1
AC   CVCL_KB97
SY   IL5.13
DR   Wikidata; Q54872183
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12631.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.7.2
AC   CVCL_KB98
SY   IL5.14
DR   Wikidata; Q54872184
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12629.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   h5.7.3
AC   CVCL_KB99
SY   IL5.15
DR   Wikidata; Q54872185
RX   Patent=US6395274;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12632.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05113; Human IL5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   H52
AC   CVCL_B7BE
DR   DSHB; H52
DR   Wikidata; Q111733256
RX   PubMed=2580022;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   H534C
AC   CVCL_WG78
DR   Cosmic; 1518152
DR   Wikidata; Q93937039
RX   PubMed=16941478;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   H542C
AC   CVCL_WG79
DR   Cosmic; 1518153
DR   Wikidata; Q93937043
RX   PubMed=16941478;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   H566C
AC   CVCL_WG80
DR   Cosmic; 1518154
DR   Wikidata; Q93937046
RX   PubMed=16941478;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   H57
AC   CVCL_D667
DR   BCRJ; 0097
DR   Wikidata; Q54872186
CC   Doubling time: ~24-30 hours (BCRJ=0097).
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 6
//
ID   H57-597
AC   CVCL_8959
DR   CLO; CLO_0003608
DR   ABCD; ABCD_AF579
DR   ATCC; HB-218
DR   Wikidata; Q54872187
RX   PubMed=2467936;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR).
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 6
//
ID   H572
AC   CVCL_KB77
DR   ATCC; HB-11608
DR   Wikidata; Q54872188
RX   Patent=US5536641;
RX   PubMed=7933987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11608.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H8L6; Human MMRN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   H58
AC   CVCL_YP34
DR   cancercelllines; CVCL_YP34
DR   Wikidata; Q93937071
RX   PubMed=32005909;
CC   Doubling time: 36 hours (PubMed=32005909).
CC   Sequence variation: Gene fusion; HGNC; HGNC:22170; BCAR4 + HGNC; HGNC:30959; ZC3H7A; Name(s)=ZC3H7A-BCAR4 (PubMed=32005909).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1175Ter (c.3523C>T); ClinVar=VCV000537459; Zygosity=Unspecified (PubMed=32005909).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (PubMed=32005909).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=32005909).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=32005909
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D21S11: 28,30
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C95506; Pancreatic intraductal tubulopapillary neoplasm
DI   ORDO; Orphanet_580572; Intraductal tubulopapillary neoplasm of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   H583-5
AC   CVCL_H784
DR   Wikidata; Q54872189
RX   PubMed=1316607;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   H5A4
AC   CVCL_B7BF
DR   DSHB; H5A4
DR   Wikidata; Q111733257
RX   PubMed=2580022;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   H5B9
AC   CVCL_B7BI
DR   Wikidata; Q111733258
RX   PubMed=2580022;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   H5C6
AC   CVCL_B7BG
DR   DSHB; H5C6
DR   Wikidata; Q111733259
RX   PubMed=1984792;
RX   PubMed=34634047;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   H5CL-B
AC   CVCL_Z094
SY   Tn-H5CL-B; High 5 clone B
DR   ICLDB; h5cl-b
DR   Wikidata; Q54872190
RX   Patent=US7179648;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5635.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   H5CL-F
AC   CVCL_Z095
SY   Tn-H5CL-F; High 5 clone F
DR   ICLDB; h5cl-f
DR   Wikidata; Q54872191
RX   Patent=US7179648;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5636.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   H5D
AC   CVCL_6734
SY   THC-H5D
DR   BTO; BTO_0004337
DR   Wikidata; Q54972294
RX   PubMed=2193646;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   H5D.61
AC   CVCL_X359
DR   Wikidata; Q54872192
RX   PubMed=2193646;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6734 ! H5D
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 9
//
ID   H5D.7
AC   CVCL_X360
SY   H5D-7
DR   Wikidata; Q54872194
RX   CelloPub=CLPUB00147;
RX   PubMed=2193646;
RX   PubMed=9745712;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6734 ! H5D
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   H5D2
AC   CVCL_B7BH
DR   Wikidata; Q111733260
RX   PubMed=1984792;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   H5G11
AC   CVCL_B7BJ
DR   Wikidata; Q111733261
RX   PubMed=2912382;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11279; Human LAMP1/CD107a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   H5V
AC   CVCL_AZ87
DR   Wikidata; Q54872195
RX   PubMed=8041783;
RX   PubMed=9301641;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   15FD
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   H6
AC   CVCL_1N70
DR   Wikidata; Q54872196
RX   PubMed=2791350;
RX   PubMed=6891836;
CC   Breed/subspecies: CBA.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   H6-1.12F10
AC   CVCL_B0HB
SY   H6-1.12F10-2E11
DR   Wikidata; Q108820358
RX   Patent=US6372215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-1.15D7
AC   CVCL_B0HC
SY   H6-1.15D7-1B11
DR   Wikidata; Q108820359
RX   Patent=US6372215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-1.5E1
AC   CVCL_B0HD
SY   H6-1.5E1-2A9
DR   Wikidata; Q108820360
RX   Patent=US6372215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-1.7H6
AC   CVCL_B0HE
SY   H6-1.7H6-2A11; 7H6
DR   ATCC; HB-12292
DR   Wikidata; Q108820361
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12292.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.10A5
AC   CVCL_B0HF
SY   H6-2.10A5-1D2; 10A5
DR   ATCC; HB-12289
DR   Wikidata; Q108820362
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12289.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.10D1
AC   CVCL_B0HG
SY   H6-2.10D1-1H10; 10D1
DR   ATCC; HB-12290
DR   Wikidata; Q108820363
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12290.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.12A5
AC   CVCL_B0HH
SY   H6-2.12A5-1C6; 12A5
DR   Wikidata; Q108820364
RX   Patent=US6372215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.13C3
AC   CVCL_B0HI
SY   H6-2.13C3-1A11; 13C3
DR   Wikidata; Q108820365
RX   Patent=US6372215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.14H2
AC   CVCL_B0HJ
SY   H6-2.14H2-1F3
DR   ATCC; HB-12294
DR   Wikidata; Q108820366
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12294.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.15B12
AC   CVCL_B0HK
SY   H6-2.15B12-2F8; 15B12
DR   ATCC; HB-12293
DR   Wikidata; Q108820367
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12293.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.16A3
AC   CVCL_B0HL
SY   H6-2.16A3-1D1; 16A3
DR   ATCC; HB-12296
DR   Wikidata; Q108820368
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12296.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.5D4
AC   CVCL_B0HM
SY   H6-2.5D4-2D11; 5D4
DR   ATCC; HB-12291
DR   Wikidata; Q108820369
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12291.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.5E8
AC   CVCL_B0HN
SY   H6-2.5E8-2D1; 5E8
DR   ATCC; HB-12295
DR   Wikidata; Q108820370
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12295.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.5F7
AC   CVCL_B0HP
SY   H6-2.5F7-2E5
DR   Wikidata; Q108820371
RX   Patent=US6372215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.7C7
AC   CVCL_B0HQ
SY   H6-2.7C7-1E2; 7C7
DR   ATCC; HB-12288
DR   Wikidata; Q108820372
RX   Patent=US6372215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12288.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-2.8A7
AC   CVCL_B0HR
SY   H6-2.8A7-2C7; 8A7
DR   Wikidata; Q108820373
RX   Patent=US6372215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   H6-3C4
AC   CVCL_QZ05
DR   TKG; TKG 0728
DR   Wikidata; Q54872197
RX   PubMed=3295232;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human carbohydrate moiety of male reproductive tract CD52.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   H6/31HL
AC   CVCL_L842
DR   ECACC; 85102214
DR   Wikidata; Q54872198
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   H61-15
AC   CVCL_C5LH
DR   ABCD; ABCD_AE216
DR   Wikidata; Q116049272
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H667
AC   CVCL_F0WH
RX   PubMed=1845828;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Epstein-Barr virus (strain B95-8) early membrane antigen Gp43.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   H69/BCNU
AC   CVCL_0B21
DR   cancercelllines; CVCL_0B21
DR   Wikidata; Q54872200
RX   PubMed=9062409;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_3423; Carmustine (BCNU).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   H69/DAU
AC   CVCL_0B22
SY   NCI-H69-DAU
DR   cancercelllines; CVCL_0B22
DR   Wikidata; Q54872201
RX   PubMed=9062409;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   H69/Txl
AC   CVCL_X029
DR   cancercelllines; CVCL_X029
DR   Wikidata; Q54872202
RX   PubMed=7514586;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 17
//
ID   H69/VDS
AC   CVCL_AZ78
DR   cancercelllines; CVCL_AZ78
DR   Wikidata; Q38568625
RX   PubMed=8391305;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_36373; Vindesine.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   H69/VP
AC   CVCL_0B23
DR   cancercelllines; CVCL_0B23
DR   Wikidata; Q54872203
RX   PubMed=8784480;
RX   PubMed=9062409;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   H69PR
AC   CVCL_4T78
DR   ATCC; CRL-11350
DR   cancercelllines; CVCL_4T78
DR   Wikidata; Q54872206
RX   Patent=US5489519;
RX   PubMed=1314068;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11350.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3513 ! NCI-H69AR
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   H69R
AC   CVCL_RS65
DR   cancercelllines; CVCL_RS65
DR   Wikidata; Q54872207
RX   PubMed=27610620;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   H69V
AC   CVCL_2466
AS   CVCL_S829
SY   H69v; MOG-H69V
DR   CLO; CLO_0003611
DR   CLDB; cl1554
DR   cancercelllines; CVCL_2466
DR   ECACC; 91091803
DR   GEO; GSM827449
DR   LINCS_LDP; LCL-1875
DR   Progenetix; CVCL_2466
DR   Wikidata; Q54872208
RX   PubMed=1662924;
RX   PubMed=8712684;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Doubling time: 34.0 hours (PubMed=1662924).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=91091803
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   H69VZ
AC   CVCL_S830
SY   MOG-H69VZ
DR   cancercelllines; CVCL_S830
DR   Wikidata; Q54872209
RX   PubMed=1662924;
RX   PubMed=8712684;
CC   Population: Caucasian.
CC   Doubling time: 34.5 hours (PubMed=1662924).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   H7.s14
AC   CVCL_S798
SY   H7 s14
DR   IGRhCellID; H7%20s14%20p38
DR   IGRhCellID; H7s14%20p30
DR   IGRhCellID; H7s14%20p38
DR   Wikidata; Q54872210
RX   PubMed=19415777;
RX   PubMed=27829140;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   H7.s14-Tomato
AC   CVCL_A5KY
DR   Wikidata; Q107115220
RX   PubMed=27829140;
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S798 ! H7.s14
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   H7.s6
AC   CVCL_S799
SY   H7 s6
DR   IGRhCellID; H7%20s6%20p128
DR   IGRhCellID; H7%20s6%20p132-2
DR   IGRhCellID; H7%20s6%20p230
DR   IGRhCellID; H7%20s6%20p237-2
DR   IGRhCellID; H7%20s6%20teratoma%20p125
DR   IGRhCellID; H7%20s6%20teratoma%20p127
DR   Wikidata; Q54872211
RX   PubMed=19415777;
RX   PubMed=27829140;
CC   Karyotypic information: 47,XX,+del(1)(p22p22),der(6)t(6;17)(q27;q1) (PubMed=27829140).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   H7.s6-GFP
AC   CVCL_A5KW
SY   H7v1,12,17q,20q-GFP
DR   Wikidata; Q107115221
RX   PubMed=27829140;
CC   Characteristics: Aneuploid WA07 subline with gain of chromosome 1 that has an interstitial deletion at 1p22, gain of chromosome 17q, trisomy chromosome 12 and gain of copy number variant 20q11.21 (PubMed=27829140).
CC   Karyotypic information: 48,XX,+del(1)(p22;p22),der(6)t(6;17)(q27;q1),+12,ish dup(q11.21;q11.21) (PubMed=27829140).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S799 ! H7.s6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   H7.s9
AC   CVCL_S800
SY   H7 s9
DR   Wikidata; Q54872218
RX   PubMed=19415777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   H7-9
AC   CVCL_D2QW
DR   Wikidata; Q127380981
RX   PubMed=29571514;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   H7-FOXA2-GFP
AC   CVCL_E9DF
SY   H7.FOXA2-GFP
RX   DOI=10.1101/2021.07.18.452860;
CC   Registration: Swiss research registry; BAG-hES-IMP-0080.
CC   Characteristics: Using TALEN eGFP was inserted at the C-terminal end of FOXA2 (DOI=10.1101/2021.07.18.452860).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H7-H2B-RFP
AC   CVCL_A5NJ
DR   Wikidata; Q107115222
RX   PubMed=34407428;
CC   Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4761; H2BC11.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   H7-YAP1
AC   CVCL_A5LL
SY   H7-YAP
DR   Wikidata; Q107115223
RX   PubMed=34407428;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   H72
AC   CVCL_XX75
DR   ABCD; ABCD_AJ513
DR   Wikidata; Q93937256
RX   DOI=10.24450/journals/abrep.2019.e44;
RX   PubMed=11831389;
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Dictyostelium discoideum 25 kDa antigen at plasma membrane and endosomal compartments.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   H73C11
AC   CVCL_JK06
SY   H7NS
DR   Wikidata; Q54872219
RX   PubMed=1651789;
RX   PubMed=7492749;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
HI   CVCL_JK05 ! GLI-H7
CA   Hybrid cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 3
//
ID   H7D7A
AC   CVCL_1T06
SY   H7D7-A
DR   BioSample; SAMN03151769
DR   cancercelllines; CVCL_1T06
DR   Wikidata; Q54872220
RX   PubMed=12619888;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00203.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=12619888
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   H7D7B
AC   CVCL_1T07
SY   H7D7-B
DR   BioSample; SAMN03151770
DR   cancercelllines; CVCL_1T07
DR   Wikidata; Q54872221
RX   PubMed=12619888;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00204.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=12619888
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   H7D7BD5
AC   CVCL_1T10
SY   H7D7-BD5; BD5; HepG2-BD5
DR   cancercelllines; CVCL_1T10
DR   Wikidata; Q54872222
RX   PubMed=12619888;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (H7D7B) has been shown to be a Hep-G2 derivative (PubMed=12619888).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00560.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1T07 ! H7D7B
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   H7D7C
AC   CVCL_1T08
SY   H7D7-C
DR   BioSample; SAMN03151771
DR   cancercelllines; CVCL_1T08
DR   Wikidata; Q54872223
RX   PubMed=12619888;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00205.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=12619888
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   H7D7D
AC   CVCL_1T09
SY   H7D7-D
DR   BioSample; SAMN03151772
DR   cancercelllines; CVCL_1T09
DR   Wikidata; Q54872224
RX   PubMed=12619888;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00206.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=12619888
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   H7v1,17q,i20
AC   CVCL_A5LK
SY   H7 v1,17q,i20
DR   Wikidata; Q107115224
RX   PubMed=34407428;
CC   Characteristics: Aneuploid WA07 subline with gain of chromosome 1 that has an interstitial deletion at 1p22, gain of chromosome 17q and isochromosome of the long (q) arm of chromosome 20 (PubMed=34407428).
CC   Karyotypic information: 47,XX,+del(1)(p22p22),der(6)t(6;17)(q27;q1),t(12;20)(q13;q11.2),i(2)(q10)ish dup(20)(q11.21;q11.21) (PubMed=34407428).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   H7v1q
AC   CVCL_A5KR
SY   H7 v1q
DR   Wikidata; Q107115225
RX   PubMed=34407428;
CC   Characteristics: Aneuploid WA07 subline with gain of chromosome 1q (PubMed=34407428).
CC   Karyotypic information: 46,XX,dup(1)(q21;q42) (PubMed=34407428).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   H7v17q
AC   CVCL_A5KS
DR   Wikidata; Q107115226
CC   Characteristics: Aneuploid WA07 subline with gain of chromosome 17q.
CC   Karyotypic information: 46,XX,der(6)t(6;17)(q27;q1) (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Price, Christopher John.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   H7v20q
AC   CVCL_A5KT
SY   H7 v20q
DR   Wikidata; Q107115227
RX   PubMed=34407428;
CC   Characteristics: Aneuploid WA07 subline with gain of a copy number variant 20q11.21 (PubMed=34407428).
CC   Karyotypic information: 46,XX,ish dup(20)(q11.21;q11.21) (PubMed=34407428).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   H8-2D1
AC   CVCL_C5LI
DR   Wikidata; Q116049273
RX   PubMed=6600489;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   H80HrPE-6
AC   CVCL_VC45
DR   Wikidata; Q54872225
RX   PubMed=11669377;
RX   PubMed=25177495;
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   H81-208.22.6
AC   CVCL_L843
DR   ECACC; 85062136
DR   Wikidata; Q54872226
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   H81C17
AC   CVCL_A9R6
SY   HCV H81C17
DR   ATCC; HB-10588
DR   Wikidata; Q102114085
RX   Patent=US5753430;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10588.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26664; Hepatitis C virus genotype 1a (isolate 1) genome polyprotein (Note=AA 1-150 = Core protein p21).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   H82R
AC   CVCL_RS66
DR   cancercelllines; CVCL_RS66
DR   Wikidata; Q54872227
RX   PubMed=27610620;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>T); ClinVar=VCV000237948; Zygosity=Unspecified; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1591 ! NCI-H82
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   H83-82.6.1
AC   CVCL_M105
DR   ECACC; 85062102
DR   Wikidata; Q54872229
CC   Discontinued: ECACC; 85062102; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 5
//
ID   H9
AC   CVCL_1240
SY   HT clone H9; HT(H9); H 9; H-9
DR   BTO; BTO_0001944
DR   CLO; CLO_0003581
DR   CLO; CLO_0003612
DR   EFO; EFO_0003045
DR   CLDB; cl1556
DR   CLDB; cl1557
DR   CLDB; cl7167
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-176
DR   BEI_Resources; ARP-87
DR   BioSample; SAMN03472731
DR   cancercelllines; CVCL_1240
DR   CCRID; 4201MOU-CCTCC00031
DR   CCTCC; GDC0031
DR   Cell_Model_Passport; SIDM01251
DR   ChEMBL-Cells; CHEMBL3308402
DR   ChEMBL-Targets; CHEMBL614806
DR   CLS; 300460
DR   Cosmic; 687842
DR   Cosmic; 907043
DR   Cosmic; 933542
DR   Cosmic; 2301568
DR   Cosmic; 2668295
DR   Cosmic-CLP; 907043
DR   DepMap; ACH-002240
DR   ECACC; 85050301
DR   EGA; EGAS00001000978
DR   GDSC; 907043
DR   GEO; GSM1669836
DR   IARC_TP53; 21356
DR   ICLC; HTL05006
DR   IZSLER; BS TCL 19
DR   KCB; KCB 200418YJ
DR   KCLB; 30176
DR   LINCS_LDP; LCL-1144
DR   Lonza; 910
DR   PharmacoDB; H9_439_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1240
DR   TOKU-E; 3613
DR   Wikidata; Q54872230
RX   PubMed=1460674;
RX   PubMed=2193399;
RX   PubMed=2567177;
RX   PubMed=6151082;
RX   PubMed=7707540;
RX   PubMed=8127147;
RX   PubMed=8320746;
RX   PubMed=8641406;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; -; -; https://www.bmj.com/rapid-response/2011/10/30/cell-lines-hut102-and-hut78
WW   Provider; NIBSC; 0001; http://www.nibsc.org/Default.aspx?pageid=597&id=0001&theme=default
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: Permissive for HIV-1 replication. Is accordingly used to isolate and propagate HIV-1 from the blood of patients with AIDS.
CC   HLA typing: DRB1*04:01 (PubMed=7707540).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=907043; DepMap=ACH-002240).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (Cosmic-CLP=907043; DepMap=ACH-002240).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.91%; Native American=1.41%; East Asian, North=5.59%; East Asian, South=0%; South Asian=0%; European, North=61.37%; European, South=26.72% (PubMed=30894373).
CC   Anecdotal: For a number of years it was not known that H9 used by Gallo's lab to isolate HIV-1 (HTLV-III) was in fact a clone of Hut 78 from Minna's lab (PubMed=2567177). This created a controversy between the labs of Minna and Gallo (PubMed=2193399).
CC   Discontinued: IZSLER; BS TCL 19; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=HTB-176; CLS=300460; Cosmic-CLP=907043; ECACC=85050301; KCLB=30176
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 18,23
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 18
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 13,15
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   H9 [Mouse hybridoma against D.discoideum 23 kda antigen]
AC   CVCL_A9H5
DR   ABCD; ABCD_AN700
DR   Wikidata; Q102114086
RX   PubMed=32276653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Dictyostelium discoideum 23 kDa antigen at plasma membrane and intracellular compartments.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2
AC   CVCL_C4EK
DR   Wikidata; Q116049274
RX   PubMed=34699746;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (PubMed=34699746).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   H9 AAVS1-TRE3G-NGN2 3xFLAG-EEA1
AC   CVCL_D1KV
SY   H9 ES AAVS1-NGN2 3xFLAG-EEA1
DR   Wikidata; Q127380982
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 EAA1 was N-terminally tagged on both alleles with a 3xFLAG tag (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 3xFLAG-EEA1 TMEM230-/-
AC   CVCL_E2VV
SY   H9 ES AAVS1-NGN2 Flag-EEA1 TMEM230-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 EAA1 was N-terminally tagged on both alleles with a 3xFLAG tag (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15876; TMEM230.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KV ! H9 AAVS1-TRE3G-NGN2 3xFLAG-EEA1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9 AAVS1-TRE3G-NGN2 Flag-EEA1 TMEM230 X121W
AC   CVCL_E2VW
SY   H9 ES AAVS1-NGN2 Flag-EEA1 TMEM230X121W
CC   Characteristics: The X121W mutation introduced into TMEM230 leads to a C-terminal extension with the sequence WHPPHS (Direct_author_submission).
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 EAA1 was N-terminally tagged on both alleles with a 3xFLAG tag (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15876; TMEM230; Simple_edited; p.Ter121Trpext*6 (c.362A>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KV ! H9 AAVS1-TRE3G-NGN2 3xFLAG-EEA1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9 AAVS1-TRE3G-NGN2 Flag-EEA1 TMEM9-/-
AC   CVCL_E2VX
SY   H9 ES AAVS1-NGN2 Flag-EEA1 TMEM9-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 EAA1 was N-terminally tagged on both alleles with a 3xFLAG tag (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18823; TMEM9.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KV ! H9 AAVS1-TRE3G-NGN2 3xFLAG-EEA1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9 AAVS1-TRE3G-NGN2 Flag-EEA1 TMEM9-/-; TMEM9B-/-
AC   CVCL_E2VY
SY   H9 ES AAVS1-NGN2 Flag-EEA1 TMEM9-/-;TMEM9B-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 EAA1 was N-terminally tagged on both alleles with a 3xFLAG tag (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18823; TMEM9.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1168; TMEM9B.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2VX ! H9 AAVS1-TRE3G-NGN2 Flag-EEA1 TMEM9-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9 AAVS1-TRE3G-NGN2 ATG12-/-
AC   CVCL_C4EL
SY   H9 TRE3G-NGN2 ATG12-/-
DR   Wikidata; Q116049275
RX   PubMed=34699746;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:588; ATG12.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   H9 AAVS1-TRE3G-NGN2 CCPG1-/-
AC   CVCL_D1IJ
SY   H9 ES AAVS1-NGN2 CCPG1-/-
DR   Wikidata; Q127380983
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24227; CCPG1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 CCPG1-/- Keima-RAMP4
AC   CVCL_D1IK
SY   H9 ES AAVS1-NGN2 CCPG1-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127380984
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24227; CCPG1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IJ ! H9 AAVS1-TRE3G-NGN2 CCPG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 CCPG1-/- Keima-REEP5
AC   CVCL_D1IL
SY   H9 ES AAVS1-NGN2 CCPG1-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127380985
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24227; CCPG1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IJ ! H9 AAVS1-TRE3G-NGN2 CCPG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 FBXO7-/-
AC   CVCL_C4EN
DR   Wikidata; Q116049276
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13586; FBXO7.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Paoli, Julia C.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   H9 AAVS1-TRE3G-NGN2 GRN-/-
AC   CVCL_D1IH
SY   H9 ES AAVS1-NGN2 GRN-/-
DR   Wikidata; Q127380986
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 OPTN-/-
AC   CVCL_E2VU
SY   H9 ES AAVS1-NGN2 OPTN-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17142; OPTN.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9 AAVS1-TRE3G-NGN2 PINK1-/-
AC   CVCL_C4EM
DR   Wikidata; Q116049277
RX   PubMed=34699746;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG1-/-
AC   CVCL_D1IF
SY   H9 ES AAVS1-NGN2 FAM134B-/-
DR   Wikidata; Q127380987
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG1-/- Keima-RAMP4
AC   CVCL_D1IM
SY   H9 ES AAVS1-NGN2 FAM134B-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127380988
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IF ! H9 AAVS1-TRE3G-NGN2 RETREG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG1-/- Keima-REEP5
AC   CVCL_D1IN
SY   H9 ES AAVS1-NGN2 FAM134B-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127380989
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IF ! H9 AAVS1-TRE3G-NGN2 RETREG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG2-/-
AC   CVCL_D1IG
SY   H9 ES AAVS1-NGN2 FAM134A-/-
DR   Wikidata; Q127380990
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG2-/- Keima-RAMP4
AC   CVCL_D1J1
SY   H9 ES AAVS1-NGN2 FAM134A-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127380992
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IG ! H9 AAVS1-TRE3G-NGN2 RETREG2-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG2-/- Keima-REEP5
AC   CVCL_D1J2
SY   H9 ES AAVS1-NGN2 FAM134A-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127380993
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IG ! H9 AAVS1-TRE3G-NGN2 RETREG2-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/-
AC   CVCL_D1IA
SY   H9 ES AAVS1-NGN2 FAM134C-/-
DR   Wikidata; Q127380994
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- Keima-RAMP4
AC   CVCL_D1IP
SY   H9 ES AAVS1-NGN2 FAM134C-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127380995
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IA ! H9 AAVS1-TRE3G-NGN2 RETREG3-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- Keima-REEP5
AC   CVCL_D1IQ
SY   H9 ES AAVS1-NGN2 FAM134C-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127380996
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IA ! H9 AAVS1-TRE3G-NGN2 RETREG3-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/-
AC   CVCL_D1IB
SY   H9 ES AAVS1-NGN2 FAM134C/A-/-
DR   Wikidata; Q127380997
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IA ! H9 AAVS1-TRE3G-NGN2 RETREG3-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- Keima-RAMP4
AC   CVCL_D1IR
SY   H9 ES AAVS1-NGN2 FAM134C/A-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127380998
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IB ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- Keima-REEP5
AC   CVCL_D1IS
SY   H9 ES AAVS1-NGN2 FAM134C/A-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127380999
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IB ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/-
AC   CVCL_D1IC
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-
DR   Wikidata; Q127381000
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IB ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- Keima-RAMP4
AC   CVCL_D1IT
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127381001
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IC ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- Keima-REEP5
AC   CVCL_D1IU
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127381002
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IC ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/-
AC   CVCL_D1ID
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-;TEX264-/-; H9 FAM134A/B/C/TEX264-/-
DR   Wikidata; Q127381003
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IC ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/- Keima-RAMP4
AC   CVCL_D1IV
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-;TEX264-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127381004
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1ID ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/- Keima-REEP5
AC   CVCL_D1IW
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-;TEX264-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127381005
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1ID ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/- CCPG1-/-
AC   CVCL_D1IE
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-;TEX264-/-; CCPG1-/-; H9 FAM134A/B/C/TEX264/CCPG1-/-
DR   Wikidata; Q127381006
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24227; CCPG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1ID ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/- CCPG1-/- Keima-RAMP4
AC   CVCL_D1IX
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-;TEX264-/-; CCPG1-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127381007
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24227; CCPG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IE ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/- CCPG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/- CCPG1-/- Keima-REEP5
AC   CVCL_D1IY
SY   H9 ES AAVS1-NGN2 FAM134C/A/B-/-;TEX264-/-; CCPG1-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127381008
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24227; CCPG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28450; RETREG2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27258; RETREG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1IE ! H9 AAVS1-TRE3G-NGN2 RETREG3-/- RETREG2-/- RETREG1-/- TEX264-/- CCPG1-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 TEX264-/-
AC   CVCL_D1II
SY   H9 ES AAVS1-NGN2 TEX264-/-
DR   Wikidata; Q127381009
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 TEX264-/- Keima-RAMP4
AC   CVCL_D1IZ
SY   H9 ES AAVS1-NGN2 TEX264-/-; PiggyBac-Keima-RAMP4
DR   Wikidata; Q127381010
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-RAMP4/SERP1 that localizes to endoplasmic reticulum (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10759; SERP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1II ! H9 AAVS1-TRE3G-NGN2 TEX264-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 TEX264-/- Keima-REEP5
AC   CVCL_D1J0
SY   H9 ES AAVS1-NGN2 TEX264-/-; PiggyBac-Keima-REEP5
DR   Wikidata; Q127381011
RX   PubMed=38429475;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Transposed with a PiggyBac transposon vector pAC150-PBLHL-4xHS-EF1a-Keima-REEP5 that localizes specifically to endoplasmic reticulum tubules (PubMed=38429475).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30247; TEX264.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; SXBT1; mKeima (Note=Long stokes shift fluorescent protein from Montipora sp. 20).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30077; REEP5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1II ! H9 AAVS1-TRE3G-NGN2 TEX264-/-
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA
AC   CVCL_D1KT
SY   H9 ES AAVS1-NGN2 TMEM192-3xHA
DR   Wikidata; Q127381012
RX   PubMed=37757899;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (PubMed=37757899).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
AC   CVCL_E3KT
SY   H9 ES AAVS1-NGN2 TMEM192-3xHA (heterozygous)
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EK ! H9 AAVS1-TRE3G-NGN2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) ASAH1-/-
AC   CVCL_F0PK
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::ASAH1-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:735; ASAH1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) ATP13A2-/-
AC   CVCL_F0PL
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::ATP13A2-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30213; ATP13A2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) CLN3-/-
AC   CVCL_F0PM
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::CLN3-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2074; CLN3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) CLN5-/-
AC   CVCL_F0PN
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::CLN5-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2076; CLN5.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) CLN6-/-
AC   CVCL_F0PP
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::CLN6-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2077; CLN6.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) CLN8-/-
AC   CVCL_F0PQ
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::CLN8-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2079; CLN8.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) CTSD-/-
AC   CVCL_F0PR
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::CTSD-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2529; CTSD.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) CTSF-/-
AC   CVCL_F0PS
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::CTSF-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2531; CTSF.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) DNAJC5-/-
AC   CVCL_F0PT
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::DNAJC5-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16235; DNAJC5.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) GAA-/-
AC   CVCL_F0PU
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::GAA-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) GBA1-/-
AC   CVCL_F0PV
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::GBA1-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) GRN-/-
AC   CVCL_F0PW
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::GRN-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) HEXA-/-
AC   CVCL_F0PX
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::HEXA-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4878; HEXA.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) HEXB-/-
AC   CVCL_F0PY
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::HEXB-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4879; HEXB.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) LIPA-/-
AC   CVCL_F0PZ
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::LIPA-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6617; LIPA.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) MCOLN1-/-
AC   CVCL_F0Q0
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::MCOLN1-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) MFSD8-/-
AC   CVCL_F0Q1
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::MFSD8-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) PSAP-/-
AC   CVCL_F0Q2
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::PSAP-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9498; PSAP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) PPT1-/-
AC   CVCL_F0Q3
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::PPT1-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9325; PPT1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) SMPD1-/-
AC   CVCL_F0Q4
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::SMPD1-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous) TPP1-/-
AC   CVCL_F0Q5
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::TPP1-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on one allele with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA (heterozygous)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA 3xFLAG-EEA1
AC   CVCL_D1KW
SY   H9 ES AAVS1-NGN2 TMEM192-3xHA 3xFLAG-EEA1
DR   Wikidata; Q127381013
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 EAA1 was N-terminally tagged on both alleles with a 3xFLAG tag (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA NPC1-/-
AC   CVCL_E3BP
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::NPC1-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA NPC2-/-
AC   CVCL_E3BQ
SY   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA::NPC2-/-
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14537; NPC2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA YIPF4-/-
AC   CVCL_D1KU
SY   H9 ES AAVS1-NGN2 TMEM192-3xHA YIPF4-/-
DR   Wikidata; Q127381014
RX   PubMed=37757899;
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (PubMed=37757899).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28145; YIPF4.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KT ! H9 AAVS1-TRE3G-NGN2 TMEM192-3xHA
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   H9 Cre-LoxP
AC   CVCL_U160
DR   WiCell; h9-cre-loxp
DR   Wikidata; Q54872231
RX   PubMed=19415769;
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-06.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=h9-cre-loxp
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   H9 hNanog-pGZ
AC   CVCL_U161
DR   WiCell; h9-hnanog-pgz
DR   Wikidata; Q54872232
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=h9-hnanog-pgz
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   H9 hOct4-pGZ
AC   CVCL_U162
DR   WiCell; h9-hoct4-pgz
DR   Wikidata; Q54872233
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=h9-hoct4-pgz
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   H9 inGFPhES
AC   CVCL_U163
SY   H9inGFPhES; inGFPhES#3; WA09 inGFPhES#3
DR   WiCell; h9-ingfphes
DR   Wikidata; Q54872234
RX   PubMed=18032700;
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=h9-ingfphes
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   H9 NANOG
AC   CVCL_F0SK
SY   H9N
RX   PubMed=19139263;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20857; NANOG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   H9 NR4A2-eGFP
AC   CVCL_E7GG
SY   H9 NURR1-GFP reporter; H9-Nurr1::H2B-GFP
RX   PubMed=31543366;
RX   PubMed=38866017;
CC   Characteristics: Using CRISPR/Cas9 a P2A-H2B-eGFP-PGKp-PuroR construct was introduced at the C-terminus of NR4A2/NURR1 (PubMed=31543366).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9 NR4A2-eGFP iCas9
AC   CVCL_E7GJ
SY   H9-Nurr1::H2B-GFP-iCas9; H9 iCas9/NURR1::GFP
RX   PubMed=38866017;
RX   PubMed=38917806;
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9 (PubMed=38866017).
CC   Characteristics: Using CRISPR/Cas9 a P2A-H2B-eGFP-PGKp-PuroR construct was introduced at the C-terminus of NR4A2/NURR1 (from parent cell line).
CC   Characteristics: Using TALEN two constructs SA-2A-HygR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele (PubMed=38866017).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7GG ! H9 NR4A2-eGFP
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9 NR4A2-eGFP iCas9 LRRK2(G2019S/G2019S)
AC   CVCL_E7GK
SY   H9-Nurr1::H2B-GFP-iCas9-LRRK2G2019S/G2019S
RX   PubMed=38917806;
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9 and an edited homozygous LRRK2 (G2019S) mutation (PubMed=38917806).
CC   Characteristics: Using CRISPR/Cas9 a P2A-H2B-eGFP-PGKp-PuroR construct was introduced at the C-terminus of NR4A2/NURR1 (from parent cell line).
CC   Characteristics: Using TALEN two constructs SA-2A-HygR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38917806).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7GJ ! H9 NR4A2-eGFP iCas9
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9 NR4A2-eGFP SATB1 KO
AC   CVCL_E7GH
SY   H9 NURR1-GFP reporter SATB1KO
RX   PubMed=31543366;
CC   Characteristics: Using CRISPR/Cas9 a P2A-H2B-eGFP-PGKp-PuroR construct was introduced at the C-terminus of NR4A2/NURR1 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10541; SATB1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7GG ! H9 NR4A2-eGFP
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9 NR4A2-eGFP TNF KO
AC   CVCL_E7GI
SY   H9 TNFa KO/NURR1-GFP
RX   PubMed=38866017;
CC   Characteristics: Using CRISPR/Cas9 a P2A-H2B-eGFP-PGKp-PuroR construct was introduced at the C-terminus of NR4A2/NURR1 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11892; TNF.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7GG ! H9 NR4A2-eGFP
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9 PINK1-/-
AC   CVCL_C4EP
SY   H9 ES PINK1-/-
DR   Wikidata; Q116049278
RX   PubMed=29656925;
RX   PubMed=34699746;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   H9 Rex1-EGFP
AC   CVCL_C8ZD
SY   H9 REX1-EGFP
DR   Wikidata; Q123031390
RX   PubMed=11413002;
RX   PubMed=29662178;
CC   Characteristics: The eGFP gene is under the control of the mouse Rex1 promoter (PubMed=11413002).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   H9 RM
AC   CVCL_JL69
SY   H9 RBM15-MKL1
DR   Wikidata; Q54872235
RX   PubMed=28412998;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:14334; MRTFA (Note=RBM15-MKL1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:14959; RBM15 (Note=RBM15-MKL1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=28412998
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   H9 Syn-GFP
AC   CVCL_U164
SY   H9-SYN-GFP
DR   WiCell; h9-syn-gfp
DR   Wikidata; Q54872236
CC   Registration: Swiss research registry; BAG-hES-IMP-0103.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-12.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=h9-syn-gfp
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   H9-14.8
AC   CVCL_M106
DR   ECACC; 85103106
DR   Wikidata; Q54872237
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   H9-A15
AC   CVCL_5J96
SY   WC00040
DR   CLO; CLO_0012731
DR   ABCD; ABCD_AE217
DR   BioSamples; SAME17789
DR   Coriell; WC00040
DR   Wikidata; Q54872238
RX   PubMed=1908881;
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00040; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H9-D3
AC   CVCL_5J97
SY   WC00039
DR   CLO; CLO_0012730
DR   ABCD; ABCD_AE212
DR   BioSamples; SAME17725
DR   Coriell; WC00039
DR   Wikidata; Q54872239
RX   PubMed=1908881;
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00039; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   H9-hTnnT2-pGZ-TD2
AC   CVCL_U165
SY   H9-cTnT-GFP clone TD2
DR   WiCell; h9-htnnt2-pgz-td2
DR   Wikidata; Q54872241
RX   PubMed=25422477;
CC   Registration: Swiss research registry; BAG-hES-IMP-0072.
CC   Characteristics: Expresses copGFP under the control of a cardiac troponin T (cTnT) promoter. Transduced with a hTNNT2p-copGFP-Zeo-WPRE construct (PubMed=25422477).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Misspelling: H9-hTnnTZ-pGZ-D2; Note=In Cellosaurus releases 8 to 52 due to an error in the original Wicell product page.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=h9-htnnt2-pgz-td2
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   H9-iCas9
AC   CVCL_E7G4
RX   PubMed=38917806;
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9 (PubMed=38917806).
CC   Characteristics: Using TALEN two constructs SA-2A-HygR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele (PubMed=38917806).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9-iCas9-APP(swe/swe)
AC   CVCL_E7G5
SY   H9-iCas9-APPswe/swe
RX   PubMed=38917806;
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9 and an edited homozygous APP(Swe) mutation (PubMed=38917806).
CC   Characteristics: Using TALEN two constructs SA-2A-HygR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Lys670_Met671delinsAsnLeu (c.2010_2011inv) (c.2010_2011delGAinsTC); ClinVar=VCV000018093; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38917806).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7G4 ! H9-iCas9
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9-iCas9.SAM
AC   CVCL_E7G6
RX   PubMed=39676795;
CC   Characteristics: Cell line with Dox-inducible CRISPR-based Synergistic Activation Mediator (SAM) system (PubMed=39676795).
CC   Characteristics: Using CRISPR/Cas9 a TRE3G-dCas9-VP64-P2A-MS2-p65-HSF1-T2A-mCherry-Insulator-TETon3G-EF1a-Neo construct was introduced in the AAVS1 safe harbor locus (PubMed=39676795).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03612; Escherichia phage MS2 capsid protein (Note=With p.Asn56Lys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   H9-NSC
AC   CVCL_IU37
SY   H9-derived neural stem cells
DR   Wikidata; Q54872242
WW   Provider; Thermo Fisher; N7800100; https://www.thermofisher.com/order/catalog/product/N7800100
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   H9-SOX2-GFP
AC   CVCL_JW66
SY   hSOX2-23; hsox2-23
DR   WiCell; h9-sox2-gfp
DR   Wikidata; Q54872243
RX   PubMed=24286033;
CC   Characteristics: SOX2 reporter line expressing GFP only when SOX2 is expressed (PubMed=24286033).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 8
//
ID   H9-T-Venus
AC   CVCL_F0CV
SY   H9.T-Venus; BRA-Venus-H2B
RX   PubMed=25042702;
CC   Registration: Swiss research registry; BAG-hES-IMP-0078.
CC   Characteristics: Using homologous recombination a H2B-Venus fusion construct was introduced at the C-terminus of T/BRA (PubMed=25042702).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   H9-WISP3KO
AC   CVCL_D1GU
DR   GEO; GSM7192008
DR   GEO; GSM7192009
DR   GEO; GSM7192010
DR   GEO; GSM7192028
DR   GEO; GSM7192029
DR   Wikidata; Q127381017
RX   PubMed=37679035;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12771; CCN6.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C202612; Progressive pseudorheumatoid dysplasia
DI   ORDO; Orphanet_1159; Progressive pseudorheumatoid arthropathy of childhood
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   H9/HIV-2MVP-11971
AC   CVCL_X680
DR   BEI_Resources; ARP-1107
DR   cancercelllines; CVCL_X680
DR   Wikidata; Q54872244
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   H9/HIV-2MVP-15132
AC   CVCL_X681
DR   BEI_Resources; ARP-1108
DR   cancercelllines; CVCL_X681
DR   Wikidata; Q54872245
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   H9/HTLV-IIIB
AC   CVCL_3514
SY   H9/HTLV-IIIB NIH 1983
DR   CLO; CLO_0003613
DR   ATCC; CRL-8543
DR   BEI_Resources; ARP-400
DR   cancercelllines; CVCL_3514
DR   Wikidata; Q54872246
RX   Patent=US4520113;
RX   PubMed=2567177;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8543.
CC   Population: Caucasian.
CC   Virology: In vitro infected by HIV-1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8543
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 18
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 13,15
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   H9/HTLV-IIICC
AC   CVCL_X621
SY   H9/HTLV-IIICC NIH 1983
DR   BEI_Resources; ARP-403
DR   cancercelllines; CVCL_X621
DR   Wikidata; Q54872247
CC   Population: Caucasian.
CC   Virology: In vitro infected by HIV-1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 18
//
ID   H9/HTLV-IIIMN
AC   CVCL_X620
SY   H9/HTLV-IIIMN NIH 1984
DR   BEI_Resources; ARP-402
DR   cancercelllines; CVCL_X620
DR   Wikidata; Q54872248
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   H9/HTLV-IIIRF
AC   CVCL_X619
SY   H9/HTLV-IIIRF NIH 1983
DR   BEI_Resources; ARP-401
DR   cancercelllines; CVCL_X619
DR   Wikidata; Q54872249
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   H9/R7hyg
AC   CVCL_E3D8
RX   PubMed=7523570;
CC   Population: Caucasian.
CC   Characteristics: Transfected with plasmid R7hyg containing a human immunodeficiency virus 1 (HIV-1) isolate HXB2 proviral clone containing HygR in place of the HIV-1 nef gene (PubMed=7523570).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   H9/R7neo
AC   CVCL_E3D9
RX   PubMed=7523570;
CC   Population: Caucasian.
CC   Characteristics: Transfected with plasmid R7neo containing a human immunodeficiency virus 1 (HIV-1) isolate HXB2 proviral clone containing Neo in place of the HIV-1 nef gene (PubMed=7523570).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   H9/SIVmac186
AC   CVCL_X610
DR   BEI_Resources; ARP-161
DR   cancercelllines; CVCL_X610
DR   Wikidata; Q54872250
CC   Population: Caucasian.
CC   Virology: Infected with simian immunodeficiency virus isolate SIVmac316 (BEI_Resources=ARP-161).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   H91H4.2H8
AC   CVCL_A2HT
SY   AI-10
DR   Wikidata; Q105507536
RX   Patent=US4828986;
RX   Patent=US5126240;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9200.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   H938
AC   CVCL_D536
DR   BEI_Resources; ARP-1298
DR   cancercelllines; CVCL_D536
DR   ChEMBL-Cells; CHEMBL3307889
DR   ChEMBL-Targets; CHEMBL614161
DR   PubChem_Cell_line; CVCL_D536
DR   Wikidata; Q54872251
RX   PubMed=3422113;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   H97-102.11.3
AC   CVCL_M107
DR   ECACC; 85062137
DR   Wikidata; Q54872252
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   H9c2 Trpm4 KO
AC   CVCL_B0FS
SY   H9c2 TRPM4KO
DR   Wikidata; Q108820374
RX   PubMed=34144257;
RX   PubMed=34430300;
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 620244; Trpm4.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   H9c2(2-1)
AC   CVCL_0286
SY   H9c2 (2-1); H9c2; H9C2
DR   BTO; BTO_0001879
DR   CLO; CLO_0003614
DR   MCCL; MCC:0000176
DR   CLDB; cl1558
DR   CLDB; cl5196
DR   AddexBio; C0031002/5017
DR   ATCC; CRL-1446
DR   BCRC; 60096
DR   BCRJ; 0098
DR   CCRID; 1101RAT-PUMC000219
DR   CCRID; 3101RATGNR5
DR   CCRID; 4201RAT-CCTCC00606
DR   CCTCC; GDC0606
DR   ChEMBL-Cells; CHEMBL3307653
DR   ChEMBL-Targets; CHEMBL614576
DR   CLS; 305203
DR   ECACC; 88092904
DR   GEO; GSM1513690
DR   IZSLER; BS CL 151
DR   KCLB; 21446
DR   Lonza; 1016
DR   NCBI_Iran; C585
DR   PubChem_Cell_line; CVCL_0286
DR   Ubigene; YC-A009
DR   Wikidata; Q9363821
RX   PubMed=943302;
RX   PubMed=1683272;
RX   PubMed=17662623;
RX   PubMed=21082279;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-409.html
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   H9C2(2-1)-Luc
AC   CVCL_C8V4
DR   Ubigene; YC-A009-Luc-P
DR   Wikidata; Q123031391
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   H9C2(2-1)-Luc2-tdT
AC   CVCL_XE64
DR   CCRID; 1101RAT-PUMC000659
DR   Wikidata; Q93937439
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   H9C2(2-1)-mCherry
AC   CVCL_XE65
DR   CCRID; 1101RAT-PUMC000658
DR   Wikidata; Q93937441
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   H9C2(2-1)-tdT
AC   CVCL_XE66
DR   CCRID; 1101RAT-PUMC000657
DR   Wikidata; Q93937444
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 11
//
ID   H9EOS
AC   CVCL_C0VX
DR   Wikidata; Q114311558
RX   PubMed=25215486;
RX   PubMed=28765214;
CC   Characteristics: Transduced with a EOS-C(3+)-GFP/puroR construct. EOS (ETn, Oct-4 and Sox2) combines a highly active promoter from a mouse early transposon (ETn) that is specific for undifferentiated pluripotent stem cells and combined it with Oct-4 (Pou5f1) and Sox2-binding motifs. EOS regulates an enhanced green fluorescent protein (eGFP), an internal ribosome entry site (IRES) and a puromycin resistance gene to allow live-cell visualization and antibiotic selection simultaneously.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   H9Keap1KO-A31
AC   CVCL_JL61
DR   Wikidata; Q54872254
RX   PubMed=28413007;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Misspelling: H9Keap1KO-A13; PubMed=28413007; Note=In one instance in the text.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 7
//
ID   H9Nrf2KO-A13
AC   CVCL_JJ84
DR   Wikidata; Q54872256
RX   PubMed=28413005;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2 (Note=Exon 4 targeted).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 7
//
ID   H9SNTA1KO
AC   CVCL_C5TU
DR   Wikidata; Q116049279
RX   PubMed=35773684;
CC   From: Qiqihar Medical University; Qiqihar; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11167; SNTA1.
CC   Caution: There is another H9SNTA1KO cell line established in China, it is also known as WAe009-A-50 (Cellosaurus=CVCL_A5EP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192202; Long QT syndrome 12
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HA
AC   CVCL_E2WQ
RX   DOI=10.1007/BF02618143;
RX   PubMed=16593974;
RX   PubMed=16665552;
CC   Group: Haploid karyotype cell line.
CC   Group: Plant cell line.
CC   Doubling time: 3.5 days (DOI=10.1007/BF02618143).
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Juwarot.
OX   NCBI_TaxID=79200; ! Daucus carota subsp. sativus (Carrot)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HA cl. 55
AC   CVCL_L844
DR   ECACC; 95040311
DR   Wikidata; Q54872257
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   Ha Fe
AC   CVCL_2816
DR   CLO; CLO_0003615
DR   ATCC; CRL-1396
DR   BioSample; SAMN03472817
DR   Wikidata; Q54872258
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1396
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 12,16
ST   D19S433: 12,13
ST   D21S11: 29,33.2
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 20,21
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HA-1
AC   CVCL_E3C5
RX   PubMed=6058352;
CC   Transformant: ChEBI; CHEBI_28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
DI   NCIt; C134992; Hamster fibrosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_E3C6 ! HA-2
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HA-2
AC   CVCL_E3C6
RX   PubMed=6058352;
CC   Doubling time: 14.3 hours (PubMed=6058352).
CC   Transformant: ChEBI; CHEBI_28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
DI   NCIt; C134992; Hamster fibrosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_E3C5 ! HA-1
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HA-CHO
AC   CVCL_DD03
DR   Wikidata; Q54872259
RX   PubMed=2537314;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03451; Influenza A virus (strain A/Japan/305/1957 H2N2) hemagglutinin (HA).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   HA-CHO clone 4B
AC   CVCL_DD04
SY   4B
DR   Wikidata; Q54872260
RX   PubMed=2267628;
RX   PubMed=2537314;
CC   Characteristics: Temperature defective (at 39 Celsius) expression of hemagglutinin (HA) on the cell surface (PubMed=2537314).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03451; Influenza A virus (strain A/Japan/305/1957 H2N2) hemagglutinin (HA).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DD03 ! HA-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   HA-CHO clone 4J
AC   CVCL_DD05
SY   4J
DR   Wikidata; Q54872261
RX   PubMed=2267628;
RX   PubMed=2537314;
CC   Characteristics: Temperature defective (at 39 Celsius) expression of hemagglutinin (HA) on the cell surface (PubMed=2537314).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03451; Influenza A virus (strain A/Japan/305/1957 H2N2) hemagglutinin (HA).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DD03 ! HA-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   HA-E
AC   CVCL_0C12
DR   Cosmic; 2239095
DR   Wikidata; Q54872276
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HA-OH1
AC   CVCL_S869
DR   Wikidata; Q54872278
RX   PubMed=12904596;
RX   PubMed=23665679;
RX   PubMed=23882450;
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   HA-R-Spondin1-Fc 293T
AC   CVCL_RU08
SY   HA-R-Spondin-Fc293T
DR   Wikidata; Q54872280
RX   PubMed=19398967;
WW   Provider; AMSBIO; -; https://www.amsbio.com/r-spondin-rspo1/
CC   Characteristics: Expresses mouse Fc-Rspo1 which consist of the fusion of mouse IgG2a Fc region to the N-terminal of Rspo1 with a N-terminal HA epitope tag (AMSBIO).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2183426; Rspo1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Caution: Could be identical to 293T R-Spondin1 expressing (Cellosaurus=CVCL_RU09) distributed by Millipore. Both cell line product pages cite PubMed=19398967 but the Millipore page states "Cell line is not the published cell line from the Kuo lab, but rather a related cell line developed in the same lab using the reference protocol".
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   HA1
AC   CVCL_C9AK
SY   HA-1
DR   Wikidata; Q123031392
RX   PubMed=1845837;
RX   PubMed=9843956;
RX   PubMed=10440377;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Ha1-1.16
AC   CVCL_B0TV
DR   Wikidata; Q108820375
RX   Patent=US8278424;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6698.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Ha1-4.117
AC   CVCL_B0TW
DR   Wikidata; Q108820376
RX   Patent=US8278424;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6699.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Ha1-4.120
AC   CVCL_B0TX
DR   Wikidata; Q108820377
RX   Patent=US8278424;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6700.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Ha1-4.121
AC   CVCL_B0TY
DR   Wikidata; Q108820378
RX   Patent=US8278424;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6701.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Ha1-4.37
AC   CVCL_B0TZ
DR   Wikidata; Q108820379
RX   Patent=US8278424;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6702.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Ha1-5.99
AC   CVCL_B0U0
DR   Wikidata; Q108820380
RX   Patent=US8278424;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6703.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Ha16-1(1)11
AC   CVCL_W163
DR   Wikidata; Q54872281
RX   Patent=US8236310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7450.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14638; Human ENPP3/CD203c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   Ha16-1(3,5)18
AC   CVCL_W162
DR   Wikidata; Q54872283
RX   Patent=US8236310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7452.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14638; Human ENPP3/CD203c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
ID   Ha168
AC   CVCL_A9Q5
DR   Wikidata; Q102114087
RX   PubMed=32827128;
CC   Group: Insect cell line.
CC   Doubling time: 58 hours (Note=At 25th passage) (PubMed=32827128).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   HA1E
AC   CVCL_VU89
DR   CLO; CLO_0037169
DR   Cell_Model_Passport; SIDM01712
DR   DepMap; ACH-001310
DR   LINCS_LDP; LCL-2090
DR   Wikidata; Q93937521
RX   PubMed=9843956;
RX   PubMed=15509531;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9AK ! HA1
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   HA22T/VGH
AC   CVCL_7046
SY   Ha22T/VGH; HA 22T/VGH; HA22T
DR   BTO; BTO_0002429
DR   BCRC; 60168
DR   ChEMBL-Cells; CHEMBL3308657
DR   ChEMBL-Targets; CHEMBL614807
DR   Cosmic; 932991
DR   Cosmic; 934552
DR   Cosmic; 2668280
DR   PubChem_Cell_line; CVCL_7046
DR   Wikidata; Q54872284
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=2441881;
RX   PubMed=3023526;
RX   PubMed=3032404;
RX   PubMed=3431441;
RX   PubMed=6291875;
RX   PubMed=6683778;
RX   PubMed=7972006;
RX   PubMed=8050184;
RX   PubMed=8224613;
RX   PubMed=29051253;
WW   Provider; Asia Bioscience; GRL-CLC011; https://www.abscience.com.tw/product/ha22t-vgh/
CC   Population: Chinese.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg22Glyfs*14 (c.63_85del23); Zygosity=Unspecified (PubMed=7972006).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Misspelling: HA22T/VGF; PubMed=3431441.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): BCRC=60168
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 7,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HA47T/VGH
AC   CVCL_LJ94
DR   Wikidata; Q54872285
RX   DOI=10.1007/978-4-431-68349-0_4;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   HA59T/VGH
AC   CVCL_Y018
SY   HA 59 T/VGH; Hepa59T/VGH; HEPA 59T/VGH; HA59T
DR   BCRC; 60169
DR   Wikidata; Q54872286
RX   PubMed=1973703;
RX   PubMed=8050184;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): BCRC=60169
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D5S818: 10,11,12
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,21
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 10
//
ID   HA7-EBV
AC   CVCL_E909
DR   Cell_Model_Passport; SIDM01711
DR   DepMap; ACH-002350
DR   Wikidata; Q54872288
RX   PubMed=11369790;
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1241 ! HA7-RCC
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   HA7-RCC
AC   CVCL_1241
SY   HA7RCC
DR   CLO; CLO_0009976
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1241
DR   Cell_Model_Passport; SIDM00188
DR   Cosmic; 753558
DR   Cosmic-CLP; 753558
DR   DepMap; ACH-002139
DR   EGA; EGAS00001000978
DR   GDSC; 753558
DR   GEO; GSM1669837
DR   IARC_TP53; 21357
DR   LINCS_LDP; LCL-1764
DR   PharmacoDB; HA7RCC_440_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54872289
RX   PubMed=11369790;
RX   PubMed=14762065;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0.85%; East Asian, North=0%; East Asian, South=0.47%; South Asian=1.99%; European, North=74.38%; European, South=22.26% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753558
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E909 ! HA7-EBV
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   HAA-1
AC   CVCL_C7GH
SY   HAA1; Human Adrenocortical Adenoma 1
DR   ABM; T8159
DR   Wikidata; Q117704459
RX   PubMed=36614027;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) (Note=p16HHMo).
CC   Derived from site: In situ; Adrenal gland, zona reticularis; UBERON=UBERON_0002055.
ST   Source(s): PubMed=36614027
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 14,15
ST   D21S11: 27,32.2
ST   D2S1338: 24,25
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 10,14
ST   FGA: 21,22,24
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C9003; Adrenal cortical adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   HAA1
AC   CVCL_8960
DR   CLO; CLO_0003617
DR   ATCC; HB-8534
DR   Wikidata; Q54872290
RX   Patent=US4624921;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8534.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6416 ! LTR228
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   HAA58OD-8C
AC   CVCL_F759
DR   Wikidata; Q54872292
RX   PubMed=1855484;
CC   Characteristics: At the permissive temperature (33 Celsius) the cells exhibits a transformed phenotype with low levels of expression of PSG1, CGA and CGB. At the non-permissive temperature (39.5 Celsius) exhibits a differentiated phenotype with increased expression of PSG1, CGA and CGB.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   HAAE-1
AC   CVCL_3692
SY   Human Abdominal Aorta Endothelial-1; HAAE-1/6-5; AG09799; AG09799C
DR   CLO; CLO_0003618
DR   CLO; CLO_0021951
DR   ATCC; CRL-2472
DR   BioSample; SAMN03471586
DR   Coriell; AG09799
DR   Wikidata; Q54872293
RX   CelloPub=CLPUB00597;
RX   PubMed=1309825;
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2472; true.
CC   Derived from site: In situ; Abdomen, aorta; UBERON=UBERON_0001516.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
ST   Source(s): ATCC=CRL-2472
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HAAE-1F
AC   CVCL_A2DB
SY   Human Abdominal Aorta Endothelial-1F
DR   Wikidata; Q105507540
RX   PubMed=3156882;
CC   Derived from site: In situ; Abdomen, aorta; UBERON=UBERON_0001516.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3692 ! HAAE-1
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HAAE-2
AC   CVCL_3693
SY   Human Abdominal Aorta Endothelial-2
DR   CLO; CLO_0003619
DR   ATCC; CRL-2473
DR   BioSample; SAMN03471585
DR   Wikidata; Q54872294
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2473; true.
CC   Derived from site: In situ; Abdomen, aorta; UBERON=UBERON_0001516.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
ST   Source(s): ATCC=CRL-2473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3437 ! HFAE-2
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HAAE-26
AC   CVCL_0E12
SY   Human Abdominal Aorta Endothelial-26
DR   ATCC; CRL-2602
DR   Wikidata; Q54872295
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2602; true.
CC   Derived from site: In situ; Abdomen, aorta; UBERON=UBERON_0001516.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
ST   Source(s): ATCC=CRL-2602
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13,14
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3292 ! HIVE-26
OI   CVCL_3716 ! HPAE-26
OI   CVCL_3718 ! HPVE-26
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   HAAE-27
AC   CVCL_0E14
SY   Human Abdominal Aorta Endothelial-27
DR   Wikidata; Q54872296
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Abdomen, aorta; UBERON=UBERON_0001516.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E13 ! HIAE-27
OI   CVCL_0F02 ! HIVE-27
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   haAQC2
AC   CVCL_5A35
SY   AQ.C2 clone 11B
DR   Wikidata; Q54872297
RX   Patent=US7358054;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3274.
CC   Characteristics: Produces a humanized version of mAB mAQC2 (Patent=US7358054).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   HAB-1
AC   CVCL_9V19
DR   Wikidata; Q54872298
RX   PubMed=2223577;
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 25-30 hours (PubMed=2223577).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   HAB-40
AC   CVCL_HA66
DR   Wikidata; Q54872299
RX   PubMed=2423613;
CC   Characteristics: IL4 dependent.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   HAb18Gedomab1
AC   CVCL_XC80
DR   Wikidata; Q93937621
RX   DOI=10.11569/wcjd.v12.i9.2061;
RX   Patent=CN100480388C;
RX   PubMed=16704305;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200408.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   HAb18Gedomab2
AC   CVCL_XC81
SY   HAb18GC2
DR   CCRID; 4201PAT-CCTCC00205
DR   Wikidata; Q93937623
RX   Patent=CN100586960C;
RX   PubMed=16704305;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200636.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   HABL
AC   CVCL_LI15
DR   Wikidata; Q54872300
RX   PubMed=8486778;
RX   PubMed=10637496;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8486778).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI16 ! HATL
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   HAC-2
AC   CVCL_8354
SY   HAC 2; Hac2
DR   cancercelllines; CVCL_8354
DR   Cosmic; 877480
DR   Cosmic; 931363
DR   Cosmic; 945375
DR   Cosmic; 1152560
DR   Cosmic; 2582795
DR   JCRB; JCRB1359
DR   JCRB; JCRB1539
DR   JCRB; NIHS0567
DR   Wikidata; Q54872301
RX   CelloPub=CLPUB00045;
RX   PubMed=8980248;
RX   PubMed=25846456;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 46.8 hours (CelloPub=CLPUB00045).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=25846456).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Discontinued: JCRB; NIHS0567; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1359; JCRB=JCRB1539
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   HAC-84
AC   CVCL_6906
DR   KCB; KCB 86016YJ
DR   Wikidata; Q54872303
RX   PubMed=2838234;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (GLC-82) has been shown to be a HeLa derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00605.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3371 ! GLC-82
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HAC-HPV16-E6/E7
AC   CVCL_B0BV
SY   Human articular chondrocytes HPV16-E6/E7 immortalized
DR   Wikidata; Q108820381
RX   PubMed=12435333;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) (Note=p16HHMo).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Articular cartilage; UBERON=UBERON_0010996.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   HAC13
AC   CVCL_5V09
DR   ABM; T8321
DR   cancercelllines; CVCL_5V09
DR   Wikidata; Q54872305
RX   PubMed=22266826;
RX   PubMed=35764904;
CC   Population: Caribbean; Bahamas.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0458 ! NCI-H295R
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 14
//
ID   HAC15
AC   CVCL_S898
SY   HAC-15; HAC clone 15
DR   ABM; T8322
DR   ATCC; CRL-3301
DR   BioSample; SAMN06481111
DR   cancercelllines; CVCL_S898
DR   Wikidata; Q54872306
RX   PubMed=18713819;
RX   PubMed=21924324;
RX   PubMed=22266826;
RX   PubMed=35764904;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NCI-H295R derivative (PubMed=21924324). Originally thought to originate from a 11 month old female patient with adrenal cortex carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00518.
CC   Population: Caribbean; Bahamas.
CC   Characteristics: Exhibits hormonal responses, steroidogenesis and expression of steroid-metabolizing enzymes.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): ATCC=CRL-3301
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0458 ! NCI-H295R
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 24
//
ID   HAC50
AC   CVCL_5V08
DR   ABM; T8323
DR   cancercelllines; CVCL_5V08
DR   Wikidata; Q54872307
RX   PubMed=22266826;
RX   PubMed=35764904;
CC   Population: Caribbean; Bahamas.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0458 ! NCI-H295R
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 14
//
ID   HaCa-4
AC   CVCL_4970
SY   HACA-4; HaCa 4; HaCa4
DR   BTO; BTO_0003895
DR   Wikidata; Q54872308
RX   PubMed=1918152;
RX   PubMed=8599577;
CC   Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV).
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   HaCaT
AC   CVCL_0038
SY   HaCAT; HACAT; Hacat
DR   BTO; BTO_0000552
DR   EFO; EFO_0002056
DR   CLDB; cl7229
DR   AddexBio; T0020001/117
DR   BCRJ; 0341
DR   CCRID; 1101HUM-PUMC000373
DR   CCRID; 4201HUM-CCTCC00106
DR   CCTCC; GDC0106
DR   ChEMBL-Cells; CHEMBL3308509
DR   ChEMBL-Targets; CHEMBL614392
DR   CLS; 300493
DR   Cosmic; 1530737
DR   DSMZ; ACC-771
DR   DSMZCellDive; ACC-771
DR   GEO; GSE57080
DR   GEO; GSM913344
DR   GEO; GSM913345
DR   GEO; GSM960278
DR   GEO; GSM960279
DR   GEO; GSM960280
DR   GEO; GSM960286
DR   GEO; GSM960287
DR   GEO; GSM960288
DR   GEO; GSM960294
DR   GEO; GSM960295
DR   GEO; GSM960296
DR   GEO; GSM1375594
DR   GEO; GSM1375595
DR   GEO; GSM1375596
DR   GEO; GSM1375597
DR   GEO; GSM1375598
DR   GEO; GSM1375599
DR   GEO; GSM1375600
DR   GEO; GSM1375601
DR   GEO; GSM1375602
DR   GEO; GSM1375603
DR   GEO; GSM1375604
DR   GEO; GSM1375605
DR   GEO; GSM1861816
DR   GEO; GSM1861817
DR   GEO; GSM1861820
DR   GEO; GSM1861821
DR   GEO; GSM2112559
DR   GEO; GSM2112563
DR   GEO; GSM2495796
DR   GEO; GSM2495797
DR   GEO; GSM2495798
DR   GEO; GSM7701420
DR   GEO; GSM7701421
DR   IARC_TP53; 1820
DR   ICLC; HL14001
DR   IZSLER; BS CL 168
DR   KCB; KCB 200442YJ
DR   Lonza; 56
DR   MeSH; D000084282
DR   MetaboLights; MTBLS127
DR   PRIDE; PXD000496
DR   PRIDE; PXD000670
DR   PRIDE; PXD002460
DR   PRIDE; PXD007789
DR   PRIDE; PXD013113
DR   PRIDE; PXD017536
DR   PRIDE; PXD030700
DR   PRIDE; PXD033538
DR   PubChem_Cell_line; CVCL_0038
DR   TOKU-E; 3890
DR   Ubigene; YC-A018
DR   Wikidata; Q5636366
RX   PubMed=2450098;
RX   PubMed=8162337;
RX   PubMed=8504475;
RX   PubMed=9290701;
RX   PubMed=9406811;
RX   PubMed=10350023;
RX   PubMed=10523843;
RX   PubMed=11416159;
RX   PubMed=11583982;
RX   PubMed=15389883;
RX   PubMed=16957166;
RX   PubMed=20097197;
RX   PubMed=20100199;
RX   PubMed=21185708;
RX   PubMed=21269460;
RX   PubMed=21868764;
RX   PubMed=24155234;
RX   PubMed=26989177;
RX   PubMed=29468137;
RX   PubMed=29660373;
RX   PubMed=31629070;
RX   PubMed=32938951;
RX   PubMed=33718544;
RX   PubMed=35072517;
RX   PubMed=35647242;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-347.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HaCaT
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Virology: Susceptible to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   Doubling time: 28 hours (PubMed=32938951).
CC   HLA typing: A*31:01:02; B*40:01:02,51:01:01; C*03:04:01,15:02:01; DPB1*03:01:01,04:01:01; DQA1*01:02:01,03:03:01; DQB1*03:01:01,06:02:01; DRB1*04:01:01,15:01:01 (CLS=300493).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (PubMed=8504475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (PubMed=8504475).
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Although HaCaT is distributed by a number of sources, the only official DKFZ-approved supplier is CLS.
CC   Discontinued: BCRJ; 0341; true.
CC   Discontinued: DSMZ; ACC-771; true.
CC   Discontinued: ICLC; HL14001; true.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): CCRID; CLS=300493; DSMZ=ACC-771; PubMed=11416159; PubMed=21868764; PubMed=35072517; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D10S1248: 14,15
ST   D12S391: 18,23
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D1S1656: 11,12
ST   D21S11: 28 (DSMZ=ACC-771)
ST   D21S11: 28,30.2 (CLS=300493; PubMed=11416159; PubMed=35072517; Technion Genomics Center)
ST   D21S11: 30.2 (CCRID)
ST   D22S1045: 15,16
ST   D2S1338: 17,25
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 12,19
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 24 (CCRID; DSMZ=ACC-771; PubMed=11416159; PubMed=35072517; Technion Genomics Center)
ST   FGA: 24,27.2 (CLS=300493)
ST   Penta D: 11,13
ST   Penta E: 7,12
ST   SE33: 15,18.2
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   HaCaT A-5
AC   CVCL_XK16
SY   HaCaT-ras clone A-5; HaCaT-ras A5; A-5; A5
DR   CLS; 300494
DR   PRIDE; PXD013113
DR   Wikidata; Q93937678
RX   PubMed=11583982;
RX   PubMed=20097197;
CC   Population: Caucasian.
CC   Characteristics: Non-tumorigenic.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): CLS=300494
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D10S1248: 14,15
ST   D12S391: 18,23
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D1S1656: 11,12
ST   D21S11: 28,30.2
ST   D22S1045: 15,16
ST   D2S1338: 17,25
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 24,27.2
ST   SE33: 15,18.2
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 13
//
ID   HaCaT BHLHE40 (-/-)
AC   CVCL_HD65
SY   BHLHE40 (-/-) HACAT; DEC1-/- HaCaT
DR   Horizon_Discovery; HD+R01-001
DR   Wikidata; Q54872309
RX   PubMed=11880636;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1046; BHLHE40.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   HaCaT HSP70B'-GFP reporter
AC   CVCL_FA29
DR   Wikidata; Q54872311
RX   PubMed=24967604;
CC   Population: Caucasian.
CC   Characteristics: Stably expresses GFP under the control of the stress-inducible HSPA6 (HSP70B') promoter (PubMed=24967604).
CC   Characteristics: Used as a sensor cell line to quantify skin response upon exposure to chemical substances that are known to cause irritation or allergies through the generation of reactive oxygen species (PubMed=24967604).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   HaCaT II-4
AC   CVCL_3868
SY   HaCaT-ras clone II-4; HaCaT-ras II-4; II-4
DR   BTO; BTO_0005111
DR   CLS; 300495
DR   PRIDE; PXD013113
DR   Wikidata; Q54872312
RX   PubMed=11583982;
RX   PubMed=17056607;
RX   PubMed=20097197;
CC   Population: Caucasian.
CC   Characteristics: Tumorigenic.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): CLS=300495
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D10S1248: 14,15
ST   D12S391: 18,23
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D1S1656: 11,12
ST   D21S11: 28,30.2
ST   D22S1045: 15,16
ST   D2S1338: 17,25
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 24,27.2
ST   SE33: 15,18.2
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 21
//
ID   HaCaT RT3
AC   CVCL_XK15
SY   A-5RT3; RT3
DR   PRIDE; PXD013113
DR   Wikidata; Q93937698
RX   PubMed=11583982;
RX   PubMed=20097197;
CC   Population: Caucasian.
CC   Characteristics: Metastatic.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XK16 ! HaCaT A-5
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   HaCaT SimpleCell O-GalNAc
AC   CVCL_S024
SY   HaCaT SimpleCell; HaCaT SC; Cosmc KO HaCaT
DR   Wikidata; Q54872314
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   HaCaT siYAP
AC   CVCL_QX09
SY   siYAP_HaCAT
DR   GEO; GSM2112560
DR   GEO; GSM2112561
DR   GEO; GSM2112562
DR   Wikidata; Q54872313
RX   PubMed=26989177;
CC   Population: Caucasian.
CC   Knockout cell: Method=siRNA knockdown; HGNC; HGNC:16262; YAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HaCaT YAP-5SA
AC   CVCL_QX10
SY   YAP_5SA_HaCAT
DR   GEO; GSM2112564
DR   GEO; GSM2112565
DR   GEO; GSM2112566
DR   Wikidata; Q54872315
RX   PubMed=26989177;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser61Ala, p.Ser109Ala, p.Ser127Ala, p.Ser164Ala and p.Ser381Ala = YAP-5SA).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 14
//
ID   HaCaT-16E5
AC   CVCL_B0AY
DR   Wikidata; Q108820382
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06927; Human papillomavirus type 16 protein E5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-16E6
AC   CVCL_B0AZ
DR   Wikidata; Q108820383
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-16E6E7
AC   CVCL_B0B0
DR   Wikidata; Q108820384
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HaCaT-16E7
AC   CVCL_B0B1
DR   Wikidata; Q108820385
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-18E5
AC   CVCL_B0B2
DR   Wikidata; Q108820386
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06792; Human papillomavirus type 18 protein E5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-18E6
AC   CVCL_B0B3
DR   Wikidata; Q108820387
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06463; Human papillomavirus type 18 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-18E7
AC   CVCL_B0B4
DR   Wikidata; Q108820388
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06788; Human papillomavirus type 18 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-62E5
AC   CVCL_B0B5
DR   Wikidata; Q108820389
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Human papillomavirus type 62 protein E5.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HaCaT-62E6
AC   CVCL_B0B6
DR   Wikidata; Q108820390
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q676V2; Human papillomavirus type 62 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-62E7
AC   CVCL_B0B7
DR   Wikidata; Q108820391
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q676V1; Human papillomavirus type 62 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-84E5
AC   CVCL_B0B8
DR   Wikidata; Q108820392
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Human papillomavirus type 84 protein E5.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HaCaT-84E6
AC   CVCL_B0B9
DR   Wikidata; Q108820393
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99FX3; Human papillomavirus type 84 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-84E7
AC   CVCL_B0BA
DR   Wikidata; Q108820394
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99FX2; Human papillomavirus type 84 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HaCaT-hGSTP1 ARE-SV40p-Luc2
AC   CVCL_B6YN
DR   CCRID; 4201PAT-CCTCC01845
DR   Wikidata; Q111733262
RX   Patent=CN113265423B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021113.
CC   Population: Caucasian.
CC   Characteristics: Expression of the luciferase reporter gene is under the control of the antioxidant response element (ARE) of GSTP1 (Patent=CN113265423B).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HaCaT-pLVX
AC   CVCL_B0BB
DR   Wikidata; Q108820395
RX   PubMed=31396215;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for a series of HaCaT HPV E5, E6 and E7 transfected cell lines.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HaCaT-shNeg
AC   CVCL_ZW69
DR   Wikidata; Q102114088
RX   PubMed=31319135;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for the HaCaT-shNrf2 cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   HaCaT-shNrf2#1
AC   CVCL_ZW70
DR   Wikidata; Q102114089
RX   PubMed=31319135;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HaCaT-shNrf2#2
AC   CVCL_ZW71
DR   Wikidata; Q102114091
RX   PubMed=31319135;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HaCaT-shNrf2#3
AC   CVCL_ZW72
DR   Wikidata; Q102114092
RX   PubMed=31319135;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HaCaT-TRS4
AC   CVCL_RL61
DR   Wikidata; Q54872316
RX   PubMed=16135802;
CC   Population: Caucasian.
CC   Characteristics: Expresses tetracyclin-inducible SMAD4 siRNA.
CC   Knockout cell: Method=siRNA knockdown; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   HaCaT/SM
AC   CVCL_4Z60
DR   Wikidata; Q54872317
RX   PubMed=26463895;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_25434; Bis(2-chloroethyl) sulfide (Sulfur mustard; Mustard agent).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   HaCaT40degree
AC   CVCL_XK18
DR   Wikidata; Q93937740
RX   PubMed=10523843;
RX   PubMed=11583982;
CC   Population: Caucasian.
CC   Characteristics: Adapted to grow at 40 Celsius.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 11
//
ID   HAD-C 100
AC   CVCL_B860
SY   HADe007-A; HADe007-A-2; HADe007-B; HADe007-C
DR   BioSamples; SAMEA6560458
DR   BioSamples; SAMEA6560652
DR   BioSamples; SAMEA8093238
DR   hPSCreg; HADe007-A
DR   hPSCreg; HADe007-B
DR   hPSCreg; HADe007-C
DR   NIHhESC; NIHhESC-11-0123
DR   SKIP; SKIP002677
DR   Wikidata; Q54872320
RX   PubMed=22745653;
RX   PubMed=31838378;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0123.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
ID   HAD-C 102
AC   CVCL_B861
SY   HADe008-A; HADe008-A-1; HADe008-B
DR   BioSamples; SAMEA6567198
DR   BioSamples; SAMEA6568766
DR   hPSCreg; HADe008-A
DR   hPSCreg; HADe008-B
DR   NIHhESC; NIHhESC-11-0124
DR   SKIP; SKIP002685
DR   Wikidata; Q54872321
RX   PubMed=22745653;
RX   PubMed=31838378;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0124.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
ID   HAD-C 103
AC   CVCL_WW09
SY   HADe010-A
DR   BioSamples; SAMEA6582093
DR   hPSCreg; HADe010-A
DR   NIHhESC; NIHhESC-20-0411
DR   Wikidata; Q93937761
RX   PubMed=31838378;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0411.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 7
//
ID   HAD-C 104
AC   CVCL_WW10
SY   HADe011-A
DR   BioSamples; SAMEA6583350
DR   hPSCreg; HADe011-A
DR   NIHhESC; NIHhESC-20-0412
DR   Wikidata; Q93937763
RX   PubMed=31838378;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0412.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 7
//
ID   HAD-C 105
AC   CVCL_WW11
SY   HADe012-A
DR   BioSamples; SAMEA6592707
DR   hPSCreg; HADe012-A
DR   NIHhESC; NIHhESC-20-0413
DR   Wikidata; Q93937764
RX   PubMed=31838378;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0413.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 7
//
ID   HAD-C 106
AC   CVCL_B862
SY   HADe009-A; HADe009-A-1; HADe009-B
DR   BioSamples; SAMEA6567603
DR   BioSamples; SAMEA6592706
DR   hPSCreg; HADe009-A
DR   hPSCreg; HADe009-B
DR   NIHhESC; NIHhESC-11-0125
DR   SKIP; SKIP002686
DR   Wikidata; Q54872322
RX   PubMed=22745653;
RX   PubMed=31838378;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0125.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 18
//
ID   HAD-C 107
AC   CVCL_WW12
SY   HADe013-A
DR   BioSamples; SAMEA6592709
DR   hPSCreg; HADe013-A
DR   NIHhESC; NIHhESC-20-0414
DR   Wikidata; Q93937769
RX   PubMed=31838378;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0414.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 7
//
ID   HAD1
AC   CVCL_C069
SY   HAD 1; HADe001-A
DR   BioSamples; SAMEA6601468
DR   hPSCreg; HADe001-A
DR   SKIP; SKIP001853
DR   Wikidata; Q54872323
RX   PubMed=17989069;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HAD17
AC   CVCL_C070
DR   Wikidata; Q54872324
RX   PubMed=20351691;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   HAD18
AC   CVCL_C071
DR   Wikidata; Q54872329
RX   PubMed=20351691;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   HAD19
AC   CVCL_C072
DR   Wikidata; Q54872330
RX   PubMed=20351691;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   HAD2
AC   CVCL_C073
SY   HAD 2; HADe002-A
DR   BioSamples; SAMEA6613184
DR   hPSCreg; HADe002-A
DR   SKIP; SKIP001854
DR   Wikidata; Q54872331
RX   PubMed=17989069;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HAD3
AC   CVCL_C074
SY   HAD 3; HADe003-A
DR   BioSamples; SAMEA6613185
DR   hPSCreg; HADe003-A
DR   SKIP; SKIP001855
DR   Wikidata; Q54872332
RX   PubMed=17989069;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HAD4
AC   CVCL_C075
SY   HAD 4; HADe004-A; PGD-HAD-4; FD-hESC
DR   BioSamples; SAMEA6613187
DR   hPSCreg; HADe004-A
DR   SKIP; SKIP001856
DR   Wikidata; Q54872333
RX   PubMed=26437462;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=26437462).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84706; Familial dysautonomia
DI   ORDO; Orphanet_1764; Familial dysautonomia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   HAD5
AC   CVCL_C076
SY   HAD 5; HADe005-A
DR   BioSamples; SAMEA6621223
DR   hPSCreg; HADe005-A
DR   SKIP; SKIP001857
DR   Wikidata; Q54872334
RX   PubMed=17989069;
RX   PubMed=27690107;
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[300]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   HAD6
AC   CVCL_C077
SY   HAD 6; HADe006-A
DR   BioSamples; SAMEA6621258
DR   hPSCreg; HADe006-A
DR   SKIP; SKIP001858
DR   Wikidata; Q54872335
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HAD9
AC   CVCL_B5H3
SY   HAD 9; HAD-9; HADe014-A
DR   BioSamples; SAMEA9086684
DR   hPSCreg; HADe014-A
DR   Wikidata; Q110432833
CC   From: Hadassah Hebrew University Medical Center; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   HADMEC-5
AC   CVCL_C3XA
SY   Human ADipose Microvascular Endothelial Cell line-5
DR   Wikidata; Q116049281
RX   PubMed=9249912;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Perirenal fat; UBERON=UBERON_0005406.
CC   Cell type: Adipose microvascular endothelial cell; CL=CL_2000072.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HAdpc-23-E6E7
AC   CVCL_6F30
DR   Wikidata; Q54872336
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F31 ! HAdpc-24-Bmi-1
OI   CVCL_4W37 ! HAdpc-25-Bmi-1-TERT
OI   CVCL_4W38 ! HAdpc-26-E6-Bmi-1-TERT
OI   CVCL_6F29 ! HAdpc-27-TERT
OI   CVCL_4W39 ! HAdpc-28-E6E7-TERT
OI   CVCL_4W40 ! HAdpc-29-E7-TERT
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   HAdpc-24-Bmi-1
AC   CVCL_6F31
DR   Wikidata; Q54872337
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F30 ! HAdpc-23-E6E7
OI   CVCL_4W37 ! HAdpc-25-Bmi-1-TERT
OI   CVCL_4W38 ! HAdpc-26-E6-Bmi-1-TERT
OI   CVCL_6F29 ! HAdpc-27-TERT
OI   CVCL_4W39 ! HAdpc-28-E6E7-TERT
OI   CVCL_4W40 ! HAdpc-29-E7-TERT
SX   Female
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   HAdpc-25-Bmi-1-TERT
AC   CVCL_4W37
DR   JCRB; JCRB1550
DR   Wikidata; Q54872338
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): JCRB=JCRB1550
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F30 ! HAdpc-23-E6E7
OI   CVCL_6F31 ! HAdpc-24-Bmi-1
OI   CVCL_4W38 ! HAdpc-26-E6-Bmi-1-TERT
OI   CVCL_6F29 ! HAdpc-27-TERT
OI   CVCL_4W39 ! HAdpc-28-E6E7-TERT
OI   CVCL_4W40 ! HAdpc-29-E7-TERT
SX   Female
CA   Telomerase immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   HAdpc-26-E6-Bmi-1-TERT
AC   CVCL_4W38
SY   HAdpc-26-E6-Bmi-1-TE
DR   JCRB; JCRB1555
DR   Wikidata; Q54872339
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): JCRB=JCRB1555
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F30 ! HAdpc-23-E6E7
OI   CVCL_6F31 ! HAdpc-24-Bmi-1
OI   CVCL_4W37 ! HAdpc-25-Bmi-1-TERT
OI   CVCL_6F29 ! HAdpc-27-TERT
OI   CVCL_4W39 ! HAdpc-28-E6E7-TERT
OI   CVCL_4W40 ! HAdpc-29-E7-TERT
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HAdpc-27-TERT
AC   CVCL_6F29
DR   Wikidata; Q54872341
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F30 ! HAdpc-23-E6E7
OI   CVCL_6F31 ! HAdpc-24-Bmi-1
OI   CVCL_4W37 ! HAdpc-25-Bmi-1-TERT
OI   CVCL_4W38 ! HAdpc-26-E6-Bmi-1-TERT
OI   CVCL_4W39 ! HAdpc-28-E6E7-TERT
OI   CVCL_4W40 ! HAdpc-29-E7-TERT
SX   Female
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   HAdpc-28-E6E7-TERT
AC   CVCL_4W39
DR   JCRB; JCRB1572
DR   Wikidata; Q54872342
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): JCRB=JCRB1572
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F30 ! HAdpc-23-E6E7
OI   CVCL_6F31 ! HAdpc-24-Bmi-1
OI   CVCL_4W37 ! HAdpc-25-Bmi-1-TERT
OI   CVCL_4W38 ! HAdpc-26-E6-Bmi-1-TERT
OI   CVCL_6F29 ! HAdpc-27-TERT
OI   CVCL_4W40 ! HAdpc-29-E7-TERT
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HAdpc-29-E7-TERT
AC   CVCL_4W40
DR   JCRB; JCRB1563
DR   Wikidata; Q54872343
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
ST   Source(s): JCRB=JCRB1563
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F30 ! HAdpc-23-E6E7
OI   CVCL_6F31 ! HAdpc-24-Bmi-1
OI   CVCL_4W37 ! HAdpc-25-Bmi-1-TERT
OI   CVCL_4W38 ! HAdpc-26-E6-Bmi-1-TERT
OI   CVCL_6F29 ! HAdpc-27-TERT
OI   CVCL_4W39 ! HAdpc-28-E6E7-TERT
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HAE-01
AC   CVCL_WA80
SY   Hereditary AngioedEma-01
DR   IBRC; C10710
DR   Wikidata; Q93937862
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84758; Hereditary angioedema
DI   ORDO; Orphanet_91378; Hereditary angioedema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HAE-02
AC   CVCL_WA81
SY   Hereditary AngioedEma-02
DR   IBRC; C10816
DR   Wikidata; Q93937864
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84758; Hereditary angioedema
DI   ORDO; Orphanet_91378; Hereditary angioedema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HAE-03
AC   CVCL_WA82
SY   Hereditary AngioedEma-03
DR   IBRC; C10848
DR   Wikidata; Q93937867
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84758; Hereditary angioedema
DI   ORDO; Orphanet_91378; Hereditary angioedema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HAE-1
AC   CVCL_LJ55
DR   ATCC; HB-9466
DR   Wikidata; Q54872344
RX   Patent=US4837171;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9466.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q5SSG8; Human MUC21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   HAE-3
AC   CVCL_LJ56
DR   ATCC; HB-9467
DR   Wikidata; Q54872345
RX   Patent=US4837171;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9467.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q5SSG8; Human MUC21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   HAE-4
AC   CVCL_LJ57
DR   ATCC; HB-9468
DR   Wikidata; Q54872346
RX   Patent=US4837171;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9468.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q5SSG8; Human MUC21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   HAE/CTVM10
AC   CVCL_Z151
SY   HAE/CTVM 10
DR   Wikidata; Q54872347
RX   PubMed=1779279;
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=22743047;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=176093; ! Hyalomma anatolicum anatolicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   HAE/CTVM11
AC   CVCL_Z152
SY   HAE/CTVM 11
DR   ECACC; 94022801
DR   Wikidata; Q54872348
RX   PubMed=1779279;
RX   PubMed=17662657;
RX   PubMed=22743047;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022801; true.
OX   NCBI_TaxID=176093; ! Hyalomma anatolicum anatolicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   HAE/CTVM15
AC   CVCL_Z234
SY   HAE/CTVM 15
DR   ECACC; 94022810
DR   Wikidata; Q54872350
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line no longer available (personal communication of Bell-Sakyi, Lesley).
CC   Discontinued: ECACC; 94022810; true.
OX   NCBI_TaxID=176093; ! Hyalomma anatolicum anatolicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   HAE/CTVM7
AC   CVCL_Z153
SY   HAE/CTVM 7
DR   Wikidata; Q54872351
RX   PubMed=1779279;
RX   PubMed=17662657;
RX   PubMed=22743047;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=176093; ! Hyalomma anatolicum anatolicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   HAE/CTVM8
AC   CVCL_Z154
SY   HAE/CTVM 8
DR   CLDB; cl5167
DR   ECACC; 94022802
DR   Wikidata; Q54872352
RX   PubMed=1779279;
RX   PubMed=17662657;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022802; true.
OX   NCBI_TaxID=176093; ! Hyalomma anatolicum anatolicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   HAE/CTVM9
AC   CVCL_Z155
SY   HAE/CTVM 9
DR   ECACC; 94022809
DR   Wikidata; Q54872353
RX   PubMed=1779279;
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022809; true.
OX   NCBI_TaxID=176093; ! Hyalomma anatolicum anatolicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   HaE9
AC   CVCL_YA22
DR   Wikidata; Q93937934
RX   DOI=10.29321/MAJ.10.100028;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Helicoverpa armigera nucleopolyhedrovirus (HearNPV) (DOI=10.29321/MAJ.10.100028).
CC   Doubling time: 3.63 days (Note=At 1th passage), 4.75 days (Note=At 5th passage) (DOI=10.29321/MAJ.10.100028).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   HAECT-1
AC   CVCL_VU17
SY   HAECT; Human Aorta Endothelial Cell Transformed-1
DR   GEO; GSE13139
DR   Wikidata; Q93937936
RX   PubMed=9521860;
RX   PubMed=15699342;
RX   PubMed=19279231;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   HAEL-1
AC   CVCL_E4B5
SY   Human Alveolar Epithelial Lung cell line-1
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-10
AC   CVCL_E4BE
SY   Human Alveolar Epithelial Lung cell line-10
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-11
AC   CVCL_E4BF
SY   Human Alveolar Epithelial Lung cell line-11
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-12
AC   CVCL_E4BG
SY   Human Alveolar Epithelial Lung cell line-12
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-2
AC   CVCL_E4B6
SY   Human Alveolar Epithelial Lung cell line-2
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-3
AC   CVCL_E4B7
SY   Human Alveolar Epithelial Lung cell line-3
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-4
AC   CVCL_E4B8
SY   Human Alveolar Epithelial Lung cell line-4
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-5
AC   CVCL_E4B9
SY   Human Alveolar Epithelial Lung cell line-5
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-6
AC   CVCL_E4BA
SY   Human Alveolar Epithelial Lung cell line-6
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-7
AC   CVCL_E4BB
SY   Human Alveolar Epithelial Lung cell line-7
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-8
AC   CVCL_E4BC
SY   Human Alveolar Epithelial Lung cell line-8
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BD ! HAEL-9
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HAEL-9
AC   CVCL_E4BD
SY   Human Alveolar Epithelial Lung cell line-9
RX   PubMed=33235275;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4B5 ! HAEL-1
OI   CVCL_E4B6 ! HAEL-2
OI   CVCL_E4B7 ! HAEL-3
OI   CVCL_E4B8 ! HAEL-4
OI   CVCL_E4B9 ! HAEL-5
OI   CVCL_E4BA ! HAEL-6
OI   CVCL_E4BB ! HAEL-7
OI   CVCL_E4BC ! HAEL-8
OI   CVCL_E4BE ! HAEL-10
OI   CVCL_E4BF ! HAEL-11
OI   CVCL_E4BG ! HAEL-12
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   hAELVi.B
AC   CVCL_C1M1
SY   human Alveolar Epithelial Lentivirus immortalized clone B
DR   Wikidata; Q114311561
RX   PubMed=26985677;
RX   PubMed=29169185;
CC   Characteristics: Suitable to model the air-blood barrier of the peripheral lung. Forms tight intercellular junctions, with high trans-epithelial electrical resistance (PubMed=26985677).
CC   Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 1 pneumocyte; CL=CL_0002062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1M0 ! CI-hAELVi
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   HAEND
AC   CVCL_8690
SY   AG13420; Human Angiosarcoma ENDothelial
DR   Coriell; AG13420
DR   Wikidata; Q54872354
RX   PubMed=8096506;
RX   PubMed=12453433;
CC   Problematic cell line: Contaminated. Unknown origin but not an umbilical vein endothelium cell line (PubMed=12453433).
CC   Doubling time: ~24 hours (PubMed=8096506).
CC   Discontinued: Coriell; AG13420; probable.
DI   NCIt; C3088; Angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   HaEpi
AC   CVCL_Z589
SY   Helicoverpa armigera Epidermal
DR   BTO; BTO_0005460
DR   ICLDB; haepi
DR   Wikidata; Q54872355
RX   PubMed=18769621;
CC   Group: Insect cell line.
CC   Doubling time: 64 hours (PubMed=18769621).
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
ID   HAEST
AC   CVCL_VS97
SY   Human Akimoto Endodermal Sinus Tumor
DR   Wikidata; Q93937949
RX   PubMed=2429643;
RX   PubMed=2430863;
RX   PubMed=9436037;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=2430863).
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 6
//
ID   HAF
AC   CVCL_A9FX
DR   CCRID; 5301HUM-KCB19021YJ
DR   KCB; KCB 2019021YJ
DR   Wikidata; Q108820396
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): CCRID=5301HUM-KCB19021YJ
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   HaF 1A10
AC   CVCL_E5Q5
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50203.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HaF 1C10
AC   CVCL_E5Q1
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2605.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50197.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HaF 1E6
AC   CVCL_E5Q0
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50200.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HaF 1F9
AC   CVCL_E5Q6
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50196.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HaF 1H11
AC   CVCL_E5PZ
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50198.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HaF 2B7
AC   CVCL_E5Q4
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50199.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HaF 2E6
AC   CVCL_E5Q3
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2606.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50202.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HaF 2F9
AC   CVCL_E5Q2
RX   Patent=US5437995;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50201.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43427; Human FIBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HAF-01
AC   CVCL_WA83
SY   Human Amniotic Fluid-01
DR   IBRC; C10890
DR   Wikidata; Q93937952
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HAF-SRK01
AC   CVCL_ZG36
SY   Human Atrial Fibroblast-SRK01
DR   Wikidata; Q98126652
RX   PubMed=32421922;
CC   Senescence: Has an extended lifespan due to the lentiviral transfer of Upcyte(R) proliferation genes.
CC   Doubling time: ~3-4 days (Direct_author_submission).
CC   Miscellaneous: Doubling time from personal communication of Kunzel, Stephan R.
CC   Derived from site: In situ; Heart, atrium; UBERON=UBERON_0002081.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   hAFDC-iPS-14
AC   CVCL_Y643
DR   Wikidata; Q54872356
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hAFDC-iPS-15
AC   CVCL_Y644
DR   Wikidata; Q54872357
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hAFDC-iPS-16
AC   CVCL_Y645
DR   SKIP; SKIP001381
DR   Wikidata; Q54872358
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): PubMed=19679563
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 8,10
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   FGA: 22,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hAFDC-iPS-19
AC   CVCL_Y646
DR   SKIP; SKIP001382
DR   Wikidata; Q54872360
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): PubMed=19679563
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 8,10
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   FGA: 22,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hAFDC-iPS-35
AC   CVCL_Y647
DR   Wikidata; Q54872361
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hAFDC-iPS-36
AC   CVCL_Y648
DR   SKIP; SKIP001383
DR   Wikidata; Q54872362
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hAFDC-iPS-4
AC   CVCL_Y649
DR   SKIP; SKIP001378
DR   Wikidata; Q54872363
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): PubMed=19679563
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 8,10
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   FGA: 22,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   hAFDC-iPS-6
AC   CVCL_C447
SY   HAFDC-IPS-6
DR   SKIP; SKIP001379
DR   Wikidata; Q54872364
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   hAFDC-iPS-7
AC   CVCL_Y650
DR   SKIP; SKIP001380
DR   Wikidata; Q54872365
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): PubMed=19679563
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 8,10
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   FGA: 22,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y651 ! hAFDC-iPS-9
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   hAFDC-iPS-9
AC   CVCL_Y651
DR   Wikidata; Q54872366
RX   PubMed=19679563;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y649 ! hAFDC-iPS-4
OI   CVCL_C447 ! hAFDC-iPS-6
OI   CVCL_Y650 ! hAFDC-iPS-7
OI   CVCL_Y643 ! hAFDC-iPS-14
OI   CVCL_Y644 ! hAFDC-iPS-15
OI   CVCL_Y645 ! hAFDC-iPS-16
OI   CVCL_Y646 ! hAFDC-iPS-19
OI   CVCL_Y647 ! hAFDC-iPS-35
OI   CVCL_Y648 ! hAFDC-iPS-36
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hAG
AC   CVCL_8223
SY   HAG; human Adenomatous Goiter
DR   BioSample; SAMN03151941
DR   cancercelllines; CVCL_8223
DR   Wikidata; Q54872367
RX   PubMed=7787432;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a 59 year old female patient with adenomatous goiter.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00124.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 60 hours (Note=In HAM + 10% FBS) (PubMed=7787432).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 27
//
ID   HAG
AC   CVCL_E681
DR   dbMHC; 48877
DR   ECACC; 94070722
DR   IHW; IHW09297
DR   IPD-IMGT/HLA; 10708
DR   Wikidata; Q54872368
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; German.
CC   HLA typing: A*02:01:01; B*41:02; C*17:01; DPB1*02:01:02,03:01:01; DQA1*05:01; DQB1*03:01:01; DRB1*13:03:01; DRB3*01:01:02:01 (IPD-IMGT/HLA=10708).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 16
//
ID   HAG-1
AC   CVCL_8225
DR   Wikidata; Q54872369
RX   PubMed=7881622;
CC   Population: Japanese.
CC   Doubling time: 26 hours (PubMed=7881622).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   hAGES
AC   CVCL_1H33
SY   human AndroGenetic Embryonic Stem cell line
DR   Wikidata; Q54872370
RX   PubMed=26076706;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   Hair iPS1
AC   CVCL_C392
SY   HAIR IPS1
DR   Wikidata; Q54872371
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C393 ! Hair iPS2
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   Hair iPS2
AC   CVCL_C393
SY   HAIR IPS2
DR   Wikidata; Q54872375
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C392 ! Hair iPS1
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   Hair-M
AC   CVCL_B401
SY   HAIR-M; Hair M
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   Cosmic; 999764
DR   Cosmic; 1809511
DR   Cosmic; 2690008
DR   DSMZ; ACC-762
DR   DSMZCellDive; ACC-762
DR   Wikidata; Q54872376
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2418246;
RX   PubMed=6608852;
RX   PubMed=11060441;
RX   PubMed=22653958;
RX   PubMed=31160637;
CC   Problematic cell line: Possibly misclassified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=2418246); ~48 hours (DSMZ=ACC-762).
CC   HLA typing: A*24:02:01,26:02:01; B*40:06:01,48:01:01; C*08:01:01,08:01:01; DPA1*02:02:02,02:02:02; DPB1*05:01:01,05:01:01; DQA1*01:03:01,01:04:01; DQB1*05:03:01,06:01:01; DRA*01:01:01,01:02:02; DRB1*08:03:02,14:05:01 (DSMZCellDive=ACC-762).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:11648; TCL1A; Name(s)=IGH-TCL1A (PubMed=31160637).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-762
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,10
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 10,15
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   HaK
AC   CVCL_3315
SY   Hak; Hamster Kidney
DR   CLO; CLO_0003620
DR   CLDB; cl1563
DR   CLDB; cl1564
DR   CLDB; cl1565
DR   CLDB; cl1566
DR   ATCC; CCL-15
DR   ECACC; 90102522
DR   IZSLER; BS CL 48
DR   Wikidata; Q54872377
RX   DOI=10.1007/BF02618370;
RX   PubMed=11541489;
RX   PubMed=14185313;
CC   Group: Space-flown cell line (cellonaut).
CC   Anecdotal: Have been flown in space on shuttle flight STS-42 (Spacelab IML-1) to study growth and metabolism in microgravity (PubMed=11541489).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   HAK-1A
AC   CVCL_7957
DR   cancercelllines; CVCL_7957
DR   Wikidata; Q54872378
RX   PubMed=7537711;
RX   PubMed=8393423;
RX   PubMed=10347112;
RX   PubMed=27329724;
CC   Population: Japanese.
CC   Doubling time: 27 hours (Note=At 8th passage) (PubMed=8393423).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Tyr (c.725G>A); ClinVar=VCV000012354; Zygosity=Unspecified (PubMed=8393423).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7958 ! HAK-1B
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   HAK-1B
AC   CVCL_7958
DR   cancercelllines; CVCL_7958
DR   Wikidata; Q54872379
RX   PubMed=7537711;
RX   PubMed=8393423;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=10347112;
RX   PubMed=27329724;
CC   Population: Japanese.
CC   Doubling time: 11 hours (Note=At 19th passage) (PubMed=8393423).
CC   HLA typing: A*02:01,33:02; B*44:03:01,54:01; C*01:02,14:03; DQA1*01:01,01:02; DQB1*06:02,06:04; DRB1*13:02,15:01 (PubMed=9178645).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Tyr (c.725G>A); ClinVar=VCV000012354; Zygosity=Unspecified (PubMed=8393423).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7957 ! HAK-1A
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   HAK-2
AC   CVCL_W445
DR   Wikidata; Q54872380
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9436038;
RX   PubMed=10347112;
CC   Population: Japanese.
CC   Doubling time: 36.8 hours (Note=At 47th passage) (PubMed=9436038).
CC   HLA typing: A*02:01,11:01; B*38:01; C*12:03; DQA1*01:02; DQB1*06:04; DRB1*13:02 (PubMed=9178645).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   HAK-3
AC   CVCL_E419
DR   Wikidata; Q54872382
RX   PubMed=10347112;
RX   PubMed=10493947;
CC   Population: Japanese.
CC   Doubling time: ~26 hours (Note=At 52th passage) (PubMed=10493947).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HAK-4
AC   CVCL_JL52
DR   Wikidata; Q54872383
RX   PubMed=10347112;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HAK-5
AC   CVCL_JL53
DR   Wikidata; Q54872384
RX   PubMed=10347112;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HAK-6
AC   CVCL_JL54
DR   Wikidata; Q54872385
RX   PubMed=10347112;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   hAKPC-P
AC   CVCL_YP01
SY   human Amniotic-fluid Kidney Progenitor Cells-Podocytes
DR   GEO; GSM1199231
DR   GEO; GSM1199232
DR   GEO; GSM1199233
DR   GEO; GSM1199234
DR   GEO; GSM1199235
DR   GEO; GSM1199236
DR   Wikidata; Q93938119
RX   PubMed=24349133;
CC   Doubling time: ~28 hours (PubMed=24349133).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-20FW
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 5
//
ID   HAL
AC   CVCL_D788
DR   cancercelllines; CVCL_D788
DR   Cosmic; 1529908
DR   GEO; GSM879207
DR   IARC_TP53; 27019
DR   Progenetix; CVCL_D788
DR   Wikidata; Q54872386
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   Doubling time: ~48 hours (PubMed=21519327).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X,Y
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 15,15.2
ST   D21S11: 31
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 11
ST   D8S1179: 12,13
ST   FGA: 23
ST   SE33: 19,24.2
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17,24.1
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   HAL-01
AC   CVCL_1242
SY   HAL-O1; HAL01; HAL-1; HALO1
DR   BTO; BTO_0004942
DR   CLO; CLO_0050976
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821626
DR   BioSample; SAMN03473501
DR   cancercelllines; CVCL_1242
DR   Cell_Model_Passport; SIDM00289
DR   ChEMBL-Cells; CHEMBL3308233
DR   ChEMBL-Targets; CHEMBL2366142
DR   CLS; 305140
DR   Cosmic; 949153
DR   Cosmic; 996300
DR   Cosmic; 998738
DR   Cosmic; 999742
DR   Cosmic; 1037744
DR   Cosmic-CLP; 949153
DR   DepMap; ACH-002241
DR   DSMZ; ACC-610
DR   DSMZCellDive; ACC-610
DR   EGA; EGAS00001000978
DR   GDSC; 949153
DR   GEO; GSM1669838
DR   GEO; GSM5137716
DR   IARC_TP53; 27557
DR   KCB; KCB 94011YJ
DR   LINCS_LDP; LCL-1046
DR   PharmacoDB; HAL01_441_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1242
DR   RCB; RCB0540
DR   Wikidata; Q54872387
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=1516826;
RX   PubMed=2027299;
RX   PubMed=9680106;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=20147975;
RX   PubMed=20164919;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=27397505;
RX   PubMed=29786757;
RX   PubMed=30894373;
RX   PubMed=31305009;
RX   PubMed=35124168;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=2027299); ~48 hours (DSMZ=ACC-610).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:4977; HLF + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-HLF, E2A-HLF; Note=In frame (PubMed=1516826).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Arg366Lysfs*8 (c.1096dup); Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Arg477Gly (c.1429C>G) (p.Arg478Gly, c.1432C>G); Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.89%; East Asian, North=78.59%; East Asian, South=19.2%; South Asian=0%; European, North=0%; European, South=1.33% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=949153; DSMZ=ACC-610; RCB=RCB0540
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 18,24
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 11,17
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C199241; B acute lymphoblastic leukemia with TCF3-HLF rearrangement
DI   ORDO; Orphanet_641375; B-lymphoblastic leukemia/lymphoma with t(17;19)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   HAL-24
AC   CVCL_VG93
DR   Wikidata; Q54872388
RX   PubMed=1676353;
RX   PubMed=9537262;
CC   Population: Japanese.
CC   Characteristics: Non-metastatic.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W526 ! KUM.LK-2
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   HAL-24Luc
AC   CVCL_VG96
DR   Wikidata; Q54872389
RX   PubMed=9537262;
RX   PubMed=10376968;
CC   Population: Japanese.
CC   Characteristics: Non-metastatic.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VG93 ! HAL-24
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HAL-33
AC   CVCL_VG94
DR   Wikidata; Q54872390
RX   PubMed=1676353;
CC   Population: Japanese.
CC   Characteristics: Low metastatic potential.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W526 ! KUM.LK-2
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   HAL-8
AC   CVCL_VG95
DR   Wikidata; Q54872391
RX   PubMed=1676353;
RX   PubMed=9537262;
CC   Population: Japanese.
CC   Characteristics: High metastatic potential.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W526 ! KUM.LK-2
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   HAL-8Luc
AC   CVCL_VG97
DR   Wikidata; Q54872392
RX   PubMed=9537262;
RX   PubMed=10376968;
CC   Population: Japanese.
CC   Characteristics: High metastatic potential.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VG95 ! HAL-8
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HaLCCA-1.1
AC   CVCL_HF40
SY   HaLCCA-1
DR   Wikidata; Q54872393
RX   PubMed=8629051;
RX   PubMed=10072166;
CC   Characteristics: Obtained by both Opisthorchis viverrini infection and N-nitrosodimethylamine treatment (PubMed=8629051).
CC   Doubling time: 31 hours (PubMed=8629051).
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Transformant: NCBI_TaxID; 6198; Opisthorchis viverrini.
DI   NCIt; C134566; Hamster cholangiocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   7M-11M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 6
//
ID   HaLCCA-2
AC   CVCL_HF41
DR   Wikidata; Q54872394
RX   PubMed=10072166;
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Transformant: NCBI_TaxID; 6198; Opisthorchis viverrini.
DI   NCIt; C134566; Hamster cholangiocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 6
//
ID   Ham-1
AC   CVCL_W387
SY   Ham-1 CCA
DR   ABM; T8201
DR   Wikidata; Q54872395
RX   PubMed=24516278;
RX   PubMed=34549357;
CC   Characteristics: Obtained by both Opisthorchis viverrini infection and N-nitrosodimethylamine treatment (PubMed=24516278).
CC   Doubling time: 36 hours (PubMed=24516278); 39.4 +- 2.6 hours (PubMed=34549357).
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Transformant: NCBI_TaxID; 6198; Opisthorchis viverrini.
DI   NCIt; C134566; Hamster cholangiocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   7M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   HAM-1
AC   CVCL_W388
SY   Human Amniotic Membrane-1
DR   Wikidata; Q54872396
RX   PubMed=15859157;
CC   Population: Japanese.
CC   Doubling time: 24 hours (Note=At 5th passage), 18 hours (Note=At 30th passage) (PubMed=15859157).
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   Ham-2
AC   CVCL_B1CT
DR   ABM; T8170
DR   Wikidata; Q110432835
RX   PubMed=34549357;
CC   Characteristics: Obtained by both Opisthorchis viverrini infection and N-nitrosodimethylamine treatment (PubMed=34549357).
CC   Doubling time: 45.8 +- 2.1 hours (PubMed=34549357).
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Transformant: NCBI_TaxID; 6198; Opisthorchis viverrini.
DI   NCIt; C134566; Hamster cholangiocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   7M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   Ham-IIA
AC   CVCL_X691
DR   Wikidata; Q54872397
RX   PubMed=2118885;
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   HAM001
AC   CVCL_E682
SY   HAM 001
DR   dbMHC; 48878
DR   ECACC; 94082274
DR   IHW; IHW09174
DR   IPD-IMGT/HLA; 11717
DR   Wikidata; Q54872398
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: African; Zulu.
CC   HLA typing: A*01,34; B*17,58:02; C*02; DPB1*01:01:01,04:01; DQA1*05:01,03; DQB1*03:01,02:01; DRB1*11:01,07:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11717).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   HAM006
AC   CVCL_E683
SY   HAM 006
DR   dbMHC; 48879
DR   ECACC; 94092275
DR   IHW; IHW09175
DR   IPD-IMGT/HLA; 10709
DR   Wikidata; Q54872400
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: African; Zulu.
CC   HLA typing: A*02,68; B*58:01,44; C*02,05; DPA1*01:03:01,03:01; DPB1*18:01,58:01; DQA1*03,02:01; DQB1*02:01,04:02; DRB1*04,07; DRB4*01:01 (IPD-IMGT/HLA=10709).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94092275; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   HAM008
AC   CVCL_E684
SY   HAM 008
DR   dbMHC; 48880
DR   ECACC; 04082276
DR   IHW; IHW09176
DR   IPD-IMGT/HLA; 11718
DR   Wikidata; Q54872401
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: African; Zulu.
CC   HLA typing: A*28; B*44,58; C*02,04 (IPD-IMGT/HLA=11718).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 04082276; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   HAM013
AC   CVCL_E685
SY   HAM 013
DR   dbMHC; 48881
DR   ECACC; 94082278
DR   IHW; IHW09178
DR   IPD-IMGT/HLA; 11720
DR   Wikidata; Q54872402
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01; B*08; C*07; DPB1*04:01; DQA1*05:01; DQB1*03:01,02:01; DRB1*12:01,03:01; DRB3*02:02,01:01 (IPD-IMGT/HLA=11720).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HAM014
AC   CVCL_E686
SY   HAM 014
DR   dbMHC; 48882
DR   ECACC; 94082277
DR   IHW; IHW09177
DR   IPD-IMGT/HLA; 11719
DR   Wikidata; Q54872403
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*08,58; C*06,07; DPB1*04:01; DQA1*05:01,02:01; DQB1*03:01,03:02; DRB1*12:01,07:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11719).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HAM1C
AC   CVCL_A6XC
DR   Wikidata; Q107115228
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179058; HTLV-1 associated myelopathy/tropical spastic paraparesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HAMOI-EnK
AC   CVCL_IP70
SY   HAMOI-Eptesicus nilssonii Kidney
DR   Wikidata; Q28872918
RX   PubMed=27499253;
CC   Group: Bat cell line.
CC   Doubling time: 23.4-25.2 hours (PubMed=27499253).
CC   Anecdotal: The first part of the name, HAMOI, is derived from the initial letter of the surnames of the 4 authors of the paper.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=3371016; ! Cnephaeus nilssonii (Northern bat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   HAMON
AC   CVCL_D3W8
SY   Human Angiosarcoma MONoclonal
DR   TKG; TKG 0810
DR   Wikidata; Q127381018
RX   PubMed=23522954;
CC   Population: Japanese.
CC   Characteristics: Established from a NOD/Scid mouse xenograft (PubMed=23522954).
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
ST   Source(s): TKG=TKG 0810
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 3
//
ID   hAMSC-01
AC   CVCL_WG61
SY   human Amniotic Mesenchymal Stem Cells-01
DR   IBRC; C10680
DR   Wikidata; Q93938253
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   hAMSC-02
AC   CVCL_WG62
SY   human Amniotic Mesenchymal Stem Cells-02
DR   IBRC; C10893
DR   Wikidata; Q93938255
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   hAMSC76telo
AC   CVCL_U604
DR   ATCC; CRL-4035
DR   BioSample; SAMN03471736
DR   Wikidata; Q54872404
RX   PubMed=19125642;
CC   Doubling time: ~24 hours (ATCC=CRL-4035).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
ST   Source(s): ATCC=CRL-4035
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8,9.3
ST   TPOX: 9,10
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   hAMSC83telo
AC   CVCL_U605
DR   ATCC; CRL-4033
DR   Wikidata; Q54872405
RX   PubMed=19125642;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-4033; true.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
ST   Source(s): ATCC=CRL-4033
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HAMT-1
AC   CVCL_D248
DR   Wikidata; Q54872406
RX   PubMed=2625822;
RX   PubMed=21597716;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 18-20 hours (PubMed=2625822; PubMed=21597716).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Hana3A
AC   CVCL_RW32
DR   EFO; EFO_0022525
DR   Wikidata; Q54872407
RX   PubMed=15550249;
RX   PubMed=18772867;
CC   Characteristics: Used for the recombinant expression of olfactory receptors.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95774; Gnal.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1098827; Reep1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2685450; Rtp1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2685451; Rtp2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   HaNaFECart
AC   CVCL_E6M8
DR   ABM; T0516
RX   PubMed=23987139;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Domestic shorthair.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   1-3Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HaNaFECven
AC   CVCL_E6M9
DR   ABM; T0517
RX   PubMed=23987139;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Inferior vena cava; UBERON=UBERON_0001072.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Domestic shorthair.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   1-3Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Handman
AC   CVCL_0G14
SY   HANDMAN
DR   Wikidata; Q54872408
RX   PubMed=19358282;
CC   From: Inghirami, Giorgio; Weill Cornell Medical College; New York; USA.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   haNK
AC   CVCL_IM23
SY   high affinity NK; CD16-V158.NK-92.05
DR   Wikidata; Q54872409
RX   PubMed=27861156;
WW   Provider; Brink Biologics; -; https://brinkbiologics.com/platform/
CC   Population: Caucasian.
CC   Characteristics: No longer dependent on IL2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers for this cell line. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   haNK GFP
AC   CVCL_VN53
SY   GFP haNK; GFP+CD16-V158.NK-92.05
DR   Wikidata; Q93938283
WW   Provider; Brink Biologics; -; https://brinkbiologics.com/platform/
CC   Population: Caucasian.
CC   Characteristics: No longer dependent on IL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers for this cell line. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IM23 ! haNK
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
ID   HANK1
AC   CVCL_8226
SY   HANK-1; HANK
DR   cancercelllines; CVCL_8226
DR   Cosmic; 1534876
DR   Cosmic; 1542076
DR   Cosmic; 2025322
DR   GEO; GSM471997
DR   GEO; GSM3021081
DR   Progenetix; CVCL_8226
DR   Wikidata; Q54872411
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9858215;
RX   PubMed=10803505;
RX   PubMed=16827800;
RX   PubMed=19194464;
RX   PubMed=21052088;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: 3 days (PubMed=9858215).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Retroperitoneal lymph node; UBERON=UBERON_0035371.
CC   Cell type: NK T-cell; CL=CL_0000814.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Hansi
AC   CVCL_F1FG
SY   HANSI
RX   PubMed=7520721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V08 ! CB-F7
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HAP-1
AC   CVCL_5G07
SY   HAP1
DR   Wikidata; Q54872412
RX   Patent=US11085020;
RX   PubMed=21900896;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 10
//
ID   HAP-2
AC   CVCL_5G08
SY   HAP2
DR   Wikidata; Q54872413
RX   Patent=US10450586;
RX   Patent=US11085020;
RX   PubMed=21900896;
CC   Group: Haploid karyotype cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3220.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   HaP-T1
AC   CVCL_2054
SY   HAP-T1; HaPT-1
DR   CLO; CLO_0003621
DR   CLO; CLO_0051588
DR   CLDB; cl1567
DR   CLDB; cl1568
DR   DSMZ; ACC-222
DR   DSMZCellDive; ACC-222
DR   ECACC; 93121054
DR   RCB; RCB0411
DR   Wikidata; Q54872414
RX   PubMed=2838375;
RX   PubMed=6513115;
CC   Doubling time: 16.9 hours (PubMed=2838375); ~25-30 hours (DSMZ=ACC-222).
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Inbred GN; VBO=VBO_0017487.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   HAP1
AC   CVCL_Y019
SY   HAP-1
DR   EFO; EFO_0007598
DR   4DN; 4DNSRCVNIBZG
DR   4DN; 4DNSRNIAESOK
DR   ArrayExpress; E-MTAB-7061
DR   BioGRID_ORCS_Cell_line; 1143
DR   cancercelllines; CVCL_Y019
DR   ChEMBL-Cells; CHEMBL4630769
DR   ChEMBL-Targets; CHEMBL4630777
DR   DepMap; ACH-002475
DR   ENCODE; ENCBS217AEF
DR   ENCODE; ENCBS912MMS
DR   GEO; GSM7701488
DR   GEO; GSM7701489
DR   Horizon_Discovery; C631
DR   PRIDE; PXD006614
DR   PRIDE; PXD006856
DR   PRIDE; PXD010335
DR   PubChem_Cell_line; CVCL_Y019
DR   Wikidata; Q18347803
RX   PubMed=21866103;
RX   PubMed=24644259;
RX   PubMed=25373145;
RX   PubMed=29474001;
RX   PubMed=31659326;
RX   PubMed=33184093;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HAP1_cells
CC   Group: Haploid karyotype cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Karyotypic information: Has lost the second copy of chromosome 8 of parent cell line KBM-7. Retains a second copy of a fragment of chromosome 15 fused to chromosome 19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 15
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 15
ST   D1S1656: 17.3
ST   D21S11: 30
ST   D22S1045: 16
ST   D2S1338: 25
ST   D2S441: 14
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 8,14
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A426 ! KBM-7
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 28
//
ID   HAP1 AAK1 (-)
AC   CVCL_SA85
SY   HZGHC000248c027; AAK1 knockout cell line 4bp deletion in exon 4
DR   cancercelllines; CVCL_SA85
DR   Horizon_Discovery; HZGHC000248c027
DR   Wikidata; Q54872415
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19679; AAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AAR2 (-) 1
AC   CVCL_E1IC
SY   HZGHC007940c003; AAR2 Knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007940c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15886; AAR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AAR2 (-) 2
AC   CVCL_E1ID
SY   HZGHC007940c010; AAR2 Knockout cell line 10bp deletion
DR   Horizon_Discovery; HZGHC007940c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15886; AAR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AATK (-) 1
AC   CVCL_SA86
SY   HZGHC000354c011; AATK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SA86
DR   Horizon_Discovery; HZGHC000354c011
DR   Wikidata; Q54872417
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21; AATK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AATK (-) 2
AC   CVCL_SA87
SY   HZGHC000354c017; AATK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SA87
DR   Horizon_Discovery; HZGHC000354c017
DR   Wikidata; Q54872418
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21; AATK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AATK (-) 3
AC   CVCL_SA88
SY   HZGHC000354c020; AATK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SA88
DR   Horizon_Discovery; HZGHC000354c020
DR   Wikidata; Q54872431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21; AATK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABAT (-)
AC   CVCL_SA89
SY   HZGHC003873c009; ABAT knockout cell line 10bp deletion in exon 5
DR   cancercelllines; CVCL_SA89
DR   Horizon_Discovery; HZGHC003873c009
DR   Wikidata; Q54872433
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23; ABAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCA1 (-) 1
AC   CVCL_SA90
SY   HZGHC003932c001; ABCA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SA90
DR   Horizon_Discovery; HZGHC003932c001
DR   Wikidata; Q54872434
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29; ABCA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003932c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCA1 (-) 2
AC   CVCL_SA91
SY   HZGHC003932c012; ABCA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SA91
DR   Horizon_Discovery; HZGHC003932c012
DR   Wikidata; Q54872435
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29; ABCA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCA3 (-) 1
AC   CVCL_SA92
SY   HZGHC006065c002; ABCA3 knockout cell line 1bp insertion; HAP1 ABCA3 (-)
DR   cancercelllines; CVCL_SA92
DR   Horizon_Discovery; HZGHC006065c002
DR   Wikidata; Q54872436
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33; ABCA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCA3 (-) 2
AC   CVCL_XK88
SY   HZGHC006065c005; ABCA3 knockout cell line 160bp insertion
DR   cancercelllines; CVCL_XK88
DR   Horizon_Discovery; HZGHC006065c005
DR   Wikidata; Q93938321
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33; ABCA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006065c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCA7 (-) 1
AC   CVCL_SA93
SY   HZGHC004950c002; ABCA7 knockout cell line 7bp deletion in exon 9
DR   cancercelllines; CVCL_SA93
DR   Horizon_Discovery; HZGHC004950c002
DR   Wikidata; Q54872438
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37; ABCA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCA7 (-) 2
AC   CVCL_SA94
SY   HZGHC004950c011; ABCA7 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SA94
DR   Horizon_Discovery; HZGHC004950c011
DR   Wikidata; Q54872439
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37; ABCA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB1 (-) 1
AC   CVCL_SA95
SY   HZGHC002430c001; ABCB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SA95
DR   Horizon_Discovery; HZGHC002430c001
DR   Wikidata; Q54872440
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB1 (-) 2
AC   CVCL_SA96
SY   HZGHC002430c005; ABCB1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SA96
DR   Horizon_Discovery; HZGHC002430c005
DR   Wikidata; Q54872441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB5 (-) 1
AC   CVCL_SA97
SY   HZGHC000800c004; ABCB5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SA97
DR   Horizon_Discovery; HZGHC000800c004
DR   Wikidata; Q54872442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB5 (-) 2
AC   CVCL_SA98
SY   HZGHC000800c009; ABCB5 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SA98
DR   Horizon_Discovery; HZGHC000800c009
DR   Wikidata; Q54872443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000800c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCB5 (-) 3
AC   CVCL_SA99
SY   HZGHC002516c010; ABCB5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SA99
DR   Horizon_Discovery; HZGHC002516c010
DR   Wikidata; Q54872444
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB5 (-) 4
AC   CVCL_SB00
SY   HZGHC002516c011; ABCB5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB00
DR   Horizon_Discovery; HZGHC002516c011
DR   Wikidata; Q54872445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB5 (-) 5
AC   CVCL_SB01
SY   HZGHC002517c005; ABCB5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SB01
DR   Horizon_Discovery; HZGHC002517c005
DR   Wikidata; Q54872446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB5 (-) 6
AC   CVCL_SB02
SY   HZGHC002517c008; ABCB5 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SB02
DR   Horizon_Discovery; HZGHC002517c008
DR   Wikidata; Q54872447
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCB8 (-)
AC   CVCL_XK95
SY   HZGHC006944c008; HZGHC11194; ABCB8 knockout cell line 41bp deletion in exon 4
DR   cancercelllines; CVCL_XK95
DR   Horizon_Discovery; HZGHC006944c008
DR   Wikidata; Q93938348
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:49; ABCB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCC1 (-) 1
AC   CVCL_SB03
SY   HZGHC003801c001; ABCC1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SB03
DR   Horizon_Discovery; HZGHC003801c001
DR   Wikidata; Q54872448
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCC1 (-) 2
AC   CVCL_SB04
SY   HZGHC003801c003; ABCC1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SB04
DR   Horizon_Discovery; HZGHC003801c003
DR   Wikidata; Q54872450
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCC1 (-) 3
AC   CVCL_SB05
SY   HZGHC003801c009; ABCC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SB05
DR   Horizon_Discovery; HZGHC003801c009
DR   Wikidata; Q54872451
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCC4 (-) 1
AC   CVCL_SB06
SY   HZGHC006327c010; ABCC4 knockout cell line 25bp deletion; HAP1 ABCC4 (-)
DR   cancercelllines; CVCL_SB06
DR   Horizon_Discovery; HZGHC006327c010
DR   Wikidata; Q54872452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:55; ABCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ABCC4 (-) 2
AC   CVCL_XK89
SY   HZGHC006328c002; ABCC4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XK89
DR   Horizon_Discovery; HZGHC006328c002
DR   Wikidata; Q93938367
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:55; ABCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCC4 (-) 3
AC   CVCL_XK90
SY   HZGHC006328c003; ABCC4 knockout cell line 67bp deletion
DR   cancercelllines; CVCL_XK90
DR   Horizon_Discovery; HZGHC006328c003
DR   Wikidata; Q93938370
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:55; ABCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCD1 (-) 1
AC   CVCL_SB07
SY   HZGHC005686c001; ABCD1 knockout cell line 10bp deletion; HAP1 ABCD1 (-)
DR   cancercelllines; CVCL_SB07
DR   Horizon_Discovery; HZGHC005686c001
DR   Wikidata; Q54872453
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCD1 (-) 2
AC   CVCL_XK91
SY   HZGHC005687c011; ABCD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XK91
DR   Horizon_Discovery; HZGHC005687c011
DR   Wikidata; Q93938374
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCD1 (-) 3
AC   CVCL_XK92
SY   HZGHC006381c003; ABCD1 knockout cell line 79bp deletion
DR   cancercelllines; CVCL_XK92
DR   Horizon_Discovery; HZGHC006381c003
DR   Wikidata; Q93938376
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCD1 (-) 4
AC   CVCL_XK93
SY   HZGHC006381c007; ABCD1 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_XK93
DR   Horizon_Discovery; HZGHC006381c007
DR   Wikidata; Q93938377
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABCD3 (-) 1
AC   CVCL_SB08
SY   HZGHC006233c003; ABCD3 knockout cell line 8bp deletion; HAP1 ABCD3 (-)
DR   cancercelllines; CVCL_SB08
DR   Horizon_Discovery; HZGHC006233c003
DR   Wikidata; Q54872454
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:67; ABCD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABCD3 (-) 2
AC   CVCL_XK94
SY   HZGHC006233c005; ABCD3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XK94
DR   Horizon_Discovery; HZGHC006233c005
DR   Wikidata; Q93938381
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:67; ABCD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABHD13 (-) 1
AC   CVCL_E1NM
SY   HZGHC007545c006; ABHD13 knockout cell line 5bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007545c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20293; ABHD13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ABHD13 (-) 2
AC   CVCL_E1NN
SY   HZGHC007545c009; ABHD13 knockout cell line 10bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007545c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20293; ABHD13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ABL1 (-)
AC   CVCL_SB09
SY   HZGHC000243c016; ABL1 knockout cell line 7bp deletion in exon 4
DR   cancercelllines; CVCL_SB09
DR   Horizon_Discovery; HZGHC000243c016
DR   Wikidata; Q54872455
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ABL2 (-) 1
AC   CVCL_SB10
SY   HZGHC029163c001; ABL2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB10
DR   Horizon_Discovery; HZGHC029163c001
DR   Wikidata; Q54872456
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABL2 (-) 2
AC   CVCL_SB11
SY   HZGHC029163c010; ABL2 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_SB11
DR   Horizon_Discovery; HZGHC029163c010
DR   Wikidata; Q54872457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ABL2 (-) 3
AC   CVCL_SB12
SY   HZGHC029163c014; ABL2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SB12
DR   Horizon_Discovery; HZGHC029163c014
DR   Wikidata; Q54872458
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACAA2 (-) 1
AC   CVCL_E1P7
SY   HZGHC007664c005
DR   Horizon_Discovery; HZGHC007664c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:83; ACAA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACAA2 (-) 2
AC   CVCL_E1P8
SY   HZGHC007665c008
DR   Horizon_Discovery; HZGHC007665c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:83; ACAA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACACA (-) 1
AC   CVCL_SB13
SY   HZGHC004903c002; ACACA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB13
DR   Horizon_Discovery; HZGHC004903c002
DR   Wikidata; Q54872459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:84; ACACA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACACA (-) 2
AC   CVCL_SB14
SY   HZGHC004903c012; ACACA knockout cell line 16bp deletion
DR   Horizon_Discovery; HZGHC004903c012
DR   Wikidata; Q54872460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:84; ACACA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004903c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACAD10 (-) 1
AC   CVCL_SB15
SY   HZGHC006479c001; ACAD10 knockout cell line 5bp deletion in exon 2; HAP1 ACAD10 (-)
DR   cancercelllines; CVCL_SB15
DR   Horizon_Discovery; HZGHC006479c001
DR   Wikidata; Q54872461
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21597; ACAD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 ACAD10 (-) 2
AC   CVCL_XK96
SY   HZGHC006479c005; ACAD10 knockout cell line 11bp deletion in exon 2
DR   cancercelllines; CVCL_XK96
DR   Horizon_Discovery; HZGHC006479c005
DR   Wikidata; Q93938408
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21597; ACAD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACAD10 (-) ACAD11 (-)
AC   CVCL_DX20
SY   HZGHC007789c010; Double knockout cell line ACAD10 11bp deletion in exon 2 and ACAD11 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007789c010
DR   Wikidata; Q127381019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21597; ACAD10.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30211; ACAD11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XK96 ! HAP1 ACAD10 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACAD11 (-)
AC   CVCL_C7ZB
SY   HZGHC007728c001; ACAD11 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007728c001
DR   Wikidata; Q123031393
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30211; ACAD11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACAD9 (-) 1
AC   CVCL_C7ZC
SY   HZGHC007703c004; ACAD9 knockout cell line 19bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007703c004
DR   Wikidata; Q123031394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21497; ACAD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACAD9 (-) 2
AC   CVCL_C7ZD
SY   HZGHC007703c007; ACAD9 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007703c007
DR   Wikidata; Q123031395
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21497; ACAD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACADS (-) 1
AC   CVCL_E1P9
SY   HZGHC007663c001
DR   Horizon_Discovery; HZGHC007663c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:90; ACADS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACADS (-) 2
AC   CVCL_E1PA
SY   HZGHC007663c004
DR   Horizon_Discovery; HZGHC007663c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:90; ACADS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACADS (-) 3
AC   CVCL_E1PB
SY   HZGHC007663c005
DR   Horizon_Discovery; HZGHC007663c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:90; ACADS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACADVL (-) 1
AC   CVCL_E1PC
SY   HZGHC007534c001
DR   Horizon_Discovery; HZGHC007534c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:92; ACADVL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACADVL (-) 2
AC   CVCL_E1PD
SY   HZGHC007534c005
DR   Horizon_Discovery; HZGHC007534c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:92; ACADVL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACADVL (-) 3
AC   CVCL_E1PE
SY   HZGHC007534c006
DR   Horizon_Discovery; HZGHC007534c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:92; ACADVL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACADVL (-) 4
AC   CVCL_E1PF
SY   HZGHC007534c008
DR   Horizon_Discovery; HZGHC007534c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:92; ACADVL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACAT2 (-) 1
AC   CVCL_E1PG
SY   HZGHC007752c014
DR   Horizon_Discovery; HZGHC007752c014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:94; ACAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACAT2 (-) 2
AC   CVCL_E1PH
SY   HZGHC007752c015
DR   Horizon_Discovery; HZGHC007752c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:94; ACAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACAT2 (-) 3
AC   CVCL_E1PI
SY   HZGHC007752c022
DR   Horizon_Discovery; HZGHC007752c022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:94; ACAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACAT2 (-) 4
AC   CVCL_E1PJ
SY   HZGHC007752c023
DR   Horizon_Discovery; HZGHC007752c023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:94; ACAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ACBD3 (-)
AC   CVCL_SB16
SY   HZGHC000673c009; ACBD3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SB16
DR   Horizon_Discovery; HZGHC000673c009
DR   Wikidata; Q54872462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15453; ACBD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000673c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACD (-) 1
AC   CVCL_SB17
SY   HZGHC005062c003; ACD knockout cell line 62bp deletion
DR   cancercelllines; CVCL_SB17
DR   Horizon_Discovery; HZGHC005062c003
DR   Wikidata; Q54872464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25070; ACD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACD (-) 2
AC   CVCL_SB18
SY   HZGHC005062c010; ACD knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SB18
DR   Horizon_Discovery; HZGHC005062c010
DR   Wikidata; Q54872465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25070; ACD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACE (-) 1
AC   CVCL_SB19
SY   HZGHC003877c004; ACE knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB19
DR   Horizon_Discovery; HZGHC003877c004
DR   Wikidata; Q54872466
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2707; ACE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACE (-) 2
AC   CVCL_SB20
SY   HZGHC003877c005; ACE knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SB20
DR   Horizon_Discovery; HZGHC003877c005
DR   Wikidata; Q54872467
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2707; ACE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACHE (-) 1
AC   CVCL_SB21
SY   HZGHC003880c005; ACHE knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SB21
DR   Horizon_Discovery; HZGHC003880c005
DR   Wikidata; Q54872468
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:108; ACHE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACHE (-) 2
AC   CVCL_SB22
SY   HZGHC003880c012; ACHE knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SB22
DR   Horizon_Discovery; HZGHC003880c012
DR   Wikidata; Q54872469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:108; ACHE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACLY (-) 1
AC   CVCL_SB23
SY   HZGHC005811c011; ACLY knockout cell line 2bp deletion; HAP1 ACLY (-)
DR   cancercelllines; CVCL_SB23
DR   Horizon_Discovery; HZGHC005811c011
DR   Wikidata; Q54872470
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:115; ACLY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACLY (-) 2
AC   CVCL_XK97
SY   HZGHC005811c002; ACLY knockout cell line 56bp deletion
DR   cancercelllines; CVCL_XK97
DR   Horizon_Discovery; HZGHC005811c002
DR   Wikidata; Q93938450
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:115; ACLY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACO2 (-) 1
AC   CVCL_SB24
SY   HZGHC004906c008; ACO2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB24
DR   Horizon_Discovery; HZGHC004906c008
DR   Wikidata; Q54872471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:118; ACO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACO2 (-) 2
AC   CVCL_SB25
SY   HZGHC004906c011; ACO2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SB25
DR   Horizon_Discovery; HZGHC004906c011
DR   Wikidata; Q54872472
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:118; ACO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACOD1 (-) 1
AC   CVCL_ST04
SY   HZGHC001502c002; ACOD1 knockout cell line 26bp deletion in exon 3; HAP1 IRG1 (-) 1
DR   cancercelllines; CVCL_ST04
DR   Horizon_Discovery; HZGHC001502c002
DR   Wikidata; Q54875800
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33904; ACOD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACOD1 (-) 2
AC   CVCL_ST05
SY   HZGHC001502c005; ACOD1 knockout cell line 10bp deletion in exon 3; HAP1 IRG1 (-) 2
DR   cancercelllines; CVCL_ST05
DR   Horizon_Discovery; HZGHC001502c005
DR   Wikidata; Q54875801
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33904; ACOD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACOX1 (-) 1
AC   CVCL_C7ZE
SY   HZGHC007533c001; ACOX1 knockout cell line 1bp insertion in exon 7
DR   Horizon_Discovery; HZGHC007533c001
DR   Wikidata; Q123031396
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:119; ACOX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007533c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 ACOX1 (-) 2
AC   CVCL_C7ZF
SY   HZGHC007533c003; ACOX1 knockout cell line 187bp deletion in exon 7
DR   Horizon_Discovery; HZGHC007533c003
DR   Wikidata; Q123031397
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:119; ACOX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007533c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 ACSL3 (-)
AC   CVCL_XK98
SY   HZGHC006931c012; HZGHC2181; ACSL3 knockout cell line 2bp insertion in exon 4
DR   cancercelllines; CVCL_XK98
DR   Horizon_Discovery; HZGHC006931c012
DR   Wikidata; Q93938462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3570; ACSL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACSL3 (-) ACSL4 (-)
AC   CVCL_DX21
SY   HZGHC007235c010; Double knockout cell line ACSL3 2bp insertion in exon 4 and ACSL4 11bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007235c010
DR   Wikidata; Q127381020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3570; ACSL3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XK98 ! HAP1 ACSL3 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACSL4 (-) 1
AC   CVCL_XK99
SY   HZGHC006933c006; HZGHC2182; ACSL4 knockout cell line 1bp insertion in exon 3; HAP1 ACSL4 (-)
DR   cancercelllines; CVCL_XK99
DR   Horizon_Discovery; HZGHC006933c006
DR   Wikidata; Q93938463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACSL4 (-) 2
AC   CVCL_B5JF
SY   HZGHC006933c012; ACSL4 knockout cell line 2bp deletion in exon 3
DR   cancercelllines; CVCL_B5JF
DR   Horizon_Discovery; HZGHC006933c012
DR   Wikidata; Q111733263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ACSS1 (-) 1
AC   CVCL_C7ZG
SY   HZGHC007519c003; ACSS1 knockout cell line 11bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007519c003
DR   Wikidata; Q123031399
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16091; ACSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACSS1 (-) 2
AC   CVCL_C7ZH
SY   HZGHC007519c004; ACSS1 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007519c004
DR   Wikidata; Q123031400
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16091; ACSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACSS1 (-) 3
AC   CVCL_C7ZI
SY   HZGHC007519c007; ACSS1 knockout cell line 4bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007519c007
DR   Wikidata; Q123031401
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16091; ACSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACSS1 (-) 4
AC   CVCL_C7ZJ
SY   HZGHC007519c008; ACSS1 knockout cell line 2bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007519c008
DR   Wikidata; Q123031402
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16091; ACSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACSS1 (-) 5
AC   CVCL_C7ZK
SY   HZGHC007519c009; ACSS1 knockout cell line 62bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007519c009
DR   Wikidata; Q123031403
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16091; ACSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ACSS2 (-) 1
AC   CVCL_SB26
SY   HZGHC005283c011; ACSS2 knockout cell line 7bp deletion; HAP1 ACSS2 (-)
DR   cancercelllines; CVCL_SB26
DR   Horizon_Discovery; HZGHC005283c011
DR   Wikidata; Q54872473
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15814; ACSS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACSS2 (-) 2
AC   CVCL_XL00
SY   HZGHC005283c007; ACSS2 knockout cell line 113bp deletion
DR   cancercelllines; CVCL_XL00
DR   Horizon_Discovery; HZGHC005283c007
DR   Wikidata; Q93938465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15814; ACSS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACTB (-) 1
AC   CVCL_SB27
SY   HZGHC002471c002; ACTB knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SB27
DR   Horizon_Discovery; HZGHC002471c002
DR   Wikidata; Q54872474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:132; ACTB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002471c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACTB (-) 2
AC   CVCL_SB28
SY   HZGHC002471c010; ACTB knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SB28
DR   Horizon_Discovery; HZGHC002471c010
DR   Wikidata; Q54872478
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:132; ACTB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002471c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACTN1 (-) 1
AC   CVCL_SB29
SY   HZGHC006311c012; ACTN1 knockout cell line 1bp insertion; HAP1 ACTN1 (-)
DR   cancercelllines; CVCL_SB29
DR   Horizon_Discovery; HZGHC006311c012
DR   Wikidata; Q54872479
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:163; ACTN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACTN1 (-) 2
AC   CVCL_XL01
SY   HZGHC006311c002; ACTN1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XL01
DR   Horizon_Discovery; HZGHC006311c002
DR   Wikidata; Q93938469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:163; ACTN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACTN4 (-) 1
AC   CVCL_SB30
SY   HZGHC006295c006; ACTN4 knockout cell line 10bp deletion; HAP1 ACTN4 (-)
DR   cancercelllines; CVCL_SB30
DR   Horizon_Discovery; HZGHC006295c006
DR   Wikidata; Q54872480
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:166; ACTN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACTN4 (-) 2
AC   CVCL_XL02
SY   HZGHC006295c009; ACTN4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XL02
DR   Horizon_Discovery; HZGHC006295c009
DR   Wikidata; Q93938470
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:166; ACTN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR1 (-)
AC   CVCL_SB31
SY   HZGHC000195c001; ACVR1 knockout cell line 2bp insertion in exon 4
DR   cancercelllines; CVCL_SB31
DR   Horizon_Discovery; HZGHC000195c001
DR   Wikidata; Q54872481
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:171; ACVR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACVR1B (-)
AC   CVCL_SB32
SY   HZGHC000254c009; ACVR1B knockout cell line 5bp deletion in exon 2
DR   cancercelllines; CVCL_SB32
DR   Horizon_Discovery; HZGHC000254c009
DR   Wikidata; Q54872482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:172; ACVR1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACVR2A (-) 1
AC   CVCL_SB33
SY   HZGHC003568c005; ACVR2A knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SB33
DR   Horizon_Discovery; HZGHC003568c005
DR   Wikidata; Q54872483
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:173; ACVR2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2A (-) 2
AC   CVCL_SB34
SY   HZGHC000400c009; ACVR2A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SB34
DR   Horizon_Discovery; HZGHC000400c009
DR   Wikidata; Q54872484
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:173; ACVR2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2A (-) 3
AC   CVCL_SB35
SY   HZGHC004080c001; ACVR2A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB35
DR   Horizon_Discovery; HZGHC004080c001
DR   Wikidata; Q54872485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:173; ACVR2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2A (-) 4
AC   CVCL_SB36
SY   HZGHC004080c005; ACVR2A knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SB36
DR   Horizon_Discovery; HZGHC004080c005
DR   Wikidata; Q54872487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:173; ACVR2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2A (-) 5
AC   CVCL_SB37
SY   HZGHC003568c004; ACVR2A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SB37
DR   Horizon_Discovery; HZGHC003568c004
DR   Wikidata; Q54872488
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:173; ACVR2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2B (-) 1
AC   CVCL_SB38
SY   HZGHC000196c021; ACVR2B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SB38
DR   Horizon_Discovery; HZGHC000196c021
DR   Wikidata; Q54872489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2B (-) 2
AC   CVCL_SB39
SY   HZGHC002842c004; ACVR2B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SB39
DR   Horizon_Discovery; HZGHC002842c004
DR   Wikidata; Q54872490
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2B (-) 3
AC   CVCL_SB40
SY   HZGHC002842c007; ACVR2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB40
DR   Horizon_Discovery; HZGHC002842c007
DR   Wikidata; Q54872491
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2B (-) 4
AC   CVCL_SB41
SY   HZGHC003427c002; ACVR2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB41
DR   Horizon_Discovery; HZGHC003427c002
DR   Wikidata; Q54872492
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2B (-) 5
AC   CVCL_SB42
SY   HZGHC003427c009; ACVR2B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SB42
DR   Horizon_Discovery; HZGHC003427c009
DR   Wikidata; Q54872493
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ACVR2B (-) 6
AC   CVCL_SB43
SY   HZGHC003567c008; ACVR2B knockout cell line 418bp insertion
DR   cancercelllines; CVCL_SB43
DR   Horizon_Discovery; HZGHC003567c008
DR   Wikidata; Q54872494
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003567c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ACY1 (-)
AC   CVCL_DX69
SY   HZGHC007797c004; ACY1 knockout cell line 5bp deletion in exon 13
DR   Horizon_Discovery; HZGHC007797c004
DR   Wikidata; Q127381021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:177; ACY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ADA (-)
AC   CVCL_SB44
SY   HZGHC003818c011; ADA knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_SB44
DR   Horizon_Discovery; HZGHC003818c011
DR   Wikidata; Q54872496
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:186; ADA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADAM10 (-) 1
AC   CVCL_SB45
SY   HZGHC001517c011; ADAM10 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB45
DR   Horizon_Discovery; HZGHC001517c011
DR   Wikidata; Q54872497
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADAM10 (-) 2
AC   CVCL_SB46
SY   HZGHC001517c012; ADAM10 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SB46
DR   Horizon_Discovery; HZGHC001517c012
DR   Wikidata; Q54872498
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADAM17 (-) 1
AC   CVCL_SB47
SY   HZGHC001515c002; ADAM17 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SB47
DR   Horizon_Discovery; HZGHC001515c002
DR   Wikidata; Q54872499
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADAM17 (-) 2
AC   CVCL_SB48
SY   HZGHC001515c012; ADAM17 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SB48
DR   Horizon_Discovery; HZGHC001515c012
DR   Wikidata; Q54872500
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADAM9 (-) 1
AC   CVCL_SB49
SY   HZGHC000687c007; ADAM9 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SB49
DR   Horizon_Discovery; HZGHC000687c007
DR   Wikidata; Q54872502
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000687c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADAM9 (-) 2
AC   CVCL_SB50
SY   HZGHC000687c011; ADAM9 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SB50
DR   Horizon_Discovery; HZGHC000687c011
DR   Wikidata; Q54872503
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADAM9 (-) 3
AC   CVCL_SB51
SY   HZGHC000688c009; ADAM9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB51
DR   Horizon_Discovery; HZGHC000688c009
DR   Wikidata; Q54872504
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADAM9 (-) 4
AC   CVCL_SB52
SY   HZGHC000688c012; ADAM9 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SB52
DR   Horizon_Discovery; HZGHC000688c012
DR   Wikidata; Q54872505
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADAR (-) 1
AC   CVCL_SB53
SY   HZGHC001513c010; ADAR knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SB53
DR   Horizon_Discovery; HZGHC001513c010
DR   Wikidata; Q54872506
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001513c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADAR (-) 2
AC   CVCL_SB54
SY   HZGHC001513c011; ADAR knockout cell line 31bp deletion
DR   cancercelllines; CVCL_SB54
DR   Horizon_Discovery; HZGHC001513c011
DR   Wikidata; Q54872507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001513c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADAR (-) ADARB1 (-)
AC   CVCL_DX22
SY   HZGHC007931c007; Double knockout cell line ADAR 17bp deletion and 5bp deletion
DR   Horizon_Discovery; HZGHC007931c007
DR   Wikidata; Q127381022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:226; ADARB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007931c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SB53 ! HAP1 ADAR (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ADARB1 (-)
AC   CVCL_SB55
SY   HZGHC005068c002; ADARB1 knockout cell line 2bp deletion in exon 4
DR   cancercelllines; CVCL_SB55
DR   Horizon_Discovery; HZGHC005068c002
DR   Wikidata; Q54872508
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:226; ADARB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADCK1 (-) 1
AC   CVCL_SB56
SY   HZGHC004962c001; ADCK1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SB56
DR   Horizon_Discovery; HZGHC004962c001
DR   Wikidata; Q54872509
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19038; ADCK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCK1 (-) 2
AC   CVCL_SB57
SY   HZGHC004962c009; ADCK1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SB57
DR   Horizon_Discovery; HZGHC004962c009
DR   Wikidata; Q54872510
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19038; ADCK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCK2 (-) 1
AC   CVCL_SB58
SY   HZGHC001492c004; ADCK2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SB58
DR   Horizon_Discovery; HZGHC001492c004
DR   Wikidata; Q54872511
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19039; ADCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCK2 (-) 2
AC   CVCL_SB59
SY   HZGHC002981c010; ADCK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SB59
DR   Horizon_Discovery; HZGHC002981c010
DR   Wikidata; Q54872512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19039; ADCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCK2 (-) 3
AC   CVCL_SB60
SY   HZGHC002981c011; ADCK2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SB60
DR   Horizon_Discovery; HZGHC002981c011
DR   Wikidata; Q54872513
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19039; ADCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCK5 (-) 1
AC   CVCL_SB65
SY   HZGHC000316c010; ADCK5 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SB65
DR   Horizon_Discovery; HZGHC000316c010
DR   Wikidata; Q54872518
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21738; ADCK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCK5 (-) 2
AC   CVCL_SB66
SY   HZGHC000316c015; ADCK5 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SB66
DR   Horizon_Discovery; HZGHC000316c015
DR   Wikidata; Q54872519
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21738; ADCK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCY3 (-) 1
AC   CVCL_SB67
SY   HZGHC005600c010; ADCY3 knockout cell line 2bp insertion; HAP1 ADCY3 (-)
DR   cancercelllines; CVCL_SB67
DR   Horizon_Discovery; HZGHC005600c010
DR   Wikidata; Q54872520
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:234; ADCY3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADCY3 (-) 2
AC   CVCL_XL04
SY   HZGHC005600c008; ADCY3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XL04
DR   Horizon_Discovery; HZGHC005600c008
DR   Wikidata; Q93938647
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:234; ADCY3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCY6 (-) 1
AC   CVCL_SB68
SY   HZGHC005602c010; ADCY6 knockout cell line 1bp insertion; HAP1 ADCY6 (-)
DR   cancercelllines; CVCL_SB68
DR   Horizon_Discovery; HZGHC005602c010
DR   Wikidata; Q54872525
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:237; ADCY6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADCY6 (-) 2
AC   CVCL_XL05
SY   HZGHC005602c011; ADCY6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL05
DR   Horizon_Discovery; HZGHC005602c011
DR   Wikidata; Q93938653
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:237; ADCY6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCY7 (-) 1
AC   CVCL_SB69
SY   HZGHC005604c001; ADCY7 knockout cell line 14bp deletion; HAP1 ADCY7 (-)
DR   cancercelllines; CVCL_SB69
DR   Horizon_Discovery; HZGHC005604c001
DR   Wikidata; Q54872526
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:238; ADCY7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADCY7 (-) 2
AC   CVCL_XL06
SY   HZGHC005604c012; ADCY7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XL06
DR   Horizon_Discovery; HZGHC005604c012
DR   Wikidata; Q93938664
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:238; ADCY7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADCY9 (-) 1
AC   CVCL_SB70
SY   HZGHC005605c010; ADCY9 knockout cell line 8bp deletion; HAP1 ADCY9 (-)
DR   cancercelllines; CVCL_SB70
DR   Horizon_Discovery; HZGHC005605c010
DR   Wikidata; Q54872527
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:240; ADCY9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADCY9 (-) 2
AC   CVCL_XL07
SY   HZGHC005605c009; ADCY9 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XL07
DR   Horizon_Discovery; HZGHC005605c009
DR   Wikidata; Q93938672
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:240; ADCY9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADH5 (-)
AC   CVCL_XL08
SY   HZGHC007179c009; HZGHC128; ADH5 knockout cell line 2bp deletion in exon 5
DR   cancercelllines; CVCL_XL08
DR   Horizon_Discovery; HZGHC007179c009
DR   Wikidata; Q93938675
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:253; ADH5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADIPOR1 (-) 1
AC   CVCL_SB71
SY   HZGHC003914c011; ADIPOR1 knockout cell line 5bp deletion; HAP1 ADIPOR1 (-)
DR   cancercelllines; CVCL_SB71
DR   Horizon_Discovery; HZGHC003914c011
DR   Wikidata; Q54872528
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24040; ADIPOR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADIPOR1 (-) 2
AC   CVCL_XL09
SY   HZGHC003914c001; ADIPOR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL09
DR   Horizon_Discovery; HZGHC003914c001
DR   Wikidata; Q93938683
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24040; ADIPOR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADIPOR1 (-) 3
AC   CVCL_XL10
SY   HZGHC003914c003; ADIPOR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XL10
DR   Horizon_Discovery; HZGHC003914c003
DR   Wikidata; Q93938686
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24040; ADIPOR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADIPOR1 (-) 4
AC   CVCL_XL11
SY   HZGHC003914c012; ADIPOR1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XL11
DR   Horizon_Discovery; HZGHC003914c012
DR   Wikidata; Q93938688
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24040; ADIPOR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADIPOR2 (-) 1
AC   CVCL_SB72
SY   HZGHC003913c002; ADIPOR2 knockout cell line 5bp deletion; HAP1 ADIPOR2 (-)
DR   cancercelllines; CVCL_SB72
DR   Horizon_Discovery; HZGHC003913c002
DR   Wikidata; Q54872529
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24041; ADIPOR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADIPOR2 (-) 2
AC   CVCL_XL12
SY   HZGHC003913c006; ADIPOR2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL12
DR   Horizon_Discovery; HZGHC003913c006
DR   Wikidata; Q93938697
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24041; ADIPOR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADK (-) 1
AC   CVCL_SB73
SY   HZGHC003773c002; ADK knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SB73
DR   Horizon_Discovery; HZGHC003773c002
DR   Wikidata; Q54872530
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:257; ADK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADK (-) 2
AC   CVCL_SB74
SY   HZGHC003773c011; ADK knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SB74
DR   Horizon_Discovery; HZGHC003773c011
DR   Wikidata; Q54872531
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:257; ADK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADO (-)
AC   CVCL_E1PK
SY   HZGHC008126c004; ADO knockout cell line 8bp deletion in exon 1
DR   Horizon_Discovery; HZGHC008126c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23506; ADO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ADORA2A (-) 1
AC   CVCL_SB75
SY   HZGHC003921c002; ADORA2A knockout cell line 17bp insertion
DR   cancercelllines; CVCL_SB75
DR   Horizon_Discovery; HZGHC003921c002
DR   Wikidata; Q54872532
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003921c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADORA2A (-) 2
AC   CVCL_SB76
SY   HZGHC003921c012; ADORA2A knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SB76
DR   Horizon_Discovery; HZGHC003921c012
DR   Wikidata; Q54872533
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADORA2B (-) 1
AC   CVCL_SB77
SY   HZGHC004232c001; ADORA2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB77
DR   Horizon_Discovery; HZGHC004232c001
DR   Wikidata; Q54872534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:264; ADORA2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADORA2B (-) 2
AC   CVCL_SB78
SY   HZGHC004232c005; ADORA2B knockout cell line 223bp insertion
DR   cancercelllines; CVCL_SB78
DR   Horizon_Discovery; HZGHC004232c005
DR   Wikidata; Q54872535
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:264; ADORA2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004232c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADPRHL2 (-)
AC   CVCL_E1PL
SY   HZGHC008084c011; ADPRHL2 knockout cell line 31bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008084c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21304; ADPRS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ADRA1A (-) 1
AC   CVCL_SB79
SY   HZGHC003934c001; ADRA1A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SB79
DR   Horizon_Discovery; HZGHC003934c001
DR   Wikidata; Q54872536
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:277; ADRA1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADRA1A (-) 2
AC   CVCL_SB80
SY   HZGHC003934c012; ADRA1A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SB80
DR   Horizon_Discovery; HZGHC003934c012
DR   Wikidata; Q54872537
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:277; ADRA1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADRBK1 (-)
AC   CVCL_SB81
SY   HZGHC000706c012; ADRBK1 knockout cell line 32bp deletion in exon 6
DR   cancercelllines; CVCL_SB81
DR   Horizon_Discovery; HZGHC000706c012
DR   Wikidata; Q54872538
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:289; GRK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ADRBK2 (-) 1
AC   CVCL_SB82
SY   HZGHC000041c010; ADRBK2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SB82
DR   Horizon_Discovery; HZGHC000041c010
DR   Wikidata; Q54872539
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADRBK2 (-) 2
AC   CVCL_SB83
SY   HZGHC000041c011; ADRBK2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SB83
DR   Horizon_Discovery; HZGHC000041c011
DR   Wikidata; Q54872540
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ADRBK2 (-) 3
AC   CVCL_SB84
SY   HZGHC000041c014; ADRBK2 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SB84
DR   Horizon_Discovery; HZGHC000041c014
DR   Wikidata; Q54872541
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000041c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AEBP2 (-) 1
AC   CVCL_SB85
SY   HZGHC001393c003; AEBP2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SB85
DR   Horizon_Discovery; HZGHC001393c003
DR   Wikidata; Q54872542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24051; AEBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AEBP2 (-) 2
AC   CVCL_SB86
SY   HZGHC001393c006; AEBP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB86
DR   Horizon_Discovery; HZGHC001393c006
DR   Wikidata; Q54872543
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24051; AEBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AEBP2 (-) 3
AC   CVCL_SB87
SY   HZGHC001394c006; AEBP2 knockout cell line 38bp deletion
DR   cancercelllines; CVCL_SB87
DR   Horizon_Discovery; HZGHC001394c006
DR   Wikidata; Q54872544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24051; AEBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AEBP2 (-) 4
AC   CVCL_SB88
SY   HZGHC001394c012; AEBP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SB88
DR   Horizon_Discovery; HZGHC001394c012
DR   Wikidata; Q54872545
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24051; AEBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AFTPH (-) 1
AC   CVCL_SB89
SY   HZGHC000847c002; AFTPH knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SB89
DR   Horizon_Discovery; HZGHC000847c002
DR   Wikidata; Q54872546
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25951; AFTPH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AFTPH (-) 2
AC   CVCL_SB90
SY   HZGHC000847c005; AFTPH knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SB90
DR   Horizon_Discovery; HZGHC000847c005
DR   Wikidata; Q54872547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25951; AFTPH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AGAP1 (-) 1
AC   CVCL_E1PM
SY   HZGHC007476c001
DR   Horizon_Discovery; HZGHC007476c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16922; AGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGAP1 (-) 2
AC   CVCL_E1PN
SY   HZGHC007476c003
DR   Horizon_Discovery; HZGHC007476c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16922; AGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGAP1 (-) 3
AC   CVCL_E1PP
SY   HZGHC007476c007
DR   Horizon_Discovery; HZGHC007476c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16922; AGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGER (-) 1
AC   CVCL_SB91
SY   HZGHC005364c001; AGER knockout cell line 23bp deletion; HAP1 AGER (-)
DR   cancercelllines; CVCL_SB91
DR   Horizon_Discovery; HZGHC005364c001
DR   Wikidata; Q54872548
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:320; AGER.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AGER (-) 2
AC   CVCL_XL13
SY   HZGHC005364c012; AGER knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XL13
DR   Horizon_Discovery; HZGHC005364c012
DR   Wikidata; Q93938801
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:320; AGER.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AGK (-) 1
AC   CVCL_E1PQ
SY   HZGHC008058c009
DR   Horizon_Discovery; HZGHC008058c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21869; AGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGK (-) 2
AC   CVCL_E1PR
SY   HZGHC008059c007
DR   Horizon_Discovery; HZGHC008059c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21869; AGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGK (-) 3
AC   CVCL_E1PS
SY   HZGHC008059c009
DR   Horizon_Discovery; HZGHC008059c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21869; AGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGL (-) 1
AC   CVCL_SB92
SY   HZGHC003782c011; AGL knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SB92
DR   Horizon_Discovery; HZGHC003782c011
DR   Wikidata; Q54872549
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:321; AGL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AGL (-) 2
AC   CVCL_SB93
SY   HZGHC003782c012; AGL knockout cell line 200bp insertion
DR   cancercelllines; CVCL_SB93
DR   Horizon_Discovery; HZGHC003782c012
DR   Wikidata; Q54872550
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:321; AGL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003782c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AGO1 (-) 1
AC   CVCL_SB94
SY   HZGHC002455c010; AGO1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SB94
DR   Horizon_Discovery; HZGHC002455c010
DR   Wikidata; Q54872551
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3262; AGO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002455c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AGO1 (-) 2
AC   CVCL_SB95
SY   HZGHC001541c005; AGO1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SB95
DR   Horizon_Discovery; HZGHC001541c005
DR   Wikidata; Q54872552
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3262; AGO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AGO1 (-) 3
AC   CVCL_SB96
SY   HZGHC002455c001; AGO1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SB96
DR   Horizon_Discovery; HZGHC002455c001
DR   Wikidata; Q54872554
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3262; AGO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AGO1 (-) 4
AC   CVCL_SB97
SY   HZGHC002455c012; AGO1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SB97
DR   Horizon_Discovery; HZGHC002455c012
DR   Wikidata; Q54872555
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3262; AGO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AGO3 (-) 1
AC   CVCL_C7ZL
SY   HZGHC007332c002; AGO3 knockout cell line 20bp deletion in exon 15
DR   Horizon_Discovery; HZGHC007332c002
DR   Wikidata; Q123031404
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18421; AGO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 AGO3 (-) 2
AC   CVCL_C7ZM
SY   HZGHC007332c012; AGO3 knockout cell line 13bp deletion in exon 15
DR   Horizon_Discovery; HZGHC007332c012
DR   Wikidata; Q123031405
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18421; AGO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 AGPAT3 (-) 1
AC   CVCL_E1PT
SY   HZGHC007828c002
DR   Horizon_Discovery; HZGHC007828c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:326; AGPAT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGPAT3 (-) 2
AC   CVCL_E1PU
SY   HZGHC007828c009
DR   Horizon_Discovery; HZGHC007828c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:326; AGPAT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AGRN (-) 1
AC   CVCL_SB98
SY   HZGHC001296c007; AGRN knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SB98
DR   Horizon_Discovery; HZGHC001296c007
DR   Wikidata; Q54872556
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:329; AGRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AGRN (-) 2
AC   CVCL_SB99
SY   HZGHC001296c010; AGRN knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SB99
DR   Horizon_Discovery; HZGHC001296c010
DR   Wikidata; Q54872558
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:329; AGRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AHR (-) 1
AC   CVCL_SC00
SY   HZGHC003993c002; AHR knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SC00
DR   Horizon_Discovery; HZGHC003993c002
DR   Wikidata; Q54872559
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AHR (-) 2
AC   CVCL_SC01
SY   HZGHC003993c010; AHR knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SC01
DR   Horizon_Discovery; HZGHC003993c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54872560
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AHSA1 (-) 1
AC   CVCL_XL14
SY   HZGHC007137c013; HZGHC10598; AHSA1 knockout cell line 40bp deletion in exon 2; HAP1 AHSA1 (-)
DR   cancercelllines; CVCL_XL14
DR   Horizon_Discovery; HZGHC007137c013
DR   Wikidata; Q93938878
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1189; AHSA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 AHSA1 (-) 2
AC   CVCL_E1PV
SY   HZGHC007137c014
DR   Horizon_Discovery; HZGHC007137c014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1189; AHSA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AHSA1 (-) 3
AC   CVCL_E1PW
SY   HZGHC007137c019
DR   Horizon_Discovery; HZGHC007137c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1189; AHSA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AHSA1 (-) 4
AC   CVCL_E1PX
SY   HZGHC007137c021
DR   Horizon_Discovery; HZGHC007137c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1189; AHSA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AIFM1 (-)
AC   CVCL_SC02
SY   HZGHC005414c005; AIFM1 knockout cell line 185bp insertion
DR   cancercelllines; CVCL_SC02
DR   Horizon_Discovery; HZGHC005414c005
DR   Wikidata; Q54872561
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8768; AIFM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005414c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AIM2 (-) 1
AC   CVCL_E1PY
SY   HZGHC008070c008
DR   Horizon_Discovery; HZGHC008070c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:357; AIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AIM2 (-) 2
AC   CVCL_E1PZ
SY   HZGHC008070c009
DR   Horizon_Discovery; HZGHC008070c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:357; AIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AIM2 (-) 3
AC   CVCL_E1Q0
SY   HZGHC008071c012
DR   Horizon_Discovery; HZGHC008071c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:357; AIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AIMP1 (-) 1
AC   CVCL_E1Q1
SY   HZGHC007522c003
DR   Horizon_Discovery; HZGHC007522c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10648; AIMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AIMP1 (-) 2
AC   CVCL_E1Q2
SY   HZGHC007522c008
DR   Horizon_Discovery; HZGHC007522c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10648; AIMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AJUBA (-) 1
AC   CVCL_XL15
SY   HZGHC006899c004; HZGHC84962; AJUBA knockout cell line 19bp deletion in exon 1; HAP1 AJUBA (-)
DR   cancercelllines; CVCL_XL15
DR   Horizon_Discovery; HZGHC006899c004
DR   Wikidata; Q93938886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20250; AJUBA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006899c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 AJUBA (-) 2
AC   CVCL_E1Q3
SY   HZGHC006899c010; AJUBA knockout cell line 19bp deletion in exon 1
DR   Horizon_Discovery; HZGHC006899c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20250; AJUBA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AKAP1 (-) 1
AC   CVCL_SC03
SY   HZGHC003077c001; AKAP1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SC03
DR   Horizon_Discovery; HZGHC003077c001
DR   Wikidata; Q54872562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:367; AKAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKAP1 (-) 2
AC   CVCL_SC04
SY   HZGHC003077c004; AKAP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC04
DR   Horizon_Discovery; HZGHC003077c004
DR   Wikidata; Q54872563
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:367; AKAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKAP11 (-) 1
AC   CVCL_SC05
SY   HZGHC003078c002; AKAP11 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SC05
DR   Horizon_Discovery; HZGHC003078c002
DR   Wikidata; Q54872564
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:369; AKAP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKAP11 (-) 2
AC   CVCL_SC06
SY   HZGHC003078c011; AKAP11 knockout cell line 434bp insertion
DR   cancercelllines; CVCL_SC06
DR   Horizon_Discovery; HZGHC003078c011
DR   Wikidata; Q54872565
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:369; AKAP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003078c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AKAP8 (-)
AC   CVCL_XL16
SY   HZGHC007128c010; HZGHC10270; AKAP8 knockout cell line 128bp insertion in exon 5
DR   cancercelllines; CVCL_XL16
DR   Horizon_Discovery; HZGHC007128c010
DR   Wikidata; Q93938898
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:378; AKAP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007128c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 AKAP9 (-) 1
AC   CVCL_SC07
SY   HZGHC003079c010; AKAP9 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SC07
DR   Horizon_Discovery; HZGHC003079c010
DR   Wikidata; Q54872566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:379; AKAP9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKAP9 (-) 2
AC   CVCL_SC08
SY   HZGHC003079c012; AKAP9 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SC08
DR   Horizon_Discovery; HZGHC003079c012
DR   Wikidata; Q54872571
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:379; AKAP9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKR1B1 (-) 1
AC   CVCL_SC09
SY   HZGHC005255c001; AKR1B1 knockout cell line 2bp deletion; HAP1 AKR1B1 (-)
DR   cancercelllines; CVCL_SC09
DR   Horizon_Discovery; HZGHC005255c001
DR   Wikidata; Q54872572
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AKR1B1 (-) 2
AC   CVCL_XL17
SY   HZGHC005255c012; AKR1B1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XL17
DR   Horizon_Discovery; HZGHC005255c012
DR   Wikidata; Q93938907
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKR1B1 (-) 3
AC   CVCL_XL18
SY   HZGHC005256c001; AKR1B1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XL18
DR   Horizon_Discovery; HZGHC005256c001
DR   Wikidata; Q93938909
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKR1B1 (-) 4
AC   CVCL_XL19
SY   HZGHC005256c009; AKR1B1 knockout cell line 155bp insertion
DR   cancercelllines; CVCL_XL19
DR   Horizon_Discovery; HZGHC005256c009
DR   Wikidata; Q93938910
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005256c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AKR1B10 (-)
AC   CVCL_SC10
SY   HZGHC005258c003; AKR1B10 knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_SC10
DR   Horizon_Discovery; HZGHC005258c003
DR   Wikidata; Q54872573
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:382; AKR1B10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 AKT1 (-) 1
AC   CVCL_SC11
SY   HZGHC000127c007; AKT1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SC11
DR   Horizon_Discovery; HZGHC000127c007
DR   PRIDE; PXD010335
DR   Wikidata; Q54872574
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AKT1 (-) 2
AC   CVCL_SC12
SY   HZGHC000127c018; AKT1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SC12
DR   Horizon_Discovery; HZGHC000127c018
DR   Wikidata; Q54872575
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000127c018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AKT1S1 (-) 1
AC   CVCL_SC13
SY   HZGHC006301c011; AKT1S1 knockout cell line 56bp deletion; HAP1 AKT1S1 (-)
DR   cancercelllines; CVCL_SC13
DR   Horizon_Discovery; HZGHC006301c011
DR   Wikidata; Q54872576
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28426; AKT1S1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AKT1S1 (-) 2
AC   CVCL_XL20
SY   HZGHC006301c007; AKT1S1 knockout cell line 61bp deletion
DR   cancercelllines; CVCL_XL20
DR   Horizon_Discovery; HZGHC006301c007
DR   Wikidata; Q93938928
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28426; AKT1S1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKT1S1 (-) 3
AC   CVCL_XL21
SY   HZGHC006302c001; AKT1S1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XL21
DR   Horizon_Discovery; HZGHC006302c001
DR   Wikidata; Q93938930
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28426; AKT1S1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKT1S1 (-) 4
AC   CVCL_XL22
SY   HZGHC006302c002; AKT1S1 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_XL22
DR   Horizon_Discovery; HZGHC006302c002
DR   Wikidata; Q93938931
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28426; AKT1S1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKT2 (-)
AC   CVCL_SC14
SY   HZGHC000206c006; AKT2 knockout cell line 13bp deletion in exon 2
DR   cancercelllines; CVCL_SC14
DR   Horizon_Discovery; HZGHC000206c006
DR   Wikidata; Q54872577
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AKT3 (-) 1
AC   CVCL_SC15
SY   HZGHC009800c015; AKT3 knockout cell line 100bp insertion
DR   cancercelllines; CVCL_SC15
DR   Horizon_Discovery; HZGHC009800c015
DR   Wikidata; Q54872578
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC009800c015; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 AKT3 (-) 2
AC   CVCL_SC16
SY   HZGHC009800c016; AKT3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC16
DR   Horizon_Discovery; HZGHC009800c016
DR   Wikidata; Q54872579
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKTIP (-) 1
AC   CVCL_SC17
SY   HZGHC002549c005; AKTIP knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SC17
DR   Horizon_Discovery; HZGHC002549c005
DR   Wikidata; Q54872580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16710; AKTIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AKTIP (-) 2
AC   CVCL_SC18
SY   HZGHC002549c010; AKTIP knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC18
DR   Horizon_Discovery; HZGHC002549c010
DR   Wikidata; Q54872581
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16710; AKTIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALAS1 (-) 1
AC   CVCL_SC19
SY   HZGHC000614c004; ALAS1 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_SC19
DR   Horizon_Discovery; HZGHC000614c004
DR   Wikidata; Q54872582
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:396; ALAS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALAS1 (-) 2
AC   CVCL_SC20
SY   HZGHC000614c007; ALAS1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SC20
DR   Horizon_Discovery; HZGHC000614c007
DR   Wikidata; Q54872583
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:396; ALAS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000614c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ALCAM (-) 1
AC   CVCL_SC21
SY   HZGHC006150c011; ALCAM knockout cell line 7bp deletion; HAP1 ALCAM (-)
DR   cancercelllines; CVCL_SC21
DR   Horizon_Discovery; HZGHC006150c011
DR   Wikidata; Q54872585
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:400; ALCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ALCAM (-) 2
AC   CVCL_XL23
SY   HZGHC006150c002; ALCAM knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XL23
DR   Horizon_Discovery; HZGHC006150c002
DR   Wikidata; Q93938960
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:400; ALCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALDH18A1 (-) 1
AC   CVCL_XL24
SY   HZGHC006881c002; HZGHC5832; ALDH18A1 knockout cell line 10bp deletion in exon 3; HAP1 ALDH18A1 (-)
DR   cancercelllines; CVCL_XL24
DR   Horizon_Discovery; HZGHC006881c002
DR   Wikidata; Q93938962
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9722; ALDH18A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ALDH18A1 (-) 2
AC   CVCL_E1Q4
SY   HZGHC006882c003; ALDH18A1 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC006882c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9722; ALDH18A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALDH18A1 (-) 3
AC   CVCL_E1Q5
SY   HZGHC006882c010; ALDH18A1 knockout cell line 7bp deletion in exon 4
DR   Horizon_Discovery; HZGHC006882c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9722; ALDH18A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALDH3A2 (-) 1
AC   CVCL_SC22
SY   HZGHC006476c010; ALDH3A2 knockout cell line 5bp deletion; HAP1 ALDH3A2 (-)
DR   cancercelllines; CVCL_SC22
DR   Horizon_Discovery; HZGHC006476c010
DR   Wikidata; Q54872586
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:403; ALDH3A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ALDH3A2 (-) 2
AC   CVCL_XL25
SY   HZGHC006476c003; ALDH3A2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XL25
DR   Horizon_Discovery; HZGHC006476c003
DR   Wikidata; Q93938968
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:403; ALDH3A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALDH9A1 (-) 1
AC   CVCL_SC23
SY   HZGHC006486c010; ALDH9A1 knockout cell line 11bp deletion; HAP1 ALDH9A1 (-)
DR   cancercelllines; CVCL_SC23
DR   Horizon_Discovery; HZGHC006486c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54872587
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:412; ALDH9A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ALDH9A1 (-) 2
AC   CVCL_XL26
SY   HZGHC006486c003; ALDH9A1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XL26
DR   Horizon_Discovery; HZGHC006486c003
DR   PRIDE; PXD010335
DR   Wikidata; Q93938974
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:412; ALDH9A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG12 (-) 1
AC   CVCL_SC24
SY   HZGHC004061c002; ALG12 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SC24
DR   Horizon_Discovery; HZGHC004061c002
DR   Wikidata; Q54872589
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19358; ALG12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004061c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ALG12 (-) 2
AC   CVCL_SC25
SY   HZGHC004061c006; ALG12 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SC25
DR   Horizon_Discovery; HZGHC004061c006
DR   Wikidata; Q54872590
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19358; ALG12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG3 (-) 1
AC   CVCL_SC26
SY   HZGHC002387c001; ALG3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SC26
DR   Horizon_Discovery; HZGHC002387c001
DR   Wikidata; Q54872591
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23056; ALG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG3 (-) 2
AC   CVCL_SC27
SY   HZGHC002387c006; ALG3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC27
DR   Horizon_Discovery; HZGHC002387c006
DR   Wikidata; Q54872592
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23056; ALG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG6 (-) 1
AC   CVCL_SC28
SY   HZGHC000282c005; ALG6 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC28
DR   Horizon_Discovery; HZGHC000282c005
DR   Wikidata; Q54872593
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23157; ALG6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG6 (-) 2
AC   CVCL_SC29
SY   HZGHC000282c012; ALG6 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SC29
DR   Horizon_Discovery; HZGHC000282c012
DR   Wikidata; Q54872594
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23157; ALG6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG8 (-) 1
AC   CVCL_SC30
SY   HZGHC004908c003; ALG8 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC30
DR   Horizon_Discovery; HZGHC004908c003
DR   Wikidata; Q54872595
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23161; ALG8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG8 (-) 2
AC   CVCL_SC31
SY   HZGHC004908c010; ALG8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SC31
DR   Horizon_Discovery; HZGHC004908c010
DR   Wikidata; Q54872596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23161; ALG8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG9 (-) 1
AC   CVCL_SC32
SY   HZGHC004062c012; ALG9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC32
DR   Horizon_Discovery; HZGHC004062c012
DR   Wikidata; Q54872597
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15672; ALG9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALG9 (-) 2
AC   CVCL_SC33
SY   HZGHC004062c010; ALG9 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SC33
DR   Horizon_Discovery; HZGHC004062c010
DR   Wikidata; Q54872598
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15672; ALG9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALK (-) 1
AC   CVCL_SC34
SY   HZGHC002406c005; ALK knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SC34
DR   Horizon_Discovery; HZGHC002406c005
DR   Wikidata; Q54872599
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:427; ALK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALK (-) 2
AC   CVCL_SC35
SY   HZGHC002406c012; ALK knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SC35
DR   Horizon_Discovery; HZGHC002406c012
DR   Wikidata; Q54872600
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:427; ALK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALKBH1 (-) 1
AC   CVCL_SC36
SY   HZGHC005433c010; ALKBH1 knockout cell line 11bp deletion; HAP1 ALKBH1 (-)
DR   cancercelllines; CVCL_SC36
DR   Horizon_Discovery; HZGHC005433c010
DR   Wikidata; Q54872601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17911; ALKBH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ALKBH1 (-) 2
AC   CVCL_XL27
SY   HZGHC005433c004; ALKBH1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XL27
DR   Horizon_Discovery; HZGHC005433c004
DR   Wikidata; Q93939045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17911; ALKBH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALKBH2 (-) 1
AC   CVCL_SC37
SY   HZGHC000425c002; ALKBH2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SC37
DR   Horizon_Discovery; HZGHC000425c002
DR   Wikidata; Q54872602
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32487; ALKBH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALKBH2 (-) 2
AC   CVCL_SC38
SY   HZGHC000425c019; ALKBH2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC38
DR   Horizon_Discovery; HZGHC000425c019
DR   Wikidata; Q54872603
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32487; ALKBH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALKBH3 (-) 1
AC   CVCL_SC39
SY   HZGHC005729c010; ALKBH3 knockout cell line 1bp insertion; HAP1 ALKBH3 (-)
DR   cancercelllines; CVCL_SC39
DR   Horizon_Discovery; HZGHC005729c010
DR   Wikidata; Q54872604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30141; ALKBH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ALKBH3 (-) 2
AC   CVCL_XL28
SY   HZGHC005729c008; ALKBH3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL28
DR   Horizon_Discovery; HZGHC005729c008
DR   Wikidata; Q93939052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30141; ALKBH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALKBH5 (-) 1
AC   CVCL_E1Q6
SY   HZGHC007680c005
DR   Horizon_Discovery; HZGHC007680c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALKBH5 (-) 2
AC   CVCL_E1Q7
SY   HZGHC007680c009
DR   Horizon_Discovery; HZGHC007680c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALKBH5 (-) 3
AC   CVCL_E1Q8
SY   HZGHC007680c011
DR   Horizon_Discovery; HZGHC007680c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALKBH6 (-) 1
AC   CVCL_XL29
SY   HZGHC007256c011; HZGHC84964; ALKBH6 knockout cell line 1bp deletion in exon 2; HAP1 ALKBH6 (-)
DR   cancercelllines; CVCL_XL29
DR   Horizon_Discovery; HZGHC007256c011
DR   Wikidata; Q93939054
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28243; ALKBH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ALKBH6 (-) 2
AC   CVCL_E1Q9
SY   HZGHC007256c002; ALKBH6 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007256c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28243; ALKBH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALKBH6 (-) 3
AC   CVCL_E1QA
SY   HZGHC007256c009; ALKBH6 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007256c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28243; ALKBH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALKBH8 (-) 1
AC   CVCL_XL30
SY   HZGHC007303c004; HZGHC91801; ALKBH8 knockout cell line 2bp deletion in exon 3; HAP1 ALKBH8 (-)
DR   cancercelllines; CVCL_XL30
DR   Horizon_Discovery; HZGHC007303c004
DR   Wikidata; Q93939055
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25189; ALKBH8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ALKBH8 (-) 2
AC   CVCL_E1QB
SY   HZGHC007302c008; ALKBH8 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007302c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25189; ALKBH8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ALOX12 (-) 1
AC   CVCL_C7ZN
SY   HZGHC007340c003; ALOX12 knockout cell line 1bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007340c003
DR   Wikidata; Q123031406
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:429; ALOX12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX12 (-) 2
AC   CVCL_C7ZP
SY   HZGHC007340c006; ALOX12 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007340c006
DR   Wikidata; Q123031407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:429; ALOX12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX12 (-) ALOX15 (-)
AC   CVCL_DX23
SY   HZGHC007962c009; Double knockout cell line ALOX12 1bp insertion in exon 2 and ALOX15 1bp insertion
DR   Horizon_Discovery; HZGHC007962c009
DR   Wikidata; Q127381023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:429; ALOX12.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:433; ALOX15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7ZP ! HAP1 ALOX12 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX15 (-) 1
AC   CVCL_C7ZQ
SY   HZGHC007334c001; ALOX15 knockout cell line 7bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007334c001
DR   Wikidata; Q123031408
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:433; ALOX15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX15 (-) 2
AC   CVCL_C7ZR
SY   HZGHC007334c007; ALOX15 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007334c007
DR   Wikidata; Q123031409
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:433; ALOX15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX15 (-) 3
AC   CVCL_C7ZS
SY   HZGHC007334c009; ALOX15 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007334c009
DR   Wikidata; Q123031410
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:433; ALOX15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX15B (-) 1
AC   CVCL_C7ZT
SY   HZGHC007943c005; ALOX15B knockout cell line 59bp deletion in exon 13
DR   Horizon_Discovery; HZGHC007943c005
DR   Wikidata; Q123031411
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:434; ALOX15B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX15B (-) 2
AC   CVCL_C7ZU
SY   HZGHC007943c011; ALOX15B knockout cell line 10bp deletion in exon 13
DR   Horizon_Discovery; HZGHC007943c011
DR   Wikidata; Q123031412
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:434; ALOX15B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALOX5 (-) 1
AC   CVCL_XL31
SY   HZGHC007043c001; HZGHC240; ALOX5 knockout cell line 1bp insertion in exon 4; HAP1 ALOX5 (-)
DR   cancercelllines; CVCL_XL31
DR   Horizon_Discovery; HZGHC007043c001
DR   Wikidata; Q93939058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:435; ALOX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ALOX5 (-) 2
AC   CVCL_B5JG
SY   HZGHC007043c002; ALOX5 knockout cell line 25bp deletion in exon 4
DR   cancercelllines; CVCL_B5JG
DR   Horizon_Discovery; HZGHC007043c002
DR   Wikidata; Q111733264
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:435; ALOX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ALOX5 (-) 3
AC   CVCL_B5JH
SY   HZGHC007043c012; ALOX5 knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_B5JH
DR   Horizon_Discovery; HZGHC007043c012
DR   Wikidata; Q111733265
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:435; ALOX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007043c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 ALPK1 (-) 1
AC   CVCL_SC40
SY   HZGHC001243c012; ALPK1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC40
DR   Horizon_Discovery; HZGHC001243c012
DR   Wikidata; Q54872606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20917; ALPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALPK1 (-) 2
AC   CVCL_SC41
SY   HZGHC002982c003; ALPK1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SC41
DR   Horizon_Discovery; HZGHC002982c003
DR   Wikidata; Q54872608
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20917; ALPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALPK1 (-) 3
AC   CVCL_SC42
SY   HZGHC002982c010; ALPK1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC42
DR   Horizon_Discovery; HZGHC002982c010
DR   Wikidata; Q54872609
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20917; ALPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALPK2 (-) 1
AC   CVCL_SC43
SY   HZGHC000042c005; ALPK2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC43
DR   Horizon_Discovery; HZGHC000042c005
DR   Wikidata; Q54872610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20565; ALPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALPK2 (-) 2
AC   CVCL_SC44
SY   HZGHC000042c018; ALPK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SC44
DR   Horizon_Discovery; HZGHC000042c018
DR   Wikidata; Q54872611
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20565; ALPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALPK2 (-) 3
AC   CVCL_SC45
SY   HZGHC000042c022; ALPK2 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SC45
DR   Horizon_Discovery; HZGHC000042c022
DR   Wikidata; Q54872612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20565; ALPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ALPL (-) 1
AC   CVCL_SC46
SY   HZGHC006530c002; ALPL knockout cell line 2bp deletion in exon 6; HAP1 ALPL (-)
DR   cancercelllines; CVCL_SC46
DR   Horizon_Discovery; HZGHC006530c002
DR   Wikidata; Q54872613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:438; ALPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ALPL (-) 2
AC   CVCL_DX14
SY   HZGHC006901c007; ALPL knockout cell line 2bp deletion in exon 6
DR   Horizon_Discovery; HZGHC006901c007
DR   Wikidata; Q127381024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:438; ALPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALS2 (-) 1
AC   CVCL_C7HF
SY   HZGHC007913c005; ALS2 knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC007913c005
DR   Wikidata; Q117704460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:443; ALS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALS2 (-) 2
AC   CVCL_C7HG
SY   HZGHC007913c008; ALS2 knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC007913c008
DR   Wikidata; Q117704461
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:443; ALS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ALS2CR12 (-)
AC   CVCL_E1QC
SY   HZGHC007689c011; ALS2CR12 knockout cell line 7bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007689c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14439; FLACC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ANAPC16 (-) 1
AC   CVCL_XL32
SY   HZGHC007163c001; HZGHC119504; ANAPC16 knockout cell line 1bp deletion in exon 4; HAP1 ANAPC16 (-)
DR   cancercelllines; CVCL_XL32
DR   Horizon_Discovery; HZGHC007163c001
DR   Wikidata; Q93939100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26976; ANAPC16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ANAPC16 (-) 2
AC   CVCL_E1QD
SY   HZGHC007163c012; ANAPC16 knockout cell line 4bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007163c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26976; ANAPC16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ANAPC7 (-) 1
AC   CVCL_SC47
SY   HZGHC005187c002; ANAPC7 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC47
DR   Horizon_Discovery; HZGHC005187c002
DR   Wikidata; Q54872614
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17380; ANAPC7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANAPC7 (-) 2
AC   CVCL_SC48
SY   HZGHC005187c012; ANAPC7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SC48
DR   Horizon_Discovery; HZGHC005187c012
DR   Wikidata; Q54872620
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17380; ANAPC7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANG (-) 1
AC   CVCL_SC49
SY   HZGHC003507c011; ANG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC49
DR   Horizon_Discovery; HZGHC003507c011
DR   Wikidata; Q54872621
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:483; ANG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003507c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ANG (-) 2
AC   CVCL_SC50
SY   HZGHC003507c001; ANG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC50
DR   Horizon_Discovery; HZGHC003507c001
DR   Wikidata; Q54872623
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:483; ANG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANGPTL4 (-) 1
AC   CVCL_SC51
SY   HZGHC006555c008; ANGPTL4 knockout cell line 40bp insertion; HAP1 ANGPTL4 (-)
DR   cancercelllines; CVCL_SC51
DR   Horizon_Discovery; HZGHC006555c008
DR   Wikidata; Q54872624
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16039; ANGPTL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006555c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ANGPTL4 (-) 2
AC   CVCL_XL33
SY   HZGHC006555c009; ANGPTL4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XL33
DR   Horizon_Discovery; HZGHC006555c009
DR   Wikidata; Q93939123
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16039; ANGPTL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKHD1 (-) 1
AC   CVCL_XL34
SY   HZGHC006459c003; ANKHD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL34
DR   Horizon_Discovery; HZGHC006459c003
DR   Wikidata; Q93939126
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24714; ANKHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKHD1 (-) 2
AC   CVCL_XL35
SY   HZGHC006459c007; ANKHD1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XL35
DR   Horizon_Discovery; HZGHC006459c007
DR   Wikidata; Q93939127
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24714; ANKHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD11 (-)
AC   CVCL_E1QE
SY   HZGHC007922c002
DR   Horizon_Discovery; HZGHC007922c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21316; ANKRD11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ANKRD17 (-) 1
AC   CVCL_SC52
SY   HZGHC000822c003; ANKRD17 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC52
DR   Horizon_Discovery; HZGHC000822c003
DR   Wikidata; Q54872625
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23575; ANKRD17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD17 (-) 2
AC   CVCL_SC53
SY   HZGHC000822c005; ANKRD17 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SC53
DR   Horizon_Discovery; HZGHC000822c005
DR   Wikidata; Q54872626
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23575; ANKRD17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD28 (-) 1
AC   CVCL_SC54
SY   HZGHC003080c001; ANKRD28 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SC54
DR   Horizon_Discovery; HZGHC003080c001
DR   Wikidata; Q54872627
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29024; ANKRD28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD28 (-) 2
AC   CVCL_SC55
SY   HZGHC003080c011; ANKRD28 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SC55
DR   Horizon_Discovery; HZGHC003080c011
DR   Wikidata; Q54872628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29024; ANKRD28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD40 (-)
AC   CVCL_E1QF
SY   HZGHC007853c011
DR   Horizon_Discovery; HZGHC007853c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28233; ANKRD40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ANKRD44 (-) 1
AC   CVCL_SC56
SY   HZGHC003081c006; ANKRD44 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SC56
DR   Horizon_Discovery; HZGHC003081c006
DR   Wikidata; Q54872629
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25259; ANKRD44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD44 (-) 2
AC   CVCL_SC57
SY   HZGHC003081c010; ANKRD44 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SC57
DR   Horizon_Discovery; HZGHC003081c010
DR   Wikidata; Q54872631
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25259; ANKRD44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD52 (-) 1
AC   CVCL_SC58
SY   HZGHC003082c001; ANKRD52 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SC58
DR   Horizon_Discovery; HZGHC003082c001
DR   Wikidata; Q54872632
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26614; ANKRD52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD52 (-) 2
AC   CVCL_SC59
SY   HZGHC003082c012; ANKRD52 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC59
DR   Horizon_Discovery; HZGHC003082c012
DR   Wikidata; Q54872633
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26614; ANKRD52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANKRD9 (-) 1
AC   CVCL_E1QG
SY   HZGHC007401c009
DR   Horizon_Discovery; HZGHC007401c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20096; ANKRD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ANKRD9 (-) 2
AC   CVCL_E1QH
SY   HZGHC007402c003
DR   Horizon_Discovery; HZGHC007402c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20096; ANKRD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ANKRD9 (-) 3
AC   CVCL_E1QI
SY   HZGHC007402c005
DR   Horizon_Discovery; HZGHC007402c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20096; ANKRD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ANO10 (-) 1
AC   CVCL_SC60
SY   HZGHC005280c010; ANO10 knockout cell line 8bp deletion; HAP1 ANO10 (-)
DR   cancercelllines; CVCL_SC60
DR   Horizon_Discovery; HZGHC005280c010
DR   Wikidata; Q54872634
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25519; ANO10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ANO10 (-) 2
AC   CVCL_XL36
SY   HZGHC005280c009; ANO10 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XL36
DR   Horizon_Discovery; HZGHC005280c009
DR   Wikidata; Q93939169
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25519; ANO10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANO5 (-)
AC   CVCL_SC61
SY   HZGHC001300c004; ANO5 knockout cell line 7bp deletion in exon 7
DR   cancercelllines; CVCL_SC61
DR   Horizon_Discovery; HZGHC001300c004
DR   Wikidata; Q54872636
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27337; ANO5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ANO6 (-) 1
AC   CVCL_RX74
SY   HZGHC002956c003; ANO6 knockout cell line 20bp deletion in exon 5; KO-T16F
DR   cancercelllines; CVCL_RX74
DR   Horizon_Discovery; HZGHC002956c003
DR   Wikidata; Q54872637
RX   PubMed=29463790;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ANO6 (-) 2
AC   CVCL_SA81
SY   HZGHC002956c005; ANO6 knockout cell line 7bp deletion in exon 5
DR   cancercelllines; CVCL_SA81
DR   Horizon_Discovery; HZGHC002956c005
DR   Wikidata; Q54872638
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ANO6 (-) XKR8 (-) 1
AC   CVCL_DX24
SY   HZGHC007134c013; Double knockout cell line ANO6 20bp deletion in exon 5 and XPR8 2bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007134c013
DR   Wikidata; Q127381025
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25508; XKR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RX74 ! HAP1 ANO6 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ANO6 (-) XKR8 (-) 2
AC   CVCL_DX25
SY   HZGHC007134c020; Double knockout cell line ANO6 20bp deletion in exon 5 and XPR8 1bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007134c020
DR   Wikidata; Q127381026
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25508; XKR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RX74 ! HAP1 ANO6 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ANO6 (-) XKR8 (-) 3
AC   CVCL_DX26
SY   HZGHC007134c022; Double knockout cell line ANO6 20bp deletion in exon 5 and XPR8 19bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007134c022
DR   Wikidata; Q127381027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25508; XKR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RX74 ! HAP1 ANO6 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ANO6 (-) XKR8 (-) 4
AC   CVCL_DX27
SY   HZGHC007134c023; Double knockout cell line ANO6 20bp deletion in exon 5 and XPR8 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007134c023
DR   Wikidata; Q127381028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25508; XKR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RX74 ! HAP1 ANO6 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ANO8 (-)
AC   CVCL_DX15
SY   HZGHC008008c006; ANO8 knockout cell line 2bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008008c006
DR   Wikidata; Q127381029
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29329; ANO8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ANPEP (-)
AC   CVCL_SC62
SY   HZGHC004127c007; ANPEP knockout cell line 73bp deletion
DR   cancercelllines; CVCL_SC62
DR   Horizon_Discovery; HZGHC004127c007
DR   Wikidata; Q54872639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:500; ANPEP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004127c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ANTXR1 (-) 1
AC   CVCL_SC63
SY   HZGHC000603c001; ANTXR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC63
DR   Horizon_Discovery; HZGHC000603c001
DR   Wikidata; Q54872640
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21014; ANTXR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANTXR1 (-) 2
AC   CVCL_SC64
SY   HZGHC000603c012; ANTXR1 knockout cell line 47bp deletion
DR   cancercelllines; CVCL_SC64
DR   Horizon_Discovery; HZGHC000603c012
DR   Wikidata; Q54872641
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21014; ANTXR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANTXR2 (-)
AC   CVCL_SC65
SY   HZGHC000600c008; ANTXR2 knockout cell line 11bp deletion in exon 1
DR   cancercelllines; CVCL_SC65
DR   Horizon_Discovery; HZGHC000600c008
DR   Wikidata; Q54872642
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21732; ANTXR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ANXA1 (-) 1
AC   CVCL_SC66
SY   HZGHC003699c006; ANXA1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SC66
DR   Horizon_Discovery; HZGHC003699c006
DR   Wikidata; Q54872643
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:533; ANXA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANXA1 (-) 2
AC   CVCL_SC67
SY   HZGHC003699c007; ANXA1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SC67
DR   Horizon_Discovery; HZGHC003699c007
DR   Wikidata; Q54872644
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:533; ANXA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ANXA11 (-)
AC   CVCL_C7ZV
SY   HZGHC007910c020; ANXA11 knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC007910c020
DR   Wikidata; Q123031413
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:535; ANXA11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ANXA5 (-) 1
AC   CVCL_SC68
SY   HZGHC006174c001; ANXA5 knockout cell line 20bp deletion; HAP1 ANXA5 (-)
DR   cancercelllines; CVCL_SC68
DR   Horizon_Discovery; HZGHC006174c001
DR   Wikidata; Q54872645
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:543; ANXA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ANXA5 (-) 2
AC   CVCL_XL37
SY   HZGHC006174c002; ANXA5 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XL37
DR   Horizon_Discovery; HZGHC006174c002
DR   Wikidata; Q93939236
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:543; ANXA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1G1 (-) 1
AC   CVCL_SC69
SY   HZGHC000770c006; AP1G1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC69
DR   Horizon_Discovery; HZGHC000770c006
DR   Wikidata; Q54872646
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:555; AP1G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1G1 (-) 2
AC   CVCL_SC70
SY   HZGHC000770c008; AP1G1 knockout cell line 124bp insertion
DR   cancercelllines; CVCL_SC70
DR   Horizon_Discovery; HZGHC000770c008
DR   Wikidata; Q54872648
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:555; AP1G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000770c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AP1G2 (-)
AC   CVCL_SC71
SY   HZGHC000852c002; AP1G2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC71
DR   Horizon_Discovery; HZGHC000852c002
DR   Wikidata; Q54872649
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:556; AP1G2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1S1 (-) 1
AC   CVCL_SC72
SY   HZGHC000866c002; AP1S1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SC72
DR   Horizon_Discovery; HZGHC000866c002
DR   Wikidata; Q54872650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:559; AP1S1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1S1 (-) 2
AC   CVCL_SC73
SY   HZGHC000866c011; AP1S1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC73
DR   Horizon_Discovery; HZGHC000866c011
DR   Wikidata; Q54872651
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:559; AP1S1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1S2 (-) 1
AC   CVCL_SC74
SY   HZGHC000868c004; AP1S2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SC74
DR   Horizon_Discovery; HZGHC000868c004
DR   Wikidata; Q54872652
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:560; AP1S2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1S2 (-) 2
AC   CVCL_SC75
SY   HZGHC000868c007; AP1S2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SC75
DR   Horizon_Discovery; HZGHC000868c007
DR   Wikidata; Q54872653
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:560; AP1S2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1S3 (-) 1
AC   CVCL_SC76
SY   HZGHC000864c002; AP1S3 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SC76
DR   Horizon_Discovery; HZGHC000864c002
DR   Wikidata; Q54872654
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18971; AP1S3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP1S3 (-) 2
AC   CVCL_SC77
SY   HZGHC000864c006; AP1S3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SC77
DR   Horizon_Discovery; HZGHC000864c006
DR   Wikidata; Q54872655
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18971; AP1S3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP2M1 (-) 1
AC   CVCL_SC78
SY   HZGHC000877c010; AP2M1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC78
DR   Horizon_Discovery; HZGHC000877c010
DR   Wikidata; Q54872656
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:564; AP2M1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP2M1 (-) 2
AC   CVCL_SC79
SY   HZGHC000878c005; AP2M1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SC79
DR   Horizon_Discovery; HZGHC000878c005
DR   Wikidata; Q54872657
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:564; AP2M1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP3D1 (-) 1
AC   CVCL_SC80
SY   HZGHC000772c010; AP3D1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC80
DR   Horizon_Discovery; HZGHC000772c010
DR   Wikidata; Q54872658
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:568; AP3D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP3D1 (-) 2
AC   CVCL_SC81
SY   HZGHC000772c012; AP3D1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SC81
DR   Horizon_Discovery; HZGHC000772c012
DR   Wikidata; Q54872659
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:568; AP3D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000772c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AP4E1 (-) 1
AC   CVCL_SC82
SY   HZGHC000768c001; AP4E1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC82
DR   Horizon_Discovery; HZGHC000768c001
DR   Wikidata; Q54872660
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:573; AP4E1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP4E1 (-) 2
AC   CVCL_SC83
SY   HZGHC000768c002; AP4E1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SC83
DR   Horizon_Discovery; HZGHC000768c002
DR   Wikidata; Q54872661
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:573; AP4E1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000768c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AP4E1 (-) 3
AC   CVCL_SC84
SY   HZGHC000768c003; AP4E1 knockout cell line 64bp insertion
DR   cancercelllines; CVCL_SC84
DR   Horizon_Discovery; HZGHC000768c003
DR   Wikidata; Q54872662
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:573; AP4E1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000768c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AP5Z1 (-) 1
AC   CVCL_SC85
SY   HZGHC000843c006; AP5Z1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SC85
DR   Horizon_Discovery; HZGHC000843c006
DR   Wikidata; Q54872663
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22197; AP5Z1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AP5Z1 (-) 2
AC   CVCL_SC86
SY   HZGHC000843c010; AP5Z1 knockout cell line 7bp insertion
DR   cancercelllines; CVCL_SC86
DR   Horizon_Discovery; HZGHC000843c010
DR   Wikidata; Q54872670
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22197; AP5Z1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000843c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 APAF1 (-) 1
AC   CVCL_SC87
SY   HZGHC004466c001; APAF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC87
DR   Horizon_Discovery; HZGHC004466c001
DR   Wikidata; Q54872671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:576; APAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APAF1 (-) 2
AC   CVCL_SC88
SY   HZGHC004466c012; APAF1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SC88
DR   Horizon_Discovery; HZGHC004466c012
DR   Wikidata; Q54872672
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:576; APAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APAF1 (-) 3
AC   CVCL_SC89
SY   HZGHC004467c005; APAF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC89
DR   Horizon_Discovery; HZGHC004467c005
DR   Wikidata; Q54872673
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:576; APAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APAF1 (-) 4
AC   CVCL_SC90
SY   HZGHC004467c011; APAF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SC90
DR   Horizon_Discovery; HZGHC004467c011
DR   Wikidata; Q54872674
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:576; APAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APC (-)
AC   CVCL_SC91
SY   HZGHC000998c005; APC knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SC91
DR   Horizon_Discovery; HZGHC000998c005
DR   Wikidata; Q54872675
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000998c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 APEH (-)
AC   CVCL_E1QJ
SY   HZGHC007799c010
DR   Horizon_Discovery; HZGHC007799c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:586; APEH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 APEX1 (-) 1
AC   CVCL_SC92
SY   HZGHC005289c003; APEX1 knockout cell line 2bp deletion in exon 3; HAP1 APEX1 (-)
DR   cancercelllines; CVCL_SC92
DR   Horizon_Discovery; HZGHC005289c003
DR   Wikidata; Q54872676
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 APEX1 (-) 2
AC   CVCL_XL38
SY   HZGHC005289c007; APEX1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XL38
DR   Horizon_Discovery; HZGHC005289c007
DR   Wikidata; Q93939399
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APEX1 (-) XPA (-)
AC   CVCL_DX28
SY   HZGHC006991c010; Double knockout cell line APEX1 2bp deletion in exon 3 and XPA 4bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006991c010
DR   Wikidata; Q127381030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12814; XPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SC92 ! HAP1 APEX1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 APLP2 (-) 1
AC   CVCL_SC93
SY   HZGHC000837c011; APLP2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SC93
DR   Horizon_Discovery; HZGHC000837c011
DR   Wikidata; Q54872678
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:598; APLP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APLP2 (-) 2
AC   CVCL_SC94
SY   HZGHC000837c012; APLP2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SC94
DR   Horizon_Discovery; HZGHC000837c012
DR   Wikidata; Q54872679
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:598; APLP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APMAP (-) 1
AC   CVCL_E1QK
SY   HZGHC007412c001
DR   Horizon_Discovery; HZGHC007412c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13238; APMAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 APMAP (-) 2
AC   CVCL_E1QL
SY   HZGHC007412c002
DR   Horizon_Discovery; HZGHC007412c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13238; APMAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 APMAP (-) 3
AC   CVCL_E1QM
SY   HZGHC007412c010
DR   Horizon_Discovery; HZGHC007412c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13238; APMAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 APOBEC3A (-) 1
AC   CVCL_C7ZW
SY   HZGHC008174c005; APOBEC3A knockout cell line 8bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008174c005
DR   Wikidata; Q123031414
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 APOBEC3A (-) 2
AC   CVCL_C7ZX
SY   HZGHC008174c009; APOBEC3A knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC008174c009
DR   Wikidata; Q123031415
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC008174c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 APOBEC3A (-) 3
AC   CVCL_C7ZY
SY   HZGHC008174c010; APOBEC3A knockout cell line 5bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008174c010
DR   Wikidata; Q123031416
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 APOBEC3A (-) 4
AC   CVCL_C7ZZ
SY   HZGHC008174c011; APOBEC3A knockout cell line 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008174c011
DR   Wikidata; Q123031417
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 APOBEC3A (-) 5
AC   CVCL_E1QN
SY   HZGHC008175c009
DR   Horizon_Discovery; HZGHC008175c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 APOBEC3C (-) 1
AC   CVCL_SC95
SY   HZGHC004360c008; APOBEC3C knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SC95
DR   Horizon_Discovery; HZGHC004360c008
DR   Wikidata; Q54872680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17353; APOBEC3C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOBEC3C (-) 2
AC   CVCL_SC96
SY   HZGHC004360c011; APOBEC3C knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SC96
DR   Horizon_Discovery; HZGHC004360c011
DR   Wikidata; Q54872681
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17353; APOBEC3C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOE (-) 1
AC   CVCL_SC97
SY   HZGHC005366c001; APOE knockout cell line 16bp deletion; HAP1 APOE (-)
DR   cancercelllines; CVCL_SC97
DR   Horizon_Discovery; HZGHC005366c001
DR   Wikidata; Q54872682
RX   PubMed=38161428;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 APOE (-) 2
AC   CVCL_XL39
SY   HZGHC005366c003; APOE knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XL39
DR   Horizon_Discovery; HZGHC005366c003
DR   Wikidata; Q93939441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOO (-) 1
AC   CVCL_SC98
SY   HZGHC005038c002; APOO knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC98
DR   Horizon_Discovery; HZGHC005038c002
DR   Wikidata; Q54872683
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28727; APOO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOO (-) 2
AC   CVCL_SC99
SY   HZGHC005038c010; APOO knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SC99
DR   Horizon_Discovery; HZGHC005038c010
DR   Wikidata; Q54872685
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28727; APOO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOO (-) 3
AC   CVCL_SD00
SY   HZGHC005039c006; APOO knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SD00
DR   Horizon_Discovery; HZGHC005039c006
DR   Wikidata; Q54872686
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28727; APOO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOOL (-) 1
AC   CVCL_SD01
SY   HZGHC005036c005; APOOL knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SD01
DR   Horizon_Discovery; HZGHC005036c005
DR   Wikidata; Q54872688
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24009; APOOL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOOL (-) 2
AC   CVCL_SD02
SY   HZGHC005036c009; APOOL knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD02
DR   Horizon_Discovery; HZGHC005036c009
DR   Wikidata; Q54872689
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24009; APOOL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APOOL (-) 3
AC   CVCL_SD03
SY   HZGHC005037c012; APOOL knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD03
DR   Horizon_Discovery; HZGHC005037c012
DR   Wikidata; Q54872690
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24009; APOOL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APP (-) 1
AC   CVCL_SD04
SY   HZGHC005368c010; APP knockout cell line 2bp deletion; HAP1 APP (-)
DR   cancercelllines; CVCL_SD04
DR   Horizon_Discovery; HZGHC005368c010
DR   Wikidata; Q54872691
RX   PubMed=39359612;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 APP (-) 2
AC   CVCL_XL40
SY   HZGHC005368c005; APP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL40
DR   Horizon_Discovery; HZGHC005368c005
DR   Wikidata; Q93939494
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APPL1 (-) 1
AC   CVCL_XL41
SY   HZGHC007050c009; HZGHC26060; APPL1 knockout cell line 13bp deletion in exon 2; HAP1 APPL1 (-)
DR   cancercelllines; CVCL_XL41
DR   Horizon_Discovery; HZGHC007050c009
DR   Wikidata; Q93939496
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24035; APPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 APPL1 (-) 2
AC   CVCL_E1QP
SY   HZGHC007050c010; APPL1 knockout cell line 11bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007050c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24035; APPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 APRT (-) 1
AC   CVCL_SD05
SY   HZGHC004290c003; APRT knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SD05
DR   Horizon_Discovery; HZGHC004290c003
DR   Wikidata; Q54872692
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:626; APRT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APRT (-) 2
AC   CVCL_SD06
SY   HZGHC004290c006; APRT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD06
DR   Horizon_Discovery; HZGHC004290c006
DR   Wikidata; Q54872693
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:626; APRT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APTX (-) 1
AC   CVCL_SD07
SY   HZGHC000431c002; APTX knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SD07
DR   Horizon_Discovery; HZGHC000431c002
DR   Wikidata; Q54872694
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15984; APTX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 APTX (-) 2
AC   CVCL_SD08
SY   HZGHC000431c014; APTX knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SD08
DR   Horizon_Discovery; HZGHC000431c014
DR   Wikidata; Q54872695
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15984; APTX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000431c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 APTX (-) 3
AC   CVCL_SD09
SY   HZGHC000431c023; APTX knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SD09
DR   Horizon_Discovery; HZGHC000431c023
DR   Wikidata; Q54872696
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15984; APTX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AQP3 (-) 1
AC   CVCL_SD10
SY   HZGHC006182c001; AQP3 knockout cell line 14bp deletion; HAP1 AQP3 (-)
DR   cancercelllines; CVCL_SD10
DR   Horizon_Discovery; HZGHC006182c001
DR   Wikidata; Q54872697
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:636; AQP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AQP3 (-) 2
AC   CVCL_XL42
SY   HZGHC006182c005; AQP3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XL42
DR   Horizon_Discovery; HZGHC006182c005
DR   Wikidata; Q93939542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:636; AQP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AR (-) 1
AC   CVCL_SD11
SY   HZGHC003811c003; AR knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SD11
DR   Horizon_Discovery; HZGHC003811c003
DR   Wikidata; Q54872698
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003811c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AR (-) 2
AC   CVCL_SD12
SY   HZGHC003811c012; AR knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SD12
DR   Horizon_Discovery; HZGHC003811c012
DR   Wikidata; Q54872699
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AR (-) 3
AC   CVCL_SD13
SY   HZGHC004384c005; AR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD13
DR   Horizon_Discovery; HZGHC004384c005
DR   Wikidata; Q54872701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AR (-) 4
AC   CVCL_SD14
SY   HZGHC004384c008; AR knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD14
DR   Horizon_Discovery; HZGHC004384c008
DR   Wikidata; Q54872702
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 1
AC   CVCL_SD15
SY   HZGHC000001c010; ARAF knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SD15
DR   Horizon_Discovery; HZGHC000001c010
DR   Wikidata; Q54872703
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 2
AC   CVCL_SD16
SY   HZGHC000001c013; ARAF knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SD16
DR   Horizon_Discovery; HZGHC000001c013
DR   Wikidata; Q54872704
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 3
AC   CVCL_SD17
SY   HZGHC002806c004; ARAF knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SD17
DR   Horizon_Discovery; HZGHC002806c004
DR   Wikidata; Q54872705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 4
AC   CVCL_SD18
SY   HZGHC002806c008; ARAF knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD18
DR   Horizon_Discovery; HZGHC002806c008
DR   Wikidata; Q54872706
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 5
AC   CVCL_SD19
SY   HZGHC002808c008; ARAF knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD19
DR   Horizon_Discovery; HZGHC002808c008
DR   Wikidata; Q54872707
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 6
AC   CVCL_SD20
SY   HZGHC002808c009; ARAF knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SD20
DR   Horizon_Discovery; HZGHC002808c009
DR   Wikidata; Q54872708
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 7
AC   CVCL_SD21
SY   HZGHC003259c008; ARAF knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SD21
DR   Horizon_Discovery; HZGHC003259c008
DR   Wikidata; Q54872710
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAF (-) 8
AC   CVCL_SD22
SY   HZGHC003259c010; ARAF knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SD22
DR   Horizon_Discovery; HZGHC003259c010
DR   Wikidata; Q54872711
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAP3 (-) 1
AC   CVCL_SD23
SY   HZGHC000606c003; ARAP3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD23
DR   Horizon_Discovery; HZGHC000606c003
DR   Wikidata; Q54872712
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24097; ARAP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARAP3 (-) 2
AC   CVCL_SD24
SY   HZGHC000606c005; ARAP3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SD24
DR   Horizon_Discovery; HZGHC000606c005
DR   Wikidata; Q54872713
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24097; ARAP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARF1 (-) 1
AC   CVCL_SD25
SY   HZGHC002914c002; ARF1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SD25
DR   Horizon_Discovery; HZGHC002914c002
DR   Wikidata; Q54872714
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:652; ARF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002914c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARF1 (-) 2
AC   CVCL_SD26
SY   HZGHC002914c006; ARF1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SD26
DR   Horizon_Discovery; HZGHC002914c006
DR   Wikidata; Q54872719
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:652; ARF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARF3 (-) 1
AC   CVCL_SD27
SY   HZGHC003337c004; ARF3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD27
DR   Horizon_Discovery; HZGHC003337c004
DR   Wikidata; Q54872720
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:654; ARF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARF3 (-) 2
AC   CVCL_SD28
SY   HZGHC003337c008; ARF3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SD28
DR   Horizon_Discovery; HZGHC003337c008
DR   Wikidata; Q54872721
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:654; ARF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARF4 (-)
AC   CVCL_SD29
SY   HZGHC002764c011; ARF4 knockout cell line 12bp deletion
DR   cancercelllines; CVCL_SD29
DR   Horizon_Discovery; HZGHC002764c011
DR   Wikidata; Q54872723
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:655; ARF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002764c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARF6 (-) 1
AC   CVCL_SD30
SY   HZGHC003403c005; ARF6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD30
DR   Horizon_Discovery; HZGHC003403c005
DR   Wikidata; Q54872725
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:659; ARF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARF6 (-) 2
AC   CVCL_SD31
SY   HZGHC003403c006; ARF6 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SD31
DR   Horizon_Discovery; HZGHC003403c006
DR   Wikidata; Q54872726
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:659; ARF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARF6 (-) 3
AC   CVCL_SD32
SY   HZGHC003403c009; ARF6 knockout cell line 40bp deletion
DR   cancercelllines; CVCL_SD32
DR   Horizon_Discovery; HZGHC003403c009
DR   Wikidata; Q54872727
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:659; ARF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARFGAP2 (-)
AC   CVCL_XL43
SY   HZGHC007188c011; HZGHC84364; ARFGAP2 knockout cell line 10bp deletion in exon 4
DR   cancercelllines; CVCL_XL43
DR   Horizon_Discovery; HZGHC007188c011
DR   Wikidata; Q93939659
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13504; ARFGAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARFGAP3 (-) 1
AC   CVCL_XL44
SY   HZGHC007189c007; HZGHC26286; ARFGAP3 knockout cell line 239bp insertion in exon 4; HAP1 ARFGAP3 (-)
DR   cancercelllines; CVCL_XL44
DR   Horizon_Discovery; HZGHC007189c007
DR   Wikidata; Q93939661
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:661; ARFGAP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007189c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ARFGAP3 (-) 2
AC   CVCL_E1QQ
SY   HZGHC007189c009; ARFGAP3 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007189c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:661; ARFGAP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARG2 (-) 1
AC   CVCL_E1QR
SY   HZGHC007494c007
DR   Horizon_Discovery; HZGHC007494c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:664; ARG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARG2 (-) 2
AC   CVCL_E1QS
SY   HZGHC007494c008
DR   Horizon_Discovery; HZGHC007494c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:664; ARG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARG2 (-) 3
AC   CVCL_E1QT
SY   HZGHC007494c010
DR   Horizon_Discovery; HZGHC007494c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:664; ARG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARHGAP31 (-) 1
AC   CVCL_SD33
SY   HZGHC002978c003; ARHGAP31 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD33
DR   Horizon_Discovery; HZGHC002978c003
DR   Wikidata; Q54872728
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29216; ARHGAP31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGAP31 (-) 2
AC   CVCL_SD34
SY   HZGHC002978c012; ARHGAP31 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SD34
DR   Horizon_Discovery; HZGHC002978c012
DR   Wikidata; Q54872729
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29216; ARHGAP31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGAP32 (-) 1
AC   CVCL_SD35
SY   HZGHC005254c006; ARHGAP32 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SD35
DR   Horizon_Discovery; HZGHC005254c006
DR   Wikidata; Q54872730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17399; ARHGAP32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGAP32 (-) 2
AC   CVCL_SD36
SY   HZGHC005254c010; ARHGAP32 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SD36
DR   Horizon_Discovery; HZGHC005254c010
DR   Wikidata; Q54872731
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17399; ARHGAP32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGAP32 (-) 3
AC   CVCL_XL45
SY   HZGHC005253c007; ARHGAP32 knockout cell line 295bp insertion
DR   cancercelllines; CVCL_XL45
DR   Horizon_Discovery; HZGHC005253c007
DR   Wikidata; Q93939671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17399; ARHGAP32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005253c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARHGAP32 (-) 4
AC   CVCL_XL46
SY   HZGHC005253c010; ARHGAP32 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XL46
DR   Horizon_Discovery; HZGHC005253c010
DR   Wikidata; Q93939672
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17399; ARHGAP32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGEF1 (-) 1
AC   CVCL_SD37
SY   HZGHC000776c002; ARHGEF1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SD37
DR   Horizon_Discovery; HZGHC000776c002
DR   Wikidata; Q54872732
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:681; ARHGEF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGEF1 (-) 2
AC   CVCL_SD38
SY   HZGHC000776c004; ARHGEF1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SD38
DR   Horizon_Discovery; HZGHC000776c004
DR   Wikidata; Q54872733
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:681; ARHGEF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGEF39 (-) 1
AC   CVCL_XL47
SY   HZGHC005725c001; ARHGEF39 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL47
DR   Horizon_Discovery; HZGHC005725c001
DR   Wikidata; Q93939677
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25909; ARHGEF39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGEF39 (-) 2
AC   CVCL_XL48
SY   HZGHC005725c002; ARHGEF39 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XL48
DR   Horizon_Discovery; HZGHC005725c002
DR   Wikidata; Q93939678
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25909; ARHGEF39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGEF39 (-) 3
AC   CVCL_XL49
SY   HZGHC005726c002; ARHGEF39 knockout cell line 71bp deletion
DR   cancercelllines; CVCL_XL49
DR   Horizon_Discovery; HZGHC005726c002
DR   Wikidata; Q93939680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25909; ARHGEF39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARHGEF7 (-) 1
AC   CVCL_E1QU
SY   HZGHC007655c001
DR   Horizon_Discovery; HZGHC007655c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15607; ARHGEF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARHGEF7 (-) 2
AC   CVCL_E1QV
SY   HZGHC007655c003
DR   Horizon_Discovery; HZGHC007655c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15607; ARHGEF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARHGEF7 (-) 3
AC   CVCL_E1QW
SY   HZGHC007655c004
DR   Horizon_Discovery; HZGHC007655c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15607; ARHGEF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARHGEF7 (-) 4
AC   CVCL_E1QX
SY   HZGHC007655c005
DR   Horizon_Discovery; HZGHC007655c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15607; ARHGEF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARID1A (-) 1
AC   CVCL_SD39
SY   HZGHC000618c003; ARID1A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD39
DR   Horizon_Discovery; HZGHC000618c003
DR   Wikidata; Q54872734
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARID1A (-) 2
AC   CVCL_SD40
SY   HZGHC000618c010; ARID1A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SD40
DR   Horizon_Discovery; HZGHC000618c010
DR   Wikidata; Q54872735
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARID1A (-) 3
AC   CVCL_SD41
SY   HZGHC000619c004; ARID1A knockout cell line 154bp insertion
DR   cancercelllines; CVCL_SD41
DR   Horizon_Discovery; HZGHC000619c004
DR   Wikidata; Q54872736
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000619c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARID1A (-) 4
AC   CVCL_SD42
SY   HZGHC000619c005; ARID1A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SD42
DR   Horizon_Discovery; HZGHC000619c005
DR   Wikidata; Q54872737
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARID1A (-) 5
AC   CVCL_SD43
SY   HZGHC000619c006; ARID1A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD43
DR   Horizon_Discovery; HZGHC000619c006
DR   Wikidata; Q54872739
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARID1B (-) 1
AC   CVCL_SD44
SY   HZGHC000582c005; ARID1B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SD44
DR   Horizon_Discovery; HZGHC000582c005
DR   Wikidata; Q54872740
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARID1B (-) 2
AC   CVCL_SD45
SY   HZGHC000582c007; ARID1B knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SD45
DR   Horizon_Discovery; HZGHC000582c007
DR   PRIDE; PXD010335
DR   Wikidata; Q54872741
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARID2 (-) 1
AC   CVCL_SD46
SY   HZGHC000907c007; ARID2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD46
DR   Horizon_Discovery; HZGHC000907c007
DR   Wikidata; Q54872742
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARID2 (-) 2
AC   CVCL_SD47
SY   HZGHC000907c009; ARID2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SD47
DR   Horizon_Discovery; HZGHC000907c009
DR   Wikidata; Q54872743
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARID5B (-)
AC   CVCL_SD48
SY   HZGHC004193c012; ARID5B knockout cell line 274bp insertion
DR   cancercelllines; CVCL_SD48
DR   Horizon_Discovery; HZGHC004193c012
DR   Wikidata; Q54872744
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17362; ARID5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004193c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARIH1 (-) 1
AC   CVCL_SD49
SY   HZGHC003063c009; ARIH1 knockout cell line 1bp insertion; HAP1 ARIH1 (-)
DR   cancercelllines; CVCL_SD49
DR   Horizon_Discovery; HZGHC003063c009
DR   Wikidata; Q54872746
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:689; ARIH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003063c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ARIH1 (-) 2
AC   CVCL_XL50
SY   HZGHC003064c005; ARIH1 knockout cell line
DR   cancercelllines; CVCL_XL50
DR   Horizon_Discovery; HZGHC003064c005
DR   Wikidata; Q93939709
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:689; ARIH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003064c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 14
//
ID   HAP1 ARL1 (-)
AC   CVCL_E1QY
SY   HZGHC007311c011
DR   Horizon_Discovery; HZGHC007311c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:692; ARL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARMC10 (-) 1
AC   CVCL_SD50
SY   HZGHC005198c009; ARMC10 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD50
DR   Horizon_Discovery; HZGHC005198c009
DR   Wikidata; Q54872747
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21706; ARMC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARMC10 (-) 2
AC   CVCL_SD51
SY   HZGHC005198c012; ARMC10 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SD51
DR   Horizon_Discovery; HZGHC005198c012
DR   Wikidata; Q54872748
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21706; ARMC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARMC5 (-) 1
AC   CVCL_SD52
SY   HZGHC004678c011; ARMC5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD52
DR   Horizon_Discovery; HZGHC004678c011
DR   Wikidata; Q54872749
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25781; ARMC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARMC5 (-) 2
AC   CVCL_SD53
SY   HZGHC004678c012; ARMC5 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SD53
DR   Horizon_Discovery; HZGHC004678c012
DR   Wikidata; Q54872750
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25781; ARMC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARMCX2 (-) 1
AC   CVCL_XL51
SY   HZGHC006896c007; HZGHC9823; ARMCX2 knockout cell line 1bp deletion in exon 5; HAP1 ARMCX2 (-)
DR   cancercelllines; CVCL_XL51
DR   Horizon_Discovery; HZGHC006896c007
DR   Wikidata; Q93939734
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16869; ARMCX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ARMCX2 (-) 2
AC   CVCL_E1QZ
SY   HZGHC006896c001; ARMCX2 knockout cell line 1bp insertion in exon 5
DR   Horizon_Discovery; HZGHC006896c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16869; ARMCX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ARNT (-)
AC   CVCL_XL52
SY   HZGHC007237c006; HZGHC405; ARNT knockout cell line 1bp insertion in exon 6
DR   cancercelllines; CVCL_XL52
DR   Horizon_Discovery; HZGHC007237c006
DR   Wikidata; Q93939736
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:700; ARNT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARNTL (-) 1
AC   CVCL_SD54
SY   HZGHC005955c010; ARNTL knockout cell line 1bp deletion; HAP1 ARNTL (-)
DR   cancercelllines; CVCL_SD54
DR   Horizon_Discovery; HZGHC005955c010
DR   Wikidata; Q54872751
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:701; BMAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ARNTL (-) 2
AC   CVCL_XL53
SY   HZGHC005955c003; ARNTL knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XL53
DR   Horizon_Discovery; HZGHC005955c003
DR   Wikidata; Q93939745
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:701; BMAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARPC5 (-)
AC   CVCL_SD55
SY   HZGHC004728c009; ARPC5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SD55
DR   Horizon_Discovery; HZGHC004728c009
DR   Wikidata; Q54872752
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:708; ARPC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARRB1 (-) 1
AC   CVCL_SD56
SY   HZGHC005371c012; ARRB1 knockout cell line 122bp deletion; HAP1 ARRB1 (-)
DR   cancercelllines; CVCL_SD56
DR   Horizon_Discovery; HZGHC005371c012
DR   Wikidata; Q54872753
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:711; ARRB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARRB1 (-) 2
AC   CVCL_XL54
SY   HZGHC005371c002; ARRB1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XL54
DR   Horizon_Discovery; HZGHC005371c002
DR   Wikidata; Q93939759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:711; ARRB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ARRDC1 (-) 1
AC   CVCL_XL55
SY   HZGHC006798c003; HZGHC92714; ARRDC1 knockout cell line 124bp deletion in exon 2; HAP1 ARRDC1 (-)
DR   cancercelllines; CVCL_XL55
DR   Horizon_Discovery; HZGHC006798c003
DR   Wikidata; Q93939762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28633; ARRDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ARRDC1 (-) 2
AC   CVCL_B5JI
SY   HZGHC006798c007; ARRDC1 knockout cell line 167bp insertion in exon 2
DR   cancercelllines; CVCL_B5JI
DR   Horizon_Discovery; HZGHC006798c007
DR   Wikidata; Q111733266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28633; ARRDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006798c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 ARRDC1 (-) 3
AC   CVCL_B5JJ
SY   HZGHC006798c010; ARRDC1 knockout cell line 17bp deletion in exon 2
DR   cancercelllines; CVCL_B5JJ
DR   Horizon_Discovery; HZGHC006798c010
DR   Wikidata; Q111733267
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28633; ARRDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ARSB (-) 1
AC   CVCL_XL56
SY   HZGHC006885c012; HZGHC411; ARSB knockout cell line 197bp insertion in exon 2; HAP1 ARSB (-)
DR   cancercelllines; CVCL_XL56
DR   Horizon_Discovery; HZGHC006885c012
DR   Wikidata; Q93939764
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:714; ARSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006885c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ARSB (-) 2
AC   CVCL_E1R0
SY   HZGHC006885c003
DR   Horizon_Discovery; HZGHC006885c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:714; ARSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ASCC1 (-) 1
AC   CVCL_SD57
SY   HZGHC006422c003; ASCC1 knockout cell line 28bp deletion; HAP1 ASCC1 (-)
DR   cancercelllines; CVCL_SD57
DR   Horizon_Discovery; HZGHC006422c003
DR   Wikidata; Q54872754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24268; ASCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ASCC1 (-) 2
AC   CVCL_XL57
SY   HZGHC006422c004; ASCC1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XL57
DR   Horizon_Discovery; HZGHC006422c004
DR   Wikidata; Q93939771
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24268; ASCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASCC2 (-)
AC   CVCL_SD58
SY   HZGHC006425c004; ASCC2 knockout cell line 86bp insertion
DR   cancercelllines; CVCL_SD58
DR   Horizon_Discovery; HZGHC006425c004
DR   Wikidata; Q54872755
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24103; ASCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006425c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ASF1A (-)
AC   CVCL_XL58
SY   HZGHC007215c004; HZGHC25842; ASF1A knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_XL58
DR   Horizon_Discovery; HZGHC007215c004
DR   Wikidata; Q93939778
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20995; ASF1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ASF1B (-) 1
AC   CVCL_XL59
SY   HZGHC007216c003; HZGHC55723; ASF1B knockout cell line 2bp deletion in exon 3; HAP1 ASF1B (-)
DR   cancercelllines; CVCL_XL59
DR   Horizon_Discovery; HZGHC007216c003
DR   Wikidata; Q93939782
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20996; ASF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ASF1B (-) 2
AC   CVCL_E1R1
SY   HZGHC007216c008
DR   Horizon_Discovery; HZGHC007216c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20996; ASF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ASGR1 (-) 1
AC   CVCL_SD59
SY   HZGHC004235c002; ASGR1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SD59
DR   Horizon_Discovery; HZGHC004235c002
DR   Wikidata; Q54872756
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:742; ASGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASGR1 (-) 2
AC   CVCL_SD60
SY   HZGHC004235c003; ASGR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD60
DR   Horizon_Discovery; HZGHC004235c003
DR   Wikidata; Q54872757
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:742; ASGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASH1L (-) 1
AC   CVCL_SD61
SY   HZGHC000942c001; ASH1L knockout cell line 53bp deletion
DR   cancercelllines; CVCL_SD61
DR   Horizon_Discovery; HZGHC000942c001
DR   Wikidata; Q54872759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19088; ASH1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASH1L (-) 2
AC   CVCL_SD62
SY   HZGHC000942c010; ASH1L knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SD62
DR   Horizon_Discovery; HZGHC000942c010
DR   Wikidata; Q54872760
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19088; ASH1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASIC1 (-)
AC   CVCL_SD63
SY   HZGHC003810c007; ASIC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD63
DR   Horizon_Discovery; HZGHC003810c007
DR   Wikidata; Q54872761
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:100; ASIC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASL (-)
AC   CVCL_E1R2
SY   HZGHC007641c012
DR   Horizon_Discovery; HZGHC007641c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:746; ASL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ASMTL (-) 1
AC   CVCL_SD64
SY   HZGHC006502c010; ASMTL knockout cell line 13bp deletion; HAP1 ASMTL (-)
DR   cancercelllines; CVCL_SD64
DR   Horizon_Discovery; HZGHC006502c010
DR   Wikidata; Q54872762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:751; ASMTL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ASMTL (-) 2
AC   CVCL_XL60
SY   HZGHC006502c003; ASMTL knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XL60
DR   Horizon_Discovery; HZGHC006502c003
DR   Wikidata; Q93939817
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:751; ASMTL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASPH (-) 1
AC   CVCL_SD65
SY   HZGHC004045c006; ASPH knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SD65
DR   Horizon_Discovery; HZGHC004045c006
DR   Wikidata; Q54872763
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:757; ASPH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASPH (-) 2
AC   CVCL_SD66
SY   HZGHC004045c010; ASPH knockout cell line 70bp deletion
DR   cancercelllines; CVCL_SD66
DR   Horizon_Discovery; HZGHC004045c010
DR   Wikidata; Q54872769
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:757; ASPH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASPM (-) 1
AC   CVCL_SD67
SY   HZGHC003472c007; ASPM knockout cell line 2bp deletion in exon 1; HAP1 ASPM (-)
DR   cancercelllines; CVCL_SD67
DR   Horizon_Discovery; HZGHC003472c007
DR   Wikidata; Q54872770
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19048; ASPM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ASPM (-) 2
AC   CVCL_XL61
SY   HZGHC003472c008; ASPM knockout cell line
DR   cancercelllines; CVCL_XL61
DR   Horizon_Discovery; HZGHC003472c008
DR   Wikidata; Q93939840
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19048; ASPM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003472c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 14
//
ID   HAP1 ASPM (-) 3
AC   CVCL_XL62
SY   HZGHC003472c010; ASPM knockout cell line
DR   cancercelllines; CVCL_XL62
DR   Horizon_Discovery; HZGHC003472c010
DR   Wikidata; Q93939842
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19048; ASPM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003472c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 14
//
ID   HAP1 ASPSCR1 (-) 1
AC   CVCL_SD68
SY   HZGHC004012c002; ASPSCR1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SD68
DR   Horizon_Discovery; HZGHC004012c002
DR   Wikidata; Q54872771
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13825; ASPSCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASPSCR1 (-) 2
AC   CVCL_SD69
SY   HZGHC004012c007; ASPSCR1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SD69
DR   Horizon_Discovery; HZGHC004012c007
DR   Wikidata; Q54872772
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13825; ASPSCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASPSCR1 (-) 3
AC   CVCL_SD70
SY   HZGHC003479c010; ASPSCR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD70
DR   Horizon_Discovery; HZGHC003479c010
DR   Wikidata; Q54872773
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13825; ASPSCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASS1 (-) 1
AC   CVCL_SD71
SY   HZGHC005372c011; ASS1 knockout cell line 61bp insertion; HAP1 ASS1 (-)
DR   cancercelllines; CVCL_SD71
DR   Horizon_Discovery; HZGHC005372c011
DR   Wikidata; Q54872774
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:758; ASS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005372c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ASS1 (-) 2
AC   CVCL_XL63
SY   HZGHC005372c004; ASS1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XL63
DR   Horizon_Discovery; HZGHC005372c004
DR   Wikidata; Q93939865
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:758; ASS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASTE1 (-) 1
AC   CVCL_E1R3
SY   HZGHC008067c009
DR   Horizon_Discovery; HZGHC008067c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25021; ASTE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ASTE1 (-) 2
AC   CVCL_E1R4
SY   HZGHC008068c005
DR   Horizon_Discovery; HZGHC008068c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25021; ASTE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ASXL1 (-) 1
AC   CVCL_SD72
SY   HZGHC004032c010; ASXL1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD72
DR   Horizon_Discovery; HZGHC004032c010
DR   Wikidata; Q54872775
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18318; ASXL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASXL1 (-) 2
AC   CVCL_SD73
SY   HZGHC004032c012; ASXL1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SD73
DR   Horizon_Discovery; HZGHC004032c012
DR   Wikidata; Q54872776
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18318; ASXL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASXL1 (-) 3
AC   CVCL_SD74
SY   HZGHC003627c006; ASXL1 knockout cell line 178bp insertion
DR   cancercelllines; CVCL_SD74
DR   Horizon_Discovery; HZGHC003627c006
DR   Wikidata; Q54872777
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18318; ASXL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003627c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ASXL2 (-) 1
AC   CVCL_SD75
SY   HZGHC001119c008; ASXL2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SD75
DR   Horizon_Discovery; HZGHC001119c008
DR   Wikidata; Q54872778
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23805; ASXL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASXL2 (-) 2
AC   CVCL_SD76
SY   HZGHC001119c010; ASXL2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD76
DR   Horizon_Discovery; HZGHC001119c010
DR   Wikidata; Q54872779
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23805; ASXL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ASXL2 (-) 3
AC   CVCL_SD77
SY   HZGHC001119c012; ASXL2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD77
DR   Horizon_Discovery; HZGHC001119c012
DR   Wikidata; Q54872780
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23805; ASXL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATAD1 (-)
AC   CVCL_SD78
SY   HZGHC006028c011; ATAD1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SD78
DR   Horizon_Discovery; HZGHC006028c011
DR   Wikidata; Q54872781
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25903; ATAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATAD2 (-) 1
AC   CVCL_SD79
SY   HZGHC003753c008; ATAD2 knockout cell line 7bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC003753c008
DR   PRIDE; PXD010335
DR   Wikidata; Q54872782
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30123; ATAD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 ATAD2 (-) 2
AC   CVCL_SD80
SY   HZGHC003753c012; ATAD2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD80
DR   Horizon_Discovery; HZGHC003753c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54872783
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30123; ATAD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATAD2B (-) 1
AC   CVCL_SD81
SY   HZGHC000947c010; ATAD2B knockout cell line 104bp insertion
DR   cancercelllines; CVCL_SD81
DR   Horizon_Discovery; HZGHC000947c010
DR   Wikidata; Q54872785
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29230; ATAD2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000947c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATAD2B (-) 2
AC   CVCL_SD82
SY   HZGHC000947c012; ATAD2B knockout cell line 130bp insertion
DR   cancercelllines; CVCL_SD82
DR   Horizon_Discovery; HZGHC000947c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54872786
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29230; ATAD2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000947c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ATE1 (-) 1
AC   CVCL_XL64
SY   HZGHC006903c016; HZGHC11101; ATE1 knockout cell line 16bp deletion in exon 6; HAP1 ATE1 (-)
DR   cancercelllines; CVCL_XL64
DR   Horizon_Discovery; HZGHC006903c016
DR   Wikidata; Q93939939
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:782; ATE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATE1 (-) 2
AC   CVCL_B5JK
SY   HZGHC006903c023; ATE1 knockout cell line 2bp insertion in exon 6
DR   cancercelllines; CVCL_B5JK
DR   Horizon_Discovery; HZGHC006903c023
DR   Wikidata; Q111733268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:782; ATE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ATF2 (-)
AC   CVCL_E1R5
SY   HZGHC007984c012
DR   Horizon_Discovery; HZGHC007984c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATF3 (-) 1
AC   CVCL_SD83
SY   HZGHC006339c003; ATF3 knockout cell line 1bp insertion in exon 2; HAP1 ATF3 (-)
DR   cancercelllines; CVCL_SD83
DR   Horizon_Discovery; HZGHC006339c003
DR   Wikidata; Q54872787
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ATF3 (-) 2
AC   CVCL_XL65
SY   HZGHC006339c008; ATF3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL65
DR   Horizon_Discovery; HZGHC006339c008
DR   Wikidata; Q93939948
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006339c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATF3 (-) 3
AC   CVCL_XL66
SY   HZGHC006340c001; ATF3 knockout cell line 13bp deletion in exon 2
DR   cancercelllines; CVCL_XL66
DR   Horizon_Discovery; HZGHC006340c001
DR   Wikidata; Q93939950
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATF3 (-) 4
AC   CVCL_XL67
SY   HZGHC006340c004; ATF3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XL67
DR   Horizon_Discovery; HZGHC006340c004
DR   Wikidata; Q93939953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATF4 (-) 1
AC   CVCL_E1R6
SY   HZGHC007380c002
DR   Horizon_Discovery; HZGHC007380c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATF4 (-) 2
AC   CVCL_E1R7
SY   HZGHC007380c010
DR   Horizon_Discovery; HZGHC007380c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATF5 (-) 1
AC   CVCL_SD84
SY   HZGHC005144c003; ATF5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SD84
DR   Horizon_Discovery; HZGHC005144c003
DR   Wikidata; Q54872788
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATF5 (-) 2
AC   CVCL_SD85
SY   HZGHC005144c004; ATF5 knockout cell line 38bp deletion
DR   cancercelllines; CVCL_SD85
DR   Horizon_Discovery; HZGHC005144c004
DR   Wikidata; Q54872789
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATF5 (-) 3
AC   CVCL_XL68
SY   HZGHC006497c012; ATF5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XL68
DR   Horizon_Discovery; HZGHC006497c012
DR   Wikidata; Q93939967
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATF6 (-) 1
AC   CVCL_SD86
SY   HZGHC003031c004; ATF6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD86
DR   Horizon_Discovery; HZGHC003031c004
DR   Wikidata; Q54872790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATF6 (-) 2
AC   CVCL_SD87
SY   HZGHC003031c011; ATF6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD87
DR   Horizon_Discovery; HZGHC003031c011
DR   Wikidata; Q54872791
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATF6 (-) 3
AC   CVCL_SD88
SY   HZGHC003429c006; ATF6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD88
DR   Horizon_Discovery; HZGHC003429c006
DR   Wikidata; Q54872793
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATF6 (-) 4
AC   CVCL_SD89
SY   HZGHC003429c012; ATF6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SD89
DR   Horizon_Discovery; HZGHC003429c012
DR   Wikidata; Q54872794
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG101 (-) 1
AC   CVCL_SG01
SY   HZGHC001023c005; ATG101 knockout cell line 4bp deletion; HAP1 C12orf44 (-) 1
DR   cancercelllines; CVCL_SG01
DR   Horizon_Discovery; HZGHC001023c005
DR   Wikidata; Q54873059
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25679; ATG101.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG101 (-) 2
AC   CVCL_SG02
SY   HZGHC001024c012; ATG101 knockout cell line 10bp deletion; HAP1 C12orf44 (-) 2
DR   cancercelllines; CVCL_SG02
DR   Horizon_Discovery; HZGHC001024c012
DR   Wikidata; Q54873060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25679; ATG101.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG12 (-) 1
AC   CVCL_SD90
SY   HZGHC000303c004; ATG12 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SD90
DR   Horizon_Discovery; HZGHC000303c004
DR   Wikidata; Q54872795
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:588; ATG12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG12 (-) 2
AC   CVCL_SD91
SY   HZGHC000303c008; ATG12 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SD91
DR   Horizon_Discovery; HZGHC000303c008
DR   Wikidata; Q54872796
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:588; ATG12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG13 (-)
AC   CVCL_SD92
SY   HZGHC000304c001; ATG13 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SD92
DR   Horizon_Discovery; HZGHC000304c001
DR   Wikidata; Q54872797
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG14 (-) 1
AC   CVCL_SD93
SY   HZGHC024663c003; ATG14 knockout cell line 103bp insertion
DR   cancercelllines; CVCL_SD93
DR   Horizon_Discovery; HZGHC024663c003
DR   Wikidata; Q54872798
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC024663c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATG14 (-) 2
AC   CVCL_SD94
SY   HZGHC024663c006; ATG14 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SD94
DR   Horizon_Discovery; HZGHC024663c006
DR   Wikidata; Q54872799
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG14 (-) 3
AC   CVCL_SD95
SY   HZGHC024663c012; ATG14 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SD95
DR   Horizon_Discovery; HZGHC024663c012
DR   Wikidata; Q54872800
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG16L1 (-) 1
AC   CVCL_SD96
SY   HZGHC000296c010; ATG16L1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SD96
DR   Horizon_Discovery; HZGHC000296c010
DR   Wikidata; Q54872801
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG16L1 (-) 2
AC   CVCL_SD97
SY   HZGHC000296c011; ATG16L1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SD97
DR   Horizon_Discovery; HZGHC000296c011
DR   Wikidata; Q54872802
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000296c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATG2A (-) 1
AC   CVCL_E1R8
SY   HZGHC008152c009
DR   Horizon_Discovery; HZGHC008152c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG2A (-) 2
AC   CVCL_E1R9
SY   HZGHC008153c001
DR   Horizon_Discovery; HZGHC008153c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG2A (-) 3
AC   CVCL_E1RA
SY   HZGHC008153c002
DR   Horizon_Discovery; HZGHC008153c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG2A (-) 4
AC   CVCL_E1RB
SY   HZGHC008153c005
DR   Horizon_Discovery; HZGHC008153c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG2A (-) 5
AC   CVCL_E1RC
SY   HZGHC008153c006
DR   Horizon_Discovery; HZGHC008153c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG2B (-) 1
AC   CVCL_E1RD
SY   HZGHC008154c006
DR   Horizon_Discovery; HZGHC008154c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG2B (-) 2
AC   CVCL_E1RE
SY   HZGHC008155c005
DR   Horizon_Discovery; HZGHC008155c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG2B (-) 3
AC   CVCL_E1RF
SY   HZGHC008155c010
DR   Horizon_Discovery; HZGHC008155c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG4B (-) 1
AC   CVCL_SD98
SY   HZGHC001241c010; ATG4B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SD98
DR   Horizon_Discovery; HZGHC001241c010
DR   Wikidata; Q54872803
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20790; ATG4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG4B (-) 2
AC   CVCL_SD99
SY   HZGHC001241c011; ATG4B knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SD99
DR   Horizon_Discovery; HZGHC001241c011
DR   Wikidata; Q54872804
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20790; ATG4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG4D (-)
AC   CVCL_E1RG
SY   HZGHC007564c009
DR   Horizon_Discovery; HZGHC007564c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20789; ATG4D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG5 (-) 1
AC   CVCL_SE00
SY   HZGHC016335c006; ATG5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE00
DR   Horizon_Discovery; HZGHC016335c006
DR   Wikidata; Q54872805
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG5 (-) 2
AC   CVCL_SE01
SY   HZGHC016335c010; ATG5 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SE01
DR   Horizon_Discovery; HZGHC016335c010
DR   Wikidata; Q54872806
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG7 (-) 1
AC   CVCL_SE02
SY   HZGHC000302c003; ATG7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SE02
DR   Horizon_Discovery; HZGHC000302c003
DR   Wikidata; Q54872808
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000302c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATG7 (-) 2
AC   CVCL_SE03
SY   HZGHC000302c022; ATG7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE03
DR   Horizon_Discovery; HZGHC000302c022
DR   Wikidata; Q54872809
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG7 (-) 3
AC   CVCL_SE04
SY   HZGHC000302c023; ATG7 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SE04
DR   Horizon_Discovery; HZGHC000302c023
DR   Wikidata; Q54872810
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000302c023; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATG9A (-) 1
AC   CVCL_SE05
SY   HZGHC000297c014; ATG9A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE05
DR   Horizon_Discovery; HZGHC000297c014
DR   Wikidata; Q54872812
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000297c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATG9A (-) 2
AC   CVCL_SE06
SY   HZGHC000297c017; ATG9A knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SE06
DR   Horizon_Discovery; HZGHC000297c017
DR   Wikidata; Q54872817
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000297c017; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATG9A (-) 3
AC   CVCL_SE07
SY   HZGHC000297c020; ATG9A knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SE07
DR   Horizon_Discovery; HZGHC000297c020
DR   Wikidata; Q54872818
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATG9A-GFP-TEV-Flag clone 2A3
AC   CVCL_E2TR
CC   Group: Haploid karyotype cell line.
CC   Characteristics: Using CRISPR/Cas9 ATG9 been endogenously tagged at the C-terminus with an eGFP itself tagged by a TEV site followed by a FLAG tag (Direct_author_submission).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Miscellaneous: Cell line information from personal communication of Adriaenssens, Elias.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATG9A-GFP-TEV-Flag ATG2A/ATG2B DKO clone 1.3
AC   CVCL_F0LE
CC   Group: Haploid karyotype cell line.
CC   Characteristics: Using CRISPR/Cas9 ATG9 been endogenously tagged at the C-terminus with an eGFP itself tagged by a TEV site followed by a FLAG tag (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Miscellaneous: Cell line information from personal communication of Holzer, Elisabeth.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2TR ! HAP1 ATG9A-GFP-TEV-Flag clone 2A3
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HAP1 ATN1 (-) 1
AC   CVCL_E1RH
SY   HZGHC007918c002
DR   Horizon_Discovery; HZGHC007918c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3033; ATN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATN1 (-) 2
AC   CVCL_E1RI
SY   HZGHC007918c011
DR   Horizon_Discovery; HZGHC007918c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3033; ATN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATP11C (-) 1
AC   CVCL_SE08
SY   HZGHC005338c011; ATP11C knockout cell line 94bp deletion; HAP1 ATP11C (-)
DR   cancercelllines; CVCL_SE08
DR   Horizon_Discovery; HZGHC005338c011
DR   Wikidata; Q54872819
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13554; ATP11C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP11C (-) 2
AC   CVCL_XL69
SY   HZGHC005338c006; ATP11C knockout cell line 17bp deletion
DR   cancercelllines; CVCL_XL69
DR   Horizon_Discovery; HZGHC005338c006
DR   Wikidata; Q93940121
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13554; ATP11C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP13A2 (-) 1
AC   CVCL_SE09
SY   HZGHC003547c002; ATP13A2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SE09
DR   Horizon_Discovery; HZGHC003547c002
DR   Wikidata; Q54872820
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30213; ATP13A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP13A2 (-) 2
AC   CVCL_SE10
SY   HZGHC003547c012; ATP13A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE10
DR   Horizon_Discovery; HZGHC003547c012
DR   Wikidata; Q54872821
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30213; ATP13A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP1A3 (-) 1
AC   CVCL_SE11
SY   HZGHC006215c002; ATP1A3 knockout cell line 1bp deletion; HAP1 ATP1A3 (-)
DR   cancercelllines; CVCL_SE11
DR   Horizon_Discovery; HZGHC006215c002
DR   Wikidata; Q54872822
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:801; ATP1A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP1A3 (-) 2
AC   CVCL_XL70
SY   HZGHC006215c006; ATP1A3 knockout cell line 218bp insertion
DR   cancercelllines; CVCL_XL70
DR   Horizon_Discovery; HZGHC006215c006
DR   Wikidata; Q93940134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:801; ATP1A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006215c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP1A3 (-) 3
AC   CVCL_XL71
SY   HZGHC006216c011; ATP1A3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL71
DR   Horizon_Discovery; HZGHC006216c011
DR   Wikidata; Q93940137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:801; ATP1A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP1A3 (-) 4
AC   CVCL_XL72
SY   HZGHC006216c012; ATP1A3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XL72
DR   Horizon_Discovery; HZGHC006216c012
DR   Wikidata; Q93940142
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:801; ATP1A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP2B1 (-) 1
AC   CVCL_C7XX
SY   HZGHC008050c008; ATP2B1 knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC008050c008
DR   Wikidata; Q123031418
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:814; ATP2B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ATP2B1 (-) 2
AC   CVCL_C7XY
SY   HZGHC008050c009; ATP2B1 knockout cell line 1bp deletion
DR   Horizon_Discovery; HZGHC008050c009
DR   Wikidata; Q123031419
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:814; ATP2B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ATP5I (-) 1
AC   CVCL_SE12
SY   HZGHC004183c008; ATP5I knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SE12
DR   Horizon_Discovery; HZGHC004183c008
DR   Wikidata; Q54872823
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:846; ATP5ME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP5I (-) 2
AC   CVCL_SE13
SY   HZGHC004183c012; ATP5I knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SE13
DR   Horizon_Discovery; HZGHC004183c012
DR   Wikidata; Q54872824
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:846; ATP5ME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP5I (-) 3
AC   CVCL_SE14
SY   HZGHC005049c010; ATP5I knockout cell line 203bp insertion
DR   cancercelllines; CVCL_SE14
DR   Horizon_Discovery; HZGHC005049c010
DR   Wikidata; Q54872827
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:846; ATP5ME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005049c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP5I (-) 4
AC   CVCL_XL73
SY   HZGHC005050c009; ATP5I knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XL73
DR   Horizon_Discovery; HZGHC005050c009
DR   Wikidata; Q93940165
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:846; ATP5ME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP5J (-) 1
AC   CVCL_SE15
SY   HZGHC005022c002; ATP5J knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE15
DR   Horizon_Discovery; HZGHC005022c002
DR   Wikidata; Q54872828
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:847; ATP5PF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP5J (-) 2
AC   CVCL_SE16
SY   HZGHC005022c012; ATP5J knockout cell line 71bp insertion
DR   cancercelllines; CVCL_SE16
DR   Horizon_Discovery; HZGHC005022c012
DR   Wikidata; Q54872829
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:847; ATP5PF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005022c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP5L (-) 1
AC   CVCL_XL74
SY   HZGHC005867c007; ATP5L knockout cell line 4bp insertion
DR   cancercelllines; CVCL_XL74
DR   Horizon_Discovery; HZGHC005867c007
DR   Wikidata; Q93940177
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14247; ATP5MG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005867c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP5L (-) 2
AC   CVCL_XL75
SY   HZGHC005868c005; ATP5L knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL75
DR   Horizon_Discovery; HZGHC005868c005
DR   Wikidata; Q93940179
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14247; ATP5MG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005868c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP5L (-) 3
AC   CVCL_XL76
SY   HZGHC005868c009; ATP5L knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XL76
DR   Horizon_Discovery; HZGHC005868c009
DR   Wikidata; Q93940180
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14247; ATP5MG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005868c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP6V0A2 (-) 1
AC   CVCL_SE17
SY   HZGHC004063c003; ATP6V0A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE17
DR   Horizon_Discovery; HZGHC004063c003
DR   Wikidata; Q54872830
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18481; ATP6V0A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP6V0A2 (-) 2
AC   CVCL_SE18
SY   HZGHC004063c008; ATP6V0A2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SE18
DR   Horizon_Discovery; HZGHC004063c008
DR   Wikidata; Q54872831
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18481; ATP6V0A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP6V1H (-) 1
AC   CVCL_SE19
SY   HZGHC003349c001; ATP6V1H knockout cell line 38bp deletion
DR   cancercelllines; CVCL_SE19
DR   Horizon_Discovery; HZGHC003349c001
DR   Wikidata; Q54872832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18303; ATP6V1H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATP6V1H (-) 2
AC   CVCL_SE20
SY   HZGHC003349c011; ATP6V1H knockout cell line 182bp insertion
DR   cancercelllines; CVCL_SE20
DR   Horizon_Discovery; HZGHC003349c011
DR   Wikidata; Q54872833
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18303; ATP6V1H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003349c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP7B (-)
AC   CVCL_XL77
AS   CVCL_E1RJ
SY   HZGHC006967c010; HZGHC540; ATP7B knockout cell line
DR   cancercelllines; CVCL_XL77
DR   Horizon_Discovery; HZGHC006967c010
DR   Wikidata; Q93940190
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:870; ATP7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 15
//
ID   HAP1 ATP9A (-) 1
AC   CVCL_SE21
SY   HZGHC005837c012; ATP9A knockout cell line 8bp deletion; HAP1 ATP9A (-)
DR   cancercelllines; CVCL_SE21
DR   Horizon_Discovery; HZGHC005837c012
DR   Wikidata; Q54872834
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13540; ATP9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005837c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ATP9A (-) 2
AC   CVCL_XL78
SY   HZGHC005837c006; ATP9A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XL78
DR   Horizon_Discovery; HZGHC005837c006
DR   Wikidata; Q93940194
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13540; ATP9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005837c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP9B (-) 1
AC   CVCL_SE22
SY   HZGHC005838c001; ATP9B knockout cell line 1bp insertion; HAP1 ATP9B (-)
DR   cancercelllines; CVCL_SE22
DR   Horizon_Discovery; HZGHC005838c001
DR   Wikidata; Q54872835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13541; ATP9B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005838c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ATP9B (-) 2
AC   CVCL_XL79
SY   HZGHC005838c004; ATP9B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL79
DR   Horizon_Discovery; HZGHC005838c004
DR   Wikidata; Q93940199
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13541; ATP9B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005838c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATP9B (-) 3
AC   CVCL_XL80
SY   HZGHC005838c006; ATP9B knockout cell line 95bp deletion
DR   cancercelllines; CVCL_XL80
DR   Horizon_Discovery; HZGHC005838c006
DR   Wikidata; Q93940202
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13541; ATP9B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005838c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATPAF1 (-) 1
AC   CVCL_SE23
SY   HZGHC004752c002; ATPAF1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SE23
DR   Horizon_Discovery; HZGHC004752c002
DR   Wikidata; Q54872836
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18803; ATPAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATPAF1 (-) 2
AC   CVCL_SE24
SY   HZGHC004752c011; ATPAF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE24
DR   Horizon_Discovery; HZGHC004752c011
DR   Wikidata; Q54872837
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18803; ATPAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATPAF2 (-) 1
AC   CVCL_SE25
SY   HZGHC004753c006; ATPAF2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SE25
DR   Horizon_Discovery; HZGHC004753c006
DR   Wikidata; Q54872838
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18802; ATPAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATPAF2 (-) 2
AC   CVCL_SE26
SY   HZGHC004753c011; ATPAF2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SE26
DR   Horizon_Discovery; HZGHC004753c011
DR   Wikidata; Q54872839
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18802; ATPAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATPIF1 (-) 1
AC   CVCL_SE27
SY   HZGHC002416c004; ATPIF1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SE27
DR   Horizon_Discovery; HZGHC002416c004
DR   Wikidata; Q54872840
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:871; ATP5IF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATPIF1 (-) 2
AC   CVCL_SE28
SY   HZGHC002416c007; ATPIF1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SE28
DR   Horizon_Discovery; HZGHC002416c007
DR   Wikidata; Q54872842
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:871; ATP5IF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATRX (-) 1
AC   CVCL_SE29
SY   HZGHC000627c007; ATRX knockout cell line 7bp deletion; HAP1 ATRX (-)
DR   cancercelllines; CVCL_SE29
DR   Horizon_Discovery; HZGHC000627c007
DR   Wikidata; Q54872843
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATRX (-) 2
AC   CVCL_XL81
SY   HZGHC006632c010; ATRX knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XL81
DR   Horizon_Discovery; HZGHC006632c010
DR   Wikidata; Q93940241
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATRX (-) 3
AC   CVCL_XL82
SY   HZGHC006632c011; ATRX knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XL82
DR   Horizon_Discovery; HZGHC006632c011
DR   Wikidata; Q93940247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006632c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ATXN2 (-) 1
AC   CVCL_SE30
SY   HZGHC003203c002; ATXN2 knockout cell line 67bp deletion
DR   cancercelllines; CVCL_SE30
DR   Horizon_Discovery; HZGHC003203c002
DR   Wikidata; Q54872844
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10555; ATXN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATXN2 (-) 2
AC   CVCL_SE31
SY   HZGHC003203c011; ATXN2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SE31
DR   Horizon_Discovery; HZGHC003203c011
DR   Wikidata; Q54872845
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10555; ATXN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ATXN2L (-)
AC   CVCL_E1RK
SY   HZGHC007934c010
DR   Horizon_Discovery; HZGHC007934c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31326; ATXN2L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ATXN3 (-)
AC   CVCL_SE32
SY   HZGHC000727c008; ATXN3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SE32
DR   Horizon_Discovery; HZGHC000727c008
DR   Wikidata; Q54872846
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7106; ATXN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AUNIP (-) 1
AC   CVCL_XL83
SY   HZGHC006936c002; HZGHC79000; AUNIP knockout cell line 10bp deletion in exon 3; HAP1 AUNIP (-)
DR   cancercelllines; CVCL_XL83
DR   Horizon_Discovery; HZGHC006936c002
DR   Wikidata; Q93940273
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28363; AUNIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 AUNIP (-) 2
AC   CVCL_E1RL
SY   HZGHC006936c001; AUNIP knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC006936c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28363; AUNIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 AXIN1 (-) 1
AC   CVCL_SE33
SY   HZGHC000355c010; AXIN1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SE33
DR   Horizon_Discovery; HZGHC000355c010
DR   Wikidata; Q54872847
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AXIN1 (-) 2
AC   CVCL_SE34
SY   HZGHC000355c011; AXIN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE34
DR   Horizon_Discovery; HZGHC000355c011
DR   Wikidata; Q54872848
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AXIN1 (-) 3
AC   CVCL_SE35
SY   HZGHC000355c019; AXIN1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SE35
DR   Horizon_Discovery; HZGHC000355c019
DR   Wikidata; Q54872850
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AXIN1 (-) 4
AC   CVCL_SE36
SY   HZGHC000355c021; AXIN1 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_SE36
DR   Horizon_Discovery; HZGHC000355c021
DR   Wikidata; Q54872851
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AXIN1 (-) 5
AC   CVCL_SE37
SY   HZGHC000355c024; AXIN1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SE37
DR   Horizon_Discovery; HZGHC000355c024
DR   Wikidata; Q54872852
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AXIN2 (-) 1
AC   CVCL_SE38
SY   HZGHC006299c010; AXIN2 knockout cell line 8bp deletion; HAP1 AXIN2 (-)
DR   cancercelllines; CVCL_SE38
DR   Horizon_Discovery; HZGHC006299c010
DR   Wikidata; Q54872854
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:904; AXIN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AXIN2 (-) 2
AC   CVCL_XL84
SY   HZGHC006300c007; AXIN2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XL84
DR   Horizon_Discovery; HZGHC006300c007
DR   Wikidata; Q93940311
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:904; AXIN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AXIN2 (-) 3
AC   CVCL_XL85
SY   HZGHC006300c012; AXIN2 knockout cell line 181bp insertion
DR   cancercelllines; CVCL_XL85
DR   Horizon_Discovery; HZGHC006300c012
DR   Wikidata; Q93940314
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:904; AXIN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006300c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AXL (-)
AC   CVCL_SE39
SY   HZGHC000695c012; AXL knockout cell line 1bp insertion in exon 8
DR   cancercelllines; CVCL_SE39
DR   Horizon_Discovery; HZGHC000695c012
DR   Wikidata; Q54872855
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:905; AXL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 AZI2 (-) 1
AC   CVCL_SE40
SY   HZGHC003895c005; AZI2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SE40
DR   Horizon_Discovery; HZGHC003895c005
DR   Wikidata; Q54872856
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 AZI2 (-) 2
AC   CVCL_SE41
SY   HZGHC003895c008; AZI2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE41
DR   Horizon_Discovery; HZGHC003895c008
DR   Wikidata; Q54872857
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B2M (-) 1
AC   CVCL_SE42
SY   HZGHC006074c010; B2M knockout cell line 2bp deletion; HAP1 B2M (-)
DR   cancercelllines; CVCL_SE42
DR   Horizon_Discovery; HZGHC006074c010
DR   Wikidata; Q54872858
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 B2M (-) 2
AC   CVCL_XL86
SY   HZGHC006074c007; B2M knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XL86
DR   Horizon_Discovery; HZGHC006074c007
DR   Wikidata; Q93940334
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B3GALNT2 (-)
AC   CVCL_SE43
SY   HZGHC005932c003; B3GALNT2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SE43
DR   Horizon_Discovery; HZGHC005932c003
DR   Wikidata; Q54872859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28596; B3GALNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B3GALTL (-) 1
AC   CVCL_SE44
SY   HZGHC004393c001; B3GALTL knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE44
DR   Horizon_Discovery; HZGHC004393c001
DR   Wikidata; Q54872861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20207; B3GLCT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B3GALTL (-) 2
AC   CVCL_SE45
SY   HZGHC004393c005; B3GALTL knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SE45
DR   Horizon_Discovery; HZGHC004393c005
DR   Wikidata; Q54872862
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20207; B3GLCT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B3GNT1 (-) 1
AC   CVCL_SE46
SY   HZGHC000119c011; B3GNT1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE46
DR   Horizon_Discovery; HZGHC000119c011
DR   Wikidata; Q54872869
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15629; B3GNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B3GNT1 (-) 2
AC   CVCL_SE47
SY   HZGHC000119c017; B3GNT1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SE47
DR   Horizon_Discovery; HZGHC000119c017
DR   Wikidata; Q54872870
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15629; B3GNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B3GNT4 (-) 1
AC   CVCL_SE48
SY   HZGHC005430c012; B3GNT4 knockout cell line 2bp deletion; HAP1 B3GNT4 (-)
DR   cancercelllines; CVCL_SE48
DR   Horizon_Discovery; HZGHC005430c012
DR   Wikidata; Q54872871
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15683; B3GNT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 B3GNT4 (-) 2
AC   CVCL_XL87
SY   HZGHC005430c008; B3GNT4 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XL87
DR   Horizon_Discovery; HZGHC005430c008
DR   Wikidata; Q93940388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15683; B3GNT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALNT1 (-)
AC   CVCL_XL88
SY   HZGHC007259c007; HZGHC2583; B4GALNT1 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_XL88
DR   Horizon_Discovery; HZGHC007259c007
DR   Wikidata; Q93940390
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4117; B4GALNT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 B4GALNT2 (-) 1
AC   CVCL_SE49
SY   HZGHC005933c010; B4GALNT2 knockout cell line 11bp deletion; HAP1 B4GALNT2 (-)
DR   cancercelllines; CVCL_SE49
DR   Horizon_Discovery; HZGHC005933c010
DR   Wikidata; Q54872872
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24136; B4GALNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 B4GALNT2 (-) 2
AC   CVCL_XL89
SY   HZGHC005933c003; B4GALNT2 knockout cell line 146bp insertion
DR   cancercelllines; CVCL_XL89
DR   Horizon_Discovery; HZGHC005933c003
DR   Wikidata; Q93940403
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24136; B4GALNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005933c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 B4GALNT2 (-) 3
AC   CVCL_XL90
SY   HZGHC005933c011; B4GALNT2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XL90
DR   Horizon_Discovery; HZGHC005933c011
DR   Wikidata; Q93940407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24136; B4GALNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALNT3 (-) 1
AC   CVCL_SE50
SY   HZGHC004336c006; B4GALNT3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SE50
DR   Horizon_Discovery; HZGHC004336c006
DR   Wikidata; Q54872873
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24137; B4GALNT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALNT3 (-) 2
AC   CVCL_SE51
SY   HZGHC004336c011; B4GALNT3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SE51
DR   Horizon_Discovery; HZGHC004336c011
DR   Wikidata; Q54872874
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24137; B4GALNT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALNT4 (-) 1
AC   CVCL_SE52
SY   HZGHC004337c004; B4GALNT4 knockout cell line 143bp deletion
DR   cancercelllines; CVCL_SE52
DR   Horizon_Discovery; HZGHC004337c004
DR   Wikidata; Q54872875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26315; B4GALNT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALNT4 (-) 2
AC   CVCL_SE53
SY   HZGHC004337c006; B4GALNT4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE53
DR   Horizon_Discovery; HZGHC004337c006
DR   Wikidata; Q54872876
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26315; B4GALNT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALT1 (-) 1
AC   CVCL_SE54
SY   HZGHC004065c004; B4GALT1 knockout cell line 133bp insertion
DR   cancercelllines; CVCL_SE54
DR   Horizon_Discovery; HZGHC004065c004
DR   Wikidata; Q54872877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:924; B4GALT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004065c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 B4GALT1 (-) 2
AC   CVCL_SE55
SY   HZGHC004065c012; B4GALT1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SE55
DR   Horizon_Discovery; HZGHC004065c012
DR   Wikidata; Q54872878
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:924; B4GALT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALT5 (-)
AC   CVCL_XL91
SY   HZGHC007047c007; HZGHC9334; B4GALT5 knockout cell line 2bp deletion in exon 4
DR   cancercelllines; CVCL_XL91
DR   Horizon_Discovery; HZGHC007047c007
DR   Wikidata; Q93940460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:928; B4GALT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 B4GALT7 (-) 1
AC   CVCL_SE56
SY   HZGHC004066c001; B4GALT7 knockout cell line 100bp deletion
DR   cancercelllines; CVCL_SE56
DR   Horizon_Discovery; HZGHC004066c001
DR   Wikidata; Q54872879
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:930; B4GALT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 B4GALT7 (-) 2
AC   CVCL_SE57
SY   HZGHC004066c011; B4GALT7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SE57
DR   Horizon_Discovery; HZGHC004066c011
DR   Wikidata; Q54872880
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:930; B4GALT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BACE1 (-) 1
AC   CVCL_SE58
SY   HZGHC005958c001; BACE1 knockout cell line 11bp deletion; HAP1 BACE1 (-)
DR   cancercelllines; CVCL_SE58
DR   Horizon_Discovery; HZGHC005958c001
DR   Wikidata; Q54872881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:933; BACE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BACE1 (-) 2
AC   CVCL_XL92
SY   HZGHC005958c008; BACE1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XL92
DR   Horizon_Discovery; HZGHC005958c008
DR   Wikidata; Q93940489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:933; BACE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BACH1 (-) 1
AC   CVCL_SE59
SY   HZGHC005332c010; BACH1 knockout cell line 31bp deletion; HAP1 BACH1 (-)
DR   cancercelllines; CVCL_SE59
DR   Horizon_Discovery; HZGHC005332c010
DR   Wikidata; Q54872882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:935; BACH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BACH1 (-) 2
AC   CVCL_XL93
SY   HZGHC005332c004; BACH1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XL93
DR   Horizon_Discovery; HZGHC005332c004
DR   Wikidata; Q93940501
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:935; BACH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAD (-) 1
AC   CVCL_SE60
SY   HZGHC005959c001; BAD knockout cell line 23bp deletion; HAP1 BAD (-)
DR   cancercelllines; CVCL_SE60
DR   Horizon_Discovery; HZGHC005959c001
DR   Wikidata; Q54872883
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAD (-) 2
AC   CVCL_XL94
SY   HZGHC005959c002; BAD knockout cell line 29bp deletion
DR   cancercelllines; CVCL_XL94
DR   Horizon_Discovery; HZGHC005959c002
DR   Wikidata; Q93940512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAG3 (-) 1
AC   CVCL_SE61
SY   HZGHC005834c001; BAG3 knockout cell line 11bp deletion; HAP1 BAG3 (-)
DR   cancercelllines; CVCL_SE61
DR   Horizon_Discovery; HZGHC005834c001
DR   Wikidata; Q54872884
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:939; BAG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAG3 (-) 2
AC   CVCL_XL95
SY   HZGHC005834c012; BAG3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XL95
DR   Horizon_Discovery; HZGHC005834c012
DR   Wikidata; Q93940525
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:939; BAG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAG4 (-) 1
AC   CVCL_SE62
SY   HZGHC004077c005; BAG4 knockout cell line 67bp deletion
DR   cancercelllines; CVCL_SE62
DR   Horizon_Discovery; HZGHC004077c005
DR   Wikidata; Q54872885
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:940; BAG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAG4 (-) 2
AC   CVCL_SE63
SY   HZGHC004077c009; BAG4 knockout cell line 869bp insertion
DR   cancercelllines; CVCL_SE63
DR   Horizon_Discovery; HZGHC004077c009
DR   Wikidata; Q54872886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:940; BAG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004077c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAG6 (-) 1
AC   CVCL_SE64
SY   HZGHC004676c001; BAG6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SE64
DR   Horizon_Discovery; HZGHC004676c001
DR   Wikidata; Q54872887
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13919; BAG6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAG6 (-) 2
AC   CVCL_SE65
SY   HZGHC004676c006; BAG6 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SE65
DR   Horizon_Discovery; HZGHC004676c006
DR   Wikidata; Q54872889
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13919; BAG6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAIAP2 (-) 1
AC   CVCL_E1RM
SY   HZGHC008015c001
DR   Horizon_Discovery; HZGHC008015c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:947; BAIAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BAIAP2 (-) 2
AC   CVCL_E1RN
SY   HZGHC008015c002
DR   Horizon_Discovery; HZGHC008015c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:947; BAIAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BAIAP2 (-) 3
AC   CVCL_E1RP
SY   HZGHC008015c003
DR   Horizon_Discovery; HZGHC008015c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:947; BAIAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BAIAP2 (-) 4
AC   CVCL_E1RQ
SY   HZGHC008015c010
DR   Horizon_Discovery; HZGHC008015c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:947; BAIAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BAIAP2 (-) 5
AC   CVCL_E1RR
SY   HZGHC008016c007
DR   Horizon_Discovery; HZGHC008016c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:947; BAIAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BAK1 (-) 1
AC   CVCL_SE66
SY   HZGHC005962c001; BAK1 knockout cell line 1bp insertion; HAP1 BAK1 (-)
DR   cancercelllines; CVCL_SE66
DR   Horizon_Discovery; HZGHC005962c001
DR   Wikidata; Q54872891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAK1 (-) 2
AC   CVCL_XL96
SY   HZGHC005962c010; BAK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XL96
DR   Horizon_Discovery; HZGHC005962c010
DR   Wikidata; Q93940552
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005962c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAP1 (-)
AC   CVCL_SE67
SY   HZGHC003319c004; BAP1 knockout cell line 109bp insertion
DR   cancercelllines; CVCL_SE67
DR   Horizon_Discovery; HZGHC003319c004
DR   Wikidata; Q54872892
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:950; BAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003319c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BATF2 (-) 1
AC   CVCL_E1RS
SY   HZGHC008072c005
DR   Horizon_Discovery; HZGHC008072c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25163; BATF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BATF2 (-) 2
AC   CVCL_E1RT
SY   HZGHC008072c008
DR   Horizon_Discovery; HZGHC008072c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25163; BATF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BAX (-) 1
AC   CVCL_SE68
SY   HZGHC000879c005; BAX knockout cell line 7bp insertion
DR   cancercelllines; CVCL_SE68
DR   Horizon_Discovery; HZGHC000879c005
DR   Wikidata; Q54872893
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAX (-) 2
AC   CVCL_SE69
SY   HZGHC000879c009; BAX knockout cell line 350bp insertion
DR   cancercelllines; CVCL_SE69
DR   Horizon_Discovery; HZGHC000879c009
DR   Wikidata; Q54872894
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000879c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAZ1A (-) 1
AC   CVCL_SE70
SY   HZGHC000927c008; BAZ1A knockout cell line 202bp insertion
DR   cancercelllines; CVCL_SE70
DR   Horizon_Discovery; HZGHC000927c008
DR   Wikidata; Q54872895
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:960; BAZ1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000927c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAZ1A (-) 2
AC   CVCL_SE71
SY   HZGHC000927c012; BAZ1A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SE71
DR   Horizon_Discovery; HZGHC000927c012
DR   Wikidata; Q54872896
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:960; BAZ1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAZ1B (-)
AC   CVCL_SE72
SY   HZGHC000925c010; BAZ1B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SE72
DR   Horizon_Discovery; HZGHC000925c010
DR   Wikidata; Q54872898
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:961; BAZ1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAZ2A (-) 1
AC   CVCL_SE73
SY   HZGHC000931c001; BAZ2A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SE73
DR   Horizon_Discovery; HZGHC000931c001
DR   Wikidata; Q54872899
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:962; BAZ2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAZ2A (-) 2
AC   CVCL_SE74
SY   HZGHC000931c010; BAZ2A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SE74
DR   Horizon_Discovery; HZGHC000931c010
DR   Wikidata; Q54872900
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:962; BAZ2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAZ2A (-) 3
AC   CVCL_SE75
SY   HZGHC000931c011; BAZ2A knockout cell line 16bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000931c011
DR   PRIDE; PXD010335
DR   Wikidata; Q54872901
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:962; BAZ2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 BAZ2B (-) 1
AC   CVCL_SE76
SY   HZGHC001374c004; BAZ2B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE76
DR   Horizon_Discovery; HZGHC001374c004
DR   Wikidata; Q54872902
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:963; BAZ2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001374c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAZ2B (-) 2
AC   CVCL_SE77
SY   HZGHC001374c007; BAZ2B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE77
DR   Horizon_Discovery; HZGHC001374c007
DR   Wikidata; Q54872903
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:963; BAZ2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001374c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAZ2B (-) 3
AC   CVCL_SE78
SY   HZGHC000523c005; BAZ2B knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SE78
DR   Horizon_Discovery; HZGHC000523c005
DR   Wikidata; Q54872904
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:963; BAZ2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAZ2B (-) 4
AC   CVCL_SE79
SY   HZGHC000523c010; BAZ2B knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SE79
DR   Horizon_Discovery; HZGHC000523c010
DR   Wikidata; Q54872905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:963; BAZ2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000523c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BAZ2B (-) 5
AC   CVCL_SE80
SY   HZGHC000524c005; BAZ2B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SE80
DR   Horizon_Discovery; HZGHC000524c005
DR   Wikidata; Q54872906
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:963; BAZ2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BAZ2B (-) 6
AC   CVCL_SE81
SY   HZGHC001374c002; BAZ2B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE81
DR   Horizon_Discovery; HZGHC001374c002
DR   Wikidata; Q54872907
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:963; BAZ2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BBC3 (-)
AC   CVCL_SE82
SY   HZGHC002752c010; BBC3 knockout cell line 56bp deletion
DR   cancercelllines; CVCL_SE82
DR   Horizon_Discovery; HZGHC002752c010
DR   Wikidata; Q54872908
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17868; BBC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCAP31 (-)
AC   CVCL_E1RU
SY   HZGHC008083c009
DR   Horizon_Discovery; HZGHC008083c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16695; BCAP31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCAT1 (-) 1
AC   CVCL_E1RV
SY   HZGHC007580c009
DR   Horizon_Discovery; HZGHC007580c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCAT1 (-) 2
AC   CVCL_E1RW
SY   HZGHC007580c012
DR   Horizon_Discovery; HZGHC007580c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCAT2 (-)
AC   CVCL_XL97
SY   HZGHC007149c003; HZGHC587; BCAT2 knockout cell line 13bp deletion in exon 5
DR   cancercelllines; CVCL_XL97
DR   Horizon_Discovery; HZGHC007149c003
DR   Wikidata; Q93940643
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:977; BCAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BCDIN3D (-) 1
AC   CVCL_XL98
SY   HZGHC006866c003; HZGHC144233; BCDIN3D knockout cell line 1bp insertion in exon 1; HAP1 BCDIN3D (-)
DR   cancercelllines; CVCL_XL98
DR   Horizon_Discovery; HZGHC006866c003
DR   Wikidata; Q93940646
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27050; BCDIN3D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 BCDIN3D (-) 2
AC   CVCL_E1RX
SY   HZGHC006866c002
DR   Horizon_Discovery; HZGHC006866c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27050; BCDIN3D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCDIN3D (-) 3
AC   CVCL_E1RY
SY   HZGHC006866c007
DR   Horizon_Discovery; HZGHC006866c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27050; BCDIN3D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCHE (-) 1
AC   CVCL_SE83
SY   HZGHC003875c001; BCHE knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SE83
DR   Horizon_Discovery; HZGHC003875c001
DR   Wikidata; Q54872909
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:983; BCHE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCHE (-) 2
AC   CVCL_SE84
SY   HZGHC003875c011; BCHE knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE84
DR   Horizon_Discovery; HZGHC003875c011
DR   Wikidata; Q54872910
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:983; BCHE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCHE (-) 3
AC   CVCL_SE85
SY   HZGHC003875c002; BCHE knockout cell line 5bp insertion
DR   cancercelllines; CVCL_SE85
DR   Horizon_Discovery; HZGHC003875c002
DR   Wikidata; Q54872911
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:983; BCHE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCKDHA (-) 1
AC   CVCL_XL99
SY   HZGHC006918c009; HZGHC593; BCKDHA knockout cell line 71bp insertion in exon 2; HAP1 BCKDHA (-)
DR   cancercelllines; CVCL_XL99
DR   Horizon_Discovery; HZGHC006918c009
DR   Wikidata; Q93940668
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:986; BCKDHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006918c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 BCKDHA (-) 2
AC   CVCL_B5JL
SY   HZGHC006918c010; BCKDHA knockout cell line 10bp deletion in exon 2
DR   cancercelllines; CVCL_B5JL
DR   Horizon_Discovery; HZGHC006918c010
DR   Wikidata; Q111733269
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:986; BCKDHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 BCKDK (-)
AC   CVCL_SE86
SY   HZGHC000197c006; BCKDK knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SE86
DR   Horizon_Discovery; HZGHC000197c006
DR   Wikidata; Q54872917
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16902; BCKDK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL10 (-) 1
AC   CVCL_E1RZ
SY   HZGHC007809c003
DR   Horizon_Discovery; HZGHC007809c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCL10 (-) 2
AC   CVCL_E1S0
SY   HZGHC007809c004
DR   Horizon_Discovery; HZGHC007809c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCL10 (-) 3
AC   CVCL_E1S1
SY   HZGHC007809c007
DR   Horizon_Discovery; HZGHC007809c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCL10 (-) 4
AC   CVCL_E1S2
SY   HZGHC007809c008
DR   Horizon_Discovery; HZGHC007809c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BCL11A (-) 1
AC   CVCL_SE87
SY   HZGHC002426c005; BCL11A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SE87
DR   Horizon_Discovery; HZGHC002426c005
DR   Wikidata; Q54872918
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13221; BCL11A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL11A (-) 2
AC   CVCL_SE88
SY   HZGHC002426c010; BCL11A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SE88
DR   Horizon_Discovery; HZGHC002426c010
DR   Wikidata; Q54872919
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13221; BCL11A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL11B (-) 1
AC   CVCL_SE89
SY   HZGHC002432c005; BCL11B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SE89
DR   Horizon_Discovery; HZGHC002432c005
DR   Wikidata; Q54872920
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13222; BCL11B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL11B (-) 2
AC   CVCL_SE90
SY   HZGHC002432c010; BCL11B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SE90
DR   Horizon_Discovery; HZGHC002432c010
DR   Wikidata; Q54872921
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13222; BCL11B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL2 (-) 1
AC   CVCL_SE91
SY   HZGHC004740c001; BCL2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SE91
DR   Horizon_Discovery; HZGHC004740c001
DR   Wikidata; Q54872922
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL2 (-) 2
AC   CVCL_SE92
SY   HZGHC004740c012; BCL2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SE92
DR   Horizon_Discovery; HZGHC004740c012
DR   Wikidata; Q54872923
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL2 (-) 3
AC   CVCL_SE93
SY   HZGHC004759c001; BCL2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SE93
DR   Horizon_Discovery; HZGHC004759c001
DR   Wikidata; Q54872924
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL2 (-) 4
AC   CVCL_SE94
SY   HZGHC004759c007; BCL2 knockout cell line 145bp insertion
DR   cancercelllines; CVCL_SE94
DR   Horizon_Discovery; HZGHC004759c007
DR   Wikidata; Q54872925
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004759c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BCL2L2 (-) 1
AC   CVCL_SE95
SY   HZGHC003084c001; BCL2L2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE95
DR   Horizon_Discovery; HZGHC003084c001
DR   Wikidata; Q54872926
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:995; BCL2L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL2L2 (-) 2
AC   CVCL_SE96
SY   HZGHC003084c007; BCL2L2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SE96
DR   Horizon_Discovery; HZGHC003084c007
DR   Wikidata; Q54872928
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:995; BCL2L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL2L2 (-) 3
AC   CVCL_SE97
SY   HZGHC003084c010; BCL2L2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SE97
DR   Horizon_Discovery; HZGHC003084c010
DR   Wikidata; Q54872929
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:995; BCL2L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL3 (-) 1
AC   CVCL_SE98
SY   HZGHC002607c001; BCL3 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SE98
DR   Horizon_Discovery; HZGHC002607c001
DR   Wikidata; Q54872930
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:998; BCL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL3 (-) 2
AC   CVCL_SE99
SY   HZGHC002607c010; BCL3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SE99
DR   Horizon_Discovery; HZGHC002607c010
DR   Wikidata; Q54872931
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:998; BCL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL6 (-) 1
AC   CVCL_SF00
SY   HZGHC005373c012; BCL6 knockout cell line 13bp deletion; HAP1 BCL6 (-)
DR   cancercelllines; CVCL_SF00
DR   Horizon_Discovery; HZGHC005373c012
DR   Wikidata; Q54872932
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BCL6 (-) 2
AC   CVCL_XM00
SY   HZGHC005373c002; BCL6 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XM00
DR   Horizon_Discovery; HZGHC005373c002
DR   Wikidata; Q93940754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL7A (-) 1
AC   CVCL_SF01
SY   HZGHC002434c010; BCL7A knockout cell line 7bp deletion; HAP1 BCL7A (-)
DR   cancercelllines; CVCL_SF01
DR   Horizon_Discovery; HZGHC002434c010
DR   Wikidata; Q54872933
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1004; BCL7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BCL7A (-) 2
AC   CVCL_XM01
SY   HZGHC005864c010; BCL7A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XM01
DR   Horizon_Discovery; HZGHC005864c010
DR   Wikidata; Q93940760
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1004; BCL7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005864c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BCL7A (-) 3
AC   CVCL_XM02
SY   HZGHC005864c011; BCL7A knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XM02
DR   Horizon_Discovery; HZGHC005864c011
DR   Wikidata; Q93940762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1004; BCL7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005864c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BCL7B (-) 1
AC   CVCL_SF02
SY   HZGHC004278c003; BCL7B knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SF02
DR   Horizon_Discovery; HZGHC004278c003
DR   Wikidata; Q54872934
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1005; BCL7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL7B (-) 2
AC   CVCL_SF03
SY   HZGHC004278c008; BCL7B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SF03
DR   Horizon_Discovery; HZGHC004278c008
DR   Wikidata; Q54872936
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1005; BCL7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL7B (-) 3
AC   CVCL_SF04
SY   HZGHC004278c010; BCL7B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF04
DR   Horizon_Discovery; HZGHC004278c010
DR   Wikidata; Q54872937
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1005; BCL7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL9 (-) 1
AC   CVCL_SF05
SY   HZGHC004044c006; BCL9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF05
DR   Horizon_Discovery; HZGHC004044c006
DR   Wikidata; Q54872938
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1008; BCL9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCL9 (-) 2
AC   CVCL_SF06
SY   HZGHC004044c008; BCL9 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SF06
DR   Horizon_Discovery; HZGHC004044c008
DR   Wikidata; Q54872939
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1008; BCL9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCOR (-) 1
AC   CVCL_SF07
SY   HZGHC004895c005; BCOR knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF07
DR   Horizon_Discovery; HZGHC004895c005
DR   Wikidata; Q54872940
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20893; BCOR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCOR (-) 2
AC   CVCL_SF08
SY   HZGHC004895c010; BCOR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF08
DR   Horizon_Discovery; HZGHC004895c010
DR   Wikidata; Q54872941
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20893; BCOR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCR (-) 1
AC   CVCL_SF09
SY   HZGHC001276c025; BCR knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SF09
DR   Horizon_Discovery; HZGHC001276c025
DR   Wikidata; Q54872942
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1014; BCR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCR (-) 2
AC   CVCL_SF10
SY   HZGHC002983c001; BCR knockout cell line 41bp deletion
DR   cancercelllines; CVCL_SF10
DR   Horizon_Discovery; HZGHC002983c001
DR   Wikidata; Q54872943
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1014; BCR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BCR (-) 3
AC   CVCL_SF11
SY   HZGHC002983c010; BCR knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF11
DR   Horizon_Discovery; HZGHC002983c010
DR   Wikidata; Q54872944
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1014; BCR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BDH1 (-)
AC   CVCL_E1S3
SY   HZGHC007900c010
DR   Horizon_Discovery; HZGHC007900c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1027; BDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BEND3 (-) 1
AC   CVCL_SF12
SY   HZGHC001754c002; BEND3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SF12
DR   Horizon_Discovery; HZGHC001754c002
DR   Wikidata; Q54872945
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23040; BEND3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BEND3 (-) 2
AC   CVCL_SF13
SY   HZGHC001754c004; BEND3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SF13
DR   Horizon_Discovery; HZGHC001754c004
DR   Wikidata; Q54872946
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23040; BEND3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIN1 (-) 1
AC   CVCL_SF14
SY   HZGHC004348c002; BIN1 knockout cell line 13bp insertion
DR   cancercelllines; CVCL_SF14
DR   Horizon_Discovery; HZGHC004348c002
DR   Wikidata; Q54872947
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1052; BIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004348c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BIN1 (-) 2
AC   CVCL_SF15
SY   HZGHC004348c005; BIN1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SF15
DR   Horizon_Discovery; HZGHC004348c005
DR   Wikidata; Q54872948
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1052; BIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIRC2 (-) 1
AC   CVCL_SF16
SY   HZGHC002590c010; BIRC2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SF16
DR   Horizon_Discovery; HZGHC002590c010
DR   Wikidata; Q54872949
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:590; BIRC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BIRC2 (-) 2
AC   CVCL_SF17
SY   HZGHC002590c011; BIRC2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SF17
DR   Horizon_Discovery; HZGHC002590c011
DR   PRIDE; PXD010335
DR   Wikidata; Q54872950
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:590; BIRC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BIRC3 (-) 1
AC   CVCL_SF18
SY   HZGHC002811c010; BIRC3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF18
DR   Horizon_Discovery; HZGHC002811c010
DR   Wikidata; Q54872951
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:591; BIRC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIRC3 (-) 2
AC   CVCL_SF19
SY   HZGHC002816c007; BIRC3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SF19
DR   Horizon_Discovery; HZGHC002816c007
DR   Wikidata; Q54872953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:591; BIRC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIRC3 (-) 3
AC   CVCL_SF20
SY   HZGHC002816c013; BIRC3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SF20
DR   Horizon_Discovery; HZGHC002816c013
DR   Wikidata; Q54872954
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:591; BIRC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIRC6 (-) 1
AC   CVCL_SF21
SY   HZGHC002550c004; BIRC6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF21
DR   Horizon_Discovery; HZGHC002550c004
DR   Wikidata; Q54872955
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13516; BIRC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIRC6 (-) 2
AC   CVCL_SF22
SY   HZGHC002550c005; BIRC6 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF22
DR   Horizon_Discovery; HZGHC002550c005
DR   Wikidata; Q54872956
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13516; BIRC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIVM-ERCC5 (-) 1
AC   CVCL_SF23
SY   HZGHC004035c002; BIVM-ERCC5 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SF23
DR   Horizon_Discovery; HZGHC004035c002
DR   Wikidata; Q54872958
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43690; BIVM-ERCC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BIVM-ERCC5 (-) 2
AC   CVCL_SF24
SY   HZGHC004035c006; BIVM-ERCC5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SF24
DR   Horizon_Discovery; HZGHC004035c006
DR   Wikidata; Q54872959
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43690; BIVM-ERCC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BLM (-) 1
AC   CVCL_SF25
SY   HZGHC000629c005; BLM knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF25
DR   Horizon_Discovery; HZGHC000629c005
DR   Wikidata; Q54872960
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1058; BLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BLM (-) 2
AC   CVCL_SF26
SY   HZGHC000629c007; BLM knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SF26
DR   Horizon_Discovery; HZGHC000629c007
DR   Wikidata; Q54872967
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1058; BLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000629c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BLVRB (-) 1
AC   CVCL_SF27
SY   HZGHC003760c002; BLVRB knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SF27
DR   Horizon_Discovery; HZGHC003760c002
DR   Wikidata; Q54872969
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1063; BLVRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BLVRB (-) 2
AC   CVCL_SF28
SY   HZGHC003760c007; BLVRB knockout cell line 206bp insertion
DR   cancercelllines; CVCL_SF28
DR   Horizon_Discovery; HZGHC003760c007
DR   Wikidata; Q54872970
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1063; BLVRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003760c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BLVRB (-) 3
AC   CVCL_SF29
SY   HZGHC003760c010; BLVRB knockout cell line 10bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC003760c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54872971
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1063; BLVRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 BLVRB (-) 4
AC   CVCL_SF30
SY   HZGHC003760c011; BLVRB knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF30
DR   Horizon_Discovery; HZGHC003760c011
DR   Wikidata; Q54872973
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1063; BLVRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMI1 (-) 1
AC   CVCL_SF31
SY   HZGHC001110c002; BMI1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SF31
DR   Horizon_Discovery; HZGHC001110c002
DR   Wikidata; Q54872974
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1066; BMI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMI1 (-) 2
AC   CVCL_SF32
SY   HZGHC001110c004; BMI1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SF32
DR   Horizon_Discovery; HZGHC001110c004
DR   Wikidata; Q54872975
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1066; BMI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMI1 (-) 3
AC   CVCL_SF33
SY   HZGHC001110c008; BMI1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF33
DR   Horizon_Discovery; HZGHC001110c008
DR   Wikidata; Q54872976
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1066; BMI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001110c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BMP1 (-) 1
AC   CVCL_E1S4
SY   HZGHC008121c005
DR   Horizon_Discovery; HZGHC008121c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1067; BMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BMP1 (-) 2
AC   CVCL_E1S5
SY   HZGHC008121c007
DR   Horizon_Discovery; HZGHC008121c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1067; BMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BMP1 (-) 3
AC   CVCL_E1S6
SY   HZGHC008121c012
DR   Horizon_Discovery; HZGHC008121c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1067; BMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BMP2K (-) 1
AC   CVCL_SF34
SY   HZGHC000128c009; BMP2K knockout cell line 7bp insertion
DR   cancercelllines; CVCL_SF34
DR   Horizon_Discovery; HZGHC000128c009
DR   Wikidata; Q54872977
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18041; BMP2K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMP2K (-) 2
AC   CVCL_SF35
SY   HZGHC000128c016; BMP2K knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF35
DR   Horizon_Discovery; HZGHC000128c016
DR   Wikidata; Q54872978
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18041; BMP2K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMP4 (-) 1
AC   CVCL_SF36
SY   HZGHC006008c001; BMP4 knockout cell line 31bp deletion; HAP1 BMP4 (-)
DR   cancercelllines; CVCL_SF36
DR   Horizon_Discovery; HZGHC006008c001
DR   Wikidata; Q54872979
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1071; BMP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BMP4 (-) 2
AC   CVCL_XM03
SY   HZGHC006008c003; BMP4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM03
DR   Horizon_Discovery; HZGHC006008c003
DR   Wikidata; Q93940957
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1071; BMP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMP7 (-) 1
AC   CVCL_SF37
SY   HZGHC005964c001; BMP7 knockout cell line 4bp deletion; HAP1 BMP7 (-)
DR   cancercelllines; CVCL_SF37
DR   Horizon_Discovery; HZGHC005964c001
DR   Wikidata; Q54872980
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1074; BMP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BMP7 (-) 2
AC   CVCL_XM04
SY   HZGHC005964c002; BMP7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XM04
DR   Horizon_Discovery; HZGHC005964c002
DR   Wikidata; Q93940966
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1074; BMP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMPR1A (-) 1
AC   CVCL_SF38
SY   HZGHC004546c007; BMPR1A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SF38
DR   Horizon_Discovery; HZGHC004546c007
DR   Wikidata; Q54872981
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMPR1A (-) 2
AC   CVCL_SF39
SY   HZGHC004546c010; BMPR1A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF39
DR   Horizon_Discovery; HZGHC004546c010
DR   Wikidata; Q54872982
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMPR1B (-)
AC   CVCL_SF40
SY   HZGHC000366c011; BMPR1B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF40
DR   Horizon_Discovery; HZGHC000366c011
DR   Wikidata; Q54872983
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1077; BMPR1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMPR2 (-) 1
AC   CVCL_SF41
SY   HZGHC000076c005; BMPR2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SF41
DR   Horizon_Discovery; HZGHC000076c005
DR   Wikidata; Q54872984
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BMPR2 (-) 2
AC   CVCL_SF42
SY   HZGHC000076c011; BMPR2 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SF42
DR   Horizon_Discovery; HZGHC000076c011
DR   Wikidata; Q54872985
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BNIP3 (-) 1
AC   CVCL_SF43
SY   HZGHC006249c005; BNIP3 knockout cell line 2bp insertion; HAP1 BNIP3 (-)
DR   cancercelllines; CVCL_SF43
DR   Horizon_Discovery; HZGHC006249c005
DR   Wikidata; Q54872987
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1084; BNIP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BNIP3 (-) 2
AC   CVCL_XM05
SY   HZGHC006249c006; BNIP3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XM05
DR   Horizon_Discovery; HZGHC006249c006
DR   Wikidata; Q93941009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1084; BNIP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BOLA3 (-)
AC   CVCL_XM06
SY   HZGHC007087c010; HZGHC388962; BOLA3 knockout cell line 5bp deletion in exon 2
DR   cancercelllines; CVCL_XM06
DR   Horizon_Discovery; HZGHC007087c010
DR   Wikidata; Q93941011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24415; BOLA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BPGM (-) 1
AC   CVCL_SF44
SY   HZGHC005448c012; BPGM knockout cell line 11bp deletion; HAP1 BPGM (-)
DR   cancercelllines; CVCL_SF44
DR   Horizon_Discovery; HZGHC005448c012
DR   Wikidata; Q54872988
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1093; BPGM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BPGM (-) 2
AC   CVCL_XM07
SY   HZGHC005448c002; BPGM knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XM07
DR   Horizon_Discovery; HZGHC005448c002
DR   Wikidata; Q93941020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1093; BPGM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BPTF (-) 1
AC   CVCL_SF45
SY   HZGHC001369c010; BPTF knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SF45
DR   Horizon_Discovery; HZGHC001369c010
DR   Wikidata; Q54872989
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3581; BPTF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BPTF (-) 2
AC   CVCL_SF46
SY   HZGHC001369c012; BPTF knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SF46
DR   Horizon_Discovery; HZGHC001369c012
DR   Wikidata; Q54872990
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3581; BPTF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRAF (-) 1
AC   CVCL_SF47
SY   HZGHC000002c001; BRAF knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SF47
DR   Horizon_Discovery; HZGHC000002c001
DR   Wikidata; Q54872991
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRAF (-) 2
AC   CVCL_SF48
SY   HZGHC000002c015; BRAF knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF48
DR   Horizon_Discovery; HZGHC000002c015
DR   Wikidata; Q54872992
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000002c015; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRAF (-) 3
AC   CVCL_SF49
SY   HZGHC000002c016; BRAF knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SF49
DR   Horizon_Discovery; HZGHC000002c016
DR   Wikidata; Q54872993
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000002c016; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRAP (-) 1
AC   CVCL_E1S7
SY   HZGHC008201c009
DR   Horizon_Discovery; HZGHC008201c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1099; BRAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BRAP (-) 2
AC   CVCL_E1S8
SY   HZGHC008201c010
DR   Horizon_Discovery; HZGHC008201c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1099; BRAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BRCC3 (-) 1
AC   CVCL_SF50
SY   HZGHC000498c009; BRCC3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF50
DR   Horizon_Discovery; HZGHC000498c009
DR   Wikidata; Q54872996
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24185; BRCC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRCC3 (-) 2
AC   CVCL_SF51
SY   HZGHC004018c012; BRCC3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SF51
DR   Horizon_Discovery; HZGHC004018c012
DR   Wikidata; Q54872997
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24185; BRCC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRD1 (-) 1
AC   CVCL_SF52
SY   HZGHC000941c001; BRD1 knockout cell line 106bp insertion; HAP1 BRD1 (-)
DR   cancercelllines; CVCL_SF52
DR   Horizon_Discovery; HZGHC000941c001
DR   Wikidata; Q54872998
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000941c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 BRD1 (-) 2
AC   CVCL_XM08
SY   HZGHC000941c006; BRD1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XM08
DR   Horizon_Discovery; HZGHC000941c006
DR   Wikidata; Q93941096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRD1 (-) 3
AC   CVCL_XM09
SY   HZGHC000956c001; BRD1 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_XM09
DR   Horizon_Discovery; HZGHC000956c001
DR   Wikidata; Q93941100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRD1 (-) 4
AC   CVCL_XM10
SY   HZGHC000956c002; BRD1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XM10
DR   Horizon_Discovery; HZGHC000956c002
DR   Wikidata; Q93941104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRD1 (-) 5
AC   CVCL_XM11
SY   HZGHC000956c012; BRD1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XM11
DR   Horizon_Discovery; HZGHC000956c012
DR   Wikidata; Q93941108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRD2 (-) 1
AC   CVCL_SF53
SY   HZGHC000356c010; BRD2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF53
DR   Horizon_Discovery; HZGHC000356c010
DR   Wikidata; Q54872999
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD2 (-) 2
AC   CVCL_SF54
SY   HZGHC000356c015; BRD2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF54
DR   Horizon_Discovery; HZGHC000356c015
DR   Wikidata; Q54873000
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRD2 (-) 3
AC   CVCL_SF55
SY   HZGHC000356c017; BRD2 knockout cell line 4bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000356c017
DR   PRIDE; PXD010335
DR   Wikidata; Q54873001
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 BRD3 (-) 1
AC   CVCL_SF56
SY   HZGHC000244c004; BRD3 knockout cell line 22bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000244c004
DR   PRIDE; PXD010335
DR   Wikidata; Q54873002
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 BRD3 (-) 2
AC   CVCL_SF57
SY   HZGHC005081c002; BRD3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SF57
DR   Horizon_Discovery; HZGHC005081c002
DR   Wikidata; Q54873004
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD3 (-) 3
AC   CVCL_SF58
SY   HZGHC005081c010; BRD3 knockout cell line 86bp deletion
DR   cancercelllines; CVCL_SF58
DR   Horizon_Discovery; HZGHC005081c010
DR   Wikidata; Q54873005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRD4 (-) 1
AC   CVCL_SF59
SY   HZGHC000937c004; BRD4 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SF59
DR   Horizon_Discovery; HZGHC000937c004
DR   Wikidata; Q54873006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000937c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD4 (-) 2
AC   CVCL_SF60
SY   HZGHC000937c006; BRD4 knockout cell line 178bp insertion
DR   cancercelllines; CVCL_SF60
DR   Horizon_Discovery; HZGHC000937c006
DR   Wikidata; Q54873007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000937c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD4 (-) 3
AC   CVCL_SF61
SY   HZGHC000937c007; BRD4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF61
DR   Horizon_Discovery; HZGHC000937c007
DR   Wikidata; Q54873008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000937c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD4 (-) 4
AC   CVCL_SF62
SY   HZGHC001340c002; BRD4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SF62
DR   Horizon_Discovery; HZGHC001340c002
DR   Wikidata; Q54873010
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001340c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 BRD4 (-) 5
AC   CVCL_SF63
SY   HZGHC001340c004; BRD4 knockout cell line 16bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC001340c004
DR   PRIDE; PXD010335
DR   Wikidata; Q54873011
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Horizon_Discovery; HZGHC001340c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 BRD7 (-)
AC   CVCL_SF64
SY   HZGHC000923c010; BRD7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF64
DR   Horizon_Discovery; HZGHC000923c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54873012
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14310; BRD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD8 (-) 1
AC   CVCL_SF65
SY   HZGHC000926c005; BRD8 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SF65
DR   Horizon_Discovery; HZGHC000926c005
DR   Wikidata; Q54873013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19874; BRD8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000926c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD8 (-) 2
AC   CVCL_SF66
SY   HZGHC000926c007; BRD8 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SF66
DR   Horizon_Discovery; HZGHC000926c007
DR   Wikidata; Q54873020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19874; BRD8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000926c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD9 (-) 1
AC   CVCL_SF67
SY   HZGHC000934c003; BRD9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF67
DR   Horizon_Discovery; HZGHC000934c003
DR   Wikidata; Q54873021
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRD9 (-) 2
AC   CVCL_SF68
SY   HZGHC000934c010; BRD9 knockout cell line 8bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000934c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54873022
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 BRDT (-) 1
AC   CVCL_SF69
SY   HZGHC001321c005; BRDT knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF69
DR   Horizon_Discovery; HZGHC001321c005
DR   Wikidata; Q54873023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1105; BRDT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRDT (-) 2
AC   CVCL_SF70
SY   HZGHC001321c008; BRDT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SF70
DR   Horizon_Discovery; HZGHC001321c008
DR   Wikidata; Q54873024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1105; BRDT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRE (-) 1
AC   CVCL_E1S9
SY   HZGHC007550c003; BRE knockout cell line 8bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007550c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1106; BABAM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BRE (-) 2
AC   CVCL_E1SA
SY   HZGHC007551c011; BRE knockout cell line 1bp insertion in exon 7
DR   Horizon_Discovery; HZGHC007551c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1106; BABAM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BRIP1 (-) 1
AC   CVCL_SF71
SY   HZGHC005588c011; BRIP1 knockout cell line 4bp deletion; HAP1 BRIP1 (-)
DR   cancercelllines; CVCL_SF71
DR   Horizon_Discovery; HZGHC005588c011
DR   Wikidata; Q54873025
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20473; BRIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRIP1 (-) 2
AC   CVCL_XM12
SY   HZGHC005588c003; BRIP1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XM12
DR   Horizon_Discovery; HZGHC005588c003
DR   Wikidata; Q93941232
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20473; BRIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRK1 (-) 1
AC   CVCL_SF72
SY   HZGHC004027c003; BRK1 knockout cell line 115bp insertion
DR   cancercelllines; CVCL_SF72
DR   Horizon_Discovery; HZGHC004027c003
DR   Wikidata; Q54873026
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23057; BRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004027c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRK1 (-) 2
AC   CVCL_SF73
SY   HZGHC004027c009; BRK1 knockout cell line 314bp insertion
DR   cancercelllines; CVCL_SF73
DR   Horizon_Discovery; HZGHC004027c009
DR   Wikidata; Q54873027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23057; BRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004027c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRK1 (-) 3
AC   CVCL_SF74
SY   HZGHC003542c006; BRK1 knockout cell line 235bp insertion
DR   cancercelllines; CVCL_SF74
DR   Horizon_Discovery; HZGHC003542c006
DR   Wikidata; Q54873028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23057; BRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003542c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BRPF1 (-) 1
AC   CVCL_SF75
SY   HZGHC000958c001; BRPF1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SF75
DR   Horizon_Discovery; HZGHC000958c001
DR   Wikidata; Q54873029
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14255; BRPF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRPF1 (-) 2
AC   CVCL_SF76
SY   HZGHC000958c003; BRPF1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF76
DR   Horizon_Discovery; HZGHC000958c003
DR   Wikidata; Q54873030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14255; BRPF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRPF1 (-) 3
AC   CVCL_SF77
SY   HZGHC000958c010; BRPF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF77
DR   Horizon_Discovery; HZGHC000958c010
DR   Wikidata; Q54873031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14255; BRPF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRPF3 (-) 1
AC   CVCL_SF78
SY   HZGHC000950c004; BRPF3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SF78
DR   Horizon_Discovery; HZGHC000950c004
DR   Wikidata; Q54873033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14256; BRPF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRPF3 (-) 2
AC   CVCL_SF79
SY   HZGHC000950c012; BRPF3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SF79
DR   Horizon_Discovery; HZGHC000950c012
DR   Wikidata; Q54873034
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14256; BRPF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRSK1 (-) 1
AC   CVCL_SF80
SY   HZGHC000347c005; BRSK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF80
DR   Horizon_Discovery; HZGHC000347c005
DR   Wikidata; Q54873035
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18994; BRSK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRSK1 (-) 2
AC   CVCL_SF81
SY   HZGHC000347c019; BRSK1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SF81
DR   Horizon_Discovery; HZGHC000347c019
DR   Wikidata; Q54873037
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18994; BRSK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRSK2 (-) 1
AC   CVCL_SF82
SY   HZGHC000345c017; BRSK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF82
DR   Horizon_Discovery; HZGHC000345c017
DR   Wikidata; Q54873038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11405; BRSK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRSK2 (-) 2
AC   CVCL_SF83
SY   HZGHC000345c022; BRSK2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SF83
DR   Horizon_Discovery; HZGHC000345c022
DR   Wikidata; Q54873039
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11405; BRSK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRWD1 (-) 1
AC   CVCL_SF84
SY   HZGHC000932c003; BRWD1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SF84
DR   Horizon_Discovery; HZGHC000932c003
DR   Wikidata; Q54873040
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12760; BRWD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRWD1 (-) 2
AC   CVCL_SF85
SY   HZGHC000932c012; BRWD1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SF85
DR   Horizon_Discovery; HZGHC000932c012
DR   Wikidata; Q54873041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12760; BRWD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BRWD3 (-)
AC   CVCL_SF86
SY   HZGHC000940c006; BRWD3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SF86
DR   Horizon_Discovery; HZGHC000940c006
DR   Wikidata; Q54873042
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17342; BRWD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BSG (-)
AC   CVCL_SF87
SY   HZGHC006255c003; BSG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF87
DR   Horizon_Discovery; HZGHC006255c003
DR   Wikidata; Q54873043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BST2 (-) 1
AC   CVCL_SF88
SY   HZGHC005111c007; BST2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SF88
DR   Horizon_Discovery; HZGHC005111c007
DR   Wikidata; Q54873044
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1119; BST2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BST2 (-) 2
AC   CVCL_SF89
SY   HZGHC005111c010; BST2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SF89
DR   Horizon_Discovery; HZGHC005111c010
DR   Wikidata; Q54873045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1119; BST2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BTBD7 (-) 1
AC   CVCL_E1SB
SY   HZGHC008192c003
DR   Horizon_Discovery; HZGHC008192c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18269; BTBD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BTBD7 (-) 2
AC   CVCL_E1SC
SY   HZGHC008192c005
DR   Horizon_Discovery; HZGHC008192c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18269; BTBD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BTBD7 (-) 3
AC   CVCL_E1SD
SY   HZGHC008192c011
DR   Horizon_Discovery; HZGHC008192c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18269; BTBD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BTBD9 (-)
AC   CVCL_E1SE
SY   HZGHC007595c009
DR   Horizon_Discovery; HZGHC007595c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21228; BTBD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BTD (-) 1
AC   CVCL_SF90
SY   HZGHC006407c001; BTD knockout cell line 7bp deletion; HAP1 BTD (-)
DR   cancercelllines; CVCL_SF90
DR   Horizon_Discovery; HZGHC006407c001
DR   Wikidata; Q54873046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1122; BTD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BTD (-) 2
AC   CVCL_XM13
SY   HZGHC006407c012; BTD knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XM13
DR   Horizon_Discovery; HZGHC006407c012
DR   Wikidata; Q93941339
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1122; BTD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BTG1 (-) 1
AC   CVCL_XM14
SY   HZGHC006963c008; HZGHC694; BTG1 knockout cell line 1bp deletion in exon 2; HAP1 BTG1 (-)
DR   cancercelllines; CVCL_XM14
DR   Horizon_Discovery; HZGHC006963c008
DR   Wikidata; Q93941341
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1130; BTG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 BTG1 (-) 2
AC   CVCL_E1SF
SY   HZGHC006963c009; BTG1 knockout cell line 2bp insertion in exon 2
DR   Horizon_Discovery; HZGHC006963c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1130; BTG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BTN1A1 (-) 1
AC   CVCL_E1SG
SY   HZGHC008003c006
DR   Horizon_Discovery; HZGHC008003c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1135; BTN1A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BTN1A1 (-) 2
AC   CVCL_E1SH
SY   HZGHC008003c012
DR   Horizon_Discovery; HZGHC008003c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1135; BTN1A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BTRC (-) 1
AC   CVCL_SF91
SY   HZGHC005127c007; BTRC knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SF91
DR   Horizon_Discovery; HZGHC005127c007
DR   Wikidata; Q54873048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BTRC (-) 2
AC   CVCL_SF92
SY   HZGHC005127c010; BTRC knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF92
DR   Horizon_Discovery; HZGHC005127c010
DR   Wikidata; Q54873049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 BUB1 (-) 1
AC   CVCL_SF93
SY   HZGHC004132c001; BUB1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SF93
DR   Horizon_Discovery; HZGHC004132c001
DR   Wikidata; Q54873050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1148; BUB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004132c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BUB1 (-) 2
AC   CVCL_SF94
SY   HZGHC004132c004; BUB1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SF94
DR   Horizon_Discovery; HZGHC004132c004
DR   Wikidata; Q54873051
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1148; BUB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004132c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BUB1 (-) 3
AC   CVCL_SF95
SY   HZGHC003682c001; BUB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SF95
DR   Horizon_Discovery; HZGHC003682c001
DR   Wikidata; Q54873052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1148; BUB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003682c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 BZW1 (-) 1
AC   CVCL_E1SI
SY   HZGHC008104c005
DR   Horizon_Discovery; HZGHC008104c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18380; BZW1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BZW1 (-) 2
AC   CVCL_E1SJ
SY   HZGHC008104c007
DR   Horizon_Discovery; HZGHC008104c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18380; BZW1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BZW1 (-) 3
AC   CVCL_E1SK
SY   HZGHC008104c011
DR   Horizon_Discovery; HZGHC008104c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18380; BZW1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BZW1 (-) 4
AC   CVCL_E1SL
SY   HZGHC008105c010
DR   Horizon_Discovery; HZGHC008105c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18380; BZW1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BZW2 (-) 1
AC   CVCL_E1SM
SY   HZGHC008106c003
DR   Horizon_Discovery; HZGHC008106c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18808; BZW2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BZW2 (-) 2
AC   CVCL_E1SN
SY   HZGHC008106c005
DR   Horizon_Discovery; HZGHC008106c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18808; BZW2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BZW2 (-) 3
AC   CVCL_E1SP
SY   HZGHC008106c007
DR   Horizon_Discovery; HZGHC008106c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18808; BZW2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 BZW2 (-) 4
AC   CVCL_E1SQ
SY   HZGHC008106c008
DR   Horizon_Discovery; HZGHC008106c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18808; BZW2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C10orf2 (-)
AC   CVCL_XM15
SY   HZGHC56652; C10orf2 knockout cell line
DR   cancercelllines; CVCL_XM15
DR   Horizon_Discovery; HZGHC56652
DR   Wikidata; Q93941369
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1160; TWNK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC56652; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C10orf32 (-) 1
AC   CVCL_SF96
SY   HZGHC000874c005; C10orf32 knockout cell line 22bp deletion in exon 1
DR   cancercelllines; CVCL_SF96
DR   Horizon_Discovery; HZGHC000874c005
DR   Wikidata; Q54873053
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23516; BORCS7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C10orf32 (-) 2
AC   CVCL_SF97
SY   HZGHC000874c009; C10orf32 knockout cell line 16bp deletion in exon 1
DR   cancercelllines; CVCL_SF97
DR   Horizon_Discovery; HZGHC000874c009
DR   Wikidata; Q54873054
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23516; BORCS7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C11orf30 (-) 1
AC   CVCL_SF98
SY   HZGHC003974c006; C11orf30 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SF98
DR   Horizon_Discovery; HZGHC003974c006
DR   Wikidata; Q54873056
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18071; EMSY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C11orf30 (-) 2
AC   CVCL_SF99
SY   HZGHC003974c012; C11orf30 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SF99
DR   Horizon_Discovery; HZGHC003974c012
DR   Wikidata; Q54873057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18071; EMSY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C12orf10 (-) 1
AC   CVCL_SG00
SY   HZGHC006604c010; C12orf10 knockout cell line 26bp deletion; HAP1 C12orf10 (-)
DR   cancercelllines; CVCL_SG00
DR   Horizon_Discovery; HZGHC006604c010
DR   Wikidata; Q54873058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17590; MYG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C12orf10 (-) 2
AC   CVCL_XM16
SY   HZGHC006604c008; C12orf10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XM16
DR   Horizon_Discovery; HZGHC006604c008
DR   Wikidata; Q93941405
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17590; MYG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C14orf159 (-) 1
AC   CVCL_SG03
SY   HZGHC005735c011; C14orf159 knockout cell line 10bp deletion; HAP1 C14orf159 (-)
DR   cancercelllines; CVCL_SG03
DR   Horizon_Discovery; HZGHC005735c011
DR   Wikidata; Q54873061
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20498; DGLUCY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C14orf159 (-) 2
AC   CVCL_XM17
SY   HZGHC005735c008; C14orf159 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XM17
DR   Horizon_Discovery; HZGHC005735c008
DR   Wikidata; Q93941441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20498; DGLUCY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C14orf159 (-) 3
AC   CVCL_XM18
SY   HZGHC005736c001; C14orf159 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XM18
DR   Horizon_Discovery; HZGHC005736c001
DR   Wikidata; Q93941443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20498; DGLUCY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C14orf159 (-) 4
AC   CVCL_XM19
SY   HZGHC005736c011; C14orf159 knockout cell line 43bp deletion
DR   cancercelllines; CVCL_XM19
DR   Horizon_Discovery; HZGHC005736c011
DR   Wikidata; Q93941446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20498; DGLUCY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C14orf2 (-) 1
AC   CVCL_SG04
SY   HZGHC005108c002; C14orf2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SG04
DR   Horizon_Discovery; HZGHC005108c002
DR   Wikidata; Q54873062
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1188; ATP5MJ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005108c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C14orf2 (-) 2
AC   CVCL_SG05
SY   HZGHC005108c003; C14orf2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG05
DR   Horizon_Discovery; HZGHC005108c003
DR   Wikidata; Q54873063
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1188; ATP5MJ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005108c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C15orf40 (-) 1
AC   CVCL_SG06
SY   HZGHC005737c001; C15orf40 knockout cell line 1bp deletion; HAP1 C15orf40 (-)
DR   cancercelllines; CVCL_SG06
DR   Horizon_Discovery; HZGHC005737c001
DR   Wikidata; Q54873069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28443; C15orf40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005737c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C15orf40 (-) 2
AC   CVCL_XM20
SY   HZGHC005737c009; C15orf40 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM20
DR   Horizon_Discovery; HZGHC005737c009
DR   Wikidata; Q93941469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28443; C15orf40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005737c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C15orf40 (-) 3
AC   CVCL_XM21
SY   HZGHC005738c001; C15orf40 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XM21
DR   Horizon_Discovery; HZGHC005738c001
DR   Wikidata; Q93941472
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28443; C15orf40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005738c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C15orf61 (-) 1
AC   CVCL_SG07
SY   HZGHC006447c010; C15orf61 knockout cell line 11bp deletion; HAP1 C15orf61 (-)
DR   cancercelllines; CVCL_SG07
DR   Horizon_Discovery; HZGHC006447c010
DR   Wikidata; Q54873070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34453; C15orf61.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006447c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C15orf61 (-) 2
AC   CVCL_XM22
SY   HZGHC006447c004; C15orf61 knockout cell line 74bp insertion
DR   cancercelllines; CVCL_XM22
DR   Horizon_Discovery; HZGHC006447c004
DR   Wikidata; Q93941481
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34453; C15orf61.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006447c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C15orf61 (-) 3
AC   CVCL_XM23
SY   HZGHC006448c001; C15orf61 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM23
DR   Horizon_Discovery; HZGHC006448c001
DR   Wikidata; Q93941484
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34453; C15orf61.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006448c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C15orf61 (-) 4
AC   CVCL_XM24
SY   HZGHC006448c005; C15orf61 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM24
DR   Horizon_Discovery; HZGHC006448c005
DR   Wikidata; Q93941487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34453; C15orf61.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006448c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C15orf61 (-) 5
AC   CVCL_XM25
SY   HZGHC006448c011; C15orf61 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM25
DR   Horizon_Discovery; HZGHC006448c011
DR   Wikidata; Q93941490
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34453; C15orf61.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006448c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C16orf91 (-) 1
AC   CVCL_E1SR
SY   HZGHC007695c002
DR   Horizon_Discovery; HZGHC007695c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27558; UQCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C16orf91 (-) 2
AC   CVCL_E1SS
SY   HZGHC007695c008
DR   Horizon_Discovery; HZGHC007695c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27558; UQCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C16orf91 (-) 3
AC   CVCL_E1ST
SY   HZGHC007695c009
DR   Horizon_Discovery; HZGHC007695c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27558; UQCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C17orf59 (-)
AC   CVCL_SG10
SY   HZGHC000693c010; C17orf59 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG10
DR   Horizon_Discovery; HZGHC000693c010
DR   Wikidata; Q54873074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25939; BORCS6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C17orf70 (-) 1
AC   CVCL_SG11
SY   HZGHC003678c001; C17orf70 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SG11
DR   Horizon_Discovery; HZGHC003678c001
DR   Wikidata; Q54873075
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26171; FAAP100.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C17orf70 (-) 2
AC   CVCL_SG12
SY   HZGHC003678c003; C17orf70 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SG12
DR   Horizon_Discovery; HZGHC003678c003
DR   Wikidata; Q54873076
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26171; FAAP100.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C17orf80 (-) 1
AC   CVCL_XM26
SY   HZGHC007058c002; HZGHC55028; C17orf80 knockout cell line 16bp deletion in exon 3; HAP1 C17orf80 (-)
DR   cancercelllines; CVCL_XM26
DR   Horizon_Discovery; HZGHC007058c002
DR   Wikidata; Q93941517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C17orf80 (-) 2
AC   CVCL_B5JM
SY   HZGHC007058c015; C17orf80 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5JM
DR   Horizon_Discovery; HZGHC007058c015
DR   Wikidata; Q111733270
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 C17orf80 (-) 3
AC   CVCL_B5JN
SY   HZGHC007058c017; C17orf80 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5JN
DR   Horizon_Discovery; HZGHC007058c017
DR   Wikidata; Q111733271
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007058c017; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 C17orf80 (-) 4
AC   CVCL_B5JP
SY   HZGHC007058c019; C17orf80 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5JP
DR   Horizon_Discovery; HZGHC007058c019
DR   Wikidata; Q111733272
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007058c019; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 C17orf80 (-) 5
AC   CVCL_B5JQ
SY   HZGHC007058c022; C17orf80 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5JQ
DR   Horizon_Discovery; HZGHC007058c022
DR   Wikidata; Q111733273
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007058c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 C17orf89 (-)
AC   CVCL_E1SU
SY   HZGHC007710c001
DR   Horizon_Discovery; HZGHC007710c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33551; NDUFAF8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C19orf70 (-) 1
AC   CVCL_SG13
SY   HZGHC005040c010; C19orf70 knockout cell line 55bp deletion in exon 2
DR   cancercelllines; CVCL_SG13
DR   Horizon_Discovery; HZGHC005040c010
DR   Wikidata; Q54873077
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33702; MICOS13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C19orf70 (-) 2
AC   CVCL_SG14
SY   HZGHC005040c012; C19orf70 knockout cell line 20bp deletion in exon 2
DR   cancercelllines; CVCL_SG14
DR   Horizon_Discovery; HZGHC005040c012
DR   Wikidata; Q54873078
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33702; MICOS13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C1GALT1C1 (-) 1
AC   CVCL_SG15
SY   HZGHC004067c003; C1GALT1C1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SG15
DR   Horizon_Discovery; HZGHC004067c003
DR   Wikidata; Q54873079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1GALT1C1 (-) 2
AC   CVCL_SG16
SY   HZGHC004067c008; C1GALT1C1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SG16
DR   Horizon_Discovery; HZGHC004067c008
DR   Wikidata; Q54873080
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf112 (-) 1
AC   CVCL_SG17
SY   HZGHC004317c001; C1orf112 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG17
DR   Horizon_Discovery; HZGHC004317c001
DR   Wikidata; Q54873081
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25565; FIRRM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C1orf112 (-) 2
AC   CVCL_SG18
SY   HZGHC004317c002; C1orf112 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG18
DR   Horizon_Discovery; HZGHC004317c002
DR   Wikidata; Q54873082
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25565; FIRRM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004317c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C1orf112 (-) 3
AC   CVCL_XM27
SY   HZGHC006385c011; C1orf112 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XM27
DR   Horizon_Discovery; HZGHC006385c011
DR   Wikidata; Q93941556
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25565; FIRRM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C1orf112 (-) 4
AC   CVCL_XM28
SY   HZGHC006385c012; C1orf112 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XM28
DR   Horizon_Discovery; HZGHC006385c012
DR   Wikidata; Q93941559
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25565; FIRRM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C1orf115 (-) 1
AC   CVCL_SG19
SY   HZGHC005078c010; C1orf115 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SG19
DR   Horizon_Discovery; HZGHC005078c010
DR   Wikidata; Q54873083
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25873; C1orf115.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf115 (-) 2
AC   CVCL_SG20
SY   HZGHC005078c011; C1orf115 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG20
DR   Horizon_Discovery; HZGHC005078c011
DR   Wikidata; Q54873084
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25873; C1orf115.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf115 (-) 3
AC   CVCL_SG21
SY   HZGHC005079c006; C1orf115 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG21
DR   Horizon_Discovery; HZGHC005079c006
DR   Wikidata; Q54873085
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25873; C1orf115.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf115 (-) 4
AC   CVCL_SG22
SY   HZGHC005079c012; C1orf115 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SG22
DR   Horizon_Discovery; HZGHC005079c012
DR   Wikidata; Q54873086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25873; C1orf115.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf43 (-) 1
AC   CVCL_SG23
SY   HZGHC000677c001; C1orf43 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG23
DR   Horizon_Discovery; HZGHC000677c001
DR   Wikidata; Q54873088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29876; C1orf43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf43 (-) 2
AC   CVCL_SG24
SY   HZGHC000677c005; C1orf43 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG24
DR   Horizon_Discovery; HZGHC000677c005
DR   Wikidata; Q54873089
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29876; C1orf43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf43 (-) 3
AC   CVCL_SG25
SY   HZGHC000678c010; C1orf43 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG25
DR   Horizon_Discovery; HZGHC000678c010
DR   Wikidata; Q54873090
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29876; C1orf43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1orf43 (-) 4
AC   CVCL_SG26
SY   HZGHC000678c012; C1orf43 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SG26
DR   Horizon_Discovery; HZGHC000678c012
DR   Wikidata; Q54873091
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29876; C1orf43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C1QBP (-) 1
AC   CVCL_SG27
SY   HZGHC006107c001; C1QBP knockout cell line 14bp deletion; HAP1 C1QBP (-)
DR   cancercelllines; CVCL_SG27
DR   Horizon_Discovery; HZGHC006107c001
DR   Wikidata; Q54873092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1243; C1QBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006107c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C1QBP (-) 2
AC   CVCL_E1SV
SY   HZGHC008097c009; C1QBP knockout cell line 1bp insertion in exon 5
DR   Horizon_Discovery; HZGHC008097c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1243; C1QBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C20orf194 (-)
AC   CVCL_E1SW
SY   HZGHC007338c001; C20orf194 knockout cell line 8bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007338c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17721; DNAAF9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C20orf24 (-) 1
AC   CVCL_SG28
SY   HZGHC005742c004; C20orf24 knockout cell line 2bp deletion; HAP1 C20orf24 (-)
DR   cancercelllines; CVCL_SG28
DR   Horizon_Discovery; HZGHC005742c004
DR   Wikidata; Q54873093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15870; RAB5IF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C20orf24 (-) 2
AC   CVCL_XM29
SY   HZGHC005742c007; C20orf24 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM29
DR   Horizon_Discovery; HZGHC005742c007
DR   Wikidata; Q93941625
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15870; RAB5IF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C2orf69 (-) 1
AC   CVCL_SG29
SY   HZGHC005743c010; C2orf69 knockout cell line 1bp insertion; HAP1 C2orf69 (-)
DR   cancercelllines; CVCL_SG29
DR   Horizon_Discovery; HZGHC005743c010
DR   Wikidata; Q54873094
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26799; C2orf69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C2orf69 (-) 2
AC   CVCL_XM30
SY   HZGHC005743c006; C2orf69 knockout cell line 181bp deletion
DR   cancercelllines; CVCL_XM30
DR   Horizon_Discovery; HZGHC005743c006
DR   Wikidata; Q93941631
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26799; C2orf69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C2orf69 (-) 3
AC   CVCL_XM31
SY   HZGHC005743c009; C2orf69 knockout cell line 185bp insertion
DR   cancercelllines; CVCL_XM31
DR   Horizon_Discovery; HZGHC005743c009
DR   Wikidata; Q93941633
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26799; C2orf69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005743c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C2orf69 (-) 4
AC   CVCL_XM32
SY   HZGHC005744c004; C2orf69 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_XM32
DR   Horizon_Discovery; HZGHC005744c004
DR   Wikidata; Q93941636
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26799; C2orf69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C2orf69 (-) 5
AC   CVCL_XM33
SY   HZGHC005744c007; C2orf69 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XM33
DR   Horizon_Discovery; HZGHC005744c007
DR   Wikidata; Q93941639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26799; C2orf69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C3 (-)
AC   CVCL_XM34
SY   HZGHC007094c006; HZGHC718; C3 knockout cell line 2bp insertion in exon 2
DR   cancercelllines; CVCL_XM34
DR   Horizon_Discovery; HZGHC007094c006
DR   Wikidata; Q93941641
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1318; C3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C3orf33 (-) 1
AC   CVCL_SG30
SY   HZGHC005745c002; C3orf33 knockout cell line 1bp insertion; HAP1 C3orf33 (-)
DR   cancercelllines; CVCL_SG30
DR   Horizon_Discovery; HZGHC005745c002
DR   Wikidata; Q54873096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26434; C3orf33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C3orf33 (-) 2
AC   CVCL_XM35
SY   HZGHC005745c006; C3orf33 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM35
DR   Horizon_Discovery; HZGHC005745c006
DR   Wikidata; Q93941650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26434; C3orf33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005745c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C3orf33 (-) 3
AC   CVCL_XM36
SY   HZGHC005746c007; C3orf33 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM36
DR   Horizon_Discovery; HZGHC005746c007
DR   Wikidata; Q93941653
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26434; C3orf33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C3orf33 (-) 4
AC   CVCL_XM37
SY   HZGHC005746c008; C3orf33 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM37
DR   Horizon_Discovery; HZGHC005746c008
DR   Wikidata; Q93941655
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26434; C3orf33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005746c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C5 (-) 1
AC   CVCL_SG31
SY   HZGHC004200c007; C5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG31
DR   Horizon_Discovery; HZGHC004200c007
DR   Wikidata; Q54873097
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1331; C5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C5 (-) 2
AC   CVCL_SG32
SY   HZGHC004200c008; C5 knockout cell line 109bp insertion
DR   cancercelllines; CVCL_SG32
DR   Horizon_Discovery; HZGHC004200c008
DR   Wikidata; Q54873098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1331; C5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004200c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C6orf106 (-) 1
AC   CVCL_XM38
SY   HZGHC006946c003; HZGHC64771; C6orf106 knockout cell line 10bp deletion in exon 1; HAP1 C6orf106 (-)
DR   cancercelllines; CVCL_XM38
DR   Horizon_Discovery; HZGHC006946c003
DR   Wikidata; Q93941670
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21215; ILRUN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 C6orf106 (-) 2
AC   CVCL_E1SX
SY   HZGHC006946c010; C6orf106 knockout cell line 2bp deletion in exon 1
DR   Horizon_Discovery; HZGHC006946c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21215; ILRUN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C6orf106 (-) 3
AC   CVCL_E1SY
SY   HZGHC006947c008; C6orf106 knockout cell line 38bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006947c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21215; ILRUN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C6orf136 (-)
AC   CVCL_E1SZ
SY   HZGHC007313c010
DR   Horizon_Discovery; HZGHC007313c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21301; C6orf136.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 C6orf203 (-) 1
AC   CVCL_SG33
SY   HZGHC004965c003; C6orf203 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SG33
DR   Horizon_Discovery; HZGHC004965c003
DR   Wikidata; Q54873099
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17971; MTRES1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C6orf203 (-) 2
AC   CVCL_SG34
SY   HZGHC004965c010; C6orf203 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SG34
DR   Horizon_Discovery; HZGHC004965c010
DR   Wikidata; Q54873100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17971; MTRES1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C7orf49 (-) 1
AC   CVCL_SG35
SY   HZGHC005061c001; C7orf49 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SG35
DR   Horizon_Discovery; HZGHC005061c001
DR   Wikidata; Q54873101
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22432; CYREN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C7orf49 (-) 2
AC   CVCL_SG36
SY   HZGHC005061c004; C7orf49 knockout cell line 325bp insertion
DR   cancercelllines; CVCL_SG36
DR   Horizon_Discovery; HZGHC005061c004
DR   Wikidata; Q54873102
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22432; CYREN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005061c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C7orf55 (-) 1
AC   CVCL_XM39
SY   HZGHC007013c005; HZGHC154791; C7orf55 knockout cell line 1bp insertion in exon 1; HAP1 C7orf55 (-)
DR   cancercelllines; CVCL_XM39
DR   Horizon_Discovery; HZGHC007013c005
DR   Wikidata; Q93941696
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26946; FMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C7orf55 (-) 2
AC   CVCL_B5JR
SY   HZGHC007013c009; C7orf55 knockout cell line 2bp deletion in exon 1
DR   cancercelllines; CVCL_B5JR
DR   Horizon_Discovery; HZGHC007013c009
DR   Wikidata; Q111733274
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26946; FMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 C9orf142 (-) 1
AC   CVCL_SG37
SY   HZGHC004376c005; C9orf142 knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_SG37
DR   Horizon_Discovery; HZGHC004376c005
DR   Wikidata; Q54873103
RX   PubMed=31141305;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27849; PAXX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C9orf142 (-) 2
AC   CVCL_SG38
SY   HZGHC004376c006; C9orf142 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG38
DR   Horizon_Discovery; HZGHC004376c006
DR   Wikidata; Q54873104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27849; PAXX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 C9orf72 (-) 1
AC   CVCL_SG39
SY   HZGHC003729c002; C9orf72 knockout cell line 13bp deletion in exon 3
DR   cancercelllines; CVCL_SG39
DR   Horizon_Discovery; HZGHC003729c002
DR   Wikidata; Q54873105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C9orf72 (-) 2
AC   CVCL_SG40
SY   HZGHC003729c004; C9orf72 knockout cell line 2bp insertion in exon 3
DR   cancercelllines; CVCL_SG40
DR   Horizon_Discovery; HZGHC003729c004
DR   Wikidata; Q54873106
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 C9orf72 (-) SMCR8 (-) 1
AC   CVCL_DX29
SY   HZGHC007562c004; Double knockout cell line C9orf72 2bp insertion in exon 3 and SMCR8 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC007562c004
DR   Wikidata; Q127381031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17921; SMCR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SG40 ! HAP1 C9orf72 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 C9orf72 (-) SMCR8 (-) 2
AC   CVCL_DX30
SY   HZGHC007562c008; Double knockout cell line C9orf72 2bp insertion in exon 3 and SMCR8 1bp deletion in exon 1
DR   Horizon_Discovery; HZGHC007562c008
DR   Wikidata; Q127381032
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17921; SMCR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SG40 ! HAP1 C9orf72 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 C9orf72 (-) SMCR8 (-) 3
AC   CVCL_DX31
SY   HZGHC007563c006; Double knockout cell line C9orf72 29bp deletion in exon 3 and SMCR8 7bp deletion in exon 1
DR   Horizon_Discovery; HZGHC007563c006
DR   Wikidata; Q127381033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17921; SMCR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TP64 ! HAP1 SMCR8 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 C9orf72 (-) SMCR8 (-) 4
AC   CVCL_DX32
SY   HZGHC007563c007; Double knockout cell line C9orf72 37bp deletion in exon 3 and SMCR8 7bp deletion in exon 1
DR   Horizon_Discovery; HZGHC007563c007
DR   Wikidata; Q127381034
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17921; SMCR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TP64 ! HAP1 SMCR8 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 CA2 (-) 1
AC   CVCL_SG41
SY   HZGHC003823c008; CA2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG41
DR   Horizon_Discovery; HZGHC003823c008
DR   Wikidata; Q54873108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1373; CA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CA2 (-) 2
AC   CVCL_SG42
SY   HZGHC003823c012; CA2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SG42
DR   Horizon_Discovery; HZGHC003823c012
DR   Wikidata; Q54873109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1373; CA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CABIN1 (-) 1
AC   CVCL_SG43
SY   HZGHC006582c001; CABIN1 knockout cell line 5bp deletion; HAP1 CABIN1 (-)
DR   cancercelllines; CVCL_SG43
DR   Horizon_Discovery; HZGHC006582c001
DR   Wikidata; Q54873110
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24187; CABIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CABIN1 (-) 2
AC   CVCL_XM40
SY   HZGHC006582c003; CABIN1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XM40
DR   Horizon_Discovery; HZGHC006582c003
DR   Wikidata; Q93941730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24187; CABIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CABIN1 (-) 3
AC   CVCL_XM41
SY   HZGHC006583c009; CABIN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM41
DR   Horizon_Discovery; HZGHC006583c009
DR   Wikidata; Q93941733
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24187; CABIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNA1H (-) 1
AC   CVCL_SG44
SY   HZGHC004119c004; CACNA1H knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG44
DR   Horizon_Discovery; HZGHC004119c004
DR   Wikidata; Q54873111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1395; CACNA1H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNA1H (-) 2
AC   CVCL_SG45
SY   HZGHC004119c007; CACNA1H knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SG45
DR   Horizon_Discovery; HZGHC004119c007
DR   Wikidata; Q54873112
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1395; CACNA1H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNA2D1 (-)
AC   CVCL_SG46
SY   HZGHC003868c012; CACNA2D1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG46
DR   Horizon_Discovery; HZGHC003868c012
DR   Wikidata; Q54873118
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1399; CACNA2D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNA2D2 (-) 1
AC   CVCL_SG47
SY   HZGHC003821c005; CACNA2D2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SG47
DR   Horizon_Discovery; HZGHC003821c005
DR   Wikidata; Q54873119
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1400; CACNA2D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNA2D2 (-) 2
AC   CVCL_SG48
SY   HZGHC003821c010; CACNA2D2 knockout cell line 133bp insertion
DR   cancercelllines; CVCL_SG48
DR   Horizon_Discovery; HZGHC003821c010
DR   Wikidata; Q54873120
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1400; CACNA2D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003821c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CACNB1 (-)
AC   CVCL_SG49
SY   HZGHC003870c007; CACNB1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SG49
DR   Horizon_Discovery; HZGHC003870c007
DR   Wikidata; Q54873121
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1401; CACNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNB2 (-) 1
AC   CVCL_SG50
SY   HZGHC003849c009; CACNB2 knockout cell line 493bp insertion
DR   cancercelllines; CVCL_SG50
DR   Horizon_Discovery; HZGHC003849c009
DR   Wikidata; Q54873122
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1402; CACNB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003849c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CACNB2 (-) 2
AC   CVCL_SG51
SY   HZGHC003849c010; CACNB2 knockout cell line 200bp insertion
DR   cancercelllines; CVCL_SG51
DR   Horizon_Discovery; HZGHC003849c010
DR   Wikidata; Q54873123
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1402; CACNB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003849c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CACNB3 (-) 1
AC   CVCL_SG52
SY   HZGHC003828c001; CACNB3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SG52
DR   Horizon_Discovery; HZGHC003828c001
DR   Wikidata; Q54873124
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1403; CACNB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNB3 (-) 2
AC   CVCL_SG53
SY   HZGHC003828c011; CACNB3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SG53
DR   Horizon_Discovery; HZGHC003828c011
DR   Wikidata; Q54873125
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1403; CACNB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNB4 (-) 1
AC   CVCL_SG54
SY   HZGHC003865c001; CACNB4 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SG54
DR   Horizon_Discovery; HZGHC003865c001
DR   Wikidata; Q54873126
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1404; CACNB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CACNB4 (-) 2
AC   CVCL_SG55
SY   HZGHC003865c011; CACNB4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SG55
DR   Horizon_Discovery; HZGHC003865c011
DR   Wikidata; Q54873127
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1404; CACNB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAD (-)
AC   CVCL_XM42
SY   HZGHC790; CAD knockout cell line
DR   cancercelllines; CVCL_XM42
DR   Horizon_Discovery; HZGHC790
DR   Wikidata; Q93941825
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1424; CAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC790; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CALB1 (-) 1
AC   CVCL_SG56
SY   HZGHC006291c012; CALB1 knockout cell line 16bp deletion; HAP1 CALB1 (-)
DR   cancercelllines; CVCL_SG56
DR   Horizon_Discovery; HZGHC006291c012
DR   Wikidata; Q54873128
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1434; CALB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CALB1 (-) 2
AC   CVCL_XM43
SY   HZGHC006291c005; CALB1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM43
DR   Horizon_Discovery; HZGHC006291c005
DR   Wikidata; Q93941835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1434; CALB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CALM2 (-) 1
AC   CVCL_SG57
SY   HZGHC001217c001; CALM2 knockout cell line 311bp insertion
DR   cancercelllines; CVCL_SG57
DR   Horizon_Discovery; HZGHC001217c001
DR   Wikidata; Q54873129
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1445; CALM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001217c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CALM2 (-) 2
AC   CVCL_SG58
SY   HZGHC001217c012; CALM2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SG58
DR   Horizon_Discovery; HZGHC001217c012
DR   Wikidata; Q54873130
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1445; CALM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CALM3 (-) 1
AC   CVCL_SG59
SY   HZGHC001214c003; CALM3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SG59
DR   Horizon_Discovery; HZGHC001214c003
DR   Wikidata; Q54873131
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1449; CALM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CALM3 (-) 2
AC   CVCL_SG60
SY   HZGHC001214c012; CALM3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SG60
DR   Horizon_Discovery; HZGHC001214c012
DR   Wikidata; Q54873133
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1449; CALM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CALR (-) 1
AC   CVCL_SG61
SY   HZGHC018222c012; CALR knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SG61
DR   Horizon_Discovery; HZGHC018222c012
DR   Wikidata; Q54873134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1455; CALR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC018222c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CALR (-) 2
AC   CVCL_SG62
SY   HZGHC018222c016; CALR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG62
DR   Horizon_Discovery; HZGHC018222c016
DR   Wikidata; Q54873136
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1455; CALR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CALR (-) 3
AC   CVCL_SG63
SY   HZGHC018222c019; CALR knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SG63
DR   Horizon_Discovery; HZGHC018222c019
DR   Wikidata; Q54873138
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1455; CALR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMK1D (-) 1
AC   CVCL_SG64
SY   HZGHC000129c018; CAMK1D knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SG64
DR   Horizon_Discovery; HZGHC000129c018
DR   Wikidata; Q54873139
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19341; CAMK1D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMK1D (-) 2
AC   CVCL_SG65
SY   HZGHC000129c020; CAMK1D knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SG65
DR   Horizon_Discovery; HZGHC000129c020
DR   Wikidata; Q54873140
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19341; CAMK1D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMK2D (-)
AC   CVCL_SG66
SY   HZGHC000130c011; CAMK2D knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG66
DR   Horizon_Discovery; HZGHC000130c011
DR   Wikidata; Q54873141
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1462; CAMK2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMK2G (-)
AC   CVCL_SG67
SY   HZGHC000278c001; CAMK2G knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SG67
DR   Horizon_Discovery; HZGHC000278c001
DR   Wikidata; Q54873142
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1463; CAMK2G.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMKK1 (-) 1
AC   CVCL_SG68
SY   HZGHC000309c001; CAMKK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG68
DR   Horizon_Discovery; HZGHC000309c001
DR   Wikidata; Q54873143
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1469; CAMKK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMKK1 (-) 2
AC   CVCL_SG69
SY   HZGHC000309c005; CAMKK1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG69
DR   Horizon_Discovery; HZGHC000309c005
DR   Wikidata; Q54873144
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1469; CAMKK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMKK1 (-) 3
AC   CVCL_SG70
SY   HZGHC000309c018; CAMKK1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SG70
DR   Horizon_Discovery; HZGHC000309c018
DR   Wikidata; Q54873145
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1469; CAMKK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMKK2 (-)
AC   CVCL_SG71
SY   HZGHC000279c003; CAMKK2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SG71
DR   Horizon_Discovery; HZGHC000279c003
DR   Wikidata; Q54873146
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1470; CAMKK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMKV (-) 1
AC   CVCL_SG72
SY   HZGHC000077c003; CAMKV knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SG72
DR   Horizon_Discovery; HZGHC000077c003
DR   Wikidata; Q54873147
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28788; CAMKV.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMKV (-) 2
AC   CVCL_SG73
SY   HZGHC000077c016; CAMKV knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG73
DR   Horizon_Discovery; HZGHC000077c016
DR   Wikidata; Q54873148
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28788; CAMKV.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMKV (-) 3
AC   CVCL_SG74
SY   HZGHC000077c023; CAMKV knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG74
DR   Horizon_Discovery; HZGHC000077c023
DR   Wikidata; Q54873149
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28788; CAMKV.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAMP (-) 1
AC   CVCL_E1T0
SY   HZGHC008113c010
DR   Horizon_Discovery; HZGHC008113c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1472; CAMP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CAMP (-) 2
AC   CVCL_E1T1
SY   HZGHC008113c012
DR   Horizon_Discovery; HZGHC008113c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1472; CAMP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CANX (-) 1
AC   CVCL_SG75
SY   HZGHC000597c002; CANX knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SG75
DR   Horizon_Discovery; HZGHC000597c002
DR   Wikidata; Q54873150
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1473; CANX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000597c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CANX (-) 2
AC   CVCL_SG76
SY   HZGHC000597c006; CANX knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG76
DR   Horizon_Discovery; HZGHC000597c006
DR   Wikidata; Q54873151
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1473; CANX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAPN1 (-)
AC   CVCL_SG77
SY   HZGHC006297c010; CAPN1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SG77
DR   Horizon_Discovery; HZGHC006297c010
DR   Wikidata; Q54873152
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1476; CAPN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAPN2 (-)
AC   CVCL_XM44
SY   HZGHC007281c011; HZGHC824; CAPN2 knockout cell line 1bp insertion in exon 12
DR   cancercelllines; CVCL_XM44
DR   Horizon_Discovery; HZGHC007281c011
DR   Wikidata; Q93941995
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1479; CAPN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CAPNS1 (-) 1
AC   CVCL_SG78
SY   HZGHC001298c004; CAPNS1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SG78
DR   Horizon_Discovery; HZGHC001298c004
DR   Wikidata; Q54873153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1481; CAPNS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAPNS1 (-) 2
AC   CVCL_SG79
SY   HZGHC001298c006; CAPNS1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SG79
DR   Horizon_Discovery; HZGHC001298c006
DR   Wikidata; Q54873154
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1481; CAPNS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CARKD (-) 1
AC   CVCL_SG80
SY   HZGHC002518c004; CARKD knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG80
DR   Horizon_Discovery; HZGHC002518c004
DR   Wikidata; Q54873155
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25576; NAXD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CARKD (-) 2
AC   CVCL_SG81
SY   HZGHC002518c011; CARKD knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SG81
DR   Horizon_Discovery; HZGHC002518c011
DR   Wikidata; Q54873156
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25576; NAXD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CARM1 (-) 1
AC   CVCL_SG82
SY   HZGHC001129c002; CARM1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG82
DR   Horizon_Discovery; HZGHC001129c002
DR   Wikidata; Q54873158
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CARM1 (-) 2
AC   CVCL_SG83
SY   HZGHC001129c003; CARM1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG83
DR   Horizon_Discovery; HZGHC001129c003
DR   Wikidata; Q54873159
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CARM1 (-) 3
AC   CVCL_SG84
SY   HZGHC001129c007; CARM1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SG84
DR   Horizon_Discovery; HZGHC001129c007
DR   Wikidata; Q54873160
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 Cas9
AC   CVCL_DX72
DR   Horizon_Discovery; HD+Cas9-011
DR   Wikidata; Q127381035
CC   Group: Haploid karyotype cell line.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-011).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 6
//
ID   HAP1 CASC3 (-) 1
AC   CVCL_SG85
SY   HZGHC004114c002; CASC3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG85
DR   Horizon_Discovery; HZGHC004114c002
DR   Wikidata; Q54873162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17040; CASC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASC3 (-) 2
AC   CVCL_SG86
SY   HZGHC004114c010; CASC3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG86
DR   Horizon_Discovery; HZGHC004114c010
DR   Wikidata; Q54873168
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17040; CASC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASC3 (-) 3
AC   CVCL_SG87
SY   HZGHC004114c012; CASC3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG87
DR   Horizon_Discovery; HZGHC004114c012
DR   Wikidata; Q54873169
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17040; CASC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASD1 (-)
AC   CVCL_SG88
SY   HZGHC000520c003; CASD1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SG88
DR   Horizon_Discovery; HZGHC000520c003
DR   Wikidata; Q54873170
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16014; CASD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASK (-)
AC   CVCL_SG89
SY   HZGHC000404c023; CASK knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SG89
DR   Horizon_Discovery; HZGHC000404c023
DR   Wikidata; Q54873171
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1497; CASK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP2 (-) 1
AC   CVCL_SG90
SY   HZGHC001507c001; CASP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG90
DR   Horizon_Discovery; HZGHC001507c001
DR   Wikidata; Q54873172
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1503; CASP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP2 (-) 2
AC   CVCL_SG91
SY   HZGHC001507c003; CASP2 knockout cell line 233bp insertion
DR   cancercelllines; CVCL_SG91
DR   Horizon_Discovery; HZGHC001507c003
DR   Wikidata; Q54873173
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1503; CASP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001507c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CASP2 (-) 3
AC   CVCL_SG92
SY   HZGHC001507c008; CASP2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SG92
DR   Horizon_Discovery; HZGHC001507c008
DR   Wikidata; Q54873174
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1503; CASP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP3 (-)
AC   CVCL_SG93
SY   HZGHC001508c004; CASP3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG93
DR   Horizon_Discovery; HZGHC001508c004
DR   Wikidata; Q54873175
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP6 (-) 1
AC   CVCL_SG94
SY   HZGHC001509c004; CASP6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SG94
DR   Horizon_Discovery; HZGHC001509c004
DR   Wikidata; Q54873176
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1507; CASP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP6 (-) 2
AC   CVCL_SG95
SY   HZGHC001509c010; CASP6 knockout cell line 157bp insertion
DR   cancercelllines; CVCL_SG95
DR   Horizon_Discovery; HZGHC001509c010
DR   Wikidata; Q54873177
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1507; CASP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001509c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CASP7 (-) 1
AC   CVCL_SG96
SY   HZGHC001510c003; CASP7 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SG96
DR   Horizon_Discovery; HZGHC001510c003
DR   Wikidata; Q54873179
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1508; CASP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP7 (-) 2
AC   CVCL_SG97
SY   HZGHC001510c004; CASP7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG97
DR   Horizon_Discovery; HZGHC001510c004
DR   Wikidata; Q54873180
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1508; CASP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP8 (-) 1
AC   CVCL_SG98
SY   HZGHC001511c007; CASP8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SG98
DR   Horizon_Discovery; HZGHC001511c007
DR   Wikidata; Q54873181
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP8 (-) 2
AC   CVCL_SG99
SY   HZGHC001511c011; CASP8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SG99
DR   Horizon_Discovery; HZGHC001511c011
DR   Wikidata; Q54873182
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CASP9 (-)
AC   CVCL_SH00
SY   HZGHC001512c010; CASP9 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH00
DR   Horizon_Discovery; HZGHC001512c010
DR   Wikidata; Q54873183
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1511; CASP9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAST (-) 1
AC   CVCL_SH01
SY   HZGHC003257c001; CAST knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SH01
DR   Horizon_Discovery; HZGHC003257c001
DR   Wikidata; Q54873184
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1515; CAST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAST (-) 2
AC   CVCL_SH02
SY   HZGHC003257c012; CAST knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SH02
DR   Horizon_Discovery; HZGHC003257c012
DR   Wikidata; Q54873186
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1515; CAST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAT (-) 1
AC   CVCL_SH03
SY   HZGHC003768c005; CAT knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SH03
DR   Horizon_Discovery; HZGHC003768c005
DR   Wikidata; Q54873187
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1516; CAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CAT (-) 2
AC   CVCL_SH04
SY   HZGHC003768c012; CAT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH04
DR   Horizon_Discovery; HZGHC003768c012
DR   Wikidata; Q54873188
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1516; CAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBL (-) 1
AC   CVCL_SH05
SY   HZGHC006309c011; CBL knockout cell line 2bp deletion; HAP1 CBL (-)
DR   cancercelllines; CVCL_SH05
DR   Horizon_Discovery; HZGHC006309c011
DR   Wikidata; Q54873189
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CBL (-) 2
AC   CVCL_XM45
SY   HZGHC006309c012; CBL knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XM45
DR   Horizon_Discovery; HZGHC006309c012
DR   Wikidata; Q93942216
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBR1 (-) 1
AC   CVCL_E1T2
SY   HZGHC007648c002
DR   Horizon_Discovery; HZGHC007648c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1548; CBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CBR1 (-) 2
AC   CVCL_E1T3
SY   HZGHC007648c003
DR   Horizon_Discovery; HZGHC007648c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1548; CBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CBR1 (-) 3
AC   CVCL_E1T4
SY   HZGHC007648c006
DR   Horizon_Discovery; HZGHC007648c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1548; CBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CBR1 (-) 4
AC   CVCL_E1T5
SY   HZGHC007648c010
DR   Horizon_Discovery; HZGHC007648c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1548; CBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CBR4 (-)
AC   CVCL_E1T6
SY   HZGHC007650c010
DR   Horizon_Discovery; HZGHC007650c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25891; CBR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CBX1 (-) 1
AC   CVCL_SH06
SY   HZGHC001178c001; CBX1 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SH06
DR   Horizon_Discovery; HZGHC001178c001
DR   Wikidata; Q54873190
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1551; CBX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001178c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CBX1 (-) 2
AC   CVCL_SH07
SY   HZGHC001178c002; CBX1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SH07
DR   Horizon_Discovery; HZGHC001178c002
DR   Wikidata; Q54873191
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1551; CBX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBX1 (-) 3
AC   CVCL_SH08
SY   HZGHC001178c003; CBX1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SH08
DR   Horizon_Discovery; HZGHC001178c003
DR   Wikidata; Q54873192
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1551; CBX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001178c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CBX3 (-) 1
AC   CVCL_SH09
SY   HZGHC002481c001; CBX3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH09
DR   Horizon_Discovery; HZGHC002481c001
DR   Wikidata; Q54873193
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1553; CBX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBX3 (-) 2
AC   CVCL_SH10
SY   HZGHC002481c005; CBX3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH10
DR   Horizon_Discovery; HZGHC002481c005
DR   Wikidata; Q54873195
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1553; CBX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBX3 (-) 3
AC   CVCL_SH11
SY   HZGHC002482c005; CBX3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SH11
DR   Horizon_Discovery; HZGHC002482c005
DR   Wikidata; Q54873196
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1553; CBX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBX5 (-) 1
AC   CVCL_SH12
SY   HZGHC001179c006; CBX5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SH12
DR   Horizon_Discovery; HZGHC001179c006
DR   Wikidata; Q54873197
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001179c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CBX5 (-) 2
AC   CVCL_SH13
SY   HZGHC001179c007; CBX5 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SH13
DR   Horizon_Discovery; HZGHC001179c007
DR   Wikidata; Q54873198
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001179c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CBX5 (-) 3
AC   CVCL_SH14
SY   HZGHC001179c010; CBX5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH14
DR   Horizon_Discovery; HZGHC001179c010
DR   Wikidata; Q54873199
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001179c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CBX5 (-) 4
AC   CVCL_SH15
SY   HZGHC001179c011; CBX5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SH15
DR   Horizon_Discovery; HZGHC001179c011
DR   Wikidata; Q54873200
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBX5 (-) 5
AC   CVCL_SH16
SY   HZGHC001330c005; CBX5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SH16
DR   Horizon_Discovery; HZGHC001330c005
DR   Wikidata; Q54873201
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CBX5 (-) 6
AC   CVCL_SH17
SY   HZGHC001330c010; CBX5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH17
DR   Horizon_Discovery; HZGHC001330c010
DR   Wikidata; Q54873202
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1555; CBX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC101 (-)
AC   CVCL_SH18
SY   HZGHC004910c011; CCDC101 knockout cell line 206bp insertion
DR   cancercelllines; CVCL_SH18
DR   Horizon_Discovery; HZGHC004910c011
DR   Wikidata; Q54873203
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25156; SGF29.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004910c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCDC109B (-) 1
AC   CVCL_XM46
SY   HZGHC007266c009; HZGHC55013; CCDC109B knockout cell line 1bp insertion in exon 2; HAP1 CCDC109B (-)
DR   cancercelllines; CVCL_XM46
DR   Horizon_Discovery; HZGHC007266c009
DR   Wikidata; Q93942278
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26076; MCUB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CCDC109B (-) 2
AC   CVCL_E1T7
SY   HZGHC007266c012; CCDC109B knockout cell line 5bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007266c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26076; MCUB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CCDC132 (-)
AC   CVCL_SH19
SY   HZGHC000858c008; CCDC132 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SH19
DR   Horizon_Discovery; HZGHC000858c008
DR   Wikidata; Q54873204
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25956; VPS50.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC51 (-) 1
AC   CVCL_SH20
SY   HZGHC005749c001; CCDC51 knockout cell line 31bp deletion; HAP1 CCDC51 (-)
DR   cancercelllines; CVCL_SH20
DR   Horizon_Discovery; HZGHC005749c001
DR   Wikidata; Q54873205
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25714; CCDC51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCDC51 (-) 2
AC   CVCL_XM47
SY   HZGHC005749c002; CCDC51 knockout cell line 65bp insertion
DR   cancercelllines; CVCL_XM47
DR   Horizon_Discovery; HZGHC005749c002
DR   Wikidata; Q93942298
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25714; CCDC51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005749c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCDC51 (-) 3
AC   CVCL_XM48
SY   HZGHC005749c004; CCDC51 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XM48
DR   Horizon_Discovery; HZGHC005749c004
DR   Wikidata; Q93942300
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25714; CCDC51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC51 (-) 4
AC   CVCL_XM49
SY   HZGHC005750c001; CCDC51 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM49
DR   Horizon_Discovery; HZGHC005750c001
DR   Wikidata; Q93942305
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25714; CCDC51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC51 (-) 5
AC   CVCL_XM50
SY   HZGHC005750c003; CCDC51 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM50
DR   Horizon_Discovery; HZGHC005750c003
DR   Wikidata; Q93942307
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25714; CCDC51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005750c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCDC53 (-) 1
AC   CVCL_SH21
SY   HZGHC004026c001; CCDC53 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH21
DR   Horizon_Discovery; HZGHC004026c001
DR   Wikidata; Q54873206
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24256; WASHC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC53 (-) 2
AC   CVCL_SH22
SY   HZGHC004026c004; CCDC53 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH22
DR   Horizon_Discovery; HZGHC004026c004
DR   Wikidata; Q54873207
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24256; WASHC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004026c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCDC53 (-) 3
AC   CVCL_SH23
SY   HZGHC004026c008; CCDC53 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SH23
DR   Horizon_Discovery; HZGHC004026c008
DR   Wikidata; Q54873208
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24256; WASHC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC6 (-) 1
AC   CVCL_SH24
SY   HZGHC004371c006; CCDC6 knockout cell line 56bp deletion
DR   cancercelllines; CVCL_SH24
DR   Horizon_Discovery; HZGHC004371c006
DR   Wikidata; Q54873209
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18782; CCDC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC6 (-) 2
AC   CVCL_SH25
SY   HZGHC004372c003; CCDC6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH25
DR   Horizon_Discovery; HZGHC004372c003
DR   Wikidata; Q54873210
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18782; CCDC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCDC6 (-) 3
AC   CVCL_SH26
SY   HZGHC004372c007; CCDC6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH26
DR   Horizon_Discovery; HZGHC004372c007
DR   Wikidata; Q54873215
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18782; CCDC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004372c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCDC92 (-) 1
AC   CVCL_XM51
SY   HZGHC006948c012; HZGHC80212; CCDC92 knockout cell line 17bp deletion in exon 3; HAP1 CCDC92 (-)
DR   cancercelllines; CVCL_XM51
DR   Horizon_Discovery; HZGHC006948c012
DR   Wikidata; Q93942336
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29563; CCDC92.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCDC92 (-) 2
AC   CVCL_B5JS
SY   HZGHC006949c008; CCDC92 knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_B5JS
DR   Horizon_Discovery; HZGHC006949c008
DR   Wikidata; Q111733275
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29563; CCDC92.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 CCDC92 (-) 3
AC   CVCL_B5JT
SY   HZGHC006949c010; CCDC92 knockout cell line 77bp insertion in exon 4
DR   cancercelllines; CVCL_B5JT
DR   Horizon_Discovery; HZGHC006949c010
DR   Wikidata; Q111733276
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29563; CCDC92.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006949c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 CCKBR (-) 1
AC   CVCL_SH27
SY   HZGHC003857c005; CCKBR knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SH27
DR   Horizon_Discovery; HZGHC003857c005
DR   Wikidata; Q54873216
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1571; CCKBR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCKBR (-) 2
AC   CVCL_SH28
SY   HZGHC003857c006; CCKBR knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SH28
DR   Horizon_Discovery; HZGHC003857c006
DR   Wikidata; Q54873217
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1571; CCKBR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCL2 (-) 1
AC   CVCL_SH29
SY   HZGHC006510c012; CCL2 knockout cell line 20bp deletion; HAP1 CCL2 (-)
DR   cancercelllines; CVCL_SH29
DR   Horizon_Discovery; HZGHC006510c012
DR   Wikidata; Q54873218
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10618; CCL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCL2 (-) 2
AC   CVCL_XM52
SY   HZGHC006510c004; CCL2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XM52
DR   Horizon_Discovery; HZGHC006510c004
DR   Wikidata; Q93942345
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10618; CCL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNB1 (-) 1
AC   CVCL_SH30
SY   HZGHC004760c003; CCNB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH30
DR   Horizon_Discovery; HZGHC004760c003
DR   Wikidata; Q54873219
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1579; CCNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNB1 (-) 2
AC   CVCL_SH31
SY   HZGHC004760c008; CCNB1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH31
DR   Horizon_Discovery; HZGHC004760c008
DR   Wikidata; Q54873220
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1579; CCNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNB1IP1 (-) 1
AC   CVCL_SH32
SY   HZGHC006398c002; CCNB1IP1 knockout cell line 11bp deletion; HAP1 CCNB1IP1 (-)
DR   cancercelllines; CVCL_SH32
DR   Horizon_Discovery; HZGHC006398c002
DR   Wikidata; Q54873221
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19437; CCNB1IP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCNB1IP1 (-) 2
AC   CVCL_XM53
SY   HZGHC006398c005; CCNB1IP1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XM53
DR   Horizon_Discovery; HZGHC006398c005
DR   Wikidata; Q93942354
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19437; CCNB1IP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCND1 (-) 1
AC   CVCL_SH33
SY   HZGHC003878c005; CCND1 knockout cell line 176bp insertion
DR   cancercelllines; CVCL_SH33
DR   Horizon_Discovery; HZGHC003878c005
DR   Wikidata; Q54873222
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003878c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCND1 (-) 2
AC   CVCL_SH34
SY   HZGHC003878c010; CCND1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH34
DR   Horizon_Discovery; HZGHC003878c010
DR   Wikidata; Q54873223
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCND2 (-) 1
AC   CVCL_SH35
SY   HZGHC004777c005; CCND2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SH35
DR   Horizon_Discovery; HZGHC004777c005
DR   Wikidata; Q54873224
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCND2 (-) 2
AC   CVCL_SH36
SY   HZGHC004777c010; CCND2 knockout cell line 652bp insertion
DR   cancercelllines; CVCL_SH36
DR   Horizon_Discovery; HZGHC004777c010
DR   Wikidata; Q54873225
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004777c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCND3 (-)
AC   CVCL_SH37
SY   HZGHC004828c009; HZGHC896; CCND3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SH37
DR   Horizon_Discovery; HZGHC004828c009
DR   Wikidata; Q54873226
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1585; CCND3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004828c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CCNE1 (-) 1
AC   CVCL_SH38
SY   HZGHC004808c010; CCNE1 knockout cell line 82bp deletion; HAP1 CCNE1 (-)
DR   cancercelllines; CVCL_SH38
DR   Horizon_Discovery; HZGHC004808c010
DR   Wikidata; Q54873228
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1589; CCNE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004808c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CCNE1 (-) 2
AC   CVCL_XM54
SY   HZGHC004808c002; CCNE1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XM54
DR   Horizon_Discovery; HZGHC004808c002
DR   Wikidata; Q93942372
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1589; CCNE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNE2 (-) 1
AC   CVCL_SH39
SY   HZGHC004824c001; CCNE2 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SH39
DR   Horizon_Discovery; HZGHC004824c001
DR   Wikidata; Q54873229
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1590; CCNE2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNE2 (-) 2
AC   CVCL_SH40
SY   HZGHC004824c002; CCNE2 knockout cell line 106bp insertion
DR   cancercelllines; CVCL_SH40
DR   Horizon_Discovery; HZGHC004824c002
DR   Wikidata; Q54873230
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1590; CCNE2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004824c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCNG1 (-) 1
AC   CVCL_SH41
SY   HZGHC004818c003; CCNG1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH41
DR   Horizon_Discovery; HZGHC004818c003
DR   Wikidata; Q54873231
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1592; CCNG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNG1 (-) 2
AC   CVCL_SH42
SY   HZGHC004818c011; CCNG1 knockout cell line 118bp insertion
DR   cancercelllines; CVCL_SH42
DR   Horizon_Discovery; HZGHC004818c011
DR   Wikidata; Q54873232
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1592; CCNG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004818c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCNG2 (-) 1
AC   CVCL_SH43
SY   HZGHC004820c009; CCNG2 knockout cell line 1bp insertion; HAP1 CCNG2 (-)
DR   cancercelllines; CVCL_SH43
DR   Horizon_Discovery; HZGHC004820c009
DR   Wikidata; Q54873233
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1593; CCNG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCNG2 (-) 2
AC   CVCL_XM55
SY   HZGHC004820c004; CCNG2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XM55
DR   Horizon_Discovery; HZGHC004820c004
DR   Wikidata; Q93942388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1593; CCNG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNJ (-)
AC   CVCL_SH44
SY   HZGHC004826c006; CCNJ knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH44
DR   Horizon_Discovery; HZGHC004826c006
DR   Wikidata; Q54873234
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23434; CCNJ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNL2 (-)
AC   CVCL_SH45
SY   HZGHC004816c001; CCNL2 knockout cell line 178bp deletion
DR   cancercelllines; CVCL_SH45
DR   Horizon_Discovery; HZGHC004816c001
DR   Wikidata; Q54873235
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20570; CCNL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNO (-) 1
AC   CVCL_SH46
SY   HZGHC004814c006; CCNO knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SH46
DR   Horizon_Discovery; HZGHC004814c006
DR   Wikidata; Q54873236
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18576; CCNO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNO (-) 2
AC   CVCL_SH47
SY   HZGHC004814c009; CCNO knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH47
DR   Horizon_Discovery; HZGHC004814c009
DR   Wikidata; Q54873237
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18576; CCNO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNT1 (-) 1
AC   CVCL_SH48
SY   HZGHC004812c001; CCNT1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH48
DR   Horizon_Discovery; HZGHC004812c001
DR   Wikidata; Q54873238
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1599; CCNT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNT1 (-) 2
AC   CVCL_SH49
SY   HZGHC004812c004; CCNT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH49
DR   Horizon_Discovery; HZGHC004812c004
DR   Wikidata; Q54873239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1599; CCNT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNT2 (-) 1
AC   CVCL_SH50
SY   HZGHC004810c007; CCNT2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH50
DR   Horizon_Discovery; HZGHC004810c007
DR   Wikidata; Q54873240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1600; CCNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNT2 (-) 2
AC   CVCL_SH51
SY   HZGHC004810c009; CCNT2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH51
DR   Horizon_Discovery; HZGHC004810c009
DR   Wikidata; Q54873241
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1600; CCNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004810c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCNY (-) 1
AC   CVCL_SH52
SY   HZGHC004835c008; CCNY knockout cell line 409bp insertion
DR   cancercelllines; CVCL_SH52
DR   Horizon_Discovery; HZGHC004835c008
DR   Wikidata; Q54873242
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23354; CCNY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004835c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCNY (-) 2
AC   CVCL_SH53
SY   HZGHC004835c012; CCNY knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SH53
DR   Horizon_Discovery; HZGHC004835c012
DR   Wikidata; Q54873243
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23354; CCNY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCNYL1 (-)
AC   CVCL_SH54
SY   HZGHC005235c005; CCNYL1 knockout cell line 130bp deletion
DR   cancercelllines; CVCL_SH54
DR   Horizon_Discovery; HZGHC005235c005
DR   Wikidata; Q54873244
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26868; CCNYL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCR5 (-) 1
AC   CVCL_SH55
SY   HZGHC002947c001; CCR5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH55
DR   Horizon_Discovery; HZGHC002947c001
DR   Wikidata; Q54873245
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1606; CCR5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCR5 (-) 2
AC   CVCL_SH56
SY   HZGHC002947c002; CCR5 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SH56
DR   Horizon_Discovery; HZGHC002947c002
DR   Wikidata; Q54873246
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1606; CCR5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CCSER1 (-) 1
AC   CVCL_SH57
SY   HZGHC006359c011; CCSER1 knockout cell line 22bp deletion; HAP1 CCSER1 (-)
DR   cancercelllines; CVCL_SH57
DR   Horizon_Discovery; HZGHC006359c011
DR   Wikidata; Q54873247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29349; CCSER1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CCSER1 (-) 2
AC   CVCL_XM56
SY   HZGHC006359c005; CCSER1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XM56
DR   Horizon_Discovery; HZGHC006359c005
DR   Wikidata; Q93942424
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29349; CCSER1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD164 (-)
AC   CVCL_E1T8
SY   HZGHC008143c012
DR   Horizon_Discovery; HZGHC008143c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1632; CD164.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CD226 (-) 1
AC   CVCL_SH58
SY   HZGHC004098c003; CD226 knockout cell line 221bp insertion
DR   cancercelllines; CVCL_SH58
DR   Horizon_Discovery; HZGHC004098c003
DR   Wikidata; Q54873248
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16961; CD226.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004098c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD226 (-) 2
AC   CVCL_SH59
SY   HZGHC004098c006; CD226 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SH59
DR   Horizon_Discovery; HZGHC004098c006
DR   Wikidata; Q54873249
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16961; CD226.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 1
AC   CVCL_SH60
SY   HZGHC003432c001; CD24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH60
DR   Horizon_Discovery; HZGHC003432c001
DR   Wikidata; Q54873250
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 2
AC   CVCL_SH61
SY   HZGHC003433c008; CD24 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SH61
DR   Horizon_Discovery; HZGHC003433c008
DR   Wikidata; Q54873251
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 3
AC   CVCL_SH62
SY   HZGHC003433c009; CD24 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SH62
DR   Horizon_Discovery; HZGHC003433c009
DR   Wikidata; Q54873252
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 4
AC   CVCL_SH63
SY   HZGHC003434c003; CD24 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SH63
DR   Horizon_Discovery; HZGHC003434c003
DR   Wikidata; Q54873253
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 5
AC   CVCL_SH64
SY   HZGHC003434c011; CD24 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SH64
DR   Horizon_Discovery; HZGHC003434c011
DR   Wikidata; Q54873254
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 6
AC   CVCL_SH65
SY   HZGHC003435c009; CD24 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH65
DR   Horizon_Discovery; HZGHC003435c009
DR   Wikidata; Q54873255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 7
AC   CVCL_SH66
SY   HZGHC003435c010; CD24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH66
DR   Horizon_Discovery; HZGHC003435c010
DR   Wikidata; Q54873261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD24 (-) 8
AC   CVCL_SH67
SY   HZGHC003435c012; CD24 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH67
DR   Horizon_Discovery; HZGHC003435c012
DR   Wikidata; Q54873262
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1645; CD24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD274 (-) 1
AC   CVCL_SH68
SY   HZGHC006660c001; CD274 knockout cell line 17bp deletion; HAP1 CD274 (-)
DR   cancercelllines; CVCL_SH68
DR   Horizon_Discovery; HZGHC006660c001
DR   Wikidata; Q54873263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD274 (-) 2
AC   CVCL_XM57
SY   HZGHC006660c003; CD274 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XM57
DR   Horizon_Discovery; HZGHC006660c003
DR   Wikidata; Q93942482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD276 (-)
AC   CVCL_E1T9
SY   HZGHC007807c009
DR   Horizon_Discovery; HZGHC007807c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19137; CD276.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CD2BP2 (-) 1
AC   CVCL_SH69
SY   HZGHC003085c001; CD2BP2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SH69
DR   Horizon_Discovery; HZGHC003085c001
DR   Wikidata; Q54873264
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1656; CD2BP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD2BP2 (-) 2
AC   CVCL_SH70
SY   HZGHC003085c010; CD2BP2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SH70
DR   Horizon_Discovery; HZGHC003085c010
DR   Wikidata; Q54873266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1656; CD2BP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD36 (-) 1
AC   CVCL_SH71
SY   HZGHC005966c010; CD36 knockout cell line 1bp insertion; HAP1 CD36 (-)
DR   cancercelllines; CVCL_SH71
DR   Horizon_Discovery; HZGHC005966c010
DR   Wikidata; Q54873267
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1663; CD36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD36 (-) 2
AC   CVCL_XM58
SY   HZGHC005966c002; CD36 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XM58
DR   Horizon_Discovery; HZGHC005966c002
DR   Wikidata; Q93942493
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1663; CD36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD44 (-) 1
AC   CVCL_SH72
SY   HZGHC005968c010; CD44 knockout cell line 26bp deletion; HAP1 CD44 (-)
DR   cancercelllines; CVCL_SH72
DR   Horizon_Discovery; HZGHC005968c010
DR   Wikidata; Q54873268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD44 (-) 2
AC   CVCL_XM59
SY   HZGHC005968c012; CD44 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_XM59
DR   Horizon_Discovery; HZGHC005968c012
DR   Wikidata; Q93942497
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 1
AC   CVCL_SH73
SY   HZGHC003437c003; CD46 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH73
DR   Horizon_Discovery; HZGHC003437c003
DR   Wikidata; Q54873269
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003437c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD46 (-) 10
AC   CVCL_SH82
SY   HZGHC004296c005; CD46 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH82
DR   Horizon_Discovery; HZGHC004296c005
DR   Wikidata; Q54873278
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 11
AC   CVCL_SH83
SY   HZGHC004296c007; CD46 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH83
DR   Horizon_Discovery; HZGHC004296c007
DR   Wikidata; Q54873279
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 2
AC   CVCL_SH74
SY   HZGHC003436c005; CD46 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SH74
DR   Horizon_Discovery; HZGHC003436c005
DR   Wikidata; Q54873270
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 3
AC   CVCL_SH75
SY   HZGHC003437c001; CD46 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SH75
DR   Horizon_Discovery; HZGHC003437c001
DR   Wikidata; Q54873271
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 4
AC   CVCL_SH76
SY   HZGHC003437c006; CD46 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH76
DR   Horizon_Discovery; HZGHC003437c006
DR   Wikidata; Q54873272
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 5
AC   CVCL_SH77
SY   HZGHC003438c008; CD46 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SH77
DR   Horizon_Discovery; HZGHC003438c008
DR   Wikidata; Q54873273
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 6
AC   CVCL_SH78
SY   HZGHC004081c006; CD46 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SH78
DR   Horizon_Discovery; HZGHC004081c006
DR   Wikidata; Q54873274
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 7
AC   CVCL_SH79
SY   HZGHC004081c011; CD46 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH79
DR   Horizon_Discovery; HZGHC004081c011
DR   Wikidata; Q54873275
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 8
AC   CVCL_SH80
SY   HZGHC004295c009; CD46 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SH80
DR   Horizon_Discovery; HZGHC004295c009
DR   Wikidata; Q54873276
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD46 (-) 9
AC   CVCL_SH81
SY   HZGHC004295c012; CD46 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH81
DR   Horizon_Discovery; HZGHC004295c012
DR   Wikidata; Q54873277
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD47 (-) 1
AC   CVCL_SH84
SY   HZGHC005561c011; CD47 knockout cell line 11bp deletion; HAP1 CD47 (-)
DR   cancercelllines; CVCL_SH84
DR   Horizon_Discovery; HZGHC005561c011
DR   Wikidata; Q54873280
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD47 (-) 2
AC   CVCL_XM60
SY   HZGHC005561c003; CD47 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XM60
DR   Horizon_Discovery; HZGHC005561c003
DR   Wikidata; Q93942512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD55 (-) 1
AC   CVCL_SH85
SY   HZGHC005129c002; CD55 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SH85
DR   Horizon_Discovery; HZGHC005129c002
DR   Wikidata; Q54873282
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2665; CD55.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD55 (-) 2
AC   CVCL_SH86
SY   HZGHC005129c010; CD55 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SH86
DR   Horizon_Discovery; HZGHC005129c010
DR   Wikidata; Q54873283
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2665; CD55.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD58 (-)
AC   CVCL_SH87
SY   HZGHC004192c010; CD58 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SH87
DR   Horizon_Discovery; HZGHC004192c010
DR   Wikidata; Q54873284
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1688; CD58.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD59 (-) 1
AC   CVCL_SH88
SY   HZGHC005131c005; CD59 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SH88
DR   Horizon_Discovery; HZGHC005131c005
DR   Wikidata; Q54873285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1689; CD59.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD59 (-) 2
AC   CVCL_SH89
SY   HZGHC005131c007; CD59 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SH89
DR   Horizon_Discovery; HZGHC005131c007
DR   Wikidata; Q54873286
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1689; CD59.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD63 (-)
AC   CVCL_SH90
SY   HZGHC004386c003; CD63 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH90
DR   Horizon_Discovery; HZGHC004386c003
DR   Wikidata; Q54873287
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1692; CD63.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD74 (-) 1
AC   CVCL_XM61
SY   HZGHC007126c002; HZGHC972; CD74 knockout cell line 5bp deletion in exon 2; HAP1 CD74 (-)
DR   cancercelllines; CVCL_XM61
DR   Horizon_Discovery; HZGHC007126c002
DR   Wikidata; Q93942548
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CD74 (-) 2
AC   CVCL_E1TA
SY   HZGHC007126c006
DR   Horizon_Discovery; HZGHC007126c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CD74 (-) 3
AC   CVCL_E1TB
SY   HZGHC007126c011
DR   Horizon_Discovery; HZGHC007126c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CD81 (-) 1
AC   CVCL_SH91
SY   HZGHC003441c012; CD81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH91
DR   Horizon_Discovery; HZGHC003441c012
DR   Wikidata; Q54873288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003441c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD81 (-) 2
AC   CVCL_SH92
SY   HZGHC003440c006; CD81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH92
DR   Horizon_Discovery; HZGHC003440c006
DR   Wikidata; Q54873289
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD81 (-) 3
AC   CVCL_SH93
SY   HZGHC004297c001; CD81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH93
DR   Horizon_Discovery; HZGHC004297c001
DR   Wikidata; Q54873290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD81 (-) 4
AC   CVCL_SH94
SY   HZGHC004297c005; CD81 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SH94
DR   Horizon_Discovery; HZGHC004297c005
DR   Wikidata; Q54873291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD81 (-) 5
AC   CVCL_SH95
SY   HZGHC004297c008; CD81 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SH95
DR   Horizon_Discovery; HZGHC004297c008
DR   Wikidata; Q54873292
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD81 (-) 6
AC   CVCL_SH96
SY   HZGHC004297c009; CD81 knockout cell line 92bp deletion
DR   cancercelllines; CVCL_SH96
DR   Horizon_Discovery; HZGHC004297c009
DR   Wikidata; Q54873293
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD81 (-) 7
AC   CVCL_SH97
SY   HZGHC004298c002; CD81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH97
DR   Horizon_Discovery; HZGHC004298c002
DR   Wikidata; Q54873294
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CD81 (-) 8
AC   CVCL_SH98
SY   HZGHC004298c003; CD81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH98
DR   Horizon_Discovery; HZGHC004298c003
DR   Wikidata; Q54873296
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004298c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD81 (-) 9
AC   CVCL_SH99
SY   HZGHC004298c007; CD81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SH99
DR   Horizon_Discovery; HZGHC004298c007
DR   Wikidata; Q54873297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004298c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CD9 (-) 1
AC   CVCL_SI00
SY   HZGHC006343c012; CD9 knockout cell line 86bp insertion; HAP1 CD9 (-)
DR   cancercelllines; CVCL_SI00
DR   Horizon_Discovery; HZGHC006343c012
DR   Wikidata; Q54873298
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006343c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CD9 (-) 2
AC   CVCL_XM62
SY   HZGHC006343c006; CD9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XM62
DR   Horizon_Discovery; HZGHC006343c006
DR   Wikidata; Q93942594
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDA (-) 1
AC   CVCL_E1TC
SY   HZGHC007390c003
DR   Horizon_Discovery; HZGHC007390c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1712; CDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDA (-) 2
AC   CVCL_E1TD
SY   HZGHC007390c005
DR   Horizon_Discovery; HZGHC007390c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1712; CDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDA (-) 3
AC   CVCL_E1TE
SY   HZGHC007390c007
DR   Horizon_Discovery; HZGHC007390c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1712; CDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDA (-) 4
AC   CVCL_E1TF
SY   HZGHC007390c008
DR   Horizon_Discovery; HZGHC007390c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1712; CDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDA (-) 5
AC   CVCL_E1TG
SY   HZGHC007390c012
DR   Horizon_Discovery; HZGHC007390c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1712; CDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDAN1 (-)
AC   CVCL_XM63
SY   HZGHC146059; CDAN1 knockout cell line
DR   cancercelllines; CVCL_XM63
DR   Horizon_Discovery; HZGHC146059
DR   Wikidata; Q93942596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1713; CDAN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC146059; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDC25A (-) 1
AC   CVCL_SI01
SY   HZGHC006322c001; CDC25A knockout cell line 2bp insertion; HAP1 CDC25A (-)
DR   cancercelllines; CVCL_SI01
DR   Horizon_Discovery; HZGHC006322c001
DR   Wikidata; Q54873299
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1725; CDC25A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDC25A (-) 2
AC   CVCL_XM64
SY   HZGHC006322c010; CDC25A knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XM64
DR   Horizon_Discovery; HZGHC006322c010
DR   Wikidata; Q93942599
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1725; CDC25A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDC25C (-)
AC   CVCL_SI02
SY   HZGHC003086c001; CDC25C knockout cell line 35bp deletion
DR   cancercelllines; CVCL_SI02
DR   Horizon_Discovery; HZGHC003086c001
DR   Wikidata; Q54873300
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1727; CDC25C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDC34 (-) 1
AC   CVCL_SI03
SY   HZGHC002551c001; CDC34 knockout cell line 40bp insertion
DR   cancercelllines; CVCL_SI03
DR   Horizon_Discovery; HZGHC002551c001
DR   Wikidata; Q54873301
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1734; CDC34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002551c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDC34 (-) 2
AC   CVCL_SI04
SY   HZGHC002551c004; CDC34 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SI04
DR   Horizon_Discovery; HZGHC002551c004
DR   Wikidata; Q54873302
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1734; CDC34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDC42 (-) 1
AC   CVCL_SI05
SY   HZGHC003404c002; CDC42 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI05
DR   Horizon_Discovery; HZGHC003404c002
DR   Wikidata; Q54873303
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1736; CDC42.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003404c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDC42 (-) 2
AC   CVCL_SI06
SY   HZGHC003404c010; CDC42 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SI06
DR   Horizon_Discovery; HZGHC003404c010
DR   Wikidata; Q54873308
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1736; CDC42.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003404c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDC42BPA (-) 1
AC   CVCL_XM65
SY   HZGHC000131c001; CDC42BPA knockout cell line
DR   cancercelllines; CVCL_XM65
DR   Horizon_Discovery; HZGHC000131c001
DR   Wikidata; Q93942612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1737; CDC42BPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000131c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDC42BPA (-) 2
AC   CVCL_XM66
SY   HZGHC000131c023; CDC42BPA knockout cell line
DR   cancercelllines; CVCL_XM66
DR   Horizon_Discovery; HZGHC000131c023
DR   Wikidata; Q93942614
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1737; CDC42BPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000131c023; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDC42BPB (-) 1
AC   CVCL_SI07
SY   HZGHC002968c004; CDC42BPB knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SI07
DR   Horizon_Discovery; HZGHC002968c004
DR   Wikidata; Q54873309
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1738; CDC42BPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDC42BPB (-) 2
AC   CVCL_SI08
SY   HZGHC002968c006; CDC42BPB knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SI08
DR   Horizon_Discovery; HZGHC002968c006
DR   Wikidata; Q54873310
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1738; CDC42BPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDC42BPG (-)
AC   CVCL_SI09
SY   HZGHC000361c014; CDC42BPG knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SI09
DR   Horizon_Discovery; HZGHC000361c014
DR   Wikidata; Q54873311
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29829; CDC42BPG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDCA2 (-) 1
AC   CVCL_SI10
SY   HZGHC003275c001; CDCA2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SI10
DR   Horizon_Discovery; HZGHC003275c001
DR   Wikidata; Q54873312
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14623; CDCA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDCA2 (-) 2
AC   CVCL_SI11
SY   HZGHC003275c011; CDCA2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI11
DR   Horizon_Discovery; HZGHC003275c011
DR   Wikidata; Q54873313
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14623; CDCA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDCA7 (-) 1
AC   CVCL_SI12
SY   HZGHC004000c001; CDCA7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SI12
DR   Horizon_Discovery; HZGHC004000c001
DR   Wikidata; Q54873314
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14628; CDCA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDCA7 (-) 2
AC   CVCL_SI13
SY   HZGHC004000c012; CDCA7 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SI13
DR   Horizon_Discovery; HZGHC004000c012
DR   Wikidata; Q54873316
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14628; CDCA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDH1 (-) 1
AC   CVCL_E1TH
SY   HZGHC007682c003
DR   Horizon_Discovery; HZGHC007682c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1748; CDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDH1 (-) 2
AC   CVCL_E1TI
SY   HZGHC007682c004
DR   Horizon_Discovery; HZGHC007682c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1748; CDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDH1 (-) 3
AC   CVCL_E1TJ
SY   HZGHC007682c006
DR   Horizon_Discovery; HZGHC007682c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1748; CDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDH1 (-) 4
AC   CVCL_E1TK
SY   HZGHC007682c008
DR   Horizon_Discovery; HZGHC007682c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1748; CDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDH2 (-) 1
AC   CVCL_SI14
SY   HZGHC005969c011; CDH2 knockout cell line 2bp deletion; HAP1 CDH2 (-)
DR   cancercelllines; CVCL_SI14
DR   Horizon_Discovery; HZGHC005969c011
DR   Wikidata; Q54873317
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1759; CDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDH2 (-) 2
AC   CVCL_XM67
SY   HZGHC005969c007; CDH2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XM67
DR   Horizon_Discovery; HZGHC005969c007
DR   Wikidata; Q93942644
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1759; CDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDH3 (-) 1
AC   CVCL_SI15
SY   HZGHC003983c004; CDH3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI15
DR   Horizon_Discovery; HZGHC003983c004
DR   Wikidata; Q54873318
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1762; CDH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDH3 (-) 2
AC   CVCL_SI16
SY   HZGHC003983c005; CDH3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SI16
DR   Horizon_Discovery; HZGHC003983c005
DR   Wikidata; Q54873319
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1762; CDH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDH3 (-) 3
AC   CVCL_SI17
SY   HZGHC004260c002; CDH3 knockout cell line 80bp deletion
DR   cancercelllines; CVCL_SI17
DR   Horizon_Discovery; HZGHC004260c002
DR   Wikidata; Q54873320
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1762; CDH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDH3 (-) 4
AC   CVCL_SI18
SY   HZGHC004260c003; CDH3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SI18
DR   Horizon_Discovery; HZGHC004260c003
DR   Wikidata; Q54873321
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1762; CDH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDH6 (-) 1
AC   CVCL_XM68
SY   HZGHC007274c007; HZGHC1004; CDH6 knockout cell line 10bp deletion in exon 4; HAP1 CDH6 (-)
DR   cancercelllines; CVCL_XM68
DR   Horizon_Discovery; HZGHC007274c007
DR   Wikidata; Q93942671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1765; CDH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CDH6 (-) 2
AC   CVCL_E1TL
SY   HZGHC007274c012
DR   Horizon_Discovery; HZGHC007274c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1765; CDH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CDK10 (-)
AC   CVCL_SI19
SY   HZGHC000270c005; CDK10 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SI19
DR   Horizon_Discovery; HZGHC000270c005
DR   Wikidata; Q54873322
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1770; CDK10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK11A (-)
AC   CVCL_SI20
SY   HZGHC002629c012; CDK11A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI20
DR   Horizon_Discovery; HZGHC002629c012
DR   Wikidata; Q54873323
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1730; CDK11A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK13 (-) 1
AC   CVCL_SI21
SY   HZGHC000317c002; CDK13 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SI21
DR   Horizon_Discovery; HZGHC000317c002
DR   Wikidata; Q54873324
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1733; CDK13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK13 (-) 2
AC   CVCL_SI22
SY   HZGHC000317c007; CDK13 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SI22
DR   Horizon_Discovery; HZGHC000317c007
DR   Wikidata; Q54873325
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1733; CDK13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK13 (-) 3
AC   CVCL_SI23
SY   HZGHC000317c016; CDK13 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SI23
DR   Horizon_Discovery; HZGHC000317c016
DR   Wikidata; Q54873326
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1733; CDK13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK14 (-)
AC   CVCL_SI24
SY   HZGHC000043c019; CDK14 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SI24
DR   Horizon_Discovery; HZGHC000043c019
DR   Wikidata; Q54873327
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8883; CDK14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK16 (-)
AC   CVCL_SI25
SY   HZGHC000235c010; CDK16 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI25
DR   Horizon_Discovery; HZGHC000235c010
DR   Wikidata; Q54873328
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8749; CDK16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK17 (-) 1
AC   CVCL_SI26
SY   HZGHC000132c004; CDK17 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SI26
DR   Horizon_Discovery; HZGHC000132c004
DR   Wikidata; Q54873329
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8750; CDK17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK17 (-) 2
AC   CVCL_SI27
SY   HZGHC000132c009; CDK17 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI27
DR   Horizon_Discovery; HZGHC000132c009
DR   Wikidata; Q54873330
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8750; CDK17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK18 (-) 1
AC   CVCL_SI28
SY   HZGHC000305c011; CDK18 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SI28
DR   Horizon_Discovery; HZGHC000305c011
DR   Wikidata; Q54873332
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8751; CDK18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK18 (-) 2
AC   CVCL_SI29
SY   HZGHC000305c013; CDK18 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI29
DR   Horizon_Discovery; HZGHC000305c013
DR   Wikidata; Q54873333
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8751; CDK18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK18 (-) 3
AC   CVCL_SI30
SY   HZGHC000305c020; CDK18 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI30
DR   Horizon_Discovery; HZGHC000305c020
DR   Wikidata; Q54873334
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8751; CDK18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK19 (-)
AC   CVCL_SI31
SY   HZGHC000078c020; CDK19 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI31
DR   Horizon_Discovery; HZGHC000078c020
DR   Wikidata; Q54873335
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19338; CDK19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK2 (-)
AC   CVCL_SI32
SY   HZGHC000133c011; CDK2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SI32
DR   Horizon_Discovery; HZGHC000133c011
DR   Wikidata; Q54873336
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1771; CDK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK3 (-) 1
AC   CVCL_SI33
SY   HZGHC000079c003; CDK3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SI33
DR   Horizon_Discovery; HZGHC000079c003
DR   Wikidata; Q54873337
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1772; CDK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK3 (-) 2
AC   CVCL_SI34
SY   HZGHC000079c006; CDK3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI34
DR   Horizon_Discovery; HZGHC000079c006
DR   Wikidata; Q54873338
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1772; CDK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK3 (-) 3
AC   CVCL_SI35
SY   HZGHC000079c011; CDK3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SI35
DR   Horizon_Discovery; HZGHC000079c011
DR   Wikidata; Q54873339
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1772; CDK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK4 (-) 1
AC   CVCL_SI36
SY   HZGHC000044c011; CDK4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SI36
DR   Horizon_Discovery; HZGHC000044c011
DR   Wikidata; Q54873340
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1773; CDK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK4 (-) 2
AC   CVCL_SI37
SY   HZGHC000044c020; CDK4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SI37
DR   Horizon_Discovery; HZGHC000044c020
DR   Wikidata; Q54873341
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1773; CDK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK5 (-) 1
AC   CVCL_SI38
SY   HZGHC005189c010; CDK5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SI38
DR   Horizon_Discovery; HZGHC005189c010
DR   Wikidata; Q54873342
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK5 (-) 2
AC   CVCL_SI39
SY   HZGHC005189c011; CDK5 knockout cell line 49bp deletion
DR   cancercelllines; CVCL_SI39
DR   Horizon_Discovery; HZGHC005189c011
DR   Wikidata; Q54873343
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK5RAP1 (-) 1
AC   CVCL_SI40
SY   HZGHC002612c006; CDK5RAP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SI40
DR   Horizon_Discovery; HZGHC002612c006
DR   Wikidata; Q54873344
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15880; CDK5RAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK5RAP1 (-) 2
AC   CVCL_SI41
SY   HZGHC002612c012; CDK5RAP1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SI41
DR   Horizon_Discovery; HZGHC002612c012
DR   Wikidata; Q54873345
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15880; CDK5RAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDK6 (-)
AC   CVCL_SI42
SY   HZGHC007052c010; CDK6 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SI42
DR   Horizon_Discovery; HZGHC007052c010
DR   Wikidata; Q54873346
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007052c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDK8 (-)
AC   CVCL_SI43
SY   HZGHC000325c001; CDK8 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI43
DR   Horizon_Discovery; HZGHC000325c001
DR   Wikidata; Q54873347
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1779; CDK8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKL1 (-) 1
AC   CVCL_SI44
SY   HZGHC000332c010; CDKL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI44
DR   Horizon_Discovery; HZGHC000332c010
DR   Wikidata; Q54873348
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1781; CDKL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKL1 (-) 2
AC   CVCL_SI45
SY   HZGHC000332c012; CDKL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI45
DR   Horizon_Discovery; HZGHC000332c012
DR   Wikidata; Q54873349
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1781; CDKL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000332c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDKL3 (-) 1
AC   CVCL_SI46
SY   HZGHC000134c010; CDKL3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI46
DR   Horizon_Discovery; HZGHC000134c010
DR   Wikidata; Q54873354
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15483; CDKL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKL3 (-) 2
AC   CVCL_SI47
SY   HZGHC000134c012; CDKL3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SI47
DR   Horizon_Discovery; HZGHC000134c012
DR   Wikidata; Q54873356
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15483; CDKL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKL5 (-) 1
AC   CVCL_SI48
SY   HZGHC001261c009; CDKL5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI48
DR   Horizon_Discovery; HZGHC001261c009
DR   Wikidata; Q54873357
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11411; CDKL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKL5 (-) 2
AC   CVCL_SI49
SY   HZGHC002984c001; CDKL5 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SI49
DR   Horizon_Discovery; HZGHC002984c001
DR   Wikidata; Q54873358
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11411; CDKL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKL5 (-) 3
AC   CVCL_SI50
SY   HZGHC002984c010; CDKL5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SI50
DR   Horizon_Discovery; HZGHC002984c010
DR   Wikidata; Q54873359
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11411; CDKL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002984c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDKN1A (-) 1
AC   CVCL_SI51
SY   HZGHC004015c009; CDKN1A knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SI51
DR   Horizon_Discovery; HZGHC004015c009
DR   Wikidata; Q54873360
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKN1A (-) 2
AC   CVCL_SI52
SY   HZGHC004015c010; CDKN1A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI52
DR   Horizon_Discovery; HZGHC004015c010
DR   Wikidata; Q54873361
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKN1A (-) 3
AC   CVCL_SI53
SY   HZGHC004015c011; CDKN1A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI53
DR   Horizon_Discovery; HZGHC004015c011
DR   Wikidata; Q54873363
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004015c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDKN1B (-) 1
AC   CVCL_SI54
SY   HZGHC004761c002; CDKN1B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI54
DR   Horizon_Discovery; HZGHC004761c002
DR   Wikidata; Q54873364
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKN1B (-) 2
AC   CVCL_SI55
SY   HZGHC004761c006; CDKN1B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI55
DR   Horizon_Discovery; HZGHC004761c006
DR   Wikidata; Q54873365
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKN1B (-) 3
AC   CVCL_SI56
SY   HZGHC004761c008; CDKN1B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI56
DR   Horizon_Discovery; HZGHC004761c008
DR   Wikidata; Q54873366
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKN1C (-) 1
AC   CVCL_SI57
SY   HZGHC006112c007; CDKN1C knockout cell line 1bp deletion; HAP1 CDKN1C (-)
DR   cancercelllines; CVCL_SI57
DR   Horizon_Discovery; HZGHC006112c007
DR   Wikidata; Q54873367
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1786; CDKN1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDKN1C (-) 2
AC   CVCL_XM69
SY   HZGHC006112c008; CDKN1C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM69
DR   Horizon_Discovery; HZGHC006112c008
DR   Wikidata; Q93942965
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1786; CDKN1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKN2A (-) 1
AC   CVCL_SI58
SY   HZGHC003751c004; CDKN2A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SI58
DR   Horizon_Discovery; HZGHC003751c004
DR   Wikidata; Q54873368
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDKN2A (-) 2
AC   CVCL_SI59
SY   HZGHC003751c011; CDKN2A knockout cell line 121bp insertion
DR   cancercelllines; CVCL_SI59
DR   Horizon_Discovery; HZGHC003751c011
DR   Wikidata; Q54873369
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003751c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CDKN2B (-)
AC   CVCL_SI60
SY   HZGHC002774c010; CDKN2B knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SI60
DR   Horizon_Discovery; HZGHC002774c010
DR   Wikidata; Q54873370
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1788; CDKN2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CDS1 (-)
AC   CVCL_SI61
SY   HZGHC000209c022; CDS1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SI61
DR   Horizon_Discovery; HZGHC000209c022
DR   Wikidata; Q54873371
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1800; CDS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CEBPA (-) 1
AC   CVCL_SI62
SY   HZGHC005015c006; CEBPA knockout cell line 218bp deletion
DR   cancercelllines; CVCL_SI62
DR   Horizon_Discovery; HZGHC005015c006
DR   Wikidata; Q54873372
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CEBPA (-) 2
AC   CVCL_SI63
SY   HZGHC005015c007; CEBPA knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SI63
DR   Horizon_Discovery; HZGHC005015c007
DR   Wikidata; Q54873373
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CEBPA (-) 3
AC   CVCL_SI64
SY   HZGHC005016c012; CEBPA knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SI64
DR   Horizon_Discovery; HZGHC005016c012
DR   Wikidata; Q54873374
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CEBPB (-) 1
AC   CVCL_SI65
SY   HZGHC003598c007; CEBPB knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SI65
DR   Horizon_Discovery; HZGHC003598c007
DR   Wikidata; Q54873375
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1834; CEBPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CEBPB (-) 2
AC   CVCL_SI66
SY   HZGHC003598c002; CEBPB knockout cell line 6bp deletion
DR   cancercelllines; CVCL_SI66
DR   Horizon_Discovery; HZGHC003598c002
DR   Wikidata; Q54873376
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1834; CEBPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CECR2 (-) 1
AC   CVCL_SI67
SY   HZGHC000946c001; CECR2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SI67
DR   Horizon_Discovery; HZGHC000946c001
DR   Wikidata; Q54873377
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1840; CECR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CECR2 (-) 2
AC   CVCL_SI68
SY   HZGHC000946c011; CECR2 knockout cell line 191bp insertion
DR   cancercelllines; CVCL_SI68
DR   Horizon_Discovery; HZGHC000946c011
DR   Wikidata; Q54873378
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1840; CECR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000946c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CECR5 (-) 1
AC   CVCL_SI69
SY   HZGHC005751c012; CECR5 knockout cell line 1bp deletion; HAP1 CECR5 (-)
DR   cancercelllines; CVCL_SI69
DR   Horizon_Discovery; HZGHC005751c012
DR   Wikidata; Q54873379
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1843; HDHD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CECR5 (-) 2
AC   CVCL_XM70
SY   HZGHC005751c004; CECR5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XM70
DR   Horizon_Discovery; HZGHC005751c004
DR   Wikidata; Q93943045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1843; HDHD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CECR5 (-) 3
AC   CVCL_XM71
SY   HZGHC005751c005; CECR5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM71
DR   Horizon_Discovery; HZGHC005751c005
DR   Wikidata; Q93943047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1843; HDHD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CECR5 (-) 4
AC   CVCL_XM72
SY   HZGHC005752c001; CECR5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XM72
DR   Horizon_Discovery; HZGHC005752c001
DR   Wikidata; Q93943050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1843; HDHD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CECR5 (-) 5
AC   CVCL_XM73
SY   HZGHC005752c011; CECR5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM73
DR   Horizon_Discovery; HZGHC005752c011
DR   Wikidata; Q93943053
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1843; HDHD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CENPE (-) 1
AC   CVCL_SI70
SY   HZGHC003087c003; CENPE knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SI70
DR   Horizon_Discovery; HZGHC003087c003
DR   Wikidata; Q54873381
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1856; CENPE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CENPE (-) 2
AC   CVCL_SI71
SY   HZGHC003087c012; CENPE knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SI71
DR   Horizon_Discovery; HZGHC003087c012
DR   Wikidata; Q54873382
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1856; CENPE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CERS2 (-) 1
AC   CVCL_XM74
SY   HZGHC29956; CERS2 knockout cell line; HAP1 CERS2 (-)
DR   cancercelllines; CVCL_XM74
DR   Horizon_Discovery; HZGHC29956
DR   Wikidata; Q93943069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14076; CERS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC29956; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CERS2 (-) 2
AC   CVCL_DX09
SY   HZGHC007117c004; CERS2 knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007117c004
DR   Wikidata; Q127381036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14076; CERS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 CES2 (-) 1
AC   CVCL_E1TM
SY   HZGHC007591c001
DR   Horizon_Discovery; HZGHC007591c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1864; CES2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CES2 (-) 2
AC   CVCL_E1TN
SY   HZGHC007591c010
DR   Horizon_Discovery; HZGHC007591c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1864; CES2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CETN2 (-) 1
AC   CVCL_E1TP
SY   HZGHC007927c001
DR   Horizon_Discovery; HZGHC007927c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1867; CETN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CETN2 (-) 2
AC   CVCL_E1TQ
SY   HZGHC007927c009
DR   Horizon_Discovery; HZGHC007927c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1867; CETN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CETN2 (-) 3
AC   CVCL_E1TR
SY   HZGHC007927c012
DR   Horizon_Discovery; HZGHC007927c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1867; CETN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CFLAR (-) 1
AC   CVCL_SI72
SY   HZGHC006351c002; CFLAR knockout cell line 11bp deletion; HAP1 CFLAR (-)
DR   cancercelllines; CVCL_SI72
DR   Horizon_Discovery; HZGHC006351c002
DR   Wikidata; Q54873384
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1876; CFLAR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CFLAR (-) 2
AC   CVCL_XM75
SY   HZGHC006351c003; CFLAR knockout cell line 25bp deletion
DR   cancercelllines; CVCL_XM75
DR   Horizon_Discovery; HZGHC006351c003
DR   Wikidata; Q93943079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1876; CFLAR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CH25H (-)
AC   CVCL_SI73
SY   HZGHC004181c005; CH25H knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SI73
DR   Horizon_Discovery; HZGHC004181c005
DR   Wikidata; Q54873386
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1907; CH25H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHAMP1 (-)
AC   CVCL_SI74
SY   HZGHC003065c009; CHAMP1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SI74
DR   Horizon_Discovery; HZGHC003065c009
DR   Wikidata; Q54873387
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20311; CHAMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD10 (-) 1
AC   CVCL_SI75
SY   HZGHC005042c002; CHCHD10 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SI75
DR   Horizon_Discovery; HZGHC005042c002
DR   Wikidata; Q54873388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15559; CHCHD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD10 (-) 2
AC   CVCL_SI76
SY   HZGHC005042c011; CHCHD10 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_SI76
DR   Horizon_Discovery; HZGHC005042c011
DR   Wikidata; Q54873389
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15559; CHCHD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD10 (-) 3
AC   CVCL_SI77
SY   HZGHC005043c003; CHCHD10 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SI77
DR   Horizon_Discovery; HZGHC005043c003
DR   Wikidata; Q54873390
RX   PubMed=37767023;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15559; CHCHD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHCHD10 (-) 4
AC   CVCL_SI78
SY   HZGHC005043c007; CHCHD10 knockout cell line 110bp deletion
DR   cancercelllines; CVCL_SI78
DR   Horizon_Discovery; HZGHC005043c007
DR   Wikidata; Q54873391
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15559; CHCHD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD2 (-) 1
AC   CVCL_SI79
SY   HZGHC002686c002; CHCHD2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SI79
DR   Horizon_Discovery; HZGHC002686c002
DR   Wikidata; Q54873392
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21645; CHCHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD2 (-) 2
AC   CVCL_SI80
SY   HZGHC002686c003; CHCHD2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SI80
DR   Horizon_Discovery; HZGHC002686c003
DR   Wikidata; Q54873393
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21645; CHCHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD3 (-) 1
AC   CVCL_SI81
SY   HZGHC003088c006; CHCHD3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SI81
DR   Horizon_Discovery; HZGHC003088c006
DR   Wikidata; Q54873394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21906; CHCHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD3 (-) 2
AC   CVCL_SI82
SY   HZGHC003088c010; CHCHD3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI82
DR   Horizon_Discovery; HZGHC003088c010
DR   Wikidata; Q54873395
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21906; CHCHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD6 (-) 1
AC   CVCL_SI83
SY   HZGHC003089c001; CHCHD6 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SI83
DR   Horizon_Discovery; HZGHC003089c001
DR   Wikidata; Q54873396
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28184; CHCHD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHCHD6 (-) 2
AC   CVCL_SI84
SY   HZGHC003089c010; CHCHD6 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SI84
DR   Horizon_Discovery; HZGHC003089c010
DR   Wikidata; Q54873397
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28184; CHCHD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD1 (-) 1
AC   CVCL_SI85
SY   HZGHC003796c002; CHD1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SI85
DR   Horizon_Discovery; HZGHC003796c002
DR   Wikidata; Q54873398
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1915; CHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD1 (-) 2
AC   CVCL_SI86
SY   HZGHC003796c010; CHD1 knockout cell line 82bp deletion
DR   cancercelllines; CVCL_SI86
DR   Horizon_Discovery; HZGHC003796c010
DR   Wikidata; Q54873402
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1915; CHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD1L (-) 1
AC   CVCL_SI87
SY   HZGHC003363c002; CHD1L knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SI87
DR   Horizon_Discovery; HZGHC003363c002
DR   Wikidata; Q54873403
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1916; CHD1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD1L (-) 2
AC   CVCL_SI88
SY   HZGHC003363c010; CHD1L knockout cell line 224bp insertion
DR   cancercelllines; CVCL_SI88
DR   Horizon_Discovery; HZGHC003363c010
DR   Wikidata; Q54873405
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1916; CHD1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003363c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHD2 (-) 1
AC   CVCL_SI89
SY   HZGHC003236c005; CHD2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SI89
DR   Horizon_Discovery; HZGHC003236c005
DR   Wikidata; Q54873406
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1917; CHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD2 (-) 2
AC   CVCL_SI90
SY   HZGHC003236c012; CHD2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI90
DR   Horizon_Discovery; HZGHC003236c012
DR   Wikidata; Q54873407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1917; CHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD2 (-) 3
AC   CVCL_SI91
SY   HZGHC003238c010; CHD2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI91
DR   Horizon_Discovery; HZGHC003238c010
DR   Wikidata; Q54873408
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1917; CHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD2 (-) 4
AC   CVCL_SI92
SY   HZGHC003238c012; CHD2 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_SI92
DR   Horizon_Discovery; HZGHC003238c012
DR   Wikidata; Q54873409
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1917; CHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD3 (-) 1
AC   CVCL_SI93
SY   HZGHC003630c003; CHD3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI93
DR   Horizon_Discovery; HZGHC003630c003
DR   Wikidata; Q54873410
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1918; CHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHD3 (-) 2
AC   CVCL_SI94
SY   HZGHC003630c006; CHD3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SI94
DR   Horizon_Discovery; HZGHC003630c006
DR   Wikidata; Q54873411
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1918; CHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003630c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHEK2 (-) 1
AC   CVCL_SI95
SY   HZGHC013714c010; CHEK2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SI95
DR   Horizon_Discovery; HZGHC013714c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54873413
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHEK2 (-) 2
AC   CVCL_SI96
SY   HZGHC013714c021; CHEK2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SI96
DR   Horizon_Discovery; HZGHC013714c021
DR   Wikidata; Q54873414
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC013714c021; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHEK2 (-) 3
AC   CVCL_SI97
SY   HZGHC013714c024; CHEK2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SI97
DR   Horizon_Discovery; HZGHC013714c024
DR   Wikidata; Q54873415
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC013714c024; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHMP1A (-) 1
AC   CVCL_SI98
AS   CVCL_TQ67
SY   HZGHC005340c003; CHMP1A knockout cell line 2bp deletion; HAP1 CHMP1A (-)
DR   cancercelllines; CVCL_SI98
DR   Horizon_Discovery; HZGHC005340c003
DR   Wikidata; Q54873416
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8740; CHMP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CHMP1A (-) 2
AC   CVCL_XM76
SY   HZGHC005340c007; CHMP1A knockout cell line 172bp insertion
DR   cancercelllines; CVCL_XM76
DR   Horizon_Discovery; HZGHC005340c007
DR   Wikidata; Q93943238
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8740; CHMP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005340c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHMP1A (-) 3
AC   CVCL_XM77
SY   HZGHC005341c001; CHMP1A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XM77
DR   Horizon_Discovery; HZGHC005341c001
DR   Wikidata; Q93943240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8740; CHMP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHMP1A (-) 4
AC   CVCL_XM78
SY   HZGHC005341c012; CHMP1A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XM78
DR   Horizon_Discovery; HZGHC005341c012
DR   Wikidata; Q93943242
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8740; CHMP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHMP1B (-)
AC   CVCL_XM79
SY   HZGHC007219c010; HZGHC57132; CHMP1B knockout cell line 1bp insertion in exon 1
DR   cancercelllines; CVCL_XM79
DR   Horizon_Discovery; HZGHC007219c010
DR   Wikidata; Q93943244
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24287; CHMP1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHMP2B (-) 1
AC   CVCL_C7HH
SY   HZGHC007915c007; CHMP2B knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC007915c007
DR   Wikidata; Q117704462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 CHMP2B (-) 2
AC   CVCL_C7HI
SY   HZGHC007915c011; CHMP2B knockout cell line 8bp deletion
DR   Horizon_Discovery; HZGHC007915c011
DR   Wikidata; Q117704463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 CHMP7 (-) 1
AC   CVCL_SI99
SY   HZGHC005342c011; CHMP7 knockout cell line 10bp deletion; HAP1 CHMP7 (-)
DR   cancercelllines; CVCL_SI99
DR   Horizon_Discovery; HZGHC005342c011
DR   Wikidata; Q54873417
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28439; CHMP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHMP7 (-) 2
AC   CVCL_XM80
SY   HZGHC005342c008; CHMP7 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XM80
DR   Horizon_Discovery; HZGHC005342c008
DR   Wikidata; Q93943247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28439; CHMP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHRNA7 (-)
AC   CVCL_SJ00
SY   HZGHC003352c012; CHRNA7 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SJ00
DR   Horizon_Discovery; HZGHC003352c012
DR   Wikidata; Q54873418
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1960; CHRNA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHRNB2 (-) 1
AC   CVCL_SJ01
SY   HZGHC003850c006; CHRNB2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SJ01
DR   Horizon_Discovery; HZGHC003850c006
DR   Wikidata; Q54873419
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1962; CHRNB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHRNB2 (-) 2
AC   CVCL_SJ02
SY   HZGHC003850c011; CHRNB2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SJ02
DR   Horizon_Discovery; HZGHC003850c011
DR   Wikidata; Q54873421
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1962; CHRNB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHST10 (-) 1
AC   CVCL_SJ03
SY   HZGHC005935c011; CHST10 knockout cell line 14bp deletion; HAP1 CHST10 (-)
DR   cancercelllines; CVCL_SJ03
DR   Horizon_Discovery; HZGHC005935c011
DR   Wikidata; Q54873422
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19650; CHST10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CHST10 (-) 2
AC   CVCL_XM81
SY   HZGHC005935c005; CHST10 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XM81
DR   Horizon_Discovery; HZGHC005935c005
DR   Wikidata; Q93943258
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19650; CHST10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CHUK (-)
AC   CVCL_SJ04
SY   HZGHC000003c011; CHUK knockout cell line 26bp deletion in exon 1
DR   cancercelllines; CVCL_SJ04
DR   Horizon_Discovery; HZGHC000003c011
DR   Wikidata; Q54873423
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CIC (-) 1
AC   CVCL_SJ05
SY   HZGHC004831c001; CIC knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SJ05
DR   Horizon_Discovery; HZGHC004831c001
DR   Wikidata; Q54873424
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14214; CIC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CIC (-) 2
AC   CVCL_SJ06
SY   HZGHC004831c012; CIC knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SJ06
DR   Horizon_Discovery; HZGHC004831c012
DR   Wikidata; Q54873425
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14214; CIC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CIC (-) 3
AC   CVCL_SJ07
SY   HZGHC004832c003; CIC knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SJ07
DR   Horizon_Discovery; HZGHC004832c003
DR   Wikidata; Q54873426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14214; CIC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CIC (-) 4
AC   CVCL_SJ08
SY   HZGHC004832c004; CIC knockout cell line 95bp deletion
DR   cancercelllines; CVCL_SJ08
DR   Horizon_Discovery; HZGHC004832c004
DR   Wikidata; Q54873427
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14214; CIC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CISD2 (-) 1
AC   CVCL_SJ09
SY   HZGHC004852c001; CISD2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SJ09
DR   Horizon_Discovery; HZGHC004852c001
DR   Wikidata; Q54873428
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24212; CISD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CISD2 (-) 2
AC   CVCL_SJ10
SY   HZGHC004852c009; CISD2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ10
DR   Horizon_Discovery; HZGHC004852c009
DR   Wikidata; Q54873429
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24212; CISD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CKAP4 (-)
AC   CVCL_SJ11
SY   HZGHC000590c009; CKAP4 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SJ11
DR   Horizon_Discovery; HZGHC000590c009
DR   Wikidata; Q54873430
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16991; CKAP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CKB (-)
AC   CVCL_SJ12
SY   HZGHC003691c007; CKB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SJ12
DR   Horizon_Discovery; HZGHC003691c007
DR   Wikidata; Q54873431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1991; CKB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLASP1 (-) 1
AC   CVCL_SJ13
SY   HZGHC004899c001; CLASP1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SJ13
DR   Horizon_Discovery; HZGHC004899c001
DR   Wikidata; Q54873432
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17088; CLASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLASP1 (-) 2
AC   CVCL_SJ14
SY   HZGHC004899c010; CLASP1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SJ14
DR   Horizon_Discovery; HZGHC004899c010
DR   Wikidata; Q54873433
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17088; CLASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLCN2 (-) 1
AC   CVCL_SJ15
SY   HZGHC003856c002; CLCN2 knockout cell line 176bp insertion
DR   cancercelllines; CVCL_SJ15
DR   Horizon_Discovery; HZGHC003856c002
DR   Wikidata; Q54873434
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2020; CLCN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003856c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLCN2 (-) 2
AC   CVCL_SJ16
SY   HZGHC003856c005; CLCN2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SJ16
DR   Horizon_Discovery; HZGHC003856c005
DR   Wikidata; Q54873436
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2020; CLCN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLCN5 (-) 1
AC   CVCL_XM82
SY   HZGHC006943c006; HZGHC1184; CLCN5 knockout cell line 58bp deletion in exon 5; HAP1 CLCN5 (-)
DR   cancercelllines; CVCL_XM82
DR   Horizon_Discovery; HZGHC006943c006
DR   Wikidata; Q93943348
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2023; CLCN5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CLCN5 (-) 2
AC   CVCL_E1TS
SY   HZGHC006943c008
DR   Horizon_Discovery; HZGHC006943c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2023; CLCN5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLCN7 (-)
AC   CVCL_SJ17
SY   HZGHC003090c001; CLCN7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SJ17
DR   Horizon_Discovery; HZGHC003090c001
DR   Wikidata; Q54873437
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2025; CLCN7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLDN9 (-)
AC   CVCL_E1TT
SY   HZGHC007560c012
DR   Horizon_Discovery; HZGHC007560c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2051; CLDN9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLEC2B (-)
AC   CVCL_E1TU
SY   HZGHC007951c010
DR   Horizon_Discovery; HZGHC007951c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2053; CLEC2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLK1 (-) 1
AC   CVCL_SJ18
SY   HZGHC000135c009; CLK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ18
DR   Horizon_Discovery; HZGHC000135c009
DR   Wikidata; Q54873438
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2068; CLK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLK1 (-) 2
AC   CVCL_SJ19
SY   HZGHC000135c020; CLK1 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_SJ19
DR   Horizon_Discovery; HZGHC000135c020
DR   Wikidata; Q54873439
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2068; CLK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLK2 (-) 1
AC   CVCL_SJ20
SY   HZGHC000080c007; CLK2 knockout cell line 7bp insertion
DR   cancercelllines; CVCL_SJ20
DR   Horizon_Discovery; HZGHC000080c007
DR   Wikidata; Q54873440
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2069; CLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000080c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLK2 (-) 2
AC   CVCL_SJ21
SY   HZGHC000080c012; CLK2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SJ21
DR   Horizon_Discovery; HZGHC000080c012
DR   Wikidata; Q54873441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2069; CLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLK2 (-) 3
AC   CVCL_SJ22
SY   HZGHC000080c014; CLK2 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SJ22
DR   Horizon_Discovery; HZGHC000080c014
DR   Wikidata; Q54873442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2069; CLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLK3 (-)
AC   CVCL_SJ23
SY   HZGHC004957c007; CLK3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SJ23
DR   Horizon_Discovery; HZGHC004957c007
DR   Wikidata; Q54873443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2071; CLK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004957c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLK4 (-) 1
AC   CVCL_SJ24
SY   HZGHC000081c001; CLK4 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SJ24
DR   Horizon_Discovery; HZGHC000081c001
DR   Wikidata; Q54873444
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13659; CLK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLK4 (-) 2
AC   CVCL_SJ25
SY   HZGHC000081c012; CLK4 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SJ25
DR   Horizon_Discovery; HZGHC000081c012
DR   Wikidata; Q54873445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13659; CLK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLK4 (-) 3
AC   CVCL_SJ26
SY   HZGHC000081c014; CLK4 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SJ26
DR   Horizon_Discovery; HZGHC000081c014
DR   Wikidata; Q54873449
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13659; CLK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLN3 (-) 1
AC   CVCL_SJ27
SY   HZGHC003369c002; CLN3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SJ27
DR   Horizon_Discovery; HZGHC003369c002
DR   Wikidata; Q54873450
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2074; CLN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLN3 (-) 2
AC   CVCL_SJ28
SY   HZGHC003369c010; CLN3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SJ28
DR   Horizon_Discovery; HZGHC003369c010
DR   Wikidata; Q54873452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2074; CLN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLN5 (-)
AC   CVCL_XM83
SY   HZGHC007202c008; HZGHC1203; CLN5 knockout cell line 1bp deletion in exon 1
DR   cancercelllines; CVCL_XM83
DR   Horizon_Discovery; HZGHC007202c008
DR   Wikidata; Q93943443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2076; CLN5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLN6 (-)
AC   CVCL_SJ29
SY   HZGHC004659c009; CLN6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SJ29
DR   Horizon_Discovery; HZGHC004659c009
DR   Wikidata; Q54873454
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2077; CLN6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004659c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLN8 (-)
AC   CVCL_XM84
SY   HZGHC007204c006; HZGHC2055; CLN8 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_XM84
DR   Horizon_Discovery; HZGHC007204c006
DR   Wikidata; Q93943453
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2079; CLN8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLPB (-)
AC   CVCL_E1TV
SY   HZGHC007326c001
DR   Horizon_Discovery; HZGHC007326c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30664; CLPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLPP (-) 1
AC   CVCL_XM85
SY   HZGHC006811c008; HZGHC8192; CLPP knockout cell line 1bp insertion in exon 3; HAP1 CLPP (-)
DR   cancercelllines; CVCL_XM85
DR   Horizon_Discovery; HZGHC006811c008
DR   Wikidata; Q93943456
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2084; CLPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CLPP (-) 2
AC   CVCL_E1TW
SY   HZGHC006810c003
DR   Horizon_Discovery; HZGHC006810c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2084; CLPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLPP (-) 3
AC   CVCL_E1TX
SY   HZGHC006811c007
DR   Horizon_Discovery; HZGHC006811c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2084; CLPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLPTM1 (-) 1
AC   CVCL_SJ30
SY   HZGHC006617c006; CLPTM1 knockout cell line 2bp insertion; HAP1 CLPTM1 (-)
DR   cancercelllines; CVCL_SJ30
DR   Horizon_Discovery; HZGHC006617c006
DR   Wikidata; Q54873455
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2087; CLPTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLPTM1 (-) 2
AC   CVCL_XM86
SY   HZGHC006617c008; CLPTM1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XM86
DR   Horizon_Discovery; HZGHC006617c008
DR   Wikidata; Q93943464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2087; CLPTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CLPTM1 (-) 3
AC   CVCL_E1TY
SY   HZGHC006906c008
DR   Horizon_Discovery; HZGHC006906c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2087; CLPTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLPTM1 (-) 4
AC   CVCL_E1TZ
SY   HZGHC006906c012
DR   Horizon_Discovery; HZGHC006906c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2087; CLPTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CLPX (-)
AC   CVCL_XM87
SY   HZGHC10845; CLPX knockout cell line
DR   cancercelllines; CVCL_XM87
DR   Horizon_Discovery; HZGHC10845
DR   Wikidata; Q93943467
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2088; CLPX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC10845; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CLU (-) 1
AC   CVCL_SJ31
SY   HZGHC006120c011; CLU knockout cell line 20bp deletion; HAP1 CLU (-)
DR   cancercelllines; CVCL_SJ31
DR   Horizon_Discovery; HZGHC006120c011
DR   Wikidata; Q54873456
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2095; CLU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CLU (-) 2
AC   CVCL_XM88
SY   HZGHC006120c007; CLU knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XM88
DR   Horizon_Discovery; HZGHC006120c007
DR   Wikidata; Q93943476
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2095; CLU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CMAS (-)
AC   CVCL_SJ32
SY   HZGHC000743c001; CMAS knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SJ32
DR   Horizon_Discovery; HZGHC000743c001
DR   Wikidata; Q54873457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18290; CMAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CMTM6 (-) 1
AC   CVCL_XM89
SY   HZGHC006876c004; HZGHC54918; CMTM6 knockout cell line 143bp insertion in exon 1; HAP1 CMTM6 (-)HAP1 CMTM6 (-)
DR   cancercelllines; CVCL_XM89
DR   Horizon_Discovery; HZGHC006876c004
DR   Wikidata; Q93943487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006876c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CMTM6 (-) 2
AC   CVCL_E1U0
SY   HZGHC006876c009
DR   Horizon_Discovery; HZGHC006876c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CMTR1 (-) 1
AC   CVCL_SJ33
SY   HZGHC004217c006; CMTR1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SJ33
DR   Horizon_Discovery; HZGHC004217c006
DR   Wikidata; Q54873458
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21077; CMTR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004217c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CMTR1 (-) 2
AC   CVCL_SJ34
SY   HZGHC004217c007; CMTR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ34
DR   Horizon_Discovery; HZGHC004217c007
DR   Wikidata; Q54873459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21077; CMTR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004217c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CMTR1 (-) 3
AC   CVCL_E1U1
SY   HZGHC008002c008
DR   Horizon_Discovery; HZGHC008002c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21077; CMTR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CNKSR1 (-) 1
AC   CVCL_SJ35
SY   HZGHC002408c011; CNKSR1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SJ35
DR   Horizon_Discovery; HZGHC002408c011
DR   Wikidata; Q54873460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19700; CNKSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNKSR1 (-) 2
AC   CVCL_SJ36
SY   HZGHC002408c012; CNKSR1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SJ36
DR   Horizon_Discovery; HZGHC002408c012
DR   Wikidata; Q54873461
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19700; CNKSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNKSR1 (-) 3
AC   CVCL_SJ37
SY   HZGHC002409c002; CNKSR1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SJ37
DR   Horizon_Discovery; HZGHC002409c002
DR   Wikidata; Q54873462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19700; CNKSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNKSR2 (-) 1
AC   CVCL_SJ38
SY   HZGHC002410c008; CNKSR2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SJ38
DR   Horizon_Discovery; HZGHC002410c008
DR   Wikidata; Q54873463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19701; CNKSR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNKSR2 (-) 2
AC   CVCL_SJ39
SY   HZGHC002411c001; CNKSR2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SJ39
DR   Horizon_Discovery; HZGHC002411c001
DR   Wikidata; Q54873464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19701; CNKSR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNKSR2 (-) 3
AC   CVCL_SJ40
SY   HZGHC002411c002; CNKSR2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SJ40
DR   Horizon_Discovery; HZGHC002411c002
DR   Wikidata; Q54873465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19701; CNKSR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNN3 (-)
AC   CVCL_C8FJ
SY   HZGHC008148c009; CNN3 knockout cell line 8bp deletion in exon 6
DR   Horizon_Discovery; HZGHC008148c009
DR   Wikidata; Q123031420
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2157; CNN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC008148c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 CNP (-) 1
AC   CVCL_SJ41
SY   HZGHC006124c005; CNP knockout cell line 7bp deletion in exon 2; HAP1 CNP (-)
DR   cancercelllines; CVCL_SJ41
DR   Horizon_Discovery; HZGHC006124c005
DR   Wikidata; Q54873466
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2158; CNP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CNP (-) 2
AC   CVCL_XM90
SY   HZGHC006124c006; CNP knockout cell line 14bp insertion
DR   cancercelllines; CVCL_XM90
DR   Horizon_Discovery; HZGHC006124c006
DR   Wikidata; Q93943562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2158; CNP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006124c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CNR1 (-) 1
AC   CVCL_SJ42
SY   HZGHC003864c001; CNR1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SJ42
DR   Horizon_Discovery; HZGHC003864c001
DR   Wikidata; Q54873467
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2159; CNR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNR1 (-) 2
AC   CVCL_SJ43
SY   HZGHC003864c007; CNR1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SJ43
DR   Horizon_Discovery; HZGHC003864c007
DR   Wikidata; Q54873468
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2159; CNR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNST (-) 1
AC   CVCL_SJ44
SY   HZGHC003091c001; CNST knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SJ44
DR   Horizon_Discovery; HZGHC003091c001
DR   Wikidata; Q54873469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26486; CNST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNST (-) 2
AC   CVCL_SJ45
SY   HZGHC003091c010; CNST knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SJ45
DR   Horizon_Discovery; HZGHC003091c010
DR   Wikidata; Q54873470
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26486; CNST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CNTNAP1 (-) 1
AC   CVCL_SJ46
SY   HZGHC006304c004; CNTNAP1 knockout cell line 94bp insertion; HAP1 CNTNAP1 (-)
DR   cancercelllines; CVCL_SJ46
DR   Horizon_Discovery; HZGHC006304c004
DR   Wikidata; Q54873471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8011; CNTNAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006304c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CNTNAP1 (-) 2
AC   CVCL_XM91
SY   HZGHC006304c007; CNTNAP1 knockout cell line 37bp deletion
DR   cancercelllines; CVCL_XM91
DR   Horizon_Discovery; HZGHC006304c007
DR   Wikidata; Q93943601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8011; CNTNAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COL1A1 (-) 1
AC   CVCL_SJ47
SY   HZGHC005473c001; COL1A1 knockout cell line 5bp deletion; HAP1 COL1A1 (-)
DR   cancercelllines; CVCL_SJ47
DR   Horizon_Discovery; HZGHC005473c001
DR   Wikidata; Q54873473
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005473c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 COL1A1 (-) 2
AC   CVCL_XM92
SY   HZGHC005473c008; COL1A1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XM92
DR   Horizon_Discovery; HZGHC005473c008
DR   Wikidata; Q93943612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COL4A3BP (-) 1
AC   CVCL_SJ48
SY   HZGHC005597c003; COL4A3BP knockout cell line 16bp deletion; HAP1 COL4A3BP (-)
DR   cancercelllines; CVCL_SJ48
DR   Horizon_Discovery; HZGHC005597c003
DR   Wikidata; Q54873474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2205; CERT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 COL4A3BP (-) 2
AC   CVCL_XM93
SY   HZGHC005597c005; COL4A3BP knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XM93
DR   Horizon_Discovery; HZGHC005597c005
DR   Wikidata; Q93943624
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2205; CERT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COL4A5 (-) 1
AC   CVCL_E1U2
SY   HZGHC007756c019
DR   Horizon_Discovery; HZGHC007756c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COL4A5 (-) 2
AC   CVCL_E1U3
SY   HZGHC007756c022
DR   Horizon_Discovery; HZGHC007756c022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COL7A1 (-) 1
AC   CVCL_E1U4
SY   HZGHC007413c009
DR   Horizon_Discovery; HZGHC007413c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2214; COL7A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COL7A1 (-) 2
AC   CVCL_E1U5
SY   HZGHC007413c011
DR   Horizon_Discovery; HZGHC007413c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2214; COL7A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COMT (-) 1
AC   CVCL_SJ49
SY   HZGHC003817c001; COMT knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SJ49
DR   Horizon_Discovery; HZGHC003817c001
DR   Wikidata; Q54873475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2228; COMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COMT (-) 2
AC   CVCL_SJ50
SY   HZGHC003817c003; COMT knockout cell line 148bp deletion
DR   cancercelllines; CVCL_SJ50
DR   Horizon_Discovery; HZGHC003817c003
DR   Wikidata; Q54873476
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2228; COMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COMTD1 (-)
AC   CVCL_SJ51
SY   HZGHC006504c011; COMTD1 knockout cell line 197bp deletion
DR   cancercelllines; CVCL_SJ51
DR   Horizon_Discovery; HZGHC006504c011
DR   Wikidata; Q54873477
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26309; COMTD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COPS6 (-) 1
AC   CVCL_SJ52
SY   HZGHC000446c001; COPS6 knockout cell line 40bp deletion
DR   cancercelllines; CVCL_SJ52
DR   Horizon_Discovery; HZGHC000446c001
DR   Wikidata; Q54873478
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21749; COPS6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COPS6 (-) 2
AC   CVCL_SJ53
SY   HZGHC000446c005; COPS6 knockout cell line 37bp deletion
DR   cancercelllines; CVCL_SJ53
DR   Horizon_Discovery; HZGHC000446c005
DR   Wikidata; Q54873479
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21749; COPS6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COPS7A (-) 1
AC   CVCL_SJ54
SY   HZGHC000914c001; COPS7A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ54
DR   Horizon_Discovery; HZGHC000914c001
DR   Wikidata; Q54873480
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16758; COPS7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COPS7A (-) 2
AC   CVCL_SJ55
SY   HZGHC000914c003; COPS7A knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SJ55
DR   Horizon_Discovery; HZGHC000914c003
DR   Wikidata; Q54873481
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16758; COPS7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COPS7B (-) 1
AC   CVCL_SJ56
SY   HZGHC000636c003; COPS7B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ56
DR   Horizon_Discovery; HZGHC000636c003
DR   Wikidata; Q54873482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16760; COPS7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COPS7B (-) 2
AC   CVCL_SJ57
SY   HZGHC000636c011; COPS7B knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SJ57
DR   Horizon_Discovery; HZGHC000636c011
DR   Wikidata; Q54873483
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16760; COPS7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ10A (-) 1
AC   CVCL_E1U6
SY   HZGHC007721c009
DR   Horizon_Discovery; HZGHC007721c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26515; COQ10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ10A (-) 2
AC   CVCL_E1U7
SY   HZGHC007721c012
DR   Horizon_Discovery; HZGHC007721c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26515; COQ10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ10B (-) 1
AC   CVCL_E1U8
SY   HZGHC007723c013
DR   Horizon_Discovery; HZGHC007723c013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25819; COQ10B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ10B (-) 2
AC   CVCL_E1U9
SY   HZGHC007723c020
DR   Horizon_Discovery; HZGHC007723c020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25819; COQ10B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ2 (-) 1
AC   CVCL_SJ58
SY   HZGHC002683c001; COQ2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SJ58
DR   Horizon_Discovery; HZGHC002683c001
DR   Wikidata; Q54873485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25223; COQ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ2 (-) 2
AC   CVCL_SJ59
SY   HZGHC002683c011; COQ2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ59
DR   Horizon_Discovery; HZGHC002683c011
DR   Wikidata; Q54873486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25223; COQ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ3 (-)
AC   CVCL_E1UA
SY   HZGHC007716c011
DR   Horizon_Discovery; HZGHC007716c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18175; COQ3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ4 (-)
AC   CVCL_E1UB
SY   HZGHC007718c009
DR   Horizon_Discovery; HZGHC007718c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19693; COQ4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ5 (-)
AC   CVCL_SJ60
SY   HZGHC004967c003; COQ5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SJ60
DR   Horizon_Discovery; HZGHC004967c003
DR   Wikidata; Q54873487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28722; COQ5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ6 (-) 1
AC   CVCL_E1UC
SY   HZGHC007719c005
DR   Horizon_Discovery; HZGHC007719c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20233; COQ6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ6 (-) 2
AC   CVCL_E1UD
SY   HZGHC007719c011
DR   Horizon_Discovery; HZGHC007719c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20233; COQ6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ6 (-) 3
AC   CVCL_E1UE
SY   HZGHC007719c012
DR   Horizon_Discovery; HZGHC007719c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20233; COQ6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COQ7 (-) 1
AC   CVCL_SJ61
SY   HZGHC004974c002; COQ7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SJ61
DR   Horizon_Discovery; HZGHC004974c002
DR   Wikidata; Q54873488
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2244; COQ7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ7 (-) 2
AC   CVCL_SJ62
SY   HZGHC004974c005; COQ7 knockout cell line 46bp deletion
DR   cancercelllines; CVCL_SJ62
DR   Horizon_Discovery; HZGHC004974c005
DR   Wikidata; Q54873489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2244; COQ7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ8A (-) 1
AC   CVCL_SB61
SY   HZGHC001506c003; HAP1 ADCK3 (-) 1; COQ8A knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_SB61
DR   Horizon_Discovery; HZGHC001506c003
DR   Wikidata; Q54872514
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16812; COQ8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ8A (-) 2
AC   CVCL_SB62
SY   HZGHC001506c011; HAP1 ADCK3 (-) 2; COQ8A knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_SB62
DR   Horizon_Discovery; HZGHC001506c011
DR   Wikidata; Q54872515
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16812; COQ8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ8B (-) 1
AC   CVCL_SB63
SY   HZGHC000315c016; HAP1 ADCK4 (-) 1; COQ8B knockout cell line 2bp insertion in exon 2
DR   cancercelllines; CVCL_SB63
DR   Horizon_Discovery; HZGHC000315c016
DR   Wikidata; Q54872516
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19041; COQ8B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ8B (-) 2
AC   CVCL_SB64
SY   HZGHC000315c019; HAP1 ADCK4 (-) 2; COQ8B knockout cell line 8bp deletion in exon 2
DR   cancercelllines; CVCL_SB64
DR   Horizon_Discovery; HZGHC000315c019
DR   Wikidata; Q54872517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19041; COQ8B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COQ9 (-) 1
AC   CVCL_SJ63
SY   HZGHC004977c006; COQ9 knockout cell line 254bp insertion
DR   cancercelllines; CVCL_SJ63
DR   Horizon_Discovery; HZGHC004977c006
DR   Wikidata; Q54873490
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25302; COQ9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004977c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 COQ9 (-) 2
AC   CVCL_SJ64
SY   HZGHC004977c008; COQ9 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SJ64
DR   Horizon_Discovery; HZGHC004977c008
DR   Wikidata; Q54873491
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25302; COQ9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 COX11 (-)
AC   CVCL_SJ65
SY   HZGHC005462c010; COX11 knockout cell line 214bp insertion
DR   cancercelllines; CVCL_SJ65
DR   Horizon_Discovery; HZGHC005462c010
DR   Wikidata; Q54873492
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2261; COX11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005462c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 COX6A1 (-) 1
AC   CVCL_XM94
SY   HZGHC006834c005; HZGHC1337; COX6A1 knockout cell line 17bp deletion in exon 1; HAP1 COX6A1 (-)
DR   cancercelllines; CVCL_XM94
DR   Horizon_Discovery; HZGHC006834c005
DR   Wikidata; Q93943758
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2277; COX6A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 COX6A1 (-) 2
AC   CVCL_E1UF
SY   HZGHC006834c003; COX6A1 knockout cell line 7bp deletion in exon 1
DR   Horizon_Discovery; HZGHC006834c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2277; COX6A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COX6A1 (-) 3
AC   CVCL_E1UG
SY   HZGHC006834c011; COX6A1 knockout cell line 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC006834c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2277; COX6A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COX6A1 (-) 4
AC   CVCL_E1UH
SY   HZGHC006835c004; COX6A1 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC006835c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2277; COX6A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COX6A1 (-) 5
AC   CVCL_E1UI
SY   HZGHC006835c005; COX6A1 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC006835c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2277; COX6A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 COX6A1 (-) 6
AC   CVCL_E1UJ
SY   HZGHC006835c007; COX6A1 knockout cell line 7bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006835c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2277; COX6A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CPOX (-) 1
AC   CVCL_E1UK
SY   HZGHC006830c003; CPOX knockout cell line 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC006830c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2321; CPOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CPOX (-) 2
AC   CVCL_E1UL
SY   HZGHC006831c013; CPOX knockout cell line 5bp deletion in exon 1
DR   Horizon_Discovery; HZGHC006831c013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2321; CPOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CPT1A (-) 1
AC   CVCL_SJ66
SY   HZGHC003786c010; CPT1A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ66
DR   Horizon_Discovery; HZGHC003786c010
DR   Wikidata; Q54873498
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2328; CPT1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CPT1A (-) 2
AC   CVCL_SJ67
SY   HZGHC003786c012; CPT1A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SJ67
DR   Horizon_Discovery; HZGHC003786c012
DR   Wikidata; Q54873499
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2328; CPT1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CPT2 (-)
AC   CVCL_SJ68
SY   HZGHC003795c011; CPT2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SJ68
DR   Horizon_Discovery; HZGHC003795c011
DR   Wikidata; Q54873500
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2330; CPT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CRBN (-) 1
AC   CVCL_SJ69
SY   HZGHC003752c001; CRBN knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SJ69
DR   Horizon_Discovery; HZGHC003752c001
DR   Wikidata; Q54873501
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CRBN (-) 2
AC   CVCL_SJ70
SY   HZGHC003752c006; CRBN knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SJ70
DR   Horizon_Discovery; HZGHC003752c006
DR   Wikidata; Q54873502
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003752c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CRBN (-) 3
AC   CVCL_SJ71
SY   HZGHC003752c010; CRBN knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SJ71
DR   Horizon_Discovery; HZGHC003752c010
DR   Wikidata; Q54873503
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003752c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CREB1 (-) 1
AC   CVCL_SJ72
SY   HZGHC002598c006; CREB1 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_SJ72
DR   Horizon_Discovery; HZGHC002598c006
DR   Wikidata; Q54873504
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CREB1 (-) 2
AC   CVCL_SJ73
SY   HZGHC002598c011; CREB1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ73
DR   Horizon_Discovery; HZGHC002598c011
DR   Wikidata; Q54873505
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CREBBP (-) 1
AC   CVCL_SJ74
SY   HZGHC001109c005; CREBBP knockout cell line 1bp insertion; HAP1 CREBBP (-)
DR   cancercelllines; CVCL_SJ74
DR   Horizon_Discovery; HZGHC001109c005
DR   Wikidata; Q54873506
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001109c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CREBBP (-) 2
AC   CVCL_XM95
SY   HZGHC001109c006; CREBBP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM95
DR   Horizon_Discovery; HZGHC001109c006
DR   Wikidata; Q93943776
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001109c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CRELD1 (-) 1
AC   CVCL_SJ75
SY   HZGHC004111c004; CRELD1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SJ75
DR   Horizon_Discovery; HZGHC004111c004
DR   Wikidata; Q54873507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14630; CRELD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CRELD1 (-) 2
AC   CVCL_SJ76
SY   HZGHC004111c009; CRELD1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SJ76
DR   Horizon_Discovery; HZGHC004111c009
DR   Wikidata; Q54873508
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14630; CRELD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSF1 (-) 1
AC   CVCL_SJ77
SY   HZGHC006128c011; CSF1 knockout cell line 31bp deletion; HAP1 CSF1 (-)
DR   cancercelllines; CVCL_SJ77
DR   Horizon_Discovery; HZGHC006128c011
DR   Wikidata; Q54873510
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSF1 (-) 2
AC   CVCL_XM96
SY   HZGHC006129c004; CSF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM96
DR   Horizon_Discovery; HZGHC006129c004
DR   Wikidata; Q93943784
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSF1 (-) 3
AC   CVCL_XM97
SY   HZGHC006129c008; CSF1 knockout cell line 562bp insertion
DR   cancercelllines; CVCL_XM97
DR   Horizon_Discovery; HZGHC006129c008
DR   Wikidata; Q93943786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006129c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSF1 (-) 4
AC   CVCL_XM98
SY   HZGHC006129c012; CSF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XM98
DR   Horizon_Discovery; HZGHC006129c012
DR   Wikidata; Q93943789
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSK (-)
AC   CVCL_SJ78
SY   HZGHC000198c003; CSK knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SJ78
DR   Horizon_Discovery; HZGHC000198c003
DR   Wikidata; Q54873511
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2444; CSK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000198c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSMD1 (-) 1
AC   CVCL_SJ79
SY   HZGHC003092c006; CSMD1 knockout cell line 271bp insertion
DR   cancercelllines; CVCL_SJ79
DR   Horizon_Discovery; HZGHC003092c006
DR   Wikidata; Q54873512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14026; CSMD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003092c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSMD1 (-) 2
AC   CVCL_SJ80
SY   HZGHC003092c011; CSMD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SJ80
DR   Horizon_Discovery; HZGHC003092c011
DR   Wikidata; Q54873513
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14026; CSMD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSNK1D (-) 1
AC   CVCL_SJ81
SY   HZGHC000274c010; CSNK1D knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SJ81
DR   Horizon_Discovery; HZGHC000274c010
DR   Wikidata; Q54873514
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSNK1D (-) 2
AC   CVCL_SJ82
SY   HZGHC004527c012; CSNK1D knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SJ82
DR   Horizon_Discovery; HZGHC004527c012
DR   Wikidata; Q54873515
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSNK1E (-)
AC   CVCL_SJ83
SY   HZGHC000362c004; CSNK1E knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SJ83
DR   Horizon_Discovery; HZGHC000362c004
DR   PRIDE; PXD010335
DR   Wikidata; Q54873516
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2453; CSNK1E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSNK1G1 (-) 1
AC   CVCL_SJ84
SY   HZGHC000082c007; CSNK1G1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SJ84
DR   Horizon_Discovery; HZGHC000082c007
DR   Wikidata; Q54873517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000082c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSNK1G1 (-) 2
AC   CVCL_SJ85
SY   HZGHC000082c021; CSNK1G1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SJ85
DR   Horizon_Discovery; HZGHC000082c021
DR   Wikidata; Q54873519
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000082c021; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSNK1G1 (-) 3
AC   CVCL_SJ86
SY   HZGHC000082c024; CSNK1G1 knockout cell line 263bp insertion
DR   cancercelllines; CVCL_SJ86
DR   Horizon_Discovery; HZGHC000082c024
DR   Wikidata; Q54873521
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000082c024; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSNK1G2 (-) 1
AC   CVCL_SJ87
SY   HZGHC000045c010; CSNK1G2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SJ87
DR   Horizon_Discovery; HZGHC000045c010
DR   Wikidata; Q54873522
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2455; CSNK1G2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSNK1G2 (-) 2
AC   CVCL_SJ88
SY   HZGHC000045c015; CSNK1G2 knockout cell line 77bp insertion
DR   cancercelllines; CVCL_SJ88
DR   Horizon_Discovery; HZGHC000045c015
DR   Wikidata; Q54873523
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2455; CSNK1G2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000045c015; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSNK1G3 (-) 1
AC   CVCL_SJ89
SY   HZGHC000138c008; CSNK1G3 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_SJ89
DR   Horizon_Discovery; HZGHC000138c008
DR   Wikidata; Q54873524
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2456; CSNK1G3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSNK1G3 (-) 2
AC   CVCL_SJ90
SY   HZGHC000138c018; CSNK1G3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SJ90
DR   Horizon_Discovery; HZGHC000138c018
DR   Wikidata; Q54873526
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2456; CSNK1G3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSNK2A1 (-) 1
AC   CVCL_SJ91
SY   HZGHC004051c002; CSNK2A1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SJ91
DR   Horizon_Discovery; HZGHC004051c002
DR   PRIDE; PXD010335
DR   Wikidata; Q54873527
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2457; CSNK2A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CSNK2A1 (-) 2
AC   CVCL_SJ92
SY   HZGHC004051c003; CSNK2A1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ92
DR   Horizon_Discovery; HZGHC004051c003
DR   Wikidata; Q54873528
RX   PubMed=39403680;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2457; CSNK2A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   HAP1 CSNK2A2 (-) 1
AC   CVCL_SJ93
SY   HZGHC000083c002; CSNK2A2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SJ93
DR   Horizon_Discovery; HZGHC000083c002
DR   Wikidata; Q54873529
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2459; CSNK2A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSNK2A2 (-) 2
AC   CVCL_SJ94
SY   HZGHC000083c017; CSNK2A2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SJ94
DR   Horizon_Discovery; HZGHC000083c017
DR   Wikidata; Q54873530
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2459; CSNK2A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSRNP2 (-) 1
AC   CVCL_SJ95
SY   HZGHC003093c002; CSRNP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SJ95
DR   Horizon_Discovery; HZGHC003093c002
DR   Wikidata; Q54873531
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16006; CSRNP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSRNP2 (-) 2
AC   CVCL_SJ96
SY   HZGHC003093c011; CSRNP2 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SJ96
DR   Horizon_Discovery; HZGHC003093c011
DR   Wikidata; Q54873532
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16006; CSRNP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CSRP3 (-)
AC   CVCL_E1UM
SY   HZGHC007952c003
DR   Horizon_Discovery; HZGHC007952c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2472; CSRP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CST3 (-)
AC   CVCL_SJ97
SY   HZGHC005376c002; CST3 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SJ97
DR   Horizon_Discovery; HZGHC005376c002
DR   Wikidata; Q54873533
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2475; CST3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CT83 (-) 1
AC   CVCL_E1UN
SY   HZGHC007316c015
DR   Horizon_Discovery; HZGHC007316c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33494; CT83.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CT83 (-) 2
AC   CVCL_E1UP
SY   HZGHC007316c018
DR   Horizon_Discovery; HZGHC007316c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33494; CT83.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CT83 (-) 3
AC   CVCL_E1UQ
SY   HZGHC007316c019
DR   Horizon_Discovery; HZGHC007316c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33494; CT83.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CTAGE5 (-) 1
AC   CVCL_C6Y3
SY   HZGHC007862c005; CTAGE5 knockout cell line 1bp deletion in exon 23; HAP1 CTAGE5 (-)
DR   Horizon_Discovery; HZGHC007862c005
DR   Wikidata; Q117704464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18432; MIA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 CTAGE5 (-) 2
AC   CVCL_E1UR
SY   HZGHC007861c007; CTAGE5 knockout cell line 22bp deletion in exon 20
DR   Horizon_Discovery; HZGHC007861c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7057; CTAGE5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CTDNEP1 (-) 1
AC   CVCL_SJ98
SY   HZGHC003094c006; CTDNEP1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SJ98
DR   Horizon_Discovery; HZGHC003094c006
DR   Wikidata; Q54873534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19085; CTDNEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTDNEP1 (-) 2
AC   CVCL_SJ99
SY   HZGHC003094c012; CTDNEP1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SJ99
DR   Horizon_Discovery; HZGHC003094c012
DR   Wikidata; Q54873535
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19085; CTDNEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTDSP1 (-) 1
AC   CVCL_SK00
SY   HZGHC003095c005; CTDSP1 knockout cell line 325bp insertion
DR   cancercelllines; CVCL_SK00
DR   Horizon_Discovery; HZGHC003095c005
DR   Wikidata; Q54873536
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21614; CTDSP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003095c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTDSP1 (-) 2
AC   CVCL_SK01
SY   HZGHC003095c009; CTDSP1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SK01
DR   Horizon_Discovery; HZGHC003095c009
DR   Wikidata; Q54873537
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21614; CTDSP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTDSP2 (-) 1
AC   CVCL_SK02
SY   HZGHC003096c001; CTDSP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK02
DR   Horizon_Discovery; HZGHC003096c001
DR   Wikidata; Q54873538
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17077; CTDSP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTDSP2 (-) 2
AC   CVCL_SK03
SY   HZGHC003096c002; CTDSP2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SK03
DR   Horizon_Discovery; HZGHC003096c002
DR   Wikidata; Q54873540
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17077; CTDSP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTDSPL (-) 1
AC   CVCL_SK04
SY   HZGHC003097c012; CTDSPL knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK04
DR   Horizon_Discovery; HZGHC003097c012
DR   Wikidata; Q54873541
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16890; CTDSPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003097c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTDSPL (-) 2
AC   CVCL_SK05
SY   HZGHC003097c001; CTDSPL knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK05
DR   Horizon_Discovery; HZGHC003097c001
DR   Wikidata; Q54873542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16890; CTDSPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTDSPL (-) 3
AC   CVCL_SK06
SY   HZGHC003097c006; CTDSPL knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SK06
DR   Horizon_Discovery; HZGHC003097c006
DR   Wikidata; Q54873546
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16890; CTDSPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTH (-) 1
AC   CVCL_SK07
SY   HZGHC006130c010; CTH knockout cell line 1bp insertion; HAP1 CTH (-)
DR   cancercelllines; CVCL_SK07
DR   Horizon_Discovery; HZGHC006130c010
DR   Wikidata; Q54873547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2501; CTH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTH (-) 2
AC   CVCL_XM99
SY   HZGHC006130c002; CTH knockout cell line 214bp insertion
DR   cancercelllines; CVCL_XM99
DR   Horizon_Discovery; HZGHC006130c002
DR   Wikidata; Q93943988
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2501; CTH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006130c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTIF (-) 1
AC   CVCL_SK08
SY   HZGHC003451c003; CTIF knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK08
DR   Horizon_Discovery; HZGHC003451c003
DR   Wikidata; Q54873548
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23925; CTIF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTIF (-) 2
AC   CVCL_SK09
SY   HZGHC003451c006; CTIF knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SK09
DR   Horizon_Discovery; HZGHC003451c006
DR   Wikidata; Q54873549
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23925; CTIF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTNNA1 (-) 1
AC   CVCL_SK10
SY   HZGHC005974c001; CTNNA1 knockout cell line 23bp deletion; HAP1 CTNNA1 (-)
DR   cancercelllines; CVCL_SK10
DR   Horizon_Discovery; HZGHC005974c001
DR   Wikidata; Q54873550
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2509; CTNNA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTNNA1 (-) 2
AC   CVCL_XN00
SY   HZGHC005974c003; CTNNA1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XN00
DR   Horizon_Discovery; HZGHC005974c003
DR   Wikidata; Q93944018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2509; CTNNA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTNNB1 (-) 1
AC   CVCL_SK11
SY   HZGHC001032c004; CTNNB1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK11
DR   Horizon_Discovery; HZGHC001032c004
DR   Wikidata; Q54873551
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTNNB1 (-) 2
AC   CVCL_SK12
SY   HZGHC001032c012; CTNNB1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SK12
DR   Horizon_Discovery; HZGHC001032c012
DR   Wikidata; Q54873553
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTNNB1 (-) 3
AC   CVCL_SK13
SY   HZGHC001062c006; CTNNB1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SK13
DR   Horizon_Discovery; HZGHC001062c006
DR   Wikidata; Q54873554
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTNNB1 (-) 4
AC   CVCL_SK14
SY   HZGHC001062c011; CTNNB1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SK14
DR   Horizon_Discovery; HZGHC001062c011
DR   Wikidata; Q54873555
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTNS (-) 1
AC   CVCL_SK15
SY   HZGHC006455c005; CTNS knockout cell line 2bp deletion; HAP1 CTNS (-)
DR   cancercelllines; CVCL_SK15
DR   Horizon_Discovery; HZGHC006455c005
DR   Wikidata; Q54873556
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2518; CTNS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTNS (-) 2
AC   CVCL_XN01
SY   HZGHC006455c008; CTNS knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XN01
DR   Horizon_Discovery; HZGHC006455c008
DR   Wikidata; Q93944057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2518; CTNS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTSB (-) 1
AC   CVCL_SK16
SY   HZGHC006132c001; CTSB knockout cell line 1bp deletion; HAP1 CTSB (-)
DR   cancercelllines; CVCL_SK16
DR   Horizon_Discovery; HZGHC006132c001
DR   Wikidata; Q54873557
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTSB (-) 2
AC   CVCL_XN02
SY   HZGHC006132c010; CTSB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN02
DR   Horizon_Discovery; HZGHC006132c010
DR   Wikidata; Q93944067
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTSB (-) 3
AC   CVCL_XN03
SY   HZGHC006132c011; CTSB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN03
DR   Horizon_Discovery; HZGHC006132c011
DR   Wikidata; Q93944069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006132c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CTSD (-)
AC   CVCL_E1US
SY   HZGHC007625c009
DR   Horizon_Discovery; HZGHC007625c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2529; CTSD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CTTN (-) 1
AC   CVCL_SK17
SY   HZGHC002627c002; CTTN knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK17
DR   Horizon_Discovery; HZGHC002627c002
DR   Wikidata; Q54873558
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3338; CTTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTTN (-) 2
AC   CVCL_SK18
SY   HZGHC002627c009; CTTN knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SK18
DR   Horizon_Discovery; HZGHC002627c009
DR   Wikidata; Q54873559
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3338; CTTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTTN (-) 3
AC   CVCL_SK19
SY   HZGHC002628c003; CTTN knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SK19
DR   Horizon_Discovery; HZGHC002628c003
DR   Wikidata; Q54873560
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3338; CTTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CTTN (-) 4
AC   CVCL_SK20
SY   HZGHC002628c011; CTTN knockout cell line 260bp insertion
DR   cancercelllines; CVCL_SK20
DR   Horizon_Discovery; HZGHC002628c011
DR   Wikidata; Q54873561
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3338; CTTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002628c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CUL4B (-) 1
AC   CVCL_E1UT
SY   HZGHC007739c006
DR   Horizon_Discovery; HZGHC007739c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2555; CUL4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CUL4B (-) 2
AC   CVCL_E1UU
SY   HZGHC007739c010
DR   Horizon_Discovery; HZGHC007739c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2555; CUL4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CUL7 (-) 1
AC   CVCL_E1UV
SY   HZGHC007683c005
DR   Horizon_Discovery; HZGHC007683c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21024; CUL7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CUL7 (-) 2
AC   CVCL_E1UW
SY   HZGHC007683c011
DR   Horizon_Discovery; HZGHC007683c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21024; CUL7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CXADR (-) 1
AC   CVCL_SK21
SY   HZGHC005362c001; CXADR knockout cell line 5bp deletion; HAP1 CXADR (-)
DR   cancercelllines; CVCL_SK21
DR   Horizon_Discovery; HZGHC005362c001
DR   Wikidata; Q54873562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2559; CXADR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CXADR (-) 2
AC   CVCL_XN04
SY   HZGHC005362c008; CXADR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN04
DR   Horizon_Discovery; HZGHC005362c008
DR   Wikidata; Q93944109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2559; CXADR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CXXC1 (-) 1
AC   CVCL_SK22
SY   HZGHC001160c006; CXXC1 knockout cell line 29bp deletion in exon 3
DR   cancercelllines; CVCL_SK22
DR   Horizon_Discovery; HZGHC001160c006
DR   Wikidata; Q54873564
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24343; CXXC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CXXC1 (-) 2
AC   CVCL_SK23
SY   HZGHC001160c008; CXXC1 knockout cell line 7bp deletion in exon 3
DR   cancercelllines; CVCL_SK23
DR   Horizon_Discovery; HZGHC001160c008
DR   Wikidata; Q54873565
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24343; CXXC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CYB5R4 (-)
AC   CVCL_E1UX
SY   HZGHC007867c009
DR   Horizon_Discovery; HZGHC007867c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20147; CYB5R4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYC1 (-) 1
AC   CVCL_XN05
SY   HZGHC006836c002; HZGHC1537; CYC1 knockout cell line 19bp deletion in exon 2; HAP1 CYC1 (-)
DR   cancercelllines; CVCL_XN05
DR   Horizon_Discovery; HZGHC006836c002
DR   Wikidata; Q93944125
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2579; CYC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CYC1 (-) 2
AC   CVCL_E1UY
SY   HZGHC006836c020; CYC1 knockout cell line 1bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006836c020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2579; CYC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYC1 (-) 3
AC   CVCL_E1UZ
SY   HZGHC006836c021; CYC1 knockout cell line 31bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006836c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2579; CYC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYLD (-) 1
AC   CVCL_SK24
SY   HZGHC000471c004; CYLD knockout cell line 172bp insertion
DR   cancercelllines; CVCL_SK24
DR   Horizon_Discovery; HZGHC000471c004
DR   Wikidata; Q54873566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000471c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 CYLD (-) 2
AC   CVCL_SK25
SY   HZGHC000471c010; CYLD knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK25
DR   Horizon_Discovery; HZGHC000471c010
DR   Wikidata; Q54873567
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CYP19A1 (-) 1
AC   CVCL_XN06
SY   HZGHC006921c005; HZGHC1588; CYP19A1 knockout cell line 13bp deletion in exon 4; HAP1 CYP19A1
DR   cancercelllines; CVCL_XN06
DR   Horizon_Discovery; HZGHC006921c005
DR   Wikidata; Q93944144
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CYP19A1 (-) 2
AC   CVCL_E1V0
SY   HZGHC006921c001
DR   Horizon_Discovery; HZGHC006921c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYP19A1 (-) 3
AC   CVCL_E1V1
SY   HZGHC006921c006
DR   Horizon_Discovery; HZGHC006921c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYP19A1 (-) 4
AC   CVCL_E1V2
SY   HZGHC006921c007
DR   Horizon_Discovery; HZGHC006921c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYP19A1 (-) 5
AC   CVCL_E1V3
SY   HZGHC006921c009
DR   Horizon_Discovery; HZGHC006921c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYP19A1 (-) 6
AC   CVCL_E1V4
SY   HZGHC006921c010
DR   Horizon_Discovery; HZGHC006921c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYP19A1 (-) 7
AC   CVCL_E1V5
SY   HZGHC006973c007
DR   Horizon_Discovery; HZGHC006973c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYP19A1 (-) 8
AC   CVCL_E1V6
SY   HZGHC006973c009
DR   Horizon_Discovery; HZGHC006973c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2594; CYP19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 CYP51A1 (-) 1
AC   CVCL_SK26
SY   HZGHC003762c002; CYP51A1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SK26
DR   Horizon_Discovery; HZGHC003762c002
DR   Wikidata; Q54873568
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2649; CYP51A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CYP51A1 (-) 2
AC   CVCL_SK27
SY   HZGHC003762c012; CYP51A1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SK27
DR   Horizon_Discovery; HZGHC003762c012
DR   Wikidata; Q54873569
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2649; CYP51A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 CYR61 (-) 1
AC   CVCL_SK28
SY   HZGHC006180c011; CYR61 knockout cell line 1bp insertion; HAP1 CYR61 (-)
DR   cancercelllines; CVCL_SK28
DR   Horizon_Discovery; HZGHC006180c011
DR   Wikidata; Q54873570
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2654; CCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CYR61 (-) 2
AC   CVCL_XN07
SY   HZGHC006180c002; CYR61 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN07
DR   Horizon_Discovery; HZGHC006180c002
DR   Wikidata; Q93944162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2654; CCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006180c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 CYR61 (-) 3
AC   CVCL_XN08
SY   HZGHC006180c006; CYR61 knockout cell line 238bp insertion
DR   cancercelllines; CVCL_XN08
DR   Horizon_Discovery; HZGHC006180c006
DR   Wikidata; Q93944164
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2654; CCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006180c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DAG1 (-) 1
AC   CVCL_SK29
SY   HZGHC000120c013; DAG1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SK29
DR   Horizon_Discovery; HZGHC000120c013
DR   Wikidata; Q54873571
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2666; DAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DAG1 (-) 2
AC   CVCL_SK30
SY   HZGHC000120c016; DAG1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SK30
DR   Horizon_Discovery; HZGHC000120c016
DR   Wikidata; Q54873573
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2666; DAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DALRD3 (-) 1
AC   CVCL_XN09
SY   HZGHC006904c008; HZGHC55152; DALRD3 knockout cell line 5bp deletion in exon 4; HAP1 DALRD3 (-)
DR   cancercelllines; CVCL_XN09
DR   Horizon_Discovery; HZGHC006904c008
DR   Wikidata; Q93944182
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25536; DALRD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DALRD3 (-) 2
AC   CVCL_E1V7
SY   HZGHC006904c005
DR   Horizon_Discovery; HZGHC006904c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25536; DALRD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DALRD3 (-) 3
AC   CVCL_E1V8
SY   HZGHC006904c009
DR   Horizon_Discovery; HZGHC006904c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25536; DALRD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DAPK1 (-) 1
AC   CVCL_SK31
SY   HZGHC000626c006; DAPK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK31
DR   Horizon_Discovery; HZGHC000626c006
DR   Wikidata; Q54873574
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2674; DAPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DAPK1 (-) 2
AC   CVCL_SK32
SY   HZGHC000626c010; DAPK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK32
DR   Horizon_Discovery; HZGHC000626c010
DR   Wikidata; Q54873575
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2674; DAPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DAPK2 (-)
AC   CVCL_SK33
SY   HZGHC000005c018; DAPK2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK33
DR   Horizon_Discovery; HZGHC000005c018
DR   Wikidata; Q54873576
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2675; DAPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000005c018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DAPK3 (-) 1
AC   CVCL_SK34
SY   HZGHC000084c001; DAPK3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK34
DR   Horizon_Discovery; HZGHC000084c001
DR   Wikidata; Q54873577
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2676; DAPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DAPK3 (-) 2
AC   CVCL_SK35
SY   HZGHC000084c019; DAPK3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK35
DR   Horizon_Discovery; HZGHC000084c019
DR   Wikidata; Q54873578
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2676; DAPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DAXX (-) 1
AC   CVCL_SK36
SY   HZGHC004429c005; DAXX knockout cell line 218bp insertion
DR   cancercelllines; CVCL_SK36
DR   Horizon_Discovery; HZGHC004429c005
DR   Wikidata; Q54873579
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004429c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DAXX (-) 2
AC   CVCL_SK37
SY   HZGHC004446c010; DAXX knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK37
DR   Horizon_Discovery; HZGHC004446c010
DR   Wikidata; Q54873580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DBF4 (-)
AC   CVCL_SK38
SY   HZGHC003520c008; DBF4 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SK38
DR   Horizon_Discovery; HZGHC003520c008
DR   Wikidata; Q54873581
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17364; DBF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DBF4B (-) 1
AC   CVCL_SK39
SY   HZGHC003523c005; DBF4B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK39
DR   Horizon_Discovery; HZGHC003523c005
DR   Wikidata; Q54873582
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17883; DBF4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003523c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DBF4B (-) 2
AC   CVCL_SK40
SY   HZGHC003523c002; DBF4B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK40
DR   Horizon_Discovery; HZGHC003523c002
DR   Wikidata; Q54873583
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17883; DBF4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DBN1 (-) 1
AC   CVCL_SK41
SY   HZGHC006134c001; DBN1 knockout cell line 17bp deletion; HAP1 DBN1 (-)
DR   cancercelllines; CVCL_SK41
DR   Horizon_Discovery; HZGHC006134c001
DR   Wikidata; Q54873584
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2695; DBN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DBN1 (-) 2
AC   CVCL_XN10
SY   HZGHC006134c010; DBN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN10
DR   Horizon_Discovery; HZGHC006134c010
DR   Wikidata; Q93944263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2695; DBN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DBT (-) 1
AC   CVCL_SK42
SY   HZGHC005074c002; DBT knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SK42
DR   Horizon_Discovery; HZGHC005074c002
DR   Wikidata; Q54873585
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2698; DBT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DBT (-) 2
AC   CVCL_SK43
SY   HZGHC005074c007; DBT knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SK43
DR   Horizon_Discovery; HZGHC005074c007
DR   Wikidata; Q54873586
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2698; DBT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCAF11 (-)
AC   CVCL_E1V9
SY   HZGHC008218c007
DR   Horizon_Discovery; HZGHC008218c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20258; DCAF11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DCAF16 (-) 1
AC   CVCL_E1VA
SY   HZGHC007866c005
DR   Horizon_Discovery; HZGHC007866c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25987; DCAF16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DCAF16 (-) 2
AC   CVCL_E1VB
SY   HZGHC007866c009
DR   Horizon_Discovery; HZGHC007866c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25987; DCAF16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DCAKD (-) 1
AC   CVCL_SK44
SY   HZGHC005753c011; DCAKD knockout cell line 2bp insertion; HAP1 DCAKD (-)
DR   cancercelllines; CVCL_SK44
DR   Horizon_Discovery; HZGHC005753c011
DR   Wikidata; Q54873588
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26238; DCAKD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DCAKD (-) 2
AC   CVCL_XN11
SY   HZGHC005753c007; DCAKD knockout cell line 91bp deletion
DR   cancercelllines; CVCL_XN11
DR   Horizon_Discovery; HZGHC005753c007
DR   Wikidata; Q93944288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26238; DCAKD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCAKD (-) 3
AC   CVCL_XN12
SY   HZGHC005754c005; DCAKD knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XN12
DR   Horizon_Discovery; HZGHC005754c005
DR   Wikidata; Q93944290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26238; DCAKD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCAKD (-) 4
AC   CVCL_XN13
SY   HZGHC005754c006; DCAKD knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XN13
DR   Horizon_Discovery; HZGHC005754c006
DR   Wikidata; Q93944293
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26238; DCAKD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCAKD (-) 5
AC   CVCL_XN14
SY   HZGHC005754c008; DCAKD knockout cell line 74bp insertion
DR   cancercelllines; CVCL_XN14
DR   Horizon_Discovery; HZGHC005754c008
DR   Wikidata; Q93944297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26238; DCAKD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005754c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 dCas9-VPR
AC   CVCL_DX73
DR   Horizon_Discovery; HD+dCas9-VPR-011
DR   Wikidata; Q127381037
CC   Group: Haploid karyotype cell line.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-dCas9-VPR-WPRE, where VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA (Horizon_Discovery=HD+dCas9-VPR-011).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 6
//
ID   HAP1 DCK (-) 1
AC   CVCL_SK45
SY   HZGHC002417c011; DCK knockout cell line 7bp deletion in exon 2; HAP1 DCK (-)
DR   cancercelllines; CVCL_SK45
DR   Horizon_Discovery; HZGHC002417c011
DR   Wikidata; Q54873589
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2704; DCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DCK (-) 2
AC   CVCL_XN15
SY   HZGHC002417c001; HZGHC1633; DCK knockout cell line
DR   cancercelllines; CVCL_XN15
DR   Horizon_Discovery; HZGHC002417c001
DR   Wikidata; Q93944307
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2704; DCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002417c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 14
//
ID   HAP1 DCLK1 (-) 1
AC   CVCL_SK46
SY   HZGHC000226c005; DCLK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK46
DR   Horizon_Discovery; HZGHC000226c005
DR   Wikidata; Q54873594
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2700; DCLK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000226c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DCLK1 (-) 2
AC   CVCL_SK47
SY   HZGHC000226c012; DCLK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK47
DR   Horizon_Discovery; HZGHC000226c012
DR   Wikidata; Q54873595
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2700; DCLK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCLK2 (-)
AC   CVCL_XN16
SY   HZGHC000352c005; HZGHC166614; DCLK2 knockout cell line
DR   cancercelllines; CVCL_XN16
DR   Horizon_Discovery; HZGHC000352c005
DR   Wikidata; Q93944325
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19002; DCLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000352c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 14
//
ID   HAP1 DCLRE1A (-) 1
AC   CVCL_E1VC
SY   HZGHC008114c003
DR   Horizon_Discovery; HZGHC008114c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17660; DCLRE1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DCLRE1A (-) 2
AC   CVCL_E1VD
SY   HZGHC008115c009
DR   Horizon_Discovery; HZGHC008115c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17660; DCLRE1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DCLRE1A (-) 3
AC   CVCL_E1VE
SY   HZGHC008115c010
DR   Horizon_Discovery; HZGHC008115c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17660; DCLRE1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DCLRE1C (-) 1
AC   CVCL_SK48
SY   HZGHC000429c002; DCLRE1C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK48
DR   Horizon_Discovery; HZGHC000429c002
DR   Wikidata; Q54873596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17642; DCLRE1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCLRE1C (-) 2
AC   CVCL_SK49
SY   HZGHC000429c006; DCLRE1C knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SK49
DR   Horizon_Discovery; HZGHC000429c006
DR   Wikidata; Q54873597
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17642; DCLRE1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCLRE1C (-) 3
AC   CVCL_SK50
SY   HZGHC000429c012; DCLRE1C knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK50
DR   Horizon_Discovery; HZGHC000429c012
DR   Wikidata; Q54873598
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17642; DCLRE1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DCTD (-)
AC   CVCL_XN17
SY   HZGHC007066c004; HZGHC1635; DCTD knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_XN17
DR   Horizon_Discovery; HZGHC007066c004
DR   Wikidata; Q93944347
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2710; DCTD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DCTPP1 (-) 1
AC   CVCL_SK51
SY   HZGHC003248c001; DCTPP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK51
DR   Horizon_Discovery; HZGHC003248c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54873599
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28777; DCTPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DCTPP1 (-) 2
AC   CVCL_SK52
SY   HZGHC003248c012; DCTPP1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SK52
DR   Horizon_Discovery; HZGHC003248c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54873600
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28777; DCTPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DDHD2 (-) 1
AC   CVCL_XN18
SY   HZGHC007083c009; HZGHC23259; DDHD2 knockout cell line 1bp insertion in exon 3; HAP1 DDHD2 (-)
DR   cancercelllines; CVCL_XN18
DR   Horizon_Discovery; HZGHC007083c009
DR   Wikidata; Q93944363
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29106; DDHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DDHD2 (-) 2
AC   CVCL_E1VF
SY   HZGHC007083c003; DDHD2 knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007083c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29106; DDHD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DDI2 (-) 1
AC   CVCL_SK53
SY   HZGHC000182c006; DDI2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK53
DR   Horizon_Discovery; HZGHC000182c006
DR   Wikidata; Q54873601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24578; DDI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDI2 (-) 2
AC   CVCL_SK54
SY   HZGHC000182c023; DDI2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK54
DR   Horizon_Discovery; HZGHC000182c023
DR   Wikidata; Q54873602
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24578; DDI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDI2 (-) 3
AC   CVCL_SK55
SY   HZGHC000396c007; DDI2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK55
DR   Horizon_Discovery; HZGHC000396c007
DR   Wikidata; Q54873603
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24578; DDI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000396c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DDI2 (-) 4
AC   CVCL_SK56
SY   HZGHC000396c010; DDI2 knockout cell line 41bp deletion
DR   cancercelllines; CVCL_SK56
DR   Horizon_Discovery; HZGHC000396c010
DR   Wikidata; Q54873604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24578; DDI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDIT4 (-) 1
AC   CVCL_SK57
SY   HZGHC001351c001; DDIT4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SK57
DR   Horizon_Discovery; HZGHC001351c001
DR   Wikidata; Q54873606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24944; DDIT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDIT4 (-) 2
AC   CVCL_SK58
SY   HZGHC001351c005; DDIT4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK58
DR   Horizon_Discovery; HZGHC001351c005
DR   Wikidata; Q54873607
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24944; DDIT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDIT4L (-)
AC   CVCL_SK59
SY   HZGHC001352c010; DDIT4L knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SK59
DR   Horizon_Discovery; HZGHC001352c010
DR   Wikidata; Q54873608
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30555; DDIT4L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDR1 (-)
AC   CVCL_SK60
SY   HZGHC001244c013; HZGHC780; DDR1 knockout cell line
DR   cancercelllines; CVCL_SK60
DR   Horizon_Discovery; HZGHC001244c013
DR   Wikidata; Q54873609
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2730; DDR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001244c013; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DDR2 (-) 1
AC   CVCL_SK61
SY   HZGHC004053c010; DDR2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SK61
DR   Horizon_Discovery; HZGHC004053c010
DR   Wikidata; Q54873610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDR2 (-) 2
AC   CVCL_SK62
SY   HZGHC004053c011; DDR2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SK62
DR   Horizon_Discovery; HZGHC004053c011
DR   Wikidata; Q54873611
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX1 (-) 1
AC   CVCL_SK63
SY   HZGHC005237c005; DDX1 knockout cell line 548bp insertion; HAP1 DDX1 (-)
DR   cancercelllines; CVCL_SK63
DR   Horizon_Discovery; HZGHC005237c005
DR   Wikidata; Q54873612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2734; DDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005237c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DDX1 (-) 2
AC   CVCL_XN19
SY   HZGHC005524c005; DDX1 knockout cell line 7bp insertion
DR   cancercelllines; CVCL_XN19
DR   Horizon_Discovery; HZGHC005524c005
DR   Wikidata; Q93944405
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2734; DDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX17 (-) 1
AC   CVCL_XN20
SY   HZGHC007221c009; HZGHC10521; DDX17 knockout cell line 7bp deletion in exon 3; HAP1 DDX17 (-)
DR   cancercelllines; CVCL_XN20
DR   Horizon_Discovery; HZGHC007221c009
DR   Wikidata; Q93944407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2740; DDX17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DDX17 (-) 2
AC   CVCL_E1VG
SY   HZGHC007221c012; DDX17 knockout cell line 17bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007221c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2740; DDX17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DDX31 (-) 1
AC   CVCL_SK64
SY   HZGHC003098c004; DDX31 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SK64
DR   Horizon_Discovery; HZGHC003098c004
DR   Wikidata; Q54873613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16715; DDX31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX31 (-) 2
AC   CVCL_SK65
SY   HZGHC003098c006; DDX31 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SK65
DR   Horizon_Discovery; HZGHC003098c006
DR   Wikidata; Q54873614
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16715; DDX31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX3X (-)
AC   CVCL_SK66
SY   HZGHC005445c005; DDX3X knockout cell line 119bp insertion
DR   cancercelllines; CVCL_SK66
DR   Horizon_Discovery; HZGHC005445c005
DR   Wikidata; Q54873615
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2745; DDX3X.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005445c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DDX41 (-) 1
AC   CVCL_SK67
SY   HZGHC003902c001; DDX41 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK67
DR   Horizon_Discovery; HZGHC003902c001
DR   Wikidata; Q54873616
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18674; DDX41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX41 (-) 2
AC   CVCL_SK68
SY   HZGHC003902c005; DDX41 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SK68
DR   Horizon_Discovery; HZGHC003902c005
DR   Wikidata; Q54873617
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18674; DDX41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX5 (-) 1
AC   CVCL_SK69
SY   HZGHC006136c010; DDX5 knockout cell line 5bp deletion; HAP1 DDX5 (-)
DR   cancercelllines; CVCL_SK69
DR   Horizon_Discovery; HZGHC006136c010
DR   Wikidata; Q54873618
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2746; DDX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DDX5 (-) 2
AC   CVCL_XN21
SY   HZGHC006136c012; DDX5 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XN21
DR   Horizon_Discovery; HZGHC006136c012
DR   Wikidata; Q93944436
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2746; DDX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX58 (-) 1
AC   CVCL_SK70
SY   HZGHC001441c001; DDX58 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SK70
DR   Horizon_Discovery; HZGHC001441c001
DR   Wikidata; Q54873619
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DDX58 (-) 2
AC   CVCL_SK71
SY   HZGHC001441c004; DDX58 knockout cell line 160bp insertion
DR   cancercelllines; CVCL_SK71
DR   Horizon_Discovery; HZGHC001441c004
DR   Wikidata; Q54873620
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001441c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DDX6 (-) 1
AC   CVCL_SK72
SY   HZGHC000116c001; DDX6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK72
DR   Horizon_Discovery; HZGHC000116c001
DR   Wikidata; Q54873621
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2747; DDX6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DDX6 (-) 2
AC   CVCL_SK73
SY   HZGHC000116c005; DDX6 knockout cell line 169bp insertion
DR   cancercelllines; CVCL_SK73
DR   Horizon_Discovery; HZGHC000116c005
DR   Wikidata; Q54873622
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2747; DDX6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000116c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DEGS1 (-)
AC   CVCL_E1VH
SY   HZGHC006771c008
DR   Horizon_Discovery; HZGHC006771c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13709; DEGS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DEPDC5 (-) 1
AC   CVCL_SK74
SY   HZGHC001288c005; DEPDC5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK74
DR   Horizon_Discovery; HZGHC001288c005
DR   Wikidata; Q54873624
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18423; DEPDC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DEPDC5 (-) 2
AC   CVCL_SK75
SY   HZGHC001288c012; DEPDC5 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SK75
DR   Horizon_Discovery; HZGHC001288c012
DR   Wikidata; Q54873625
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18423; DEPDC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DFNA5 (-) 1
AC   CVCL_E1VI
SY   HZGHC007619c002
DR   Horizon_Discovery; HZGHC007619c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2810; GSDME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DFNA5 (-) 2
AC   CVCL_E1VJ
SY   HZGHC007619c011
DR   Horizon_Discovery; HZGHC007619c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2810; GSDME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DGAT1 (-) 1
AC   CVCL_E1VK
SY   HZGHC008231c013
DR   Horizon_Discovery; HZGHC008231c013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2843; DGAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DGAT1 (-) 2
AC   CVCL_E1VL
SY   HZGHC008231c017
DR   Horizon_Discovery; HZGHC008231c017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2843; DGAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DGUOK (-) 1
AC   CVCL_XN22
SY   HZGHC006865c005; HZGHC1716; DGUOK knockout cell line 4bp deletion in exon 2; HAP1 DGUOK (-)
DR   cancercelllines; CVCL_XN22
DR   Horizon_Discovery; HZGHC006865c005
DR   Wikidata; Q93944452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DGUOK (-) 2
AC   CVCL_B5JU
SY   HZGHC006865c010; DGUOK knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_B5JU
DR   Horizon_Discovery; HZGHC006865c010
DR   Wikidata; Q111733277
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 DGUOK (-) 3
AC   CVCL_B5JV
SY   HZGHC006865c011; DGUOK knockout cell line 46bp insertion in exon 2
DR   cancercelllines; CVCL_B5JV
DR   Horizon_Discovery; HZGHC006865c011
DR   Wikidata; Q111733278
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006865c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 DHCR7 (-) 1
AC   CVCL_SK76
SY   HZGHC006471c003; DHCR7 knockout cell line 1bp insertion; HAP1 DHCR7 (-)
DR   cancercelllines; CVCL_SK76
DR   Horizon_Discovery; HZGHC006471c003
DR   PRIDE; PXD010335
DR   Wikidata; Q54873626
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2860; DHCR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DHCR7 (-) 2
AC   CVCL_XN23
SY   HZGHC006471c006; DHCR7 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_XN23
DR   Horizon_Discovery; HZGHC006471c006
DR   Wikidata; Q93944457
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2860; DHCR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DHODH (-)
AC   CVCL_XN24
SY   HZGHC1723; DHODH knockout cell line
DR   cancercelllines; CVCL_XN24
DR   Horizon_Discovery; HZGHC1723
DR   Wikidata; Q93944459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2867; DHODH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC1723; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DHRS1 (-) 1
AC   CVCL_SK77
SY   HZGHC005755c001; DHRS1 knockout cell line 7bp deletion; HAP1 DHRS1 (-)
DR   cancercelllines; CVCL_SK77
DR   Horizon_Discovery; HZGHC005755c001
DR   Wikidata; Q54873627
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16445; DHRS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DHRS1 (-) 2
AC   CVCL_XN25
SY   HZGHC005755c002; DHRS1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XN25
DR   Horizon_Discovery; HZGHC005755c002
DR   Wikidata; Q93944464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16445; DHRS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DHRS1 (-) 3
AC   CVCL_XN26
SY   HZGHC005756c004; DHRS1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XN26
DR   Horizon_Discovery; HZGHC005756c004
DR   Wikidata; Q93944465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16445; DHRS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DHRS1 (-) 4
AC   CVCL_XN27
SY   HZGHC005756c006; DHRS1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XN27
DR   Horizon_Discovery; HZGHC005756c006
DR   Wikidata; Q93944468
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16445; DHRS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DHRS4 (-) 1
AC   CVCL_SK78
SY   HZGHC004960c001; DHRS4 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SK78
DR   Horizon_Discovery; HZGHC004960c001
DR   Wikidata; Q54873628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16985; DHRS4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DHRS4 (-) 2
AC   CVCL_SK79
SY   HZGHC004960c012; DHRS4 knockout cell line 349bp insertion
DR   cancercelllines; CVCL_SK79
DR   Horizon_Discovery; HZGHC004960c012
DR   Wikidata; Q54873629
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16985; DHRS4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004960c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DHRSX (-) 1
AC   CVCL_E1VM
SY   HZGHC007899c003
DR   Horizon_Discovery; HZGHC007899c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18399; DHRSX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DHRSX (-) 2
AC   CVCL_E1VN
SY   HZGHC007899c011
DR   Horizon_Discovery; HZGHC007899c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18399; DHRSX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DHTKD1 (-) 1
AC   CVCL_XN28
SY   HZGHC006849c003; HZGHC55526; DHTKD1 knockout cell line 11bp deletion in exon 4; HAP1 DHTKD1 (-)
DR   cancercelllines; CVCL_XN28
DR   Horizon_Discovery; HZGHC006849c003
DR   Wikidata; Q93944485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DHTKD1 (-) 2
AC   CVCL_B5JW
SY   HZGHC006849c005; DHTKD1 knockout cell line 11bp deletion in exon 4
DR   cancercelllines; CVCL_B5JW
DR   Horizon_Discovery; HZGHC006849c005
DR   Wikidata; Q111733279
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006849c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 DHTKD1 (-) 3
AC   CVCL_B5JX
SY   HZGHC006849c008; DHTKD1 knockout cell line 106bp insertion in exon 4
DR   cancercelllines; CVCL_B5JX
DR   Horizon_Discovery; HZGHC006849c008
DR   Wikidata; Q111733280
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006849c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 DHTKD1 (-) 4
AC   CVCL_B5JY
SY   HZGHC006849c011; DHTKD1 knockout cell line 229bp insertion in exon 4
DR   cancercelllines; CVCL_B5JY
DR   Horizon_Discovery; HZGHC006849c011
DR   Wikidata; Q111733281
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006849c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 DHTKD1 (-) 5
AC   CVCL_B5JZ
SY   HZGHC006849c012; DHTKD1 knockout cell line 43bp deletion in exon 4
DR   cancercelllines; CVCL_B5JZ
DR   Horizon_Discovery; HZGHC006849c012
DR   Wikidata; Q111733282
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 DHTKD1 (-) 6
AC   CVCL_B5K0
SY   HZGHC006880c007; DHTKD1 knockout cell line 8bp deletion in exon 5
DR   cancercelllines; CVCL_B5K0
DR   Horizon_Discovery; HZGHC006880c007
DR   Wikidata; Q111733283
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 DHX30 (-)
AC   CVCL_B5J6
SY   HZGHC007945c004; DHX30 knockout cell line 26bp deletion in exon 7
DR   cancercelllines; CVCL_B5J6
DR   Horizon_Discovery; HZGHC007945c004
DR   Wikidata; Q111733284
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16716; DHX30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 DHX40 (-)
AC   CVCL_XN29
SY   HZGHC007110c008; HZGHC79665; DHX40 knockout cell line 5bp deletion in exon 2
DR   cancercelllines; CVCL_XN29
DR   Horizon_Discovery; HZGHC007110c008
DR   Wikidata; Q93944489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18018; DHX40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DHX58 (-) 1
AC   CVCL_SK80
SY   HZGHC002927c011; DHX58 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK80
DR   Horizon_Discovery; HZGHC002927c011
DR   Wikidata; Q54873630
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29517; DHX58.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DHX58 (-) 2
AC   CVCL_SK81
SY   HZGHC002927c012; DHX58 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SK81
DR   Horizon_Discovery; HZGHC002927c012
DR   Wikidata; Q54873631
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29517; DHX58.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DIAPH1 (-) 1
AC   CVCL_SK82
SY   HZGHC004911c001; DIAPH1 knockout cell line 82bp deletion
DR   cancercelllines; CVCL_SK82
DR   Horizon_Discovery; HZGHC004911c001
DR   Wikidata; Q54873632
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2876; DIAPH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DIAPH1 (-) 2
AC   CVCL_SK83
SY   HZGHC004911c003; DIAPH1 knockout cell line 64bp deletion
DR   cancercelllines; CVCL_SK83
DR   Horizon_Discovery; HZGHC004911c003
DR   Wikidata; Q54873633
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2876; DIAPH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DIAPH3 (-) 1
AC   CVCL_E1VP
SY   HZGHC007675c008
DR   Horizon_Discovery; HZGHC007675c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15480; DIAPH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DIAPH3 (-) 2
AC   CVCL_E1VQ
SY   HZGHC007675c009
DR   Horizon_Discovery; HZGHC007675c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15480; DIAPH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DIAPH3 (-) 3
AC   CVCL_E1VR
SY   HZGHC007676c007
DR   Horizon_Discovery; HZGHC007676c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15480; DIAPH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DIAPH3 (-) 4
AC   CVCL_E1VS
SY   HZGHC007676c010
DR   Horizon_Discovery; HZGHC007676c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15480; DIAPH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DICER1 (-) 1
AC   CVCL_SK84
SY   HZGHC000909c002; DICER1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK84
DR   Horizon_Discovery; HZGHC000909c002
DR   Wikidata; Q54873634
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17098; DICER1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DICER1 (-) 2
AC   CVCL_SK85
SY   HZGHC000909c006; DICER1 knockout cell line 47bp insertion
DR   cancercelllines; CVCL_SK85
DR   Horizon_Discovery; HZGHC000909c006
DR   Wikidata; Q54873635
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17098; DICER1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000909c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DICER1 (-) 3
AC   CVCL_SK86
SY   HZGHC000909c012; DICER1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK86
DR   Horizon_Discovery; HZGHC000909c012
DR   Wikidata; Q54873639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17098; DICER1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DIRC2 (-) 1
AC   CVCL_SK87
SY   HZGHC002849c011; DIRC2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK87
DR   Horizon_Discovery; HZGHC002849c011
DR   Wikidata; Q54873640
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16628; SLC49A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DIRC2 (-) 2
AC   CVCL_SK88
SY   HZGHC002849c012; DIRC2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK88
DR   Horizon_Discovery; HZGHC002849c012
DR   Wikidata; Q54873641
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16628; SLC49A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DIS3L (-) 1
AC   CVCL_SK89
SY   HZGHC001554c001; DIS3L knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SK89
DR   Horizon_Discovery; HZGHC001554c001
DR   Wikidata; Q54873642
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28698; DIS3L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001554c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DIS3L (-) 2
AC   CVCL_SK90
SY   HZGHC001554c008; DIS3L knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SK90
DR   Horizon_Discovery; HZGHC001554c008
DR   Wikidata; Q54873643
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28698; DIS3L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001554c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DLAT (-) 1
AC   CVCL_SK91
SY   HZGHC005212c003; DLAT knockout cell line 14bp deletion; HAP1 DLAT (-)
DR   cancercelllines; CVCL_SK91
DR   Horizon_Discovery; HZGHC005212c003
DR   Wikidata; Q54873644
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2896; DLAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DLAT (-) 2
AC   CVCL_XN30
SY   HZGHC005212c011; DLAT knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XN30
DR   Horizon_Discovery; HZGHC005212c011
DR   Wikidata; Q93944576
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2896; DLAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DLG2 (-)
AC   CVCL_SK92
SY   HZGHC003099c005; DLG2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SK92
DR   Horizon_Discovery; HZGHC003099c005
DR   Wikidata; Q54873645
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2901; DLG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DMD (-) 1
AC   CVCL_SK93
SY   HZGHC001379c001; DMD knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SK93
DR   Horizon_Discovery; HZGHC001379c001
DR   Wikidata; Q54873646
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2928; DMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DMD (-) 2
AC   CVCL_SK94
SY   HZGHC001379c003; DMD knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SK94
DR   Horizon_Discovery; HZGHC001379c003
DR   Wikidata; Q54873647
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2928; DMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DMD (-) 3
AC   CVCL_SK95
SY   HZGHC001380c010; DMD knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SK95
DR   Horizon_Discovery; HZGHC001380c010
DR   Wikidata; Q54873648
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2928; DMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DMD (-) 4
AC   CVCL_SK96
SY   HZGHC001380c011; DMD knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SK96
DR   Horizon_Discovery; HZGHC001380c011
DR   Wikidata; Q54873649
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2928; DMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DMPK (-) 1
AC   CVCL_SK97
SY   HZGHC000194c007; DMPK knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SK97
DR   Horizon_Discovery; HZGHC000194c007
DR   Wikidata; Q54873650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2933; DMPK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DMPK (-) 2
AC   CVCL_SK98
SY   HZGHC002985c001; DMPK knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SK98
DR   Horizon_Discovery; HZGHC002985c001
DR   Wikidata; Q54873651
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2933; DMPK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DMPK (-) 3
AC   CVCL_SK99
SY   HZGHC002985c010; DMPK knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SK99
DR   Horizon_Discovery; HZGHC002985c010
DR   Wikidata; Q54873652
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2933; DMPK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DNAJA1 (-) 1
AC   CVCL_SL00
SY   HZGHC004473c007; DNAJA1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL00
DR   Horizon_Discovery; HZGHC004473c007
DR   Wikidata; Q54873653
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5229; DNAJA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DNAJA1 (-) 2
AC   CVCL_SL01
SY   HZGHC004473c011; DNAJA1 knockout cell line 145bp insertion
DR   cancercelllines; CVCL_SL01
DR   Horizon_Discovery; HZGHC004473c011
DR   Wikidata; Q54873654
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5229; DNAJA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004473c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DNMT1 (-) 1
AC   CVCL_SL02
SY   HZGHC001017c006; DNMT1 knockout cell line 20bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC001017c006
DR   PRIDE; PXD010335
DR   Wikidata; Q54873656
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2976; DNMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Horizon_Discovery; HZGHC001017c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 DNMT1 (-) 2
AC   CVCL_SL03
SY   HZGHC005083c012; DNMT1 knockout cell line 5bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC005083c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54873657
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2976; DNMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Horizon_Discovery; HZGHC005083c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 DNMT3A (-) 1
AC   CVCL_SL04
SY   HZGHC001018c001; DNMT3A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SL04
DR   Horizon_Discovery; HZGHC001018c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54873658
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2978; DNMT3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DNMT3A (-) 2
AC   CVCL_SL05
SY   HZGHC001018c006; DNMT3A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SL05
DR   Horizon_Discovery; HZGHC001018c006
DR   Wikidata; Q54873659
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2978; DNMT3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DNMT3B (-) 1
AC   CVCL_SL06
SY   HZGHC001168c001; DNMT3B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL06
DR   Horizon_Discovery; HZGHC001168c001
DR   Wikidata; Q54873660
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001168c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 DNMT3B (-) 2
AC   CVCL_SL07
SY   HZGHC001168c002; DNMT3B knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SL07
DR   Horizon_Discovery; HZGHC001168c002
DR   Wikidata; Q54873661
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DOT1L (-)
AC   CVCL_SL08
SY   HZGHC003324c005; DOT1L knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL08
DR   Horizon_Discovery; HZGHC003324c005
DR   Wikidata; Q54873662
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24948; DOT1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DPF1 (-) 1
AC   CVCL_SL09
SY   HZGHC002779c011; DPF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL09
DR   Horizon_Discovery; HZGHC002779c011
DR   Wikidata; Q54873663
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20225; DPF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPF1 (-) 2
AC   CVCL_SL10
SY   HZGHC002779c012; DPF1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SL10
DR   Horizon_Discovery; HZGHC002779c012
DR   Wikidata; Q54873664
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20225; DPF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPF2 (-)
AC   CVCL_SL11
SY   HZGHC002777c004; DPF2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL11
DR   Horizon_Discovery; HZGHC002777c004
DR   Wikidata; Q54873665
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9964; DPF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPF3 (-) 1
AC   CVCL_SL12
SY   HZGHC002776c001; DPF3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL12
DR   Horizon_Discovery; HZGHC002776c001
DR   Wikidata; Q54873666
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17427; DPF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPF3 (-) 2
AC   CVCL_SL13
SY   HZGHC002776c012; DPF3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SL13
DR   Horizon_Discovery; HZGHC002776c012
DR   Wikidata; Q54873667
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17427; DPF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPH2 (-)
AC   CVCL_E1VT
SY   HZGHC007314c006
DR   Horizon_Discovery; HZGHC007314c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3004; DPH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DPM1 (-) 1
AC   CVCL_SL14
SY   HZGHC002825c011; DPM1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SL14
DR   Horizon_Discovery; HZGHC002825c011
DR   Wikidata; Q54873668
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3005; DPM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPM1 (-) 2
AC   CVCL_SL15
SY   HZGHC002825c012; DPM1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SL15
DR   Horizon_Discovery; HZGHC002825c012
DR   Wikidata; Q54873669
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3005; DPM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPP4 (-) 1
AC   CVCL_SL16
SY   HZGHC003881c003; DPP4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SL16
DR   Horizon_Discovery; HZGHC003881c003
DR   Wikidata; Q54873670
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3009; DPP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DPP4 (-) 2
AC   CVCL_SL17
SY   HZGHC003881c011; DPP4 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SL17
DR   Horizon_Discovery; HZGHC003881c011
DR   Wikidata; Q54873671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3009; DPP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DSG2 (-) 1
AC   CVCL_SL18
SY   HZGHC006142c002; DSG2 knockout cell line 1bp insertion; HAP1 DSG2 (-)
DR   cancercelllines; CVCL_SL18
DR   Horizon_Discovery; HZGHC006142c002
DR   Wikidata; Q54873672
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DSG2 (-) 2
AC   CVCL_XN31
SY   HZGHC006142c004; DSG2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XN31
DR   Horizon_Discovery; HZGHC006142c004
DR   Wikidata; Q93944757
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DSTYK (-) 1
AC   CVCL_SL19
SY   HZGHC000139c005; DSTYK knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SL19
DR   Horizon_Discovery; HZGHC000139c005
DR   Wikidata; Q54873673
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29043; DSTYK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DSTYK (-) 2
AC   CVCL_SL20
SY   HZGHC000139c018; DSTYK knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SL20
DR   Horizon_Discovery; HZGHC000139c018
DR   Wikidata; Q54873674
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29043; DSTYK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DUSP2 (-) 1
AC   CVCL_E1VU
SY   HZGHC008223c001
DR   Horizon_Discovery; HZGHC008223c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3068; DUSP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DUSP2 (-) 2
AC   CVCL_E1VV
SY   HZGHC008224c001
DR   Horizon_Discovery; HZGHC008224c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3068; DUSP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 DXO (-) 1
AC   CVCL_SL21
SY   HZGHC001555c001; DXO knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SL21
DR   Horizon_Discovery; HZGHC001555c001
DR   Wikidata; Q54873675
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2992; DXO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001555c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 DXO (-) 2
AC   CVCL_SL22
SY   HZGHC001555c009; DXO knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SL22
DR   Horizon_Discovery; HZGHC001555c009
DR   Wikidata; Q54873676
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2992; DXO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DYRK1B (-)
AC   CVCL_SL23
SY   HZGHC000363c010; DYRK1B knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SL23
DR   Horizon_Discovery; HZGHC000363c010
DR   Wikidata; Q54873678
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3092; DYRK1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DYRK2 (-) 1
AC   CVCL_SL24
SY   HZGHC000140c005; DYRK2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL24
DR   Horizon_Discovery; HZGHC000140c005
DR   Wikidata; Q54873679
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3093; DYRK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DYRK2 (-) 2
AC   CVCL_SL25
SY   HZGHC000140c006; DYRK2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SL25
DR   Horizon_Discovery; HZGHC000140c006
DR   Wikidata; Q54873680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3093; DYRK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DYRK2 (-) 3
AC   CVCL_SL26
SY   HZGHC000140c009; DYRK2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SL26
DR   Horizon_Discovery; HZGHC000140c009
DR   Wikidata; Q54873684
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3093; DYRK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DYRK3 (-)
AC   CVCL_SL27
SY   HZGHC000185c006; DYRK3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SL27
DR   Horizon_Discovery; HZGHC000185c006
DR   Wikidata; Q54873686
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3094; DYRK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DYRK4 (-)
AC   CVCL_SL28
SY   HZGHC030332c006; DYRK4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SL28
DR   Horizon_Discovery; HZGHC030332c006
DR   Wikidata; Q54873687
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3095; DYRK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 DZIP3 (-)
AC   CVCL_SL29
SY   HZGHC003100c011; DZIP3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL29
DR   Horizon_Discovery; HZGHC003100c011
DR   Wikidata; Q54873688
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30938; DZIP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 E2F1 (-) 1
AC   CVCL_SL30
SY   HZGHC003071c001; E2F1 knockout cell line 163bp insertion
DR   cancercelllines; CVCL_SL30
DR   Horizon_Discovery; HZGHC003071c001
DR   Wikidata; Q54873689
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003071c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 E2F1 (-) 2
AC   CVCL_SL31
SY   HZGHC003071c007; E2F1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL31
DR   Horizon_Discovery; HZGHC003071c007
DR   Wikidata; Q54873690
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 E2F8 (-) 1
AC   CVCL_SL32
SY   HZGHC005819c010; E2F8 knockout cell line 2bp insertion; HAP1 E2F8 (-)
DR   cancercelllines; CVCL_SL32
DR   Horizon_Discovery; HZGHC005819c010
DR   Wikidata; Q54873691
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24727; E2F8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 E2F8 (-) 2
AC   CVCL_XN32
SY   HZGHC005819c011; E2F8 knockout cell line 7bp insertion
DR   cancercelllines; CVCL_XN32
DR   Horizon_Discovery; HZGHC005819c011
DR   Wikidata; Q93944866
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24727; E2F8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EAPP (-) 1
AC   CVCL_SL33
SY   HZGHC001377c004; EAPP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SL33
DR   Horizon_Discovery; HZGHC001377c004
DR   Wikidata; Q54873692
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19312; EAPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001377c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EAPP (-) 2
AC   CVCL_SL34
SY   HZGHC001377c009; EAPP knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL34
DR   Horizon_Discovery; HZGHC001377c009
DR   Wikidata; Q54873693
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19312; EAPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EAPP (-) 3
AC   CVCL_SL35
SY   HZGHC001378c003; EAPP knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SL35
DR   Horizon_Discovery; HZGHC001378c003
DR   Wikidata; Q54873694
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19312; EAPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EAPP (-) 4
AC   CVCL_SL36
SY   HZGHC001378c012; EAPP knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SL36
DR   Horizon_Discovery; HZGHC001378c012
DR   Wikidata; Q54873695
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19312; EAPP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ECE2 (-) 1
AC   CVCL_SL37
SY   HZGHC000530c008; ECE2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL37
DR   Horizon_Discovery; HZGHC000530c008
DR   Wikidata; Q54873696
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13275; ECE2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ECE2 (-) 2
AC   CVCL_SL38
SY   HZGHC000530c010; ECE2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SL38
DR   Horizon_Discovery; HZGHC000530c010
DR   Wikidata; Q54873697
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13275; ECE2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ECH1 (-) 1
AC   CVCL_SL39
SY   HZGHC006465c001; ECH1 knockout cell line 1bp insertion; HAP1 ECH1 (-)
DR   cancercelllines; CVCL_SL39
DR   Horizon_Discovery; HZGHC006465c001
DR   Wikidata; Q54873698
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3149; ECH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ECH1 (-) 2
AC   CVCL_XN33
SY   HZGHC006465c010; ECH1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN33
DR   Horizon_Discovery; HZGHC006465c010
DR   Wikidata; Q93944912
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3149; ECH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006465c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ECH1 (-) 3
AC   CVCL_XN34
SY   HZGHC006465c011; ECH1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN34
DR   Horizon_Discovery; HZGHC006465c011
DR   Wikidata; Q93944915
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3149; ECH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006465c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ECHS1 (-) 1
AC   CVCL_XN35
SY   HZGHC006852c012; HZGHC1892; ECHS1 knockout cell line 2bp deletion in exon 2; HAP1 ECHS1 (-)
DR   cancercelllines; CVCL_XN35
DR   Horizon_Discovery; HZGHC006852c012
DR   Wikidata; Q93944918
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ECHS1 (-) 2
AC   CVCL_B5K1
SY   HZGHC006853c001; ECHS1 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_B5K1
DR   Horizon_Discovery; HZGHC006853c001
DR   Wikidata; Q111733285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ECHS1 (-) 3
AC   CVCL_B5K2
SY   HZGHC006853c002; ECHS1 knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_B5K2
DR   Horizon_Discovery; HZGHC006853c002
DR   Wikidata; Q111733286
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ECHS1 (-) 4
AC   CVCL_B5K3
SY   HZGHC006853c006; ECHS1 knockout cell line 20bp deletion in exon 2
DR   cancercelllines; CVCL_B5K3
DR   Horizon_Discovery; HZGHC006853c006
DR   Wikidata; Q111733287
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ECHS1 (-) 5
AC   CVCL_B5K4
SY   HZGHC006853c009; ECHS1 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_B5K4
DR   Horizon_Discovery; HZGHC006853c009
DR   Wikidata; Q111733288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ECI2 (-) 1
AC   CVCL_SL40
SY   HZGHC006469c001; ECI2 knockout cell line 11bp deletion; HAP1 ECI2 (-)
DR   cancercelllines; CVCL_SL40
DR   Horizon_Discovery; HZGHC006469c001
DR   Wikidata; Q54873699
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14601; ECI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ECI2 (-) 2
AC   CVCL_XN36
SY   HZGHC006469c010; ECI2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XN36
DR   Horizon_Discovery; HZGHC006469c010
DR   Wikidata; Q93944930
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14601; ECI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EEA1 (-)
AC   CVCL_SL41
SY   HZGHC006337c010; EEA1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SL41
DR   Horizon_Discovery; HZGHC006337c010
DR   Wikidata; Q54873700
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3185; EEA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EED (-) 1
AC   CVCL_SL42
SY   HZGHC001200c001; EED knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SL42
DR   Horizon_Discovery; HZGHC001200c001
DR   Wikidata; Q54873702
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3188; EED.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EED (-) 2
AC   CVCL_SL43
SY   HZGHC001200c004; EED knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SL43
DR   Horizon_Discovery; HZGHC001200c004
DR   Wikidata; Q54873703
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3188; EED.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EEF1A2 (-) 1
AC   CVCL_SL44
SY   HZGHC002647c006; EEF1A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL44
DR   Horizon_Discovery; HZGHC002647c006
DR   Wikidata; Q54873704
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3192; EEF1A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EEF1A2 (-) 2
AC   CVCL_SL45
SY   HZGHC002648c006; EEF1A2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SL45
DR   Horizon_Discovery; HZGHC002648c006
DR   Wikidata; Q54873705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3192; EEF1A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EEF2K (-) 1
AC   CVCL_SL46
SY   HZGHC000085c014; EEF2K knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SL46
DR   Horizon_Discovery; HZGHC000085c014
DR   Wikidata; Q54873706
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24615; EEF2K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EEF2K (-) 2
AC   CVCL_SL47
SY   HZGHC000085c016; EEF2K knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SL47
DR   Horizon_Discovery; HZGHC000085c016
DR   Wikidata; Q54873707
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24615; EEF2K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EFR3A (-)
AC   CVCL_SL48
SY   HZGHC003674c012; EFR3A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SL48
DR   Horizon_Discovery; HZGHC003674c012
DR   Wikidata; Q54873708
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28970; EFR3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EGFL6 (-) 1
AC   CVCL_SL49
SY   HZGHC004526c008; EGFL6 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_SL49
DR   Horizon_Discovery; HZGHC004526c008
DR   Wikidata; Q54873709
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3235; EGFL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004526c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EGFL6 (-) 2
AC   CVCL_SL50
SY   HZGHC004526c009; EGFL6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SL50
DR   Horizon_Discovery; HZGHC004526c009
DR   Wikidata; Q54873710
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3235; EGFL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EGLN1 (-)
AC   CVCL_SL51
SY   HZGHC002490c004; EGLN1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SL51
DR   Horizon_Discovery; HZGHC002490c004
DR   Wikidata; Q54873711
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1232; EGLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EGLN2 (-) 1
AC   CVCL_XN37
SY   HZGHC007124c005; HZGHC112398; EGLN2 knockout cell line 5bp deletion in exon 2; HAP1 EGLN2 (-)
DR   cancercelllines; CVCL_XN37
DR   Horizon_Discovery; HZGHC007124c005
DR   Wikidata; Q93944989
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14660; EGLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 EGLN2 (-) 2
AC   CVCL_E1VW
SY   HZGHC007124c006
DR   Horizon_Discovery; HZGHC007124c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14660; EGLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EGR1 (-)
AC   CVCL_XN38
SY   HZGHC006803c005; EGR1 knockout cell line 20bp deletion in exon 2
DR   cancercelllines; CVCL_XN38
DR   Horizon_Discovery; HZGHC006803c005
DR   Wikidata; Q93944991
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3238; EGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EHMT1 (-) 1
AC   CVCL_SL52
SY   HZGHC001128c002; EHMT1 knockout cell line 155bp insertion
DR   cancercelllines; CVCL_SL52
DR   Horizon_Discovery; HZGHC001128c002
DR   Wikidata; Q54873712
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001128c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EHMT1 (-) 2
AC   CVCL_SL53
SY   HZGHC001128c005; EHMT1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SL53
DR   Horizon_Discovery; HZGHC001128c005
DR   Wikidata; Q54873713
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001128c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EHMT1 (-) 3
AC   CVCL_SL54
SY   HZGHC001128c009; EHMT1 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SL54
DR   Horizon_Discovery; HZGHC001128c009
DR   Wikidata; Q54873714
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EHMT1 (-) 4
AC   CVCL_SL55
SY   HZGHC001128c011; EHMT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SL55
DR   Horizon_Discovery; HZGHC001128c011
DR   Wikidata; Q54873716
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001128c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EHMT2 (-) 1
AC   CVCL_SL56
SY   HZGHC001106c003; EHMT2 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SL56
DR   Horizon_Discovery; HZGHC001106c003
DR   Wikidata; Q54873717
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EHMT2 (-) 2
AC   CVCL_SL57
SY   HZGHC001106c004; EHMT2 knockout cell line 188bp insertion
DR   cancercelllines; CVCL_SL57
DR   Horizon_Discovery; HZGHC001106c004
DR   Wikidata; Q54873718
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001106c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 EIF1 (-) 1
AC   CVCL_SL58
SY   HZGHC003234c008; EIF1 knockout cell line 265bp insertion
DR   cancercelllines; CVCL_SL58
DR   Horizon_Discovery; HZGHC003234c008
DR   Wikidata; Q54873719
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3249; EIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003234c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF1 (-) 2
AC   CVCL_SL59
SY   HZGHC003235c012; EIF1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SL59
DR   Horizon_Discovery; HZGHC003235c012
DR   Wikidata; Q54873720
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3249; EIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003235c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF1B (-) 1
AC   CVCL_SL60
SY   HZGHC003231c010; EIF1B knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SL60
DR   Horizon_Discovery; HZGHC003231c010
DR   Wikidata; Q54873721
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30792; EIF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF1B (-) 2
AC   CVCL_SL61
SY   HZGHC003231c012; EIF1B knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SL61
DR   Horizon_Discovery; HZGHC003231c012
DR   Wikidata; Q54873722
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30792; EIF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF2A (-)
AC   CVCL_SL62
SY   HZGHC002650c001; EIF2A knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SL62
DR   Horizon_Discovery; HZGHC002650c001
DR   Wikidata; Q54873723
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3254; EIF2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF2AK1 (-)
AC   CVCL_SL63
SY   HZGHC000141c006; EIF2AK1 knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_SL63
DR   Horizon_Discovery; HZGHC000141c006
DR   Wikidata; Q54873724
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24921; EIF2AK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF2AK1 (-) EIF2AK3 (-) 1
AC   CVCL_E1NQ
SY   HZGHC008248c030; Double knockout cell line EIF2AK1 1bp deletion in exon 2 and EIF2AK3 1bp insertion in exon 5
DR   Horizon_Discovery; HZGHC008248c030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24921; EIF2AK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SL63 ! HAP1 EIF2AK1 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF2AK1 (-) EIF2AK3 (-) 2
AC   CVCL_E1NR
SY   HZGHC008248c036; Double knockout cell line EIF2AK1 1bp deletion in exon 2 and EIF2AK3 29bp deletion in exon 5
DR   Horizon_Discovery; HZGHC008248c036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24921; EIF2AK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SL63 ! HAP1 EIF2AK1 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF2AK1 (-) EIF2AK4 (-) 1
AC   CVCL_E1NS
SY   HZGHC008247c001; Double knockout cell line EIF2AK1 1bp deletion in exon 2 and EIFA2K4 11bp deletion in exon 4
DR   Horizon_Discovery; HZGHC008247c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24921; EIF2AK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SL63 ! HAP1 EIF2AK1 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF2AK1 (-) EIF2AK4 (-) 2
AC   CVCL_E1NT
SY   HZGHC008247c010; Double knockout cell line EIF2AK1 1bp deletion in exon 2 and EIF2AK4 10bp deletion in exon 4
DR   Horizon_Discovery; HZGHC008247c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24921; EIF2AK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SL63 ! HAP1 EIF2AK1 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF2AK1 (-) EIF2AK4 (-) 3
AC   CVCL_E1NU
SY   HZGHC008247c012; Double knockout cell line EIF2AK1 1bp deletion in exon 2 and EIF2AK4 7bp deletion in exon 4
DR   Horizon_Discovery; HZGHC008247c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24921; EIF2AK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SL63 ! HAP1 EIF2AK1 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF2AK2 (-) 1
AC   CVCL_SL64
SY   HZGHC000338c010; EIF2AK2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SL64
DR   Horizon_Discovery; HZGHC000338c010
DR   Wikidata; Q54873725
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF2AK2 (-) 2
AC   CVCL_SL65
SY   HZGHC000338c020; EIF2AK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SL65
DR   Horizon_Discovery; HZGHC000338c020
DR   Wikidata; Q54873726
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF2AK3 (-) 1
AC   CVCL_SL66
SY   HZGHC002033c003; EIF2AK3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL66
DR   Horizon_Discovery; HZGHC002033c003
DR   Wikidata; Q54873730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF2AK3 (-) 2
AC   CVCL_SL67
SY   HZGHC003428c002; EIF2AK3 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SL67
DR   Horizon_Discovery; HZGHC003428c002
DR   Wikidata; Q54873731
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003428c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF2AK3 (-) 3
AC   CVCL_SL68
SY   HZGHC003428c005; EIF2AK3 knockout cell line 13bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC003428c005
DR   PRIDE; PXD010335
DR   Wikidata; Q54873732
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Horizon_Discovery; HZGHC003428c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 EIF2AK3 (-) EIF2AK4 (-) 1
AC   CVCL_E1NV
SY   HZGHC008246c010; Double knockout cell line EIF2AK3 44bp deletion in exon 5 and EIFA2K4 10bp deletion in exon 4
DR   Horizon_Discovery; HZGHC008246c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SL70 ! HAP1 EIF2AK4 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF2AK3 (-) EIF2AK4 (-) 2
AC   CVCL_E1NW
SY   HZGHC008246c011; Double knockout cell line EIF2AK3 8bp deletion in exon 5 and EIFA2K4 10bp deletion in exon 4
DR   Horizon_Discovery; HZGHC008246c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SL70 ! HAP1 EIF2AK4 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF2AK4 (-) 1
AC   CVCL_SL69
SY   HZGHC001245c030; EIF2AK4 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SL69
DR   Horizon_Discovery; HZGHC001245c030
DR   Wikidata; Q54873733
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF2AK4 (-) 2
AC   CVCL_SL70
SY   HZGHC002987c002; EIF2AK4 knockout cell line 10bp deletion in exon 4
DR   cancercelllines; CVCL_SL70
DR   Horizon_Discovery; HZGHC002987c002
DR   Wikidata; Q54873734
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF2AK4 (-) 3
AC   CVCL_SL71
SY   HZGHC002987c010; EIF2AK4 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SL71
DR   Horizon_Discovery; HZGHC002987c010
DR   Wikidata; Q54873735
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002987c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF2D (-) 1
AC   CVCL_SL72
SY   HZGHC002652c004; EIF2D knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL72
DR   Horizon_Discovery; HZGHC002652c004
DR   Wikidata; Q54873737
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6583; EIF2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002652c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF2D (-) 2
AC   CVCL_SL73
SY   HZGHC002651c012; EIF2D knockout cell line 206bp deletion
DR   cancercelllines; CVCL_SL73
DR   Horizon_Discovery; HZGHC002651c012
DR   Wikidata; Q54873738
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6583; EIF2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF2D (-) 3
AC   CVCL_SL74
SY   HZGHC002652c005; EIF2D knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SL74
DR   Horizon_Discovery; HZGHC002652c005
DR   Wikidata; Q54873739
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6583; EIF2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF2D (-) 4
AC   CVCL_SL75
SY   HZGHC002652c011; EIF2D knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL75
DR   Horizon_Discovery; HZGHC002652c011
DR   Wikidata; Q54873740
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6583; EIF2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF3L (-)
AC   CVCL_E1VX
SY   HZGHC007916c020
DR   Horizon_Discovery; HZGHC007916c020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18138; EIF3L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EIF4E2 (-) 1
AC   CVCL_SL76
SY   HZGHC003226c001; EIF4E2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL76
DR   Horizon_Discovery; HZGHC003226c001
DR   Wikidata; Q54873741
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3293; EIF4E2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF4E2 (-) 2
AC   CVCL_SL77
SY   HZGHC003226c005; EIF4E2 knockout cell line 248bp insertion
DR   cancercelllines; CVCL_SL77
DR   Horizon_Discovery; HZGHC003226c005
DR   Wikidata; Q54873742
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3293; EIF4E2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003226c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF4E2 (-) 3
AC   CVCL_SL78
SY   HZGHC003226c010; EIF4E2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SL78
DR   Horizon_Discovery; HZGHC003226c010
DR   Wikidata; Q54873743
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3293; EIF4E2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF4EBP1 (-)
AC   CVCL_SL79
SY   HZGHC001353c002; EIF4EBP1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SL79
DR   Horizon_Discovery; HZGHC001353c002
DR   Wikidata; Q54873744
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3288; EIF4EBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EIF4EBP2 (-) 1
AC   CVCL_SL80
SY   HZGHC002414c004; EIF4EBP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL80
DR   Horizon_Discovery; HZGHC002414c004
DR   Wikidata; Q54873745
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3289; EIF4EBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002414c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EIF4EBP2 (-) 2
AC   CVCL_SL81
SY   HZGHC002414c005; EIF4EBP2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SL81
DR   Horizon_Discovery; HZGHC002414c005
DR   Wikidata; Q54873746
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3289; EIF4EBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELAC1 (-)
AC   CVCL_SL82
SY   HZGHC006052c003; ELAC1 knockout cell line 127bp deletion
DR   cancercelllines; CVCL_SL82
DR   Horizon_Discovery; HZGHC006052c003
DR   Wikidata; Q54873747
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14197; ELAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELAVL1 (-) 1
AC   CVCL_SL83
SY   HZGHC005133c003; ELAVL1 knockout cell line 130bp deletion
DR   cancercelllines; CVCL_SL83
DR   Horizon_Discovery; HZGHC005133c003
DR   Wikidata; Q54873748
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3312; ELAVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELAVL1 (-) 2
AC   CVCL_SL84
SY   HZGHC005133c004; ELAVL1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SL84
DR   Horizon_Discovery; HZGHC005133c004
DR   Wikidata; Q54873749
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3312; ELAVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELAVL1 (-) 3
AC   CVCL_SL85
SY   HZGHC005134c001; ELAVL1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL85
DR   Horizon_Discovery; HZGHC005134c001
DR   Wikidata; Q54873750
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3312; ELAVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELAVL1 (-) 4
AC   CVCL_SL86
SY   HZGHC005134c006; ELAVL1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SL86
DR   Horizon_Discovery; HZGHC005134c006
DR   Wikidata; Q54873751
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3312; ELAVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELFN1 (-) 1
AC   CVCL_SL87
SY   HZGHC003101c003; ELFN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL87
DR   Horizon_Discovery; HZGHC003101c003
DR   Wikidata; Q54873752
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33154; ELFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003101c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ELFN1 (-) 2
AC   CVCL_SL88
SY   HZGHC003101c002; ELFN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL88
DR   Horizon_Discovery; HZGHC003101c002
DR   Wikidata; Q54873754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33154; ELFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELFN2 (-) 1
AC   CVCL_SL89
SY   HZGHC003102c010; ELFN2 knockout cell line 64bp deletion
DR   cancercelllines; CVCL_SL89
DR   Horizon_Discovery; HZGHC003102c010
DR   Wikidata; Q54873755
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29396; ELFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELFN2 (-) 2
AC   CVCL_SL90
SY   HZGHC003102c011; ELFN2 knockout cell line 46bp deletion
DR   cancercelllines; CVCL_SL90
DR   Horizon_Discovery; HZGHC003102c011
DR   Wikidata; Q54873756
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29396; ELFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELK1 (-) 1
AC   CVCL_SL91
SY   HZGHC006144c006; ELK1 knockout cell line 8bp deletion; HAP1 ELK1 (-)
DR   cancercelllines; CVCL_SL91
DR   Horizon_Discovery; HZGHC006144c006
DR   Wikidata; Q54873757
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ELK1 (-) 2
AC   CVCL_XN39
SY   HZGHC006144c008; ELK1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XN39
DR   Horizon_Discovery; HZGHC006144c008
DR   Wikidata; Q93945240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELOVL1 (-) 1
AC   CVCL_SL92
SY   HZGHC005685c011; ELOVL1 knockout cell line 2bp insertion; HAP1 ELOVL1 (-)
DR   cancercelllines; CVCL_SL92
DR   Horizon_Discovery; HZGHC005685c011
DR   Wikidata; Q54873758
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14418; ELOVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ELOVL1 (-) 2
AC   CVCL_XN40
SY   HZGHC005685c009; ELOVL1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XN40
DR   Horizon_Discovery; HZGHC005685c009
DR   Wikidata; Q93945254
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14418; ELOVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELOVL1 (-) 3
AC   CVCL_XN41
SY   HZGHC006382c003; ELOVL1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN41
DR   Horizon_Discovery; HZGHC006382c003
DR   Wikidata; Q93945257
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14418; ELOVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELOVL1 (-) 4
AC   CVCL_XN42
SY   HZGHC006382c009; ELOVL1 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_XN42
DR   Horizon_Discovery; HZGHC006382c009
DR   Wikidata; Q93945259
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14418; ELOVL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ELOVL4 (-) 1
AC   CVCL_E1VY
SY   HZGHC008221c006
DR   Horizon_Discovery; HZGHC008221c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14415; ELOVL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ELOVL4 (-) 2
AC   CVCL_E1VZ
SY   HZGHC008221c009
DR   Horizon_Discovery; HZGHC008221c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14415; ELOVL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EMC2 (-)
AC   CVCL_E1W0
SY   HZGHC007505c011
DR   Horizon_Discovery; HZGHC007505c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28963; EMC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EMC6 (-) 1
AC   CVCL_SL93
SY   HZGHC004449c005; EMC6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SL93
DR   Horizon_Discovery; HZGHC004449c005
DR   Wikidata; Q54873759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28430; EMC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EMC6 (-) 2
AC   CVCL_SL94
SY   HZGHC004449c007; EMC6 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SL94
DR   Horizon_Discovery; HZGHC004449c007
DR   Wikidata; Q54873760
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28430; EMC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EMD (-) 1
AC   CVCL_SL95
SY   HZGHC006146c006; EMD knockout cell line 118bp deletion; HAP1 EMD (-)
DR   cancercelllines; CVCL_SL95
DR   Horizon_Discovery; HZGHC006146c006
DR   Wikidata; Q54873761
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3331; EMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EMD (-) 2
AC   CVCL_XN43
SY   HZGHC006147c001; EMD knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN43
DR   Horizon_Discovery; HZGHC006147c001
DR   Wikidata; Q93945285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3331; EMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EMD (-) 3
AC   CVCL_XN44
SY   HZGHC006147c002; EMD knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XN44
DR   Horizon_Discovery; HZGHC006147c002
DR   Wikidata; Q93945288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3331; EMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EMD (-) 4
AC   CVCL_XN45
SY   HZGHC006147c012; EMD knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN45
DR   Horizon_Discovery; HZGHC006147c012
DR   Wikidata; Q93945291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3331; EMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006147c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EME1 (-) 1
AC   CVCL_SL96
SY   HZGHC000899c003; EME1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SL96
DR   Horizon_Discovery; HZGHC000899c003
DR   Wikidata; Q54873762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24965; EME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EME1 (-) 2
AC   CVCL_SL97
SY   HZGHC000899c004; EME1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SL97
DR   Horizon_Discovery; HZGHC000899c004
DR   Wikidata; Q54873763
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24965; EME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EME2 (-) 1
AC   CVCL_SL98
SY   HZGHC000897c003; EME2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SL98
DR   Horizon_Discovery; HZGHC000897c003
DR   Wikidata; Q54873764
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27289; EME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EME2 (-) 2
AC   CVCL_SL99
SY   HZGHC000897c011; EME2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SL99
DR   Horizon_Discovery; HZGHC000897c011
DR   Wikidata; Q54873765
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27289; EME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EME2 (-) 3
AC   CVCL_SM00
SY   HZGHC000897c012; EME2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SM00
DR   Horizon_Discovery; HZGHC000897c012
DR   Wikidata; Q54873766
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27289; EME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ENDOG (-) 1
AC   CVCL_SM01
SY   HZGHC002510c002; ENDOG knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SM01
DR   Horizon_Discovery; HZGHC002510c002
DR   Wikidata; Q54873767
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3346; ENDOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ENDOG (-) 2
AC   CVCL_SM02
SY   HZGHC002510c011; ENDOG knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SM02
DR   Horizon_Discovery; HZGHC002510c011
DR   Wikidata; Q54873768
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3346; ENDOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ENDOG (-) 3
AC   CVCL_SM03
SY   HZGHC002511c002; ENDOG knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM03
DR   Horizon_Discovery; HZGHC002511c002
DR   Wikidata; Q54873769
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3346; ENDOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ENDOG (-) 4
AC   CVCL_SM04
SY   HZGHC002511c003; ENDOG knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SM04
DR   Horizon_Discovery; HZGHC002511c003
DR   Wikidata; Q54873770
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3346; ENDOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ENDOV (-)
AC   CVCL_SM05
SY   HZGHC002792c002; ENDOV knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SM05
DR   Horizon_Discovery; HZGHC002792c002
DR   Wikidata; Q54873771
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26640; ENDOV.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ENPP1 (-)
AC   CVCL_E1W1
SY   HZGHC007639c012
DR   Horizon_Discovery; HZGHC007639c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3356; ENPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ENTHD2 (-) 1
AC   CVCL_SM06
SY   HZGHC000845c001; ENTHD2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM06
DR   Horizon_Discovery; HZGHC000845c001
DR   Wikidata; Q54873775
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26458; TEPSIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000845c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ENTHD2 (-) 2
AC   CVCL_SM07
SY   HZGHC000845c002; ENTHD2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM07
DR   Horizon_Discovery; HZGHC000845c002
DR   Wikidata; Q54873777
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26458; TEPSIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ENTHD2 (-) 3
AC   CVCL_SM08
SY   HZGHC000845c003; ENTHD2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM08
DR   Horizon_Discovery; HZGHC000845c003
DR   Wikidata; Q54873778
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26458; TEPSIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000845c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ENTPD1 (-) 1
AC   CVCL_SM09
SY   HZGHC006317c001; ENTPD1 knockout cell line 1bp deletion; HAP1 ENTPD1 (-)
DR   cancercelllines; CVCL_SM09
DR   Horizon_Discovery; HZGHC006317c001
DR   Wikidata; Q54873779
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3363; ENTPD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ENTPD1 (-) 2
AC   CVCL_XN46
SY   HZGHC006317c011; ENTPD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN46
DR   Horizon_Discovery; HZGHC006317c011
DR   Wikidata; Q93945395
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3363; ENTPD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EOGT (-)
AC   CVCL_E1W2
SY   HZGHC007440c005; EOGT knockout cell line 1bp insertion in exon 8
DR   Horizon_Discovery; HZGHC007440c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28526; EOGT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EP300 (-) 1
AC   CVCL_SM10
SY   HZGHC001318c011; EP300 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SM10
DR   Horizon_Discovery; HZGHC001318c011
DR   Wikidata; Q54873780
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001318c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 EP300 (-) 2
AC   CVCL_SM11
SY   HZGHC001318c012; EP300 knockout cell line 17bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC001318c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54873781
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Horizon_Discovery; HZGHC001318c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 EP400 (-) 1
AC   CVCL_XN47
SY   HZGHC006940c003; HZGHC57634; EP400 knockout cell line 1bp insertion in exon 2; HAP1 EP400 (-)
DR   cancercelllines; CVCL_XN47
DR   Horizon_Discovery; HZGHC006940c003
DR   Wikidata; Q93945413
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11958; EP400.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006940c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 EP400 (-) 2
AC   CVCL_E1W3
SY   HZGHC006940c010; EP400 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC006940c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11958; EP400.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EPC1 (-) 1
AC   CVCL_E1W4
SY   HZGHC007818c001
DR   Horizon_Discovery; HZGHC007818c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19876; EPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EPC1 (-) 2
AC   CVCL_E1W5
SY   HZGHC007818c004
DR   Horizon_Discovery; HZGHC007818c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19876; EPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EPHA2 (-)
AC   CVCL_SM12
SY   HZGHC000222c011; EPHA2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SM12
DR   Horizon_Discovery; HZGHC000222c011
DR   Wikidata; Q54873782
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHA3 (-) 1
AC   CVCL_SM13
SY   HZGHC000295c011; EPHA3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SM13
DR   Horizon_Discovery; HZGHC000295c011
DR   Wikidata; Q54873783
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3387; EPHA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHA3 (-) 2
AC   CVCL_SM14
SY   HZGHC000295c019; EPHA3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SM14
DR   Horizon_Discovery; HZGHC000295c019
DR   Wikidata; Q54873784
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3387; EPHA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHA4 (-)
AC   CVCL_SM15
SY   HZGHC000223c007; EPHA4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM15
DR   Horizon_Discovery; HZGHC000223c007
DR   Wikidata; Q54873785
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3388; EPHA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EPHA6 (-) 1
AC   CVCL_SM16
SY   HZGHC000143c005; EPHA6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SM16
DR   Horizon_Discovery; HZGHC000143c005
DR   Wikidata; Q54873786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19296; EPHA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHA6 (-) 2
AC   CVCL_SM17
SY   HZGHC000143c024; EPHA6 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM17
DR   Horizon_Discovery; HZGHC000143c024
DR   Wikidata; Q54873787
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19296; EPHA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHB1 (-)
AC   CVCL_SM18
SY   HZGHC000699c028; EPHB1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SM18
DR   Horizon_Discovery; HZGHC000699c028
DR   Wikidata; Q54873788
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3392; EPHB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHB2 (-) 1
AC   CVCL_SM19
SY   HZGHC000251c032; EPHB2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SM19
DR   Horizon_Discovery; HZGHC000251c032
DR   Wikidata; Q54873789
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3393; EPHB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHB2 (-) 2
AC   CVCL_SM20
SY   HZGHC002962c001; EPHB2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM20
DR   Horizon_Discovery; HZGHC002962c001
DR   Wikidata; Q54873790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3393; EPHB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHB2 (-) 3
AC   CVCL_SM21
SY   HZGHC002962c003; EPHB2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SM21
DR   Horizon_Discovery; HZGHC002962c003
DR   Wikidata; Q54873791
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3393; EPHB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHB3 (-)
AC   CVCL_SM22
SY   HZGHC000707c029; EPHB3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SM22
DR   Horizon_Discovery; HZGHC000707c029
DR   Wikidata; Q54873792
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3394; EPHB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPHB4 (-)
AC   CVCL_SM23
SY   HZGHC001278c011; HZGHC2050; EPHB4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SM23
DR   Horizon_Discovery; HZGHC001278c011
DR   Wikidata; Q54873793
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001278c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 EPHB6 (-)
AC   CVCL_SM24
SY   HZGHC000046c010; EPHB6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM24
DR   Horizon_Discovery; HZGHC000046c010
DR   Wikidata; Q54873794
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3396; EPHB6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPOR (-) 1
AC   CVCL_SM25
SY   HZGHC003882c005; EPOR knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM25
DR   Horizon_Discovery; HZGHC003882c005
DR   Wikidata; Q54873795
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3416; EPOR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPOR (-) 2
AC   CVCL_SM26
SY   HZGHC003882c008; EPOR knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SM26
DR   Horizon_Discovery; HZGHC003882c008
DR   Wikidata; Q54873797
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3416; EPOR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPS15 (-) 1
AC   CVCL_SM27
SY   HZGHC005589c006; EPS15 knockout cell line 23bp deletion; HAP1 EPS15 (-)
DR   cancercelllines; CVCL_SM27
DR   Horizon_Discovery; HZGHC005589c006
DR   Wikidata; Q54873798
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3419; EPS15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EPS15 (-) 2
AC   CVCL_XN48
SY   HZGHC005589c008; EPS15 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XN48
DR   Horizon_Discovery; HZGHC005589c008
DR   Wikidata; Q93945512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3419; EPS15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EPSTI1 (-) 1
AC   CVCL_XN49
SY   HZGHC007086c004; HZGHC94240; EPSTI1 knockout cell line 10bp deletion in exon 1; HAP1 EPSTI1 (-)
DR   cancercelllines; CVCL_XN49
DR   Horizon_Discovery; HZGHC007086c004
DR   Wikidata; Q93945513
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16465; EPSTI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 EPSTI1 (-) 2
AC   CVCL_E1W6
SY   HZGHC007086c001
DR   Horizon_Discovery; HZGHC007086c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16465; EPSTI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EPSTI1 (-) 3
AC   CVCL_E1W7
SY   HZGHC007086c002
DR   Horizon_Discovery; HZGHC007086c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16465; EPSTI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EPT1 (-) 1
AC   CVCL_E1W8
SY   HZGHC007597c003; EPT1 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007597c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29361; SELENOI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EPT1 (-) 2
AC   CVCL_E1W9
SY   HZGHC007597c012; EPT1 knockout cell line 5bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007597c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29361; SELENOI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ERAP1 (-) 1
AC   CVCL_XN50
SY   HZGHC006887c012; HZGHC51752; ERAP1 knockout cell line 4bp deletion in exon 2; HAP1 ERAP1 (-)
DR   cancercelllines; CVCL_XN50
DR   Horizon_Discovery; HZGHC006887c012
DR   Wikidata; Q93945515
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ERAP1 (-) 2
AC   CVCL_E1WA
SY   HZGHC006887c008
DR   Horizon_Discovery; HZGHC006887c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ERAP1 (-) 3
AC   CVCL_E1WB
SY   HZGHC006887c009
DR   Horizon_Discovery; HZGHC006887c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ERBB2 (-) 1
AC   CVCL_SM28
SY   HZGHC000342c001; ERBB2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SM28
DR   Horizon_Discovery; HZGHC000342c001
DR   Wikidata; Q54873799
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERBB2 (-) 2
AC   CVCL_SM29
SY   HZGHC000342c002; ERBB2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SM29
DR   Horizon_Discovery; HZGHC000342c002
DR   Wikidata; Q54873802
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERBB2 (-) 3
AC   CVCL_SM30
SY   HZGHC000342c017; ERBB2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SM30
DR   Horizon_Discovery; HZGHC000342c017
DR   Wikidata; Q54873803
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERBB3 (-)
AC   CVCL_SM31
SY   HZGHC000211c030; ERBB3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM31
DR   Horizon_Discovery; HZGHC000211c030
DR   Wikidata; Q54873804
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERCC1 (-)
AC   CVCL_SM32
SY   HZGHC005378c005; ERCC1 knockout cell line 44bp deletion
DR   cancercelllines; CVCL_SM32
DR   Horizon_Discovery; HZGHC005378c005
DR   Wikidata; Q54873805
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3433; ERCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005378c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ERCC5 (-) 1
AC   CVCL_E1WC
SY   HZGHC007552c004
DR   Horizon_Discovery; HZGHC007552c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3437; ERCC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ERCC5 (-) 2
AC   CVCL_E1WD
SY   HZGHC007553c004
DR   Horizon_Discovery; HZGHC007553c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3437; ERCC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ERCC5 (-) 3
AC   CVCL_E1WE
SY   HZGHC007553c006
DR   Horizon_Discovery; HZGHC007553c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3437; ERCC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ERCC6 (-) 1
AC   CVCL_SM33
SY   HZGHC000422c003; ERCC6 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM33
DR   Horizon_Discovery; HZGHC000422c003
DR   Wikidata; Q54873806
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3438; ERCC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000422c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ERCC6 (-) 2
AC   CVCL_SM34
SY   HZGHC000422c005; ERCC6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SM34
DR   Horizon_Discovery; HZGHC000422c005
DR   Wikidata; Q54873807
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3438; ERCC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000422c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ERCC6 (-) 3
AC   CVCL_SM35
SY   HZGHC000422c011; ERCC6 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SM35
DR   Horizon_Discovery; HZGHC000422c011
DR   Wikidata; Q54873808
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3438; ERCC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERCC6L (-) 1
AC   CVCL_SM36
SY   HZGHC000750c002; ERCC6L knockout cell line 176bp insertion
DR   cancercelllines; CVCL_SM36
DR   Horizon_Discovery; HZGHC000750c002
DR   Wikidata; Q54873809
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20794; ERCC6L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000750c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ERCC6L (-) 2
AC   CVCL_SM37
SY   HZGHC000750c011; ERCC6L knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM37
DR   Horizon_Discovery; HZGHC000750c011
DR   Wikidata; Q54873810
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20794; ERCC6L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERCC6L (-) 3
AC   CVCL_SM38
SY   HZGHC000751c006; ERCC6L knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SM38
DR   Horizon_Discovery; HZGHC000751c006
DR   Wikidata; Q54873811
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20794; ERCC6L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERCC6L (-) 4
AC   CVCL_SM39
SY   HZGHC000751c011; ERCC6L knockout cell line 23bp insertion
DR   cancercelllines; CVCL_SM39
DR   Horizon_Discovery; HZGHC000751c011
DR   Wikidata; Q54873812
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20794; ERCC6L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000751c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ERCC6L2 (-) 1
AC   CVCL_SM40
SY   HZGHC006416c004; ERCC6L2 knockout cell line 8bp deletion; HAP1 ERCC6L2 (-)
DR   cancercelllines; CVCL_SM40
DR   Horizon_Discovery; HZGHC006416c004
DR   Wikidata; Q54873813
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26922; ERCC6L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ERCC6L2 (-) 2
AC   CVCL_XN51
SY   HZGHC006416c005; ERCC6L2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XN51
DR   Horizon_Discovery; HZGHC006416c005
DR   Wikidata; Q93945540
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26922; ERCC6L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERCC8 (-) 1
AC   CVCL_SM41
SY   HZGHC000421c013; ERCC8 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM41
DR   Horizon_Discovery; HZGHC000421c013
DR   Wikidata; Q54873814
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3439; ERCC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ERCC8 (-) 2
AC   CVCL_SM42
SY   HZGHC000421c024; ERCC8 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SM42
DR   Horizon_Discovery; HZGHC000421c024
DR   Wikidata; Q54873815
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3439; ERCC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000421c024; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ERN1 (-) 1
AC   CVCL_SM43
SY   HZGHC000742c006; ERN1 knockout cell line 8bp deletion in exon 6; HAP1 ERN1 (-)
DR   cancercelllines; CVCL_SM43
DR   Horizon_Discovery; HZGHC000742c006
DR   Wikidata; Q54873816
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ERN1 (-) 2
AC   CVCL_XN52
SY   HZGHC000742c018; ERN1 knockout cell line
DR   cancercelllines; CVCL_XN52
DR   Horizon_Discovery; HZGHC000742c018
DR   Wikidata; Q93945562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000742c018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 14
//
ID   HAP1 ESCO1 (-) 1
AC   CVCL_E1WF
SY   HZGHC008207c008
DR   Horizon_Discovery; HZGHC008207c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24645; ESCO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ESCO1 (-) 2
AC   CVCL_E1WG
SY   HZGHC008208c002
DR   Horizon_Discovery; HZGHC008208c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24645; ESCO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ESR1 (-) 1
AC   CVCL_XN53
SY   HZGHC007238c003; HZGHC2099; ESR1 knockout cell line 1bp deletion in exon 3; HAP1 ESR1 (-)
DR   cancercelllines; CVCL_XN53
DR   Horizon_Discovery; HZGHC007238c003
DR   Wikidata; Q93945565
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3467; ESR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ESR1 (-) 2
AC   CVCL_B5K5
SY   HZGHC007238c010; ESR1 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5K5
DR   Horizon_Discovery; HZGHC007238c010
DR   Wikidata; Q111733289
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3467; ESR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 ESR2 (-) 1
AC   CVCL_XN54
SY   HZGHC007241c003; HZGHC2100; ESR2 knockout cell line 2bp deletion in exon 2; HAP1 ESR2 (-)
DR   cancercelllines; CVCL_XN54
DR   Horizon_Discovery; HZGHC007241c003
DR   Wikidata; Q93945567
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3468; ESR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ESR2 (-) 2
AC   CVCL_E1WH
SY   HZGHC007240c003
DR   Horizon_Discovery; HZGHC007240c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3468; ESR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ESR2 (-) 3
AC   CVCL_E1WI
SY   HZGHC007241c004
DR   Horizon_Discovery; HZGHC007241c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3468; ESR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ESR2 (-) 4
AC   CVCL_E1WJ
SY   HZGHC007241c012
DR   Horizon_Discovery; HZGHC007241c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3468; ESR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ESRRA (-) 1
AC   CVCL_SM44
SY   HZGHC006148c004; ESRRA knockout cell line 32bp deletion; HAP1 ESRRA (-)
DR   cancercelllines; CVCL_SM44
DR   Horizon_Discovery; HZGHC006148c004
DR   Wikidata; Q54873817
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3471; ESRRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ESRRA (-) 2
AC   CVCL_XN55
SY   HZGHC006148c005; ESRRA knockout cell line 335bp insertion
DR   cancercelllines; CVCL_XN55
DR   Horizon_Discovery; HZGHC006148c005
DR   Wikidata; Q93945580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3471; ESRRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006148c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ESRRG (-)
AC   CVCL_SM45
SY   HZGHC003931c002; ESRRG knockout cell line 455bp insertion
DR   cancercelllines; CVCL_SM45
DR   Horizon_Discovery; HZGHC003931c002
DR   Wikidata; Q54873818
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3474; ESRRG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003931c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ESYT1 (-) 1
AC   CVCL_SM46
SY   HZGHC003669c001; ESYT1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SM46
DR   Horizon_Discovery; HZGHC003669c001
DR   Wikidata; Q54873821
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29534; ESYT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ESYT1 (-) 2
AC   CVCL_SM47
SY   HZGHC003669c011; ESYT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM47
DR   Horizon_Discovery; HZGHC003669c011
DR   Wikidata; Q54873822
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29534; ESYT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ESYT2 (-) 1
AC   CVCL_SM48
SY   HZGHC003672c007; ESYT2 knockout cell line 194bp insertion
DR   cancercelllines; CVCL_SM48
DR   Horizon_Discovery; HZGHC003672c007
DR   Wikidata; Q54873823
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22211; ESYT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003672c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ESYT2 (-) 2
AC   CVCL_SM49
SY   HZGHC003672c011; ESYT2 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SM49
DR   Horizon_Discovery; HZGHC003672c011
DR   Wikidata; Q54873824
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22211; ESYT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ETFB (-) 1
AC   CVCL_SM50
SY   HZGHC001787c010; ETFB knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM50
DR   Horizon_Discovery; HZGHC001787c010
DR   Wikidata; Q54873825
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3482; ETFB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ETFB (-) 2
AC   CVCL_SM51
SY   HZGHC001787c011; ETFB knockout cell line 110bp insertion
DR   cancercelllines; CVCL_SM51
DR   Horizon_Discovery; HZGHC001787c011
DR   Wikidata; Q54873826
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3482; ETFB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001787c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ETHE1 (-) 1
AC   CVCL_XN56
SY   HZGHC006855c001; HZGHC23474; ETHE1 knockout cell line 1bp insertion in exon 2; HAP1 ETHE1 (-)
DR   cancercelllines; CVCL_XN56
DR   Horizon_Discovery; HZGHC006855c001
DR   Wikidata; Q93945635
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23287; ETHE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ETHE1 (-) 2
AC   CVCL_E1WK
SY   HZGHC006854c009; ETHE1 knockout cell line 2bp deletion in exon 3
DR   Horizon_Discovery; HZGHC006854c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23287; ETHE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ETS1 (-) 1
AC   CVCL_E1WL
SY   HZGHC007540c001
DR   Horizon_Discovery; HZGHC007540c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ETS1 (-) 2
AC   CVCL_E1WM
SY   HZGHC007540c012
DR   Horizon_Discovery; HZGHC007540c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ETS1 (-) 3
AC   CVCL_E1WN
SY   HZGHC007541c007
DR   Horizon_Discovery; HZGHC007541c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ETS1 (-) 4
AC   CVCL_E1WP
SY   HZGHC007541c012
DR   Horizon_Discovery; HZGHC007541c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ETV6 (-) 1
AC   CVCL_SM52
SY   HZGHC003605c002; ETV6 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM52
DR   Horizon_Discovery; HZGHC003605c002
DR   Wikidata; Q54873827
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ETV6 (-) 2
AC   CVCL_SM53
SY   HZGHC003605c012; ETV6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SM53
DR   Horizon_Discovery; HZGHC003605c012
DR   Wikidata; Q54873828
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ETV6 (-) 3
AC   CVCL_SM54
SY   HZGHC005142c004; ETV6 knockout cell line 248bp insertion
DR   cancercelllines; CVCL_SM54
DR   Horizon_Discovery; HZGHC005142c004
DR   Wikidata; Q54873829
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005142c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ETV6 (-) 4
AC   CVCL_SM55
SY   HZGHC005142c008; ETV6 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SM55
DR   Horizon_Discovery; HZGHC005142c008
DR   Wikidata; Q54873830
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXD2 (-) 1
AC   CVCL_SM56
SY   HZGHC001557c003; EXD2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM56
DR   Horizon_Discovery; HZGHC001557c003
DR   Wikidata; Q54873831
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20217; EXD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXD2 (-) 2
AC   CVCL_SM57
SY   HZGHC001557c007; EXD2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SM57
DR   Horizon_Discovery; HZGHC001557c007
DR   Wikidata; Q54873832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20217; EXD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXO1 (-) 1
AC   CVCL_SM58
SY   HZGHC000752c011; EXO1 knockout cell line 1bp insertion; HAP1 EXO1 (-)
DR   cancercelllines; CVCL_SM58
DR   Horizon_Discovery; HZGHC000752c011
DR   Wikidata; Q54873833
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3511; EXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EXO1 (-) 2
AC   CVCL_XN57
SY   HZGHC000752c007; EXO1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XN57
DR   Horizon_Discovery; HZGHC000752c007
DR   Wikidata; Q93945691
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3511; EXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXO5 (-) 1
AC   CVCL_SM59
SY   HZGHC005698c003; EXO5 knockout cell line 7bp deletion; HAP1 EXO5 (-)
DR   cancercelllines; CVCL_SM59
DR   Horizon_Discovery; HZGHC005698c003
DR   Wikidata; Q54873834
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26115; EXO5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EXO5 (-) 2
AC   CVCL_XN58
SY   HZGHC005698c007; EXO5 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XN58
DR   Horizon_Discovery; HZGHC005698c007
DR   Wikidata; Q93945699
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26115; EXO5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXOG (-) 1
AC   CVCL_DX16
SY   HZGHC006889c002; EXOG knockout cell line 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC006889c002
DR   Wikidata; Q127381038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3347; EXOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 EXOG (-) 2
AC   CVCL_DX17
SY   HZGHC006889c003; EXOG knockout cell line 1bp deletion in exon 1
DR   Horizon_Discovery; HZGHC006889c003
DR   Wikidata; Q127381039
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3347; EXOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 EXOG (-) 3
AC   CVCL_XN59
SY   HZGHC006889c008; HZGHC9941; EXOG knockout cell line 14bp deletion in exon 1; HAP1 EXOG (-)
DR   cancercelllines; CVCL_XN59
DR   Horizon_Discovery; HZGHC006889c008
DR   Wikidata; Q93945701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3347; EXOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 EXOG (-) 4
AC   CVCL_DX18
SY   HZGHC006889c012; EXOG knockout cell line 23bp deletion in exon 1
DR   Horizon_Discovery; HZGHC006889c012
DR   Wikidata; Q127381040
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3347; EXOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 EXOG (-) 5
AC   CVCL_DX19
SY   HZGHC006890c001; EXOG knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC006890c001
DR   Wikidata; Q127381041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3347; EXOG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 EXOSC6 (-) 1
AC   CVCL_E1WQ
SY   HZGHC007490c001
DR   Horizon_Discovery; HZGHC007490c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19055; EXOSC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EXOSC6 (-) 2
AC   CVCL_E1WR
SY   HZGHC007490c002
DR   Horizon_Discovery; HZGHC007490c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19055; EXOSC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 EXT1 (-) 1
AC   CVCL_SM60
SY   HZGHC004069c001; EXT1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SM60
DR   Horizon_Discovery; HZGHC004069c001
DR   Wikidata; Q54873835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3512; EXT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXT1 (-) 2
AC   CVCL_SM61
SY   HZGHC004069c008; EXT1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SM61
DR   Horizon_Discovery; HZGHC004069c008
DR   Wikidata; Q54873837
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3512; EXT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXT2 (-) 1
AC   CVCL_SM62
SY   HZGHC004070c010; EXT2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SM62
DR   Horizon_Discovery; HZGHC004070c010
DR   Wikidata; Q54873838
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3513; EXT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EXT2 (-) 2
AC   CVCL_SM63
SY   HZGHC004070c011; EXT2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SM63
DR   Horizon_Discovery; HZGHC004070c011
DR   Wikidata; Q54873839
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3513; EXT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EZH1 (-) 1
AC   CVCL_SM64
SY   HZGHC001130c001; EZH1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SM64
DR   Horizon_Discovery; HZGHC001130c001
DR   Wikidata; Q54873841
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3526; EZH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EZH1 (-) 2
AC   CVCL_SM65
SY   HZGHC001130c002; EZH1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM65
DR   Horizon_Discovery; HZGHC001130c002
DR   Wikidata; Q54873842
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3526; EZH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EZH2 (-) 1
AC   CVCL_SM66
SY   HZGHC002494c001; EZH2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SM66
DR   Horizon_Discovery; HZGHC002494c001
DR   Wikidata; Q54873843
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EZH2 (-) 2
AC   CVCL_SM67
SY   HZGHC004488c006; EZH2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SM67
DR   Horizon_Discovery; HZGHC004488c006
DR   Wikidata; Q54873844
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 EZH2 (-) 3
AC   CVCL_SM68
SY   HZGHC004488c010; EZH2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SM68
DR   Horizon_Discovery; HZGHC004488c010
DR   Wikidata; Q54873845
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 EZR (-) 1
AC   CVCL_SM69
SY   HZGHC005976c010; EZR knockout cell line 307bp insertion; HAP1 EZR (-)
DR   cancercelllines; CVCL_SM69
DR   Horizon_Discovery; HZGHC005976c010
DR   Wikidata; Q54873846
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12691; EZR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005976c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 EZR (-) 2
AC   CVCL_XN60
SY   HZGHC005976c007; EZR knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XN60
DR   Horizon_Discovery; HZGHC005976c007
DR   Wikidata; Q93945783
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12691; EZR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 F11R (-) 1
AC   CVCL_SM70
SY   HZGHC006221c006; F11R knockout cell line 22bp deletion; HAP1 F11R (-)
DR   cancercelllines; CVCL_SM70
DR   Horizon_Discovery; HZGHC006221c006
DR   Wikidata; Q54873847
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14685; F11R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 F11R (-) 2
AC   CVCL_XN61
SY   HZGHC006221c008; F11R knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XN61
DR   Horizon_Discovery; HZGHC006221c008
DR   Wikidata; Q93945790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14685; F11R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 F2RL1 (-) 1
AC   CVCL_SM71
SY   HZGHC006152c002; F2RL1 knockout cell line 4bp deletion; HAP1 F2RL1 (-)
DR   cancercelllines; CVCL_SM71
DR   Horizon_Discovery; HZGHC006152c002
DR   Wikidata; Q54873848
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3538; F2RL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 F2RL1 (-) 2
AC   CVCL_XN62
SY   HZGHC006152c009; F2RL1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN62
DR   Horizon_Discovery; HZGHC006152c009
DR   Wikidata; Q93945801
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3538; F2RL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 F3 (-) 1
AC   CVCL_SM72
SY   HZGHC004781c001; F3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SM72
DR   Horizon_Discovery; HZGHC004781c001
DR   Wikidata; Q54873849
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3541; F3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 F3 (-) 2
AC   CVCL_SM73
SY   HZGHC004781c012; F3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SM73
DR   Horizon_Discovery; HZGHC004781c012
DR   Wikidata; Q54873850
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3541; F3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FADD (-) 1
AC   CVCL_SM74
SY   HZGHC002596c006; FADD knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SM74
DR   Horizon_Discovery; HZGHC002596c006
DR   Wikidata; Q54873851
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3573; FADD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FADD (-) 2
AC   CVCL_SM75
SY   HZGHC002596c007; FADD knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SM75
DR   Horizon_Discovery; HZGHC002596c007
DR   Wikidata; Q54873852
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3573; FADD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FADS1 (-) 1
AC   CVCL_SM76
SY   HZGHC003743c003; FADS1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM76
DR   Horizon_Discovery; HZGHC003743c003
DR   Wikidata; Q54873853
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3574; FADS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FADS1 (-) 2
AC   CVCL_SM77
SY   HZGHC003743c007; FADS1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SM77
DR   Horizon_Discovery; HZGHC003743c007
DR   Wikidata; Q54873854
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3574; FADS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM111A (-) 1
AC   CVCL_SM78
SY   HZGHC004409c008; FAM111A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SM78
DR   Horizon_Discovery; HZGHC004409c008
DR   Wikidata; Q54873855
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24725; FAM111A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM111A (-) 2
AC   CVCL_SM79
SY   HZGHC004409c010; FAM111A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM79
DR   Horizon_Discovery; HZGHC004409c010
DR   Wikidata; Q54873856
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24725; FAM111A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM111A (-) 3
AC   CVCL_SM80
SY   HZGHC004410c010; FAM111A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM80
DR   Horizon_Discovery; HZGHC004410c010
DR   Wikidata; Q54873858
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24725; FAM111A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM111A (-) 4
AC   CVCL_SM81
SY   HZGHC004410c011; FAM111A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM81
DR   Horizon_Discovery; HZGHC004410c011
DR   Wikidata; Q54873859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24725; FAM111A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004410c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM122A (-) 1
AC   CVCL_SM82
SY   HZGHC006551c012; FAM122A knockout cell line 133bp insertion; HAP1 FAM122A (-)
DR   cancercelllines; CVCL_SM82
DR   Horizon_Discovery; HZGHC006551c012
DR   Wikidata; Q54873860
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23490; PABIR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006551c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 FAM122A (-) 2
AC   CVCL_XN63
SY   HZGHC006551c008; FAM122A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XN63
DR   Horizon_Discovery; HZGHC006551c008
DR   Wikidata; Q93945894
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23490; PABIR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM134B (-) 1
AC   CVCL_SM83
SY   HZGHC005287c012; FAM134B knockout cell line 2bp deletion; HAP1 FAM134B (-)
DR   cancercelllines; CVCL_SM83
DR   Horizon_Discovery; HZGHC005287c012
DR   Wikidata; Q54873861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM134B (-) 2
AC   CVCL_XN64
SY   HZGHC005287c002; FAM134B knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XN64
DR   Horizon_Discovery; HZGHC005287c002
DR   Wikidata; Q93945904
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25964; RETREG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM136A (-) 1
AC   CVCL_SM84
SY   HZGHC005758c007; FAM136A knockout cell line 14bp deletion; HAP1 FAM136A (-)
DR   cancercelllines; CVCL_SM84
DR   Horizon_Discovery; HZGHC005758c007
DR   Wikidata; Q54873862
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25911; FAM136A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM136A (-) 2
AC   CVCL_XN65
SY   HZGHC005758c008; FAM136A knockout cell line 32bp deletion
DR   cancercelllines; CVCL_XN65
DR   Horizon_Discovery; HZGHC005758c008
DR   Wikidata; Q93945916
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25911; FAM136A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM168A (-)
AC   CVCL_XN66
SY   HZGHC006951c003; HZGHC23201; FAM168A knockout cell line 23bp deletion in exon 4
DR   cancercelllines; CVCL_XN66
DR   Horizon_Discovery; HZGHC006951c003
DR   Wikidata; Q93945918
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28999; FAM168A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM173A (-)
AC   CVCL_SM85
SY   HZGHC000532c005; FAM173A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM85
DR   Horizon_Discovery; HZGHC000532c005
DR   Wikidata; Q54873864
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14152; ANTKMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM173B (-) 1
AC   CVCL_SM86
SY   HZGHC000533c006; FAM173B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SM86
DR   Horizon_Discovery; HZGHC000533c006
DR   Wikidata; Q54873876
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27029; ATPSCKMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM173B (-) 2
AC   CVCL_SM87
SY   HZGHC000533c008; FAM173B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SM87
DR   Horizon_Discovery; HZGHC000533c008
DR   Wikidata; Q54873878
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27029; ATPSCKMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM173B (-) 3
AC   CVCL_SM88
SY   HZGHC000534c010; FAM173B knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SM88
DR   Horizon_Discovery; HZGHC000534c010
DR   Wikidata; Q54873879
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27029; ATPSCKMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM175A (-) 1
AC   CVCL_SM89
SY   HZGHC001193c003; FAM175A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM89
DR   Horizon_Discovery; HZGHC001193c003
DR   Wikidata; Q54873880
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25829; ABRAXAS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM175A (-) 2
AC   CVCL_SM90
SY   HZGHC001193c004; FAM175A knockout cell line 271bp insertion
DR   cancercelllines; CVCL_SM90
DR   Horizon_Discovery; HZGHC001193c004
DR   Wikidata; Q54873881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25829; ABRAXAS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001193c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM195A (-) 1
AC   CVCL_SM91
SY   HZGHC003050c001; FAM195A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SM91
DR   Horizon_Discovery; HZGHC003050c001
DR   Wikidata; Q54873882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14142; MCRIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM195A (-) 2
AC   CVCL_SM92
SY   HZGHC003050c007; FAM195A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SM92
DR   Horizon_Discovery; HZGHC003050c007
DR   Wikidata; Q54873883
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14142; MCRIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM195A (-) 3
AC   CVCL_SM93
SY   HZGHC003050c011; FAM195A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM93
DR   Horizon_Discovery; HZGHC003050c011
DR   Wikidata; Q54873884
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14142; MCRIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM195B (-) 1
AC   CVCL_SM94
SY   HZGHC003046c001; FAM195B knockout cell line 131bp insertion
DR   cancercelllines; CVCL_SM94
DR   Horizon_Discovery; HZGHC003046c001
DR   Wikidata; Q54873886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28007; MCRIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003046c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM195B (-) 2
AC   CVCL_SM95
SY   HZGHC003046c005; FAM195B knockout cell line 257bp insertion
DR   cancercelllines; CVCL_SM95
DR   Horizon_Discovery; HZGHC003046c005
DR   Wikidata; Q54873887
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28007; MCRIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003046c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAM20B (-) 1
AC   CVCL_XN67
SY   HZGHC006909c018; HZGHC9917; FAM20B knockout cell line 17bp deletion in exon 2; HAP1 FAM20B (-)
DR   cancercelllines; CVCL_XN67
DR   Horizon_Discovery; HZGHC006909c018
DR   Wikidata; Q93946000
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23017; FAM20B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 FAM20B (-) 2
AC   CVCL_DX00
SY   HZGHC006909c017; FAM20B knockout cell line 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006909c017
DR   Wikidata; Q127381042
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23017; FAM20B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FAM20B (-) IDS (-) 1
AC   CVCL_DX33
SY   HZGHC006987c002; Double knockout cell line FAM20B 17bp deletion in exon 2 and IDS 1bp deletion in exon 5
DR   Horizon_Discovery; HZGHC006987c002
DR   Wikidata; Q127381043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23017; FAM20B.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5389; IDS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XN67 ! HAP1 FAM20B (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FAM20B (-) IDS (-) 2
AC   CVCL_DX34
SY   HZGHC006987c004; Double knockout cell line FAM20B 1bp insertion in exon 2 and IDS 1bp deletion in exon 5
DR   Horizon_Discovery; HZGHC006987c004
DR   Wikidata; Q127381044
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23017; FAM20B.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5389; IDS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SS08 ! HAP1 IDS (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FAM20C (-) 1
AC   CVCL_E1WS
SY   HZGHC007959c002
DR   Horizon_Discovery; HZGHC007959c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22140; FAM20C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FAM20C (-) 2
AC   CVCL_E1WT
SY   HZGHC007959c003
DR   Horizon_Discovery; HZGHC007959c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22140; FAM20C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FAM50B (-)
AC   CVCL_E1WU
SY   HZGHC007336c011
DR   Horizon_Discovery; HZGHC007336c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18789; FAM50B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FAM83A (-) 1
AC   CVCL_E1WV
SY   HZGHC007318c014
DR   Horizon_Discovery; HZGHC007318c014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28210; FAM83A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FAM83A (-) 2
AC   CVCL_E1WW
SY   HZGHC007318c015
DR   Horizon_Discovery; HZGHC007318c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28210; FAM83A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FAM83A (-) 3
AC   CVCL_E1WX
SY   HZGHC007318c017
DR   Horizon_Discovery; HZGHC007318c017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28210; FAM83A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FAM91A1 (-) 1
AC   CVCL_SM96
SY   HZGHC004315c011; FAM91A1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SM96
DR   Horizon_Discovery; HZGHC004315c011
DR   Wikidata; Q54873888
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26306; FAM91A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAM91A1 (-) 2
AC   CVCL_SM97
SY   HZGHC004315c012; FAM91A1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SM97
DR   Horizon_Discovery; HZGHC004315c012
DR   Wikidata; Q54873889
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26306; FAM91A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAN1 (-)
AC   CVCL_E1WY
SY   HZGHC007822c024
DR   Horizon_Discovery; HZGHC007822c024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29170; FAN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FANCA (-) 1
AC   CVCL_SM98
SY   HZGHC000648c005; FANCA knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SM98
DR   Horizon_Discovery; HZGHC000648c005
DR   Wikidata; Q54873892
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FANCA (-) 2
AC   CVCL_SM99
SY   HZGHC000648c006; FANCA knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SM99
DR   Horizon_Discovery; HZGHC000648c006
DR   Wikidata; Q54873893
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000648c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCA (-) 3
AC   CVCL_SN00
SY   HZGHC000648c007; FANCA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN00
DR   Horizon_Discovery; HZGHC000648c007
DR   Wikidata; Q54873894
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000648c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCA (-) 4
AC   CVCL_SN01
SY   HZGHC004231c005; FANCA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN01
DR   Horizon_Discovery; HZGHC004231c005
DR   Wikidata; Q54873896
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FANCA (-) 5
AC   CVCL_SN02
SY   HZGHC004231c010; FANCA knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SN02
DR   Horizon_Discovery; HZGHC004231c010
DR   Wikidata; Q54873897
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004231c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCB (-)
AC   CVCL_SN03
SY   HZGHC000649c005; FANCB knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SN03
DR   Horizon_Discovery; HZGHC000649c005
DR   Wikidata; Q54873898
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3583; FANCB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000649c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCD2 (-) 1
AC   CVCL_SN04
SY   HZGHC002922c002; FANCD2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SN04
DR   Horizon_Discovery; HZGHC002922c002
DR   Wikidata; Q54873900
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002922c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCD2 (-) 2
AC   CVCL_SN05
SY   HZGHC002922c004; FANCD2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN05
DR   Horizon_Discovery; HZGHC002922c004
DR   Wikidata; Q54873901
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FANCE (-) 1
AC   CVCL_SN06
SY   HZGHC000645c005; FANCE knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SN06
DR   Horizon_Discovery; HZGHC000645c005
DR   Wikidata; Q54873902
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3586; FANCE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FANCE (-) 2
AC   CVCL_SN07
SY   HZGHC000645c012; FANCE knockout cell line 184bp insertion
DR   cancercelllines; CVCL_SN07
DR   Horizon_Discovery; HZGHC000645c012
DR   Wikidata; Q54873903
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3586; FANCE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000645c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCF (-) 1
AC   CVCL_E1WZ
SY   HZGHC007573c007
DR   Horizon_Discovery; HZGHC007573c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3587; FANCF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FANCF (-) 2
AC   CVCL_E1X0
SY   HZGHC007573c011
DR   Horizon_Discovery; HZGHC007573c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3587; FANCF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FANCG (-)
AC   CVCL_SN08
SY   HZGHC000646c006; FANCG knockout cell line 1bp insertion in exon 1
DR   cancercelllines; CVCL_SN08
DR   Horizon_Discovery; HZGHC000646c006
DR   Wikidata; Q54873905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3588; FANCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCI (-)
AC   CVCL_SN09
SY   HZGHC000641c004; FANCI knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN09
DR   Horizon_Discovery; HZGHC000641c004
DR   Wikidata; Q54873906
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25568; FANCI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000641c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FANCI (-) XPA (-)
AC   CVCL_DX35
SY   HZGHC006990c007; Double knockout cell line FANCI 1bp insertion and XPA 5bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006990c007
DR   Wikidata; Q127381045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25568; FANCI.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12814; XPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SN09 ! HAP1 FANCI (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FANCL (-)
AC   CVCL_SN10
SY   HZGHC000761c003; FANCL knockout cell line 10bp deletion in exon 1
DR   cancercelllines; CVCL_SN10
DR   Horizon_Discovery; HZGHC000761c003
DR   Wikidata; Q54873907
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20748; FANCL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FARP1 (-) 1
AC   CVCL_SN11
SY   HZGHC003103c004; FARP1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SN11
DR   Horizon_Discovery; HZGHC003103c004
DR   Wikidata; Q54873910
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3591; FARP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FARP1 (-) 2
AC   CVCL_SN12
SY   HZGHC003103c012; FARP1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SN12
DR   Horizon_Discovery; HZGHC003103c012
DR   Wikidata; Q54873911
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3591; FARP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FAS (-)
AC   CVCL_SN13
SY   HZGHC003028c004; FAS knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SN13
DR   Horizon_Discovery; HZGHC003028c004
DR   Wikidata; Q54873912
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASLG (-) 1
AC   CVCL_SN14
SY   HZGHC003030c002; FASLG knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SN14
DR   Horizon_Discovery; HZGHC003030c002
DR   Wikidata; Q54873913
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11936; FASLG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASLG (-) 2
AC   CVCL_SN15
SY   HZGHC003030c010; FASLG knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SN15
DR   Horizon_Discovery; HZGHC003030c010
DR   Wikidata; Q54873915
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11936; FASLG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASN (-) 1
AC   CVCL_SN16
SY   HZGHC003700c006; FASN knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SN16
DR   Horizon_Discovery; HZGHC003700c006
DR   Wikidata; Q54873916
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3594; FASN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASN (-) 2
AC   CVCL_SN17
SY   HZGHC003700c011; FASN knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SN17
DR   Horizon_Discovery; HZGHC003700c011
DR   Wikidata; Q54873918
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3594; FASN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASTK (-) 1
AC   CVCL_SN18
SY   HZGHC000734c056; FASTK knockout cell line 57bp deletion
DR   cancercelllines; CVCL_SN18
DR   Horizon_Discovery; HZGHC000734c056
DR   Wikidata; Q54873919
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24676; FASTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASTK (-) 2
AC   CVCL_SN19
SY   HZGHC004548c005; FASTK knockout cell line 70bp deletion
DR   cancercelllines; CVCL_SN19
DR   Horizon_Discovery; HZGHC004548c005
DR   Wikidata; Q54873920
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24676; FASTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASTK (-) 3
AC   CVCL_SN20
SY   HZGHC004548c008; FASTK knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SN20
DR   Horizon_Discovery; HZGHC004548c008
DR   Wikidata; Q54873921
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24676; FASTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASTKD2 (-) 1
AC   CVCL_XN68
SY   HZGHC006858c007; HZGHC22868; FASTKD2 knockout cell line 28bp insertion in exon 3; HAP1 FASTKD2 (-)
DR   cancercelllines; CVCL_XN68
DR   Horizon_Discovery; HZGHC006858c007
DR   Wikidata; Q93946137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29160; FASTKD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006858c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 FASTKD2 (-) 2
AC   CVCL_B5J3
SY   HZGHC006859c004; FASTKD2 knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_B5J3
DR   Horizon_Discovery; HZGHC006859c004
DR   Wikidata; Q111733290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29160; FASTKD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 FASTKD2 (-) 3
AC   CVCL_B5J4
SY   HZGHC006859c007; FASTKD2 knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_B5J4
DR   Horizon_Discovery; HZGHC006859c007
DR   Wikidata; Q111733291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29160; FASTKD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 FASTKD2 (-) 4
AC   CVCL_B5J5
SY   HZGHC006859c011; FASTKD2 knockout cell line 29bp deletion in exon 2
DR   cancercelllines; CVCL_B5J5
DR   Horizon_Discovery; HZGHC006859c011
DR   Wikidata; Q111733292
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29160; FASTKD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 FASTKD3 (-) 1
AC   CVCL_SN21
SY   HZGHC005288c002; FASTKD3 knockout cell line 2bp deletion; HAP1 FASTKD3 (-)
DR   cancercelllines; CVCL_SN21
DR   Horizon_Discovery; HZGHC005288c002
DR   Wikidata; Q54873923
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28758; FASTKD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FASTKD3 (-) 2
AC   CVCL_XN69
SY   HZGHC005288c006; FASTKD3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XN69
DR   Horizon_Discovery; HZGHC005288c006
DR   Wikidata; Q93946141
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28758; FASTKD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FASTKD3-sKO
AC   CVCL_C6Y4
DR   Wikidata; Q117704465
RX   PubMed=34748562;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28758; FASTKD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FASTKD3&4-dKO
AC   CVCL_C6Y7
DR   Wikidata; Q117704466
RX   PubMed=34748562;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28758; FASTKD3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17443; TBRG4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25790; FASTKD5 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 FASTKD4-sKO
AC   CVCL_C6Y5
DR   Wikidata; Q117704467
RX   PubMed=34748562;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17443; TBRG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FASTKD4&5-dKO
AC   CVCL_C6Y8
DR   Wikidata; Q117704468
RX   PubMed=34748562;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17443; TBRG4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25790; FASTKD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FASTKD5-sKO
AC   CVCL_C6Y6
DR   Wikidata; Q117704469
RX   PubMed=34748562;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25790; FASTKD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FAT1 (-) 1
AC   CVCL_SN22
SY   HZGHC006025c001; FAT1 knockout cell line 8bp deletion; HAP1 FAT1 (-)
DR   cancercelllines; CVCL_SN22
DR   Horizon_Discovery; HZGHC006025c001
DR   Wikidata; Q54873924
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3595; FAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FAT1 (-) 2
AC   CVCL_XN70
SY   HZGHC006025c011; FAT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN70
DR   Horizon_Discovery; HZGHC006025c011
DR   Wikidata; Q93946145
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3595; FAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FBXL14 (-) 1
AC   CVCL_E1X1
SY   HZGHC007397c001
DR   Horizon_Discovery; HZGHC007397c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28624; FBXL14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FBXL14 (-) 2
AC   CVCL_E1X2
SY   HZGHC007397c010
DR   Horizon_Discovery; HZGHC007397c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28624; FBXL14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FBXO18 (-) 1
AC   CVCL_SN23
SY   HZGHC005715c011; FBXO18 knockout cell line 1bp deletion; HAP1 FBXO18 (-)
DR   cancercelllines; CVCL_SN23
DR   Horizon_Discovery; HZGHC005715c011
DR   Wikidata; Q54873925
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13620; FBH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FBXO18 (-) 2
AC   CVCL_XN71
SY   HZGHC005715c005; FBXO18 knockout cell line 121bp insertion
DR   cancercelllines; CVCL_XN71
DR   Horizon_Discovery; HZGHC005715c005
DR   Wikidata; Q93946151
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13620; FBH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005715c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FBXO18 (-) 3
AC   CVCL_XN72
SY   HZGHC005715c008; FBXO18 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN72
DR   Horizon_Discovery; HZGHC005715c008
DR   Wikidata; Q93946154
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13620; FBH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FBXO34 (-) 1
AC   CVCL_SN24
SY   HZGHC004714c001; FBXO34 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN24
DR   Horizon_Discovery; HZGHC004714c001
DR   Wikidata; Q54873927
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20201; FBXO34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FBXO34 (-) 2
AC   CVCL_SN25
SY   HZGHC004714c002; FBXO34 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SN25
DR   Horizon_Discovery; HZGHC004714c002
DR   Wikidata; Q54873928
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20201; FBXO34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FBXO34 (-) 3
AC   CVCL_SN26
SY   HZGHC004714c003; FBXO34 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SN26
DR   Horizon_Discovery; HZGHC004714c003
DR   Wikidata; Q54873951
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20201; FBXO34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004714c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FBXO6 (-)
AC   CVCL_E1X3
SY   HZGHC007365c015
DR   Horizon_Discovery; HZGHC007365c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13585; FBXO6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FBXO7 (-) 1
AC   CVCL_SN27
SY   HZGHC002684c003; FBXO7 knockout cell line 115bp insertion
DR   cancercelllines; CVCL_SN27
DR   Horizon_Discovery; HZGHC002684c003
DR   Wikidata; Q54873952
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13586; FBXO7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002684c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FBXO7 (-) 2
AC   CVCL_SN28
SY   HZGHC002685c006; FBXO7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN28
DR   Horizon_Discovery; HZGHC002685c006
DR   Wikidata; Q54873953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13586; FBXO7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FBXW11 (-) 1
AC   CVCL_SN29
SY   HZGHC006419c011; FBXW11 knockout cell line 11bp deletion; HAP1 FBXW11 (-)
DR   cancercelllines; CVCL_SN29
DR   Horizon_Discovery; HZGHC006419c011
DR   Wikidata; Q54873955
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13607; FBXW11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FBXW11 (-) 2
AC   CVCL_XN73
SY   HZGHC006419c002; FBXW11 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN73
DR   Horizon_Discovery; HZGHC006419c002
DR   Wikidata; Q93946171
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13607; FBXW11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FBXW7 (-) 1
AC   CVCL_SN30
SY   HZGHC003212c002; FBXW7 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_SN30
DR   Horizon_Discovery; HZGHC003212c002
DR   Wikidata; Q54873957
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FBXW7 (-) 2
AC   CVCL_SN31
SY   HZGHC003212c008; FBXW7 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SN31
DR   Horizon_Discovery; HZGHC003212c008
DR   Wikidata; Q54873958
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO1 (-) 1
AC   CVCL_SN32
SY   HZGHC000581c011; FCHO1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN32
DR   Horizon_Discovery; HZGHC000581c011
DR   Wikidata; Q54873960
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29002; FCHO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000581c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FCHO1 (-) 2
AC   CVCL_SN33
SY   HZGHC000580c001; FCHO1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN33
DR   Horizon_Discovery; HZGHC000580c001
DR   Wikidata; Q54873962
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29002; FCHO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO1 (-) 3
AC   CVCL_SN34
SY   HZGHC000580c002; FCHO1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SN34
DR   Horizon_Discovery; HZGHC000580c002
DR   Wikidata; Q54873963
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29002; FCHO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO1 (-) 4
AC   CVCL_SN35
SY   HZGHC000581c001; FCHO1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN35
DR   Horizon_Discovery; HZGHC000581c001
DR   Wikidata; Q54873964
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29002; FCHO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO1 (-) 5
AC   CVCL_SN36
SY   HZGHC000581c009; FCHO1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN36
DR   Horizon_Discovery; HZGHC000581c009
DR   Wikidata; Q54873966
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29002; FCHO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO2 (-) 1
AC   CVCL_SN37
SY   HZGHC000610c004; FCHO2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SN37
DR   Horizon_Discovery; HZGHC000610c004
DR   Wikidata; Q54873968
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25180; FCHO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO2 (-) 2
AC   CVCL_SN38
SY   HZGHC000610c011; FCHO2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN38
DR   Horizon_Discovery; HZGHC000610c011
DR   Wikidata; Q54873969
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25180; FCHO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO2 (-) 3
AC   CVCL_SN39
SY   HZGHC000611c004; FCHO2 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SN39
DR   Horizon_Discovery; HZGHC000611c004
DR   Wikidata; Q54873970
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25180; FCHO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FCHO2 (-) 4
AC   CVCL_SN40
SY   HZGHC000611c005; FCHO2 knockout cell line 242bp insertion
DR   cancercelllines; CVCL_SN40
DR   Horizon_Discovery; HZGHC000611c005
DR   Wikidata; Q54873973
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25180; FCHO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000611c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FEM1A (-) 1
AC   CVCL_E1X4
SY   HZGHC008033c008
DR   Horizon_Discovery; HZGHC008033c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16934; FEM1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FEM1A (-) 2
AC   CVCL_E1X5
SY   HZGHC008033c009
DR   Horizon_Discovery; HZGHC008033c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16934; FEM1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FEM1A (-) 3
AC   CVCL_E1X6
SY   HZGHC008033c012
DR   Horizon_Discovery; HZGHC008033c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16934; FEM1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FEM1C (-) 1
AC   CVCL_E1X7
SY   HZGHC008035c002
DR   Horizon_Discovery; HZGHC008035c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16933; FEM1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FEM1C (-) 2
AC   CVCL_E1X8
SY   HZGHC008035c004
DR   Horizon_Discovery; HZGHC008035c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16933; FEM1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FEM1C (-) 3
AC   CVCL_E1X9
SY   HZGHC008035c005
DR   Horizon_Discovery; HZGHC008035c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16933; FEM1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FEM1C (-) 4
AC   CVCL_E1XA
SY   HZGHC008035c009
DR   Horizon_Discovery; HZGHC008035c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16933; FEM1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FEM1C (-) 5
AC   CVCL_E1XB
SY   HZGHC008035c011
DR   Horizon_Discovery; HZGHC008035c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16933; FEM1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FER (-) 1
AC   CVCL_SN41
SY   HZGHC003755c004; FER knockout cell line 59bp deletion
DR   cancercelllines; CVCL_SN41
DR   Horizon_Discovery; HZGHC003755c004
DR   Wikidata; Q54873974
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3655; FER.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FER (-) 2
AC   CVCL_SN42
SY   HZGHC003755c010; FER knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SN42
DR   Horizon_Discovery; HZGHC003755c010
DR   Wikidata; Q54873975
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3655; FER.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FES (-) 1
AC   CVCL_SN43
SY   HZGHC000307c016; FES knockout cell line 38bp deletion
DR   cancercelllines; CVCL_SN43
DR   Horizon_Discovery; HZGHC000307c016
DR   Wikidata; Q54873977
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3657; FES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FES (-) 2
AC   CVCL_SN44
SY   HZGHC000307c019; FES knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SN44
DR   Horizon_Discovery; HZGHC000307c019
DR   Wikidata; Q54873978
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3657; FES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FES (-) 3
AC   CVCL_SN45
SY   HZGHC000307c023; FES knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SN45
DR   Horizon_Discovery; HZGHC000307c023
DR   Wikidata; Q54873980
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3657; FES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FGD4 (-) 1
AC   CVCL_SN46
SY   HZGHC004680c001; FGD4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SN46
DR   Horizon_Discovery; HZGHC004680c001
DR   Wikidata; Q54873981
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19125; FGD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FGD4 (-) 2
AC   CVCL_SN47
SY   HZGHC004680c010; FGD4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN47
DR   Horizon_Discovery; HZGHC004680c010
DR   Wikidata; Q54873983
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19125; FGD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FGF2 (-) 1
AC   CVCL_SN48
SY   HZGHC003854c001; FGF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN48
DR   Horizon_Discovery; HZGHC003854c001
DR   Wikidata; Q54873984
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3676; FGF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FGF2 (-) 2
AC   CVCL_SN49
SY   HZGHC003854c005; FGF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN49
DR   Horizon_Discovery; HZGHC003854c005
DR   Wikidata; Q54873986
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3676; FGF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FGFR1 (-) 1
AC   CVCL_SN50
SY   HZGHC003952c004; FGFR1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SN50
DR   Horizon_Discovery; HZGHC003952c004
DR   Wikidata; Q54873988
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FGFR1 (-) 2
AC   CVCL_SN51
SY   HZGHC003952c011; FGFR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN51
DR   Horizon_Discovery; HZGHC003952c011
DR   Wikidata; Q54873989
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FGFR1 (-) 3
AC   CVCL_XN74
SY   HZGHC001427c011; FGFR1 knockout cell line
DR   cancercelllines; CVCL_XN74
DR   Horizon_Discovery; HZGHC001427c011
DR   Wikidata; Q93946248
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001427c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FGFR1 (-) 4
AC   CVCL_XN75
SY   HZGHC001427c012; FGFR1 knockout cell line
DR   cancercelllines; CVCL_XN75
DR   Horizon_Discovery; HZGHC001427c012
DR   Wikidata; Q93946251
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001427c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FGFR2 (-)
AC   CVCL_SN52
SY   HZGHC000203c010; FGFR2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SN52
DR   Horizon_Discovery; HZGHC000203c010
DR   Wikidata; Q54873990
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3689; FGFR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FGFR3 (-)
AC   CVCL_SN53
SY   HZGHC001346c024; FGFR3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SN53
DR   Horizon_Discovery; HZGHC001346c024
DR   Wikidata; Q54873991
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3690; FGFR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001346c024; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FGFR4 (-)
AC   CVCL_SN54
SY   HZGHC000257c007; HZGHC2264; FGFR4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SN54
DR   Horizon_Discovery; HZGHC000257c007
DR   Wikidata; Q54873994
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000257c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 FGGY (-) 1
AC   CVCL_SN55
SY   HZGHC005260c004; FGGY knockout cell line 2bp deletion; HAP1 FGGY (-)
DR   cancercelllines; CVCL_SN55
DR   Horizon_Discovery; HZGHC005260c004
DR   Wikidata; Q54873995
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25610; FGGY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FGGY (-) 2
AC   CVCL_XN76
SY   HZGHC005260c009; FGGY knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XN76
DR   Horizon_Discovery; HZGHC005260c009
DR   Wikidata; Q93946271
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25610; FGGY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FHIT (-)
AC   CVCL_SN56
SY   HZGHC006520c008; FHIT knockout cell line 164bp insertion
DR   cancercelllines; CVCL_SN56
DR   Horizon_Discovery; HZGHC006520c008
DR   Wikidata; Q54873996
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3701; FHIT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006520c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FIG4 (-) 1
AC   CVCL_SN57
SY   HZGHC002912c006; FIG4 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SN57
DR   Horizon_Discovery; HZGHC002912c006
DR   Wikidata; Q54873998
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16873; FIG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FIG4 (-) 2
AC   CVCL_SN58
SY   HZGHC002912c010; FIG4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN58
DR   Horizon_Discovery; HZGHC002912c010
DR   Wikidata; Q54874000
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16873; FIG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FIGNL1 (-)
AC   CVCL_E1XC
SY   HZGHC007568c003
DR   Horizon_Discovery; HZGHC007568c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13286; FIGNL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FKBP10 (-) 1
AC   CVCL_E1XD
SY   HZGHC008118c007
DR   Horizon_Discovery; HZGHC008118c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18169; FKBP10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FKBP10 (-) 2
AC   CVCL_E1XE
SY   HZGHC008119c010
DR   Horizon_Discovery; HZGHC008119c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18169; FKBP10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FKBP15 (-) 1
AC   CVCL_SN59
SY   HZGHC003104c007; FKBP15 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SN59
DR   Horizon_Discovery; HZGHC003104c007
DR   Wikidata; Q54874001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23397; FKBP15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKBP15 (-) 2
AC   CVCL_SN60
SY   HZGHC003104c009; FKBP15 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN60
DR   Horizon_Discovery; HZGHC003104c009
DR   Wikidata; Q54874003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23397; FKBP15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKBP1A (-) 1
AC   CVCL_SN61
SY   HZGHC006154c010; FKBP1A knockout cell line 1bp insertion; HAP1 FKBP1A (-)
DR   cancercelllines; CVCL_SN61
DR   Horizon_Discovery; HZGHC006154c010
DR   Wikidata; Q54874004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3711; FKBP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FKBP1A (-) 2
AC   CVCL_XN77
SY   HZGHC006154c004; FKBP1A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN77
DR   Horizon_Discovery; HZGHC006154c004
DR   Wikidata; Q93946298
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3711; FKBP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKBP1A (-) 3
AC   CVCL_XN78
SY   HZGHC006154c005; FKBP1A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN78
DR   Horizon_Discovery; HZGHC006154c005
DR   Wikidata; Q93946301
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3711; FKBP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006154c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FKBP4 (-) 1
AC   CVCL_E1XF
SY   HZGHC007896c011
DR   Horizon_Discovery; HZGHC007896c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3720; FKBP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FKBP4 (-) 2
AC   CVCL_E1XG
SY   HZGHC007896c012
DR   Horizon_Discovery; HZGHC007896c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3720; FKBP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FKBP5 (-) 1
AC   CVCL_SN62
SY   HZGHC006155c011; FKBP5 knockout cell line 2bp deletion; HAP1 FKBP5 (-)
DR   cancercelllines; CVCL_SN62
DR   Horizon_Discovery; HZGHC006155c011
DR   Wikidata; Q54874007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3721; FKBP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FKBP5 (-) 2
AC   CVCL_XN79
SY   HZGHC006155c007; FKBP5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XN79
DR   Horizon_Discovery; HZGHC006155c007
DR   Wikidata; Q93946309
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3721; FKBP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKBP8 (-) 1
AC   CVCL_SN63
SY   HZGHC001404c002; FKBP8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN63
DR   Horizon_Discovery; HZGHC001404c002
DR   Wikidata; Q54874009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3724; FKBP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKBP8 (-) 2
AC   CVCL_SN64
SY   HZGHC001404c003; FKBP8 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SN64
DR   Horizon_Discovery; HZGHC001404c003
DR   Wikidata; Q54874010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3724; FKBP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKRP (-) 1
AC   CVCL_SN65
SY   HZGHC000726c004; FKRP knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN65
DR   Horizon_Discovery; HZGHC000726c004
DR   Wikidata; Q54874011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17997; FKRP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKRP (-) 2
AC   CVCL_SN66
SY   HZGHC000726c009; FKRP knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SN66
DR   Horizon_Discovery; HZGHC000726c009
DR   Wikidata; Q54874027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17997; FKRP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKTN (-) 1
AC   CVCL_SN67
SY   HZGHC000721c002; FKTN knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SN67
DR   Horizon_Discovery; HZGHC000721c002
DR   Wikidata; Q54874028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3622; FKTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000721c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FKTN (-) 2
AC   CVCL_SN68
SY   HZGHC000721c010; FKTN knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SN68
DR   Horizon_Discovery; HZGHC000721c010
DR   Wikidata; Q54874029
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3622; FKTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKTN (-) 3
AC   CVCL_SN69
SY   HZGHC000722c003; FKTN knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SN69
DR   Horizon_Discovery; HZGHC000722c003
DR   Wikidata; Q54874030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3622; FKTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FKTN (-) 4
AC   CVCL_SN70
SY   HZGHC000722c008; FKTN knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SN70
DR   Horizon_Discovery; HZGHC000722c008
DR   Wikidata; Q54874031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3622; FKTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FLCN (-)
AC   CVCL_SN71
SY   HZGHC006077c006; FLCN knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SN71
DR   Horizon_Discovery; HZGHC006077c006
DR   Wikidata; Q54874033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27310; FLCN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FLNA (-) 1
AC   CVCL_SN72
SY   HZGHC005381c012; FLNA knockout cell line 1bp insertion; HAP1 FLNA (-)
DR   cancercelllines; CVCL_SN72
DR   Horizon_Discovery; HZGHC005381c012
DR   Wikidata; Q54874034
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3754; FLNA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FLNA (-) 2
AC   CVCL_XN80
SY   HZGHC005381c004; FLNA knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XN80
DR   Horizon_Discovery; HZGHC005381c004
DR   Wikidata; Q93946373
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3754; FLNA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FLOT1 (-) 1
AC   CVCL_SN73
SY   HZGHC005977c002; FLOT1 knockout cell line 5bp deletion; HAP1 FLOT1 (-)
DR   cancercelllines; CVCL_SN73
DR   Horizon_Discovery; HZGHC005977c002
DR   Wikidata; Q54874035
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3757; FLOT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FLOT1 (-) 2
AC   CVCL_XN81
SY   HZGHC005977c006; FLOT1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XN81
DR   Horizon_Discovery; HZGHC005977c006
DR   Wikidata; Q93946382
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3757; FLOT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FLT1 (-) 1
AC   CVCL_SN74
SY   HZGHC000358c006; FLT1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SN74
DR   Horizon_Discovery; HZGHC000358c006
DR   Wikidata; Q54874037
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FLT1 (-) 2
AC   CVCL_SN75
SY   HZGHC000358c010; FLT1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SN75
DR   Horizon_Discovery; HZGHC000358c010
DR   Wikidata; Q54874038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FLT4 (-)
AC   CVCL_SN76
SY   HZGHC001246c039; FLT4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SN76
DR   Horizon_Discovery; HZGHC001246c039
DR   Wikidata; Q54874040
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3767; FLT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FLVCR1 (-) 1
AC   CVCL_SN77
SY   HZGHC001469c003; FLVCR1 knockout cell line 151bp insertion
DR   cancercelllines; CVCL_SN77
DR   Horizon_Discovery; HZGHC001469c003
DR   Wikidata; Q54874041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24682; FLVCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001469c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FLVCR1 (-) 2
AC   CVCL_SN78
SY   HZGHC001469c004; FLVCR1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SN78
DR   Horizon_Discovery; HZGHC001469c004
DR   Wikidata; Q54874042
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24682; FLVCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FMR1 (-) 1
AC   CVCL_SN79
SY   HZGHC005871c008; FMR1 knockout cell line 23bp deletion; HAP1 FMR1 (-)
DR   cancercelllines; CVCL_SN79
DR   Horizon_Discovery; HZGHC005871c008
DR   Wikidata; Q54874043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FMR1 (-) 2
AC   CVCL_XN82
SY   HZGHC005871c009; FMR1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XN82
DR   Horizon_Discovery; HZGHC005871c009
DR   Wikidata; Q93946426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005871c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FMR1 (-) 3
AC   CVCL_XN83
SY   HZGHC005872c002; FMR1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XN83
DR   Horizon_Discovery; HZGHC005872c002
DR   Wikidata; Q93946429
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FMR1 (-) 4
AC   CVCL_XN84
SY   HZGHC005872c005; FMR1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XN84
DR   Horizon_Discovery; HZGHC005872c005
DR   Wikidata; Q93946431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FN1 (-) 1
AC   CVCL_SN80
SY   HZGHC003830c002; FN1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SN80
DR   Horizon_Discovery; HZGHC003830c002
DR   Wikidata; Q54874044
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FN1 (-) 2
AC   CVCL_SN81
SY   HZGHC003830c008; FN1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SN81
DR   Horizon_Discovery; HZGHC003830c008
DR   Wikidata; Q54874045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FNDC5 (-) 1
AC   CVCL_SN82
SY   HZGHC006159c001; FNDC5 knockout cell line 1bp insertion; HAP1 FNDC5 (-)
DR   cancercelllines; CVCL_SN82
DR   Horizon_Discovery; HZGHC006159c001
DR   Wikidata; Q54874047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20240; FNDC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FNDC5 (-) 2
AC   CVCL_XN85
SY   HZGHC006159c012; FNDC5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XN85
DR   Horizon_Discovery; HZGHC006159c012
DR   Wikidata; Q93946452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20240; FNDC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FNIP1 (-)
AC   CVCL_XN86
SY   HZGHC007140c004; HZGHC96459; FNIP1 knockout cell line 8bp deletion in exon 4
DR   cancercelllines; CVCL_XN86
DR   Horizon_Discovery; HZGHC007140c004
DR   Wikidata; Q93946455
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29418; FNIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FNIP2 (-) 1
AC   CVCL_XN87
SY   HZGHC007298c001; HZGHC57600; FNIP2 knockout cell line 1bp insertion in exon 2; HAP1 FNIP2 (-)
DR   cancercelllines; CVCL_XN87
DR   Horizon_Discovery; HZGHC007298c001
DR   Wikidata; Q93946457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29280; FNIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 FNIP2 (-) 2
AC   CVCL_E1XH
SY   HZGHC007141c014
DR   Horizon_Discovery; HZGHC007141c014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29280; FNIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FNIP2 (-) 3
AC   CVCL_E1XI
SY   HZGHC007141c015
DR   Horizon_Discovery; HZGHC007141c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29280; FNIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FNIP2 (-) 4
AC   CVCL_E1XJ
SY   HZGHC007141c016
DR   Horizon_Discovery; HZGHC007141c016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29280; FNIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOCAD (-) 1
AC   CVCL_E1XK
SY   HZGHC008249c012
DR   Horizon_Discovery; HZGHC008249c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23377; FOCAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOCAD (-) 2
AC   CVCL_E1XL
SY   HZGHC008250c001
DR   Horizon_Discovery; HZGHC008250c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23377; FOCAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOCAD (-) 3
AC   CVCL_E1XM
SY   HZGHC008250c008
DR   Horizon_Discovery; HZGHC008250c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23377; FOCAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOLH1 (-)
AC   CVCL_SN83
SY   HZGHC003929c003; FOLH1 knockout cell line 310bp insertion
DR   cancercelllines; CVCL_SN83
DR   Horizon_Discovery; HZGHC003929c003
DR   Wikidata; Q54874048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3788; FOLH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003929c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FOLR1 (-) 1
AC   CVCL_SN84
SY   HZGHC005591c012; FOLR1 knockout cell line 8bp deletion; HAP1 FOLR1 (-)
DR   cancercelllines; CVCL_SN84
DR   Horizon_Discovery; HZGHC005591c012
DR   Wikidata; Q54874049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FOLR1 (-) 2
AC   CVCL_XN88
SY   HZGHC005591c006; FOLR1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XN88
DR   Horizon_Discovery; HZGHC005591c006
DR   Wikidata; Q93946471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOS (-) 1
AC   CVCL_SN85
SY   HZGHC004779c001; FOS knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SN85
DR   Horizon_Discovery; HZGHC004779c001
DR   Wikidata; Q54874050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOS (-) 2
AC   CVCL_SN86
SY   HZGHC004779c004; FOS knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SN86
DR   Horizon_Discovery; HZGHC004779c004
DR   Wikidata; Q54874052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOSB (-) 1
AC   CVCL_E1XN
SY   HZGHC007447c002
DR   Horizon_Discovery; HZGHC007447c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3797; FOSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOSB (-) 2
AC   CVCL_E1XP
SY   HZGHC007447c006
DR   Horizon_Discovery; HZGHC007447c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3797; FOSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOSB (-) 3
AC   CVCL_E1XQ
SY   HZGHC007447c007
DR   Horizon_Discovery; HZGHC007447c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3797; FOSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOSL1 (-)
AC   CVCL_E1XR
SY   HZGHC007892c008
DR   Horizon_Discovery; HZGHC007892c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOXA1 (-) 1
AC   CVCL_SN87
SY   HZGHC006060c010; FOXA1 knockout cell line 20bp deletion; HAP1 FOXA1 (-)
DR   cancercelllines; CVCL_SN87
DR   Horizon_Discovery; HZGHC006060c010
DR   Wikidata; Q54874054
CC   Group: Haploid karyotype cell line.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FOXA1 (-) 2
AC   CVCL_XN89
SY   HZGHC006060c006; FOXA1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XN89
DR   Horizon_Discovery; HZGHC006060c006
DR   Wikidata; Q93946495
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006060c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FOXA2 (-)
AC   CVCL_E1XS
SY   HZGHC007636c011
DR   Horizon_Discovery; HZGHC007636c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FOXM1 (-) 1
AC   CVCL_SN88
SY   HZGHC000835c002; FOXM1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SN88
DR   Horizon_Discovery; HZGHC000835c002
DR   Wikidata; Q54874055
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOXM1 (-) 2
AC   CVCL_SN89
SY   HZGHC000835c006; FOXM1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SN89
DR   Horizon_Discovery; HZGHC000835c006
DR   Wikidata; Q54874056
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOXO1 (-) 1
AC   CVCL_SN90
SY   HZGHC005384c001; FOXO1 knockout cell line 1bp insertion; HAP1 FOXO1 (-)
DR   cancercelllines; CVCL_SN90
DR   Horizon_Discovery; HZGHC005384c001
DR   Wikidata; Q54874057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3819; FOXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FOXO1 (-) 2
AC   CVCL_XN90
SY   HZGHC005385c001; FOXO1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN90
DR   Horizon_Discovery; HZGHC005385c001
DR   Wikidata; Q93946517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3819; FOXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOXO1 (-) 3
AC   CVCL_XN91
SY   HZGHC005385c010; FOXO1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XN91
DR   Horizon_Discovery; HZGHC005385c010
DR   Wikidata; Q93946520
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3819; FOXO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOXRED1 (-) 1
AC   CVCL_SN91
SY   HZGHC002525c006; FOXRED1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SN91
DR   Horizon_Discovery; HZGHC002525c006
DR   Wikidata; Q54874059
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26927; FOXRED1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FOXRED1 (-) 2
AC   CVCL_SN92
SY   HZGHC002525c011; FOXRED1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SN92
DR   Horizon_Discovery; HZGHC002525c011
DR   Wikidata; Q54874060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26927; FOXRED1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FRS2 (-) 1
AC   CVCL_E1XT
SY   HZGHC007502c007
DR   Horizon_Discovery; HZGHC007502c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16971; FRS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FRS2 (-) 2
AC   CVCL_E1XU
SY   HZGHC007502c012
DR   Horizon_Discovery; HZGHC007502c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16971; FRS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FRYL (-) 1
AC   CVCL_SN93
SY   HZGHC006584c010; FRYL knockout cell line 1bp insertion; HAP1 FRYL (-)
DR   cancercelllines; CVCL_SN93
DR   Horizon_Discovery; HZGHC006584c010
DR   Wikidata; Q54874061
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29127; FRYL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FRYL (-) 2
AC   CVCL_XN92
SY   HZGHC006584c011; FRYL knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XN92
DR   Horizon_Discovery; HZGHC006584c011
DR   Wikidata; Q93946544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29127; FRYL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FRYL (-) 3
AC   CVCL_XN93
SY   HZGHC006585c012; FRYL knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XN93
DR   Horizon_Discovery; HZGHC006585c012
DR   Wikidata; Q93946547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29127; FRYL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FSCN1 (-)
AC   CVCL_SN94
SY   HZGHC006247c008; FSCN1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SN94
DR   Horizon_Discovery; HZGHC006247c008
DR   Wikidata; Q54874063
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11148; FSCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FTH1 (-) 1
AC   CVCL_E1NG
SY   HZGHC005137c002; FTH1 knockout cell line 2bp insertion
DR   Horizon_Discovery; HZGHC005137c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3976; FTH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FTH1 (-) 2
AC   CVCL_E1NH
SY   HZGHC005137c012; FTH1 knockout cell line 8bp deletion
DR   Horizon_Discovery; HZGHC005137c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3976; FTH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FTH1 (-) 3
AC   CVCL_E1NI
SY   HZGHC005138c002; FTH1 knockout cell line 19bp deletion
DR   Horizon_Discovery; HZGHC005138c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3976; FTH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FTH1 (-) 4
AC   CVCL_E1NJ
SY   HZGHC005138c010; FTH1 knockout cell line 10bp deletion
DR   Horizon_Discovery; HZGHC005138c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3976; FTH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FTL (-) 1
AC   CVCL_SN95
SY   HZGHC003693c009; FTL knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SN95
DR   Horizon_Discovery; HZGHC003693c009
DR   Wikidata; Q54874064
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FTL (-) 2
AC   CVCL_SN96
SY   HZGHC003693c012; FTL knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN96
DR   Horizon_Discovery; HZGHC003693c012
DR   Wikidata; Q54874066
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FTO (-) 1
AC   CVCL_SN97
SY   HZGHC004875c012; FTO knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SN97
DR   Horizon_Discovery; HZGHC004875c012
DR   Wikidata; Q54874067
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FTO (-) 2
AC   CVCL_SN98
SY   HZGHC004876c011; FTO knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SN98
DR   Horizon_Discovery; HZGHC004876c011
DR   Wikidata; Q54874068
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FTO (-) 3
AC   CVCL_SN99
SY   HZGHC004876c012; FTO knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SN99
DR   Horizon_Discovery; HZGHC004876c012
DR   Wikidata; Q54874069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FTSJ1 (-) 1
AC   CVCL_SP00
SY   HZGHC005697c012; FTSJ1 knockout cell line 1bp insertion; HAP1 FTSJ1 (-)
DR   cancercelllines; CVCL_SP00
DR   Horizon_Discovery; HZGHC005697c012
DR   Wikidata; Q54874070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13254; FTSJ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FTSJ1 (-) 2
AC   CVCL_XN94
SY   HZGHC005697c009; FTSJ1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XN94
DR   Horizon_Discovery; HZGHC005697c009
DR   Wikidata; Q93946596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13254; FTSJ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FUBP3 (-)
AC   CVCL_E1XV
SY   HZGHC007885c004
DR   Horizon_Discovery; HZGHC007885c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4005; FUBP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FUNDC2 (-) 1
AC   CVCL_SP01
SY   HZGHC005759c012; FUNDC2 knockout cell line 1bp insertion; HAP1 FUNDC2 (-)
DR   cancercelllines; CVCL_SP01
DR   Horizon_Discovery; HZGHC005759c012
DR   Wikidata; Q54874072
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24925; FUNDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FUNDC2 (-) 2
AC   CVCL_XN95
SY   HZGHC005759c009; FUNDC2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XN95
DR   Horizon_Discovery; HZGHC005759c009
DR   Wikidata; Q93946604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24925; FUNDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FUNDC2 (-) 3
AC   CVCL_XN96
SY   HZGHC005760c003; FUNDC2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XN96
DR   Horizon_Discovery; HZGHC005760c003
DR   Wikidata; Q93946607
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24925; FUNDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FUNDC2 (-) 4
AC   CVCL_XN97
SY   HZGHC005760c004; FUNDC2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XN97
DR   Horizon_Discovery; HZGHC005760c004
DR   Wikidata; Q93946610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24925; FUNDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FUNDC2 (-) 5
AC   CVCL_XN98
SY   HZGHC005760c008; FUNDC2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XN98
DR   Horizon_Discovery; HZGHC005760c008
DR   Wikidata; Q93946613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24925; FUNDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FURIN (-) 1
AC   CVCL_SP02
SY   HZGHC001302c001; FURIN knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP02
DR   Horizon_Discovery; HZGHC001302c001
DR   Wikidata; Q54874073
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8568; FURIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FURIN (-) 2
AC   CVCL_SP03
SY   HZGHC001302c010; FURIN knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SP03
DR   Horizon_Discovery; HZGHC001302c010
DR   Wikidata; Q54874074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8568; FURIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FUS (-) 1
AC   CVCL_SP04
SY   HZGHC001314c002; FUS knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP04
DR   Horizon_Discovery; HZGHC001314c002
DR   Wikidata; Q54874075
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FUS (-) 2
AC   CVCL_SP05
SY   HZGHC001314c006; FUS knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SP05
DR   Horizon_Discovery; HZGHC001314c006
DR   Wikidata; Q54874077
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FUT8 (-) 1
AC   CVCL_E1XW
SY   HZGHC007939c001
DR   Horizon_Discovery; HZGHC007939c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4019; FUT8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FUT8 (-) 2
AC   CVCL_E1XX
SY   HZGHC007939c004
DR   Horizon_Discovery; HZGHC007939c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4019; FUT8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FUT8 (-) 3
AC   CVCL_E1XY
SY   HZGHC007939c006
DR   Horizon_Discovery; HZGHC007939c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4019; FUT8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 FXR1 (-) 1
AC   CVCL_SP06
SY   HZGHC005626c010; FXR1 knockout cell line 17bp deletion; HAP1 FXR1 (-)
DR   cancercelllines; CVCL_SP06
DR   Horizon_Discovery; HZGHC005626c010
DR   Wikidata; Q54874091
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4023; FXR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FXR1 (-) 2
AC   CVCL_XN99
SY   HZGHC005626c004; FXR1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_XN99
DR   Horizon_Discovery; HZGHC005626c004
DR   Wikidata; Q93946650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4023; FXR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FXR1 (-) 3
AC   CVCL_XP00
SY   HZGHC005627c001; FXR1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XP00
DR   Horizon_Discovery; HZGHC005627c001
DR   Wikidata; Q93946652
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4023; FXR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FXR1 (-) 4
AC   CVCL_XP01
SY   HZGHC005627c009; FXR1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XP01
DR   Horizon_Discovery; HZGHC005627c009
DR   Wikidata; Q93946655
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4023; FXR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FXR2 (-)
AC   CVCL_C8FM
SY   HZGHC007894c012; FXR2 knockout cell line 32bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007894c012
DR   Wikidata; Q123031422
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4024; FXR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 FYN (-) 1
AC   CVCL_SP07
SY   HZGHC022023c008; FYN knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SP07
DR   Horizon_Discovery; HZGHC022023c008
DR   Wikidata; Q54874093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FYN (-) 2
AC   CVCL_SP08
SY   HZGHC022023c020; FYN knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SP08
DR   Horizon_Discovery; HZGHC022023c020
DR   Wikidata; Q54874095
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FYN (-) 3
AC   CVCL_SP09
SY   HZGHC022023c023; FYN knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP09
DR   Horizon_Discovery; HZGHC022023c023
DR   Wikidata; Q54874096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD1 (-) 1
AC   CVCL_SP10
SY   HZGHC001072c003; FZD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP10
DR   Horizon_Discovery; HZGHC001072c003
DR   Wikidata; Q54874097
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4038; FZD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD1 (-) 2
AC   CVCL_SP11
SY   HZGHC001072c005; FZD1 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SP11
DR   Horizon_Discovery; HZGHC001072c005
DR   Wikidata; Q54874098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4038; FZD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD2 (-)
AC   CVCL_SP12
SY   HZGHC001527c005; FZD2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP12
DR   Horizon_Discovery; HZGHC001527c005
DR   Wikidata; Q54874099
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4040; FZD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001527c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FZD3 (-) 1
AC   CVCL_SP13
SY   HZGHC001074c002; FZD3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SP13
DR   Horizon_Discovery; HZGHC001074c002
DR   Wikidata; Q54874101
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4041; FZD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD3 (-) 2
AC   CVCL_SP14
SY   HZGHC001074c004; FZD3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP14
DR   Horizon_Discovery; HZGHC001074c004
DR   Wikidata; Q54874103
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4041; FZD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD4 (-) 1
AC   CVCL_SP15
SY   HZGHC001079c012; FZD4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP15
DR   Horizon_Discovery; HZGHC001079c012
DR   Wikidata; Q54874104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4042; FZD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001079c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 FZD4 (-) 2
AC   CVCL_SP16
SY   HZGHC001079c008; FZD4 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SP16
DR   Horizon_Discovery; HZGHC001079c008
DR   Wikidata; Q54874105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4042; FZD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD4 (-) 3
AC   CVCL_SP17
SY   HZGHC001079c010; FZD4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP17
DR   Horizon_Discovery; HZGHC001079c010
DR   Wikidata; Q54874106
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4042; FZD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD5 (-)
AC   CVCL_SP18
SY   HZGHC001528c001; FZD5 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SP18
DR   Horizon_Discovery; HZGHC001528c001
DR   Wikidata; Q54874108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4043; FZD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD6 (-) 1
AC   CVCL_SP19
SY   HZGHC001049c011; FZD6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP19
DR   Horizon_Discovery; HZGHC001049c011
DR   Wikidata; Q54874109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4044; FZD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD6 (-) 2
AC   CVCL_SP20
SY   HZGHC001049c012; FZD6 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SP20
DR   Horizon_Discovery; HZGHC001049c012
DR   Wikidata; Q54874110
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4044; FZD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD7 (-) 1
AC   CVCL_SP21
SY   HZGHC001080c002; FZD7 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SP21
DR   Horizon_Discovery; HZGHC001080c002
DR   Wikidata; Q54874111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD7 (-) 2
AC   CVCL_SP22
SY   HZGHC001080c012; FZD7 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SP22
DR   Horizon_Discovery; HZGHC001080c012
DR   Wikidata; Q54874112
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD8 (-) 1
AC   CVCL_SP23
SY   HZGHC001525c002; FZD8 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SP23
DR   Horizon_Discovery; HZGHC001525c002
DR   Wikidata; Q54874113
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4046; FZD8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD8 (-) 2
AC   CVCL_SP24
SY   HZGHC001525c007; FZD8 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SP24
DR   Horizon_Discovery; HZGHC001525c007
DR   Wikidata; Q54874115
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4046; FZD8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD9 (-) 1
AC   CVCL_SP25
SY   HZGHC001065c001; FZD9 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SP25
DR   Horizon_Discovery; HZGHC001065c001
DR   Wikidata; Q54874116
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4047; FZD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD9 (-) 2
AC   CVCL_SP26
SY   HZGHC001065c011; FZD9 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SP26
DR   Horizon_Discovery; HZGHC001065c011
DR   Wikidata; Q54874117
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4047; FZD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD9 (-) 3
AC   CVCL_SP27
SY   HZGHC001489c003; FZD9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP27
DR   Horizon_Discovery; HZGHC001489c003
DR   Wikidata; Q54874119
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4047; FZD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD9 (-) 4
AC   CVCL_SP28
SY   HZGHC001489c006; FZD9 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SP28
DR   Horizon_Discovery; HZGHC001489c006
DR   Wikidata; Q54874120
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4047; FZD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 FZD9 (-) 5
AC   CVCL_SP29
SY   HZGHC001489c008; FZD9 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SP29
DR   Horizon_Discovery; HZGHC001489c008
DR   Wikidata; Q54874121
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4047; FZD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GAA (-)
AC   CVCL_SP30
SY   HZGHC004204c004; GAA knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SP30
DR   Horizon_Discovery; HZGHC004204c004
DR   Wikidata; Q54874123
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GAB1 (-) 1
AC   CVCL_SP31
SY   HZGHC005387c010; GAB1 knockout cell line 35bp deletion; HAP1 GAB1 (-)
DR   cancercelllines; CVCL_SP31
DR   Horizon_Discovery; HZGHC005387c010
DR   Wikidata; Q54874124
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4066; GAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005387c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GAB1 (-) 2
AC   CVCL_XP02
SY   HZGHC005387c011; GAB1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XP02
DR   Horizon_Discovery; HZGHC005387c011
DR   Wikidata; Q93946815
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4066; GAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABARAP (-) 1
AC   CVCL_SP32
SY   HZGHC003053c009; GABARAP knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SP32
DR   Horizon_Discovery; HZGHC003053c009
DR   Wikidata; Q54874126
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4067; GABARAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABARAP (-) 2
AC   CVCL_SP33
SY   HZGHC003053c012; GABARAP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SP33
DR   Horizon_Discovery; HZGHC003053c012
DR   Wikidata; Q54874127
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4067; GABARAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABARAP (-) 3
AC   CVCL_SP34
SY   HZGHC003054c004; GABARAP knockout cell line 1bp deletion in exon 3
DR   cancercelllines; CVCL_SP34
DR   Horizon_Discovery; HZGHC003054c004
DR   Wikidata; Q54874128
RX   PubMed=30679523;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4067; GABARAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GABARAP (-) 4
AC   CVCL_SP35
SY   HZGHC003054c011; GABARAP knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SP35
DR   Horizon_Discovery; HZGHC003054c011
DR   Wikidata; Q54874129
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4067; GABARAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABARAP (-) 5
AC   CVCL_SP36
SY   HZGHC003054c012; GABARAP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP36
DR   Horizon_Discovery; HZGHC003054c012
DR   Wikidata; Q54874130
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4067; GABARAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003054c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GABARAPL1 (-) 1
AC   CVCL_SP37
SY   HZGHC003055c010; GABARAPL1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP37
DR   Horizon_Discovery; HZGHC003055c010
DR   Wikidata; Q54874132
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4068; GABARAPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABARAPL1 (-) 2
AC   CVCL_SP38
SY   HZGHC003055c011; GABARAPL1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SP38
DR   Horizon_Discovery; HZGHC003055c011
DR   Wikidata; Q54874133
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4068; GABARAPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABARAPL2 (-) 1
AC   CVCL_SP39
SY   HZGHC003057c001; GABARAPL2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP39
DR   Horizon_Discovery; HZGHC003057c001
DR   Wikidata; Q54874134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13291; GABARAPL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABARAPL2 (-) 2
AC   CVCL_SP40
SY   HZGHC003057c006; GABARAPL2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SP40
DR   Horizon_Discovery; HZGHC003057c006
DR   Wikidata; Q54874136
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13291; GABARAPL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABBR1 (-) 1
AC   CVCL_SP41
SY   HZGHC003820c010; GABBR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP41
DR   Horizon_Discovery; HZGHC003820c010
DR   Wikidata; Q54874137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4070; GABBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABBR1 (-) 2
AC   CVCL_SP42
SY   HZGHC003820c011; GABBR1 knockout cell line 89bp insertion
DR   cancercelllines; CVCL_SP42
DR   Horizon_Discovery; HZGHC003820c011
DR   Wikidata; Q54874138
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4070; GABBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003820c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GABRA5 (-) 1
AC   CVCL_SP43
SY   HZGHC003834c004; GABRA5 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SP43
DR   Horizon_Discovery; HZGHC003834c004
DR   Wikidata; Q54874139
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4079; GABRA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABRA5 (-) 2
AC   CVCL_SP44
SY   HZGHC003834c011; GABRA5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SP44
DR   Horizon_Discovery; HZGHC003834c011
DR   Wikidata; Q54874140
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4079; GABRA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABRB3 (-) 1
AC   CVCL_SP45
SY   HZGHC003826c003; GABRB3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP45
DR   Horizon_Discovery; HZGHC003826c003
DR   Wikidata; Q54874142
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4083; GABRB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GABRB3 (-) 2
AC   CVCL_SP46
SY   HZGHC003826c011; GABRB3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP46
DR   Horizon_Discovery; HZGHC003826c011
DR   Wikidata; Q54875424
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4083; GABRB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GAD1 (-) 1
AC   CVCL_SP47
SY   HZGHC006161c001; GAD1 knockout cell line 1bp insertion; HAP1 GAD1 (-)
DR   cancercelllines; CVCL_SP47
DR   Horizon_Discovery; HZGHC006161c001
DR   Wikidata; Q54875425
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4092; GAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GAD1 (-) 2
AC   CVCL_XP03
SY   HZGHC006161c002; GAD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XP03
DR   Horizon_Discovery; HZGHC006161c002
DR   Wikidata; Q93946874
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4092; GAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GAK (-) 1
AC   CVCL_SP48
SY   HZGHC000086c004; GAK knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SP48
DR   Horizon_Discovery; HZGHC000086c004
DR   Wikidata; Q54875426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4113; GAK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GAK (-) 2
AC   CVCL_SP49
SY   HZGHC000086c007; GAK knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP49
DR   Horizon_Discovery; HZGHC000086c007
DR   Wikidata; Q54875427
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4113; GAK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GAK (-) 3
AC   CVCL_SP50
SY   HZGHC000086c020; GAK knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP50
DR   Horizon_Discovery; HZGHC000086c020
DR   Wikidata; Q54875428
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4113; GAK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GALC (-)
AC   CVCL_E1XZ
SY   HZGHC008137c005
DR   Horizon_Discovery; HZGHC008137c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4115; GALC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GALK2 (-) 1
AC   CVCL_DX01
SY   HZGHC007481c003; GALK2 knockout cell line 1bp insertion in exon 8
DR   Horizon_Discovery; HZGHC007481c003
DR   Wikidata; Q127381047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4119; GALK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GALK2 (-) 2
AC   CVCL_DX02
SY   HZGHC007481c012; GALK2 knockout cell line 8bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007481c012
DR   Wikidata; Q127381048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4119; GALK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GALK2 (-) NAGK (-)
AC   CVCL_DX36
SY   HZGHC007492c010; Double knockout cell line GALK2 1bp insertion in exon 8 and NAGK 29bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007492c010
DR   Wikidata; Q127381049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4119; GALK2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17174; NAGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DX01 ! HAP1 GALK2 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GALNS (-) 1
AC   CVCL_E1Y0
SY   HZGHC007982c007
DR   Horizon_Discovery; HZGHC007982c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4122; GALNS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GALNS (-) 2
AC   CVCL_E1Y1
SY   HZGHC007982c011
DR   Horizon_Discovery; HZGHC007982c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4122; GALNS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GALT (-) 1
AC   CVCL_SP51
SY   HZGHC000518c003; GALT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP51
DR   Horizon_Discovery; HZGHC000518c003
DR   Wikidata; Q54875429
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4135; GALT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GALT (-) 2
AC   CVCL_SP52
SY   HZGHC000518c005; GALT knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP52
DR   Horizon_Discovery; HZGHC000518c005
DR   Wikidata; Q54875430
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4135; GALT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000518c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GAMT (-)
AC   CVCL_SP53
SY   HZGHC003770c002; GAMT knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SP53
DR   Horizon_Discovery; HZGHC003770c002
DR   Wikidata; Q54875431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4136; GAMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GAN (-)
AC   CVCL_DX03
SY   HZGHC008040c002; GAN knockout cell line 19bp deletion
DR   Horizon_Discovery; HZGHC008040c002
DR   Wikidata; Q127381050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4137; GAN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GAN (-) SLC35A1 (-) 1
AC   CVCL_DX37
SY   HZGHC008094c003; Double knockout cell line GAN 10bp deletion and SLC35A1 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008094c003
DR   Wikidata; Q127381051
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4137; GAN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TN03 ! HAP1 SLC35A1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GAN (-) SLC35A1 (-) 2
AC   CVCL_DX38
SY   HZGHC008094c006; Double knockout cell line GAN 16bp deletion and SLC35A1 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008094c006
DR   Wikidata; Q127381052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4137; GAN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TN03 ! HAP1 SLC35A1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GAN (-) SLC35A1 (-) 3
AC   CVCL_DX39
SY   HZGHC008094c007; Double knockout cell line GAN 19bp deletion and SLC35A1 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008094c007
DR   Wikidata; Q127381053
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4137; GAN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TN03 ! HAP1 SLC35A1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GAN (-) SLC35A1 (-) 4
AC   CVCL_DX40
SY   HZGHC008094c008; Double knockout cell line GAN 85bp deletion and SLC35A1 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008094c008
DR   Wikidata; Q127381054
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4137; GAN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TN03 ! HAP1 SLC35A1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GANAB (-) 1
AC   CVCL_SP54
SY   HZGHC003695c004; GANAB knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP54
DR   Horizon_Discovery; HZGHC003695c004
DR   Wikidata; Q54875432
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4138; GANAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GANAB (-) 2
AC   CVCL_SP55
SY   HZGHC003695c012; GANAB knockout cell line 190bp insertion
DR   cancercelllines; CVCL_SP55
DR   Horizon_Discovery; HZGHC003695c012
DR   Wikidata; Q54875433
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4138; GANAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GANC (-) 1
AC   CVCL_SP56
SY   HZGHC003841c003; GANC knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SP56
DR   Horizon_Discovery; HZGHC003841c003
DR   Wikidata; Q54875434
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4139; GANC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GANC (-) 2
AC   CVCL_SP57
SY   HZGHC003841c004; GANC knockout cell line 37bp deletion
DR   cancercelllines; CVCL_SP57
DR   Horizon_Discovery; HZGHC003841c004
DR   Wikidata; Q54875435
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4139; GANC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GATA2 (-) 1
AC   CVCL_SP58
SY   HZGHC006598c012; GATA2 knockout cell line 1bp insertion; HAP1 GATA2 (-)
DR   cancercelllines; CVCL_SP58
DR   Horizon_Discovery; HZGHC006598c012
DR   Wikidata; Q54875436
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GATA2 (-) 2
AC   CVCL_XP04
SY   HZGHC006598c002; GATA2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP04
DR   Horizon_Discovery; HZGHC006598c002
DR   Wikidata; Q93946973
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006598c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GATA2 (-) 3
AC   CVCL_XP05
SY   HZGHC006599c002; GATA2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XP05
DR   Horizon_Discovery; HZGHC006599c002
DR   Wikidata; Q93946975
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GATA2 (-) 4
AC   CVCL_XP06
SY   HZGHC006599c011; GATA2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XP06
DR   Horizon_Discovery; HZGHC006599c011
DR   Wikidata; Q93946978
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GATA3 (-) 1
AC   CVCL_SP59
SY   HZGHC005389c010; GATA3 knockout cell line 37bp deletion; HAP1 GATA3 (-)
DR   cancercelllines; CVCL_SP59
DR   Horizon_Discovery; HZGHC005389c010
DR   Wikidata; Q54875437
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4172; GATA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GATA3 (-) 2
AC   CVCL_XP07
SY   HZGHC005389c002; GATA3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XP07
DR   Horizon_Discovery; HZGHC005389c002
DR   Wikidata; Q93946986
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4172; GATA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GATM (-) 1
AC   CVCL_E1Y2
SY   HZGHC007887c010
DR   Horizon_Discovery; HZGHC007887c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4175; GATM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GATM (-) 2
AC   CVCL_E1Y3
SY   HZGHC007887c011
DR   Horizon_Discovery; HZGHC007887c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4175; GATM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GBA (-) 1
AC   CVCL_SP60
SY   HZGHC002786c001; GBA knockout cell line 479bp insertion
DR   cancercelllines; CVCL_SP60
DR   Horizon_Discovery; HZGHC002786c001
DR   Wikidata; Q54875438
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002786c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GBA (-) 2
AC   CVCL_SP61
SY   HZGHC004523c001; GBA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP61
DR   Horizon_Discovery; HZGHC004523c001
DR   Wikidata; Q54875439
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBA (-) 3
AC   CVCL_SP62
SY   HZGHC004523c011; GBA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP62
DR   Horizon_Discovery; HZGHC004523c011
DR   Wikidata; Q54875440
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004523c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GBA (-) 4
AC   CVCL_SP63
SY   HZGHC004541c001; GBA knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SP63
DR   Horizon_Discovery; HZGHC004541c001
DR   Wikidata; Q54875441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBA (-) 5
AC   CVCL_SP64
SY   HZGHC004541c010; GBA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP64
DR   Horizon_Discovery; HZGHC004541c010
DR   Wikidata; Q54875442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBA (-) 6
AC   CVCL_SP65
SY   HZGHC004542c002; GBA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP65
DR   Horizon_Discovery; HZGHC004542c002
DR   Wikidata; Q54875443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBA (-) 7
AC   CVCL_SP66
SY   HZGHC004542c003; GBA knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SP66
DR   Horizon_Discovery; HZGHC004542c003
DR   Wikidata; Q54875444
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004542c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GBA (-) 8
AC   CVCL_SP67
SY   HZGHC004542c012; GBA knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SP67
DR   Horizon_Discovery; HZGHC004542c012
DR   Wikidata; Q54875445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBA2 (-) 1
AC   CVCL_SP68
SY   HZGHC004109c001; GBA2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SP68
DR   Horizon_Discovery; HZGHC004109c001
DR   Wikidata; Q54875446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18986; GBA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GBA2 (-) 2
AC   CVCL_SP69
SY   HZGHC004109c011; GBA2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP69
DR   Horizon_Discovery; HZGHC004109c011
DR   Wikidata; Q54875447
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18986; GBA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GBE1 (-) 1
AC   CVCL_SP70
SY   HZGHC006051c010; GBE1 knockout cell line 1bp deletion; HAP1 GBE1 (-)
DR   cancercelllines; CVCL_SP70
DR   Horizon_Discovery; HZGHC006051c010
DR   Wikidata; Q54875448
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4180; GBE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBE1 (-) 2
AC   CVCL_XP08
SY   HZGHC006051c004; GBE1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XP08
DR   Horizon_Discovery; HZGHC006051c004
DR   Wikidata; Q93947097
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4180; GBE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GBP1 (-) 1
AC   CVCL_SP71
SY   HZGHC001497c003; GBP1 knockout cell line 194bp insertion
DR   cancercelllines; CVCL_SP71
DR   Horizon_Discovery; HZGHC001497c003
DR   Wikidata; Q54875449
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4182; GBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001497c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBP1 (-) 2
AC   CVCL_SP72
SY   HZGHC001497c005; GBP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SP72
DR   Horizon_Discovery; HZGHC001497c005
DR   Wikidata; Q54875450
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4182; GBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GBP2 (-) 1
AC   CVCL_SP73
SY   HZGHC001500c012; GBP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP73
DR   Horizon_Discovery; HZGHC001500c012
DR   Wikidata; Q54875451
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4183; GBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001500c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GBP2 (-) 2
AC   CVCL_SP74
SY   HZGHC001500c002; GBP2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP74
DR   Horizon_Discovery; HZGHC001500c002
DR   Wikidata; Q54875452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4183; GBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GBP2 (-) 3
AC   CVCL_SP75
SY   HZGHC001500c010; GBP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP75
DR   Horizon_Discovery; HZGHC001500c010
DR   Wikidata; Q54875453
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4183; GBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GBP5 (-) 1
AC   CVCL_SP76
SY   HZGHC001503c003; GBP5 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SP76
DR   Horizon_Discovery; HZGHC001503c003
DR   Wikidata; Q54875454
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19895; GBP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GBP5 (-) 2
AC   CVCL_SP77
SY   HZGHC001503c010; GBP5 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SP77
DR   Horizon_Discovery; HZGHC001503c010
DR   Wikidata; Q54875455
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19895; GBP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCDH (-) 1
AC   CVCL_SP78
SY   HZGHC001789c009; GCDH knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SP78
DR   Horizon_Discovery; HZGHC001789c009
DR   Wikidata; Q54875456
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4189; GCDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCDH (-) 2
AC   CVCL_SP79
SY   HZGHC001789c010; GCDH knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SP79
DR   Horizon_Discovery; HZGHC001789c010
DR   Wikidata; Q54875457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4189; GCDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCDH (-) 3
AC   CVCL_SP80
SY   HZGHC001824c004; GCDH knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SP80
DR   Horizon_Discovery; HZGHC001824c004
DR   Wikidata; Q54875458
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4189; GCDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCH1 (-) 1
AC   CVCL_SP81
SY   HZGHC003409c003; GCH1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP81
DR   Horizon_Discovery; HZGHC003409c003
DR   Wikidata; Q54875459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4193; GCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCH1 (-) 2
AC   CVCL_SP82
SY   HZGHC003409c012; GCH1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP82
DR   Horizon_Discovery; HZGHC003409c012
DR   Wikidata; Q54875460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4193; GCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCLM (-) 1
AC   CVCL_SP83
SY   HZGHC004783c005; GCLM knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SP83
DR   Horizon_Discovery; HZGHC004783c005
DR   Wikidata; Q54875461
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4312; GCLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCLM (-) 2
AC   CVCL_SP84
SY   HZGHC004783c006; GCLM knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SP84
DR   Horizon_Discovery; HZGHC004783c006
DR   Wikidata; Q54875462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4312; GCLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCN1L1 (-) 1
AC   CVCL_SP85
SY   HZGHC000815c005; GCN1L1 knockout cell line 110bp insertion
DR   cancercelllines; CVCL_SP85
DR   Horizon_Discovery; HZGHC000815c005
DR   Wikidata; Q54875463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4199; GCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000815c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GCN1L1 (-) 2
AC   CVCL_SP86
SY   HZGHC000815c012; GCN1L1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SP86
DR   Horizon_Discovery; HZGHC000815c012
DR   Wikidata; Q54875465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4199; GCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCN1L1 (-) 3
AC   CVCL_SP87
SY   HZGHC000816c004; GCN1L1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SP87
DR   Horizon_Discovery; HZGHC000816c004
DR   Wikidata; Q54875466
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4199; GCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GCN1L1 (-) 4
AC   CVCL_SP88
SY   HZGHC000816c010; GCN1L1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SP88
DR   Horizon_Discovery; HZGHC000816c010
DR   Wikidata; Q54875467
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4199; GCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GEN1 (-)
AC   CVCL_SP89
SY   HZGHC002924c005; GEN1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP89
DR   Horizon_Discovery; HZGHC002924c005
DR   Wikidata; Q54875468
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26881; GEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GFPT1 (-)
AC   CVCL_SP90
SY   HZGHC006080c007; GFPT1 knockout cell line 82bp deletion
DR   cancercelllines; CVCL_SP90
DR   Horizon_Discovery; HZGHC006080c007
DR   Wikidata; Q54875469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4241; GFPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GGA1 (-) 1
AC   CVCL_SP91
SY   HZGHC002831c012; GGA1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SP91
DR   Horizon_Discovery; HZGHC002831c012
DR   Wikidata; Q54875470
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17842; GGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GGA1 (-) 2
AC   CVCL_SP92
SY   HZGHC003406c010; GGA1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP92
DR   Horizon_Discovery; HZGHC003406c010
DR   Wikidata; Q54875471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17842; GGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GGA1 (-) 3
AC   CVCL_SP93
SY   HZGHC003406c011; GGA1 knockout cell line 122bp deletion
DR   cancercelllines; CVCL_SP93
DR   Horizon_Discovery; HZGHC003406c011
DR   Wikidata; Q54875472
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17842; GGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GGA1 (-) 4
AC   CVCL_SP94
SY   HZGHC003407c001; GGA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP94
DR   Horizon_Discovery; HZGHC003407c001
DR   Wikidata; Q54875473
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17842; GGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GGA1 (-) 5
AC   CVCL_SP95
SY   HZGHC003407c006; GGA1 knockout cell line 46bp deletion
DR   cancercelllines; CVCL_SP95
DR   Horizon_Discovery; HZGHC003407c006
DR   Wikidata; Q54875474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17842; GGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GGCX (-)
AC   CVCL_SP96
SY   HZGHC003833c011; GGCX knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SP96
DR   Horizon_Discovery; HZGHC003833c011
DR   Wikidata; Q54875475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4247; GGCX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GGT7 (-)
AC   CVCL_SP97
SY   HZGHC006602c007; GGT7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SP97
DR   Horizon_Discovery; HZGHC006602c007
DR   Wikidata; Q54875476
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4259; GGT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GHITM (-) 1
AC   CVCL_SP98
SY   HZGHC004039c003; GHITM knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SP98
DR   Horizon_Discovery; HZGHC004039c003
DR   Wikidata; Q54875477
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17281; GHITM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GHITM (-) 2
AC   CVCL_SP99
SY   HZGHC004039c011; GHITM knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SP99
DR   Horizon_Discovery; HZGHC004039c011
DR   Wikidata; Q54875478
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17281; GHITM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GHITM (-) 3
AC   CVCL_SQ00
SY   HZGHC004040c002; GHITM knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SQ00
DR   Horizon_Discovery; HZGHC004040c002
DR   Wikidata; Q54875479
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17281; GHITM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GID4 (-) 1
AC   CVCL_SQ01
SY   HZGHC005714c002; GID4 knockout cell line 2bp insertion; HAP1 GID4 (-)
DR   cancercelllines; CVCL_SQ01
DR   Horizon_Discovery; HZGHC005714c002
DR   Wikidata; Q54875480
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28453; GID4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GID4 (-) 2
AC   CVCL_XP09
SY   HZGHC005714c003; GID4 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_XP09
DR   Horizon_Discovery; HZGHC005714c003
DR   Wikidata; Q93947297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28453; GID4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GID4 (-) 3
AC   CVCL_XP10
SY   HZGHC005724c004; GID4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XP10
DR   Horizon_Discovery; HZGHC005724c004
DR   Wikidata; Q93947299
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28453; GID4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GID4 (-) 4
AC   CVCL_XP11
SY   HZGHC005724c011; GID4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XP11
DR   Horizon_Discovery; HZGHC005724c011
DR   Wikidata; Q93947302
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28453; GID4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GIT1 (-) 1
AC   CVCL_SQ02
SY   HZGHC005828c003; GIT1 knockout cell line 1bp insertion; HAP1 GIT1 (-)
DR   cancercelllines; CVCL_SQ02
DR   Horizon_Discovery; HZGHC005828c003
DR   Wikidata; Q54875481
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4272; GIT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GIT1 (-) 2
AC   CVCL_XP12
SY   HZGHC005828c009; GIT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP12
DR   Horizon_Discovery; HZGHC005828c009
DR   Wikidata; Q93947310
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4272; GIT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005828c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GJB6 (-)
AC   CVCL_E1Y4
SY   HZGHC007790c004
DR   Horizon_Discovery; HZGHC007790c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4288; GJB6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GLA (-) 1
AC   CVCL_SQ03
SY   HZGHC006165c003; GLA knockout cell line 170bp insertion; HAP1 GLA (-)
DR   cancercelllines; CVCL_SQ03
DR   Horizon_Discovery; HZGHC006165c003
DR   Wikidata; Q54875482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006165c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GLA (-) 2
AC   CVCL_XP13
SY   HZGHC006165c004; GLA knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XP13
DR   Horizon_Discovery; HZGHC006165c004
DR   Wikidata; Q93947320
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006165c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLB1 (-) 1
AC   CVCL_XP14
SY   HZGHC007272c002; HZGHC2720; GLB1 knockout cell line 1bp insertion in exon 8; HAP1 GLB1 (-)
DR   cancercelllines; CVCL_XP14
DR   Horizon_Discovery; HZGHC007272c002
DR   Wikidata; Q93947324
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLB1 (-) 2
AC   CVCL_B5K6
SY   HZGHC007272c006; GLB1 knockout cell line 70bp insertion in exon 8
DR   cancercelllines; CVCL_B5K6
DR   Horizon_Discovery; HZGHC007272c006
DR   Wikidata; Q111733293
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007272c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 GLO1 (-) 1
AC   CVCL_SQ04
SY   HZGHC006372c004; GLO1 knockout cell line 7bp deletion; HAP1 GLO1 (-)
DR   cancercelllines; CVCL_SQ04
DR   Horizon_Discovery; HZGHC006372c004
DR   Wikidata; Q54875483
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4323; GLO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLO1 (-) 2
AC   CVCL_XP15
SY   HZGHC006372c008; GLO1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP15
DR   Horizon_Discovery; HZGHC006372c008
DR   Wikidata; Q93947332
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4323; GLO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GLOD4 (-) 1
AC   CVCL_SQ05
SY   HZGHC005761c011; GLOD4 knockout cell line 19bp deletion; HAP1 GLOD4 (-)
DR   cancercelllines; CVCL_SQ05
DR   Horizon_Discovery; HZGHC005761c011
DR   Wikidata; Q54875484
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14111; GLOD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLOD4 (-) 2
AC   CVCL_XP16
SY   HZGHC005762c001; GLOD4 knockout cell line 61bp insertion
DR   cancercelllines; CVCL_XP16
DR   Horizon_Discovery; HZGHC005762c001
DR   Wikidata; Q93947340
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14111; GLOD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005762c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLOD4 (-) 3
AC   CVCL_XP17
SY   HZGHC005762c010; GLOD4 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XP17
DR   Horizon_Discovery; HZGHC005762c010
DR   Wikidata; Q93947344
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14111; GLOD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GLRB (-) 1
AC   CVCL_SQ06
SY   HZGHC003738c004; GLRB knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SQ06
DR   Horizon_Discovery; HZGHC003738c004
DR   Wikidata; Q54875485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4329; GLRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GLRB (-) 2
AC   CVCL_SQ07
SY   HZGHC003738c012; GLRB knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SQ07
DR   Horizon_Discovery; HZGHC003738c012
DR   Wikidata; Q54875486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4329; GLRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GLRX5 (-) 1
AC   CVCL_XP18
SY   HZGHC006827c012; HZGHC51218; GLRX5 knockout cell line 25bp deletion in exon 1; HAP1 GLRX5 (-)
DR   cancercelllines; CVCL_XP18
DR   Horizon_Discovery; HZGHC006827c012
DR   Wikidata; Q93947358
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20134; GLRX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GLRX5 (-) 2
AC   CVCL_E1Y5
SY   HZGHC006826c002; GLRX5 knockout cell line 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC006826c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20134; GLRX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GLS (-) 1
AC   CVCL_SQ08
SY   HZGHC004071c005; GLS knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ08
DR   Horizon_Discovery; HZGHC004071c005
DR   Wikidata; Q54875487
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4331; GLS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLS (-) 2
AC   CVCL_SQ09
SY   HZGHC004071c007; GLS knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ09
DR   Horizon_Discovery; HZGHC004071c007
DR   Wikidata; Q54875488
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4331; GLS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLUD1 (-) 1
AC   CVCL_SQ10
SY   HZGHC006487c001; GLUD1 knockout cell line 1bp insertion; HAP1 GLUD1 (-)
DR   cancercelllines; CVCL_SQ10
DR   Horizon_Discovery; HZGHC006487c001
DR   Wikidata; Q54875489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4335; GLUD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLUD1 (-) 2
AC   CVCL_XP19
SY   HZGHC006487c010; GLUD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP19
DR   Horizon_Discovery; HZGHC006487c010
DR   PRIDE; PXD010335
DR   Wikidata; Q93947372
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4335; GLUD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GLUD1 (-) 3
AC   CVCL_XP20
SY   HZGHC006487c011; GLUD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP20
DR   Horizon_Discovery; HZGHC006487c011
DR   PRIDE; PXD010335
DR   Wikidata; Q93947374
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4335; GLUD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006487c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLUD1 (-) 4
AC   CVCL_XP21
SY   HZGHC006488c010; GLUD1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XP21
DR   Horizon_Discovery; HZGHC006488c010
DR   Wikidata; Q93947377
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4335; GLUD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GLUD1 (-) 5
AC   CVCL_XP22
SY   HZGHC006488c012; GLUD1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XP22
DR   Horizon_Discovery; HZGHC006488c012
DR   Wikidata; Q93947379
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4335; GLUD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GLUL (-) 1
AC   CVCL_SQ11
SY   HZGHC005979c001; GLUL knockout cell line 4bp deletion; HAP1 GLUL (-)
DR   cancercelllines; CVCL_SQ11
DR   Horizon_Discovery; HZGHC005979c001
DR   Wikidata; Q54875490
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GLUL (-) 2
AC   CVCL_XP23
SY   HZGHC005979c010; GLUL knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XP23
DR   Horizon_Discovery; HZGHC005979c010
DR   Wikidata; Q93947388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GMDS (-)
AC   CVCL_SQ12
SY   HZGHC006029c006; GMDS knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SQ12
DR   Horizon_Discovery; HZGHC006029c006
DR   Wikidata; Q54875491
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4369; GMDS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNAQ (-) 1
AC   CVCL_SQ13
SY   HZGHC004862c001; GNAQ knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SQ13
DR   Horizon_Discovery; HZGHC004862c001
DR   Wikidata; Q54875492
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4390; GNAQ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNAQ (-) 2
AC   CVCL_SQ14
SY   HZGHC004862c012; GNAQ knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SQ14
DR   Horizon_Discovery; HZGHC004862c012
DR   Wikidata; Q54875493
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4390; GNAQ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNE (-) 1
AC   CVCL_SQ15
SY   HZGHC032395c007; GNE knockout cell line 40bp deletion
DR   cancercelllines; CVCL_SQ15
DR   Horizon_Discovery; HZGHC032395c007
DR   Wikidata; Q54875494
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23657; GNE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNE (-) 2
AC   CVCL_SQ16
SY   HZGHC032395c010; GNE knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ16
DR   Horizon_Discovery; HZGHC032395c010
DR   Wikidata; Q54875495
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23657; GNE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC032395c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GNE (-) 3
AC   CVCL_SQ17
SY   HZGHC032395c020; GNE knockout cell line 184bp insertion
DR   cancercelllines; CVCL_SQ17
DR   Horizon_Discovery; HZGHC032395c020
DR   Wikidata; Q54875496
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23657; GNE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC032395c020; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GNG5 (-) 1
AC   CVCL_SQ18
SY   HZGHC005763c001; GNG5 knockout cell line 1bp insertion; HAP1 GNG5 (-)
DR   cancercelllines; CVCL_SQ18
DR   Horizon_Discovery; HZGHC005763c001
DR   Wikidata; Q54875497
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4408; GNG5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GNG5 (-) 2
AC   CVCL_XP24
SY   HZGHC005763c007; GNG5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XP24
DR   Horizon_Discovery; HZGHC005763c007
DR   Wikidata; Q93947432
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4408; GNG5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNPDA2 (-)
AC   CVCL_XP25
SY   HZGHC007210c002; HZGHC132789; GNPDA2 knockout cell line 1bp insertion in exon 5
DR   cancercelllines; CVCL_XP25
DR   Horizon_Discovery; HZGHC007210c002
DR   Wikidata; Q93947433
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21526; GNPDA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GNPTAB (-)
AC   CVCL_SQ19
SY   HZGHC001785c004; GNPTAB knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SQ19
DR   Horizon_Discovery; HZGHC001785c004
DR   Wikidata; Q54875498
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29670; GNPTAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNPTAB (-) POMK (-) 1
AC   CVCL_DX41
SY   HZGHC007375c003; Double knockout cell line GNPTAB 1bp deletion in exon 2 and POMK 10bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007375c003
DR   Wikidata; Q127381055
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29670; GNPTAB.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26267; POMK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TF19 ! HAP1 POMK (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GNPTAB (-) POMK (-) 2
AC   CVCL_DX42
SY   HZGHC007375c012; Double knockout cell line GNPTAB 2bp deletion in exon 2 and POMK 10bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007375c012
DR   Wikidata; Q127381056
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29670; GNPTAB.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26267; POMK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TF19 ! HAP1 POMK (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 GNPTG (-) 1
AC   CVCL_SQ20
SY   HZGHC001784c005; GNPTG knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SQ20
DR   Horizon_Discovery; HZGHC001784c005
DR   Wikidata; Q54875499
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23026; GNPTG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNPTG (-) 2
AC   CVCL_SQ21
SY   HZGHC001784c012; GNPTG knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ21
DR   Horizon_Discovery; HZGHC001784c012
DR   Wikidata; Q54875500
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23026; GNPTG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNPTG (-) 3
AC   CVCL_SQ22
SY   HZGHC002542c002; GNPTG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SQ22
DR   Horizon_Discovery; HZGHC002542c002
DR   Wikidata; Q54875501
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23026; GNPTG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNPTG (-) 4
AC   CVCL_SQ23
SY   HZGHC002542c004; GNPTG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SQ23
DR   Horizon_Discovery; HZGHC002542c004
DR   Wikidata; Q54875502
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23026; GNPTG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNPTG (-) 5
AC   CVCL_SQ24
SY   HZGHC002542c006; GNPTG knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SQ24
DR   Horizon_Discovery; HZGHC002542c006
DR   Wikidata; Q54875503
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23026; GNPTG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GNS (-) 1
AC   CVCL_E1Y6
SY   HZGHC008076c005
DR   Horizon_Discovery; HZGHC008076c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4422; GNS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GNS (-) 2
AC   CVCL_E1Y7
SY   HZGHC008076c008
DR   Horizon_Discovery; HZGHC008076c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4422; GNS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GOLGA2 (-) 1
AC   CVCL_SQ25
SY   HZGHC006330c001; GOLGA2 knockout cell line 13bp deletion; HAP1 GOLGA2 (-)
DR   cancercelllines; CVCL_SQ25
DR   Horizon_Discovery; HZGHC006330c001
DR   Wikidata; Q54875505
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4425; GOLGA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GOLGA2 (-) 2
AC   CVCL_XP26
SY   HZGHC006330c011; GOLGA2 knockout cell line 46bp deletion
DR   cancercelllines; CVCL_XP26
DR   Horizon_Discovery; HZGHC006330c011
DR   Wikidata; Q93947459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4425; GOLGA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GOLGB1 (-) 1
AC   CVCL_SQ26
SY   HZGHC006169c001; GOLGB1 knockout cell line 1bp deletion; HAP1 GOLGB1 (-)
DR   cancercelllines; CVCL_SQ26
DR   Horizon_Discovery; HZGHC006169c001
DR   Wikidata; Q54875507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4429; GOLGB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GOLGB1 (-) 2
AC   CVCL_XP27
SY   HZGHC006169c003; GOLGB1 knockout cell line 176bp insertion
DR   cancercelllines; CVCL_XP27
DR   Horizon_Discovery; HZGHC006169c003
DR   Wikidata; Q93947463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4429; GOLGB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006169c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GOLIM4 (-) 1
AC   CVCL_E1Y8
SY   HZGHC008225c006
DR   Horizon_Discovery; HZGHC008225c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15448; GOLIM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GOLIM4 (-) 2
AC   CVCL_E1Y9
SY   HZGHC008225c012
DR   Horizon_Discovery; HZGHC008225c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15448; GOLIM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GOLIM4 (-) 3
AC   CVCL_E1YA
SY   HZGHC008226c004
DR   Horizon_Discovery; HZGHC008226c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15448; GOLIM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GOLM1 (-) 1
AC   CVCL_XP28
SY   HZGHC007022c003; HZGHC51280; GOLM1 knockout cell line 1bp insertion in exon 8; HAP1 GOLM1 (-)
DR   cancercelllines; CVCL_XP28
DR   Horizon_Discovery; HZGHC007022c003
DR   Wikidata; Q93947464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15451; GOLM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GOLM1 (-) 2
AC   CVCL_E1YB
SY   HZGHC007022c005
DR   Horizon_Discovery; HZGHC007022c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15451; GOLM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GOLPH3 (-) 1
AC   CVCL_SQ27
SY   HZGHC004972c004; GOLPH3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ27
DR   Horizon_Discovery; HZGHC004972c004
DR   Wikidata; Q54875508
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15452; GOLPH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GOLPH3 (-) 2
AC   CVCL_SQ28
SY   HZGHC004972c007; GOLPH3 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SQ28
DR   Horizon_Discovery; HZGHC004972c007
DR   Wikidata; Q54875509
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15452; GOLPH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GORAB (-) 1
AC   CVCL_SQ29
SY   HZGHC006414c002; GORAB knockout cell line 1bp insertion; HAP1 GORAB (-)
DR   cancercelllines; CVCL_SQ29
DR   Horizon_Discovery; HZGHC006414c002
DR   Wikidata; Q54875510
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25676; GORAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GORAB (-) 2
AC   CVCL_XP29
SY   HZGHC006415c010; GORAB knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XP29
DR   Horizon_Discovery; HZGHC006415c010
DR   Wikidata; Q93947474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25676; GORAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GORAB (-) 3
AC   CVCL_XP30
SY   HZGHC006415c011; GORAB knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XP30
DR   Horizon_Discovery; HZGHC006415c011
DR   Wikidata; Q93947477
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25676; GORAB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GOT1 (-) 1
AC   CVCL_SQ30
SY   HZGHC004913c004; GOT1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SQ30
DR   Horizon_Discovery; HZGHC004913c004
DR   Wikidata; Q54875511
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4432; GOT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GOT1 (-) 2
AC   CVCL_SQ31
SY   HZGHC004913c010; GOT1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SQ31
DR   Horizon_Discovery; HZGHC004913c010
DR   Wikidata; Q54875512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4432; GOT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GOT2 (-) 1
AC   CVCL_XP31
SY   HZGHC007199c005; HZGHC2806; GOT2 knockout cell line 4bp deletion in exon 6; HAP1 GOT2 (-)
DR   cancercelllines; CVCL_XP31
DR   Horizon_Discovery; HZGHC007199c005
DR   Wikidata; Q93947485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4433; GOT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GOT2 (-) 2
AC   CVCL_E1YC
SY   HZGHC007199c002
DR   Horizon_Discovery; HZGHC007199c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4433; GOT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPATCH2 (-) 1
AC   CVCL_SQ32
SY   HZGHC003511c002; GPATCH2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SQ32
DR   Horizon_Discovery; HZGHC003511c002
DR   Wikidata; Q54875513
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25499; GPATCH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPATCH2 (-) 2
AC   CVCL_SQ33
SY   HZGHC003511c012; GPATCH2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SQ33
DR   Horizon_Discovery; HZGHC003511c012
DR   Wikidata; Q54875514
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25499; GPATCH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPATCH2 (-) 3
AC   CVCL_SQ34
SY   HZGHC004130c003; GPATCH2 knockout cell line 142bp deletion
DR   cancercelllines; CVCL_SQ34
DR   Horizon_Discovery; HZGHC004130c003
DR   Wikidata; Q54875515
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25499; GPATCH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPATCH2 (-) 4
AC   CVCL_SQ35
SY   HZGHC004130c006; GPATCH2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SQ35
DR   Horizon_Discovery; HZGHC004130c006
DR   Wikidata; Q54875516
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25499; GPATCH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPC3 (-)
AC   CVCL_SQ36
SY   HZGHC006167c012; GPC3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SQ36
DR   Horizon_Discovery; HZGHC006167c012
DR   Wikidata; Q54875517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4451; GPC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPC4 (-) 1
AC   CVCL_SQ37
SY   HZGHC000672c002; GPC4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SQ37
DR   Horizon_Discovery; HZGHC000672c002
DR   Wikidata; Q54875518
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4452; GPC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPC4 (-) 2
AC   CVCL_SQ38
SY   HZGHC000672c006; GPC4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SQ38
DR   Horizon_Discovery; HZGHC000672c006
DR   Wikidata; Q54875519
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4452; GPC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000672c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPD2 (-) 1
AC   CVCL_XP32
SY   HZGHC006862c006; HZGHC2820; GPD2 knockout cell line 182bp deletion in exon 7; HAP1 GPD2 (-)
DR   cancercelllines; CVCL_XP32
DR   Horizon_Discovery; HZGHC006862c006
DR   Wikidata; Q93947534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4456; GPD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GPD2 (-) 2
AC   CVCL_E1YD
SY   HZGHC006862c003
DR   Horizon_Discovery; HZGHC006862c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4456; GPD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPD2 (-) 3
AC   CVCL_E1YE
SY   HZGHC006862c010
DR   Horizon_Discovery; HZGHC006862c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4456; GPD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPHN (-)
AC   CVCL_SQ39
SY   HZGHC006111c003; GPHN knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SQ39
DR   Horizon_Discovery; HZGHC006111c003
DR   Wikidata; Q54875520
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15465; GPHN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPR137 (-) 1
AC   CVCL_SQ40
SY   HZGHC004029c002; GPR137 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SQ40
DR   Horizon_Discovery; HZGHC004029c002
DR   Wikidata; Q54875521
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24300; GPR137.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPR137 (-) 2
AC   CVCL_SQ41
SY   HZGHC004029c003; GPR137 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SQ41
DR   Horizon_Discovery; HZGHC004029c003
DR   Wikidata; Q54875523
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24300; GPR137.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004029c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPR137 (-) 3
AC   CVCL_SQ42
SY   HZGHC004029c007; GPR137 knockout cell line 487bp insertion
DR   cancercelllines; CVCL_SQ42
DR   Horizon_Discovery; HZGHC004029c007
DR   Wikidata; Q54875524
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24300; GPR137.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004029c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPR137 (-) 4
AC   CVCL_SQ43
SY   HZGHC003554c010; GPR137 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SQ43
DR   Horizon_Discovery; HZGHC003554c010
DR   Wikidata; Q54875525
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24300; GPR137.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003554c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPR137B (-) 1
AC   CVCL_SQ44
SY   HZGHC004259c003; GPR137B knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SQ44
DR   Horizon_Discovery; HZGHC004259c003
DR   Wikidata; Q54875526
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11862; GPR137B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPR137B (-) 2
AC   CVCL_SQ45
SY   HZGHC004259c011; GPR137B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SQ45
DR   Horizon_Discovery; HZGHC004259c011
DR   Wikidata; Q54875528
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11862; GPR137B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004259c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPR137C (-) 1
AC   CVCL_SQ46
SY   HZGHC003558c006; GPR137C knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ46
DR   Horizon_Discovery; HZGHC003558c006
DR   Wikidata; Q54875529
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25445; GPR137C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPR137C (-) 2
AC   CVCL_SQ47
SY   HZGHC003558c011; GPR137C knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SQ47
DR   Horizon_Discovery; HZGHC003558c011
DR   Wikidata; Q54875530
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25445; GPR137C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPR137C (-) 3
AC   CVCL_XP33
SY   HZGHC003558c001; GPR137C knockout cell line
DR   cancercelllines; CVCL_XP33
DR   Horizon_Discovery; HZGHC003558c001
DR   Wikidata; Q93947566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25445; GPR137C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003558c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPR75 (-) 1
AC   CVCL_E1YF
SY   HZGHC008028c006
DR   Horizon_Discovery; HZGHC008028c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4526; GPR75.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPR75 (-) 2
AC   CVCL_E1YG
SY   HZGHC008029c010
DR   Horizon_Discovery; HZGHC008029c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4526; GPR75.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPR75 (-) 3
AC   CVCL_E1YH
SY   HZGHC008029c011
DR   Horizon_Discovery; HZGHC008029c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4526; GPR75.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPR75-ASB3 (-) 1
AC   CVCL_E1YI
SY   HZGHC008030c009
DR   Horizon_Discovery; HZGHC008030c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40043; GPR75-ASB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPR75-ASB3 (-) 2
AC   CVCL_E1YJ
SY   HZGHC008031c005
DR   Horizon_Discovery; HZGHC008031c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40043; GPR75-ASB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPR75-ASB3 (-) 3
AC   CVCL_E1YK
SY   HZGHC008031c006
DR   Horizon_Discovery; HZGHC008031c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40043; GPR75-ASB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GPR78 (-)
AC   CVCL_XP34
SY   HZGHC007285c010; HZGHC27201; GPR78 knockout cell line 1bp insertion in exon 1
DR   cancercelllines; CVCL_XP34
DR   Horizon_Discovery; HZGHC007285c010
DR   Wikidata; Q93947568
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4528; GPR78.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPT2 (-) 1
AC   CVCL_SQ48
SY   HZGHC002829c002; GPT2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SQ48
DR   Horizon_Discovery; HZGHC002829c002
DR   Wikidata; Q54875531
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18062; GPT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPT2 (-) 2
AC   CVCL_SQ49
SY   HZGHC002829c004; GPT2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SQ49
DR   Horizon_Discovery; HZGHC002829c004
DR   Wikidata; Q54875532
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18062; GPT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPX1 (-) 1
AC   CVCL_SQ50
SY   HZGHC003261c004; GPX1 knockout cell line 110bp deletion
DR   cancercelllines; CVCL_SQ50
DR   Horizon_Discovery; HZGHC003261c004
DR   Wikidata; Q54875533
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4553; GPX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPX1 (-) 2
AC   CVCL_SQ51
SY   HZGHC003261c010; GPX1 knockout cell line 38bp deletion
DR   cancercelllines; CVCL_SQ51
DR   Horizon_Discovery; HZGHC003261c010
DR   Wikidata; Q54875534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4553; GPX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GPX4 (-) 1
AC   CVCL_SQ52
SY   HZGHC005981c005; GPX4 knockout cell line 1bp insertion; HAP1 GPX4 (-)
DR   cancercelllines; CVCL_SQ52
DR   Horizon_Discovery; HZGHC005981c005
DR   Wikidata; Q54875535
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4556; GPX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GPX4 (-) 2
AC   CVCL_XP35
SY   HZGHC005982c001; GPX4 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XP35
DR   Horizon_Discovery; HZGHC005982c001
DR   Wikidata; Q93947592
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4556; GPX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRHL1 (-) 1
AC   CVCL_XP36
SY   HZGHC007156c005; HZGHC29841; GRHL1 knockout cell line 5bp deletion in exon 2; HAP1 GRHL1 (-)
DR   cancercelllines; CVCL_XP36
DR   Horizon_Discovery; HZGHC007156c005
DR   Wikidata; Q93947594
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17923; GRHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GRHL1 (-) 2
AC   CVCL_E1YL
SY   HZGHC007156c002
DR   Horizon_Discovery; HZGHC007156c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17923; GRHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GRINA (-) 1
AC   CVCL_SQ53
SY   HZGHC006437c010; GRINA knockout cell line 4bp deletion; HAP1 GRINA (-)
DR   cancercelllines; CVCL_SQ53
DR   Horizon_Discovery; HZGHC006437c010
DR   Wikidata; Q54875536
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4589; GRINA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GRINA (-) 2
AC   CVCL_XP37
SY   HZGHC006437c004; GRINA knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XP37
DR   Horizon_Discovery; HZGHC006437c004
DR   Wikidata; Q93947606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4589; GRINA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRINA (-) 3
AC   CVCL_XP38
SY   HZGHC006438c004; GRINA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XP38
DR   Horizon_Discovery; HZGHC006438c004
DR   Wikidata; Q93947610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4589; GRINA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRINA (-) 4
AC   CVCL_XP39
SY   HZGHC006438c009; GRINA knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XP39
DR   Horizon_Discovery; HZGHC006438c009
DR   Wikidata; Q93947613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4589; GRINA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRK5 (-) 1
AC   CVCL_SQ54
SY   HZGHC000087c007; GRK5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SQ54
DR   Horizon_Discovery; HZGHC000087c007
DR   Wikidata; Q54875537
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4544; GRK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRK5 (-) 2
AC   CVCL_SQ55
SY   HZGHC000087c013; GRK5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SQ55
DR   Horizon_Discovery; HZGHC000087c013
DR   Wikidata; Q54875538
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4544; GRK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000087c013; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GRK5 (-) 3
AC   CVCL_SQ56
SY   HZGHC000087c016; GRK5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SQ56
DR   Horizon_Discovery; HZGHC000087c016
DR   Wikidata; Q54875539
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4544; GRK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000087c016; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GRK6 (-) 1
AC   CVCL_SQ57
SY   HZGHC000364c014; GRK6 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SQ57
DR   Horizon_Discovery; HZGHC000364c014
DR   Wikidata; Q54875540
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4545; GRK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRK6 (-) 2
AC   CVCL_SQ58
SY   HZGHC003303c003; GRK6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ58
DR   Horizon_Discovery; HZGHC003303c003
DR   Wikidata; Q54875541
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4545; GRK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRM8 (-) 1
AC   CVCL_SQ59
SY   HZGHC001325c002; GRM8 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SQ59
DR   Horizon_Discovery; HZGHC001325c002
DR   Wikidata; Q54875542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4600; GRM8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRM8 (-) 2
AC   CVCL_SQ60
SY   HZGHC001325c012; GRM8 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SQ60
DR   Horizon_Discovery; HZGHC001325c012
DR   Wikidata; Q54875543
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4600; GRM8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRN (-) 1
AC   CVCL_SQ61
SY   HZGHC004031c006; GRN knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SQ61
DR   Horizon_Discovery; HZGHC004031c006
DR   Wikidata; Q54875544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GRN (-) 2
AC   CVCL_SQ62
SY   HZGHC004031c009; GRN knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ62
DR   Horizon_Discovery; HZGHC004031c009
DR   Wikidata; Q54875545
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GSDMD (-) 1
AC   CVCL_XP40
SY   HZGHC007097c004; HZGHC79792; GSDMD knockout cell line 1bp insertion in exon 3; HAP1 GSDMD (-)
DR   cancercelllines; CVCL_XP40
DR   Horizon_Discovery; HZGHC007097c004
DR   Wikidata; Q93947671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25697; GSDMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GSDMD (-) 2
AC   CVCL_B5K7
SY   HZGHC007097c005; GSDMD knockout cell line 196bp insertion in exon 3
DR   cancercelllines; CVCL_B5K7
DR   Horizon_Discovery; HZGHC007097c005
DR   Wikidata; Q111733294
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25697; GSDMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007097c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 GSE1 (-) 1
AC   CVCL_E1YM
SY   HZGHC007762c007
DR   Horizon_Discovery; HZGHC007762c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28979; GSE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GSE1 (-) 2
AC   CVCL_E1YN
SY   HZGHC007762c008
DR   Horizon_Discovery; HZGHC007762c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28979; GSE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GSE1 (-) 3
AC   CVCL_E1YP
SY   HZGHC007762c010
DR   Horizon_Discovery; HZGHC007762c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28979; GSE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GSG2 (-)
AC   CVCL_SQ63
SY   HZGHC000047c016; GSG2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ63
DR   Horizon_Discovery; HZGHC000047c016
DR   Wikidata; Q54875546
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19682; HASPIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GSK3A (-) 1
AC   CVCL_SQ64
SY   HZGHC000006c013; GSK3A knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ64
DR   Horizon_Discovery; HZGHC000006c013
DR   Wikidata; Q54875547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4616; GSK3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000006c013; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GSK3A (-) 2
AC   CVCL_SQ65
SY   HZGHC000006c023; GSK3A knockout cell line 286bp deletion
DR   cancercelllines; CVCL_SQ65
DR   Horizon_Discovery; HZGHC000006c023
DR   Wikidata; Q54875548
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4616; GSK3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GSK3B (-) 1
AC   CVCL_SQ66
SY   HZGHC000007c011; GSK3B knockout cell line 31bp deletion
DR   cancercelllines; CVCL_SQ66
DR   Horizon_Discovery; HZGHC000007c011
DR   Wikidata; Q54875550
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GSK3B (-) 2
AC   CVCL_SQ67
SY   HZGHC000007c024; GSK3B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SQ67
DR   Horizon_Discovery; HZGHC000007c024
DR   Wikidata; Q54875551
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000007c024; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GSKIP (-) 1
AC   CVCL_XP41
SY   HZGHC006935c010; HZGHC51527; GSKIP knockout cell line 7bp deletion in exon 3; HAP1 GSKIP (-)
DR   cancercelllines; CVCL_XP41
DR   Horizon_Discovery; HZGHC006935c010
DR   Wikidata; Q93947710
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20343; GSKIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 GSKIP (-) 2
AC   CVCL_E1YQ
SY   HZGHC006935c005; GSKIP knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC006935c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20343; GSKIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 GSN (-) 1
AC   CVCL_SQ68
SY   HZGHC005703c012; GSN knockout cell line 1bp insertion; HAP1 GSN (-)
DR   cancercelllines; CVCL_SQ68
DR   Horizon_Discovery; HZGHC005703c012
DR   Wikidata; Q54875552
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4620; GSN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GSN (-) 2
AC   CVCL_XP42
SY   HZGHC005703c004; GSN knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XP42
DR   Horizon_Discovery; HZGHC005703c004
DR   Wikidata; Q93947720
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4620; GSN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GSR (-)
AC   CVCL_SQ69
SY   HZGHC003767c003; GSR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ69
DR   Horizon_Discovery; HZGHC003767c003
DR   Wikidata; Q54875553
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4623; GSR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GSTM2 (-) 1
AC   CVCL_SQ70
SY   HZGHC005954c010; GSTM2 knockout cell line 2bp deletion; HAP1 GSTM2 (-)
DR   cancercelllines; CVCL_SQ70
DR   Horizon_Discovery; HZGHC005954c010
DR   Wikidata; Q54875554
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4634; GSTM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GSTM2 (-) 2
AC   CVCL_XP43
SY   HZGHC005954c003; GSTM2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XP43
DR   Horizon_Discovery; HZGHC005954c003
DR   Wikidata; Q93947731
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4634; GSTM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GSTP1 (-)
AC   CVCL_SQ71
SY   HZGHC005390c009; GSTP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ71
DR   Horizon_Discovery; HZGHC005390c009
DR   Wikidata; Q54875555
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4638; GSTP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GTF2I (-) 1
AC   CVCL_SQ72
SY   HZGHC005629c002; GTF2I knockout cell line 17bp deletion; HAP1 GTF2I (-)
DR   cancercelllines; CVCL_SQ72
DR   Horizon_Discovery; HZGHC005629c002
DR   Wikidata; Q54875556
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4659; GTF2I.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 GTF2I (-) 2
AC   CVCL_XP44
SY   HZGHC005629c007; GTF2I knockout cell line 28bp deletion
DR   cancercelllines; CVCL_XP44
DR   Horizon_Discovery; HZGHC005629c007
DR   Wikidata; Q93947750
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4659; GTF2I.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GUSB (-) 1
AC   CVCL_SQ73
SY   HZGHC005064c008; GUSB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SQ73
DR   Horizon_Discovery; HZGHC005064c008
DR   Wikidata; Q54875557
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4696; GUSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 GUSB (-) 2
AC   CVCL_SQ74
SY   HZGHC005064c011; GUSB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SQ74
DR   Horizon_Discovery; HZGHC005064c011
DR   Wikidata; Q54875558
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4696; GUSB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 H2AFX (-)
AC   CVCL_SQ75
SY   HZGHC005630c003; H2AFX knockout cell line 2bp deletion in exon 1
DR   cancercelllines; CVCL_SQ75
DR   Horizon_Discovery; HZGHC005630c003
DR   Wikidata; Q54875559
RX   PubMed=31141305;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4739; H2AX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 H2AFY (-) 1
AC   CVCL_SQ76
SY   HZGHC005392c001; H2AFY knockout cell line 38bp deletion; HAP1 H2AFY (-)
DR   cancercelllines; CVCL_SQ76
DR   Horizon_Discovery; HZGHC005392c001
DR   Wikidata; Q54875560
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4740; MACROH2A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 H2AFY (-) 2
AC   CVCL_XP45
SY   HZGHC005392c012; H2AFY knockout cell line 17bp deletion
DR   cancercelllines; CVCL_XP45
DR   Horizon_Discovery; HZGHC005392c012
DR   Wikidata; Q93947785
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4740; MACROH2A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 H2AFZ (-) 1
AC   CVCL_SQ77
SY   HZGHC001140c004; H2AFZ knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SQ77
DR   Horizon_Discovery; HZGHC001140c004
DR   Wikidata; Q54875561
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4741; H2AZ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001140c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 H2AFZ (-) 2
AC   CVCL_SQ78
SY   HZGHC001140c006; H2AFZ knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ78
DR   Horizon_Discovery; HZGHC001140c006
DR   Wikidata; Q54875562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4741; H2AZ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001140c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 H2AFZ (-) 3
AC   CVCL_SQ79
SY   HZGHC001140c010; H2AFZ knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SQ79
DR   Horizon_Discovery; HZGHC001140c010
DR   Wikidata; Q54875563
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4741; H2AZ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001140c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 H3F3A (-) 1
AC   CVCL_SQ80
SY   HZGHC001174c003; H3F3A knockout cell line 137bp insertion
DR   cancercelllines; CVCL_SQ80
DR   Horizon_Discovery; HZGHC001174c003
DR   Wikidata; Q54875564
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4764; H3-3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001174c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 H3F3A (-) 2
AC   CVCL_SQ81
SY   HZGHC001174c006; H3F3A knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ81
DR   Horizon_Discovery; HZGHC001174c006
DR   Wikidata; Q54875565
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4764; H3-3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 H3F3A (-) 3
AC   CVCL_SQ82
SY   HZGHC001174c007; H3F3A knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SQ82
DR   Horizon_Discovery; HZGHC001174c007
DR   Wikidata; Q54875566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4764; H3-3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001174c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 H3F3B (-) 1
AC   CVCL_SQ83
SY   HZGHC004094c001; H3F3B knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SQ83
DR   Horizon_Discovery; HZGHC004094c001
DR   Wikidata; Q54875567
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4765; H3-3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 H3F3B (-) 2
AC   CVCL_SQ84
SY   HZGHC004094c008; H3F3B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SQ84
DR   Horizon_Discovery; HZGHC004094c008
DR   Wikidata; Q54875568
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4765; H3-3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HADH (-) 1
AC   CVCL_E1YR
SY   HZGHC007920c003
DR   Horizon_Discovery; HZGHC007920c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4799; HADH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HADH (-) 2
AC   CVCL_E1YS
SY   HZGHC007920c005
DR   Horizon_Discovery; HZGHC007920c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4799; HADH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HADH (-) 3
AC   CVCL_E1YT
SY   HZGHC007920c006
DR   Horizon_Discovery; HZGHC007920c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4799; HADH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HADHA (-) 1
AC   CVCL_SQ85
SY   HZGHC002529c002; HADHA knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SQ85
DR   Horizon_Discovery; HZGHC002529c002
DR   Wikidata; Q54875569
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4801; HADHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HADHA (-) 2
AC   CVCL_SQ86
SY   HZGHC002529c004; HADHA knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SQ86
DR   Horizon_Discovery; HZGHC002529c004
DR   Wikidata; Q54875570
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4801; HADHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HAGH (-) 1
AC   CVCL_SQ87
SY   HZGHC005070c003; HAGH knockout cell line 52bp deletion
DR   cancercelllines; CVCL_SQ87
DR   Horizon_Discovery; HZGHC005070c003
DR   Wikidata; Q54875571
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4805; HAGH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HAGH (-) 2
AC   CVCL_SQ88
SY   HZGHC005070c008; HAGH knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SQ88
DR   Horizon_Discovery; HZGHC005070c008
DR   Wikidata; Q54875572
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4805; HAGH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HAP1 (-) 1
AC   CVCL_E1YU
SY   HZGHC007770c001
DR   Horizon_Discovery; HZGHC007770c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4812; HAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HAP1 (-) 2
AC   CVCL_E1YV
SY   HZGHC007770c006
DR   Horizon_Discovery; HZGHC007770c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4812; HAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HARBI1 (-)
AC   CVCL_SQ89
SY   HZGHC004559c003; HARBI1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SQ89
DR   Horizon_Discovery; HZGHC004559c003
DR   Wikidata; Q54875573
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26522; HARBI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HAT1 (-) 1
AC   CVCL_SQ90
SY   HZGHC001186c001; HAT1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SQ90
DR   Horizon_Discovery; HZGHC001186c001
DR   Wikidata; Q54875574
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4821; HAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HAT1 (-) 2
AC   CVCL_SQ91
SY   HZGHC001186c005; HAT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SQ91
DR   Horizon_Discovery; HZGHC001186c005
DR   Wikidata; Q54875575
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4821; HAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HAX1 (-) 1
AC   CVCL_SQ92
SY   HZGHC003734c003; HAX1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SQ92
DR   Horizon_Discovery; HZGHC003734c003
DR   Wikidata; Q54875576
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16915; HAX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HAX1 (-) 2
AC   CVCL_SQ93
SY   HZGHC003734c012; HAX1 knockout cell line 209bp insertion
DR   cancercelllines; CVCL_SQ93
DR   Horizon_Discovery; HZGHC003734c012
DR   Wikidata; Q54875577
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16915; HAX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003734c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HBEGF (-) 1
AC   CVCL_SQ94
SY   HZGHC000974c003; HBEGF knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SQ94
DR   Horizon_Discovery; HZGHC000974c003
DR   Wikidata; Q54875578
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3059; HBEGF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HBEGF (-) 2
AC   CVCL_SQ95
SY   HZGHC000974c005; HBEGF knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SQ95
DR   Horizon_Discovery; HZGHC000974c005
DR   Wikidata; Q54875579
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3059; HBEGF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HCK (-) 1
AC   CVCL_SQ96
SY   HZGHC000008c013; HCK knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SQ96
DR   Horizon_Discovery; HZGHC000008c013
DR   Wikidata; Q54875580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4840; HCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HCK (-) 2
AC   CVCL_SQ97
SY   HZGHC000008c016; HCK knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SQ97
DR   Horizon_Discovery; HZGHC000008c016
DR   Wikidata; Q54875581
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4840; HCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC1 (-) 1
AC   CVCL_SQ98
SY   HZGHC001013c008; HDAC1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SQ98
DR   Horizon_Discovery; HZGHC001013c008
DR   Wikidata; Q54875582
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC1 (-) 2
AC   CVCL_SQ99
SY   HZGHC001013c010; HDAC1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SQ99
DR   Horizon_Discovery; HZGHC001013c010
DR   Wikidata; Q54875583
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC1 (-) 3
AC   CVCL_SR00
SY   HZGHC004120c002; HDAC1 knockout cell line 8bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC004120c002
DR   PRIDE; PXD010335
DR   Wikidata; Q54875584
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 HDAC1 (-) 4
AC   CVCL_SR01
SY   HZGHC004120c004; HDAC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR01
DR   Horizon_Discovery; HZGHC004120c004
DR   PRIDE; PXD010335
DR   Wikidata; Q54875585
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HDAC10 (-) 1
AC   CVCL_SR02
SY   HZGHC001003c002; HDAC10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SR02
DR   Horizon_Discovery; HZGHC001003c002
DR   Wikidata; Q54875586
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18128; HDAC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC10 (-) 2
AC   CVCL_SR03
SY   HZGHC001003c005; HDAC10 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SR03
DR   Horizon_Discovery; HZGHC001003c005
DR   Wikidata; Q54875587
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18128; HDAC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC11 (-) 1
AC   CVCL_SR04
SY   HZGHC001007c002; HDAC11 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SR04
DR   Horizon_Discovery; HZGHC001007c002
DR   Wikidata; Q54875588
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19086; HDAC11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC11 (-) 2
AC   CVCL_SR05
SY   HZGHC001007c012; HDAC11 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR05
DR   Horizon_Discovery; HZGHC001007c012
DR   Wikidata; Q54875589
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19086; HDAC11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC2 (-) 1
AC   CVCL_SR06
SY   HZGHC001012c004; HDAC2 knockout cell line 182bp insertion
DR   cancercelllines; CVCL_SR06
DR   Horizon_Discovery; HZGHC001012c004
DR   Wikidata; Q54875591
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001012c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HDAC2 (-) 2
AC   CVCL_SR07
SY   HZGHC001012c006; HDAC2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SR07
DR   Horizon_Discovery; HZGHC001012c006
DR   Wikidata; Q54875592
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HDAC3 (-)
AC   CVCL_SR08
SY   HZGHC000579c003; HDAC3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR08
DR   Horizon_Discovery; HZGHC000579c003
DR   Wikidata; Q54875593
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4854; HDAC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC4 (-) 1
AC   CVCL_SR09
SY   HZGHC001011c003; HDAC4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR09
DR   Horizon_Discovery; HZGHC001011c003
DR   PRIDE; PXD010335
DR   Wikidata; Q54875594
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14063; HDAC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HDAC4 (-) 2
AC   CVCL_SR10
SY   HZGHC001011c011; HDAC4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SR10
DR   Horizon_Discovery; HZGHC001011c011
DR   Wikidata; Q54875595
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14063; HDAC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HDAC5 (-) 1
AC   CVCL_SR11
SY   HZGHC001010c007; HDAC5 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SR11
DR   Horizon_Discovery; HZGHC001010c007
DR   Wikidata; Q54875596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14068; HDAC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC5 (-) 2
AC   CVCL_SR12
SY   HZGHC001010c011; HDAC5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SR12
DR   Horizon_Discovery; HZGHC001010c011
DR   Wikidata; Q54875597
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14068; HDAC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC6 (-) 1
AC   CVCL_SR13
SY   HZGHC000806c001; HDAC6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR13
DR   Horizon_Discovery; HZGHC000806c001
DR   Wikidata; Q54875598
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC6 (-) 2
AC   CVCL_SR14
SY   HZGHC004106c005; HDAC6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SR14
DR   Horizon_Discovery; HZGHC004106c005
DR   Wikidata; Q54875599
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004106c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HDAC6 (-) 3
AC   CVCL_SR15
SY   HZGHC004106c010; HDAC6 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SR15
DR   Horizon_Discovery; HZGHC004106c010
DR   Wikidata; Q54875600
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004106c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HDAC7 (-) 1
AC   CVCL_SR16
SY   HZGHC001016c001; HDAC7 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SR16
DR   Horizon_Discovery; HZGHC001016c001
DR   Wikidata; Q54875601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14067; HDAC7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC7 (-) 2
AC   CVCL_SR17
SY   HZGHC001016c002; HDAC7 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SR17
DR   Horizon_Discovery; HZGHC001016c002
DR   Wikidata; Q54875602
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14067; HDAC7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC8 (-) 1
AC   CVCL_SR18
SY   HZGHC001015c001; HDAC8 knockout cell line 154bp insertion
DR   cancercelllines; CVCL_SR18
DR   Horizon_Discovery; HZGHC001015c001
DR   Wikidata; Q54875603
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13315; HDAC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001015c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HDAC8 (-) 2
AC   CVCL_SR19
SY   HZGHC001015c010; HDAC8 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SR19
DR   Horizon_Discovery; HZGHC001015c010
DR   Wikidata; Q54875604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13315; HDAC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC8 (-) 3
AC   CVCL_SR20
SY   HZGHC003316c002; HDAC8 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SR20
DR   Horizon_Discovery; HZGHC003316c002
DR   Wikidata; Q54875605
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13315; HDAC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC8 (-) 4
AC   CVCL_SR21
SY   HZGHC003316c006; HDAC8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR21
DR   Horizon_Discovery; HZGHC003316c006
DR   Wikidata; Q54875606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13315; HDAC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDAC9 (-) 1
AC   CVCL_SR22
SY   HZGHC001014c010; HDAC9 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SR22
DR   Horizon_Discovery; HZGHC001014c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54875607
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14065; HDAC9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HDAC9 (-) 2
AC   CVCL_SR23
SY   HZGHC001014c011; HDAC9 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SR23
DR   Horizon_Discovery; HZGHC001014c011
DR   Wikidata; Q54875608
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14065; HDAC9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001014c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HDHD3 (-) 1
AC   CVCL_SR24
SY   HZGHC005766c002; HDHD3 knockout cell line 35bp deletion; HAP1 HDHD3 (-)
DR   cancercelllines; CVCL_SR24
DR   Horizon_Discovery; HZGHC005766c002
DR   Wikidata; Q54875609
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28171; HDHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HDHD3 (-) 2
AC   CVCL_XP46
SY   HZGHC005766c003; HDHD3 knockout cell line 116bp deletion
DR   cancercelllines; CVCL_XP46
DR   Horizon_Discovery; HZGHC005766c003
DR   Wikidata; Q93948128
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28171; HDHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDHD3 (-) 3
AC   CVCL_XP47
SY   HZGHC005767c004; HDHD3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP47
DR   Horizon_Discovery; HZGHC005767c004
DR   Wikidata; Q93948132
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28171; HDHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDHD3 (-) 4
AC   CVCL_XP48
SY   HZGHC005767c008; HDHD3 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_XP48
DR   Horizon_Discovery; HZGHC005767c008
DR   Wikidata; Q93948134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28171; HDHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDHD3 (-) 5
AC   CVCL_XP49
SY   HZGHC005767c012; HDHD3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP49
DR   Horizon_Discovery; HZGHC005767c012
DR   Wikidata; Q93948137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28171; HDHD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HDLBP (-) 1
AC   CVCL_E1YW
SY   HZGHC007442c015
DR   Horizon_Discovery; HZGHC007442c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4857; HDLBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HDLBP (-) 2
AC   CVCL_E1YX
SY   HZGHC007442c025
DR   Horizon_Discovery; HZGHC007442c025
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4857; HDLBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HDLBP (-) 3
AC   CVCL_E1YY
SY   HZGHC007442c027
DR   Horizon_Discovery; HZGHC007442c027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4857; HDLBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HDLBP (-) 4
AC   CVCL_E1YZ
SY   HZGHC007442c030
DR   Horizon_Discovery; HZGHC007442c030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4857; HDLBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HECTD1 (-) 1
AC   CVCL_XP50
SY   HZGHC006800c010; HZGHC25831; HECTD1 knockout cell line 7bp deletion in exon 3; HAP1 HECTD1 (-)
DR   cancercelllines; CVCL_XP50
DR   Horizon_Discovery; HZGHC006800c010
DR   Wikidata; Q93948139
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20157; HECTD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HECTD1 (-) 2
AC   CVCL_B5K8
SY   HZGHC006800c011; HECTD1 knockout cell line 32bp deletion in exon 3
DR   cancercelllines; CVCL_B5K8
DR   Horizon_Discovery; HZGHC006800c011
DR   Wikidata; Q111733295
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20157; HECTD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 HELLS (-)
AC   CVCL_SR25
SY   HZGHC001202c003; HELLS knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR25
DR   Horizon_Discovery; HZGHC001202c003
DR   Wikidata; Q54875610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4861; HELLS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HELQ (-) 1
AC   CVCL_E1Z0
SY   HZGHC007758c003
DR   Horizon_Discovery; HZGHC007758c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18536; HELQ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HELQ (-) 2
AC   CVCL_E1Z1
SY   HZGHC007758c005
DR   Horizon_Discovery; HZGHC007758c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18536; HELQ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HELZ2 (-)
AC   CVCL_E1Z2
SY   HZGHC007786c006
DR   Horizon_Discovery; HZGHC007786c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30021; HELZ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HERC1 (-)
AC   CVCL_XP51
SY   HZGHC8925; HERC1 knockout cell line
DR   cancercelllines; CVCL_XP51
DR   Horizon_Discovery; HZGHC8925
DR   Wikidata; Q93948153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4867; HERC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC8925; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HERPUD2 (-) 1
AC   CVCL_SR26
SY   HZGHC005881c001; HERPUD2 knockout cell line 10bp deletion; HAP1 HERPUD2 (-)
DR   cancercelllines; CVCL_SR26
DR   Horizon_Discovery; HZGHC005881c001
DR   Wikidata; Q54875611
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21915; HERPUD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HERPUD2 (-) 2
AC   CVCL_XP52
SY   HZGHC005881c010; HERPUD2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XP52
DR   Horizon_Discovery; HZGHC005881c010
DR   Wikidata; Q93948162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21915; HERPUD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HES1 (-)
AC   CVCL_SR27
SY   HZGHC002622c005; HES1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SR27
DR   Horizon_Discovery; HZGHC002622c005
DR   Wikidata; Q54875612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HEXA (-)
AC   CVCL_SR28
SY   HZGHC003333c010; HZGHC3073; HEXA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR28
DR   Horizon_Discovery; HZGHC003333c010
DR   Wikidata; Q54875613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4878; HEXA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003333c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 HEXB (-) 1
AC   CVCL_SR29
SY   HZGHC003336c011; HEXB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR29
DR   Horizon_Discovery; HZGHC003336c011
DR   Wikidata; Q54875614
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4879; HEXB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003336c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HEXB (-) 2
AC   CVCL_SR30
SY   HZGHC003336c001; HEXB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR30
DR   Horizon_Discovery; HZGHC003336c001
DR   Wikidata; Q54875615
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4879; HEXB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HEXB (-) 3
AC   CVCL_SR31
SY   HZGHC003336c010; HEXB knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SR31
DR   Horizon_Discovery; HZGHC003336c010
DR   Wikidata; Q54875616
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4879; HEXB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HEXDC (-) 1
AC   CVCL_SR32
SY   HZGHC001958c002; HEXDC knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR32
DR   Horizon_Discovery; HZGHC001958c002
DR   Wikidata; Q54875617
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26307; HEXD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HEXDC (-) 2
AC   CVCL_SR33
SY   HZGHC001958c010; HEXDC knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SR33
DR   Horizon_Discovery; HZGHC001958c010
DR   Wikidata; Q54875618
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26307; HEXD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HGS (-) 1
AC   CVCL_SR34
SY   HZGHC004626c005; HGS knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SR34
DR   Horizon_Discovery; HZGHC004626c005
DR   Wikidata; Q54875619
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4897; HGS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HGS (-) 2
AC   CVCL_SR35
SY   HZGHC004626c010; HGS knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SR35
DR   Horizon_Discovery; HZGHC004626c010
DR   Wikidata; Q54875620
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4897; HGS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HGS (-) 3
AC   CVCL_SR36
SY   HZGHC004671c012; HGS knockout cell line 331bp insertion
DR   cancercelllines; CVCL_SR36
DR   Horizon_Discovery; HZGHC004671c012
DR   Wikidata; Q54875621
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4897; HGS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004671c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HIAT1 (-) 1
AC   CVCL_SR37
SY   HZGHC005426c011; HIAT1 knockout cell line 5bp deletion; HAP1 HIAT1 (-)
DR   cancercelllines; CVCL_SR37
DR   Horizon_Discovery; HZGHC005426c011
DR   Wikidata; Q54875622
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23363; MFSD14A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HIAT1 (-) 2
AC   CVCL_XP53
SY   HZGHC005426c002; HIAT1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XP53
DR   Horizon_Discovery; HZGHC005426c002
DR   Wikidata; Q93948240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23363; MFSD14A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIF1A (-) 1
AC   CVCL_SR38
SY   HZGHC001165c003; HIF1A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SR38
DR   Horizon_Discovery; HZGHC001165c003
DR   Wikidata; Q54875623
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIF1A (-) 2
AC   CVCL_SR39
SY   HZGHC001165c010; HIF1A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR39
DR   Horizon_Discovery; HZGHC001165c010
DR   Wikidata; Q54875624
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIF1AN (-) 1
AC   CVCL_XP54
SY   HZGHC007289c005; HZGHC55662; HIF1AN knockout cell line 11bp deletion in exon 4; HAP1 HIF1AN (-)
DR   cancercelllines; CVCL_XP54
DR   Horizon_Discovery; HZGHC007289c005
DR   Wikidata; Q93948257
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17113; HIF1AN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HIF1AN (-) 2
AC   CVCL_B5K9
SY   HZGHC007289c007; HIF1AN knockout cell line 103bp deletion in exon 4
DR   cancercelllines; CVCL_B5K9
DR   Horizon_Discovery; HZGHC007289c007
DR   Wikidata; Q111733296
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17113; HIF1AN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 HINT1 (-)
AC   CVCL_E1Z3
SY   HZGHC007594c010
DR   Horizon_Discovery; HZGHC007594c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4912; HINT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HIP1 (-) 1
AC   CVCL_SR40
SY   HZGHC005327c005; HIP1 knockout cell line 2bp deletion in exon 3; HAP1 HIP1 (-)
DR   cancercelllines; CVCL_SR40
DR   Horizon_Discovery; HZGHC005327c005
DR   Wikidata; Q54875625
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4913; HIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HIP1 (-) 2
AC   CVCL_XP55
SY   HZGHC005327c009; HIP1 knockout cell line 13bp deletion in exon 3
DR   cancercelllines; CVCL_XP55
DR   Horizon_Discovery; HZGHC005327c009
DR   Wikidata; Q93948268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4913; HIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HIP1 (-) HIP1R (-) 1
AC   CVCL_DX43
SY   HZGHC007427c002; Double knockout cell line HIP1 2bp deletion in exon 3 and HIP1R 5bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007427c002
DR   Wikidata; Q127381057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4913; HIP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18415; HIP1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SR40 ! HAP1 HIP1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HIP1 (-) HIP1R (-) 2
AC   CVCL_DX44
SY   HZGHC007427c003; Double knockout cell line HIP1 2bp deletion in exon 3 and HIP1R 2bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007427c003
DR   Wikidata; Q127381058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4913; HIP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18415; HIP1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SR40 ! HAP1 HIP1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HIP1 (-) HIP1R (-) 3
AC   CVCL_DX45
SY   HZGHC007427c012; Double knockout cell line HIP1 2bp deletion in exon 3 and HIP1R 4bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007427c012
DR   Wikidata; Q127381059
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4913; HIP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18415; HIP1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SR40 ! HAP1 HIP1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HIP1R (-) 1
AC   CVCL_DX04
SY   HZGHC007351c003; HIP1R knockout cell line 14bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007351c003
DR   Wikidata; Q127381060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18415; HIP1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HIP1R (-) 2
AC   CVCL_DX05
SY   HZGHC007351c004; HIP1R knockout cell line 2bp insertion in exon 8
DR   Horizon_Discovery; HZGHC007351c004
DR   Wikidata; Q127381061
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18415; HIP1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HIPK1 (-) 1
AC   CVCL_SR41
SY   HZGHC008753c018; HIPK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR41
DR   Horizon_Discovery; HZGHC008753c018
DR   Wikidata; Q54875626
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19006; HIPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIPK1 (-) 2
AC   CVCL_SR42
SY   HZGHC008753c020; HIPK1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SR42
DR   Horizon_Discovery; HZGHC008753c020
DR   Wikidata; Q54875627
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19006; HIPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC008753c020; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HIPK1 (-) 3
AC   CVCL_SR43
SY   HZGHC008753c023; HIPK1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SR43
DR   Horizon_Discovery; HZGHC008753c023
DR   Wikidata; Q54875628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19006; HIPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIPK2 (-) 1
AC   CVCL_SR44
SY   HZGHC000335c010; HIPK2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SR44
DR   Horizon_Discovery; HZGHC000335c010
DR   Wikidata; Q54875629
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14402; HIPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIPK2 (-) 2
AC   CVCL_SR45
SY   HZGHC000335c011; HIPK2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SR45
DR   Horizon_Discovery; HZGHC000335c011
DR   Wikidata; Q54875630
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14402; HIPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIPK2 (-) 3
AC   CVCL_SR46
SY   HZGHC000335c022; HIPK2 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SR46
DR   Horizon_Discovery; HZGHC000335c022
DR   Wikidata; Q54875633
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14402; HIPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIPK3 (-) 1
AC   CVCL_SR47
SY   HZGHC000334c010; HIPK3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR47
DR   Horizon_Discovery; HZGHC000334c010
DR   Wikidata; Q54875634
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4915; HIPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HIPK3 (-) 2
AC   CVCL_SR48
SY   HZGHC000334c012; HIPK3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR48
DR   Horizon_Discovery; HZGHC000334c012
DR   Wikidata; Q54875635
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4915; HIPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HLA-E (-) 1
AC   CVCL_XP56
SY   HZGHC007177c009; HZGHC3133; HLA-E knockout cell line 7bp deletion in exon 2; HAP1 HLA-E (-)
DR   cancercelllines; CVCL_XP56
DR   Horizon_Discovery; HZGHC007177c009
DR   Wikidata; Q93948318
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HLA-E (-) 2
AC   CVCL_E1Z4
SY   HZGHC007177c005
DR   Horizon_Discovery; HZGHC007177c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HLA-E (-) 3
AC   CVCL_E1Z5
SY   HZGHC007177c007
DR   Horizon_Discovery; HZGHC007177c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HLA-E (-) 4
AC   CVCL_E1Z6
SY   HZGHC007178c002
DR   Horizon_Discovery; HZGHC007178c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HLA-E (-) 5
AC   CVCL_E1Z7
SY   HZGHC007178c003
DR   Horizon_Discovery; HZGHC007178c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HLA-G (-) 1
AC   CVCL_SR49
SY   HZGHC006176c005; HLA-G knockout cell line 13bp deletion; HAP1 HLA-G (-)
DR   cancercelllines; CVCL_SR49
DR   Horizon_Discovery; HZGHC006176c005
DR   Wikidata; Q54875636
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4964; HLA-G.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HLA-G (-) 2
AC   CVCL_XP57
SY   HZGHC006176c008; HLA-G knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XP57
DR   Horizon_Discovery; HZGHC006176c008
DR   Wikidata; Q93948328
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4964; HLA-G.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HLTF (-) 1
AC   CVCL_SR50
SY   HZGHC004435c003; HLTF knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_SR50
DR   Horizon_Discovery; HZGHC004435c003
DR   Wikidata; Q54875637
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11099; HLTF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HLTF (-) 2
AC   CVCL_SR51
SY   HZGHC004435c010; HLTF knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_SR51
DR   Horizon_Discovery; HZGHC004435c010
DR   Wikidata; Q54875638
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11099; HLTF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HLTF (-) 3
AC   CVCL_SR52
SY   HZGHC004436c009; HLTF knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_SR52
DR   Horizon_Discovery; HZGHC004436c009
DR   Wikidata; Q54875639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11099; HLTF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HLTF (-) SHPRH (-) 1
AC   CVCL_DX46
SY   HZGHC006988c001; Double knockout cell line HLTF 2bp deletion in exon 2 and SHPRH 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC006988c001
DR   Wikidata; Q127381062
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11099; HLTF.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19336; SHPRH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SR50 ! HAP1 HLTF (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HLTF (-) SHPRH (-) 2
AC   CVCL_DX47
SY   HZGHC006988c003; Double knockout cell line HLTF 2bp deletion in exon 2 and SHPRH 1bp deletion in exon 4
DR   Horizon_Discovery; HZGHC006988c003
DR   Wikidata; Q127381063
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11099; HLTF.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19336; SHPRH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SR50 ! HAP1 HLTF (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HMBS (-) 1
AC   CVCL_E1Z8
SY   HZGHC007839c007
DR   Horizon_Discovery; HZGHC007839c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4982; HMBS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HMBS (-) 2
AC   CVCL_E1Z9
SY   HZGHC007839c009
DR   Horizon_Discovery; HZGHC007839c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4982; HMBS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HMCES (-) 1
AC   CVCL_E1ZA
SY   HZGHC008151c008
DR   Horizon_Discovery; HZGHC008151c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24446; HMCES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HMCES (-) 2
AC   CVCL_E1ZB
SY   HZGHC008151c010
DR   Horizon_Discovery; HZGHC008151c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24446; HMCES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HMGB2 (-) 1
AC   CVCL_SR53
SY   HZGHC005113c002; HMGB2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SR53
DR   Horizon_Discovery; HZGHC005113c002
DR   Wikidata; Q54875640
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5000; HMGB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HMGB2 (-) 2
AC   CVCL_SR54
SY   HZGHC005113c008; HMGB2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SR54
DR   Horizon_Discovery; HZGHC005113c008
DR   Wikidata; Q54875642
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5000; HMGB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HMMR (-) 1
AC   CVCL_SR55
SY   HZGHC003698c004; HMMR knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SR55
DR   Horizon_Discovery; HZGHC003698c004
DR   Wikidata; Q54875643
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5012; HMMR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HMMR (-) 2
AC   CVCL_SR56
SY   HZGHC003698c006; HMMR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR56
DR   Horizon_Discovery; HZGHC003698c006
DR   Wikidata; Q54875644
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5012; HMMR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HMOX1 (-) 1
AC   CVCL_SR57
SY   HZGHC005983c001; HMOX1 knockout cell line 110bp deletion; HAP1 HMOX1 (-)
DR   cancercelllines; CVCL_SR57
DR   Horizon_Discovery; HZGHC005983c001
DR   Wikidata; Q54875645
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5013; HMOX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HMOX1 (-) 2
AC   CVCL_XP58
SY   HZGHC005983c003; HMOX1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XP58
DR   Horizon_Discovery; HZGHC005983c003
DR   Wikidata; Q93948382
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5013; HMOX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HMOX2 (-) 1
AC   CVCL_SR58
SY   HZGHC006665c011; HMOX2 knockout cell line 1bp deletion; HAP1 HMOX2 (-)
DR   cancercelllines; CVCL_SR58
DR   Horizon_Discovery; HZGHC006665c011
DR   Wikidata; Q54875646
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5014; HMOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HMOX2 (-) 2
AC   CVCL_XP59
SY   HZGHC006665c003; HMOX2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XP59
DR   Horizon_Discovery; HZGHC006665c003
DR   Wikidata; Q93948391
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5014; HMOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HN1 (-) 1
AC   CVCL_E1ZC
SY   HZGHC007668c001
DR   Horizon_Discovery; HZGHC007668c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14569; JPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HN1 (-) 2
AC   CVCL_E1ZD
SY   HZGHC007668c003
DR   Horizon_Discovery; HZGHC007668c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14569; JPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HN1 (-) 3
AC   CVCL_E1ZE
SY   HZGHC007668c005
DR   Horizon_Discovery; HZGHC007668c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14569; JPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HN1 (-) 4
AC   CVCL_E1ZF
SY   HZGHC007668c006
DR   Horizon_Discovery; HZGHC007668c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14569; JPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HN1L (-)
AC   CVCL_E1ZG
SY   HZGHC007667c007; HN1L knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007667c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14137; JPT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HNF4A (-)
AC   CVCL_E1ZH
SY   HZGHC008258c004
DR   Horizon_Discovery; HZGHC008258c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5024; HNF4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HNRNPA2B1 (-)
AC   CVCL_C9EQ
SY   HZGHC007378c010; HNRNPA2B1 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007378c010
DR   Wikidata; Q123031423
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5033; HNRNPA2B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 HNRNPDL (-) 1
AC   CVCL_SR59
SY   HZGHC003981c010; HNRNPDL knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_SR59
DR   Horizon_Discovery; HZGHC003981c010
DR   Wikidata; Q54875647
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5037; HNRNPDL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HNRNPDL (-) 2
AC   CVCL_SR60
SY   HZGHC003981c012; HNRNPDL knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_SR60
DR   Horizon_Discovery; HZGHC003981c012
DR   Wikidata; Q54875648
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5037; HNRNPDL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HOOK3 (-)
AC   CVCL_SR61
SY   HZGHC005827c012; HOOK3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR61
DR   Horizon_Discovery; HZGHC005827c012
DR   Wikidata; Q54875649
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23576; HOOK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HPRT1 (-) 1
AC   CVCL_SR62
SY   HZGHC003696c011; HPRT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SR62
DR   Horizon_Discovery; HZGHC003696c011
DR   Wikidata; Q54875650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5157; HPRT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HPRT1 (-) 2
AC   CVCL_SR63
SY   HZGHC003696c012; HPRT1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SR63
DR   Horizon_Discovery; HZGHC003696c012
DR   Wikidata; Q54875651
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5157; HPRT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HPS1 (-) 1
AC   CVCL_SR64
SY   HZGHC006517c010; HPS1 knockout cell line 1bp deletion; HAP1 HPS1 (-)
DR   cancercelllines; CVCL_SR64
DR   Horizon_Discovery; HZGHC006517c010
DR   Wikidata; Q54875652
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5163; HPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HPS1 (-) 2
AC   CVCL_XP60
SY   HZGHC006517c002; HPS1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XP60
DR   Horizon_Discovery; HZGHC006517c002
DR   Wikidata; Q93948430
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5163; HPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006517c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HPS1 (-) 3
AC   CVCL_XP61
SY   HZGHC006517c005; HPS1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP61
DR   Horizon_Discovery; HZGHC006517c005
DR   Wikidata; Q93948433
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5163; HPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HPS4 (-)
AC   CVCL_E1ZI
SY   HZGHC007924c005
DR   Horizon_Discovery; HZGHC007924c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15844; HPS4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HPSE (-)
AC   CVCL_SR65
SY   HZGHC006118c010; HPSE knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SR65
DR   Horizon_Discovery; HZGHC006118c010
DR   Wikidata; Q54875653
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5164; HPSE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HRSP12 (-) 1
AC   CVCL_SR66
SY   HZGHC004873c012; HRSP12 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR66
DR   Horizon_Discovery; HZGHC004873c012
DR   Wikidata; Q54875654
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16897; RIDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HRSP12 (-) 2
AC   CVCL_SR67
SY   HZGHC004874c001; HRSP12 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SR67
DR   Horizon_Discovery; HZGHC004874c001
DR   Wikidata; Q54875655
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16897; RIDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HRSP12 (-) 3
AC   CVCL_SR68
SY   HZGHC004874c002; HRSP12 knockout cell line 152bp insertion
DR   cancercelllines; CVCL_SR68
DR   Horizon_Discovery; HZGHC004874c002
DR   Wikidata; Q54875656
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16897; RIDA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004874c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HS2ST1 (-) 1
AC   CVCL_E1ZJ
SY   HZGHC007632c010
DR   Horizon_Discovery; HZGHC007632c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5193; HS2ST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HS2ST1 (-) 2
AC   CVCL_E1ZK
SY   HZGHC007632c011
DR   Horizon_Discovery; HZGHC007632c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5193; HS2ST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HS2ST1 (-) 3
AC   CVCL_E1ZL
SY   HZGHC007632c021
DR   Horizon_Discovery; HZGHC007632c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5193; HS2ST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HSD17B12 (-)
AC   CVCL_XP62
SY   HZGHC007175c002; HZGHC51144; HSD17B12 knockout cell line 16bp deletion in exon 1
DR   cancercelllines; CVCL_XP62
DR   Horizon_Discovery; HZGHC007175c002
DR   Wikidata; Q93948460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18646; HSD17B12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HSD17B4 (-) 1
AC   CVCL_SR69
SY   HZGHC005053c006; HSD17B4 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SR69
DR   Horizon_Discovery; HZGHC005053c006
DR   Wikidata; Q54875657
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5213; HSD17B4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSD17B4 (-) 2
AC   CVCL_SR70
SY   HZGHC005053c012; HSD17B4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SR70
DR   Horizon_Discovery; HZGHC005053c012
DR   Wikidata; Q54875658
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5213; HSD17B4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005053c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HSF1 (-) 1
AC   CVCL_SR71
SY   HZGHC004801c008; HSF1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SR71
DR   Horizon_Discovery; HZGHC004801c008
DR   Wikidata; Q54875659
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5224; HSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSF1 (-) 2
AC   CVCL_SR72
SY   HZGHC004802c002; HSF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR72
DR   Horizon_Discovery; HZGHC004802c002
DR   Wikidata; Q54875660
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5224; HSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSF1 (-) 3
AC   CVCL_SR73
SY   HZGHC004802c006; HSF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR73
DR   Horizon_Discovery; HZGHC004802c006
DR   Wikidata; Q54875661
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5224; HSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSP90AA1 (-) 1
AC   CVCL_SR74
SY   HZGHC005396c010; HSP90AA1 knockout cell line 1bp deletion; HAP1 HSP90AA1 (-)
DR   cancercelllines; CVCL_SR74
DR   Horizon_Discovery; HZGHC005396c010
DR   Wikidata; Q54875662
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HSP90AA1 (-) 2
AC   CVCL_XP63
SY   HZGHC005396c002; HSP90AA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP63
DR   Horizon_Discovery; HZGHC005396c002
DR   Wikidata; Q93948521
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005396c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HSPA1L (-) 1
AC   CVCL_SR75
SY   HZGHC004078c002; HSPA1L knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SR75
DR   Horizon_Discovery; HZGHC004078c002
DR   Wikidata; Q54875663
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5234; HSPA1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSPA1L (-) 2
AC   CVCL_SR76
SY   HZGHC004078c012; HSPA1L knockout cell line 49bp deletion
DR   cancercelllines; CVCL_SR76
DR   Horizon_Discovery; HZGHC004078c012
DR   Wikidata; Q54875664
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5234; HSPA1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSPB1 (-) 1
AC   CVCL_SR77
SY   HZGHC004733c006; HSPB1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SR77
DR   Horizon_Discovery; HZGHC004733c006
DR   Wikidata; Q54875665
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004733c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HSPB1 (-) 2
AC   CVCL_SR78
SY   HZGHC004733c011; HSPB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR78
DR   Horizon_Discovery; HZGHC004733c011
DR   Wikidata; Q54875666
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSPB1 (-) 3
AC   CVCL_SR79
SY   HZGHC004943c001; HSPB1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SR79
DR   Horizon_Discovery; HZGHC004943c001
DR   Wikidata; Q54875667
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSPB1 (-) 4
AC   CVCL_SR80
SY   HZGHC004943c012; HSPB1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SR80
DR   Horizon_Discovery; HZGHC004943c012
DR   Wikidata; Q54875668
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSPG2 (-) 1
AC   CVCL_SR81
SY   HZGHC003848c001; HSPG2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SR81
DR   Horizon_Discovery; HZGHC003848c001
DR   Wikidata; Q54875669
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSPG2 (-) 2
AC   CVCL_SR82
SY   HZGHC003848c009; HSPG2 knockout cell line 73bp deletion
DR   cancercelllines; CVCL_SR82
DR   Horizon_Discovery; HZGHC003848c009
DR   Wikidata; Q54875670
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HSPG2 (-) 3
AC   CVCL_SR83
SY   HZGHC003848c010; HSPG2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SR83
DR   Horizon_Discovery; HZGHC003848c010
DR   Wikidata; Q54875671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HTR6 (-) 1
AC   CVCL_SR84
SY   HZGHC003930c007; HTR6 knockout cell line 149bp deletion
DR   cancercelllines; CVCL_SR84
DR   Horizon_Discovery; HZGHC003930c007
DR   Wikidata; Q54875672
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5301; HTR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HTR6 (-) 2
AC   CVCL_SR85
SY   HZGHC003930c009; HTR6 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SR85
DR   Horizon_Discovery; HZGHC003930c009
DR   Wikidata; Q54875673
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5301; HTR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HTRA1 (-) 1
AC   CVCL_C1LH
SY   HZGHC007986c006; HTRA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_C1LH
DR   Horizon_Discovery; HZGHC007986c006
DR   Wikidata; Q114311562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9476; HTRA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 HTRA1 (-) 2
AC   CVCL_C1LI
SY   HZGHC007986c007; HTRA1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_C1LI
DR   Horizon_Discovery; HZGHC007986c007
DR   Wikidata; Q114311563
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9476; HTRA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 HTRA2 (-) 1
AC   CVCL_XP64
SY   HZGHC006813c004; HZGHC27429; HTRA2 knockout cell line 1bp insertion in exon 1; HAP1 HTRA2 (-)
DR   cancercelllines; CVCL_XP64
DR   Horizon_Discovery; HZGHC006813c004
DR   Wikidata; Q93948599
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14348; HTRA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 HTRA2 (-) 2
AC   CVCL_E1ZM
SY   HZGHC006812c009
DR   Horizon_Discovery; HZGHC006812c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14348; HTRA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HTRA2 (-) 3
AC   CVCL_E1ZN
SY   HZGHC006812c012
DR   Horizon_Discovery; HZGHC006812c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14348; HTRA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HTRA2 (-) 4
AC   CVCL_E1ZP
SY   HZGHC006813c005
DR   Horizon_Discovery; HZGHC006813c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14348; HTRA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 HTT (-) 1
AC   CVCL_SR86
SY   HZGHC004595c006; HTT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SR86
DR   Horizon_Discovery; HZGHC004595c006
DR   Wikidata; Q54875675
RX   PubMed=39257448;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   HAP1 HTT (-) 2
AC   CVCL_SR87
SY   HZGHC004595c012; HTT knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SR87
DR   Horizon_Discovery; HZGHC004595c012
DR   Wikidata; Q54875676
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004595c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 HUNK (-)
AC   CVCL_SR88
SY   HZGHC000088c005; HUNK knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SR88
DR   Horizon_Discovery; HZGHC000088c005
DR   Wikidata; Q54875677
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13326; HUNK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HUWE1 (-) 1
AC   CVCL_SR89
SY   HZGHC003321c010; HUWE1 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SR89
DR   Horizon_Discovery; HZGHC003321c010
DR   Wikidata; Q54875678
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30892; HUWE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 HUWE1 (-) 2
AC   CVCL_SR90
SY   HZGHC003321c011; HUWE1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SR90
DR   Horizon_Discovery; HZGHC003321c011
DR   Wikidata; Q54875679
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30892; HUWE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IAH1 (-)
AC   CVCL_E1ZQ
SY   HZGHC007968c007
DR   Horizon_Discovery; HZGHC007968c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27696; IAH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IBTK (-) 1
AC   CVCL_SR91
SY   HZGHC004785c004; IBTK knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SR91
DR   Horizon_Discovery; HZGHC004785c004
DR   Wikidata; Q54875680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17853; IBTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IBTK (-) 2
AC   CVCL_SR92
SY   HZGHC004785c012; IBTK knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SR92
DR   Horizon_Discovery; HZGHC004785c012
DR   Wikidata; Q54875681
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17853; IBTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ICAM1 (-) 1
AC   CVCL_SR93
SY   HZGHC005398c004; ICAM1 knockout cell line 13bp deletion; HAP1 ICAM1 (-)
DR   cancercelllines; CVCL_SR93
DR   Horizon_Discovery; HZGHC005398c004
DR   Wikidata; Q54875682
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ICAM1 (-) 2
AC   CVCL_XP65
SY   HZGHC005398c001; ICAM1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XP65
DR   Horizon_Discovery; HZGHC005398c001
DR   Wikidata; Q93948647
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ICAM5 (-) 1
AC   CVCL_SR94
SY   HZGHC002844c003; ICAM5 knockout cell line 1bp insertion; HAP1 ICAM5 (-)
DR   cancercelllines; CVCL_SR94
DR   Horizon_Discovery; HZGHC002844c003
DR   Wikidata; Q54875683
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5348; ICAM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ICAM5 (-) 2
AC   CVCL_XP66
SY   HZGHC002844c008; ICAM5 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XP66
DR   Horizon_Discovery; HZGHC002844c008
DR   Wikidata; Q93948661
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5348; ICAM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ICAM5 (-) 3
AC   CVCL_XP67
SY   HZGHC002845c005; ICAM5 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XP67
DR   Horizon_Discovery; HZGHC002845c005
DR   Wikidata; Q93948664
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5348; ICAM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ICAM5 (-) 4
AC   CVCL_XP68
SY   HZGHC002845c011; ICAM5 knockout cell line 125bp deletion
DR   cancercelllines; CVCL_XP68
DR   Horizon_Discovery; HZGHC002845c011
DR   Wikidata; Q93948667
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5348; ICAM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ICK (-)
AC   CVCL_SR95
SY   HZGHC000144c017; ICK knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SR95
DR   Horizon_Discovery; HZGHC000144c017
DR   Wikidata; Q54875684
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21219; CILK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ICMT (-) 1
AC   CVCL_SR96
SY   HZGHC004898c001; ICMT knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SR96
DR   Horizon_Discovery; HZGHC004898c001
DR   Wikidata; Q54875685
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5350; ICMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ICMT (-) 2
AC   CVCL_SR97
SY   HZGHC004898c006; ICMT knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SR97
DR   Horizon_Discovery; HZGHC004898c006
DR   Wikidata; Q54875686
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5350; ICMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ID1 (-) 1
AC   CVCL_SR98
SY   HZGHC006512c004; ID1 knockout cell line 2bp deletion; HAP1 ID1 (-)
DR   cancercelllines; CVCL_SR98
DR   Horizon_Discovery; HZGHC006512c004
DR   Wikidata; Q54875687
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5360; ID1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ID1 (-) 2
AC   CVCL_XP69
SY   HZGHC006512c006; ID1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP69
DR   Horizon_Discovery; HZGHC006512c006
DR   Wikidata; Q93948704
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5360; ID1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ID1 (-) 3
AC   CVCL_XP70
SY   HZGHC006513c007; ID1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XP70
DR   Horizon_Discovery; HZGHC006513c007
DR   Wikidata; Q93948707
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5360; ID1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IDE (-) 1
AC   CVCL_SR99
SY   HZGHC000715c001; IDE knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SR99
DR   Horizon_Discovery; HZGHC000715c001
DR   Wikidata; Q54875688
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5381; IDE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IDE (-) 2
AC   CVCL_SS00
SY   HZGHC000715c010; IDE knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SS00
DR   Horizon_Discovery; HZGHC000715c010
DR   Wikidata; Q54875689
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5381; IDE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IDE (-) 3
AC   CVCL_SS01
SY   HZGHC000716c010; IDE knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SS01
DR   Horizon_Discovery; HZGHC000716c010
DR   Wikidata; Q54875690
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5381; IDE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IDE (-) 4
AC   CVCL_SS02
SY   HZGHC000716c012; IDE knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SS02
DR   Horizon_Discovery; HZGHC000716c012
DR   Wikidata; Q54875691
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5381; IDE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000716c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IDH1 (-) 1
AC   CVCL_SS03
SY   HZGHC003323c006; IDH1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SS03
DR   Horizon_Discovery; HZGHC003323c006
DR   Wikidata; Q54875692
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IDH1 (-) 2
AC   CVCL_SS04
SY   HZGHC003323c010; IDH1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SS04
DR   Horizon_Discovery; HZGHC003323c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54875693
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IDH1 (-) 3
AC   CVCL_SS05
SY   HZGHC003323c012; IDH1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SS05
DR   Horizon_Discovery; HZGHC003323c012
DR   Wikidata; Q54875694
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IDH2 (-) 1
AC   CVCL_SS06
SY   HZGHC000919c009; IDH2 knockout cell line 40bp deletion
DR   cancercelllines; CVCL_SS06
DR   Horizon_Discovery; HZGHC000919c009
DR   Wikidata; Q54875695
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000919c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 IDH2 (-) 2
AC   CVCL_SS07
SY   HZGHC000919c010; IDH2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SS07
DR   Horizon_Discovery; HZGHC000919c010
DR   Wikidata; Q54875696
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IDS (-)
AC   CVCL_SS08
SY   HZGHC004716c002; IDS knockout cell line 1bp deletion in exon 5
DR   cancercelllines; CVCL_SS08
DR   Horizon_Discovery; HZGHC004716c002
DR   Wikidata; Q54875697
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5389; IDS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IDUA (-) 1
AC   CVCL_SS09
SY   HZGHC005175c001; IDUA knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SS09
DR   Horizon_Discovery; HZGHC005175c001
DR   Wikidata; Q54875698
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5391; IDUA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IDUA (-) 2
AC   CVCL_SS10
SY   HZGHC005175c004; IDUA knockout cell line 62bp insertion
DR   cancercelllines; CVCL_SS10
DR   Horizon_Discovery; HZGHC005175c004
DR   Wikidata; Q54875699
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5391; IDUA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005175c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IFI16 (-) 1
AC   CVCL_SS11
SY   HZGHC003894c007; IFI16 knockout cell line 53bp deletion
DR   cancercelllines; CVCL_SS11
DR   Horizon_Discovery; HZGHC003894c007
DR   Wikidata; Q54875700
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5395; IFI16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFI16 (-) 2
AC   CVCL_SS12
SY   HZGHC003894c009; IFI16 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SS12
DR   Horizon_Discovery; HZGHC003894c009
DR   Wikidata; Q54875701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5395; IFI16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFI35 (-) 1
AC   CVCL_SS13
SY   HZGHC002639c005; IFI35 knockout cell line 47bp insertion
DR   cancercelllines; CVCL_SS13
DR   Horizon_Discovery; HZGHC002639c005
DR   Wikidata; Q54875702
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5399; IFI35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002639c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IFI35 (-) 2
AC   CVCL_SS14
SY   HZGHC002639c008; IFI35 knockout cell line 160bp insertion
DR   cancercelllines; CVCL_SS14
DR   Horizon_Discovery; HZGHC002639c008
DR   Wikidata; Q54875703
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5399; IFI35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002639c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IFI44 (-) 1
AC   CVCL_XP71
SY   HZGHC007006c009; HZGHC10561; IFI44 knockout cell line 2bp deletion in exon 2; HAP1 IFI44 (-)
DR   cancercelllines; CVCL_XP71
DR   Horizon_Discovery; HZGHC007006c009
DR   Wikidata; Q93948788
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16938; IFI44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 IFI44 (-) 2
AC   CVCL_E1ZR
SY   HZGHC007006c002
DR   Horizon_Discovery; HZGHC007006c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16938; IFI44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFI44L (-)
AC   CVCL_XP72
SY   HZGHC007009c010; HZGHC10964; IFI44L knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_XP72
DR   Horizon_Discovery; HZGHC007009c010
DR   Wikidata; Q93948790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17817; IFI44L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IFI6 (-) 1
AC   CVCL_XP73
SY   HZGHC007011c004; HZGHC2537; IFI6 knockout cell line 1bp insertion in exon 3; HAP1 IFI6 (-)
DR   cancercelllines; CVCL_XP73
DR   Horizon_Discovery; HZGHC007011c004
DR   Wikidata; Q93948792
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4054; IFI6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 IFI6 (-) 2
AC   CVCL_E1ZS
SY   HZGHC007011c002; IFI6 knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007011c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4054; IFI6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFIH1 (-) 1
AC   CVCL_SS15
SY   HZGHC001448c006; IFIH1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SS15
DR   Horizon_Discovery; HZGHC001448c006
DR   Wikidata; Q54875704
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFIH1 (-) 2
AC   CVCL_SS16
SY   HZGHC001448c012; IFIH1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SS16
DR   Horizon_Discovery; HZGHC001448c012
DR   Wikidata; Q54875705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFITM1 (-) 1
AC   CVCL_SS17
SY   HZGHC004350c009; IFITM1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SS17
DR   Horizon_Discovery; HZGHC004350c009
DR   Wikidata; Q54875706
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFITM1 (-) 2
AC   CVCL_SS18
SY   HZGHC004350c010; IFITM1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SS18
DR   Horizon_Discovery; HZGHC004350c010
DR   Wikidata; Q54875707
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFITM2 (-) 1
AC   CVCL_SS19
SY   HZGHC004353c001; IFITM2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SS19
DR   Horizon_Discovery; HZGHC004353c001
DR   Wikidata; Q54875708
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFITM2 (-) 2
AC   CVCL_SS20
SY   HZGHC004353c006; IFITM2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SS20
DR   Horizon_Discovery; HZGHC004353c006
DR   Wikidata; Q54875709
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFITM3 (-) 1
AC   CVCL_SS21
SY   HZGHC004186c010; IFITM3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SS21
DR   Horizon_Discovery; HZGHC004186c010
DR   Wikidata; Q54875710
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFITM3 (-) 2
AC   CVCL_SS22
SY   HZGHC004186c011; IFITM3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SS22
DR   Horizon_Discovery; HZGHC004186c011
DR   Wikidata; Q54875711
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFITM5 (-) 1
AC   CVCL_E1ZT
SY   HZGHC008116c005
DR   Horizon_Discovery; HZGHC008116c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16644; IFITM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFITM5 (-) 2
AC   CVCL_E1ZU
SY   HZGHC008117c001
DR   Horizon_Discovery; HZGHC008117c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16644; IFITM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFITM5 (-) 3
AC   CVCL_E1ZV
SY   HZGHC008117c009
DR   Horizon_Discovery; HZGHC008117c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16644; IFITM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFITM5 (-) 4
AC   CVCL_E1ZW
SY   HZGHC008117c010
DR   Horizon_Discovery; HZGHC008117c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16644; IFITM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFNAR1 (-) 1
AC   CVCL_SS23
SY   HZGHC003836c005; IFNAR1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SS23
DR   Horizon_Discovery; HZGHC003836c005
DR   Wikidata; Q54875712
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFNAR1 (-) 2
AC   CVCL_SS24
SY   HZGHC003836c006; IFNAR1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SS24
DR   Horizon_Discovery; HZGHC003836c006
DR   Wikidata; Q54875713
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003836c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IFNAR2 (-) 1
AC   CVCL_SS25
SY   HZGHC003809c001; IFNAR2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SS25
DR   Horizon_Discovery; HZGHC003809c001
DR   Wikidata; Q54875714
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5433; IFNAR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFNAR2 (-) 2
AC   CVCL_SS26
SY   HZGHC003809c002; IFNAR2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SS26
DR   Horizon_Discovery; HZGHC003809c002
DR   Wikidata; Q54875716
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5433; IFNAR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFNB1 (-) 1
AC   CVCL_E1ZX
SY   HZGHC008214c006
DR   Horizon_Discovery; HZGHC008214c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5434; IFNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFNB1 (-) 2
AC   CVCL_E1ZY
SY   HZGHC008214c007
DR   Horizon_Discovery; HZGHC008214c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5434; IFNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IFNGR1 (-) 1
AC   CVCL_SS27
SY   HZGHC003814c010; IFNGR1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SS27
DR   Horizon_Discovery; HZGHC003814c010
DR   Wikidata; Q54875717
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFNGR1 (-) 2
AC   CVCL_SS28
SY   HZGHC003814c011; IFNGR1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SS28
DR   Horizon_Discovery; HZGHC003814c011
DR   Wikidata; Q54875718
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFNGR2 (-) 1
AC   CVCL_SS29
SY   HZGHC003785c003; IFNGR2 knockout cell line 188bp insertion
DR   cancercelllines; CVCL_SS29
DR   Horizon_Discovery; HZGHC003785c003
DR   Wikidata; Q54875719
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003785c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IFNGR2 (-) 2
AC   CVCL_SS30
SY   HZGHC003785c008; IFNGR2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SS30
DR   Horizon_Discovery; HZGHC003785c008
DR   Wikidata; Q54875720
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IFNLR1 (-)
AC   CVCL_E1ZZ
SY   HZGHC007902c002
DR   Horizon_Discovery; HZGHC007902c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18584; IFNLR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IGF1R (-)
AC   CVCL_SS31
SY   HZGHC000184c015; IGF1R knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SS31
DR   Horizon_Discovery; HZGHC000184c015
DR   PRIDE; PXD010335
DR   Wikidata; Q54875721
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IGF2BP3 (-) 1
AC   CVCL_SS32
SY   HZGHC003551c002; IGF2BP3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SS32
DR   Horizon_Discovery; HZGHC003551c002
DR   Wikidata; Q54875723
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IGF2BP3 (-) 2
AC   CVCL_SS33
SY   HZGHC003551c005; IGF2BP3 knockout cell line 172bp insertion
DR   cancercelllines; CVCL_SS33
DR   Horizon_Discovery; HZGHC003551c005
DR   Wikidata; Q54875724
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003551c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IGF2BP3 (-) 3
AC   CVCL_XP74
SY   HZGHC003551c010; IGF2BP3 knockout cell line
DR   cancercelllines; CVCL_XP74
DR   Horizon_Discovery; HZGHC003551c010
DR   Wikidata; Q93948877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003551c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IGF2BP3 (-) 4
AC   CVCL_XP75
SY   HZGHC003551c012; IGF2BP3 knockout cell line
DR   cancercelllines; CVCL_XP75
DR   Horizon_Discovery; HZGHC003551c012
DR   Wikidata; Q93948881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003551c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IGF2R (-) 1
AC   CVCL_SS34
SY   HZGHC006178c011; IGF2R knockout cell line 14bp deletion; HAP1 IGF2R (-)
DR   cancercelllines; CVCL_SS34
DR   Horizon_Discovery; HZGHC006178c011
DR   Wikidata; Q54875725
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5467; IGF2R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IGF2R (-) 2
AC   CVCL_XP76
SY   HZGHC006178c009; IGF2R knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XP76
DR   Horizon_Discovery; HZGHC006178c009
DR   Wikidata; Q93948888
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5467; IGF2R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IKBKB (-) 1
AC   CVCL_SS35
SY   HZGHC023808c003; IKBKB knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SS35
DR   Horizon_Discovery; HZGHC023808c003
DR   Wikidata; Q54875726
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC023808c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IKBKB (-) 2
AC   CVCL_SS36
SY   HZGHC023808c011; IKBKB knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SS36
DR   Horizon_Discovery; HZGHC023808c011
DR   Wikidata; Q54875727
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IKBKB (-) 3
AC   CVCL_SS37
SY   HZGHC023808c014; IKBKB knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SS37
DR   Horizon_Discovery; HZGHC023808c014
DR   Wikidata; Q54875728
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC023808c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IKBKE (-) 1
AC   CVCL_SS38
SY   HZGHC002933c001; IKBKE knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SS38
DR   Horizon_Discovery; HZGHC002933c001
DR   Wikidata; Q54875729
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IKBKE (-) 2
AC   CVCL_SS39
SY   HZGHC002933c007; IKBKE knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SS39
DR   Horizon_Discovery; HZGHC002933c007
DR   Wikidata; Q54875730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IKBKG (-) 1
AC   CVCL_SS40
SY   HZGHC002594c011; IKBKG knockout cell line 269bp insertion
DR   cancercelllines; CVCL_SS40
DR   Horizon_Discovery; HZGHC002594c011
DR   Wikidata; Q54875731
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002594c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IKBKG (-) 2
AC   CVCL_SS41
SY   HZGHC002594c012; IKBKG knockout cell line 598bp insertion
DR   cancercelllines; CVCL_SS41
DR   Horizon_Discovery; HZGHC002594c012
DR   Wikidata; Q54875732
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002594c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IL11RA (-) 1
AC   CVCL_SS42
SY   HZGHC003917c005; IL11RA knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SS42
DR   Horizon_Discovery; HZGHC003917c005
DR   Wikidata; Q54875733
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5967; IL11RA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IL11RA (-) 2
AC   CVCL_SS43
SY   HZGHC003917c006; IL11RA knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SS43
DR   Horizon_Discovery; HZGHC003917c006
DR   Wikidata; Q54875734
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5967; IL11RA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IL17RA (-) 1
AC   CVCL_SS44
SY   HZGHC005986c004; IL17RA knockout cell line 2bp deletion; HAP1 IL17RA (-)
DR   cancercelllines; CVCL_SS44
DR   Horizon_Discovery; HZGHC005986c004
DR   Wikidata; Q54875735
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5985; IL17RA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IL17RA (-) 2
AC   CVCL_XP77
SY   HZGHC005986c009; IL17RA knockout cell line 94bp deletion
DR   cancercelllines; CVCL_XP77
DR   Horizon_Discovery; HZGHC005986c009
DR   Wikidata; Q93948942
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5985; IL17RA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IL32 (-) 1
AC   CVCL_XP78
SY   HZGHC007145c011; HZGHC9235; IL32 knockout cell line 1bp insertion in exon 6; HAP1 IL32 (-)
DR   cancercelllines; CVCL_XP78
DR   Horizon_Discovery; HZGHC007145c011
DR   Wikidata; Q93948944
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16830; IL32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 IL32 (-) 2
AC   CVCL_E2A0
SY   HZGHC007145c006; IL32 knockout cell line 2bp deletion in exon 6
DR   Horizon_Discovery; HZGHC007145c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16830; IL32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IL4R (-) 1
AC   CVCL_SS45
SY   HZGHC005292c012; IL4R knockout cell line 110bp deletion; HAP1 IL4R (-)
DR   cancercelllines; CVCL_SS45
DR   Horizon_Discovery; HZGHC005292c012
DR   Wikidata; Q54875736
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IL4R (-) 2
AC   CVCL_XP79
SY   HZGHC005292c005; IL4R knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XP79
DR   Horizon_Discovery; HZGHC005292c005
DR   Wikidata; Q93948952
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IL6R (-) 1
AC   CVCL_SS46
SY   HZGHC004201c005; IL6R knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SS46
DR   Horizon_Discovery; HZGHC004201c005
DR   Wikidata; Q54875737
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IL6R (-) 2
AC   CVCL_SS47
SY   HZGHC004201c007; IL6R knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SS47
DR   Horizon_Discovery; HZGHC004201c007
DR   Wikidata; Q54875738
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IL6ST (-) 1
AC   CVCL_SS48
SY   HZGHC004191c007; IL6ST knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SS48
DR   Horizon_Discovery; HZGHC004191c007
DR   Wikidata; Q54875739
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IL6ST (-) 2
AC   CVCL_SS49
SY   HZGHC004191c008; IL6ST knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SS49
DR   Horizon_Discovery; HZGHC004191c008
DR   Wikidata; Q54875740
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ILK (-)
AC   CVCL_SS50
SY   HZGHC019082c001; ILK knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SS50
DR   Horizon_Discovery; HZGHC019082c001
DR   Wikidata; Q54875741
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6040; ILK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ILKAP (-) 1
AC   CVCL_SS51
SY   HZGHC003106c001; ILKAP knockout cell line 62bp insertion
DR   cancercelllines; CVCL_SS51
DR   Horizon_Discovery; HZGHC003106c001
DR   Wikidata; Q54875742
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15566; ILKAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003106c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ILKAP (-) 2
AC   CVCL_SS52
SY   HZGHC003106c012; ILKAP knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SS52
DR   Horizon_Discovery; HZGHC003106c012
DR   Wikidata; Q54875743
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15566; ILKAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IMMP2L (-) 1
AC   CVCL_SS53
SY   HZGHC006035c010; IMMP2L knockout cell line 1bp insertion; HAP1 IMMP2L (-)
DR   cancercelllines; CVCL_SS53
DR   Horizon_Discovery; HZGHC006035c010
DR   Wikidata; Q54875744
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14598; IMMP2L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IMMP2L (-) 2
AC   CVCL_XP80
SY   HZGHC006035c012; IMMP2L knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP80
DR   Horizon_Discovery; HZGHC006035c012
DR   Wikidata; Q93948992
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14598; IMMP2L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006035c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IMMT (-) 1
AC   CVCL_SS54
SY   HZGHC005045c003; IMMT knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SS54
DR   Horizon_Discovery; HZGHC005045c003
DR   Wikidata; Q54875745
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6047; IMMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005045c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IMMT (-) 2
AC   CVCL_SS55
SY   HZGHC005045c007; IMMT knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SS55
DR   Horizon_Discovery; HZGHC005045c007
DR   Wikidata; Q54875746
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6047; IMMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005045c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IMPA1 (-) 1
AC   CVCL_E2A1
SY   HZGHC007754c007
DR   Horizon_Discovery; HZGHC007754c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6050; IMPA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IMPA1 (-) 2
AC   CVCL_E2A2
SY   HZGHC007754c008
DR   Horizon_Discovery; HZGHC007754c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6050; IMPA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IMPDH1 (-) 1
AC   CVCL_SS56
SY   HZGHC003769c001; IMPDH1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SS56
DR   Horizon_Discovery; HZGHC003769c001
DR   Wikidata; Q54875747
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6052; IMPDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IMPDH1 (-) 2
AC   CVCL_SS57
SY   HZGHC003769c002; IMPDH1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SS57
DR   Horizon_Discovery; HZGHC003769c002
DR   Wikidata; Q54875748
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6052; IMPDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IMPDH2 (-) 1
AC   CVCL_C8FK
SY   HZGHC007566c010; IMPDH2 knockout cell line 1bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007566c010
DR   Wikidata; Q123031424
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6053; IMPDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 IMPDH2 (-) 2
AC   CVCL_C8FL
SY   HZGHC007567c002; IMPDH2 knockout cell line 25bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007567c002
DR   Wikidata; Q123031425
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6053; IMPDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 INF2 (-) 1
AC   CVCL_SS58
SY   HZGHC004246c012; INF2 knockout cell line 17bp deletion in exon 3
DR   cancercelllines; CVCL_SS58
DR   Horizon_Discovery; HZGHC004246c012
DR   Wikidata; Q54875749
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23791; INF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INF2 (-) 2
AC   CVCL_SS59
SY   HZGHC004333c007; INF2 knockout cell line 10bp deletion in exon 22
DR   cancercelllines; CVCL_SS59
DR   Horizon_Discovery; HZGHC004333c007
DR   Wikidata; Q54875750
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23791; INF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INF2 (-) 3
AC   CVCL_SS60
SY   HZGHC004333c008; INF2 knockout cell line 11bp deletion in exon 22
DR   cancercelllines; CVCL_SS60
DR   Horizon_Discovery; HZGHC004333c008
DR   Wikidata; Q54875751
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23791; INF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INO80E (-) 1
AC   CVCL_SS61
SY   HZGHC004389c002; INO80E knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SS61
DR   Horizon_Discovery; HZGHC004389c002
DR   Wikidata; Q54875752
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26905; INO80E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INO80E (-) 2
AC   CVCL_SS62
SY   HZGHC004390c001; INO80E knockout cell line 170bp deletion
DR   cancercelllines; CVCL_SS62
DR   Horizon_Discovery; HZGHC004390c001
DR   Wikidata; Q54875753
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26905; INO80E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP4A (-) 1
AC   CVCL_SS63
SY   HZGHC000831c003; INPP4A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SS63
DR   Horizon_Discovery; HZGHC000831c003
DR   Wikidata; Q54875754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6074; INPP4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP4A (-) 2
AC   CVCL_SS64
SY   HZGHC000831c010; INPP4A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SS64
DR   Horizon_Discovery; HZGHC000831c010
DR   Wikidata; Q54875755
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6074; INPP4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP4A (-) 3
AC   CVCL_SS65
SY   HZGHC000832c001; INPP4A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SS65
DR   Horizon_Discovery; HZGHC000832c001
DR   Wikidata; Q54875756
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6074; INPP4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP4A (-) 4
AC   CVCL_SS66
SY   HZGHC000832c002; INPP4A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SS66
DR   Horizon_Discovery; HZGHC000832c002
DR   Wikidata; Q54875761
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6074; INPP4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP5A (-) 1
AC   CVCL_SS67
SY   HZGHC006619c002; INPP5A knockout cell line 1bp insertion; HAP1 INPP5A (-)
DR   cancercelllines; CVCL_SS67
DR   Horizon_Discovery; HZGHC006619c002
DR   Wikidata; Q54875762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6076; INPP5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 INPP5A (-) 2
AC   CVCL_XP81
SY   HZGHC006619c005; INPP5A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP81
DR   Horizon_Discovery; HZGHC006619c005
DR   Wikidata; Q93949086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6076; INPP5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006619c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 INPP5A (-) 3
AC   CVCL_XP82
SY   HZGHC006619c008; INPP5A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XP82
DR   Horizon_Discovery; HZGHC006619c008
DR   Wikidata; Q93949088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6076; INPP5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP5E (-) 1
AC   CVCL_SS68
SY   HZGHC002902c012; INPP5E knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SS68
DR   Horizon_Discovery; HZGHC002902c012
DR   Wikidata; Q54875763
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21474; INPP5E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002902c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 INPP5E (-) 2
AC   CVCL_SS69
SY   HZGHC002902c002; INPP5E knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SS69
DR   Horizon_Discovery; HZGHC002902c002
DR   Wikidata; Q54875764
RX   PubMed=28031327;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21474; INPP5E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 INPP5E (-) 3
AC   CVCL_SS70
SY   HZGHC002902c010; INPP5E knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SS70
DR   Horizon_Discovery; HZGHC002902c010
DR   Wikidata; Q54875765
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21474; INPP5E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP5J (-)
AC   CVCL_SS71
SY   HZGHC002899c012; INPP5J knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_SS71
DR   Horizon_Discovery; HZGHC002899c012
DR   Wikidata; Q54875766
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8956; INPP5J.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP5K (-) 1
AC   CVCL_SS72
SY   HZGHC002898c003; INPP5K knockout cell line 133bp deletion
DR   cancercelllines; CVCL_SS72
DR   Horizon_Discovery; HZGHC002898c003
DR   Wikidata; Q54875767
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33882; INPP5K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPP5K (-) 2
AC   CVCL_SS73
SY   HZGHC002898c008; INPP5K knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SS73
DR   Horizon_Discovery; HZGHC002898c008
DR   Wikidata; Q54875768
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33882; INPP5K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPPL1 (-) 1
AC   CVCL_SS74
SY   HZGHC002911c003; INPPL1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SS74
DR   Horizon_Discovery; HZGHC002911c003
DR   Wikidata; Q54875769
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6080; INPPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INPPL1 (-) 2
AC   CVCL_SS75
SY   HZGHC002911c004; INPPL1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SS75
DR   Horizon_Discovery; HZGHC002911c004
DR   Wikidata; Q54875770
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6080; INPPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 INSR (-)
AC   CVCL_SS76
SY   HZGHC000730c014; INSR knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SS76
DR   Horizon_Discovery; HZGHC000730c014
DR   PRIDE; PXD010335
DR   Wikidata; Q54875771
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6091; INSR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IPO4 (-) 1
AC   CVCL_E2A3
SY   HZGHC007824c002
DR   Horizon_Discovery; HZGHC007824c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19426; IPO4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IPO4 (-) 2
AC   CVCL_E2A4
SY   HZGHC007824c010
DR   Horizon_Discovery; HZGHC007824c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19426; IPO4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 IQGAP1 (-) 1
AC   CVCL_SS77
SY   HZGHC000784c001; IQGAP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SS77
DR   Horizon_Discovery; HZGHC000784c001
DR   Wikidata; Q54875772
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6110; IQGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IQGAP1 (-) 2
AC   CVCL_SS78
SY   HZGHC000784c009; IQGAP1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SS78
DR   Horizon_Discovery; HZGHC000784c009
DR   Wikidata; Q54875773
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6110; IQGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IQGAP2 (-) 1
AC   CVCL_SS79
SY   HZGHC005732c002; IQGAP2 knockout cell line 17bp deletion; HAP1 IQGAP2 (-)
DR   cancercelllines; CVCL_SS79
DR   Horizon_Discovery; HZGHC005732c002
DR   Wikidata; Q54875774
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6111; IQGAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IQGAP2 (-) 2
AC   CVCL_XP83
SY   HZGHC005732c005; IQGAP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP83
DR   Horizon_Discovery; HZGHC005732c005
DR   Wikidata; Q93949153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6111; IQGAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IQSEC1 (-) 1
AC   CVCL_SS80
SY   HZGHC004028c001; IQSEC1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SS80
DR   Horizon_Discovery; HZGHC004028c001
DR   Wikidata; Q54875775
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29112; IQSEC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IQSEC1 (-) 2
AC   CVCL_SS81
SY   HZGHC004028c007; IQSEC1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SS81
DR   Horizon_Discovery; HZGHC004028c007
DR   Wikidata; Q54875776
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29112; IQSEC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IQSEC2 (-)
AC   CVCL_SS82
SY   HZGHC003572c011; IQSEC2 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SS82
DR   Horizon_Discovery; HZGHC003572c011
DR   Wikidata; Q54875777
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29059; IQSEC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRAK1 (-) 1
AC   CVCL_SS83
SY   HZGHC000009c005; IRAK1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SS83
DR   Horizon_Discovery; HZGHC000009c005
DR   Wikidata; Q54875778
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IRAK1 (-) 2
AC   CVCL_SS84
SY   HZGHC000009c019; IRAK1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SS84
DR   Horizon_Discovery; HZGHC000009c019
DR   Wikidata; Q54875779
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000009c019; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IRAK2 (-) 1
AC   CVCL_SS85
SY   HZGHC000010c002; IRAK2 knockout cell line 1bp insertion; HAP1 IRAK2 (-)
DR   cancercelllines; CVCL_SS85
DR   Horizon_Discovery; HZGHC000010c002
DR   Wikidata; Q54875780
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6113; IRAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IRAK2 (-) 2
AC   CVCL_XP84
SY   HZGHC000010c012; IRAK2 knockout cell line
DR   cancercelllines; CVCL_XP84
DR   Horizon_Discovery; HZGHC000010c012
DR   Wikidata; Q93949173
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6113; IRAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000010c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IRAK3 (-)
AC   CVCL_SS86
SY   HZGHC000201c006; IRAK3 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SS86
DR   Horizon_Discovery; HZGHC000201c006
DR   Wikidata; Q54875781
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17020; IRAK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000201c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IRAK4 (-)
AC   CVCL_SS87
SY   HZGHC000204c007; IRAK4 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SS87
DR   Horizon_Discovery; HZGHC000204c007
DR   Wikidata; Q54875782
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF1 (-) 1
AC   CVCL_SS88
SY   HZGHC005136c011; IRF1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SS88
DR   Horizon_Discovery; HZGHC005136c011
DR   Wikidata; Q54875783
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF1 (-) 2
AC   CVCL_SS89
SY   HZGHC005136c012; IRF1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SS89
DR   Horizon_Discovery; HZGHC005136c012
DR   Wikidata; Q54875784
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF2 (-) 1
AC   CVCL_SS90
SY   HZGHC004411c001; IRF2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SS90
DR   Horizon_Discovery; HZGHC004411c001
DR   Wikidata; Q54875785
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF2 (-) 2
AC   CVCL_SS91
SY   HZGHC004411c003; IRF2 knockout cell line 43bp insertion
DR   cancercelllines; CVCL_SS91
DR   Horizon_Discovery; HZGHC004411c003
DR   Wikidata; Q54875786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004411c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IRF2 (-) 3
AC   CVCL_SS92
SY   HZGHC004412c008; IRF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SS92
DR   Horizon_Discovery; HZGHC004412c008
DR   Wikidata; Q54875787
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF2 (-) 4
AC   CVCL_SS93
SY   HZGHC004412c010; IRF2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SS93
DR   Horizon_Discovery; HZGHC004412c010
DR   Wikidata; Q54875788
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF2BPL (-) 1
AC   CVCL_SS94
SY   HZGHC006439c002; IRF2BPL knockout cell line 14bp deletion; HAP1 IRF2BPL (-)
DR   cancercelllines; CVCL_SS94
DR   Horizon_Discovery; HZGHC006439c002
DR   Wikidata; Q54875789
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14282; IRF2BPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IRF2BPL (-) 2
AC   CVCL_XP85
SY   HZGHC006439c009; IRF2BPL knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XP85
DR   Horizon_Discovery; HZGHC006439c009
DR   Wikidata; Q93949239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14282; IRF2BPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF3 (-) 1
AC   CVCL_SS95
SY   HZGHC002931c005; IRF3 knockout cell line 40bp deletion
DR   cancercelllines; CVCL_SS95
DR   Horizon_Discovery; HZGHC002931c005
DR   Wikidata; Q54875790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF3 (-) 2
AC   CVCL_SS96
SY   HZGHC002931c012; IRF3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SS96
DR   Horizon_Discovery; HZGHC002931c012
DR   Wikidata; Q54875791
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF5 (-) 1
AC   CVCL_SS97
SY   HZGHC003896c004; IRF5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SS97
DR   Horizon_Discovery; HZGHC003896c004
DR   Wikidata; Q54875792
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6120; IRF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF5 (-) 2
AC   CVCL_SS98
SY   HZGHC003896c005; IRF5 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SS98
DR   Horizon_Discovery; HZGHC003896c005
DR   Wikidata; Q54875793
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6120; IRF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF5 (-) 3
AC   CVCL_SS99
SY   HZGHC003896c011; IRF5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SS99
DR   Horizon_Discovery; HZGHC003896c011
DR   Wikidata; Q54875794
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6120; IRF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF7 (-) 1
AC   CVCL_ST00
SY   HZGHC003897c003; IRF7 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_ST00
DR   Horizon_Discovery; HZGHC003897c003
DR   Wikidata; Q54875795
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF7 (-) 2
AC   CVCL_ST01
SY   HZGHC003897c005; IRF7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST01
DR   Horizon_Discovery; HZGHC003897c005
DR   Wikidata; Q54875796
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF7 (-) 3
AC   CVCL_ST02
SY   HZGHC003897c012; IRF7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST02
DR   Horizon_Discovery; HZGHC003897c012
DR   Wikidata; Q54875797
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRF8 (-)
AC   CVCL_ST03
SY   HZGHC004199c005; IRF8 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_ST03
DR   Horizon_Discovery; HZGHC004199c005
DR   Wikidata; Q54875799
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRS1 (-) 1
AC   CVCL_ST06
SY   HZGHC001355c002; IRS1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_ST06
DR   Horizon_Discovery; HZGHC001355c002
DR   Wikidata; Q54875803
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6125; IRS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IRS1 (-) 2
AC   CVCL_ST07
SY   HZGHC001355c004; IRS1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_ST07
DR   Horizon_Discovery; HZGHC001355c004
DR   Wikidata; Q54875804
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6125; IRS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ISG15 (-) 1
AC   CVCL_ST08
SY   HZGHC002552c002; ISG15 knockout cell line 70bp deletion
DR   cancercelllines; CVCL_ST08
DR   Horizon_Discovery; HZGHC002552c002
DR   Wikidata; Q54875805
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4053; ISG15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ISG15 (-) 2
AC   CVCL_ST09
SY   HZGHC002552c004; ISG15 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_ST09
DR   Horizon_Discovery; HZGHC002552c004
DR   Wikidata; Q54875806
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4053; ISG15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ISL1 (-) 1
AC   CVCL_ST10
SY   HZGHC006184c010; ISL1 knockout cell line 4bp insertion; HAP1 ISL1 (-)
DR   cancercelllines; CVCL_ST10
DR   Horizon_Discovery; HZGHC006184c010
DR   Wikidata; Q54875807
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6132; ISL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ISL1 (-) 2
AC   CVCL_XP86
SY   HZGHC006184c004; ISL1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XP86
DR   Horizon_Discovery; HZGHC006184c004
DR   Wikidata; Q93949365
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6132; ISL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ISOC2 (-) 1
AC   CVCL_ST11
SY   HZGHC005875c011; ISOC2 knockout cell line 16bp deletion; HAP1 ISOC2 (-)
DR   cancercelllines; CVCL_ST11
DR   Horizon_Discovery; HZGHC005875c011
DR   Wikidata; Q54875808
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26278; ISOC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ISOC2 (-) 2
AC   CVCL_XP87
SY   HZGHC005875c002; ISOC2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XP87
DR   Horizon_Discovery; HZGHC005875c002
DR   Wikidata; Q93949378
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26278; ISOC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ISPD (-) 1
AC   CVCL_ST12
SY   HZGHC000744c004; ISPD knockout cell line 14bp deletion
DR   cancercelllines; CVCL_ST12
DR   Horizon_Discovery; HZGHC000744c004
DR   Wikidata; Q54875809
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37276; CRPPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ISPD (-) 2
AC   CVCL_ST13
SY   HZGHC000744c009; ISPD knockout cell line 29bp deletion
DR   cancercelllines; CVCL_ST13
DR   Horizon_Discovery; HZGHC000744c009
DR   Wikidata; Q54875810
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37276; CRPPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ISPD (-) 3
AC   CVCL_ST14
SY   HZGHC000745c010; ISPD knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST14
DR   Horizon_Discovery; HZGHC000745c010
DR   Wikidata; Q54875811
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37276; CRPPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ISPD (-) 4
AC   CVCL_ST15
SY   HZGHC000745c012; ISPD knockout cell line 26bp deletion
DR   cancercelllines; CVCL_ST15
DR   Horizon_Discovery; HZGHC000745c012
DR   Wikidata; Q54875812
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37276; CRPPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IST1 (-)
AC   CVCL_E2A5
SY   HZGHC008234c009
DR   Horizon_Discovery; HZGHC008234c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28977; IST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ITCH (-)
AC   CVCL_ST16
SY   HZGHC002597c009; ITCH knockout cell line 4bp deletion
DR   cancercelllines; CVCL_ST16
DR   Horizon_Discovery; HZGHC002597c009
DR   Wikidata; Q54875813
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13890; ITCH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA1 (-) 1
AC   CVCL_ST17
SY   HZGHC001039c001; ITGA1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_ST17
DR   Horizon_Discovery; HZGHC001039c001
DR   Wikidata; Q54875814
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6134; ITGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA1 (-) 2
AC   CVCL_ST18
SY   HZGHC001039c012; ITGA1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_ST18
DR   Horizon_Discovery; HZGHC001039c012
DR   Wikidata; Q54875815
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6134; ITGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA1 (-) 3
AC   CVCL_ST19
SY   HZGHC001071c010; ITGA1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_ST19
DR   Horizon_Discovery; HZGHC001071c010
DR   Wikidata; Q54875816
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6134; ITGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA1 (-) 4
AC   CVCL_ST20
SY   HZGHC001071c011; ITGA1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_ST20
DR   Horizon_Discovery; HZGHC001071c011
DR   Wikidata; Q54875817
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6134; ITGA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA2 (-) 1
AC   CVCL_ST21
SY   HZGHC001073c010; ITGA2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_ST21
DR   Horizon_Discovery; HZGHC001073c010
DR   Wikidata; Q54875818
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA2 (-) 2
AC   CVCL_ST22
SY   HZGHC001073c011; ITGA2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST22
DR   Horizon_Discovery; HZGHC001073c011
DR   Wikidata; Q54875819
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA2B (-) 1
AC   CVCL_ST23
SY   HZGHC003872c002; ITGA2B knockout cell line 2bp insertion
DR   cancercelllines; CVCL_ST23
DR   Horizon_Discovery; HZGHC003872c002
DR   Wikidata; Q54875820
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6138; ITGA2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA2B (-) 2
AC   CVCL_ST24
SY   HZGHC003872c006; ITGA2B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_ST24
DR   Horizon_Discovery; HZGHC003872c006
DR   Wikidata; Q54875821
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6138; ITGA2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA3 (-) 1
AC   CVCL_ST25
SY   HZGHC001043c001; ITGA3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST25
DR   Horizon_Discovery; HZGHC001043c001
DR   Wikidata; Q54875822
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6139; ITGA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA3 (-) 2
AC   CVCL_ST26
SY   HZGHC001043c008; ITGA3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_ST26
DR   Horizon_Discovery; HZGHC001043c008
DR   Wikidata; Q54875823
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6139; ITGA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA4 (-) 1
AC   CVCL_ST27
SY   HZGHC001077c007; ITGA4 knockout cell line 166bp insertion
DR   cancercelllines; CVCL_ST27
DR   Horizon_Discovery; HZGHC001077c007
DR   Wikidata; Q54875824
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6140; ITGA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001077c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ITGA4 (-) 2
AC   CVCL_ST28
SY   HZGHC001077c009; ITGA4 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_ST28
DR   Horizon_Discovery; HZGHC001077c009
DR   Wikidata; Q54875825
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6140; ITGA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA5 (-) 1
AC   CVCL_ST29
SY   HZGHC001085c001; ITGA5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_ST29
DR   Horizon_Discovery; HZGHC001085c001
DR   Wikidata; Q54875826
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA5 (-) 2
AC   CVCL_ST30
SY   HZGHC001085c011; ITGA5 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_ST30
DR   Horizon_Discovery; HZGHC001085c011
DR   Wikidata; Q54875827
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA6 (-) 1
AC   CVCL_ST31
SY   HZGHC001052c002; ITGA6 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_ST31
DR   Horizon_Discovery; HZGHC001052c002
DR   Wikidata; Q54875828
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6142; ITGA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA6 (-) 2
AC   CVCL_ST32
SY   HZGHC001052c010; ITGA6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_ST32
DR   Horizon_Discovery; HZGHC001052c010
DR   Wikidata; Q54875829
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6142; ITGA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA7 (-) 1
AC   CVCL_ST33
SY   HZGHC001054c001; ITGA7 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_ST33
DR   Horizon_Discovery; HZGHC001054c001
DR   Wikidata; Q54875830
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6143; ITGA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA7 (-) 2
AC   CVCL_ST34
SY   HZGHC001054c012; ITGA7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST34
DR   Horizon_Discovery; HZGHC001054c012
DR   Wikidata; Q54875831
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6143; ITGA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA7 (-) 3
AC   CVCL_ST35
SY   HZGHC001086c002; ITGA7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_ST35
DR   Horizon_Discovery; HZGHC001086c002
DR   Wikidata; Q54875832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6143; ITGA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA7 (-) 4
AC   CVCL_ST36
SY   HZGHC001086c009; ITGA7 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_ST36
DR   Horizon_Discovery; HZGHC001086c009
DR   Wikidata; Q54875833
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6143; ITGA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA9 (-) 1
AC   CVCL_ST37
SY   HZGHC001050c002; ITGA9 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_ST37
DR   Horizon_Discovery; HZGHC001050c002
DR   Wikidata; Q54875834
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6145; ITGA9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGA9 (-) 2
AC   CVCL_ST38
SY   HZGHC001050c009; ITGA9 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_ST38
DR   Horizon_Discovery; HZGHC001050c009
DR   Wikidata; Q54875835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6145; ITGA9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGAE (-) 1
AC   CVCL_ST39
SY   HZGHC001026c007; ITGAE knockout cell line 7bp deletion
DR   cancercelllines; CVCL_ST39
DR   Horizon_Discovery; HZGHC001026c007
DR   Wikidata; Q54875836
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGAE (-) 2
AC   CVCL_ST40
SY   HZGHC001026c008; ITGAE knockout cell line 4bp deletion
DR   cancercelllines; CVCL_ST40
DR   Horizon_Discovery; HZGHC001026c008
DR   Wikidata; Q54875837
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGAE (-) 3
AC   CVCL_ST41
SY   HZGHC001056c003; ITGAE knockout cell line 13bp deletion
DR   cancercelllines; CVCL_ST41
DR   Horizon_Discovery; HZGHC001056c003
DR   Wikidata; Q54875838
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGAE (-) 4
AC   CVCL_ST42
SY   HZGHC001056c004; ITGAE knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST42
DR   Horizon_Discovery; HZGHC001056c004
DR   Wikidata; Q54875839
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB1 (-) 1
AC   CVCL_ST43
SY   HZGHC001029c003; ITGB1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST43
DR   Horizon_Discovery; HZGHC001029c003
DR   Wikidata; Q54875840
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB1 (-) 2
AC   CVCL_ST44
SY   HZGHC001059c010; ITGB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST44
DR   Horizon_Discovery; HZGHC001059c010
DR   Wikidata; Q54875841
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB1 (-) 3
AC   CVCL_ST45
SY   HZGHC001059c012; ITGB1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_ST45
DR   Horizon_Discovery; HZGHC001059c012
DR   Wikidata; Q54875842
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB4 (-) 1
AC   CVCL_ST46
SY   HZGHC001027c002; ITGB4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST46
DR   Horizon_Discovery; HZGHC001027c002
DR   Wikidata; Q54875845
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6158; ITGB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB4 (-) 2
AC   CVCL_ST47
SY   HZGHC001027c011; ITGB4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_ST47
DR   Horizon_Discovery; HZGHC001027c011
DR   Wikidata; Q54875847
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6158; ITGB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB4 (-) 3
AC   CVCL_ST48
SY   HZGHC001057c010; ITGB4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_ST48
DR   Horizon_Discovery; HZGHC001057c010
DR   Wikidata; Q54875848
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6158; ITGB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB5 (-) 1
AC   CVCL_ST49
SY   HZGHC001058c010; ITGB5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST49
DR   Horizon_Discovery; HZGHC001058c010
DR   Wikidata; Q54875849
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6160; ITGB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB5 (-) 2
AC   CVCL_ST50
SY   HZGHC001028c001; ITGB5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_ST50
DR   Horizon_Discovery; HZGHC001028c001
DR   Wikidata; Q54875850
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6160; ITGB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB5 (-) 3
AC   CVCL_ST51
SY   HZGHC001028c010; ITGB5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_ST51
DR   Horizon_Discovery; HZGHC001028c010
DR   Wikidata; Q54875851
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6160; ITGB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITGB5 (-) 4
AC   CVCL_ST52
SY   HZGHC001058c001; ITGB5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST52
DR   Horizon_Discovery; HZGHC001058c001
DR   Wikidata; Q54875852
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6160; ITGB5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITK (-)
AC   CVCL_ST53
SY   HZGHC000011c004; ITK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST53
DR   Horizon_Discovery; HZGHC000011c004
DR   Wikidata; Q54875853
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6171; ITK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR1 (-) 1
AC   CVCL_ST54
SY   HZGHC003775c011; ITPR1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_ST54
DR   Horizon_Discovery; HZGHC003775c011
DR   Wikidata; Q54875854
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR1 (-) 2
AC   CVCL_ST55
SY   HZGHC003775c012; ITPR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST55
DR   Horizon_Discovery; HZGHC003775c012
DR   Wikidata; Q54875855
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR1 (-) 3
AC   CVCL_ST56
SY   HZGHC004439c004; ITPR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST56
DR   Horizon_Discovery; HZGHC004439c004
DR   Wikidata; Q54875856
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR1 (-) 4
AC   CVCL_ST57
SY   HZGHC004439c005; ITPR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST57
DR   Horizon_Discovery; HZGHC004439c005
DR   Wikidata; Q54875857
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004439c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ITPR1 (-) 5
AC   CVCL_ST58
SY   HZGHC004439c006; ITPR1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_ST58
DR   Horizon_Discovery; HZGHC004439c006
DR   Wikidata; Q54875858
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR1 (-) 6
AC   CVCL_ST59
SY   HZGHC004439c009; ITPR1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_ST59
DR   Horizon_Discovery; HZGHC004439c009
DR   Wikidata; Q54875859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR2 (-) 1
AC   CVCL_ST60
SY   HZGHC003777c003; ITPR2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_ST60
DR   Horizon_Discovery; HZGHC003777c003
DR   Wikidata; Q54875860
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR2 (-) 2
AC   CVCL_ST61
SY   HZGHC003777c007; ITPR2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST61
DR   Horizon_Discovery; HZGHC003777c007
DR   Wikidata; Q54875861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR2 (-) 3
AC   CVCL_ST62
SY   HZGHC003778c002; ITPR2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_ST62
DR   Horizon_Discovery; HZGHC003778c002
DR   Wikidata; Q54875862
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR2 (-) 4
AC   CVCL_ST63
SY   HZGHC003778c011; ITPR2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_ST63
DR   Horizon_Discovery; HZGHC003778c011
DR   Wikidata; Q54875863
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ITPR3 (-)
AC   CVCL_ST64
SY   HZGHC003780c001; ITPR3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST64
DR   Horizon_Discovery; HZGHC003780c001
DR   Wikidata; Q54875864
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IVNS1ABP (-) 1
AC   CVCL_ST65
SY   HZGHC005161c005; IVNS1ABP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST65
DR   Horizon_Discovery; HZGHC005161c005
DR   Wikidata; Q54875865
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16951; IVNS1ABP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IVNS1ABP (-) 2
AC   CVCL_ST66
SY   HZGHC005161c007; IVNS1ABP knockout cell line 1bp deletion
DR   cancercelllines; CVCL_ST66
DR   Horizon_Discovery; HZGHC005161c007
DR   Wikidata; Q54875866
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16951; IVNS1ABP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 IVNS1ABP (-) 3
AC   CVCL_ST67
SY   HZGHC005162c008; IVNS1ABP knockout cell line 100bp insertion
DR   cancercelllines; CVCL_ST67
DR   Horizon_Discovery; HZGHC005162c008
DR   Wikidata; Q54875867
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16951; IVNS1ABP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005162c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 IVNS1ABP (-) 4
AC   CVCL_ST68
SY   HZGHC005162c009; IVNS1ABP knockout cell line 8bp deletion
DR   cancercelllines; CVCL_ST68
DR   Horizon_Discovery; HZGHC005162c009
DR   Wikidata; Q54875868
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16951; IVNS1ABP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JAG1 (-) 1
AC   CVCL_ST69
SY   HZGHC006140c002; JAG1 knockout cell line 1bp insertion; HAP1 JAG1 (-)
DR   cancercelllines; CVCL_ST69
DR   Horizon_Discovery; HZGHC006140c002
DR   Wikidata; Q54875869
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JAG1 (-) 2
AC   CVCL_XP88
SY   HZGHC006140c004; JAG1 knockout cell line 220bp insertion
DR   cancercelllines; CVCL_XP88
DR   Horizon_Discovery; HZGHC006140c004
DR   Wikidata; Q93949716
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006140c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JAK1 (-) 1
AC   CVCL_ST70
SY   HZGHC000012c001; JAK1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_ST70
DR   Horizon_Discovery; HZGHC000012c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54875870
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JAK1 (-) 2
AC   CVCL_ST71
SY   HZGHC000012c022; JAK1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_ST71
DR   Horizon_Discovery; HZGHC000012c022
DR   Wikidata; Q54875871
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JAK2 (-) 1
AC   CVCL_ST72
SY   HZGHC000013c005; JAK2 knockout cell line 55bp insertion; HAP1 JAK2 (-)
DR   cancercelllines; CVCL_ST72
DR   Horizon_Discovery; HZGHC000013c005
DR   Wikidata; Q54875872
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000013c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JAK2 (-) 2
AC   CVCL_E1NK
SY   HZGHC000013c019; JAK2 knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC000013c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 JARID2 (-) 1
AC   CVCL_ST73
SY   HZGHC016202c018; JARID2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_ST73
DR   Horizon_Discovery; HZGHC016202c018
DR   Wikidata; Q54875873
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6196; JARID2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JARID2 (-) 2
AC   CVCL_ST74
SY   HZGHC016202c022; JARID2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_ST74
DR   Horizon_Discovery; HZGHC016202c022
DR   Wikidata; Q54875874
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6196; JARID2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC016202c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JARID2 (-) 3
AC   CVCL_ST75
SY   HZGHC016202c023; JARID2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST75
DR   Horizon_Discovery; HZGHC016202c023
DR   Wikidata; Q54875875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6196; JARID2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC016202c023; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JMJD1C (-) 1
AC   CVCL_ST76
SY   HZGHC004168c002; JMJD1C knockout cell line 1bp deletion
DR   cancercelllines; CVCL_ST76
DR   Horizon_Discovery; HZGHC004168c002
DR   Wikidata; Q54875876
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12313; JMJD1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JMJD1C (-) 2
AC   CVCL_ST77
SY   HZGHC004168c006; JMJD1C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST77
DR   Horizon_Discovery; HZGHC004168c006
DR   Wikidata; Q54875877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12313; JMJD1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JMJD1C (-) 3
AC   CVCL_ST78
SY   HZGHC004168c007; JMJD1C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST78
DR   Horizon_Discovery; HZGHC004168c007
DR   Wikidata; Q54875878
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12313; JMJD1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004168c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JMJD6 (-)
AC   CVCL_ST79
SY   HZGHC022063c012; JMJD6 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_ST79
DR   Horizon_Discovery; HZGHC022063c012
DR   Wikidata; Q54875879
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JMY (-) 1
AC   CVCL_ST80
SY   HZGHC002630c002; JMY knockout cell line 10bp deletion
DR   cancercelllines; CVCL_ST80
DR   Horizon_Discovery; HZGHC002630c002
DR   Wikidata; Q54875880
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28916; JMY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JMY (-) 2
AC   CVCL_ST81
SY   HZGHC002631c007; JMY knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST81
DR   Horizon_Discovery; HZGHC002631c007
DR   Wikidata; Q54875881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28916; JMY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JMY (-) 3
AC   CVCL_ST82
SY   HZGHC002631c011; JMY knockout cell line 106bp insertion
DR   cancercelllines; CVCL_ST82
DR   Horizon_Discovery; HZGHC002631c011
DR   Wikidata; Q54875882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28916; JMY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002631c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JOSD1 (-)
AC   CVCL_ST83
SY   HZGHC000456c012; JOSD1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_ST83
DR   Horizon_Discovery; HZGHC000456c012
DR   Wikidata; Q54875883
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28953; JOSD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JOSD2 (-)
AC   CVCL_ST84
SY   HZGHC000458c012; JOSD2 knockout cell line 343bp insertion
DR   cancercelllines; CVCL_ST84
DR   Horizon_Discovery; HZGHC000458c012
DR   Wikidata; Q54875884
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28853; JOSD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000458c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 JUN (-) 1
AC   CVCL_ST85
SY   HZGHC003793c002; JUN knockout cell line 8bp deletion
DR   cancercelllines; CVCL_ST85
DR   Horizon_Discovery; HZGHC003793c002
DR   Wikidata; Q54875885
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 JUN (-) 2
AC   CVCL_ST86
SY   HZGHC003793c005; JUN knockout cell line 13bp deletion
DR   cancercelllines; CVCL_ST86
DR   Horizon_Discovery; HZGHC003793c005
DR   Wikidata; Q54875888
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT2A (-) 1
AC   CVCL_ST87
SY   HZGHC000929c001; KAT2A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST87
DR   Horizon_Discovery; HZGHC000929c001
DR   Wikidata; Q54875889
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4201; KAT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT2A (-) 2
AC   CVCL_ST88
SY   HZGHC000929c002; KAT2A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_ST88
DR   Horizon_Discovery; HZGHC000929c002
DR   Wikidata; Q54875890
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4201; KAT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT2B (-) 1
AC   CVCL_ST89
SY   HZGHC000948c004; KAT2B knockout cell line 17bp deletion
DR   cancercelllines; CVCL_ST89
DR   Horizon_Discovery; HZGHC000948c004
DR   Wikidata; Q54875891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000948c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KAT2B (-) 2
AC   CVCL_ST90
SY   HZGHC000948c012; KAT2B knockout cell line 31bp deletion
DR   cancercelllines; CVCL_ST90
DR   Horizon_Discovery; HZGHC000948c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54875892
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KAT6A (-) 1
AC   CVCL_ST91
SY   HZGHC006373c004; KAT6A knockout cell line 5bp deletion; HAP1 KAT6A (-)
DR   cancercelllines; CVCL_ST91
DR   Horizon_Discovery; HZGHC006373c004
DR   Wikidata; Q54875893
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13013; KAT6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KAT6A (-) 2
AC   CVCL_XP89
SY   HZGHC006373c006; KAT6A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XP89
DR   Horizon_Discovery; HZGHC006373c006
DR   Wikidata; Q93949865
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13013; KAT6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT6B (-) 1
AC   CVCL_ST92
SY   HZGHC006375c006; KAT6B knockout cell line 1bp insertion; HAP1 KAT6B (-)
DR   cancercelllines; CVCL_ST92
DR   Horizon_Discovery; HZGHC006375c006
DR   Wikidata; Q54875894
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17582; KAT6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KAT6B (-) 2
AC   CVCL_XP90
SY   HZGHC006376c001; KAT6B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP90
DR   Horizon_Discovery; HZGHC006376c001
DR   Wikidata; Q93949872
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17582; KAT6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT6B (-) 3
AC   CVCL_XP91
SY   HZGHC006376c009; KAT6B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XP91
DR   Horizon_Discovery; HZGHC006376c009
DR   Wikidata; Q93949875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17582; KAT6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT7 (-) 1
AC   CVCL_ST93
SY   HZGHC003518c004; KAT7 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_ST93
DR   Horizon_Discovery; HZGHC003518c004
DR   Wikidata; Q54875895
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT7 (-) 2
AC   CVCL_ST94
SY   HZGHC003518c008; KAT7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_ST94
DR   Horizon_Discovery; HZGHC003518c008
DR   Wikidata; Q54875896
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KAT7 (-) 3
AC   CVCL_XP92
SY   HZGHC003518c007; KAT7 knockout cell line
DR   cancercelllines; CVCL_XP92
DR   Horizon_Discovery; HZGHC003518c007
DR   Wikidata; Q93949890
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003518c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KAT7 (-) 4
AC   CVCL_XP93
SY   HZGHC003518c012; KAT7 knockout cell line
DR   cancercelllines; CVCL_XP93
DR   Horizon_Discovery; HZGHC003518c012
DR   Wikidata; Q93949892
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003518c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KCNC1 (-) 1
AC   CVCL_ST95
SY   HZGHC003933c004; KCNC1 knockout cell line 83bp insertion
DR   cancercelllines; CVCL_ST95
DR   Horizon_Discovery; HZGHC003933c004
DR   Wikidata; Q54875897
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6233; KCNC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003933c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KCNC1 (-) 2
AC   CVCL_ST96
SY   HZGHC003933c008; KCNC1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_ST96
DR   Horizon_Discovery; HZGHC003933c008
DR   Wikidata; Q54875898
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6233; KCNC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNC3 (-)
AC   CVCL_XP94
SY   HZGHC007028c012; HZGHC3748; KCNC3 knockout cell line 73bp deletion in exon 1
DR   cancercelllines; CVCL_XP94
DR   Horizon_Discovery; HZGHC007028c012
DR   Wikidata; Q93949905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6235; KCNC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KCND2 (-) 1
AC   CVCL_ST97
SY   HZGHC003922c001; KCND2 knockout cell line 61bp deletion
DR   cancercelllines; CVCL_ST97
DR   Horizon_Discovery; HZGHC003922c001
DR   Wikidata; Q54875899
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6238; KCND2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCND2 (-) 2
AC   CVCL_ST98
SY   HZGHC003922c010; KCND2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_ST98
DR   Horizon_Discovery; HZGHC003922c010
DR   Wikidata; Q54875900
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6238; KCND2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNH2 (-) 1
AC   CVCL_ST99
SY   HZGHC003837c001; KCNH2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_ST99
DR   Horizon_Discovery; HZGHC003837c001
DR   Wikidata; Q54875901
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6251; KCNH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNH2 (-) 2
AC   CVCL_SU00
SY   HZGHC003837c011; KCNH2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU00
DR   Horizon_Discovery; HZGHC003837c011
DR   Wikidata; Q54875902
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6251; KCNH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNJ11 (-) 1
AC   CVCL_SU01
SY   HZGHC003858c011; KCNJ11 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU01
DR   Horizon_Discovery; HZGHC003858c011
DR   Wikidata; Q54875903
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6257; KCNJ11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNJ11 (-) 2
AC   CVCL_SU02
SY   HZGHC003858c012; KCNJ11 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SU02
DR   Horizon_Discovery; HZGHC003858c012
DR   Wikidata; Q54875904
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6257; KCNJ11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNK1 (-) 1
AC   CVCL_SU03
SY   HZGHC004275c011; KCNK1 knockout cell line 725bp insertion
DR   cancercelllines; CVCL_SU03
DR   Horizon_Discovery; HZGHC004275c011
DR   Wikidata; Q54875905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6272; KCNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004275c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KCNK1 (-) 2
AC   CVCL_SU04
SY   HZGHC004276c001; KCNK1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU04
DR   Horizon_Discovery; HZGHC004276c001
DR   Wikidata; Q54875906
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6272; KCNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNK1 (-) 3
AC   CVCL_SU05
SY   HZGHC004276c011; KCNK1 knockout cell line 301bp insertion
DR   cancercelllines; CVCL_SU05
DR   Horizon_Discovery; HZGHC004276c011
DR   Wikidata; Q54875907
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6272; KCNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004276c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KCNK2 (-) 1
AC   CVCL_SU06
SY   HZGHC003816c008; KCNK2 knockout cell line 53bp deletion
DR   cancercelllines; CVCL_SU06
DR   Horizon_Discovery; HZGHC003816c008
DR   Wikidata; Q54875908
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6277; KCNK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNK2 (-) 2
AC   CVCL_SU07
SY   HZGHC003816c009; KCNK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SU07
DR   Horizon_Discovery; HZGHC003816c009
DR   Wikidata; Q54875909
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6277; KCNK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNK6 (-) 1
AC   CVCL_E2A6
SY   HZGHC008057c002
DR   Horizon_Discovery; HZGHC008057c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6281; KCNK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KCNK6 (-) 2
AC   CVCL_E2A7
SY   HZGHC008057c012
DR   Horizon_Discovery; HZGHC008057c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6281; KCNK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KCNQ1 (-) 1
AC   CVCL_SU08
SY   HZGHC003926c005; KCNQ1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SU08
DR   Horizon_Discovery; HZGHC003926c005
DR   Wikidata; Q54875910
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNQ1 (-) 2
AC   CVCL_SU09
SY   HZGHC004175c002; KCNQ1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU09
DR   Horizon_Discovery; HZGHC004175c002
DR   Wikidata; Q54875911
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNQ1 (-) 3
AC   CVCL_SU10
SY   HZGHC004175c003; KCNQ1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU10
DR   Horizon_Discovery; HZGHC004175c003
DR   Wikidata; Q54875912
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004175c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KCNQ1 (-) 4
AC   CVCL_SU11
SY   HZGHC004175c009; KCNQ1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU11
DR   Horizon_Discovery; HZGHC004175c009
DR   Wikidata; Q54875913
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNQ2 (-) 1
AC   CVCL_SU12
SY   HZGHC003800c012; KCNQ2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU12
DR   Horizon_Discovery; HZGHC003800c012
DR   Wikidata; Q54875915
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6296; KCNQ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNQ2 (-) 2
AC   CVCL_SU13
SY   HZGHC003800c004; KCNQ2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SU13
DR   Horizon_Discovery; HZGHC003800c004
DR   Wikidata; Q54875916
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6296; KCNQ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KCNS3 (-) 1
AC   CVCL_E2A8
SY   HZGHC008054c006
DR   Horizon_Discovery; HZGHC008054c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6302; KCNS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KCNS3 (-) 2
AC   CVCL_E2A9
SY   HZGHC008055c008
DR   Horizon_Discovery; HZGHC008055c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6302; KCNS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KDELR1 (-) 1
AC   CVCL_SU14
SY   HZGHC005700c011; KDELR1 knockout cell line 1bp deletion; HAP1 KDELR1 (-)
DR   cancercelllines; CVCL_SU14
DR   Horizon_Discovery; HZGHC005700c011
DR   Wikidata; Q54875917
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6304; KDELR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDELR1 (-) 2
AC   CVCL_XP95
SY   HZGHC005700c006; KDELR1 knockout cell line 298bp insertion
DR   cancercelllines; CVCL_XP95
DR   Horizon_Discovery; HZGHC005700c006
DR   Wikidata; Q93950033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6304; KDELR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005700c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDELR2 (-) 1
AC   CVCL_XP96
SY   HZGHC007252c012; HZGHC11014; KDELR2 knockout cell line 1bp insertion in exon 2; HAP1 KDELR2 (-)
DR   cancercelllines; CVCL_XP96
DR   Horizon_Discovery; HZGHC007252c012
DR   Wikidata; Q93950036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6305; KDELR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 KDELR2 (-) 2
AC   CVCL_E2AA
SY   HZGHC007252c005; KDELR2 knockout cell line 8bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007252c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6305; KDELR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KDM1A (-) 1
AC   CVCL_RK67
SY   HZGHC000509c010; KDM1A knockout cell line 10bp deletion; HAP1-LSD1-
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000509c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54875918
RX   PubMed=29205263;
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   HAP1 KDM1A (-) 2
AC   CVCL_SA82
SY   HZGHC000509c012; KDM1A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SA82
DR   Horizon_Discovery; HZGHC000509c012
DR   Wikidata; Q54875919
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000509c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 KDM1B (-) 1
AC   CVCL_SU15
SY   HZGHC000525c005; KDM1B knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SU15
DR   Horizon_Discovery; HZGHC000525c005
DR   Wikidata; Q54875920
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM1B (-) 2
AC   CVCL_SU16
SY   HZGHC000525c011; KDM1B knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SU16
DR   Horizon_Discovery; HZGHC000525c011
DR   Wikidata; Q54875921
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM2A (-) 1
AC   CVCL_SU17
SY   HZGHC004154c010; KDM2A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU17
DR   Horizon_Discovery; HZGHC004154c010
DR   Wikidata; Q54875922
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13606; KDM2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM2A (-) 2
AC   CVCL_SU18
SY   HZGHC004154c012; KDM2A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU18
DR   Horizon_Discovery; HZGHC004154c012
DR   Wikidata; Q54875923
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13606; KDM2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004154c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM2A (-) 3
AC   CVCL_SU19
SY   HZGHC005141c011; KDM2A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SU19
DR   Horizon_Discovery; HZGHC005141c011
DR   Wikidata; Q54875924
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13606; KDM2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005141c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM2A (-) 4
AC   CVCL_SU20
SY   HZGHC005141c012; KDM2A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU20
DR   Horizon_Discovery; HZGHC005141c012
DR   Wikidata; Q54875925
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13606; KDM2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM2B (-)
AC   CVCL_SU21
SY   HZGHC014730c012; KDM2B knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SU21
DR   Horizon_Discovery; HZGHC014730c012
DR   Wikidata; Q54875926
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13610; KDM2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM3A (-) 1
AC   CVCL_SU22
SY   HZGHC004156c010; KDM3A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SU22
DR   Horizon_Discovery; HZGHC004156c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54875927
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20815; KDM3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM3A (-) 2
AC   CVCL_SU23
SY   HZGHC004156c012; KDM3A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SU23
DR   Horizon_Discovery; HZGHC004156c012
DR   Wikidata; Q54875928
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20815; KDM3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM3B (-) 1
AC   CVCL_SU24
SY   HZGHC001145c003; KDM3B knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SU24
DR   Horizon_Discovery; HZGHC001145c003
DR   Wikidata; Q54875930
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1337; KDM3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM3B (-) 2
AC   CVCL_SU25
SY   HZGHC001145c010; KDM3B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU25
DR   Horizon_Discovery; HZGHC001145c010
DR   Wikidata; Q54875931
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1337; KDM3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM3B (-) 3
AC   CVCL_SU26
SY   HZGHC001145c011; KDM3B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU26
DR   Horizon_Discovery; HZGHC001145c011
DR   Wikidata; Q54875932
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1337; KDM3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4A (-) 1
AC   CVCL_SU27
SY   HZGHC001122c010; KDM4A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SU27
DR   Horizon_Discovery; HZGHC001122c010
DR   Wikidata; Q54875933
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22978; KDM4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM4A (-) 2
AC   CVCL_SU28
SY   HZGHC001122c011; KDM4A knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SU28
DR   Horizon_Discovery; HZGHC001122c011
DR   Wikidata; Q54875934
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22978; KDM4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001122c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 KDM4A (-) 3
AC   CVCL_SU29
SY   HZGHC001122c012; KDM4A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU29
DR   Horizon_Discovery; HZGHC001122c012
DR   Wikidata; Q54875935
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22978; KDM4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4B (-) 1
AC   CVCL_SU30
SY   HZGHC004158c004; KDM4B knockout cell line 118bp deletion
DR   cancercelllines; CVCL_SU30
DR   Horizon_Discovery; HZGHC004158c004
DR   Wikidata; Q54875936
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29136; KDM4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4B (-) 2
AC   CVCL_SU31
SY   HZGHC004158c008; KDM4B knockout cell line 79bp deletion
DR   cancercelllines; CVCL_SU31
DR   Horizon_Discovery; HZGHC004158c008
DR   Wikidata; Q54875937
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29136; KDM4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4C (-)
AC   CVCL_SU32
SY   HZGHC004161c004; KDM4C knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU32
DR   Horizon_Discovery; HZGHC004161c004
DR   Wikidata; Q54875938
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17071; KDM4C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4D (-) 1
AC   CVCL_SU33
SY   HZGHC001561c004; KDM4D knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SU33
DR   Horizon_Discovery; HZGHC001561c004
DR   Wikidata; Q54875939
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25498; KDM4D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4D (-) 2
AC   CVCL_SU34
SY   HZGHC001561c005; KDM4D knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU34
DR   Horizon_Discovery; HZGHC001561c005
DR   Wikidata; Q54875940
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25498; KDM4D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4E (-) 1
AC   CVCL_SU35
SY   HZGHC001562c001; KDM4E knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU35
DR   Horizon_Discovery; HZGHC001562c001
DR   Wikidata; Q54875941
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37098; KDM4E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4E (-) 2
AC   CVCL_SU36
SY   HZGHC002495c001; KDM4E knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU36
DR   Horizon_Discovery; HZGHC002495c001
DR   Wikidata; Q54875942
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37098; KDM4E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4E (-) 3
AC   CVCL_SU37
SY   HZGHC002495c011; KDM4E knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU37
DR   Horizon_Discovery; HZGHC002495c011
DR   Wikidata; Q54875943
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37098; KDM4E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4E (-) 4
AC   CVCL_SU38
SY   HZGHC002496c004; KDM4E knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SU38
DR   Horizon_Discovery; HZGHC002496c004
DR   Wikidata; Q54875944
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37098; KDM4E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM4E (-) 5
AC   CVCL_SU39
SY   HZGHC002496c012; KDM4E knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SU39
DR   Horizon_Discovery; HZGHC002496c012
DR   Wikidata; Q54875945
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37098; KDM4E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM5A (-) 1
AC   CVCL_SU40
SY   HZGHC004366c001; KDM5A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU40
DR   Horizon_Discovery; HZGHC004366c001
DR   Wikidata; Q54875946
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM5A (-) 2
AC   CVCL_SU41
SY   HZGHC004366c006; KDM5A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SU41
DR   Horizon_Discovery; HZGHC004366c006
DR   Wikidata; Q54875947
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM5B (-) 1
AC   CVCL_SU42
SY   HZGHC004164c008; KDM5B knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SU42
DR   Horizon_Discovery; HZGHC004164c008
DR   Wikidata; Q54875948
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM5B (-) 2
AC   CVCL_SU43
SY   HZGHC004164c009; KDM5B knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SU43
DR   Horizon_Discovery; HZGHC004164c009
DR   Wikidata; Q54875949
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004164c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 KDM5B (-) 3
AC   CVCL_SU44
SY   HZGHC004164c011; KDM5B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU44
DR   Horizon_Discovery; HZGHC004164c011
DR   Wikidata; Q54875951
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM5C (-) 1
AC   CVCL_SU45
SY   HZGHC001177c001; KDM5C knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SU45
DR   Horizon_Discovery; HZGHC001177c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54875952
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11114; KDM5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM5C (-) 2
AC   CVCL_SU46
SY   HZGHC001177c002; KDM5C knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SU46
DR   Horizon_Discovery; HZGHC001177c002
DR   Wikidata; Q54875953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11114; KDM5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM5C (-) 3
AC   CVCL_SU47
SY   HZGHC001177c010; KDM5C knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU47
DR   Horizon_Discovery; HZGHC001177c010
DR   Wikidata; Q54875954
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11114; KDM5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM6A (-) 1
AC   CVCL_SU48
SY   HZGHC004134c001; KDM6A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU48
DR   Horizon_Discovery; HZGHC004134c001
DR   Wikidata; Q54875955
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM6A (-) 2
AC   CVCL_SU49
SY   HZGHC003625c010; KDM6A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SU49
DR   Horizon_Discovery; HZGHC003625c010
DR   Wikidata; Q54875956
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM6A (-) 3
AC   CVCL_SU50
SY   HZGHC004134c011; KDM6A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SU50
DR   Horizon_Discovery; HZGHC004134c011
DR   Wikidata; Q54875957
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KDM6B (-) 1
AC   CVCL_SU51
SY   HZGHC001123c001; KDM6B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU51
DR   Horizon_Discovery; HZGHC001123c001
DR   Wikidata; Q54875958
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM6B (-) 2
AC   CVCL_SU52
SY   HZGHC001123c002; KDM6B knockout cell line 62bp deletion
DR   cancercelllines; CVCL_SU52
DR   Horizon_Discovery; HZGHC001123c002
DR   Wikidata; Q54875959
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM7A (-) 1
AC   CVCL_SU53
SY   HZGHC004166c006; KDM7A knockout cell line 8bp insertion
DR   cancercelllines; CVCL_SU53
DR   Horizon_Discovery; HZGHC004166c006
DR   Wikidata; Q54875960
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22224; KDM7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDM7A (-) 2
AC   CVCL_SU54
SY   HZGHC004166c011; KDM7A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SU54
DR   Horizon_Discovery; HZGHC004166c011
DR   Wikidata; Q54875961
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22224; KDM7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDR (-) 1
AC   CVCL_SU55
SY   HZGHC003783c004; KDR knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU55
DR   Horizon_Discovery; HZGHC003783c004
DR   Wikidata; Q54875962
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6307; KDR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KDR (-) 2
AC   CVCL_SU56
SY   HZGHC003783c010; KDR knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SU56
DR   Horizon_Discovery; HZGHC003783c010
DR   Wikidata; Q54875963
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6307; KDR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KEAP1 (-) 1
AC   CVCL_SU57
SY   HZGHC003774c005; KEAP1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SU57
DR   Horizon_Discovery; HZGHC003774c005
DR   PRIDE; PXD010335
DR   Wikidata; Q54875964
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KEAP1 (-) 2
AC   CVCL_SU58
SY   HZGHC003774c009; KEAP1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SU58
DR   Horizon_Discovery; HZGHC003774c009
DR   Wikidata; Q54875965
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIAA0100 (-) 1
AC   CVCL_SU59
SY   HZGHC005770c003; KIAA0100 knockout cell line 20bp deletion; HAP1 KIAA0100 (-)
DR   cancercelllines; CVCL_SU59
DR   Horizon_Discovery; HZGHC005770c003
DR   Wikidata; Q54875966
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28960; BLTP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 KIAA0100 (-) 2
AC   CVCL_XP97
SY   HZGHC005770c004; KIAA0100 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XP97
DR   Horizon_Discovery; HZGHC005770c004
DR   Wikidata; Q93950377
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28960; BLTP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIAA0100 (-) 3
AC   CVCL_XP98
SY   HZGHC005770c007; KIAA0100 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XP98
DR   Horizon_Discovery; HZGHC005770c007
DR   Wikidata; Q93950380
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28960; BLTP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005770c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 KIAA0100 (-) 4
AC   CVCL_XP99
SY   HZGHC005771c011; KIAA0100 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XP99
DR   Horizon_Discovery; HZGHC005771c011
DR   Wikidata; Q93950382
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28960; BLTP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIAA0196 (-) 1
AC   CVCL_SU60
SY   HZGHC002497c002; KIAA0196 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU60
DR   Horizon_Discovery; HZGHC002497c002
DR   Wikidata; Q54875967
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28984; WASHC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA0196 (-) 2
AC   CVCL_SU61
SY   HZGHC002497c011; KIAA0196 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SU61
DR   Horizon_Discovery; HZGHC002497c011
DR   Wikidata; Q54875968
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28984; WASHC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA0196 (-) 3
AC   CVCL_SU62
SY   HZGHC002498c010; KIAA0196 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SU62
DR   Horizon_Discovery; HZGHC002498c010
DR   Wikidata; Q54875969
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28984; WASHC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA0319L (-)
AC   CVCL_XQ00
SY   HZGHC007114c005; HZGHC79932; KIAA0319L knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_XQ00
DR   Horizon_Discovery; HZGHC007114c005
DR   Wikidata; Q93950391
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30071; KIAA0319L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIAA0556 (-) 1
AC   CVCL_E2AB
SY   HZGHC007528c001
DR   Horizon_Discovery; HZGHC007528c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29068; KATNIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KIAA0556 (-) 2
AC   CVCL_E2AC
SY   HZGHC007528c008
DR   Horizon_Discovery; HZGHC007528c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29068; KATNIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KIAA1244 (-) 1
AC   CVCL_SU63
SY   HZGHC003083c003; KIAA1244 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SU63
DR   Horizon_Discovery; HZGHC003083c003
DR   Wikidata; Q54875970
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21213; ARFGEF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA1244 (-) 2
AC   CVCL_SU64
SY   HZGHC003083c010; KIAA1244 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU64
DR   Horizon_Discovery; HZGHC003083c010
DR   Wikidata; Q54875972
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21213; ARFGEF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA1524 (-) 1
AC   CVCL_SU65
SY   HZGHC006669c003; KIAA1524 knockout cell line 2bp deletion; HAP1 KIAA1524 (-)
DR   cancercelllines; CVCL_SU65
DR   Horizon_Discovery; HZGHC006669c003
DR   Wikidata; Q54875973
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29302; CIP2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIAA1524 (-) 2
AC   CVCL_XQ01
SY   HZGHC006669c004; KIAA1524 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XQ01
DR   Horizon_Discovery; HZGHC006669c004
DR   Wikidata; Q93950398
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29302; CIP2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA1804 (-) 1
AC   CVCL_SU66
SY   HZGHC001268c020; KIAA1804 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU66
DR   Horizon_Discovery; HZGHC001268c020
DR   Wikidata; Q54875974
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29798; MAP3K21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA1804 (-) 2
AC   CVCL_SU67
SY   HZGHC002990c002; KIAA1804 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU67
DR   Horizon_Discovery; HZGHC002990c002
DR   Wikidata; Q54875975
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29798; MAP3K21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA1804 (-) 3
AC   CVCL_SU68
SY   HZGHC002990c007; KIAA1804 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SU68
DR   Horizon_Discovery; HZGHC002990c007
DR   Wikidata; Q54875976
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29798; MAP3K21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIAA1804 (-) 4
AC   CVCL_SU69
SY   HZGHC002990c010; KIAA1804 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU69
DR   Horizon_Discovery; HZGHC002990c010
DR   Wikidata; Q54875977
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29798; MAP3K21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF15 (-) 1
AC   CVCL_SU70
SY   HZGHC002439c010; KIF15 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU70
DR   Horizon_Discovery; HZGHC002439c010
DR   Wikidata; Q54875978
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17273; KIF15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF15 (-) 2
AC   CVCL_SU71
SY   HZGHC002440c003; KIF15 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SU71
DR   Horizon_Discovery; HZGHC002440c003
DR   Wikidata; Q54875979
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17273; KIF15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF18B (-) 1
AC   CVCL_SU72
SY   HZGHC006403c008; KIF18B knockout cell line 1bp insertion; HAP1 KIF18B (-)
DR   cancercelllines; CVCL_SU72
DR   Horizon_Discovery; HZGHC006403c008
DR   Wikidata; Q54875980
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27102; KIF18B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIF18B (-) 2
AC   CVCL_XQ02
SY   HZGHC006403c009; KIF18B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ02
DR   Horizon_Discovery; HZGHC006403c009
DR   Wikidata; Q93950442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27102; KIF18B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006403c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIF1C (-) 1
AC   CVCL_SU73
SY   HZGHC002428c010; KIF1C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU73
DR   Horizon_Discovery; HZGHC002428c010
DR   Wikidata; Q54875981
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6317; KIF1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002428c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIF1C (-) 2
AC   CVCL_SU74
SY   HZGHC002428c011; KIF1C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU74
DR   Horizon_Discovery; HZGHC002428c011
DR   Wikidata; Q54875982
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6317; KIF1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002428c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIF1C (-) 3
AC   CVCL_SU75
SY   HZGHC002428c001; KIF1C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SU75
DR   Horizon_Discovery; HZGHC002428c001
DR   Wikidata; Q54875983
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6317; KIF1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF1C (-) 4
AC   CVCL_SU76
SY   HZGHC002429c006; KIF1C knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SU76
DR   Horizon_Discovery; HZGHC002429c006
DR   Wikidata; Q54875984
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6317; KIF1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF1C (-) 5
AC   CVCL_SU77
SY   HZGHC002429c010; KIF1C knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SU77
DR   Horizon_Discovery; HZGHC002429c010
DR   Wikidata; Q54875985
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6317; KIF1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF2A (-) 1
AC   CVCL_SU78
SY   HZGHC004223c009; KIF2A knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SU78
DR   Horizon_Discovery; HZGHC004223c009
DR   Wikidata; Q54875986
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6318; KIF2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF2A (-) 2
AC   CVCL_SU79
SY   HZGHC004223c012; KIF2A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SU79
DR   Horizon_Discovery; HZGHC004223c012
DR   Wikidata; Q54875987
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6318; KIF2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF2C (-) 1
AC   CVCL_SU80
SY   HZGHC004225c008; KIF2C knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SU80
DR   Horizon_Discovery; HZGHC004225c008
DR   Wikidata; Q54875988
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6393; KIF2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF2C (-) 2
AC   CVCL_SU81
SY   HZGHC004225c012; KIF2C knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU81
DR   Horizon_Discovery; HZGHC004225c012
DR   Wikidata; Q54875989
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6393; KIF2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF4A (-)
AC   CVCL_SU82
SY   HZGHC004224c006; KIF4A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SU82
DR   Horizon_Discovery; HZGHC004224c006
DR   Wikidata; Q54875990
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13339; KIF4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF5B (-) 1
AC   CVCL_SU83
SY   HZGHC004719c001; KIF5B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SU83
DR   Horizon_Discovery; HZGHC004719c001
DR   Wikidata; Q54875991
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6324; KIF5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004719c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIF5B (-) 2
AC   CVCL_SU84
SY   HZGHC004719c002; KIF5B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU84
DR   Horizon_Discovery; HZGHC004719c002
DR   Wikidata; Q54875992
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6324; KIF5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIF7 (-) 1
AC   CVCL_SU85
SY   HZGHC004407c006; KIF7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU85
DR   Horizon_Discovery; HZGHC004407c006
DR   Wikidata; Q54875993
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30497; KIF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004407c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIF7 (-) 2
AC   CVCL_SU86
SY   HZGHC004408c010; KIF7 knockout cell line 43bp deletion
DR   cancercelllines; CVCL_SU86
DR   Horizon_Discovery; HZGHC004408c010
DR   Wikidata; Q54875994
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30497; KIF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004408c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIF7 (-) 3
AC   CVCL_SU87
SY   HZGHC004408c011; KIF7 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SU87
DR   Horizon_Discovery; HZGHC004408c011
DR   Wikidata; Q54875995
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30497; KIF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004408c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KIFC1 (-) 1
AC   CVCL_SU88
SY   HZGHC004226c003; KIFC1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SU88
DR   Horizon_Discovery; HZGHC004226c003
DR   Wikidata; Q54875996
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6389; KIFC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIFC1 (-) 2
AC   CVCL_SU89
SY   HZGHC004226c006; KIFC1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SU89
DR   Horizon_Discovery; HZGHC004226c006
DR   Wikidata; Q54875997
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6389; KIFC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIT (-) 1
AC   CVCL_SU90
SY   HZGHC002453c003; KIT knockout cell line 37bp deletion
DR   cancercelllines; CVCL_SU90
DR   Horizon_Discovery; HZGHC002453c003
DR   Wikidata; Q54875998
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KIT (-) 2
AC   CVCL_SU91
SY   HZGHC002453c012; KIT knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SU91
DR   Horizon_Discovery; HZGHC002453c012
DR   Wikidata; Q54875999
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002453c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KITLG (-)
AC   CVCL_SU92
SY   HZGHC006205c002; KITLG knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SU92
DR   Horizon_Discovery; HZGHC006205c002
DR   Wikidata; Q54876000
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6343; KITLG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KLF10 (-) 1
AC   CVCL_SU93
SY   HZGHC004915c010; KLF10 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SU93
DR   Horizon_Discovery; HZGHC004915c010
DR   Wikidata; Q54876001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11810; KLF10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KLF10 (-) 2
AC   CVCL_SU94
SY   HZGHC004915c011; KLF10 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU94
DR   Horizon_Discovery; HZGHC004915c011
DR   Wikidata; Q54876002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11810; KLF10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KLHDC10 (-) 1
AC   CVCL_E2AD
SY   HZGHC008081c005
DR   Horizon_Discovery; HZGHC008081c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22194; KLHDC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHDC10 (-) 2
AC   CVCL_E2AE
SY   HZGHC008081c009
DR   Horizon_Discovery; HZGHC008081c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22194; KLHDC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHDC2 (-) 1
AC   CVCL_E2AF
SY   HZGHC008036c002
DR   Horizon_Discovery; HZGHC008036c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20231; KLHDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHDC2 (-) 2
AC   CVCL_E2AG
SY   HZGHC008036c009
DR   Horizon_Discovery; HZGHC008036c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20231; KLHDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHDC2 (-) 3
AC   CVCL_E2AH
SY   HZGHC008036c011
DR   Horizon_Discovery; HZGHC008036c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20231; KLHDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHDC3 (-) 1
AC   CVCL_E2AI
SY   HZGHC007352c006
DR   Horizon_Discovery; HZGHC007352c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20704; KLHDC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHDC3 (-) 2
AC   CVCL_E2AJ
SY   HZGHC007352c007
DR   Horizon_Discovery; HZGHC007352c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20704; KLHDC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHDC3 (-) 3
AC   CVCL_E2AK
SY   HZGHC007352c008
DR   Horizon_Discovery; HZGHC007352c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20704; KLHDC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHL24 (-) 1
AC   CVCL_E2AL
SY   HZGHC007621c003
DR   Horizon_Discovery; HZGHC007621c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25947; KLHL24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHL24 (-) 2
AC   CVCL_E2AM
SY   HZGHC007621c010
DR   Horizon_Discovery; HZGHC007621c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25947; KLHL24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KLHL3 (-) 1
AC   CVCL_SU95
SY   HZGHC000840c005; KLHL3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SU95
DR   Horizon_Discovery; HZGHC000840c005
DR   Wikidata; Q54876003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6354; KLHL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KLHL3 (-) 2
AC   CVCL_SU96
SY   HZGHC000840c010; KLHL3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SU96
DR   Horizon_Discovery; HZGHC000840c010
DR   Wikidata; Q54876004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6354; KLHL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KMT2A (-) 1
AC   CVCL_SU97
SY   HZGHC001319c008; KMT2A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SU97
DR   Horizon_Discovery; HZGHC001319c008
DR   PRIDE; PXD010335
DR   Wikidata; Q54876005
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7132; KMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KMT2A (-) 2
AC   CVCL_SU98
SY   HZGHC001319c012; KMT2A knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SU98
DR   Horizon_Discovery; HZGHC001319c012
DR   Wikidata; Q54876006
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7132; KMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KMT2B (-) 1
AC   CVCL_SU99
SY   HZGHC001115c007; KMT2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SU99
DR   Horizon_Discovery; HZGHC001115c007
DR   Wikidata; Q54876007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15840; KMT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KMT2B (-) 2
AC   CVCL_SV00
SY   HZGHC001115c008; KMT2B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV00
DR   Horizon_Discovery; HZGHC001115c008
DR   Wikidata; Q54876008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15840; KMT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KMT2B (-) 3
AC   CVCL_SV01
SY   HZGHC001115c009; KMT2B knockout cell line 185bp insertion
DR   cancercelllines; CVCL_SV01
DR   Horizon_Discovery; HZGHC001115c009
DR   Wikidata; Q54876009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15840; KMT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001115c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KMT2C (-) 1
AC   CVCL_SV02
SY   HZGHC003909c002; KMT2C knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SV02
DR   Horizon_Discovery; HZGHC003909c002
DR   Wikidata; Q54876010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13726; KMT2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KMT2C (-) 2
AC   CVCL_SV03
SY   HZGHC003909c012; KMT2C knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV03
DR   Horizon_Discovery; HZGHC003909c012
DR   Wikidata; Q54876011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13726; KMT2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KMT2D (-)
AC   CVCL_SV04
SY   HZGHC001114c006; KMT2D knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV04
DR   Horizon_Discovery; HZGHC001114c006
DR   Wikidata; Q54876013
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KRAS (-) 1
AC   CVCL_SV05
SY   HZGHC005816c001; KRAS knockout cell line 5bp deletion; HAP1 KRAS (-)
DR   cancercelllines; CVCL_SV05
DR   Horizon_Discovery; HZGHC005816c001
DR   Wikidata; Q54876014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KRAS (-) 2
AC   CVCL_XQ03
SY   HZGHC005816c002; KRAS knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XQ03
DR   Horizon_Discovery; HZGHC005816c002
DR   Wikidata; Q93950572
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KRAS (-) 3
AC   CVCL_XQ04
SY   HZGHC005816c012; KRAS knockout cell line 260bp insertion
DR   cancercelllines; CVCL_XQ04
DR   Horizon_Discovery; HZGHC005816c012
DR   Wikidata; Q93950574
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005816c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KRT10 (-) 1
AC   CVCL_SV06
SY   HZGHC004867c007; KRT10 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SV06
DR   Horizon_Discovery; HZGHC004867c007
DR   Wikidata; Q54876015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6413; KRT10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KRT10 (-) 2
AC   CVCL_SV07
SY   HZGHC004867c011; KRT10 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SV07
DR   Horizon_Discovery; HZGHC004867c011
DR   Wikidata; Q54876016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6413; KRT10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KRT18 (-) 1
AC   CVCL_SV08
SY   HZGHC004944c002; KRT18 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV08
DR   Horizon_Discovery; HZGHC004944c002
DR   Wikidata; Q54876017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6430; KRT18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KRT18 (-) 2
AC   CVCL_SV09
SY   HZGHC004944c003; KRT18 knockout cell line 64bp deletion
DR   cancercelllines; CVCL_SV09
DR   Horizon_Discovery; HZGHC004944c003
DR   Wikidata; Q54876018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6430; KRT18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KRT8 (-) 1
AC   CVCL_SV10
SY   HZGHC004735c005; KRT8 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV10
DR   Horizon_Discovery; HZGHC004735c005
DR   Wikidata; Q54876019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6446; KRT8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KRT8 (-) 2
AC   CVCL_SV11
SY   HZGHC004735c006; KRT8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV11
DR   Horizon_Discovery; HZGHC004735c006
DR   Wikidata; Q54876020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6446; KRT8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KSR1 (-) 1
AC   CVCL_SV12
SY   HZGHC000369c001; KSR1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SV12
DR   Horizon_Discovery; HZGHC000369c001
DR   Wikidata; Q54876021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6465; KSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KSR1 (-) 2
AC   CVCL_SV13
SY   HZGHC000369c003; KSR1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SV13
DR   Horizon_Discovery; HZGHC000369c003
DR   Wikidata; Q54876022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6465; KSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KSR2 (-) 1
AC   CVCL_SV14
SY   HZGHC000048c003; KSR2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV14
DR   Horizon_Discovery; HZGHC000048c003
DR   Wikidata; Q54876023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18610; KSR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KSR2 (-) 2
AC   CVCL_SV15
SY   HZGHC000048c009; KSR2 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SV15
DR   Horizon_Discovery; HZGHC000048c009
DR   Wikidata; Q54876024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18610; KSR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 KTN1 (-) 1
AC   CVCL_E2AN
SY   HZGHC007386c004
DR   Horizon_Discovery; HZGHC007386c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6467; KTN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KTN1 (-) 2
AC   CVCL_E2AP
SY   HZGHC007386c008
DR   Horizon_Discovery; HZGHC007386c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6467; KTN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 KXD1 (-) 1
AC   CVCL_SV16
SY   HZGHC000872c005; KXD1 knockout cell line 68bp insertion
DR   cancercelllines; CVCL_SV16
DR   Horizon_Discovery; HZGHC000872c005
DR   Wikidata; Q54876025
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28420; KXD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000872c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 KXD1 (-) 2
AC   CVCL_SV17
SY   HZGHC000872c006; KXD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV17
DR   Horizon_Discovery; HZGHC000872c006
DR   Wikidata; Q54876026
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28420; KXD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 L1TD1 (-) 1
AC   CVCL_SV18
SY   HZGHC004585c004; L1TD1 knockout cell line 97bp deletion
DR   cancercelllines; CVCL_SV18
DR   Horizon_Discovery; HZGHC004585c004
DR   Wikidata; Q54876027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25595; L1TD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 L1TD1 (-) 2
AC   CVCL_SV19
SY   HZGHC004585c008; L1TD1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SV19
DR   Horizon_Discovery; HZGHC004585c008
DR   Wikidata; Q54876028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25595; L1TD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 L2HGDH (-) 1
AC   CVCL_XQ05
SY   HZGHC006914c012; HZGHC79944; L2HGDH knockout cell line 10bp deletion in exon 2; HAP1 L2HGDH (-)
DR   cancercelllines; CVCL_XQ05
DR   Horizon_Discovery; HZGHC006914c012
DR   Wikidata; Q93950668
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20499; L2HGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 L2HGDH (-) 2
AC   CVCL_E2AQ
SY   HZGHC006914c002
DR   Horizon_Discovery; HZGHC006914c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20499; L2HGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 L2HGDH (-) 3
AC   CVCL_E2AR
SY   HZGHC006914c006
DR   Horizon_Discovery; HZGHC006914c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20499; L2HGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 L2HGDH (-) 4
AC   CVCL_E2AS
SY   HZGHC006914c008
DR   Horizon_Discovery; HZGHC006914c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20499; L2HGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 L2HGDH (-) 5
AC   CVCL_E2AT
SY   HZGHC006915c009
DR   Horizon_Discovery; HZGHC006915c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20499; L2HGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 L3MBTL2 (-) 1
AC   CVCL_SV20
SY   HZGHC001126c003; L3MBTL2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SV20
DR   Horizon_Discovery; HZGHC001126c003
DR   Wikidata; Q54876029
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18594; L3MBTL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 L3MBTL2 (-) 2
AC   CVCL_SV21
SY   HZGHC001126c006; L3MBTL2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV21
DR   Horizon_Discovery; HZGHC001126c006
DR   Wikidata; Q54876030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18594; L3MBTL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 L3MBTL2 (-) 3
AC   CVCL_SV22
SY   HZGHC001126c011; L3MBTL2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV22
DR   Horizon_Discovery; HZGHC001126c011
DR   Wikidata; Q54876031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18594; L3MBTL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LACTB2 (-) 1
AC   CVCL_SV23
SY   HZGHC005159c002; LACTB2 knockout cell line 80bp deletion
DR   cancercelllines; CVCL_SV23
DR   Horizon_Discovery; HZGHC005159c002
DR   Wikidata; Q54876032
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18512; LACTB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LACTB2 (-) 2
AC   CVCL_SV24
SY   HZGHC005159c009; LACTB2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SV24
DR   Horizon_Discovery; HZGHC005159c009
DR   Wikidata; Q54876033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18512; LACTB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LACTB2 (-) 3
AC   CVCL_SV25
SY   HZGHC005160c010; LACTB2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV25
DR   Horizon_Discovery; HZGHC005160c010
DR   Wikidata; Q54876034
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18512; LACTB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LAMP1 (-) 1
AC   CVCL_SV26
SY   HZGHC005119c002; LAMP1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV26
DR   Horizon_Discovery; HZGHC005119c002
DR   Wikidata; Q54876035
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LAMP1 (-) 2
AC   CVCL_SV27
SY   HZGHC005119c006; LAMP1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SV27
DR   Horizon_Discovery; HZGHC005119c006
DR   Wikidata; Q54876036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LAMP2 (-) 1
AC   CVCL_E2AU
SY   HZGHC008237c009
DR   Horizon_Discovery; HZGHC008237c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LAMP2 (-) 2
AC   CVCL_E2AV
SY   HZGHC008238c001
DR   Horizon_Discovery; HZGHC008238c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LAMTOR4 (-) 1
AC   CVCL_SV28
SY   HZGHC000374c009; LAMTOR4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV28
DR   Horizon_Discovery; HZGHC000374c009
DR   Wikidata; Q54876037
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33772; LAMTOR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LAMTOR4 (-) 2
AC   CVCL_SV29
SY   HZGHC000374c010; LAMTOR4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV29
DR   Horizon_Discovery; HZGHC000374c010
DR   Wikidata; Q54876038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33772; LAMTOR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LAMTOR4 (-) 3
AC   CVCL_SV30
SY   HZGHC000374c012; LAMTOR4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV30
DR   Horizon_Discovery; HZGHC000374c012
DR   Wikidata; Q54876039
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33772; LAMTOR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LARGE (-)
AC   CVCL_SV31
SY   HZGHC000122c007; HZGHC000122c006; LARGE knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_SV31
DR   Horizon_Discovery; HZGHC000122c007
DR   Wikidata; Q54876040
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6511; LARGE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LARGE (-) POMK (-)
AC   CVCL_A1CH
SY   HZGHC007364c011; Double knockout cell line LARGE 43bp deletion in exon 3 and POMK 10bp deletion in exon 4; HAP1 POMK/LARGE1 (-)
DR   cancercelllines; CVCL_A1CH
DR   Horizon_Discovery; HZGHC007364c011
DR   Wikidata; Q102114093
RX   PubMed=32975514;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6511; LARGE1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26267; POMK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TF19 ! HAP1 POMK (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   HAP1 LARP1 (-) 1
AC   CVCL_XQ06
SY   HZGHC007082c013; HZGHC23367; LARP1 knockout cell line 5bp deletion in exon 3; HAP1 LARP1 (-)
DR   cancercelllines; CVCL_XQ06
DR   Horizon_Discovery; HZGHC007082c013
DR   Wikidata; Q93950770
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29531; LARP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LARP1 (-) 2
AC   CVCL_E2AW
SY   HZGHC007082c002; LARP1 knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007082c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29531; LARP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LAT (-) 1
AC   CVCL_SV32
SY   HZGHC006163c011; LAT knockout cell line 1bp insertion; HAP1 LAT (-)
DR   cancercelllines; CVCL_SV32
DR   Horizon_Discovery; HZGHC006163c011
DR   Wikidata; Q54876041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18874; LAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LAT (-) 2
AC   CVCL_XQ07
SY   HZGHC006163c006; LAT knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ07
DR   Horizon_Discovery; HZGHC006163c006
DR   Wikidata; Q93950782
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18874; LAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006163c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LAT (-) 3
AC   CVCL_XQ08
SY   HZGHC006164c001; LAT knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XQ08
DR   Horizon_Discovery; HZGHC006164c001
DR   Wikidata; Q93950786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18874; LAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LAT (-) 4
AC   CVCL_XQ09
SY   HZGHC006164c010; LAT knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XQ09
DR   Horizon_Discovery; HZGHC006164c010
DR   Wikidata; Q93950790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18874; LAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LATS1 (-) 1
AC   CVCL_SV33
SY   HZGHC000308c001; LATS1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV33
DR   Horizon_Discovery; HZGHC000308c001
DR   Wikidata; Q54876042
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LATS1 (-) 2
AC   CVCL_SV34
SY   HZGHC000308c004; LATS1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SV34
DR   Horizon_Discovery; HZGHC000308c004
DR   Wikidata; Q54876043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LATS1 (-) 3
AC   CVCL_E2AX
SY   HZGHC007674c003
DR   Horizon_Discovery; HZGHC007674c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LATS1 (-) 4
AC   CVCL_E2AY
SY   HZGHC007674c011
DR   Horizon_Discovery; HZGHC007674c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LATS2 (-) 1
AC   CVCL_SV35
SY   HZGHC000089c003; LATS2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV35
DR   Horizon_Discovery; HZGHC000089c003
DR   Wikidata; Q54876044
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LATS2 (-) 2
AC   CVCL_SV36
SY   HZGHC000089c013; LATS2 knockout cell line 17bp insertion
DR   cancercelllines; CVCL_SV36
DR   Horizon_Discovery; HZGHC000089c013
DR   Wikidata; Q54876045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000089c013; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LBR (-)
AC   CVCL_E2AZ
SY   HZGHC007357c013
DR   Horizon_Discovery; HZGHC007357c013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6518; LBR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LCMT1 (-) 1
AC   CVCL_SV37
SY   HZGHC004373c001; LCMT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SV37
DR   Horizon_Discovery; HZGHC004373c001
DR   Wikidata; Q54876046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17557; LCMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LCMT1 (-) 2
AC   CVCL_SV38
SY   HZGHC004373c012; LCMT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SV38
DR   Horizon_Discovery; HZGHC004373c012
DR   Wikidata; Q54876047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17557; LCMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LCMT1 (-) 3
AC   CVCL_SV39
SY   HZGHC004374c006; LCMT1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV39
DR   Horizon_Discovery; HZGHC004374c006
DR   Wikidata; Q54876048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17557; LCMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LDHA (-) 1
AC   CVCL_SV40
SY   HZGHC004917c002; LDHA knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SV40
DR   Horizon_Discovery; HZGHC004917c002
DR   Wikidata; Q54876049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LDHA (-) 2
AC   CVCL_SV41
SY   HZGHC004917c008; LDHA knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SV41
DR   Horizon_Discovery; HZGHC004917c008
DR   Wikidata; Q54876050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LDHB (-)
AC   CVCL_SV42
SY   HZGHC005907c010; LDHB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV42
DR   Horizon_Discovery; HZGHC005907c010
DR   Wikidata; Q54876051
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6541; LDHB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LDLR (-) 1
AC   CVCL_SV43
SY   HZGHC003978c007; LDLR knockout cell line 8bp deletion; HAP1 LDLR (-)
DR   cancercelllines; CVCL_SV43
DR   Horizon_Discovery; HZGHC003978c007
DR   Wikidata; Q54876052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003978c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LDLR (-) 2
AC   CVCL_E2B0
SY   HZGHC003978c019
DR   Horizon_Discovery; HZGHC003978c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LEF1 (-) 1
AC   CVCL_SV44
SY   HZGHC005988c004; LEF1 knockout cell line 13bp deletion; HAP1 LEF1 (-)
DR   cancercelllines; CVCL_SV44
DR   Horizon_Discovery; HZGHC005988c004
DR   Wikidata; Q54876056
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6551; LEF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LEF1 (-) 2
AC   CVCL_XQ10
SY   HZGHC005988c008; LEF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XQ10
DR   Horizon_Discovery; HZGHC005988c008
DR   Wikidata; Q93950852
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6551; LEF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LEPR (-)
AC   CVCL_SV45
SY   HZGHC006199c002; LEPR knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV45
DR   Horizon_Discovery; HZGHC006199c002
DR   Wikidata; Q54876057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6554; LEPR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LETMD1 (-) 1
AC   CVCL_SV46
SY   HZGHC005772c002; LETMD1 knockout cell line 259bp insertion; HAP1 LETMD1 (-)
DR   cancercelllines; CVCL_SV46
DR   Horizon_Discovery; HZGHC005772c002
DR   Wikidata; Q54876058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24241; LETMD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005772c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LETMD1 (-) 2
AC   CVCL_XQ11
SY   HZGHC005772c007; LETMD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ11
DR   Horizon_Discovery; HZGHC005772c007
DR   Wikidata; Q93950862
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24241; LETMD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LETMD1 (-) 3
AC   CVCL_XQ12
SY   HZGHC005772c008; LETMD1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XQ12
DR   Horizon_Discovery; HZGHC005772c008
DR   Wikidata; Q93950864
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24241; LETMD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LETMD1 (-) 4
AC   CVCL_XQ13
SY   HZGHC005773c003; LETMD1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XQ13
DR   Horizon_Discovery; HZGHC005773c003
DR   Wikidata; Q93950865
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24241; LETMD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LGALS1 (-) 1
AC   CVCL_SV47
SY   HZGHC005989c003; LGALS1 knockout cell line 1bp insertion; HAP1 LGALS1 (-)
DR   cancercelllines; CVCL_SV47
DR   Horizon_Discovery; HZGHC005989c003
DR   Wikidata; Q54876059
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LGALS1 (-) 2
AC   CVCL_XQ14
SY   HZGHC005989c006; LGALS1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XQ14
DR   Horizon_Discovery; HZGHC005989c006
DR   Wikidata; Q93950869
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LGALS3 (-) 1
AC   CVCL_SV48
SY   HZGHC005401c001; LGALS3 knockout cell line 10bp deletion; HAP1 LGALS3 (-)
DR   cancercelllines; CVCL_SV48
DR   Horizon_Discovery; HZGHC005401c001
DR   Wikidata; Q54876060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LGALS3 (-) 2
AC   CVCL_XQ15
SY   HZGHC005401c005; LGALS3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XQ15
DR   Horizon_Discovery; HZGHC005401c005
DR   Wikidata; Q93950875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LGR4 (-) 1
AC   CVCL_SV49
SY   HZGHC001031c005; LGR4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV49
DR   Horizon_Discovery; HZGHC001031c005
DR   Wikidata; Q54876061
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LGR4 (-) 2
AC   CVCL_SV50
SY   HZGHC001031c006; LGR4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV50
DR   Horizon_Discovery; HZGHC001031c006
DR   Wikidata; Q54876062
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LGR4 (-) 3
AC   CVCL_SV51
SY   HZGHC001061c004; LGR4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV51
DR   Horizon_Discovery; HZGHC001061c004
DR   Wikidata; Q54876063
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LGR4 (-) 4
AC   CVCL_SV52
SY   HZGHC001061c011; LGR4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV52
DR   Horizon_Discovery; HZGHC001061c011
DR   Wikidata; Q54876064
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LIAS (-) 1
AC   CVCL_XQ16
SY   HZGHC006842c004; HZGHC11019; LIAS knockout cell line 340bp insertion in exon 2; HAP1 LIAS (-)
DR   cancercelllines; CVCL_XQ16
DR   Horizon_Discovery; HZGHC006842c004
DR   Wikidata; Q93950891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16429; LIAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006842c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LIAS (-) 2
AC   CVCL_E2B1
SY   HZGHC006842c003
DR   Horizon_Discovery; HZGHC006842c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16429; LIAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LIAS (-) 3
AC   CVCL_E2B2
SY   HZGHC006843c006
DR   Horizon_Discovery; HZGHC006843c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16429; LIAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LIG3 (-) 1
AC   CVCL_SV53
SY   HZGHC001530c001; LIG3 knockout cell line 185bp insertion
DR   cancercelllines; CVCL_SV53
DR   Horizon_Discovery; HZGHC001530c001
DR   Wikidata; Q54876065
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6600; LIG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001530c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LIG3 (-) 2
AC   CVCL_SV54
SY   HZGHC001530c007; LIG3 knockout cell line 86bp insertion
DR   cancercelllines; CVCL_SV54
DR   Horizon_Discovery; HZGHC001530c007
DR   Wikidata; Q54876066
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6600; LIG3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001530c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LIG4 (-) 1
AC   CVCL_SV55
SY   HZGHC000759c005; LIG4 knockout cell line 10bp deletion in exon 2
DR   cancercelllines; CVCL_SV55
DR   Horizon_Discovery; HZGHC000759c005
DR   Wikidata; Q54876068
RX   PubMed=31141305;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6601; LIG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000759c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LIG4 (-) 2
AC   CVCL_SV56
SY   HZGHC000759c006; LIG4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV56
DR   Horizon_Discovery; HZGHC000759c006
DR   Wikidata; Q54876069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6601; LIG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000759c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LIG4 (-) 3
AC   CVCL_E2B3
SY   HZGHC000759c014
DR   Horizon_Discovery; HZGHC000759c014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6601; LIG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LIG4 (-) 4
AC   CVCL_E2B4
SY   HZGHC000759c016
DR   Horizon_Discovery; HZGHC000759c016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6601; LIG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LIMCH1 (-) 1
AC   CVCL_SV57
SY   HZGHC005870c010; LIMCH1 knockout cell line 1bp insertion; HAP1 LIMCH1 (-)
DR   cancercelllines; CVCL_SV57
DR   Horizon_Discovery; HZGHC005870c010
DR   Wikidata; Q54876070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29191; LIMCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005870c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LIMCH1 (-) 2
AC   CVCL_XQ17
SY   HZGHC005870c002; LIMCH1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ17
DR   Horizon_Discovery; HZGHC005870c002
DR   Wikidata; Q93950921
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29191; LIMCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005870c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LIMCH1 (-) 3
AC   CVCL_XQ18
SY   HZGHC005870c012; LIMCH1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XQ18
DR   Horizon_Discovery; HZGHC005870c012
DR   Wikidata; Q93950923
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29191; LIMCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005870c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LIMK1 (-) 1
AC   CVCL_SV58
SY   HZGHC002670c001; LIMK1 knockout cell line 124bp deletion
DR   cancercelllines; CVCL_SV58
DR   Horizon_Discovery; HZGHC002670c001
DR   Wikidata; Q54876071
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6613; LIMK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LIMK1 (-) 2
AC   CVCL_SV59
SY   HZGHC002670c007; LIMK1 knockout cell line 38bp deletion
DR   cancercelllines; CVCL_SV59
DR   Horizon_Discovery; HZGHC002670c007
DR   Wikidata; Q54876072
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6613; LIMK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LIMK2 (-)
AC   CVCL_SV60
SY   HZGHC000405c015; LIMK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV60
DR   Horizon_Discovery; HZGHC000405c015
DR   Wikidata; Q54876073
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6614; LIMK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LIPT2 (-)
AC   CVCL_E2B5
SY   HZGHC007883c011
DR   Horizon_Discovery; HZGHC007883c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37216; LIPT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LITAF (-) 1
AC   CVCL_SV61
SY   HZGHC003295c002; LITAF knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV61
DR   Horizon_Discovery; HZGHC003295c002
DR   Wikidata; Q54876074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16841; LITAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LITAF (-) 2
AC   CVCL_SV62
SY   HZGHC003295c003; LITAF knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SV62
DR   Horizon_Discovery; HZGHC003295c003
DR   Wikidata; Q54876075
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16841; LITAF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMBR1L (-) 1
AC   CVCL_E2B6
SY   HZGHC007405c003
DR   Horizon_Discovery; HZGHC007405c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18268; LMBR1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LMBR1L (-) 2
AC   CVCL_E2B7
SY   HZGHC007405c006
DR   Horizon_Discovery; HZGHC007405c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18268; LMBR1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LMBR1L (-) 3
AC   CVCL_E2B8
SY   HZGHC007405c011
DR   Horizon_Discovery; HZGHC007405c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18268; LMBR1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LMBRD1 (-) 1
AC   CVCL_XQ19
SY   HZGHC007122c002; HZGHC55788; LMBRD1 knockout cell line 2bp deletion in exon 2; HAP1 LMBRD1 (-)
DR   cancercelllines; CVCL_XQ19
DR   Horizon_Discovery; HZGHC007122c002
DR   Wikidata; Q93950953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23038; LMBRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LMBRD1 (-) 2
AC   CVCL_E2B9
SY   HZGHC007122c001
DR   Horizon_Discovery; HZGHC007122c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23038; LMBRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LMBRD1 (-) 3
AC   CVCL_E2BA
SY   HZGHC007122c010
DR   Horizon_Discovery; HZGHC007122c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23038; LMBRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LMBRD1 (-) 4
AC   CVCL_E2BB
SY   HZGHC007122c011
DR   Horizon_Discovery; HZGHC007122c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23038; LMBRD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LMNA (-) 1
AC   CVCL_SV63
SY   HZGHC000758c001; LMNA knockout cell line 101bp insertion
DR   cancercelllines; CVCL_SV63
DR   Horizon_Discovery; HZGHC000758c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54876076
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000758c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LMNA (-) 2
AC   CVCL_SV64
SY   HZGHC000758c110; LMNA knockout cell line 101bp insertion
DR   cancercelllines; CVCL_SV64
DR   Horizon_Discovery; HZGHC000758c110
DR   Wikidata; Q54876077
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000758c110; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LMNA (-) 3
AC   CVCL_SV65
SY   HZGHC000758c012; LMNA knockout cell line 112bp insertion
DR   cancercelllines; CVCL_SV65
DR   Horizon_Discovery; HZGHC000758c012
DR   Wikidata; Q54876078
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000758c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LMNB1 (-) 1
AC   CVCL_SV66
SY   HZGHC003977c005; LMNB1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV66
DR   Horizon_Discovery; HZGHC003977c005
DR   Wikidata; Q54876079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMNB1 (-) 2
AC   CVCL_SV67
SY   HZGHC003977c006; LMNB1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV67
DR   Horizon_Discovery; HZGHC003977c006
DR   Wikidata; Q54876080
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMNB1 (-) 3
AC   CVCL_SV68
SY   HZGHC000808c012; LMNB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV68
DR   Horizon_Discovery; HZGHC000808c012
DR   Wikidata; Q54876081
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMNB2 (-) 1
AC   CVCL_SV69
SY   HZGHC006514c010; LMNB2 knockout cell line 1bp insertion; HAP1 LMNB2 (-)
DR   cancercelllines; CVCL_SV69
DR   Horizon_Discovery; HZGHC006514c010
DR   Wikidata; Q54876082
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6638; LMNB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LMNB2 (-) 2
AC   CVCL_XQ20
SY   HZGHC006514c003; LMNB2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XQ20
DR   Horizon_Discovery; HZGHC006514c003
DR   Wikidata; Q93950988
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6638; LMNB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMO4 (-) 1
AC   CVCL_SV70
SY   HZGHC002805c009; LMO4 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SV70
DR   Horizon_Discovery; HZGHC002805c009
DR   Wikidata; Q54876083
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6644; LMO4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMO4 (-) 2
AC   CVCL_SV71
SY   HZGHC002805c012; LMO4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV71
DR   Horizon_Discovery; HZGHC002805c012
DR   Wikidata; Q54876084
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6644; LMO4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMTK2 (-)
AC   CVCL_SV72
SY   HZGHC000708c008; LMTK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV72
DR   Horizon_Discovery; HZGHC000708c008
DR   Wikidata; Q54876085
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17880; LMTK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMTK3 (-) 1
AC   CVCL_SV73
SY   HZGHC000702c004; LMTK3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SV73
DR   Horizon_Discovery; HZGHC000702c004
DR   Wikidata; Q54876086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19295; LMTK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMTK3 (-) 2
AC   CVCL_SV74
SY   HZGHC003500c005; LMTK3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV74
DR   Horizon_Discovery; HZGHC003500c005
DR   Wikidata; Q54876087
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19295; LMTK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LMTK3 (-) 3
AC   CVCL_SV75
SY   HZGHC003500c006; LMTK3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SV75
DR   Horizon_Discovery; HZGHC003500c006
DR   Wikidata; Q54876088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19295; LMTK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LOH12CR1 (-) 1
AC   CVCL_SV76
SY   HZGHC000869c005; LOH12CR1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SV76
DR   Horizon_Discovery; HZGHC000869c005
DR   Wikidata; Q54876089
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17950; BORCS5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LOH12CR1 (-) 2
AC   CVCL_SV77
SY   HZGHC000870c005; LOH12CR1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SV77
DR   Horizon_Discovery; HZGHC000870c005
DR   Wikidata; Q54876090
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17950; BORCS5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LOX (-) 1
AC   CVCL_SV78
SY   HZGHC006201c001; LOX knockout cell line 8bp deletion; HAP1 LOX (-)
DR   cancercelllines; CVCL_SV78
DR   Horizon_Discovery; HZGHC006201c001
DR   Wikidata; Q54876091
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6664; LOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LOX (-) 2
AC   CVCL_XQ21
SY   HZGHC006201c010; LOX knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XQ21
DR   Horizon_Discovery; HZGHC006201c010
DR   Wikidata; Q93951045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6664; LOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LPIN1 (-) 1
AC   CVCL_XQ22
SY   HZGHC006923c007; HZGHC23175; LPIN1 knockout cell line 1bp deletion in exon 2; HAP1 LPIN1 (-)
DR   cancercelllines; CVCL_XQ22
DR   Horizon_Discovery; HZGHC006923c007
DR   Wikidata; Q93951047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13345; LPIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LPIN1 (-) 2
AC   CVCL_B5KA
SY   HZGHC006923c008; LPIN1 knockout cell line 4bp deletion in exon 2
DR   cancercelllines; CVCL_B5KA
DR   Horizon_Discovery; HZGHC006923c008
DR   Wikidata; Q111733297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13345; LPIN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 LPPR5 (-)
AC   CVCL_SV79
SY   HZGHC003375c006; LPPR5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SV79
DR   Horizon_Discovery; HZGHC003375c006
DR   Wikidata; Q54876092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31703; PLPPR5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRBA (-) 1
AC   CVCL_SV80
SY   HZGHC001309c004; LRBA knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SV80
DR   Horizon_Discovery; HZGHC001309c004
DR   Wikidata; Q54876093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1742; LRBA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRBA (-) 2
AC   CVCL_SV81
SY   HZGHC001309c006; LRBA knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SV81
DR   Horizon_Discovery; HZGHC001309c006
DR   Wikidata; Q54876094
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1742; LRBA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRBA (-) 3
AC   CVCL_SV82
SY   HZGHC001310c004; LRBA knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SV82
DR   Horizon_Discovery; HZGHC001310c004
DR   Wikidata; Q54876095
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1742; LRBA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRBA (-) 4
AC   CVCL_SV83
SY   HZGHC001310c011; LRBA knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SV83
DR   Horizon_Discovery; HZGHC001310c011
DR   Wikidata; Q54876096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1742; LRBA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP1 (-) 1
AC   CVCL_SV84
SY   HZGHC001773c001; LRP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV84
DR   Horizon_Discovery; HZGHC001773c001
DR   Wikidata; Q54876100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6692; LRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP1 (-) 2
AC   CVCL_SV85
SY   HZGHC001773c010; LRP1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV85
DR   Horizon_Discovery; HZGHC001773c010
DR   Wikidata; Q54876101
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6692; LRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP1 (-) 3
AC   CVCL_SV86
SY   HZGHC001774c001; LRP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV86
DR   Horizon_Discovery; HZGHC001774c001
DR   Wikidata; Q54876102
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6692; LRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP1 (-) 4
AC   CVCL_SV87
SY   HZGHC001774c009; LRP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV87
DR   Horizon_Discovery; HZGHC001774c009
DR   Wikidata; Q54876103
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6692; LRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP4 (-) 1
AC   CVCL_E2BC
SY   HZGHC007394c007
DR   Horizon_Discovery; HZGHC007394c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6696; LRP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRP4 (-) 2
AC   CVCL_E2BD
SY   HZGHC007394c008
DR   Horizon_Discovery; HZGHC007394c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6696; LRP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRP4 (-) 3
AC   CVCL_E2BE
SY   HZGHC007394c012
DR   Horizon_Discovery; HZGHC007394c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6696; LRP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRP5 (-) 1
AC   CVCL_SV88
SY   HZGHC001055c005; LRP5 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SV88
DR   Horizon_Discovery; HZGHC001055c005
DR   Wikidata; Q54876104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP5 (-) 2
AC   CVCL_SV89
SY   HZGHC004020c009; LRP5 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SV89
DR   Horizon_Discovery; HZGHC004020c009
DR   Wikidata; Q54876105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP5 (-) 3
AC   CVCL_SV90
SY   HZGHC004020c012; LRP5 knockout cell line 40bp insertion
DR   cancercelllines; CVCL_SV90
DR   Horizon_Discovery; HZGHC004020c012
DR   Wikidata; Q54876106
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004020c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LRP6 (-) 1
AC   CVCL_SV91
SY   HZGHC000598c007; LRP6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SV91
DR   Horizon_Discovery; HZGHC000598c007
DR   Wikidata; Q54876107
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6698; LRP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP6 (-) 2
AC   CVCL_SV92
SY   HZGHC000598c010; LRP6 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV92
DR   Horizon_Discovery; HZGHC000598c010
DR   Wikidata; Q54876108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6698; LRP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRP8 (-)
AC   CVCL_SV93
SY   HZGHC006198c001; LRP8 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV93
DR   Horizon_Discovery; HZGHC006198c001
DR   Wikidata; Q54876109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6700; LRP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRPAP1 (-) 1
AC   CVCL_E2BF
SY   HZGHC007383c003
DR   Horizon_Discovery; HZGHC007383c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6701; LRPAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRPAP1 (-) 2
AC   CVCL_E2BG
SY   HZGHC007383c007
DR   Horizon_Discovery; HZGHC007383c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6701; LRPAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRRC16A (-) 1
AC   CVCL_XQ23
SY   HZGHC006998c003; HZGHC55604; LRRC16A knockout cell line 1bp insertion in exon 3; HAP1 LRRC16A (-)
DR   cancercelllines; CVCL_XQ23
DR   Horizon_Discovery; HZGHC006998c003
DR   Wikidata; Q93951171
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21581; CARMIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LRRC16A (-) 2
AC   CVCL_E2BH
SY   HZGHC006998c001; LRRC16A knockout cell line 4bp deletion in exon 3
DR   Horizon_Discovery; HZGHC006998c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21581; CARMIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRRC32 (-) 1
AC   CVCL_E2BI
SY   HZGHC007536c012
DR   Horizon_Discovery; HZGHC007536c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4161; LRRC32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRRC32 (-) 2
AC   CVCL_E2BJ
SY   HZGHC007537c008
DR   Horizon_Discovery; HZGHC007537c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4161; LRRC32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRRC32 (-) 3
AC   CVCL_E2BK
SY   HZGHC007537c012
DR   Horizon_Discovery; HZGHC007537c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4161; LRRC32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRRC8A (-) 1
AC   CVCL_SV94
SY   HZGHC000574c006; LRRC8A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV94
DR   Horizon_Discovery; HZGHC000574c006
DR   Wikidata; Q54876110
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19027; LRRC8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRC8A (-) 2
AC   CVCL_SV95
SY   HZGHC000574c010; LRRC8A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SV95
DR   Horizon_Discovery; HZGHC000574c010
DR   Wikidata; Q54876111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19027; LRRC8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000574c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LRRC8D (-) 1
AC   CVCL_SV96
SY   HZGHC000576c001; LRRC8D knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SV96
DR   Horizon_Discovery; HZGHC000576c001
DR   Wikidata; Q54876112
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16992; LRRC8D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRC8D (-) 2
AC   CVCL_SV97
SY   HZGHC000576c010; LRRC8D knockout cell line 67bp insertion
DR   cancercelllines; CVCL_SV97
DR   Horizon_Discovery; HZGHC000576c010
DR   Wikidata; Q54876113
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16992; LRRC8D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000576c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LRRC8D (-) 3
AC   CVCL_SV98
SY   HZGHC000577c005; LRRC8D knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SV98
DR   Horizon_Discovery; HZGHC000577c005
DR   Wikidata; Q54876114
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16992; LRRC8D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRC8D (-) 4
AC   CVCL_SV99
SY   HZGHC000577c007; LRRC8D knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SV99
DR   Horizon_Discovery; HZGHC000577c007
DR   Wikidata; Q54876115
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16992; LRRC8D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRK1 (-) 1
AC   CVCL_SW00
SY   HZGHC001345c012; LRRK1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SW00
DR   Horizon_Discovery; HZGHC001345c012
DR   Wikidata; Q54876116
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18608; LRRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRK1 (-) 2
AC   CVCL_SW01
SY   HZGHC002991c002; LRRK1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SW01
DR   Horizon_Discovery; HZGHC002991c002
DR   Wikidata; Q54876117
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18608; LRRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRK1 (-) 3
AC   CVCL_SW02
SY   HZGHC002991c011; LRRK1 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SW02
DR   Horizon_Discovery; HZGHC002991c011
DR   Wikidata; Q54876118
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18608; LRRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRK2 (-) 1
AC   CVCL_SW03
SY   HZGHC002500c005; LRRK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SW03
DR   Horizon_Discovery; HZGHC002500c005
DR   Wikidata; Q54876119
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRRK2 (-) 2
AC   CVCL_SW04
SY   HZGHC002500c007; LRRK2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW04
DR   Horizon_Discovery; HZGHC002500c007
DR   PRIDE; PXD010335
DR   Wikidata; Q54876120
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LRSAM1 (-) 1
AC   CVCL_SW05
SY   HZGHC003062c002; LRSAM1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW05
DR   Horizon_Discovery; HZGHC003062c002
DR   Wikidata; Q54876121
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25135; LRSAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRSAM1 (-) 2
AC   CVCL_SW06
SY   HZGHC003062c010; LRSAM1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW06
DR   Horizon_Discovery; HZGHC003062c010
DR   Wikidata; Q54876122
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25135; LRSAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LRWD1 (-) 1
AC   CVCL_E2BL
SY   HZGHC007575c005
DR   Horizon_Discovery; HZGHC007575c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21769; LRWD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LRWD1 (-) 2
AC   CVCL_E2BM
SY   HZGHC007575c008
DR   Horizon_Discovery; HZGHC007575c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21769; LRWD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LSM12 (-) 1
AC   CVCL_E2BN
SY   HZGHC007031c001
DR   Horizon_Discovery; HZGHC007031c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26407; LSM12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LSM12 (-) 2
AC   CVCL_E2BP
SY   HZGHC007031c011
DR   Horizon_Discovery; HZGHC007031c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26407; LSM12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LTF (-) 1
AC   CVCL_XQ24
SY   HZGHC007255c001; HZGHC4057; LTF knockout cell line 2bp insertion in exon 4; HAP1 LTF (-)
DR   cancercelllines; CVCL_XQ24
DR   Horizon_Discovery; HZGHC007255c001
DR   Wikidata; Q93951239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6720; LTF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 LTF (-) 2
AC   CVCL_E2BQ
SY   HZGHC007255c007; LTF knockout cell line 2bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007255c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6720; LTF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 LTK (-) 1
AC   CVCL_SW07
SY   HZGHC000357c018; LTK knockout cell line 37bp deletion
DR   cancercelllines; CVCL_SW07
DR   Horizon_Discovery; HZGHC000357c018
DR   Wikidata; Q54876123
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6721; LTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LTK (-) 2
AC   CVCL_SW08
SY   HZGHC000357c019; LTK knockout cell line 23bp deletion
DR   cancercelllines; CVCL_SW08
DR   Horizon_Discovery; HZGHC000357c019
DR   Wikidata; Q54876124
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6721; LTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LYN (-)
AC   CVCL_SW09
SY   HZGHC001664c005; LYN knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SW09
DR   Horizon_Discovery; HZGHC001664c005
DR   Wikidata; Q54876125
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LYPLA1 (-) 1
AC   CVCL_SW10
SY   HZGHC000594c005; LYPLA1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW10
DR   Horizon_Discovery; HZGHC000594c005
DR   Wikidata; Q54876126
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6737; LYPLA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LYPLA1 (-) 2
AC   CVCL_SW11
SY   HZGHC000594c006; LYPLA1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SW11
DR   Horizon_Discovery; HZGHC000594c006
DR   Wikidata; Q54876127
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6737; LYPLA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LYPLA2 (-) 1
AC   CVCL_SW12
SY   HZGHC000593c008; LYPLA2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW12
DR   Horizon_Discovery; HZGHC000593c008
DR   Wikidata; Q54876128
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6738; LYPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LYPLA2 (-) 2
AC   CVCL_SW13
SY   HZGHC000593c012; LYPLA2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SW13
DR   Horizon_Discovery; HZGHC000593c012
DR   Wikidata; Q54876129
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6738; LYPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LYPLAL1 (-) 1
AC   CVCL_SW14
SY   HZGHC000604c004; LYPLAL1 knockout cell line 148bp insertion
DR   cancercelllines; CVCL_SW14
DR   Horizon_Discovery; HZGHC000604c004
DR   Wikidata; Q54876130
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20440; LYPLAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000604c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LYPLAL1 (-) 2
AC   CVCL_SW15
SY   HZGHC000604c010; LYPLAL1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW15
DR   Horizon_Discovery; HZGHC000604c010
DR   Wikidata; Q54876131
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20440; LYPLAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LYPLAL1 (-) 3
AC   CVCL_SW16
SY   HZGHC000605c001; LYPLAL1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SW16
DR   Horizon_Discovery; HZGHC000605c001
DR   Wikidata; Q54876132
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20440; LYPLAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 LYRM2 (-) 1
AC   CVCL_SW17
SY   HZGHC005774c001; LYRM2 knockout cell line 28bp deletion; HAP1 LYRM2 (-)
DR   cancercelllines; CVCL_SW17
DR   Horizon_Discovery; HZGHC005774c001
DR   Wikidata; Q54876133
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25229; LYRM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 LYRM2 (-) 2
AC   CVCL_XQ25
SY   HZGHC005774c004; LYRM2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XQ25
DR   Horizon_Discovery; HZGHC005774c004
DR   Wikidata; Q93951334
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25229; LYRM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 M6PR (-) 1
AC   CVCL_SW18
SY   HZGHC003759c001; M6PR knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SW18
DR   Horizon_Discovery; HZGHC003759c001
DR   Wikidata; Q54876134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6752; M6PR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 M6PR (-) 2
AC   CVCL_SW19
SY   HZGHC003759c010; M6PR knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SW19
DR   Horizon_Discovery; HZGHC003759c010
DR   Wikidata; Q54876135
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6752; M6PR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAD2L1 (-) 1
AC   CVCL_SW20
SY   HZGHC006609c011; MAD2L1 knockout cell line 38bp deletion; HAP1 MAD2L1 (-)
DR   cancercelllines; CVCL_SW20
DR   Horizon_Discovery; HZGHC006609c011
DR   Wikidata; Q54876137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6763; MAD2L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAD2L1 (-) 2
AC   CVCL_XQ26
SY   HZGHC006609c006; MAD2L1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XQ26
DR   Horizon_Discovery; HZGHC006609c006
DR   Wikidata; Q93951367
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6763; MAD2L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MADD (-) 1
AC   CVCL_SW21
SY   HZGHC003962c004; MADD knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SW21
DR   Horizon_Discovery; HZGHC003962c004
DR   Wikidata; Q54876138
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6766; MADD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MADD (-) 2
AC   CVCL_SW22
SY   HZGHC003962c010; MADD knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW22
DR   Horizon_Discovery; HZGHC003962c010
DR   Wikidata; Q54876139
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6766; MADD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAEA (-) 1
AC   CVCL_E2BR
SY   HZGHC007454c002
DR   Horizon_Discovery; HZGHC007454c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13731; MAEA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MAEA (-) 2
AC   CVCL_E2BS
SY   HZGHC007454c004
DR   Horizon_Discovery; HZGHC007454c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13731; MAEA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MAGT1 (-)
AC   CVCL_XQ27
SY   HZGHC007223c007; HZGHC84061; MAGT1 knockout cell line 7bp deletion in exon 2
DR   cancercelllines; CVCL_XQ27
DR   Horizon_Discovery; HZGHC007223c007
DR   Wikidata; Q93951392
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28880; MAGT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAK (-) 1
AC   CVCL_SW23
SY   HZGHC001342c013; MAK knockout cell line 71bp insertion
DR   cancercelllines; CVCL_SW23
DR   Horizon_Discovery; HZGHC001342c013
DR   Wikidata; Q54876140
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6816; MAK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001342c013; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAK (-) 2
AC   CVCL_SW24
SY   HZGHC002992c007; MAK knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SW24
DR   Horizon_Discovery; HZGHC002992c007
DR   Wikidata; Q54876143
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6816; MAK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MALT1 (-)
AC   CVCL_E2BT
SY   HZGHC007449c007
DR   Horizon_Discovery; HZGHC007449c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MAML2 (-) 1
AC   CVCL_SW25
SY   HZGHC004632c002; MAML2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW25
DR   Horizon_Discovery; HZGHC004632c002
DR   Wikidata; Q54876144
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16259; MAML2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAML2 (-) 2
AC   CVCL_SW26
SY   HZGHC004632c005; MAML2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW26
DR   Horizon_Discovery; HZGHC004632c005
DR   Wikidata; Q54876145
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16259; MAML2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004632c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAOA (-) 1
AC   CVCL_SW27
SY   HZGHC003794c001; MAOA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW27
DR   Horizon_Discovery; HZGHC003794c001
DR   Wikidata; Q54876146
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6833; MAOA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAOA (-) 2
AC   CVCL_SW28
SY   HZGHC003794c004; MAOA knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SW28
DR   Horizon_Discovery; HZGHC003794c004
DR   Wikidata; Q54876147
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6833; MAOA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP1A (-) 1
AC   CVCL_SW29
SY   HZGHC003885c010; MAP1A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SW29
DR   Horizon_Discovery; HZGHC003885c010
DR   Wikidata; Q54876148
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6835; MAP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP1A (-) 2
AC   CVCL_SW30
SY   HZGHC003885c011; MAP1A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW30
DR   Horizon_Discovery; HZGHC003885c011
DR   Wikidata; Q54876149
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6835; MAP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP1A (-) 3
AC   CVCL_SW31
SY   HZGHC003885c012; MAP1A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SW31
DR   Horizon_Discovery; HZGHC003885c012
DR   Wikidata; Q54876150
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6835; MAP1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP1LC3B (-) 1
AC   CVCL_SW32
SY   HZGHC003241c005; MAP1LC3B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SW32
DR   Horizon_Discovery; HZGHC003241c005
DR   Wikidata; Q54876151
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13352; MAP1LC3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP1LC3B (-) 2
AC   CVCL_SW33
SY   HZGHC003242c007; MAP1LC3B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SW33
DR   Horizon_Discovery; HZGHC003242c007
DR   Wikidata; Q54876152
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13352; MAP1LC3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP1LC3C (-)
AC   CVCL_SW34
SY   HZGHC003052c005; MAP1LC3C knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SW34
DR   Horizon_Discovery; HZGHC003052c005
DR   Wikidata; Q54876153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13353; MAP1LC3C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2 (-) 1
AC   CVCL_SW35
SY   HZGHC003927c006; MAP2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SW35
DR   Horizon_Discovery; HZGHC003927c006
DR   Wikidata; Q54876154
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6839; MAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2 (-) 2
AC   CVCL_SW36
SY   HZGHC003927c012; MAP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW36
DR   Horizon_Discovery; HZGHC003927c012
DR   Wikidata; Q54876155
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6839; MAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2K1 (-) 1
AC   CVCL_SW37
SY   HZGHC000015c006; MAP2K1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW37
DR   Horizon_Discovery; HZGHC000015c006
DR   Wikidata; Q54876156
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000015c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP2K1 (-) 2
AC   CVCL_SW38
SY   HZGHC002964c001; MAP2K1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW38
DR   Horizon_Discovery; HZGHC002964c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54876158
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002964c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MAP2K2 (-) 1
AC   CVCL_SW39
SY   HZGHC000016c018; MAP2K2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SW39
DR   Horizon_Discovery; HZGHC000016c018
DR   Wikidata; Q54876159
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2K2 (-) 2
AC   CVCL_SW40
SY   HZGHC002965c001; MAP2K2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SW40
DR   Horizon_Discovery; HZGHC002965c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54876160
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP2K2 (-) 3
AC   CVCL_SW41
SY   HZGHC002965c003; MAP2K2 knockout cell line 86bp deletion
DR   cancercelllines; CVCL_SW41
DR   Horizon_Discovery; HZGHC002965c003
DR   Wikidata; Q54876161
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002965c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP2K3 (-) 1
AC   CVCL_SW42
SY   HZGHC000145c015; MAP2K3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SW42
DR   Horizon_Discovery; HZGHC000145c015
DR   Wikidata; Q54876163
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2K3 (-) 2
AC   CVCL_SW43
SY   HZGHC000145c021; MAP2K3 knockout cell line 139bp insertion
DR   cancercelllines; CVCL_SW43
DR   Horizon_Discovery; HZGHC000145c021
DR   Wikidata; Q54876164
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000145c021; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP2K4 (-) 1
AC   CVCL_SW44
SY   HZGHC001253c016; MAP2K4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SW44
DR   Horizon_Discovery; HZGHC001253c016
DR   Wikidata; Q54876165
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2K4 (-) 2
AC   CVCL_SW45
SY   HZGHC002993c003; MAP2K4 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SW45
DR   Horizon_Discovery; HZGHC002993c003
DR   Wikidata; Q54876166
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2K4 (-) 3
AC   CVCL_SW46
SY   HZGHC002993c012; MAP2K4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW46
DR   Horizon_Discovery; HZGHC002993c012
DR   Wikidata; Q54876167
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002993c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP2K5 (-)
AC   CVCL_SW47
SY   HZGHC004054c008; MAP2K5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SW47
DR   Horizon_Discovery; HZGHC004054c008
DR   Wikidata; Q54876168
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6845; MAP2K5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004054c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP2K6 (-)
AC   CVCL_SW48
SY   HZGHC000213c022; MAP2K6 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SW48
DR   Horizon_Discovery; HZGHC000213c022
DR   Wikidata; Q54876169
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6846; MAP2K6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2K7 (-) 1
AC   CVCL_SW49
SY   HZGHC000049c001; MAP2K7 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SW49
DR   Horizon_Discovery; HZGHC000049c001
DR   Wikidata; Q54876170
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP2K7 (-) 2
AC   CVCL_SW50
SY   HZGHC000049c008; MAP2K7 knockout cell line 116bp insertion
DR   cancercelllines; CVCL_SW50
DR   Horizon_Discovery; HZGHC000049c008
DR   Wikidata; Q54876171
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000049c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP2K7 (-) 3
AC   CVCL_SW51
SY   HZGHC000049c009; MAP2K7 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SW51
DR   Horizon_Discovery; HZGHC000049c009
DR   PRIDE; PXD010335
DR   Wikidata; Q54876172
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP3K1 (-) 1
AC   CVCL_SW52
SY   HZGHC000740c011; MAP3K1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SW52
DR   Horizon_Discovery; HZGHC000740c011
DR   Wikidata; Q54876173
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K1 (-) 2
AC   CVCL_SW53
SY   HZGHC004019c002; MAP3K1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW53
DR   Horizon_Discovery; HZGHC004019c002
DR   Wikidata; Q54876174
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K1 (-) 3
AC   CVCL_SW54
SY   HZGHC004019c009; MAP3K1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SW54
DR   Horizon_Discovery; HZGHC004019c009
DR   Wikidata; Q54876175
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K10 (-) 1
AC   CVCL_SW55
SY   HZGHC000090c009; MAP3K10 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SW55
DR   Horizon_Discovery; HZGHC000090c009
DR   Wikidata; Q54876176
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6849; MAP3K10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K10 (-) 2
AC   CVCL_SW56
SY   HZGHC000090c011; MAP3K10 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW56
DR   Horizon_Discovery; HZGHC000090c011
DR   Wikidata; Q54876177
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6849; MAP3K10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K10 (-) 3
AC   CVCL_SW57
SY   HZGHC000090c014; MAP3K10 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SW57
DR   Horizon_Discovery; HZGHC000090c014
DR   Wikidata; Q54876178
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6849; MAP3K10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K11 (-) 1
AC   CVCL_SW58
SY   HZGHC000091c002; MAP3K11 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SW58
DR   Horizon_Discovery; HZGHC000091c002
DR   Wikidata; Q54876179
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K11 (-) 2
AC   CVCL_SW59
SY   HZGHC000091c007; MAP3K11 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SW59
DR   Horizon_Discovery; HZGHC000091c007
DR   Wikidata; Q54876180
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K12 (-) 1
AC   CVCL_SW60
SY   HZGHC000147c001; MAP3K12 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SW60
DR   Horizon_Discovery; HZGHC000147c001
DR   Wikidata; Q54876181
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6851; MAP3K12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K12 (-) 2
AC   CVCL_SW61
SY   HZGHC000147c014; MAP3K12 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SW61
DR   Horizon_Discovery; HZGHC000147c014
DR   Wikidata; Q54876182
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6851; MAP3K12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K12 (-) 3
AC   CVCL_SW62
SY   HZGHC000147c024; MAP3K12 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW62
DR   Horizon_Discovery; HZGHC000147c024
DR   Wikidata; Q54876183
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6851; MAP3K12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K14 (-)
AC   CVCL_SW63
SY   HZGHC000218c019; MAP3K14 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SW63
DR   Horizon_Discovery; HZGHC000218c019
DR   Wikidata; Q54876184
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6853; MAP3K14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K2 (-) 1
AC   CVCL_SW64
SY   HZGHC000092c001; MAP3K2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SW64
DR   Horizon_Discovery; HZGHC000092c001
DR   Wikidata; Q54876187
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K2 (-) 2
AC   CVCL_SW65
SY   HZGHC000092c006; MAP3K2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SW65
DR   Horizon_Discovery; HZGHC000092c006
DR   Wikidata; Q54876188
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K2 (-) 3
AC   CVCL_SW66
SY   HZGHC000092c014; MAP3K2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SW66
DR   Horizon_Discovery; HZGHC000092c014
DR   Wikidata; Q54876189
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K3 (-)
AC   CVCL_SW67
SY   HZGHC000148c004; MAP3K3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SW67
DR   Horizon_Discovery; HZGHC000148c004
DR   Wikidata; Q54876190
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6855; MAP3K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K4 (-) 1
AC   CVCL_SW68
SY   HZGHC001275c013; MAP3K4 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SW68
DR   Horizon_Discovery; HZGHC001275c013
DR   Wikidata; Q54876191
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K4 (-) 2
AC   CVCL_SW69
SY   HZGHC002994c001; MAP3K4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW69
DR   Horizon_Discovery; HZGHC002994c001
DR   Wikidata; Q54876192
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K4 (-) 3
AC   CVCL_SW70
SY   HZGHC002994c011; MAP3K4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW70
DR   Horizon_Discovery; HZGHC002994c011
DR   Wikidata; Q54876193
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K5 (-)
AC   CVCL_SW71
SY   HZGHC000093c001; MAP3K5 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SW71
DR   Horizon_Discovery; HZGHC000093c001
DR   Wikidata; Q54876194
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6857; MAP3K5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K6 (-)
AC   CVCL_SW72
SY   HZGHC000225c011; MAP3K6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW72
DR   Horizon_Discovery; HZGHC000225c011
DR   Wikidata; Q54876195
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6858; MAP3K6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K7 (-)
AC   CVCL_SW73
SY   HZGHC000149c018; MAP3K7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW73
DR   Horizon_Discovery; HZGHC000149c018
DR   Wikidata; Q54876196
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP3K8 (-) 1
AC   CVCL_SW74
SY   HZGHC004116c002; MAP3K8 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_SW74
DR   Horizon_Discovery; HZGHC004116c002
DR   Wikidata; Q54876197
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6860; MAP3K8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K8 (-) 2
AC   CVCL_SW75
SY   HZGHC004116c012; MAP3K8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW75
DR   Horizon_Discovery; HZGHC004116c012
DR   Wikidata; Q54876198
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6860; MAP3K8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K8 (-) 3
AC   CVCL_SW76
SY   HZGHC000228c002; MAP3K8 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SW76
DR   Horizon_Discovery; HZGHC000228c002
DR   Wikidata; Q54876199
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6860; MAP3K8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K9 (-) 1
AC   CVCL_SW77
SY   HZGHC000311c012; MAP3K9 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SW77
DR   Horizon_Discovery; HZGHC000311c012
DR   Wikidata; Q54876200
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6861; MAP3K9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP3K9 (-) 2
AC   CVCL_SW78
SY   HZGHC000311c020; MAP3K9 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SW78
DR   Horizon_Discovery; HZGHC000311c020
DR   Wikidata; Q54876201
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6861; MAP3K9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP4 (-) 1
AC   CVCL_SW79
SY   HZGHC003701c011; MAP4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SW79
DR   Horizon_Discovery; HZGHC003701c011
DR   Wikidata; Q54876202
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6862; MAP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP4 (-) 2
AC   CVCL_SW80
SY   HZGHC003701c012; MAP4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW80
DR   Horizon_Discovery; HZGHC003701c012
DR   Wikidata; Q54876203
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6862; MAP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP4K3 (-) 1
AC   CVCL_SW81
SY   HZGHC000017c008; MAP4K3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SW81
DR   Horizon_Discovery; HZGHC000017c008
DR   Wikidata; Q54876204
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6865; MAP4K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP4K3 (-) 2
AC   CVCL_SW82
SY   HZGHC000017c014; MAP4K3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SW82
DR   Horizon_Discovery; HZGHC000017c014
DR   Wikidata; Q54876205
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6865; MAP4K3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP4K4 (-)
AC   CVCL_SW83
SY   HZGHC000732c022; MAP4K4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SW83
DR   Horizon_Discovery; HZGHC000732c022
DR   PRIDE; PXD010335
DR   Wikidata; Q54876206
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6866; MAP4K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAP4K5 (-)
AC   CVCL_SW84
SY   HZGHC000018c007; MAP4K5 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SW84
DR   Horizon_Discovery; HZGHC000018c007
DR   Wikidata; Q54876207
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6867; MAP4K5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAP7D1 (-)
AC   CVCL_E2BU
SY   HZGHC008089c006
DR   Horizon_Discovery; HZGHC008089c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25514; MAP7D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MAPK11 (-)
AC   CVCL_SW85
SY   HZGHC000911c011; MAPK11 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SW85
DR   Horizon_Discovery; HZGHC000911c011
DR   Wikidata; Q54876208
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6873; MAPK11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK12 (-)
AC   CVCL_SW86
SY   HZGHC000021c014; MAPK12 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW86
DR   Horizon_Discovery; HZGHC000021c014
DR   Wikidata; Q54876209
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6874; MAPK12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK13 (-) 1
AC   CVCL_SW87
SY   HZGHC004396c011; MAPK13 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SW87
DR   Horizon_Discovery; HZGHC004396c011
DR   Wikidata; Q54876210
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6875; MAPK13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK13 (-) 2
AC   CVCL_SW88
SY   HZGHC004396c012; MAPK13 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SW88
DR   Horizon_Discovery; HZGHC004396c012
DR   Wikidata; Q54876211
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6875; MAPK13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK14 (-) 1
AC   CVCL_SW89
SY   HZGHC002595c010; MAPK14 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SW89
DR   Horizon_Discovery; HZGHC002595c010
DR   Wikidata; Q54876212
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPK14 (-) 2
AC   CVCL_SW90
SY   HZGHC002595c011; MAPK14 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SW90
DR   Horizon_Discovery; HZGHC002595c011
DR   Wikidata; Q54876213
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK15 (-)
AC   CVCL_SW91
SY   HZGHC002970c011; MAPK15 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SW91
DR   Horizon_Discovery; HZGHC002970c011
DR   Wikidata; Q54876214
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24667; MAPK15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK4 (-) 1
AC   CVCL_SW92
SY   HZGHC000333c005; MAPK4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SW92
DR   Horizon_Discovery; HZGHC000333c005
DR   Wikidata; Q54876215
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6878; MAPK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK4 (-) 2
AC   CVCL_SW93
SY   HZGHC000333c012; MAPK4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW93
DR   Horizon_Discovery; HZGHC000333c012
DR   Wikidata; Q54876216
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6878; MAPK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK4 (-) 3
AC   CVCL_SW94
SY   HZGHC000333c022; MAPK4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW94
DR   Horizon_Discovery; HZGHC000333c022
DR   Wikidata; Q54876217
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6878; MAPK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK6 (-) 1
AC   CVCL_SW95
SY   HZGHC004955c001; MAPK6 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SW95
DR   Horizon_Discovery; HZGHC004955c001
DR   Wikidata; Q54876218
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6879; MAPK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK6 (-) 2
AC   CVCL_SW96
SY   HZGHC004955c005; MAPK6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SW96
DR   Horizon_Discovery; HZGHC004955c005
DR   Wikidata; Q54876219
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6879; MAPK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK7 (-) 1
AC   CVCL_SW97
SY   HZGHC004222c004; MAPK7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SW97
DR   Horizon_Discovery; HZGHC004222c004
DR   Wikidata; Q54876220
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK7 (-) 2
AC   CVCL_SW98
SY   HZGHC004222c008; MAPK7 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SW98
DR   Horizon_Discovery; HZGHC004222c008
DR   Wikidata; Q54876221
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK8 (-) 1
AC   CVCL_SW99
SY   HZGHC000526c003; MAPK8 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SW99
DR   Horizon_Discovery; HZGHC000526c003
DR   Wikidata; Q54876223
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6881; MAPK8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPK8 (-) 2
AC   CVCL_SX00
SY   HZGHC000526c004; MAPK8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SX00
DR   Horizon_Discovery; HZGHC000526c004
DR   Wikidata; Q54876224
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6881; MAPK8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPK9 (-)
AC   CVCL_SX01
SY   HZGHC000024c004; MAPK9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX01
DR   Horizon_Discovery; HZGHC000024c004
DR   Wikidata; Q54876225
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6886; MAPK9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPKAP1 (-) 1
AC   CVCL_SX02
SY   HZGHC000997c002; MAPKAP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX02
DR   Horizon_Discovery; HZGHC000997c002
DR   Wikidata; Q54876226
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18752; MAPKAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000997c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPKAP1 (-) 2
AC   CVCL_SX03
SY   HZGHC000997c007; MAPKAP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX03
DR   Horizon_Discovery; HZGHC000997c007
DR   Wikidata; Q54876227
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18752; MAPKAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000997c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPKAPK2 (-) 1
AC   CVCL_SX04
SY   HZGHC000025c013; MAPKAPK2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX04
DR   Horizon_Discovery; HZGHC000025c013
DR   PRIDE; PXD010335
DR   Wikidata; Q54876229
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6887; MAPKAPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPKAPK2 (-) 2
AC   CVCL_SX05
SY   HZGHC000025c016; MAPKAPK2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SX05
DR   Horizon_Discovery; HZGHC000025c016
DR   Wikidata; Q54876230
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6887; MAPKAPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000025c016; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPKAPK3 (-)
AC   CVCL_SX06
SY   HZGHC000208c012; MAPKAPK3 knockout cell line 5bp deletion in exon 2
DR   cancercelllines; CVCL_SX06
DR   Horizon_Discovery; HZGHC000208c012
DR   Wikidata; Q54876231
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6888; MAPKAPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPKAPK5 (-) 1
AC   CVCL_SX07
SY   HZGHC000217c004; MAPKAPK5 knockout cell line 4bp deletion; HAP1 MAPKAPK5 (-)
DR   Horizon_Discovery; HZGHC000217c004
DR   Wikidata; Q54876232
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000217c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPKAPK5 (-) 2
AC   CVCL_XQ28
SY   HZGHC006287c007; MAPKAPK5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XQ28
DR   Horizon_Discovery; HZGHC006287c007
DR   Wikidata; Q93952486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPKAPK5 (-) 3
AC   CVCL_XQ29
SY   HZGHC006287c012; MAPKAPK5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XQ29
DR   Horizon_Discovery; HZGHC006287c012
DR   Wikidata; Q93952489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPKBP1 (-)
AC   CVCL_XQ30
SY   HZGHC007099c002; HZGHC23005; MAPKBP1 knockout cell line 1bp insertion in exon 8
DR   cancercelllines; CVCL_XQ30
DR   Horizon_Discovery; HZGHC007099c002
DR   Wikidata; Q93952493
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29536; MAPKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAPT (-) 1
AC   CVCL_SX08
SY   HZGHC003277c003; MAPT knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SX08
DR   Horizon_Discovery; HZGHC003277c003
DR   Wikidata; Q54876233
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAPT (-) 2
AC   CVCL_SX09
SY   HZGHC003277c009; MAPT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX09
DR   Horizon_Discovery; HZGHC003277c009
DR   Wikidata; Q54876234
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK1 (-) 1
AC   CVCL_SX10
SY   HZGHC000050c001; MARK1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SX10
DR   Horizon_Discovery; HZGHC000050c001
DR   Wikidata; Q54876236
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6896; MARK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK1 (-) 2
AC   CVCL_SX11
SY   HZGHC000050c012; MARK1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SX11
DR   Horizon_Discovery; HZGHC000050c012
DR   Wikidata; Q54876237
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6896; MARK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK1 (-) 3
AC   CVCL_SX12
SY   HZGHC000050c020; MARK1 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SX12
DR   Horizon_Discovery; HZGHC000050c020
DR   Wikidata; Q54876238
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6896; MARK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK2 (-) 1
AC   CVCL_SX13
SY   HZGHC000328c013; MARK2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SX13
DR   Horizon_Discovery; HZGHC000328c013
DR   Wikidata; Q54876239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3332; MARK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK2 (-) 2
AC   CVCL_SX14
SY   HZGHC000328c014; MARK2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX14
DR   Horizon_Discovery; HZGHC000328c014
DR   Wikidata; Q54876240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3332; MARK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK3 (-) 1
AC   CVCL_SX15
SY   HZGHC000151c001; MARK3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX15
DR   Horizon_Discovery; HZGHC000151c001
DR   Wikidata; Q54876241
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6897; MARK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK3 (-) 2
AC   CVCL_SX16
SY   HZGHC000151c014; MARK3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX16
DR   Horizon_Discovery; HZGHC000151c014
DR   Wikidata; Q54876242
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6897; MARK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MARK3 (-) 3
AC   CVCL_SX17
SY   HZGHC000151c016; MARK3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SX17
DR   Horizon_Discovery; HZGHC000151c016
DR   Wikidata; Q54876243
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6897; MARK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK4 (-) 1
AC   CVCL_SX18
SY   HZGHC000152c006; MARK4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX18
DR   Horizon_Discovery; HZGHC000152c006
DR   Wikidata; Q54876244
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13538; MARK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MARK4 (-) 2
AC   CVCL_SX19
SY   HZGHC000152c008; MARK4 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SX19
DR   Horizon_Discovery; HZGHC000152c008
DR   Wikidata; Q54876245
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13538; MARK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST1 (-)
AC   CVCL_SX20
SY   HZGHC000331c013; MAST1 knockout cell line 2bp insertion in exon 2
DR   cancercelllines; CVCL_SX20
DR   Horizon_Discovery; HZGHC000331c013
DR   Wikidata; Q54876246
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19034; MAST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAST2 (-)
AC   CVCL_SX21
SY   HZGHC000094c020; MAST2 knockout cell line 17bp deletion in exon 2
DR   cancercelllines; CVCL_SX21
DR   Horizon_Discovery; HZGHC000094c020
DR   Wikidata; Q54876247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19035; MAST2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAST3 (-) 1
AC   CVCL_SX22
SY   HZGHC000095c009; MAST3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SX22
DR   Horizon_Discovery; HZGHC000095c009
DR   Wikidata; Q54876248
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19036; MAST3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST3 (-) 2
AC   CVCL_SX23
SY   HZGHC000095c022; MAST3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SX23
DR   Horizon_Discovery; HZGHC000095c022
DR   Wikidata; Q54876249
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19036; MAST3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST4 (-) 1
AC   CVCL_SX24
SY   HZGHC000153c003; MAST4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SX24
DR   Horizon_Discovery; HZGHC000153c003
DR   Wikidata; Q54876250
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19037; MAST4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST4 (-) 2
AC   CVCL_SX25
SY   HZGHC000153c023; MAST4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX25
DR   Horizon_Discovery; HZGHC000153c023
DR   Wikidata; Q54876251
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19037; MAST4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST4 (-) 3
AC   CVCL_SX26
SY   HZGHC004742c001; MAST4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SX26
DR   Horizon_Discovery; HZGHC004742c001
DR   Wikidata; Q54876252
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19037; MAST4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST4 (-) 4
AC   CVCL_SX27
SY   HZGHC004742c002; MAST4 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SX27
DR   Horizon_Discovery; HZGHC004742c002
DR   Wikidata; Q54876253
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19037; MAST4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST4 (-) 5
AC   CVCL_SX28
SY   HZGHC004743c002; MAST4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SX28
DR   Horizon_Discovery; HZGHC004743c002
DR   Wikidata; Q54876254
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19037; MAST4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAST4 (-) 6
AC   CVCL_SX29
SY   HZGHC004743c003; MAST4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX29
DR   Horizon_Discovery; HZGHC004743c003
DR   Wikidata; Q54876255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19037; MAST4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAT2B (-) 1
AC   CVCL_SX30
SY   HZGHC004921c006; MAT2B knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SX30
DR   Horizon_Discovery; HZGHC004921c006
DR   Wikidata; Q54876256
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6905; MAT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAT2B (-) 2
AC   CVCL_SX31
SY   HZGHC004921c010; MAT2B knockout cell line 182bp insertion
DR   cancercelllines; CVCL_SX31
DR   Horizon_Discovery; HZGHC004921c010
DR   Wikidata; Q54876257
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6905; MAT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004921c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAT2B (-) 3
AC   CVCL_SX32
SY   HZGHC004922c001; MAT2B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX32
DR   Horizon_Discovery; HZGHC004922c001
DR   Wikidata; Q54876258
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6905; MAT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MAT2B (-) 4
AC   CVCL_SX33
SY   HZGHC004922c005; MAT2B knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SX33
DR   Horizon_Discovery; HZGHC004922c005
DR   Wikidata; Q54876259
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6905; MAT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MATK (-) 1
AC   CVCL_SX34
SY   HZGHC000154c022; MATK knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SX34
DR   Horizon_Discovery; HZGHC000154c022
DR   Wikidata; Q54876260
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6906; MATK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MATK (-) 2
AC   CVCL_SX35
SY   HZGHC000154c010; MATK knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX35
DR   Horizon_Discovery; HZGHC000154c010
DR   Wikidata; Q54876261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6906; MATK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MATR3 (-) 1
AC   CVCL_D1HX
SY   HZGHC007500c001; MATR3 knockout cell line 2bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007500c001
DR   Wikidata; Q127381064
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6912; MATR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 MATR3 (-) 2
AC   CVCL_D1HY
SY   HZGHC007500c004; MATR3 knockout cell line 1bp insertion in exon 8
DR   Horizon_Discovery; HZGHC007500c004
DR   Wikidata; Q127381065
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6912; MATR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 MATR3 (-) 3
AC   CVCL_D1HZ
SY   HZGHC007500c005; MATR3 knockout cell line 17bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007500c005
DR   Wikidata; Q127381066
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6912; MATR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 MAVS (-) 1
AC   CVCL_SX36
SY   HZGHC001456c011; MAVS knockout cell line 4bp deletion in exon 6
DR   cancercelllines; CVCL_SX36
DR   Horizon_Discovery; HZGHC001456c011
DR   Wikidata; Q54876262
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAVS (-) 2
AC   CVCL_SX37
SY   HZGHC001456c012; MAVS knockout cell line 2bp deletion in exon 6
DR   cancercelllines; CVCL_SX37
DR   Horizon_Discovery; HZGHC001456c012
DR   Wikidata; Q54876263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MAZ (-) 1
AC   CVCL_E2BV
SY   HZGHC007747c003
DR   Horizon_Discovery; HZGHC007747c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6914; MAZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MAZ (-) 2
AC   CVCL_E2BW
SY   HZGHC007747c009
DR   Horizon_Discovery; HZGHC007747c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6914; MAZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MB21D1 (-) 1
AC   CVCL_SX38
SY   HZGHC003946c003; MB21D1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX38
DR   Horizon_Discovery; HZGHC003946c003
DR   Wikidata; Q54876264
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21367; CGAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MB21D1 (-) 2
AC   CVCL_SX39
SY   HZGHC003946c007; MB21D1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SX39
DR   Horizon_Discovery; HZGHC003946c007
DR   Wikidata; Q54876265
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21367; CGAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD1 (-) 1
AC   CVCL_SX40
SY   HZGHC001171c002; MBD1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SX40
DR   Horizon_Discovery; HZGHC001171c002
DR   Wikidata; Q54876266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD1 (-) 2
AC   CVCL_SX41
SY   HZGHC001171c003; MBD1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SX41
DR   Horizon_Discovery; HZGHC001171c003
DR   Wikidata; Q54876267
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD1 (-) 3
AC   CVCL_SX42
SY   HZGHC001171c008; MBD1 knockout cell line 287bp insertion
DR   cancercelllines; CVCL_SX42
DR   Horizon_Discovery; HZGHC001171c008
DR   Wikidata; Q54876268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001171c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MBD2 (-) 1
AC   CVCL_SX43
SY   HZGHC003628c010; MBD2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX43
DR   Horizon_Discovery; HZGHC003628c010
DR   Wikidata; Q54876269
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6917; MBD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD2 (-) 2
AC   CVCL_SX44
SY   HZGHC003628c011; MBD2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SX44
DR   Horizon_Discovery; HZGHC003628c011
DR   Wikidata; Q54876271
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6917; MBD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD2 (-) 3
AC   CVCL_XQ31
SY   HZGHC003628c001; MBD2 knockout cell line
DR   cancercelllines; CVCL_XQ31
DR   Horizon_Discovery; HZGHC003628c001
DR   Wikidata; Q93952853
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6917; MBD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003628c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MBD3 (-) 1
AC   CVCL_SX45
SY   HZGHC001113c008; MBD3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SX45
DR   Horizon_Discovery; HZGHC001113c008
DR   Wikidata; Q54876272
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6918; MBD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD3 (-) 2
AC   CVCL_SX46
SY   HZGHC001113c009; MBD3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SX46
DR   Horizon_Discovery; HZGHC001113c009
DR   Wikidata; Q54876273
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6918; MBD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD3 (-) 3
AC   CVCL_SX47
SY   HZGHC001113c010; MBD3 knockout cell line 64bp insertion
DR   cancercelllines; CVCL_SX47
DR   Horizon_Discovery; HZGHC001113c010
DR   Wikidata; Q54876274
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6918; MBD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001113c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MBD4 (-) 1
AC   CVCL_SX48
SY   HZGHC000921c002; MBD4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX48
DR   Horizon_Discovery; HZGHC000921c002
DR   Wikidata; Q54876275
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6919; MBD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD4 (-) 2
AC   CVCL_SX49
SY   HZGHC000921c004; MBD4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SX49
DR   Horizon_Discovery; HZGHC000921c004
DR   Wikidata; Q54876276
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6919; MBD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD4 (-) 3
AC   CVCL_SX50
SY   HZGHC000921c005; MBD4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX50
DR   Horizon_Discovery; HZGHC000921c005
DR   Wikidata; Q54876277
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6919; MBD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBD4 (-) 4
AC   CVCL_SX51
SY   HZGHC000921c011; MBD4 knockout cell line 404bp insertion
DR   cancercelllines; CVCL_SX51
DR   Horizon_Discovery; HZGHC000921c011
DR   Wikidata; Q54876278
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6919; MBD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000921c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MBOAT1 (-) 1
AC   CVCL_E2BX
SY   HZGHC007776c006
DR   Horizon_Discovery; HZGHC007776c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21579; MBOAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MBOAT1 (-) 2
AC   CVCL_E2BY
SY   HZGHC007776c009
DR   Horizon_Discovery; HZGHC007776c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21579; MBOAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MBP (-) 1
AC   CVCL_SX52
SY   HZGHC005992c011; MBP knockout cell line 1bp insertion; HAP1 MBP (-)
DR   cancercelllines; CVCL_SX52
DR   Horizon_Discovery; HZGHC005992c011
DR   Wikidata; Q54876279
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6925; MBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MBP (-) 2
AC   CVCL_XQ32
SY   HZGHC005992c012; MBP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XQ32
DR   Horizon_Discovery; HZGHC005992c012
DR   Wikidata; Q93952930
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6925; MBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBTPS1 (-) 1
AC   CVCL_SX53
SY   HZGHC001520c005; MBTPS1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX53
DR   Horizon_Discovery; HZGHC001520c005
DR   Wikidata; Q54876280
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15456; MBTPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBTPS1 (-) 2
AC   CVCL_SX54
SY   HZGHC001520c009; MBTPS1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX54
DR   Horizon_Discovery; HZGHC001520c009
DR   Wikidata; Q54876281
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15456; MBTPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBTPS1 (-) 3
AC   CVCL_SX55
SY   HZGHC001520c011; MBTPS1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX55
DR   Horizon_Discovery; HZGHC001520c011
DR   Wikidata; Q54876282
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15456; MBTPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MBTPS2 (-)
AC   CVCL_SX56
SY   HZGHC001523c010; MBTPS2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX56
DR   Horizon_Discovery; HZGHC001523c010
DR   Wikidata; Q54876283
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15455; MBTPS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MCAM (-)
AC   CVCL_SX57
SY   HZGHC006203c012; MCAM knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SX57
DR   Horizon_Discovery; HZGHC006203c012
DR   Wikidata; Q54876284
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6934; MCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MCOLN1 (-) 1
AC   CVCL_SX58
SY   HZGHC002537c029; MCOLN1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX58
DR   Horizon_Discovery; HZGHC002537c029
DR   Wikidata; Q54876285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002537c029; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MCOLN1 (-) 2
AC   CVCL_SX59
SY   HZGHC002537c033; MCOLN1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX59
DR   Horizon_Discovery; HZGHC002537c033
DR   Wikidata; Q54876286
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002537c033; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MCOLN1 (-) 3
AC   CVCL_SX60
SY   HZGHC002538c035; MCOLN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX60
DR   Horizon_Discovery; HZGHC002538c035
DR   Wikidata; Q54876287
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002538c035; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MCOLN1 (-) 4
AC   CVCL_SX61
SY   HZGHC002538c036; MCOLN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX61
DR   Horizon_Discovery; HZGHC002538c036
DR   Wikidata; Q54876288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002538c036; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MCOLN1 (-) 5
AC   CVCL_SX62
SY   HZGHC002537c002; MCOLN1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SX62
DR   Horizon_Discovery; HZGHC002537c002
DR   Wikidata; Q54876289
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MCOLN1 (-) 6
AC   CVCL_SX63
SY   HZGHC002537c011; MCOLN1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX63
DR   Horizon_Discovery; HZGHC002537c011
DR   Wikidata; Q54876290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MCOLN1 (-) 7
AC   CVCL_SX64
SY   HZGHC002538c001; MCOLN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX64
DR   Horizon_Discovery; HZGHC002538c001
DR   Wikidata; Q54876291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MCOLN2 (-) 1
AC   CVCL_D1I0
SY   HZGHC008090c001; MCOLN2 knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC008090c001
DR   Wikidata; Q127381067
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13357; MCOLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 MCOLN2 (-) 2
AC   CVCL_D1I1
SY   HZGHC008091c006; MCOLN2 knockout cell line 4bp deletion
DR   Horizon_Discovery; HZGHC008091c006
DR   Wikidata; Q127381068
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13357; MCOLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 MCOLN3 (-) 1
AC   CVCL_SX65
SY   HZGHC006396c010; MCOLN3 knockout cell line 122bp deletion; HAP1 MCOLN3 (-)
DR   cancercelllines; CVCL_SX65
DR   Horizon_Discovery; HZGHC006396c010
DR   Wikidata; Q54876292
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13358; MCOLN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MCOLN3 (-) 2
AC   CVCL_XQ33
SY   HZGHC006396c002; MCOLN3 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_XQ33
DR   Horizon_Discovery; HZGHC006396c002
DR   Wikidata; Q93953043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13358; MCOLN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MCUR1 (-)
AC   CVCL_XQ34
SY   HZGHC007269c010; HZGHC63933; MCUR1 knockout cell line 28bp deletion in exon 1
DR   cancercelllines; CVCL_XQ34
DR   Horizon_Discovery; HZGHC007269c010
DR   Wikidata; Q93953046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21097; MCUR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007269c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MDC1 (-)
AC   CVCL_SX66
SY   HZGHC005077c003; HZGHC9656; MDC1 knockout cell line 37bp deletion
DR   cancercelllines; CVCL_SX66
DR   Horizon_Discovery; HZGHC005077c003
DR   Wikidata; Q54876294
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21163; MDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005077c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MDH1 (-)
AC   CVCL_XQ35
SY   HZGHC007264c008; HZGHC4190; MDH1 knockout cell line 7bp deletion in exon 6
DR   cancercelllines; CVCL_XQ35
DR   Horizon_Discovery; HZGHC007264c008
DR   Wikidata; Q93953060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6970; MDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MDH2 (-) 1
AC   CVCL_XQ36
SY   HZGHC006847c003; HZGHC4191; MDH2 knockout cell line 2bp insertion in exon 4; HAP1 MDH2 (-)
DR   cancercelllines; CVCL_XQ36
DR   Horizon_Discovery; HZGHC006847c003
DR   Wikidata; Q93953064
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6971; MDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MDH2 (-) 2
AC   CVCL_B5KB
SY   HZGHC006847c007; MDH2 knockout cell line 64bp insertion in exon 4
DR   cancercelllines; CVCL_B5KB
DR   Horizon_Discovery; HZGHC006847c007
DR   Wikidata; Q111733298
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6971; MDH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006847c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 MDK (-)
AC   CVCL_C6Y2
SY   HZGHC007906c008; MDK knockout cell line 2bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007906c008
DR   Wikidata; Q117704470
RX   PubMed=39092005;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6972; MDK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 MDM2 (-) 1
AC   CVCL_SX67
SY   HZGHC004736c005; MDM2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SX67
DR   Horizon_Discovery; HZGHC004736c005
DR   Wikidata; Q54876295
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6973; MDM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MDM2 (-) 2
AC   CVCL_SX68
SY   HZGHC004736c008; MDM2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SX68
DR   Horizon_Discovery; HZGHC004736c008
DR   Wikidata; Q54876296
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6973; MDM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ME1 (-) 1
AC   CVCL_SX69
SY   HZGHC005910c001; ME1 knockout cell line 4bp deletion in exon 4; HAP1 ME1 (-)
DR   cancercelllines; CVCL_SX69
DR   Horizon_Discovery; HZGHC005910c001
DR   Wikidata; Q54876297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6983; ME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ME1 (-) 2
AC   CVCL_XQ37
SY   HZGHC005910c011; ME1 knockout cell line 1bp insertion in exon4
DR   cancercelllines; CVCL_XQ37
DR   Horizon_Discovery; HZGHC005910c011
DR   Wikidata; Q93953079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6983; ME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ME2 (-) 1
AC   CVCL_SX70
SY   HZGHC006020c010; ME2 knockout cell line 1bp insertion; HAP1 ME2 (-)
DR   cancercelllines; CVCL_SX70
DR   Horizon_Discovery; HZGHC006020c010
DR   Wikidata; Q54876298
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6984; ME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ME2 (-) 2
AC   CVCL_XQ38
SY   HZGHC006020c003; ME2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ38
DR   Horizon_Discovery; HZGHC006020c003
DR   Wikidata; Q93953086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6984; ME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006020c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MECP2 (-) 1
AC   CVCL_SX71
SY   HZGHC001102c009; MECP2 knockout cell line 2bp insertion in exon 2
DR   cancercelllines; CVCL_SX71
DR   Horizon_Discovery; HZGHC001102c009
DR   PRIDE; PXD010335
DR   Wikidata; Q54876299
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6990; MECP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MECP2 (-) 2
AC   CVCL_SX72
SY   HZGHC001102c010; MECP2 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_SX72
DR   Horizon_Discovery; HZGHC001102c010
DR   Wikidata; Q54876300
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6990; MECP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001102c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MECR (-) 1
AC   CVCL_XQ39
SY   HZGHC006856c002; HZGHC51102; MECR knockout cell line 65bp deletion in exon 4; HAP1 MECR (-)
DR   cancercelllines; CVCL_XQ39
DR   Horizon_Discovery; HZGHC006856c002
DR   Wikidata; Q93953098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19691; MECR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MECR (-) 2
AC   CVCL_E2BZ
SY   HZGHC006857c007
DR   Horizon_Discovery; HZGHC006857c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19691; MECR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MECR (-) 3
AC   CVCL_E2C0
SY   HZGHC006857c010
DR   Horizon_Discovery; HZGHC006857c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19691; MECR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MED13L (-) 1
AC   CVCL_SX73
SY   HZGHC003719c009; MED13L knockout cell line 152bp insertion
DR   cancercelllines; CVCL_SX73
DR   Horizon_Discovery; HZGHC003719c009
DR   Wikidata; Q54876301
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22962; MED13L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003719c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MED13L (-) 2
AC   CVCL_SX74
SY   HZGHC003719c010; MED13L knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SX74
DR   Horizon_Discovery; HZGHC003719c010
DR   Wikidata; Q54876302
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22962; MED13L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MEF2B (-) 1
AC   CVCL_SX75
SY   HZGHC000860c008; MEF2B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX75
DR   Horizon_Discovery; HZGHC000860c008
DR   Wikidata; Q54876303
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6995; MEF2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MEF2B (-) 2
AC   CVCL_SX76
SY   HZGHC000860c010; MEF2B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SX76
DR   Horizon_Discovery; HZGHC000860c010
DR   Wikidata; Q54876304
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6995; MEF2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MEIS1 (-) 1
AC   CVCL_SX77
SY   HZGHC006323c011; MEIS1 knockout cell line 142bp insertion; HAP1 MEIS1 (-)
DR   cancercelllines; CVCL_SX77
DR   Horizon_Discovery; HZGHC006323c011
DR   Wikidata; Q54876305
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7000; MEIS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006323c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MEIS1 (-) 2
AC   CVCL_XQ40
SY   HZGHC006324c003; MEIS1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XQ40
DR   Horizon_Discovery; HZGHC006324c003
DR   Wikidata; Q93953122
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7000; MEIS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MEIS1 (-) 3
AC   CVCL_XQ41
SY   HZGHC006324c012; MEIS1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XQ41
DR   Horizon_Discovery; HZGHC006324c012
DR   Wikidata; Q93953125
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7000; MEIS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MELK (-)
AC   CVCL_SX78
SY   HZGHC000401c007; MELK knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SX78
DR   Horizon_Discovery; HZGHC000401c007
DR   PRIDE; PXD010335
DR   Wikidata; Q54876306
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16870; MELK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MEN1 (-) 1
AC   CVCL_SX79
SY   HZGHC001139c001; MEN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX79
DR   Horizon_Discovery; HZGHC001139c001
DR   Wikidata; Q54876307
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001139c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MEN1 (-) 2
AC   CVCL_SX80
SY   HZGHC001139c008; MEN1 knockout cell line 2bp insertion
DR   Horizon_Discovery; HZGHC001139c008
DR   Wikidata; Q54876308
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001139c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MEN1 (-) 3
AC   CVCL_SX81
SY   HZGHC001139c009; MEN1 knockout cell line 425bp insertion
DR   cancercelllines; CVCL_SX81
DR   Horizon_Discovery; HZGHC001139c009
DR   Wikidata; Q54876309
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001139c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MEN1 (-) 4
AC   CVCL_SX82
SY   HZGHC001139c012; MEN1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SX82
DR   Horizon_Discovery; HZGHC001139c012
DR   Wikidata; Q54876310
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MERTK (-) 1
AC   CVCL_SX83
SY   HZGHC015332c009; MERTK knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SX83
DR   Horizon_Discovery; HZGHC015332c009
DR   Wikidata; Q54876311
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MERTK (-) 2
AC   CVCL_SX84
SY   HZGHC015332c010; MERTK knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SX84
DR   Horizon_Discovery; HZGHC015332c010
DR   Wikidata; Q54876313
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MERTK (-) 3
AC   CVCL_SX85
SY   HZGHC015332c014; MERTK knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX85
DR   Horizon_Discovery; HZGHC015332c014
DR   Wikidata; Q54876314
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MERTK (-) 4
AC   CVCL_XQ42
SY   HZGHC015332c019; MERTK knockout cell line
DR   cancercelllines; CVCL_XQ42
DR   Horizon_Discovery; HZGHC015332c019
DR   Wikidata; Q93953194
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC015332c019; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MET (-)
AC   CVCL_SX86
SY   HZGHC002886c004; MET knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SX86
DR   Horizon_Discovery; HZGHC002886c004
DR   Wikidata; Q54876315
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL10 (-) 1
AC   CVCL_SX87
SY   HZGHC005337c007; METTL10 knockout cell line 8bp deletion; HAP1 METTL10 (-)
DR   cancercelllines; CVCL_SX87
DR   Horizon_Discovery; HZGHC005337c007
DR   Wikidata; Q54876316
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33787; EEF1AKMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL10 (-) 2
AC   CVCL_XQ43
SY   HZGHC005337c008; METTL10 knockout cell line 164bp insertion
DR   cancercelllines; CVCL_XQ43
DR   Horizon_Discovery; HZGHC005337c008
DR   Wikidata; Q93953215
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33787; EEF1AKMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005337c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL12 (-)
AC   CVCL_SX88
SY   HZGHC000536c011; METTL12 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SX88
DR   Horizon_Discovery; HZGHC000536c011
DR   Wikidata; Q54876317
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33113; CSKMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL13 (-) 1
AC   CVCL_SX89
SY   HZGHC000537c001; METTL13 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SX89
DR   Horizon_Discovery; HZGHC000537c001
DR   Wikidata; Q54876318
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24248; METTL13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL13 (-) 2
AC   CVCL_SX90
SY   HZGHC000537c007; METTL13 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SX90
DR   Horizon_Discovery; HZGHC000537c007
DR   Wikidata; Q54876319
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24248; METTL13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000537c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL13 (-) 3
AC   CVCL_SX91
SY   HZGHC000539c006; METTL13 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SX91
DR   Horizon_Discovery; HZGHC000539c006
DR   Wikidata; Q54876320
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24248; METTL13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL13 (-) 4
AC   CVCL_SX92
SY   HZGHC000539c012; METTL13 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SX92
DR   Horizon_Discovery; HZGHC000539c012
DR   Wikidata; Q54876321
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24248; METTL13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL14 (-)
AC   CVCL_SX93
SY   HZGHC003575c010; METTL14 knockout cell line 1bp deletion
DR   Horizon_Discovery; HZGHC003575c010
DR   Wikidata; Q54876322
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29330; METTL14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003575c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL15 (-) 1
AC   CVCL_SX94
SY   HZGHC005105c003; METTL15 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_SX94
DR   Horizon_Discovery; HZGHC005105c003
DR   Wikidata; Q54876323
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26606; METTL15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL15 (-) 2
AC   CVCL_SX95
SY   HZGHC005105c010; METTL15 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SX95
DR   Horizon_Discovery; HZGHC005105c010
DR   Wikidata; Q54876324
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26606; METTL15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL18 (-) 1
AC   CVCL_SX96
SY   HZGHC000541c002; METTL18 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SX96
DR   Horizon_Discovery; HZGHC000541c002
DR   Wikidata; Q54876325
RX   PubMed=35674491;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28793; METTL18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 12
//
ID   HAP1 METTL18 (-) 2
AC   CVCL_SX97
SY   HZGHC000541c009; METTL18 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SX97
DR   Horizon_Discovery; HZGHC000541c009
DR   Wikidata; Q54876326
RX   PubMed=35674491;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28793; METTL18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 12
//
ID   HAP1 METTL18 (-) 3
AC   CVCL_SX98
SY   HZGHC000541c012; METTL18 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SX98
DR   Horizon_Discovery; HZGHC000541c012
DR   Wikidata; Q54876327
RX   PubMed=35674491;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28793; METTL18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 12
//
ID   HAP1 METTL20 (-) 1
AC   CVCL_XQ44
SY   HZGHC000543c008; METTL20 knockout cell line
DR   cancercelllines; CVCL_XQ44
DR   Horizon_Discovery; HZGHC000543c008
DR   Wikidata; Q93953302
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28739; ETFBKMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000543c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL20 (-) 2
AC   CVCL_XQ45
SY   HZGHC000543c009; METTL20 knockout cell line
DR   cancercelllines; CVCL_XQ45
DR   Horizon_Discovery; HZGHC000543c009
DR   Wikidata; Q93953305
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28739; ETFBKMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000543c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL21B (-) 1
AC   CVCL_SX99
SY   HZGHC000546c004; METTL21B knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SX99
DR   Horizon_Discovery; HZGHC000546c004
DR   Wikidata; Q54876328
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24936; EEF1AKMT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL21B (-) 2
AC   CVCL_SY00
SY   HZGHC000546c012; METTL21B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY00
DR   Horizon_Discovery; HZGHC000546c012
DR   Wikidata; Q54876329
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24936; EEF1AKMT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL22 (-) 1
AC   CVCL_SY01
SY   HZGHC000547c011; METTL22 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SY01
DR   Horizon_Discovery; HZGHC000547c011
DR   Wikidata; Q54876330
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28368; METTL22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL22 (-) 2
AC   CVCL_SY02
SY   HZGHC000547c012; METTL22 knockout cell line 97bp insertion
DR   cancercelllines; CVCL_SY02
DR   Horizon_Discovery; HZGHC000547c012
DR   Wikidata; Q54876331
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28368; METTL22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000547c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL23 (-) 1
AC   CVCL_SY03
SY   HZGHC000549c005; METTL23 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SY03
DR   Horizon_Discovery; HZGHC000549c005
DR   Wikidata; Q54876332
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26988; METTL23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL23 (-) 2
AC   CVCL_SY04
SY   HZGHC000549c006; METTL23 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY04
DR   Horizon_Discovery; HZGHC000549c006
DR   Wikidata; Q54876333
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26988; METTL23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL4 (-)
AC   CVCL_XQ46
SY   HZGHC007201c003; HZGHC64863; METTL4 knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_XQ46
DR   Horizon_Discovery; HZGHC007201c003
DR   Wikidata; Q93953354
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24726; METTL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL5 (-) 1
AC   CVCL_SY05
SY   HZGHC005028c004; METTL5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY05
DR   Horizon_Discovery; HZGHC005028c004
DR   Wikidata; Q54876334
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25006; METTL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005028c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL5 (-) 2
AC   CVCL_SY06
SY   HZGHC005028c010; METTL5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY06
DR   Horizon_Discovery; HZGHC005028c010
DR   Wikidata; Q54876335
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25006; METTL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL5 (-) 3
AC   CVCL_SY07
SY   HZGHC005029c003; METTL5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY07
DR   Horizon_Discovery; HZGHC005029c003
DR   Wikidata; Q54876336
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25006; METTL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL5 (-) 5
AC   CVCL_SY08
SY   HZGHC005029c005; METTL5 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SY08
DR   Horizon_Discovery; HZGHC005029c005
DR   Wikidata; Q54876337
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25006; METTL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL6 (-) 1
AC   CVCL_SY09
SY   HZGHC005030c008; METTL6 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY09
DR   Horizon_Discovery; HZGHC005030c008
DR   Wikidata; Q54876338
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28343; METTL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL6 (-) 2
AC   CVCL_SY10
SY   HZGHC005030c009; METTL6 knockout cell line 241bp insertion
DR   cancercelllines; CVCL_SY10
DR   Horizon_Discovery; HZGHC005030c009
DR   Wikidata; Q54876339
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28343; METTL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005030c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 METTL6 (-) 3
AC   CVCL_SY11
SY   HZGHC005031c010; METTL6 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SY11
DR   Horizon_Discovery; HZGHC005031c010
DR   Wikidata; Q54876340
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28343; METTL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL6 (-) 4
AC   CVCL_SY12
SY   HZGHC005031c011; METTL6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY12
DR   Horizon_Discovery; HZGHC005031c011
DR   Wikidata; Q54876341
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28343; METTL6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL8 (-) 1
AC   CVCL_SY13
SY   HZGHC005033c009; METTL8 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SY13
DR   Horizon_Discovery; HZGHC005033c009
DR   Wikidata; Q54876342
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25856; METTL8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL8 (-) 2
AC   CVCL_SY14
SY   HZGHC005033c012; METTL8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY14
DR   Horizon_Discovery; HZGHC005033c012
DR   Wikidata; Q54876343
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25856; METTL8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL9 (-) 1
AC   CVCL_SY15
SY   HZGHC004343c005; METTL9 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SY15
DR   Horizon_Discovery; HZGHC004343c005
DR   Wikidata; Q54876344
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24586; METTL9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 METTL9 (-) 2
AC   CVCL_SY16
SY   HZGHC004343c010; METTL9 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SY16
DR   Horizon_Discovery; HZGHC004343c010
DR   Wikidata; Q54876345
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24586; METTL9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MEX3C (-)
AC   CVCL_SY17
SY   HZGHC006054c007; MEX3C knockout cell line 17bp deletion in exon 2
DR   cancercelllines; CVCL_SY17
DR   Horizon_Discovery; HZGHC006054c007
DR   Wikidata; Q54876347
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28040; MEX3C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MFF (-) 1
AC   CVCL_XQ47
SY   HZGHC006819c007; HZGHC56947; MFF knockout cell line 1bp insertion in exon 5; HAP1 MFF (-)
DR   cancercelllines; CVCL_XQ47
DR   Horizon_Discovery; HZGHC006819c007
DR   Wikidata; Q93953475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24858; MFF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MFF (-) 2
AC   CVCL_E2C1
SY   HZGHC006818c010
DR   Horizon_Discovery; HZGHC006818c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24858; MFF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MFF (-) 3
AC   CVCL_E2C2
SY   HZGHC006818c011
DR   Horizon_Discovery; HZGHC006818c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24858; MFF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MFF (-) 4
AC   CVCL_E2C3
SY   HZGHC006819c001
DR   Horizon_Discovery; HZGHC006819c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24858; MFF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MFN1 (-)
AC   CVCL_SY18
SY   HZGHC006229c003; MFN1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY18
DR   Horizon_Discovery; HZGHC006229c003
DR   Wikidata; Q54876348
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18262; MFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MFN2 (-) 1
AC   CVCL_XQ48
SY   HZGHC006808c004; HZGHC9927; MFN2 knockout cell line 10bp deletion in exon 5; HAP1 MFN2 (-)
DR   cancercelllines; CVCL_XQ48
DR   Horizon_Discovery; HZGHC006808c004
DR   Wikidata; Q93953488
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16877; MFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MFN2 (-) 2
AC   CVCL_E2C4
SY   HZGHC006808c012
DR   Horizon_Discovery; HZGHC006808c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16877; MFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MFN2 (-) 3
AC   CVCL_E2C5
SY   HZGHC006809c003
DR   Horizon_Discovery; HZGHC006809c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16877; MFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MFN2 (-) 4
AC   CVCL_E2C6
SY   HZGHC006809c005
DR   Horizon_Discovery; HZGHC006809c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16877; MFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MFSD2A (-)
AC   CVCL_SY19
SY   HZGHC002418c002; MFSD2A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY19
DR   Horizon_Discovery; HZGHC002418c002
DR   Wikidata; Q54876349
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25897; MFSD2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MFSD7 (-) 1
AC   CVCL_SY20
SY   HZGHC004490c001; MFSD7 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY20
DR   Horizon_Discovery; HZGHC004490c001
DR   Wikidata; Q54876350
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26177; SLC49A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MFSD7 (-) 2
AC   CVCL_SY21
SY   HZGHC004490c012; MFSD7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY21
DR   Horizon_Discovery; HZGHC004490c012
DR   Wikidata; Q54876351
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26177; SLC49A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MFSD8 (-) 1
AC   CVCL_SY22
SY   HZGHC005346c011; MFSD8 knockout cell line 80bp insertion; HAP1 MFSD8 (-)
DR   cancercelllines; CVCL_SY22
DR   Horizon_Discovery; HZGHC005346c011
DR   Wikidata; Q54876352
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005346c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MFSD8 (-) 2
AC   CVCL_XQ49
SY   HZGHC005346c003; MFSD8 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XQ49
DR   Horizon_Discovery; HZGHC005346c003
DR   Wikidata; Q93953531
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MFSD9 (-) 1
AC   CVCL_SY23
SY   HZGHC005585c001; MFSD9 knockout cell line 25bp deletion; HAP1 MFSD9 (-)
DR   cancercelllines; CVCL_SY23
DR   Horizon_Discovery; HZGHC005585c001
DR   Wikidata; Q54876353
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28158; MFSD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MFSD9 (-) 2
AC   CVCL_XQ50
SY   HZGHC005585c008; MFSD9 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XQ50
DR   Horizon_Discovery; HZGHC005585c008
DR   Wikidata; Q93953544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28158; MFSD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MGAT1 (-) 1
AC   CVCL_SY24
SY   HZGHC005842c001; MGAT1 knockout cell line 1bp deletion; HAP1 MGAT1 (-)
DR   cancercelllines; CVCL_SY24
DR   Horizon_Discovery; HZGHC005842c001
DR   Wikidata; Q54876355
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7044; MGAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005842c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MGAT1 (-) 2
AC   CVCL_XQ51
SY   HZGHC005842c011; MGAT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ51
DR   Horizon_Discovery; HZGHC005842c011
DR   Wikidata; Q93953557
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7044; MGAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005842c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGAT1 (-) 3
AC   CVCL_XQ52
SY   HZGHC005842c012; MGAT1 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_XQ52
DR   Horizon_Discovery; HZGHC005842c012
DR   Wikidata; Q93953561
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7044; MGAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005842c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGAT2 (-) 1
AC   CVCL_SY25
SY   HZGHC004072c003; MGAT2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SY25
DR   Horizon_Discovery; HZGHC004072c003
DR   Wikidata; Q54876356
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7045; MGAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MGAT2 (-) 2
AC   CVCL_SY26
SY   HZGHC004072c005; MGAT2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SY26
DR   Horizon_Discovery; HZGHC004072c005
DR   Wikidata; Q54876357
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7045; MGAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MGAT5 (-)
AC   CVCL_SY27
SY   HZGHC005845c012; MGAT5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SY27
DR   Horizon_Discovery; HZGHC005845c012
DR   Wikidata; Q54876358
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7049; MGAT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005845c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGEA5 (-) 1
AC   CVCL_SY28
SY   HZGHC006084c005; MGEA5 knockout cell line 16bp deletion in exon 4; HAP1 MGEA5 (-)
DR   cancercelllines; CVCL_SY28
DR   Horizon_Discovery; HZGHC006084c005
DR   Wikidata; Q54876359
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7056; OGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MGEA5 (-) 2
AC   CVCL_XQ53
SY   HZGHC006084c008; MGEA5 knockout cell line 4bp deletion in exon 4
DR   cancercelllines; CVCL_XQ53
DR   Horizon_Discovery; HZGHC006084c008
DR   Wikidata; Q93953605
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7056; OGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGME1 (-) 1
AC   CVCL_SY29
SY   HZGHC004657c006; MGME1 knockout cell line 160bp insertion
DR   cancercelllines; CVCL_SY29
DR   Horizon_Discovery; HZGHC004657c006
DR   Wikidata; Q54876360
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16205; MGME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004657c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGME1 (-) 2
AC   CVCL_SY30
SY   HZGHC004657c008; MGME1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SY30
DR   Horizon_Discovery; HZGHC004657c008
DR   Wikidata; Q54876361
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16205; MGME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004657c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGME1 (-) 3
AC   CVCL_SY31
SY   HZGHC004657c012; MGME1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SY31
DR   Horizon_Discovery; HZGHC004657c012
DR   Wikidata; Q54876362
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16205; MGME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MGME1 (-) 4
AC   CVCL_SY32
SY   HZGHC004658c004; MGME1 knockout cell line 322bp insertion
DR   cancercelllines; CVCL_SY32
DR   Horizon_Discovery; HZGHC004658c004
DR   Wikidata; Q54876363
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16205; MGME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004658c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGME1 (-) 5
AC   CVCL_SY33
SY   HZGHC004658c009; MGME1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SY33
DR   Horizon_Discovery; HZGHC004658c009
DR   Wikidata; Q54876364
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16205; MGME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MGMT (-) 1
AC   CVCL_SY34
SY   HZGHC000430c004; MGMT knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SY34
DR   Horizon_Discovery; HZGHC000430c004
DR   Wikidata; Q54876365
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MGMT (-) 2
AC   CVCL_SY35
SY   HZGHC000430c006; MGMT knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SY35
DR   Horizon_Discovery; HZGHC000430c006
DR   Wikidata; Q54876366
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000430c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MGMT (-) 3
AC   CVCL_SY36
SY   HZGHC000430c010; MGMT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY36
DR   Horizon_Discovery; HZGHC000430c010
DR   Wikidata; Q54876367
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MIA3 (-)
AC   CVCL_E2C7
SY   HZGHC007860c010
DR   Horizon_Discovery; HZGHC007860c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24008; MIA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MICAL1 (-)
AC   CVCL_E2C8
SY   HZGHC007558c006
DR   Horizon_Discovery; HZGHC007558c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20619; MICAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MICU1 (-) 1
AC   CVCL_E2C9
SY   HZGHC006828c009; MICU1 knockout cell line 10bp deletion in exon 8
DR   Horizon_Discovery; HZGHC006828c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1530; MICU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MICU1 (-) 2
AC   CVCL_E2CA
SY   HZGHC006829c008; MICU1 knockout cell line 1bp insertion in exon 8
DR   Horizon_Discovery; HZGHC006829c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1530; MICU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MID1 (-) 1
AC   CVCL_E2CB
SY   HZGHC008013c005
DR   Horizon_Discovery; HZGHC008013c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7095; MID1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MID1 (-) 2
AC   CVCL_E2CC
SY   HZGHC008013c006
DR   Horizon_Discovery; HZGHC008013c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7095; MID1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MID1 (-) 3
AC   CVCL_E2CD
SY   HZGHC008014c008
DR   Horizon_Discovery; HZGHC008014c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7095; MID1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MIEN1 (-) 1
AC   CVCL_XQ54
SY   HZGHC007151c005; HZGHC84299; MIEN1 knockout cell line 14bp deletion in exon 2; HAP1 MIEN1 (-)
DR   cancercelllines; CVCL_XQ54
DR   Horizon_Discovery; HZGHC007151c005
DR   Wikidata; Q93953684
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28230; MIEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MIEN1 (-) 2
AC   CVCL_E2CE
SY   HZGHC007151c006; MIEN1 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007151c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28230; MIEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MIF (-) 1
AC   CVCL_SY37
SY   HZGHC005402c001; MIF knockout cell line 74bp insertion; HAP1 MIF (-)
DR   cancercelllines; CVCL_SY37
DR   Horizon_Discovery; HZGHC005402c001
DR   Wikidata; Q54876368
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7097; MIF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005402c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MIF (-) 2
AC   CVCL_XQ55
SY   HZGHC005402c003; MIF knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ55
DR   Horizon_Discovery; HZGHC005402c003
DR   Wikidata; Q93953701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7097; MIF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MINK1 (-)
AC   CVCL_SY38
SY   HZGHC000277c036; MINK1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_SY38
DR   Horizon_Discovery; HZGHC000277c036
DR   Wikidata; Q54876369
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17565; MINK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MINOS1 (-)
AC   CVCL_SY39
SY   HZGHC005046c001; MINOS1 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SY39
DR   Horizon_Discovery; HZGHC005046c001
DR   Wikidata; Q54876370
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32068; MICOS10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MIOS (-)
AC   CVCL_SY40
SY   HZGHC001281c011; MIOS knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SY40
DR   Horizon_Discovery; HZGHC001281c011
DR   Wikidata; Q54876371
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21905; MIOS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MIPEP (-)
AC   CVCL_SY41
SY   HZGHC004963c012; MIPEP knockout cell line 184bp insertion
DR   cancercelllines; CVCL_SY41
DR   Horizon_Discovery; HZGHC004963c012
DR   Wikidata; Q54876372
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7104; MIPEP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004963c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MISP (-) 1
AC   CVCL_XQ56
SY   HZGHC007029c006; HZGHC126353; MISP knockout cell line 1bp deletion in exon 2; HAP1 MISP (-)
DR   cancercelllines; CVCL_XQ56
DR   Horizon_Discovery; HZGHC007029c006
DR   Wikidata; Q93953740
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27000; MISP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MISP (-) 2
AC   CVCL_E2CF
SY   HZGHC007029c009
DR   Horizon_Discovery; HZGHC007029c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27000; MISP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MISP (-) 3
AC   CVCL_E2CG
SY   HZGHC007029c010
DR   Horizon_Discovery; HZGHC007029c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27000; MISP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MITF (-)
AC   CVCL_SY42
SY   HZGHC006207c011; MITF knockout cell line 100bp insertion
DR   cancercelllines; CVCL_SY42
DR   Horizon_Discovery; HZGHC006207c011
DR   Wikidata; Q54876373
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7105; MITF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006207c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MKI67 (-) 1
AC   CVCL_SY43
SY   HZGHC000981c006; MKI67 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SY43
DR   Horizon_Discovery; HZGHC000981c006
DR   Wikidata; Q54876374
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MKI67 (-) 2
AC   CVCL_SY44
SY   HZGHC000981c010; MKI67 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY44
DR   Horizon_Discovery; HZGHC000981c010
DR   Wikidata; Q54876375
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MKI67 (-) 3
AC   CVCL_SY45
SY   HZGHC000982c004; MKI67 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SY45
DR   Horizon_Discovery; HZGHC000982c004
DR   Wikidata; Q54876376
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MKI67 (-) 4
AC   CVCL_SY46
SY   HZGHC000982c009; MKI67 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SY46
DR   Horizon_Discovery; HZGHC000982c009
DR   Wikidata; Q54876377
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MKI67 (-) 5
AC   CVCL_E2CH
SY   HZGHC000981c001
DR   Horizon_Discovery; HZGHC000981c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MKNK1 (-) 1
AC   CVCL_SY47
SY   HZGHC000397c002; MKNK1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY47
DR   Horizon_Discovery; HZGHC000397c002
DR   Wikidata; Q54876378
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000397c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MKNK1 (-) 2
AC   CVCL_SY48
SY   HZGHC000397c012; MKNK1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY48
DR   Horizon_Discovery; HZGHC000397c012
DR   Wikidata; Q54876379
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MKNK1 (-) 3
AC   CVCL_SY49
SY   HZGHC000397c018; MKNK1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SY49
DR   Horizon_Discovery; HZGHC000397c018
DR   Wikidata; Q54876380
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MKNK2 (-) 1
AC   CVCL_SY50
SY   HZGHC000156c008; MKNK2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SY50
DR   Horizon_Discovery; HZGHC000156c008
DR   Wikidata; Q54876381
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MKNK2 (-) 2
AC   CVCL_SY51
SY   HZGHC000156c020; MKNK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SY51
DR   Horizon_Discovery; HZGHC000156c020
DR   Wikidata; Q54876382
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MLH1 (-) 1
AC   CVCL_SY52
SY   HZGHC000343c021; MLH1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_SY52
DR   Horizon_Discovery; HZGHC000343c021
DR   Wikidata; Q54876383
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000343c021; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MLH1 (-) 2
AC   CVCL_SY53
SY   HZGHC000343c022; MLH1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SY53
DR   Horizon_Discovery; HZGHC000343c022
DR   Wikidata; Q54876384
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000343c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MLH1 (-) 3
AC   CVCL_E2CI
SY   HZGHC000343c011
DR   Horizon_Discovery; HZGHC000343c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MLKL (-)
AC   CVCL_SY54
SY   HZGHC000712c013; MLKL knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY54
DR   Horizon_Discovery; HZGHC000712c013
DR   Wikidata; Q54876385
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26617; MLKL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MLLT3 (-) 1
AC   CVCL_E2CJ
SY   HZGHC008198c005
DR   Horizon_Discovery; HZGHC008198c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7136; MLLT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MLLT3 (-) 2
AC   CVCL_E2CK
SY   HZGHC008198c013
DR   Horizon_Discovery; HZGHC008198c013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7136; MLLT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MLST8 (-)
AC   CVCL_SY55
SY   HZGHC001356c002; MLST8 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY55
DR   Horizon_Discovery; HZGHC001356c002
DR   Wikidata; Q54876386
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24825; MLST8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MLXIP (-) 1
AC   CVCL_SY56
SY   HZGHC005421c010; MLXIP knockout cell line 53bp insertion; HAP1 MLXIP (-)
DR   cancercelllines; CVCL_SY56
DR   Horizon_Discovery; HZGHC005421c010
DR   Wikidata; Q54876387
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17055; MLXIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005421c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MLXIP (-) 2
AC   CVCL_XQ57
SY   HZGHC005421c012; MLXIP knockout cell line 4bp insertion
DR   cancercelllines; CVCL_XQ57
DR   Horizon_Discovery; HZGHC005421c012
DR   Wikidata; Q93953851
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17055; MLXIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MME (-)
AC   CVCL_SY57
SY   HZGHC003851c006; MME knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SY57
DR   Horizon_Discovery; HZGHC003851c006
DR   Wikidata; Q54876388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7154; MME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP11 (-) 1
AC   CVCL_SY58
SY   HZGHC003860c002; MMP11 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SY58
DR   Horizon_Discovery; HZGHC003860c002
DR   Wikidata; Q54876389
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7157; MMP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP11 (-) 2
AC   CVCL_SY59
SY   HZGHC003860c009; MMP11 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SY59
DR   Horizon_Discovery; HZGHC003860c009
DR   Wikidata; Q54876390
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7157; MMP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP15 (-) 1
AC   CVCL_SY60
SY   HZGHC003861c005; MMP15 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SY60
DR   Horizon_Discovery; HZGHC003861c005
DR   Wikidata; Q54876391
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7161; MMP15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP15 (-) 2
AC   CVCL_SY61
SY   HZGHC003861c011; MMP15 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY61
DR   Horizon_Discovery; HZGHC003861c011
DR   Wikidata; Q54876392
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7161; MMP15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP16 (-) 1
AC   CVCL_SY62
SY   HZGHC003863c002; MMP16 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SY62
DR   Horizon_Discovery; HZGHC003863c002
DR   Wikidata; Q54876393
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7162; MMP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP16 (-) 2
AC   CVCL_SY63
SY   HZGHC003863c004; MMP16 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SY63
DR   Horizon_Discovery; HZGHC003863c004
DR   Wikidata; Q54876394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7162; MMP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP17 (-) 1
AC   CVCL_SY64
SY   HZGHC003822c002; MMP17 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SY64
DR   Horizon_Discovery; HZGHC003822c002
DR   Wikidata; Q54876397
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7163; MMP17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP17 (-) 2
AC   CVCL_SY65
SY   HZGHC003822c011; MMP17 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SY65
DR   Horizon_Discovery; HZGHC003822c011
DR   Wikidata; Q54876398
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7163; MMP17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP2 (-) 1
AC   CVCL_XQ58
SY   HZGHC007136c001; HZGHC4313; MMP2 knockout cell line 2bp deletion in exon 2; HAP1 MMP2 (-)
DR   cancercelllines; CVCL_XQ58
DR   Horizon_Discovery; HZGHC007136c001
DR   Wikidata; Q93953936
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7166; MMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MMP2 (-) 2
AC   CVCL_E2CL
SY   HZGHC007136c007; MMP2 knockout cell line 11bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007136c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7166; MMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MMP24 (-) 1
AC   CVCL_SY66
SY   HZGHC003910c007; MMP24 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SY66
DR   Horizon_Discovery; HZGHC003910c007
DR   Wikidata; Q54876399
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7172; MMP24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP24 (-) 2
AC   CVCL_SY67
SY   HZGHC003910c009; MMP24 knockout cell line 242bp insertion
DR   cancercelllines; CVCL_SY67
DR   Horizon_Discovery; HZGHC003910c009
DR   Wikidata; Q54876400
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7172; MMP24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003910c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MMP24 (-) 3
AC   CVCL_SY68
SY   HZGHC003910c010; MMP24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY68
DR   Horizon_Discovery; HZGHC003910c010
DR   Wikidata; Q54876401
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7172; MMP24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP25 (-) 1
AC   CVCL_SY69
SY   HZGHC003928c001; MMP25 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SY69
DR   Horizon_Discovery; HZGHC003928c001
DR   Wikidata; Q54876402
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14246; MMP25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MMP25 (-) 2
AC   CVCL_SY70
SY   HZGHC003928c012; MMP25 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SY70
DR   Horizon_Discovery; HZGHC003928c012
DR   Wikidata; Q54876403
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14246; MMP25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MND1 (-)
AC   CVCL_E2CM
SY   HZGHC008009c007
DR   Horizon_Discovery; HZGHC008009c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24839; MND1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MNT (-) 1
AC   CVCL_SY71
SY   HZGHC003376c011; MNT knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY71
DR   Horizon_Discovery; HZGHC003376c011
DR   Wikidata; Q54876404
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7188; MNT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003376c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MNT (-) 2
AC   CVCL_SY72
SY   HZGHC003376c010; MNT knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY72
DR   Horizon_Discovery; HZGHC003376c010
DR   Wikidata; Q54876405
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7188; MNT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MNT (-) 3
AC   CVCL_SY73
SY   HZGHC003376c012; MNT knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SY73
DR   Horizon_Discovery; HZGHC003376c012
DR   Wikidata; Q54876406
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7188; MNT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MOK (-) 1
AC   CVCL_SY74
SY   HZGHC000075c011; MOK knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SY74
DR   Horizon_Discovery; HZGHC000075c011
DR   Wikidata; Q54876407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9833; MOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MOK (-) 2
AC   CVCL_SY75
SY   HZGHC000075c014; MOK knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SY75
DR   Horizon_Discovery; HZGHC000075c014
DR   Wikidata; Q54876408
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9833; MOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MOK (-) 3
AC   CVCL_SY76
SY   HZGHC000075c017; MOK knockout cell line 35bp deletion
DR   cancercelllines; CVCL_SY76
DR   Horizon_Discovery; HZGHC000075c017
DR   Wikidata; Q54876409
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9833; MOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPC1 (-) 1
AC   CVCL_XQ59
SY   HZGHC006817c011; HZGHC51660; MPC1 knockout cell line 4bp deletion in exon 4; HAP1 MPC1 (-)
DR   cancercelllines; CVCL_XQ59
DR   Horizon_Discovery; HZGHC006817c011
DR   Wikidata; Q93953991
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21606; MPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MPC1 (-) 2
AC   CVCL_E2CN
SY   HZGHC006816c010
DR   Horizon_Discovery; HZGHC006816c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21606; MPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MPC1 (-) 3
AC   CVCL_E2CP
SY   HZGHC006817c012
DR   Horizon_Discovery; HZGHC006817c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21606; MPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MPDU1 (-) 1
AC   CVCL_SY77
SY   HZGHC004060c001; MPDU1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY77
DR   Horizon_Discovery; HZGHC004060c001
DR   Wikidata; Q54876410
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7207; MPDU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPDU1 (-) 2
AC   CVCL_SY78
SY   HZGHC004060c012; MPDU1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SY78
DR   Horizon_Discovery; HZGHC004060c012
DR   Wikidata; Q54876411
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7207; MPDU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPG (-) 1
AC   CVCL_SY79
SY   HZGHC001537c002; MPG knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SY79
DR   Horizon_Discovery; HZGHC001537c002
DR   Wikidata; Q54876412
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7211; MPG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPG (-) 2
AC   CVCL_SY80
SY   HZGHC001537c003; MPG knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY80
DR   Horizon_Discovery; HZGHC001537c003
DR   Wikidata; Q54876413
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7211; MPG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPI (-) 1
AC   CVCL_SY81
SY   HZGHC000124c001; MPI knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY81
DR   Horizon_Discovery; HZGHC000124c001
DR   Wikidata; Q54876414
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7216; MPI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000124c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MPI (-) 2
AC   CVCL_SY82
SY   HZGHC000124c024; MPI knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY82
DR   Horizon_Discovery; HZGHC000124c024
DR   Wikidata; Q54876415
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7216; MPI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000124c024; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MPND (-) 1
AC   CVCL_SY83
SY   HZGHC005017c002; MPND knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SY83
DR   Horizon_Discovery; HZGHC005017c002
DR   Wikidata; Q54876416
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25934; MPND.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPND (-) 2
AC   CVCL_SY84
SY   HZGHC005017c006; MPND knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SY84
DR   Horizon_Discovery; HZGHC005017c006
DR   Wikidata; Q54876417
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25934; MPND.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPND (-) 3
AC   CVCL_XQ60
SY   HZGHC000488c007; MPND knockout cell line
DR   cancercelllines; CVCL_XQ60
DR   Horizon_Discovery; HZGHC000488c007
DR   Wikidata; Q93954043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25934; MPND.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000488c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MPV17 (-) 1
AC   CVCL_SY85
SY   HZGHC006100c001; MPV17 knockout cell line 4bp deletion; HAP1 MPV17 (-)
DR   cancercelllines; CVCL_SY85
DR   Horizon_Discovery; HZGHC006100c001
DR   Wikidata; Q54876418
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7224; MPV17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MPV17 (-) 2
AC   CVCL_XQ61
SY   HZGHC006101c002; MPV17 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_XQ61
DR   Horizon_Discovery; HZGHC006101c002
DR   Wikidata; Q93954048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7224; MPV17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MPV17 (-) 3
AC   CVCL_XQ62
SY   HZGHC006101c009; MPV17 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XQ62
DR   Horizon_Discovery; HZGHC006101c009
DR   Wikidata; Q93954050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7224; MPV17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MRPS22 (-)
AC   CVCL_XQ63
SY   HZGHC006820c010; HZGHC56945; MRPS22 knockout cell line 2bp insertion in exon 1
DR   cancercelllines; CVCL_XQ63
DR   Horizon_Discovery; HZGHC006820c010
DR   Wikidata; Q93954052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14508; MRPS22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MS4A2 (-) 1
AC   CVCL_SY86
SY   HZGHC003907c002; MS4A2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SY86
DR   Horizon_Discovery; HZGHC003907c002
DR   Wikidata; Q54876419
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7316; MS4A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MS4A2 (-) 2
AC   CVCL_SY87
SY   HZGHC003907c010; MS4A2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SY87
DR   Horizon_Discovery; HZGHC003907c010
DR   Wikidata; Q54876420
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7316; MS4A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSANTD3-TMEFF1 (-) 1
AC   CVCL_SY88
SY   HZGHC005199c004; MSANTD3-TMEFF1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SY88
DR   Horizon_Discovery; HZGHC005199c004
DR   Wikidata; Q54876421
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:38838; MSANTD3-TMEFF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSANTD3-TMEFF1 (-) 2
AC   CVCL_SY89
SY   HZGHC005199c011; MSANTD3-TMEFF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY89
DR   Horizon_Discovery; HZGHC005199c011
DR   Wikidata; Q54876422
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:38838; MSANTD3-TMEFF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSANTD3-TMEFF1 (-) 3
AC   CVCL_SY90
SY   HZGHC005200c005; MSANTD3-TMEFF1 knockout cell line 202bp insertion
DR   cancercelllines; CVCL_SY90
DR   Horizon_Discovery; HZGHC005200c005
DR   Wikidata; Q54876423
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:38838; MSANTD3-TMEFF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005200c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MSANTD3-TMEFF1 (-) 4
AC   CVCL_SY91
SY   HZGHC005200c010; MSANTD3-TMEFF1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SY91
DR   Horizon_Discovery; HZGHC005200c010
DR   Wikidata; Q54876424
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:38838; MSANTD3-TMEFF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH2 (-) 1
AC   CVCL_SY92
SY   HZGHC024799c006; MSH2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY92
DR   Horizon_Discovery; HZGHC024799c006
DR   Wikidata; Q54876425
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH2 (-) 2
AC   CVCL_SY93
SY   HZGHC004302c006; MSH2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SY93
DR   Horizon_Discovery; HZGHC004302c006
DR   Wikidata; Q54876426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH2 (-) 3
AC   CVCL_SY94
SY   HZGHC004302c010; MSH2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY94
DR   Horizon_Discovery; HZGHC004302c010
DR   Wikidata; Q54876427
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH2 (-) 4
AC   CVCL_SY95
SY   HZGHC024799c015; MSH2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SY95
DR   Horizon_Discovery; HZGHC024799c015
DR   Wikidata; Q54876428
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH3 (-) 1
AC   CVCL_SY96
SY   HZGHC000656c001; MSH3 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_SY96
DR   Horizon_Discovery; HZGHC000656c001
DR   Wikidata; Q54876429
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH3 (-) 2
AC   CVCL_SY97
SY   HZGHC000656c005; MSH3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SY97
DR   Horizon_Discovery; HZGHC000656c005
DR   Wikidata; Q54876430
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH3 (-) 3
AC   CVCL_SY98
SY   HZGHC000656c010; MSH3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SY98
DR   Horizon_Discovery; HZGHC000656c010
DR   Wikidata; Q54876431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000656c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MSH5 (-) 1
AC   CVCL_SY99
SY   HZGHC001367c010; MSH5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SY99
DR   Horizon_Discovery; HZGHC001367c010
DR   Wikidata; Q54876432
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7328; MSH5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH5 (-) 2
AC   CVCL_SZ00
SY   HZGHC001367c011; MSH5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ00
DR   Horizon_Discovery; HZGHC001367c011
DR   Wikidata; Q54876433
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7328; MSH5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH6 (-) 1
AC   CVCL_SZ01
SY   HZGHC000653c003; MSH6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ01
DR   Horizon_Discovery; HZGHC000653c003
DR   Wikidata; Q54876434
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH6 (-) 2
AC   CVCL_SZ02
SY   HZGHC000653c005; MSH6 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SZ02
DR   Horizon_Discovery; HZGHC000653c005
DR   Wikidata; Q54876435
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSH6 (-) 3
AC   CVCL_SZ03
SY   HZGHC000653c007; MSH6 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SZ03
DR   Horizon_Discovery; HZGHC000653c007
DR   Wikidata; Q54876436
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSI1 (-) 1
AC   CVCL_SZ04
SY   HZGHC006209c002; MSI1 knockout cell line 1bp insertion; HAP1 MSI1 (-)
DR   cancercelllines; CVCL_SZ04
DR   Horizon_Discovery; HZGHC006209c002
DR   Wikidata; Q54876439
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7330; MSI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MSI1 (-) 2
AC   CVCL_XQ64
SY   HZGHC006209c003; MSI1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ64
DR   Horizon_Discovery; HZGHC006209c003
DR   Wikidata; Q93954156
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7330; MSI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSI2 (-) 1
AC   CVCL_SZ05
SY   HZGHC006122c011; MSI2 knockout cell line 65bp deletion; HAP1 MSI2 (-)
DR   cancercelllines; CVCL_SZ05
DR   Horizon_Discovery; HZGHC006122c011
DR   Wikidata; Q54876440
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18585; MSI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MSI2 (-) 2
AC   CVCL_XQ65
SY   HZGHC006122c002; MSI2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XQ65
DR   Horizon_Discovery; HZGHC006122c002
DR   Wikidata; Q93954164
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18585; MSI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSI2 (-) 3
AC   CVCL_XQ66
SY   HZGHC006122c003; MSI2 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XQ66
DR   Horizon_Discovery; HZGHC006122c003
DR   Wikidata; Q93954168
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18585; MSI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MSLN (-) 1
AC   CVCL_E2CQ
SY   HZGHC007830c008
DR   Horizon_Discovery; HZGHC007830c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7371; MSLN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MSLN (-) 2
AC   CVCL_E2CR
SY   HZGHC007830c010
DR   Horizon_Discovery; HZGHC007830c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7371; MSLN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MSN (-)
AC   CVCL_SZ06
SY   HZGHC006211c011; MSN knockout cell line 373bp insertion
DR   cancercelllines; CVCL_SZ06
DR   Horizon_Discovery; HZGHC006211c011
DR   Wikidata; Q54876441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7373; MSN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006211c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MSRB1 (-)
AC   CVCL_E2CS
SY   HZGHC007556c010
DR   Horizon_Discovery; HZGHC007556c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14133; MSRB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MST1 (-)
AC   CVCL_E2CT
SY   HZGHC007794c001
DR   Horizon_Discovery; HZGHC007794c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7380; MST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MST4 (-) 1
AC   CVCL_SZ07
SY   HZGHC000157c014; MST4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SZ07
DR   Horizon_Discovery; HZGHC000157c014
DR   Wikidata; Q54876442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18174; STK26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MST4 (-) 2
AC   CVCL_SZ08
SY   HZGHC000157c015; MST4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SZ08
DR   Horizon_Discovery; HZGHC000157c015
DR   Wikidata; Q54876443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18174; STK26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTAP (-) 1
AC   CVCL_SZ09
SY   HZGHC004894c005; MTAP knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SZ09
DR   Horizon_Discovery; HZGHC004894c005
DR   Wikidata; Q54876444
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTAP (-) 2
AC   CVCL_SZ10
SY   HZGHC004894c012; MTAP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ10
DR   Horizon_Discovery; HZGHC004894c012
DR   Wikidata; Q54876445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTCH1 (-) 1
AC   CVCL_SZ11
SY   HZGHC001651c011; MTCH1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ11
DR   Horizon_Discovery; HZGHC001651c011
DR   Wikidata; Q54876446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17586; MTCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001651c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTCH1 (-) 2
AC   CVCL_SZ12
SY   HZGHC001651c001; MTCH1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ12
DR   Horizon_Discovery; HZGHC001651c001
DR   Wikidata; Q54876447
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17586; MTCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTCH1 (-) 3
AC   CVCL_SZ13
SY   HZGHC001651c002; MTCH1 knockout cell line 113bp insertion
DR   cancercelllines; CVCL_SZ13
DR   Horizon_Discovery; HZGHC001651c002
DR   Wikidata; Q54876448
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17586; MTCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001651c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTCH2 (-)
AC   CVCL_E2CU
SY   HZGHC001428c011
DR   Horizon_Discovery; HZGHC001428c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17587; MTCH2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MTERF (-) 1
AC   CVCL_XQ67
SY   HZGHC007063c007; HZGHC7978; MTERF knockout cell line 13bp deletion in exon 3; HAP1 MTERF (-)
DR   cancercelllines; CVCL_XQ67
DR   Horizon_Discovery; HZGHC007063c007
DR   Wikidata; Q93954215
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21463; MTERF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MTERF (-) 2
AC   CVCL_E2CV
SY   HZGHC007063c010; MTERF knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007063c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21463; MTERF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MTERFD1 (-)
AC   CVCL_XQ68
SY   HZGHC007062c002; HZGHC51001; MTERFD1 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_XQ68
DR   Horizon_Discovery; HZGHC007062c002
DR   Wikidata; Q93954217
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24258; MTERF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTERFD3 (-) 1
AC   CVCL_XQ69
SY   HZGHC007060c003; HZGHC80298; MTERFD3 knockout cell line 1bp insertion in exon 3; HAP1 MTERFD3 (-)
DR   cancercelllines; CVCL_XQ69
DR   Horizon_Discovery; HZGHC007060c003
DR   Wikidata; Q93954219
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30779; MTERF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MTERFD3 (-) 2
AC   CVCL_E2CW
SY   HZGHC007060c001; MTERFD3 knockout cell line 1bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007060c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30779; MTERF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MTF2 (-) 1
AC   CVCL_SZ14
SY   HZGHC000984c010; MTF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ14
DR   Horizon_Discovery; HZGHC000984c010
DR   Wikidata; Q54876449
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29535; MTF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTF2 (-) 2
AC   CVCL_SZ15
SY   HZGHC000984c011; MTF2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ15
DR   Horizon_Discovery; HZGHC000984c011
DR   PRIDE; PXD010335
DR   Wikidata; Q54876450
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29535; MTF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTF2 (-) 3
AC   CVCL_SZ16
SY   HZGHC003599c002; MTF2 knockout cell line 1bp insertion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC003599c002
DR   PRIDE; PXD010335
DR   Wikidata; Q54876451
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29535; MTF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 MTF2 (-) 4
AC   CVCL_SZ17
SY   HZGHC003599c009; MTF2 knockout cell line 104bp insertion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC003599c009
DR   PRIDE; PXD010335
DR   Wikidata; Q54876452
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29535; MTF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Horizon_Discovery; HZGHC003599c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 MTF2 (-) 5
AC   CVCL_SZ18
SY   HZGHC003599c011; MTF2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SZ18
DR   Horizon_Discovery; HZGHC003599c011
DR   Wikidata; Q54876453
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29535; MTF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003599c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTFR1L (-) 1
AC   CVCL_SZ19
SY   HZGHC005776c001; MTFR1L knockout cell line 1bp insertion; HAP1 MTFR1L (-)
DR   cancercelllines; CVCL_SZ19
DR   Horizon_Discovery; HZGHC005776c001
DR   Wikidata; Q54876454
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28836; MTFR1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTFR1L (-) 2
AC   CVCL_XQ71
SY   HZGHC005776c002; MTFR1L knockout cell line 466bp insertion
DR   cancercelllines; CVCL_XQ71
DR   Horizon_Discovery; HZGHC005776c002
DR   Wikidata; Q93954246
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28836; MTFR1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005776c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTFR1L (-) 3
AC   CVCL_XQ72
SY   HZGHC005777c001; MTFR1L knockout cell line 65bp insertion
DR   cancercelllines; CVCL_XQ72
DR   Horizon_Discovery; HZGHC005777c001
DR   Wikidata; Q93954247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28836; MTFR1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005777c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTFR1L (-) 4
AC   CVCL_XQ73
SY   HZGHC005777c005; MTFR1L knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XQ73
DR   Horizon_Discovery; HZGHC005777c005
DR   Wikidata; Q93954249
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28836; MTFR1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTHFD1L (-) 1
AC   CVCL_SZ20
SY   HZGHC006500c011; MTHFD1L knockout cell line 4bp deletion; HAP1 MTHFD1L (-)
DR   cancercelllines; CVCL_SZ20
DR   Horizon_Discovery; HZGHC006500c011
DR   Wikidata; Q54876455
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21055; MTHFD1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTHFD1L (-) 2
AC   CVCL_XQ74
SY   HZGHC006500c012; MTHFD1L knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XQ74
DR   Horizon_Discovery; HZGHC006500c012
DR   Wikidata; Q93954255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21055; MTHFD1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTHFD2 (-) 1
AC   CVCL_SZ21
SY   HZGHC004667c010; MTHFD2 knockout cell line 1bp insertion; HAP1 MTHFD2 (-)
DR   cancercelllines; CVCL_SZ21
DR   Horizon_Discovery; HZGHC004667c010
DR   Wikidata; Q54876456
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7434; MTHFD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTHFD2 (-) 2
AC   CVCL_XQ75
SY   HZGHC004667c002; MTHFD2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ75
DR   Horizon_Discovery; HZGHC004667c002
DR   Wikidata; Q93954262
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7434; MTHFD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004667c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTHFD2 (-) 3
AC   CVCL_XQ76
SY   HZGHC004667c004; MTHFD2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XQ76
DR   Horizon_Discovery; HZGHC004667c004
DR   Wikidata; Q93954264
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7434; MTHFD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTM1 (-) 1
AC   CVCL_SZ22
SY   HZGHC002896c003; MTM1 knockout cell line 89bp deletion
DR   cancercelllines; CVCL_SZ22
DR   Horizon_Discovery; HZGHC002896c003
DR   Wikidata; Q54876457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7448; MTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002896c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MTM1 (-) 2
AC   CVCL_SZ23
SY   HZGHC002896c008; MTM1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SZ23
DR   Horizon_Discovery; HZGHC002896c008
DR   Wikidata; Q54876458
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7448; MTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR1 (-)
AC   CVCL_SZ24
SY   HZGHC002897c007; MTMR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ24
DR   Horizon_Discovery; HZGHC002897c007
DR   Wikidata; Q54876459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7449; MTMR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR14 (-) 1
AC   CVCL_SZ25
SY   HZGHC002913c010; MTMR14 knockout cell line 173bp deletion
DR   cancercelllines; CVCL_SZ25
DR   Horizon_Discovery; HZGHC002913c010
DR   Wikidata; Q54876460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26190; MTMR14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR14 (-) 2
AC   CVCL_SZ26
SY   HZGHC002913c012; MTMR14 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SZ26
DR   Horizon_Discovery; HZGHC002913c012
DR   Wikidata; Q54876461
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26190; MTMR14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR2 (-) 1
AC   CVCL_SZ27
SY   HZGHC003737c002; MTMR2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SZ27
DR   Horizon_Discovery; HZGHC003737c002
DR   Wikidata; Q54876462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7450; MTMR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR2 (-) 2
AC   CVCL_SZ28
SY   HZGHC003737c012; MTMR2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SZ28
DR   Horizon_Discovery; HZGHC003737c012
DR   Wikidata; Q54876463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7450; MTMR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR3 (-)
AC   CVCL_SZ29
SY   HZGHC002895c010; MTMR3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ29
DR   Horizon_Discovery; HZGHC002895c010
DR   Wikidata; Q54876464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7451; MTMR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR4 (-) 1
AC   CVCL_SZ30
SY   HZGHC002907c002; MTMR4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SZ30
DR   Horizon_Discovery; HZGHC002907c002
DR   Wikidata; Q54876465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7452; MTMR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR4 (-) 2
AC   CVCL_SZ31
SY   HZGHC002907c006; MTMR4 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_SZ31
DR   Horizon_Discovery; HZGHC002907c006
DR   Wikidata; Q54876466
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7452; MTMR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR6 (-)
AC   CVCL_SZ32
SY   HZGHC002904c004; MTMR6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ32
DR   Horizon_Discovery; HZGHC002904c004
DR   Wikidata; Q54876467
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7453; MTMR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR7 (-) 1
AC   CVCL_SZ33
SY   HZGHC002906c004; MTMR7 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_SZ33
DR   Horizon_Discovery; HZGHC002906c004
DR   Wikidata; Q54876468
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7454; MTMR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTMR7 (-) 2
AC   CVCL_SZ34
SY   HZGHC002906c010; MTMR7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ34
DR   Horizon_Discovery; HZGHC002906c010
DR   Wikidata; Q54876469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7454; MTMR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTO1 (-) 1
AC   CVCL_XQ77
SY   HZGHC006861c011; HZGHC25821; MTO1 knockout cell line 1bp insertion in exon 1; HAP1 MTO1 (-)
DR   cancercelllines; CVCL_XQ77
DR   Horizon_Discovery; HZGHC006861c011
DR   Wikidata; Q93954338
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19261; MTO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MTO1 (-) 2
AC   CVCL_E2CX
SY   HZGHC006860c011
DR   Horizon_Discovery; HZGHC006860c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19261; MTO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MTR (-) 1
AC   CVCL_SZ35
SY   HZGHC003808c002; MTR knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SZ35
DR   Horizon_Discovery; HZGHC003808c002
DR   Wikidata; Q54876470
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7468; MTR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MTR (-) 2
AC   CVCL_SZ36
SY   HZGHC003808c003; MTR knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ36
DR   Horizon_Discovery; HZGHC003808c003
DR   Wikidata; Q54876471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7468; MTR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUM1 (-)
AC   CVCL_XQ78
SY   HZGHC007143c012; HZGHC84939; MUM1 knockout cell line 1bp insertion in exon 5
DR   cancercelllines; CVCL_XQ78
DR   Horizon_Discovery; HZGHC007143c012
DR   Wikidata; Q93954354
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29641; PWWP3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MUS81 (-) 1
AC   CVCL_SZ37
SY   HZGHC002646c008; MUS81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ37
DR   Horizon_Discovery; HZGHC002646c008
DR   Wikidata; Q54876472
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002646c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MUS81 (-) 2
AC   CVCL_SZ38
SY   HZGHC000901c002; MUS81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ38
DR   Horizon_Discovery; HZGHC000901c002
DR   Wikidata; Q54876473
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUS81 (-) 3
AC   CVCL_SZ39
SY   HZGHC000901c010; MUS81 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SZ39
DR   Horizon_Discovery; HZGHC000901c010
DR   Wikidata; Q54876474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUS81 (-) 4
AC   CVCL_SZ40
SY   HZGHC000901c012; MUS81 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SZ40
DR   Horizon_Discovery; HZGHC000901c012
DR   Wikidata; Q54876475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUS81 (-) 5
AC   CVCL_SZ41
SY   HZGHC002646c006; MUS81 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ41
DR   Horizon_Discovery; HZGHC002646c006
DR   Wikidata; Q54876476
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUS81 (-) 6
AC   CVCL_SZ42
SY   HZGHC002960c005; MUS81 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SZ42
DR   Horizon_Discovery; HZGHC002960c005
DR   Wikidata; Q54876477
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUS81 (-) 7
AC   CVCL_SZ43
SY   HZGHC002960c011; MUS81 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ43
DR   Horizon_Discovery; HZGHC002960c011
DR   Wikidata; Q54876478
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUS81 (-) 8
AC   CVCL_SZ44
SY   HZGHC002961c002; MUS81 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ44
DR   Horizon_Discovery; HZGHC002961c002
DR   Wikidata; Q54876480
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUS81 (-) 9
AC   CVCL_SZ45
SY   HZGHC002961c011; MUS81 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SZ45
DR   Horizon_Discovery; HZGHC002961c011
DR   Wikidata; Q54876481
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUSK (-) 1
AC   CVCL_E2CY
SY   HZGHC007629c007
DR   Horizon_Discovery; HZGHC007629c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7525; MUSK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MUSK (-) 2
AC   CVCL_E2CZ
SY   HZGHC007629c011
DR   Horizon_Discovery; HZGHC007629c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7525; MUSK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 MUT (-) 1
AC   CVCL_SZ46
SY   HZGHC003790c004; MUT knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SZ46
DR   Horizon_Discovery; HZGHC003790c004
DR   Wikidata; Q54876482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7526; MMUT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MUT (-) 2
AC   CVCL_SZ47
SY   HZGHC003790c005; MUT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ47
DR   Horizon_Discovery; HZGHC003790c005
DR   Wikidata; Q54876483
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7526; MMUT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MUTYH (-) 1
AC   CVCL_SZ48
SY   HZGHC000788c007; MUTYH knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SZ48
DR   Horizon_Discovery; HZGHC000788c007
DR   Wikidata; Q54876484
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7527; MUTYH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MUTYH (-) 2
AC   CVCL_SZ49
SY   HZGHC000788c008; MUTYH knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SZ49
DR   Horizon_Discovery; HZGHC000788c008
DR   Wikidata; Q54876485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7527; MUTYH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MVP (-) 1
AC   CVCL_SZ50
SY   HZGHC003713c002; MVP knockout cell line 14bp deletion
DR   cancercelllines; CVCL_SZ50
DR   Horizon_Discovery; HZGHC003713c002
DR   Wikidata; Q54876486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7531; MVP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MVP (-) 2
AC   CVCL_SZ51
SY   HZGHC003713c007; MVP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ51
DR   Horizon_Discovery; HZGHC003713c007
DR   Wikidata; Q54876487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7531; MVP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MX2 (-) 1
AC   CVCL_SZ52
SY   HZGHC005608c001; MX2 knockout cell line 2bp insertion; HAP1 MX2 (-)
DR   cancercelllines; CVCL_SZ52
DR   Horizon_Discovery; HZGHC005608c001
DR   Wikidata; Q54876488
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7533; MX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MX2 (-) 2
AC   CVCL_XQ79
SY   HZGHC005608c003; MX2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XQ79
DR   Horizon_Discovery; HZGHC005608c003
DR   Wikidata; Q93954467
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7533; MX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYB (-) 1
AC   CVCL_SZ53
SY   HZGHC006213c001; MYB knockout cell line 169bp insertion; HAP1 MYB (-)
DR   cancercelllines; CVCL_SZ53
DR   Horizon_Discovery; HZGHC006213c001
DR   Wikidata; Q54876489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006213c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MYB (-) 2
AC   CVCL_XQ80
SY   HZGHC006213c012; MYB knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XQ80
DR   Horizon_Discovery; HZGHC006213c012
DR   Wikidata; Q93954480
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYD88 (-) 1
AC   CVCL_SZ54
SY   HZGHC002929c003; MYD88 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ54
DR   Horizon_Discovery; HZGHC002929c003
DR   Wikidata; Q54876490
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYD88 (-) 2
AC   CVCL_SZ55
SY   HZGHC002929c011; MYD88 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_SZ55
DR   Horizon_Discovery; HZGHC002929c011
DR   Wikidata; Q54876491
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYEOV2 (-) 1
AC   CVCL_SZ56
SY   HZGHC002637c010; MYEOV2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SZ56
DR   Horizon_Discovery; HZGHC002637c010
DR   Wikidata; Q54876492
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21314; COPS9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYEOV2 (-) 2
AC   CVCL_SZ57
SY   HZGHC002637c012; MYEOV2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SZ57
DR   Horizon_Discovery; HZGHC002637c012
DR   Wikidata; Q54876493
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21314; COPS9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYH9 (-) 1
AC   CVCL_SZ58
SY   HZGHC001088c009; MYH9 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_SZ58
DR   Horizon_Discovery; HZGHC001088c009
DR   Wikidata; Q54876494
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7579; MYH9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYH9 (-) 2
AC   CVCL_SZ59
SY   HZGHC001088c012; MYH9 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SZ59
DR   Horizon_Discovery; HZGHC001088c012
DR   Wikidata; Q54876495
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7579; MYH9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYLK (-) 1
AC   CVCL_SZ60
SY   HZGHC007194c010; MYLK knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SZ60
DR   Horizon_Discovery; HZGHC007194c010
DR   Wikidata; Q54876496
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7590; MYLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYLK (-) 2
AC   CVCL_SZ61
SY   HZGHC007194c022; MYLK knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ61
DR   Horizon_Discovery; HZGHC007194c022
DR   Wikidata; Q54876497
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7590; MYLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007194c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MYLK3 (-) 1
AC   CVCL_SZ62
SY   HZGHC000051c002; MYLK3 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_SZ62
DR   Horizon_Discovery; HZGHC000051c002
DR   Wikidata; Q54876498
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29826; MYLK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYLK3 (-) 2
AC   CVCL_SZ63
SY   HZGHC000051c007; MYLK3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SZ63
DR   Horizon_Discovery; HZGHC000051c007
DR   Wikidata; Q54876500
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29826; MYLK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYLK3 (-) 3
AC   CVCL_SZ64
SY   HZGHC000051c012; MYLK3 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_SZ64
DR   Horizon_Discovery; HZGHC000051c012
DR   Wikidata; Q54876501
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29826; MYLK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYLK3 (-) 4
AC   CVCL_SZ65
SY   HZGHC000051c015; MYLK3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ65
DR   Horizon_Discovery; HZGHC000051c015
DR   Wikidata; Q54876502
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29826; MYLK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYO18A (-) 1
AC   CVCL_XQ81
SY   HZGHC006929c003; HZGHC399687; MYO18A knockout cell line 148bp insertion in exon 2; HAP1 MYO18A (-)
DR   cancercelllines; CVCL_XQ81
DR   Horizon_Discovery; HZGHC006929c003
DR   Wikidata; Q93954566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31104; MYO18A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006929c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 MYO18A (-) 2
AC   CVCL_B5KC
SY   HZGHC006929c009; MYO18A knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_B5KC
DR   Horizon_Discovery; HZGHC006929c009
DR   Wikidata; Q111733299
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31104; MYO18A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 MYO18A (-) 3
AC   CVCL_B5KD
SY   HZGHC006929c012; MYO18A knockout cell line 10bp deletion in exon 2
DR   cancercelllines; CVCL_B5KD
DR   Horizon_Discovery; HZGHC006929c012
DR   Wikidata; Q111733300
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31104; MYO18A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 MYO1E (-)
AC   CVCL_C7Y0
SY   HZGHC007765c003; MYO1E knockout cell line 1bp insertion in exon 9
DR   Horizon_Discovery; HZGHC007765c003
DR   Wikidata; Q123031426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7599; MYO1E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 MYO5B (-) 1
AC   CVCL_SZ66
SY   HZGHC006413c011; MYO5B knockout cell line 1bp insertion; HAP1 MYO5B (-)
DR   cancercelllines; CVCL_SZ66
DR   Horizon_Discovery; HZGHC006413c011
DR   Wikidata; Q54876504
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7603; MYO5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MYO5B (-) 2
AC   CVCL_XQ82
SY   HZGHC006413c006; MYO5B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XQ82
DR   Horizon_Discovery; HZGHC006413c006
DR   Wikidata; Q93954575
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7603; MYO5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYSM1 (-) 1
AC   CVCL_SZ67
SY   HZGHC000504c005; MYSM1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SZ67
DR   Horizon_Discovery; HZGHC000504c005
DR   Wikidata; Q54876505
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29401; MYSM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYSM1 (-) 2
AC   CVCL_SZ68
SY   HZGHC000504c008; MYSM1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ68
DR   Horizon_Discovery; HZGHC000504c008
DR   Wikidata; Q54876506
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29401; MYSM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000504c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 MYT1 (-) 1
AC   CVCL_SZ69
SY   HZGHC000370c010; MYT1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ69
DR   Horizon_Discovery; HZGHC000370c010
DR   Wikidata; Q54876507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7622; MYT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYT1 (-) 2
AC   CVCL_SZ70
SY   HZGHC000370c015; MYT1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ70
DR   Horizon_Discovery; HZGHC000370c015
DR   Wikidata; Q54876508
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7622; MYT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 MYT1 (-) 3
AC   CVCL_SZ71
SY   HZGHC000370c021; MYT1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_SZ71
DR   Horizon_Discovery; HZGHC000370c021
DR   Wikidata; Q54876509
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7622; MYT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 N4BP2 (-) 1
AC   CVCL_E2D0
SY   HZGHC007512c001
DR   Horizon_Discovery; HZGHC007512c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29851; N4BP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 N4BP2 (-) 2
AC   CVCL_E2D1
SY   HZGHC007512c012
DR   Horizon_Discovery; HZGHC007512c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29851; N4BP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 N6AMT2 (-)
AC   CVCL_SZ72
SY   HZGHC004249c001; N6AMT2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ72
DR   Horizon_Discovery; HZGHC004249c001
DR   Wikidata; Q54876510
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27351; EEF1AKMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA16 (-)
AC   CVCL_SZ73
SY   HZGHC006071c003; NAA16 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ73
DR   Horizon_Discovery; HZGHC006071c003
DR   Wikidata; Q54876511
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26164; NAA16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA30 (-) 1
AC   CVCL_SZ74
SY   HZGHC006637c010; NAA30 knockout cell line 1bp insertion; HAP1 NAA30 (-)
DR   cancercelllines; CVCL_SZ74
DR   Horizon_Discovery; HZGHC006637c010
DR   Wikidata; Q54876512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19844; NAA30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NAA30 (-) 2
AC   CVCL_XQ83
SY   HZGHC006638c003; NAA30 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XQ83
DR   Horizon_Discovery; HZGHC006638c003
DR   Wikidata; Q93954630
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19844; NAA30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA35 (-)
AC   CVCL_SZ75
SY   HZGHC006636c011; NAA35 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_SZ75
DR   Horizon_Discovery; HZGHC006636c011
DR   Wikidata; Q54876513
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24340; NAA35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA40 (-) 1
AC   CVCL_SZ76
SY   HZGHC003224c001; NAA40 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ76
DR   Horizon_Discovery; HZGHC003224c001
DR   Wikidata; Q54876514
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25845; NAA40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA40 (-) 2
AC   CVCL_SZ77
SY   HZGHC003224c012; NAA40 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ77
DR   Horizon_Discovery; HZGHC003224c012
DR   Wikidata; Q54876515
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25845; NAA40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA40 (-) 3
AC   CVCL_SZ78
SY   HZGHC003228c011; NAA40 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SZ78
DR   Horizon_Discovery; HZGHC003228c011
DR   Wikidata; Q54876516
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25845; NAA40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA40 (-) 4
AC   CVCL_SZ79
SY   HZGHC003228c012; NAA40 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_SZ79
DR   Horizon_Discovery; HZGHC003228c012
DR   Wikidata; Q54876517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25845; NAA40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA40 (-) 5
AC   CVCL_SZ80
SY   HZGHC003497c007; NAA40 knockout cell line 187bp insertion
DR   cancercelllines; CVCL_SZ80
DR   Horizon_Discovery; HZGHC003497c007
DR   Wikidata; Q54876518
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25845; NAA40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003497c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NAA40 (-) 6
AC   CVCL_SZ81
SY   HZGHC003497c012; NAA40 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SZ81
DR   Horizon_Discovery; HZGHC003497c012
DR   Wikidata; Q54876519
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25845; NAA40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA60 (-) 1
AC   CVCL_SZ82
SY   HZGHC003172c003; NAA60 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ82
DR   Horizon_Discovery; HZGHC003172c003
DR   Wikidata; Q54876520
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25875; NAA60.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAA60 (-) 2
AC   CVCL_SZ83
SY   HZGHC003172c010; NAA60 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_SZ83
DR   Horizon_Discovery; HZGHC003172c010
DR   Wikidata; Q54876521
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25875; NAA60.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NADK (-)
AC   CVCL_XQ84
SY   HZGHC007196c001; HZGHC65220; NADK knockout cell line 1bp deletion in exon 4
DR   cancercelllines; CVCL_XQ84
DR   Horizon_Discovery; HZGHC007196c001
DR   Wikidata; Q93954692
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29831; NADK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NADK2 (-) 1
AC   CVCL_XQ85
SY   HZGHC006916c001; HZGHC133686; NADK2 knockout cell line 10bp deletion in exon 5; HAP1 NADK2 (-)
DR   cancercelllines; CVCL_XQ85
DR   Horizon_Discovery; HZGHC006916c001
DR   Wikidata; Q93954696
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26404; NADK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NADK2 (-) 2
AC   CVCL_E2D2
SY   HZGHC006916c010
DR   Horizon_Discovery; HZGHC006916c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26404; NADK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NADK2 (-) 3
AC   CVCL_E2D3
SY   HZGHC006916c012
DR   Horizon_Discovery; HZGHC006916c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26404; NADK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NAGK (-) 1
AC   CVCL_SZ84
SY   HZGHC005266c003; NAGK knockout cell line 4bp deletion in exon 3; HAP1 NAGK (-)
DR   cancercelllines; CVCL_SZ84
DR   Horizon_Discovery; HZGHC005266c003
DR   Wikidata; Q54876523
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17174; NAGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NAGK (-) 2
AC   CVCL_XQ86
SY   HZGHC005266c004; NAGK knockout cell line 29bp deletion in exon 3
DR   cancercelllines; CVCL_XQ86
DR   Horizon_Discovery; HZGHC005266c004
DR   Wikidata; Q93954705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17174; NAGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NAGLU (-) 1
AC   CVCL_E2D4
SY   HZGHC007488c004
DR   Horizon_Discovery; HZGHC007488c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7632; NAGLU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NAGLU (-) 2
AC   CVCL_E2D5
SY   HZGHC007488c007
DR   Horizon_Discovery; HZGHC007488c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7632; NAGLU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NAIF1 (-) 1
AC   CVCL_SZ85
SY   HZGHC005026c012; NAIF1 knockout cell line 137bp insertion
DR   cancercelllines; CVCL_SZ85
DR   Horizon_Discovery; HZGHC005026c012
DR   Wikidata; Q54876524
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25446; NAIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005026c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NAIF1 (-) 2
AC   CVCL_SZ86
SY   HZGHC005027c003; NAIF1 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_SZ86
DR   Horizon_Discovery; HZGHC005027c003
DR   Wikidata; Q54876525
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25446; NAIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAIF1 (-) 3
AC   CVCL_SZ87
SY   HZGHC005027c012; NAIF1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_SZ87
DR   Horizon_Discovery; HZGHC005027c012
DR   Wikidata; Q54876526
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25446; NAIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NANP (-) 1
AC   CVCL_SZ88
SY   HZGHC036488c012; NANP knockout cell line 16bp deletion
DR   cancercelllines; CVCL_SZ88
DR   Horizon_Discovery; HZGHC036488c012
DR   Wikidata; Q54876527
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16140; NANP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NANP (-) 2
AC   CVCL_SZ89
SY   HZGHC036488c018; NANP knockout cell line 26bp deletion
DR   cancercelllines; CVCL_SZ89
DR   Horizon_Discovery; HZGHC036488c018
DR   Wikidata; Q54876528
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16140; NANP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NANP (-) 3
AC   CVCL_SZ90
SY   HZGHC036488c024; NANP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ90
DR   Horizon_Discovery; HZGHC036488c024
DR   Wikidata; Q54876529
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16140; NANP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NANS (-) 1
AC   CVCL_SZ91
SY   HZGHC010617c015; NANS knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SZ91
DR   Horizon_Discovery; HZGHC010617c015
DR   Wikidata; Q54876530
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19237; NANS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NANS (-) 2
AC   CVCL_SZ92
SY   HZGHC010617c017; NANS knockout cell line 4bp deletion
DR   cancercelllines; CVCL_SZ92
DR   Horizon_Discovery; HZGHC010617c017
DR   Wikidata; Q54876531
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19237; NANS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAT14 (-) 1
AC   CVCL_SZ93
SY   HZGHC004004c006; NAT14 knockout cell line 134bp deletion
DR   cancercelllines; CVCL_SZ93
DR   Horizon_Discovery; HZGHC004004c006
DR   Wikidata; Q54876532
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28918; NAT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAT14 (-) 2
AC   CVCL_SZ94
SY   HZGHC004003c011; NAT14 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ94
DR   Horizon_Discovery; HZGHC004003c011
DR   Wikidata; Q54876533
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28918; NAT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004003c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NAT14 (-) 3
AC   CVCL_SZ95
SY   HZGHC004003c010; NAT14 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ95
DR   Horizon_Discovery; HZGHC004003c010
DR   Wikidata; Q54876534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28918; NAT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAT14 (-) 4
AC   CVCL_SZ96
SY   HZGHC004003c007; NAT14 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_SZ96
DR   Horizon_Discovery; HZGHC004003c007
DR   Wikidata; Q54876535
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28918; NAT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAT16 (-)
AC   CVCL_E2D6
SY   HZGHC007792c003
DR   Horizon_Discovery; HZGHC007792c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22030; NAT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NAT6 (-) 1
AC   CVCL_SZ97
SY   HZGHC003171c003; NAT6 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_SZ97
DR   Horizon_Discovery; HZGHC003171c003
DR   Wikidata; Q54876536
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30252; NAA80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NAT6 (-) 2
AC   CVCL_SZ98
SY   HZGHC003171c012; NAT6 knockout cell line 404bp insertion
DR   cancercelllines; CVCL_SZ98
DR   Horizon_Discovery; HZGHC003171c012
DR   Wikidata; Q54876538
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30252; NAA80.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003171c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NAT9 (-) 1
AC   CVCL_SZ99
SY   HZGHC004002c008; NAT9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SZ99
DR   Horizon_Discovery; HZGHC004002c008
DR   Wikidata; Q54876539
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23133; NAT9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NAT9 (-) 2
AC   CVCL_TA00
SY   HZGHC004002c010; NAT9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA00
DR   Horizon_Discovery; HZGHC004002c010
DR   Wikidata; Q54876540
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23133; NAT9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NATD1 (-) 1
AC   CVCL_SG08
SY   HZGHC004005c005; HAP1 C17orf103 (-) 1; NATD1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_SG08
DR   Horizon_Discovery; HZGHC004005c005
DR   Wikidata; Q54873071
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30770; NATD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NATD1 (-) 2
AC   CVCL_SG09
SY   HZGHC004005c010; HAP1 C17orf103 (-) 2; NATD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SG09
DR   Horizon_Discovery; HZGHC004005c010
DR   Wikidata; Q54873073
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30770; NATD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NBEA (-) 1
AC   CVCL_TA01
SY   HZGHC004421c002; NBEA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA01
DR   Horizon_Discovery; HZGHC004421c002
DR   Wikidata; Q54876541
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7648; NBEA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NBEA (-) 2
AC   CVCL_TA02
SY   HZGHC004421c006; NBEA knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TA02
DR   Horizon_Discovery; HZGHC004421c006
DR   Wikidata; Q54876542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7648; NBEA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NBEAL1 (-)
AC   CVCL_TA03
SY   HZGHC000720c011; NBEAL1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA03
DR   Horizon_Discovery; HZGHC000720c011
DR   Wikidata; Q54876543
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20681; NBEAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NBEAL2 (-) 1
AC   CVCL_TA04
SY   HZGHC000717c001; NBEAL2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TA04
DR   Horizon_Discovery; HZGHC000717c001
DR   Wikidata; Q54876544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31928; NBEAL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NBEAL2 (-) 2
AC   CVCL_TA05
SY   HZGHC000717c004; NBEAL2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TA05
DR   Horizon_Discovery; HZGHC000717c004
DR   Wikidata; Q54876545
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31928; NBEAL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000717c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NCKAP1 (-) 1
AC   CVCL_TA06
SY   HZGHC003401c001; NCKAP1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TA06
DR   Horizon_Discovery; HZGHC003401c001
DR   Wikidata; Q54876546
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7666; NCKAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003401c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NCKAP1 (-) 2
AC   CVCL_TA07
SY   HZGHC003401c004; NCKAP1 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TA07
DR   Horizon_Discovery; HZGHC003401c004
DR   Wikidata; Q54876547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7666; NCKAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003401c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NCKIPSD (-) 1
AC   CVCL_TA08
SY   HZGHC003331c002; NCKIPSD knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TA08
DR   Horizon_Discovery; HZGHC003331c002
DR   Wikidata; Q54876548
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15486; NCKIPSD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NCKIPSD (-) 2
AC   CVCL_TA09
SY   HZGHC003331c004; NCKIPSD knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TA09
DR   Horizon_Discovery; HZGHC003331c004
DR   Wikidata; Q54876549
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15486; NCKIPSD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NCOA4 (-) 2
AC   CVCL_TA10
SY   HZGHC003617c010; NCOA4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA10
DR   Horizon_Discovery; HZGHC003617c010
DR   Wikidata; Q54876550
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7671; NCOA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NCOA4 (-) 3
AC   CVCL_TA11
SY   HZGHC003617c011; NCOA4 knockout cell line 53bp insertion
DR   cancercelllines; CVCL_TA11
DR   Horizon_Discovery; HZGHC003617c011
DR   Wikidata; Q54876551
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7671; NCOA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003617c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NDUFA2 (-) 1
AC   CVCL_TA12
SY   HZGHC004228c001; NDUFA2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TA12
DR   Horizon_Discovery; HZGHC004228c001
DR   Wikidata; Q54876552
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7685; NDUFA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFA2 (-) 2
AC   CVCL_TA13
SY   HZGHC004228c008; NDUFA2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TA13
DR   Horizon_Discovery; HZGHC004228c008
DR   Wikidata; Q54876553
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7685; NDUFA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFA9 (-) 1
AC   CVCL_TA14
SY   HZGHC002487c004; NDUFA9 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TA14
DR   Horizon_Discovery; HZGHC002487c004
DR   Wikidata; Q54876554
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7693; NDUFA9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFA9 (-) 2
AC   CVCL_TA15
SY   HZGHC002487c006; NDUFA9 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TA15
DR   Horizon_Discovery; HZGHC002487c006
DR   Wikidata; Q54876555
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7693; NDUFA9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFAF2 (-) 1
AC   CVCL_E2D7
SY   HZGHC007711c005
DR   Horizon_Discovery; HZGHC007711c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28086; NDUFAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NDUFAF2 (-) 2
AC   CVCL_E2D8
SY   HZGHC007712c012
DR   Horizon_Discovery; HZGHC007712c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28086; NDUFAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NDUFAF4 (-)
AC   CVCL_E2D9
SY   HZGHC007700c006
DR   Horizon_Discovery; HZGHC007700c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21034; NDUFAF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NDUFAF5 (-)
AC   CVCL_E2DA
SY   HZGHC007697c010
DR   Horizon_Discovery; HZGHC007697c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15899; NDUFAF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NDUFAF6 (-)
AC   CVCL_XQ87
SY   HZGHC007089c018; HZGHC137682; NDUFAF6 knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_XQ87
DR   Horizon_Discovery; HZGHC007089c018
DR   Wikidata; Q93954866
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28625; NDUFAF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NDUFAF7 (-) 1
AC   CVCL_E2DB
SY   HZGHC007706c005
DR   Horizon_Discovery; HZGHC007706c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28816; NDUFAF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NDUFAF7 (-) 2
AC   CVCL_E2DC
SY   HZGHC007706c006
DR   Horizon_Discovery; HZGHC007706c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28816; NDUFAF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NDUFB10 (-)
AC   CVCL_TA16
SY   HZGHC004569c012; NDUFB10 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA16
DR   Horizon_Discovery; HZGHC004569c012
DR   Wikidata; Q54876556
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7696; NDUFB10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004569c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NDUFB8 (-) 1
AC   CVCL_TA17
SY   HZGHC005993c003; NDUFB8 knockout cell line 1bp deletion; HAP1 NDUFB8 (-)
DR   cancercelllines; CVCL_TA17
DR   Horizon_Discovery; HZGHC005993c003
DR   Wikidata; Q54876557
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7703; NDUFB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NDUFB8 (-) 2
AC   CVCL_XQ88
SY   HZGHC005994c006; NDUFB8 knockout cell line 37bp deletion
DR   cancercelllines; CVCL_XQ88
DR   Horizon_Discovery; HZGHC005994c006
DR   Wikidata; Q93954880
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7703; NDUFB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFS2 (-) 1
AC   CVCL_TA18
SY   HZGHC003745c003; NDUFS2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TA18
DR   Horizon_Discovery; HZGHC003745c003
DR   Wikidata; Q54876558
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7708; NDUFS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFS2 (-) 2
AC   CVCL_TA19
SY   HZGHC003745c010; NDUFS2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TA19
DR   Horizon_Discovery; HZGHC003745c010
DR   Wikidata; Q54876559
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7708; NDUFS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFS3 (-) 1
AC   CVCL_XQ89
SY   HZGHC006832c005; HZGHC4722; NDUFS3 knockout cell line 10bp deletion in exon 3; HAP1 NDUFS3 (-)
DR   cancercelllines; CVCL_XQ89
DR   Horizon_Discovery; HZGHC006832c005
DR   Wikidata; Q93954891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006832c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NDUFS3 (-) 2
AC   CVCL_B5KF
SY   HZGHC006832c010; NDUFS3 knockout cell line 271bp insertion in exon 3
DR   cancercelllines; CVCL_B5KF
DR   Horizon_Discovery; HZGHC006832c010
DR   Wikidata; Q111733301
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006832c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 NDUFS3 (-) 3
AC   CVCL_B5KG
SY   HZGHC006832c012; NDUFS3 knockout cell line 10bp deletion in exon 3
DR   cancercelllines; CVCL_B5KG
DR   Horizon_Discovery; HZGHC006832c012
DR   Wikidata; Q111733302
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 NDUFS3 (-) 4
AC   CVCL_B5KH
SY   HZGHC006833c003; NDUFS3 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5KH
DR   Horizon_Discovery; HZGHC006833c003
DR   Wikidata; Q111733303
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 NDUFS4 (-) 1
AC   CVCL_TA20
SY   HZGHC002835c001; NDUFS4 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TA20
DR   Horizon_Discovery; HZGHC002835c001
DR   Wikidata; Q54876560
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7711; NDUFS4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NDUFS4 (-) 2
AC   CVCL_TA21
SY   HZGHC002835c009; NDUFS4 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TA21
DR   Horizon_Discovery; HZGHC002835c009
DR   Wikidata; Q54876561
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7711; NDUFS4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEDD4 (-) 1
AC   CVCL_TA22
SY   HZGHC004416c002; NEDD4 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TA22
DR   Horizon_Discovery; HZGHC004416c002
DR   Wikidata; Q54876562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7727; NEDD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEDD4 (-) 2
AC   CVCL_TA23
SY   HZGHC004416c007; NEDD4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TA23
DR   Horizon_Discovery; HZGHC004416c007
DR   Wikidata; Q54876563
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7727; NEDD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEDD4L (-) 1
AC   CVCL_TA24
SY   HZGHC006157c010; NEDD4L knockout cell line 62bp deletion; HAP1 NEDD4L (-)
DR   cancercelllines; CVCL_TA24
DR   Horizon_Discovery; HZGHC006157c010
DR   Wikidata; Q54876566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7728; NEDD4L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NEDD4L (-) 2
AC   CVCL_XQ90
SY   HZGHC006157c012; NEDD4L knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XQ90
DR   Horizon_Discovery; HZGHC006157c012
DR   Wikidata; Q93954905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7728; NEDD4L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEGR1 (-) 1
AC   CVCL_E2DD
SY   HZGHC007651c010
DR   Horizon_Discovery; HZGHC007651c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17302; NEGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEGR1 (-) 2
AC   CVCL_E2DE
SY   HZGHC007652c002
DR   Horizon_Discovery; HZGHC007652c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17302; NEGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEGR1 (-) 3
AC   CVCL_E2DF
SY   HZGHC007652c012
DR   Horizon_Discovery; HZGHC007652c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17302; NEGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL1 (-) 1
AC   CVCL_TA25
SY   HZGHC000418c013; NEIL1 knockout cell line 1bp insertion; HAP1 NEIL1 (-)
DR   cancercelllines; CVCL_TA25
DR   Horizon_Discovery; HZGHC000418c013
DR   Wikidata; Q54876567
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000418c013; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NEIL1 (-) 2
AC   CVCL_E2DG
SY   HZGHC000418c017
DR   Horizon_Discovery; HZGHC000418c017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL1 (-) 3
AC   CVCL_E2DH
SY   HZGHC000418c018
DR   Horizon_Discovery; HZGHC000418c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL1 (-) 4
AC   CVCL_E2DI
SY   HZGHC000418c021
DR   Horizon_Discovery; HZGHC000418c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL2 (-) 1
AC   CVCL_TA26
SY   HZGHC001545c011; NEIL2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TA26
DR   Horizon_Discovery; HZGHC001545c011
DR   Wikidata; Q54876568
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18956; NEIL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEIL2 (-) 2
AC   CVCL_TA27
SY   HZGHC001545c012; NEIL2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA27
DR   Horizon_Discovery; HZGHC001545c012
DR   Wikidata; Q54876569
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18956; NEIL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEIL2 (-) 3
AC   CVCL_E2DJ
SY   HZGHC001545c017
DR   Horizon_Discovery; HZGHC001545c017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18956; NEIL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL2 (-) 4
AC   CVCL_E2DK
SY   HZGHC001545c018
DR   Horizon_Discovery; HZGHC001545c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18956; NEIL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL3 (-) 1
AC   CVCL_TA28
SY   HZGHC001536c002; NEIL3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA28
DR   Horizon_Discovery; HZGHC001536c002
DR   Wikidata; Q54876570
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24573; NEIL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEIL3 (-) 2
AC   CVCL_TA29
SY   HZGHC001536c004; NEIL3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA29
DR   Horizon_Discovery; HZGHC001536c004
DR   Wikidata; Q54876571
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24573; NEIL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEIL3 (-) 3
AC   CVCL_E2DL
SY   HZGHC001536c021
DR   Horizon_Discovery; HZGHC001536c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24573; NEIL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL3 (-) 4
AC   CVCL_E2DM
SY   HZGHC001536c023
DR   Horizon_Discovery; HZGHC001536c023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24573; NEIL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEIL3 (-) 5
AC   CVCL_E2DN
SY   HZGHC001536c024
DR   Horizon_Discovery; HZGHC001536c024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24573; NEIL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEK1 (-) 1
AC   CVCL_TA30
SY   HZGHC000344c010; NEK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA30
DR   Horizon_Discovery; HZGHC000344c010
DR   Wikidata; Q54876573
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7744; NEK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK1 (-) 2
AC   CVCL_TA31
SY   HZGHC000344c012; NEK1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA31
DR   Horizon_Discovery; HZGHC000344c012
DR   Wikidata; Q54876574
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7744; NEK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK10 (-) 1
AC   CVCL_TA32
SY   HZGHC001263c016; NEK10 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TA32
DR   Horizon_Discovery; HZGHC001263c016
DR   Wikidata; Q54876575
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18592; NEK10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK10 (-) 2
AC   CVCL_TA33
SY   HZGHC002995c010; NEK10 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TA33
DR   Horizon_Discovery; HZGHC002995c010
DR   Wikidata; Q54876576
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18592; NEK10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK10 (-) 3
AC   CVCL_TA34
SY   HZGHC002995c011; NEK10 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TA34
DR   Horizon_Discovery; HZGHC002995c011
DR   Wikidata; Q54876577
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18592; NEK10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK2 (-) 1
AC   CVCL_TA35
SY   HZGHC000158c002; NEK2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA35
DR   Horizon_Discovery; HZGHC000158c002
DR   Wikidata; Q54876578
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7745; NEK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK2 (-) 2
AC   CVCL_TA36
SY   HZGHC000158c023; NEK2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TA36
DR   Horizon_Discovery; HZGHC000158c023
DR   Wikidata; Q54876579
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7745; NEK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK3 (-) 1
AC   CVCL_TA37
SY   HZGHC003237c005; NEK3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TA37
DR   Horizon_Discovery; HZGHC003237c005
DR   Wikidata; Q54876580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7746; NEK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK3 (-) 2
AC   CVCL_TA38
SY   HZGHC003237c010; NEK3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TA38
DR   Horizon_Discovery; HZGHC003237c010
DR   Wikidata; Q54876581
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7746; NEK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK3 (-) 3
AC   CVCL_TA39
SY   HZGHC003237c022; NEK3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TA39
DR   Horizon_Discovery; HZGHC003237c022
DR   Wikidata; Q54876582
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7746; NEK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK4 (-) 1
AC   CVCL_TA40
SY   HZGHC000159c014; NEK4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TA40
DR   Horizon_Discovery; HZGHC000159c014
DR   Wikidata; Q54876583
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11399; NEK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK4 (-) 2
AC   CVCL_TA41
SY   HZGHC000159c015; NEK4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TA41
DR   Horizon_Discovery; HZGHC000159c015
DR   Wikidata; Q54876584
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11399; NEK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK7 (-) 1
AC   CVCL_TA42
SY   HZGHC000340c006; NEK7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA42
DR   Horizon_Discovery; HZGHC000340c006
DR   Wikidata; Q54876585
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13386; NEK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK7 (-) 2
AC   CVCL_TA43
SY   HZGHC000340c010; NEK7 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TA43
DR   Horizon_Discovery; HZGHC000340c010
DR   Wikidata; Q54876586
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13386; NEK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK7 (-) 3
AC   CVCL_TA44
SY   HZGHC000340c011; NEK7 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TA44
DR   Horizon_Discovery; HZGHC000340c011
DR   Wikidata; Q54876587
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13386; NEK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK8 (-) 1
AC   CVCL_TA45
SY   HZGHC000052c002; NEK8 knockout cell line 62bp insertion
DR   cancercelllines; CVCL_TA45
DR   Horizon_Discovery; HZGHC000052c002
DR   Wikidata; Q54876588
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13387; NEK8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000052c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NEK8 (-) 2
AC   CVCL_TA46
SY   HZGHC000052c004; NEK8 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TA46
DR   Horizon_Discovery; HZGHC000052c004
DR   Wikidata; Q54876589
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13387; NEK8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK8 (-) 3
AC   CVCL_TA47
SY   HZGHC000052c009; NEK8 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TA47
DR   Horizon_Discovery; HZGHC000052c009
DR   Wikidata; Q54876590
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13387; NEK8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK8 (-) 4
AC   CVCL_TA48
SY   HZGHC000052c011; NEK8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TA48
DR   Horizon_Discovery; HZGHC000052c011
DR   Wikidata; Q54876591
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13387; NEK8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEK9 (-)
AC   CVCL_TA49
SY   HZGHC000711c016; NEK9 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TA49
DR   Horizon_Discovery; HZGHC000711c016
DR   Wikidata; Q54876592
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18591; NEK9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NES (-) 1
AC   CVCL_TA50
SY   HZGHC006117c001; NES knockout cell line 1bp insertion; HAP1 NES (-)
DR   cancercelllines; CVCL_TA50
DR   Horizon_Discovery; HZGHC006117c001
DR   Wikidata; Q54876593
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7756; NES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NES (-) 2
AC   CVCL_XQ91
SY   HZGHC006117c003; NES knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XQ91
DR   Horizon_Discovery; HZGHC006117c003
DR   Wikidata; Q93955003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7756; NES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NEU1 (-) 1
AC   CVCL_E2DP
SY   HZGHC008074c007
DR   Horizon_Discovery; HZGHC008074c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEU1 (-) 2
AC   CVCL_E2DQ
SY   HZGHC008074c011
DR   Horizon_Discovery; HZGHC008074c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEU1 (-) 3
AC   CVCL_E2DR
SY   HZGHC008075c005
DR   Horizon_Discovery; HZGHC008075c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEU1 (-) 4
AC   CVCL_E2DS
SY   HZGHC008075c007
DR   Horizon_Discovery; HZGHC008075c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEU1 (-) 5
AC   CVCL_E2DT
SY   HZGHC008075c009
DR   Horizon_Discovery; HZGHC008075c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEU1 (-) 6
AC   CVCL_E2DU
SY   HZGHC008075c012
DR   Horizon_Discovery; HZGHC008075c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NEU3 (-)
AC   CVCL_E2DV
SY   HZGHC007864c011
DR   Horizon_Discovery; HZGHC007864c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7760; NEU3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NF1 (-) 1
AC   CVCL_TA51
SY   HZGHC001037c004; NF1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TA51
DR   Horizon_Discovery; HZGHC001037c004
DR   Wikidata; Q54876594
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NF1 (-) 2
AC   CVCL_TA52
SY   HZGHC001037c011; NF1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TA52
DR   Horizon_Discovery; HZGHC001037c011
DR   Wikidata; Q54876595
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NF1 (-) 3
AC   CVCL_TA53
SY   HZGHC001067c001; NF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA53
DR   Horizon_Discovery; HZGHC001067c001
DR   Wikidata; Q54876596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NF1 (-) 4
AC   CVCL_TA54
SY   HZGHC001067c005; NF1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TA54
DR   Horizon_Discovery; HZGHC001067c005
DR   Wikidata; Q54876597
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NF2 (-)
AC   CVCL_TA55
SY   HZGHC001293c001; NF2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TA55
DR   Horizon_Discovery; HZGHC001293c001
DR   Wikidata; Q54876598
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFAT5 (-) 1
AC   CVCL_E2DW
SY   HZGHC007626c010
DR   Horizon_Discovery; HZGHC007626c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7774; NFAT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NFAT5 (-) 2
AC   CVCL_E2DX
SY   HZGHC007626c012
DR   Horizon_Discovery; HZGHC007626c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7774; NFAT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NFATC1 (-) 1
AC   CVCL_TA56
SY   HZGHC005995c004; NFATC1 knockout cell line 1bp deletion; HAP1 NFATC1 (-)
DR   cancercelllines; CVCL_TA56
DR   Horizon_Discovery; HZGHC005995c004
DR   Wikidata; Q54876599
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NFATC1 (-) 2
AC   CVCL_XQ92
SY   HZGHC005995c005; NFATC1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XQ92
DR   Horizon_Discovery; HZGHC005995c005
DR   Wikidata; Q93955052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFE2L1 (-) 1
AC   CVCL_TA57
SY   HZGHC005847c001; NFE2L1 knockout cell line 1bp insertion; HAP1 NFE2L1 (-)
DR   cancercelllines; CVCL_TA57
DR   Horizon_Discovery; HZGHC005847c001
DR   Wikidata; Q54876600
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7781; NFE2L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005847c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NFE2L1 (-) 2
AC   CVCL_XQ93
SY   HZGHC005847c012; NFE2L1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XQ93
DR   Horizon_Discovery; HZGHC005847c012
DR   Wikidata; Q93955057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7781; NFE2L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005847c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NFE2L2 (-) 1
AC   CVCL_XQ94
SY   HZGHC006968c001; NFE2L2 knockout cell line 1bp insertion in exon 4; HAP1 NFE2L2 (-)
DR   cancercelllines; CVCL_XQ94
DR   Horizon_Discovery; HZGHC006968c001
DR   Wikidata; Q93955060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NFE2L2 (-) 2
AC   CVCL_E2DY
SY   HZGHC006969c010; NFE2L2 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC006969c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NFIL3 (-)
AC   CVCL_XQ95
SY   HZGHC007044c022; HZGHC4783; NFIL3 knockout cell line 8bp deletion in exon 2
DR   cancercelllines; CVCL_XQ95
DR   Horizon_Discovery; HZGHC007044c022
DR   Wikidata; Q93955062
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7787; NFIL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NFKB1 (-) 1
AC   CVCL_TA58
SY   HZGHC002602c001; NFKB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA58
DR   Horizon_Discovery; HZGHC002602c001
DR   Wikidata; Q54876601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKB1 (-) 2
AC   CVCL_TA59
SY   HZGHC002602c002; NFKB1 knockout cell line 67bp insertion
DR   cancercelllines; CVCL_TA59
DR   Horizon_Discovery; HZGHC002602c002
DR   Wikidata; Q54876602
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002602c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NFKB2 (-) 1
AC   CVCL_TA60
SY   HZGHC002603c002; NFKB2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TA60
DR   Horizon_Discovery; HZGHC002603c002
DR   Wikidata; Q54876603
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKB2 (-) 2
AC   CVCL_TA61
SY   HZGHC002603c011; NFKB2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA61
DR   Horizon_Discovery; HZGHC002603c011
DR   Wikidata; Q54876604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKBIA (-) 1
AC   CVCL_TA62
SY   HZGHC002599c002; NFKBIA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA62
DR   Horizon_Discovery; HZGHC002599c002
DR   Wikidata; Q54876606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKBIA (-) 2
AC   CVCL_TA63
SY   HZGHC002834c004; NFKBIA knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TA63
DR   Horizon_Discovery; HZGHC002834c004
DR   Wikidata; Q54876607
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKBIA (-) 3
AC   CVCL_TA64
SY   HZGHC002834c010; NFKBIA knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TA64
DR   Horizon_Discovery; HZGHC002834c010
DR   Wikidata; Q54876611
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKBIB (-)
AC   CVCL_TA65
SY   HZGHC002600c002; NFKBIB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA65
DR   Horizon_Discovery; HZGHC002600c002
DR   Wikidata; Q54876612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7798; NFKBIB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKBIE (-) 1
AC   CVCL_TA66
SY   HZGHC002884c004; NFKBIE knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TA66
DR   Horizon_Discovery; HZGHC002884c004
DR   Wikidata; Q54876613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7799; NFKBIE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NFKBIE (-) 2
AC   CVCL_TA67
SY   HZGHC002884c010; NFKBIE knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TA67
DR   Horizon_Discovery; HZGHC002884c010
DR   Wikidata; Q54876614
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7799; NFKBIE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NGFR (-) 1
AC   CVCL_TA68
SY   HZGHC003985c003; NGFR knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA68
DR   Horizon_Discovery; HZGHC003985c003
DR   Wikidata; Q54876615
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7809; NGFR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NGFR (-) 2
AC   CVCL_TA69
SY   HZGHC003985c004; NGFR knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA69
DR   Horizon_Discovery; HZGHC003985c004
DR   Wikidata; Q54876616
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7809; NGFR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NGLY1 (-) 1
AC   CVCL_TA70
SY   HZGHC004929c005; NGLY1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA70
DR   Horizon_Discovery; HZGHC004929c005
DR   Wikidata; Q54876617
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NGLY1 (-) 2
AC   CVCL_TA71
SY   HZGHC004929c006; NGLY1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TA71
DR   Horizon_Discovery; HZGHC004929c006
DR   Wikidata; Q54876618
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NHEJ1 (-) 1
AC   CVCL_TA72
SY   HZGHC000426c004; NHEJ1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TA72
DR   Horizon_Discovery; HZGHC000426c004
DR   Wikidata; Q54876619
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25737; NHEJ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000426c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NHEJ1 (-) 2
AC   CVCL_TA73
SY   HZGHC000426c017; NHEJ1 knockout cell line 4bp deletion in exon 3
DR   cancercelllines; CVCL_TA73
DR   Horizon_Discovery; HZGHC000426c017
DR   Wikidata; Q54876620
RX   PubMed=31141305;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25737; NHEJ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NINJ2 (-) 1
AC   CVCL_E2DZ
SY   HZGHC007484c003
DR   Horizon_Discovery; HZGHC007484c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7825; NINJ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NINJ2 (-) 2
AC   CVCL_E2E0
SY   HZGHC007485c003
DR   Horizon_Discovery; HZGHC007485c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7825; NINJ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NIPSNAP3A (-) 1
AC   CVCL_TA74
SY   HZGHC005778c011; NIPSNAP3A knockout cell line 5bp deletion; HAP1 NIPSNAP3A (-)
DR   cancercelllines; CVCL_TA74
DR   Horizon_Discovery; HZGHC005778c011
DR   Wikidata; Q54876621
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23619; NIPSNAP3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NIPSNAP3A (-) 2
AC   CVCL_XQ96
SY   HZGHC005778c002; NIPSNAP3A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XQ96
DR   Horizon_Discovery; HZGHC005778c002
DR   Wikidata; Q93955151
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23619; NIPSNAP3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005778c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NIPSNAP3A (-) 3
AC   CVCL_XQ97
SY   HZGHC005779c004; NIPSNAP3A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XQ97
DR   Horizon_Discovery; HZGHC005779c004
DR   Wikidata; Q93955157
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23619; NIPSNAP3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NIPSNAP3A (-) 4
AC   CVCL_XQ98
SY   HZGHC005779c010; NIPSNAP3A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XQ98
DR   Horizon_Discovery; HZGHC005779c010
DR   Wikidata; Q93955159
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23619; NIPSNAP3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NLK (-) 1
AC   CVCL_TA75
SY   HZGHC000096c005; NLK knockout cell line 8bp insertion
DR   cancercelllines; CVCL_TA75
DR   Horizon_Discovery; HZGHC000096c005
DR   Wikidata; Q54876622
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29858; NLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000096c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NLK (-) 2
AC   CVCL_TA76
SY   HZGHC000096c023; NLK knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TA76
DR   Horizon_Discovery; HZGHC000096c023
DR   Wikidata; Q54876623
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29858; NLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NLRC5 (-) 1
AC   CVCL_E2E1
SY   HZGHC008215c018
DR   Horizon_Discovery; HZGHC008215c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29933; NLRC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NLRC5 (-) 2
AC   CVCL_E2E2
SY   HZGHC008216c024
DR   Horizon_Discovery; HZGHC008216c024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29933; NLRC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NME1-NME2 (-) 1
AC   CVCL_E2E3
SY   HZGHC007464c018
DR   Horizon_Discovery; HZGHC007464c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33531; NME1-NME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NME1-NME2 (-) 2
AC   CVCL_E2E4
SY   HZGHC007464c021
DR   Horizon_Discovery; HZGHC007464c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33531; NME1-NME2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NME4 (-) 1
AC   CVCL_E2E5
SY   HZGHC008186c008
DR   Horizon_Discovery; HZGHC008186c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NME4 (-) 2
AC   CVCL_E2E6
SY   HZGHC008187c002
DR   Horizon_Discovery; HZGHC008187c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NME4 (-) 3
AC   CVCL_E2E7
SY   HZGHC008187c003
DR   Horizon_Discovery; HZGHC008187c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NME4 (-) 4
AC   CVCL_E2E8
SY   HZGHC008187c010
DR   Horizon_Discovery; HZGHC008187c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NMI (-)
AC   CVCL_TA77
SY   HZGHC002641c007; NMI knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA77
DR   Horizon_Discovery; HZGHC002641c007
DR   Wikidata; Q54876624
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7854; NMI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NMNAT3 (-) 1
AC   CVCL_TA78
SY   HZGHC006367c011; NMNAT3 knockout cell line 14bp deletion; HAP1 NMNAT3 (-)
DR   cancercelllines; CVCL_TA78
DR   Horizon_Discovery; HZGHC006367c011
DR   Wikidata; Q54876625
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20989; NMNAT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NMNAT3 (-) 2
AC   CVCL_XQ99
SY   HZGHC006367c002; NMNAT3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XQ99
DR   Horizon_Discovery; HZGHC006367c002
DR   Wikidata; Q93955181
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20989; NMNAT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NMRAL1 (-) 1
AC   CVCL_TA79
SY   HZGHC006467c010; NMRAL1 knockout cell line 2bp deletion; HAP1 NMRAL1 (-)
DR   cancercelllines; CVCL_TA79
DR   Horizon_Discovery; HZGHC006467c010
DR   Wikidata; Q54876626
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24987; NMRAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NMRAL1 (-) 2
AC   CVCL_XR00
SY   HZGHC006467c003; NMRAL1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_XR00
DR   Horizon_Discovery; HZGHC006467c003
DR   PRIDE; PXD010335
DR   Wikidata; Q93955188
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24987; NMRAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NMRK1 (-) 1
AC   CVCL_XR01
SY   HZGHC007276c001; HZGHC54981; NMRK1 knockout cell line 1bp insertion in exon 5; HAP1 NMRK1 (-)
DR   cancercelllines; CVCL_XR01
DR   Horizon_Discovery; HZGHC007276c001
DR   Wikidata; Q93955192
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26057; NMRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NMRK1 (-) 2
AC   CVCL_B5KI
SY   HZGHC007276c002; NMRK1 knockout cell line 1bp insertion in exon 5
DR   cancercelllines; CVCL_B5KI
DR   Horizon_Discovery; HZGHC007276c002
DR   Wikidata; Q111733304
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26057; NMRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007276c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 NMT1 (-) 1
AC   CVCL_TA80
SY   HZGHC000565c009; NMT1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TA80
DR   Horizon_Discovery; HZGHC000565c009
DR   Wikidata; Q54876627
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NMT1 (-) 2
AC   CVCL_TA81
SY   HZGHC000565c011; NMT1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TA81
DR   Horizon_Discovery; HZGHC000565c011
DR   Wikidata; Q54876628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NMT1 (-) 3
AC   CVCL_TA82
SY   HZGHC004318c001; NMT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA82
DR   Horizon_Discovery; HZGHC004318c001
DR   Wikidata; Q54876629
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NMT1 (-) 4
AC   CVCL_TA83
SY   HZGHC004318c007; NMT1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TA83
DR   Horizon_Discovery; HZGHC004318c007
DR   Wikidata; Q54876630
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NMT2 (-)
AC   CVCL_TA84
SY   HZGHC000562c006; NMT2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TA84
DR   Horizon_Discovery; HZGHC000562c006
DR   Wikidata; Q54876631
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7858; NMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NONO (-) 1
AC   CVCL_E2E9
SY   HZGHC007548c001
DR   Horizon_Discovery; HZGHC007548c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7871; NONO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NONO (-) 2
AC   CVCL_E2EA
SY   HZGHC007548c004
DR   Horizon_Discovery; HZGHC007548c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7871; NONO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NONO (-) 3
AC   CVCL_E2EB
SY   HZGHC007548c006
DR   Horizon_Discovery; HZGHC007548c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7871; NONO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NOS2 (-) 1
AC   CVCL_TA85
SY   HZGHC003936c011; NOS2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA85
DR   Horizon_Discovery; HZGHC003936c011
DR   Wikidata; Q54876632
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NOS2 (-) 2
AC   CVCL_TA86
SY   HZGHC003936c010; NOS2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TA86
DR   Horizon_Discovery; HZGHC003936c010
DR   Wikidata; Q54876633
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NOTCH1 (-)
AC   CVCL_TA87
SY   HZGHC005051c006; NOTCH1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TA87
DR   Horizon_Discovery; HZGHC005051c006
DR   Wikidata; Q54876634
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NOTCH3 (-) 1
AC   CVCL_TA88
SY   HZGHC006217c010; NOTCH3 knockout cell line 23bp deletion; HAP1 NOTCH3 (-)
DR   cancercelllines; CVCL_TA88
DR   Horizon_Discovery; HZGHC006217c010
DR   Wikidata; Q54876635
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006217c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NOTCH3 (-) 2
AC   CVCL_XR02
SY   HZGHC006217c012; NOTCH3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XR02
DR   Horizon_Discovery; HZGHC006217c012
DR   Wikidata; Q93955248
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NOXA1 (-) 1
AC   CVCL_TA89
SY   HZGHC000880c001; NOXA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA89
DR   Horizon_Discovery; HZGHC000880c001
DR   Wikidata; Q54876636
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10668; NOXA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NOXA1 (-) 2
AC   CVCL_TA90
SY   HZGHC000880c010; NOXA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA90
DR   Horizon_Discovery; HZGHC000880c010
DR   Wikidata; Q54876637
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10668; NOXA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NPC1 (-) 1
AC   CVCL_TA91
SY   HZGHC006219c010; NPC1 knockout cell line 13bp insertion; HAP1 NPC1 (-)
DR   cancercelllines; CVCL_TA91
DR   Horizon_Discovery; HZGHC006219c010
DR   Wikidata; Q54876638
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006219c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NPC1 (-) 2
AC   CVCL_XR03
SY   HZGHC006219c002; NPC1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XR03
DR   Horizon_Discovery; HZGHC006219c002
DR   Wikidata; Q93955266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NPC2 (-) 1
AC   CVCL_XR04
SY   HZGHC007104c005; HZGHC10577; NPC2 knockout cell line 1bp deletion in exon 3; HAP1 NPC2 (-)
DR   cancercelllines; CVCL_XR04
DR   Horizon_Discovery; HZGHC007104c005
DR   Wikidata; Q93955267
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14537; NPC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NPC2 (-) 2
AC   CVCL_E2EC
SY   HZGHC007103c001; NPC2 knockout cell line 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC007103c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14537; NPC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NPDC1 (-) 1
AC   CVCL_E2ED
SY   HZGHC008261c006
DR   Horizon_Discovery; HZGHC008261c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7899; NPDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NPDC1 (-) 2
AC   CVCL_E2EE
SY   HZGHC008261c009
DR   Horizon_Discovery; HZGHC008261c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7899; NPDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NPDC1 (-) 3
AC   CVCL_E2EF
SY   HZGHC008261c010
DR   Horizon_Discovery; HZGHC008261c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7899; NPDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NPEPPS (-) 1
AC   CVCL_E2EG
SY   HZGHC008184c008
DR   Horizon_Discovery; HZGHC008184c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7900; NPEPPS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NPEPPS (-) 2
AC   CVCL_E2EH
SY   HZGHC008185c001
DR   Horizon_Discovery; HZGHC008185c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7900; NPEPPS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NPEPPS (-) 3
AC   CVCL_E2EI
SY   HZGHC008185c011
DR   Horizon_Discovery; HZGHC008185c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7900; NPEPPS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NPL (-) 1
AC   CVCL_TA92
SY   HZGHC005269c001; NPL knockout cell line 22bp deletion; HAP1 NPL (-)
DR   cancercelllines; CVCL_TA92
DR   Horizon_Discovery; HZGHC005269c001
DR   Wikidata; Q54876639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16781; NPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NPL (-) 2
AC   CVCL_XR05
SY   HZGHC005269c002; NPL knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XR05
DR   Horizon_Discovery; HZGHC005269c002
DR   Wikidata; Q93955272
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16781; NPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NPL (-) 3
AC   CVCL_XR06
SY   HZGHC005270c005; NPL knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XR06
DR   Horizon_Discovery; HZGHC005270c005
DR   Wikidata; Q93955275
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16781; NPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NPRL2 (-) 1
AC   CVCL_TA93
SY   HZGHC001810c001; NPRL2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TA93
DR   Horizon_Discovery; HZGHC001810c001
DR   Wikidata; Q54876640
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24969; NPRL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NPRL2 (-) 2
AC   CVCL_TA94
SY   HZGHC001810c002; NPRL2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TA94
DR   Horizon_Discovery; HZGHC001810c002
DR   Wikidata; Q54876641
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24969; NPRL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NPRL2 (-) 3
AC   CVCL_TA95
SY   HZGHC001810c010; NPRL2 knockout cell line 163bp insertion
DR   cancercelllines; CVCL_TA95
DR   Horizon_Discovery; HZGHC001810c010
DR   Wikidata; Q54876642
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24969; NPRL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001810c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NPRL3 (-) 1
AC   CVCL_TA96
SY   HZGHC001287c003; NPRL3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TA96
DR   Horizon_Discovery; HZGHC001287c003
DR   Wikidata; Q54876643
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14124; NPRL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NPRL3 (-) 2
AC   CVCL_TA97
SY   HZGHC001287c004; NPRL3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TA97
DR   Horizon_Discovery; HZGHC001287c004
DR   Wikidata; Q54876644
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14124; NPRL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NQO1 (-)
AC   CVCL_TA98
SY   HZGHC006138c004; NQO1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TA98
DR   Horizon_Discovery; HZGHC006138c004
DR   Wikidata; Q54876645
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2874; NQO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006138c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NQO2 (-) 1
AC   CVCL_TA99
SY   HZGHC006474c012; NQO2 knockout cell line 1bp insertion; HAP1 NQO2 (-)
DR   cancercelllines; CVCL_TA99
DR   Horizon_Discovery; HZGHC006474c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54876646
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7856; NQO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006474c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 NQO2 (-) 2
AC   CVCL_XR07
SY   HZGHC006474c002; NQO2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XR07
DR   Horizon_Discovery; HZGHC006474c002
DR   PRIDE; PXD010335
DR   Wikidata; Q93955324
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7856; NQO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NR1H2 (-) 1
AC   CVCL_E2EJ
SY   HZGHC007842c002
DR   Horizon_Discovery; HZGHC007842c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7965; NR1H2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NR1H2 (-) 2
AC   CVCL_E2EK
SY   HZGHC007842c012
DR   Horizon_Discovery; HZGHC007842c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7965; NR1H2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NR1H3 (-) 1
AC   CVCL_E2EL
SY   HZGHC007844c001
DR   Horizon_Discovery; HZGHC007844c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NR1H3 (-) 2
AC   CVCL_E2EM
SY   HZGHC007844c010
DR   Horizon_Discovery; HZGHC007844c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NR2F2 (-)
AC   CVCL_TB00
SY   HZGHC006265c004; NR2F2 knockout cell line 155bp insertion
DR   cancercelllines; CVCL_TB00
DR   Horizon_Discovery; HZGHC006265c004
DR   Wikidata; Q54876647
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7976; NR2F2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006265c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NR3C1 (-)
AC   CVCL_XR08
SY   HZGHC007248c006; HZGHC2908; NR3C1 knockout cell line 7bp deletion in exon 4
DR   cancercelllines; CVCL_XR08
DR   Horizon_Discovery; HZGHC007248c006
DR   Wikidata; Q93955340
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NR3C2 (-) 1
AC   CVCL_TB01
SY   HZGHC003923c009; NR3C2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TB01
DR   Horizon_Discovery; HZGHC003923c009
DR   Wikidata; Q54876648
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NR3C2 (-) 2
AC   CVCL_TB02
SY   HZGHC003923c012; NR3C2 knockout cell line 194bp insertion
DR   cancercelllines; CVCL_TB02
DR   Horizon_Discovery; HZGHC003923c012
DR   Wikidata; Q54876649
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003923c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NR4A1 (-) 1
AC   CVCL_TB03
SY   HZGHC005463c001; NR4A1 knockout cell line 2bp deletion; HAP1 NR4A1 (-)
DR   cancercelllines; CVCL_TB03
DR   Horizon_Discovery; HZGHC005463c001
DR   Wikidata; Q54876650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NR4A1 (-) 2
AC   CVCL_XR09
SY   HZGHC005463c003; NR4A1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XR09
DR   Horizon_Discovery; HZGHC005463c003
DR   Wikidata; Q93955371
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005463c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NR5A2 (-) 1
AC   CVCL_XR10
SY   HZGHC007193c006; HZGHC2494; NR5A2 knockout cell line 1bp insertion in exon 5; HAP1 NR5A2 (-)
DR   cancercelllines; CVCL_XR10
DR   Horizon_Discovery; HZGHC007193c006
DR   Wikidata; Q93955374
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7984; NR5A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NR5A2 (-) 2
AC   CVCL_B5KJ
SY   HZGHC007193c010; NR5A2 knockout cell line 7bp deletion in exon 5
DR   cancercelllines; CVCL_B5KJ
DR   Horizon_Discovery; HZGHC007193c010
DR   Wikidata; Q111733305
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7984; NR5A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 NRBP1 (-) 1
AC   CVCL_TB04
SY   HZGHC004221c009; NRBP1 knockout cell line 8bp deletion; HAP1 NRBP1 (-)
DR   cancercelllines; CVCL_TB04
DR   Horizon_Discovery; HZGHC004221c009
DR   Wikidata; Q54876654
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7993; NRBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004221c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NRBP1 (-) 2
AC   CVCL_XR11
SY   HZGHC022490c004; NRBP1 knockout cell line
DR   cancercelllines; CVCL_XR11
DR   Horizon_Discovery; HZGHC022490c004
DR   Wikidata; Q93955386
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7993; NRBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC022490c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NRBP1 (-) 3
AC   CVCL_XR12
SY   HZGHC022490c017; NRBP1 knockout cell line
DR   cancercelllines; CVCL_XR12
DR   Horizon_Discovery; HZGHC022490c017
DR   Wikidata; Q93955390
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7993; NRBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC022490c017; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NRBP1 (-) 4
AC   CVCL_XR13
SY   HZGHC022490c018; NRBP1 knockout cell line
DR   cancercelllines; CVCL_XR13
DR   Horizon_Discovery; HZGHC022490c018
DR   Wikidata; Q93955394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7993; NRBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC022490c018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NRBP2 (-) 1
AC   CVCL_TB05
SY   HZGHC002436c002; NRBP2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TB05
DR   Horizon_Discovery; HZGHC002436c002
DR   Wikidata; Q54876655
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19339; NRBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NRBP2 (-) 2
AC   CVCL_TB06
SY   HZGHC002436c004; NRBP2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TB06
DR   Horizon_Discovery; HZGHC002436c004
DR   Wikidata; Q54876656
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19339; NRBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NRBP2 (-) 3
AC   CVCL_TB07
SY   HZGHC002671c001; NRBP2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TB07
DR   Horizon_Discovery; HZGHC002671c001
DR   Wikidata; Q54876657
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19339; NRBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NRD1 (-)
AC   CVCL_TB08
SY   HZGHC002634c002; NRD1 knockout cell line 5bp deletion in exon 3
DR   cancercelllines; CVCL_TB08
DR   Horizon_Discovery; HZGHC002634c002
DR   Wikidata; Q54876658
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7995; NRDC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NRP1 (-) 1
AC   CVCL_TB09
SY   HZGHC006068c003; NRP1 knockout cell line 2bp insertion; HAP1 NRP1 (-)
DR   cancercelllines; CVCL_TB09
DR   Horizon_Discovery; HZGHC006068c003
DR   Wikidata; Q54876659
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8004; NRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NRP1 (-) 2
AC   CVCL_XR14
SY   HZGHC006068c006; NRP1 knockout cell line 74bp deletion
DR   cancercelllines; CVCL_XR14
DR   Horizon_Discovery; HZGHC006068c006
DR   Wikidata; Q93955434
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8004; NRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NRP2 (-) 1
AC   CVCL_TB10
SY   HZGHC006066c003; NRP2 knockout cell line 10bp deletion; HAP1 NRP2 (-)
DR   cancercelllines; CVCL_TB10
DR   Horizon_Discovery; HZGHC006066c003
DR   Wikidata; Q54876660
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8005; NRP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NRP2 (-) 2
AC   CVCL_XR15
SY   HZGHC006066c004; NRP2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XR15
DR   Horizon_Discovery; HZGHC006066c004
DR   Wikidata; Q93955446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8005; NRP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NSD1 (-) 1
AC   CVCL_TB11
SY   HZGHC001127c002; NSD1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TB11
DR   Horizon_Discovery; HZGHC001127c002
DR   Wikidata; Q54876661
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14234; NSD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NSD1 (-) 2
AC   CVCL_TB12
SY   HZGHC001127c011; NSD1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TB12
DR   Horizon_Discovery; HZGHC001127c011
DR   Wikidata; Q54876662
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14234; NSD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001127c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NSD1 (-) 3
AC   CVCL_TB13
SY   HZGHC001127c004; NSD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB13
DR   Horizon_Discovery; HZGHC001127c004
DR   Wikidata; Q54876663
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14234; NSD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NSD1 (-) 4
AC   CVCL_TB14
SY   HZGHC001127c010; NSD1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TB14
DR   Horizon_Discovery; HZGHC001127c010
DR   Wikidata; Q54876664
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14234; NSD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NSUN2 (-) 1
AC   CVCL_TB15
SY   HZGHC006587c010; NSUN2 knockout cell line 2bp insertion; HAP1 NSUN2 (-)
DR   cancercelllines; CVCL_TB15
DR   Horizon_Discovery; HZGHC006587c010
DR   Wikidata; Q54876665
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25994; NSUN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006587c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NSUN2 (-) 2
AC   CVCL_XR16
SY   HZGHC006587c007; NSUN2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XR16
DR   Horizon_Discovery; HZGHC006587c007
DR   Wikidata; Q93955479
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25994; NSUN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NSUN3 (-) 1
AC   CVCL_TB16
SY   HZGHC004798c002; NSUN3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TB16
DR   Horizon_Discovery; HZGHC004798c002
DR   Wikidata; Q54876666
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26208; NSUN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NSUN3 (-) 2
AC   CVCL_TB17
SY   HZGHC004798c004; NSUN3 knockout cell line 179bp insertion
DR   cancercelllines; CVCL_TB17
DR   Horizon_Discovery; HZGHC004798c004
DR   Wikidata; Q54876667
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26208; NSUN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004798c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NSUN3 (-) 3
AC   CVCL_TB18
SY   HZGHC004798c005; NSUN3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB18
DR   Horizon_Discovery; HZGHC004798c005
DR   Wikidata; Q54876669
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26208; NSUN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NSUN5 (-) 1
AC   CVCL_TB19
SY   HZGHC006531c001; NSUN5 knockout cell line 1bp insertion; HAP1 NSUN5 (-)
DR   cancercelllines; CVCL_TB19
DR   Horizon_Discovery; HZGHC006531c001
DR   Wikidata; Q54876670
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16385; NSUN5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NSUN5 (-) 2
AC   CVCL_XR17
SY   HZGHC006531c003; NSUN5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR17
DR   Horizon_Discovery; HZGHC006531c003
DR   Wikidata; Q93955507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16385; NSUN5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006531c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NSUN5 (-) 3
AC   CVCL_XR18
SY   HZGHC006531c004; NSUN5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR18
DR   Horizon_Discovery; HZGHC006531c004
DR   Wikidata; Q93955510
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16385; NSUN5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006531c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NSUN5 (-) 4
AC   CVCL_XR19
SY   HZGHC006532c003; NSUN5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XR19
DR   Horizon_Discovery; HZGHC006532c003
DR   Wikidata; Q93955511
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16385; NSUN5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NT5C3A (-) 1
AC   CVCL_TB20
SY   HZGHC005176c003; NT5C3A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TB20
DR   Horizon_Discovery; HZGHC005176c003
DR   Wikidata; Q54876671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NT5C3A (-) 2
AC   CVCL_TB21
SY   HZGHC005176c010; NT5C3A knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TB21
DR   Horizon_Discovery; HZGHC005176c010
DR   Wikidata; Q54876672
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NT5C3A (-) 3
AC   CVCL_TB22
SY   HZGHC005177c001; NT5C3A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TB22
DR   Horizon_Discovery; HZGHC005177c001
DR   Wikidata; Q54876673
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NT5C3A (-) 4
AC   CVCL_TB23
SY   HZGHC005177c004; NT5C3A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB23
DR   Horizon_Discovery; HZGHC005177c004
DR   Wikidata; Q54876674
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NT5DC2 (-) 1
AC   CVCL_TB24
SY   HZGHC005780c012; NT5DC2 knockout cell line 4bp deletion; HAP1 NT5DC2 (-)
DR   cancercelllines; CVCL_TB24
DR   Horizon_Discovery; HZGHC005780c012
DR   Wikidata; Q54876675
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25717; NT5DC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NT5DC2 (-) 2
AC   CVCL_XR20
SY   HZGHC005781c001; NT5DC2 knockout cell line 206bp insertion
DR   cancercelllines; CVCL_XR20
DR   Horizon_Discovery; HZGHC005781c001
DR   Wikidata; Q93955538
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25717; NT5DC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005781c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NT5DC2 (-) 3
AC   CVCL_XR21
SY   HZGHC005781c002; NT5DC2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XR21
DR   Horizon_Discovery; HZGHC005781c002
DR   Wikidata; Q93955539
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25717; NT5DC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NT5DC2 (-) 4
AC   CVCL_XR22
SY   HZGHC005781c006; NT5DC2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XR22
DR   Horizon_Discovery; HZGHC005781c006
DR   Wikidata; Q93955542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25717; NT5DC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NTHL1 (-) 1
AC   CVCL_TB25
SY   HZGHC001539c011; NTHL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB25
DR   Horizon_Discovery; HZGHC001539c011
DR   Wikidata; Q54876676
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001539c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NTHL1 (-) 2
AC   CVCL_TB26
SY   HZGHC001539c012; NTHL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB26
DR   Horizon_Discovery; HZGHC001539c012
DR   Wikidata; Q54876677
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001539c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NTHL1 (-) 3
AC   CVCL_TB27
SY   HZGHC001539c010; NTHL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB27
DR   Horizon_Discovery; HZGHC001539c010
DR   Wikidata; Q54876678
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NTHL1 (-) 4
AC   CVCL_TB28
SY   HZGHC001540c010; NTHL1 knockout cell line 5bp deletion in exon 3
DR   cancercelllines; CVCL_TB28
DR   Horizon_Discovery; HZGHC001540c010
DR   Wikidata; Q54876679
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NTHL1 (-) 5
AC   CVCL_TB29
SY   HZGHC001540c011; NTHL1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TB29
DR   Horizon_Discovery; HZGHC001540c011
DR   Wikidata; Q54876680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NTHL1 (-) XPA (-) 1
AC   CVCL_DX48
SY   HZGHC006992c001; Double knockout cell line NTHL1 5bp deletion in exon 3 and XPA 2bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006992c001
DR   Wikidata; Q127381069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12814; XPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TB28 ! HAP1 NTHL1 (-) 4
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NTHL1 (-) XPA (-) 2
AC   CVCL_DX49
SY   HZGHC006992c003; Double knockout cell line NTHL1 5bp deletion in exon 3 and XPA 4bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006992c003
DR   Wikidata; Q127381070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12814; XPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TB28 ! HAP1 NTHL1 (-) 4
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NTHL1 (-) XPA (-) 3
AC   CVCL_DX50
SY   HZGHC006992c005; Double knockout cell line NTHL1 5bp deletion in exon 3 and XPA 5bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006992c005
DR   Wikidata; Q127381071
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8028; NTHL1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12814; XPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TB28 ! HAP1 NTHL1 (-) 4
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NTRK1 (-)
AC   CVCL_TB30
SY   HZGHC001259c015; NTRK1 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TB30
DR   Horizon_Discovery; HZGHC001259c015
DR   Wikidata; Q54876681
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8031; NTRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUAK1 (-)
AC   CVCL_TB31
SY   HZGHC000247c012; NUAK1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TB31
DR   Horizon_Discovery; HZGHC000247c012
DR   Wikidata; Q54876682
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14311; NUAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT1 (-) 1
AC   CVCL_RQ86
SY   HZGHC000753c002; NUDT1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_RQ86
DR   Horizon_Discovery; HZGHC000753c002
DR   Wikidata; Q54876683
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8048; NUDT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 NUDT1 (-) 2
AC   CVCL_SA83
SY   HZGHC000753c003; NUDT1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_SA83
DR   Horizon_Discovery; HZGHC000753c003
DR   PRIDE; PXD010335
DR   Wikidata; Q54876684
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8048; NUDT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 NUDT10 (-) 1
AC   CVCL_E2EN
SY   HZGHC008204c012
DR   Horizon_Discovery; HZGHC008204c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17621; NUDT10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT10 (-) 2
AC   CVCL_E2EP
SY   HZGHC008204c017
DR   Horizon_Discovery; HZGHC008204c017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17621; NUDT10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT11 (-) 1
AC   CVCL_D1I2
SY   HZGHC008165c005; NUDT11 knockout cell line 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC008165c005
DR   Wikidata; Q127381072
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18011; NUDT11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT11 (-) 2
AC   CVCL_D1I3
SY   HZGHC008165c006; NUDT11 knockout cell line 1bp insertion in exon 1
DR   Horizon_Discovery; HZGHC008165c006
DR   Wikidata; Q127381073
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18011; NUDT11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT13 (-) 1
AC   CVCL_D1I4
SY   HZGHC008180c005; NUDT13 knockout cell line 4bp deletion in exon 8
DR   Horizon_Discovery; HZGHC008180c005
DR   Wikidata; Q127381074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18827; NUDT13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT13 (-) 2
AC   CVCL_D1I5
SY   HZGHC008181c012; NUDT13 knockout cell line 1bp insertion in exon 9
DR   Horizon_Discovery; HZGHC008181c012
DR   Wikidata; Q127381075
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18827; NUDT13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT14 (-) 1
AC   CVCL_D1I6
SY   HZGHC008162c004; NUDT14 knockout cell line 2bp deletion in exon 5
DR   Horizon_Discovery; HZGHC008162c004
DR   Wikidata; Q127381076
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20141; NUDT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT14 (-) 2
AC   CVCL_D1I7
SY   HZGHC008162c005; NUDT14 knockout cell line 1bp deletion in exon 5
DR   Horizon_Discovery; HZGHC008162c005
DR   Wikidata; Q127381077
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20141; NUDT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT14 (-) 3
AC   CVCL_D1I8
SY   HZGHC008162c009; NUDT14 knockout cell line 112bp deletion in exon 5
DR   Horizon_Discovery; HZGHC008162c009
DR   Wikidata; Q127381078
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20141; NUDT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT14 (-) 4
AC   CVCL_D1I9
SY   HZGHC008163c008; NUDT14 knockout cell line 10bp deletion in exon 4
DR   Horizon_Discovery; HZGHC008163c008
DR   Wikidata; Q127381079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20141; NUDT14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT15 (-) 1
AC   CVCL_TB32
SY   HZGHC003250c002; NUDT15 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TB32
DR   Horizon_Discovery; HZGHC003250c002
DR   Wikidata; Q54876685
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23063; NUDT15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT15 (-) 2
AC   CVCL_TB33
SY   HZGHC003250c003; NUDT15 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TB33
DR   Horizon_Discovery; HZGHC003250c003
DR   Wikidata; Q54876686
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23063; NUDT15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT16 (-) 1
AC   CVCL_TB34
SY   HZGHC003251c006; NUDT16 knockout cell line 44bp insertion
DR   cancercelllines; CVCL_TB34
DR   Horizon_Discovery; HZGHC003251c006
DR   Wikidata; Q54876687
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26442; NUDT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003251c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUDT16 (-) 2
AC   CVCL_TB35
SY   HZGHC003251c008; NUDT16 knockout cell line 281bp insertion
DR   cancercelllines; CVCL_TB35
DR   Horizon_Discovery; HZGHC003251c008
DR   Wikidata; Q54876688
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26442; NUDT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003251c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUDT16 (-) 3
AC   CVCL_E2EQ
SY   HZGHC008170c005
DR   Horizon_Discovery; HZGHC008170c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26442; NUDT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT16 (-) 4
AC   CVCL_E2ER
SY   HZGHC008170c007
DR   Horizon_Discovery; HZGHC008170c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26442; NUDT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT16 (-) 5
AC   CVCL_E2ES
SY   HZGHC008171c004
DR   Horizon_Discovery; HZGHC008171c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26442; NUDT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT16 (-) 6
AC   CVCL_E2ET
SY   HZGHC008171c006
DR   Horizon_Discovery; HZGHC008171c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26442; NUDT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT16 (-) 7
AC   CVCL_E2EU
SY   HZGHC008171c012
DR   Horizon_Discovery; HZGHC008171c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26442; NUDT16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT18 (-) 1
AC   CVCL_E2EV
SY   HZGHC008166c005
DR   Horizon_Discovery; HZGHC008166c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26194; NUDT18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT18 (-) 2
AC   CVCL_E2EW
SY   HZGHC008166c011
DR   Horizon_Discovery; HZGHC008166c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26194; NUDT18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT18 (-) 3
AC   CVCL_E2EX
SY   HZGHC008167c005
DR   Horizon_Discovery; HZGHC008167c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26194; NUDT18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT18 (-) 4
AC   CVCL_E2EY
SY   HZGHC008167c006
DR   Horizon_Discovery; HZGHC008167c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26194; NUDT18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT19 (-) 1
AC   CVCL_TB36
SY   HZGHC003252c010; NUDT19 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TB36
DR   Horizon_Discovery; HZGHC003252c010
DR   Wikidata; Q54876689
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32036; NUDT19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT19 (-) 2
AC   CVCL_TB37
SY   HZGHC003252c011; NUDT19 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TB37
DR   Horizon_Discovery; HZGHC003252c011
DR   Wikidata; Q54876690
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32036; NUDT19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT2 (-) 1
AC   CVCL_TB38
SY   HZGHC003253c001; NUDT2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB38
DR   Horizon_Discovery; HZGHC003253c001
DR   Wikidata; Q54876691
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8049; NUDT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT2 (-) 2
AC   CVCL_TB39
SY   HZGHC003253c003; NUDT2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TB39
DR   Horizon_Discovery; HZGHC003253c003
DR   Wikidata; Q54876692
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8049; NUDT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT22 (-) 1
AC   CVCL_E2EZ
SY   HZGHC008168c003
DR   Horizon_Discovery; HZGHC008168c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28189; NUDT22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT22 (-) 2
AC   CVCL_E2F0
SY   HZGHC008168c004
DR   Horizon_Discovery; HZGHC008168c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28189; NUDT22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT22 (-) 3
AC   CVCL_E2F1
SY   HZGHC008168c005
DR   Horizon_Discovery; HZGHC008168c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28189; NUDT22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT3 (-) 1
AC   CVCL_TB40
SY   HZGHC003254c007; NUDT3 knockout cell line 296bp insertion
DR   cancercelllines; CVCL_TB40
DR   Horizon_Discovery; HZGHC003254c007
DR   Wikidata; Q54876693
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8050; NUDT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003254c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUDT3 (-) 2
AC   CVCL_TB41
SY   HZGHC003254c012; NUDT3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TB41
DR   Horizon_Discovery; HZGHC003254c012
DR   Wikidata; Q54876694
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8050; NUDT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT4 (-) 1
AC   CVCL_E2F2
SY   HZGHC008176c005
DR   Horizon_Discovery; HZGHC008176c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8051; NUDT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT4 (-) 2
AC   CVCL_E2F3
SY   HZGHC008176c006
DR   Horizon_Discovery; HZGHC008176c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8051; NUDT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT4 (-) 3
AC   CVCL_E2F4
SY   HZGHC008176c010
DR   Horizon_Discovery; HZGHC008176c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8051; NUDT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT5 (-) 1
AC   CVCL_E2F5
SY   HZGHC008159c005
DR   Horizon_Discovery; HZGHC008159c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8052; NUDT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT5 (-) 2
AC   CVCL_E2F6
SY   HZGHC008159c007
DR   Horizon_Discovery; HZGHC008159c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8052; NUDT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT5 (-) 3
AC   CVCL_E2F7
SY   HZGHC008159c010
DR   Horizon_Discovery; HZGHC008159c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8052; NUDT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT5 (-) 4
AC   CVCL_E2F8
SY   HZGHC008159c011
DR   Horizon_Discovery; HZGHC008159c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8052; NUDT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT5 (-) 5
AC   CVCL_E2F9
SY   HZGHC008159c012
DR   Horizon_Discovery; HZGHC008159c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8052; NUDT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT6 (-) 1
AC   CVCL_TB42
SY   HZGHC003255c004; NUDT6 knockout cell line 10bp deletion in exon 4
DR   cancercelllines; CVCL_TB42
DR   Horizon_Discovery; HZGHC003255c004
DR   Wikidata; Q54876696
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8053; NUDT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUDT6 (-) 2
AC   CVCL_TB43
SY   HZGHC003255c006; NUDT6 knockout cell line 11bp deletion in exon 4
DR   cancercelllines; CVCL_TB43
DR   Horizon_Discovery; HZGHC003255c006
DR   Wikidata; Q54876697
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8053; NUDT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUDT6 (-) NUDT9 (-)
AC   CVCL_DX51
SY   HZGHC007530c012; Double knockout cell line NUDT6 10bp deletion in exon 4 and NUDT9 11bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007530c012
DR   Wikidata; Q127381080
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8053; NUDT6.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8056; NUDT9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TB42 ! HAP1 NUDT6 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 NUDT7 (-) 1
AC   CVCL_TB44
SY   HZGHC003256c003; NUDT7 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TB44
DR   Horizon_Discovery; HZGHC003256c003
DR   Wikidata; Q54876698
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8054; NUDT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT7 (-) 2
AC   CVCL_TB45
SY   HZGHC003256c006; NUDT7 knockout cell line 61bp deletion
DR   cancercelllines; CVCL_TB45
DR   Horizon_Discovery; HZGHC003256c006
DR   Wikidata; Q54876699
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8054; NUDT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUDT8 (-) 1
AC   CVCL_E2FA
SY   HZGHC008160c002
DR   Horizon_Discovery; HZGHC008160c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8055; NUDT8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT8 (-) 2
AC   CVCL_E2FB
SY   HZGHC008161c009
DR   Horizon_Discovery; HZGHC008161c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8055; NUDT8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NUDT9 (-) 1
AC   CVCL_XR23
SY   HZGHC007283c004; HZGHC53343; NUDT9 knockout cell line 41bp deletion in exon 4; HAP1 NUDT9 (-)
DR   cancercelllines; CVCL_XR23
DR   Horizon_Discovery; HZGHC007283c004
DR   Wikidata; Q93955751
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8056; NUDT9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUDT9 (-) 2
AC   CVCL_B5KK
SY   HZGHC007284c012; NUDT9 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_B5KK
DR   Horizon_Discovery; HZGHC007284c012
DR   Wikidata; Q111733306
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8056; NUDT9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 NUMB (-) 1
AC   CVCL_TB46
SY   HZGHC006307c003; NUMB knockout cell line 14bp deletion; HAP1 NUMB (-)
DR   cancercelllines; CVCL_TB46
DR   Horizon_Discovery; HZGHC006307c003
DR   Wikidata; Q54876700
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUMB (-) 2
AC   CVCL_XR24
SY   HZGHC006308c001; NUMB knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XR24
DR   Horizon_Discovery; HZGHC006308c001
DR   Wikidata; Q93955763
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUMB (-) 3
AC   CVCL_XR25
SY   HZGHC006308c010; NUMB knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XR25
DR   Horizon_Discovery; HZGHC006308c010
DR   Wikidata; Q93955766
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUP210 (-) 1
AC   CVCL_TB47
SY   HZGHC000825c003; NUP210 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB47
DR   Horizon_Discovery; HZGHC000825c003
DR   Wikidata; Q54876701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30052; NUP210.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUP210 (-) 2
AC   CVCL_TB48
SY   HZGHC000825c011; NUP210 knockout cell line 121bp insertion
DR   cancercelllines; CVCL_TB48
DR   Horizon_Discovery; HZGHC000825c011
DR   Wikidata; Q54876702
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30052; NUP210.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000825c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUP210 (-) 3
AC   CVCL_TB49
SY   HZGHC000826c003; NUP210 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TB49
DR   Horizon_Discovery; HZGHC000826c003
DR   Wikidata; Q54876703
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30052; NUP210.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUP210 (-) 4
AC   CVCL_TB50
SY   HZGHC000826c010; NUP210 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TB50
DR   Horizon_Discovery; HZGHC000826c010
DR   Wikidata; Q54876704
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30052; NUP210.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NUSAP1 (-) 1
AC   CVCL_TB51
SY   HZGHC004902c011; NUSAP1 knockout cell line 64bp insertion
DR   cancercelllines; CVCL_TB51
DR   Horizon_Discovery; HZGHC004902c011
DR   Wikidata; Q54876705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18538; NUSAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004902c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 NUSAP1 (-) 2
AC   CVCL_TB52
SY   HZGHC004902c012; NUSAP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB52
DR   Horizon_Discovery; HZGHC004902c012
DR   Wikidata; Q54876707
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18538; NUSAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NXN (-)
AC   CVCL_TB53
SY   HZGHC002769c001; NXN knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TB53
DR   Horizon_Discovery; HZGHC002769c001
DR   Wikidata; Q54876708
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18008; NXN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 NXT2 (-) 1
AC   CVCL_E2FC
SY   HZGHC008140c001
DR   Horizon_Discovery; HZGHC008140c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18151; NXT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NXT2 (-) 2
AC   CVCL_E2FD
SY   HZGHC008140c002
DR   Horizon_Discovery; HZGHC008140c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18151; NXT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 NXT2 (-) 3
AC   CVCL_E2FE
SY   HZGHC008140c009
DR   Horizon_Discovery; HZGHC008140c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18151; NXT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OARD1 (-) 1
AC   CVCL_E2FF
SY   HZGHC008144c004
DR   Horizon_Discovery; HZGHC008144c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21257; OARD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OARD1 (-) 2
AC   CVCL_E2FG
SY   HZGHC008144c006
DR   Horizon_Discovery; HZGHC008144c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21257; OARD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OARD1 (-) 3
AC   CVCL_E2FH
SY   HZGHC008144c010
DR   Horizon_Discovery; HZGHC008144c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21257; OARD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OARD1 (-) 4
AC   CVCL_E2FI
SY   HZGHC008144c011
DR   Horizon_Discovery; HZGHC008144c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21257; OARD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OBSCN (-) 1
AC   CVCL_TB54
SY   HZGHC001262c004; OBSCN knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TB54
DR   Horizon_Discovery; HZGHC001262c004
DR   Wikidata; Q54876709
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15719; OBSCN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OBSCN (-) 2
AC   CVCL_TB55
SY   HZGHC003431c001; OBSCN knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TB55
DR   Horizon_Discovery; HZGHC003431c001
DR   Wikidata; Q54876710
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15719; OBSCN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OBSCN (-) 3
AC   CVCL_TB56
SY   HZGHC003431c010; OBSCN knockout cell line 62bp deletion
DR   cancercelllines; CVCL_TB56
DR   Horizon_Discovery; HZGHC003431c010
DR   Wikidata; Q54876711
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15719; OBSCN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OCIAD1 (-) 1
AC   CVCL_TB57
SY   HZGHC005782c010; OCIAD1 knockout cell line 2bp deletion; HAP1 OCIAD1 (-)
DR   cancercelllines; CVCL_TB57
DR   Horizon_Discovery; HZGHC005782c010
DR   Wikidata; Q54876712
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16074; OCIAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 OCIAD1 (-) 2
AC   CVCL_XR26
SY   HZGHC005782c003; OCIAD1 knockout cell line 70bp insertion
DR   cancercelllines; CVCL_XR26
DR   Horizon_Discovery; HZGHC005782c003
DR   Wikidata; Q93955857
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16074; OCIAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005782c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 OCIAD1 (-) 3
AC   CVCL_XR27
SY   HZGHC005783c004; OCIAD1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XR27
DR   Horizon_Discovery; HZGHC005783c004
DR   Wikidata; Q93955859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16074; OCIAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OCLN (-) 1
AC   CVCL_TB58
SY   HZGHC006108c010; OCLN knockout cell line 5bp deletion; HAP1 OCLN (-)
DR   cancercelllines; CVCL_TB58
DR   Horizon_Discovery; HZGHC006108c010
DR   Wikidata; Q54876713
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8104; OCLN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 OCLN (-) 2
AC   CVCL_XR28
SY   HZGHC006108c011; OCLN knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XR28
DR   Horizon_Discovery; HZGHC006108c011
DR   Wikidata; Q93955871
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8104; OCLN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OCRL (-) 1
AC   CVCL_TB59
SY   HZGHC002893c002; OCRL knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB59
DR   Horizon_Discovery; HZGHC002893c002
DR   Wikidata; Q54876714
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8108; OCRL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OCRL (-) 2
AC   CVCL_TB60
SY   HZGHC002893c006; OCRL knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TB60
DR   Horizon_Discovery; HZGHC002893c006
DR   Wikidata; Q54876715
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8108; OCRL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OGG1 (-) 1
AC   CVCL_TB61
SY   HZGHC000424c001; OGG1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TB61
DR   Horizon_Discovery; HZGHC000424c001
DR   Wikidata; Q54876716
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8125; OGG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000424c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 OGG1 (-) 2
AC   CVCL_TB62
SY   HZGHC000424c015; OGG1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TB62
DR   Horizon_Discovery; HZGHC000424c015
DR   Wikidata; Q54876717
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8125; OGG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OGG1 (-) 3
AC   CVCL_TB63
SY   HZGHC000424c022; OGG1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TB63
DR   Horizon_Discovery; HZGHC000424c022
DR   Wikidata; Q54876718
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8125; OGG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OPTN (-)
AC   CVCL_E2FJ
SY   HZGHC007890c002
DR   Horizon_Discovery; HZGHC007890c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17142; OPTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OSBPL7 (-) 1
AC   CVCL_E2FK
SY   HZGHC008203c018
DR   Horizon_Discovery; HZGHC008203c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16387; OSBPL7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OSBPL7 (-) 2
AC   CVCL_E2FL
SY   HZGHC008203c019
DR   Horizon_Discovery; HZGHC008203c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16387; OSBPL7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OSBPL7 (-) 3
AC   CVCL_E2FM
SY   HZGHC008203c020
DR   Horizon_Discovery; HZGHC008203c020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16387; OSBPL7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OSR1 (-) 1
AC   CVCL_TB64
SY   HZGHC001269c016; OSR1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TB64
DR   Horizon_Discovery; HZGHC001269c016
DR   Wikidata; Q54876719
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8111; OSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OSR1 (-) 2
AC   CVCL_TB65
SY   HZGHC002997c003; OSR1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TB65
DR   Horizon_Discovery; HZGHC002997c003
DR   Wikidata; Q54876720
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8111; OSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OSR1 (-) 3
AC   CVCL_TB66
SY   HZGHC002997c011; OSR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB66
DR   Horizon_Discovery; HZGHC002997c011
DR   Wikidata; Q54876721
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8111; OSR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUB1 (-)
AC   CVCL_TB67
SY   HZGHC000506c003; OTUB1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TB67
DR   Horizon_Discovery; HZGHC000506c003
DR   Wikidata; Q54876722
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23077; OTUB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUB2 (-) 1
AC   CVCL_TB68
SY   HZGHC000638c001; OTUB2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TB68
DR   Horizon_Discovery; HZGHC000638c001
DR   Wikidata; Q54876723
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20351; OTUB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUB2 (-) 2
AC   CVCL_TB69
SY   HZGHC000638c006; OTUB2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TB69
DR   Horizon_Discovery; HZGHC000638c006
DR   Wikidata; Q54876724
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20351; OTUB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD1 (-) 1
AC   CVCL_TB70
SY   HZGHC000904c004; OTUD1 knockout cell line 50bp deletion
DR   cancercelllines; CVCL_TB70
DR   Horizon_Discovery; HZGHC000904c004
DR   Wikidata; Q54876725
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27346; OTUD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD1 (-) 2
AC   CVCL_TB71
SY   HZGHC000904c010; OTUD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB71
DR   Horizon_Discovery; HZGHC000904c010
DR   Wikidata; Q54876726
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27346; OTUD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD3 (-) 1
AC   CVCL_TB72
SY   HZGHC000500c002; OTUD3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB72
DR   Horizon_Discovery; HZGHC000500c002
DR   Wikidata; Q54876727
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29038; OTUD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD3 (-) 2
AC   CVCL_TB73
SY   HZGHC000500c003; OTUD3 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TB73
DR   Horizon_Discovery; HZGHC000500c003
DR   Wikidata; Q54876728
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29038; OTUD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD4 (-)
AC   CVCL_TB74
SY   HZGHC000501c002; OTUD4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TB74
DR   Horizon_Discovery; HZGHC000501c002
DR   Wikidata; Q54876729
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24949; OTUD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD5 (-) 1
AC   CVCL_TB75
SY   HZGHC000502c002; OTUD5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB75
DR   Horizon_Discovery; HZGHC000502c002
DR   Wikidata; Q54876730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25402; OTUD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD5 (-) 2
AC   CVCL_TB76
SY   HZGHC000502c003; OTUD5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TB76
DR   Horizon_Discovery; HZGHC000502c003
DR   Wikidata; Q54876731
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25402; OTUD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD6B (-)
AC   CVCL_TB77
SY   HZGHC000469c004; OTUD6B knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TB77
DR   Horizon_Discovery; HZGHC000469c004
DR   Wikidata; Q54876732
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24281; OTUD6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD7A (-) 1
AC   CVCL_E2FN
SY   HZGHC007374c002
DR   Horizon_Discovery; HZGHC007374c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20718; OTUD7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OTUD7A (-) 2
AC   CVCL_E2FP
SY   HZGHC007374c003
DR   Horizon_Discovery; HZGHC007374c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20718; OTUD7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OTUD7A (-) 3
AC   CVCL_E2FQ
SY   HZGHC007374c009
DR   Horizon_Discovery; HZGHC007374c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20718; OTUD7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 OTUD7B (-) 1
AC   CVCL_TB78
SY   HZGHC000475c006; OTUD7B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TB78
DR   Horizon_Discovery; HZGHC000475c006
DR   Wikidata; Q54876733
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16683; OTUD7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OTUD7B (-) 2
AC   CVCL_TB79
SY   HZGHC000475c011; OTUD7B knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TB79
DR   Horizon_Discovery; HZGHC000475c011
DR   Wikidata; Q54876734
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16683; OTUD7B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OXLD1 (-) 1
AC   CVCL_TB80
SY   HZGHC004174c004; OXLD1 knockout cell line 574bp insertion
DR   cancercelllines; CVCL_TB80
DR   Horizon_Discovery; HZGHC004174c004
DR   Wikidata; Q54876735
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27901; OXLD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004174c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 OXLD1 (-) 2
AC   CVCL_TB81
SY   HZGHC004174c008; OXLD1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TB81
DR   Horizon_Discovery; HZGHC004174c008
DR   Wikidata; Q54876736
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27901; OXLD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 OXNAD1 (-) 1
AC   CVCL_TB82
SY   HZGHC005865c001; OXNAD1 knockout cell line 28bp deletion; HAP1 OXNAD1 (-)
DR   cancercelllines; CVCL_TB82
DR   Horizon_Discovery; HZGHC005865c001
DR   Wikidata; Q54876739
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25128; OXNAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 OXNAD1 (-) 2
AC   CVCL_XR29
SY   HZGHC005865c008; OXNAD1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XR29
DR   Horizon_Discovery; HZGHC005865c008
DR   Wikidata; Q93956057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25128; OXNAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005865c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 OXNAD1 (-) 3
AC   CVCL_XR30
SY   HZGHC005865c009; OXNAD1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XR30
DR   Horizon_Discovery; HZGHC005865c009
DR   Wikidata; Q93956060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25128; OXNAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005865c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 P4HB (-) 1
AC   CVCL_E2FR
SY   HZGHC008052c003
DR   Horizon_Discovery; HZGHC008052c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8548; P4HB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 P4HB (-) 2
AC   CVCL_E2FS
SY   HZGHC008052c009
DR   Horizon_Discovery; HZGHC008052c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8548; P4HB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PABPC4 (-) 1
AC   CVCL_TB83
SY   HZGHC003272c002; PABPC4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB83
DR   Horizon_Discovery; HZGHC003272c002
DR   Wikidata; Q54876740
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8557; PABPC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PABPC4 (-) 2
AC   CVCL_TB84
SY   HZGHC003272c003; PABPC4 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TB84
DR   Horizon_Discovery; HZGHC003272c003
DR   Wikidata; Q54876741
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8557; PABPC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PABPC4 (-) 3
AC   CVCL_TB85
SY   HZGHC003272c010; PABPC4 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TB85
DR   Horizon_Discovery; HZGHC003272c010
DR   Wikidata; Q54876742
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8557; PABPC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PACRG (-) 1
AC   CVCL_TB86
SY   HZGHC006045c012; PACRG knockout cell line 11bp deletion; HAP1 PACRG (-)
DR   cancercelllines; CVCL_TB86
DR   Horizon_Discovery; HZGHC006045c012
DR   Wikidata; Q54876743
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19152; PACRG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PACRG (-) 2
AC   CVCL_XR31
SY   HZGHC006045c008; PACRG knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XR31
DR   Horizon_Discovery; HZGHC006045c008
DR   Wikidata; Q93956092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19152; PACRG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PACS1 (-) 1
AC   CVCL_E2FT
SY   HZGHC008045c008
DR   Horizon_Discovery; HZGHC008045c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30032; PACS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PACS1 (-) 2
AC   CVCL_E2FU
SY   HZGHC008045c012
DR   Horizon_Discovery; HZGHC008045c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30032; PACS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PAK1 (-) 1
AC   CVCL_TB87
SY   HZGHC000160c012; PAK1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TB87
DR   Horizon_Discovery; HZGHC000160c012
DR   Wikidata; Q54876744
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAK1 (-) 2
AC   CVCL_TB88
SY   HZGHC000160c014; PAK1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TB88
DR   Horizon_Discovery; HZGHC000160c014
DR   Wikidata; Q54876745
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000160c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAK1 (-) 3
AC   CVCL_TB89
SY   HZGHC000160c015; PAK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TB89
DR   Horizon_Discovery; HZGHC000160c015
DR   Wikidata; Q54876746
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000160c015; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAK2 (-) 1
AC   CVCL_TB90
SY   HZGHC000053c001; PAK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TB90
DR   Horizon_Discovery; HZGHC000053c001
DR   Wikidata; Q54876747
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAK2 (-) 2
AC   CVCL_TB91
SY   HZGHC000053c003; PAK2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TB91
DR   Horizon_Discovery; HZGHC000053c003
DR   Wikidata; Q54876748
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAK2 (-) 3
AC   CVCL_TB92
SY   HZGHC000053c015; PAK2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB92
DR   Horizon_Discovery; HZGHC000053c015
DR   Wikidata; Q54876749
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAK2 (-) 4
AC   CVCL_TB93
SY   HZGHC000053c016; PAK2 knockout cell line 86bp insertion
DR   cancercelllines; CVCL_TB93
DR   Horizon_Discovery; HZGHC000053c016
DR   Wikidata; Q54876750
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000053c016; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAK4 (-) 1
AC   CVCL_TB94
SY   HZGHC000161c010; PAK4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB94
DR   Horizon_Discovery; HZGHC000161c010
DR   Wikidata; Q54876751
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAK4 (-) 2
AC   CVCL_TB95
SY   HZGHC000161c014; PAK4 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TB95
DR   Horizon_Discovery; HZGHC000161c014
DR   Wikidata; Q54876752
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAK4 (-) 3
AC   CVCL_TB96
SY   HZGHC000161c022; PAK4 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TB96
DR   Horizon_Discovery; HZGHC000161c022
DR   Wikidata; Q54876753
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAK6 (-)
AC   CVCL_TB97
SY   HZGHC000310c018; PAK6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TB97
DR   Horizon_Discovery; HZGHC000310c018
DR   Wikidata; Q54876754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16061; PAK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PALM (-) 1
AC   CVCL_TB98
SY   HZGHC004206c012; PALM knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TB98
DR   Horizon_Discovery; HZGHC004206c012
DR   Wikidata; Q54876755
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8594; PALM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PALM (-) 2
AC   CVCL_TB99
SY   HZGHC004544c007; PALM knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TB99
DR   Horizon_Discovery; HZGHC004544c007
DR   Wikidata; Q54876756
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8594; PALM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PALM (-) 3
AC   CVCL_TC00
SY   HZGHC004544c010; PALM knockout cell line 49bp deletion
DR   cancercelllines; CVCL_TC00
DR   Horizon_Discovery; HZGHC004544c010
DR   Wikidata; Q54876757
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8594; PALM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAN2 (-) 1
AC   CVCL_TC01
SY   HZGHC000454c006; PAN2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TC01
DR   Horizon_Discovery; HZGHC000454c006
DR   Wikidata; Q54876758
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20074; PAN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAN2 (-) 2
AC   CVCL_TC02
SY   HZGHC000454c008; PAN2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TC02
DR   Horizon_Discovery; HZGHC000454c008
DR   Wikidata; Q54876759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20074; PAN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAN3 (-) 1
AC   CVCL_XR32
SY   HZGHC007073c006; HZGHC255967; PAN3 knockout cell line 1bp deletion in exon 5; HAP1 PAN3 (-)
DR   cancercelllines; CVCL_XR32
DR   Horizon_Discovery; HZGHC007073c006
DR   Wikidata; Q93956205
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29991; PAN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAN3 (-) 2
AC   CVCL_B5KL
SY   HZGHC007073c008; PAN3 knockout cell line 1bp insertion in exon 5
DR   cancercelllines; CVCL_B5KL
DR   Horizon_Discovery; HZGHC007073c008
DR   Wikidata; Q111733307
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29991; PAN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 PANK1 (-) 1
AC   CVCL_E2FV
SY   HZGHC007510c004
DR   Horizon_Discovery; HZGHC007510c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8598; PANK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PANK1 (-) 2
AC   CVCL_E2FW
SY   HZGHC007510c006
DR   Horizon_Discovery; HZGHC007510c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8598; PANK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PANK1 (-) 3
AC   CVCL_E2FX
SY   HZGHC007511c007
DR   Horizon_Discovery; HZGHC007511c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8598; PANK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PANK2 (-) 1
AC   CVCL_E2FY
SY   HZGHC007363c003
DR   Horizon_Discovery; HZGHC007363c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15894; PANK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PANK2 (-) 2
AC   CVCL_E2FZ
SY   HZGHC007363c012
DR   Horizon_Discovery; HZGHC007363c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15894; PANK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PANK3 (-) 1
AC   CVCL_E2G0
SY   HZGHC007431c001
DR   Horizon_Discovery; HZGHC007431c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19365; PANK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PANK3 (-) 2
AC   CVCL_E2G1
SY   HZGHC007431c012
DR   Horizon_Discovery; HZGHC007431c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19365; PANK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PANX2 (-)
AC   CVCL_XR33
SY   HZGHC007112c012; HZGHC56666; PANX2 knockout cell line 26bp deletion in exon 2
DR   cancercelllines; CVCL_XR33
DR   Horizon_Discovery; HZGHC007112c012
DR   Wikidata; Q93956208
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8600; PANX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAPSS1 (-) 1
AC   CVCL_E2G2
SY   HZGHC007590c005
DR   Horizon_Discovery; HZGHC007590c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8603; PAPSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PAPSS1 (-) 2
AC   CVCL_E2G3
SY   HZGHC007590c011
DR   Horizon_Discovery; HZGHC007590c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8603; PAPSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PAPSS1 (-) 3
AC   CVCL_E2G4
SY   HZGHC007590c012
DR   Horizon_Discovery; HZGHC007590c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8603; PAPSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PAPSS2 (-) 1
AC   CVCL_TC03
SY   HZGHC004332c002; PAPSS2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TC03
DR   Horizon_Discovery; HZGHC004332c002
DR   Wikidata; Q54876760
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8604; PAPSS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAPSS2 (-) 2
AC   CVCL_TC04
SY   HZGHC004332c004; PAPSS2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TC04
DR   Horizon_Discovery; HZGHC004332c004
DR   Wikidata; Q54876761
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8604; PAPSS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAPSS2 (-) 3
AC   CVCL_TC05
SY   HZGHC004332c012; PAPSS2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TC05
DR   Horizon_Discovery; HZGHC004332c012
DR   Wikidata; Q54876762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8604; PAPSS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARG (-) 1
AC   CVCL_TC06
SY   HZGHC006390c010; PARG knockout cell line 5bp deletion; HAP1 PARG (-)
DR   cancercelllines; CVCL_TC06
DR   Horizon_Discovery; HZGHC006390c010
DR   Wikidata; Q54876763
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARG (-) 2
AC   CVCL_XR34
SY   HZGHC006390c012; PARG knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XR34
DR   Horizon_Discovery; HZGHC006390c012
DR   Wikidata; Q93956219
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006390c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARK2 (-) 1
AC   CVCL_TC07
SY   HZGHC003208c002; PARK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TC07
DR   Horizon_Discovery; HZGHC003208c002
DR   Wikidata; Q54876764
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARK2 (-) 2
AC   CVCL_TC08
SY   HZGHC003208c005; PARK2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TC08
DR   Horizon_Discovery; HZGHC003208c005
DR   Wikidata; Q54876765
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARK7 (-) 1
AC   CVCL_TC09
SY   HZGHC001316c002; PARK7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC09
DR   Horizon_Discovery; HZGHC001316c002
DR   Wikidata; Q54876767
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARK7 (-) 2
AC   CVCL_TC10
SY   HZGHC001316c008; PARK7 knockout cell line 167bp insertion
DR   cancercelllines; CVCL_TC10
DR   Horizon_Discovery; HZGHC001316c008
DR   Wikidata; Q54876768
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001316c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARL (-) 1
AC   CVCL_E2G5
SY   HZGHC007660c003
DR   Horizon_Discovery; HZGHC007660c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18253; PARL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PARL (-) 2
AC   CVCL_E2G6
SY   HZGHC007660c010
DR   Horizon_Discovery; HZGHC007660c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18253; PARL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PARP1 (-) 1
AC   CVCL_TC11
SY   HZGHC003943c006; PARP1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TC11
DR   Horizon_Discovery; HZGHC003943c006
DR   Wikidata; Q54876769
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003943c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARP1 (-) 2
AC   CVCL_TC12
SY   HZGHC003943c008; PARP1 knockout cell line 268bp insertion
DR   cancercelllines; CVCL_TC12
DR   Horizon_Discovery; HZGHC003943c008
DR   Wikidata; Q54876770
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003943c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARP12 (-) 1
AC   CVCL_TC13
SY   HZGHC006104c002; PARP12 knockout cell line 13bp deletion; HAP1 PARP12 (-)
DR   cancercelllines; CVCL_TC13
DR   Horizon_Discovery; HZGHC006104c002
DR   Wikidata; Q54876771
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21919; PARP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARP12 (-) 2
AC   CVCL_XR35
SY   HZGHC006104c005; PARP12 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XR35
DR   Horizon_Discovery; HZGHC006104c005
DR   Wikidata; Q93956240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21919; PARP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP16 (-) 1
AC   CVCL_TC14
SY   HZGHC006463c009; PARP16 knockout cell line 1bp deletion; HAP1 PARP16 (-)
DR   cancercelllines; CVCL_TC14
DR   Horizon_Discovery; HZGHC006463c009
DR   Wikidata; Q54876772
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26040; PARP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006463c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PARP16 (-) 2
AC   CVCL_XR36
SY   HZGHC006464c010; PARP16 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XR36
DR   Horizon_Discovery; HZGHC006464c010
DR   Wikidata; Q93956245
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26040; PARP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006464c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARP2 (-) 1
AC   CVCL_TC15
SY   HZGHC000665c006; PARP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC15
DR   Horizon_Discovery; HZGHC000665c006
DR   Wikidata; Q54876773
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP2 (-) 2
AC   CVCL_TC16
SY   HZGHC000665c011; PARP2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TC16
DR   Horizon_Discovery; HZGHC000665c011
DR   Wikidata; Q54876774
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP2 (-) 3
AC   CVCL_XR37
SY   HZGHC006378c003; PARP2 knockout cell line 67bp deletion
DR   cancercelllines; CVCL_XR37
DR   Horizon_Discovery; HZGHC006378c003
DR   Wikidata; Q93956253
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP2 (-) 4
AC   CVCL_XR38
SY   HZGHC006378c005; PARP2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XR38
DR   Horizon_Discovery; HZGHC006378c005
DR   Wikidata; Q93956255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP3 (-) 1
AC   CVCL_TC17
SY   HZGHC001196c003; PARP3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TC17
DR   Horizon_Discovery; HZGHC001196c003
DR   Wikidata; Q54876775
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP3 (-) 2
AC   CVCL_TC18
SY   HZGHC001196c008; PARP3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TC18
DR   Horizon_Discovery; HZGHC001196c008
DR   Wikidata; Q54876776
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP4 (-) 1
AC   CVCL_TC19
SY   HZGHC004689c004; PARP4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC19
DR   Horizon_Discovery; HZGHC004689c004
DR   Wikidata; Q54876777
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:271; PARP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP4 (-) 2
AC   CVCL_TC20
SY   HZGHC004689c007; PARP4 knockout cell line 7bp insertion
DR   cancercelllines; CVCL_TC20
DR   Horizon_Discovery; HZGHC004689c007
DR   Wikidata; Q54876778
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:271; PARP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP6 (-) 1
AC   CVCL_TC21
SY   HZGHC004690c004; PARP6 knockout cell line 46bp deletion
DR   cancercelllines; CVCL_TC21
DR   Horizon_Discovery; HZGHC004690c004
DR   Wikidata; Q54876779
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26921; PARP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004690c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARP6 (-) 2
AC   CVCL_TC22
SY   HZGHC004690c005; PARP6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TC22
DR   Horizon_Discovery; HZGHC004690c005
DR   Wikidata; Q54876781
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26921; PARP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004690c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARP6 (-) 3
AC   CVCL_TC23
SY   HZGHC004690c007; PARP6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TC23
DR   Horizon_Discovery; HZGHC004690c007
DR   Wikidata; Q54876782
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26921; PARP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004690c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PARP9 (-) 1
AC   CVCL_TC24
SY   HZGHC004692c010; PARP9 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TC24
DR   Horizon_Discovery; HZGHC004692c010
DR   Wikidata; Q54876783
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24118; PARP9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARP9 (-) 2
AC   CVCL_TC25
SY   HZGHC004692c011; PARP9 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_TC25
DR   Horizon_Discovery; HZGHC004692c011
DR   Wikidata; Q54876784
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24118; PARP9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARPBP (-) 1
AC   CVCL_TC26
SY   HZGHC004755c003; PARPBP knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TC26
DR   Horizon_Discovery; HZGHC004755c003
DR   Wikidata; Q54876785
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26074; PARPBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PARPBP (-) 2
AC   CVCL_TC27
SY   HZGHC004755c012; PARPBP knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC27
DR   Horizon_Discovery; HZGHC004755c012
DR   Wikidata; Q54876786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26074; PARPBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PASK (-) 1
AC   CVCL_TC28
SY   HZGHC000162c003; PASK knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TC28
DR   Horizon_Discovery; HZGHC000162c003
DR   Wikidata; Q54876787
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17270; PASK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PASK (-) 2
AC   CVCL_TC29
SY   HZGHC000162c006; PASK knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC29
DR   Horizon_Discovery; HZGHC000162c006
DR   Wikidata; Q54876788
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17270; PASK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PASK (-) 3
AC   CVCL_TC30
SY   HZGHC000162c021; PASK knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TC30
DR   Horizon_Discovery; HZGHC000162c021
DR   Wikidata; Q54876789
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17270; PASK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAX5 (-) 1
AC   CVCL_C7Y1
SY   HZGHC007506c011; PAX5 knockout cell line 5bp deletion in exon 6
DR   Horizon_Discovery; HZGHC007506c011
DR   Wikidata; Q123031427
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8619; PAX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PAX5 (-) 2
AC   CVCL_C7Y2
SY   HZGHC007506c012; PAX5 knockout cell line 1bp deletion in exon 6
DR   Horizon_Discovery; HZGHC007506c012
DR   Wikidata; Q123031428
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8619; PAX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PAX8 (-) 1
AC   CVCL_TC31
SY   HZGHC006273c001; PAX8 knockout cell line 2bp deletion; HAP1 PAX8 (-)
DR   cancercelllines; CVCL_TC31
DR   Horizon_Discovery; HZGHC006273c001
DR   Wikidata; Q54876790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8622; PAX8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAX8 (-) 2
AC   CVCL_XR39
SY   HZGHC006273c012; PAX8 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_XR39
DR   Horizon_Discovery; HZGHC006273c012
DR   Wikidata; Q93956373
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8622; PAX8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PAXIP1 (-) 1
AC   CVCL_TC32
SY   HZGHC000762c006; PAXIP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC32
DR   Horizon_Discovery; HZGHC000762c006
DR   Wikidata; Q54876791
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8624; PAXIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000762c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PAXIP1 (-) 2
AC   CVCL_TC33
SY   HZGHC000762c007; PAXIP1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TC33
DR   Horizon_Discovery; HZGHC000762c007
DR   Wikidata; Q54876792
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8624; PAXIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000762c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PBK (-) 1
AC   CVCL_TC34
SY   HZGHC000098c014; PBK knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC34
DR   Horizon_Discovery; HZGHC000098c014
DR   Wikidata; Q54876793
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PBK (-) 2
AC   CVCL_TC35
SY   HZGHC000098c016; PBK knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TC35
DR   Horizon_Discovery; HZGHC000098c016
DR   Wikidata; Q54876794
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PBK (-) 3
AC   CVCL_XR40
SY   HZGHC000289c003; PBK knockout cell line 25bp deletion
DR   cancercelllines; CVCL_XR40
DR   Horizon_Discovery; HZGHC000289c003
DR   Wikidata; Q93956398
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PBK (-) 4
AC   CVCL_XR41
SY   HZGHC000289c017; PBK knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XR41
DR   Horizon_Discovery; HZGHC000289c017
DR   Wikidata; Q93956402
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PBK (-) 5
AC   CVCL_XR42
SY   HZGHC000289c023; PBK knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XR42
DR   Horizon_Discovery; HZGHC000289c023
DR   Wikidata; Q93956404
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PBRM1 (-) 1
AC   CVCL_TC36
SY   HZGHC001135c006; PBRM1 knockout cell line 10bp deletion
DR   Horizon_Discovery; HZGHC001135c006
DR   Wikidata; Q54876795
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001135c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PBRM1 (-) 2
AC   CVCL_TC37
SY   HZGHC001135c010; PBRM1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TC37
DR   Horizon_Discovery; HZGHC001135c010
DR   Wikidata; Q54876796
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PBRM1 (-) 3
AC   CVCL_TC38
SY   HZGHC001135c012; PBRM1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TC38
DR   Horizon_Discovery; HZGHC001135c012
DR   Wikidata; Q54876797
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PC (-)
AC   CVCL_TC39
SY   HZGHC006325c001; PC knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TC39
DR   Horizon_Discovery; HZGHC006325c001
DR   Wikidata; Q54876798
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8636; PC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCCA (-) 1
AC   CVCL_TC40
SY   HZGHC005361c001; PCCA knockout cell line 92bp deletion; HAP1 PCCA (-)
DR   cancercelllines; CVCL_TC40
DR   Horizon_Discovery; HZGHC005361c001
DR   Wikidata; Q54876799
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8653; PCCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PCCA (-) 2
AC   CVCL_XR43
SY   HZGHC005361c005; PCCA knockout cell line 103bp deletion
DR   cancercelllines; CVCL_XR43
DR   Horizon_Discovery; HZGHC005361c005
DR   Wikidata; Q93956445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8653; PCCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH1 (-) 1
AC   CVCL_TC41
SY   HZGHC000179c008; PCDH1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TC41
DR   Horizon_Discovery; HZGHC000179c008
DR   Wikidata; Q54876800
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8655; PCDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH1 (-) 2
AC   CVCL_TC42
SY   HZGHC000179c011; PCDH1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TC42
DR   Horizon_Discovery; HZGHC000179c011
DR   Wikidata; Q54876801
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8655; PCDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH1 (-) 3
AC   CVCL_TC43
SY   HZGHC000179c013; PCDH1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC43
DR   Horizon_Discovery; HZGHC000179c013
DR   Wikidata; Q54876802
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8655; PCDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH1 (-) 4
AC   CVCL_TC44
SY   HZGHC000558c009; PCDH1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TC44
DR   Horizon_Discovery; HZGHC000558c009
DR   Wikidata; Q54876803
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8655; PCDH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH7 (-) 1
AC   CVCL_TC45
SY   HZGHC000410c009; PCDH7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC45
DR   Horizon_Discovery; HZGHC000410c009
DR   Wikidata; Q54876804
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8659; PCDH7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH7 (-) 2
AC   CVCL_TC46
SY   HZGHC000410c010; PCDH7 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TC46
DR   Horizon_Discovery; HZGHC000410c010
DR   Wikidata; Q54876805
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8659; PCDH7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH9 (-) 1
AC   CVCL_TC47
SY   HZGHC000372c003; PCDH9 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TC47
DR   Horizon_Discovery; HZGHC000372c003
DR   Wikidata; Q54876806
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8661; PCDH9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH9 (-) 2
AC   CVCL_TC48
SY   HZGHC000372c004; PCDH9 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TC48
DR   Horizon_Discovery; HZGHC000372c004
DR   Wikidata; Q54876807
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8661; PCDH9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDH9 (-) 3
AC   CVCL_TC49
SY   HZGHC000372c008; PCDH9 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TC49
DR   Horizon_Discovery; HZGHC000372c008
DR   Wikidata; Q54876808
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8661; PCDH9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDHA1 (-) 1
AC   CVCL_TC50
SY   HZGHC003987c003; PCDHA1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TC50
DR   Horizon_Discovery; HZGHC003987c003
DR   Wikidata; Q54876809
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8663; PCDHA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDHA1 (-) 2
AC   CVCL_TC51
SY   HZGHC003987c011; PCDHA1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC51
DR   Horizon_Discovery; HZGHC003987c011
DR   Wikidata; Q54876810
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8663; PCDHA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCDHA3 (-)
AC   CVCL_TC52
SY   HZGHC004085c004; PCDHA3 knockout cell line 1bp deletion in exon 1
DR   cancercelllines; CVCL_TC52
DR   Horizon_Discovery; HZGHC004085c004
DR   Wikidata; Q54876811
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8669; PCDHA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCGF1 (-)
AC   CVCL_E2G7
SY   HZGHC007733c006
DR   Horizon_Discovery; HZGHC007733c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17615; PCGF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCGF2 (-)
AC   CVCL_E2G8
SY   HZGHC007653c004
DR   Horizon_Discovery; HZGHC007653c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12929; PCGF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCGF3 (-)
AC   CVCL_E2G9
SY   HZGHC007738c007
DR   Horizon_Discovery; HZGHC007738c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10066; PCGF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCGF5 (-)
AC   CVCL_E2GA
SY   HZGHC007731c008
DR   Horizon_Discovery; HZGHC007731c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28264; PCGF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCGF6 (-) 1
AC   CVCL_E2GB
SY   HZGHC007736c003
DR   Horizon_Discovery; HZGHC007736c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21156; PCGF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCGF6 (-) 2
AC   CVCL_E2GC
SY   HZGHC007736c009
DR   Horizon_Discovery; HZGHC007736c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21156; PCGF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCIF1 (-) 1
AC   CVCL_E2GD
SY   HZGHC007305c001
DR   Horizon_Discovery; HZGHC007305c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16200; PCIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCIF1 (-) 2
AC   CVCL_E2GE
SY   HZGHC007305c004
DR   Horizon_Discovery; HZGHC007305c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16200; PCIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCIF1 (-) 3
AC   CVCL_E2GF
SY   HZGHC007305c006
DR   Horizon_Discovery; HZGHC007305c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16200; PCIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCIF1 (-) 4
AC   CVCL_E2GG
SY   HZGHC007305c010
DR   Horizon_Discovery; HZGHC007305c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16200; PCIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCIF1 (-) 5
AC   CVCL_E2GH
SY   HZGHC007305c011
DR   Horizon_Discovery; HZGHC007305c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16200; PCIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PCMT1 (-) 1
AC   CVCL_TC53
SY   HZGHC002524c001; PCMT1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TC53
DR   Horizon_Discovery; HZGHC002524c001
DR   Wikidata; Q54876812
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8728; PCMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCMT1 (-) 2
AC   CVCL_TC54
SY   HZGHC002524c002; PCMT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TC54
DR   Horizon_Discovery; HZGHC002524c002
DR   Wikidata; Q54876813
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8728; PCMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002524c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PCSK6 (-) 1
AC   CVCL_TC55
SY   HZGHC002763c008; PCSK6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC55
DR   Horizon_Discovery; HZGHC002763c008
DR   Wikidata; Q54876814
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8569; PCSK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCSK6 (-) 2
AC   CVCL_TC56
SY   HZGHC002762c003; PCSK6 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TC56
DR   Horizon_Discovery; HZGHC002762c003
DR   Wikidata; Q54876815
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8569; PCSK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PCSK6 (-) 3
AC   CVCL_TC57
SY   HZGHC002763c012; PCSK6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TC57
DR   Horizon_Discovery; HZGHC002763c012
DR   Wikidata; Q54876816
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8569; PCSK6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDCD10 (-) 1
AC   CVCL_TC58
SY   HZGHC006588c010; PDCD10 knockout cell line 34bp insertion; HAP1 PDCD10 (-)
DR   cancercelllines; CVCL_TC58
DR   Horizon_Discovery; HZGHC006588c010
DR   Wikidata; Q54876817
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8761; PDCD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006588c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PDCD10 (-) 2
AC   CVCL_XR44
SY   HZGHC006588c002; PDCD10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XR44
DR   Horizon_Discovery; HZGHC006588c002
DR   Wikidata; Q93956562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8761; PDCD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDCD1LG2 (-) 1
AC   CVCL_TC59
SY   HZGHC006662c010; PDCD1LG2 knockout cell line 19bp deletion; HAP1 PDCD1LG2 (-)
DR   cancercelllines; CVCL_TC59
DR   Horizon_Discovery; HZGHC006662c010
DR   Wikidata; Q54876818
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PDCD1LG2 (-) 2
AC   CVCL_XR45
SY   HZGHC006662c002; PDCD1LG2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XR45
DR   Horizon_Discovery; HZGHC006662c002
DR   Wikidata; Q93956573
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDCD4 (-) 1
AC   CVCL_TC60
SY   HZGHC005167c003; PDCD4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TC60
DR   Horizon_Discovery; HZGHC005167c003
DR   Wikidata; Q54876819
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8763; PDCD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDCD4 (-) 2
AC   CVCL_TC61
SY   HZGHC005167c011; PDCD4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC61
DR   Horizon_Discovery; HZGHC005167c011
DR   Wikidata; Q54876820
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8763; PDCD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDCD5 (-) 1
AC   CVCL_TC62
SY   HZGHC005843c002; PDCD5 knockout cell line 5bp insertion; HAP1 PDCD5 (-)
DR   cancercelllines; CVCL_TC62
DR   Horizon_Discovery; HZGHC005843c002
DR   Wikidata; Q54876824
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8764; PDCD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005843c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PDCD5 (-) 2
AC   CVCL_XR46
SY   HZGHC005843c006; PDCD5 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XR46
DR   Horizon_Discovery; HZGHC005843c006
DR   Wikidata; Q93956592
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8764; PDCD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005843c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PDE10A (-) 1
AC   CVCL_TC63
SY   HZGHC003859c003; PDE10A knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TC63
DR   Horizon_Discovery; HZGHC003859c003
DR   Wikidata; Q54876825
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8772; PDE10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE10A (-) 2
AC   CVCL_TC64
SY   HZGHC003859c011; PDE10A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TC64
DR   Horizon_Discovery; HZGHC003859c011
DR   Wikidata; Q54876826
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8772; PDE10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE4A (-) 1
AC   CVCL_TC65
SY   HZGHC003883c002; PDE4A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TC65
DR   Horizon_Discovery; HZGHC003883c002
DR   Wikidata; Q54876827
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8780; PDE4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE4A (-) 2
AC   CVCL_TC66
SY   HZGHC003883c010; PDE4A knockout cell line 95bp deletion
DR   cancercelllines; CVCL_TC66
DR   Horizon_Discovery; HZGHC003883c010
DR   Wikidata; Q54876828
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8780; PDE4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE5A (-)
AC   CVCL_TC67
SY   HZGHC003906c012; PDE5A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC67
DR   Horizon_Discovery; HZGHC003906c012
DR   Wikidata; Q54876829
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8784; PDE5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE6D (-) 1
AC   CVCL_TC68
SY   HZGHC006484c010; PDE6D knockout cell line 184bp insertion; HAP1 PDE6D (-)
DR   cancercelllines; CVCL_TC68
DR   Horizon_Discovery; HZGHC006484c010
DR   Wikidata; Q54876830
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8788; PDE6D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006484c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PDE6D (-) 2
AC   CVCL_XR47
SY   HZGHC006484c003; PDE6D knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XR47
DR   Horizon_Discovery; HZGHC006484c003
DR   Wikidata; Q93956634
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8788; PDE6D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE7A (-) 1
AC   CVCL_TC69
SY   HZGHC003840c008; PDE7A knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TC69
DR   Horizon_Discovery; HZGHC003840c008
DR   Wikidata; Q54876831
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8791; PDE7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE7A (-) 2
AC   CVCL_TC70
SY   HZGHC003840c011; PDE7A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TC70
DR   Horizon_Discovery; HZGHC003840c011
DR   Wikidata; Q54876832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8791; PDE7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDE8A (-)
AC   CVCL_TC71
SY   HZGHC003772c010; PDE8A knockout cell line 98bp insertion
DR   cancercelllines; CVCL_TC71
DR   Horizon_Discovery; HZGHC003772c010
DR   Wikidata; Q54876833
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8793; PDE8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003772c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PDGFC (-) 1
AC   CVCL_E2GI
SY   HZGHC007936c007
DR   Horizon_Discovery; HZGHC007936c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8801; PDGFC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PDGFC (-) 2
AC   CVCL_E2GJ
SY   HZGHC007936c012
DR   Horizon_Discovery; HZGHC007936c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8801; PDGFC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PDGFRA (-)
AC   CVCL_TC72
SY   HZGHC000236c007; PDGFRA knockout cell line 176bp insertion
DR   cancercelllines; CVCL_TC72
DR   Horizon_Discovery; HZGHC000236c007
DR   Wikidata; Q54876834
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000236c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PDIA2 (-) 1
AC   CVCL_TC73
SY   HZGHC006243c005; PDIA2 knockout cell line 2bp insertion; HAP1 PDIA2 (-)
DR   cancercelllines; CVCL_TC73
DR   Horizon_Discovery; HZGHC006243c005
DR   Wikidata; Q54876835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14180; PDIA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PDIA2 (-) 2
AC   CVCL_XR48
SY   HZGHC006243c007; PDIA2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XR48
DR   Horizon_Discovery; HZGHC006243c007
DR   Wikidata; Q93956671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14180; PDIA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDIA3 (-) 1
AC   CVCL_TC74
SY   HZGHC006171c011; PDIA3 knockout cell line 8bp deletion; HAP1 PDIA3 (-)
DR   cancercelllines; CVCL_TC74
DR   Horizon_Discovery; HZGHC006171c011
DR   Wikidata; Q54876836
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4606; PDIA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PDIA3 (-) 2
AC   CVCL_XR49
SY   HZGHC006171c004; PDIA3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XR49
DR   Horizon_Discovery; HZGHC006171c004
DR   Wikidata; Q93956680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4606; PDIA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDIK1L (-) 1
AC   CVCL_TC75
SY   HZGHC004547c001; PDIK1L knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC75
DR   Horizon_Discovery; HZGHC004547c001
DR   Wikidata; Q54876837
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18981; PDIK1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDIK1L (-) 2
AC   CVCL_TC76
SY   HZGHC004547c010; PDIK1L knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TC76
DR   Horizon_Discovery; HZGHC004547c010
DR   Wikidata; Q54876838
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18981; PDIK1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDIK1L (-) 3
AC   CVCL_TC77
SY   HZGHC004547c012; PDIK1L knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TC77
DR   Horizon_Discovery; HZGHC004547c012
DR   Wikidata; Q54876839
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18981; PDIK1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDK1 (-) 1
AC   CVCL_TC78
SY   HZGHC000027c012; PDK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TC78
DR   Horizon_Discovery; HZGHC000027c012
DR   Wikidata; Q54876840
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8809; PDK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDK1 (-) 2
AC   CVCL_TC79
SY   HZGHC000027c024; PDK1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TC79
DR   Horizon_Discovery; HZGHC000027c024
DR   Wikidata; Q54876841
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8809; PDK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDK2 (-) 1
AC   CVCL_TC80
SY   HZGHC000163c014; PDK2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TC80
DR   Horizon_Discovery; HZGHC000163c014
DR   Wikidata; Q54876842
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8810; PDK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDK2 (-) 2
AC   CVCL_TC81
SY   HZGHC000163c020; PDK2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TC81
DR   Horizon_Discovery; HZGHC000163c020
DR   Wikidata; Q54876843
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8810; PDK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDK2 (-) 3
AC   CVCL_TC82
SY   HZGHC000163c023; PDK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC82
DR   Horizon_Discovery; HZGHC000163c023
DR   Wikidata; Q54876844
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8810; PDK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDK3 (-)
AC   CVCL_TC83
SY   HZGHC000230c005; PDK3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TC83
DR   Horizon_Discovery; HZGHC000230c005
DR   Wikidata; Q54876845
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8811; PDK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000230c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PDP1 (-)
AC   CVCL_TC84
SY   HZGHC003107c007; PDP1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TC84
DR   Horizon_Discovery; HZGHC003107c007
DR   Wikidata; Q54876846
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9279; PDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDP2 (-)
AC   CVCL_TC85
SY   HZGHC003512c010; PDP2 knockout cell line 44bp deletion
DR   cancercelllines; CVCL_TC85
DR   Horizon_Discovery; HZGHC003512c010
DR   Wikidata; Q54876847
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30263; PDP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDPK1 (-)
AC   CVCL_TC86
SY   HZGHC000416c011; PDPK1 knockout cell line 276bp insertion
DR   cancercelllines; CVCL_TC86
DR   Horizon_Discovery; HZGHC000416c011
DR   PRIDE; PXD010335
DR   Wikidata; Q54876848
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8816; PDPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000416c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PDPN (-) 1
AC   CVCL_TC87
SY   HZGHC006114c011; PDPN knockout cell line 19bp deletion; HAP1 PDPN (-)
DR   cancercelllines; CVCL_TC87
DR   Horizon_Discovery; HZGHC006114c011
DR   Wikidata; Q54876849
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PDPN (-) 2
AC   CVCL_XR50
SY   HZGHC006114c003; PDPN knockout cell line 31bp deletion
DR   cancercelllines; CVCL_XR50
DR   Horizon_Discovery; HZGHC006114c003
DR   Wikidata; Q93956744
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PDSS1 (-)
AC   CVCL_E2GK
SY   HZGHC007693c003
DR   Horizon_Discovery; HZGHC007693c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17759; PDSS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PDSS2 (-)
AC   CVCL_E2GL
SY   HZGHC007713c012
DR   Horizon_Discovery; HZGHC007713c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23041; PDSS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PDXK (-) 1
AC   CVCL_TC88
SY   HZGHC006461c011; PDXK knockout cell line 4bp deletion; HAP1 PDXK (-)
DR   cancercelllines; CVCL_TC88
DR   Horizon_Discovery; HZGHC006461c011
DR   PRIDE; PXD010335
DR   Wikidata; Q54876850
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8819; PDXK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PDXK (-) 2
AC   CVCL_XR51
SY   HZGHC006461c006; PDXK knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XR51
DR   Horizon_Discovery; HZGHC006461c006
DR   PRIDE; PXD010335
DR   Wikidata; Q93956748
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8819; PDXK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PEAK1 (-)
AC   CVCL_TC89
SY   HZGHC001505c004; PEAK1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TC89
DR   Horizon_Discovery; HZGHC001505c004
DR   Wikidata; Q54876851
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29431; PEAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001505c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PEG10 (-) 1
AC   CVCL_TC90
SY   HZGHC005358c002; PEG10 knockout cell line 7bp deletion; HAP1 PEG10 (-)
DR   cancercelllines; CVCL_TC90
DR   Horizon_Discovery; HZGHC005358c002
DR   Wikidata; Q54876852
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14005; PEG10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PEG10 (-) 2
AC   CVCL_XR52
SY   HZGHC005358c004; PEG10 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XR52
DR   Horizon_Discovery; HZGHC005358c004
DR   Wikidata; Q93956762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14005; PEG10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PELO (-) 1
AC   CVCL_TC91
SY   HZGHC005109c001; PELO knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TC91
DR   Horizon_Discovery; HZGHC005109c001
DR   Wikidata; Q54876853
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8829; PELO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PELO (-) 2
AC   CVCL_TC92
SY   HZGHC005109c008; PELO knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TC92
DR   Horizon_Discovery; HZGHC005109c008
DR   Wikidata; Q54876854
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8829; PELO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PEX13 (-) 1
AC   CVCL_TC93
SY   HZGHC000820c001; PEX13 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TC93
DR   Horizon_Discovery; HZGHC000820c001
DR   Wikidata; Q54876855
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8855; PEX13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PEX13 (-) 2
AC   CVCL_TC94
SY   HZGHC000820c006; PEX13 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TC94
DR   Horizon_Discovery; HZGHC000820c006
DR   Wikidata; Q54876856
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8855; PEX13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000820c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PEX16 (-) 1
AC   CVCL_C7Y6
SY   HZGHC008062c007; PEX16 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC008062c007
DR   Wikidata; Q123031429
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8857; PEX16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX16 (-) 2
AC   CVCL_C7Y7
SY   HZGHC008063c007; PEX16 knockout cell line 1bp insertion in exon 5
DR   Horizon_Discovery; HZGHC008063c007
DR   Wikidata; Q123031430
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8857; PEX16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX19 (-) 1
AC   CVCL_C7Y3
SY   HZGHC008065c003; PEX19 knockout cell line 11bp deletion in exon 6
DR   Horizon_Discovery; HZGHC008065c003
DR   Wikidata; Q123031431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9713; PEX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX19 (-) 2
AC   CVCL_C7Y4
SY   HZGHC008065c004; PEX19 knockout cell line 10bp deletion in exon 6
DR   Horizon_Discovery; HZGHC008065c004
DR   Wikidata; Q123031432
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9713; PEX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX19 (-) 3
AC   CVCL_C7Y5
SY   HZGHC008065c006; PEX19 knockout cell line 5bp deletion in exon 6
DR   Horizon_Discovery; HZGHC008065c006
DR   Wikidata; Q123031434
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9713; PEX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX3 (-) 1
AC   CVCL_XR53
SY   HZGHC006955c003; HZGHC8504; PEX3 knockout cell line 4bp deletion in exon 5; HAP1 PEX3 (-)
DR   cancercelllines; CVCL_XR53
DR   Horizon_Discovery; HZGHC006955c003
DR   Wikidata; Q93956790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8858; PEX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PEX3 (-) 2
AC   CVCL_B5KM
SY   HZGHC006955c009; PEX3 knockout cell line 4bp deletion in exon 5
DR   cancercelllines; CVCL_B5KM
DR   Horizon_Discovery; HZGHC006955c009
DR   Wikidata; Q111733309
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8858; PEX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006955c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 PEX3 (-) 3
AC   CVCL_B5KN
SY   HZGHC006955c011; PEX3 knockout cell line 1bp insertion in exon 5
DR   cancercelllines; CVCL_B5KN
DR   Horizon_Discovery; HZGHC006955c011
DR   Wikidata; Q111733310
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8858; PEX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 PEX5 (-) 1
AC   CVCL_C7Y8
SY   HZGHC008086c006; PEX5 knockout cell line 1bp deletion
DR   Horizon_Discovery; HZGHC008086c006
DR   Wikidata; Q123031435
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9719; PEX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX5 (-) 2
AC   CVCL_C7Y9
SY   HZGHC008086c008; PEX5 knockout cell line 2bp deletion
DR   Horizon_Discovery; HZGHC008086c008
DR   Wikidata; Q123031436
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9719; PEX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX5 (-) 3
AC   CVCL_C7YA
SY   HZGHC008086c009; PEX5 knockout cell line 73bp deletion
DR   Horizon_Discovery; HZGHC008086c009
DR   Wikidata; Q123031437
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9719; PEX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PEX5 (-) 4
AC   CVCL_C7YB
SY   HZGHC008086c010; PEX5 knockout cell line 5bp deletion
DR   Horizon_Discovery; HZGHC008086c010
DR   Wikidata; Q123031438
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9719; PEX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC008086c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 PEX5 (-) 5
AC   CVCL_E2GM
SY   HZGHC008087c010
DR   Horizon_Discovery; HZGHC008087c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9719; PEX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PFKFB3 (-) 1
AC   CVCL_TC95
SY   HZGHC004434c009; PFKFB3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TC95
DR   Horizon_Discovery; HZGHC004434c009
DR   Wikidata; Q54876857
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PFKFB3 (-) 2
AC   CVCL_TC96
SY   HZGHC004434c010; PFKFB3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TC96
DR   Horizon_Discovery; HZGHC004434c010
DR   Wikidata; Q54876858
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PFN1 (-) 1
AC   CVCL_TC97
SY   HZGHC005831c004; PFN1 knockout cell line 1bp insertion; HAP1 PFN1 (-)
DR   cancercelllines; CVCL_TC97
DR   Horizon_Discovery; HZGHC005831c004
DR   Wikidata; Q54876859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8881; PFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005831c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PFN1 (-) 2
AC   CVCL_XR54
SY   HZGHC005831c009; PFN1 knockout cell line 157bp insertion
DR   cancercelllines; CVCL_XR54
DR   Horizon_Discovery; HZGHC005831c009
DR   Wikidata; Q93956815
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8881; PFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005831c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PFN1 (-) 3
AC   CVCL_C4J6
SY   HZGHC005831c016; PFN1 knockout cell line 7bp deletion
DR   Horizon_Discovery; HZGHC005831c016
DR   Wikidata; Q116049282
RX   PubMed=37576538;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8881; PFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 6
//
ID   HAP1 PFN1 (-) 4
AC   CVCL_C4J7
SY   HZGHC005831c017; PFN1 knockout cell line 13bp deletion
DR   Horizon_Discovery; HZGHC005831c017
DR   Wikidata; Q116049283
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8881; PFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HAP1 PFN1 (-) 5
AC   CVCL_C4J8
SY   HZGHC005831c020; PFN1 knockout cell line 1bp deletion
DR   Horizon_Discovery; HZGHC005831c020
DR   Wikidata; Q116049285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8881; PFN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HAP1 PFN2 (-) 1
AC   CVCL_TC98
SY   HZGHC005248c001; PFN2 knockout cell line 1bp insertion; HAP1 PFN2 (-)
DR   cancercelllines; CVCL_TC98
DR   Horizon_Discovery; HZGHC005248c001
DR   Wikidata; Q54876860
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8882; PFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PFN2 (-) 2
AC   CVCL_XR55
SY   HZGHC005248c009; PFN2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XR55
DR   Horizon_Discovery; HZGHC005248c009
DR   Wikidata; Q93956824
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8882; PFN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PGAM5 (-) 1
AC   CVCL_E2GN
SY   HZGHC008131c006
DR   Horizon_Discovery; HZGHC008131c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28763; PGAM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PGAM5 (-) 2
AC   CVCL_E2GP
SY   HZGHC008131c012
DR   Horizon_Discovery; HZGHC008131c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28763; PGAM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PGAP3 (-)
AC   CVCL_TC99
SY   HZGHC005919c010; PGAP3 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TC99
DR   Horizon_Discovery; HZGHC005919c010
DR   Wikidata; Q54876861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23719; PGAP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PGF (-) 1
AC   CVCL_TD00
SY   HZGHC003935c003; PGF knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TD00
DR   Horizon_Discovery; HZGHC003935c003
DR   Wikidata; Q54876862
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8893; PGF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PGF (-) 2
AC   CVCL_TD01
SY   HZGHC003935c012; PGF knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD01
DR   Horizon_Discovery; HZGHC003935c012
DR   Wikidata; Q54876863
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8893; PGF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PGLS (-)
AC   CVCL_TD02
SY   HZGHC004920c010; PGLS knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD02
DR   Horizon_Discovery; HZGHC004920c010
DR   Wikidata; Q54876867
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8903; PGLS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PGP (-) 1
AC   CVCL_TD03
SY   HZGHC004923c003; PGP knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD03
DR   Horizon_Discovery; HZGHC004923c003
DR   Wikidata; Q54876868
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8909; PGP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PGP (-) 2
AC   CVCL_TD04
SY   HZGHC004923c009; PGP knockout cell line 83bp insertion
DR   cancercelllines; CVCL_TD04
DR   Horizon_Discovery; HZGHC004923c009
DR   Wikidata; Q54876869
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8909; PGP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004923c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PGP (-) 3
AC   CVCL_TD05
SY   HZGHC004924c002; PGP knockout cell line 250bp insertion
DR   cancercelllines; CVCL_TD05
DR   Horizon_Discovery; HZGHC004924c002
DR   Wikidata; Q54876870
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8909; PGP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004924c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PGP (-) 4
AC   CVCL_TD06
SY   HZGHC004924c003; PGP knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TD06
DR   Horizon_Discovery; HZGHC004924c003
DR   Wikidata; Q54876871
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8909; PGP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PGR (-)
AC   CVCL_XR56
SY   HZGHC007247c012; HZGHC5241; PGR knockout cell line 34bp deletion in exon 1
DR   cancercelllines; CVCL_XR56
DR   Horizon_Discovery; HZGHC007247c012
DR   Wikidata; Q93956886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8910; PGR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PHF10 (-) 1
AC   CVCL_TD07
SY   HZGHC002778c011; PHF10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD07
DR   Horizon_Discovery; HZGHC002778c011
DR   Wikidata; Q54876872
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18250; PHF10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF10 (-) 2
AC   CVCL_TD08
SY   HZGHC002778c012; PHF10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD08
DR   Horizon_Discovery; HZGHC002778c012
DR   Wikidata; Q54876873
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18250; PHF10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF13 (-) 1
AC   CVCL_TD09
SY   HZGHC003353c003; PHF13 knockout cell line 79bp deletion
DR   cancercelllines; CVCL_TD09
DR   Horizon_Discovery; HZGHC003353c003
DR   Wikidata; Q54876874
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22983; PHF13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF13 (-) 2
AC   CVCL_TD10
SY   HZGHC003353c012; PHF13 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TD10
DR   Horizon_Discovery; HZGHC003353c012
DR   Wikidata; Q54876875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22983; PHF13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF2 (-) 1
AC   CVCL_TD11
SY   HZGHC004169c007; PHF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD11
DR   Horizon_Discovery; HZGHC004169c007
DR   Wikidata; Q54876876
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8920; PHF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF2 (-) 2
AC   CVCL_TD12
SY   HZGHC004169c009; PHF2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TD12
DR   Horizon_Discovery; HZGHC004169c009
DR   Wikidata; Q54876877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8920; PHF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF3 (-) 1
AC   CVCL_TD13
SY   HZGHC000522c011; PHF3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD13
DR   Horizon_Discovery; HZGHC000522c011
DR   Wikidata; Q54876878
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8921; PHF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF3 (-) 2
AC   CVCL_TD14
SY   HZGHC000522c012; PHF3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TD14
DR   Horizon_Discovery; HZGHC000522c012
DR   Wikidata; Q54876879
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8921; PHF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF3 (-) 3
AC   CVCL_TD15
SY   HZGHC001370c005; PHF3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD15
DR   Horizon_Discovery; HZGHC001370c005
DR   Wikidata; Q54876880
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8921; PHF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF3 (-) 4
AC   CVCL_TD16
SY   HZGHC001370c010; PHF3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD16
DR   Horizon_Discovery; HZGHC001370c010
DR   Wikidata; Q54876881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8921; PHF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF6 (-) 1
AC   CVCL_TD17
SY   HZGHC001175c003; PHF6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TD17
DR   Horizon_Discovery; HZGHC001175c003
DR   Wikidata; Q54876882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001175c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PHF6 (-) 2
AC   CVCL_TD18
SY   HZGHC001175c002; PHF6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD18
DR   Horizon_Discovery; HZGHC001175c002
DR   Wikidata; Q54876883
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF6 (-) 3
AC   CVCL_TD19
SY   HZGHC001175c006; PHF6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD19
DR   Horizon_Discovery; HZGHC001175c006
DR   Wikidata; Q54876885
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF6 (-) 4
AC   CVCL_TD20
SY   HZGHC001175c010; PHF6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TD20
DR   Horizon_Discovery; HZGHC001175c010
DR   Wikidata; Q54876886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF6 (-) 5
AC   CVCL_XR57
SY   HZGHC005348c006; PHF6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XR57
DR   Horizon_Discovery; HZGHC005348c006
DR   Wikidata; Q93956999
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF6 (-) 6
AC   CVCL_XR58
SY   HZGHC005348c007; PHF6 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_XR58
DR   Horizon_Discovery; HZGHC005348c007
DR   Wikidata; Q93957001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF8 (-) 1
AC   CVCL_TD21
SY   HZGHC004171c002; PHF8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD21
DR   Horizon_Discovery; HZGHC004171c002
DR   Wikidata; Q54876887
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20672; PHF8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHF8 (-) 2
AC   CVCL_TD22
SY   HZGHC004171c010; PHF8 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD22
DR   Horizon_Discovery; HZGHC004171c010
DR   Wikidata; Q54876888
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20672; PHF8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHGDH (-) 1
AC   CVCL_TD23
SY   HZGHC004925c001; PHGDH knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TD23
DR   Horizon_Discovery; HZGHC004925c001
DR   Wikidata; Q54876889
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8923; PHGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHGDH (-) 2
AC   CVCL_TD24
SY   HZGHC004925c011; PHGDH knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TD24
DR   Horizon_Discovery; HZGHC004925c011
DR   Wikidata; Q54876890
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8923; PHGDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHIP (-) 1
AC   CVCL_TD25
SY   HZGHC001487c006; PHIP knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD25
DR   Horizon_Discovery; HZGHC001487c006
DR   Wikidata; Q54876891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15673; PHIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHIP (-) 2
AC   CVCL_TD26
SY   HZGHC001487c008; PHIP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD26
DR   Horizon_Discovery; HZGHC001487c008
DR   Wikidata; Q54876892
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15673; PHIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHKG1 (-) 1
AC   CVCL_TD27
SY   HZGHC000322c002; PHKG1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TD27
DR   Horizon_Discovery; HZGHC000322c002
DR   Wikidata; Q54876893
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8930; PHKG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHKG1 (-) 2
AC   CVCL_TD28
SY   HZGHC000322c016; PHKG1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD28
DR   Horizon_Discovery; HZGHC000322c016
DR   Wikidata; Q54876894
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8930; PHKG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHKG1 (-) 3
AC   CVCL_TD29
SY   HZGHC000322c018; PHKG1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TD29
DR   Horizon_Discovery; HZGHC000322c018
DR   Wikidata; Q54876895
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8930; PHKG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHKG2 (-)
AC   CVCL_TD30
SY   HZGHC000164c018; PHKG2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD30
DR   Horizon_Discovery; HZGHC000164c018
DR   Wikidata; Q54876896
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8931; PHKG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHLPP1 (-) 1
AC   CVCL_TD31
SY   HZGHC003109c001; PHLPP1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TD31
DR   Horizon_Discovery; HZGHC003109c001
DR   Wikidata; Q54876897
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20610; PHLPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHLPP1 (-) 2
AC   CVCL_TD32
SY   HZGHC003109c004; PHLPP1 knockout cell line 154bp deletion
DR   cancercelllines; CVCL_TD32
DR   Horizon_Discovery; HZGHC003109c004
DR   Wikidata; Q54876898
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20610; PHLPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHLPP2 (-) 1
AC   CVCL_TD33
SY   HZGHC003110c009; PHLPP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD33
DR   Horizon_Discovery; HZGHC003110c009
DR   Wikidata; Q54876899
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29149; PHLPP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHLPP2 (-) 2
AC   CVCL_TD34
SY   HZGHC003110c010; PHLPP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD34
DR   Horizon_Discovery; HZGHC003110c010
DR   Wikidata; Q54876900
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29149; PHLPP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHLPP2 (-) 3
AC   CVCL_TD35
SY   HZGHC003110c011; PHLPP2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD35
DR   Horizon_Discovery; HZGHC003110c011
DR   Wikidata; Q54876901
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29149; PHLPP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PHPT1 (-) 1
AC   CVCL_E2GQ
SY   HZGHC007465c015
DR   Horizon_Discovery; HZGHC007465c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30033; PHPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PHPT1 (-) 2
AC   CVCL_E2GR
SY   HZGHC007465c016
DR   Horizon_Discovery; HZGHC007465c016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30033; PHPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PHRF1 (-)
AC   CVCL_XR59
SY   HZGHC006938c008; HZGHC57661; PHRF1 knockout cell line 37bp deletion in exon 4
DR   cancercelllines; CVCL_XR59
DR   Horizon_Discovery; HZGHC006938c008
DR   Wikidata; Q93957112
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24351; PHRF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PI4K2A (-) 1
AC   CVCL_TD36
SY   HZGHC002916c001; PI4K2A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TD36
DR   Horizon_Discovery; HZGHC002916c001
DR   Wikidata; Q54876902
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PI4K2A (-) 2
AC   CVCL_TD37
SY   HZGHC002916c010; PI4K2A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD37
DR   Horizon_Discovery; HZGHC002916c010
DR   Wikidata; Q54876903
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PI4K2B (-) 1
AC   CVCL_TD38
SY   HZGHC002892c004; PI4K2B knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TD38
DR   Horizon_Discovery; HZGHC002892c004
DR   Wikidata; Q54876904
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PI4K2B (-) 2
AC   CVCL_TD39
SY   HZGHC002892c009; PI4K2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD39
DR   Horizon_Discovery; HZGHC002892c009
DR   Wikidata; Q54876905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PI4KB (-) 1
AC   CVCL_TD40
SY   HZGHC000679c003; PI4KB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD40
DR   Horizon_Discovery; HZGHC000679c003
DR   Wikidata; Q54876907
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PI4KB (-) 2
AC   CVCL_TD41
SY   HZGHC000679c004; PI4KB knockout cell line 7bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000679c004
DR   PRIDE; PXD010335
DR   Wikidata; Q54876908
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 PIAS1 (-)
AC   CVCL_TD42
SY   HZGHC002972c004; PIAS1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TD42
DR   Horizon_Discovery; HZGHC002972c004
DR   Wikidata; Q54876911
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2752; PIAS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002972c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIAS2 (-) 1
AC   CVCL_TD43
SY   HZGHC004750c001; PIAS2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD43
DR   Horizon_Discovery; HZGHC004750c001
DR   Wikidata; Q54876912
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17311; PIAS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIAS2 (-) 2
AC   CVCL_TD44
SY   HZGHC004750c008; PIAS2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TD44
DR   Horizon_Discovery; HZGHC004750c008
DR   Wikidata; Q54876913
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17311; PIAS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIEZO1 (-) 1
AC   CVCL_TD45
SY   HZGHC002507c002; PIEZO1 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_TD45
DR   Horizon_Discovery; HZGHC002507c002
DR   Wikidata; Q54876914
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28993; PIEZO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIEZO1 (-) 2
AC   CVCL_TD46
SY   HZGHC002507c009; PIEZO1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TD46
DR   Horizon_Discovery; HZGHC002507c009
DR   Wikidata; Q54876915
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28993; PIEZO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIF1 (-)
AC   CVCL_TD47
SY   HZGHC004570c006; PIF1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TD47
DR   Horizon_Discovery; HZGHC004570c006
DR   Wikidata; Q54876916
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26220; PIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004570c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIGA (-) 1
AC   CVCL_TD48
SY   HZGHC003355c001; PIGA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD48
DR   Horizon_Discovery; HZGHC003355c001
DR   Wikidata; Q54876917
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8957; PIGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIGA (-) 2
AC   CVCL_TD49
SY   HZGHC003355c004; PIGA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD49
DR   Horizon_Discovery; HZGHC003355c004
DR   Wikidata; Q54876918
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8957; PIGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIGM (-) 1
AC   CVCL_TD50
SY   HZGHC004074c001; PIGM knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD50
DR   Horizon_Discovery; HZGHC004074c001
DR   Wikidata; Q54876920
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18858; PIGM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIGM (-) 2
AC   CVCL_TD51
SY   HZGHC004074c005; PIGM knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD51
DR   Horizon_Discovery; HZGHC004074c005
DR   Wikidata; Q54876921
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18858; PIGM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004074c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIGM (-) 3
AC   CVCL_TD52
SY   HZGHC004074c010; PIGM knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD52
DR   Horizon_Discovery; HZGHC004074c010
DR   Wikidata; Q54876922
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18858; PIGM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004074c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIGT (-) 1
AC   CVCL_TD53
SY   HZGHC011966c001; PIGT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD53
DR   Horizon_Discovery; HZGHC011966c001
DR   Wikidata; Q54876923
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14938; PIGT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIGT (-) 2
AC   CVCL_TD54
SY   HZGHC011966c011; PIGT knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TD54
DR   Horizon_Discovery; HZGHC011966c011
DR   Wikidata; Q54876924
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14938; PIGT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIGT (-) 3
AC   CVCL_TD55
SY   HZGHC011966c021; PIGT knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD55
DR   Horizon_Discovery; HZGHC011966c021
DR   Wikidata; Q54876925
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14938; PIGT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIH1D1 (-)
AC   CVCL_XR60
SY   HZGHC007019c009; HZGHC55011; PIH1D1 knockout cell line 1bp insertion in exon 6
DR   cancercelllines; CVCL_XR60
DR   Horizon_Discovery; HZGHC007019c009
DR   Wikidata; Q93957245
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26075; PIH1D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIK3C2A (-) 1
AC   CVCL_TD56
SY   HZGHC000696c002; PIK3C2A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD56
DR   Horizon_Discovery; HZGHC000696c002
DR   Wikidata; Q54876926
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3C2A (-) 2
AC   CVCL_TD57
SY   HZGHC000696c011; PIK3C2A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TD57
DR   Horizon_Discovery; HZGHC000696c011
DR   Wikidata; Q54876927
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3C2B (-) 1
AC   CVCL_TD58
SY   HZGHC000697c006; PIK3C2B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TD58
DR   Horizon_Discovery; HZGHC000697c006
DR   Wikidata; Q54876928
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8972; PIK3C2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3C2B (-) 2
AC   CVCL_TD59
SY   HZGHC000697c009; PIK3C2B knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TD59
DR   Horizon_Discovery; HZGHC000697c009
DR   Wikidata; Q54876929
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8972; PIK3C2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3CA (-) 1
AC   CVCL_TD60
SY   HZGHC000691c006; PIK3CA knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD60
DR   Horizon_Discovery; HZGHC000691c006
DR   Wikidata; Q54876930
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3CA (-) 2
AC   CVCL_TD61
SY   HZGHC000691c007; PIK3CA knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD61
DR   Horizon_Discovery; HZGHC000691c007
DR   Wikidata; Q54876931
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000691c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIK3CB (-)
AC   CVCL_TD62
SY   HZGHC000714c003; PIK3CB knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TD62
DR   Horizon_Discovery; HZGHC000714c003
DR   PRIDE; PXD010335
DR   Wikidata; Q54876932
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8976; PIK3CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIK3CD (-) 1
AC   CVCL_TD63
SY   HZGHC000698c003; PIK3CD knockout cell line 155bp insertion
DR   cancercelllines; CVCL_TD63
DR   Horizon_Discovery; HZGHC000698c003
DR   PRIDE; PXD010335
DR   Wikidata; Q54876933
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000698c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PIK3CD (-) 2
AC   CVCL_TD64
SY   HZGHC000698c004; PIK3CD knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD64
DR   Horizon_Discovery; HZGHC000698c004
DR   Wikidata; Q54876934
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3CD (-) 3
AC   CVCL_TD65
SY   HZGHC000698c007; PIK3CD knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD65
DR   Horizon_Discovery; HZGHC000698c007
DR   Wikidata; Q54876935
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3R1 (-) 1
AC   CVCL_TD66
SY   HZGHC002908c002; PIK3R1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TD66
DR   Horizon_Discovery; HZGHC002908c002
DR   Wikidata; Q54876936
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3R1 (-) 2
AC   CVCL_TD67
SY   HZGHC002908c007; PIK3R1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TD67
DR   Horizon_Discovery; HZGHC002908c007
DR   Wikidata; Q54876937
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3R2 (-) 1
AC   CVCL_TD68
SY   HZGHC003292c004; PIK3R2 knockout cell line 185bp insertion
DR   cancercelllines; CVCL_TD68
DR   Horizon_Discovery; HZGHC003292c004
DR   Wikidata; Q54876938
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003292c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIK3R2 (-) 2
AC   CVCL_TD69
SY   HZGHC003292c006; PIK3R2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD69
DR   Horizon_Discovery; HZGHC003292c006
DR   Wikidata; Q54876939
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3R3 (-) 1
AC   CVCL_TD70
SY   HZGHC002905c001; PIK3R3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TD70
DR   Horizon_Discovery; HZGHC002905c001
DR   Wikidata; Q54876940
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8981; PIK3R3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3R3 (-) 2
AC   CVCL_TD71
SY   HZGHC002905c003; PIK3R3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD71
DR   Horizon_Discovery; HZGHC002905c003
DR   Wikidata; Q54876941
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8981; PIK3R3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3R6 (-) 1
AC   CVCL_TD72
SY   HZGHC002903c001; PIK3R6 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TD72
DR   Horizon_Discovery; HZGHC002903c001
DR   Wikidata; Q54876942
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27101; PIK3R6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIK3R6 (-) 2
AC   CVCL_TD73
SY   HZGHC002903c003; PIK3R6 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TD73
DR   Horizon_Discovery; HZGHC002903c003
DR   Wikidata; Q54876943
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27101; PIK3R6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIKFYVE (-) 1
AC   CVCL_TD74
SY   HZGHC003245c003; PIKFYVE knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TD74
DR   Horizon_Discovery; HZGHC003245c003
DR   Wikidata; Q54876944
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23785; PIKFYVE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIKFYVE (-) 2
AC   CVCL_TD75
SY   HZGHC003245c012; PIKFYVE knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TD75
DR   Horizon_Discovery; HZGHC003245c012
DR   PRIDE; PXD010335
DR   Wikidata; Q54876945
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23785; PIKFYVE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIM1 (-) 1
AC   CVCL_TD76
SY   HZGHC001348c003; PIM1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD76
DR   Horizon_Discovery; HZGHC001348c003
DR   Wikidata; Q54876946
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM1 (-) 2
AC   CVCL_TD77
SY   HZGHC002998c008; PIM1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TD77
DR   Horizon_Discovery; HZGHC002998c008
DR   Wikidata; Q54876947
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM1 (-) 3
AC   CVCL_TD78
SY   HZGHC002998c010; PIM1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD78
DR   Horizon_Discovery; HZGHC002998c010
DR   Wikidata; Q54876948
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM2 (-) 1
AC   CVCL_TD79
SY   HZGHC001248c026; PIM2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TD79
DR   Horizon_Discovery; HZGHC001248c026
DR   Wikidata; Q54876949
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8987; PIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM2 (-) 2
AC   CVCL_TD80
SY   HZGHC002999c008; PIM2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD80
DR   Horizon_Discovery; HZGHC002999c008
DR   Wikidata; Q54876950
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8987; PIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM2 (-) 3
AC   CVCL_TD81
SY   HZGHC002999c010; PIM2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TD81
DR   Horizon_Discovery; HZGHC002999c010
DR   Wikidata; Q54876951
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8987; PIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM3 (-) 1
AC   CVCL_TD82
SY   HZGHC000054c004; PIM3 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TD82
DR   Horizon_Discovery; HZGHC000054c004
DR   Wikidata; Q54876953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19310; PIM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM3 (-) 2
AC   CVCL_TD83
SY   HZGHC000054c011; PIM3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TD83
DR   Horizon_Discovery; HZGHC000054c011
DR   Wikidata; Q54876954
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19310; PIM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIM3 (-) 3
AC   CVCL_TD84
SY   HZGHC000054c014; PIM3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TD84
DR   Horizon_Discovery; HZGHC000054c014
DR   Wikidata; Q54876955
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19310; PIM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PINK1 (-) 1
AC   CVCL_TD85
SY   HZGHC000798c008; PINK1 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TD85
DR   Horizon_Discovery; HZGHC000798c008
DR   Wikidata; Q54876956
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PINK1 (-) 2
AC   CVCL_TD86
SY   HZGHC000798c009; PINK1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TD86
DR   Horizon_Discovery; HZGHC000798c009
DR   Wikidata; Q54876957
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIP4K2A (-) 1
AC   CVCL_TD87
SY   HZGHC002917c003; PIP4K2A knockout cell line 121bp deletion
DR   cancercelllines; CVCL_TD87
DR   Horizon_Discovery; HZGHC002917c003
DR   Wikidata; Q54876958
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002917c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIP4K2A (-) 2
AC   CVCL_TD88
SY   HZGHC002917c010; PIP4K2A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TD88
DR   Horizon_Discovery; HZGHC002917c010
DR   Wikidata; Q54876959
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIP4K2B (-) 1
AC   CVCL_TD89
SY   HZGHC002918c002; PIP4K2B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TD89
DR   Horizon_Discovery; HZGHC002918c002
DR   Wikidata; Q54876960
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8998; PIP4K2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002918c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIP4K2B (-) 2
AC   CVCL_TD90
SY   HZGHC002918c012; PIP4K2B knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TD90
DR   Horizon_Discovery; HZGHC002918c012
DR   Wikidata; Q54876961
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8998; PIP4K2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIP4K2C (-)
AC   CVCL_TD91
SY   HZGHC004190c004; PIP4K2C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TD91
DR   Horizon_Discovery; HZGHC004190c004
DR   Wikidata; Q54876962
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23786; PIP4K2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PIP5K1A (-) 1
AC   CVCL_TD92
SY   HZGHC002891c003; PIP5K1A knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TD92
DR   Horizon_Discovery; HZGHC002891c003
DR   Wikidata; Q54876963
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIP5K1A (-) 2
AC   CVCL_TD93
SY   HZGHC002891c006; PIP5K1A knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TD93
DR   Horizon_Discovery; HZGHC002891c006
DR   Wikidata; Q54876964
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIP5K1C (-) 1
AC   CVCL_TD94
SY   HZGHC002890c004; PIP5K1C knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TD94
DR   Horizon_Discovery; HZGHC002890c004
DR   Wikidata; Q54876965
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PIP5K1C (-) 2
AC   CVCL_TD95
SY   HZGHC002890c012; PIP5K1C knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TD95
DR   Horizon_Discovery; HZGHC002890c012
DR   Wikidata; Q54876966
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PISD (-) 1
AC   CVCL_XR61
SY   HZGHC006851c001; HZGHC23761; PISD knockout cell line 1bp insertion in exon 4; HAP1 PISD (-)
DR   cancercelllines; CVCL_XR61
DR   Horizon_Discovery; HZGHC006851c001
DR   Wikidata; Q93957382
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8999; PISD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PISD (-) 2
AC   CVCL_E2GS
SY   HZGHC006851c004; PISD knockout cell line 10bp deletion in exon 4
DR   Horizon_Discovery; HZGHC006851c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8999; PISD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PITPNB (-)
AC   CVCL_TD96
SY   HZGHC002889c009; PITPNB knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD96
DR   Horizon_Discovery; HZGHC002889c009
DR   Wikidata; Q54876967
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9002; PITPNB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PJA1 (-)
AC   CVCL_E2GT
SY   HZGHC007999c012
DR   Horizon_Discovery; HZGHC007999c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16648; PJA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PKD1 (-)
AC   CVCL_C7YC
SY   HZGHC007329c002; PKD1 knockout cell line 1bp insertion in exon 15
DR   Horizon_Discovery; HZGHC007329c002
DR   Wikidata; Q123031439
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PKD2 (-)
AC   CVCL_TD97
SY   HZGHC003076c007; PKD2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TD97
DR   Horizon_Discovery; HZGHC003076c007
DR   Wikidata; Q54876968
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PKDCC (-) 1
AC   CVCL_TD98
SY   HZGHC002969c001; PKDCC knockout cell line 209bp insertion
DR   cancercelllines; CVCL_TD98
DR   Horizon_Discovery; HZGHC002969c001
DR   Wikidata; Q54876969
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25123; PKDCC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002969c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PKDCC (-) 2
AC   CVCL_TD99
SY   HZGHC002969c004; PKDCC knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TD99
DR   Horizon_Discovery; HZGHC002969c004
DR   Wikidata; Q54876970
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25123; PKDCC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PKN1 (-) 1
AC   CVCL_TE00
SY   HZGHC000165c001; PKN1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TE00
DR   Horizon_Discovery; HZGHC000165c001
DR   Wikidata; Q54876971
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PKN1 (-) 2
AC   CVCL_TE01
SY   HZGHC000165c017; PKN1 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TE01
DR   Horizon_Discovery; HZGHC000165c017
DR   Wikidata; Q54876972
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PKN2 (-)
AC   CVCL_TE02
SY   HZGHC036174c003; PKN2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TE02
DR   Horizon_Discovery; HZGHC036174c003
DR   Wikidata; Q54876973
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC036174c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PKN3 (-) 1
AC   CVCL_TE03
SY   HZGHC000100c011; PKN3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TE03
DR   Horizon_Discovery; HZGHC000100c011
DR   PRIDE; PXD010335
DR   Wikidata; Q54876974
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17999; PKN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PKN3 (-) 2
AC   CVCL_TE04
SY   HZGHC000100c015; PKN3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE04
DR   Horizon_Discovery; HZGHC000100c015
DR   Wikidata; Q54876975
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17999; PKN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PKNOX1 (-)
AC   CVCL_E2GU
SY   HZGHC007577c007
DR   Horizon_Discovery; HZGHC007577c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9022; PKNOX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PKP2 (-) 1
AC   CVCL_E2GV
SY   HZGHC008244c002
DR   Horizon_Discovery; HZGHC008244c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9024; PKP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PKP2 (-) 2
AC   CVCL_E2GW
SY   HZGHC008244c007
DR   Horizon_Discovery; HZGHC008244c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9024; PKP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PKP2 (-) 3
AC   CVCL_E2GX
SY   HZGHC008244c010
DR   Horizon_Discovery; HZGHC008244c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9024; PKP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PLA2G12A (-) 1
AC   CVCL_TE05
SY   HZGHC003378c005; PLA2G12A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TE05
DR   Horizon_Discovery; HZGHC003378c005
DR   Wikidata; Q54876976
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18554; PLA2G12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G12A (-) 2
AC   CVCL_TE06
SY   HZGHC003378c011; PLA2G12A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE06
DR   Horizon_Discovery; HZGHC003378c011
DR   Wikidata; Q54876977
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18554; PLA2G12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G15 (-) 1
AC   CVCL_TE07
SY   HZGHC003379c007; PLA2G15 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TE07
DR   Horizon_Discovery; HZGHC003379c007
DR   Wikidata; Q54876978
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17163; PLA2G15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G15 (-) 2
AC   CVCL_TE08
SY   HZGHC003379c008; PLA2G15 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TE08
DR   Horizon_Discovery; HZGHC003379c008
DR   Wikidata; Q54876979
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17163; PLA2G15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G4A (-) 1
AC   CVCL_TE09
SY   HZGHC003380c010; PLA2G4A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE09
DR   Horizon_Discovery; HZGHC003380c010
DR   Wikidata; Q54876980
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003380c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLA2G4A (-) 2
AC   CVCL_TE10
SY   HZGHC003380c011; PLA2G4A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE10
DR   Horizon_Discovery; HZGHC003380c011
DR   Wikidata; Q54876981
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003380c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLA2G4A (-) 3
AC   CVCL_TE11
SY   HZGHC003380c001; PLA2G4A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE11
DR   Horizon_Discovery; HZGHC003380c001
DR   Wikidata; Q54876982
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G4B (-) 1
AC   CVCL_TE12
SY   HZGHC003381c001; PLA2G4B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE12
DR   Horizon_Discovery; HZGHC003381c001
DR   Wikidata; Q54876983
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9036; PLA2G4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G4B (-) 2
AC   CVCL_TE13
SY   HZGHC003381c002; PLA2G4B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE13
DR   Horizon_Discovery; HZGHC003381c002
DR   Wikidata; Q54876984
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9036; PLA2G4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G6 (-) 1
AC   CVCL_TE14
SY   HZGHC003382c001; PLA2G6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TE14
DR   Horizon_Discovery; HZGHC003382c001
DR   Wikidata; Q54876986
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9039; PLA2G6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLA2G6 (-) 2
AC   CVCL_TE15
SY   HZGHC003382c011; PLA2G6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE15
DR   Horizon_Discovery; HZGHC003382c011
DR   Wikidata; Q54876987
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9039; PLA2G6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLAU (-) 1
AC   CVCL_TE16
SY   HZGHC003938c005; PLAU knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TE16
DR   Horizon_Discovery; HZGHC003938c005
DR   Wikidata; Q54876988
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9052; PLAU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLAU (-) 2
AC   CVCL_TE17
SY   HZGHC003938c011; PLAU knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TE17
DR   Horizon_Discovery; HZGHC003938c011
DR   Wikidata; Q54876989
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9052; PLAU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLAUR (-) 1
AC   CVCL_TE18
SY   HZGHC003866c001; PLAUR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE18
DR   Horizon_Discovery; HZGHC003866c001
DR   Wikidata; Q54876990
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9053; PLAUR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLAUR (-) 2
AC   CVCL_TE19
SY   HZGHC003866c002; PLAUR knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TE19
DR   Horizon_Discovery; HZGHC003866c002
DR   Wikidata; Q54876991
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9053; PLAUR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCB1 (-) 1
AC   CVCL_TE20
SY   HZGHC003383c010; PLCB1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TE20
DR   Horizon_Discovery; HZGHC003383c010
DR   Wikidata; Q54876992
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15917; PLCB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCB1 (-) 2
AC   CVCL_TE21
SY   HZGHC003383c012; PLCB1 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TE21
DR   Horizon_Discovery; HZGHC003383c012
DR   Wikidata; Q54876993
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15917; PLCB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCB3 (-) 1
AC   CVCL_TE22
SY   HZGHC003384c010; PLCB3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TE22
DR   Horizon_Discovery; HZGHC003384c010
DR   Wikidata; Q54876995
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCB3 (-) 2
AC   CVCL_TE23
SY   HZGHC003384c012; PLCB3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TE23
DR   Horizon_Discovery; HZGHC003384c012
DR   Wikidata; Q54876996
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCB4 (-) 1
AC   CVCL_TE24
SY   HZGHC003385c003; PLCB4 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TE24
DR   Horizon_Discovery; HZGHC003385c003
DR   Wikidata; Q54876997
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9059; PLCB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCB4 (-) 2
AC   CVCL_TE25
SY   HZGHC003385c005; PLCB4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TE25
DR   Horizon_Discovery; HZGHC003385c005
DR   Wikidata; Q54876998
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9059; PLCB4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCD1 (-) 1
AC   CVCL_TE26
SY   HZGHC003386c007; PLCD1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TE26
DR   Horizon_Discovery; HZGHC003386c007
DR   Wikidata; Q54876999
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9060; PLCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCD1 (-) 2
AC   CVCL_TE27
SY   HZGHC003386c008; PLCD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE27
DR   Horizon_Discovery; HZGHC003386c008
DR   Wikidata; Q54877000
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9060; PLCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCD3 (-) 1
AC   CVCL_TE28
SY   HZGHC003387c011; PLCD3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE28
DR   Horizon_Discovery; HZGHC003387c011
DR   Wikidata; Q54877001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9061; PLCD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003387c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLCD3 (-) 2
AC   CVCL_TE29
SY   HZGHC003387c012; PLCD3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE29
DR   Horizon_Discovery; HZGHC003387c012
DR   Wikidata; Q54877002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9061; PLCD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003387c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLCD3 (-) 3
AC   CVCL_TE30
SY   HZGHC003387c010; PLCD3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE30
DR   Horizon_Discovery; HZGHC003387c010
DR   Wikidata; Q54877003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9061; PLCD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCD4 (-) 1
AC   CVCL_TE31
SY   HZGHC003388c001; PLCD4 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TE31
DR   Horizon_Discovery; HZGHC003388c001
DR   Wikidata; Q54877004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9062; PLCD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCD4 (-) 2
AC   CVCL_TE32
SY   HZGHC003388c011; PLCD4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TE32
DR   Horizon_Discovery; HZGHC003388c011
DR   Wikidata; Q54877005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9062; PLCD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCE1 (-) 1
AC   CVCL_TE33
SY   HZGHC003389c010; PLCE1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE33
DR   Horizon_Discovery; HZGHC003389c010
DR   Wikidata; Q54877006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17175; PLCE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003389c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLCE1 (-) 2
AC   CVCL_TE34
SY   HZGHC003389c011; PLCE1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE34
DR   Horizon_Discovery; HZGHC003389c011
DR   Wikidata; Q54877007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17175; PLCE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003389c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLCE1 (-) 3
AC   CVCL_TE35
SY   HZGHC003389c001; PLCE1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE35
DR   Horizon_Discovery; HZGHC003389c001
DR   Wikidata; Q54877008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17175; PLCE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCG1 (-) 1
AC   CVCL_TE36
SY   HZGHC003390c010; PLCG1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TE36
DR   Horizon_Discovery; HZGHC003390c010
DR   Wikidata; Q54877009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCG1 (-) 2
AC   CVCL_TE37
SY   HZGHC003390c011; PLCG1 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_TE37
DR   Horizon_Discovery; HZGHC003390c011
DR   Wikidata; Q54877010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCG2 (-) 1
AC   CVCL_TE38
SY   HZGHC003391c005; PLCG2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE38
DR   Horizon_Discovery; HZGHC003391c005
DR   Wikidata; Q54877011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCG2 (-) 2
AC   CVCL_TE39
SY   HZGHC003391c006; PLCG2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE39
DR   Horizon_Discovery; HZGHC003391c006
DR   Wikidata; Q54877012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCH1 (-) 1
AC   CVCL_TE40
SY   HZGHC003739c001; PLCH1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TE40
DR   Horizon_Discovery; HZGHC003739c001
DR   Wikidata; Q54877013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29185; PLCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLCH1 (-) 2
AC   CVCL_TE41
SY   HZGHC003739c011; PLCH1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE41
DR   Horizon_Discovery; HZGHC003739c011
DR   Wikidata; Q54877014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29185; PLCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD1 (-) 1
AC   CVCL_TE42
SY   HZGHC003393c002; PLD1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE42
DR   Horizon_Discovery; HZGHC003393c002
DR   Wikidata; Q54877015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9067; PLD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD1 (-) 2
AC   CVCL_TE43
SY   HZGHC003393c005; PLD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE43
DR   Horizon_Discovery; HZGHC003393c005
DR   Wikidata; Q54877016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9067; PLD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD2 (-) 1
AC   CVCL_TE44
SY   HZGHC003394c011; PLD2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE44
DR   Horizon_Discovery; HZGHC003394c011
DR   Wikidata; Q54877017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9068; PLD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003394c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLD2 (-) 2
AC   CVCL_TE45
SY   HZGHC003394c001; PLD2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE45
DR   Horizon_Discovery; HZGHC003394c001
DR   Wikidata; Q54877018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9068; PLD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD2 (-) 3
AC   CVCL_TE46
SY   HZGHC003394c007; PLD2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TE46
DR   Horizon_Discovery; HZGHC003394c007
DR   Wikidata; Q54877019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9068; PLD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD3 (-) 1
AC   CVCL_TE47
SY   HZGHC003395c011; PLD3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TE47
DR   Horizon_Discovery; HZGHC003395c011
DR   Wikidata; Q54877020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD3 (-) 2
AC   CVCL_TE48
SY   HZGHC003395c012; PLD3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TE48
DR   Horizon_Discovery; HZGHC003395c012
DR   Wikidata; Q54877021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD5 (-) 1
AC   CVCL_TE49
SY   HZGHC003396c001; PLD5 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TE49
DR   Horizon_Discovery; HZGHC003396c001
DR   Wikidata; Q54877022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26879; PLD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD5 (-) 2
AC   CVCL_TE50
SY   HZGHC003396c011; PLD5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TE50
DR   Horizon_Discovery; HZGHC003396c011
DR   Wikidata; Q54877023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26879; PLD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLD6 (-)
AC   CVCL_TE51
SY   HZGHC003397c002; PLD6 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TE51
DR   Horizon_Discovery; HZGHC003397c002
DR   Wikidata; Q54877024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30447; PLD6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLEKHA1 (-) 1
AC   CVCL_TE52
SY   HZGHC003803c006; PLEKHA1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TE52
DR   Horizon_Discovery; HZGHC003803c006
DR   Wikidata; Q54877025
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14335; PLEKHA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLEKHA1 (-) 2
AC   CVCL_TE53
SY   HZGHC003803c011; PLEKHA1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TE53
DR   Horizon_Discovery; HZGHC003803c011
DR   Wikidata; Q54877026
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14335; PLEKHA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLEKHM2 (-) 1
AC   CVCL_TE54
SY   HZGHC000851c003; PLEKHM2 knockout cell line 173bp insertion
DR   cancercelllines; CVCL_TE54
DR   Horizon_Discovery; HZGHC000851c003
DR   Wikidata; Q54877027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29131; PLEKHM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000851c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLEKHM2 (-) 2
AC   CVCL_TE55
SY   HZGHC000851c006; PLEKHM2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE55
DR   Horizon_Discovery; HZGHC000851c006
DR   Wikidata; Q54877028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29131; PLEKHM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLGRKT (-) 1
AC   CVCL_TE56
SY   HZGHC004234c010; PLGRKT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE56
DR   Horizon_Discovery; HZGHC004234c010
DR   Wikidata; Q54877029
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23633; PLGRKT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLGRKT (-) 2
AC   CVCL_TE57
SY   HZGHC004234c011; PLGRKT knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TE57
DR   Horizon_Discovery; HZGHC004234c011
DR   Wikidata; Q54877030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23633; PLGRKT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLIN2 (-) 1
AC   CVCL_TE58
SY   HZGHC005998c010; PLIN2 knockout cell line 25bp deletion; HAP1 PLIN2 (-)
DR   cancercelllines; CVCL_TE58
DR   Horizon_Discovery; HZGHC005998c010
DR   Wikidata; Q54877031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:248; PLIN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLIN2 (-) 2
AC   CVCL_XR62
SY   HZGHC005998c004; PLIN2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XR62
DR   Horizon_Discovery; HZGHC005998c004
DR   Wikidata; Q93958036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:248; PLIN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLIN3 (-) 1
AC   CVCL_TE59
SY   HZGHC000675c001; PLIN3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TE59
DR   Horizon_Discovery; HZGHC000675c001
DR   Wikidata; Q54877032
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16893; PLIN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLIN3 (-) 2
AC   CVCL_TE60
SY   HZGHC000675c006; PLIN3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TE60
DR   Horizon_Discovery; HZGHC000675c006
DR   Wikidata; Q54877033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16893; PLIN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000675c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLIN3 (-) 3
AC   CVCL_TE61
SY   HZGHC000676c010; PLIN3 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TE61
DR   Horizon_Discovery; HZGHC000676c010
DR   Wikidata; Q54877034
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16893; PLIN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLK2 (-)
AC   CVCL_TE62
SY   HZGHC000406c001; PLK2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TE62
DR   Horizon_Discovery; HZGHC000406c001
DR   Wikidata; Q54877037
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLK2 (-) 1
AC   CVCL_TE63
SY   HZGHC000406c010; PLK2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TE63
DR   Horizon_Discovery; HZGHC000406c010
DR   Wikidata; Q54877038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLK2 (-) 2
AC   CVCL_TE64
SY   HZGHC000406c017; PLK2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE64
DR   Horizon_Discovery; HZGHC000406c017
DR   Wikidata; Q54877039
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLK2 (-) 3
AC   CVCL_TE65
SY   HZGHC003286c006; PLK2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TE65
DR   Horizon_Discovery; HZGHC003286c006
DR   Wikidata; Q54877040
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLK2 (-) 4
AC   CVCL_TE66
SY   HZGHC003286c010; PLK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TE66
DR   Horizon_Discovery; HZGHC003286c010
DR   Wikidata; Q54877041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLK3 (-) 1
AC   CVCL_TE67
SY   HZGHC003037c002; PLK3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TE67
DR   Horizon_Discovery; HZGHC003037c002
DR   Wikidata; Q54877042
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2154; PLK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLK3 (-) 2
AC   CVCL_TE68
SY   HZGHC003037c011; PLK3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TE68
DR   Horizon_Discovery; HZGHC003037c011
DR   Wikidata; Q54877043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2154; PLK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLOD1 (-)
AC   CVCL_XR63
SY   HZGHC007075c006; HZGHC5351; PLOD1 knockout cell line 10bp deletion in exon 4
DR   cancercelllines; CVCL_XR63
DR   Horizon_Discovery; HZGHC007075c006
DR   Wikidata; Q93958145
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9081; PLOD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLOD2 (-) 1
AC   CVCL_TE69
SY   HZGHC005475c004; PLOD2 knockout cell line 1bp insertion; HAP1 PLOD2 (-)
DR   cancercelllines; CVCL_TE69
DR   Horizon_Discovery; HZGHC005475c004
DR   Wikidata; Q54877044
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9082; PLOD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLOD2 (-) 2
AC   CVCL_XR64
SY   HZGHC005475c005; PLOD2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR64
DR   Horizon_Discovery; HZGHC005475c005
DR   Wikidata; Q93958159
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9082; PLOD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005475c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PLP2 (-) 1
AC   CVCL_TE70
SY   HZGHC003989c004; PLP2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TE70
DR   Horizon_Discovery; HZGHC003989c004
DR   Wikidata; Q54877045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9087; PLP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PLP2 (-) 2
AC   CVCL_TE71
SY   HZGHC003989c007; PLP2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE71
DR   Horizon_Discovery; HZGHC003989c007
DR   Wikidata; Q54877046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9087; PLP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PMAIP1 (-) 1
AC   CVCL_TE72
SY   HZGHC006332c010; PMAIP1 knockout cell line 4bp deletion; HAP1 PMAIP1 (-)
DR   cancercelllines; CVCL_TE72
DR   Horizon_Discovery; HZGHC006332c010
DR   Wikidata; Q54877047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9108; PMAIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PMAIP1 (-) 2
AC   CVCL_XR65
SY   HZGHC006332c011; PMAIP1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XR65
DR   Horizon_Discovery; HZGHC006332c011
DR   Wikidata; Q93958194
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9108; PMAIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PML (-) 1
AC   CVCL_TE73
SY   HZGHC005428c002; PML knockout cell line 1bp insertion; HAP1 PML (-)
DR   cancercelllines; CVCL_TE73
DR   Horizon_Discovery; HZGHC005428c002
DR   Wikidata; Q54877048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005428c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PML (-) 2
AC   CVCL_XR66
SY   HZGHC005428c003; PML knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR66
DR   Horizon_Discovery; HZGHC005428c003
DR   Wikidata; Q93958210
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005428c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PML (-) 3
AC   CVCL_XR67
SY   HZGHC005429c004; PML knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XR67
DR   Horizon_Discovery; HZGHC005429c004
DR   Wikidata; Q93958215
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005429c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PMS1 (-) 1
AC   CVCL_XR68
SY   HZGHC007262c005; HZGHC5378; PMS1 knockout cell line 11bp deletion in exon 9; HAP1 PMS1 (-)
DR   cancercelllines; CVCL_XR68
DR   Horizon_Discovery; HZGHC007262c005
DR   Wikidata; Q93958218
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9121; PMS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PMS1 (-) 2
AC   CVCL_B5KP
SY   HZGHC007262c008; PMS1 knockout cell line 344bp insertion in exon 9
DR   cancercelllines; CVCL_B5KP
DR   Horizon_Discovery; HZGHC007262c008
DR   Wikidata; Q111733311
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9121; PMS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007262c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HAP1 PMS2 (-)
AC   CVCL_TE74
SY   HZGHC000763c004; PMS2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE74
DR   Horizon_Discovery; HZGHC000763c004
DR   Wikidata; Q54877049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9122; PMS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PNCK (-) 1
AC   CVCL_TE75
SY   HZGHC000324c013; PNCK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TE75
DR   Horizon_Discovery; HZGHC000324c013
DR   Wikidata; Q54877050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13415; PNCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PNCK (-) 2
AC   CVCL_TE76
SY   HZGHC000324c020; PNCK knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TE76
DR   Horizon_Discovery; HZGHC000324c020
DR   Wikidata; Q54877051
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13415; PNCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PNP (-) 1
AC   CVCL_TE77
SY   HZGHC003765c001; PNP knockout cell line 340bp insertion
DR   cancercelllines; CVCL_TE77
DR   Horizon_Discovery; HZGHC003765c001
DR   Wikidata; Q54877052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7892; PNP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003765c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PNP (-) 2
AC   CVCL_TE78
SY   HZGHC003765c003; PNP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE78
DR   Horizon_Discovery; HZGHC003765c003
DR   Wikidata; Q54877053
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7892; PNP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PNPLA2 (-) 1
AC   CVCL_TE79
SY   HZGHC004666c011; PNPLA2 knockout cell line 29bp deletion; HAP1 PNPLA2 (-)
DR   cancercelllines; CVCL_TE79
DR   Horizon_Discovery; HZGHC004666c011
DR   Wikidata; Q54877054
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30802; PNPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004666c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PNPLA2 (-) 2
AC   CVCL_XR69
SY   HZGHC004666c009; PNPLA2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XR69
DR   Horizon_Discovery; HZGHC004666c009
DR   Wikidata; Q93958297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30802; PNPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004666c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PNPLA2 (-) 3
AC   CVCL_E2GY
SY   HZGHC004666c014
DR   Horizon_Discovery; HZGHC004666c014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30802; PNPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PNPLA2 (-) 4
AC   CVCL_E2GZ
SY   HZGHC004666c018
DR   Horizon_Discovery; HZGHC004666c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30802; PNPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PNPLA2 (-) 5
AC   CVCL_E2H0
SY   HZGHC004666c020
DR   Horizon_Discovery; HZGHC004666c020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30802; PNPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PNPLA2 (-) 6
AC   CVCL_E2H1
SY   HZGHC004666c021
DR   Horizon_Discovery; HZGHC004666c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30802; PNPLA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PODXL (-) 1
AC   CVCL_TE80
SY   HZGHC006227c006; PODXL knockout cell line 7bp insertion; HAP1 PODXL (-)
DR   cancercelllines; CVCL_TE80
DR   Horizon_Discovery; HZGHC006227c006
DR   Wikidata; Q54877055
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PODXL (-) 2
AC   CVCL_XR70
SY   HZGHC006228c004; PODXL knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR70
DR   Horizon_Discovery; HZGHC006228c004
DR   Wikidata; Q93958310
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PODXL (-) 3
AC   CVCL_XR71
SY   HZGHC006228c005; PODXL knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XR71
DR   Horizon_Discovery; HZGHC006228c005
DR   Wikidata; Q93958313
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PODXL (-) 4
AC   CVCL_XR72
SY   HZGHC006228c007; PODXL knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XR72
DR   Horizon_Discovery; HZGHC006228c007
DR   Wikidata; Q93958316
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POGK (-) 1
AC   CVCL_TE81
SY   HZGHC000555c006; POGK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE81
DR   Horizon_Discovery; HZGHC000555c006
DR   Wikidata; Q54877056
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18800; POGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POGK (-) 2
AC   CVCL_TE82
SY   HZGHC000554c007; POGK knockout cell line 34bp deletion
DR   cancercelllines; CVCL_TE82
DR   Horizon_Discovery; HZGHC000554c007
DR   Wikidata; Q54877057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18800; POGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POGK (-) 3
AC   CVCL_TE83
SY   HZGHC000554c010; POGK knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TE83
DR   Horizon_Discovery; HZGHC000554c010
DR   Wikidata; Q54877058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18800; POGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POGK (-) 4
AC   CVCL_TE84
SY   HZGHC000555c005; POGK knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TE84
DR   Horizon_Discovery; HZGHC000555c005
DR   Wikidata; Q54877059
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18800; POGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000555c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POGLUT1 (-) 1
AC   CVCL_E2H2
SY   HZGHC007745c005
DR   Horizon_Discovery; HZGHC007745c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22954; POGLUT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POGLUT1 (-) 2
AC   CVCL_E2H3
SY   HZGHC007745c011
DR   Horizon_Discovery; HZGHC007745c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22954; POGLUT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POGZ (-) 1
AC   CVCL_TE85
SY   HZGHC003068c002; POGZ knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE85
DR   Horizon_Discovery; HZGHC003068c002
DR   Wikidata; Q54877060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18801; POGZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003068c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POGZ (-) 2
AC   CVCL_TE86
SY   HZGHC003068c011; POGZ knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE86
DR   Horizon_Discovery; HZGHC003068c011
DR   Wikidata; Q54877061
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18801; POGZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003068c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POGZ (-) 3
AC   CVCL_TE87
SY   HZGHC003068c010; POGZ knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE87
DR   Horizon_Discovery; HZGHC003068c010
DR   Wikidata; Q54877062
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18801; POGZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLB (-) 1
AC   CVCL_TE88
SY   HZGHC004503c010; POLB knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TE88
DR   Horizon_Discovery; HZGHC004503c010
DR   Wikidata; Q54877063
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004503c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 POLB (-) 2
AC   CVCL_TE89
SY   HZGHC004504c003; POLB knockout cell line 172bp insertion
DR   cancercelllines; CVCL_TE89
DR   Horizon_Discovery; HZGHC004504c003
DR   Wikidata; Q54877064
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004504c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 POLB (-) 3
AC   CVCL_E2H4
SY   HZGHC008239c008
DR   Horizon_Discovery; HZGHC008239c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POLB (-) 4
AC   CVCL_E2H5
SY   HZGHC008239c010
DR   Horizon_Discovery; HZGHC008239c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POLB (-) 5
AC   CVCL_E2H6
SY   HZGHC008239c011
DR   Horizon_Discovery; HZGHC008239c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POLDIP2 (-) 1
AC   CVCL_TE90
SY   HZGHC004414c001; POLDIP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE90
DR   Horizon_Discovery; HZGHC004414c001
DR   Wikidata; Q54877065
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23781; POLDIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLDIP2 (-) 2
AC   CVCL_TE91
SY   HZGHC004414c008; POLDIP2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TE91
DR   Horizon_Discovery; HZGHC004414c008
DR   Wikidata; Q54877066
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23781; POLDIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLE (-) 1
AC   CVCL_TE92
SY   HZGHC000659c003; POLE knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE92
DR   Horizon_Discovery; HZGHC000659c003
DR   Wikidata; Q54877067
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9177; POLE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000659c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLE (-) 2
AC   CVCL_TE93
SY   HZGHC000659c005; POLE knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TE93
DR   Horizon_Discovery; HZGHC000659c005
DR   Wikidata; Q54877068
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9177; POLE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000659c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLE (-) 3
AC   CVCL_TE94
SY   HZGHC000659c006; POLE knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TE94
DR   Horizon_Discovery; HZGHC000659c006
DR   Wikidata; Q54877069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9177; POLE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000659c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLE4 (-)
AC   CVCL_TE95
SY   HZGHC004113c006; POLE4 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TE95
DR   Horizon_Discovery; HZGHC004113c006
DR   Wikidata; Q54877070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18755; POLE4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLH (-) 1
AC   CVCL_TE96
SY   HZGHC000655c007; POLH knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TE96
DR   Horizon_Discovery; HZGHC000655c007
DR   Wikidata; Q54877071
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9181; POLH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLH (-) 2
AC   CVCL_TE97
SY   HZGHC000655c010; POLH knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE97
DR   Horizon_Discovery; HZGHC000655c010
DR   Wikidata; Q54877072
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9181; POLH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLI (-) 1
AC   CVCL_TE98
SY   HZGHC003483c011; POLI knockout cell line 583bp insertion
DR   cancercelllines; CVCL_TE98
DR   Horizon_Discovery; HZGHC003483c011
DR   Wikidata; Q54877073
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9182; POLI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003483c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLI (-) 2
AC   CVCL_TE99
SY   HZGHC003483c012; POLI knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TE99
DR   Horizon_Discovery; HZGHC003483c012
DR   Wikidata; Q54877074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9182; POLI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLK (-) 1
AC   CVCL_TF00
SY   HZGHC000652c002; POLK knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TF00
DR   Horizon_Discovery; HZGHC000652c002
DR   Wikidata; Q54877075
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9183; POLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLK (-) 2
AC   CVCL_TF01
SY   HZGHC000652c003; POLK knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF01
DR   Horizon_Discovery; HZGHC000652c003
DR   Wikidata; Q54877076
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9183; POLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000652c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLK (-) 3
AC   CVCL_TF02
SY   HZGHC000652c005; POLK knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TF02
DR   Horizon_Discovery; HZGHC000652c005
DR   Wikidata; Q54877079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9183; POLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000652c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLL (-) 1
AC   CVCL_TF03
SY   HZGHC000651c002; POLL knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF03
DR   Horizon_Discovery; HZGHC000651c002
DR   Wikidata; Q54877080
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9184; POLL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLL (-) 2
AC   CVCL_TF04
SY   HZGHC000651c006; POLL knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF04
DR   Horizon_Discovery; HZGHC000651c006
DR   Wikidata; Q54877081
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9184; POLL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLL (-) 3
AC   CVCL_TF05
SY   HZGHC000651c007; POLL knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TF05
DR   Horizon_Discovery; HZGHC000651c007
DR   Wikidata; Q54877082
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9184; POLL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLM (-) 1
AC   CVCL_TF06
SY   HZGHC000643c002; POLM knockout cell line 29bp insertion
DR   cancercelllines; CVCL_TF06
DR   Horizon_Discovery; HZGHC000643c002
DR   Wikidata; Q54877084
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9185; POLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000643c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLM (-) 2
AC   CVCL_TF07
SY   HZGHC000643c006; POLM knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TF07
DR   Horizon_Discovery; HZGHC000643c006
DR   Wikidata; Q54877085
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9185; POLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLM (-) 3
AC   CVCL_TF08
SY   HZGHC000643c007; POLM knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF08
DR   Horizon_Discovery; HZGHC000643c007
DR   Wikidata; Q54877086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9185; POLM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLN (-) 1
AC   CVCL_TF09
SY   HZGHC000644c001; POLN knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TF09
DR   Horizon_Discovery; HZGHC000644c001
DR   Wikidata; Q54877087
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18870; POLN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLN (-) 2
AC   CVCL_TF10
SY   HZGHC000644c003; POLN knockout cell line 160bp insertion
DR   cancercelllines; CVCL_TF10
DR   Horizon_Discovery; HZGHC000644c003
DR   Wikidata; Q54877088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18870; POLN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000644c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POLN (-) 3
AC   CVCL_TF11
SY   HZGHC000644c011; POLN knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TF11
DR   Horizon_Discovery; HZGHC000644c011
DR   Wikidata; Q54877089
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18870; POLN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLQ (-) 1
AC   CVCL_TF12
SY   HZGHC000647c003; POLQ knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF12
DR   Horizon_Discovery; HZGHC000647c003
DR   Wikidata; Q54877090
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9186; POLQ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POLQ (-) 2
AC   CVCL_TF13
SY   HZGHC000647c005; POLQ knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF13
DR   Horizon_Discovery; HZGHC000647c005
DR   Wikidata; Q54877091
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9186; POLQ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POMGNT1 (-) 1
AC   CVCL_TF14
SY   HZGHC000747c003; POMGNT1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF14
DR   Horizon_Discovery; HZGHC000747c003
DR   Wikidata; Q54877092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19139; POMGNT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POMGNT1 (-) 2
AC   CVCL_TF15
SY   HZGHC000747c012; POMGNT1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TF15
DR   Horizon_Discovery; HZGHC000747c012
DR   Wikidata; Q54877093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19139; POMGNT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POMGNT2 (-) 1
AC   CVCL_TF16
SY   HZGHC001334c002; POMGNT2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TF16
DR   Horizon_Discovery; HZGHC001334c002
DR   Wikidata; Q54877094
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25902; POMGNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POMGNT2 (-) 2
AC   CVCL_TF17
SY   HZGHC001334c011; POMGNT2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TF17
DR   Horizon_Discovery; HZGHC001334c011
DR   Wikidata; Q54877095
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25902; POMGNT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POMK (-) 1
AC   CVCL_TF18
SY   HZGHC001338c001; POMK knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_TF18
DR   Horizon_Discovery; HZGHC001338c001
DR   Wikidata; Q54877096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26267; POMK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POMK (-) 2
AC   CVCL_TF19
SY   HZGHC001338c004; POMK knockout cell line 10bp deletion in exon 4
DR   cancercelllines; CVCL_TF19
DR   Horizon_Discovery; HZGHC001338c004
DR   Wikidata; Q54877097
RX   PubMed=32975514;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26267; POMK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 POMT1 (-) 1
AC   CVCL_TF20
SY   HZGHC000723c006; POMT1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TF20
DR   Horizon_Discovery; HZGHC000723c006
DR   Wikidata; Q54877098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9202; POMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POMT1 (-) 2
AC   CVCL_TF21
SY   HZGHC000724c006; POMT1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TF21
DR   Horizon_Discovery; HZGHC000724c006
DR   Wikidata; Q54877099
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9202; POMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 POMT1 (-) 3
AC   CVCL_E2H7
SY   HZGHC000723c019
DR   Horizon_Discovery; HZGHC000723c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9202; POMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POMT1 (-) 4
AC   CVCL_E2H8
SY   HZGHC000723c024
DR   Horizon_Discovery; HZGHC000723c024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9202; POMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POMT2 (-) 1
AC   CVCL_TF22
SY   HZGHC003205c001; POMT2 knockout cell line 157bp insertion
DR   cancercelllines; CVCL_TF22
DR   Horizon_Discovery; HZGHC003205c001
DR   Wikidata; Q54877100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19743; POMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003205c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POMT2 (-) 2
AC   CVCL_TF23
SY   HZGHC003205c010; POMT2 knockout cell line 137bp insertion
DR   cancercelllines; CVCL_TF23
DR   Horizon_Discovery; HZGHC003205c010
DR   Wikidata; Q54877101
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19743; POMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003205c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POR (-) 1
AC   CVCL_XR73
SY   HZGHC006912c002; POR knockout cell line 26bp deletion in exon 8; HAP1 POR (-)
DR   cancercelllines; CVCL_XR73
DR   Horizon_Discovery; HZGHC006912c002
DR   Wikidata; Q93958875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 POR (-) 2
AC   CVCL_E2H9
SY   HZGHC006912c001; POR knockout cell line 1bp insertion in exon 8
DR   Horizon_Discovery; HZGHC006912c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 POT1 (-) 1
AC   CVCL_TF24
SY   HZGHC006533c006; POT1 knockout cell line 71bp insertion; HAP1 POT1 (-)
DR   cancercelllines; CVCL_TF24
DR   Horizon_Discovery; HZGHC006533c006
DR   Wikidata; Q54877103
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17284; POT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006533c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 POT1 (-) 2
AC   CVCL_XR74
SY   HZGHC006533c008; POT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR74
DR   Horizon_Discovery; HZGHC006533c008
DR   Wikidata; Q93958885
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17284; POT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPARA (-)
AC   CVCL_TF25
SY   HZGHC002330c003; PPARA knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TF25
DR   Horizon_Discovery; HZGHC002330c003
DR   Wikidata; Q54877104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPARD (-) 1
AC   CVCL_TF26
SY   HZGHC004117c004; PPARD knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF26
DR   Horizon_Discovery; HZGHC004117c004
DR   Wikidata; Q54877105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9235; PPARD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPARD (-) 2
AC   CVCL_TF27
SY   HZGHC004117c011; PPARD knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TF27
DR   Horizon_Discovery; HZGHC004117c011
DR   Wikidata; Q54877106
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9235; PPARD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPARG (-) 1
AC   CVCL_XR75
SY   HZGHC006971c012; HZGHC5468; PPARG knockout cell line 1bp deletion in exon 4; HAP1 PPARG (-)
DR   cancercelllines; CVCL_XR75
DR   Horizon_Discovery; HZGHC006971c012
DR   Wikidata; Q93958910
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PPARG (-) 2
AC   CVCL_E2HA
SY   HZGHC006970c002
DR   Horizon_Discovery; HZGHC006970c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPARG (-) 3
AC   CVCL_E2HB
SY   HZGHC006970c009
DR   Horizon_Discovery; HZGHC006970c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPARG (-) 4
AC   CVCL_E2HC
SY   HZGHC006971c006
DR   Horizon_Discovery; HZGHC006971c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPARGC1A (-) 1
AC   CVCL_XR76
SY   HZGHC007048c004; HZGHC10891; PPARGC1A knockout cell line 10bp deletion in exon 3; HAP1 PPARGC1A (-)
DR   cancercelllines; CVCL_XR76
DR   Horizon_Discovery; HZGHC007048c004
DR   Wikidata; Q93958913
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9237; PPARGC1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPARGC1A (-) 2
AC   CVCL_B5KQ
SY   HZGHC007048c007; PARGC1A knockout cell line 4bp deletion in exon 3
DR   cancercelllines; CVCL_B5KQ
DR   Horizon_Discovery; HZGHC007048c007
DR   Wikidata; Q111733312
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9237; PPARGC1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 PPARGC1A (-) 3
AC   CVCL_B5KR
SY   HZGHC007048c008; PARGC1A knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5KR
DR   Horizon_Discovery; HZGHC007048c008
DR   Wikidata; Q111733313
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9237; PPARGC1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 PPARGC1A (-) 4
AC   CVCL_B5KS
SY   HZGHC007048c009; PARGC1A knockout cell line 83bp deletion in exon 3
DR   cancercelllines; CVCL_B5KS
DR   Horizon_Discovery; HZGHC007048c009
DR   Wikidata; Q111733314
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9237; PPARGC1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 PPEF1 (-)
AC   CVCL_TF28
SY   HZGHC003111c006; PPEF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF28
DR   Horizon_Discovery; HZGHC003111c006
DR   Wikidata; Q54877107
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9243; PPEF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPIB (-) 1
AC   CVCL_TF29
SY   HZGHC005477c009; PPIB knockout cell line 22bp deletion; HAP1 PPIB (-)
DR   cancercelllines; CVCL_TF29
DR   Horizon_Discovery; HZGHC005477c009
DR   Wikidata; Q54877108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9255; PPIB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005477c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PPIB (-) 2
AC   CVCL_XR77
SY   HZGHC005478c002; PPIB knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XR77
DR   Horizon_Discovery; HZGHC005478c002
DR   Wikidata; Q93958934
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9255; PPIB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005478c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPIB (-) 3
AC   CVCL_XR78
SY   HZGHC005478c010; PPIB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR78
DR   Horizon_Discovery; HZGHC005478c010
DR   Wikidata; Q93958940
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9255; PPIB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005478c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPIF (-) 1
AC   CVCL_TF30
SY   HZGHC004184c004; PPIF knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF30
DR   Horizon_Discovery; HZGHC004184c004
DR   Wikidata; Q54877109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9259; PPIF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPIF (-) 2
AC   CVCL_TF31
SY   HZGHC004185c012; PPIF knockout cell line 37bp deletion
DR   cancercelllines; CVCL_TF31
DR   Horizon_Discovery; HZGHC004185c012
DR   Wikidata; Q54877110
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9259; PPIF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPIG (-)
AC   CVCL_E2HD
SY   HZGHC007509c001
DR   Horizon_Discovery; HZGHC007509c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14650; PPIG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPIL1 (-) 1
AC   CVCL_TF32
SY   HZGHC005943c001; PPIL1 knockout cell line 22bp deletion; HAP1 PPIL1 (-)
DR   cancercelllines; CVCL_TF32
DR   Horizon_Discovery; HZGHC005943c001
DR   Wikidata; Q54877111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9260; PPIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPIL1 (-) 2
AC   CVCL_XR79
SY   HZGHC005943c006; PPIL1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XR79
DR   Horizon_Discovery; HZGHC005943c006
DR   Wikidata; Q93958985
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9260; PPIL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1A (-) 1
AC   CVCL_TF33
SY   HZGHC003112c003; PPM1A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TF33
DR   Horizon_Discovery; HZGHC003112c003
DR   Wikidata; Q54877112
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9275; PPM1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1A (-) 2
AC   CVCL_TF34
SY   HZGHC003112c011; PPM1A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF34
DR   Horizon_Discovery; HZGHC003112c011
DR   Wikidata; Q54877113
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9275; PPM1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1B (-)
AC   CVCL_TF35
SY   HZGHC003113c006; PPM1B knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TF35
DR   Horizon_Discovery; HZGHC003113c006
DR   Wikidata; Q54877114
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9276; PPM1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1D (-)
AC   CVCL_TF36
SY   HZGHC003114c011; PPM1D knockout cell line 344bp insertion
DR   cancercelllines; CVCL_TF36
DR   Horizon_Discovery; HZGHC003114c011
DR   Wikidata; Q54877115
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9277; PPM1D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003114c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPM1E (-) 1
AC   CVCL_TF37
SY   HZGHC003115c010; PPM1E knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF37
DR   Horizon_Discovery; HZGHC003115c010
DR   Wikidata; Q54877116
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19322; PPM1E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003115c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPM1E (-) 2
AC   CVCL_TF38
SY   HZGHC003115c011; PPM1E knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF38
DR   Horizon_Discovery; HZGHC003115c011
DR   Wikidata; Q54877117
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19322; PPM1E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003115c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPM1E (-) 3
AC   CVCL_TF39
SY   HZGHC003115c001; PPM1E knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF39
DR   Horizon_Discovery; HZGHC003115c001
DR   Wikidata; Q54877118
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19322; PPM1E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1F (-) 1
AC   CVCL_TF40
SY   HZGHC003116c006; PPM1F knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TF40
DR   Horizon_Discovery; HZGHC003116c006
DR   Wikidata; Q54877119
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19388; PPM1F.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1F (-) 2
AC   CVCL_TF41
SY   HZGHC003116c010; PPM1F knockout cell line 188bp deletion
DR   cancercelllines; CVCL_TF41
DR   Horizon_Discovery; HZGHC003116c010
DR   Wikidata; Q54877120
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19388; PPM1F.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1G (-)
AC   CVCL_TF42
SY   HZGHC003117c001; PPM1G knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF42
DR   Horizon_Discovery; HZGHC003117c001
DR   Wikidata; Q54877122
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9278; PPM1G.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1H (-)
AC   CVCL_TF43
SY   HZGHC003118c010; PPM1H knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TF43
DR   Horizon_Discovery; HZGHC003118c010
DR   Wikidata; Q54877123
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18583; PPM1H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1J (-) 1
AC   CVCL_TF44
SY   HZGHC003119c001; PPM1J knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF44
DR   Horizon_Discovery; HZGHC003119c001
DR   Wikidata; Q54877124
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20785; PPM1J.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1J (-) 2
AC   CVCL_TF45
SY   HZGHC003119c011; PPM1J knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TF45
DR   Horizon_Discovery; HZGHC003119c011
DR   Wikidata; Q54877125
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20785; PPM1J.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1K (-) 1
AC   CVCL_TF46
SY   HZGHC003120c006; PPM1K knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TF46
DR   Horizon_Discovery; HZGHC003120c006
DR   Wikidata; Q54877126
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25415; PPM1K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1K (-) 2
AC   CVCL_TF47
SY   HZGHC003120c008; PPM1K knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF47
DR   Horizon_Discovery; HZGHC003120c008
DR   Wikidata; Q54877127
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25415; PPM1K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1L (-) 1
AC   CVCL_TF48
SY   HZGHC003121c006; PPM1L knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TF48
DR   Horizon_Discovery; HZGHC003121c006
DR   Wikidata; Q54877128
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16381; PPM1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1L (-) 2
AC   CVCL_TF49
SY   HZGHC003121c011; PPM1L knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF49
DR   Horizon_Discovery; HZGHC003121c011
DR   Wikidata; Q54877129
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16381; PPM1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1M (-)
AC   CVCL_TF50
SY   HZGHC003122c012; PPM1M knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TF50
DR   Horizon_Discovery; HZGHC003122c012
DR   Wikidata; Q54877130
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26506; PPM1M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1N (-) 1
AC   CVCL_TF51
SY   HZGHC003123c003; PPM1N knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TF51
DR   Horizon_Discovery; HZGHC003123c003
DR   Wikidata; Q54877131
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26845; PPM1N.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPM1N (-) 2
AC   CVCL_TF52
SY   HZGHC003123c009; PPM1N knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TF52
DR   Horizon_Discovery; HZGHC003123c009
DR   Wikidata; Q54877132
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26845; PPM1N.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPME1 (-) 1
AC   CVCL_E2HE
SY   HZGHC007760c001
DR   Horizon_Discovery; HZGHC007760c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30178; PPME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPME1 (-) 2
AC   CVCL_E2HF
SY   HZGHC007760c012
DR   Horizon_Discovery; HZGHC007760c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30178; PPME1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPOX (-)
AC   CVCL_TF53
SY   HZGHC006493c003; PPOX knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TF53
DR   Horizon_Discovery; HZGHC006493c003
DR   Wikidata; Q54877133
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9280; PPOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP1CA (-) 1
AC   CVCL_TF54
SY   HZGHC003124c001; PPP1CA knockout cell line 58bp insertion
DR   cancercelllines; CVCL_TF54
DR   Horizon_Discovery; HZGHC003124c001
DR   Wikidata; Q54877134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9281; PPP1CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003124c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP1CA (-) 2
AC   CVCL_TF55
SY   HZGHC003124c003; PPP1CA knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TF55
DR   Horizon_Discovery; HZGHC003124c003
DR   Wikidata; Q54877135
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9281; PPP1CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R12C (-) 1
AC   CVCL_TF56
SY   HZGHC000977c001; PPP1R12C knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF56
DR   Horizon_Discovery; HZGHC000977c001
DR   Wikidata; Q54877136
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14947; PPP1R12C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R12C (-) 2
AC   CVCL_TF57
SY   HZGHC000977c002; PPP1R12C knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF57
DR   Horizon_Discovery; HZGHC000977c002
DR   Wikidata; Q54877137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14947; PPP1R12C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R12C (-) 3
AC   CVCL_TF58
SY   HZGHC000978c002; PPP1R12C knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TF58
DR   Horizon_Discovery; HZGHC000978c002
DR   Wikidata; Q54877138
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14947; PPP1R12C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R12C (-) 4
AC   CVCL_TF59
SY   HZGHC000978c011; PPP1R12C knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF59
DR   Horizon_Discovery; HZGHC000978c011
DR   Wikidata; Q54877139
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14947; PPP1R12C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R13B (-) 1
AC   CVCL_TF60
SY   HZGHC003127c005; PPP1R13B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF60
DR   Horizon_Discovery; HZGHC003127c005
DR   Wikidata; Q54877140
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14950; PPP1R13B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R13B (-) 2
AC   CVCL_TF61
SY   HZGHC003127c008; PPP1R13B knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TF61
DR   Horizon_Discovery; HZGHC003127c008
DR   Wikidata; Q54877141
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14950; PPP1R13B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R14A (-)
AC   CVCL_TF62
SY   HZGHC003128c006; PPP1R14A knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TF62
DR   Horizon_Discovery; HZGHC003128c006
DR   Wikidata; Q54877142
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14871; PPP1R14A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R14B (-)
AC   CVCL_TF63
SY   HZGHC003750c012; PPP1R14B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF63
DR   Horizon_Discovery; HZGHC003750c012
DR   Wikidata; Q54877143
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9057; PPP1R14B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R14C (-)
AC   CVCL_TF64
SY   HZGHC003129c012; PPP1R14C knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TF64
DR   Horizon_Discovery; HZGHC003129c012
DR   Wikidata; Q54877145
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14952; PPP1R14C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R15A (-) 1
AC   CVCL_TF65
SY   HZGHC003130c011; PPP1R15A knockout cell line 659bp insertion; HAP1 PPP1R15A (-)
DR   cancercelllines; CVCL_TF65
DR   Horizon_Discovery; HZGHC003130c011
DR   Wikidata; Q54877146
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14375; PPP1R15A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003130c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP1R15A (-) 2
AC   CVCL_E2HG
SY   HZGHC003130c018; PPP1R15A knockout cell line 17bp deletion in exon 2
DR   Horizon_Discovery; HZGHC003130c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14375; PPP1R15A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPP1R16A (-)
AC   CVCL_TF66
SY   HZGHC003131c002; PPP1R16A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TF66
DR   Horizon_Discovery; HZGHC003131c002
DR   Wikidata; Q54877147
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14941; PPP1R16A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R16B (-)
AC   CVCL_TF67
SY   HZGHC003132c002; PPP1R16B knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TF67
DR   Horizon_Discovery; HZGHC003132c002
DR   Wikidata; Q54877148
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15850; PPP1R16B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R18 (-) 1
AC   CVCL_TF68
SY   HZGHC003133c004; PPP1R18 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF68
DR   Horizon_Discovery; HZGHC003133c004
DR   Wikidata; Q54877149
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29413; PPP1R18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R18 (-) 2
AC   CVCL_TF69
SY   HZGHC003133c006; PPP1R18 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TF69
DR   Horizon_Discovery; HZGHC003133c006
DR   Wikidata; Q54877150
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29413; PPP1R18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R1A (-) 1
AC   CVCL_TF70
SY   HZGHC004105c001; PPP1R1A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF70
DR   Horizon_Discovery; HZGHC004105c001
DR   Wikidata; Q54877151
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9286; PPP1R1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R1A (-) 2
AC   CVCL_TF71
SY   HZGHC004105c003; PPP1R1A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF71
DR   Horizon_Discovery; HZGHC004105c003
DR   Wikidata; Q54877152
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9286; PPP1R1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R1A (-) 3
AC   CVCL_TF72
SY   HZGHC004105c005; PPP1R1A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TF72
DR   Horizon_Discovery; HZGHC004105c005
DR   Wikidata; Q54877153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9286; PPP1R1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R1A (-) 4
AC   CVCL_TF73
SY   HZGHC003489c010; PPP1R1A knockout cell line 52bp deletion
DR   cancercelllines; CVCL_TF73
DR   Horizon_Discovery; HZGHC003489c010
DR   Wikidata; Q54877154
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9286; PPP1R1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R21 (-) 1
AC   CVCL_TF74
SY   HZGHC003136c004; PPP1R21 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TF74
DR   Horizon_Discovery; HZGHC003136c004
DR   Wikidata; Q54877155
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30595; PPP1R21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R21 (-) 2
AC   CVCL_TF75
SY   HZGHC003136c006; PPP1R21 knockout cell line 167bp insertion
DR   cancercelllines; CVCL_TF75
DR   Horizon_Discovery; HZGHC003136c006
DR   Wikidata; Q54877156
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30595; PPP1R21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003136c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP1R26 (-)
AC   CVCL_TF76
SY   HZGHC003135c001; PPP1R26 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TF76
DR   Horizon_Discovery; HZGHC003135c001
DR   Wikidata; Q54877157
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29089; PPP1R26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R32 (-)
AC   CVCL_TF77
SY   HZGHC003137c010; PPP1R32 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF77
DR   Horizon_Discovery; HZGHC003137c010
DR   Wikidata; Q54877158
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28869; SAXO4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP1R37 (-) 1
AC   CVCL_TF78
SY   HZGHC003139c010; PPP1R37 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF78
DR   Horizon_Discovery; HZGHC003139c010
DR   Wikidata; Q54877159
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27607; PPP1R37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R37 (-) 2
AC   CVCL_TF79
SY   HZGHC003139c011; PPP1R37 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TF79
DR   Horizon_Discovery; HZGHC003139c011
DR   Wikidata; Q54877160
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27607; PPP1R37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R3B (-) 1
AC   CVCL_TF80
SY   HZGHC003140c005; PPP1R3B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF80
DR   Horizon_Discovery; HZGHC003140c005
DR   Wikidata; Q54877161
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14942; PPP1R3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R3B (-) 2
AC   CVCL_TF81
SY   HZGHC003140c012; PPP1R3B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF81
DR   Horizon_Discovery; HZGHC003140c012
DR   Wikidata; Q54877162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14942; PPP1R3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R3D (-) 1
AC   CVCL_TF82
SY   HZGHC003141c001; PPP1R3D knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF82
DR   Horizon_Discovery; HZGHC003141c001
DR   Wikidata; Q54877165
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9294; PPP1R3D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R3D (-) 2
AC   CVCL_TF83
SY   HZGHC003141c012; PPP1R3D knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TF83
DR   Horizon_Discovery; HZGHC003141c012
DR   Wikidata; Q54877166
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9294; PPP1R3D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R3F (-) 1
AC   CVCL_TF84
SY   HZGHC003143c002; PPP1R3F knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TF84
DR   Horizon_Discovery; HZGHC003143c002
DR   Wikidata; Q54877167
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14944; PPP1R3F.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R3F (-) 2
AC   CVCL_TF85
SY   HZGHC003143c011; PPP1R3F knockout cell line 154bp insertion
DR   cancercelllines; CVCL_TF85
DR   Horizon_Discovery; HZGHC003143c011
DR   Wikidata; Q54877168
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14944; PPP1R3F.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003143c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP1R9A (-) 1
AC   CVCL_TF86
SY   HZGHC003144c003; PPP1R9A knockout cell line 122bp deletion
DR   cancercelllines; CVCL_TF86
DR   Horizon_Discovery; HZGHC003144c003
DR   Wikidata; Q54877169
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14946; PPP1R9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R9A (-) 2
AC   CVCL_TF87
SY   HZGHC003144c011; PPP1R9A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TF87
DR   Horizon_Discovery; HZGHC003144c011
DR   Wikidata; Q54877170
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14946; PPP1R9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP1R9B (-) 1
AC   CVCL_TF88
SY   HZGHC003145c001; PPP1R9B knockout cell line 109bp insertion
DR   cancercelllines; CVCL_TF88
DR   Horizon_Discovery; HZGHC003145c001
DR   Wikidata; Q54877171
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9298; PPP1R9B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003145c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP1R9B (-) 2
AC   CVCL_TF89
SY   HZGHC003145c005; PPP1R9B knockout cell line 125bp insertion
DR   cancercelllines; CVCL_TF89
DR   Horizon_Discovery; HZGHC003145c005
DR   Wikidata; Q54877172
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9298; PPP1R9B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003145c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP2CB (-) 1
AC   CVCL_TF90
SY   HZGHC003146c001; PPP2CB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF90
DR   Horizon_Discovery; HZGHC003146c001
DR   Wikidata; Q54877173
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9300; PPP2CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2CB (-) 2
AC   CVCL_TF91
SY   HZGHC003146c005; PPP2CB knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TF91
DR   Horizon_Discovery; HZGHC003146c005
DR   Wikidata; Q54877174
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9300; PPP2CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2CB (-) 3
AC   CVCL_TF92
SY   HZGHC003146c010; PPP2CB knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TF92
DR   Horizon_Discovery; HZGHC003146c010
DR   Wikidata; Q54877175
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9300; PPP2CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R1B (-) 1
AC   CVCL_TF93
SY   HZGHC003147c002; PPP2R1B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TF93
DR   Horizon_Discovery; HZGHC003147c002
DR   Wikidata; Q54877176
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9303; PPP2R1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R1B (-) 2
AC   CVCL_TF94
SY   HZGHC003147c010; PPP2R1B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TF94
DR   Horizon_Discovery; HZGHC003147c010
DR   Wikidata; Q54877177
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9303; PPP2R1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R2A (-)
AC   CVCL_E2HH
SY   HZGHC007687c009
DR   Horizon_Discovery; HZGHC007687c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9304; PPP2R2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPP2R2B (-) 1
AC   CVCL_TF95
SY   HZGHC003148c001; PPP2R2B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TF95
DR   Horizon_Discovery; HZGHC003148c001
DR   Wikidata; Q54877178
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9305; PPP2R2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R2B (-) 2
AC   CVCL_TF96
SY   HZGHC003148c003; PPP2R2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF96
DR   Horizon_Discovery; HZGHC003148c003
DR   Wikidata; Q54877179
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9305; PPP2R2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R2C (-)
AC   CVCL_TF97
SY   HZGHC003149c010; PPP2R2C knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TF97
DR   Horizon_Discovery; HZGHC003149c010
DR   Wikidata; Q54877180
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9306; PPP2R2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R2D (-) 1
AC   CVCL_TF98
SY   HZGHC003150c002; PPP2R2D knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TF98
DR   Horizon_Discovery; HZGHC003150c002
DR   Wikidata; Q54877181
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23732; PPP2R2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R2D (-) 2
AC   CVCL_TF99
SY   HZGHC003150c004; PPP2R2D knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TF99
DR   Horizon_Discovery; HZGHC003150c004
DR   Wikidata; Q54877182
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23732; PPP2R2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R2D (-) 3
AC   CVCL_TG00
SY   HZGHC003150c006; PPP2R2D knockout cell line 293bp insertion
DR   cancercelllines; CVCL_TG00
DR   Horizon_Discovery; HZGHC003150c006
DR   Wikidata; Q54877183
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23732; PPP2R2D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003150c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP2R3A (-) 1
AC   CVCL_TG01
SY   HZGHC003151c001; PPP2R3A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG01
DR   Horizon_Discovery; HZGHC003151c001
DR   Wikidata; Q54877184
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9307; PPP2R3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R3A (-) 2
AC   CVCL_TG02
SY   HZGHC003151c010; PPP2R3A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG02
DR   Horizon_Discovery; HZGHC003151c010
DR   Wikidata; Q54877185
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9307; PPP2R3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R4 (-) 1
AC   CVCL_TG03
SY   HZGHC001099c003; PPP2R4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG03
DR   Horizon_Discovery; HZGHC001099c003
DR   Wikidata; Q54877186
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9308; PTPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R4 (-) 2
AC   CVCL_TG04
SY   HZGHC004644c012; PPP2R4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG04
DR   Horizon_Discovery; HZGHC004644c012
DR   Wikidata; Q54877187
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9308; PTPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R5A (-) 1
AC   CVCL_TG05
SY   HZGHC003152c002; PPP2R5A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG05
DR   Horizon_Discovery; HZGHC003152c002
DR   Wikidata; Q54877188
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9309; PPP2R5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R5A (-) 2
AC   CVCL_TG06
SY   HZGHC003152c012; PPP2R5A knockout cell line 757bp insertion
DR   cancercelllines; CVCL_TG06
DR   Horizon_Discovery; HZGHC003152c012
DR   Wikidata; Q54877189
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9309; PPP2R5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003152c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP2R5B (-) 1
AC   CVCL_TG07
SY   HZGHC003153c001; PPP2R5B knockout cell line 169bp insertion
DR   cancercelllines; CVCL_TG07
DR   Horizon_Discovery; HZGHC003153c001
DR   Wikidata; Q54877190
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9310; PPP2R5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003153c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP2R5B (-) 2
AC   CVCL_TG08
SY   HZGHC003153c009; PPP2R5B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG08
DR   Horizon_Discovery; HZGHC003153c009
DR   Wikidata; Q54877191
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9310; PPP2R5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R5C (-) 1
AC   CVCL_TG09
SY   HZGHC003154c010; PPP2R5C knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG09
DR   Horizon_Discovery; HZGHC003154c010
DR   Wikidata; Q54877192
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9311; PPP2R5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R5C (-) 2
AC   CVCL_TG10
SY   HZGHC003154c011; PPP2R5C knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TG10
DR   Horizon_Discovery; HZGHC003154c011
DR   Wikidata; Q54877193
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9311; PPP2R5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R5D (-)
AC   CVCL_TG11
SY   HZGHC003155c003; PPP2R5D knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG11
DR   Horizon_Discovery; HZGHC003155c003
DR   Wikidata; Q54877194
RX   PubMed=39935523;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9312; PPP2R5D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   HAP1 PPP2R5E (-) 1
AC   CVCL_TG12
SY   HZGHC003156c001; PPP2R5E knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TG12
DR   Horizon_Discovery; HZGHC003156c001
DR   Wikidata; Q54877195
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9313; PPP2R5E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP2R5E (-) 2
AC   CVCL_TG13
SY   HZGHC003156c011; PPP2R5E knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG13
DR   Horizon_Discovery; HZGHC003156c011
DR   Wikidata; Q54877196
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9313; PPP2R5E.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP3CA (-) 1
AC   CVCL_TG14
SY   HZGHC003157c002; PPP3CA knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TG14
DR   Horizon_Discovery; HZGHC003157c002
DR   Wikidata; Q54877197
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9314; PPP3CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP3CA (-) 2
AC   CVCL_TG15
SY   HZGHC003157c011; PPP3CA knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TG15
DR   Horizon_Discovery; HZGHC003157c011
DR   Wikidata; Q54877198
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9314; PPP3CA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003157c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PPP3CB (-) 1
AC   CVCL_TG16
SY   HZGHC003158c010; PPP3CB knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TG16
DR   Horizon_Discovery; HZGHC003158c010
DR   Wikidata; Q54877199
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9315; PPP3CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP3CB (-) 2
AC   CVCL_TG17
SY   HZGHC003158c011; PPP3CB knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TG17
DR   Horizon_Discovery; HZGHC003158c011
DR   Wikidata; Q54877200
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9315; PPP3CB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP3CC (-) 1
AC   CVCL_TG18
SY   HZGHC003159c006; PPP3CC knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG18
DR   Horizon_Discovery; HZGHC003159c006
DR   Wikidata; Q54877201
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9316; PPP3CC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP3CC (-) 2
AC   CVCL_TG19
SY   HZGHC003159c010; PPP3CC knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG19
DR   Horizon_Discovery; HZGHC003159c010
DR   Wikidata; Q54877202
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9316; PPP3CC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP3R1 (-) 1
AC   CVCL_TG20
SY   HZGHC002540c002; PPP3R1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG20
DR   Horizon_Discovery; HZGHC002540c002
DR   Wikidata; Q54877203
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9317; PPP3R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP3R1 (-) 2
AC   CVCL_TG21
SY   HZGHC002540c012; PPP3R1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG21
DR   Horizon_Discovery; HZGHC002540c012
DR   Wikidata; Q54877204
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9317; PPP3R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP4R1 (-) 1
AC   CVCL_TG22
SY   HZGHC003160c003; PPP4R1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG22
DR   Horizon_Discovery; HZGHC003160c003
DR   Wikidata; Q54877208
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9320; PPP4R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP4R1 (-) 2
AC   CVCL_TG23
SY   HZGHC003160c011; PPP4R1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG23
DR   Horizon_Discovery; HZGHC003160c011
DR   Wikidata; Q54877209
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9320; PPP4R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP4R2 (-) 1
AC   CVCL_TG24
SY   HZGHC003161c002; PPP4R2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG24
DR   Horizon_Discovery; HZGHC003161c002
DR   Wikidata; Q54877210
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18296; PPP4R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP4R2 (-) 2
AC   CVCL_TG25
SY   HZGHC003161c011; PPP4R2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TG25
DR   Horizon_Discovery; HZGHC003161c011
DR   Wikidata; Q54877211
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18296; PPP4R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP4R4 (-) 1
AC   CVCL_TG26
SY   HZGHC003162c010; PPP4R4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG26
DR   Horizon_Discovery; HZGHC003162c010
DR   Wikidata; Q54877212
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23788; PPP4R4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP4R4 (-) 2
AC   CVCL_TG27
SY   HZGHC003162c012; PPP4R4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TG27
DR   Horizon_Discovery; HZGHC003162c012
DR   Wikidata; Q54877213
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23788; PPP4R4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP5C (-) 1
AC   CVCL_TG28
SY   HZGHC003163c001; PPP5C knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TG28
DR   Horizon_Discovery; HZGHC003163c001
DR   Wikidata; Q54877214
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9322; PPP5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP5C (-) 2
AC   CVCL_TG29
SY   HZGHC003163c011; PPP5C knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TG29
DR   Horizon_Discovery; HZGHC003163c011
DR   Wikidata; Q54877215
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9322; PPP5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP6R1 (-) 1
AC   CVCL_TG30
SY   HZGHC003164c001; PPP6R1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TG30
DR   Horizon_Discovery; HZGHC003164c001
DR   Wikidata; Q54877216
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29195; PPP6R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP6R1 (-) 2
AC   CVCL_TG31
SY   HZGHC003164c010; PPP6R1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG31
DR   Horizon_Discovery; HZGHC003164c010
DR   Wikidata; Q54877217
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29195; PPP6R1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP6R2 (-) 1
AC   CVCL_TG32
SY   HZGHC003165c003; PPP6R2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG32
DR   Horizon_Discovery; HZGHC003165c003
DR   Wikidata; Q54877218
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19253; PPP6R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPP6R2 (-) 2
AC   CVCL_TG33
SY   HZGHC003165c006; PPP6R2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG33
DR   Horizon_Discovery; HZGHC003165c006
DR   Wikidata; Q54877219
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19253; PPP6R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PPT1 (-) 1
AC   CVCL_E2HI
SY   HZGHC007486c007
DR   Horizon_Discovery; HZGHC007486c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9325; PPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPT1 (-) 2
AC   CVCL_E2HJ
SY   HZGHC007486c008
DR   Horizon_Discovery; HZGHC007486c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9325; PPT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PPTC7 (-)
AC   CVCL_TG34
SY   HZGHC004959c002; PPTC7 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG34
DR   Horizon_Discovery; HZGHC004959c002
DR   Wikidata; Q54877220
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30695; PPTC7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PQLC1 (-) 1
AC   CVCL_TG35
SY   HZGHC005851c011; PQLC1 knockout cell line 103bp insertion; HAP1 PQLC1 (-)
DR   cancercelllines; CVCL_TG35
DR   Horizon_Discovery; HZGHC005851c011
DR   Wikidata; Q54877222
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26188; SLC66A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005851c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 PQLC1 (-) 2
AC   CVCL_XR80
SY   HZGHC005851c003; PQLC1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XR80
DR   Horizon_Discovery; HZGHC005851c003
DR   Wikidata; Q93960051
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26188; SLC66A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005851c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PQLC2 (-) 1
AC   CVCL_TG36
SY   HZGHC006457c001; PQLC2 knockout cell line 1bp deletion; HAP1 PQLC2 (-)
DR   cancercelllines; CVCL_TG36
DR   Horizon_Discovery; HZGHC006457c001
DR   Wikidata; Q54877223
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26001; SLC66A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PQLC2 (-) 2
AC   CVCL_XR81
SY   HZGHC006457c002; PQLC2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XR81
DR   Horizon_Discovery; HZGHC006457c002
DR   Wikidata; Q93960057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26001; SLC66A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRDX1 (-) 1
AC   CVCL_TG37
SY   HZGHC002675c002; PRDX1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TG37
DR   Horizon_Discovery; HZGHC002675c002
DR   Wikidata; Q54877224
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX1 (-) 2
AC   CVCL_TG38
SY   HZGHC002675c008; PRDX1 knockout cell line 172bp deletion
DR   cancercelllines; CVCL_TG38
DR   Horizon_Discovery; HZGHC002675c008
DR   Wikidata; Q54877225
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX1 (-) 3
AC   CVCL_TG39
SY   HZGHC004022c005; PRDX1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TG39
DR   Horizon_Discovery; HZGHC004022c005
DR   Wikidata; Q54877226
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX1 (-) 4
AC   CVCL_TG40
SY   HZGHC004022c010; PRDX1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TG40
DR   Horizon_Discovery; HZGHC004022c010
DR   Wikidata; Q54877227
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX1 (-) 5
AC   CVCL_TG41
SY   HZGHC004016c003; PRDX1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG41
DR   Horizon_Discovery; HZGHC004016c003
DR   Wikidata; Q54877228
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX1 (-) 6
AC   CVCL_TG42
SY   HZGHC004016c001; PRDX1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG42
DR   Horizon_Discovery; HZGHC004016c001
DR   Wikidata; Q54877229
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX1 (-) 7
AC   CVCL_TG43
SY   HZGHC004016c010; PRDX1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TG43
DR   Horizon_Discovery; HZGHC004016c010
DR   Wikidata; Q54877230
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX2 (-) 1
AC   CVCL_TG44
SY   HZGHC002676c002; PRDX2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TG44
DR   Horizon_Discovery; HZGHC002676c002
DR   Wikidata; Q54877231
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9353; PRDX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX2 (-) 2
AC   CVCL_TG45
SY   HZGHC002676c003; PRDX2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TG45
DR   Horizon_Discovery; HZGHC002676c003
DR   Wikidata; Q54877232
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9353; PRDX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX2 (-) 3
AC   CVCL_TG46
SY   HZGHC002678c006; PRDX2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG46
DR   Horizon_Discovery; HZGHC002678c006
DR   Wikidata; Q54877233
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9353; PRDX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX2 (-) 4
AC   CVCL_TG47
SY   HZGHC002678c011; PRDX2 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TG47
DR   Horizon_Discovery; HZGHC002678c011
DR   Wikidata; Q54877235
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9353; PRDX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX3 (-) 1
AC   CVCL_TG48
SY   HZGHC004049c001; PRDX3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG48
DR   Horizon_Discovery; HZGHC004049c001
DR   Wikidata; Q54877236
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9354; PRDX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX3 (-) 2
AC   CVCL_TG49
SY   HZGHC004049c011; PRDX3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG49
DR   Horizon_Discovery; HZGHC004049c011
DR   Wikidata; Q54877237
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9354; PRDX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX3 (-) 3
AC   CVCL_TG50
SY   HZGHC004049c012; PRDX3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG50
DR   Horizon_Discovery; HZGHC004049c012
DR   Wikidata; Q54877238
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9354; PRDX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004049c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRDX3 (-) 4
AC   CVCL_TG51
SY   HZGHC002679c003; PRDX3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TG51
DR   Horizon_Discovery; HZGHC002679c003
DR   Wikidata; Q54877239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9354; PRDX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX3 (-) 5
AC   CVCL_TG52
SY   HZGHC002679c008; PRDX3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TG52
DR   Horizon_Discovery; HZGHC002679c008
DR   Wikidata; Q54877240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9354; PRDX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX4 (-) 1
AC   CVCL_E2HK
SY   HZGHC007451c002
DR   Horizon_Discovery; HZGHC007451c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17169; PRDX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRDX4 (-) 2
AC   CVCL_E2HL
SY   HZGHC007451c008
DR   Horizon_Discovery; HZGHC007451c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17169; PRDX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRDX4 (-) 3
AC   CVCL_E2HM
SY   HZGHC007451c009
DR   Horizon_Discovery; HZGHC007451c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17169; PRDX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRDX4 (-) 4
AC   CVCL_E2HN
SY   HZGHC007451c011
DR   Horizon_Discovery; HZGHC007451c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17169; PRDX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRDX4 (-) 5
AC   CVCL_E2HP
SY   HZGHC007451c012
DR   Horizon_Discovery; HZGHC007451c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17169; PRDX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRDX5 (-) 1
AC   CVCL_TG53
SY   HZGHC002681c003; PRDX5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG53
DR   Horizon_Discovery; HZGHC002681c003
DR   Wikidata; Q54877241
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9355; PRDX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX5 (-) 2
AC   CVCL_TG54
SY   HZGHC002681c012; PRDX5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG54
DR   Horizon_Discovery; HZGHC002681c012
DR   Wikidata; Q54877242
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9355; PRDX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRDX6 (-) 1
AC   CVCL_TG55
SY   HZGHC006320c001; PRDX6 knockout cell line 11bp deletion; HAP1 PRDX6 (-)
DR   cancercelllines; CVCL_TG55
DR   Horizon_Discovery; HZGHC006320c001
DR   Wikidata; Q54877243
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16753; PRDX6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRDX6 (-) 2
AC   CVCL_XR82
SY   HZGHC006320c012; PRDX6 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XR82
DR   Horizon_Discovery; HZGHC006320c012
DR   Wikidata; Q93960200
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16753; PRDX6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PREP (-) 1
AC   CVCL_TG56
SY   HZGHC005733c001; PREP knockout cell line 2bp deletion; HAP1 PREP (-)
DR   cancercelllines; CVCL_TG56
DR   Horizon_Discovery; HZGHC005733c001
DR   Wikidata; Q54877244
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9358; PREP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PREP (-) 2
AC   CVCL_XR83
SY   HZGHC005733c002; PREP knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XR83
DR   Horizon_Discovery; HZGHC005733c002
DR   Wikidata; Q93960210
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9358; PREP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PREP (-) 3
AC   CVCL_XR84
SY   HZGHC005734c003; PREP knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XR84
DR   Horizon_Discovery; HZGHC005734c003
DR   Wikidata; Q93960213
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9358; PREP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PREP (-) 4
AC   CVCL_XR85
SY   HZGHC005734c005; PREP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR85
DR   Horizon_Discovery; HZGHC005734c005
DR   Wikidata; Q93960214
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9358; PREP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PREP (-) 5
AC   CVCL_XR86
SY   HZGHC005734c012; PREP knockout cell line 211bp insertion
DR   cancercelllines; CVCL_XR86
DR   Horizon_Discovery; HZGHC005734c012
DR   Wikidata; Q93960217
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9358; PREP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005734c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PREPL (-) 1
AC   CVCL_TG57
SY   HZGHC005784c012; PREPL knockout cell line 13bp deletion; HAP1 PREPL (-)
DR   cancercelllines; CVCL_TG57
DR   Horizon_Discovery; HZGHC005784c012
DR   Wikidata; Q54877245
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30228; PREPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PREPL (-) 2
AC   CVCL_XR87
SY   HZGHC005784c002; PREPL knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XR87
DR   Horizon_Discovery; HZGHC005784c002
DR   Wikidata; Q93960223
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30228; PREPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PREPL (-) 3
AC   CVCL_XR88
SY   HZGHC005785c001; PREPL knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XR88
DR   Horizon_Discovery; HZGHC005785c001
DR   Wikidata; Q93960225
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30228; PREPL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRICKLE1 (-) 1
AC   CVCL_E2HQ
SY   HZGHC008100c005
DR   Horizon_Discovery; HZGHC008100c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17019; PRICKLE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRICKLE1 (-) 2
AC   CVCL_E2HR
SY   HZGHC008100c007
DR   Horizon_Discovery; HZGHC008100c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17019; PRICKLE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRICKLE1 (-) 3
AC   CVCL_E2HS
SY   HZGHC008100c008
DR   Horizon_Discovery; HZGHC008100c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17019; PRICKLE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRICKLE1 (-) 4
AC   CVCL_E2HT
SY   HZGHC008101c005
DR   Horizon_Discovery; HZGHC008101c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17019; PRICKLE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRICKLE1 (-) 5
AC   CVCL_E2HU
SY   HZGHC008101c010
DR   Horizon_Discovery; HZGHC008101c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17019; PRICKLE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRIMPOL (-) 1
AC   CVCL_TG58
SY   HZGHC004469c008; PRIMPOL knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG58
DR   Horizon_Discovery; HZGHC004469c008
DR   Wikidata; Q54877247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26575; PRIMPOL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRIMPOL (-) 2
AC   CVCL_TG59
SY   HZGHC004469c012; PRIMPOL knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TG59
DR   Horizon_Discovery; HZGHC004469c012
DR   Wikidata; Q54877248
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26575; PRIMPOL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAA1 (-) 1
AC   CVCL_TG60
SY   HZGHC000167c004; PRKAA1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG60
DR   Horizon_Discovery; HZGHC000167c004
DR   Wikidata; Q54877249
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAA1 (-) 2
AC   CVCL_TG61
SY   HZGHC000167c010; PRKAA1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG61
DR   Horizon_Discovery; HZGHC000167c010
DR   Wikidata; Q54877250
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAA2 (-) 1
AC   CVCL_TG62
SY   HZGHC000055c015; PRKAA2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG62
DR   Horizon_Discovery; HZGHC000055c015
DR   Wikidata; Q54877255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000055c015; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKAA2 (-) 2
AC   CVCL_TG63
SY   HZGHC000055c013; PRKAA2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG63
DR   Horizon_Discovery; HZGHC000055c013
DR   Wikidata; Q54877257
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAB1 (-) 1
AC   CVCL_TG64
SY   HZGHC000996c002; PRKAB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG64
DR   Horizon_Discovery; HZGHC000996c002
DR   Wikidata; Q54877258
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAB1 (-) 2
AC   CVCL_TG65
SY   HZGHC000995c002; PRKAB1 knockout cell line 308bp insertion
DR   cancercelllines; CVCL_TG65
DR   Horizon_Discovery; HZGHC000995c002
DR   Wikidata; Q54877259
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000995c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKAB1 (-) 3
AC   CVCL_TG66
SY   HZGHC000995c011; PRKAB1 knockout cell line 110bp insertion
DR   cancercelllines; CVCL_TG66
DR   Horizon_Discovery; HZGHC000995c011
DR   Wikidata; Q54877260
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000995c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKAB1 (-) 4
AC   CVCL_TG67
SY   HZGHC000996c001; PRKAB1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TG67
DR   Horizon_Discovery; HZGHC000996c001
DR   Wikidata; Q54877261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAB2 (-) 1
AC   CVCL_TG68
SY   HZGHC000557c001; PRKAB2 knockout cell line 56bp insertion
DR   cancercelllines; CVCL_TG68
DR   Horizon_Discovery; HZGHC000557c001
DR   Wikidata; Q54877262
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9379; PRKAB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000557c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKAB2 (-) 2
AC   CVCL_TG69
SY   HZGHC000557c002; PRKAB2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG69
DR   Horizon_Discovery; HZGHC000557c002
DR   Wikidata; Q54877263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9379; PRKAB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKACA (-) 1
AC   CVCL_TG70
SY   HZGHC000313c001; PRKACA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG70
DR   Horizon_Discovery; HZGHC000313c001
DR   Wikidata; Q54877264
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9380; PRKACA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKACA (-) 2
AC   CVCL_TG71
SY   HZGHC000313c012; PRKACA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG71
DR   Horizon_Discovery; HZGHC000313c012
DR   Wikidata; Q54877265
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9380; PRKACA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKACB (-) 1
AC   CVCL_TG72
SY   HZGHC000314c004; PRKACB knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TG72
DR   Horizon_Discovery; HZGHC000314c004
DR   Wikidata; Q54877266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKACB (-) 2
AC   CVCL_TG73
SY   HZGHC000314c011; PRKACB knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TG73
DR   Horizon_Discovery; HZGHC000314c011
DR   Wikidata; Q54877267
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAG1 (-) 1
AC   CVCL_TG74
SY   HZGHC003911c003; PRKAG1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG74
DR   Horizon_Discovery; HZGHC003911c003
DR   Wikidata; Q54877268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAG1 (-) 2
AC   CVCL_TG75
SY   HZGHC003911c004; PRKAG1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TG75
DR   Horizon_Discovery; HZGHC003911c004
DR   Wikidata; Q54877269
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAG1 (-) 3
AC   CVCL_TG76
SY   HZGHC003911c008; PRKAG1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG76
DR   Horizon_Discovery; HZGHC003911c008
DR   Wikidata; Q54877270
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAG1 (-) 4
AC   CVCL_TG77
SY   HZGHC003911c009; PRKAG1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG77
DR   Horizon_Discovery; HZGHC003911c009
DR   Wikidata; Q54877271
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAG2 (-) 1
AC   CVCL_TG78
SY   HZGHC003912c004; PRKAG2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TG78
DR   Horizon_Discovery; HZGHC003912c004
DR   Wikidata; Q54877272
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9386; PRKAG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKAG2 (-) 2
AC   CVCL_TG79
SY   HZGHC003912c011; PRKAG2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TG79
DR   Horizon_Discovery; HZGHC003912c011
DR   Wikidata; Q54877273
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9386; PRKAG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCA (-) 1
AC   CVCL_TG80
SY   HZGHC000056c007; PRKCA knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TG80
DR   Horizon_Discovery; HZGHC000056c007
DR   Wikidata; Q54877274
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCA (-) 2
AC   CVCL_TG81
SY   HZGHC000056c018; PRKCA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG81
DR   Horizon_Discovery; HZGHC000056c018
DR   Wikidata; Q54877275
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCD (-) 1
AC   CVCL_TG82
SY   HZGHC000168c004; PRKCD knockout cell line 4bp insertion
DR   cancercelllines; CVCL_TG82
DR   Horizon_Discovery; HZGHC000168c004
DR   Wikidata; Q54877276
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9399; PRKCD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKCD (-) 2
AC   CVCL_TG83
SY   HZGHC000168c014; PRKCD knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TG83
DR   Horizon_Discovery; HZGHC000168c014
DR   Wikidata; Q54877277
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9399; PRKCD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCE (-) 1
AC   CVCL_TG84
SY   HZGHC001271c016; PRKCE knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG84
DR   Horizon_Discovery; HZGHC001271c016
DR   Wikidata; Q54877278
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9401; PRKCE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCE (-) 2
AC   CVCL_TG85
SY   HZGHC003000c005; PRKCE knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TG85
DR   Horizon_Discovery; HZGHC003000c005
DR   Wikidata; Q54877279
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9401; PRKCE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCE (-) 3
AC   CVCL_TG86
SY   HZGHC003000c012; PRKCE knockout cell line 152bp insertion
DR   cancercelllines; CVCL_TG86
DR   Horizon_Discovery; HZGHC003000c012
DR   Wikidata; Q54877280
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9401; PRKCE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003000c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKCG (-) 1
AC   CVCL_TG87
SY   HZGHC000326c007; PRKCG knockout cell line 43bp deletion
DR   cancercelllines; CVCL_TG87
DR   Horizon_Discovery; HZGHC000326c007
DR   Wikidata; Q54877281
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCG (-) 2
AC   CVCL_TG88
SY   HZGHC000326c011; PRKCG knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG88
DR   Horizon_Discovery; HZGHC000326c011
DR   Wikidata; Q54877282
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCG (-) 3
AC   CVCL_TG89
SY   HZGHC000326c014; PRKCG knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TG89
DR   Horizon_Discovery; HZGHC000326c014
DR   Wikidata; Q54877283
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCI (-) 1
AC   CVCL_TG90
SY   HZGHC000057c007; PRKCI knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG90
DR   Horizon_Discovery; HZGHC000057c007
DR   Wikidata; Q54877284
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCI (-) 2
AC   CVCL_TG91
SY   HZGHC000057c008; PRKCI knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TG91
DR   Horizon_Discovery; HZGHC000057c008
DR   Wikidata; Q54877285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCQ (-)
AC   CVCL_TG92
SY   HZGHC000237c003; PRKCQ knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG92
DR   Horizon_Discovery; HZGHC000237c003
DR   Wikidata; Q54877286
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9410; PRKCQ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCSH (-)
AC   CVCL_E2HV
SY   HZGHC007360c006
DR   Horizon_Discovery; HZGHC007360c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9411; PRKCSH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRKCZ (-) 1
AC   CVCL_TG93
SY   HZGHC001273c002; PRKCZ knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TG93
DR   Horizon_Discovery; HZGHC001273c002
DR   Wikidata; Q54877287
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCZ (-) 2
AC   CVCL_TG94
SY   HZGHC003001c001; PRKCZ knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TG94
DR   Horizon_Discovery; HZGHC003001c001
DR   Wikidata; Q54877288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKCZ (-) 3
AC   CVCL_TG95
SY   HZGHC003001c002; PRKCZ knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TG95
DR   Horizon_Discovery; HZGHC003001c002
DR   Wikidata; Q54877289
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003001c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKD1 (-) 1
AC   CVCL_TG96
SY   HZGHC000394c001; PRKD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TG96
DR   Horizon_Discovery; HZGHC000394c001
DR   Wikidata; Q54877290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9407; PRKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKD1 (-) 2
AC   CVCL_TG97
SY   HZGHC000394c011; PRKD1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TG97
DR   Horizon_Discovery; HZGHC000394c011
DR   Wikidata; Q54877291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9407; PRKD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKD2 (-) 1
AC   CVCL_TG98
SY   HZGHC000169c008; PRKD2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TG98
DR   Horizon_Discovery; HZGHC000169c008
DR   Wikidata; Q54877292
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000169c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKD2 (-) 2
AC   CVCL_TG99
SY   HZGHC000169c023; PRKD2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TG99
DR   Horizon_Discovery; HZGHC000169c023
DR   PRIDE; PXD010335
DR   Wikidata; Q54877293
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKD3 (-)
AC   CVCL_TH00
SY   HZGHC000102c014; PRKD3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH00
DR   Horizon_Discovery; HZGHC000102c014
DR   Wikidata; Q54877294
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9408; PRKD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKDC (-) 1
AC   CVCL_TH01
SY   HZGHC024034c005; PRKDC knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TH01
DR   Horizon_Discovery; HZGHC024034c005
DR   Wikidata; Q54877295
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9413; PRKDC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC024034c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKDC (-) 2
AC   CVCL_TH02
SY   HZGHC024034c011; PRKDC knockout cell line 11bp deletion in exon 25
DR   cancercelllines; CVCL_TH02
DR   Horizon_Discovery; HZGHC024034c011
DR   Wikidata; Q54877302
RX   PubMed=31141305;
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9413; PRKDC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PRKDC (-) PAXX (-)
AC   CVCL_DX08
SY   HZGHC005239c011; Double knockout cell line PRKDC 11bp deletion in exon 25 and PAXX 28bp deletion in exon 4
DR   Horizon_Discovery; HZGHC005239c011
DR   Wikidata; Q127381081
RX   PubMed=31141305;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27849; PAXX.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9413; PRKDC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005239c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TH02 ! HAP1 PRKDC (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PRKDC (-) XRCC4 (-)
AC   CVCL_DX10
SY   HZGHC005633c001; Double knockout cell line PRKDC 11bp deletion in exon 25 and XRCC4 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC005633c001
DR   Wikidata; Q127381082
RX   PubMed=31141305;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9413; PRKDC.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12831; XRCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005633c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TH02 ! HAP1 PRKDC (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 PRKG2 (-) 1
AC   CVCL_TH03
SY   HZGHC033981c016; PRKG2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH03
DR   Horizon_Discovery; HZGHC033981c016
DR   Wikidata; Q54877303
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9416; PRKG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKG2 (-) 2
AC   CVCL_TH04
SY   HZGHC033981c021; PRKG2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TH04
DR   Horizon_Discovery; HZGHC033981c021
DR   Wikidata; Q54877304
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9416; PRKG2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKRA (-) 1
AC   CVCL_TH05
SY   HZGHC000514c012; PRKRA knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TH05
DR   Horizon_Discovery; HZGHC000514c012
DR   Wikidata; Q54877305
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9438; PRKRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000514c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRKRA (-) 2
AC   CVCL_TH06
SY   HZGHC000515c003; PRKRA knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TH06
DR   Horizon_Discovery; HZGHC000515c003
DR   Wikidata; Q54877307
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9438; PRKRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKRA (-) 3
AC   CVCL_TH07
SY   HZGHC000515c007; PRKRA knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TH07
DR   Horizon_Discovery; HZGHC000515c007
DR   Wikidata; Q54877308
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9438; PRKRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKRIR (-) 1
AC   CVCL_E2HW
SY   HZGHC008182c003
DR   Horizon_Discovery; HZGHC008182c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9440; THAP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRKRIR (-) 2
AC   CVCL_E2HX
SY   HZGHC008182c005
DR   Horizon_Discovery; HZGHC008182c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9440; THAP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRKRIR (-) 3
AC   CVCL_E2HY
SY   HZGHC008182c006
DR   Horizon_Discovery; HZGHC008182c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9440; THAP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRKX (-) 1
AC   CVCL_TH08
SY   HZGHC000058c012; PRKX knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TH08
DR   Horizon_Discovery; HZGHC000058c012
DR   Wikidata; Q54877309
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9441; PRKX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRKX (-) 2
AC   CVCL_TH09
SY   HZGHC000058c019; PRKX knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TH09
DR   Horizon_Discovery; HZGHC000058c019
DR   Wikidata; Q54877310
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9441; PRKX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRLR (-) 1
AC   CVCL_TH10
SY   HZGHC003937c011; PRLR knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TH10
DR   Horizon_Discovery; HZGHC003937c011
DR   Wikidata; Q54877311
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9446; PRLR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRLR (-) 2
AC   CVCL_TH11
SY   HZGHC003937c006; PRLR knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TH11
DR   Horizon_Discovery; HZGHC003937c006
DR   Wikidata; Q54877312
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9446; PRLR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRMT3 (-) 1
AC   CVCL_TH12
SY   HZGHC001131c010; PRMT3 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TH12
DR   Horizon_Discovery; HZGHC001131c010
DR   Wikidata; Q54877313
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30163; PRMT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRMT3 (-) 2
AC   CVCL_TH13
SY   HZGHC001131c011; PRMT3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH13
DR   Horizon_Discovery; HZGHC001131c011
DR   Wikidata; Q54877314
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30163; PRMT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRMT6 (-) 1
AC   CVCL_TH14
SY   HZGHC006482c007; PRMT6 knockout cell line 23bp deletion; HAP1 PRMT6 (-)
DR   cancercelllines; CVCL_TH14
DR   Horizon_Discovery; HZGHC006482c007
DR   Wikidata; Q54877315
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18241; PRMT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PRMT6 (-) 2
AC   CVCL_XR89
SY   HZGHC006482c009; PRMT6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR89
DR   Horizon_Discovery; HZGHC006482c009
DR   PRIDE; PXD010335
DR   Wikidata; Q93960949
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18241; PRMT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRMT9 (-)
AC   CVCL_E2HZ
SY   HZGHC007443c007
DR   Horizon_Discovery; HZGHC007443c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25099; PRMT9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PRNP (-) 1
AC   CVCL_TH15
SY   HZGHC001519c003; PRNP knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TH15
DR   Horizon_Discovery; HZGHC001519c003
DR   Wikidata; Q54877316
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9449; PRNP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRNP (-) 2
AC   CVCL_TH16
SY   HZGHC001519c010; PRNP knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TH16
DR   Horizon_Discovery; HZGHC001519c010
DR   Wikidata; Q54879342
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9449; PRNP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PROCR (-)
AC   CVCL_TH17
SY   HZGHC002030c004; PROCR knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TH17
DR   Horizon_Discovery; HZGHC002030c004
DR   Wikidata; Q54879343
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9452; PROCR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRODH (-) 1
AC   CVCL_TH18
SY   HZGHC006031c002; PRODH knockout cell line 1bp insertion; HAP1 PRODH (-)
DR   cancercelllines; CVCL_TH18
DR   Horizon_Discovery; HZGHC006031c002
DR   Wikidata; Q54879344
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9453; PRODH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRODH (-) 2
AC   CVCL_XR90
SY   HZGHC006031c006; PRODH knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XR90
DR   Horizon_Discovery; HZGHC006031c006
DR   Wikidata; Q93961048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9453; PRODH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRODH (-) 3
AC   CVCL_XR91
SY   HZGHC006031c009; PRODH knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR91
DR   Horizon_Discovery; HZGHC006031c009
DR   Wikidata; Q93961055
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9453; PRODH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006031c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PROM1 (-) 1
AC   CVCL_XR92
SY   HZGHC007056c009; HZGHC8842; PROM1 knockout cell line 8bp deletion in exon 8; HAP1 PROM1 (-)
DR   cancercelllines; CVCL_XR92
DR   Horizon_Discovery; HZGHC007056c009
DR   Wikidata; Q93961062
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9454; PROM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PROM1 (-) 2
AC   CVCL_E2I0
SY   HZGHC007055c002; PROM1 knockout cell line 5bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007055c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9454; PROM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PROS1 (-) 1
AC   CVCL_TH19
SY   HZGHC003876c004; PROS1 knockout cell line 10bp deletion in exon 2
DR   cancercelllines; CVCL_TH19
DR   Horizon_Discovery; HZGHC003876c004
DR   Wikidata; Q54879345
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9456; PROS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PROS1 (-) 2
AC   CVCL_TH20
SY   HZGHC003876c005; PROS1 knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_TH20
DR   Horizon_Discovery; HZGHC003876c005
DR   Wikidata; Q54879346
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9456; PROS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRPF39 (-)
AC   CVCL_TH21
SY   HZGHC000811c010; PRPF39 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH21
DR   Horizon_Discovery; HZGHC000811c010
DR   Wikidata; Q54879347
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20314; PRPF39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRPF40B (-) 1
AC   CVCL_TH22
SY   HZGHC004209c007; PRPF40B knockout cell line 1bp insertion; HAP1 PRPF40B (-)
DR   cancercelllines; CVCL_TH22
DR   Horizon_Discovery; HZGHC004209c007
DR   Wikidata; Q54879348
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25031; PRPF40B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRPF40B (-) 2
AC   CVCL_XR93
SY   HZGHC002940c014; PRPF40B knockout cell line
DR   cancercelllines; CVCL_XR93
DR   Horizon_Discovery; HZGHC002940c014
DR   Wikidata; Q93961153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25031; PRPF40B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002940c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PRPS1 (-) 1
AC   CVCL_TH23
SY   HZGHC004289c002; PRPS1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TH23
DR   Horizon_Discovery; HZGHC004289c002
DR   Wikidata; Q54879349
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9462; PRPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PRPS1 (-) 2
AC   CVCL_TH24
SY   HZGHC004289c007; PRPS1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TH24
DR   Horizon_Discovery; HZGHC004289c007
DR   Wikidata; Q54879350
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9462; PRPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSAP (-) 1
AC   CVCL_E2I1
SY   HZGHC007419c006
DR   Horizon_Discovery; HZGHC007419c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9498; PSAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PSAP (-) 2
AC   CVCL_E2I2
SY   HZGHC007420c001
DR   Horizon_Discovery; HZGHC007420c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9498; PSAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PSAT1 (-) 1
AC   CVCL_TH25
SY   HZGHC006353c001; PSAT1 knockout cell line 1bp insertion; HAP1 PSAT1 (-)
DR   cancercelllines; CVCL_TH25
DR   Horizon_Discovery; HZGHC006353c001
DR   Wikidata; Q54879351
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19129; PSAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSAT1 (-) 2
AC   CVCL_XR94
SY   HZGHC006353c010; PSAT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR94
DR   Horizon_Discovery; HZGHC006353c010
DR   Wikidata; Q93961250
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19129; PSAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSAT1 (-) 3
AC   CVCL_XR95
SY   HZGHC006353c012; PSAT1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XR95
DR   Horizon_Discovery; HZGHC006353c012
DR   Wikidata; Q93961256
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19129; PSAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSAT1 (-) 4
AC   CVCL_XR96
SY   HZGHC006354c010; PSAT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XR96
DR   Horizon_Discovery; HZGHC006354c010
DR   Wikidata; Q93961263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19129; PSAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSEN1 (-) 1
AC   CVCL_TH26
SY   HZGHC005404c003; PSEN1 knockout cell line 5bp deletion; HAP1 PSEN1 (-)
DR   cancercelllines; CVCL_TH26
DR   Horizon_Discovery; HZGHC005404c003
DR   Wikidata; Q54879352
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSEN1 (-) 2
AC   CVCL_XR97
SY   HZGHC005404c007; PSEN1 knockout cell line 49bp deletion
DR   cancercelllines; CVCL_XR97
DR   Horizon_Discovery; HZGHC005404c007
DR   Wikidata; Q93961286
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSEN1 (-) 3
AC   CVCL_XR98
SY   HZGHC005405c006; PSEN1 knockout cell line 131bp deletion
DR   cancercelllines; CVCL_XR98
DR   Horizon_Discovery; HZGHC005405c006
DR   Wikidata; Q93961291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSEN1 (-) 4
AC   CVCL_XR99
SY   HZGHC005405c012; PSEN1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XR99
DR   Horizon_Discovery; HZGHC005405c012
DR   Wikidata; Q93961295
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSENEN (-) 1
AC   CVCL_XS00
SY   HZGHC006985c005; HZGHC55851; PSENEN knockout cell line 13bp deletion in exon 3; HAP1 PSENEN (-)
DR   cancercelllines; CVCL_XS00
DR   Horizon_Discovery; HZGHC006985c005
DR   Wikidata; Q93961301
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30100; PSENEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 PSENEN (-) 2
AC   CVCL_E2I3
SY   HZGHC006985c006; PSENEN knockout cell line 14bp deletion in exon 3
DR   Horizon_Discovery; HZGHC006985c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30100; PSENEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PSKH1 (-)
AC   CVCL_TH27
SY   HZGHC000240c009; PSKH1 knockout cell line 41bp deletion
DR   cancercelllines; CVCL_TH27
DR   Horizon_Discovery; HZGHC000240c009
DR   Wikidata; Q54879353
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9529; PSKH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSMB10 (-) 1
AC   CVCL_TH28
SY   HZGHC003835c002; PSMB10 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TH28
DR   Horizon_Discovery; HZGHC003835c002
DR   Wikidata; Q54879354
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9538; PSMB10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSMB10 (-) 2
AC   CVCL_TH29
SY   HZGHC003835c005; PSMB10 knockout cell line 116bp insertion
DR   cancercelllines; CVCL_TH29
DR   Horizon_Discovery; HZGHC003835c005
DR   Wikidata; Q54879355
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9538; PSMB10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003835c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSMB8 (-) 1
AC   CVCL_TH30
SY   HZGHC003838c004; PSMB8 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TH30
DR   Horizon_Discovery; HZGHC003838c004
DR   Wikidata; Q54879356
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9545; PSMB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003838c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSMB8 (-) 2
AC   CVCL_TH31
SY   HZGHC003838c009; PSMB8 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_TH31
DR   Horizon_Discovery; HZGHC003838c009
DR   Wikidata; Q54879357
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9545; PSMB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSMB8 (-) 3
AC   CVCL_TH32
SY   HZGHC003838c011; PSMB8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH32
DR   Horizon_Discovery; HZGHC003838c011
DR   Wikidata; Q54879358
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9545; PSMB8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003838c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSMB9 (-) 1
AC   CVCL_TH33
SY   HZGHC003867c003; PSMB9 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TH33
DR   Horizon_Discovery; HZGHC003867c003
DR   Wikidata; Q54879359
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9546; PSMB9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSMB9 (-) 2
AC   CVCL_TH34
SY   HZGHC003867c008; PSMB9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH34
DR   Horizon_Discovery; HZGHC003867c008
DR   Wikidata; Q54879360
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9546; PSMB9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSMB9 (-) 3
AC   CVCL_TH35
SY   HZGHC003867c011; PSMB9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH35
DR   Horizon_Discovery; HZGHC003867c011
DR   Wikidata; Q54879361
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9546; PSMB9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PSMD10 (-) 1
AC   CVCL_E2I4
SY   HZGHC007904c009
DR   Horizon_Discovery; HZGHC007904c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9555; PSMD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PSMD10 (-) 2
AC   CVCL_E2I5
SY   HZGHC007904c012
DR   Horizon_Discovery; HZGHC007904c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9555; PSMD10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PSMF1 (-) 1
AC   CVCL_TH36
SY   HZGHC002821c001; PSMF1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TH36
DR   Horizon_Discovery; HZGHC002821c001
DR   Wikidata; Q54879362
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9571; PSMF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002821c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSMF1 (-) 2
AC   CVCL_TH37
SY   HZGHC002821c004; PSMF1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TH37
DR   Horizon_Discovery; HZGHC002821c004
DR   Wikidata; Q54879363
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9571; PSMF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002821c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSPC1 (-) 1
AC   CVCL_TH38
SY   HZGHC006048c003; PSPC1 knockout cell line 26bp deletion; HAP1 PSPC1 (-)
DR   cancercelllines; CVCL_TH38
DR   Horizon_Discovery; HZGHC006048c003
DR   Wikidata; Q54879364
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20320; PSPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSPC1 (-) 2
AC   CVCL_XS01
SY   HZGHC006048c006; PSPC1 knockout cell line 245bp insertion
DR   cancercelllines; CVCL_XS01
DR   Horizon_Discovery; HZGHC006048c006
DR   Wikidata; Q93961471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20320; PSPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006048c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PSPC1 (-) 3
AC   CVCL_XS02
SY   HZGHC006049c007; PSPC1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XS02
DR   Horizon_Discovery; HZGHC006049c007
DR   Wikidata; Q93961475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20320; PSPC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTAR1 (-) 1
AC   CVCL_TH39
SY   HZGHC003043c001; PTAR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH39
DR   Horizon_Discovery; HZGHC003043c001
DR   Wikidata; Q54879365
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30449; PTAR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTAR1 (-) 2
AC   CVCL_TH40
SY   HZGHC003043c007; PTAR1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TH40
DR   Horizon_Discovery; HZGHC003043c007
DR   Wikidata; Q54879366
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30449; PTAR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTBP1 (-)
AC   CVCL_TH41
SY   HZGHC006231c002; PTBP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH41
DR   Horizon_Discovery; HZGHC006231c002
DR   Wikidata; Q54879367
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9583; PTBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTCH1 (-) 1
AC   CVCL_TH42
SY   HZGHC004419c006; PTCH1 knockout cell line 245bp insertion
DR   cancercelllines; CVCL_TH42
DR   Horizon_Discovery; HZGHC004419c006
DR   Wikidata; Q54879368
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004419c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PTCH1 (-) 2
AC   CVCL_TH43
SY   HZGHC004419c010; PTCH1 knockout cell line 94bp deletion
DR   cancercelllines; CVCL_TH43
DR   Horizon_Discovery; HZGHC004419c010
DR   Wikidata; Q54879369
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTCHD4 (-) 1
AC   CVCL_TH44
SY   HZGHC005195c003; PTCHD4 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TH44
DR   Horizon_Discovery; HZGHC005195c003
DR   Wikidata; Q54879370
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21345; PTCHD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTCHD4 (-) 2
AC   CVCL_TH45
SY   HZGHC005195c004; PTCHD4 knockout cell line 104bp deletion
DR   cancercelllines; CVCL_TH45
DR   Horizon_Discovery; HZGHC005195c004
DR   Wikidata; Q54879371
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21345; PTCHD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTEN (-) 1
AC   CVCL_TH46
SY   HZGHC000625c006; PTEN knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH46
DR   Horizon_Discovery; HZGHC000625c006
DR   Wikidata; Q54879372
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTEN (-) 2
AC   CVCL_TH47
SY   HZGHC000624c004; PTEN knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TH47
DR   Horizon_Discovery; HZGHC000624c004
DR   Wikidata; Q54879373
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTEN (-) 3
AC   CVCL_TH48
SY   HZGHC000624c009; PTEN knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TH48
DR   Horizon_Discovery; HZGHC000624c009
DR   Wikidata; Q54879374
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000624c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PTEN (-) 4
AC   CVCL_TH49
SY   HZGHC000625c005; PTEN knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TH49
DR   Horizon_Discovery; HZGHC000625c005
DR   Wikidata; Q54879375
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000625c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PTGER3 (-) 1
AC   CVCL_TH50
SY   HZGHC003805c008; PTGER3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TH50
DR   Horizon_Discovery; HZGHC003805c008
DR   Wikidata; Q54879376
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9595; PTGER3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTGER3 (-) 2
AC   CVCL_TH51
SY   HZGHC003805c010; PTGER3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH51
DR   Horizon_Discovery; HZGHC003805c010
DR   Wikidata; Q54879377
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9595; PTGER3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTGER4 (-) 1
AC   CVCL_E2I6
SY   HZGHC008235c017
DR   Horizon_Discovery; HZGHC008235c017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9596; PTGER4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PTGER4 (-) 2
AC   CVCL_E2I7
SY   HZGHC008235c021
DR   Horizon_Discovery; HZGHC008235c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9596; PTGER4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 PTH1R (-)
AC   CVCL_TH52
SY   HZGHC006073c010; PTH1R knockout cell line 119bp deletion
DR   cancercelllines; CVCL_TH52
DR   Horizon_Discovery; HZGHC006073c010
DR   Wikidata; Q54879378
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9608; PTH1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006073c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PTK2B (-) 1
AC   CVCL_TH53
SY   HZGHC000350c012; PTK2B knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TH53
DR   Horizon_Discovery; HZGHC000350c012
DR   Wikidata; Q54879379
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTK2B (-) 2
AC   CVCL_TH54
SY   HZGHC000350c020; PTK2B knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TH54
DR   Horizon_Discovery; HZGHC000350c020
DR   Wikidata; Q54879380
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTK7 (-) 1
AC   CVCL_TH55
SY   HZGHC000276c009; PTK7 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TH55
DR   Horizon_Discovery; HZGHC000276c009
DR   Wikidata; Q54879381
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9618; PTK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTK7 (-) 2
AC   CVCL_TH56
SY   HZGHC000276c022; PTK7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH56
DR   Horizon_Discovery; HZGHC000276c022
DR   Wikidata; Q54879385
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9618; PTK7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000276c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PTPN1 (-) 1
AC   CVCL_TH57
SY   HZGHC001294c010; PTPN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH57
DR   Horizon_Discovery; HZGHC001294c010
DR   Wikidata; Q54879386
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPN1 (-) 2
AC   CVCL_TH58
SY   HZGHC001294c012; PTPN1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TH58
DR   Horizon_Discovery; HZGHC001294c012
DR   Wikidata; Q54879387
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPN11 (-) 1
AC   CVCL_TH59
SY   HZGHC000686c011; PTPN11 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH59
DR   Horizon_Discovery; HZGHC000686c011
DR   Wikidata; Q54879388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPN11 (-) 2
AC   CVCL_TH60
SY   HZGHC003949c003; PTPN11 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH60
DR   Horizon_Discovery; HZGHC003949c003
DR   Wikidata; Q54879389
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPN3 (-) 1
AC   CVCL_TH61
SY   HZGHC004424c004; PTPN3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TH61
DR   Horizon_Discovery; HZGHC004424c004
DR   Wikidata; Q54879390
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9655; PTPN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPN3 (-) 2
AC   CVCL_TH62
SY   HZGHC004424c008; PTPN3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TH62
DR   Horizon_Discovery; HZGHC004424c008
DR   Wikidata; Q54879392
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9655; PTPN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRC (-) 1
AC   CVCL_TH63
SY   HZGHC004082c001; PTPRC knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TH63
DR   Horizon_Discovery; HZGHC004082c001
DR   Wikidata; Q54879393
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9666; PTPRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRC (-) 2
AC   CVCL_TH64
SY   HZGHC004082c002; PTPRC knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TH64
DR   Horizon_Discovery; HZGHC004082c002
DR   Wikidata; Q54879394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9666; PTPRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRC (-) 3
AC   CVCL_TH65
SY   HZGHC004082c009; PTPRC knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH65
DR   Horizon_Discovery; HZGHC004082c009
DR   Wikidata; Q54879395
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9666; PTPRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRD (-) 1
AC   CVCL_TH66
SY   HZGHC006021c001; PTPRD knockout cell line 1bp insertion; HAP1 PTPRD (-)
DR   cancercelllines; CVCL_TH66
DR   Horizon_Discovery; HZGHC006021c001
DR   Wikidata; Q54879396
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9668; PTPRD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PTPRD (-) 2
AC   CVCL_XS03
SY   HZGHC006021c011; PTPRD knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XS03
DR   Horizon_Discovery; HZGHC006021c011
DR   Wikidata; Q93961847
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9668; PTPRD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRJ (-) 1
AC   CVCL_TH67
SY   HZGHC005419c005; PTPRJ knockout cell line 5bp deletion; HAP1 PTPRJ (-)
DR   cancercelllines; CVCL_TH67
DR   Horizon_Discovery; HZGHC005419c005
DR   Wikidata; Q54879397
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9673; PTPRJ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PTPRJ (-) 2
AC   CVCL_XS04
SY   HZGHC005419c008; PTPRJ knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS04
DR   Horizon_Discovery; HZGHC005419c008
DR   Wikidata; Q93961861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9673; PTPRJ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRK (-) 1
AC   CVCL_TH68
SY   HZGHC005233c003; PTPRK knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TH68
DR   Horizon_Discovery; HZGHC005233c003
DR   Wikidata; Q54879398
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRK (-) 2
AC   CVCL_TH69
SY   HZGHC005233c012; PTPRK knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TH69
DR   Horizon_Discovery; HZGHC005233c012
DR   Wikidata; Q54879399
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRK (-) 3
AC   CVCL_TH70
SY   HZGHC005234c003; PTPRK knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TH70
DR   Horizon_Discovery; HZGHC005234c003
DR   Wikidata; Q54879400
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRK (-) 4
AC   CVCL_TH71
SY   HZGHC005234c010; PTPRK knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TH71
DR   Horizon_Discovery; HZGHC005234c010
DR   Wikidata; Q54879401
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRS (-) 1
AC   CVCL_TH72
SY   HZGHC003309c005; PTPRS knockout cell line 46bp deletion
DR   cancercelllines; CVCL_TH72
DR   Horizon_Discovery; HZGHC003309c005
DR   Wikidata; Q54879402
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9681; PTPRS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRS (-) 2
AC   CVCL_TH73
SY   HZGHC003309c006; PTPRS knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TH73
DR   Horizon_Discovery; HZGHC003309c006
DR   Wikidata; Q54879403
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9681; PTPRS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PTPRS (-) 3
AC   CVCL_TH74
SY   HZGHC003311c003; PTPRS knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH74
DR   Horizon_Discovery; HZGHC003311c003
DR   Wikidata; Q54879404
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9681; PTPRS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PUSL1 (-) 1
AC   CVCL_TH75
SY   HZGHC005912c010; PUSL1 knockout cell line 1bp insertion; HAP1 PUSL1 (-)
DR   cancercelllines; CVCL_TH75
DR   Horizon_Discovery; HZGHC005912c010
DR   Wikidata; Q54879405
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26914; PUSL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PUSL1 (-) 2
AC   CVCL_XS05
SY   HZGHC005912c007; PUSL1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XS05
DR   Horizon_Discovery; HZGHC005912c007
DR   Wikidata; Q93961915
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26914; PUSL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PVR (-) 1
AC   CVCL_TH76
SY   HZGHC003710c008; PVR knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TH76
DR   Horizon_Discovery; HZGHC003710c008
DR   Wikidata; Q54879406
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003710c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PVR (-) 2
AC   CVCL_TH77
SY   HZGHC003710c009; PVR knockout cell line 166bp insertion
DR   cancercelllines; CVCL_TH77
DR   Horizon_Discovery; HZGHC003710c009
DR   Wikidata; Q54879407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003710c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PWWP2B (-) 1
AC   CVCL_TH78
SY   HZGHC004391c010; PWWP2B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TH78
DR   Horizon_Discovery; HZGHC004391c010
DR   Wikidata; Q54879408
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25150; PWWP2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PWWP2B (-) 2
AC   CVCL_TH79
SY   HZGHC004392c001; PWWP2B knockout cell line 38bp deletion
DR   cancercelllines; CVCL_TH79
DR   Horizon_Discovery; HZGHC004392c001
DR   Wikidata; Q54879409
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25150; PWWP2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PXK (-) 1
AC   CVCL_TH80
SY   HZGHC000103c013; PXK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH80
DR   Horizon_Discovery; HZGHC000103c013
DR   Wikidata; Q54879410
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23326; PXK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PXK (-) 2
AC   CVCL_TH81
SY   HZGHC000103c020; PXK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TH81
DR   Horizon_Discovery; HZGHC000103c020
DR   Wikidata; Q54879411
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23326; PXK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PYCARD (-) 1
AC   CVCL_TH82
SY   HZGHC003899c001; PYCARD knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TH82
DR   Horizon_Discovery; HZGHC003899c001
DR   Wikidata; Q54879412
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16608; PYCARD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PYCARD (-) 2
AC   CVCL_TH83
SY   HZGHC003899c010; PYCARD knockout cell line 71bp deletion
DR   cancercelllines; CVCL_TH83
DR   Horizon_Discovery; HZGHC003899c010
DR   Wikidata; Q54879413
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16608; PYCARD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PYCR1 (-) 1
AC   CVCL_TH84
SY   HZGHC003073c012; PYCR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH84
DR   Horizon_Discovery; HZGHC003073c012
DR   Wikidata; Q54879414
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9721; PYCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003073c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PYCR1 (-) 2
AC   CVCL_TH85
SY   HZGHC003073c001; PYCR1 knockout cell line 400bp insertion
DR   cancercelllines; CVCL_TH85
DR   Horizon_Discovery; HZGHC003073c001
DR   Wikidata; Q54879415
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9721; PYCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003073c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 PYCR1 (-) 3
AC   CVCL_TH86
SY   HZGHC003073c011; PYCR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH86
DR   Horizon_Discovery; HZGHC003073c011
DR   Wikidata; Q54879416
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9721; PYCR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PYURF (-) 1
AC   CVCL_TH87
SY   HZGHC004970c001; PYURF knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TH87
DR   Horizon_Discovery; HZGHC004970c001
DR   Wikidata; Q54879418
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:44317; PYURF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 PYURF (-) 2
AC   CVCL_TH88
SY   HZGHC004970c006; PYURF knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH88
DR   Horizon_Discovery; HZGHC004970c006
DR   Wikidata; Q54879419
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:44317; PYURF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 QKI (-) 1
AC   CVCL_TH89
SY   HZGHC006395c011; QKI knockout cell line 14bp deletion; HAP1 QKI (-)
DR   cancercelllines; CVCL_TH89
DR   Horizon_Discovery; HZGHC006395c011
DR   Wikidata; Q54879420
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21100; QKI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 QKI (-) 2
AC   CVCL_XS06
SY   HZGHC006395c007; QKI knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XS06
DR   Horizon_Discovery; HZGHC006395c007
DR   Wikidata; Q93962011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21100; QKI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 QPRT (-) 1
AC   CVCL_TH90
SY   HZGHC003815c010; QPRT knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TH90
DR   Horizon_Discovery; HZGHC003815c010
DR   Wikidata; Q54879421
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9755; QPRT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 QPRT (-) 2
AC   CVCL_TH91
SY   HZGHC003815c011; QPRT knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TH91
DR   Horizon_Discovery; HZGHC003815c011
DR   Wikidata; Q54879422
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9755; QPRT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 QSOX1 (-) 1
AC   CVCL_TH92
SY   HZGHC003945c004; QSOX1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH92
DR   Horizon_Discovery; HZGHC003945c004
DR   Wikidata; Q54879423
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9756; QSOX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 QSOX1 (-) 2
AC   CVCL_TH93
SY   HZGHC003945c010; QSOX1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TH93
DR   Horizon_Discovery; HZGHC003945c010
DR   Wikidata; Q54879424
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9756; QSOX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB10 (-) 1
AC   CVCL_D3U6
SY   HZGHC008098c001; RAB10 knockout cell line 4bp deletion
DR   Horizon_Discovery; HZGHC008098c001
DR   Wikidata; Q127381083
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RAB10 (-) 2
AC   CVCL_D3U7
SY   HZGHC008098c007; RAB10 knockout cell line 28bp deletion
DR   Horizon_Discovery; HZGHC008098c007
DR   Wikidata; Q127381084
RX   DOI=10.12688/f1000research.156209.1;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HAP1 RAB10 (-) 3
AC   CVCL_D3U8
SY   HZGHC008099c011; RAB10 knockout cell line 1bp insertion
DR   Horizon_Discovery; HZGHC008099c011
DR   Wikidata; Q127381085
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RAB11B (-) 1
AC   CVCL_TH94
SY   HZGHC006313c010; RAB11B knockout cell line 1bp deletion; HAP1 RAB11B (-)
DR   cancercelllines; CVCL_TH94
DR   Horizon_Discovery; HZGHC006313c010
DR   Wikidata; Q54879425
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9761; RAB11B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB11B (-) 2
AC   CVCL_XS07
SY   HZGHC006313c002; RAB11B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS07
DR   Horizon_Discovery; HZGHC006313c002
DR   Wikidata; Q93962036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9761; RAB11B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006313c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB11B (-) 3
AC   CVCL_XS08
SY   HZGHC006313c011; RAB11B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS08
DR   Horizon_Discovery; HZGHC006313c011
DR   Wikidata; Q93962039
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9761; RAB11B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB12 (-)
AC   CVCL_TH95
SY   HZGHC001232c004; RAB12 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH95
DR   Horizon_Discovery; HZGHC001232c004
DR   Wikidata; Q54879426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31332; RAB12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB13 (-) 1
AC   CVCL_TH96
SY   HZGHC001234c001; RAB13 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TH96
DR   Horizon_Discovery; HZGHC001234c001
DR   Wikidata; Q54879440
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9762; RAB13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB13 (-) 2
AC   CVCL_TH97
SY   HZGHC001234c002; RAB13 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TH97
DR   Horizon_Discovery; HZGHC001234c002
DR   Wikidata; Q54879441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9762; RAB13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB14 (-)
AC   CVCL_TH98
SY   HZGHC001230c007; RAB14 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TH98
DR   Horizon_Discovery; HZGHC001230c007
DR   Wikidata; Q54879442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16524; RAB14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB1A (-) 1
AC   CVCL_XS09
SY   HZGHC007227c002; HZGHC5861; RAB1A knockout cell line 50bp deletion in exon 4; HAP1 RAB1A (-)
DR   cancercelllines; CVCL_XS09
DR   Horizon_Discovery; HZGHC007227c002
DR   Wikidata; Q93962093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9758; RAB1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB1A (-) 2
AC   CVCL_B5KT
SY   HZGHC007227c012; RAB1A knockout cell line 1bp deletion in exon 4
DR   cancercelllines; CVCL_B5KT
DR   Horizon_Discovery; HZGHC007227c012
DR   Wikidata; Q111733315
RX   PubMed=38559361;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9758; RAB1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 8
//
ID   HAP1 RAB1B (-) 1
AC   CVCL_TH99
SY   HZGHC001225c005; RAB1B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TH99
DR   Horizon_Discovery; HZGHC001225c005
DR   Wikidata; Q54879443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18370; RAB1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001225c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB1B (-) 2
AC   CVCL_TI00
SY   HZGHC001225c011; RAB1B knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TI00
DR   Horizon_Discovery; HZGHC001225c011
DR   Wikidata; Q54879444
RX   PubMed=38559361;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18370; RAB1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   HAP1 RAB20 (-) 1
AC   CVCL_TI01
SY   HZGHC001236c003; RAB20 knockout cell line 64bp insertion
DR   cancercelllines; CVCL_TI01
DR   Horizon_Discovery; HZGHC001236c003
DR   Wikidata; Q54879445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18260; RAB20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001236c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB20 (-) 2
AC   CVCL_TI02
SY   HZGHC001236c007; RAB20 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI02
DR   Horizon_Discovery; HZGHC001236c007
DR   Wikidata; Q54879446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18260; RAB20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB20 (-) 3
AC   CVCL_TI03
SY   HZGHC001236c011; RAB20 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI03
DR   Horizon_Discovery; HZGHC001236c011
DR   Wikidata; Q54879447
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18260; RAB20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB21 (-) 1
AC   CVCL_TI04
SY   HZGHC001239c001; RAB21 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI04
DR   Horizon_Discovery; HZGHC001239c001
DR   Wikidata; Q54879448
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18263; RAB21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB21 (-) 2
AC   CVCL_TI05
SY   HZGHC001239c011; RAB21 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TI05
DR   Horizon_Discovery; HZGHC001239c011
DR   Wikidata; Q54879449
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18263; RAB21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB27A (-) 1
AC   CVCL_TI06
SY   HZGHC001240c001; RAB27A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI06
DR   Horizon_Discovery; HZGHC001240c001
DR   Wikidata; Q54879450
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB27A (-) 2
AC   CVCL_TI07
SY   HZGHC001240c011; RAB27A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TI07
DR   Horizon_Discovery; HZGHC001240c011
DR   Wikidata; Q54879451
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB2A (-) 1
AC   CVCL_TI08
SY   HZGHC017214c001; RAB2A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TI08
DR   Horizon_Discovery; HZGHC017214c001
DR   Wikidata; Q54879452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9763; RAB2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB2A (-) 2
AC   CVCL_TI09
SY   HZGHC017214c009; RAB2A knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TI09
DR   Horizon_Discovery; HZGHC017214c009
DR   Wikidata; Q54879453
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9763; RAB2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB2A (-) 3
AC   CVCL_TI10
SY   HZGHC017214c014; RAB2A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TI10
DR   Horizon_Discovery; HZGHC017214c014
DR   Wikidata; Q54879454
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9763; RAB2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB31 (-) 1
AC   CVCL_TI11
SY   HZGHC001226c010; RAB31 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI11
DR   Horizon_Discovery; HZGHC001226c010
DR   Wikidata; Q54879455
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9771; RAB31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB31 (-) 2
AC   CVCL_TI12
SY   HZGHC001226c011; RAB31 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TI12
DR   Horizon_Discovery; HZGHC001226c011
DR   Wikidata; Q54879456
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9771; RAB31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB32 (-) 1
AC   CVCL_TI13
SY   HZGHC002827c006; RAB32 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TI13
DR   Horizon_Discovery; HZGHC002827c006
DR   Wikidata; Q54879457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9772; RAB32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB32 (-) 2
AC   CVCL_TI14
SY   HZGHC002827c010; RAB32 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI14
DR   Horizon_Discovery; HZGHC002827c010
DR   Wikidata; Q54879459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9772; RAB32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB33B (-) 1
AC   CVCL_E2I8
SY   HZGHC007343c015
DR   Horizon_Discovery; HZGHC007343c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16075; RAB33B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAB33B (-) 2
AC   CVCL_E2I9
SY   HZGHC007343c023
DR   Horizon_Discovery; HZGHC007343c023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16075; RAB33B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAB35 (-) 1
AC   CVCL_TI15
SY   HZGHC005709c003; RAB35 knockout cell line 1bp deletion; HAP1 RAB35 (-)
DR   cancercelllines; CVCL_TI15
DR   Horizon_Discovery; HZGHC005709c003
DR   Wikidata; Q54879460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9774; RAB35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB35 (-) 2
AC   CVCL_XS10
SY   HZGHC005709c007; RAB35 knockout cell line 275bp insertion
DR   cancercelllines; CVCL_XS10
DR   Horizon_Discovery; HZGHC005709c007
DR   Wikidata; Q93962351
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9774; RAB35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005709c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB35 (-) 3
AC   CVCL_XS11
SY   HZGHC005710c006; RAB35 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XS11
DR   Horizon_Discovery; HZGHC005710c006
DR   Wikidata; Q93962360
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9774; RAB35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB35 (-) 4
AC   CVCL_XS12
SY   HZGHC005710c011; RAB35 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS12
DR   Horizon_Discovery; HZGHC005710c011
DR   Wikidata; Q93962368
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9774; RAB35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB39B (-) 1
AC   CVCL_E2IA
SY   HZGHC007462c002
DR   Horizon_Discovery; HZGHC007462c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16499; RAB39B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAB39B (-) 2
AC   CVCL_E2IB
SY   HZGHC007462c003
DR   Horizon_Discovery; HZGHC007462c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16499; RAB39B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAB39B (-) 3
AC   CVCL_E2IC
SY   HZGHC007462c008
DR   Horizon_Discovery; HZGHC007462c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16499; RAB39B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAB3A (-) 1
AC   CVCL_TI16
SY   HZGHC001219c001; RAB3A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TI16
DR   Horizon_Discovery; HZGHC001219c001
DR   Wikidata; Q54879461
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9777; RAB3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB3A (-) 2
AC   CVCL_TI17
SY   HZGHC001219c002; RAB3A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI17
DR   Horizon_Discovery; HZGHC001219c002
DR   Wikidata; Q54879462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9777; RAB3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB4A (-) 1
AC   CVCL_TI18
SY   HZGHC001224c007; RAB4A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TI18
DR   Horizon_Discovery; HZGHC001224c007
DR   Wikidata; Q54879463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9781; RAB4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001224c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB4A (-) 2
AC   CVCL_TI19
SY   HZGHC001224c006; RAB4A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TI19
DR   Horizon_Discovery; HZGHC001224c006
DR   Wikidata; Q54879464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9781; RAB4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB5A (-) 1
AC   CVCL_TI20
SY   HZGHC001809c001; RAB5A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TI20
DR   Horizon_Discovery; HZGHC001809c001
DR   Wikidata; Q54879465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9783; RAB5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB5A (-) 2
AC   CVCL_TI21
SY   HZGHC001809c010; RAB5A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI21
DR   Horizon_Discovery; HZGHC001809c010
DR   Wikidata; Q54879466
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9783; RAB5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB5B (-) 1
AC   CVCL_E1NE
SY   HD-HAP1-64070
DR   Horizon_Discovery; HD-HAP1-64070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9784; RAB5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAB5B (-) 2
AC   CVCL_E1NF
SY   HD-HAP1-64071
DR   Horizon_Discovery; HD-HAP1-64071
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9784; RAB5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAB5C (-) 1
AC   CVCL_D3U3
SY   HZGHC007774c002; RAB5C knockout cell line 5bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007774c002
DR   Wikidata; Q127381086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9785; RAB5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RAB5C (-) 2
AC   CVCL_D3U4
SY   HZGHC007774c006; RAB5C knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007774c006
DR   Wikidata; Q127381087
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9785; RAB5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RAB5C (-) 3
AC   CVCL_D3U5
SY   HZGHC007774c011; RAB5C knockout cell line 11bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007774c011
DR   Wikidata; Q127381088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9785; RAB5C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RAB6A (-) 1
AC   CVCL_TI22
SY   HZGHC001233c001; RAB6A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TI22
DR   Horizon_Discovery; HZGHC001233c001
DR   Wikidata; Q54879467
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9786; RAB6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB6A (-) 2
AC   CVCL_TI23
SY   HZGHC001233c012; RAB6A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TI23
DR   Horizon_Discovery; HZGHC001233c012
DR   Wikidata; Q54879468
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9786; RAB6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB7A (-) 1
AC   CVCL_TI24
SY   HZGHC000635c001; RAB7A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI24
DR   Horizon_Discovery; HZGHC000635c001
DR   Wikidata; Q54879469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB7A (-) 2
AC   CVCL_TI25
SY   HZGHC000635c022; RAB7A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TI25
DR   Horizon_Discovery; HZGHC000635c022
DR   Wikidata; Q54879470
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB8A (-) 1
AC   CVCL_TI26
SY   HZGHC001221c010; RAB8A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI26
DR   Horizon_Discovery; HZGHC001221c010
DR   Wikidata; Q54879471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001221c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB8A (-) 2
AC   CVCL_TI27
SY   HZGHC001221c001; RAB8A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI27
DR   Horizon_Discovery; HZGHC001221c001
DR   Wikidata; Q54879472
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB8A (-) 3
AC   CVCL_TI28
SY   HZGHC001221c008; RAB8A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TI28
DR   Horizon_Discovery; HZGHC001221c008
DR   Wikidata; Q54879474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAB8A (-) 4
AC   CVCL_TI29
SY   HZGHC001221c009; RAB8A knockout cell line 49bp insertion
DR   cancercelllines; CVCL_TI29
DR   Horizon_Discovery; HZGHC001221c009
DR   Wikidata; Q54879475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001221c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAB9A (-)
AC   CVCL_TI30
SY   HZGHC005522c003; RAB9A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI30
DR   Horizon_Discovery; HZGHC005522c003
DR   Wikidata; Q54879476
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9792; RAB9A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RABEP1 (-) 1
AC   CVCL_C7YJ
SY   HZGHC008146c009; RABEP1 knockout cell line 5bp deletion in exon 5
DR   Horizon_Discovery; HZGHC008146c009
DR   Wikidata; Q123031440
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17677; RABEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RABEP1 (-) 2
AC   CVCL_C7YK
SY   HZGHC008146c012; RABEP1 knockout cell line 95bp deletion in exon 5
DR   Horizon_Discovery; HZGHC008146c012
DR   Wikidata; Q123031441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17677; RABEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RABGAP1 (-) 1
AC   CVCL_TI31
SY   HZGHC004125c006; RABGAP1 knockout cell line 73bp insertion
DR   cancercelllines; CVCL_TI31
DR   Horizon_Discovery; HZGHC004125c006
DR   Wikidata; Q54879477
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17155; RABGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004125c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RABGAP1 (-) 2
AC   CVCL_TI32
SY   HZGHC004125c011; RABGAP1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TI32
DR   Horizon_Discovery; HZGHC004125c011
DR   Wikidata; Q54879478
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17155; RABGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAC1 (-)
AC   CVCL_TI33
SY   HZGHC003399c004; RAC1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TI33
DR   Horizon_Discovery; HZGHC003399c004
DR   Wikidata; Q54879479
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9801; RAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003399c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAD18 (-) 1
AC   CVCL_E2ID
SY   HZGHC007527c001
DR   Horizon_Discovery; HZGHC007527c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18278; RAD18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAD18 (-) 2
AC   CVCL_E2IE
SY   HZGHC007527c002
DR   Horizon_Discovery; HZGHC007527c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18278; RAD18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAD18 (-) 3
AC   CVCL_E2IF
SY   HZGHC007527c010
DR   Horizon_Discovery; HZGHC007527c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18278; RAD18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAD51B (-)
AC   CVCL_TI34
SY   HZGHC006058c011; RAD51B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI34
DR   Horizon_Discovery; HZGHC006058c011
DR   Wikidata; Q54879480
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9822; RAD51B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAD52 (-)
AC   CVCL_TI35
SY   HZGHC000623c002; RAD52 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TI35
DR   Horizon_Discovery; HZGHC000623c002
DR   Wikidata; Q54879481
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9824; RAD52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000623c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAD54L (-) 1
AC   CVCL_C7YL
SY   HZGHC007543c008; RAD54L knockout cell line 1bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007543c008
DR   Wikidata; Q123031443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9826; RAD54L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RAD54L (-) 2
AC   CVCL_C7YM
SY   HZGHC007543c011; RAD54L knockout cell line 1bp deletion in exon 8
DR   Horizon_Discovery; HZGHC007543c011
DR   Wikidata; Q123031445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9826; RAD54L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RAF1 (-) 1
AC   CVCL_TI36
SY   HZGHC000214c011; RAF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI36
DR   Horizon_Discovery; HZGHC000214c011
DR   Wikidata; Q54879485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAF1 (-) 2
AC   CVCL_TI37
SY   HZGHC002807c010; RAF1 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TI37
DR   Horizon_Discovery; HZGHC002807c010
DR   Wikidata; Q54879486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAF1 (-) 3
AC   CVCL_TI38
SY   HZGHC002807c012; RAF1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI38
DR   Horizon_Discovery; HZGHC002807c012
DR   Wikidata; Q54879487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAF1 (-) 4
AC   CVCL_TI39
SY   HZGHC002809c001; RAF1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TI39
DR   Horizon_Discovery; HZGHC002809c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54879488
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAF1 (-) 5
AC   CVCL_TI40
SY   HZGHC002809c011; RAF1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TI40
DR   Horizon_Discovery; HZGHC002809c011
DR   Wikidata; Q54879489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAF1 (-) 6
AC   CVCL_TI41
SY   HZGHC003260c004; RAF1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TI41
DR   Horizon_Discovery; HZGHC003260c004
DR   Wikidata; Q54879490
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAF1 (-) 7
AC   CVCL_TI42
SY   HZGHC003260c011; RAF1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TI42
DR   Horizon_Discovery; HZGHC003260c011
DR   Wikidata; Q54879491
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAMP1 (-) 1
AC   CVCL_TI43
SY   HZGHC003813c001; RAMP1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TI43
DR   Horizon_Discovery; HZGHC003813c001
DR   Wikidata; Q54879492
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9843; RAMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAMP1 (-) 2
AC   CVCL_TI44
SY   HZGHC003813c009; RAMP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI44
DR   Horizon_Discovery; HZGHC003813c009
DR   Wikidata; Q54879494
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9843; RAMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAMP2 (-) 1
AC   CVCL_TI45
SY   HZGHC003905c001; RAMP2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TI45
DR   Horizon_Discovery; HZGHC003905c001
DR   Wikidata; Q54879495
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9844; RAMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAMP2 (-) 2
AC   CVCL_TI46
SY   HZGHC003905c002; RAMP2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TI46
DR   Horizon_Discovery; HZGHC003905c002
DR   Wikidata; Q54879496
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9844; RAMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RANBP9 (-)
AC   CVCL_E2IG
SY   HZGHC007455c011
DR   Horizon_Discovery; HZGHC007455c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13727; RANBP9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RAP1GAP (-) 1
AC   CVCL_TI47
SY   HZGHC006276c001; RAP1GAP knockout cell line 28bp deletion; HAP1 RAP1GAP (-)
DR   cancercelllines; CVCL_TI47
DR   Horizon_Discovery; HZGHC006276c001
DR   Wikidata; Q54879497
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9858; RAP1GAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RAP1GAP (-) 2
AC   CVCL_XS13
SY   HZGHC006276c010; RAP1GAP knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XS13
DR   Horizon_Discovery; HZGHC006276c010
DR   Wikidata; Q93962835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9858; RAP1GAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RAPGEF5 (-)
AC   CVCL_E2IH
SY   HZGHC007354c011
DR   Horizon_Discovery; HZGHC007354c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16862; RAPGEF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RARA (-)
AC   CVCL_TI48
SY   HZGHC003862c012; RARA knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TI48
DR   Horizon_Discovery; HZGHC003862c012
DR   Wikidata; Q54879498
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9864; RARA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RARG (-) 1
AC   CVCL_TI49
SY   HZGHC003825c004; RARG knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TI49
DR   Horizon_Discovery; HZGHC003825c004
DR   Wikidata; Q54879499
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9866; RARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RARG (-) 2
AC   CVCL_TI50
SY   HZGHC003825c006; RARG knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TI50
DR   Horizon_Discovery; HZGHC003825c006
DR   Wikidata; Q54879500
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9866; RARG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RASA1 (-)
AC   CVCL_E2II
SY   HZGHC007771c002
DR   Horizon_Discovery; HZGHC007771c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9871; RASA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RASD1 (-) 1
AC   CVCL_TI51
SY   HZGHC001546c003; RASD1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TI51
DR   Horizon_Discovery; HZGHC001546c003
DR   Wikidata; Q54879501
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15828; RASD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RASD1 (-) 2
AC   CVCL_TI52
SY   HZGHC001546c005; RASD1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TI52
DR   Horizon_Discovery; HZGHC001546c005
DR   Wikidata; Q54879502
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15828; RASD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RASGRP1 (-) 1
AC   CVCL_TI53
SY   HZGHC004195c001; RASGRP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI53
DR   Horizon_Discovery; HZGHC004195c001
DR   Wikidata; Q54879503
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9878; RASGRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RASGRP1 (-) 2
AC   CVCL_TI54
SY   HZGHC004195c002; RASGRP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TI54
DR   Horizon_Discovery; HZGHC004195c002
DR   Wikidata; Q54879504
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9878; RASGRP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RASSF4 (-)
AC   CVCL_XS14
SY   HZGHC007102c003; HZGHC83937; RASSF4 knockout cell line 1bp insertion in exon 5
DR   cancercelllines; CVCL_XS14
DR   Horizon_Discovery; HZGHC007102c003
DR   Wikidata; Q93962920
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20793; RASSF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RASSF5 (-)
AC   CVCL_TI55
SY   HZGHC006702c008; RASSF5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TI55
DR   Horizon_Discovery; HZGHC006702c008
DR   Wikidata; Q54879505
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17609; RASSF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RB1 (-) 1
AC   CVCL_TI56
SY   HZGHC004737c001; RB1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TI56
DR   Horizon_Discovery; HZGHC004737c001
DR   Wikidata; Q54879506
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RB1 (-) 2
AC   CVCL_TI57
SY   HZGHC004945c002; RB1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TI57
DR   Horizon_Discovery; HZGHC004945c002
DR   Wikidata; Q54879507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RB1 (-) 3
AC   CVCL_TI58
SY   HZGHC004945c006; RB1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TI58
DR   Horizon_Discovery; HZGHC004945c006
DR   Wikidata; Q54879508
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RB1CC1 (-)
AC   CVCL_TI59
SY   HZGHC000567c007; RB1CC1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI59
DR   Horizon_Discovery; HZGHC000567c007
DR   Wikidata; Q54879509
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15574; RB1CC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RBBP7 (-) 1
AC   CVCL_TI60
SY   HZGHC001138c008; RBBP7 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TI60
DR   Horizon_Discovery; HZGHC001138c008
DR   Wikidata; Q54879510
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9890; RBBP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RBBP7 (-) 2
AC   CVCL_TI61
SY   HZGHC001138c010; RBBP7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI61
DR   Horizon_Discovery; HZGHC001138c010
DR   Wikidata; Q54879511
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9890; RBBP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RBBP7 (-) 3
AC   CVCL_TI62
SY   HZGHC001138c012; RBBP7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TI62
DR   Horizon_Discovery; HZGHC001138c012
DR   Wikidata; Q54879512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9890; RBBP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RBKS (-) 1
AC   CVCL_TI63
SY   HZGHC005261c010; RBKS knockout cell line 2bp deletion; HAP1 RBKS (-)
DR   cancercelllines; CVCL_TI63
DR   Horizon_Discovery; HZGHC005261c010
DR   Wikidata; Q54879513
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30325; RBKS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RBKS (-) 2
AC   CVCL_XS15
SY   HZGHC005261c009; RBKS knockout cell line 58bp deletion
DR   cancercelllines; CVCL_XS15
DR   Horizon_Discovery; HZGHC005261c009
DR   Wikidata; Q93963033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30325; RBKS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RBKS (-) 3
AC   CVCL_XS16
SY   HZGHC005262c007; RBKS knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XS16
DR   Horizon_Discovery; HZGHC005262c007
DR   Wikidata; Q93963037
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30325; RBKS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RBKS (-) 4
AC   CVCL_XS17
SY   HZGHC005262c011; RBKS knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS17
DR   Horizon_Discovery; HZGHC005262c011
DR   Wikidata; Q93963041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30325; RBKS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RBL2 (-) 1
AC   CVCL_E2IJ
SY   HZGHC008042c006
DR   Horizon_Discovery; HZGHC008042c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9894; RBL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBL2 (-) 2
AC   CVCL_E2IK
SY   HZGHC008042c007
DR   Horizon_Discovery; HZGHC008042c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9894; RBL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBL2 (-) 3
AC   CVCL_E2IL
SY   HZGHC008043c007
DR   Horizon_Discovery; HZGHC008043c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9894; RBL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBM4 (-) 1
AC   CVCL_E2IM
SY   HZGHC007496c001
DR   Horizon_Discovery; HZGHC007496c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9901; RBM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBM4 (-) 2
AC   CVCL_E2IN
SY   HZGHC007497c005
DR   Horizon_Discovery; HZGHC007497c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9901; RBM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBM4B (-)
AC   CVCL_E2IP
SY   HZGHC007498c001
DR   Horizon_Discovery; HZGHC007498c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28842; RBM4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBM7 (-) 1
AC   CVCL_E2IQ
SY   HZGHC007478c004
DR   Horizon_Discovery; HZGHC007478c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9904; RBM7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBM7 (-) 2
AC   CVCL_E2IR
SY   HZGHC007479c003
DR   Horizon_Discovery; HZGHC007479c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9904; RBM7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RBM7 (-) 3
AC   CVCL_E2IS
SY   HZGHC007479c010
DR   Horizon_Discovery; HZGHC007479c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9904; RBM7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RC3H1 (-)
AC   CVCL_E2IT
SY   HZGHC007428c012
DR   Horizon_Discovery; HZGHC007428c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29434; RC3H1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RC3H2 (-) 1
AC   CVCL_E2IU
SY   HZGHC007421c005
DR   Horizon_Discovery; HZGHC007421c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21461; RC3H2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RC3H2 (-) 2
AC   CVCL_E2IV
SY   HZGHC007421c008
DR   Horizon_Discovery; HZGHC007421c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21461; RC3H2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RC3H2 (-) 3
AC   CVCL_E2IW
SY   HZGHC007421c010
DR   Horizon_Discovery; HZGHC007421c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21461; RC3H2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RCAN1 (-)
AC   CVCL_TI64
SY   HZGHC004188c010; RCAN1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TI64
DR   Horizon_Discovery; HZGHC004188c010
DR   Wikidata; Q54879514
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3040; RCAN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RCBTB2 (-) 1
AC   CVCL_TI65
SY   HZGHC006363c002; RCBTB2 knockout cell line 2bp deletion; HAP1 RCBTB2 (-)
DR   cancercelllines; CVCL_TI65
DR   Horizon_Discovery; HZGHC006363c002
DR   Wikidata; Q54879515
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1914; RCBTB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RCBTB2 (-) 2
AC   CVCL_XS18
SY   HZGHC006364c002; RCBTB2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XS18
DR   Horizon_Discovery; HZGHC006364c002
DR   Wikidata; Q93963069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1914; RCBTB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RCBTB2 (-) 3
AC   CVCL_XS19
SY   HZGHC006364c008; RCBTB2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XS19
DR   Horizon_Discovery; HZGHC006364c008
DR   Wikidata; Q93963074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1914; RCBTB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006364c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RCC2 (-) 1
AC   CVCL_TI66
SY   HZGHC005171c010; RCC2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TI66
DR   Horizon_Discovery; HZGHC005171c010
DR   Wikidata; Q54879516
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30297; RCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RCC2 (-) 2
AC   CVCL_TI67
SY   HZGHC005171c012; RCC2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TI67
DR   Horizon_Discovery; HZGHC005171c012
DR   Wikidata; Q54879517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30297; RCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RCOR2 (-) 1
AC   CVCL_E2IX
SY   HZGHC007571c007
DR   Horizon_Discovery; HZGHC007571c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27455; RCOR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RCOR2 (-) 2
AC   CVCL_E2IY
SY   HZGHC007572c002
DR   Horizon_Discovery; HZGHC007572c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27455; RCOR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RCOR2 (-) 3
AC   CVCL_E2IZ
SY   HZGHC007572c004
DR   Horizon_Discovery; HZGHC007572c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27455; RCOR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RCOR2 (-) 4
AC   CVCL_E2J0
SY   HZGHC007572c012
DR   Horizon_Discovery; HZGHC007572c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27455; RCOR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RDH13 (-) 1
AC   CVCL_TI68
SY   HZGHC006408c001; RDH13 knockout cell line 1bp insertion; HAP1 RDH13 (-)
DR   cancercelllines; CVCL_TI68
DR   Horizon_Discovery; HZGHC006408c001
DR   Wikidata; Q54879518
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19978; RDH13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RDH13 (-) 2
AC   CVCL_XS20
SY   HZGHC006408c002; RDH13 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XS20
DR   Horizon_Discovery; HZGHC006408c002
DR   Wikidata; Q93963114
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19978; RDH13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RECQL (-) 1
AC   CVCL_TI69
SY   HZGHC004514c006; RECQL knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TI69
DR   Horizon_Discovery; HZGHC004514c006
DR   Wikidata; Q54879519
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9948; RECQL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RECQL (-) 2
AC   CVCL_TI70
SY   HZGHC004514c010; RECQL knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TI70
DR   Horizon_Discovery; HZGHC004514c010
DR   Wikidata; Q54879520
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9948; RECQL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RECQL4 (-) 1
AC   CVCL_TI71
SY   HZGHC000427c003; RECQL4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI71
DR   Horizon_Discovery; HZGHC000427c003
DR   Wikidata; Q54879521
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9949; RECQL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RECQL4 (-) 2
AC   CVCL_TI72
SY   HZGHC000427c009; RECQL4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI72
DR   Horizon_Discovery; HZGHC000427c009
DR   Wikidata; Q54879523
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9949; RECQL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RECQL4 (-) 3
AC   CVCL_TI73
SY   HZGHC000427c011; RECQL4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TI73
DR   Horizon_Discovery; HZGHC000427c011
DR   Wikidata; Q54879524
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9949; RECQL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 REL (-)
AC   CVCL_TI74
SY   HZGHC002604c004; REL knockout cell line 136bp insertion
DR   cancercelllines; CVCL_TI74
DR   Horizon_Discovery; HZGHC002604c004
DR   Wikidata; Q54879525
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9954; REL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002604c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RELA (-) 1
AC   CVCL_TI75
SY   HZGHC002605c002; RELA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI75
DR   Horizon_Discovery; HZGHC002605c002
DR   Wikidata; Q54879526
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RELA (-) 2
AC   CVCL_TI76
SY   HZGHC002605c004; RELA knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TI76
DR   Horizon_Discovery; HZGHC002605c004
DR   Wikidata; Q54879532
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RELA (-) 3
AC   CVCL_TI77
SY   HZGHC002605c010; RELA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TI77
DR   Horizon_Discovery; HZGHC002605c010
DR   Wikidata; Q54879533
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RELB (-)
AC   CVCL_TI78
SY   HZGHC002883c012; RELB knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TI78
DR   Horizon_Discovery; HZGHC002883c012
DR   Wikidata; Q54879534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9956; RELB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RENBP (-) 1
AC   CVCL_TI79
SY   HZGHC005263c011; RENBP knockout cell line 43bp deletion; HAP1 RENBP (-)
DR   cancercelllines; CVCL_TI79
DR   Horizon_Discovery; HZGHC005263c011
DR   Wikidata; Q54879535
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9959; RENBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RENBP (-) 2
AC   CVCL_XS21
SY   HZGHC005263c006; RENBP knockout cell line 91bp deletion
DR   cancercelllines; CVCL_XS21
DR   Horizon_Discovery; HZGHC005263c006
DR   Wikidata; Q93963239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9959; RENBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 REPS1 (-) 1
AC   CVCL_XS22
SY   HZGHC006982c003; HZGHC85021; REPS1 knockout cell line 11bp deletion in exon 4; HAP1 REPS1 (-)
DR   cancercelllines; CVCL_XS22
DR   Horizon_Discovery; HZGHC006982c003
DR   Wikidata; Q93963241
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15578; REPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 REPS1 (-) 2
AC   CVCL_E2J1
SY   HZGHC006982c010; REPS1 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC006982c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15578; REPS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RER1 (-) 1
AC   CVCL_TI80
SY   HZGHC002443c002; RER1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI80
DR   Horizon_Discovery; HZGHC002443c002
DR   Wikidata; Q54879536
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30309; RER1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RER1 (-) 2
AC   CVCL_TI81
SY   HZGHC002443c006; RER1 knockout cell line 118bp insertion
DR   cancercelllines; CVCL_TI81
DR   Horizon_Discovery; HZGHC002443c006
DR   Wikidata; Q54879538
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30309; RER1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002443c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RERE (-) 1
AC   CVCL_TI82
SY   HZGHC006046c011; RERE knockout cell line 20bp deletion; HAP1 RERE (-)
DR   cancercelllines; CVCL_TI82
DR   Horizon_Discovery; HZGHC006046c011
DR   Wikidata; Q54879539
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9965; RERE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RERE (-) 2
AC   CVCL_XS23
SY   HZGHC006046c008; RERE knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XS23
DR   Horizon_Discovery; HZGHC006046c008
DR   Wikidata; Q93963261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9965; RERE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 REST (-) 1
AC   CVCL_TI83
SY   HZGHC006341c004; REST knockout cell line 1bp insertion; HAP1 REST (-)
DR   cancercelllines; CVCL_TI83
DR   Horizon_Discovery; HZGHC006341c004
DR   Wikidata; Q54879540
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9966; REST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 REST (-) 2
AC   CVCL_XS24
SY   HZGHC006341c008; REST knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS24
DR   Horizon_Discovery; HZGHC006341c008
DR   Wikidata; Q93963268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9966; REST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006341c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RET (-)
AC   CVCL_TI84
SY   HZGHC001368c011; RET knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI84
DR   Horizon_Discovery; HZGHC001368c011
DR   Wikidata; Q54879541
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RETSAT (-) 1
AC   CVCL_E2J2
SY   HZGHC007670c001
DR   Horizon_Discovery; HZGHC007670c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25991; RETSAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RETSAT (-) 2
AC   CVCL_E2J3
SY   HZGHC007670c006
DR   Horizon_Discovery; HZGHC007670c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25991; RETSAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RETSAT (-) 3
AC   CVCL_E2J4
SY   HZGHC007670c008
DR   Horizon_Discovery; HZGHC007670c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25991; RETSAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RETSAT (-) 4
AC   CVCL_E2J5
SY   HZGHC007670c011
DR   Horizon_Discovery; HZGHC007670c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25991; RETSAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RETSAT (-) 5
AC   CVCL_E2J6
SY   HZGHC007670c012
DR   Horizon_Discovery; HZGHC007670c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25991; RETSAT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 REV1 (-) 1
AC   CVCL_TI85
SY   HZGHC000754c002; REV1 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TI85
DR   Horizon_Discovery; HZGHC000754c002
DR   Wikidata; Q54879542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14060; REV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 REV1 (-) 2
AC   CVCL_TI86
SY   HZGHC000754c005; REV1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TI86
DR   Horizon_Discovery; HZGHC000754c005
DR   Wikidata; Q54879543
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14060; REV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 REXO2 (-)
AC   CVCL_TI87
SY   HZGHC003748c001; REXO2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TI87
DR   Horizon_Discovery; HZGHC003748c001
DR   Wikidata; Q54879544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17851; REXO2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 REXO4 (-) 1
AC   CVCL_TI88
SY   HZGHC006590c010; REXO4 knockout cell line 2bp deletion; HAP1 REXO4 (-)
DR   cancercelllines; CVCL_TI88
DR   Horizon_Discovery; HZGHC006590c010
DR   Wikidata; Q54879545
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12820; REXO4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 REXO4 (-) 2
AC   CVCL_XS25
SY   HZGHC006590c002; REXO4 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XS25
DR   Horizon_Discovery; HZGHC006590c002
DR   Wikidata; Q93963309
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12820; REXO4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RFWD3 (-) 1
AC   CVCL_TI89
SY   HZGHC002532c002; RFWD3 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TI89
DR   Horizon_Discovery; HZGHC002532c002
DR   Wikidata; Q54879546
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25539; RFWD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RFWD3 (-) 2
AC   CVCL_TI90
SY   HZGHC002532c010; RFWD3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TI90
DR   Horizon_Discovery; HZGHC002532c010
DR   Wikidata; Q54879547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25539; RFWD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RFX5 (-) 1
AC   CVCL_TI91
SY   HZGHC004500c001; RFX5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI91
DR   Horizon_Discovery; HZGHC004500c001
DR   Wikidata; Q54879548
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9986; RFX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RFX5 (-) 2
AC   CVCL_TI92
SY   HZGHC004500c002; RFX5 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TI92
DR   Horizon_Discovery; HZGHC004500c002
DR   Wikidata; Q54879549
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9986; RFX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RFX5 (-) 3
AC   CVCL_TI93
SY   HZGHC004571c006; RFX5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI93
DR   Horizon_Discovery; HZGHC004571c006
DR   Wikidata; Q54879550
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9986; RFX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RFX5 (-) 4
AC   CVCL_TI94
SY   HZGHC004571c010; RFX5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI94
DR   Horizon_Discovery; HZGHC004571c010
DR   Wikidata; Q54879551
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9986; RFX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RGP1 (-)
AC   CVCL_E2J7
SY   HZGHC007308c009
DR   Horizon_Discovery; HZGHC007308c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21965; RGP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RHBDD2 (-) 1
AC   CVCL_TI95
SY   HZGHC003474c005; RHBDD2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TI95
DR   Horizon_Discovery; HZGHC003474c005
DR   Wikidata; Q54879552
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23082; RHBDD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RHBDD2 (-) 2
AC   CVCL_TI96
SY   HZGHC003474c009; RHBDD2 knockout cell line 229bp insertion
DR   cancercelllines; CVCL_TI96
DR   Horizon_Discovery; HZGHC003474c009
DR   Wikidata; Q54879553
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23082; RHBDD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003474c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RHOD (-) 1
AC   CVCL_TI97
SY   HZGHC005085c003; RHOD knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TI97
DR   Horizon_Discovery; HZGHC005085c003
DR   Wikidata; Q54879554
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:670; RHOD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RHOD (-) 2
AC   CVCL_TI98
SY   HZGHC005085c011; RHOD knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TI98
DR   Horizon_Discovery; HZGHC005085c011
DR   Wikidata; Q54879555
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:670; RHOD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RHOT1 (-) 1
AC   CVCL_E2J8
SY   HZGHC007372c006
DR   Horizon_Discovery; HZGHC007372c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21168; RHOT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RHOT1 (-) 2
AC   CVCL_E2J9
SY   HZGHC007372c011
DR   Horizon_Discovery; HZGHC007372c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21168; RHOT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RHOT2 (-)
AC   CVCL_E2JA
SY   HZGHC007436c005
DR   Horizon_Discovery; HZGHC007436c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21169; RHOT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RIC1 (-)
AC   CVCL_C7YN
SY   HZGHC007306c002; RIC1 knockout cell line 1bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007306c002
DR   Wikidata; Q123031446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17686; RIC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RIC3 (-) 1
AC   CVCL_XS26
SY   HZGHC007166c003; HZGHC79608; RIC3 knockout cell line 1bp insertion in exon 2; HAP1 RIC3 (-)
DR   cancercelllines; CVCL_XS26
DR   Horizon_Discovery; HZGHC007166c003
DR   Wikidata; Q93963394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30338; RIC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 RIC3 (-) 2
AC   CVCL_E2JB
SY   HZGHC007165c007
DR   Horizon_Discovery; HZGHC007165c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30338; RIC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RIC3 (-) 3
AC   CVCL_E2JC
SY   HZGHC007166c007
DR   Horizon_Discovery; HZGHC007166c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30338; RIC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RICTOR (-) 1
AC   CVCL_TI99
SY   HZGHC001020c003; RICTOR knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TI99
DR   Horizon_Discovery; HZGHC001020c003
DR   Wikidata; Q54879556
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001020c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RICTOR (-) 2
AC   CVCL_TJ00
SY   HZGHC001020c010; RICTOR knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TJ00
DR   Horizon_Discovery; HZGHC001020c010
DR   Wikidata; Q54879558
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001020c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RIF1 (-) 1
AC   CVCL_TJ01
SY   HZGHC000663c003; RIF1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TJ01
DR   Horizon_Discovery; HZGHC000663c003
DR   Wikidata; Q54879561
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23207; RIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000663c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RIF1 (-) 2
AC   CVCL_TJ02
SY   HZGHC000663c010; RIF1 knockout cell line 37bp insertion
DR   cancercelllines; CVCL_TJ02
DR   Horizon_Discovery; HZGHC000663c010
DR   Wikidata; Q54879562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23207; RIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000663c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RIF1 (-) 3
AC   CVCL_TJ03
SY   HZGHC000663c012; RIF1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TJ03
DR   Horizon_Discovery; HZGHC000663c012
DR   Wikidata; Q54879563
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23207; RIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000663c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RIF1 (-) 4
AC   CVCL_TJ04
SY   HZGHC000748c002; RIF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ04
DR   Horizon_Discovery; HZGHC000748c002
DR   Wikidata; Q54879564
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23207; RIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000748c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RIF1 (-) 5
AC   CVCL_TJ05
SY   HZGHC000748c004; RIF1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TJ05
DR   Horizon_Discovery; HZGHC000748c004
DR   Wikidata; Q54879565
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23207; RIF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000748c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RING1 (-) 1
AC   CVCL_TJ06
SY   HZGHC001111c001; RING1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TJ06
DR   Horizon_Discovery; HZGHC001111c001
DR   Wikidata; Q54879566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001111c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RING1 (-) 2
AC   CVCL_TJ07
SY   HZGHC001111c003; RING1 knockout cell line 2bp deletion in exon 3
DR   cancercelllines; CVCL_TJ07
DR   Horizon_Discovery; HZGHC001111c003
DR   Wikidata; Q54879567
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RING1 (-) 3
AC   CVCL_TJ08
SY   HZGHC001111c012; RING1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ08
DR   Horizon_Discovery; HZGHC001111c012
DR   Wikidata; Q54879568
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001111c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RING1 (-) RNF2 (-) 1
AC   CVCL_DX52
SY   HZGHC008022c026; Double knockout cell line RING1 17bp deletion in exon 3 and RNF2 10bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008022c026
DR   Wikidata; Q127381089
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TJ34 ! HAP1 RNF2 (-) 5
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RING1 (-) RNF2 (-) 2
AC   CVCL_E1NP
SY   HZGHC008022c027; Double knockout cell line RING1 1bp insertion in exon 3 and RNF2 10bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008022c027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TJ34 ! HAP1 RNF2 (-) 5
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RIOK3 (-)
AC   CVCL_TJ09
SY   HZGHC000059c011; RIOK3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TJ09
DR   Horizon_Discovery; HZGHC000059c011
DR   Wikidata; Q54879569
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11451; RIOK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RIPK1 (-) 1
AC   CVCL_TJ10
SY   HZGHC000060c015; RIPK1 knockout cell line 14bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000060c015
DR   PRIDE; PXD010335
DR   Wikidata; Q54879570
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 RIPK1 (-) 2
AC   CVCL_TJ11
SY   HZGHC000060c018; RIPK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ11
DR   Horizon_Discovery; HZGHC000060c018
DR   Wikidata; Q54879571
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000060c018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RIPK2 (-)
AC   CVCL_TJ12
SY   HZGHC000028c005; RIPK2 knockout cell line 5bp deletion
DR   ArrayExpress; E-MTAB-7061
DR   Horizon_Discovery; HZGHC000028c005
DR   PRIDE; PXD010335
DR   Wikidata; Q54879572
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10020; RIPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HAP1 RIPK3 (-) 1
AC   CVCL_XS27
SY   HZGHC007244c009; HZGHC11035; RIPK3 knockout cell line 1bp insertion in exon 3; HAP1 RIPK3 (-)
DR   cancercelllines; CVCL_XS27
DR   Horizon_Discovery; HZGHC007244c009
DR   Wikidata; Q93963499
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10021; RIPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 RIPK3 (-) 2
AC   CVCL_E2JD
SY   HZGHC007244c011
DR   Horizon_Discovery; HZGHC007244c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10021; RIPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RIPK3 (-) 3
AC   CVCL_E2JE
SY   HZGHC007245c022
DR   Horizon_Discovery; HZGHC007245c022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10021; RIPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RLIM (-) 1
AC   CVCL_TJ13
SY   HZGHC004255c001; RLIM knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ13
DR   Horizon_Discovery; HZGHC004255c001
DR   Wikidata; Q54879573
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13429; RLIM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RLIM (-) 2
AC   CVCL_TJ14
SY   HZGHC004255c004; RLIM knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ14
DR   Horizon_Discovery; HZGHC004255c004
DR   Wikidata; Q54879574
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13429; RLIM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RMND5A (-) 1
AC   CVCL_E2JF
SY   HZGHC007458c006
DR   Horizon_Discovery; HZGHC007458c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25850; RMND5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RMND5A (-) 2
AC   CVCL_E2JG
SY   HZGHC007458c007
DR   Horizon_Discovery; HZGHC007458c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25850; RMND5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RMND5A (-) 3
AC   CVCL_E2JH
SY   HZGHC007458c011
DR   Horizon_Discovery; HZGHC007458c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25850; RMND5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RNASEH2C (-) 1
AC   CVCL_TJ15
SY   HZGHC004633c003; RNASEH2C knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TJ15
DR   Horizon_Discovery; HZGHC004633c003
DR   Wikidata; Q54879575
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24116; RNASEH2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNASEH2C (-) 2
AC   CVCL_TJ16
SY   HZGHC004633c005; RNASEH2C knockout cell line 17bp insertion
DR   cancercelllines; CVCL_TJ16
DR   Horizon_Discovery; HZGHC004633c005
DR   Wikidata; Q54879580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24116; RNASEH2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004633c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNASEK (-) 1
AC   CVCL_TJ17
SY   HZGHC000436c003; RNASEK knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TJ17
DR   Horizon_Discovery; HZGHC000436c003
DR   Wikidata; Q54879581
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33911; RNASEK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000436c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNASEK (-) 2
AC   CVCL_TJ18
SY   HZGHC000436c009; RNASEK knockout cell line 152bp insertion
DR   cancercelllines; CVCL_TJ18
DR   Horizon_Discovery; HZGHC000436c009
DR   Wikidata; Q54879582
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33911; RNASEK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000436c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNASEK (-) 3
AC   CVCL_TJ19
SY   HZGHC000436c011; RNASEK knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ19
DR   Horizon_Discovery; HZGHC000436c011
DR   Wikidata; Q54879583
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33911; RNASEK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNASEK (-) 4
AC   CVCL_TJ20
SY   HZGHC000436c012; RNASEK knockout cell line 40bp insertion
DR   cancercelllines; CVCL_TJ20
DR   Horizon_Discovery; HZGHC000436c012
DR   Wikidata; Q54879584
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33911; RNASEK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000436c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNASEL (-) 1
AC   CVCL_TJ21
SY   HZGHC003288c001; RNASEL knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TJ21
DR   Horizon_Discovery; HZGHC003288c001
DR   Wikidata; Q54879585
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10050; RNASEL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNASEL (-) 2
AC   CVCL_TJ22
SY   HZGHC003288c010; RNASEL knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TJ22
DR   Horizon_Discovery; HZGHC003288c010
DR   Wikidata; Q54879586
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10050; RNASEL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNASET2 (-) 1
AC   CVCL_E2JI
SY   HZGHC007685c001
DR   Horizon_Discovery; HZGHC007685c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21686; RNASET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RNASET2 (-) 2
AC   CVCL_E2JJ
SY   HZGHC007685c008
DR   Horizon_Discovery; HZGHC007685c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21686; RNASET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RNF111 (-) 1
AC   CVCL_TJ23
SY   HZGHC004250c003; RNF111 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TJ23
DR   Horizon_Discovery; HZGHC004250c003
DR   Wikidata; Q54879587
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17384; RNF111.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF111 (-) 2
AC   CVCL_TJ24
SY   HZGHC004250c009; RNF111 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ24
DR   Horizon_Discovery; HZGHC004250c009
DR   Wikidata; Q54879588
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17384; RNF111.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF123 (-) 1
AC   CVCL_TJ25
SY   HZGHC000980c007; RNF123 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ25
DR   Horizon_Discovery; HZGHC000980c007
DR   Wikidata; Q54879589
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21148; RNF123.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000980c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNF123 (-) 2
AC   CVCL_TJ26
SY   HZGHC000980c002; RNF123 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TJ26
DR   Horizon_Discovery; HZGHC000980c002
DR   Wikidata; Q54879590
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21148; RNF123.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF123 (-) 3
AC   CVCL_TJ27
SY   HZGHC000980c011; RNF123 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ27
DR   Horizon_Discovery; HZGHC000980c011
DR   Wikidata; Q54879591
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21148; RNF123.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF123 (-) 4
AC   CVCL_TJ28
SY   HZGHC001025c006; RNF123 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TJ28
DR   Horizon_Discovery; HZGHC001025c006
DR   Wikidata; Q54879592
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21148; RNF123.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF123 (-) 5
AC   CVCL_TJ29
SY   HZGHC001025c011; RNF123 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ29
DR   Horizon_Discovery; HZGHC001025c011
DR   Wikidata; Q54879593
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21148; RNF123.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF126 (-)
AC   CVCL_E2JK
SY   HZGHC008001c006
DR   Horizon_Discovery; HZGHC008001c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21151; RNF126.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RNF2 (-) 1
AC   CVCL_TJ30
SY   HZGHC001181c007; RNF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ30
DR   Horizon_Discovery; HZGHC001181c007
DR   Wikidata; Q54879594
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001181c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNF2 (-) 2
AC   CVCL_TJ31
SY   HZGHC001181c001; RNF2 knockout cell line 553bp insertion
DR   cancercelllines; CVCL_TJ31
DR   Horizon_Discovery; HZGHC001181c001
DR   Wikidata; Q54879596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001181c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNF2 (-) 3
AC   CVCL_TJ32
SY   HZGHC001181c002; RNF2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TJ32
DR   Horizon_Discovery; HZGHC001181c002
DR   Wikidata; Q54879597
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001181c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNF2 (-) 4
AC   CVCL_TJ33
SY   HZGHC001181c003; RNF2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TJ33
DR   Horizon_Discovery; HZGHC001181c003
DR   Wikidata; Q54879598
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001181c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNF2 (-) 5
AC   CVCL_TJ34
SY   HZGHC001181c005; RNF2 knockout cell line 10bp deletion in exon 3
DR   cancercelllines; CVCL_TJ34
DR   Horizon_Discovery; HZGHC001181c005
DR   Wikidata; Q54879599
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNF216 (-)
AC   CVCL_TJ35
SY   HZGHC006692c007; RNF216 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TJ35
DR   Horizon_Discovery; HZGHC006692c007
DR   Wikidata; Q54879600
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21698; RNF216.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF31 (-) 1
AC   CVCL_TJ36
SY   HZGHC004529c011; RNF31 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ36
DR   Horizon_Discovery; HZGHC004529c011
DR   Wikidata; Q54879601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16031; RNF31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF31 (-) 2
AC   CVCL_TJ37
SY   HZGHC004529c012; RNF31 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ37
DR   Horizon_Discovery; HZGHC004529c012
DR   Wikidata; Q54879602
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16031; RNF31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF41 (-) 1
AC   CVCL_TJ38
SY   HZGHC000608c001; RNF41 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TJ38
DR   Horizon_Discovery; HZGHC000608c001
DR   Wikidata; Q54879603
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18401; RNF41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF41 (-) 2
AC   CVCL_TJ39
SY   HZGHC000608c011; RNF41 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TJ39
DR   Horizon_Discovery; HZGHC000608c011
DR   Wikidata; Q54879604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18401; RNF41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF41 (-) 3
AC   CVCL_TJ40
SY   HZGHC000609c006; RNF41 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ40
DR   Horizon_Discovery; HZGHC000609c006
DR   Wikidata; Q54879605
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18401; RNF41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF41 (-) 4
AC   CVCL_TJ41
SY   HZGHC000609c009; RNF41 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TJ41
DR   Horizon_Discovery; HZGHC000609c009
DR   Wikidata; Q54879606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18401; RNF41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF43 (-) 1
AC   CVCL_TJ42
SY   HZGHC004387c002; RNF43 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TJ42
DR   Horizon_Discovery; HZGHC004387c002
DR   Wikidata; Q54879607
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18505; RNF43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF43 (-) 2
AC   CVCL_TJ43
SY   HZGHC004387c003; RNF43 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ43
DR   Horizon_Discovery; HZGHC004387c003
DR   Wikidata; Q54879608
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18505; RNF43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RNF43 (-) 3
AC   CVCL_TJ44
SY   HZGHC004387c010; RNF43 knockout cell line 358bp insertion
DR   cancercelllines; CVCL_TJ44
DR   Horizon_Discovery; HZGHC004387c010
DR   Wikidata; Q54879609
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18505; RNF43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004387c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RNF8 (-)
AC   CVCL_TJ45
SY   HZGHC000662c011; RNF8 knockout cell line 152bp insertion
DR   cancercelllines; CVCL_TJ45
DR   Horizon_Discovery; HZGHC000662c011
DR   Wikidata; Q54879610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10071; RNF8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000662c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ROBO1 (-) 1
AC   CVCL_TJ46
SY   HZGHC006235c011; ROBO1 knockout cell line 158bp insertion; HAP1 ROBO1 (-)
DR   cancercelllines; CVCL_TJ46
DR   Horizon_Discovery; HZGHC006235c011
DR   Wikidata; Q54879611
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10249; ROBO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006235c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ROBO1 (-) 2
AC   CVCL_XS28
SY   HZGHC006235c004; ROBO1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS28
DR   Horizon_Discovery; HZGHC006235c004
DR   Wikidata; Q93964008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10249; ROBO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROCK1 (-) 1
AC   CVCL_TJ47
SY   HZGHC000320c011; ROCK1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TJ47
DR   Horizon_Discovery; HZGHC000320c011
DR   Wikidata; Q54879612
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ROCK1 (-) 2
AC   CVCL_TJ48
SY   HZGHC000320c012; ROCK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ48
DR   Horizon_Discovery; HZGHC000320c012
DR   Wikidata; Q54879613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROCK1 (-) 3
AC   CVCL_TJ49
SY   HZGHC000320c016; ROCK1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TJ49
DR   Horizon_Discovery; HZGHC000320c016
DR   Wikidata; Q54879614
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROCK2 (-) 1
AC   CVCL_TJ50
SY   HZGHC000061c017; ROCK2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TJ50
DR   Horizon_Discovery; HZGHC000061c017
DR   Wikidata; Q54879615
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ROCK2 (-) 2
AC   CVCL_TJ51
SY   HZGHC000061c018; ROCK2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TJ51
DR   Horizon_Discovery; HZGHC000061c018
DR   Wikidata; Q54879616
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROCK2 (-) 3
AC   CVCL_TJ52
SY   HZGHC000061c021; ROCK2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TJ52
DR   Horizon_Discovery; HZGHC000061c021
DR   Wikidata; Q54879617
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROR1 (-) 1
AC   CVCL_TJ53
SY   HZGHC004050c002; ROR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ53
DR   Horizon_Discovery; HZGHC004050c002
DR   Wikidata; Q54879619
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10256; ROR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROR1 (-) 2
AC   CVCL_TJ54
SY   HZGHC004050c007; ROR1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TJ54
DR   Horizon_Discovery; HZGHC004050c007
DR   Wikidata; Q54879620
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10256; ROR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROR1 (-) 3
AC   CVCL_TJ55
SY   HZGHC001343c015; ROR1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TJ55
DR   Horizon_Discovery; HZGHC001343c015
DR   Wikidata; Q54879621
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10256; ROR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ROR2 (-) 4
AC   CVCL_TJ56
SY   HZGHC000336c004; ROR2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TJ56
DR   Horizon_Discovery; HZGHC000336c004
DR   Wikidata; Q54879627
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000336c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ROR2 (-) 5
AC   CVCL_TJ57
SY   HZGHC000336c014; ROR2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TJ57
DR   Horizon_Discovery; HZGHC000336c014
DR   Wikidata; Q54879628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS25 (-) 1
AC   CVCL_TJ58
SY   HZGHC005084c002; RPS25 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TJ58
DR   Horizon_Discovery; HZGHC005084c002
DR   Wikidata; Q54879629
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10413; RPS25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS25 (-) 2
AC   CVCL_TJ59
SY   HZGHC005084c011; RPS25 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TJ59
DR   Horizon_Discovery; HZGHC005084c011
DR   Wikidata; Q54879630
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10413; RPS25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KA1 (-)
AC   CVCL_TJ60
SY   HZGHC000215c018; RPS6KA1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TJ60
DR   Horizon_Discovery; HZGHC000215c018
DR   Wikidata; Q54879631
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10430; RPS6KA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KA2 (-)
AC   CVCL_TJ61
SY   HZGHC000170c008; RPS6KA2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TJ61
DR   Horizon_Discovery; HZGHC000170c008
DR   Wikidata; Q54879632
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10431; RPS6KA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KA3 (-)
AC   CVCL_TJ62
SY   HZGHC000731c010; RPS6KA3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TJ62
DR   Horizon_Discovery; HZGHC000731c010
DR   Wikidata; Q54879633
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10432; RPS6KA3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KA4 (-) 1
AC   CVCL_TJ63
SY   HZGHC001494c011; RPS6KA4 knockout cell line 10bp deletion in exon 3
DR   cancercelllines; CVCL_TJ63
DR   Horizon_Discovery; HZGHC001494c011
DR   Wikidata; Q54879634
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 RPS6KA4 (-) 2
AC   CVCL_TJ64
SY   HZGHC003002c001; RPS6KA4 knockout cell line 2bp insertion in exon 2
DR   cancercelllines; CVCL_TJ64
DR   Horizon_Discovery; HZGHC003002c001
DR   Wikidata; Q54879635
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RPS6KA4 (-) 3
AC   CVCL_TJ65
SY   HZGHC003002c008; RPS6KA4 knockout cell line 7bp deletion in exon 4
DR   cancercelllines; CVCL_TJ65
DR   Horizon_Discovery; HZGHC003002c008
DR   Wikidata; Q54879636
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RPS6KA4 (-) RPS6KA5 (-) 1
AC   CVCL_DX53
SY   HZGHC006960c001; Double knockout cell line RPS6KA4 1bp insertion in exon 4 and RPS6KA5 19bp deletion in exon 3
DR   Horizon_Discovery; HZGHC006960c001
DR   Wikidata; Q127381090
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10434; RPS6KA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TJ66 ! HAP1 RPS6KA5 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RPS6KA4 (-) RPS6KA5 (-) 2
AC   CVCL_DX54
SY   HZGHC006960c002; Double knockout cell line RPS6KA4 85bp deletion in exon 4 and RPS6KA5 19bp deletion in exon 3
DR   Horizon_Discovery; HZGHC006960c002
DR   Wikidata; Q127381091
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10434; RPS6KA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TJ66 ! HAP1 RPS6KA5 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RPS6KA4 (-) RPS6KA5 (-) 3
AC   CVCL_DX55
SY   HZGHC006961c009; Double knockout cell line RPS6KA4 7bp deletion in exon 4 and RPS6KA5 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC006961c009
DR   Wikidata; Q127381092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10434; RPS6KA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TJ65 ! HAP1 RPS6KA4 (-) 3
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 RPS6KA5 (-) 1
AC   CVCL_TJ66
SY   HZGHC002673c003; RPS6KA5 knockout cell line 19bp deletion in exon 3
DR   cancercelllines; CVCL_TJ66
DR   Horizon_Discovery; HZGHC002673c003
DR   Wikidata; Q54879637
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10434; RPS6KA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RPS6KA5 (-) 2
AC   CVCL_TJ67
SY   HZGHC002673c005; RPS6KA5 knockout cell line 8bp deletion in exon 3
DR   cancercelllines; CVCL_TJ67
DR   Horizon_Discovery; HZGHC002673c005
DR   Wikidata; Q54879638
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10434; RPS6KA5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RPS6KA6 (-)
AC   CVCL_TJ68
SY   HZGHC000705c004; RPS6KA6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ68
DR   Horizon_Discovery; HZGHC000705c004
DR   Wikidata; Q54879639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10435; RPS6KA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KB1 (-)
AC   CVCL_TJ69
SY   HZGHC000104c011; RPS6KB1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ69
DR   Horizon_Discovery; HZGHC000104c011
DR   Wikidata; Q54879640
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10436; RPS6KB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KB2 (-)
AC   CVCL_TJ70
SY   HZGHC000105c011; RPS6KB2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TJ70
DR   Horizon_Discovery; HZGHC000105c011
DR   Wikidata; Q54879641
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10437; RPS6KB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KC1 (-) 1
AC   CVCL_TJ71
SY   HZGHC000171c005; RPS6KC1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TJ71
DR   Horizon_Discovery; HZGHC000171c005
DR   Wikidata; Q54879642
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10439; RPS6KC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KC1 (-) 2
AC   CVCL_TJ72
SY   HZGHC000171c011; RPS6KC1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TJ72
DR   Horizon_Discovery; HZGHC000171c011
DR   Wikidata; Q54879643
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10439; RPS6KC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KL1 (-) 1
AC   CVCL_TJ73
SY   HZGHC001347c002; RPS6KL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TJ73
DR   Horizon_Discovery; HZGHC001347c002
DR   Wikidata; Q54879644
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20222; RPS6KL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KL1 (-) 2
AC   CVCL_TJ74
SY   HZGHC003003c011; RPS6KL1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TJ74
DR   Horizon_Discovery; HZGHC003003c011
DR   Wikidata; Q54879645
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20222; RPS6KL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RPS6KL1 (-) 3
AC   CVCL_TJ75
SY   HZGHC003003c012; RPS6KL1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TJ75
DR   Horizon_Discovery; HZGHC003003c012
DR   Wikidata; Q54879646
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20222; RPS6KL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RRAGA (-) 1
AC   CVCL_TJ76
SY   HZGHC005330c011; RRAGA knockout cell line 20bp deletion; HAP1 RRAGA (-)
DR   cancercelllines; CVCL_TJ76
DR   Horizon_Discovery; HZGHC005330c011
DR   Wikidata; Q54879647
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16963; RRAGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RRAGA (-) 2
AC   CVCL_XS29
SY   HZGHC005330c003; RRAGA knockout cell line 25bp deletion
DR   cancercelllines; CVCL_XS29
DR   Horizon_Discovery; HZGHC005330c003
DR   Wikidata; Q93964323
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16963; RRAGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RRM2B (-) 1
AC   CVCL_TJ77
SY   HZGHC000572c009; RRM2B knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TJ77
DR   Horizon_Discovery; HZGHC000572c009
DR   Wikidata; Q54879649
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17296; RRM2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RRM2B (-) 2
AC   CVCL_TJ78
SY   HZGHC000572c010; RRM2B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TJ78
DR   Horizon_Discovery; HZGHC000572c010
DR   Wikidata; Q54879650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17296; RRM2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RRNAD1 (-) 1
AC   CVCL_TJ79
SY   HZGHC006506c010; RRNAD1 knockout cell line 1bp insertion; HAP1 RRNAD1 (-)
DR   cancercelllines; CVCL_TJ79
DR   Horizon_Discovery; HZGHC006506c010
DR   Wikidata; Q54879651
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24273; METTL25B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 RRNAD1 (-) 2
AC   CVCL_XS30
SY   HZGHC006506c002; RRNAD1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XS30
DR   Horizon_Discovery; HZGHC006506c002
DR   Wikidata; Q93964364
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24273; METTL25B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RRNAD1 (-) 3
AC   CVCL_XS31
SY   HZGHC006506c003; RRNAD1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XS31
DR   Horizon_Discovery; HZGHC006506c003
DR   Wikidata; Q93964368
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24273; METTL25B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006506c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 RSAD1 (-) 1
AC   CVCL_TJ80
SY   HZGHC005786c010; RSAD1 knockout cell line 5bp deletion; HAP1 RSAD1 (-)
DR   cancercelllines; CVCL_TJ80
DR   Horizon_Discovery; HZGHC005786c010
DR   Wikidata; Q54879652
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25634; RSAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005786c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 RSAD1 (-) 2
AC   CVCL_XS32
SY   HZGHC005786c002; RSAD1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XS32
DR   Horizon_Discovery; HZGHC005786c002
DR   Wikidata; Q93964384
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25634; RSAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RSAD1 (-) 3
AC   CVCL_XS33
SY   HZGHC005787c007; RSAD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS33
DR   Horizon_Discovery; HZGHC005787c007
DR   Wikidata; Q93964389
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25634; RSAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RSAD1 (-) 4
AC   CVCL_XS34
SY   HZGHC005787c011; RSAD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS34
DR   Horizon_Discovery; HZGHC005787c011
DR   Wikidata; Q93964394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25634; RSAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RSF1 (-)
AC   CVCL_E2JL
SY   HZGHC007814c012
DR   Horizon_Discovery; HZGHC007814c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18118; RSF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RTN4 (-) 1
AC   CVCL_TJ81
SY   HZGHC004345c003; RTN4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TJ81
DR   Horizon_Discovery; HZGHC004345c003
DR   Wikidata; Q54879653
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14085; RTN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RTN4 (-) 2
AC   CVCL_TJ82
SY   HZGHC004345c005; RTN4 knockout cell line 67bp deletion
DR   cancercelllines; CVCL_TJ82
DR   Horizon_Discovery; HZGHC004345c005
DR   Wikidata; Q54879654
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14085; RTN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RTN4 (-) 3
AC   CVCL_TJ83
SY   HZGHC004346c003; RTN4 knockout cell line 67bp deletion
DR   cancercelllines; CVCL_TJ83
DR   Horizon_Discovery; HZGHC004346c003
DR   Wikidata; Q54879655
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14085; RTN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004346c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RTN4 (-) 4
AC   CVCL_TJ84
SY   HZGHC004346c012; RTN4 knockout cell line 67bp deletion
DR   cancercelllines; CVCL_TJ84
DR   Horizon_Discovery; HZGHC004346c012
DR   Wikidata; Q54879656
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14085; RTN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RUNX1 (-)
AC   CVCL_TJ85
SY   HZGHC004198c004; RUNX1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TJ85
DR   Horizon_Discovery; HZGHC004198c004
DR   Wikidata; Q54879657
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RUNX3 (-) 1
AC   CVCL_TJ86
SY   HZGHC006305c010; RUNX3 knockout cell line 1bp insertion; HAP1 RUNX3 (-)
DR   cancercelllines; CVCL_TJ86
DR   Horizon_Discovery; HZGHC006305c010
DR   Wikidata; Q54879658
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10473; RUNX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RUNX3 (-) 2
AC   CVCL_XS35
SY   HZGHC006305c007; RUNX3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS35
DR   Horizon_Discovery; HZGHC006305c007
DR   Wikidata; Q93964475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10473; RUNX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RUNX3 (-) 3
AC   CVCL_XS36
SY   HZGHC006305c011; RUNX3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS36
DR   Horizon_Discovery; HZGHC006305c011
DR   Wikidata; Q93964479
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10473; RUNX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006305c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RXRA (-) 1
AC   CVCL_TJ87
SY   HZGHC003852c008; RXRA knockout cell line 280bp insertion
DR   cancercelllines; CVCL_TJ87
DR   Horizon_Discovery; HZGHC003852c008
DR   Wikidata; Q54879659
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003852c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RXRA (-) 2
AC   CVCL_TJ88
SY   HZGHC003852c012; RXRA knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TJ88
DR   Horizon_Discovery; HZGHC003852c012
DR   Wikidata; Q54879660
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RXRB (-) 1
AC   CVCL_TJ89
SY   HZGHC003797c005; RXRB knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TJ89
DR   Horizon_Discovery; HZGHC003797c005
DR   Wikidata; Q54879661
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10478; RXRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RXRB (-) 2
AC   CVCL_TJ90
SY   HZGHC003797c012; RXRB knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TJ90
DR   Horizon_Discovery; HZGHC003797c012
DR   Wikidata; Q54879662
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10478; RXRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RYBP (-) 1
AC   CVCL_E2JM
SY   HZGHC007989c006
DR   Horizon_Discovery; HZGHC007989c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10480; RYBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RYBP (-) 2
AC   CVCL_E2JN
SY   HZGHC007989c010
DR   Horizon_Discovery; HZGHC007989c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10480; RYBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 RYK (-) 1
AC   CVCL_TJ91
SY   HZGHC008066c005; RYK knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TJ91
DR   Horizon_Discovery; HZGHC008066c005
DR   Wikidata; Q54879663
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10481; RYK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 RYK (-) 2
AC   CVCL_TJ92
SY   HZGHC008066c006; RYK knockout cell line 40bp deletion
DR   cancercelllines; CVCL_TJ92
DR   Horizon_Discovery; HZGHC008066c006
DR   Wikidata; Q54879664
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10481; RYK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC008066c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RYK (-) 3
AC   CVCL_TJ93
SY   HZGHC008066c009; RYK knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TJ93
DR   Horizon_Discovery; HZGHC008066c009
DR   Wikidata; Q54879665
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10481; RYK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC008066c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RYR2 (-) 1
AC   CVCL_TJ94
SY   HZGHC005191c007; RYR2 knockout cell line 2bp insertion; HAP1 RYR2 (-)
DR   cancercelllines; CVCL_TJ94
DR   Horizon_Discovery; HZGHC005191c007
DR   Wikidata; Q54879666
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10484; RYR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 RYR2 (-) 2
AC   CVCL_XS37
SY   HZGHC005191c008; RYR2 knockout cell line 41bp insertion
DR   cancercelllines; CVCL_XS37
DR   Horizon_Discovery; HZGHC005191c008
DR   Wikidata; Q93964590
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10484; RYR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005191c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 S100A10 (-) 1
AC   CVCL_TJ95
SY   HZGHC005496c010; S100A10 knockout cell line 197bp deletion; HAP1 S100A10 (-)
DR   cancercelllines; CVCL_TJ95
DR   Horizon_Discovery; HZGHC005496c010
DR   Wikidata; Q54879667
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10487; S100A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 S100A10 (-) 2
AC   CVCL_XS38
SY   HZGHC005496c012; S100A10 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XS38
DR   Horizon_Discovery; HZGHC005496c012
DR   Wikidata; Q93964606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10487; S100A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 S100PBP (-) 1
AC   CVCL_XS39
SY   HZGHC007160c011; HZGHC64766; S100PBP knockout cell line 4bp deletion in exon 3; HAP1 S100PBP (-)
DR   cancercelllines; CVCL_XS39
DR   Horizon_Discovery; HZGHC007160c011
DR   Wikidata; Q93964610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25768; S100PBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 S100PBP (-) 2
AC   CVCL_E2JP
SY   HZGHC007159c008; S100PBP knockout cell line 13bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007159c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25768; S100PBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 S1PR1 (-) 1
AC   CVCL_TJ96
SY   HZGHC003246c007; S1PR1 knockout cell line 19bp deletion; HAP1 S1PR1 (-)
DR   cancercelllines; CVCL_TJ96
DR   Horizon_Discovery; HZGHC003246c007
DR   Wikidata; Q54879674
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 S1PR1 (-) 2
AC   CVCL_XS40
SY   HZGHC003246c005; S1PR1 knockout cell line
DR   cancercelllines; CVCL_XS40
DR   Horizon_Discovery; HZGHC003246c005
DR   Wikidata; Q93964623
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003246c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 S1PR1 (-) 3
AC   CVCL_XS41
SY   HZGHC003246c011; S1PR1 knockout cell line
DR   cancercelllines; CVCL_XS41
DR   Horizon_Discovery; HZGHC003246c011
DR   Wikidata; Q93964625
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003246c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 S1PR5 (-) 1
AC   CVCL_TJ97
SY   HZGHC003884c004; S1PR5 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TJ97
DR   Horizon_Discovery; HZGHC003884c004
DR   Wikidata; Q54879675
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14299; S1PR5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 S1PR5 (-) 2
AC   CVCL_TJ98
SY   HZGHC003884c010; S1PR5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TJ98
DR   Horizon_Discovery; HZGHC003884c010
DR   Wikidata; Q54879676
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14299; S1PR5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SAMD9 (-)
AC   CVCL_TJ99
SY   HZGHC006557c005; SAMD9 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TJ99
DR   Horizon_Discovery; HZGHC006557c005
DR   Wikidata; Q54879677
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1348; SAMD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SAMHD1 (-) 1
AC   CVCL_TK00
SY   HZGHC000813c004; SAMHD1 knockout cell line 454bp insertion
DR   cancercelllines; CVCL_TK00
DR   Horizon_Discovery; HZGHC000813c004
DR   Wikidata; Q54879678
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15925; SAMHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000813c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SAMHD1 (-) 2
AC   CVCL_TK01
SY   HZGHC000813c005; SAMHD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK01
DR   Horizon_Discovery; HZGHC000813c005
DR   Wikidata; Q54879679
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15925; SAMHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000813c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SAMHD1 (-) 3
AC   CVCL_TK02
SY   HZGHC000813c007; SAMHD1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TK02
DR   Horizon_Discovery; HZGHC000813c007
DR   Wikidata; Q54879680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15925; SAMHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SAT2 (-) 1
AC   CVCL_TK03
SY   HZGHC006034c001; SAT2 knockout cell line 11bp deletion; HAP1 SAT2 (-)
DR   cancercelllines; CVCL_TK03
DR   Horizon_Discovery; HZGHC006034c001
DR   Wikidata; Q54879681
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23160; SAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SAT2 (-) 2
AC   CVCL_XS42
SY   HZGHC006034c007; SAT2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_XS42
DR   Horizon_Discovery; HZGHC006034c007
DR   Wikidata; Q93964689
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23160; SAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SATB1 (-) 1
AC   CVCL_TK04
SY   HZGHC006237c010; SATB1 knockout cell line 14bp deletion; HAP1 SATB1 (-)
DR   cancercelllines; CVCL_TK04
DR   Horizon_Discovery; HZGHC006237c010
DR   Wikidata; Q54879682
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10541; SATB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SATB1 (-) 2
AC   CVCL_XS43
SY   HZGHC006237c003; SATB1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS43
DR   Horizon_Discovery; HZGHC006237c003
DR   Wikidata; Q93964701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10541; SATB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SATB2 (-)
AC   CVCL_TK05
SY   HZGHC005999c010; SATB2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TK05
DR   Horizon_Discovery; HZGHC005999c010
DR   Wikidata; Q54879683
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21637; SATB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SAV1 (-) 1
AC   CVCL_TK06
SY   HZGHC006600c004; SAV1 knockout cell line 1bp insertion; HAP1 SAV1 (-)
DR   cancercelllines; CVCL_TK06
DR   Horizon_Discovery; HZGHC006600c004
DR   Wikidata; Q54879684
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17795; SAV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SAV1 (-) 2
AC   CVCL_XS44
SY   HZGHC006600c007; SAV1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XS44
DR   Horizon_Discovery; HZGHC006600c007
DR   Wikidata; Q93964722
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17795; SAV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SAV1 (-) 3
AC   CVCL_XS45
SY   HZGHC006601c001; SAV1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XS45
DR   Horizon_Discovery; HZGHC006601c001
DR   Wikidata; Q93964726
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17795; SAV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SAV1 (-) 4
AC   CVCL_XS46
SY   HZGHC006601c002; SAV1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XS46
DR   Horizon_Discovery; HZGHC006601c002
DR   Wikidata; Q93964728
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17795; SAV1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SBK1 (-) 1
AC   CVCL_TK07
SY   HZGHC000106c010; SBK1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TK07
DR   Horizon_Discovery; HZGHC000106c010
DR   Wikidata; Q54879685
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17699; SBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SBK1 (-) 2
AC   CVCL_TK08
SY   HZGHC000106c017; SBK1 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TK08
DR   Horizon_Discovery; HZGHC000106c017
DR   Wikidata; Q54879687
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17699; SBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SBK1 (-) 3
AC   CVCL_TK09
SY   HZGHC000106c018; SBK1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TK09
DR   Horizon_Discovery; HZGHC000106c018
DR   Wikidata; Q54879688
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17699; SBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCARB1 (-) 1
AC   CVCL_TK10
SY   HZGHC005495c012; SCARB1 knockout cell line 5bp deletion; HAP1 SCARB1 (-)
DR   cancercelllines; CVCL_TK10
DR   Horizon_Discovery; HZGHC005495c012
DR   Wikidata; Q54879689
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1664; SCARB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SCARB1 (-) 2
AC   CVCL_XS47
SY   HZGHC005495c003; SCARB1 knockout cell line 173bp insertion
DR   cancercelllines; CVCL_XS47
DR   Horizon_Discovery; HZGHC005495c003
DR   Wikidata; Q93964771
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1664; SCARB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005495c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SCCPDH (-) 1
AC   CVCL_TK11
SY   HZGHC005788c010; SCCPDH knockout cell line 5bp deletion; HAP1 SCCPDH (-)
DR   cancercelllines; CVCL_TK11
DR   Horizon_Discovery; HZGHC005788c010
DR   Wikidata; Q54879690
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24275; SCCPDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SCCPDH (-) 2
AC   CVCL_XS48
SY   HZGHC005788c009; SCCPDH knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS48
DR   Horizon_Discovery; HZGHC005788c009
DR   Wikidata; Q93964785
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24275; SCCPDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCCPDH (-) 3
AC   CVCL_XS49
SY   HZGHC005789c004; SCCPDH knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS49
DR   Horizon_Discovery; HZGHC005789c004
DR   Wikidata; Q93964789
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24275; SCCPDH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCFD2 (-) 1
AC   CVCL_TK12
SY   HZGHC001227c003; SCFD2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TK12
DR   Horizon_Discovery; HZGHC001227c003
DR   Wikidata; Q54879691
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30676; SCFD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCFD2 (-) 2
AC   CVCL_TK13
SY   HZGHC001227c009; SCFD2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TK13
DR   Horizon_Discovery; HZGHC001227c009
DR   Wikidata; Q54879692
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30676; SCFD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCML2 (-) 1
AC   CVCL_TK14
SY   HZGHC006441c005; SCML2 knockout cell line 5bp deletion; HAP1 SCML2 (-)
DR   cancercelllines; CVCL_TK14
DR   Horizon_Discovery; HZGHC006441c005
DR   Wikidata; Q54879693
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10581; SCML2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SCML2 (-) 2
AC   CVCL_XS50
SY   HZGHC006441c007; SCML2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XS50
DR   Horizon_Discovery; HZGHC006441c007
DR   Wikidata; Q93964819
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10581; SCML2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCN1B (-) 1
AC   CVCL_TK15
SY   HZGHC003919c003; SCN1B knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TK15
DR   Horizon_Discovery; HZGHC003919c003
DR   Wikidata; Q54879694
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10586; SCN1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCN1B (-) 2
AC   CVCL_TK16
SY   HZGHC003919c005; SCN1B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TK16
DR   Horizon_Discovery; HZGHC003919c005
DR   Wikidata; Q54879695
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10586; SCN1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCNN1D (-)
AC   CVCL_TK17
SY   HZGHC004247c002; SCNN1D knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK17
DR   Horizon_Discovery; HZGHC004247c002
DR   Wikidata; Q54879696
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10601; SCNN1D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCYL1 (-) 1
AC   CVCL_TK18
SY   HZGHC000286c003; SCYL1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TK18
DR   Horizon_Discovery; HZGHC000286c003
DR   Wikidata; Q54879697
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14372; SCYL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCYL1 (-) 2
AC   CVCL_TK19
SY   HZGHC000286c005; SCYL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK19
DR   Horizon_Discovery; HZGHC000286c005
DR   Wikidata; Q54879698
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14372; SCYL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCYL2 (-) 1
AC   CVCL_TK20
SY   HZGHC000173c011; SCYL2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TK20
DR   Horizon_Discovery; HZGHC000173c011
DR   Wikidata; Q54879699
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19286; SCYL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCYL2 (-) 2
AC   CVCL_TK21
SY   HZGHC000173c013; SCYL2 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TK21
DR   Horizon_Discovery; HZGHC000173c013
DR   Wikidata; Q54879700
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19286; SCYL2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCYL3 (-) 1
AC   CVCL_TK22
SY   HZGHC000174c004; SCYL3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TK22
DR   Horizon_Discovery; HZGHC000174c004
DR   Wikidata; Q54879701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19285; SCYL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SCYL3 (-) 2
AC   CVCL_TK23
SY   HZGHC000174c005; SCYL3 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TK23
DR   Horizon_Discovery; HZGHC000174c005
DR   Wikidata; Q54879702
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19285; SCYL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SDC1 (-) 1
AC   CVCL_TK24
SY   HZGHC005407c001; SDC1 knockout cell line 4bp deletion; HAP1 SDC1 (-)
DR   cancercelllines; CVCL_TK24
DR   Horizon_Discovery; HZGHC005407c001
DR   Wikidata; Q54879703
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10658; SDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SDC1 (-) 2
AC   CVCL_XS51
SY   HZGHC005407c010; SDC1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XS51
DR   Horizon_Discovery; HZGHC005407c010
DR   Wikidata; Q93964911
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10658; SDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SDC2 (-) 1
AC   CVCL_TK25
SY   HZGHC004431c002; SDC2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TK25
DR   Horizon_Discovery; HZGHC004431c002
DR   Wikidata; Q54879704
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10659; SDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SDC2 (-) 2
AC   CVCL_TK26
SY   HZGHC004431c005; SDC2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TK26
DR   Horizon_Discovery; HZGHC004431c005
DR   Wikidata; Q54879705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10659; SDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SDC2 (-) 3
AC   CVCL_TK27
SY   HZGHC004432c003; SDC2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TK27
DR   Horizon_Discovery; HZGHC004432c003
DR   Wikidata; Q54879706
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10659; SDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SDC2 (-) 4
AC   CVCL_TK28
SY   HZGHC004432c009; SDC2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TK28
DR   Horizon_Discovery; HZGHC004432c009
DR   Wikidata; Q54879707
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10659; SDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SDC4 (-)
AC   CVCL_E2JQ
SY   HZGHC007908c006
DR   Horizon_Discovery; HZGHC007908c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10661; SDC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SDCBP (-) 1
AC   CVCL_TK29
SY   HZGHC006239c003; SDCBP knockout cell line 11bp deletion; HAP1 SDCBP (-)
DR   cancercelllines; CVCL_TK29
DR   Horizon_Discovery; HZGHC006239c003
DR   Wikidata; Q54879708
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10662; SDCBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SDCBP (-) 2
AC   CVCL_XS52
SY   HZGHC006239c007; SDCBP knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XS52
DR   Horizon_Discovery; HZGHC006239c007
DR   Wikidata; Q93964943
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10662; SDCBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SDF4 (-)
AC   CVCL_E2JR
SY   HZGHC007888c008
DR   Horizon_Discovery; HZGHC007888c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24188; SDF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SDHAF2 (-)
AC   CVCL_XS53
SY   HZGHC54949; SDHAF2 knockout cell line
DR   cancercelllines; CVCL_XS53
DR   Horizon_Discovery; HZGHC54949
DR   Wikidata; Q93964946
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26034; SDHAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC54949; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SDR39U1 (-)
AC   CVCL_TK30
SY   HZGHC006478c005; SDR39U1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK30
DR   Horizon_Discovery; HZGHC006478c005
DR   Wikidata; Q54879709
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20275; SDR39U1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEC22A (-) 1
AC   CVCL_TK31
SY   HZGHC001229c003; SEC22A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK31
DR   Horizon_Discovery; HZGHC001229c003
DR   Wikidata; Q54879710
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20260; SEC22A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001229c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEC22A (-) 2
AC   CVCL_TK32
SY   HZGHC001229c010; SEC22A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK32
DR   Horizon_Discovery; HZGHC001229c010
DR   Wikidata; Q54879712
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20260; SEC22A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC22A (-) 3
AC   CVCL_TK33
SY   HZGHC001229c011; SEC22A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TK33
DR   Horizon_Discovery; HZGHC001229c011
DR   Wikidata; Q54879713
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20260; SEC22A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC22C (-) 1
AC   CVCL_TK34
SY   HZGHC001231c001; SEC22C knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TK34
DR   Horizon_Discovery; HZGHC001231c001
DR   Wikidata; Q54879714
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16828; SEC22C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC22C (-) 2
AC   CVCL_TK35
SY   HZGHC001231c006; SEC22C knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TK35
DR   Horizon_Discovery; HZGHC001231c006
DR   Wikidata; Q54879715
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16828; SEC22C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC23A (-) 1
AC   CVCL_TK36
SY   HZGHC001218c001; SEC23A knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TK36
DR   Horizon_Discovery; HZGHC001218c001
DR   Wikidata; Q54879721
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10701; SEC23A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC23A (-) 2
AC   CVCL_TK37
SY   HZGHC001218c006; SEC23A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TK37
DR   Horizon_Discovery; HZGHC001218c006
DR   Wikidata; Q54879722
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10701; SEC23A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC23B (-) 1
AC   CVCL_TK38
SY   HZGHC020241c005; SEC23B knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TK38
DR   Horizon_Discovery; HZGHC020241c005
DR   Wikidata; Q54879724
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10702; SEC23B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC23B (-) 2
AC   CVCL_TK39
SY   HZGHC020241c010; SEC23B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TK39
DR   Horizon_Discovery; HZGHC020241c010
DR   Wikidata; Q54879725
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10702; SEC23B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC23B (-) 3
AC   CVCL_TK40
SY   HZGHC020241c016; SEC23B knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TK40
DR   Horizon_Discovery; HZGHC020241c016
DR   Wikidata; Q54879726
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10702; SEC23B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC020241c016; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEC23IP (-) 1
AC   CVCL_TK41
SY   HZGHC001237c001; SEC23IP knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TK41
DR   Horizon_Discovery; HZGHC001237c001
DR   Wikidata; Q54879727
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17018; SEC23IP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC23IP (-) 2
AC   CVCL_TK42
SY   HZGHC001237c010; SEC23IP knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TK42
DR   Horizon_Discovery; HZGHC001237c010
DR   Wikidata; Q54879728
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17018; SEC23IP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC24A (-) 1
AC   CVCL_TK43
SY   HZGHC001223c010; SEC24A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TK43
DR   Horizon_Discovery; HZGHC001223c010
DR   Wikidata; Q54879729
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10703; SEC24A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC24A (-) 2
AC   CVCL_TK44
SY   HZGHC001223c011; SEC24A knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TK44
DR   Horizon_Discovery; HZGHC001223c011
DR   Wikidata; Q54879730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10703; SEC24A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC24B (-) 1
AC   CVCL_TK45
SY   HZGHC001222c002; SEC24B knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TK45
DR   Horizon_Discovery; HZGHC001222c002
DR   Wikidata; Q54879731
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10704; SEC24B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC24B (-) 2
AC   CVCL_TK46
SY   HZGHC001222c010; SEC24B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TK46
DR   Horizon_Discovery; HZGHC001222c010
DR   Wikidata; Q54879732
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10704; SEC24B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC24C (-)
AC   CVCL_TK47
SY   HZGHC001235c001; SEC24C knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TK47
DR   Horizon_Discovery; HZGHC001235c001
DR   Wikidata; Q54879733
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10705; SEC24C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEC24D (-)
AC   CVCL_TK48
SY   HZGHC001238c001; SEC24D knockout cell line 251bp insertion
DR   cancercelllines; CVCL_TK48
DR   Horizon_Discovery; HZGHC001238c001
DR   Wikidata; Q54879734
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10706; SEC24D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001238c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEC31A (-)
AC   CVCL_XS54
SY   HZGHC007186c005; HZGHC22872; SEC31A knockout cell line 5bp deletion in exon 7
DR   cancercelllines; CVCL_XS54
DR   Horizon_Discovery; HZGHC007186c005
DR   Wikidata; Q93965052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17052; SEC31A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEC31B (-) 1
AC   CVCL_XS55
SY   HZGHC007183c001; HZGHC25956; SEC31B knockout cell line 2bp deletion in exon 4; HAP1 SEC31B (-)
DR   cancercelllines; CVCL_XS55
DR   Horizon_Discovery; HZGHC007183c001
DR   Wikidata; Q93965054
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23197; SEC31B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEC31B (-) 2
AC   CVCL_B5KU
SY   HZGHC007183c012; SEC31B knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_B5KU
DR   Horizon_Discovery; HZGHC007183c012
DR   Wikidata; Q111733316
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23197; SEC31B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 SECISBP2 (-)
AC   CVCL_TK49
SY   HZGHC003034c012; SECISBP2 knockout cell line 181bp insertion
DR   cancercelllines; CVCL_TK49
DR   Horizon_Discovery; HZGHC003034c012
DR   Wikidata; Q54879735
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30972; SECISBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003034c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SECISBP2L (-) 1
AC   CVCL_TK50
SY   HZGHC003035c011; SECISBP2L knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK50
DR   Horizon_Discovery; HZGHC003035c011
DR   Wikidata; Q54879736
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28997; SECISBP2L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SECISBP2L (-) 2
AC   CVCL_TK51
SY   HZGHC003035c012; SECISBP2L knockout cell line 290bp insertion
DR   cancercelllines; CVCL_TK51
DR   Horizon_Discovery; HZGHC003035c012
DR   Wikidata; Q54879737
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28997; SECISBP2L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003035c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SELK (-) 1
AC   CVCL_TK52
SY   HZGHC002824c010; SELK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK52
DR   Horizon_Discovery; HZGHC002824c010
DR   Wikidata; Q54879738
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30394; SELENOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002824c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SELK (-) 2
AC   CVCL_TK53
SY   HZGHC002824c001; SELK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK53
DR   Horizon_Discovery; HZGHC002824c001
DR   Wikidata; Q54879739
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30394; SELENOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SELK (-) 3
AC   CVCL_TK54
SY   HZGHC002824c004; SELK knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TK54
DR   Horizon_Discovery; HZGHC002824c004
DR   Wikidata; Q54879740
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30394; SELENOK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SEMA7A (-)
AC   CVCL_TK55
SY   HZGHC002328c004; SEMA7A knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TK55
DR   Horizon_Discovery; HZGHC002328c004
DR   Wikidata; Q54879741
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10741; SEMA7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002328c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SENP1 (-)
AC   CVCL_TK56
SY   HZGHC002973c001; SENP1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TK56
DR   Horizon_Discovery; HZGHC002973c001
DR   Wikidata; Q54879742
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17927; SENP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SENP2 (-) 1
AC   CVCL_TK57
SY   HZGHC002974c003; SENP2 knockout cell line 128bp deletion
DR   cancercelllines; CVCL_TK57
DR   Horizon_Discovery; HZGHC002974c003
DR   Wikidata; Q54879743
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23116; SENP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SENP2 (-) 2
AC   CVCL_TK58
SY   HZGHC002974c005; SENP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TK58
DR   Horizon_Discovery; HZGHC002974c005
DR   Wikidata; Q54879744
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23116; SENP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SENP3 (-) 1
AC   CVCL_TK59
SY   HZGHC002975c001; SENP3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TK59
DR   Horizon_Discovery; HZGHC002975c001
DR   Wikidata; Q54879746
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17862; SENP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SENP3 (-) 2
AC   CVCL_TK60
SY   HZGHC002975c003; SENP3 knockout cell line 221bp deletion
DR   cancercelllines; CVCL_TK60
DR   Horizon_Discovery; HZGHC002975c003
DR   Wikidata; Q54879747
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17862; SENP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SENP5 (-)
AC   CVCL_TK61
SY   HZGHC002976c009; SENP5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK61
DR   Horizon_Discovery; HZGHC002976c009
DR   Wikidata; Q54879748
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28407; SENP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SENP7 (-) 1
AC   CVCL_XS56
SY   HZGHC006875c002; HZGHC57337; SENP7 knockout cell line 10bp deletion in exon 4; HAP1 SENP7 (-)
DR   cancercelllines; CVCL_XS56
DR   Horizon_Discovery; HZGHC006875c002
DR   Wikidata; Q93965188
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30402; SENP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SENP7 (-) 2
AC   CVCL_E2JS
SY   HZGHC006874c003
DR   Horizon_Discovery; HZGHC006874c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30402; SENP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SENP7 (-) 3
AC   CVCL_E2JT
SY   HZGHC006875c010
DR   Horizon_Discovery; HZGHC006875c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30402; SENP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SEPT6 (-) 1
AC   CVCL_TK62
SY   HZGHC003603c001; SEPT6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK62
DR   Horizon_Discovery; HZGHC003603c001
DR   Wikidata; Q54879749
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15848; SEPTIN6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEPT6 (-) 2
AC   CVCL_TK63
SY   HZGHC003603c002; SEPT6 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TK63
DR   Horizon_Discovery; HZGHC003603c002
DR   Wikidata; Q54879750
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15848; SEPTIN6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEPT6 (-) 3
AC   CVCL_TK64
SY   HZGHC003603c004; SEPT6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TK64
DR   Horizon_Discovery; HZGHC003603c004
DR   Wikidata; Q54879751
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15848; SEPTIN6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SEPT6 (-) 4
AC   CVCL_XS57
SY   HZGHC003603c010; SEPT6 knockout cell line
DR   cancercelllines; CVCL_XS57
DR   Horizon_Discovery; HZGHC003603c010
DR   Wikidata; Q93965224
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15848; SEPTIN6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003603c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SERAC1 (-)
AC   CVCL_E2JU
SY   HZGHC008061c010
DR   Horizon_Discovery; HZGHC008061c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21061; SERAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SERPINF1 (-) 1
AC   CVCL_TK65
SY   HZGHC006225c010; SERPINF1 knockout cell line 220bp insertion; HAP1 SERPINF1 (-)
DR   cancercelllines; CVCL_TK65
DR   Horizon_Discovery; HZGHC006225c010
DR   Wikidata; Q54879752
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8824; SERPINF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006225c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SERPINF1 (-) 2
AC   CVCL_XS58
SY   HZGHC006225c012; SERPINF1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS58
DR   Horizon_Discovery; HZGHC006225c012
DR   Wikidata; Q93965239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8824; SERPINF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SERPING1 (-) 1
AC   CVCL_E2JV
SY   HZGHC008108c005
DR   Horizon_Discovery; HZGHC008108c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1228; SERPING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SERPING1 (-) 2
AC   CVCL_E2JW
SY   HZGHC008109c005
DR   Horizon_Discovery; HZGHC008109c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1228; SERPING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SERPINH1 (-) 1
AC   CVCL_TK66
SY   HZGHC005480c004; SERPINH1 knockout cell line 13bp deletion; HAP1 SERPINH1 (-)
DR   cancercelllines; CVCL_TK66
DR   Horizon_Discovery; HZGHC005480c004
DR   Wikidata; Q54879753
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1546; SERPINH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SERPINH1 (-) 2
AC   CVCL_XS59
SY   HZGHC005480c006; SERPINH1 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_XS59
DR   Horizon_Discovery; HZGHC005480c006
DR   Wikidata; Q93965252
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1546; SERPINH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETD2 (-) 1
AC   CVCL_TK67
SY   HZGHC003361c006; SETD2 knockout cell line 128bp deletion
DR   cancercelllines; CVCL_TK67
DR   Horizon_Discovery; HZGHC003361c006
DR   Wikidata; Q54879754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003361c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SETD2 (-) 2
AC   CVCL_TK68
SY   HZGHC003361c011; SETD2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TK68
DR   Horizon_Discovery; HZGHC003361c011
DR   PRIDE; PXD010335
DR   Wikidata; Q54879755
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SETD4 (-) 1
AC   CVCL_TK69
SY   HZGHC006508c012; SETD4 knockout cell line 1bp deletion; HAP1 SETD4 (-)
DR   cancercelllines; CVCL_TK69
DR   Horizon_Discovery; HZGHC006508c012
DR   Wikidata; Q54879756
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1258; SETD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SETD4 (-) 2
AC   CVCL_XS60
SY   HZGHC006508c008; SETD4 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XS60
DR   Horizon_Discovery; HZGHC006508c008
DR   Wikidata; Q93965288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1258; SETD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETD5 (-)
AC   CVCL_DX06
SY   HZGHC008020c010; SETD5 knockout cell line 34bp deletion in exon 6
DR   Horizon_Discovery; HZGHC008020c010
DR   Wikidata; Q127381093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25566; SETD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SETD8 (-) 1
AC   CVCL_TK70
SY   HZGHC005717c010; SETD8 knockout cell line 38bp deletion; HAP1 SETD8 (-)
DR   cancercelllines; CVCL_TK70
DR   Horizon_Discovery; HZGHC005717c010
DR   Wikidata; Q54879757
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29489; KMT5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SETD8 (-) 2
AC   CVCL_XS61
SY   HZGHC005717c005; SETD8 knockout cell line 64bp deletion
DR   cancercelllines; CVCL_XS61
DR   Horizon_Discovery; HZGHC005717c005
DR   Wikidata; Q93965307
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29489; KMT5A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETD9 (-) 1
AC   CVCL_TK71
SY   HZGHC003722c004; SETD9 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TK71
DR   Horizon_Discovery; HZGHC003722c004
DR   Wikidata; Q54879758
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28508; SETD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETD9 (-) 2
AC   CVCL_TK72
SY   HZGHC003722c005; SETD9 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TK72
DR   Horizon_Discovery; HZGHC003722c005
DR   Wikidata; Q54879759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28508; SETD9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETDB1 (-) 1
AC   CVCL_TK73
SY   HZGHC001331c001; SETDB1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TK73
DR   Horizon_Discovery; HZGHC001331c001
DR   PRIDE; PXD010335
DR   Wikidata; Q54879760
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10761; SETDB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SETDB1 (-) 2
AC   CVCL_TK74
SY   HZGHC001331c010; SETDB1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TK74
DR   Horizon_Discovery; HZGHC001331c010
DR   Wikidata; Q54879761
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10761; SETDB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SETDB2 (-) 1
AC   CVCL_TK75
SY   HZGHC001180c007; SETDB2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TK75
DR   Horizon_Discovery; HZGHC001180c007
DR   Wikidata; Q54879762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20263; SETDB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETDB2 (-) 2
AC   CVCL_TK76
SY   HZGHC001180c008; SETDB2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TK76
DR   Horizon_Discovery; HZGHC001180c008
DR   Wikidata; Q54879766
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20263; SETDB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETDB2 (-) 3
AC   CVCL_TK77
SY   HZGHC001180c011; SETDB2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TK77
DR   Horizon_Discovery; HZGHC001180c011
DR   Wikidata; Q54879767
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20263; SETDB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETMAR (-) 1
AC   CVCL_TK78
SY   HZGHC004540c003; SETMAR knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TK78
DR   Horizon_Discovery; HZGHC004540c003
DR   Wikidata; Q54879768
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10762; SETMAR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETMAR (-) 2
AC   CVCL_TK79
SY   HZGHC004540c004; SETMAR knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TK79
DR   Horizon_Discovery; HZGHC004540c004
DR   Wikidata; Q54879769
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10762; SETMAR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETX (-) 1
AC   CVCL_TK80
SY   HZGHC001565c001; SETX knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TK80
DR   Horizon_Discovery; HZGHC001565c001
DR   Wikidata; Q54879770
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:445; SETX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SETX (-) 2
AC   CVCL_TK81
SY   HZGHC001565c005; SETX knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TK81
DR   Horizon_Discovery; HZGHC001565c005
DR   Wikidata; Q54879771
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:445; SETX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SFI1 (-) 1
AC   CVCL_XS62
SY   HZGHC003314c001; SFI1 knockout cell line
DR   cancercelllines; CVCL_XS62
DR   Horizon_Discovery; HZGHC003314c001
DR   Wikidata; Q93965459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29064; SFI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003314c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFI1 (-) 2
AC   CVCL_XS63
SY   HZGHC003314c010; SFI1 knockout cell line
DR   cancercelllines; CVCL_XS63
DR   Horizon_Discovery; HZGHC003314c010
DR   Wikidata; Q93965463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29064; SFI1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003314c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFR1 (-) 1
AC   CVCL_TK82
SY   HZGHC006606c001; SFR1 knockout cell line 12bp deletion; HAP1 SFR1 (-)
DR   cancercelllines; CVCL_TK82
DR   Horizon_Discovery; HZGHC006606c001
DR   Wikidata; Q54879773
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29574; SFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFR1 (-) 2
AC   CVCL_XS64
SY   HZGHC006606c002; SFR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XS64
DR   Horizon_Discovery; HZGHC006606c002
DR   Wikidata; Q93965482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29574; SFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006606c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFR1 (-) 3
AC   CVCL_XS65
SY   HZGHC006607c002; SFR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS65
DR   Horizon_Discovery; HZGHC006607c002
DR   Wikidata; Q93965485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29574; SFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006607c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFR1 (-) 4
AC   CVCL_XS66
SY   HZGHC006607c004; SFR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS66
DR   Horizon_Discovery; HZGHC006607c004
DR   Wikidata; Q93965491
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29574; SFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006607c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFR1 (-) 5
AC   CVCL_XS67
SY   HZGHC006607c010; SFR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS67
DR   Horizon_Discovery; HZGHC006607c010
DR   Wikidata; Q93965495
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29574; SFR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SFXN3 (-) 1
AC   CVCL_TK83
SY   HZGHC005790c010; SFXN3 knockout cell line 1bp insertion; HAP1 SFXN3 (-)
DR   cancercelllines; CVCL_TK83
DR   Horizon_Discovery; HZGHC005790c010
DR   Wikidata; Q54879774
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16087; SFXN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFXN3 (-) 2
AC   CVCL_XS68
SY   HZGHC005790c011; SFXN3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS68
DR   Horizon_Discovery; HZGHC005790c011
DR   Wikidata; Q93965513
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16087; SFXN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005790c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SFXN3 (-) 3
AC   CVCL_XS69
SY   HZGHC005791c005; SFXN3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS69
DR   Horizon_Discovery; HZGHC005791c005
DR   Wikidata; Q93965516
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16087; SFXN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGCB (-) 1
AC   CVCL_XS70
SY   HZGHC007077c003; HZGHC6443; SGCB knockout cell line 17bp deletion in exon 3; HAP1 SGCB (-)
DR   cancercelllines; CVCL_XS70
DR   Horizon_Discovery; HZGHC007077c003
DR   Wikidata; Q93965522
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10806; SGCB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SGCB (-) 2
AC   CVCL_E2JX
SY   HZGHC007077c002
DR   Horizon_Discovery; HZGHC007077c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10806; SGCB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SGCB (-) 3
AC   CVCL_E2JY
SY   HZGHC007077c007
DR   Horizon_Discovery; HZGHC007077c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10806; SGCB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SGK1 (-) 1
AC   CVCL_TK84
SY   HZGHC000231c006; SGK1 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_TK84
DR   Horizon_Discovery; HZGHC000231c006
DR   Wikidata; Q54879775
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10810; SGK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGK1 (-) 2
AC   CVCL_TK85
SY   HZGHC000231c007; SGK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TK85
DR   Horizon_Discovery; HZGHC000231c007
DR   Wikidata; Q54879776
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10810; SGK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGK1 (-) 3
AC   CVCL_TK86
SY   HZGHC005209c005; SGK1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TK86
DR   Horizon_Discovery; HZGHC005209c005
DR   Wikidata; Q54879777
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10810; SGK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGK223 (-) 1
AC   CVCL_TK87
SY   HZGHC001344c015; SGK223 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TK87
DR   Horizon_Discovery; HZGHC001344c015
DR   Wikidata; Q54879778
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25438; PRAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGK223 (-) 2
AC   CVCL_TK88
SY   HZGHC003004c002; SGK223 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TK88
DR   Horizon_Discovery; HZGHC003004c002
DR   Wikidata; Q54879779
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25438; PRAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGK223 (-) 3
AC   CVCL_TK89
SY   HZGHC003004c010; SGK223 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TK89
DR   Horizon_Discovery; HZGHC003004c010
DR   Wikidata; Q54879780
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25438; PRAG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGK3 (-)
AC   CVCL_TK90
SY   HZGHC000735c009; SGK3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TK90
DR   Horizon_Discovery; HZGHC000735c009
DR   Wikidata; Q54879781
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10812; SGK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGK494 (-) 1
AC   CVCL_TK91
SY   HZGHC000062c013; SGK494 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TK91
DR   Horizon_Discovery; HZGHC000062c013
DR   Wikidata; Q54879782
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26314; RSKR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SGK494 (-) 2
AC   CVCL_TK92
SY   HZGHC000062c021; SGK494 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TK92
DR   Horizon_Discovery; HZGHC000062c021
DR   Wikidata; Q54879783
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26314; RSKR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SGMS1 (-)
AC   CVCL_E2JZ
SY   HZGHC007880c010
DR   Horizon_Discovery; HZGHC007880c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29799; SGMS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SGMS2 (-) 1
AC   CVCL_E2K0
SY   HZGHC008024c001
DR   Horizon_Discovery; HZGHC008024c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28395; SGMS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SGMS2 (-) 2
AC   CVCL_E2K1
SY   HZGHC008024c011
DR   Horizon_Discovery; HZGHC008024c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28395; SGMS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SGPL1 (-) 1
AC   CVCL_TK93
SY   HZGHC005492c005; SGPL1 knockout cell line 8bp deletion; HAP1 SGPL1 (-)
DR   cancercelllines; CVCL_TK93
DR   Horizon_Discovery; HZGHC005492c005
DR   Wikidata; Q54879784
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10817; SGPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SGPL1 (-) 2
AC   CVCL_XS71
SY   HZGHC005493c001; SGPL1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XS71
DR   Horizon_Discovery; HZGHC005493c001
DR   Wikidata; Q93965735
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10817; SGPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGPL1 (-) 3
AC   CVCL_XS72
SY   HZGHC005493c012; SGPL1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XS72
DR   Horizon_Discovery; HZGHC005493c012
DR   Wikidata; Q93965739
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10817; SGPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SGSH (-) 1
AC   CVCL_XS73
SY   HZGHC007072c005; HZGHC6448; SGSH knockout cell line 1bp insertion in exon 4; HAP1 SGSH (-)
DR   cancercelllines; CVCL_XS73
DR   Horizon_Discovery; HZGHC007072c005
DR   Wikidata; Q93965743
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10818; SGSH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SGSH (-) 2
AC   CVCL_B5KV
SY   HZGHC007072c006; SGSH knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_B5KV
DR   Horizon_Discovery; HZGHC007072c006
DR   Wikidata; Q111733317
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10818; SGSH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 SH3BP5 (-) 1
AC   CVCL_TK94
SY   HZGHC005707c001; SH3BP5 knockout cell line 1bp deletion; HAP1 SH3BP5 (-)
DR   cancercelllines; CVCL_TK94
DR   Horizon_Discovery; HZGHC005707c001
DR   Wikidata; Q54879785
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10827; SH3BP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SH3BP5 (-) 2
AC   CVCL_XS74
SY   HZGHC005708c007; SH3BP5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS74
DR   Horizon_Discovery; HZGHC005708c007
DR   Wikidata; Q93965759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10827; SH3BP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005708c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SH3BP5 (-) 3
AC   CVCL_XS75
SY   HZGHC005708c011; SH3BP5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS75
DR   Horizon_Discovery; HZGHC005708c011
DR   Wikidata; Q93965761
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10827; SH3BP5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SH3BP5L (-) 1
AC   CVCL_TK95
SY   HZGHC005690c010; SH3BP5L knockout cell line 8bp deletion; HAP1 SH3BP5L (-)
DR   cancercelllines; CVCL_TK95
DR   Horizon_Discovery; HZGHC005690c010
DR   Wikidata; Q54879786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29360; SH3BP5L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SH3BP5L (-) 2
AC   CVCL_XS76
SY   HZGHC005690c012; SH3BP5L knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XS76
DR   Horizon_Discovery; HZGHC005690c012
DR   Wikidata; Q93965772
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29360; SH3BP5L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SH3D19 (-) 1
AC   CVCL_E2K2
SY   HZGHC007349c001
DR   Horizon_Discovery; HZGHC007349c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30418; SH3D19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SH3D19 (-) 2
AC   CVCL_E2K3
SY   HZGHC007349c002
DR   Horizon_Discovery; HZGHC007349c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30418; SH3D19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SH3GLB1 (-) 1
AC   CVCL_TK96
SY   HZGHC003166c002; SH3GLB1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TK96
DR   Horizon_Discovery; HZGHC003166c002
DR   Wikidata; Q54879787
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10833; SH3GLB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SH3GLB1 (-) 2
AC   CVCL_TK97
SY   HZGHC003166c011; SH3GLB1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TK97
DR   Horizon_Discovery; HZGHC003166c011
DR   Wikidata; Q54879788
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10833; SH3GLB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SHARPIN (-) 1
AC   CVCL_TK98
SY   HZGHC006445c003; SHARPIN knockout cell line 5bp deletion; HAP1 SHARPIN (-)
DR   cancercelllines; CVCL_TK98
DR   Horizon_Discovery; HZGHC006445c003
DR   Wikidata; Q54879789
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25321; SHARPIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SHARPIN (-) 2
AC   CVCL_XS77
SY   HZGHC006445c008; SHARPIN knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XS77
DR   Horizon_Discovery; HZGHC006445c008
DR   Wikidata; Q93965800
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25321; SHARPIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SHC1 (-) 1
AC   CVCL_TK99
SY   HZGHC006241c011; SHC1 knockout cell line 11bp deletion; HAP1 SHC1 (-)
DR   cancercelllines; CVCL_TK99
DR   Horizon_Discovery; HZGHC006241c011
DR   Wikidata; Q54879790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10840; SHC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SHC1 (-) 2
AC   CVCL_XS78
SY   HZGHC006241c012; SHC1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XS78
DR   Horizon_Discovery; HZGHC006241c012
DR   Wikidata; Q93965813
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10840; SHC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SHMT1 (-) 1
AC   CVCL_TL00
SY   HZGHC003788c004; SHMT1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TL00
DR   Horizon_Discovery; HZGHC003788c004
DR   Wikidata; Q54879791
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10850; SHMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SHMT1 (-) 2
AC   CVCL_TL01
SY   HZGHC003788c008; SHMT1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL01
DR   Horizon_Discovery; HZGHC003788c008
DR   Wikidata; Q54879792
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10850; SHMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SHMT2 (-)
AC   CVCL_TL02
SY   HZGHC001954c006; SHMT2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL02
DR   Horizon_Discovery; HZGHC001954c006
DR   Wikidata; Q54879794
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10852; SHMT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SHOX2 (-) 1
AC   CVCL_TL03
SY   HZGHC003726c002; SHOX2 knockout cell line 70bp deletion in exon 1
DR   cancercelllines; CVCL_TL03
DR   Horizon_Discovery; HZGHC003726c002
DR   Wikidata; Q54879795
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10854; SHOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SHOX2 (-) 2
AC   CVCL_TL04
SY   HZGHC003727c005; SHOX2 knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_TL04
DR   Horizon_Discovery; HZGHC003727c005
DR   Wikidata; Q54879796
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10854; SHOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SHOX2 (-) 3
AC   CVCL_TL05
SY   HZGHC003727c006; SHOX2 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_TL05
DR   Horizon_Discovery; HZGHC003727c006
DR   Wikidata; Q54879797
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10854; SHOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SHOX2 (-) 4
AC   CVCL_TL06
SY   HZGHC003727c011; SHOX2 knockout cell line 10bp deletion in exon 2
DR   cancercelllines; CVCL_TL06
DR   Horizon_Discovery; HZGHC003727c011
DR   Wikidata; Q54879798
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10854; SHOX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SHPRH (-) 1
AC   CVCL_XS79
SY   HZGHC006910c007; HZGHC257218; SHPRH knockout cell line 1bp deletion in exon 4; HAP1 SHPRH (-)
DR   cancercelllines; CVCL_XS79
DR   Horizon_Discovery; HZGHC006910c007
DR   Wikidata; Q93965872
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19336; SHPRH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SHPRH (-) 2
AC   CVCL_B5KX
SY   HZGHC006910c008; SHPRH knockout cell line 16bp deletion in exon 4
DR   cancercelllines; CVCL_B5KX
DR   Horizon_Discovery; HZGHC006910c008
DR   Wikidata; Q111733318
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19336; SHPRH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 SHPRH (-) 3
AC   CVCL_B5KY
SY   HZGHC006910c010; SHPRH knockout cell line 16bp deletion in exon 4
DR   cancercelllines; CVCL_B5KY
DR   Horizon_Discovery; HZGHC006910c010
DR   Wikidata; Q111733319
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19336; SHPRH.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 SIAE (-) 1
AC   CVCL_TL07
SY   HZGHC001387c002; SIAE knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TL07
DR   Horizon_Discovery; HZGHC001387c002
DR   Wikidata; Q54879799
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18187; SIAE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIAE (-) 2
AC   CVCL_TL08
SY   HZGHC001387c004; SIAE knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TL08
DR   Horizon_Discovery; HZGHC001387c004
DR   Wikidata; Q54879800
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18187; SIAE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIAE (-) 3
AC   CVCL_TL09
SY   HZGHC001490c005; SIAE knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TL09
DR   Horizon_Discovery; HZGHC001490c005
DR   Wikidata; Q54879801
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18187; SIAE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIGMAR1 (-) 1
AC   CVCL_TL10
SY   HZGHC003792c010; SIGMAR1 knockout cell line 80bp deletion
DR   cancercelllines; CVCL_TL10
DR   Horizon_Discovery; HZGHC003792c010
DR   Wikidata; Q54879802
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIGMAR1 (-) 2
AC   CVCL_TL11
SY   HZGHC003792c011; SIGMAR1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL11
DR   Horizon_Discovery; HZGHC003792c011
DR   Wikidata; Q54879803
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIK1 (-) 1
AC   CVCL_TL12
SY   HZGHC000063c012; SIK1 knockout cell line 1bp insertion in exon 5; HAP1 SIK1 (-)
DR   cancercelllines; CVCL_TL12
DR   Horizon_Discovery; HZGHC000063c012
DR   Wikidata; Q54879804
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11142; SIK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SIK1 (-) 2
AC   CVCL_XS80
SY   HZGHC000063c022; SIK1 knockout cell line
DR   cancercelllines; CVCL_XS80
DR   Horizon_Discovery; HZGHC000063c022
DR   Wikidata; Q93965913
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11142; SIK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000063c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SIK1 (-) SIK3 (-) 1
AC   CVCL_DX56
SY   HZGHC007841c002; Double knockout cell line SIK1 1bp insertion in exon 5 and SIK3 7bp deletion
DR   Horizon_Discovery; HZGHC007841c002
DR   Wikidata; Q127381094
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11142; SIK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29165; SIK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TL12 ! HAP1 SIK1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SIK1 (-) SIK3 (-) 2
AC   CVCL_DX57
SY   HZGHC007841c007; Double knockout cell line SIK1 1bp insertion in exon 5 and SIK3 1bp insertion
DR   Horizon_Discovery; HZGHC007841c007
DR   Wikidata; Q127381095
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11142; SIK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29165; SIK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TL12 ! HAP1 SIK1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SIK2 (-)
AC   CVCL_TL13
SY   HZGHC000107c012; SIK2 knockout cell line 1bp insertion in exon 1
DR   cancercelllines; CVCL_TL13
DR   Horizon_Discovery; HZGHC000107c012
DR   Wikidata; Q54879805
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21680; SIK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIK3 (-) 1
AC   CVCL_TL14
SY   HZGHC000064c008; SIK3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TL14
DR   Horizon_Discovery; HZGHC000064c008
DR   Wikidata; Q54879806
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29165; SIK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000064c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIK3 (-) 2
AC   CVCL_TL15
SY   HZGHC000064c018; SIK3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL15
DR   Horizon_Discovery; HZGHC000064c018
DR   Wikidata; Q54879807
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29165; SIK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000064c018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIK3 (-) 3
AC   CVCL_TL16
SY   HZGHC000064c021; SIK3 knockout cell line 13bp deletion in exon 3
DR   cancercelllines; CVCL_TL16
DR   Horizon_Discovery; HZGHC000064c021
DR   Wikidata; Q54879811
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29165; SIK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIKE1 (-) 1
AC   CVCL_TL17
SY   HZGHC003366c007; SIKE1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TL17
DR   Horizon_Discovery; HZGHC003366c007
DR   Wikidata; Q54879812
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26119; SIKE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIKE1 (-) 2
AC   CVCL_TL18
SY   HZGHC003366c008; SIKE1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TL18
DR   Horizon_Discovery; HZGHC003366c008
DR   Wikidata; Q54879813
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26119; SIKE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIN3A (-) 1
AC   CVCL_TL19
SY   HZGHC001133c006; SIN3A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL19
DR   Horizon_Discovery; HZGHC001133c006
DR   Wikidata; Q54879814
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19353; SIN3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001133c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIN3A (-) 2
AC   CVCL_TL20
SY   HZGHC001133c003; SIN3A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL20
DR   Horizon_Discovery; HZGHC001133c003
DR   Wikidata; Q54879815
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19353; SIN3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001133c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIN3A (-) 3
AC   CVCL_TL21
SY   HZGHC001133c009; SIN3A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL21
DR   Horizon_Discovery; HZGHC001133c009
DR   Wikidata; Q54879816
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19353; SIN3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001133c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIRPA (-) 1
AC   CVCL_TL22
SY   HZGHC006127c012; SIRPA knockout cell line 1bp insertion; HAP1 SIRPA (-)
DR   cancercelllines; CVCL_TL22
DR   Horizon_Discovery; HZGHC006127c012
DR   Wikidata; Q54879817
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9662; SIRPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIRPA (-) 2
AC   CVCL_XS81
SY   HZGHC006127c004; SIRPA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS81
DR   Horizon_Discovery; HZGHC006127c004
DR   Wikidata; Q93965999
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9662; SIRPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT1 (-) 1
AC   CVCL_TL23
SY   HZGHC004099c002; SIRT1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TL23
DR   Horizon_Discovery; HZGHC004099c002
DR   Wikidata; Q54879818
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT1 (-) 2
AC   CVCL_TL24
SY   HZGHC001008c002; SIRT1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TL24
DR   Horizon_Discovery; HZGHC001008c002
DR   Wikidata; Q54879819
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIRT1 (-) 3
AC   CVCL_TL25
SY   HZGHC001008c008; SIRT1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TL25
DR   Horizon_Discovery; HZGHC001008c008
DR   Wikidata; Q54879820
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIRT1 (-) 4
AC   CVCL_TL26
SY   HZGHC004099c010; SIRT1 knockout cell line 199bp insertion
DR   cancercelllines; CVCL_TL26
DR   Horizon_Discovery; HZGHC004099c010
DR   Wikidata; Q54879822
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004099c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SIRT2 (-) 1
AC   CVCL_TL27
SY   HZGHC000803c006; SIRT2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL27
DR   Horizon_Discovery; HZGHC000803c006
DR   Wikidata; Q54879823
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT2 (-) 2
AC   CVCL_TL28
SY   HZGHC000803c008; SIRT2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TL28
DR   Horizon_Discovery; HZGHC000803c008
DR   Wikidata; Q54879824
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT2 (-) 3
AC   CVCL_TL29
SY   HZGHC000804c004; SIRT2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL29
DR   Horizon_Discovery; HZGHC000804c004
DR   Wikidata; Q54879825
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT3 (-) 1
AC   CVCL_TL30
SY   HZGHC001009c002; SIRT3 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TL30
DR   Horizon_Discovery; HZGHC001009c002
DR   Wikidata; Q54879826
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT3 (-) 2
AC   CVCL_TL31
SY   HZGHC001009c012; SIRT3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL31
DR   Horizon_Discovery; HZGHC001009c012
DR   Wikidata; Q54879827
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT4 (-) 1
AC   CVCL_TL32
SY   HZGHC001002c001; SIRT4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL32
DR   Horizon_Discovery; HZGHC001002c001
DR   Wikidata; Q54879828
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14932; SIRT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT4 (-) 2
AC   CVCL_TL33
SY   HZGHC001002c002; SIRT4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TL33
DR   Horizon_Discovery; HZGHC001002c002
DR   Wikidata; Q54879829
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14932; SIRT4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT5 (-)
AC   CVCL_TL34
SY   HZGHC001004c009; SIRT5 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TL34
DR   Horizon_Discovery; HZGHC001004c009
DR   Wikidata; Q54879830
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14933; SIRT5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT6 (-) 1
AC   CVCL_TL35
SY   HZGHC001005c004; SIRT6 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_TL35
DR   Horizon_Discovery; HZGHC001005c004
DR   Wikidata; Q54879831
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT6 (-) 2
AC   CVCL_TL36
SY   HZGHC001005c010; SIRT6 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TL36
DR   Horizon_Discovery; HZGHC001005c010
DR   Wikidata; Q54879832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SIRT7 (-)
AC   CVCL_TL37
SY   HZGHC002412c004; SIRT7 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TL37
DR   Horizon_Discovery; HZGHC002412c004
DR   Wikidata; Q54879833
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14935; SIRT7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SKIV2L (-) 1
AC   CVCL_E2K4
SY   HZGHC008251c009; SKIV2L knockout cell line 10bp deletion in exon 11
DR   Horizon_Discovery; HZGHC008251c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10898; SKIC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SKIV2L (-) 2
AC   CVCL_E2K5
SY   HZGHC008252c012; SKIV2L knockout cell line 1bp deletion in exon 16
DR   Horizon_Discovery; HZGHC008252c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10898; SKIC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SKOR1 (-) 1
AC   CVCL_TL38
SY   HZGHC006614c012; SKOR1 knockout cell line 1bp insertion; HAP1 SKOR1 (-)
DR   cancercelllines; CVCL_TL38
DR   Horizon_Discovery; HZGHC006614c012
DR   Wikidata; Q54879834
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21326; SKOR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006614c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SKOR1 (-) 2
AC   CVCL_XS82
SY   HZGHC006614c003; SKOR1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS82
DR   Horizon_Discovery; HZGHC006614c003
DR   Wikidata; Q93966233
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21326; SKOR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006614c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SKOR1 (-) 3
AC   CVCL_XS83
SY   HZGHC006614c009; SKOR1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XS83
DR   Horizon_Discovery; HZGHC006614c009
DR   Wikidata; Q93966235
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21326; SKOR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006614c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SKP2 (-) 1
AC   CVCL_TL39
SY   HZGHC005193c001; SKP2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TL39
DR   Horizon_Discovery; HZGHC005193c001
DR   Wikidata; Q54879835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005193c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SKP2 (-) 2
AC   CVCL_TL40
SY   HZGHC005193c012; SKP2 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TL40
DR   Horizon_Discovery; HZGHC005193c012
DR   Wikidata; Q54879836
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005193c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC10A3 (-)
AC   CVCL_TL41
SY   HZGHC005854c005; SLC10A3 knockout cell line 104bp deletion
DR   cancercelllines; CVCL_TL41
DR   Horizon_Discovery; HZGHC005854c005
DR   Wikidata; Q54879837
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22979; SLC10A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC10A4 (-) 1
AC   CVCL_TL42
SY   HZGHC005503c007; SLC10A4 knockout cell line 1bp insertion; HAP1 SLC10A4 (-)
DR   cancercelllines; CVCL_TL42
DR   Horizon_Discovery; HZGHC005503c007
DR   Wikidata; Q54879839
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22980; SLC10A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC10A4 (-) 2
AC   CVCL_XS84
SY   HZGHC005503c009; SLC10A4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XS84
DR   Horizon_Discovery; HZGHC005503c009
DR   Wikidata; Q93966255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22980; SLC10A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC10A7 (-) 1
AC   CVCL_TL43
SY   HZGHC005271c001; SLC10A7 knockout cell line 1bp insertion; HAP1 SLC10A7 (-)
DR   cancercelllines; CVCL_TL43
DR   Horizon_Discovery; HZGHC005271c001
DR   Wikidata; Q54879840
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23088; SLC10A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC10A7 (-) 2
AC   CVCL_XS85
SY   HZGHC005271c011; SLC10A7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS85
DR   Horizon_Discovery; HZGHC005271c011
DR   Wikidata; Q93966261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23088; SLC10A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005271c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC10A7 (-) 3
AC   CVCL_XS86
SY   HZGHC005272c003; SLC10A7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XS86
DR   Horizon_Discovery; HZGHC005272c003
DR   Wikidata; Q93966263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23088; SLC10A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC10A7 (-) 4
AC   CVCL_XS87
SY   HZGHC005272c010; SLC10A7 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_XS87
DR   Horizon_Discovery; HZGHC005272c010
DR   Wikidata; Q93966265
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23088; SLC10A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC11A2 (-) 1
AC   CVCL_TL44
SY   HZGHC004052c003; SLC11A2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TL44
DR   Horizon_Discovery; HZGHC004052c003
DR   Wikidata; Q54879841
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10908; SLC11A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC11A2 (-) 2
AC   CVCL_TL45
SY   HZGHC004052c004; SLC11A2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TL45
DR   Horizon_Discovery; HZGHC004052c004
DR   Wikidata; Q54879842
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10908; SLC11A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC11A2 (-) 3
AC   CVCL_TL46
AS   CVCL_TM81
SY   HZGHC001897c011; SLC11A2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL46
DR   Horizon_Discovery; HZGHC001897c011
DR   Wikidata; Q54879843
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10908; SLC11A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC12A2 (-) 4
AC   CVCL_TL47
SY   HZGHC002848c001; SLC12A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL47
DR   Horizon_Discovery; HZGHC002848c001
DR   Wikidata; Q54879844
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10911; SLC12A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A2 (-) 5
AC   CVCL_TL48
SY   HZGHC002848c002; SLC12A2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL48
DR   Horizon_Discovery; HZGHC002848c002
DR   Wikidata; Q54879846
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10911; SLC12A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A2 (-) 6
AC   CVCL_TL49
SY   HZGHC002848c011; SLC12A2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TL49
DR   Horizon_Discovery; HZGHC002848c011
DR   Wikidata; Q54879847
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10911; SLC12A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A4 (-) 1
AC   CVCL_TL50
SY   HZGHC001720c006; SLC12A4 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL50
DR   Horizon_Discovery; HZGHC001720c006
DR   Wikidata; Q54879848
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10913; SLC12A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A4 (-) 2
AC   CVCL_TL51
SY   HZGHC001720c007; SLC12A4 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TL51
DR   Horizon_Discovery; HZGHC001720c007
DR   Wikidata; Q54879849
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10913; SLC12A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A5 (-) 1
AC   CVCL_TL52
SY   HZGHC001825c001; SLC12A5 knockout cell line 10bp insertion
DR   cancercelllines; CVCL_TL52
DR   Horizon_Discovery; HZGHC001825c001
DR   Wikidata; Q54879850
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13818; SLC12A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A5 (-) 2
AC   CVCL_TL53
SY   HZGHC001825c004; SLC12A5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TL53
DR   Horizon_Discovery; HZGHC001825c004
DR   Wikidata; Q54879851
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13818; SLC12A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A6 (-)
AC   CVCL_TL54
SY   HZGHC001702c002; SLC12A6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TL54
DR   Horizon_Discovery; HZGHC001702c002
DR   Wikidata; Q54879852
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10914; SLC12A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A7 (-) 1
AC   CVCL_TL55
SY   HZGHC001697c005; SLC12A7 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TL55
DR   Horizon_Discovery; HZGHC001697c005
DR   Wikidata; Q54879853
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10915; SLC12A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A7 (-) 2
AC   CVCL_TL56
SY   HZGHC001697c006; SLC12A7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL56
DR   Horizon_Discovery; HZGHC001697c006
DR   Wikidata; Q54879858
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10915; SLC12A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A9 (-) 1
AC   CVCL_TL57
SY   HZGHC001677c001; SLC12A9 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TL57
DR   Horizon_Discovery; HZGHC001677c001
DR   Wikidata; Q54879859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17435; SLC12A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC12A9 (-) 2
AC   CVCL_TL58
SY   HZGHC001677c012; SLC12A9 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL58
DR   Horizon_Discovery; HZGHC001677c012
DR   Wikidata; Q54879860
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17435; SLC12A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC15A4 (-) 1
AC   CVCL_TL59
SY   HZGHC002530c001; SLC15A4 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_TL59
DR   Horizon_Discovery; HZGHC002530c001
DR   Wikidata; Q54879861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC15A4 (-) 2
AC   CVCL_TL60
SY   HZGHC002530c002; SLC15A4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TL60
DR   Horizon_Discovery; HZGHC002530c002
DR   Wikidata; Q54879862
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A1 (-) 1
AC   CVCL_TL61
SY   HZGHC002882c002; SLC16A1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TL61
DR   Horizon_Discovery; HZGHC002882c002
DR   Wikidata; Q54879863
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10922; SLC16A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A1 (-) 2
AC   CVCL_TL62
SY   HZGHC002882c010; SLC16A1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TL62
DR   Horizon_Discovery; HZGHC002882c010
DR   Wikidata; Q54879864
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10922; SLC16A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A10 (-) 1
AC   CVCL_TL63
SY   HZGHC002232c004; SLC16A10 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TL63
DR   Horizon_Discovery; HZGHC002232c004
DR   Wikidata; Q54879865
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17027; SLC16A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A10 (-) 2
AC   CVCL_TL64
SY   HZGHC002232c007; SLC16A10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TL64
DR   Horizon_Discovery; HZGHC002232c007
DR   Wikidata; Q54879867
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17027; SLC16A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A13 (-)
AC   CVCL_TL65
SY   HZGHC002176c010; SLC16A13 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL65
DR   Horizon_Discovery; HZGHC002176c010
DR   Wikidata; Q54879868
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31037; SLC16A13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A14 (-)
AC   CVCL_TL66
SY   HZGHC005504c008; SLC16A14 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TL66
DR   Horizon_Discovery; HZGHC005504c008
DR   Wikidata; Q54879869
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26417; SLC16A14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A2 (-) 1
AC   CVCL_TL67
SY   HZGHC005853c010; SLC16A2 knockout cell line 25bp deletion; HAP1 SLC16A2 (-)
DR   cancercelllines; CVCL_TL67
DR   Horizon_Discovery; HZGHC005853c010
DR   Wikidata; Q54879870
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10923; SLC16A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005853c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC16A2 (-) 2
AC   CVCL_XS88
SY   HZGHC005853c005; SLC16A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XS88
DR   Horizon_Discovery; HZGHC005853c005
DR   Wikidata; Q93966369
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10923; SLC16A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005853c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC16A3 (-) 1
AC   CVCL_TL68
SY   HZGHC001844c001; SLC16A3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL68
DR   Horizon_Discovery; HZGHC001844c001
DR   Wikidata; Q54879871
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10924; SLC16A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A3 (-) 2
AC   CVCL_TL69
SY   HZGHC001844c010; SLC16A3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TL69
DR   Horizon_Discovery; HZGHC001844c010
DR   Wikidata; Q54879872
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10924; SLC16A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC16A9 (-) 1
AC   CVCL_TL70
SY   HZGHC005506c004; SLC16A9 knockout cell line 19bp deletion; HAP1 SLC16A9 (-)
DR   cancercelllines; CVCL_TL70
DR   Horizon_Discovery; HZGHC005506c004
DR   Wikidata; Q54879873
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23520; SLC16A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC16A9 (-) 2
AC   CVCL_XS89
SY   HZGHC005506c005; SLC16A9 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XS89
DR   Horizon_Discovery; HZGHC005506c005
DR   Wikidata; Q93966425
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23520; SLC16A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC17A5 (-) 1
AC   CVCL_TL71
SY   HZGHC002214c006; SLC17A5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL71
DR   Horizon_Discovery; HZGHC002214c006
DR   Wikidata; Q54879874
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC17A5 (-) 2
AC   CVCL_TL72
SY   HZGHC002214c012; SLC17A5 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TL72
DR   Horizon_Discovery; HZGHC002214c012
DR   Wikidata; Q54879875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC17A9 (-)
AC   CVCL_TL73
SY   HZGHC002153c005; SLC17A9 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TL73
DR   Horizon_Discovery; HZGHC002153c005
DR   Wikidata; Q54879876
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16192; SLC17A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC18A2 (-) 1
AC   CVCL_TL74
SY   HZGHC003918c008; SLC18A2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TL74
DR   Horizon_Discovery; HZGHC003918c008
DR   Wikidata; Q54879877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10935; SLC18A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC18A2 (-) 2
AC   CVCL_TL75
SY   HZGHC003918c011; SLC18A2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TL75
DR   Horizon_Discovery; HZGHC003918c011
DR   Wikidata; Q54879879
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10935; SLC18A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC18B1 (-) 1
AC   CVCL_TL76
SY   HZGHC005507c011; SLC18B1 knockout cell line 20bp deletion; HAP1 SLC18B1 (-)
DR   cancercelllines; CVCL_TL76
DR   Horizon_Discovery; HZGHC005507c011
DR   Wikidata; Q54879880
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21573; SLC18B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC18B1 (-) 2
AC   CVCL_XS90
SY   HZGHC005507c012; SLC18B1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XS90
DR   Horizon_Discovery; HZGHC005507c012
DR   Wikidata; Q93966544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21573; SLC18B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC19A1 (-) 1
AC   CVCL_TL77
SY   HZGHC001771c002; SLC19A1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TL77
DR   Horizon_Discovery; HZGHC001771c002
DR   Wikidata; Q54879881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10937; SLC19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC19A1 (-) 2
AC   CVCL_TL78
SY   HZGHC001771c012; SLC19A1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TL78
DR   Horizon_Discovery; HZGHC001771c012
DR   Wikidata; Q54879882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10937; SLC19A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC19A2 (-) 1
AC   CVCL_TL79
SY   HZGHC001936c006; SLC19A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL79
DR   Horizon_Discovery; HZGHC001936c006
DR   Wikidata; Q54879883
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10938; SLC19A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC19A2 (-) 2
AC   CVCL_TL80
SY   HZGHC001936c008; SLC19A2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TL80
DR   Horizon_Discovery; HZGHC001936c008
DR   Wikidata; Q54879884
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10938; SLC19A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC19A3 (-) 1
AC   CVCL_TL81
SY   HZGHC005508c010; SLC19A3 knockout cell line 7bp deletion; HAP1 SLC19A3 (-)
DR   cancercelllines; CVCL_TL81
DR   Horizon_Discovery; HZGHC005508c010
DR   Wikidata; Q54879885
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16266; SLC19A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC19A3 (-) 2
AC   CVCL_XS91
SY   HZGHC005508c006; SLC19A3 knockout cell line 127bp insertion
DR   cancercelllines; CVCL_XS91
DR   Horizon_Discovery; HZGHC005508c006
DR   Wikidata; Q93966612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16266; SLC19A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005508c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC1A1 (-)
AC   CVCL_TL82
SY   HZGHC005457c004; SLC1A1 knockout cell line 227bp insertion
DR   cancercelllines; CVCL_TL82
DR   Horizon_Discovery; HZGHC005457c004
DR   Wikidata; Q54879886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10939; SLC1A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005457c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC1A3 (-) 1
AC   CVCL_TL83
SY   HZGHC001578c010; SLC1A3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TL83
DR   Horizon_Discovery; HZGHC001578c010
DR   Wikidata; Q54879887
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10941; SLC1A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC1A3 (-) 2
AC   CVCL_TL84
SY   HZGHC001578c011; SLC1A3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TL84
DR   Horizon_Discovery; HZGHC001578c011
DR   Wikidata; Q54879889
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10941; SLC1A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC1A4 (-)
AC   CVCL_TL85
SY   HZGHC001585c002; SLC1A4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TL85
DR   Horizon_Discovery; HZGHC001585c002
DR   Wikidata; Q54879890
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10942; SLC1A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC1A5 (-) 1
AC   CVCL_TL86
SY   HZGHC004512c005; SLC1A5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TL86
DR   Horizon_Discovery; HZGHC004512c005
DR   Wikidata; Q54879891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC1A5 (-) 2
AC   CVCL_TL87
SY   HZGHC004512c006; SLC1A5 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TL87
DR   Horizon_Discovery; HZGHC004512c006
DR   Wikidata; Q54879892
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC1A5 (-) 3
AC   CVCL_TL88
SY   HZGHC004543c006; SLC1A5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL88
DR   Horizon_Discovery; HZGHC004543c006
DR   Wikidata; Q54879893
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC20A1 (-) 1
AC   CVCL_TL89
SY   HZGHC005018c003; SLC20A1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TL89
DR   Horizon_Discovery; HZGHC005018c003
DR   Wikidata; Q54879894
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10946; SLC20A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC20A1 (-) 2
AC   CVCL_TL90
SY   HZGHC005019c004; SLC20A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL90
DR   Horizon_Discovery; HZGHC005019c004
DR   Wikidata; Q54879895
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10946; SLC20A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC20A2 (-) 1
AC   CVCL_TL91
SY   HZGHC002158c003; SLC20A2 knockout cell line 122bp insertion; HAP1 SLC20A2 (-)
DR   cancercelllines; CVCL_TL91
DR   Horizon_Discovery; HZGHC002158c003
DR   Wikidata; Q54879896
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002158c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC20A2 (-) 2
AC   CVCL_XS92
SY   HZGHC005437c007; SLC20A2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XS92
DR   Horizon_Discovery; HZGHC005437c007
DR   Wikidata; Q93966676
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC20A2 (-) 3
AC   CVCL_XS93
SY   HZGHC005437c010; SLC20A2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_XS93
DR   Horizon_Discovery; HZGHC005437c010
DR   Wikidata; Q93966679
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC20A2 (-) 4
AC   CVCL_XS94
SY   HZGHC005438c010; SLC20A2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XS94
DR   Horizon_Discovery; HZGHC005438c010
DR   Wikidata; Q93966682
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC20A2 (-) 5
AC   CVCL_XS95
SY   HZGHC005438c011; SLC20A2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XS95
DR   Horizon_Discovery; HZGHC005438c011
DR   Wikidata; Q93966685
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A1 (-) 1
AC   CVCL_TL92
SY   HZGHC004518c001; SLC22A1 knockout cell line 49bp deletion
DR   cancercelllines; CVCL_TL92
DR   Horizon_Discovery; HZGHC004518c001
DR   Wikidata; Q54879897
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10963; SLC22A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A1 (-) 2
AC   CVCL_TL93
SY   HZGHC004518c003; SLC22A1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TL93
DR   Horizon_Discovery; HZGHC004518c003
DR   Wikidata; Q54879898
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10963; SLC22A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A1 (-) 3
AC   CVCL_TL94
SY   HZGHC004572c009; SLC22A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TL94
DR   Horizon_Discovery; HZGHC004572c009
DR   Wikidata; Q54879899
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10963; SLC22A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A1 (-) 4
AC   CVCL_TL95
SY   HZGHC004572c011; SLC22A1 knockout cell line 65bp deletion
DR   cancercelllines; CVCL_TL95
DR   Horizon_Discovery; HZGHC004572c011
DR   Wikidata; Q54879900
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10963; SLC22A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A15 (-) 1
AC   CVCL_TL96
SY   HZGHC005509c008; SLC22A15 knockout cell line 2bp insertion; HAP1 SLC22A15 (-)
DR   cancercelllines; CVCL_TL96
DR   Horizon_Discovery; HZGHC005509c008
DR   Wikidata; Q54879904
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20301; SLC22A15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC22A15 (-) 2
AC   CVCL_XS96
SY   HZGHC005509c009; SLC22A15 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XS96
DR   Horizon_Discovery; HZGHC005509c009
DR   Wikidata; Q93966717
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20301; SLC22A15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A18 (-) 1
AC   CVCL_TL97
SY   HZGHC001911c002; SLC22A18 knockout cell line 190bp insertion
DR   cancercelllines; CVCL_TL97
DR   Horizon_Discovery; HZGHC001911c002
DR   Wikidata; Q54879905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10964; SLC22A18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001911c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC22A18 (-) 2
AC   CVCL_TL98
SY   HZGHC001911c011; SLC22A18 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TL98
DR   Horizon_Discovery; HZGHC001911c011
DR   Wikidata; Q54879906
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10964; SLC22A18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A23 (-) 1
AC   CVCL_TL99
SY   HZGHC005510c001; SLC22A23 knockout cell line 1bp insertion; HAP1 SLC22A23 (-)
DR   cancercelllines; CVCL_TL99
DR   Horizon_Discovery; HZGHC005510c001
DR   Wikidata; Q54879907
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21106; SLC22A23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC22A23 (-) 2
AC   CVCL_XS97
SY   HZGHC005510c012; SLC22A23 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XS97
DR   Horizon_Discovery; HZGHC005510c012
DR   Wikidata; Q93966736
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21106; SLC22A23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC22A5 (-)
AC   CVCL_TM00
SY   HZGHC002234c003; SLC22A5 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_TM00
DR   Horizon_Discovery; HZGHC002234c003
DR   Wikidata; Q54879909
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10969; SLC22A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC23A2 (-) 1
AC   CVCL_TM01
SY   HZGHC005511c001; SLC23A2 knockout cell line 7bp deletion; HAP1 SLC23A2 (-)
DR   cancercelllines; CVCL_TM01
DR   Horizon_Discovery; HZGHC005511c001
DR   Wikidata; Q54879910
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10973; SLC23A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC23A2 (-) 2
AC   CVCL_XS98
SY   HZGHC005511c006; SLC23A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XS98
DR   Horizon_Discovery; HZGHC005511c006
DR   Wikidata; Q93966748
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10973; SLC23A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC24A1 (-) 1
AC   CVCL_TM02
SY   HZGHC005512c004; SLC24A1 knockout cell line 1bp insertion; HAP1 SLC24A1 (-)
DR   cancercelllines; CVCL_TM02
DR   Horizon_Discovery; HZGHC005512c004
DR   Wikidata; Q54879911
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10975; SLC24A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005512c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC24A1 (-) 2
AC   CVCL_XT00
SY   HZGHC005512c009; SLC24A1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XT00
DR   Horizon_Discovery; HZGHC005512c009
DR   Wikidata; Q93966754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10975; SLC24A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005512c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A1 (-) 1
AC   CVCL_TM03
SY   HZGHC001753c002; SLC25A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM03
DR   Horizon_Discovery; HZGHC001753c002
DR   Wikidata; Q54879912
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10979; SLC25A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001753c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A1 (-) 2
AC   CVCL_TM04
SY   HZGHC001753c003; SLC25A1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TM04
DR   Horizon_Discovery; HZGHC001753c003
DR   Wikidata; Q54879913
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10979; SLC25A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A1 (-) 3
AC   CVCL_TM05
SY   HZGHC001753c010; SLC25A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM05
DR   Horizon_Discovery; HZGHC001753c010
DR   Wikidata; Q54879914
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10979; SLC25A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A10 (-) 1
AC   CVCL_TM06
SY   HZGHC000790c001; SLC25A10 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM06
DR   Horizon_Discovery; HZGHC000790c001
DR   Wikidata; Q54879915
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10980; SLC25A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A10 (-) 2
AC   CVCL_TM07
SY   HZGHC000790c002; SLC25A10 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TM07
DR   Horizon_Discovery; HZGHC000790c002
DR   Wikidata; Q54879916
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10980; SLC25A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A11 (-) 1
AC   CVCL_TM08
SY   HZGHC002127c010; SLC25A11 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TM08
DR   Horizon_Discovery; HZGHC002127c010
DR   Wikidata; Q54879917
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10981; SLC25A11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A11 (-) 2
AC   CVCL_TM09
SY   HZGHC002127c012; SLC25A11 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TM09
DR   Horizon_Discovery; HZGHC002127c012
DR   Wikidata; Q54879918
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10981; SLC25A11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A12 (-) 1
AC   CVCL_TM10
SY   HZGHC001735c010; SLC25A12 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM10
DR   Horizon_Discovery; HZGHC001735c010
DR   Wikidata; Q54879919
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10982; SLC25A12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A12 (-) 2
AC   CVCL_TM11
SY   HZGHC001735c011; SLC25A12 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM11
DR   Horizon_Discovery; HZGHC001735c011
DR   Wikidata; Q54879920
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10982; SLC25A12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A13 (-)
AC   CVCL_TM12
SY   HZGHC000789c001; SLC25A13 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TM12
DR   Horizon_Discovery; HZGHC000789c001
DR   Wikidata; Q54879921
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10983; SLC25A13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A14 (-) 1
AC   CVCL_TM13
SY   HZGHC002074c009; SLC25A14 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TM13
DR   Horizon_Discovery; HZGHC002074c009
DR   Wikidata; Q54879922
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10984; SLC25A14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A14 (-) 2
AC   CVCL_TM14
SY   HZGHC002074c010; SLC25A14 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TM14
DR   Horizon_Discovery; HZGHC002074c010
DR   Wikidata; Q54879923
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10984; SLC25A14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A15 (-) 1
AC   CVCL_TM15
SY   HZGHC000797c002; SLC25A15 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM15
DR   Horizon_Discovery; HZGHC000797c002
DR   Wikidata; Q54879924
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10985; SLC25A15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A15 (-) 2
AC   CVCL_TM16
SY   HZGHC000797c004; SLC25A15 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TM16
DR   Horizon_Discovery; HZGHC000797c004
DR   Wikidata; Q54879925
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10985; SLC25A15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A17 (-) 1
AC   CVCL_TM17
SY   HZGHC002268c006; SLC25A17 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM17
DR   Horizon_Discovery; HZGHC002268c006
DR   Wikidata; Q54879926
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10987; SLC25A17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A17 (-) 2
AC   CVCL_TM18
SY   HZGHC002268c007; SLC25A17 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TM18
DR   Horizon_Discovery; HZGHC002268c007
DR   Wikidata; Q54879927
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10987; SLC25A17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A18 (-) 1
AC   CVCL_TM19
SY   HZGHC001981c002; SLC25A18 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TM19
DR   Horizon_Discovery; HZGHC001981c002
DR   Wikidata; Q54879928
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10988; SLC25A18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A18 (-) 2
AC   CVCL_TM20
SY   HZGHC001981c011; SLC25A18 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM20
DR   Horizon_Discovery; HZGHC001981c011
DR   Wikidata; Q54879930
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10988; SLC25A18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A20 (-) 1
AC   CVCL_TM21
SY   HZGHC000787c003; SLC25A20 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TM21
DR   Horizon_Discovery; HZGHC000787c003
DR   Wikidata; Q54879931
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1421; SLC25A20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A20 (-) 2
AC   CVCL_TM22
SY   HZGHC000787c004; SLC25A20 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM22
DR   Horizon_Discovery; HZGHC000787c004
DR   Wikidata; Q54879932
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1421; SLC25A20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A22 (-)
AC   CVCL_TM23
SY   HZGHC000791c004; SLC25A22 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM23
DR   Horizon_Discovery; HZGHC000791c004
DR   Wikidata; Q54879933
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19954; SLC25A22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A23 (-) 1
AC   CVCL_TM24
SY   HZGHC005513c001; SLC25A23 knockout cell line 1bp insertion; HAP1 SLC25A23 (-)
DR   cancercelllines; CVCL_TM24
DR   Horizon_Discovery; HZGHC005513c001
DR   Wikidata; Q54879934
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19375; SLC25A23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A23 (-) 2
AC   CVCL_XT01
SY   HZGHC005513c011; SLC25A23 knockout cell line 190bp insertion
DR   cancercelllines; CVCL_XT01
DR   Horizon_Discovery; HZGHC005513c011
DR   Wikidata; Q93967043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19375; SLC25A23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005513c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A23 (-) 3
AC   CVCL_XT02
SY   HZGHC005513c012; SLC25A23 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT02
DR   Horizon_Discovery; HZGHC005513c012
DR   Wikidata; Q93967046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19375; SLC25A23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005513c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A24 (-) 1
AC   CVCL_TM25
SY   HZGHC005514c001; SLC25A24 knockout cell line 1bp deletion; HAP1 SLC25A24 (-)
DR   cancercelllines; CVCL_TM25
DR   Horizon_Discovery; HZGHC005514c001
DR   Wikidata; Q54879935
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20662; SLC25A24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A24 (-) 2
AC   CVCL_XT03
SY   HZGHC005514c003; SLC25A24 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT03
DR   Horizon_Discovery; HZGHC005514c003
DR   Wikidata; Q93967058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20662; SLC25A24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A25 (-) 1
AC   CVCL_TM26
SY   HZGHC001999c001; SLC25A25 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM26
DR   Horizon_Discovery; HZGHC001999c001
DR   Wikidata; Q54879936
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20663; SLC25A25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A25 (-) 2
AC   CVCL_TM27
SY   HZGHC001999c003; SLC25A25 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TM27
DR   Horizon_Discovery; HZGHC001999c003
DR   Wikidata; Q54879937
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20663; SLC25A25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A28 (-) 1
AC   CVCL_TM28
SY   HZGHC005516c002; SLC25A28 knockout cell line 16bp deletion; HAP1 SLC25A28 (-)
DR   cancercelllines; CVCL_TM28
DR   Horizon_Discovery; HZGHC005516c002
DR   Wikidata; Q54879938
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A28 (-) 2
AC   CVCL_XT04
SY   HZGHC005516c004; SLC25A28 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XT04
DR   Horizon_Discovery; HZGHC005516c004
DR   Wikidata; Q93967088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A29 (-)
AC   CVCL_TM29
SY   HZGHC002012c004; SLC25A29 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_TM29
DR   Horizon_Discovery; HZGHC002012c004
DR   Wikidata; Q54879939
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20116; SLC25A29.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A3 (-) 1
AC   CVCL_TM30
SY   HZGHC000792c006; SLC25A3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM30
DR   Horizon_Discovery; HZGHC000792c006
DR   Wikidata; Q54879940
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10989; SLC25A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000792c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A3 (-) 2
AC   CVCL_TM31
SY   HZGHC000792c010; SLC25A3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM31
DR   Horizon_Discovery; HZGHC000792c010
DR   Wikidata; Q54879941
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10989; SLC25A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000792c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A30 (-)
AC   CVCL_TM32
SY   HZGHC002288c001; SLC25A30 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM32
DR   Horizon_Discovery; HZGHC002288c001
DR   Wikidata; Q54879943
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27371; SLC25A30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A32 (-)
AC   CVCL_TM33
SY   HZGHC001715c010; SLC25A32 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TM33
DR   Horizon_Discovery; HZGHC001715c010
DR   Wikidata; Q54879944
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29683; SLC25A32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A33 (-) 1
AC   CVCL_TM34
SY   HZGHC001971c006; SLC25A33 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TM34
DR   Horizon_Discovery; HZGHC001971c006
DR   Wikidata; Q54879945
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29681; SLC25A33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A33 (-) 2
AC   CVCL_TM35
SY   HZGHC001971c010; SLC25A33 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TM35
DR   Horizon_Discovery; HZGHC001971c010
DR   Wikidata; Q54879946
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29681; SLC25A33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A35 (-)
AC   CVCL_TM36
SY   HZGHC002183c011; SLC25A35 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM36
DR   Horizon_Discovery; HZGHC002183c011
DR   Wikidata; Q54879948
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31921; SLC25A35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A36 (-)
AC   CVCL_TM37
SY   HZGHC002039c004; SLC25A36 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TM37
DR   Horizon_Discovery; HZGHC002039c004
DR   Wikidata; Q54879949
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25554; SLC25A36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A37 (-) 1
AC   CVCL_TM38
SY   HZGHC001952c001; SLC25A37 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM38
DR   Horizon_Discovery; HZGHC001952c001
DR   Wikidata; Q54879950
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29786; SLC25A37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A37 (-) 2
AC   CVCL_TM39
SY   HZGHC001952c010; SLC25A37 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM39
DR   Horizon_Discovery; HZGHC001952c010
DR   Wikidata; Q54879951
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29786; SLC25A37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A38 (-)
AC   CVCL_TM40
SY   HZGHC002134c011; SLC25A38 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM40
DR   Horizon_Discovery; HZGHC002134c011
DR   Wikidata; Q54879952
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26054; SLC25A38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A39 (-) 1
AC   CVCL_TM41
SY   HZGHC002113c011; SLC25A39 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM41
DR   Horizon_Discovery; HZGHC002113c011
DR   Wikidata; Q54879953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24279; SLC25A39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002113c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A39 (-) 2
AC   CVCL_TM42
SY   HZGHC002113c003; SLC25A39 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM42
DR   Horizon_Discovery; HZGHC002113c003
DR   Wikidata; Q54879954
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24279; SLC25A39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A39 (-) 3
AC   CVCL_TM43
SY   HZGHC002113c010; SLC25A39 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM43
DR   Horizon_Discovery; HZGHC002113c010
DR   Wikidata; Q54879955
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24279; SLC25A39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A4 (-) 1
AC   CVCL_TM44
SY   HZGHC000778c005; SLC25A4 knockout cell line 56bp insertion
DR   cancercelllines; CVCL_TM44
DR   Horizon_Discovery; HZGHC000778c005
DR   Wikidata; Q54879956
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000778c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A4 (-) 2
AC   CVCL_TM45
SY   HZGHC000778c011; SLC25A4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM45
DR   Horizon_Discovery; HZGHC000778c011
DR   Wikidata; Q54879957
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A40 (-) 1
AC   CVCL_TM46
SY   HZGHC001757c007; SLC25A40 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM46
DR   Horizon_Discovery; HZGHC001757c007
DR   Wikidata; Q54879958
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001757c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A40 (-) 2
AC   CVCL_TM47
SY   HZGHC001757c005; SLC25A40 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TM47
DR   Horizon_Discovery; HZGHC001757c005
DR   Wikidata; Q54879959
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A40 (-) 3
AC   CVCL_TM48
SY   HZGHC001757c012; SLC25A40 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM48
DR   Horizon_Discovery; HZGHC001757c012
DR   Wikidata; Q54879960
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A42 (-) 1
AC   CVCL_TM49
SY   HZGHC005525c006; SLC25A42 knockout cell line 1bp insertion; HAP1 SLC25A42 (-)
DR   cancercelllines; CVCL_TM49
DR   Horizon_Discovery; HZGHC005525c006
DR   Wikidata; Q54879961
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28380; SLC25A42.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A42 (-) 2
AC   CVCL_XT05
SY   HZGHC005525c009; SLC25A42 knockout cell line 482bp insertion
DR   cancercelllines; CVCL_XT05
DR   Horizon_Discovery; HZGHC005525c009
DR   Wikidata; Q93967395
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28380; SLC25A42.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005525c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A43 (-) 1
AC   CVCL_TM50
SY   HZGHC005527c010; SLC25A43 knockout cell line 2bp deletion; HAP1 SLC25A43 (-)
DR   cancercelllines; CVCL_TM50
DR   Horizon_Discovery; HZGHC005527c010
DR   Wikidata; Q54879962
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30557; SLC25A43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A43 (-) 2
AC   CVCL_XT06
SY   HZGHC005527c003; SLC25A43 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XT06
DR   Horizon_Discovery; HZGHC005527c003
DR   Wikidata; Q93967411
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30557; SLC25A43.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A44 (-) 1
AC   CVCL_TM51
SY   HZGHC005526c010; SLC25A44 knockout cell line 7bp deletion; HAP1 SLC25A44 (-)
DR   cancercelllines; CVCL_TM51
DR   Horizon_Discovery; HZGHC005526c010
DR   Wikidata; Q54879963
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29036; SLC25A44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A44 (-) 2
AC   CVCL_XT07
SY   HZGHC005526c004; SLC25A44 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT07
DR   Horizon_Discovery; HZGHC005526c004
DR   Wikidata; Q93967426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29036; SLC25A44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A45 (-)
AC   CVCL_TM52
SY   HZGHC005528c008; SLC25A45 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TM52
DR   Horizon_Discovery; HZGHC005528c008
DR   Wikidata; Q54879964
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27442; SLC25A45.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A46 (-) 1
AC   CVCL_TM53
SY   HZGHC000793c002; SLC25A46 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TM53
DR   Horizon_Discovery; HZGHC000793c002
DR   Wikidata; Q54879965
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25198; SLC25A46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A46 (-) 2
AC   CVCL_TM54
SY   HZGHC000793c010; SLC25A46 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM54
DR   Horizon_Discovery; HZGHC000793c010
DR   Wikidata; Q54879966
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25198; SLC25A46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A5 (-)
AC   CVCL_TM55
SY   HZGHC000779c002; SLC25A5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TM55
DR   Horizon_Discovery; HZGHC000779c002
DR   Wikidata; Q54879967
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A51 (-) 1
AC   CVCL_TM56
SY   HZGHC001927c010; SLC25A51 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TM56
DR   Horizon_Discovery; HZGHC001927c010
DR   Wikidata; Q54879968
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23323; SLC25A51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A51 (-) 2
AC   CVCL_TM57
SY   HZGHC001927c011; SLC25A51 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM57
DR   Horizon_Discovery; HZGHC001927c011
DR   Wikidata; Q54879969
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23323; SLC25A51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC25A6 (-) 1
AC   CVCL_TM58
SY   HZGHC000780c011; SLC25A6 knockout cell line 232bp insertion; HAP1 SLC25A6 (-)
DR   cancercelllines; CVCL_TM58
DR   Horizon_Discovery; HZGHC000780c011
DR   Wikidata; Q54879970
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10992; SLC25A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000780c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC25A6 (-) 2
AC   CVCL_E2K6
SY   HZGHC000780c028; SLC25A6 knockout cell line 19bp deletion in exon 1
DR   Horizon_Discovery; HZGHC000780c028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10992; SLC25A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SLC26A10 (-) 1
AC   CVCL_XT08
SY   HZGHC005529c011; SLC26A10 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XT08
DR   Horizon_Discovery; HZGHC005529c011
DR   Wikidata; Q93967486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14470; SLC26A10P.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC26A10 (-) 2
AC   CVCL_XT09
SY   HZGHC005529c012; SLC26A10 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_XT09
DR   Horizon_Discovery; HZGHC005529c012
DR   Wikidata; Q93967488
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14470; SLC26A10P.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC26A11 (-)
AC   CVCL_TM59
SY   HZGHC002080c004; SLC26A11 knockout cell line 199bp insertion
DR   cancercelllines; CVCL_TM59
DR   Horizon_Discovery; HZGHC002080c004
DR   Wikidata; Q54879971
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14471; SLC26A11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002080c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC26A2 (-) 1
AC   CVCL_TM60
SY   HZGHC001849c006; SLC26A2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TM60
DR   Horizon_Discovery; HZGHC001849c006
DR   Wikidata; Q54879972
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10994; SLC26A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC26A2 (-) 2
AC   CVCL_TM61
SY   HZGHC001849c010; SLC26A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM61
DR   Horizon_Discovery; HZGHC001849c010
DR   Wikidata; Q54879973
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10994; SLC26A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC26A6 (-)
AC   CVCL_TM62
SY   HZGHC005530c007; SLC26A6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TM62
DR   Horizon_Discovery; HZGHC005530c007
DR   Wikidata; Q54879974
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14472; SLC26A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A1 (-) 1
AC   CVCL_TM63
SY   HZGHC001838c002; SLC27A1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TM63
DR   Horizon_Discovery; HZGHC001838c002
DR   Wikidata; Q54879975
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10995; SLC27A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A1 (-) 2
AC   CVCL_TM64
SY   HZGHC001838c011; SLC27A1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TM64
DR   Horizon_Discovery; HZGHC001838c011
DR   Wikidata; Q54879976
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10995; SLC27A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A2 (-) 1
AC   CVCL_TM65
SY   HZGHC000796c003; SLC27A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM65
DR   Horizon_Discovery; HZGHC000796c003
DR   Wikidata; Q54879977
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10996; SLC27A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A2 (-) 2
AC   CVCL_TM66
SY   HZGHC000796c004; SLC27A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM66
DR   Horizon_Discovery; HZGHC000796c004
DR   Wikidata; Q54879978
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10996; SLC27A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A2 (-) 3
AC   CVCL_TM67
SY   HZGHC000796c011; SLC27A2 knockout cell line 283bp insertion
DR   cancercelllines; CVCL_TM67
DR   Horizon_Discovery; HZGHC000796c011
DR   Wikidata; Q54879979
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10996; SLC27A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000796c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC27A3 (-)
AC   CVCL_TM68
SY   HZGHC001727c012; SLC27A3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TM68
DR   Horizon_Discovery; HZGHC001727c012
DR   Wikidata; Q54879980
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10997; SLC27A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A4 (-) 1
AC   CVCL_TM69
SY   HZGHC001656c001; SLC27A4 knockout cell line 43bp deletion
DR   cancercelllines; CVCL_TM69
DR   Horizon_Discovery; HZGHC001656c001
DR   Wikidata; Q54879981
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10998; SLC27A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A4 (-) 2
AC   CVCL_TM70
SY   HZGHC001656c002; SLC27A4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TM70
DR   Horizon_Discovery; HZGHC001656c002
DR   Wikidata; Q54879982
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10998; SLC27A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A5 (-) 1
AC   CVCL_TM71
SY   HZGHC005531c006; SLC27A5 knockout cell line 5bp insertion; HAP1 SLC27A5 (-)
DR   cancercelllines; CVCL_TM71
DR   Horizon_Discovery; HZGHC005531c006
DR   Wikidata; Q54879983
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10999; SLC27A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC27A5 (-) 2
AC   CVCL_XT10
SY   HZGHC005531c007; SLC27A5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT10
DR   Horizon_Discovery; HZGHC005531c007
DR   Wikidata; Q93967564
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10999; SLC27A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A6 (-) 1
AC   CVCL_TM72
SY   HZGHC002051c003; SLC27A6 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TM72
DR   Horizon_Discovery; HZGHC002051c003
DR   Wikidata; Q54879984
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11000; SLC27A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC27A6 (-) 2
AC   CVCL_TM73
SY   HZGHC002051c010; SLC27A6 knockout cell line 188bp deletion
DR   cancercelllines; CVCL_TM73
DR   Horizon_Discovery; HZGHC002051c010
DR   Wikidata; Q54879985
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11000; SLC27A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC29A1 (-)
AC   CVCL_TM74
SY   HZGHC000785c004; SLC29A1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TM74
DR   Horizon_Discovery; HZGHC000785c004
DR   Wikidata; Q54879986
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC29A2 (-) 1
AC   CVCL_TM75
SY   HZGHC005532c010; SLC29A2 knockout cell line 1bp insertion; HAP1 SLC29A2 (-)
DR   cancercelllines; CVCL_TM75
DR   Horizon_Discovery; HZGHC005532c010
DR   Wikidata; Q54879987
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11004; SLC29A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC29A2 (-) 2
AC   CVCL_XT11
SY   HZGHC005532c011; SLC29A2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XT11
DR   Horizon_Discovery; HZGHC005532c011
DR   Wikidata; Q93967593
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11004; SLC29A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC29A3 (-) 1
AC   CVCL_TM76
SY   HZGHC001939c007; SLC29A3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM76
DR   Horizon_Discovery; HZGHC001939c007
DR   Wikidata; Q54879992
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23096; SLC29A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC29A3 (-) 2
AC   CVCL_TM77
SY   HZGHC001939c010; SLC29A3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TM77
DR   Horizon_Discovery; HZGHC001939c010
DR   Wikidata; Q54879993
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23096; SLC29A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC29A4 (-) 1
AC   CVCL_TM78
SY   HZGHC002139c003; SLC29A4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM78
DR   Horizon_Discovery; HZGHC002139c003
DR   Wikidata; Q54879994
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23097; SLC29A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC29A4 (-) 2
AC   CVCL_TM79
SY   HZGHC002139c005; SLC29A4 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TM79
DR   Horizon_Discovery; HZGHC002139c005
DR   Wikidata; Q54879995
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23097; SLC29A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC29A4 (-) 3
AC   CVCL_TM80
SY   HZGHC002139c009; SLC29A4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM80
DR   Horizon_Discovery; HZGHC002139c009
DR   Wikidata; Q54879996
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23097; SLC29A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC2A11 (-) 1
AC   CVCL_XT12
SY   HZGHC005458c002; SLC2A11 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XT12
DR   Horizon_Discovery; HZGHC005458c002
DR   Wikidata; Q93967623
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14239; SLC2A11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC2A11 (-) 2
AC   CVCL_XT13
SY   HZGHC005458c008; SLC2A11 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT13
DR   Horizon_Discovery; HZGHC005458c008
DR   Wikidata; Q93967624
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14239; SLC2A11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC2A4RG (-)
AC   CVCL_TM82
SY   HZGHC005533c003; SLC2A4RG knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TM82
DR   Horizon_Discovery; HZGHC005533c003
DR   Wikidata; Q54879998
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15930; SLC2A4RG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC2A6 (-) 1
AC   CVCL_TM83
SY   HZGHC005485c003; SLC2A6 knockout cell line 1bp deletion; HAP1 SLC2A6 (-)
DR   cancercelllines; CVCL_TM83
DR   Horizon_Discovery; HZGHC005485c003
DR   Wikidata; Q54879999
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11011; SLC2A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC2A6 (-) 2
AC   CVCL_XT14
SY   HZGHC005485c005; SLC2A6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT14
DR   Horizon_Discovery; HZGHC005485c005
DR   Wikidata; Q93967628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11011; SLC2A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC2A8 (-) 1
AC   CVCL_TM84
SY   HZGHC002276c001; SLC2A8 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM84
DR   Horizon_Discovery; HZGHC002276c001
DR   Wikidata; Q54880000
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13812; SLC2A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC2A8 (-) 2
AC   CVCL_TM85
SY   HZGHC002276c010; SLC2A8 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TM85
DR   Horizon_Discovery; HZGHC002276c010
DR   Wikidata; Q54880001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13812; SLC2A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A1 (-)
AC   CVCL_TM86
SY   HZGHC001777c010; SLC30A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM86
DR   Horizon_Discovery; HZGHC001777c010
DR   Wikidata; Q54880002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11012; SLC30A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A10 (-) 1
AC   CVCL_TM87
SY   HZGHC004693c005; SLC30A10 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TM87
DR   Horizon_Discovery; HZGHC004693c005
DR   Wikidata; Q54880003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25355; SLC30A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A10 (-) 2
AC   CVCL_TM88
SY   HZGHC004693c006; SLC30A10 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM88
DR   Horizon_Discovery; HZGHC004693c006
DR   Wikidata; Q54880004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25355; SLC30A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004693c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC30A10 (-) 3
AC   CVCL_TM89
SY   HZGHC004693c012; SLC30A10 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TM89
DR   Horizon_Discovery; HZGHC004693c012
DR   Wikidata; Q54880005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25355; SLC30A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A3 (-) 1
AC   CVCL_TM90
SY   HZGHC001903c011; SLC30A3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TM90
DR   Horizon_Discovery; HZGHC001903c011
DR   Wikidata; Q54880006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11014; SLC30A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A3 (-) 2
AC   CVCL_TM91
SY   HZGHC001903c012; SLC30A3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TM91
DR   Horizon_Discovery; HZGHC001903c012
DR   Wikidata; Q54880007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11014; SLC30A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A5 (-) 1
AC   CVCL_TM92
SY   HZGHC005490c002; SLC30A5 knockout cell line 14bp deletion; HAP1 SLC30A5 (-)
DR   cancercelllines; CVCL_TM92
DR   Horizon_Discovery; HZGHC005490c002
DR   Wikidata; Q54880008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19089; SLC30A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC30A5 (-) 2
AC   CVCL_XT15
SY   HZGHC005490c003; SLC30A5 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XT15
DR   Horizon_Discovery; HZGHC005490c003
DR   Wikidata; Q93967681
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19089; SLC30A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A5 (-) 3
AC   CVCL_XT16
SY   HZGHC005491c001; SLC30A5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT16
DR   Horizon_Discovery; HZGHC005491c001
DR   Wikidata; Q93967688
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19089; SLC30A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A6 (-)
AC   CVCL_TM93
SY   HZGHC002784c010; SLC30A6 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TM93
DR   Horizon_Discovery; HZGHC002784c010
DR   Wikidata; Q54880009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19305; SLC30A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A7 (-) 1
AC   CVCL_TM94
SY   HZGHC001751c005; SLC30A7 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TM94
DR   Horizon_Discovery; HZGHC001751c005
DR   Wikidata; Q54880010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19306; SLC30A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A7 (-) 2
AC   CVCL_TM95
SY   HZGHC001751c012; SLC30A7 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TM95
DR   Horizon_Discovery; HZGHC001751c012
DR   Wikidata; Q54880011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19306; SLC30A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC30A9 (-)
AC   CVCL_TM96
SY   HZGHC005454c008; SLC30A9 knockout cell line 239bp insertion
DR   cancercelllines; CVCL_TM96
DR   Horizon_Discovery; HZGHC005454c008
DR   Wikidata; Q54880012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1329; SLC30A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005454c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC31A1 (-)
AC   CVCL_TM97
SY   HZGHC002093c005; SLC31A1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TM97
DR   Horizon_Discovery; HZGHC002093c005
DR   Wikidata; Q54880013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11016; SLC31A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC31A2 (-) 1
AC   CVCL_TM98
SY   HZGHC005534c010; SLC31A2 knockout cell line 16bp deletion; HAP1 SLC31A2 (-)
DR   cancercelllines; CVCL_TM98
DR   Horizon_Discovery; HZGHC005534c010
DR   Wikidata; Q54880014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11017; SLC31A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC31A2 (-) 2
AC   CVCL_XT17
SY   HZGHC005534c008; SLC31A2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XT17
DR   Horizon_Discovery; HZGHC005534c008
DR   Wikidata; Q93967745
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11017; SLC31A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC33A1 (-) 1
AC   CVCL_TM99
SY   HZGHC001384c002; SLC33A1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TM99
DR   Horizon_Discovery; HZGHC001384c002
DR   Wikidata; Q54880015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:95; SLC33A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC33A1 (-) 2
AC   CVCL_TN00
SY   HZGHC001384c007; SLC33A1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN00
DR   Horizon_Discovery; HZGHC001384c007
DR   Wikidata; Q54880016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:95; SLC33A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC34A2 (-) 1
AC   CVCL_TN01
SY   HZGHC001922c008; SLC34A2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TN01
DR   Horizon_Discovery; HZGHC001922c008
DR   Wikidata; Q54880017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11020; SLC34A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC34A2 (-) 2
AC   CVCL_TN02
SY   HZGHC001922c010; SLC34A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN02
DR   Horizon_Discovery; HZGHC001922c010
DR   Wikidata; Q54880018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11020; SLC34A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35A1 (-) 1
AC   CVCL_TN03
SY   HZGHC010158c010; SLC35A1 knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_TN03
DR   Horizon_Discovery; HZGHC010158c010
DR   Wikidata; Q54880019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35A1 (-) 2
AC   CVCL_TN04
SY   HZGHC010158c015; SLC35A1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TN04
DR   Horizon_Discovery; HZGHC010158c015
DR   Wikidata; Q54880020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC010158c015; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35A3 (-) 1
AC   CVCL_TN05
SY   HZGHC000783c003; SLC35A3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN05
DR   Horizon_Discovery; HZGHC000783c003
DR   Wikidata; Q54880021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11023; SLC35A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35A3 (-) 2
AC   CVCL_TN06
SY   HZGHC000783c012; SLC35A3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TN06
DR   Horizon_Discovery; HZGHC000783c012
DR   Wikidata; Q54880022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11023; SLC35A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35A4 (-) 1
AC   CVCL_TN07
SY   HZGHC005267c001; SLC35A4 knockout cell line 19bp deletion; HAP1 SLC35A4 (-)
DR   cancercelllines; CVCL_TN07
DR   Horizon_Discovery; HZGHC005267c001
DR   Wikidata; Q54880023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20753; SLC35A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35A4 (-) 2
AC   CVCL_XT18
SY   HZGHC005267c004; SLC35A4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT18
DR   Horizon_Discovery; HZGHC005267c004
DR   Wikidata; Q93967832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20753; SLC35A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35A5 (-) 1
AC   CVCL_TN08
SY   HZGHC002170c006; SLC35A5 knockout cell line 343bp insertion
DR   cancercelllines; CVCL_TN08
DR   Horizon_Discovery; HZGHC002170c006
DR   Wikidata; Q54880024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20792; SLC35A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002170c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35A5 (-) 2
AC   CVCL_TN09
SY   HZGHC002170c009; SLC35A5 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TN09
DR   Horizon_Discovery; HZGHC002170c009
DR   Wikidata; Q54880025
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20792; SLC35A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35B2 (-) 1
AC   CVCL_TN10
SY   HZGHC005536c010; SLC35B2 knockout cell line 41bp deletion in exon 4; HAP1 SLC35B2 (-)
DR   cancercelllines; CVCL_TN10
DR   Horizon_Discovery; HZGHC005536c010
DR   Wikidata; Q54880026
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16872; SLC35B2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC35B2 (-) 2
AC   CVCL_XT19
SY   HZGHC005536c002; SLC35B2 knockout cell line 13bp deletion in exon 4
DR   cancercelllines; CVCL_XT19
DR   Horizon_Discovery; HZGHC005536c002
DR   Wikidata; Q93967855
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16872; SLC35B2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35B2 (-) XYLT2 (-)
AC   CVCL_DX58
SY   HZGHC007836c009; Double knockout cell line SLC35B2 13bp deletion in exon 4 and XYLT2 1bp insertion
DR   Horizon_Discovery; HZGHC007836c009
DR   Wikidata; Q127381096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16872; SLC35B2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15517; XYLT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XT19 ! HAP1 SLC35B2 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SLC35B3 (-) 1
AC   CVCL_TN11
SY   HZGHC005537c012; SLC35B3 knockout cell line 68bp deletion; HAP1 SLC35B3 (-)
DR   cancercelllines; CVCL_TN11
DR   Horizon_Discovery; HZGHC005537c012
DR   Wikidata; Q54880027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21601; SLC35B3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35B3 (-) 2
AC   CVCL_XT20
SY   HZGHC005537c006; SLC35B3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XT20
DR   Horizon_Discovery; HZGHC005537c006
DR   Wikidata; Q93967859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21601; SLC35B3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35B4 (-) 1
AC   CVCL_TN12
SY   HZGHC002204c001; SLC35B4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN12
DR   Horizon_Discovery; HZGHC002204c001
DR   Wikidata; Q54880028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20584; SLC35B4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35B4 (-) 2
AC   CVCL_TN13
SY   HZGHC002204c010; SLC35B4 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TN13
DR   Horizon_Discovery; HZGHC002204c010
DR   Wikidata; Q54880029
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20584; SLC35B4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35C1 (-) 1
AC   CVCL_TN14
SY   HZGHC005486c001; SLC35C1 knockout cell line 1bp insertion; HAP1 SLC35C1 (-)
DR   cancercelllines; CVCL_TN14
DR   Horizon_Discovery; HZGHC005486c001
DR   Wikidata; Q54880030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35C1 (-) 2
AC   CVCL_XT21
SY   HZGHC005486c006; SLC35C1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT21
DR   Horizon_Discovery; HZGHC005486c006
DR   Wikidata; Q93967863
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35C2 (-) 1
AC   CVCL_TN15
SY   HZGHC005538c001; SLC35C2 knockout cell line 1bp deletion; HAP1 SLC35C2 (-)
DR   cancercelllines; CVCL_TN15
DR   Horizon_Discovery; HZGHC005538c001
DR   Wikidata; Q54880031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17117; SLC35C2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35C2 (-) 2
AC   CVCL_XT22
SY   HZGHC005538c006; SLC35C2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XT22
DR   Horizon_Discovery; HZGHC005538c006
DR   Wikidata; Q93967864
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17117; SLC35C2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35D1 (-) 1
AC   CVCL_TN16
SY   HZGHC003586c001; SLC35D1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN16
DR   Horizon_Discovery; HZGHC003586c001
DR   Wikidata; Q54880034
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20800; SLC35D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35D1 (-) 2
AC   CVCL_TN17
SY   HZGHC003586c002; SLC35D1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN17
DR   Horizon_Discovery; HZGHC003586c002
DR   Wikidata; Q54880035
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20800; SLC35D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35D2 (-) 1
AC   CVCL_TN18
SY   HZGHC005539c010; SLC35D2 knockout cell line 8bp insertion; HAP1 SLC35D2 (-)
DR   cancercelllines; CVCL_TN18
DR   Horizon_Discovery; HZGHC005539c010
DR   Wikidata; Q54880036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20799; SLC35D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35D2 (-) 2
AC   CVCL_XT23
SY   HZGHC005539c008; SLC35D2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XT23
DR   Horizon_Discovery; HZGHC005539c008
DR   Wikidata; Q93967869
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20799; SLC35D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35E1 (-) 1
AC   CVCL_TN19
SY   HZGHC002613c001; SLC35E1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TN19
DR   Horizon_Discovery; HZGHC002613c001
DR   Wikidata; Q54880037
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20803; SLC35E1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35E1 (-) 2
AC   CVCL_TN20
SY   HZGHC002613c011; SLC35E1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TN20
DR   Horizon_Discovery; HZGHC002613c011
DR   Wikidata; Q54880038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20803; SLC35E1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35E2B (-) 1
AC   CVCL_TN21
SY   HZGHC002191c003; SLC35E2B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TN21
DR   Horizon_Discovery; HZGHC002191c003
DR   Wikidata; Q54880039
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33941; SLC35E2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35E2B (-) 2
AC   CVCL_TN22
SY   HZGHC002191c008; SLC35E2B knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TN22
DR   Horizon_Discovery; HZGHC002191c008
DR   Wikidata; Q54880040
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33941; SLC35E2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35E3 (-) 1
AC   CVCL_TN23
SY   HZGHC005540c003; SLC35E3 knockout cell line 11bp deletion; HAP1 SLC35E3 (-)
DR   cancercelllines; CVCL_TN23
DR   Horizon_Discovery; HZGHC005540c003
DR   Wikidata; Q54880041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20864; SLC35E3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35E3 (-) 2
AC   CVCL_XT24
SY   HZGHC005540c004; SLC35E3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT24
DR   Horizon_Discovery; HZGHC005540c004
DR   Wikidata; Q93967876
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20864; SLC35E3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35E4 (-) 1
AC   CVCL_TN24
SY   HZGHC005541c002; SLC35E4 knockout cell line 14bp deletion; HAP1 SLC35E4 (-)
DR   cancercelllines; CVCL_TN24
DR   Horizon_Discovery; HZGHC005541c002
DR   Wikidata; Q54880042
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17058; SLC35E4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35E4 (-) 2
AC   CVCL_XT25
SY   HZGHC005541c003; SLC35E4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XT25
DR   Horizon_Discovery; HZGHC005541c003
DR   Wikidata; Q93967877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17058; SLC35E4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35F1 (-) 1
AC   CVCL_TN25
SY   HZGHC002211c002; SLC35F1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TN25
DR   Horizon_Discovery; HZGHC002211c002
DR   Wikidata; Q54880043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21483; SLC35F1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35F1 (-) 2
AC   CVCL_TN26
SY   HZGHC002211c006; SLC35F1 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TN26
DR   Horizon_Discovery; HZGHC002211c006
DR   Wikidata; Q54880044
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21483; SLC35F1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35F2 (-) 1
AC   CVCL_TN27
SY   HZGHC002119c004; SLC35F2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TN27
DR   Horizon_Discovery; HZGHC002119c004
DR   Wikidata; Q54880045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23615; SLC35F2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35F2 (-) 2
AC   CVCL_TN28
SY   HZGHC002119c003; SLC35F2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN28
DR   Horizon_Discovery; HZGHC002119c003
DR   Wikidata; Q54880046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23615; SLC35F2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35F5 (-) 1
AC   CVCL_TN29
SY   HZGHC005833c008; SLC35F5 knockout cell line 5bp deletion; HAP1 SLC35F5 (-)
DR   cancercelllines; CVCL_TN29
DR   Horizon_Discovery; HZGHC005833c008
DR   Wikidata; Q54880047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23617; SLC35F5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC35F5 (-) 2
AC   CVCL_XT26
SY   HZGHC005833c009; SLC35F5 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT26
DR   Horizon_Discovery; HZGHC005833c009
DR   Wikidata; Q93967881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23617; SLC35F5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35G1 (-)
AC   CVCL_TN30
SY   HZGHC005832c005; SLC35G1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TN30
DR   Horizon_Discovery; HZGHC005832c005
DR   Wikidata; Q54880048
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26607; SLC35G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC35G2 (-)
AC   CVCL_TN31
SY   HZGHC005544c004; SLC35G2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TN31
DR   Horizon_Discovery; HZGHC005544c004
DR   Wikidata; Q54880049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28480; SLC35G2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC36A1 (-) 1
AC   CVCL_TN32
SY   HZGHC005563c010; SLC36A1 knockout cell line 1bp insertion; HAP1 SLC36A1 (-)
DR   cancercelllines; CVCL_TN32
DR   Horizon_Discovery; HZGHC005563c010
DR   Wikidata; Q54880050
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18761; SLC36A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC36A1 (-) 2
AC   CVCL_XT27
SY   HZGHC005563c011; SLC36A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT27
DR   Horizon_Discovery; HZGHC005563c011
DR   Wikidata; Q93967884
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18761; SLC36A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC36A1 (-) 3
AC   CVCL_XT28
SY   HZGHC005563c012; SLC36A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT28
DR   Horizon_Discovery; HZGHC005563c012
DR   Wikidata; Q93967885
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18761; SLC36A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005563c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC36A4 (-) 1
AC   CVCL_TN33
SY   HZGHC001862c012; SLC36A4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN33
DR   Horizon_Discovery; HZGHC001862c012
DR   Wikidata; Q54880051
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19660; SLC36A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001862c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC36A4 (-) 2
AC   CVCL_TN34
SY   HZGHC001862c005; SLC36A4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN34
DR   Horizon_Discovery; HZGHC001862c005
DR   Wikidata; Q54880052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19660; SLC36A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC36A4 (-) 3
AC   CVCL_TN35
SY   HZGHC001862c010; SLC36A4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN35
DR   Horizon_Discovery; HZGHC001862c010
DR   Wikidata; Q54880053
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19660; SLC36A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC37A1 (-) 1
AC   CVCL_TN36
SY   HZGHC005564c011; SLC37A1 knockout cell line 16bp deletion; HAP1 SLC37A1 (-)
DR   cancercelllines; CVCL_TN36
DR   Horizon_Discovery; HZGHC005564c011
DR   Wikidata; Q54880054
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11024; SLC37A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC37A1 (-) 2
AC   CVCL_XT29
SY   HZGHC005564c008; SLC37A1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT29
DR   Horizon_Discovery; HZGHC005564c008
DR   Wikidata; Q93967897
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11024; SLC37A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC37A4 (-) 1
AC   CVCL_TN37
SY   HZGHC001454c004; SLC37A4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN37
DR   Horizon_Discovery; HZGHC001454c004
DR   Wikidata; Q54880055
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4061; SLC37A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC37A4 (-) 2
AC   CVCL_TN38
SY   HZGHC001454c006; SLC37A4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN38
DR   Horizon_Discovery; HZGHC001454c006
DR   Wikidata; Q54880056
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4061; SLC37A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A1 (-)
AC   CVCL_TN39
SY   HZGHC002006c002; SLC38A1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN39
DR   Horizon_Discovery; HZGHC002006c002
DR   Wikidata; Q54880057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13447; SLC38A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A10 (-) 1
AC   CVCL_TN40
SY   HZGHC001745c006; SLC38A10 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TN40
DR   Horizon_Discovery; HZGHC001745c006
DR   Wikidata; Q54880058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28237; SLC38A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A10 (-) 2
AC   CVCL_TN41
SY   HZGHC001745c009; SLC38A10 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN41
DR   Horizon_Discovery; HZGHC001745c009
DR   Wikidata; Q54880059
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28237; SLC38A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A2 (-) 1
AC   CVCL_TN42
SY   HZGHC001975c002; SLC38A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN42
DR   Horizon_Discovery; HZGHC001975c002
DR   Wikidata; Q54880061
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13448; SLC38A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A2 (-) 2
AC   CVCL_TN43
SY   HZGHC001975c006; SLC38A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN43
DR   Horizon_Discovery; HZGHC001975c006
DR   Wikidata; Q54880062
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13448; SLC38A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A5 (-) 1
AC   CVCL_TN44
SY   HZGHC001691c002; SLC38A5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TN44
DR   Horizon_Discovery; HZGHC001691c002
DR   Wikidata; Q54880063
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18070; SLC38A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A5 (-) 2
AC   CVCL_TN45
SY   HZGHC001691c011; SLC38A5 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TN45
DR   Horizon_Discovery; HZGHC001691c011
DR   Wikidata; Q54880064
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18070; SLC38A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A6 (-)
AC   CVCL_TN46
SY   HZGHC005566c003; SLC38A6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN46
DR   Horizon_Discovery; HZGHC005566c003
DR   Wikidata; Q54880065
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19863; SLC38A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A7 (-)
AC   CVCL_TN47
SY   HZGHC005567c005; SLC38A7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TN47
DR   Horizon_Discovery; HZGHC005567c005
DR   Wikidata; Q54880066
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25582; SLC38A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A9 (-) 1
AC   CVCL_TN48
SY   HZGHC000777c006; SLC38A9 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN48
DR   Horizon_Discovery; HZGHC000777c006
DR   Wikidata; Q54880067
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC38A9 (-) 2
AC   CVCL_TN49
SY   HZGHC000777c011; SLC38A9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN49
DR   Horizon_Discovery; HZGHC000777c011
DR   Wikidata; Q54880068
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A1 (-) 1
AC   CVCL_TN50
SY   HZGHC002125c006; SLC39A1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TN50
DR   Horizon_Discovery; HZGHC002125c006
DR   Wikidata; Q54880069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12876; SLC39A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A1 (-) 2
AC   CVCL_TN51
SY   HZGHC002125c012; SLC39A1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN51
DR   Horizon_Discovery; HZGHC002125c012
DR   Wikidata; Q54880070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12876; SLC39A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A11 (-)
AC   CVCL_TN52
SY   HZGHC005568c008; SLC39A11 knockout cell line 55bp deletion
DR   cancercelllines; CVCL_TN52
DR   Horizon_Discovery; HZGHC005568c008
DR   Wikidata; Q54880071
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14463; SLC39A11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A13 (-) 1
AC   CVCL_TN53
SY   HZGHC005569c001; SLC39A13 knockout cell line 7bp deletion; HAP1 SLC39A13 (-)
DR   cancercelllines; CVCL_TN53
DR   Horizon_Discovery; HZGHC005569c001
DR   Wikidata; Q54880072
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20859; SLC39A13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC39A13 (-) 2
AC   CVCL_XT30
SY   HZGHC005569c007; SLC39A13 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XT30
DR   Horizon_Discovery; HZGHC005569c007
DR   Wikidata; Q93968049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20859; SLC39A13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005569c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC39A14 (-) 1
AC   CVCL_TN54
SY   HZGHC000775c006; SLC39A14 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN54
DR   Horizon_Discovery; HZGHC000775c006
DR   Wikidata; Q54880073
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20858; SLC39A14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A14 (-) 2
AC   CVCL_TN55
SY   HZGHC000775c011; SLC39A14 knockout cell line 56bp deletion
DR   cancercelllines; CVCL_TN55
DR   Horizon_Discovery; HZGHC000775c011
DR   Wikidata; Q54880074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20858; SLC39A14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A3 (-) 1
AC   CVCL_TN56
SY   HZGHC002246c001; SLC39A3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TN56
DR   Horizon_Discovery; HZGHC002246c001
DR   Wikidata; Q54880077
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17128; SLC39A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A3 (-) 2
AC   CVCL_TN57
SY   HZGHC002246c005; SLC39A3 knockout cell line 29bp deletion
DR   cancercelllines; CVCL_TN57
DR   Horizon_Discovery; HZGHC002246c005
DR   Wikidata; Q54880078
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17128; SLC39A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A6 (-)
AC   CVCL_TN58
SY   HZGHC001832c004; SLC39A6 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TN58
DR   Horizon_Discovery; HZGHC001832c004
DR   Wikidata; Q54880079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18607; SLC39A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A8 (-) 1
AC   CVCL_TN59
SY   HZGHC004021c006; SLC39A8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TN59
DR   Horizon_Discovery; HZGHC004021c006
DR   Wikidata; Q54880080
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A8 (-) 2
AC   CVCL_TN60
SY   HZGHC004021c011; SLC39A8 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TN60
DR   Horizon_Discovery; HZGHC004021c011
DR   Wikidata; Q54880081
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A8 (-) 3
AC   CVCL_TN61
SY   HZGHC002069c017; SLC39A8 knockout cell line 67bp insertion
DR   cancercelllines; CVCL_TN61
DR   Horizon_Discovery; HZGHC002069c017
DR   Wikidata; Q54880082
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002069c017; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC39A9 (-) 1
AC   CVCL_TN62
SY   HZGHC002017c007; SLC39A9 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN62
DR   Horizon_Discovery; HZGHC002017c007
DR   Wikidata; Q54880083
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20182; SLC39A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC39A9 (-) 2
AC   CVCL_TN63
SY   HZGHC002017c011; SLC39A9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN63
DR   Horizon_Discovery; HZGHC002017c011
DR   Wikidata; Q54880084
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20182; SLC39A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC40A1 (-) 1
AC   CVCL_TN64
SY   HZGHC004521c002; SLC40A1 knockout cell line 113bp insertion
DR   cancercelllines; CVCL_TN64
DR   Horizon_Discovery; HZGHC004521c002
DR   Wikidata; Q54880085
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10909; SLC40A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004521c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC40A1 (-) 2
AC   CVCL_TN65
SY   HZGHC004521c010; SLC40A1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TN65
DR   Horizon_Discovery; HZGHC004521c010
DR   Wikidata; Q54880086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10909; SLC40A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC41A1 (-)
AC   CVCL_TN66
SY   HZGHC005570c012; SLC41A1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TN66
DR   Horizon_Discovery; HZGHC005570c012
DR   Wikidata; Q54880087
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19429; SLC41A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC41A2 (-)
AC   CVCL_TN67
SY   HZGHC005571c008; SLC41A2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TN67
DR   Horizon_Discovery; HZGHC005571c008
DR   Wikidata; Q54880088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31045; SLC41A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC41A3 (-) 1
AC   CVCL_TN68
SY   HZGHC002098c007; SLC41A3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN68
DR   Horizon_Discovery; HZGHC002098c007
DR   Wikidata; Q54880089
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31046; SLC41A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC41A3 (-) 2
AC   CVCL_TN69
SY   HZGHC002098c009; SLC41A3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN69
DR   Horizon_Discovery; HZGHC002098c009
DR   Wikidata; Q54880090
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31046; SLC41A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC43A1 (-)
AC   CVCL_TN70
SY   HZGHC001814c001; SLC43A1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TN70
DR   Horizon_Discovery; HZGHC001814c001
DR   Wikidata; Q54880091
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9225; SLC43A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC43A2 (-) 1
AC   CVCL_TN71
SY   HZGHC001877c002; SLC43A2 knockout cell line 4bp insertion
DR   cancercelllines; CVCL_TN71
DR   Horizon_Discovery; HZGHC001877c002
DR   Wikidata; Q54880092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23087; SLC43A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC43A2 (-) 2
AC   CVCL_TN72
SY   HZGHC001877c008; SLC43A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN72
DR   Horizon_Discovery; HZGHC001877c008
DR   Wikidata; Q54880093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23087; SLC43A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC43A3 (-) 1
AC   CVCL_TN73
SY   HZGHC002241c001; SLC43A3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN73
DR   Horizon_Discovery; HZGHC002241c001
DR   Wikidata; Q54880094
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17466; SLC43A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC43A3 (-) 2
AC   CVCL_TN74
SY   HZGHC002241c005; SLC43A3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TN74
DR   Horizon_Discovery; HZGHC002241c005
DR   Wikidata; Q54880095
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17466; SLC43A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC44A1 (-)
AC   CVCL_TN75
SY   HZGHC001665c001; SLC44A1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN75
DR   Horizon_Discovery; HZGHC001665c001
DR   Wikidata; Q54880096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18798; SLC44A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC44A2 (-) 1
AC   CVCL_TN76
SY   HZGHC001963c001; SLC44A2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TN76
DR   Horizon_Discovery; HZGHC001963c001
DR   Wikidata; Q54880097
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17292; SLC44A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC44A2 (-) 2
AC   CVCL_TN77
SY   HZGHC001963c002; SLC44A2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TN77
DR   Horizon_Discovery; HZGHC001963c002
DR   Wikidata; Q54880098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17292; SLC44A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC44A3 (-) 1
AC   CVCL_TN78
SY   HZGHC005873c011; SLC44A3 knockout cell line 28bp deletion; HAP1 SLC44A3 (-)
DR   cancercelllines; CVCL_TN78
DR   Horizon_Discovery; HZGHC005873c011
DR   Wikidata; Q54880099
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28689; SLC44A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005873c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC44A3 (-) 2
AC   CVCL_XT31
SY   HZGHC005873c006; SLC44A3 knockout cell line 139bp deletion
DR   cancercelllines; CVCL_XT31
DR   Horizon_Discovery; HZGHC005873c006
DR   Wikidata; Q93968314
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28689; SLC44A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005873c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC45A3 (-) 1
AC   CVCL_TN79
SY   HZGHC002760c002; SLC45A3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN79
DR   Horizon_Discovery; HZGHC002760c002
DR   Wikidata; Q54880100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8642; SLC45A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC45A3 (-) 2
AC   CVCL_TN80
SY   HZGHC002760c012; SLC45A3 knockout cell line 32bp insertion
DR   cancercelllines; CVCL_TN80
DR   Horizon_Discovery; HZGHC002760c012
DR   Wikidata; Q54880101
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8642; SLC45A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002760c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC46A1 (-) 1
AC   CVCL_TN81
SY   HZGHC005489c005; SLC46A1 knockout cell line 1bp deletion; HAP1 SLC46A1 (-)
DR   cancercelllines; CVCL_TN81
DR   Horizon_Discovery; HZGHC005489c005
DR   Wikidata; Q54880102
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30521; SLC46A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC46A1 (-) 2
AC   CVCL_XT32
SY   HZGHC005489c008; SLC46A1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT32
DR   Horizon_Discovery; HZGHC005489c008
DR   Wikidata; Q93968340
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30521; SLC46A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC46A3 (-) 1
AC   CVCL_TN82
SY   HZGHC002222c001; SLC46A3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN82
DR   Horizon_Discovery; HZGHC002222c001
DR   Wikidata; Q54880103
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27501; SLC46A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC46A3 (-) 2
AC   CVCL_TN83
SY   HZGHC002222c006; SLC46A3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN83
DR   Horizon_Discovery; HZGHC002222c006
DR   Wikidata; Q54880104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27501; SLC46A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC46A3 (-) 3
AC   CVCL_TN84
SY   HZGHC002222c009; SLC46A3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TN84
DR   Horizon_Discovery; HZGHC002222c009
DR   Wikidata; Q54880105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27501; SLC46A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC47A1 (-)
AC   CVCL_TN85
SY   HZGHC005425c004; SLC47A1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TN85
DR   Horizon_Discovery; HZGHC005425c004
DR   Wikidata; Q54880106
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25588; SLC47A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC48A1 (-)
AC   CVCL_TN86
SY   HZGHC005825c004; SLC48A1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN86
DR   Horizon_Discovery; HZGHC005825c004
DR   Wikidata; Q54880107
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26035; SLC48A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC4A10 (-)
AC   CVCL_TN87
SY   HZGHC002062c012; SLC4A10 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN87
DR   Horizon_Discovery; HZGHC002062c012
DR   Wikidata; Q54880108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13811; SLC4A10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC4A11 (-)
AC   CVCL_TN88
SY   HZGHC005575c001; SLC4A11 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN88
DR   Horizon_Discovery; HZGHC005575c001
DR   Wikidata; Q54880109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16438; SLC4A11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC4A1AP (-)
AC   CVCL_TN89
SY   HZGHC005576c004; SLC4A1AP knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TN89
DR   Horizon_Discovery; HZGHC005576c004
DR   Wikidata; Q54880110
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13813; SLC4A1AP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC4A2 (-) 1
AC   CVCL_TN90
SY   HZGHC001880c004; SLC4A2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN90
DR   Horizon_Discovery; HZGHC001880c004
DR   Wikidata; Q54880111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11028; SLC4A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001880c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC4A2 (-) 2
AC   CVCL_TN91
SY   HZGHC001880c007; SLC4A2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TN91
DR   Horizon_Discovery; HZGHC001880c007
DR   Wikidata; Q54880112
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11028; SLC4A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC4A3 (-)
AC   CVCL_TN92
SY   HZGHC005577c005; SLC4A3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TN92
DR   Horizon_Discovery; HZGHC005577c005
DR   Wikidata; Q54880113
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11029; SLC4A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC4A8 (-) 1
AC   CVCL_TN93
SY   HZGHC001987c001; SLC4A8 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN93
DR   Horizon_Discovery; HZGHC001987c001
DR   Wikidata; Q54880114
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11034; SLC4A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC4A8 (-) 2
AC   CVCL_TN94
SY   HZGHC001987c010; SLC4A8 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TN94
DR   Horizon_Discovery; HZGHC001987c010
DR   Wikidata; Q54880115
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11034; SLC4A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC50A1 (-)
AC   CVCL_TN95
SY   HZGHC005578c010; SLC50A1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TN95
DR   Horizon_Discovery; HZGHC005578c010
DR   Wikidata; Q54880116
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30657; SLC50A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A2 (-) 1
AC   CVCL_TN96
SY   HZGHC003874c001; SLC5A2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TN96
DR   Horizon_Discovery; HZGHC003874c001
DR   Wikidata; Q54880118
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11037; SLC5A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A2 (-) 2
AC   CVCL_TN97
SY   HZGHC003874c012; SLC5A2 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TN97
DR   Horizon_Discovery; HZGHC003874c012
DR   Wikidata; Q54880119
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11037; SLC5A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A3 (-)
AC   CVCL_TN98
SY   HZGHC005579c004; SLC5A3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TN98
DR   Horizon_Discovery; HZGHC005579c004
DR   Wikidata; Q54880120
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11038; SLC5A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A4 (-)
AC   CVCL_TN99
SY   HZGHC002107c001; SLC5A4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TN99
DR   Horizon_Discovery; HZGHC002107c001
DR   Wikidata; Q54880121
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11039; SLC5A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A6 (-) 1
AC   CVCL_TP00
SY   HZGHC001869c004; SLC5A6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TP00
DR   Horizon_Discovery; HZGHC001869c004
DR   Wikidata; Q54880122
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11041; SLC5A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A6 (-) 2
AC   CVCL_TP01
SY   HZGHC001869c012; SLC5A6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP01
DR   Horizon_Discovery; HZGHC001869c012
DR   Wikidata; Q54880123
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11041; SLC5A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A7 (-) 1
AC   CVCL_TP02
SY   HZGHC004520c005; SLC5A7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP02
DR   Horizon_Discovery; HZGHC004520c005
DR   Wikidata; Q54880124
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14025; SLC5A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC5A7 (-) 2
AC   CVCL_TP03
SY   HZGHC004520c007; SLC5A7 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP03
DR   Horizon_Discovery; HZGHC004520c007
DR   Wikidata; Q54880125
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14025; SLC5A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC6A6 (-) 1
AC   CVCL_TP04
SY   HZGHC005580c010; SLC6A6 knockout cell line 17bp deletion; HAP1 SLC6A6 (-)
DR   cancercelllines; CVCL_TP04
DR   Horizon_Discovery; HZGHC005580c010
DR   Wikidata; Q54880126
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11052; SLC6A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC6A6 (-) 2
AC   CVCL_XT33
SY   HZGHC005580c009; SLC6A6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT33
DR   Horizon_Discovery; HZGHC005580c009
DR   Wikidata; Q93968534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11052; SLC6A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC6A8 (-) 1
AC   CVCL_TP05
SY   HZGHC002946c006; SLC6A8 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP05
DR   Horizon_Discovery; HZGHC002946c006
DR   Wikidata; Q54880127
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11055; SLC6A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC6A8 (-) 2
AC   CVCL_TP06
SY   HZGHC002946c008; SLC6A8 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TP06
DR   Horizon_Discovery; HZGHC002946c008
DR   Wikidata; Q54880128
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11055; SLC6A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC6A9 (-) 1
AC   CVCL_TP07
SY   HZGHC005456c010; SLC6A9 knockout cell line 41bp deletion; HAP1 SLC6A9 (-)
DR   cancercelllines; CVCL_TP07
DR   Horizon_Discovery; HZGHC005456c010
DR   Wikidata; Q54880129
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11056; SLC6A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC6A9 (-) 2
AC   CVCL_XT34
SY   HZGHC005456c012; SLC6A9 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XT34
DR   Horizon_Discovery; HZGHC005456c012
DR   Wikidata; Q93968580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11056; SLC6A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC7A1 (-) 1
AC   CVCL_TP08
SY   HZGHC001741c010; SLC7A1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP08
DR   Horizon_Discovery; HZGHC001741c010
DR   Wikidata; Q54880130
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11057; SLC7A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC7A1 (-) 2
AC   CVCL_TP09
SY   HZGHC001741c012; SLC7A1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP09
DR   Horizon_Discovery; HZGHC001741c012
DR   Wikidata; Q54880131
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11057; SLC7A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC7A2 (-) 1
AC   CVCL_TP10
SY   HZGHC001888c002; SLC7A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP10
DR   Horizon_Discovery; HZGHC001888c002
DR   Wikidata; Q54880132
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11060; SLC7A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001888c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC7A2 (-) 2
AC   CVCL_TP11
SY   HZGHC001888c001; SLC7A2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP11
DR   Horizon_Discovery; HZGHC001888c001
DR   Wikidata; Q54880133
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11060; SLC7A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC7A3 (-) 1
AC   CVCL_TP12
SY   HZGHC002044c005; SLC7A3 knockout cell line 137bp insertion
DR   cancercelllines; CVCL_TP12
DR   Horizon_Discovery; HZGHC002044c005
DR   Wikidata; Q54880134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11061; SLC7A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002044c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC7A3 (-) 2
AC   CVCL_TP13
SY   HZGHC002044c011; SLC7A3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TP13
DR   Horizon_Discovery; HZGHC002044c011
DR   Wikidata; Q54880135
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11061; SLC7A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC7A5 (-) 1
AC   CVCL_TP14
SY   HZGHC005452c002; SLC7A5 knockout cell line 1bp insertion in exon 4; HAP1 SLC7A5 (-)
DR   cancercelllines; CVCL_TP14
DR   Horizon_Discovery; HZGHC005452c002
DR   Wikidata; Q54880136
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC7A5 (-) 2
AC   CVCL_XT35
SY   HZGHC005452c005; SLC7A5 knockout cell line 16bp deletion in exon 4
DR   cancercelllines; CVCL_XT35
DR   Horizon_Discovery; HZGHC005452c005
DR   Wikidata; Q93968668
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC7A5 (-) SLC7A8 (-) 1
AC   CVCL_DX59
SY   HZGHC007555c002; Double knockout cell line SLC7A5 1bp insertion in exon 4 and SLC7A8 2bp deletion in exon 7
DR   Horizon_Discovery; HZGHC007555c002
DR   Wikidata; Q127381097
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11066; SLC7A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TP14 ! HAP1 SLC7A5 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SLC7A5 (-) SLC7A8 (-) 2
AC   CVCL_DX60
SY   HZGHC007554c007; Double knockout cell line SLC7A5 16bp deletion in exon 4 and SLC7A8 1bp insertion in exon 7
DR   Horizon_Discovery; HZGHC007554c007
DR   Wikidata; Q127381098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11066; SLC7A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XT35 ! HAP1 SLC7A5 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SLC7A6 (-)
AC   CVCL_TP15
SY   HZGHC001688c011; SLC7A6 knockout cell line 8bp deletion in exon 3
DR   cancercelllines; CVCL_TP15
DR   Horizon_Discovery; HZGHC001688c011
DR   Wikidata; Q54880137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11064; SLC7A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC7A8 (-) 1
AC   CVCL_TP16
SY   HZGHC005852c011; SLC7A8 knockout cell line 2bp deletion in exon 7; HAP1 SLC7A8 (-)
DR   cancercelllines; CVCL_TP16
DR   Horizon_Discovery; HZGHC005852c011
DR   Wikidata; Q54880138
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11066; SLC7A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLC7A8 (-) 2
AC   CVCL_XT36
SY   HZGHC005852c006; SLC7A8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XT36
DR   Horizon_Discovery; HZGHC005852c006
DR   Wikidata; Q93968671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11066; SLC7A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005852c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC7A8 (-) 3
AC   CVCL_XT37
SY   HZGHC005852c007; SLC7A8 knockout cell line 80bp deletion
DR   cancercelllines; CVCL_XT37
DR   Horizon_Discovery; HZGHC005852c007
DR   Wikidata; Q93968674
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11066; SLC7A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005852c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC8B1 (-) 1
AC   CVCL_TP17
SY   HZGHC005617c004; SLC8B1 knockout cell line 4bp deletion; HAP1 SLC8B1 (-)
DR   cancercelllines; CVCL_TP17
DR   Horizon_Discovery; HZGHC005617c004
DR   Wikidata; Q54880139
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26175; SLC8B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC8B1 (-) 2
AC   CVCL_XT38
SY   HZGHC005617c005; SLC8B1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT38
DR   Horizon_Discovery; HZGHC005617c005
DR   Wikidata; Q93968680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26175; SLC8B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC8B1 (-) 3
AC   CVCL_XT39
SY   HZGHC005617c007; SLC8B1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT39
DR   Horizon_Discovery; HZGHC005617c007
DR   Wikidata; Q93968682
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26175; SLC8B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A1 (-) 1
AC   CVCL_TP18
SY   HZGHC005618c011; SLC9A1 knockout cell line 23bp deletion; HAP1 SLC9A1 (-)
DR   cancercelllines; CVCL_TP18
DR   Horizon_Discovery; HZGHC005618c011
DR   Wikidata; Q54880140
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A1 (-) 2
AC   CVCL_XT40
SY   HZGHC005618c004; SLC9A1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XT40
DR   Horizon_Discovery; HZGHC005618c004
DR   Wikidata; Q93968691
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A3 (-)
AC   CVCL_TP19
SY   HZGHC005619c002; SLC9A3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP19
DR   Horizon_Discovery; HZGHC005619c002
DR   Wikidata; Q54880141
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11073; SLC9A3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A3R1 (-) 1
AC   CVCL_TP20
SY   HZGHC000781c002; SLC9A3R1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TP20
DR   Horizon_Discovery; HZGHC000781c002
DR   Wikidata; Q54880142
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11075; NHERF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A3R1 (-) 2
AC   CVCL_TP21
SY   HZGHC000781c012; SLC9A3R1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP21
DR   Horizon_Discovery; HZGHC000781c012
DR   Wikidata; Q54880143
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11075; NHERF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A3R2 (-) 1
AC   CVCL_TP22
SY   HZGHC000782c010; SLC9A3R2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP22
DR   Horizon_Discovery; HZGHC000782c010
DR   Wikidata; Q54880144
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11076; NHERF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A3R2 (-) 2
AC   CVCL_TP23
SY   HZGHC000782c012; SLC9A3R2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP23
DR   Horizon_Discovery; HZGHC000782c012
DR   Wikidata; Q54880145
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11076; NHERF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A6 (-) 1
AC   CVCL_TP24
SY   HZGHC004524c003; SLC9A6 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP24
DR   Horizon_Discovery; HZGHC004524c003
DR   Wikidata; Q54880146
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11079; SLC9A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A6 (-) 2
AC   CVCL_TP25
SY   HZGHC004524c006; SLC9A6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP25
DR   Horizon_Discovery; HZGHC004524c006
DR   Wikidata; Q54880147
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11079; SLC9A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A6 (-) 3
AC   CVCL_TP26
SY   HZGHC004524c011; SLC9A6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TP26
DR   Horizon_Discovery; HZGHC004524c011
DR   Wikidata; Q54880148
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11079; SLC9A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A7 (-) 1
AC   CVCL_TP27
SY   HZGHC001918c011; SLC9A7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP27
DR   Horizon_Discovery; HZGHC001918c011
DR   Wikidata; Q54880149
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17123; SLC9A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001918c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A7 (-) 2
AC   CVCL_TP28
SY   HZGHC001918c001; SLC9A7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP28
DR   Horizon_Discovery; HZGHC001918c001
DR   Wikidata; Q54880150
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17123; SLC9A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A7 (-) 3
AC   CVCL_TP29
SY   HZGHC001918c008; SLC9A7 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TP29
DR   Horizon_Discovery; HZGHC001918c008
DR   Wikidata; Q54880151
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17123; SLC9A7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A8 (-) 1
AC   CVCL_TP30
SY   HZGHC005620c011; SLC9A8 knockout cell line 1bp deletion; HAP1 SLC9A8 (-)
DR   cancercelllines; CVCL_TP30
DR   Horizon_Discovery; HZGHC005620c011
DR   Wikidata; Q54880152
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20728; SLC9A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A8 (-) 2
AC   CVCL_XT41
SY   HZGHC005620c002; SLC9A8 knockout cell line 85bp deletion
DR   cancercelllines; CVCL_XT41
DR   Horizon_Discovery; HZGHC005620c002
DR   Wikidata; Q93968760
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20728; SLC9A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A8 (-) 3
AC   CVCL_XT42
SY   HZGHC005620c005; SLC9A8 knockout cell line 85bp deletion
DR   cancercelllines; CVCL_XT42
DR   Horizon_Discovery; HZGHC005620c005
DR   Wikidata; Q93968764
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20728; SLC9A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005620c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9A9 (-) 1
AC   CVCL_TP31
SY   HZGHC004847c005; SLC9A9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP31
DR   Horizon_Discovery; HZGHC004847c005
DR   Wikidata; Q54880153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20653; SLC9A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A9 (-) 2
AC   CVCL_TP32
SY   HZGHC004850c005; SLC9A9 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TP32
DR   Horizon_Discovery; HZGHC004850c005
DR   Wikidata; Q54880154
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20653; SLC9A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9A9 (-) 3
AC   CVCL_TP33
SY   HZGHC004850c007; SLC9A9 knockout cell line 152bp insertion
DR   cancercelllines; CVCL_TP33
DR   Horizon_Discovery; HZGHC004850c007
DR   Wikidata; Q54880155
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20653; SLC9A9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004850c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9B2 (-)
AC   CVCL_TP34
SY   HZGHC005621c001; SLC9B2 knockout cell line 103bp insertion
DR   cancercelllines; CVCL_TP34
DR   Horizon_Discovery; HZGHC005621c001
DR   Wikidata; Q54880156
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25143; SLC9B2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005621c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLC9C1 (-) 1
AC   CVCL_TP35
SY   HZGHC002145c004; SLC9C1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TP35
DR   Horizon_Discovery; HZGHC002145c004
DR   Wikidata; Q54880157
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31401; SLC9C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLC9C1 (-) 2
AC   CVCL_TP36
SY   HZGHC002145c012; SLC9C1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TP36
DR   Horizon_Discovery; HZGHC002145c012
DR   Wikidata; Q54880162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31401; SLC9C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLCO1A2 (-)
AC   CVCL_XT43
SY   HZGHC007168c006; HZGHC6579; SLCO1A2 knockout cell line 2bp deletion in exon 5
DR   cancercelllines; CVCL_XT43
DR   Horizon_Discovery; HZGHC007168c006
DR   Wikidata; Q93968808
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10956; SLCO1A2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLCO3A1 (-) 1
AC   CVCL_TP37
SY   HZGHC005913c012; SLCO3A1 knockout cell line 7bp deletion; HAP1 SLCO3A1 (-)
DR   cancercelllines; CVCL_TP37
DR   Horizon_Discovery; HZGHC005913c012
DR   Wikidata; Q54880163
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10952; SLCO3A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLCO3A1 (-) 2
AC   CVCL_XT44
SY   HZGHC005913c006; SLCO3A1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT44
DR   Horizon_Discovery; HZGHC005913c006
DR   Wikidata; Q93968821
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10952; SLCO3A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLCO4A1 (-) 1
AC   CVCL_TP38
SY   HZGHC005501c004; SLCO4A1 knockout cell line 2bp deletion; HAP1 SLCO4A1 (-)
DR   cancercelllines; CVCL_TP38
DR   Horizon_Discovery; HZGHC005501c004
DR   Wikidata; Q54880164
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10953; SLCO4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLCO4A1 (-) 2
AC   CVCL_XT45
SY   HZGHC005501c006; SLCO4A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT45
DR   Horizon_Discovery; HZGHC005501c006
DR   Wikidata; Q93968832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10953; SLCO4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLCO4A1 (-) 3
AC   CVCL_XT46
SY   HZGHC005501c007; SLCO4A1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT46
DR   Horizon_Discovery; HZGHC005501c007
DR   Wikidata; Q93968834
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10953; SLCO4A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLCO5A1 (-) 1
AC   CVCL_TP39
SY   HZGHC005623c012; SLCO5A1 knockout cell line 32bp deletion; HAP1 SLCO5A1 (-)
DR   cancercelllines; CVCL_TP39
DR   Horizon_Discovery; HZGHC005623c012
DR   Wikidata; Q54880165
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19046; SLCO5A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLCO5A1 (-) 2
AC   CVCL_XT47
SY   HZGHC005623c004; SLCO5A1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT47
DR   Horizon_Discovery; HZGHC005623c004
DR   Wikidata; Q93968846
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19046; SLCO5A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLCO5A1 (-) 3
AC   CVCL_XT48
SY   HZGHC005623c006; SLCO5A1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT48
DR   Horizon_Discovery; HZGHC005623c006
DR   Wikidata; Q93968848
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19046; SLCO5A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLFN11 (-) 1
AC   CVCL_TP40
SY   HZGHC006593c004; SLFN11 knockout cell line 10bp deletion in exon 2; HAP1 SLFN11 (-)
DR   cancercelllines; CVCL_TP40
DR   Horizon_Discovery; HZGHC006593c004
DR   Wikidata; Q54880167
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SLFN11 (-) 2
AC   CVCL_XT49
SY   HZGHC006593c008; SLFN11 knockout cell line 2bp deletion in exon 2
DR   cancercelllines; CVCL_XT49
DR   Horizon_Discovery; HZGHC006593c008
DR   Wikidata; Q93968861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLIT2 (-) 1
AC   CVCL_TP41
SY   HZGHC006315c012; SLIT2 knockout cell line 7bp deletion; HAP1 SLIT2 (-)
DR   cancercelllines; CVCL_TP41
DR   Horizon_Discovery; HZGHC006315c012
DR   Wikidata; Q54880168
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11086; SLIT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLIT2 (-) 2
AC   CVCL_XT50
SY   HZGHC006316c002; SLIT2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT50
DR   Horizon_Discovery; HZGHC006316c002
DR   Wikidata; Q93968873
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11086; SLIT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLIT2 (-) 3
AC   CVCL_XT51
SY   HZGHC006316c005; SLIT2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XT51
DR   Horizon_Discovery; HZGHC006316c005
DR   Wikidata; Q93968877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11086; SLIT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLK (-) 1
AC   CVCL_TP42
SY   HZGHC001258c010; SLK knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TP42
DR   Horizon_Discovery; HZGHC001258c010
DR   Wikidata; Q54880169
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11088; SLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLK (-) 2
AC   CVCL_TP43
SY   HZGHC003005c003; SLK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TP43
DR   Horizon_Discovery; HZGHC003005c003
DR   Wikidata; Q54880170
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11088; SLK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLX1B (-) 1
AC   CVCL_TP44
SY   HZGHC002935c002; SLX1B knockout cell line 215bp insertion
DR   cancercelllines; CVCL_TP44
DR   Horizon_Discovery; HZGHC002935c002
DR   Wikidata; Q54880171
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28748; SLX1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002935c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SLX1B (-) 2
AC   CVCL_TP45
SY   HZGHC002935c004; SLX1B knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TP45
DR   Horizon_Discovery; HZGHC002935c004
DR   Wikidata; Q54880172
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28748; SLX1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SLX4 (-)
AC   CVCL_TP46
SY   HZGHC000902c012; SLX4 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TP46
DR   Horizon_Discovery; HZGHC000902c012
DR   Wikidata; Q54880173
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23845; SLX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000902c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMAD4 (-) 1
AC   CVCL_TP47
SY   HZGHC005408c005; SMAD4 knockout cell line 1bp insertion; HAP1 SMAD4 (-)
DR   cancercelllines; CVCL_TP47
DR   Horizon_Discovery; HZGHC005408c005
DR   Wikidata; Q54880174
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMAD4 (-) 2
AC   CVCL_XT52
SY   HZGHC005408c007; SMAD4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT52
DR   Horizon_Discovery; HZGHC005408c007
DR   Wikidata; Q93968961
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMAD4 (-) 3
AC   CVCL_XT53
SY   HZGHC005409c003; SMAD4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XT53
DR   Horizon_Discovery; HZGHC005409c003
DR   Wikidata; Q93968967
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCA2 (-) 1
AC   CVCL_TP48
SY   HZGHC004055c008; SMARCA2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TP48
DR   Horizon_Discovery; HZGHC004055c008
DR   Wikidata; Q54880175
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11098; SMARCA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMARCA2 (-) 2
AC   CVCL_TP49
SY   HZGHC004055c012; SMARCA2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TP49
DR   Horizon_Discovery; HZGHC004055c012
DR   Wikidata; Q54880176
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11098; SMARCA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMARCA4 (-) 1
AC   CVCL_TP50
SY   HZGHC000922c003; SMARCA4 knockout cell line 37bp deletion
DR   cancercelllines; CVCL_TP50
DR   Horizon_Discovery; HZGHC000922c003
DR   Wikidata; Q54880177
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCA4 (-) 2
AC   CVCL_TP51
SY   HZGHC000922c004; SMARCA4 knockout cell line 41bp deletion
DR   cancercelllines; CVCL_TP51
DR   Horizon_Discovery; HZGHC000922c004
DR   Wikidata; Q54880178
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCA4 (-) 3
AC   CVCL_TP52
SY   HZGHC002878c004; SMARCA4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP52
DR   Horizon_Discovery; HZGHC002878c004
DR   Wikidata; Q54880179
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCA4 (-) 4
AC   CVCL_TP53
SY   HZGHC002878c006; SMARCA4 knockout cell line 10bp deletion in exon 1
DR   cancercelllines; CVCL_TP53
DR   Horizon_Discovery; HZGHC002878c006
DR   Wikidata; Q54880180
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMARCA4 (-) 5
AC   CVCL_TP54
SY   HZGHC004218c005; SMARCA4 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TP54
DR   Horizon_Discovery; HZGHC004218c005
DR   Wikidata; Q54880181
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCAL1 (-) 1
AC   CVCL_E2K7
SY   HZGHC007949c006
DR   Horizon_Discovery; HZGHC007949c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMARCAL1 (-) 2
AC   CVCL_E2K8
SY   HZGHC007949c009
DR   Horizon_Discovery; HZGHC007949c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMARCAL1 (-) 3
AC   CVCL_E2K9
SY   HZGHC007949c010
DR   Horizon_Discovery; HZGHC007949c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMARCC1 (-) 1
AC   CVCL_TP55
SY   HZGHC002476c011; SMARCC1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TP55
DR   Horizon_Discovery; HZGHC002476c011
DR   Wikidata; Q54880182
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCC1 (-) 2
AC   CVCL_TP56
SY   HZGHC002476c012; SMARCC1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP56
DR   Horizon_Discovery; HZGHC002476c012
DR   Wikidata; Q54880183
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCC2 (-) 1
AC   CVCL_TP57
SY   HZGHC002783c011; SMARCC2 knockout cell line 2bp deletion; HAP1 SMARCC2 (-)
DR   cancercelllines; CVCL_TP57
DR   Horizon_Discovery; HZGHC002783c011
DR   Wikidata; Q54880184
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11105; SMARCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMARCC2 (-) 2
AC   CVCL_XT54
SY   HZGHC006062c010; SMARCC2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XT54
DR   Horizon_Discovery; HZGHC006062c010
DR   Wikidata; Q93969102
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11105; SMARCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCD1 (-) 1
AC   CVCL_TP58
SY   HZGHC002478c001; SMARCD1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TP58
DR   Horizon_Discovery; HZGHC002478c001
DR   Wikidata; Q54880185
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11106; SMARCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCD1 (-) 2
AC   CVCL_TP59
SY   HZGHC002478c006; SMARCD1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TP59
DR   Horizon_Discovery; HZGHC002478c006
DR   Wikidata; Q54880186
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11106; SMARCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCD1 (-) 3
AC   CVCL_TP60
SY   HZGHC002478c010; SMARCD1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP60
DR   Horizon_Discovery; HZGHC002478c010
DR   Wikidata; Q54880187
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11106; SMARCD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCD2 (-)
AC   CVCL_TP61
SY   HZGHC002782c010; SMARCD2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TP61
DR   Horizon_Discovery; HZGHC002782c010
DR   Wikidata; Q54880189
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11107; SMARCD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCD3 (-) 1
AC   CVCL_TP62
SY   HZGHC002480c002; SMARCD3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TP62
DR   Horizon_Discovery; HZGHC002480c002
DR   Wikidata; Q54880190
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11108; SMARCD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMARCD3 (-) 2
AC   CVCL_TP63
SY   HZGHC002480c012; SMARCD3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TP63
DR   Horizon_Discovery; HZGHC002480c012
DR   Wikidata; Q54880191
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11108; SMARCD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMCHD1 (-)
AC   CVCL_XT55
SY   HZGHC007271c006; HZGHC23347; SMCHD1 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_XT55
DR   Horizon_Discovery; HZGHC007271c006
DR   Wikidata; Q93969148
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29090; SMCHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMCR8 (-)
AC   CVCL_TP64
SY   HZGHC003606c011; SMCR8 knockout cell line 7bp deletion in exon 1
DR   cancercelllines; CVCL_TP64
DR   Horizon_Discovery; HZGHC003606c011
DR   Wikidata; Q54880192
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17921; SMCR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMG7 (-)
AC   CVCL_E2KA
SY   HZGHC007996c030
DR   Horizon_Discovery; HZGHC007996c030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16792; SMG7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMG8 (-)
AC   CVCL_E2KB
SY   HZGHC007408c007
DR   Horizon_Discovery; HZGHC007408c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25551; SMG8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMG9 (-)
AC   CVCL_E2KC
SY   HZGHC007409c009
DR   Horizon_Discovery; HZGHC007409c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25763; SMG9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMIM26 (-) 1
AC   CVCL_E2KD
SY   HZGHC007777c011
DR   Horizon_Discovery; HZGHC007777c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43430; SMIM26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMIM26 (-) 2
AC   CVCL_E2KE
SY   HZGHC007777c012
DR   Horizon_Discovery; HZGHC007777c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43430; SMIM26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SMO (-) 1
AC   CVCL_TP65
SY   HZGHC003175c010; SMO knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TP65
DR   Horizon_Discovery; HZGHC003175c010
DR   Wikidata; Q54880193
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMO (-) 2
AC   CVCL_TP66
SY   HZGHC003175c012; SMO knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TP66
DR   Horizon_Discovery; HZGHC003175c012
DR   Wikidata; Q54880194
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMOX (-) 1
AC   CVCL_TP67
SY   HZGHC001955c010; SMOX knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TP67
DR   Horizon_Discovery; HZGHC001955c010
DR   Wikidata; Q54880195
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15862; SMOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMOX (-) 2
AC   CVCL_TP68
SY   HZGHC001955c011; SMOX knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TP68
DR   Horizon_Discovery; HZGHC001955c011
DR   Wikidata; Q54880196
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15862; SMOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMPD1 (-) 1
AC   CVCL_TP69
SY   HZGHC002979c005; SMPD1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP69
DR   Horizon_Discovery; HZGHC002979c005
DR   Wikidata; Q54880197
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMPD1 (-) 2
AC   CVCL_TP70
SY   HZGHC002979c012; SMPD1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TP70
DR   Horizon_Discovery; HZGHC002979c012
DR   Wikidata; Q54880198
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMS (-)
AC   CVCL_TP71
SY   HZGHC003824c010; SMS knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP71
DR   Horizon_Discovery; HZGHC003824c010
DR   Wikidata; Q54880199
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11123; SMS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMTN (-) 1
AC   CVCL_TP72
SY   HZGHC006246c012; SMTN knockout cell line 10bp deletion; HAP1 SMTN (-)
DR   cancercelllines; CVCL_TP72
DR   Horizon_Discovery; HZGHC006246c012
DR   Wikidata; Q54880200
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11126; SMTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMTN (-) 2
AC   CVCL_XT56
SY   HZGHC006246c007; SMTN knockout cell line 194bp insertion
DR   cancercelllines; CVCL_XT56
DR   Horizon_Discovery; HZGHC006246c007
DR   Wikidata; Q93969223
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11126; SMTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006246c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMUG1 (-)
AC   CVCL_TP73
SY   HZGHC003300c009; SMUG1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP73
DR   Horizon_Discovery; HZGHC003300c009
DR   Wikidata; Q54880201
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17148; SMUG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMURF1 (-)
AC   CVCL_XT57
SY   HZGHC007207c011; HZGHC57154; SMURF1 knockout cell line 7bp deletion in exon 5
DR   cancercelllines; CVCL_XT57
DR   Horizon_Discovery; HZGHC007207c011
DR   Wikidata; Q93969235
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMURF2 (-)
AC   CVCL_XT58
SY   HZGHC007209c003; HZGHC64750; SMURF2 knockout cell line 1bp insertion in exon 8
DR   cancercelllines; CVCL_XT58
DR   Horizon_Discovery; HZGHC007209c003
DR   Wikidata; Q93969239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16809; SMURF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMYD3 (-) 1
AC   CVCL_TP74
SY   HZGHC006042c010; SMYD3 knockout cell line 10bp deletion; HAP1 SMYD3 (-)
DR   cancercelllines; CVCL_TP74
DR   Horizon_Discovery; HZGHC006042c010
DR   Wikidata; Q54880202
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15513; SMYD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMYD3 (-) 2
AC   CVCL_XT59
SY   HZGHC006042c004; SMYD3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XT59
DR   Horizon_Discovery; HZGHC006042c004
DR   Wikidata; Q93969250
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15513; SMYD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SMYD5 (-) 1
AC   CVCL_TP75
SY   HZGHC005249c011; SMYD5 knockout cell line 140bp deletion; HAP1 SMYD5 (-)
DR   cancercelllines; CVCL_TP75
DR   Horizon_Discovery; HZGHC005249c011
DR   Wikidata; Q54880203
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16258; SMYD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SMYD5 (-) 2
AC   CVCL_XT60
SY   HZGHC005249c002; SMYD5 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XT60
DR   Horizon_Discovery; HZGHC005249c002
DR   Wikidata; Q93969262
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16258; SMYD5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNAP23 (-) 1
AC   CVCL_TP76
SY   HZGHC002610c004; SNAP23 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP76
DR   Horizon_Discovery; HZGHC002610c004
DR   Wikidata; Q54880210
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11131; SNAP23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002610c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SNAP23 (-) 2
AC   CVCL_TP77
SY   HZGHC002610c005; SNAP23 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP77
DR   Horizon_Discovery; HZGHC002610c005
DR   Wikidata; Q54880211
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11131; SNAP23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002610c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SNAP23 (-) 3
AC   CVCL_TP78
SY   HZGHC002609c003; SNAP23 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TP78
DR   Horizon_Discovery; HZGHC002609c003
DR   Wikidata; Q54880212
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11131; SNAP23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNAP23 (-) 4
AC   CVCL_TP79
SY   HZGHC002609c010; SNAP23 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TP79
DR   Horizon_Discovery; HZGHC002609c010
DR   Wikidata; Q54880213
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11131; SNAP23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNAP23 (-) 5
AC   CVCL_TP80
SY   HZGHC002610c011; SNAP23 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP80
DR   Horizon_Discovery; HZGHC002610c011
DR   Wikidata; Q54880214
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11131; SNAP23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNCA (-) 1
AC   CVCL_TP81
SY   HZGHC003210c011; SNCA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP81
DR   Horizon_Discovery; HZGHC003210c011
DR   Wikidata; Q54880215
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003210c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SNCA (-) 2
AC   CVCL_TP82
SY   HZGHC003210c003; SNCA knockout cell line 103bp deletion in exon 4
DR   cancercelllines; CVCL_TP82
DR   Horizon_Discovery; HZGHC003210c003
DR   Wikidata; Q54880216
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SNCA (-) 3
AC   CVCL_TP83
SY   HZGHC003210c010; SNCA knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_TP83
DR   Horizon_Discovery; HZGHC003210c010
DR   Wikidata; Q54880217
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SNCA (-) SNCB (-)
AC   CVCL_DX61
SY   HZGHC007870c004; Double knockout cell line SNCA 1bp insertion in exon 4 and SNCB 17bp deletion
DR   Horizon_Discovery; HZGHC007870c004
DR   Wikidata; Q127381099
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11140; SNCB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TP83 ! HAP1 SNCA (-) 3
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SNCB (-)
AC   CVCL_DX11
SY   HZGHC007803c001; SNCB knockout cell line 86bp deletion in exon 4
DR   Horizon_Discovery; HZGHC007803c001
DR   Wikidata; Q127381100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11140; SNCB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 SND1 (-)
AC   CVCL_E2KF
SY   HZGHC007964c004
DR   Horizon_Discovery; HZGHC007964c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30646; SND1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SNRK (-)
AC   CVCL_TP84
SY   HZGHC000252c008; SNRK knockout cell line 319bp insertion
DR   cancercelllines; CVCL_TP84
DR   Horizon_Discovery; HZGHC000252c008
DR   Wikidata; Q54880218
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30598; SNRK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000252c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SNX10 (-) 1
AC   CVCL_TP85
SY   HZGHC004363c003; SNX10 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TP85
DR   Horizon_Discovery; HZGHC004363c003
DR   Wikidata; Q54880219
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14974; SNX10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX10 (-) 2
AC   CVCL_TP86
SY   HZGHC004363c006; SNX10 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TP86
DR   Horizon_Discovery; HZGHC004363c006
DR   Wikidata; Q54880220
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14974; SNX10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX10 (-) 3
AC   CVCL_XT61
SY   HZGHC006099c011; SNX10 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XT61
DR   Horizon_Discovery; HZGHC006099c011
DR   Wikidata; Q93969342
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14974; SNX10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX10 (-) 4
AC   CVCL_XT62
SY   HZGHC006099c012; SNX10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XT62
DR   Horizon_Discovery; HZGHC006099c012
DR   Wikidata; Q93969345
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14974; SNX10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX13 (-)
AC   CVCL_E2KG
SY   HZGHC007780c011
DR   Horizon_Discovery; HZGHC007780c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21335; SNX13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SNX17 (-) 1
AC   CVCL_TP87
SY   HZGHC003416c006; SNX17 knockout cell line 179bp insertion
DR   cancercelllines; CVCL_TP87
DR   Horizon_Discovery; HZGHC003416c006
DR   Wikidata; Q54880221
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14979; SNX17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003416c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SNX17 (-) 2
AC   CVCL_TP88
SY   HZGHC003416c008; SNX17 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TP88
DR   Horizon_Discovery; HZGHC003416c008
DR   Wikidata; Q54880222
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14979; SNX17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX19 (-) 1
AC   CVCL_XT63
SY   HZGHC006894c008; HZGHC399979; SNX19 knockout cell line 4bp deletion in exon 1; HAP1 SNX19 (-)
DR   cancercelllines; CVCL_XT63
DR   Horizon_Discovery; HZGHC006894c008
DR   Wikidata; Q93969352
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21532; SNX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SNX19 (-) 2
AC   CVCL_E2KH
SY   HZGHC006893c001
DR   Horizon_Discovery; HZGHC006893c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21532; SNX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SNX19 (-) 3
AC   CVCL_E2KI
SY   HZGHC006893c004
DR   Horizon_Discovery; HZGHC006893c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21532; SNX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SNX19 (-) 4
AC   CVCL_E2KJ
SY   HZGHC006894c005
DR   Horizon_Discovery; HZGHC006894c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21532; SNX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SNX19 (-) 5
AC   CVCL_E2KK
SY   HZGHC006894c010
DR   Horizon_Discovery; HZGHC006894c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21532; SNX19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SNX3 (-) 1
AC   CVCL_TP89
SY   HZGHC002795c010; SNX3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TP89
DR   Horizon_Discovery; HZGHC002795c010
DR   Wikidata; Q54880223
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11174; SNX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX3 (-) 2
AC   CVCL_TP90
SY   HZGHC002795c011; SNX3 knockout cell line 38bp deletion
DR   cancercelllines; CVCL_TP90
DR   Horizon_Discovery; HZGHC002795c011
DR   Wikidata; Q54880225
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11174; SNX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX9 (-) 1
AC   CVCL_TP91
SY   HZGHC002803c005; SNX9 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TP91
DR   Horizon_Discovery; HZGHC002803c005
DR   Wikidata; Q54880226
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14973; SNX9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX9 (-) 2
AC   CVCL_TP92
SY   HZGHC002803c010; SNX9 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TP92
DR   Horizon_Discovery; HZGHC002803c010
DR   Wikidata; Q54880227
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14973; SNX9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SNX9 (-) 3
AC   CVCL_TP93
SY   HZGHC002810c005; SNX9 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TP93
DR   Horizon_Discovery; HZGHC002810c005
DR   Wikidata; Q54880228
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14973; SNX9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SOAT1 (-) 1
AC   CVCL_TP94
SY   HZGHC003789c001; SOAT1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TP94
DR   Horizon_Discovery; HZGHC003789c001
DR   Wikidata; Q54880229
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11177; SOAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SOAT1 (-) 2
AC   CVCL_TP95
SY   HZGHC003789c008; SOAT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP95
DR   Horizon_Discovery; HZGHC003789c008
DR   Wikidata; Q54880230
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11177; SOAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SOAT1 (-) 3
AC   CVCL_TP96
SY   HZGHC003789c010; SOAT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TP96
DR   Horizon_Discovery; HZGHC003789c010
DR   Wikidata; Q54880231
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11177; SOAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SOCS2 (-)
AC   CVCL_XT64
SY   HZGHC007147c009; HZGHC8835; SOCS2 knockout cell line 1bp insertion in exon 1
DR   cancercelllines; CVCL_XT64
DR   Horizon_Discovery; HZGHC007147c009
DR   Wikidata; Q93969388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19382; SOCS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SOCS3 (-) 1
AC   CVCL_TP97
SY   HZGHC005447c010; SOCS3 knockout cell line 25bp deletion; HAP1 SOCS3 (-)
DR   cancercelllines; CVCL_TP97
DR   Horizon_Discovery; HZGHC005447c010
DR   Wikidata; Q54880232
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SOCS3 (-) 2
AC   CVCL_XT65
SY   HZGHC006290c011; SOCS3 knockout cell line 323bp insertion
DR   cancercelllines; CVCL_XT65
DR   Horizon_Discovery; HZGHC006290c011
DR   Wikidata; Q93969395
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006290c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SOCS3 (-) 3
AC   CVCL_XT66
SY   HZGHC006290c012; SOCS3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XT66
DR   Horizon_Discovery; HZGHC006290c012
DR   Wikidata; Q93969397
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SOD2 (-)
AC   CVCL_TP98
SY   HZGHC002751c002; SOD2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TP98
DR   Horizon_Discovery; HZGHC002751c002
DR   Wikidata; Q54880233
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11180; SOD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002751c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SORD (-) 1
AC   CVCL_TP99
SY   HZGHC006543c001; SORD knockout cell line 2bp insertion; HAP1 SORD (-)
DR   cancercelllines; CVCL_TP99
DR   Horizon_Discovery; HZGHC006543c001
DR   Wikidata; Q54880234
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11184; SORD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SORD (-) 2
AC   CVCL_XT68
SY   HZGHC006543c005; SORD knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XT68
DR   Horizon_Discovery; HZGHC006543c005
DR   Wikidata; Q93969415
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11184; SORD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SORL1 (-) 1
AC   CVCL_E2KL
SY   HZGHC008111c011
DR   Horizon_Discovery; HZGHC008111c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11185; SORL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SORL1 (-) 2
AC   CVCL_E2KM
SY   HZGHC008111c012
DR   Horizon_Discovery; HZGHC008111c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11185; SORL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SORT1 (-) 1
AC   CVCL_TQ00
SY   HZGHC001782c002; SORT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ00
DR   Horizon_Discovery; HZGHC001782c002
DR   Wikidata; Q54880235
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11186; SORT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SORT1 (-) 2
AC   CVCL_TQ01
SY   HZGHC001782c010; SORT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ01
DR   Horizon_Discovery; HZGHC001782c010
DR   Wikidata; Q54880236
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11186; SORT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SOX5 (-) 1
AC   CVCL_TQ02
SY   HZGHC003888c011; SOX5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TQ02
DR   Horizon_Discovery; HZGHC003888c011
DR   Wikidata; Q54880237
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11201; SOX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SOX5 (-) 2
AC   CVCL_TQ03
SY   HZGHC003888c004; SOX5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TQ03
DR   Horizon_Discovery; HZGHC003888c004
DR   Wikidata; Q54880238
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11201; SOX5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003888c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SP1 (-)
AC   CVCL_TQ04
SY   HZGHC001141c002; SP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ04
DR   Horizon_Discovery; HZGHC001141c002
DR   Wikidata; Q54880239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP100 (-) 1
AC   CVCL_TQ05
SY   HZGHC000952c005; SP100 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TQ05
DR   Horizon_Discovery; HZGHC000952c005
DR   Wikidata; Q54880240
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11206; SP100.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP100 (-) 2
AC   CVCL_TQ06
SY   HZGHC000952c008; SP100 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TQ06
DR   Horizon_Discovery; HZGHC000952c008
DR   Wikidata; Q54880241
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11206; SP100.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP110 (-) 1
AC   CVCL_TQ07
SY   HZGHC000949c004; SP110 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ07
DR   Horizon_Discovery; HZGHC000949c004
DR   Wikidata; Q54880242
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5401; SP110.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP110 (-) 2
AC   CVCL_TQ08
SY   HZGHC000949c010; SP110 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TQ08
DR   Horizon_Discovery; HZGHC000949c010
DR   Wikidata; Q54880243
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5401; SP110.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP140 (-) 1
AC   CVCL_TQ09
SY   HZGHC000953c003; SP140 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TQ09
DR   Horizon_Discovery; HZGHC000953c003
DR   Wikidata; Q54880244
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17133; SP140.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP140 (-) 2
AC   CVCL_TQ10
SY   HZGHC000953c007; SP140 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TQ10
DR   Horizon_Discovery; HZGHC000953c007
DR   Wikidata; Q54880245
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17133; SP140.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP3 (-) 1
AC   CVCL_TQ11
SY   HZGHC001142c007; SP3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ11
DR   Horizon_Discovery; HZGHC001142c007
DR   Wikidata; Q54880246
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11208; SP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SP3 (-) 2
AC   CVCL_TQ12
SY   HZGHC001142c010; SP3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ12
DR   Horizon_Discovery; HZGHC001142c010
DR   Wikidata; Q54880247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11208; SP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001142c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPAG9 (-) 1
AC   CVCL_XT69
SY   HZGHC007115c008; HZGHC9043; SPAG9 knockout cell line 2bp insertion in exon 8; HAP1 SPAG9 (-)
DR   cancercelllines; CVCL_XT69
DR   Horizon_Discovery; HZGHC007115c008
DR   Wikidata; Q93969558
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14524; SPAG9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SPAG9 (-) 2
AC   CVCL_E2KN
SY   HZGHC007115c005; SPAG9 knockout cell line 1bp insertion in exon 8
DR   Horizon_Discovery; HZGHC007115c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14524; SPAG9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SPARC (-) 1
AC   CVCL_TQ13
SY   HZGHC005481c001; SPARC knockout cell line 5bp deletion; HAP1 SPARC (-)
DR   cancercelllines; CVCL_TQ13
DR   Horizon_Discovery; HZGHC005481c001
DR   Wikidata; Q54880248
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11219; SPARC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPARC (-) 2
AC   CVCL_XT70
SY   HZGHC005481c010; SPARC knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XT70
DR   Horizon_Discovery; HZGHC005481c010
DR   Wikidata; Q93969575
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11219; SPARC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPAST (-)
AC   CVCL_E2KP
SY   HZGHC007766c012
DR   Horizon_Discovery; HZGHC007766c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SPATA20 (-) 1
AC   CVCL_TQ14
SY   HZGHC005792c005; SPATA20 knockout cell line 20bp deletion; HAP1 SPATA20 (-)
DR   cancercelllines; CVCL_TQ14
DR   Horizon_Discovery; HZGHC005792c005
DR   Wikidata; Q54880249
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26125; SPATA20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPATA20 (-) 2
AC   CVCL_XT71
SY   HZGHC005792c009; SPATA20 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XT71
DR   Horizon_Discovery; HZGHC005792c009
DR   Wikidata; Q93969591
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26125; SPATA20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPATA20 (-) 3
AC   CVCL_XT72
SY   HZGHC005793c010; SPATA20 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XT72
DR   Horizon_Discovery; HZGHC005793c010
DR   Wikidata; Q93969595
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26125; SPATA20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPATA20 (-) 4
AC   CVCL_XT73
SY   HZGHC005793c011; SPATA20 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XT73
DR   Horizon_Discovery; HZGHC005793c011
DR   Wikidata; Q93969601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26125; SPATA20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPEG (-) 1
AC   CVCL_TQ15
SY   HZGHC000351c002; SPEG knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TQ15
DR   Horizon_Discovery; HZGHC000351c002
DR   Wikidata; Q54880250
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16901; SPEG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPEG (-) 2
AC   CVCL_TQ16
SY   HZGHC000351c012; SPEG knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ16
DR   Horizon_Discovery; HZGHC000351c012
DR   Wikidata; Q54880255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16901; SPEG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPEG (-) 3
AC   CVCL_TQ17
SY   HZGHC000351c016; SPEG knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TQ17
DR   Horizon_Discovery; HZGHC000351c016
DR   Wikidata; Q54880256
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16901; SPEG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPG11 (-)
AC   CVCL_C6IE
SY   HZGHC007971c006; SPG11 knockout cell line 2bp deletion
DR   Horizon_Discovery; HZGHC007971c006
DR   Wikidata; Q116049286
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11226; SPG11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HAP1 SPG21 (-)
AC   CVCL_TQ18
SY   HZGHC003464c002; SPG21 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ18
DR   Horizon_Discovery; HZGHC003464c002
DR   Wikidata; Q54880257
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20373; SPG21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003464c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPHK1 (-)
AC   CVCL_E2KQ
SY   HZGHC007644c005
DR   Horizon_Discovery; HZGHC007644c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SPHK2 (-) 1
AC   CVCL_E2KR
SY   HZGHC007645c003
DR   Horizon_Discovery; HZGHC007645c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SPHK2 (-) 2
AC   CVCL_E2KS
SY   HZGHC007645c008
DR   Horizon_Discovery; HZGHC007645c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SPHK2 (-) 3
AC   CVCL_E2KT
SY   HZGHC007645c011
DR   Horizon_Discovery; HZGHC007645c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SPIRE1 (-) 1
AC   CVCL_TQ19
SY   HZGHC004243c005; SPIRE1 knockout cell line 86bp deletion
DR   cancercelllines; CVCL_TQ19
DR   Horizon_Discovery; HZGHC004243c005
DR   Wikidata; Q54880258
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30622; SPIRE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPIRE1 (-) 2
AC   CVCL_TQ20
SY   HZGHC004243c008; SPIRE1 knockout cell line 164bp insertion
DR   cancercelllines; CVCL_TQ20
DR   Horizon_Discovery; HZGHC004243c008
DR   Wikidata; Q54880259
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30622; SPIRE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004243c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPNS1 (-) 1
AC   CVCL_TQ21
SY   HZGHC006420c011; SPNS1 knockout cell line 1bp insertion; HAP1 SPNS1 (-)
DR   cancercelllines; CVCL_TQ21
DR   Horizon_Discovery; HZGHC006420c011
DR   Wikidata; Q54880260
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPNS1 (-) 2
AC   CVCL_XT74
SY   HZGHC006420c005; SPNS1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT74
DR   Horizon_Discovery; HZGHC006420c005
DR   Wikidata; Q93969712
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006420c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPNS1 (-) 3
AC   CVCL_XT75
SY   HZGHC006420c012; SPNS1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT75
DR   Horizon_Discovery; HZGHC006420c012
DR   Wikidata; Q93969718
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006420c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPNS1 (-) 4
AC   CVCL_XT76
SY   HZGHC006421c011; SPNS1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XT76
DR   Horizon_Discovery; HZGHC006421c011
DR   Wikidata; Q93969724
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPNS1 (-) 5
AC   CVCL_XT77
SY   HZGHC006421c012; SPNS1 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_XT77
DR   Horizon_Discovery; HZGHC006421c012
DR   Wikidata; Q93969730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPOP (-)
AC   CVCL_XT78
SY   HZGHC007297c006; HZGHC8405; SPOP knockout cell line 47bp insertion in exon 5
DR   cancercelllines; CVCL_XT78
DR   Horizon_Discovery; HZGHC007297c006
DR   Wikidata; Q93969737
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11254; SPOP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007297c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SPP1 (-) 1
AC   CVCL_TQ22
SY   HZGHC006663c009; SPP1 knockout cell line 1bp insertion; HAP1 SPP1 (-)
DR   cancercelllines; CVCL_TQ22
DR   Horizon_Discovery; HZGHC006663c009
DR   Wikidata; Q54880261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPP1 (-) 2
AC   CVCL_XT79
SY   HZGHC006664c003; SPP1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XT79
DR   Horizon_Discovery; HZGHC006664c003
DR   Wikidata; Q93969758
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPP1 (-) 3
AC   CVCL_XT80
SY   HZGHC006664c012; SPP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XT80
DR   Horizon_Discovery; HZGHC006664c012
DR   Wikidata; Q93969763
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006664c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPR (-) 1
AC   CVCL_TQ23
SY   HZGHC005173c001; SPR knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TQ23
DR   Horizon_Discovery; HZGHC005173c001
DR   Wikidata; Q54880262
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11257; SPR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPR (-) 2
AC   CVCL_TQ24
SY   HZGHC005173c010; SPR knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TQ24
DR   Horizon_Discovery; HZGHC005173c010
DR   Wikidata; Q54880263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11257; SPR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPRED2 (-) 1
AC   CVCL_TQ25
SY   HZGHC004189c003; SPRED2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TQ25
DR   Horizon_Discovery; HZGHC004189c003
DR   Wikidata; Q54880264
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17722; SPRED2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPRED2 (-) 2
AC   CVCL_TQ26
SY   HZGHC004189c012; SPRED2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ26
DR   Horizon_Discovery; HZGHC004189c012
DR   Wikidata; Q54880265
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17722; SPRED2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPRYD4 (-) 1
AC   CVCL_TQ27
SY   HZGHC005794c008; SPRYD4 knockout cell line 17bp deletion; HAP1 SPRYD4 (-)
DR   cancercelllines; CVCL_TQ27
DR   Horizon_Discovery; HZGHC005794c008
DR   Wikidata; Q54880266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27468; SPRYD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPRYD4 (-) 2
AC   CVCL_XT81
SY   HZGHC005794c009; SPRYD4 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_XT81
DR   Horizon_Discovery; HZGHC005794c009
DR   Wikidata; Q93969829
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27468; SPRYD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPRYD4 (-) 3
AC   CVCL_XT82
SY   HZGHC005795c001; SPRYD4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XT82
DR   Horizon_Discovery; HZGHC005795c001
DR   Wikidata; Q93969835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27468; SPRYD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPRYD4 (-) 4
AC   CVCL_XT83
SY   HZGHC005795c011; SPRYD4 knockout cell line 37bp deletion
DR   cancercelllines; CVCL_XT83
DR   Horizon_Discovery; HZGHC005795c011
DR   Wikidata; Q93969839
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27468; SPRYD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPTLC1 (-) 1
AC   CVCL_TQ28
SY   HZGHC003579c006; SPTLC1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ28
DR   Horizon_Discovery; HZGHC003579c006
DR   Wikidata; Q54880267
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11277; SPTLC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPTLC1 (-) 2
AC   CVCL_TQ29
SY   HZGHC003579c012; SPTLC1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TQ29
DR   Horizon_Discovery; HZGHC003579c012
DR   Wikidata; Q54880268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11277; SPTLC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SPTLC2 (-) 1
AC   CVCL_TQ30
SY   HZGHC005595c003; SPTLC2 knockout cell line 1bp insertion; HAP1 SPTLC2 (-)
DR   cancercelllines; CVCL_TQ30
DR   Horizon_Discovery; HZGHC005595c003
DR   Wikidata; Q54880269
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11278; SPTLC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPTLC2 (-) 2
AC   CVCL_XT84
SY   HZGHC005595c006; SPTLC2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT84
DR   Horizon_Discovery; HZGHC005595c006
DR   Wikidata; Q93969886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11278; SPTLC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005595c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SPTLC2 (-) 3
AC   CVCL_XT85
SY   HZGHC005596c004; SPTLC2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XT85
DR   Horizon_Discovery; HZGHC005596c004
DR   Wikidata; Q93969891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11278; SPTLC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SQLE (-) 1
AC   CVCL_TQ31
SY   HZGHC003754c006; SQLE knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TQ31
DR   Horizon_Discovery; HZGHC003754c006
DR   Wikidata; Q54880270
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11279; SQLE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SQLE (-) 2
AC   CVCL_TQ32
SY   HZGHC003754c007; SQLE knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TQ32
DR   Horizon_Discovery; HZGHC003754c007
DR   Wikidata; Q54880271
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11279; SQLE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SQRDL (-)
AC   CVCL_TQ33
SY   HZGHC004630c011; SQRDL knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ33
DR   Horizon_Discovery; HZGHC004630c011
DR   Wikidata; Q54880272
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20390; SQOR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SQSTM1 (-) 1
AC   CVCL_TQ34
SY   HZGHC000298c002; SQSTM1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TQ34
DR   Horizon_Discovery; HZGHC000298c002
DR   Wikidata; Q54880273
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SQSTM1 (-) 2
AC   CVCL_TQ35
SY   HZGHC000298c015; SQSTM1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TQ35
DR   Horizon_Discovery; HZGHC000298c015
DR   Wikidata; Q54880274
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRC (-) 1
AC   CVCL_TQ36
SY   HZGHC000348c014; SRC knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TQ36
DR   Horizon_Discovery; HZGHC000348c014
DR   PRIDE; PXD010335
DR   Wikidata; Q54880275
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SRC (-) 2
AC   CVCL_TQ37
SY   HZGHC000348c017; SRC knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TQ37
DR   Horizon_Discovery; HZGHC000348c017
DR   Wikidata; Q54880276
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRC (-) 3
AC   CVCL_TQ38
SY   HZGHC000348c023; SRC knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TQ38
DR   Horizon_Discovery; HZGHC000348c023
DR   Wikidata; Q54880277
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRD5A1 (-) 1
AC   CVCL_TQ39
SY   HZGHC003819c007; SRD5A1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TQ39
DR   Horizon_Discovery; HZGHC003819c007
DR   Wikidata; Q54880278
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11284; SRD5A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRD5A1 (-) 2
AC   CVCL_TQ40
SY   HZGHC003819c009; SRD5A1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ40
DR   Horizon_Discovery; HZGHC003819c009
DR   Wikidata; Q54880279
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11284; SRD5A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SREBF1 (-)
AC   CVCL_TQ41
SY   HZGHC001361c012; SREBF1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TQ41
DR   Horizon_Discovery; HZGHC001361c012
DR   Wikidata; Q54880280
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11289; SREBF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SREBF2 (-) 1
AC   CVCL_TQ42
SY   HZGHC000975c005; SREBF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ42
DR   Horizon_Discovery; HZGHC000975c005
DR   Wikidata; Q54880281
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000975c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SREBF2 (-) 2
AC   CVCL_TQ43
SY   HZGHC000683c004; SREBF2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ43
DR   Horizon_Discovery; HZGHC000683c004
DR   Wikidata; Q54880282
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SREBF2 (-) 3
AC   CVCL_TQ44
SY   HZGHC000683c007; SREBF2 knockout cell line 146bp insertion
DR   cancercelllines; CVCL_TQ44
DR   Horizon_Discovery; HZGHC000683c007
DR   Wikidata; Q54880283
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000683c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SREBF2 (-) 4
AC   CVCL_TQ45
SY   HZGHC000975c003; SREBF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ45
DR   Horizon_Discovery; HZGHC000975c003
DR   Wikidata; Q54880284
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRPK1 (-) 1
AC   CVCL_TQ46
SY   HZGHC000108c003; SRPK1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TQ46
DR   Horizon_Discovery; HZGHC000108c003
DR   Wikidata; Q54880285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRPK1 (-) 2
AC   CVCL_TQ47
SY   HZGHC000108c016; SRPK1 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TQ47
DR   Horizon_Discovery; HZGHC000108c016
DR   PRIDE; PXD010335
DR   Wikidata; Q54880286
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SRPK2 (-)
AC   CVCL_TQ48
SY   HZGHC000280c020; SRPK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TQ48
DR   Horizon_Discovery; HZGHC000280c020
DR   Wikidata; Q54880287
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11306; SRPK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRPK3 (-)
AC   CVCL_TQ49
SY   HZGHC004397c012; SRPK3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TQ49
DR   Horizon_Discovery; HZGHC004397c012
DR   Wikidata; Q54880288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11402; SRPK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRRD (-) 1
AC   CVCL_E2KU
SY   HZGHC008156c011
DR   Horizon_Discovery; HZGHC008156c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33910; SRRD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SRRD (-) 2
AC   CVCL_E2KV
SY   HZGHC008157c011
DR   Horizon_Discovery; HZGHC008157c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33910; SRRD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SRXN1 (-) 1
AC   CVCL_TQ50
SY   HZGHC006355c009; SRXN1 knockout cell line 8bp deletion; HAP1 SRXN1 (-)
DR   cancercelllines; CVCL_TQ50
DR   Horizon_Discovery; HZGHC006355c009
DR   Wikidata; Q54880289
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16132; SRXN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SRXN1 (-) 2
AC   CVCL_XT86
SY   HZGHC006356c003; SRXN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT86
DR   Horizon_Discovery; HZGHC006356c003
DR   Wikidata; Q93970152
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16132; SRXN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SRXN1 (-) 3
AC   CVCL_XT87
SY   HZGHC006356c005; SRXN1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT87
DR   Horizon_Discovery; HZGHC006356c005
DR   Wikidata; Q93970156
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16132; SRXN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006356c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SS18 (-) 1
AC   CVCL_E2KW
SY   HZGHC007415c005
DR   Horizon_Discovery; HZGHC007415c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SS18 (-) 2
AC   CVCL_E2KX
SY   HZGHC007416c010
DR   Horizon_Discovery; HZGHC007416c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SS18L1 (-) 1
AC   CVCL_E2KY
SY   HZGHC007417c004
DR   Horizon_Discovery; HZGHC007417c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15592; SS18L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SS18L1 (-) 2
AC   CVCL_E2KZ
SY   HZGHC007417c007
DR   Horizon_Discovery; HZGHC007417c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15592; SS18L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SS18L1 (-) 3
AC   CVCL_E2L0
SY   HZGHC007417c009
DR   Horizon_Discovery; HZGHC007417c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15592; SS18L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SS18L1 (-) 4
AC   CVCL_E2L1
SY   HZGHC007417c011
DR   Horizon_Discovery; HZGHC007417c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15592; SS18L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SSBP4 (-) 1
AC   CVCL_TQ51
SY   HZGHC006195c001; SSBP4 knockout cell line 2bp insertion; HAP1 SSBP4 (-)
DR   cancercelllines; CVCL_TQ51
DR   Horizon_Discovery; HZGHC006195c001
DR   Wikidata; Q54880290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15676; SSBP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SSBP4 (-) 2
AC   CVCL_XT88
SY   HZGHC006195c002; SSBP4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XT88
DR   Horizon_Discovery; HZGHC006195c002
DR   Wikidata; Q93970173
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15676; SSBP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SSBP4 (-) 3
AC   CVCL_XT89
SY   HZGHC006196c004; SSBP4 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XT89
DR   Horizon_Discovery; HZGHC006196c004
DR   Wikidata; Q93970177
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15676; SSBP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SSTR2 (-)
AC   CVCL_E2L2
SY   HZGHC007849c007
DR   Horizon_Discovery; HZGHC007849c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11331; SSTR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SSTR5 (-)
AC   CVCL_E2L3
SY   HZGHC007851c001
DR   Horizon_Discovery; HZGHC007851c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11334; SSTR5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ST3GAL5 (-) 1
AC   CVCL_TQ52
SY   HZGHC004075c001; ST3GAL5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ52
DR   Horizon_Discovery; HZGHC004075c001
DR   Wikidata; Q54880291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10872; ST3GAL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ST3GAL5 (-) 2
AC   CVCL_TQ53
SY   HZGHC004075c009; ST3GAL5 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TQ53
DR   Horizon_Discovery; HZGHC004075c009
DR   Wikidata; Q54880292
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10872; ST3GAL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAMBP (-)
AC   CVCL_TQ54
SY   HZGHC000484c007; STAMBP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ54
DR   Horizon_Discovery; HZGHC000484c007
DR   Wikidata; Q54880293
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16950; STAMBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAMBPL1 (-) 1
AC   CVCL_TQ55
SY   HZGHC000474c003; STAMBPL1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ55
DR   Horizon_Discovery; HZGHC000474c003
DR   Wikidata; Q54880294
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24105; STAMBPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAMBPL1 (-) 2
AC   CVCL_TQ56
SY   HZGHC000474c007; STAMBPL1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TQ56
DR   Horizon_Discovery; HZGHC000474c007
DR   Wikidata; Q54880296
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24105; STAMBPL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT1 (-) 1
AC   CVCL_TQ57
SY   HZGHC004739c001; STAT1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TQ57
DR   Horizon_Discovery; HZGHC004739c001
DR   Wikidata; Q54880297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT1 (-) 2
AC   CVCL_TQ58
SY   HZGHC004739c010; STAT1 knockout cell line 145bp insertion
DR   cancercelllines; CVCL_TQ58
DR   Horizon_Discovery; HZGHC004739c010
DR   Wikidata; Q54880298
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004739c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STAT1 (-) 3
AC   CVCL_TQ59
SY   HZGHC004946c001; STAT1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ59
DR   Horizon_Discovery; HZGHC004946c001
DR   Wikidata; Q54880299
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT1 (-) 4
AC   CVCL_TQ60
SY   HZGHC004946c002; STAT1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TQ60
DR   Horizon_Discovery; HZGHC004946c002
DR   Wikidata; Q54880300
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT2 (-) 1
AC   CVCL_TQ61
SY   HZGHC006251c010; STAT2 knockout cell line 1bp insertion; HAP1 STAT2 (-)
DR   cancercelllines; CVCL_TQ61
DR   Horizon_Discovery; HZGHC006251c010
DR   Wikidata; Q54880301
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STAT2 (-) 2
AC   CVCL_XT90
SY   HZGHC006251c002; STAT2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XT90
DR   Horizon_Discovery; HZGHC006251c002
DR   Wikidata; Q93970275
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT2 (-) 3
AC   CVCL_XT91
SY   HZGHC006251c008; STAT2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XT91
DR   Horizon_Discovery; HZGHC006251c008
DR   Wikidata; Q93970278
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT3 (-) 1
AC   CVCL_TQ62
SY   HZGHC004516c002; STAT3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TQ62
DR   Horizon_Discovery; HZGHC004516c002
DR   Wikidata; Q54880302
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT3 (-) 2
AC   CVCL_TQ63
SY   HZGHC004516c003; STAT3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ63
DR   Horizon_Discovery; HZGHC004516c003
DR   Wikidata; Q54880303
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT5B (-) 1
AC   CVCL_TQ64
SY   HZGHC005185c001; STAT5B knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TQ64
DR   Horizon_Discovery; HZGHC005185c001
DR   Wikidata; Q54880304
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT5B (-) 2
AC   CVCL_TQ65
SY   HZGHC005185c004; STAT5B knockout cell line 149bp deletion
DR   cancercelllines; CVCL_TQ65
DR   Horizon_Discovery; HZGHC005185c004
DR   Wikidata; Q54880305
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STAT6 (-) 1
AC   CVCL_TQ66
SY   HZGHC006001c004; STAT6 knockout cell line 4bp deletion; HAP1 STAT6 (-)
DR   cancercelllines; CVCL_TQ66
DR   Horizon_Discovery; HZGHC006001c004
DR   Wikidata; Q54880306
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STAT6 (-) 2
AC   CVCL_XT92
SY   HZGHC006001c007; STAT6 knockout cell line 43bp insertion
DR   cancercelllines; CVCL_XT92
DR   Horizon_Discovery; HZGHC006001c007
DR   Wikidata; Q93970310
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006001c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STIM1 (-) 1
AC   CVCL_XT93
SY   HZGHC006253c006; STIM1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XT93
DR   Horizon_Discovery; HZGHC006253c006
DR   Wikidata; Q93970312
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11386; STIM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STIM1 (-) 2
AC   CVCL_XT94
SY   HZGHC006253c009; STIM1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XT94
DR   Horizon_Discovery; HZGHC006253c009
DR   Wikidata; Q93970315
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11386; STIM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STIM1 (-) 3
AC   CVCL_XT95
SY   HZGHC006254c005; STIM1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XT95
DR   Horizon_Discovery; HZGHC006254c005
DR   Wikidata; Q93970317
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11386; STIM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STIM1 (-) 4
AC   CVCL_XT96
SY   HZGHC006254c011; STIM1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XT96
DR   Horizon_Discovery; HZGHC006254c011
DR   Wikidata; Q93970320
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11386; STIM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STIP1 (-) 1
AC   CVCL_TQ68
SY   HZGHC006357c002; STIP1 knockout cell line 5bp deletion; HAP1 STIP1 (-)
DR   cancercelllines; CVCL_TQ68
DR   Horizon_Discovery; HZGHC006357c002
DR   Wikidata; Q54880308
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11387; STIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STIP1 (-) 2
AC   CVCL_XT97
SY   HZGHC006357c005; STIP1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XT97
DR   Horizon_Discovery; HZGHC006357c005
DR   Wikidata; Q93970329
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11387; STIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK10 (-) 1
AC   CVCL_TQ69
SY   HZGHC003322c002; STK10 knockout cell line 241bp insertion
DR   cancercelllines; CVCL_TQ69
DR   Horizon_Discovery; HZGHC003322c002
DR   Wikidata; Q54880309
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11388; STK10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003322c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STK10 (-) 2
AC   CVCL_TQ70
SY   HZGHC003322c008; STK10 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TQ70
DR   Horizon_Discovery; HZGHC003322c008
DR   Wikidata; Q54880310
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11388; STK10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK11 (-) 1
AC   CVCL_TQ71
SY   HZGHC002413c004; STK11 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TQ71
DR   Horizon_Discovery; HZGHC002413c004
DR   Wikidata; Q54880311
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK11 (-) 2
AC   CVCL_TQ72
SY   HZGHC002413c011; STK11 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ72
DR   Horizon_Discovery; HZGHC002413c011
DR   Wikidata; Q54880312
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK16 (-) 1
AC   CVCL_TQ73
SY   HZGHC000065c002; STK16 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TQ73
DR   Horizon_Discovery; HZGHC000065c002
DR   Wikidata; Q54880313
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11394; STK16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK16 (-) 2
AC   CVCL_TQ74
SY   HZGHC000065c007; STK16 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TQ74
DR   Horizon_Discovery; HZGHC000065c007
DR   Wikidata; Q54880314
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11394; STK16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK17A (-)
AC   CVCL_TQ75
SY   HZGHC001251c011; STK17A knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TQ75
DR   Horizon_Discovery; HZGHC001251c011
DR   Wikidata; Q54880315
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11395; STK17A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK17B (-) 1
AC   CVCL_TQ76
SY   HZGHC000066c017; STK17B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TQ76
DR   Horizon_Discovery; HZGHC000066c017
DR   Wikidata; Q54880316
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11396; STK17B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK17B (-) 2
AC   CVCL_TQ77
SY   HZGHC000066c019; STK17B knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TQ77
DR   Horizon_Discovery; HZGHC000066c019
DR   Wikidata; Q54880317
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11396; STK17B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK19 (-) 1
AC   CVCL_TQ78
SY   HZGHC000353c003; STK19 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TQ78
DR   Horizon_Discovery; HZGHC000353c003
DR   Wikidata; Q54880318
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11398; STK19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK19 (-) 2
AC   CVCL_TQ79
SY   HZGHC000353c008; STK19 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TQ79
DR   Horizon_Discovery; HZGHC000353c008
DR   Wikidata; Q54880319
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11398; STK19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK25 (-) 1
AC   CVCL_TQ80
SY   HZGHC034364c002; STK25 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TQ80
DR   Horizon_Discovery; HZGHC034364c002
DR   Wikidata; Q54880320
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11404; STK25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK25 (-) 2
AC   CVCL_TQ81
SY   HZGHC034364c011; STK25 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TQ81
DR   Horizon_Discovery; HZGHC034364c011
DR   Wikidata; Q54880321
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11404; STK25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK25 (-) 3
AC   CVCL_TQ82
SY   HZGHC034364c012; STK25 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TQ82
DR   Horizon_Discovery; HZGHC034364c012
DR   Wikidata; Q54880322
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11404; STK25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK3 (-) 1
AC   CVCL_TQ83
SY   HZGHC001256c002; STK3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TQ83
DR   Horizon_Discovery; HZGHC001256c002
DR   Wikidata; Q54880323
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11406; STK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK3 (-) 2
AC   CVCL_TQ84
SY   HZGHC003006c001; STK3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TQ84
DR   Horizon_Discovery; HZGHC003006c001
DR   Wikidata; Q54880324
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11406; STK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK3 (-) 3
AC   CVCL_TQ85
SY   HZGHC003006c002; STK3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TQ85
DR   Horizon_Discovery; HZGHC003006c002
DR   Wikidata; Q54880325
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11406; STK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK32B (-) 1
AC   CVCL_TQ86
SY   HZGHC000349c006; STK32B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TQ86
DR   Horizon_Discovery; HZGHC000349c006
DR   Wikidata; Q54880326
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14217; STK32B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK32B (-) 2
AC   CVCL_TQ87
SY   HZGHC000349c012; STK32B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ87
DR   Horizon_Discovery; HZGHC000349c012
DR   Wikidata; Q54880327
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14217; STK32B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK32C (-) 1
AC   CVCL_TQ88
SY   HZGHC000067c006; STK32C knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TQ88
DR   Horizon_Discovery; HZGHC000067c006
DR   Wikidata; Q54880328
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21332; STK32C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK32C (-) 2
AC   CVCL_TQ89
SY   HZGHC000067c021; STK32C knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TQ89
DR   Horizon_Discovery; HZGHC000067c021
DR   Wikidata; Q54880329
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21332; STK32C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK33 (-) 1
AC   CVCL_XT98
SY   HZGHC000068c010; STK33 knockout cell line
DR   cancercelllines; CVCL_XT98
DR   Horizon_Discovery; HZGHC000068c010
DR   Wikidata; Q93970445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14568; STK33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000068c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STK33 (-) 2
AC   CVCL_XT99
SY   HZGHC000068c012; STK33 knockout cell line
DR   cancercelllines; CVCL_XT99
DR   Horizon_Discovery; HZGHC000068c012
DR   Wikidata; Q93970449
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14568; STK33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000068c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STK33 (-) 3
AC   CVCL_XU00
SY   HZGHC000068c018; STK33 knockout cell line
DR   cancercelllines; CVCL_XU00
DR   Horizon_Discovery; HZGHC000068c018
DR   Wikidata; Q93970452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14568; STK33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000068c018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STK38 (-)
AC   CVCL_TQ90
SY   HZGHC000242c035; STK38 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ90
DR   Horizon_Discovery; HZGHC000242c035
DR   Wikidata; Q54880330
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17847; STK38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK38L (-)
AC   CVCL_TQ91
SY   HZGHC000249c001; STK38L knockout cell line 37bp deletion
DR   cancercelllines; CVCL_TQ91
DR   Horizon_Discovery; HZGHC000249c001
DR   Wikidata; Q54880331
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17848; STK38L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK39 (-) 1
AC   CVCL_TQ92
SY   HZGHC000069c007; STK39 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TQ92
DR   Horizon_Discovery; HZGHC000069c007
DR   Wikidata; Q54880332
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17717; STK39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK39 (-) 2
AC   CVCL_TQ93
SY   HZGHC000069c012; STK39 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TQ93
DR   Horizon_Discovery; HZGHC000069c012
DR   Wikidata; Q54880333
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17717; STK39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000069c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STK39 (-) 3
AC   CVCL_TQ94
SY   HZGHC000069c020; STK39 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TQ94
DR   Horizon_Discovery; HZGHC000069c020
DR   Wikidata; Q54880334
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17717; STK39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000069c020; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STK4 (-) 1
AC   CVCL_TQ95
SY   HZGHC000109c007; STK4 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TQ95
DR   Horizon_Discovery; HZGHC000109c007
DR   Wikidata; Q54880335
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK4 (-) 2
AC   CVCL_TQ96
SY   HZGHC000109c008; STK4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TQ96
DR   Horizon_Discovery; HZGHC000109c008
DR   Wikidata; Q54880339
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STK40 (-)
AC   CVCL_TQ97
SY   HZGHC000263c005; STK40 knockout cell line 146bp insertion
DR   cancercelllines; CVCL_TQ97
DR   Horizon_Discovery; HZGHC000263c005
DR   Wikidata; Q54880340
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21373; STK40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000263c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STOML2 (-) 1
AC   CVCL_E2L4
SY   HZGHC007816c015
DR   Horizon_Discovery; HZGHC007816c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14559; STOML2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 STOML2 (-) 2
AC   CVCL_E2L5
SY   HZGHC007816c019
DR   Horizon_Discovery; HZGHC007816c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14559; STOML2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 STOML2 (-) 3
AC   CVCL_E2L6
SY   HZGHC007817c023
DR   Horizon_Discovery; HZGHC007817c023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14559; STOML2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 STRADA (-) 1
AC   CVCL_TQ98
SY   HZGHC000176c010; STRADA knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TQ98
DR   Horizon_Discovery; HZGHC000176c010
DR   Wikidata; Q54880341
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30172; STRADA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STRADA (-) 2
AC   CVCL_TQ99
SY   HZGHC000176c011; STRADA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TQ99
DR   Horizon_Discovery; HZGHC000176c011
DR   Wikidata; Q54880342
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30172; STRADA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STRADB (-) 1
AC   CVCL_TR00
SY   HZGHC001495c019; STRADB knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TR00
DR   Horizon_Discovery; HZGHC001495c019
DR   Wikidata; Q54880343
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13205; STRADB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STRADB (-) 2
AC   CVCL_TR01
SY   HZGHC003007c001; STRADB knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR01
DR   Horizon_Discovery; HZGHC003007c001
DR   Wikidata; Q54880344
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13205; STRADB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STRADB (-) 3
AC   CVCL_TR02
SY   HZGHC003007c012; STRADB knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR02
DR   Horizon_Discovery; HZGHC003007c012
DR   Wikidata; Q54880345
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13205; STRADB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STRN3 (-) 1
AC   CVCL_TR03
SY   HZGHC000833c006; STRN3 knockout cell line 185bp insertion
DR   cancercelllines; CVCL_TR03
DR   Horizon_Discovery; HZGHC000833c006
DR   Wikidata; Q54880346
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15720; STRN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000833c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STRN3 (-) 2
AC   CVCL_TR04
SY   HZGHC000833c010; STRN3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR04
DR   Horizon_Discovery; HZGHC000833c010
DR   Wikidata; Q54880347
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15720; STRN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STRN3 (-) 3
AC   CVCL_TR05
SY   HZGHC000834c011; STRN3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR05
DR   Horizon_Discovery; HZGHC000834c011
DR   Wikidata; Q54880348
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15720; STRN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STRN3 (-) 4
AC   CVCL_TR06
SY   HZGHC000834c012; STRN3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TR06
DR   Horizon_Discovery; HZGHC000834c012
DR   Wikidata; Q54880349
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15720; STRN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STS (-)
AC   CVCL_TR07
SY   HZGHC006362c001; STS knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR07
DR   Horizon_Discovery; HZGHC006362c001
DR   Wikidata; Q54880350
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11425; STS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STX17 (-) 1
AC   CVCL_TR08
SY   HZGHC006011c001; STX17 knockout cell line 1bp insertion; HAP1 STX17 (-)
DR   cancercelllines; CVCL_TR08
DR   Horizon_Discovery; HZGHC006011c001
DR   Wikidata; Q54880351
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11432; STX17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STX17 (-) 2
AC   CVCL_XU01
SY   HZGHC006011c003; STX17 knockout cell line 128bp insertion
DR   cancercelllines; CVCL_XU01
DR   Horizon_Discovery; HZGHC006011c003
DR   Wikidata; Q93970700
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11432; STX17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006011c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STX17 (-) 3
AC   CVCL_XU02
SY   HZGHC006011c005; STX17 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU02
DR   Horizon_Discovery; HZGHC006011c005
DR   Wikidata; Q93970705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11432; STX17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STX2 (-) 1
AC   CVCL_TR09
SY   HZGHC002616c005; STX2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR09
DR   Horizon_Discovery; HZGHC002616c005
DR   Wikidata; Q54880352
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3403; STX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002616c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STX2 (-) 2
AC   CVCL_TR10
SY   HZGHC002615c002; STX2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR10
DR   Horizon_Discovery; HZGHC002615c002
DR   Wikidata; Q54880353
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3403; STX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STX2 (-) 3
AC   CVCL_TR11
SY   HZGHC002615c012; STX2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TR11
DR   Horizon_Discovery; HZGHC002615c012
DR   Wikidata; Q54880354
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3403; STX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STX2 (-) 4
AC   CVCL_TR12
SY   HZGHC002616c003; STX2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR12
DR   Horizon_Discovery; HZGHC002616c003
DR   Wikidata; Q54880356
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3403; STX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STX4 (-) 1
AC   CVCL_TR13
SY   HZGHC002617c005; STX4 knockout cell line 34bp insertion
DR   cancercelllines; CVCL_TR13
DR   Horizon_Discovery; HZGHC002617c005
DR   Wikidata; Q54880357
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11439; STX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002617c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STX4 (-) 2
AC   CVCL_TR14
SY   HZGHC002617c009; STX4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR14
DR   Horizon_Discovery; HZGHC002617c009
DR   Wikidata; Q54880358
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11439; STX4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STYK1 (-) 1
AC   CVCL_TR15
SY   HZGHC000070c002; STYK1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TR15
DR   Horizon_Discovery; HZGHC000070c002
DR   Wikidata; Q54880359
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18889; STYK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000070c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 STYK1 (-) 2
AC   CVCL_TR16
SY   HZGHC000070c009; STYK1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR16
DR   Horizon_Discovery; HZGHC000070c009
DR   Wikidata; Q54880360
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18889; STYK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 STYK1 (-) 3
AC   CVCL_TR17
SY   HZGHC000070c019; STYK1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TR17
DR   Horizon_Discovery; HZGHC000070c019
DR   Wikidata; Q54880361
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18889; STYK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUFU (-) 1
AC   CVCL_TR18
SY   HZGHC003413c006; SUFU knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TR18
DR   Horizon_Discovery; HZGHC003413c006
DR   Wikidata; Q54880362
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUFU (-) 2
AC   CVCL_TR19
SY   HZGHC003413c007; SUFU knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TR19
DR   Horizon_Discovery; HZGHC003413c007
DR   Wikidata; Q54880363
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SULT1A1 (-)
AC   CVCL_E2L7
SY   HZGHC007446c008
DR   Horizon_Discovery; HZGHC007446c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11453; SULT1A1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SUMO1 (-) 1
AC   CVCL_TR20
SY   HZGHC002501c006; SUMO1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TR20
DR   Horizon_Discovery; HZGHC002501c006
DR   Wikidata; Q54880364
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12502; SUMO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUMO1 (-) 2
AC   CVCL_TR21
SY   HZGHC002501c010; SUMO1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR21
DR   Horizon_Discovery; HZGHC002501c010
DR   Wikidata; Q54880365
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12502; SUMO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUMO1 (-) 3
AC   CVCL_TR22
SY   HZGHC002502c005; SUMO1 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TR22
DR   Horizon_Discovery; HZGHC002502c005
DR   Wikidata; Q54880366
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12502; SUMO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUMO1 (-) 4
AC   CVCL_TR23
SY   HZGHC002502c008; SUMO1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR23
DR   Horizon_Discovery; HZGHC002502c008
DR   Wikidata; Q54880367
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12502; SUMO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUMO3 (-) 1
AC   CVCL_TR24
SY   HZGHC002553c001; SUMO3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TR24
DR   Horizon_Discovery; HZGHC002553c001
DR   Wikidata; Q54880368
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11124; SUMO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUMO3 (-) 2
AC   CVCL_TR25
SY   HZGHC002553c011; SUMO3 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TR25
DR   Horizon_Discovery; HZGHC002553c011
DR   Wikidata; Q54880369
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11124; SUMO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUN1 (-) 1
AC   CVCL_C7YQ
SY   HZGHC007612c010; SUN1 knockout cell line 1bp deletion in exon 2; HAP1 SUN1 (-)
DR   Horizon_Discovery; HZGHC007612c010
DR   Wikidata; Q123031448
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18587; SUN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007612c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 SUN1 (-) 2
AC   CVCL_E2L8
SY   HZGHC007515c010; SUN1 knockout cell line 1bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007515c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18587; SUN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SUN1 (-) SUN2 (-)
AC   CVCL_C7YP
SY   HZGHC007612c009; Double knockout cell line SUN1 1bp insertion in exon 2 and SUN2 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007612c009
DR   Wikidata; Q123031447
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18587; SUN1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14210; SUN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2L8 ! HAP1 SUN1 (-) 2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   HAP1 SUN2 (-) 1
AC   CVCL_XU03
SY   HZGHC006873c003; HZGHC25777; SUN2 knockout cell line 8bp deletion in exon 4; HAP1 SUN2 (-)
DR   cancercelllines; CVCL_XU03
DR   Horizon_Discovery; HZGHC006873c003
DR   Wikidata; Q93970877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14210; SUN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SUN2 (-) 2
AC   CVCL_E2L9
SY   HZGHC006873c010; SUN2 knockout cell line 25bp deletion in exon 4
DR   Horizon_Discovery; HZGHC006873c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14210; SUN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SURF1 (-) 1
AC   CVCL_XU04
SY   HZGHC007090c009; HZGHC6834; SURF1 knockout cell line 2bp deletion in exon 3; HAP1 SURF1 (-)
DR   cancercelllines; CVCL_XU04
DR   Horizon_Discovery; HZGHC007090c009
DR   Wikidata; Q93970882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11474; SURF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SURF1 (-) 2
AC   CVCL_E2LA
SY   HZGHC007090c002
DR   Horizon_Discovery; HZGHC007090c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11474; SURF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SURF1 (-) 3
AC   CVCL_E2LB
SY   HZGHC007090c008
DR   Horizon_Discovery; HZGHC007090c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11474; SURF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SURF4 (-) 1
AC   CVCL_TR26
SY   HZGHC002442c001; SURF4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TR26
DR   Horizon_Discovery; HZGHC002442c001
DR   Wikidata; Q54880370
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11476; SURF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SURF4 (-) 2
AC   CVCL_TR27
SY   HZGHC002442c002; SURF4 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TR27
DR   Horizon_Discovery; HZGHC002442c002
DR   Wikidata; Q54880371
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11476; SURF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUV39H1 (-) 1
AC   CVCL_TR28
SY   HZGHC001132c005; SUV39H1 knockout cell line 244bp insertion
DR   cancercelllines; CVCL_TR28
DR   Horizon_Discovery; HZGHC001132c005
DR   Wikidata; Q54880372
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001132c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SUV39H1 (-) 2
AC   CVCL_TR29
SY   HZGHC001132c012; SUV39H1 knockout cell line 142bp insertion
DR   cancercelllines; CVCL_TR29
DR   Horizon_Discovery; HZGHC001132c012
DR   Wikidata; Q54880373
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001132c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SUZ12 (-) 1
AC   CVCL_TR30
SY   HZGHC003853c001; SUZ12 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR30
DR   Horizon_Discovery; HZGHC003853c001
DR   Wikidata; Q54880374
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SUZ12 (-) 2
AC   CVCL_TR31
SY   HZGHC003853c011; SUZ12 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR31
DR   Horizon_Discovery; HZGHC003853c011
DR   Wikidata; Q54880375
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SYK (-)
AC   CVCL_TR32
SY   HZGHC006898c017; SYK knockout cell line 29bp deletion
DR   cancercelllines; CVCL_TR32
DR   Horizon_Discovery; HZGHC006898c017
DR   Wikidata; Q54880376
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006898c017; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SYNCRIP (-) 1
AC   CVCL_XU05
SY   HZGHC007105c006; HZGHC10492; SYNCRIP knockout cell line 2bp deletion in exon 9; HAP1 SYNCRIP (-)
DR   cancercelllines; CVCL_XU05
DR   Horizon_Discovery; HZGHC007105c006
DR   Wikidata; Q93970940
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16918; SYNCRIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 SYNCRIP (-) 2
AC   CVCL_E2LC
SY   HZGHC007106c005; SYNCRIP knockout cell line 1bp insertion in exon 8
DR   Horizon_Discovery; HZGHC007106c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16918; SYNCRIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SYNGAP1 (-) 1
AC   CVCL_E2LD
SY   HZGHC008241c007
DR   Horizon_Discovery; HZGHC008241c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11497; SYNGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SYNGAP1 (-) 2
AC   CVCL_E2LE
SY   HZGHC008241c011
DR   Horizon_Discovery; HZGHC008241c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11497; SYNGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SYNGAP1 (-) 3
AC   CVCL_E2LF
SY   HZGHC008242c002
DR   Horizon_Discovery; HZGHC008242c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11497; SYNGAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 SYNJ1 (-) 1
AC   CVCL_TR33
SY   HZGHC002887c001; SYNJ1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR33
DR   Horizon_Discovery; HZGHC002887c001
DR   Wikidata; Q54880377
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11503; SYNJ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SYNJ1 (-) 2
AC   CVCL_TR34
SY   HZGHC002887c004; SYNJ1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TR34
DR   Horizon_Discovery; HZGHC002887c004
DR   Wikidata; Q54880378
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11503; SYNJ1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SYNJ2 (-) 1
AC   CVCL_TR35
SY   HZGHC002901c002; SYNJ2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR35
DR   Horizon_Discovery; HZGHC002901c002
DR   Wikidata; Q54880379
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11504; SYNJ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002901c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SYNJ2 (-) 2
AC   CVCL_TR36
SY   HZGHC002901c012; SYNJ2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR36
DR   Horizon_Discovery; HZGHC002901c012
DR   Wikidata; Q54880382
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11504; SYNJ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002901c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 SYNJ2 (-) 3
AC   CVCL_TR37
SY   HZGHC002901c010; SYNJ2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR37
DR   Horizon_Discovery; HZGHC002901c010
DR   Wikidata; Q54880383
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11504; SYNJ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SYT2 (-) 1
AC   CVCL_TR38
SY   HZGHC003925c002; SYT2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR38
DR   Horizon_Discovery; HZGHC003925c002
DR   Wikidata; Q54880384
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11510; SYT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SYT2 (-) 2
AC   CVCL_TR39
SY   HZGHC003925c007; SYT2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TR39
DR   Horizon_Discovery; HZGHC003925c007
DR   Wikidata; Q54880385
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11510; SYT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 SZT2 (-) 3
AC   CVCL_TR40
SY   HZGHC005559c001; SZT2 knockout cell line 79bp deletion
DR   cancercelllines; CVCL_TR40
DR   Horizon_Discovery; HZGHC005559c001
DR   Wikidata; Q54880386
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29040; SZT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAB1 (-) 1
AC   CVCL_TR41
SY   HZGHC002591c004; TAB1 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TR41
DR   Horizon_Discovery; HZGHC002591c004
DR   Wikidata; Q54880387
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAB1 (-) 2
AC   CVCL_TR42
SY   HZGHC002591c008; TAB1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR42
DR   Horizon_Discovery; HZGHC002591c008
DR   Wikidata; Q54880388
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAB2 (-) 1
AC   CVCL_TR43
SY   HZGHC002592c005; TAB2 knockout cell line 167bp insertion
DR   cancercelllines; CVCL_TR43
DR   Horizon_Discovery; HZGHC002592c005
DR   Wikidata; Q54880389
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002592c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TAB2 (-) 2
AC   CVCL_TR44
SY   HZGHC002592c012; TAB2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TR44
DR   Horizon_Discovery; HZGHC002592c012
DR   Wikidata; Q54880390
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAB3 (-)
AC   CVCL_TR45
SY   HZGHC002593c003; TAB3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR45
DR   Horizon_Discovery; HZGHC002593c003
DR   Wikidata; Q54880391
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30681; TAB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAF15 (-) 1
AC   CVCL_TR46
SY   HZGHC004653c001; TAF15 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR46
DR   Horizon_Discovery; HZGHC004653c001
DR   Wikidata; Q54880392
RX   DOI=10.12688/f1000research.160371.1;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11547; TAF15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   HAP1 TAF15 (-) 2
AC   CVCL_TR47
SY   HZGHC004653c012; TAF15 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR47
DR   Horizon_Discovery; HZGHC004653c012
DR   Wikidata; Q54880393
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11547; TAF15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAF1L (-)
AC   CVCL_TR48
SY   HZGHC000954c011; TAF1L knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR48
DR   Horizon_Discovery; HZGHC000954c011
DR   Wikidata; Q54880394
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18056; TAF1L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAF5L (-) 1
AC   CVCL_TR49
SY   HZGHC004928c010; TAF5L knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TR49
DR   Horizon_Discovery; HZGHC004928c010
DR   Wikidata; Q54880395
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17304; TAF5L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAF5L (-) 2
AC   CVCL_TR50
SY   HZGHC004928c012; TAF5L knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR50
DR   Horizon_Discovery; HZGHC004928c012
DR   Wikidata; Q54880396
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17304; TAF5L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAGLN2 (-) 1
AC   CVCL_TR51
SY   HZGHC005947c010; TAGLN2 knockout cell line 71bp deletion; HAP1 TAGLN2 (-)
DR   cancercelllines; CVCL_TR51
DR   Horizon_Discovery; HZGHC005947c010
DR   Wikidata; Q54880397
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11554; TAGLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TAGLN2 (-) 2
AC   CVCL_XU06
SY   HZGHC005947c002; TAGLN2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XU06
DR   Horizon_Discovery; HZGHC005947c002
DR   Wikidata; Q93971108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11554; TAGLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TANK (-) 1
AC   CVCL_TR52
SY   HZGHC003904c003; TANK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR52
DR   Horizon_Discovery; HZGHC003904c003
DR   Wikidata; Q54880398
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TANK (-) 2
AC   CVCL_TR53
SY   HZGHC003904c010; TANK knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR53
DR   Horizon_Discovery; HZGHC003904c010
DR   Wikidata; Q54880399
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAOK1 (-) 1
AC   CVCL_TR54
SY   HZGHC000029c015; TAOK1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TR54
DR   Horizon_Discovery; HZGHC000029c015
DR   Wikidata; Q54880400
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29259; TAOK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAOK1 (-) 2
AC   CVCL_TR55
SY   HZGHC000029c020; TAOK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR55
DR   Horizon_Discovery; HZGHC000029c020
DR   Wikidata; Q54880401
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29259; TAOK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAOK2 (-) 1
AC   CVCL_TR56
SY   HZGHC000030c002; TAOK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR56
DR   Horizon_Discovery; HZGHC000030c002
DR   Wikidata; Q54880402
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16835; TAOK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAOK2 (-) 2
AC   CVCL_TR57
SY   HZGHC000030c010; TAOK2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR57
DR   Horizon_Discovery; HZGHC000030c010
DR   Wikidata; Q54880404
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16835; TAOK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAOK3 (-) 1
AC   CVCL_TR58
SY   HZGHC000071c013; TAOK3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR58
DR   Horizon_Discovery; HZGHC000071c013
DR   Wikidata; Q54880405
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18133; TAOK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAOK3 (-) 2
AC   CVCL_TR59
SY   HZGHC000071c016; TAOK3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TR59
DR   Horizon_Discovery; HZGHC000071c016
DR   Wikidata; Q54880406
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18133; TAOK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAP1 (-) 1
AC   CVCL_E2LG
SY   HZGHC007615c003
DR   Horizon_Discovery; HZGHC007615c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43; TAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TAP1 (-) 2
AC   CVCL_E2LH
SY   HZGHC007615c008
DR   Horizon_Discovery; HZGHC007615c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43; TAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TAP2 (-) 1
AC   CVCL_E2LI
SY   HZGHC002663c004
DR   Horizon_Discovery; HZGHC002663c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:44; TAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TAP2 (-) 2
AC   CVCL_E2LJ
SY   HZGHC002663c005
DR   Horizon_Discovery; HZGHC002663c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:44; TAP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TARBP2 (-) 1
AC   CVCL_TR60
SY   HZGHC000516c001; TARBP2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR60
DR   Horizon_Discovery; HZGHC000516c001
DR   Wikidata; Q54880407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11569; TARBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TARBP2 (-) 2
AC   CVCL_TR61
SY   HZGHC000516c008; TARBP2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR61
DR   Horizon_Discovery; HZGHC000516c008
DR   Wikidata; Q54880408
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11569; TARBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TARBP2 (-) 3
AC   CVCL_TR62
SY   HZGHC000517c002; TARBP2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TR62
DR   Horizon_Discovery; HZGHC000517c002
DR   Wikidata; Q54880409
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11569; TARBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TARBP2 (-) 4
AC   CVCL_TR63
SY   HZGHC000517c010; TARBP2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TR63
DR   Horizon_Discovery; HZGHC000517c010
DR   Wikidata; Q54880410
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11569; TARBP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TARDBP (-) 1
AC   CVCL_TR64
SY   HZGHC003730c001; TARDBP knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TR64
DR   Horizon_Discovery; HZGHC003730c001
DR   Wikidata; Q54880411
RX   PubMed=37359785;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11571; TARDBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003730c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TARDBP (-) 2
AC   CVCL_TR65
SY   HZGHC003730c011; TARDBP knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR65
DR   Horizon_Discovery; HZGHC003730c011
DR   Wikidata; Q54880412
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11571; TARDBP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003730c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TASP1 (-) 1
AC   CVCL_TR66
SY   HZGHC005284c012; TASP1 knockout cell line 7bp deletion; HAP1 TASP1 (-)
DR   cancercelllines; CVCL_TR66
DR   Horizon_Discovery; HZGHC005284c012
DR   Wikidata; Q54880413
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15859; TASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TASP1 (-) 2
AC   CVCL_XU07
SY   HZGHC005284c002; TASP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XU07
DR   Horizon_Discovery; HZGHC005284c002
DR   Wikidata; Q93971391
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15859; TASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TAZ (-) 1
AC   CVCL_TR67
SY   HZGHC004024c008; TAZ knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TR67
DR   Horizon_Discovery; HZGHC004024c008
DR   Wikidata; Q54880414
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TAZ (-) 2
AC   CVCL_TR68
SY   HZGHC004024c009; TAZ knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TR68
DR   Horizon_Discovery; HZGHC004024c009
DR   Wikidata; Q54880415
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TAZ (-) 3
AC   CVCL_XU08
SY   HZGHC003351c010; TAZ knockout cell line
DR   cancercelllines; CVCL_XU08
DR   Horizon_Discovery; HZGHC003351c010
DR   Wikidata; Q93971426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003351c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TBC1D24 (-) 1
AC   CVCL_TR69
SY   HZGHC002029c002; TBC1D24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR69
DR   Horizon_Discovery; HZGHC002029c002
DR   Wikidata; Q54880416
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29203; TBC1D24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002029c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TBC1D24 (-) 2
AC   CVCL_TR70
SY   HZGHC002029c010; TBC1D24 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TR70
DR   Horizon_Discovery; HZGHC002029c010
DR   Wikidata; Q54880417
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29203; TBC1D24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TBCK (-)
AC   CVCL_TR71
SY   HZGHC000267c023; TBCK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR71
DR   Horizon_Discovery; HZGHC000267c023
DR   Wikidata; Q54880419
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28261; TBCK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TBK1 (-) 1
AC   CVCL_TR72
SY   HZGHC000031c010; TBK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR72
DR   Horizon_Discovery; HZGHC000031c010
DR   Wikidata; Q54880420
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TBK1 (-) 2
AC   CVCL_TR73
SY   HZGHC000031c012; TBK1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TR73
DR   Horizon_Discovery; HZGHC000031c012
DR   Wikidata; Q54880421
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000031c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TBKBP1 (-) 1
AC   CVCL_TR74
SY   HZGHC003903c004; TBKBP1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TR74
DR   Horizon_Discovery; HZGHC003903c004
DR   Wikidata; Q54880422
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003903c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TBKBP1 (-) 2
AC   CVCL_TR75
SY   HZGHC003903c012; TBKBP1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR75
DR   Horizon_Discovery; HZGHC003903c012
DR   Wikidata; Q54880423
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003903c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TBKBP1 (-) 3
AC   CVCL_E2LK
SY   HZGHC008194c001
DR   Horizon_Discovery; HZGHC008194c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TBKBP1 (-) 4
AC   CVCL_E2LL
SY   HZGHC008194c002
DR   Horizon_Discovery; HZGHC008194c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TBKBP1 (-) 5
AC   CVCL_E2LM
SY   HZGHC008194c003
DR   Horizon_Discovery; HZGHC008194c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TBKBP1 (-) 6
AC   CVCL_E2LN
SY   HZGHC008194c005
DR   Horizon_Discovery; HZGHC008194c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TBKBP1 (-) 7
AC   CVCL_E2LP
SY   HZGHC008194c010
DR   Horizon_Discovery; HZGHC008194c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TBX21 (-) 1
AC   CVCL_TR76
SY   HZGHC006454c011; TBX21 knockout cell line 20bp deletion; HAP1 TBX21 (-)
DR   cancercelllines; CVCL_TR76
DR   Horizon_Discovery; HZGHC006454c011
DR   Wikidata; Q54880426
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11599; TBX21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TBX21 (-) 2
AC   CVCL_XU09
SY   HZGHC006454c003; TBX21 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XU09
DR   Horizon_Discovery; HZGHC006454c003
DR   Wikidata; Q93971528
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11599; TBX21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TBX3 (-) 1
AC   CVCL_TR77
SY   HZGHC003721c004; TBX3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TR77
DR   Horizon_Discovery; HZGHC003721c004
DR   Wikidata; Q54880427
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11602; TBX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TBX3 (-) 2
AC   CVCL_TR78
SY   HZGHC003721c007; TBX3 knockout cell line 67bp insertion
DR   cancercelllines; CVCL_TR78
DR   Horizon_Discovery; HZGHC003721c007
DR   Wikidata; Q54880428
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11602; TBX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003721c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TCERG1 (-)
AC   CVCL_TR79
SY   HZGHC002880c012; TCERG1 knockout cell line 382bp insertion
DR   cancercelllines; CVCL_TR79
DR   Horizon_Discovery; HZGHC002880c012
DR   Wikidata; Q54880429
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15630; TCERG1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002880c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TCF19 (-) 1
AC   CVCL_TR80
SY   HZGHC005823c002; TCF19 knockout cell line 1bp insertion; HAP1 TCF19 (-)
DR   cancercelllines; CVCL_TR80
DR   Horizon_Discovery; HZGHC005823c002
DR   Wikidata; Q54880430
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11629; TCF19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TCF19 (-) 2
AC   CVCL_XU10
SY   HZGHC005823c004; TCF19 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU10
DR   Horizon_Discovery; HZGHC005823c004
DR   Wikidata; Q93971584
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11629; TCF19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005823c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TCF4 (-)
AC   CVCL_C7YR
SY   HZGHC008053c006; TCF4 knockout cell line 1bp insertion in exon 16
DR   Horizon_Discovery; HZGHC008053c006
DR   Wikidata; Q123031449
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11634; TCF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TCF7L2 (-) 1
AC   CVCL_TR81
SY   HZGHC006257c001; TCF7L2 knockout cell line 20bp deletion; HAP1 TCF7L2 (-)
DR   cancercelllines; CVCL_TR81
DR   Horizon_Discovery; HZGHC006257c001
DR   Wikidata; Q54880431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11641; TCF7L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TCF7L2 (-) 2
AC   CVCL_XU11
SY   HZGHC006257c004; TCF7L2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XU11
DR   Horizon_Discovery; HZGHC006257c004
DR   Wikidata; Q93971601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11641; TCF7L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TDG (-) 1
AC   CVCL_TR82
SY   HZGHC000632c008; TDG knockout cell line 2bp insertion; HAP1 TDG (-)
DR   cancercelllines; CVCL_TR82
DR   Horizon_Discovery; HZGHC000632c008
DR   Wikidata; Q54880432
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11700; TDG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TDG (-) 2
AC   CVCL_XU12
SY   HZGHC006387c006; TDG knockout cell line 53bp deletion
DR   cancercelllines; CVCL_XU12
DR   Horizon_Discovery; HZGHC006387c006
DR   Wikidata; Q93971619
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11700; TDG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TDG (-) 3
AC   CVCL_XU13
SY   HZGHC006387c010; TDG knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XU13
DR   Horizon_Discovery; HZGHC006387c010
DR   Wikidata; Q93971622
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11700; TDG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TDP1 (-) 1
AC   CVCL_TR83
SY   HZGHC000423c003; TDP1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TR83
DR   Horizon_Discovery; HZGHC000423c003
DR   Wikidata; Q54880433
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18884; TDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000423c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TDP1 (-) 2
AC   CVCL_TR84
SY   HZGHC000423c005; TDP1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TR84
DR   Horizon_Discovery; HZGHC000423c005
DR   Wikidata; Q54880434
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18884; TDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TDP1 (-) 3
AC   CVCL_TR85
SY   HZGHC000423c006; TDP1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR85
DR   Horizon_Discovery; HZGHC000423c006
DR   Wikidata; Q54880435
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18884; TDP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000423c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TDP2 (-) 1
AC   CVCL_XU14
SY   HZGHC007181c009; HZGHC51567; TDP2 knockout cell line 1bp insertion in exon 2; HAP1 TDP2 (-)
DR   cancercelllines; CVCL_XU14
DR   Horizon_Discovery; HZGHC007181c009
DR   Wikidata; Q93971660
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17768; TDP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007181c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TDP2 (-) 2
AC   CVCL_E2LQ
SY   HZGHC007181c003; TDP2 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007181c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17768; TDP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TEAD4 (-) 1
AC   CVCL_TR86
SY   HZGHC006261c003; TEAD4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TR86
DR   Horizon_Discovery; HZGHC006261c003
DR   Wikidata; Q54880436
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11717; TEAD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TEAD4 (-) 2
AC   CVCL_XU16
SY   HZGHC006261c004; TEAD4 knockout cell line 113bp deletion
DR   cancercelllines; CVCL_XU16
DR   Horizon_Discovery; HZGHC006261c004
DR   Wikidata; Q93971681
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11717; TEAD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TEC (-)
AC   CVCL_TR87
SY   HZGHC001272c019; TEC knockout cell line 187bp deletion
DR   cancercelllines; CVCL_TR87
DR   Horizon_Discovery; HZGHC001272c019
DR   Wikidata; Q54880437
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11719; TEC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TECPR2 (-) 1
AC   CVCL_TR88
SY   HZGHC003060c002; TECPR2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR88
DR   Horizon_Discovery; HZGHC003060c002
DR   Wikidata; Q54880438
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19957; TECPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TECPR2 (-) 2
AC   CVCL_TR89
SY   HZGHC003060c003; TECPR2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TR89
DR   Horizon_Discovery; HZGHC003060c003
DR   Wikidata; Q54880439
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19957; TECPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TECPR2 (-) 3
AC   CVCL_TR90
SY   HZGHC003060c011; TECPR2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TR90
DR   Horizon_Discovery; HZGHC003060c011
DR   Wikidata; Q54880440
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19957; TECPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TEK (-) 1
AC   CVCL_TR91
SY   HZGHC003717c001; TEK knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR91
DR   Horizon_Discovery; HZGHC003717c001
DR   Wikidata; Q54880441
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11724; TEK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TEK (-) 2
AC   CVCL_TR92
SY   HZGHC003717c005; TEK knockout cell line 50bp deletion
DR   cancercelllines; CVCL_TR92
DR   Horizon_Discovery; HZGHC003717c005
DR   Wikidata; Q54880442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11724; TEK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TEK (-) 3
AC   CVCL_TR93
SY   HZGHC003717c011; TEK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TR93
DR   Horizon_Discovery; HZGHC003717c011
DR   Wikidata; Q54880443
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11724; TEK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TEP1 (-) 1
AC   CVCL_TR94
SY   HZGHC003715c001; TEP1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TR94
DR   Horizon_Discovery; HZGHC003715c001
DR   Wikidata; Q54880444
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11726; TEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003715c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TEP1 (-) 2
AC   CVCL_TR95
SY   HZGHC003715c002; TEP1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TR95
DR   Horizon_Discovery; HZGHC003715c002
DR   Wikidata; Q54880445
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11726; TEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TEP1 (-) 3
AC   CVCL_TR96
SY   HZGHC003715c011; TEP1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TR96
DR   Horizon_Discovery; HZGHC003715c011
DR   Wikidata; Q54880446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11726; TEP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TERF2IP (-)
AC   CVCL_E2LR
SY   HZGHC007820c007
DR   Horizon_Discovery; HZGHC007820c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19246; TERF2IP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TERT (-) 1
AC   CVCL_TR97
SY   HZGHC003354c001; TERT knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TR97
DR   Horizon_Discovery; HZGHC003354c001
DR   Wikidata; Q54880447
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TERT (-) 2
AC   CVCL_TR98
SY   HZGHC003354c006; TERT knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TR98
DR   Horizon_Discovery; HZGHC003354c006
DR   Wikidata; Q54880448
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TESK1 (-) 1
AC   CVCL_TR99
SY   HZGHC000294c008; TESK1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TR99
DR   Horizon_Discovery; HZGHC000294c008
DR   Wikidata; Q54880449
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11731; TESK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TESK1 (-) 2
AC   CVCL_TS00
SY   HZGHC000294c013; TESK1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS00
DR   Horizon_Discovery; HZGHC000294c013
DR   Wikidata; Q54880450
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11731; TESK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TESK2 (-) 1
AC   CVCL_TS01
SY   HZGHC000033c002; TESK2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TS01
DR   Horizon_Discovery; HZGHC000033c002
DR   Wikidata; Q54880451
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11732; TESK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TESK2 (-) 2
AC   CVCL_TS02
SY   HZGHC000033c012; TESK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TS02
DR   Horizon_Discovery; HZGHC000033c012
DR   Wikidata; Q54880452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11732; TESK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TET1 (-) 1
AC   CVCL_TS03
SY   HZGHC001121c002; TET1 knockout cell line 20bp deletion in exon 2
DR   cancercelllines; CVCL_TS03
DR   Horizon_Discovery; HZGHC001121c002
DR   Wikidata; Q54880453
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET1 (-) 2
AC   CVCL_TS04
SY   HZGHC001121c010; TET1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TS04
DR   Horizon_Discovery; HZGHC001121c010
DR   Wikidata; Q54880454
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001121c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET1 (-) TET2 (-) 1
AC   CVCL_DX62
SY   HZGHC007806c008; Double knockout cell line TET1 20bp deletion in exon 2 and TET2 10bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007806c008
DR   Wikidata; Q127381101
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TS03 ! HAP1 TET1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TET1 (-) TET2 (-) 2
AC   CVCL_DX63
SY   HZGHC007806c011; Double knockout cell line TET1 20bp deletion in exon 2 and TET2 26bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007806c011
DR   Wikidata; Q127381102
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TS03 ! HAP1 TET1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TET1 (-) TET2 (-) 3
AC   CVCL_DX64
SY   HZGHC007806c012; Double knockout cell line TET1 20bp deletion in exon 2 and TET2 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007806c012
DR   Wikidata; Q127381103
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TS03 ! HAP1 TET1 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TET2 (-) 1
AC   CVCL_TS05
SY   HZGHC003562c006; TET2 knockout cell line 4bp deletion in exon 3
DR   cancercelllines; CVCL_TS05
DR   Horizon_Discovery; HZGHC003562c006
DR   Wikidata; Q54880455
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET2 (-) 2
AC   CVCL_TS06
SY   HZGHC003562c011; TET2 knockout cell line 8bp deletion in exon 3
DR   cancercelllines; CVCL_TS06
DR   Horizon_Discovery; HZGHC003562c011
DR   Wikidata; Q54880456
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET2 (-) 3
AC   CVCL_TS07
SY   HZGHC001091c009; TET2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS07
DR   Horizon_Discovery; HZGHC001091c009
DR   Wikidata; Q54880457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001091c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET2 (-) 4
AC   CVCL_TS08
SY   HZGHC001091c010; TET2 knockout cell line 19bp deletion in exon 3
DR   cancercelllines; CVCL_TS08
DR   Horizon_Discovery; HZGHC001091c010
DR   Wikidata; Q54880458
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET2 (-) 5
AC   CVCL_TS09
SY   HZGHC001091c012; TET2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS09
DR   Horizon_Discovery; HZGHC001091c012
DR   Wikidata; Q54880459
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001091c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET3 (-) 1
AC   CVCL_TS10
SY   HZGHC001112c004; TET3 knockout cell line 14bp deletion in exon 4
DR   cancercelllines; CVCL_TS10
DR   Horizon_Discovery; HZGHC001112c004
DR   Wikidata; Q54880460
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28313; TET3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET3 (-) 2
AC   CVCL_TS11
SY   HZGHC001112c008; TET3 knockout cell line 122bp insertion
DR   cancercelllines; CVCL_TS11
DR   Horizon_Discovery; HZGHC001112c008
DR   Wikidata; Q54880461
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28313; TET3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001112c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TET3 (-) 3
AC   CVCL_TS12
SY   HZGHC001112c010; TET3 knockout cell line 154bp insertion
DR   cancercelllines; CVCL_TS12
DR   Horizon_Discovery; HZGHC001112c010
DR   Wikidata; Q54880462
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28313; TET3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001112c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TEX2 (-) 1
AC   CVCL_TS13
SY   HZGHC004593c010; TEX2 knockout cell line 7bp deletion in exon 2
DR   cancercelllines; CVCL_TS13
DR   Horizon_Discovery; HZGHC004593c010
DR   Wikidata; Q54880463
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30884; TEX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TEX2 (-) 2
AC   CVCL_TS14
SY   HZGHC004593c011; TEX2 knockout cell line 10bp deletion in exon 2
DR   cancercelllines; CVCL_TS14
DR   Horizon_Discovery; HZGHC004593c011
DR   Wikidata; Q54880464
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30884; TEX2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TFAP2A (-)
AC   CVCL_TS15
SY   HZGHC006263c004; TFAP2A knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TS15
DR   Horizon_Discovery; HZGHC006263c004
DR   Wikidata; Q54880465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11742; TFAP2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TFE3 (-) 1
AC   CVCL_TS16
SY   HZGHC004592c009; TFE3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS16
DR   Horizon_Discovery; HZGHC004592c009
DR   Wikidata; Q54880469
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11752; TFE3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TFE3 (-) 2
AC   CVCL_TS17
SY   HZGHC004592c010; TFE3 knockout cell line 58bp deletion
DR   cancercelllines; CVCL_TS17
DR   Horizon_Discovery; HZGHC004592c010
DR   Wikidata; Q54880470
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11752; TFE3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TFEB (-) 1
AC   CVCL_TS18
SY   HZGHC003476c010; TFEB knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TS18
DR   Horizon_Discovery; HZGHC003476c010
DR   Wikidata; Q54880471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11753; TFEB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TFEB (-) 2
AC   CVCL_TS19
SY   HZGHC003476c012; TFEB knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TS19
DR   Horizon_Discovery; HZGHC003476c012
DR   Wikidata; Q54880472
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11753; TFEB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TFG (-) 1
AC   CVCL_TS20
SY   HZGHC006696c004; TFG knockout cell line 1bp insertion; HAP1 TFG (-)
DR   cancercelllines; CVCL_TS20
DR   Horizon_Discovery; HZGHC006696c004
DR   Wikidata; Q54880473
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11758; TFG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TFG (-) 2
AC   CVCL_XU17
SY   HZGHC006696c005; TFG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU17
DR   Horizon_Discovery; HZGHC006696c005
DR   Wikidata; Q93972093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11758; TFG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFB1 (-)
AC   CVCL_XU18
SY   HZGHC006883c005; HZGHC7040; TGFB1 knockout cell line 32bp deletion in exon 2
DR   cancercelllines; CVCL_XU18
DR   Horizon_Discovery; HZGHC006883c005
DR   Wikidata; Q93972095
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TGFBR1 (-) 1
AC   CVCL_TS21
SY   HZGHC000034c011; TGFBR1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TS21
DR   Horizon_Discovery; HZGHC000034c011
DR   Wikidata; Q54880474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR1 (-) 2
AC   CVCL_TS22
SY   HZGHC000034c012; TGFBR1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS22
DR   Horizon_Discovery; HZGHC000034c012
DR   Wikidata; Q54880475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR2 (-) 1
AC   CVCL_TS23
SY   HZGHC000035c014; TGFBR2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TS23
DR   Horizon_Discovery; HZGHC000035c014
DR   Wikidata; Q54880476
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR2 (-) 2
AC   CVCL_TS24
SY   HZGHC000035c015; TGFBR2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TS24
DR   Horizon_Discovery; HZGHC000035c015
DR   Wikidata; Q54880477
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR2 (-) 3
AC   CVCL_TS25
SY   HZGHC000035c020; TGFBR2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS25
DR   Horizon_Discovery; HZGHC000035c020
DR   Wikidata; Q54880478
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR2 (-) 4
AC   CVCL_XU19
SY   HZGHC006288c010; TGFBR2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XU19
DR   Horizon_Discovery; HZGHC006288c010
DR   Wikidata; Q93972155
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR2 (-) 5
AC   CVCL_XU20
SY   HZGHC006288c011; TGFBR2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XU20
DR   Horizon_Discovery; HZGHC006288c011
DR   Wikidata; Q93972159
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR2 (-) 6
AC   CVCL_XU21
SY   HZGHC006289c002; TGFBR2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XU21
DR   Horizon_Discovery; HZGHC006289c002
DR   Wikidata; Q93972162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGFBR2 (-) 7
AC   CVCL_XU22
SY   HZGHC006289c006; TGFBR2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XU22
DR   Horizon_Discovery; HZGHC006289c006
DR   Wikidata; Q93972166
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TGOLN2 (-)
AC   CVCL_TS26
SY   HZGHC006003c003; TGOLN2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TS26
DR   Horizon_Discovery; HZGHC006003c003
DR   Wikidata; Q54880479
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15450; TGOLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 THADA (-)
AC   CVCL_E2LS
SY   HZGHC007438c012
DR   Horizon_Discovery; HZGHC007438c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19217; THADA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 THRB (-) 1
AC   CVCL_TS27
SY   HZGHC003871c002; THRB knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TS27
DR   Horizon_Discovery; HZGHC003871c002
DR   Wikidata; Q54880480
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11799; THRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 THRB (-) 2
AC   CVCL_TS28
SY   HZGHC003871c003; THRB knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TS28
DR   Horizon_Discovery; HZGHC003871c003
DR   Wikidata; Q54880481
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11799; THRB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIA1 (-) 1
AC   CVCL_TS29
SY   HZGHC003047c008; TIA1 knockout cell line 155bp insertion
DR   cancercelllines; CVCL_TS29
DR   Horizon_Discovery; HZGHC003047c008
DR   Wikidata; Q54880482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003047c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIA1 (-) 2
AC   CVCL_TS30
SY   HZGHC003048c010; TIA1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS30
DR   Horizon_Discovery; HZGHC003048c010
DR   Wikidata; Q54880483
RX   PubMed=38638178;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIA1 (-) 3
AC   CVCL_TS31
SY   HZGHC003048c011; TIA1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TS31
DR   Horizon_Discovery; HZGHC003048c011
DR   Wikidata; Q54880484
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TICAM1 (-) 1
AC   CVCL_TS32
SY   HZGHC003898c004; TICAM1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS32
DR   Horizon_Discovery; HZGHC003898c004
DR   Wikidata; Q54880485
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18348; TICAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TICAM1 (-) 2
AC   CVCL_TS33
SY   HZGHC003898c007; TICAM1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TS33
DR   Horizon_Discovery; HZGHC003898c007
DR   Wikidata; Q54880486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18348; TICAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TICAM2 (-)
AC   CVCL_TS34
SY   HZGHC003900c011; TICAM2 knockout cell line 355bp insertion
DR   cancercelllines; CVCL_TS34
DR   Horizon_Discovery; HZGHC003900c011
DR   Wikidata; Q54880487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21354; TICAM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003900c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIGIT (-) 1
AC   CVCL_TS35
SY   HZGHC004096c001; TIGIT knockout cell line 193bp insertion
DR   cancercelllines; CVCL_TS35
DR   Horizon_Discovery; HZGHC004096c001
DR   Wikidata; Q54880488
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26838; TIGIT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004096c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIGIT (-) 2
AC   CVCL_TS36
SY   HZGHC004096c005; TIGIT knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TS36
DR   Horizon_Discovery; HZGHC004096c005
DR   Wikidata; Q54880489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26838; TIGIT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIMM17B (-) 1
AC   CVCL_XU23
SY   HZGHC006879c002; HZGHC10245; TIMM17B knockout cell line 1bp insertion in exon 5; HAP1 TIMM17B (-)
DR   cancercelllines; CVCL_XU23
DR   Horizon_Discovery; HZGHC006879c002
DR   Wikidata; Q93972256
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17310; TIMM17B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TIMM17B (-) 2
AC   CVCL_E2LT
SY   HZGHC006878c006
DR   Horizon_Discovery; HZGHC006878c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17310; TIMM17B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TIMM17B (-) 3
AC   CVCL_E2LU
SY   HZGHC006879c004
DR   Horizon_Discovery; HZGHC006879c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17310; TIMM17B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TIMM8A (-) 1
AC   CVCL_TS37
SY   HZGHC006691c002; TIMM8A knockout cell line 1bp insertion; HAP1 TIMM8A (-)
DR   cancercelllines; CVCL_TS37
DR   Horizon_Discovery; HZGHC006691c002
DR   Wikidata; Q54880490
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11817; TIMM8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIMM8A (-) 2
AC   CVCL_XU24
SY   HZGHC006691c004; TIMM8A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU24
DR   Horizon_Discovery; HZGHC006691c004
DR   Wikidata; Q93972266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11817; TIMM8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIMM8A (-) 3
AC   CVCL_XU25
SY   HZGHC006691c006; TIMM8A knockout cell line 367bp insertion
DR   cancercelllines; CVCL_XU25
DR   Horizon_Discovery; HZGHC006691c006
DR   Wikidata; Q93972270
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11817; TIMM8A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006691c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIMMDC1 (-) 1
AC   CVCL_E2LV
SY   HZGHC007707c004
DR   Horizon_Discovery; HZGHC007707c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1321; TIMMDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TIMMDC1 (-) 2
AC   CVCL_E2LW
SY   HZGHC007707c008
DR   Horizon_Discovery; HZGHC007707c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1321; TIMMDC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TIMP1 (-) 1
AC   CVCL_TS38
SY   HZGHC006267c011; TIMP1 knockout cell line 71bp insertion; HAP1 TIMP1 (-)
DR   cancercelllines; CVCL_TS38
DR   Horizon_Discovery; HZGHC006267c011
DR   Wikidata; Q54880491
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11820; TIMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006267c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TIMP1 (-) 2
AC   CVCL_XU26
SY   HZGHC006267c002; TIMP1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XU26
DR   Horizon_Discovery; HZGHC006267c002
DR   Wikidata; Q93972280
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11820; TIMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIMP2 (-) 1
AC   CVCL_TS39
SY   HZGHC006269c001; TIMP2 knockout cell line 14bp deletion; HAP1 TIMP2 (-)
DR   cancercelllines; CVCL_TS39
DR   Horizon_Discovery; HZGHC006269c001
DR   Wikidata; Q54880492
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11821; TIMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIMP2 (-) 2
AC   CVCL_XU27
SY   HZGHC006269c002; TIMP2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_XU27
DR   Horizon_Discovery; HZGHC006269c002
DR   Wikidata; Q93972290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11821; TIMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIPARP (-) 1
AC   CVCL_TS40
SY   HZGHC003970c002; TIPARP knockout cell line 37bp insertion
DR   cancercelllines; CVCL_TS40
DR   Horizon_Discovery; HZGHC003970c002
DR   Wikidata; Q54880493
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23696; TIPARP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003970c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIPARP (-) 2
AC   CVCL_TS41
SY   HZGHC003970c007; TIPARP knockout cell line 572bp insertion
DR   cancercelllines; CVCL_TS41
DR   Horizon_Discovery; HZGHC003970c007
DR   Wikidata; Q54880494
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23696; TIPARP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003970c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TIPRL (-)
AC   CVCL_TS42
SY   HZGHC004369c002; TIPRL knockout cell line 4bp insertion
DR   cancercelllines; CVCL_TS42
DR   Horizon_Discovery; HZGHC004369c002
DR   Wikidata; Q54880495
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30231; TIPRL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIRAP (-) 1
AC   CVCL_TS43
SY   HZGHC003892c002; TIRAP knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS43
DR   Horizon_Discovery; HZGHC003892c002
DR   Wikidata; Q54880496
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17192; TIRAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TIRAP (-) 2
AC   CVCL_TS44
SY   HZGHC003892c004; TIRAP knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS44
DR   Horizon_Discovery; HZGHC003892c004
DR   Wikidata; Q54880497
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17192; TIRAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TJP1 (-) 1
AC   CVCL_TS45
SY   HZGHC006271c002; TJP1 knockout cell line 4bp deletion; HAP1 TJP1 (-)
DR   cancercelllines; CVCL_TS45
DR   Horizon_Discovery; HZGHC006271c002
DR   Wikidata; Q54880498
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11827; TJP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TJP1 (-) 2
AC   CVCL_XU28
SY   HZGHC006271c003; TJP1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XU28
DR   Horizon_Discovery; HZGHC006271c003
DR   Wikidata; Q93972336
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11827; TJP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TK1 (-) 1
AC   CVCL_TS46
SY   HZGHC004471c004; TK1 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TS46
DR   Horizon_Discovery; HZGHC004471c004
DR   Wikidata; Q54880499
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11830; TK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TK1 (-) 2
AC   CVCL_TS47
SY   HZGHC004471c012; TK1 knockout cell line 68bp deletion
DR   cancercelllines; CVCL_TS47
DR   Horizon_Discovery; HZGHC004471c012
DR   Wikidata; Q54880500
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11830; TK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TLE1 (-) 1
AC   CVCL_TS48
SY   HZGHC002620c001; TLE1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TS48
DR   Horizon_Discovery; HZGHC002620c001
DR   Wikidata; Q54880501
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TLE1 (-) 2
AC   CVCL_TS49
SY   HZGHC002620c011; TLE1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TS49
DR   Horizon_Discovery; HZGHC002620c011
DR   Wikidata; Q54880502
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TLE3 (-) 1
AC   CVCL_TS50
SY   HZGHC004203c002; TLE3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS50
DR   Horizon_Discovery; HZGHC004203c002
DR   Wikidata; Q54880503
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004203c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TLE3 (-) 2
AC   CVCL_TS51
SY   HZGHC004203c012; TLE3 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TS51
DR   Horizon_Discovery; HZGHC004203c012
DR   Wikidata; Q54880504
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004203c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TLK1 (-)
AC   CVCL_TS52
SY   HZGHC000200c007; TLK1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TS52
DR   Horizon_Discovery; HZGHC000200c007
DR   Wikidata; Q54880505
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11841; TLK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TLR2 (-) 1
AC   CVCL_TS53
SY   HZGHC003893c002; TLR2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TS53
DR   Horizon_Discovery; HZGHC003893c002
DR   Wikidata; Q54880506
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TLR2 (-) 2
AC   CVCL_TS54
SY   HZGHC003893c011; TLR2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS54
DR   Horizon_Discovery; HZGHC003893c011
DR   Wikidata; Q54880507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TLR4 (-) 1
AC   CVCL_XU29
SY   HZGHC007000c003; HZGHC7099; TLR4 knockout cell line 1bp insertion in exon 4; HAP1 TLR4 (-)
DR   cancercelllines; CVCL_XU29
DR   Horizon_Discovery; HZGHC007000c003
DR   Wikidata; Q93972431
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TLR4 (-) 2
AC   CVCL_B5KZ
SY   HZGHC007000c005; TLR4 knockout cell line 13bp deletion in exon 4
DR   cancercelllines; CVCL_B5KZ
DR   Horizon_Discovery; HZGHC007000c005
DR   Wikidata; Q111733320
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 TLR4 (-) 3
AC   CVCL_B5L0
SY   HZGHC007000c010; TLR4 knockout cell line 1bp deletion in exon 4
DR   cancercelllines; CVCL_B5L0
DR   Horizon_Discovery; HZGHC007000c010
DR   Wikidata; Q111733321
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 TLR7 (-)
AC   CVCL_C7YS
SY   HZGHC008209c003; TLR7 knockout cell line 17bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008209c003
DR   Wikidata; Q123031450
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15631; TLR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TLR8 (-)
AC   CVCL_E2LX
SY   HZGHC008211c010
DR   Horizon_Discovery; HZGHC008211c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15632; TLR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TM6SF1 (-) 1
AC   CVCL_TS55
SY   HZGHC006548c001; TM6SF1 knockout cell line 1bp insertion; HAP1 TM6SF1 (-)
DR   cancercelllines; CVCL_TS55
DR   Horizon_Discovery; HZGHC006548c001
DR   Wikidata; Q54880508
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11860; TM6SF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006548c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TM6SF1 (-) 2
AC   CVCL_XU30
SY   HZGHC006548c012; TM6SF1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XU30
DR   Horizon_Discovery; HZGHC006548c012
DR   Wikidata; Q93972446
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11860; TM6SF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006548c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TM9SF1 (-) 1
AC   CVCL_TS56
SY   HZGHC000437c001; TM9SF1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TS56
DR   Horizon_Discovery; HZGHC000437c001
DR   Wikidata; Q54880514
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11864; TM9SF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000437c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TM9SF1 (-) 2
AC   CVCL_TS57
SY   HZGHC000437c002; TM9SF1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TS57
DR   Horizon_Discovery; HZGHC000437c002
DR   Wikidata; Q54880515
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11864; TM9SF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TM9SF2 (-) 1
AC   CVCL_TS58
SY   HZGHC000439c005; TM9SF2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TS58
DR   Horizon_Discovery; HZGHC000439c005
DR   Wikidata; Q54880516
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11865; TM9SF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TM9SF2 (-) 2
AC   CVCL_TS59
SY   HZGHC000439c006; TM9SF2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TS59
DR   Horizon_Discovery; HZGHC000439c006
DR   Wikidata; Q54880517
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11865; TM9SF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TM9SF3 (-) 1
AC   CVCL_TS60
SY   HZGHC000444c005; TM9SF3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS60
DR   Horizon_Discovery; HZGHC000444c005
DR   Wikidata; Q54880518
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21529; TM9SF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TM9SF3 (-) 2
AC   CVCL_TS61
SY   HZGHC000444c006; TM9SF3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TS61
DR   Horizon_Discovery; HZGHC000444c006
DR   Wikidata; Q54880519
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21529; TM9SF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TM9SF4 (-) 1
AC   CVCL_TS62
SY   HZGHC000441c008; TM9SF4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TS62
DR   Horizon_Discovery; HZGHC000441c008
DR   Wikidata; Q54880520
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30797; TM9SF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TM9SF4 (-) 2
AC   CVCL_TS63
SY   HZGHC000441c010; TM9SF4 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TS63
DR   Horizon_Discovery; HZGHC000441c010
DR   Wikidata; Q54880521
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30797; TM9SF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMBIM6 (-) 1
AC   CVCL_TS64
SY   HZGHC004041c001; TMBIM6 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TS64
DR   Horizon_Discovery; HZGHC004041c001
DR   Wikidata; Q54880522
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11723; TMBIM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMBIM6 (-) 2
AC   CVCL_TS65
SY   HZGHC004041c003; TMBIM6 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TS65
DR   Horizon_Discovery; HZGHC004041c003
DR   Wikidata; Q54880523
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11723; TMBIM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMBIM6 (-) 3
AC   CVCL_TS66
SY   HZGHC004041c011; TMBIM6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TS66
DR   Horizon_Discovery; HZGHC004041c011
DR   Wikidata; Q54880524
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11723; TMBIM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMBIM6 (-) 4
AC   CVCL_TS67
SY   HZGHC004042c005; TMBIM6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS67
DR   Horizon_Discovery; HZGHC004042c005
DR   Wikidata; Q54880525
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11723; TMBIM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMBIM6 (-) 5
AC   CVCL_TS68
SY   HZGHC004042c006; TMBIM6 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TS68
DR   Horizon_Discovery; HZGHC004042c006
DR   Wikidata; Q54880526
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11723; TMBIM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMC1 (-) 1
AC   CVCL_TS69
SY   HZGHC004121c008; TMC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TS69
DR   Horizon_Discovery; HZGHC004121c008
DR   Wikidata; Q54880527
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16513; TMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMC1 (-) 2
AC   CVCL_TS70
SY   HZGHC004121c011; TMC1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TS70
DR   Horizon_Discovery; HZGHC004121c011
DR   Wikidata; Q54880528
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16513; TMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMC6 (-) 1
AC   CVCL_E2LY
SY   HZGHC007474c005
DR   Horizon_Discovery; HZGHC007474c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18021; TMC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMC6 (-) 2
AC   CVCL_E2LZ
SY   HZGHC007474c008
DR   Horizon_Discovery; HZGHC007474c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18021; TMC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMC6 (-) 3
AC   CVCL_E2M0
SY   HZGHC007474c009
DR   Horizon_Discovery; HZGHC007474c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18021; TMC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMCC3 (-) 1
AC   CVCL_TS71
SY   HZGHC006560c002; TMCC3 knockout cell line 1bp deletion; HAP1 TMCC3 (-)
DR   cancercelllines; CVCL_TS71
DR   Horizon_Discovery; HZGHC006560c002
DR   Wikidata; Q54880529
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29199; TMCC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMCC3 (-) 2
AC   CVCL_XU31
SY   HZGHC006560c004; TMCC3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XU31
DR   Horizon_Discovery; HZGHC006560c004
DR   Wikidata; Q93972944
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29199; TMCC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMCC3 (-) 3
AC   CVCL_XU32
SY   HZGHC006560c009; TMCC3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU32
DR   Horizon_Discovery; HZGHC006560c009
DR   Wikidata; Q93972951
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29199; TMCC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMCO1 (-)
AC   CVCL_E2M1
SY   HZGHC007729c006
DR   Horizon_Discovery; HZGHC007729c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18188; TMCO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMED1 (-) 1
AC   CVCL_C7YT
SY   HZGHC008048c006; TMED1 knockout cell line 10bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008048c006
DR   Wikidata; Q123031451
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17291; TMED1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TMED1 (-) 2
AC   CVCL_C7YU
SY   HZGHC008048c009; TMED1 knockout cell line 22bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008048c009
DR   Wikidata; Q123031452
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17291; TMED1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TMED1 (-) 3
AC   CVCL_C7YV
SY   HZGHC008048c012; TMED1 knockout cell line 11bp deletion in exon 3
DR   Horizon_Discovery; HZGHC008048c012
DR   Wikidata; Q123031454
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17291; TMED1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TMED1 (-) 4
AC   CVCL_C7YW
SY   HZGHC008049c010; TMED1 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC008049c010
DR   Wikidata; Q123031457
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17291; TMED1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TMED5 (-) 1
AC   CVCL_TS72
SY   HZGHC005921c001; TMED5 knockout cell line 2bp deletion; HAP1 TMED5 (-)
DR   cancercelllines; CVCL_TS72
DR   Horizon_Discovery; HZGHC005921c001
DR   Wikidata; Q54880530
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24251; TMED5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMED5 (-) 2
AC   CVCL_XU33
SY   HZGHC005921c004; TMED5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU33
DR   Horizon_Discovery; HZGHC005921c004
DR   Wikidata; Q93972979
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24251; TMED5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMED7 (-) 1
AC   CVCL_TS73
SY   HZGHC005923c002; TMED7 knockout cell line 1bp insertion; HAP1 TMED7 (-)
DR   cancercelllines; CVCL_TS73
DR   Horizon_Discovery; HZGHC005923c002
DR   Wikidata; Q54880531
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24253; TMED7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMED7 (-) 2
AC   CVCL_XU34
SY   HZGHC005923c007; TMED7 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XU34
DR   Horizon_Discovery; HZGHC005923c007
DR   Wikidata; Q93973004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24253; TMED7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMED9 (-) 1
AC   CVCL_TS74
SY   HZGHC005924c006; TMED9 knockout cell line 5bp deletion; HAP1 TMED9 (-)
DR   cancercelllines; CVCL_TS74
DR   Horizon_Discovery; HZGHC005924c006
DR   Wikidata; Q54880532
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24878; TMED9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMED9 (-) 2
AC   CVCL_XU35
SY   HZGHC005925c005; TMED9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU35
DR   Horizon_Discovery; HZGHC005925c005
DR   Wikidata; Q93973031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24878; TMED9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMED9 (-) 3
AC   CVCL_XU36
SY   HZGHC005925c009; TMED9 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU36
DR   Horizon_Discovery; HZGHC005925c009
DR   Wikidata; Q93973038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24878; TMED9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005925c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM106B (-) 1
AC   CVCL_TS75
SY   HZGHC005876c009; TMEM106B knockout cell line 19bp deletion; HAP1 TMEM106B (-)
DR   cancercelllines; CVCL_TS75
DR   Horizon_Discovery; HZGHC005876c009
DR   Wikidata; Q54880534
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22407; TMEM106B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM106B (-) 2
AC   CVCL_XU37
SY   HZGHC005877c002; TMEM106B knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XU37
DR   Horizon_Discovery; HZGHC005877c002
DR   Wikidata; Q93973065
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22407; TMEM106B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM106B (-) 3
AC   CVCL_XU38
SY   HZGHC005877c010; TMEM106B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XU38
DR   Horizon_Discovery; HZGHC005877c010
DR   Wikidata; Q93973071
RX   PubMed=37545650;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22407; TMEM106B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM126A (-) 1
AC   CVCL_TS76
SY   HZGHC005796c011; TMEM126A knockout cell line 14bp deletion; HAP1 TMEM126A (-)
DR   cancercelllines; CVCL_TS76
DR   Horizon_Discovery; HZGHC005796c011
DR   Wikidata; Q54880535
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25382; TMEM126A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM126A (-) 2
AC   CVCL_XU39
SY   HZGHC005796c002; TMEM126A knockout cell line 79bp insertion
DR   cancercelllines; CVCL_XU39
DR   Horizon_Discovery; HZGHC005796c002
DR   Wikidata; Q93973098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25382; TMEM126A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005796c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM126A (-) 3
AC   CVCL_XU40
SY   HZGHC005797c004; TMEM126A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU40
DR   Horizon_Discovery; HZGHC005797c004
DR   Wikidata; Q93973105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25382; TMEM126A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM126A (-) 4
AC   CVCL_XU41
SY   HZGHC005797c006; TMEM126A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XU41
DR   Horizon_Discovery; HZGHC005797c006
DR   Wikidata; Q93973111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25382; TMEM126A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM150A (-) 1
AC   CVCL_TS77
SY   HZGHC003812c007; TMEM150A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TS77
DR   Horizon_Discovery; HZGHC003812c007
DR   Wikidata; Q54880536
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24677; TMEM150A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM150A (-) 2
AC   CVCL_TS78
SY   HZGHC003812c012; TMEM150A knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TS78
DR   Horizon_Discovery; HZGHC003812c012
DR   Wikidata; Q54880537
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24677; TMEM150A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM150C (-) 1
AC   CVCL_TS79
SY   HZGHC003676c001; TMEM150C knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS79
DR   Horizon_Discovery; HZGHC003676c001
DR   Wikidata; Q54880538
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37263; TMEM150C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM150C (-) 2
AC   CVCL_TS80
SY   HZGHC003676c007; TMEM150C knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TS80
DR   Horizon_Discovery; HZGHC003676c007
DR   Wikidata; Q54880539
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37263; TMEM150C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003676c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM165 (-) 1
AC   CVCL_E2M2
SY   HZGHC008178c006
DR   Horizon_Discovery; HZGHC008178c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30760; TMEM165.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM165 (-) 2
AC   CVCL_E2M3
SY   HZGHC008178c007
DR   Horizon_Discovery; HZGHC008178c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30760; TMEM165.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM173 (-) 1
AC   CVCL_TS81
SY   HZGHC002925c005; TMEM173 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TS81
DR   Horizon_Discovery; HZGHC002925c005
DR   Wikidata; Q54880540
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM173 (-) 2
AC   CVCL_TS82
SY   HZGHC002925c010; TMEM173 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TS82
DR   Horizon_Discovery; HZGHC002925c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54880541
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TMEM173 (-) 3
AC   CVCL_TS83
SY   HZGHC002926c007; TMEM173 knockout cell line 61bp insertion
DR   cancercelllines; CVCL_TS83
DR   Horizon_Discovery; HZGHC002926c007
DR   Wikidata; Q54880542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002926c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TMEM173 (-) 4
AC   CVCL_TS84
SY   HZGHC002926c011; TMEM173 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TS84
DR   Horizon_Discovery; HZGHC002926c011
DR   Wikidata; Q54880543
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM175 (-) 1
AC   CVCL_TS85
SY   HZGHC005593c004; TMEM175 knockout cell line 13bp deletion; HAP1 TMEM175 (-)
DR   cancercelllines; CVCL_TS85
DR   Horizon_Discovery; HZGHC005593c004
DR   Wikidata; Q54880544
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM175 (-) 2
AC   CVCL_XU42
SY   HZGHC005593c009; TMEM175 knockout cell line 70bp deletion
DR   cancercelllines; CVCL_XU42
DR   Horizon_Discovery; HZGHC005593c009
DR   Wikidata; Q93973279
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005593c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM175 (-) 3
AC   CVCL_XU43
SY   HZGHC005594c010; TMEM175 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XU43
DR   Horizon_Discovery; HZGHC005594c010
DR   Wikidata; Q93973284
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM177 (-) 1
AC   CVCL_TS86
SY   HZGHC004057c011; TMEM177 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TS86
DR   Horizon_Discovery; HZGHC004057c011
DR   Wikidata; Q54880545
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28143; TMEM177.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM177 (-) 2
AC   CVCL_TS87
SY   HZGHC004057c012; TMEM177 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TS87
DR   Horizon_Discovery; HZGHC004057c012
DR   Wikidata; Q54880546
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28143; TMEM177.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM189 (-) 1
AC   CVCL_XU44
SY   HZGHC007279c004; HZGHC387521; TMEM189 knockout cell line 61bp deletion in exon 5; HAP1 TMEM189 (-)
DR   cancercelllines; CVCL_XU44
DR   Horizon_Discovery; HZGHC007279c004
DR   Wikidata; Q93973330
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16735; PEDS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM189 (-) 2
AC   CVCL_B5L1
SY   HZGHC007279c007; TMEM189 knockout cell line 17bp deletion in exon 5
DR   cancercelllines; CVCL_B5L1
DR   Horizon_Discovery; HZGHC007279c007
DR   Wikidata; Q111733322
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16735; PEDS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 TMEM189 (-) 3
AC   CVCL_B5L2
SY   HZGHC007279c008; TMEM189 knockout cell line 17bp deletion in exon 5
DR   cancercelllines; CVCL_B5L2
DR   Horizon_Discovery; HZGHC007279c008
DR   Wikidata; Q111733323
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16735; PEDS1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 TMEM2 (-) 1
AC   CVCL_TS88
SY   HZGHC005251c010; TMEM2 knockout cell line 2bp deletion; HAP1 TMEM2 (-)
DR   cancercelllines; CVCL_TS88
DR   Horizon_Discovery; HZGHC005251c010
DR   Wikidata; Q54880547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11869; CEMIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM2 (-) 2
AC   CVCL_XU45
SY   HZGHC005251c007; TMEM2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XU45
DR   Horizon_Discovery; HZGHC005251c007
DR   Wikidata; Q93973355
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11869; CEMIP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM205 (-) 1
AC   CVCL_TS89
SY   HZGHC005798c001; TMEM205 knockout cell line 1bp deletion; HAP1 TMEM205 (-)
DR   cancercelllines; CVCL_TS89
DR   Horizon_Discovery; HZGHC005798c001
DR   Wikidata; Q54880548
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29631; TMEM205.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM205 (-) 2
AC   CVCL_XU46
SY   HZGHC005798c006; TMEM205 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XU46
DR   Horizon_Discovery; HZGHC005798c006
DR   Wikidata; Q93973385
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29631; TMEM205.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005798c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM205 (-) 3
AC   CVCL_XU47
SY   HZGHC005799c001; TMEM205 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU47
DR   Horizon_Discovery; HZGHC005799c001
DR   Wikidata; Q93973398
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29631; TMEM205.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM205 (-) 4
AC   CVCL_XU48
SY   HZGHC005799c005; TMEM205 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XU48
DR   Horizon_Discovery; HZGHC005799c005
DR   Wikidata; Q93973402
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29631; TMEM205.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM205 (-) 5
AC   CVCL_XU49
SY   HZGHC005799c010; TMEM205 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XU49
DR   Horizon_Discovery; HZGHC005799c010
DR   Wikidata; Q93973408
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29631; TMEM205.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM209 (-) 1
AC   CVCL_TS90
SY   HZGHC000817c010; TMEM209 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TS90
DR   Horizon_Discovery; HZGHC000817c010
DR   Wikidata; Q54880549
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21898; TMEM209.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM209 (-) 2
AC   CVCL_TS91
SY   HZGHC000817c011; TMEM209 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TS91
DR   Horizon_Discovery; HZGHC000817c011
DR   Wikidata; Q54880550
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21898; TMEM209.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM223 (-) 1
AC   CVCL_TS92
SY   HZGHC003614c003; TMEM223 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TS92
DR   Horizon_Discovery; HZGHC003614c003
DR   Wikidata; Q54880551
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28464; TMEM223.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM223 (-) 2
AC   CVCL_TS93
SY   HZGHC003614c005; TMEM223 knockout cell line 112bp insertion
DR   cancercelllines; CVCL_TS93
DR   Horizon_Discovery; HZGHC003614c005
DR   Wikidata; Q54880552
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28464; TMEM223.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003614c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM251 (-)
AC   CVCL_E2M4
SY   HZGHC007846c002; TMEM251 knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC007846c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20218; LYSET.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM30A (-) 1
AC   CVCL_TS94
SY   HZGHC005423c007; TMEM30A knockout cell line 152bp insertion; HAP1 TMEM30A (-)
DR   cancercelllines; CVCL_TS94
DR   Horizon_Discovery; HZGHC005423c007
DR   Wikidata; Q54880553
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16667; TMEM30A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005423c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TMEM30A (-) 2
AC   CVCL_XU50
SY   HZGHC005423c009; TMEM30A knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XU50
DR   Horizon_Discovery; HZGHC005423c009
DR   Wikidata; Q93973487
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16667; TMEM30A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM38B (-) 1
AC   CVCL_TS95
SY   HZGHC005483c010; TMEM38B knockout cell line 8bp deletion; HAP1 TMEM38B (-)
DR   cancercelllines; CVCL_TS95
DR   Horizon_Discovery; HZGHC005483c010
DR   Wikidata; Q54880554
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25535; TMEM38B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM38B (-) 2
AC   CVCL_XU51
SY   HZGHC005483c011; TMEM38B knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XU51
DR   Horizon_Discovery; HZGHC005483c011
DR   Wikidata; Q93973507
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25535; TMEM38B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM39B (-) 1
AC   CVCL_XU52
SY   HZGHC007170c001; HZGHC55116; TMEM39B knockout cell line 16bp deletion in exon 4; HAP1 TMEM39B (-)
DR   cancercelllines; CVCL_XU52
DR   Horizon_Discovery; HZGHC007170c001
DR   Wikidata; Q93973512
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25510; TMEM39B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM39B (-) 2
AC   CVCL_B5L3
SY   HZGHC007170c009; TMEM39B knockout cell line 14bp deletion in exon 4
DR   cancercelllines; CVCL_B5L3
DR   Horizon_Discovery; HZGHC007170c009
DR   Wikidata; Q111733324
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25510; TMEM39B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 TMEM5 (-) 1
AC   CVCL_TS96
SY   HZGHC000511c007; TMEM5 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TS96
DR   Horizon_Discovery; HZGHC000511c007
DR   Wikidata; Q54880559
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13530; RXYLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM5 (-) 2
AC   CVCL_TS97
SY   HZGHC000511c011; TMEM5 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TS97
DR   Horizon_Discovery; HZGHC000511c011
DR   Wikidata; Q54880560
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13530; RXYLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM5 (-) 3
AC   CVCL_TS98
SY   HZGHC004662c010; TMEM5 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TS98
DR   Horizon_Discovery; HZGHC004662c010
DR   Wikidata; Q54880561
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13530; RXYLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM5 (-) 4
AC   CVCL_TS99
SY   HZGHC004663c001; TMEM5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TS99
DR   Horizon_Discovery; HZGHC004663c001
DR   Wikidata; Q54880562
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13530; RXYLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM5 (-) 5
AC   CVCL_TT00
SY   HZGHC004663c004; TMEM5 knockout cell line 59bp insertion
DR   cancercelllines; CVCL_TT00
DR   Horizon_Discovery; HZGHC004663c004
DR   Wikidata; Q54880563
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13530; RXYLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004663c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM5 (-) 6
AC   CVCL_TT01
SY   HZGHC004663c009; TMEM5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT01
DR   Horizon_Discovery; HZGHC004663c009
DR   Wikidata; Q54880564
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13530; RXYLT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM56 (-) 1
AC   CVCL_TT02
SY   HZGHC002768c002; TMEM56 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TT02
DR   Horizon_Discovery; HZGHC002768c002
DR   Wikidata; Q54880565
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26477; TLCD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM56 (-) 2
AC   CVCL_TT03
SY   HZGHC002768c009; TMEM56 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT03
DR   Horizon_Discovery; HZGHC002768c009
DR   Wikidata; Q54880566
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26477; TLCD4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM65 (-) 1
AC   CVCL_E2M5
SY   HZGHC008254c006
DR   Horizon_Discovery; HZGHC008254c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25203; TMEM65.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM65 (-) 2
AC   CVCL_E2M6
SY   HZGHC008255c002
DR   Horizon_Discovery; HZGHC008255c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25203; TMEM65.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM65 (-) 3
AC   CVCL_E2M7
SY   HZGHC008255c010
DR   Horizon_Discovery; HZGHC008255c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25203; TMEM65.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM69 (-) 1
AC   CVCL_XU53
SY   HZGHC007171c003; HZGHC51249; TMEM69 knockout cell line 20bp deletion in exon 3; HAP1 TMEM69 (-)
DR   cancercelllines; CVCL_XU53
DR   Horizon_Discovery; HZGHC007171c003
DR   Wikidata; Q93973639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28035; TMEM69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM69 (-) 2
AC   CVCL_B5L4
SY   HZGHC007171c010; TMEM69 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_B5L4
DR   Horizon_Discovery; HZGHC007171c010
DR   Wikidata; Q111733325
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28035; TMEM69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 TMEM70 (-) 1
AC   CVCL_TT04
SY   HZGHC003615c001; TMEM70 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_TT04
DR   Horizon_Discovery; HZGHC003615c001
DR   Wikidata; Q54880567
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26050; TMEM70.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM70 (-) 2
AC   CVCL_TT05
SY   HZGHC003615c010; TMEM70 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TT05
DR   Horizon_Discovery; HZGHC003615c010
DR   Wikidata; Q54880568
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26050; TMEM70.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TMEM8A (-) 1
AC   CVCL_XU54
SY   HZGHC007120c003; HZGHC58986; TMEM8A knockout cell line 4bp deletion in exon 3; HAP1 TMEM8A (-)
DR   cancercelllines; CVCL_XU54
DR   Horizon_Discovery; HZGHC007120c003
DR   Wikidata; Q93973662
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17205; PGAP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TMEM8A (-) 2
AC   CVCL_B5L5
SY   HZGHC007120c008; TMEM8A knockout cell line 14bp deletion in exon 3
DR   cancercelllines; CVCL_B5L5
DR   Horizon_Discovery; HZGHC007120c008
DR   Wikidata; Q111733326
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17205; PGAP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 TMEM97 (-) 1
AC   CVCL_E2M8
SY   HZGHC007423c002
DR   Horizon_Discovery; HZGHC007423c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28106; TMEM97.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM97 (-) 2
AC   CVCL_E2M9
SY   HZGHC007423c005
DR   Horizon_Discovery; HZGHC007423c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28106; TMEM97.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM97 (-) 3
AC   CVCL_E2MA
SY   HZGHC007423c009
DR   Horizon_Discovery; HZGHC007423c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28106; TMEM97.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMEM98 (-)
AC   CVCL_E2MB
SY   HZGHC007524c011
DR   Horizon_Discovery; HZGHC007524c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24529; TMEM98.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMTC3 (-) 1
AC   CVCL_E2MC
SY   HZGHC007369c002
DR   Horizon_Discovery; HZGHC007369c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26899; TMTC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TMTC3 (-) 2
AC   CVCL_E2MD
SY   HZGHC007369c003
DR   Horizon_Discovery; HZGHC007369c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26899; TMTC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TNFRSF10B (-)
AC   CVCL_TT06
SY   HZGHC005520c002; TNFRSF10B knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT06
DR   Horizon_Discovery; HZGHC005520c002
DR   Wikidata; Q54880569
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFRSF12A (-) 1
AC   CVCL_TT07
SY   HZGHC006223c011; TNFRSF12A knockout cell line 184bp deletion; HAP1 TNFRSF12A (-)
DR   cancercelllines; CVCL_TT07
DR   Horizon_Discovery; HZGHC006223c011
DR   Wikidata; Q54880570
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18152; TNFRSF12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNFRSF12A (-) 2
AC   CVCL_XU55
SY   HZGHC006223c008; TNFRSF12A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XU55
DR   Horizon_Discovery; HZGHC006223c008
DR   Wikidata; Q93973690
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18152; TNFRSF12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFRSF12A (-) 3
AC   CVCL_XU56
SY   HZGHC006224c004; TNFRSF12A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU56
DR   Horizon_Discovery; HZGHC006224c004
DR   Wikidata; Q93973693
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18152; TNFRSF12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFRSF12A (-) 4
AC   CVCL_XU57
SY   HZGHC006224c010; TNFRSF12A knockout cell line 238bp insertion
DR   cancercelllines; CVCL_XU57
DR   Horizon_Discovery; HZGHC006224c010
DR   Wikidata; Q93973698
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18152; TNFRSF12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006224c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNFRSF12A (-) 5
AC   CVCL_XU58
SY   HZGHC006224c011; TNFRSF12A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU58
DR   Horizon_Discovery; HZGHC006224c011
DR   Wikidata; Q93973702
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18152; TNFRSF12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFRSF1A (-) 1
AC   CVCL_TT08
SY   HZGHC002585c006; TNFRSF1A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TT08
DR   Horizon_Discovery; HZGHC002585c006
DR   Wikidata; Q54880571
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFRSF1A (-) 2
AC   CVCL_TT09
SY   HZGHC002585c008; TNFRSF1A knockout cell line 70bp insertion
DR   cancercelllines; CVCL_TT09
DR   Horizon_Discovery; HZGHC002585c008
DR   Wikidata; Q54880572
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002585c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNFRSF1B (-) 1
AC   CVCL_TT10
SY   HZGHC002586c006; TNFRSF1B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT10
DR   Horizon_Discovery; HZGHC002586c006
DR   Wikidata; Q54880573
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11917; TNFRSF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFRSF1B (-) 2
AC   CVCL_TT11
SY   HZGHC002586c011; TNFRSF1B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT11
DR   Horizon_Discovery; HZGHC002586c011
DR   Wikidata; Q54880574
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11917; TNFRSF1B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFSF9 (-) 1
AC   CVCL_TT12
SY   HZGHC005359c012; TNFSF9 knockout cell line 35bp deletion; HAP1 TNFSF9 (-)
DR   cancercelllines; CVCL_TT12
DR   Horizon_Discovery; HZGHC005359c012
DR   Wikidata; Q54880575
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11939; TNFSF9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNFSF9 (-) 2
AC   CVCL_XU59
SY   HZGHC005359c004; TNFSF9 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XU59
DR   Horizon_Discovery; HZGHC005359c004
DR   Wikidata; Q93973756
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11939; TNFSF9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNFSF9 (-) 3
AC   CVCL_XU60
SY   HZGHC005360c010; TNFSF9 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_XU60
DR   Horizon_Discovery; HZGHC005360c010
DR   Wikidata; Q93973759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11939; TNFSF9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNIK (-) 1
AC   CVCL_TT13
SY   HZGHC000709c002; TNIK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TT13
DR   Horizon_Discovery; HZGHC000709c002
DR   PRIDE; PXD010335
DR   Wikidata; Q54880576
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30765; TNIK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNK1 (-)
AC   CVCL_TT14
SY   HZGHC000177c002; TNK1 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TT14
DR   Horizon_Discovery; HZGHC000177c002
DR   Wikidata; Q54880577
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11940; TNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNK2 (-)
AC   CVCL_TT15
SY   HZGHC002454c026; TNK2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TT15
DR   Horizon_Discovery; HZGHC002454c026
DR   Wikidata; Q54880578
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19297; TNK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNKS (-)
AC   CVCL_TT16
SY   HZGHC006450c001; TNKS knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT16
DR   Horizon_Discovery; HZGHC006450c001
DR   Wikidata; Q54880579
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11941; TNKS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNKS2 (-) 1
AC   CVCL_TT17
SY   HZGHC006451c010; TNKS2 knockout cell line 4bp deletion; HAP1 TNKS2 (-)
DR   cancercelllines; CVCL_TT17
DR   Horizon_Discovery; HZGHC006451c010
DR   Wikidata; Q54880580
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15677; TNKS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNKS2 (-) 2
AC   CVCL_XU61
SY   HZGHC006451c003; TNKS2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XU61
DR   Horizon_Discovery; HZGHC006451c003
DR   Wikidata; Q93973807
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15677; TNKS2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNPO1 (-) 1
AC   CVCL_TT18
SY   HZGHC003548c007; TNPO1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT18
DR   Horizon_Discovery; HZGHC003548c007
DR   Wikidata; Q54880581
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6401; TNPO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNPO1 (-) 2
AC   CVCL_TT19
SY   HZGHC003548c008; TNPO1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT19
DR   Horizon_Discovery; HZGHC003548c008
DR   Wikidata; Q54880582
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6401; TNPO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNPO1 (-) 3
AC   CVCL_TT20
SY   HZGHC003548c001; TNPO1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TT20
DR   Horizon_Discovery; HZGHC003548c001
DR   Wikidata; Q54880583
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6401; TNPO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TNPO1 (-) 4
AC   CVCL_XU62
SY   HZGHC003548c010; TNPO1 knockout cell line
DR   cancercelllines; CVCL_XU62
DR   Horizon_Discovery; HZGHC003548c010
DR   Wikidata; Q93973834
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6401; TNPO1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003548c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNRC6A (-) 1
AC   CVCL_TT21
SY   HZGHC005879c011; TNRC6A knockout cell line 7bp deletion; HAP1 TNRC6A (-)
DR   cancercelllines; CVCL_TT21
DR   Horizon_Discovery; HZGHC005879c011
DR   Wikidata; Q54880584
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11969; TNRC6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TNRC6A (-) 2
AC   CVCL_XU63
SY   HZGHC005879c006; TNRC6A knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XU63
DR   Horizon_Discovery; HZGHC005879c006
DR   Wikidata; Q93973845
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11969; TNRC6A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOM1 (-) 1
AC   CVCL_TT22
SY   HZGHC004405c003; TOM1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT22
DR   Horizon_Discovery; HZGHC004405c003
DR   Wikidata; Q54880585
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11982; TOM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOM1 (-) 2
AC   CVCL_TT23
SY   HZGHC004405c006; TOM1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT23
DR   Horizon_Discovery; HZGHC004405c006
DR   Wikidata; Q54880586
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11982; TOM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOM1 (-) 3
AC   CVCL_TT24
SY   HZGHC004405c012; TOM1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TT24
DR   Horizon_Discovery; HZGHC004405c012
DR   Wikidata; Q54880587
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11982; TOM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOM1 (-) 4
AC   CVCL_TT25
SY   HZGHC004406c009; TOM1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TT25
DR   Horizon_Discovery; HZGHC004406c009
DR   Wikidata; Q54880588
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11982; TOM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOMM7 (-) 1
AC   CVCL_TT26
SY   HZGHC004079c006; TOMM7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TT26
DR   Horizon_Discovery; HZGHC004079c006
DR   Wikidata; Q54880589
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21648; TOMM7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOMM7 (-) 2
AC   CVCL_TT27
SY   HZGHC004079c005; TOMM7 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TT27
DR   Horizon_Discovery; HZGHC004079c005
DR   Wikidata; Q54880590
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21648; TOMM7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOP1 (-) 1
AC   CVCL_TT28
SY   HZGHC001210c003; TOP1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TT28
DR   Horizon_Discovery; HZGHC001210c003
DR   Wikidata; Q54880591
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11986; TOP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001210c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TOP1 (-) 2
AC   CVCL_TT29
SY   HZGHC001210c009; TOP1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TT29
DR   Horizon_Discovery; HZGHC001210c009
DR   Wikidata; Q54880592
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11986; TOP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001210c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TOP1MT (-) 1
AC   CVCL_TT30
SY   HZGHC003771c001; TOP1MT knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TT30
DR   Horizon_Discovery; HZGHC003771c001
DR   Wikidata; Q54880593
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29787; TOP1MT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOP1MT (-) 2
AC   CVCL_TT31
SY   HZGHC003771c010; TOP1MT knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT31
DR   Horizon_Discovery; HZGHC003771c010
DR   Wikidata; Q54880594
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29787; TOP1MT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOP2B (-) 1
AC   CVCL_TT32
SY   HZGHC003697c011; TOP2B knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TT32
DR   Horizon_Discovery; HZGHC003697c011
DR   Wikidata; Q54880595
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11990; TOP2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOP2B (-) 2
AC   CVCL_TT33
SY   HZGHC003697c012; TOP2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT33
DR   Horizon_Discovery; HZGHC003697c012
DR   Wikidata; Q54880596
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11990; TOP2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOP3B (-)
AC   CVCL_E2ME
SY   HZGHC007811c004
DR   Horizon_Discovery; HZGHC007811c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11993; TOP3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TOPORS (-)
AC   CVCL_E2MF
SY   HZGHC008005c006
DR   Horizon_Discovery; HZGHC008005c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21653; TOPORS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TOX (-) 1
AC   CVCL_TT34
SY   HZGHC001324c002; TOX knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TT34
DR   Horizon_Discovery; HZGHC001324c002
DR   Wikidata; Q54880597
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18988; TOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOX (-) 2
AC   CVCL_TT35
SY   HZGHC001324c003; TOX knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TT35
DR   Horizon_Discovery; HZGHC001324c003
DR   Wikidata; Q54880598
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18988; TOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOX3 (-) 1
AC   CVCL_TT36
SY   HZGHC004187c004; TOX3 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_TT36
DR   Horizon_Discovery; HZGHC004187c004
DR   Wikidata; Q54880604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11972; TOX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TOX3 (-) 2
AC   CVCL_TT37
SY   HZGHC004187c011; TOX3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT37
DR   Horizon_Discovery; HZGHC004187c011
DR   Wikidata; Q54880605
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11972; TOX3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53 (-) 1
AC   CVCL_RJ70
SY   HZGHC001068c007; TP53 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_RJ70
DR   Horizon_Discovery; HZGHC001068c007
DR   Wikidata; Q54880606
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001068c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 14
//
ID   HAP1 TP53 (-) 2
AC   CVCL_SA84
SY   HZGHC001068c001; TP53 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_SA84
DR   Horizon_Discovery; HZGHC001068c001
DR   Wikidata; Q54880607
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 13
//
ID   HAP1 TP53 KO
AC   CVCL_F1CB
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Park, Yang-Nim.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HAP1 TP53BP1 (-) 1
AC   CVCL_TT38
SY   HZGHC000413c010; TP53BP1 knockout cell line 40bp deletion
DR   cancercelllines; CVCL_TT38
DR   Horizon_Discovery; HZGHC000413c010
DR   Wikidata; Q54880608
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53BP1 (-) 2
AC   CVCL_TT39
SY   HZGHC000413c011; TP53BP1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT39
DR   Horizon_Discovery; HZGHC000413c011
DR   Wikidata; Q54880609
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53BP1 (-) 3
AC   CVCL_TT40
SY   HZGHC004776c002; TP53BP1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT40
DR   Horizon_Discovery; HZGHC004776c002
DR   Wikidata; Q54880610
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53BP1 (-) 4
AC   CVCL_TT41
SY   HZGHC004776c010; TP53BP1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT41
DR   Horizon_Discovery; HZGHC004776c010
DR   Wikidata; Q54880611
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53BP1 (-) 5
AC   CVCL_TT42
SY   HZGHC004776c012; TP53BP1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT42
DR   Horizon_Discovery; HZGHC004776c012
DR   Wikidata; Q54880612
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53BP2 (-) 1
AC   CVCL_TT43
SY   HZGHC003167c001; TP53BP2 knockout cell line 121bp insertion
DR   cancercelllines; CVCL_TT43
DR   Horizon_Discovery; HZGHC003167c001
DR   Wikidata; Q54880613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12000; TP53BP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003167c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TP53BP2 (-) 2
AC   CVCL_TT44
SY   HZGHC003167c011; TP53BP2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT44
DR   Horizon_Discovery; HZGHC003167c011
DR   Wikidata; Q54880614
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12000; TP53BP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53BP2 (-) 3
AC   CVCL_TT45
SY   HZGHC003167c012; TP53BP2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT45
DR   Horizon_Discovery; HZGHC003167c012
DR   Wikidata; Q54880615
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12000; TP53BP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53INP2 (-) 1
AC   CVCL_TT46
SY   HZGHC003042c007; TP53INP2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TT46
DR   Horizon_Discovery; HZGHC003042c007
DR   Wikidata; Q54880616
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16104; TP53INP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53INP2 (-) 2
AC   CVCL_TT47
SY   HZGHC003042c009; TP53INP2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TT47
DR   Horizon_Discovery; HZGHC003042c009
DR   Wikidata; Q54880617
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16104; TP53INP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP53INP2 (-) 3
AC   CVCL_TT48
SY   HZGHC003462c006; TP53INP2 knockout cell line 623bp insertion
DR   cancercelllines; CVCL_TT48
DR   Horizon_Discovery; HZGHC003462c006
DR   Wikidata; Q54880618
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16104; TP53INP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003462c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TP73 (-) 1
AC   CVCL_TT49
SY   HZGHC006006c001; TP73 knockout cell line 1bp insertion; HAP1 TP73 (-)
DR   cancercelllines; CVCL_TT49
DR   Horizon_Discovery; HZGHC006006c001
DR   Wikidata; Q54880619
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12003; TP73.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TP73 (-) 2
AC   CVCL_XU64
SY   HZGHC006006c004; TP73 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_XU64
DR   Horizon_Discovery; HZGHC006006c004
DR   Wikidata; Q93974121
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12003; TP73.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TP73 (-) 3
AC   CVCL_XU65
SY   HZGHC006006c011; TP73 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU65
DR   Horizon_Discovery; HZGHC006006c011
DR   Wikidata; Q93974124
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12003; TP73.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TPCN1 (-)
AC   CVCL_E2MG
SY   HZGHC007874c010
DR   Horizon_Discovery; HZGHC007874c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18182; TPCN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TPCN2 (-)
AC   CVCL_E2MH
SY   HZGHC007876c010
DR   Horizon_Discovery; HZGHC007876c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20820; TPCN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TPMT (-) 1
AC   CVCL_TT50
SY   HZGHC003831c004; TPMT knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TT50
DR   Horizon_Discovery; HZGHC003831c004
DR   Wikidata; Q54880620
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12014; TPMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TPMT (-) 2
AC   CVCL_TT51
SY   HZGHC003831c011; TPMT knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TT51
DR   Horizon_Discovery; HZGHC003831c011
DR   Wikidata; Q54880621
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12014; TPMT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TPP1 (-) 1
AC   CVCL_XU66
SY   HZGHC007213c006; HZGHC1200; TPP1 knockout cell line 1bp insertion in exon 6; HAP1 TPP1 (-)
DR   cancercelllines; CVCL_XU66
DR   Horizon_Discovery; HZGHC007213c006
DR   Wikidata; Q93974146
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TPP1 (-) 2
AC   CVCL_E2MI
SY   HZGHC007213c009; TPP1 knockout cell line 7bp deletion in exon 6
DR   Horizon_Discovery; HZGHC007213c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRA2A (-) 1
AC   CVCL_TT52
SY   HZGHC006489c001; TRA2A knockout cell line 26bp deletion; HAP1 TRA2A (-)
DR   cancercelllines; CVCL_TT52
DR   Horizon_Discovery; HZGHC006489c001
DR   Wikidata; Q54880622
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16645; TRA2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TRA2A (-) 2
AC   CVCL_XU67
SY   HZGHC006489c004; TRA2A knockout cell line 70bp deletion
DR   cancercelllines; CVCL_XU67
DR   Horizon_Discovery; HZGHC006489c004
DR   Wikidata; Q93974158
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16645; TRA2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRA2A (-) 3
AC   CVCL_XU68
SY   HZGHC006490c004; TRA2A knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XU68
DR   Horizon_Discovery; HZGHC006490c004
DR   Wikidata; Q93974162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16645; TRA2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF1 (-)
AC   CVCL_TT53
SY   HZGHC004202c001; TRAF1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT53
DR   Horizon_Discovery; HZGHC004202c001
DR   Wikidata; Q54880623
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12031; TRAF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF2 (-) 1
AC   CVCL_TT54
SY   HZGHC002588c002; TRAF2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT54
DR   Horizon_Discovery; HZGHC002588c002
DR   Wikidata; Q54880624
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12032; TRAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF2 (-) 2
AC   CVCL_TT55
SY   HZGHC002588c010; TRAF2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TT55
DR   Horizon_Discovery; HZGHC002588c010
DR   Wikidata; Q54880625
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12032; TRAF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002588c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRAF3 (-) 1
AC   CVCL_TT56
SY   HZGHC002608c011; TRAF3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT56
DR   Horizon_Discovery; HZGHC002608c011
DR   Wikidata; Q54880626
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002608c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRAF3 (-) 2
AC   CVCL_TT57
SY   HZGHC002608c001; TRAF3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT57
DR   Horizon_Discovery; HZGHC002608c001
DR   Wikidata; Q54880627
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF3 (-) 3
AC   CVCL_TT58
SY   HZGHC002608c006; TRAF3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TT58
DR   Horizon_Discovery; HZGHC002608c006
DR   Wikidata; Q54880628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF3IP2 (-) 1
AC   CVCL_TT59
SY   HZGHC004717c002; TRAF3IP2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT59
DR   Horizon_Discovery; HZGHC004717c002
DR   Wikidata; Q54880629
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1343; TRAF3IP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF3IP2 (-) 2
AC   CVCL_TT60
SY   HZGHC004717c008; TRAF3IP2 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TT60
DR   Horizon_Discovery; HZGHC004717c008
DR   Wikidata; Q54880630
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1343; TRAF3IP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF3IP2 (-) 3
AC   CVCL_TT61
SY   HZGHC004718c005; TRAF3IP2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TT61
DR   Horizon_Discovery; HZGHC004718c005
DR   Wikidata; Q54880631
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1343; TRAF3IP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF5 (-)
AC   CVCL_TT62
SY   HZGHC002589c007; TRAF5 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT62
DR   Horizon_Discovery; HZGHC002589c007
DR   Wikidata; Q54880632
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12035; TRAF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF6 (-) 1
AC   CVCL_TT63
SY   HZGHC003466c008; TRAF6 knockout cell line 59bp insertion
DR   cancercelllines; CVCL_TT63
DR   Horizon_Discovery; HZGHC003466c008
DR   Wikidata; Q54880633
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003466c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRAF6 (-) 2
AC   CVCL_TT64
SY   HZGHC003466c011; TRAF6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TT64
DR   Horizon_Discovery; HZGHC003466c011
DR   Wikidata; Q54880634
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF7 (-) 1
AC   CVCL_TT65
SY   HZGHC003901c010; TRAF7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TT65
DR   Horizon_Discovery; HZGHC003901c010
DR   Wikidata; Q54880635
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20456; TRAF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAF7 (-) 2
AC   CVCL_TT66
SY   HZGHC003901c012; TRAF7 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TT66
DR   Horizon_Discovery; HZGHC003901c012
DR   Wikidata; Q54880636
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20456; TRAF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAK1 (-) 1
AC   CVCL_TT67
SY   HZGHC006545c001; TRAK1 knockout cell line 11bp deletion; HAP1 TRAK1 (-)
DR   cancercelllines; CVCL_TT67
DR   Horizon_Discovery; HZGHC006545c001
DR   Wikidata; Q54880637
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29947; TRAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRAK1 (-) 2
AC   CVCL_XU69
SY   HZGHC006545c011; TRAK1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XU69
DR   Horizon_Discovery; HZGHC006545c011
DR   Wikidata; Q93974322
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29947; TRAK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRAP1 (-) 1
AC   CVCL_A9H4
SY   HZGHC007587c001; HZGHC10131; TRAP1 knockout cell line 5bp deletion in exon 4
DR   cancercelllines; CVCL_A9H4
DR   Horizon_Discovery; HZGHC007587c001
DR   Wikidata; Q102114094
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16264; TRAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRAP1 (-) 2
AC   CVCL_E2MJ
SY   HZGHC007587c005
DR   Horizon_Discovery; HZGHC007587c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16264; TRAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRAP1 (-) 3
AC   CVCL_E2MK
SY   HZGHC007588c006
DR   Horizon_Discovery; HZGHC007588c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16264; TRAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRAPPC10 (-)
AC   CVCL_XU70
SY   HZGHC007293c005; HZGHC7109; TRAPPC10 knockout cell line 1bp deletion in exon 7
DR   cancercelllines; CVCL_XU70
DR   Horizon_Discovery; HZGHC007293c005
DR   Wikidata; Q93974325
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11868; TRAPPC10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRAPPC6B (-)
AC   CVCL_E2ML
SY   HZGHC007325c005
DR   Horizon_Discovery; HZGHC007325c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23066; TRAPPC6B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRAPPC9 (-)
AC   CVCL_XU71
SY   HZGHC007291c002; HZGHC83696; TRAPPC9 knockout cell line 8bp deletion in exon 2
DR   cancercelllines; CVCL_XU71
DR   Horizon_Discovery; HZGHC007291c002
DR   Wikidata; Q93974328
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30832; TRAPPC9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRDMT1 (-) 1
AC   CVCL_TT68
SY   HZGHC001019c008; TRDMT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT68
DR   Horizon_Discovery; HZGHC001019c008
DR   Wikidata; Q54880638
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2977; TRDMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRDMT1 (-) 2
AC   CVCL_TT69
SY   HZGHC001019c010; TRDMT1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT69
DR   Horizon_Discovery; HZGHC001019c010
DR   Wikidata; Q54880639
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2977; TRDMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRDMT1 (-) 3
AC   CVCL_TT70
SY   HZGHC001019c011; TRDMT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT70
DR   Horizon_Discovery; HZGHC001019c011
DR   Wikidata; Q54880640
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2977; TRDMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TREX1 (-) 1
AC   CVCL_TT71
SY   HZGHC000419c010; TREX1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT71
DR   Horizon_Discovery; HZGHC000419c010
DR   Wikidata; Q54880641
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TREX1 (-) 2
AC   CVCL_TT72
SY   HZGHC000419c011; TREX1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT72
DR   Horizon_Discovery; HZGHC000419c011
DR   Wikidata; Q54880642
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TREX1 (-) 3
AC   CVCL_TT73
SY   HZGHC000419c020; TREX1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TT73
DR   Horizon_Discovery; HZGHC000419c020
DR   Wikidata; Q54880643
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIB1 (-) 1
AC   CVCL_TT74
SY   HZGHC001267c024; TRIB1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TT74
DR   Horizon_Discovery; HZGHC001267c024
DR   Wikidata; Q54880647
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16891; TRIB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIB1 (-) 2
AC   CVCL_TT75
SY   HZGHC003008c004; TRIB1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TT75
DR   Horizon_Discovery; HZGHC003008c004
DR   Wikidata; Q54880648
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16891; TRIB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIB1 (-) 3
AC   CVCL_TT76
SY   HZGHC003008c006; TRIB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT76
DR   Horizon_Discovery; HZGHC003008c006
DR   Wikidata; Q54880649
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16891; TRIB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIB2 (-)
AC   CVCL_TT77
SY   HZGHC000110c017; TRIB2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT77
DR   Horizon_Discovery; HZGHC000110c017
DR   Wikidata; Q54880650
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30809; TRIB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIB3 (-) 1
AC   CVCL_TT78
SY   HZGHC000111c009; TRIB3 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TT78
DR   Horizon_Discovery; HZGHC000111c009
DR   Wikidata; Q54880651
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000111c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIB3 (-) 2
AC   CVCL_TT79
SY   HZGHC000111c010; TRIB3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TT79
DR   Horizon_Discovery; HZGHC000111c010
DR   Wikidata; Q54880652
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIB3 (-) 3
AC   CVCL_TT80
SY   HZGHC000111c022; TRIB3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TT80
DR   Horizon_Discovery; HZGHC000111c022
DR   Wikidata; Q54880653
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000111c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM11 (-)
AC   CVCL_TT81
SY   HZGHC003651c008; TRIM11 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT81
DR   Horizon_Discovery; HZGHC003651c008
DR   Wikidata; Q54880654
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16281; TRIM11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM14 (-) 1
AC   CVCL_TT82
SY   HZGHC003639c005; TRIM14 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TT82
DR   Horizon_Discovery; HZGHC003639c005
DR   Wikidata; Q54880655
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16283; TRIM14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM14 (-) 2
AC   CVCL_TT83
SY   HZGHC003639c006; TRIM14 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT83
DR   Horizon_Discovery; HZGHC003639c006
DR   Wikidata; Q54880656
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16283; TRIM14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM16 (-)
AC   CVCL_TT84
SY   HZGHC003663c001; TRIM16 knockout cell line 107bp deletion
DR   cancercelllines; CVCL_TT84
DR   Horizon_Discovery; HZGHC003663c001
DR   Wikidata; Q54880657
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17241; TRIM16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM2 (-) 1
AC   CVCL_TT85
SY   HZGHC003635c001; TRIM2 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TT85
DR   Horizon_Discovery; HZGHC003635c001
DR   Wikidata; Q54880658
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15974; TRIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM2 (-) 2
AC   CVCL_TT86
SY   HZGHC003635c005; TRIM2 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TT86
DR   Horizon_Discovery; HZGHC003635c005
DR   Wikidata; Q54880659
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15974; TRIM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM21 (-) 1
AC   CVCL_TT87
SY   HZGHC003657c005; TRIM21 knockout cell line 139bp deletion
DR   cancercelllines; CVCL_TT87
DR   Horizon_Discovery; HZGHC003657c005
DR   Wikidata; Q54880660
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM21 (-) 2
AC   CVCL_TT88
SY   HZGHC003657c011; TRIM21 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TT88
DR   Horizon_Discovery; HZGHC003657c011
DR   Wikidata; Q54880661
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM22 (-) 1
AC   CVCL_TT89
SY   HZGHC003637c001; TRIM22 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT89
DR   Horizon_Discovery; HZGHC003637c001
DR   Wikidata; Q54880662
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16379; TRIM22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM22 (-) 2
AC   CVCL_TT90
SY   HZGHC003637c006; TRIM22 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TT90
DR   Horizon_Discovery; HZGHC003637c006
DR   Wikidata; Q54880663
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16379; TRIM22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM23 (-) 1
AC   CVCL_TT91
SY   HZGHC003656c001; TRIM23 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT91
DR   Horizon_Discovery; HZGHC003656c001
DR   Wikidata; Q54880664
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:660; TRIM23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM23 (-) 2
AC   CVCL_TT92
SY   HZGHC003656c010; TRIM23 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT92
DR   Horizon_Discovery; HZGHC003656c010
DR   Wikidata; Q54880665
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:660; TRIM23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM24 (-) 1
AC   CVCL_TT93
SY   HZGHC000928c004; TRIM24 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TT93
DR   Horizon_Discovery; HZGHC000928c004
DR   Wikidata; Q54880666
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11812; TRIM24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM24 (-) 2
AC   CVCL_TT94
SY   HZGHC000928c011; TRIM24 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TT94
DR   Horizon_Discovery; HZGHC000928c011
DR   Wikidata; Q54880667
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11812; TRIM24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM25 (-) 1
AC   CVCL_TT95
SY   HZGHC003633c001; TRIM25 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT95
DR   Horizon_Discovery; HZGHC003633c001
DR   Wikidata; Q54880668
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12932; TRIM25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM25 (-) 2
AC   CVCL_TT96
SY   HZGHC003633c004; TRIM25 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TT96
DR   Horizon_Discovery; HZGHC003633c004
DR   Wikidata; Q54880669
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12932; TRIM25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM25 (-) 3
AC   CVCL_TT97
SY   HZGHC003633c010; TRIM25 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TT97
DR   Horizon_Discovery; HZGHC003633c010
DR   Wikidata; Q54880670
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12932; TRIM25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003633c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM26 (-) 1
AC   CVCL_TT98
SY   HZGHC003642c001; TRIM26 knockout cell line 55bp deletion
DR   cancercelllines; CVCL_TT98
DR   Horizon_Discovery; HZGHC003642c001
DR   Wikidata; Q54880671
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12962; TRIM26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM26 (-) 2
AC   CVCL_TT99
SY   HZGHC003642c007; TRIM26 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TT99
DR   Horizon_Discovery; HZGHC003642c007
DR   Wikidata; Q54880672
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12962; TRIM26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM27 (-) 1
AC   CVCL_TU00
SY   HZGHC003632c003; TRIM27 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TU00
DR   Horizon_Discovery; HZGHC003632c003
DR   Wikidata; Q54880673
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9975; TRIM27.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM27 (-) 3
AC   CVCL_TU01
SY   HZGHC003632c010; TRIM27 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU01
DR   Horizon_Discovery; HZGHC003632c010
DR   Wikidata; Q54880674
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9975; TRIM27.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM28 (-) 1
AC   CVCL_TU02
SY   HZGHC000293c001; TRIM28 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TU02
DR   Horizon_Discovery; HZGHC000293c001
DR   Wikidata; Q54880675
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16384; TRIM28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM28 (-) 2
AC   CVCL_TU03
SY   HZGHC000293c003; TRIM28 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TU03
DR   Horizon_Discovery; HZGHC000293c003
DR   Wikidata; Q54880676
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16384; TRIM28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM3 (-) 1
AC   CVCL_TU04
SY   HZGHC003662c005; TRIM3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TU04
DR   Horizon_Discovery; HZGHC003662c005
DR   Wikidata; Q54880677
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10064; TRIM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM3 (-) 2
AC   CVCL_TU05
SY   HZGHC003662c012; TRIM3 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TU05
DR   Horizon_Discovery; HZGHC003662c012
DR   Wikidata; Q54880678
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10064; TRIM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM32 (-) 1
AC   CVCL_TU06
SY   HZGHC002740c007; TRIM32 knockout cell line 100bp deletion
DR   cancercelllines; CVCL_TU06
DR   Horizon_Discovery; HZGHC002740c007
DR   Wikidata; Q54880679
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16380; TRIM32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM32 (-) 2
AC   CVCL_TU07
SY   HZGHC002741c006; TRIM32 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TU07
DR   Horizon_Discovery; HZGHC002741c006
DR   Wikidata; Q54880680
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16380; TRIM32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM32 (-) 3
AC   CVCL_TU08
SY   HZGHC002741c010; TRIM32 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU08
DR   Horizon_Discovery; HZGHC002741c010
DR   Wikidata; Q54880681
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16380; TRIM32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM33 (-) 1
AC   CVCL_TU09
SY   HZGHC000266c011; TRIM33 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TU09
DR   Horizon_Discovery; HZGHC000266c011
DR   Wikidata; Q54880682
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16290; TRIM33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM33 (-) 2
AC   CVCL_TU10
SY   HZGHC003009c001; TRIM33 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TU10
DR   Horizon_Discovery; HZGHC003009c001
DR   Wikidata; Q54880683
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16290; TRIM33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM33 (-) 3
AC   CVCL_TU11
SY   HZGHC003009c002; TRIM33 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TU11
DR   Horizon_Discovery; HZGHC003009c002
DR   Wikidata; Q54880684
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16290; TRIM33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM34 (-) 1
AC   CVCL_TU12
SY   HZGHC003688c004; TRIM34 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU12
DR   Horizon_Discovery; HZGHC003688c004
DR   Wikidata; Q54880685
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10063; TRIM34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM34 (-) 2
AC   CVCL_TU13
SY   HZGHC003688c008; TRIM34 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TU13
DR   Horizon_Discovery; HZGHC003688c008
DR   Wikidata; Q54880686
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10063; TRIM34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM35 (-)
AC   CVCL_TU14
SY   HZGHC003658c002; TRIM35 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TU14
DR   Horizon_Discovery; HZGHC003658c002
DR   Wikidata; Q54880689
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16285; TRIM35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM37 (-) 1
AC   CVCL_TU15
SY   HZGHC003638c002; TRIM37 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TU15
DR   Horizon_Discovery; HZGHC003638c002
DR   Wikidata; Q54880690
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7523; TRIM37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM37 (-) 2
AC   CVCL_TU16
SY   HZGHC003638c011; TRIM37 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TU16
DR   Horizon_Discovery; HZGHC003638c011
DR   Wikidata; Q54880691
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7523; TRIM37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM38 (-) 1
AC   CVCL_TU17
SY   HZGHC003661c003; TRIM38 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU17
DR   Horizon_Discovery; HZGHC003661c003
DR   Wikidata; Q54880692
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10059; TRIM38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM38 (-) 2
AC   CVCL_TU18
SY   HZGHC003661c010; TRIM38 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TU18
DR   Horizon_Discovery; HZGHC003661c010
DR   Wikidata; Q54880693
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10059; TRIM38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM39 (-) 1
AC   CVCL_TU19
SY   HZGHC003659c007; TRIM39 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TU19
DR   Horizon_Discovery; HZGHC003659c007
DR   Wikidata; Q54880694
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10065; TRIM39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM39 (-) 2
AC   CVCL_TU20
SY   HZGHC003659c010; TRIM39 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TU20
DR   Horizon_Discovery; HZGHC003659c010
DR   Wikidata; Q54880695
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10065; TRIM39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM4 (-) 1
AC   CVCL_TU21
SY   HZGHC004093c001; TRIM4 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TU21
DR   Horizon_Discovery; HZGHC004093c001
DR   Wikidata; Q54880696
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16275; TRIM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM4 (-) 2
AC   CVCL_TU22
SY   HZGHC004093c012; TRIM4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU22
DR   Horizon_Discovery; HZGHC004093c012
DR   Wikidata; Q54880697
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16275; TRIM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM41 (-) 1
AC   CVCL_TU23
SY   HZGHC003641c009; TRIM41 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU23
DR   Horizon_Discovery; HZGHC003641c009
DR   Wikidata; Q54880698
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19013; TRIM41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003641c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM41 (-) 2
AC   CVCL_TU24
SY   HZGHC003641c010; TRIM41 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU24
DR   Horizon_Discovery; HZGHC003641c010
DR   Wikidata; Q54880699
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19013; TRIM41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM44 (-) 1
AC   CVCL_TU25
SY   HZGHC003646c001; TRIM44 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU25
DR   Horizon_Discovery; HZGHC003646c001
DR   Wikidata; Q54880700
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19016; TRIM44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM44 (-) 2
AC   CVCL_TU26
SY   HZGHC003646c010; TRIM44 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU26
DR   Horizon_Discovery; HZGHC003646c010
DR   Wikidata; Q54880701
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19016; TRIM44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003646c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM44 (-) 3
AC   CVCL_TU27
SY   HZGHC003646c011; TRIM44 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU27
DR   Horizon_Discovery; HZGHC003646c011
DR   Wikidata; Q54880702
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19016; TRIM44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003646c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM45 (-)
AC   CVCL_TU28
SY   HZGHC003664c010; TRIM45 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TU28
DR   Horizon_Discovery; HZGHC003664c010
DR   Wikidata; Q54880703
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19018; TRIM45.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM46 (-)
AC   CVCL_TU29
SY   HZGHC003690c011; TRIM46 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TU29
DR   Horizon_Discovery; HZGHC003690c011
DR   Wikidata; Q54880704
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19019; TRIM46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM47 (-) 1
AC   CVCL_TU30
SY   HZGHC003644c010; TRIM47 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TU30
DR   Horizon_Discovery; HZGHC003644c010
DR   Wikidata; Q54880705
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19020; TRIM47.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM47 (-) 2
AC   CVCL_TU31
SY   HZGHC003644c012; TRIM47 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU31
DR   Horizon_Discovery; HZGHC003644c012
DR   Wikidata; Q54880706
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19020; TRIM47.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM5 (-) 1
AC   CVCL_TU32
SY   HZGHC003640c006; TRIM5 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_TU32
DR   Horizon_Discovery; HZGHC003640c006
DR   Wikidata; Q54880707
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16276; TRIM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM5 (-) 2
AC   CVCL_TU33
SY   HZGHC003640c009; TRIM5 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TU33
DR   Horizon_Discovery; HZGHC003640c009
DR   Wikidata; Q54880708
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16276; TRIM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM52 (-) 1
AC   CVCL_TU34
SY   HZGHC003652c001; TRIM52 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU34
DR   Horizon_Discovery; HZGHC003652c001
DR   Wikidata; Q54880709
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19024; TRIM52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM52 (-) 2
AC   CVCL_TU35
SY   HZGHC003652c012; TRIM52 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TU35
DR   Horizon_Discovery; HZGHC003652c012
DR   Wikidata; Q54880710
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19024; TRIM52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM54 (-) 1
AC   CVCL_TU36
SY   HZGHC003649c003; TRIM54 knockout cell line 154bp insertion
DR   cancercelllines; CVCL_TU36
DR   Horizon_Discovery; HZGHC003649c003
DR   Wikidata; Q54880711
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16008; TRIM54.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003649c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM54 (-) 2
AC   CVCL_TU37
SY   HZGHC003649c012; TRIM54 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TU37
DR   Horizon_Discovery; HZGHC003649c012
DR   Wikidata; Q54880712
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16008; TRIM54.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM56 (-)
AC   CVCL_TU38
SY   HZGHC003685c001; TRIM56 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TU38
DR   Horizon_Discovery; HZGHC003685c001
DR   Wikidata; Q54880713
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19028; TRIM56.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM58 (-) 1
AC   CVCL_TU39
SY   HZGHC003654c004; TRIM58 knockout cell line 196bp insertion
DR   cancercelllines; CVCL_TU39
DR   Horizon_Discovery; HZGHC003654c004
DR   Wikidata; Q54880714
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24150; TRIM58.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003654c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM58 (-) 2
AC   CVCL_TU40
SY   HZGHC003654c008; TRIM58 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU40
DR   Horizon_Discovery; HZGHC003654c008
DR   Wikidata; Q54880715
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24150; TRIM58.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM59 (-)
AC   CVCL_TU41
SY   HZGHC003689c012; TRIM59 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TU41
DR   Horizon_Discovery; HZGHC003689c012
DR   Wikidata; Q54880716
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30834; TRIM59.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM6 (-) 1
AC   CVCL_TU42
SY   HZGHC003653c001; TRIM6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU42
DR   Horizon_Discovery; HZGHC003653c001
DR   Wikidata; Q54880717
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16277; TRIM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM6 (-) 2
AC   CVCL_TU43
SY   HZGHC003653c010; TRIM6 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TU43
DR   Horizon_Discovery; HZGHC003653c010
DR   Wikidata; Q54880718
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16277; TRIM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003653c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM62 (-) 1
AC   CVCL_TU44
SY   HZGHC003684c002; TRIM62 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TU44
DR   Horizon_Discovery; HZGHC003684c002
DR   Wikidata; Q54880719
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25574; TRIM62.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM62 (-) 2
AC   CVCL_TU45
SY   HZGHC003684c003; TRIM62 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TU45
DR   Horizon_Discovery; HZGHC003684c003
DR   Wikidata; Q54880720
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25574; TRIM62.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM65 (-) 1
AC   CVCL_TU46
SY   HZGHC003636c002; TRIM65 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TU46
DR   Horizon_Discovery; HZGHC003636c002
DR   Wikidata; Q54880721
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27316; TRIM65.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM65 (-) 2
AC   CVCL_TU47
SY   HZGHC003636c005; TRIM65 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU47
DR   Horizon_Discovery; HZGHC003636c005
DR   Wikidata; Q54880722
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27316; TRIM65.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM65 (-) 3
AC   CVCL_TU48
SY   HZGHC003636c010; TRIM65 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TU48
DR   Horizon_Discovery; HZGHC003636c010
DR   Wikidata; Q54880723
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27316; TRIM65.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM66 (-) 1
AC   CVCL_TU49
SY   HZGHC000951c003; TRIM66 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TU49
DR   Horizon_Discovery; HZGHC000951c003
DR   Wikidata; Q54880724
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29005; TRIM66.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM66 (-) 2
AC   CVCL_TU50
SY   HZGHC000951c012; TRIM66 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TU50
DR   Horizon_Discovery; HZGHC000951c012
DR   Wikidata; Q54880725
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29005; TRIM66.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM68 (-) 1
AC   CVCL_TU51
SY   HZGHC003681c002; TRIM68 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU51
DR   Horizon_Discovery; HZGHC003681c002
DR   Wikidata; Q54880726
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21161; TRIM68.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM68 (-) 2
AC   CVCL_TU52
SY   HZGHC003681c004; TRIM68 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TU52
DR   Horizon_Discovery; HZGHC003681c004
DR   Wikidata; Q54880727
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21161; TRIM68.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003681c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM69 (-) 1
AC   CVCL_TU53
SY   HZGHC003687c001; TRIM69 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TU53
DR   Horizon_Discovery; HZGHC003687c001
DR   Wikidata; Q54880728
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17857; TRIM69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM69 (-) 2
AC   CVCL_TU54
SY   HZGHC003687c010; TRIM69 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TU54
DR   Horizon_Discovery; HZGHC003687c010
DR   Wikidata; Q54880730
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17857; TRIM69.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM71 (-) 1
AC   CVCL_TU55
SY   HZGHC003686c008; TRIM71 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TU55
DR   Horizon_Discovery; HZGHC003686c008
DR   Wikidata; Q54880731
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32669; TRIM71.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM71 (-) 2
AC   CVCL_TU56
SY   HZGHC003686c012; TRIM71 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TU56
DR   Horizon_Discovery; HZGHC003686c012
DR   Wikidata; Q54880733
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32669; TRIM71.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM72 (-) 1
AC   CVCL_TU57
SY   HZGHC002759c003; TRIM72 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU57
DR   Horizon_Discovery; HZGHC002759c003
DR   Wikidata; Q54880734
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32671; TRIM72.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM72 (-) 2
AC   CVCL_TU58
SY   HZGHC002759c012; TRIM72 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU58
DR   Horizon_Discovery; HZGHC002759c012
DR   Wikidata; Q54880735
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32671; TRIM72.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM8 (-) 1
AC   CVCL_TU59
SY   HZGHC003643c007; TRIM8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TU59
DR   Horizon_Discovery; HZGHC003643c007
DR   Wikidata; Q54880736
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15579; TRIM8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003643c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIM8 (-) 3
AC   CVCL_TU60
SY   HZGHC003643c012; TRIM8 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TU60
DR   Horizon_Discovery; HZGHC003643c012
DR   Wikidata; Q54880737
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15579; TRIM8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM9 (-) 1
AC   CVCL_TU61
SY   HZGHC003634c005; TRIM9 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TU61
DR   Horizon_Discovery; HZGHC003634c005
DR   Wikidata; Q54880738
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16288; TRIM9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIM9 (-) 2
AC   CVCL_TU62
SY   HZGHC003634c006; TRIM9 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TU62
DR   Horizon_Discovery; HZGHC003634c006
DR   Wikidata; Q54880739
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16288; TRIM9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIO (-)
AC   CVCL_TU63
SY   HZGHC000359c007; TRIO knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TU63
DR   Horizon_Discovery; HZGHC000359c007
DR   Wikidata; Q54880740
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12303; TRIO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIP11 (-)
AC   CVCL_C7Z0
SY   HZGHC007471c011; TRIP11 knockout cell line 13bp deletion in exon 6
DR   Horizon_Discovery; HZGHC007471c011
DR   Wikidata; Q123031461
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12305; TRIP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TRIP12 (-) 1
AC   CVCL_C7YX
SY   HZGHC008102c004; TRIP12 knockout cell line 10bp deletion in exon 7
DR   Horizon_Discovery; HZGHC008102c004
DR   Wikidata; Q123031465
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12306; TRIP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TRIP12 (-) 2
AC   CVCL_C7YY
SY   HZGHC008103c010; TRIP12 knockout cell line 1bp insertion in exon 18
DR   Horizon_Discovery; HZGHC008103c010
DR   Wikidata; Q123031466
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12306; TRIP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TRIP12 (-) 3
AC   CVCL_C7YZ
SY   HZGHC008103c011; TRIP12 knockout cell line 1bp deletion in exon 18
DR   Horizon_Discovery; HZGHC008103c011
DR   Wikidata; Q123031468
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12306; TRIP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TRIP13 (-) 1
AC   CVCL_TU64
SY   HZGHC006400c001; TRIP13 knockout cell line 1bp deletion; HAP1 TRIP13 (-)
DR   cancercelllines; CVCL_TU64
DR   Horizon_Discovery; HZGHC006400c001
DR   Wikidata; Q54880741
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12307; TRIP13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIP13 (-) 2
AC   CVCL_XU72
SY   HZGHC006400c002; TRIP13 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU72
DR   Horizon_Discovery; HZGHC006400c002
DR   Wikidata; Q93974778
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12307; TRIP13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIP13 (-) 3
AC   CVCL_XU73
SY   HZGHC006400c010; TRIP13 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_XU73
DR   Horizon_Discovery; HZGHC006400c010
DR   Wikidata; Q93974780
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12307; TRIP13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRIP4 (-) 1
AC   CVCL_TU65
SY   HZGHC006429c010; TRIP4 knockout cell line 16bp deletion; HAP1 TRIP4 (-)
DR   cancercelllines; CVCL_TU65
DR   Horizon_Discovery; HZGHC006429c010
DR   Wikidata; Q54880742
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12310; TRIP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006429c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TRIP4 (-) 2
AC   CVCL_XU74
SY   HZGHC006429c002; TRIP4 knockout cell line 46bp insertion
DR   cancercelllines; CVCL_XU74
DR   Horizon_Discovery; HZGHC006429c002
DR   Wikidata; Q93974786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12310; TRIP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006429c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRIT1 (-)
AC   CVCL_TU66
SY   HZGHC005140c003; HZGHC54802; TRIT1 knockout cell line 17bp insertion
DR   cancercelllines; CVCL_TU66
DR   Horizon_Discovery; HZGHC005140c003
DR   Wikidata; Q54880743
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20286; TRIT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005140c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TRMT1 (-) 1
AC   CVCL_TU67
SY   HZGHC004984c010; TRMT1 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TU67
DR   Horizon_Discovery; HZGHC004984c010
DR   Wikidata; Q54880744
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25980; TRMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT1 (-) 2
AC   CVCL_TU68
SY   HZGHC004984c011; TRMT1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TU68
DR   Horizon_Discovery; HZGHC004984c011
DR   Wikidata; Q54880745
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25980; TRMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT1 (-) 3
AC   CVCL_TU69
SY   HZGHC004985c012; TRMT1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU69
DR   Horizon_Discovery; HZGHC004985c012
DR   Wikidata; Q54880746
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25980; TRMT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT10A (-) 1
AC   CVCL_TU70
SY   HZGHC002623c004; TRMT10A knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TU70
DR   Horizon_Discovery; HZGHC002623c004
DR   Wikidata; Q54880747
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28403; TRMT10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT10A (-) 2
AC   CVCL_TU71
SY   HZGHC002623c010; TRMT10A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU71
DR   Horizon_Discovery; HZGHC002623c010
DR   Wikidata; Q54880748
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28403; TRMT10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT10A (-) 3
AC   CVCL_TU72
SY   HZGHC002624c008; TRMT10A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU72
DR   Horizon_Discovery; HZGHC002624c008
DR   Wikidata; Q54880749
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28403; TRMT10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT10A (-) 4
AC   CVCL_TU73
SY   HZGHC002623c012; TRMT10A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU73
DR   Horizon_Discovery; HZGHC002623c012
DR   Wikidata; Q54880750
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28403; TRMT10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002623c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRMT10B (-) 1
AC   CVCL_TU74
SY   HZGHC002626c004; TRMT10B knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TU74
DR   Horizon_Discovery; HZGHC002626c004
DR   Wikidata; Q54880751
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26454; TRMT10B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT10B (-) 2
AC   CVCL_TU75
SY   HZGHC002626c009; TRMT10B knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TU75
DR   Horizon_Discovery; HZGHC002626c009
DR   Wikidata; Q54880752
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26454; TRMT10B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT2A (-) 1
AC   CVCL_TU76
SY   HZGHC005020c001; TRMT2A knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TU76
DR   Horizon_Discovery; HZGHC005020c001
DR   Wikidata; Q54880754
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT2A (-) 2
AC   CVCL_TU77
SY   HZGHC005020c007; TRMT2A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU77
DR   Horizon_Discovery; HZGHC005020c007
DR   Wikidata; Q54880755
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT2A (-) 3
AC   CVCL_TU78
SY   HZGHC005021c005; TRMT2A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TU78
DR   Horizon_Discovery; HZGHC005021c005
DR   Wikidata; Q54880756
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT2A (-) 4
AC   CVCL_TU79
SY   HZGHC005021c011; TRMT2A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU79
DR   Horizon_Discovery; HZGHC005021c011
DR   Wikidata; Q54880757
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT2B (-) 1
AC   CVCL_TU80
SY   HZGHC004364c004; TRMT2B knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TU80
DR   Horizon_Discovery; HZGHC004364c004
DR   Wikidata; Q54880758
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25748; TRMT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT2B (-) 2
AC   CVCL_TU81
SY   HZGHC004364c006; TRMT2B knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TU81
DR   Horizon_Discovery; HZGHC004364c006
DR   Wikidata; Q54880759
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25748; TRMT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRMT2B (-) 3
AC   CVCL_TU82
SY   HZGHC004364c008; TRMT2B knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU82
DR   Horizon_Discovery; HZGHC004364c008
DR   Wikidata; Q54880760
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25748; TRMT2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TROVE2 (-) 1
AC   CVCL_TU83
SY   HZGHC002796c007; TROVE2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TU83
DR   Horizon_Discovery; HZGHC002796c007
DR   Wikidata; Q54880761
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11313; RO60.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TROVE2 (-) 2
AC   CVCL_TU84
SY   HZGHC002796c011; TROVE2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU84
DR   Horizon_Discovery; HZGHC002796c011
DR   Wikidata; Q54880762
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11313; RO60.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TROVE2 (-) 3
AC   CVCL_TU85
SY   HZGHC004744c002; TROVE2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TU85
DR   Horizon_Discovery; HZGHC004744c002
DR   Wikidata; Q54880763
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11313; RO60.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TROVE2 (-) 4
AC   CVCL_TU86
SY   HZGHC004744c008; TROVE2 knockout cell line 320bp insertion
DR   cancercelllines; CVCL_TU86
DR   Horizon_Discovery; HZGHC004744c008
DR   Wikidata; Q54880764
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11313; RO60.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004744c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TRPC4AP (-) 1
AC   CVCL_E2MM
SY   HZGHC008039c010
DR   Horizon_Discovery; HZGHC008039c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16181; TRPC4AP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRPC4AP (-) 2
AC   CVCL_E2MN
SY   HZGHC008039c011
DR   Horizon_Discovery; HZGHC008039c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16181; TRPC4AP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRPM2 (-) 1
AC   CVCL_E2MP
SY   HZGHC007742c001
DR   Horizon_Discovery; HZGHC007742c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12339; TRPM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRPM2 (-) 2
AC   CVCL_E2MQ
SY   HZGHC007742c002
DR   Horizon_Discovery; HZGHC007742c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12339; TRPM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRPM2 (-) 3
AC   CVCL_E2MR
SY   HZGHC007742c003
DR   Horizon_Discovery; HZGHC007742c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12339; TRPM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRPM5 (-) 1
AC   CVCL_C7Z1
SY   HZGHC007743c005; TRPM5 knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007743c005
DR   Wikidata; Q123031471
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14323; TRPM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TRPM5 (-) 2
AC   CVCL_C7Z2
SY   HZGHC007743c007; TRPM5 knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007743c007
DR   Wikidata; Q123031474
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14323; TRPM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 TRPM5 (-) 3
AC   CVCL_E2MS
SY   HZGHC007743c002
DR   Horizon_Discovery; HZGHC007743c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14323; TRPM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TRPM7 (-)
AC   CVCL_TU87
SY   HZGHC002483c004; TRPM7 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TU87
DR   Horizon_Discovery; HZGHC002483c004
DR   Wikidata; Q54880765
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17994; TRPM7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002483c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRPV5 (-)
AC   CVCL_XU75
SY   HZGHC56302; TRPV5 knockout cell line
DR   cancercelllines; CVCL_XU75
DR   Horizon_Discovery; HZGHC56302
DR   Wikidata; Q93974955
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3145; TRPV5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC56302; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRPV6 (-) 1
AC   CVCL_TU88
SY   HZGHC006671c009; TRPV6 knockout cell line 1bp insertion; HAP1 TRPV6 (-)
DR   cancercelllines; CVCL_TU88
DR   Horizon_Discovery; HZGHC006671c009
DR   Wikidata; Q54880766
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14006; TRPV6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TRPV6 (-) 2
AC   CVCL_XU76
SY   HZGHC006672c002; TRPV6 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_XU76
DR   Horizon_Discovery; HZGHC006672c002
DR   Wikidata; Q93974967
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14006; TRPV6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TRPV6 (-) 3
AC   CVCL_XU77
SY   HZGHC006672c005; TRPV6 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XU77
DR   Horizon_Discovery; HZGHC006672c005
DR   Wikidata; Q93974970
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14006; TRPV6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSC1 (-) 1
AC   CVCL_TU89
SY   HZGHC001290c009; TSC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TU89
DR   Horizon_Discovery; HZGHC001290c009
DR   Wikidata; Q54880767
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSC1 (-) 2
AC   CVCL_TU90
SY   HZGHC001290c011; TSC1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU90
DR   Horizon_Discovery; HZGHC001290c011
DR   Wikidata; Q54880768
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSC2 (-) 1
AC   CVCL_TU91
SY   HZGHC001363c004; TSC2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TU91
DR   Horizon_Discovery; HZGHC001363c004
DR   Wikidata; Q54880769
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSC2 (-) 2
AC   CVCL_TU92
SY   HZGHC001363c010; TSC2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU92
DR   Horizon_Discovery; HZGHC001363c010
DR   Wikidata; Q54880770
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSFM (-)
AC   CVCL_XU78
SY   HZGHC006845c024; HZGHC10102; TSFM knockout cell line 28bp deletion in exon 2
DR   cancercelllines; CVCL_XU78
DR   Horizon_Discovery; HZGHC006845c024
DR   Wikidata; Q93975008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12367; TSFM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TSPAN13 (-) 1
AC   CVCL_TU93
SY   HZGHC001100c002; TSPAN13 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TU93
DR   Horizon_Discovery; HZGHC001100c002
DR   Wikidata; Q54880771
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21643; TSPAN13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSPAN13 (-) 2
AC   CVCL_TU94
SY   HZGHC001100c005; TSPAN13 knockout cell line 166bp insertion
DR   cancercelllines; CVCL_TU94
DR   Horizon_Discovery; HZGHC001100c005
DR   Wikidata; Q54880776
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21643; TSPAN13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001100c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TSPAN4 (-)
AC   CVCL_XU79
SY   HZGHC007251c001; HZGHC7106; TSPAN4 knockout cell line 1bp insertion in exon 6
DR   cancercelllines; CVCL_XU79
DR   Horizon_Discovery; HZGHC007251c001
DR   Wikidata; Q93975032
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11859; TSPAN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TSPO (-) 1
AC   CVCL_TU95
SY   HZGHC003742c011; TSPO knockout cell line 29bp deletion
DR   cancercelllines; CVCL_TU95
DR   Horizon_Discovery; HZGHC003742c011
DR   Wikidata; Q54880777
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSPO (-) 2
AC   CVCL_TU96
SY   HZGHC003742c012; TSPO knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TU96
DR   Horizon_Discovery; HZGHC003742c012
DR   Wikidata; Q54880778
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSSC1 (-) 1
AC   CVCL_TU97
SY   HZGHC000857c006; TSSC1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TU97
DR   Horizon_Discovery; HZGHC000857c006
DR   Wikidata; Q54880779
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12383; EIPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSSC1 (-) 2
AC   CVCL_TU98
SY   HZGHC000857c008; TSSC1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TU98
DR   Horizon_Discovery; HZGHC000857c008
DR   Wikidata; Q54880780
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12383; EIPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSSK2 (-)
AC   CVCL_TU99
SY   HZGHC000701c010; TSSK2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TU99
DR   Horizon_Discovery; HZGHC000701c010
DR   Wikidata; Q54880781
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11401; TSSK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSSK3 (-)
AC   CVCL_TV00
SY   HZGHC000368c013; TSSK3 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TV00
DR   Horizon_Discovery; HZGHC000368c013
DR   Wikidata; Q54880782
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15473; TSSK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSSK4 (-) 1
AC   CVCL_TV01
SY   HZGHC000367c002; TSSK4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV01
DR   Horizon_Discovery; HZGHC000367c002
DR   Wikidata; Q54880783
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19825; TSSK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TSSK4 (-) 2
AC   CVCL_TV02
SY   HZGHC000367c016; TSSK4 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TV02
DR   Horizon_Discovery; HZGHC000367c016
DR   Wikidata; Q54880784
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19825; TSSK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TST (-) 1
AC   CVCL_E2MT
SY   HZGHC008190c002
DR   Horizon_Discovery; HZGHC008190c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12388; TST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TST (-) 2
AC   CVCL_E2MU
SY   HZGHC008190c005
DR   Horizon_Discovery; HZGHC008190c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12388; TST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TST (-) 3
AC   CVCL_E2MV
SY   HZGHC008190c007
DR   Horizon_Discovery; HZGHC008190c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12388; TST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TST (-) 4
AC   CVCL_E2MW
SY   HZGHC008190c010
DR   Horizon_Discovery; HZGHC008190c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12388; TST.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TTBK2 (-) 1
AC   CVCL_TV03
SY   HZGHC000113c001; TTBK2 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TV03
DR   Horizon_Discovery; HZGHC000113c001
DR   Wikidata; Q54880785
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19141; TTBK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TTBK2 (-) 2
AC   CVCL_TV04
SY   HZGHC000113c011; TTBK2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TV04
DR   Horizon_Discovery; HZGHC000113c011
DR   Wikidata; Q54880787
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19141; TTBK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TTBK2 (-) 3
AC   CVCL_TV05
SY   HZGHC000113c021; TTBK2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TV05
DR   Horizon_Discovery; HZGHC000113c021
DR   Wikidata; Q54880788
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19141; TTBK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TTC38 (-) 1
AC   CVCL_TV06
SY   HZGHC006492c010; TTC38 knockout cell line 10bp deletion; HAP1 TTC38 (-)
DR   cancercelllines; CVCL_TV06
DR   Horizon_Discovery; HZGHC006492c010
DR   Wikidata; Q54880789
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26082; TTC38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 TTC38 (-) 2
AC   CVCL_XU80
SY   HZGHC006492c011; TTC38 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_XU80
DR   Horizon_Discovery; HZGHC006492c011
DR   PRIDE; PXD010335
DR   Wikidata; Q93975212
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26082; TTC38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TTC7A (-) 1
AC   CVCL_TV07
SY   HZGHC005624c010; TTC7A knockout cell line 1bp insertion; HAP1 TTC7A (-)
DR   cancercelllines; CVCL_TV07
DR   Horizon_Discovery; HZGHC005624c010
DR   Wikidata; Q54880790
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19750; TTC7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TTC7A (-) 2
AC   CVCL_XU81
SY   HZGHC005624c003; TTC7A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XU81
DR   Horizon_Discovery; HZGHC005624c003
DR   Wikidata; Q93975228
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19750; TTC7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TTL (-)
AC   CVCL_XU82
SY   HZGHC007023c001; HZGHC150465; TTL knockout cell line 17bp deletion in exon 2
DR   cancercelllines; CVCL_XU82
DR   Horizon_Discovery; HZGHC007023c001
DR   Wikidata; Q93975232
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21586; TTL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TUBA1A (-) 1
AC   CVCL_TV08
SY   HZGHC003694c003; TUBA1A knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TV08
DR   Horizon_Discovery; HZGHC003694c003
DR   Wikidata; Q54880792
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20766; TUBA1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBA1A (-) 2
AC   CVCL_TV09
SY   HZGHC003694c006; TUBA1A knockout cell line 140bp insertion
DR   cancercelllines; CVCL_TV09
DR   Horizon_Discovery; HZGHC003694c006
DR   Wikidata; Q54880793
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20766; TUBA1A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003694c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TUBA1C (-) 1
AC   CVCL_TV10
SY   HZGHC002323c001; TUBA1C knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TV10
DR   Horizon_Discovery; HZGHC002323c001
DR   Wikidata; Q54880794
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20768; TUBA1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBA1C (-) 2
AC   CVCL_TV11
SY   HZGHC002323c010; TUBA1C knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TV11
DR   Horizon_Discovery; HZGHC002323c010
DR   Wikidata; Q54880795
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20768; TUBA1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBA1C (-) 3
AC   CVCL_TV12
SY   HZGHC005221c004; TUBA1C knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TV12
DR   Horizon_Discovery; HZGHC005221c004
DR   Wikidata; Q54880796
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20768; TUBA1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBA1C (-) 4
AC   CVCL_TV13
SY   HZGHC005221c008; TUBA1C knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TV13
DR   Horizon_Discovery; HZGHC005221c008
DR   Wikidata; Q54880797
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20768; TUBA1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005221c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TUBA4A (-) 1
AC   CVCL_TV14
SY   HZGHC003761c001; TUBA4A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV14
DR   Horizon_Discovery; HZGHC003761c001
DR   Wikidata; Q54880798
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12407; TUBA4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBA4A (-) 2
AC   CVCL_TV15
SY   HZGHC003761c002; TUBA4A knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV15
DR   Horizon_Discovery; HZGHC003761c002
DR   Wikidata; Q54880799
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12407; TUBA4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBB1 (-) 1
AC   CVCL_TV16
SY   HZGHC003924c007; TUBB1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV16
DR   Horizon_Discovery; HZGHC003924c007
DR   Wikidata; Q54880800
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16257; TUBB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBB1 (-) 2
AC   CVCL_TV17
SY   HZGHC003924c010; TUBB1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV17
DR   Horizon_Discovery; HZGHC003924c010
DR   Wikidata; Q54880801
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16257; TUBB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBB1 (-) 3
AC   CVCL_TV18
SY   HZGHC003924c012; TUBB1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV18
DR   Horizon_Discovery; HZGHC003924c012
DR   Wikidata; Q54880802
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16257; TUBB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBB3 (-) 1
AC   CVCL_TV19
SY   HZGHC004770c002; TUBB3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TV19
DR   Horizon_Discovery; HZGHC004770c002
DR   Wikidata; Q54880803
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20772; TUBB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBB3 (-) 2
AC   CVCL_TV20
SY   HZGHC004770c009; TUBB3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV20
DR   Horizon_Discovery; HZGHC004770c009
DR   Wikidata; Q54880804
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20772; TUBB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBB4B (-) 1
AC   CVCL_TV21
SY   HZGHC003692c001; TUBB4B knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TV21
DR   Horizon_Discovery; HZGHC003692c001
DR   Wikidata; Q54880805
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20771; TUBB4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUBB4B (-) 2
AC   CVCL_TV22
SY   HZGHC003692c011; TUBB4B knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TV22
DR   Horizon_Discovery; HZGHC003692c011
DR   Wikidata; Q54880806
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20771; TUBB4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TUSC3 (-) 1
AC   CVCL_TV23
SY   HZGHC004076c003; TUSC3 knockout cell line 259bp insertion
DR   cancercelllines; CVCL_TV23
DR   Horizon_Discovery; HZGHC004076c003
DR   Wikidata; Q54880807
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30242; TUSC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004076c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TUSC3 (-) 2
AC   CVCL_TV24
SY   HZGHC004076c007; TUSC3 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TV24
DR   Horizon_Discovery; HZGHC004076c007
DR   Wikidata; Q54880808
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30242; TUSC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TWF1 (-)
AC   CVCL_TV25
SY   HZGHC002698c002; TWF1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TV25
DR   Horizon_Discovery; HZGHC002698c002
DR   Wikidata; Q54880809
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9620; TWF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TWF2 (-) 1
AC   CVCL_TV26
SY   HZGHC000114c004; TWF2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TV26
DR   Horizon_Discovery; HZGHC000114c004
DR   Wikidata; Q54880810
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9621; TWF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TWF2 (-) 2
AC   CVCL_TV27
SY   HZGHC000114c005; TWF2 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TV27
DR   Horizon_Discovery; HZGHC000114c005
DR   Wikidata; Q54880811
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9621; TWF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TWIST1 (-)
AC   CVCL_TV28
SY   HZGHC006088c011; TWIST1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV28
DR   Horizon_Discovery; HZGHC006088c011
DR   Wikidata; Q54880812
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12428; TWIST1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TXNDC17 (-)
AC   CVCL_E2MX
SY   HZGHC007430c012
DR   Horizon_Discovery; HZGHC007430c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28218; TXNDC17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 TXNIP (-) 1
AC   CVCL_TV29
SY   HZGHC005467c012; TXNIP knockout cell line 2bp deletion; HAP1 TXNIP (-)
DR   cancercelllines; CVCL_TV29
DR   Horizon_Discovery; HZGHC005467c012
DR   Wikidata; Q54880813
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16952; TXNIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TXNIP (-) 2
AC   CVCL_XU83
SY   HZGHC005467c005; TXNIP knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XU83
DR   Horizon_Discovery; HZGHC005467c005
DR   Wikidata; Q93975531
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16952; TXNIP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TYK2 (-) 1
AC   CVCL_TV30
SY   HZGHC000036c008; TYK2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV30
DR   Horizon_Discovery; HZGHC000036c008
DR   Wikidata; Q54880814
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TYK2 (-) 2
AC   CVCL_TV31
SY   HZGHC002840c002; TYK2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TV31
DR   Horizon_Discovery; HZGHC002840c002
DR   Wikidata; Q54880815
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TYK2 (-) 3
AC   CVCL_TV32
SY   HZGHC002840c011; TYK2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV32
DR   Horizon_Discovery; HZGHC002840c011
DR   Wikidata; Q54880816
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TYK2 (-) 4
AC   CVCL_TV33
SY   HZGHC003415c010; TYK2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TV33
DR   Horizon_Discovery; HZGHC003415c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54880817
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 TYK2 (-) 5
AC   CVCL_TV34
SY   HZGHC003415c011; TYK2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TV34
DR   Horizon_Discovery; HZGHC003415c011
DR   Wikidata; Q54880825
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TYRO3 (-) 1
AC   CVCL_TV35
SY   HZGHC000115c011; TYRO3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TV35
DR   Horizon_Discovery; HZGHC000115c011
DR   Wikidata; Q54880826
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12446; TYRO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TYRO3 (-) 2
AC   CVCL_TV36
SY   HZGHC000115c015; TYRO3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TV36
DR   Horizon_Discovery; HZGHC000115c015
DR   Wikidata; Q54880827
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12446; TYRO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 TYRO3 (-) 3
AC   CVCL_TV37
SY   HZGHC000115c016; TYRO3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TV37
DR   Horizon_Discovery; HZGHC000115c016
DR   Wikidata; Q54880828
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12446; TYRO3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBA6 (-) 1
AC   CVCL_XU84
SY   HZGHC006965c003; HZGHC55236; UBA6 knockout cell line 16bp deletion in exon 12; HAP1 UBA6 (-)
DR   cancercelllines; CVCL_XU84
DR   Horizon_Discovery; HZGHC006965c003
DR   Wikidata; Q93975613
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25581; UBA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 UBA6 (-) 2
AC   CVCL_E2MY
SY   HZGHC006964c011
DR   Horizon_Discovery; HZGHC006964c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25581; UBA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBA6 (-) 3
AC   CVCL_E2MZ
SY   HZGHC006965c001
DR   Horizon_Discovery; HZGHC006965c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25581; UBA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBA6 (-) 4
AC   CVCL_E2N0
SY   HZGHC006965c004
DR   Horizon_Discovery; HZGHC006965c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25581; UBA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBA6 (-) 5
AC   CVCL_E2N1
SY   HZGHC006965c008
DR   Horizon_Discovery; HZGHC006965c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25581; UBA6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBA7 (-) 1
AC   CVCL_TV38
SY   HZGHC004014c003; UBA7 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV38
DR   Horizon_Discovery; HZGHC004014c003
DR   Wikidata; Q54880829
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12471; UBA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBA7 (-) 2
AC   CVCL_TV39
SY   HZGHC004014c007; UBA7 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TV39
DR   Horizon_Discovery; HZGHC004014c007
DR   Wikidata; Q54880830
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12471; UBA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBA7 (-) 3
AC   CVCL_TV40
SY   HZGHC004014c010; UBA7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV40
DR   Horizon_Discovery; HZGHC004014c010
DR   Wikidata; Q54880831
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12471; UBA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBAC1 (-) 1
AC   CVCL_TV41
SY   HZGHC000992c001; UBAC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV41
DR   Horizon_Discovery; HZGHC000992c001
DR   Wikidata; Q54880832
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30221; UBAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBAC1 (-) 2
AC   CVCL_TV42
SY   HZGHC000992c003; UBAC1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV42
DR   Horizon_Discovery; HZGHC000992c003
DR   Wikidata; Q54880833
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30221; UBAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBAC1 (-) 3
AC   CVCL_TV43
SY   HZGHC000992c010; UBAC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV43
DR   Horizon_Discovery; HZGHC000992c010
DR   Wikidata; Q54880834
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30221; UBAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBAC2 (-) 1
AC   CVCL_TV44
SY   HZGHC004123c004; UBAC2 knockout cell line 328bp insertion
DR   cancercelllines; CVCL_TV44
DR   Horizon_Discovery; HZGHC004123c004
DR   Wikidata; Q54880835
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20486; UBAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004123c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBAC2 (-) 2
AC   CVCL_TV45
SY   HZGHC004123c006; UBAC2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV45
DR   Horizon_Discovery; HZGHC004123c006
DR   Wikidata; Q54880836
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20486; UBAC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2A (-) 1
AC   CVCL_TV46
SY   HZGHC002554c004; UBE2A knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TV46
DR   Horizon_Discovery; HZGHC002554c004
DR   Wikidata; Q54880837
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12472; UBE2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2A (-) 2
AC   CVCL_TV47
SY   HZGHC002554c009; UBE2A knockout cell line 5bp insertion
DR   cancercelllines; CVCL_TV47
DR   Horizon_Discovery; HZGHC002554c009
DR   Wikidata; Q54880838
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12472; UBE2A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2B (-) 1
AC   CVCL_TV48
SY   HZGHC002555c001; UBE2B knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV48
DR   Horizon_Discovery; HZGHC002555c001
DR   Wikidata; Q54880839
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12473; UBE2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2B (-) 2
AC   CVCL_TV49
SY   HZGHC002555c004; UBE2B knockout cell line 76bp insertion
DR   cancercelllines; CVCL_TV49
DR   Horizon_Discovery; HZGHC002555c004
DR   Wikidata; Q54880840
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12473; UBE2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002555c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2C (-) 1
AC   CVCL_TV50
SY   HZGHC002556c001; UBE2C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV50
DR   Horizon_Discovery; HZGHC002556c001
DR   Wikidata; Q54880841
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15937; UBE2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2C (-) 2
AC   CVCL_TV51
SY   HZGHC002556c009; UBE2C knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV51
DR   Horizon_Discovery; HZGHC002556c009
DR   Wikidata; Q54880842
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15937; UBE2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2C (-) 3
AC   CVCL_TV52
SY   HZGHC002556c010; UBE2C knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV52
DR   Horizon_Discovery; HZGHC002556c010
DR   Wikidata; Q54880843
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15937; UBE2C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002556c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2D1 (-) 1
AC   CVCL_TV53
SY   HZGHC002557c001; UBE2D1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TV53
DR   Horizon_Discovery; HZGHC002557c001
DR   Wikidata; Q54880844
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12474; UBE2D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2D1 (-) 2
AC   CVCL_TV54
SY   HZGHC002557c005; UBE2D1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TV54
DR   Horizon_Discovery; HZGHC002557c005
DR   Wikidata; Q54880845
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12474; UBE2D1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2D2 (-) 1
AC   CVCL_TV55
SY   HZGHC002558c004; UBE2D2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV55
DR   Horizon_Discovery; HZGHC002558c004
DR   Wikidata; Q54880846
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12475; UBE2D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002558c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2D2 (-) 2
AC   CVCL_TV56
SY   HZGHC002558c003; UBE2D2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV56
DR   Horizon_Discovery; HZGHC002558c003
DR   Wikidata; Q54880847
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12475; UBE2D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2D2 (-) 3
AC   CVCL_TV57
SY   HZGHC002558c010; UBE2D2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV57
DR   Horizon_Discovery; HZGHC002558c010
DR   Wikidata; Q54880848
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12475; UBE2D2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2D3 (-) 1
AC   CVCL_TV58
SY   HZGHC002559c004; UBE2D3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV58
DR   Horizon_Discovery; HZGHC002559c004
DR   Wikidata; Q54880850
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12476; UBE2D3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2D3 (-) 2
AC   CVCL_TV59
SY   HZGHC002559c007; UBE2D3 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TV59
DR   Horizon_Discovery; HZGHC002559c007
DR   Wikidata; Q54880851
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12476; UBE2D3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2D4 (-) 1
AC   CVCL_TV60
SY   HZGHC002560c007; UBE2D4 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TV60
DR   Horizon_Discovery; HZGHC002560c007
DR   Wikidata; Q54880852
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21647; UBE2D4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2D4 (-) 2
AC   CVCL_TV61
SY   HZGHC002560c008; UBE2D4 knockout cell line 452bp insertion
DR   cancercelllines; CVCL_TV61
DR   Horizon_Discovery; HZGHC002560c008
DR   Wikidata; Q54880853
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21647; UBE2D4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002560c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2E1 (-) 1
AC   CVCL_TV62
SY   HZGHC002561c001; UBE2E1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TV62
DR   Horizon_Discovery; HZGHC002561c001
DR   Wikidata; Q54880854
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12477; UBE2E1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2E1 (-) 2
AC   CVCL_TV63
SY   HZGHC002561c010; UBE2E1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TV63
DR   Horizon_Discovery; HZGHC002561c010
DR   Wikidata; Q54880855
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12477; UBE2E1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2E2 (-)
AC   CVCL_TV64
SY   HZGHC002562c010; UBE2E2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TV64
DR   Horizon_Discovery; HZGHC002562c010
DR   Wikidata; Q54880856
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12478; UBE2E2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2E3 (-) 1
AC   CVCL_TV65
SY   HZGHC002563c001; UBE2E3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TV65
DR   Horizon_Discovery; HZGHC002563c001
DR   Wikidata; Q54880857
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12479; UBE2E3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2E3 (-) 2
AC   CVCL_TV66
SY   HZGHC002563c002; UBE2E3 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TV66
DR   Horizon_Discovery; HZGHC002563c002
DR   Wikidata; Q54880858
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12479; UBE2E3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2F (-)
AC   CVCL_TV67
SY   HZGHC002565c011; HZGHC140739; UBE2F knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TV67
DR   Horizon_Discovery; HZGHC002565c011
DR   Wikidata; Q54880859
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12480; UBE2F.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002565c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 UBE2G1 (-) 1
AC   CVCL_TV68
SY   HZGHC002850c011; UBE2G1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TV68
DR   Horizon_Discovery; HZGHC002850c011
DR   Wikidata; Q54880860
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12482; UBE2G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2G1 (-) 2
AC   CVCL_TV69
SY   HZGHC002850c012; UBE2G1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TV69
DR   Horizon_Discovery; HZGHC002850c012
DR   Wikidata; Q54880861
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12482; UBE2G1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2G2 (-) 1
AC   CVCL_TV70
SY   HZGHC002566c007; UBE2G2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV70
DR   Horizon_Discovery; HZGHC002566c007
DR   Wikidata; Q54880862
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12483; UBE2G2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2G2 (-) 2
AC   CVCL_TV71
SY   HZGHC002566c009; UBE2G2 knockout cell line 136bp insertion
DR   cancercelllines; CVCL_TV71
DR   Horizon_Discovery; HZGHC002566c009
DR   Wikidata; Q54880863
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12483; UBE2G2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002566c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2H (-) 1
AC   CVCL_TV72
SY   HZGHC000989c006; UBE2H knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV72
DR   Horizon_Discovery; HZGHC000989c006
DR   Wikidata; Q54880864
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12484; UBE2H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2H (-) 2
AC   CVCL_TV73
SY   HZGHC000989c010; UBE2H knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TV73
DR   Horizon_Discovery; HZGHC000989c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54880865
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12484; UBE2H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2J1 (-) 1
AC   CVCL_TV74
SY   HZGHC002567c003; UBE2J1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TV74
DR   Horizon_Discovery; HZGHC002567c003
DR   Wikidata; Q54880872
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17598; UBE2J1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2J1 (-) 2
AC   CVCL_TV75
SY   HZGHC002567c010; UBE2J1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TV75
DR   Horizon_Discovery; HZGHC002567c010
DR   Wikidata; Q54880873
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17598; UBE2J1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2J2 (-) 1
AC   CVCL_TV76
SY   HZGHC002568c003; UBE2J2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TV76
DR   Horizon_Discovery; HZGHC002568c003
DR   Wikidata; Q54880874
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19268; UBE2J2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2J2 (-) 2
AC   CVCL_TV77
SY   HZGHC002568c006; UBE2J2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TV77
DR   Horizon_Discovery; HZGHC002568c006
DR   Wikidata; Q54880875
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19268; UBE2J2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2K (-) 1
AC   CVCL_TV78
SY   HZGHC002569c003; UBE2K knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV78
DR   Horizon_Discovery; HZGHC002569c003
DR   Wikidata; Q54880876
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4914; UBE2K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2K (-) 2
AC   CVCL_TV79
SY   HZGHC002569c010; UBE2K knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TV79
DR   Horizon_Discovery; HZGHC002569c010
DR   Wikidata; Q54880877
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4914; UBE2K.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2L6 (-) 1
AC   CVCL_TV80
SY   HZGHC002570c001; UBE2L6 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TV80
DR   Horizon_Discovery; HZGHC002570c001
DR   Wikidata; Q54880878
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12490; UBE2L6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2L6 (-) 2
AC   CVCL_TV81
SY   HZGHC002570c002; UBE2L6 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TV81
DR   Horizon_Discovery; HZGHC002570c002
DR   Wikidata; Q54880879
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12490; UBE2L6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2O (-) 1
AC   CVCL_TV82
SY   HZGHC002571c005; UBE2O knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TV82
DR   Horizon_Discovery; HZGHC002571c005
DR   Wikidata; Q54880881
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29554; UBE2O.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2O (-) 2
AC   CVCL_TV83
SY   HZGHC002571c012; UBE2O knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TV83
DR   Horizon_Discovery; HZGHC002571c012
DR   Wikidata; Q54880882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29554; UBE2O.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2Q1 (-) 1
AC   CVCL_TV84
SY   HZGHC002572c011; UBE2Q1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV84
DR   Horizon_Discovery; HZGHC002572c011
DR   Wikidata; Q54880883
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15698; UBE2Q1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002572c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2Q1 (-) 2
AC   CVCL_TV85
SY   HZGHC002572c010; UBE2Q1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV85
DR   Horizon_Discovery; HZGHC002572c010
DR   Wikidata; Q54880884
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15698; UBE2Q1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2Q1 (-) 3
AC   CVCL_TV86
SY   HZGHC002572c012; UBE2Q1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TV86
DR   Horizon_Discovery; HZGHC002572c012
DR   Wikidata; Q54880885
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15698; UBE2Q1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2R2 (-) 1
AC   CVCL_TV87
SY   HZGHC003024c003; UBE2R2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TV87
DR   Horizon_Discovery; HZGHC003024c003
DR   Wikidata; Q54880886
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19907; UBE2R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2R2 (-) 2
AC   CVCL_TV88
SY   HZGHC003024c004; UBE2R2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TV88
DR   Horizon_Discovery; HZGHC003024c004
DR   Wikidata; Q54880887
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19907; UBE2R2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2T (-)
AC   CVCL_TV89
SY   HZGHC002533c001; UBE2T knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV89
DR   Horizon_Discovery; HZGHC002533c001
DR   Wikidata; Q54880888
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25009; UBE2T.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002533c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2V1 (-) 1
AC   CVCL_XU85
SY   HZGHC003299c009; UBE2V1 knockout cell line
DR   cancercelllines; CVCL_XU85
DR   Horizon_Discovery; HZGHC003299c009
DR   Wikidata; Q93976258
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12494; UBE2V1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003299c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2V1 (-) 2
AC   CVCL_XU86
SY   HZGHC003299c010; UBE2V1 knockout cell line
DR   cancercelllines; CVCL_XU86
DR   Horizon_Discovery; HZGHC003299c010
DR   Wikidata; Q93976261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12494; UBE2V1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003299c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2V2 (-) 1
AC   CVCL_TV90
SY   HZGHC003075c001; UBE2V2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TV90
DR   Horizon_Discovery; HZGHC003075c001
DR   Wikidata; Q54880889
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12495; UBE2V2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2V2 (-) 2
AC   CVCL_TV91
SY   HZGHC003075c011; UBE2V2 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TV91
DR   Horizon_Discovery; HZGHC003075c011
DR   Wikidata; Q54880890
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12495; UBE2V2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2W (-) 1
AC   CVCL_TV92
SY   HZGHC002576c001; UBE2W knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV92
DR   Horizon_Discovery; HZGHC002576c001
DR   Wikidata; Q54880891
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25616; UBE2W.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2W (-) 2
AC   CVCL_TV93
SY   HZGHC002576c008; UBE2W knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TV93
DR   Horizon_Discovery; HZGHC002576c008
DR   Wikidata; Q54880892
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25616; UBE2W.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2W (-) 3
AC   CVCL_TV94
SY   HZGHC002576c009; UBE2W knockout cell line 202bp insertion
DR   cancercelllines; CVCL_TV94
DR   Horizon_Discovery; HZGHC002576c009
DR   Wikidata; Q54880893
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25616; UBE2W.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002576c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE2Z (-) 1
AC   CVCL_TV95
SY   HZGHC002577c003; UBE2Z knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TV95
DR   Horizon_Discovery; HZGHC002577c003
DR   Wikidata; Q54880894
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25847; UBE2Z.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE2Z (-) 2
AC   CVCL_TV96
SY   HZGHC002577c012; UBE2Z knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TV96
DR   Horizon_Discovery; HZGHC002577c012
DR   Wikidata; Q54880895
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25847; UBE2Z.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE3A (-) 1
AC   CVCL_TV97
SY   HZGHC006009c010; UBE3A knockout cell line 8bp deletion; HAP1 UBE3A (-)
DR   cancercelllines; CVCL_TV97
DR   Horizon_Discovery; HZGHC006009c010
DR   Wikidata; Q54880896
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12496; UBE3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBE3A (-) 2
AC   CVCL_XU87
SY   HZGHC006009c012; UBE3A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_XU87
DR   Horizon_Discovery; HZGHC006009c012
DR   Wikidata; Q93976362
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12496; UBE3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE3C (-) 1
AC   CVCL_E2N2
SY   HZGHC007991c020
DR   Horizon_Discovery; HZGHC007991c020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16803; UBE3C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBE3C (-) 2
AC   CVCL_E2N3
SY   HZGHC007991c021
DR   Horizon_Discovery; HZGHC007991c021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16803; UBE3C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBE4A (-) 1
AC   CVCL_TV98
SY   HZGHC002942c001; UBE4A knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TV98
DR   Horizon_Discovery; HZGHC002942c001
DR   Wikidata; Q54880897
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12499; UBE4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE4A (-) 2
AC   CVCL_TV99
SY   HZGHC002942c006; UBE4A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TV99
DR   Horizon_Discovery; HZGHC002942c006
DR   Wikidata; Q54880898
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12499; UBE4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE4B (-) 1
AC   CVCL_TW00
SY   HZGHC002579c002; UBE4B knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW00
DR   Horizon_Discovery; HZGHC002579c002
DR   Wikidata; Q54880900
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12500; UBE4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBE4B (-) 2
AC   CVCL_TW01
SY   HZGHC002579c011; UBE4B knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TW01
DR   Horizon_Discovery; HZGHC002579c011
DR   Wikidata; Q54880901
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12500; UBE4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBIAD1 (-)
AC   CVCL_E2N4
SY   HZGHC007725c010
DR   Horizon_Discovery; HZGHC007725c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30791; UBIAD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBL3 (-) 1
AC   CVCL_TW02
SY   HZGHC002580c003; UBL3 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TW02
DR   Horizon_Discovery; HZGHC002580c003
DR   Wikidata; Q54880902
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12504; UBL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBL3 (-) 2
AC   CVCL_TW03
SY   HZGHC002580c007; UBL3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW03
DR   Horizon_Discovery; HZGHC002580c007
DR   Wikidata; Q54880903
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12504; UBL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBL4A (-)
AC   CVCL_TW04
SY   HZGHC002581c002; UBL4A knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TW04
DR   Horizon_Discovery; HZGHC002581c002
DR   Wikidata; Q54880904
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12505; UBL4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBLCP1 (-) 1
AC   CVCL_TW05
SY   HZGHC003482c001; UBLCP1 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TW05
DR   Horizon_Discovery; HZGHC003482c001
DR   Wikidata; Q54880905
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28110; UBLCP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBLCP1 (-) 2
AC   CVCL_TW06
SY   HZGHC003482c002; UBLCP1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TW06
DR   Horizon_Discovery; HZGHC003482c002
DR   Wikidata; Q54880906
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28110; UBLCP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBQLN1 (-) 2
AC   CVCL_TW07
SY   HZGHC004088c002; UBQLN1 knockout cell line 172bp deletion in exon 2
DR   cancercelllines; CVCL_TW07
DR   Horizon_Discovery; HZGHC004088c002
DR   Wikidata; Q54880908
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBQLN1 (-) 3
AC   CVCL_TW08
SY   HZGHC004088c009; UBQLN1 knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_TW08
DR   Horizon_Discovery; HZGHC004088c009
DR   Wikidata; Q54880909
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UBQLN1 (-) UBQLN4 (-) 1
AC   CVCL_DX65
SY   HZGHC007678c004; Double knockout cell line UBQLN1 1bp deletion in exon 2 and UBQLN4 2bp deletion in exon 10
DR   Horizon_Discovery; HZGHC007678c004
DR   Wikidata; Q127381104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1237; UBQLN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TW08 ! HAP1 UBQLN1 (-) 3
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 UBQLN1 (-) UBQLN4 (-) 2
AC   CVCL_DX66
SY   HZGHC007678c008; Double knockout cell line UBQLN1 1bp deletion in exon 2 and UBQLN4 1bp insertion in exon 10
DR   Horizon_Discovery; HZGHC007678c008
DR   Wikidata; Q127381105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1237; UBQLN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TW08 ! HAP1 UBQLN1 (-) 3
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 UBQLN2 (-) 1
AC   CVCL_TW09
SY   HZGHC004089c001; UBQLN2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TW09
DR   Horizon_Discovery; HZGHC004089c001
DR   Wikidata; Q54880910
RX   PubMed=37359784;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12509; UBQLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBQLN2 (-) 2
AC   CVCL_TW10
SY   HZGHC004089c007; UBQLN2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TW10
DR   Horizon_Discovery; HZGHC004089c007
DR   Wikidata; Q54880911
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12509; UBQLN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UBQLN4 (-) 1
AC   CVCL_DX12
SY   HZGHC007658c002; UBQLN4 knockout cell line 2bp deletion in exon 10
DR   Horizon_Discovery; HZGHC007658c002
DR   Wikidata; Q127381106
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1237; UBQLN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 UBQLN4 (-) 2
AC   CVCL_DX13
SY   HZGHC007658c009; UBQLN4 knockout cell line 2bp deletion in exon 10
DR   Horizon_Discovery; HZGHC007658c009
DR   Wikidata; Q127381107
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1237; UBQLN4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 UBR7 (-) 1
AC   CVCL_E2N5
SY   HZGHC007433c001
DR   Horizon_Discovery; HZGHC007433c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20344; UBR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBR7 (-) 2
AC   CVCL_E2N6
SY   HZGHC007433c005
DR   Horizon_Discovery; HZGHC007433c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20344; UBR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UBR7 (-) 3
AC   CVCL_E2N7
SY   HZGHC007433c007
DR   Horizon_Discovery; HZGHC007433c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20344; UBR7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UCHL1 (-) 1
AC   CVCL_TW11
SY   HZGHC003960c004; UCHL1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW11
DR   Horizon_Discovery; HZGHC003960c004
DR   PRIDE; PXD010335
DR   Wikidata; Q54880912
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12513; UCHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UCHL1 (-) 2
AC   CVCL_TW12
SY   HZGHC003960c010; UCHL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW12
DR   Horizon_Discovery; HZGHC003960c010
DR   Wikidata; Q54880913
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12513; UCHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UCHL1 (-) 3
AC   CVCL_TW13
SY   HZGHC003960c007; UCHL1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW13
DR   Horizon_Discovery; HZGHC003960c007
DR   Wikidata; Q54880914
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12513; UCHL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003960c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UCHL3 (-) 1
AC   CVCL_TW14
SY   HZGHC000637c003; UCHL3 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TW14
DR   Horizon_Discovery; HZGHC000637c003
DR   Wikidata; Q54880918
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12515; UCHL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UCHL3 (-) 2
AC   CVCL_TW15
SY   HZGHC000637c011; UCHL3 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW15
DR   Horizon_Discovery; HZGHC000637c011
DR   Wikidata; Q54880919
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12515; UCHL3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UCHL5 (-) 1
AC   CVCL_E2N8
SY   HZGHC007388c001
DR   Horizon_Discovery; HZGHC007388c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19678; UCHL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UCHL5 (-) 2
AC   CVCL_E2N9
SY   HZGHC007388c002
DR   Horizon_Discovery; HZGHC007388c002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19678; UCHL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UCHL5 (-) 3
AC   CVCL_E2NA
SY   HZGHC007388c004
DR   Horizon_Discovery; HZGHC007388c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19678; UCHL5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UCK2 (-)
AC   CVCL_XU88
SY   HZGHC007067c006; HZGHC7371; UCK2 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_XU88
DR   Horizon_Discovery; HZGHC007067c006
DR   Wikidata; Q93976542
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12562; UCK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007067c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 UCP1 (-) 1
AC   CVCL_TW16
SY   HZGHC001409c003; UCP1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW16
DR   Horizon_Discovery; HZGHC001409c003
DR   Wikidata; Q54880920
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12517; UCP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UCP1 (-) 2
AC   CVCL_TW17
SY   HZGHC001409c007; UCP1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TW17
DR   Horizon_Discovery; HZGHC001409c007
DR   Wikidata; Q54880922
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12517; UCP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UCP2 (-) 1
AC   CVCL_C7Z3
SY   HZGHC008189c004; UCP2 knockout cell line 26bp deletion in exon 7
DR   Horizon_Discovery; HZGHC008189c004
DR   Wikidata; Q123031478
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 UCP2 (-) 2
AC   CVCL_C7Z4
SY   HZGHC008189c008; UCP2 knockout cell line 1bp deletion in exon 7
DR   Horizon_Discovery; HZGHC008189c008
DR   Wikidata; Q123031482
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 UCP2 (-) 3
AC   CVCL_E2NB
SY   HZGHC008189c006
DR   Horizon_Discovery; HZGHC008189c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UCP2 (-) 4
AC   CVCL_E2NC
SY   HZGHC008189c009
DR   Horizon_Discovery; HZGHC008189c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12518; UCP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UEVLD (-) 1
AC   CVCL_TW18
SY   HZGHC002582c005; UEVLD knockout cell line 26bp deletion
DR   cancercelllines; CVCL_TW18
DR   Horizon_Discovery; HZGHC002582c005
DR   Wikidata; Q54880923
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30866; UEVLD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UEVLD (-) 2
AC   CVCL_TW19
SY   HZGHC002582c011; UEVLD knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TW19
DR   Horizon_Discovery; HZGHC002582c011
DR   Wikidata; Q54880924
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30866; UEVLD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UFC1 (-) 1
AC   CVCL_TW20
SY   HZGHC002583c005; UFC1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW20
DR   Horizon_Discovery; HZGHC002583c005
DR   Wikidata; Q54880925
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26941; UFC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UFC1 (-) 2
AC   CVCL_TW21
SY   HZGHC002583c012; UFC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW21
DR   Horizon_Discovery; HZGHC002583c012
DR   Wikidata; Q54880926
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26941; UFC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UFM1 (-)
AC   CVCL_TW22
SY   HZGHC002584c004; UFM1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TW22
DR   Horizon_Discovery; HZGHC002584c004
DR   Wikidata; Q54880927
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20597; UFM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UGCG (-) 1
AC   CVCL_TW23
SY   HZGHC003829c001; UGCG knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TW23
DR   Horizon_Discovery; HZGHC003829c001
DR   Wikidata; Q54880928
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12524; UGCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UGCG (-) 2
AC   CVCL_TW24
SY   HZGHC003829c006; UGCG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW24
DR   Horizon_Discovery; HZGHC003829c006
DR   Wikidata; Q54880929
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12524; UGCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UGCG (-) 3
AC   CVCL_TW25
SY   HZGHC003829c010; UGCG knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW25
DR   Horizon_Discovery; HZGHC003829c010
DR   Wikidata; Q54880930
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12524; UGCG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UHMK1 (-) 1
AC   CVCL_TW26
SY   HZGHC000178c010; UHMK1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TW26
DR   Horizon_Discovery; HZGHC000178c010
DR   Wikidata; Q54880931
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19683; UHMK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UHMK1 (-) 2
AC   CVCL_TW27
SY   HZGHC000178c016; UHMK1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TW27
DR   Horizon_Discovery; HZGHC000178c016
DR   Wikidata; Q54880932
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19683; UHMK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UHMK1 (-) 3
AC   CVCL_TW28
SY   HZGHC000178c022; UHMK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TW28
DR   Horizon_Discovery; HZGHC000178c022
DR   Wikidata; Q54880933
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19683; UHMK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UIMC1 (-) 1
AC   CVCL_TW29
SY   HZGHC000760c001; UIMC1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW29
DR   Horizon_Discovery; HZGHC000760c001
DR   Wikidata; Q54880934
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30298; UIMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UIMC1 (-) 2
AC   CVCL_TW30
SY   HZGHC000760c010; UIMC1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TW30
DR   Horizon_Discovery; HZGHC000760c010
DR   Wikidata; Q54880935
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30298; UIMC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ULK1 (-)
AC   CVCL_TW31
SY   HZGHC000072c011; ULK1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW31
DR   Horizon_Discovery; HZGHC000072c011
DR   Wikidata; Q54880936
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ULK2 (-) 1
AC   CVCL_TW32
SY   HZGHC004367c010; ULK2 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TW32
DR   Horizon_Discovery; HZGHC004367c010
DR   Wikidata; Q54880937
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ULK2 (-) 2
AC   CVCL_TW33
SY   HZGHC004367c012; ULK2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW33
DR   Horizon_Discovery; HZGHC004367c012
DR   Wikidata; Q54880938
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ULK3 (-) 1
AC   CVCL_TW34
SY   HZGHC011004c009; ULK3 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TW34
DR   Horizon_Discovery; HZGHC011004c009
DR   Wikidata; Q54880939
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19703; ULK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC011004c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ULK3 (-) 2
AC   CVCL_TW35
SY   HZGHC011004c014; ULK3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TW35
DR   Horizon_Discovery; HZGHC011004c014
DR   Wikidata; Q54880940
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19703; ULK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC011004c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ULK3 (-) 3
AC   CVCL_TW36
SY   HZGHC011004c024; ULK3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TW36
DR   Horizon_Discovery; HZGHC011004c024
DR   Wikidata; Q54880941
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19703; ULK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC011004c024; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ULK4 (-)
AC   CVCL_TW37
SY   HZGHC000346c009; ULK4 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TW37
DR   Horizon_Discovery; HZGHC000346c009
DR   Wikidata; Q54880942
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15784; ULK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UNG (-) 1
AC   CVCL_TW38
SY   HZGHC000630c001; UNG knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW38
DR   Horizon_Discovery; HZGHC000630c001
DR   Wikidata; Q54880943
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12572; UNG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UNG (-) 2
AC   CVCL_TW39
SY   HZGHC000630c007; UNG knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TW39
DR   Horizon_Discovery; HZGHC000630c007
DR   Wikidata; Q54880944
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12572; UNG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UNG (-) 3
AC   CVCL_TW40
SY   HZGHC001531c005; UNG knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW40
DR   Horizon_Discovery; HZGHC001531c005
DR   Wikidata; Q54880945
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12572; UNG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UNG (-) 4
AC   CVCL_TW41
SY   HZGHC001531c012; UNG knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW41
DR   Horizon_Discovery; HZGHC001531c012
DR   Wikidata; Q54880947
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12572; UNG.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UPF3A (-) 1
AC   CVCL_E2ND
SY   HZGHC007992c018
DR   Horizon_Discovery; HZGHC007992c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20332; UPF3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UPF3A (-) 2
AC   CVCL_E2NE
SY   HZGHC007992c022
DR   Horizon_Discovery; HZGHC007992c022
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20332; UPF3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UPF3A (-) 3
AC   CVCL_E2NF
SY   HZGHC007992c024
DR   Horizon_Discovery; HZGHC007992c024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20332; UPF3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UPF3B (-)
AC   CVCL_E2NG
SY   HZGHC007994c008
DR   Horizon_Discovery; HZGHC007994c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20439; UPF3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UQCC1 (-)
AC   CVCL_E2NH
SY   HZGHC007955c006
DR   Horizon_Discovery; HZGHC007955c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15891; UQCC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 UQCC2 (-)
AC   CVCL_E2NI
SY   HZGHC007957c008
DR   Horizon_Discovery; HZGHC007957c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21237; UQCC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 USMG5 (-) 1
AC   CVCL_TW42
SY   HZGHC004597c002; USMG5 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW42
DR   Horizon_Discovery; HZGHC004597c002
DR   Wikidata; Q54880948
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30889; ATP5MK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USMG5 (-) 2
AC   CVCL_TW43
SY   HZGHC004597c012; USMG5 knockout cell line 43bp deletion
DR   cancercelllines; CVCL_TW43
DR   Horizon_Discovery; HZGHC004597c012
DR   Wikidata; Q54880949
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30889; ATP5MK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP1 (-) 1
AC   CVCL_TW44
SY   HZGHC000455c005; USP1 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TW44
DR   Horizon_Discovery; HZGHC000455c005
DR   Wikidata; Q54880950
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12607; USP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP1 (-) 2
AC   CVCL_TW45
SY   HZGHC000455c007; USP1 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TW45
DR   Horizon_Discovery; HZGHC000455c007
DR   Wikidata; Q54880951
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12607; USP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP1 (-) 3
AC   CVCL_TW46
SY   HZGHC000620c005; USP1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW46
DR   Horizon_Discovery; HZGHC000620c005
DR   Wikidata; Q54880952
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12607; USP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP1 (-) 4
AC   CVCL_TW47
SY   HZGHC000620c012; USP1 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TW47
DR   Horizon_Discovery; HZGHC000620c012
DR   Wikidata; Q54880953
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12607; USP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP10 (-)
AC   CVCL_TW48
SY   HZGHC000450c001; USP10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TW48
DR   Horizon_Discovery; HZGHC000450c001
DR   Wikidata; Q54880954
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12608; USP10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP11 (-) 1
AC   CVCL_TW49
SY   HZGHC000494c002; USP11 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TW49
DR   Horizon_Discovery; HZGHC000494c002
DR   Wikidata; Q54880955
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12609; USP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000494c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP11 (-) 2
AC   CVCL_TW50
SY   HZGHC000494c005; USP11 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TW50
DR   Horizon_Discovery; HZGHC000494c005
DR   Wikidata; Q54880956
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12609; USP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP11 (-) 3
AC   CVCL_TW51
SY   HZGHC000634c005; USP11 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW51
DR   Horizon_Discovery; HZGHC000634c005
DR   Wikidata; Q54880957
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12609; USP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP11 (-) 4
AC   CVCL_TW52
SY   HZGHC000634c008; USP11 knockout cell line 229bp insertion
DR   cancercelllines; CVCL_TW52
DR   Horizon_Discovery; HZGHC000634c008
DR   Wikidata; Q54880958
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12609; USP11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000634c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP12 (-) 1
AC   CVCL_TW53
SY   HZGHC000493c001; USP12 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TW53
DR   Horizon_Discovery; HZGHC000493c001
DR   Wikidata; Q54880959
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20485; USP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP12 (-) 2
AC   CVCL_TW54
SY   HZGHC000493c006; USP12 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TW54
DR   Horizon_Discovery; HZGHC000493c006
DR   Wikidata; Q54880964
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20485; USP12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP13 (-)
AC   CVCL_TW55
SY   HZGHC000453c006; USP13 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TW55
DR   Horizon_Discovery; HZGHC000453c006
DR   Wikidata; Q54880965
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12611; USP13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP14 (-) 1
AC   CVCL_TW56
SY   HZGHC000497c002; USP14 knockout cell line 62bp insertion
DR   cancercelllines; CVCL_TW56
DR   Horizon_Discovery; HZGHC000497c002
DR   Wikidata; Q54880966
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12612; USP14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000497c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 USP14 (-) 2
AC   CVCL_TW57
SY   HZGHC000497c008; USP14 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TW57
DR   Horizon_Discovery; HZGHC000497c008
DR   PRIDE; PXD010335
DR   Wikidata; Q54880967
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12612; USP14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP15 (-) 1
AC   CVCL_TW58
SY   HZGHC000451c001; USP15 knockout cell line 32bp deletion
DR   cancercelllines; CVCL_TW58
DR   Horizon_Discovery; HZGHC000451c001
DR   Wikidata; Q54880968
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12613; USP15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP15 (-) 2
AC   CVCL_TW59
SY   HZGHC000451c002; USP15 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TW59
DR   Horizon_Discovery; HZGHC000451c002
DR   Wikidata; Q54880969
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12613; USP15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP15 (-) 3
AC   CVCL_TW60
SY   HZGHC000451c003; USP15 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TW60
DR   Horizon_Discovery; HZGHC000451c003
DR   Wikidata; Q54880970
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12613; USP15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP16 (-) 1
AC   CVCL_TW61
SY   HZGHC000495c002; USP16 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TW61
DR   Horizon_Discovery; HZGHC000495c002
DR   Wikidata; Q54880971
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP16 (-) 2
AC   CVCL_TW62
SY   HZGHC000495c007; USP16 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TW62
DR   Horizon_Discovery; HZGHC000495c007
DR   Wikidata; Q54880972
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP16 (-) 3
AC   CVCL_TW63
SY   HZGHC003566c002; USP16 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW63
DR   Horizon_Discovery; HZGHC003566c002
DR   Wikidata; Q54880973
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP16 (-) 4
AC   CVCL_TW64
SY   HZGHC003566c010; USP16 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TW64
DR   Horizon_Discovery; HZGHC003566c010
DR   Wikidata; Q54880974
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP16 (-) 5
AC   CVCL_TW65
SY   HZGHC003566c011; USP16 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TW65
DR   Horizon_Discovery; HZGHC003566c011
DR   Wikidata; Q54880975
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP18 (-) 1
AC   CVCL_TW66
SY   HZGHC000492c006; USP18 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TW66
DR   Horizon_Discovery; HZGHC000492c006
DR   Wikidata; Q54880976
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP18 (-) 2
AC   CVCL_TW67
SY   HZGHC000492c011; USP18 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TW67
DR   Horizon_Discovery; HZGHC000492c011
DR   Wikidata; Q54880977
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000492c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP19 (-) 1
AC   CVCL_TW68
SY   HZGHC000491c002; USP19 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TW68
DR   Horizon_Discovery; HZGHC000491c002
DR   Wikidata; Q54880978
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12617; USP19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000491c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP19 (-) 2
AC   CVCL_TW69
SY   HZGHC000491c008; USP19 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TW69
DR   Horizon_Discovery; HZGHC000491c008
DR   Wikidata; Q54880979
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12617; USP19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP2 (-) 1
AC   CVCL_TW70
SY   HZGHC000467c006; USP2 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TW70
DR   Horizon_Discovery; HZGHC000467c006
DR   Wikidata; Q54880980
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12618; USP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP2 (-) 2
AC   CVCL_TW71
SY   HZGHC000467c010; USP2 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW71
DR   Horizon_Discovery; HZGHC000467c010
DR   Wikidata; Q54880981
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12618; USP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP2 (-) 3
AC   CVCL_XU89
SY   HZGHC005436c003; USP2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XU89
DR   Horizon_Discovery; HZGHC005436c003
DR   Wikidata; Q93976979
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12618; USP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP2 (-) 4
AC   CVCL_XU90
SY   HZGHC005436c007; USP2 knockout cell line 26bp deletion
DR   cancercelllines; CVCL_XU90
DR   Horizon_Discovery; HZGHC005436c007
DR   Wikidata; Q93976981
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12618; USP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP20 (-) 1
AC   CVCL_TW72
SY   HZGHC000460c008; USP20 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TW72
DR   Horizon_Discovery; HZGHC000460c008
DR   Wikidata; Q54880982
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12619; USP20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP20 (-) 2
AC   CVCL_TW73
SY   HZGHC000460c009; USP20 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TW73
DR   Horizon_Discovery; HZGHC000460c009
DR   Wikidata; Q54880983
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12619; USP20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000460c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP21 (-) 1
AC   CVCL_TW74
SY   HZGHC000459c001; USP21 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TW74
DR   Horizon_Discovery; HZGHC000459c001
DR   Wikidata; Q54880984
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12620; USP21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP21 (-) 2
AC   CVCL_TW75
SY   HZGHC000459c002; USP21 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TW75
DR   Horizon_Discovery; HZGHC000459c002
DR   Wikidata; Q54880986
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12620; USP21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP21 (-) 3
AC   CVCL_E2NJ
SY   HZGHC007623c001
DR   Horizon_Discovery; HZGHC007623c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12620; USP21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 USP21 (-) 4
AC   CVCL_E2NK
SY   HZGHC007623c003
DR   Horizon_Discovery; HZGHC007623c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12620; USP21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 USP21 (-) 5
AC   CVCL_E2NL
SY   HZGHC007623c008
DR   Horizon_Discovery; HZGHC007623c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12620; USP21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 USP22 (-) 1
AC   CVCL_TW76
SY   HZGHC000461c009; USP22 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TW76
DR   Horizon_Discovery; HZGHC000461c009
DR   Wikidata; Q54880987
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP22 (-) 2
AC   CVCL_TW77
SY   HZGHC000461c010; USP22 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW77
DR   Horizon_Discovery; HZGHC000461c010
DR   Wikidata; Q54880988
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000461c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP24 (-)
AC   CVCL_TW78
SY   HZGHC000463c001; USP24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW78
DR   Horizon_Discovery; HZGHC000463c001
DR   Wikidata; Q54880989
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12623; USP24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP25 (-)
AC   CVCL_TW79
SY   HZGHC000462c001; USP25 knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_TW79
DR   Horizon_Discovery; HZGHC000462c001
DR   Wikidata; Q54880990
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12624; USP25.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP25 (-) USP28 (-) 1
AC   CVCL_DX67
SY   HZGHC007871c010; Double knockout cell line USP25 1bp insertion in exon 4 and USP28 5bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007871c010
DR   Wikidata; Q127381108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12624; USP25.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TW79 ! HAP1 USP25 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 USP25 (-) USP28 (-) 2
AC   CVCL_DX68
SY   HZGHC007871c019; Double knockout cell line USP25 1bp insertion in exon 4 and USP28 5bp deletion
DR   Horizon_Discovery; HZGHC007871c019
DR   Wikidata; Q127381109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12624; USP25.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TW79 ! HAP1 USP25 (-)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 USP27X (-)
AC   CVCL_TW80
SY   HZGHC000448c002; USP27X knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW80
DR   Horizon_Discovery; HZGHC000448c002
DR   Wikidata; Q54880991
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13486; USP27X.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP28 (-) 1
AC   CVCL_TW81
SY   HZGHC000499c005; USP28 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TW81
DR   Horizon_Discovery; HZGHC000499c005
DR   Wikidata; Q54880992
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000499c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP28 (-) 2
AC   CVCL_TW82
SY   HZGHC000499c006; USP28 knockout cell line 10bp deletion in exon 3
DR   cancercelllines; CVCL_TW82
DR   Horizon_Discovery; HZGHC000499c006
DR   Wikidata; Q54880993
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP28 (-) 3
AC   CVCL_XU91
SY   HZGHC005323c007; USP28 knockout cell line 5bp deletion in exon 5
DR   cancercelllines; CVCL_XU91
DR   Horizon_Discovery; HZGHC005323c007
DR   Wikidata; Q93977043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP28 (-) 4
AC   CVCL_XU92
SY   HZGHC005323c008; USP28 knockout cell line 8bp deletion in exon 5
DR   cancercelllines; CVCL_XU92
DR   Horizon_Discovery; HZGHC005323c008
DR   Wikidata; Q93977046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP28 (-) 5
AC   CVCL_XU93
SY   HZGHC005354c009; USP28 knockout cell line 1bp insertion in exon 3
DR   cancercelllines; CVCL_XU93
DR   Horizon_Discovery; HZGHC005354c009
DR   Wikidata; Q93977049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP3 (-)
AC   CVCL_TW83
SY   HZGHC000881c010; USP3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW83
DR   Horizon_Discovery; HZGHC000881c010
DR   Wikidata; Q54880994
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12626; USP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000881c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP30 (-) 1
AC   CVCL_TW84
SY   HZGHC000465c002; USP30 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW84
DR   Horizon_Discovery; HZGHC000465c002
DR   Wikidata; Q54880995
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20065; USP30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP30 (-) 2
AC   CVCL_TW85
SY   HZGHC000465c005; USP30 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TW85
DR   Horizon_Discovery; HZGHC000465c005
DR   Wikidata; Q54880996
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20065; USP30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP30 (-) 3
AC   CVCL_E2NM
SY   HZGHC007482c008; USP30 knockout cell line 1bp insertion in exon 10
DR   Horizon_Discovery; HZGHC007482c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20065; USP30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 USP30 (-) 4
AC   CVCL_E2NN
SY   HZGHC007482c012; USP30 knockout cell line 2bp deletion in exon 10
DR   Horizon_Discovery; HZGHC007482c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20065; USP30.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 USP31 (-) 1
AC   CVCL_TW86
SY   HZGHC000483c001; USP31 knockout cell line 43bp deletion
DR   cancercelllines; CVCL_TW86
DR   Horizon_Discovery; HZGHC000483c001
DR   Wikidata; Q54880997
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20060; USP31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP31 (-) 2
AC   CVCL_TW87
SY   HZGHC000483c009; USP31 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW87
DR   Horizon_Discovery; HZGHC000483c009
DR   Wikidata; Q54880998
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20060; USP31.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP32 (-) 1
AC   CVCL_TW88
SY   HZGHC000482c009; USP32 knockout cell line 227bp insertion
DR   cancercelllines; CVCL_TW88
DR   Horizon_Discovery; HZGHC000482c009
DR   Wikidata; Q54880999
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19143; USP32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000482c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP32 (-) 2
AC   CVCL_TW89
SY   HZGHC000482c010; USP32 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TW89
DR   Horizon_Discovery; HZGHC000482c010
DR   Wikidata; Q54881000
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19143; USP32.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP33 (-) 1
AC   CVCL_TW90
SY   HZGHC000481c006; USP33 knockout cell line 175bp insertion
DR   cancercelllines; CVCL_TW90
DR   Horizon_Discovery; HZGHC000481c006
DR   Wikidata; Q54881001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20059; USP33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000481c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP33 (-) 2
AC   CVCL_TW91
SY   HZGHC000481c008; USP33 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TW91
DR   Horizon_Discovery; HZGHC000481c008
DR   Wikidata; Q54881002
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20059; USP33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000481c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP34 (-)
AC   CVCL_TW92
SY   HZGHC000480c001; USP34 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TW92
DR   Horizon_Discovery; HZGHC000480c001
DR   Wikidata; Q54881003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20066; USP34.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000480c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP35 (-)
AC   CVCL_TW93
SY   HZGHC000613c012; USP35 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TW93
DR   Horizon_Discovery; HZGHC000613c012
DR   Wikidata; Q54881004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20061; USP35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP38 (-) 1
AC   CVCL_TW94
SY   HZGHC000476c004; USP38 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW94
DR   Horizon_Discovery; HZGHC000476c004
DR   Wikidata; Q54881008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20067; USP38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP38 (-) 2
AC   CVCL_TW95
SY   HZGHC000476c012; USP38 knockout cell line 263bp insertion
DR   cancercelllines; CVCL_TW95
DR   Horizon_Discovery; HZGHC000476c012
DR   Wikidata; Q54881009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20067; USP38.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000476c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP4 (-) 1
AC   CVCL_TW96
SY   HZGHC000470c003; USP4 knockout cell line 2bp insertion; HAP1 USP4 (-)
DR   cancercelllines; CVCL_TW96
DR   Horizon_Discovery; HZGHC000470c003
DR   Wikidata; Q54881010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12627; USP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP4 (-) 2
AC   CVCL_XU94
SY   HZGHC005324c001; USP4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XU94
DR   Horizon_Discovery; HZGHC005324c001
DR   Wikidata; Q93977167
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12627; USP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP4 (-) 3
AC   CVCL_XU95
SY   HZGHC005324c012; USP4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XU95
DR   Horizon_Discovery; HZGHC005324c012
DR   Wikidata; Q93977172
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12627; USP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP40 (-) 1
AC   CVCL_TW97
SY   HZGHC000505c008; USP40 knockout cell line 55bp insertion
DR   cancercelllines; CVCL_TW97
DR   Horizon_Discovery; HZGHC000505c008
DR   Wikidata; Q54881011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20069; USP40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000505c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP40 (-) 2
AC   CVCL_TW98
SY   HZGHC000505c009; USP40 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TW98
DR   Horizon_Discovery; HZGHC000505c009
DR   Wikidata; Q54881012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20069; USP40.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP42 (-)
AC   CVCL_XU96
SY   HZGHC000489c009; USP42 knockout cell line
DR   cancercelllines; CVCL_XU96
DR   Horizon_Discovery; HZGHC000489c009
DR   Wikidata; Q93977191
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20068; USP42.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000489c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP45 (-) 1
AC   CVCL_TW99
SY   HZGHC000910c001; USP45 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TW99
DR   Horizon_Discovery; HZGHC000910c001
DR   Wikidata; Q54881013
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20080; USP45.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP45 (-) 2
AC   CVCL_TX00
SY   HZGHC000910c004; USP45 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TX00
DR   Horizon_Discovery; HZGHC000910c004
DR   Wikidata; Q54881014
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20080; USP45.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP46 (-)
AC   CVCL_TX01
SY   HZGHC000486c004; USP46 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX01
DR   Horizon_Discovery; HZGHC000486c004
DR   Wikidata; Q54881015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20075; USP46.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP47 (-) 1
AC   CVCL_TX02
SY   HZGHC000906c010; USP47 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TX02
DR   Horizon_Discovery; HZGHC000906c010
DR   Wikidata; Q54881016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20076; USP47.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP47 (-) 2
AC   CVCL_TX03
SY   HZGHC000906c011; USP47 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TX03
DR   Horizon_Discovery; HZGHC000906c011
DR   Wikidata; Q54881017
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20076; USP47.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP48 (-) 1
AC   CVCL_TX04
SY   HZGHC000915c011; USP48 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TX04
DR   Horizon_Discovery; HZGHC000915c011
DR   Wikidata; Q54881018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18533; USP48.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP48 (-) 2
AC   CVCL_TX05
SY   HZGHC000915c012; USP48 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX05
DR   Horizon_Discovery; HZGHC000915c012
DR   Wikidata; Q54881019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18533; USP48.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP49 (-) 1
AC   CVCL_TX06
SY   HZGHC000487c006; USP49 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TX06
DR   Horizon_Discovery; HZGHC000487c006
DR   Wikidata; Q54881020
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20078; USP49.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP49 (-) 2
AC   CVCL_TX07
SY   HZGHC000487c011; USP49 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TX07
DR   Horizon_Discovery; HZGHC000487c011
DR   Wikidata; Q54881021
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20078; USP49.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP53 (-) 1
AC   CVCL_TX08
SY   HZGHC000447c007; USP53 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TX08
DR   Horizon_Discovery; HZGHC000447c007
DR   Wikidata; Q54881023
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29255; USP53.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP53 (-) 2
AC   CVCL_TX09
SY   HZGHC000447c010; USP53 knockout cell line 5bp insertion
DR   cancercelllines; CVCL_TX09
DR   Horizon_Discovery; HZGHC000447c010
DR   Wikidata; Q54881024
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29255; USP53.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000447c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP54 (-)
AC   CVCL_TX10
SY   HZGHC000449c010; USP54 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX10
DR   Horizon_Discovery; HZGHC000449c010
DR   Wikidata; Q54881025
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23513; USP54.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP6 (-) 1
AC   CVCL_TX11
SY   HZGHC000628c011; USP6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX11
DR   Horizon_Discovery; HZGHC000628c011
DR   Wikidata; Q54881026
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12629; USP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP6 (-) 2
AC   CVCL_TX12
SY   HZGHC000628c012; USP6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX12
DR   Horizon_Discovery; HZGHC000628c012
DR   Wikidata; Q54881027
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12629; USP6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP7 (-)
AC   CVCL_TX13
SY   HZGHC000464c002; USP7 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX13
DR   Horizon_Discovery; HZGHC000464c002
DR   Wikidata; Q54881028
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12630; USP7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 USP8 (-) 1
AC   CVCL_TX14
SY   HZGHC000503c003; USP8 knockout cell line 181bp insertion
DR   cancercelllines; CVCL_TX14
DR   Horizon_Discovery; HZGHC000503c003
DR   Wikidata; Q54881029
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000503c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP8 (-) 2
AC   CVCL_TX15
SY   HZGHC000503c005; USP8 knockout cell line 98bp insertion
DR   cancercelllines; CVCL_TX15
DR   Horizon_Discovery; HZGHC000503c005
DR   Wikidata; Q54881030
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000503c005; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP9X (-) 1
AC   CVCL_TX16
SY   HZGHC000468c003; USP9X knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TX16
DR   Horizon_Discovery; HZGHC000468c003
DR   Wikidata; Q54881031
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12632; USP9X.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000468c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 USP9X (-) 2
AC   CVCL_TX17
SY   HZGHC000468c007; USP9X knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TX17
DR   Horizon_Discovery; HZGHC000468c007
DR   Wikidata; Q54881032
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12632; USP9X.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000468c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 UTRN (-) 1
AC   CVCL_TX18
SY   HZGHC001381c010; UTRN knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TX18
DR   Horizon_Discovery; HZGHC001381c010
DR   Wikidata; Q54881033
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12635; UTRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UTRN (-) 2
AC   CVCL_TX19
SY   HZGHC001381c012; UTRN knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TX19
DR   Horizon_Discovery; HZGHC001381c012
DR   Wikidata; Q54881034
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12635; UTRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UTRN (-) 3
AC   CVCL_TX20
SY   HZGHC001382c001; UTRN knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX20
DR   Horizon_Discovery; HZGHC001382c001
DR   Wikidata; Q54881035
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12635; UTRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UTRN (-) 4
AC   CVCL_TX21
SY   HZGHC001382c002; UTRN knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TX21
DR   Horizon_Discovery; HZGHC001382c002
DR   Wikidata; Q54881036
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12635; UTRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 UVSSA (-)
AC   CVCL_TX22
SY   HZGHC005817c010; UVSSA knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TX22
DR   Horizon_Discovery; HZGHC005817c010
DR   Wikidata; Q54881037
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29304; UVSSA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAC14 (-) 1
AC   CVCL_TX23
SY   HZGHC002910c001; VAC14 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TX23
DR   Horizon_Discovery; HZGHC002910c001
DR   Wikidata; Q54881038
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25507; VAC14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAC14 (-) 2
AC   CVCL_TX24
SY   HZGHC002910c011; VAC14 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TX24
DR   Horizon_Discovery; HZGHC002910c011
DR   Wikidata; Q54881039
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25507; VAC14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAMP1 (-) 1
AC   CVCL_TX25
SY   HZGHC003832c003; VAMP1 knockout cell line 163bp insertion
DR   cancercelllines; CVCL_TX25
DR   Horizon_Discovery; HZGHC003832c003
DR   Wikidata; Q54881040
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12642; VAMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003832c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VAMP1 (-) 2
AC   CVCL_TX26
SY   HZGHC003832c012; VAMP1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TX26
DR   Horizon_Discovery; HZGHC003832c012
DR   Wikidata; Q54881041
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12642; VAMP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAPA (-) 1
AC   CVCL_TX27
SY   HZGHC003665c001; VAPA knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX27
DR   Horizon_Discovery; HZGHC003665c001
DR   Wikidata; Q54881042
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12648; VAPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAPA (-) 2
AC   CVCL_TX28
SY   HZGHC003665c008; VAPA knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TX28
DR   Horizon_Discovery; HZGHC003665c008
DR   Wikidata; Q54881043
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12648; VAPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAPB (-) 1
AC   CVCL_TX29
SY   HZGHC003668c007; VAPB knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TX29
DR   Horizon_Discovery; HZGHC003668c007
DR   Wikidata; Q54881044
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12649; VAPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAPB (-) 2
AC   CVCL_TX30
SY   HZGHC003668c009; VAPB knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX30
DR   Horizon_Discovery; HZGHC003668c009
DR   Wikidata; Q54881045
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12649; VAPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAV2 (-) 1
AC   CVCL_TX31
SY   HZGHC004498c002; VAV2 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TX31
DR   Horizon_Discovery; HZGHC004498c002
DR   Wikidata; Q54881046
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12658; VAV2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAV2 (-) 2
AC   CVCL_TX32
SY   HZGHC004498c012; VAV2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TX32
DR   Horizon_Discovery; HZGHC004498c012
DR   Wikidata; Q54881047
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12658; VAV2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAV2 (-) 3
AC   CVCL_TX33
SY   HZGHC004499c003; VAV2 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TX33
DR   Horizon_Discovery; HZGHC004499c003
DR   Wikidata; Q54881049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12658; VAV2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VAV2 (-) 4
AC   CVCL_TX34
SY   HZGHC004499c011; VAV2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX34
DR   Horizon_Discovery; HZGHC004499c011
DR   Wikidata; Q54881053
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12658; VAV2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VCPIP1 (-) 1
AC   CVCL_TX35
SY   HZGHC000452c002; VCPIP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX35
DR   Horizon_Discovery; HZGHC000452c002
DR   Wikidata; Q54881054
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30897; VCPIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000452c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VCPIP1 (-) 2
AC   CVCL_TX36
SY   HZGHC000452c006; VCPIP1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TX36
DR   Horizon_Discovery; HZGHC000452c006
DR   Wikidata; Q54881055
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30897; VCPIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VDAC1 (-) 1
AC   CVCL_TX37
SY   HZGHC005706c001; VDAC1 knockout cell line 14bp deletion in exon 6; HAP1 VDAC1 (-)
DR   cancercelllines; CVCL_TX37
DR   Horizon_Discovery; HZGHC005706c001
DR   Wikidata; Q54881056
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12669; VDAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 VDAC1 (-) 2
AC   CVCL_XU97
SY   HZGHC005706c002; VDAC1 knockout cell line 2bp deletion in exon 6
DR   cancercelllines; CVCL_XU97
DR   Horizon_Discovery; HZGHC005706c002
DR   Wikidata; Q93977587
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12669; VDAC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VDAC3 (-) 1
AC   CVCL_TX38
SY   HZGHC005689c006; VDAC3 knockout cell line 17bp deletion; HAP1 VDAC3 (-)
DR   cancercelllines; CVCL_TX38
DR   Horizon_Discovery; HZGHC005689c006
DR   Wikidata; Q54881057
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VDAC3 (-) 2
AC   CVCL_XU98
SY   HZGHC005689c008; VDAC3 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_XU98
DR   Horizon_Discovery; HZGHC005689c008
DR   Wikidata; Q93977601
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VDR (-)
AC   CVCL_XU99
SY   HZGHC007243c008; HZGHC7421; VDR knockout cell line 1bp insertion in exon 4
DR   cancercelllines; CVCL_XU99
DR   Horizon_Discovery; HZGHC007243c008
DR   Wikidata; Q93977604
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VEGFA (-) 1
AC   CVCL_TX39
SY   HZGHC003799c008; VEGFA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX39
DR   Horizon_Discovery; HZGHC003799c008
DR   Wikidata; Q54881058
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VEGFA (-) 2
AC   CVCL_TX40
SY   HZGHC003799c011; VEGFA knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TX40
DR   Horizon_Discovery; HZGHC003799c011
DR   Wikidata; Q54881059
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VEGFB (-) 1
AC   CVCL_TX41
SY   HZGHC003798c007; VEGFB knockout cell line 2bp deletion in exon 3
DR   cancercelllines; CVCL_TX41
DR   Horizon_Discovery; HZGHC003798c007
DR   Wikidata; Q54881060
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12681; VEGFB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VEGFB (-) 2
AC   CVCL_TX42
SY   HZGHC003798c008; VEGFB knockout cell line 170bp deletion in exon 3
DR   cancercelllines; CVCL_TX42
DR   Horizon_Discovery; HZGHC003798c008
DR   Wikidata; Q54881061
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12681; VEGFB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VHL (-)
AC   CVCL_XV00
SY   HZGHC002468c010; VHL knockout cell line
DR   cancercelllines; CVCL_XV00
DR   Horizon_Discovery; HZGHC002468c010
DR   Wikidata; Q93977638
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12687; VHL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002468c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VIM (-) 1
AC   CVCL_TX43
SY   HZGHC003297c001; VIM knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX43
DR   Horizon_Discovery; HZGHC003297c001
DR   Wikidata; Q54881063
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VIM (-) 2
AC   CVCL_TX44
SY   HZGHC003297c010; VIM knockout cell line 221bp insertion
DR   cancercelllines; CVCL_TX44
DR   Horizon_Discovery; HZGHC003297c010
DR   Wikidata; Q54881064
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003297c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VIMP (-) 1
AC   CVCL_XV01
SY   HZGHC006805c012; HZGHC55829; VIMP knockout cell line 706bp insertion in exon 2; HAP1 VIMP (-)
DR   cancercelllines; CVCL_XV01
DR   Horizon_Discovery; HZGHC006805c012
DR   Wikidata; Q93977656
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30396; SELENOS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006805c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 VIMP (-) 2
AC   CVCL_E2NP
SY   HZGHC006805c011; VIMP knockout cell line 4bp deletion in exon 2
DR   Horizon_Discovery; HZGHC006805c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30396; SELENOS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VKORC1 (-) 1
AC   CVCL_TX45
SY   HZGHC003757c005; VKORC1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX45
DR   Horizon_Discovery; HZGHC003757c005
DR   Wikidata; Q54881065
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23663; VKORC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VKORC1 (-) 2
AC   CVCL_TX46
SY   HZGHC003757c010; VKORC1 knockout cell line 82bp insertion
DR   cancercelllines; CVCL_TX46
DR   Horizon_Discovery; HZGHC003757c010
DR   Wikidata; Q54881066
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23663; VKORC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC003757c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VKORC1L1 (-) 1
AC   CVCL_TX47
SY   HZGHC003791c001; VKORC1L1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX47
DR   Horizon_Discovery; HZGHC003791c001
DR   Wikidata; Q54881067
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21492; VKORC1L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VKORC1L1 (-) 2
AC   CVCL_TX48
SY   HZGHC003791c003; VKORC1L1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TX48
DR   Horizon_Discovery; HZGHC003791c003
DR   Wikidata; Q54881068
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21492; VKORC1L1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS11 (-) 1
AC   CVCL_E2NQ
SY   HZGHC007330c007
DR   Horizon_Discovery; HZGHC007330c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14583; VPS11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS11 (-) 2
AC   CVCL_E2NR
SY   HZGHC007331c004
DR   Horizon_Discovery; HZGHC007331c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14583; VPS11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS11 (-) 3
AC   CVCL_E2NS
SY   HZGHC007331c005
DR   Horizon_Discovery; HZGHC007331c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14583; VPS11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS13A (-) 1
AC   CVCL_TX49
SY   HZGHC005443c011; VPS13A knockout cell line 197bp deletion; HAP1 VPS13A (-)
DR   cancercelllines; CVCL_TX49
DR   Horizon_Discovery; HZGHC005443c011
DR   Wikidata; Q54881069
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1908; VPS13A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS13A (-) 2
AC   CVCL_XV02
SY   HZGHC005443c002; VPS13A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_XV02
DR   Horizon_Discovery; HZGHC005443c002
DR   Wikidata; Q93977687
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1908; VPS13A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS13C (-)
AC   CVCL_TX50
SY   HZGHC005440c009; VPS13C knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TX50
DR   Horizon_Discovery; HZGHC005440c009
DR   Wikidata; Q54881070
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005440c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS26A (-) 1
AC   CVCL_TX51
SY   HZGHC000875c007; VPS26A knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TX51
DR   Horizon_Discovery; HZGHC000875c007
DR   Wikidata; Q54881071
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12711; VPS26A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS26A (-) 2
AC   CVCL_TX52
SY   HZGHC000875c011; VPS26A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TX52
DR   Horizon_Discovery; HZGHC000875c011
DR   Wikidata; Q54881072
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12711; VPS26A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS35 (-) 1
AC   CVCL_TX53
SY   HZGHC000862c001; VPS35 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX53
DR   Horizon_Discovery; HZGHC000862c001
DR   Wikidata; Q54881073
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13487; VPS35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000862c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS35 (-) 2
AC   CVCL_TX54
SY   HZGHC000862c008; VPS35 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TX54
DR   Horizon_Discovery; HZGHC000862c008
DR   Wikidata; Q54881074
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13487; VPS35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000862c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS35 (-) 3
AC   CVCL_TX55
SY   HZGHC000862c010; VPS35 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TX55
DR   Horizon_Discovery; HZGHC000862c010
DR   Wikidata; Q54881075
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13487; VPS35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000862c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS35 (-) 4
AC   CVCL_TX56
SY   HZGHC000863c010; VPS35 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX56
DR   Horizon_Discovery; HZGHC000863c010
DR   Wikidata; Q54881076
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13487; VPS35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000863c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS35 (-) 5
AC   CVCL_TX57
SY   HZGHC000863c012; VPS35 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TX57
DR   Horizon_Discovery; HZGHC000863c012
DR   Wikidata; Q54881077
RX   PubMed=38434631;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13487; VPS35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000863c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS36 (-)
AC   CVCL_TX58
SY   HZGHC001070c011; VPS36 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TX58
DR   Horizon_Discovery; HZGHC001070c011
DR   Wikidata; Q54881078
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20312; VPS36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS39 (-) 1
AC   CVCL_E2NT
SY   HZGHC007932c004
DR   Horizon_Discovery; HZGHC007932c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20593; VPS39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS39 (-) 2
AC   CVCL_E2NU
SY   HZGHC007932c010
DR   Horizon_Discovery; HZGHC007932c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20593; VPS39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS41 (-)
AC   CVCL_E2NV
SY   HZGHC007359c004
DR   Horizon_Discovery; HZGHC007359c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12713; VPS41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS4A (-) 1
AC   CVCL_TX59
SY   HZGHC004623c005; VPS4A knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TX59
DR   Horizon_Discovery; HZGHC004623c005
DR   Wikidata; Q54881079
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4A (-) 2
AC   CVCL_TX60
SY   HZGHC004623c007; VPS4A knockout cell line 143bp deletion
DR   cancercelllines; CVCL_TX60
DR   Horizon_Discovery; HZGHC004623c007
DR   Wikidata; Q54881080
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4A (-) 3
AC   CVCL_TX61
SY   HZGHC004624c001; VPS4A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TX61
DR   Horizon_Discovery; HZGHC004624c001
DR   Wikidata; Q54881081
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4A (-) 4
AC   CVCL_TX62
SY   HZGHC004624c003; VPS4A knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX62
DR   Horizon_Discovery; HZGHC004624c003
DR   Wikidata; Q54881082
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4A (-) 5
AC   CVCL_TX63
SY   HZGHC004668c001; VPS4A knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TX63
DR   Horizon_Discovery; HZGHC004668c001
DR   Wikidata; Q54881083
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4A (-) 6
AC   CVCL_TX64
SY   HZGHC004668c004; VPS4A knockout cell line 100bp deletion
DR   cancercelllines; CVCL_TX64
DR   Horizon_Discovery; HZGHC004668c004
DR   Wikidata; Q54881084
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4A (-) 7
AC   CVCL_TX65
SY   HZGHC004669c001; VPS4A knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TX65
DR   Horizon_Discovery; HZGHC004669c001
DR   Wikidata; Q54881086
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4A (-) 8
AC   CVCL_TX66
SY   HZGHC004669c010; VPS4A knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TX66
DR   Horizon_Discovery; HZGHC004669c010
DR   Wikidata; Q54881087
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13488; VPS4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS4B (-) 1
AC   CVCL_XV03
SY   HZGHC006869c004; HZGHC9525; VPS4B knockout cell line 2bp deletion in exon 5; HAP1 VPS4B (-)
DR   cancercelllines; CVCL_XV03
DR   Horizon_Discovery; HZGHC006869c004
DR   Wikidata; Q93977786
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10895; VPS4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 VPS4B (-) 2
AC   CVCL_E1NL
SY   HZGHC006869c011; VPS4B knockout cell line 47bp deletion
DR   Horizon_Discovery; HZGHC006869c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10895; VPS4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS4B (-) 3
AC   CVCL_E2NW
SY   HZGHC006869c005
DR   Horizon_Discovery; HZGHC006869c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10895; VPS4B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 VPS51 (-)
AC   CVCL_TX67
SY   HZGHC004878c010; VPS51 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX67
DR   Horizon_Discovery; HZGHC004878c010
DR   Wikidata; Q54881088
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1172; VPS51.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS52 (-) 1
AC   CVCL_TX68
SY   HZGHC004879c003; VPS52 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX68
DR   Horizon_Discovery; HZGHC004879c003
DR   Wikidata; Q54881089
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10518; VPS52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS52 (-) 2
AC   CVCL_TX69
SY   HZGHC004879c006; VPS52 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TX69
DR   Horizon_Discovery; HZGHC004879c006
DR   Wikidata; Q54881090
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10518; VPS52.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VPS54 (-) 1
AC   CVCL_TX70
SY   HZGHC000854c007; VPS54 knockout cell line 190bp insertion
DR   cancercelllines; CVCL_TX70
DR   Horizon_Discovery; HZGHC000854c007
DR   Wikidata; Q54881091
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18652; VPS54.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000854c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 VPS54 (-) 2
AC   CVCL_TX71
SY   HZGHC000854c012; VPS54 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TX71
DR   Horizon_Discovery; HZGHC000854c012
DR   Wikidata; Q54881092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18652; VPS54.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VRK1 (-) 1
AC   CVCL_TX72
SY   HZGHC000073c014; VRK1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TX72
DR   Horizon_Discovery; HZGHC000073c014
DR   Wikidata; Q54881093
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12718; VRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VRK1 (-) 2
AC   CVCL_TX73
SY   HZGHC000073c019; VRK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX73
DR   Horizon_Discovery; HZGHC000073c019
DR   Wikidata; Q54881094
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12718; VRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VRK1 (-) 3
AC   CVCL_TX74
SY   HZGHC000073c024; VRK1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TX74
DR   Horizon_Discovery; HZGHC000073c024
DR   Wikidata; Q54881097
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12718; VRK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VRK2 (-)
AC   CVCL_TX75
SY   HZGHC000403c006; VRK2 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TX75
DR   Horizon_Discovery; HZGHC000403c006
DR   Wikidata; Q54881098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12719; VRK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 VRK3 (-)
AC   CVCL_TX76
SY   HZGHC000189c011; VRK3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX76
DR   Horizon_Discovery; HZGHC000189c011
DR   Wikidata; Q54881100
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18996; VRK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WAS (-) 1
AC   CVCL_TX77
SY   HZGHC006633c012; WAS knockout cell line 1bp insertion; HAP1 WAS (-)
DR   cancercelllines; CVCL_TX77
DR   Horizon_Discovery; HZGHC006633c012
DR   Wikidata; Q54881101
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12731; WAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WAS (-) 2
AC   CVCL_XV04
SY   HZGHC006634c009; WAS knockout cell line 95bp deletion
DR   cancercelllines; CVCL_XV04
DR   Horizon_Discovery; HZGHC006634c009
DR   Wikidata; Q93977882
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12731; WAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASF1 (-) 1
AC   CVCL_TX78
SY   HZGHC003330c002; WASF1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TX78
DR   Horizon_Discovery; HZGHC003330c002
DR   Wikidata; Q54881102
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12732; WASF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASF1 (-) 2
AC   CVCL_TX79
SY   HZGHC003330c010; WASF1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TX79
DR   Horizon_Discovery; HZGHC003330c010
DR   Wikidata; Q54881103
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12732; WASF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASF2 (-)
AC   CVCL_TX80
SY   HZGHC003327c004; WASF2 knockout cell line 46bp deletion
DR   cancercelllines; CVCL_TX80
DR   Horizon_Discovery; HZGHC003327c004
DR   Wikidata; Q54881104
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12733; WASF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASF3 (-) 1
AC   CVCL_TX81
SY   HZGHC003325c004; WASF3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TX81
DR   Horizon_Discovery; HZGHC003325c004
DR   Wikidata; Q54881105
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12734; WASF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASF3 (-) 2
AC   CVCL_TX82
SY   HZGHC003325c005; WASF3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TX82
DR   Horizon_Discovery; HZGHC003325c005
DR   Wikidata; Q54881106
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12734; WASF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASL (-) 1
AC   CVCL_TX83
SY   HZGHC002632c003; WASL knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TX83
DR   Horizon_Discovery; HZGHC002632c003
DR   Wikidata; Q54881107
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12735; WASL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASL (-) 2
AC   CVCL_TX84
SY   HZGHC002632c011; WASL knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TX84
DR   Horizon_Discovery; HZGHC002632c011
DR   Wikidata; Q54881108
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12735; WASL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WASL (-) 3
AC   CVCL_TX85
SY   HZGHC002633c002; WASL knockout cell line 77bp insertion
DR   cancercelllines; CVCL_TX85
DR   Horizon_Discovery; HZGHC002633c002
DR   Wikidata; Q54881109
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12735; WASL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002633c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WDR24 (-) 1
AC   CVCL_TX86
SY   HZGHC001282c007; WDR24 knockout cell line 64bp insertion
DR   cancercelllines; CVCL_TX86
DR   Horizon_Discovery; HZGHC001282c007
DR   Wikidata; Q54881110
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20852; WDR24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001282c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WDR24 (-) 2
AC   CVCL_TX87
SY   HZGHC001282c011; WDR24 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TX87
DR   Horizon_Discovery; HZGHC001282c011
DR   Wikidata; Q54881111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20852; WDR24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR26 (-) 1
AC   CVCL_E2NX
SY   HZGHC007459c003
DR   Horizon_Discovery; HZGHC007459c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21208; WDR26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR26 (-) 2
AC   CVCL_E2NY
SY   HZGHC007459c005
DR   Horizon_Discovery; HZGHC007459c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21208; WDR26.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR37 (-) 1
AC   CVCL_TX88
SY   HZGHC004030c011; WDR37 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TX88
DR   Horizon_Discovery; HZGHC004030c011
DR   Wikidata; Q54881112
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31406; WDR37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR37 (-) 2
AC   CVCL_TX89
SY   HZGHC004030c004; WDR37 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TX89
DR   Horizon_Discovery; HZGHC004030c004
DR   Wikidata; Q54881113
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31406; WDR37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004030c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WDR37 (-) 3
AC   CVCL_TX90
SY   HZGHC003592c010; WDR37 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TX90
DR   Horizon_Discovery; HZGHC003592c010
DR   Wikidata; Q54881114
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31406; WDR37.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR41 (-) 1
AC   CVCL_E2NZ
SY   HZGHC007538c001
DR   Horizon_Discovery; HZGHC007538c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25601; WDR41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR41 (-) 2
AC   CVCL_E2P0
SY   HZGHC007538c009
DR   Horizon_Discovery; HZGHC007538c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25601; WDR41.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR45 (-) 1
AC   CVCL_XV05
SY   HZGHC007158c009; HZGHC11152; WDR45 knockout cell line 1bp insertion in exon 8; HAP1 WDR45 (-)
DR   cancercelllines; CVCL_XV05
DR   Horizon_Discovery; HZGHC007158c009
DR   Wikidata; Q93977993
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28912; WDR45.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC007158c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 WDR45 (-) 2
AC   CVCL_B5L6
SY   HZGHC007158c012; WDR45 knockout cell line 1bp insertion in exon 8
DR   cancercelllines; CVCL_B5L6
DR   Horizon_Discovery; HZGHC007158c012
DR   Wikidata; Q111733327
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28912; WDR45.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 WDR45B (-) 1
AC   CVCL_E2P1
SY   HZGHC007395c006
DR   Horizon_Discovery; HZGHC007395c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25072; WDR45B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR45B (-) 2
AC   CVCL_E2P2
SY   HZGHC007395c012
DR   Horizon_Discovery; HZGHC007395c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25072; WDR45B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR48 (-) 1
AC   CVCL_E2P3
SY   HZGHC008205c003
DR   Horizon_Discovery; HZGHC008205c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30914; WDR48.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR48 (-) 2
AC   CVCL_E2P4
SY   HZGHC008205c018
DR   Horizon_Discovery; HZGHC008205c018
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30914; WDR48.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WDR6 (-) 1
AC   CVCL_TX91
SY   HZGHC005694c001; WDR6 knockout cell line 4bp deletion; HAP1 WDR6 (-)
DR   cancercelllines; CVCL_TX91
DR   Horizon_Discovery; HZGHC005694c001
DR   Wikidata; Q54881115
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12758; WDR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WDR6 (-) 2
AC   CVCL_XV06
SY   HZGHC005694c006; WDR6 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XV06
DR   Horizon_Discovery; HZGHC005694c006
DR   Wikidata; Q93978003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12758; WDR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR6 (-) 3
AC   CVCL_XV07
SY   HZGHC005695c006; WDR6 knockout cell line 152bp insertion
DR   cancercelllines; CVCL_XV07
DR   Horizon_Discovery; HZGHC005695c006
DR   Wikidata; Q93978006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12758; WDR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005695c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WDR6 (-) 4
AC   CVCL_XV08
SY   HZGHC005695c010; WDR6 knockout cell line 73bp deletion
DR   cancercelllines; CVCL_XV08
DR   Horizon_Discovery; HZGHC005695c010
DR   Wikidata; Q93978009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12758; WDR6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR73 (-)
AC   CVCL_TX92
SY   HZGHC001033c001; WDR73 knockout cell line 10bp insertion
DR   cancercelllines; CVCL_TX92
DR   Horizon_Discovery; HZGHC001033c001
DR   Wikidata; Q54881116
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25928; WDR73.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001033c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WDR76 (-) 1
AC   CVCL_TX93
SY   HZGHC004377c007; WDR76 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TX93
DR   Horizon_Discovery; HZGHC004377c007
DR   Wikidata; Q54881117
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25773; WDR76.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR76 (-) 2
AC   CVCL_TX94
SY   HZGHC004377c011; WDR76 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TX94
DR   Horizon_Discovery; HZGHC004377c011
DR   Wikidata; Q54881118
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25773; WDR76.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR81 (-)
AC   CVCL_TX95
SY   HZGHC006404c010; WDR81 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TX95
DR   Horizon_Discovery; HZGHC006404c010
DR   Wikidata; Q54881119
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26600; WDR81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WDR91 (-) 1
AC   CVCL_TX96
SY   HZGHC006518c005; WDR91 knockout cell line 13bp deletion; HAP1 WDR91 (-)
DR   cancercelllines; CVCL_TX96
DR   Horizon_Discovery; HZGHC006518c005
DR   Wikidata; Q54881120
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24997; WDR91.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WDR91 (-) 2
AC   CVCL_XV09
SY   HZGHC006518c007; WDR91 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XV09
DR   Horizon_Discovery; HZGHC006518c007
DR   Wikidata; Q93978052
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24997; WDR91.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WHAMM (-) 1
AC   CVCL_TX97
SY   HZGHC001030c006; WHAMM knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TX97
DR   Horizon_Discovery; HZGHC001030c006
DR   Wikidata; Q54881121
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30493; WHAMM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001030c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WHAMM (-) 2
AC   CVCL_TX98
SY   HZGHC001030c008; WHAMM knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TX98
DR   Horizon_Discovery; HZGHC001030c008
DR   Wikidata; Q54881122
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30493; WHAMM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001030c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WHAMM (-) 3
AC   CVCL_TX99
SY   HZGHC001060c001; WHAMM knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TX99
DR   Horizon_Discovery; HZGHC001060c001
DR   Wikidata; Q54881123
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30493; WHAMM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001060c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WHAMM (-) 4
AC   CVCL_TY00
SY   HZGHC001060c006; WHAMM knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY00
DR   Horizon_Discovery; HZGHC001060c006
DR   Wikidata; Q54881124
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30493; WHAMM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001060c006; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WHSC1 (-) 1
AC   CVCL_TY01
SY   HZGHC001116c010; HZGHC001116c001; WHSC1 knockout cell line 1bp insertion; HAP1 WHSC1 (-)
DR   cancercelllines; CVCL_TY01
DR   Horizon_Discovery; HZGHC001116c010
DR   PRIDE; PXD010335
DR   Wikidata; Q54881125
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001116c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 WHSC1 (-) 2
AC   CVCL_XV10
SY   HZGHC001116c002; WHSC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XV10
DR   Horizon_Discovery; HZGHC001116c002
DR   Wikidata; Q93978098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001116c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WHSC1 (-) 3
AC   CVCL_XV12
SY   HZGHC001116c011; WHSC1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XV12
DR   Horizon_Discovery; HZGHC001116c011
DR   Wikidata; Q93978102
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001116c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WHSC1L1 (-) 1
AC   CVCL_TY02
SY   HZGHC002945c011; WHSC1L1 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TY02
DR   Horizon_Discovery; HZGHC002945c011
DR   Wikidata; Q54881126
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12767; NSD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002945c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 WHSC1L1 (-) 2
AC   CVCL_TY03
SY   HZGHC002945c012; WHSC1L1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TY03
DR   Horizon_Discovery; HZGHC002945c012
DR   Wikidata; Q54881127
RX   PubMed=31659326;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12767; NSD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WIPF1 (-) 1
AC   CVCL_E2P5
SY   HZGHC007346c016
DR   Horizon_Discovery; HZGHC007346c016
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12736; WIPF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WIPF1 (-) 2
AC   CVCL_E2P6
SY   HZGHC007346c019
DR   Horizon_Discovery; HZGHC007346c019
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12736; WIPF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WIPI2 (-) 1
AC   CVCL_TY04
SY   HZGHC006335c001; WIPI2 knockout cell line 8bp deletion; HAP1 WIPI2 (-)
DR   cancercelllines; CVCL_TY04
DR   Horizon_Discovery; HZGHC006335c001
DR   Wikidata; Q54881128
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32225; WIPI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WIPI2 (-) 2
AC   CVCL_XV13
SY   HZGHC006335c002; WIPI2 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XV13
DR   Horizon_Discovery; HZGHC006335c002
DR   Wikidata; Q93978128
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32225; WIPI2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WIZ (-)
AC   CVCL_E2P7
SY   HZGHC007782c006
DR   Horizon_Discovery; HZGHC007782c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30917; WIZ.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WLS (-) 1
AC   CVCL_E2P8
SY   HZGHC007368c005
DR   Horizon_Discovery; HZGHC007368c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30238; WLS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WLS (-) 2
AC   CVCL_E2P9
SY   HZGHC007368c008
DR   Horizon_Discovery; HZGHC007368c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30238; WLS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WNK1 (-) 1
AC   CVCL_TY05
SY   HZGHC000802c003; WNK1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY05
DR   Horizon_Discovery; HZGHC000802c003
DR   Wikidata; Q54881130
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14540; WNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK1 (-) 2
AC   CVCL_TY06
SY   HZGHC000802c008; WNK1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY06
DR   Horizon_Discovery; HZGHC000802c008
DR   Wikidata; Q54881131
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14540; WNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK1 (-) 3
AC   CVCL_TY07
SY   HZGHC002696c009; WNK1 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TY07
DR   Horizon_Discovery; HZGHC002696c009
DR   Wikidata; Q54881132
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14540; WNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK1 (-) 4
AC   CVCL_TY08
SY   HZGHC002696c011; WNK1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY08
DR   Horizon_Discovery; HZGHC002696c011
DR   Wikidata; Q54881133
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14540; WNK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK2 (-) 1
AC   CVCL_TY09
SY   HZGHC000622c011; WNK2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY09
DR   Horizon_Discovery; HZGHC000622c011
DR   Wikidata; Q54881134
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14542; WNK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000622c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WNK2 (-) 2
AC   CVCL_TY10
SY   HZGHC000622c012; WNK2 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY10
DR   Horizon_Discovery; HZGHC000622c012
DR   Wikidata; Q54881135
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14542; WNK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000622c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WNK3 (-) 1
AC   CVCL_TY11
SY   HZGHC000038c013; WNK3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY11
DR   Horizon_Discovery; HZGHC000038c013
DR   Wikidata; Q54881136
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14543; WNK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK3 (-) 2
AC   CVCL_TY12
SY   HZGHC000038c024; WNK3 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TY12
DR   Horizon_Discovery; HZGHC000038c024
DR   Wikidata; Q54881137
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14543; WNK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK3 (-) 3
AC   CVCL_TY13
SY   HZGHC002701c001; WNK3 knockout cell line 20bp insertion
DR   cancercelllines; CVCL_TY13
DR   Horizon_Discovery; HZGHC002701c001
DR   Wikidata; Q54881138
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14543; WNK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002701c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WNK3 (-) 4
AC   CVCL_TY14
SY   HZGHC002701c007; WNK3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TY14
DR   Horizon_Discovery; HZGHC002701c007
DR   Wikidata; Q54881142
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14543; WNK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK3 (-) 5
AC   CVCL_TY15
SY   HZGHC002702c002; WNK3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TY15
DR   Horizon_Discovery; HZGHC002702c002
DR   Wikidata; Q54881143
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14543; WNK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK4 (-) 1
AC   CVCL_TY16
SY   HZGHC003517c004; WNK4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY16
DR   Horizon_Discovery; HZGHC003517c004
DR   Wikidata; Q54881145
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14544; WNK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WNK4 (-) 2
AC   CVCL_TY17
SY   HZGHC003517c010; WNK4 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TY17
DR   Horizon_Discovery; HZGHC003517c010
DR   Wikidata; Q54881147
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14544; WNK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WRN (-) 1
AC   CVCL_TY18
SY   HZGHC000432c001; WRN knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TY18
DR   Horizon_Discovery; HZGHC000432c001
DR   Wikidata; Q54881148
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12791; WRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000432c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WRN (-) 2
AC   CVCL_TY19
SY   HZGHC000432c002; WRN knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY19
DR   Horizon_Discovery; HZGHC000432c002
DR   Wikidata; Q54881149
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12791; WRN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000432c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WT1 (-) 1
AC   CVCL_TY20
SY   HZGHC000126c009; WT1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY20
DR   Horizon_Discovery; HZGHC000126c009
DR   Wikidata; Q54881150
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WT1 (-) 2
AC   CVCL_TY21
SY   HZGHC000126c010; WT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY21
DR   Horizon_Discovery; HZGHC000126c010
DR   Wikidata; Q54881151
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WT1 (-) 3
AC   CVCL_TY22
SY   HZGHC000126c020; WT1 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY22
DR   Horizon_Discovery; HZGHC000126c020
DR   Wikidata; Q54881152
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WTAP (-) 1
AC   CVCL_TY23
SY   HZGHC003593c002; WTAP knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TY23
DR   Horizon_Discovery; HZGHC003593c002
DR   Wikidata; Q54881153
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16846; WTAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WTAP (-) 2
AC   CVCL_TY24
SY   HZGHC003593c005; WTAP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY24
DR   Horizon_Discovery; HZGHC003593c005
DR   Wikidata; Q54881154
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16846; WTAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WTAP (-) 3
AC   CVCL_TY25
SY   HZGHC003593c008; WTAP knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY25
DR   Horizon_Discovery; HZGHC003593c008
DR   Wikidata; Q54881155
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16846; WTAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WWOX (-) 1
AC   CVCL_TY26
SY   HZGHC006024c001; WWOX knockout cell line 1bp insertion; HAP1 WWOX (-)
DR   cancercelllines; CVCL_TY26
DR   Horizon_Discovery; HZGHC006024c001
DR   Wikidata; Q54881156
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12799; WWOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006024c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 WWOX (-) 2
AC   CVCL_XV14
SY   HZGHC006024c010; WWOX knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XV14
DR   Horizon_Discovery; HZGHC006024c010
DR   Wikidata; Q93978319
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12799; WWOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006024c010; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WWOX (-) 3
AC   CVCL_E2PA
SY   HZGHC008138c005
DR   Horizon_Discovery; HZGHC008138c005
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12799; WWOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WWOX (-) 4
AC   CVCL_E2PB
SY   HZGHC008138c008
DR   Horizon_Discovery; HZGHC008138c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12799; WWOX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 WWP1 (-) 1
AC   CVCL_TY27
SY   HZGHC003468c009; WWP1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TY27
DR   Horizon_Discovery; HZGHC003468c009
DR   Wikidata; Q54881158
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17004; WWP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WWP1 (-) 2
AC   CVCL_TY28
SY   HZGHC003468c011; WWP1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TY28
DR   Horizon_Discovery; HZGHC003468c011
DR   Wikidata; Q54881159
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17004; WWP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 WWTR1 (-) 1
AC   CVCL_TY29
SY   HZGHC006370c010; WWTR1 knockout cell line 14bp deletion; HAP1 WWTR1 (-)
DR   cancercelllines; CVCL_TY29
DR   Horizon_Discovery; HZGHC006370c010
DR   Wikidata; Q54881160
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 WWTR1 (-) 2
AC   CVCL_XV15
SY   HZGHC006370c004; WWTR1 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_XV15
DR   Horizon_Discovery; HZGHC006370c004
DR   Wikidata; Q93978393
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 XBP1 (-) 1
AC   CVCL_TY30
SY   HZGHC001364c011; XBP1 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TY30
DR   Horizon_Discovery; HZGHC001364c011
DR   Wikidata; Q54881161
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12801; XBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 XBP1 (-) 2
AC   CVCL_TY31
SY   HZGHC001364c012; XBP1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY31
DR   Horizon_Discovery; HZGHC001364c012
DR   Wikidata; Q54881162
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12801; XBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 XIAP (-) 1
AC   CVCL_E2PC
SY   HZGHC008092c010
DR   Horizon_Discovery; HZGHC008092c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 XIAP (-) 2
AC   CVCL_E2PD
SY   HZGHC008093c009
DR   Horizon_Discovery; HZGHC008093c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 XKR8 (-) 1
AC   CVCL_TY32
SY   HZGHC005916c007; XKR8 knockout cell line 2bp insertion in exon 2; HAP1 XKR8 (-)
DR   cancercelllines; CVCL_TY32
DR   Horizon_Discovery; HZGHC005916c007
DR   Wikidata; Q54881163
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25508; XKR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 XKR8 (-) 2
AC   CVCL_XV16
SY   HZGHC005917c010; XKR8 knockout cell line 1bp deletion in exon 2
DR   cancercelllines; CVCL_XV16
DR   Horizon_Discovery; HZGHC005917c010
DR   Wikidata; Q93978424
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25508; XKR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 XPA (-) 1
AC   CVCL_TY33
SY   HZGHC000433c001; XPA knockout cell line 4bp deletion in exon 2
DR   cancercelllines; CVCL_TY33
DR   Horizon_Discovery; HZGHC000433c001
DR   Wikidata; Q54881164
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12814; XPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 XPA (-) 2
AC   CVCL_TY34
SY   HZGHC000433c011; XPA knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY34
DR   Horizon_Discovery; HZGHC000433c011
DR   Wikidata; Q54881165
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12814; XPA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000433c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 XPC (-) 1
AC   CVCL_TY35
SY   HZGHC019996c001; XPC knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY35
DR   Horizon_Discovery; HZGHC019996c001
DR   Wikidata; Q54881167
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12816; XPC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 XPC (-) 2
AC   CVCL_TY36
SY   HZGHC019996c007; XPC knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TY36
DR   Horizon_Discovery; HZGHC019996c007
DR   Wikidata; Q54881168
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12816; XPC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC019996c007; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 XPC (-) 3
AC   CVCL_TY37
SY   HZGHC019996c016; XPC knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY37
DR   Horizon_Discovery; HZGHC019996c016
DR   Wikidata; Q54881169
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12816; XPC.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC019996c016; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 XPR1 (-) 1
AC   CVCL_TY38
SY   HZGHC004238c006; XPR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY38
DR   Horizon_Discovery; HZGHC004238c006
DR   Wikidata; Q54881170
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12827; XPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 XPR1 (-) 2
AC   CVCL_TY39
SY   HZGHC004238c008; XPR1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY39
DR   Horizon_Discovery; HZGHC004238c008
DR   Wikidata; Q54881171
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12827; XPR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 XRCC4 (-) 1
AC   CVCL_TY40
SY   HZGHC000428c019; XRCC4 knockout cell line 8bp deletion in exon 2; HAP1 XRCC4 (-)
DR   cancercelllines; CVCL_TY40
DR   Horizon_Discovery; HZGHC000428c019
DR   Wikidata; Q54881172
RX   PubMed=31141305;
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12831; XRCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000428c019; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 XRCC4 (-) 2
AC   CVCL_DX07
SY   HZGHC008123c011; XRCC4 knockout cell line 1bp insertion in exon 5
DR   Horizon_Discovery; HZGHC008123c011
DR   Wikidata; Q127381110
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12831; XRCC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   HAP1 XYLT2 (-)
AC   CVCL_XV17
SY   HZGHC007108c008; HZGHC64132; XYLT2 knockout cell line 1bp insertion in exon 2
DR   cancercelllines; CVCL_XV17
DR   Horizon_Discovery; HZGHC007108c008
DR   Wikidata; Q93978475
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15517; XYLT2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YAP1 (-) 1
AC   CVCL_TY41
SY   HZGHC005066c003; YAP1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY41
DR   Horizon_Discovery; HZGHC005066c003
DR   Wikidata; Q54881173
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 YAP1 (-) 2
AC   CVCL_TY42
SY   HZGHC005066c005; YAP1 knockout cell line 35bp deletion
DR   cancercelllines; CVCL_TY42
DR   Horizon_Discovery; HZGHC005066c005
DR   Wikidata; Q54881174
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 YBEY (-) 1
AC   CVCL_TY43
SY   HZGHC002765c014; YBEY knockout cell line 31bp insertion
DR   cancercelllines; CVCL_TY43
DR   Horizon_Discovery; HZGHC002765c014
DR   Wikidata; Q54881175
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1299; YBEY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002765c014; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YBEY (-) 2
AC   CVCL_TY44
SY   HZGHC002765c022; YBEY knockout cell line 31bp insertion
DR   cancercelllines; CVCL_TY44
DR   Horizon_Discovery; HZGHC002765c022
DR   Wikidata; Q54881176
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1299; YBEY.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002765c022; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YES1 (-) 1
AC   CVCL_TY45
SY   HZGHC022696c001; YES1 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TY45
DR   Horizon_Discovery; HZGHC022696c001
DR   Wikidata; Q54881177
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12841; YES1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC022696c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YES1 (-) 2
AC   CVCL_TY46
SY   HZGHC022696c013; YES1 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TY46
DR   Horizon_Discovery; HZGHC022696c013
DR   Wikidata; Q54881179
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12841; YES1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC022696c013; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YTHDC2 (-)
AC   CVCL_XV18
SY   HZGHC007080c010; HZGHC64848; YTHDC2 knockout cell line 1bp deletion in exon 6
DR   cancercelllines; CVCL_XV18
DR   Horizon_Discovery; HZGHC007080c010
DR   Wikidata; Q93978522
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24721; YTHDC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YTHDF1 (-) 1
AC   CVCL_XV19
SY   HZGHC007002c004; HZGHC54915; YTHDF1 knockout cell line 22bp deletion in exon 4; HAP1 YTHDF1 (-)
DR   cancercelllines; CVCL_XV19
DR   Horizon_Discovery; HZGHC007002c004
DR   Wikidata; Q93978526
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YTHDF1 (-) 2
AC   CVCL_B5L7
SY   HZGHC007002c007; YTHDF1 knockout cell line 1bp deletion in exon 4
DR   cancercelllines; CVCL_B5L7
DR   Horizon_Discovery; HZGHC007002c007
DR   Wikidata; Q111733328
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 YTHDF1 (-) 3
AC   CVCL_B5L8
SY   HZGHC007002c010; YTHDF1 knockout cell line 14bp deletion in exon 4
DR   cancercelllines; CVCL_B5L8
DR   Horizon_Discovery; HZGHC007002c010
DR   Wikidata; Q111733329
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HAP1 YTHDF2 (-) 1
AC   CVCL_TY47
SY   HZGHC006677c010; YTHDF2 knockout cell line 130bp deletion; HAP1 YTHDF2 (-)
DR   cancercelllines; CVCL_TY47
DR   Horizon_Discovery; HZGHC006677c010
DR   Wikidata; Q54881180
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31675; YTHDF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 YTHDF2 (-) 2
AC   CVCL_XV20
SY   HZGHC006678c001; YTHDF2 knockout cell line 140bp deletion
DR   cancercelllines; CVCL_XV20
DR   Horizon_Discovery; HZGHC006678c001
DR   Wikidata; Q93978537
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31675; YTHDF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 YTHDF3 (-) 1
AC   CVCL_XV21
SY   HZGHC007005c002; HZGHC253943; YTHDF3 knockout cell line 1bp insertion in exon 4; HAP1 YTHDF3 (-)
DR   cancercelllines; CVCL_XV21
DR   Horizon_Discovery; HZGHC007005c002
DR   Wikidata; Q93978541
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26465; YTHDF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 YTHDF3 (-) 2
AC   CVCL_E2PE
SY   HZGHC007005c012; YTHDF3 knockout cell line 1bp insertion in exon 4
DR   Horizon_Discovery; HZGHC007005c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26465; YTHDF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZADH2 (-) 1
AC   CVCL_TY48
SY   HZGHC005800c001; ZADH2 knockout cell line 232bp deletion; HAP1 ZADH2 (-)
DR   cancercelllines; CVCL_TY48
DR   Horizon_Discovery; HZGHC005800c001
DR   Wikidata; Q54881181
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28697; PTGR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC005800c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   HAP1 ZADH2 (-) 2
AC   CVCL_XV22
SY   HZGHC005800c009; ZADH2 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XV22
DR   Horizon_Discovery; HZGHC005800c009
DR   Wikidata; Q93978551
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28697; PTGR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZADH2 (-) 3
AC   CVCL_XV23
SY   HZGHC005801c007; ZADH2 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_XV23
DR   Horizon_Discovery; HZGHC005801c007
DR   Wikidata; Q93978555
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28697; PTGR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZADH2 (-) 4
AC   CVCL_XV24
SY   HZGHC005801c009; ZADH2 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_XV24
DR   Horizon_Discovery; HZGHC005801c009
DR   Wikidata; Q93978558
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28697; PTGR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZAK (-) 1
AC   CVCL_TY49
SY   HZGHC000039c001; ZAK knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY49
DR   Horizon_Discovery; HZGHC000039c001
DR   Wikidata; Q54881182
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17797; MAP3K20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZAK (-) 2
AC   CVCL_TY50
SY   HZGHC000039c003; ZAK knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TY50
DR   Horizon_Discovery; HZGHC000039c003
DR   Wikidata; Q54881183
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17797; MAP3K20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZBTB1 (-)
AC   CVCL_C7Z5
SY   HZGHC007634c005; ZBTB1 knockout cell line 13bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007634c005
DR   Wikidata; Q123031483
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20259; ZBTB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ZBTB24 (-) 1
AC   CVCL_TY51
SY   HZGHC003997c003; ZBTB24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY51
DR   Horizon_Discovery; HZGHC003997c003
DR   Wikidata; Q54881184
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21143; ZBTB24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZBTB24 (-) 2
AC   CVCL_TY52
SY   HZGHC003997c010; ZBTB24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY52
DR   Horizon_Discovery; HZGHC003997c010
DR   Wikidata; Q54881185
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21143; ZBTB24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZBTB24 (-) 3
AC   CVCL_TY53
SY   HZGHC003997c011; ZBTB24 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY53
DR   Horizon_Discovery; HZGHC003997c011
DR   Wikidata; Q54881186
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21143; ZBTB24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZBTB33 (-) 1
AC   CVCL_TY54
SY   HZGHC000918c007; ZBTB33 knockout cell line 46bp deletion
DR   cancercelllines; CVCL_TY54
DR   Horizon_Discovery; HZGHC000918c007
DR   Wikidata; Q54881190
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16682; ZBTB33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZBTB33 (-) 2
AC   CVCL_TY55
SY   HZGHC000918c008; ZBTB33 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TY55
DR   Horizon_Discovery; HZGHC000918c008
DR   Wikidata; Q54881191
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16682; ZBTB33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZBTB7A (-) 1
AC   CVCL_C7Z6
SY   HZGHC008017c007; ZBTB7A knockout cell line 1bp insertion in exon 2
DR   Horizon_Discovery; HZGHC008017c007
DR   Wikidata; Q123031484
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18078; ZBTB7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ZBTB7A (-) 2
AC   CVCL_C7Z7
SY   HZGHC008017c010; ZBTB7A knockout cell line 20bp deletion in exon 2
DR   Horizon_Discovery; HZGHC008017c010
DR   Wikidata; Q123031486
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18078; ZBTB7A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ZC3H12A (-) 1
AC   CVCL_TY56
SY   HZGHC006348c002; ZC3H12A knockout cell line 16bp deletion; HAP1 ZC3H12A (-)
DR   cancercelllines; CVCL_TY56
DR   Horizon_Discovery; HZGHC006348c002
DR   Wikidata; Q54881193
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26259; ZC3H12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZC3H12A (-) 2
AC   CVCL_XV25
SY   HZGHC006348c006; ZC3H12A knockout cell line 1bp deletion
DR   cancercelllines; CVCL_XV25
DR   Horizon_Discovery; HZGHC006348c006
DR   Wikidata; Q93978628
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26259; ZC3H12A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZC3H12B (-) 1
AC   CVCL_E2PF
SY   HZGHC007320c010
DR   Horizon_Discovery; HZGHC007320c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17407; ZC3H12B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZC3H12B (-) 2
AC   CVCL_E2PG
SY   HZGHC007320c011
DR   Horizon_Discovery; HZGHC007320c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17407; ZC3H12B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZC3H12B (-) 3
AC   CVCL_E2PH
SY   HZGHC007321c012
DR   Horizon_Discovery; HZGHC007321c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17407; ZC3H12B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZC3H12C (-) 1
AC   CVCL_E2PI
SY   HZGHC007322c011
DR   Horizon_Discovery; HZGHC007322c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29362; ZC3H12C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZC3H12C (-) 2
AC   CVCL_E2PJ
SY   HZGHC007323c003
DR   Horizon_Discovery; HZGHC007323c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29362; ZC3H12C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZC3H12D (-) 1
AC   CVCL_E2PK
SY   HZGHC007800c010
DR   Horizon_Discovery; HZGHC007800c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21175; ZC3H12D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZC3H12D (-) 2
AC   CVCL_E2PL
SY   HZGHC007800c011
DR   Horizon_Discovery; HZGHC007800c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21175; ZC3H12D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZCCHC4 (-) 1
AC   CVCL_TY57
SY   HZGHC004252c007; ZCCHC4 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TY57
DR   Horizon_Discovery; HZGHC004252c007
DR   Wikidata; Q54881194
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22917; ZCCHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZCCHC4 (-) 2
AC   CVCL_TY58
SY   HZGHC004252c009; ZCCHC4 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY58
DR   Horizon_Discovery; HZGHC004252c009
DR   Wikidata; Q54881195
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22917; ZCCHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZCCHC4 (-) 3
AC   CVCL_TY59
SY   HZGHC004253c004; ZCCHC4 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TY59
DR   Horizon_Discovery; HZGHC004253c004
DR   Wikidata; Q54881196
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22917; ZCCHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZCCHC4 (-) 4
AC   CVCL_TY60
SY   HZGHC004253c012; ZCCHC4 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TY60
DR   Horizon_Discovery; HZGHC004253c012
DR   Wikidata; Q54881197
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22917; ZCCHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZCCHC8 (-)
AC   CVCL_TY61
SY   HZGHC005158c012; ZCCHC8 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY61
DR   Horizon_Discovery; HZGHC005158c012
DR   Wikidata; Q54881198
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25265; ZCCHC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC1 (-)
AC   CVCL_TY62
SY   HZGHC001791c012; ZDHHC1 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY62
DR   Horizon_Discovery; HZGHC001791c012
DR   Wikidata; Q54881199
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17916; ZDHHC1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC11 (-) 1
AC   CVCL_TY63
SY   HZGHC002688c003; ZDHHC11 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TY63
DR   Horizon_Discovery; HZGHC002688c003
DR   Wikidata; Q54881200
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19158; ZDHHC11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC11 (-) 2
AC   CVCL_TY64
SY   HZGHC002688c008; ZDHHC11 knockout cell line 97bp insertion
DR   cancercelllines; CVCL_TY64
DR   Horizon_Discovery; HZGHC002688c008
DR   Wikidata; Q54881201
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19158; ZDHHC11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002688c008; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZDHHC12 (-) 1
AC   CVCL_TY65
SY   HZGHC002445c011; ZDHHC12 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY65
DR   Horizon_Discovery; HZGHC002445c011
DR   Wikidata; Q54881202
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19159; ZDHHC12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC002445c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZDHHC12 (-) 2
AC   CVCL_TY66
SY   HZGHC002445c009; ZDHHC12 knockout cell line 25bp deletion
DR   cancercelllines; CVCL_TY66
DR   Horizon_Discovery; HZGHC002445c009
DR   Wikidata; Q54881204
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19159; ZDHHC12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC12 (-) 3
AC   CVCL_TY67
SY   HZGHC002445c010; ZDHHC12 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY67
DR   Horizon_Discovery; HZGHC002445c010
DR   Wikidata; Q54881205
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19159; ZDHHC12.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC13 (-) 1
AC   CVCL_TY68
SY   HZGHC002447c003; ZDHHC13 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY68
DR   Horizon_Discovery; HZGHC002447c003
DR   Wikidata; Q54881206
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18413; ZDHHC13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC13 (-) 2
AC   CVCL_TY69
SY   HZGHC002447c011; ZDHHC13 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TY69
DR   Horizon_Discovery; HZGHC002447c011
DR   Wikidata; Q54881207
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18413; ZDHHC13.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC14 (-) 1
AC   CVCL_TY70
SY   HZGHC002450c003; ZDHHC14 knockout cell line 7bp deletion in exon 2
DR   cancercelllines; CVCL_TY70
DR   Horizon_Discovery; HZGHC002450c003
DR   Wikidata; Q54881208
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20341; ZDHHC14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZDHHC14 (-) 2
AC   CVCL_TY71
SY   HZGHC002450c006; ZDHHC14 knockout cell line 10bp deletion in exon 2
DR   cancercelllines; CVCL_TY71
DR   Horizon_Discovery; HZGHC002450c006
DR   Wikidata; Q54881209
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20341; ZDHHC14.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZDHHC15 (-)
AC   CVCL_TY72
SY   HZGHC002452c008; ZDHHC15 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY72
DR   Horizon_Discovery; HZGHC002452c008
DR   Wikidata; Q54881210
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20342; ZDHHC15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC16 (-) 1
AC   CVCL_TY73
SY   HZGHC001305c009; ZDHHC16 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TY73
DR   Horizon_Discovery; HZGHC001305c009
DR   Wikidata; Q54881211
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20714; ZDHHC16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC16 (-) 2
AC   CVCL_TY74
SY   HZGHC001305c011; ZDHHC16 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY74
DR   Horizon_Discovery; HZGHC001305c011
DR   Wikidata; Q54881212
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20714; ZDHHC16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC17 (-) 1
AC   CVCL_TY75
SY   HZGHC002690c007; ZDHHC17 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY75
DR   Horizon_Discovery; HZGHC002690c007
DR   Wikidata; Q54881213
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18412; ZDHHC17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC17 (-) 2
AC   CVCL_TY76
SY   HZGHC002691c003; ZDHHC17 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TY76
DR   Horizon_Discovery; HZGHC002691c003
DR   Wikidata; Q54881214
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18412; ZDHHC17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC17 (-) 3
AC   CVCL_TY77
SY   HZGHC002691c004; ZDHHC17 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TY77
DR   Horizon_Discovery; HZGHC002691c004
DR   Wikidata; Q54881216
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18412; ZDHHC17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC18 (-) 1
AC   CVCL_TY78
SY   HZGHC001308c011; ZDHHC18 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY78
DR   Horizon_Discovery; HZGHC001308c011
DR   Wikidata; Q54881217
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20712; ZDHHC18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC18 (-) 2
AC   CVCL_TY79
SY   HZGHC001308c012; ZDHHC18 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TY79
DR   Horizon_Discovery; HZGHC001308c012
DR   Wikidata; Q54881218
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20712; ZDHHC18.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC19 (-) 1
AC   CVCL_TY80
SY   HZGHC002692c004; ZDHHC19 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TY80
DR   Horizon_Discovery; HZGHC002692c004
DR   Wikidata; Q54881219
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20713; ZDHHC19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC19 (-) 2
AC   CVCL_TY81
SY   HZGHC002692c006; ZDHHC19 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TY81
DR   Horizon_Discovery; HZGHC002692c006
DR   Wikidata; Q54881220
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20713; ZDHHC19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC19 (-) 3
AC   CVCL_TY82
SY   HZGHC002693c008; ZDHHC19 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY82
DR   Horizon_Discovery; HZGHC002693c008
DR   Wikidata; Q54881221
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20713; ZDHHC19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC2 (-) 1
AC   CVCL_TY83
SY   HZGHC000584c001; ZDHHC2 knockout cell line 181bp insertion
DR   cancercelllines; CVCL_TY83
DR   Horizon_Discovery; HZGHC000584c001
DR   Wikidata; Q54881222
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18469; ZDHHC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000584c001; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZDHHC2 (-) 2
AC   CVCL_TY84
SY   HZGHC000584c003; ZDHHC2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY84
DR   Horizon_Discovery; HZGHC000584c003
DR   Wikidata; Q54881223
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18469; ZDHHC2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC20 (-) 1
AC   CVCL_TY85
SY   HZGHC002695c001; ZDHHC20 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY85
DR   Horizon_Discovery; HZGHC002695c001
DR   Wikidata; Q54881224
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20749; ZDHHC20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC20 (-) 2
AC   CVCL_TY86
SY   HZGHC002695c010; ZDHHC20 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY86
DR   Horizon_Discovery; HZGHC002695c010
DR   Wikidata; Q54881225
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20749; ZDHHC20.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC21 (-)
AC   CVCL_TY87
SY   HZGHC001303c002; ZDHHC21 knockout cell line 4bp deletion in exon 5
DR   cancercelllines; CVCL_TY87
DR   Horizon_Discovery; HZGHC001303c002
DR   Wikidata; Q54881226
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20750; ZDHHC21.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZDHHC22 (-) 1
AC   CVCL_TY88
SY   HZGHC001803c011; ZDHHC22 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TY88
DR   Horizon_Discovery; HZGHC001803c011
DR   Wikidata; Q54881228
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20106; ZDHHC22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC22 (-) 2
AC   CVCL_TY89
SY   HZGHC001803c001; ZDHHC22 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TY89
DR   Horizon_Discovery; HZGHC001803c001
DR   Wikidata; Q54881229
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20106; ZDHHC22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC23 (-) 1
AC   CVCL_TY90
SY   HZGHC001805c002; ZDHHC23 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TY90
DR   Horizon_Discovery; HZGHC001805c002
DR   Wikidata; Q54881230
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28654; ZDHHC23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC23 (-) 2
AC   CVCL_TY91
SY   HZGHC001805c012; ZDHHC23 knockout cell line 19bp deletion
DR   cancercelllines; CVCL_TY91
DR   Horizon_Discovery; HZGHC001805c012
DR   Wikidata; Q54881231
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28654; ZDHHC23.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC24 (-) 1
AC   CVCL_TY92
SY   HZGHC001806c010; ZDHHC24 knockout cell line 13bp deletion
DR   cancercelllines; CVCL_TY92
DR   Horizon_Discovery; HZGHC001806c010
DR   Wikidata; Q54881232
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27387; ZDHHC24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC24 (-) 2
AC   CVCL_TY93
SY   HZGHC001806c011; ZDHHC24 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TY93
DR   Horizon_Discovery; HZGHC001806c011
DR   Wikidata; Q54881233
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27387; ZDHHC24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC3 (-) 1
AC   CVCL_TY94
SY   HZGHC001792c010; ZDHHC3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TY94
DR   Horizon_Discovery; HZGHC001792c010
DR   Wikidata; Q54881238
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18470; ZDHHC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC3 (-) 2
AC   CVCL_TY95
SY   HZGHC001792c012; ZDHHC3 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TY95
DR   Horizon_Discovery; HZGHC001792c012
DR   Wikidata; Q54881239
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18470; ZDHHC3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC4 (-) 1
AC   CVCL_TY96
SY   HZGHC001794c001; ZDHHC4 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TY96
DR   Horizon_Discovery; HZGHC001794c001
DR   Wikidata; Q54881241
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18471; ZDHHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC4 (-) 2
AC   CVCL_TY97
SY   HZGHC001794c007; ZDHHC4 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TY97
DR   Horizon_Discovery; HZGHC001794c007
DR   Wikidata; Q54881242
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18471; ZDHHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC4 (-) 3
AC   CVCL_TY98
SY   HZGHC001795c010; ZDHHC4 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TY98
DR   Horizon_Discovery; HZGHC001795c010
DR   Wikidata; Q54881243
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18471; ZDHHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC4 (-) 4
AC   CVCL_TY99
SY   HZGHC001795c011; ZDHHC4 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TY99
DR   Horizon_Discovery; HZGHC001795c011
DR   Wikidata; Q54881244
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18471; ZDHHC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC5 (-) 1
AC   CVCL_TZ00
SY   HZGHC000589c008; ZDHHC5 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TZ00
DR   Horizon_Discovery; HZGHC000589c008
DR   Wikidata; Q54881245
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18472; ZDHHC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC5 (-) 2
AC   CVCL_TZ01
SY   HZGHC000589c012; ZDHHC5 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TZ01
DR   Horizon_Discovery; HZGHC000589c012
DR   Wikidata; Q54881246
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18472; ZDHHC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC6 (-) 1
AC   CVCL_TZ02
SY   HZGHC000586c001; ZDHHC6 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TZ02
DR   Horizon_Discovery; HZGHC000586c001
DR   Wikidata; Q54881247
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19160; ZDHHC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC6 (-) 2
AC   CVCL_TZ03
SY   HZGHC000586c002; ZDHHC6 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TZ03
DR   Horizon_Discovery; HZGHC000586c002
DR   Wikidata; Q54881248
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19160; ZDHHC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC7 (-) 1
AC   CVCL_TZ04
SY   HZGHC001796c003; ZDHHC7 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TZ04
DR   Horizon_Discovery; HZGHC001796c003
DR   Wikidata; Q54881249
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18459; ZDHHC7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC7 (-) 2
AC   CVCL_TZ05
SY   HZGHC001796c010; ZDHHC7 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TZ05
DR   Horizon_Discovery; HZGHC001796c010
DR   Wikidata; Q54881250
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18459; ZDHHC7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC8 (-) 1
AC   CVCL_TZ06
SY   HZGHC001798c004; ZDHHC8 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TZ06
DR   Horizon_Discovery; HZGHC001798c004
DR   Wikidata; Q54881251
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18474; ZDHHC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC8 (-) 2
AC   CVCL_TZ07
SY   HZGHC001798c005; ZDHHC8 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TZ07
DR   Horizon_Discovery; HZGHC001798c005
DR   Wikidata; Q54881252
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18474; ZDHHC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC8 (-) 3
AC   CVCL_TZ08
SY   HZGHC001799c011; ZDHHC8 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TZ08
DR   Horizon_Discovery; HZGHC001799c011
DR   Wikidata; Q54881253
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18474; ZDHHC8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC9 (-) 1
AC   CVCL_TZ09
SY   HZGHC001801c009; ZDHHC9 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TZ09
DR   Horizon_Discovery; HZGHC001801c009
DR   Wikidata; Q54881254
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18475; ZDHHC9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZDHHC9 (-) 2
AC   CVCL_TZ10
SY   HZGHC001801c012; ZDHHC9 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TZ10
DR   Horizon_Discovery; HZGHC001801c012
DR   Wikidata; Q54881255
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18475; ZDHHC9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZEB1 (-) 1
AC   CVCL_TZ11
SY   HZGHC006259c003; ZEB1 knockout cell line 1bp insertion; HAP1 ZEB1 (-)
DR   cancercelllines; CVCL_TZ11
DR   Horizon_Discovery; HZGHC006259c003
DR   Wikidata; Q54881256
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZEB1 (-) 2
AC   CVCL_XV26
SY   HZGHC006259c006; ZEB1 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_XV26
DR   Horizon_Discovery; HZGHC006259c006
DR   Wikidata; Q93979092
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZEB1 (-) 3
AC   CVCL_XV27
SY   HZGHC006260c009; ZEB1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_XV27
DR   Horizon_Discovery; HZGHC006260c009
DR   Wikidata; Q93979096
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZEB1 (-) 4
AC   CVCL_XV28
SY   HZGHC006260c010; ZEB1 knockout cell line 193bp deletion
DR   cancercelllines; CVCL_XV28
DR   Horizon_Discovery; HZGHC006260c010
DR   Wikidata; Q93979098
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZEB2 (-) 1
AC   CVCL_TZ12
SY   HZGHC006597c012; ZEB2 knockout cell line 172bp deletion; HAP1 ZEB2 (-)
DR   cancercelllines; CVCL_TZ12
DR   Horizon_Discovery; HZGHC006597c012
DR   Wikidata; Q54881257
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006597c012; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ZEB2 (-) 2
AC   CVCL_XV29
SY   HZGHC006597c005; ZEB2 knockout cell line 43bp deletion
DR   cancercelllines; CVCL_XV29
DR   Horizon_Discovery; HZGHC006597c005
DR   Wikidata; Q93979111
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZFP36 (-) 1
AC   CVCL_TZ13
SY   HZGHC003410c003; ZFP36 knockout cell line 55bp deletion
DR   cancercelllines; CVCL_TZ13
DR   Horizon_Discovery; HZGHC003410c003
DR   Wikidata; Q54881258
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12862; ZFP36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZFP36 (-) 2
AC   CVCL_TZ14
SY   HZGHC003410c007; ZFP36 knockout cell line 28bp deletion
DR   cancercelllines; CVCL_TZ14
DR   Horizon_Discovery; HZGHC003410c007
DR   Wikidata; Q54881259
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12862; ZFP36.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZFX (-) 1
AC   CVCL_XV30
SY   HZGHC007294c011; HZGHC7543; ZFX knockout cell line 10bp deletion in exon 3
DR   cancercelllines; CVCL_XV30
DR   Horizon_Discovery; HZGHC007294c011
DR   Wikidata; Q93979132
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12869; ZFX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ZFX (-) 2
AC   CVCL_E2PM
SY   HZGHC007294c003
DR   Horizon_Discovery; HZGHC007294c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12869; ZFX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZFX (-) 3
AC   CVCL_E2PN
SY   HZGHC007294c007
DR   Horizon_Discovery; HZGHC007294c007
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12869; ZFX.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZFYVE1 (-) 1
AC   CVCL_TZ15
SY   HZGHC000301c013; ZFYVE1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TZ15
DR   Horizon_Discovery; HZGHC000301c013
DR   Wikidata; Q54881260
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13180; ZFYVE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZFYVE1 (-) 2
AC   CVCL_TZ16
SY   HZGHC000301c021; ZFYVE1 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TZ16
DR   Horizon_Discovery; HZGHC000301c021
DR   Wikidata; Q54881261
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13180; ZFYVE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000301c021; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZFYVE1 (-) 3
AC   CVCL_TZ17
SY   HZGHC000301c023; ZFYVE1 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TZ17
DR   Horizon_Discovery; HZGHC000301c023
DR   Wikidata; Q54881262
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13180; ZFYVE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000301c023; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZFYVE1 (-) 4
AC   CVCL_TZ18
SY   HZGHC004239c003; ZFYVE1 knockout cell line 196bp insertion
DR   cancercelllines; CVCL_TZ18
DR   Horizon_Discovery; HZGHC004239c003
DR   Wikidata; Q54881263
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13180; ZFYVE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC004239c003; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZFYVE1 (-) 5
AC   CVCL_TZ19
SY   HZGHC004239c005; ZFYVE1 knockout cell line 22bp deletion
DR   cancercelllines; CVCL_TZ19
DR   Horizon_Discovery; HZGHC004239c005
DR   Wikidata; Q54881264
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13180; ZFYVE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZFYVE16 (-) 1
AC   CVCL_TZ20
SY   HZGHC003169c001; ZFYVE16 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TZ20
DR   Horizon_Discovery; HZGHC003169c001
DR   Wikidata; Q54881265
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZFYVE16 (-) 2
AC   CVCL_TZ21
SY   HZGHC003169c007; ZFYVE16 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TZ21
DR   Horizon_Discovery; HZGHC003169c007
DR   Wikidata; Q54881266
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMIZ2 (-) 1
AC   CVCL_TZ22
SY   HZGHC002513c004; ZMIZ2 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TZ22
DR   Horizon_Discovery; HZGHC002513c004
DR   Wikidata; Q54881267
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22229; ZMIZ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMIZ2 (-) 2
AC   CVCL_TZ23
SY   HZGHC002513c008; ZMIZ2 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TZ23
DR   Horizon_Discovery; HZGHC002513c008
DR   Wikidata; Q54881268
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22229; ZMIZ2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMPSTE24 (-) 1
AC   CVCL_TZ24
SY   HZGHC002703c001; ZMPSTE24 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TZ24
DR   Horizon_Discovery; HZGHC002703c001
DR   Wikidata; Q54881269
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12877; ZMPSTE24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMPSTE24 (-) 2
AC   CVCL_TZ25
SY   HZGHC002703c007; ZMPSTE24 knockout cell line 17bp deletion
DR   cancercelllines; CVCL_TZ25
DR   Horizon_Discovery; HZGHC002703c007
DR   Wikidata; Q54881270
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12877; ZMPSTE24.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMYM3 (-) 1
AC   CVCL_TZ26
SY   HZGHC001118c002; ZMYM3 knockout cell line 74bp insertion
DR   cancercelllines; CVCL_TZ26
DR   Horizon_Discovery; HZGHC001118c002
DR   Wikidata; Q54881271
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13054; ZMYM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001118c002; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZMYM3 (-) 2
AC   CVCL_TZ27
SY   HZGHC001118c004; ZMYM3 knockout cell line 302bp insertion
DR   cancercelllines; CVCL_TZ27
DR   Horizon_Discovery; HZGHC001118c004
DR   Wikidata; Q54881272
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13054; ZMYM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC001118c004; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZMYM3 (-) 3
AC   CVCL_TZ28
SY   HZGHC001118c008; ZMYM3 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_TZ28
DR   Horizon_Discovery; HZGHC001118c008
DR   Wikidata; Q54881273
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13054; ZMYM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMYM3 (-) 4
AC   CVCL_TZ29
SY   HZGHC001118c009; ZMYM3 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TZ29
DR   Horizon_Discovery; HZGHC001118c009
DR   Wikidata; Q54881274
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13054; ZMYM3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMYM4 (-) 1
AC   CVCL_C7Z8
SY   HZGHC007547c001; ZMYM4 knockout cell line 2bp insertion in exon 9
DR   Horizon_Discovery; HZGHC007547c001
DR   Wikidata; Q123031489
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13055; ZMYM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ZMYM4 (-) 2
AC   CVCL_C7Z9
SY   HZGHC007547c005; ZMYM4 knockout cell line 10bp deletion in exon 9
DR   Horizon_Discovery; HZGHC007547c005
DR   Wikidata; Q123031493
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13055; ZMYM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ZMYM4 (-) 3
AC   CVCL_C7ZA
SY   HZGHC007547c012; ZMYM4 knockout cell line 7bp deletion in exon 9
DR   Horizon_Discovery; HZGHC007547c012
DR   Wikidata; Q123031497
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13055; ZMYM4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ZMYND11 (-) 1
AC   CVCL_TZ30
SY   HZGHC000936c003; ZMYND11 knockout cell line 31bp deletion
DR   cancercelllines; CVCL_TZ30
DR   Horizon_Discovery; HZGHC000936c003
DR   Wikidata; Q54881275
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16966; ZMYND11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMYND11 (-) 2
AC   CVCL_TZ31
SY   HZGHC000936c004; ZMYND11 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_TZ31
DR   Horizon_Discovery; HZGHC000936c004
DR   Wikidata; Q54881276
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16966; ZMYND11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMYND8 (-) 1
AC   CVCL_TZ32
SY   HZGHC000930c003; ZMYND8 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TZ32
DR   Horizon_Discovery; HZGHC000930c003
DR   Wikidata; Q54881277
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9397; ZMYND8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZMYND8 (-) 2
AC   CVCL_TZ33
SY   HZGHC000930c006; ZMYND8 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TZ33
DR   Horizon_Discovery; HZGHC000930c006
DR   Wikidata; Q54881279
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9397; ZMYND8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF10 (-)
AC   CVCL_TZ34
SY   HZGHC003733c002; ZNF10 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TZ34
DR   Horizon_Discovery; HZGHC003733c002
DR   Wikidata; Q54881281
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12879; ZNF10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF143 (-) 1
AC   CVCL_XV31
SY   HZGHC007026c009; HZGHC7702; ZNF143 knockout cell line 2bp deletion in exon 5; HAP1 ZNF143 (-)
DR   cancercelllines; CVCL_XV31
DR   Horizon_Discovery; HZGHC007026c009
DR   Wikidata; Q93979349
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12928; ZNF143.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ZNF143 (-) 2
AC   CVCL_E2PP
SY   HZGHC007026c001; ZNF143 knockout cell line 1bp deletion in exon 5
DR   Horizon_Discovery; HZGHC007026c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12928; ZNF143.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF174 (-) 1
AC   CVCL_TZ35
SY   HZGHC003725c003; ZNF174 knockout cell line 115bp deletion
DR   cancercelllines; CVCL_TZ35
DR   Horizon_Discovery; HZGHC003725c003
DR   Wikidata; Q54881282
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12963; ZNF174.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF174 (-) 2
AC   CVCL_TZ36
SY   HZGHC003725c011; ZNF174 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TZ36
DR   Horizon_Discovery; HZGHC003725c011
DR   Wikidata; Q54881283
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12963; ZNF174.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF189 (-) 1
AC   CVCL_E2PQ
SY   HZGHC008219c008
DR   Horizon_Discovery; HZGHC008219c008
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12980; ZNF189.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF189 (-) 2
AC   CVCL_E2PR
SY   HZGHC008219c009
DR   Horizon_Discovery; HZGHC008219c009
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12980; ZNF189.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF267 (-) 1
AC   CVCL_TZ37
SY   HZGHC002324c004; ZNF267 knockout cell line 2bp insertion
DR   cancercelllines; CVCL_TZ37
DR   Horizon_Discovery; HZGHC002324c004
DR   Wikidata; Q54881285
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13060; ZNF267.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF267 (-) 2
AC   CVCL_TZ38
SY   HZGHC002324c005; ZNF267 knockout cell line 11bp deletion
DR   cancercelllines; CVCL_TZ38
DR   Horizon_Discovery; HZGHC002324c005
DR   Wikidata; Q54881286
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13060; ZNF267.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF274 (-) 1
AC   CVCL_E2PS
SY   HZGHC007928c003
DR   Horizon_Discovery; HZGHC007928c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13068; ZNF274.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF274 (-) 2
AC   CVCL_E2PT
SY   HZGHC007928c006
DR   Horizon_Discovery; HZGHC007928c006
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13068; ZNF274.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF367 (-) 1
AC   CVCL_TZ39
SY   HZGHC005822c011; ZNF367 knockout cell line 5bp deletion; HAP1 ZNF367 (-)
DR   cancercelllines; CVCL_TZ39
DR   Horizon_Discovery; HZGHC005822c011
DR   Wikidata; Q54881287
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18320; ZNF367.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZNF367 (-) 2
AC   CVCL_XV32
SY   HZGHC005822c012; ZNF367 knockout cell line 2bp deletion
DR   cancercelllines; CVCL_XV32
DR   Horizon_Discovery; HZGHC005822c012
DR   Wikidata; Q93979403
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18320; ZNF367.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF536 (-) 1
AC   CVCL_XV33
SY   HZGHC007301c011; HZGHC9745; ZNF536 knockout cell line 8bp deletion in exon 2; HAP1 ZNF536 (-)
DR   cancercelllines; CVCL_XV33
DR   Horizon_Discovery; HZGHC007301c011
DR   Wikidata; Q93979407
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29025; ZNF536.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ZNF536 (-) 2
AC   CVCL_E2PU
SY   HZGHC007301c003; ZNF536 knockout cell line 10bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007301c003
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29025; ZNF536.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF589 (-) 1
AC   CVCL_TZ40
SY   HZGHC004037c003; ZNF589 knockout cell line 23bp deletion
DR   cancercelllines; CVCL_TZ40
DR   Horizon_Discovery; HZGHC004037c003
DR   Wikidata; Q54881288
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16747; ZNF589.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF589 (-) 2
AC   CVCL_TZ41
SY   HZGHC004037c008; ZNF589 knockout cell line 7bp deletion
DR   cancercelllines; CVCL_TZ41
DR   Horizon_Discovery; HZGHC004037c008
DR   Wikidata; Q54881289
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16747; ZNF589.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF598 (-)
AC   CVCL_C7XZ
SY   HZGHC007966c011; ZNF598 knockout cell line 1bp deletion
DR   Horizon_Discovery; HZGHC007966c011
DR   Wikidata; Q123031498
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28079; ZNF598.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   HAP1 ZNF646 (-) 1
AC   CVCL_TZ42
SY   HZGHC006499c001; ZNF646 knockout cell line 1bp insertion; HAP1 ZNF646 (-)
DR   cancercelllines; CVCL_TZ42
DR   Horizon_Discovery; HZGHC006499c001
DR   Wikidata; Q54881290
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29004; ZNF646.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAP1 ZNF646 (-) 2
AC   CVCL_XV34
SY   HZGHC006499c003; ZNF646 knockout cell line 41bp deletion
DR   cancercelllines; CVCL_XV34
DR   Horizon_Discovery; HZGHC006499c003
DR   Wikidata; Q93979442
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29004; ZNF646.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF646 (-) 3
AC   CVCL_XV35
SY   HZGHC006499c012; ZNF646 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XV35
DR   Horizon_Discovery; HZGHC006499c012
DR   Wikidata; Q93979447
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29004; ZNF646.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF655 (-) 1
AC   CVCL_E2PV
SY   HZGHC008227c011
DR   Horizon_Discovery; HZGHC008227c011
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30899; ZNF655.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF655 (-) 2
AC   CVCL_E2PW
SY   HZGHC008228c010
DR   Horizon_Discovery; HZGHC008228c010
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30899; ZNF655.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF655 (-) 3
AC   CVCL_E2PX
SY   HZGHC008228c015
DR   Horizon_Discovery; HZGHC008228c015
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30899; ZNF655.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNF74 (-) 1
AC   CVCL_TZ43
SY   HZGHC003963c009; ZNF74 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TZ43
DR   Horizon_Discovery; HZGHC003963c009
DR   Wikidata; Q54881291
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13144; ZNF74.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF74 (-) 2
AC   CVCL_TZ44
SY   HZGHC003963c010; ZNF74 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TZ44
DR   Horizon_Discovery; HZGHC003963c010
DR   Wikidata; Q54881293
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13144; ZNF74.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF746 (-)
AC   CVCL_TZ45
SY   HZGHC003975c005; ZNF746 knockout cell line 47bp deletion
DR   cancercelllines; CVCL_TZ45
DR   Horizon_Discovery; HZGHC003975c005
DR   Wikidata; Q54881294
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21948; ZNF746.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF764 (-) 1
AC   CVCL_TZ46
SY   HZGHC002326c001; ZNF764 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TZ46
DR   Horizon_Discovery; HZGHC002326c001
DR   Wikidata; Q54881295
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28200; ZNF764.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF764 (-) 2
AC   CVCL_TZ47
SY   HZGHC002326c008; ZNF764 knockout cell line 20bp deletion
DR   cancercelllines; CVCL_TZ47
DR   Horizon_Discovery; HZGHC002326c008
DR   Wikidata; Q54881297
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28200; ZNF764.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF777 (-) 1
AC   CVCL_TZ48
SY   HZGHC003968c005; ZNF777 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_TZ48
DR   Horizon_Discovery; HZGHC003968c005
DR   Wikidata; Q54881298
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22213; ZNF777.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF777 (-) 2
AC   CVCL_TZ49
SY   HZGHC003968c010; ZNF777 knockout cell line 34bp deletion
DR   cancercelllines; CVCL_TZ49
DR   Horizon_Discovery; HZGHC003968c010
DR   Wikidata; Q54881299
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22213; ZNF777.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF816 (-) 1
AC   CVCL_TZ50
SY   HZGHC004722c011; ZNF816 knockout cell line 8bp deletion
DR   cancercelllines; CVCL_TZ50
DR   Horizon_Discovery; HZGHC004722c011
DR   Wikidata; Q54881300
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26995; ZNF816.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF816 (-) 2
AC   CVCL_TZ51
SY   HZGHC004722c012; ZNF816 knockout cell line 16bp deletion
DR   cancercelllines; CVCL_TZ51
DR   Horizon_Discovery; HZGHC004722c012
DR   Wikidata; Q54881301
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26995; ZNF816.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF91 (-) 1
AC   CVCL_TZ52
SY   HZGHC003965c005; ZNF91 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_TZ52
DR   Horizon_Discovery; HZGHC003965c005
DR   Wikidata; Q54881302
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13166; ZNF91.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF91 (-) 2
AC   CVCL_TZ53
SY   HZGHC003965c008; ZNF91 knockout cell line 5bp deletion
DR   cancercelllines; CVCL_TZ53
DR   Horizon_Discovery; HZGHC003965c008
DR   Wikidata; Q54881303
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13166; ZNF91.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNF91 (-) 3
AC   CVCL_TZ54
SY   HZGHC003965c009; ZNF91 knockout cell line 1bp deletion
DR   cancercelllines; CVCL_TZ54
DR   Horizon_Discovery; HZGHC003965c009
DR   Wikidata; Q54881304
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13166; ZNF91.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNRD1 (-) 1
AC   CVCL_E2PY
SY   HZGHC007399c012; ZNRD1 knockout cell line 17bp deletion in exon 2
DR   Horizon_Discovery; HZGHC007399c012
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13182; POLR1H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNRD1 (-) 2
AC   CVCL_E2PZ
SY   HZGHC007400c004; ZNRD1 knockout cell line 1bp insertion in exon 3
DR   Horizon_Discovery; HZGHC007400c004
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13182; POLR1H.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HAP1 ZNRF3 (-) 1
AC   CVCL_TZ55
SY   HZGHC006558c011; ZNRF3 knockout cell line 1bp insertion; HAP1 ZNRF3 (-)
DR   cancercelllines; CVCL_TZ55
DR   Horizon_Discovery; HZGHC006558c011
DR   Wikidata; Q54881305
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18126; ZNRF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC006558c011; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   HAP1 ZNRF3 (-) 2
AC   CVCL_XV36
SY   HZGHC006558c003; ZNRF3 knockout cell line 1bp insertion
DR   cancercelllines; CVCL_XV36
DR   Horizon_Discovery; HZGHC006558c003
DR   Wikidata; Q93979543
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18126; ZNRF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNRF3 (-) 3
AC   CVCL_XV37
SY   HZGHC006559c003; ZNRF3 knockout cell line 10bp deletion
DR   cancercelllines; CVCL_XV37
DR   Horizon_Discovery; HZGHC006559c003
DR   Wikidata; Q93979547
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18126; ZNRF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZNRF3 (-) 4
AC   CVCL_XV38
SY   HZGHC006559c010; ZNRF3 knockout cell line 4bp deletion
DR   cancercelllines; CVCL_XV38
DR   Horizon_Discovery; HZGHC006559c010
DR   Wikidata; Q93979550
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18126; ZNRF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZRANB1 (-) 1
AC   CVCL_TZ56
SY   HZGHC000485c007; ZRANB1 knockout cell line 14bp deletion
DR   cancercelllines; CVCL_TZ56
DR   Horizon_Discovery; HZGHC000485c007
DR   Wikidata; Q54881306
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18224; ZRANB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   HAP1 ZRANB1 (-) 2
AC   CVCL_TZ57
SY   HZGHC000485c009; ZRANB1 knockout cell line 128bp insertion
DR   cancercelllines; CVCL_TZ57
DR   Horizon_Discovery; HZGHC000485c009
DR   Wikidata; Q54881307
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18224; ZRANB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Discontinued: Horizon_Discovery; HZGHC000485c009; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   HAPI
AC   CVCL_0F62
SY   Highly Aggressively Proliferating Immortalized
DR   BTO; BTO_0003618
DR   ATCC; CRL-2815
DR   Millipore; SCC103
DR   PRIDE; PXD000518
DR   Wikidata; Q54881308
RX   PubMed=11424192;
RX   PubMed=22121004;
RX   PubMed=22651808;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be a microgial cell of rat origin (3 day old Wistar rat) but found to be from mouse (Millipore).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00602.
CC   Omics: Proteomics.
CC   Misspelling: HAP1; Note=Occasionally.
CC   Discontinued: ATCC; CRL-2815; true.
CC   Discontinued: Millipore; SCC103; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Undefined cell line type
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   HAPPY
AC   CVCL_WH52
DR   Wikidata; Q93979572
RX   PubMed=30268330;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   hAQC2
AC   CVCL_5A34
SY   AQ.C2 clone 100A
DR   Wikidata; Q54881309
RX   Patent=US7358054;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3275.
CC   Characteristics: Produces a humanized version of mAB mAQC2 (Patent=US7358054).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   HAR
AC   CVCL_1M71
SY   GM06822; GM06822B
DR   CLO; CLO_0036530
DR   Coriell; GM06822
DR   Wikidata; Q54881310
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=6417008;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 12
//
ID   HAR,G
AC   CVCL_E687
SY   HAR, G
DR   dbMHC; 48883
DR   ECACC; 94082249
DR   IHW; IHW09149
DR   IPD-IMGT/HLA; 11692
DR   Wikidata; Q54881311
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*01:01:01:01,32; B*08:01:01,14:01; C*07:01:01; DPB1*04:01:01,04:02; DQA1*02:01,05:01:01; DQB1*02:01:01; DRB1*03:01:01,07:01; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=11692).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082249; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   HARA [Human B-cell IHW]
AC   CVCL_E688
DR   dbMHC; 48884
DR   ECACC; 94082242
DR   IHW; IHW09142
DR   IPD-IMGT/HLA; 11685
DR   Wikidata; Q54881312
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01; B*52:01:01; C*12:02; DPB1*09:01; DQA1*01:03; DQB1*06:01; DRB1*15:02:01; DRB5*01:02 (IPD-IMGT/HLA=11685).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 18
//
ID   HARA [Human squamous cell lung carcinoma]
AC   CVCL_2914
SY   KCC-C1
DR   CLO; CLO_0009998
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 714
DR   BioSample; SAMN03472500
DR   BioSample; SAMN10987873
DR   cancercelllines; CVCL_2914
DR   Cell_Model_Passport; SIDM00598
DR   Cosmic; 1995421
DR   Cosmic; 2060530
DR   Cosmic-CLP; 1240142
DR   DepMap; ACH-000843
DR   EGA; EGAS00001000978
DR   GDSC; 1240142
DR   GEO; GSM827377
DR   GEO; GSM887032
DR   GEO; GSM888102
DR   GEO; GSM1374487
DR   GEO; GSM1669839
DR   IARC_TP53; 28383
DR   JCRB; JCRB1080.0
DR   JCRB; NIHS0352.0
DR   LiGeA; CCLE_673
DR   LINCS_LDP; LCL-1585
DR   PharmacoDB; HARA_442_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2914
DR   Wikidata; Q54881313
RX   PubMed=8287365;
RX   PubMed=8752176;
RX   PubMed=12569360;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Produces high level of parathyroid hormone-related peptide (PTHrP).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Homozygous (Cosmic-CLP=1240142; DepMap=ACH-000843).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.26%; Native American=0%; East Asian, North=78.38%; East Asian, South=20.35%; South Asian=0.8%; European, North=0%; European, South=0.21% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0352.0; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1240142; JCRB=JCRB1080.0
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   HARA-B
AC   CVCL_2915
SY   HARAB
DR   cancercelllines; CVCL_2915
DR   CCRID; 5301HUM-KCB16077YJ
DR   CLS; 300465
DR   GEO; GSM1374488
DR   JCRB; JCRB1080.1
DR   JCRB; NIHS0352.1
DR   KCB; KCB 2016077YJ
DR   Wikidata; Q54881314
RX   PubMed=8752176;
RX   PubMed=11668474;
CC   Population: Japanese.
CC   Characteristics: Produces high level of parathyroid hormone-related peptide (PTHrP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0352.1; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300465; JCRB=JCRB1080.1
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D12S391: 18,19
ST   D13S317: 9
ST   D16S539: 10
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 12
ST   D6S1043: 11,14
ST   D7S820: 12
ST   D8S1179: 10,12
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2914 ! HARA [Human squamous cell lung carcinoma]
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   HARA-B-GFP
AC   CVCL_A9FF
DR   cancercelllines; CVCL_A9FF
DR   CCRID; 5301HUM-KCB17030YJ
DR   KCB; KCB 2017030YJ
DR   Wikidata; Q108820397
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2915 ! HARA-B
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   HARA-B4
AC   CVCL_4W91
DR   cancercelllines; CVCL_4W91
DR   JCRB; JCRB1552
DR   Wikidata; Q54881315
RX   PubMed=24534874;
CC   Population: Japanese.
CC   Characteristics: Produces high level of parathyroid hormone-related peptide (PTHrP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1552
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2915 ! HARA-B
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HARA/CMV-Luc
AC   CVCL_JG55
SY   HARA CMV-Luc
DR   cancercelllines; CVCL_JG55
DR   JCRB; JCRB1683
DR   JCRB; NIHS1043
DR   Wikidata; Q54881316
CC   Population: Japanese.
CC   Characteristics: Produces high level of parathyroid hormone-related peptide (PTHrP) (from parent cell line).
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1683).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1043; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1683
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2914 ! HARA [Human squamous cell lung carcinoma]
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HARA/Luc-YFP
AC   CVCL_E8TL
RX   PubMed=17370040;
CC   Population: Japanese.
CC   Characteristics: Transduced with a luciferase-YFP fusion protein (PubMed=17370040).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2914 ! HARA [Human squamous cell lung carcinoma]
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Harv
AC   CVCL_6F58
DR   Wikidata; Q54881317
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   Has
AC   CVCL_6758
DR   CLO; CLO_0051582
DR   RCB; RCB2076
DR   Wikidata; Q54881318
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   HAS-15
AC   CVCL_E689
SY   HAS
DR   dbMHC; 48885
DR   ECACC; 86072919
DR   IHW; IHW09298
DR   IPD-IMGT/HLA; 10710
DR   Wikidata; Q54881319
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02; B*54:01,15; C*01:02,03:03; DPB1*05:01,19:01; DRB1*04:05 (IPD-IMGT/HLA=10710).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   HAS3
AC   CVCL_A8S4
SY   HAS-3
DR   Wikidata; Q102114095
RX   PubMed=7521749;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   HAS301
AC   CVCL_5286
SY   HAS-301
DR   Wikidata; Q54881320
RX   PubMed=1652589;
RX   PubMed=8187845;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   HAS303
AC   CVCL_5287
SY   HAS-303
DR   Wikidata; Q54881321
RX   PubMed=1652589;
RX   PubMed=8187845;
RX   PubMed=10706070;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HAS303
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   HAS304
AC   CVCL_5288
SY   HAS-304
DR   Wikidata; Q54881322
RX   PubMed=1652589;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   HAS4
AC   CVCL_A8S5
SY   HAS-4
DR   Wikidata; Q102114096
RX   PubMed=7521749;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   HAS6
AC   CVCL_A8S6
SY   HAS-6
DR   Wikidata; Q102114097
RX   PubMed=7521749;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   HAS701
AC   CVCL_B5X1
DR   Wikidata; Q111733330
RX   PubMed=8187845;
RX   PubMed=10706070;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   HaSKpw
AC   CVCL_A1LV
SY   HaSkpwC7
DR   Wikidata; Q102114099
RX   PubMed=32938951;
CC   Doubling time: 43.4 hours (PubMed=32938951).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Heterozygous (PubMed=32938951).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=32938951
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   HASTR/ci35
AC   CVCL_4U69
SY   Human ASTRocyte/conditionally immortalized, clone 35
DR   Wikidata; Q54881323
RX   PubMed=26365151;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   4M
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   HAT-7
AC   CVCL_RW36
SY   HAT7
DR   Wikidata; Q54881328
RX   PubMed=12489191;
RX   PubMed=21082283;
CC   Derived from site: In situ; Tooth, incisor; UBERON=UBERON_0001098.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   HATAK
AC   CVCL_HA65
DR   Wikidata; Q54881329
RX   CelloPub=CLPUB00359;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (CelloPub=CLPUB00359).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   HaTCCA-1.1
AC   CVCL_HF42
SY   HaTCCA-1
DR   Wikidata; Q54881330
RX   PubMed=8629051;
RX   PubMed=10072166;
CC   Characteristics: Obtained by both Opisthorchis viverrini infection and N-nitrosodimethylamine treatment (PubMed=8629051).
CC   Doubling time: 26 hours (PubMed=8629051).
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Transformant: NCBI_TaxID; 6198; Opisthorchis viverrini.
DI   NCIt; C134566; Hamster cholangiocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   7M-11M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 6
//
ID   HATL
AC   CVCL_LI16
DR   Wikidata; Q54881331
RX   PubMed=8486778;
RX   PubMed=10637496;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Pro (c.524G>C); Zygosity=Heterozygous (PubMed=8486778).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI15 ! HABL
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   Hattori
AC   CVCL_IW44
SY   HATTORI
DR   Wikidata; Q54881332
RX   PubMed=1001868;
RX   PubMed=2982333;
RX   PubMed=4377005;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   HAU,ML
AC   CVCL_E690
SY   HAU, ML
DR   dbMHC; 48886
DR   ECACC; 94082257
DR   IHW; IHW09157
DR   IPD-IMGT/HLA; 11700
DR   Wikidata; Q54881333
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*33; B*58:01; C*03:02; DPB1*05:01,13:01; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*02 (IPD-IMGT/HLA=11700).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HAV-102
AC   CVCL_LN16
SY   HAV102
DR   Wikidata; Q54881334
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American; Havasupai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 7
//
ID   HAV-1131
AC   CVCL_LN15
SY   HAV1131
DR   Wikidata; Q54881335
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American; Havasupai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 7
//
ID   HAV-256
AC   CVCL_LN17
SY   HAV256
DR   Wikidata; Q54881336
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American; Havasupai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 7
//
ID   HAV-280
AC   CVCL_LN18
SY   HAV280
DR   Wikidata; Q54881337
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American; Havasupai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 7
//
ID   HAV-281
AC   CVCL_LN19
SY   HAV281
DR   Wikidata; Q54881338
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American; Havasupai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 7
//
ID   HAV-42
AC   CVCL_LN20
SY   HAV42
DR   Wikidata; Q54881339
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American; Havasupai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 7
//
ID   HAVCH.01
AC   CVCL_A5YQ
DR   Wikidata; Q107115229
RX   PubMed=2989374;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_A5YR ! HAVCH.02
OI   CVCL_A5YS ! HAVCH.03
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HAVCH.02
AC   CVCL_A5YR
DR   Wikidata; Q107115230
RX   PubMed=2989374;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_A5YQ ! HAVCH.01
OI   CVCL_A5YS ! HAVCH.03
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HAVCH.03
AC   CVCL_A5YS
DR   Wikidata; Q107115231
RX   PubMed=2989374;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_A5YQ ! HAVCH.01
OI   CVCL_A5YR ! HAVCH.02
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HAVHU.01
AC   CVCL_A5YT
DR   Wikidata; Q107115233
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5YU ! HBCHU.02
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HAX1corrected-iPSC#1
AC   CVCL_A4HM
DR   SKIP; SKIP003025
DR   Wikidata; Q105507543
RX   PubMed=29296734;
CC   From: Department of Pediatric Hematology and Oncology, Hannover Medical School; Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:16915; HAX1; Simple_corrected; p.Trp44Ter (c.130_131insA); ClinVar=VCV000004651; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=29296734).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C166153; Severe congenital neutropenia type 3, autosomal recessive
DI   ORDO; Orphanet_99749; Kostmann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4HL ! HAX1W44X-iPSC
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HAX1corrected-iPSC#2
AC   CVCL_A4HN
DR   SKIP; SKIP003042
DR   Wikidata; Q105507545
RX   PubMed=29296734;
CC   From: Department of Pediatric Hematology and Oncology, Hannover Medical School; Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:16915; HAX1; Simple_corrected; p.Trp44Ter (c.130_131insA); ClinVar=VCV000004651; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=29296734).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C166153; Severe congenital neutropenia type 3, autosomal recessive
DI   ORDO; Orphanet_99749; Kostmann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4HL ! HAX1W44X-iPSC
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HAX1W44X-iPSC
AC   CVCL_A4HL
DR   SKIP; SKIP003023
DR   Wikidata; Q105507550
RX   PubMed=29296734;
CC   Sequence variation: Mutation; HGNC; HGNC:16915; HAX1; Simple; p.Trp44Ter (c.130_131insA); ClinVar=VCV000004651; Zygosity=Homozygous (PubMed=29296734).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C166153; Severe congenital neutropenia type 3, autosomal recessive
DI   ORDO; Orphanet_99749; Kostmann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HAY
AC   CVCL_N813
DR   Cosmic; 1656049
DR   Wikidata; Q54881340
RX   PubMed=15274292;
RX   PubMed=22426987;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HAY,BD
AC   CVCL_E691
SY   HAY, BD; TER301; TER-301; Ter 301; TER357; TER-357; Ter 357; TER493; TER-493; Ter-493; Ter 493
DR   dbMHC; 48887
DR   ECACC; 94082222
DR   IHW; IHW09123
DR   IPD-IMGT/HLA; 11667
DR   Wikidata; Q54881341
RX   PubMed=8307784;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/376cx.pdf
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*24:02:01:01; B*07:02:01,40:02:01; C*07:02:01:03,15:02:01:01; DPA1*01:03:01:02,02:02:02; DPB1*04:01:01:01,05:01:01; DQA1*01:04:01:04,01:02:01:01; DQB1*06:02:01,05:03:01; DRB1*14:07:01,15:01:01; DRB3*02:02:01,02:02:01:02; DRB5*01:01:01 (IPD-IMGT/HLA=11667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   HAY,KJ
AC   CVCL_E692
SY   HAY, KJ
DR   dbMHC; 48888
DR   ECACC; 94082296
DR   IHW; IHW09196
DR   IPD-IMGT/HLA; 11737
DR   Wikidata; Q54881342
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*02; B*15; DPB1*05:01,17:01; DQA1*01:03,05:01; DQB1*06:03,03:01; DRB1*13:01,14; DRB3*01:01 (IPD-IMGT/HLA=11737).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   Hayai
AC   CVCL_9471
SY   H582
DR   Wikidata; Q54881343
RX   PubMed=1765142;
RX   PubMed=3001699;
RX   PubMed=9045636;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HB [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC20
DR   Wikidata; Q98126653
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   HB [Human epidermolysis bullosa]
AC   CVCL_3694
DR   CLO; CLO_0003622
DR   ATCC; CRL-7729
DR   Wikidata; Q54881344
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7729; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C67383; Epidermolysis bullosa
DI   ORDO; Orphanet_79361; Inherited epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   HB [Human peritoneal carcinoma]
AC   CVCL_A1GX
DR   Wikidata; Q102114101
RX   DOI=10.5282/edoc.3898;
RX   PubMed=15706405;
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma. The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   HB 34-1
AC   CVCL_DF71
SY   Hybridoma 34-1
DR   Wikidata; Q54881345
RX   Patent=US5618700;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-813.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05231; Human IL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
ID   HB-2
AC   CVCL_C1LF
SY   HB-second generation
DR   Wikidata; Q114311564
RX   PubMed=20464641;
CC   Characteristics: Increased tumorigenicity compared to the parent cell line. Established from a tumor obtained from inoculation of the parent cell line in nude mice (PubMed=20464641).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E44 ! HIOEC-B(a)P-96
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HB-5
AC   CVCL_B6CI
DR   Wikidata; Q111733331
RX   PubMed=3804938;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_73300; Poly(deoxythymidylic acid) (poly(dT)).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   HB-7
AC   CVCL_B6CG
DR   Wikidata; Q111733332
RX   DOI=10.1080/00021369.1986.10867575;
RX   PubMed=3804938;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   HB-894
AC   CVCL_2055
DR   DSMZ; ACC-631
DR   DSMZCellDive; ACC-631
DR   Wikidata; Q54881346
CC   Doubling time: ~3 days (DSMZ=ACC-631).
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   HB-CLS-1
AC   CVCL_6213
SY   HBCLS1
DR   CLS; 300190
DR   Wikidata; Q54881347
RX   PubMed=28196595;
RX   PubMed=29732388;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): CLS=300190
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 8
ST   D18S51: 17,19
ST   D21S11: 29
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 19
ST   Penta D: 11,12
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   HB-CLS-2
AC   CVCL_6214
SY   HBCLS2
DR   CLS; 300191
DR   Wikidata; Q54881348
RX   PubMed=28196595;
RX   PubMed=29732388;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01,32:01:01; B*27:02:00,55:01:01; C*02:02:02,03:03:01; DPB1*02:01,03:01; DQA1*01:05:01,04:01:01; DQB1*04:02:01,05:01:01; DRB1*08:01:01,10:01:01 (CLS=300191).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): CLS=300191
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 15,17
ST   D21S11: 32.2,35.2
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 13
ST   TH01: 8,10
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HB-CLS-3
AC   CVCL_5761
DR   CLS; 500460
DR   Wikidata; Q54881349
CC   Discontinued: CLS; 500460; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   HB1 [Human breast]
AC   CVCL_E4BH
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HB1 [Human hepatoblastoma]
AC   CVCL_E7R8
RX   PubMed=7595832;
CC   Doubling time: ~2 days (PubMed=7595832).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB1 [Mouse hybridoma against HBV HBsAg]
AC   CVCL_E5P2
DR   ABCD; ABCD_AI643
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB1.1-ED
AC   CVCL_D358
DR   Wikidata; Q54881350
RX   PubMed=8378083;
CC   Characteristics: EPO dependent.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU143.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D359 ! HB1.1-EI
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   HB1.1-EI
AC   CVCL_D359
SY   HB1.1
DR   Wikidata; Q54881351
RX   PubMed=8378083;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU145.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   HB1.F3
AC   CVCL_LJ44
SY   F3; F3-WT
DR   BTO; BTO_0002893
DR   GEO; GSM456723
DR   GEO; GSM456725
DR   Wikidata; Q54881352
RX   PubMed=12167771;
RX   PubMed=15484694;
RX   PubMed=19813087;
RX   PubMed=21755312;
RX   PubMed=25096191;
RX   PubMed=25198726;
RX   PubMed=28830458;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   HB1.F3.CD21
AC   CVCL_LJ45
SY   HB1.F3.CD clone 21
DR   Wikidata; Q54881353
RX   PubMed=27546534;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ44 ! HB1.F3
SX   Female
AG   14FW
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   HB1.F3.EGFRviii
AC   CVCL_LJ46
SY   F3.EGFRviii
DR   Wikidata; Q54881354
RX   PubMed=28830458;
CC   Characteristics: EGFRviii expression is doxycycline inducible (PubMed=28830458).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ44 ! HB1.F3
SX   Female
AG   14FW
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   HB1.F3.NeuroD
AC   CVCL_E3V6
RX   PubMed=12167771;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7762; NEUROD1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ44 ! HB1.F3
SX   Female
AG   14FW
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HB1.F3.Ngn1
AC   CVCL_LJ47
SY   HB1.F3-Ngn1; F3-Ngn1
DR   GEO; GSM456722
DR   GEO; GSM456724
DR   Wikidata; Q54881355
RX   PubMed=19813087;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7764; NEUROG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: v-Myc.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ44 ! HB1.F3
SX   Female
AG   14FW
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   HB1.F3.Ras
AC   CVCL_LJ48
SY   F3.Ras
DR   Wikidata; Q54881356
RX   PubMed=21755312;
RX   PubMed=25096191;
CC   Characteristics: Tumorigenic, forms brain cancers when injected in mouse brains.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: v-Myc.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ44 ! HB1.F3
SX   Female
AG   14FW
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   HB11;19
AC   CVCL_8227
SY   HB(11;19); HB11.19; HB 11;19; HB1119
DR   EFO; EFO_0022450
DR   cancercelllines; CVCL_8227
DR   Cell_Model_Passport; SIDM01428
DR   DepMap; ACH-001736
DR   Wikidata; Q54881357
RX   PubMed=1423624;
RX   PubMed=16523483;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=1423624; PubMed=16523483; DepMap=ACH-001736).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (DepMap=ACH-001736).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Met (c.374C>T); ClinVar=VCV000183748; Zygosity=Unspecified (DepMap=ACH-001736).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (DepMap=ACH-001736).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   HB12
AC   CVCL_A0GP
DR   Wikidata; Q108820398
RX   Patent=US7087396;
RX   PubMed=10868795;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10191.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HB2 [Mouse adipose]
AC   CVCL_S886
DR   Wikidata; Q54881358
RX   PubMed=10049689;
CC   Doubling time: 30-40 hours (PubMed=10049689).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <7D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   HB2 [Mouse hybridoma against HBV HBsAg]
AC   CVCL_E5P3
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB2/CD82
AC   CVCL_8650
DR   Wikidata; Q54881359
RX   PubMed=10985391;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6210; CD82.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2261 ! MTSV1-7 HB2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   HB2/zeo
AC   CVCL_8649
SY   HB2/ZEO
DR   Wikidata; Q54881360
RX   PubMed=10985391;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2261 ! MTSV1-7 HB2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   HB2a
AC   CVCL_E3X1
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3X2 ! HB2b
OI   CVCL_E3X3 ! HB2c
OI   CVCL_E3X4 ! HB2d
SX   Female
AG   22Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HB2b
AC   CVCL_E3X2
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3X1 ! HB2a
OI   CVCL_E3X3 ! HB2c
OI   CVCL_E3X4 ! HB2d
SX   Female
AG   22Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HB2c
AC   CVCL_E3X3
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3X1 ! HB2a
OI   CVCL_E3X2 ! HB2b
OI   CVCL_E3X4 ! HB2d
SX   Female
AG   22Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HB2d
AC   CVCL_E3X4
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3X1 ! HB2a
OI   CVCL_E3X2 ! HB2b
OI   CVCL_E3X3 ! HB2c
SX   Female
AG   22Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HB3
AC   CVCL_E5P4
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB3-U19
AC   CVCL_E3WX
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HB4
AC   CVCL_E5P5
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB4a
AC   CVCL_J982
SY   Hb-4a; HB 4a
DR   BTO; BTO_0003893
DR   ChEMBL-Cells; CHEMBL3308647
DR   ChEMBL-Targets; CHEMBL614786
DR   Cosmic; 687470
DR   Cosmic; 1609467
DR   PRIDE; PXD004195
DR   PubChem_Cell_line; CVCL_J982
DR   Wikidata; Q54881361
RX   CelloPub=CLPUB00734;
RX   PubMed=8206680;
RX   PubMed=11044355;
RX   PubMed=12671075;
RX   PubMed=16685446;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/hb4a.htm
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Massively parallel signature sequencing (MPSS).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3WV ! HB4b
OI   CVCL_E3WW ! HB4c
SX   Female
AG   18Y
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   HB4b
AC   CVCL_E3WV
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J982 ! HB4a
OI   CVCL_E3WW ! HB4c
SX   Female
AG   18Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HB4c
AC   CVCL_E3WW
RX   PubMed=8206680;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58+U19).
CC   Donor information: Established from reduction mammoplasty tissue (PubMed=8206680).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J982 ! HB4a
OI   CVCL_E3WV ! HB4b
SX   Female
AG   18Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HB4C5
AC   CVCL_4Y79
DR   Wikidata; Q54881362
RX   PubMed=1368811;
RX   PubMed=1369345;
RX   PubMed=1873501;
RX   PubMed=3902783;
RX   PubMed=22359119;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human histone H2B.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U821 ! NAT-30
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   HB4G7
AC   CVCL_4Y80
DR   Wikidata; Q54881363
RX   PubMed=3902783;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on lung cancer cell lines.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U821 ! NAT-30
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   HB5
AC   CVCL_E5P6
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB56B
AC   CVCL_UR58
DR   Wikidata; Q93980091
RX   PubMed=1712759;
CC   Population: African American.
CC   Senescence: Senesces at 125-200 PDL (PubMed=1712759).
CC   Doubling time: ~48 hours (Note=At 3-10th passages), >90 hours (Note=At 25-50th passages) (PubMed=1712759).
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   HB56B/5T
AC   CVCL_UR59
SY   HB56B/passage 5 T antigen transfected
DR   Wikidata; Q93980094
RX   PubMed=1712759;
RX   PubMed=8504475;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UR58 ! HB56B
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   HB6
AC   CVCL_E5P7
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB60-5
AC   CVCL_D360
DR   Wikidata; Q54881364
RX   PubMed=10330185;
RX   PubMed=10822380;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-431.html
CC   Characteristics: Grows in the presence of EPO and KITLG, but undergo terminal differentiation when stimulated with EPO alone.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU142.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   HB60-ED
AC   CVCL_AP97
DR   Wikidata; Q54881365
RX   PubMed=10330185;
RX   PubMed=10822380;
CC   Characteristics: EPO dependent.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D360 ! HB60-5
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HB611
AC   CVCL_6907
SY   HB 611
DR   BTO; BTO_0001665
DR   cancercelllines; CVCL_6907
DR   CCRID; 1102HUM-NIFDC00072
DR   Cosmic; 934553
DR   Cosmic; 2668286
DR   Wikidata; Q54881366
RX   PubMed=3025872;
RX   PubMed=7972006;
RX   PubMed=8389256;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Asp (c.476C>A); ClinVar=VCV001026335; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1102HUM-NIFDC00072
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 13,21
ST   D21S11: 29,30
ST   D3S1358: 14,17
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,24
ST   Penta D: 9,13
ST   Penta E: 10,16
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1296 ! HuH-6 Clone 5
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   HB7
AC   CVCL_E5P8
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB8
AC   CVCL_E5P9
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB9
AC   CVCL_E5PA
RX   PubMed=26541316;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HB9.1-ED
AC   CVCL_D361
SY   HB9.1ED
DR   Wikidata; Q54881367
RX   PubMed=8378083;
RX   PubMed=10822380;
CC   Characteristics: EPO dependent.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU144.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D362 ! HB9.1-EI
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   HB9.1-EI
AC   CVCL_D362
SY   HB9.1
DR   Wikidata; Q54881369
RX   PubMed=8378083;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU146.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   HBA
AC   CVCL_D5Y0
DR   Wikidata; Q127381111
RX   PubMed=6208132;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human alpha interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HBC
AC   CVCL_M630
DR   BioSample; SAMN03152010
DR   Wikidata; Q54881370
RX   PubMed=557237;
RX   PubMed=1016945;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=557237; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00024.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HBC-4
AC   CVCL_B496
SY   HBC4
DR   EFO; EFO_0022354
DR   Cosmic; 1436028
DR   IARC_TP53; 21643
DR   Wikidata; Q54881371
RX   PubMed=8882729;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=22336246;
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   HBC-5
AC   CVCL_B497
SY   HBC5
DR   cancercelllines; CVCL_B497
DR   Cosmic; 1436030
DR   IARC_TP53; 21645
DR   Wikidata; Q54881372
RX   PubMed=8882729;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=22336246;
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Unspecified (PubMed=15900046).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   HBC-7
AC   CVCL_B498
DR   Wikidata; Q54881373
RX   PubMed=8882729;
CC   Population: Japanese.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HBC-8
AC   CVCL_L496
DR   Wikidata; Q54881374
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   HBC-9
AC   CVCL_L497
DR   Wikidata; Q54881375
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   HBC2
AC   CVCL_0U06
SY   BHC2
DR   Wikidata; Q54881376
RX   DOI=10.3760/cma.j.issn.1001-2346.2014.06.010;
CC   Population: Chinese.
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   HBCC/HL-004
AC   CVCL_B6Z7
SY   Human Breast Cancer Cell/HL-004
DR   CCRID; 4201PAT-CCTCC00664
DR   Wikidata; Q111733333
RX   Patent=CN107988160A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201535.
CC   Population: Chinese.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): Patent=CN107988160A
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,16
ST   D12S391: 18,21
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 17,18
ST   D19S433: 15,16
ST   D21S11: 30
ST   D2S1338: 22,23,28
ST   D2S441: 10
ST   D3S1358: 15,16
ST   D5S818: 7,11
ST   D6S1043: 17,19
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HBCHU.01
AC   CVCL_A5YV
DR   Wikidata; Q107115234
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HBCHU.02
AC   CVCL_A5YU
DR   Wikidata; Q107115235
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5YT ! HAVHU.01
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HBCHU.09
AC   CVCL_A5ZC
DR   Wikidata; Q107115236
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5ZD ! HBCHU.15
OI   CVCL_A5ZE ! HBCHU.16
OI   CVCL_A5ZF ! HBCHU.18
OI   CVCL_A5ZG ! HBCHU.20
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HBCHU.15
AC   CVCL_A5ZD
DR   Wikidata; Q107115238
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5ZC ! HBCHU.09
OI   CVCL_A5ZE ! HBCHU.16
OI   CVCL_A5ZF ! HBCHU.18
OI   CVCL_A5ZG ! HBCHU.20
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HBCHU.16
AC   CVCL_A5ZE
DR   Wikidata; Q107115239
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5ZC ! HBCHU.09
OI   CVCL_A5ZD ! HBCHU.15
OI   CVCL_A5ZF ! HBCHU.18
OI   CVCL_A5ZG ! HBCHU.20
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HBCHU.18
AC   CVCL_A5ZF
DR   Wikidata; Q107115240
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5ZC ! HBCHU.09
OI   CVCL_A5ZD ! HBCHU.15
OI   CVCL_A5ZE ! HBCHU.16
OI   CVCL_A5ZG ! HBCHU.20
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HBCHU.20
AC   CVCL_A5ZG
DR   Wikidata; Q107115241
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5ZC ! HBCHU.09
OI   CVCL_A5ZD ! HBCHU.15
OI   CVCL_A5ZE ! HBCHU.16
OI   CVCL_A5ZF ! HBCHU.18
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HBDC
AC   CVCL_M273
SY   Hilar Bile Duct Carcinoma
DR   Wikidata; Q54881377
RX   CelloPub=CLPUB00275;
RX   PubMed=11180864;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 32.25 hours (PubMed=11180864).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   HBE-1A1
AC   CVCL_ZW91
DR   Wikidata; Q102114102
RX   PubMed=31295644;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0112 ! 16HBE14o-
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   HBE1
AC   CVCL_0287
SY   HBE-1; Human Bronchial Epithelial cell Line 1
DR   BTO; BTO_0002023
DR   MCCL; MCC:0000177
DR   Kerafast; ENC002
DR   Wikidata; Q54881378
RX   PubMed=7684560;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=pUC19).
CC   Donor information: Established from a patient who had a single lung transplant for idiopathic pulmonary fibrosis (PubMed=7684560).
CC   Discontinued: Kerafast; ENC002; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HBE135-E6E7
AC   CVCL_3695
SY   HBE 135-E6E7; HBE 135-E6/E7
DR   BTO; BTO_0005461
DR   CLO; CLO_0003623
DR   ATCC; CRL-2741
DR   BioSample; SAMN03471782
DR   Wikidata; Q54881379
RX   PubMed=8601403;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-2741
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 13,16
ST   D21S11: 28,30
ST   D2S1338: 16,17
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 5,6
ST   TPOX: 8,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   HBE4-E6/E7
AC   CVCL_3696
SY   HBE4-E6E7; NBE4-E6/E7
DR   CLO; CLO_0003624
DR   ATCC; CRL-2078
DR   BioSample; SAMN03471436
DR   cancercelllines; CVCL_3696
DR   GEO; GSM827168
DR   Progenetix; CVCL_3696
DR   Wikidata; Q54881380
RX   PubMed=8174640;
RX   PubMed=8601403;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (ATCC=CRL-2078).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a patient undergoing left upper lobectomy for a poorly differentiated adenocarcinoma (PubMed=8174640).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-2078
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 16,18
ST   D19S433: 15.2,16.2
ST   D21S11: 33.2
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 12
ST   Penta E: 5,13
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HBE4-E6/E7-C1
AC   CVCL_3697
SY   HBE4-E6E7-C1; NBE4-E6/E7-C1
DR   CLO; CLO_0003625
DR   ATCC; CRL-2079
DR   BioSample; SAMN03471439
DR   IZSLER; BS CL 225
DR   Wikidata; Q54881381
RX   PubMed=8174640;
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (ATCC=CRL-2079).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient undergoing left upper lobectomy for a poorly differentiated adenocarcinoma (PubMed=8174640).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-2079
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3696 ! HBE4-E6/E7
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   HBEC-5i
AC   CVCL_4D10
SY   HBEC5i; Human Brain Endothelial Cell line-5i
DR   AddexBio; T0005011/5009
DR   ATCC; CRL-3245
DR   Wikidata; Q54881382
RX   PubMed=16369021;
RX   PubMed=30240829;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
ST   Source(s): AddexBio=T0005011/5009; ATCC=CRL-3245
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 11
//
ID   HBEC1-KT
AC   CVCL_X489
SY   HBEC1 KT; HBEC1KT; HBEC1
DR   Wikidata; Q54881383
RX   PubMed=15604268;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 17
//
ID   HBEC10-KT
AC   CVCL_EQ77
SY   HBEC 10KT; HBEC/10KT
DR   GEO; GSM794414
DR   Wikidata; Q54881384
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC11-KT
AC   CVCL_EQ80
SY   HBEC11KT
DR   GEO; GSM794415
DR   Wikidata; Q54881385
RX   PubMed=30038707;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC12-KT
AC   CVCL_EQ81
SY   HBEC12KT
DR   GEO; GSM794416
DR   Wikidata; Q54881386
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC13-KT
AC   CVCL_EQ82
SY   HBEC13KT
DR   GEO; GSM794417
DR   Wikidata; Q54881387
RX   PubMed=29681454;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC14-KT
AC   CVCL_EQ83
SY   HBEC14KT
DR   GEO; GSM794418
DR   Wikidata; Q54881388
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC15-KT
AC   CVCL_EQ84
SY   HBEC15KT
DR   GEO; GSM794419
DR   Wikidata; Q54881389
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC16-KT
AC   CVCL_EQ85
SY   HBEC16KT
DR   GEO; GSM794420
DR   Wikidata; Q54881390
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC17-KT
AC   CVCL_EQ86
SY   HBEC17KT
DR   GEO; GSM794421
DR   Wikidata; Q54881391
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC18-KT
AC   CVCL_EQ87
DR   GEO; GSM794422
DR   Wikidata; Q54881392
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC2-E
AC   CVCL_DH91
SY   HBEC2 HPV16 E6/E7
DR   GEO; GSM171892
DR   GEO; GSM253435
DR   Wikidata; Q54881393
RX   PubMed=15604268;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X490 ! HBEC2-KT
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   HBEC2-KT
AC   CVCL_X490
SY   HBEC2 KT; HBEC2KT; HBEC 2-KT; HBEC2 Cdk4-hTERT; HBEC2
DR   GEO; GSM171893
DR   GEO; GSM253436
DR   GEO; GSM794408
DR   Wikidata; Q54881394
RX   PubMed=15604268;
RX   PubMed=20624269;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH91 ! HBEC2-E
SX   Male
AG   68Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 22
//
ID   HBEC24-KT
AC   CVCL_EQ88
SY   HBEC24KT
DR   GEO; GSM794423
DR   Wikidata; Q54881395
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC26-KT
AC   CVCL_EQ89
DR   GEO; GSM794424
DR   Wikidata; Q54881396
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC27-KT
AC   CVCL_EQ90
SY   HBEC27KT
DR   GEO; GSM794425
DR   Wikidata; Q54881397
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC28-KT
AC   CVCL_EQ91
SY   HBEC28KT
DR   GEO; GSM794426
DR   Wikidata; Q54881398
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC29-KT
AC   CVCL_EQ92
DR   GEO; GSM794427
DR   Wikidata; Q54881399
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC3-ET
AC   CVCL_D4C2
SY   HBEC3 HPV16 E6/E7 hTERT
DR   GEO; GSM171894
DR   Wikidata; Q127381112
RX   PubMed=15604268;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X491 ! HBEC3-KT
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HBEC3-KT
AC   CVCL_X491
SY   HBEC3 KT; HBEC 3KT; HBEC3KT; HBEC3 Cdk4-hTERT; HBEC3
DR   ABM; T0753
DR   ATCC; CRL-4051
DR   Evercyte; CkHT-004-0230
DR   GEO; GSM171895
DR   GEO; GSM253438
DR   GEO; GSM794409
DR   GEO; GSM7701486
DR   GEO; GSM7701487
DR   Wikidata; Q54881400
RX   PubMed=15604268;
RX   PubMed=20079948;
RX   PubMed=20624269;
RX   PubMed=21760947;
RX   PubMed=24240690;
RX   PubMed=29681454;
RX   PubMed=32586780;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: 36-48 hours (Evercyte=CkHT-004-0230).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4051
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D4C2 ! HBEC3-ET
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 26
//
ID   HBEC30-KT
AC   CVCL_AS83
SY   HBEC30KT
DR   GEO; GSM794428
DR   GEO; GSM817130
DR   Wikidata; Q54881401
RX   PubMed=24240690;
RX   PubMed=29681454;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V579 ! HCC4017
SX   Female
AG   62Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 17
//
ID   HBEC31-KT
AC   CVCL_EQ93
DR   GEO; GSM794429
DR   Wikidata; Q54881402
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC32-KT
AC   CVCL_EQ94
DR   GEO; GSM794430
DR   Wikidata; Q54881403
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC33-KT
AC   CVCL_EQ95
DR   GEO; GSM794431
DR   Wikidata; Q54881404
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 13
//
ID   HBEC34-KT
AC   CVCL_AS84
SY   HBEC34KT
DR   GEO; GSM794432
DR   GEO; GSM817131
DR   Wikidata; Q54881405
RX   PubMed=29681454;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 17
//
ID   HBEC35-KT
AC   CVCL_EQ96
SY   HBEC35KT
DR   GEO; GSM794433
DR   Wikidata; Q54881406
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC36-KT
AC   CVCL_EQ97
SY   HBEC36KT
DR   GEO; GSM794434
DR   Wikidata; Q54881407
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC37-KT
AC   CVCL_EQ98
SY   HBEC37KT
DR   GEO; GSM794435
DR   Wikidata; Q54881408
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 13
//
ID   HBEC38-KT
AC   CVCL_EQ99
DR   GEO; GSM794436
DR   Wikidata; Q54881413
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC39-KT
AC   CVCL_ER00
DR   GEO; GSM794437
DR   Wikidata; Q54881414
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC3KT53
AC   CVCL_EQ78
SY   HBEC 3KT53
DR   Wikidata; Q54881415
RX   PubMed=24240690;
CC   Knockout cell: Method=siRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X491 ! HBEC3-KT
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 17
//
ID   HBEC3KTRL53
AC   CVCL_EQ79
DR   Wikidata; Q54881416
RX   PubMed=24240690;
CC   Knockout cell: Method=siRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ78 ! HBEC3KT53
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 18
//
ID   HBEC4-KT
AC   CVCL_X492
SY   HBEC4 KT; HBEC 4-KT; HBEC4KT; HBEC4
DR   GEO; GSM171896
DR   GEO; GSM253433
DR   GEO; GSM794410
DR   Wikidata; Q54881417
RX   PubMed=15604268;
RX   PubMed=20624269;
RX   PubMed=32586780;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 21
//
ID   HBEC5-KT
AC   CVCL_X493
SY   HBEC5 KT; HBEC5KT; HBEC5
DR   GEO; GSM171897
DR   GEO; GSM253434
DR   GEO; GSM794411
DR   Wikidata; Q54881418
RX   PubMed=15604268;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 20
//
ID   HBEC6-KT
AC   CVCL_ER01
SY   HBEC6KT
DR   GEO; GSM794412
DR   Wikidata; Q54881419
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBEC7-KT
AC   CVCL_ER02
SY   HBEC7KT; HBEC7kt
DR   GEO; GSM794413
DR   Wikidata; Q54881420
RX   PubMed=30038707;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HBF
AC   CVCL_1G89
SY   Horabagrus Brachysoma Fin
DR   NRFC; NRFC008
DR   Wikidata; Q38224327
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=25359669;
WW   Provider; NRFC; NRFC008; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC008.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=337739; ! Horabagrus brachysoma (Gunther's catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   HBF/TERT88
AC   CVCL_9Q52
SY   HBF TERT88
DR   Evercyte; CHT-xxxxx1
DR   GEO; GSM7701476
DR   GEO; GSM7701477
DR   Wikidata; Q54881421
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Provider; Evercyte; -; https://web.archive.org/web/20150302212425/http://www.evercyte.com:80/medizin/cell-lines/immortalized-human-somatic-cells/hbf-tert88.html#.WroQ1S5uYgA
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: We could not find the catalog number of this discontinued Evercyte cell line.
CC   Discontinued: Evercyte; CHT-xxxxx1; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HbF12
AC   CVCL_E5PC
SY   MoAb12; MAb12
RX   Patent=US5858779;
RX   PubMed=2469638;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50142.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   HbF161
AC   CVCL_E5PJ
SY   MoAb161
RX   Patent=US5858779;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50123.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HbF165
AC   CVCL_E5PK
SY   MoAb165
RX   Patent=US5858779;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50124.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HbF45
AC   CVCL_E5PG
SY   MoAb45
RX   Patent=US5858779;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HbF52
AC   CVCL_E5PE
SY   MoAb52; MAb52
RX   Patent=US5858779;
RX   PubMed=2469638;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50143.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   HbF47
AC   CVCL_E5PH
SY   MoAb47
RX   Patent=US5858779;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HbF78
AC   CVCL_E5PF
SY   MoAb78; MAb78
RX   Patent=US5858779;
RX   PubMed=2469638;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50144.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   HbF98
AC   CVCL_E5PD
SY   MoAb98; MAb98
RX   Patent=US5858779;
RX   PubMed=2469638;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50145.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   HbF99
AC   CVCL_E5PI
SY   MoAb99
RX   Patent=US5858779;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50122.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P09038; Human FGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HBG
AC   CVCL_IW92
DR   Wikidata; Q54881422
RX   PubMed=9486853;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HBG BC2
AC   CVCL_IW93
SY   HBG-BC2; HBG, clone BC2; BC2
DR   Wikidata; Q30133230
RX   PubMed=9486853;
RX   PubMed=12776925;
RX   PubMed=23577442;
CC   Characteristics: Possesses the capacity of being reversibly differentiated in vitro and of maintaining a relatively higher metabolic rate when in the differentiated state (3 weeks). May be used for repeated toxicity testing on cells in culture.
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW92 ! HBG
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HBL
AC   CVCL_J075
DR   cancercelllines; CVCL_J075
DR   ChEMBL-Cells; CHEMBL3307524
DR   ChEMBL-Targets; CHEMBL614070
DR   Cosmic; 2051678
DR   PubChem_Cell_line; CVCL_J075
DR   Wikidata; Q54881423
RX   PubMed=2174414;
RX   PubMed=23489693;
RX   PubMed=25623468;
RX   PubMed=27540956;
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Unspecified (PubMed=23489693).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   HBL-1 [Human AIDS-related non-Hodgkin lymphoma]
AC   CVCL_M572
SY   HBL1
DR   ABM; T8204
DR   cancercelllines; CVCL_M572
DR   Cosmic; 1086334
DR   Cosmic; 1515192
DR   IARC_TP53; 22828
DR   PRIDE; PXD000589
DR   Wikidata; Q54881424
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8412324;
RX   PubMed=8568269;
RX   PubMed=25894527;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=8412324).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C5051; AIDS-related non-Hodgkin lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HBL-1 [Human diffuse large B-cell lymphoma]
AC   CVCL_4213
SY   HBL1
DR   BTO; BTO_0002522
DR   CLO; CLO_0037256
DR   EFO; EFO_0022408
DR   BioGRID_ORCS_Cell_line; 747
DR   cancercelllines; CVCL_4213
DR   Cosmic; 1486586
DR   Cosmic; 1487545
DR   Cosmic; 1517652
DR   Cosmic; 2129634
DR   Cosmic; 2437308
DR   GEO; GSM1035338
DR   GEO; GSM1059804
DR   GEO; GSM1374489
DR   GEO; GSM1890017
DR   GEO; GSM1890018
DR   GEO; GSM1890019
DR   GEO; GSM1890020
DR   GEO; GSM2037050
DR   GEO; GSM2037051
DR   Progenetix; CVCL_4213
DR   Wikidata; Q54881426
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2854303;
RX   PubMed=3338018;
RX   PubMed=8558920;
RX   PubMed=15028022;
RX   PubMed=20054396;
RX   PubMed=21179087;
RX   PubMed=23257783;
RX   PubMed=26787899;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30165192;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=3338018).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196Phe (c.587A>T); Zygosity=Heterozygous (PubMed=20054396).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (PubMed=21179087).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   HBL-10
AC   CVCL_4214
DR   BTO; BTO_0002531
DR   Wikidata; Q54881427
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   HBL-100
AC   CVCL_4362
SY   HBL 100; HBL100
DR   BTO; BTO_0004734
DR   CLO; CLO_0003626
DR   EFO; EFO_0001167
DR   CLDB; cl1571
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-TABM-157
DR   ATCC; HTB-124
DR   BioSample; SAMN03152011
DR   BioSample; SAMN03471101
DR   BioSample; SAMN03472914
DR   CCRID; 1101HUM-PUMC000374
DR   CCRID; 3101HUMGNHu10
DR   CCTCC; GDC0195
DR   ChEMBL-Cells; CHEMBL3307713
DR   ChEMBL-Targets; CHEMBL614811
DR   CLS; 300178
DR   Cosmic; 687471
DR   Cosmic; 877447
DR   Cosmic; 934533
DR   Cosmic; 979722
DR   Cosmic; 991323
DR   Cosmic; 1010933
DR   Cosmic; 1136364
DR   Cosmic; 1176632
DR   Cosmic; 1434949
DR   Cosmic; 1524348
DR   Cosmic; 1609469
DR   DepMap; ACH-002321
DR   EGA; EGAS00001000610
DR   GEO; GSM1053697
DR   IARC_TP53; 21063
DR   LINCS_HMS; 51117
DR   PharmacoDB; HBL100_443_2019
DR   PubChem_Cell_line; CVCL_4362
DR   RCB; RCB0460
DR   TOKU-E; 3589
DR   Ubigene; YC-C013
DR   Wikidata; Q54881428
RX   CelloPub=CLPUB00368;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=2547730;
RX   PubMed=2840847;
RX   PubMed=2995096;
RX   PubMed=3109929;
RX   PubMed=6500159;
RX   PubMed=6891286;
RX   PubMed=9671407;
RX   PubMed=10969801;
RX   PubMed=11416159;
RX   PubMed=12661003;
RX   PubMed=16643607;
RX   PubMed=17157791;
RX   PubMed=20143388;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28889351;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-297.html
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line from a 27 year old Caucasian woman. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00207.
CC   Virology: Contains 2 copies of the SV40 genome, one complete the other incomplete tandemly integrated in the cell line genome.
CC   Doubling time: 28 hours (Note=At 10th passage) (PubMed=6891286); 1.5 days (PubMed=9671407); ~40 hours (CLS=300178); 30.21 hours (JWGray panel).
CC   HLA typing: A*01:01,02:01; B*08:01,40:01; C*03:04,07:01; DRB1*14:76,15:01 (PubMed=26589293).
CC   Karyotypic information: Near triploid with the modal number of 67 chromosomes (ATCC=HTB-124).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; HTB-124; true.
CC   Discontinued: RCB; RCB0460; true.
ST   Source(s): ATCC=HTB-124; CCRID; CLS=300178; PubMed=11416159; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X (CCRID; PubMed=25877200; PubMed=28889351)
ST   Amelogenin: X,Y (ATCC=HTB-124; CLS=300178; PubMed=11416159)
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 15
ST   D21S11: 28,30
ST   D2S1338: 18,24
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,15
ST   FGA: 25
ST   Penta D: 12
ST   Penta E: 7
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   HBl-10U
AC   CVCL_UZ47
SY   HBL-10U; HBl 10U
DR   Wikidata; Q93980593
RX   PubMed=3866508;
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   20FW
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   HBl-10U/bmi1/TERT
AC   CVCL_UZ48
DR   Wikidata; Q93980595
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ47 ! HBl-10U
SX   Sex unspecified
AG   20FW
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   HBl-10U/E6E7
AC   CVCL_UZ49
DR   Wikidata; Q93980599
RX   PubMed=19489101;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ47 ! HBl-10U
SX   Sex unspecified
AG   20FW
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   HBL-11
AC   CVCL_4215
DR   BTO; BTO_0002533
DR   Wikidata; Q54881429
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   HBL-2 [Human AIDS-related non-Hodgkin lymphoma]
AC   CVCL_M574
SY   HBL2
DR   ABM; T8205
DR   cancercelllines; CVCL_M574
DR   Cosmic; 1086335
DR   Cosmic; 1515193
DR   GEO; GSM115801
DR   IARC_TP53; 22829
DR   Progenetix; CVCL_M574
DR   Wikidata; Q54881430
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8412324;
RX   PubMed=8568269;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Asn (c.700T>A); ClinVar=VCV000376692; Zygosity=Unspecified (PubMed=8412324).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8412324).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C5051; AIDS-related non-Hodgkin lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   HBL-2 [Human B-cell lymphoma]
AC   CVCL_M573
DR   cancercelllines; CVCL_M573
DR   IARC_TP53; 5997
DR   Wikidata; Q54881431
RX   PubMed=3899542;
RX   PubMed=8558920;
RX   PubMed=8878455;
CC   Population: Chinese.
CC   Doubling time: ~20 hours (PubMed=3899542).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Arg (c.838A>C); ClinVar=VCV000926213; Zygosity=Unspecified (PubMed=8878455).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Gly (c.842A>G); ClinVar=VCV000141141; Zygosity=Unspecified (PubMed=8878455).
CC   Misspelling: AKA96-2; IARC_TP53=5997; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   HBL-2 [Human mantle cell lymphoma]
AC   CVCL_4216
SY   Hbl-2; HBL2
DR   BTO; BTO_0002523
DR   Cosmic; 1047112
DR   Cosmic; 2296990
DR   GEO; GSM155078
DR   GEO; GSM155079
DR   GEO; GSM155080
DR   GEO; GSM629486
DR   GEO; GSM629487
DR   GEO; GSM1266775
DR   GEO; GSM1266776
DR   Wikidata; Q54881432
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3338018;
RX   PubMed=15028022;
RX   PubMed=16183118;
RX   PubMed=16960149;
RX   PubMed=17332242;
RX   PubMed=21746927;
RX   PubMed=24362935;
RX   PubMed=25960936;
RX   PubMed=26194763;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=3338018).
CC   HLA typing: A*31:01,24:02; B*52:01,35:01; C*04:01,12:02; DQA1*03:02,01:03; DQB1*06:01,03:03; DRB1*09:01,15:02 (PubMed=25960936).
CC   Karyotypic information: Has lost chromosome Y.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   HBL-3 [Human AIDS-related non-Hodgkin lymphoma]
AC   CVCL_M575
SY   HBL3
DR   ABM; T8206
DR   cancercelllines; CVCL_M575
DR   Cosmic; 1086336
DR   Cosmic; 1515194
DR   IARC_TP53; 122830
DR   Wikidata; Q54881433
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8412324;
RX   PubMed=8568269;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=8412324).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C5051; AIDS-related non-Hodgkin lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HBL-3 [Human leukemia]
AC   CVCL_4217
SY   HBL3
DR   BTO; BTO_0002534
DR   Wikidata; Q54881434
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1977232;
RX   PubMed=2486608;
RX   PubMed=15028022;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=2486608).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HBL-4 [Human AIDS-related non-Hodgkin lymphoma]
AC   CVCL_LI27
SY   HBL4
DR   Cosmic; 1515195
DR   Wikidata; Q54881435
RX   PubMed=8684008;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5051; AIDS-related non-Hodgkin lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   HBL-4 [Human Burkitt lymphoma]
AC   CVCL_4218
DR   BTO; BTO_0002526
DR   Wikidata; Q54881436
RX   PubMed=1309680;
RX   PubMed=9454894;
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: ~36 hours (PubMed=1309680).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   HBL-5
AC   CVCL_4219
DR   BTO; BTO_0002527
DR   Wikidata; Q54881437
RX   PubMed=1309680;
RX   PubMed=1592367;
RX   PubMed=2486609;
RX   PubMed=9454894;
RX   PubMed=12967475;
RX   PubMed=15028022;
RX   PubMed=24504345;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=2486609); ~48 hours (PubMed=1309680).
CC   Karyotypic information: Near tetraploid karyotype.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=9454894; PubMed=12967475).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5817; IGKV3-20 + HGNC; HGNC:37659; RNA28S5; Name(s)=IGKV3-20-RNA28S5, IGKV3-20-RN28S1 (PubMed=24504345).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   HBL-52
AC   CVCL_4220
SY   HBL 52
DR   BTO; BTO_0004430
DR   CLS; 300188
DR   Wikidata; Q54881438
RX   PubMed=12845453;
RX   PubMed=28552950;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, optic canal; UBERON=UBERON_0005745.
ST   Source(s): CLS=300188
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23,26
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,20
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   HBL-6
AC   CVCL_4221
SY   HBL6; BHL-6
DR   BTO; BTO_0002723
DR   Cosmic; 1515189
DR   Wikidata; Q54881439
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5849564;
RX   Patent=US5861500;
RX   PubMed=8523568;
RX   PubMed=8684008;
RX   PubMed=9473233;
RX   PubMed=9766492;
RX   PubMed=15028022;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HBL-6
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11762.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1079 ! BC-1
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HBL-7
AC   CVCL_4222
DR   BTO; BTO_0002528
DR   Wikidata; Q54881440
RX   PubMed=8905871;
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: ~84 hours (PubMed=8905871).
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   HBL-8
AC   CVCL_4223
DR   BTO; BTO_0002529
DR   Wikidata; Q54881441
RX   PubMed=8905871;
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: ~58 hours (PubMed=8905871).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   HBL-9
AC   CVCL_4224
DR   BTO; BTO_0002530
DR   Wikidata; Q54881442
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   HBLAK
AC   CVCL_JQ59
DR   Wikidata; Q54881443
RX   PubMed=28035326;
WW   Provider; CELLnTEC; -; https://cellntec.com/products/hblak/
CC   Doubling time: ~30 hours (PubMed=28035326).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=28035326).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28035326).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
ST   Source(s): PubMed=28035326
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 13,14
ST   D12S391: 17,21
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 14,15
ST   D1S1656: 15,18
ST   D21S11: 30,33.2
ST   D22S1045: 13,16
ST   D2S1338: 19,25
ST   D2S441: 10,11
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 20,22
ST   SE33: 24.2,27.2
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 13,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   HBLT-11
AC   CVCL_A5RV
DR   Wikidata; Q107115242
RX   PubMed=2840847;
RX   PubMed=3109929;
CC   Problematic cell line: Misidentified. Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin.
CC   Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4362 ! HBL-100
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HBLT-12
AC   CVCL_A5RW
DR   Wikidata; Q107115243
RX   PubMed=2840847;
RX   PubMed=3109929;
CC   Problematic cell line: Misidentified. Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin.
CC   Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4362 ! HBL-100
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HBLT-13
AC   CVCL_A5RX
DR   Wikidata; Q107115244
RX   PubMed=2840847;
CC   Problematic cell line: Misidentified. Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin.
CC   Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4362 ! HBL-100
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HBM-Noda
AC   CVCL_WT67
SY   Noda
DR   Wikidata; Q93980793
RX   PubMed=10849313;
RX   PubMed=11380694;
CC   Population: Japanese.
CC   Characteristics: Produces IgG lambda.
CC   Virology: Contains an EBV genome.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   HBME-1 [Human bone marrow]
AC   CVCL_U718
SY   Human Bone Marrow Endothelial-1
DR   ATCC; CRL-2767
DR   Wikidata; Q54881444
RX   PubMed=9450571;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMT10D).
CC   Discontinued: ATCC; CRL-2767; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   HBME-1 [Mouse hybridoma against human mesothelioma cells]
AC   CVCL_C8GC
SY   HBME1; Hector Battifora MEsothelial-1
DR   Wikidata; Q123031499
RX   CelloPub=CLPUB00740;
RX   PubMed=8972756;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown antigen on the microvilli of mesothelioma cells.
CC   Anecdotal: Named after the pathologist Battifora, Hector Antonio.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 3
//
ID   HBMEC-2
AC   CVCL_AT91
DR   ATCC; CRL-3023
DR   cancercelllines; CVCL_AT91
DR   ChEMBL-Cells; CHEMBL4513109
DR   PubChem_Cell_line; CVCL_AT91
DR   Wikidata; Q54881445
CC   Problematic cell line: Probably contaminated. The STR profile is identical to that of the T24 cell line.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-3023; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-3023
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   HBMEC-27
AC   CVCL_A4BE
SY   Human Bone Marrow Endothelial Cell line-27
DR   Wikidata; Q105507553
RX   PubMed=10428507;
RX   PubMed=10886302;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4BF ! HBMEC-28
OI   CVCL_A4BG ! HBMEC-33
OI   CVCL_A4BH ! HBMEC-60
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   HBMEC-28
AC   CVCL_A4BF
SY   Human Bone Marrow Endothelial Cell line-28
DR   Wikidata; Q105507557
RX   PubMed=10428507;
RX   PubMed=10886302;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4BE ! HBMEC-27
OI   CVCL_A4BG ! HBMEC-33
OI   CVCL_A4BH ! HBMEC-60
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   HBMEC-3
AC   CVCL_AT92
DR   ATCC; CRL-3024
DR   Wikidata; Q54881446
CC   Discontinued: ATCC; CRL-3024; true.
ST   Source(s): ATCC=CRL-3024
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 9,13
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Undefined cell line type
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 4
//
ID   HBMEC-33
AC   CVCL_A4BG
SY   Human Bone Marrow Endothelial Cell line-33
DR   Wikidata; Q105507561
RX   PubMed=10428507;
RX   PubMed=10886302;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4BE ! HBMEC-27
OI   CVCL_A4BF ! HBMEC-28
OI   CVCL_A4BH ! HBMEC-60
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   HBMEC-4
AC   CVCL_AT93
DR   ATCC; CRL-3025
DR   Wikidata; Q54881447
CC   Discontinued: ATCC; CRL-3025; true.
ST   Source(s): ATCC=CRL-3025
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Undefined cell line type
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 4
//
ID   HBMEC-60
AC   CVCL_A4BH
SY   Human Bone Marrow Endothelial Cell line-60
DR   Wikidata; Q105507565
RX   PubMed=10428507;
RX   PubMed=10886302;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4BE ! HBMEC-27
OI   CVCL_A4BF ! HBMEC-28
OI   CVCL_A4BG ! HBMEC-33
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   HBMEC/cibeta
AC   CVCL_4U95
SY   HBMEC/cib; Human BMEC/conditionally immortalized, clone beta
DR   Wikidata; Q54881448
RX   PubMed=23041702;
RX   PubMed=25763180;
RX   PubMed=30983357;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; Subcellular; Membrane; Quantitative.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HBMF-SPH
AC   CVCL_9V44
DR   NCBI_Iran; C171
DR   Wikidata; Q54881449
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HBMSC
AC   CVCL_A9JT
SY   Human Bone Marrow Mesenchymal Stem Cells
DR   CCRID; 5301HUM-KCB17038ZJ
DR   KCB; KCB 2017038ZJ
DR   Wikidata; Q108820399
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): CCRID=5301HUM-KCB17038ZJ
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   HBN8
AC   CVCL_C5BT
DR   Wikidata; Q116049287
RX   PubMed=23244322;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08987; Streptococcus mutans glucosyltransferase B (gtfB).
CC   Caution: Isotype indicated as IgG2b in results section and IgG2a in abstract of PubMed=23244322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HBPC-1
AC   CVCL_D3XA
SY   Hamster Buccal Pouch Cells-1
DR   Wikidata; Q127381114
RX   PubMed=1708371;
CC   Doubling time: ~18 hours (PubMed=1708371).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Cheek pouch; UBERON=UBERON_0008802.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C134565; Hamster buccal pouch carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HBPC-2
AC   CVCL_D3XB
SY   Hamster Buccal Pouch Cells-2
DR   Wikidata; Q127381115
RX   PubMed=1708371;
CC   Doubling time: ~18 hours (PubMed=1708371).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Transformant: NCBI_TaxID; 10304; Human herpesvirus 1 (strain F) (HHV-1).
CC   Derived from site: In situ; Cheek pouch; UBERON=UBERON_0008802.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C134565; Hamster buccal pouch carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   HBPC-3
AC   CVCL_D3XC
SY   Hamster Buccal Pouch Cells-3
DR   Wikidata; Q127381116
RX   PubMed=1708371;
CC   Doubling time: ~18 hours (PubMed=1708371).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Transformant: NCBI_TaxID; 10314; Human herpesvirus 2 (HHV-2) (strain G).
CC   Derived from site: In situ; Cheek pouch; UBERON=UBERON_0008802.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HBPC/ci37
AC   CVCL_QX23
SY   Human Brain PeriCytes/conditionally immortalized, clone 37
DR   Wikidata; Q54881450
RX   PubMed=29128907;
CC   Doubling time: 2.1 days (PubMed=29128907).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Pericyte; CL=CL_0000669.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Conditionally immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   HBR-M1
AC   CVCL_A9IM
SY   HBRM1
DR   CCRID; 5301MAM-KCB02002ZJ
DR   KCB; KCB 200202ZJ
DR   Wikidata; Q108820400
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=53275; ! Rhizomys pruinosus (Hoary bamboo rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HBR-S2
AC   CVCL_A9IN
SY   HBRS2
DR   CCRID; 5301MAM-KCB03021ZJ
DR   KCB; KCB 200321ZJ
DR   Wikidata; Q108820401
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=53275; ! Rhizomys pruinosus (Hoary bamboo rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   hBRIE 380
AC   CVCL_GZ57
SY   hybrid Berkeley Rat Intestinal Epithelial clone 380
DR   Wikidata; Q54881451
RX   PubMed=1711225;
RX   PubMed=7943338;
RX   PubMed=9487140;
CC   Characteristics: Fusion of the BRI 291 cell line with a freshly dispersed small intestinal mucosa epithelial cell (PubMed=1711225).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GZ56 ! BRIE 291
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   hBRIE 380i
AC   CVCL_GZ58
DR   Wikidata; Q54881452
RX   PubMed=7943338;
RX   PubMed=9487140;
CC   Characteristics: Selected specifically for FABP2 (I-FABP) expression without FABP1 (L-FABP) expression (PubMed=7943338).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GZ57 ! hBRIE 380
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   hBRIE 380i-neg
AC   CVCL_GZ59
DR   TOKU-E; 4034
DR   Wikidata; Q54881453
RX   PubMed=9487140;
CC   Characteristics: Does not express FABP2 (I-FABP) (PubMed=9487140).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_GZ57 ! hBRIE 380
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HBS-1
AC   CVCL_D7CU
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-18
AC   CVCL_D7CV
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-19
AC   CVCL_D7CW
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-2
AC   CVCL_D7CX
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-20
AC   CVCL_D7CY
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-22
AC   CVCL_D7CZ
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-23
AC   CVCL_D7D0
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-28
AC   CVCL_D7D1
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-3
AC   CVCL_D7D2
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-8
AC   CVCL_D7D3
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-9
AC   CVCL_D7D4
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-C
AC   CVCL_D7D5
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBS-L
AC   CVCL_D7D6
RX   PubMed=25897606;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Hepatitis B virus HBsAg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HBs128
AC   CVCL_8534
DR   JCRB; JCRB1381
DR   Wikidata; Q54881455
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Hepatitis B virus surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   HBs320
AC   CVCL_8535
DR   JCRB; JCRB1380
DR   Wikidata; Q54881456
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Hepatitis B virus surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   hBSM
AC   CVCL_9T95
SY   human Bladder wall Smooth Muscle
DR   Wikidata; Q54881457
RX   PubMed=22259013;
CC   Doubling time: ~72 hours (PubMed=22259013).
CC   Donor information: Established from a the normal region of bladder tissue from a patient who underwent cystectomy for a transitional cell tumor.
CC   Derived from site: In situ; Urinary bladder, smooth muscle; UBERON=UBERON_0004228.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HBT-3
AC   CVCL_D281
SY   HBT3
DR   BioSample; SAMN03151699
DR   Wikidata; Q54881458
RX   CelloPub=CLPUB00262;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=1246601;
RX   PubMed=4344270;
RX   PubMed=4469665;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00052.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   HBT-39b
AC   CVCL_J652
SY   HBT-39B; HBT39B; HBT39b; HBT-39; HT-39
DR   BioSample; SAMN03151700
DR   Wikidata; Q54881459
RX   CelloPub=CLPUB00262;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=884688;
RX   PubMed=1000504;
RX   PubMed=1000506;
RX   PubMed=1246601;
RX   PubMed=4122211;
RX   PubMed=4469665;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=884688; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00053.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 22
//
ID   HBT-E
AC   CVCL_M746
SY   HBTE; 16c
DR   BioSample; SAMN03151701
DR   Wikidata; Q54881460
RX   PubMed=1246601;
RX   PubMed=4469665;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00054.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D281 ! HBT-3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HBZY-1
AC   CVCL_7213
SY   HBZY 1; HBZY1
DR   CCRID; 1101RAT-PUMC000375
DR   CCRID; 4201RAT-CCTCC00124
DR   CCTCC; GDC0124
DR   ChEMBL-Cells; CHEMBL4482989
DR   ChEMBL-Targets; CHEMBL4483242
DR   CLS; 305206
DR   PubChem_Cell_line; CVCL_7213
DR   Wikidata; Q54881461
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HC-04
AC   CVCL_Z631
SY   HC04; HCO4
DR   ArrayExpress; E-MTAB-6919
DR   BEI_Resources; MRA-975
DR   cancercelllines; CVCL_Z631
DR   PRIDE; PXD008613
DR   Wikidata; Q54881462
RX   Patent=US7015036;
RX   PubMed=16687667;
RX   PubMed=17590308;
RX   PubMed=22990793;
RX   PubMed=24532842;
RX   PubMed=29370800;
RX   PubMed=30891005;
CC   Group: Malaria research cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Possibly contaminated. Indicated (PubMed=24532842) to have a near genetic identity with Hep-G2 cells. But they are functionally different from Hep-G2 cells since they support sporozoite invasion and liver stage exoerythrocytic development of Plasmodium falciparum and Plasmodium vivax. But STR profile from BEI Resources is identical to that of Hep-G2. Originally thought to originate from the spontaneous immortalization of a normal liver tissue of an hepatoma patient.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3441.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (PubMed=17590308); 40 hours (PubMed=29370800).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): BEI_Resources=MRA-975
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 26
//
ID   HC-04.J7
AC   CVCL_B7D7
DR   ArrayExpress; E-MTAB-6919
DR   cancercelllines; CVCL_B7D7
DR   PRIDE; PXD008613
DR   Wikidata; Q112929640
RX   PubMed=30891005;
CC   Group: Malaria research cell line.
CC   Problematic cell line: Possibly contaminated. Parent cell line (HC-04) has been shown to have an STR profile identical to that of Hep-G2.
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, has an inscreased susceptibility to Plasmodium falciparum sporozoite invasion (PubMed=30891005).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z631 ! HC-04
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 9
//
ID   HC-1
AC   CVCL_1243
SY   HC1
DR   CLO; CLO_0003627
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473346
DR   cancercelllines; CVCL_1243
DR   Cell_Model_Passport; SIDM01073
DR   ChEMBL-Cells; CHEMBL3308522
DR   ChEMBL-Targets; CHEMBL2366299
DR   Cosmic; 907044
DR   Cosmic; 1809512
DR   Cosmic; 2690009
DR   Cosmic-CLP; 907044
DR   DepMap; ACH-002242
DR   DSMZ; ACC-301
DR   DSMZCellDive; ACC-301
DR   EGA; EGAS00001000978
DR   GDSC; 907044
DR   GEO; GSM1669840
DR   IARC_TP53; 21358
DR   LINCS_LDP; LCL-1086
DR   PharmacoDB; HC1_444_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1243
DR   Wikidata; Q54881463
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1851909;
RX   PubMed=20164919;
RX   PubMed=20454443;
RX   PubMed=22653958;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Problematic cell line: Possibly misclassified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~45 hours (DSMZ=ACC-301).
CC   HLA typing: A*03:01:01,03:01:01; B*15:01:01,35:03:01; C*03:04:01,03:04:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRA*01:01:01,01:01:01; DRB1*04:01:01,11:04:01 (DSMZCellDive=ACC-301).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.03%; East Asian, South=0%; South Asian=1.15%; European, North=70.39%; European, South=28.43% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=907044; DSMZ=ACC-301
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 30.2,33.2
ST   D2S1338: 20,25
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 11
ST   Penta E: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   HC-2
AC   CVCL_X173
DR   Wikidata; Q54881464
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2914273;
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X211 ! HC-3
OI   CVCL_X212 ! HC-4
OI   CVCL_X213 ! HC-7
OI   CVCL_X214 ! HC-9
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   HC-2-6
AC   CVCL_RJ61
DR   Wikidata; Q54881465
RX   PubMed=2914273;
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X173 ! HC-2
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   HC-3
AC   CVCL_X211
DR   Wikidata; Q54881466
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2914273;
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X173 ! HC-2
OI   CVCL_X212 ! HC-4
OI   CVCL_X213 ! HC-7
OI   CVCL_X214 ! HC-9
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   HC-4
AC   CVCL_X212
DR   Wikidata; Q54881467
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2914273;
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X173 ! HC-2
OI   CVCL_X211 ! HC-3
OI   CVCL_X213 ! HC-7
OI   CVCL_X214 ! HC-9
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   HC-4-EL1
AC   CVCL_RJ59
DR   GEO; GSM2265464
DR   GEO; GSM2265465
DR   SKIP; SKIP001275
DR   Wikidata; Q54881468
RX   PubMed=27806289;
CC   Population: Asian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   HC-6-1
AC   CVCL_RJ60
DR   SKIP; SKIP001276
DR   Wikidata; Q54881469
RX   PubMed=27806289;
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   HC-7
AC   CVCL_X213
DR   Wikidata; Q54881470
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2914273;
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X173 ! HC-2
OI   CVCL_X211 ! HC-3
OI   CVCL_X212 ! HC-4
OI   CVCL_X214 ! HC-9
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   HC-7-5
AC   CVCL_X215
DR   Wikidata; Q54881471
RX   PubMed=2914273;
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X213 ! HC-7
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   HC-7-5/VCR
AC   CVCL_X216
DR   Wikidata; Q54881472
RX   PubMed=2568984;
RX   PubMed=2914273;
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X215 ! HC-7-5
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
ID   HC-9
AC   CVCL_X214
DR   Wikidata; Q54881473
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2914273;
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X173 ! HC-2
OI   CVCL_X211 ! HC-3
OI   CVCL_X212 ! HC-4
OI   CVCL_X213 ! HC-7
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   HC-AFW1
AC   CVCL_M172
SY   HCAFW1
DR   cancercelllines; CVCL_M172
DR   GEO; GSE29283
DR   Progenetix; CVCL_M172
DR   Wikidata; Q54881474
RX   PubMed=22666492;
RX   PubMed=26310804;
CC   Doubling time: 40 hours (PubMed=22666492).
CC   Sequence variation: Gene deletion; HGNC; HGNC:2625; CYP2D6; Zygosity=Heterozygous (PubMed=26310804).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Val22_Phe70del; Zygosity=Heterozygous (PubMed=22666492).
CC   Omics: Variations; CNV analysis.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   HC-R1
AC   CVCL_F1BF
RX   PubMed=12190868;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HC030101,F.G.
AC   CVCL_6G69
SY   HC030101
DR   IPD-IMGT/HLA; 12648
DR   Wikidata; Q54881475
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*36:03,68:02; B*42:01,53:01; C*04:01,17; DPB1*01:01; DQA1*04:01; DQB1*04:02; DRB1*03:02; DRB3*01:01 (IPD-IMGT/HLA=12648).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   HC0597
AC   CVCL_UZ31
SY   HCO597
DR   Wikidata; Q93981246
RX   CelloPub=CLPUB00479;
RX   Patent=US6030789;
RX   PubMed=29787296;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12658.
CC   Doubling time: 31.7 +- 0.5 hours (Patent=US6030789).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Anecdotal: Developed and patented by Gillette as a model to replace the Draize rabbit eye test for evaluation of the eye irritation potential of products.
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
ST   Source(s): PubMed=29787296
ST   Amelogenin: X
ST   D13S317: 11,12
ST   D16S539: 10
ST   D18S51: 23,24
ST   D21S11: 28,32.3
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 22
ST   Penta D: 5,9
ST   Penta E: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   HC0708
AC   CVCL_UZ32
SY   HC7.08
DR   Wikidata; Q93981252
RX   CelloPub=CLPUB00479;
RX   Patent=US6030789;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12659.
CC   Doubling time: 30.9 +- 0.4 hours (Patent=US6030789).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Anecdotal: Developed and patented by Gillette as a model to replace the Draize rabbit eye test for evaluation of the eye irritation potential of products.
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   HC1
AC   CVCL_C6W1
DR   SKIP; SKIP001029
DR   Wikidata; Q117704471
RX   PubMed=27402089;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   HC1042
AC   CVCL_C8C5
DR   Wikidata; Q123031501
RX   PubMed=3785179;
RX   PubMed=7162515;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179; PubMed=7162515).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8BY ! HC4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC1047
AC   CVCL_C8C4
SY   HC47
DR   Wikidata; Q123031505
RX   PubMed=3785179;
RX   PubMed=7162515;
RX   PubMed=8569793;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179; PubMed=7162515).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8BY ! HC4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC1055
AC   CVCL_C8C9
DR   Wikidata; Q123031508
RX   PubMed=3785179;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8BZ ! HC5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC1056
AC   CVCL_C8CA
DR   Wikidata; Q123031512
RX   PubMed=3785179;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8BZ ! HC5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC1061
AC   CVCL_C8C1
DR   Wikidata; Q123031514
RX   PubMed=3785179;
RX   PubMed=7162515;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179; PubMed=7162515).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C0 ! HC6
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC1063
AC   CVCL_C8C6
DR   Wikidata; Q123031515
RX   PubMed=3785179;
RX   PubMed=7162515;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179; PubMed=7162515).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C0 ! HC6
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC11
AC   CVCL_0288
SY   HC-11; HC11 Mammary Epithelium
DR   BTO; BTO_0003892
DR   EFO; EFO_0006414
DR   MCCL; MCC:0000178
DR   ABM; T0672
DR   ATCC; CRL-3062
DR   CCRID; 3101MOUSCSP5037
DR   CCRID; 5301MOU-KCB21044YJ
DR   CLS; 305050
DR   DSMZ; ACC-780
DR   DSMZCellDive; ACC-780
DR   KCB; KCB 2021044YJ
DR   Lonza; 967
DR   Wikidata; Q54881476
RX   PubMed=3416834;
RX   PubMed=12702582;
RX   PubMed=19523745;
WW   Info; -; -; https://cpb-us-e2.wpmucdn.com/faculty.sites.uci.edu/dist/0/349/files/2014/03/HC11-Culture-KW-BG.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-143.html
CC   Doubling time: ~50-80 hours (DSMZ=ACC-780).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 28
//
ID   HC11-BC20
AC   CVCL_5G41
SY   BC20
DR   Wikidata; Q54881477
RX   PubMed=10198285;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0288 ! HC11
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 10
//
ID   HC11-BC44
AC   CVCL_5G42
SY   BC44
DR   Wikidata; Q54881478
RX   PubMed=10198285;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0288 ! HC11
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 10
//
ID   HC11-C24
AC   CVCL_0R13
DR   BTO; BTO_0004015
DR   Wikidata; Q54881479
RX   PubMed=18767115;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0288 ! HC11
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   HC11-C4
AC   CVCL_0R14
DR   Wikidata; Q54881480
RX   PubMed=18767115;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0288 ! HC11
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   HC11/MV7
AC   CVCL_B4FA
DR   Wikidata; Q110432836
RX   PubMed=12702582;
CC   Characteristics: Control cell line for HC11/Twist (Cellosaurus=CVCL_B4FB) and HC11/Wnt-1 (Cellosaurus=CVCL_B4FC) (PubMed=12702582).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0288 ! HC11
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HC11/Twist
AC   CVCL_B4FB
DR   Wikidata; Q110432837
RX   PubMed=12702582;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98872; Twist1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0288 ! HC11
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HC11/Wnt-1
AC   CVCL_B4FC
DR   Wikidata; Q110432838
RX   PubMed=12702582;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0288 ! HC11
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HC11.13.1
AC   CVCL_B0WL
DR   Wikidata; Q108820402
RX   PubMed=2267410;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HC11.151.1
AC   CVCL_B0WM
DR   Wikidata; Q108820403
RX   PubMed=2267410;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HC11.208.1
AC   CVCL_B0WN
DR   Wikidata; Q108820404
RX   PubMed=2267410;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HC2
AC   CVCL_C6W2
DR   SKIP; SKIP001030
DR   Wikidata; Q117704472
RX   PubMed=27402089;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   HC2561
AC   CVCL_C8C2
DR   Wikidata; Q123031517
RX   PubMed=7162515;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=7162515).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C1 ! HC1061
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC2S2
AC   CVCL_6A80
DR   Wikidata; Q54881481
RX   PubMed=8643664;
RX   PubMed=9634594;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3M
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HC2SPEx
AC   CVCL_1G90
SY   HoneyComb grouper 2 SPleen Explant
DR   NRFC; NRFC038
DR   Wikidata; Q54881482
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC038; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC038.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=215346; ! Epinephelus merra (Honeycomb grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   HC3
AC   CVCL_C6W3
DR   SKIP; SKIP001031
DR   Wikidata; Q117704473
RX   PubMed=27402089;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Hc3716-hTERT
AC   CVCL_B6EH
DR   Wikidata; Q111733334
RX   PubMed=20456367;
CC   Doubling time: ~2.5 days (PubMed=20456367).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HC4
AC   CVCL_C8BY
DR   Wikidata; Q123031520
RX   PubMed=3785179;
RX   PubMed=7162515;
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG47 ! GMA32
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC45
AC   CVCL_S962
DR   Wikidata; Q54881483
RX   PubMed=18247165;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=AD-SVR4).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   HC49
AC   CVCL_S963
DR   Wikidata; Q54881484
RX   PubMed=18247165;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=AD-SVR4).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C6423; Hindgut carcinoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   HC5
AC   CVCL_C8BZ
DR   Wikidata; Q123031524
RX   PubMed=3785179;
RX   PubMed=7162515;
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG47 ! GMA32
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC50422
AC   CVCL_C8C8
DR   Wikidata; Q123031528
RX   PubMed=3785179;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C5 ! HC1042
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC50474
AC   CVCL_C8C7
SY   HC474
DR   Wikidata; Q123031529
RX   PubMed=3785179;
RX   PubMed=6526013;
RX   PubMed=8569793;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=6526013).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C4 ! HC1047
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC50551
AC   CVCL_C8CB
DR   Wikidata; Q123031530
RX   PubMed=3785179;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C9 ! HC1055
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC50562
AC   CVCL_C8CC
DR   Wikidata; Q123031532
RX   PubMed=3785179;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8CA ! HC1056
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC50611
AC   CVCL_C8C3
SY   HC5061
DR   Wikidata; Q123031536
RX   PubMed=3785179;
RX   PubMed=6526013;
RX   PubMed=7162515;
CC   Characteristics: Overproduces adenylate deaminase. Expresses 150-fold more AMPD activity than wild-type GMA32 cells (PubMed=6526013; PubMed=7162515).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C2 ! HC2561
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC50633
AC   CVCL_C8CD
DR   Wikidata; Q123031539
RX   PubMed=3785179;
CC   Characteristics: Overproduces adenylate deaminase (PubMed=3785179).
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_C8C6 ! HC1063
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC6
AC   CVCL_C8C0
DR   Wikidata; Q123031543
RX   PubMed=3785179;
RX   PubMed=7162515;
CC   Selected for resistance to: ChEBI; CHEBI_16213; Coformycin.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG47 ! GMA32
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   HC84S
AC   CVCL_A9Y0
DR   cancercelllines; CVCL_A9Y0
DR   Wikidata; Q102114104
RX   PubMed=6932031;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Doubling time: 6-7 days (PubMed=6932031).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu1488Phefs*19 (c.4464delA); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Lys340Asn (c.1020G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>T; ClinVar=VCV003148249; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0555 ! T84
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   HCA-1
AC   CVCL_E2Y9
SY   HCa-1
RX   PubMed=3742713;
RX   PubMed=26203823;
CC   Characteristics: Established from a transplantable tumor.
CC   Doubling time: 12-14 hours (PubMed=3742713).
CC   Miscellaneous: Sex of donor from personal communication of Duda, Dan Gabriel.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3Hf/Kam.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HCA-155H
AC   CVCL_A0EW
DR   Wikidata; Q108820405
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-1R
AC   CVCL_E2YA
RX   PubMed=24403450;
CC   Population: Japanese.
CC   Doubling time: 20 hours (PubMed=24403450).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2916 ! HCA1
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HCA-212
AC   CVCL_A0EX
DR   Wikidata; Q108820406
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-231H
AC   CVCL_A0EY
DR   Wikidata; Q108820407
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-290
AC   CVCL_A0EZ
DR   Wikidata; Q108820408
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-293HDR
AC   CVCL_A0FA
DR   Wikidata; Q108820409
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-350DHR
AC   CVCL_A0FB
DR   Wikidata; Q108820410
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-507HD
AC   CVCL_A0FC
DR   Wikidata; Q108820411
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-57HDR
AC   CVCL_A0FD
DR   Wikidata; Q108820412
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-627
AC   CVCL_A0FE
DR   Wikidata; Q108820413
RX   Patent=US5767247;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5284.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-646HD
AC   CVCL_A0FF
DR   Wikidata; Q108820414
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-656
AC   CVCL_A0FG
DR   Wikidata; Q108820415
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-660HD
AC   CVCL_A0FH
DR   Wikidata; Q108820416
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-671H
AC   CVCL_A0FI
DR   Wikidata; Q108820417
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-69H
AC   CVCL_A0FJ
DR   Wikidata; Q108820418
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-713
AC   CVCL_A0FK
DR   Wikidata; Q108820419
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-770H
AC   CVCL_A0FL
DR   Wikidata; Q108820420
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-784H
AC   CVCL_A0FM
DR   Wikidata; Q108820421
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-803H
AC   CVCL_A0FN
DR   Wikidata; Q108820422
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-805
AC   CVCL_A0FP
DR   Wikidata; Q108820423
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-805HDR
AC   CVCL_A0FQ
DR   Wikidata; Q108820424
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HCA-838H
AC   CVCL_A0FR
DR   Wikidata; Q108820425
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Hca-F
AC   CVCL_D015
SY   HcaF; HCa/16A3-F
DR   BTO; BTO_0003642
DR   Wikidata; Q54881485
RX   CelloPub=CLPUB00046;
RX   PubMed=15633228;
RX   PubMed=19562801;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Omics: Genomics; Mitochondrial genome sequencing; Partial.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H613 ! H22
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   Hca-P
AC   CVCL_D016
SY   HcaP; Hca/A2-P
DR   BTO; BTO_0006509
DR   Wikidata; Q54881486
RX   CelloPub=CLPUB00046;
RX   PubMed=15633228;
RX   PubMed=19562801;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Omics: Genomics; Mitochondrial genome sequencing; Partial.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H613 ! H22
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   HCA1
AC   CVCL_2916
SY   HCA-1
DR   BioSample; SAMN03470914
DR   BioSample; SAMN03472467
DR   cancercelllines; CVCL_2916
DR   Cell_Model_Passport; SIDM01813
DR   DepMap; ACH-001513
DR   JCRB; JCRB1153
DR   JCRB; NIHS0406
DR   Wikidata; Q54881487
RX   CelloPub=CLPUB00777;
RX   PubMed=24403450;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 26.4 hours (CelloPub=CLPUB00777); 21 hours (PubMed=24403450).
CC   Discontinued: JCRB; NIHS0406; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): DepMap=ACH-001513; JCRB=JCRB1153; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 10
ST   Penta E: 18,21
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   HCA2 [Human colon carcinoma]
AC   CVCL_2056
SY   HCA-2
DR   ECACC; 06061901
DR   GEO; GSM3145579
DR   GEO; GSM3145706
DR   Wikidata; Q54881488
DR   Ximbio; 152461
RX   PubMed=3718830;
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Ximbio; 152461; probable.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C43584; Rectosigmoid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   HCA2 [Human foreskin fibroblast]
AC   CVCL_E2UW
SY   HCA 2
DR   GEO; GSE198396
RX   PubMed=7753810;
RX   PubMed=9310070;
RX   PubMed=36323784;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HCA24
AC   CVCL_2467
SY   HCA-24
DR   ECACC; 06061903
DR   GEO; GSM1448109
DR   GEO; GSM3145580
DR   GEO; GSM3145707
DR   Wikidata; Q54881489
DR   Ximbio; 152462
RX   PubMed=3718830;
RX   PubMed=25926053;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Ximbio; 152462; probable.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 13
ST   D7S820: 8,11.3
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   HCA46
AC   CVCL_2468
SY   HCA-46; HCA 46
DR   ColonAtlas; HCA46
DR   Cosmic; 876708
DR   Cosmic; 948844
DR   Cosmic; 986013
DR   Cosmic; 995411
DR   Cosmic; 1043812
DR   Cosmic; 1223139
DR   Cosmic; 1312300
DR   Cosmic; 2301975
DR   Cosmic; 2760083
DR   Cosmic; 2800581
DR   Cosmic; 2841363
DR   ECACC; 07031601
DR   GEO; GSM1346836
DR   GEO; GSM1374490
DR   GEO; GSM1448177
DR   IARC_TP53; 21759
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54881490
DR   Ximbio; 152463
RX   PubMed=3718830;
RX   PubMed=8464898;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25623215;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala183Ser (c.547G>T); Zygosity=Heterozygous (PubMed=9294210).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Alafs*33 (c.815_816delTG); Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Ximbio; 152463; probable.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): ECACC=07031601; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   HCA46 R1 Cetux
AC   CVCL_A2BY
SY   HCA-46 R1 Cetux
DR   Cosmic; 2841364
DR   Wikidata; Q105507568
RX   PubMed=25623215;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala183Ser (c.547G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Alafs*33 (c.815_816delTG); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2468 ! HCA46
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HCA46 R2 Cetux
AC   CVCL_A2BZ
SY   HCA-46 R2 Cetux
DR   Cosmic; 2841365
DR   Wikidata; Q105507572
RX   PubMed=25623215;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala183Ser (c.547G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Alafs*33 (c.815_816delTG); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2468 ! HCA46
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HCA7
AC   CVCL_0289
SY   HCA-7; HCA 7
DR   BTO; BTO_0003031
DR   EFO; EFO_0006415
DR   MCCL; MCC:0000179
DR   AddexBio; C0009003/40
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471988
DR   cancercelllines; CVCL_0289
DR   ColonAtlas; HCA7
DR   Cosmic; 876722
DR   Cosmic; 948860
DR   Cosmic; 985995
DR   Cosmic; 995407
DR   Cosmic; 1043813
DR   Cosmic; 1223140
DR   Cosmic; 1312301
DR   Cosmic; 1479629
DR   Cosmic; 1486131
DR   Cosmic; 1805252
DR   Cosmic; 1933017
DR   Cosmic; 2301976
DR   Cosmic; 2760084
DR   ECACC; 06061902
DR   EGA; EGAS00001000610
DR   GEO; GSM741260
DR   GEO; GSM1346872
DR   GEO; GSM1374491
DR   GEO; GSM1374492
DR   GEO; GSM1448125
DR   GEO; GSM3145609
DR   GEO; GSM3145708
DR   IARC_TP53; 21760
DR   PharmacoDB; HCA7_445_2019
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54881491
DR   Ximbio; 152451
RX   PubMed=3718830;
RX   PubMed=4016751;
RX   PubMed=8410493;
RX   PubMed=8464898;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=29101300;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/HCA7.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-584.html
CC   Part of: KuDOS 95 cell line panel.
CC   HLA typing: A*01:01,02:01; B*37:01,51:01; C*06:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (PubMed=16418264; PubMed=24755471).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Ximbio; 152451; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009003/40; ECACC=06061902; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,11 (AddexBio=C0009003/40; ECACC=06061902; PubMed=25926053)
ST   D16S539: 11 (PubMed=25877200)
ST   D18S51: 19
ST   D21S11: 26,28.2 (PubMed=25877200)
ST   D21S11: 26,28.2,29.2 (PubMed=25926053)
ST   D3S1358: 15,19
ST   D5S818: 8,12 (ECACC=06061902; PubMed=25877200)
ST   D5S818: 9,11,12 (PubMed=25926053)
ST   D5S818: 9,12 (AddexBio=C0009003/40)
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18.2,22
ST   Penta D: 9
ST   Penta E: 12,18
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   HCA7 colony 1
AC   CVCL_2469
SY   HCA-7 Colony 1; HCA-7 Colony1; HCA-7 Col-1; Colony-1; Col-1; Col 1
DR   BTO; BTO_0003258
DR   ECACC; 09071501
DR   Wikidata; Q54881492
DR   Ximbio; 152452
RX   CelloPub=CLPUB00715;
RX   PubMed=8410493;
RX   PubMed=9050010;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152452; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HCA7 colony 1 C1Y1-15
AC   CVCL_C1KR
SY   C1Y1-15
DR   Wikidata; Q114311565
RX   PubMed=12788810;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2469 ! HCA7 colony 1
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   HCA7 colony 1 C1Y1-6
AC   CVCL_C1KM
SY   C1Y1-6
DR   Wikidata; Q114311566
RX   CelloPub=CLPUB00715;
RX   PubMed=10737675;
RX   PubMed=12788810;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2469 ! HCA7 colony 1
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   HCA7 colony 1 C1Y1C-3
AC   CVCL_C1KS
SY   C1Y1C-3
DR   Wikidata; Q114311567
RX   CelloPub=CLPUB00715;
RX   PubMed=12788810;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r (Note=With p.Cys337Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2469 ! HCA7 colony 1
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   HCA7 colony 1 C1Y1C-5
AC   CVCL_C1KT
SY   C1Y1C-5
DR   Wikidata; Q114311568
RX   PubMed=12788810;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r (Note=With p.Cys337Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2469 ! HCA7 colony 1
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   HCA7 colony 11
AC   CVCL_2470
SY   HCA-7 Colony 11; HCA-7 Colony11; Col-11; Col 11
DR   ECACC; 09071506
DR   Wikidata; Q54881493
DR   Ximbio; 152455
RX   PubMed=8410493;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152455; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=09071506
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,12
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HCA7 colony 24
AC   CVCL_2471
SY   HCA-7 Colony 24; Colony-24; Col-24; Col 24
DR   BTO; BTO_0003259
DR   ECACC; 09071509
DR   Wikidata; Q54881494
DR   Ximbio; 152456
RX   PubMed=8410493;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152456; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=09071509
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 8,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HCA7 colony 26
AC   CVCL_2472
SY   HCA-7 Colony 26; HCA-7 Colony26; Col 26
DR   ECACC; 09071511
DR   Wikidata; Q54881496
DR   Ximbio; 152457
RX   PubMed=8410493;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152457; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=09071511
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 8,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HCA7 colony 27
AC   CVCL_2473
SY   HCA-7 Colony 27; HCA-7 Colony27; Col 27
DR   ECACC; 09071513
DR   Wikidata; Q54881497
DR   Ximbio; 152458
RX   PubMed=8410493;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152458; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HCA7 colony 29
AC   CVCL_2474
SY   HCA-7 Colony 29; HCA-7 Colony29; Col 29
DR   ECACC; 02091238
DR   Wikidata; Q54881498
DR   Ximbio; 152459
RX   PubMed=8410493;
RX   PubMed=9012840;
CC   Characteristics: Useful for studying the role of PTGS2 (Cox-2) in cancer cell biology and the investigation of colorectal epithelial cell polarity.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152459; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=02091238
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 8,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HCA7 colony 3
AC   CVCL_2475
SY   HCA-7 Colony 3; HCA-7 Colony3; Col 3
DR   ECACC; 09071502
DR   Wikidata; Q54881499
DR   Ximbio; 152453
RX   PubMed=8410493;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152453; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=09071502
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HCA7 colony 30
AC   CVCL_2476
SY   HCA-7 Colony 30; HCA-7 Colony30; Col 30
DR   ECACC; 09071516
DR   Wikidata; Q54881500
DR   Ximbio; 152460
RX   PubMed=8410493;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152460; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=09071516
ST   Amelogenin: X
ST   CSF1PO: 11,15
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HCA7 colony 6
AC   CVCL_2477
SY   HCA-7 Colony 6; HCA-7 Colony6; Colony-6; Col-6; Col 6
DR   BTO; BTO_0003260
DR   ECACC; 09071504
DR   Wikidata; Q54881501
DR   Ximbio; 152454
RX   PubMed=8410493;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152454; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=09071504
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 8,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HCAM
AC   CVCL_ZV40
SY   Hepatocellular Carcinoma Ahmed Majeed
DR   Wikidata; Q98126654
RX   DOI=10.37506/v14/i1/2020/ijfmt/193025;
RX   DOI=10.47275/0032-745X-S1-009;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Swiss albino.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   HCB-514
AC   CVCL_UZ55
SY   Hospital de Cancer de Barretos-514
DR   cancercelllines; CVCL_UZ55
DR   Wikidata; Q93981608
RX   PubMed=30760827;
CC   Virology: Contains HPV16 genomes integrated at two separate chromosomal locations (PubMed=30760827).
CC   Doubling time: 18 hours (Note=In 10% FBS), 24 hours (Note=In 5% FBS) (PubMed=30760827).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Trp2830Ter (c.8490G>A); ClinVar=VCV000155722; Zygosity=Heterozygous (PubMed=30760827).
CC   Sequence variation: Mutation; HGNC; HGNC:14359; IRX2; Simple; p.Tyr48Ter (c.144T>G); Zygosity=Heterozygous (PubMed=30760827).
CC   Sequence variation: Mutation; HGNC; HGNC:11772; TGFBR1; Simple; p.Ala202Val (c.605C>T); ClinVar=VCV000635251; Zygosity=Heterozygous (PubMed=30760827).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=30760827
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 13
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   HCB-541
AC   CVCL_E2T2
SY   Hospital de Cancer de Barretos-541
RX   PubMed=38565739;
CC   Doubling time: 19-22 hours (PubMed=38565739).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=38565739).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61His (c.183G>T); ClinVar=VCV000376318; Zygosity=Heterozygous (PubMed=38565739).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=38565739).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=38565739).
CC   Derived from site: In situ; Axilla, skin; UBERON=UBERON_0015474.
ST   Source(s): PubMed=38565739
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 6,8,11
ST   vWA: 15,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HCB1-SV40
AC   CVCL_6256
DR   Wikidata; Q54881503
RX   PubMed=14767565;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HCB1-SV40
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   HCC-1.1
AC   CVCL_0C52
SY   HCC.1.1; HCC1.1; 3SP; 3sp
DR   Cosmic; 1628381
DR   Cosmic; 2162522
DR   Wikidata; Q54881504
RX   PubMed=18594539;
RX   PubMed=21364009;
RX   PubMed=23887712;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/HCC.1.1
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C42 ! BLC-1
OI   CVCL_0C53 ! HCC-1.2
OI   CVCL_0C47 ! MF-1 [Human]
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   HCC-1.2
AC   CVCL_0C53
SY   HCC.1.2; HCC1.2; 1.2; 3P; 3p
DR   ChEMBL-Cells; CHEMBL4295407
DR   ChEMBL-Targets; CHEMBL4296419
DR   Cosmic; 1628382
DR   Cosmic; 2162520
DR   Cosmic; 2162521
DR   PubChem_Cell_line; CVCL_0C53
DR   Wikidata; Q54881505
RX   PubMed=18594539;
RX   PubMed=21364009;
RX   PubMed=23887712;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/HCC.1.2
CC   Miscellaneous: Direct author submission of STR profile from Rohr-Udilova N.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 14,16
ST   D21S11: 28,29
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C42 ! BLC-1
OI   CVCL_0C52 ! HCC-1.1
OI   CVCL_0C47 ! MF-1 [Human]
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   HCC-2
AC   CVCL_0C54
AS   CVCL_0C56
SY   HCC.2; HCC2; AKH12
DR   Cosmic; 1628383
DR   TOKU-E; 3989
DR   Wikidata; Q54881507
RX   PubMed=16809312;
RX   PubMed=18594539;
CC   Miscellaneous: Direct author submission of STR profile from Rohr-Udilova N.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 12,17
ST   D21S11: 31,32.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 11,14
ST   Penta E: 7,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C43 ! BLC-2
OI   CVCL_0C48 ! MF-2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HCC-3
AC   CVCL_0C57
AS   CVCL_0C55
SY   HCC.3; HCC3; AKH13
DR   cancercelllines; CVCL_0C57
DR   Cosmic; 1628384
DR   Cosmic; 2162535
DR   TOKU-E; 3990
DR   Wikidata; Q54749093
RX   PubMed=16809312;
RX   PubMed=18594539;
RX   PubMed=23887712;
RX   PubMed=31063779;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/HCC.3
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Unspecified (PubMed=31063779).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Direct author submission of STR profile from Rohr-Udilova N.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 14,17
ST   D21S11: 29
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C49 ! MF-3
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   HCC-48
AC   CVCL_T732
SY   HCC48; HCC-48B2
DR   BioSample; SAMN03471646
DR   JCRB; JCRB0185
DR   Wikidata; Q54881509
RX   PubMed=8242641;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=8242641).
CC   Discontinued: JCRB; JCRB0185; probable.
ST   Source(s): JCRB=JCRB0185
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 9
//
ID   HCC-50
AC   CVCL_T733
SY   HCC50; HCC-50D3
DR   BioSample; SAMN03471647
DR   JCRB; JCRB0184
DR   Wikidata; Q54881510
RX   PubMed=8242641;
CC   Population: Japanese.
CC   Doubling time: 22 hours (PubMed=8242641).
CC   Discontinued: JCRB; JCRB0184; probable.
ST   Source(s): JCRB=JCRB0184
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 9
//
ID   HCC-56
AC   CVCL_2917
SY   HCC56
DR   CLO; CLO_0009963
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 659
DR   BioSample; SAMN03472484
DR   BioSample; SAMN10988141
DR   cancercelllines; CVCL_2917
DR   ColonAtlas; HCC56
DR   Cosmic; 1995434
DR   Cosmic-CLP; 1290907
DR   DepMap; ACH-000467
DR   GDSC; 1290907
DR   GEO; GSM827288
DR   GEO; GSM887057
DR   GEO; GSM888127
DR   GEO; GSM1669861
DR   IARC_TP53; 28343
DR   JCRB; JCRB1037
DR   LiGeA; CCLE_518
DR   LINCS_LDP; LCL-1177
DR   PharmacoDB; HCC56_460_2019
DR   PRIDE; PXD005235
DR   Progenetix; CVCL_2917
DR   PubChem_Cell_line; CVCL_2917
DR   Wikidata; Q54881511
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
CC   Problematic cell line: Contaminated. Shown to be a HSC-57 derivative (JCRB=JCRB1037). Originally thought to originate from a colon adenocarcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*44:03,51:01; C*03:04,14:03; DQB1*06:04,06:04; DRB1*13:10,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=1290907; DepMap=ACH-000467).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Pro (c.587G>C); ClinVar=VCV000231165; Zygosity=Homozygous (Cosmic-CLP=1290907; DepMap=ACH-000467).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.92%; Native American=0%; East Asian, North=80.09%; East Asian, South=11.5%; South Asian=0%; European, North=0%; European, South=4.49% (PubMed=30894373).
CC   Discontinued: JCRB; JCRB1037; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1290907; JCRB=JCRB1037
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D5S818: 10,14
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A613 ! HSC-57
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   HCC-DJ711
AC   CVCL_YI86
DR   CCRID; 4201PAT-CCTCC01208
DR   Wikidata; Q93981681
RX   Patent=CN111440769B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201889.
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 8
//
ID   HCC-M
AC   CVCL_V641
DR   Wikidata; Q54881512
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=1661347;
RX   PubMed=6307892;
RX   PubMed=10870966;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=6307892).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   HCC-S102
AC   CVCL_M359
SY   HCC S102; S102
DR   Wikidata; Q54881514
RX   PubMed=20069059;
RX   PubMed=30034552;
WW   Info; -; -; https://www2.cri.or.th/lab/biochemistry/res_act
CC   Population: Southeast Asian; Thai.
CC   Omics: Proteomics; Subcellular; Secretome.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   HCC-T
AC   CVCL_V642
DR   Wikidata; Q54881513
RX   PubMed=1661347;
RX   PubMed=2474366;
RX   PubMed=2854579;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=2474366; PubMed=2854579).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC10
AC   CVCL_V708
SY   HCC0010; Hamon Cancer Center 10
DR   BioSample; SAMN03473054
DR   Wikidata; Q54881516
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 17
ST   D21S11: 28,30
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 11,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HCC1007
AC   CVCL_3374
SY   HCC-1007; Hamon Cancer Center 1007
DR   EFO; EFO_0001168
DR   ATCC; CRL-2318
DR   BioSample; SAMN03471869
DR   cancercelllines; CVCL_3374
DR   GEO; GSM350518
DR   IARC_TP53; 10270
DR   KCLB; 9S1007
DR   Progenetix; CVCL_3374
DR   Wikidata; Q54881517
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=24094812;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281His (c.841G>C); ClinVar=VCV000376588; Zygosity=Unspecified (PubMed=9865903).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Discontinued: ATCC; CRL-2318; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2318; Direct_author_submission; KCLB=9S1007
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 14,15
ST   D18S51: 17
ST   D19S433: 13.2,14.2
ST   D1S1656: 14,15
ST   D21S11: 29
ST   D22S1045: 14,15
ST   D2S1338: 21
ST   D2S441: 11,13
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 23
ST   Penta D: 8,12
ST   Penta E: 9,11
ST   TH01: 7
ST   TPOX: 6,11
ST   vWA: 16,19 (KCLB=9S1007)
ST   vWA: 19 (ATCC=CRL-2318; Direct_author_submission)
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3282 ! HCC1007 BL
OI   CVCL_1244 ! HCC1008
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   HCC1007 BL
AC   CVCL_3282
SY   HCC-1007BL; HCC1007-BL; HCC1007BL; Hamon Cancer Center 1007 BL
DR   CLO; CLO_0003628
DR   ATCC; CRL-2319
DR   BioSample; SAMN03471870
DR   Wikidata; Q54881518
RX   PubMed=9833771;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2319
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,14
ST   D18S51: 17,21
ST   D19S433: 13.2,14.2
ST   D21S11: 29,33
ST   D2S1338: 21
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 23
ST   Penta D: 8,12
ST   Penta E: 9,11
ST   TH01: 7,8
ST   TPOX: 6,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3374 ! HCC1007
OI   CVCL_1244 ! HCC1008
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   HCC1008
AC   CVCL_1244
SY   Hamon Cancer Center 1008
DR   CLO; CLO_0003629
DR   EFO; EFO_0002057
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2320
DR   BioSample; SAMN03473055
DR   cancercelllines; CVCL_1244
DR   Cosmic; 904359
DR   Cosmic; 1235076
DR   Cosmic; 1287883
DR   Cosmic; 1430344
DR   Cosmic; 1473073
DR   Cosmic; 1518106
DR   Cosmic; 1603197
DR   DepMap; ACH-001514
DR   GEO; GSM533399
DR   GEO; GSM533406
DR   GEO; GSM537969
DR   GEO; GSM783931
DR   GEO; GSM847318
DR   GEO; GSM847472
DR   IGRhCellID; HCC1008
DR   KCLB; 9S1008
DR   PharmacoDB; HCC1008_464_2019
DR   Progenetix; CVCL_1244
DR   Wikidata; Q54881519
RX   PubMed=9833771;
RX   PubMed=11314036;
RX   PubMed=16959974;
RX   PubMed=17932254;
RX   PubMed=20070913;
RX   PubMed=20215515;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25877200;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ATCC=CRL-2320; Direct_author_submission; KCLB=9S1008; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 12
ST   D12S391: 15,20
ST   D13S317: 12
ST   D16S539: 14,15
ST   D18S51: 17
ST   D19S433: 13.2 (Direct_author_submission)
ST   D19S433: 13.2,14.2 (ATCC=CRL-2320; PubMed=25877200)
ST   D21S11: 29
ST   D22S1045: 14,15
ST   D2S1338: 21
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 23
ST   Penta D: 8,12
ST   Penta E: 9,11
ST   TH01: 7
ST   TPOX: 6,11 (ATCC=CRL-2320; PubMed=25877200)
ST   TPOX: 11 (Direct_author_submission; KCLB=9S1008)
ST   vWA: 17,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3374 ! HCC1007
OI   CVCL_3282 ! HCC1007 BL
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 34
//
ID   HCC1010
AC   CVCL_V674
SY   Hamon Cancer Center 1010
DR   BioSample; SAMN03470947
DR   Wikidata; Q54881520
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Hispanic.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 19
ST   D19S433: 13.2
ST   D21S11: 31,32.2,33.2
ST   D2S1338: 17,22
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 10,13
ST   Penta E: 15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27893; Sarcomatoid renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1011
AC   CVCL_V675
SY   Hamon Cancer Center 1011
DR   EFO; EFO_0006422
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473024
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC1011_465_2019
DR   Wikidata; Q54881521
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Hispanic.
CC   HLA typing: A*01:01,32:01; B*08:01,40:02; C*02:02,07:01; DQB1*05:03,05:03; DRB1*03:02,14:01 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 10,11
ST   D18S51: 14,17
ST   D21S11: 28,29
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 10
ST   Penta E: 21
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4524; Multilocular cystic renal neoplasm of low malignant potential
DI   ORDO; Orphanet_319287; Multilocular cystic renal neoplasm of low malignant potential
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 18
//
ID   HCC103
AC   CVCL_V705
SY   HCC0103; Hamon Cancer Center 103
DR   Wikidata; Q54881522
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC1033
AC   CVCL_V676
SY   Hamon Cancer Center 1033
DR   BioSample; SAMN03470837
DR   Wikidata; Q54881523
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,14
ST   D12S391: 19.3
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 14,16.2
ST   D1S1656: 12,13
ST   D21S11: 30
ST   D22S1045: 11,15
ST   D2S1338: 18
ST   D2S441: 12.3
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9.3,12
ST   D8S1179: 12 (Direct_author_submission)
ST   D8S1179: 12,14 (PubMed=25877200)
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 11,19
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC1042
AC   CVCL_V677
SY   Hamon Cancer Center 1042
DR   Wikidata; Q54881524
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma. The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1054
AC   CVCL_V678
SY   Hamon Cancer Center 1054
DR   BioSample; SAMN03470843
DR   Wikidata; Q54881525
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 33.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 20
ST   Penta D: 11
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BR ! HCC1054 BL
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1054 BL
AC   CVCL_E9BR
SY   HCC-1054BL; HCC1054-BL; HCC1054BL; Hamon Cancer Center 1054 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V678 ! HCC1054
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1057
AC   CVCL_V679
SY   Hamon Cancer Center 1057
DR   Wikidata; Q54881526
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1068
AC   CVCL_V680
SY   Hamon Cancer Center 1068
DR   Wikidata; Q54881528
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1106
AC   CVCL_V681
DR   Wikidata; Q54881529
DI   NCIt; C6344; Cervical clear cell adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   HCC1143
AC   CVCL_1245
SY   HCC-1143; Hamon Cancer Center 1144
DR   CLO; CLO_0003630
DR   EFO; EFO_0001169
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2321
DR   BioGRID_ORCS_Cell_line; 667
DR   BioSample; SAMN01821553
DR   BioSample; SAMN01821627
DR   BioSample; SAMN03471844
DR   BioSample; SAMN10987917
DR   cancercelllines; CVCL_1245
DR   Cell_Model_Passport; SIDM00866
DR   ChEMBL-Cells; CHEMBL3308737
DR   ChEMBL-Targets; CHEMBL1075453
DR   Cosmic; 749710
DR   Cosmic; 904360
DR   Cosmic; 1047708
DR   Cosmic; 1176639
DR   Cosmic; 1235079
DR   Cosmic; 1287934
DR   Cosmic; 1430347
DR   Cosmic; 1460230
DR   Cosmic; 1473032
DR   Cosmic; 1518109
DR   Cosmic; 1603198
DR   Cosmic; 1935003
DR   Cosmic; 2009509
DR   Cosmic; 2164989
DR   Cosmic-CLP; 749710
DR   dbGAP; phs001839.v1.p1
DR   DepMap; ACH-000374
DR   DSMZ; ACC-517
DR   DSMZCellDive; ACC-517
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 749710
DR   GEO; GSE82032
DR   GEO; GSM184404
DR   GEO; GSM184405
DR   GEO; GSM217570
DR   GEO; GSM274677
DR   GEO; GSM303672
DR   GEO; GSM303674
DR   GEO; GSM303676
DR   GEO; GSM303677
DR   GEO; GSM303678
DR   GEO; GSM303679
DR   GEO; GSM303681
DR   GEO; GSM303683
DR   GEO; GSM303685
DR   GEO; GSM303686
DR   GEO; GSM303688
DR   GEO; GSM303690
DR   GEO; GSM303692
DR   GEO; GSM303693
DR   GEO; GSM303694
DR   GEO; GSM303696
DR   GEO; GSM303697
DR   GEO; GSM303699
DR   GEO; GSM303701
DR   GEO; GSM303702
DR   GEO; GSM303703
DR   GEO; GSM303705
DR   GEO; GSM303706
DR   GEO; GSM303708
DR   GEO; GSM303710
DR   GEO; GSM303711
DR   GEO; GSM303713
DR   GEO; GSM303714
DR   GEO; GSM303716
DR   GEO; GSM303717
DR   GEO; GSM303718
DR   GEO; GSM303720
DR   GEO; GSM303722
DR   GEO; GSM303724
DR   GEO; GSM303725
DR   GEO; GSM303727
DR   GEO; GSM303728
DR   GEO; GSM303730
DR   GEO; GSM303732
DR   GEO; GSM303733
DR   GEO; GSM303734
DR   GEO; GSM303736
DR   GEO; GSM303737
DR   GEO; GSM303739
DR   GEO; GSM303741
DR   GEO; GSM303743
DR   GEO; GSM303744
DR   GEO; GSM303746
DR   GEO; GSM303748
DR   GEO; GSM303749
DR   GEO; GSM303751
DR   GEO; GSM303752
DR   GEO; GSM303755
DR   GEO; GSM303756
DR   GEO; GSM303757
DR   GEO; GSM303758
DR   GEO; GSM303759
DR   GEO; GSM303761
DR   GEO; GSM303763
DR   GEO; GSM303764
DR   GEO; GSM303765
DR   GEO; GSM303767
DR   GEO; GSM303768
DR   GEO; GSM303771
DR   GEO; GSM303772
DR   GEO; GSM303773
DR   GEO; GSM303774
DR   GEO; GSM303776
DR   GEO; GSM303778
DR   GEO; GSM303779
DR   GEO; GSM303781
DR   GEO; GSM303782
DR   GEO; GSM303783
DR   GEO; GSM303785
DR   GEO; GSM303787
DR   GEO; GSM303788
DR   GEO; GSM303790
DR   GEO; GSM337641
DR   GEO; GSM337642
DR   GEO; GSM337643
DR   GEO; GSM337644
DR   GEO; GSM337645
DR   GEO; GSM337646
DR   GEO; GSM337647
DR   GEO; GSM337648
DR   GEO; GSM337649
DR   GEO; GSM337650
DR   GEO; GSM337651
DR   GEO; GSM337652
DR   GEO; GSM337653
DR   GEO; GSM337654
DR   GEO; GSM337655
DR   GEO; GSM337656
DR   GEO; GSM337657
DR   GEO; GSM337658
DR   GEO; GSM337659
DR   GEO; GSM337660
DR   GEO; GSM337661
DR   GEO; GSM344378
DR   GEO; GSM344428
DR   GEO; GSM350550
DR   GEO; GSM481298
DR   GEO; GSM533400
DR   GEO; GSM533407
DR   GEO; GSM537970
DR   GEO; GSM783932
DR   GEO; GSM844541
DR   GEO; GSM847319
DR   GEO; GSM854615
DR   GEO; GSM854616
DR   GEO; GSM854617
DR   GEO; GSM854618
DR   GEO; GSM854619
DR   GEO; GSM887033
DR   GEO; GSM888103
DR   GEO; GSM1008895
DR   GEO; GSM1053704
DR   GEO; GSM1172861
DR   GEO; GSM1172954
DR   GEO; GSM1214576
DR   GEO; GSM1215281
DR   GEO; GSM1215282
DR   GEO; GSM1215283
DR   GEO; GSM1215284
DR   GEO; GSM1215285
DR   GEO; GSM1215286
DR   GEO; GSM1215287
DR   GEO; GSM1215288
DR   GEO; GSM1374493
DR   GEO; GSM1401661
DR   GEO; GSM1669841
DR   IARC_TP53; 21359
DR   IARC_TP53; 22809
DR   IARC_TP53; 30200
DR   IGRhCellID; HCC1143
DR   LiGeA; CCLE_262
DR   LINCS_HMS; 50205
DR   LINCS_LDP; LCL-1329
DR   PharmacoDB; HCC1143_466_2019
DR   PRIDE; PXD000309
DR   PRIDE; PXD000394
DR   PRIDE; PXD002486
DR   PRIDE; PXD005295
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1245
DR   PubChem_Cell_line; CVCL_1245
DR   SLKBase; 3503
DR   Wikidata; Q54881530
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=16959974;
RX   PubMed=17157791;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22414580;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25576301;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1143.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~45-60 hours (DSMZ=ACC-517); 54.63 hours (JWGray panel).
CC   HLA typing: A*31:01,31:01; B*35:08,37:01; C*04:01,06:02; DQA1*04:01,04:01; DQB1*04:02,04:02; DRB1*03:01,08:01 (PubMed=25960936).
CC   HLA typing: A*31:01,31:01; B*35:08,37:01; C*04:01,06:02; DQA1*04:01,04:01; DQB1*04:02,04:02; DRB1*03:01,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=28889351; ATCC=CRL-2321).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.22%; Native American=0.04%; East Asian, North=3.69%; East Asian, South=0%; South Asian=0%; European, North=59.57%; European, South=35.48% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2321; Cosmic-CLP=749710; Direct_author_submission; DSMZ=ACC-517; DOI=10.4172/2157-7145.S2-005; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13
ST   D12S391: 21
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 14 (PubMed=25877200)
ST   D18S51: 14,17 (ATCC=CRL-2321; DSMZ=ACC-517; DOI=10.4172/2157-7145.S2-005; Technion Genomics Center)
ST   D19S433: 13 (DSMZ=ACC-517)
ST   D19S433: 13,16.2 (ATCC=CRL-2321; DOI=10.4172/2157-7145.S2-005; Technion Genomics Center)
ST   D1S1656: 13
ST   D21S11: 30.2 (ATCC=CRL-2321; DSMZ=ACC-517; DOI=10.4172/2157-7145.S2-005; PubMed=25877200; PubMed=28889351; Technion Genomics Center)
ST   D21S11: 30.2,33 (Direct_author_submission)
ST   D22S1045: 15,16
ST   D2S1338: 20,23
ST   D2S441: 10,15
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 8
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 12
ST   vWA: 16
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1246 ! HCC1143 BL
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   HCC1143 BL
AC   CVCL_1246
SY   HCC-1143BL; HCC1143-BL; HCC1143BL; Hamon Cancer Center 1143 BL
DR   CLO; CLO_0003631
DR   ATCC; CRL-2362
DR   BioSample; SAMN03471830
DR   cancercelllines; CVCL_1246
DR   Cell_Model_Passport; SIDM00868
DR   dbGAP; phs001839.v1.p1
DR   DepMap; ACH-002378
DR   DSMZ; ACC-893
DR   DSMZCellDive; ACC-893
DR   GEO; GSM854620
DR   GEO; GSM1172955
DR   PharmacoDB; HCC1143BL_467_2019
DR   Progenetix; CVCL_1246
DR   Wikidata; Q54881531
RX   PubMed=9833771;
RX   PubMed=20164919;
RX   PubMed=24176112;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-893).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2362; DSMZ=ACC-893
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D19S433: 13,17
ST   D21S11: 30.2,31
ST   D2S1338: 20,23
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 8,12
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 10,12
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1245 ! HCC1143
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HCC1159
AC   CVCL_9699
SY   Hamon Cancer Center 1159
DR   EFO; EFO_0003127
DR   BioSample; SAMN03473057
DR   Wikidata; Q54881532
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 13,14
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 12
ST   Penta E: 10,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   HCC1162
AC   CVCL_V651
SY   Hamon Cancer Center 1162
DR   EFO; EFO_0006423
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473028
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC1162_468_2019
DR   Wikidata; Q54881533
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   HLA typing: A*30:02,33:01; B*37:01,57:03; C*06:02,18:02; DQA1*03:02,03:02; DQB1*05:01,05:01; DRB1*04:02,13:01 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 28,30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 24.2,47.2
ST   Penta D: 10,11
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC1171
AC   CVCL_5126
SY   HCC-1171; Hamon Cancer Center 1171
DR   BTO; BTO_0006028
DR   EFO; EFO_0003126
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473217
DR   BioSample; SAMN10987756
DR   cancercelllines; CVCL_5126
DR   Cell_Model_Passport; SIDM01553
DR   Cosmic; 903635
DR   Cosmic; 909908
DR   Cosmic; 1146924
DR   DepMap; ACH-000578
DR   EGA; EGAS00001000610
DR   GEO; GSM108857
DR   GEO; GSM108858
DR   GEO; GSM253406
DR   GEO; GSM434258
DR   GEO; GSM794384
DR   GEO; GSM817118
DR   GEO; GSM887034
DR   GEO; GSM888104
DR   IARC_TP53; 11447
DR   IGRhCellID; HCC1171GEO
DR   KCLB; 71171
DR   LiGeA; CCLE_622
DR   PharmacoDB; HCC1171_446_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_5126
DR   Wikidata; Q54881534
RX   PubMed=9559342;
RX   PubMed=10353731;
RX   PubMed=10987304;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 47.5 hours (PubMed=29681454).
CC   HLA typing: A*02:01,03:01; B*40:01,40:01; C*02:02,03:04; DQA1*01:04,03:02; DQB1*03:04,05:03; DRB1*03:17,14:07 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=10353731; DepMap=ACH-000578).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn247Ile (c.740A>T); ClinVar=VCV000184882; Zygosity=Homozygous (PubMed=10353731; DepMap=ACH-000578).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.8%; Native American=0%; East Asian, North=0.4%; East Asian, South=0%; South Asian=0%; European, North=65.59%; European, South=32.21% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; KCLB=71171; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D10S1248: 13,15
ST   D12S391: 17,17.3
ST   D13S317: 11
ST   D16S539: 14
ST   D18S51: 12,16 (Direct_author_submission)
ST   D18S51: 16 (PubMed=25877200)
ST   D19S433: 15.2
ST   D1S1656: 12
ST   D21S11: 30,31
ST   D22S1045: 11
ST   D2S1338: 17,25
ST   D2S441: 11.3,14
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 20,25
ST   Penta D: 11,12
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S842 ! HCC1171 BL
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   HCC1171 BL
AC   CVCL_S842
SY   HCC-1171BL; HCC1171-BL; HCC1171BL; Hamon Cancer Center 1171 BL
DR   Wikidata; Q54881535
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5126 ! HCC1171
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 12
//
ID   HCC1187
AC   CVCL_1247
SY   HCC-1187; Hamon Cancer Center 1187
DR   CLO; CLO_0003632
DR   EFO; EFO_0001170
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2322
DR   BioGRID_ORCS_Cell_line; 874
DR   BioSample; SAMN03471273
DR   BioSample; SAMN10987946
DR   cancercelllines; CVCL_1247
DR   Cell_Model_Passport; SIDM00885
DR   ChEMBL-Cells; CHEMBL3308845
DR   ChEMBL-Targets; CHEMBL2366202
DR   Cosmic; 749711
DR   Cosmic; 904361
DR   Cosmic; 1136366
DR   Cosmic; 1235080
DR   Cosmic; 1287916
DR   Cosmic; 1430348
DR   Cosmic; 1460231
DR   Cosmic; 1473100
DR   Cosmic; 1518110
DR   Cosmic; 1603199
DR   Cosmic; 1995422
DR   Cosmic-CLP; 749711
DR   dbGAP; phs001839.v1.p1
DR   DepMap; ACH-000111
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 749711
DR   GEO; GSM185077
DR   GEO; GSM185078
DR   GEO; GSM186712
DR   GEO; GSM186713
DR   GEO; GSM217571
DR   GEO; GSM219916
DR   GEO; GSM344370
DR   GEO; GSM344420
DR   GEO; GSM350540
DR   GEO; GSM378152
DR   GEO; GSM783933
DR   GEO; GSM844542
DR   GEO; GSM847320
DR   GEO; GSM847473
DR   GEO; GSM887035
DR   GEO; GSM888105
DR   GEO; GSM1008896
DR   GEO; GSM1053708
DR   GEO; GSM1172956
DR   GEO; GSM1214579
DR   GEO; GSM1374494
DR   GEO; GSM1374495
DR   GEO; GSM1401672
DR   GEO; GSM1661979
DR   GEO; GSM1669842
DR   IARC_TP53; 21360
DR   IARC_TP53; 22810
DR   IARC_TP53; 30201
DR   LiGeA; CCLE_850
DR   LINCS_HMS; 50578
DR   LINCS_LDP; LCL-1324
DR   PharmacoDB; HCC1187_469_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1247
DR   PubChem_Cell_line; CVCL_1247
DR   SLKBase; 3507
DR   Wikidata; Q54881536
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=12800145;
RX   PubMed=16959974;
RX   PubMed=17157791;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1187.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 100 hours (PubMed=25984343); 69.35 hours (JWGray panel).
CC   HLA typing: A*01:01,31:01; B*08:01,40:01; C*03:04,07:01; DQA1*01:02,01:02; DQB1*05:01,05:01; DRB1*01:01,03:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly108del (c.322_324delGGT); ClinVar=VCV000156516; Zygosity=Homozygous (Cosmic-CLP=749711; DepMap=ACH-000111).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.83%; Native American=0%; East Asian, North=3.32%; East Asian, South=0%; South Asian=0%; European, North=62.5%; European, South=32.34% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2322; Cosmic-CLP=749711; Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D10S1248: 13
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 17
ST   D19S433: 13,15
ST   D1S1656: 14,17
ST   D21S11: 29,30
ST   D22S1045: 15
ST   D2S1338: 19
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 11
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 16
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1248 ! HCC1187 BL
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   HCC1187 BL
AC   CVCL_1248
SY   HCC-1187BL; HCC1187-BL; HCC1187BL; Hamon Cancer Center 1187 BL
DR   CLO; CLO_0003633
DR   ATCC; CRL-2323
DR   BioSample; SAMN03471871
DR   Cell_Model_Passport; SIDM00869
DR   dbGAP; phs001839.v1.p1
DR   DepMap; ACH-002373
DR   KCLB; 9S1187BL
DR   Wikidata; Q54881537
RX   PubMed=9833771;
RX   PubMed=20164919;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2323
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 19,26
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,12
ST   FGA: 21,23
ST   Penta D: 11
ST   Penta E: 12,16
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1247 ! HCC1187
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HCC1192
AC   CVCL_V709
SY   Hamon Cancer Center 1192
DR   Wikidata; Q54881538
RX   PubMed=29681454;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 10
ST   D21S11: 28
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BS ! HCC1192 BL
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1192 BL
AC   CVCL_E9BS
SY   HCC-1192BL; HCC1192-BL; HC1192BL; Hamon Cancer Center 1192 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V709 ! HCC1192
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1195
AC   CVCL_5127
SY   HCC-1195; Hamon Cancer Center 1195
DR   EFO; EFO_0005371
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988074
DR   cancercelllines; CVCL_5127
DR   Cell_Model_Passport; SIDM01607
DR   Cosmic; 903636
DR   Cosmic; 1146925
DR   Cosmic; 1925842
DR   DepMap; ACH-000868
DR   GEO; GSM62337
DR   GEO; GSM253429
DR   GEO; GSM434298
DR   GEO; GSM794385
DR   GEO; GSM817119
DR   GEO; GSM887036
DR   GEO; GSM888106
DR   IARC_TP53; 11448
DR   IGRhCellID; HCC1195_02GEO
DR   KCLB; 71195
DR   LiGeA; CCLE_352
DR   PharmacoDB; HCC1195_447_2019
DR   Progenetix; CVCL_5127
DR   Wikidata; Q54881541
RX   PubMed=10353731;
RX   PubMed=16187286;
RX   PubMed=20624269;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 70.4 hours (PubMed=29681454).
CC   HLA typing: A*30:01,33:03; B*42:02,58:02; C*06:02,17:01; DQB1*06:13,06:13 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (DepMap=ACH-000868).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262_Asn263delinsProAsp (c.784_789del6insCCTGAT); Zygosity=Heterozygous (PubMed=10353731; DepMap=ACH-000868).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=70.13%; Native American=0%; East Asian, North=4.8%; East Asian, South=0%; South Asian=0%; European, North=6.41%; European, South=18.66% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; KCLB=71195; PubMed=20679594
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 10,11
ST   FGA: 21
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   HCC12
AC   CVCL_V719
SY   HCC0012; Hamon Cancer Center 12
DR   EFO; EFO_0006416
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473014
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC12_470_2019
DR   Wikidata; Q54881542
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*03:01,03:01; B*40:15,47:01; C*06:02,06:02; DQB1*02:02,02:02 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 9
ST   D18S51: 16
ST   D21S11: 32.2
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 8
ST   D8S1179: 14,16
ST   FGA: 26
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   HCC1205
AC   CVCL_V683
SY   Hamon Cancer Center 1205
DR   Wikidata; Q54881543
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1210
AC   CVCL_V682
SY   Hamon Cancer Center 1210
DR   Wikidata; Q54881544
RX   PubMed=29681454;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BT ! HCC1210 BL
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1210 BL
AC   CVCL_E9BT
SY   HCC-1210BL; HCC1210-BL; HC1210BL; Hamon Cancer Center 1210 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V682 ! HCC1210
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1217
AC   CVCL_V684
SY   Hamon Cancer Center 1217
DR   BioSample; SAMN03470844
DR   Wikidata; Q54881545
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 19
ST   D21S11: 29,30
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 13,14
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 7,9
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC122
AC   CVCL_V704
SY   HCC0122; Hamon Cancer Center 122
DR   BioSample; SAMN03473025
DR   GEO; GSM1682811
DR   Wikidata; Q54881546
RX   PubMed=25877200;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 12,18
ST   D21S11: 31
ST   D3S1358: 14
ST   D5S818: 8
ST   D7S820: 10,12
ST   D8S1179: 14,16
ST   FGA: 21,27
ST   Penta D: 12
ST   Penta E: 13,16
ST   TH01: 7
ST   TPOX: 7,11
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF19 ! HCC122 BL
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC122 BL
AC   CVCL_LF19
SY   HCC-122BL; HCC122-BL; HCC122BL; Hamon Cancer Center 122 BL
DR   Wikidata; Q54881547
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V704 ! HCC122
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HCC1261
AC   CVCL_V685
SY   Hamon Cancer Center 1261
DR   BioSample; SAMN03470839
DR   Wikidata; Q54881548
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 8
ST   D18S51: 12,18
ST   D21S11: 31,33.2
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 9,10,12
ST   D8S1179: 10,15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 12,18
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1263
AC   CVCL_V686
SY   Hamon Cancer Center 1263
DR   EFO; EFO_0006424
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473031
DR   ColonAtlas; HCC1263
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC1263_471_2019
DR   Wikidata; Q54881549
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   HLA typing: A*01:01,23:01; B*07:02,50:01; C*06:02,07:02; DQB1*06:02,06:02; DRB1*04:03,13:01 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 20
ST   D21S11: 27,32.2
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 3.2,8
ST   Penta E: 17
ST   TH01: 6,8
ST   TPOX: 6
ST   vWA: 13,15
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC1266
AC   CVCL_V687
SY   Hamon Cancer Center 1266
DR   Wikidata; Q54881550
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC128
AC   CVCL_V703
SY   HCC0128; Hamon Cancer Center 128
DR   Wikidata; Q54881551
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC1311
AC   CVCL_V688
SY   Hamon Cancer Center 1311
DR   Wikidata; Q54881552
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1313
AC   CVCL_L087
SY   HCC-1313; Hamon Cancer Center 1313
DR   Cosmic; 903637
DR   GEO; GSM794386
DR   Wikidata; Q54881553
RX   PubMed=10353731;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 7
ST   D10S1248: 15
ST   D12S391: 15,20
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 11,14
ST   D1S1656: 14,15
ST   D21S11: 30,33.2
ST   D22S1045: 16
ST   D2S1338: 21,23
ST   D2S441: 12
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 14
ST   FGA: 28
ST   Penta D: 2.2,10
ST   Penta E: 13,20
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 17
//
ID   HCC1314
AC   CVCL_V670
SY   Hamon Cancer Center 1314
DR   BioSample; SAMN03473032
DR   Wikidata; Q54881554
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 20
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1319
AC   CVCL_V671
SY   Hamon Cancer Center 1329
DR   EFO; EFO_0006425
DR   ArrayExpress; E-MTAB-2706
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC1319_472_2019
DR   Wikidata; Q54881555
RX   PubMed=25485619;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   HLA typing: A*68:01,68:01; B*14:02,14:02; C*08:02,08:02; DQB1*05:01,05:01; DRB1*01:02,01:02 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HCC1323
AC   CVCL_V672
SY   Hamon Cancer Center 1323
DR   Wikidata; Q54881556
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BU ! HCC1323 BL
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1323 BL
AC   CVCL_E9BU
SY   HCC-1323BL; HCC1323-BL; HC1323BL; Hamon Cancer Center 1323 BL
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V672 ! HCC1323
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1347
AC   CVCL_V673
SY   Hamon Cancer Center 1347
DR   BioSample; SAMN03470911
DR   Wikidata; Q54881557
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 14,19
ST   D21S11: 29,31.2
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 12
ST   Penta E: 10,11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1354
AC   CVCL_V663
SY   Hamon Cancer Center 1354
DR   BioSample; SAMN03470852
DR   Wikidata; Q54881558
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 8,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 11,12,13
ST   D21S11: 28,29
ST   D2S1338: 16,26
ST   D3S1358: 14
ST   D5S818: 8,12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 7,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HCC1359
AC   CVCL_5128
SY   HCC-1359; Hamon Cancer Center 1359
DR   EFO; EFO_0003128
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 666
DR   BioSample; SAMN03473015
DR   BioSample; SAMN10987969
DR   cancercelllines; CVCL_5128
DR   Cell_Model_Passport; SIDM01606
DR   Cosmic; 1146926
DR   DepMap; ACH-000901
DR   EGA; EGAS00001000610
DR   GEO; GSM108861
DR   GEO; GSM108862
DR   GEO; GSM253422
DR   GEO; GSM434259
DR   GEO; GSM794387
DR   GEO; GSM817120
DR   IARC_TP53; 11449
DR   IGRhCellID; HCC1359GEO
DR   KCLB; 71359
DR   LiGeA; CCLE_076
DR   PharmacoDB; HCC1359_448_2019
DR   Progenetix; CVCL_5128
DR   Wikidata; Q54881559
RX   PubMed=10353731;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 62.8 hours (PubMed=29681454).
CC   HLA typing: A*30:01,66:01; B*35:01,58:02; C*06:02,16:01; DQB1*06:13,06:13; DRB1*13:26,15:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Phe (c.388C>T); ClinVar=VCV000216466; Zygosity=Unspecified (PubMed=10353731).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=86.21%; Native American=0%; East Asian, North=3%; East Asian, South=0%; South Asian=0%; European, North=1.07%; European, South=9.72% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D10S1248: 15,16
ST   D12S391: 18,22
ST   D13S317: 12,14
ST   D16S539: 8,11
ST   D18S51: 19
ST   D19S433: 15
ST   D1S1656: 14,16.3
ST   D21S11: 28,29
ST   D22S1045: 16,17
ST   D2S1338: 24
ST   D2S441: 11,11.3
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20,21,22 (Direct_author_submission)
ST   FGA: 21,22 (PubMed=25877200)
ST   Penta D: 11,13
ST   Penta E: 8,11
ST   TH01: 8,9
ST   TPOX: 7,10
ST   vWA: 16
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BV ! HCC1359 BL
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   HCC1359 BL
AC   CVCL_E9BV
SY   HCC-1359BL; HCC1359-BL; HC1359BL; Hamon Cancer Center 1359 BL
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5128 ! HCC1359
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1360
AC   CVCL_V664
SY   Hamon Cancer Center 1360
DR   Wikidata; Q54881560
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC1367
AC   CVCL_V665
SY   Hamon Cancer Center 1367
DR   BioSample; SAMN03470853
DR   Wikidata; Q54881561
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 14
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 33.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1375
AC   CVCL_V666
SY   Hamon Cancer Center 1375
DR   BioSample; SAMN03470854
DR   Wikidata; Q54881562
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13,14
ST   D19S433: 15,15.2
ST   D21S11: 31.2
ST   D2S1338: 24
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 11,14
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C7724; Small intestinal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC1385
AC   CVCL_V667
SY   Hamon Cancer Center 1385
DR   Wikidata; Q54881563
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BW ! HCC1385 BL
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1385 BL
AC   CVCL_E9BW
SY   HCC-1385BL; HCC1385-BL; HC1385BL; Hamon Cancer Center 1385 BL
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V667 ! HCC1385
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1386
AC   CVCL_V668
SY   Hamon Cancer Center 1386
DR   Wikidata; Q54881564
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BX ! HCC1386 BL
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1386 BL
AC   CVCL_E9BX
SY   HCC-1386BL; HCC1386-BL; HC1386BL; Hamon Cancer Center 1386 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V668 ! HCC1386
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1395
AC   CVCL_1249
SY   HCC-1395; SCC-1395; Hamon Cancer Center 1395
DR   BTO; BTO_0003444
DR   CLO; CLO_0003634
DR   EFO; EFO_0002185
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2324
DR   BioGRID_ORCS_Cell_line; 428
DR   BioSample; SAMN03471290
DR   BioSample; SAMN03471814
DR   BioSample; SAMN10987926
DR   cancercelllines; CVCL_1249
DR   Cell_Model_Passport; SIDM00884
DR   ChEMBL-Cells; CHEMBL3308106
DR   ChEMBL-Targets; CHEMBL1075454
DR   Cosmic; 749712
DR   Cosmic; 904362
DR   Cosmic; 1047707
DR   Cosmic; 1235081
DR   Cosmic; 1287935
DR   Cosmic; 1309005
DR   Cosmic; 1430349
DR   Cosmic; 1460232
DR   Cosmic; 1473080
DR   Cosmic; 1518111
DR   Cosmic; 1603200
DR   Cosmic; 1935004
DR   Cosmic; 2164990
DR   Cosmic-CLP; 749712
DR   DepMap; ACH-000699
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 749712
DR   GEO; GSM186714
DR   GEO; GSM186715
DR   GEO; GSM217572
DR   GEO; GSM219969
DR   GEO; GSM302884
DR   GEO; GSM302885
DR   GEO; GSM302886
DR   GEO; GSM302887
DR   GEO; GSM302888
DR   GEO; GSM302889
DR   GEO; GSM302890
DR   GEO; GSM302891
DR   GEO; GSM302892
DR   GEO; GSM302893
DR   GEO; GSM302894
DR   GEO; GSM344377
DR   GEO; GSM344427
DR   GEO; GSM350539
DR   GEO; GSM481302
DR   GEO; GSM533401
DR   GEO; GSM533408
DR   GEO; GSM537971
DR   GEO; GSM783934
DR   GEO; GSM844543
DR   GEO; GSM847321
DR   GEO; GSM887037
DR   GEO; GSM888107
DR   GEO; GSM1008897
DR   GEO; GSM1053698
DR   GEO; GSM1172863
DR   GEO; GSM1172957
DR   GEO; GSM1214582
DR   GEO; GSM1374496
DR   GEO; GSM1374497
DR   GEO; GSM1669843
DR   IARC_TP53; 10271
DR   IGRhCellID; HCC1395
DR   KCLB; 9S1395
DR   LiGeA; CCLE_314
DR   LINCS_HMS; 50206
DR   LINCS_LDP; LCL-1330
DR   PharmacoDB; HCC1395_473_2019
DR   PRIDE; PXD005295
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1249
DR   PubChem_Cell_line; CVCL_1249
DR   SLKBase; 3511
DR   Wikidata; Q54881565
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=12800145;
RX   PubMed=14762065;
RX   PubMed=16959974;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23601657;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=25984343); 84.07 hours (JWGray panel).
CC   HLA typing: A*29:02,29:02; B*08:01,45:01; C*06:02,07:01; DQA1*03:02,03:02; DRB1*03:01,04:05 (PubMed=25960936).
CC   HLA typing: A*29:02,29:02; B*08:01,45:01; C*06:02,07:01; DQA1*03:02,05:02; DQB1*02:02,05:01; DRB1*03:01,04:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=9865903; Cosmic-CLP=749712; DepMap=ACH-000699).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2%; Native American=0%; East Asian, North=1.43%; East Asian, South=0%; South Asian=0.64%; European, North=62.97%; European, South=32.96% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2324; Cosmic-CLP=749712; Direct_author_submission; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 15
ST   D12S391: 20,21
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13
ST   D1S1656: 17.3
ST   D21S11: 31,32.2
ST   D22S1045: 16
ST   D2S1338: 23,24,25 (Technion Genomics Center)
ST   D2S1338: 23,25 (ATCC=CRL-2324; Direct_author_submission; PubMed=25877200)
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 11 (ATCC=CRL-2324; Cosmic-CLP=749712; Direct_author_submission; Technion Genomics Center)
ST   D5S818: 11,12 (PubMed=25877200)
ST   D7S820: 10 (PubMed=25877200)
ST   D7S820: 10,12 (ATCC=CRL-2324; Cosmic-CLP=749712; Direct_author_submission; Technion Genomics Center)
ST   D8S1179: 14
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15 (ATCC=CRL-2324; Cosmic-CLP=749712; Direct_author_submission; Technion Genomics Center)
ST   vWA: 15,16 (PubMed=25877200)
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1250 ! HCC1395 BL
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   HCC1395 BL
AC   CVCL_1250
SY   HCC-1395BL; HCC1395-BL; HCC1395BL; SCC-1395BL; Hamon Cancer Center 1395 BL
DR   CLO; CLO_0003635
DR   ATCC; CRL-2325
DR   BioSample; SAMN03471815
DR   cancercelllines; CVCL_1250
DR   Cell_Model_Passport; SIDM00883
DR   DepMap; ACH-002382
DR   GEO; GSM302883
DR   KCLB; 9S1395BL
DR   Progenetix; CVCL_1250
DR   Wikidata; Q54881566
RX   PubMed=9833771;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2325
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31,32.2
ST   D2S1338: 23,25
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 20,21
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1249 ! HCC1395
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   HCC1419
AC   CVCL_1251
SY   HCC-1419; Hamon Cancer Center 1419
DR   CLO; CLO_0003636
DR   EFO; EFO_0005372
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2326
DR   BioGRID_ORCS_Cell_line; 665
DR   BioSample; SAMN03471438
DR   BioSample; SAMN10988522
DR   cancercelllines; CVCL_1251
DR   Cell_Model_Passport; SIDM00882
DR   ChEMBL-Cells; CHEMBL3308738
DR   ChEMBL-Targets; CHEMBL1075455
DR   Cosmic; 687475
DR   Cosmic; 904363
DR   Cosmic; 907045
DR   Cosmic; 1287884
DR   Cosmic; 1308992
DR   Cosmic; 1603201
DR   Cosmic; 1935005
DR   Cosmic; 2165005
DR   Cosmic-CLP; 907045
DR   DepMap; ACH-000277
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 907045
DR   GEO; GSM149984
DR   GEO; GSM149992
DR   GEO; GSM150000
DR   GEO; GSM186716
DR   GEO; GSM186717
DR   GEO; GSM217573
DR   GEO; GSM219874
DR   GEO; GSM274661
DR   GEO; GSM344371
DR   GEO; GSM344421
DR   GEO; GSM350553
DR   GEO; GSM378145
DR   GEO; GSM459729
DR   GEO; GSM783940
DR   GEO; GSM844544
DR   GEO; GSM847322
DR   GEO; GSM887038
DR   GEO; GSM888108
DR   GEO; GSM984231
DR   GEO; GSM1053722
DR   GEO; GSM1172864
DR   GEO; GSM1374498
DR   GEO; GSM1421430
DR   GEO; GSM1669844
DR   IARC_TP53; 21361
DR   IARC_TP53; 22811
DR   IARC_TP53; 30202
DR   KCLB; 9S1419
DR   LiGeA; CCLE_174
DR   LINCS_HMS; 50207
DR   LINCS_LDP; LCL-1314
DR   PharmacoDB; HCC1419_474_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1251
DR   PubChem_Cell_line; CVCL_1251
DR   SLKBase; 3514
DR   Wikidata; Q54881567
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=19582160;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1419.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 161.42 hours (JWGray panel).
CC   HLA typing: A*02:01,24:02; B*46:01,52:01; C*01:02,03:03; DQB1*03:04,03:04; DRB1*03:35,03:35 (PubMed=25960936).
CC   HLA typing: A*02:01,24:02; B*15:01,52:01; C*01:02,03:03; DQA1*02:01,02:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala74fs*47 (c.220_226delGCCCCTG); Zygosity=Heterozygous (Cosmic-CLP=907045).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (Cosmic-CLP=907045).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.31%; Native American=36.71%; East Asian, North=7.6%; East Asian, South=0%; South Asian=0%; European, North=17.9%; European, South=32.48% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2326; Cosmic-CLP=907045; Direct_author_submission; KCLB=9S1419; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14
ST   D12S391: 20,21
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 12,15
ST   D1S1656: 14
ST   D21S11: 27,30
ST   D22S1045: 15,16
ST   D2S1338: 17,23
ST   D2S441: 11,14
ST   D3S1358: 14,17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 13,15 (ATCC=CRL-2326)
ST   D8S1179: 15 (Direct_author_submission; PubMed=25877200)
ST   FGA: 20,24
ST   Penta D: 11,13
ST   Penta E: 15,21 (ATCC=CRL-2326; PubMed=25877200)
ST   Penta E: 21 (Direct_author_submission)
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   HCC1419-Luc
AC   CVCL_J253
SY   HCC-1419-Luc
DR   cancercelllines; CVCL_J253
DR   JCRB; JCRB1466
DR   JCRB; NIHS0706
DR   Wikidata; Q54881568
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala74fs*47 (c.220_226delGCCCCTG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0706; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB=JCRB1466
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1251 ! HCC1419
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 21
//
ID   HCC1419/TDR
AC   CVCL_B3ML
DR   cancercelllines; CVCL_B3ML
DR   Wikidata; Q110432839
RX   CelloPub=CLPUB00650;
RX   PubMed=28821558;
CC   Selected for resistance to: DrugBank; DB05773; Trastuzumab emtansine (T-DM1).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala74fs*47 (c.220_226delGCCCCTG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1251 ! HCC1419
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   HCC1426
AC   CVCL_V689
SY   Hamon Cancer Center 1426
DR   Wikidata; Q54881569
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma. The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1428
AC   CVCL_1252
SY   HCC-1428; Hamon Cancer Center 1428
DR   CLO; CLO_0003637
DR   EFO; EFO_0001171
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2327
DR   BioGRID_ORCS_Cell_line; 664
DR   BioSample; SAMN03472560
DR   BioSample; SAMN10988527
DR   cancercelllines; CVCL_1252
DR   Cell_Model_Passport; SIDM00881
DR   Cosmic; 904364
DR   Cosmic; 1460233
DR   Cosmic; 1603202
DR   Cosmic; 1995423
DR   Cosmic; 2165021
DR   Cosmic; 2750521
DR   Cosmic-CLP; 1290905
DR   DepMap; ACH-000352
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290905
DR   GEO; GSM274666
DR   GEO; GSM344373
DR   GEO; GSM344423
DR   GEO; GSM350510
DR   GEO; GSM827277
DR   GEO; GSM887039
DR   GEO; GSM888109
DR   GEO; GSM1008898
DR   GEO; GSM1053693
DR   GEO; GSM1172865
DR   GEO; GSM1172958
DR   GEO; GSM1214570
DR   GEO; GSM1613822
DR   GEO; GSM1669845
DR   IARC_TP53; 22818
DR   IARC_TP53; 30203
DR   KCLB; 9S1428
DR   LiGeA; CCLE_644
DR   LINCS_HMS; 50208
DR   LINCS_LDP; LCL-1467
DR   PharmacoDB; HCC1428_475_2019
DR   PRIDE; PXD005390
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1252
DR   SLKBase; 3517
DR   Wikidata; Q54881570
RX   PubMed=9288768;
RX   PubMed=9833771;
RX   PubMed=11314036;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=20070913;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 88.48 hours (JWGray panel).
CC   HLA typing: A*01:01,02:01; B*07:02,07:02; C*07:02,07:02; DQB1*06:02,05:01 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*07:02,07:02; C*07:02,07:02; DQA1*01:02,04:01; DQB1*06:23,06:23; DRB1*01:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:73; ABCG1 + HGNC; HGNC:11024; SLC37A1; Name(s)=SLC37A1-ABCG1 (PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (PubMed=9288768).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.84%; Native American=0%; East Asian, North=5.45%; East Asian, South=0%; South Asian=0%; European, North=49.75%; European, South=40.96% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2327; Cosmic-CLP=1290905; Direct_author_submission; KCLB=9S1428; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13
ST   D12S391: 18,20
ST   D13S317: 12
ST   D16S539: 8,12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D1S1656: 14,15
ST   D21S11: 30,33.2
ST   D22S1045: 16
ST   D2S1338: 17,24
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 14
ST   FGA: 21 (KCLB=9S1428)
ST   FGA: 21,22 (ATCC=CRL-2327; Direct_author_submission; PubMed=25877200)
ST   Penta D: 8,9
ST   Penta E: 7,18 (ATCC=CRL-2327)
ST   Penta E: 18 (Direct_author_submission; PubMed=25877200)
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17 (ATCC=CRL-2327; Direct_author_submission; KCLB=9S1428; PubMed=20679594; PubMed=25877200)
ST   vWA: 17,18 (Cosmic-CLP=1290905)
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1253 ! HCC1428 BL
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   HCC1428 BL
AC   CVCL_1253
SY   HCC-1428BL; HCC1428-BL; HCC1428BL; Hamon Cancer Center 1428 BL
DR   CLO; CLO_0003638
DR   ATCC; CRL-2328
DR   BioSample; SAMN03471816
DR   Cell_Model_Passport; SIDM00880
DR   KCLB; 9S1428BL
DR   Wikidata; Q54881571
RX   PubMed=9833771;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2328; KCLB=9S1428BL
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 8,12
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 30,33.2
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 8,9
ST   Penta E: 7,18
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1252 ! HCC1428
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   HCC1428-LTED
AC   CVCL_YX83
SY   HCC1428 LTED; HCC1428-Long Term Estrogen-Deprived
DR   Wikidata; Q93982296
RX   PubMed=26116361;
CC   Population: Caucasian.
CC   Characteristics: Derived from parent cell line by long-term culture in the presence of RPMI 1640 medium containing 10% dextran charcoal stripped serum (DCC) (PubMed=26116361).
CC   Sequence variation: Gene fusion; HGNC; HGNC:73; ABCG1 + HGNC; HGNC:11024; SLC37A1; Name(s)=SLC37A1-ABCG1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1252 ! HCC1428
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 12
//
ID   HCC1428/Cas9-hyg
AC   CVCL_C9DB
DR   GeneCopoeia; SL558
DR   Wikidata; Q123031544
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL558).
CC   Sequence variation: Gene fusion; HGNC; HGNC:73; ABCG1 + HGNC; HGNC:11024; SLC37A1; Name(s)=SLC37A1-ABCG1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1252 ! HCC1428
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HCC1438
AC   CVCL_L088
SY   HCC-1438; Hamon Cancer Center 1438
DR   BTO; BTO_0006440
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470855
DR   BioSample; SAMN10987962
DR   cancercelllines; CVCL_L088
DR   Cell_Model_Passport; SIDM01605
DR   Cosmic; 2699649
DR   DepMap; ACH-000891
DR   GEO; GSM794388
DR   IARC_TP53; 11450
DR   KCLB; 71438
DR   LiGeA; CCLE_022
DR   PharmacoDB; HCC1438_449_2019
DR   Wikidata; Q54881572
RX   PubMed=10353731;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 37 hours (PubMed=29681454).
CC   HLA typing: A*29:02,29:02; B*44:03,44:03; C*16:01,16:01; DQA1*01:02,03:02; DQB1*05:03,06:04; DRB1*03:17,14:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139fs (c.415delG); Zygosity=Unspecified (PubMed=10353731).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; KCLB=71438; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 15
ST   D18S51: 14,20
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,24 (KCLB=71438)
ST   FGA: 24 (PubMed=25877200)
ST   Penta D: 7,11
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 26
//
ID   HCC1445
AC   CVCL_V589
SY   Hamon Cancer Center 1445
DR   BioSample; SAMN03470856
DR   Wikidata; Q54881573
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 17,20
ST   D3S1358: 14,15
ST   D5S818: 9,13
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 12,15
ST   Penta E: 16
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC1448
AC   CVCL_V590
SY   Hamon Cancer Center 1448
DR   Wikidata; Q54881574
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1482
AC   CVCL_V591
SY   Hamon Cancer Center 1482
DR   EFO; EFO_0006426
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473030
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC1482_476_2019
DR   Wikidata; Q54881575
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   HLA typing: A*33:03,68:01; B*35:03,58:01; C*03:02,04:01; DQB1*06:04,06:04; DRB1*11:86,11:86 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 11,13,14
ST   D18S51: 11,12,13
ST   D19S433: 14,16
ST   D21S11: 29,33.2
ST   D2S1338: 16,18
ST   D3S1358: 12,16
ST   D5S818: 11
ST   D7S820: 10.3,12
ST   D8S1179: 13
ST   FGA: 18,23
ST   Penta D: 12,13
ST   Penta E: 10,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC149
AC   CVCL_V702
SY   HCC0149; Hamon Cancer Center 149
DR   BioSample; SAMN03470857
DR   Wikidata; Q54881576
RX   PubMed=25877200;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 15.2
ST   D1S1656: 14,15
ST   D21S11: 29,31.2
ST   D22S1045: 12
ST   D2S1338: 19,23
ST   D2S441: 10,14
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 10,11
ST   Penta E: 14 (Direct_author_submission)
ST   Penta E: 14,17 (PubMed=25877200)
ST   TH01: 7
ST   TPOX: 6
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   HCC1493
AC   CVCL_V592
SY   Hamon Cancer Center 1493
DR   EFO; EFO_0006427
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473016
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   PharmacoDB; HCC1493_477_2019
DR   Wikidata; Q54881577
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   HLA typing: A*26:01,69:01; B*13:02,55:01; C*01:02,06:02; DQA1*05:02,05:02; DQB1*03:01,03:01; DRB1*11:01,11:01 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (PubMed=25485619).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13,14
ST   D12S391: 15,19
ST   D13S317: 11,12
ST   D16S539: 8,9
ST   D18S51: 11,17
ST   D19S433: 13,14
ST   D1S1656: 12,17.3
ST   D21S11: 30
ST   D22S1045: 11,15
ST   D2S1338: 19,22
ST   D2S441: 11,14
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 8,14
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 11,23
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 23
//
ID   HCC1498
AC   CVCL_V706
SY   Hamon Cancer Center 1498
DR   Wikidata; Q54881578
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC15
AC   CVCL_2057
SY   HCC-15; HCC0015; Hamon Cancer Center 15
DR   CLO; CLO_0009999
DR   EFO; EFO_0003129
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 663
DR   BioSample; SAMN03473175
DR   BioSample; SAMN10987789
DR   cancercelllines; CVCL_2057
DR   Cell_Model_Passport; SIDM01072
DR   Cosmic; 877105
DR   Cosmic; 903625
DR   Cosmic; 1146927
DR   Cosmic; 1219058
DR   Cosmic; 1239908
DR   Cosmic; 1518094
DR   Cosmic; 1802314
DR   Cosmic; 1925846
DR   Cosmic; 2060531
DR   Cosmic; 2125188
DR   Cosmic-CLP; 1240143
DR   DepMap; ACH-000878
DR   DSMZ; ACC-496
DR   DSMZCellDive; ACC-496
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240143
DR   GEO; GSM62968
DR   GEO; GSM108863
DR   GEO; GSM108864
DR   GEO; GSM253336
DR   GEO; GSM434318
DR   GEO; GSM784212
DR   GEO; GSM784277
DR   GEO; GSM794372
DR   GEO; GSM817109
DR   GEO; GSM827364
DR   GEO; GSM887043
DR   GEO; GSM888113
DR   GEO; GSM1374499
DR   GEO; GSM1669846
DR   IARC_TP53; 28297
DR   IGRhCellID; HCC15GEO
DR   KCLB; 70015
DR   LiGeA; CCLE_031
DR   LINCS_LDP; LCL-1604
DR   PharmacoDB; HCC15_450_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2057
DR   Wikidata; Q54881579
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=11464291;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23381221;
RX   PubMed=24002593;
RX   PubMed=25120651;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 29.1 hours (PubMed=29681454); ~30-40 hours (DSMZ=ACC-496).
CC   HLA typing: A*30:02,30:02; B*15:17,15:17; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (PubMed=11464291; Cosmic-CLP=1240143; DepMap=ACH-000878).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Asnfs*3 (c.4408dupA); Zygosity=Heterozygous (Cosmic-CLP=1240143; DepMap=ACH-000878).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1240143; DepMap=ACH-000878).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys652Ter (c.1954A>T); ClinVar=VCV003237040; Zygosity=Homozygous (Cosmic-CLP=1240143; DepMap=ACH-000878).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Val (c.776A>T); ClinVar=VCV000485034; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=1240143; DepMap=ACH-000878).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=76.99%; Native American=0%; East Asian, North=7.3%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=15.71% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1240143; Direct_author_submission; DSMZ=ACC-496; KCLB=70015; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 14,16
ST   D12S391: 17,18
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 13,15.2 (Direct_author_submission)
ST   D19S433: 13,16 (DSMZ=ACC-496)
ST   D1S1656: 15
ST   D21S11: 28
ST   D22S1045: 15
ST   D2S1338: 17,22
ST   D2S441: 11,12
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20.2 (KCLB=70015)
ST   FGA: 47.2 (DSMZ=ACC-496; Direct_author_submission; PubMed=25877200)
ST   Penta D: 10
ST   Penta E: 5,8
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L062 ! HCC15 BL
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   HCC15 BL
AC   CVCL_L062
SY   HCC-15BL; HCC15-BL; HCC15BL; C-15BL; Hamon Cancer Center 15 BL
DR   DSMZ; ACC-890
DR   DSMZCellDive; ACC-890
DR   Wikidata; Q54881580
RX   PubMed=9559342;
CC   Population: African American.
CC   Doubling time: ~40-45 hours (DSMZ=ACC-890).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-890
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D19S433: 13,15.2
ST   D21S11: 28,33.2
ST   D2S1338: 17,22
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20.2,47.2
ST   Penta D: 10,12
ST   Penta E: 5,8
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2057 ! HCC15
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 16
//
ID   HCC1500
AC   CVCL_1254
SY   HCC-1500; Hamon Cancer Center 1500
DR   BTO; BTO_0006441
DR   CLO; CLO_0003639
DR   EFO; EFO_0001172
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-2329
DR   BioSample; SAMN03471865
DR   BioSample; SAMN10988466
DR   cancercelllines; CVCL_1254
DR   Cell_Model_Passport; SIDM00879
DR   Cosmic; 687476
DR   Cosmic; 904365
DR   Cosmic; 1018471
DR   Cosmic; 1047709
DR   Cosmic; 1136374
DR   Cosmic; 1287885
DR   Cosmic; 1603203
DR   Cosmic; 1935006
DR   Cosmic; 1995424
DR   Cosmic; 2165022
DR   Cosmic; 2750522
DR   Cosmic-CLP; 1303900
DR   DepMap; ACH-000349
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1303900
DR   GEO; GSM217574
DR   GEO; GSM219982
DR   GEO; GSM344376
DR   GEO; GSM344426
DR   GEO; GSM350538
DR   GEO; GSM459706
DR   GEO; GSM783971
DR   GEO; GSM887040
DR   GEO; GSM888110
DR   GEO; GSM984232
DR   GEO; GSM1008899
DR   GEO; GSM1053690
DR   GEO; GSM1214571
DR   GEO; GSM1374500
DR   GEO; GSM1669847
DR   IARC_TP53; 22812
DR   LiGeA; CCLE_498
DR   LINCS_HMS; 50579
DR   LINCS_LDP; LCL-1325
DR   PharmacoDB; HCC1500_478_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1254
DR   SLKBase; 3524
DR   Wikidata; Q54881583
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=12800145;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1500.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: African American.
CC   Doubling time: 46.85 hours (JWGray panel).
CC   HLA typing: A*02:02,02:02; B*15:80,37:19; C*03:04,04:01 (PubMed=25960936).
CC   HLA typing: A*02:02,02:02; B*15:10,15:10; C*03:04,04:01; DQA1*01:02,05:02; DQB1*06:13,06:13; DRB1*03:08,04:08 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=75.35%; Native American=1.42%; East Asian, North=6.28%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=16.94% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2329; Cosmic-CLP=1303900; Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 12
ST   D12S391: 19,22
ST   D13S317: 10
ST   D16S539: 9,10
ST   D18S51: 13 (PubMed=25877200)
ST   D18S51: 13,16 (ATCC=CRL-2329; Direct_author_submission)
ST   D19S433: 13
ST   D1S1656: 10,14
ST   D21S11: 27,30
ST   D22S1045: 17
ST   D2S1338: 18,23
ST   D2S441: 12
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 2.2,5
ST   Penta E: 7
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 13,16
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   HCC1501
AC   CVCL_V594
SY   Hamon Cancer Center 1501
DR   Wikidata; Q54881584
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1534
AC   CVCL_V595
SY   Hamon Cancer Center 1534
DR   EFO; EFO_0006428
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472977
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC1534_479_2019
DR   Wikidata; Q54881585
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   HLA typing: A*30:04,30:04; B*41:01,41:01; C*17:01,17:01; DQB1*03:03,03:03; DRB1*11:02,11:02 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 18,19,20
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 11,12
ST   Penta E: 15
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC1561
AC   CVCL_V596
SY   Hamon Cancer Center 1561
DR   BioSample; SAMN03470858
DR   Wikidata; Q54881586
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 15,15.2
ST   D21S11: 30.2,32.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   Penta D: 9
ST   Penta E: 5,7
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC1569
AC   CVCL_1255
SY   HCC-1569; Hamon Cancer Center 1569
DR   BTO; BTO_0006090
DR   CLO; CLO_0003640
DR   EFO; EFO_0001173
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-2330
DR   BioSample; SAMN03471817
DR   BioSample; SAMN03473137
DR   BioSample; SAMN10987921
DR   cancercelllines; CVCL_1255
DR   Cell_Model_Passport; SIDM00878
DR   ChEMBL-Cells; CHEMBL3308497
DR   ChEMBL-Targets; CHEMBL1075456
DR   Cosmic; 687477
DR   Cosmic; 907046
DR   Cosmic; 1136354
DR   Cosmic; 1176644
DR   Cosmic; 1287886
DR   Cosmic; 1603204
DR   Cosmic; 1935007
DR   Cosmic; 1995425
DR   Cosmic; 2165006
DR   Cosmic; 2787232
DR   Cosmic-CLP; 907046
DR   DepMap; ACH-000930
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907046
DR   GEO; GSM186718
DR   GEO; GSM186719
DR   GEO; GSM217575
DR   GEO; GSM219971
DR   GEO; GSM274679
DR   GEO; GSM344381
DR   GEO; GSM344431
DR   GEO; GSM350503
DR   GEO; GSM481315
DR   GEO; GSM783966
DR   GEO; GSM844545
DR   GEO; GSM847323
DR   GEO; GSM847474
DR   GEO; GSM887041
DR   GEO; GSM888111
DR   GEO; GSM1053726
DR   GEO; GSM1172867
DR   GEO; GSM1172959
DR   GEO; GSM1374501
DR   GEO; GSM1374502
DR   GEO; GSM1401674
DR   GEO; GSM1669848
DR   IARC_TP53; 10272
DR   KCLB; 71569
DR   KCLB; 9S1569
DR   LiGeA; CCLE_878
DR   LINCS_HMS; 50210
DR   LINCS_LDP; LCL-1480
DR   PharmacoDB; HCC1569_480_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1255
DR   PubChem_Cell_line; CVCL_1255
DR   SLKBase; 3530
DR   Wikidata; Q54881587
RX   PubMed=9288768;
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26759240;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1569.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 45.43 hours (JWGray panel).
CC   HLA typing: A*30:04,68:02; B*53:01,58:01; C*04:01,15:05 (PubMed=25960936).
CC   HLA typing: A*30:04,68:02; B*53:01,58:01; C*04:01,15:05; DQB1*06:02,06:02; DRB1*13:03,13:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1100Thr (c.3299A>C); Zygosity=Heterozygous (Cosmic-CLP=907046; DepMap=ACH-000930).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Val1862fs*1 (c.5578delA); Zygosity=Heterozygous (Cosmic-CLP=907046; DepMap=ACH-000930).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Simple; p.Val97Phe (c.289G>T) (651G>T); dbSNP=rs139666727; Zygosity=Heterozygous; Note=Germline (PubMed=9288768).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (Cosmic-CLP=907046; DepMap=ACH-000930).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Heterozygous (PubMed=9865903; Cosmic-CLP=907046; DepMap=ACH-000930).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=80.08%; Native American=0%; East Asian, North=2.86%; East Asian, South=0%; South Asian=0%; European, North=4.32%; European, South=12.74% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
ST   Source(s): ATCC=CRL-2330; Cosmic-CLP=907046; Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11,12 (Cosmic-CLP=907046; Direct_author_submission; PubMed=25877200)
ST   CSF1PO: 11,12 (ATCC=CRL-2330; PubMed=20679594)
ST   D10S1248: 14
ST   D12S391: 19
ST   D13S317: 12
ST   D16S539: 11,12 (PubMed=20679594)
ST   D16S539: 11,12,13 (ATCC=CRL-2330; Direct_author_submission; PubMed=25877200)
ST   D16S539: 12,13 (Cosmic-CLP=907046)
ST   D18S51: 17,18,19 (PubMed=25877200)
ST   D18S51: 18,19 (Direct_author_submission)
ST   D19S433: 12.2
ST   D1S1656: 14,15
ST   D21S11: 28
ST   D22S1045: 16
ST   D2S1338: 18,22,24
ST   D2S441: 11,11.3
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,8.3,9 (ATCC=CRL-2330)
ST   D7S820: 8,9 (Cosmic-CLP=907046; Direct_author_submission; PubMed=20679594; PubMed=25877200)
ST   D8S1179: 12,14,15
ST   FGA: 19.2,24
ST   Penta D: 8
ST   Penta E: 16,17
ST   TH01: 6,7 (Direct_author_submission)
ST   TH01: 7 (ATCC=CRL-2330; Cosmic-CLP=907046; PubMed=20679594; PubMed=25877200)
ST   TPOX: 6,11
ST   vWA: 17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   HCC1569 GDC-0941_resistant
AC   CVCL_A1FP
DR   cancercelllines; CVCL_A1FP
DR   Wikidata; Q102114105
RX   PubMed=26759240;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_65326; Pictrelisib (Pictilisib; GDC-0941).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1100Thr (c.3299A>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Val1862fs*1 (c.5578delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Simple; p.Val97Phe (c.289G>T) (651G>T); dbSNP=rs139666727; Zygosity=Heterozygous; Note=Germline (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1255 ! HCC1569
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HCC1576
AC   CVCL_V597
SY   Hamon Cancer Center 1576
DR   EFO; EFO_0006429
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473033
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC1576_481_2019
DR   Wikidata; Q54881588
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*32:01,68:01; B*08:01,44:02; C*02:02,07:04 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17
ST   D21S11: 28
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC1581
AC   CVCL_V598
SY   Hamon Cancer Center 1581
DR   Wikidata; Q54881589
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC1588
AC   CVCL_A351
SY   HCC-1588; Hamon Cancer Center 1588
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473071
DR   BioSample; SAMN10987742
DR   cancercelllines; CVCL_A351
DR   Cell_Model_Passport; SIDM01820
DR   Cosmic; 903638
DR   DepMap; ACH-001078
DR   GEO; GSM1374503
DR   IARC_TP53; 11451
DR   KCLB; 71588
DR   LiGeA; CCLE_148
DR   PharmacoDB; HCC1588_451_2019
DR   Wikidata; Q54881590
RX   PubMed=10353731;
RX   PubMed=24002593;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   HLA typing: A*32:01,32:01; B*51:01,51:01; C*01:02,01:02; DRB1*11:101,13:07 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.886_910del25; Zygosity=Unspecified (PubMed=10353731).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; KCLB=71588; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D10S1248: 16
ST   D12S391: 19,21
ST   D13S317: 10,11 (PubMed=25877200)
ST   D13S317: 11 (Direct_author_submission; KCLB=71588)
ST   D16S539: 10
ST   D18S51: 15,20
ST   D19S433: 12.2,13.2
ST   D1S1656: 14
ST   D21S11: 27,28
ST   D22S1045: 15,16
ST   D2S1338: 24
ST   D2S441: 11,11.3
ST   D3S1358: 17
ST   D5S818: 8
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 7,13
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 28
//
ID   HCC1599
AC   CVCL_1256
SY   HCC-1599; Hamon Cancer Center 1599
DR   CLO; CLO_0003641
DR   EFO; EFO_0002186
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2331
DR   BioSample; SAMN01821554
DR   BioSample; SAMN01821628
DR   BioSample; SAMN03471818
DR   BioSample; SAMN10988467
DR   cancercelllines; CVCL_1256
DR   Cell_Model_Passport; SIDM00877
DR   ChEMBL-Cells; CHEMBL3308262
DR   ChEMBL-Targets; CHEMBL2366063
DR   Cosmic; 749713
DR   Cosmic; 904366
DR   Cosmic; 1047710
DR   Cosmic; 1235082
DR   Cosmic; 1287887
DR   Cosmic; 1430350
DR   Cosmic; 1518112
DR   Cosmic; 1603205
DR   Cosmic; 1995426
DR   Cosmic; 2009510
DR   Cosmic-CLP; 749713
DR   DepMap; ACH-000196
DR   DSMZ; ACC-503
DR   DSMZCellDive; ACC-503
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 749713
DR   GEO; GSM186720
DR   GEO; GSM186721
DR   GEO; GSM186722
DR   GEO; GSM217612
DR   GEO; GSM350526
DR   GEO; GSM533402
DR   GEO; GSM533409
DR   GEO; GSM537972
DR   GEO; GSM783935
DR   GEO; GSM847324
DR   GEO; GSM847481
DR   GEO; GSM887042
DR   GEO; GSM888112
DR   GEO; GSM1053706
DR   GEO; GSM1172868
DR   GEO; GSM1401655
DR   GEO; GSM1669849
DR   IARC_TP53; 21362
DR   IGRhCellID; HCC1599
DR   LiGeA; CCLE_632
DR   LINCS_HMS; 50580
DR   LINCS_LDP; LCL-1326
DR   PharmacoDB; HCC1599_482_2019
DR   PRIDE; PXD000309
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1256
DR   PubChem_Cell_line; CVCL_1256
DR   Wikidata; Q54881591
RX   PubMed=9833771;
RX   PubMed=11314036;
RX   PubMed=16959974;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22414580;
RX   PubMed=22460905;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1599.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~4-5 days (DSMZ=ACC-503).
CC   HLA typing: A*01:01,02:01; B*08:01,13:02; C*06:02,07:01; DQA1*03:02,03:02; DQB1*02:02,03:03; DRB1*04:01,13:60 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*08:01,13:02; C*06:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=749713; DepMap=ACH-000196).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.77%; Native American=0.18%; East Asian, North=6.87%; East Asian, South=0%; South Asian=0%; European, North=46.32%; European, South=41.85% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2331; Cosmic-CLP=749713; Direct_author_submission; DSMZ=ACC-503; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 19.3
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 15,19 (Direct_author_submission)
ST   D18S51: 19 (ATCC=CRL-2331; DSMZ=ACC-503; PubMed=25877200)
ST   D19S433: 13,16.2 (ATCC=CRL-2331)
ST   D19S433: 13,17 (DSMZ=ACC-503)
ST   D19S433: 16.2 (Direct_author_submission)
ST   D1S1656: 11,15
ST   D21S11: 29
ST   D22S1045: 11,15
ST   D2S1338: 17,25
ST   D2S441: 14,15
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1257 ! HCC1599 BL
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   HCC1599 BL
AC   CVCL_1257
SY   HCC-1599BL; HCC1599-BL; HCC1599BL; Hamon Cancer Center 1599 BL
DR   CLO; CLO_0003642
DR   ATCC; CRL-2332
DR   BioSample; SAMN03471819
DR   Cell_Model_Passport; SIDM00876
DR   DepMap; ACH-002374
DR   DSMZ; ACC-894
DR   DSMZCellDive; ACC-894
DR   KCLB; 9S1599BL
DR   Wikidata; Q54881592
RX   PubMed=9833771;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~48-72 hours (DSMZ=ACC-894).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2332; DSMZ=ACC-894
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 15,19
ST   D19S433: 13,17
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 13
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1256 ! HCC1599
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HCC1623
AC   CVCL_V657
SY   Hamon Cancer Center 1623
DR   BioSample; SAMN03470998
DR   cancercelllines; CVCL_V657
DR   EGA; EGAS00001002554
DR   Wikidata; Q54881593
RX   PubMed=25877200;
RX   PubMed=29045385;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Unspecified (PubMed=29045385).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 12,14
ST   D12S391: 15,18
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 18,19
ST   D19S433: 14,16.2
ST   D1S1656: 11,13
ST   D21S11: 28,31
ST   D22S1045: 12,16
ST   D2S1338: 19,23
ST   D2S441: 11,12
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 21.2,27
ST   Penta D: 10,13
ST   Penta E: 8,10
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 13,17
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HCC1629
AC   CVCL_V656
SY   Hamon Cancer Center 1629
DR   Wikidata; Q54881594
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 13
ST   D21S11: 31.2
ST   D5S818: 13
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8,14
ST   vWA: 14,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1637
AC   CVCL_9Y85
SY   Hamon Cancer Center 1637
DR   Wikidata; Q54881595
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC1671
AC   CVCL_V655
SY   Hamon Cancer Center 1671
DR   Wikidata; Q54881596
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1685
AC   CVCL_V658
SY   Hamon Cancer Center 1685
DR   IARC_TP53; 22813
DR   Wikidata; Q54881597
RX   PubMed=9865903;
CC   Population: Hispanic.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9CM ! HCC1685 BL
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC1685 BL
AC   CVCL_E9CM
SY   HCC-1685bL; HCC1685-BL; HCC1685BL; Hamon Cancer Center 1685 BL
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V658 ! HCC1685
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC1686
AC   CVCL_V659
SY   Hamon Cancer Center 1686
DR   Wikidata; Q54881598
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D10S1248: 12,15
ST   D12S391: 22,23
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 17
ST   D19S433: 14,16
ST   D1S1656: 17,18.3
ST   D21S11: 28
ST   D22S1045: 15
ST   D2S1338: 24
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 16
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC1688
AC   CVCL_V660
SY   Hamon Cancer Center 1688
DR   Wikidata; Q54881599
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C6340; Uterine corpus leiomyosarcoma
DI   ORDO; Orphanet_213625; Leiomyosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC1705
AC   CVCL_V654
SY   Hamon Cancer Center 1705
DR   BioSample; SAMN03470859
DR   Wikidata; Q54881600
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 16,17
ST   D3S1358: 18,19
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1719
AC   CVCL_L089
SY   HCC-1719; Hamon Cancer Center 1719
DR   BioSample; SAMN03470840
DR   KCLB; 71719
DR   Wikidata; Q54881601
RX   PubMed=25877200;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 9
ST   D18S51: 14,17
ST   D21S11: 30,31
ST   D3S1358: 19
ST   D5S818: 13
ST   D7S820: 9,13
ST   D8S1179: 11
ST   FGA: 22
ST   Penta D: 2.2,11
ST   Penta E: 16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   HCC1739
AC   CVCL_9877
SY   HCC-1739; Hamon Cancer Center 1739
DR   ATCC; CRL-2333
DR   IARC_TP53; 22814
DR   Wikidata; Q54881602
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=21778573;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Discontinued: ATCC; CRL-2333; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 15
ST   D12S391: 16,18
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 15
ST   D1S1656: 12,15
ST   D21S11: 30,32
ST   D22S1045: 16
ST   D2S1338: 26
ST   D2S441: 10
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3280 ! HCC1739 BL
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   HCC1739 BL
AC   CVCL_3280
SY   HCC-1739BL; HCC1739-BL; HCC1739BL; Hamon Cancer Center 1739 BL
DR   CLO; CLO_0003643
DR   ATCC; CRL-2334
DR   BioSample; SAMN03471820
DR   KCLB; 9S1739BL
DR   Wikidata; Q54881603
RX   PubMed=9833771;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2334
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 16,18
ST   D19S433: 15
ST   D21S11: 30,32
ST   D2S1338: 21,26
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9877 ! HCC1739
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   HCC1772
AC   CVCL_V653
SY   Hamon Cancer Center 1772
DR   Wikidata; Q54881604
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1806
AC   CVCL_1258
SY   Hcc1806; HCC-1806; Hamon Cancer Center 1806
DR   BTO; BTO_0006395
DR   CLO; CLO_0003644
DR   EFO; EFO_0005373
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2335
DR   BioGRID_ORCS_Cell_line; 662
DR   BioSample; SAMN03472709
DR   BioSample; SAMN10988428
DR   cancercelllines; CVCL_1258
DR   Cell_Model_Passport; SIDM00875
DR   ChEMBL-Cells; CHEMBL3308135
DR   ChEMBL-Targets; CHEMBL1075457
DR   CLS; 300467
DR   Cosmic; 687479
DR   Cosmic; 904367
DR   Cosmic; 907047
DR   Cosmic; 1047705
DR   Cosmic; 1287888
DR   Cosmic; 1460234
DR   Cosmic; 1603206
DR   Cosmic; 1935008
DR   Cosmic-CLP; 907047
DR   DepMap; ACH-000624
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10717-109I6
DR   GDSC; 907047
DR   GEO; GSM217576
DR   GEO; GSM219878
DR   GEO; GSM344339
DR   GEO; GSM344389
DR   GEO; GSM350528
DR   GEO; GSM378147
DR   GEO; GSM783942
DR   GEO; GSM844546
DR   GEO; GSM844547
DR   GEO; GSM847325
DR   GEO; GSM847482
DR   GEO; GSM887044
DR   GEO; GSM888114
DR   GEO; GSM1053713
DR   GEO; GSM1172869
DR   GEO; GSM1172960
DR   GEO; GSM1374504
DR   GEO; GSM1374505
DR   GEO; GSM1669850
DR   IARC_TP53; 10273
DR   KCB; KCB 2014032YJ
DR   LiGeA; CCLE_250
DR   LINCS_HMS; 50211
DR   LINCS_LDP; LCL-1960
DR   PharmacoDB; HCC1806_483_2019
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1258
DR   PubChem_Cell_line; CVCL_1258
DR   SLKBase; 3534
DR   Ubigene; YC-C073
DR   Wikidata; Q54881605
RX   PubMed=9288768;
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=19582160;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20679594;
RX   PubMed=21603256;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30787054;
RX   PubMed=30835260;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=40300663;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1806.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/hcc-1806-xenograft-model/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 36.66 hours (JWGray panel).
CC   HLA typing: A*23:01,68:01; B*15:03,51:01; C*02:02,02:02; DQB1*06:02,06:02 (PubMed=25960936).
CC   HLA typing: A*23:01,68:01; B*15:03,51:01; C*02:02,02:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (PubMed=9288768).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (PubMed=9865903; Cosmic-CLP=907047; DepMap=ACH-000624).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H2A.Z.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; ChIP-seq; Pol2.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=80.71%; Native American=0%; East Asian, North=3.77%; East Asian, South=0%; South Asian=0%; European, North=6.8%; European, South=8.72% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2335; CLS=300467; Cosmic-CLP=907047; Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 12,17
ST   D12S391: 19,21
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 14
ST   D1S1656: 15.3
ST   D21S11: 29
ST   D22S1045: 11
ST   D2S1338: 17
ST   D2S441: 14
ST   D3S1358: 16
ST   D5S818: 13
ST   D6S1043: 12
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 25
ST   Penta D: 15
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 51
//
ID   HCC1806-EGFP
AC   CVCL_C8VV
DR   Ubigene; YC-C073-EGFP-P
DR   Wikidata; Q123031545
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HCC1806r5-F1500
AC   CVCL_D6VJ
SY   HCC1806 r5-Fluorouracil1500
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCC1806rCDDP500
AC   CVCL_D6VE
SY   HCC1806 rCDDP500
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCC1806rDOX12.5
AC   CVCL_D6VF
SY   HCC1806 rDoxorubicin12.5
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCC1806rERI50
AC   CVCL_D6VG
SY   HCC1806 rEribulin50
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63587; Eribulin (Halaven).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCC1806rGEM20
AC   CVCL_D6VH
SY   HCC1806 rGemcitabine20
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCC1806rPCL20
AC   CVCL_D6VI
SY   HCC1806 rPaclitaxel20
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCC1806rYM155_20nM
AC   CVCL_RS40
SY   HCC-1806rYM155_20nM; HCC-1806rYM155(20nM)
DR   Wikidata; Q54881506
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_139608; Sepantronium bromide (YM155).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   HCC1820
AC   CVCL_V652
SY   Hamon Cancer Center 1820
DR   Wikidata; Q54881606
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 12
ST   D21S11: 29,32.2
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1833
AC   CVCL_5129
SY   HCC-1833; Hamon Cancer Center 1833
DR   BTO; BTO_0006442
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470860
DR   BioSample; SAMN10988044
DR   cancercelllines; CVCL_5129
DR   Cell_Model_Passport; SIDM01604
DR   Cosmic; 903639
DR   Cosmic; 1146928
DR   DepMap; ACH-000712
DR   GEO; GSM62338
DR   GEO; GSM171898
DR   GEO; GSM171899
DR   GEO; GSM253423
DR   GEO; GSM434312
DR   GEO; GSM794389
DR   GEO; GSM817121
DR   IARC_TP53; 11452
DR   IGRhCellID; HCC1833_02GEO
DR   KCLB; 71833
DR   LiGeA; CCLE_921
DR   PharmacoDB; HCC1833_452_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_5129
DR   Wikidata; Q54881607
RX   PubMed=10353731;
RX   PubMed=16187286;
RX   PubMed=20679594;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 46.8 hours (PubMed=29681454).
CC   HLA typing: A*24:02,24:02; B*35:03,35:03; C*12:03,12:03; DQA1*01:02,03:02; DQB1*03:02,05:03; DRB1*04:01,11:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr284_Glu286del (c.850_858delACAGAGGAA); Zygosity=Unspecified (PubMed=10353731).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; KCLB=71833; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13
ST   D12S391: 24
ST   D13S317: 8,11
ST   D16S539: 9,11 (Direct_author_submission; PubMed=25877200)
ST   D16S539: 11 (PubMed=20679594)
ST   D18S51: 17
ST   D19S433: 13,14
ST   D1S1656: 12,14
ST   D21S11: 28
ST   D22S1045: 15
ST   D2S1338: 19,23 (PubMed=25877200)
ST   D2S1338: 23 (Direct_author_submission)
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 7
ST   Penta E: 12
ST   TH01: 8,9.3 (Direct_author_submission; KCLB=71833; PubMed=20679594)
ST   TH01: 9.3 (PubMed=25877200)
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   HCC1897
AC   CVCL_V578
SY   HCC-1897; Hamon Cancer Center 1897
DR   BioSample; SAMN03470862
DR   Cell_Model_Passport; SIDM01814
DR   DepMap; ACH-001079
DR   GEO; GSM794390
DR   PharmacoDB; HCC1897_453_2019
DR   Progenetix; CVCL_V578
DR   Wikidata; Q54881608
RX   PubMed=20679594;
RX   PubMed=24002593;
RX   PubMed=25877200;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=77.47%; Native American=1.11%; East Asian, North=4.48%; East Asian, South=0%; South Asian=0%; European, North=1.19%; European, South=15.76% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 13.2
ST   D1S1656: 11,16.3
ST   D21S11: 28
ST   D22S1045: 11
ST   D2S1338: 19
ST   D2S441: 11,14
ST   D3S1358: 17
ST   D5S818: 9
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 9,10
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 20
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 23
//
ID   HCC19
AC   CVCL_V720
SY   HCC0019; Hamon Cancer Center 19
DR   Wikidata; Q54881609
CC   Population: Caucasian.
CC   Characteristics: Metastatic adenocarcinoma from unknown primary site.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4124; Metastatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC1908
AC   CVCL_V639
SY   Hamon Cancer Center 1908
DR   Wikidata; Q54881610
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D21S11: 30.2,32.2
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC193
AC   CVCL_5130
SY   HCC-193; HCC0193; Hamon Cancer Center 193
DR   EFO; EFO_0003130
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472990
DR   cancercelllines; CVCL_5130
DR   Cosmic; 877256
DR   Cosmic; 903629
DR   Cosmic; 1146929
DR   Cosmic; 1239872
DR   Cosmic; 1518093
DR   Cosmic; 2125260
DR   EGA; EGAS00001000610
DR   GEO; GSM62334
DR   GEO; GSM108865
DR   GEO; GSM108866
DR   GEO; GSM253372
DR   GEO; GSM434260
DR   GEO; GSM794377
DR   IARC_TP53; 28436
DR   IGRhCellID; HCC193GEO
DR   PharmacoDB; HCC193_484_2019
DR   Progenetix; CVCL_5130
DR   Wikidata; Q54881611
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=16187286;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 45.5 hours (PubMed=29681454).
CC   HLA typing: A*01:01,24:02; B*08:01,40:01; C*03:04,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=20557307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,18
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 25,26
ST   Penta D: 9,13
ST   Penta E: 14,18
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S838 ! HCC193 BL
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   HCC193 BL
AC   CVCL_S838
SY   HCC-193BL; HCC193-BL; HCC193BL; Hamon Cancer Center 193 BL
DR   Wikidata; Q54881612
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5130 ! HCC193
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   HCC1937
AC   CVCL_0290
SY   Hcc1937; HCC-1937; HCC/1937; Hamon Cancer Center 1937
DR   BTO; BTO_0003323
DR   CLO; CLO_0003645
DR   EFO; EFO_0001174
DR   MCCL; MCC:0000180
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2336
DR   BCRJ; 0387
DR   BioGRID_ORCS_Cell_line; 427
DR   BioSample; SAMN01821555
DR   BioSample; SAMN01821629
DR   BioSample; SAMN03473202
DR   BioSample; SAMN05292445
DR   BioSample; SAMN10987920
DR   cancercelllines; CVCL_0290
DR   CCRID; 1101HUM-PUMC000471
DR   CCRID; 3101HUMTCHu148
DR   CCRID; 5301HUM-KCB09044YJ
DR   Cell_Model_Passport; SIDM00874
DR   ChEMBL-Cells; CHEMBL3308371
DR   ChEMBL-Targets; CHEMBL1075458
DR   CLS; 305064
DR   Cosmic; 749714
DR   Cosmic; 904368
DR   Cosmic; 1007153
DR   Cosmic; 1046927
DR   Cosmic; 1047704
DR   Cosmic; 1176626
DR   Cosmic; 1235083
DR   Cosmic; 1287892
DR   Cosmic; 1289389
DR   Cosmic; 1309007
DR   Cosmic; 1430351
DR   Cosmic; 1460235
DR   Cosmic; 1472999
DR   Cosmic; 1518113
DR   Cosmic; 1603207
DR   Cosmic; 1995427
DR   Cosmic; 2009511
DR   Cosmic; 2164992
DR   Cosmic-CLP; 749714
DR   DepMap; ACH-000223
DR   DSMZ; ACC-513
DR   DSMZCellDive; ACC-513
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 749714
DR   GEO; GSM155209
DR   GEO; GSM185079
DR   GEO; GSM185080
DR   GEO; GSM186723
DR   GEO; GSM217577
DR   GEO; GSM219873
DR   GEO; GSM274654
DR   GEO; GSM344367
DR   GEO; GSM344417
DR   GEO; GSM350544
DR   GEO; GSM378151
DR   GEO; GSM421867
DR   GEO; GSM459723
DR   GEO; GSM481301
DR   GEO; GSM533403
DR   GEO; GSM533410
DR   GEO; GSM537973
DR   GEO; GSM783936
DR   GEO; GSM783943
DR   GEO; GSM847340
DR   GEO; GSM887045
DR   GEO; GSM888115
DR   GEO; GSM1008900
DR   GEO; GSM1053709
DR   GEO; GSM1172870
DR   GEO; GSM1172961
DR   GEO; GSM1214588
DR   GEO; GSM1238126
DR   GEO; GSM1374506
DR   GEO; GSM1374507
DR   GEO; GSM1401668
DR   GEO; GSM1669851
DR   GEO; GSM2258902
DR   GEO; GSM2258903
DR   GEO; GSM2258904
DR   GEO; GSM2258905
DR   GEO; GSM2258906
DR   GEO; GSM2258907
DR   GEO; GSM2258908
DR   GEO; GSM2258909
DR   GEO; GSM2258910
DR   GEO; GSM2258911
DR   GEO; GSM2258912
DR   GEO; GSM2258913
DR   GEO; GSM2258914
DR   GEO; GSM2258915
DR   GEO; GSM2258916
DR   GEO; GSM2258917
DR   GEO; GSM2258918
DR   GEO; GSM2258919
DR   GEO; GSM2258926
DR   GEO; GSM2258927
DR   GEO; GSM2258928
DR   IARC_TP53; 10102
DR   IARC_TP53; 10274
DR   IGRhCellID; HCC1937
DR   KCB; KCB 200944YJ
DR   KCLB; 9S1937
DR   LiGeA; CCLE_424
DR   LINCS_HMS; 50212
DR   LINCS_LDP; LCL-1331
DR   Lonza; 905
DR   MetaboLights; MTBLS337
DR   PharmacoDB; HCC1937_485_2019
DR   PRIDE; PXD000309
DR   PRIDE; PXD000394
DR   PRIDE; PXD005295
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0290
DR   PubChem_Cell_line; CVCL_0290
DR   SLKBase; 3539
DR   TOKU-E; 1402
DR   Wikidata; Q28872477
RX   DOI=10.25904/1912/1434;
RX   PubMed=9699648;
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=10635334;
RX   PubMed=11314036;
RX   PubMed=12353263;
RX   PubMed=12419185;
RX   PubMed=12800145;
RX   PubMed=14762065;
RX   PubMed=15162061;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=16959974;
RX   PubMed=17157791;
RX   PubMed=17334996;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22032724;
RX   PubMed=22414580;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25576301;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34339474;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1937.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544550
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-513); ~61 hours (PBCF); 53.49 hours (JWGray panel).
CC   HLA typing: A*23:01,24:02; B*07:02,40:01; C*03:04,07:02; DQA1*04:01,04:01; DQB1*06:02,06:02; DRB1*15:01,08:01 (PubMed=25960936).
CC   HLA typing: A*23:01,24:02; B*40:16,81:03; C*03:04,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17334996; PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Homozygous; Note=The lymphoblastoid cell line HCC1937 BL (Cellosaurus=CVCL_3281) is heterozygous for the same mutation (PubMed=9699648; PubMed=15162061; PubMed=16397213; PubMed=22032724; Cosmic-CLP=749714; DepMap=ACH-000223).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Thr738_Arg775del38 (c.2212_2325del114); Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11876; TMPRSS2; Simple; p.Gly8Val (c.23G>T) (c.-57+99G>T); ClinVar=VCV001273671; Zygosity=Homozygous (PubMed=34339474).
CC   Sequence variation: Mutation; HGNC; HGNC:11876; TMPRSS2; Simple; p.Val197Met (c.589G>A) (p.Val160Met, c.478G>A); ClinVar=VCV001257425; Zygosity=Homozygous (PubMed=34339474).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (PubMed=9865903; PubMed=16541312; PubMed=28889351; ATCC=CRL-2336; Cosmic-CLP=749714; DepMap=ACH-000223).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.19%; Native American=0%; East Asian, North=5.95%; East Asian, South=0%; South Asian=0%; European, North=57.75%; European, South=34.11% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Misspelling: Tom98; IARC_TP53=10102; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2336; Cosmic-CLP=749714; Direct_author_submission; DSMZ=ACC-513; KCLB=9S1937; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,14
ST   D12S391: 21
ST   D13S317: 13
ST   D16S539: 13,14
ST   D18S51: 12
ST   D19S433: 14,15
ST   D1S1656: 15
ST   D21S11: 28
ST   D22S1045: 16
ST   D2S1338: 25
ST   D2S441: 10
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 13
ST   TH01: 6 (ATCC=CRL-2336; Cosmic-CLP=749714; Direct_author_submission; DSMZ=ACC-513; PubMed=25877200; PubMed=28889351)
ST   TH01: 6,8 (KCLB=9S1937)
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3281 ! HCC1937 BL
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 54
//
ID   HCC1937 BL
AC   CVCL_3281
SY   HCC-1937BL; HCC1937-BL; HCC1937BL; Hamon Cancer Center 1937 BL
DR   CLO; CLO_0003646
DR   ATCC; CRL-2337
DR   BioSample; SAMN03471821
DR   Cell_Model_Passport; SIDM00873
DR   DepMap; ACH-002375
DR   DSMZ; ACC-891
DR   DSMZCellDive; ACC-891
DR   KCLB; 9S1937BL
DR   Wikidata; Q28872486
RX   PubMed=9699648;
RX   PubMed=9833771;
RX   PubMed=20164919;
RX   PubMed=22032724;
RX   PubMed=25960936;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (DSMZ=ACC-891).
CC   HLA typing: A*23:01,24:02; B*40:01,07:02; C*03:04,07:02; DQA1*04:01,01:02; DQB1*06:02,04:02; DRB1*08:01,15:01 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous; Note=The breast carcinoma cell line HCC1937 (Cellosaurus=CVCL_0290) is homozygous for the same mutation (PubMed=9699648; PubMed=22032724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: HCC2337; PubMed=22032724; Note=Probably due to confusion with ATCC catalog number (CRL-2337).
CC   Misspelling: HCC-2337; PubMed=25960936; Note=Probably due to confusion with ATCC catalog number (CRL-2337).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2337; DSMZ=ACC-891
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13 (ATCC=CRL-2337)
ST   D13S317: 13,14 (DSMZ=ACC-891)
ST   D16S539: 13 (DSMZ=ACC-891)
ST   D16S539: 13,14 (ATCC=CRL-2337)
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 28,32.2
ST   D2S1338: 20,25
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 7,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0290 ! HCC1937
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   HCC1937 shPARG
AC   CVCL_RA87
SY   shPARG HCC1937
DR   cancercelllines; CVCL_RA87
DR   Wikidata; Q54881613
RX   PubMed=29166620;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Thr738_Arg775del38 (c.2212_2325del114); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0290 ! HCC1937
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   HCC1937/CMV-Luc
AC   CVCL_4W92
SY   HCC-1937/CMV-Luc
DR   cancercelllines; CVCL_4W92
DR   JCRB; JCRB1508
DR   JCRB; NIHS0707
DR   Wikidata; Q54881614
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1508).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Thr738_Arg775del38 (c.2212_2325del114); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0707; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB=JCRB1508
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 13,14
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0290 ! HCC1937
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 22
//
ID   HCC1943
AC   CVCL_V661
SY   Hamon Cancer Center 1943
DR   BioSample; SAMN03470863
DR   Wikidata; Q54881615
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 16,19
ST   D19S433: 15
ST   D21S11: 30,32.2
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 10
ST   FGA: 19,21
ST   Penta D: 11,12
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC1944
AC   CVCL_V603
SY   Hamon Cancer Center 1944
DR   BioSample; SAMN03470845
DR   Wikidata; Q54881616
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC1945
AC   CVCL_V604
SY   Hamon Cancer Center 1945
DR   Wikidata; Q54881617
RX   PubMed=31803961;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 9
//
ID   HCC1954
AC   CVCL_1259
SY   HCC-1954; Hamon Cancer Center 1954
DR   BTO; BTO_0005368
DR   CLO; CLO_0003647
DR   EFO; EFO_0001175
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2338
DR   BCRJ; 0280
DR   BioGRID_ORCS_Cell_line; 425
DR   BioSample; SAMN03473018
DR   BioSample; SAMN10987850
DR   cancercelllines; CVCL_1259
DR   Cell_Model_Passport; SIDM00872
DR   ChEMBL-Cells; CHEMBL3308107
DR   ChEMBL-Targets; CHEMBL1075459
DR   CLS; 305268
DR   Cosmic; 749709
DR   Cosmic; 904369
DR   Cosmic; 1136367
DR   Cosmic; 1235077
DR   Cosmic; 1287889
DR   Cosmic; 1308993
DR   Cosmic; 1430345
DR   Cosmic; 1473150
DR   Cosmic; 1518107
DR   Cosmic; 1603208
DR   Cosmic; 1717243
DR   Cosmic; 1935009
DR   Cosmic; 1995428
DR   Cosmic; 2165007
DR   Cosmic-CLP; 749709
DR   DepMap; ACH-000859
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 749709
DR   GEO; GSM185081
DR   GEO; GSM185082
DR   GEO; GSM186724
DR   GEO; GSM217578
DR   GEO; GSM219962
DR   GEO; GSM274675
DR   GEO; GSM303673
DR   GEO; GSM303675
DR   GEO; GSM303680
DR   GEO; GSM303682
DR   GEO; GSM303684
DR   GEO; GSM303687
DR   GEO; GSM303689
DR   GEO; GSM303691
DR   GEO; GSM303695
DR   GEO; GSM303698
DR   GEO; GSM303700
DR   GEO; GSM303704
DR   GEO; GSM303707
DR   GEO; GSM303709
DR   GEO; GSM303712
DR   GEO; GSM303715
DR   GEO; GSM303719
DR   GEO; GSM303721
DR   GEO; GSM303723
DR   GEO; GSM303726
DR   GEO; GSM303729
DR   GEO; GSM303731
DR   GEO; GSM303735
DR   GEO; GSM303738
DR   GEO; GSM303740
DR   GEO; GSM303742
DR   GEO; GSM303745
DR   GEO; GSM303747
DR   GEO; GSM303750
DR   GEO; GSM303753
DR   GEO; GSM303754
DR   GEO; GSM303760
DR   GEO; GSM303762
DR   GEO; GSM303766
DR   GEO; GSM303769
DR   GEO; GSM303770
DR   GEO; GSM303775
DR   GEO; GSM303777
DR   GEO; GSM303780
DR   GEO; GSM303784
DR   GEO; GSM303786
DR   GEO; GSM303789
DR   GEO; GSM337683
DR   GEO; GSM337684
DR   GEO; GSM337685
DR   GEO; GSM337686
DR   GEO; GSM337687
DR   GEO; GSM337688
DR   GEO; GSM337689
DR   GEO; GSM337690
DR   GEO; GSM337691
DR   GEO; GSM337692
DR   GEO; GSM337693
DR   GEO; GSM337694
DR   GEO; GSM337695
DR   GEO; GSM344374
DR   GEO; GSM344424
DR   GEO; GSM350499
DR   GEO; GSM481299
DR   GEO; GSM718290
DR   GEO; GSM783937
DR   GEO; GSM847341
DR   GEO; GSM847483
DR   GEO; GSM887046
DR   GEO; GSM888116
DR   GEO; GSM1008901
DR   GEO; GSM1053712
DR   GEO; GSM1172871
DR   GEO; GSM1172962
DR   GEO; GSM1215272
DR   GEO; GSM1374508
DR   GEO; GSM1374509
DR   GEO; GSM1401665
DR   GEO; GSM1669852
DR   GEO; GSM2258830
DR   GEO; GSM2258831
DR   GEO; GSM2258832
DR   GEO; GSM2258833
DR   GEO; GSM2258834
DR   GEO; GSM2258835
DR   GEO; GSM2258836
DR   GEO; GSM2258837
DR   GEO; GSM2258838
DR   GEO; GSM2258839
DR   GEO; GSM2258840
DR   GEO; GSM2258841
DR   GEO; GSM2258842
DR   GEO; GSM2258843
DR   GEO; GSM2258844
DR   GEO; GSM2258845
DR   GEO; GSM2258846
DR   GEO; GSM2258847
DR   GEO; GSM2258929
DR   GEO; GSM2258930
DR   GEO; GSM2258931
DR   GEO; GSM3258551
DR   IARC_TP53; 21363
DR   IGRhCellID; HCC1954
DR   KCLB; 9S1954
DR   LiGeA; CCLE_705
DR   LINCS_HMS; 50213
DR   LINCS_LDP; LCL-1332
DR   Lonza; 1357
DR   PharmacoDB; HCC1954_486_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD005339
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1259
DR   PubChem_Cell_line; CVCL_1259
DR   SLKBase; 3543
DR   Wikidata; Q54881618
RX   PubMed=9833771;
RX   PubMed=11314036;
RX   PubMed=16959974;
RX   PubMed=17157791;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21378333;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=23637631;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC1954.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/hcc1954-xenograft-model/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: East Indian.
CC   Doubling time: 45 hours (PubMed=25984343); 43.81 hours (JWGray panel).
CC   HLA typing: A*24:02,24:02; B*35:01,40:06; C*04:01,15:02; DQA1*03:02,01:02; DRB1*16:05,16:05 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*35:01,40:06; C*04:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (ATCC=CRL-2338).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (PubMed=28889351; ATCC=CRL-2338).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.47%; Native American=0%; East Asian, North=5.83%; East Asian, South=0%; South Asian=78.3%; European, North=2.65%; European, South=12.74% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2338; Cosmic-CLP=749709; Direct_author_submission; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 14 (Direct_author_submission)
ST   D10S1248: 14,15 (Technion Genomics Center)
ST   D12S391: 22
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,15.2
ST   D1S1656: 15,16 (Technion Genomics Center)
ST   D1S1656: 16 (Direct_author_submission)
ST   D21S11: 28,32.2 (ATCC=CRL-2338; PubMed=25877200; PubMed=28889351; Technion Genomics Center)
ST   D21S11: 32.2 (Direct_author_submission)
ST   D22S1045: 11,15
ST   D2S1338: 17 (Direct_author_submission)
ST   D2S1338: 17,26 (ATCC=CRL-2338; Technion Genomics Center)
ST   D2S441: 10,11
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1260 ! HCC1954 BL
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 52
//
ID   HCC1954 BL
AC   CVCL_1260
SY   HCC-1954BL; HCC1954-BL; HCC1954BL; Hamon Cancer Center 1954 BL
DR   CLO; CLO_0003648
DR   ATCC; CRL-2339
DR   BioSample; SAMN03471822
DR   Cell_Model_Passport; SIDM00871
DR   DepMap; ACH-002384
DR   KCLB; 9S1954BL
DR   Wikidata; Q54881619
RX   PubMed=9833771;
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: East Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2339
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 17,26
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1259 ! HCC1954
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HCC1954-LCC1
AC   CVCL_VR25
SY   HCC1954 LCC1; HCC1954-Latency Competent Cancer 1
DR   cancercelllines; CVCL_VR25
DR   GEO; GSM1875310
DR   GEO; GSM1875311
DR   GEO; GSM1875317
DR   GEO; GSM1875318
DR   Wikidata; Q93982603
RX   PubMed=27015306;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Population: East Indian.
CC   Characteristics: After 3 months was recovered from the brain of healthy FOXN1nu mice that had been intracardially injected with the parent cell line.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 18
ST   D19S433: 13,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 17,26
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR24 ! HCC1954-TGL
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 16
//
ID   HCC1954-LCC2
AC   CVCL_VR26
SY   HCC1954 LCC2; HCC1954-Latency Competent Cancer 2
DR   cancercelllines; CVCL_VR26
DR   GEO; GSM1875312
DR   GEO; GSM1875313
DR   GEO; GSM1875319
DR   GEO; GSM1875320
DR   GEO; GSM2066432
DR   GEO; GSM2066436
DR   GEO; GSM2066440
DR   Wikidata; Q93982605
RX   PubMed=27015306;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Population: East Indian.
CC   Characteristics: After 3 months was recovered from the brain of healthy FOXN1nu mice that had been intracardially injected with the parent cell line.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 9,10,11
ST   D18S51: 18
ST   D19S433: 13,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 17,26
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR25 ! HCC1954-LCC1
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 15
//
ID   HCC1954-LeptoM
AC   CVCL_XA23
SY   HCC1954 LeptoM
DR   cancercelllines; CVCL_XA23
DR   GEO; GSM2194092
DR   GEO; GSM2194093
DR   GEO; GSM2194094
DR   Wikidata; Q93982608
RX   PubMed=28283064;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Population: East Indian.
CC   Characteristics: Brain leptomeningeal space metastatic derivative of parental cell line. Established after 3 passages in nude mice from intracisternal injection, followed by one passage from intracardiac injection and obtained from mice bearing leptomeningeal metastases.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL) and with PuroR/pac.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR24 ! HCC1954-TGL
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HCC1954-LR
AC   CVCL_LG20
DR   cancercelllines; CVCL_LG20
DR   Wikidata; Q54881621
RX   PubMed=24876102;
CC   Population: East Indian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1259 ! HCC1954
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   HCC1954-Luc
AC   CVCL_4W93
SY   HCC-1954-Luc
DR   cancercelllines; CVCL_4W93
DR   JCRB; JCRB1476
DR   JCRB; NIHS0708
DR   Wikidata; Q54881620
CC   Population: East Indian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0708; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB=JCRB1476
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1259 ! HCC1954
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   HCC1954-NR
AC   CVCL_LG21
DR   cancercelllines; CVCL_LG21
DR   Wikidata; Q54881622
RX   PubMed=24876102;
CC   Population: East Indian.
CC   Selected for resistance to: ChEBI; CHEBI_61397; Neratinib (Nerlynx; HKI-272).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1259 ! HCC1954
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   HCC1954-TGL
AC   CVCL_VR24
SY   HCC1954-HSV1-TK/GFP/Fluc
DR   cancercelllines; CVCL_VR24
DR   GEO; GSM1875307
DR   GEO; GSM1875308
DR   GEO; GSM1875309
DR   GEO; GSM1875314
DR   GEO; GSM1875315
DR   GEO; GSM1875316
DR   GEO; GSM2066431
DR   GEO; GSM2066435
DR   GEO; GSM2066439
DR   GEO; GSM2194085
DR   GEO; GSM2194086
DR   GEO; GSM2194087
DR   Wikidata; Q93982624
RX   PubMed=27015306;
RX   PubMed=28283064;
CC   Population: East Indian.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL) and with PuroR/pac.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Caution: In PubMed=27015306, PubMed=28283064 and the associated GEO data sets HCC1954-TGL is termed HCC1954 Parental.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 17,26
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1259 ! HCC1954
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 15
//
ID   HCC1954/TDR
AC   CVCL_B3MM
DR   cancercelllines; CVCL_B3MM
DR   Wikidata; Q110432840
RX   CelloPub=CLPUB00650;
RX   PubMed=28821558;
CC   Population: East Indian.
CC   Selected for resistance to: DrugBank; DB05773; Trastuzumab emtansine (T-DM1).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1259 ! HCC1954
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   HCC1963
AC   CVCL_V614
SY   Hamon Cancer Center 1963
DR   Cosmic; 903640
DR   Wikidata; Q54881625
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC1972
AC   CVCL_V739
SY   Hamon Cancer Center 1972
DR   BioSample; SAMN03470864
DR   Wikidata; Q54881626
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 11,12
ST   D19S433: 12,14
ST   D21S11: 30,31.2
ST   D2S1338: 19,24
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 12,15
ST   FGA: 21,22
ST   Penta D: 13,14
ST   Penta E: 7,13
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HCC1974
AC   CVCL_V615
SY   Hamon Cancer Center 1974
DR   Wikidata; Q54881627
RX   PubMed=31803961;
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 31,32.2
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9CN ! HCC1975 BL
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC1975 BL
AC   CVCL_E9CN
SY   HCC-1975BL; HCC1975-BL; HCC1975BL; Hamon Cancer Center 1975 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V615 ! HCC1974
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC20
AC   CVCL_WG81
SY   Hamon Cancer Center 20
DR   Cosmic; 1518098
DR   Wikidata; Q93982638
RX   PubMed=16941478;
RX   PubMed=31803961;
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   HCC202
AC   CVCL_2062
SY   HCC-202; HCC0202; Hamon Cancer Center 202
DR   CLO; CLO_0003649
DR   EFO; EFO_0001176
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2316
DR   BioGRID_ORCS_Cell_line; 660
DR   BioSample; SAMN03471302
DR   BioSample; SAMN10988183
DR   cancercelllines; CVCL_2062
DR   Cell_Model_Passport; SIDM00870
DR   Cosmic; 687482
DR   Cosmic; 904358
DR   Cosmic; 1018461
DR   Cosmic; 1047702
DR   Cosmic; 1136360
DR   Cosmic; 1287882
DR   Cosmic; 1603209
DR   Cosmic; 1935002
DR   Cosmic; 1995429
DR   Cosmic; 2165008
DR   Cosmic-CLP; 1290906
DR   DepMap; ACH-000725
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290906
DR   GEO; GSM186725
DR   GEO; GSM186726
DR   GEO; GSM344369
DR   GEO; GSM344419
DR   GEO; GSM350515
DR   GEO; GSM783972
DR   GEO; GSM827455
DR   GEO; GSM844089
DR   GEO; GSM847342
DR   GEO; GSM847484
DR   GEO; GSM887047
DR   GEO; GSM888117
DR   GEO; GSM1053699
DR   GEO; GSM1172872
DR   GEO; GSM1172963
DR   GEO; GSM1374510
DR   GEO; GSM1669853
DR   IARC_TP53; 28273
DR   KCLB; 9S0202
DR   LiGeA; CCLE_133
DR   LINCS_HMS; 50214
DR   LINCS_LDP; LCL-1333
DR   PharmacoDB; HCC202_487_2019
DR   PRIDE; PXD000309
DR   Progenetix; CVCL_2062
DR   SLKBase; 3500
DR   Wikidata; Q54881628
RX   PubMed=9833771;
RX   PubMed=11314036;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=20215515;
RX   PubMed=22414580;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 212.49 hours (JWGray panel).
CC   HLA typing: A*23:05,68:01; B*27:34,51:12; C*02:02,15:02; DQA1*05:02,01:02; DQB1*03:09,06:02; DRB1*11:01,03:17 (PubMed=25960936).
CC   HLA typing: A*32:01,32:01; B*27:07,27:07; C*15:02,15:02; DQA1*05:02,03:02; DQB1*03:04,03:04; DRB1*04:05,04:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=1290906; DepMap=ACH-000725).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr284Argfs*21 (c.851_852delCA) (p.R283fs, c.849_850del2); Zygosity=Heterozygous (Cosmic-CLP=1290906; DepMap=ACH-000725).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.66%; Native American=0%; East Asian, North=3.54%; East Asian, South=0%; South Asian=0%; European, North=58.19%; European, South=35.61% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2316; Cosmic-CLP=1290906; Direct_author_submission; KCLB=9S0202; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 13
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 26
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 13,15 (ATCC=CRL-2316)
ST   D8S1179: 15 (PubMed=25877200)
ST   FGA: 24
ST   Penta D: 12,15
ST   Penta E: 8
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   HCC2036
AC   CVCL_9Y86
SY   Hamon Cancer Center 2036
DR   Wikidata; Q54881630
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC2041
AC   CVCL_V619
SY   Hamon Cancer Center 2041
DR   Wikidata; Q54881631
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9119; Breast medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC21
AC   CVCL_VF97
SY   HepatoCellular Carcinoma case #21
DR   cancercelllines; CVCL_VF97
DR   Wikidata; Q54881632
RX   PubMed=25349534;
CC   Doubling time: ~95 hours (PubMed=25349534).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.796G>C); ClinVar=VCV000376605; Zygosity=Unspecified (PubMed=25349534).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=25349534
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 12,15
ST   D19S433: 13.2,14.2
ST   D21S11: 30,31.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 24
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   HCC2108
AC   CVCL_A352
SY   HCC-2108; Hamon Cancer Center 2108
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470865
DR   BioSample; SAMN10987967
DR   cancercelllines; CVCL_A352
DR   Cell_Model_Passport; SIDM01603
DR   Cosmic; 903641
DR   DepMap; ACH-000314
DR   GEO; GSM794391
DR   IARC_TP53; 11453
DR   KCLB; 72108
DR   LiGeA; CCLE_785
DR   PharmacoDB; HCC2108_454_2019
DR   Wikidata; Q54881633
RX   PubMed=10353731;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01; DQA1*03:02,03:02; DQB1*03:04,03:04; DRB1*04:01,11:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (DepMap=ACH-000314).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (PubMed=10353731; DepMap=ACH-000314).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; KCLB=72108; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,15
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 13
ST   D1S1656: 15,16
ST   D21S11: 28,30
ST   D22S1045: 15
ST   D2S1338: 19
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 12,13 (PubMed=25877200)
ST   D8S1179: 13 (Direct_author_submission)
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 12
ST   TH01: 7,9 (KCLB=72108)
ST   TH01: 9 (Direct_author_submission; PubMed=25877200)
ST   TPOX: 10,11
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9CP ! HCC2108 BL
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 27
//
ID   HCC2108 BL
AC   CVCL_E9CP
SY   HCC-2108BL; HCC2108-BL; HCC2108BL; Hamon Cancer Center 2108 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A352 ! HCC2108
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC2157
AC   CVCL_1261
SY   Hamon Cancer Center 2157
DR   CLO; CLO_0003650
DR   EFO; EFO_0001177
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2340
DR   BioSample; SAMN03470829
DR   BioSample; SAMN03471823
DR   BioSample; SAMN10987607
DR   cancercelllines; CVCL_1261
DR   Cell_Model_Passport; SIDM00774
DR   ChEMBL-Cells; CHEMBL3308891
DR   ChEMBL-Targets; CHEMBL2366126
DR   Cosmic; 749715
DR   Cosmic; 904370
DR   Cosmic; 1018472
DR   Cosmic; 1235084
DR   Cosmic; 1430341
DR   Cosmic; 1460236
DR   Cosmic; 1473033
DR   Cosmic; 1518114
DR   Cosmic; 1603210
DR   Cosmic; 1995430
DR   Cosmic-CLP; 749715
DR   DepMap; ACH-000691
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 749715
DR   GEO; GSM350525
DR   GEO; GSM783938
DR   GEO; GSM847343
DR   GEO; GSM847485
DR   GEO; GSM887048
DR   GEO; GSM888118
DR   GEO; GSM1669854
DR   IARC_TP53; 21364
DR   IARC_TP53; 22815
DR   IARC_TP53; 30204
DR   IGRhCellID; HCC2157
DR   LiGeA; CCLE_003
DR   LINCS_HMS; 50581
DR   LINCS_LDP; LCL-1327
DR   PharmacoDB; HCC2157_488_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1261
DR   PubChem_Cell_line; CVCL_1261
DR   Wikidata; Q54881634
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=16959974;
RX   PubMed=17157791;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=24094812;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: African American.
CC   HLA typing: A*02:02,30:01; B*41:02,42:01; C*17:01,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (Cosmic-CLP=749715).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=87.84%; Native American=0%; East Asian, North=4.38%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=7.78% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2340; Cosmic-CLP=749715; Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 11,15
ST   D12S391: 18
ST   D13S317: 12
ST   D16S539: 11 (ATCC=CRL-2340; Cosmic-CLP=749715)
ST   D16S539: 11,12 (Direct_author_submission; PubMed=25877200)
ST   D18S51: 15
ST   D19S433: 13
ST   D1S1656: 16.3
ST   D21S11: 28,29
ST   D22S1045: 11,15
ST   D2S1338: 21
ST   D2S441: 11,12
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 8,10
ST   Penta E: 12,15
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1262 ! HCC2157 BL
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   HCC2157 BL
AC   CVCL_1262
SY   HCC-2157BL; HCC2157-BL; HCC2157BL; Hamon Cancer Center 2157 BL
DR   CLO; CLO_0003651
DR   ATCC; CRL-2341
DR   BioSample; SAMN03471825
DR   Cell_Model_Passport; SIDM00773
DR   DepMap; ACH-002381
DR   KCLB; 9S2157BL
DR   Wikidata; Q54881635
RX   PubMed=9833771;
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2341; KCLB=9S2157BL
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13,13.2
ST   D21S11: 28,29
ST   D2S1338: 21,22
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 8,10
ST   Penta E: 12,15
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1261 ! HCC2157
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HCC2185
AC   CVCL_3375
SY   HCC-2185; HCC 2185; Hamon Cancer Center 2185
DR   CLO; CLO_0009909
DR   EFO; EFO_0001178
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2342
DR   BioSample; SAMN03472913
DR   cancercelllines; CVCL_3375
DR   Cosmic; 1136368
DR   DepMap; ACH-002322
DR   GEO; GSM350519
DR   GEO; GSM1053696
DR   GEO; GSM1172964
DR   KCLB; 9S2185
DR   LINCS_HMS; 51093
DR   LINCS_LDP; LCL-2074
DR   PharmacoDB; HCC2185_489_2019
DR   Progenetix; CVCL_3375
DR   Wikidata; Q54881636
RX   PubMed=9833771;
RX   PubMed=11314036;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=20679594;
RX   PubMed=21778573;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25757734;
RX   PubMed=25877200;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive.
CC   Doubling time: 163.56 hours (JWGray panel).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Discontinued: ATCC; CRL-2342; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 32.2
ST   D2S1338: 20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C76328; Metastatic breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   HCC2218
AC   CVCL_1263
SY   HCC-2218; Hamon Cancer Center 2218
DR   CLO; CLO_0003652
DR   EFO; EFO_0002187
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2343
DR   BioSample; SAMN03471426
DR   BioSample; SAMN03471824
DR   BioSample; SAMN10987816
DR   cancercelllines; CVCL_1263
DR   Cell_Model_Passport; SIDM00772
DR   ChEMBL-Cells; CHEMBL3308869
DR   ChEMBL-Targets; CHEMBL2366221
DR   Cosmic; 749716
DR   Cosmic; 904371
DR   Cosmic; 1047711
DR   Cosmic; 1235085
DR   Cosmic; 1287915
DR   Cosmic; 1430342
DR   Cosmic; 1473120
DR   Cosmic; 1518115
DR   Cosmic; 1603211
DR   Cosmic; 1995431
DR   Cosmic; 2165009
DR   Cosmic-CLP; 749716
DR   DepMap; ACH-000755
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 749716
DR   GEO; GSM155211
DR   GEO; GSM185083
DR   GEO; GSM185084
DR   GEO; GSM186727
DR   GEO; GSM274676
DR   GEO; GSM344375
DR   GEO; GSM344425
DR   GEO; GSM350520
DR   GEO; GSM533404
DR   GEO; GSM533411
DR   GEO; GSM537974
DR   GEO; GSM783939
DR   GEO; GSM844548
DR   GEO; GSM847344
DR   GEO; GSM847486
DR   GEO; GSM887049
DR   GEO; GSM888119
DR   GEO; GSM1053718
DR   GEO; GSM1172873
DR   GEO; GSM1172965
DR   GEO; GSM1661980
DR   GEO; GSM1669855
DR   IARC_TP53; 10275
DR   IARC_TP53; 21365
DR   IGRhCellID; HCC2218
DR   KCLB; 9S2218
DR   LiGeA; CCLE_103
DR   LINCS_HMS; 50582
DR   LINCS_LDP; LCL-1328
DR   PharmacoDB; HCC2218_490_2019
DR   PRIDE; PXD000309
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1263
DR   PubChem_Cell_line; CVCL_1263
DR   SLKBase; 3548
DR   Wikidata; Q54881637
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=16959974;
RX   PubMed=17334996;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22414580;
RX   PubMed=22460905;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 120 hours (PubMed=25984343).
CC   HLA typing: A*24; B*35:08,15:17; C*07:01,06:02; DQB1*06:04,05:03 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*35:08,58:01; C*06:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; c.3083-1G>T; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=749716).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283Cys (c.847C>T); ClinVar=VCV000127824; Zygosity=Unspecified (PubMed=9865903).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.2%; Native American=0%; East Asian, North=1.97%; East Asian, South=0%; South Asian=2%; European, North=55.07%; European, South=39.75% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2343; Cosmic-CLP=749716; Direct_author_submission; KCLB=9S2218; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 15
ST   D12S391: 20,21
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 10,13,14 (PubMed=25877200)
ST   D18S51: 13,14 (ATCC=CRL-2343; Direct_author_submission)
ST   D19S433: 13,15
ST   D1S1656: 12
ST   D21S11: 28
ST   D22S1045: 17
ST   D2S1338: 21,25
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,14 (ATCC=CRL-2343; PubMed=20679594)
ST   D7S820: 14 (Cosmic-CLP=749716; Direct_author_submission; KCLB=9S2218; PubMed=25877200)
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 12,14
ST   Penta E: 15,18
ST   TH01: 8,9.3
ST   TPOX: 8 (KCLB=9S2218)
ST   TPOX: 8,11 (ATCC=CRL-2343; Cosmic-CLP=749716; Direct_author_submission; PubMed=20679594; PubMed=25877200)
ST   vWA: 14,18
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1264 ! HCC2218 BL
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   HCC2218 BL
AC   CVCL_1264
SY   HCC-2218BL; HCC 2218 BL; HCC2218-BL; HCC2218BL; Hamon Cancer Center 2218 BL
DR   CLO; CLO_0003653
DR   ATCC; CRL-2363
DR   BioSample; SAMN03471831
DR   Cell_Model_Passport; SIDM00696
DR   DepMap; ACH-002383
DR   Wikidata; Q54881638
RX   PubMed=9833771;
RX   PubMed=14762065;
RX   PubMed=20164919;
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2363
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 13,14
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 21,25
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,14
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 12,14
ST   Penta E: 15,18
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1263 ! HCC2218
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   HCC2270
AC   CVCL_V635
SY   Hamon Cancer Center 2270
DR   EFO; EFO_0006430
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473069
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC2270_491_2019
DR   Wikidata; Q54881639
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   HLA typing: A*01:01,03:01; B*08:01,50:01; C*06:02,07:01 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 18,24
ST   Penta D: 12,14
ST   Penta E: 5,13
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   HCC2279
AC   CVCL_5131
SY   HCC-2279; Hamon Cancer Center 2279
DR   BTO; BTO_0006025
DR   EFO; EFO_0006431
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2870
DR   BioSample; SAMN03472992
DR   BioSample; SAMN10987735
DR   cancercelllines; CVCL_5131
DR   Cell_Model_Passport; SIDM01602
DR   Cosmic; 903642
DR   Cosmic; 1128248
DR   Cosmic; 1146930
DR   DepMap; ACH-000731
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM63348
DR   GEO; GSM108867
DR   GEO; GSM108868
DR   GEO; GSM253421
DR   GEO; GSM434283
DR   GEO; GSM794392
DR   GEO; GSM817122
DR   GEO; GSM887050
DR   GEO; GSM888120
DR   IARC_TP53; 11454
DR   IGRhCellID; HCC2279GEO
DR   KCLB; 72279
DR   LiGeA; CCLE_256
DR   PharmacoDB; HCC2279_455_2019
DR   Progenetix; CVCL_5131
DR   Wikidata; Q54881640
RX   PubMed=10353731;
RX   PubMed=16187286;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Asian.
CC   Doubling time: 49.3 hours (PubMed=29681454).
CC   HLA typing: A*11:01,11:01; B*40:01,40:01; C*03:04,03:04; DQA1*01:02,01:02; DQB1*06:01,03:02; DRB1*08:03,08:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Unspecified (PubMed=10353731).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.25%; Native American=0%; East Asian, North=46.33%; East Asian, South=40.38%; South Asian=0%; European, North=0%; European, South=9.04% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Misspelling: HCC227; EFO=EFO_0005374; Note=Now obsoleted.
CC   Discontinued: ATCC; CRL-2870; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-2870; Direct_author_submission; KCLB=72279; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 14
ST   D12S391: 19,22
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 20
ST   D19S433: 13
ST   D1S1656: 16,17.3
ST   D21S11: 29,32.2
ST   D22S1045: 11,17
ST   D2S1338: 18,25
ST   D2S441: 11
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 16
ST   FGA: 19 (PubMed=25877200)
ST   FGA: 19,25 (Direct_author_submission; KCLB=72279)
ST   Penta D: 10,12
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   HCC229
AC   CVCL_V721
SY   HCC0229; Hamon Cancer Center 229
DR   Wikidata; Q54881641
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 8,9
ST   D21S11: 30
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF72 ! HCC229 BL
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC229 BL
AC   CVCL_LF72
SY   HCC-229BL; HCC229-BL; HCC229BL; Hamon Cancer Center 229 BL
DR   Wikidata; Q54881642
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V721 ! HCC229
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   HCC2302
AC   CVCL_V636
SY   Hamon Cancer Center 2302
DR   EFO; EFO_0006432
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473005
DR   EGA; EGAS00001000610
DR   GEO; GSM1682812
DR   PharmacoDB; HCC2302_492_2019
DR   Wikidata; Q54881643
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29681454;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   HLA typing: A*03:01,03:01; B*07:02,14:02; C*07:02,07:02; DQB1*06:02,06:02; DRB1*15:01,13:07 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 12,18
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   Penta D: 12
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9CQ ! HCC2302 BL
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC2302 BL
AC   CVCL_E9CQ
SY   HCC-2302BL; HCC2302-BL; HCC2302BL; Hamon Cancer Center 2302 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V636 ! HCC2302
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC2308
AC   CVCL_V662
SY   Hamon Cancer Center 2308
DR   Wikidata; Q54881644
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC2312
AC   CVCL_V669
SY   Hamon Cancer Center 2312
DR   Wikidata; Q54881646
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC2344
AC   CVCL_V638
SY   Hamon Cancer Center 2344
DR   Wikidata; Q54881647
RX   PubMed=29681454;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13
ST   D12S391: 15,21
ST   D13S317: 9
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13
ST   D1S1656: 15
ST   D21S11: 28,29
ST   D22S1045: 15,17
ST   D2S1338: 19,23
ST   D2S441: 11.3,14
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 21
ST   Penta D: 8,10
ST   Penta E: 8,10
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC2352
AC   CVCL_V637
SY   Hamon Cancer Center 2352
DR   Wikidata; Q54881648
RX   PubMed=29681454;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13
ST   D12S391: 20,22
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 16
ST   D19S433: 12
ST   D1S1656: 15
ST   D21S11: 31.2
ST   D22S1045: 11
ST   D2S1338: 24
ST   D2S441: 10,14
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 26
ST   Penta D: 11
ST   Penta E: 8
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC2373
AC   CVCL_L090
SY   HCC-2373; Hamon Cancer Center 2373
DR   KCLB; 72373
DR   Wikidata; Q54881649
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   HCC2374
AC   CVCL_A353
SY   HCC-2374; Hamon Cancer Center 2374
DR   BioSample; SAMN03470866
DR   Cosmic; 903643
DR   GEO; GSM794393
DR   Wikidata; Q54881650
RX   PubMed=20679594;
RX   PubMed=25877200;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 7
ST   D10S1248: 13,14
ST   D12S391: 18,23
ST   D13S317: 11,14 (Direct_author_submission; PubMed=20679594)
ST   D13S317: 14 (PubMed=25877200)
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 13,15
ST   D1S1656: 14,16
ST   D21S11: 28,30
ST   D22S1045: 11
ST   D2S1338: 22,24
ST   D2S441: 12,14
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 18.2
ST   Penta D: 8
ST   Penta E: 7 (PubMed=25877200)
ST   Penta E: 7,9 (Direct_author_submission)
ST   TH01: 8 (PubMed=25877200)
ST   TH01: 8,9.3 (Direct_author_submission; PubMed=20679594)
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   HCC2389
AC   CVCL_V600
SY   Hamon Cancer Center 2389
DR   IARC_TP53; 22816
DR   Wikidata; Q54881651
RX   PubMed=9865903;
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9CR ! HCC2389 BL
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC2389 BL
AC   CVCL_E9CR
SY   HCC-2389BL; HCC2389-BL; HCC2389BL; Hamon Cancer Center 2389 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V600 ! HCC2389
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC2393
AC   CVCL_V601
SY   Hamon Cancer Center 2393
DR   Wikidata; Q54881652
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC2414
AC   CVCL_V602
SY   Hamon Cancer Center 2414
DR   Wikidata; Q54881653
CC   Population: Hispanic.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC242
AC   CVCL_V722
SY   HCC0242; Hamon Cancer Center 242
DR   Wikidata; Q54881654
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC2429
AC   CVCL_5132
SY   HCC-2429; Hamon Cancer Center 2429
DR   EFO; EFO_0022526
DR   BioSample; SAMN10989601
DR   cancercelllines; CVCL_5132
DR   Cell_Model_Passport; SIDM01601
DR   Cosmic; 903644
DR   Cosmic; 1146931
DR   Cosmic; 1340147
DR   Cosmic; 1518099
DR   DepMap; ACH-000143
DR   GEO; GSM171900
DR   GEO; GSM171901
DR   GEO; GSM253412
DR   GEO; GSM434319
DR   GEO; GSM794394
DR   GEO; GSM817123
DR   IGRhCellID; HCC2429GEO
DR   Progenetix; CVCL_5132
DR   Wikidata; Q54881655
RX   PubMed=10944559;
RX   PubMed=15994877;
RX   PubMed=20679594;
RX   PubMed=24736545;
RX   PubMed=28196595;
RX   PubMed=29348827;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; VCCTC; MKT11126; https://vanderbilt.technologypublisher.com/technology/12194
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=15994877; PubMed=29348827).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Gln (c.800G>A); ClinVar=VCV000127823; Zygosity=Homozygous (DepMap=ACH-000143).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: HCC-2425; PubMed=29348827; Note=In table of supplementary material.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C2926; Lung non-small cell carcinoma
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V989 ! HCC2429 BL
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   HCC2429 BL
AC   CVCL_V989
SY   HCC-2429BL; HCC2429-BL; HCC2429BL; BL2429; Hamon Cancer Center 2429 BL
DR   Wikidata; Q54881657
RX   PubMed=10944559;
RX   PubMed=15994877;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5132 ! HCC2429
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC2433
AC   CVCL_V599
SY   Hamon Cancer Center 2433
DR   Wikidata; Q54881658
RX   PubMed=31803961;
CC   Population: African American.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 12,16
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 18,20
ST   D19S433: 14,15
ST   D1S1656: 12,14
ST   D21S11: 28,31
ST   D22S1045: 15,17
ST   D2S1338: 18,22
ST   D2S441: 13,14
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   DYS391: 10
ST   FGA: 24,25
ST   Penta D: 9,13
ST   Penta E: 5,8
ST   TH01: 8,9.3
ST   TPOX: 7,9
ST   vWA: 15,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9CS ! HCC2433 BL
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC2433 BL
AC   CVCL_E9CS
SY   HCC-2433BL; HCC2433-BL; HCC2433BL; Hamon Cancer Center 2433 BL
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V599 ! HCC2433
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC2450
AC   CVCL_5133
SY   HCC-2450; Hamon Cancer Center 2450
DR   BioSample; SAMN10989602
DR   cancercelllines; CVCL_5133
DR   Cell_Model_Passport; SIDM01600
DR   Cosmic; 903645
DR   Cosmic; 1146932
DR   DepMap; ACH-000975
DR   EGA; EGAS00001002554
DR   GEO; GSM62970
DR   GEO; GSM171902
DR   GEO; GSM171903
DR   GEO; GSM253431
DR   GEO; GSM434320
DR   GEO; GSM794395
DR   GEO; GSM817124
DR   IARC_TP53; 11455
DR   IGRhCellID; HCC2450GEO
DR   Progenetix; CVCL_5133
DR   Wikidata; Q54881661
RX   PubMed=10353731;
RX   PubMed=16187286;
RX   PubMed=20624269;
RX   PubMed=20679594;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (DepMap=ACH-000975).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Thr (c.746G>C); ClinVar=VCV000376015; Zygosity=Homozygous (PubMed=10353731; DepMap=ACH-000975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; PubMed=20679594
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D10S1248: 15
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 12,15
ST   D1S1656: 15.3
ST   D21S11: 28,33.2
ST   D22S1045: 15,16
ST   D2S1338: 20
ST   D2S441: 10
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 13
ST   DYS391: 11
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   HCC267
AC   CVCL_V723
SY   HCC0267; Hamon Cancer Center 267
DR   Wikidata; Q54881662
CC   Population: Hispanic.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BJ ! HCC267 BL
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC267 BL
AC   CVCL_E9BJ
SY   HCC-267BL; HCC267-BL; HCC267BL; Hamon Cancer Center 267 BL
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V723 ! HCC267
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC2677
AC   CVCL_V584
SY   Hamon Cancer Center 2677
DR   Wikidata; Q54881663
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC2688
AC   CVCL_3376
SY   Hamon Cancer Center 2688
DR   EFO; EFO_0006433
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473199
DR   cancercelllines; CVCL_3376
DR   DepMap; ACH-002323
DR   EGA; EGAS00001000610
DR   GEO; GSM350545
DR   PharmacoDB; HCC2688_493_2019
DR   Progenetix; CVCL_3376
DR   Wikidata; Q54881664
RX   PubMed=19582160;
RX   PubMed=20679594;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01; DQB1*02:02,02:02; DRB1*03:01,03:01 (PubMed=26589293).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13
ST   D12S391: 17,21
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 15,16.2
ST   D1S1656: 16
ST   D21S11: 27,31.2
ST   D22S1045: 11,15
ST   D2S1338: 24,25
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   HCC2695
AC   CVCL_E9CT
SY   Hamon Cancer Center 2695
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 15
ST   D12S391: 19,23
ST   D13S317: 13
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D1S1656: 15,16
ST   D21S11: 29,30
ST   D22S1045: 15
ST   D2S1338: 19
ST   D2S441: 10,11.3
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 20
ST   Penta D: 11,12
ST   Penta E: 7,9
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC2713
AC   CVCL_A350
SY   HCC-2713; Hamon Cancer Center 2713
DR   Cosmic; 1235087
DR   Wikidata; Q54881665
RX   PubMed=16959974;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 30.2,35
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 6,8
ST   TPOX: 6,9
ST   vWA: 14,18
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9CU ! HCC2713 BL
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   HCC2713 BL
AC   CVCL_E9CU
SY   HCC-2713BL; HCC2713-BL; HCC2713BL; Hamon Cancer Center 2713 BL
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A350 ! HCC2713
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC2771
AC   CVCL_V583
SY   Hamon Cancer Center 2771
DR   Wikidata; Q54881666
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC2783
AC   CVCL_V585
SY   Hamon Cancer Center 2783
DR   Wikidata; Q54881667
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC2814
AC   CVCL_V586
SY   HCC-2814; Hamon Cancer Center 2814
DR   BioSample; SAMN03470867
DR   BioSample; SAMN10988397
DR   cancercelllines; CVCL_V586
DR   Cell_Model_Passport; SIDM01599
DR   DepMap; ACH-000690
DR   GEO; GSM794396
DR   PharmacoDB; HCC2814_456_2019
DR   Wikidata; Q54881668
RX   PubMed=20679594;
RX   PubMed=24002593;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (DepMap=ACH-000690).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Metfs*68 (c.535delC); Zygosity=Homozygous (DepMap=ACH-000690).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.59%; Native American=0%; East Asian, North=5.79%; East Asian, South=0%; South Asian=0%; European, North=54.45%; European, South=38.17% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D10S1248: 13
ST   D12S391: 21
ST   D13S317: 10,11
ST   D16S539: 10,11,13 (PubMed=25877200)
ST   D16S539: 11,13 (Direct_author_submission; PubMed=20679594)
ST   D18S51: 12
ST   D19S433: 13,14
ST   D1S1656: 14.3,18.3
ST   D21S11: 29
ST   D22S1045: 11,16
ST   D2S1338: 24
ST   D2S441: 14
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 7,10 (Direct_author_submission)
ST   Penta E: 10 (PubMed=25877200)
ST   TH01: 6,8 (Direct_author_submission; PubMed=20679594)
ST   TH01: 8 (PubMed=25877200)
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 26
//
ID   HCC2846
AC   CVCL_V587
SY   Hamon Cancer Center 2846
DR   BioSample; SAMN03470868
DR   Wikidata; Q54881669
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 22,24
ST   D3S1358: 15,19
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC2858
AC   CVCL_9Y87
SY   Hamon Cancer Center 2858
DR   Wikidata; Q54881676
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC2879
AC   CVCL_9Y88
SY   Hamon Cancer Center 2879
DR   Wikidata; Q54881677
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,15
ST   D12S391: 19
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 13,14.2
ST   D1S1656: 12,13
ST   D21S11: 29
ST   D22S1045: 16
ST   D2S1338: 19,24
ST   D2S441: 12,13
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta D: 8
ST   Penta E: 8,19
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC2885
AC   CVCL_V588
SY   Hamon Cancer Center 2885
DR   EFO; EFO_0006434
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473013
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC2885_494_2019
DR   Wikidata; Q54881678
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   HLA typing: A*02:01,03:01; B*14:02,27:05; C*02:02,08:02 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10
ST   D16S539: 9,11
ST   D18S51: 12
ST   D21S11: 32
ST   D3S1358: 14
ST   D5S818: 7,11
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 20,23
ST   Penta D: 13
ST   Penta E: 5,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   HCC2911
AC   CVCL_0V16
SY   Hamon Cancer Center 2911
DR   EFO; EFO_0006435
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473200
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   PharmacoDB; HCC2911_495_2019
DR   Wikidata; Q54881679
RX   PubMed=25485619;
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 8,13
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 30,32.2
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 12,14
ST   FGA: 21
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 9,12
ST   vWA: 16,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   HCC2935
AC   CVCL_1265
SY   HCC-2935; Hamon Cancer Center 2935
DR   BTO; BTO_0004083
DR   CLO; CLO_0003654
DR   EFO; EFO_0005375
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2869
DR   BioSample; SAMN03471880
DR   BioSample; SAMN10988553
DR   cancercelllines; CVCL_1265
DR   Cell_Model_Passport; SIDM01598
DR   ChEMBL-Cells; CHEMBL4523543
DR   ChEMBL-Targets; CHEMBL4523574
DR   Cosmic; 903646
DR   Cosmic; 1128249
DR   Cosmic; 1146933
DR   DepMap; ACH-000150
DR   EGA; EGAS00001000610
DR   GEO; GSM108869
DR   GEO; GSM108870
DR   GEO; GSM253407
DR   GEO; GSM434284
DR   GEO; GSM794397
DR   GEO; GSM817125
DR   GEO; GSM844549
DR   GEO; GSM887051
DR   GEO; GSM888121
DR   IARC_TP53; 28331
DR   IARC_TP53; 30034
DR   IGRhCellID; HCC2935GEO
DR   LiGeA; CCLE_347
DR   PharmacoDB; HCC2935_496_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_1265
DR   PubChem_Cell_line; CVCL_1265
DR   Wikidata; Q54881680
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=26929325;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 70.4 hours (PubMed=29681454).
CC   HLA typing: A*02:01,26:01; B*37:01,49:01; C*06:02,07:01 (PubMed=26589293).
CC   HLA typing: A*02:01,26:01; B*37:01:01,49:01; C*06:02,07:01 (PubMed=26929325).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (DepMap=ACH-000150).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (DepMap=ACH-000150).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.09%; Native American=0.03%; East Asian, North=3.93%; East Asian, South=0%; South Asian=0.78%; European, North=54.96%; European, South=37.21% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): ATCC=CRL-2869; Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 12,13
ST   D8S1179: 12
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   HCC2962
AC   CVCL_9Y89
SY   Hamon Cancer Center 2962
DR   Wikidata; Q54881681
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC2974
AC   CVCL_9Y90
SY   Hamon Cancer Center 2974
DR   Wikidata; Q54881682
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC2998
AC   CVCL_1266
SY   HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998
DR   BTO; BTO_0003322
DR   CLO; CLO_0009962
DR   EFO; EFO_0005370
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 872
DR   cancercelllines; CVCL_1266
DR   Cell_Model_Passport; SIDM00118
DR   ChEMBL-Cells; CHEMBL3308074
DR   ChEMBL-Targets; CHEMBL613855
DR   ColonAtlas; HCC2998
DR   Cosmic; 875899
DR   Cosmic; 905971
DR   Cosmic; 974245
DR   Cosmic; 1092599
DR   Cosmic; 1305352
DR   Cosmic; 1312337
DR   Cosmic; 1436017
DR   Cosmic; 1479602
DR   Cosmic; 1676741
DR   Cosmic; 1803942
DR   Cosmic; 1998441
DR   Cosmic; 2301977
DR   Cosmic; 2811049
DR   Cosmic-CLP; 905971
DR   DepMap; ACH-001081
DR   EGA; EGAS00001000978
DR   GDSC; 905971
DR   GEO; GSM2146
DR   GEO; GSM50187
DR   GEO; GSM50251
DR   GEO; GSM743442
DR   GEO; GSM750796
DR   GEO; GSM799330
DR   GEO; GSM799393
DR   GEO; GSM844550
DR   GEO; GSM844551
DR   GEO; GSM846354
DR   GEO; GSM1153401
DR   GEO; GSM1178115
DR   GEO; GSM1178116
DR   GEO; GSM1178117
DR   GEO; GSM1181249
DR   GEO; GSM1181265
DR   GEO; GSM1346873
DR   GEO; GSM1448169
DR   GEO; GSM1669856
DR   GEO; GSM2124654
DR   GEO; GSM2550000
DR   IARC_TP53; 18070
DR   IARC_TP53; 21115
DR   LINCS_LDP; LCL-1191
DR   NCI-DTP; HCC-2998
DR   PharmacoDB; HCC2998_497_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005235
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1266
DR   PubChem_Cell_line; CVCL_1266
DR   SKY/M-FISH/CGH; 2794
DR   Wikidata; Q54881683
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=16969076;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28179481;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=16
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 44.40 hours (PubMed=25944804); 31.5 hours (NCI-DTP=HCC-2998).
CC   HLA typing: A*02,24; B*37:01,40:06:01; C*04,06:02; DPB1*04:01; DQB1*03:01:01,05:02:01; DRB1*11,16 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg168Ile (c.503G>T); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu665Ter (c.1994T>A); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1864Tyr (c.5591C>A); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile2167Ser (c.6500T>G); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn2720Lys (c.8160T>G); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Arg1989Ter (c.5965C>T); ClinVar=VCV000225842; Zygosity=Heterozygous (Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu277Ter (c.829G>T); ClinVar=VCV000234216; Zygosity=Heterozygous (Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000127327; Zygosity=Heterozygous (Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (PubMed=16969076; PubMed=20570890; PubMed=28683746; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gln (c.389G>A); ClinVar=VCV000007829; Zygosity=Heterozygous (PubMed=24755471; PubMed=28683746; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Phe341Val (c.1021T>G); ClinVar=VCV000495806; Zygosity=Heterozygous (PubMed=24755471; PubMed=28683746; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu137Ter (c.409G>T); ClinVar=VCV000126810; Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ser276Leu (c.827C>T); ClinVar=VCV002097524; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Arg321Gln (c.962G>A); Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:6769; SMAD3; Simple; p.Ser266Leu (c.797C>T); ClinVar=VCV001417802; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (PubMed=9331090; PubMed=15900046; PubMed=17088437; PubMed=18277095; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905971; DepMap=ACH-001081).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.41%; Native American=0%; East Asian, North=0%; East Asian, South=1.46%; South Asian=8.24%; European, North=35.72%; European, South=53.15% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=905971; PubMed=19372543; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D19S433: 12,15
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 17,19
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 25
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   HCC3051
AC   CVCL_V582
SY   Hamon Cancer Center 3051
DR   BioSample; SAMN03470869
DR   GEO; GSM794398
DR   Wikidata; Q54881684
RX   PubMed=25877200;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 7,9
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 22,23
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13,17
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 5,7
ST   TH01: 7,9.3
ST   TPOX: 6,9
ST   vWA: 17,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 18
//
ID   HCC31
AC   CVCL_V724
SY   HCC0031; Hamon Cancer Center 31
DR   Wikidata; Q54881685
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC3153
AC   CVCL_3377
SY   HCC 3153; HCC-3153; Hamon Cancer Center 3153
DR   CLO; CLO_0009910
DR   EFO; EFO_0001179
DR   ArrayExpress; E-TABM-157
DR   BioSample; SAMN03470870
DR   cancercelllines; CVCL_3377
DR   Cosmic; 1136375
DR   Cosmic; 1176634
DR   DepMap; ACH-002324
DR   GEO; GSM350507
DR   GEO; GSM1053691
DR   GEO; GSM1172874
DR   GEO; GSM1172966
DR   GEO; GSM3145576
DR   GEO; GSM3145709
DR   LINCS_HMS; 51094
DR   LINCS_LDP; LCL-2075
DR   PharmacoDB; HCC3153_498_2019
DR   Progenetix; CVCL_3377
DR   Wikidata; Q54881686
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=20679594;
RX   PubMed=21778573;
RX   PubMed=22032724;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25877200;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Doubling time: 72.26 hours (JWGray panel).
CC   HLA typing: A*34:02,34:02; B*08:01,15:03; C*07:01,02:02; DQB1*06:04,06:04 (PubMed=25960936).
CC   Sequence variation: Gene fusion; HGNC; HGNC:290; GRK3 + HGNC; HGNC:29435; WWC1; Name(s)=WWC1-GRK3, WWC1-ADRBK2; Note=In frame (PubMed=22032724).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Thr276Alafs*14 (c.815_824dupAGCCATGTGG); ClinVar=VCV000055723; Zygosity=Unspecified (PubMed=22032724).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 12,14
ST   D12S391: 18
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 12,14.2
ST   D1S1656: 12
ST   D21S11: 28,32
ST   D22S1045: 11,17
ST   D2S1338: 20
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 2.2,5
ST   Penta E: 7,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 13,16
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   HCC317
AC   CVCL_V725
SY   HCC0317; Hamon Cancer Center 317
DR   Wikidata; Q54881687
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC3172
AC   CVCL_9Y91
SY   Hamon Cancer Center 3172
DR   Wikidata; Q54881688
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3212
AC   CVCL_0V17
SY   Hamon Cancer Center 3212
DR   BioSample; SAMN03470875
DR   Wikidata; Q54881690
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 9,13
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   HCC3270
AC   CVCL_9Y92
SY   Hamon Cancer Center 3270
DR   Wikidata; Q54881691
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 7,9
ST   D13S317: 13,14
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 10,14
ST   D7S820: 9,10
ST   TH01: 7,9
ST   TPOX: 6,11
ST   vWA: 18,19
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC33
AC   CVCL_2058
SY   HCC-33; HCC0033; Hamon Cancer Center 33
DR   BTO; BTO_0006529
DR   CLO; CLO_0010000
DR   EFO; EFO_0006417
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473100
DR   BioSample; SAMN10987702
DR   cancercelllines; CVCL_2058
DR   Cell_Model_Passport; SIDM01071
DR   Cosmic; 877235
DR   Cosmic; 1219093
DR   Cosmic; 1239927
DR   Cosmic; 1320184
DR   Cosmic; 1518101
DR   Cosmic; 2125212
DR   Cosmic-CLP; 1303901
DR   DepMap; ACH-000515
DR   DSMZ; ACC-487
DR   DSMZCellDive; ACC-487
DR   EGA; EGAS00001000610
DR   GDSC; 1303901
DR   GEO; GSM171904
DR   GEO; GSM171905
DR   GEO; GSM794373
DR   GEO; GSM887052
DR   GEO; GSM888122
DR   GEO; GSM1669857
DR   IARC_TP53; 28312
DR   KCLB; 70033
DR   LiGeA; CCLE_798
DR   LINCS_LDP; LCL-1833
DR   PharmacoDB; HCC33_457_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2058
DR   Wikidata; Q54881692
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (DSMZ=ACC-487).
CC   HLA typing: A*03:01,24:02; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:32308; C1QTNF12 + HGNC; HGNC:10025; RLF; Name(s)=RLF-C1QTNF12, RLF-FAM132A (PubMed=23716474).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10025; RLF + HGNC; HGNC:19268; UBE2J2; Name(s)=RLF-UBE2J2 (PubMed=23716474).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser402fs*8 (c.1202delT) (p.I401fs); Zygosity=Heterozygous (Cosmic-CLP=1303901; DepMap=ACH-000515).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Tyr (c.725G>A); ClinVar=VCV000012354; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=1303901; DepMap=ACH-000515).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.5%; Native American=0%; East Asian, North=2.1%; East Asian, South=0%; South Asian=0.21%; European, North=61.5%; European, South=33.69% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1303901; Direct_author_submission; DSMZ=ACC-487; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D21S11: 30,32
ST   D2S1338: 16,25
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 10,12
ST   Penta E: 14
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L063 ! HCC33 BL
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   HCC33 BL
AC   CVCL_L063
SY   HCC-33BL; HCC33-BL; HCC33BL; Hamon Cancer Center 33 BL
DR   DSMZ; ACC-889
DR   DSMZCellDive; ACC-889
DR   Wikidata; Q54881693
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (DSMZ=ACC-889).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-889
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D21S11: 30,32
ST   D2S1338: 16,25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 10,12
ST   Penta E: 11,14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2058 ! HCC33
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 17
//
ID   HCC3303
AC   CVCL_0V18
SY   Hamon Cancer Center 3303
DR   BioSample; SAMN03470876
DR   Wikidata; Q54881694
RX   PubMed=25877200;
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 13
ST   D18S51: 18,19
ST   D19S433: 14,17
ST   D21S11: 35
ST   D2S1338: 20,24
ST   D3S1358: 15
ST   D5S818: 8
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 7,9
ST   TH01: 7
ST   TPOX: 6,8
ST   vWA: 15,16
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   HCC3321
AC   CVCL_9Y93
SY   Hamon Cancer Center 3321
DR   Wikidata; Q54881695
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma. The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3335
AC   CVCL_9Y94
SY   Hamon Cancer Center 3335
DR   Wikidata; Q54881696
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14
ST   D12S391: 16
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 11,13
ST   D1S1656: 14,17.3
ST   D21S11: 29
ST   D22S1045: 15
ST   D2S1338: 24
ST   D2S441: 11,14
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 9
ST   TH01: 9.3
ST   TPOX: 6,10
ST   vWA: 17
DI   NCIt; C9119; Breast medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3350
AC   CVCL_9Y95
SY   Hamon Cancer Center 3350
DR   Wikidata; Q54881697
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 18,19
ST   D13S317: 13
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13,14
ST   D1S1656: 13,16.3
ST   D21S11: 28,32.2
ST   D22S1045: 15,17
ST   D2S1338: 21
ST   D2S441: 14
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 19.2
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 7,9.3
ST   TPOX: 10
ST   vWA: 16,17
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3369
AC   CVCL_9Y96
SY   Hamon Cancer Center 3369
DR   Wikidata; Q54881698
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3388
AC   CVCL_9Y97
SY   Hamon Cancer Center 3388
DR   Wikidata; Q54881699
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3410
AC   CVCL_9Y98
SY   Hamon Cancer Center 3410
DR   Wikidata; Q54881700
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3418
AC   CVCL_9Y99
SY   Hamon Cancer Center 3418
DR   Wikidata; Q54881701
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D10S1248: 12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D19S433: 12
ST   D1S1656: 14,15.3
ST   D21S11: 28,35
ST   D22S1045: 15,16
ST   D2S1338: 21
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,12
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 5,9
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3440
AC   CVCL_9Z00
SY   Hamon Cancer Center 3440
DR   Wikidata; Q54881702
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC345
AC   CVCL_V726
SY   HCC0345; Hamon Cancer Center 345
DR   BioSample; SAMN03470838
DR   Wikidata; Q54881703
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 18
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 2.2
ST   Penta E: 11,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC3498
AC   CVCL_9Z01
SY   Hamon Cancer Center 3498
DR   Wikidata; Q54881704
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D21S11: 30
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3524
AC   CVCL_9Z02
SY   Hamon Cancer Center 3524
DR   Wikidata; Q54881705
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC3531
AC   CVCL_9Z03
SY   Hamon Cancer Center 3531
DR   Wikidata; Q54881706
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC36
AC   CVCL_VI90
DR   Wikidata; Q93983353
RX   PubMed=7928289;
RX   PubMed=8384076;
CC   Virology: Contains integrated hepatitis B virus (HBV) genome DNA in at least 4 sites.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 5
//
ID   HCC364
AC   CVCL_5134
SY   HCC0364; HCC-364; Hamon Cancer Center 364
DR   EFO; EFO_0006420
DR   ArrayExpress; E-MTAB-2706
DR   BioGRID_ORCS_Cell_line; 231
DR   BioSample; SAMN03473003
DR   BioSample; SAMN10988412
DR   cancercelllines; CVCL_5134
DR   Cell_Model_Passport; SIDM01597
DR   Cosmic; 903630
DR   Cosmic; 1146934
DR   Cosmic; 1209733
DR   Cosmic; 2472917
DR   DepMap; ACH-000575
DR   EGA; EGAS00001000610
DR   GEO; GSM434285
DR   GEO; GSM794378
DR   GEO; GSM817113
DR   IGRhCellID; HCC364GEO
DR   PharmacoDB; HCC364_499_2019
DR   Progenetix; CVCL_5134
DR   Wikidata; Q54881707
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=25984343).
CC   HLA typing: A*24:02,24:02; B*35:02,35:02; C*04:01,04:01; DQA1*05:01,05:01; DQB1*03:01,03:01; DRB1*03:17,11:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000575).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180Lys (c.538G>A); ClinVar=VCV000245711; Zygosity=Homozygous (DepMap=ACH-000575).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.01%; Native American=0.31%; East Asian, North=6.71%; East Asian, South=0%; South Asian=5.19%; European, North=21.75%; European, South=64.04% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 14
ST   D12S391: 17,20
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 16,17.3
ST   D21S11: 29
ST   D22S1045: 16
ST   D2S1338: 25
ST   D2S441: 11,14
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   DYS391: 10
ST   FGA: 20,24 (PubMed=25877200)
ST   FGA: 24 (Direct_author_submission)
ST   Penta D: 13 (PubMed=25877200)
ST   Penta D: 13,17 (Direct_author_submission)
ST   Penta E: 12,18
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   HCC366
AC   CVCL_2059
AS   CVCL_L086
SY   HCC-366; HCC0366; Hamon Cancer Center 366
DR   CLO; CLO_0037011
DR   EFO; EFO_0003131
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473079
DR   BioSample; SAMN10988035
DR   cancercelllines; CVCL_2059
DR   Cell_Model_Passport; SIDM01070
DR   CLS; 302155
DR   Cosmic; 877261
DR   Cosmic; 903631
DR   Cosmic; 1146935
DR   Cosmic; 1239916
DR   Cosmic; 1518096
DR   Cosmic; 2125184
DR   Cosmic; 2559771
DR   Cosmic-CLP; 1240144
DR   DepMap; ACH-000840
DR   DSMZ; ACC-492
DR   DSMZCellDive; ACC-492
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GEO; GSM62335
DR   GEO; GSM108871
DR   GEO; GSM108872
DR   GEO; GSM253363
DR   GEO; GSM434261
DR   GEO; GSM784223
DR   GEO; GSM794379
DR   GEO; GSM817114
DR   GEO; GSM827365
DR   GEO; GSM887053
DR   GEO; GSM888123
DR   GEO; GSM1669858
DR   GEO; GSM2807229
DR   GEO; GSM2807230
DR   IARC_TP53; 28330
DR   IGRhCellID; HCC366_02GEO
DR   KCLB; 70366
DR   KCLB; 70966
DR   LiGeA; CCLE_150
DR   LINCS_LDP; LCL-1605
DR   PharmacoDB; HCC366_458_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2059
DR   Wikidata; Q54881708
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20624269;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27602502;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~60-70 hours (DSMZ=ACC-492).
CC   HLA typing: A*11:01,11:01; B*55:01,55:01; C*03:03,03:03; DQA1*03:02,03:02; DQB1*06:08,06:08; DRB1*03:02,13:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro534Ala (c.1600C>G); Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=1240144; DepMap=ACH-000840).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=1240144; DepMap=ACH-000840).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.18%; Native American=0.77%; East Asian, North=2.6%; East Asian, South=0%; South Asian=0%; European, North=62.65%; European, South=32.8% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Misspelling: HCC-966; KCLB=70966.
CC   Discontinued: KCLB; 70966; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1240144; Direct_author_submission; DSMZ=ACC-492; KCLB=70366; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 15,17
ST   D12S391: 17.3,20
ST   D13S317: 11,13 (Cosmic-CLP=1240144; DSMZ=ACC-492; PubMed=25877200)
ST   D13S317: 13 (Direct_author_submission; KCLB=70366; PubMed=20679594)
ST   D16S539: 11
ST   D18S51: 19
ST   D19S433: 12.2 (Direct_author_submission)
ST   D19S433: 13 (DSMZ=ACC-492)
ST   D1S1656: 13,17.3
ST   D21S11: 28
ST   D22S1045: 15,16
ST   D2S1338: 18,20
ST   D2S441: 11
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 19,21
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M077 ! HCC366 BL
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   HCC366 BL
AC   CVCL_M077
SY   HCC-366BL; HCC366-BL; HCC366BL; Hamon Cancer Center 366 BL
DR   DSMZ; ACC-895
DR   DSMZCellDive; ACC-895
DR   Wikidata; Q54881709
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Doubling time: ~15-24 hours (DSMZ=ACC-895).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-895
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 19
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 19,21
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2059 ! HCC366
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 14
//
ID   HCC374
AC   CVCL_V727
SY   HCC00374; Hamon Cancer Center 374
DR   Wikidata; Q54881710
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3539; Malignant splenic neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC379
AC   CVCL_V728
SY   HCC0379; Hamon Cancer Center 379
DR   Wikidata; Q54881711
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC38
AC   CVCL_1267
SY   Hcc38; HCC-38; HCC 38; HCC0038; Hamon Cancer Center 38
DR   BTO; BTO_0005295
DR   CLO; CLO_0003655
DR   EFO; EFO_0001180
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-2314
DR   BioGRID_ORCS_Cell_line; 871
DR   BioSample; SAMN03471264
DR   BioSample; SAMN10987659
DR   cancercelllines; CVCL_1267
DR   CCRID; 1101HUM-PUMC000220
DR   Cell_Model_Passport; SIDM00675
DR   ChEMBL-Cells; CHEMBL3308578
DR   ChEMBL-Targets; CHEMBL1075460
DR   Cosmic; 749717
DR   Cosmic; 904356
DR   Cosmic; 1018475
DR   Cosmic; 1047706
DR   Cosmic; 1136365
DR   Cosmic; 1235078
DR   Cosmic; 1287932
DR   Cosmic; 1430346
DR   Cosmic; 1460229
DR   Cosmic; 1518108
DR   Cosmic; 1603212
DR   Cosmic; 1935000
DR   Cosmic; 1995432
DR   Cosmic; 2009508
DR   Cosmic; 2164993
DR   Cosmic-CLP; 749717
DR   DepMap; ACH-000276
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 749717
DR   GEO; GSM149979
DR   GEO; GSM149987
DR   GEO; GSM149995
DR   GEO; GSM185085
DR   GEO; GSM185086
DR   GEO; GSM217579
DR   GEO; GSM344382
DR   GEO; GSM344432
DR   GEO; GSM350536
DR   GEO; GSM378150
DR   GEO; GSM533398
DR   GEO; GSM533405
DR   GEO; GSM537968
DR   GEO; GSM783968
DR   GEO; GSM827244
DR   GEO; GSM844013
DR   GEO; GSM847390
DR   GEO; GSM847487
DR   GEO; GSM854621
DR   GEO; GSM854622
DR   GEO; GSM854623
DR   GEO; GSM854624
DR   GEO; GSM854625
DR   GEO; GSM887054
DR   GEO; GSM888124
DR   GEO; GSM1008902
DR   GEO; GSM1053702
DR   GEO; GSM1172875
DR   GEO; GSM1172967
DR   GEO; GSM1214580
DR   GEO; GSM1215289
DR   GEO; GSM1215290
DR   GEO; GSM1215291
DR   GEO; GSM1215292
DR   GEO; GSM1215293
DR   GEO; GSM1215294
DR   GEO; GSM1215295
DR   GEO; GSM1215296
DR   GEO; GSM1374511
DR   GEO; GSM1401651
DR   GEO; GSM1669859
DR   IARC_TP53; 10268
DR   IGRhCellID; HCC38
DR   KCLB; 9S0038
DR   LiGeA; CCLE_393
DR   LINCS_HMS; 50216
DR   LINCS_LDP; LCL-1334
DR   PharmacoDB; HCC38_500_2019
DR   PRIDE; PXD005295
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1267
DR   PubChem_Cell_line; CVCL_1267
DR   Wikidata; Q54881712
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=12800145;
RX   PubMed=14762065;
RX   PubMed=16959974;
RX   PubMed=17157791;
RX   PubMed=17932254;
RX   PubMed=19582160;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=40300663;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC38.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 50.98 hours (JWGray panel).
CC   HLA typing: A*03:01,03:01; B*35:03,35:03; C*12:03,12:03; DRB1*09:07,09:07 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*35:03,35:03; C*12:03,12:03; DQA1*01:02,03:02; DQB1*06:02,06:02; DRB1*13:07,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=9865903; ATCC=CRL-2314).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.51%; Native American=0%; East Asian, North=2.67%; East Asian, South=0%; South Asian=0.58%; European, North=60.89%; European, South=34.34% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-2314; CCRID=1101HUM-PUMC000220; Cosmic-CLP=749717; Direct_author_submission; DOI=10.4172/2157-7145.S2-005; KCLB=9S0038; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13
ST   D12S391: 18,18.3
ST   D13S317: 12,14
ST   D16S539: 10,14
ST   D18S51: 15
ST   D19S433: 13,15
ST   D1S1656: 15,17.3
ST   D21S11: 27,28
ST   D22S1045: 15
ST   D2S1338: 17,19
ST   D2S441: 14
ST   D3S1358: 18
ST   D5S818: 9
ST   D7S820: 10
ST   D8S1179: 8,10
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 16,17
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1268 ! HCC38 BL
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   HCC38 BL
AC   CVCL_1268
SY   HCC-38BL; HCC38-BL; HCC 38BL; HCC38BL; Hamon Cancer Center 38 BL
DR   CLO; CLO_0003656
DR   ATCC; CRL-2346
DR   BioSample; SAMN03471826
DR   cancercelllines; CVCL_1268
DR   Cell_Model_Passport; SIDM00674
DR   DepMap; ACH-002377
DR   GEO; GSM854626
DR   GEO; GSM1172968
DR   KCLB; 9S0038BL
DR   PharmacoDB; HCC38BL_501_2019
DR   Progenetix; CVCL_1268
DR   Wikidata; Q54881713
RX   PubMed=9833771;
RX   PubMed=14762065;
RX   PubMed=20164919;
RX   PubMed=24176112;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2346; KCLB=9S0038BL
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 10,14
ST   D18S51: 15,16
ST   D19S433: 13,15
ST   D21S11: 27,28
ST   D2S1338: 17,19
ST   D3S1358: 15,18
ST   D5S818: 9,12
ST   D7S820: 10
ST   D8S1179: 8,10
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 5,11
ST   TH01: 7,9.3 (ATCC=CRL-2346)
ST   TH01: 8,9.3 (KCLB=9S0038BL)
ST   TPOX: 9,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1267 ! HCC38
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   HCC38/Cas9-hyg
AC   CVCL_C9DD
DR   GeneCopoeia; SL563
DR   Wikidata; Q123031547
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL563).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1267 ! HCC38
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HCC38rCDDP3000
AC   CVCL_D6VK
SY   HCC38 rCDDP3000
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1267 ! HCC38
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HCC38rDOX40
AC   CVCL_D6VL
SY   HCC38 rDoxorubicin40
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1267 ! HCC38
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HCC38rERI10
AC   CVCL_D6VM
SY   HCC38 rEribulin10
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63587; Eribulin (Halaven).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1267 ! HCC38
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HCC38rGEM20
AC   CVCL_D6VN
SY   HCC38 rGemcitabine20
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1267 ! HCC38
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HCC38rPCL2.5
AC   CVCL_D6VP
SY   HCC38 rPaclitaxel2.5
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1267 ! HCC38
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HCC40-CL
AC   CVCL_VG04
DR   Wikidata; Q54881714
RX   PubMed=27279800;
CC   Population: Chinese.
CC   Doubling time: ~43 hours (PubMed=27279800).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Pro (c.311A>C); Zygosity=Unspecified (PubMed=27279800).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=27279800
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,21
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22,25
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   HCC4000
AC   CVCL_9Z04
SY   Hamon Cancer Center 4000
DR   Wikidata; Q54881715
RX   PubMed=39154123;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D21S11: 30,32.2
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4001
AC   CVCL_9Z05
SY   Hamon Cancer Center 4001
DR   Wikidata; Q54881716
RX   PubMed=34439128;
RX   PubMed=39154123;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 15
ST   D12S391: 19.3,20
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D1S1656: 16,17.3
ST   D21S11: 28,30
ST   D22S1045: 15,17
ST   D2S1338: 19,25
ST   D2S441: 11,14
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,12
ST   DYS391: 10
ST   FGA: 19
ST   Penta D: 11,13
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HCC4002
AC   CVCL_9Z06
SY   Hamon Cancer Center 4002
DR   Wikidata; Q54881720
RX   PubMed=34439128;
RX   PubMed=39154123;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 15,16
ST   D12S391: 18,25
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D1S1656: 11,15
ST   D21S11: 32.2,34.2
ST   D22S1045: 14,17
ST   D2S1338: 17
ST   D2S441: 10,11.3
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   DYS391: 10
ST   FGA: 24.2
ST   Penta D: 9,14
ST   Penta E: 16
ST   TH01: 8
ST   TPOX: 9
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z08 ! HCC4004
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4003
AC   CVCL_9Z07
SY   Hamon Cancer Center 4003
DR   Wikidata; Q54881721
RX   PubMed=34439128;
RX   PubMed=39154123;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 13,15
ST   D12S391: 22,23
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 14.2,17.2
ST   D1S1656: 12,18.3
ST   D21S11: 29,30
ST   D22S1045: 15
ST   D2S1338: 19,20
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13,16
ST   DYS391: 11
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 6
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 15,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4004
AC   CVCL_9Z08
SY   Hamon Cancer Center 4004
DR   Wikidata; Q54881722
RX   PubMed=34439128;
RX   PubMed=39154123;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 15,16
ST   D12S391: 18,25
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D1S1656: 11,15
ST   D21S11: 32.2,34.2
ST   D22S1045: 14,17
ST   D2S1338: 17
ST   D2S441: 10,11.3
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   DYS391: 10
ST   FGA: 24.2
ST   Penta D: 9,14
ST   Penta E: 16
ST   TH01: 8
ST   TPOX: 9
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z06 ! HCC4002
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HCC4005
AC   CVCL_9Z09
SY   Hamon Cancer Center 4005
DR   Wikidata; Q54881723
RX   PubMed=34439128;
RX   PubMed=39154123;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 17
ST   D12S391: 15,22
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 17
ST   D19S433: 13,15
ST   D1S1656: 16,17.3
ST   D21S11: 31.2,32.2
ST   D22S1045: 15
ST   D2S1338: 18,22
ST   D2S441: 11,11.3
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 8,13
ST   DYS391: 10
ST   FGA: 22,25
ST   Penta D: 8,13
ST   Penta E: 12,14
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4006
AC   CVCL_1269
SY   HCC-4006; Hamon Cancer Center 4006
DR   BTO; BTO_0004081
DR   CLO; CLO_0003657
DR   EFO; EFO_0003132
DR   AddexBio; C0016012/4917
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2871
DR   BioSample; SAMN03471807
DR   BioSample; SAMN03473288
DR   BioSample; SAMN10988526
DR   cancercelllines; CVCL_1269
DR   Cell_Model_Passport; SIDM01596
DR   ChEMBL-Cells; CHEMBL4523544
DR   ChEMBL-Targets; CHEMBL4523575
DR   Cosmic; 903602
DR   Cosmic; 1028938
DR   Cosmic; 1128250
DR   Cosmic; 1146936
DR   Cosmic; 1802302
DR   Cosmic; 2015233
DR   DepMap; ACH-000066
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM63351
DR   GEO; GSM108873
DR   GEO; GSM108874
DR   GEO; GSM253408
DR   GEO; GSM434286
DR   GEO; GSM794399
DR   GEO; GSM817126
DR   GEO; GSM844552
DR   GEO; GSM887055
DR   GEO; GSM888125
DR   IARC_TP53; 30035
DR   IGRhCellID; HCC4006GEO
DR   LiGeA; CCLE_139
DR   PharmacoDB; HCC4006_502_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_1269
DR   PubChem_Cell_line; CVCL_1269
DR   Wikidata; Q54881724
RX   PubMed=16187286;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23733853;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=39061985;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 46.8 hours (PubMed=29681454); ~41 hours (ATCC=CRL-2871).
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*07:01,07:01; DQB1*02:02,02:02; DRB1*07:01,14:05 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (ATCC=CRL-2871; DepMap=ACH-000066).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (DepMap=ACH-000066).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.52%; Native American=0%; East Asian, North=5.13%; East Asian, South=0%; South Asian=0%; European, North=54.8%; European, South=38.54% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): AddexBio=C0016012/4917; ATCC=CRL-2871; Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X (AddexBio=C0016012/4917; ATCC=CRL-2871; Direct_author_submission; PubMed=25877200)
ST   Amelogenin: X,Y (PubMed=20679594)
ST   CSF1PO: 10
ST   D10S1248: 13,15
ST   D12S391: 21,22
ST   D13S317: 11,12
ST   D16S539: 11,12 (AddexBio=C0016012/4917; ATCC=CRL-2871; Direct_author_submission; PubMed=20679594)
ST   D16S539: 12 (PubMed=25877200)
ST   D18S51: 19
ST   D19S433: 12,13
ST   D1S1656: 16,17.3
ST   D21S11: 31
ST   D22S1045: 15
ST   D2S1338: 17,24
ST   D2S441: 11.3,14
ST   D3S1358: 16,18 (ATCC=CRL-2871; Direct_author_submission)
ST   D3S1358: 18 (PubMed=25877200)
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   Penta D: 9,14
ST   Penta E: 7,13
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   HCC4006 BIR
AC   CVCL_E4DJ
SY   HCC4006BIR
RX   PubMed=39061985;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_232716; (20R)-10,15,20-trimethyl-2-[(4-methylpiperazin-1-yl)methyl]-18,19,20,21-tetrahydro-15H,17H-12,8-(metheno)pyrazolo[3',4':2,3][1,5,10,12]oxatriazacycloheptadecino[12,11-a]benzimidazol-7(6H)-one (BI-4020).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1269 ! HCC4006
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HCC4006-GR-high
AC   CVCL_S698
DR   cancercelllines; CVCL_S698
DR   Cosmic; 1896431
DR   Wikidata; Q54881725
RX   PubMed=23542356;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1269 ! HCC4006
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 17
//
ID   HCC4006-GR-step
AC   CVCL_S699
DR   cancercelllines; CVCL_S699
DR   Cosmic; 1896430
DR   Wikidata; Q54881726
RX   PubMed=23542356;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1269 ! HCC4006
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 17
//
ID   HCC4006-OsiR
AC   CVCL_A7EW
DR   cancercelllines; CVCL_A7EW
DR   Wikidata; Q107115246
RX   PubMed=32928921;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1269 ! HCC4006
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HCC4006/R
AC   CVCL_S746
SY   HCC4006R; HCC4006/ER; HCC4006ER
DR   cancercelllines; CVCL_S746
DR   Cosmic; 1890457
DR   Cosmic; 2015232
DR   Wikidata; Q54881727
RX   PubMed=22773810;
RX   PubMed=23733853;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1269 ! HCC4006
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   HCC4006rERLO1mUM
AC   CVCL_RS46
DR   cancercelllines; CVCL_RS46
DR   Wikidata; Q54881729
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1269 ! HCC4006
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   HCC4006rGEFI1muM
AC   CVCL_RS47
DR   cancercelllines; CVCL_RS47
DR   Wikidata; Q54881730
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1269 ! HCC4006
SX   Male
AG   >50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   HCC4011
AC   CVCL_S700
SY   Hamon Cancer Center 4011
DR   EFO; EFO_0006436
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473004
DR   cancercelllines; CVCL_S700
DR   EGA; EGAS00001000610
DR   GEO; GSM794400
DR   GEO; GSM817127
DR   PharmacoDB; HCC4011_503_2019
DR   Wikidata; Q54881731
RX   PubMed=20679594;
RX   PubMed=22773810;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 49.9 hours (PubMed=29681454).
CC   HLA typing: A*02:01,32:01; B*40:02,44:02; C*02:02,05:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=22773810).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 12
ST   D16S539: 8,11
ST   D18S51: 19,20
ST   D21S11: 31,31.2
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 19,20
ST   Penta D: 12,14
ST   Penta E: 17
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 25
//
ID   HCC4011-GR-high
AC   CVCL_S701
DR   cancercelllines; CVCL_S701
DR   Cosmic; 1896433
DR   Wikidata; Q54881732
RX   PubMed=23542356;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (from parent cell line).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S700 ! HCC4011
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   HCC4011-GR-step
AC   CVCL_S702
DR   cancercelllines; CVCL_S702
DR   Cosmic; 1896432
DR   Wikidata; Q54881733
RX   PubMed=23542356;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (from parent cell line).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S700 ! HCC4011
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   HCC4011/R
AC   CVCL_S747
SY   HCC4011/ER; HCC4011R
DR   cancercelllines; CVCL_S747
DR   Cosmic; 1890458
DR   Wikidata; Q54881734
RX   PubMed=22773810;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (from parent cell line).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S700 ! HCC4011
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   HCC4012
AC   CVCL_IT30
SY   HCC-4012; Hamon Cancer Center 4012
DR   PRIDE; PXD000589
DR   Wikidata; Q54881735
RX   PubMed=24207061;
RX   PubMed=24926545;
RX   PubMed=25894527;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   HCC4017
AC   CVCL_V579
SY   Hamon Cancer Center 4017
DR   EFO; EFO_0006437
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473218
DR   ChEMBL-Cells; CHEMBL4483179
DR   ChEMBL-Targets; CHEMBL4483243
DR   EGA; EGAS00001000610
DR   GEO; GSM794401
DR   GEO; GSM817128
DR   PharmacoDB; HCC4017_504_2019
DR   PubChem_Cell_line; CVCL_V579
DR   Wikidata; Q54881736
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 46.3 hours (PubMed=29681454).
CC   HLA typing: A*29:02,29:02; B*07:02,07:02; C*07:02,07:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*13:07,15:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 14,17
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 12,16.2
ST   D1S1656: 14,15
ST   D21S11: 28,30
ST   D22S1045: 14,15
ST   D2S1338: 20,25
ST   D2S441: 11,14
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 13,16 (PubMed=20679594)
ST   vWA: 16 (Direct_author_submission; PubMed=25877200)
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS83 ! HBEC30-KT
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 22
//
ID   HCC4018
AC   CVCL_V580
SY   Hamon Cancer Center 4018
DR   GEO; GSM794402
DR   GEO; GSM817129
DR   Wikidata; Q54881737
RX   PubMed=20679594;
RX   PubMed=28196595;
RX   PubMed=29681454;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D21S11: 30,33.2
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HCC4019
AC   CVCL_V581
SY   Hamon Cancer Center 4019
DR   BioSample; SAMN03472973
DR   GEO; GSM794403
DR   Wikidata; Q54881738
RX   PubMed=25877200;
RX   PubMed=28196595;
RX   PubMed=29681454;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 61.2 hours (PubMed=29681454).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,14
ST   D12S391: 17,22
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12,18
ST   D19S433: 13
ST   D1S1656: 13,16.3
ST   D21S11: 25.2,31
ST   D22S1045: 16
ST   D2S1338: 22,25
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 24,25
ST   Penta D: 12,13
ST   Penta E: 17
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC4021
AC   CVCL_9Z10
SY   Hamon Cancer Center 4021
DR   Wikidata; Q54881739
RX   PubMed=29681454;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 15,17
ST   D12S391: 20
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13
ST   D1S1656: 13,18.3
ST   D21S11: 27,32.2
ST   D22S1045: 15
ST   D2S1338: 20,25
ST   D2S441: 10,13
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 20
ST   Penta D: 8,10
ST   Penta E: 10,11
ST   TH01: 5,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HCC4032
AC   CVCL_E9BD
SY   Hamon Cancer Center 4032
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 11
ST   D21S11: 29,30.2
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BE ! HCC4032 BL
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC4032 BL
AC   CVCL_E9BE
SY   HCC-4032BL; HCC4032-BL; HCC4032BL; Hamon Cancer Center 4032 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BD ! HCC4032
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC4034
AC   CVCL_9Z11
SY   Hamon Cancer Center 4034
DR   Wikidata; Q54881740
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12
ST   D21S11: 28
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 5,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z13 ! HCC4038
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4037
AC   CVCL_9Z12
SY   Hamon Cancer Center 4037
DR   Wikidata; Q54881742
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4038
AC   CVCL_9Z13
SY   Hamon Cancer Center 4038
DR   Wikidata; Q54881743
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12
ST   D21S11: 28
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 5,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z11 ! HCC4034
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4047
AC   CVCL_9Z14
SY   Hamon Cancer Center 4047
DR   Wikidata; Q54881744
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 11
ST   D21S11: 32.2
ST   D5S818: 10
ST   D7S820: 9,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BF ! HCC4047 BL
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4047 BL
AC   CVCL_E9BF
SY   HCC-4047BL; HCC4047-BL; HCC4047BL; Hamon Cancer Center 4047 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z14 ! HCC4047
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC4054
AC   CVCL_9Z15
SY   Hamon Cancer Center 4054
DR   Wikidata; Q54881745
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 9
ST   D7S820: 9,10
ST   TH01: 6,8
ST   TPOX: 8,9,12
ST   vWA: 19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BG ! HCC4054 BL
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4054 BL
AC   CVCL_E9BG
SY   HCC-4054BL; HCC4054-BL; HCC4054BL; Hamon Cancer Center 4054 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z15 ! HCC4054
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC4058
AC   CVCL_9Z16
SY   Hamon Cancer Center 4058
DR   Wikidata; Q54881746
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 17
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 11,14
ST   D1S1656: 17.3
ST   D21S11: 27,28
ST   D22S1045: 16
ST   D2S1338: 17,24
ST   D2S441: 11.3
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 11,15
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4059
AC   CVCL_9Z17
SY   Hamon Cancer Center 4059
DR   Wikidata; Q54881747
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 29,31
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BH ! HCC4059 BL
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4059 BL
AC   CVCL_E9BH
SY   HCC-4059BL; HCC4059-BL; HCC4059BL; Hamon Cancer Center 4059 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z17 ! HCC4059
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC407
AC   CVCL_V707
SY   HCC0407; Hamon Cancer Center 407
DR   BioSample; SAMN03473027
DR   Wikidata; Q54881748
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 13,15
ST   D21S11: 28,29
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 21,24,25
ST   Penta D: 9,11
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BK ! HCC412 BL
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC4087
AC   CVCL_9Z18
SY   Hamon Cancer Center 4087
DR   Wikidata; Q54881749
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,16
ST   D12S391: 18
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 10,17
ST   D19S433: 14
ST   D1S1656: 14
ST   D21S11: 28,31.2
ST   D22S1045: 11
ST   D2S1338: 23,24
ST   D2S441: 14
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 7
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BI ! HCC4087 BL
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HCC4087 BL
AC   CVCL_E9BI
SY   HCC-4087BL; HCC4087-BL; HCC4087BL; Hamon Cancer Center 4087 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9Z18 ! HCC4087
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC41
AC   CVCL_V733
SY   HCC0041; Hamon Cancer Center 41
DR   Wikidata; Q54881750
RX   PubMed=31803961;
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LC75 ! HCC41 BL
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC41 BL
AC   CVCL_LC75
SY   HCC-41BL; HCC41-BL; HCC41BL; Hamon Cancer Center 41 BL
DR   Wikidata; Q54881751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V733 ! HCC41
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HCC412 BL
AC   CVCL_E9BK
SY   HCC-412BL; HCC412-BL; HCC412BL; Hamon Cancer Center 412 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V707 ! HCC407
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC420
AC   CVCL_V734
SY   HCC0420; Hamon Cancer Center 420
DR   Wikidata; Q54881752
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C5169; Breast neuroendocrine neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC435
AC   CVCL_V735
SY   HCC0435; Hamon Cancer Center 435
DR   Wikidata; Q54881753
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC44
AC   CVCL_2060
SY   HCC-44; HCC0044; Hamon Cancer Center 44
DR   CLO; CLO_0037012
DR   EFO; EFO_0003133
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 177
DR   BioSample; SAMN03473080
DR   BioSample; SAMN03473528
DR   BioSample; SAMN10988276
DR   cancercelllines; CVCL_2060
DR   Cell_Model_Passport; SIDM01069
DR   ChEMBL-Cells; CHEMBL4295429
DR   ChEMBL-Targets; CHEMBL4296385
DR   Cosmic; 877254
DR   Cosmic; 903626
DR   Cosmic; 1146937
DR   Cosmic; 1239870
DR   Cosmic; 1995433
DR   Cosmic; 2125202
DR   Cosmic-CLP; 1240145
DR   DepMap; ACH-000667
DR   DSMZ; ACC-534
DR   DSMZCellDive; ACC-534
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1240145
DR   GEO; GSM108875
DR   GEO; GSM108876
DR   GEO; GSM253314
DR   GEO; GSM434321
DR   GEO; GSM794374
DR   GEO; GSM817110
DR   GEO; GSM827372
DR   GEO; GSM887056
DR   GEO; GSM888126
DR   GEO; GSM1669860
DR   IARC_TP53; 28359
DR   IARC_TP53; 28435
DR   IGRhCellID; HCC44GEO
DR   KCLB; 70044
DR   LiGeA; CCLE_613
DR   LINCS_LDP; LCL-1606
DR   PharmacoDB; HCC44_459_2019
DR   Progenetix; CVCL_2060
DR   PubChem_Cell_line; CVCL_2060
DR   Wikidata; Q54881754
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (PubMed=25984343); 36.8 hours (PubMed=29681454); ~30 hours (DSMZ=ACC-534).
CC   HLA typing: A*24:02,24:02; B*35:03,35:03; C*04:01,04:01; DRB1*03:17,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (Cosmic-CLP=1240145; DepMap=ACH-000667).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>A (c.228C>A) (C228A); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser94Ter (c.281C>G); Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=1240145; DepMap=ACH-000667).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=1240145; DepMap=ACH-000667).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.25%; East Asian, South=0%; South Asian=0%; European, North=61.76%; European, South=35.99% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1240145; Direct_author_submission; DSMZ=ACC-534; KCLB=70044; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D10S1248: 13,14
ST   D12S391: 20
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 14,16
ST   D1S1656: 16
ST   D21S11: 28,32.2 (Direct_author_submission; DSMZ=ACC-534)
ST   D21S11: 28,32.2,33.2 (PubMed=25877200)
ST   D22S1045: 14,15
ST   D2S1338: 17 (Direct_author_submission)
ST   D2S1338: 17,24 (DSMZ=ACC-534)
ST   D2S441: 14
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 10,12
ST   TH01: 9
ST   TPOX: 8,12 (Cosmic-CLP=1240145; Direct_author_submission; DSMZ=ACC-534; KCLB=70044; PubMed=20679594)
ST   TPOX: 12 (PubMed=25877200)
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L065 ! HCC44 BL
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   HCC44 BL
AC   CVCL_L065
SY   HCC-44BL; HCC44-BL; HCC44BL; Hamon Cancer Center 44 BL
DR   Wikidata; Q54881755
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2060 ! HCC44
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 16
//
ID   HCC446
AC   CVCL_V736
SY   HCC0446; Hamon Cancer Center 446
DR   Wikidata; Q54881756
RX   PubMed=29681454;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,10
ST   D16S539: 11,14
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BL ! HCC446 BL
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC446 BL
AC   CVCL_E9BL
SY   HCC-446BL; HCC446-BL; HCC446BL; Hamon Cancer Center 446 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V736 ! HCC446
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC461
AC   CVCL_5135
SY   HCC0461; Hamon Cancer Center 461
DR   EFO; EFO_0003134
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471006
DR   BioSample; SAMN10989603
DR   cancercelllines; CVCL_5135
DR   Cell_Model_Passport; SIDM01595
DR   Cosmic; 903632
DR   Cosmic; 1146938
DR   Cosmic; 2699648
DR   DepMap; ACH-000339
DR   EGA; EGAS00001000610
DR   GEO; GSM62336
DR   GEO; GSM108877
DR   GEO; GSM108878
DR   GEO; GSM253392
DR   GEO; GSM434262
DR   GEO; GSM794380
DR   GEO; GSM817115
DR   IARC_TP53; 11446
DR   IGRhCellID; HCC461GEO
DR   PharmacoDB; HCC461_505_2019
DR   Progenetix; CVCL_5135
DR   Wikidata; Q54881757
RX   PubMed=10353731;
RX   PubMed=16187286;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*03:01,03:01; B*07:02,40:01; C*03:04,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=10353731; DepMap=ACH-000339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser149Profs*21 (c.445delT); ClinVar=VCV000419519; Zygosity=Heterozygous (DepMap=ACH-000339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Gln (c.800G>A); ClinVar=VCV000127823; Zygosity=Heterozygous (DepMap=ACH-000339).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X (PubMed=20679594)
ST   Amelogenin: X,Y (Direct_author_submission; PubMed=25877200)
ST   CSF1PO: 10,12
ST   D10S1248: 14
ST   D12S391: 18,18.3
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 12,16
ST   D1S1656: 17,19.3
ST   D21S11: 30
ST   D22S1045: 16,17
ST   D2S1338: 17,23
ST   D2S441: 11,11.3
ST   D3S1358: 15,18
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   HCC4977
AC   CVCL_E050
SY   Hamon Cancer Center 4977
DR   Wikidata; Q54881758
RX   PubMed=22460906;
CC   Miscellaneous: Only mentioned as a hepatocellular carcinoma cell line in PubMed=22460906.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 12
//
ID   HCC515
AC   CVCL_5136
SY   HCC-515; HCC0515; Hamon Cancer Center 515
DR   CLO; CLO_0037013
DR   EFO; EFO_0003135
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473216
DR   BioSample; SAMN10989604
DR   cancercelllines; CVCL_5136
DR   Cell_Model_Passport; SIDM01610
DR   ChEMBL-Cells; CHEMBL4296203
DR   ChEMBL-Targets; CHEMBL4296386
DR   Cosmic; 877257
DR   Cosmic; 903633
DR   Cosmic; 1146939
DR   Cosmic; 1239873
DR   Cosmic; 1518097
DR   Cosmic; 2125261
DR   DepMap; ACH-000872
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM108879
DR   GEO; GSM108880
DR   GEO; GSM253364
DR   GEO; GSM434263
DR   GEO; GSM794381
DR   GEO; GSM817116
DR   IARC_TP53; 28437
DR   IGRhCellID; HCC515_02v
DR   LINCS_LDP; LCL-2084
DR   PharmacoDB; HCC515_506_2019
DR   Progenetix; CVCL_5136
DR   PubChem_Cell_line; CVCL_5136
DR   Wikidata; Q54881759
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 39.3 hours (PubMed=29681454).
CC   HLA typing: A*11:01,11:01; B*51:01,51:01; C*15:02,15:02; DRB1*15:01,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84His (c.250G>C) (p.Arg98Pro, c.293G>C); ClinVar=VCV002200354; Zygosity=Homozygous (DepMap=ACH-000872).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (DepMap=ACH-000872).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (PubMed=20557307; DepMap=ACH-000872).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Direct_author_submission; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,14
ST   D12S391: 21,24
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 9,20
ST   D19S433: 13
ST   D1S1656: 15
ST   D21S11: 29,30
ST   D22S1045: 16
ST   D2S1338: 18,23
ST   D2S441: 14
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 7,8
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   Penta D: 11,15
ST   Penta E: 9,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S839 ! HCC515 BL
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   HCC515 BL
AC   CVCL_S839
SY   HCC-515BL; HCC515-BL; HCC515BL; Hamon Cancer Center 515 BL
DR   Wikidata; Q54881760
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5136 ! HCC515
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 13
//
ID   HCC590
AC   CVCL_V700
SY   HCC0590; Hamon Cancer Center 590
DR   Wikidata; Q54881761
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC597
AC   CVCL_V701
SY   HCC0597; Hamon Cancer Center 597
DR   BioSample; SAMN03470871
DR   Wikidata; Q54881768
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 17.2
ST   D21S11: 29,30
ST   D2S1338: 20,26
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 9,11
ST   Penta E: 15
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HCC60
AC   CVCL_G002
SY   HCC0060; Hamon Cancer Center 60
DR   EFO; EFO_0006418
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473068
DR   cancercelllines; CVCL_G002
DR   Cosmic; 1113279
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC60_507_2019
DR   Wikidata; Q54881769
RX   PubMed=12429618;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NCI-H23 derivative (PubMed=25877200). Originally thought to originate from a 26 year old female patient with an ovarian cystadenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00533.
CC   Population: African American.
CC   HLA typing: A*80:01,80:01; B*50:01,50:01; C*06:02,06:02; DQB1*06:13,06:13; DRB1*13:01,03:17 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1919Pro (c.5756A>C); ClinVar=VCV000580726; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Trp332Ter (c.996G>A); ClinVar=VCV000376339; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>C); ClinVar=VCV001758655; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 8
ST   Penta E: 7,17
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1547 ! NCI-H23
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 27
//
ID   HCC620 BL
AC   CVCL_E9BM
SY   HCC-620BL; HCC620-BL; HCC620BL; Hamon Cancer Center 620 BL
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3378 ! HCC712
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC630
AC   CVCL_V729
SY   HCC0630; Hamon Cancer Center 630
DR   EFO; EFO_0006421
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472978
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC630_508_2019
DR   Wikidata; Q54881770
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Population: Hispanic.
CC   HLA typing: A*11:01,24:02; B*18:01,37:01; C*07:04,07:04 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12,13
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D21S11: 30,33.2
ST   D3S1358: 13,16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,16
ST   FGA: 20.2,21
ST   Penta D: 15
ST   Penta E: 7
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,16,17,18
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HCC653
AC   CVCL_V730
SY   HCC0653; Hamon Cancer Center 653
DR   Wikidata; Q54881771
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC70
AC   CVCL_1270
SY   HCC-70; HCC 70; HCC0070; Hamon Cancer Center 70
DR   BTO; BTO_0005963
DR   CLO; CLO_0003658
DR   EFO; EFO_0001181
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-2315
DR   BCRJ; 0386
DR   BioGRID_ORCS_Cell_line; 870
DR   BioSample; SAMN03471365
DR   BioSample; SAMN03471868
DR   BioSample; SAMN10988137
DR   cancercelllines; CVCL_1270
DR   Cell_Model_Passport; SIDM00673
DR   ChEMBL-Cells; CHEMBL3308739
DR   ChEMBL-Targets; CHEMBL1075461
DR   CLS; 305464
DR   Cosmic; 687486
DR   Cosmic; 904357
DR   Cosmic; 907048
DR   Cosmic; 1018474
DR   Cosmic; 1047703
DR   Cosmic; 1136352
DR   Cosmic; 1287933
DR   Cosmic; 1603213
DR   Cosmic; 1935001
DR   Cosmic; 1995435
DR   Cosmic; 2164994
DR   Cosmic-CLP; 907048
DR   DepMap; ACH-000668
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907048
DR   GEO; GSM217580
DR   GEO; GSM344372
DR   GEO; GSM344422
DR   GEO; GSM350500
DR   GEO; GSM718288
DR   GEO; GSM783941
DR   GEO; GSM844014
DR   GEO; GSM844015
DR   GEO; GSM847391
DR   GEO; GSM887058
DR   GEO; GSM888128
DR   GEO; GSM1053711
DR   GEO; GSM1172876
DR   GEO; GSM1172969
DR   GEO; GSM1374512
DR   GEO; GSM1401660
DR   GEO; GSM1669862
DR   IARC_TP53; 10269
DR   IGRhCellID; HCC70
DR   KCLB; 9S0070
DR   LiGeA; CCLE_774
DR   LINCS_HMS; 50219
DR   LINCS_LDP; LCL-1335
DR   PharmacoDB; HCC70_509_2019
DR   PRIDE; PXD005295
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1270
DR   PubChem_Cell_line; CVCL_1270
DR   SLKBase; 3492
DR   Wikidata; Q54881772
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29473000;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/HCC70.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 93 hours (PubMed=25984343); 67.80 hours (JWGray panel).
CC   HLA typing: A*03:01,30:02; B*15:16,78:01; C*16:01,16:01; DQB1*05:01,05:01; DRB1*01:02,07:01 (PubMed=25960936).
CC   HLA typing: A*03:01,30:02; B*15:16,78:01; C*16:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=9865903; PubMed=28889351; ATCC=CRL-2315).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=70.85%; Native American=0%; East Asian, North=5.47%; East Asian, South=0%; South Asian=0%; European, North=3.61%; European, South=20.07% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
ST   Source(s): ATCC=CRL-2315; Cosmic-CLP=907048; Direct_author_submission; KCLB=9S0070; PubMed=20679594; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10 (KCLB=9S0070)
ST   CSF1PO: 10,14 (ATCC=CRL-2315; Cosmic-CLP=907048; Direct_author_submission; PubMed=20679594; PubMed=25877200; PubMed=28889351; Technion Genomics Center)
ST   D10S1248: 13
ST   D12S391: 15,19
ST   D13S317: 12
ST   D16S539: 9,13 (ATCC=CRL-2315; Cosmic-CLP=907048; Direct_author_submission; PubMed=28889351; Technion Genomics Center)
ST   D16S539: 13 (PubMed=20679594; PubMed=25877200)
ST   D18S51: 13,16
ST   D19S433: 12.2,15.2
ST   D1S1656: 14
ST   D21S11: 30
ST   D22S1045: 14
ST   D2S1338: 23,25 (PubMed=25877200; Technion Genomics Center)
ST   D2S1338: 25 (ATCC=CRL-2315; Direct_author_submission)
ST   D2S441: 11
ST   D3S1358: 16 (KCLB=9S0070)
ST   D3S1358: 16,17 (ATCC=CRL-2315; Direct_author_submission; PubMed=25877200; Technion Genomics Center)
ST   D5S818: 12,13 (ATCC=CRL-2315; Cosmic-CLP=907048; Direct_author_submission; KCLB=9S0070; PubMed=20679594; PubMed=28889351; Technion Genomics Center)
ST   D5S818: 13 (PubMed=25877200)
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 19.2,24 (ATCC=CRL-2315; Direct_author_submission; PubMed=25877200; Technion Genomics Center)
ST   FGA: 24 (KCLB=9S0070)
ST   Penta D: 10
ST   Penta E: 9,16
ST   TH01: 9
ST   TPOX: 9,10 (Direct_author_submission; PubMed=20679594; PubMed=25877200; Technion Genomics Center)
ST   TPOX: 10 (ATCC=CRL-2315; Cosmic-CLP=907048; KCLB=9S0070; PubMed=28889351)
ST   vWA: 13,15
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   HCC70/Cas9-hyg
AC   CVCL_C9CI
DR   GeneCopoeia; SL544
DR   Wikidata; Q123031551
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL544).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1270 ! HCC70
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HCC711
AC   CVCL_V698
SY   HCC0711; Hamon Cancer Center 711
DR   Wikidata; Q54881773
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC712
AC   CVCL_3378
SY   HCC0712; Hamon Cancer Center 712
DR   ATCC; CRL-2317
DR   cancercelllines; CVCL_3378
DR   GEO; GSM350512
DR   GEO; GSM378144
DR   IARC_TP53; 22808
DR   PharmacoDB; HCC712_510_2019
DR   Progenetix; CVCL_3378
DR   Wikidata; Q54881774
RX   PubMed=9833771;
RX   PubMed=9865903;
RX   PubMed=11314036;
RX   PubMed=19582160;
RX   PubMed=20679594;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Asian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Discontinued: ATCC; CRL-2317; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): Direct_author_submission; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 16,17
ST   D19S433: 15.2,16.2
ST   D1S1656: 16,17.3
ST   D21S11: 29
ST   D22S1045: 15
ST   D2S1338: 17,18
ST   D2S441: 11,13
ST   D3S1358: 17
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   D8S1179: 11,12
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BM ! HCC620 BL
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   HCC78
AC   CVCL_2061
SY   HCC-78; HCC0078; Hamon Cancer Center 78
DR   CLO; CLO_0037014
DR   EFO; EFO_0003136
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 875
DR   BioSample; SAMN03473081
DR   BioSample; SAMN10988287
DR   cancercelllines; CVCL_2061
DR   Cell_Model_Passport; SIDM01068
DR   ChEMBL-Cells; CHEMBL4295389
DR   ChEMBL-Targets; CHEMBL4296421
DR   CLS; 302156
DR   Cosmic; 877255
DR   Cosmic; 903627
DR   Cosmic; 1146940
DR   Cosmic; 1239871
DR   Cosmic; 1518095
DR   Cosmic; 1612230
DR   Cosmic; 2125262
DR   Cosmic; 2647634
DR   Cosmic-CLP; 1290908
DR   DepMap; ACH-000562
DR   DSMZ; ACC-563
DR   DSMZCellDive; ACC-563
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290908
DR   GEO; GSM62333
DR   GEO; GSM108881
DR   GEO; GSM108882
DR   GEO; GSM253403
DR   GEO; GSM434264
DR   GEO; GSM784275
DR   GEO; GSM794375
DR   GEO; GSM817111
DR   GEO; GSM827373
DR   GEO; GSM887059
DR   GEO; GSM888129
DR   GEO; GSM1669863
DR   GEO; GSM7675391
DR   GEO; GSM7675392
DR   GEO; GSM7675393
DR   GEO; GSM7675394
DR   GEO; GSM7675395
DR   GEO; GSM7675396
DR   IARC_TP53; 28315
DR   IGRhCellID; HCC78GEO
DR   LiGeA; CCLE_435
DR   LINCS_LDP; LCL-1607
DR   PharmacoDB; HCC78_461_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2061
DR   PubChem_Cell_line; CVCL_2061
DR   Wikidata; Q54881777
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24349229;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30538120;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
RX   PubMed=38433235;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 38.7 hours (PubMed=29681454); ~60-70 hours (DSMZ=ACC-563).
CC   HLA typing: A*02:05,02:05; B*13:02,15:03; C*06:02,12:03; DQA1*01:02;03:02; DQB1*06:02;06:02; DRB1*13:26;15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (PubMed=18083107; PubMed=25485619; PubMed=30894373).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Homozygous (DepMap=ACH-000562).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=1290908; DepMap=ACH-000562).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.1%; East Asian, North=0%; East Asian, South=0.13%; South Asian=2.41%; European, North=67.1%; European, South=30.25% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1290908; Direct_author_submission; DSMZ=ACC-563; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 14,16
ST   D12S391: 19,21
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 16,16.2 (Direct_author_submission)
ST   D19S433: 16,17 (DSMZ=ACC-563)
ST   D1S1656: 15.3,17.3
ST   D21S11: 29,30
ST   D22S1045: 15,16
ST   D2S1338: 17,21
ST   D2S441: 11,14
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   DYS391: 12
ST   FGA: 21,22
ST   Penta D: 7,11
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L064 ! HCC78 BL
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   HCC78 BL
AC   CVCL_L064
SY   HCC-78BL; HCC78-BL; HCC78BL; Hamon Cancer Center 78 BL
DR   Wikidata; Q54881778
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2061 ! HCC78
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 14
//
ID   HCC78 ROS1 p.G2032R
AC   CVCL_E6J3
RX   DOI=10.63028/10067/2105480151162165141;
RX   PubMed=38433235;
CC   Population: Caucasian.
CC   Characteristics: The ROS1 mutation introduced is most prevalent among patients presenting relapsed disease. Shows significant resistance to ceritinib, crizotinib, entrectinib and lorlatinib (PubMed=38433235).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Gly2032Arg (c.6094G>A) (p.Gly2026Arg, c.6076G>A); ClinVar=VCV000376139; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38433235).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2061 ! HCC78
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCC78 ROS1 p.L2026M
AC   CVCL_E6J2
RX   DOI=10.63028/10067/2105480151162165141;
RX   PubMed=38433235;
CC   Population: Caucasian.
CC   Characteristics: Shows significant resistance towards crizotinib (PubMed=38433235).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Leu2026Met (c.6076C>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38433235).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2061 ! HCC78
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCC78 ROS1 p.S1986Y
AC   CVCL_E6J4
RX   DOI=10.63028/10067/2105480151162165141;
RX   PubMed=38433235;
CC   Population: Caucasian.
CC   Characteristics: Shows significant resistance towards crizotinib (PubMed=38433235).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Ser1986Tyr (c.5957C>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38433235).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2061 ! HCC78
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCC78-TR
AC   CVCL_UJ33
DR   cancercelllines; CVCL_UJ33
DR   Wikidata; Q93983894
RX   PubMed=24349229;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_91338; 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine (TAE684).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2061 ! HCC78
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   HCC815
AC   CVCL_V699
SY   HCC0815; Hamon Cancer Center 815
DR   Wikidata; Q54366485
CC   Population: Hispanic.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC824
AC   CVCL_V738
SY   HCC0824; Hamon Cancer Center 824
DR   Wikidata; Q54881779
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   HCC826
AC   CVCL_V593
SY   HCC0826; Hamon Cancer Center 826
DR   BioSample; SAMN03470842
DR   Wikidata; Q54881780
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 18
ST   D21S11: 30,30.2
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 24
ST   Penta D: 2.2,10
ST   Penta E: 14
ST   TH01: 7,10
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC827
AC   CVCL_2063
SY   HCC-827; HCC 827; HCC0827; HCC827-P; Hamon Cancer Center 827
DR   BTO; BTO_0004082
DR   CLO; CLO_0003659
DR   CLO; CLO_0037015
DR   EFO; EFO_0003137
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2868
DR   BCRJ; 0351
DR   BioGRID_ORCS_Cell_line; 424
DR   BioSample; SAMN03472697
DR   BioSample; SAMN10988440
DR   cancercelllines; CVCL_2063
DR   CCRID; 1101HUM-PUMC000478
DR   CCRID; 3101HUMSCSP538
DR   CCRID; 3101HUMTCHu153
DR   Cell_Model_Passport; SIDM01067
DR   ChEMBL-Cells; CHEMBL4295384
DR   ChEMBL-Targets; CHEMBL4296422
DR   CLS; 305041
DR   Cosmic; 903634
DR   Cosmic; 1028936
DR   Cosmic; 1128251
DR   Cosmic; 1146941
DR   Cosmic; 1219071
DR   Cosmic; 1352407
DR   Cosmic; 1802300
DR   Cosmic; 1995436
DR   Cosmic; 2125263
DR   Cosmic-CLP; 1240146
DR   DepMap; ACH-000012
DR   DSMZ; ACC-566
DR   DSMZCellDive; ACC-566
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240146
DR   GEO; GSM63350
DR   GEO; GSM108883
DR   GEO; GSM108884
DR   GEO; GSM183436
DR   GEO; GSM183437
DR   GEO; GSM253425
DR   GEO; GSM434274
DR   GEO; GSM466319
DR   GEO; GSM513969
DR   GEO; GSM514323
DR   GEO; GSM784276
DR   GEO; GSM794382
DR   GEO; GSM817117
DR   GEO; GSM827206
DR   GEO; GSM844553
DR   GEO; GSM887060
DR   GEO; GSM888130
DR   GEO; GSM935083
DR   GEO; GSM938752
DR   GEO; GSM938753
DR   GEO; GSM938754
DR   GEO; GSM938755
DR   GEO; GSM938756
DR   GEO; GSM938757
DR   GEO; GSM1557132
DR   GEO; GSM1669864
DR   IARC_TP53; 28333
DR   IGRhCellID; HCC827GEO
DR   KCLB; 70827
DR   LiGeA; CCLE_221
DR   LINCS_LDP; LCL-1608
DR   PharmacoDB; HCC827_512_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2063
DR   PubChem_Cell_line; CVCL_2063
DR   Ubigene; YC-C043
DR   Wikidata; Q54881781
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22751098;
RX   PubMed=22961666;
RX   PubMed=23733853;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32163227;
RX   PubMed=35117401;
RX   PubMed=35839778;
RX   PubMed=39061985;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 71 hours (PubMed=25984343); 44.5 hours (PubMed=29681454); 28 hours (ATCC=CRL-2868); ~50-60 hours (DSMZ=ACC-566).
CC   HLA typing: A*11:01,11:01; B*51:01,52:01; C*12:02,12:02; DRB1*09:07,15:02 (PubMed=25960936).
CC   HLA typing: A*11:01,11:01; B*35:01,52:01; C*12:02,12:02; DQA1*03:02,05:01; DQB1*06:01,06:01; DRB1*01:01,15:01 (PubMed=26589293).
CC   Karyotypic information: Flat-moded hypotriploid karyotype with 6% polyploidy (DSMZ=ACC-566).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (DepMap=ACH-000012).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (Cosmic-CLP=1240146; DepMap=ACH-000012).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.62%; Native American=0.39%; East Asian, North=3.47%; East Asian, South=0%; South Asian=7.09%; European, North=19.48%; European, South=67.96% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-2868; CCRID; Cosmic-CLP=1240146; DSMZ=ACC-566; KCLB=70827; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 22,24
ST   Penta D: 14
ST   Penta E: 20
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S840 ! HCC827 BL
OI   CVCL_E9BP ! HCC842 BL
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   HCC827 BIR
AC   CVCL_E4DK
SY   HCC827BIR
RX   PubMed=39061985;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_232716; (20R)-10,15,20-trimethyl-2-[(4-methylpiperazin-1-yl)methyl]-18,19,20,21-tetrahydro-15H,17H-12,8-(metheno)pyrazolo[3',4':2,3][1,5,10,12]oxatriazacycloheptadecino[12,11-a]benzimidazol-7(6H)-one (BI-4020).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   HCC827 BL
AC   CVCL_S840
SY   HCC-827BL; HCC827-BL; HCC827BL; Hamon Cancer Center 827 BL
DR   DSMZCellDive; HCC-827BL
DR   Wikidata; Q54881782
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2063 ! HCC827
OI   CVCL_E9BP ! HCC842 BL
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   HCC827 ER1
AC   CVCL_EJ07
SY   HCC827-ER1; HCC 827 ER1; ER1
DR   cancercelllines; CVCL_EJ07
DR   Cosmic; 1716792
DR   GEO; GSM935084
DR   Wikidata; Q54881783
RX   PubMed=22751098;
RX   PubMed=32928921;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   HCC827 ER2
AC   CVCL_EJ08
SY   HCC 827 ER2; ER2
DR   cancercelllines; CVCL_EJ08
DR   Cosmic; 1716793
DR   GEO; GSM935085
DR   Wikidata; Q54881784
RX   PubMed=22751098;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   HCC827 ER3
AC   CVCL_EJ09
SY   ER3
DR   cancercelllines; CVCL_EJ09
DR   Cosmic; 1716794
DR   GEO; GSM938758
DR   GEO; GSM938759
DR   GEO; GSM938760
DR   GEO; GSM938761
DR   GEO; GSM938762
DR   GEO; GSM938763
DR   Wikidata; Q54881785
RX   PubMed=22751098;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   HCC827 ER4
AC   CVCL_EJ10
SY   ER4
DR   cancercelllines; CVCL_EJ10
DR   Cosmic; 1716795
DR   Wikidata; Q54881786
RX   PubMed=22751098;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827 ER5
AC   CVCL_EJ11
SY   ER5
DR   cancercelllines; CVCL_EJ11
DR   Cosmic; 1716796
DR   Wikidata; Q54881787
RX   PubMed=22751098;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827 GR1
AC   CVCL_V620
DR   cancercelllines; CVCL_V620
DR   GEO; GSM466320
DR   Progenetix; CVCL_V620
DR   Wikidata; Q54881788
RX   PubMed=17463250;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   HCC827 GR2
AC   CVCL_V621
DR   cancercelllines; CVCL_V621
DR   GEO; GSM466321
DR   Progenetix; CVCL_V621
DR   Wikidata; Q54881789
RX   PubMed=17463250;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   HCC827 GR5
AC   CVCL_V622
SY   HCC827-GR5; HCC-827-GR5; HCC827GR5
DR   BioSample; SAMN10988418
DR   cancercelllines; CVCL_V622
DR   Cell_Model_Passport; SIDM01636
DR   DepMap; ACH-000029
DR   GEO; GSM466322
DR   PharmacoDB; HCC827GR5_462_2019
DR   Progenetix; CVCL_V622
DR   Wikidata; Q54881790
RX   PubMed=17463250;
RX   PubMed=20716641;
RX   PubMed=25984343;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=25984343).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 21
//
ID   HCC827 GR6
AC   CVCL_V623
DR   cancercelllines; CVCL_V623
DR   GEO; GSM466323
DR   Millipore; SCC426
DR   Progenetix; CVCL_V623
DR   Wikidata; Q54881791
RX   PubMed=17463250;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Millipore=SCC426
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 24
ST   Penta D: 14
ST   Penta E: 19,20
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   HCC827 GR7
AC   CVCL_V624
DR   cancercelllines; CVCL_V624
DR   GEO; GSM466324
DR   Progenetix; CVCL_V624
DR   Wikidata; Q54881792
RX   PubMed=17463250;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   HCC827 GR8
AC   CVCL_V625
DR   cancercelllines; CVCL_V625
DR   GEO; GSM466325
DR   Progenetix; CVCL_V625
DR   Wikidata; Q54881794
RX   PubMed=17463250;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   HCC827 PFR1
AC   CVCL_DH92
SY   HCC827 PFR-1
DR   cancercelllines; CVCL_DH92
DR   GEO; GSM466326
DR   Progenetix; CVCL_DH92
DR   Wikidata; Q54881795
RX   PubMed=20129249;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827 PFR3
AC   CVCL_DH93
SY   HCC827 PFR-3
DR   cancercelllines; CVCL_DH93
DR   GEO; GSM466327
DR   Progenetix; CVCL_DH93
DR   Wikidata; Q54881796
RX   PubMed=20129249;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827 PFR4
AC   CVCL_DH94
SY   HCC827 PFR-4
DR   cancercelllines; CVCL_DH94
DR   GEO; GSM466328
DR   Progenetix; CVCL_DH94
DR   Wikidata; Q54881797
RX   PubMed=20129249;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827 PFR5
AC   CVCL_DH95
SY   HCC827 PFR-5
DR   cancercelllines; CVCL_DH95
DR   GEO; GSM466329
DR   Progenetix; CVCL_DH95
DR   Wikidata; Q54881798
RX   PubMed=20129249;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827 PFR6
AC   CVCL_DH96
SY   HCC827 PFR-6
DR   cancercelllines; CVCL_DH96
DR   GEO; GSM466330
DR   Progenetix; CVCL_DH96
DR   Wikidata; Q54881799
RX   PubMed=20129249;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827-EGFP
AC   CVCL_C8VX
DR   Ubigene; YC-C043-EGFP-P
DR   Wikidata; Q123031555
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HCC827-GAS-Luc2
AC   CVCL_C9CW
DR   ATCC; CRL-2868-GAS-LUC2
DR   Wikidata; Q123031558
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the gamma-activated site (GAS) promoter (ATCC=CRL-2868-GAS-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-2868-GAS-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HCC827-GR-high1
AC   CVCL_S703
DR   cancercelllines; CVCL_S703
DR   Cosmic; 1896426
DR   Wikidata; Q54881800
RX   PubMed=23542356;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   HCC827-GR-high2
AC   CVCL_S704
DR   cancercelllines; CVCL_S704
DR   Cosmic; 1896427
DR   Wikidata; Q54881801
RX   PubMed=23542356;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   HCC827-GR-step
AC   CVCL_S705
DR   cancercelllines; CVCL_S705
DR   Cosmic; 1896425
DR   Wikidata; Q54881802
RX   PubMed=23542356;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   HCC827-HGF1
AC   CVCL_B7N2
DR   cancercelllines; CVCL_B7N2
DR   Wikidata; Q112929641
RX   PubMed=20716641;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   HCC827-HGF2
AC   CVCL_B7N3
DR   cancercelllines; CVCL_B7N3
DR   Wikidata; Q112929642
RX   PubMed=20716641;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   HCC827-Luc [JCRB]
AC   CVCL_4W94
SY   HCC-827-Luc
DR   cancercelllines; CVCL_4W94
DR   JCRB; JCRB1516
DR   JCRB; NIHS0709
DR   Wikidata; Q54881803
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0709; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1516
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   HCC827-Luc [Ubigene]
AC   CVCL_C8VW
DR   Ubigene; YC-C043-Luc-P
DR   Wikidata; Q123031559
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HCC827-Luc-mCh-Puro
AC   CVCL_B3SC
DR   cancercelllines; CVCL_B3SC
DR   Wikidata; Q110432841
WW   Provider; Creative Biolabs; IOC-ZP160; https://www.creative-biolabs.com/immuno-oncology/cellonco-human-hcc827-luc-mch-puro-reporter-tumor-cell-line-160.htm
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   HCC827-PR
AC   CVCL_EQ68
SY   HCC827 PR
DR   cancercelllines; CVCL_EQ68
DR   GEO; GSM183438
DR   GEO; GSM183439
DR   Wikidata; Q54881804
RX   PubMed=17560336;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   HCC827-TK
AC   CVCL_E6ZQ
RX   PubMed=32163227;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (PubMed=32163227).
CC   Sequence variation: Mutation; HGNC; HGNC:3676; FGF2; Simple; p.Gly34Val (c.101G>T); Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=32163227).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCC827/Cas9-hyg
AC   CVCL_C8PW
DR   GeneCopoeia; SL578
DR   Wikidata; Q123031560
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL578).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HCC827/GR
AC   CVCL_E7R9
RX   PubMed=39080187;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCC827/R1
AC   CVCL_S748
SY   HCC827R1
DR   cancercelllines; CVCL_S748
DR   Cosmic; 1890455
DR   Cosmic; 2015228
DR   Cosmic; 2015230
DR   Wikidata; Q54881805
RX   PubMed=22773810;
RX   PubMed=23733853;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=22773810).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   HCC827/R2
AC   CVCL_S749
SY   HCC827R2
DR   cancercelllines; CVCL_S749
DR   Cosmic; 1890456
DR   Cosmic; 2015229
DR   Cosmic; 2015231
DR   Wikidata; Q54881806
RX   PubMed=22773810;
RX   PubMed=23733853;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   HCC827/WR
AC   CVCL_DG26
DR   cancercelllines; CVCL_DG26
DR   Wikidata; Q54881807
RX   PubMed=26980747;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   HCC827(gFGFR1)
AC   CVCL_E8FJ
DR   ABM; T6464
RX   PubMed=30562682;
CC   Population: Caucasian.
CC   Characteristics: FGFR1 gene expression was genetically up-regulated. First transduced with a CRISPR-based Synergistic Activation Mediator (SAM) system composed of two lentiviral vectors dCAS-VP64_Blast (EF1a-dCas9-VP64-Bsd-WPE) and MS2-P65-HSF1-Hygro (EF1a-MS2(N55K)-SV40(NLS)-RELA-HSF1-hygR-WPRE) and then a PiggyBac transposon containing three unique SAM compatible gRNAs spanning the promoter region of FGFR1 (gFGFR1) and a puroR-IRES-AsRed-CMV construct (PubMed=30562682).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; 8TL1P; AsRed2 (Note=Red fluorescent protein derived from Anemonia sulcata).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03612; Escherichia phage MS2 capsid protein (Note=With p.Asn56Lys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HCC827CLR
AC   CVCL_V406
DR   cancercelllines; CVCL_V406
DR   Cosmic; 1604992
DR   Wikidata; Q54881808
RX   PubMed=22133747;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90180; CL-387785 (EKI-785).
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Selected for resistance to: ChEBI; CHEBI_90197; PHA-665752.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V407 ! HCC827EPR
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   HCC827EPR
AC   CVCL_V407
DR   cancercelllines; CVCL_V407
DR   Wikidata; Q54881809
RX   PubMed=21062933;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Selected for resistance to: ChEBI; CHEBI_90197; PHA-665752.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   HCC827ER
AC   CVCL_V408
DR   cancercelllines; CVCL_V408
DR   Wikidata; Q54881810
RX   PubMed=21062933;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   HCC842 BL
AC   CVCL_E9BP
SY   HCC-842BL; HCC842-BL; HCC842BL; Hamon Cancer Center 842 BL
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2063 ! HCC827
OI   CVCL_S840 ! HCC827 BL
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC845
AC   CVCL_V693
SY   HCC0845; Hamon Cancer Center 845
DR   Wikidata; Q54881814
RX   PubMed=31803961;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC850
AC   CVCL_V694
SY   HCC0850; Hamon Cancer Center 850
DR   BioSample; SAMN03473026
DR   Wikidata; Q54881815
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 16,17
ST   D21S11: 28,33.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 24
ST   Penta D: 2.2,9
ST   Penta E: 8,13
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C27390; Ovarian small cell carcinoma
DI   ORDO; Orphanet_370396; Small cell carcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9BN ! HCC852 BL
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC852 BL
AC   CVCL_E9BN
SY   HCC-852BL; HCC852-BL; HCC852BL; Hamon Cancer Center 852 BL
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V694 ! HCC850
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC853
AC   CVCL_V695
SY   HCC0853; Hamon Cancer Center 853
DR   Wikidata; Q54881816
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C4752; T-cell prolymphocytic leukemia
DI   ORDO; Orphanet_86871; T-cell prolymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   HCC880
AC   CVCL_V691
SY   HCC0880; Hamon Cancer Center 880
DR   BioSample; SAMN03470873
DR   Wikidata; Q54881817
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Hispanic.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,13
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 10
ST   FGA: 20,23
ST   Penta D: 10,12
ST   Penta E: 7,10
ST   TH01: 7,8
ST   TPOX: 11,12
ST   vWA: 15
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC889
AC   CVCL_V692
SY   HCC0889; Hamon Cancer Center 889
DR   BioSample; SAMN03473070
DR   Cosmic; 2699650
DR   Wikidata; Q54881818
RX   PubMed=25877200;
CC   Population: African American.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 8
ST   D18S51: 13,18
ST   D21S11: 31.2,33.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 10,15
ST   Penta E: 7
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCC89
AC   CVCL_V731
SY   HCC0089; Hamon Cancer Center 89
DR   EFO; EFO_0006419
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473012
DR   EGA; EGAS00001000610
DR   PharmacoDB; HCC89_513_2019
DR   Wikidata; Q54881820
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   HLA typing: A*02:01,32:01; B*08:01,18:01; C*05:01,07:01 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 14
ST   D21S11: 28
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 12,16
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 18
//
ID   HCC90
AC   CVCL_V732
SY   HCC0090; Hamon Cancer Center 90
DR   Wikidata; Q54881821
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE99 ! HCC90 BL
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HCC90 BL
AC   CVCL_LE99
SY   HCC-90BL; HCC90-BL; HCC90BL; Hamon Cancer Center 90 BL
DR   Wikidata; Q54881822
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V732 ! HCC90
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HCC9204
AC   CVCL_A605
SY   HCC-9204
DR   Cosmic; 1060082
DR   Wikidata; Q54881823
RX   PubMed=10766346;
CC   Misspelling: SMMC-9204; Cosmic=1060082; Note=Prior to 2020.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   HCC930599
AC   CVCL_LJ43
DR   Wikidata; Q54881824
RX   PubMed=24534130;
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129298; Canine hepatocellular carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 5
//
ID   HCC94
AC   CVCL_6945
SY   HCC-94; HCC 94; HCC941122
DR   BTO; BTO_0006026
DR   CCRID; 1101HUM-PUMC000277
DR   CCRID; 3101HUMTCHu81
DR   Wikidata; Q54881825
RX   PubMed=9596902;
CC   Characteristics: Established from a xenograft (HCC-94V) obtained by subcutaneous injection in nude mice.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 14,19
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 22,24.2
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   HCC95
AC   CVCL_5137
SY   HCC-95; HCC0095; Hamon Cancer Center 95
DR   BTO; BTO_0006027
DR   EFO; EFO_0003138
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 423
DR   BioSample; SAMN03470831
DR   BioSample; SAMN10987960
DR   cancercelllines; CVCL_5137
DR   Cell_Model_Passport; SIDM01593
DR   ChEMBL-Cells; CHEMBL4295471
DR   ChEMBL-Targets; CHEMBL4296387
DR   Cosmic; 877260
DR   Cosmic; 903628
DR   Cosmic; 1146942
DR   Cosmic; 1219070
DR   Cosmic; 1239909
DR   Cosmic; 1608838
DR   Cosmic; 2060521
DR   Cosmic; 2125264
DR   Cosmic; 2696403
DR   DepMap; ACH-000454
DR   GEO; GSM62969
DR   GEO; GSM108885
DR   GEO; GSM108886
DR   GEO; GSM253404
DR   GEO; GSM434322
DR   GEO; GSM794376
DR   GEO; GSM817112
DR   GEO; GSM887061
DR   GEO; GSM888131
DR   GEO; GSM1374513
DR   IARC_TP53; 28445
DR   IGRhCellID; HCC95_GEO
DR   KCLB; 70095
DR   LiGeA; CCLE_512
DR   Millipore; SCC483
DR   PharmacoDB; HCC95_463_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_5137
DR   PubChem_Cell_line; CVCL_5137
DR   Wikidata; Q54881826
RX   PubMed=9559342;
RX   PubMed=10353731;
RX   PubMed=10987304;
RX   PubMed=16187286;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24002593;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29610121;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31803961;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 40.6 hours (PubMed=29681454).
CC   HLA typing: A*11:01,29:02; B*13:02,18:01; C*16:01,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg335Valfs*10 (c.1002delG) (p.Gly334fs); Zygosity=Homozygous (PubMed=20557307; DepMap=ACH-000454).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.18%; Native American=0.36%; East Asian, North=1.64%; East Asian, South=0%; South Asian=2.05%; European, North=62.63%; European, South=33.13% (PubMed=30894373).
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
CC   Caution: Indicated as originating from a 65 year old male patient in PubMed=10353731 and from a 70 year old in PubMed=9559342.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission; KCLB=70095; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12 (Direct_author_submission; PubMed=20679594; PubMed=25877200)
ST   CSF1PO: 12 (KCLB=70095)
ST   D10S1248: 13,14
ST   D12S391: 17,22
ST   D13S317: 11 (KCLB=70095; PubMed=20679594)
ST   D13S317: 11,12 (Direct_author_submission; PubMed=25877200)
ST   D16S539: 9
ST   D18S51: 16,20
ST   D19S433: 15,16
ST   D1S1656: 17.3
ST   D21S11: 29,30
ST   D22S1045: 16
ST   D2S1338: 23
ST   D2S441: 10,14
ST   D3S1358: 17
ST   D5S818: 10,11 (KCLB=70095)
ST   D5S818: 11 (Direct_author_submission; PubMed=20679594)
ST   D5S818: 11,12 (PubMed=25877200)
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 12,17
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S841 ! HCC95 BL
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   HCC95 BL
AC   CVCL_S841
SY   HCC-95BL; HCC95-BL; HCC95BL; Hamon Cancer Center 95 BL
DR   Wikidata; Q54881827
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5137 ! HCC95
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   HCC954
AC   CVCL_V697
SY   HCC0954; Hamon Cancer Center 954
DR   BioSample; SAMN03473017
DR   Wikidata; Q54881828
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: Caucasian.
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,15
ST   D12S391: 17,19
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 12,18 (Direct_author_submission)
ST   D18S51: 18 (PubMed=25877200)
ST   D19S433: 13,14
ST   D1S1656: 17.3
ST   D21S11: 30,31.2
ST   D22S1045: 16,17
ST   D2S1338: 17,23
ST   D2S441: 10,15
ST   D3S1358: 14
ST   D5S818: 9
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19,20
ST   Penta D: 11,12
ST   Penta E: 7
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HCC970
AC   CVCL_A354
SY   HCC-970; HCC0970; Hamon Cancer Center 970
DR   Cosmic; 877236
DR   Cosmic; 1518102
DR   GEO; GSM171906
DR   GEO; GSM171907
DR   GEO; GSM794383
DR   Wikidata; Q54881830
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=20679594;
RX   PubMed=31803961;
RX   PubMed=39154123;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S843 ! HCC970 BL
OI   CVCL_E9BQ ! HCC971 BL
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   HCC970 BL
AC   CVCL_S843
SY   HCC-970BL; HCC970-BL; HCC970BL; Hamon Cancer Center 970 BL
DR   Wikidata; Q54881831
RX   PubMed=9559342;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A354 ! HCC970
OI   CVCL_E9BQ ! HCC971 BL
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   HCC971 BL
AC   CVCL_E9BQ
SY   HCC-971BL; HCC971-BL; HCC971BL; Hamon Cancer Center 971 BL
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A354 ! HCC970
OI   CVCL_S843 ! HCC970 BL
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCC9724
AC   CVCL_A606
SY   HCC-9724
DR   Cosmic; 1060083
DR   Wikidata; Q54881833
CC   Misspelling: SMMC-9724; Cosmic=1060083; Note=Prior to 2020.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   HCC973
AC   CVCL_V696
SY   HCC0973; Hamon Cancer Center 973
DR   Wikidata; Q54881834
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Population: African American.
CC   Miscellaneous: Cell line information from personal communication of Girard, Luc & Gazdar, Adi F.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HCC985
AC   CVCL_V690
SY   HCC0985; Hamon Cancer Center 985
DR   BioSample; SAMN03470874
DR   Wikidata; Q54881835
RX   PubMed=25877200;
WW   Provider; UT Southwestern; -; https://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC   Miscellaneous: Direct author submission of STR profile from Girard, Luc & Gazdar, Adi F.
ST   Source(s): Direct_author_submission; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 14
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 33.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HCCC-9810
AC   CVCL_6908
SY   HCCC9810; Hccc9810
DR   CCRID; 1101HUM-PUMC000278
DR   GEO; GSM936756
DR   GEO; GSM1374514
DR   Wikidata; Q54881836
RX   CelloPub=CLPUB00275;
RX   PubMed=23505090;
RX   PubMed=23646150;
RX   PubMed=35640676;
CC   Population: Chinese.
CC   Doubling time: 20.4 hours (CCRID=1101HUM-PUMC000278).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000278
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30,32
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   HCCLM3
AC   CVCL_6832
AS   CVCL_7679
SY   HCCLM-3; HCC-LM3; LM3; MHCC-LM3; MHCCLM3
DR   BTO; BTO_0004469
DR   EFO; EFO_0022678
DR   cancercelllines; CVCL_6832
DR   CCRID; 4201HUM-CCTCC00289
DR   CCTCC; GDC0289
DR   ChEMBL-Cells; CHEMBL4513111
DR   GEO; GSM1374515
DR   PRIDE; PXD000529
DR   PRIDE; PXD005291
DR   PubChem_Cell_line; CVCL_6832
DR   Wikidata; Q54881837
RX   PubMed=12133480;
RX   PubMed=12618900;
RX   PubMed=15796966;
RX   PubMed=19335983;
RX   PubMed=32884988;
CC   Population: Chinese.
CC   Characteristics: Established from pulmonary metastatic lesions produced in nude mice by 3 rounds of subcutaneous inoculation of parent cell line (PubMed=12133480).
CC   Doubling time: 34.9 hours (PubMed=12133480; PubMed=12618900).
CC   Karyotypic information: Hypotriploid karyotype. Has lost chromosome Y (PubMed=12618900).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 24
//
ID   HCCLM3-GFP-LC3
AC   CVCL_WJ13
DR   cancercelllines; CVCL_WJ13
DR   CCRID; 4201PAT-CCTCC00405
DR   Wikidata; Q93984342
RX   Patent=CN102115730A;
RX   PubMed=24058558;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2010102.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6838; MAP1LC3A.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6832 ! HCCLM3
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   HCCLM6
AC   CVCL_7680
SY   HCCLM-6; LM6
DR   BTO; BTO_0004470
DR   cancercelllines; CVCL_7680
DR   Wikidata; Q54881838
RX   PubMed=15146329;
RX   PubMed=19335983;
RX   PubMed=32884988;
CC   Population: Chinese.
CC   Characteristics: Established from pulmonary metastatic lesions produced in nude mice by 6 rounds of subcutaneous inoculation of parent cell line.
CC   Doubling time: 32 hours (PubMed=15146329).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6832 ! HCCLM3
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HCCLM9
AC   CVCL_A5CU
SY   HCCLM-9; LM9
DR   BTO; BTO_0006452
DR   cancercelllines; CVCL_A5CU
DR   Wikidata; Q107115247
RX   PubMed=23904371;
RX   PubMed=32884988;
CC   Population: Chinese.
CC   Characteristics: Established from pulmonary metastatic lesions produced in nude mice by 9 rounds of subcutaneous inoculation of parent cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7680 ! HCCLM6
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   HCCM-5
AC   CVCL_M687
DR   IARC_TP53; 21419
DR   Wikidata; Q54881839
RX   DOI=10.1007/0-306-46861-1_8;
RX   DOI=10.1111/j.1447-0756.1980.tb00508.x;
RX   PubMed=2878840;
RX   PubMed=4039287;
RX   PubMed=6682628;
RX   PubMed=7819056;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=4039287).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 13
//
ID   HCCM-5MTXr
AC   CVCL_W857
DR   Wikidata; Q54881840
RX   PubMed=4039287;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=4039287).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M687 ! HCCM-5
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   HCD
AC   CVCL_WW26
SY   Human Collecting Duct
DR   Wikidata; Q93984358
RX   PubMed=7637260;
RX   PubMed=8995744;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVHB1).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   HCD-57
AC   CVCL_5289
SY   HCD 57; HCD57; HC-D57
DR   TOKU-E; 3596
DR   Wikidata; Q54881841
RX   CelloPub=CLPUB00343;
RX   DOI=10.1182/blood-2021-150007;
RX   PubMed=1705834;
RX   PubMed=2154592;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HCD57
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-544.html
CC   Characteristics: EPO dependent.
CC   Doubling time: ~24 hours (PubMed=1705834).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: NIH Swiss.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   HCD-57 SHP2-D61Y
AC   CVCL_B6YD
SY   HCD57-SHP2-D61Y
DR   Wikidata; Q111733335
RX   DOI=10.1182/blood-2021-150007;
CC   Characteristics: EPO independent (DOI=10.1182/blood-2021-150007).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9644; PTPN11 (Note=With p.Asp61Tyr).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: NIH Swiss.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5289 ! HCD-57
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HCD-57 SHP2-E76K
AC   CVCL_B6YE
SY   HCD57-SHP2-E76K
DR   Wikidata; Q111733336
RX   DOI=10.1182/blood-2021-150007;
CC   Characteristics: EPO independent (DOI=10.1182/blood-2021-150007).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9644; PTPN11 (Note=With p.Glu76Lys).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: NIH Swiss.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5289 ! HCD-57
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   hCD271mAb#13
AC   CVCL_YU11
DR   Wikidata; Q93984365
RX   PubMed=32069133;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08138; Human NGFR/CD271.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   hCD40L-M90
AC   CVCL_L522
SY   M90
DR   CLO; CLO_0003660
DR   ATCC; HB-12055
DR   Wikidata; Q54881842
RX   Patent=US7309489;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12055.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29965; Human CD40LG/CD154.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   hCD40L-M91
AC   CVCL_L523
SY   M91
DR   CLO; CLO_0003661
DR   ATCC; HB-12056
DR   Wikidata; Q54881843
RX   Patent=US7309489;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12056.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29965; Human CD40LG/CD154.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   HCDB-1
AC   CVCL_A343
SY   HBP Carcinoma induced by DMBA/BQ extract treatment-1
DR   Wikidata; Q54881844
RX   PubMed=10943946;
CC   Characteristics: Buccal pouch carcinoma cell line induced by DMBA and betel quid (BQ).
CC   Doubling time: 19 hours (PubMed=10943946).
CC   Sequence variation: Mutation; UniProtKB; Q00366; TP53; Simple; p.Ala141Val (c.422T>C); Zygosity=Unspecified (PubMed=10943946).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Cheek pouch; UBERON=UBERON_0008802.
DI   NCIt; C134565; Hamster buccal pouch carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   20W
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   HCE
AC   CVCL_M619
DR   BTO; BTO_0003321
DR   BioSample; SAMN03151702
DR   Wikidata; Q54881845
RX   PubMed=1246601;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00055.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   HCE-1(NM)
AC   CVCL_A8SM
DR   Wikidata; Q108820426
RX   PubMed=2302677;
CC   Characteristics: Established from a tumor transplanted in nude mice.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   HCE-2
AC   CVCL_3316
SY   50.B1
DR   CLO; CLO_0003662
DR   ATCC; CRL-3582
DR   ATCC; CRL-11135
DR   BioSample; SAMN03471330
DR   Wikidata; Q54881847
RX   Patent=US5672498;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-11135
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11135.
CC   Population: African American.
CC   Doubling time: ~30 hours (ATCC=CRL-3582).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-11135; true.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
ST   Source(s): ATCC=CRL-3582
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   HCE-3
AC   CVCL_A355
DR   Cosmic; 932974
DR   Wikidata; Q54881848
RX   PubMed=2302677;
RX   PubMed=2415247;
RX   PubMed=2420787;
CC   Doubling time: 33 hours (PubMed=2415247).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HCE-4
AC   CVCL_1271
SY   HCE4
DR   BTO; BTO_0005572
DR   CLO; CLO_0009932
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 869
DR   cancercelllines; CVCL_1271
DR   Cell_Model_Passport; SIDM00052
DR   ChEMBL-Cells; CHEMBL3308199
DR   ChEMBL-Targets; CHEMBL2366207
DR   Cosmic; 753559
DR   Cosmic; 923186
DR   Cosmic; 934539
DR   Cosmic; 1394519
DR   Cosmic-CLP; 753559
DR   DepMap; ACH-002243
DR   EGA; EGAS00001000978
DR   GDSC; 753559
DR   GEO; GSM482501
DR   GEO; GSM1669865
DR   IARC_TP53; 258
DR   LINCS_LDP; LCL-1563
DR   PharmacoDB; HCE4_514_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1271
DR   PubChem_Cell_line; CVCL_1271
DR   Wikidata; Q54881849
RX   PubMed=2263646;
RX   PubMed=2302677;
RX   PubMed=2415247;
RX   PubMed=2420787;
RX   PubMed=7972006;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Doubling time: 48 hours (PubMed=2415247).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Homozygous (PubMed=2263646; Cosmic-CLP=753559; DepMap=ACH-002243).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=93.38%; Native American=0%; East Asian, North=0.25%; East Asian, South=0%; South Asian=0%; European, North=1.6%; European, South=4.77% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753559
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 8,11
ST   TH01: 8
ST   TPOX: 7,8
ST   vWA: 16,20
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5138 ! HCE-7
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   HCE-5
AC   CVCL_A356
DR   Wikidata; Q54881850
RX   PubMed=2302677;
RX   PubMed=2415247;
RX   PubMed=2420787;
CC   Doubling time: 60 hours (PubMed=2415247).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HCE-6
AC   CVCL_A357
DR   BTO; BTO_0005573
DR   cancercelllines; CVCL_A357
DR   Cosmic; 1394514
DR   IARC_TP53; 259
DR   Wikidata; Q54881851
RX   PubMed=2263646;
RX   PubMed=2302677;
RX   PubMed=2415247;
RX   PubMed=2420787;
CC   Doubling time: 27 hours (PubMed=2415247).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Unspecified (PubMed=2263646).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   HCE-7
AC   CVCL_5138
SY   HCE7; HCE-7 (NM); HCE-7(NM)
DR   BTO; BTO_0002818
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_5138
DR   Cell_Model_Passport; SIDM00067
DR   Cosmic; 923187
DR   Cosmic; 932975
DR   Cosmic; 2668298
DR   GEO; GSM827169
DR   GEO; GSM1669866
DR   PharmacoDB; HCE7_515_2019
DR   Progenetix; CVCL_5138
DR   Wikidata; Q54881852
RX   PubMed=2302677;
RX   PubMed=2415247;
RX   PubMed=2420787;
RX   PubMed=20215515;
CC   Population: African American.
CC   Characteristics: Established from a tumor transplanted in nude mice.
CC   Doubling time: 53 hours (PubMed=2415247).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1271 ! HCE-4
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HCE-8
AC   CVCL_A358
DR   Wikidata; Q54881853
RX   PubMed=2302677;
RX   PubMed=2415247;
RX   PubMed=2420787;
CC   Doubling time: 66 hours (PubMed=2415247).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HCe-8693
AC   CVCL_6909
SY   Hce-8693; HCE-8693; Hce8693; HCE8693
DR   CCRID; 3101HUMTCHu70
DR   Ubigene; YC-B090
DR   Wikidata; Q54881854
RX   PubMed=2634537;
RX   PubMed=7954969;
CC   Population: Chinese.
CC   Doubling time: 30.4 hours (PubMed=2634537).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=3101HUMTCHu70; Ubigene=YC-B090
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 23,24
ST   D3S1358: 15,16
ST   D5S818: 11,15
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 21,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   HCE-9
AC   CVCL_S846
DR   Wikidata; Q54881855
RX   PubMed=2302677;
RX   PubMed=2415247;
RX   PubMed=2420787;
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HCE-S
AC   CVCL_E6BS
SY   Human Corneal Epithelial cells-Spontaneously formed
DR   ABM; T0737
RX   PubMed=19699783;
CC   Characteristics: Expresses a set of markers associated with corneal epithelial cell function (such as ABCG2, cytokeratin 3, PAX6 as well as integrins ITGA9 and ITGB1. Exhibits responsiveness to epidermal growth factor in proliferation, migration and scratch wound assays (PubMed=19699783).
CC   Karyotypic information: Displays a hypo-triploid modal chromosome number (71 +- 5) and a satellite chromosome (PubMed=19699783).
CC   Derived from site: In situ; Eye, cornea, limbus; UBERON=UBERON_0006761.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCE-T
AC   CVCL_1272
SY   HCET; Human Corneal Epithelial cells-Transformed; HCE; SV40-HCEC
DR   BTO; BTO_0006396
DR   CLO; CLO_0050405
DR   CLO; CLO_0050406
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0349
DR   BioSample; SAMN03472134
DR   Cell_Model_Passport; SIDM00075
DR   ChEMBL-Cells; CHEMBL3308200
DR   ChEMBL-Targets; CHEMBL2366139
DR   CLS; 305255
DR   Cosmic; 907049
DR   DepMap; ACH-002336
DR   EGA; EGAS00001000978
DR   FCS-free; 4-2-4-2-4-3
DR   FCS-free; 4-2-6-1-4-3
DR   GEO; GSE73060
DR   GEO; GSM1669867
DR   IARC_TP53; 27695
DR   LINCS_LDP; LCL-1047
DR   PharmacoDB; HCET_516_2019
DR   PubChem_Cell_line; CVCL_1272
DR   RCB; RCB1384
DR   RCB; RCB2280
DR   Wikidata; Q54881856
RX   DOI=10.22028/D291-35665;
RX   PubMed=7534282;
RX   PubMed=20164919;
RX   PubMed=26900324;
RX   PubMed=28315467;
RX   PubMed=29787296;
RX   PubMed=31927639;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 24.4 hours (PubMed=7534282).
CC   Transformant: Ad-SV40 hybrid virus.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: BCRJ; 0349; probable.
CC   Discontinued: RCB; RCB1384; probable.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
ST   Source(s): PubMed=26900324; PubMed=29787296; RCB=RCB2280
ST   Amelogenin: X
ST   CSF1PO: 9,12 (PubMed=26900324)
ST   CSF1PO: 12 (RCB=RCB2280; PubMed=29787296)
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 13 (PubMed=29787296)
ST   D18S51: 13,15 (PubMed=26900324)
ST   D19S433: 13,14
ST   D21S11: 27,30
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 9,13 (PubMed=26900324; PubMed=29787296)
ST   D5S818: 13 (RCB=RCB2280)
ST   D7S820: 10,13
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 12,15
ST   Penta E: 15,16
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   HCEC 1CT
AC   CVCL_AQ45
SY   HCEC-1CT; hCEC-1CT; 1CT-HCEC; Human Colonic Epithelial Cells 1 transduced with CDK4 and Telomerase; 1CT
DR   EFO; EFO_0009500
DR   ENCODE; ENCBS573VIG
DR   ENCODE; ENCBS654NDM
DR   Evercyte; CkHT-039-0229
DR   Wikidata; Q54881860
RX   PubMed=19962984;
RX   PubMed=21472139;
RX   PubMed=21527559;
RX   PubMed=25923178;
RX   PubMed=27047802;
CC   Doubling time: 18-24 hours (Evercyte=CkHT-039-0229).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): PubMed=27047802
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 28
ST   D5S818: 11,14
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   HCEC 1CT+7
AC   CVCL_AQ46
SY   HCEC 1CT7; 1CT7
DR   Wikidata; Q54881864
RX   PubMed=21472139;
RX   PubMed=25923178;
CC   Karyotypic information: Has acquired a chromosome 7 trisomy.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ45 ! HCEC 1CT
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   HCEC 1CTA
AC   CVCL_AV01
DR   Wikidata; Q54881861
RX   PubMed=27047802;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:583; APC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): PubMed=27047802
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 28
ST   D5S818: 11,14
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ45 ! HCEC 1CT
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 8
//
ID   HCEC 1CTP
AC   CVCL_AV02
SY   HCEC 1CT + KrasV12; 1CTP
DR   Wikidata; Q54881862
RX   PubMed=21527559;
RX   PubMed=27047802;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): PubMed=27047802
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 28
ST   D5S818: 11,14
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ45 ! HCEC 1CT
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   HCEC 1CTR
AC   CVCL_AV03
SY   HCEC 1CT + shTP53; 1CTR
DR   Wikidata; Q54881863
RX   PubMed=21527559;
RX   PubMed=27047802;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): PubMed=27047802
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D21S11: 28
ST   D5S818: 11,14
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ45 ! HCEC 1CT
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 8
//
ID   HCEC 2CT
AC   CVCL_AQ47
SY   Human Colonic Epithelial Cells 2 transduced with CDK4 and Telomerase; 2CT
DR   EFO; EFO_0009499
DR   Wikidata; Q54881865
RX   PubMed=19962984;
RX   PubMed=21527559;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 8
//
ID   HCEC-12
AC   CVCL_2064
SY   Human Corneal Endothelial Cells-12
DR   BioSample; SAMN03473460
DR   DSMZ; ACC-646
DR   DSMZCellDive; ACC-646
DR   FCS-free; 208-2-425-3-4-12
DR   Wikidata; Q54881866
RX   PubMed=10794243;
RX   PubMed=18196893;
RX   PubMed=20974632;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-646).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
ST   Source(s): DSMZ=ACC-646
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 18,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 26
ST   Penta D: 11,12
ST   Penta E: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   HCEC-B4G12
AC   CVCL_2065
SY   B4G12
DR   DSMZ; ACC-647
DR   DSMZCellDive; ACC-647
DR   Wikidata; Q54881867
RX   PubMed=18196893;
CC   Doubling time: 62.26 +- 14.5 hours (PubMed=18196893); ~40-50 hours (DSMZ=ACC-647).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
ST   Source(s): DSMZ=ACC-647
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 18,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 26
ST   Penta D: 11,12
ST   Penta E: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2064 ! HCEC-12
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   HCEC-H9C1
AC   CVCL_2066
SY   H9C1
DR   BioSample; SAMN03473462
DR   DSMZ; ACC-649
DR   DSMZCellDive; ACC-649
DR   Wikidata; Q54881868
RX   PubMed=18196893;
CC   Doubling time: 44.05 +- 5.05 hours (PubMed=18196893); ~50-60 hours (DSMZ=ACC-649).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
ST   Source(s): DSMZ=ACC-649
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 18,25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 26
ST   Penta D: 11,12
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2064 ! HCEC-12
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   HCEFi
AC   CVCL_B6MN
SY   Heart-derived CEF immortal
DR   Wikidata; Q111733337
RX   PubMed=11237869;
RX   PubMed=11420679;
RX   PubMed=11513975;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HCEM-1
AC   CVCL_B3PE
SY   Human CEMentoblast-like 1
DR   Wikidata; Q110432842
RX   PubMed=16857433;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Cementoblast; CL=CL_0000061.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3PF ! HCEM-2
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HCEM-2
AC   CVCL_B3PF
SY   Human CEMentoblast-like 2
DR   Wikidata; Q110432844
RX   PubMed=16857433;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Cementoblast; CL=CL_0000061.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3PE ! HCEM-1
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HCEnC-21
AC   CVCL_B7DU
DR   Wikidata; Q112929643
RX   PubMed=23284695;
CC   Doubling time: ~30 hours (Note=At earlier passages), 39 hours (Note=At later passages) (PubMed=23284695).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   HCEnT-21T
AC   CVCL_S876
DR   Wikidata; Q54881869
RX   PubMed=23284695;
CC   Doubling time: ~30 hours (PubMed=23284695).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7DU ! HCEnC-21
SX   Male
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   hCF
AC   CVCL_WD14
SY   human Corneal Fibroblast
DR   IBRC; C10974
DR   Wikidata; Q93984490
CC   Population: Iranian.
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HCF
AC   CVCL_B6XH
SY   Hybrid Catfish Fin
DR   Wikidata; Q111733338
RX   DOI=10.1111/jwas.12869;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=1491728; ! Ictalurus punctatus x Ictalurus furcatus (Hybrid catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HCF-MLp-N
AC   CVCL_WT68
SY   HCF-MLpN
DR   JCRB; JCRB1977
DR   Wikidata; Q93984496
RX   PubMed=2140233;
RX   PubMed=8759883;
CC   Population: Japanese.
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
ST   Source(s): JCRB=JCRB1977
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 02-05-24; Version: 7
//
ID   HCFMK-1
AC   CVCL_5762
SY   HCFMK1
DR   BTO; BTO_0004017
DR   Wikidata; Q54881870
RX   PubMed=8561821;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HCG-1-#31
AC   CVCL_RJ19
DR   SKIP; SKIP000803
DR   Wikidata; Q54881872
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly450Arg (c.1348G>C); ClinVar=VCV001326897; Zygosity=Heterozygous (PubMed=25187577).
CC   Donor information: Established from a patient said to be suffering from hypochondrogenesis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ20 ! HCG-1-#32
OI   CVCL_RJ21 ! HCG-1-#33
OI   CVCL_RJ22 ! HCG-1-iChon
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   HCG-1-#32
AC   CVCL_RJ20
DR   SKIP; SKIP000804
DR   Wikidata; Q54881873
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly450Arg (c.1348G>C); ClinVar=VCV001326897; Zygosity=Heterozygous (PubMed=25187577).
CC   Donor information: Established from a patient said to be suffering from hypochondrogenesis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ19 ! HCG-1-#31
OI   CVCL_RJ21 ! HCG-1-#33
OI   CVCL_RJ22 ! HCG-1-iChon
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   HCG-1-#33
AC   CVCL_RJ21
DR   SKIP; SKIP000805
DR   Wikidata; Q54881874
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly450Arg (c.1348G>C); ClinVar=VCV001326897; Zygosity=Heterozygous (PubMed=25187577).
CC   Donor information: Established from a patient said to be suffering from hypochondrogenesis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ19 ! HCG-1-#31
OI   CVCL_RJ20 ! HCG-1-#32
OI   CVCL_RJ22 ! HCG-1-iChon
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   HCG-1-iChon
AC   CVCL_RJ22
DR   SKIP; SKIP001226
DR   Wikidata; Q54881875
RX   PubMed=25187577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Gly450Arg (c.1348G>C); ClinVar=VCV001326897; Zygosity=Heterozygous (PubMed=25187577).
CC   Donor information: Established from a patient said to be suffering from hypochondrogenesis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ19 ! HCG-1-#31
OI   CVCL_RJ20 ! HCG-1-#32
OI   CVCL_RJ21 ! HCG-1-#33
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   HCH-1
AC   CVCL_DF05
DR   Wikidata; Q54881876
RX   PubMed=27259990;
CC   Population: Japanese.
CC   Doubling time: 66.4 hours (Note=At 6th passage), 48.7 hours (Note=At 25th passage) (PubMed=27259990).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   HCH-3
AC   CVCL_KV96
DR   cancercelllines; CVCL_KV96
DR   Wikidata; Q54881877
RX   DOI=10.4172/2157-2518.1000292;
CC   Population: Japanese.
CC   Doubling time: 82 hours (DOI=10.4172/2157-2518.1000292).
CC   Karyotypic information: Near tetraploid karyotype.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DOI=10.4172/2157-2518.1000292).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (DOI=10.4172/2157-2518.1000292).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   HChEpC1b
AC   CVCL_E8U9
RX   PubMed=19148547;
CC   Doubling time: 23.9 hours (Note=At 75th passage) (PubMed=19148547).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Trophoblast, extravillous; UBERON=UBERON_0000426.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HChol-Y1
AC   CVCL_M256
DR   Wikidata; Q54881878
RX   CelloPub=CLPUB00275;
RX   PubMed=2989602;
RX   PubMed=35640676;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=2989602).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   HCI-EC-23
AC   CVCL_E3GB
SY   Huntsman Cancer Institute-Endometrial cancer-23
DR   ABM; T8158
DR   GEO; GSM6421755
DR   GEO; GSM6421756
DR   GEO; GSM6421757
DR   GEO; GSM6421761
DR   GEO; GSM6421762
DR   GEO; GSM6421763
DR   GEO; GSM6421764
DR   GEO; GSM6421765
DR   GEO; GSM6421766
DR   GEO; GSM6421767
DR   GEO; GSM6421768
DR   GEO; GSM6727284
DR   GEO; GSM6727285
DR   Millipore; SCC641
RX   PubMed=36396974;
CC   Characteristics: Retains ER expression and hormonal responsiveness (PubMed=36396974).
CC   Characteristics: Established from a mouse xenograft (EC-PDX-23) (PubMed=36396974).
CC   Doubling time: ~30 hours (PubMed=36396974).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly801Valfs*32 (c.2402delG); Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gln2070Ter (c.6208C>T); Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:15840; KMT2B; Simple; p.Gly1733Trpfs*6 (c.5196dupT); Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Ser4327Glnfs*7 (c.12978dupG); Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:14234; NSD1; Simple; p.Met1531Cysfs*43 (c.4591delA); Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu39Lys (c.115G>A); ClinVar=VCV003258061; Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg93Gln (c.278G>A); ClinVar=VCV000419128; Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gly (c.388C>G); ClinVar=VCV000375958; Zygosity=Unspecified (PubMed=36396974).
CC   Sequence variation: Mutation; HGNC; HGNC:777; ZFHX3; Simple; p.Arg2693Ter (c.8077C>T); ClinVar=VCV004292719; Zygosity=Unspecified (PubMed=36396974).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ABM=T8158; Millipore=SCC641
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 28,29
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,13,14
ST   FGA: 20,24,25
ST   Penta D: 11,12
ST   Penta E: 12,15
ST   TH01: 9.3,10
ST   TPOX: 8,9
ST   vWA: 17,19,20
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 4
//
ID   HCINC/HL-017
AC   CVCL_C0ML
SY   VIN; Human Cervical Intraepithelial Neoplasia Cell/HL-017
DR   Wikidata; Q112929644
RX   Patent=CN109666643B;
RX   PubMed=36146860;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015124.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
ST   Source(s): Patent=CN109666643B; PubMed=36146860
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,16
ST   D12S391: 18,22
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 9,15
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D2S441: 10,12
ST   D3S1358: 15,17
ST   D5S818: 7,11
ST   D6S1043: 12,13
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 11,12
ST   Penta E: 10,20
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4756; Vulvar intraepithelial neoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   HCjE
AC   CVCL_9700
SY   HCjE-Gi; ConjEp-1/p53DD/cdk4R/TERT
DR   EFO; EFO_0003139
DR   Wikidata; Q54881879
RX   PubMed=12077343;
RX   PubMed=12766048;
RX   PubMed=29787296;
RX   PubMed=32545782;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Characteristics: Can form 3D spheroids (PubMed=32545782).
CC   Karyotypic information: Has lost chromosome Y (PubMed=29787296).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=29787296
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 31,34.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,12
ST   FGA: 20,24
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ27 ! ConjEp-1
SX   Male
AG   82Y
CA   Telomerase immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   hCK
AC   CVCL_WL43
DR   Wikidata; Q93984530
RX   PubMed=31036910;
CC   Group: Vaccine production cell line.
CC   Characteristics: Expresses large amounts of alpha-2,6-sialoglycans and small amounts of alpha-2,3-sialoglycans.
CC   Virology: Will be useful for influenza virus research, particularly studies involving human A/H3N2 influenza viruses and possibly for vaccine production.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:46850; ST3GAL1.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:46851; ST3GAL2.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:108234; ST3GAL3.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:46852; ST3GAL4.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:46853; ST3GAL5.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:46854; ST3GAL6.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; F1Q495; ST3GAL2L.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10860; ST6GAL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   HCK
AC   CVCL_6F04
SY   Human Corneal Keratocytes
DR   FCS-free; 4-2-4-2-4-3
DR   FCS-free; 4-2-6-1-4-3
DR   Wikidata; Q54881880
RX   PubMed=15813699;
RX   PubMed=19326031;
CC   Doubling time: 34 hours (PubMed=15813699).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Keratocyte; CL=CL_0002363.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   HCK12-E6E7
AC   CVCL_C7IP
SY   Human Cervical Keratinocytes 12 E6E7-immortalized
DR   Wikidata; Q117704474
RX   PubMed=17146442;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   HCK1T
AC   CVCL_C7IN
SY   Human Cervical Keratinocytes 1 TERT-immortalized
DR   Wikidata; Q117704475
RX   PubMed=17146442;
RX   PubMed=28261610;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   HCK1T-E6
AC   CVCL_C7IQ
DR   Wikidata; Q117704476
RX   PubMed=17146442;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7IN ! HCK1T
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   HCK1T-E6E7
AC   CVCL_C7IR
DR   Wikidata; Q117704477
RX   PubMed=17146442;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7IN ! HCK1T
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   HCK1T-E7
AC   CVCL_C7IS
DR   Wikidata; Q117704478
RX   PubMed=17146442;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7IN ! HCK1T
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   HCL BMF-PI 51
AC   CVCL_9V72
DR   NCBI_Iran; C489
DR   Wikidata; Q54881881
RX   PubMed=17254797;
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 27,32
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V46 ! LCL CL-PI 50
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   HCLE
AC   CVCL_UZ28
SY   HuCl-22/cdk4R/p53DD/TERT
DR   Wikidata; Q93984540
RX   PubMed=12077343;
RX   PubMed=12766048;
RX   PubMed=29787296;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, cornea, limbus; UBERON=UBERON_0006761.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=29787296
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D21S11: 31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 19,24
ST   Penta D: 11,16
ST   Penta E: 7
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ26 ! HuCL-22
SX   Male
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   HCLL-7876
AC   CVCL_0B40
SY   HCLL 7876; HCLL7876
DR   Cosmic; 1809513
DR   Wikidata; Q54881882
RX   PubMed=3495441;
RX   PubMed=7686949;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   HCLO
AC   CVCL_M353
DR   ChEMBL-Cells; CHEMBL3308659
DR   ChEMBL-Targets; CHEMBL614814
DR   PubChem_Cell_line; CVCL_M353
DR   Wikidata; Q54881883
RX   PubMed=7779711;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   HCLv-07
AC   CVCL_EI72
SY   Hairy Cell Leukemia variant-07
DR   Cosmic; 1809514
DR   Wikidata; Q54881884
RX   PubMed=19332987;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7401; Hairy cell leukemia variant
DI   ORDO; Orphanet_300878; Hairy cell leukemia variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HCM HJ 1-i
AC   CVCL_T925
SY   HCM HJ; HCM 3
DR   SKIP; SKIP000213
DR   SKIP; SKIP000583
DR   Wikidata; Q54881885
RX   PubMed=25389285;
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Gly999_Gln1004del; Zygosity=Unspecified (PubMed=25389285).
CC   Discontinued: SKIP; SKIP000213; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T926 ! HCM HJ 1-n
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   HCM HJ 1-n
AC   CVCL_T926
DR   SKIP; SKIP000212
DR   Wikidata; Q54881886
RX   PubMed=25389285;
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Gly999_Gln1004del; Zygosity=Unspecified (PubMed=25389285).
CC   Discontinued: SKIP; SKIP000212; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T925 ! HCM HJ 1-i
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   HCM-MEC010
AC   CVCL_B7H4
SY   Hyogo College of Medicine-MucoEpidermoid Carcinoma 010
DR   Wikidata; Q112929645
RX   PubMed=35251626;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2; Note=In frame. CRTC1 exon 1 fused to MAML2 exon 2 (PubMed=35251626).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
ST   Source(s): PubMed=35251626
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 10,14
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   HCM-SqCC010
AC   CVCL_C1L1
DR   Wikidata; Q114311569
RX   PubMed=36299342;
CC   Population: Japanese.
CC   Doubling time: 27.3 hours (PubMed=36299342).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C8173; Upper gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HCM090909-3F2
AC   CVCL_T909
SY   HCM 090909-3F2; HCM 090909; HCM 1
DR   SKIP; SKIP000208
DR   SKIP; SKIP000581
DR   Wikidata; Q54881887
RX   PubMed=25389285;
CC   Discontinued: SKIP; SKIP000208; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T910 ! HCM090909-3G1
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HCM090909-3G1
AC   CVCL_T910
SY   HCM 090909-3G1
DR   SKIP; SKIP000209
DR   Wikidata; Q54881888
CC   Discontinued: SKIP; SKIP000209; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T909 ! HCM090909-3F2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HCM512519-b3
AC   CVCL_T911
SY   HCM 512519; HCM 2
DR   SKIP; SKIP000210
DR   SKIP; SKIP000582
DR   Wikidata; Q54881889
RX   PubMed=25389285;
CC   Discontinued: SKIP; SKIP000210; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T912 ! HCM512519-c1
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HCM512519-c1
AC   CVCL_T912
DR   SKIP; SKIP000211
DR   Wikidata; Q54881890
CC   Discontinued: SKIP; SKIP000211; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T911 ! HCM512519-b3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HCMC
AC   CVCL_0084
SY   Human Colonic Mucosal Cells
DR   ATCC; CCL-239
DR   Wikidata; Q54881891
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/hcmc-atcc-ccl-239
CC   Senescence: Has been discontinued from ATCC because the cells senesced.
CC   Discontinued: ATCC; CCL-239; true.
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   hCMEC/D3
AC   CVCL_U985
SY   HCMEC/D3; CMEC/D3; human Cortical Microvessels Endothelial Cells/D3
DR   BTO; BTO_0003339
DR   BCRJ; 0401
DR   CCRID; 5301HUM-KCB19022YJ
DR   ChEMBL-Cells; CHEMBL4513105
DR   CLS; 305024
DR   KCB; KCB 2019022YJ
DR   Millipore; SCC066
DR   PRIDE; PXD002292
DR   PubChem_Cell_line; CVCL_U985
DR   Ubigene; YC-C029
DR   Wikidata; Q54881892
RX   Patent=US8084254;
RX   PubMed=16141364;
RX   PubMed=23531482;
RX   PubMed=26718731;
RX   PubMed=30983357;
WW   Provider; Cedarlane; CLU512; https://www.cedarlanelabs.com/Products/Detail/CLU512?lob=AllProducts
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/bc9b2b68-4f6b-4071-bece-64241c21e438
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3308.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; Subcellular; Membrane; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Derived from site: In situ; Brain, temporal lobe, blood microvessel; UBERON=UBERON_0001871+UBERON_8410081.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=5301HUM-KCB19022YJ; Millipore=SCC066; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14,15
ST   D12S391: 19.3,22
ST   D13S317: 11,14
ST   D16S539: 9,12
ST   D18S51: 12,19
ST   D1S1656: 15.3,17.3
ST   D21S11: 30,32.2
ST   D22S1045: 11,15
ST   D2S1338: 16,20
ST   D2S441: 13
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 15,16
ST   FGA: 22,26
ST   Penta D: 10,12
ST   Penta E: 5,10
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 24
//
ID   HCMEC/D3-Luc
AC   CVCL_C8XS
DR   Ubigene; YC-C029-Luc-P
DR   Wikidata; Q123031563
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, temporal lobe, blood microvessel; UBERON=UBERON_0001871+UBERON_8410081.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U985 ! hCMEC/D3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HCmel1274
AC   CVCL_B0CF
SY   Melanoma model 3; M3
DR   ATCC; CRL-3475
DR   GEO; GSM4301284
DR   Wikidata; Q108820427
RX   PubMed=32284588;
CC   Doubling time: ~16-20 hours (ATCC=CRL-3475).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 Cdk4R24C/R24C, Hgftg.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   HCN-1
AC   CVCL_4T79
SY   Human Cortical Neuronal cells-1
DR   Wikidata; Q54881893
RX   Patent=US5196315;
RX   PubMed=1692158;
RX   PubMed=7700510;
CC   Doubling time: ~72 hours (PubMed=7700510).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 8
//
ID   HCN-1A
AC   CVCL_3283
SY   HCN1A; Human Cortical Neuronal cells-1A
DR   BTO; BTO_0003261
DR   CLO; CLO_0003663
DR   EFO; EFO_0022594
DR   ATCC; CRL-10442
DR   BioSample; SAMN03471301
DR   Wikidata; Q54881895
RX   Patent=US5196315;
RX   PubMed=1692158;
RX   PubMed=8779309;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/hcn/hcncells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-normal-brain-cell-lines
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10442.
CC   Doubling time: ~72 hours (PubMed=1692158).
CC   Miscellaneous: Cell line no longer available due to depletion of the original seed stock.
CC   Discontinued: ATCC; CRL-10442; true.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
ST   Source(s): ATCC=CRL-10442
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T79 ! HCN-1
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   HCN-2
AC   CVCL_3284
SY   HCN2; Human Cortical Neuronal cells-2
DR   BTO; BTO_0003262
DR   CLO; CLO_0003664
DR   ATCC; CRL-3592
DR   ATCC; CRL-10742
DR   BioSample; SAMN03471304
DR   Wikidata; Q54881896
RX   Patent=US5196315;
RX   PubMed=7700510;
RX   PubMed=14615026;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-normal-brain-cell-lines
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10742.
CC   Senescence: The original stock from the patent deposition senesced at ~21 PDL, the one currently distributed has only 4-5 PDL remaining (ATCC=CRL-3592).
CC   Doubling time: ~48 hours (PubMed=7700510).
CC   Omics: Proteomics; 2DE-MS.
CC   Discontinued: ATCC; CRL-10742; true.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
ST   Source(s): ATCC=CRL-3592
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 11,12
ST   D16S539: 8,11
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HCORDi001-A
AC   CVCL_D6IG
SY   M2_IPSC3_A
DR   BioSamples; SAMEA115295916
DR   hPSCreg; HCORDi001-A
DR   Wikidata; Q127381117
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HCORDi001-B
AC   CVCL_D6IH
SY   M2_IPSC3_B
DR   BioSamples; SAMEA115296937
DR   hPSCreg; HCORDi001-B
DR   Wikidata; Q127381118
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HCORDi001-C
AC   CVCL_D6II
SY   M2_IPSC3_C
DR   BioSamples; SAMEA114470364
DR   hPSCreg; HCORDi001-C
DR   Wikidata; Q127381119
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HCORDi001-D
AC   CVCL_D6IJ
SY   M2_IPSC3_K
DR   BioSamples; SAMEA115297085
DR   hPSCreg; HCORDi001-D
DR   Wikidata; Q127381120
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HCORDi001-E
AC   CVCL_D6IK
SY   M2_IPSC3_L
DR   BioSamples; SAMEA115297213
DR   hPSCreg; HCORDi001-E
DR   Wikidata; Q127381121
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   HCORDi001-F
AC   CVCL_D6IL
SY   M2_IPSC3_M
DR   BioSamples; SAMEA115297279
DR   hPSCreg; HCORDi001-F
DR   Wikidata; Q127381122
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   HCORDi001-G
AC   CVCL_D6IM
SY   M2_IPSC3_N
DR   BioSamples; SAMEA115299010
DR   hPSCreg; HCORDi001-G
DR   Wikidata; Q127381123
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   HCORDi001-H
AC   CVCL_D6IN
SY   M2_IPSC3_O
DR   BioSamples; SAMEA115299658
DR   hPSCreg; HCORDi001-H
DR   Wikidata; Q127381125
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IP ! HCORDi001-I
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   HCORDi001-I
AC   CVCL_D6IP
SY   M2_IPSC3_P
DR   BioSamples; SAMEA115299662
DR   hPSCreg; HCORDi001-I
DR   Wikidata; Q127381126
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IQ ! HCORDi001-J
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   HCORDi001-J
AC   CVCL_D6IQ
SY   M2_IPSC3_R
DR   BioSamples; SAMEA115299693
DR   hPSCreg; HCORDi001-J
DR   Wikidata; Q127381127
RX   PubMed=38402590;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Hemocord Clinica Medica, Ltda; Sao Leopoldo; Brazil.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): PubMed=38402590
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 12,21
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 15,18
ST   D19S433: 14,15.2
ST   D1S1656: 11,12
ST   D21S11: 30,32.2
ST   D22S1045: 15,16
ST   D2S1338: 16,22
ST   D2S441: 10
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   SE33: 16,21
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IG ! HCORDi001-A
OI   CVCL_D6IH ! HCORDi001-B
OI   CVCL_D6II ! HCORDi001-C
OI   CVCL_D6IJ ! HCORDi001-D
OI   CVCL_D6IK ! HCORDi001-E
OI   CVCL_D6IL ! HCORDi001-F
OI   CVCL_D6IM ! HCORDi001-G
OI   CVCL_D6IN ! HCORDi001-H
OI   CVCL_D6IP ! HCORDi001-I
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   hCPP
AC   CVCL_D3FC
SY   human-derived Choroid Plexus Papilloma
DR   Wikidata; Q127381128
RX   Patent=CN116875551A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.45152.
CC   Population: Chinese.
CC   Doubling time: 16.0 +- 1.3 hours (Patent=CN116875551A).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): Patent=CN116875551A
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 22,24
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 14,14.2
ST   D21S11: 30,30.3
ST   D2S1338: 18,23
ST   D2S441: 10
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D6S1043: 12,17
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 13,17
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3698; Choroid plexus papilloma
DI   ORDO; Orphanet_2807; Papilloma of choroid plexus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   HCPRi001-A
AC   CVCL_B5H8
DR   BioSamples; SAMEA7124983
DR   hPSCreg; HCPRi001-A
DR   Wikidata; Q110432845
CC   From: Hastings Center for Pulmonary Research, University of Southern California; Los Angeles; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 4
//
ID   HCRL-ATO10
AC   CVCL_Z692
SY   HCRL-ATO-10; AT10
DR   Wikidata; Q54881897
RX   DOI=10.1016/0022-2011(90)90038-8;
CC   Group: Insect cell line.
CC   Doubling time: 34 hours (DOI=10.1016/0022-2011(90)90038-8).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=680683; ! Amyelois transitella (Navel orangeworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HCRL-ATO20
AC   CVCL_Z693
SY   HCRL-ATO-20; AT20
DR   Wikidata; Q54881898
RX   DOI=10.1016/0022-2011(90)90038-8;
CC   Group: Insect cell line.
CC   Doubling time: 35 hours (DOI=10.1016/0022-2011(90)90038-8).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=680683; ! Amyelois transitella (Navel orangeworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HCS-2
AC   CVCL_2918
SY   HCS2
DR   BioSample; SAMN03470913
DR   cancercelllines; CVCL_2918
DR   Cell_Model_Passport; SIDM01815
DR   DepMap; ACH-001515
DR   JCRB; JCRB1203
DR   JCRB; NIHS0405
DR   Wikidata; Q54881899
RX   PubMed=2979208;
RX   PubMed=9023415;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~65 hours (Note=At 17th passage) (PubMed=2979208); ~39 hours (Note=Lot 09092016) (JCRB=JCRB1203).
CC   HLA typing: A*24:02; B*52:01; C*12:02 (PubMed=9023415).
CC   Discontinued: JCRB; NIHS0405; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DepMap=ACH-001515; JCRB=JCRB1203; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 13,14
ST   D19S433: 12,13
ST   D21S11: 31.2
ST   D2S1338: 24
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 11,13
ST   Penta E: 5,21
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   HCS-2/8
AC   CVCL_E261
SY   HCS2/8
DR   EFO; EFO_0022527
DR   PRIDE; PXD005551
DR   Wikidata; Q54881900
RX   DOI=10.11418/jtca1981.9.2_68;
RX   PubMed=2736538;
RX   PubMed=8200849;
RX   PubMed=15087127;
RX   PubMed=15501409;
CC   Population: Japanese.
CC   Doubling time: 3.5 days (PubMed=2736538).
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E262 ! HCS-2/A
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   HCS-2/A
AC   CVCL_E262
DR   Wikidata; Q54881901
RX   PubMed=2071232;
CC   Population: Japanese.
CC   Doubling time: 3.5 days (PubMed=2071232).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E261 ! HCS-2/8
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 11
//
ID   HCS-TG
AC   CVCL_B6GU
DR   Wikidata; Q111733339
RX   PubMed=15118855;
CC   Population: Japanese.
CC   Characteristics: Established from a tumor obtained by subcutaneous injection of cancer cell in athymic ICR nu/nu mice (PubMed=15118855).
CC   Derived from site: In situ; Bone, ilium; UBERON=UBERON_0001273.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HCS-TG C3
AC   CVCL_B6GV
SY   C3
DR   Wikidata; Q111733340
RX   PubMed=15118855;
CC   Population: Japanese.
CC   Doubling time: 68 hours (Note=In 20% FBS) (PubMed=15118855).
CC   Derived from site: In situ; Bone, ilium; UBERON=UBERON_0001273.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6GU ! HCS-TG
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HCS-TG E2
AC   CVCL_B6GW
SY   E2
DR   Wikidata; Q111733341
RX   PubMed=15118855;
CC   Population: Japanese.
CC   Doubling time: 48 hours (Note=In 20% FBS) (PubMed=15118855).
CC   Derived from site: In situ; Bone, ilium; UBERON=UBERON_0001273.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6GU ! HCS-TG
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HCS1220
AC   CVCL_UF06
DR   Wikidata; Q93984607
RX   PubMed=30214379;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=30214379
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 17
ST   D19S433: 15.2,16.2
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D6S1043: 12,19
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 25
ST   Penta D: 11
ST   Penta E: 16,17
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   HCSC-1
AC   CVCL_2919
SY   HCSC1
DR   BioSample; SAMN03470912
DR   cancercelllines; CVCL_2919
DR   Cell_Model_Passport; SIDM01816
DR   DepMap; ACH-001516
DR   FANTOM5_SSTAR; 10800-110I8
DR   JCRB; JCRB1205
DR   Wikidata; Q54881905
RX   CelloPub=CLPUB00373;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 24.3 hours (CelloPub=CLPUB00373).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001516; JCRB=JCRB1205; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D18S51: 14
ST   D19S433: 13,15.2,16.2
ST   D21S11: 28
ST   D2S1338: 22,24
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11
ST   FGA: 22,26
ST   Penta D: 12
ST   Penta E: 16,18
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   HCT 116
AC   CVCL_0291
SY   HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; HCT-116/P; HCT-116/parental; CoCL2
DR   BTO; BTO_0001109
DR   CLO; CLO_0003665
DR   EFO; EFO_0002824
DR   MCCL; MCC:0000181
DR   CLDB; cl1574
DR   CLDB; cl1575
DR   CLDB; cl5198
DR   4DN; 4DNSRMYUIVGD
DR   Abcam; ab255451
DR   Abcam; ab273730
DR   Abcam; ab288559
DR   ABM; T8240
DR   AddexBio; C0009005/41
DR   ArrayExpress; E-MEXP-2623
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-5197
DR   ATCC; CCL-247
DR   BCRC; 60349
DR   BCRJ; 0288
DR   BioGRID_ORCS_Cell_line; 97
DR   BioSample; SAMN03470980
DR   BioSample; SAMN03471481
DR   BioSample; SAMN03473487
DR   BioSample; SAMN05292433
DR   BioSample; SAMN10988251
DR   cancercelllines; CVCL_0291
DR   CCRID; 1101HUM-PUMC000158
DR   CCRID; 1101HUM-PUMC000331
DR   CCRID; 3101HUMTCHu99
DR   CCRID; 4201HUM-CCTCC00625
DR   Cell_Model_Passport; SIDM00783
DR   ChEMBL-Cells; CHEMBL3308372
DR   ChEMBL-Targets; CHEMBL394
DR   CLS; 300195
DR   ColonAtlas; HCT116
DR   Cosmic; 711257
DR   Cosmic; 720329
DR   Cosmic; 724840
DR   Cosmic; 869794
DR   Cosmic; 870449
DR   Cosmic; 873701
DR   Cosmic; 875296
DR   Cosmic; 875425
DR   Cosmic; 875847
DR   Cosmic; 876644
DR   Cosmic; 876706
DR   Cosmic; 887223
DR   Cosmic; 889535
DR   Cosmic; 897457
DR   Cosmic; 902790
DR   Cosmic; 905936
DR   Cosmic; 913887
DR   Cosmic; 934564
DR   Cosmic; 947355
DR   Cosmic; 948126
DR   Cosmic; 948861
DR   Cosmic; 985996
DR   Cosmic; 995410
DR   Cosmic; 1043815
DR   Cosmic; 1044257
DR   Cosmic; 1045410
DR   Cosmic; 1057752
DR   Cosmic; 1066205
DR   Cosmic; 1067220
DR   Cosmic; 1092600
DR   Cosmic; 1102383
DR   Cosmic; 1122325
DR   Cosmic; 1131683
DR   Cosmic; 1132568
DR   Cosmic; 1132689
DR   Cosmic; 1154644
DR   Cosmic; 1175840
DR   Cosmic; 1176588
DR   Cosmic; 1183769
DR   Cosmic; 1184080
DR   Cosmic; 1184333
DR   Cosmic; 1187306
DR   Cosmic; 1218874
DR   Cosmic; 1223141
DR   Cosmic; 1305353
DR   Cosmic; 1310945
DR   Cosmic; 1332008
DR   Cosmic; 1436021
DR   Cosmic; 1466804
DR   Cosmic; 1466815
DR   Cosmic; 1479594
DR   Cosmic; 1486132
DR   Cosmic; 1519359
DR   Cosmic; 1524003
DR   Cosmic; 1524333
DR   Cosmic; 1552179
DR   Cosmic; 1571772
DR   Cosmic; 1609495
DR   Cosmic; 1672408
DR   Cosmic; 1676727
DR   Cosmic; 1708402
DR   Cosmic; 1805253
DR   Cosmic; 1927246
DR   Cosmic; 1945865
DR   Cosmic; 1995437
DR   Cosmic; 1998442
DR   Cosmic; 2036656
DR   Cosmic; 2046556
DR   Cosmic; 2052593
DR   Cosmic; 2145576
DR   Cosmic; 2301978
DR   Cosmic; 2389569
DR   Cosmic; 2433755
DR   Cosmic; 2464667
DR   Cosmic; 2550353
DR   Cosmic; 2646766
DR   Cosmic; 2651864
DR   Cosmic; 2667881
DR   Cosmic; 2667972
DR   Cosmic; 2668248
DR   Cosmic; 2727479
DR   Cosmic; 2760068
DR   Cosmic; 2787545
DR   Cosmic; 2811054
DR   Cosmic-CLP; 905936
DR   DepMap; ACH-000971
DR   DSMZ; ACC-581
DR   DSMZCellDive; ACC-581
DR   ECACC; 91091005
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS004UZY
DR   ENCODE; ENCBS009DQE
DR   ENCODE; ENCBS257IHV
DR   ENCODE; ENCBS378ENC
DR   ENCODE; ENCBS389ENC
DR   ENCODE; ENCBS409ENC
DR   ENCODE; ENCBS409MTT
DR   ENCODE; ENCBS431ENC
DR   ENCODE; ENCBS471AAA
DR   ENCODE; ENCBS472AAA
DR   ENCODE; ENCBS475AAA
DR   ENCODE; ENCBS476AAA
DR   ENCODE; ENCBS494OPB
DR   ENCODE; ENCBS615KTO
DR   ENCODE; ENCBS626JHZ
DR   ENCODE; ENCBS650OZU
DR   ENCODE; ENCBS847SOB
DR   ENCODE; ENCBS851PYB
DR   GDSC; 905936
DR   GEO; GSM810
DR   GEO; GSM2143
DR   GEO; GSM50188
DR   GEO; GSM50252
DR   GEO; GSM115118
DR   GEO; GSM206501
DR   GEO; GSM274713
DR   GEO; GSM274714
DR   GEO; GSM274726
DR   GEO; GSM383862
DR   GEO; GSM383867
DR   GEO; GSM383868
DR   GEO; GSM384091
DR   GEO; GSM384092
DR   GEO; GSM481405
DR   GEO; GSM513818
DR   GEO; GSM514292
DR   GEO; GSM580039
DR   GEO; GSM580040
DR   GEO; GSM741266
DR   GEO; GSM743443
DR   GEO; GSM749774
DR   GEO; GSM750773
DR   GEO; GSM750793
DR   GEO; GSM784012
DR   GEO; GSM799331
DR   GEO; GSM799394
DR   GEO; GSM827446
DR   GEO; GSM846355
DR   GEO; GSM887062
DR   GEO; GSM888132
DR   GEO; GSM945287
DR   GEO; GSM945304
DR   GEO; GSM1022651
DR   GEO; GSM1022652
DR   GEO; GSM1153399
DR   GEO; GSM1178133
DR   GEO; GSM1178134
DR   GEO; GSM1178135
DR   GEO; GSM1181250
DR   GEO; GSM1181367
DR   GEO; GSM1346874
DR   GEO; GSM1374516
DR   GEO; GSM1374517
DR   GEO; GSM1374518
DR   GEO; GSM1404391
DR   GEO; GSM1404392
DR   GEO; GSM1448092
DR   GEO; GSM1669868
DR   GEO; GSM2124655
DR   GEO; GSM2550001
DR   GEO; GSM3145712
DR   GEO; GSM3591761
DR   IARC_TP53; 21064
DR   ICLC; HTL95025
DR   IZSLER; BS TCL 100
DR   KCB; KCB 200706YJ
DR   KCLB; 10247
DR   LiGeA; CCLE_168
DR   LINCS_LDP; LCL-1161
DR   Lonza; 691
DR   MeSH; D045325
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C570
DR   NCI-DTP; HCT-116
DR   PharmacoDB; HCT116_517_2019
DR   PRIDE; PXD000089
DR   PRIDE; PXD000394
DR   PRIDE; PXD001352
DR   PRIDE; PXD001426
DR   PRIDE; PXD001546
DR   PRIDE; PXD001550
DR   PRIDE; PXD002453
DR   PRIDE; PXD002793
DR   PRIDE; PXD003539
DR   PRIDE; PXD004452
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD025898
DR   PRIDE; PXD030304
DR   PRIDE; PXD032264
DR   PRIDE; PXD037651
DR   Progenetix; CVCL_0291
DR   PubChem_Cell_line; CVCL_0291
DR   RCB; RCB2979
DR   SKY/M-FISH/CGH; 1687
DR   SKY/M-FISH/CGH; 2778
DR   SKY/M-FISH/CGH; 2785
DR   SKY/M-FISH/CGH; 3883
DR   TOKU-E; 1422
DR   Ubigene; YC-C004
DR   Wikidata; Q28334584
RX   PubMed=2041050;
RX   PubMed=2835152;
RX   PubMed=3335022;
RX   PubMed=3955419;
RX   PubMed=6437669;
RX   PubMed=7214343;
RX   PubMed=7761852;
RX   PubMed=7824277;
RX   PubMed=7972006;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9023415;
RX   PubMed=9174048;
RX   PubMed=9178645;
RX   PubMed=9294210;
RX   PubMed=9331090;
RX   PubMed=9515795;
RX   PubMed=9563901;
RX   PubMed=9715273;
RX   PubMed=10612807;
RX   PubMed=10674020;
RX   PubMed=10700174;
RX   PubMed=10700188;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11314036;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11526487;
RX   PubMed=11687795;
RX   PubMed=12068308;
RX   PubMed=12584437;
RX   PubMed=12615714;
RX   PubMed=12671075;
RX   PubMed=12714694;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=17088437;
RX   PubMed=17178751;
RX   PubMed=17363507;
RX   PubMed=18258742;
RX   PubMed=18340113;
RX   PubMed=19372543;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23272949;
RX   PubMed=23546019;
RX   PubMed=23631600;
RX   PubMed=23649806;
RX   PubMed=23671654;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24042735;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25576301;
RX   PubMed=25841592;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26169745;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=26719794;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28179481;
RX   PubMed=28192450;
RX   PubMed=28196595;
RX   PubMed=28601559;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29207035;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32172478;
RX   PubMed=32927768;
RX   PubMed=34320349;
RX   PubMed=35839778;
RX   PubMed=36648961;
RX   PubMed=38861359;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/HCT-116_protocol.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/HCT116.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=17
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544583
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-88.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HCT116_cells
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/hct116-xenograft-model/
WW   Provider; BRICS; BRICS0098; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3904
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=9563901); 17.1 hours (PubMed=22628656); 22 hours (PubMed=23546019); 25.02 hours (PubMed=25944804); 36 hours (PubMed=25984343); 18.14 +- 0.051 hours (PubMed=32927768); ~25-48 hours (DSMZ=ACC-581); 17.4 hours (NCI-DTP=HCT-116); ~21 hours (PBCF).
CC   HLA typing: A*01,02; B*18,45:01; C*05,07; DPB1*03:01:01,04:02; DQB1*02,03 (PubMed=15748285).
CC   HLA typing: A*01:01,02:01; B*45:01; C*05:01,07:01 (PubMed=9178645).
CC   HLA typing: A*01:01,02:01; B*18:01,45:01; C*05:01,07:01; DQA1*05:02,05:02; DQB1*03:09,02:02; DRB1*03:05,11:02 (PubMed=25960936).
CC   HLA typing: A*01:01,02:01; B*18:01,45:01; C*05:01,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,02:01:01; B*18:01:01,21:01:01; C*05:01:01,07:01:01; DPB1*03:01:01G,04:02:01G; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:19:01; DRB1*03:01:01,11:02:01 (CLS=300195).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=9000147; PubMed=10674020; PubMed=12714694; PubMed=23671654; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714; Cosmic-CLP=905936; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905936; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (PubMed=17088437; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu33Argfs*20 (c.97delG); Zygosity=Heterozygous (DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp74fs*21 (c.220delG); Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (PubMed=9294210; PubMed=24755471; ATCC=CCL-247; Cosmic-CLP=905936; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (Cosmic-CLP=905936; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (PubMed=10700188; Cosmic-CLP=905936; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905936; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905936; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (PubMed=23649806; DepMap=ACH-000971).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9715273; PubMed=15900046; PubMed=16418264).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Extracellular vesicles.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Massively parallel signature sequencing (MPSS).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.08%; East Asian, North=1.16%; East Asian, South=0%; South Asian=0.97%; European, North=64.85%; European, South=32.93% (PubMed=30894373).
CC   Misspelling: HCT-166; Note=In a BTO entry (BTO_0004743) now obsoleted.
CC   Misspelling: HTC 116; Note=Occasionally.
CC   Misspelling: HTC-116; Note=Occasionally.
CC   Misspelling: Htc-116; Note=Occasionally.
CC   Misspelling: HTC116; Note=Occasionally.
CC   Misspelling: HTC1116; Note=Occasionally.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009005/41; ATCC=CCL-247; CCRID; CLS=300195; Cosmic-CLP=905936; DSMZ=ACC-581; ECACC=91091005; KCLB=10247; PubMed=11416159; PubMed=19372543; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X (CLS=300195; PubMed=11416159; PubMed=19372543; PubMed=25877200; PubMed=25926053)
ST   Amelogenin: X,Y (AddexBio=C0009005/41; ATCC=CCL-247; CCRID; Cosmic-CLP=905936; DSMZ=ACC-581; ECACC=91091005; KCLB=10247)
ST   CSF1PO: 7,9,10,11 (Cosmic-CLP=905936)
ST   CSF1PO: 7,10 (AddexBio=C0009005/41; ATCC=CCL-247; CCRID; CLS=300195; DSMZ=ACC-581; ECACC=91091005; KCLB=10247; PubMed=19372543; PubMed=25877200; PubMed=25926053)
ST   D13S317: 10,12
ST   D16S539: 11,12,13,14 (DSMZ=ACC-581)
ST   D16S539: 11,13 (AddexBio=C0009005/41; ATCC=CCL-247; CCRID; CLS=300195; Cosmic-CLP=905936; ECACC=91091005; PubMed=19372543; PubMed=25877200; PubMed=25926053)
ST   D18S51: 16,17 (ATCC=CCL-247; CCRID; CLS=300195; DSMZ=ACC-581; PubMed=19372543)
ST   D18S51: 17 (PubMed=25877200)
ST   D19S433: 12 (ATCC=CCL-247)
ST   D19S433: 12,13 (CCRID; DSMZ=ACC-581)
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,18,19 (ATCC=CCL-247; CCRID; CLS=300195; DSMZ=ACC-581)
ST   D3S1358: 12,19 (PubMed=19372543; PubMed=25877200)
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 10,12,14,15 (CLS=300195)
ST   D8S1179: 11,12,13,14 (DSMZ=ACC-581)
ST   D8S1179: 11,12,14 (ATCC=CCL-247)
ST   D8S1179: 12,14 (CCRID; PubMed=19372543; PubMed=25877200)
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 12,13,14 (CLS=300195)
ST   Penta E: 13,14 (ATCC=CCL-247; DSMZ=ACC-581; PubMed=25877200)
ST   TH01: 8,9 (AddexBio=C0009005/41; ATCC=CCL-247; CCRID; CLS=300195; Cosmic-CLP=905936; DSMZ=ACC-581; ECACC=91091005; KCLB=10247; PubMed=11416159; PubMed=19372543; PubMed=25877200)
ST   TH01: 8,9,10 (PubMed=25926053)
ST   TPOX: 8 (ECACC=91091005; KCLB=10247; PubMed=19372543; PubMed=25877200; PubMed=25926053)
ST   TPOX: 8,9 (AddexBio=C0009005/41; ATCC=CCL-247; CCRID; CLS=300195; Cosmic-CLP=905936; DSMZ=ACC-581)
ST   vWA: 17 (PubMed=11416159; PubMed=19372543)
ST   vWA: 17,21,22,23 (DSMZ=ACC-581)
ST   vWA: 17,22 (AddexBio=C0009005/41; ATCC=CCL-247; CCRID; CLS=300195; Cosmic-CLP=905936; ECACC=91091005; KCLB=10247; PubMed=25877200; PubMed=25926053)
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R729 ! HCT 116a
OI   CVCL_R730 ! HCT 116b
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   HCT 116 ABL1 (T315I/+)
AC   CVCL_LD40
SY   ABL1 (T315I/+) HCT116
DR   cancercelllines; CVCL_LD40
DR   Horizon_Discovery; HD+104-023
DR   Wikidata; Q54881906
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a ABL1 drug resistance mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple_edited; p.Thr315Ile (c.944C>T) (c.1001C>T); ClinVar=VCV000012624; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-023).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 ADAM17
AC   CVCL_HG03
SY   HCT116 ADAM17
DR   cancercelllines; CVCL_HG03
DR   CancerTools; 153209
DR   Wikidata; Q54881907
DR   Ximbio; 153209
RX   PubMed=20570921;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1096335; Adam17 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 16
//
ID   HCT 116 AKT1(-/-)
AC   CVCL_HD66
SY   AKT1 (-/-) HCT116
DR   cancercelllines; CVCL_HD66
DR   Horizon_Discovery; HD+R02-004
DR   Wikidata; Q54881908
RX   PubMed=20133737;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 AKT2(-/-)
AC   CVCL_HD67
SY   AKT2 (-/-) HCT116
DR   cancercelllines; CVCL_HD67
DR   Horizon_Discovery; HD+R02-005
DR   Wikidata; Q54881909
RX   PubMed=20133737;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 ALK (F1174L/+)
AC   CVCL_LD41
SY   ALK (F1174L/+) HCT116
DR   cancercelllines; CVCL_LD41
DR   Horizon_Discovery; HD+104-024
DR   Wikidata; Q54881910
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a ALK activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple_edited; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-024).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 APOC1(-/-)
AC   CVCL_HD68
SY   APOC1 (-/-) HCT116
DR   cancercelllines; CVCL_HD68
DR   Horizon_Discovery; HD+R02-007
DR   Wikidata; Q54881911
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:607; APOC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 AXL KO Tet-inducible
AC   CVCL_HG04
DR   cancercelllines; CVCL_HG04
DR   CancerTools; 153206
DR   Wikidata; Q54881912
DR   Ximbio; 153206
RX   PubMed=24170546;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:905; AXL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 BAX(-/-)
AC   CVCL_HD69
SY   BAX (-/-) HCT116
DR   cancercelllines; CVCL_HD69
DR   Horizon_Discovery; HD+R02-008
DR   Wikidata; Q54881913
RX   PubMed=11062132;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:959; BAX.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BBC3(-/-)
AC   CVCL_HD70
SY   BBC3 (-/-) HCT116; HCT116 PUMA-/-
DR   cancercelllines; CVCL_HD70
DR   Horizon_Discovery; HD+R02-040
DR   Wikidata; Q54881914
RX   PubMed=12574499;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17868; BBC3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BLM(-/-)
AC   CVCL_HD71
SY   BLM (-/-) HCT116; BLM-/- HCT116
DR   cancercelllines; CVCL_HD71
DR   Horizon_Discovery; HD+R02-011
DR   Wikidata; Q54881915
RX   PubMed=14695165;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1058; BLM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BRAF (V600A/+)
AC   CVCL_LD61
SY   BRAF (V600A/+) HCT116
DR   cancercelllines; CVCL_LD61
DR   Horizon_Discovery; HD+104-075
DR   Wikidata; Q54881917
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a BRAF mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Ala (c.1799T>C); ClinVar=VCV000376288; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-075).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BRAF (V600E/+)
AC   CVCL_LD62
SY   BRAF (V600E/+) HCT116
DR   cancercelllines; CVCL_LD62
DR   Horizon_Discovery; HD+104-048
DR   Wikidata; Q54881918
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a BRAF activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-048).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BRAF (V600G/+)
AC   CVCL_LD63
SY   BRAF (V600G/+) HCT116
DR   cancercelllines; CVCL_LD63
DR   Horizon_Discovery; HD+104-066
DR   Wikidata; Q54881919
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a BRAF mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Gly (c.1799T>G); ClinVar=VCV000040389; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-066).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BRAF (V600K/+)
AC   CVCL_LD64
SY   BRAF (V600K/+) HCT116
DR   cancercelllines; CVCL_LD64
DR   Horizon_Discovery; HD+104-022
DR   Wikidata; Q54881920
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a BRAF activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-022).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BRAF (V600M/+)
AC   CVCL_LD65
SY   BRAF (V600M/+) HCT116
DR   cancercelllines; CVCL_LD65
DR   Horizon_Discovery; HD+104-067
DR   Wikidata; Q54881921
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a BRAF mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Met (c.1798G>A); ClinVar=VCV000044815; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-067).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BRAF (V600R/+)
AC   CVCL_LD66
SY   BRAF (V600R/+) HCT116
DR   cancercelllines; CVCL_LD66
DR   Horizon_Discovery; HD+104-037
DR   Wikidata; Q54881922
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a BRAF activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-037).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 BRCA2(-/-) clone 42
AC   CVCL_AS10
SY   HCT 116 BRCA2 -/- [42]; HCT 116 BRCA2-/-
DR   cancercelllines; CVCL_AS10
DR   CancerTools; 152628
DR   ECACC; 16071901
DR   Wikidata; Q54881923
DR   Ximbio; 152628
RX   PubMed=25043256;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1101; BRCA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 16071901; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=16071901
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 12,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,21
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 18
//
ID   HCT 116 BRCA2(-/-) clone 46
AC   CVCL_VP26
SY   HCT 116 BRCA2 -/- [46]; HCT 116 BRCA2-/-
DR   cancercelllines; CVCL_VP26
DR   CancerTools; 153531
DR   ECACC; 18061301
DR   Wikidata; Q93984751
DR   Ximbio; 153531
RX   PubMed=25043256;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1101; BRCA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 18061301; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=18061301
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 12,19
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 12,13,14
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,21
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 CDK2 (D145N/+)
AC   CVCL_LD87
SY   CDK2 (D145N/+) HCT116
DR   cancercelllines; CVCL_LD87
DR   Horizon_Discovery; HD+104-029
DR   Wikidata; Q54881924
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a CDK2 dominant negative mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1771; CDK2; Simple_edited; p.Asp145Asn; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-029).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 CDK2(-/-)
AC   CVCL_HD72
SY   CDK2 (-/-) HCT116; CDK2-/- HCT116
DR   cancercelllines; CVCL_HD72
DR   Horizon_Discovery; HD+R02-015
DR   Wikidata; Q54881925
RX   PubMed=20195506;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1771; CDK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 CDKN1A(-/-)
AC   CVCL_HD73
SY   CDKN1A (-/-) HCT116; HCT116 p21-/-; 80S14
DR   BTO; BTO_0006532
DR   cancercelllines; CVCL_HD73
DR   Horizon_Discovery; HD+R02-035
DR   Wikidata; Q54881926
RX   PubMed=7585571;
RX   PubMed=8756351;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Caution: There are two clones of p21-/- cells that were created, 80S4 and 80S14. It is not clear which clone this cell line corresponds to, but as 80S14 was much more used than 80S4 we believe it is that clone.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 CMV-OsTIR1
AC   CVCL_RJ11
SY   HCT116 CMV-OsTIR1
DR   cancercelllines; CVCL_RJ11
DR   RCB; RCB4662
DR   Wikidata; Q54881927
RX   PubMed=27052166;
CC   Population: Caucasian.
CC   Characteristics: Parent cell line to study the rapid depletion of a protein. The expressed rice TIR1 can form a functional SCF(OsTIR1) E3 ligase complex with the endogenous components in human cells. In the presence of auxin, a protein of interest fused with mAID is rapidly degraded upon poly-ubiquitylation.
CC   Characteristics: Using CRISPR/Cas9 a CMV-OsTIR1-PuroR (pMK232) vector was introduced in both alleles of the AAVS1 safe harbor locus.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q7XVM8; Oryza sativa subsp. japonica TIR1-like protein Os04g0395600.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   HCT 116 CTNNB1(+/-)
AC   CVCL_HD74
SY   CTNNB1 (+/-) HCT116; CTNNB1 WT/- HCT116
DR   cancercelllines; CVCL_HD74
DR   Horizon_Discovery; HD+104-009
DR   Wikidata; Q54881928
RX   PubMed=12060769;
CC   Population: Caucasian.
CC   Characteristics: In HCT 116 one of the two CTNNB1 alleles has a 3-bp deletion that eliminates S-45. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2514; CTNNB1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   HCT 116 DIABLO(-/-)
AC   CVCL_HD75
SY   DIABLO (-/-) HCT116; SMAC-KO HCT116
DR   cancercelllines; CVCL_HD75
DR   Horizon_Discovery; HD+R02-045
DR   Wikidata; Q54881930
RX   PubMed=15557007;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:21528; DIABLO.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 DICER1(-/-)
AC   CVCL_HD76
SY   DICER1 (-/-) HCT116
DR   cancercelllines; CVCL_HD76
DR   Horizon_Discovery; HD+R02-019
DR   Wikidata; Q54881931
RX   PubMed=16505370;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17098; DICER1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 DNMT1(-/-)
AC   CVCL_E5EU
SY   HCT116 DNMT1 (Delta exons3-5/Delta exons3-5); MT1KO; HCT-116 DNMT1-/-
DR   Horizon_Discovery; HD+R02-020
RX   PubMed=10801130;
RX   PubMed=11932749;
RX   PubMed=12915469;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2976; DNMT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCT 116 DNMT1(-/-) DNMT3B(-/-)
AC   CVCL_E5EV
SY   HCT116 DNMT1 (Delta exons3-5/Delta exons3-5) DNMT3B (-/-); HCT-116 double DNMT1-/- DNMT3b-/- KO
DR   Horizon_Discovery; HD+R02-022
RX   PubMed=11932749;
RX   PubMed=12915469;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2976; DNMT1.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCT 116 DNMT1(-/-) DNMT3B(-/-) CDKN2A (R24fs*20/-)
AC   CVCL_E5EW
SY   HCT116 DNMT1 (Delta exons3-5/Delta exons3-5) DNMT3B (-/-) CDKN2A (R24fs*20/-)
DR   Horizon_Discovery; HD+R02-026
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1787; CDKN2A (Note=1 of 2 alleles).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2976; DNMT1.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCT 116 DNMT1(-/-) DNMT3B(-/-) CDKN2A (sil/-)
AC   CVCL_E5EY
SY   HCT116 DNMT1 (Delta exons3-5/Delta exons3-5) DNMT3B (-/-) CDKN2A (sil/-)
DR   Horizon_Discovery; HD+R02-025
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1787; CDKN2A.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2976; DNMT1.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCT 116 DNMT1(-/-) DNMT3B(-/-) retains methylation
AC   CVCL_E5EX
SY   HCT116 DNMT1 (Delta exons3-5/Delta exons3-5) DNMT3B (-/-) retains CH3
DR   Horizon_Discovery; HD+R02-079
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2976; DNMT1.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCT 116 DNMT3B(-/-)
AC   CVCL_HD77
SY   DNMT3B (-/-) HCT116; HCT116 DNMT3b-/-; 3bKO; HCT-116 DNMT3b-/-
DR   cancercelllines; CVCL_HD77
DR   Horizon_Discovery; HD+R02-023
DR   Wikidata; Q54881932
RX   PubMed=11932749;
RX   PubMed=12915469;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   HCT 116 EP300 WT
AC   CVCL_HG26
SY   HCT 116 p300 WT
DR   cancercelllines; CVCL_HG26
DR   CancerTools; 153183
DR   ECACC; 17011214
DR   Wikidata; Q54881933
DR   Ximbio; 153183
RX   PubMed=15123817;
CC   Population: Caucasian.
CC   Characteristics: HCT 116 is hemizygous for EP300. This cell line is a normal derivative of HCT 116 from which a number of clones KO for the EP300 single allele were established.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 17011214; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=17011214
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 12.1,18.1
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 10.1,14.1
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 17
//
ID   HCT 116 EP300(-) clone D10
AC   CVCL_HG27
SY   HCT 116 p300 KO Clone D10; HCT 116 p300 KO [D10]; p300 KO Clone D10
DR   cancercelllines; CVCL_HG27
DR   CancerTools; 151479
DR   ECACC; 17011201
DR   Wikidata; Q54881934
DR   Ximbio; 151479
RX   PubMed=15123817;
CC   Population: Caucasian.
CC   Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 17011201; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=17011201
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13.1
ST   D18S51: 11,14
ST   D21S11: 29,30
ST   D3S1358: 12,17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,21
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HG26 ! HCT 116 EP300 WT
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 18
//
ID   HCT 116 EP300(-) clone F2
AC   CVCL_HG28
SY   HCT 116 p300 KO Clone F2; HCT 116 p300 KO [F2]; p300 KO Clone F2
DR   cancercelllines; CVCL_HG28
DR   CancerTools; 153185
DR   ECACC; 17011215
DR   Wikidata; Q54881935
DR   Ximbio; 153185
RX   PubMed=15123817;
CC   Population: Caucasian.
CC   Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele (PubMed=15123817).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 17011215; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=17011215
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13.1
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 12,17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,21
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HG26 ! HCT 116 EP300 WT
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 18
//
ID   HCT 116 EP300(-) clone F5
AC   CVCL_HG29
SY   HCT 116 p300 KO Clone F5; HCT 116 p300 KO [F5]; p300 KO Clone F5
DR   cancercelllines; CVCL_HG29
DR   CancerTools; 153184
DR   ECACC; 17011216
DR   Wikidata; Q54881936
DR   Ximbio; 153184
RX   PubMed=15123817;
CC   Population: Caucasian.
CC   Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele (PubMed=15123817).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 17011216; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=17011216
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13.1
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 12,17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HG26 ! HCT 116 EP300 WT
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 18
//
ID   HCT 116 EP300(-) rescued
AC   CVCL_HG30
SY   HCT 116 p300 KO Rescue
DR   cancercelllines; CVCL_HG30
DR   CancerTools; 153186
DR   ECACC; 17011211
DR   Wikidata; Q54881937
DR   Ximbio; 153186
RX   PubMed=15123817;
CC   Population: Caucasian.
CC   Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele and is rescued by transfection of a wild-type copy of EP300 (PubMed=15123817).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3373; EP300.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ECACC; 17011211; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=17011211
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 12,17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 18,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HG29 ! HCT 116 EP300(-) clone F5
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 19
//
ID   HCT 116 EphA2 KO Tet-inducible
AC   CVCL_HG05
DR   cancercelllines; CVCL_HG05
DR   CancerTools; 153207
DR   Wikidata; Q54881938
DR   Ximbio; 153207
RX   PubMed=26283684;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:3386; EPHA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 FBXW7(-/-)
AC   CVCL_HD78
SY   FBXW7 (-/-) HCT116; HCT116 hCDC4 -/-
DR   cancercelllines; CVCL_HD78
DR   Horizon_Discovery; HD+R02-013
DR   Wikidata; Q54881939
RX   PubMed=14999283;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 FGFR2 (S252W/+/+)
AC   CVCL_LD88
SY   FGFR2 (S252W/+/+) HCT116
DR   cancercelllines; CVCL_LD88
DR   Horizon_Discovery; HD+104-030
DR   Wikidata; Q54881941
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a FGFR2 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3689; FGFR2; Simple_edited; p.Ser252Trp (c.755C>G); ClinVar=VCV000013272; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-030).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 FGFR3 (S249C/+)
AC   CVCL_LD89
SY   FGFR3 (S249C/+) HCT116
DR   cancercelllines; CVCL_LD89
DR   Horizon_Discovery; HD+104-044
DR   Wikidata; Q54881942
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a FGFR3 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple_edited; p.Ser249Cys (c.746C>G); ClinVar=VCV000016339; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-044).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 FLT3 (D835Y/+)
AC   CVCL_LD90
SY   FLT3 (D835Y/+) HCT116
DR   cancercelllines; CVCL_LD90
DR   Horizon_Discovery; HD+104-041
DR   Wikidata; Q54881943
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a FLT3 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple_edited; p.Asp835Tyr (c.2503G>T); ClinVar=VCV000016276; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-041).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 GNA11 (Q209L/+)
AC   CVCL_LD91
SY   GNA11 (Q209L/+) HCT116
DR   cancercelllines; CVCL_LD91
DR   Horizon_Discovery; HD+104-052
DR   Wikidata; Q54881944
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a GNA11 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple_edited; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-052).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 GNAQ (Q209L/+)
AC   CVCL_LD92
SY   GNAQ (Q209L/+) HCT116
DR   cancercelllines; CVCL_LD92
DR   Horizon_Discovery; HD+104-045
DR   Wikidata; Q54881945
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a GNAQ activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple_edited; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-045).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 GNAS (R201C/+)
AC   CVCL_LD67
SY   GNAS (R201C/+) HCT116
DR   cancercelllines; CVCL_LD67
DR   Horizon_Discovery; HD+104-083
DR   Wikidata; Q54881946
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a GNAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4392; GNAS; Simple_edited; p.Arg201Cys (c.601C>T); ClinVar=VCV000015933; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-083).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 IDH1 (R132C/+)
AC   CVCL_LD68
SY   IDH1 (R132C/+) HCT116
DR   cancercelllines; CVCL_LD68
DR   Horizon_Discovery; HD+104-021
DR   Wikidata; Q54881947
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a IDH1 altered metabolic activity mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple_edited; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-021).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 IDH1 (R132H/+)
AC   CVCL_LD69
SY   IDH1 (R132H/+) HCT116
DR   cancercelllines; CVCL_LD69
DR   Horizon_Discovery; HD+104-013
DR   Wikidata; Q54881952
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a IDH1 dominant negative mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple_edited; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-013).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 IDH2 (R140Q/+)
AC   CVCL_LD70
SY   IDH2 (R140Q/+) HCT116
DR   cancercelllines; CVCL_LD70
DR   Horizon_Discovery; HD+104-020
DR   Wikidata; Q54881953
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a IDH2 altered metabolic activity mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple_edited; p.Arg140Gln (c.419G>A); ClinVar=VCV000014716; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-020).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 IDH2 (R172K/+)
AC   CVCL_LD71
SY   IDH2 (R172K/+) HCT116
DR   cancercelllines; CVCL_LD71
DR   Horizon_Discovery; HD+104-019
DR   Wikidata; Q54881954
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a IDH2 altered metabolic activity mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple_edited; p.Arg172Lys (c.515G>A); ClinVar=VCV000375987; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-019).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 JAK2 (V617F/+)
AC   CVCL_LD93
SY   JAK2 (V617F/+) HCT116
DR   cancercelllines; CVCL_LD93
DR   Horizon_Discovery; HD+104-025
DR   Wikidata; Q54881955
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a JAK2 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple_edited; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-025).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 KDM5A(+/-)
AC   CVCL_HD79
SY   KDM5A (+/-) HCT116
DR   cancercelllines; CVCL_HD79
DR   Horizon_Discovery; HD+104-053
DR   Wikidata; Q54881956
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9886; KDM5A (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 KDM5A(-/-)
AC   CVCL_HD80
SY   KDM5A (-/-) HCT116
DR   cancercelllines; CVCL_HD80
DR   Horizon_Discovery; HD+104-105
DR   Wikidata; Q54881957
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9886; KDM5A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 KIT (D816V/+)
AC   CVCL_LD94
SY   KIT (D816V/+) HCT116
DR   cancercelllines; CVCL_LD94
DR   Horizon_Discovery; HD+104-026
DR   Wikidata; Q54881958
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KIT activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple_edited; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-026).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 KRAS(+/-)
AC   CVCL_HD81
SY   KRAS (+/-) HCT116
DR   cancercelllines; CVCL_HD81
DR   Horizon_Discovery; HD+104-008
DR   Wikidata; Q54881959
RX   PubMed=19661383;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 LIG4(+/-)
AC   CVCL_HD82
SY   LIG4 (+/-) HCT116; LIGIV+/- HCT116
DR   cancercelllines; CVCL_HD82
DR   Horizon_Discovery; HD+R02-062
DR   Wikidata; Q54881960
RX   PubMed=20195511;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6601; LIG4 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 LIG4(-/-)
AC   CVCL_HD83
SY   LIG4 (-/-) HCT116; LIGIV-/- HCT116
DR   cancercelllines; CVCL_HD83
DR   Horizon_Discovery; HD+R02-063
DR   Wikidata; Q54881961
RX   PubMed=20195511;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6601; LIG4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 MAP2K1 (P124L/+)
AC   CVCL_LD95
SY   MAP2K1 (P124L/+) HCT116
DR   cancercelllines; CVCL_LD95
DR   Horizon_Discovery; HD+104-034
DR   Wikidata; Q54881962
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a MAP2K1 activating mutation conferring drug resistance.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple_edited; p.Pro124Leu (c.371C>T); ClinVar=VCV000040744; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-034).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 MET (Y1253D/+)
AC   CVCL_LD96
SY   MET (Y1253D/+) HCT116
DR   cancercelllines; CVCL_LD96
DR   Horizon_Discovery; HD+104-056
DR   Wikidata; Q54881963
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a MET activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple_edited; p.Tyr1235Asp (c.3703T>G) (p.Tyr1253Asp, c.3757T>G); ClinVar=VCV000376200; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-056).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 MLH1(+/-)
AC   CVCL_HD84
SY   MLH1 (+/-) HCT116; BVEC-E2; Bipartite Vector Exon 9 Corrected clone E2
DR   cancercelllines; CVCL_HD84
DR   Horizon_Discovery; HD+104-006
DR   Wikidata; Q54881964
RX   PubMed=17082796;
CC   Population: Caucasian.
CC   Characteristics: HCT 116 has a point mutation C755A in exon 9 of MLH1. This cell line is knockin by homologous recombination of the wild-type MLH1 in 1 of the 2 alleles.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:7127; MLH1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 MTOR (S2035I/+)
AC   CVCL_LD97
SY   MTOR (S2035I/+) HCT116
DR   cancercelllines; CVCL_LD97
DR   Horizon_Discovery; HD+104-014
DR   Wikidata; Q54881965
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a MTOR rapamycin resistance mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3942; MTOR; Simple_edited; p.Ser2035Ile; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-014).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 NFE2L2 (E79K/+)
AC   CVCL_LD98
SY   NFE2L2 (E79K/+) HCT116
DR   cancercelllines; CVCL_LD98
DR   Horizon_Discovery; HD+104-095
DR   Wikidata; Q54881966
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NFE2L2 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7782; NFE2L2; Simple_edited; p.Glu79Lys (c.235G>A); ClinVar=VCV000376466; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-095).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 NHEJ1(+/-)
AC   CVCL_HD85
SY   NHEJ1 (+/-) HCT116; XLF+/- HCT116
DR   cancercelllines; CVCL_HD85
DR   Horizon_Discovery; HD+R02-067
DR   Wikidata; Q54881968
RX   PubMed=20195511;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:25737; NHEJ1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 NHEJ1(-/-)
AC   CVCL_HD86
SY   NHEJ1 (-/-) HCT116; XLF-/- HCT116
DR   cancercelllines; CVCL_HD86
DR   Horizon_Discovery; HD+R02-068
DR   Wikidata; Q54881970
RX   PubMed=20195511;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:25737; NHEJ1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 NOTCH1 (L1601P/+)
AC   CVCL_LD99
SY   NOTCH1 (L1601P/+) HCT116
DR   cancercelllines; CVCL_LD99
DR   Horizon_Discovery; HD+104-027
DR   Wikidata; Q54881971
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NOTCH1 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple_edited; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-027).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 NUF2mCherry/mCherry
AC   CVCL_UF05
SY   HCT116 NUF2mCherry/mCherry
DR   cancercelllines; CVCL_UF05
DR   Wikidata; Q93985108
RX   PubMed=30364636;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 NUF2 has been endogenously tagged in both alleles at the C-terminus with mCherry.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   HCT 116 PDGFRA (D842V/+)
AC   CVCL_LE00
SY   PDGFRA (D842V/+) HCT116
DR   cancercelllines; CVCL_LE00
DR   Horizon_Discovery; HD+104-064
DR   Wikidata; Q54881972
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a PDGFRA activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple_edited; p.Asp842Val (c.2525A>T); ClinVar=VCV000013543; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-064).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 PDPK1(+/-)
AC   CVCL_HD87
SY   PDPK1 (+/-) HCT116
DR   cancercelllines; CVCL_HD87
DR   Horizon_Discovery; HD+R02-080
DR   Wikidata; Q54881973
RX   PubMed=20133737;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:8816; PDPK1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 PIK3CA (H1047R/-)
AC   CVCL_LD54
SY   PIK3CA (H1047R/-) HCT116
DR   cancercelllines; CVCL_LD54
DR   Horizon_Discovery; HD+104-012
DR   Wikidata; Q54881974
RX   PubMed=15950905;
CC   Population: Caucasian.
CC   Characteristics: Knockout of PIK3CA wild-type allele in heterozygous parental cells (PubMed=15950905).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:8975; PIK3CA (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Hemizygous (PubMed=15950905).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   HCT 116 PIK3CA H1047R KO
AC   CVCL_RQ06
SY   PIK3CA^(+/-) HCT116
DR   cancercelllines; CVCL_RQ06
DR   Horizon_Discovery; HD+104-007
DR   Wikidata; Q54881975
RX   PubMed=15950905;
CC   Population: Caucasian.
CC   Characteristics: Knockout of PIK3CA mutant allele (H1047R) in heterozygous parental cells (PubMed=15950905).
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:8975; PIK3CA (Note=1 of 2 alleles, that with p.His1047Arg).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 PPARD(-/-)
AC   CVCL_HD88
SY   PPARD (-/-) HCT116; HCT116 PPARdelta -/-
DR   cancercelllines; CVCL_HD88
DR   Horizon_Discovery; HD+R02-038
DR   Wikidata; Q54881976
RX   PubMed=11226285;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9235; PPARD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 PRKDC(+/-)
AC   CVCL_HD89
SY   PRKDC (+/-) HCT116
DR   cancercelllines; CVCL_HD89
DR   Horizon_Discovery; HD+R02-048
DR   Wikidata; Q54881977
RX   PubMed=18710952;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9413; PRKDC (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 PRKDC(-/-)
AC   CVCL_HD90
SY   PRKDC (-/-) HCT116
DR   cancercelllines; CVCL_HD90
DR   Horizon_Discovery; HD+R02-049
DR   Wikidata; Q54881978
RX   PubMed=18710952;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9413; PRKDC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 PTEN(+/-)
AC   CVCL_HD91
SY   PTEN (+/-) HCT116
DR   cancercelllines; CVCL_HD91
DR   Horizon_Discovery; HD+104-057
DR   Wikidata; Q54881979
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9588; PTEN (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 PTEN(-/-)
AC   CVCL_HD92
SY   PTEN (-/-) HCT116
DR   cancercelllines; CVCL_HD92
DR   Horizon_Discovery; HD+104-004
DR   Wikidata; Q54881980
RX   PubMed=15466180;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 PTTG1(-/-)
AC   CVCL_HD93
SY   PTTG1 (-/-) HCT116; hSecurin-/- HCT116
DR   cancercelllines; CVCL_HD93
DR   Horizon_Discovery; HD+R02-043
DR   Wikidata; Q54881981
RX   PubMed=11371342;
RX   PubMed=16292982;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9690; PTTG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 SFN(-/-)
AC   CVCL_HD94
SY   SFN (-/-) HCT116; 14-3-3s-/- HCT116; 14-3-3sigma-/- HCT116
DR   cancercelllines; CVCL_HD94
DR   Horizon_Discovery; HD+R02-001
DR   Wikidata; Q54881982
RX   PubMed=10524633;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:10773; SFN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 shPARG
AC   CVCL_QZ52
SY   shPARG HCT116
DR   cancercelllines; CVCL_QZ52
DR   Wikidata; Q54881983
RX   PubMed=23955771;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   HCT 116 SMAD4(-/-)
AC   CVCL_HD95
SY   SMAD4 (-/-) HCT116; Smad-/- HCT116
DR   cancercelllines; CVCL_HD95
DR   Horizon_Discovery; HD+104-005
DR   Wikidata; Q54881984
RX   PubMed=9482899;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   HCT 116 SYT1 KO
AC   CVCL_B3P8
DR   cancercelllines; CVCL_B3P8
DR   Wikidata; Q110432846
RX   PubMed=39169954;
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11509; SYT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   HCT 116 TP53 (R248W/+)
AC   CVCL_RJ69
SY   TP53 (R248W/+) HCT116
DR   cancercelllines; CVCL_RJ69
DR   Horizon_Discovery; HD+104-002
DR   Wikidata; Q54881985
RX   PubMed=19225112;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a TP53 mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple_edited; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+104-002).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   HCT 116 TP53 (R248W/-)
AC   CVCL_RJ68
SY   TP53 (R248W/-) HCT116
DR   cancercelllines; CVCL_RJ68
DR   Horizon_Discovery; HD+104-003
DR   Wikidata; Q54881986
RX   PubMed=19225112;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a TP53 mutation.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:11998; TP53 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple_edited; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Hemizygous; Note=By method not specified (Horizon_Discovery=HD+104-003).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   HCT 116 TP53(+/-)
AC   CVCL_HD96
SY   TP53 (+/-) HCT116
DR   cancercelllines; CVCL_HD96
DR   Horizon_Discovery; HD+R02-037
DR   Wikidata; Q54881987
RX   PubMed=19225112;
CC   Population: Caucasian.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:11998; TP53 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 TP53(-/-)
AC   CVCL_HD97
SY   TP53 (-/-) HCT116; HCT116-p53-null; Hct116_p53_knockout
DR   cancercelllines; CVCL_HD97
DR   GEO; GSM383865
DR   GEO; GSM383866
DR   GEO; GSM384089
DR   GEO; GSM384090
DR   Horizon_Discovery; HD+104-001
DR   Wikidata; Q54881988
RX   PubMed=19225112;
RX   PubMed=29045385;
CC   Population: Caucasian.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 15
//
ID   HCT 116 USP7(+/-)
AC   CVCL_HD98
SY   USP7 (+/-) HCT116; HAUSP+/- HCT116
DR   cancercelllines; CVCL_HD98
DR   Horizon_Discovery; HD+R02-029
DR   Wikidata; Q54881990
RX   PubMed=15118411;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12630; USP7 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 USP7(-/-)
AC   CVCL_HD99
SY   USP7 (-/-) HCT116; HAUSP-/- HCT116; HCT-116 USP7-null
DR   cancercelllines; CVCL_HD99
DR   Horizon_Discovery; HD+R02-028
DR   Wikidata; Q54881991
RX   PubMed=15118411;
RX   PubMed=29045385;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12630; USP7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 XRCC4(-/-)
AC   CVCL_HE00
SY   XRCC4 (-/-) HCT116
DR   cancercelllines; CVCL_HE00
DR   Horizon_Discovery; HD+R02-076
DR   Wikidata; Q54881992
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12831; XRCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116 XRCC6(+/-)
AC   CVCL_HE01
SY   XRCC6 (+/-) HCT116; Ku70+/- HCT116
DR   cancercelllines; CVCL_HE01
DR   Horizon_Discovery; HD+R02-053
DR   Wikidata; Q54881993
RX   PubMed=18387344;
RX   PubMed=18562296;
RX   PubMed=20195511;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:4055; XRCC6 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116-EGFP
AC   CVCL_C8WS
DR   Ubigene; YC-C004-EGFP-P
DR   Wikidata; Q123031566
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HCT 116-I6
AC   CVCL_HG06
SY   HCT116-I6
DR   cancercelllines; CVCL_HG06
DR   CancerTools; 153208
DR   Wikidata; Q54881994
DR   Ximbio; 153208
RX   PubMed=24170546;
CC   Population: Caucasian.
CC   Characteristics: Demonstrates a 4x and 20x increase in migration and invasion rate respectively compared to HCT 116.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   HCT 116-Luc
AC   CVCL_C8WT
DR   Ubigene; YC-C004-Luc-P
DR   Wikidata; Q123031569
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HCT 116-Luc2 [ATCC]
AC   CVCL_VU38
DR   ATCC; CCL-247-LUC2
DR   cancercelllines; CVCL_VU38
DR   Wikidata; Q93985295
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-247-LUC2).
CC   Doubling time: ~14 hours (ATCC=CCL-247-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-247-LUC2
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   HCT 116-luc2 [Caliper]
AC   CVCL_5J19
DR   cancercelllines; CVCL_5J19
DR   Revvity/PerkinElmer; 124318
DR   Wikidata; Q54881999
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124318; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   HCT 116-OX
AC   CVCL_4V73
DR   cancercelllines; CVCL_4V73
DR   Wikidata; Q54882000
RX   PubMed=24761924;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HCT 116-Red-FLuc
AC   CVCL_5I94
SY   HCT116-Red-FLuc; HCT116 Red-FLuc; Bioware Brite HCT116 Red-FLuc; IVISbrite HCT-116 Red F-luc
DR   cancercelllines; CVCL_5I94
DR   Revvity/PerkinElmer; BW124318
DR   Wikidata; Q54882001
CC   Population: Caucasian.
CC   Doubling time: 16 hours (Revvity/PerkinElmer=BW124318).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   HCT 116(Cas9)
AC   CVCL_E7J4
WW   Provider; BRICS; ECC3014; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3948
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCT 116_184R
AC   CVCL_C3GH
SY   H184-R
DR   cancercelllines; CVCL_C3GH
DR   Wikidata; Q114311570
RX   PubMed=21447798;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_91353; 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide (CI-1040; PD184352).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HCT 116_6244R
AC   CVCL_C3GI
SY   H6244-R; H6244-R1; HCT116R_6244R
DR   cancercelllines; CVCL_C3GI
DR   GEO; GSM3591762
DR   Wikidata; Q114311571
RX   PubMed=21447798;
RX   PubMed=31048689;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   HCT 116a
AC   CVCL_R729
SY   HCT-116a
DR   Wikidata; Q54882002
RX   PubMed=3349466;
RX   PubMed=3955419;
RX   PubMed=6437669;
RX   PubMed=6578361;
RX   PubMed=7214343;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0291 ! HCT 116
OI   CVCL_R730 ! HCT 116b
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   HCT 116b
AC   CVCL_R730
DR   Wikidata; Q54882003
RX   PubMed=2835152;
RX   PubMed=3955419;
RX   PubMed=6437669;
RX   PubMed=7214343;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0291 ! HCT 116
OI   CVCL_R729 ! HCT 116a
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   HCT 116R11
AC   CVCL_4V28
SY   HCT116R11
DR   cancercelllines; CVCL_4V28
DR   Wikidata; Q54882004
RX   PubMed=6437674;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HCT 116R26
AC   CVCL_4V29
SY   HCT116R26
DR   cancercelllines; CVCL_4V29
DR   Wikidata; Q54882005
RX   PubMed=6437674;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HCT 15
AC   CVCL_0292
SY   HCT-15; HCT.15; HCT15
DR   BTO; BTO_0002201
DR   CLO; CLO_0003666
DR   EFO; EFO_0002188
DR   MCCL; MCC:0000182
DR   CLDB; cl1576
DR   CLDB; cl4985
DR   ABM; T8966
DR   AddexBio; C0009010/381
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-225
DR   BCRC; 60539
DR   BioGRID_ORCS_Cell_line; 868
DR   BioSample; SAMN01821556
DR   BioSample; SAMN01821630
DR   BioSample; SAMN03471553
DR   BioSample; SAMN10987770
DR   cancercelllines; CVCL_0292
DR   CCRID; 1101HUM-PUMC000247
DR   CCRID; 3101HUMTCHu133
DR   CCRID; 4201HUM-CCTCC00250
DR   CCTCC; GDC0250
DR   Cell_Model_Passport; SIDM00789
DR   ChEMBL-Cells; CHEMBL3307945
DR   ChEMBL-Targets; CHEMBL612263
DR   CLS; 300229
DR   ColonAtlas; HCT15
DR   Cosmic; 711261
DR   Cosmic; 873700
DR   Cosmic; 875902
DR   Cosmic; 887222
DR   Cosmic; 897458
DR   Cosmic; 905007
DR   Cosmic; 905937
DR   Cosmic; 913889
DR   Cosmic; 934567
DR   Cosmic; 947354
DR   Cosmic; 995403
DR   Cosmic; 1044258
DR   Cosmic; 1057756
DR   Cosmic; 1066206
DR   Cosmic; 1092601
DR   Cosmic; 1122324
DR   Cosmic; 1132569
DR   Cosmic; 1175841
DR   Cosmic; 1184092
DR   Cosmic; 1187307
DR   Cosmic; 1218878
DR   Cosmic; 1305354
DR   Cosmic; 1310950
DR   Cosmic; 1312338
DR   Cosmic; 1436020
DR   Cosmic; 1466814
DR   Cosmic; 1479592
DR   Cosmic; 1526922
DR   Cosmic; 1609492
DR   Cosmic; 1676747
DR   Cosmic; 1708403
DR   Cosmic; 1995438
DR   Cosmic; 1998443
DR   Cosmic; 2036655
DR   Cosmic; 2156942
DR   Cosmic; 2301979
DR   Cosmic; 2664053
DR   Cosmic; 2727470
DR   Cosmic; 2760066
DR   Cosmic; 2800585
DR   Cosmic; 2811051
DR   Cosmic-CLP; 905937
DR   DepMap; ACH-000997
DR   DSMZ; ACC-357
DR   DSMZCellDive; ACC-357
DR   ECACC; 91030712
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 905937
DR   GEO; GSM2129
DR   GEO; GSM50189
DR   GEO; GSM50253
DR   GEO; GSM206502
DR   GEO; GSM274763
DR   GEO; GSM274764
DR   GEO; GSM481406
DR   GEO; GSM513816
DR   GEO; GSM514293
DR   GEO; GSM741257
DR   GEO; GSM743444
DR   GEO; GSM750792
DR   GEO; GSM784011
DR   GEO; GSM799332
DR   GEO; GSM799395
DR   GEO; GSM844554
DR   GEO; GSM846356
DR   GEO; GSM887063
DR   GEO; GSM888133
DR   GEO; GSM1153402
DR   GEO; GSM1178151
DR   GEO; GSM1178152
DR   GEO; GSM1178153
DR   GEO; GSM1181251
DR   GEO; GSM1181363
DR   GEO; GSM1346875
DR   GEO; GSM1374519
DR   GEO; GSM1374520
DR   GEO; GSM1374521
DR   GEO; GSM1374522
DR   GEO; GSM1448178
DR   GEO; GSM1669869
DR   GEO; GSM2124665
DR   GEO; GSM2550002
DR   IARC_TP53; 21114
DR   ICLC; HTL00001
DR   IGRhCellID; HCT15
DR   KCB; KCB 2011097YJ
DR   KCLB; 10225
DR   LiGeA; CCLE_761
DR   LINCS_LDP; LCL-1178
DR   Lonza; 492
DR   MetaboLights; MTBLS227
DR   NCI-DTP; HCT-15
DR   PharmacoDB; HCT15_518_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005235
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0292
DR   PubChem_Cell_line; CVCL_0292
DR   RCB; RCB1958
DR   SKY/M-FISH/CGH; 2786
DR   TKG; TKG 0504
DR   TOKU-E; 1423
DR   Wikidata; Q54882006
RX   PubMed=427742;
RX   PubMed=2041050;
RX   PubMed=7139607;
RX   PubMed=7247963;
RX   PubMed=7621404;
RX   PubMed=7972006;
RX   PubMed=8197130;
RX   PubMed=8464898;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9331090;
RX   PubMed=9809040;
RX   PubMed=10700174;
RX   PubMed=10737795;
RX   PubMed=11314036;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11526487;
RX   PubMed=11668190;
RX   PubMed=12584437;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=16854228;
RX   PubMed=17088437;
RX   PubMed=18167186;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24042735;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26169745;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28179481;
RX   PubMed=28192450;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/genomic_reference_materials/1st_cancer_genomes/hct_15.aspx
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/HCT15.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=20
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/hct-15-xenograft-model/
WW   Provider; BRICS; BRICS0127; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3930
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Population: Caucasian.
CC   Doubling time: 19 hours (PubMed=427742); ~20 hours (PubMed=7139607); 29.57 hours (PubMed=25944804); 15 hours (CLS=300229); ~20-25 hours (DSMZ=ACC-357); 20.6 hours (NCI-DTP=HCT-15).
CC   HLA typing: A*02,24; B*08,35:01:01; C*04,07; DPB1*01:01:01,04:01; DQB1*02,05:03:01; DRB1*03,14 (PubMed=15748285).
CC   HLA typing: A*02:01,24:02; B*08:01,35:01; C*04:01,07:06; DQB1*05:03,05:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=11526487; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=8197130; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (PubMed=8197130; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (PubMed=18167186; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; ATCC=CCL-225; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (PubMed=9000147; PubMed=15900046; PubMed=17088437; PubMed=28683746; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=9000147; PubMed=15900046; PubMed=17088437; PubMed=28683746; Cosmic-CLP=905937; DepMap=ACH-000997).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.68%; Native American=0%; East Asian, North=5.84%; East Asian, South=0%; South Asian=0%; European, North=49.17%; European, South=42.32% (PubMed=30894373).
CC   Misspelling: HTC-15; Note=Occasionally.
CC   Misspelling: HTC15; Note=Occasionally.
CC   Discontinued: RCB; RCB1958; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): AddexBio=C0009010/381; ATCC=CCL-225; CCRID; CLS=300229; Cosmic-CLP=905937; DSMZ=ACC-357; ECACC=91030712; KCLB=10225; PubMed=11416159; PubMed=19372543; PubMed=25877200; PubMed=25926053; Technion Genomics Center; TKG=TKG 0504
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 13,15
ST   D12S391: 19,22
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D1S1656: 17.3,19.3
ST   D21S11: 29,32.2
ST   D22S1045: 17
ST   D2S1338: 17,25
ST   D2S441: 13,15
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   DYS391: 11
ST   FGA: 15,22 (DSMZ=ACC-357)
ST   FGA: 22 (ATCC=CCL-225; CCRID; CLS=300229; PubMed=11416159; PubMed=19372543; PubMed=25877200; Technion Genomics Center)
ST   Penta D: 9,14
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3449 ! __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   HCT 15-Luc#1
AC   CVCL_4Y02
SY   HCT-15-Luc#1
DR   cancercelllines; CVCL_4Y02
DR   JCRB; JCRB1479
DR   JCRB; NIHS0710
DR   Wikidata; Q54882007
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0710; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): JCRB=JCRB1479
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0292 ! HCT 15
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 21
//
ID   HCT 8
AC   CVCL_2478
SY   HCT-8; HCT8
DR   BTO; BTO_0002255
DR   CLO; CLO_0003667
DR   EFO; EFO_0002189
DR   CLDB; cl1577
DR   CLDB; cl1578
DR   CLDB; cl4949
DR   CLDB; cl5197
DR   AddexBio; C0009017/4907
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   BCRC; 60303
DR   BioSample; SAMN03473138
DR   cancercelllines; CVCL_2478
DR   CCRID; 1101HUM-PUMC000104
DR   CCRID; 3101HUMTCHu18
DR   CCRID; 4201HUM-CCTCC00201
DR   CCTCC; GDC0201
DR   Cell_Model_Passport; SIDM00786
DR   ChEMBL-Cells; CHEMBL3308035
DR   ChEMBL-Targets; CHEMBL613510
DR   CLS; 300210
DR   ColonAtlas; HCT8
DR   Cosmic; 887226
DR   Cosmic; 948853
DR   Cosmic; 983738
DR   Cosmic; 988873
DR   Cosmic; 1043814
DR   Cosmic; 1310946
DR   Cosmic; 1479593
DR   Cosmic; 1609484
DR   Cosmic; 1676735
DR   Cosmic; 2267316
DR   Cosmic; 2301980
DR   Cosmic; 2651867
DR   DepMap; ACH-001084
DR   ECACC; 90032006
DR   EGA; EGAS00001000610
DR   GEO; GSM206504
DR   GEO; GSM274709
DR   GEO; GSM274710
DR   GEO; GSM274723
DR   GEO; GSM513910
DR   GEO; GSM514294
DR   GEO; GSM827344
DR   GEO; GSM1346876
DR   GEO; GSM1374523
DR   GEO; GSM1374524
DR   GEO; GSM1448162
DR   ICLC; HTL99005
DR   IGRhCellID; HCT8
DR   IZSLER; BS TCL 97
DR   KCB; KCB 2011103YJ
DR   KCLB; 10244
DR   LINCS_LDP; LCL-1198
DR   MetaboLights; MTBLS227
DR   PharmacoDB; HCT8_519_2019
DR   Progenetix; CVCL_2478
DR   PubChem_Cell_line; CVCL_2478
DR   Wikidata; Q54882008
RX   PubMed=77569;
RX   PubMed=8422623;
RX   PubMed=9809040;
RX   PubMed=10674020;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=31068700;
RX   PubMed=33389257;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 27.49 hours (PubMed=25944804).
CC   HLA typing: A*03,09; B*08 (PubMed=77569).
CC   HLA typing: A*02:01,24:02; B*08:01,35:01; C*04:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Val79Ile (c.235G>A); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Pro164fs*8 (c.490_491insA); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6769; SMAD3; Simple; p.Val244Ile (c.730G>A); ClinVar=VCV000919044; Zygosity=Unspecified (PubMed=24755471).
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: HCT 18; Note=Occasionally.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): AddexBio=C0009017/4907; CCRID; CLS=300210; KCLB=10244; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X (CCRID; PubMed=25877200)
ST   Amelogenin: X,Y (AddexBio=C0009017/4907; CLS=300210; KCLB=10244; PubMed=25926053)
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,11.3 (CCRID; PubMed=25877200)
ST   D7S820: 10,11.3,12 (AddexBio=C0009017/4907)
ST   D7S820: 10,12 (CLS=300210; KCLB=10244; PubMed=25926053)
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 9,14
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3449 ! __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   HCT C
AC   CVCL_A607
DR   Wikidata; Q54882009
RX   PubMed=6437669;
RX   PubMed=6578361;
RX   PubMed=6830688;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A608 ! HCT C Col
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   HCT C Col
AC   CVCL_A608
SY   C Col
DR   Wikidata; Q54882010
RX   PubMed=6437669;
RX   PubMed=6830688;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A607 ! HCT C
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   HCT R
AC   CVCL_RB18
SY   HCT-R; R
DR   Wikidata; Q54882012
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=6578361;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   HCT-1
AC   CVCL_M747
SY   HCT 1; HCT1
DR   Wikidata; Q54882013
RX   PubMed=3009333;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   HCT-116 Cas9
AC   CVCL_DX74
DR   Horizon_Discovery; HD+Cas9-002
DR   Wikidata; Q127381129
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-002).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HCT-116 clone#2-Luc
AC   CVCL_J254
DR   cancercelllines; CVCL_J254
DR   JCRB; JCRB1408
DR   JCRB; NIHS0649
DR   Wikidata; Q54882014
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0649; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): JCRB=JCRB1408
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 11,13,14
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18,22,23
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   HCT-116 dCas9-VPR
AC   CVCL_DX75
DR   Horizon_Discovery; HD+dCas9-VPR-002
DR   Wikidata; Q127381130
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-dCas9-VPR-WPRE, where VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA (Horizon_Discovery=HD+dCas9-VPR-002).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HCT-116 MTBP-mClover
AC   CVCL_C7SR
DR   Wikidata; Q117704479
RX   PubMed=34534348;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 the fluorescent protein mClover was integrated at the C-terminus of MTBP (PubMed=34534348).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 6
//
ID   HCT-116 MTBP-mClover-XLoneGemininT25D
AC   CVCL_E0W0
RX   DOI=10.1101/2024.02.02.578516;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two plasmids, XLone-GemininT25D and pCMV-hyPBase. The XLone-GemininT25D plasmid contains in one orientation a EF1A-rtTA-P2A-Bsd region where rtTA is a reverse tetracycline-controlled transactivator, a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and in the other orientation a TRE3G-GemininT25D region thus allowing the doxycycline induction of gemimin (DOI=10.1101/2024.02.02.578516).
CC   Characteristics: Using CRISPR/Cas9 the fluorescent protein mClover was integrated at the C-terminus of MTBP (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Thr25Asp; stabilized against degradation).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7SR ! HCT-116 MTBP-mClover
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCT-116 Safe Harbor Landing Pad
AC   CVCL_C3EY
DR   cancercelllines; CVCL_C3EY
DR   Sigma-Aldrich; CLL1222
DR   Wikidata; Q114311572
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a fluorescent mKATE2 tag flanked by Cre-lox sites (LoxN-EF1a-Lox2272-mKATE2-LoxP) was introduced in the AAVS1 safe harbor locus. The mKATE2 tag can be exchanged for a payload of the user's choice using Cre recombinase and a targeting vector with appropriate lox sites (Sigma-Aldrich=CLL1222).
CC   Doubling time: ~22 hours (Sigma-Aldrich=CLL1222).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   HCT-116 TICRR-mClover
AC   CVCL_C7SS
DR   Wikidata; Q117704480
RX   PubMed=34534348;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 the fluorescent protein mClover was integrated at the C-terminus of TICRR (PubMed=34534348).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Misspelling: HCT-116 TICCR-mClover; Note=In Cellosaurus releases 45 to 49.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 6
//
ID   HCT-116 TICRR-mClover-XLoneGemininT25D
AC   CVCL_E0W1
RX   DOI=10.1101/2024.02.02.578516;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two plasmids, XLone-GemininT25D and pCMV-hyPBase. The XLone-GemininT25D plasmid contains in one orientation a EF1A-rtTA-P2A-Bsd region where rtTA is a reverse tetracycline-controlled transactivator, a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and in the other orientation a TRE3G-GemininT25D region thus allowing the doxycycline induction of gemimin (DOI=10.1101/2024.02.02.578516).
CC   Characteristics: Using CRISPR/Cas9 the fluorescent protein mClover was integrated at the C-terminus of TICRR (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Thr25Asp; stabilized against degradation).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7SS ! HCT-116 TICRR-mClover
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCT-116-MEK-R
AC   CVCL_V401
DR   cancercelllines; CVCL_V401
DR   Cosmic; 1927247
DR   Wikidata; Q54882015
RX   PubMed=22402123;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88249; 391210-10-9 (PD0325901).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   HCT-116-XLoneGemininT25D
AC   CVCL_E0W2
RX   DOI=10.1101/2024.02.02.578516;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two plasmids, XLone-GemininT25D and pCMV-hyPBase. The XLone-GemininT25D plasmid contains in one orientation a EF1A-rtTA-P2A-Bsd region where rtTA is a reverse tetracycline-controlled transactivator, a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and in the other orientation a TRE3G-GemininT25D region thus allowing the doxycycline induction of gemimin (DOI=10.1101/2024.02.02.578516).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Thr25Asp; stabilized against degradation).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HCT-116/CMV-1
AC   CVCL_E7EB
RX   PubMed=9174048;
RX   PubMed=9563901;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for HCT-116/E6-1 (Cellosaurus=CVCL_E7ED), HCT-116/E6-2 (Cellosaurus=CVCL_E7EE), HCT-116/E6-5 (Cellosaurus=CVCL_E7EF) and HCT-16/Mu-p53-2 (Cellosaurus=CVCL_E7EG) (PubMed=PubMed=9174048; PubMed=9563901).
CC   Doubling time: 25 hours (PubMed=9563901).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HCT-116/CMV-2
AC   CVCL_E7EC
RX   PubMed=9174048;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for HCT-116/E6-1 (Cellosaurus=CVCL_E7ED), HCT-116/E6-2 (Cellosaurus=CVCL_E7EE), HCT-116/E6-5 (Cellosaurus=CVCL_E7EF) and HCT-16/Mu-p53-2 (Cellosaurus=CVCL_E7EG) (PubMed=PubMed=9174048).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HCT-116/E6-1
AC   CVCL_E7ED
RX   PubMed=9174048;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HCT-116/E6-2
AC   CVCL_E7EE
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HCT-116/E6-5
AC   CVCL_E7EF
RX   PubMed=9174048;
RX   PubMed=9563901;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=9563901).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HCT-16/Mu-p53-2
AC   CVCL_E7EG
RX   PubMed=9563901;
CC   Population: Caucasian.
CC   Doubling time: 21 hours (PubMed=9563901).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg248Trp).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HCT-116/SN-38
AC   CVCL_WV82
DR   cancercelllines; CVCL_WV82
DR   Wikidata; Q93985421
RX   PubMed=23546019;
CC   Population: Caucasian.
CC   Doubling time: 29 hours (PubMed=23546019).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   HCT-116/VM34
AC   CVCL_4V05
SY   HCT116(VM)34; HCT-VM34
DR   cancercelllines; CVCL_4V05
DR   Wikidata; Q54882016
RX   PubMed=1717144;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HCT-116/VM46
AC   CVCL_N508
SY   HCT116/VM46; HCT116-VM46; HCT116(VM46); HCT-VM46; HCT/VM46; VM46
DR   cancercelllines; CVCL_N508
DR   ChEMBL-Cells; CHEMBL3307407
DR   ChEMBL-Targets; CHEMBL614575
DR   PubChem_Cell_line; CVCL_N508
DR   Wikidata; Q54882017
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: HCT166/VM46; Note=Occasionally.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   HCT-116/VP35
AC   CVCL_N509
SY   HCT116/VP35; HCT116(VP35); HCT116(VP)35; HCT-VP35; HCT/VP35; VP35
DR   cancercelllines; CVCL_N509
DR   Wikidata; Q54882018
RX   PubMed=1717144;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   HCT-116RB
AC   CVCL_IU66
DR   cancercelllines; CVCL_IU66
DR   Wikidata; Q54882019
RX   PubMed=12507930;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9177; Sodium deoxycholate (NaDOC).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   HCT-116RC
AC   CVCL_IU67
DR   cancercelllines; CVCL_IU67
DR   Wikidata; Q54882020
RX   PubMed=12507930;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9177; Sodium deoxycholate (NaDOC).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   HCT-116RD
AC   CVCL_IU68
DR   cancercelllines; CVCL_IU68
DR   Wikidata; Q54882021
RX   PubMed=12507930;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9177; Sodium deoxycholate (NaDOC).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   HCT-15-Luc2
AC   CVCL_A4BZ
DR   ATCC; CCL-225-LUC2
DR   cancercelllines; CVCL_A4BZ
DR   Wikidata; Q105507575
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-225-LUC2).
CC   Doubling time: ~34 hours (ATCC=CCL-225-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): ATCC=CCL-225-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0292 ! HCT 15
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   HCT-2
AC   CVCL_2920
SY   HCT 2; HCT2
DR   JCRB; JCRB1362
DR   Wikidata; Q54882022
RX   PubMed=3009333;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   HCT-8/E11
AC   CVCL_5679
SY   E11
DR   TOKU-E; 3539
DR   Wikidata; Q54882023
RX   PubMed=7553655;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HCT-8/R1
AC   CVCL_5945
DR   Wikidata; Q54882024
RX   PubMed=7553655;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   HCT-8/S10
AC   CVCL_5947
DR   Wikidata; Q54882025
RX   PubMed=7553655;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   HCT-8/S11
AC   CVCL_5682
SY   HCT8/S11
DR   TOKU-E; 4073
DR   Wikidata; Q54882026
RX   PubMed=7553655;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HCT-8/VCR
AC   CVCL_A9CF
SY   HCT-8/V
DR   ABM; T8236
DR   CCRID; 1101HUM-PUMC000486
DR   Wikidata; Q108820428
RX   PubMed=27633085;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): CCRID=1101HUM-PUMC000486
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,22
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D6S1043: 11,13
ST   D7S820: 10,11.3
ST   D8S1179: 15
ST   FGA: 22
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HCT-8-Luc2-tdT
AC   CVCL_A9CQ
DR   CCRID; 1101HUM-PUMC000652
DR   Wikidata; Q108820429
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): CCRID=1101HUM-PUMC000652
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,22
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D6S1043: 11,13
ST   D7S820: 10,11.3
ST   D8S1179: 15
ST   FGA: 22
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   HCT-8-mCherry
AC   CVCL_A9CR
DR   CCRID; 1101HUM-PUMC000650
DR   Wikidata; Q108820430
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): CCRID=1101HUM-PUMC000650
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,22
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D6S1043: 11,13
ST   D7S820: 10,11.3
ST   D8S1179: 15
ST   FGA: 22
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   HCT-8-tdT
AC   CVCL_A9CS
DR   CCRID; 1101HUM-PUMC000649
DR   Wikidata; Q108820431
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): CCRID=1101HUM-PUMC000649
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,22
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D6S1043: 11,13
ST   D7S820: 10,11.3
ST   D8S1179: 15
ST   FGA: 22
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   HCT-8R
AC   CVCL_S851
DR   Wikidata; Q54882027
RX   PubMed=908038;
RX   PubMed=3349466;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2478 ! HCT 8
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 8
//
ID   HCT116 VIM RFP
AC   CVCL_UR40
DR   ATCC; CCL-247EMT
DR   cancercelllines; CVCL_UR40
DR   Wikidata; Q93985520
CC   Population: Caucasian.
CC   Characteristics: Useful in vitro cell model for dissecting the molecular switches underlying epithelial to mesenchymal transition (EMT) and for identifying compounds that target EMT in colorectal cancer (ATCC=CCL-247EMT).
CC   Characteristics: Using CRISPR/Cas9 a RFP reporter gene was integrated at the C-terminus of VIM (ATCC=CCL-247EMT).
CC   Doubling time: 22 hours (ATCC=CCL-247EMT).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-247EMT
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 10,13
ST   D16S539: 11,13,14
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 20,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   HCT116-53BPI(+/-)
AC   CVCL_1R00
DR   cancercelllines; CVCL_1R00
DR   RCB; RCB2996
DR   Wikidata; Q54882028
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11999; TP53BP1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-A2
AC   CVCL_B7PU
DR   cancercelllines; CVCL_B7PU
DR   Wikidata; Q112929646
RX   PubMed=21619602;
CC   Population: Caucasian.
CC   Doubling time: 25.0 hours (PubMed=21619602).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Leu617Ile (c.1849C>A); Zygosity=Homozygous (PubMed=21619602).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7PT ! HCT116-s
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   HCT116-ANKH-KO-c3
AC   CVCL_D4FT
SY   CE06G7-F
DR   Wikidata; Q127381131
WW   Info; RESOLUTE; CE06G7-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15492; ANKH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-ANKH-KO-c7
AC   CVCL_D4FU
SY   CE06G6-T
DR   Wikidata; Q127381132
WW   Info; RESOLUTE; CE06G6-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15492; ANKH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-Artemis(+/-)
AC   CVCL_T770
SY   HCT116-ARTEMIS(+/-); Artemis+/-
DR   cancercelllines; CVCL_T770
DR   RCB; RCB2984
DR   Wikidata; Q54882029
RX   PubMed=21785230;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17642; DCLRE1C (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   HCT116-Artemis(-/-)
AC   CVCL_T771
SY   HCT116-ARTEMIS(-/-); Artemis-/-
DR   cancercelllines; CVCL_T771
DR   RCB; RCB2985
DR   Wikidata; Q54882030
RX   PubMed=21785230;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17642; DCLRE1C.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   HCT116-C8
AC   CVCL_B7PV
DR   cancercelllines; CVCL_B7PV
DR   Wikidata; Q112929648
RX   PubMed=21619602;
CC   Population: Caucasian.
CC   Doubling time: 38.7 hours (PubMed=21619602).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg621His (c.1862G>A); Zygosity=Heterozygous (PubMed=21619602).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu710Gly (c.2129A>G); Zygosity=Heterozygous (PubMed=21619602).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7PT ! HCT116-s
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   HCT116-Cas9-565
AC   CVCL_XC97
DR   cancercelllines; CVCL_XC97
DR   CCRID; 1101HUM-PUMC000565
DR   Wikidata; Q93985550
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000565
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D12S391: 17,20
ST   D13S317: 10,13
ST   D16S539: 11,14
ST   D18S51: 17,18
ST   D19S433: 12
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,17
ST   D5S818: 10,11
ST   D6S1043: 14
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HCT116-Cas9-566
AC   CVCL_XC98
DR   cancercelllines; CVCL_XC98
DR   CCRID; 1101HUM-PUMC000566
DR   Wikidata; Q93985554
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000566
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D12S391: 17,21
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,19
ST   D5S818: 10,11
ST   D6S1043: 13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HCT116-Cas9-567
AC   CVCL_XC99
DR   cancercelllines; CVCL_XC99
DR   CCRID; 1101HUM-PUMC000567
DR   Wikidata; Q93985557
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000567
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D12S391: 17,22
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,19
ST   D5S818: 10,11
ST   D6S1043: 13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HCT116-Cas9-568
AC   CVCL_XD00
DR   cancercelllines; CVCL_XD00
DR   CCRID; 1101HUM-PUMC000568
DR   Wikidata; Q93985559
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000568
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D12S391: 17,21
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,19
ST   D5S818: 10,11
ST   D6S1043: 13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HCT116-Cas9-TSC22KO-569
AC   CVCL_XD01
DR   cancercelllines; CVCL_XD01
DR   CCRID; 1101HUM-PUMC000569
DR   Wikidata; Q93985562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16826; TSC22D1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000569
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D12S391: 17,22
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,19
ST   D5S818: 10,11
ST   D6S1043: 13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 18,23
ST   Penta E: 13
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HCT116-CLN3-KO-c10
AC   CVCL_D4FV
SY   CE06GC-H
DR   Wikidata; Q127381133
WW   Info; RESOLUTE; CE06GC-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2074; CLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-CLN3-KO-c12
AC   CVCL_D4FW
SY   CE0666-G
DR   Wikidata; Q127381134
WW   Info; RESOLUTE; CE0666-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2074; CLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-DIRC2-KO-c5
AC   CVCL_D4FX
SY   CE0797-Y
DR   Wikidata; Q127381135
WW   Info; RESOLUTE; CE0797-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16628; SLC49A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-DIRC2-KO-c7
AC   CVCL_D4FY
SY   CE0798-3
DR   Wikidata; Q127381136
WW   Info; RESOLUTE; CE0798-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16628; SLC49A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-DNAPKcs(+/-)
AC   CVCL_1R01
DR   cancercelllines; CVCL_1R01
DR   RCB; RCB2992
DR   Wikidata; Q54882031
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9413; PRKDC (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-Dual
AC   CVCL_5I74
DR   cancercelllines; CVCL_5I74
DR   InvivoGen; hctd-nfis
DR   Wikidata; Q54882033
CC   Population: Caucasian.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hctd-nfis).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   HCT116-EGFP
AC   CVCL_XE63
DR   cancercelllines; CVCL_XE63
DR   Wikidata; Q93985580
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000661). It was the sole source of information for this entry.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D12S391: 17,21
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,19
ST   D5S818: 10,11
ST   D6S1043: 13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HCT116-eGFP-Puro
AC   CVCL_RA37
DR   cancercelllines; CVCL_RA37
DR   Imanis; CL063
DR   Wikidata; Q54882035
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL063).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   HCT116-Fluc-Neo/eGFP-Puro
AC   CVCL_RA38
DR   cancercelllines; CVCL_RA38
DR   Imanis; CL070
DR   Wikidata; Q54882036
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL070).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HCT116-Fluc-Neo/iRFP-Puro
AC   CVCL_RA39
DR   cancercelllines; CVCL_RA39
DR   Imanis; CL096
DR   Wikidata; Q54882037
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-iRFP-P2A-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL096).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HCT116-Fluc-Puro
AC   CVCL_RA40
DR   cancercelllines; CVCL_RA40
DR   Imanis; CL008
DR   Wikidata; Q54882038
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL008).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   HCT116-FLVCR1-KO-c10
AC   CVCL_D4FZ
SY   CE0799-M
DR   Wikidata; Q127381137
WW   Info; RESOLUTE; CE0799-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24682; FLVCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-FLVCR1-KO-c2
AC   CVCL_D4G0
SY   CE079A-T
DR   Wikidata; Q127381138
WW   Info; RESOLUTE; CE079A-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24682; FLVCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-FX-R
AC   CVCL_C4RX
DR   Wikidata; Q116049288
RX   PubMed=36230735;
CC   Population: Caucasian.
CC   Characteristics: Resistant to FOLFOXIRI, the combination of 5-FU, folinic acic, oxaliplatin and SN-38.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Selected for resistance to: ChEBI; CHEBI_15640; 5-formyltetrahydrofolic acid (Folinic acid; Leucovorin).
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HCT116-G7
AC   CVCL_B7PW
DR   cancercelllines; CVCL_B7PW
DR   Wikidata; Q112929649
RX   PubMed=21619602;
CC   Population: Caucasian.
CC   Doubling time: 42.1 hours (PubMed=21619602).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg621His (c.1862G>A); Zygosity=Heterozygous (PubMed=21619602).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu710Gly (c.2129A>G); Zygosity=Heterozygous (PubMed=21619602).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7PT ! HCT116-s
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   HCT116-hNIS-Neo
AC   CVCL_RA41
DR   cancercelllines; CVCL_RA41
DR   Imanis; CL005
DR   Wikidata; Q54882039
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-hNIS-IRES-Neo vector encoding for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL005).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   HCT116-hNIS-Neo/eGFP-Puro
AC   CVCL_RA42
DR   cancercelllines; CVCL_RA42
DR   Imanis; CL028
DR   Wikidata; Q54882040
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-eGFP-PGKp-Puro vectors. LV-hNIS-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL028).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HCT116-hNIS-Neo/Fluc-Puro
AC   CVCL_RA43
DR   cancercelllines; CVCL_RA43
DR   Imanis; CL009
DR   Wikidata; Q54882041
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-Fluc-P2A-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL009).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HCT116-hNIS-Neo/iRFP-Puro
AC   CVCL_RA44
DR   cancercelllines; CVCL_RA44
DR   Imanis; CL095
DR   Wikidata; Q54882046
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-iRFP-P2A-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL095).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HCT116-iRFP-Puro
AC   CVCL_RA45
DR   cancercelllines; CVCL_RA45
DR   Imanis; CL074
DR   Wikidata; Q54882047
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Puro vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL074).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   HCT116-Ku70(+/-)
AC   CVCL_1R02
DR   cancercelllines; CVCL_1R02
DR   RCB; RCB2991
DR   Wikidata; Q54882048
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:4055; XRCC6 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-LETM2-KO-c11
AC   CVCL_D4G1
SY   CE06GH-C
DR   Wikidata; Q127381139
WW   Info; RESOLUTE; CE06GH-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14648; LETM2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-LETM2-KO-c2
AC   CVCL_D4G2
SY   CE06GG-R
DR   Wikidata; Q127381140
WW   Info; RESOLUTE; CE06GG-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14648; LETM2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-LETMD1-KO-c11
AC   CVCL_D4G3
SY   CE06WX-2
DR   Wikidata; Q127381141
WW   Info; RESOLUTE; CE06WX-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24241; LETMD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-LETMD1-KO-c7
AC   CVCL_D4G4
SY   CE06WV-0
DR   Wikidata; Q127381142
WW   Info; RESOLUTE; CE06WV-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24241; LETMD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-LIG3(+/-)
AC   CVCL_1R03
DR   cancercelllines; CVCL_1R03
DR   RCB; RCB2994
DR   Wikidata; Q54882049
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6600; LIG3 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-LIG4(+/-)
AC   CVCL_1R04
DR   cancercelllines; CVCL_1R04
DR   RCB; RCB2995
DR   Wikidata; Q54882050
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6601; LIG4 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-Luc-GFP
AC   CVCL_B7NU
SY   Luciferase/GFP Dual-Reporter HCT116 Cell Line
DR   cancercelllines; CVCL_B7NU
DR   Wikidata; Q112929650
WW   Provider; ALSTEM; LGL02; https://www.alstembio.com/web/product_details.php?id=92
CC   Population: Caucasian.
CC   Characteristics: Transduced with a CAG-Luc-PGKp-GFP-T2A-PuroR lentiviral reporter construct.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HCT116-MAGT1-KO-c6
AC   CVCL_D4G5
SY   CE0667-Y
DR   Wikidata; Q127381143
WW   Info; RESOLUTE; CE0667-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28880; MAGT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MAGT1-KO-c8
AC   CVCL_D4G6
SY   CE0668-3
DR   Wikidata; Q127381145
WW   Info; RESOLUTE; CE0668-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28880; MAGT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MDC1(+/-)
AC   CVCL_1R05
DR   cancercelllines; CVCL_1R05
DR   RCB; RCB2986
DR   Wikidata; Q54882051
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:21163; MDC1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-MDC1(-/-)
AC   CVCL_1R06
DR   cancercelllines; CVCL_1R06
DR   RCB; RCB2987
DR   Wikidata; Q54882052
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:21163; MDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   HCT116-MFSD10-KO-c18
AC   CVCL_D4G7
SY   CE04KB-1
DR   Wikidata; Q127381146
WW   Info; RESOLUTE; CE04KB-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16894; MFSD10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD10-KO-c24
AC   CVCL_D4G8
SY   CE04KE-E
DR   Wikidata; Q127381147
WW   Info; RESOLUTE; CE04KE-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16894; MFSD10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD11-KO-c16
AC   CVCL_D4G9
SY   CE061E-U
DR   Wikidata; Q127381148
WW   Info; RESOLUTE; CE061E-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25458; MFSD11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD11-KO-c17
AC   CVCL_D4GA
SY   CE061F-0
DR   Wikidata; Q127381149
WW   Info; RESOLUTE; CE061F-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25458; MFSD11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD12-KO-c10
AC   CVCL_D4GB
SY   CE079E-9
DR   Wikidata; Q127381150
WW   Info; RESOLUTE; CE079E-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28299; MFSD12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD12-KO-c9
AC   CVCL_D4GC
SY   CE079H-H
DR   Wikidata; Q127381151
WW   Info; RESOLUTE; CE079H-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28299; MFSD12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD13A-KO-c29
AC   CVCL_D4GD
SY   CE05HG-Y
DR   Wikidata; Q127381152
WW   Info; RESOLUTE; CE05HG-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26196; MFSD13A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD14A-KO-c1
AC   CVCL_D4GE
SY   CE06XE-N
DR   Wikidata; Q127381153
WW   Info; RESOLUTE; CE06XE-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23363; MFSD14A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD14A-KO-c2
AC   CVCL_D4GF
SY   CE06XF-H
DR   Wikidata; Q127381155
WW   Info; RESOLUTE; CE06XF-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23363; MFSD14A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD14A-KO-c5
AC   CVCL_D4GG
SY   CE06XG-Z
DR   Wikidata; Q127381158
WW   Info; RESOLUTE; CE06XG-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23363; MFSD14A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD14B-KO-c2
AC   CVCL_D4GH
SY   CE061K-4
DR   Wikidata; Q127381160
WW   Info; RESOLUTE; CE061K-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23376; MFSD14B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD14B-KO-c3
AC   CVCL_D4GI
SY   CE061M-K
DR   Wikidata; Q127381161
WW   Info; RESOLUTE; CE061M-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23376; MFSD14B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD2A-KO-c1
AC   CVCL_D4GJ
SY   CE058K-K
DR   Wikidata; Q127381163
WW   Info; RESOLUTE; CE058K-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25897; MFSD2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD2A-KO-c2
AC   CVCL_D4GK
SY   CE058M-8
DR   Wikidata; Q127381164
WW   Info; RESOLUTE; CE058M-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25897; MFSD2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD2B-KO-c17
AC   CVCL_D4GL
SY   CE0526-M
DR   Wikidata; Q127381165
WW   Info; RESOLUTE; CE0526-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37207; MFSD2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD2B-KO-c21
AC   CVCL_D4GM
SY   CE0527-T
DR   Wikidata; Q127381166
WW   Info; RESOLUTE; CE0527-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37207; MFSD2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD4B-KO-c2
AC   CVCL_D4GN
SY   CE079M-P
DR   Wikidata; Q127381167
WW   Info; RESOLUTE; CE079M-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21053; MFSD4B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD4B-KO-c3
AC   CVCL_D4GP
SY   CE079N-R
DR   Wikidata; Q127381168
WW   Info; RESOLUTE; CE079N-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21053; MFSD4B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD5-KO-c4
AC   CVCL_D4GQ
SY   CE06XM-C
DR   Wikidata; Q127381169
WW   Info; RESOLUTE; CE06XM-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28156; MFSD5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD5-KO-c9
AC   CVCL_D4GR
SY   CE06XN-5
DR   Wikidata; Q127381170
WW   Info; RESOLUTE; CE06XN-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28156; MFSD5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD6-KO-c15
AC   CVCL_D4GS
SY   CE079T-W
DR   Wikidata; Q127381171
WW   Info; RESOLUTE; CE079T-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24711; MFSD6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD6-KO-c5
AC   CVCL_D4GT
SY   CE06X0-K
DR   Wikidata; Q127381172
WW   Info; RESOLUTE; CE06X0-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24711; MFSD6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD8-KO-c2
AC   CVCL_D4GU
SY   CE06X1-8
DR   Wikidata; Q127381173
WW   Info; RESOLUTE; CE06X1-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD8-KO-c22
AC   CVCL_D4GV
SY   CE06X2-A
DR   Wikidata; Q127381174
WW   Info; RESOLUTE; CE06X2-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD9-KO-c12
AC   CVCL_D4GW
SY   CE066E-9
DR   Wikidata; Q127381175
WW   Info; RESOLUTE; CE066E-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28158; MFSD9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MFSD9-KO-c9
AC   CVCL_D4GX
SY   CE066F-V
DR   Wikidata; Q127381176
WW   Info; RESOLUTE; CE066F-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28158; MFSD9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MPC1-KO-c2
AC   CVCL_D4GY
SY   CE042A-A
DR   Wikidata; Q127381177
WW   Info; RESOLUTE; CE042A-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21606; MPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MPC1-KO-c7
AC   CVCL_D4GZ
SY   CE042B-X
DR   Wikidata; Q127381178
WW   Info; RESOLUTE; CE042B-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21606; MPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MTCH1-KO-c4
AC   CVCL_D4CF
SY   CE00ZE-C
DR   ATCC; CRL-3498
DR   Wikidata; Q127381179
WW   Info; RESOLUTE; CE00ZE-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17586; MTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-MTCH1-KO-c7
AC   CVCL_D4CG
SY   MTCH1
DR   ATCC; CRL-3499
DR   Wikidata; Q127381180
WW   Info; RESOLUTE; -; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17586; MTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-NanoLuc-RFP
AC   CVCL_B7NV
SY   Nanoluciferase/tdTomato Dual-Reporter HCT116 Cell Line
DR   cancercelllines; CVCL_B7NV
DR   Wikidata; Q112929651
WW   Provider; ALSTEM; NRL02; https://www.alstembio.com/web/product_details.php?id=39
CC   Population: Caucasian.
CC   Characteristics: Transduced with a CAG-NanoLuc-PGKp-TdTomato-T2A-PuroR lentiviral reporter construct.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HCT116-NIPA1-KO-c16
AC   CVCL_D4H0
SY   CE00PG-S
DR   Wikidata; Q127381181
WW   Info; RESOLUTE; CE00PG-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17043; NIPA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-NIPA1-KO-c22
AC   CVCL_D4H1
SY   CE052H-R
DR   Wikidata; Q127381183
WW   Info; RESOLUTE; CE052H-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17043; NIPA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-NIPA2-KO-c22
AC   CVCL_D4H2
SY   CE052S-B
DR   Wikidata; Q127381184
WW   Info; RESOLUTE; CE052S-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17044; NIPA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-NIPA2-KO-c3
AC   CVCL_D4H3
SY   CE015G-A
DR   Wikidata; Q127381185
WW   Info; RESOLUTE; CE015G-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17044; NIPA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-NIPAL2-KO-c3
AC   CVCL_D4H4
SY   CE015M-Y
DR   Wikidata; Q127381186
WW   Info; RESOLUTE; CE015M-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25854; NIPAL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-NIPAL2-KO-c5
AC   CVCL_D4H5
SY   CE015N-3
DR   Wikidata; Q127381187
WW   Info; RESOLUTE; CE015N-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25854; NIPAL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-POLM(+/-)
AC   CVCL_1R07
DR   cancercelllines; CVCL_1R07
DR   RCB; RCB2993
DR   Wikidata; Q54882053
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9185; POLM (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-RAD18(+/-)
AC   CVCL_1R08
SY   RAD18+/-
DR   cancercelllines; CVCL_1R08
DR   RCB; RCB2982
DR   Wikidata; Q54882054
RX   PubMed=17158148;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:18278; RAD18 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-RAD18(-/-)
AC   CVCL_1R09
SY   RAD18-/-
DR   cancercelllines; CVCL_1R09
DR   RCB; RCB2983
DR   Wikidata; Q54882055
RX   PubMed=17158148;
CC   Population: Caucasian.
CC   Doubling time: ~18 hours (PubMed=17158148).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:18278; RAD18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 14
//
ID   HCT116-REV1(+/-)
AC   CVCL_1R10
DR   cancercelllines; CVCL_1R10
DR   RCB; RCB2988
DR   Wikidata; Q54882056
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:14060; REV1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-REV1(-/-)
AC   CVCL_1R11
DR   cancercelllines; CVCL_1R11
DR   RCB; RCB2989
DR   Wikidata; Q54882057
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:14060; REV1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   HCT116-REV3L(+/-)
AC   CVCL_1R12
DR   cancercelllines; CVCL_1R12
DR   RCB; RCB2990
DR   Wikidata; Q54882058
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9968; REV3L (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   HCT116-RHBG-KO-c16
AC   CVCL_D4H6
SY   CE04KF-B
DR   Wikidata; Q127381188
WW   Info; RESOLUTE; CE04KF-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14572; RHBG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-RHBG-KO-c23
AC   CVCL_D4H7
SY   CE04KG-7
DR   Wikidata; Q127381189
WW   Info; RESOLUTE; CE04KG-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14572; RHBG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-s
AC   CVCL_B7PT
DR   cancercelllines; CVCL_B7PT
DR   Wikidata; Q112929652
RX   PubMed=21619602;
CC   Population: Caucasian.
CC   Doubling time: 19.8 hours (PubMed=21619602).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg621His (c.1862G>A); Zygosity=Heterozygous (PubMed=21619602).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu710Gly (c.2129A>G); Zygosity=Heterozygous (PubMed=21619602).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   HCT116-SFXN1-KO-c5
AC   CVCL_D4H8
SY   CE066H-H
DR   Wikidata; Q127381190
WW   Info; RESOLUTE; CE066H-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16085; SFXN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SFXN1-KO-c8
AC   CVCL_D4H9
SY   CE066K-Z
DR   Wikidata; Q127381191
WW   Info; RESOLUTE; CE066K-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16085; SFXN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SFXN2-KO-c1
AC   CVCL_D4HA
SY   CE06XR-W
DR   Wikidata; Q127381192
WW   Info; RESOLUTE; CE06XR-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16086; SFXN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SFXN2-KO-c11
AC   CVCL_D4HB
SY   CE06XV-7
DR   Wikidata; Q127381193
WW   Info; RESOLUTE; CE06XV-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16086; SFXN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SFXN3-KO-c4
AC   CVCL_D4HC
SY   CE015V-9
DR   Wikidata; Q127381194
WW   Info; RESOLUTE; CE015V-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16087; SFXN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SFXN3-KO-c7
AC   CVCL_D4HD
SY   CE015X-N
DR   Wikidata; Q127381195
WW   Info; RESOLUTE; CE015X-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16087; SFXN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SFXN4-KO-c34
AC   CVCL_D4HE
SY   CE077E-R
DR   Wikidata; Q127381196
WW   Info; RESOLUTE; CE077E-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16088; SFXN4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC10A3-KO-c2
AC   CVCL_D4HF
SY   CE05CC-H
DR   Wikidata; Q127381197
WW   Info; RESOLUTE; CE05CC-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22979; SLC10A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC10A3-KO-c6
AC   CVCL_D4HG
SY   CE05CE-Z
DR   Wikidata; Q127381198
WW   Info; RESOLUTE; CE05CE-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22979; SLC10A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC10A4-KO-c2
AC   CVCL_D4CH
SY   CE00P4-4
DR   ATCC; CRL-3504
DR   Wikidata; Q127381199
WW   Info; RESOLUTE; CE00P4-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22980; SLC10A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC10A4-KO-c8
AC   CVCL_D4CI
SY   CE00P6-8
DR   ATCC; CRL-3505
DR   Wikidata; Q127381200
WW   Info; RESOLUTE; CE00P6-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22980; SLC10A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC10A7-KO-c21
AC   CVCL_D4HH
SY   CE06GR-B
DR   Wikidata; Q127381201
WW   Info; RESOLUTE; CE06GR-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23088; SLC10A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC10A7-KO-c4
AC   CVCL_D4HI
SY   CE05CG-R
DR   Wikidata; Q127381202
WW   Info; RESOLUTE; CE05CG-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23088; SLC10A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC11A2-KO-c5
AC   CVCL_D4HJ
SY   CE05BZ-8
DR   Wikidata; Q127381203
WW   Info; RESOLUTE; CE05BZ-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10908; SLC11A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC11A2-KO-c6
AC   CVCL_D4HK
SY   CE05C0-A
DR   Wikidata; Q127381204
WW   Info; RESOLUTE; CE05C0-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10908; SLC11A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A4-KO-c12
AC   CVCL_D4HL
SY   CE0160-Z
DR   Wikidata; Q127381205
WW   Info; RESOLUTE; CE0160-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10913; SLC12A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A4-KO-c6
AC   CVCL_D4HM
SY   CE06GS-7
DR   Wikidata; Q127381206
WW   Info; RESOLUTE; CE06GS-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10913; SLC12A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A6-KO-c17
AC   CVCL_D4HN
SY   CE06GW-0
DR   Wikidata; Q127381207
WW   Info; RESOLUTE; CE06GW-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10914; SLC12A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A6-KO-c19
AC   CVCL_D4HP
SY   CE06GX-6
DR   Wikidata; Q127381208
WW   Info; RESOLUTE; CE06GX-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10914; SLC12A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A7-KO-c13
AC   CVCL_D4HQ
SY   CE0627-R
DR   Wikidata; Q127381209
WW   Info; RESOLUTE; CE0627-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10915; SLC12A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A7-KO-c22
AC   CVCL_D4HR
SY   CE0629-5
DR   Wikidata; Q127381210
WW   Info; RESOLUTE; CE0629-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10915; SLC12A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A8-KO-c4
AC   CVCL_D4HS
SY   CE05C2-G
DR   Wikidata; Q127381211
WW   Info; RESOLUTE; CE05C2-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15595; SLC12A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A8-KO-c5
AC   CVCL_D4HT
SY   CE05C3-Y
DR   Wikidata; Q127381212
WW   Info; RESOLUTE; CE05C3-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15595; SLC12A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A9-KO-c3
AC   CVCL_D4HU
SY   CE05C6-T
DR   Wikidata; Q127381213
WW   Info; RESOLUTE; CE05C6-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17435; SLC12A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC12A9-KO-c5
AC   CVCL_D4HV
SY   CE05C8-S
DR   Wikidata; Q127381214
WW   Info; RESOLUTE; CE05C8-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17435; SLC12A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC15A2-KO-c9
AC   CVCL_D4HW
SY   CE079V-E
DR   Wikidata; Q127381216
WW   Info; RESOLUTE; CE079V-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10921; SLC15A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC15A4-KO-c10
AC   CVCL_D4CJ
SY   CE0162-R
DR   ATCC; CRL-3510
DR   Wikidata; Q127381217
WW   Info; RESOLUTE; CE0162-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC15A4-KO-c12
AC   CVCL_D4CK
SY   CE0163-C
DR   ATCC; CRL-3511
DR   Wikidata; Q127381218
WW   Info; RESOLUTE; CE0163-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A1-KO-c6
AC   CVCL_D4HX
SY   CE05CH-C
DR   Wikidata; Q127381219
WW   Info; RESOLUTE; CE05CH-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10922; SLC16A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A1-KO-c7
AC   CVCL_D4HY
SY   CE05CK-5
DR   Wikidata; Q127381220
WW   Info; RESOLUTE; CE05CK-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10922; SLC16A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A10-KO-c3
AC   CVCL_D4HZ
SY   CE05FN-Z
DR   Wikidata; Q127381221
WW   Info; RESOLUTE; CE05FN-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17027; SLC16A10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A10-KO-c5
AC   CVCL_D4I0
SY   CE05FP-P
DR   Wikidata; Q127381222
WW   Info; RESOLUTE; CE05FP-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17027; SLC16A10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A13-KO-c4
AC   CVCL_D4I1
SY   CE052C-N
DR   Wikidata; Q127381223
WW   Info; RESOLUTE; CE052C-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31037; SLC16A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A13-KO-c9
AC   CVCL_D4I2
SY   CE052E-H
DR   Wikidata; Q127381224
WW   Info; RESOLUTE; CE052E-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31037; SLC16A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A14-KO-c4
AC   CVCL_D4I3
SY   CE04CT-P
DR   Wikidata; Q127381225
WW   Info; RESOLUTE; CE04CT-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26417; SLC16A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A14-KO-c5
AC   CVCL_D4I4
SY   CE04CV-R
DR   Wikidata; Q127381226
WW   Info; RESOLUTE; CE04CV-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26417; SLC16A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A3-KO-c5
AC   CVCL_D4I5
SY   CE00V7-W
DR   Wikidata; Q127381227
WW   Info; RESOLUTE; CE00V7-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10924; SLC16A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A3-KO-c9
AC   CVCL_D4I6
SY   CE00ZN-7
DR   Wikidata; Q127381228
WW   Info; RESOLUTE; CE00ZN-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10924; SLC16A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A5-KO-c10
AC   CVCL_D4I7
SY   CE057R-M
DR   Wikidata; Q127381229
WW   Info; RESOLUTE; CE057R-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10926; SLC16A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A5-KO-c4
AC   CVCL_D4I8
SY   CE057N-Y
DR   Wikidata; Q127381230
WW   Info; RESOLUTE; CE057N-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10926; SLC16A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A7-KO-c3
AC   CVCL_D4I9
SY   CE05C9-9
DR   Wikidata; Q127381231
WW   Info; RESOLUTE; CE05C9-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10928; SLC16A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A7-KO-c7
AC   CVCL_D4IA
SY   CE05CA-V
DR   Wikidata; Q127381232
WW   Info; RESOLUTE; CE05CA-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10928; SLC16A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A9-KO-c10
AC   CVCL_D4IB
SY   CE06Z9-3
DR   Wikidata; Q127381233
WW   Info; RESOLUTE; CE06Z9-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23520; SLC16A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC16A9-KO-c7
AC   CVCL_D4IC
SY   CE06Z8-Y
DR   Wikidata; Q127381234
WW   Info; RESOLUTE; CE06Z8-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23520; SLC16A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC17A5-KO-c3
AC   CVCL_D4ID
SY   CE05GK-S
DR   Wikidata; Q127381235
WW   Info; RESOLUTE; CE05GK-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC17A5-KO-c4
AC   CVCL_D4IE
SY   CE05GM-9
DR   Wikidata; Q127381236
WW   Info; RESOLUTE; CE05GM-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC18B1-KO-c3
AC   CVCL_D4IF
SY   CE05PK-U
DR   Wikidata; Q127381237
WW   Info; RESOLUTE; CE05PK-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21573; SLC18B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC18B1-KO-c4
AC   CVCL_D4IG
SY   CE05PM-0
DR   Wikidata; Q127381238
WW   Info; RESOLUTE; CE05PM-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21573; SLC18B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC19A1-KO-c4
AC   CVCL_D4IH
SY   CE0540-U
DR   Wikidata; Q127381239
WW   Info; RESOLUTE; CE0540-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10937; SLC19A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC19A1-KO-c7
AC   CVCL_D4II
SY   CE0541-0
DR   Wikidata; Q127381240
WW   Info; RESOLUTE; CE0541-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10937; SLC19A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC19A2-KO-c5
AC   CVCL_D4IJ
SY   CE057S-T
DR   Wikidata; Q127381241
WW   Info; RESOLUTE; CE057S-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10938; SLC19A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC19A2-KO-c8
AC   CVCL_D4IK
SY   CE057V-S
DR   Wikidata; Q127381242
WW   Info; RESOLUTE; CE057V-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10938; SLC19A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC1A1-KO-c6
AC   CVCL_D4IL
SY   CE04CZ-1
DR   Wikidata; Q127381243
WW   Info; RESOLUTE; CE04CZ-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10939; SLC1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC1A1-KO-c8
AC   CVCL_D4IM
SY   CE04E0-W
DR   Wikidata; Q127381244
WW   Info; RESOLUTE; CE04E0-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10939; SLC1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC1A3-KO-c2
AC   CVCL_D4IN
SY   CE0518-V
DR   Wikidata; Q127381245
WW   Info; RESOLUTE; CE0518-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10941; SLC1A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC1A3-KO-c6
AC   CVCL_D4IP
SY   CE058N-A
DR   Wikidata; Q127381246
WW   Info; RESOLUTE; CE058N-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10941; SLC1A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC1A5-KO-c7
AC   CVCL_D4IQ
SY   CE0623-N
DR   Wikidata; Q127381247
WW   Info; RESOLUTE; CE0623-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC1A5-KO-c8
AC   CVCL_D4IR
SY   CE0624-H
DR   Wikidata; Q127381248
WW   Info; RESOLUTE; CE0624-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC20A1-KO-c11
AC   CVCL_D4IS
SY   CE05PW-X
DR   Wikidata; Q127381250
WW   Info; RESOLUTE; CE05PW-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10946; SLC20A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC20A1-KO-c7
AC   CVCL_D4IT
SY   CE05PS-K
DR   Wikidata; Q127381251
WW   Info; RESOLUTE; CE05PS-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10946; SLC20A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC20A2-KO-c6
AC   CVCL_D4IU
SY   CE0545-K
DR   Wikidata; Q127381252
WW   Info; RESOLUTE; CE0545-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC20A2-KO-c8
AC   CVCL_D4IV
SY   CE0546-8
DR   Wikidata; Q127381253
WW   Info; RESOLUTE; CE0546-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A17-KO-c2
AC   CVCL_D4IW
SY   CE077G-5
DR   Wikidata; Q127381254
WW   Info; RESOLUTE; CE077G-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23095; SLC22A17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A17-KO-c3
AC   CVCL_D4IX
SY   CE04E1-E
DR   Wikidata; Q127381255
WW   Info; RESOLUTE; CE04E1-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23095; SLC22A17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A17-KO-c7
AC   CVCL_D4IY
SY   CE077H-1
DR   Wikidata; Q127381256
WW   Info; RESOLUTE; CE077H-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23095; SLC22A17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A23-KO-c10
AC   CVCL_D4IZ
SY   CE079W-B
DR   Wikidata; Q127381257
WW   Info; RESOLUTE; CE079W-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21106; SLC22A23.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A23-KO-c7
AC   CVCL_D4J0
SY   CE07A0-U
DR   Wikidata; Q127381258
WW   Info; RESOLUTE; CE07A0-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21106; SLC22A23.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A31-KO-c12
AC   CVCL_D4J1
SY   CE05AP-6
DR   Wikidata; Q127381259
WW   Info; RESOLUTE; CE05AP-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27091; SLC22A31.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A31-KO-c80
AC   CVCL_D4J2
SY   CE05AR-2
DR   Wikidata; Q127381260
WW   Info; RESOLUTE; CE05AR-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27091; SLC22A31.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A5-KO-c4
AC   CVCL_D4J3
SY   CE00Z9-H
DR   Wikidata; Q127381261
WW   Info; RESOLUTE; CE00Z9-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10969; SLC22A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC22A5-KO-c5
AC   CVCL_D4J4
SY   CE00ZA-Z
DR   Wikidata; Q127381262
WW   Info; RESOLUTE; CE00ZA-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10969; SLC22A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC23A2-KO-c4
AC   CVCL_D4J5
SY   CE0547-A
DR   Wikidata; Q127381263
WW   Info; RESOLUTE; CE0547-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10973; SLC23A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC23A2-KO-c8
AC   CVCL_D4J6
SY   CE0548-X
DR   Wikidata; Q127381264
WW   Info; RESOLUTE; CE0548-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10973; SLC23A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC24A1-KO-c1
AC   CVCL_D4J7
SY   CE0620-S
DR   Wikidata; Q127381265
WW   Info; RESOLUTE; CE0620-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10975; SLC24A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC24A1-KO-c5
AC   CVCL_D4J8
SY   CE0621-9
DR   Wikidata; Q127381266
WW   Info; RESOLUTE; CE0621-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10975; SLC24A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A1-KO-c12
AC   CVCL_D4J9
SY   CE04MB-R
DR   Wikidata; Q127381267
WW   Info; RESOLUTE; CE04MB-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10979; SLC25A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A1-KO-c2
AC   CVCL_D4JA
SY   CE04EK-M
DR   Wikidata; Q127381268
WW   Info; RESOLUTE; CE04EK-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10979; SLC25A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A10-KO-c2
AC   CVCL_D4JB
SY   CE05GP-N
DR   Wikidata; Q127381269
WW   Info; RESOLUTE; CE05GP-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10980; SLC25A10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A10-KO-c5
AC   CVCL_D4JC
SY   CE05GR-H
DR   Wikidata; Q127381270
WW   Info; RESOLUTE; CE05GR-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10980; SLC25A10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A11-KO-c16
AC   CVCL_D4JD
SY   CE051T-0
DR   Wikidata; Q127381271
WW   Info; RESOLUTE; CE051T-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10981; SLC25A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A12-KO-c5
AC   CVCL_D4JE
SY   CE04F3-W
DR   Wikidata; Q127381272
WW   Info; RESOLUTE; CE04F3-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10982; SLC25A12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A12-KO-c8
AC   CVCL_D4JF
SY   CE04F5-B
DR   Wikidata; Q127381273
WW   Info; RESOLUTE; CE04F5-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10982; SLC25A12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A13-KO-c2
AC   CVCL_D4JG
SY   CE06H3-A
DR   Wikidata; Q127381274
WW   Info; RESOLUTE; CE06H3-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10983; SLC25A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A13-KO-c8
AC   CVCL_D4JH
SY   CE06XZ-0
DR   Wikidata; Q127381275
WW   Info; RESOLUTE; CE06XZ-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10983; SLC25A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A14-KO-c10
AC   CVCL_D4CL
SY   CE00VH-4
DR   ATCC; CRL-3482
DR   Wikidata; Q127381276
WW   Info; RESOLUTE; CE00VH-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10984; SLC25A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-3482
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HCT116-SLC25A14-KO-c11
AC   CVCL_D4CM
SY   CE00VK-K
DR   ATCC; CRL-3483
DR   Wikidata; Q127381277
WW   Info; RESOLUTE; CE00VK-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10984; SLC25A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-3483
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HCT116-SLC25A15-KO-c6
AC   CVCL_D4CN
SY   CE00VS-Y
DR   ATCC; CRL-3484
DR   Wikidata; Q127381278
WW   Info; RESOLUTE; CE00VS-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10985; SLC25A15.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-3484
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HCT116-SLC25A15-KO-c7
AC   CVCL_D4CP
SY   CE00VT-3
DR   ATCC; CRL-3485
DR   Wikidata; Q127381279
WW   Info; RESOLUTE; CE00VT-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10985; SLC25A15.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-3485
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HCT116-SLC25A16-KO-c4
AC   CVCL_D4CQ
SY   CE00VV-M
DR   ATCC; CRL-3486
DR   Wikidata; Q127381280
WW   Info; RESOLUTE; CE00VV-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10986; SLC25A16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-3486
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 11,13,14
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HCT116-SLC25A16-KO-c7
AC   CVCL_D4CR
SY   CE00VZ-S
DR   ATCC; CRL-3487
DR   Wikidata; Q127381281
WW   Info; RESOLUTE; CE00VZ-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10986; SLC25A16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-3487
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HCT116-SLC25A17-KO-c2
AC   CVCL_D4CS
SY   CE016R-Y
DR   ATCC; CRL-3490
DR   Wikidata; Q127381282
WW   Info; RESOLUTE; CE016R-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10987; SLC25A17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A17-KO-c4
AC   CVCL_D4CT
SY   CE016S-3
DR   ATCC; CRL-3491
DR   Wikidata; Q127381283
WW   Info; RESOLUTE; CE016S-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10987; SLC25A17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A19-KO-c11
AC   CVCL_D4JI
SY   CE0170-V
DR   Wikidata; Q127381284
WW   Info; RESOLUTE; CE0170-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14409; SLC25A19.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A19-KO-c2
AC   CVCL_D4JJ
SY   CE0172-H
DR   Wikidata; Q127381285
WW   Info; RESOLUTE; CE0172-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14409; SLC25A19.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A22-KO-c27
AC   CVCL_D4JK
SY   CE07EK-X
DR   Wikidata; Q127381286
WW   Info; RESOLUTE; CE07EK-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19954; SLC25A22.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A23-KO-c2
AC   CVCL_D4CU
SY   CE00W1-V
DR   ATCC; CRL-3488
DR   Wikidata; Q127381287
WW   Info; RESOLUTE; CE00W1-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19375; SLC25A23.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-3488
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HCT116-SLC25A23-KO-c9
AC   CVCL_D4CV
SY   CE00W3-H
DR   ATCC; CRL-3489
DR   Wikidata; Q127381288
WW   Info; RESOLUTE; CE00W3-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19375; SLC25A23.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A24-KO-c3
AC   CVCL_D4CW
SY   CE016V-T
DR   ATCC; CRL-3492
DR   Wikidata; Q127381289
WW   Info; RESOLUTE; CE016V-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20662; SLC25A24.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A24-KO-c4
AC   CVCL_D4D9
SY   CE016W-F
DR   ATCC; CRL-3493
DR   Wikidata; Q127381290
WW   Info; RESOLUTE; CE016W-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20662; SLC25A24.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A25-KO-c11
AC   CVCL_D4JL
SY   CE016Z-9
DR   Wikidata; Q127381292
WW   Info; RESOLUTE; CE016Z-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20663; SLC25A25.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A27-KO-c2
AC   CVCL_D4JM
SY   CE0174-P
DR   Wikidata; Q127381293
WW   Info; RESOLUTE; CE0174-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21065; SLC25A27.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A27-KO-c3
AC   CVCL_D4JN
SY   CE0175-R
DR   Wikidata; Q127381294
WW   Info; RESOLUTE; CE0175-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21065; SLC25A27.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A28-KO-c3
AC   CVCL_D4JP
SY   CE06ZK-H
DR   Wikidata; Q127381295
WW   Info; RESOLUTE; CE06ZK-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A28-KO-c9
AC   CVCL_D4JQ
SY   CE06ZN-P
DR   Wikidata; Q127381296
WW   Info; RESOLUTE; CE06ZN-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A29-KO-c2
AC   CVCL_D4JR
SY   CE04MC-C
DR   Wikidata; Q127381297
WW   Info; RESOLUTE; CE04MC-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20116; SLC25A29.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A29-KO-c8
AC   CVCL_D4JS
SY   CE04EA-K
DR   Wikidata; Q127381298
WW   Info; RESOLUTE; CE04EA-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20116; SLC25A29.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A30-KO-c10
AC   CVCL_D4JT
SY   CE04KW-X
DR   Wikidata; Q127381299
WW   Info; RESOLUTE; CE04KW-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27371; SLC25A30.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A30-KO-c9
AC   CVCL_D4JU
SY   CE04M0-3
DR   Wikidata; Q127381300
WW   Info; RESOLUTE; CE04M0-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27371; SLC25A30.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A32-KO-c1
AC   CVCL_D4JV
SY   CE0177-5
DR   Wikidata; Q127381301
WW   Info; RESOLUTE; CE0177-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29683; SLC25A32.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A32-KO-c5
AC   CVCL_D4JW
SY   CE017A-E
DR   Wikidata; Q127381302
WW   Info; RESOLUTE; CE017A-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29683; SLC25A32.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A33-KO-c25
AC   CVCL_D4JX
SY   CE05R7-N
DR   Wikidata; Q127381304
WW   Info; RESOLUTE; CE05R7-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29681; SLC25A33.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A33-KO-c7
AC   CVCL_D4JY
SY   CE00VG-2
DR   Wikidata; Q127381305
WW   Info; RESOLUTE; CE00VG-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29681; SLC25A33.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A36-KO-c10
AC   CVCL_D4JZ
SY   CE04EG-Y
DR   Wikidata; Q127381306
WW   Info; RESOLUTE; CE04EG-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25554; SLC25A36.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A36-KO-c8
AC   CVCL_D4K0
SY   CE04EF-G
DR   Wikidata; Q127381307
WW   Info; RESOLUTE; CE04EF-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25554; SLC25A36.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A37-KO-c2
AC   CVCL_D4K1
SY   CE04KV-A
DR   Wikidata; Q127381308
WW   Info; RESOLUTE; CE04KV-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29786; SLC25A37.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A37-KO-c6
AC   CVCL_D4K2
SY   CE066N-R
DR   Wikidata; Q127381309
WW   Info; RESOLUTE; CE066N-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29786; SLC25A37.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A38-KO-c11
AC   CVCL_D4K3
SY   CE00W6-R
DR   Wikidata; Q127381310
WW   Info; RESOLUTE; CE00W6-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26054; SLC25A38.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A38-KO-c9
AC   CVCL_D4K4
SY   CE00W7-C
DR   Wikidata; Q127381311
WW   Info; RESOLUTE; CE00W7-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26054; SLC25A38.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A39-KO-c7
AC   CVCL_D4K5
SY   CE04P9-F
DR   Wikidata; Q127381312
WW   Info; RESOLUTE; CE04P9-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24279; SLC25A39.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A39-KO-c8
AC   CVCL_D4K6
SY   CE04PA-S
DR   Wikidata; Q127381313
WW   Info; RESOLUTE; CE04PA-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24279; SLC25A39.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A4-KO-c10
AC   CVCL_D4K7
SY   CE00VC-U
DR   Wikidata; Q127381314
WW   Info; RESOLUTE; CE00VC-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A4-KO-c8
AC   CVCL_D4K8
SY   CE015B-2
DR   Wikidata; Q127381315
WW   Info; RESOLUTE; CE015B-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A40-KO-c3
AC   CVCL_D4K9
SY   CE066P-C
DR   Wikidata; Q127381316
WW   Info; RESOLUTE; CE066P-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A40-KO-c8
AC   CVCL_D4KA
SY   CE066R-5
DR   Wikidata; Q127381317
WW   Info; RESOLUTE; CE066R-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A43-KO-c18
AC   CVCL_D4KB
SY   CE04K1-S
DR   Wikidata; Q127381318
WW   Info; RESOLUTE; CE04K1-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30557; SLC25A43.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A43-KO-c4
AC   CVCL_D4KC
SY   CE042G-M
DR   Wikidata; Q127381319
WW   Info; RESOLUTE; CE042G-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30557; SLC25A43.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A44-KO-c2
AC   CVCL_D4CX
SY   CE00W9-1
DR   ATCC; CRL-3494
DR   Wikidata; Q127381320
WW   Info; RESOLUTE; CE00W9-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29036; SLC25A44.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A44-KO-c6
AC   CVCL_D4CY
SY   CE00WA-W
DR   ATCC; CRL-3495
DR   Wikidata; Q127381321
WW   Info; RESOLUTE; CE00WA-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29036; SLC25A44.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A46-KO-c11
AC   CVCL_D4CZ
SY   CE04ET-N
DR   ATCC; CRL-3506
DR   Wikidata; Q127381322
WW   Info; RESOLUTE; CE04ET-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25198; SLC25A46.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A46-KO-c12
AC   CVCL_D4D0
SY   CE04EV-H
DR   ATCC; CRL-3507
DR   Wikidata; Q127381324
WW   Info; RESOLUTE; CE04EV-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25198; SLC25A46.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A48-KO-c10
AC   CVCL_D4KD
SY   CE017B-B
DR   Wikidata; Q127381325
WW   Info; RESOLUTE; CE017B-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30451; SLC25A48.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A48-KO-c11
AC   CVCL_D4KE
SY   CE017C-7
DR   Wikidata; Q127381326
WW   Info; RESOLUTE; CE017C-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30451; SLC25A48.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A5-KO-c10
AC   CVCL_D4KF
SY   CE017G-0
DR   Wikidata; Q127381327
WW   Info; RESOLUTE; CE017G-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A5-KO-c2
AC   CVCL_D4KG
SY   CE07A1-0
DR   Wikidata; Q127381328
WW   Info; RESOLUTE; CE07A1-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A51-KO-c4
AC   CVCL_D4KH
SY   CE07A5-K
DR   Wikidata; Q127381329
WW   Info; RESOLUTE; CE07A5-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23323; SLC25A51.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A51-KO-c5
AC   CVCL_D4KI
SY   CE07A6-8
DR   Wikidata; Q127381330
WW   Info; RESOLUTE; CE07A6-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23323; SLC25A51.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A53-KO-c2
AC   CVCL_D4KJ
SY   CE04EW-Z
DR   Wikidata; Q127381331
WW   Info; RESOLUTE; CE04EW-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31894; SLC25A53.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A53-KO-c30
AC   CVCL_D4KK
SY   CE066S-1
DR   Wikidata; Q127381332
WW   Info; RESOLUTE; CE066S-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31894; SLC25A53.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A6-KO-c4
AC   CVCL_D4D1
SY   CE00WE-7
DR   ATCC; CRL-3496
DR   Wikidata; Q127381333
WW   Info; RESOLUTE; CE00WE-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10992; SLC25A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC25A6-KO-c8
AC   CVCL_D4D2
SY   CE00WF-Q
DR   ATCC; CRL-3497
DR   Wikidata; Q127381336
WW   Info; RESOLUTE; CE00WF-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10992; SLC25A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC26A11-KO-c3
AC   CVCL_D4KL
SY   CE0583-R
DR   Wikidata; Q127381337
WW   Info; RESOLUTE; CE0583-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14471; SLC26A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC26A11-KO-c4
AC   CVCL_D4KM
SY   CE0584-C
DR   Wikidata; Q127381338
WW   Info; RESOLUTE; CE0584-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14471; SLC26A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC26A6-KO-c10
AC   CVCL_D4KN
SY   CE05CZ-2
DR   Wikidata; Q127381339
WW   Info; RESOLUTE; CE05CZ-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14472; SLC26A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC26A6-KO-c2
AC   CVCL_D4KP
SY   CE05CW-0
DR   Wikidata; Q127381340
WW   Info; RESOLUTE; CE05CW-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14472; SLC26A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A1-KO-c1
AC   CVCL_D4KQ
SY   CE0586-1
DR   Wikidata; Q127381342
WW   Info; RESOLUTE; CE0586-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10995; SLC27A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A1-KO-c3
AC   CVCL_D4KR
SY   CE0587-W
DR   Wikidata; Q127381344
WW   Info; RESOLUTE; CE0587-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10995; SLC27A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A2-KO-c10
AC   CVCL_D4D3
SY   CE015F-8
DR   ATCC; CRL-3508
DR   Wikidata; Q127381346
WW   Info; RESOLUTE; CE015F-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10996; SLC27A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A2-KO-c7
AC   CVCL_D4D4
SY   CE015E-K
DR   ATCC; CRL-3509
DR   Wikidata; Q127381349
WW   Info; RESOLUTE; CE015E-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10996; SLC27A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A4-KO-c1
AC   CVCL_D4KS
SY   CE05CP-E
DR   Wikidata; Q127381351
WW   Info; RESOLUTE; CE05CP-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10998; SLC27A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A4-KO-c4
AC   CVCL_D4KT
SY   CE05CS-7
DR   Wikidata; Q127381353
WW   Info; RESOLUTE; CE05CS-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10998; SLC27A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A5-KO-c12
AC   CVCL_D4KU
SY   CE04E6-0
DR   Wikidata; Q127381355
WW   Info; RESOLUTE; CE04E6-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10999; SLC27A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A5-KO-c9
AC   CVCL_D4KV
SY   CE04E4-Q
DR   Wikidata; Q127381357
WW   Info; RESOLUTE; CE04E4-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10999; SLC27A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A6-KO-c10
AC   CVCL_D4KW
SY   CE05E0-4
DR   Wikidata; Q127381359
WW   Info; RESOLUTE; CE05E0-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11000; SLC27A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC27A6-KO-c2
AC   CVCL_D4KX
SY   CE05E3-A
DR   Wikidata; Q127381361
WW   Info; RESOLUTE; CE05E3-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11000; SLC27A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC29A1-KO-c10
AC   CVCL_D4KY
SY   CE04KH-Q
DR   Wikidata; Q127381363
WW   Info; RESOLUTE; CE04KH-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC29A1-KO-c4
AC   CVCL_D4KZ
SY   CE04KK-U
DR   Wikidata; Q127381366
WW   Info; RESOLUTE; CE04KK-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC29A4-KO-c22
AC   CVCL_D4L0
SY   CE05AC-1
DR   Wikidata; Q127381368
WW   Info; RESOLUTE; CE05AC-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23097; SLC29A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC29A4-KO-c9
AC   CVCL_D4L1
SY   CE016C-0
DR   Wikidata; Q127381370
WW   Info; RESOLUTE; CE016C-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23097; SLC29A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A1-KO-c3
AC   CVCL_D4L2
SY   CE05FT-5
DR   Wikidata; Q127381372
WW   Info; RESOLUTE; CE05FT-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A1-KO-c4
AC   CVCL_D4L3
SY   CE05FV-1
DR   Wikidata; Q127381374
WW   Info; RESOLUTE; CE05FV-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A11-KO-c7
AC   CVCL_D4L4
SY   CE058T-3
DR   Wikidata; Q127381377
WW   Info; RESOLUTE; CE058T-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14239; SLC2A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A11-KO-c9
AC   CVCL_D4L5
SY   CE058V-M
DR   Wikidata; Q127381379
WW   Info; RESOLUTE; CE058V-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14239; SLC2A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A13-KO-c10
AC   CVCL_D4L6
SY   CE05EA-F
DR   Wikidata; Q127381381
WW   Info; RESOLUTE; CE05EA-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15956; SLC2A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A13-KO-c7
AC   CVCL_D4L7
SY   CE05E8-M
DR   Wikidata; Q127381383
WW   Info; RESOLUTE; CE05E8-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15956; SLC2A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A6-KO-c6
AC   CVCL_D4L8
SY   CE04S4-2
DR   Wikidata; Q127381385
WW   Info; RESOLUTE; CE04S4-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11011; SLC2A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC2A6-KO-c8
AC   CVCL_D4L9
SY   CE04S5-4
DR   Wikidata; Q127381387
WW   Info; RESOLUTE; CE04S5-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11011; SLC2A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A1-KO-c3
AC   CVCL_D4LA
SY   CE05FX-E
DR   Wikidata; Q127381390
WW   Info; RESOLUTE; CE05FX-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11012; SLC30A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A1-KO-c4
AC   CVCL_D4LB
SY   CE05FZ-B
DR   Wikidata; Q127381392
WW   Info; RESOLUTE; CE05FZ-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11012; SLC30A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A3-KO-c14
AC   CVCL_D4LC
SY   CE05AG-B
DR   Wikidata; Q127381394
WW   Info; RESOLUTE; CE05AG-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11014; SLC30A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A3-KO-c15
AC   CVCL_D4LD
SY   CE05AH-7
DR   Wikidata; Q127381397
WW   Info; RESOLUTE; CE05AH-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11014; SLC30A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A4-KO-c10
AC   CVCL_D4LE
SY   CE05EM-R
DR   Wikidata; Q127381399
WW   Info; RESOLUTE; CE05EM-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11015; SLC30A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A4-KO-c18
AC   CVCL_D4LF
SY   CE060Z-V
DR   Wikidata; Q127381401
WW   Info; RESOLUTE; CE060Z-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11015; SLC30A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A5-KO-c5
AC   CVCL_D4LG
SY   CE06X8-T
DR   Wikidata; Q127381403
WW   Info; RESOLUTE; CE06X8-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19089; SLC30A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A5-KO-c8
AC   CVCL_D4LH
SY   CE06X9-F
DR   Wikidata; Q127381405
WW   Info; RESOLUTE; CE06X9-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19089; SLC30A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A6-KO-c1
AC   CVCL_D4LI
SY   CE066Z-Q
DR   Wikidata; Q127381407
WW   Info; RESOLUTE; CE066Z-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19305; SLC30A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A6-KO-c2
AC   CVCL_D4LJ
SY   CE0670-U
DR   Wikidata; Q127381410
WW   Info; RESOLUTE; CE0670-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19305; SLC30A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A7-KO-c4
AC   CVCL_D4LK
SY   CE06HT-E
DR   Wikidata; Q127381412
WW   Info; RESOLUTE; CE06HT-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19306; SLC30A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC30A7-KO-c8
AC   CVCL_D4LL
SY   CE06HV-B
DR   Wikidata; Q127381414
WW   Info; RESOLUTE; CE06HV-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19306; SLC30A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC31A1-KO-c12
AC   CVCL_D4LM
SY   CE04MA-P
DR   Wikidata; Q127381416
WW   Info; RESOLUTE; CE04MA-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11016; SLC31A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC31A1-KO-c35
AC   CVCL_D4LN
SY   CE06HZ-U
DR   Wikidata; Q127381417
WW   Info; RESOLUTE; CE06HZ-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11016; SLC31A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC31A2-KO-c1
AC   CVCL_D4LP
SY   CE06Z0-6
DR   Wikidata; Q127381418
WW   Info; RESOLUTE; CE06Z0-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11017; SLC31A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC31A2-KO-c9
AC   CVCL_D4LQ
SY   CE06Z2-4
DR   Wikidata; Q127381419
WW   Info; RESOLUTE; CE06Z2-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11017; SLC31A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC33A1-KO-c6
AC   CVCL_D4LR
SY   CE06K0-0
DR   Wikidata; Q127381420
WW   Info; RESOLUTE; CE06K0-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:95; SLC33A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC33A1-KO-c9
AC   CVCL_D4LS
SY   CE06K1-6
DR   Wikidata; Q127381421
WW   Info; RESOLUTE; CE06K1-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:95; SLC33A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A2-KO-c2
AC   CVCL_D4LT
SY   CE06K2-2
DR   Wikidata; Q127381422
WW   Info; RESOLUTE; CE06K2-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11022; SLC35A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A2-KO-c4
AC   CVCL_D4LU
SY   CE06K3-4
DR   Wikidata; Q127381423
WW   Info; RESOLUTE; CE06K3-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11022; SLC35A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A3-KO-c5
AC   CVCL_D4LV
SY   CE06K6-A
DR   Wikidata; Q127381424
WW   Info; RESOLUTE; CE06K6-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11023; SLC35A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A3-KO-c7
AC   CVCL_D4LW
SY   CE06K7-X
DR   Wikidata; Q127381425
WW   Info; RESOLUTE; CE06K7-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11023; SLC35A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A4-KO-c20
AC   CVCL_D4LX
SY   CE05AM-U
DR   Wikidata; Q127381426
WW   Info; RESOLUTE; CE05AM-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20753; SLC35A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A4-KO-c7
AC   CVCL_D4LY
SY   CE04F2-1
DR   Wikidata; Q127381427
WW   Info; RESOLUTE; CE04F2-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20753; SLC35A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A5-KO-c1
AC   CVCL_D4LZ
SY   CE04E7-6
DR   Wikidata; Q127381428
WW   Info; RESOLUTE; CE04E7-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20792; SLC35A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35A5-KO-c9
AC   CVCL_D4M0
SY   CE04E8-2
DR   Wikidata; Q127381429
WW   Info; RESOLUTE; CE04E8-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20792; SLC35A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35B2-KO-c4
AC   CVCL_D4M1
SY   CE06K9-Y
DR   Wikidata; Q127381430
WW   Info; RESOLUTE; CE06K9-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16872; SLC35B2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35B2-KO-c5
AC   CVCL_D4M2
SY   CE06KA-3
DR   Wikidata; Q127381431
WW   Info; RESOLUTE; CE06KA-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16872; SLC35B2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35B3-KO-c11
AC   CVCL_D4D5
SY   CE0167-E
DR   ATCC; CRL-3500
DR   Wikidata; Q127381432
WW   Info; RESOLUTE; CE0167-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21601; SLC35B3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35B3-KO-c9
AC   CVCL_D4D6
SY   CE0166-W
DR   ATCC; CRL-3501
DR   Wikidata; Q127381433
WW   Info; RESOLUTE; CE0166-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21601; SLC35B3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35B4-KO-c10
AC   CVCL_D4M3
SY   CE06N2-B
DR   Wikidata; Q127381434
WW   Info; RESOLUTE; CE06N2-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20584; SLC35B4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35B4-KO-c7
AC   CVCL_D4M4
SY   CE06N3-7
DR   Wikidata; Q127381435
WW   Info; RESOLUTE; CE06N3-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20584; SLC35B4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35C1-KO-c1
AC   CVCL_D4M5
SY   CE06SH-6
DR   Wikidata; Q127381436
WW   Info; RESOLUTE; CE06SH-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35C1-KO-c2
AC   CVCL_D4M6
SY   CE06SK-2
DR   Wikidata; Q127381437
WW   Info; RESOLUTE; CE06SK-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35C2-KO-c18
AC   CVCL_D4M7
SY   CE06SV-Y
DR   Wikidata; Q127381438
WW   Info; RESOLUTE; CE06SV-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17117; SLC35C2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35C2-KO-c7
AC   CVCL_D4M8
SY   CE05EK-P
DR   Wikidata; Q127381439
WW   Info; RESOLUTE; CE05EK-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17117; SLC35C2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E1-KO-c4
AC   CVCL_D4M9
SY   CE0672-6
DR   Wikidata; Q127381440
WW   Info; RESOLUTE; CE0672-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20803; SLC35E1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E1-KO-c5
AC   CVCL_D4MA
SY   CE0673-2
DR   Wikidata; Q127381441
WW   Info; RESOLUTE; CE0673-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20803; SLC35E1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E2A-KO-c10
AC   CVCL_D4MB
SY   CE0169-7
DR   Wikidata; Q127381442
WW   Info; RESOLUTE; CE0169-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20863; SLC35E2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E2A-KO-c29
AC   CVCL_D4MC
SY   CE05RN-Q
DR   Wikidata; Q127381443
WW   Info; RESOLUTE; CE05RN-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20863; SLC35E2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E2B-KO-c15
AC   CVCL_D4MD
SY   CE06RF-2
DR   Wikidata; Q127381444
WW   Info; RESOLUTE; CE06RF-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33941; SLC35E2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E2B-KO-c8
AC   CVCL_D4ME
SY   CE06RE-6
DR   Wikidata; Q127381445
WW   Info; RESOLUTE; CE06RE-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33941; SLC35E2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E3-KO-c7
AC   CVCL_D4MF
SY   CE06KF-S
DR   Wikidata; Q127381446
WW   Info; RESOLUTE; CE06KF-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20864; SLC35E3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E3-KO-c9
AC   CVCL_D4MG
SY   CE06KG-9
DR   Wikidata; Q127381447
WW   Info; RESOLUTE; CE06KG-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20864; SLC35E3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E4-KO-c4
AC   CVCL_D4MH
SY   CE04S0-Q
DR   Wikidata; Q127381448
WW   Info; RESOLUTE; CE04S0-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17058; SLC35E4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35E4-KO-c8
AC   CVCL_D4MI
SY   CE04S2-0
DR   Wikidata; Q127381449
WW   Info; RESOLUTE; CE04S2-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17058; SLC35E4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35F2-KO-c2
AC   CVCL_D4D7
SY   CE04CK-S
DR   ATCC; CRL-3502
DR   Wikidata; Q127381450
WW   Info; RESOLUTE; CE04CK-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23615; SLC35F2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35F2-KO-c3
AC   CVCL_D4D8
SY   CE04CM-9
DR   ATCC; CRL-3503
DR   Wikidata; Q127381451
WW   Info; RESOLUTE; CE04CM-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23615; SLC35F2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35F3-KO-c2
AC   CVCL_D4MJ
SY   CE0589-B
DR   Wikidata; Q127381453
WW   Info; RESOLUTE; CE0589-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23616; SLC35F3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35F3-KO-c3
AC   CVCL_D4MK
SY   CE058A-7
DR   Wikidata; Q127381454
WW   Info; RESOLUTE; CE058A-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23616; SLC35F3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35F6-KO-c1
AC   CVCL_D4ML
SY   CE07A7-A
DR   Wikidata; Q127381455
WW   Info; RESOLUTE; CE07A7-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26055; SLC35F6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35F6-KO-c10
AC   CVCL_D4MM
SY   CE07A8-X
DR   Wikidata; Q127381456
WW   Info; RESOLUTE; CE07A8-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26055; SLC35F6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35F6-KO-c8
AC   CVCL_D4MN
SY   CE05EH-Z
DR   Wikidata; Q127381457
WW   Info; RESOLUTE; CE05EH-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26055; SLC35F6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35G1-KO-c3
AC   CVCL_D4MP
SY   CE05H4-Q
DR   Wikidata; Q127381458
WW   Info; RESOLUTE; CE05H4-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26607; SLC35G1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC35G1-KO-c4
AC   CVCL_D4MQ
SY   CE05H5-U
DR   Wikidata; Q127381459
WW   Info; RESOLUTE; CE05H5-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26607; SLC35G1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC36A1-KO-c1
AC   CVCL_D4MR
SY   CE04E2-B
DR   Wikidata; Q127381460
WW   Info; RESOLUTE; CE04E2-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18761; SLC36A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC36A1-KO-c11
AC   CVCL_D4MS
SY   CE04E3-7
DR   Wikidata; Q127381461
WW   Info; RESOLUTE; CE04E3-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18761; SLC36A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC36A4-KO-c3
AC   CVCL_D4MT
SY   CE06N5-U
DR   Wikidata; Q127381462
WW   Info; RESOLUTE; CE06N5-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19660; SLC36A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC36A4-KO-c5
AC   CVCL_D4MU
SY   CE06N6-0
DR   Wikidata; Q127381463
WW   Info; RESOLUTE; CE06N6-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19660; SLC36A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC37A3-KO-c11
AC   CVCL_D4MV
SY   CE07AA-Y
DR   Wikidata; Q127381465
WW   Info; RESOLUTE; CE07AA-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20651; SLC37A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC37A3-KO-c4
AC   CVCL_D4MW
SY   CE05EN-C
DR   Wikidata; Q127381466
WW   Info; RESOLUTE; CE05EN-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20651; SLC37A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC37A3-KO-c9
AC   CVCL_D4MX
SY   CE07AC-M
DR   Wikidata; Q127381467
WW   Info; RESOLUTE; CE07AC-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20651; SLC37A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A1-KO-c5
AC   CVCL_D4MY
SY   CE070K-9
DR   Wikidata; Q127381468
WW   Info; RESOLUTE; CE070K-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13447; SLC38A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A1-KO-c7
AC   CVCL_D4MZ
SY   CE070M-V
DR   Wikidata; Q127381469
WW   Info; RESOLUTE; CE070M-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13447; SLC38A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A10-KO-c5
AC   CVCL_D4N0
SY   CE07AE-T
DR   Wikidata; Q127381470
WW   Info; RESOLUTE; CE07AE-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28237; SLC38A10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A10-KO-c6
AC   CVCL_D4N1
SY   CE07AF-F
DR   Wikidata; Q127381471
WW   Info; RESOLUTE; CE07AF-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28237; SLC38A10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A2-KO-c1
AC   CVCL_D4N2
SY   CE07AK-V
DR   Wikidata; Q127381472
WW   Info; RESOLUTE; CE07AK-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13448; SLC38A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A2-KO-c3
AC   CVCL_D4N3
SY   CE07AM-N
DR   Wikidata; Q127381473
WW   Info; RESOLUTE; CE07AM-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13448; SLC38A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A5-KO-c2
AC   CVCL_D4N4
SY   CE056F-X
DR   Wikidata; Q127381474
WW   Info; RESOLUTE; CE056F-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18070; SLC38A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A5-KO-c8
AC   CVCL_D4N5
SY   CE056K-3
DR   Wikidata; Q127381475
WW   Info; RESOLUTE; CE056K-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18070; SLC38A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A7-KO-c1
AC   CVCL_D4N6
SY   CE04PB-9
DR   Wikidata; Q127381476
WW   Info; RESOLUTE; CE04PB-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25582; SLC38A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A7-KO-c22
AC   CVCL_D4N7
SY   CE053F-V
DR   Wikidata; Q127381477
WW   Info; RESOLUTE; CE053F-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25582; SLC38A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A9-KO-c1
AC   CVCL_D4N8
SY   CE06ZR-C
DR   Wikidata; Q127381478
WW   Info; RESOLUTE; CE06ZR-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC38A9-KO-c8
AC   CVCL_D4N9
SY   CE06ZV-W
DR   Wikidata; Q127381479
WW   Info; RESOLUTE; CE06ZV-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A1-KO-c10
AC   CVCL_D4NA
SY   CE055P-V
DR   Wikidata; Q127381480
WW   Info; RESOLUTE; CE055P-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12876; SLC39A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A1-KO-c8
AC   CVCL_D4NB
SY   CE055N-9
DR   Wikidata; Q127381481
WW   Info; RESOLUTE; CE055N-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12876; SLC39A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A11-KO-c23
AC   CVCL_D4NC
SY   CE07EM-G
DR   Wikidata; Q127381482
WW   Info; RESOLUTE; CE07EM-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14463; SLC39A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A11-KO-c5
AC   CVCL_D4ND
SY   CE0562-E
DR   Wikidata; Q127381483
WW   Info; RESOLUTE; CE0562-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14463; SLC39A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A13-KO-c5
AC   CVCL_D4NE
SY   CE06KH-V
DR   Wikidata; Q127381484
WW   Info; RESOLUTE; CE06KH-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20859; SLC39A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A13-KO-c6
AC   CVCL_D4NF
SY   CE06KK-N
DR   Wikidata; Q127381485
WW   Info; RESOLUTE; CE06KK-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20859; SLC39A13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A14-KO-c8
AC   CVCL_D4NG
SY   CE0555-6
DR   Wikidata; Q127381487
WW   Info; RESOLUTE; CE0555-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20858; SLC39A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A14-KO-c9
AC   CVCL_D4NH
SY   CE0556-2
DR   Wikidata; Q127381488
WW   Info; RESOLUTE; CE0556-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20858; SLC39A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A3-KO-c2
AC   CVCL_D4NI
SY   CE055B-X
DR   Wikidata; Q127381489
WW   Info; RESOLUTE; CE055B-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17128; SLC39A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A3-KO-c4
AC   CVCL_D4NJ
SY   CE055C-G
DR   Wikidata; Q127381490
WW   Info; RESOLUTE; CE055C-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17128; SLC39A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A4-KO-c16
AC   CVCL_D4NK
SY   CE06RN-X
DR   Wikidata; Q127381491
WW   Info; RESOLUTE; CE06RN-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17129; SLC39A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A4-KO-c5
AC   CVCL_D4NL
SY   CE06RK-8
DR   Wikidata; Q127381492
WW   Info; RESOLUTE; CE06RK-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17129; SLC39A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A6-KO-c12
AC   CVCL_D4NM
SY   CE0590-9
DR   Wikidata; Q127381494
WW   Info; RESOLUTE; CE0590-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18607; SLC39A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A6-KO-c8
AC   CVCL_D4NN
SY   CE058Z-S
DR   Wikidata; Q127381495
WW   Info; RESOLUTE; CE058Z-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18607; SLC39A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A7-KO-c15
AC   CVCL_D4NP
SY   CE07EN-Y
DR   Wikidata; Q127381496
WW   Info; RESOLUTE; CE07EN-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4927; SLC39A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A7-KO-c8
AC   CVCL_D4NQ
SY   CE06Z4-8
DR   Wikidata; Q127381497
WW   Info; RESOLUTE; CE06Z4-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4927; SLC39A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A8-KO-c6
AC   CVCL_D4NR
SY   CE04PC-V
DR   Wikidata; Q127381498
WW   Info; RESOLUTE; CE04PC-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A8-KO-c9
AC   CVCL_D4NS
SY   CE04PE-N
DR   Wikidata; Q127381499
WW   Info; RESOLUTE; CE04PE-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A9-KO-c1
AC   CVCL_D4NT
SY   CE04PG-Z
DR   Wikidata; Q127381500
WW   Info; RESOLUTE; CE04PG-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20182; SLC39A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC39A9-KO-c14
AC   CVCL_D4NU
SY   CE053H-H
DR   Wikidata; Q127381501
WW   Info; RESOLUTE; CE053H-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20182; SLC39A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC3A2-KO-c6
AC   CVCL_D4NV
SY   CE05S5-T
DR   Wikidata; Q127381502
WW   Info; RESOLUTE; CE05S5-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11026; SLC3A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC41A1-KO-c5
AC   CVCL_D4NW
SY   CE055V-P
DR   Wikidata; Q127381503
WW   Info; RESOLUTE; CE055V-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19429; SLC41A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC41A1-KO-c7
AC   CVCL_D4NX
SY   CE055W-R
DR   Wikidata; Q127381504
WW   Info; RESOLUTE; CE055W-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19429; SLC41A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC41A2-KO-c4
AC   CVCL_D4NY
SY   CE04PH-P
DR   Wikidata; Q127381505
WW   Info; RESOLUTE; CE04PH-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31045; SLC41A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC41A2-KO-c6
AC   CVCL_D4NZ
SY   CE04PK-R
DR   Wikidata; Q127381506
WW   Info; RESOLUTE; CE04PK-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31045; SLC41A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC41A3-KO-c10
AC   CVCL_D4P0
SY   CE056P-F
DR   Wikidata; Q127381507
WW   Info; RESOLUTE; CE056P-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31046; SLC41A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC41A3-KO-c6
AC   CVCL_D4P1
SY   CE056N-T
DR   Wikidata; Q127381510
WW   Info; RESOLUTE; CE056N-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31046; SLC41A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC43A2-KO-c7
AC   CVCL_D4P2
SY   CE06KR-R
DR   Wikidata; Q127381511
WW   Info; RESOLUTE; CE06KR-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23087; SLC43A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC43A2-KO-c9
AC   CVCL_D4P3
SY   CE06KT-5
DR   Wikidata; Q127381512
WW   Info; RESOLUTE; CE06KT-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23087; SLC43A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC44A1-KO-c14
AC   CVCL_D4P4
SY   CE053K-Z
DR   Wikidata; Q127381513
WW   Info; RESOLUTE; CE053K-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18798; SLC44A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC44A1-KO-c32
AC   CVCL_D4P5
SY   CE0617-1
DR   Wikidata; Q127381514
WW   Info; RESOLUTE; CE0617-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18798; SLC44A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC44A2-KO-c1
AC   CVCL_D4P6
SY   CE058E-0
DR   Wikidata; Q127381515
WW   Info; RESOLUTE; CE058E-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17292; SLC44A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC44A2-KO-c2
AC   CVCL_D4P7
SY   CE058F-6
DR   Wikidata; Q127381516
WW   Info; RESOLUTE; CE058F-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17292; SLC44A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC44A3-KO-c2
AC   CVCL_D4P8
SY   CE055Z-5
DR   Wikidata; Q127381517
WW   Info; RESOLUTE; CE055Z-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28689; SLC44A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC44A3-KO-c8
AC   CVCL_D4P9
SY   CE0560-1
DR   Wikidata; Q127381518
WW   Info; RESOLUTE; CE0560-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28689; SLC44A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC45A1-KO-c2
AC   CVCL_D4PA
SY   CE04PN-5
DR   Wikidata; Q127381519
WW   Info; RESOLUTE; CE04PN-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17939; SLC45A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC45A1-KO-c4
AC   CVCL_D4PB
SY   CE04PP-1
DR   Wikidata; Q127381520
WW   Info; RESOLUTE; CE04PP-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17939; SLC45A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC45A3-KO-c10
AC   CVCL_D4PC
SY   CE04PX-U
DR   Wikidata; Q127381521
WW   Info; RESOLUTE; CE04PX-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8642; SLC45A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC45A3-KO-c6
AC   CVCL_D4PD
SY   CE04PW-Q
DR   Wikidata; Q127381522
WW   Info; RESOLUTE; CE04PW-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8642; SLC45A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC45A4-KO-c10
AC   CVCL_D4PE
SY   CE04R1-2
DR   Wikidata; Q127381523
WW   Info; RESOLUTE; CE04R1-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29196; SLC45A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC45A4-KO-c7
AC   CVCL_D4PF
SY   CE04PZ-0
DR   Wikidata; Q127381524
WW   Info; RESOLUTE; CE04PZ-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29196; SLC45A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC45A4-KO-c8
AC   CVCL_D4PG
SY   CE04R0-6
DR   Wikidata; Q127381525
WW   Info; RESOLUTE; CE04R0-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29196; SLC45A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC46A1-KO-c11
AC   CVCL_D4PH
SY   CE055S-H
DR   Wikidata; Q127381526
WW   Info; RESOLUTE; CE055S-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30521; SLC46A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC46A1-KO-c5
AC   CVCL_D4PI
SY   CE055R-N
DR   Wikidata; Q127381527
WW   Info; RESOLUTE; CE055R-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30521; SLC46A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC48A1-KO-c10
AC   CVCL_D4PJ
SY   CE06M1-Q
DR   Wikidata; Q127381529
WW   Info; RESOLUTE; CE06M1-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26035; SLC48A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC48A1-KO-c5
AC   CVCL_D4PK
SY   CE06KZ-B
DR   Wikidata; Q127381530
WW   Info; RESOLUTE; CE06KZ-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26035; SLC48A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC49A3-KO-c10
AC   CVCL_D4PL
SY   CE06RR-Y
DR   Wikidata; Q127381531
WW   Info; RESOLUTE; CE06RR-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26177; SLC49A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC49A3-KO-c7
AC   CVCL_D4PM
SY   CE06RP-G
DR   Wikidata; Q127381532
WW   Info; RESOLUTE; CE06RP-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26177; SLC49A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A11-KO-c6
AC   CVCL_D4PN
SY   CE07AR-P
DR   Wikidata; Q127381533
WW   Info; RESOLUTE; CE07AR-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16438; SLC4A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A11-KO-c9
AC   CVCL_D4PP
SY   CE07AS-R
DR   Wikidata; Q127381534
WW   Info; RESOLUTE; CE07AS-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16438; SLC4A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A2-KO-c3
AC   CVCL_D4PQ
SY   CE0564-7
DR   Wikidata; Q127381535
WW   Info; RESOLUTE; CE0564-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11028; SLC4A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A2-KO-c5
AC   CVCL_D4PR
SY   CE0565-Q
DR   Wikidata; Q127381536
WW   Info; RESOLUTE; CE0565-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11028; SLC4A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A3-KO-c12
AC   CVCL_D4PS
SY   CE05S9-V
DR   Wikidata; Q127381537
WW   Info; RESOLUTE; CE05S9-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11029; SLC4A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A3-KO-c8
AC   CVCL_D4PT
SY   CE05S8-9
DR   Wikidata; Q127381538
WW   Info; RESOLUTE; CE05S8-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11029; SLC4A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A7-KO-c10
AC   CVCL_D4PU
SY   CE05H6-0
DR   Wikidata; Q127381539
WW   Info; RESOLUTE; CE05H6-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11033; SLC4A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC4A7-KO-c20
AC   CVCL_D4PV
SY   CE07AT-C
DR   Wikidata; Q127381540
WW   Info; RESOLUTE; CE07AT-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11033; SLC4A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC50A1-KO-c4
AC   CVCL_D4PW
SY   CE06M3-0
DR   Wikidata; Q127381541
WW   Info; RESOLUTE; CE06M3-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30657; SLC50A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC50A1-KO-c8
AC   CVCL_D4PX
SY   CE06M4-6
DR   Wikidata; Q127381542
WW   Info; RESOLUTE; CE06M4-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30657; SLC50A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC52A2-KO-c4
AC   CVCL_D4PY
SY   CE06ZA-M
DR   Wikidata; Q127381543
WW   Info; RESOLUTE; CE06ZA-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30224; SLC52A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC52A2-KO-c7
AC   CVCL_D4PZ
SY   CE06ZB-T
DR   Wikidata; Q127381544
WW   Info; RESOLUTE; CE06ZB-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30224; SLC52A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC52A3-KO-c12
AC   CVCL_D4Q0
SY   CE0559-8
DR   Wikidata; Q127381545
WW   Info; RESOLUTE; CE0559-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16187; SLC52A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC52A3-KO-c5
AC   CVCL_D4Q1
SY   CE0558-K
DR   Wikidata; Q127381546
WW   Info; RESOLUTE; CE0558-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16187; SLC52A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC5A3-KO-c6
AC   CVCL_D4Q2
SY   CE06ZG-V
DR   Wikidata; Q127381547
WW   Info; RESOLUTE; CE06ZG-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11038; SLC5A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC5A3-KO-c7
AC   CVCL_D4Q3
SY   CE06ZH-N
DR   Wikidata; Q127381549
WW   Info; RESOLUTE; CE06ZH-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11038; SLC5A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC5A6-KO-c3
AC   CVCL_D4Q4
SY   CE055F-3
DR   Wikidata; Q127381550
WW   Info; RESOLUTE; CE055F-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11041; SLC5A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC5A6-KO-c5
AC   CVCL_D4Q5
SY   CE055H-T
DR   Wikidata; Q127381551
WW   Info; RESOLUTE; CE055H-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11041; SLC5A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A16-KO-c10
AC   CVCL_D4Q6
SY   CE05G3-0
DR   Wikidata; Q127381552
WW   Info; RESOLUTE; CE05G3-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13622; SLC6A16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A16-KO-c9
AC   CVCL_D4Q7
SY   CE05G2-U
DR   Wikidata; Q127381553
WW   Info; RESOLUTE; CE05G2-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13622; SLC6A16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A17-KO-c2
AC   CVCL_D4Q8
SY   CE0567-0
DR   Wikidata; Q127381554
WW   Info; RESOLUTE; CE0567-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31399; SLC6A17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A17-KO-c6
AC   CVCL_D4Q9
SY   CE0568-6
DR   Wikidata; Q127381556
WW   Info; RESOLUTE; CE0568-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31399; SLC6A17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A6-KO-c8
AC   CVCL_D4QA
SY   CE056B-K
DR   Wikidata; Q127381557
WW   Info; RESOLUTE; CE056B-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11052; SLC6A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A6-KO-c9
AC   CVCL_D4QB
SY   CE056C-8
DR   Wikidata; Q127381558
WW   Info; RESOLUTE; CE056C-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11052; SLC6A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A8-KO-c10
AC   CVCL_D4QC
SY   CE0700-Q
DR   Wikidata; Q127381559
WW   Info; RESOLUTE; CE0700-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11055; SLC6A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC6A8-KO-c8
AC   CVCL_D4QD
SY   CE06ZX-B
DR   Wikidata; Q127381560
WW   Info; RESOLUTE; CE06ZX-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11055; SLC6A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC7A1-KO-c3
AC   CVCL_D4QE
SY   CE05G5-2
DR   Wikidata; Q127381561
WW   Info; RESOLUTE; CE05G5-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11057; SLC7A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC7A1-KO-c5
AC   CVCL_D4QF
SY   CE05G7-K
DR   Wikidata; Q127381562
WW   Info; RESOLUTE; CE05G7-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11057; SLC7A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC7A11-KO-c11
AC   CVCL_D4QG
SY   CE07AV-5
DR   Wikidata; Q127381563
WW   Info; RESOLUTE; CE07AV-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11059; SLC7A11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC7A5-KO-c12
AC   CVCL_D4QH
SY   CE051K-W
DR   Wikidata; Q127381564
WW   Info; RESOLUTE; CE051K-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC7A5-KO-c21
AC   CVCL_D4QI
SY   CE051H-1
DR   Wikidata; Q127381565
WW   Info; RESOLUTE; CE051H-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC7A6-KO-c10
AC   CVCL_D4QJ
SY   CE056X-Z
DR   Wikidata; Q127381566
WW   Info; RESOLUTE; CE056X-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11064; SLC7A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC7A6-KO-c6
AC   CVCL_D4QK
SY   CE056W-H
DR   Wikidata; Q127381567
WW   Info; RESOLUTE; CE056W-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11064; SLC7A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC8A2-KO-c4
AC   CVCL_D4QL
SY   CE04R5-A
DR   Wikidata; Q127381568
WW   Info; RESOLUTE; CE04R5-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11069; SLC8A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC8A2-KO-c6
AC   CVCL_D4QM
SY   CE04R6-X
DR   Wikidata; Q127381569
WW   Info; RESOLUTE; CE04R6-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11069; SLC8A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC8B1-KO-c5
AC   CVCL_D4QN
SY   CE056R-S
DR   Wikidata; Q127381570
WW   Info; RESOLUTE; CE056R-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26175; SLC8B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC8B1-KO-c6
AC   CVCL_D4QP
SY   CE056S-9
DR   Wikidata; Q127381571
WW   Info; RESOLUTE; CE056S-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26175; SLC8B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A1-KO-c12
AC   CVCL_D4QQ
SY   CE04R8-Y
DR   Wikidata; Q127381572
WW   Info; RESOLUTE; CE04R8-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A1-KO-c5
AC   CVCL_D4QR
SY   CE04R7-G
DR   Wikidata; Q127381573
WW   Info; RESOLUTE; CE04R7-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A5-KO-c7
AC   CVCL_D4QS
SY   CE04RB-T
DR   Wikidata; Q127381574
WW   Info; RESOLUTE; CE04RB-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11078; SLC9A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A5-KO-c8
AC   CVCL_D4QT
SY   CE04RC-F
DR   Wikidata; Q127381575
WW   Info; RESOLUTE; CE04RC-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11078; SLC9A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A6-KO-c16
AC   CVCL_D4QU
SY   CE05SW-6
DR   Wikidata; Q127381576
WW   Info; RESOLUTE; CE05SW-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11079; SLC9A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A6-KO-c21
AC   CVCL_D4QV
SY   CE05SX-2
DR   Wikidata; Q127381577
WW   Info; RESOLUTE; CE05SX-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11079; SLC9A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A7-KO-c15
AC   CVCL_D4QW
SY   CE06M5-2
DR   Wikidata; Q127381578
WW   Info; RESOLUTE; CE06M5-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17123; SLC9A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A7-KO-c22
AC   CVCL_D4QX
SY   CE06M6-4
DR   Wikidata; Q127381579
WW   Info; RESOLUTE; CE06M6-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17123; SLC9A7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A8-KO-c12
AC   CVCL_D4QY
SY   CE0676-8
DR   Wikidata; Q127381580
WW   Info; RESOLUTE; CE0676-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20728; SLC9A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9A8-KO-c2
AC   CVCL_D4QZ
SY   CE0674-4
DR   Wikidata; Q127381581
WW   Info; RESOLUTE; CE0674-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20728; SLC9A8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9B2-KO-c2
AC   CVCL_D4R0
SY   CE0740-N
DR   Wikidata; Q127381583
WW   Info; RESOLUTE; CE0740-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25143; SLC9B2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLC9B2-KO-c8
AC   CVCL_D4R1
SY   CE0702-0
DR   Wikidata; Q127381584
WW   Info; RESOLUTE; CE0702-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25143; SLC9B2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLCO4A1-KO-c5
AC   CVCL_D4R2
SY   CE04RN-P
DR   Wikidata; Q127381585
WW   Info; RESOLUTE; CE04RN-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10953; SLCO4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SLCO4A1-KO-c9
AC   CVCL_D4R3
SY   CE04RP-R
DR   Wikidata; Q127381586
WW   Info; RESOLUTE; CE04RP-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10953; SLCO4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SN50
AC   CVCL_Y553
DR   cancercelllines; CVCL_Y553
DR   Wikidata; Q54882059
RX   PubMed=15027118;
RX   PubMed=18340113;
RX   PubMed=21619602;
CC   Population: Caucasian.
CC   Doubling time: 23.2 hours (PubMed=21619602).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Leu617Ile (c.1849C>A); Zygosity=Homozygous (PubMed=21619602).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7PT ! HCT116-s
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 16
//
ID   HCT116-SN6
AC   CVCL_Y554
DR   cancercelllines; CVCL_Y554
DR   Wikidata; Q54882061
RX   PubMed=15027118;
RX   PubMed=18340113;
RX   PubMed=21619602;
CC   Population: Caucasian.
CC   Doubling time: 31.7 hours (PubMed=21619602).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg621His (c.1862G>A); Zygosity=Heterozygous (PubMed=21619602).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu710Gly (c.2129A>G); Zygosity=Heterozygous (PubMed=21619602).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7PT ! HCT116-s
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 17
//
ID   HCT116-SPNS1-KO-c15
AC   CVCL_D4R4
SY   CE061T-Y
DR   Wikidata; Q127381587
WW   Info; RESOLUTE; CE061T-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-SPNS1-KO-c16
AC   CVCL_D4R5
SY   CE061V-3
DR   Wikidata; Q127381588
WW   Info; RESOLUTE; CE061V-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-TMEM104-KO-c4
AC   CVCL_D4R6
SY   CE0705-4
DR   Wikidata; Q127381590
WW   Info; RESOLUTE; CE0705-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25984; TMEM104.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-TMEM104-KO-c5
AC   CVCL_D4R7
SY   CE0706-K
DR   Wikidata; Q127381591
WW   Info; RESOLUTE; CE0706-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25984; TMEM104.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-TMEM165-KO-c21
AC   CVCL_D4R8
SY   CE062A-1
DR   Wikidata; Q127381592
WW   Info; RESOLUTE; CE062A-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30760; TMEM165.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-TMEM165-KO-c36
AC   CVCL_D4R9
SY   CE06M7-K
DR   Wikidata; Q127381593
WW   Info; RESOLUTE; CE06M7-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30760; TMEM165.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-TMEM241-KO-c3
AC   CVCL_D4RA
SY   CE070A-G
DR   Wikidata; Q127381595
WW   Info; RESOLUTE; CE070A-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31723; TMEM241.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-TMEM241-KO-c4
AC   CVCL_D4RB
SY   CE070B-Y
DR   Wikidata; Q127381596
WW   Info; RESOLUTE; CE070B-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31723; TMEM241.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-TrxR1-KO
AC   CVCL_C3N9
DR   Wikidata; Q116049289
RX   PubMed=35355475;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12437; TXNRD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HCT116-UNC93B1-KO-c20
AC   CVCL_D4RC
SY   CE06RX-S
DR   Wikidata; Q127381597
WW   Info; RESOLUTE; CE06RX-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13481; UNC93B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-UNC93B1-KO-c24
AC   CVCL_D4RD
SY   CE06RZ-9
DR   Wikidata; Q127381598
WW   Info; RESOLUTE; CE06RZ-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13481; UNC93B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-XPR1-KO-c20
AC   CVCL_D4RE
SY   CE07ER-M
DR   Wikidata; Q127381599
WW   Info; RESOLUTE; CE07ER-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12827; XPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-XPR1-KO-c9
AC   CVCL_D4RF
SY   CE07AW-1
DR   Wikidata; Q127381600
WW   Info; RESOLUTE; CE07AW-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12827; XPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HCT116-XRCC4(+/-)
AC   CVCL_T772
SY   XRCC4+/-
DR   cancercelllines; CVCL_T772
DR   RCB; RCB2980
DR   Wikidata; Q54882062
RX   PubMed=21785230;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12831; XRCC4 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   HCT116-XRCC4(-/-)
AC   CVCL_T773
SY   XRCC4-/-
DR   cancercelllines; CVCL_T773
DR   RCB; RCB2981
DR   Wikidata; Q54882063
RX   PubMed=21785230;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12831; XRCC4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   HCT116/4008#13 rho-0
AC   CVCL_C0DW
DR   cancercelllines; CVCL_C0DW
DR   CancerTools; 162189
DR   Kerafast; ESA116
DR   Wikidata; Q112929653
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Produced by transient transfection with plasmid pMA4008 encoding HSV-1 UL12.5M185 protein, which damages mtDNA by an unknown mechanism.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   HCT116/5FUR
AC   CVCL_AU09
DR   cancercelllines; CVCL_AU09
DR   Wikidata; Q54882064
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HCT116/BEVA
AC   CVCL_AU10
DR   cancercelllines; CVCL_AU10
DR   Wikidata; Q54882065
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00112; Bevacizumab (Avastin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   HCT116/C
AC   CVCL_E9WC
RX   DOI=10.1134/S1990519X22060037;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HCT116/Cas9 AAVS1
AC   CVCL_C9EW
SY   HCT116/CBH-Cas9-HYG-AAVS1
DR   GeneCopoeia; SL572
DR   Wikidata; Q123031572
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL572).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HCT116/OXR
AC   CVCL_E7ZE
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HCT116/SN38R
AC   CVCL_AU11
DR   cancercelllines; CVCL_AU11
DR   Wikidata; Q54882066
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HCT116nut
AC   CVCL_C0UT
DR   cancercelllines; CVCL_C0UT
DR   Wikidata; Q112929654
RX   PubMed=33974899;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   HCT116tax
AC   CVCL_C0UU
DR   cancercelllines; CVCL_C0UU
DR   Wikidata; Q112929655
RX   PubMed=33974899;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   HCTK-1
AC   CVCL_5763
SY   HCTK1
DR   BTO; BTO_0004018
DR   Wikidata; Q54882067
RX   PubMed=8561821;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HCu 10
AC   CVCL_M850
SY   Hcu 10; HCU 10; HCu-10
DR   BioSample; SAMN03151647
DR   Wikidata; Q54882068
RX   PubMed=3167823;
RX   PubMed=6571927;
RX   PubMed=7408279;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00056.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M852 ! HCu 18
OI   CVCL_M853 ! HCu 22
OI   CVCL_M854 ! HCu 27
OI   CVCL_M855 ! HCu 33
OI   CVCL_M856 ! HCu 37
OI   CVCL_M857 ! HCu 39
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HCu 13
AC   CVCL_M851
SY   Hcu 13; HCU 13; HCu-13; HCU-13
DR   Wikidata; Q54882069
RX   PubMed=2302677;
RX   PubMed=2420787;
RX   PubMed=3167823;
RX   PubMed=6571927;
RX   PubMed=7408279;
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HCu 18
AC   CVCL_M852
SY   Hcu 18; HCU 18; HCu-18; HCU-18; Hcu18
DR   BioSample; SAMN03151648
DR   Wikidata; Q54882070
RX   CelloPub=CLPUB00771;
RX   PubMed=2302677;
RX   PubMed=2420787;
RX   PubMed=3167823;
RX   PubMed=6571927;
RX   PubMed=7408279;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00057.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M850 ! HCu 10
OI   CVCL_M853 ! HCu 22
OI   CVCL_M854 ! HCu 27
OI   CVCL_M855 ! HCu 33
OI   CVCL_M856 ! HCu 37
OI   CVCL_M857 ! HCu 39
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HCu 22
AC   CVCL_M853
SY   HCU 22; HCu-22
DR   BioSample; SAMN03151649
DR   Wikidata; Q54882071
RX   PubMed=7408279;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00058.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M850 ! HCu 10
OI   CVCL_M852 ! HCu 18
OI   CVCL_M854 ! HCu 27
OI   CVCL_M855 ! HCu 33
OI   CVCL_M856 ! HCu 37
OI   CVCL_M857 ! HCu 39
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HCu 27
AC   CVCL_M854
SY   HCU 27; HCu-27
DR   BioSample; SAMN03151650
DR   Wikidata; Q54882072
RX   PubMed=7408279;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00059.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M850 ! HCu 10
OI   CVCL_M852 ! HCu 18
OI   CVCL_M853 ! HCu 22
OI   CVCL_M855 ! HCu 33
OI   CVCL_M856 ! HCu 37
OI   CVCL_M857 ! HCu 39
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HCu 33
AC   CVCL_M855
SY   Hcu 33; HCU 33; HCu-33; Hcu33
DR   BioSample; SAMN03151651
DR   Wikidata; Q54882073
RX   CelloPub=CLPUB00771;
RX   PubMed=3167823;
RX   PubMed=6571927;
RX   PubMed=7408279;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00060.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M850 ! HCu 10
OI   CVCL_M852 ! HCu 18
OI   CVCL_M853 ! HCu 22
OI   CVCL_M854 ! HCu 27
OI   CVCL_M856 ! HCu 37
OI   CVCL_M857 ! HCu 39
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HCu 35
AC   CVCL_M859
SY   Hcu 35; HCU 35
DR   Wikidata; Q54882074
RX   PubMed=6571927;
RX   PubMed=7408279;
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   HCu 37
AC   CVCL_M856
SY   Hcu 37; HCU 37; HCu-37
DR   BioSample; SAMN03151652
DR   Wikidata; Q54882075
RX   PubMed=3167823;
RX   PubMed=6571927;
RX   PubMed=7408279;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00061.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M850 ! HCu 10
OI   CVCL_M852 ! HCu 18
OI   CVCL_M853 ! HCu 22
OI   CVCL_M854 ! HCu 27
OI   CVCL_M855 ! HCu 33
OI   CVCL_M857 ! HCu 39
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HCu 39
AC   CVCL_M857
SY   Hcu 39; HCU 39; HCu-39; HCU-39
DR   BioSample; SAMN03151653
DR   Wikidata; Q54882076
RX   PubMed=2302677;
RX   PubMed=2420787;
RX   PubMed=3167823;
RX   PubMed=6571927;
RX   PubMed=7408279;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00062.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M850 ! HCu 10
OI   CVCL_M852 ! HCu 18
OI   CVCL_M853 ! HCu 22
OI   CVCL_M854 ! HCu 27
OI   CVCL_M855 ! HCu 33
OI   CVCL_M856 ! HCu 37
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HCu 57
AC   CVCL_M860
SY   Hcu 57; HCU 57
DR   Wikidata; Q54882077
RX   PubMed=6571927;
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   HCV-29
AC   CVCL_8228
SY   HCV.29; HCV 29; HCV29
DR   cancercelllines; CVCL_8228
DR   Cosmic; 925834
DR   Cosmic; 1286002
DR   Cosmic; 1927313
DR   Cosmic; 2212692
DR   Wikidata; Q54882078
RX   PubMed=3708594;
RX   PubMed=3800330;
RX   PubMed=6244232;
RX   PubMed=7905254;
RX   PubMed=8900435;
RX   PubMed=11416159;
RX   PubMed=15846775;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=29732388;
RX   PubMed=30193179;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Val (c.1406G>T); ClinVar=VCV000044803; Zygosity=Heterozygous (PubMed=23401075).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Gln55Ter (c.163C>T); ClinVar=VCV000048808; Zygosity=Homozygous (PubMed=23401075).
CC   Caution: HCV-29 is said to be a non-malignant bladder epithelial cell line. But due to the fact that it is immortal and contains AKT and BRAF mutations we consider it to be a bladder carcinoma cell line.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 13,14
ST   D21S11: 28,29
ST   D8S1179: 13,16
ST   FGA: 22
ST   TH01: 6,8
ST   vWA: 19,21
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   HCV-29TMV
AC   CVCL_8229
SY   HCV-29Tmv
DR   BioSample; SAMN03151942
DR   cancercelllines; CVCL_8229
DR   Wikidata; Q54882080
RX   PubMed=8105864;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388). Originally thought to be a derivative of HCV-29.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00125.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HCY-23
AC   CVCL_XC34
SY   Human Cementocyte-clone 23
DR   Wikidata; Q93985928
RX   PubMed=31432925;
CC   Characteristics: Produces mineral-like nodules in vitro under differentiation conditions.
CC   Derived from site: In situ; Tooth, cementum; UBERON=UBERON_0001753.
CC   Cell type: Cementocyte; CL=CL_0000141.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Hcycu-1
AC   CVCL_WA84
DR   IBRC; C10635
DR   Wikidata; Q93985931
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84765; Homocystinuria
DI   ORDO; Orphanet_394; Classic homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HD II
AC   CVCL_6D71
DR   Wikidata; Q54882081
RX   PubMed=3597519;
RX   PubMed=6190961;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   HD-10
AC   CVCL_A1IC
DR   Wikidata; Q102114106
RX   PubMed=6752490;
RX   PubMed=6991350;
CC   Population: Japanese.
CC   Doubling time: 17.5 hours (PubMed=6991350).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   HD-70
AC   CVCL_2921
DR   JCRB; JCRB1335
DR   JCRB; NIHS0540
DR   Wikidata; Q54882082
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1735070;
RX   PubMed=29533902;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=1735070; JCRB=JCRB1335).
CC   Discontinued: JCRB; NIHS0540; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1335
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 12
ST   D5S818: 8,12
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hd-AA
AC   CVCL_C2SY
DR   ICLDB; hd-aa
DR   Wikidata; Q114311573
RX   PubMed=15039529;
CC   Group: Insect cell line.
CC   Doubling time: 2 days (PubMed=15039529).
OX   NCBI_TaxID=260305; ! Hyposoter didymator (Parasitoid wasp)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Hd-AD
AC   CVCL_C2SZ
DR   ICLDB; hd-ad
DR   Wikidata; Q114311574
RX   PubMed=15039529;
CC   Group: Insect cell line.
CC   Doubling time: 4 days (PubMed=15039529).
OX   NCBI_TaxID=260305; ! Hyposoter didymator (Parasitoid wasp)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Hd-BBA
AC   CVCL_C2T0
DR   ICLDB; hd-bba
DR   Wikidata; Q114311575
RX   PubMed=15039529;
CC   Group: Insect cell line.
CC   Doubling time: 8 days (PubMed=15039529).
OX   NCBI_TaxID=260305; ! Hyposoter didymator (Parasitoid wasp)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HD-iPS1
AC   CVCL_D078
SY   HD-IPS1; HD1-iPS1
DR   Wikidata; Q54882083
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=18691744).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   HD-iPS11
AC   CVCL_D079
SY   HD-IPS11
DR   Wikidata; Q54882084
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=18691744).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   HD-iPS4
AC   CVCL_D080
SY   HD-IPS4; HD1-iPS4
DR   Wikidata; Q54882085
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=18691744).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   HD-iPShet 3F-1
AC   CVCL_W315
DR   Wikidata; Q54882086
RX   PubMed=22405424;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22405424).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   HD-iPShom 3F-1
AC   CVCL_W310
SY   CHIPS31
DR   Wikidata; Q54882087
RX   PubMed=22405424;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42-44] (c.52CAG(42-44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Homozygous (PubMed=22405424).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W311 ! HD-iPShom 3F-2
OI   CVCL_W312 ! HD-iPShom 4F-1
OI   CVCL_W313 ! HD-iPShom 4F-2
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   HD-iPShom 3F-2
AC   CVCL_W311
DR   Wikidata; Q54882091
RX   PubMed=22405424;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42-44] (c.52CAG(42-44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Homozygous (PubMed=22405424).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W310 ! HD-iPShom 3F-1
OI   CVCL_W312 ! HD-iPShom 4F-1
OI   CVCL_W313 ! HD-iPShom 4F-2
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   HD-iPShom 4F-1
AC   CVCL_W312
DR   Wikidata; Q54882092
RX   PubMed=22405424;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42-44] (c.52CAG(42-44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Homozygous (PubMed=22405424).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W310 ! HD-iPShom 3F-1
OI   CVCL_W311 ! HD-iPShom 3F-2
OI   CVCL_W313 ! HD-iPShom 4F-2
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   HD-iPShom 4F-2
AC   CVCL_W313
DR   Wikidata; Q54882093
RX   PubMed=22405424;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42-44] (c.52CAG(42-44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Homozygous (PubMed=22405424).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W310 ! HD-iPShom 3F-1
OI   CVCL_W311 ! HD-iPShom 3F-2
OI   CVCL_W312 ! HD-iPShom 4F-1
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   HD-iPShom 4F-3
AC   CVCL_W314
DR   Wikidata; Q54882094
RX   PubMed=22405424;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[39-43] (c.52CAG(39-43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Homozygous (PubMed=22405424).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   Hd-K
AC   CVCL_C2T1
DR   ICLDB; hd-k
DR   Wikidata; Q114311576
RX   PubMed=15039529;
CC   Group: Insect cell line.
CC   Doubling time: 4 days (PubMed=15039529).
OX   NCBI_TaxID=260305; ! Hyposoter didymator (Parasitoid wasp)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HD-Mar
AC   CVCL_B367
SY   HD-MAR
DR   ATCC; CRL-2626
DR   BioSample; SAMN03471754
DR   Wikidata; Q54882095
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6154663;
RX   PubMed=6181032;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
CC   Doubling time: 24-30 hours (PubMed=6154663).
CC   Discontinued: ATCC; CRL-2626; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2626
ST   Amelogenin: X,Y
ST   CSF1PO: 6,10
ST   D13S317: 8,13
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7226; Adult T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 18
//
ID   HD-Mar-2
AC   CVCL_2247
SY   HD-MAR-2; HD-MAR 2; HD-MAR2; HD-Mar2
DR   CLO; CLO_0050144
DR   BioSample; SAMN03473438
DR   Cosmic; 933541
DR   DSMZ; ACC-685
DR   DSMZCellDive; ACC-685
DR   FANTOM5_SSTAR; 10435-106E3
DR   RCB; RCB1981
DR   TKG; TKG 0198
DR   Wikidata; Q54882096
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a T lymphoblastic lymphoma (PubMed=29533902).
CC   Doubling time: ~50 hours (DSMZ=ACC-685).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-685; RCB=RCB1981; TKG=TKG 0198
ST   Amelogenin: X,Y
ST   CSF1PO: 6,10
ST   D13S317: 8,13
ST   D16S539: 13
ST   D18S51: 16,18
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 16,21
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 21,25
ST   Penta D: 11
ST   Penta E: 11,15
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7226; Adult T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B367 ! HD-Mar
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HD-MB03
AC   CVCL_S506
DR   DSMZ; ACC-740
DR   DSMZCellDive; ACC-740
DR   Wikidata; Q54882097
RX   PubMed=23054560;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 23.32 hours (Note=Early passage), 23.98 hours (Note=Late passage) (PubMed=23054560); ~48 hours (DSMZ=ACC-740).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=23054560).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): DSMZ=ACC-740
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,13
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 24,27
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 9,14
ST   Penta E: 5,15
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   HD-MY-Z
AC   CVCL_1273
SY   HD-MyZ; HDMYZ
DR   CLO; CLO_0003672
DR   EFO; EFO_0002190
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473357
DR   BioSample; SAMN10988283
DR   cancercelllines; CVCL_1273
DR   Cell_Model_Passport; SIDM01063
DR   ChEMBL-Cells; CHEMBL3308544
DR   ChEMBL-Targets; CHEMBL2366322
DR   Cosmic; 907050
DR   Cosmic; 1086356
DR   Cosmic; 1278833
DR   Cosmic-CLP; 907050
DR   DepMap; ACH-000190
DR   DSMZ; ACC-346
DR   DSMZCellDive; ACC-346
DR   EGA; EGAS00001000978
DR   GDSC; 907050
DR   GEO; GSM887065
DR   GEO; GSM888135
DR   GEO; GSM1669871
DR   IARC_TP53; 21366
DR   IGRhCellID; HDMYZ
DR   LiGeA; CCLE_625
DR   LINCS_LDP; LCL-2008
DR   PharmacoDB; HDMYZ_520_2019
DR   Progenetix; CVCL_1273
DR   PubChem_Cell_line; CVCL_1273
DR   Wikidata; Q54882098
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.1159/000425254;
RX   PubMed=8386741;
RX   PubMed=8558920;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be an acute myeloid leukemia cell line (PubMed=29533902).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~35 hours (DSMZ=ACC-346).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Heterozygous (Cosmic-CLP=907050).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Valfs*2 (c.696_706del11); Zygosity=Heterozygous (Cosmic-CLP=907050).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.65%; Native American=0%; East Asian, North=4.15%; East Asian, South=0%; South Asian=0%; European, North=66.43%; European, South=28.77% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=907050; DSMZ=ACC-346
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 19,20
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 12,17
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 12,13
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   HD00n
AC   CVCL_W578
DR   Wikidata; Q54882099
RX   PubMed=22748968;
CC   Population: African American.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7426 ! GM05400
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   HD10.6
AC   CVCL_WG82
DR   Wikidata; Q93986083
RX   CelloPub=CLPUB00486;
RX   PubMed=10377351;
RX   PubMed=28404842;
RX   PubMed=32636736;
RX   PubMed=35890047;
CC   Characteristics: Immortalized dorsal root ganglion (DRG) cell line that in the presence of doxycycline can differentiate into sensory neurons with nociceptive features (PubMed=10377351).
CC   Virology: Susceptible to infection by herpes simplex virus 1 (HHV-1). A quiescent state resembling latency can be established in the HSV-1 infection in the presence of acyclovir (PubMed=28404842).
CC   Doubling time: 1.2 days (PubMed=10377351).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc (Note=Tetracycline-regulated).
CC   Miscellaneous: STR profile from personal communication of Triezenberg, Steven J.
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 8,9.3
ST   TPOX: 10,12
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <12FW
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   HD109i.1
AC   CVCL_W579
DR   Wikidata; Q54882100
RX   PubMed=22748968;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22748968).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC78 ! ND39258
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   HD129
AC   CVCL_Y595
SY   HD129/FE08-005-L1; HD129/D28E13; D28
DR   Wikidata; Q54882101
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd129.pdf
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Registration: French Agence de la Biomedecine; FE08-005-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   HD168
AC   CVCL_9179
DR   CLO; CLO_0003669
DR   ATCC; HB-252
DR   Wikidata; Q54882102
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   HD180i.5
AC   CVCL_W580
DR   SKIP; SKIP000317
DR   Wikidata; Q54882103
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD180i.6
AC   CVCL_W581
DR   Wikidata; Q54882104
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   HD180i.7
AC   CVCL_W582
DR   Wikidata; Q54882105
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD180n
AC   CVCL_W583
DR   Wikidata; Q54882107
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD1A
AC   CVCL_IY26
DR   Wikidata; Q54882108
RX   PubMed=25807535;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x Wild-type].
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Conditionally immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   HD1B
AC   CVCL_IY27
DR   Wikidata; Q54882109
RX   PubMed=25807535;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96789; Lipa.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x Wild-type Lal-/-].
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Conditionally immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   HD1BR
AC   CVCL_C3QH
SY   Huntington Disease 1 BRighton
DR   Wikidata; Q116049290
RX   PubMed=6459055;
CC   Doubling time: 77.0 hours (PubMed=6459055).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HD1LO
AC   CVCL_C3QJ
SY   Huntington Disease 1 LOndon; HD1
DR   Wikidata; Q116049291
RX   PubMed=140146;
RX   PubMed=6459055;
CC   Doubling time: 38.9 hours (PubMed=6459055).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   HD2-4
AC   CVCL_J684
DR   CLO; CLO_0003670
DR   ATCC; HB-86
DR   Wikidata; Q54882110
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02741; Human CRP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HD21i.5
AC   CVCL_W584
DR   Wikidata; Q54882111
RX   PubMed=22748968;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 5
//
ID   HD287
AC   CVCL_Y596
SY   HD287/D73E6; D73
DR   Wikidata; Q54882112
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd287.pdf
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Registration: French Agence de la Biomedecine; FE10-0158-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   HD28i.2
AC   CVCL_W585
DR   Wikidata; Q54882113
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   HD291
AC   CVCL_Y597
SY   HD291/D74E2; D74
DR   Wikidata; Q54882114
RX   PubMed=21714037;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd291.pdf
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Registration: French Agence de la Biomedecine; FE10-0162-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   HD2BR
AC   CVCL_C3QI
SY   Huntington Disease 2 BRighton
DR   Wikidata; Q116049292
RX   PubMed=6459055;
RX   PubMed=7067035;
CC   Population: Caucasian; British.
CC   Doubling time: 40.7 hours (PubMed=6459055).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   hD2L-CHO
AC   CVCL_VL22
SY   CHO/hD2
DR   Wikidata; Q93986212
RX   PubMed=10411608;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3023; DRD2 (Note=Isoform long).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   HD2LO
AC   CVCL_C3QK
SY   Huntington Disease 2 LOndon; HD2
DR   Wikidata; Q116049293
RX   PubMed=140146;
RX   PubMed=6459055;
CC   Doubling time: 38.0 hours (PubMed=6459055).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   hD3-CHO
AC   CVCL_VL23
DR   Wikidata; Q93986216
RX   PubMed=10411608;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3023; DRD2 (Note=Isoform long).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   HD33i.2
AC   CVCL_W586
DR   Wikidata; Q54882116
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (from parent cell line).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD33i.8
AC   CVCL_W587
DR   SKIP; SKIP000315
DR   Wikidata; Q54882117
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (from parent cell line).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD33n
AC   CVCL_W588
DR   Wikidata; Q54882118
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (from parent cell line).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD3LO
AC   CVCL_C3QL
SY   Huntington Disease 3 LOndon
DR   Wikidata; Q116049294
RX   PubMed=6459055;
CC   Doubling time: 48.8 hours (PubMed=6459055).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   HD4LO
AC   CVCL_C3QM
SY   HD4 LO; Huntington Disease 4 LOndon
DR   Wikidata; Q116049295
RX   PubMed=6459055;
CC   Doubling time: 32.4 hours (PubMed=6459055).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   HD5
AC   CVCL_GS37
DR   Wikidata; Q54882120
RX   PubMed=3143916;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   HD511ABR
AC   CVCL_RP05
SY   Huntington Disease 511 Australia BRisbane
DR   Wikidata; Q54882121
RX   PubMed=6197197;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HD513ABR
AC   CVCL_RP06
SY   Huntington Disease 513 Australia BRisbane
DR   Wikidata; Q54882122
RX   PubMed=6197197;
RX   PubMed=6228733;
CC   From: Queensland Institute of Medical Research; Brisbane; Australia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HD5LO
AC   CVCL_C3QN
SY   Huntington Disease 5 LOndon
DR   Wikidata; Q116049296
RX   PubMed=6459055;
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   HD6
AC   CVCL_XD60
DR   Wikidata; Q94089589
RX   Patent=CN102409028B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.2937.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q66479; Human enterovirus 71 (EV71) genome polyprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 6
//
ID   HD60i.3
AC   CVCL_W589
DR   Wikidata; Q54882124
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[60] (c.52CAG(60)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F063 ! GM03621
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD60i.4
AC   CVCL_W590
DR   SKIP; SKIP000316
DR   Wikidata; Q54882125
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[60] (c.52CAG(60)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F063 ! GM03621
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD60n
AC   CVCL_W591
DR   Wikidata; Q54882127
RX   PubMed=22748968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[60] (c.52CAG(60)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F063 ! GM03621
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   HD7/1A1.15.24
AC   CVCL_B6E2
SY   HD7/1A1
DR   Wikidata; Q111733342
RX   PubMed=3101287;
CC   Doubling time: ~24 hours (PubMed=3101287).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02161; Human RHD.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6741 ! WI-L2-729HF2
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   HD83
AC   CVCL_Y598
SY   HD83/FE07-135-L1; HD83/D17/FE07-135-L1; HD83/D17E12; D17
DR   Wikidata; Q54882129
RX   PubMed=19128516;
RX   PubMed=21714037;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd83.pdf
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Registration: French Agence de la Biomedecine; FE07-135-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   HD9
AC   CVCL_E5RU
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68440; Vaccinia virus scaffold protein OPG125 (D13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HDA-1018
AC   CVCL_A0FV
DR   Wikidata; Q108820432
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDA-1606
AC   CVCL_A0FW
DR   Wikidata; Q108820433
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDA-1884
AC   CVCL_A0FX
DR   Wikidata; Q108820434
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDA-1937
AC   CVCL_A0FY
DR   Wikidata; Q108820435
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDA-2003
AC   CVCL_A0FZ
DR   Wikidata; Q108820436
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDA-202
AC   CVCL_A0FS
DR   Wikidata; Q108820437
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDA-676
AC   CVCL_A0FT
DR   Wikidata; Q108820438
RX   Patent=US5767247;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDA-907
AC   CVCL_A0FU
DR   Wikidata; Q108820439
RX   Patent=US5767247;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5286.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5.
CC   Monoclonal antibody target: UniProtKB; P08758; Human ANXA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HDB
AC   CVCL_JD43
SY   33401; TER221; TER-221; Ter 221; TER411; TER-411; Ter 411
DR   IPD-IMGT/HLA; 10721
DR   Wikidata; Q54882130
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/335cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,02; B*15,35; C*01,04; DPB1*04:02,04:02; DQA1*05:03,05:03; DQB1*03:01:01,03:01:01; DRB1*14:06:01,14:24; DRB3*01:01:02,01:01:02 (IPD-IMGT/HLA=10721).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   HDC
AC   CVCL_K098
DR   CLO; CLO_0050940
DR   BioSample; SAMN03472211
DR   RCB; RCB0679
DR   Wikidata; Q54882131
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB0679
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   HDC-101
AC   CVCL_A372
SY   HDC101
DR   ColonAtlas; HDC101
DR   Cosmic; 715198
DR   Cosmic; 2301981
DR   GEO; GSM1346837
DR   Wikidata; Q54882132
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
RX   PubMed=24755471;
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   HDC-102
AC   CVCL_A373
SY   HDC102
DR   ColonAtlas; HDC102
DR   Cosmic; 715199
DR   Wikidata; Q54882136
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HDC-108
AC   CVCL_A374
SY   HDC108
DR   Cosmic; 715201
DR   Wikidata; Q54882138
RX   PubMed=1980607;
RX   PubMed=25944804;
CC   Doubling time: 49.72 hours (PubMed=25944804).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   HDC-111
AC   CVCL_A375
SY   HDC111
DR   Cosmic; 715202
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882139
RX   PubMed=1980607;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=25944804;
RX   PubMed=29101300;
CC   Doubling time: 43.98 hours (PubMed=25944804).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   HDC-114
AC   CVCL_A376
SY   HDC114
DR   Cosmic; 715203
DR   Cosmic; 1803944
DR   GEO; GSM1448184
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882140
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
RX   PubMed=18258742;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=29101300;
CC   Doubling time: 50.28 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: HDCC114; Cosmic=1803944.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 28,30
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   HDC-117
AC   CVCL_A377
SY   HDC117
DR   Cosmic; 715204
DR   Wikidata; Q54882141
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   HDC-119
AC   CVCL_A378
SY   HDC119
DR   ColonAtlas; HDC119
DR   Cosmic; 715205
DR   Wikidata; Q54882142
RX   PubMed=1980607;
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   HDC-120
AC   CVCL_A379
SY   HDC120
DR   Cosmic; 715206
DR   Wikidata; Q54882143
RX   PubMed=1980607;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   HDC-127
AC   CVCL_W278
SY   HDC127
DR   Wikidata; Q54882144
RX   PubMed=1980607;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   HDC-133
AC   CVCL_A380
SY   HDC133
DR   ColonAtlas; HDC133
DR   Cosmic; 715207
DR   Wikidata; Q54882145
RX   PubMed=1980607;
RX   PubMed=25944804;
CC   Doubling time: 99.15 hours (PubMed=25944804).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   HDC-135
AC   CVCL_A381
SY   HDC135
DR   Cosmic; 715208
DR   Cosmic; 1803943
DR   GEO; GSM1448069
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882146
RX   PubMed=1980607;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9
ST   D16S539: 10,12
ST   D21S11: 26,28
ST   D5S818: 10,14
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 7,8
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   HDC-137
AC   CVCL_A382
SY   HDC137
DR   ColonAtlas; HDC137
DR   Cosmic; 715209
DR   Wikidata; Q54882147
RX   PubMed=1980607;
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   HDC-142
AC   CVCL_A383
SY   HDC142
DR   GEO; GSM1448129
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882148
RX   PubMed=1980607;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D21S11: 27,28
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   HDC-143
AC   CVCL_A384
SY   HDC143
DR   Cosmic; 715210
DR   Cosmic; 1805254
DR   GEO; GSM1448185
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882149
RX   PubMed=1980607;
RX   PubMed=18258742;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D21S11: 30,32.2
ST   D5S818: 9,10
ST   D7S820: 9,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   HDC-15
AC   CVCL_A361
SY   HDC15
DR   Wikidata; Q54882150
RX   PubMed=1980607;
RX   PubMed=25944804;
CC   Doubling time: 59.26 hours (PubMed=25944804).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   HDC-150
AC   CVCL_W279
SY   HDC150
DR   Wikidata; Q54882152
RX   PubMed=1980607;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   HDC-54
AC   CVCL_A362
SY   HDC54
DR   ColonAtlas; HDC54
DR   Cosmic; 715190
DR   Cosmic; 2301982
DR   GEO; GSM1346838
DR   GEO; GSM1448130
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882153
RX   PubMed=1980607;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=29101300;
CC   Doubling time: 42.86 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 30.2,32.2
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 9,10
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   HDC-57
AC   CVCL_A363
SY   HDC57
DR   Cosmic; 715191
DR   Cosmic; 1805255
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882154
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=29101300;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   HDC-63
AC   CVCL_A364
SY   HDC63
DR   Cosmic; 715192
DR   Wikidata; Q54882155
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   HDC-73
AC   CVCL_A365
SY   HDC73
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882156
RX   PubMed=1980607;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=29101300;
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   HDC-75
AC   CVCL_A366
SY   HDC75
DR   Cosmic; 715193
DR   Wikidata; Q54882157
RX   PubMed=1980607;
RX   PubMed=25944804;
CC   Doubling time: 42.53 hours (PubMed=25944804).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   HDC-77
AC   CVCL_A367
SY   HDC77
DR   Cosmic; 715194
DR   Wikidata; Q54882159
RX   PubMed=1980607;
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   HDC-8
AC   CVCL_A359
SY   HDC8
DR   ColonAtlas; HDC8
DR   Cosmic; 715188
DR   GEO; GSM1448104
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882160
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=29101300;
CC   Doubling time: 52.40 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D21S11: 31
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 15,19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HDC-82
AC   CVCL_A368
SY   HDC82
DR   ColonAtlas; HDC82
DR   Cosmic; 715195
DR   Cosmic; 2301983
DR   GEO; GSM1346839
DR   GEO; GSM1448128
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882161
RX   PubMed=1980607;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 9,11
ST   D16S539: 13
ST   D21S11: 29,30.2
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   HDC-87
AC   CVCL_A369
SY   HDC87
DR   ColonAtlas; HDC87
DR   Cosmic; 2301984
DR   GEO; GSM1346840
DR   Wikidata; Q54882162
RX   PubMed=1980607;
RX   PubMed=24755471;
RX   PubMed=25944804;
CC   Doubling time: 39.02 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   HDC-8NMIIK1
AC   CVCL_EI73
SY   HDC-8 NMII K1
DR   Wikidata; Q54882163
RX   PubMed=7812507;
RX   PubMed=8168998;
CC   Characteristics: Derived from parent cell line after passage in nude mice.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A359 ! HDC-8
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   HDC-9
AC   CVCL_A360
SY   HDC9
DR   Cosmic; 1849337
DR   GEO; GSM1448070
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54882164
RX   PubMed=1980607;
RX   PubMed=7812507;
RX   PubMed=8168998;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=22808230;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=29101300;
CC   Doubling time: 49.16 hours (PubMed=25944804).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12,13
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D21S11: 26,31.2
ST   D5S818: 11,12
ST   D7S820: 7,13
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HDC-90
AC   CVCL_A370
SY   HDC90
DR   ColonAtlas; HDC90
DR   Cosmic; 715196
DR   Cosmic; 2301985
DR   GEO; GSM1346841
DR   Wikidata; Q54882165
RX   PubMed=1980607;
RX   PubMed=24755471;
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   HDC-97
AC   CVCL_A371
SY   HDC97
DR   Cosmic; 715197
DR   Wikidata; Q54882166
RX   PubMed=1980607;
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C7421; Rectosigmoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   HDC-9NMI
AC   CVCL_EI74
SY   HDC-9 NMI
DR   Wikidata; Q54882167
RX   PubMed=7812507;
RX   PubMed=8168998;
CC   Characteristics: Derived from parent cell line after passage in nude mice.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A360 ! HDC-9
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   HDDF
AC   CVCL_E3QQ
SY   Huntington's Disease Dermal Fibroblasts
RX   PubMed=39218021;
CC   Doubling time: 24 hours (Note=At 7th passage), 32 hours (Note=At 20th passage), 45 hours (Note=At 30th passage), 55 hours (Note=At 40th passage) (PubMed=39218021).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46+-1] (c.52CAG(46+-1)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=39218021).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HDE-14
AC   CVCL_XG50
SY   HDE14
DR   Wikidata; Q94089926
RX   PubMed=8874215;
RX   PubMed=10887139;
RX   PubMed=15735731;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   HDE/LURF39
AC   CVCL_UD44
DR   Wikidata; Q94089928
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34626; ! Hyalomma dromedarii (Camel tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   HDE/PILS37
AC   CVCL_UD45
DR   Wikidata; Q94089931
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34626; ! Hyalomma dromedarii (Camel tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   HDE/PIPA33
AC   CVCL_UD46
DR   Wikidata; Q94089935
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34626; ! Hyalomma dromedarii (Camel tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   HDF-11
AC   CVCL_RJ31
DR   SKIP; SKIP000819
DR   Wikidata; Q54882168
RX   PubMed=25231866;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HDF-f
AC   CVCL_UF42
SY   HDF51; Human Dermal Fibroblast-fetal
DR   Wikidata; Q94089944
RX   PubMed=23514962;
RX   PubMed=26892726;
WW   Provider; ScienCell; 2300; https://www.sciencellonline.com/human-dermal-fibroblasts-fetal.html
CC   Senescence: Senesces at ~15 PDL (ScienCell).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   HDF-iPS-SV10
AC   CVCL_E6ZP
SY   HDF-iPSC-SV10
RX   PubMed=37253077;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_HDF-iPS-SV10-v2-f.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_HDF-iPS-SV10.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Nacional de Investigaciones Cardiovasculares (CNIC); Madrid; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D21S11: 29,33.2
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HDF/TERT1
AC   CVCL_9Q55
DR   Evercyte; CHT-008-0012
DR   Wikidata; Q54882172
WW   Provider; Evercyte; CHT-008-0012; https://web.archive.org/web/20150224112841/http://www.evercyte.com/hdf-tert1.html#.VOxgfcnP0a9
CC   Doubling time: 72-96 hours (Evercyte).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: Evercyte; CHT-008-0012; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HDF/TERT164
AC   CVCL_B5SS
DR   Evercyte; CHT-008-0164
DR   Wikidata; Q111733343
CC   Doubling time: 60-72 hours (Evercyte=CHT-008-0164).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile and age of donor from personal communication of Evercyte.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): Evercyte=CHT-008-0164
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5SW ! HDMVEC/TERT164-B
SX   Female
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   HDF1375
AC   CVCL_A3YA
DR   Wikidata; Q105507577
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HDF1377
AC   CVCL_A3XZ
SY   1377
DR   Wikidata; Q105507582
RX   PubMed=19956543;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HDF1388
AC   CVCL_DP59
SY   HDF-1388; aHDF1388; 1388
DR   GEO; GSM1040299
DR   GEO; GSM1040369
DR   GEO; GSM1493702
DR   PRIDE; PXD000071
DR   Wikidata; Q28245330
RX   PubMed=18035408;
RX   PubMed=19956543;
RX   PubMed=21460823;
RX   PubMed=23210603;
RX   PubMed=24259714;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18035408; PubMed=21460823
ST   Amelogenin: X
ST   CSF1PO: 10 (PubMed=18035408)
ST   CSF1PO: 11 (PubMed=21460823)
ST   D13S317: 9,13 (PubMed=21460823)
ST   D13S317: 10,14 (PubMed=18035408)
ST   D16S539: 11,13
ST   D18S51: 14 (PubMed=18035408)
ST   D18S51: 15 (PubMed=21460823)
ST   D21S11: 28 (PubMed=18035408)
ST   D21S11: 29 (PubMed=21460823)
ST   D3S1358: 15,17 (PubMed=18035408)
ST   D3S1358: 16,18 (PubMed=21460823)
ST   D5S818: 11 (PubMed=18035408)
ST   D5S818: 12 (PubMed=21460823)
ST   D7S820: 9,10
ST   D8S1179: 8,10
ST   FGA: 20,22
ST   Penta D: 8,10 (PubMed=18035408)
ST   Penta D: 9,11 (PubMed=21460823)
ST   Penta E: 7,19
ST   TH01: 5 (PubMed=18035408)
ST   TH01: 6 (PubMed=21460823)
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   HDF1392
AC   CVCL_A3XW
SY   1392
DR   Wikidata; Q105507585
RX   PubMed=19956543;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HDF1419
AC   CVCL_DP65
SY   aHDF1419; 1419
DR   PRIDE; PXD000071
DR   Wikidata; Q54882169
RX   PubMed=23210603;
RX   PubMed=24259714;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-6M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   HDF1437
AC   CVCL_DP66
SY   HDF-1437; 1437
DR   GEO; GSM1493708
DR   GEO; GSM1899756
DR   Wikidata; Q54882170
RX   PubMed=21460823;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   HDF1488
AC   CVCL_A3XX
SY   1488
DR   Wikidata; Q105507588
RX   PubMed=19956543;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HDF1503
AC   CVCL_A3XV
SY   1503
DR   Wikidata; Q105507591
RX   PubMed=19956543;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HDF1554
AC   CVCL_DP67
SY   1554
DR   Wikidata; Q54882171
RX   PubMed=19956543;
RX   PubMed=21460823;
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   HDF1616
AC   CVCL_A3XY
SY   1616
DR   Wikidata; Q105507595
RX   PubMed=19956543;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HDH-R
AC   CVCL_XH17
DR   CCLV; CCLV-RIE 0056
DR   Wikidata; Q94090325
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   HDL-R
AC   CVCL_XH16
DR   CCLV; CCLV-RIE 0054
DR   Wikidata; Q94090448
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HDLM-1
AC   CVCL_M693
SY   HDLM1
DR   Wikidata; Q54882173
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3359046;
RX   PubMed=3565539;
RX   PubMed=3713248;
RX   PubMed=29533902;
CC   Population: Caucasian.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0009 ! HDLM-2
OI   CVCL_M697 ! HDLM-3
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   HDLM-1d
AC   CVCL_M695
DR   Wikidata; Q54882174
RX   PubMed=3359046;
CC   Population: Caucasian.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M693 ! HDLM-1
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   HDLM-2
AC   CVCL_0009
SY   HD-LM-2; HDLM2
DR   CLO; CLO_0003671
DR   CLDB; cl1580
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473364
DR   BioSample; SAMN10988513
DR   cancercelllines; CVCL_0009
DR   Cell_Model_Passport; SIDM01064
DR   ChEMBL-Cells; CHEMBL3308234
DR   ChEMBL-Targets; CHEMBL2366231
DR   Cosmic; 924110
DR   Cosmic; 988701
DR   Cosmic; 1013909
DR   Cosmic; 1086355
DR   Cosmic; 1278832
DR   Cosmic; 1289699
DR   Cosmic; 1290220
DR   Cosmic; 1432040
DR   Cosmic; 2276322
DR   Cosmic; 2464309
DR   Cosmic-CLP; 924110
DR   DepMap; ACH-000267
DR   DSMZ; ACC-17
DR   DSMZCellDive; ACC-17
DR   EGA; EGAS00001000978
DR   GDSC; 924110
DR   GEO; GSM335390
DR   GEO; GSM381298
DR   GEO; GSM499724
DR   GEO; GSM499732
DR   GEO; GSM552430
DR   GEO; GSM646534
DR   GEO; GSM887064
DR   GEO; GSM888134
DR   GEO; GSM1669870
DR   GEO; GSM7701399
DR   IARC_TP53; 23613
DR   IGRhCellID; HDLM2
DR   LINCS_LDP; LCL-2007
DR   PharmacoDB; HDLM2_521_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0009
DR   PubChem_Cell_line; CVCL_0009
DR   Wikidata; Q54882175
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2602652;
RX   PubMed=2690233;
RX   PubMed=3713248;
RX   PubMed=8558920;
RX   PubMed=9685479;
RX   PubMed=12581897;
RX   PubMed=16957166;
RX   PubMed=17065008;
RX   PubMed=19380639;
RX   PubMed=20164919;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=25894527;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~70-75 hours (DSMZ=ACC-17).
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,44:02:01; C*05:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,04:01:01; DQA1*01:02:01,01:03:01; DQB1*06:02:01,06:03:01; DRA*01:02:02,01:02:03; DRB1*13:01:01,15:01:01 (DSMZCellDive=ACC-17).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11896; TNFAIP3; Zygosity=Heterozygous (PubMed=19380639).
CC   Sequence variation: Mutation; HGNC; HGNC:11896; TNFAIP3; Simple; p.Met174fs (c.520_548dup) (dup 586-614); Zygosity=Heterozygous (PubMed=19380639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Fusion with an Alu-element at the Ex7-Ex8 junction; Zygosity=Unspecified (PubMed=17065008).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.09%; Native American=0%; East Asian, North=1.64%; East Asian, South=0%; South Asian=0.05%; European, North=62.14%; European, South=35.08% (PubMed=30894373).
CC   Misspelling: HDML-2; PubMed=16957166.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=924110; DSMZ=ACC-17
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 12,15
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 13,14
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M693 ! HDLM-1
OI   CVCL_M697 ! HDLM-3
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   HDLM-2d
AC   CVCL_M696
DR   Wikidata; Q54882176
RX   PubMed=3359046;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Fusion with an Alu-element at the Ex7-Ex8 junction; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0009 ! HDLM-2
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   HDLM-3
AC   CVCL_M697
SY   HDLM3
DR   Wikidata; Q54882177
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3713248;
RX   PubMed=29533902;
CC   Population: Caucasian.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M693 ! HDLM-1
OI   CVCL_0009 ! HDLM-2
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   HDm-15
AC   CVCL_1Q26
DR   Wikidata; Q54882178
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0601 ! 3T6-Swiss albino
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   HDm-18
AC   CVCL_1Q27
DR   Wikidata; Q54882181
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0601 ! 3T6-Swiss albino
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   HDm-20
AC   CVCL_1Q28
DR   Wikidata; Q54882182
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0601 ! 3T6-Swiss albino
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   HDm-4
AC   CVCL_1Q29
SY   GM10478; GM10478A
DR   CLO; CLO_0028484
DR   Coriell; GM10478
DR   Wikidata; Q54882183
RX   CelloPub=CLPUB00447;
RX   PubMed=2823107;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0601 ! 3T6-Swiss albino
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   HDm-5
AC   CVCL_1Q30
SY   GM10479
DR   CLO; CLO_0028480
DR   Coriell; GM10479
DR   Wikidata; Q54882184
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=2823107;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 14 mapping. Contains a complete copy of chromosome 14.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0601 ! 3T6-Swiss albino
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   HDm-9
AC   CVCL_1Q31
DR   Wikidata; Q54882186
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0601 ! 3T6-Swiss albino
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   hDMD/mdx ES
AC   CVCL_YJ48
DR   CancerTools; 154188
DR   Wikidata; Q94090765
DR   Ximbio; 154188
RX   PubMed=24057032;
CC   Sequence variation: Mutation; MGI; MGI:94909; Dmd; Simple; p.Gln995Ter (c.2983C>T); Zygosity=Hemizygous; Note=mdx mutation (PubMed=24057032).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:2928; DMD.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: B6.DBA2.129-hDMDtg/tg.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   HDMVEC/TERT164-B
AC   CVCL_B5SW
DR   Evercyte; CHT-013-0164-B
DR   Wikidata; Q111733344
CC   Doubling time: 72-96 hours (Evercyte=CHT-013-0164-B).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
CC   Cell type: Dermis microvascular lymphatic vessel endothelial cell; CL=CL_2000041.
ST   Source(s): Evercyte=CHT-013-0164-B
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5SS ! HDF/TERT164
SX   Female
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HDN-1-R
AC   CVCL_XH33
DR   CCLV; CCLV-RIE 0053
DR   Wikidata; Q94090772
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   HDN-16
AC   CVCL_D019
SY   HD-N-16
DR   Cosmic; 1167990
DR   Wikidata; Q54882188
RX   PubMed=2601700;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   HDN-3
AC   CVCL_D020
DR   Wikidata; Q54882189
RX   PubMed=2601700;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   HDN-R
AC   CVCL_XH12
DR   CCLV; CCLV-RIE 0032
DR   Wikidata; Q94090787
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   HDNS13
AC   CVCL_XG51
DR   Wikidata; Q94090791
RX   PubMed=8874215;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   hDPC-TERT
AC   CVCL_D2PL
SY   human Dental Papilla Cells-TERT
DR   Wikidata; Q127381601
RX   PubMed=23186070;
CC   Population: Chinese.
CC   Characteristics: Transduced with a pLOX-hTERT-IRES-TK lentiviral construct. The TK gene allows selection using ganciclovir (GCV) (PubMed=23186070).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HDQ-P1
AC   CVCL_2067
SY   HDQP1
DR   CLO; CLO_0009911
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471695
DR   BioSample; SAMN10988509
DR   cancercelllines; CVCL_2067
DR   Cell_Model_Passport; SIDM01062
DR   ChEMBL-Cells; CHEMBL4482998
DR   ChEMBL-Targets; CHEMBL4483244
DR   Cosmic; 1995439
DR   Cosmic; 2164995
DR   Cosmic-CLP; 1290922
DR   DepMap; ACH-000643
DR   DSMZ; ACC-494
DR   DSMZCellDive; ACC-494
DR   EGA; EGAS00001000978
DR   GDSC; 1290922
DR   GEO; GSM827279
DR   GEO; GSM887066
DR   GEO; GSM888136
DR   GEO; GSM1172970
DR   GEO; GSM1669872
DR   IARC_TP53; 17911
DR   LiGeA; CCLE_297
DR   LINCS_LDP; LCL-1481
DR   Lonza; 1216
DR   PharmacoDB; HDQP1_522_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2067
DR   PubChem_Cell_line; CVCL_2067
DR   Wikidata; Q54882190
RX   PubMed=10913678;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24176112;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34339474;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 60 hours (Note=At 88th passage) (PubMed=10913678); ~72 hours (DSMZ=ACC-494).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:12637; KDM6A; Simple; p.Arg165Ter (c.493C>T); ClinVar=VCV000692010; Zygosity=Homozygous (Cosmic-CLP=1290922; DepMap=ACH-000643).
CC   Sequence variation: Mutation; HGNC; HGNC:11876; TMPRSS2; Simple; p.Gly8Val (c.23G>T) (c.-57+99G>T); ClinVar=VCV001273671; Zygosity=Heterozygous (PubMed=34339474).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=1290922; DepMap=ACH-000643).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.07%; Native American=0%; East Asian, North=3.35%; East Asian, South=0%; South Asian=2.35%; European, North=51.89%; European, South=41.35% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): Cosmic-CLP=1290922; DSMZ=ACC-494; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,14
ST   D12S391: 19,21
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 13,16.3
ST   D21S11: 29
ST   D22S1045: 11
ST   D2S1338: 17
ST   D2S441: 10
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,15 (DSMZ=ACC-494; Technion Genomics Center)
ST   D8S1179: 15 (PubMed=25877200)
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 11,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 42
//
ID   HDS
AC   CVCL_W592
DR   Wikidata; Q54882191
RX   PubMed=27463353;
WW   Info; -; -; https://web.archive.org/web/20111028023456/https://www.sbir.gov/sbirsearch/detail/88095
CC   Doubling time: ~24 hours (PubMed=27463353).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   HDZi001-A
AC   CVCL_ZW15
SY   hiPSC NP0039
DR   BioSamples; SAMEA7001542
DR   hPSCreg; HDZi001-A
DR   Wikidata; Q102114108
RX   PubMed=32858485;
CC   From: Heart and Diabetes Center North Rhine Westphalia; Bad Oeynhausen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28472; TMEM43; Simple; p.Ser358Leu (c.1073C>T); ClinVar=VCV000000734; Zygosity=Heterozygous (PubMed=32858485).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173470; Familial arrhythmogenic right ventricular dysplasia 5
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   HDZi003-A
AC   CVCL_D0QG
SY   hiPSC NP0038
DR   BioSamples; SAMEA114251188
DR   hPSCreg; HDZi003-A
DR   Wikidata; Q123031574
RX   PubMed=38430734;
CC   From: Heart and Diabetes Center North Rhine Westphalia; Bad Oeynhausen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28472; TMEM43; Simple; p.Ser358Leu (c.1073C>T); ClinVar=VCV000000734; Zygosity=Heterozygous (PubMed=38430734).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173470; Familial arrhythmogenic right ventricular dysplasia 5
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HDZi003-A-1
AC   CVCL_D6IR
SY   hiPSC NP0038 KO15
DR   BioSamples; SAMEA114633124
DR   hPSCreg; HDZi003-A-1
DR   Wikidata; Q127381602
RX   PubMed=38430734;
CC   From: Heart and Diabetes Center North Rhine Westphalia; Bad Oeynhausen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28472; TMEM43.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173470; Familial arrhythmogenic right ventricular dysplasia 5
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0QG ! HDZi003-A
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   He Geg
AC   CVCL_U777
SY   Culture 346
DR   ATCC; CRL-1174
DR   Wikidata; Q54882192
RX   PubMed=4582519;
CC   Discontinued: ATCC; CRL-1174; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   He We
AC   CVCL_0611
DR   CLO; CLO_0003673
DR   ATCC; CRL-1338
DR   Wikidata; Q54882193
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118636; Stiff skin syndrome
DI   ORDO; Orphanet_2833; Stiff skin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   HE-1
AC   CVCL_2922
DR   BioSample; SAMN03472777
DR   JCRB; IFO50297
DR   Wikidata; Q54882194
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=IFO50297
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   HE-209
AC   CVCL_6E85
DR   Wikidata; Q54882195
RX   PubMed=2423124;
RX   PubMed=6187748;
CC   Characteristics: Has a different growth rate at the permissive temperature (33 Celsius) than at the restrictive temperature of 40 Celsius.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E86 ! HE-SV
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   HE-239
AC   CVCL_A5XY
SY   HE239
DR   Wikidata; Q107115248
RX   PubMed=6250657;
RX   PubMed=8647644;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA239).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
AG   Embryo
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   HE-30
AC   CVCL_A5XZ
SY   HE30
DR   Wikidata; Q107115250
RX   PubMed=6250657;
RX   PubMed=8647644;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA30).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
AG   Embryo
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   HE-LU (Rifkin)
AC   CVCL_3698
SY   HE-LU(Rifkin)
DR   CLO; CLO_0003700
DR   ATCC; CRL-7717
DR   BioSample; SAMN03471141
DR   Wikidata; Q54882196
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7717; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-7717
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HE-SK
AC   CVCL_3699
DR   CLO; CLO_0003717
DR   ATCC; CRL-7718
DR   Wikidata; Q54882197
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7718; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7718
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   HE-SV
AC   CVCL_6E86
DR   Wikidata; Q54882198
RX   PubMed=2423124;
RX   PubMed=6187748;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E85 ! HE-209
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HE12
AC   CVCL_0T75
SY   Human Embryo 12
DR   CLO; CLO_0050435
DR   BioSample; SAMN03472030
DR   RCB; RCB2233
DR   Wikidata; Q54882199
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2233
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE13
AC   CVCL_0T76
SY   Human Embryo 13
DR   CLO; CLO_0050436
DR   BioSample; SAMN03472031
DR   RCB; RCB2234
DR   Wikidata; Q54882200
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2234
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE16
AC   CVCL_0T77
SY   Human Embryo 16
DR   CLO; CLO_0050437
DR   BioSample; SAMN03472032
DR   RCB; RCB2237
DR   Wikidata; Q54882201
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2237
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,13
ST   D16S539: 10,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   HE17
AC   CVCL_RM28
SY   Human Embryo 17
DR   Wikidata; Q54882202
RX   PubMed=1362764;
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7-8FW
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HE18
AC   CVCL_0T78
SY   Human Embryo 18
DR   CLO; CLO_0050438
DR   BioSample; SAMN03472033
DR   RCB; RCB2238
DR   Wikidata; Q54882203
RX   PubMed=1362764;
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2238
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE19
AC   CVCL_0T79
SY   Human Embryo 19
DR   CLO; CLO_0050439
DR   BioSample; SAMN03471974
DR   RCB; RCB2239
DR   Wikidata; Q54882204
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2239
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE20
AC   CVCL_RM29
SY   Human Embryo 20
DR   Wikidata; Q54882205
RX   PubMed=1362764;
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7-8FW
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HE21
AC   CVCL_0T80
SY   Human Embryo 21
DR   CLO; CLO_0050440
DR   BioSample; SAMN03471975
DR   RCB; RCB2240
DR   Wikidata; Q54882206
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2240
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 9,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE22
AC   CVCL_0T81
SY   Human Embryo 22
DR   CLO; CLO_0050441
DR   BioSample; SAMN03471977
DR   RCB; RCB2241
DR   Wikidata; Q54882208
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2241
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE23
AC   CVCL_H257
SY   Human Embryo 23
DR   Wikidata; Q54882209
RX   PubMed=9610031;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   HE27
AC   CVCL_0T82
SY   Human Embryo 27
DR   CLO; CLO_0050442
DR   BioSample; SAMN03471978
DR   RCB; RCB2244
DR   Wikidata; Q54882210
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 8
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE28
AC   CVCL_0T83
SY   Human Embryo 28
DR   CLO; CLO_0050443
DR   BioSample; SAMN03471979
DR   RCB; RCB2245
DR   Wikidata; Q54882211
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2245
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,10
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE29
AC   CVCL_0T84
SY   Human Embryo 29
DR   CLO; CLO_0050444
DR   BioSample; SAMN03471980
DR   RCB; RCB2246
DR   Wikidata; Q54882212
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2246
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 9,11
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE3-2
AC   CVCL_B5ZA
DR   Wikidata; Q111733345
RX   PubMed=5832644;
RX   PubMed=5955241;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   Embryo
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HE30
AC   CVCL_0T85
SY   Human Embryo 30
DR   CLO; CLO_0050445
DR   BioSample; SAMN03471981
DR   RCB; RCB2247
DR   Wikidata; Q54882213
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2247
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 11,14
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE31
AC   CVCL_H258
SY   Human Embryo 31
DR   CLO; CLO_0050446
DR   BioSample; SAMN03471982
DR   RCB; RCB2248
DR   Wikidata; Q54882214
RX   PubMed=9610031;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2248
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   HE32
AC   CVCL_0T86
SY   Human Embryo 32
DR   CLO; CLO_0050447
DR   BioSample; SAMN03471983
DR   RCB; RCB2249
DR   Wikidata; Q54882215
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2249
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 10,13
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE33
AC   CVCL_0T87
SY   Human Embryo 33
DR   CLO; CLO_0050448
DR   BioSample; SAMN03471984
DR   RCB; RCB2250
DR   Wikidata; Q54882216
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2250
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE34
AC   CVCL_0T88
SY   Human Embryo 34
DR   CLO; CLO_0050449
DR   BioSample; SAMN03471985
DR   RCB; RCB2251
DR   Wikidata; Q54882217
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2251
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE36
AC   CVCL_0T89
SY   Human Embryo 36
DR   CLO; CLO_0050450
DR   BioSample; SAMN03471989
DR   RCB; RCB2254
DR   Wikidata; Q54882218
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2254
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE37
AC   CVCL_0T90
SY   Human Embryo 37
DR   CLO; CLO_0050451
DR   RCB; RCB2256
DR   Wikidata; Q54882219
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   HE38
AC   CVCL_0T91
SY   Human Embryo 38
DR   CLO; CLO_0050452
DR   BioSample; SAMN03471990
DR   RCB; RCB2257
DR   Wikidata; Q54882220
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2257
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE39
AC   CVCL_0T92
SY   Human Embryo 39
DR   CLO; CLO_0050453
DR   BioSample; SAMN03471991
DR   RCB; RCB2258
DR   Wikidata; Q54882221
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2258
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D5S818: 12,15
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE4
AC   CVCL_RM30
SY   Human Embryo 4
DR   Wikidata; Q54882222
RX   PubMed=1362764;
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal bone, femur; UBERON=UBERON_0000981.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7-8FW
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HE4-2
AC   CVCL_B5ZB
DR   Wikidata; Q111733348
RX   PubMed=5832644;
RX   PubMed=5955241;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   Embryo
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HE40
AC   CVCL_H259
SY   Human Embryo 40
DR   CLO; CLO_0050454
DR   BioSample; SAMN03471992
DR   RCB; RCB2259
DR   Wikidata; Q54882227
RX   PubMed=9610031;
RX   PubMed=38639832;
CC   Population: Korean.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2259
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   HE41
AC   CVCL_0T93
SY   Human Embryo 41
DR   CLO; CLO_0050456
DR   BioSample; SAMN03471993
DR   RCB; RCB2260
DR   Wikidata; Q54882228
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2260
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE42
AC   CVCL_0T94
SY   Human Embryo 42
DR   CLO; CLO_0050457
DR   BioSample; SAMN03471994
DR   RCB; RCB2261
DR   Wikidata; Q54882229
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2261
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE46
AC   CVCL_0T95
SY   Human Embryo 46
DR   CLO; CLO_0050455
DR   BioSample; SAMN03471995
DR   RCB; RCB2262
DR   Wikidata; Q54882230
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2262
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE47
AC   CVCL_0T96
SY   Human Embryo 47
DR   CLO; CLO_0050458
DR   BioSample; SAMN03471996
DR   RCB; RCB2263
DR   Wikidata; Q54882231
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2263
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE48
AC   CVCL_0T97
SY   Human Embryo 48
DR   CLO; CLO_0050459
DR   BioSample; SAMN03471997
DR   RCB; RCB2264
DR   Wikidata; Q54882232
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2264
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE49
AC   CVCL_0T98
SY   Human Embryo 49
DR   CLO; CLO_0050460
DR   BioSample; SAMN03471998
DR   RCB; RCB2265
DR   Wikidata; Q54882233
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2265
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE50
AC   CVCL_0T99
SY   Human Embryo 50
DR   CLO; CLO_0050466
DR   BioSample; SAMN03472000
DR   RCB; RCB2266
DR   Wikidata; Q54882234
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2266
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE51
AC   CVCL_0U00
SY   Human Embryo 51
DR   CLO; CLO_0050461
DR   BioSample; SAMN03472001
DR   RCB; RCB2267
DR   Wikidata; Q54882235
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2267
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE52
AC   CVCL_0U01
SY   Human Embryo 52
DR   CLO; CLO_0050462
DR   BioSample; SAMN03472002
DR   RCB; RCB2268
DR   Wikidata; Q54882236
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2268
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D5S818: 9,13
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE53
AC   CVCL_0U02
SY   Human Embryo 53
DR   CLO; CLO_0050463
DR   BioSample; SAMN03472003
DR   RCB; RCB2269
DR   Wikidata; Q54882237
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2269
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE54
AC   CVCL_0U03
SY   Human Embryo 54
DR   CLO; CLO_0050467
DR   BioSample; SAMN03471944
DR   RCB; RCB2270
DR   Wikidata; Q54882238
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2270
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE55
AC   CVCL_0U04
SY   Human Embryo 55
DR   CLO; CLO_0050464
DR   BioSample; SAMN03471945
DR   RCB; RCB2271
DR   Wikidata; Q54882239
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2271
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 10
//
ID   HE57
AC   CVCL_0U05
SY   Human Embryo 57
DR   CLO; CLO_0050465
DR   BioSample; SAMN03471946
DR   RCB; RCB2273
DR   Wikidata; Q54882240
CC   Population: Japanese.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB2273
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   HE6 [Human fibroblast]
AC   CVCL_RM31
SY   Human Embryo 6
DR   Wikidata; Q54882241
RX   PubMed=1362764;
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal abdomen; UBERON=UBERON_0000916.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7-8FW
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   HE6 [Mouse hybridoma against vaccinia A14L]
AC   CVCL_E5QX
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG2b (PubMed=29558682); IgG1 (PubMed=21056889).
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HE7 [Human fibroblast]
AC   CVCL_RM32
SY   Human Embryo 7
DR   Wikidata; Q54882242
RX   PubMed=1362764;
RX   PubMed=7586138;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal chest; UBERON=UBERON_0001443.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8FW
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   HE7 [Mouse hybridoma against vaccinia A25]
AC   CVCL_E5RD
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P24759; Vaccinia virus A-type inclusion protein A25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeB5
AC   CVCL_S549
DR   ECACC; 11033104
DR   Wikidata; Q54882243
CC   Characteristics: Can be used for detection of mouse Cyp1a induction by chemicals (ECACC=11033104).
CC   Characteristics: Expression of the luciferase gene is under the control of a xenobiotic-responsive element (XRE) driven by a TATA promoter. HeB5 can be used for detection of mouse CYP1A induction by chemicals (ECACC=11033104).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   HEBHMUi001-A
AC   CVCL_WG48
SY   PDSHB-002
DR   BioSamples; SAMEA5574028
DR   hPSCreg; HEBHMUi001-A
DR   SKIP; SKIP005543
DR   Wikidata; Q94091398
RX   PubMed=30875588;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   HEBHMUi002-A
AC   CVCL_YJ63
SY   HCHB-002
DR   BioSamples; SAMEA6357840
DR   hPSCreg; HEBHMUi002-A
DR   SKIP; SKIP005777
DR   Wikidata; Q94091401
RX   PubMed=31791011;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   HEBHMUi003-A
AC   CVCL_YZ85
SY   HCHB-003
DR   BioSamples; SAMEA7059981
DR   hPSCreg; HEBHMUi003-A
DR   SKIP; SKIP005811
DR   Wikidata; Q98126655
RX   PubMed=32203916;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   HEBHMUi004-A
AC   CVCL_ZJ17
SY   HCHB-004; ALSHB-004
DR   BioSamples; SAMEA7059983
DR   hPSCreg; HEBHMUi004-A
DR   SKIP; SKIP005800
DR   Wikidata; Q98126656
RX   PubMed=32434130;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   HEBHMUi005-A
AC   CVCL_YZ86
SY   HCHB-005
DR   BioSamples; SAMEA7059985
DR   hPSCreg; HEBHMUi005-A
DR   SKIP; SKIP005809
DR   Wikidata; Q98126657
RX   PubMed=32224419;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32224419
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 9,14
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 20,22
ST   D2S441: 11,12
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D6S1043: 18,20
ST   D7S820: 10,14
ST   D8S1179: 15,16
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 5,18
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   HEBHMUi006-A
AC   CVCL_A7IX
SY   HCHB-006
DR   BioSamples; SAMEA8716725
DR   hPSCreg; HEBHMUi006-A
DR   Wikidata; Q107115251
RX   PubMed=33839548;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Discontinued: hPSCreg; HEBHMUi006-A; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124846; Potocki-Lupski syndrome
DI   ORDO; Orphanet_1713; 17p11.2 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HEBHMUi007-A
AC   CVCL_A7JE
SY   HCHB-007
DR   BioSamples; SAMEA10201998
DR   hPSCreg; HEBHMUi007-A
DR   Wikidata; Q107115252
RX   PubMed=33892291;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   HEBHMUi008-A
AC   CVCL_A8WJ
SY   HCHB-008
DR   BioSamples; SAMEA10202000
DR   hPSCreg; HEBHMUi008-A
DR   Wikidata; Q108820440
RX   PubMed=34088020;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34088020).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C180840; Cerebral vascular insufficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   HEBHMUi009-A
AC   CVCL_A0KA
SY   HCHB-009
DR   BioSamples; SAMEA10202001
DR   hPSCreg; HEBHMUi009-A
DR   Wikidata; Q108820441
RX   PubMed=34218115;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34218115).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   NCIt; C180840; Cerebral vascular insufficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   HEBHMUi010-A
AC   CVCL_B5EV
SY   HCHB-0010
DR   BioSamples; SAMEA10201600
DR   hPSCreg; HEBHMUi010-A
DR   Wikidata; Q110432847
RX   PubMed=34871962;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Misspelling: HEBHMUi0010-A; Note=In Cellosaurus releases 40 to 44.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   HEBHMUi011-A
AC   CVCL_B5EW
SY   HCHB-011
DR   BioSamples; SAMEA10977250
DR   hPSCreg; HEBHMUi011-A
DR   Wikidata; Q110432849
RX   PubMed=35305470;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=35305470).
CC   Misspelling: HEBHMUi0011-A; Note=In Cellosaurus releases 40 to 44.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   HEBHMUi012-A
AC   CVCL_B7E3
SY   HCHB-012
DR   BioSamples; SAMEA13570474
DR   hPSCreg; HEBHMUi012-A
DR   Wikidata; Q112929656
RX   PubMed=35717858;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=35717858).
CC   Misspelling: HEBHMUi0012-A; Note=In Cellosaurus releases 42 to 44.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   HEBHMUi013-A
AC   CVCL_C7RE
SY   HCHB-013
DR   BioSamples; SAMEA112356743
DR   hPSCreg; HEBHMUi013-A
DR   Wikidata; Q117704481
RX   PubMed=36870256;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   HEBHMUi014-A
AC   CVCL_D0F6
SY   HCHB-014
DR   BioSamples; SAMEA112484167
DR   hPSCreg; HEBHMUi014-A
DR   Wikidata; Q123031575
RX   PubMed=37178573;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=37178573).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HEBHMUi015-A
AC   CVCL_D0F7
SY   HCHB-015
DR   BioSamples; SAMEA113968836
DR   hPSCreg; HEBHMUi015-A
DR   Wikidata; Q123031578
RX   PubMed=37856927;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HEBHMUi016-A
AC   CVCL_E4D9
SY   HCHB-016
DR   hPSCreg; HEBHMUi016-A
CC   From: Hebei Medical University; Shijiazhuang; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HEBHMUi017-A
AC   CVCL_E4DA
SY   HCHB-017
DR   BioSamples; SAMEA115489663
DR   hPSCreg; HEBHMUi017-A
RX   PubMed=39094506;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Homozygous; Note=ApoE2 allele (PubMed=39094506).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HEBHMUi018-A
AC   CVCL_E4DB
SY   HCHB-018
DR   BioSamples; SAMEA115793210
DR   hPSCreg; HEBHMUi018-A
RX   PubMed=39437565;
CC   From: Hebei Medical University; Shijiazhuang; China.
CC   Sequence variation: Mutation; HGNC; HGNC:132; ACTB; Simple; p.Ser199Arg (c.597C>G); ClinVar=VCV000279938; Zygosity=Heterozygous (PubMed=39437565).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C205644; Nicolaides-Baraitser syndrome
DI   ORDO; Orphanet_3051; Nicolaides-Baraitser syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HEC
AC   CVCL_N814
DR   Cosmic; 735332
DR   Cosmic; 1656050
DR   Wikidata; Q54882244
RX   PubMed=15274292;
RX   PubMed=22426987;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HEC-1
AC   CVCL_1274
SY   HEC1; Human Endometrial Cancer-1; HEC-B-296
DR   CLO; CLO_0037162
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 867
DR   BioSample; SAMN03472810
DR   cancercelllines; CVCL_1274
DR   Cell_Model_Passport; SIDM00596
DR   ChEMBL-Cells; CHEMBL3308740
DR   ChEMBL-Targets; CHEMBL1075462
DR   Cosmic; 907051
DR   Cosmic-CLP; 907051
DR   DepMap; ACH-001517
DR   EGA; EGAS00001000978
DR   GDSC; 907051
DR   GEO; GSM827285
DR   GEO; GSM1669873
DR   IARC_TP53; 21367
DR   JCRB; JCRB0042
DR   LINCS_HMS; 50014
DR   LINCS_LDP; LCL-1496
DR   PharmacoDB; HEC1_523_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1274
DR   PubChem_Cell_line; CVCL_1274
DR   Wikidata; Q54882245
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=2064198;
RX   PubMed=4673779;
RX   PubMed=4678779;
RX   PubMed=7448794;
RX   PubMed=9290701;
RX   PubMed=12227503;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=907051; DepMap=ACH-001517).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (DepMap=ACH-001517).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (Cosmic-CLP=907051; DepMap=ACH-001517).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (DepMap=ACH-001517).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=907051; DepMap=ACH-001517).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=89.14%; East Asian, South=10.41%; South Asian=0.45%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Cosmic-CLP=907051; DepMap=ACH-001517; JCRB=JCRB0042
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11 (JCRB=JCRB0042)
ST   D13S317: 11,16 (Cosmic-CLP=907051; DepMap=ACH-001517)
ST   D16S539: 11,12
ST   D18S51: 16,20,21
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   HEC-1-A
AC   CVCL_0293
SY   Hec-1-A; HEC-1A; HEC1-A; HEC1A; Hec1A
DR   BTO; BTO_0002960
DR   CLO; CLO_0003674
DR   EFO; EFO_0002191
DR   MCCL; MCC:0000183
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-112
DR   BCRC; 60552
DR   BioGRID_ORCS_Cell_line; 421
DR   BioSample; SAMN03471093
DR   BioSample; SAMN03472456
DR   BioSample; SAMN10988293
DR   cancercelllines; CVCL_0293
DR   CCRID; 3101HUMTCHu149
DR   Cell_Model_Passport; SIDM00595
DR   ChEMBL-Cells; CHEMBL4295424
DR   ChEMBL-Targets; CHEMBL4296424
DR   CLS; 305077
DR   Cosmic; 713474
DR   Cosmic; 713494
DR   Cosmic; 724853
DR   Cosmic; 809130
DR   Cosmic; 846177
DR   Cosmic; 871552
DR   Cosmic; 889115
DR   Cosmic; 1007160
DR   Cosmic; 1066222
DR   Cosmic; 1177620
DR   Cosmic; 1177685
DR   Cosmic; 1576457
DR   Cosmic; 1594188
DR   Cosmic; 1622896
DR   Cosmic; 2030464
DR   Cosmic; 2301550
DR   Cosmic; 2464665
DR   Cosmic; 2646619
DR   DepMap; ACH-000954
DR   EGA; EGAS00001000610
DR   GEO; GSM844555
DR   GEO; GSM844556
DR   GEO; GSM887069
DR   GEO; GSM888139
DR   IARC_TP53; 1110
DR   IGRhCellID; HEC1A
DR   JCRB; JCRB1117
DR   JCRB; NIHS0388
DR   LiGeA; CCLE_208
DR   PharmacoDB; HEC1A_524_2019
DR   Progenetix; CVCL_0293
DR   PubChem_Cell_line; CVCL_0293
DR   Wikidata; Q54882246
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2436984;
RX   PubMed=3410349;
RX   PubMed=3518877;
RX   PubMed=4678779;
RX   PubMed=7459858;
RX   PubMed=10381137;
RX   PubMed=12068308;
RX   PubMed=12227503;
RX   PubMed=12714694;
RX   PubMed=12893190;
RX   PubMed=15053063;
RX   PubMed=15901131;
RX   PubMed=20215515;
RX   PubMed=20218740;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=25485619;
RX   PubMed=25984343;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; IdentiCell; -; https://web.archive.org/web/20211023035823/http://www.identicell.eu/files/Sample-IdentiCell-report.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Population: Japanese.
CC   Doubling time: 31 hours (DOI=10.1007/978-4-431-53981-0_1); 27 hours (PubMed=25984343).
CC   Microsatellite instability: Instable (MSI) (PubMed=12714694; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-000954).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (DepMap=ACH-000954).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (DepMap=ACH-000954).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (DepMap=ACH-000954).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=15053063; PubMed=15901131; DepMap=ACH-000954).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.14%; East Asian, North=91.32%; East Asian, South=6.71%; South Asian=0.34%; European, North=0.49%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0388; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ATCC=HTB-112; IdentiCell; JCRB=JCRB1117; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12 (ATCC=HTB-112; IdentiCell; Technion Genomics Center)
ST   CSF1PO: 10,13 (JCRB=JCRB1117)
ST   D10S1248: 12,14
ST   D12S391: 19
ST   D13S317: 9,11,14 (IdentiCell)
ST   D13S317: 11 (Technion Genomics Center)
ST   D13S317: 11,12 (ATCC=HTB-112)
ST   D13S317: 11,14 (JCRB=JCRB1117)
ST   D16S539: 12 (IdentiCell; Technion Genomics Center)
ST   D16S539: 12,13 (ATCC=HTB-112; JCRB=JCRB1117)
ST   D18S51: 16,21
ST   D19S433: 13
ST   D1S1656: 18.3,19
ST   D21S11: 30,31
ST   D22S1045: 11,15
ST   D2S1338: 18,19
ST   D2S441: 11,13
ST   D3S1358: 15
ST   D5S818: 11,12,15,16 (JCRB=JCRB1117)
ST   D5S818: 11,14,15 (ATCC=HTB-112)
ST   D5S818: 11,15 (IdentiCell; Technion Genomics Center)
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19 (ATCC=HTB-112; Technion Genomics Center)
ST   vWA: 18,19,20 (IdentiCell)
ST   vWA: 19,23 (JCRB=JCRB1117)
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1274 ! HEC-1
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   HEC-1-A-OZA1
AC   CVCL_AR90
DR   BioSample; SAMN03472374
DR   cancercelllines; CVCL_AR90
DR   JCRB; NIHS0388.1
DR   Wikidata; Q54882247
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0388.1; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=NIHS0388.1
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,13
ST   D16S539: 13
ST   D5S818: 11,13,16
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 19,24
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0293 ! HEC-1-A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   HEC-1-A-OZA2
AC   CVCL_AR91
DR   BioSample; SAMN03472376
DR   cancercelllines; CVCL_AR91
DR   JCRB; NIHS0388.2
DR   Wikidata; Q54882248
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0388.2; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=NIHS0388.2
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D5S818: 11,12,16
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 19,24
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0293 ! HEC-1-A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   HEC-1-A-OZA3
AC   CVCL_AR92
DR   BioSample; SAMN03472377
DR   cancercelllines; CVCL_AR92
DR   JCRB; NIHS0388.3
DR   Wikidata; Q54882249
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0388.3; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=NIHS0388.3
ST   Amelogenin: X
ST   CSF1PO: 10,11,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,15
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 19,22
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0293 ! HEC-1-A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   HEC-1-A-OZA4
AC   CVCL_AR93
DR   BioSample; SAMN03472378
DR   cancercelllines; CVCL_AR93
DR   JCRB; NIHS0388.4
DR   Wikidata; Q54882250
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0388.4; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=NIHS0388.4
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,15
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 19,22
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0293 ! HEC-1-A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   HEC-1-A-OZA5
AC   CVCL_AR94
DR   BioSample; SAMN03472379
DR   cancercelllines; CVCL_AR94
DR   JCRB; NIHS0388.5
DR   Wikidata; Q54882251
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0388.5; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=NIHS0388.5
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12,15
ST   D16S539: 12,13
ST   D5S818: 11,12,16
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 19,24
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0293 ! HEC-1-A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   HEC-1-A-OZA6
AC   CVCL_AR95
DR   BioSample; SAMN03472380
DR   cancercelllines; CVCL_AR95
DR   JCRB; NIHS0388.6
DR   Wikidata; Q54882252
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0388.6; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=NIHS0388.6
ST   Amelogenin: X
ST   CSF1PO: 10,11,14
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,15
ST   D7S820: 9,11
ST   TH01: 6,7,8
ST   TPOX: 8,11
ST   vWA: 19,25
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0293 ! HEC-1-A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   HEC-1-B
AC   CVCL_0294
SY   Hec-1-B; HEC-1B; Hec-1b; HEC1-B; HEC1B; Hec1B
DR   BTO; BTO_0003038
DR   CLO; CLO_0003675
DR   EFO; EFO_0002192
DR   MCCL; MCC:0000184
DR   CLDB; cl1582
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-113
DR   BioGRID_ORCS_Cell_line; 420
DR   BioSample; SAMN03471094
DR   BioSample; SAMN03472427
DR   BioSample; SAMN03473077
DR   BioSample; SAMN10987737
DR   cancercelllines; CVCL_0294
DR   CCRID; 1101HUM-PUMC000105
DR   CCRID; 3101HUMTCHu115
DR   CCRID; 4201HUM-CCTCC00129
DR   CCTCC; GDC0129
DR   Cell_Model_Passport; SIDM01241
DR   ChEMBL-Cells; CHEMBL3308662
DR   ChEMBL-Targets; CHEMBL614817
DR   CLS; 305095
DR   Cosmic; 687552
DR   Cosmic; 809131
DR   Cosmic; 846178
DR   Cosmic; 980635
DR   Cosmic; 1070807
DR   Cosmic; 1177621
DR   Cosmic; 1223486
DR   Cosmic; 1241345
DR   Cosmic; 1576458
DR   Cosmic; 1696757
DR   Cosmic; 2030465
DR   DepMap; ACH-000941
DR   GEO; GSM844557
DR   GEO; GSM887070
DR   GEO; GSM888140
DR   IARC_TP53; 1111
DR   IGRhCellID; HEC1B
DR   JCRB; JCRB1193
DR   JCRB; NIHS0480
DR   KCB; KCB 200551YJ
DR   LiGeA; CCLE_480
DR   PharmacoDB; HEC1B_532_2019
DR   Progenetix; CVCL_0294
DR   PubChem_Cell_line; CVCL_0294
DR   Ubigene; YC-C108
DR   Wikidata; Q54882253
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4678779;
RX   PubMed=6163305;
RX   PubMed=6174649;
RX   PubMed=6220172;
RX   PubMed=12227503;
RX   PubMed=20215515;
RX   PubMed=20218740;
RX   PubMed=20944090;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=25877200;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000941).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (DepMap=ACH-000941).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (DepMap=ACH-000941).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (DepMap=ACH-000941).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; None_reported; -; Zygosity=- (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DepMap=ACH-000941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.76%; East Asian, North=92.48%; East Asian, South=6.76%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0480; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ATCC=HTB-113; CCRID; JCRB=JCRB1193; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11 (JCRB=JCRB1193; PubMed=25877200)
ST   D13S317: 11,16 (ATCC=HTB-113; CCRID)
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 6 (PubMed=25877200)
ST   TH01: 6,7 (ATCC=HTB-113; CCRID; JCRB=JCRB1193)
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0293 ! HEC-1-A
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   HEC-1-B-Cas9-580
AC   CVCL_XC84
DR   cancercelllines; CVCL_XC84
DR   CCRID; 1101HUM-PUMC000580
DR   Wikidata; Q94091526
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000580
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-581
AC   CVCL_XC85
DR   cancercelllines; CVCL_XC85
DR   CCRID; 1101HUM-PUMC000581
DR   Wikidata; Q94091532
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000581
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-582
AC   CVCL_XC86
DR   cancercelllines; CVCL_XC86
DR   CCRID; 1101HUM-PUMC000582
DR   Wikidata; Q94091537
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000582
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-583
AC   CVCL_XC87
DR   cancercelllines; CVCL_XC87
DR   CCRID; 1101HUM-PUMC000583
DR   Wikidata; Q94091542
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000583
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-584
AC   CVCL_XC88
DR   cancercelllines; CVCL_XC88
DR   CCRID; 1101HUM-PUMC000584
DR   Wikidata; Q94091546
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000584
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-585
AC   CVCL_XC89
DR   cancercelllines; CVCL_XC89
DR   CCRID; 1101HUM-PUMC000585
DR   Wikidata; Q94091552
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000585
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-586
AC   CVCL_XC90
DR   cancercelllines; CVCL_XC90
DR   CCRID; 1101HUM-PUMC000586
DR   Wikidata; Q94091558
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000586
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-587
AC   CVCL_XC91
DR   cancercelllines; CVCL_XC91
DR   CCRID; 1101HUM-PUMC000587
DR   Wikidata; Q94091563
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000587
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-588
AC   CVCL_XC92
DR   cancercelllines; CVCL_XC92
DR   CCRID; 1101HUM-PUMC000588
DR   Wikidata; Q94091566
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000588
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-589
AC   CVCL_XC93
DR   cancercelllines; CVCL_XC93
DR   CCRID; 1101HUM-PUMC000589
DR   Wikidata; Q94091570
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000589
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-590
AC   CVCL_XC94
DR   cancercelllines; CVCL_XC94
DR   CCRID; 1101HUM-PUMC000590
DR   Wikidata; Q94091575
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000590
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-591
AC   CVCL_XC95
DR   cancercelllines; CVCL_XC95
DR   CCRID; 1101HUM-PUMC000591
DR   Wikidata; Q94091579
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000591
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-1-B-Cas9-592
AC   CVCL_XC96
DR   cancercelllines; CVCL_XC96
DR   CCRID; 1101HUM-PUMC000592
DR   Wikidata; Q94091584
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID=1101HUM-PUMC000592
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 12,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HEC-108
AC   CVCL_2923
SY   HEC108
DR   CLO; CLO_0037286
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470971
DR   BioSample; SAMN03472459
DR   BioSample; SAMN10987841
DR   cancercelllines; CVCL_2923
DR   Cell_Model_Passport; SIDM01608
DR   Cosmic; 1223494
DR   Cosmic; 1241342
DR   Cosmic; 1696755
DR   Cosmic; 2030466
DR   DepMap; ACH-000990
DR   GEO; GSM887067
DR   GEO; GSM888137
DR   IARC_TP53; 21065
DR   IARC_TP53; 30205
DR   JCRB; JCRB1123
DR   JCRB; NIHS0394
DR   LiGeA; CCLE_091
DR   PharmacoDB; HEC108_525_2019
DR   Progenetix; CVCL_2923
DR   Wikidata; Q54882254
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   DOI=10.5795/jjscc.26.433;
RX   PubMed=2064198;
RX   PubMed=8847459;
RX   PubMed=12893190;
RX   PubMed=15053063;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 26.5 hours (Note=At 19th passage) (DOI=10.5795/jjscc.26.433); ~42 hours (Note=Lot 07072012) (JCRB=JCRB1123).
CC   HLA typing: A*24:20,26:01; B*40:01,52:01; C*12:02,15:02; DQA1*01:03,02:01; DQB1*03:02,03:02; DRB1*14:05,15:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Arg1446Ter (c.4336C>T); Zygosity=Heterozygous (DepMap=ACH-000990).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Heterozygous (DepMap=ACH-000990).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.21%; East Asian, South=21.79%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0394; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1123; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,10,11,12,13 (PubMed=25877200)
ST   D13S317: 9,10,11,13,14 (JCRB=JCRB1123)
ST   D16S539: 11,12,13 (PubMed=25877200)
ST   D16S539: 12,13 (JCRB=JCRB1123)
ST   D18S51: 11,12,13
ST   D19S433: 11.2,12.2,14.2,15.2,16.2
ST   D21S11: 29,30,31
ST   D2S1338: 16,17,19,20
ST   D3S1358: 15,16,17
ST   D5S818: 6,12 (JCRB=JCRB1123)
ST   D5S818: 12 (PubMed=25877200)
ST   D7S820: 8,9,12
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 8,9,10
ST   Penta E: 15,19,20
ST   TH01: 8,9
ST   TPOX: 11 (PubMed=25877200)
ST   TPOX: 11,12 (JCRB=JCRB1123)
ST   vWA: 15,16,17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   HEC-116
AC   CVCL_2924
SY   HEC116
DR   BioSample; SAMN03470936
DR   cancercelllines; CVCL_2924
DR   Cosmic; 1223495
DR   Cosmic; 1696748
DR   Cosmic; 2030467
DR   DepMap; ACH-001518
DR   IARC_TP53; 20592
DR   JCRB; JCRB1124
DR   JCRB; NIHS0395
DR   Wikidata; Q54882255
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=2064198;
RX   PubMed=15053063;
RX   PubMed=25877200;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 27.2 hours (PubMed=2064198).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Unspecified (DepMap=ACH-001518).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=15053063).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Discontinued: JCRB; NIHS0395; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): DepMap=ACH-001518; JCRB=JCRB1124; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 17,25
ST   D19S433: 14,16.2
ST   D21S11: 29
ST   D2S1338: 20,21
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 23,25
ST   Penta D: 12,13
ST   Penta E: 14,18
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 20
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   HEC-151
AC   CVCL_2925
SY   HEC151
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470938
DR   BioSample; SAMN10987651
DR   cancercelllines; CVCL_2925
DR   Cell_Model_Passport; SIDM01609
DR   Cosmic; 1696754
DR   Cosmic; 2030468
DR   DepMap; ACH-000972
DR   GEO; GSM887068
DR   GEO; GSM888138
DR   IARC_TP53; 21066
DR   IARC_TP53; 30206
DR   JCRB; JCRB1122
DR   JCRB; NIHS0396
DR   LiGeA; CCLE_926
DR   PharmacoDB; HEC151_526_2019
DR   Progenetix; CVCL_2925
DR   Wikidata; Q54882256
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=2064198;
RX   PubMed=15053063;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 38 hours (PubMed=2064198).
CC   HLA typing: A*24:02,31:01; B*51:01,52:01; C*12:02,14:02; DRB1*15:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (DepMap=ACH-000972).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val31Ile (c.91G>A); ClinVar=VCV000127827; Zygosity=Heterozygous (DepMap=ACH-000972).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.66%; East Asian, North=76.07%; East Asian, South=23.27%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0396; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1122; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 8,13,14
ST   D16S539: 9,11
ST   D18S51: 13,23,24
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,20,24
ST   D3S1358: 14,15
ST   D5S818: 10,13,14
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 19.1,22,23,24
ST   Penta D: 8.4,9,10
ST   Penta E: 13,14,19
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HEC-155
AC   CVCL_2926
DR   BioSample; SAMN03151656
DR   BioSample; SAMN03472460
DR   JCRB; JCRB1127
DR   JCRB; NIHS0397
DR   Wikidata; Q54882257
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=2064198;
RX   PubMed=15053063;
RX   PubMed=15285295;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. HEC-155 and HEC-180 have been shown to be identical (PubMed=20143388). Originally thought to originate from a 56 year old female patient with primary endometrial cancer.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00307.
CC   Population: Japanese.
CC   Discontinued: JCRB; JCRB1127; true.
CC   Discontinued: JCRB; NIHS0397; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1127
ST   Amelogenin: X
ST   CSF1PO: 9,13,14
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 14
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8313 ! HEC-180
SX   Female
AG   56-64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HEC-180
AC   CVCL_8313
DR   BioSample; SAMN03151655
DR   JCRB; JCRB1144
DR   JCRB; NIHS0398
DR   Wikidata; Q54882258
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=15053063;
RX   PubMed=15285295;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. HEC-155 and HEC-180 have been shown to be identical (PubMed=20143388). Originally thought to originate from a 64 year old female patient with endometrial carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00308.
CC   Population: Japanese.
CC   Discontinued: JCRB; JCRB1144; true.
CC   Discontinued: JCRB; NIHS0398; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1144
ST   Amelogenin: X
ST   CSF1PO: 9,13,14
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 14
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2926 ! HEC-155
SX   Female
AG   56-64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   HEC-1BE
AC   CVCL_YJ46
SY   HEC1BE
DR   cancercelllines; CVCL_YJ46
DR   Wikidata; Q94091657
RX   PubMed=8847459;
RX   PubMed=12893190;
RX   PubMed=15901131;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=15901131).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0294 ! HEC-1-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   HEC-1C
AC   CVCL_S835
SY   HEC-1 C; HEC-IC
DR   cancercelllines; CVCL_S835
DR   Wikidata; Q54882259
RX   PubMed=6299971;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1274 ! HEC-1
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   HEC-1D
AC   CVCL_S836
SY   HEC-1 D; HEC-ID
DR   cancercelllines; CVCL_S836
DR   Wikidata; Q54882260
RX   PubMed=6299971;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; c.4001+1G>T; ClinVar=VCV001736936; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Arg802Ter (c.2404C>T); ClinVar=VCV000009237; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1274 ! HEC-1
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   HEC-251
AC   CVCL_2927
SY   HEC251
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 719
DR   BioSample; SAMD00048820
DR   BioSample; SAMN03470931
DR   BioSample; SAMN10987959
DR   cancercelllines; CVCL_2927
DR   Cell_Model_Passport; SIDM01611
DR   Cosmic; 2030469
DR   DepMap; ACH-000996
DR   GEO; GSM887071
DR   GEO; GSM888141
DR   IARC_TP53; 20593
DR   JCRB; JCRB1141
DR   LiGeA; CCLE_436
DR   PharmacoDB; HEC251_527_2019
DR   Progenetix; CVCL_2927
DR   Wikidata; Q54882261
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=15053063;
RX   PubMed=15171304;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 36 hours (Note=At 3rd passage) (PubMed=15171304); 30 hours (DOI=10.1007/978-4-431-53981-0_1).
CC   HLA typing: A*24:08,24:08; B*54:01,54:01; C*01:02,01:02; DQA1*01:02,02:01; DQB1*05:01,06:08 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Heterozygous (Cosmic-CLP; DepMap=ACH-000996).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu299Ter (c.895G>T); ClinVar=VCV000428263; Zygosity=Heterozygous (DepMap=ACH-000996).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg552Ter (c.1654C>T); ClinVar=VCV000126840; Zygosity=Heterozygous (DepMap=ACH-000996).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Asp (c.461G>A); ClinVar=VCV000237950; Zygosity=Unspecified (PubMed=15053063).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (DepMap=ACH-000996).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Tyr (c.722C>A); ClinVar=VCV000376663; Zygosity=Heterozygous (DepMap=ACH-000996).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.73%; East Asian, North=78.55%; East Asian, South=20.72%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1141; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13,20
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 16,19
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   HEC-265
AC   CVCL_2928
SY   HEC265
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMD00048821
DR   BioSample; SAMN03470883
DR   BioSample; SAMN10987845
DR   cancercelllines; CVCL_2928
DR   Cell_Model_Passport; SIDM01612
DR   Cosmic; 2030470
DR   DepMap; ACH-000946
DR   GEO; GSM887072
DR   GEO; GSM888142
DR   IARC_TP53; 21067
DR   JCRB; JCRB1142
DR   JCRB; NIHS0400
DR   LiGeA; CCLE_015
DR   PharmacoDB; HEC265_528_2019
DR   Progenetix; CVCL_2928
DR   Wikidata; Q54882262
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=15053063;
RX   PubMed=15171304;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 72 hours (Note=At 7th passage) (PubMed=15171304); 36 hours (DOI=10.1007/978-4-431-53981-0_1).
CC   HLA typing: A*02:17,03:01; B*08:01,51:24; C*01:02,03:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Val (c.95A>T); ClinVar=VCV000376230; Zygosity=Heterozygous (DepMap=ACH-000946).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=72.25%; East Asian, South=27.75%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0400; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1142; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 14,16.2
ST   D21S11: 30
ST   D2S1338: 22,24
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14,15,16
ST   FGA: 20,22,23
ST   Penta D: 9
ST   Penta E: 14,16
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 19,22
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   HEC-46
AC   CVCL_T734
SY   HEC46; HEC-46R1
DR   JCRB; NIHS0258
DR   Wikidata; Q54882263
RX   PubMed=8242641;
CC   Population: Japanese.
CC   Doubling time: 22 hours (PubMed=8242641).
CC   Discontinued: JCRB; NIHS0258; true.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   HEC-50B
AC   CVCL_2929
SY   HEC50B; HEC-50 clone B; HEC-50; HEC50; Hec50
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 718
DR   BioSample; SAMN03470885
DR   BioSample; SAMN10987854
DR   cancercelllines; CVCL_2929
DR   Cell_Model_Passport; SIDM01614
DR   Cosmic; 1223491
DR   Cosmic; 1576459
DR   Cosmic; 1696760
DR   Cosmic; 2030471
DR   DepMap; ACH-000831
DR   GEO; GSM887073
DR   GEO; GSM888143
DR   JCRB; JCRB1145
DR   JCRB; NIHS0391
DR   LiGeA; CCLE_584
DR   PharmacoDB; HEC50B_529_2019
DR   Progenetix; CVCL_2929
DR   Wikidata; Q54882264
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=2064198;
RX   PubMed=10381137;
RX   PubMed=12893190;
RX   PubMed=15053063;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 30.4 hours (PubMed=2064198).
CC   HLA typing: A*02:07,02:07; B*08:01,15:39; C*01:02:01:02; DQB1*03:02,06:01; DRB1*01:01,11:09 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:391; AKT1; Simple; p.Glu40Lys (c.118G>A); Zygosity=Homozygous (DepMap=ACH-000831).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (DepMap=ACH-000831).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.78%; Native American=0%; East Asian, North=83.13%; East Asian, South=14.2%; South Asian=0%; European, North=0%; European, South=1.9% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0391; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1145; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 8
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   HEC-59
AC   CVCL_2930
SY   HEC59; Hec59
DR   AddexBio; C0026001/42
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 717
DR   BioSample; SAMN03470882
DR   BioSample; SAMN03472458
DR   BioSample; SAMN10988108
DR   cancercelllines; CVCL_2930
DR   Cell_Model_Passport; SIDM01617
DR   Cosmic; 1070806
DR   Cosmic; 1223492
DR   Cosmic; 1576460
DR   Cosmic; 1622901
DR   Cosmic; 1696750
DR   Cosmic; 2030472
DR   DepMap; ACH-000994
DR   GEO; GSM887074
DR   GEO; GSM888144
DR   IARC_TP53; 20591
DR   JCRB; JCRB1120
DR   JCRB; NIHS0392
DR   LiGeA; CCLE_600
DR   PharmacoDB; HEC59_530_2019
DR   Progenetix; CVCL_2930
DR   Wikidata; Q54882265
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   DOI=10.5795/jjscc.26.433;
RX   PubMed=2064198;
RX   PubMed=9000572;
RX   PubMed=10381137;
RX   PubMed=12227503;
RX   PubMed=15053063;
RX   PubMed=20944090;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 24.3 hours (Note=At 152th passage) (DOI=10.5795/jjscc.26.433).
CC   HLA typing: A*24:02,24:02; B*40:06,40:06; C*08:01,08:01; DQA1*02:01,02:01; DRB1*04:66,04:66 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Val (c.437C>T); Zygosity=Heterozygous (DepMap=ACH-000994).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr46His (c.136T>C); ClinVar=VCV001701143; Zygosity=Heterozygous (PubMed=20944090; DepMap=ACH-000994).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro213Leufs (c.637_638insT) (c.637C>CT); Zygosity=Heterozygous (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (PubMed=20944090; DepMap=ACH-000994).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (PubMed=20944090; DepMap=ACH-000994).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser95Phe (c.284C>T); ClinVar=VCV001796813; Zygosity=Heterozygous (DepMap=ACH-000994).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=15053063; DepMap=ACH-000994).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.33%; Native American=0.09%; East Asian, North=79.33%; East Asian, South=17.72%; South Asian=0.28%; European, North=0%; European, South=1.25% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0392; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): AddexBio=C0026001/42; JCRB=JCRB1120; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9,10,11
ST   D16S539: 11,12,13
ST   D18S51: 12,13
ST   D19S433: 12,13
ST   D21S11: 29,32
ST   D2S1338: 15,16
ST   D3S1358: 13,14,16,17
ST   D5S818: 10,11,12
ST   D7S820: 10,11,14
ST   D8S1179: 12,15
ST   FGA: 21,22,23
ST   Penta D: 9,10,11
ST   Penta E: 15,16
ST   TH01: 7,9.3
ST   TPOX: 11 (PubMed=25877200)
ST   TPOX: 11,14 (AddexBio=C0026001/42; JCRB=JCRB1120)
ST   vWA: 17,20,22
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   HEC-6
AC   CVCL_2931
SY   HEC6
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 716
DR   BioSample; SAMN03470939
DR   BioSample; SAMN03472457
DR   BioSample; SAMN10987852
DR   cancercelllines; CVCL_2931
DR   Cell_Model_Passport; SIDM01619
DR   Cosmic; 1223490
DR   Cosmic; 1696749
DR   Cosmic; 2030473
DR   DepMap; ACH-000984
DR   GEO; GSM887075
DR   GEO; GSM888145
DR   IARC_TP53; 21068
DR   IARC_TP53; 30207
DR   JCRB; JCRB1118
DR   JCRB; NIHS0390
DR   LiGeA; CCLE_478
DR   PharmacoDB; HEC6_531_2019
DR   Progenetix; CVCL_2931
DR   Wikidata; Q54882266
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   PubMed=862644;
RX   PubMed=2064198;
RX   PubMed=10381137;
RX   PubMed=15053063;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=862644).
CC   HLA typing: A*24:02,24:02; B*59:01,59:01; C*01:02,01:02; DQA1*05:02,05:02; DQB1*04:01,04:01; DRB1*04:05,11:04 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Val (c.95A>T); ClinVar=VCV000376230; Zygosity=Heterozygous (DepMap=ACH-000984).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Val160Ala (c.479T>C); Zygosity=Heterozygous (DepMap=ACH-000984).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000280875; Zygosity=Heterozygous (DepMap=ACH-000984).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420_Pro421del (c.1258_1263delTGTCCA); Zygosity=Heterozygous (DepMap=ACH-000984).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (DepMap=ACH-000984).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (DepMap=ACH-000984).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.17%; East Asian, South=23.89%; South Asian=0%; European, North=0%; European, South=0.94% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0390; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1118; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10,13
ST   D13S317: 11,12
ST   D16S539: 8,10
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 27.2,29
ST   D2S1338: 21,23
ST   D3S1358: 16,17
ST   D5S818: 13,14,15
ST   D7S820: 8,9,11,12
ST   D8S1179: 9,10,12
ST   FGA: 20,21,22
ST   Penta D: 10
ST   Penta E: 14,15,17
ST   TH01: 6,9,10 (JCRB=JCRB1118)
ST   TH01: 6,10 (PubMed=25877200)
ST   TPOX: 8,9,10
ST   vWA: 16,18 (PubMed=25877200)
ST   vWA: 16,18,19 (JCRB=JCRB1118)
DI   NCIt; C6290; Endometrial endometrioid adenocarcinoma, variant with squamous differentiation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   HEC-88nu
AC   CVCL_2932
SY   HEC-88 nu; HEC88nu; HEC88NU; HEC-88
DR   BioSample; SAMN03470941
DR   Cosmic; 1223493
DR   Cosmic; 1696751
DR   IARC_TP53; 21069
DR   JCRB; JCRB1121
DR   JCRB; NIHS0393
DR   Wikidata; Q54882269
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   DOI=10.5795/jjscc.26.433;
RX   PubMed=2064198;
RX   PubMed=12227503;
RX   PubMed=15053063;
RX   PubMed=25877200;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Established from a tumor transplanted in nude mice.
CC   Doubling time: 43.8 hours (Note=At 58th passage) (DOI=10.5795/jjscc.26.433); 48 hours (PubMed=2064198).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Discontinued: JCRB; NIHS0393; true.
ST   Source(s): JCRB=JCRB1121; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,13
ST   D16S539: 11
ST   D18S51: 14,16,17
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 5,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   HEC-LTT
AC   CVCL_A7FW
SY   HUVEC Uni-TAg/bi-hTert
DR   Wikidata; Q107115253
RX   PubMed=19705962;
RX   PubMed=26345505;
CC   Characteristics: Transduced with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Characteristics: In the presence of doxycycline, hTERT and SV40-TAg expression are activated, resulting in high cell proliferation and unlimited expansion. In the absence of the doxycycline, cells stop proliferating and can be maintained in a growth-arrested state that reflects the status of endothelial cells in vivo (PubMed=26345505).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Hec50Co
AC   CVCL_4Y59
SY   HEC-50CO
DR   cancercelllines; CVCL_4Y59
DR   Cosmic; 1393157
DR   Wikidata; Q54882270
RX   PubMed=11830547;
RX   PubMed=33174010;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:391; AKT1; Simple; p.Glu40Lys (c.118G>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=33174010
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,16,17
ST   D5S818: 8
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 20
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2929 ! HEC-50B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   HECA-452
AC   CVCL_4577
DR   CLO; CLO_0003676
DR   ATCC; HB-11485
DR   Wikidata; Q54882271
RX   Patent=US5316913;
RX   PubMed=3276207;
WW   Provider; Stanford OTL; S90-088; https://stanford.resoluteinnovation.com/technologies/S90-088_skin-associated-lymphocytes-and
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11485.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   HECD-1
AC   CVCL_A6WY
DR   RCB; RCB5260
DR   Wikidata; Q107115254
RX   PubMed=2702654;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HECi001-A
AC   CVCL_C0CP
SY   Islet iPSC-C3
DR   hPSCreg; HECi001-A
DR   Wikidata; Q112929657
RX   PubMed=34600296;
CC   From: Dongguan HEC Biopharmaceutical R&D Co., Ltd; Chang'an Town; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   HECV
AC   CVCL_0295
DR   CLO; CLO_0003677
DR   MCCL; MCC:0000185
DR   CLDB; cl5543
DR   ICLC; HL01001
DR   Wikidata; Q54882272
CC   Population: Caucasian.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
ST   Source(s): ICLC=HL01001
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 29
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 8
//
ID   HEEM
AC   CVCL_M603
DR   Wikidata; Q54882273
RX   PubMed=857824;
CC   Population: Caucasian; Dutch.
CC   Doubling time: 2 days (PubMed=857824).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   HEFX
AC   CVCL_9837
SY   HEFX1; HUJIe001-A
DR   hPSCreg; HUJIe001-A
DR   SKIP; SKIP001950
DR   Wikidata; Q54882274
RX   PubMed=18371394;
CC   From: Hebrew University; Jerusalem; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HEH2
AC   CVCL_A9HA
DR   CCRID; 5301HUM-KCB0911HZJ
DR   KCB; KCB 200911HZJ
DR   Wikidata; Q108820442
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HEI-286 F-GFP
AC   CVCL_E9C0
SY   HEI-286-GFP
RX   PubMed=26999607;
RX   PubMed=35881881;
CC   Characteristics: Expresses farnesylated GFP (PubMed=26999607).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from an acoustic neuroma patient (CelloPub=CLPUB00805).
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E9BY ! HEI286
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEI-286 F-GFP JUN KO
AC   CVCL_E9C1
SY   c-Jun KO HEI-GFP
RX   PubMed=35881881;
CC   Characteristics: Expresses farnesylated GFP (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from an acoustic neuroma patient (CelloPub=CLPUB00805).
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E9C0 ! HEI-286 F-GFP
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEI-OC1
AC   CVCL_D899
SY   HEIOC1; House Ear Institute-Organ of Corti 1
DR   BTO; BTO_0004862
DR   Ubigene; YC-A025
DR   Wikidata; Q27653205
RX   PubMed=12811000;
RX   PubMed=26854618;
RX   PubMed=26930622;
RX   PubMed=27684094;
WW   Info; -; -; https://web.archive.org/web/20140831220805/http://www.molmeth.org/protocol/culturing-hei-oc1
CC   Characteristics: Growth at the permissive (33 Celsius) temperature results in dedifferentiation of the cells and accelerated proliferation. At the restrictive temperature (39 Celsius) cell proliferation halts in about 48h.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
ST   Source(s): Ubigene=YC-A025
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 13
ST   Mouse STR 6-4: 17.4
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15.2
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.1,17.1
ST   Mouse STR 15-3: 26.3
ST   Mouse STR 17-2: 14
ST   Mouse STR 18-3: 15,16
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7D
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   HEI182
AC   CVCL_E9BZ
SY   HEI-182; HEI 182; House Ear Institute 182
RX   CelloPub=CLPUB00805;
CC   Doubling time: 36 hours (CelloPub=CLPUB00805).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   NCIt; C3276; Vestibular schwannoma
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
DI   ORDO; Orphanet_252175; Vestibular schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEI193
AC   CVCL_7670
SY   HEI-193; HEI 193; House Ear Institute 193
DR   BTO; BTO_0005037
DR   Wikidata; Q54882275
RX   CelloPub=CLPUB00805;
RX   PubMed=11836557;
RX   PubMed=17304235;
RX   PubMed=17868749;
RX   PubMed=28469964;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4544.
CC   Doubling time: 12 hours (PubMed=17304235); 41 hours (CelloPub=CLPUB00805).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; c.1575-1G>A; ClinVar=VCV001285395; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=11836557).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   NCIt; C3276; Vestibular schwannoma
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
DI   ORDO; Orphanet_252175; Vestibular schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   HEI286
AC   CVCL_E9BY
SY   HEI-286; HEI 286; House Ear Institute 286
DR   GEO; GSM5481587
DR   GEO; GSM5481588
DR   GEO; GSM5481589
DR   GEO; GSM5481590
RX   CelloPub=CLPUB00805;
RX   PubMed=20178741;
RX   PubMed=26999607;
RX   PubMed=35881881;
CC   Doubling time: 38 hours (CelloPub=CLPUB00805).
CC   Karyotypic information: Hypo-triploid male (XO) with most chromosome counts in the 60-68 range (CelloPub=CLPUB00805).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from an acoustic neuroma patient (CelloPub=CLPUB00805).
CC   Miscellaneous: STR profile from personal communication of Stupakov, Pavel.
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 14
ST   D18S51: 17
ST   D21S11: 31,31.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 16
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK
AC   CVCL_M624
SY   Human Embryonic Kidney; HEK-1; HEK-RLV
DR   BioSample; SAMN03151703
DR   Wikidata; Q54882276
RX   CelloPub=CLPUB00339;
RX   PubMed=1246601;
RX   PubMed=4137948;
RX   PubMed=4469665;
RX   PubMed=4621398;
RX   PubMed=4864103;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=4864103; PubMed=20143388). Originally thought to originate from an embryonic kidney.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00063.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: Not to be confused with cell line HEK293 (Cellosaurus=CVCL_0045).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   HEK 293 HTR2B Gq
AC   CVCL_KU63
DR   DiscoverX; 95-1024C1
DR   Wikidata; Q54882277
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5294; HTR2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   HEK 293 myc-mCCR8
AC   CVCL_E6IY
SY   HEK 293/CCR8
RX   PubMed=14573924;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1201402; Ccr8 (Note=With a N-terminal Myc tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK 293 STF
AC   CVCL_AQ26
SY   STF; Super TOP-FLASH; SuperTopFlash
DR   ATCC; CRL-3249
DR   Kerafast; EJH014
DR   Wikidata; Q54882278
RX   PubMed=15035989;
CC   Characteristics: Responds to activation of the canonical Wnt signaling pathway by increasing expression of firefly luciferase. Luciferase reporter gene expression is under the control of a promoter with 7 LEF/TCF binding sites (PubMed=15035989).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3249
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 14
//
ID   HEK 293 Tet-Off
AC   CVCL_V349
SY   293 Tet-Off
DR   Wikidata; Q54882279
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Takara/Clontech; Catalog number 630908.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   HEK 293 Tet-Off Advanced
AC   CVCL_KU39
DR   Wikidata; Q54882280
WW   Provider; Takara Bio; 632107; https://www.takarabio.com/documents/Components%20List/631152_071817.pdf
CC   Characteristics: Transfected with an advanced tetracycline transactivator (tTA2(S)-M2) protein, a fusion of a mutated E.coli tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HEK 293 Tet-On
AC   CVCL_KS31
SY   293 Tet-On; Tet-293
DR   Wikidata; Q54882281
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Takara/Clontech; Catalog number 630903.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HEK 293 Tet-On 3G
AC   CVCL_V350
SY   HEK293 Tet-On 3G
DR   BTO; BTO_0003347
DR   Wikidata; Q54882282
WW   Provider; Takara Bio; 631182; https://www.takarabio.com/products/gene-function/tet-inducible-expression-systems/tet-on-3g-systems/tet-on-3g-cell-lines
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   HEK 293 Tet-On Advanced
AC   CVCL_KU43
SY   HEK293 Tet-On Advanced; HEK293 TET-On Advanced
DR   Wikidata; Q54882283
WW   Provider; Takara Bio; 630931; https://www.takarabio.com/documents/Certificate%20of%20Analysis/630931/630931-050918.pdf
CC   Characteristics: Transfected with an advanced reverse tetracycline-controlled transactivator (rtTA2(S)-M2), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Takara/Clontech; Catalog number 630931.
CC   Discontinued: Takara/Clontech; Catalog number 631149.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HEK 293 tTS
AC   CVCL_V351
DR   Wikidata; Q54882290
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Takara/Clontech; Catalog number 630927.
CC   Discontinued: Takara/Clontech; Catalog number 631146.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HEK 293/CCR6
AC   CVCL_E6IW
SY   HEK 293/hCCR6
RX   PubMed=10577517;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1607; CCR6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK 293/TLR3/NF-kB Luciferase Reporter
AC   CVCL_RQ74
SY   TLR3/NF-kB/HEK293
DR   Wikidata; Q54882284
CC   Characteristics: Transfected with a construct containing TLR3 and Renilla luciferase reporter gene under the transcriptional control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Crown Bioscience; Catalog number C3029.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HEK 293/TLR5/NF-kB Luciferase Reporter
AC   CVCL_RQ75
SY   TLR5/NF-kB/HEK293
DR   Wikidata; Q54882285
CC   Characteristics: Transfected with a construct containing TLR5 and Renilla luciferase reporter gene under the transcriptional control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11851; TLR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Crown Bioscience; Catalog number C3040.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HEK 293/TLR7/NF-kB Luciferase Reporter
AC   CVCL_RQ76
SY   TLR7/NF-kB/HEK293
DR   Wikidata; Q54882286
CC   Characteristics: Transfected with a construct containing TLR7 and Renilla luciferase reporter gene under the transcriptional control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15631; TLR7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Crown Bioscience; Catalog number C3030.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HEK 293/TLR8/NF-kB Luciferase Reporter
AC   CVCL_RQ77
SY   TLR8/NF-kB/HEK293
DR   Wikidata; Q54882287
CC   Characteristics: Transfected with a construct containing TLR8 and Renilla luciferase reporter gene under the transcriptional control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15632; TLR8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Crown Bioscience; Catalog number C3031.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HEK 293/TLR9/NF-kB Luciferase Reporter
AC   CVCL_RQ78
SY   TLR9/NF-kB/HEK293
DR   Wikidata; Q54882289
CC   Characteristics: Transfected with a construct containing TLR9 and Renilla luciferase reporter gene under the transcriptional control of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Crown Bioscience; Catalog number C3032.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HEK 293T-hACE2
AC   CVCL_C1G1
DR   Wikidata; Q114311577
RX   PubMed=35757815;
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Transduced with a pHIV-CMV-hACE2-IRES-PuroR construct.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HEK 293T-Spike-HIV-TV
AC   CVCL_C1D1
DR   Wikidata; Q114311578
RX   PubMed=35757815;
CC   Characteristics: Transduced with a pT-PB-SARS-CoV-2-Spike-IRES-Bsd construct and a HIV-TV plasmid pUCHR-inGLuc-pgkhygro that encodes the intron-regulated HIV-based Gaussia luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   HEK Flp-In T-REx-293-C22orf39-KO
AC   CVCL_C0QN
DR   Wikidata; Q112929658
RX   PubMed=34800366;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27012; C22orf39.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK Flp-In T-REx-293-LYRM9-KO
AC   CVCL_C0QP
DR   PRIDE; PXD028149
DR   Wikidata; Q112929659
RX   PubMed=34800366;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27314; LYRM9.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK TE
AC   CVCL_WS59
SY   HEK-TE; HEKTE
DR   CLO; CLO_0037298
DR   BioSample; SAMN10988406
DR   Cell_Model_Passport; SIDM01723
DR   DepMap; ACH-000049
DR   PharmacoDB; HEKTE_533_2019
DR   Progenetix; CVCL_WS59
DR   Wikidata; Q94092066
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Caution: No information is available about this cell line except that it is an immortalized kidney cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   HEK-2
AC   CVCL_WZ56
SY   Human Embryo Kidney-2
DR   CCRID; 5301HUM-KCB86020YJ
DR   KCB; KCB 86020YJ
DR   Wikidata; Q94092072
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 9
//
ID   HEK-293 hCLCA2
AC   CVCL_E7X0
SY   HEK 293 hCLCA2
WW   Provider; UC 1819 Innovation Hub; 102009; https://uc.technologypublisher.com/tech/Calcium_Activated_Cl-_Channel_in_HEK_293_Cells
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2016; CLCA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 hClc-2
AC   CVCL_E7X1
SY   HEK-293 Clc-2
RX   PubMed=10898715;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2020; CLCN2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 hCTR clone HR12
AC   CVCL_E7XA
SY   HR12
RX   PubMed=10517675;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR (Note=Isoform insert-negative).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 hNav1.9
AC   CVCL_YN15
SY   HEK-hNav1.9; HEK-hNav1.9 (+hbeta1/beta2)
DR   Wikidata; Q94092075
RX   PubMed=27556810;
RX   PubMed=30503201;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10583; SCN11A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10586; SCN1B.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10589; SCN2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 8
//
ID   HEK-293 mNav1.9
AC   CVCL_YN16
SY   HEK-mNav1.9; HEK-mNav1.9 (+mbeta1/beta2)
DR   Wikidata; Q94092079
RX   PubMed=27556810;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1345149; Scn11a.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98247; Scn1b.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:106921; Scn2b.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 7
//
ID   HEK-293 pCTR clone A7
AC   CVCL_E7XB
SY   A7
RX   PubMed=7723741;
CC   Characteristics: Expresses ~600,000 receptors/cell (PubMed=7723741).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:86142; Pig CALCR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 rbCTR C1a
AC   CVCL_E7X9
SY   C1a-HEK
RX   PubMed=8940110;
RX   PubMed=9677414;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P79222; Rabbit CALCR (Note=Isoform C1a with a HA-tag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 rbCTR CTRDeltae13
AC   CVCL_E7X8
RX   PubMed=8940110;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P79222; Rabbit CALCR (Note=Isoform CTRDeltae13 with a HA-tag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 rCTR C1a clone D11
AC   CVCL_E7XC
SY   D11
RX   PubMed=7723741;
RX   PubMed=10517675;
CC   Characteristics: Expresses ~500,000 receptors/cell (PubMed=7723741).
CC   Genetic integration: Method=Transfection; Gene=RGD; 621001; Calcr (Note=Isoform C1a).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 rCTR C1a clone F12
AC   CVCL_E7XD
SY   F12
RX   PubMed=7723741;
RX   PubMed=10517675;
CC   Characteristics: Expresses ~60,000 receptors/cell (PubMed=7723741).
CC   Genetic integration: Method=Transfection; Gene=RGD; 621001; Calcr (Note=Isoform C1a).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 rCTR C1b clone B8-H10
AC   CVCL_E7XE
SY   B8-H10
RX   PubMed=7723741;
CC   Characteristics: Expresses ~6,000,000 receptors/cell (PubMed=7723741).
CC   Genetic integration: Method=Transfection; Gene=RGD; 621001; Calcr (Note=Isoform C1b).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 rCTR C1b clone G12-E12
AC   CVCL_E7XF
SY   G12-E12
RX   PubMed=7723741;
CC   Characteristics: Expresses ~60,000 receptors/cell (PubMed=7723741).
CC   Genetic integration: Method=Transfection; Gene=RGD; 621001; Calcr (Note=Isoform C1b).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293 rNav1.9
AC   CVCL_YN17
SY   HEK-rNav1.9; HEK-rNav1.9 (+rbeta1/beta2)
DR   Wikidata; Q94092084
RX   PubMed=27556810;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3630; Scn11a.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3631; Scn1b.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3633; Scn2b.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 7
//
ID   HEK-293-AChE
AC   CVCL_VT77
SY   293-AChE
DR   Wikidata; Q94092086
RX   PubMed=9841877;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1966; CHRNE.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   HEK-293-AChE-ST
AC   CVCL_VT78
SY   293-AChE-ST
DR   Wikidata; Q94092090
RX   PubMed=9841877;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1966; CHRNE.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3676; St6gal1 (Note=With p.Tyr123Cys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VT77 ! HEK-293-AChE
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   HEK-293-AT1
AC   CVCL_C8P7
SY   HEK-293AT1
DR   BTO; BTO_0006513
DR   Wikidata; Q123031580
RX   PubMed=18077555;
CC   From: Olivares-Reyes, Jesus Alberto & Catt, Kevin John; National Institute of Child Health and Human Development, National Institutes of Health; Bethesda; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2070; Agtr1a (Note=With a FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2070; Agtr1a (Note=With a HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HEK-293-F coTIMP-2-6XHis
AC   CVCL_E8D8
WW   Provider; NCI TTC; TAB-3982/E-216-2017-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-3982
CC   Characteristics: Transfected with a construct that contains a codon-optimized TIMP2 fused to a six-histidine tag (6XHis) (PubMed=29140689).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11821; TIMP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D603 ! FreeStyle 293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293-F TIMP-2-EK-6XHis
AC   CVCL_E8D9
RX   PubMed=29140689;
CC   Characteristics: Transfected with a construct that contains an enterokinase cleavage site (EK) inserted between the C-terminus of TIMP2 and a six-histidine tag (6XHis) (PubMed=29140689).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11821; TIMP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D603 ! FreeStyle 293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-293-Munc18b
AC   CVCL_GR68
SY   HEK-Munc18b18
DR   TOKU-E; 4146
DR   Wikidata; Q54882292
RX   PubMed=19723587;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11445; STXBP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 10
//
ID   HEK-293-TrkB
AC   CVCL_9868
SY   HEK-TrkB; HEK293-TrkB
DR   BTO; BTO_0005025
DR   Wikidata; Q54882293
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8032; NTRK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   HEK-293.2sus
AC   CVCL_4W07
DR   ATCC; CRL-1573.3
DR   Wikidata; Q54882294
CC   Characteristics: Adapted to growth in suspension (ATCC=CRL-1573.3).
CC   Doubling time: ~34 hours (ATCC=CRL-1573.3).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1573.3
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   HEK-293B1
AC   CVCL_W457
DR   Wikidata; Q54882295
RX   PubMed=10952671;
CC   Characteristics: Transfected with a FLAG-ADRB1-GFP construct (PubMed=10952671).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:285; ADRB1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   HEK-293B2
AC   CVCL_9869
SY   293-B2; HEK293B2
DR   BTO; BTO_0003468
DR   Wikidata; Q54882296
RX   PubMed=10952671;
CC   Characteristics: Transfected with a FLAG-ADRB2-GFP construct (PubMed=10952671).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   HEK-293CymR
AC   CVCL_9870
SY   QBI-HEK 293CymR; QBI-HEK 293-CymR; QBI-HEK293CymR; 293-CymR
DR   BTO; BTO_0002732
DR   Wikidata; Q54882297
RX   PubMed=17083727;
WW   Provider; Qbiogene; AES2044; https://web.archive.org/web/20091110005046/http://www.qbiogene.com/adenovirus/products/celllines/
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; O33453; Pseudomonas putida cymR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Qbiogene; Catalog number AES2044.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   HEK-293T-hACE2
AC   CVCL_A7UK
SY   293T-ACE2
DR   BEI_Resources; NR-52511
DR   Wikidata; Q107115255
RX   PubMed=33495308;
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Expresses ACE2 under the control of the EF1a promoter (BEI_Resources=NR-52511).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-3KO
AC   CVCL_HB82
SY   IP3R Null HEK-293
DR   Kerafast; EUR030
DR   Wikidata; Q54882298
RX   PubMed=27048566;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue CD122/CD132
AC   CVCL_E8ED
DR   InvivoGen; hkb-il2bg
CC   Characteristics: Designed to monitor the activation of the JAK-STAT pathway by both human IL2 and IL15 but not mouse IL2 (InvivoGen=hkb-il2bg).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT5 promoter (InvivoGen=hkb-il2bg).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6009; IL2RB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6010; IL2RG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6193; JAK3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11366; STAT5A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue CD40L
AC   CVCL_A8CE
DR   InvivoGen; hkb-cd40
DR   Wikidata; Q107115256
CC   Characteristics: Designed to detect bioactive CD40L by monitoring the activation of the NF-kappaB pathway (InvivoGen=hkb-cd40).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-cd40).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11919; CD40.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue hACE2
AC   CVCL_A7YK
DR   InvivoGen; hkb-hace2
DR   Wikidata; Q107115257
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (Invivogen=hkb-hace2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue hACE2-TMPRSS2
AC   CVCL_C3S5
DR   InvivoGen; hkb-hace2tpsa
DR   Wikidata; Q116049297
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hace2tpsa).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YK ! HEK-Blue hACE2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue hDectin-1a
AC   CVCL_VV19
DR   InvivoGen; hkb-hdect1a
DR   Wikidata; Q94092175
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hdect1a).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14558; CLEC7A (Note=Isoform A).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue hDectin-1b
AC   CVCL_VV20
SY   HEK-Blue hDectin1b
DR   InvivoGen; hkb-hdect1b
DR   Wikidata; Q94092177
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hdect1b).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14558; CLEC7A (Note=Isoform B).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue hMD2-CD14
AC   CVCL_IM95
DR   InvivoGen; hkb-hmdcd
DR   Wikidata; Q54882299
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL-12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hmdcd).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue hNOD1
AC   CVCL_A7YQ
DR   InvivoGen; hkb-hnod1
DR   Wikidata; Q107115258
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hnod1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16390; NOD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-Blue hNOD2
AC   CVCL_A7YR
DR   InvivoGen; hkb-hnod2
DR   Wikidata; Q107115259
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (Invivogen=hkb-hnod2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5331; NOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; hkb-hnod2; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YM ! HEK-Blue Null2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-Blue hNOD2 v2
AC   CVCL_E8FH
DR   InvivoGen; hkb-hnod2v2
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (Invivogen=hkb-hnod2v2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5331; NOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YM ! HEK-Blue Null2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue hTLR2
AC   CVCL_IM80
SY   HEK-BLUE-hTLR2; HEK-Blue-TLR2
DR   InvivoGen; hkb-htlr2
DR   NCBI_Iran; C629
DR   Wikidata; Q54882300
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue hTLR2 KO-TLR1/6
AC   CVCL_UF27
DR   InvivoGen; hkb-htlr2k16
DR   Wikidata; Q94092202
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr2k16).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11847; TLR1.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:16711; TLR6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IM80 ! HEK-Blue hTLR2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue hTLR2-TLR1
AC   CVCL_UF28
DR   InvivoGen; hkb-htlr21
DR   Wikidata; Q94092206
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr21).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11847; TLR1.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:16711; TLR6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11847; TLR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF27 ! HEK-Blue hTLR2 KO-TLR1/6
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue hTLR2-TLR6
AC   CVCL_UF29
DR   InvivoGen; hkb-htlr26
DR   Wikidata; Q94092210
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr26).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11847; TLR1.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:16711; TLR6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16711; TLR6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF27 ! HEK-Blue hTLR2 KO-TLR1/6
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue hTLR3
AC   CVCL_IM81
DR   InvivoGen; hkb-htlr3
DR   Wikidata; Q54882301
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr3).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue hTLR4
AC   CVCL_IM82
SY   HEK-BLUE-hTLR4; HEK293-Blue-hTLR4 CD14-MD2
DR   InvivoGen; hkb-htlr4
DR   NCBI_Iran; C631
DR   Wikidata; Q54882302
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL-12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr4).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11850; TLR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YM ! HEK-Blue Null2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 16
//
ID   HEK-Blue hTLR5
AC   CVCL_IM83
SY   HEK293-Blue-hTLR5
DR   InvivoGen; hkb-htlr5
DR   NCBI_Iran; C634
DR   Wikidata; Q54882303
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr5).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11851; TLR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue hTLR7
AC   CVCL_IM84
DR   InvivoGen; hkb-htlr7
DR   Wikidata; Q54882304
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr7).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15631; TLR7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; hkb-htlr7; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YN ! HEK-Blue Null1-k
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK-Blue hTLR7 v2
AC   CVCL_E8DA
DR   InvivoGen; hkb-htlr7v2
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr7v2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15631; TLR7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue hTLR8
AC   CVCL_IM85
DR   InvivoGen; hkb-htlr8
DR   Wikidata; Q54882305
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr8).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15632; TLR8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK-Blue hTLR9
AC   CVCL_IM86
DR   InvivoGen; hkb-htlr9
DR   Wikidata; Q54882306
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-htlr9).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK-Blue IFN-alpha/beta
AC   CVCL_KT26
SY   HEK-Blue IFN-a/b
DR   InvivoGen; hkb-ifnab
DR   Wikidata; Q54882307
CC   Characteristics: Designed to detect bioactive human type I IFNs by monitoring the activation of the ISGF3 pathway (InvivoGen=hkb-ifnab).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the ISG54 promoter (InvivoGen=hkb-ifnab).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6131; IRF9.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11363; STAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; hkb-ifnab; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HEK-Blue IFN-alpha/beta v2
AC   CVCL_E8DB
SY   HEK-Blue IFN-a/b v2
DR   InvivoGen; hkb-ifnabv2
CC   Characteristics: Designed to detect bioactive human type I IFNs by monitoring the activation of the ISGF3 pathway. Has an improved Type I IFN response compared to HEK-Blue IFN-alpha/beta (Cellosaurus=CVCL_KT26) (InvivoGen=hkb-ifnabv2).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the ISG54 promoter (InvivoGen=hkb-ifnabv2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6131; IRF9.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11363; STAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue IFN-gamma
AC   CVCL_UF30
SY   HEK-Blue IFN-g
DR   InvivoGen; hkb-ifng
DR   Wikidata; Q94092297
CC   Characteristics: Designed to detect bioactive human IFN-gamma by monitoring the activation of the JAK/STAT1 pathway (InvivoGen=hkb-ifng).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the ISG54 promoter fused to four interferon-gamma-activated sites (GAS) (InvivoGen=hkb-ifng).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11362; STAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue IL-10
AC   CVCL_A8CF
DR   InvivoGen; hkb-il10
DR   Wikidata; Q107115260
CC   Characteristics: Designed to detect bioactive human IL10 (and to a lesser extent mouse IL10) by monitoring the activation of the STAT3 pathway (InvivoGen=hkb-il10).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-il10).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5964; IL10RA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5965; IL10RB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue IL-12
AC   CVCL_UF31
DR   InvivoGen; hkb-il12
DR   Wikidata; Q94092301
CC   Characteristics: Designed to detect bioactive human and mouse IL12 by monitoring the activation of the STAT4 pathway (InvivoGen=hkb-il12).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT4 promoter (InvivoGen=hkb-il12).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5971; IL12RB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5972; IL12RB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6192; JAK2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11365; STAT4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12440; TYK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue IL-17
AC   CVCL_UF32
DR   InvivoGen; hkb-il17
DR   Wikidata; Q94092304
CC   Characteristics: Designed to detect bioactive human and murine IL17A and IL17F by monitoring the activation of the NF-kappaB and AP-1 pathways (InvivoGen=hkb-il17).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the IFN-beta minimal promoter fused to five NF-kappaB and five AP-1 binding sites (InvivoGen=hkb-il17).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5985; IL17RA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18358; IL17RC.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1343; TRAF3IP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue IL-17C
AC   CVCL_A8CK
DR   InvivoGen; hkb-il17c
DR   Wikidata; Q107115262
CC   Characteristics: Designed to detect bioactive human and murine IL17C and IL17F by monitoring the activation of the NF-kappaB and AP-1 pathways (InvivoGen=hkb-il17c).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the IFN-beta minimal promoter fused to five NF-kappaB and five AP-1 binding sites (InvivoGen=hkb-il17c).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5985; IL17RA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18439; IL17RE.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1343; TRAF3IP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue IL-18
AC   CVCL_UF33
DR   InvivoGen; hkb-hmil18
DR   Wikidata; Q94092308
CC   Characteristics: Designed to detect bioactive human IL18 (and to a lesser extent mouse IL18) by monitoring the activation of the NF-kappaB and AP-1 pathways. In addition, the TNF-alpha and the IL-1beta responses have been blocked (InvivoGen=hkb-hmil18).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a promoter with NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hmil18).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:5993; IL1R1.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:5995; IL1RAP.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5988; IL18R1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5989; IL18RAP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue IL-19/IL-20
AC   CVCL_E8EE
DR   InvivoGen; hkb-il1920
CC   Characteristics: Designed to detect bioactive human and mouse IL19, IL20 and IL24 by monitoring the activation of the JAK/STAT3 pathway (InvivoGen=hkb-il1920).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-il1920).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6003; IL20RA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6004; IL20RB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue IL-1beta
AC   CVCL_A8CL
DR   InvivoGen; hkb-il1b
DR   Wikidata; Q107115263
CC   Characteristics: Designed to detect bioactive human and mouse IL1B monitoring the activation of the NF-kappaB and AP-1 pathways. In addition, the TNF-alpha, TLR3 and TLR5 responses have been blocked (InvivoGen=hkb-il1b).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-il1b).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; hkb-il1b; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue IL-1beta v2
AC   CVCL_E8DC
DR   InvivoGen; hkb-il1bv2
CC   Characteristics: Designed to detect bioactive human and mouse IL1B monitoring the activation of the NF-kappaB and AP-1 pathways. In addition, the TNF-alpha, TLR3 and TLR5 responses have been blocked (InvivoGen=hkb-il1bv2).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-il1bv2).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue IL-1R
AC   CVCL_A8CM
DR   InvivoGen; hkb-il1r
DR   Wikidata; Q107115264
CC   Characteristics: Designed to detect bioactive human and mouse IL1A and IL1B by monitoring the activation of the NF-kappaB and AP-1 pathways. In addition, the TNF-alpha, TLR3 and TLR5 responses have been blocked (InvivoGen=hkb-il1r).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-il1r).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96545; Il1r1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104975; Il1rap.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CL ! HEK-Blue IL-1beta
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue IL-2
AC   CVCL_UF26
DR   InvivoGen; hkb-il2
DR   Wikidata; Q94092312
CC   Characteristics: Designed to monitor the activation of the JAK-STAT pathway by both human and murine IL2 and also human IL25 (InvivoGen=hkb-il2).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT5 promoter (InvivoGen=hkb-il2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6008; IL2RA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6009; IL2RB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6010; IL2RG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6193; JAK3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11366; STAT5A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue IL-20
AC   CVCL_E8EF
DR   InvivoGen; hkb-il20
CC   Characteristics: Designed to detect bioactive human and mouse IL20, IL22 and IL24 by monitoring the activation of the JAK/STAT3 pathway (InvivoGen=hkb-il1920).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-hkb-il20).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6004; IL20RB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13700; IL22RA1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue IL-22
AC   CVCL_A8CG
DR   InvivoGen; hkb-il22
DR   Wikidata; Q107115265
CC   Characteristics: Designed to detect bioactive human and mouse IL22 by monitoring the activation of the STAT3 pathway (InvivoGen=hkb-il22).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-il22).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5965; IL10RB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13700; IL22RA1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-Blue IL-23
AC   CVCL_A8CH
DR   InvivoGen; hkb-il23
DR   Wikidata; Q107115266
CC   Characteristics: Designed to detect bioactive human and mouse IL23 by monitoring the activation of the STAT3 pathway (InvivoGen=hkb-il23).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-il23).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5971; IL12RB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19100; IL23R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue IL-31
AC   CVCL_E8EG
DR   InvivoGen; hkb-il31
CC   Characteristics: Designed to detect bioactive human IL31 (but not mouse IL31) by monitoring the activation of the JAK/STAT5 pathway (InvivoGen=hkb-il31).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT5-responsive promoter (InvivoGen=hkb-il31).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18969; IL31RA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8507; OSMR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11367; STAT5B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue IL-33
AC   CVCL_UF59
DR   InvivoGen; hkb-hil33
DR   Wikidata; Q94092315
CC   Characteristics: Designed to detect bioactive IL33 by monitoring the activation of the NF-kappaB and AP-1 pathways. In addition, the TNF-alpha and the IL-1beta responses have been blocked (InvivoGen=hkb-hil33).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a promoter with NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hil33).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:5993; IL1R1.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5998; IL1RL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue IL-36
AC   CVCL_E8EH
DR   InvivoGen; hkb-hil36r
CC   Characteristics: Designed to detect bioactive IL36A, IL36B and IL36G by monitoring the activation of the NF-kappaB and AP-1 pathways (InvivoGen=hkb-hil36r).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a promoter with NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hil36r).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5995; IL1RAP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5999; IL1RL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue IL-4/IL-13
AC   CVCL_A8DA
DR   InvivoGen; hkb-il413
DR   Wikidata; Q107115267
CC   Characteristics: Designed to detect bioactive human IL4 and IL13 by monitoring the activation of the STAT-6 pathway (InvivoGen=hkb-il413).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT6-responsive promoter (InvivoGen=hkb-il413).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11368; STAT6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue IL-6
AC   CVCL_UF60
DR   InvivoGen; hkb-hil6
DR   Wikidata; Q94092318
CC   Characteristics: Designed to detect bioactive human IL6 by monitoring the activation of the STAT3 pathway (InvivoGen=hkb-hil6).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-hil6).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6019; IL6R.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue IL-7
AC   CVCL_E8EI
DR   InvivoGen; hkb-hil7
CC   Characteristics: Designed to detect bioactive human IL7 by monitoring the activation of the JAK/STAT5 pathway (InvivoGen=hkb-hil7).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT5 promoter (InvivoGen=hkb-hil7).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6010; IL2RG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6024; IL7R.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6193; JAK3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11367; STAT5B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue IL-9
AC   CVCL_E8EJ
DR   InvivoGen; hkb-hil9
CC   Characteristics: Designed to detect bioactive human IL9 by monitoring the activation of the JAK/STAT5 pathway (InvivoGen=hkb-hil9).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT5 promoter (InvivoGen=hkb-hil9).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6010; IL2RG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6030; IL9R.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6193; JAK3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11367; STAT5B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue ISG
AC   CVCL_A8BQ
DR   InvivoGen; hkb-isg-1
DR   Wikidata; Q107115268
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkb-isg-1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3772 ! pEAK Rapid
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue ISG-KO-STING
AC   CVCL_A8BR
DR   InvivoGen; hkb-isgkostg
DR   Wikidata; Q107115269
CC   Characteristics: Specifically designed to study the STING/TBK1/IRF3 signaling pathway. Can detect bioactive type I IFNs through the activation of the JAK-STAT-IRF9 (InvivoGen=hkb-isgkostg).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkb-isgkostg).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8BQ ! HEK-Blue ISG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue KD-TLR5
AC   CVCL_5I78
DR   InvivoGen; hkb-kdtlr5
DR   Wikidata; Q54882308
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the ISG54 promoter (InvivoGen=hkb-kdtlr5).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11851; TLR5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue KO-ALPK1
AC   CVCL_A8BU
DR   InvivoGen; hkb-koalpk
DR   Wikidata; Q107115270
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-koalpk).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:20917; ALPK1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue KO-TIFA
AC   CVCL_A8BV
DR   InvivoGen; hkb-kotifa
DR   Wikidata; Q107115272
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-kotifa).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:19075; TIFA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue mDectin-1b
AC   CVCL_VV21
DR   InvivoGen; hkb-mdect1b
DR   Wikidata; Q94092333
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mdect1b).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1861431; Clec7a (Note=Isoform b).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue mDectin-2
AC   CVCL_VV23
DR   InvivoGen; hkb-mdect2
DR   Wikidata; Q94092339
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mdect2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1861231; Clec4n.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue mMincle
AC   CVCL_VV22
DR   InvivoGen; hkb-mmcl
DR   Wikidata; Q94092341
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mmcl).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1861232; Clec4e.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue mNOD1
AC   CVCL_A7YS
DR   InvivoGen; hkb-mnod1
DR   Wikidata; Q107115273
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mnod1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341839; Nod1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-Blue mNOD2
AC   CVCL_A7YT
DR   InvivoGen; hkb-mnod2
DR   Wikidata; Q107115274
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mnod2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2429397; Nod2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YM ! HEK-Blue Null2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-Blue mTLR13
AC   CVCL_IM94
DR   InvivoGen; hkb-mtlr13
DR   Wikidata; Q54882309
WW   Provider; InvivoGen; hkb-mtlr13; https://www.invivogen.com/sites/default/files/invivogen/products/files/hek_blue_mtlr13_tds.pdf
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr13).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:3045213; Tlr13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; hkb-mtlr13; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue mTLR2
AC   CVCL_IM87
DR   InvivoGen; hkb-mtlr2
DR   Wikidata; Q54882311
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88318; Cd14.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346060; Tlr2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YM ! HEK-Blue Null2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   HEK-Blue mTLR3
AC   CVCL_IM88
DR   InvivoGen; hkb-mtlr3
DR   Wikidata; Q54882312
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr3).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2156367; Tlr3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YN ! HEK-Blue Null1-k
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK-Blue mTLR4
AC   CVCL_IM89
DR   InvivoGen; hkb-mtlr4
DR   Wikidata; Q54882313
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr4).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88318; Cd14.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341909; Ly96.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   HEK-Blue mTLR5
AC   CVCL_IM90
DR   InvivoGen; hkb-mtlr5
DR   Wikidata; Q54882314
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr5).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1858171; Tlr5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue mTLR7
AC   CVCL_IM91
DR   InvivoGen; hkb-mtlr7
DR   Wikidata; Q54882315
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr7).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2176882; Tlr7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YZ ! HEK-Blue Null2-k
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue mTLR8
AC   CVCL_IM92
DR   InvivoGen; hkb-mtlr8
DR   Wikidata; Q54882316
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr8).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2176887; Tlr8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YL ! HEK-Blue Null1-v
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue mTLR9
AC   CVCL_IM93
DR   InvivoGen; hkb-mtlr9
DR   Wikidata; Q54882317
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mtlr9).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1932389; Tlr9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7YP ! HEK-Blue Null1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK-Blue Null1
AC   CVCL_A7YP
SY   HEK-Blue-Null-1
DR   InvivoGen; hkb-null1
DR   NCBI_Iran; C635
DR   Wikidata; Q107115275
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null1).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue Null1-k
AC   CVCL_A7YN
DR   InvivoGen; hkb-null1k
DR   Wikidata; Q107115276
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null1k).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue Null1-v
AC   CVCL_A7YL
DR   InvivoGen; hkb-null1v
DR   Wikidata; Q107115277
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null1v).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue Null2
AC   CVCL_A7YM
SY   HEK-Blue-Null-2
DR   InvivoGen; hkb-null2
DR   NCBI_Iran; C636
DR   Wikidata; Q107115278
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue Null2-k
AC   CVCL_A7YZ
DR   InvivoGen; hkb-null2k
DR   Wikidata; Q107115279
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null2k).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK-Blue RANKL
AC   CVCL_A8CJ
DR   InvivoGen; hkb-rankl
DR   Wikidata; Q107115280
CC   Characteristics: Designed to detect bioactive human and mouse TNFSF11/RANKL by monitoring the activation of the NF-kappaB and AP-1 pathway (InvivoGen=hkb-rankl).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a promoter with NF-kappaB and AP-1-binding sites (InvivoGen=hkb-rankl).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11908; TNFRSF11A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-Blue STAT6-hSTING-R232
AC   CVCL_A8BY
DR   InvivoGen; hkb-st6r232
DR   Wikidata; Q107115281
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT6-responsive promoter (InvivoGen=hkb-st6r232).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11368; STAT6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue TGF-beta
AC   CVCL_A8CZ
DR   InvivoGen; hkb-tgfb
DR   Wikidata; Q107115284
CC   Characteristics: Designed to detect bioactive TGF-beta by monitoring the activation of the TGF-beta/SMAD pathway (InvivoGen=hkb-tgfb).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a beta-globin minimal promoter fused to 3 SMAD3/4-binding elements (SBE) (InvivoGen=hkb-tgfb).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6769; SMAD3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6770; SMAD4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11772; TGFBR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: InvivoGen; hkb-tgfb; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue TGF-beta v2
AC   CVCL_E8EK
DR   InvivoGen; hkb-tgfbv2
CC   Characteristics: Designed to detect bioactive human and mouse TGF-beta by monitoring the activation of the TGF-beta/SMAD pathway (InvivoGen=hkb-tgfbv2).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a beta-globin minimal promoter fused to 3 SMAD3/4-binding elements (SBE) (InvivoGen=hkb-tgfbv2).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK-Blue TNF-alpha
AC   CVCL_UF25
DR   InvivoGen; hkb-tnfdmyd
DR   Wikidata; Q94092462
CC   Characteristics: Allows the detection of bioactive human and murine TNF-alpha by monitoring the activation of the NF-kappaB pathway (InvivoGen=hkb-tnfdmyd).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-tnfdmyd).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:7562; MYD88.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11917; TNFRSF1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue TPO
AC   CVCL_A8CI
DR   InvivoGen; hkb-tpo
DR   Wikidata; Q107115285
CC   Characteristics: Designed to detect bioactive human and mouse TPO by monitoring the activation of the STAT5 pathway (InvivoGen=hkb-tpo).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT5 promoter (InvivoGen=hkb-tpo).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7217; MPL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11367; STAT5B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Blue-Lucia Null (NF/IL8)
AC   CVCL_A8CQ
SY   HEK-Blue-Lucia Null; HEK-Dual Null; HEK-Dual Null (NF/IL8); HEK-NF-KappaB-SEAP/KI-[IL-8]Lucia
DR   InvivoGen; hkd-nullni
DR   Wikidata; Q107115289
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-nullni).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue-Lucia hTLR2 (NF/IL8)
AC   CVCL_A8CR
SY   HEK-Blue-Lucia hTLR2; HEK-Dual hTLR2 (NF/IL8)
DR   InvivoGen; hkd-htlr2ni
DR   Wikidata; Q107115290
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr2ni).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CQ ! HEK-Blue-Lucia Null (NF/IL8)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue-Lucia hTLR3 (NF/IL8)
AC   CVCL_A8CS
SY   HEK-Blue-Lucia hTLR3; HEK-Dual hTLR3 (NF/IL8)
DR   InvivoGen; hkd-htlr3ni
DR   Wikidata; Q107115291
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr3ni).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CQ ! HEK-Blue-Lucia Null (NF/IL8)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue-Lucia hTLR5 (NF/IL8)
AC   CVCL_A8CT
SY   HEK-Blue-Lucia hTLR5; HEK-Dual hTLR5 (NF/IL8)
DR   InvivoGen; hkd-htlr5ni
DR   Wikidata; Q107115292
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr5ni).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11851; TLR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CQ ! HEK-Blue-Lucia Null (NF/IL8)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue-Lucia hTLR9 (NF/IL8)
AC   CVCL_A8CU
SY   HEK-Blue-Lucia hTLR9; HEK-Dual hTLR9 (NF/IL8)
DR   InvivoGen; hkd-htlr9ni
DR   Wikidata; Q107115293
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr9ni).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CQ ! HEK-Blue-Lucia Null (NF/IL8)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue-Lucia mTLR4 (NF/IL8)
AC   CVCL_A8CV
SY   HEK-Blue-Lucia mTLR4; HEK-Dual mTLR4 (NF/IL8)
DR   InvivoGen; hkd-mtlr4ni
DR   Wikidata; Q107115295
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-mtlr4ni).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88318; Cd14.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341909; Ly96.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CQ ! HEK-Blue-Lucia Null (NF/IL8)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue-Lucia mTLR7 (NF/IL8)
AC   CVCL_A8CW
SY   HEK-Blue-Lucia mTLR7; HEK-Dual mTLR7 (NF/IL8)
DR   InvivoGen; hkd-mtlr7ni
DR   Wikidata; Q107115296
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-mtlr7ni).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A.
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2176882; Tlr7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CQ ! HEK-Blue-Lucia Null (NF/IL8)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-Blue-Lucia TNF-alpha
AC   CVCL_A8CX
SY   HEK-Dual TNF-alpha
DR   InvivoGen; hkd-tnfa
DR   Wikidata; Q107115298
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line both genes are under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites (InvivoGen=hkd-tnfa).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:7562; MYD88.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HEK-CaSR
AC   CVCL_E339
SY   CaSR; CaSR-HEK
DR   AddexBio; S0014002/88
DR   Wikidata; Q54882318
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1514; CASR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   HEK-Dsup
AC   CVCL_A7AW
DR   RCB; RCB4687
DR   Wikidata; Q107115286
RX   PubMed=27649274;
CC   Characteristics: Expresses Dsup under the control of a constitutive CAG promoter (PubMed=27649274).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   HEK-DsupdeltaC
AC   CVCL_A7AY
DR   RCB; RCB4689
DR   Wikidata; Q107115287
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup (Note=With p.Lys360_Lys445del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   HEK-DsupKD
AC   CVCL_A7AX
DR   RCB; RCB4688
DR   Wikidata; Q107115288
RX   PubMed=27649274;
CC   Characteristics: Expresses Dsup under the control of a constitutive CAG promoter (PubMed=27649274).
CC   Knockout cell: Method=shRNA knockdown; UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7AW ! HEK-Dsup
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   HEK-Dual IFN-gamma
AC   CVCL_A8CY
DR   InvivoGen; hkd-ifng
DR   Wikidata; Q107115294
CC   Characteristics: Allows the detection of bioactive human IFN-gamma by monitoring the activation of the JAK/STAT1 pathway (InvivoGen=hkd-ifng).
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line both genes are under the control of an ISG54 minimal promoter in conjunction with four IFN-gamma activated sites (GAS) (InvivoGen=hkd-ifng).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11362; STAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-HT
AC   CVCL_C9AL
DR   BioGRID_ORCS_Cell_line; 1080
DR   Wikidata; Q123031581
RX   PubMed=10440377;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9AK ! HA1
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HEK-Lucia Null
AC   CVCL_A8CN
DR   InvivoGen; hkl-null
DR   Wikidata; Q107115300
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkl-null).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK-Lucia RIG-I
AC   CVCL_A8CP
DR   InvivoGen; hkl-hrigi
DR   Wikidata; Q107115301
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkl-hrigi).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19102; RIGI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8CN ! HEK-Lucia Null
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK-MFSD10-KO-c2
AC   CVCL_D4DB
SY   CE01RK-C
DR   Wikidata; Q127381603
WW   Info; RESOLUTE; CE01RK-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16894; MFSD10.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-MTCH2-KO-c1
AC   CVCL_D4DC
SY   CE07ES-T
DR   Wikidata; Q127381604
WW   Info; RESOLUTE; CE07ES-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17587; MTCH2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-MTCH2-KO-c10
AC   CVCL_D4DD
SY   CE07ET-F
DR   Wikidata; Q127381605
WW   Info; RESOLUTE; CE07ET-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17587; MTCH2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-OCT3
AC   CVCL_A2KB
DR   Wikidata; Q105507598
RX   PubMed=24056116;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10967; SLC22A3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 7
//
ID   HEK-ptdTomato-N1 8
AC   CVCL_WN84
SY   HEK-ptdTomato-N1 clone # 8
DR   Wikidata; Q94092477
RX   PubMed=26177619;
CC   Characteristics: Expression of the tdTomato gene is under control of the CMV promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   HEK-RHBG-KO-c2
AC   CVCL_D4DE
SY   CE02W0-2
DR   Wikidata; Q127381606
WW   Info; RESOLUTE; CE02W0-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14572; RHBG.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SC-293T
AC   CVCL_4U22
DR   Wikidata; Q54882319
RX   Patent=US8986991;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-12593.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 14
//
ID   HEK-SLC12A2-KO-c10
AC   CVCL_D4DF
SY   CE07EX-V
DR   Wikidata; Q127381607
WW   Info; RESOLUTE; CE07EX-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10911; SLC12A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC12A2-KO-c5
AC   CVCL_D4DG
SY   CE07EZ-N
DR   Wikidata; Q127381608
WW   Info; RESOLUTE; CE07EZ-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10911; SLC12A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC12A3-KO-c7
AC   CVCL_D4DH
SY   CE02VR-E
DR   Wikidata; Q127381609
WW   Info; RESOLUTE; CE02VR-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10912; SLC12A3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC12A3-KO-c8
AC   CVCL_D4DI
SY   CE02VS-B
DR   Wikidata; Q127381610
WW   Info; RESOLUTE; CE02VS-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10912; SLC12A3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC12A6-KO-c4
AC   CVCL_D4DJ
SY   CE07F4-C
DR   Wikidata; Q127381612
WW   Info; RESOLUTE; CE07F4-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10914; SLC12A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC12A6-KO-c5
AC   CVCL_D4DK
SY   CE07F5-5
DR   Wikidata; Q127381613
WW   Info; RESOLUTE; CE07F5-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10914; SLC12A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC13A5-KO-c12
AC   CVCL_D4DL
SY   CE01SB-F
DR   Wikidata; Q127381614
WW   Info; RESOLUTE; CE01SB-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23089; SLC13A5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC15A2-KO-c9
AC   CVCL_D4DM
SY   CE02PZ-F
DR   Wikidata; Q127381615
WW   Info; RESOLUTE; CE02PZ-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10921; SLC15A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC15A4-KO-c3
AC   CVCL_D4DN
SY   CE01G0-5
DR   Wikidata; Q127381616
WW   Info; RESOLUTE; CE01G0-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC15A4-KO-c4
AC   CVCL_D4DP
SY   CE01G1-1
DR   Wikidata; Q127381617
WW   Info; RESOLUTE; CE01G1-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC16A13-KO-c2
AC   CVCL_D4DQ
SY   CE02NV-F
DR   Wikidata; Q127381619
WW   Info; RESOLUTE; CE02NV-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31037; SLC16A13.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC16A14-KO-c2
AC   CVCL_D4DR
SY   CE017N-K
DR   Wikidata; Q127381620
WW   Info; RESOLUTE; CE017N-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26417; SLC16A14.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC16A14-KO-c6
AC   CVCL_D4DS
SY   CE00P7-A
DR   Wikidata; Q127381621
WW   Info; RESOLUTE; CE00P7-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26417; SLC16A14.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC16A9-KO-c4
AC   CVCL_D4DT
SY   CE02SX-A
DR   Wikidata; Q127381622
WW   Info; RESOLUTE; CE02SX-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23520; SLC16A9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC1A1-KO-c1
AC   CVCL_D4DU
SY   CE01SC-S
DR   Wikidata; Q127381623
WW   Info; RESOLUTE; CE01SC-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10939; SLC1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC1A2-KO-c4
AC   CVCL_D4DV
SY   CE01M7-R
DR   Wikidata; Q127381624
WW   Info; RESOLUTE; CE01M7-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10940; SLC1A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC1A5-KO-c8
AC   CVCL_D4DW
SY   CE07F8-E
DR   Wikidata; Q127381625
WW   Info; RESOLUTE; CE07F8-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC1A5-KO-c9
AC   CVCL_D4DX
SY   CE07F9-B
DR   Wikidata; Q127381626
WW   Info; RESOLUTE; CE07F9-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC25A28-KO-c1
AC   CVCL_D4DY
SY   CE07FA-7
DR   Wikidata; Q127381627
WW   Info; RESOLUTE; CE07FA-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC25A28-KO-c10
AC   CVCL_D4DZ
SY   CE07FB-Q
DR   Wikidata; Q127381628
WW   Info; RESOLUTE; CE07FB-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC25A37-KO-c3
AC   CVCL_D4E0
SY   CE07FF-6
DR   Wikidata; Q127381629
WW   Info; RESOLUTE; CE07FF-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29786; SLC25A37.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC25A37-KO-c6
AC   CVCL_D4E1
SY   CE07FK-K
DR   Wikidata; Q127381630
WW   Info; RESOLUTE; CE07FK-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29786; SLC25A37.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC26A8-KO-c1
AC   CVCL_D4E2
SY   CE005X-G
DR   Wikidata; Q127381631
WW   Info; RESOLUTE; CE005X-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14468; SLC26A8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC26A8-KO-c2
AC   CVCL_D4E3
SY   CE005Z-Y
DR   Wikidata; Q127381632
WW   Info; RESOLUTE; CE005Z-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14468; SLC26A8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC27A2-KO-c3
AC   CVCL_D4E4
SY   CE006C-C
DR   Wikidata; Q127381633
WW   Info; RESOLUTE; CE006C-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10996; SLC27A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC27A2-KO-c5
AC   CVCL_D4E5
SY   CE006F-1
DR   Wikidata; Q127381634
WW   Info; RESOLUTE; CE006F-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10996; SLC27A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC27A3-KO-c1
AC   CVCL_D4E6
SY   CE0040-V
DR   Wikidata; Q127381635
WW   Info; RESOLUTE; CE0040-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10997; SLC27A3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC29A1-KO-c2
AC   CVCL_D4E7
SY   CE00C4-B
DR   Wikidata; Q127381636
WW   Info; RESOLUTE; CE00C4-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC29A1-KO-c3
AC   CVCL_D4E8
SY   CE00C5-7
DR   Wikidata; Q127381637
WW   Info; RESOLUTE; CE00C5-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC2A9-KO-c6
AC   CVCL_D4E9
SY   CE01GR-F
DR   Wikidata; Q127381638
WW   Info; RESOLUTE; CE01GR-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13446; SLC2A9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-SLC35F4-KO-c7
AC   CVCL_D4EA
SY   CE01X2-5
DR   Wikidata; Q127381639
WW   Info; RESOLUTE; CE01X2-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19845; SLC35F4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL74 ! Jump-In T-REx HEK 293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK-TERASB56gamma
AC   CVCL_D123
SY   TERV-AntiSenseB56
DR   EFO; EFO_0001250
DR   Wikidata; Q54882320
RX   PubMed=14998489;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   HEK-TERST
AC   CVCL_D124
SY   TERV-ST
DR   EFO; EFO_0001251
DR   Wikidata; Q54882321
RX   PubMed=11884599;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   HEK-TERST110
AC   CVCL_D125
SY   TERV-ST110
DR   EFO; EFO_0001252
DR   Wikidata; Q54882322
RX   PubMed=11884599;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   HEK-TERV
AC   CVCL_D122
SY   TERV
DR   EFO; EFO_0001249
DR   Wikidata; Q54882323
RX   PubMed=11884599;
RX   PubMed=14998489;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   HEK-TLR2
AC   CVCL_IM79
DR   GEO; GSM618017
DR   GEO; GSM618018
DR   GEO; GSM618019
DR   GEO; GSM618020
DR   GEO; GSM618021
DR   GEO; GSM618022
DR   GEO; GSM618023
DR   GEO; GSM618024
DR   GEO; GSM618025
DR   GEO; GSM618026
DR   GEO; GSM618027
DR   GEO; GSM618028
DR   GEO; GSM618029
DR   GEO; GSM618030
DR   GEO; GSM618031
DR   GEO; GSM618032
DR   GEO; GSM618033
DR   GEO; GSM618034
DR   GEO; GSM618035
DR   GEO; GSM618036
DR   Wikidata; Q54882324
RX   PubMed=21220698;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11848; TLR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   HEK-TLR2-YFP
AC   CVCL_VI43
SY   HEK-TLR2YFP
DR   BEI_Resources; NR-9316
DR   Wikidata; Q54882325
RX   PubMed=12324469;
CC   Characteristics: Transfected with YFP fused in frame to the C-terminus of TLR2.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   HEK-TLR4-YFP
AC   CVCL_VI44
SY   HEK-TLR4YFP
DR   BEI_Resources; NR-9314
DR   Wikidata; Q54882326
RX   PubMed=12324469;
CC   Characteristics: Transfected with YFP fused in frame to the C-terminus of TLR4.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11850; TLR4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   HEK-TLR4-YFP/MD-2
AC   CVCL_VI45
SY   HEK-TLR4YFP/MD-2
DR   BEI_Resources; NR-9315
DR   Wikidata; Q54882327
RX   PubMed=12324469;
CC   Characteristics: Transfected with YFP fused in frame to the C-terminus of TLR4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11850; TLR4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VI44 ! HEK-TLR4-YFP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   HEK-TLR9-YFP
AC   CVCL_VI46
SY   HEK-TLR9YFP
DR   BEI_Resources; NR-9317
DR   Wikidata; Q54882328
RX   PubMed=14716310;
CC   Characteristics: Transfected with YFP fused in frame to the C-terminus of TLR9.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15633; TLR9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   HEK/HRV
AC   CVCL_M625
DR   BioSample; SAMN03151704
DR   Wikidata; Q54882291
RX   PubMed=1246601;
RX   PubMed=4469665;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HEK) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00064.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M624 ! HEK
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HEK001
AC   CVCL_3700
SY   Human Epidermal Keratinocyte 001
DR   CLO; CLO_0003678
DR   ATCC; CRL-2404
DR   BioSample; SAMN03471835
DR   Wikidata; Q54882329
RX   PubMed=10664009;
RX   PubMed=20100199;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) (Note=p1321).
CC   Derived from site: In situ; Scalp, skin, epidermis; UBERON=UBERON_8300000+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): ATCC=CRL-2404
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 12,13
ST   D8S1179: 12,14
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HEK1.1
AC   CVCL_2H48
DR   Wikidata; Q54882330
RX   PubMed=21726526;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10585; SCN1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   HEK293
AC   CVCL_0045
SY   Hek293; HEK-293; HEK/293; (HEK)293; HEK 293; HEK;293; 293; 293 HEK; 293 Ad5; Graham 293; Graham-293; Human Embryonic Kidney 293
DR   BTO; BTO_0000007
DR   CLO; CLO_0001230
DR   CLO; CLO_0050903
DR   EFO; EFO_0001182
DR   MCCL; MCC:0000006
DR   CLDB; cl45
DR   CLDB; cl46
DR   CLDB; cl47
DR   CLDB; cl7133
DR   4DN; 4DNSRVF4XB1F
DR   Abcam; ab259776
DR   Abcam; ab277915
DR   AddexBio; T0011001/76
DR   ATCC; CRL-1573
DR   BCRC; 60019
DR   BCRJ; 0009
DR   BEI_Resources; ARP-103
DR   BEI_Resources; NR-9313
DR   BioGRID_ORCS_Cell_line; 293
DR   BioSample; SAMN03471398
DR   BioSample; SAMN03473347
DR   BioSamples; SAMEA2018185
DR   CancerTools; 154153
DR   CCLV; CCLV-RIE 0197
DR   CCRID; 1101HUM-PUMC000010
DR   CCRID; 1102HUM-NIFDC00005
DR   CCRID; 3101HUMGNHu18
DR   CCRID; 3101HUMGNHu43
DR   CCRID; 4201HUM-CCTCC00067
DR   CCRID; 5301HUM-KCB09071YJ
DR   CCTCC; GDC0067
DR   ChEMBL-Cells; CHEMBL3307715
DR   ChEMBL-Targets; CHEMBL614818
DR   CLS; 300192
DR   DSMZ; ACC-305
DR   DSMZCellDive; ACC-305
DR   ECACC; 85120602
DR   ENCODE; ENCBS022BLS
DR   ENCODE; ENCBS037XHS
DR   ENCODE; ENCBS209KHO
DR   ENCODE; ENCBS253HIE
DR   ENCODE; ENCBS264HQL
DR   ENCODE; ENCBS375ENC
DR   ENCODE; ENCBS393ENC
DR   ENCODE; ENCBS421ENC
DR   ENCODE; ENCBS439ENC
DR   ENCODE; ENCBS479AAA
DR   ENCODE; ENCBS480AAA
DR   ENCODE; ENCBS481AAA
DR   ENCODE; ENCBS482AAA
DR   ENCODE; ENCBS483AAA
DR   ENCODE; ENCBS484AAA
DR   ENCODE; ENCBS486AAA
DR   ENCODE; ENCBS522ENC
DR   ENCODE; ENCBS523ENC
DR   ENCODE; ENCBS613RZL
DR   ENCODE; ENCBS906GPZ
DR   FCS-free; 6-2-284-1-4-3
DR   FCS-free; 6-2-345-1-4-12
DR   FCS-free; 6-2-372-1-16-3
DR   FCS-free; 6-2-381-1-4-3
DR   FCS-free; 6-2-409-1-16-12
DR   FCS-free; 6-2-42-1-8-11
DR   FCS-free; 6-2-421-2-4-7
DR   FCS-free; 6-2-45-1-8-3
DR   FCS-free; 6-2-46-1-8-11
DR   FCS-free; 6-2-503-1-3-3
DR   FCS-free; 6-2-533-1-4-12
DR   FCS-free; 6-2-570-3-17-1
DR   FCS-free; 6-2-586-1-18-2
DR   FCS-free; 6-2-7-1-4-3
DR   GEO; GSM580027
DR   GEO; GSM580028
DR   GEO; GSM635701
DR   GEO; GSM635702
DR   GEO; GSM635703
DR   GEO; GSM635704
DR   GEO; GSM651571
DR   GEO; GSM749668
DR   GEO; GSM749687
DR   GEO; GSM749767
DR   GEO; GSM945256
DR   GEO; GSM945288
DR   GEO; GSM1374525
DR   GEO; GSM7701365
DR   GEO; GSM7701366
DR   IBRC; C10139
DR   ICLC; HTL03003
DR   IZSLER; BS CL 129
DR   JCRB; JCRB9068
DR   KCB; KCB 200408YJ
DR   KCB; KCB 200971YJ
DR   KCLB; 21573
DR   Lonza; 46
DR   MeSH; D057809
DR   MetaboLights; MTBLS102
DR   MetaboLights; MTBLS156
DR   MetaboLights; MTBLS737
DR   NCBI_Iran; C497
DR   PRIDE; PXD000589
DR   PRIDE; PXD000623
DR   PRIDE; PXD000680
DR   PRIDE; PXD000933
DR   PRIDE; PXD000953
DR   PRIDE; PXD001468
DR   PRIDE; PXD001511
DR   PRIDE; PXD001711
DR   PRIDE; PXD001863
DR   PRIDE; PXD002383
DR   PRIDE; PXD002389
DR   PRIDE; PXD002395
DR   PRIDE; PXD002601
DR   PRIDE; PXD002613
DR   PRIDE; PXD002676
DR   PRIDE; PXD003310
DR   PRIDE; PXD003370
DR   PRIDE; PXD003700
DR   PRIDE; PXD003896
DR   PRIDE; PXD005535
DR   PRIDE; PXD005955
DR   PRIDE; PXD009668
DR   PRIDE; PXD014771
DR   PRIDE; PXD017977
DR   PRIDE; PXD030601
DR   PubChem_Cell_line; CVCL_0045
DR   RCB; RCB1637
DR   TKG; TKG 0306
DR   TOKU-E; 31
DR   Ubigene; YC-A008
DR   Wikidata; Q489618
RX   DOI=10.13005/bpj/1414;
RX   PubMed=886304;
RX   PubMed=9217065;
RX   PubMed=11416159;
RX   PubMed=15218237;
RX   PubMed=16957166;
RX   PubMed=21214938;
RX   PubMed=21269460;
RX   PubMed=21502043;
RX   PubMed=22278370;
RX   PubMed=23325432;
RX   PubMed=24618588;
RX   PubMed=25182477;
RX   PubMed=25807930;
RX   PubMed=25894527;
RX   PubMed=25903999;
RX   PubMed=25960936;
RX   PubMed=27233776;
RX   PubMed=27577262;
RX   PubMed=28196595;
RX   PubMed=29660373;
RX   PubMed=30260228;
RX   PubMed=32302230;
RX   PubMed=35339896;
WW   Info; -; -; http://hek293genome.org/v2/
WW   Info; -; -; https://cell-map.org/
WW   Info; -; -; https://hek293.com/
WW   Info; -; -; https://web.archive.org/web/20140910211526/http://webserver.mbi.ufl.edu/~shaw/293.html
WW   Info; -; -; https://www.ukbrcn.org/news/sticky-issues-with-293-cells/
WW   Info; -; -; https://www.vax-before-travel.com/vaccines/sputnik-v-vaccine
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HEK293
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-176.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HEK_293_cells
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/hek-293-xenograft-model/
WW   Provider; CH3 Biosystems; 920001; https://ch3biosystems.com/shop/hek293-cell-line/
CC   Group: Vaccine production cell line.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4488.
CC   Biotechnology: Used for the production of the Gamaleya SARS-CoV-2 (COVID-19) vaccine (Trade name: Gam-COVID-Vac; also known as Sputnik V) (DrugBank=DB15848). Caution: we are not convinced that the cell line used for the production of this vaccine is a "plain vanilla" HEK293, it is probably an engineered derivative, but there is currently (May 2021) no precise information available on this vaccine production process.
CC   Doubling time: ~30 hours (CLS=300192); ~24-30 hours (DSMZ=ACC-305).
CC   HLA typing: A*02:01,03:01; B*07:02,07:02/35:08; C*07:02,07:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*03:01:01; B*07:02:01; C*07:02:01; DPB1*04:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01 (CLS=300192).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Arginine methylation.
CC   Omics: Proteomics; PTM; Myristoylation.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: HECK293; Note=Occasionally.
CC   Misspelling: HEK239; Note=Occasionally.
CC   Misspelling: HK293; PubMed=9364930.
CC   Misspelling: HEK-393; Note=Occasionally.
CC   Misspelling: HEK393; Note=Occasionally.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1573; CCRID; CLS=300192; DSMZ=ACC-305; ECACC=85120602; JCRB=JCRB9068; KCLB=21573; PubMed=11416159; PubMed=15218237; PubMed=35339896; RCB=RCB1637; TKG=TKG 0306
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 11,15
ST   D13S317: 12 (JCRB=JCRB9068; TKG=TKG 0306)
ST   D13S317: 12,14 (ATCC=CRL-1573; CCRID; CLS=300192; DSMZ=ACC-305; ECACC=85120602; KCLB=21573; PubMed=15218237; PubMed=35339896; RCB=RCB1637)
ST   D16S539: 9 (DSMZ=ACC-305)
ST   D16S539: 9,13 (ATCC=CRL-1573; CCRID; CLS=300192; ECACC=85120602; JCRB=JCRB9068; PubMed=35339896; RCB=RCB1637; TKG=TKG 0306)
ST   D18S51: 17 (PubMed=15218237)
ST   D18S51: 17,18 (ATCC=CRL-1573; CCRID; PubMed=11416159; PubMed=35339896)
ST   D18S51: 18 (CLS=300192; DSMZ=ACC-305)
ST   D19S433: 15,18 (ATCC=CRL-1573; CCRID)
ST   D19S433: 18 (CLS=300192; DSMZ=ACC-305; PubMed=35339896)
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D2S441: 11,15
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D6S1043: 11
ST   D7S820: 11 (PubMed=35339896)
ST   D7S820: 11,12 (ATCC=CRL-1573; CCRID; CLS=300192; DSMZ=ACC-305; ECACC=85120602; JCRB=JCRB9068; KCLB=21573; PubMed=15218237; RCB=RCB1637; TKG=TKG 0306)
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   HEK293 (+Galpha16) AequoScreen
AC   CVCL_5I96
DR   Revvity/PerkinElmer; ES-000-A26
DR   Wikidata; Q54882331
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   HEK293 3xHA ControlTAG
AC   CVCL_C8A7
SY   3xHA HEK293
DR   Wikidata; Q123031582
RX   PubMed=37155866;
CC   Characteristics: Control cell line for HEK293 TMEM115-3xHA GolgiTAG (Cellosaurus=CVCL_C8A6) cell line. Expresses an empty vector with the 3xHA tag (PubMed=37155866).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   HEK293 482R
AC   CVCL_0296
SY   482R-HEK293; HEK-293 482R; HEK 293 482R
DR   MCCL; MCC:0000186
DR   Wikidata; Q54882332
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   HEK293 ABCA4-R1108C
AC   CVCL_WZ19
DR   Wikidata; Q94092741
RX   PubMed=26092729;
WW   Provider; JHTV; C13886; https://jhu.technologypublisher.com/technology/23601
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:34; ABCA4 (Note=With p.Arg1108Cys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HEK293 ABCA4-R1129C
AC   CVCL_WZ20
DR   Wikidata; Q94092746
RX   PubMed=26092729;
WW   Provider; JHTV; C13886; https://jhu.technologypublisher.com/technology/23601
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:34; ABCA4 (Note=With p.Arg1129Cys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HEK293 ABCA4-WT
AC   CVCL_WZ21
DR   Wikidata; Q94092750
RX   PubMed=26092729;
WW   Provider; JHTV; C13886; https://jhu.technologypublisher.com/technology/23601
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:34; ABCA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HEK293 Actin-cpstFRET-Actin
AC   CVCL_ZV87
SY   HEK293 AcpA; Beta-M-HEK
DR   Kerafast; EBU022
DR   Wikidata; Q98126658
RX   PubMed=25422450;
CC   Characteristics: Used to report forces in actin in living cells. Has one actin molecule attached on each end of cpstFRET. The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:132; ACTB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293 Actinin-C-cpstFRET
AC   CVCL_ZV88
SY   HEK293 C-cpstFRET
DR   Kerafast; EBU025
DR   Wikidata; Q98126659
RX   PubMed=25422450;
CC   Characteristics: Has one actinin molecule attached to the C-terminal of cpstFRET, leaving the other end of the probe dangling free and the probe devoid of tension (force-free control). The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:163; ACTN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293 Actinin-M-cpstFRET
AC   CVCL_ZV89
SY   HEK293 M-cpstFRET
DR   Kerafast; EBU024
DR   Wikidata; Q98126661
RX   PubMed=25422450;
CC   Characteristics: Used to report forces in actinin in living cells. Has one actinin molecule with the cpstFRET sensor incorporated between spectrin repeat domains 3 and 4 toward the middle of actinin. The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:163; ACTN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293 ADCYAP1R1 HiTSeeker
AC   CVCL_YJ96
SY   HiTSeeker ADCYAP1R1; HiTSeeker PAC1; ADCYAP1R1 (PACAPR1)/HEK293
DR   Innoprot; P30114
DR   Wikidata; Q94092756
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 ADORA2A HiTSeeker
AC   CVCL_YJ97
SY   HiTSeeker ADORA2A; ADORA2A/HEK293
DR   Innoprot; P30191
DR   Wikidata; Q94092760
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:263; ADORA2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 ADORA2B HiTSeeker
AC   CVCL_YJ98
SY   HiTSeeker ADORA2B; ADORA2B/HEK293
DR   Innoprot; P30192
DR   Wikidata; Q94092764
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:264; ADORA2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 ADRB2 HiTSeeker
AC   CVCL_YJ99
SY   HiTSeeker ADRB2; ADRB2/HEK293
DR   Innoprot; P30125
DR   Wikidata; Q94092769
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 ADRB3 HiTSeeker
AC   CVCL_YK00
SY   HiTSeeker ADRB3; ADRB3/HEK293
DR   Innoprot; P30101
DR   Wikidata; Q94092773
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:288; ADRB3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 AequoScreen
AC   CVCL_5I97
DR   Revvity/PerkinElmer; ES-000-A30
DR   Wikidata; Q54882333
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P07164; Aequorea victoria aequorin.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   HEK293 APPswe
AC   CVCL_A5CZ
SY   HEK293-APPswe; HEK293/APPswe; 20E2
DR   BTO; BTO_0006422
DR   Wikidata; Q107115302
RX   PubMed=22842730;
RX   PubMed=29175631;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=With p.Lys670_Met671delinsAsnLeu (c.2010_2011inv)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293 ATG2A/ATG2B DKO
AC   CVCL_E8CG
SY   HEK293 ATG2A/2B DKO
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 ATG2A/ATG2B DKO APEX2-EGFP-ATG2A
AC   CVCL_E8GU
SY   HEK293 ATG2 DKO + APEX2-EGFP-ATG2A
RX   DOI=10.1101/2025.03.24.645038;
CC   Characteristics: Transduced with an pLVX-Puro-APEX2-GFP-ATG2A construct (DOI=10.1101/2025.03.24.645038).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29028; ATG2A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q76LA6; Glycine max L-ascorbate peroxidase apx2 (Note=Engineered to be used for proximity labeling = APEX2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8CG ! HEK293 ATG2A/ATG2B DKO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293 ATG2A/2B DKO GFP-ATG2A
AC   CVCL_E8CH
RX   PubMed=30952800;
CC   Characteristics: Transduced with a eGFP-ATG2A construct (PubMed=30952800).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29028; ATG2A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8CG ! HEK293 ATG2A/ATG2B DKO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 ATG2A/ATG2B DKO GFP-ATG2A TagBFP-LC3B
AC   CVCL_E8GV
SY   HEK293 ATG2 DKO + GFP-ATG2A + TagBFP-LC3B
RX   DOI=10.1101/2025.03.24.645038;
CC   Characteristics: Transduced with a pLVX-Neo-TagBFP-LC3B construct (DOI=10.1101/2025.03.24.645038).
CC   Characteristics: Transduced with a eGFP-ATG2A construct (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29028; ATG2A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13352; MAP1LC3B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8CH ! HEK293 ATG2A/2B DKO GFP-ATG2A
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293 ATG2A/2B DKO GFP-ATG2A(1-345)
AC   CVCL_E8CI
SY   HEK293 ATG2A/2B DKO GFP-mini-ATG2A
RX   PubMed=30952800;
CC   Characteristics: Transduced with a eGFP-mini-ATG2A (with only residues 1 to 345) construct (PubMed=30952800).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29028; ATG2A (Note=With p.Pro346_Asp1938del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8CG ! HEK293 ATG2A/ATG2B DKO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 ATG2A/2B DKO GFP-ATG2A(del1-345)
AC   CVCL_E8CJ
SY   HEK293 ATG2A/2B DKO GFP-ATG2A(delta1-345)
RX   PubMed=30952800;
CC   Characteristics: Transduced with a eGFP-ATG2A (with residues 1 to 345 deleted) construct (PubMed=30952800).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29028; ATG2A (Note=With p.Met1_Glu345del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8CG ! HEK293 ATG2A/ATG2B DKO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 AVPR1A HiTSeeker
AC   CVCL_YK01
SY   HiTSeeker AVPR1A; AVPR1A/HEK293
DR   Innoprot; P30103
DR   Wikidata; Q94092788
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:895; AVPR1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 BDKRB1 HiTSeeker
AC   CVCL_YK02
SY   HiTSeeker BDKRB1; BDKRB1/HEK293
DR   Innoprot; P30109
DR   Wikidata; Q94092793
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1029; BDKRB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 BDKRB2 HiTSeeker
AC   CVCL_YK03
SY   HiTSeeker BDKRB2 (HEK293)
DR   Innoprot; P30110
DR   Wikidata; Q94092795
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 C9orf72+/-
AC   CVCL_A3KR
SY   HEK-293 C9ORF72 heterozygous
DR   Wikidata; Q105507602
RX   PubMed=31612854;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 7
//
ID   HEK293 C9orf72-/- A
AC   CVCL_A3KS
SY   HEK-293 C9ORF72 KO clone A; KOA
DR   Wikidata; Q105507604
RX   PubMed=31612854;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 C9orf72-/- B
AC   CVCL_A3KT
SY   HEK-293 C9ORF72 KO clone B; KOB
DR   Wikidata; Q105507608
RX   PubMed=31612854;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 CALCR HiTSeeker
AC   CVCL_YK04
SY   HiTSeeker CALCR; CALCR/HEK293
DR   Innoprot; P30136
DR   Wikidata; Q94092799
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 Cas9
AC   CVCL_UR28
SY   HEK-293 Cas9; 293 Cas9; 293[HEK-293] Cas9
DR   ATCC; CRL-1573Cas9
DR   Wikidata; Q94092805
CC   Characteristics: Using CRISPR/Cas9 a construct containing Cas9-2A-RFP-PA-Neo-PA was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-1573Cas9
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 Cav3.1
AC   CVCL_HC62
SY   HEK293 Cav3.1a; HEK-293 Cav3.1c; Q-31
DR   Kerafast; EG0041-FP
DR   Wikidata; Q54882334
RX   PubMed=10648811;
RX   PubMed=17477828;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1394; CACNA1G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   HEK293 Cav3.2
AC   CVCL_HC63
SY   HEK293 Cav3.2a; Hh8-5
DR   Kerafast; EG0042-FP
DR   Wikidata; Q54882336
RX   PubMed=12080115;
RX   PubMed=17477828;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1395; CACNA1H.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   HEK293 Cav3.3
AC   CVCL_HC64
SY   HEK293 Cav3.3b; LT9-8
DR   Kerafast; EG0043-FP
DR   Wikidata; Q54882337
RX   PubMed=12080115;
RX   PubMed=17477828;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1396; CACNA1I.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   HEK293 CCKBR arrestin-Nomad
AC   CVCL_YK05
SY   CCK2 Arrestin-Nomad; ArrestNomad-CCKBR
DR   Innoprot; P70808
DR   Wikidata; Q94092845
CC   Characteristics: In basal conditions, the arrestin Biosensor shows a very low fluorescence intensity. When an agonist binds to CCKBR, it is phosphorylated, promoting the recruitment of the arrestin-Nomad Biosensor and leading to a change in its structural folding and promoting an increase in fluorescence intensity.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1571; CCKBR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HEK293 CCKBR calcium-Nomad
AC   CVCL_YK06
SY   CCKBR Ca2+Nomad; CCK2 Nomad
DR   Innoprot; P70108
DR   Wikidata; Q94092849
CC   Characteristics: In absence of calcium, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1571; CCKBR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HEK293 CCR1
AC   CVCL_E4JX
SY   HEK 293 CC CKR1
RX   PubMed=8530354;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1602; CCR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293 CCR2 isoform B
AC   CVCL_E4JY
SY   HEK 293 CC CKR2b
RX   PubMed=8530354;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1603; CCR2 (Note=Isoform B).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293 CCR3
AC   CVCL_E4JZ
SY   HEK 293 CC CKR3
RX   PubMed=8530354;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293 CD63 CRISPR
AC   CVCL_UF04
DR   PRIDE; PXD006514
DR   Wikidata; Q94092854
RX   PubMed=29212935;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1692; CD63.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CHI3L1
AC   CVCL_B6SF
SY   293-CHI3L1; 293_CHI3L1
DR   Wikidata; Q111733349
RX   DOI=10.7124/bc.00010B;
RX   PubMed=23675241;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1932; CHI3L1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 CHRM1 HiTSeeker
AC   CVCL_YK07
SY   HiTSeeker CHRM1 (HEK293)
DR   Innoprot; P30104
DR   Wikidata; Q94092858
WW   Provider; Innoprot; P30104; https://web.archive.org/web/20190413083614/http://www.innoprot.com/en_productos.asp?idsf=5&id=17&idp=126
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Innoprot; P30104; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 CNR1 cAMP-Nomad
AC   CVCL_YI91
SY   CB1 cAMP-Nomad; CB1 Nomad; cAMPNomad-CB1
DR   Innoprot; P70527
DR   Wikidata; Q94092863
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Innoprot; P70527; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HEK293 CNR1 HiTSeeker
AC   CVCL_YK08
SY   HiTSeeker CNR1; CNR1/HEK293
DR   Innoprot; P30107
DR   Wikidata; Q94092865
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2159; CNR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 CNR2 HiTSeeker
AC   CVCL_YK09
SY   HiTSeeker CNR2; CNR2/HEK293
DR   Innoprot; P30108
DR   Wikidata; Q94092869
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2160; CNR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 cpstFRET-Actin
AC   CVCL_ZV86
SY   HEK293 cpA; Beta-C-HEK
DR   Kerafast; EBU023
DR   Wikidata; Q98126662
RX   PubMed=25422450;
CC   Characteristics: Has one actin molecule attached to the C-terminal of cpstFRET, leaving the other end of the probe dangling free and the probe devoid of tension (force-free control). The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:132; ACTB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293 CRHR2 HiTSeeker
AC   CVCL_YK10
SY   HiTSeeker CRHR2; CRHR-2/HEK293; CRF-2 (CRHR-2)/HEK293
DR   Innoprot; P30116
DR   Wikidata; Q94092874
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2358; CRHR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 CYP19A1*1
AC   CVCL_UH22
SY   CYP19A1*1 (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU045
DR   Wikidata; Q94092877
RX   PubMed=28603632;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU045; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP19A1*3
AC   CVCL_UH23
SY   CYP19A1*3 (T201M) Expressing HEK293 Cell Line
DR   Kerafast; EWU046
DR   Wikidata; Q94092883
RX   PubMed=28603632;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2594; CYP19A1 (Note=With p.Thr201Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU046; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP19A1*4
AC   CVCL_UH24
SY   CYP19A1*4 (R264C) Expressing HEK293 Cell Line
DR   Kerafast; EWU047
DR   Wikidata; Q94092887
RX   PubMed=28603632;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2594; CYP19A1 (Note=With p.Arg264Cys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU047; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP1A1*1
AC   CVCL_UG79
SY   CYP1A1*1 (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU003
DR   Wikidata; Q94092889
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU003; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP1A1*1-V5
AC   CVCL_UG80
SY   CYP1A1*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU002
DR   Wikidata; Q94092895
CC   Characteristics: Expresses CYP1A1*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU002; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP1A2*1A
AC   CVCL_UG81
SY   CYP1A2*1A (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU005
DR   Wikidata; Q94092899
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU005; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP1A2*1A-V5
AC   CVCL_UG82
SY   CYP1A2*1A (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU004
DR   Wikidata; Q94092903
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP1A2*1A with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU004; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP1A2*21
AC   CVCL_UG83
SY   CYP1A2*21 (S298R) Expressing HEK293 Cell Line
DR   Kerafast; EWU006
DR   Wikidata; Q94092907
RX   PubMed=28603633;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2 (Note=With p.Ser298Arg).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU006; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2A13*1A
AC   CVCL_UG86
SY   CYP2A13*1A (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU010
DR   Wikidata; Q94092912
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2608; CYP2A13.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU010; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2A13*1A-V5
AC   CVCL_UG87
SY   CYP2A13*1A (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU009
DR   Wikidata; Q94092916
CC   Characteristics: Expresses CYP2A13*1A with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2608; CYP2A13.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU009; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2A6*1A
AC   CVCL_UG84
SY   CYP2A6*1A (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU008
DR   Wikidata; Q94092920
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU008; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2A6*1A-V5
AC   CVCL_UG85
SY   CYP2A6*1A (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU007
DR   Wikidata; Q94092926
CC   Characteristics: Expresses CYP2A6*1A with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU007; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2B6*1-V5
AC   CVCL_UG89
SY   CYP2B6*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU011
DR   Wikidata; Q94092929
CC   Characteristics: Expresses CYP2B6*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU011; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C18*1-V5
AC   CVCL_UH00
SY   CYP2C18*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU023
DR   Wikidata; Q94092934
CC   Characteristics: Expresses CYP2C18*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2620; CYP2C18.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU023; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C19*1A-V5
AC   CVCL_UH02
SY   CYP2C19*1A (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU024
DR   Wikidata; Q94092939
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C19*1A with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2621; CYP2C19.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU024; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C19*1B-V5
AC   CVCL_UH03
SY   CYP2C19*1B (I331V - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU026
DR   Wikidata; Q94092942
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C19*1B with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2621; CYP2C19.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU026; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293 CYP2C19-E92D-V5
AC   CVCL_UH05
SY   CYP2C19-E92D (no allele designation - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU028
DR   Wikidata; Q94092949
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C19 E92D with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2621; CYP2C19 (Note=With p.Glu92Asp).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU028; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293 CYP2C8*1-V5
AC   CVCL_UG90
SY   CYP2C8*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU013
DR   Wikidata; Q94092955
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C8*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2622; CYP2C8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU013; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C8*2-V5
AC   CVCL_UG91
SY   CYP2C8*2 (I269F - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU014
DR   Wikidata; Q94092958
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C8*2 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2622; CYP2C8 (Note=With p.Ile269Phe).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU014; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C8*3-V5
AC   CVCL_UG92
SY   CYP2C8*3 (R139K/K399R - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU015
DR   Wikidata; Q94092964
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C8*3 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2622; CYP2C8 (Note=With p.Arg139Lys and p.Lys399Arg).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU015; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C8*4-V5
AC   CVCL_UG93
SY   CYP2C8*4 (I264M - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU016
DR   Wikidata; Q94092969
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C8*4 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2622; CYP2C8 (Note=With p.Ile264Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU016; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C9*1
AC   CVCL_UG94
SY   CYP2C9*1 (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU018
DR   Wikidata; Q94092973
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU018; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C9*1-V5
AC   CVCL_UG95
SY   CYP2C9*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU017
DR   Wikidata; Q94092979
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C9*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU017; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C9*2-V5
AC   CVCL_UG96
SY   CYP2C9*2 (R144C - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU019
DR   Wikidata; Q94092983
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C9*2 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9 (Note=With p.Arg144Cys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU019; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C9*3-V5
AC   CVCL_UG97
SY   CYP2C9*3 (I359L - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU020
DR   Wikidata; Q94092987
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C9*3 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9 (Note=With p.Ile359Leu).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU020; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C9*8-V5
AC   CVCL_UG98
SY   CYP2C9*8 (R150H - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU021
DR   Wikidata; Q94092992
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C9*8 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9 (Note=With p.Arg150His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU021; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2C9*9-V5
AC   CVCL_UG99
SY   CYP2C9*9 (H251R - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU022
DR   Wikidata; Q94092997
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2C9*9 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9 (Note=With p.His251Arg).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU022; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2D6*10
AC   CVCL_UH09
SY   CYP2D6*10 (P34S/S486T) Expressing HEK293 Cell Line
DR   Wikidata; Q94093000
RX   PubMed=28603633;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Pro34Ser and p.Ser486Thr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line has been lost. Attempt to re-clone it are underway.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293 CYP2D6*17-V5
AC   CVCL_UH10
SY   CYP2D6*17 (T107I/R296C/S486T - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU033
DR   Wikidata; Q94093005
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2D6*17 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Thr107Ile, p.Arg296Cys and p.Ser486Thr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU033; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2D6*1A-V5
AC   CVCL_UH07
SY   CYP2D6*1A (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU029
DR   Wikidata; Q94093012
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2D6*1A with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2625; CYP2D6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU029; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2D6*2-V5
AC   CVCL_UH08
SY   CYP2D6*2 (R296C/S486T - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU031
DR   Wikidata; Q94093016
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP2D6*2 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Arg296Cys and p.Ser486Thr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU031; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2E1*1A
AC   CVCL_UH11
SY   CYP2E1*1A (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU035
DR   Wikidata; Q94093020
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU035; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2E1*1A-V5
AC   CVCL_UH12
SY   CYP2E1*1A (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU034
DR   Wikidata; Q94093026
CC   Characteristics: Expresses CYP2E1*1A with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU034; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP2J2*1-V5
AC   CVCL_UH13
SY   CYP2J2*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU036
DR   Wikidata; Q94093030
CC   Characteristics: Expresses CYP2J2*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2634; CYP2J2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU036; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP3A4*15-V5
AC   CVCL_UH16
SY   CYP3A4*15 (R162Q - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU039
DR   Wikidata; Q94093036
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP3A4*15 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4 (Note=With p.Arg162Gln).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU039; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP3A4*1A-V5
AC   CVCL_UH15
SY   CYP3A4*1A (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU037
DR   Wikidata; Q94093040
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP3A4*1A with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU037; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP3A5*1
AC   CVCL_UH17
SY   CYP3A5*1 (Wild type) Expressing HEK293 Cell Line
DR   Kerafast; EWU041
DR   Wikidata; Q94093045
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2638; CYP3A5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU041; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP3A5*1-V5
AC   CVCL_UH18
SY   CYP3A5*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU040
DR   Wikidata; Q94093051
RX   PubMed=28603633;
CC   Characteristics: Expresses CYP3A5*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2638; CYP3A5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU040; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 CYP3A7*2-V5
AC   CVCL_UH20
SY   CYP3A7*2 (T409R - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU043
DR   Wikidata; Q94093056
CC   Characteristics: Expresses CYP3A7*2 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2640; CYP3A7 (Note=With p.Thr409Arg).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU043; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293 CYP4A11*1-V5
AC   CVCL_UH21
SY   CYP4A11*1 (Wild type - V5 tag) Expressing HEK293 Cell Line
DR   Kerafast; EWU044
DR   Wikidata; Q94093061
CC   Characteristics: Expresses CYP4A11*1 with a C-terminal V5 tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2642; CYP4A11.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EWU044; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 D1
AC   CVCL_E1GS
SY   D1
RX   PubMed=15659110;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3020; DRD1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293 DRD1 cAMP-Nomad
AC   CVCL_YK11
SY   DRD1 cAMP-Nomad; DRD1 Nomad; cAMPNomad DRD1
DR   Innoprot; P70508
DR   Wikidata; Q94093065
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3020; DRD1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HEK293 DRD1 HiTSeeker
AC   CVCL_YK12
SY   HiTSeeker DRD1; DRD1/HEK293
DR   Innoprot; P30118
DR   Wikidata; Q94093071
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3020; DRD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 DRD5 HiTSeeker
AC   CVCL_YK13
SY   HiTSeeker DRD5; DRD5/HEK293
DR   Innoprot; P30122
DR   Wikidata; Q94093075
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3026; DRD5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 eGFP-AEBP2
AC   CVCL_HC69
DR   ENCODE; ENCBS638MCL
DR   ENCODE; ENCBS715MMR
DR   GEO; GSM2423941
DR   GEO; GSM2423942
DR   Wikidata; Q54882338
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24051; AEBP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293 eGFP-ATF2
AC   CVCL_HC70
DR   ENCODE; ENCBS268PXW
DR   ENCODE; ENCBS818PXJ
DR   GEO; GSM2423604
DR   Wikidata; Q54882339
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:784; ATF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293 eGFP-BCL11A
AC   CVCL_XV62
DR   ENCODE; ENCBS541ZKU
DR   ENCODE; ENCBS941THM
DR   GEO; GSM2422902
DR   GEO; GSM2422903
DR   Wikidata; Q94093105
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13221; BCL11A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-BCL11B
AC   CVCL_HC71
DR   ENCODE; ENCBS395FBP
DR   ENCODE; ENCBS923OML
DR   GEO; GSM2423947
DR   GEO; GSM2423948
DR   Wikidata; Q54882340
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13222; BCL11B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293 eGFP-BCL6B
AC   CVCL_XV63
DR   ENCODE; ENCBS162FZC
DR   ENCODE; ENCBS538HOG
DR   GEO; GSM2827436
DR   GEO; GSM2827437
DR   Wikidata; Q94093124
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1002; BCL6B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-CTCF
AC   CVCL_HC72
DR   ENCODE; ENCBS268XWC
DR   ENCODE; ENCBS454VNJ
DR   GEO; GSM2423744
DR   GEO; GSM2423745
DR   Wikidata; Q54882342
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13723; CTCF.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293 eGFP-EGR2
AC   CVCL_HC73
DR   ENCODE; ENCBS738RNR
DR   ENCODE; ENCBS970WCY
DR   Wikidata; Q54882343
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3239; EGR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-FEZF1
AC   CVCL_XV64
DR   ENCODE; ENCBS416NEJ
DR   ENCODE; ENCBS945GDK
DR   Wikidata; Q94093156
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:22788; FEZF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-GFI1B
AC   CVCL_HC74
DR   ENCODE; ENCBS320GSB
DR   ENCODE; ENCBS321IHW
DR   Wikidata; Q54882344
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4238; GFI1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-GLI2
AC   CVCL_XV65
DR   ENCODE; ENCBS073JSB
DR   ENCODE; ENCBS298HKS
DR   Wikidata; Q94093172
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4318; GLI2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-GLI4
AC   CVCL_HC75
DR   ENCODE; ENCBS601JDX
DR   ENCODE; ENCBS966YJO
DR   Wikidata; Q54882345
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4320; GLI4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-GLIS1
AC   CVCL_HC76
DR   ENCODE; ENCBS300BBW
DR   ENCODE; ENCBS695XFP
DR   Wikidata; Q54882346
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29525; GLIS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-GLIS2
AC   CVCL_HC77
DR   ENCODE; ENCBS101WTD
DR   ENCODE; ENCBS627NYN
DR   Wikidata; Q54882347
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29450; GLIS2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-HIC1
AC   CVCL_XV66
DR   ENCODE; ENCBS237PTC
DR   ENCODE; ENCBS633JQE
DR   Wikidata; Q94093216
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4909; HIC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-IKZF2
AC   CVCL_XV67
DR   ENCODE; ENCBS404QSS
DR   ENCODE; ENCBS822XRF
DR   Wikidata; Q94093222
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13177; IKZF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-INSM2
AC   CVCL_HC78
DR   ENCODE; ENCBS121NOF
DR   ENCODE; ENCBS748WVG
DR   Wikidata; Q54882348
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17539; INSM2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-KLF1
AC   CVCL_HC79
DR   ENCODE; ENCBS211CSP
DR   ENCODE; ENCBS870ICB
DR   Wikidata; Q54882349
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-KLF13
AC   CVCL_XV68
DR   ENCODE; ENCBS919NDB
DR   Wikidata; Q94093254
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13672; KLF13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-KLF14
AC   CVCL_XV69
DR   ENCODE; ENCBS949DFI
DR   Wikidata; Q94093257
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23025; KLF14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-KLF16
AC   CVCL_XV70
DR   ENCODE; ENCBS099BWK
DR   ENCODE; ENCBS255NNL
DR   Wikidata; Q94093263
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16857; KLF16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-KLF17
AC   CVCL_HC80
DR   ENCODE; ENCBS328EZX
DR   ENCODE; ENCBS485LHG
DR   GEO; GSM2422946
DR   GEO; GSM2422947
DR   Wikidata; Q54882350
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18830; KLF17.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293 eGFP-KLF7
AC   CVCL_HC81
DR   ENCODE; ENCBS079LXY
DR   ENCODE; ENCBS184IBZ
DR   Wikidata; Q54882351
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6350; KLF7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-KLF8
AC   CVCL_HC82
DR   ENCODE; ENCBS132UZL
DR   ENCODE; ENCBS960DYO
DR   Wikidata; Q54882352
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6351; KLF8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-KLF9
AC   CVCL_HC83
DR   ENCODE; ENCBS321GAS
DR   ENCODE; ENCBS659BWP
DR   Wikidata; Q54882356
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1123; KLF9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-MAZ
AC   CVCL_HC84
DR   ENCODE; ENCBS099PTU
DR   ENCODE; ENCBS373QTO
DR   ENCODE; ENCBS541TCN
DR   Wikidata; Q54882357
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6914; MAZ.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-MYNN
AC   CVCL_HC85
DR   ENCODE; ENCBS187WDU
DR   ENCODE; ENCBS898VIL
DR   Wikidata; Q54882358
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14955; MYNN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-MZF1
AC   CVCL_XV71
DR   ENCODE; ENCBS647IEQ
DR   Wikidata; Q94093348
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13108; MZF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-OSR2
AC   CVCL_HC86
DR   ENCODE; ENCBS582ZUH
DR   ENCODE; ENCBS927YCP
DR   Wikidata; Q54882359
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15830; OSR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-OVOL3
AC   CVCL_HC87
DR   ENCODE; ENCBS294AQJ
DR   ENCODE; ENCBS465UQI
DR   Wikidata; Q54882360
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14186; OVOL3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-PATZ1
AC   CVCL_XV72
DR   ENCODE; ENCBS186LSD
DR   ENCODE; ENCBS577WIH
DR   Wikidata; Q94093378
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13071; PATZ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-PRDM1
AC   CVCL_HC88
DR   ENCODE; ENCBS153AXP
DR   ENCODE; ENCBS830CXI
DR   Wikidata; Q54882361
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9346; PRDM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-PRDM10
AC   CVCL_HC89
DR   ENCODE; ENCBS002NWR
DR   ENCODE; ENCBS154XJI
DR   Wikidata; Q54882362
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13995; PRDM10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-PRDM12
AC   CVCL_HC90
DR   ENCODE; ENCBS395UVF
DR   ENCODE; ENCBS568ALT
DR   Wikidata; Q54882363
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13997; PRDM12.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-PRDM2
AC   CVCL_XV73
DR   ENCODE; ENCBS077EHF
DR   ENCODE; ENCBS410VFQ
DR   Wikidata; Q94093418
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9347; PRDM2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-PRDM4
AC   CVCL_XV74
DR   ENCODE; ENCBS090OPS
DR   ENCODE; ENCBS269DNN
DR   ENCODE; ENCBS564GDD
DR   Wikidata; Q94093421
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9348; PRDM4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-PRDM6
AC   CVCL_XV75
DR   ENCODE; ENCBS568BLW
DR   ENCODE; ENCBS913UOH
DR   Wikidata; Q94093425
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9350; PRDM6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-RBAK
AC   CVCL_XV76
DR   ENCODE; ENCBS758JEW
DR   ENCODE; ENCBS826GBM
DR   Wikidata; Q94093428
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17680; RBAK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-REPIN1
AC   CVCL_XV77
DR   ENCODE; ENCBS313ZXJ
DR   ENCODE; ENCBS430QMH
DR   ENCODE; ENCBS440JWN
DR   Wikidata; Q94093432
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17922; REPIN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-REST
AC   CVCL_HC91
DR   ENCODE; ENCBS064MAI
DR   ENCODE; ENCBS988LBI
DR   Wikidata; Q54882364
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9966; REST.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-RREB1
AC   CVCL_XV78
DR   ENCODE; ENCBS051YRX
DR   ENCODE; ENCBS481FKX
DR   Wikidata; Q94093444
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10449; RREB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-SALL1
AC   CVCL_XV79
DR   ENCODE; ENCBS308KSJ
DR   ENCODE; ENCBS933NCW
DR   Wikidata; Q94093448
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10524; SALL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-SALL2
AC   CVCL_XV80
DR   ENCODE; ENCBS209PBO
DR   ENCODE; ENCBS543JCR
DR   GEO; GSM2824364
DR   GEO; GSM2824365
DR   Wikidata; Q94093452
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10526; SALL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-SALL4
AC   CVCL_HC92
DR   ENCODE; ENCBS247KOX
DR   Wikidata; Q54882365
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15924; SALL4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-SCRT1
AC   CVCL_XV81
DR   ENCODE; ENCBS570HPC
DR   ENCODE; ENCBS869DNC
DR   Wikidata; Q94093463
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15950; SCRT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-SCRT2
AC   CVCL_XV82
DR   ENCODE; ENCBS843XAC
DR   ENCODE; ENCBS969EIC
DR   Wikidata; Q94093467
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15952; SCRT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-SP2
AC   CVCL_HC93
DR   ENCODE; ENCBS525GEV
DR   ENCODE; ENCBS974ABS
DR   Wikidata; Q54882366
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11207; SP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-SP3
AC   CVCL_HC94
DR   ENCODE; ENCBS227SEC
DR   ENCODE; ENCBS451MRF
DR   Wikidata; Q54882367
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11208; SP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-SP7
AC   CVCL_HC95
DR   ENCODE; ENCBS387JTD
DR   ENCODE; ENCBS516AIH
DR   ENCODE; ENCBS983QBQ
DR   Wikidata; Q54882368
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17321; SP7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-TSHZ1
AC   CVCL_HC96
DR   ENCODE; ENCBS351LOZ
DR   ENCODE; ENCBS429FXL
DR   Wikidata; Q54882369
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10669; TSHZ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-WT1
AC   CVCL_HC97
DR   ENCODE; ENCBS740TWL
DR   ENCODE; ENCBS927FFT
DR   Wikidata; Q54882370
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12796; WT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-YY1
AC   CVCL_XV83
DR   ENCODE; ENCBS082ZRX
DR   Wikidata; Q94093516
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12856; YY1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-YY2
AC   CVCL_XV84
DR   ENCODE; ENCBS828IPH
DR   ENCODE; ENCBS957THJ
DR   Wikidata; Q94093519
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:31684; YY2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB1
AC   CVCL_HC98
DR   ENCODE; ENCBS221WVG
DR   ENCODE; ENCBS255RNI
DR   Wikidata; Q54882371
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20259; ZBTB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZBTB10
AC   CVCL_XV85
DR   ENCODE; ENCBS137HOM
DR   ENCODE; ENCBS542HYG
DR   GEO; GSM2824336
DR   GEO; GSM2824337
DR   Wikidata; Q94093539
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30953; ZBTB10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB11
AC   CVCL_HC99
DR   ENCODE; ENCBS097DHX
DR   ENCODE; ENCBS310DWJ
DR   Wikidata; Q54882372
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16740; ZBTB11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZBTB12
AC   CVCL_XV86
DR   ENCODE; ENCBS897JUR
DR   Wikidata; Q94093559
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19066; ZBTB12.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB17
AC   CVCL_XV87
DR   ENCODE; ENCBS056OOQ
DR   ENCODE; ENCBS492OGG
DR   GEO; GSM2423767
DR   GEO; GSM2423768
DR   Wikidata; Q94093565
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12936; ZBTB17.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB20
AC   CVCL_XV88
DR   ENCODE; ENCBS544JLM
DR   ENCODE; ENCBS635EFP
DR   Wikidata; Q94093571
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13503; ZBTB20.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB21
AC   CVCL_XV89
DR   ENCODE; ENCBS722WSQ
DR   ENCODE; ENCBS866NNL
DR   Wikidata; Q94093579
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13083; ZBTB21.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB26
AC   CVCL_XV90
DR   ENCODE; ENCBS097KFU
DR   ENCODE; ENCBS587LLP
DR   Wikidata; Q94093584
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23383; ZBTB26.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB33
AC   CVCL_XV91
DR   ENCODE; ENCBS233IJK
DR   ENCODE; ENCBS464TRL
DR   Wikidata; Q94093589
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16682; ZBTB33.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB48
AC   CVCL_XV92
DR   ENCODE; ENCBS608CNR
DR   ENCODE; ENCBS634DCB
DR   Wikidata; Q94093593
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4930; ZBTB48.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB49
AC   CVCL_HD00
DR   ENCODE; ENCBS652OCL
DR   ENCODE; ENCBS876NMZ
DR   Wikidata; Q54882373
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19883; ZBTB49.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZBTB6
AC   CVCL_XV93
DR   ENCODE; ENCBS537JPD
DR   Wikidata; Q94093616
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16764; ZBTB6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZBTB7A
AC   CVCL_HD01
DR   ENCODE; ENCBS241SWW
DR   ENCODE; ENCBS628NYX
DR   Wikidata; Q54882374
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18078; ZBTB7A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZBTB8A
AC   CVCL_HD02
DR   ENCODE; ENCBS078UYW
DR   ENCODE; ENCBS218CJM
DR   Wikidata; Q54882375
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24172; ZBTB8A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZEB1
AC   CVCL_HD03
DR   ENCODE; ENCBS073ZEX
DR   ENCODE; ENCBS472JNF
DR   Wikidata; Q54882376
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11642; ZEB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZEB2
AC   CVCL_HD04
DR   ENCODE; ENCBS665JKR
DR   ENCODE; ENCBS768DUW
DR   Wikidata; Q54882377
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14881; ZEB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZFHX2
AC   CVCL_XV94
DR   ENCODE; ENCBS234WKE
DR   ENCODE; ENCBS762DKV
DR   Wikidata; Q94093670
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20152; ZFHX2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZFP2
AC   CVCL_XV95
DR   ENCODE; ENCBS441WOU
DR   ENCODE; ENCBS801SRT
DR   Wikidata; Q94093675
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26138; ZFP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZFP3
AC   CVCL_HD05
DR   ENCODE; ENCBS232OEE
DR   ENCODE; ENCBS543JVF
DR   Wikidata; Q54882378
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12861; ZFP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZFP37
AC   CVCL_XV96
DR   ENCODE; ENCBS841DEH
DR   ENCODE; ENCBS853DEI
DR   Wikidata; Q94093693
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12863; ZFP37.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZFP41
AC   CVCL_HD06
DR   ENCODE; ENCBS424AYE
DR   ENCODE; ENCBS503YOP
DR   Wikidata; Q54882379
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26786; ZFP41.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZFP62
AC   CVCL_HD07
DR   ENCODE; ENCBS584YDT
DR   Wikidata; Q54882380
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23241; ZFP62.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZFP64
AC   CVCL_HD08
DR   ENCODE; ENCBS307QUS
DR   ENCODE; ENCBS502HSC
DR   Wikidata; Q54882381
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15940; ZFP64.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZFP69B
AC   CVCL_XV97
DR   ENCODE; ENCBS114DPO
DR   ENCODE; ENCBS386IWZ
DR   Wikidata; Q94093741
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28053; ZFP69B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZIC2
AC   CVCL_XV98
DR   ENCODE; ENCBS629IXE
DR   ENCODE; ENCBS763QCP
DR   Wikidata; Q94093746
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12873; ZIC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZIK1
AC   CVCL_XV99
DR   ENCODE; ENCBS853XGC
DR   ENCODE; ENCBS979VMT
DR   Wikidata; Q94093752
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:33104; ZIK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF10
AC   CVCL_XW00
DR   ENCODE; ENCBS942NZU
DR   ENCODE; ENCBS958UZO
DR   Wikidata; Q94093755
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12879; ZNF10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF101
AC   CVCL_XW01
DR   ENCODE; ENCBS096IDY
DR   ENCODE; ENCBS370DEV
DR   Wikidata; Q94093763
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12881; ZNF101.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF112
AC   CVCL_XW02
DR   ENCODE; ENCBS294ZAB
DR   ENCODE; ENCBS934EWU
DR   Wikidata; Q94093766
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12892; ZNF112.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF114
AC   CVCL_XW03
DR   ENCODE; ENCBS619DUK
DR   ENCODE; ENCBS963ZTO
DR   Wikidata; Q94093770
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12894; ZNF114.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF121
AC   CVCL_XW04
DR   ENCODE; ENCBS258CDJ
DR   ENCODE; ENCBS557JBD
DR   Wikidata; Q94093776
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12904; ZNF121.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF132
AC   CVCL_XW05
DR   ENCODE; ENCBS274LVS
DR   ENCODE; ENCBS478IQA
DR   Wikidata; Q94093782
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12916; ZNF132.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF133
AC   CVCL_XW06
DR   ENCODE; ENCBS431ZNZ
DR   ENCODE; ENCBS669LUY
DR   Wikidata; Q94093788
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12917; ZNF133.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF138
AC   CVCL_HD09
DR   ENCODE; ENCBS403FNN
DR   ENCODE; ENCBS646GOM
DR   Wikidata; Q54882382
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12922; ZNF138.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF140
AC   CVCL_XW07
DR   ENCODE; ENCBS212ZLO
DR   ENCODE; ENCBS627OXL
DR   Wikidata; Q94093805
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12925; ZNF140.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF146
AC   CVCL_HD10
DR   ENCODE; ENCBS069ZWS
DR   ENCODE; ENCBS314JHW
DR   Wikidata; Q54882383
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12931; ZNF146.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF148
AC   CVCL_XW08
DR   ENCODE; ENCBS282JFQ
DR   ENCODE; ENCBS978LXB
DR   Wikidata; Q94093822
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12933; ZNF148.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF155
AC   CVCL_XW09
DR   ENCODE; ENCBS532LAO
DR   ENCODE; ENCBS556GOV
DR   Wikidata; Q94093826
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12940; ZNF155.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF157
AC   CVCL_XW10
DR   ENCODE; ENCBS126YNT
DR   ENCODE; ENCBS436OCK
DR   Wikidata; Q94093830
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12942; ZNF157.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF16
AC   CVCL_HD11
DR   ENCODE; ENCBS213ZWT
DR   ENCODE; ENCBS617FVO
DR   Wikidata; Q54882384
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12947; ZNF16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF165
AC   CVCL_HD12
DR   ENCODE; ENCBS519XFO
DR   Wikidata; Q54882385
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12953; ZNF165.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF169
AC   CVCL_XW11
DR   ENCODE; ENCBS554TKL
DR   ENCODE; ENCBS713DJH
DR   Wikidata; Q94093862
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12957; ZNF169.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF174
AC   CVCL_XW12
DR   ENCODE; ENCBS349QTD
DR   ENCODE; ENCBS697XDQ
DR   Wikidata; Q94093866
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12963; ZNF174.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF175
AC   CVCL_HD13
DR   ENCODE; ENCBS558YVE
DR   ENCODE; ENCBS632ODA
DR   Wikidata; Q54882387
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12964; ZNF175.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF18
AC   CVCL_HD14
DR   ENCODE; ENCBS511ASG
DR   ENCODE; ENCBS867IQP
DR   Wikidata; Q54882388
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12969; ZNF18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF189
AC   CVCL_XW13
DR   ENCODE; ENCBS111GOI
DR   Wikidata; Q94093897
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12980; ZNF189.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF19
AC   CVCL_XW14
DR   ENCODE; ENCBS620EBJ
DR   ENCODE; ENCBS761ZMR
DR   Wikidata; Q94093901
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12981; ZNF19.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF195
AC   CVCL_XW15
DR   ENCODE; ENCBS345PFL
DR   ENCODE; ENCBS585TDT
DR   Wikidata; Q94093907
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12986; ZNF195.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF2
AC   CVCL_XW16
DR   ENCODE; ENCBS158KCV
DR   ENCODE; ENCBS824HHH
DR   Wikidata; Q94093910
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12991; ZNF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF202
AC   CVCL_XW17
DR   ENCODE; ENCBS684ULW
DR   ENCODE; ENCBS963BCC
DR   Wikidata; Q94093916
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12994; ZNF202.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF211
AC   CVCL_XW18
DR   ENCODE; ENCBS387JTZ
DR   ENCODE; ENCBS647GXU
DR   Wikidata; Q94093920
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13003; ZNF211.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF213
AC   CVCL_XW19
DR   ENCODE; ENCBS468SAY
DR   Wikidata; Q94093926
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13005; ZNF213.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF214
AC   CVCL_XW20
DR   ENCODE; ENCBS808LHN
DR   Wikidata; Q94093931
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13006; ZNF214.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF221
AC   CVCL_XW21
DR   ENCODE; ENCBS610GCE
DR   Wikidata; Q94093936
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13014; ZNF221.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF223
AC   CVCL_XW22
DR   ENCODE; ENCBS535XFL
DR   ENCODE; ENCBS727PQJ
DR   Wikidata; Q94093941
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13016; ZNF223.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF23
AC   CVCL_XW23
DR   ENCODE; ENCBS712HFH
DR   ENCODE; ENCBS834ZTA
DR   Wikidata; Q94093945
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13023; ZNF23.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF239
AC   CVCL_HD15
DR   ENCODE; ENCBS140ULK
DR   ENCODE; ENCBS169OUF
DR   Wikidata; Q54882389
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13031; ZNF239.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF24
AC   CVCL_HD16
DR   ENCODE; ENCBS386RAW
DR   ENCODE; ENCBS417ONA
DR   Wikidata; Q54882390
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13032; ZNF24.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF248
AC   CVCL_XW24
DR   ENCODE; ENCBS204PUC
DR   ENCODE; ENCBS756CXD
DR   Wikidata; Q94093971
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13041; ZNF248.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF26
AC   CVCL_XW25
DR   ENCODE; ENCBS022NMA
DR   ENCODE; ENCBS415OTP
DR   Wikidata; Q94093978
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13053; ZNF26.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF264
AC   CVCL_HD17
DR   ENCODE; ENCBS584HTL
DR   Wikidata; Q54882391
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13057; ZNF264.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF266
AC   CVCL_XW26
DR   ENCODE; ENCBS160NBU
DR   ENCODE; ENCBS437JQH
DR   Wikidata; Q94093997
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13059; ZNF266.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF274
AC   CVCL_XW27
DR   ENCODE; ENCBS224QCU
DR   ENCODE; ENCBS755LQF
DR   Wikidata; Q94094002
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13068; ZNF274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF280C
AC   CVCL_XW28
DR   ENCODE; ENCBS321CYC
DR   ENCODE; ENCBS348FEH
DR   Wikidata; Q94094005
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25955; ZNF280C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF280D
AC   CVCL_XW29
DR   ENCODE; ENCBS107SDK
DR   ENCODE; ENCBS214JNY
DR   Wikidata; Q94094010
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25953; ZNF280D.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF292
AC   CVCL_HD18
DR   ENCODE; ENCBS829KGK
DR   ENCODE; ENCBS918UBA
DR   Wikidata; Q54882392
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18410; ZNF292.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF300
AC   CVCL_XW30
DR   ENCODE; ENCBS173GZJ
DR   ENCODE; ENCBS904VDR
DR   Wikidata; Q94094028
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13091; ZNF300.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF302
AC   CVCL_XW31
DR   ENCODE; ENCBS644MIA
DR   ENCODE; ENCBS934RQK
DR   Wikidata; Q94094033
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13848; ZNF302.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF311
AC   CVCL_XW32
DR   ENCODE; ENCBS418NKF
DR   ENCODE; ENCBS827PYY
DR   Wikidata; Q94094036
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13847; ZNF311.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF32
AC   CVCL_HD19
DR   ENCODE; ENCBS349GQD
DR   Wikidata; Q54882393
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13095; ZNF32.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF324
AC   CVCL_HD20
DR   ENCODE; ENCBS026LOR
DR   ENCODE; ENCBS088ZVR
DR   Wikidata; Q54882394
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14096; ZNF324.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF331
AC   CVCL_XW33
DR   ENCODE; ENCBS173TWR
DR   Wikidata; Q94094066
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15489; ZNF331.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF335
AC   CVCL_HD21
DR   ENCODE; ENCBS879KEF
DR   ENCODE; ENCBS967MZW
DR   Wikidata; Q54882395
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15807; ZNF335.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF34
AC   CVCL_XW34
DR   ENCODE; ENCBS463NTZ
DR   ENCODE; ENCBS916VDS
DR   Wikidata; Q94094082
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13098; ZNF34.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF341
AC   CVCL_HD22
DR   ENCODE; ENCBS015PWI
DR   ENCODE; ENCBS020GOD
DR   Wikidata; Q54882396
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15992; ZNF341.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF346
AC   CVCL_XW35
DR   ENCODE; ENCBS550ZUY
DR   ENCODE; ENCBS960GJX
DR   Wikidata; Q94094100
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16403; ZNF346.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF350
AC   CVCL_XW36
DR   ENCODE; ENCBS413FJW
DR   ENCODE; ENCBS923GRR
DR   Wikidata; Q94094102
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16656; ZNF350.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF354C
AC   CVCL_HD23
DR   ENCODE; ENCBS836GPK
DR   ENCODE; ENCBS889KAG
DR   Wikidata; Q54882404
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16736; ZNF354C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF362
AC   CVCL_XW37
DR   ENCODE; ENCBS409JDS
DR   ENCODE; ENCBS493ARE
DR   Wikidata; Q94094120
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18079; ZNF362.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF366
AC   CVCL_XW38
DR   ENCODE; ENCBS384PIE
DR   ENCODE; ENCBS594XEQ
DR   Wikidata; Q94094125
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18316; ZNF366.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF382
AC   CVCL_XW39
DR   ENCODE; ENCBS579SBI
DR   ENCODE; ENCBS816ABD
DR   Wikidata; Q94094130
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17409; ZNF382.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF391
AC   CVCL_HD24
DR   ENCODE; ENCBS076BVM
DR   ENCODE; ENCBS813VRX
DR   Wikidata; Q54882405
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18779; ZNF391.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF394
AC   CVCL_XW40
DR   ENCODE; ENCBS890IKR
DR   ENCODE; ENCBS906WJT
DR   Wikidata; Q94094147
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18832; ZNF394.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF398
AC   CVCL_XW41
DR   ENCODE; ENCBS526RBS
DR   ENCODE; ENCBS644CZZ
DR   Wikidata; Q94094152
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18373; ZNF398.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF404
AC   CVCL_XW42
DR   ENCODE; ENCBS039IEL
DR   ENCODE; ENCBS869JBY
DR   Wikidata; Q94094155
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19417; ZNF404.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF414
AC   CVCL_XW43
DR   ENCODE; ENCBS852XCW
DR   ENCODE; ENCBS862JQY
DR   Wikidata; Q94094161
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20630; ZNF414.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF416
AC   CVCL_XW44
DR   ENCODE; ENCBS404HWV
DR   ENCODE; ENCBS685NPT
DR   Wikidata; Q94094165
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20645; ZNF416.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF423
AC   CVCL_HD25
DR   ENCODE; ENCBS519RHO
DR   ENCODE; ENCBS992HKQ
DR   Wikidata; Q54882406
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16762; ZNF423.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF426
AC   CVCL_XW45
DR   ENCODE; ENCBS441ZDG
DR   ENCODE; ENCBS888UAN
DR   Wikidata; Q94094187
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20725; ZNF426.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF433
AC   CVCL_XW46
DR   ENCODE; ENCBS329NKK
DR   ENCODE; ENCBS413IZR
DR   Wikidata; Q94094191
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20811; ZNF433.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF438
AC   CVCL_XW47
DR   ENCODE; ENCBS393YFN
DR   ENCODE; ENCBS582HQT
DR   Wikidata; Q94094196
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:21029; ZNF438.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF449
AC   CVCL_XW48
DR   ENCODE; ENCBS794TQR
DR   Wikidata; Q94094201
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:21039; ZNF449.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF473
AC   CVCL_XW49
DR   ENCODE; ENCBS387OFW
DR   ENCODE; ENCBS954TGQ
DR   Wikidata; Q94094206
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23239; ZNF473.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF48
AC   CVCL_XW50
DR   ENCODE; ENCBS214FUN
DR   ENCODE; ENCBS614LIB
DR   Wikidata; Q94094210
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13114; ZNF48.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF488
AC   CVCL_HD26
DR   ENCODE; ENCBS066RVK
DR   ENCODE; ENCBS294FAI
DR   Wikidata; Q54882407
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23535; ZNF488.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF491
AC   CVCL_XW51
DR   ENCODE; ENCBS323PSJ
DR   ENCODE; ENCBS671DPO
DR   Wikidata; Q94094230
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23706; ZNF491.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF493
AC   CVCL_XW52
DR   ENCODE; ENCBS269SYD
DR   ENCODE; ENCBS692PCT
DR   Wikidata; Q94094233
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23708; ZNF493.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF501
AC   CVCL_XW53
DR   ENCODE; ENCBS152WBM
DR   ENCODE; ENCBS207QGV
DR   Wikidata; Q94094238
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23717; ZNF501.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF510
AC   CVCL_XW54
DR   ENCODE; ENCBS977GEB
DR   Wikidata; Q94094244
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29161; ZNF510.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF514
AC   CVCL_XW55
DR   ENCODE; ENCBS899PRO
DR   ENCODE; ENCBS984ZDJ
DR   Wikidata; Q94094247
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25894; ZNF514.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF518A
AC   CVCL_XW56
DR   ENCODE; ENCBS033LOT
DR   ENCODE; ENCBS562OGG
DR   Wikidata; Q94094251
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29009; ZNF518A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF521
AC   CVCL_XW57
DR   ENCODE; ENCBS349GCF
DR   ENCODE; ENCBS931YGX
DR   Wikidata; Q94094256
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24605; ZNF521.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF524
AC   CVCL_XW58
DR   ENCODE; ENCBS483GEY
DR   ENCODE; ENCBS900SYX
DR   Wikidata; Q94094259
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28322; ZNF524.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF529
AC   CVCL_XW59
DR   ENCODE; ENCBS691ZPO
DR   Wikidata; Q94094265
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29328; ZNF529.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF530
AC   CVCL_XW60
DR   ENCODE; ENCBS599LKO
DR   ENCODE; ENCBS976SKV
DR   Wikidata; Q94094270
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29297; ZNF530.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF544
AC   CVCL_XW61
DR   ENCODE; ENCBS123EBR
DR   ENCODE; ENCBS738KJB
DR   Wikidata; Q94094275
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16759; ZNF544.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF547
AC   CVCL_HD27
DR   ENCODE; ENCBS073WLU
DR   ENCODE; ENCBS145GQX
DR   Wikidata; Q54882408
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26432; ZNF547.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF548
AC   CVCL_XW62
DR   ENCODE; ENCBS302IJW
DR   ENCODE; ENCBS867ZTE
DR   Wikidata; Q94094293
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26561; ZNF548.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF555
AC   CVCL_XW63
DR   ENCODE; ENCBS044VBG
DR   ENCODE; ENCBS920ICL
DR   Wikidata; Q94094297
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28382; ZNF555.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF558
AC   CVCL_HD28
DR   ENCODE; ENCBS079QRO
DR   ENCODE; ENCBS305FAK
DR   Wikidata; Q54882409
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26422; ZNF558.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF560
AC   CVCL_XW64
DR   ENCODE; ENCBS228APF
DR   ENCODE; ENCBS475YAL
DR   Wikidata; Q94094316
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26484; ZNF560.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF571
AC   CVCL_XW65
DR   ENCODE; ENCBS160TAY
DR   ENCODE; ENCBS745YEM
DR   Wikidata; Q94094319
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25000; ZNF571.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF572
AC   CVCL_HD29
DR   ENCODE; ENCBS882KSU
DR   Wikidata; Q54882411
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26758; ZNF572.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF577
AC   CVCL_XW66
DR   ENCODE; ENCBS990KNH
DR   Wikidata; Q94094337
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28673; ZNF577.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF580
AC   CVCL_HD30
DR   ENCODE; ENCBS507LXF
DR   ENCODE; ENCBS811AFW
DR   Wikidata; Q54882412
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29473; ZNF580.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF585B
AC   CVCL_HD31
DR   ENCODE; ENCBS284GFM
DR   ENCODE; ENCBS472HLI
DR   Wikidata; Q54882413
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30948; ZNF585B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF600
AC   CVCL_HD32
DR   ENCODE; ENCBS172MXQ
DR   ENCODE; ENCBS629GNX
DR   Wikidata; Q54882414
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30951; ZNF600.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF610
AC   CVCL_HD33
DR   ENCODE; ENCBS479SVO
DR   ENCODE; ENCBS494YKN
DR   Wikidata; Q54882415
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26687; ZNF610.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF621
AC   CVCL_XW67
DR   ENCODE; ENCBS249HTE
DR   ENCODE; ENCBS865AIG
DR   Wikidata; Q94094421
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24787; ZNF621.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF623
AC   CVCL_HD34
DR   ENCODE; ENCBS163UGH
DR   ENCODE; ENCBS644JET
DR   Wikidata; Q54882416
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29084; ZNF623.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF624
AC   CVCL_XW68
DR   ENCODE; ENCBS333EUU
DR   ENCODE; ENCBS381KVD
DR   Wikidata; Q94094445
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29254; ZNF624.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF626
AC   CVCL_XW69
DR   ENCODE; ENCBS567EMZ
DR   Wikidata; Q94094449
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30461; ZNF626.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF629
AC   CVCL_XW70
DR   ENCODE; ENCBS017LNT
DR   ENCODE; ENCBS958GEZ
DR   Wikidata; Q94094455
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29008; ZNF629.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF639
AC   CVCL_HD35
DR   ENCODE; ENCBS486AZC
DR   ENCODE; ENCBS695IQG
DR   Wikidata; Q54882417
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30950; ZNF639.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293 eGFP-ZNF641
AC   CVCL_XW71
DR   ENCODE; ENCBS150AAG
DR   ENCODE; ENCBS705NZB
DR   Wikidata; Q94094472
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:31834; ZNF641.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF645
AC   CVCL_XW72
DR   ENCODE; ENCBS493NNI
DR   ENCODE; ENCBS790DZT
DR   Wikidata; Q94094477
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26371; CBLL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF654
AC   CVCL_HD36
DR   ENCODE; ENCBS543KCA
DR   ENCODE; ENCBS603HMT
DR   Wikidata; Q54882418
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25612; ZNF654.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF655
AC   CVCL_HD37
DR   ENCODE; ENCBS659QAK
DR   Wikidata; Q54882420
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30899; ZNF655.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF658
AC   CVCL_XW73
DR   ENCODE; ENCBS496WJT
DR   ENCODE; ENCBS586MKT
DR   Wikidata; Q94094511
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25226; ZNF658.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF662
AC   CVCL_XW74
DR   ENCODE; ENCBS519NOU
DR   ENCODE; ENCBS781FBO
DR   Wikidata; Q94094517
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:31930; ZNF662.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF664
AC   CVCL_HD38
DR   ENCODE; ENCBS360VTQ
DR   ENCODE; ENCBS449AKC
DR   Wikidata; Q54882421
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25406; ZNF664.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF670
AC   CVCL_XW75
DR   ENCODE; ENCBS698KCZ
DR   ENCODE; ENCBS743ZXV
DR   Wikidata; Q94094535
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28167; ZNF670.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF680
AC   CVCL_HD39
DR   ENCODE; ENCBS789RTN
DR   ENCODE; ENCBS860LMD
DR   Wikidata; Q54882422
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26897; ZNF680.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF692
AC   CVCL_XW76
DR   ENCODE; ENCBS809DNX
DR   ENCODE; ENCBS992CJC
DR   Wikidata; Q94094556
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26049; ZNF692.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF697
AC   CVCL_HD40
DR   ENCODE; ENCBS676HTV
DR   ENCODE; ENCBS681LEN
DR   ENCODE; ENCBS879FIM
DR   Wikidata; Q54882423
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:32034; ZNF697.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293 eGFP-ZNF701
AC   CVCL_XW77
DR   ENCODE; ENCBS480YJG
DR   ENCODE; ENCBS846SLU
DR   Wikidata; Q94094576
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25597; ZNF701.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF704
AC   CVCL_XW78
DR   ENCODE; ENCBS514PWP
DR   ENCODE; ENCBS953VTG
DR   Wikidata; Q94094582
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:32291; ZNF704.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF707
AC   CVCL_HD41
DR   ENCODE; ENCBS249ESB
DR   ENCODE; ENCBS402FLP
DR   Wikidata; Q54882424
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27815; ZNF707.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF71
AC   CVCL_XW79
DR   ENCODE; ENCBS549SBY
DR   ENCODE; ENCBS592NTV
DR   Wikidata; Q94094597
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13141; ZNF71.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF747
AC   CVCL_XW80
DR   ENCODE; ENCBS456WQW
DR   ENCODE; ENCBS956LCM
DR   Wikidata; Q94094601
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28350; ZNF747.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF76
AC   CVCL_HD42
DR   ENCODE; ENCBS168VCZ
DR   ENCODE; ENCBS889BJN
DR   Wikidata; Q54882425
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13149; ZNF76.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF768
AC   CVCL_XW81
DR   ENCODE; ENCBS586QTL
DR   Wikidata; Q94094616
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26273; ZNF768.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF770
AC   CVCL_XW82
DR   ENCODE; ENCBS894HWQ
DR   Wikidata; Q94094620
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26061; ZNF770.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF776
AC   CVCL_XW83
DR   ENCODE; ENCBS077CVO
DR   ENCODE; ENCBS816FCW
DR   Wikidata; Q94094623
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26765; ZNF776.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF777
AC   CVCL_XW84
DR   ENCODE; ENCBS434EGA
DR   ENCODE; ENCBS900QTF
DR   Wikidata; Q94094629
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:22213; ZNF777.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF781
AC   CVCL_HD43
DR   ENCODE; ENCBS393FBB
DR   ENCODE; ENCBS771HHP
DR   Wikidata; Q54882426
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26745; ZNF781.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF785
AC   CVCL_XW85
DR   ENCODE; ENCBS273GWY
DR   ENCODE; ENCBS764OVL
DR   Wikidata; Q94094642
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26496; ZNF785.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF788
AC   CVCL_XW86
DR   ENCODE; ENCBS139JQX
DR   ENCODE; ENCBS206BCE
DR   Wikidata; Q94094648
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:33112; ZNF788P.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF791
AC   CVCL_XW87
DR   ENCODE; ENCBS335ETQ
DR   ENCODE; ENCBS550ALC
DR   Wikidata; Q94094653
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26895; ZNF791.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF792
AC   CVCL_XW88
DR   ENCODE; ENCBS552GTN
DR   ENCODE; ENCBS636SBW
DR   Wikidata; Q94094654
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24751; ZNF792.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZNF8
AC   CVCL_HD44
DR   ENCODE; ENCBS144HNV
DR   ENCODE; ENCBS922JHS
DR   Wikidata; Q54882427
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13154; ZNF8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF800
AC   CVCL_HD45
DR   ENCODE; ENCBS512GBG
DR   Wikidata; Q54882428
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27267; ZNF800.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF837
AC   CVCL_HD46
DR   ENCODE; ENCBS915UTY
DR   ENCODE; ENCBS927IRD
DR   Wikidata; Q54882429
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25164; ZNF837.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZNF843
AC   CVCL_XW89
DR   ENCODE; ENCBS243XVF
DR   ENCODE; ENCBS510KXV
DR   Wikidata; Q94094696
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28710; ZNF843.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZSCAN16
AC   CVCL_HD47
DR   ENCODE; ENCBS045SQX
DR   ENCODE; ENCBS844SVG
DR   Wikidata; Q54882430
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20813; ZSCAN16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZSCAN18
AC   CVCL_XW90
DR   ENCODE; ENCBS534EOJ
DR   ENCODE; ENCBS763AYG
DR   Wikidata; Q94094718
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:21037; ZSCAN18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZSCAN20
AC   CVCL_XW91
DR   ENCODE; ENCBS712GXO
DR   ENCODE; ENCBS901GWE
DR   Wikidata; Q94094724
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13093; ZSCAN20.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZSCAN21
AC   CVCL_XW92
DR   ENCODE; ENCBS685DHF
DR   ENCODE; ENCBS686CCI
DR   Wikidata; Q94094731
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13104; ZSCAN21.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZSCAN23
AC   CVCL_HD48
DR   ENCODE; ENCBS200HYZ
DR   ENCODE; ENCBS970UWN
DR   Wikidata; Q54882431
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:21193; ZSCAN23.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZSCAN26
AC   CVCL_XW93
DR   ENCODE; ENCBS510PIY
DR   ENCODE; ENCBS778HBG
DR   Wikidata; Q94094750
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12978; ZSCAN26.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZSCAN29
AC   CVCL_XW94
DR   ENCODE; ENCBS938NLO
DR   Wikidata; Q94094757
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26673; ZSCAN29.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZSCAN4
AC   CVCL_HD49
DR   ENCODE; ENCBS401QNO
DR   Wikidata; Q54882432
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23709; ZSCAN4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZSCAN5A
AC   CVCL_HD50
DR   ENCODE; ENCBS190VSK
DR   ENCODE; ENCBS882KQI
DR   Wikidata; Q54882433
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23710; ZSCAN5A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 eGFP-ZSCAN5C
AC   CVCL_XW95
DR   ENCODE; ENCBS055WSF
DR   ENCODE; ENCBS665DNN
DR   Wikidata; Q94094790
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:34294; ZSCAN5C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 eGFP-ZXDB
AC   CVCL_HD51
DR   ENCODE; ENCBS206XBQ
DR   ENCODE; ENCBS242RIC
DR   Wikidata; Q54882434
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13199; ZXDB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   HEK293 Flp-In T-Rex GLUT1
AC   CVCL_ZI10
DR   Wikidata; Q98126663
RX   PubMed=30197081;
CC   Characteristics: Transfected with a BirA-FLAG-SLC2A1 construct.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11005; SLC2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06709; Escherichia coli birA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   HEK293 Flp-In T-Rex GLUT1_P485L
AC   CVCL_ZI11
DR   Wikidata; Q98126664
RX   PubMed=30197081;
CC   Characteristics: Transfected with a BirA-FLAG-SLC2A1(P485L) construct.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11005; SLC2A1 (Note=With p.Pro485Leu).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   HEK293 Flp-In T-Rex PINK1 KO clone F1
AC   CVCL_D5JH
SY   Flp-In T-Rex HEK293 PINK1 CRISPR/Cas9 knock-out
DR   Wikidata; Q127381640
RX   PubMed=35042401;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293 FRT
AC   CVCL_D4C4
DR   Wikidata; Q127381643
RX   PubMed=40485510;
CC   From: Pastan, Ira; National Cancer Institute; Bethesda; USA.
CC   Characteristics: Contain a single stably integrated Flp recombinase recognition target (FRT) site at a transcriptionally active genomic locus (PubMed=40485510).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=40485510
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 14
ST   D12S391: 19,21
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D1S1656: 15,17.3
ST   D21S11: 28,30.2
ST   D22S1045: 16
ST   D2S1338: 19
ST   D2S441: 11,15
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 23
ST   SE33: 17
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 6
//
ID   HEK293 FRT FURIN KO
AC   CVCL_D4C5
SY   DeltaFur293; HEK293 DeltaFUR
DR   Wikidata; Q127381644
RX   PubMed=40485510;
CC   Characteristics: Contain a single stably integrated Flp recombinase recognition target (FRT) site at a transcriptionally active genomic locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8568; FURIN (Note=Exon 2 105 bp deletion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=40485510
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 14
ST   D12S391: 19,21
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D1S1656: 15,17.3
ST   D21S11: 28,30.2
ST   D22S1045: 16
ST   D2S1338: 19
ST   D2S441: 11,15
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 23
ST   SE33: 17
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D4C4 ! HEK293 FRT
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 7
//
ID   HEK293 FSHR Fluo-HiTSeeker
AC   CVCL_YK14
SY   FLUO-HitSeeker FSHR; FluoHiTSeeker FSHR; Fluo-HiTSeeker FSHR/HEK293; FSHR-CRE-tGFP/HEK293
DR   Innoprot; P30117-F
DR   Wikidata; Q94094811
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293 FSHR HiTSeeker
AC   CVCL_YK15
SY   HiTSeeker FSHR; FSHR/HEK293
DR   Innoprot; P30117
DR   Wikidata; Q94094813
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3969; FSHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 FUS KO
AC   CVCL_A0TJ
SY   HEK293 FUS knockout; FUS KO HEK293
DR   Millipore; SCC292
DR   Wikidata; Q108820443
RX   PubMed=30206235;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): Millipore=SCC292
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,10,13
ST   D18S51: 17,18
ST   D21S11: 28,30.2
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293 GFP-DUSP12
AC   CVCL_B6SE
DR   Wikidata; Q111733350
RX   PubMed=21556130;
CC   Characteristics: Stably overexpress a eGFP-DUSP12 fusion protein (PubMed=21556130).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3067; DUSP12.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293 GOT2 KO clone A3
AC   CVCL_C3NG
DR   ABM; T6424
DR   Wikidata; Q116049298
RX   PubMed=31422819;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4433; GOT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   HEK293 GOT2 KO clone A6
AC   CVCL_C3NH
DR   ABM; T6425
DR   Wikidata; Q116049300
RX   PubMed=31422819;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4433; GOT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   HEK293 GOT2 KO clone A7
AC   CVCL_C3NI
DR   ABM; T6426
DR   Wikidata; Q116049301
RX   PubMed=31422819;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4433; GOT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   HEK293 GRASP55 KO
AC   CVCL_E3WL
DR   CancerTools; 157710
RX   PubMed=28814501;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17500; GORASP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293 GRASP55/GRASP65 DKO
AC   CVCL_E3WM
DR   CancerTools; 157712
RX   PubMed=28814501;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16769; GORASP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17500; GORASP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3WN ! HEK293 GRASP65 KO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293 GRASP65 KO
AC   CVCL_E3WN
DR   CancerTools; 157711
RX   PubMed=28814501;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16769; GORASP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293 GSK3B KO
AC   CVCL_E5GF
SY   HEK293 GSK-3beta KO
RX   PubMed=35339896;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 H5M2
AC   CVCL_C3MN
DR   Wikidata; Q116049302
RX   PubMed=19256336;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q5QF15; Influenza A virus (strain A/Thailand/5(KK-494)/2004 H5N1) matrix protein 2 (M2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HEK293 HA-RB1
AC   CVCL_C0QH
SY   Rb expressing HEK 293
DR   PRIDE; PXD007708
DR   Wikidata; Q112929660
RX   PubMed=29552609;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9884; RB1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HEK293 HADH-/-
AC   CVCL_A5IP
SY   HEK293 SCHAD KO
DR   Wikidata; Q107115304
RX   PubMed=32876354;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4799; HADH.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 HaloTag7-mGFP
AC   CVCL_E8GW
SY   HEK293 WT + HaloTag7-mGFP
RX   DOI=10.1101/2025.03.24.645038;
CC   Characteristics: Ttansduced with a pMRX-IB-HaloTag7-mGFP construct (DOI=10.1101/2025.03.24.645038).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293 HaloTag7-mGFP-LC3B
AC   CVCL_E8GX
SY   HEK293 WT + HaloTag7-mGFP-LC3B
RX   DOI=10.1101/2025.03.24.645038;
CC   Characteristics: Ttansduced with a pMRX-No-HaloTag7-mGFP-LC3B construct (DOI=10.1101/2025.03.24.645038).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293 hD4.4
AC   CVCL_E7HL
SY   hD4.4/293
RX   PubMed=8200447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3025; DRD4 (Note=Allele 4.4).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 HL10
AC   CVCL_E7I7
SY   HL10; Human PRLR-Luciferase clone 10
RX   PubMed=12668884;
CC   Characteristics: Used in a transcriptional bioassay for lactogens. Upon binding a lactogen to PRLR a complex is generated that activates JAK2 which in turn activates STAT5 which results in transcriptional activation of the luciferase reporter gene. Thus, the luciferase activity reflects receptor activation by the exogenous PRLR ligand (PubMed=12668884).
CC   Characteristics: Transfected with two constructs, one containing PRLR under the control of a CMV promoter and the other a firefly luciferase reporter gene under the control of the HSV-TK promoter containing a six-repeat lactogenic hormone response element (LHRE) (PubMed=12668884).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9446; PRLR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 HL21
AC   CVCL_E7I8
SY   HL21; Human PRLR-Luciferase clone 21
RX   PubMed=12668884;
CC   Characteristics: Used in a transcriptional bioassay for lactogens. Upon binding a lactogen to PRLR a complex is generated that activates JAK2 which in turn activates STAT5 which results in transcriptional activation of the luciferase reporter gene. Thus, the luciferase activity reflects receptor activation by the exogenous PRLR ligand (PubMed=12668884).
CC   Characteristics: Transfected with two constructs, one containing PRLR under the control of a CMV promoter and the other a firefly luciferase reporter gene under the control of the HSV-TK promoter containing a six-repeat lactogenic hormone response element (LHRE) (PubMed=12668884).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9446; PRLR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 HL5
AC   CVCL_E7I6
SY   HL5; Human PRLR-Luciferase clone 5
RX   PubMed=12668884;
RX   PubMed=12824168;
WW   Provider; Inserm Transfert; RT00002; https://technology-offers.inserm-transfert.com/offer/hek-293-cells-expressing-human-prolactin-receptor-and-lhre-lucifease-reporter-gene/
CC   Characteristics: Used in a transcriptional bioassay for lactogens. Upon binding a lactogen to PRLR a complex is generated that activates JAK2 which in turn activates STAT5 which results in transcriptional activation of the luciferase reporter gene. Thus, the luciferase activity reflects receptor activation by the exogenous PRLR ligand (PubMed=12668884).
CC   Characteristics: Transfected with two constructs, one containing PRLR under the control of a CMV promoter and the other a firefly luciferase reporter gene under the control of the HSV-TK promoter containing a six-repeat lactogenic hormone response element (LHRE) (PubMed=12668884).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9446; PRLR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 HLA-A*01:01
AC   CVCL_C0UG
DR   Wikidata; Q112929661
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*01:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 HLA-A*02:01
AC   CVCL_C0UH
DR   Wikidata; Q112929662
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 HLA-A*03:01
AC   CVCL_C0UI
DR   Wikidata; Q112929663
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*03:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 HLA-A*11:01
AC   CVCL_C0UJ
DR   Wikidata; Q112929664
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*11:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 HLA-A*24:02
AC   CVCL_C0UK
DR   Wikidata; Q112929665
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*24:02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 HLA-A*26:02
AC   CVCL_C0UL
DR   Wikidata; Q112929666
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*26:02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 HLA-A*31:01
AC   CVCL_C0UM
DR   Wikidata; Q112929667
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*31:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 HLA-A*33:03
AC   CVCL_C0UN
DR   Wikidata; Q112929668
RX   PubMed=34051227;
CC   Biotechnology: Used in a modified immunocomplex capture fluorescence analysis (m-ICFA) assay to detect HLA antibodies (PubMed=34051227).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*33:03).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293 human APP695
AC   CVCL_XZ52
DR   KYinno; KC-0146
DR   Wikidata; Q94094818
CC   Doubling time: ~30 hours (KYinno=KC-0146).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP695).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   HEK293 human APP695 Swedish
AC   CVCL_XZ53
SY   HEK293 APP695 Swedish
DR   KYinno; KC-0147
DR   Wikidata; Q94094822
CC   Doubling time: ~30 hours (KYinno=KC-0147).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP695; with p.Lys670_Met671delinsAsnLeu (c.2010_2011inv)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 Kv10.1
AC   CVCL_E5JF
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6250; KCNH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv11.1
AC   CVCL_E5JG
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6251; KCNH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv1.4
AC   CVCL_E5JH
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6222; KCNA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv1.5
AC   CVCL_E5JI
SY   Kv1.5-HEK
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6224; KCNA5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv1.5-12PA
AC   CVCL_E5JJ
SY   Kv1.5-12PA-HEK
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6224; KCNA5 (Note=With all 12 Pro from AA285 to AA317 mutated to Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv1.5-DeltaN209
AC   CVCL_E5JK
SY   DeltaN209 Kv1.5-HEK
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6224; KCNA5 (Note=With p.Met1_Ala209del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv1.5-DeltaPro
AC   CVCL_E5JL
SY   DeltaPro Kv1.5-HEK
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6224; KCNA5 (Note=With p.Val64_Pro82del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv1.5-Kv1.4NT
AC   CVCL_E5JM
SY   Kv1.5-Kv1.4NT-HEK
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6224; KCNA5 (Note=With the N-terminus of KCAN5 replaced by that of KCNA4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv4.3
AC   CVCL_E5JN
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6239; KCND3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 Kv7.1 + KCNE1
AC   CVCL_E5JP
RX   PubMed=32122972;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6240; KCNE1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6294; KCNQ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 LHCGR Fluo-HiTSeeker
AC   CVCL_YK16
SY   FLUO-HitSeeker LHCGR; FluoHiTSeeker LHCGR; LHCGR/HEK293; LHCGR-CRE-tGFP/HEK293
DR   Innoprot; P30177-F
DR   Wikidata; Q94094838
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6585; LHCGR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HEK293 LHCGR HiTSeeker
AC   CVCL_YK17
SY   HiTSeeker LHCGR; LHCGR/HEK293; LHR-LCGR/HEK293
DR   Innoprot; P30177
DR   Wikidata; Q94094841
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6585; LHCGR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 MC4R HiTSeeker
AC   CVCL_YK18
SY   HiTSeeker MC4R; MC4R/HEK293
DR   Innoprot; P30410
DR   Wikidata; Q94094845
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6932; MC4R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 MRP1/ABCC1 Arg1058Gln
AC   CVCL_E5ZM
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Arg1058Gln (c.3173G>A)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 MRP1/ABCC1 Arg723Gln
AC   CVCL_E5ZN
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Arg723Gln (c.2168G>A)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 MRP1/ABCC1 Cys43Ser
AC   CVCL_E5ZP
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Cys43Ser (c.128G>C)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 MRP1/ABCC1 Thr73Ile
AC   CVCL_E5ZQ
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1 (Note=With p.Thr73lle (c.218C>T)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 MRP1/ABCC1 WT
AC   CVCL_E5ZL
DR   ABM; T6003
RX   PubMed=19214144;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:51; ABCC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 MUT-KO clone 2
AC   CVCL_C0TZ
DR   PRIDE; PXD017977
DR   Wikidata; Q112929669
RX   PubMed=32679819;
RX   PubMed=33195772;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7526; MMUT.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HEK293 NDUSF2 KO
AC   CVCL_C0D2
SY   HEK293deltaNDUFS2; HEK293deltandufs2
DR   ABM; T3224
DR   CancerTools; 156497
DR   Wikidata; Q112929670
DR   Ximbio; 156497
RX   Patent=WO2021067415A1;
RX   PubMed=33744462;
CC   Group: Patented cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7708; NDUFS2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293 Nav1.7
AC   CVCL_ZW92
SY   HEK Nav1.7
DR   Wikidata; Q102114109
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10597; SCN9A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Ruhlmann, Annika.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293 P2RX2(B)
AC   CVCL_D6U1
SY   HEK293 P2X2 B
RX   PubMed=39199330;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B was integrated in a single site and its expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX2(B)+P2RX3
AC   CVCL_D6U2
SY   HEK293 P2X2 B+P2X3
RX   PubMed=39199330;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B and P2RX3 were integrated in a single site and their expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8534; P2RX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX2(B)D273Y
AC   CVCL_E2Y2
SY   HEK293 P2X2 B D273Y
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B with p.Asp273Tyr was integrated in a single site and its expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B; with p.Asp273Tyr).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX2(B)D273Y+P2RX3
AC   CVCL_E2Y5
SY   HEK293 P2X2 B D273Y + P2X3
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B with p.Asp273Tyr and P2RX3 were integrated in a single site and their expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B; with p.Asp273Tyr).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8534; P2RX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX2(B)G353R
AC   CVCL_E2Y3
SY   HEK293 P2X2 B G353R
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B with p.Gly353Arg was integrated in a single site and its expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B; with p.Gly353Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX2(B)G353R+P2RX3
AC   CVCL_E2Y6
SY   HEK293 P2X2 B G353R + P2X3
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B with p.Gly353Arg and P2RX3 were integrated in a single site and their expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B; with p.Gly353Arg).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8534; P2RX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX2(B)V60L
AC   CVCL_E2Y1
SY   HEK293 P2X2 B V60L
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B with p.Val60Leu was integrated in a single site and its expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B; with p.Val60Leu).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX2(B)V60L+P2RX3
AC   CVCL_E2Y4
SY   HEK293 P2X2 B V60L + P2X3
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX2 isoform B with p.Val60Leu and P2RX3 were integrated in a single site and their expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15459; P2RX2 (Note=Isoform B; with p.Val60Leu).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8534; P2RX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 P2RX3
AC   CVCL_D6U3
SY   HEK293 P2X3
RX   PubMed=39199330;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, P2RX3 was integrated in a single site and its expression is regulated by tetracycline.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8534; P2RX3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 p65-HaloTag
AC   CVCL_KS50
SY   HEK-293 p65-HaloTag; HEK293-p65-HT2
DR   Wikidata; Q54882435
RX   PubMed=18533659;
CC   Characteristics: Transfected with a p65(RELA)-HaloTag fusion protein.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9955; RELA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HEK293 pcDNA5/FRT/TO-KAP1
AC   CVCL_RX69
SY   pcDNA5/FRT/TO-KAP1-HEK293
DR   Wikidata; Q54882436
RX   PubMed=26081272;
CC   Characteristics: Can express TRIM28 inducibly by the addition of doxycycline (DOX).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16384; TRIM28.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   HEK293 PTGER2 HiTSeeker
AC   CVCL_YK19
SY   HiTSeeker PTGER2; PTGER2/HEK293
DR   Innoprot; P30403
DR   Wikidata; Q94094869
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9594; PTGER2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 PTGER4 HiTSeeker
AC   CVCL_YK20
SY   HiTSeeker PTGER4; PTGER4-HEK293; PTGER4/HEK293
DR   Innoprot; P30405
DR   Wikidata; Q94094874
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9596; PTGER4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 rat P2rx2
AC   CVCL_YJ33
SY   HEK293 rat P2X2
DR   Wikidata; Q94094879
CC   Genetic integration: Method=Transfection; Gene=RGD; 620251; P2rx2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HEK293 rat P2rx2 p.H319K
AC   CVCL_YJ34
SY   HEK293 rat P2X2H319K
DR   Wikidata; Q94094883
CC   Genetic integration: Method=Transfection; Gene=RGD; 620251; P2rx2 (Note=With p.His319Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Sattler, Christian.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HEK293 rLN10
AC   CVCL_RY69
SY   rLN10; rLN-10; rLN10-293
DR   Wikidata; Q54882437
RX   PubMed=11821406;
RX   PubMed=21887386;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6485; LAMA5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6486; LAMB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6492; LAMC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 rLN10_hEcad
AC   CVCL_VN83
SY   rLN10_hEcad
DR   JCRB; JCRB1739
DR   Wikidata; Q94094899
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1748; CDH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6485; LAMA5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6486; LAMB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6492; LAMC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1739
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY69 ! HEK293 rLN10
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293 rLN10_hNid1
AC   CVCL_RY70
SY   rLN10_hNid1
DR   JCRB; JCRB1734
DR   Wikidata; Q54882438
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6485; LAMA5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6486; LAMB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6492; LAMC1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7821; NID1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY69 ! HEK293 rLN10
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 RPS2 A226Y
AC   CVCL_YD69
DR   GEO; GSM3168273
DR   GEO; GSM3168274
DR   GEO; GSM3168275
DR   MetaboLights; MTBLS106
DR   Wikidata; Q94094915
RX   PubMed=31637312;
CC   Characteristics: Transfected with mutated Rps2 linked to IRES-eGFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:105110; Rps2 (Note=With p.Ala226Tyr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 RPS2 WT
AC   CVCL_YD70
DR   GEO; GSM3168269
DR   GEO; GSM3168270
DR   GEO; GSM3168271
DR   GEO; GSM3168272
DR   MetaboLights; MTBLS106
DR   Wikidata; Q94094921
RX   PubMed=31637312;
CC   Characteristics: Transfected with wild type Rps2 linked to IRES-eGFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:105110; Rps2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 rLN8
AC   CVCL_RY71
SY   rLN8; rLN-8
DR   Wikidata; Q54882439
RX   PubMed=10809728;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6484; LAMA4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6486; LAMB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6492; LAMC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293 SCN1A/SCN1B/SCN2B
AC   CVCL_WS18
DR   Wikidata; Q94094939
RX   PubMed=23086956;
CC   Characteristics: Co-transfected the constructs pT-SCN1A:3X-FLAG and pT-SCN1B:cMyc-IRES-SCN2B:HA.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10585; SCN1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10586; SCN1B.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10589; SCN2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   HEK293 SimpleCell O-GalNAc
AC   CVCL_S025
SY   HEK293 SimpleCell; HEK293 SC
DR   Wikidata; Q54882440
RX   PubMed=23584533;
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   HEK293 suspension-adapted
AC   CVCL_C8Z5
DR   CLS; 300686
DR   Wikidata; Q123031583
CC   Characteristics: Adapted to growth in suspension (CLS=300686).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HEK293 TACR1 HiTSeeker
AC   CVCL_YK21
SY   HiTSeeker TACR1; TACR1(NK1)/HEK293; TACR1 (NKR1 or SPR)/HEK293
DR   Innoprot; P30129
DR   Wikidata; Q94094959
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11526; TACR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 TC4-2A
AC   CVCL_E3BV
SY   TC4-2A
RX   PubMed=35885927;
RX   PubMed=38714739;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, a circRNA encompassing exons 2A, 2B, 3 and 4 of human SMN gene was integrated in a single site and its expression is regulated by doxycycline (PubMed=35885927).
CC   Doubling time: 21.9 hours (Note=Without Dox), 20.8 hours (Note=With Dox) (PubMed=38714739).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11117; SMN1 (Note=circRNA with exons 2A, 2B, 3 and 4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 5
//
ID   HEK293 TC4-2B
AC   CVCL_E3BX
SY   TC4-2B
RX   PubMed=35885927;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, a circRNA encompassing exons 2B, 3 and 4 of human SMN gene was integrated in a single site and its expression is regulated by doxycycline (PubMed=35885927).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11117; SMN1 (Note=circRNA with exons 2B, 3 and 4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 TC4-3
AC   CVCL_E3BZ
SY   TC4-3
RX   PubMed=35885927;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, a circRNA encompassing exons 3 and 4 of human SMN gene was integrated in a single site and its expression is regulated by doxycycline (PubMed=35885927).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11117; SMN1 (Note=circRNA with exons 3 and 4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 TDP-43
AC   CVCL_F0R9
RX   PubMed=31100073;
CC   Characteristics: Using a pcDNA4/TO/myc-His based construct TARDBP/TDP-43 was transfected and its expression is regulated by doxycycline (PubMed=31100073).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11571; TARDBP (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293 TDP-43 A315T
AC   CVCL_F0RA
RX   PubMed=31100073;
CC   Characteristics: Using a pcDNA4/TO/myc-His based construct TARDBP/TDP-43 was transfected and its expression is regulated by doxycycline (PubMed=31100073).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11571; TARDBP (Note=With p.Ala315Thr and a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293 tGFP-BACE1
AC   CVCL_YK22
SY   HEK293/tGFP-BACE; tGFP-BACE1 HEK293
DR   Innoprot; P30700
DR   Wikidata; Q94094962
CC   Characteristics: Transfected with BACE1 N-terminally tagged with turboGFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:933; BACE1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293 THAP11F80L #8
AC   CVCL_B5E1
DR   Wikidata; Q110432850
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23194; THAP11; Simple_edited; p.Phe80Leu (c.240C>G); ClinVar=VCV000393304; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293 THAP11HBM #1
AC   CVCL_B5E2
DR   Wikidata; Q110432851
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23194; THAP11; Simple_edited; p.His244Ala (c.730_731AT>GC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Sequence variation: Mutation; HGNC; HGNC:23194; THAP11; Simple_edited; p.Tyr246Ala (c.736_737TA>GC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7DCC #27
AC   CVCL_B5DT
DR   Wikidata; Q110432852
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7DCC #36
AC   CVCL_B5DU
DR   Wikidata; Q110432853
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7DCC #40
AC   CVCL_B5DV
DR   Wikidata; Q110432854
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7DCC #7
AC   CVCL_B5DS
DR   Wikidata; Q110432855
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7HBM #34
AC   CVCL_B5DW
DR   Wikidata; Q110432856
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.His230Ala (c.688_689CA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Tyr232Ala (c.694_695TA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7HBM #76
AC   CVCL_B5DX
DR   Wikidata; Q110432857
RX   PubMed=31905202;
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.His230Ala (c.688_689CA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Tyr232Ala (c.694_695TA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7null #29
AC   CVCL_B5DY
DR   Wikidata; Q110432858
RX   PubMed=31905202;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7null #32
AC   CVCL_B5DZ
DR   Wikidata; Q110432859
RX   PubMed=31905202;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 THAP7null #44
AC   CVCL_B5E0
DR   Wikidata; Q110432860
RX   PubMed=31905202;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293 TL4-2A
AC   CVCL_E3BW
SY   TL4-2A
RX   PubMed=35885927;
RX   PubMed=38714739;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, a linear RNA encompassing exons 2A, 2B, 3 and 4 of human SMN gene was integrated in a single site and its expression is regulated by doxycycline (PubMed=35885927).
CC   Doubling time: 22.7 hours (Note=Without Dox), 20.9 hours (Note=With Dox) (PubMed=38714739).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11117; SMN1 (Note=Exons 2A, 2B, 3 and 4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 5
//
ID   HEK293 TL4-2B
AC   CVCL_E3BY
SY   TL4-2B
RX   PubMed=35885927;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, a linear RNA encompassing exons 2B, 3 and 4 of human SMN gene was integrated in a single site and its expression is regulated by doxycycline (PubMed=35885927).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11117; SMN1 (Note=Exons 2B, 3 and 4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 TL4-3
AC   CVCL_E3C0
SY   TL4-3
RX   PubMed=35885927;
CC   Characteristics: Using pcDNA5/FRT/TO and pOG44, a linear RNA encompassing exons 3 and 4 of human SMN gene was integrated in a single site and its expression is regulated by doxycycline (PubMed=35885927).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11117; SMN1 (Note=Exons 3 and 4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 TMEM115-3xHA GolgiTAG
AC   CVCL_C8A6
SY   TMEM115-3xHA HEK293
DR   Wikidata; Q123031584
RX   PubMed=37155866;
CC   Characteristics: Used to immunoprecipitate Golgi proteins (PubMed=37155866).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:30055; TMEM115 (Note=With a C-terminal 3xHA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   HEK293 TMEM192-3xHA
AC   CVCL_D6SR
SY   TMEM192-3xHA HEK293 (LysoTag)
WW   Info; protocols.io; -; https://dx.doi.org/10.17504/protocols.io.261gedz2ov47/v1
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:26775; TMEM192 (Note=With a 3xHA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Tonelli, Francesca.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293 TMEM55A/TMEM55B DKO
AC   CVCL_F0B6
SY   HEK293 PIP4P1/PIP4P2 DKO
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19299; PIP4P1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25452; PIP4P2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Pal, Prosenjit.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293 TRPML3-YFP
AC   CVCL_E6IB
DR   ABM; T6377
RX   PubMed=20189104;
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13358; MCOLN3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293 TSHR HiTSeeker
AC   CVCL_YK23
SY   HiTSeeker TSHR; TSHR/HEK293
DR   Innoprot; P30199
DR   Wikidata; Q94094969
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293 VIPR1 HiTSeeker
AC   CVCL_YK24
SY   HiTSeeker VIPR1; VIPR1/HEK293
DR   Innoprot; P30112
DR   Wikidata; Q94094975
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12694; VIPR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293_GS-KO
AC   CVCL_JZ97
DR   Wikidata; Q54882441
RX   Patent=US9567578;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 12978BP.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   HEK293-A
AC   CVCL_6910
SY   HEK-293A; HEK293A; HEK 293A; 293A; QBI-HEK 293A; QBI-293A
DR   BTO; BTO_0002524
DR   EFO; EFO_0022528
DR   BioGRID_ORCS_Cell_line; 1527
DR   ChEMBL-Cells; CHEMBL3886041
DR   CLS; 305070
DR   PubChem_Cell_line; CVCL_6910
DR   Wikidata; Q54882442
RX   DOI=10.13005/bpj/1414;
WW   Provider; Qbiogene; AES0503; https://web.archive.org/web/20091110005046/http://www.qbiogene.com/adenovirus/products/celllines/
WW   Provider; Thermo Fisher; R70507; https://www.thermofisher.com/order/catalog/product/R70507
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Qbiogene; Catalog number AES0503.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=305070
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,21
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D6S1043: 11
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   HEK293-A7
AC   CVCL_E149
SY   HEK293 A7; HEK293-A7 RheoSwitch
DR   Wikidata; Q54882443
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: New England Biolabs; Catalog number C2002.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   HEK293-ACE2-GFP
AC   CVCL_C0RY
SY   HEK293-ACE2_GFP; HEK-ACE2-GFP
DR   Wikidata; Q112929671
WW   Provider; Dexorgen; CB-97100-203; https://web.archive.org/web/20210414074642/http://codexbiosolutions.com/wp-content/uploads/cb-97100-203.pdf
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Transduced with a ACE2-GFP construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Dexorgen; Catalog number CB-97100-203.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293-ARV7-PSA-E/P-LUC
AC   CVCL_F0L6
RX   PubMed=24740322;
CC   Characteristics: Transfected with both a pcDNA3.1-AR-V7 plasmid and a PSA/e P-LUC plasmid where theluciferase gene expression is driven by the PSA promoter and enhancer (PubMed=24740322).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:644; AR (Note=Isoform ARv7).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293-ATP2B2-RFP
AC   CVCL_E9XZ
SY   HEK293-ATP2B2
WW   Provider; GenTarget; SC026-RB; https://www.gentarget.com/product/hek293-atp2b2-cell-line-with-rfp-and-blasticidin-marker/
CC   Characteristics: Transduced by lentivirus with a EF1a-ATP2B2-Rsv-RFP-Bsr construct (GenTarget=SC026-RB).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:815; ATP2B2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293-CAGA
AC   CVCL_ZD63
SY   HEK293 (CAGA)12
DR   Wikidata; Q98126665
RX   PubMed=22052913;
RX   PubMed=22593183;
RX   PubMed=23543431;
CC   Characteristics: Robustly responds to signaling by activin and TGF-beta class ligands and employed in an assay measuring inhibition of ligand activity (PubMed=23543431).
CC   Characteristics: Luciferase reporter gene expression is under the control of a promoter containing a Smad binding element (SBE) (CAGA(12)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CB1
AC   CVCL_YJ21
SY   HEK-CB1
DR   Wikidata; Q94095026
RX   PubMed=23161546;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2159; CNR1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293-CB1-CRE-Luc
AC   CVCL_YI92
DR   Wikidata; Q94095031
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2159; CNR1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Palomeros Canero, Belen.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YJ21 ! HEK293-CB1
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293-CCR8
AC   CVCL_E6AC
DR   CLS; 305426
WW   Provider; InSCREENeX; INS-SF-1024; https://www.inscreenex.de/product/hek-ccr8/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-CEACAM1-dN-Fc
AC   CVCL_C0EF
DR   CancerTools; 160686
DR   Wikidata; Q112929672
DR   Ximbio; 160686
CC   Characteristics: Overexpresses a CEACAM1 lacking the N-domain-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1814; CEACAM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CEACAM1-Fc
AC   CVCL_C0EG
DR   CancerTools; 160687
DR   Wikidata; Q112929673
DR   Ximbio; 160687
CC   Characteristics: Overexpresses a CEACAM1-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1814; CEACAM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CEACAM1-N-Fc
AC   CVCL_C0EH
DR   CancerTools; 160688
DR   Wikidata; Q112929674
DR   Ximbio; 160688
CC   Characteristics: Overexpresses a CEACAM1 N-domain-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1814; CEACAM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CEACAM3-Fc
AC   CVCL_C0EI
DR   CancerTools; 160689
DR   Wikidata; Q112929675
DR   Ximbio; 160689
CC   Characteristics: Overexpresses a CEACAM3-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1815; CEACAM3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CEACAM5-Fc
AC   CVCL_C0EJ
DR   CancerTools; 160690
DR   Wikidata; Q112929676
DR   Ximbio; 160690
CC   Characteristics: Overexpresses a CEACAM5-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CEACAM6-Fc
AC   CVCL_C0EK
DR   CancerTools; 160695
DR   Wikidata; Q112929677
DR   Ximbio; 160695
CC   Characteristics: Overexpresses a CEACAM6-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1818; CEACAM6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CEACAM8-Fc
AC   CVCL_C0EL
DR   CancerTools; 160696
DR   Wikidata; Q112929678
DR   Ximbio; 160696
RX   PubMed=24743304;
CC   Characteristics: Overexpresses a CEACAM8-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1820; CEACAM8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CFTR-RFP
AC   CVCL_E9Y0
SY   HEK293-CFTR
WW   Provider; GenTarget; SC022-RB; https://www.gentarget.com/product/hek293-cftr-cell-line-with-rfp-and-blasticidin-marker/
CC   Characteristics: Transduced by lentivirus with a EF1a-CFTR-Rsv-RFP-Bsr construct (GenTarget=SC022-RB).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1884; CFTR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293-CLCN2-RFP
AC   CVCL_E9Y1
SY   HEK293-CLCN2
WW   Provider; GenTarget; SC023-RB; https://www.gentarget.com/product/hek293-clcn2-cell-line-with-rfp-and-blasticidin-marker/
CC   Characteristics: Transduced by lentivirus with a EF1a-CLCN2-Rsv-RFP-Bsr construct (GenTarget=SC023-RB).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2020; CLCN2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293-CNG
AC   CVCL_C0RU
SY   HEK-293-CNG; HEK293/CNG; CNG-HEK293; HEK CNG; HEK oCNG-NC-5
DR   Wikidata; Q112929679
RX   PubMed=14555181;
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Parent cell line for many ACTOne cell lines.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Has Dexorgen catalog number CB-80200-200/AG-10200-200, but not distributed separately from children cell lines.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CNG-Gs
AC   CVCL_C0RW
SY   HEK 293-CNG-Gs
DR   Wikidata; Q112929680
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Expresses a constitutively active over-expressed Gs-coupled GPCR. Serves as a parent cell line for various ACTOne PDE cell lines.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Has Dexorgen catalog number CB-81200-100, but not distributed separately from children cell lines.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-CNG-Slc1a3
AC   CVCL_C0RX
SY   HEK 293-CNG-Slc1a3
DR   Wikidata; Q112929681
CC   Characteristics: Expresses a modified cyclic nucleotide gated (CNG) channel that opens in response to elevated intracellular cAMP levels and consequently result in ion flux and cell membrane depolarization. Allows sensitive detection of signaling by Gs, Gi or Gq-coupled receptors (Dexorgen).
CC   Characteristics: Parental and control cell line for ACTOne GRM2, ACTOne GRM7 and ACTOne GRM8.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10941; SLC1A3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 2367; Cnga2 (Note=With p.Phe68Ala, p.Trp81Ala, p.Cys460Trp and p.Glu583Met = oCNG-NC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Has Dexorgen catalog number CB-81200-238, but not distributed separately from children cell lines.
CC   Misspelling: HEK293-CNG-Slcla3; Note=In some Dexorgen (Codex Biosolutions) data sheets.
CC   Misspelling: HEK 293-CNG-Slcla3; Note=In some Dexorgen (Codex Biosolutions) data sheets.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0RU ! HEK293-CNG
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293-CTLA4
AC   CVCL_E6AT
DR   CLS; 305423
WW   Provider; InSCREENeX; INS-SF-1014; https://www.inscreenex.de/product/hek-ctla4/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-CXCR4
AC   CVCL_E6AR
DR   CLS; 305420
WW   Provider; InSCREENeX; INS-SF-1006; https://www.inscreenex.de/product/hek-cxcr4/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-CXCR7
AC   CVCL_E6AN
DR   CLS; 305421
WW   Provider; InSCREENeX; INS-SF-1009; https://www.inscreenex.de/product/hek-cxcr7/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:23692; ACKR3.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-DR-GFP
AC   CVCL_XX00
DR   DSMZ; ACC-844
DR   DSMZCellDive; ACC-844
DR   Wikidata; Q94095037
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~24 hours (DSMZ=ACC-844).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-844
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V349 ! HEK 293 Tet-Off
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   HEK293-DR-GFP-RAD51B-9
AC   CVCL_XX01
DR   DSMZ; ACC-845
DR   DSMZCellDive; ACC-845
DR   Wikidata; Q94095041
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~48 hours (DSMZ=ACC-845).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9822; RAD51B.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-845
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX00 ! HEK293-DR-GFP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293-DR-GFP-RAD51B-9/B+
AC   CVCL_XX06
DR   DSMZ; ACC-850
DR   DSMZCellDive; ACC-850
DR   Wikidata; Q94095046
CC   Characteristics: The parental RAD51B KO cell line is functionally reconstituted by retroviral transfection of RAD51B.
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~24-36 hours (DSMZ=ACC-850).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9822; RAD51B.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9822; RAD51B.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-850
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX01 ! HEK293-DR-GFP-RAD51B-9
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   HEK293-DR-GFP-RAD51C-2
AC   CVCL_XX02
DR   DSMZ; ACC-846
DR   DSMZCellDive; ACC-846
DR   Wikidata; Q94095050
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~40 hours (DSMZ=ACC-846).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9820; RAD51C.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-846
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX00 ! HEK293-DR-GFP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293-DR-GFP-RAD51C-2/C+
AC   CVCL_XX07
DR   DSMZ; ACC-851
DR   DSMZCellDive; ACC-851
DR   Wikidata; Q94095054
CC   Characteristics: The parental RAD51C KO cell line is functionally reconstituted by retroviral transfection of RAD51C.
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~30 hours (Note=After thawing), ~10-20 hours (Note=Later passages) (DSMZ=ACC-851).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9820; RAD51C.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9820; RAD51C.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-851
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX02 ! HEK293-DR-GFP-RAD51C-2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HEK293-DR-GFP-RAD51D-16
AC   CVCL_XX03
DR   DSMZ; ACC-847
DR   DSMZCellDive; ACC-847
DR   Wikidata; Q94095062
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~40 hours (DSMZ=ACC-847).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-847
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX00 ! HEK293-DR-GFP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293-DR-GFP-RAD51D-16/D+
AC   CVCL_XX08
DR   DSMZ; ACC-852
DR   DSMZCellDive; ACC-852
DR   Wikidata; Q94095067
CC   Characteristics: The parental RAD51D KO cell line is functionally reconstituted by retroviral transfection of RAD51D.
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~30 hours (DSMZ=ACC-852).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9823; RAD51D.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-852
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX03 ! HEK293-DR-GFP-RAD51D-16
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HEK293-DR-GFP-XRCC2-13
AC   CVCL_XX04
DR   DSMZ; ACC-848
DR   DSMZCellDive; ACC-848
DR   Wikidata; Q94095072
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~50-70 hours (DSMZ=ACC-848).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12829; XRCC2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-848
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX00 ! HEK293-DR-GFP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293-DR-GFP-XRCC2-13/X2+
AC   CVCL_XX09
DR   DSMZ; ACC-853
DR   DSMZCellDive; ACC-853
DR   Wikidata; Q94095077
CC   Characteristics: The parental XRCC2 KO cell line is functionally reconstituted by retroviral transfection of XRCC2.
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~40 hours (DSMZ=ACC-853).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12829; XRCC2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12829; XRCC2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-853
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX04 ! HEK293-DR-GFP-XRCC2-13
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HEK293-DR-GFP-XRCC3-5
AC   CVCL_XX05
DR   DSMZ; ACC-849
DR   DSMZCellDive; ACC-849
DR   Wikidata; Q94095079
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-849).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12830; XRCC3.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-849
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX00 ! HEK293-DR-GFP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293-DR-GFP-XRCC3-5/X3+
AC   CVCL_XX10
DR   DSMZ; ACC-854
DR   DSMZCellDive; ACC-854
DR   Wikidata; Q94095087
CC   Characteristics: The parental XRCC3 KO cell line is functionally reconstituted by retroviral transfection of XRCC3.
CC   Characteristics: Transfected with the hprtDR-GFP reporter construct that targets the DR-GFP into the hprt locus and includes a dominant selectable puroR marker. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Doubling time: ~20-30 hours (DSMZ=ACC-854).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12830; XRCC3.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12830; XRCC3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-854
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX05 ! HEK293-DR-GFP-XRCC3-5
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HEK293-EBNA
AC   CVCL_6974
AS   CVCL_6350
SY   293 c18; 293c18; HEK 293 c18; HEK-293 c18; HEK293-EBNA1; HEK-293-EBNA; HEK 293-EBNA; HEK 293 EBNA; HEK293EBNA; 293 EBNA; 293-EBNA1; 293-EBNA; 293/EBNA; 293EBNA; EBNA-293; EBNA293; 293E; HEK293E; HEK/EBNA; HEK-EBNA; HEK.EBNA; 293/EBNA-1
DR   BTO; BTO_0002974
DR   CLO; CLO_0001231
DR   EFO; EFO_0022562
DR   ATCC; CRL-10852
DR   CCRID; 1101HUM-PUMC000152
DR   ChEMBL-Cells; CHEMBL3833702
DR   CLS; 300264
DR   FCS-free; 6-2-513-1-16-12
DR   PubChem_Cell_line; CVCL_6974
DR   TOKU-E; 242
DR   TOKU-E; 3609
DR   TOKU-E; 3672
DR   Wikidata; Q54882445
RX   DOI=10.13005/bpj/1414;
RX   PubMed=21356792;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-131.html
WW   Provider; Thermo Fisher; R620-07; https://tools.thermofisher.com/content/sfs/manuals/293ebna_man.pdf
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10852.
CC   Characteristics: The use of recombinant protein expression vectors containing the EBV oriP in cell lines stably expressing EBV's EBNA1 protein significantly increases recombinant protein yield.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number R620-07.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-10852; CCRID=1101HUM-PUMC000152
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12 (CCRID=1101HUM-PUMC000152)
ST   D13S317: 12,14 (ATCC=CRL-10852)
ST   D16S539: 9
ST   D18S51: 18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   HEK293-EBNA1-6E
AC   CVCL_HF20
SY   HEK 293EBNA1-6E; HEK 293-6E; HEK293-6E; HEK2936E; 293-6E; 293FEt-clone 6E
DR   Wikidata; Q54882446
RX   Patent=US8551774;
RX   PubMed=21356792;
WW   Provider; NRC Canada; 11565; https://nrc.canada.ca/en/research-development/intellectual-property-licensing/hek293sf-3f6-hek293-6e-expression-platforms-l-10894-11266-11565
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 150305-01.
CC   Characteristics: The use of recombinant protein expression vectors containing the EBV oriP in cell lines stably expressing EBV's EBNA1 protein significantly increases recombinant protein yield.
CC   Characteristics: This cell line is transfected with EBNA1t, a truncated version of EBV EBNA1 lacking the Gly-Gly-Ala repeats region. It has an enhanced ability to produce recombinant protein compared to HEK293-EBNA (Cellosaurus=CVCL_6974).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1 (Note=With p.Gly101_Ala324del = EBNA1t).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6642 ! HEK293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HEK293-EGFP
AC   CVCL_C9C9
DR   Ubigene; YC-A008-EGFP-P
DR   Wikidata; Q123031585
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HEK293-EGFR
AC   CVCL_E8AY
RX   CelloPub=CLPUB00801;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-Ephb1
AC   CVCL_EP72
SY   HEK Ephrin-B1+
DR   PRIDE; PRD000814
DR   Wikidata; Q54882453
RX   PubMed=20007894;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1096337; Ephb1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HEK293-Ephb1DeltaIC
AC   CVCL_E8B0
SY   HEK Ephrin-B1DeltaIC+
RX   PubMed=20007894;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1096337; Ephb1 (Note=With deleted cytoplasmic tail and C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-Ephb2
AC   CVCL_EP73
SY   HEK EphB2+
DR   PRIDE; PRD000814
DR   Wikidata; Q54882454
RX   PubMed=20007894;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:99611; Ephb2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HEK293-Ephb2DeltaIC
AC   CVCL_E8B1
SY   HEK EphB2DeltaIC+
RX   PubMed=20007894;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:99611; Ephb2 (Note=With deleted cytoplasmic tail and C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-ET
AC   CVCL_6996
SY   HEK-293ET; HEK293ET; HEK293 ET; HEK 293 ET; 293ET
DR   BTO; BTO_0005548
DR   EFO; EFO_0022563
DR   CCRID; 1101HUM-PUMC000153
DR   Wikidata; Q54882455
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000153
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   HEK293-F
AC   CVCL_6642
SY   HEK-293-F; HEK 293-F; HEK-293F; HEK293F; 293-F; 293 F; 293F
DR   BTO; BTO_0003032
DR   EFO; EFO_0022564
DR   CCRID; 1101HUM-PUMC000393
DR   CLS; 300260
DR   Wikidata; Q54882456
RX   DOI=10.13005/bpj/1414;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-29.html
WW   Provider; Thermo Fisher; 11625019; https://www.thermofisher.com/order/catalog/product/11625019
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   HEK293-FAP
AC   CVCL_E6AD
DR   CLS; 305419
WW   Provider; InSCREENeX; INS-SF-1001; https://www.inscreenex.de/product/hek-fap/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:3590; FAP.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-Flag-beta2AR
AC   CVCL_E7X3
RX   PubMed=16280323;
WW   Provider; Duke ORI; T-003617; https://otc.duke.edu/technologies/cell-lines-for-the-overexpression-of-gpcrs/
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-Flag-beta2AR-TYY
AC   CVCL_E7X4
RX   PubMed=16280323;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2 (Note=With p.Thr68Phe, Tyr132Gly, p.Tyr219Ala and a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-FOLR1
AC   CVCL_E6AK
DR   CLS; 305425
WW   Provider; InSCREENeX; INS-SF-1018; https://www.inscreenex.de/product/hek-folr1/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:3791; FOLR1.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-FT
AC   CVCL_6911
SY   HEK-293FT; HEK 293FT; HEK-293-FT; HEK293FT; 293-FT; 293FT; FT-293
DR   BTO; BTO_0005029
DR   EFO; EFO_0022461
DR   BioGRID_ORCS_Cell_line; 292
DR   CCRID; 1101HUM-PUMC000364
DR   CLS; 305275
DR   PRIDE; PXD000834
DR   Wikidata; Q54882457
RX   DOI=10.13005/bpj/1414;
RX   PubMed=34529719;
WW   Provider; Thermo Fisher; R70007; https://www.thermofisher.com/order/catalog/product/R70007
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5077.
CC   Doubling time: 21.7 hours (PubMed=34529719).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000364
ST   Amelogenin: X
ST   CSF1PO: 7,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D21S11: 30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6642 ! HEK293-F
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   HEK293-FT APEX1 KO clone 1C4
AC   CVCL_B0WA
SY   1C4
DR   Wikidata; Q108820444
RX   PubMed=34529719;
CC   Doubling time: 20.4 hours (PubMed=34529719).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6911 ! HEK293-FT
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293-FT APEX1 KO clone 2A9
AC   CVCL_B0WB
SY   2A9
DR   Wikidata; Q108820445
RX   PubMed=34529719;
CC   Doubling time: 19.4 hours (PubMed=34529719).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6911 ! HEK293-FT
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HEK293-H
AC   CVCL_6643
SY   HEK-293-H; HEK 293-H; HEK-293H; HEK 293H; HEK293H; 293-H; 293 H; 293H
DR   BTO; BTO_0003033
DR   EFO; EFO_0001183
DR   Lonza; 1420
DR   TOKU-E; 3991
DR   Wikidata; Q54882458
RX   DOI=10.13005/bpj/1414;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-608.html
WW   Provider; Thermo Fisher; 11631017; https://www.thermofisher.com/order/catalog/product/11631017
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   HEK293-hCHT
AC   CVCL_E7VQ
RX   PubMed=23077721;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14025; SLC5A7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-hCHT LV-AA
AC   CVCL_E7VP
RX   PubMed=23077721;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14025; SLC5A7 (Note=With p.Leu531Ala and p.Val532Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-hCNR1
AC   CVCL_ZC53
SY   Human CB1 Cannabinoid Receptor Expressing HEK293 Cell Line
DR   Kerafast; EIU004
DR   Wikidata; Q98126666
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2159; CNR1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EIU004; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293-hCNR2
AC   CVCL_ZC54
SY   Human CB2 Cannabinoid Receptor Expressing HEK293 Cell Line
DR   Kerafast; EIU007
DR   Wikidata; Q98126667
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2160; CNR2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EIU007; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293-HER2
AC   CVCL_E6AI
DR   CLS; 305422
WW   Provider; InSCREENeX; INS-SF-1012; https://www.inscreenex.de/product/hek-her2/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-hERG
AC   CVCL_C0RT
DR   Wikidata; Q112929682
RX   PubMed=28879216;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6251; KCNH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-hGPR55
AC   CVCL_ZC15
SY   hGPR55-HEK293
DR   Kerafast; EIU003
DR   Wikidata; Q98126668
RX   PubMed=18263732;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4511; GPR55.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EIU003; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293-HM3
AC   CVCL_VP06
SY   HM3
DR   CancerTools; 153328
DR   Wikidata; Q94095208
DR   Ximbio; 153328
RX   PubMed=12444545;
RX   PubMed=14981547;
RX   PubMed=16513653;
CC   Characteristics: Expresses the conditional kinase DeltaMEKK3:ER* which consist of the kinase domain of MAP3K3 fused in frame to a modified form of the hormone binding domain of the estrogen receptor (ESR1) that can be de-repressed by 4-hydroxytamoxifen (4-HT) but not beta-estradiol.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6855; MAP3K3 (Note=Kinase domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293-hNOTCH1
AC   CVCL_WI13
SY   HEK-hN1
DR   Wikidata; Q94095213
RX   PubMed=22075160;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7881; NOTCH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   HEK293-hNOTCH2
AC   CVCL_WI14
SY   HEK-hN2
DR   Wikidata; Q94095218
RX   PubMed=22075160;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7882; NOTCH2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   HEK293-HR1
AC   CVCL_VP07
SY   HR1
DR   EFO; EFO_0022530
DR   CancerTools; 153329
DR   Wikidata; Q94095223
DR   Ximbio; 153329
RX   PubMed=16513653;
CC   Characteristics: Expresses the conditional kinase DeltaRaf-1:ER* which consist of the kinase domain of ARAF fused in frame to a modified form of the hormone binding domain of the estrogen receptor (ESR1) that can be de-repressed by 4-hydroxytamoxifen (4-HT) but not beta-estradiol.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:646; ARAF (Note=Kinase domain).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293-IRF3
AC   CVCL_C0N2
SY   HEK293-IRF-3; HEK293-VenusC1-IRF-3
DR   Kerafast; EMD013
DR   Wikidata; Q112929683
RX   PubMed=25100852;
CC   Characteristics: Expresses a VenusC1-IRF3 fusion protein (PubMed=25100852).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6118; IRF3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293-KCNN4-RFP
AC   CVCL_E9Y2
SY   HEK293-KCNN4
WW   Provider; GenTarget; SC025-RB; https://www.gentarget.com/product/hek293-kcnn4-cell-line-with-rfp-and-blasticidin-marker/
CC   Characteristics: Transduced by lentivirus with a EF1a-KCNN4-Rsv-RFP-Bsr construct (GenTarget=SC025-RB).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6293; KCNN4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293-KL
AC   CVCL_C0NM
DR   Wikidata; Q112929684
RX   PubMed=26461432;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6344; KL (Note=With a N-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-Luc
AC   CVCL_C9C7
DR   Ubigene; YC-A008-Luc-P
DR   Wikidata; Q123031586
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HEK293-Luc-GFP
AC   CVCL_B7NW
SY   Luciferase/GFP Dual-Reporter HEK293 Cell Line
DR   Wikidata; Q112929685
WW   Provider; ALSTEM; LGL01; https://www.alstembio.com/web/product_details.php?id=91
CC   Characteristics: Transduced with a CAG-Luc-PGKp-GFP-T2A-PuroR lentiviral reporter construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-Luc-RFP
AC   CVCL_B7NX
SY   Luciferase/tdTomato Dual-Reporter HEK293 Cell Line
DR   Wikidata; Q112929686
WW   Provider; ALSTEM; LRL01; https://www.alstembio.com/web/product_details.php?id=37
CC   Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-MacCEACAM1-Fc
AC   CVCL_C0EM
DR   CancerTools; 160699
DR   Wikidata; Q112929687
DR   Ximbio; 160699
CC   Characteristics: Overexpresses a Macaca mulatta CEACAM1-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:112765; Macaca mulatta CEACAM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293-mCnr1
AC   CVCL_ZC55
SY   Mouse CB1 Cannabinoid Receptor Expressing HEK293 Cell Line
DR   Kerafast; EIU005
DR   Wikidata; Q98126669
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104615; Cnr1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293-mCnr2
AC   CVCL_ZC56
SY   Mouse CB2 Cannabinoid Receptor Expressing HEK293 Cell Line
DR   Kerafast; EIU008
DR   Wikidata; Q98126671
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104650; Cnr2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293-mGpr55
AC   CVCL_ZC16
SY   mGPR55-HEK293
DR   Kerafast; EIU002
DR   Wikidata; Q98126672
RX   PubMed=18263732;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2685064; Gpr55.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   HEK293-mir122
AC   CVCL_B3N0
DR   Wikidata; Q110432861
RX   PubMed=34538767;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:31501; MIR122.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HEK293-MRP7
AC   CVCL_B3Q1
SY   HEK293/MRP7
DR   Wikidata; Q110432862
RX   PubMed=26579384;
RX   PubMed=34631561;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:52; ABCC10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HEK293-MRP7-C17
AC   CVCL_B7SA
SY   HEK-MRP7-C17
DR   Wikidata; Q112929688
RX   PubMed=12527806;
RX   PubMed=15256465;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:52; ABCC10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-MRP7-C18
AC   CVCL_B7SB
SY   HEK-MRP7-C18
DR   Wikidata; Q112929689
RX   PubMed=12527806;
RX   PubMed=15256465;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:52; ABCC10.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-mST2L
AC   CVCL_A0GH
DR   Wikidata; Q108820446
RX   PubMed=21529288;
CC   Characteristics: The expression of the luciferase reporter gene is under the control of a NF-kappaB-inducible promoter.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98427; Il1rl1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293-NanoLuc-RFP
AC   CVCL_B7NY
SY   Nanoluciferase/tdTomato Dual-Reporter HEK293 Cell Line
DR   Wikidata; Q112929690
WW   Provider; ALSTEM; NRL01; https://www.alstembio.com/web/product_details.php?id=38
CC   Characteristics: Transduced with a CAG-NanoLuc-PGKp-TdTomato-T2A-PuroR lentiviral reporter construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-Nav 1.3
AC   CVCL_5I43
SY   NaV 1.3 HEK
DR   Wikidata; Q54882459
RX   PubMed=11487618;
CC   Genetic integration: Method=Transfection; Gene=RGD; 3635; Scn3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   HEK293-NAV1.5
AC   CVCL_E5E3
SY   NAV1.5-HEK293
RX   PubMed=26321143;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10593; SCN5A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293-NOD2
AC   CVCL_D4ZL
SY   FLP-IN HEK 293-NOD2wt
DR   GEO; GSM560855
DR   GEO; GSM560856
DR   GEO; GSM560857
DR   GEO; GSM560864
DR   GEO; GSM560865
DR   GEO; GSM560866
DR   GEO; GSM560873
DR   GEO; GSM560874
DR   GEO; GSM560875
DR   Wikidata; Q127381645
RX   PubMed=16257953;
RX   PubMed=21335489;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5331; NOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293-NOD2 L1007fsinsC
AC   CVCL_D4ZM
SY   FLP-IN HEK 293-NOD2-L1007fsinsC; HEK293-NOD2(SNP13)
DR   GEO; GSM560858
DR   GEO; GSM560859
DR   GEO; GSM560860
DR   GEO; GSM560867
DR   GEO; GSM560868
DR   GEO; GSM560869
DR   GEO; GSM560876
DR   GEO; GSM560877
DR   GEO; GSM560878
DR   Wikidata; Q127381646
RX   PubMed=16257953;
RX   PubMed=21335489;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Leu1007Profs*2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293-Nrf2 clone 1
AC   CVCL_WG86
SY   HEK-Nrf2 (C1)
DR   Wikidata; Q94095241
RX   PubMed=30790232;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7782; NFE2L2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   HEK293-Nrf2 clone 2
AC   CVCL_WG87
SY   HEK-Nrf2 (C2)
DR   Wikidata; Q94095246
RX   PubMed=30790232;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7782; NFE2L2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   HEK293-Nrf2 clone 2-FVII
AC   CVCL_WG88
SY   HEK-Nrf2 (C2)-FVII
DR   Wikidata; Q94095250
RX   PubMed=30790232;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3544; F7.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7782; NFE2L2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WG87 ! HEK293-Nrf2 clone 2
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   HEK293-OX40
AC   CVCL_E3FR
SY   OX40-HEK293
WW   Provider; BPS Bioscience; 60682; https://bpsbioscience.com/ox40-hek293-recombinant-cell-line-60682
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11918; TNFRSF4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293-ratCEACAM1-dN-Fc
AC   CVCL_C0EN
DR   CancerTools; 160698
DR   Wikidata; Q112929691
DR   Ximbio; 160698
CC   Characteristics: Overexpresses a rat Ceacam1 lacking the N-domain-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 67396; Ceacam1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   HEK293-ratCEACAM1-Fc
AC   CVCL_C0EP
DR   CancerTools; 160697
DR   Wikidata; Q112929692
DR   Ximbio; 160697
RX   PubMed=24743304;
CC   Characteristics: Overexpresses a rat Ceacam1-human immunoglobulin G (IgG) Fc domain chimera protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 67396; Ceacam1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   HEK293-rCnr1
AC   CVCL_ZC57
SY   Rat CB1 Cannabinoid Receptor Expressing HEK293 Cell Line
DR   Kerafast; EIU006
DR   Wikidata; Q98126673
RX   PubMed=17681354;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2369; Cnr1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Kerafast; EIU006; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   HEK293-rCnr2
AC   CVCL_ZC58
SY   Rat CB2 Cannabinoid Receptor Expressing HEK293 Cell Line
DR   Kerafast; EIU009
DR   Wikidata; Q98126674
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 619713; Cnr2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   HEK293-RyR1
AC   CVCL_0P75
SY   HEK-RyR1
DR   Kerafast; EUR301
DR   Wikidata; Q54882460
RX   PubMed=24972488;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P11716; Rabbit RYR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U421 ! Flp-In-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   HEK293-SLAM
AC   CVCL_E8BM
SY   HEK293/SLAM; 293/SLAM; 293SLAM
DR   FANTOM5_SSTAR; 10450-106F9
DR   FANTOM5_SSTAR; 10451-106G1
RX   PubMed=18374960;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9GJT3; Saguinus oedipus SLAMF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-SLC1A5
AC   CVCL_C5TT
DR   Wikidata; Q116049303
RX   PubMed=35834041;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10943; SLC1A5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   HEK293-SREBP1-T2A-luciferase-KI
AC   CVCL_VR42
DR   Wikidata; Q94095267
RX   PubMed=30232659;
CC   Characteristics: Useful for studying transcriptional regulation of the SREBP1 gene and for screening drugs or chemical molecules that regulate SREBP1 gene expression (PubMed=30232659).
CC   Characteristics: CRISPR/Cas9-mediated knock-in of a T2A-luciferase-CMV-eGFP-T2A-Neomycin construct at the C-terminal end of SREBP1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   HEK293-Survivin
AC   CVCL_A8UL
SY   HEK-S
DR   Wikidata; Q108820447
RX   PubMed=33765242;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:593; BIRC5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HEK293-TA-Lv-T7 R1D3
AC   CVCL_B7Q2
DR   Wikidata; Q112929693
RX   PubMed=33592218;
CC   Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BT05 ! 293Ta
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293-TA-Lv-T7 R1D8
AC   CVCL_B7Q3
DR   Wikidata; Q112929694
RX   PubMed=33592218;
CC   Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BT05 ! 293Ta
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293-TA-Lv-T7 R5B9
AC   CVCL_B7Q4
DR   Wikidata; Q112929695
RX   PubMed=33592218;
CC   Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BT05 ! 293Ta
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293-TACD2
AC   CVCL_E6AF
DR   CLS; 305424
WW   Provider; InSCREENeX; INS-SF-1016; https://www.inscreenex.de/product/hek293-tacd2/
CC   Characteristics: The target gene was integrated using the InSCREENeX SCREENflex system.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=HGNC; HGNC:11530; TACSTD2.
CC   Genetic integration: Method=Recombinase-mediated cassette exchange; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293-TRPC3-RFP
AC   CVCL_E9Y3
SY   HEK293-TRPC3
WW   Provider; GenTarget; SC024-RB; https://www.gentarget.com/product/hek293-trpc3-cell-line-with-rfp-and-blasticidin-marker/
CC   Characteristics: Transduced by lentivirus with a EF1a-TRPC3-Rsv-RFP-Bsr construct (GenTarget=SC024-RB).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12335; TRPC3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293-TRPV1-RFP
AC   CVCL_E9Y4
SY   HEK293-TRPV1
WW   Provider; GenTarget; SC027-RB; https://www.gentarget.com/product/hek293-trpv1-cell-line-with-rfp-and-blasticidin-marker/
CC   Characteristics: Transduced by lentivirus with a EF1a-TRPV1-Rsv-RFP-Bsr construct (GenTarget=SC027-RB).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12716; TRPV1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEK293-UGT2B9
AC   CVCL_B5W5
SY   HK293-UGT2B9
DR   Wikidata; Q111733351
RX   PubMed=9364930;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; O02663; Macaca fascicularis UGT2B9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   HEK293-YFV-prM/E-opt
AC   CVCL_RZ86
DR   Wikidata; Q54882461
RX   PubMed=29513845;
CC   Characteristics: Expresses the YFV prM/E proteins and capable of trans-packaging the transcribed RNA of a YFV reporter replicon, thereby generating pseudo-infectious viral particles.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03314; Yellow fever virus (strain 17D vaccine) genome polyprotein (Note=AA 102-778; protein prM + protein E, codons optimized for expression).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   HEK293/5-HT2B
AC   CVCL_E5JQ
SY   HEK 293/5-HT2B
DR   GenScript; M00328
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5294; HTR2B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00328; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293/5-HT2C
AC   CVCL_H513
SY   HEK 293/5-HT2C
DR   GenScript; M00319
DR   Wikidata; Q54882462
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   HEK293/ACE2
AC   CVCL_E5IX
DR   GenScript; M00770
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293/AT1
AC   CVCL_H514
SY   HEK 293/AT1
DR   GenScript; M00458
DR   Wikidata; Q54882463
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:336; AGTR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   HEK293/CLDN18.2
AC   CVCL_E5J2
DR   GenScript; M00917
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293/CRE-Luc/GLP1R
AC   CVCL_KA20
DR   GenScript; M00562
DR   Wikidata; Q54882464
CC   Characteristics: Expresses firefly luciferase under the control of a 3xCRE element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00562; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H364 ! 293/CRE-Luc
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HEK293/Galpha15
AC   CVCL_KA11
DR   GenScript; M00554
DR   Wikidata; Q54882465
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HEK293/GCGR/Galpha15
AC   CVCL_H515
SY   HEK 293/GCGR/Galpha15
DR   GenScript; M00422
DR   Wikidata; Q54882466
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   HEK293/GFP-DFCP1
AC   CVCL_5A22
SY   201 cells
DR   Wikidata; Q54882467
RX   PubMed=18725538;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13180; ZFYVE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Misspelling: HEK293A/GFP-DFCP1; Note=Incorrect as this cell line is not derived from HEK293-A. From personal communication of Ktistakis, Nicholas T.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   HEK293/hABCC6
AC   CVCL_LN32
DR   MetaboLights; MTBLS61
DR   Wikidata; Q54882468
RX   PubMed=24277820;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:57; ABCC6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   HEK293/hERG
AC   CVCL_H516
DR   GenScript; M00282
DR   Wikidata; Q54882469
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6251; KCNH2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00282; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   HEK293/HF-Cas9-AAVS1
AC   CVCL_C9FA
DR   GeneCopoeia; SL553
DR   Wikidata; Q123031587
CC   Characteristics: Stably expresses a CMV-3xFLAG-HFCas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL553).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asn497Ala, p.Arg661Ala, p.Gln695Ala and p.Gln926Ala = High-fidelity Cas9).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HEK293/hKv1.5
AC   CVCL_H517
DR   GenScript; M00xx1
DR   Wikidata; Q54882470
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6224; KCNA5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Caution: We could not find the catalog number of this discontinued GenScript cell line.
CC   Discontinued: GenScript; M00xx1; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   HEK293/hKv4.2
AC   CVCL_H518
DR   GenScript; M00xx2
DR   Wikidata; Q54882471
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6238; KCND2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Caution: We could not find the catalog number of this discontinued GenScript cell line.
CC   Discontinued: GenScript; M00xx2; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   HEK293/hNav1.5
AC   CVCL_H519
DR   GenScript; M00293
DR   Wikidata; Q54882472
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10593; SCN5A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00293; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   HEK293/hNav1.7
AC   CVCL_H520
DR   GenScript; M00509
DR   Wikidata; Q54882473
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10597; SCN9A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00509; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   HEK293/LoxP-Cas9-hyg-AAVS1
AC   CVCL_C9BH
DR   GeneCopoeia; SL554
DR   Wikidata; Q123031589
CC   Characteristics: Stably expresses a loxP-CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa-loxP construct from the AAVS1 safe locus (GeneCopoeia=SL554).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HEK293/NFAT/beta-lactamase
AC   CVCL_KA65
DR   GenScript; M00146
DR   Wikidata; Q54882474
CC   Characteristics: Transfected with the 3xNFAT-beta-lactamase-Zeo plasmid containing a beta-lactamase reporter gene under control of the NFAT response element (GenScript=M00146).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00146; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   HEK293/P2X1
AC   CVCL_E5JB
DR   GenScript; M00235
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8533; P2RX1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00235; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293/P2X3
AC   CVCL_E5JC
DR   GenScript; M00236
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8534; P2RX3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00236; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293/PAFR/NFAT/beta-lactamase
AC   CVCL_KA74
SY   HEK293/PAFR/NFAT/beta-Lac
DR   GenScript; M00147
DR   Wikidata; Q54882475
CC   Characteristics: Transfected with the 3xNFAT-beta-lactamase-Zeo plasmid containing a beta-lactamase reporter gene under control of the NFAT response element (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9582; PTAFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00147; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KA65 ! HEK293/NFAT/beta-lactamase
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HEK293/PD-L1
AC   CVCL_KA07
DR   GenScript; M00544
DR   Wikidata; Q54882476
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HEK293/PTHR1/CRE/beta-lactamase
AC   CVCL_KA75
SY   HEK293/PTHR1/CRE/beta-Lac
DR   GenScript; M00148
DR   Wikidata; Q54882477
CC   Characteristics: Expresses beta-lactamase under the control of a CRE element (GenScript=M00148).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9608; PTH1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00148; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   HEK293/rABCC6
AC   CVCL_LN33
DR   MetaboLights; MTBLS61
DR   Wikidata; Q54882478
RX   PubMed=24277820;
CC   Genetic integration: Method=Transfection; Gene=RGD; 620268; Abcc6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   HEK293/rKv4.2
AC   CVCL_E5JA
SY   HEK293/Kv4.2
RX   PubMed=16271805;
CC   Genetic integration: Method=Transfection; Gene=RGD; 68393; Kcnd2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293/TRPA1
AC   CVCL_E5JD
DR   GenScript; M00234
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:497; TRPA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00234; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293/TRPV1
AC   CVCL_E5JE
DR   GenScript; M00233
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12716; TRPV1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: GenScript; M00233; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293::TMEM192-3xHA
AC   CVCL_C0I5
SY   293L
DR   Wikidata; Q112926928
RX   PubMed=36245040;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (PubMed=36245040).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293::TMEM192-3xHA APP-/-
AC   CVCL_C0I6
SY   293L-APP-/-
DR   Wikidata; Q112926930
RX   PubMed=36245040;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0I5 ! HEK293::TMEM192-3xHA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HEK293::TMEM192-3xHA mNEON-YIPF4
AC   CVCL_D1J5
SY   HEK293::TMEM192-3xHA::mNEON-YIPF4
DR   Wikidata; Q127381647
RX   PubMed=37757899;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 YIPF4 was N-terminally tagged on both alleles with mNeonGreen (PubMed=37757899).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZRKRV; mNeonGreen (Note=Derivative of Branchiostoma lanceolatum LanYFP).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0I5 ! HEK293::TMEM192-3xHA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293::TMEM192-3xHA RB1CC1-/-
AC   CVCL_D1KQ
DR   Wikidata; Q127381648
RX   PubMed=37757899;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15574; RB1CC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0I5 ! HEK293::TMEM192-3xHA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293::TMEM192-3xHA RB1CC1-/- mNEON-YIPF4
AC   CVCL_D1JA
SY   HEK293::TMEM192-3xHA FIP200-/- ::mNEON-YIPF4; HEK293 FIP200-/-
DR   Wikidata; Q127381649
RX   PubMed=37757899;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 YIPF4 was N-terminally tagged on both alleles with mNeonGreen (PubMed=37757899).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15574; RB1CC1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZRKRV; mNeonGreen (Note=Derivative of Branchiostoma lanceolatum LanYFP).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KQ ! HEK293::TMEM192-3xHA RB1CC1-/-
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293::TMEM192-3xHA YIPF4-/-
AC   CVCL_D1J3
DR   Wikidata; Q127381651
RX   PubMed=37757899;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28145; YIPF4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0I5 ! HEK293::TMEM192-3xHA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293::TMEM192-3xHA YIPF4-/-;YIPF3-/-
AC   CVCL_D1J4
SY   YIPF3/YIPF4-/- DKO HEK293; HEK293 YIPF3-/-;YIPF4-/-
DR   Wikidata; Q127381652
RX   PubMed=37757899;
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21023; YIPF3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28145; YIPF4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1J3 ! HEK293::TMEM192-3xHA YIPF4-/-
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293A mRFP-ATG9
AC   CVCL_W349
SY   HEK293A mRFP-Atg9; HEK293-A mRFP-ATG9; HEK293-A-mRFP-ATG9; 293/mRFP-Atg9
DR   CancerTools; 151828
DR   ECACC; 17100531
DR   Wikidata; Q54882479
DR   Ximbio; 151828
RX   PubMed=22456507;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:22408; ATG9A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ECACC; 17100531; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=17100531
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17
ST   D21S11: 30.2
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6910 ! HEK293-A
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 18
//
ID   HEK293A/GFP-LC3
AC   CVCL_W347
SY   HEK293A GFP-LC3; HEK293A GFP LC3; HEK293/GFP-LC3; EK293A EGFP-LC3; 293/GFP-LC3
DR   CancerTools; 151480
DR   ECACC; 14050801
DR   Wikidata; Q54882480
DR   Ximbio; 151480
RX   PubMed=16420522;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 735183; Map1lc3a.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ECACC; 14050801; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6910 ! HEK293-A
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   HEK293A/GFP-WIPI1
AC   CVCL_5F67
SY   HEK293-A GFP-WIPI1
DR   CancerTools; 151717
DR   ECACC; 17100533
DR   Wikidata; Q54882481
DR   Ximbio; 151717
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25471; WIPI1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ECACC; 17100533; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=17100533
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17
ST   D21S11: 30.2
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,15
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6910 ! HEK293-A
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HEK293A/GFP-WIPI2
AC   CVCL_5A21
SY   HEK293-A GFP-WIPI2
DR   CancerTools; 151716
DR   ECACC; 17100532
DR   Wikidata; Q54882482
DR   Ximbio; 151716
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:32225; WIPI2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ECACC; 17100532; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=17100532
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17
ST   D21S11: 28,30.2
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6910 ! HEK293-A
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HEK293E_Clu AB1
AC   CVCL_D4BR
DR   Wikidata; Q127381653
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Val26Asp, p.Met34Trp and p.Arg37Glu).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu AB2
AC   CVCL_D4BS
DR   Wikidata; Q127381654
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Val389Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu CC1
AC   CVCL_D4BJ
DR   Wikidata; Q127381656
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Asn239_Phe262del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu CC2
AC   CVCL_D4BK
DR   Wikidata; Q127381657
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Ile46Lys and p.Val50Glu).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu CC3
AC   CVCL_D4BL
DR   Wikidata; Q127381658
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Val369Lys, p.Ala373Thr and p.Thr376Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu CC4
AC   CVCL_D4BM
DR   Wikidata; Q127381659
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Ser161Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu DD1
AC   CVCL_D4BN
DR   Wikidata; Q127381660
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Ala108Glu, p.Leu109Ser, p.Glu112Lys, p.Pro115Gln, p.Lys304Ala and p.Glu307His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu DD1 + TL1
AC   CVCL_E4JU
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the everse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Ala108Glu, p.Leu109Ser, p.Glu112Lys, p.Pro115Gln, p.Arg214_Leu238del, p.Lys304Ala and p.Glu307His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293E_Clu DD2
AC   CVCL_D4BP
DR   Wikidata; Q127381662
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Tyr125Phe, p.Gly132Glu, p.Leu135Lys, p.Arg138Glu, p.Gln139Ala and p.Glu142Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu DD3
AC   CVCL_D4BQ
DR   Wikidata; Q127381663
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Lys123Gln, p. Arg127Gln, p.Arg130Gln, p.Arg138Gln, p.Arg282Gln, p.Arg286Gln and p.Arg289Gln).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu TL1
AC   CVCL_D4BE
DR   Wikidata; Q127381664
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Arg214_Leu238del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu TL2
AC   CVCL_D4BF
DR   Wikidata; Q127381665
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Tyr204Ser, p.Tyr206Ser, p.Leu207Ser, p.Phe209Ser, p.Leu211Ser, p.Phe218Ser, p.Phe219Ser and p.Phe220Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu TL2+3
AC   CVCL_D4BH
DR   Wikidata; Q127381666
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Tyr204Ser, p.Tyr206Ser, p.Leu207Ser, p.Phe209Ser, p.Leu211Ser, p.Phe218Ser, p.Phe219Ser, p.Phe220Ser, p.Leu229Ser, p.Met230Ser, p.Phe232Ser and p.Tyr235Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu TL3
AC   CVCL_D4BG
DR   Wikidata; Q127381667
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Leu229Ser, p.Met230Ser, p.Phe232Ser and p.Tyr235Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu TL4
AC   CVCL_D4BI
DR   Wikidata; Q127381668
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing mutated CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU (Note=With p.Arg227Gln).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Clu WT
AC   CVCL_D4BD
DR   Wikidata; Q127381669
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing CLU under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2095; CLU.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293E_Ecto short VLDLR-C-tag
AC   CVCL_D4BT
DR   Wikidata; Q127381670
CC   Characteristics: Transfected with the pB-T-PAF expression plasmid expressing the ectodomain of VLDLR fused to a C-terminal C-tag (EPEA) under the tet operator and the PB-RN reverse transactivator plasmid expressing the reverse tetracycline-controlled transactivator under the CMV promoter (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12698; VLDLR (Note=With p.Ala798_Ala873del and a C-terminal C-tag (EPEA)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293H ABCA1 HA-KM
AC   CVCL_E6JD
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With p.Lys1952Met and a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293H ABCA1 HA-MK
AC   CVCL_E6JE
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With p.Lys939Met and a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293H ABCA1 HA-MM
AC   CVCL_E6JF
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With p.Lys939Met, p.Lys1952Met and a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293H ABCA1 HA-WT
AC   CVCL_E6JG
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293H-cynoLRP8
AC   CVCL_F0VM
RX   DOI=10.3389/fddsv.2022.1093153;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5UU97; Macaca fascicularis LRP8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293H-hLRP8
AC   CVCL_F0VN
SY   HEK293-hLRP8; hLRP-8-HEK293
RX   DOI=10.3389/fddsv.2022.1093153;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6700; LRP8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293H-mLrp8
AC   CVCL_F0VP
RX   DOI=10.3389/fddsv.2022.1093153;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1340044; Lrp8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6643 ! HEK293-H
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293L
AC   CVCL_M775
SY   293L
DR   BEI_Resources; ARP-3553
DR   Wikidata; Q54882483
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   HEK293S
AC   CVCL_A784
SY   HEK-293S; HEK 293S; 293S
DR   BTO; BTO_0006453
DR   EFO; EFO_0022515
DR   BioSamples; SAMEA2168959
DR   CancerTools; 154155
DR   Wikidata; Q54882484
RX   DOI=10.13005/bpj/1414;
RX   PubMed=8876162;
RX   PubMed=10736692;
RX   PubMed=25182477;
WW   Info; -; -; http://hek293genome.org/v2/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-42.html
CC   Characteristics: Adapted to growth in suspension.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   HEK293S GnTI-
AC   CVCL_A785
SY   293SGnTI(-); HEK293SG; 293SG
DR   EFO; EFO_0022686
DR   ATCC; CRL-3022
DR   Wikidata; Q54882485
RX   DOI=10.13005/bpj/1414;
RX   PubMed=12370423;
RX   PubMed=25182477;
CC   Characteristics: Lacks N-acetylglucosaminyltransferase I activity and accordingly predominantly modifies glycoproteins with the Man5GlcNAc2 N-glycan. Used for the production of homogenously N-glycosylated proteins (PubMed=25182477).
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3022
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D18S51: 18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A784 ! HEK293S
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   HEK293SF
AC   CVCL_4V94
SY   HEK293-SF; 293SF
DR   BioGRID_ORCS_Cell_line; 1497
DR   Wikidata; Q54882486
RX   PubMed=10099373;
CC   Group: Serum/protein free medium cell line.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A784 ! HEK293S
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   HEK293SF-3F6
AC   CVCL_4V95
SY   HEK293-SF-3F6; HEK 293SF-3F6; 293SF-3F6
DR   ATCC; CRL-3537
DR   ATCC; CRL-12585
DR   Wikidata; Q54882487
RX   Patent=US6210922;
RX   PubMed=10099373;
RX   PubMed=31548015;
WW   Info; NRC Canada; -; https://www.canada.ca/en/national-research-council/news/2020/05/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html
WW   Provider; NRC Canada; 10894; https://nrc.canada.ca/en/research-development/intellectual-property-licensing/hek293sf-3f6-hek293-6e-expression-platforms-l-10894-11266-11565
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12585.
CC   Biotechnology: Used for the production of the CanSino Biologics Ebola virus vaccine (Trade name: Ad5-EBOV).
CC   Biotechnology: Used for the production of the CanSino Biologics SARS-CoV-2 (COVID-19) vaccine (Trade name: Convidecia; also known as Ad5-nCOV) (DrugBank=DB15655).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-12585; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V94 ! HEK293SF
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HEK293SF-3F6 GLUL KO
AC   CVCL_E3KD
SY   HEK293 4C3; GS- clone 4C3
RX   DOI=10.1016/j.bej.2019.107299;
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V95 ! HEK293SF-3F6
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293SF-3F6 TYMS KO
AC   CVCL_E3KE
SY   HEK293 2C10; TYMS- clone 2C10
RX   DOI=10.1016/j.bej.2019.107299;
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12441; TYMS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V95 ! HEK293SF-3F6
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293SF-PacLV
AC   CVCL_4V99
SY   HEK 293 SF-PacLV; 293SF-PacLV; 293SFPacLV
DR   Wikidata; Q54882488
RX   PubMed=18180776;
CC   Group: Retrovirus packaging cell line.
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; O33453; Pseudomonas putida cymR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V94 ! HEK293SF
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   HEK293T
AC   CVCL_0063
SY   Hek293T; HEK-293T; HEK 293T; HEK-293-T; HEK 293 T; 293-T; 293 T; 293T; Human Embryonic Kidney 293T; 293tsA1609neo
DR   BTO; BTO_0002181
DR   CLO; CLO_0050894
DR   EFO; EFO_0001082
DR   CLDB; cl7154
DR   Abcam; ab255449
DR   Abcam; ab255593
DR   Abcam; ab282205
DR   AddexBio; T0011002/445
DR   ATCC; CRL-3216
DR   BCRJ; 0361
DR   BioGRID_ORCS_Cell_line; 267
DR   BioSample; SAMN01821609
DR   BioSample; SAMN03473454
DR   BioSamples; SAMEA2168958
DR   BioSamples; SAMEA2536418
DR   BioSamples; SAMEA2536419
DR   CCLV; CCLV-RIE 1018
DR   CCRID; 1101HUM-PUMC000091
DR   CCRID; 3101HUMGNHu17
DR   CCRID; 3101HUMSCSP502
DR   CCRID; 4201HUM-CCTCC00187
DR   CCRID; 5301HUM-KCB07044YJ
DR   CCTCC; GDC0187
DR   ChEMBL-Cells; CHEMBL3706569
DR   ChEMBL-Targets; CHEMBL3706568
DR   CLS; 300189
DR   Cosmic; 1326280
DR   Cosmic; 2440479
DR   DSMZ; ACC-635
DR   DSMZCellDive; ACC-635
DR   ECACC; 12022001
DR   ENCODE; ENCBS276VDW
DR   ENCODE; ENCBS319KKV
DR   ENCODE; ENCBS323RYE
DR   ENCODE; ENCBS582KZL
DR   ENCODE; ENCBS634AAA
DR   ENCODE; ENCBS986WKD
DR   FCS-free; 6-2-482-1-4-3
DR   GEO; GSM1008573
DR   GEO; GSM5936927
DR   GEO; GSM5936928
DR   GEO; GSM5936929
DR   IBRC; C10683
DR   ICLC; HTL04001
DR   KCB; KCB 200744YJ
DR   Lonza; 504
DR   MeSH; D057809
DR   NCBI_Iran; C498
DR   NCBI_Iran; C644
DR   PRIDE; PXD000593
DR   PRIDE; PXD001062
DR   PRIDE; PXD001165
DR   PRIDE; PXD001609
DR   PRIDE; PXD004452
DR   PRIDE; PXD006633
DR   PRIDE; PXD006698
DR   PRIDE; PXD012357
DR   PRIDE; PXD013232
DR   PRIDE; PXD016924
DR   PRIDE; PXD018162
DR   PRIDE; PXD018182
DR   PRIDE; PXD019204
DR   PRIDE; PXD028149
DR   PRIDE; PXD029242
DR   PRIDE; PXD029738
DR   PRIDE; PXD030166
DR   PubChem_Cell_line; CVCL_0063
DR   RCB; RCB2202
DR   TOKU-E; 3537
DR   Ubigene; YC-A006
DR   Ubigene; YC-A007
DR   Wikidata; Q27546876
RX   DOI=10.13005/bpj/1414;
RX   PubMed=3031469;
RX   PubMed=15900046;
RX   PubMed=25182477;
RX   PubMed=26694163;
RX   PubMed=28196595;
RX   PubMed=28601559;
RX   PubMed=29468137;
RX   PubMed=34800366;
WW   Info; -; -; http://hek293genome.org/v2/
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-medium-for-crl-3216
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/HEK293T_Crawford_protocol.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-153.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/293T
WW   Provider; BRICS; BRICS0062; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3877
WW   Provider; GenHunter; Q401; https://www.genhunter.com/products/293t-cells.html
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: MD Anderson Cell Lines Project.
CC   Virology: Highly susceptible to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   Doubling time: ~24-30 hours (DSMZ=ACC-635).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Mitochondrion.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: HECK293T; Note=Occasionally.
CC   Misspelling: HEK 239T; Note=Occasionally.
CC   Misspelling: HEK239T; Note=Occasionally.
CC   Misspelling: HEK-393T; Note=Occasionally.
CC   Misspelling: HEK393T; Note=Occasionally.
CC   Misspelling: 239T; Note=Occasionally.
CC   Misspelling: 393T; Note=Occasionally.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3216; CCRID; DSMZ=ACC-635; ECACC=12022001; RCB=RCB2202; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14
ST   D12S391: 19,21
ST   D13S317: 12 (ECACC=12022001)
ST   D13S317: 12,14 (ATCC=CRL-3216; CCRID; DSMZ=ACC-635; RCB=RCB2202; Technion Genomics Center)
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 18
ST   D1S1656: 15,17.3
ST   D21S11: 28,30.2
ST   D22S1045: 16
ST   D2S1338: 19
ST   D2S441: 11,15
ST   D3S1358: 15,16,17 (CCRID)
ST   D3S1358: 15,17 (ATCC=CRL-3216; DSMZ=ACC-635; Technion Genomics Center)
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   HEK293T 3xFLAG-AGO2
AC   CVCL_E8FP
DR   ABM; T6352
RX   PubMed=29777751;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3263; AGO2 (Note=With a N-terminal 3xFLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293T AdipoR2 KO
AC   CVCL_C3G1
DR   GEO; GSE158834
DR   Wikidata; Q114311579
RX   PubMed=33444759;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24041; ADIPOR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   HEK293T ADRM1 K21R/K34R
AC   CVCL_E3BL
CC   Sequence variation: Mutation; HGNC; HGNC:15759; ADRM1; Simple_edited; p.Lys21Arg (c.116A>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:15759; ADRM1; Simple_edited; p.Lys34Arg (c.155A>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T ADRM1 K21R/K34R agDD-GFP
AC   CVCL_E3BM
SY   HEK293T::ADRM1K21RK34R expressing agDD-GFP
CC   Characteristics: Stably expresses agDD-GFP which consists of an aggregating destabilizing domain (AgDD) fused to the N-terminal of Superfolder GFP.
CC   Sequence variation: Mutation; HGNC; HGNC:15759; ADRM1; Simple_edited; p.Lys21Arg (c.116A>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:15759; ADRM1; Simple_edited; p.Lys34Arg (c.155A>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3BL ! HEK293T ADRM1 K21R/K34R
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T AGA KO
AC   CVCL_E2QF
SY   HEK293T-AGA-knockout
RX   PubMed=27983621;
RX   PubMed=34069698;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:318; AGA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T AGA/SLC35A1 DKO
AC   CVCL_E2QH
RX   PubMed=34069698;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:318; AGA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2QF ! HEK293T AGA KO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T ALKBH5/FTO DKO
AC   CVCL_C0U1
SY   HEK293T deltaFTO deltaALKBH5; HEK293T dALKBH5dFTO
DR   GEO; GSM5936930
DR   GEO; GSM5936931
DR   GEO; GSM5936932
DR   Wikidata; Q112929696
RX   PubMed=35516002;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HEK293T ASNS-Flag-H205P
AC   CVCL_E8E1
RX   PubMed=36873094;
CC   Characteristics: Transduced with a ASNS(H205P)-Flag-PuroR-IRES-eGFP construct (PubMed=36873094).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:753; ASNS (Note=With p.His205Pro (c.614A>C) and a C-terminal Flag tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293T ASNS-Flag-Y398Lfs*4
AC   CVCL_E8E2
RX   PubMed=36873094;
CC   Characteristics: Transduced with a ASNS(Y398Lfs*4)-Flag-PuroR-IRES-eGFP construct (PubMed=36873094).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:753; ASNS (Note=With p.Tyr398Leufs*4 (c.1192dupT) and a C-terminal Flag tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293T ATXN3 KO
AC   CVCL_A0SP
DR   Wikidata; Q108820448
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7106; ATXN3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293T Control-PEROXO
AC   CVCL_ZM06
SY   HEK-293T Control-PEROXO
DR   PRIDE; PXD018880
DR   PRIDE; PXD018918
DR   Wikidata; Q98126675
RX   PubMed=32417403;
CC   Characteristics: Expresses Control-PEROXO-Tag, a chimeric protein consisting of three Myc epitopes attached to the N-terminus of mEGFP and a segment of PEX26 fused to the EGFP C-terminus.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:22965; PEX26 (Note=With p.Met1_Val236del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   HEK293T D9
AC   CVCL_D1HM
SY   HEK293T clone D9
DR   Wikidata; Q127381671
RX   PubMed=32775497;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293T D9 T antigen and neo deletion clone #12
AC   CVCL_D1HN
DR   Wikidata; Q127381672
RX   PubMed=32775497;
CC   Characteristics: Using CRISPR/Cas9 the SV40 large and small T-antigen coding sequences were deleted as well as the neo resistance gene (PubMed=32775497).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1HM ! HEK293T D9
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T D9 T antigen and neo deletion clone #4
AC   CVCL_D1HP
DR   Wikidata; Q127381673
RX   PubMed=32775497;
CC   Characteristics: Using CRISPR/Cas9 the SV40 large and small T-antigen coding sequences were deleted as well as the neo resistance gene (PubMed=32775497).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1HM ! HEK293T D9
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T D9 T antigen deletion clone #62
AC   CVCL_D1HQ
DR   Wikidata; Q127381674
RX   PubMed=32775497;
CC   Characteristics: Using CRISPR/Cas9 the SV40 large and small T-antigen coding sequences were deleted (PubMed=32775497).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1HM ! HEK293T D9
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T D9 T antigen deletion clone #109
AC   CVCL_D1HR
DR   Wikidata; Q127381675
RX   PubMed=32775497;
CC   Characteristics: Using CRISPR/Cas9 the SV40 large and small T-antigen coding sequences were deleted (PubMed=32775497).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1HM ! HEK293T D9
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293T D9 T antigen deletion clone #126
AC   CVCL_D1HS
DR   Wikidata; Q127381677
RX   PubMed=32775497;
CC   Characteristics: Using CRISPR/Cas9 the SV40 large and small T-antigen coding sequences were deleted (PubMed=32775497).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1HM ! HEK293T D9
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293T DNAJC5 KO
AC   CVCL_C8UP
SY   HEK293T-DNAJC5-KO
DR   Wikidata; Q123031590
RX   PubMed=36626307;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16235; DNAJC5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HEK293T FBXO7-/-
AC   CVCL_C7U0
DR   Wikidata; Q123031591
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13586; FBXO7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Paoli, Julia C.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   HEK293T G6PD p.Gly131Val
AC   CVCL_WN31
DR   Wikidata; Q94095751
RX   PubMed=31068316;
CC   Sequence variation: Mutation; HGNC; HGNC:4057; G6PD; Simple_edited; p.Gly131Val (c.392G>T); ClinVar=VCV000010404; Zygosity=Unspecified; Note=By CRISPR/Cas9 (PubMed=31068316).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   HEK293T GALE KO clone 4
AC   CVCL_VR11
DR   Kerafast; EMI014
DR   Wikidata; Q94095755
RX   PubMed=28654657;
CC   Characteristics: Devoid of all O-glycosylation. But with the addition of galactose and GalNAc to the culture media, salvage pathways are able to compensate for the lack of GALE enzymatic activity and restore O-linked glycosylation.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4116; GALE.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK293T GALE+GALK1 KO clone 12
AC   CVCL_VR14
DR   Kerafast; EMI017
DR   Wikidata; Q94095762
RX   PubMed=28654657;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4116; GALE.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4118; GALK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR11 ! HEK293T GALE KO clone 4
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK293T GALE+GALK2 KO clone 7
AC   CVCL_VR15
DR   Kerafast; EMI018
DR   Wikidata; Q94095770
RX   PubMed=28654657;
CC   Characteristics: Devoid of all O-glycosylation in all culture condition.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4116; GALE.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4119; GALK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR11 ! HEK293T GALE KO clone 4
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK293T GALK1 KO clone 10
AC   CVCL_VR12
DR   Kerafast; EMI015
DR   Wikidata; Q94095775
RX   PubMed=28654657;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4118; GALK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK293T GALK2 KO clone 7
AC   CVCL_VR13
DR   Kerafast; EMI016
DR   Wikidata; Q94095782
RX   PubMed=28654657;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4119; GALK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HEK293T GAPDH-KD
AC   CVCL_YM16
SY   GAPDH-KD
DR   Kerafast; EKS001
DR   Wikidata; Q94095789
RX   PubMed=28522607;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:4141; GAPDH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   HEK293T HA-PEROXO
AC   CVCL_ZM07
SY   HEK-293T HA-PEROXO
DR   PRIDE; PXD018880
DR   PRIDE; PXD018918
DR   Wikidata; Q98126676
RX   PubMed=32417403;
CC   Characteristics: Expresses PEROXO-Tag, a chimeric protein consisting of three HA epitopes attached to the N-terminus of mEGFP and a segment of PEX26 fused to the EGFP C-terminus. This tag allows for localization to and insertion into the peroxisomal membrane.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:22965; PEX26 (Note=With p.Met1_Val236del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Proteomics; Subcellular; Peroxisome; Quantitative.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   HEK293T HNA-3aa
AC   CVCL_C0UR
DR   Wikidata; Q112929697
RX   PubMed=21883263;
CC   Biotechnology: Used in an assay for the detection of alloantibodies against the human neutrophil alloantigen-3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17292; SLC44A2 (Note=With p.Gln154Arg = HNA3a, with a C-terminal V5 tag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HEK293T HNA-3bb
AC   CVCL_C0US
DR   Wikidata; Q112929698
RX   PubMed=21883263;
CC   Biotechnology: Used in an assay for the detection of alloantibodies against the human neutrophil alloantigen-3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17292; SLC44A2 (Note=With p.Gln154Gln = HNA3b, with a C-terminal V5 tag).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HEK293T METTL18 KO
AC   CVCL_F1XD
SY   METTL18 KO HEK293T
RX   PubMed=35674491;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28793; METTL18.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293T METTL18 KO METTL18-HA
AC   CVCL_F1XG
SY   METTL18 KO HEK293T with stable METTL18 expression
RX   PubMed=35674491;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28793; METTL18.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:28793; METTL18 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1XD ! HEK293T METTL18 KO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293T PIEZO1 KO
AC   CVCL_D4Z8
SY   HEK-P1KO; Piezo1 knock-out HEK293T
DR   ATCC; CRL-3519
DR   Wikidata; Q127381678
RX   PubMed=26387913;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28993; PIEZO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3519
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293T PRKN KO
AC   CVCL_B0N8
DR   Wikidata; Q108820449
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293T SARS-CoV-2 Spike
AC   CVCL_A8DB
SY   SARS-CoV-2 Spike Glycoprotein HEK293T
DR   ABM; T6793
DR   Wikidata; Q107115305
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ABM; T6793; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293T SETD3 KO
AC   CVCL_F1XE
SY   SETD3 KO HEK293T
RX   PubMed=35674491;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20493; SETD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293T SETD3-METTL18 DKO
AC   CVCL_F1XF
SY   SETD3-METTL18 DKO HEK293T
RX   PubMed=35674491;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28793; METTL18.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20493; SETD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1XE ! HEK293T SETD3 KO
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HEK293T SLC35A1 KO
AC   CVCL_E2QG
SY   HEK293T-SLC35A1-KO
DR   DSMZ; ACC-988
RX   PubMed=34069698;
CC   Doubling time: ~24 hours (DSMZ=ACC-988).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-988
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,12,13
ST   D18S51: 16,17,18
ST   D19S433: 16,17,18
ST   D21S11: 28,29,30
ST   D2S1338: 18,19
ST   D3S1358: 16,17
ST   D5S818: 8,9
ST   D7S820: 10,11,12
ST   D8S1179: 11,12,13,14
ST   FGA: 21,22,23
ST   Penta D: 9,10
ST   Penta E: 7,15,16
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T SNCA-A53T-mRuby3 SNCA-A53T-mClover3
AC   CVCL_D4BV
SY   HEK alpha-synuclein (SNCA) FRET reporter
DR   Wikidata; Q127381679
CC   Characteristics: Transfected with two plasmids encoding mRuby3- and mClover3-tagged SNCA p.Ala53Thr expressed under the control of CMV promoters (Direct_author_submission).
CC   Genetic integration: Method=Transfection; Gene=FPbase; RYFE4; mClover3 (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=FPbase; MZMFB; mRuby3 (Note=Bright red fluorescent protein derived from eqFP611).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293T shPARG
AC   CVCL_QZ51
SY   shPARG HEK293T
DR   Wikidata; Q54882489
RX   PubMed=23955771;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   HEK293T SIRT1 KO
AC   CVCL_ZC45
DR   Kerafast; ENH131-FP
DR   Wikidata; Q98126677
CC   From: Li, Xiao-Ling; National Institute of Environmental Health Sciences, NIH; Bethesda; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   HEK293T SLC25A11 KO
AC   CVCL_A4PB
DR   Wikidata; Q105507611
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10981; SLC25A11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   HEK293T SMARCB1-/-
AC   CVCL_QW54
SY   SMARCB1-/- HEK293T; BAF47-knockout HEK293T
DR   Wikidata; Q54882490
RX   PubMed=28945250;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11103; SMARCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   HEK293T SOD2 KO
AC   CVCL_C0CZ
SY   SOD2-/- HEK293T; SOD2-null HEK293T; SOD2
DR   CancerTools; 153875
DR   Wikidata; Q112929699
DR   Ximbio; 153875
RX   PubMed=26208779;
RX   PubMed=33585836;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11180; SOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HEK293T SYT1 KO
AC   CVCL_A8JQ
DR   Wikidata; Q108820450
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11509; SYT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   HEK293T Tet-off FLTau
AC   CVCL_C1CR
SY   Tet-FLTau
DR   Wikidata; Q114311580
RX   PubMed=36732333;
CC   Characteristics: Expresses Tau/MAPT under the control of a Tet-regulated promoter (PubMed=36732333).
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6893; MAPT (Note=With p.Pro301Leu and p.Val337Met).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 10
//
ID   HEK293T Tet-off TauRD
AC   CVCL_C1CS
SY   Tet-TauRD
DR   Wikidata; Q114311581
RX   PubMed=36732333;
CC   Characteristics: Expresses the repeat domain of Tau/MAPT with a C-terminal Myc-Tag under the control of a Tet-regulated promoter (PubMed=36732333).
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6893; MAPT (Note=Repeat domain with p.Pro301Leu and p.Val337Met).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 10
//
ID   HEK293T TetOff-SNCA-A53T
AC   CVCL_D4BW
SY   Syn10
DR   Wikidata; Q127381680
CC   Characteristics: Transduced with an all-in-one TetOff construct for the controllable expression of untagged SNCA p.Ala53Thr (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293T TetOff-SNCA-A53T EGFP-RNF152-IRES-mScarlet-I
AC   CVCL_D4BY
SY   Syn10 RNF152 reporter
DR   Wikidata; Q127381681
CC   Characteristics: Transduced with an all-in-one TetOff construct for the controllable expression of untagged SNCA p.Ala53Thr (from parent cell line).
CC   Characteristics: Additional expression of a plasmid encoding a bicistronic IRES construct of EGFP-tagged RNF152, along with an mScarlet-I transfection marker (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 6VVTK; mScarlet-I (Note=Red fluorescent protein).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:26811; RNF152.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D4BW ! HEK293T TetOff-SNCA-A53T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293T TetOff-SNCA-A53T EGFP-RNF152-IRES-mScarlet-I TMEM192-3xHA
AC   CVCL_E4JW
SY   Syn10 RNF152 reporter with lyso-tag
CC   Characteristics: Transduced with an all-in-one TetOff construct for the controllable expression of untagged SNCA p.Ala53Thr (from parent cell line).
CC   Characteristics: Additional expression of a plasmid encoding a bicistronic IRES construct of EGFP-tagged RNF152, along with an mScarlet-I transfection marker (from parent cell line).
CC   Characteristics: Additional transduction with a construct encoding for the LysoTag, the lysosomal protein TMEM192 tagged with 3xHA (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 6VVTK; mScarlet-I (Note=Red fluorescent protein).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:26811; RNF152.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:26775; TMEM192 (Note=With a 3xHA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D4BY ! HEK293T TetOff-SNCA-A53T EGFP-RNF152-IRES-mScarlet-I
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T TetOff-SNCA-A53T mNeonGreen-3K-1-10-IRES-mKate2
AC   CVCL_D4BZ
SY   Syn10 split mNeonGreen
DR   Wikidata; Q127381682
CC   Characteristics: Transduced with an all-in-one TetOff construct for the controllable expression of untagged SNCA p.Ala53Thr (from parent cell line).
CC   Characteristics: Additional expression of a plasmid encoding a bicistronic IRES construct of a split mNeonGreen (3K variant, B-strands 1-10) as well as an mKate2 marker (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRKRV; mNeonGreen (Note=Derivative of Branchiostoma lanceolatum LanYFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D4BW ! HEK293T TetOff-SNCA-A53T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293T TetOff-SNCA-A53T mRuby3-Galectin-3 mClover3-Galectin-3
AC   CVCL_D4BX
SY   Syn10 Galectin-3 FRET
DR   Wikidata; Q127381683
CC   Characteristics: Transduced with an all-in-one TetOff construct for the controllable expression of untagged SNCA p.Ala53Thr (from parent cell line).
CC   Characteristics: Additional expression of two plasmids encoding mRuby3- and mClover3-tagged LGALS3, enabling a FRET-based readout of endolysosome damage (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=FPbase; RYFE4; mClover3 (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; MZMFB; mRuby3 (Note=Bright red fluorescent protein derived from eqFP611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6563; LGALS3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Yuste-Checa, Patricia.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D4BW ! HEK293T TetOff-SNCA-A53T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HEK293T TetOff-SNCA-A53T TauRD (P301L/V337M)-EYFP
AC   CVCL_F0F7
SY   Syn10 TauRD-YFP
CC   Characteristics: Transduced with an all-in-one Tet-Off construct for the controllable expression of untagged SNCA p.Ala53Thr (from parent cell line).
CC   Characteristics: Transfected with a plasmid encoding a EYFP-tagged Tau repeat domain, bearing FTD mutations (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0C2P0; Aspergillus terreus blasticidin-S deaminase (Bsd).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; EYFP (Note=Enhanced YFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6893; MAPT (Note=With p.Pro301Leu and p.Val337Met).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Sitron, Cole S.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D4BW ! HEK293T TetOff-SNCA-A53T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   HEK293T UBE3C-/-
AC   CVCL_E3BJ
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16803; UBE3C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T UBE3C-/- agDD-GFP
AC   CVCL_E3BK
SY   HEK293T::UBE3C-/- expressing agDD-GFP
CC   Characteristics: Stably expresses agDD-GFP which consists of an aggregating destabilizing domain (AgDD) fused to the N-terminal of Superfolder GFP.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16803; UBE3C.
CC   Genetic integration: Method=Transduction; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3BJ ! HEK293T UBE3C-/-
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HEK293T-CAF40-null
AC   CVCL_A5EE
SY   CAF40-null HEK293T
DR   DSMZ; ACC-872
DR   DSMZCellDive; ACC-872
DR   Wikidata; Q107115306
RX   PubMed=29255063;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-872).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10445; CNOT9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-872
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 17,18,19
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 11,12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK293T-CRISPRa
AC   CVCL_C9DX
DR   BioGRID_ORCS_Cell_line; 1656
DR   Wikidata; Q123031592
RX   PubMed=34431042;
CC   Characteristics: Transduced with lentiviral vectors dCAS-VP64_Blast (EF1a-dCas9-VP64-Bsd-WPE) and MS2-P65-HSF1-Hygro (EF1a-MS2(N55K)-SV40(NLS)-RELA-HSF1-hygR-WPRE) (PubMed=34431042).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03612; Escherichia phage MS2 capsid protein (Note=With p.Asn56Lys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HEK293T-DDX6-null
AC   CVCL_A5EF
SY   HEK293T Ddx6-null
DR   DSMZ; ACC-873
DR   DSMZCellDive; ACC-873
DR   Wikidata; Q107115307
RX   PubMed=31570513;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-873).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2747; DDX6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12,14
ST   D16S539: 9,15
ST   D18S51: 17,18
ST   D19S433: 18,19
ST   D21S11: 28,30.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16,17
ST   D5S818: 8,9
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 16,19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK293T-FVII
AC   CVCL_E3FM
SY   FVII-HEK293T
RX   PubMed=31381603;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3544; F7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293T-GIGYF1/2-null
AC   CVCL_A5EG
SY   GIGYF1/2-null HEK293T
DR   DSMZ; ACC-874
DR   DSMZCellDive; ACC-874
DR   Wikidata; Q107115308
RX   PubMed=28698298;
RX   PubMed=31439631;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-874).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9126; GIGYF1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11960; GIGYF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-874
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 18
ST   D19S433: 17,18,19
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 15,16,17
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10,11
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK293T-HELZ-null
AC   CVCL_A5EH
SY   HEK293T Helz-null
DR   DSMZ; ACC-875
DR   DSMZCellDive; ACC-875
DR   Wikidata; Q107115309
RX   PubMed=31570513;
CC   Doubling time: ~24-30 hours (DSMZ=ACC-875).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16878; HELZ.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-875
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D13S317: 11,12,13,14
ST   D16S539: 9,13
ST   D18S51: 16,17,18
ST   D19S433: 17,18
ST   D21S11: 27,28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,16,17,18
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 11,12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HEK293T-XRN1-null
AC   CVCL_A5EI
SY   HEK293T XRN1-null
DR   DSMZ; ACC-876
DR   DSMZCellDive; ACC-876
DR   Wikidata; Q107115310
RX   PubMed=31340047;
CC   Doubling time: ~24-30 hours (DSMZ=ACC-876).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30654; XRN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): DSMZ=ACC-876
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 16,18,19
ST   D21S11: 28,30
ST   D2S1338: 19,20
ST   D3S1358: 14,15,16,17
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 11,12,13
ST   FGA: 22,23,24
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HEK293T(DMT1)
AC   CVCL_HA71
SY   DMT1 Expressing HEK293T Cell Line
DR   ABM; T6000
DR   Kerafast; EF4002
DR   Wikidata; Q54882492
RX   PubMed=16984886;
CC   Characteristics: Useful to screen for potential iron transport inhibitors (Kerafast=EF4002).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1345279; Slc11a2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   HEK293T/17
AC   CVCL_1926
SY   HEK-293T/17; HEK 293T/17; 293T/17
DR   BTO; BTO_0006328
DR   CLO; CLO_0001235
DR   ATCC; CRL-11268
DR   BioSample; SAMN03471332
DR   CCRID; 1101HUM-PUMC000212
DR   CCRID; 3101HUMGNHu44
DR   CLS; 305117
DR   TOKU-E; 245
DR   Wikidata; Q28178058
RX   Patent=WO1994019478A1;
RX   PubMed=7690960;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-11268
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11268.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Misspelling: 293/17; Note=Occasionally.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-11268; CCRID
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12 (CCRID)
ST   D13S317: 12,14 (ATCC=CRL-11268)
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 17,18 (CCRID)
ST   D19S433: 18 (ATCC=CRL-11268)
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,16,17
ST   D5S818: 8,9
ST   D7S820: 11 (ATCC=CRL-11268)
ST   D7S820: 12 (CCRID)
ST   D8S1179: 11,12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18,19 (ATCC=CRL-11268)
ST   vWA: 16,19 (CCRID)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   HEK293T/17 SF
AC   CVCL_4V93
SY   HEK 293T/17 SF; 293T/17 SF
DR   ATCC; ACS-4500
DR   Wikidata; Q54882491
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=ACS-4500
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   HEK293T/ACE2
AC   CVCL_C9BE
SY   HEK293T-hACE2
DR   BioGRID_ORCS_Cell_line; 1668
DR   GeneCopoeia; SL221
DR   Wikidata; Q123031593
RX   PubMed=35086559;
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Expresses ACE2 under the control of the CMV promoter (GeneCopoeia=SL221).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HEK293T/ACE2-TMPRSS2
AC   CVCL_C9BF
DR   GeneCopoeia; SL222
DR   Wikidata; Q123031594
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Expresses ACE2 and TMPRSS2 under the control of CMV promoters and mCherry under the control of a SV40 promoter (GeneCopoeia=SL222).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HEK293T/Cas9 AAVS1
AC   CVCL_C9BG
DR   GeneCopoeia; SL502
DR   Wikidata; Q123031595
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-PuroR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL502).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HEK293T/Spike
AC   CVCL_E5J0
DR   GenScript; M00804
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HEK293T_HTT null
AC   CVCL_D7EP
RX   PubMed=33432339;
RX   PubMed=39257448;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HEK293TN
AC   CVCL_UL49
SY   293TN
DR   Wikidata; Q94095876
WW   Provider; SBI; LV900A-1; https://www.systembio.com/products/lentivirus-production/virus-packaging/293tn-producer-cell-line/
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   HEK293TN ARID2 KO 11
AC   CVCL_E3VY
SY   HEK ARID2 KO11; HEK293TN knockout for ARID2 clone 11; HEK293TN knockout for ARID2 clone A11
DR   CancerTools; 161879
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN ARID2 KO 12
AC   CVCL_E3VZ
SY   HEK ARID2 KO12; HEK293TN knockout for ARID2 clone 12; HEK293TN knockout for ARID2 clone A12
DR   CancerTools; 161880
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN ARID2 KO 21
AC   CVCL_E3W0
SY   HEK ARID2 KO21; HEK293TN knockout for ARID2 clone 21; HEK293TN knockout for ARID2 clone A21
DR   CancerTools; 161881
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN ARID2 KO 4
AC   CVCL_E3W1
SY   HEK ARID2 KO4; HEK293TN knockout for ARID2 clone 4; HEK293TN knockout for ARID2 clone A4
DR   CancerTools; 161875
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN ARID2 KO 6
AC   CVCL_E3W2
SY   HEK ARID2 KO6; HEK293TN knockout for ARID2 clone 6; HEK293TN knockout for ARID2 clone A6
DR   CancerTools; 161876
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN ARID2 KO 8
AC   CVCL_E3W3
SY   HEK ARID2 KO8; HEK293TN knockout for ARID2 clone 8; HEK293TN knockout for ARID2 clone A8
DR   CancerTools; 161877
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN ARID2 KO 9
AC   CVCL_E3W4
SY   HEK ARID2 KO9; HEK293TN knockout for ARID2 clone 9; HEK293TN knockout for ARID2 clone A9
DR   CancerTools; 161878
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN PBRM1 KO 1
AC   CVCL_E3W5
SY   HEK PBRM1 KO1; HEK293TN knockout for PBRM1 clone 1; HEK293TN knockout for PBRM1 clone B10
DR   CancerTools; 161872
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN PBRM1 KO 2
AC   CVCL_E3W6
SY   HEK PBRM1 KO2; HEK293TN knockout for PBRM1 clone 2; HEK293TN knockout for PBRM1 clone B17
DR   CancerTools; 161873
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK293TN PBRM1 KO 3
AC   CVCL_E3W7
SY   HEK PBRM1 KO3; HEK293TN knockout for PBRM1 clone 3; HEK293TN knockout for PBRM1 clone B10
DR   CancerTools; 161874
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL49 ! HEK293TN
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HEK2Express
AC   CVCL_F0B4
WW   Provider; ExcellGene; -; https://excellgene.com/technologies/hek293
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Clonally derived from the parent cell line. SV40 T-antigen-free. Highly efficient in AAV-production (> 10e15 vg/L) (ExcellGene).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8CE ! HEKExpress
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEKExpress
AC   CVCL_C8CE
DR   Wikidata; Q123031596
RX   PubMed=30591923;
RX   PubMed=37232541;
WW   Provider; ExcellGene; -; https://excellgene.com/technologies/hek293
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Grows in suspension growth conditions in animal component-free media.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Caution: This cell line is incorrectly described as being derived from HEK293 (instead of HEK293T) in PubMed=30591923.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   HEKR1
AC   CVCL_HB83
DR   Kerafast; EUR031
DR   Wikidata; Q54882495
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   HEKR2
AC   CVCL_HB84
DR   Kerafast; EUR032
DR   Wikidata; Q54882496
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   HEKR2R1
AC   CVCL_HB85
DR   Kerafast; EUR035
DR   Wikidata; Q54882497
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   HEKR2R3
AC   CVCL_HB86
DR   Kerafast; EUR034
DR   Wikidata; Q54882498
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   HEKR3
AC   CVCL_HB87
DR   Kerafast; EUR033
DR   Wikidata; Q54882499
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   HEKR3R1
AC   CVCL_HB88
DR   Kerafast; EUR036
DR   Wikidata; Q54882500
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   HEKTrp3-65
AC   CVCL_F0KJ
SY   T3-65; HEK293 hTrp3
RX   PubMed=9417057;
RX   PubMed=9498810;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12335; TRPC3 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEKTrp3-9
AC   CVCL_F0KI
SY   T3-9; HEK293 hTrp3
RX   PubMed=9417057;
RX   PubMed=9498810;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12335; TRPC3 (Note=With a C-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HEKzeroT
AC   CVCL_C8CF
SY   clone #8
DR   Wikidata; Q123031597
RX   PubMed=37232541;
WW   Provider; ExcellGene; -; https://excellgene.com/company/posts/a-superior-hek-cell-line-for-aav-production
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Using CRISPR/Cas9 the SV40 large and small T-antigen coding sequences were deleted thus rendering the cell line CMC compliant (PubMed=37232541).
CC   Characteristics: Grows in suspension growth conditions in animal component-free media.
CC   Doubling time: ~20 hours (PubMed=37232541).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8CE ! HEKExpress
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   HEL
AC   CVCL_0001
SY   Hel; GM06141; GM06141B; Human ErythroLeukemia
DR   BTO; BTO_0000565
DR   CLO; CLO_0003679
DR   CLO; CLO_0023565
DR   EFO; EFO_0006579
DR   MCCL; MCC:0000187
DR   CLDB; cl0
DR   CLDB; cl1585
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 210
DR   BioSample; SAMN03471056
DR   BioSample; SAMN03472269
DR   BioSample; SAMN10987697
DR   cancercelllines; CVCL_0001
DR   CCRID; 3101HUMTCHu71
DR   CCRID; 4201HUM-CCTCC00071
DR   CCTCC; GDC0071
DR   Cell_Model_Passport; SIDM00594
DR   ChEMBL-Cells; CHEMBL3308090
DR   ChEMBL-Targets; CHEMBL613888
DR   CLS; 305022
DR   Coriell; GM06141
DR   Cosmic; 787432
DR   Cosmic; 798663
DR   Cosmic; 850392
DR   Cosmic; 907053
DR   Cosmic; 919128
DR   Cosmic; 924040
DR   Cosmic; 947363
DR   Cosmic; 975251
DR   Cosmic; 976722
DR   Cosmic; 994176
DR   Cosmic; 996314
DR   Cosmic; 1012051
DR   Cosmic; 1013868
DR   Cosmic; 1037665
DR   Cosmic; 1070698
DR   Cosmic; 1078733
DR   Cosmic; 1122162
DR   Cosmic; 1127268
DR   Cosmic; 1139508
DR   Cosmic; 1139638
DR   Cosmic; 1140092
DR   Cosmic; 1151879
DR   Cosmic; 1168467
DR   Cosmic; 1170892
DR   Cosmic; 1171333
DR   Cosmic; 1176583
DR   Cosmic; 1191710
DR   Cosmic; 1192825
DR   Cosmic; 1601067
DR   Cosmic; 1604866
DR   Cosmic; 1633512
DR   Cosmic; 1943609
DR   Cosmic; 2089667
DR   Cosmic; 2131538
DR   Cosmic; 2306207
DR   Cosmic; 2649243
DR   Cosmic-CLP; 907053
DR   DepMap; ACH-000004
DR   DSMZ; ACC-11
DR   DSMZCellDive; ACC-11
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 907053
DR   GEO; GSM482506
DR   GEO; GSM743410
DR   GEO; GSM887077
DR   GEO; GSM888147
DR   GEO; GSM1028243
DR   GEO; GSM1446763
DR   GEO; GSM1669874
DR   GEO; GSM7701373
DR   GEO; GSM7701374
DR   IARC_TP53; 21368
DR   JCRB; JCRB0062
DR   KCB; KCB 200808YJ
DR   LiGeA; CCLE_453
DR   LINCS_LDP; LCL-1053
DR   PharmacoDB; HEL_534_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0001
DR   PubChem_Cell_line; CVCL_0001
DR   Ubigene; YC-C090
DR   Wikidata; Q54882501
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6177045;
RX   PubMed=7538619;
RX   PubMed=8558913;
RX   PubMed=9290701;
RX   PubMed=9510473;
RX   PubMed=9738977;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=16408098;
RX   PubMed=16957166;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27277069;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-346.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HEL_cell_line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (PubMed=6177045); 17.8 +- 1.8 hours (Note=In serum-containing medium), 23.3 +- 0.8 hours (Note=In serum-free medium) (PubMed=7538619); ~36 hours (DSMZ=ACC-11).
CC   HLA typing: A*03:01,32:01; B*35:08,35:08; C*04:01,04:01; DQA1*05:01,05:01; DRB1*03:38,13:03 (PubMed=26589293).
CC   HLA typing: A*03:01:01,32:01:01; B*35:08:01,35:01:01; C*04:01:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,02:01:02 (DSMZCellDive=ACC-11).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=16408098).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (Cosmic-CLP=907053; DepMap=ACH-000004).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.4%; Native American=1.79%; East Asian, North=3.9%; East Asian, South=0%; South Asian=5.12%; European, North=13.33%; European, South=73.45% (PubMed=30894373).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): CCRID; Cosmic-CLP=907053; COG; DSMZ=ACC-11; JCRB=JCRB0062; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X (CCRID; Cosmic-CLP=907053; JCRB=JCRB0062)
ST   Amelogenin: X,Y (COG; DSMZ=ACC-11; PubMed=25877200; Technion Genomics Center)
ST   CSF1PO: 10 (Cosmic-CLP=907053; COG; DSMZ=ACC-11; JCRB=JCRB0062; PubMed=25877200; Technion Genomics Center)
ST   CSF1PO: 10,11 (CCRID)
ST   D10S1248: 13
ST   D12S391: 18,21
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 12,16 (CCRID; DSMZ=ACC-11; PubMed=25877200; Technion Genomics Center)
ST   D18S51: 16 (COG)
ST   D19S433: 11,13
ST   D1S1656: 17.3
ST   D21S11: 29,30.2 (DSMZ=ACC-11; PubMed=25877200; Technion Genomics Center)
ST   D21S11: 29,30.2,31.2 (CCRID; COG)
ST   D22S1045: 15,16
ST   D2S1338: 18,19
ST   D2S441: 10,15
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 7
ST   D8S1179: 13,15
ST   DYS391: 10
ST   FGA: 21,22,23 (CCRID)
ST   FGA: 22,23 (COG; DSMZ=ACC-11; PubMed=25877200; Technion Genomics Center)
ST   Penta D: 11,13
ST   Penta E: 13,18
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   HEL 12469
AC   CVCL_2479
SY   HEL-12469; HEL12469; Human Embryonic Lung 12469
DR   CLO; CLO_0003680
DR   CLDB; cl1593
DR   ECACC; 94101201
DR   Wikidata; Q54882502
RX   PubMed=22239852;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HEL 241
AC   CVCL_XX41
DR   Wikidata; Q94096016
RX   PubMed=5668122;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   HEL 274
AC   CVCL_XX42
DR   Wikidata; Q94096020
RX   PubMed=5668122;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   HEL 286
AC   CVCL_XX43
DR   Wikidata; Q94096025
RX   PubMed=5668122;
CC   Population: African American.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   HEL 299
AC   CVCL_2480
SY   HEL-299; Hel-299; Hel 299; HEL299
DR   CLO; CLO_0003681
DR   CLDB; cl1586
DR   CLDB; cl1587
DR   CLDB; cl1589
DR   CLDB; cl1590
DR   AddexBio; T0016051/5020
DR   ATCC; CCL-137
DR   BCRC; 60117
DR   BioSample; SAMN03471455
DR   CCRID; 5301HUM-KCB15024YJ
DR   ChEMBL-Cells; CHEMBL3308663
DR   ChEMBL-Targets; CHEMBL614819
DR   CLS; 300193
DR   ECACC; 87042207
DR   IPD-IMGT/HLA; 10725
DR   IZSLER; BS CL 49
DR   KCB; KCB 2015024YJ
DR   KCLB; 10137
DR   PubChem_Cell_line; CVCL_2480
DR   Wikidata; Q54882503
RX   PubMed=375235;
RX   PubMed=6254071;
RX   PubMed=6988327;
RX   PubMed=7065527;
CC   Population: African American.
CC   HLA typing: A*30:01; B*15:03,42:01; C*02:10 (IPD-IMGT/HLA=10725).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): AddexBio=T0016051/5020; ATCC=CCL-137; CLS=300193; ECACC=87042207; KCLB=10137
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,17
ST   D19S433: 12,13
ST   D21S11: 28,31.2
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta D: 2.2,9
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
ID   HEL 92.1.7
AC   CVCL_2481
SY   HEL92.1.7; HEL-92.1.7; HEL-92-1-7; HEL-92_1_7; HEL-92; HEL9217
DR   BTO; BTO_0003320
DR   CLO; CLO_0003682
DR   CLO; CLO_0003683
DR   EFO; EFO_0002193
DR   CLDB; cl5067
DR   CLDB; cl7132
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; TIB-180
DR   BCRC; 60370
DR   BCRJ; 0308
DR   BioSample; SAMN10987842
DR   cancercelllines; CVCL_2481
DR   Cell_Model_Passport; SIDM00593
DR   ChEMBL-Cells; CHEMBL4295457
DR   ChEMBL-Targets; CHEMBL4296425
DR   CLS; 300462
DR   Cosmic; 683543
DR   Cosmic; 976723
DR   DepMap; ACH-000005
DR   ECACC; 92111706
DR   GEO; GSM887076
DR   GEO; GSM888146
DR   GEO; GSM1374526
DR   GEO; GSM1374527
DR   IARC_TP53; 21369
DR   ICLC; HTL03002
DR   IGRhCellID; HEL9217
DR   LiGeA; CCLE_672
DR   LINCS_LDP; LCL-1076
DR   Lonza; 1042
DR   PharmacoDB; HEL92_1_7_535_2019
DR   Progenetix; CVCL_2481
DR   PubChem_Cell_line; CVCL_2481
DR   Wikidata; Q54882504
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Caucasian.
CC   HLA typing: A*03,w32; B*w35 (CLS=300462).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (DepMap=ACH-000005).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=2.04%; East Asian, North=1.78%; East Asian, South=0.21%; South Asian=6.68%; European, North=17.09%; European, South=72.21% (PubMed=30894373).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Discontinued: CLS; 300462; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): ATCC=TIB-180; CLS=300462; ECACC=92111706
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 11,13
ST   D21S11: 29,30.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 7
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 11,13
ST   Penta E: 13,18
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0001 ! HEL
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   HEL 92.1.7 SOD2 KO clone 13
AC   CVCL_C0D1
SY   HEL SOD2-/- clone 13; SOD2-/- HEL clone 13; SOD2-/- cl.13
DR   cancercelllines; CVCL_C0D1
DR   Wikidata; Q112929700
RX   PubMed=33585836;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11180; SOD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2481 ! HEL 92.1.7
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   HEL 92.1.7 SOD2 KO clone 5
AC   CVCL_C0D0
SY   HEL SOD2-/- clone 5; SOD2-/- HEL clone 5; SOD2-/- cl.5
DR   cancercelllines; CVCL_C0D0
DR   Wikidata; Q112929701
RX   PubMed=33585836;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11180; SOD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2481 ! HEL 92.1.7
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   HEL-1
AC   CVCL_WZ57
SY   Human Embryo Lung-1
DR   CCRID; 5301HUM-KCB86023YJ
DR   KCB; KCB 86023YJ
DR   Wikidata; Q94096064
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
//
ID   HEL-2
AC   CVCL_WZ58
SY   Human Embryo Lung-2
DR   CCRID; 5301HUM-KCB86021YJ
DR   KCB; KCB 86021YJ
DR   Wikidata; Q94096067
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
//
ID   HEL-30
AC   CVCL_6D72
SY   Hel-30; HEL/30; HEL30; HEL; c3H-Epidermal cell Line-30
DR   Wikidata; Q54882505
RX   PubMed=383562;
RX   PubMed=1711471;
RX   PubMed=2414007;
RX   PubMed=3144940;
RX   PubMed=3597519;
RX   PubMed=6190961;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HEL-37
AC   CVCL_6D73
SY   Hel-37; HEL/37; c3H-Epidermal cell Line-37
DR   Wikidata; Q54882506
RX   PubMed=1711471;
RX   PubMed=2414007;
RX   PubMed=3597519;
RX   PubMed=6190961;
CC   Characteristics: Adapted to growth at 37 Celsius.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D72 ! HEL-30
SX   Female
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HEL-7a
AC   CVCL_C8FD
DR   Wikidata; Q123031598
RX   PubMed=6887978;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8FE ! HEL-7b
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   HEL-7b
AC   CVCL_C8FE
DR   Wikidata; Q123031599
RX   PubMed=6887978;
CC   Senescence: Senesces at 78 PDL (PubMed=6887978).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8FD ! HEL-7a
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   HEL-N1
AC   CVCL_A5ZL
DR   cancercelllines; CVCL_A5ZL
DR   Wikidata; Q107115311
RX   PubMed=7538619;
CC   Population: Caucasian.
CC   Characteristics: Subline that does not expresses KIT (PubMed=7538619).
CC   Doubling time: 19.0 +- 0.8 hours (Note=In serum-containing medium), 24.0 +- 1.1 hours (Note=In serum-free medium) (PubMed=7538619).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0001 ! HEL
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   HEL-P1
AC   CVCL_A5ZM
DR   cancercelllines; CVCL_A5ZM
DR   Wikidata; Q107115312
RX   PubMed=7538619;
CC   Population: Caucasian.
CC   Characteristics: Subline that highly expresses KIT and GYPA (PubMed=7538619).
CC   Doubling time: 18.9 +- 1.4 hours (Note=In serum-containing medium), 23.6 +- 0.9 hours (Note=In serum-free medium) (PubMed=7538619).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0001 ! HEL
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   HEL-R66
AC   CVCL_1R39
SY   HELR66
DR   BioSample; SAMN03152012
DR   Wikidata; Q54882507
RX   PubMed=116626;
RX   PubMed=218901;
RX   PubMed=6451928;
RX   PubMed=7236009;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Originally thought to be an embryonic lung cell line of human origin but found to be from Chlorocebus aethiops (PubMed=6451928; PubMed=7236009; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00065.
CC   Virology: Highly susceptible to infection by herpes simplex virus types 1 and 2, vaccinia virus, Newcastle disease virus (NDV), Japanese encephalitis virus (JEV), western equine encephalitis virus, Sindbis virus, vesicular stomatitis virus (VSV) and rabies virus (PubMed=116626; PubMed=218901).
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   HEL/TGR
AC   CVCL_4Z61
DR   cancercelllines; CVCL_4Z61
DR   Wikidata; Q54882508
RX   PubMed=21976548;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90304; TG101209 (N-(tert-butyl)-3-((5-methyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2481 ! HEL 92.1.7
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   HEL100.1
AC   CVCL_VT43
DR   Wikidata; Q94096114
RX   PubMed=27411166;
RX   PubMed=29339535;
RX   PubMed=30503263;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>200]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27411166).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT44 ! HEL100.2
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   HEL100.2
AC   CVCL_VT44
DR   Wikidata; Q94096118
RX   PubMed=27411166;
RX   PubMed=29339535;
RX   PubMed=30503263;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>200]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27411166).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT43 ! HEL100.1
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   HEL115.6
AC   CVCL_UL36
SY   Hel115.6; Hel 115.6; ULBi002-A
DR   BioSamples; SAMEA5945662
DR   hPSCreg; ULBi002-A
DR   Wikidata; Q94096123
RX   PubMed=30247717;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31FW
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HEL122.2
AC   CVCL_UL38
SY   TRMT10A-deficient iPSC
DR   Wikidata; Q94096124
RX   PubMed=30247717;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HEL23.3
AC   CVCL_VT42
DR   Wikidata; Q94096129
RX   PubMed=27411166;
RX   PubMed=29339535;
RX   PubMed=30503263;
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   HEL46.11
AC   CVCL_UL37
SY   ULBi003-A
DR   BioSamples; SAMEA5573418
DR   hPSCreg; ULBi003-A
DR   Wikidata; Q94096136
RX   PubMed=27411166;
RX   PubMed=28402852;
RX   PubMed=29339535;
RX   PubMed=30247717;
RX   PubMed=30503263;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   HEL6-1
AC   CVCL_C8D8
DR   Wikidata; Q123031600
RX   PubMed=1697410;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8D9 ! HEL6-5
OI   CVCL_C8DA ! HEL8-1
OI   CVCL_C8DB ! HEL8-3
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 4
//
ID   HEL6-5
AC   CVCL_C8D9
DR   Wikidata; Q123031602
RX   PubMed=1697410;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8D8 ! HEL6-1
OI   CVCL_C8DA ! HEL8-1
OI   CVCL_C8DB ! HEL8-3
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 4
//
ID   HEL69.5
AC   CVCL_VT45
DR   Wikidata; Q94096141
RX   PubMed=27411166;
RX   PubMed=29339535;
RX   PubMed=30503263;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>200]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27411166).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   HEL70.3
AC   CVCL_VT46
DR   Wikidata; Q94096144
RX   PubMed=27411166;
RX   PubMed=29339535;
RX   PubMed=30503263;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>200]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27411166).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   HEL72.1
AC   CVCL_UL33
DR   Wikidata; Q94096150
RX   PubMed=28402852;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Lys392Arg (c.1175A>G); ClinVar=VCV000144030; Zygosity=Heterozygous (PubMed=28402852).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2985; Diabetes mellitus
DI   NCIt; C157123; Infantile-onset multisystem autoimmune disease 1
DI   ORDO; Orphanet_438159; STAT3-related early-onset multisystem autoimmune disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL34 ! HEL72A
OI   CVCL_UL35 ! HEL72D
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   HEL72A
AC   CVCL_UL34
DR   Wikidata; Q94096154
RX   PubMed=28402852;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Lys392Arg (c.1175A>G); ClinVar=VCV000144030; Zygosity=Heterozygous (PubMed=28402852).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2985; Diabetes mellitus
DI   NCIt; C157123; Infantile-onset multisystem autoimmune disease 1
DI   ORDO; Orphanet_438159; STAT3-related early-onset multisystem autoimmune disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL33 ! HEL72.1
OI   CVCL_UL35 ! HEL72D
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   HEL72D
AC   CVCL_UL35
DR   Wikidata; Q94096158
RX   PubMed=28402852;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Lys392Arg (c.1175A>G); ClinVar=VCV000144030; Zygosity=Heterozygous (PubMed=28402852).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2985; Diabetes mellitus
DI   NCIt; C157123; Infantile-onset multisystem autoimmune disease 1
DI   ORDO; Orphanet_438159; STAT3-related early-onset multisystem autoimmune disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL33 ! HEL72.1
OI   CVCL_UL34 ! HEL72A
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   HEL8-1
AC   CVCL_C8DA
DR   Wikidata; Q123031603
RX   PubMed=1697410;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8D8 ! HEL6-1
OI   CVCL_C8D9 ! HEL6-5
OI   CVCL_C8DB ! HEL8-3
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 4
//
ID   HEL8-3
AC   CVCL_C8DB
DR   Wikidata; Q123031605
RX   PubMed=1697410;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8D8 ! HEL6-1
OI   CVCL_C8D9 ! HEL6-5
OI   CVCL_C8DA ! HEL8-1
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 4
//
ID   HeLa
AC   CVCL_0030
SY   HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri
DR   BTO; BTO_0000567
DR   CLO; CLO_0003684
DR   CLO; CLO_0050910
DR   EFO; EFO_0001185
DR   MCCL; MCC:0000219
DR   CLDB; cl1594
DR   CLDB; cl1595
DR   CLDB; cl1596
DR   CLDB; cl1597
DR   CLDB; cl1599
DR   CLDB; cl1600
DR   CLDB; cl1601
DR   CLDB; cl1603
DR   Abcam; ab255448
DR   Abcam; ab255928
DR   Abcam; ab260075
DR   Abcam; ab271142
DR   Abcam; ab275466
DR   AddexBio; C0008001/44
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-2
DR   ATCC; CRL-7923
DR   ATCC; CRM-CCL-2
DR   BCRC; 60005
DR   BCRJ; 0100
DR   BEI_Resources; ARP-153
DR   BioGRID_ORCS_Cell_line; 95
DR   BioSample; SAMN03471148
DR   BioSample; SAMN03472333
DR   BioSample; SAMN10989629
DR   cancercelllines; CVCL_0030
DR   CCLV; CCLV-RIE 0082
DR   CCRID; 1101HUM-PUMC000011
DR   CCRID; 1101HUM-PUMC000332
DR   CCRID; 1102HUM-NIFDC00057
DR   CCRID; 3101HUMSCSP504
DR   CCRID; 3101HUMTCHu187
DR   CCRID; 4201HUM-CCTCC00009
DR   CCRID; 5301HUM-KCB90024YJ
DR   CCTCC; GDC0009
DR   Cell_Model_Passport; SIDM00846
DR   ChEMBL-Cells; CHEMBL3308376
DR   ChEMBL-Targets; CHEMBL399
DR   CLS; 300194
DR   Cosmic; 760219
DR   Cosmic; 760490
DR   Cosmic; 801357
DR   Cosmic; 809231
DR   Cosmic; 877477
DR   Cosmic; 911999
DR   Cosmic; 925354
DR   Cosmic; 928907
DR   Cosmic; 944113
DR   Cosmic; 1019309
DR   Cosmic; 1057766
DR   Cosmic; 1071911
DR   Cosmic; 1131525
DR   Cosmic; 1193029
DR   Cosmic; 1201779
DR   Cosmic; 1324208
DR   Cosmic; 1336880
DR   Cosmic; 1571796
DR   Cosmic; 2301539
DR   Cosmic; 2660190
DR   Cosmic; 2750874
DR   Cosmic; 2791019
DR   Cosmic; 2816214
DR   Cosmic-CLP; 1298134
DR   dbGAP; phs000640.v4.p1
DR   DepMap; ACH-001086
DR   DSMZ; ACC-57
DR   DSMZCellDive; ACC-57
DR   ECACC; 93021013
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; phs000640
DR   FCS-free; 44-2-47-1-8-9
DR   GDSC; 1298134
DR   GEO; GSM113863
DR   GEO; GSM226739
DR   GEO; GSM226875
DR   GEO; GSM253298
DR   GEO; GSM436128
DR   GEO; GSM436129
DR   GEO; GSM501788
DR   GEO; GSM722574
DR   GEO; GSM722575
DR   GEO; GSM723055
DR   GEO; GSM723056
DR   GEO; GSM1088663
DR   GEO; GSM1088664
DR   GEO; GSM1088665
DR   GEO; GSM1088666
DR   GEO; GSM1374528
DR   GEO; GSM1669875
DR   GEO; GSM1881473
DR   GEO; GSM1881474
DR   GEO; GSM1881475
DR   GEO; GSM7701367
DR   GEO; GSM7701368
DR   ICLC; HTL95023
DR   IGRhCellID; HeLA
DR   IZSLER; BS TCL 20
DR   JCRB; JCRB9004
DR   KCB; KCB 86019YJ
DR   KCB; KCB 90024YJ
DR   KCLB; 10002
DR   LINCS_HMS; 50061
DR   LINCS_LDP; LCL-1512
DR   Lonza; 51
DR   MeSH; D006367
DR   NCBI_Iran; C115
DR   PharmacoDB; HeLa_536_2019
DR   PRIDE; PRD000007
DR   PRIDE; PRD000032
DR   PRIDE; PRD000123
DR   PRIDE; PRD000124
DR   PRIDE; PRD000345
DR   PRIDE; PRD000376
DR   PRIDE; PRD000525
DR   PRIDE; PRD000526
DR   PRIDE; PRD000527
DR   PRIDE; PXD000013
DR   PRIDE; PXD000243
DR   PRIDE; PXD000252
DR   PRIDE; PXD000279
DR   PRIDE; PXD000396
DR   PRIDE; PXD000474
DR   PRIDE; PXD000589
DR   PRIDE; PXD000661
DR   PRIDE; PXD000680
DR   PRIDE; PXD000759
DR   PRIDE; PXD000883
DR   PRIDE; PXD000895
DR   PRIDE; PXD000900
DR   PRIDE; PXD000953
DR   PRIDE; PXD000954
DR   PRIDE; PXD000999
DR   PRIDE; PXD001047
DR   PRIDE; PXD001118
DR   PRIDE; PXD001154
DR   PRIDE; PXD001175
DR   PRIDE; PXD001249
DR   PRIDE; PXD001258
DR   PRIDE; PXD001259
DR   PRIDE; PXD001278
DR   PRIDE; PXD001305
DR   PRIDE; PXD001374
DR   PRIDE; PXD001381
DR   PRIDE; PXD001396
DR   PRIDE; PXD001441
DR   PRIDE; PXD001541
DR   PRIDE; PXD001548
DR   PRIDE; PXD001574
DR   PRIDE; PXD001660
DR   PRIDE; PXD001781
DR   PRIDE; PXD001798
DR   PRIDE; PXD001805
DR   PRIDE; PXD001806
DR   PRIDE; PXD001810
DR   PRIDE; PXD001863
DR   PRIDE; PXD001907
DR   PRIDE; PXD002001
DR   PRIDE; PXD002039
DR   PRIDE; PXD002066
DR   PRIDE; PXD002252
DR   PRIDE; PXD002277
DR   PRIDE; PXD002378
DR   PRIDE; PXD002383
DR   PRIDE; PXD002395
DR   PRIDE; PXD002572
DR   PRIDE; PXD002591
DR   PRIDE; PXD002704
DR   PRIDE; PXD002844
DR   PRIDE; PXD002880
DR   PRIDE; PXD003186
DR   PRIDE; PXD003209
DR   PRIDE; PXD003258
DR   PRIDE; PXD003370
DR   PRIDE; PXD003503
DR   PRIDE; PXD003530
DR   PRIDE; PXD003560
DR   PRIDE; PXD003792
DR   PRIDE; PXD003813
DR   PRIDE; PXD003909
DR   PRIDE; PXD003913
DR   PRIDE; PXD003917
DR   PRIDE; PXD003924
DR   PRIDE; PXD004182
DR   PRIDE; PXD004271
DR   PRIDE; PXD004273
DR   PRIDE; PXD004452
DR   PRIDE; PXD004613
DR   PRIDE; PXD004736
DR   PRIDE; PXD004900
DR   PRIDE; PXD004914
DR   PRIDE; PXD004933
DR   PRIDE; PXD004934
DR   PRIDE; PXD004940
DR   PRIDE; PXD004995
DR   PRIDE; PXD005018
DR   PRIDE; PXD005107
DR   PRIDE; PXD005181
DR   PRIDE; PXD005346
DR   PRIDE; PXD005349
DR   PRIDE; PXD005366
DR   PRIDE; PXD005466
DR   PRIDE; PXD005509
DR   PRIDE; PXD005572
DR   PRIDE; PXD005712
DR   PRIDE; PXD005955
DR   PRIDE; PXD006112
DR   PRIDE; PXD006293
DR   PRIDE; PXD012045
DR   PRIDE; PXD012188
DR   PRIDE; PXD013064
DR   PRIDE; PXD023271
DR   PRIDE; PXD023835
DR   PRIDE; PXD027504
DR   PRIDE; PXD029773
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0030
DR   PubChem_Cell_line; CVCL_0030
DR   RCB; RCB0007
DR   RCB; RCB3680
DR   SKY/M-FISH/CGH; 5351
DR   TKG; TKG 0331
DR   TOKU-E; 1434
DR   Ubigene; YC-A012
DR   Wikidata; Q847482
RX   CelloPub=CLPUB00047;
RX   CelloPub=CLPUB00262;
RX   CelloPub=CLPUB00376;
RX   CelloPub=CLPUB00377;
RX   CelloPub=CLPUB00468;
RX   CelloPub=CLPUB00507;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=77569;
RX   PubMed=1246620;
RX   PubMed=1522048;
RX   PubMed=2983228;
RX   PubMed=2990217;
RX   PubMed=3028716;
RX   PubMed=3180844;
RX   PubMed=3371749;
RX   PubMed=3518877;
RX   PubMed=4942173;
RX   PubMed=5668122;
RX   PubMed=6256643;
RX   PubMed=6358339;
RX   PubMed=6401685;
RX   PubMed=6825208;
RX   PubMed=6935474;
RX   PubMed=8380785;
RX   PubMed=9892199;
RX   PubMed=10423141;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=12001993;
RX   PubMed=12661003;
RX   PubMed=12793746;
RX   PubMed=13052828;
RX   PubMed=13207312;
RX   PubMed=13261081;
RX   PubMed=14031339;
RX   PubMed=14185313;
RX   PubMed=15302935;
RX   PubMed=15531914;
RX   PubMed=15901131;
RX   PubMed=16589695;
RX   PubMed=16957166;
RX   PubMed=17311676;
RX   PubMed=19450234;
RX   PubMed=19722756;
RX   PubMed=19941903;
RX   PubMed=21269460;
RX   PubMed=21937730;
RX   PubMed=22068331;
RX   PubMed=22278370;
RX   PubMed=22412903;
RX   PubMed=23205564;
RX   PubMed=23336012;
RX   PubMed=23925224;
RX   PubMed=23925245;
RX   PubMed=24134916;
RX   PubMed=24618588;
RX   PubMed=24696503;
RX   PubMed=24908793;
RX   PubMed=25485619;
RX   PubMed=25807930;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25960936;
RX   PubMed=26554430;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28078501;
RX   PubMed=28196595;
RX   PubMed=28261610;
RX   PubMed=28601559;
RX   PubMed=29156801;
RX   PubMed=30175587;
RX   PubMed=30778230;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31433507;
RX   PubMed=31790455;
RX   PubMed=33389257;
RX   PubMed=35198691;
RX   PubMed=35839778;
RX   PubMed=37543987;
WW   Info; -; -; https://genomesunzipped.org/2013/03/henrietta-lackss-genome-sequence-has-been-publicly-available-for-years.php
WW   Info; -; -; https://lacksfamily.com/
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/hela/helacells.html
WW   Info; -; -; https://web.archive.org/web/20201001194102/https://www.cynthiaverspaget.com/the-anarchy-cell-line
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/cellsincultureindex
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Tebubio; -; https://www.tebubio.com/blog/hela-cells-the-first-cell-line/
WW   Info; The Scientist; -; https://www.the-scientist.com/henrietta-lacks-estate-sues-thermo-fisher-over-hela-69279
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-35.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HeLa
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/hela-xenograft-model/
WW   Provider; CH3 Biosystems; 940003; https://ch3biosystems.com/shop/hela/
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22)(q24;q13).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 1.3 days (PubMed=29156801); ~48 hours (DSMZ=ACC-57).
CC   HLA typing: A*03,28; B*w15,w35; C*w02,w03 (PubMed=77569).
CC   HLA typing: A*03:19,68:02; B*15:03,15:03; C*12:03,12:03; DRB1*01:02,01:02 (PubMed=25960936).
CC   HLA typing: A*68:02,68:02; B*15:03,15:03; C*12:03,12:03; DQA1*01:02,01:02; DQB1*05:01,05:01; DRB1*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; PTM; Myristoylation.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=64.74%; Native American=0.77%; East Asian, North=2.26%; East Asian, South=0%; South Asian=0%; European, North=19.45%; European, South=12.78% (PubMed=30894373).
CC   Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line.
CC   Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377).
CC   Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line.
CC   Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89.
CC   Miscellaneous: HeLa is the most frequent contributor to cell lines contamination.
CC   Discontinued: ATCC; CRL-7923; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): AddexBio=C0008001/44; ATCC=CCL-2; CCRID; CLS=300194; Cosmic-CLP=1298134; DSMZ=ACC-57; ECACC=93021013; JCRB=JCRB9004; KCLB=10002; PubMed=11416159; PubMed=25877200; PubMed=29156801; PubMed=37543987; RCB=RCB0007; Technion Genomics Center; TKG=TKG 0331
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D10S1248: 13,15
ST   D12S391: 20,25
ST   D13S317: 12 (Cosmic-CLP=1298134; RCB=RCB0007)
ST   D13S317: 12,13.3 (AddexBio=C0008001/44; ATCC=CCL-2; CCRID; DSMZ=ACC-57; JCRB=JCRB9004; KCLB=10002; PubMed=25877200; PubMed=29156801; PubMed=37543987; Technion Genomics Center; TKG=TKG 0331)
ST   D13S317: 12,14 (ECACC=93021013)
ST   D13S317: 13,13.3 (CLS=300194)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D1S1656: 12,15
ST   D21S11: 27 (CLS=300194)
ST   D21S11: 27,28 (ATCC=CCL-2; CCRID; DSMZ=ACC-57; PubMed=25877200; PubMed=37543987; Technion Genomics Center)
ST   D22S1045: 16,17
ST   D2S1338: 17
ST   D2S441: 10,11
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8 (CLS=300194)
ST   Penta D: 8,15 (ATCC=CCL-2; CCRID; DSMZ=ACC-57; PubMed=25877200; PubMed=37543987; Technion Genomics Center)
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 51
//
ID   HeLa 229
AC   CVCL_1276
SY   HeLa-229; HeLa229
DR   BTO; BTO_0005030
DR   CLO; CLO_0003685
DR   CLO; CLO_0003698
DR   CLDB; cl1604
DR   CLDB; cl1605
DR   CLDB; cl1606
DR   ATCC; CCL-2.1
DR   BCRC; 60290
DR   CCRID; 1101HUM-PUMC000181
DR   CCRID; 3101HUMTCHu20
DR   CCRID; 4201HUM-CCTCC00335
DR   CCTCC; GDC0335
DR   ChEMBL-Cells; CHEMBL4483175
DR   ChEMBL-Targets; CHEMBL4483246
DR   CLS; 305056
DR   ECACC; 86090201
DR   IZSLER; BS TCL 21
DR   JCRB; JCRB9086
DR   KCLB; 10002.1
DR   PubChem_Cell_line; CVCL_1276
DR   Wikidata; Q54882513
RX   DOI=10.1007/BF02618370;
RX   DOI=10.11418/jtca1981.17.3_101;
RX   PubMed=1522048;
RX   PubMed=2754009;
RX   PubMed=14185313;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-158.html
CC   Population: African American.
CC   Doubling time: 11 hours (Note=Lot 032792), ~26 hours (Note=Lot 03152010) (JCRB=JCRB9086).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-2.1; CCRID; CLS=305056; ECACC=86090201; IZSLER=BS TCL 21; JCRB=JCRB9086; KCLB=10002.1
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3 (ATCC=CCL-2.1; CCRID; CLS=305056; JCRB=JCRB9086; KCLB=10002.1)
ST   D13S317: 12,14 (IZSLER=BS TCL 21)
ST   D13S317: 14 (ECACC=86090201)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   HeLa 292
AC   CVCL_WH96
DR   Wikidata; Q94096191
RX   DOI=10.11418/jtca1981.17.3_101;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HeLa 382
AC   CVCL_3379
DR   CLO; CLO_0003686
DR   CLDB; cl1607
DR   CLDB; cl1608
DR   ICLC; HTL95015
DR   Wikidata; Q54882514
CC   Population: African American.
CC   Characteristics: Control cell line for HeLa 422 (Cellosaurus=CVCL_3380) and HeLa 432 (Cellosaurus=CVCL_3381); transfected with emtpy vector pBact.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HeLa 422
AC   CVCL_3380
DR   CLO; CLO_0003687
DR   CLDB; cl1609
DR   CLDB; cl1610
DR   ICLC; HTL95014
DR   Wikidata; Q54882515
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HeLa 432
AC   CVCL_3381
DR   CLO; CLO_0003688
DR   CLDB; cl1611
DR   CLDB; cl1612
DR   ICLC; HTL95016
DR   Wikidata; Q54882516
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Exon 4 defective).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HeLa AG
AC   CVCL_2933
DR   BioSample; SAMN03471657
DR   JCRB; JCRB0213
DR   Wikidata; Q54882517
RX   PubMed=1522048;
RX   PubMed=9290701;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB0213
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HeLa ANXA11 KO
AC   CVCL_B3SH
DR   Wikidata; Q110432863
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:535; ANXA11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   HeLa B
AC   CVCL_2482
DR   CLO; CLO_0003689
DR   CLDB; cl1624
DR   ECACC; 85060701
DR   Wikidata; Q54882518
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   HeLa B-50
AC   CVCL_W341
SY   B-50; B50
DR   Wikidata; Q54882519
RX   Patent=US7238526;
CC   Group: Adeno-associated virus packaging cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12401.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   HeLa BU-25
AC   CVCL_2320
SY   HeLa (BU-25); HeLa BU25; HeLa Bu25; HeLa/BU-25; HeLa(BU25); HeLa TK- (BU 25); Bu25 TK-; BU25 TK-; Bu25TK-
DR   CLO; CLO_0002050
DR   CLO; CLO_0050929
DR   CLDB; cl506
DR   cancercelllines; CVCL_2320
DR   Cosmic; 753537
DR   ECACC; 85022104
DR   GEO; GSM827315
DR   Progenetix; CVCL_2320
DR   RCB; RCB0205
DR   Wikidata; Q54882520
RX   PubMed=4639815;
RX   PubMed=5902315;
RX   PubMed=20215515;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=85022104; RCB=RCB0205
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 14
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HeLa C12
AC   CVCL_W342
SY   C12
DR   Wikidata; Q54882521
RX   PubMed=8590738;
RX   PubMed=8986439;
CC   Group: Adeno-associated virus packaging cell line.
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HeLa CD4+ Clone1022
AC   CVCL_U339
SY   HeLa CD4+Clone1022; Clone 1022
DR   CLO; CLO_0050933
DR   BEI_Resources; ARP-1109
DR   BioSample; SAMN03471970
DR   RCB; RCB2355
DR   Wikidata; Q54882525
RX   PubMed=1984477;
CC   Population: African American.
CC   Doubling time: ~38 hours (BEI_Resources=ARP-1109).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB2355
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   HeLa CD4-Clone 6C
AC   CVCL_X634
SY   HT4-6C; HeLa clone 6C
DR   BEI_Resources; ARP-459
DR   Wikidata; Q54882524
RX   PubMed=2293663;
RX   PubMed=3047430;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 14
//
ID   HeLa DH
AC   CVCL_2483
DR   CLO; CLO_0003690
DR   ECACC; 96112022
DR   Wikidata; Q54882526
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   HeLa E
AC   CVCL_ZF12
SY   HeLa-E; HeLa Essen
DR   Wikidata; Q98126678
RX   PubMed=4817575;
RX   PubMed=8397027;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   HeLa EGFP-654
AC   CVCL_VS42
DR   Wikidata; Q94096364
RX   PubMed=11574678;
RX   PubMed=11748845;
WW   Provider; UNC OTC; 16-0176; https://unc.flintbox.com/technologies/2512ea18-bd35-4199-8769-0c6bd96cbcdc
CC   Population: African American.
CC   Characteristics: Transfected with a construct containing a mutated human beta-globin intron, HBB IVS2-654, at nucleotide 105 of EGFP cDNA thus preventing its correct translation. Treatment of the cells expressing the construct with active antisense oligonucleotide should restore proper splicing and translation of EGFP, providing a rapid and sensitive positive readout for antisense activity in the nuclei of the treated cells (PubMed=11574678; PubMed=11748845).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   HeLa EV2
AC   CVCL_JA21
DR   GEO; GSM740966
DR   GEO; GSM740967
DR   GEO; GSM740968
DR   Wikidata; Q54882527
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa fat-1
AC   CVCL_E6Z9
SY   f-HeLa
DR   ABM; T6260
RX   DOI=10.1136/esmoopen-2018-EACR25.164;
CC   Population: African American.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6260).
CC   Doubling time: 20-30 hours (ABM=T6260).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa FLAG-SNAP-hTERT
AC   CVCL_ZM01
SY   FLAG-SNAP-hTERT expressing HeLa
DR   Millipore; SCC112
DR   Wikidata; Q98126680
RX   PubMed=26553065;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 a FLAG-SNAP-tag was fused to the N-terminus of TERT. The SNAP-tag may be used to visualize subcellular localization of the low abundant endogenous TERT protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): Millipore=SCC112
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   HeLa FLOT1 KO clone 2
AC   CVCL_E2QD
SY   HeLa FLOT1 knockout clone 2
RX   PubMed=27983621;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3757; FLOT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa FLOT1 KO clone 7
AC   CVCL_E2QE
SY   HeLa FLOT1 knockout clone 7
RX   PubMed=27983621;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3757; FLOT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa Flp-In T-REx
AC   CVCL_C4ET
DR   Wikidata; Q116049304
RX   PubMed=25284222;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HeLa Flp-In T-REx PINK1 KO clone 3C9
AC   CVCL_D5JI
SY   Flp-In T-Rex HeLa PINK1 CRISPR/Cas9 knock-out
DR   Wikidata; Q127381684
RX   PubMed=35042401;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4ET ! HeLa Flp-In T-REx
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa FUS KO
AC   CVCL_A8VH
DR   Wikidata; Q108820451
RX   PubMed=37384305;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa GFP-LC3-RFP-LC3deltaG
AC   CVCL_UP51
SY   GFP-LC3-RFP-LC3deltaG HeLa
DR   RCB; RCB4695
DR   Wikidata; Q94096465
RX   PubMed=27818143;
CC   Population: African American.
CC   Characteristics: Stably expresses EGFP-LC3-mRFP-LC3delta, an autophagic flux probe. GFP-LC3 is fused to the N-terminus of RFP-LC3 whose C-terminal glycine is deleted. When expressed, the probe it is separated into EGFP-LC3 and mRFP-LC3deltaG by the action of endogenous ATG4 family proteases that cleave the peptide bond after the C-terminal glycine of LC3 in the cytosol producing equimolar amounts of EGFP-LC3 and mRFP-LC3deltaG.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 735183; Map1lc3a.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   HeLa GFP-PEAK3
AC   CVCL_C0QV
DR   Wikidata; Q112929702
RX   PubMed=34944965;
CC   Population: African American.
CC   Characteristics: Transfected with a pBABE-GFP-PEAK3 construct that contains a GFP-PEAK3 fusion.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24793; PEAK3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HeLa GGA1-/-
AC   CVCL_F1B6
RX   PubMed=33206455;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17842; GGA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa GGA123-/-
AC   CVCL_F1BA
RX   PubMed=33206455;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17842; GGA1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16064; GGA2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17079; GGA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1B9 ! HeLa GGA23-/-
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa GGA2-/-
AC   CVCL_F1B7
RX   PubMed=33206455;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16064; GGA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa GGA23-/-
AC   CVCL_F1B9
RX   PubMed=33206455;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16064; GGA2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17079; GGA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1B7 ! HeLa GGA2-/-
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa GGA3-/-
AC   CVCL_F1B8
RX   PubMed=33206455;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17079; GGA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa GRASP55 KO
AC   CVCL_E3WP
DR   CancerTools; 157706
RX   PubMed=28814501;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17500; GORASP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   HeLa GRASP55/GRASP65 DKO
AC   CVCL_E3WQ
DR   CancerTools; 157708
RX   PubMed=28814501;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16769; GORASP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17500; GORASP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3WR ! HeLa GRASP65 KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   HeLa GRASP65 KO
AC   CVCL_E3WR
DR   CancerTools; 157707
RX   PubMed=28814501;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16769; GORASP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   HeLa H2B-2FP
AC   CVCL_F0QF
DR   ECACC; 21102108
RX   PubMed=30918123;
CC   Population: African American.
CC   Characteristics: Transduced with both a pWZL-H2B-eGFP-HygR construct and a pLXSN H2B-mCherry construct (PubMed=30918123).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa H2B-GFP [Australia 2019]
AC   CVCL_F0J5
DR   ECACC; 21102107
RX   PubMed=30918123;
CC   Population: African American.
CC   Characteristics: Transduced with a pWZL-H2B-eGFP-HygR construct (PubMed=30918123).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa H2B-GFP [USA 1997]
AC   CVCL_ZM02
SY   HeLa Histone H2B-GFP; Histone H2B-GFP expressing HeLa
DR   Millipore; SCC117
DR   Wikidata; Q98126681
RX   PubMed=9545195;
CC   Population: African American.
CC   Characteristics: The H2B-EGFP fusion protein is expressed under the control of the EF1a promoter (PubMed=9545195).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): Millipore=SCC117
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   HeLa HaloTag-LC3
AC   CVCL_C8QC
DR   Wikidata; Q123031606
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7IT ! HeLa S3 ATG3 KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-C264A-mCherry
AC   CVCL_C8QE
DR   Wikidata; Q123031607
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.Cys264Ala.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.Cys264Ala and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-H262A-mCherry
AC   CVCL_C8QI
DR   Wikidata; Q123031608
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.His262Ala.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.His262Ala and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-H266A-mCherry
AC   CVCL_C8QK
DR   Wikidata; Q123031609
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.His266Ala.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.His266Ala and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-K208D-mCherry
AC   CVCL_C8QL
DR   Wikidata; Q123031611
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.Lys208Asp.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.Lys208Asp and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-K62D/K64D-mCherry
AC   CVCL_C8QM
DR   Wikidata; Q123031612
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.Lys62Asp and p.Lys64Asp.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.Lys62Asp, p.Lys64Asp and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-mCherry
AC   CVCL_C8QD
DR   Wikidata; Q123031613
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-R265A-mCherry
AC   CVCL_C8QJ
DR   Wikidata; Q123031614
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.Arg265Ala.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.Arg265Ala and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-T244A-mCherry
AC   CVCL_C8QH
DR   Wikidata; Q123031615
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.Thr244Ala.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.Thr244Ala and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-Y209A-mCherry
AC   CVCL_C8QF
DR   Wikidata; Q123031616
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.Tyr209Ala.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.Tyr209Ala and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa HaloTag-LC3/ATG3-Y210A-mCherry
AC   CVCL_C8QG
DR   Wikidata; Q123031617
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux. Also expresses an internally mCherry-tagged ATG3 with p.Tyr210Ala.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20962; ATG3 (Note=With p.Tyr210Ala and a mCherry reporter inserted between Glu-125 and Ile-126).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: While described in the preprint DOI=10.1101/2023.07.17.549391, this cell line is no longer used as it has been found not be effective (personal communication of Ren, Xue-Feng).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8QC ! HeLa HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   HeLa hCD4
AC   CVCL_F0JN
RX   PubMed=8459222;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa HFT/TO-PRKN
AC   CVCL_C4EQ
SY   HeLa Flp-In T-REx/PARKIN
DR   Wikidata; Q116049306
RX   PubMed=25284222;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With 3xFLAG and HA tags).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4ET ! HeLa Flp-In T-REx
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   HeLa HFT/TO-PRKN FBXO7-/-
AC   CVCL_C4ER
DR   Wikidata; Q116049307
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13586; FBXO7.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With 3xFLAG and HA tags).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Paoli, Julia C.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EQ ! HeLa HFT/TO-PRKN
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   HeLa HFT/TO-PRKN PINK1-/-
AC   CVCL_C4ES
DR   Wikidata; Q116049308
RX   PubMed=25284222;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:14581; PINK1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With 3xFLAG and HA tags).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4EQ ! HeLa HFT/TO-PRKN
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   HeLa His10-SUMO-2 K0-Q87R
AC   CVCL_RJ62
SY   HeLa His10-SUMO-2 K0
DR   PRIDE; PXD001061
DR   PRIDE; PXD004927
DR   PRIDE; PXD005296
DR   Wikidata; Q54882528
RX   PubMed=25218447;
RX   PubMed=28112733;
CC   Population: African American.
CC   Characteristics: Transfected with a decahistidine (His10) tagged lysine-deficient (K0) and Q87R SUMO2 and GFP separated by an internal ribosome entry site (IRES).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11125; SUMO2 (Note=With p.Lys11Arg, p.Lys32Arg, p.Lys32Arg, p.Lys34Arg, p.Lys41Arg, p.Lys44Arg and p.Gln87Arg).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; PTM; Sumoylation.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   HeLa HIV-1 LTR-FFL
AC   CVCL_C7TZ
SY   HeLa HIV-1 LTR
DR   Wikidata; Q117704482
RX   PubMed=20562857;
CC   Population: African American.
CC   Characteristics: Transfected with a firefly luciferase reporter gene under the control of the HIV-1 LTR promoter (PubMed=20562857).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   HeLa HNRNPD-/- cl10
AC   CVCL_C0RH
DR   Wikidata; Q112929703
RX   PubMed=30799487;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5036; HNRNPD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   HeLa HNRNPD-/- cl4
AC   CVCL_C0RI
DR   Wikidata; Q112929704
RX   PubMed=30799487;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5036; HNRNPD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   HeLa ICRP
AC   CVCL_9T98
DR   CLO; CLO_0009926
DR   LINCS_HMS; 51102
DR   LINCS_LDP; LCL-2096
DR   Wikidata; Q54882529
RX   PubMed=25953765;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=Initiator caspase reporter protein (IC-RP). FRET donor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence ('DEVDR') linker.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HeLa ICRP Bcl-2-mCherry
AC   CVCL_9T99
DR   CLO; CLO_0009927
DR   LINCS_HMS; 51105
DR   LINCS_LDP; LCL-2097
DR   Wikidata; Q54882530
RX   PubMed=25953765;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=Initiator caspase reporter protein (IC-RP). FRET donor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence ('DEVDR') linker.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9T98 ! HeLa ICRP
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HeLa ICRP Bcl-xL-mCherry
AC   CVCL_9U00
DR   CLO; CLO_0009928
DR   LINCS_HMS; 51106
DR   LINCS_LDP; LCL-2098
DR   Wikidata; Q54882531
RX   PubMed=25953765;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection/transduction; Gene=Initiator caspase reporter protein (IC-RP). FRET donor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence ('DEVDR') linker.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9T98 ! HeLa ICRP
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HeLa ICRP FLIP-L-mCherry
AC   CVCL_9U01
DR   CLO; CLO_0009929
DR   LINCS_HMS; 51103
DR   LINCS_LDP; LCL-2099
DR   Wikidata; Q54882532
RX   PubMed=25953765;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1876; CFLAR (Note=Isoform FLIP-L).
CC   Genetic integration: Method=Transfection/transduction; Gene=Initiator caspase reporter protein (IC-RP). FRET donor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence ('DEVDR') linker.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9T98 ! HeLa ICRP
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HeLa ICRP FLIP-S-mCherry
AC   CVCL_9U02
DR   CLO; CLO_0009930
DR   LINCS_HMS; 51104
DR   LINCS_LDP; LCL-2100
DR   Wikidata; Q54882533
RX   PubMed=25953765;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1876; CFLAR (Note=Isoform FLIP-S).
CC   Genetic integration: Method=Transfection/transduction; Gene=Initiator caspase reporter protein (IC-RP). FRET donor-acceptor pair (CFP and YFP) connected by a caspase cleavage sequence ('DEVDR') linker.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9T98 ! HeLa ICRP
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HeLa IFITM1/2/3-KO
AC   CVCL_B0A4
SY   IFITM1/2/3 Knockout; C5-9
DR   ATCC; CRL-3452
DR   Wikidata; Q108820452
RX   PubMed=30643282;
CC   Population: African American.
CC   Characteristics: Facilitates the functional analysis of IFITMs and as well as their mechanisms of regulation. Can also be used to identify other innate immunity factors and/or screen for new anti-infective drug candidates (ATCC=CRL-3452).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-3452
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   HeLa IFITM2/3-KO
AC   CVCL_B0A5
SY   IFITM2/3 Knockout; C5-2
DR   Wikidata; Q108820453
RX   PubMed=30643282;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa ITCH KO
AC   CVCL_B7MV
DR   Wikidata; Q112929705
CC   From: Ayoubi, Riham; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13890; ITCH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa JW36
AC   CVCL_W331
SY   HeLa(JW36); HeLa (JW-36); JW 36; JW-36; JW36
DR   Wikidata; Q54882534
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HeLa K11
AC   CVCL_V312
SY   K11
DR   Wikidata; Q54882535
RX   PubMed=4163412;
RX   PubMed=4576519;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HeLa K11A-HG-1
AC   CVCL_V313
SY   K11A-HG-1
DR   Wikidata; Q54882538
RX   PubMed=457258;
RX   PubMed=4576519;
RX   PubMed=5334769;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V312 ! HeLa K11
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HeLa Kyoto
AC   CVCL_1922
SY   HeLa-Kyoto; HeLa (Kyoto); HeLa(Kyoto); HeLa 'Kyoto'; HeLa isolate Kyoto; Hela K
DR   PRIDE; PXD001333
DR   PRIDE; PXD002815
DR   PRIDE; PXD002829
DR   PRIDE; PXD002987
DR   Wikidata; Q54882539
RX   PubMed=26496610;
RX   PubMed=30778230;
CC   From: Narumiya, Shuh; Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Interactome.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HeLa Kyoto EGFP-alpha-tubulin/H2B-mCherry
AC   CVCL_L802
SY   HeLa Kyoto EGFP-a-tubulin/H2B-mCherry; HeLa H2B-mRFP and mEGFP-alpha-tubulin
DR   CLS; 300670
DR   Wikidata; Q54882540
RX   PubMed=19203582;
RX   PubMed=20360735;
RX   PubMed=23550136;
RX   PubMed=23594443;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 24
//
ID   HeLa Kyoto EGFP-Cap-D2
AC   CVCL_1D60
SY   HeLa Kyoto EGFP CAP-D2; HeLa Kyoto Cap-D2 EGFP
DR   CLS; 300675
DR   Wikidata; Q54882541
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24305; NCAPD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   HeLa Kyoto EGFP-EB3
AC   CVCL_1D61
SY   HeLa Kyoto EB3 EGFP; HeLa Kyoto EB3-EGFP
DR   CLS; 300668
DR   Wikidata; Q54882542
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6892; MAPRE3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   HeLa Kyoto EGFP-H2B
AC   CVCL_1D63
SY   HeLa Kyoto H2B-EGFP; HeLa Kyoto H2B EGFP; HeLa-H2B-GFP
DR   CLS; 300673
DR   Wikidata; Q54882543
RX   PubMed=19203582;
RX   PubMed=20360735;
CC   Population: African American.
CC   HLA typing: A*:68:02:01; B*:15:03:01; C*:12:03:01; DPB1*01:01:01; DQA1*01:01:02; DQB1*05:01:01; DRB1*01:02:01 (CLS=300673).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   HeLa Kyoto EGFP-Kleisin-beta
AC   CVCL_1D64
SY   HeLa Kyoto EGFP Kleisin-b; HeLa Kyoto Kleisin-beta EGFP
DR   CLS; 300674
DR   Wikidata; Q54882544
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:25071; NCAPH2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   HeLa Kyoto EGFP-LaminA/H2B-mCherry
AC   CVCL_1D62
SY   HeLa Kyoto EGFP-LaminA and H2B-mCherry
DR   CLS; 300921
DR   Wikidata; Q54882545
RX   PubMed=22986494;
CC   Population: African American.
CC   HLA typing: A*:68:02:01; B*:15:03:01; C*:12:03:01; DPB1*01:01:01; DQA1*01:01:02; DQB1*05:01:01; DRB1*01:02:01 (CLS=300921).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6636; LMNA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   HeLa Kyoto EGFP-LaminB1/H2B-mCherry
AC   CVCL_UR41
SY   HeLa Kyoto EGFP-LaminB1 and H2B-mCherry
DR   CLS; 300919
DR   Wikidata; Q94096855
RX   PubMed=22986494;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6637; LMNB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   HeLa Kyoto Mad2-LAP/H2B-mCherry
AC   CVCL_1D65
SY   HeLa Kyoto Mad2-LAP and H2B-mCherry; HeLa Kyoto Mad2-LAP
DR   CLS; 300920
DR   Wikidata; Q54882546
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1860374; Mad2l1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   HeLa LChm
AC   CVCL_IM62
DR   CLO; CLO_0003691
DR   CLDB; cl1613
DR   Wikidata; Q54882547
RX   PubMed=769341;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   HeLa LT [1992]
AC   CVCL_F0J7
SY   HeLa-LT; HeLa Long Telomere; HeLa-I; HeLa I
RX   PubMed=1537344;
RX   PubMed=11063723;
CC   Population: African American.
CC   Characteristics: Has very long telomeres (PubMed=11063723).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa LT [2014]
AC   CVCL_F0J8
SY   HeLa Long Telomere
RX   PubMed=24413054;
RX   PubMed=38213617;
CC   Population: African American.
CC   Characteristics: Has long telomeres (~20 kb) (PubMed=24413054).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5D9 ! HeLa1.2.11
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa Luc/705
AC   CVCL_E7IX
RX   PubMed=9572837;
WW   Provider; UNC OTC; 16-0176; https://unc.flintbox.com/technologies/2512ea18-bd35-4199-8769-0c6bd96cbcdc
CC   Population: African American.
CC   Characteristics: Transfected with a construct containing a luciferase gene interrupted by a mutated human beta-globin intron 2, HBB IVS2-705. The mutation in the intron causes aberrant splicing of luciferase pre-mRNA, preventing translation of luciferase. However, treatment of the cells with a 2'-O-methyl-oligoribonucleotide targeted to the aberrant splice sites induces correct splicing, restoring luciferase activity (PubMed=9572837).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V352 ! HeLa Tet-Off
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa M
AC   CVCL_R965
SY   HeLa-M; HelaM; M-HeLa
DR   CLO; CLO_0003692
DR   EFO; EFO_0022666
DR   CLDB; cl1614
DR   ChEMBL-Cells; CHEMBL4482991
DR   ChEMBL-Targets; CHEMBL4483254
DR   PubChem_Cell_line; CVCL_R965
DR   RCB; RCB5388
DR   Wikidata; Q54882548
RX   PubMed=21416529;
RX   PubMed=30700496;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HeLa M FAM177A1-KO
AC   CVCL_E1HS
SY   FAM177A1KO HeLaM
RX   PubMed=38187698;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19829; FAM177A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa M FAM117A1/VPS13B-DKO
AC   CVCL_E1HT
SY   HeLa M VPS13B-KO 1 FAM177A1-KO; VPS13BKO1,FAM177A1 DKO HeLaM
RX   PubMed=38187698;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19829; FAM177A1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2183; VPS13B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E1HQ ! HeLa M VPS13B-KO clone 1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa M KIF13A-KO
AC   CVCL_A6ZZ
SY   KIF13A-KO HeLaM
DR   RCB; RCB5093
DR   Wikidata; Q107115314
RX   PubMed=30700496;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14566; KIF13A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa M KIF13B-KO
AC   CVCL_A7AA
SY   KIF13B-KO HeLaM
DR   RCB; RCB5094
DR   Wikidata; Q107115315
RX   PubMed=30700496;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14405; KIF13B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa M KIF13A/B-DKO
AC   CVCL_A7AB
SY   HeLaM KIF13-DKO; KIF13-DKO HeLaM; KIF13A/B-DKO HeLaM
DR   RCB; RCB5095
DR   Wikidata; Q107115316
RX   PubMed=30700496;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14566; KIF13A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14405; KIF13B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa M Rab10-KO
AC   CVCL_A7AI
SY   Rab10-KO HeLaM
DR   RCB; RCB5097
DR   Wikidata; Q107115317
RX   PubMed=30700496;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa M Rab22-DKO
AC   CVCL_A7AJ
SY   Rab22-DKO HeLaM
DR   RCB; RCB5098
DR   Wikidata; Q107115318
RX   PubMed=30700496;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9764; RAB22A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9771; RAB31.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa M RAB7A-KO
AC   CVCL_D7ET
RX   PubMed=39103493;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa M RAB7A-KO + mCherry-RAB7
AC   CVCL_D7EW
RX   PubMed=39103493;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9788; RAB7A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7ET ! HeLa M RAB7A-KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa M RAB7A-KO + mCherry-RAB7-S72A
AC   CVCL_D7EX
RX   PubMed=39103493;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9788; RAB7A (Note=With p.Ser72Ala).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7ET ! HeLa M RAB7A-KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa M Rab8-DKO
AC   CVCL_A6ZY
SY   Rab8-DKO HeLaM
DR   RCB; RCB5096
DR   Wikidata; Q107115319
RX   PubMed=30700496;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30273; RAB8B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa M TBK1-KO
AC   CVCL_D7ES
RX   PubMed=39103493;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa M TBK1-KO + RAB7-KO
AC   CVCL_D7EU
RX   PubMed=39103493;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7ES ! HeLa M TBK1-KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa M TBK1-KO + TBK1-E696K-GFP
AC   CVCL_D7EV
RX   PubMed=39103493;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11584; TBK1 (Note=With p.Glu696Lys).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7ES ! HeLa M TBK1-KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa M TBK1-KO + TBK1-GFP
AC   CVCL_D7EY
RX   PubMed=39103493;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11584; TBK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7ES ! HeLa M TBK1-KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa M VPS13B-KO clone 1
AC   CVCL_E1HQ
SY   HeLa M VPS13B-KO 1; VPS13BKO1 HeLaM
RX   PubMed=38187698;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2183; VPS13B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa M VPS13B-KO clone 2
AC   CVCL_E1HR
SY   HeLa M VPS13B-KO 2; VPS13BKO2 HeLaM
RX   PubMed=38187698;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2183; VPS13B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Hela M VPS13C-KO clone 1
AC   CVCL_E6IQ
SY   VPS13C(KO) HeLa clone 1
RX   PubMed=35657605;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Hela M VPS13C-KO clone 2
AC   CVCL_E6IR
SY   VPS13C(KO) HeLa clone 2
RX   PubMed=35657605;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa mCherry-POM121
AC   CVCL_A9I6
SY   HeLa POM121-mCherry
DR   Wikidata; Q102114110
CC   Population: African American.
CC   Characteristics: Transfected with POM121 N-terminally tagged with mCherry.
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19702; POM121.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Tingey, Mark.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HeLa MR
AC   CVCL_WH97
DR   Wikidata; Q94096929
RX   DOI=10.11418/jtca1981.17.3_101;
RX   PubMed=3986962;
RX   PubMed=7554090;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HeLa NEK1 KO
AC   CVCL_A8DV
DR   Wikidata; Q107115320
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7744; NEK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa NR1
AC   CVCL_1277
SY   HeLaNR1
DR   CLO; CLO_0003693
DR   ATCC; CRL-13011
DR   Wikidata; Q54882549
RX   Patent=US6326196;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12510.
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27967; Barley nitrate reductase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-13011
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HeLa NucLight Green
AC   CVCL_DF41
DR   Wikidata; Q54882550
CC   Population: African American.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4490.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   HeLa NucLight Red
AC   CVCL_DF42
DR   Wikidata; Q54882551
CC   Population: African American.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4489.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   HeLa Ohio
AC   CVCL_2484
SY   Ohio-HeLa; HeLa (OH)
DR   CLO; CLO_0003694
DR   CLDB; cl1615
DR   CCLV; CCLV-RIE 0013
DR   ECACC; 84121901
DR   Wikidata; Q54882552
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-105.html
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   HeLa P110
AC   CVCL_WH95
DR   Wikidata; Q94096993
RX   DOI=10.11418/jtca1981.17.3_101;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HeLa P75
AC   CVCL_UF72
DR   JCRB; NIHS0038
DR   Wikidata; Q94096997
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=1522048;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: JCRB; NIHS0038; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   HeLa PF
AC   CVCL_JA22
SY   HeLa-PF; HeLa Protein-Free
DR   GEO; GSM740969
DR   GEO; GSM740970
DR   GEO; GSM740971
DR   Wikidata; Q54882553
RX   PubMed=8586536;
CC   Group: Serum/protein free medium cell line.
CC   Population: African American.
CC   Doubling time: 28 hours (PubMed=8586536).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   HeLa PINK1-GFP
AC   CVCL_F1H5
RX   DOI=10.1101/2025.10.06.680693;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 an PINK1-eGFP construct was integrated at the N-terminus of the endogenous PINK1 locus thus replacing it by PINK1-eGFP (DOI=10.1101/2025.10.06.680693).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa PRDX6 KO
AC   CVCL_A7AS
DR   Wikidata; Q107115321
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16753; PRDX6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa PurRII7
AC   CVCL_4W41
DR   Wikidata; Q54882554
RX   PubMed=3207599;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_17939; Puromycin.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   HeLa R19
AC   CVCL_M763
SY   HeLa R-19; HeLa (R19)
DR   Wikidata; Q54882555
RX   PubMed=6086949;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HeLa R19 FlpIn TREx
AC   CVCL_UR50
DR   Wikidata; Q94097089
RX   PubMed=26056140;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M763 ! HeLa R19
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   HeLa R19 FlpIn TREx H2B-Cherry/NS3-CMPK-hLBR1TM-mEGFP
AC   CVCL_UR51
SY   NS3-CMPK-hLBR1TM-mEGFP
DR   CLS; 300986
DR   Wikidata; Q94097098
RX   PubMed=26056140;
CC   Population: African American.
CC   Characteristics: Transfected with both H2B-mCherry and a DOX inducible NS3-CMPK-hLBR1TM-mEGFP construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UR50 ! HeLa R19 FlpIn TREx
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   HeLa rCD4
AC   CVCL_F0JK
RX   PubMed=8459222;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2306; Cd4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa rCD4 m2
AC   CVCL_F0JL
SY   HeLa m2
RX   PubMed=8459222;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2306; Cd4 (Note=With p.Gly36-Thr62 replaced by equivalent region of human CD4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa rCD4 m6
AC   CVCL_F0JM
SY   HeLa m6
RX   PubMed=8459222;
RX   PubMed=8995673;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2306; Cd4 (Note=With p.Gly33-Thr62 replaced by equivalent region of human CD4).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa RelA-mNeonGreen
AC   CVCL_C9AQ
SY   HeLa p65-mNeonGreen; HeLa RelA
DR   BioGRID_ORCS_Cell_line; 1605
DR   Wikidata; Q123031618
RX   PubMed=31626775;
CC   Population: African American.
CC   Characteristics: Expression of Cas9 can be induced by doxocycline (from parent cell line).
CC   Characteristics: Transduced with a pR14_p65-mNeonGreen construct (PubMed=31626775).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRKRV; mNeonGreen (Note=Derivative of Branchiostoma lanceolatum LanYFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9955; RELA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9AP ! HeLa-TetR-Cas9
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HeLa RHO
AC   CVCL_E5FV
SY   HeLa RHO clone #37
RX   PubMed=33508235;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10012; RHO.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa RHO P347S
AC   CVCL_E5FW
SY   HeLa RHO P347S clone #3; P347S RHO HeLa clone
DR   CancerTools; 161124
RX   PubMed=33508235;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10012; RHO (Note=With p.Pro347Ser (c.1039C>T)).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa S3
AC   CVCL_0058
SY   HeLa s3; HeLa-S3; HELA-S3; HeLa/S3; HeLa.S3; HeLa S 3; HeLa S-3; HeLaS3; HeLa, S3 clone; S3-HeLa; S3 HeLa
DR   BTO; BTO_0000568
DR   CLO; CLO_0003695
DR   CLO; CLO_0003696
DR   CLO; CLO_0003699
DR   CLO; CLO_0050921
DR   CLO; CLO_0050936
DR   EFO; EFO_0002791
DR   MCCL; MCC:0000220
DR   CLDB; cl1616
DR   CLDB; cl1617
DR   CLDB; cl1619
DR   CLDB; cl1620
DR   CLDB; cl1621
DR   CLDB; cl1622
DR   4DN; 4DNSRGTEEYSL
DR   ATCC; CCL-2.2
DR   ATCC; CRL-7924
DR   BCRC; 60101
DR   BioSample; SAMN03472408
DR   BioSample; SAMN03472767
DR   CCRID; 1101HUM-PUMC000188
DR   CCRID; 1102HUM-NIFDC00009
DR   CCRID; 4201HUM-CCTCC00193
DR   CCTCC; GDC0193
DR   ChEMBL-Cells; CHEMBL3886002
DR   ChEMBL-Targets; CHEMBL4296436
DR   CLS; 300384
DR   Cosmic; 846181
DR   Cosmic; 1201780
DR   Cosmic; 1324209
DR   dbGAP; phs000665.v9.p1
DR   DSMZ; ACC-161
DR   DSMZCellDive; ACC-161
DR   ECACC; 87110901
DR   ENCODE; ENCBS031GUL
DR   ENCODE; ENCBS061SJE
DR   ENCODE; ENCBS075PNA
DR   ENCODE; ENCBS094KYE
DR   ENCODE; ENCBS113ENC
DR   ENCODE; ENCBS146YHK
DR   ENCODE; ENCBS163VBG
DR   ENCODE; ENCBS199XIN
DR   ENCODE; ENCBS229UDI
DR   ENCODE; ENCBS254ZSR
DR   ENCODE; ENCBS292TEU
DR   ENCODE; ENCBS352IHZ
DR   ENCODE; ENCBS376OKH
DR   ENCODE; ENCBS403WXR
DR   ENCODE; ENCBS417UAY
DR   ENCODE; ENCBS423QWP
DR   ENCODE; ENCBS424JTA
DR   ENCODE; ENCBS432ENC
DR   ENCODE; ENCBS434SUM
DR   ENCODE; ENCBS450RLH
DR   ENCODE; ENCBS468RLW
DR   ENCODE; ENCBS493MKF
DR   ENCODE; ENCBS500SDW
DR   ENCODE; ENCBS529RSF
DR   ENCODE; ENCBS575PET
DR   ENCODE; ENCBS577WSP
DR   ENCODE; ENCBS580FYL
DR   ENCODE; ENCBS585KIN
DR   ENCODE; ENCBS598ZWC
DR   ENCODE; ENCBS635AAA
DR   ENCODE; ENCBS636AAA
DR   ENCODE; ENCBS637AAA
DR   ENCODE; ENCBS646PGB
DR   ENCODE; ENCBS647UNF
DR   ENCODE; ENCBS655ARO
DR   ENCODE; ENCBS656NDW
DR   ENCODE; ENCBS658BKJ
DR   ENCODE; ENCBS681BHB
DR   ENCODE; ENCBS684AAA
DR   ENCODE; ENCBS685AAA
DR   ENCODE; ENCBS686AAA
DR   ENCODE; ENCBS687AAA
DR   ENCODE; ENCBS688AAA
DR   ENCODE; ENCBS689AAA
DR   ENCODE; ENCBS714AAA
DR   ENCODE; ENCBS735AAA
DR   ENCODE; ENCBS736AAA
DR   ENCODE; ENCBS737AAA
DR   ENCODE; ENCBS738AAA
DR   ENCODE; ENCBS739AAA
DR   ENCODE; ENCBS740AAA
DR   ENCODE; ENCBS748HNU
DR   ENCODE; ENCBS804AAA
DR   ENCODE; ENCBS805AAA
DR   ENCODE; ENCBS812AOY
DR   ENCODE; ENCBS822AAA
DR   ENCODE; ENCBS823AAA
DR   ENCODE; ENCBS833ISA
DR   ENCODE; ENCBS834AAA
DR   ENCODE; ENCBS838AAA
DR   ENCODE; ENCBS839AAA
DR   ENCODE; ENCBS854BZN
DR   ENCODE; ENCBS877WSH
DR   ENCODE; ENCBS890POO
DR   ENCODE; ENCBS899VUW
DR   ENCODE; ENCBS979JZP
DR   FANTOM5_SSTAR; 10815-111B5
DR   FANTOM5_SSTAR; 10816-111B6
DR   FANTOM5_SSTAR; 10817-111B7
DR   GEO; GSM472905
DR   GEO; GSM472916
DR   GEO; GSM472932
DR   GEO; GSM733669
DR   GEO; GSM733682
DR   GEO; GSM733684
DR   GEO; GSM733689
DR   GEO; GSM733696
DR   GEO; GSM733711
DR   GEO; GSM733734
DR   GEO; GSM733756
DR   GEO; GSM733785
DR   GEO; GSM736510
DR   GEO; GSM736564
DR   GEO; GSM749721
DR   GEO; GSM749729
DR   GEO; GSM749739
DR   GEO; GSM798322
DR   GEO; GSM803454
DR   GEO; GSM803455
DR   GEO; GSM803478
DR   GEO; GSM803533
DR   GEO; GSM816436
DR   GEO; GSM816633
DR   GEO; GSM816643
DR   GEO; GSM822273
DR   GEO; GSM822285
DR   GEO; GSM822286
DR   GEO; GSM923449
DR   GEO; GSM935272
DR   GEO; GSM935276
DR   GEO; GSM935290
DR   GEO; GSM935302
DR   GEO; GSM935317
DR   GEO; GSM935318
DR   GEO; GSM935320
DR   GEO; GSM935326
DR   GEO; GSM935328
DR   GEO; GSM935341
DR   GEO; GSM935342
DR   GEO; GSM935351
DR   GEO; GSM935362
DR   GEO; GSM935365
DR   GEO; GSM935366
DR   GEO; GSM935367
DR   GEO; GSM935369
DR   GEO; GSM935370
DR   GEO; GSM935383
DR   GEO; GSM935384
DR   GEO; GSM935395
DR   GEO; GSM935405
DR   GEO; GSM935408
DR   GEO; GSM935416
DR   GEO; GSM935432
DR   GEO; GSM935435
DR   GEO; GSM935436
DR   GEO; GSM935459
DR   GEO; GSM935476
DR   GEO; GSM935484
DR   GEO; GSM935486
DR   GEO; GSM935489
DR   GEO; GSM935498
DR   GEO; GSM935500
DR   GEO; GSM935508
DR   GEO; GSM935511
DR   GEO; GSM935552
DR   GEO; GSM935553
DR   GEO; GSM935554
DR   GEO; GSM935555
DR   GEO; GSM935560
DR   GEO; GSM935561
DR   GEO; GSM935570
DR   GEO; GSM935571
DR   GEO; GSM935578
DR   GEO; GSM935582
DR   GEO; GSM935606
DR   GEO; GSM935615
DR   GEO; GSM935625
DR   GEO; GSM935635
DR   GEO; GSM935636
DR   GEO; GSM935637
DR   GEO; GSM935638
DR   GEO; GSM945201
DR   GEO; GSM945208
DR   GEO; GSM945230
DR   GEO; GSM945253
DR   GEO; GSM1003480
DR   GEO; GSM1003483
DR   GEO; GSM1003520
DR   GEO; GSM1003618
DR   GEO; GSM2423737
DR   GEO; GSM2423738
DR   GEO; GSM4224315
DR   GEO; GSM4226257
DR   ICLC; HTL95020
DR   IZSLER; BS TCL 22
DR   JCRB; IFO50011
DR   JCRB; JCRB9010
DR   KCLB; 10002.2
DR   Lonza; 877
DR   NCBI_Iran; C572
DR   PRIDE; PRD000146
DR   PRIDE; PXD000212
DR   PRIDE; PXD000674
DR   PRIDE; PXD000964
DR   PRIDE; PXD001200
DR   PRIDE; PXD001385
DR   PRIDE; PXD001592
DR   PRIDE; PXD002436
DR   PRIDE; PXD002802
DR   PRIDE; PXD003346
DR   PRIDE; PXD003709
DR   PRIDE; PXD004655
DR   PRIDE; PXD006322
DR   PubChem_Cell_line; CVCL_0058
DR   RCB; RCB0191
DR   RCB; RCB1525
DR   RCB; RCB3682
DR   TKG; TKG 0444
DR   TOKU-E; 1437
DR   Wikidata; Q54882556
RX   CelloPub=CLPUB00481;
RX   DOI=10.11418/jtca1981.17.3_101;
RX   PubMed=566722;
RX   PubMed=978597;
RX   PubMed=1180926;
RX   PubMed=1522048;
RX   PubMed=3180844;
RX   PubMed=3756862;
RX   PubMed=3986962;
RX   PubMed=6256643;
RX   PubMed=6825208;
RX   PubMed=9290701;
RX   PubMed=10338214;
RX   PubMed=11416159;
RX   PubMed=13286432;
RX   PubMed=13531635;
RX   PubMed=14518029;
RX   PubMed=16589695;
RX   PubMed=19450234;
RX   PubMed=23325432;
RX   PubMed=23925245;
RX   PubMed=24185095;
RX   PubMed=26550473;
RX   PubMed=30175587;
RX   PubMed=30778230;
RX   PubMed=33205894;
WW   Info; -; -; http://immortalcells.blogspot.ch/2011/12/hela-vs-hela-s3.html
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/HeLa-S3_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-157.html
CC   Part of: ENCODE project common cell types; tier 2.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Virology: Has at least 4 five HPV18 integration sites in the genome (PubMed=26550473).
CC   Doubling time: ~48 hours (DSMZ=ACC-161).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Anecdotal: The 'S' series of HeLa clones was named after Dr. Florence Sabin.
CC   Discontinued: ATCC; CRL-7924; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-2.2; CCRID; CLS=300384; DSMZ=ACC-161; ECACC=87110901; JCRB=IFO50011; JCRB=JCRB9010; KCLB=10002.2; PubMed=11416159; PubMed=14518029; RCB=RCB0191; TKG=TKG 0444
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12 (RCB=RCB0191)
ST   D13S317: 12,13.3 (DSMZ=ACC-161; JCRB=IFO50011)
ST   D13S317: 13.3 (ATCC=CCL-2.2; CCRID; CLS=300384; JCRB=JCRB9010; KCLB=10002.2; TKG=TKG 0444)
ST   D13S317: 14 (ECACC=87110901; PubMed=14518029)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11 (JCRB=IFO50011)
ST   D5S818: 11,12 (ATCC=CCL-2.2; CCRID; CLS=300384; DSMZ=ACC-161; ECACC=87110901; JCRB=JCRB9010; KCLB=10002.2; PubMed=14518029; RCB=RCB0191; TKG=TKG 0444)
ST   D7S820: 8 (JCRB=JCRB9010)
ST   D7S820: 8,12 (ATCC=CCL-2.2; CCRID; CLS=300384; DSMZ=ACC-161; ECACC=87110901; JCRB=IFO50011; KCLB=10002.2; PubMed=14518029; RCB=RCB0191; TKG=TKG 0444)
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,17,18 (JCRB=JCRB9010)
ST   vWA: 16,18 (ATCC=CCL-2.2; CCRID; CLS=300384; DSMZ=ACC-161; ECACC=87110901; KCLB=10002.2; PubMed=11416159; PubMed=14518029; RCB=RCB0191; TKG=TKG 0444)
ST   vWA: 17,18 (JCRB=IFO50011)
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   HeLa S3 (sc)
AC   CVCL_2934
SY   HeLa S3 (SC)
DR   CLO; CLO_0050911
DR   BioSample; SAMN03472352
DR   JCRB; JCRB0713
DR   RCB; RCB0271
DR   Wikidata; Q54882557
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB0713; RCB=RCB0271
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12 (RCB=RCB0271)
ST   D13S317: 12,13.3 (JCRB=JCRB0713)
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HeLa S3 9IV
AC   CVCL_ZM48
SY   HeLa S3-9IV
DR   Wikidata; Q98126682
RX   PubMed=967189;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   HeLa S3 AGO2KO
AC   CVCL_A0DW
SY   HeLaS3 AGO2KO
DR   GEO; GSM4224316
DR   Wikidata; Q108820454
RX   PubMed=30591524;
RX   PubMed=33205894;
CC   Population: African American.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3263; AGO2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   HeLa S3 ATF4 KO
AC   CVCL_C8ST
DR   Wikidata; Q123031619
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Uoselis, Louise.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa S3 ATF5 KO
AC   CVCL_C8SU
DR   Wikidata; Q123031620
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Uoselis, Louise.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa S3 ATG13 KO
AC   CVCL_F1YY
SY   ATG13-KO HeLa S3
RX   DOI=10.1101/2025.11.07.687251;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa S3 ATG13 KO clone #1
AC   CVCL_E1HE
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa S3 ATG13 KO+HaloTag-LC3
AC   CVCL_F1YZ
RX   DOI=10.1101/2025.11.07.687251;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1YY ! HeLa S3 ATG13 KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa S3 ATG13 KO+Halo-LC3+HA-ATG13-HF:DD
AC   CVCL_F1Z1
RX   DOI=10.1101/2025.11.07.687251;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29091; ATG13 (Note=With p.His214Asp and p.Phe215Asp and a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1YZ ! HeLa S3 ATG13 KO+HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa S3 ATG13 KO+Halo-LC3+HA-ATG13-WT
AC   CVCL_F1Z0
RX   DOI=10.1101/2025.11.07.687251;
CC   Population: African American.
CC   Characteristics: Stably expresses HaloTag-LC3 to measure autophagic flux.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29091; ATG13 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1YZ ! HeLa S3 ATG13 KO+HaloTag-LC3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HeLa S3 ATG2A/ATG2B DKO clone 7
AC   CVCL_F0LF
SY   HeLa ATG2A/ATG2B DKO clone 7
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Holzer, Elisabeth.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa S3 ATG3 KO
AC   CVCL_C7IT
DR   Wikidata; Q117704483
RX   DOI=10.1101/2023.07.17.549391;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa S3 ATG9A KO clone 3
AC   CVCL_F0LG
SY   HeLa ATG9A KO clone 3
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Lazarou, Michael through Holzer, Elisabeth.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa S3 AZI2 KO clone 32
AC   CVCL_D2YA
SY   HeLa S3 NAP1 KO clone #32
DR   Wikidata; Q127381685
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 AZI2 KO clone 62
AC   CVCL_D2YB
SY   HeLa S3 NAP1 KO clone #62
DR   Wikidata; Q127381686
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 AZI2/TBKBP1 DKO clone 13
AC   CVCL_C9DV
SY   HeLa S3 NAP1/SINTBAD DKO clone 13
DR   Wikidata; Q123031621
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 AZI2/TBKBP1 DKO clone 14
AC   CVCL_D2Q0
SY   HeLa S3 NAP1/SINTBAD DKO clone 14
DR   Wikidata; Q127381687
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 BNIP3 KO clone #1
AC   CVCL_E6FA
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa S3 BNIP3/BNIP3L DKO clone 10
AC   CVCL_E1HB
SY   HeLa S3 NIX/BNIP3 DKO clone 10
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1084; BNIP3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1085; BNIP3L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Adriaenssens, Elias.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa S3 BNIP3/BNIP3L DKO clone 6
AC   CVCL_E1HA
SY   HeLa S3 NIX/BNIP3 DKO clone 6
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1084; BNIP3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1085; BNIP3L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Adriaenssens, Elias.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa S3 BNIP3L KO clone #17
AC   CVCL_E6FB
SY   HeLa S3 NIX KO clone #17
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1084; BNIP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa S3 CHOP KO by CRISPR
AC   CVCL_C8SV
DR   Wikidata; Q123031622
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2726; DDIT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Uoselis, Louise.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa S3 CHOP KO by TALEN
AC   CVCL_C8SW
DR   Wikidata; Q123031623
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2726; DDIT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Uoselis, Louise.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa S3 CHOP/ATF4/ATF5 triple KO
AC   CVCL_C8SX
DR   Wikidata; Q123031624
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2726; DDIT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Uoselis, Louise.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8SW ! HeLa S3 CHOP KO by TALEN
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa S3 DELE1 KO
AC   CVCL_C8SY
DR   Wikidata; Q123031625
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28969; DELE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Uoselis, Louise.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa S3 EGFP-alpha-tubulin/H2B-mCherry
AC   CVCL_HP86
SY   HeLa mCherry-Histone H2B EGFP-Alpha Tubulin
DR   CancerTools; 152987
DR   ECACC; 17100525
DR   Wikidata; Q54882558
DR   Ximbio; 152987
RX   PubMed=21187329;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ECACC; 17100525; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   HeLa S3 EGFP-H2B
AC   CVCL_HP87
SY   HeLa EGFP-Histone H2B
DR   BTO; BTO_0003602
DR   CancerTools; 152940
DR   ECACC; 17100529
DR   Wikidata; Q54882559
DR   Ximbio; 152940
RX   PubMed=21187329;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ECACC; 17100529; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=17100529
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   HeLa S3 FBXL4 KO clone #29
AC   CVCL_E6FC
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13601; FBXL4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa S3 HA-PRKN/HaloTag7-mGFP
AC   CVCL_D5AP
SY   S3 HeLa + HA-Parkin/pSu9 + HaloTag7-mGFP
DR   Wikidata; Q127381688
RX   PubMed=38728007;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HeLa S3 HaloTag7-LC3
AC   CVCL_D5AQ
DR   Wikidata; Q127381689
RX   PubMed=38728007;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HeLa S3 mer-
AC   CVCL_U209
SY   HeLa.S3(Mer^(-))
DR   CLO; CLO_0050914
DR   RCB; RCB0503
DR   Wikidata; Q54882560
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB0503
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   HeLa S3 penta KO
AC   CVCL_C2VN
DR   Wikidata; Q114311582
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa S3 penta KO-ATG13 KO
AC   CVCL_C2VP
SY   HeLa S3 ATG13 KO/penta KO
DR   Wikidata; Q114311583
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VN ! HeLa S3 penta KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa S3 penta KO-ATG14 KO
AC   CVCL_C2VQ
SY   HeLa S3 ATG14 KO/penta KO
DR   Wikidata; Q114311584
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VN ! HeLa S3 penta KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa S3 penta KO-AZI2/TBKBP1 DKO clone 20
AC   CVCL_C8QB
SY   HeLa S3 NAP1/SINTBAD DKO/penta KO clone 20
DR   Wikidata; Q123031626
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VN ! HeLa S3 penta KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 penta KO-AZI2/TBKBP1 DKO clone 26
AC   CVCL_D2Q1
SY   HeLa S3 NAP1/SINTBAD DKO/penta KO clone 26
DR   Wikidata; Q127381690
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VN ! HeLa S3 penta KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 penta KO-TBK1 KO
AC   CVCL_C2VR
SY   HeLa S3 TBK1 KO/penta KO
DR   Wikidata; Q114311586
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VN ! HeLa S3 penta KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa S3 penta KO-TBK1/ULK1/ULK2 TKO
AC   CVCL_C2VT
SY   HeLa S3 TBK1/ULK1/ULK2 TKO/penta KO
DR   Wikidata; Q114311587
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VS ! HeLa S3 penta KO-ULK1/ULK2 DKO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa S3 penta KO-ULK1/ULK2 DKO
AC   CVCL_C2VS
SY   HeLa S3 ULK1/2 DKO/penta KO
DR   Wikidata; Q114311589
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VN ! HeLa S3 penta KO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa S3 penta KO-ULK1/ULK2 DKO-AZI2/TBKBP1 DKO
AC   CVCL_C9DW
DR   Wikidata; Q123031627
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C2VS ! HeLa S3 penta KO-ULK1/ULK2 DKO
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 PIK3C3 KO clone #56
AC   CVCL_E3KB
SY   VPS34 KO single knockout HeLa cell (clone #56)
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8974; PIK3C3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   HeLa S3 PIK3R4 KO clone #89
AC   CVCL_E3KC
SY   VPS15 KO single knockout HeLa cell (clone #89)
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8982; PIK3R4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   HeLa S3 PRKN
AC   CVCL_D5AN
DR   Wikidata; Q127381691
RX   PubMed=38728007;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8607; PRKN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 RB1CC1 KO
AC   CVCL_D1LA
SY   HeLa S3 FIP200 KO
DR   Wikidata; Q127381692
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15574; RB1CC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 RUBCN KO clone 15
AC   CVCL_D5AG
SY   Rubicon KO HeLa
DR   Wikidata; Q127381693
RX   PubMed=38728007;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28991; RUBCN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 RUBCN KO/HA-Parkin/HaloTag7-mGFP
AC   CVCL_D5AJ
SY   Rubicon KO S3 HeLa + HA-Parkin/pSu9 + HaloTag7-mGFP
DR   Wikidata; Q127381694
RX   PubMed=38728007;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28991; RUBCN.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5AG ! HeLa S3 RUBCN KO clone 15
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HeLa S3 RUBCN KO/HaloTag7-LC3
AC   CVCL_D5AK
SY   Rubicon KO S3 HeLa + HaloTag7-LC3
DR   Wikidata; Q127381695
RX   PubMed=38728007;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28991; RUBCN.
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5AG ! HeLa S3 RUBCN KO clone 15
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HeLa S3 RUBCNL KO clone 17
AC   CVCL_D5AH
SY   Pacer KO HeLa
DR   Wikidata; Q127381696
RX   PubMed=38728007;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20420; RUBCNL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 RUBCNL KO/HA-PRKN/HaloTag7-mGFP
AC   CVCL_D5AL
SY   Pacer KO S3 HeLa + HA-Parkin/pSu9 + HaloTag7-mGFP
DR   Wikidata; Q127381697
RX   PubMed=38728007;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20420; RUBCNL.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5AH ! HeLa S3 RUBCNL KO clone 17
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HeLa S3 RUBCNL KO/HaloTag7-LC3
AC   CVCL_D5AM
SY   Pacer KO S3 HeLa + HaloTag7-LC3
DR   Wikidata; Q127381699
RX   PubMed=38728007;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20420; RUBCNL.
CC   Genetic integration: Method=Transduction; Gene=RGD; 621315; Map1lc3b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5AH ! HeLa S3 RUBCNL KO clone 17
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HeLa S3 TBKBP1 KO clone 7
AC   CVCL_D2Y9
SY   HeLa S3 SINTBAD KO clone #7
DR   Wikidata; Q127381701
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa S3 Tet-Off
AC   CVCL_KU44
SY   HeLa S3 tet-off; Tet-Off HeLa S3
DR   Wikidata; Q54882561
CC   Population: African American.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Takara/Clontech; Catalog number 630902.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HeLa S3 WIPI2 KO clone #7
AC   CVCL_E6FD
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32225; WIPI2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Khuu, Grace.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa S3/HA-E2F1
AC   CVCL_XV61
DR   ENCODE; ENCBS486YGP
DR   Wikidata; Q94097232
CC   Population: African American.
CC   Characteristics: Transfected with E2F1 fused at the N-terminus to an HA tag.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3113; E2F1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   HeLa SIGMAR1 KO
AC   CVCL_B0XU
DR   Wikidata; Q110432864
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   HeLa SilenciX ABL1
AC   CVCL_KT28
SY   ABL1 HeLa SilenciX
DR   Wikidata; Q54882562
WW   Provider; Tebubio; 00301-00046; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00046.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:76; ABL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00046.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX ADAM17
AC   CVCL_KT29
SY   ADAM17 HeLa SilenciX
DR   Wikidata; Q54882563
WW   Provider; Tebubio; 00301-00110; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00110.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:195; ADAM17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00110.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX AKT1
AC   CVCL_KT30
SY   AKT1 HeLa SilenciX
DR   Wikidata; Q54882564
WW   Provider; Tebubio; 00301-00096; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00096.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:391; AKT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00096.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX APE1
AC   CVCL_KT31
SY   APE1 HeLa SilenciX
DR   Wikidata; Q54882565
WW   Provider; Tebubio; 00301-00155; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00155.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:587; APEX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00155.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Argonaute 2
AC   CVCL_KT32
SY   Argonaute 2 HeLa SilenciX
DR   Wikidata; Q54882566
WW   Provider; Tebubio; 00301-00081; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00081.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3263; AGO2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00081.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Artemis
AC   CVCL_KT33
SY   Artemis HeLa SilenciX
DR   Wikidata; Q54882567
WW   Provider; Tebubio; 00301-00150; http://www.tebu-bio.com/Product/00301-00150/Artemis_HeLa_SilenciX.html
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:17642; DCLRE1C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00150.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX ATM
AC   CVCL_KT34
SY   ATM HeLa SilenciX
DR   Wikidata; Q54882568
WW   Provider; Tebubio; 00301-00029; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00029.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:795; ATM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00029.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX ATP6AP2
AC   CVCL_KT35
SY   ATP6AP2 HeLa SilenciX
DR   Wikidata; Q54882569
WW   Provider; Tebubio; 00301-00110; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00042.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:18305; ATP6AP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00110.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX ATR
AC   CVCL_KT36
SY   ATR HeLa SilenciX
DR   Wikidata; Q54882570
WW   Provider; Tebubio; 00301-00025; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00025.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:882; ATR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00025.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BAP1
AC   CVCL_KT37
SY   BAP1 HeLa SilenciX
DR   Wikidata; Q54882571
WW   Provider; Tebubio; 00301-00153; https://web.archive.org/web/20170626013523/http://www.tebu-bio.com/Product/00301-00153/BAP1_HeLa_SilenciX.html
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:950; BAP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00153.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BAX
AC   CVCL_KT38
SY   BAX HeLa SilenciX
DR   Wikidata; Q54882572
WW   Provider; Tebubio; 00301-00067; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00067.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:959; BAX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00067.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BCL2
AC   CVCL_KT39
SY   BCL2 HeLa SilenciX
DR   Wikidata; Q54882573
WW   Provider; Tebubio; 00301-00057; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00057.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:990; BCL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00057.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BID
AC   CVCL_KT40
SY   BID HeLa SilenciX
DR   Wikidata; Q54882574
WW   Provider; Tebubio; 00301-00093; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00093.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1050; BID.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00093.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BLM
AC   CVCL_KT41
SY   BLM HeLa SilenciX
DR   Wikidata; Q54882575
WW   Provider; Tebubio; 00301-00026; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00026.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1058; BLM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00026.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BRCA1
AC   CVCL_KT42
SY   BRCA1 HeLa SilenciX
DR   Wikidata; Q54882576
WW   Provider; Tebubio; 00301-00041; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00041.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1100; BRCA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00041.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BRCA2
AC   CVCL_KT43
SY   BRCA2 HeLa SilenciX; BRCA2 deficient HeLa SilenciX
DR   Wikidata; Q54882577
WW   Provider; Tebubio; 00301-00028; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00028.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1101; BRCA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00028.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX BTG2
AC   CVCL_KT44
SY   BTG2 HeLa SilenciX
DR   Wikidata; Q54882581
WW   Provider; Tebubio; 00301-00108; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00108.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1131; BTG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00108.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Caspase 3
AC   CVCL_KT45
SY   Caspase 3 HeLa SilenciX
DR   Wikidata; Q54882582
WW   Provider; Tebubio; 00301-00066; https://web.archive.org/web/20170626042618/http://www.tebu-bio.com/Product/00301-00066/Caspase_3_HeLa_SilenciX.html
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1504; CASP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00066.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Caspase 9
AC   CVCL_KT46
SY   Caspase 9 HeLa SilenciX
DR   Wikidata; Q54882583
WW   Provider; Tebubio; 00301-00092; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/01_00092_DST10_Caspase9_170309.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1511; CASP9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00092.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX CDK2
AC   CVCL_KT47
SY   CDK2 HeLa SilenciX
DR   Wikidata; Q54882584
WW   Provider; Tebubio; 00301-00100; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00100.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1771; CDK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00100.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Control
AC   CVCL_KT27
SY   Control HeLa SilenciX
DR   Wikidata; Q54882585
RX   PubMed=16179499;
WW   Provider; Tebubio; 00301-00001; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00001.pdf
CC   Population: African American.
CC   Characteristics: Control cell line for the SilenciX series of knockdown cell lines. Transfected with a control shRNA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00001.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   HeLa SilenciX COX2
AC   CVCL_KT48
SY   COX2 HeLa SilenciX; COX-2 HeLa SilenciX
DR   Wikidata; Q54882586
WW   Provider; Tebubio; 00301-00074; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00074.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9605; PTGS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00074.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX CTNNB1
AC   CVCL_KT49
SY   CTNNB1 HeLa SilenciX
DR   Wikidata; Q54882587
WW   Provider; Tebubio; 00301-00098; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00098.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:2514; CTNNB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00098.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX DDB2
AC   CVCL_KT50
SY   DDB2 HeLa SilenciX
DR   Wikidata; Q54882588
WW   Provider; Tebubio; 00301-00152; https://web.archive.org/web/20170626040347/http://www.tebu-bio.com/Product/00301-00152/DDB2_HeLa_SilenciX.html
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:2718; DDB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00152.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX DIABLO
AC   CVCL_KT51
SY   DIABLO HeLa SilenciX
DR   Wikidata; Q54882589
WW   Provider; Tebubio; 00301-00102; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00102.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:21528; DIABLO.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00102.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX DNA-PKcs
AC   CVCL_KT52
SY   DNA-PKcs HeLa SilenciX
DR   Wikidata; Q54882590
WW   Provider; Tebubio; 00301-00005; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00005.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9413; PRKDC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00005.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX ERCC1
AC   CVCL_KT53
SY   ERCC1 HeLa SilenciX
DR   Wikidata; Q54882591
WW   Provider; Tebubio; 00301-00002; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00002.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3433; ERCC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00002.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Exportin 5
AC   CVCL_KT54
SY   Exportin 5 HeLa SilenciX
DR   Wikidata; Q54882592
WW   Provider; Tebubio; 00301-00080; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00080.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:17675; XPO5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00080.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX FADD
AC   CVCL_KT55
SY   FADD HeLa SilenciX
DR   Wikidata; Q54882593
WW   Provider; Tebubio; 00301-00083; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00083.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3573; FADD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00083.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX FancD2
AC   CVCL_KT56
SY   FancD2 HeLa SilenciX
DR   Wikidata; Q54882594
WW   Provider; Tebubio; 00301-00027; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00027.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3585; FANCD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00027.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX FEN1
AC   CVCL_KT57
SY   FEN1 HeLa SilenciX
DR   Wikidata; Q54882595
WW   Provider; Tebubio; 00301-00089; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00089.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3650; FEN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00089.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX GNAQ
AC   CVCL_KT58
SY   GNAQ HeLa SilenciX
DR   Wikidata; Q54882596
WW   Provider; Tebubio; 00301-00099; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00099.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:4390; GNAQ.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00099.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX GPS1
AC   CVCL_KT59
SY   GPS1 HeLa SilenciX
DR   Wikidata; Q54882597
WW   Provider; Tebubio; 00301-00068; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00068.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:4549; GPS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00068.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX GPX8
AC   CVCL_KT60
SY   GPX8 HeLa SilenciX
DR   Wikidata; Q54882598
WW   Provider; Tebubio; 00301-00121; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00121.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:33100; GPX8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00121.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX HDAC1
AC   CVCL_KT61
SY   HDAC1 HeLa SilenciX
DR   Wikidata; Q54882599
WW   Provider; Tebubio; 00301-00064; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00064.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:4852; HDAC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00064.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX HIF1A
AC   CVCL_KT62
SY   HIF1A HeLa SilenciX
DR   Wikidata; Q54882600
WW   Provider; Tebubio; 00301-00043; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00043.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:4910; HIF1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00043.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Hif2alpha
AC   CVCL_KT63
SY   Hif2alpha HeLa SilenciX
DR   Wikidata; Q54882602
WW   Provider; Tebubio; 00301-00130; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00130.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3374; EPAS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00130.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX HMG1L1
AC   CVCL_KT64
SY   HMG1L1 HeLa SilenciX
DR   Wikidata; Q54882603
WW   Provider; Tebubio; 00301-00075; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00075.pdf
CC   Population: African American.
CC   Characteristics: Because of the very high similarity between HMGB1 and HMGB1P1, both are knoched-down in this cell line.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:4993; HMGB1P1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00075.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX HMGB1
AC   CVCL_KT65
SY   HMGB1 HeLa SilenciX
DR   Wikidata; Q54882604
WW   Provider; Tebubio; 00301-00050; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00050.pdf
CC   Population: African American.
CC   Characteristics: Because of the very high similarity between HMGB1 and HMGB1P1, both are knoched-down in this cell line.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:4983; HMGB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00050.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX HR23A
AC   CVCL_KT66
SY   HR23A HeLa SilenciX; hHR23A HeLa SilenciX
DR   Wikidata; Q54882605
WW   Provider; Tebubio; 00301-00006; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00006.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9812; RAD23A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00006.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX HR23B
AC   CVCL_KT67
SY   HR23B HeLa SilenciX; hHR23B HeLa SilenciX
DR   Wikidata; Q54882606
WW   Provider; Tebubio; 00301-00007; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00007.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9813; RAD23B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00007.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX HuR
AC   CVCL_KT68
SY   HuR HeLa SilenciX
DR   Wikidata; Q54882607
WW   Provider; Tebubio; 00301-00091; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00091.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3312; ELAVL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00091.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX KIN17
AC   CVCL_KT69
SY   KIN17 HeLa SilenciX
DR   Wikidata; Q54882608
RX   PubMed=16179499;
WW   Provider; Tebubio; 00301-00008; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00008.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:6327; KIN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00008.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX LigI
AC   CVCL_KT70
SY   LigI HeLa SilenciX
DR   Wikidata; Q54882609
WW   Provider; Tebubio; 00301-00157; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00157.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:6598; LIG1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00157.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX LigIII
AC   CVCL_KT71
SY   LigIII HeLa SilenciX
DR   Wikidata; Q54882610
WW   Provider; Tebubio; 00301-00009; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00009.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:6600; LIG3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00009.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX LigIV
AC   CVCL_KT72
SY   LigIV HeLa SilenciX
DR   Wikidata; Q54882611
WW   Provider; Tebubio; 00301-00010; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00010.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:6601; LIG4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00010.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX MAPK1
AC   CVCL_KT73
SY   MAPK1 HeLa SilenciX
DR   Wikidata; Q54882612
WW   Provider; Tebubio; 00301-00065; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00065.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:6871; MAPK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00065.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX MCU
AC   CVCL_KT74
SY   MCU HeLa SilenciX
DR   Wikidata; Q54882613
WW   Provider; Tebubio; 0301-00166; https://web.archive.org/web/20170626053642/http://www.tebu-bio.com/Product/00301-00166/MCU_HeLa_SilenciX.html
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:23526; MCU.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00166.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX MLH1
AC   CVCL_KT75
SY   MLH1 HeLa SilenciX
DR   Wikidata; Q54882614
WW   Provider; Tebubio; 0301-00147; https://web.archive.org/web/20170625230651/http://www.tebu-bio.com/Product/00301-00147/MLH1_HeLa_SilenciX.html
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7127; MLH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00147.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX MRE11
AC   CVCL_KT76
SY   MRE11 HeLa SilenciX
DR   Wikidata; Q54882615
WW   Provider; Tebubio; 00301-00011; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00011.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7230; MRE11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX MSH2
AC   CVCL_KT77
SY   MSH2 HeLa SilenciX
DR   Wikidata; Q54882616
WW   Provider; Tebubio; 00301-00023; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00023.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7325; MSH2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00023.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX MTERFD2
AC   CVCL_KT78
SY   MTERFD2 HeLa SilenciX
DR   Wikidata; Q54882617
WW   Provider; Tebubio; 00301-00040; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00040.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:28785; MTERF4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00040.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX NBS1
AC   CVCL_KT79
SY   NBS1 HeLa SilenciX
DR   Wikidata; Q54882618
WW   Provider; Tebubio; 00301-00012; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00012.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7652; NBN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00012.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX NCL
AC   CVCL_KT80
SY   NCL HeLa SilenciX
DR   Wikidata; Q54882619
WW   Provider; Tebubio; 00301-00049; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00049.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7667; NCL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00049.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX NEIL1
AC   CVCL_KT81
SY   NEIL1 HeLa SilenciX
DR   Wikidata; Q54882620
WW   Provider; Tebubio; 00301-00053; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00053.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:18448; NEIL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00053.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX NF1
AC   CVCL_KT82
SY   NF1 HeLa SilenciX
DR   Wikidata; Q54882621
WW   Provider; Tebubio; 00301-00122; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00122.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7765; NF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00122.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX NRF2
AC   CVCL_KT83
SY   NRF2 HeLa SilenciX
DR   Wikidata; Q54882624
WW   Provider; Tebubio; 00301-00106; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00106.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7782; NFE2L2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00106.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX NUDCD1
AC   CVCL_KT84
SY   NUDCD1 HeLa SilenciX
DR   Wikidata; Q54882625
WW   Provider; Tebubio; 00301-00111; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00111.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:24306; NUDCD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00111.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Ogg1
AC   CVCL_KT85
SY   Ogg1 HeLa SilenciX
DR   Wikidata; Q54882626
WW   Provider; Tebubio; 00301-00014; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00014.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:8125; OGG1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00014.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX p21
AC   CVCL_KT86
SY   p21 HeLa SilenciX
DR   Wikidata; Q54882627
WW   Provider; Tebubio; 00301-00105; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00105.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:1784; CDKN1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00105.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX p53
AC   CVCL_KT87
SY   p53 HeLa SilenciX
DR   Wikidata; Q54882628
WW   Provider; Tebubio; 00301-00024; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00024.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00024.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PARG
AC   CVCL_KT88
SY   PARG HeLa SilenciX
DR   Wikidata; Q54882629
WW   Provider; Tebubio; 00301-00085; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00085.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PARP1
AC   CVCL_KT89
SY   PARP1 HeLa SilenciX
DR   Wikidata; Q54882630
WW   Provider; Tebubio; 00301-00019; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00019.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:270; PARP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00019.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PARP2
AC   CVCL_KT90
SY   PARP2 HeLa SilenciX
DR   Wikidata; Q54882631
WW   Provider; Tebubio; 00301-00020; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00020.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:272; PARP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00020.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PCNA
AC   CVCL_KT91
SY   PCNA HeLa SilenciX
DR   Wikidata; Q54882632
WW   Provider; Tebubio; 00301-00052; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00052.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:8729; PCNA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00052.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PIK3CD
AC   CVCL_KT92
SY   PIK3CD HeLa SilenciX
DR   Wikidata; Q54882633
WW   Provider; Tebubio; 00301-00095; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00095.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:8977; PIK3CD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00095.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PKCalpha
AC   CVCL_KT93
SY   PKCalpha HeLa SilenciX
DR   Wikidata; Q54882634
WW   Provider; Tebubio; 00301-00076; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00076.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9393; PRKCA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00076.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PolH
AC   CVCL_KT94
SY   PolH HeLa SilenciX
DR   Wikidata; Q54882635
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9181; POLH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00151.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PRDX1
AC   CVCL_KT95
SY   PRDX1 HeLa SilenciX
DR   Wikidata; Q54882636
WW   Provider; Tebubio; 00301-00114; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00114.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9352; PRDX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00114.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX PRDX2
AC   CVCL_KT96
SY   PRDX2 HeLa SilenciX
DR   Wikidata; Q54882637
WW   Provider; Tebubio; 00301-00115; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00115.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9353; PRDX2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00115.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Rad50
AC   CVCL_KT97
SY   Rad50 HeLa SilenciX
DR   Wikidata; Q54882638
WW   Provider; Tebubio; 00301-00013; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00013.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9816; RAD50.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00013.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Rad54A
AC   CVCL_KT98
SY   Rad54A HeLa SilenciX; hRad54 HeLa SilenciX
DR   Wikidata; Q54882639
WW   Provider; Tebubio; 00301-00022; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00022.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9826; RAD54L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00022.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Rad54B
AC   CVCL_KT99
SY   Rad54B HeLa SilenciX
DR   Wikidata; Q54882640
WW   Provider; Tebubio; 00301-00124; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00124.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:17228; RAD54B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00124.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX RB
AC   CVCL_KU00
SY   RB HeLa SilenciX
DR   Wikidata; Q54882641
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9884; RB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00148.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX RHOQ
AC   CVCL_KU01
SY   RHOQ HeLa SilenciX
DR   Wikidata; Q54882642
WW   Provider; Tebubio; 00301-00117; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00117.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:17736; RHOQ.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00117.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX Septin 9
AC   CVCL_KU02
SY   Septin 9 HeLa SilenciX
DR   Wikidata; Q54882643
WW   Provider; Tebubio; 00301-00129; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00129.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:7323; SEPTIN9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00129.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HeLa SilenciX SIRT1
AC   CVCL_KU03
SY   SIRT1 HeLa SilenciX
DR   Wikidata; Q54882644
WW   Provider; Tebubio; 00301-00073; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00073.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:14929; SIRT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00073.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX SNAPIN
AC   CVCL_KU04
SY   SNAPIN HeLa SilenciX
DR   Wikidata; Q54882645
WW   Provider; Tebubio; 00301-00162; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00162.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:17145; SNAPIN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00162.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX SOD2
AC   CVCL_KU05
SY   SOD2 HeLa SilenciX
DR   Wikidata; Q54882646
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11180; SOD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00156.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX SORCIN
AC   CVCL_KU06
SY   SORCIN HeLa SilenciX
DR   Wikidata; Q54882647
WW   Provider; Tebubio; 00301-00077; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00077.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11292; SRI.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00077.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX SSX2IP
AC   CVCL_KU07
SY   SSX2IP HeLa SilenciX
DR   Wikidata; Q54882648
WW   Provider; Tebubio; 00301-00103; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00103.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:16509; SSX2IP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00103.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX STAT1
AC   CVCL_KU08
SY   STAT1 HeLa SilenciX
DR   Wikidata; Q54882649
WW   Provider; Tebubio; 00301-00069; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00069.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11362; STAT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00069.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX THTPA
AC   CVCL_KU09
SY   THTPA HeLa SilenciX
DR   Wikidata; Q54882650
WW   Provider; Tebubio; 00301-00140; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00140.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:18987; THTPA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00140.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX TMSB4X
AC   CVCL_KU10
SY   TMSB4X HeLa SilenciX
DR   Wikidata; Q54882651
WW   Provider; Tebubio; 00301-00054; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00054.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11881; TMSB4X.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00054.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX TNFR1
AC   CVCL_KU11
SY   TNFR1 HeLa SilenciX
DR   Wikidata; Q54882652
WW   Provider; Tebubio; 00301-00063; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00063.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11916; TNFRSF1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00063.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX TP53BP1
AC   CVCL_KU12
SY   TP53BP1 HeLa SilenciX
DR   Wikidata; Q54882653
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11999; TP53BP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00154.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX TRAILR2
AC   CVCL_KU13
SY   TRAILR2 HeLa SilenciX
DR   Wikidata; Q54882654
WW   Provider; Tebubio; 00301-00084; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00084.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:11905; TNFRSF10B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00084.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX TRIO
AC   CVCL_KU14
SY   TRIO HeLa SilenciX
DR   Wikidata; Q54882655
WW   Provider; Tebubio; 00301-00055; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00055.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12303; TRIO.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00055.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX TXNRD2
AC   CVCL_KU15
SY   TXNRD2 HeLa SilenciX
DR   Wikidata; Q54882656
WW   Provider; Tebubio; 00301-00107; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00107.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:18155; TXNRD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00107.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX USP11
AC   CVCL_KU16
SY   USP11 HeLa SilenciX
DR   Wikidata; Q54882657
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12609; USP11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00169.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX USP14
AC   CVCL_KU17
SY   USP14 HeLa SilenciX
DR   Wikidata; Q54882658
WW   Provider; Tebubio; 00301-00163; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00163.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12612; USP14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00163.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX USP19
AC   CVCL_KU18
SY   USP19 HeLa SilenciX
DR   Wikidata; Q54882659
WW   Provider; Tebubio; 00301-00164; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00164.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12617; USP19.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00164.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX USP7
AC   CVCL_KU19
SY   USP7 HeLa SilenciX
DR   Wikidata; Q54882660
WW   Provider; Tebubio; 00301-00159; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00159.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12630; USP7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00159.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX USP9X
AC   CVCL_KU20
SY   USP9X HeLa SilenciX
DR   Wikidata; Q54882661
WW   Provider; Tebubio; 00301-00160; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00160.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12632; USP9X.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00160.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX WDR8
AC   CVCL_KU21
SY   WDR8 HeLa SilenciX
DR   Wikidata; Q54882662
WW   Provider; Tebubio; 00301-00056; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00056.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12759; WRAP73.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00056.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX WIP1
AC   CVCL_KU22
SY   WIP1 HeLa SilenciX
DR   Wikidata; Q54882663
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:9277; PPM1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00149.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX XIAP
AC   CVCL_KU23
SY   XIAP HeLa SilenciX
DR   Wikidata; Q54882669
WW   Provider; Tebubio; 00301-00104; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00104.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:592; XIAP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00104.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX XLF
AC   CVCL_KU24
SY   XLF HeLa SilenciX
DR   Wikidata; Q54882671
WW   Provider; Tebubio; 00301-00021; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00021.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:25737; NHEJ1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00021.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX XPA
AC   CVCL_KU25
SY   XPA HeLa SilenciX
DR   Wikidata; Q54882672
RX   PubMed=16179499;
WW   Provider; Tebubio; 00301-00015; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00015.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12814; XPA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00015.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX XPC
AC   CVCL_KU26
SY   XPC HeLa SilenciX
DR   Wikidata; Q54882673
RX   PubMed=16179499;
WW   Provider; Tebubio; 00301-00016; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00016.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12816; XPC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00016.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX XPF
AC   CVCL_KU27
SY   XPF HeLa SilenciX
DR   Wikidata; Q54882674
WW   Provider; Tebubio; 00301-00003; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00003.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:3436; ERCC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00003.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX XRCC1
AC   CVCL_KU28
SY   XRCC1 HeLa SilenciX
DR   Wikidata; Q54882675
WW   Provider; Tebubio; 00301-00017; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00017.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12828; XRCC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00017.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SilenciX XRCC4
AC   CVCL_KU29
SY   XRCC4 HeLa SilenciX
DR   Wikidata; Q54882676
WW   Provider; Tebubio; 00301-00018; http://www.tebubio-data.com/owl/Documents/Public_Folder/Datasheets/003/00301-00018.pdf
CC   Population: African American.
CC   Knockout cell: Method=EBV-based vector siRNA knockdown; HGNC; HGNC:12831; XRCC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Tebubio; Catalog number 00301-00018.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa SimpleCell O-GalNAc
AC   CVCL_S026
SY   HeLa SimpleCell; HeLa SC
DR   Wikidata; Q54882677
RX   PubMed=23584533;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HeLa SLC35A1 KO
AC   CVCL_E2QI
SY   HELA-SLC35A1-KO
DR   DSMZ; ACC-989
RX   PubMed=34069698;
CC   Population: African American.
CC   Doubling time: ~15-25 hours (DSMZ=ACC-989).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DSMZ=ACC-989
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,9,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa SMOC1 KO
AC   CVCL_B7DT
DR   Wikidata; Q112929706
RX   PubMed=39291144;
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20318; SMOC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 9
//
ID   HeLa SOD1 KO
AC   CVCL_A8PZ
DR   Wikidata; Q108820455
RX   PubMed=37860271;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11179; SOD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   HeLa SS6
AC   CVCL_R768
SY   HeLa-SS6
DR   Wikidata; Q54882678
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   HeLa ST
AC   CVCL_F0J9
SY   HeLa Short Telomere
RX   PubMed=24413054;
CC   Population: African American.
CC   Characteristics: Has short telomeres (~9 kb) (PubMed=24413054).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5D9 ! HeLa1.2.11
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa ST-PEAK3
AC   CVCL_C0QW
DR   PRIDE; PXD029417
DR   Wikidata; Q112929707
RX   PubMed=34944965;
CC   Population: African American.
CC   Characteristics: Transfected with a pSBbi-PuroR-ST-PEAK3 that contains a N-terminally Strep-tagged PEAK3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24793; PEAK3 (Note=With a N-terminal Strep tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HeLa Tet-Off
AC   CVCL_V352
SY   HeLa Tet-off; HeLa-TO
DR   TOKU-E; 4088
DR   Wikidata; Q54882679
CC   Population: African American.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   HeLa Tet-Off Advanced
AC   CVCL_E7XH
WW   Provider; Takara Bio; 63211; https://www.takarabio.com/documents/Components%20List/631156_071417.pdf
CC   Population: African American.
CC   Characteristics: Transfected with an advanced tetracycline transactivator (tTA2(S)-M2) protein, a fusion of a mutated E.coli tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa Tet-On
AC   CVCL_IY74
SY   HeLa-Tet-On; HeLa-tet-on
DR   TOKU-E; 3679
DR   Wikidata; Q54882680
CC   Population: African American.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Takara/Clontech; Catalog number 630901.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   HeLa Tet-On 3G
AC   CVCL_V353
DR   Wikidata; Q54882681
WW   Provider; Takara Bio; 631183; https://www.takarabio.com/products/gene-function/tet-inducible-expression-systems/tet-on-3g-systems/tet-on-3g-cell-lines
CC   Population: African American.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   HeLa Tet-On Advanced
AC   CVCL_KU41
DR   Wikidata; Q54882682
CC   Population: African American.
CC   Characteristics: Transfected with an advanced reverse tetracycline-controlled transactivator (rtTA2(S)-M2), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Takara/Clontech; Catalog number 631555.
CC   Discontinued: Takara/Clontech; Catalog number 632110.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HeLa TG
AC   CVCL_2935
SY   HeLaTG
DR   CLO; CLO_0050922
DR   JCRB; JCRB0214
DR   RCB; RCB1891
DR   TKG; TKG 0204
DR   Wikidata; Q54882683
RX   PubMed=1522048;
RX   PubMed=9290701;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB0214; RCB=RCB1891; TKG=TKG 0204
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HeLa TG Cap
AC   CVCL_2936
DR   JCRB; JCRB0215
DR   Wikidata; Q54882684
RX   PubMed=1522048;
RX   PubMed=9290701;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB0215
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HeLa TK-
AC   CVCL_9497
DR   CLO; CLO_0003697
DR   CLDB; cl1623
DR   Wikidata; Q54882685
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HeLa tTS
AC   CVCL_V354
DR   Wikidata; Q54882686
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Takara/Clontech; Catalog number 630928.
CC   Discontinued: Takara/Clontech; Catalog number 631147.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   HeLa TUBA4A KO
AC   CVCL_B4H8
DR   Wikidata; Q110432866
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12407; TUBA4A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   HeLa VAPB KO
AC   CVCL_B6RU
DR   Wikidata; Q111733352
RX   PubMed=39916983;
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12649; VAPB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 8
//
ID   HeLa VST
AC   CVCL_F0JA
SY   HeLa Very Short Telomere
RX   PubMed=24413054;
CC   Population: African American.
CC   Characteristics: Has very short telomeres (~4 kb) (PubMed=24413054).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5D9 ! HeLa1.2.11
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa(tTA)1
AC   CVCL_6E62
DR   Wikidata; Q54882707
RX   PubMed=9542626;
CC   Population: African American.
CC   Characteristics: Expresses the tetracycline-controlled transactivator (tTA).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   HeLa-2T
AC   CVCL_UM63
DR   Wikidata; Q94100490
RX   PubMed=3756862;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_72568; MTIC (5-(3-methyl-1-triazeno)imidazole-4-carboxamide).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   HeLa-80
AC   CVCL_4776
SY   HeLa 80
DR   BTO; BTO_0003180
DR   Wikidata; Q54882708
RX   PubMed=2770770;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   HeLa-AC free
AC   CVCL_VU54
SY   HeLa (AC-free)
DR   ECACC; 08011102
DR   Wikidata; Q94100518
CC   Group: Serum/protein free medium cell line.
CC   Population: African American.
CC   Characteristics: Adapted to growth in animal component free medium (EX-CELL HeLa Serum-Free Medium) (ECACC=08011102).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   HeLa-ACE2
AC   CVCL_B3LW
DR   JCRB; JCRB1845
DR   Wikidata; Q110432867
RX   PubMed=22496216;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1845
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3,14.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12,13
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1276 ! HeLa 229
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 10
//
ID   HeLa-ACE2-TMPRSS2
AC   CVCL_B3LV
DR   JCRB; JCRB1835
DR   Wikidata; Q110432868
RX   PubMed=22496216;
CC   Population: African American.
CC   Virology: Can be used to isolate human coronavirus NL63 (HCoV-NL63) (JCRB=JCRB1835).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1835
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3,14.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12,13
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1276 ! HeLa 229
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 11
//
ID   HeLa-APL
AC   CVCL_9493
SY   HeLa-R
DR   Wikidata; Q54882709
RX   PubMed=15365569;
RX   PubMed=17338558;
CC   Population: African American.
CC   Characteristics: Possesses >1000-fold relative resistance to APL than the parental cell line (PubMed=15365569).
CC   Doubling time: ~24 hours (PubMed=15365569).
CC   Selected for resistance to: ChEBI; CHEBI_90205; Plitidepsin (Dehydrodidemnin B; Aplidin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 19
//
ID   HeLa-APOBEC3G
AC   CVCL_W646
SY   APOBEC3G+ HeLa
DR   BEI_Resources; ARP-9907
DR   Wikidata; Q54882711
RX   PubMed=14557625;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17357; APOBEC3G.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   HeLa-BLMr
AC   CVCL_F0BD
RX   PubMed=2450630;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_22907; Bleomycin.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa-C3
AC   CVCL_C5RL
SY   HeLa C3
DR   ChEMBL-Cells; CHEMBL3886021
DR   Wikidata; Q116049309
RX   CelloPub=CLPUB00727;
RX   PubMed=9374378;
CC   Population: African American.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 cycles of 10 Gy of Ce-137 irradiation (CelloPub=CLPUB00727; PubMed=9374378).
CC   Doubling time: 20.5-23 hours (PubMed=9374378).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HeLa-Cas9-527
AC   CVCL_XE39
DR   CCRID; 1101HUM-PUMC000527
DR   Wikidata; Q94100565
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000527
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-528
AC   CVCL_XE40
DR   CCRID; 1101HUM-PUMC000528
DR   Wikidata; Q94100573
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000528
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-529
AC   CVCL_XE41
DR   CCRID; 1101HUM-PUMC000529
DR   Wikidata; Q94100579
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000529
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-530
AC   CVCL_XE42
DR   CCRID; 1101HUM-PUMC000530
DR   Wikidata; Q94100585
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000530
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-531
AC   CVCL_XE43
DR   CCRID; 1101HUM-PUMC000531
DR   Wikidata; Q94100596
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000531
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-532
AC   CVCL_XE44
DR   CCRID; 1101HUM-PUMC000532
DR   Wikidata; Q94100599
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000532
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-533
AC   CVCL_XE45
DR   CCRID; 1101HUM-PUMC000533
DR   Wikidata; Q94100605
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000533
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-534
AC   CVCL_XE46
DR   CCRID; 1101HUM-PUMC000534
DR   Wikidata; Q94100612
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000534
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-535
AC   CVCL_XE47
DR   CCRID; 1101HUM-PUMC000535
DR   Wikidata; Q94100617
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000535
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-536
AC   CVCL_XE48
DR   CCRID; 1101HUM-PUMC000536
DR   Wikidata; Q94100623
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000536
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-Cas9-537
AC   CVCL_XE49
DR   CCRID; 1101HUM-PUMC000537
DR   Wikidata; Q94100629
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID=1101HUM-PUMC000537
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HeLa-CD14
AC   CVCL_H339
SY   Hela-CD14
DR   Wikidata; Q54882712
RX   PubMed=22741009;
RX   PubMed=23086642;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   HeLa-CD19
AC   CVCL_E8EL
SY   HeLa CD19+
WW   Provider; ProMab; PM-HELA-CD19; https://www.promab.com/products/car-t-car-nk/car-t-cells/engineered-car-t-target-cells/hela-cd19
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1633; CD19.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HeLa-CD4
AC   CVCL_E8AI
RX   PubMed=1548759;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa-dCas9
AC   CVCL_E3BH
RX   PubMed=23849981;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HeLa-dCas9 agDD-GFP
AC   CVCL_E3BI
CC   Population: African American.
CC   Characteristics: Stably expresses agDD-GFP which consists of an aggregating destabilizing domain (AgDD) fused to the N-terminal of Superfolder GFP.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3BH ! HeLa-dCas9
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa-Difluo hLC3
AC   CVCL_A8CA
DR   InvivoGen; heldf-hlc3
DR   Wikidata; Q107115322
CC   Population: African American.
CC   Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy. Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen=heldf-hlc3).
CC   Characteristics: Stably expresses a RFP-GFP-MAP1LC3B construct (InvivoGen=heldf-hlc3).
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13352; MAP1LC3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   Hela-EGFP
AC   CVCL_C8XZ
DR   Ubigene; YC-A012-EGFP-P
DR   Wikidata; Q123031628
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HeLa-EM2-11ht
AC   CVCL_WN71
SY   HeLa EM2-11ht
DR   Wikidata; Q94100654
RX   PubMed=19264799;
CC   Population: African American.
CC   Characteristics: Stably expresses an improved version of the reverse tetracycline controlled transactivator (rtTA2S-M2) under the control of the human EF1a promoter. Also express an hygromycin B phosphotransferase-thymidine kinase (HygTk) fusion gene as a positive/negative selection marker.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HeLa-env-Eli
AC   CVCL_1H14
DR   Wikidata; Q54882713
RX   PubMed=3265154;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   HeLa-env-IIIB
AC   CVCL_1H15
DR   Wikidata; Q54882715
RX   PubMed=3265154;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   HeLa-env-Mal
AC   CVCL_1H16
DR   Wikidata; Q54882716
RX   PubMed=3265154;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   HeLa-G63
AC   CVCL_VJ28
SY   HeLa G-63; HeLa G63
DR   Wikidata; Q94100715
RX   PubMed=21113464;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   HeLa-H12
AC   CVCL_E8AQ
SY   HeLa-LTR-lacZ clone Z24 CD4 clone H12
RX   PubMed=1560526;
CC   Population: African American.
CC   Characteristics: Expression of CD4 is under the control of a SV40 promoter (PubMed=1560526).
CC   Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AP ! HeLa-LTR-lacZ clone Z24
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa-HA-hNIS
AC   CVCL_E8E8
SY   HeLa-HA-human NIS
DR   ABM; T6491
RX   PubMed=32084174;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa-HA-wNIS
AC   CVCL_E8E9
SY   HeLa-HA-whale NIS
DR   ABM; T6492
RX   PubMed=32084174;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A384B8D1; Balaenoptera acutorostrata scammoni slc5a5 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa-HA-zNIS
AC   CVCL_E8EA
SY   HeLa-HA-zebrafish NIS
DR   ABM; T6493
RX   PubMed=32084174;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A4IG60; Danio rerio slc5a5 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa-LAV
AC   CVCL_S496
SY   HeLa/LAV
DR   BEI_Resources; ARP-1301
DR   Wikidata; Q54882717
RX   PubMed=1687144;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S495 ! HeLa-T4+
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   HeLa-LTR-lacZ clone Z24
AC   CVCL_E8AP
SY   HeLa LTR-lacZ clone Z24; Z24
RX   PubMed=1560526;
RX   PubMed=7520946;
CC   Population: African American.
CC   Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (PubMed=1560526).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa-LTRHIV-1-Luc
AC   CVCL_A8JX
SY   HeLa LTRHIV-1-Luc; HeLa LTR HIV-1-Luc; HeLa LTRHIV-1wt-Luc
DR   BTO; BTO_0005038
DR   Wikidata; Q108820456
RX   PubMed=17245432;
CC   Population: African American.
CC   Characteristics: The expression of the luciferase reporter gene is under the control of the HIV-1 isolate BRU promoter (LTR from -454 to +338) (PubMed=17245432).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   HeLa-luc
AC   CVCL_5J41
DR   Revvity/PerkinElmer; 119272
DR   Wikidata; Q54882718
RX   PubMed=10933067;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: There are 3 different cell lines with almost indentical names: Hela-Luc (Cellosaurus=CVCL_C8XT), HeLa-luc (Cellosaurus=CVCL_5J41) and HeLa-Luc (Cellosaurus=CVCL_YA88).
CC   Discontinued: Revvity/PerkinElmer; 119272; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   HeLa-Luc
AC   CVCL_YA88
DR   GEO; GSM1178169
DR   GEO; GSM1178170
DR   Wikidata; Q94100762
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: There are 3 different cell lines with almost indentical names: Hela-Luc (Cellosaurus=CVCL_C8XT), HeLa-luc (Cellosaurus=CVCL_5J41) and HeLa-Luc (Cellosaurus=CVCL_YA88).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   HeLa-Luc [Ubigene]
AC   CVCL_C8XT
DR   Ubigene; YC-A012-Luc-P
DR   Wikidata; Q123031630
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: There are 3 different cell lines with almost indentical names: Hela-Luc (Cellosaurus=CVCL_C8XT), HeLa-luc (Cellosaurus=CVCL_5J41) and HeLa-Luc (Cellosaurus=CVCL_YA88).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HeLa-Luc-RFP
AC   CVCL_B7NT
SY   Luciferase/tdTomato Dual-Reporter HeLa Cell Line
DR   Wikidata; Q112929708
WW   Provider; ALSTEM; LRL03; https://www.alstembio.com/web/product_details.php?id=36
CC   Population: African American.
CC   Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HeLa-MAGI
AC   CVCL_D259
SY   HeLa MAGI; HeLa Magi; MAGI; HeLa-CD4-LTR-beta-gal; HeLa-CD4-LTR/beta-gal; CD4-LTR/beta-gal; HeLa-Multinuclear Activation of a Galactosidase Indicator
DR   BTO; BTO_0003588
DR   CLO; CLO_0050934
DR   BEI_Resources; ARP-1470
DR   RCB; RCB2356
DR   Wikidata; Q54882719
RX   PubMed=1548759;
CC   Population: African American.
CC   Characteristics: Transfected with a construct pJK2 containing the HIV-1 LTR fused to a lacZ reporter gene that contains a MPKKKRK N-terminal sequence directing it to the nucleus (PubMed=1548759).
CC   Virology: Can be used to determine quantitatively the titer of laboratory-adapted HIV-1 strains (PubMed=1548759).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB2356
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AI ! HeLa-CD4
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 24
//
ID   HeLa-MAGI-CCR5
AC   CVCL_D260
SY   HeLa-CD4-CCR5; MAGI-CCR5; MAGI-CCR-5
DR   BTO; BTO_0003587
DR   CLO; CLO_0037219
DR   BEI_Resources; ARP-3522
DR   Wikidata; Q54882720
RX   PubMed=9094670;
RX   PubMed=9201229;
RX   PubMed=11158746;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/3382-MAGI-CCR5-Cells.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-559.html
CC   Population: African American.
CC   Characteristics: Can be used to can be used to screen for anti-HIV-1 drugs (PubMed=9094670).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D259 ! HeLa-MAGI
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 26
//
ID   HeLa-mCAT#8
AC   CVCL_B3SU
DR   Wikidata; Q110432869
RX   PubMed=20837469;
RX   PubMed=24498430;
RX   PubMed=27775668;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   HeLa-mCAT#8 TAL-B4G5#2
AC   CVCL_B3T5
SY   HeLa-TAL-B4G5#2; TAL-B4G5#2
DR   Wikidata; Q110432870
RX   PubMed=24498430;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:928; B4GALT5.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-mCAT#8 TAL-CE#1
AC   CVCL_B3SY
SY   TAL-CE#1
DR   Wikidata; Q110432871
RX   PubMed=24498430;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-mCAT#8 TAL-CE#14
AC   CVCL_B3SZ
SY   HeLa-TAL-CE#14; TAL-CE#14
DR   Wikidata; Q110432872
RX   PubMed=24498430;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-mCAT#8 TAL-CE#14-UG#2
AC   CVCL_B3T4
SY   HeLa-TAL-CE#14UG#2; TAL-CE#14-UG#2; TAL-CE#14UG#2
DR   Wikidata; Q110432873
RX   PubMed=24498430;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:12524; UGCG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SZ ! HeLa-mCAT#8 TAL-CE#14
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-mCAT#8 TAL-CE#3
AC   CVCL_B3T0
SY   TAL-CE#3
DR   Wikidata; Q110432874
RX   PubMed=24498430;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-mCAT#8 TAL-CERS2#13
AC   CVCL_B3SV
SY   TAL-CERS2#13
DR   Wikidata; Q110432875
RX   PubMed=27775668;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2 (Note=3 of 4 alleles).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 10
//
ID   HeLa-mCAT#8 TAL-CERS2#16
AC   CVCL_B3SW
SY   TAL-CERS2#16
DR   Wikidata; Q110432876
RX   PubMed=27775668;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-mCAT#8 TAL-CERS2#18
AC   CVCL_B3SX
SY   TAL-CERS2#18
DR   Wikidata; Q110432877
RX   PubMed=27775668;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2 (Note=3 of 4 alleles).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 10
//
ID   HeLa-mCAT#8 TAL-CERS2#18-CERT#10
AC   CVCL_B3T1
SY   TAL-CERS2#18-CERT#10
DR   Wikidata; Q110432878
RX   PubMed=27775668;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2 (Note=3 of 4 alleles).
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SX ! HeLa-mCAT#8 TAL-CERS2#18
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 10
//
ID   HeLa-mCAT#8 TAL-UG#3
AC   CVCL_B3T2
SY   TAL-UG#3
DR   Wikidata; Q110432879
RX   PubMed=24498430;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:12524; UGCG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-mCAT#8 TAL-UG#7
AC   CVCL_B3T3
SY   HeLa-TAL-UG#7; TAL-UG#7
DR   Wikidata; Q110432880
RX   PubMed=24498430;
CC   Population: African American.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:12524; UGCG.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3SU ! HeLa-mCAT#8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa-Mitotrap
AC   CVCL_AR66
DR   ECACC; 15042201
DR   Wikidata; Q54882721
DR   Ximbio; 152426
RX   PubMed=20159602;
WW   Provider; Cambridge Enterprise; -; https://web.archive.org/web/20200923093418/http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC   Population: African American.
CC   Characteristics: Can be used to determine the function of a protein by rapidly inactivating the protein of interest by rapamycin-induced rerouting to the mitochondria. This process is termed 'knocksideway'.
CC   Characteristics: Transfected with Mitotrap, a construct composed of the import signal of yeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   HeLa-Mitotrap-Ap1g1-FKBP
AC   CVCL_AR67
SY   HeLa-Mitotrap Ap1g1-FKBP
DR   ECACC; 15042203
DR   Wikidata; Q54882722
DR   Ximbio; 152427
RX   PubMed=20159602;
WW   Provider; Cambridge Enterprise; -; https://web.archive.org/web/20200923093418/http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC   Population: African American.
CC   Characteristics: Transfected with Mitotrap, a construct composed of the import signal of yeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:555; AP1G1 (Note=Tagged with the FKBP domain from FKBP1A).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR66 ! HeLa-Mitotrap
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HeLa-Mitotrap-Ap2a2-FKBP
AC   CVCL_AR69
DR   Wikidata; Q54882723
DR   Ximbio; 152428
RX   PubMed=20159602;
WW   Provider; Cambridge Enterprise; -; https://web.archive.org/web/20200923093418/http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC   Population: African American.
CC   Characteristics: Transfected with Mitotrap, a construct composed of the import signal of yeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:562; AP2A2 (Note=Tagged with the FKBP domain from FKBP1A).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR66 ! HeLa-Mitotrap
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HeLa-Mitotrap-GGA2-FKBP
AC   CVCL_AR70
DR   Wikidata; Q54882725
DR   Ximbio; 152429
RX   PubMed=22902756;
WW   Provider; Cambridge Enterprise; -; https://web.archive.org/web/20200923093418/http://www.enterprise.cam.ac.uk/reagents/hela-mitotrap-cell-lines/
CC   Population: African American.
CC   Characteristics: Transfected with Mitotrap, a construct composed of the import signal of yeast TOM70, a YFP and the rapamycin-binding (FRB) domain from MTOR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16064; GGA2 (Note=Tagged with the FKBP domain from FKBP1A).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR66 ! HeLa-Mitotrap
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HeLa-MJ
AC   CVCL_F0J6
RX   PubMed=11063723;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HeLa-Munc18b
AC   CVCL_GR67
SY   HeLa-Munc18b15
DR   TOKU-E; 4145
DR   Wikidata; Q54882726
RX   PubMed=19723587;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11445; STXBP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   HeLa-Mx2/EGFP C5G6
AC   CVCL_RX06
SY   HeLa C5G6; C5G6
DR   Wikidata; Q54882522
RX   PubMed=22373148;
CC   Population: African American.
CC   Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency.
CC   Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HeLa-Mx2/EGFP C6C3
AC   CVCL_RX07
SY   HeLa C6C3; C6C3
DR   Wikidata; Q54882523
RX   PubMed=22373148;
RX   PubMed=27346232;
CC   Population: African American.
CC   Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency (PubMed=27346232).
CC   Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter (PubMed=27346232).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HeLa-P4
AC   CVCL_E8AR
SY   HeLa P4; P4; HeLa-LTR-lacZ clone Z24 CD4 clone P4
RX   PubMed=7520946;
CC   Population: African American.
CC   Characteristics: Expression of CD4 is under the control of a mouse PGK promoter (PubMed=7520946).
CC   Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AP ! HeLa-LTR-lacZ clone Z24
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HeLa-P4-R5 MAGI
AC   CVCL_1H21
SY   HeLa P4.R5; P4 MAGI CCR5+; P4.R5 MAGI; P4-R5 MAGI
DR   BEI_Resources; ARP-3580
DR   Wikidata; Q54937291
CC   Population: African American.
CC   Characteristics: Expression of CD4 is under the control of a mouse PGK promoter (from patent cell line).
CC   Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AR ! HeLa-P4
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   HeLa-R
AC   CVCL_A8GG
DR   TKG; TKG 0801
DR   Wikidata; Q107115323
RX   PubMed=27681752;
CC   Population: African American.
CC   Characteristics: Radioresistant. Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=27681752).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): TKG=TKG 0801
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa-R5
AC   CVCL_JL47
SY   HeLa R5; HeLa-R5-16
DR   CLO; CLO_0037220
DR   Wikidata; Q54882727
RX   PubMed=16314403;
CC   Population: African American.
CC   Characteristics: Engineered to express the gp160 envelope protein (Env) from a CCR5-tropic HIV-1 isolate as well as a Tat-GFP fusion protein (PubMed=16314403).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04610; HIV-1 isolate BRU/LAI tat.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=HIV-1 isolate 92US715 env.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY74 ! HeLa Tet-On
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HeLa-RR-B51S
AC   CVCL_1J89
SY   HeLa RR-B51S
DR   Wikidata; Q54882728
RX   Patent=US7585667;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5258.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   HeLa-SHMT2-shSHMT2
AC   CVCL_A1AR
SY   HeLa-Ss
DR   MetaboLights; MTBLS405
DR   PRIDE; PXD004629
DR   PRIDE; PXD004954
DR   Wikidata; Q102114111
RX   PubMed=32903271;
CC   Population: African American.
CC   Characteristics: Allows both a Tet-inducible over-expression of mouse Shmt2 and isopropyl beta-D-1-thiogalactopyranoside (IPTG)-inducible shRNA against SHMT2.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:10852; SHMT2.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1277989; Shmt2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D587 ! T-REx-HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   HeLa-T4+
AC   CVCL_S495
SY   HeLa T4+; HeLaT4+; Hela-T4; HeLa CD4+
DR   BEI_Resources; ARP-154
DR   Wikidata; Q54882729
RX   PubMed=3094962;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-298.html
WW   Provider; NIBSC; 0019; http://www.nibsc.org/Default.aspx?pageid=597&id=0019&theme=default
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   HeLa-T8+
AC   CVCL_1D87
SY   HeLa T8+; HeLaT8+; HeLa 8+; HeLa CD8+
DR   BEI_Resources; ARP-155
DR   Wikidata; Q54882730
RX   PubMed=3094962;
WW   Provider; NIBSC; 0020; http://www.nibsc.org/Default.aspx?pageid=597&id=0020&theme=default
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1706; CD8A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   HeLa-tat-III
AC   CVCL_1H25
SY   HeLa-Tat-III; HeLa-tatIII
DR   BEI_Resources; ARP-502
DR   Wikidata; Q54882731
RX   PubMed=3265154;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   HeLa-tat-III/CMV/d1EGFP
AC   CVCL_1H26
SY   HeLa-Tat-III/CMV/d1EGFP
DR   BEI_Resources; ARP-11062
DR   Wikidata; Q54882732
RX   PubMed=15498776;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H25 ! HeLa-tat-III
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   HeLa-tat-III/LTR/d1EGFP
AC   CVCL_1H13
SY   HeLa-Tat-III/LTR/d1EGFP
DR   BEI_Resources; ARP-11063
DR   Wikidata; Q54882733
RX   PubMed=15498776;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H25 ! HeLa-tat-III
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   HeLa-TetR-Cas9
AC   CVCL_C9AP
SY   cTT20
DR   Wikidata; Q123031631
RX   PubMed=26698661;
RX   PubMed=31626775;
CC   Population: African American.
CC   Characteristics: Expression of Cas9 can be induced by doxocycline (PubMed=26698661).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HeLa-TFEB
AC   CVCL_C3IN
DR   GEO; GSM409461
DR   GEO; GSM409462
DR   GEO; GSM409463
DR   Wikidata; Q114311590
RX   PubMed=19556463;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11753; TFEB.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   HeLa-TFEB-3xFLAG
AC   CVCL_C3IP
DR   GEO; GSM1881476
DR   GEO; GSM1881477
DR   GEO; GSM1881478
DR   Wikidata; Q114311591
RX   PubMed=19556463;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11753; TFEB (Note=With a C-terminal 3xFLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; ChIP-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   HeLa-TMPRSS2
AC   CVCL_B3M4
DR   JCRB; JCRB1838
DR   Wikidata; Q110432881
RX   PubMed=24027332;
CC   Population: African American.
CC   Virology: Can be used to isolate human coronavirus 229E (HCoV-229E) (JCRB=JCRB1838).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1838
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3,14.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12,13
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1276 ! HeLa 229
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 11
//
ID   HeLa-UGT1A9
AC   CVCL_9U03
DR   Wikidata; Q54882734
RX   PubMed=22071170;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12541; UGT1A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HeLa-X4
AC   CVCL_JL48
SY   HeLa-X4-6
DR   Wikidata; Q54882735
RX   PubMed=16314403;
CC   Population: African American.
CC   Characteristics: Engineered to express the gp160 envelope protein (Env) from a CXCR4-tropic HIV-1 isolate as well as a Tat-GFP fusion protein (PubMed=16314403).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04610; HIV-1 isolate BRU/LAI tat.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q72502; HIV-1 isolate NL4-3 env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY74 ! HeLa Tet-On
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   HeLa.EpoA9
AC   CVCL_4Z13
DR   Wikidata; Q54882687
RX   PubMed=12467233;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31549; Epothilone A (EpoA).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   HeLa.EpoB1.8
AC   CVCL_4Z14
DR   Wikidata; Q54882688
RX   PubMed=12467233;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31550; Epothilone B (EpoB).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   HeLa.P3
AC   CVCL_2937
SY   HeLa P3
DR   CLO; CLO_0050912
DR   JCRB; JCRB0649
DR   JCRB; JCRB0649.1
DR   JCRB; NIHS0372
DR   RCB; RCB0402
DR   Wikidata; Q54882689
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=1522048;
RX   PubMed=2993257;
RX   PubMed=3242846;
RX   PubMed=4328993;
RX   PubMed=5452761;
RX   PubMed=11416159;
CC   Group: Serum/protein free medium cell line.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: JCRB; JCRB0649.1; true.
CC   Discontinued: JCRB; NIHS0372; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB0649; PubMed=11416159; RCB=RCB0402
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12 (RCB=RCB0402)
ST   D13S317: 12,14 (JCRB=JCRB0649)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 8,12 (JCRB=JCRB0649)
ST   TPOX: 12 (PubMed=11416159; RCB=RCB0402)
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HeLa.P3(S)
AC   CVCL_2938
SY   HeLa.P3 (S); HeLa P3(S); HeLaP3(S)
DR   JCRB; JCRB0606
DR   RCB; RCB3681
DR   TKG; TKG 0465
DR   Wikidata; Q54882690
RX   PubMed=9290701;
CC   Group: Serum/protein free medium cell line.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): TKG=TKG 0465
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2937 ! HeLa.P3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HeLa/Blvra KO
AC   CVCL_D5I9
SY   BLVRA KO HeLa
DR   JCRB; JCRB1992
DR   Wikidata; Q127381702
RX   PubMed=29078307;
RX   PubMed=32581154;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1062; BLVRA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1992
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa/Cas9 AAVS1
AC   CVCL_C8PX
SY   HeLa-Cas9 AAVS1
DR   GeneCopoeia; SL503
DR   Wikidata; Q123031632
CC   Population: African American.
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL503).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HeLa/CMV-Luc
AC   CVCL_JG57
DR   JCRB; JCRB1679
DR   Wikidata; Q54882693
CC   Population: African American.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1679).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1679
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HeLa/crmA
AC   CVCL_JZ15
SY   HeLa-crmA
DR   Wikidata; Q54882694
RX   PubMed=7667287;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P07385; Cowpox virus crmA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa/DDP
AC   CVCL_C869
DR   CCTCC; GDC0057
DR   Wikidata; Q54882695
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000056). It was the sole source of information for this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   HeLa/Fucci
AC   CVCL_E070
SY   HeLa/Fucci #4; HeLa.S-Fucci
DR   CLO; CLO_0050931
DR   RCB; RCB2812
DR   Wikidata; Q54882691
RX   PubMed=18267078;
CC   Population: African American.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct.
CC   Characteristics: Transfected with the Fucci probe which consist of the fusion of monomeric Kusabira-Orange2 (mKO2) to the ubiquitination domain of human CDT1 (aa 30-120) and monomeric AzamiGreen (mAG) to the ubiquitination domain of human geminin (aa 1-110).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; HC91W; AzamiGreen (Note=Green fluorescent protein from G.fascicularis).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 134NN; mKusabira-Orange2 (Note=mKO2, orange fluorescent protein derived from F.concinna Kusabira-Orange (KO)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   HeLa/Fucci(CA)2
AC   CVCL_VM98
SY   HeLa/Fucci(CA)2 #3
DR   RCB; RCB4676
DR   Wikidata; Q94101207
RX   PubMed=29107535;
CC   Population: African American.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(CA2) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct.
CC   Characteristics: Transfected with the Fucci(CA)2 probe which consist of the fusion of mCherry to the ubiquitination domain of human CDT1 (aa 1-100) but with the Cy motif 68-RRL-70 replaced by AAA and of monomeric Venus (mVenus) to the ubiquitination domain of human geminin (aa 1-110).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Ser101_Leu546del and p.Arg68Ala, p.Arg69Ala and p.Leu70Ala).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   HeLa/Fucci(CA)5
AC   CVCL_A7AU
SY   HeLa/Fucci(CA)5 #16; HeLa/Fucci(CA)5#16
DR   RCB; RCB4919
DR   Wikidata; Q107115324
RX   PubMed=37394513;
CC   Population: African American.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(CA5) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct (PubMed=37394513).
CC   Characteristics: Transfected with the Fucci(CA)5 probe which consist of the fusion of AzaleaB5 to the ubiquitination domain of human CDT1 (AA 1-100) but with the Cy motif 68-RRL-70 replaced by AAA and of h2-3 to the ubiquitination domain of human geminin (AA 1-110) (PubMed=37394513).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 886AH; AzaleaB5 (Note=Red fluorescent protein from Montipora monasteriata).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YQ25V; h2-3 (Note=Bright green/yellow fluorescent protein from Ricordea sp. FP2-3).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Ser101_Leu546del and p.Arg68Ala, p.Arg69Ala and p.Leu70Ala).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa/Fucci(SA)5
AC   CVCL_A7AV
SY   HeLa/Fucci(SA)5 #16; HeLa/Fucci(SA)5#16
DR   RCB; RCB4917
DR   Wikidata; Q107115325
RX   PubMed=37394513;
CC   Population: African American.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(SA5) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct (PubMed=37394513).
CC   Characteristics: Transfected with the Fucci(SA)5 probe which consist of the fusion of AzaleaB5 to the ubiquitination domain of human CDT1 (AA 30-120) and of h2-3 to the ubiquitination domain of human geminin (AA 1-110) (PubMed=37394513).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 886AH; AzaleaB5 (Note=Red fluorescent protein from Montipora monasteriata).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YQ25V; h2-3 (Note=Bright green/yellow fluorescent protein from Ricordea sp. FP2-3).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   HeLa/Fucci(SCA)2
AC   CVCL_VM99
DR   Wikidata; Q94101209
RX   PubMed=29107535;
CC   Population: African American.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(SCA2) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct.
CC   Characteristics: Transfected with the Fucci(SCA)2 probe which consist of the fusion of mCherry) to the ubiquitination domain of human CDT1 (AA 1-100) and of monomeric Venus (mVenus) to the ubiquitination domain of human geminin (AA 1-110).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Ser101_Leu546del and p.Arg68Ala, p.Arg69Ala and p.Leu70Ala).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   HeLa/Fucci2
AC   CVCL_U187
SY   HeLa/Fucci2 #3; HeLa.S-Fucci2; HeLa/Fucci(SA)2
DR   CLO; CLO_0050932
DR   ChEMBL-Cells; CHEMBL4630774
DR   ChEMBL-Targets; CHEMBL4630782
DR   PubChem_Cell_line; CVCL_U187
DR   RCB; RCB2867
DR   Wikidata; Q54882692
RX   PubMed=21226962;
RX   PubMed=29107535;
CC   Population: African American.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci2 (Fluorescent Ubiquitination-based Cell Cycle Indicator 2) construct.
CC   Characteristics: Transfected with the Fucci2 probe which consist of the fusion of mCherry) to the ubiquitination domain of human CDT1 (AA 30-120) and of monomeric Venus (mVenus) to the ubiquitination domain of human geminin (AA 1-110).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   HeLa/GFP
AC   CVCL_JY89
DR   BCRJ; 0390
DR   Cell_Biolabs; AKR-213
DR   Wikidata; Q54882696
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HeLa/GR-luc
AC   CVCL_E3F8
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene is under the control of the glucocorticoid receptor (GR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0019.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HeLa/GSTP1
AC   CVCL_UG45
DR   Wikidata; Q94101241
RX   PubMed=26622693;
CC   Population: African American.
CC   Characteristics: Has a reduced radiosensitivity compared to the parent cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4638; GSTP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HeLa/MMTV-luc
AC   CVCL_2939
DR   ECACC; 11033106
DR   Wikidata; Q54882697
CC   Population: African American.
CC   Characteristics: Can be used to detect glucocorticoid mediated transcriptional activity of chemicals (ECACC=11033106).
CC   Characteristics: The luciferase reporter gene is under the control of the MMTV promoter (ECACC=11033106).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=11033106
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   HeLa/NFAT-luc
AC   CVCL_KS39
DR   Wikidata; Q54882698
RX   PubMed=16834536;
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NFAT response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0005.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HeLa/NFkB-luc
AC   CVCL_KS40
DR   Wikidata; Q54882699
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0013.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HeLa/PTX
AC   CVCL_HF87
DR   Wikidata; Q54882700
RX   PubMed=25015454;
CC   Population: African American.
CC   Doubling time: 32.5 +- 2.21 hours (PubMed=25015454).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 10
//
ID   HeLa/SN1
AC   CVCL_JQ52
DR   Wikidata; Q54882701
RX   PubMed=19201079;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa/SN10
AC   CVCL_JQ53
DR   Wikidata; Q54882702
RX   PubMed=19201079;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa/SN100
AC   CVCL_JQ54
SY   HeLa:SN100
DR   PRIDE; PXD002378
DR   Wikidata; Q54882703
RX   PubMed=19201079;
RX   PubMed=22200670;
RX   PubMed=26235782;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JQ53 ! HeLa/SN10
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HeLa/SRF-luc
AC   CVCL_KS42
DR   Wikidata; Q54882706
RX   PubMed=16834536;
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the SRF response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0012.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HeLa/STAT1-luc
AC   CVCL_KS41
DR   Wikidata; Q54882704
RX   PubMed=16834536;
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the STAT1 response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0004.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HeLa/STAT3-luc
AC   CVCL_KS43
SY   HeLa/Stat3-luc
DR   Wikidata; Q54882705
RX   PubMed=16834536;
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the STAT3 response element (PubMed=16834536).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0003.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   HeLa::TMEM192-3xHA
AC   CVCL_D1KR
DR   Wikidata; Q127381703
RX   PubMed=37757899;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (PubMed=37757899).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   HeLa::TMEM192-3xHA ARSA partial KO
AC   CVCL_D5F7
DR   Wikidata; Q127381704
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:713; ARSA (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA ARSB KO
AC   CVCL_D5EJ
DR   Wikidata; Q127381705
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:714; ARSB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA ASAH1 KO
AC   CVCL_D5EK
DR   Wikidata; Q127381706
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:735; ASAH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA CALCOCO1 KO
AC   CVCL_D1J7
SY   HeLa::TMEM192-3xHA CALCOCO1-/-
DR   Wikidata; Q127381708
RX   PubMed=37757899;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29306; CALCOCO1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HeLa::TMEM192-3xHA CLN3 KO
AC   CVCL_D5EL
DR   Wikidata; Q127381710
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2074; CLN3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA CLN6 partial KO
AC   CVCL_D5FC
DR   Wikidata; Q127381711
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2077; CLN6 (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA CTSA partial KO
AC   CVCL_D5FD
DR   Wikidata; Q127381712
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9251; CTSA (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA CTSD KO
AC   CVCL_D5EM
DR   Wikidata; Q127381713
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2529; CTSD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA CTSF partial KO
AC   CVCL_D5F8
DR   Wikidata; Q127381714
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2531; CTSF (Note=2 of 3 alleles).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GAA KO
AC   CVCL_D5EN
DR   Wikidata; Q127381715
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GALNS KO
AC   CVCL_D5EP
DR   Wikidata; Q127381716
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4122; GALNS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GBA1 partial KO
AC   CVCL_D5FE
DR   Wikidata; Q127381717
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1 (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GLA partial KO
AC   CVCL_D5FF
DR   Wikidata; Q127381718
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GLB1 KO
AC   CVCL_D5EQ
DR   Wikidata; Q127381719
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GM2A partial KO
AC   CVCL_D5FG
DR   Wikidata; Q127381720
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4367; GM2A (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GNPTG partial KO
AC   CVCL_D5FH
DR   Wikidata; Q127381721
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23026; GNPTG (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GNS KO
AC   CVCL_D5ER
DR   Wikidata; Q127381722
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4422; GNS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GRN KO
AC   CVCL_D5ES
DR   Wikidata; Q127381723
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA GUSB KO
AC   CVCL_D5ET
DR   Wikidata; Q127381724
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4696; GUSB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA HEXA KO
AC   CVCL_D5EU
DR   Wikidata; Q127381725
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4878; HEXA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA HEXB KO
AC   CVCL_D5EV
DR   Wikidata; Q127381727
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4879; HEXB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA IDUA KO
AC   CVCL_D5EW
DR   Wikidata; Q127381728
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5391; IDUA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA KCTD7 KO
AC   CVCL_D5EX
DR   Wikidata; Q127381729
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21957; KCTD7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA LAMP2 KO
AC   CVCL_D5EY
DR   Wikidata; Q127381730
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA LIPA KO
AC   CVCL_D5EZ
DR   Wikidata; Q127381731
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6617; LIPA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA MAN2B1 KO
AC   CVCL_D5F0
DR   Wikidata; Q127381733
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6826; MAN2B1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA MCOLN1 partial KO
AC   CVCL_D5F9
DR   Wikidata; Q127381734
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA MFSD8 KO
AC   CVCL_D5F1
DR   Wikidata; Q127381735
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA NAGLU KO
AC   CVCL_D5F2
DR   Wikidata; Q127381736
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7632; NAGLU.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA NEU1 partial KO
AC   CVCL_D5FA
DR   Wikidata; Q127381737
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA NPC1 KO
AC   CVCL_D5F3
DR   Wikidata; Q127381738
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA NPC2 KO
AC   CVCL_D5F4
DR   Wikidata; Q127381739
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14537; NPC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA PPT1 KO
AC   CVCL_D5F5
DR   Wikidata; Q127381740
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9325; PPT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA PSAP KO
AC   CVCL_D5F6
DR   Wikidata; Q127381741
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9498; PSAP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA SCARB2 partial KO
AC   CVCL_D5FI
DR   Wikidata; Q127381742
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1665; SCARB2 (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA SLC17A5 partial KO
AC   CVCL_D5FB
DR   Wikidata; Q127381743
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA SGSH partial KO
AC   CVCL_D5FJ
DR   Wikidata; Q127381744
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10818; SGSH (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA SMPD1 partial KO
AC   CVCL_D5FK
DR   Wikidata; Q127381746
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1 (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA TPP1 partial KO
AC   CVCL_D5FL
DR   Wikidata; Q127381747
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1 (Note=All alleles edited but some with in-frame deletion).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HeLa::TMEM192-3xHA YIPF3 KO
AC   CVCL_D1J8
SY   HeLa::TMEM192-3xHA YIPF3-/-
DR   Wikidata; Q127381748
RX   PubMed=37757899;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21023; YIPF3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HeLa::TMEM192-3xHA YIPF4 KO
AC   CVCL_D1J9
SY   HeLa::TMEM192-3xHA YIPF4-/-
DR   Wikidata; Q127381749
RX   PubMed=37757899;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 TMEM192 was C-terminally tagged on both alleles with a 3xHA epitope (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28145; YIPF4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1KR ! HeLa::TMEM192-3xHA
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   HeLa1.2.11
AC   CVCL_B5D9
SY   HeLa 1.2.11
DR   TOKU-E; 3894
DR   Wikidata; Q110432882
RX   PubMed=9476899;
RX   PubMed=10338214;
RX   PubMed=19864690;
RX   PubMed=24413054;
CC   Population: African American.
CC   Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (PubMed=10338214).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: The second allele values for D13S317 is incorrectly indicated as 13.5 in PubMed=19864690 (personal communication of de Lange, Titia through Korch, Christopher T.).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=19864690
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5D4 ! HeLaI
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HeLa1.3
AC   CVCL_B5DA
SY   HELA1.3; HeLa 1.3; HeLa 1.2.11 clone 1.3
DR   Wikidata; Q110432883
RX   PubMed=19864690;
RX   PubMed=32497497;
CC   Population: African American.
CC   Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (PubMed=19864690).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: The second allele values for D13S317 is incorrectly indicated as 13.5 in PubMed=19864690 (personal communication of de Lange, Titia through Korch, Christopher T.).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=19864690
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5D9 ! HeLa1.2.11
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HeLa1.3 hTR-50-3xMS2
AC   CVCL_B5DF
SY   HeLa 1.3 hTR-50-3xMS2; MS2_hTR HeLa cells (clone 15.5)
DR   Wikidata; Q110432884
RX   PubMed=32497497;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 3 MS2 stem loops sequences flanked by homologous telomerase RNA (hTR) sequences were knocked in.
CC   Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (from parent cell line).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5DA ! HeLa1.3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   HeLa1.3 hTR-50-3xMS2 TCAB1-/-
AC   CVCL_B5DG
SY   HeLa 1.3 hTR-50-3xMS2 TCAB1-/-
DR   Wikidata; Q110432886
RX   PubMed=32497497;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 3 MS2 stem loops sequences flanked by homologous telomerase RNA (hTR) sequences were knocked in.
CC   Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25522; WRAP53.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5DF ! HeLa1.3 hTR-50-3xMS2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa1.3 hTR-50-3xMS2 TERT-/-
AC   CVCL_B5DH
SY   HeLa 1.3 hTR-50-3xMS2 TERT-/-
DR   Wikidata; Q110432888
RX   PubMed=32497497;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 3 MS2 stem loops sequences flanked by homologous telomerase RNA (hTR) sequences were knocked in.
CC   Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5DF ! HeLa1.3 hTR-50-3xMS2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   HeLa204
AC   CVCL_B5DB
DR   Wikidata; Q110432889
RX   PubMed=19864690;
CC   Population: African American.
CC   Characteristics: Has telomeres of approximately 3-7 kb in length (from parent cell line).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5D5 ! HeLaII
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   HeLa9903
AC   CVCL_2485
SY   HeLa 9903; Hela-9903
DR   ECACC; 11033105
DR   JCRB; JCRB1318
DR   Wikidata; Q54882736
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=11033105; JCRB=JCRB1318
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   HeLaI
AC   CVCL_B5D4
DR   Wikidata; Q110432890
RX   PubMed=8432193;
RX   PubMed=9476899;
CC   Population: African American.
CC   Characteristics: Has telomeres of approximately 25-30 kb in length (PubMed=8432193).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   HeLaII
AC   CVCL_B5D5
DR   Wikidata; Q110432891
RX   PubMed=8432193;
RX   PubMed=19864690;
CC   Population: African American.
CC   Characteristics: Has telomeres of approximately 3-7 kb in length (PubMed=8432193).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: The second allele values for D13S317 is incorrectly indicated as 13.5 in PubMed=19864690 (personal communication of de Lange, Titia through Korch, Christopher T.).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=19864690
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HeLap121G
AC   CVCL_A9H3
DR   Wikidata; Q102114112
RX   PubMed=10362555;
CC   Population: African American.
CC   Characteristics: Transfected with POM121 C-terminally tagged with GFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:19702; POM121.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HeLaRC32
AC   CVCL_B053
SY   HeRC32
DR   ATCC; CRL-2972
DR   Wikidata; Q54882737
RX   PubMed=10953917;
CC   Group: Adeno-associated virus packaging cell line.
CC   Population: African American.
CC   Characteristics: Transfected with a recombinant adeno-associated virus type 2 (rAAV) (PubMed=10953917).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-2972
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   HeLaSF
AC   CVCL_1278
SY   HELASF; HeLa Serum Free
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-2.3
DR   Cell_Model_Passport; SIDM01209
DR   Cosmic; 687509
DR   GEO; GSM1669876
DR   PharmacoDB; HeLaSF_537_2019
DR   Wikidata; Q54882739
RX   PubMed=20164919;
CC   Group: Serum/protein free medium cell line.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CCL-2.3; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-2.3
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HELN
AC   CVCL_WI87
SY   HeLa ERE-beta-globin Luciferase Neo
DR   Wikidata; Q94101418
RX   PubMed=11312541;
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene is under the control of an estrogen-responsive element from the beta-globin promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   HELN(alpha)
AC   CVCL_WI88
SY   HELN ERalpha; HELN-ERalpha
DR   Wikidata; Q94101425
RX   PubMed=10492897;
RX   PubMed=11312541;
CC   Population: African American.
CC   Biotechnology: Used in a bioluminescent bioassay to quantitatively measure estrogenic compounds.
CC   Characteristics: The luciferase reporter gene is under the control of an estrogen-responsive element from the beta-globin promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WI87 ! HELN
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   HELN(beta)
AC   CVCL_WI89
SY   HELN ERbeta; HELN-ERbeta
DR   Wikidata; Q94101428
RX   PubMed=10492897;
RX   PubMed=11312541;
CC   Population: African American.
CC   Biotechnology: Used in a bioluminescent bioassay to quantitatively measure estrogenic compounds.
CC   Characteristics: The luciferase reporter gene is under the control of an estrogen-responsive element from the beta-globin promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3468; ESR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WI87 ! HELN
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   HELP I
AC   CVCL_6D74
DR   Wikidata; Q54882740
RX   PubMed=1711471;
RX   PubMed=2434329;
RX   PubMed=3597519;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6D75 ! HELP II
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   HELP II
AC   CVCL_6D75
DR   Wikidata; Q54882741
RX   PubMed=2434329;
RX   PubMed=6190961;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6D74 ! HELP I
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   HELP III
AC   CVCL_6D76
DR   Wikidata; Q54882742
RX   PubMed=1711471;
RX   PubMed=2434329;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   HELP IV
AC   CVCL_6D77
DR   Wikidata; Q54882743
RX   PubMed=2434329;
RX   PubMed=3597519;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   HELPi001-A
AC   CVCL_WN17
SY   BS-TL-1
DR   BioSamples; SAMEA5728929
DR   hPSCreg; HELPi001-A
DR   Wikidata; Q94101557
RX   PubMed=31426022;
CC   From: Help Stem Cell Innovations Co., Ltd; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3604; FBN2; Simple; p.Ile243Thr (c.728T>C); ClinVar=VCV000137358; Zygosity=Heterozygous (PubMed=31426022).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129865; Congenital contractural arachnodactyly
DI   ORDO; Orphanet_115; Congenital contractural arachnodactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   HELrARA-C2mug/ML
AC   CVCL_RS48
DR   cancercelllines; CVCL_RS48
DR   Wikidata; Q54882744
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0001 ! HEL
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   hEM15A
AC   CVCL_WJ05
DR   CCRID; 1101HUM-PUMC000485
DR   CCRID; 4201HUM-CCTCC00601
DR   CCTCC; GDC0601
DR   GeneCopoeia; SL430
DR   Wikidata; Q94101576
RX   CelloPub=CLPUB00490;
CC   Doubling time: ~24 hours (CelloPub=CLPUB00490).
CC   Karyotypic information: Normal diploid karyotype (CelloPub=CLPUB00490).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): CCRID; GeneCopoeia=SL430
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 21,22
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D6S1043: 14,18
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta E: 14,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   hEM3
AC   CVCL_B7IX
DR   Wikidata; Q112929709
RX   PubMed=34376780;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=34376780
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D21S11: 27,28
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 13,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   hEM3 ARID1A-KO
AC   CVCL_B7IY
SY   ARID1A-KO hEM3
DR   Wikidata; Q112929710
RX   PubMed=34376780;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7IX ! hEM3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   hEM5B2
AC   CVCL_WJ06
SY   hEM-5B2
DR   Wikidata; Q94101579
RX   CelloPub=CLPUB00490;
RX   PubMed=32106286;
CC   Doubling time: ~64.8 hours (CelloPub=CLPUB00490).
CC   Karyotypic information: Hypertetraploid karyotype. Contains between 78 and 123 chromosomes. Has chromosome breakage, deletion and translocation in ~84% of the cells (CelloPub=CLPUB00490).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   HeNC2
AC   CVCL_8601
DR   Wikidata; Q54882745
RX   PubMed=9039268;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   HEP
AC   CVCL_C3HW
DR   Wikidata; Q114311592
RX   PubMed=1711532;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pX8 ori-).
CC   Donor information: Established from a fetus heterozygous carrier of an unknown paternal CFTR mutation.
CC   Derived from site: In situ; Fetal testis, epididymis, epithelium; UBERON=UBERON_0004544.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3HT ! HVP
SX   Male
AG   19FW
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   Hep 3B-Luc
AC   CVCL_C8YA
DR   Ubigene; YC-D002-Luc-P
DR   Wikidata; Q123031633
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Hep 3B2.1-7
AC   CVCL_0326
SY   Hep 3B2_1-7; Hep 3B 2.1-7; HEP3B217; Hep 3B2; HEP-3B2; HEP3B2; Hep-3B; HEP-3B; Hep 3B; Hep3B; HEP3B
DR   BTO; BTO_0000972
DR   CLO; CLO_0003702
DR   CLO; CLO_0003703
DR   CLO; CLO_0003710
DR   EFO; EFO_0002205
DR   MCCL; MCC:0000221
DR   CLDB; cl1627
DR   CLDB; cl1628
DR   CLDB; cl1629
DR   CLDB; cl1630
DR   AddexBio; C0015001/45
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HB-8064
DR   BCRC; 60434
DR   BCRJ; 0357
DR   BioGRID_ORCS_Cell_line; 810
DR   BioSample; SAMN03473193
DR   BioSample; SAMN10988098
DR   cancercelllines; CVCL_0326
DR   CCRID; 1101HUM-PUMC000376
DR   CCRID; 1101HUM-PUMC000474
DR   CCRID; 1102HUM-NIFDC00059
DR   CCRID; 3101HUMSCSP5045
DR   CCRID; 3101HUMTCHu106
DR   CCRID; 4201HUM-CCTCC00070
DR   CCTCC; GDC0070
DR   Cell_Model_Passport; SIDM00672
DR   CGH-DB; 454-3
DR   CGH-DB; 9069-4
DR   ChEMBL-Cells; CHEMBL4106361
DR   ChEMBL-Targets; CHEMBL4296437
DR   CLS; 305141
DR   Cosmic; 873401
DR   Cosmic; 928140
DR   Cosmic; 934549
DR   Cosmic; 948066
DR   Cosmic; 979729
DR   Cosmic; 999851
DR   Cosmic; 1019316
DR   Cosmic; 1177682
DR   Cosmic; 1351510
DR   Cosmic; 1518225
DR   Cosmic; 1628385
DR   Cosmic; 2023864
DR   Cosmic; 2162536
DR   Cosmic; 2301557
DR   Cosmic; 2321030
DR   Cosmic; 2668282
DR   Cosmic; 2773181
DR   Cosmic; 2816904
DR   Cosmic-CLP; 1240147
DR   DepMap; ACH-000625
DR   DSMZ; ACC-93
DR   DSMZCellDive; ACC-93
DR   ECACC; 86062703
DR   EGA; EGAS00001000978
DR   GDSC; 1240147
DR   GEO; GSM207050
DR   GEO; GSM501778
DR   GEO; GSM565879
DR   GEO; GSM887078
DR   GEO; GSM888148
DR   GEO; GSM936759
DR   GEO; GSM1374531
DR   GEO; GSM1669879
DR   GEO; GSM2551564
DR   IARC_TP53; 30036
DR   IGRhCellID; Hep3B
DR   IZSLER; BS TCL 78
DR   KCB; KCB 200771YJ
DR   KCB; KCB 200942YJ
DR   KCLB; 88064
DR   LiGeA; CCLE_655
DR   LIMORE; Hep3B
DR   LINCS_LDP; LCL-1924
DR   Lonza; 473
DR   PharmacoDB; Hep3B2_17_538_2019
DR   PRIDE; PXD000533
DR   PRIDE; PXD000535
DR   PRIDE; PXD005291
DR   PRIDE; PXD008190
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0326
DR   PubChem_Cell_line; CVCL_0326
DR   RCB; RCB2090
DR   TKG; TKG 0291
DR   TOKU-E; 1439
DR   TOKU-E; 3574
DR   Ubigene; YC-D002
DR   Wikidata; Q54882746
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   Patent=US4393133;
RX   PubMed=233137;
RX   PubMed=2439335;
RX   PubMed=3023526;
RX   PubMed=3431441;
RX   PubMed=6248960;
RX   PubMed=6275024;
RX   PubMed=6288577;
RX   PubMed=7972006;
RX   PubMed=8050184;
RX   PubMed=8224613;
RX   PubMed=8389256;
RX   PubMed=8835345;
RX   PubMed=9290701;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=11050057;
RX   PubMed=12029633;
RX   PubMed=15767549;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=20937217;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=24116068;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29610054;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=32899426;
RX   PubMed=34320349;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/Hep3B
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Quora; -; https://www.quora.com/What-is-a-Hep-3B-cell-line
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-106.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/hep3b-xenograft-model/
WW   Provider; BRICS; BRICS0054; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3869
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8064.
CC   Population: African American.
CC   Doubling time: 28.05 hours (PubMed=31378681); ~40-50 hours (DSMZ=ACC-93).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (PubMed=31395879; Cosmic-CLP=1240147; DepMap=ACH-000625).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (PubMed=31395879; Cosmic-CLP=1240147; DepMap=ACH-000625).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=71.82%; Native American=0.52%; East Asian, North=3.16%; East Asian, South=0%; South Asian=0%; European, North=8.8%; European, South=15.69% (PubMed=30894373).
CC   Misspelling: Hep_3B1_1-7; Cosmic=2773181.
CC   Discontinued: RCB; RCB2090; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): AddexBio=C0015001/45; ATCC=HB-8064; CCRID; Cosmic-CLP=1240147; DSMZ=ACC-93; ECACC=86062703; KCLB=88064; PubMed=24116068; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D13S317: 12,14
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 12.2,14
ST   D21S11: 30,31
ST   D2S1338: 21,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 18
ST   Penta D: 12,14
ST   Penta E: 5,16 (ATCC=HB-8064; CCRID; PubMed=25877200)
ST   Penta E: 16 (DSMZ=ACC-93)
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 50
//
ID   Hep 40
AC   CVCL_EI25
SY   Hep-40; Hep40
DR   Cosmic; 2321032
DR   Wikidata; Q54882747
RX   PubMed=7590653;
RX   PubMed=25574106;
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 6
//
ID   Hep G2-C34
AC   CVCL_A2HD
SY   C34; HepG2 C34
DR   cancercelllines; CVCL_A2HD
DR   Wikidata; Q105507615
RX   PubMed=9547353;
RX   PubMed=18369917;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for Hep G2-E43 (Cellosaurus=CVCL_A2HF) and Hep G2-E47 (Cellosaurus=CVCL_A2HG) (PubMed=9547353).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Hep G2-C37
AC   CVCL_A2HE
SY   C37
DR   cancercelllines; CVCL_A2HE
DR   Wikidata; Q105507619
RX   PubMed=9547353;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for Hep G2-E43 (Cellosaurus=CVCL_A2HF) and Hep G2-E47 (Cellosaurus=CVCL_A2HG) (PubMed=9547353).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Hep G2-E43
AC   CVCL_A2HF
SY   Hep G2-Cl2E1-43; HepG2-CYP2E1 E43; E43
DR   cancercelllines; CVCL_A2HF
DR   Wikidata; Q105507625
RX   PubMed=9547353;
RX   PubMed=10748080;
CC   Population: Caucasian.
CC   Characteristics: Overexpresses CYP2E1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Hep G2-E47
AC   CVCL_A2HG
SY   Hep G2-Cl2E1-47; HepG2-CYP2E1 E47; HepG2 E47; E47; E-47
DR   cancercelllines; CVCL_A2HG
DR   Wikidata; Q105507629
RX   PubMed=9547353;
RX   PubMed=10748080;
RX   PubMed=16181800;
RX   PubMed=18369917;
CC   Population: Caucasian.
CC   Characteristics: Overexpresses CYP2E1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Hep G2-EGFP
AC   CVCL_C8WN
DR   Ubigene; YC-C001-EGFP-P
DR   Wikidata; Q123031634
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Hep G2-Luc
AC   CVCL_C8WP
DR   Ubigene; YC-C001-Luc-P
DR   Wikidata; Q123031635
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Hep G2-MV2E1-9
AC   CVCL_A2HB
SY   HepG2 clone MV2E1-9; Hep G2-MVh2E1-9; G2-MV2E1-9; MV2E1-9
DR   cancercelllines; CVCL_A2HB
DR   Wikidata; Q105507631
RX   PubMed=7687464;
RX   PubMed=9169410;
RX   PubMed=9547353;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Hep G2-MV-5
AC   CVCL_A2HC
SY   MV-5
DR   cancercelllines; CVCL_A2HC
DR   Wikidata; Q105507634
RX   PubMed=7687464;
RX   PubMed=9169410;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for Hep G2-MV2E1-9 (Cellosaurus=CVCL_A2HB) (PubMed=7687464).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Hep G2(Cas9)
AC   CVCL_E7J5
WW   Provider; BRICS; ECC3005; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3939
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HEP G2ins
AC   CVCL_HA60
SY   HEPG2ins; HepG2ins
DR   cancercelllines; CVCL_HA60
DR   Wikidata; Q54882748
RX   Patent=WO1995032740A1;
RX   PubMed=7614254;
RX   PubMed=12958175;
CC   Group: Patented cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 17
//
ID   HEP G2ins/g
AC   CVCL_HA61
SY   HEPG2ins/g; HepG2ins/g
DR   cancercelllines; CVCL_HA61
DR   Wikidata; Q54882749
RX   Patent=WO1995032740A1;
RX   PubMed=9425444;
RX   PubMed=12958175;
CC   Group: Patented cell line.
CC   Population: Caucasian.
CC   Characteristics: Synthesizes, stores and secretes insulin in a regulated manner when exposed to glucose in tissue culture.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11006; SLC2A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HA60 ! HEP G2ins
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 21
//
ID   HEp-1
AC   CVCL_JB76
SY   H.Ep. #1; H.Ep. No. 1; HEp1; Human Epidermoid carcinoma #1
DR   Wikidata; Q54882752
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=5835037;
RX   PubMed=13209540;
RX   PubMed=13261081;
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   Hep-11
AC   CVCL_A1RR
DR   cancercelllines; CVCL_A1RR
DR   Wikidata; Q105507637
RX   Patent=CN101693886B;
RX   PubMed=19897602;
RX   PubMed=19929456;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.3203.
CC   Population: Chinese.
CC   Doubling time: 44 hours (PubMed=19929456).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=19897602).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1RS ! Hep-12
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   Hep-12
AC   CVCL_A1RS
DR   cancercelllines; CVCL_A1RS
DR   Wikidata; Q105507640
RX   Patent=CN101693886B;
RX   PubMed=19897602;
RX   PubMed=19929456;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.3204.
CC   Population: Chinese.
CC   Doubling time: 53 hours (PubMed=19929456).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=19897602).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1RR ! Hep-11
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   HEp-2
AC   CVCL_1906
SY   Hep-2; HEP-2; Hep2 (HeLa derivative); HEp-2/HeLa; Hep 2; Hep2; HEp2; HEP2; H.Ep.-2; H.Ep. #2; H.Ep. No. 2; Hep II; Human Epidermoid carcinoma #2; Human Epithelioma-2
DR   BTO; BTO_0000976
DR   CLO; CLO_0003706
DR   CLO; CLO_0003707
DR   CLO; CLO_0050927
DR   EFO; EFO_0006438
DR   CLDB; cl1646
DR   CLDB; cl1647
DR   CLDB; cl1649
DR   CLDB; cl1650
DR   CLDB; cl1653
DR   CLDB; cl1654
DR   CLDB; cl1655
DR   AddexBio; C0050001/4983
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CCL-23
DR   BCRC; 60042
DR   BCRJ; 0101
DR   BioSample; SAMN03151706
DR   CCLV; CCLV-RIE 0141
DR   CCRID; 1101HUM-PUMC000068
DR   CCRID; 4201PAT-CCTCC00214
DR   CCTCC; GDC0004
DR   Cell_Model_Passport; SIDM01208
DR   ChEMBL-Cells; CHEMBL3307694
DR   ChEMBL-Targets; CHEMBL614735
DR   CLS; 300397
DR   Cosmic; 1339928
DR   Cosmic; 1530739
DR   Cosmic; 1969495
DR   Cosmic; 2301559
DR   ECACC; 86030501
DR   EGA; EGAS00001000610
DR   FANTOM5_SSTAR; 11890-125D9
DR   FANTOM5_SSTAR; 11891-125E1
DR   FANTOM5_SSTAR; 11892-125E2
DR   FANTOM5_SSTAR; 11894-125E4
DR   FANTOM5_SSTAR; 11895-125E5
DR   FANTOM5_SSTAR; 11896-125E6
DR   FANTOM5_SSTAR; 11898-125E8
DR   FANTOM5_SSTAR; 11899-125E9
DR   FANTOM5_SSTAR; 11900-125F1
DR   GEO; GSM1374529
DR   GEO; GSM1374530
DR   IZSLER; BS TCL 23
DR   KCLB; 10023
DR   NCBI_Iran; C144
DR   PharmacoDB; HEp2_540_2019
DR   PRIDE; PXD006201
DR   PRIDE; PXD013072
DR   PRIDE; PXD014913
DR   PRIDE; PXD031726
DR   PubChem_Cell_line; CVCL_1906
DR   RCB; RCB1889
DR   TKG; TKG 0403
DR   TOKU-E; 1442
DR   Wikidata; Q16554737
RX   CelloPub=CLPUB00484;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.11418/jtca1981.17.3_95;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=3180844;
RX   PubMed=4203458;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=5668122;
RX   PubMed=6988327;
RX   PubMed=8397027;
RX   PubMed=11416159;
RX   PubMed=13209540;
RX   PubMed=13261081;
RX   PubMed=14185313;
RX   PubMed=17254797;
RX   PubMed=19450234;
RX   PubMed=19941903;
RX   PubMed=20143388;
RX   PubMed=23925245;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=29483928;
RX   PubMed=29967540;
RX   PubMed=31105993;
RX   PubMed=33389257;
RX   PubMed=34024160;
RX   PubMed=34697958;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-204.html
WW   Info; Wikipedia; -; https://es.wikipedia.org/wiki/C%C3%A9lulas_HEp-2
WW   Provider; Vircell; -; https://www.vircell.com/en/products/hep-2-cell-line
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.
CC   Part of: KuDOS 95 cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00007.
CC   Population: African American.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   HLA typing: A*68:02,68:02; B*15:03,15:03; C*12:03,12:03 (PubMed=26589293).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; PTM; Ubiquitination.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: BCRC; 60042; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): AddexBio=C0050001/4983; ATCC=CCL-23; CCRID; CLS=300397; KCLB=10023; PubMed=11416159; PubMed=17254797; RCB=RCB1889; TKG=TKG 0403
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12 (RCB=RCB1889)
ST   D13S317: 12,13.3 (AddexBio=C0050001/4983; ATCC=CCL-23; CCRID; CLS=300397; KCLB=10023; TKG=TKG 0403)
ST   D13S317: 12,14 (PubMed=17254797)
ST   D16S539: 9,10
ST   D18S51: 15 (PubMed=17254797)
ST   D18S51: 16 (ATCC=CCL-23; CCRID; CLS=300397; PubMed=11416159)
ST   D19S433: 13,14
ST   D21S11: 26,27 (PubMed=17254797)
ST   D21S11: 27,28 (ATCC=CCL-23; CCRID; CLS=300397; PubMed=11416159)
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   HEp-2 clone 2B
AC   CVCL_2817
SY   Hep2 (Clone 2B); Hep2 clone B
DR   CLO; CLO_0003708
DR   CLDB; cl1657
DR   BioSample; SAMN03151705
DR   ECACC; 85011412
DR   Wikidata; Q54882754
RX   PubMed=1246601;
RX   PubMed=20143388;
RX   PubMed=32994520;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00310.
CC   Population: African American.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (PubMed=32994520).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Hep-2 TPFR
AC   CVCL_GZ00
DR   Wikidata; Q54882756
RX   PubMed=25962396;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   HEp-2-NS1
AC   CVCL_A8JP
DR   Wikidata; Q108820457
RX   PubMed=22263272;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0DOE9; Human respiratory syncytial virus A protein NS1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   HEp-2/VCR
AC   CVCL_B7H7
DR   Wikidata; Q112929711
RX   PubMed=29483928;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   Hep-2004
AC   CVCL_ZY36
SY   Hep2004
DR   Wikidata; Q102114114
RX   PubMed=33060611;
CC   Characteristics: The CCDN1, CDK4 and TERT genes expression can be silenced by administration of tetracycline/doxycycline through a Tet-Off system (PubMed=33060611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   Hep-2013
AC   CVCL_JG88
SY   Hep2013
DR   JCRB; JCRB1696
DR   Wikidata; Q54882757
RX   PubMed=33060611;
CC   Characteristics: The CCDN1, CDK4 and TERT genes expression can be silenced by administration of tetracycline/doxycycline through a Tet-Off system (PubMed=33060611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): JCRB=JCRB1696
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y10M
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   Hep-2017
AC   CVCL_ZY42
SY   Hep2017
DR   Wikidata; Q102114116
RX   PubMed=33060611;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   Hep-2018
AC   CVCL_JG89
SY   Hep2018; HepaMN
DR   JCRB; JCRB1697
DR   Wikidata; Q54882758
RX   PubMed=33060611;
CC   Characteristics: The CCDN1, CDK4 and TERT genes expression can be silenced by administration of tetracycline/doxycycline through a Tet-Off system (PubMed=33060611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): JCRB=JCRB1697
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   Hep-2020
AC   CVCL_JG90
SY   Hep2020
DR   JCRB; JCRB1699
DR   Wikidata; Q54882759
RX   PubMed=33060611;
CC   Characteristics: The CCDN1, CDK4 and TERT genes expression can be silenced by administration of tetracycline/doxycycline through a Tet-Off system (PubMed=33060611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): JCRB=JCRB1699
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C97071; Congenital hepatic fibrosis
DI   ORDO; Orphanet_485426; Isolated congenital hepatic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   Hep-2022D
AC   CVCL_ZY43
SY   Hep2022D
DR   Wikidata; Q102114118
RX   PubMed=33060611;
CC   Characteristics: The CCDN1, CDK4 and TERT genes expression can be silenced by administration of tetracycline/doxycycline through a Tet-Off system (PubMed=33060611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   Hep-2023D
AC   CVCL_JG87
SY   Hep2023D
DR   JCRB; JCRB1695
DR   Wikidata; Q54882761
RX   PubMed=33060611;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): JCRB=JCRB1695
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,14
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   Hep-2039D
AC   CVCL_ZY39
SY   Hep2039D
DR   Wikidata; Q102114119
RX   PubMed=33060611;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   Hep-2040
AC   CVCL_JG91
SY   Hep2040
DR   JCRB; JCRB1701
DR   Wikidata; Q54882762
RX   PubMed=33060611;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; JCRB1701; probable.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): JCRB=JCRB1701
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C84400; Intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 13
//
ID   Hep-2044
AC   CVCL_ZY40
SY   Hep2044
DR   Wikidata; Q102114120
RX   PubMed=33060611;
CC   Characteristics: The CCDN1, CDK4 and TERT genes expression can be silenced by administration of tetracycline/doxycycline through a Tet-Off system (PubMed=33060611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   Hep-2045
AC   CVCL_ZY41
SY   Hep2045
DR   Wikidata; Q102114121
RX   PubMed=33060611;
CC   Characteristics: The CCDN1, CDK4 and TERT genes expression can be silenced by administration of tetracycline/doxycycline through a Tet-Off system (PubMed=33060611).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HEp-2C
AC   CVCL_2940
SY   Hep-2C
DR   CLO; CLO_0003709
DR   CLDB; cl1656
DR   AddexBio; C0008008/5058
DR   BioSample; SAMN03151707
DR   ECACC; 85020207
DR   Wikidata; Q54882763
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00309.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): AddexBio=C0008008/5058
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HEp-3
AC   CVCL_JB77
SY   H.Ep. #3; H.Ep. No. 3; HEp3; Human Epidermoid carcinoma #3
DR   BTO; BTO_0005139
DR   Wikidata; Q54882764
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=1327511;
RX   PubMed=3119604;
RX   PubMed=5835037;
RX   PubMed=9650562;
RX   PubMed=13209540;
RX   PubMed=13261081;
CC   Population: African American.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   62Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   HEp-5
AC   CVCL_JC28
SY   H.Ep. #5; H.Ep. No. 5; HEp5; Human Epidermoid carcinoma #5
DR   Wikidata; Q54882765
RX   PubMed=5835037;
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   Hep-53.4
AC   CVCL_5765
SY   HEP-53.4; 53.4
DR   CLS; 400200
DR   Wikidata; Q54882766
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6J.
ST   Source(s): CLS=400200
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 20
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Hep-55.1C
AC   CVCL_5766
SY   HEP-55.1C; 55.1C
DR   CLS; 400201
DR   Wikidata; Q54882767
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Hep-56.1B
AC   CVCL_5767
SY   HEP-56.1B; 56.1B; 56.1b
DR   CLS; 400202
DR   Wikidata; Q54882768
RX   PubMed=1382443;
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg277Thr (c.830G>C); Zygosity=Heterozygous (PubMed=1382443).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5768 ! Hep-56.1C
OI   CVCL_5769 ! Hep-56.1D
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Hep-56.1C
AC   CVCL_5768
SY   HEP-56.1C; 56.1C; 56.1c
DR   CLS; 400203
DR   Wikidata; Q54882769
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5767 ! Hep-56.1B
OI   CVCL_5769 ! Hep-56.1D
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Hep-56.1D
AC   CVCL_5769
SY   HEP-56.1D; 56.1D; 56.1d
DR   CLS; 400204
DR   Wikidata; Q54882770
RX   PubMed=1382443;
CC   Doubling time: ~25-30 hours (CLS=400204).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Cys132Trp (c.396C>G); Zygosity=Heterozygous (PubMed=1382443).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5767 ! Hep-56.1B
OI   CVCL_5768 ! Hep-56.1C
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Hep-64.1
AC   CVCL_5770
SY   HEP-64.1; 64.1
DR   CLS; 400205
DR   Wikidata; Q54882771
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6 x C3H.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Hep-66.3A
AC   CVCL_5771
SY   HEP-66.3A; 66.3A
DR   CLS; 400206
DR   Wikidata; Q54882772
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6 x C3H.
ST   Source(s): CLS=400206
ST   Mouse STR 1-1: 10,16
ST   Mouse STR 1-2: 16,20
ST   Mouse STR 2-1: 9,15
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 15,16
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 7-1: 26,26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3,25.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16,18
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 28
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Hep-70.4
AC   CVCL_5772
SY   HEP-70.4; 70.4
DR   CLS; 400207
DR   Wikidata; Q54882773
RX   PubMed=1382443;
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Ala135Pro (c.403G>C); Zygosity=Heterozygous (PubMed=1382443).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Cys138Trp (c.414C>G); Zygosity=Heterozygous (PubMed=1382443).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Hep-74.3A
AC   CVCL_5773
SY   Hep-74.3; HEP-74.3a; 74.3A; 74.3a
DR   CLS; 400208
DR   Wikidata; Q54882774
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Hep-CLS-1H
AC   CVCL_5774
SY   HEP-CLS-1H
DR   CLS; 400197
DR   Wikidata; Q54882775
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Hep-CLS-1W
AC   CVCL_5775
SY   HEP-CLS-1W
DR   CLS; 400414
DR   Wikidata; Q54882776
CC   Doubling time: ~12 hours (CLS=400414).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/He.
ST   Source(s): CLS=400414
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 25.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Hep-CLS-C9
AC   CVCL_5776
SY   HEP-CLS-C9; C9
DR   CLS; 400195
DR   Wikidata; Q54882777
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/He.
ST   Source(s): CLS=400195
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 25.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Hep-CLS-E1
AC   CVCL_5777
SY   HEP-CLS-E1; E1
DR   CLS; 400196
DR   Wikidata; Q54882778
RX   PubMed=1382443;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/He.
ST   Source(s): CLS=400196
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 25.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Hep-G2
AC   CVCL_0027
SY   HEP-G2; Hep G2; HEP G2; HepG2; HEPG2
DR   BTO; BTO_0000599
DR   CLO; CLO_0003704
DR   CLO; CLO_0003713
DR   CLO; CLO_0050856
DR   CLO; CLO_0050858
DR   EFO; EFO_0001187
DR   MCCL; MCC:0000222
DR   CLDB; cl1635
DR   CLDB; cl1636
DR   CLDB; cl1637
DR   CLDB; cl1638
DR   CLDB; cl1639
DR   CLDB; cl1641
DR   CLDB; cl1642
DR   CLDB; cl1643
DR   CLDB; cl1644
DR   CLDB; cl4910
DR   Abcam; ab257304
DR   Abcam; ab275467
DR   AddexBio; C0015002/46
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-6919
DR   ATCC; HB-8065
DR   BCRC; 60025
DR   BCRJ; 0103
DR   BioGRID_ORCS_Cell_line; 809
DR   BioSample; SAMN01821557
DR   BioSample; SAMN01821681
DR   BioSample; SAMN03472183
DR   BioSample; SAMN10988201
DR   cancercelllines; CVCL_0027
DR   CCRID; 1101HUM-PUMC000035
DR   CCRID; 3101HUMSCSP510
DR   CCRID; 3101HUMTCHu72
DR   CCRID; 4201HUM-CCTCC00024
DR   CCRID; 5301HUM-KCB05007YJ
DR   CCTCC; GDC0024
DR   Cell_Model_Passport; SIDM00904
DR   CGH-DB; 9068-4
DR   ChEMBL-Cells; CHEMBL3307718
DR   ChEMBL-Targets; CHEMBL395
DR   CLS; 300198
DR   Cosmic; 690746
DR   Cosmic; 724821
DR   Cosmic; 852774
DR   Cosmic; 869169
DR   Cosmic; 869298
DR   Cosmic; 871510
DR   Cosmic; 873392
DR   Cosmic; 873713
DR   Cosmic; 928138
DR   Cosmic; 932989
DR   Cosmic; 934550
DR   Cosmic; 945158
DR   Cosmic; 948062
DR   Cosmic; 979732
DR   Cosmic; 999850
DR   Cosmic; 1060080
DR   Cosmic; 1187331
DR   Cosmic; 1351511
DR   Cosmic; 1499246
DR   Cosmic; 1518227
DR   Cosmic; 1628386
DR   Cosmic; 2162525
DR   Cosmic; 2301556
DR   Cosmic; 2321029
DR   Cosmic; 2560244
DR   Cosmic; 2668285
DR   Cosmic; 2674233
DR   Cosmic; 2773180
DR   DepMap; ACH-000739
DR   DSMZ; ACC-180
DR   DSMZCellDive; ACC-180
DR   ECACC; 85011430
DR   EGA; EGAS00001000610
DR   ENCODE; ENCBS002KIX
DR   ENCODE; ENCBS005KKO
DR   ENCODE; ENCBS005NKZ
DR   ENCODE; ENCBS006INV
DR   ENCODE; ENCBS009AVS
DR   ENCODE; ENCBS011BYX
DR   ENCODE; ENCBS011NDE
DR   ENCODE; ENCBS012DTZ
DR   ENCODE; ENCBS013LLU
DR   ENCODE; ENCBS015PAC
DR   ENCODE; ENCBS016WDR
DR   ENCODE; ENCBS017VYZ
DR   ENCODE; ENCBS018BAD
DR   ENCODE; ENCBS018WXY
DR   ENCODE; ENCBS019LAC
DR   ENCODE; ENCBS019QTJ
DR   ENCODE; ENCBS019XED
DR   ENCODE; ENCBS020YDI
DR   ENCODE; ENCBS021UTC
DR   ENCODE; ENCBS023JBH
DR   ENCODE; ENCBS024EHA
DR   ENCODE; ENCBS025AAW
DR   ENCODE; ENCBS030GWA
DR   ENCODE; ENCBS030ZIT
DR   ENCODE; ENCBS033QJG
DR   ENCODE; ENCBS034ENA
DR   ENCODE; ENCBS034PYO
DR   ENCODE; ENCBS035IIS
DR   ENCODE; ENCBS038OUO
DR   ENCODE; ENCBS038ZQB
DR   ENCODE; ENCBS039DPC
DR   ENCODE; ENCBS039XPI
DR   ENCODE; ENCBS040DES
DR   ENCODE; ENCBS040EJF
DR   ENCODE; ENCBS040QBA
DR   ENCODE; ENCBS041GAW
DR   ENCODE; ENCBS042JDA
DR   ENCODE; ENCBS044VWV
DR   ENCODE; ENCBS045GOD
DR   ENCODE; ENCBS045OVM
DR   ENCODE; ENCBS048XFP
DR   ENCODE; ENCBS049KBY
DR   ENCODE; ENCBS049QKG
DR   ENCODE; ENCBS049RJI
DR   ENCODE; ENCBS051IBT
DR   ENCODE; ENCBS053QGR
DR   ENCODE; ENCBS053TZY
DR   ENCODE; ENCBS055KDL
DR   ENCODE; ENCBS056VWP
DR   ENCODE; ENCBS060DQW
DR   ENCODE; ENCBS061GMD
DR   ENCODE; ENCBS061GZI
DR   ENCODE; ENCBS063CQL
DR   ENCODE; ENCBS063KED
DR   ENCODE; ENCBS065LQD
DR   ENCODE; ENCBS066SAB
DR   ENCODE; ENCBS066SXT
DR   ENCODE; ENCBS067QSF
DR   ENCODE; ENCBS068DNA
DR   ENCODE; ENCBS070YKP
DR   ENCODE; ENCBS072JEO
DR   ENCODE; ENCBS074GMS
DR   ENCODE; ENCBS074IZI
DR   ENCODE; ENCBS074PUV
DR   ENCODE; ENCBS074YUC
DR   ENCODE; ENCBS075HYT
DR   ENCODE; ENCBS076HTW
DR   ENCODE; ENCBS077CZP
DR   ENCODE; ENCBS077NMC
DR   ENCODE; ENCBS085GSG
DR   ENCODE; ENCBS085IZZ
DR   ENCODE; ENCBS086PXC
DR   ENCODE; ENCBS086XEN
DR   ENCODE; ENCBS087QWF
DR   ENCODE; ENCBS088KUZ
DR   ENCODE; ENCBS089VZP
DR   ENCODE; ENCBS091JMF
DR   ENCODE; ENCBS093QOO
DR   ENCODE; ENCBS096XGH
DR   ENCODE; ENCBS101LFX
DR   ENCODE; ENCBS101OYY
DR   ENCODE; ENCBS103LSZ
DR   ENCODE; ENCBS104QEK
DR   ENCODE; ENCBS106DQT
DR   ENCODE; ENCBS108PEU
DR   ENCODE; ENCBS109EEN
DR   ENCODE; ENCBS110FVC
DR   ENCODE; ENCBS111IHC
DR   ENCODE; ENCBS113GKP
DR   ENCODE; ENCBS114ENC
DR   ENCODE; ENCBS114MFP
DR   ENCODE; ENCBS116IFC
DR   ENCODE; ENCBS116LNU
DR   ENCODE; ENCBS117BTL
DR   ENCODE; ENCBS118LZR
DR   ENCODE; ENCBS120JBW
DR   ENCODE; ENCBS121IFK
DR   ENCODE; ENCBS121QNT
DR   ENCODE; ENCBS122WEH
DR   ENCODE; ENCBS127GXY
DR   ENCODE; ENCBS129BNW
DR   ENCODE; ENCBS130RRG
DR   ENCODE; ENCBS132XIH
DR   ENCODE; ENCBS133GYV
DR   ENCODE; ENCBS134OGP
DR   ENCODE; ENCBS135IEJ
DR   ENCODE; ENCBS135KID
DR   ENCODE; ENCBS136HQP
DR   ENCODE; ENCBS137REJ
DR   ENCODE; ENCBS138OWD
DR   ENCODE; ENCBS141IFN
DR   ENCODE; ENCBS142FZQ
DR   ENCODE; ENCBS143CPJ
DR   ENCODE; ENCBS143EIV
DR   ENCODE; ENCBS144MRF
DR   ENCODE; ENCBS145HYP
DR   ENCODE; ENCBS145YLE
DR   ENCODE; ENCBS147BEL
DR   ENCODE; ENCBS148AQX
DR   ENCODE; ENCBS148BFZ
DR   ENCODE; ENCBS149ZGY
DR   ENCODE; ENCBS150SBN
DR   ENCODE; ENCBS151OFF
DR   ENCODE; ENCBS152RQC
DR   ENCODE; ENCBS157CAN
DR   ENCODE; ENCBS157PJQ
DR   ENCODE; ENCBS158MMF
DR   ENCODE; ENCBS158NUW
DR   ENCODE; ENCBS164KGU
DR   ENCODE; ENCBS171TJQ
DR   ENCODE; ENCBS172NZN
DR   ENCODE; ENCBS173ACT
DR   ENCODE; ENCBS175ALJ
DR   ENCODE; ENCBS176LHZ
DR   ENCODE; ENCBS178ASF
DR   ENCODE; ENCBS180AZS
DR   ENCODE; ENCBS180QVY
DR   ENCODE; ENCBS180UZG
DR   ENCODE; ENCBS181KHF
DR   ENCODE; ENCBS183QJT
DR   ENCODE; ENCBS192GTP
DR   ENCODE; ENCBS194AMD
DR   ENCODE; ENCBS197XGU
DR   ENCODE; ENCBS199RMB
DR   ENCODE; ENCBS199ZPD
DR   ENCODE; ENCBS200OKV
DR   ENCODE; ENCBS201IDJ
DR   ENCODE; ENCBS202CLF
DR   ENCODE; ENCBS204FOO
DR   ENCODE; ENCBS204QRM
DR   ENCODE; ENCBS205JEO
DR   ENCODE; ENCBS207OWT
DR   ENCODE; ENCBS208CBB
DR   ENCODE; ENCBS210MLW
DR   ENCODE; ENCBS210TEK
DR   ENCODE; ENCBS213GIX
DR   ENCODE; ENCBS217MRJ
DR   ENCODE; ENCBS218GVF
DR   ENCODE; ENCBS218PEV
DR   ENCODE; ENCBS221OJT
DR   ENCODE; ENCBS222ZOM
DR   ENCODE; ENCBS224CAS
DR   ENCODE; ENCBS224IXA
DR   ENCODE; ENCBS224OGG
DR   ENCODE; ENCBS225ERF
DR   ENCODE; ENCBS226JWQ
DR   ENCODE; ENCBS228TBM
DR   ENCODE; ENCBS230TCM
DR   ENCODE; ENCBS231CTX
DR   ENCODE; ENCBS232MEB
DR   ENCODE; ENCBS233NIP
DR   ENCODE; ENCBS236NEP
DR   ENCODE; ENCBS237FEL
DR   ENCODE; ENCBS237TGJ
DR   ENCODE; ENCBS239AGG
DR   ENCODE; ENCBS242YTF
DR   ENCODE; ENCBS243GXZ
DR   ENCODE; ENCBS246HTK
DR   ENCODE; ENCBS248XEV
DR   ENCODE; ENCBS250DDC
DR   ENCODE; ENCBS250EAA
DR   ENCODE; ENCBS250QAH
DR   ENCODE; ENCBS252ZVH
DR   ENCODE; ENCBS253SJT
DR   ENCODE; ENCBS254GTY
DR   ENCODE; ENCBS254RNF
DR   ENCODE; ENCBS257TYR
DR   ENCODE; ENCBS257WFM
DR   ENCODE; ENCBS258IBQ
DR   ENCODE; ENCBS260QIN
DR   ENCODE; ENCBS260UFW
DR   ENCODE; ENCBS261BDP
DR   ENCODE; ENCBS263MSZ
DR   ENCODE; ENCBS266IRW
DR   ENCODE; ENCBS267AEP
DR   ENCODE; ENCBS269MQH
DR   ENCODE; ENCBS269MQV
DR   ENCODE; ENCBS269TMY
DR   ENCODE; ENCBS269UBV
DR   ENCODE; ENCBS270KOG
DR   ENCODE; ENCBS271FCJ
DR   ENCODE; ENCBS271WON
DR   ENCODE; ENCBS272IWF
DR   ENCODE; ENCBS273MKT
DR   ENCODE; ENCBS275NVW
DR   ENCODE; ENCBS280KDG
DR   ENCODE; ENCBS281JZX
DR   ENCODE; ENCBS282XVK
DR   ENCODE; ENCBS285EHM
DR   ENCODE; ENCBS287NGC
DR   ENCODE; ENCBS287RQP
DR   ENCODE; ENCBS289AAB
DR   ENCODE; ENCBS289IAE
DR   ENCODE; ENCBS292XKE
DR   ENCODE; ENCBS294TYB
DR   ENCODE; ENCBS295BTT
DR   ENCODE; ENCBS295NFS
DR   ENCODE; ENCBS296ABO
DR   ENCODE; ENCBS296SQC
DR   ENCODE; ENCBS296VMM
DR   ENCODE; ENCBS297BHJ
DR   ENCODE; ENCBS299YGH
DR   ENCODE; ENCBS300GHC
DR   ENCODE; ENCBS300YFU
DR   ENCODE; ENCBS301IGN
DR   ENCODE; ENCBS301LDQ
DR   ENCODE; ENCBS303VDB
DR   ENCODE; ENCBS306CIA
DR   ENCODE; ENCBS307OQZ
DR   ENCODE; ENCBS308ZPA
DR   ENCODE; ENCBS309MNT
DR   ENCODE; ENCBS310TGK
DR   ENCODE; ENCBS311FWL
DR   ENCODE; ENCBS313GMZ
DR   ENCODE; ENCBS313IHS
DR   ENCODE; ENCBS314VPT
DR   ENCODE; ENCBS315MGA
DR   ENCODE; ENCBS315PDD
DR   ENCODE; ENCBS319FAN
DR   ENCODE; ENCBS321SWI
DR   ENCODE; ENCBS322SEN
DR   ENCODE; ENCBS333JNJ
DR   ENCODE; ENCBS334CNK
DR   ENCODE; ENCBS335TOC
DR   ENCODE; ENCBS336RRO
DR   ENCODE; ENCBS337HXQ
DR   ENCODE; ENCBS337WJM
DR   ENCODE; ENCBS337WWP
DR   ENCODE; ENCBS338VUB
DR   ENCODE; ENCBS339GWD
DR   ENCODE; ENCBS339SIT
DR   ENCODE; ENCBS341ITG
DR   ENCODE; ENCBS342VWN
DR   ENCODE; ENCBS344JWL
DR   ENCODE; ENCBS344VFK
DR   ENCODE; ENCBS346DEZ
DR   ENCODE; ENCBS346EFV
DR   ENCODE; ENCBS349HZS
DR   ENCODE; ENCBS351JCJ
DR   ENCODE; ENCBS352ZNU
DR   ENCODE; ENCBS354HQF
DR   ENCODE; ENCBS354PIF
DR   ENCODE; ENCBS354ZLY
DR   ENCODE; ENCBS356MOV
DR   ENCODE; ENCBS357UNN
DR   ENCODE; ENCBS358XLG
DR   ENCODE; ENCBS362ASG
DR   ENCODE; ENCBS363GXU
DR   ENCODE; ENCBS366VYI
DR   ENCODE; ENCBS367TIL
DR   ENCODE; ENCBS374CKM
DR   ENCODE; ENCBS375JNA
DR   ENCODE; ENCBS380ZOW
DR   ENCODE; ENCBS381BBR
DR   ENCODE; ENCBS385LUB
DR   ENCODE; ENCBS399FDJ
DR   ENCODE; ENCBS399GAF
DR   ENCODE; ENCBS399MFO
DR   ENCODE; ENCBS400CWC
DR   ENCODE; ENCBS401LBP
DR   ENCODE; ENCBS402BUA
DR   ENCODE; ENCBS402VZL
DR   ENCODE; ENCBS403UGF
DR   ENCODE; ENCBS404EOZ
DR   ENCODE; ENCBS405FLI
DR   ENCODE; ENCBS405JBR
DR   ENCODE; ENCBS408JNN
DR   ENCODE; ENCBS408PDS
DR   ENCODE; ENCBS409PKR
DR   ENCODE; ENCBS409RQS
DR   ENCODE; ENCBS413HHW
DR   ENCODE; ENCBS415VLW
DR   ENCODE; ENCBS416UEF
DR   ENCODE; ENCBS416YET
DR   ENCODE; ENCBS421OZB
DR   ENCODE; ENCBS422FYC
DR   ENCODE; ENCBS423OQV
DR   ENCODE; ENCBS423ZZH
DR   ENCODE; ENCBS425BJH
DR   ENCODE; ENCBS425CUD
DR   ENCODE; ENCBS429YJD
DR   ENCODE; ENCBS430PSA
DR   ENCODE; ENCBS431NPJ
DR   ENCODE; ENCBS433CTJ
DR   ENCODE; ENCBS433TIQ
DR   ENCODE; ENCBS433UJJ
DR   ENCODE; ENCBS435MPV
DR   ENCODE; ENCBS435NIB
DR   ENCODE; ENCBS435NSE
DR   ENCODE; ENCBS437FDB
DR   ENCODE; ENCBS437UIO
DR   ENCODE; ENCBS440GZN
DR   ENCODE; ENCBS440MJL
DR   ENCODE; ENCBS441XTP
DR   ENCODE; ENCBS443JPP
DR   ENCODE; ENCBS444MVG
DR   ENCODE; ENCBS444QIJ
DR   ENCODE; ENCBS446KHP
DR   ENCODE; ENCBS447JNO
DR   ENCODE; ENCBS449AIA
DR   ENCODE; ENCBS449LCQ
DR   ENCODE; ENCBS453TYZ
DR   ENCODE; ENCBS455OVD
DR   ENCODE; ENCBS456NEZ
DR   ENCODE; ENCBS458WEZ
DR   ENCODE; ENCBS463HNE
DR   ENCODE; ENCBS464VEI
DR   ENCODE; ENCBS465DEI
DR   ENCODE; ENCBS466PDL
DR   ENCODE; ENCBS466ZIX
DR   ENCODE; ENCBS467HWM
DR   ENCODE; ENCBS467XVF
DR   ENCODE; ENCBS470TSC
DR   ENCODE; ENCBS470XDJ
DR   ENCODE; ENCBS471DUZ
DR   ENCODE; ENCBS471EIZ
DR   ENCODE; ENCBS472BZM
DR   ENCODE; ENCBS474AND
DR   ENCODE; ENCBS475AHQ
DR   ENCODE; ENCBS476TPW
DR   ENCODE; ENCBS479IBT
DR   ENCODE; ENCBS479RLA
DR   ENCODE; ENCBS481IVE
DR   ENCODE; ENCBS483WGW
DR   ENCODE; ENCBS484TBT
DR   ENCODE; ENCBS485OKN
DR   ENCODE; ENCBS486CUL
DR   ENCODE; ENCBS486YWI
DR   ENCODE; ENCBS487KTY
DR   ENCODE; ENCBS487SZV
DR   ENCODE; ENCBS488HLS
DR   ENCODE; ENCBS488UTE
DR   ENCODE; ENCBS489ZQI
DR   ENCODE; ENCBS491TZK
DR   ENCODE; ENCBS492SDY
DR   ENCODE; ENCBS495SHD
DR   ENCODE; ENCBS497AGN
DR   ENCODE; ENCBS501AJE
DR   ENCODE; ENCBS501FGJ
DR   ENCODE; ENCBS502APU
DR   ENCODE; ENCBS502FPQ
DR   ENCODE; ENCBS503ZYE
DR   ENCODE; ENCBS504IUW
DR   ENCODE; ENCBS504VHS
DR   ENCODE; ENCBS505LMC
DR   ENCODE; ENCBS506FKT
DR   ENCODE; ENCBS508YFO
DR   ENCODE; ENCBS510FFO
DR   ENCODE; ENCBS511ZQV
DR   ENCODE; ENCBS515IJA
DR   ENCODE; ENCBS515KFV
DR   ENCODE; ENCBS516TKV
DR   ENCODE; ENCBS520MGH
DR   ENCODE; ENCBS522AAA
DR   ENCODE; ENCBS523AAA
DR   ENCODE; ENCBS524YUI
DR   ENCODE; ENCBS525TLA
DR   ENCODE; ENCBS530ENF
DR   ENCODE; ENCBS530LIV
DR   ENCODE; ENCBS530VUT
DR   ENCODE; ENCBS531RMF
DR   ENCODE; ENCBS533IVT
DR   ENCODE; ENCBS537ADD
DR   ENCODE; ENCBS540JSU
DR   ENCODE; ENCBS540MOP
DR   ENCODE; ENCBS541YFT
DR   ENCODE; ENCBS542DRS
DR   ENCODE; ENCBS542YDW
DR   ENCODE; ENCBS544ETZ
DR   ENCODE; ENCBS544WQP
DR   ENCODE; ENCBS546FZO
DR   ENCODE; ENCBS547FPL
DR   ENCODE; ENCBS547JWV
DR   ENCODE; ENCBS548DDM
DR   ENCODE; ENCBS548DJV
DR   ENCODE; ENCBS550FNB
DR   ENCODE; ENCBS550RQC
DR   ENCODE; ENCBS551CUU
DR   ENCODE; ENCBS551DVZ
DR   ENCODE; ENCBS551QFT
DR   ENCODE; ENCBS553PEJ
DR   ENCODE; ENCBS554TEZ
DR   ENCODE; ENCBS555BYF
DR   ENCODE; ENCBS555IZN
DR   ENCODE; ENCBS556YSM
DR   ENCODE; ENCBS557NDG
DR   ENCODE; ENCBS560TQP
DR   ENCODE; ENCBS561LQQ
DR   ENCODE; ENCBS562WFV
DR   ENCODE; ENCBS571XTM
DR   ENCODE; ENCBS573EMA
DR   ENCODE; ENCBS573OLZ
DR   ENCODE; ENCBS574ZRE
DR   ENCODE; ENCBS575HTN
DR   ENCODE; ENCBS575NGC
DR   ENCODE; ENCBS576NFP
DR   ENCODE; ENCBS577XCP
DR   ENCODE; ENCBS579HCA
DR   ENCODE; ENCBS581BGT
DR   ENCODE; ENCBS581REI
DR   ENCODE; ENCBS582KNJ
DR   ENCODE; ENCBS582REX
DR   ENCODE; ENCBS590WTW
DR   ENCODE; ENCBS591PPP
DR   ENCODE; ENCBS595FPT
DR   ENCODE; ENCBS598VSF
DR   ENCODE; ENCBS599QJL
DR   ENCODE; ENCBS600ITX
DR   ENCODE; ENCBS604BAZ
DR   ENCODE; ENCBS607IVB
DR   ENCODE; ENCBS608AFV
DR   ENCODE; ENCBS608OON
DR   ENCODE; ENCBS610IGG
DR   ENCODE; ENCBS610UML
DR   ENCODE; ENCBS611LWG
DR   ENCODE; ENCBS611PFD
DR   ENCODE; ENCBS611WLI
DR   ENCODE; ENCBS612GBT
DR   ENCODE; ENCBS614CMA
DR   ENCODE; ENCBS619EOB
DR   ENCODE; ENCBS619OWS
DR   ENCODE; ENCBS621TAB
DR   ENCODE; ENCBS623BZF
DR   ENCODE; ENCBS623OHX
DR   ENCODE; ENCBS623YQT
DR   ENCODE; ENCBS624DUS
DR   ENCODE; ENCBS624MLL
DR   ENCODE; ENCBS626BOT
DR   ENCODE; ENCBS628IQK
DR   ENCODE; ENCBS628MMK
DR   ENCODE; ENCBS628ONB
DR   ENCODE; ENCBS632SNG
DR   ENCODE; ENCBS634THO
DR   ENCODE; ENCBS635NSH
DR   ENCODE; ENCBS636ANV
DR   ENCODE; ENCBS637UJM
DR   ENCODE; ENCBS638AAA
DR   ENCODE; ENCBS638ASL
DR   ENCODE; ENCBS638MWB
DR   ENCODE; ENCBS641AVI
DR   ENCODE; ENCBS644PWW
DR   ENCODE; ENCBS644SVK
DR   ENCODE; ENCBS645YGY
DR   ENCODE; ENCBS646RDV
DR   ENCODE; ENCBS648DPW
DR   ENCODE; ENCBS650CRD
DR   ENCODE; ENCBS650SLE
DR   ENCODE; ENCBS654ERN
DR   ENCODE; ENCBS656AXT
DR   ENCODE; ENCBS662HXP
DR   ENCODE; ENCBS662TZZ
DR   ENCODE; ENCBS664KGZ
DR   ENCODE; ENCBS664MRR
DR   ENCODE; ENCBS665IBY
DR   ENCODE; ENCBS665LZL
DR   ENCODE; ENCBS667BFL
DR   ENCODE; ENCBS667GKM
DR   ENCODE; ENCBS668RFG
DR   ENCODE; ENCBS669DWT
DR   ENCODE; ENCBS670FFG
DR   ENCODE; ENCBS671AAA
DR   ENCODE; ENCBS671WOF
DR   ENCODE; ENCBS672AAA
DR   ENCODE; ENCBS672UJA
DR   ENCODE; ENCBS673AAA
DR   ENCODE; ENCBS673ABW
DR   ENCODE; ENCBS674AAA
DR   ENCODE; ENCBS675AAA
DR   ENCODE; ENCBS676AAA
DR   ENCODE; ENCBS680YLF
DR   ENCODE; ENCBS684ULB
DR   ENCODE; ENCBS686ZOG
DR   ENCODE; ENCBS689DEE
DR   ENCODE; ENCBS690KCY
DR   ENCODE; ENCBS692AEI
DR   ENCODE; ENCBS692BSS
DR   ENCODE; ENCBS692HLB
DR   ENCODE; ENCBS694IAG
DR   ENCODE; ENCBS696KRJ
DR   ENCODE; ENCBS696RMN
DR   ENCODE; ENCBS697FZF
DR   ENCODE; ENCBS697NJJ
DR   ENCODE; ENCBS699OCX
DR   ENCODE; ENCBS702HBU
DR   ENCODE; ENCBS702PRB
DR   ENCODE; ENCBS704AVG
DR   ENCODE; ENCBS704TEF
DR   ENCODE; ENCBS704YEM
DR   ENCODE; ENCBS705HMQ
DR   ENCODE; ENCBS705NHL
DR   ENCODE; ENCBS706BWK
DR   ENCODE; ENCBS712AAA
DR   ENCODE; ENCBS713BFI
DR   ENCODE; ENCBS713IGS
DR   ENCODE; ENCBS714CLI
DR   ENCODE; ENCBS715MWV
DR   ENCODE; ENCBS715WYI
DR   ENCODE; ENCBS716VBH
DR   ENCODE; ENCBS716YFX
DR   ENCODE; ENCBS717MSF
DR   ENCODE; ENCBS717QJM
DR   ENCODE; ENCBS718VVA
DR   ENCODE; ENCBS719JYV
DR   ENCODE; ENCBS719OUD
DR   ENCODE; ENCBS720SBS
DR   ENCODE; ENCBS721RXI
DR   ENCODE; ENCBS722LIJ
DR   ENCODE; ENCBS722TNF
DR   ENCODE; ENCBS727GLB
DR   ENCODE; ENCBS727VRH
DR   ENCODE; ENCBS729TZG
DR   ENCODE; ENCBS730DQI
DR   ENCODE; ENCBS731WFK
DR   ENCODE; ENCBS732KTS
DR   ENCODE; ENCBS732PJR
DR   ENCODE; ENCBS734JXY
DR   ENCODE; ENCBS734KAG
DR   ENCODE; ENCBS738ADY
DR   ENCODE; ENCBS739HLB
DR   ENCODE; ENCBS739PTC
DR   ENCODE; ENCBS740FAU
DR   ENCODE; ENCBS740NNE
DR   ENCODE; ENCBS740QWK
DR   ENCODE; ENCBS741AAA
DR   ENCODE; ENCBS741RGH
DR   ENCODE; ENCBS741YEQ
DR   ENCODE; ENCBS742AAA
DR   ENCODE; ENCBS742SWZ
DR   ENCODE; ENCBS743AAA
DR   ENCODE; ENCBS743JKX
DR   ENCODE; ENCBS743RUU
DR   ENCODE; ENCBS743ZMW
DR   ENCODE; ENCBS744AAA
DR   ENCODE; ENCBS745AAA
DR   ENCODE; ENCBS745AQT
DR   ENCODE; ENCBS745UGC
DR   ENCODE; ENCBS746AAA
DR   ENCODE; ENCBS747KOI
DR   ENCODE; ENCBS747MTP
DR   ENCODE; ENCBS748YQE
DR   ENCODE; ENCBS749JUQ
DR   ENCODE; ENCBS751GYX
DR   ENCODE; ENCBS751KWS
DR   ENCODE; ENCBS753KCK
DR   ENCODE; ENCBS754KRB
DR   ENCODE; ENCBS755JGR
DR   ENCODE; ENCBS755NZH
DR   ENCODE; ENCBS756FJO
DR   ENCODE; ENCBS757QFO
DR   ENCODE; ENCBS760ISV
DR   ENCODE; ENCBS762HAX
DR   ENCODE; ENCBS763BBP
DR   ENCODE; ENCBS765FVI
DR   ENCODE; ENCBS767KUR
DR   ENCODE; ENCBS767MPH
DR   ENCODE; ENCBS767YCA
DR   ENCODE; ENCBS768GCL
DR   ENCODE; ENCBS768ZGL
DR   ENCODE; ENCBS771QGO
DR   ENCODE; ENCBS773AAA
DR   ENCODE; ENCBS773GMP
DR   ENCODE; ENCBS774QLP
DR   ENCODE; ENCBS775MDU
DR   ENCODE; ENCBS775NGD
DR   ENCODE; ENCBS775RGP
DR   ENCODE; ENCBS777STD
DR   ENCODE; ENCBS777UEV
DR   ENCODE; ENCBS777VZC
DR   ENCODE; ENCBS778JAH
DR   ENCODE; ENCBS778LCM
DR   ENCODE; ENCBS779XEH
DR   ENCODE; ENCBS780BKX
DR   ENCODE; ENCBS780HTG
DR   ENCODE; ENCBS781AWJ
DR   ENCODE; ENCBS781BOJ
DR   ENCODE; ENCBS781RAA
DR   ENCODE; ENCBS782BXQ
DR   ENCODE; ENCBS783AYY
DR   ENCODE; ENCBS783PVI
DR   ENCODE; ENCBS783YSP
DR   ENCODE; ENCBS786WUO
DR   ENCODE; ENCBS787BXG
DR   ENCODE; ENCBS787RAZ
DR   ENCODE; ENCBS789ZNN
DR   ENCODE; ENCBS791ETZ
DR   ENCODE; ENCBS791FZV
DR   ENCODE; ENCBS793GXQ
DR   ENCODE; ENCBS798HNT
DR   ENCODE; ENCBS798MOH
DR   ENCODE; ENCBS798PZJ
DR   ENCODE; ENCBS799LNH
DR   ENCODE; ENCBS799SQC
DR   ENCODE; ENCBS800QIW
DR   ENCODE; ENCBS803IPJ
DR   ENCODE; ENCBS803ZJJ
DR   ENCODE; ENCBS805PXD
DR   ENCODE; ENCBS805UZF
DR   ENCODE; ENCBS806AAA
DR   ENCODE; ENCBS807AAA
DR   ENCODE; ENCBS808XDL
DR   ENCODE; ENCBS809KDQ
DR   ENCODE; ENCBS810BDN
DR   ENCODE; ENCBS810JOY
DR   ENCODE; ENCBS811GQK
DR   ENCODE; ENCBS811PND
DR   ENCODE; ENCBS813FSC
DR   ENCODE; ENCBS814VTY
DR   ENCODE; ENCBS815MFP
DR   ENCODE; ENCBS816PYX
DR   ENCODE; ENCBS817DXX
DR   ENCODE; ENCBS817KQF
DR   ENCODE; ENCBS817NZJ
DR   ENCODE; ENCBS818CDN
DR   ENCODE; ENCBS821ETN
DR   ENCODE; ENCBS821PLV
DR   ENCODE; ENCBS824AAA
DR   ENCODE; ENCBS824QCP
DR   ENCODE; ENCBS825AAA
DR   ENCODE; ENCBS826AAA
DR   ENCODE; ENCBS827QKB
DR   ENCODE; ENCBS832ULV
DR   ENCODE; ENCBS835AAA
DR   ENCODE; ENCBS835EOX
DR   ENCODE; ENCBS835UPQ
DR   ENCODE; ENCBS836AAA
DR   ENCODE; ENCBS836LJE
DR   ENCODE; ENCBS837AAA
DR   ENCODE; ENCBS837YEZ
DR   ENCODE; ENCBS838SRU
DR   ENCODE; ENCBS839SGI
DR   ENCODE; ENCBS840QTY
DR   ENCODE; ENCBS842MLZ
DR   ENCODE; ENCBS844EBE
DR   ENCODE; ENCBS845QPP
DR   ENCODE; ENCBS847PBZ
DR   ENCODE; ENCBS848AAA
DR   ENCODE; ENCBS849AAA
DR   ENCODE; ENCBS849LND
DR   ENCODE; ENCBS850PLY
DR   ENCODE; ENCBS851ZNE
DR   ENCODE; ENCBS853NQW
DR   ENCODE; ENCBS854HTL
DR   ENCODE; ENCBS856GWK
DR   ENCODE; ENCBS856PWK
DR   ENCODE; ENCBS857THE
DR   ENCODE; ENCBS858AAA
DR   ENCODE; ENCBS859AAA
DR   ENCODE; ENCBS859FFE
DR   ENCODE; ENCBS859RAZ
DR   ENCODE; ENCBS860AAA
DR   ENCODE; ENCBS861HMN
DR   ENCODE; ENCBS862LXP
DR   ENCODE; ENCBS863WKZ
DR   ENCODE; ENCBS864WAF
DR   ENCODE; ENCBS864XFG
DR   ENCODE; ENCBS865ZOH
DR   ENCODE; ENCBS866LUZ
DR   ENCODE; ENCBS868JIC
DR   ENCODE; ENCBS869GQP
DR   ENCODE; ENCBS869WAH
DR   ENCODE; ENCBS870TBE
DR   ENCODE; ENCBS872AMP
DR   ENCODE; ENCBS872GDG
DR   ENCODE; ENCBS873PJJ
DR   ENCODE; ENCBS875LKB
DR   ENCODE; ENCBS877GRH
DR   ENCODE; ENCBS877WFF
DR   ENCODE; ENCBS879GXJ
DR   ENCODE; ENCBS879MRD
DR   ENCODE; ENCBS881CIF
DR   ENCODE; ENCBS882YXM
DR   ENCODE; ENCBS883DWI
DR   ENCODE; ENCBS885FSX
DR   ENCODE; ENCBS885JQS
DR   ENCODE; ENCBS885ORM
DR   ENCODE; ENCBS887RIJ
DR   ENCODE; ENCBS889CYZ
DR   ENCODE; ENCBS890WPB
DR   ENCODE; ENCBS892VZB
DR   ENCODE; ENCBS895EOS
DR   ENCODE; ENCBS895HRB
DR   ENCODE; ENCBS896YYX
DR   ENCODE; ENCBS897BFW
DR   ENCODE; ENCBS897HQV
DR   ENCODE; ENCBS899ZNE
DR   ENCODE; ENCBS900XSC
DR   ENCODE; ENCBS901YOY
DR   ENCODE; ENCBS902IAH
DR   ENCODE; ENCBS904EKE
DR   ENCODE; ENCBS905ULQ
DR   ENCODE; ENCBS907KSW
DR   ENCODE; ENCBS909PJP
DR   ENCODE; ENCBS910PZQ
DR   ENCODE; ENCBS910ZFQ
DR   ENCODE; ENCBS912TCF
DR   ENCODE; ENCBS913KLP
DR   ENCODE; ENCBS914FGT
DR   ENCODE; ENCBS918RGX
DR   ENCODE; ENCBS923MFQ
DR   ENCODE; ENCBS924KDO
DR   ENCODE; ENCBS924WYL
DR   ENCODE; ENCBS926EJR
DR   ENCODE; ENCBS927AKA
DR   ENCODE; ENCBS928CHW
DR   ENCODE; ENCBS930FIG
DR   ENCODE; ENCBS931EXY
DR   ENCODE; ENCBS931SHZ
DR   ENCODE; ENCBS935XAF
DR   ENCODE; ENCBS937BJO
DR   ENCODE; ENCBS937LVM
DR   ENCODE; ENCBS939AYV
DR   ENCODE; ENCBS943ASZ
DR   ENCODE; ENCBS945FES
DR   ENCODE; ENCBS948WDK
DR   ENCODE; ENCBS949DPY
DR   ENCODE; ENCBS949YDI
DR   ENCODE; ENCBS950MSQ
DR   ENCODE; ENCBS950TLN
DR   ENCODE; ENCBS955ZHF
DR   ENCODE; ENCBS956FFN
DR   ENCODE; ENCBS957WYL
DR   ENCODE; ENCBS959DVN
DR   ENCODE; ENCBS961ZJH
DR   ENCODE; ENCBS962POD
DR   ENCODE; ENCBS966ODK
DR   ENCODE; ENCBS967NRV
DR   ENCODE; ENCBS967UNG
DR   ENCODE; ENCBS967WNR
DR   ENCODE; ENCBS970EPG
DR   ENCODE; ENCBS974ELC
DR   ENCODE; ENCBS976OQX
DR   ENCODE; ENCBS976TOE
DR   ENCODE; ENCBS976ZOG
DR   ENCODE; ENCBS978CGB
DR   ENCODE; ENCBS982JDZ
DR   ENCODE; ENCBS983ECZ
DR   ENCODE; ENCBS983UEI
DR   ENCODE; ENCBS983YXQ
DR   ENCODE; ENCBS984EPA
DR   ENCODE; ENCBS985FRY
DR   ENCODE; ENCBS985WFY
DR   ENCODE; ENCBS985WNX
DR   ENCODE; ENCBS987BVJ
DR   ENCODE; ENCBS987KVB
DR   ENCODE; ENCBS989AFC
DR   ENCODE; ENCBS990SBY
DR   ENCODE; ENCBS991MPK
DR   ENCODE; ENCBS992ZRR
DR   ENCODE; ENCBS994RVB
DR   ENCODE; ENCBS994TMS
DR   ENCODE; ENCBS994VIY
DR   ENCODE; ENCBS995NXW
DR   ENCODE; ENCBS995WFW
DR   ENCODE; ENCBS998QYV
DR   FANTOM5_SSTAR; 10818-111B8
DR   FANTOM5_SSTAR; 10819-111B9
DR   FANTOM5_SSTAR; 10820-111C1
DR   GEO; GSM207049
DR   GEO; GSM472906
DR   GEO; GSM472907
DR   GEO; GSM481450
DR   GEO; GSM501780
DR   GEO; GSM565883
DR   GEO; GSM733638
DR   GEO; GSM733641
DR   GEO; GSM733645
DR   GEO; GSM733685
DR   GEO; GSM733693
DR   GEO; GSM733694
DR   GEO; GSM733737
DR   GEO; GSM733743
DR   GEO; GSM733754
DR   GEO; GSM733774
DR   GEO; GSM736637
DR   GEO; GSM736639
DR   GEO; GSM749683
DR   GEO; GSM749715
DR   GEO; GSM749756
DR   GEO; GSM782122
DR   GEO; GSM798321
DR   GEO; GSM803336
DR   GEO; GSM803343
DR   GEO; GSM803344
DR   GEO; GSM803367
DR   GEO; GSM803368
DR   GEO; GSM803381
DR   GEO; GSM803403
DR   GEO; GSM803404
DR   GEO; GSM803415
DR   GEO; GSM803418
DR   GEO; GSM803432
DR   GEO; GSM803449
DR   GEO; GSM803451
DR   GEO; GSM803452
DR   GEO; GSM803460
DR   GEO; GSM803461
DR   GEO; GSM803483
DR   GEO; GSM803486
DR   GEO; GSM803493
DR   GEO; GSM803499
DR   GEO; GSM803500
DR   GEO; GSM803502
DR   GEO; GSM803503
DR   GEO; GSM803507
DR   GEO; GSM803517
DR   GEO; GSM803527
DR   GEO; GSM803530
DR   GEO; GSM816662
DR   GEO; GSM822284
DR   GEO; GSM822287
DR   GEO; GSM822291
DR   GEO; GSM887079
DR   GEO; GSM888149
DR   GEO; GSM923446
DR   GEO; GSM935274
DR   GEO; GSM935275
DR   GEO; GSM935280
DR   GEO; GSM935304
DR   GEO; GSM935305
DR   GEO; GSM935306
DR   GEO; GSM935307
DR   GEO; GSM935335
DR   GEO; GSM935350
DR   GEO; GSM935364
DR   GEO; GSM935406
DR   GEO; GSM935437
DR   GEO; GSM935493
DR   GEO; GSM935542
DR   GEO; GSM935543
DR   GEO; GSM935545
DR   GEO; GSM935566
DR   GEO; GSM935579
DR   GEO; GSM935596
DR   GEO; GSM935603
DR   GEO; GSM935609
DR   GEO; GSM935610
DR   GEO; GSM935646
DR   GEO; GSM935647
DR   GEO; GSM935648
DR   GEO; GSM935649
DR   GEO; GSM935650
DR   GEO; GSM936760
DR   GEO; GSM945182
DR   GEO; GSM945211
DR   GEO; GSM945231
DR   GEO; GSM945291
DR   GEO; GSM1003487
DR   GEO; GSM1003519
DR   GEO; GSM1010740
DR   GEO; GSM1010741
DR   GEO; GSM1010777
DR   GEO; GSM1010778
DR   GEO; GSM1010784
DR   GEO; GSM1010787
DR   GEO; GSM1010808
DR   GEO; GSM1010809
DR   GEO; GSM1010810
DR   GEO; GSM1010821
DR   GEO; GSM1010831
DR   GEO; GSM1010865
DR   GEO; GSM1010875
DR   GEO; GSM1010876
DR   GEO; GSM1040305
DR   GEO; GSM1040375
DR   GEO; GSM1204463
DR   GEO; GSM1374138
DR   GEO; GSM1374139
DR   GEO; GSM1374140
DR   GEO; GSM1374141
DR   GEO; GSM1374142
DR   GEO; GSM1374143
DR   GEO; GSM1374144
DR   GEO; GSM1374145
DR   GEO; GSM1374146
DR   GEO; GSM1374147
DR   GEO; GSM1374148
DR   GEO; GSM1374532
DR   GEO; GSM1669878
DR   GEO; GSM2423739
DR   GEO; GSM2423740
DR   GEO; GSM2551565
DR   GEO; GSM7701361
DR   GEO; GSM7701362
DR   IARC_TP53; 30037
DR   IBRC; C10096
DR   ICLC; HTL95005
DR   IGRhCellID; HepG2
DR   IZSLER; BS TCL 79
DR   JCRB; JCRB1054
DR   JCRB; NIHS0326
DR   KCB; KCB 200507YJ
DR   KCLB; 88065
DR   LiGeA; CCLE_410
DR   LIMORE; HepG2
DR   LINCS_LDP; LCL-1925
DR   Lonza; 62
DR   MetaboLights; MTBLS127
DR   MetaboLights; MTBLS419
DR   MetaboLights; MTBLS582
DR   MetaboLights; MTBLS1358
DR   NCBI_Iran; C158
DR   PharmacoDB; HepG2_539_2019
DR   PRIDE; PXD000661
DR   PRIDE; PXD001874
DR   PRIDE; PXD002395
DR   PRIDE; PXD003370
DR   PRIDE; PXD004252
DR   PRIDE; PXD005955
DR   PRIDE; PXD008190
DR   PRIDE; PXD008613
DR   PRIDE; PXD010142
DR   PRIDE; PXD018373
DR   PRIDE; PXD018450
DR   PRIDE; PXD024206
DR   Progenetix; CVCL_0027
DR   PubChem_Cell_line; CVCL_0027
DR   RCB; RCB0459
DR   RCB; RCB1648
DR   RCB; RCB1886
DR   TKG; TKG 0205
DR   TOKU-E; 1440
DR   Ubigene; YC-C001
DR   Wikidata; Q5731621
RX   DOI=10.11418/jtca1981.16.3_173;
RX   DOI=10.1385/CP:1:3-4:313;
RX   Patent=US4393133;
RX   PubMed=233137;
RX   PubMed=2439335;
RX   PubMed=6248960;
RX   PubMed=6288577;
RX   PubMed=7972006;
RX   PubMed=8050184;
RX   PubMed=8224613;
RX   PubMed=8384076;
RX   PubMed=8389256;
RX   PubMed=8835345;
RX   PubMed=9178645;
RX   PubMed=9359923;
RX   PubMed=11050057;
RX   PubMed=11416159;
RX   PubMed=11981770;
RX   PubMed=12029633;
RX   PubMed=12068308;
RX   PubMed=14980111;
RX   PubMed=15767549;
RX   PubMed=16181800;
RX   PubMed=16935386;
RX   PubMed=16957166;
RX   PubMed=17254797;
RX   PubMed=19215227;
RX   PubMed=19751877;
RX   PubMed=20069059;
RX   PubMed=20215515;
RX   PubMed=20228232;
RX   PubMed=20937217;
RX   PubMed=21269460;
RX   PubMed=22278370;
RX   PubMed=22460905;
RX   PubMed=23325432;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=24116068;
RX   PubMed=24618588;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26160117;
RX   PubMed=26589293;
RX   PubMed=26825538;
RX   PubMed=27027780;
RX   PubMed=27329724;
RX   PubMed=27470094;
RX   PubMed=28196595;
RX   PubMed=29610054;
RX   PubMed=29660373;
RX   PubMed=30629668;
RX   PubMed=30864654;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31395879;
RX   PubMed=31561354;
RX   PubMed=31978347;
RX   PubMed=32471280;
RX   PubMed=32899426;
RX   PubMed=34320349;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-and-morphology-of-atcc-hb-8065
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HepG2
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/hep-g2/
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/HepG2
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-104.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Hep_G2
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/hepg2-xenograft-model/
WW   Provider; BRICS; BRICS0055; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3870
WW   Provider; CH3 Biosystems; 930001; https://ch3biosystems.com/shop/hepg2-cell-line/
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 1.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8065.
CC   Population: Caucasian.
CC   Doubling time: 25.65 hours (PubMed=31378681); ~50-60 hours (DSMZ=ACC-180).
CC   HLA typing: A*02:01,24:02; B*35:14,51:01; C*04:01,16:02 (PubMed=25960936).
CC   HLA typing: A*02:19,24:02; B*35:14,51:08; C*04:01,16:02; DQB1*06:04,06:04 (PubMed=26589293).
CC   HLA typing: A*02:01,24:02; B*35,51:01; C*04:01,16:02; DQA1*01:02; DQB1*05:02,06:04; DRB1*13:02,16:02 (PubMed=9178645).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=8389256; PubMed=12068308; DepMap=ACH-000739).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; DNA methylation analysis; Bisulfite sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.83%; Native American=20.88%; East Asian, North=4.48%; East Asian, South=0%; South Asian=0%; European, North=22.82%; European, South=48.99% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0326; true.
CC   Discontinued: RCB; RCB0459; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): AddexBio=C0015002/46; ATCC=HB-8065; CCRID; CLS=300198; DSMZ=ACC-180; ECACC=85011430; JCRB=JCRB1054; KCLB=88065; PubMed=11416159; PubMed=17254797; PubMed=24116068; PubMed=25877200; PubMed=31378681; RCB=RCB1648; RCB=RCB1886; Technion Genomics Center; TKG=TKG 0205
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 13
ST   D12S391: 21,25
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D19S433: 15.2 (ATCC=HB-8065; CCRID; CLS=300198; PubMed=24116068; Technion Genomics Center)
ST   D19S433: 16 (DSMZ=ACC-180)
ST   D1S1656: 11,12
ST   D21S11: 29,31
ST   D22S1045: 16
ST   D2S1338: 19,20
ST   D2S441: 11.3,14
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15,16 (ATCC=HB-8065; DSMZ=ACC-180; PubMed=24116068; PubMed=25877200; Technion Genomics Center)
ST   D8S1179: 15,16,17 (CLS=300198)
ST   DYS391: 12
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   Hep-G2 A-1
AC   CVCL_VA32
SY   A-1
DR   cancercelllines; CVCL_VA32
DR   Wikidata; Q54882779
RX   PubMed=29481805;
CC   Population: Caucasian.
CC   Virology: Contains 2 head to tails stably integrated hepatitis B virus (HBV) of the A-genotype.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 15
//
ID   Hep-G2 B-1
AC   CVCL_VA33
SY   B-1
DR   cancercelllines; CVCL_VA33
DR   Wikidata; Q54882780
RX   PubMed=29481805;
CC   Population: Caucasian.
CC   Virology: Contains 2 head to tails stably integrated hepatitis B virus (HBV) of the B-genotype.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 15
//
ID   Hep-G2 C-1
AC   CVCL_VA34
SY   C-1
DR   cancercelllines; CVCL_VA34
DR   Wikidata; Q54882781
RX   PubMed=29481805;
CC   Population: Caucasian.
CC   Virology: Contains 2 head to tails stably integrated hepatitis B virus (HBV) of the C-genotype.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 15
//
ID   Hep-G2 GPC3 KO
AC   CVCL_F0T3
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4451; GPC3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Fayn, Stanley.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Hep-G2 SERPINA1 KO
AC   CVCL_F0RL
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8941; SERPINA1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Biddle, Michael S.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Hep-G2 SimpleCell O-GalNAc
AC   CVCL_S027
SY   HepG2 SimpleCell; HepG2 SC; HepG2SC
DR   cancercelllines; CVCL_S027
DR   Wikidata; Q54882782
RX   PubMed=23584533;
RX   PubMed=26566661;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   Hep-G2 SimpleCell O-GalNAc KI GalNAc-T3
AC   CVCL_EI11
SY   HepG2SC+T3
DR   cancercelllines; CVCL_EI11
DR   PRIDE; PXD002770
DR   Wikidata; Q54882783
RX   PubMed=26566661;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24137; B4GALNT3.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S027 ! Hep-G2 SimpleCell O-GalNAc
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 17
//
ID   Hep-G2 SimpleCell O-GalNAc KO GalNAc-T1
AC   CVCL_EI09
SY   HepG2SCdeltaT1
DR   cancercelllines; CVCL_EI09
DR   PRIDE; PXD002770
DR   Wikidata; Q54882784
RX   PubMed=26566661;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:4117; B4GALNT1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S027 ! Hep-G2 SimpleCell O-GalNAc
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   Hep-G2 SimpleCell O-GalNAc KO GalNAc-T2
AC   CVCL_EI10
SY   HepG2SCdeltaT2
DR   cancercelllines; CVCL_EI10
DR   PRIDE; PXD002770
DR   Wikidata; Q54882785
RX   PubMed=26566661;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24136; B4GALNT2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S027 ! Hep-G2 SimpleCell O-GalNAc
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   Hep-G2 VA-13
AC   CVCL_A5CQ
SY   HepG2 VA-13; VA-13
DR   ABM; T3195
DR   cancercelllines; CVCL_A5CQ
DR   Wikidata; Q107115326
RX   PubMed=11981770;
RX   PubMed=16181800;
WW   Provider; UNeMed; SKU 200; https://www.unemed.com/wp-content/uploads/2012/07/a0I50000004GAje.pdf
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87921; Adh1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   Hep-G2 VA-28
AC   CVCL_A5CR
SY   VA-28
DR   cancercelllines; CVCL_A5CR
DR   Wikidata; Q107115327
RX   PubMed=11981770;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87921; Adh1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   Hep-G2 VI-7
AC   CVCL_A5CS
SY   VI-7
DR   cancercelllines; CVCL_A5CS
DR   Wikidata; Q107115328
RX   PubMed=11981770;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for Hep-G2 VA-13 (Cellosaurus=CVCL_A5CQ) and Hep-G2 VA-28 (Cellosaurus=CVCL_A5CR) (PubMed=11981770).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   Hep-G2 VL-17A
AC   CVCL_A5CT
SY   HepG2 VL-17A; VL-17A; VL17A
DR   BTO; BTO_0006458
DR   cancercelllines; CVCL_A5CT
DR   Wikidata; Q107115329
RX   PubMed=16181800;
RX   PubMed=22436864;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87921; Adh1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5CQ ! Hep-G2 VA-13
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   Hep-G2-THRA
AC   CVCL_C3G9
SY   TRalpha1-WT
DR   cancercelllines; CVCL_C3G9
DR   GEO; GSM721654
DR   GEO; GSM721655
DR   GEO; GSM721656
DR   GEO; GSM721657
DR   GEO; GSM721658
DR   GEO; GSM721659
DR   Wikidata; Q114311593
RX   PubMed=19749797;
RX   PubMed=21622534;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11796; THRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   Hep-G2-THRA MUT p.I116N;A225T;M388I
AC   CVCL_C3GA
SY   HepG2 RCCC-THRA mutant 6; rc6-TRalpha1
DR   cancercelllines; CVCL_C3GA
DR   GEO; GSM721672
DR   GEO; GSM721673
DR   GEO; GSM721674
DR   GEO; GSM721675
DR   GEO; GSM721676
DR   GEO; GSM721677
DR   Wikidata; Q114311594
RX   PubMed=21622534;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11796; THRA (Note=With p.Ile116Asn; p.Ala225Thr and p.Met388Ile).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   Hep-G2-THRA MUT p.K74E;A264V
AC   CVCL_C3GB
SY   HepG2 HCC-THRA mutant I; TRalpha1-I; hcI-TRalpha1
DR   cancercelllines; CVCL_C3GB
DR   GEO; GSM721666
DR   GEO; GSM721667
DR   GEO; GSM721668
DR   GEO; GSM721669
DR   GEO; GSM721670
DR   GEO; GSM721671
DR   Wikidata; Q114311595
RX   PubMed=19749797;
RX   PubMed=21622534;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11796; THRA (Note=With p.Lys74Glu and p.Ala264Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   Hep-G2-THRB
AC   CVCL_C3GC
SY   TRbeta1-WT
DR   cancercelllines; CVCL_C3GC
DR   GEO; GSM721660
DR   GEO; GSM721661
DR   GEO; GSM721662
DR   GEO; GSM721663
DR   GEO; GSM721664
DR   GEO; GSM721665
DR   Wikidata; Q114311596
RX   PubMed=19749797;
RX   PubMed=21622534;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   Hep-G2-THRB MUT p.K113N;T329P
AC   CVCL_C3GD
SY   HepG2 HCC-THRB mutant N; TRbeta1-N; hcN-TRbeta1
DR   cancercelllines; CVCL_C3GD
DR   GEO; GSM721678
DR   GEO; GSM721679
DR   GEO; GSM721680
DR   GEO; GSM721681
DR   GEO; GSM721682
DR   GEO; GSM721683
DR   Wikidata; Q114311597
RX   PubMed=19749797;
RX   PubMed=21622534;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB (Note=With p.Lys113Asn and p.Thr329Pro).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   Hep-G2-THRB MUT p.K155E;K411E
AC   CVCL_C3GE
SY   HepG2 RCCC-THRB mutant 15; rc15-TRbeta1
DR   cancercelllines; CVCL_C3GE
DR   GEO; GSM721684
DR   GEO; GSM721685
DR   GEO; GSM721686
DR   GEO; GSM721687
DR   GEO; GSM721688
DR   GEO; GSM721689
DR   Wikidata; Q114311602
RX   PubMed=21622534;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB (Note=With p.Lys155Glu and p.Lys411Glu).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   Hep-G2/2.2.1
AC   CVCL_3701
SY   HEP-G2/2.2.1; HEP G2/2.2.1; HepG2/2.2.1; Hep 2.2.1
DR   BTO; BTO_0004572
DR   CLO; CLO_0003705
DR   ATCC; CRL-11997
DR   BCRC; 60364
DR   cancercelllines; CVCL_3701
DR   Wikidata; Q54882786
RX   Patent=US5821057;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11997.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: ATCC; CRL-11997; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-11997
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   Hep-G2/2.2.15
AC   CVCL_L855
SY   HEP-G2/2.2.15; Hep-G2/2215; HepG2/2215; HepG2-2.2.15; HepG2 2.2.15; HepG2.2.15; HepG2(2.2.15); 2.2.15
DR   BTO; BTO_0005621
DR   CLO; CLO_0001176
DR   CLDB; cl33
DR   cancercelllines; CVCL_L855
DR   CCTCC; GDC0141
DR   ChEMBL-Cells; CHEMBL3833241
DR   ChEMBL-Targets; CHEMBL4296438
DR   Cosmic; 979733
DR   Millipore; SCC249
DR   PubChem_Cell_line; CVCL_L855
DR   Wikidata; Q54882787
RX   PubMed=3029758;
RX   PubMed=8224613;
RX   PubMed=21448419;
RX   PubMed=29481805;
CC   Population: Caucasian.
CC   Virology: Contains 2 head to tails stably integrated hepatitis B virus (HBV) of the D-genotype.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Millipore=SCC249
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15,16
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 25
//
ID   Hep-G2/BGAL
AC   CVCL_EQ66
DR   cancercelllines; CVCL_EQ66
DR   GEO; GSM138625
DR   GEO; GSM138626
DR   GEO; GSM138627
DR   Wikidata; Q54882788
RX   PubMed=17157261;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 17
//
ID   Hep-G2/C3A
AC   CVCL_1098
SY   HepG2/C3A; Hep G2/C3A; C3A
DR   BTO; BTO_0003586
DR   CLO; CLO_0002119
DR   EFO; EFO_0002121
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3581
DR   ATCC; CRL-10741
DR   BCRC; 60177
DR   BCRJ; 0291
DR   BioSample; SAMN03473207
DR   BioSample; SAMN10987645
DR   cancercelllines; CVCL_1098
DR   Cell_Model_Passport; SIDM01237
DR   ChEMBL-Cells; CHEMBL3308377
DR   ChEMBL-Targets; CHEMBL1075402
DR   Cosmic; 724820
DR   Cosmic; 910850
DR   Cosmic; 1995354
DR   Cosmic-CLP; 910850
DR   DepMap; ACH-001021
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FCS-free; 10-2-11-3-4-4
DR   GDSC; 910850
DR   GEO; GSM886899
DR   GEO; GSM887964
DR   GEO; GSM1669638
DR   IARC_TP53; 21205
DR   IARC_TP53; 27688
DR   IGRhCellID; C3A
DR   LINCS_LDP; LCL-1927
DR   PharmacoDB; C3A_156_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1098
DR   PubChem_Cell_line; CVCL_1098
DR   Ubigene; YC-C093
DR   Wikidata; Q54882789
RX   DOI=10.1016/j.bbe.2019.12.006;
RX   Patent=US5290684;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29468137;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-281.html
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10741.
CC   Population: Caucasian.
CC   Virology: Susceptible to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   HLA typing: A*02:19,24:02; B*15:137,35:14; C*04:01,16:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=910850; DepMap=ACH-001021).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.61%; Native American=22.36%; East Asian, North=0.85%; East Asian, South=1.57%; South Asian=0.18%; European, North=26.42%; European, South=47.02% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-10741; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-3581; Cosmic-CLP=910850; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 15,16
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Hep-G2/C3A-hARG1
AC   CVCL_YN88
SY   C3_A
DR   cancercelllines; CVCL_YN88
DR   Wikidata; Q94102457
RX   DOI=10.1016/j.bbe.2019.12.006;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:663; ARG1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1098 ! Hep-G2/C3A
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   Hep-G2/C3A-hARG1/hOTC
AC   CVCL_YN89
SY   C3_AO
DR   cancercelllines; CVCL_YN89
DR   Wikidata; Q94102462
RX   DOI=10.1016/j.bbe.2019.12.006;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:663; ARG1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8512; OTC.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1098 ! Hep-G2/C3A
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   Hep-G2/C3A-hOTC
AC   CVCL_YN90
SY   C3_O
DR   cancercelllines; CVCL_YN90
DR   Wikidata; Q94102467
RX   DOI=10.1016/j.bbe.2019.12.006;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8512; OTC.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1098 ! Hep-G2/C3A
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   Hep-G2/PGC-1alpha 2x9 mutant
AC   CVCL_EQ63
DR   cancercelllines; CVCL_EQ63
DR   GEO; GSM138622
DR   GEO; GSM138623
DR   GEO; GSM138624
DR   Wikidata; Q54882790
RX   PubMed=17157261;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9237; PPARGC1A (Note=With mutations in the 2nd and 3rd LXXLL motifs region).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   Hep-G2/PGC-1alpha L2L3 mutant
AC   CVCL_EQ64
DR   cancercelllines; CVCL_EQ64
DR   GEO; GSM138628
DR   GEO; GSM138629
DR   GEO; GSM138630
DR   Wikidata; Q54882791
RX   PubMed=17157261;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9237; PPARGC1A (Note=With Leu to Ala mutations in the 2nd and 3rd LXXLL motifs).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   Hep-G2/PGC-1alpha wt
AC   CVCL_EQ65
DR   cancercelllines; CVCL_EQ65
DR   GEO; GSM138631
DR   GEO; GSM138632
DR   GEO; GSM138633
DR   Wikidata; Q54882792
RX   PubMed=17157261;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   Hep-G2/SF
AC   CVCL_AS98
SY   Hep G2/SF; HepG2/SF; HepG2-SF; Hep-G2/Serum Free
DR   ATCC; HB-8065.1
DR   cancercelllines; CVCL_AS98
DR   Wikidata; Q54882793
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: ATCC; HB-8065.1; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=HB-8065.1
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   Hep-KANO clone 1
AC   CVCL_Y143
SY   Hep-KANO CL-1
DR   Wikidata; Q54882794
RX   PubMed=7829395;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=7829395).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y144 ! Hep-KANO clone 2
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hep-KANO clone 2
AC   CVCL_Y144
SY   Hep-KANO CL-2; Hep-KANO CL2
DR   CGH-DB; 9077-4
DR   Wikidata; Q54882795
RX   PubMed=7829395;
RX   PubMed=12029633;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=7829395).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y143 ! Hep-KANO clone 1
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hep-Tabata
AC   CVCL_Y145
SY   Hep-TABATA
DR   CGH-DB; 9078-4
DR   Wikidata; Q54882796
RX   PubMed=12029633;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   Hep-X1
AC   CVCL_C3MK
DR   CCRID; 4201PAT-CCTCC02164
DR   Wikidata; Q116049310
RX   PubMed=36152230;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2022181.
CC   Population: Chinese.
CC   Doubling time: ~60 hours (PubMed=36152230).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=36152230
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 18,22
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 14,20
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D6S1043: 10,12
ST   D7S820: 11,12
ST   D8S1179: 15
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 15,17
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   Hep-Y1
AC   CVCL_S801
DR   Wikidata; Q54882802
RX   PubMed=23734258;
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Hep-Y2
AC   CVCL_S802
DR   Wikidata; Q54882803
RX   PubMed=23734258;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   Hep10
AC   CVCL_HE80
SY   Hep 10; Hep 10-1-14-30
DR   Wikidata; Q54882804
RX   PubMed=3023751;
CC   Virology: Contains at least 5 copies of integrated hepatitis B virus (HBV) genomes.
CC   Karyotypic information: Has lost chromosome Y.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver, left lateral lobe; UBERON=UBERON_0006727.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   Hep1B
AC   CVCL_8122
DR   Lonza; 446
DR   Wikidata; Q54882805
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   HEp2-Mx2/EGFP L1D7
AC   CVCL_RX04
SY   HEp L1D7
DR   Wikidata; Q54882750
RX   PubMed=22373148;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency.
CC   Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   HEp2-Mx2/EGFP L1G5
AC   CVCL_RX05
SY   HEp L1G5; L1G5
DR   Wikidata; Q54882751
RX   PubMed=22373148;
RX   PubMed=27346232;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency (PubMed=27346232).
CC   Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter (PubMed=27346232).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   Hep293TT
AC   CVCL_D139
DR   ChEMBL-Cells; CHEMBL4513112
DR   ChEMBL-Targets; CHEMBL4513127
DR   Cosmic; 1286602
DR   PubChem_Cell_line; CVCL_D139
DR   Wikidata; Q54882806
RX   PubMed=19637320;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Val22_Leu139delinsVal (c.66_416del351); Zygosity=Heterozygous (PubMed=19637320).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=19637320
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,14
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9.3
ST   TPOX: 10,12
ST   vWA: 15,17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   Hep3B-c1
AC   CVCL_C8Q9
SY   Hep3Bc1
DR   BTO; BTO_0006479
DR   Wikidata; Q123031636
RX   PubMed=19020076;
CC   Population: African American.
CC   Characteristics: Expression of firefly luciferase is under the control of a 68-bp hypoxia response element (HRE) from the human ENO1 gene inserted upstream of a basal SV40 promoter. Expression of renilla luciferase is constitutive as it is driven by the SV40 promoter (PubMed=19020076).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Hep3b-Cas9-741
AC   CVCL_XE51
DR   CCRID; 1101HUM-PUMC000741
DR   Wikidata; Q94102667
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000741
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D12S391: 17,19.3
ST   D13S317: 12,14
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 12.2,14
ST   D21S11: 30,31
ST   D2S1338: 21,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 12,17
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 18
ST   Penta E: 5,16
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   Hep3b-Cas9-742
AC   CVCL_XE52
DR   CCRID; 1101HUM-PUMC000742
DR   Wikidata; Q94102671
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000742
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D12S391: 17,19.3
ST   D13S317: 12,14
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 12.2,14
ST   D21S11: 30,31
ST   D2S1338: 21,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 12,17
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 18
ST   Penta E: 5,16
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   Hep3b-Cas9-743
AC   CVCL_XE53
DR   CCRID; 1101HUM-PUMC000743
DR   Wikidata; Q94102675
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000743
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D12S391: 17
ST   D13S317: 12,14
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 12.2,14
ST   D21S11: 30,31
ST   D2S1338: 21,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 12,17
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 18
ST   Penta E: 5,16
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   Hep3b-Cas9-744
AC   CVCL_XE54
DR   CCRID; 1101HUM-PUMC000744
DR   Wikidata; Q94102681
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000744
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D12S391: 17
ST   D13S317: 12,14
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 12.2,14
ST   D21S11: 30,31
ST   D2S1338: 21,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 12,17
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 18
ST   Penta E: 5,16
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   Hep3b-Cas9-745
AC   CVCL_XE55
DR   CCRID; 1101HUM-PUMC000745
DR   Wikidata; Q94102686
CC   Population: African American.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000745
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D12S391: 17,19.3
ST   D13S317: 12,14
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 12.2,14
ST   D21S11: 30,31
ST   D2S1338: 21,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 12,17
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 18
ST   Penta E: 5,16
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   Hep3BLAP-I
AC   CVCL_DI39
SY   Hep3BLAP; Hep3B-LAP
DR   GEO; GSM311409
DR   GEO; GSM311410
DR   GEO; GSM311411
DR   GEO; GSM311412
DR   GEO; GSM311413
DR   GEO; GSM311414
DR   GEO; GSM311415
DR   GEO; GSM311416
DR   GEO; GSM311417
DR   GEO; GSM311418
DR   GEO; GSM375464
DR   GEO; GSM375465
DR   GEO; GSM375466
DR   Wikidata; Q54882807
RX   PubMed=21145827;
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1834; CEBPB (Note=Isoform LAP).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   Hep3BLAP-II
AC   CVCL_DI40
DR   Wikidata; Q54882808
RX   PubMed=21145827;
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1834; CEBPB (Note=Isoform LAP).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   Hep3BLIP-I
AC   CVCL_DI41
SY   Hep3BLIP; Hep3B-LIP
DR   GEO; GSM311419
DR   GEO; GSM311420
DR   GEO; GSM311421
DR   GEO; GSM311422
DR   GEO; GSM311423
DR   GEO; GSM311424
DR   GEO; GSM311425
DR   GEO; GSM311426
DR   GEO; GSM311427
DR   GEO; GSM311428
DR   Wikidata; Q54882809
RX   PubMed=21145827;
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1834; CEBPB (Note=Isoform LIP).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   Hep3BLIP-II
AC   CVCL_DI42
DR   Wikidata; Q54882810
RX   PubMed=21145827;
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1834; CEBPB (Note=Isoform LIP).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   Hepa 1-6
AC   CVCL_0327
SY   HEPA 1-6; Hepa-1-6; Hepa1-6
DR   BTO; BTO_0002895
DR   CLO; CLO_0003711
DR   CLO; CLO_0050769
DR   EFO; EFO_0022833
DR   MCCL; MCC:0000223
DR   CLDB; cl1658
DR   CLDB; cl1659
DR   CLDB; cl5199
DR   AddexBio; C0015005/4999
DR   ATCC; CRL-1830
DR   BCRC; 60051
DR   BioSample; SAMN11397636
DR   CCRID; 1101MOU-PUMC000106
DR   CCRID; 3101MOUSCSP512
DR   CCRID; 3101MOUTCM39
DR   CCRID; 4201MOU-CCTCC00313
DR   CCRID; 6101MOU-CERC000105
DR   CCTCC; GDC0313
DR   CLS; 400474
DR   DSMZ; ACC-175
DR   DSMZCellDive; ACC-175
DR   ECACC; 92110305
DR   GEO; GSM1374085
DR   GEO; GSM1374086
DR   GEO; GSM1374087
DR   GEO; GSM1374088
DR   GEO; GSM1374089
DR   GEO; GSM1374090
DR   IZSLER; BS TCL 157
DR   Lonza; 830
DR   NCBI_Iran; C517
DR   PRIDE; PXD000666
DR   PRIDE; PXD001792
DR   RCB; RCB1638
DR   Ubigene; YC-A005
DR   Wikidata; Q54882820
RX   DOI=10.37421/2684-4567.2021.5.121;
RX   PubMed=11004682;
RX   PubMed=12606785;
RX   PubMed=25193168;
RX   PubMed=26280412;
RX   PubMed=28152020;
RX   PubMed=31220119;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/hepa1-6-xenograft-model/
CC   Characteristics: Secretes several liver products including albumin, alpha-fetoprotein, alpha 1-antitrypin and amylase (ECACC=92110305).
CC   Doubling time: 26.99 +- 1.93 hours (PubMed=28152020); ~30 hours (DSMZ=ACC-175).
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
ST   Source(s): CLS=400474; PubMed=31220119; Ubigene=YC-A005
ST   Mouse STR 1-1: 14,15,16
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 14
ST   Mouse STR 3-2: 10
ST   Mouse STR 4-2: 18.3,19.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 15
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17.1
ST   Mouse STR 15-3: 17,18,19
ST   Mouse STR 17-2: 14
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 10,11
ST   Mouse STR X-1: 25
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S550 ! Hepa-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   Hepa 1-6-Luc
AC   CVCL_C8Y7
DR   Ubigene; YC-A005-Luc-P
DR   Wikidata; Q123031637
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Hepa 1-6/10R
AC   CVCL_A5BH
SY   Hepa 1-6/R
DR   Wikidata; Q107115330
RX   PubMed=11004682;
RX   PubMed=12606785;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   Hepa-1
AC   CVCL_S550
SY   Hepa 1; Hepa1
DR   BTO; BTO_0003319
DR   Wikidata; Q54882811
RX   PubMed=106390;
RX   PubMed=3431441;
RX   PubMed=4362668;
RX   PubMed=6102619;
CC   Characteristics: Established from a transplantable mouse hepatoma BW7756 (PubMed=6102619).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E4AK ! BW
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Hepa-1a
AC   CVCL_E4AL
SY   Hepa 1a
RX   PubMed=3431441;
RX   PubMed=4367319;
RX   PubMed=6181572;
RX   PubMed=7005077;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Hepa-1a 1/c/1
AC   CVCL_E4AR
SY   1/c/1
RX   PubMed=3431441;
RX   PubMed=6181572;
CC   Characteristics: Show significantly reduced levels of albumin production (PubMed=6181572).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4AL ! Hepa-1a
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Hepa-1a 19/2
AC   CVCL_E4AS
SY   19/2
RX   PubMed=3431441;
RX   PubMed=6181572;
CC   Characteristics: Fails to produce albumin (PubMed=6181572).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4AL ! Hepa-1a
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Hepa-1aV1
AC   CVCL_E4AM
SY   Hepa 1aV1
RX   PubMed=3431441;
RX   PubMed=7005077;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4AL ! Hepa-1a
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Hepa-1c1c7
AC   CVCL_0328
SY   Hepa 1c1c7; Hepa1c1c7; Hepa 1-clc7
DR   BTO; BTO_0002894
DR   CLO; CLO_0003712
DR   MCCL; MCC:0000224
DR   CLDB; cl1660
DR   CLDB; cl1661
DR   CLDB; cl4932
DR   ATCC; CRL-2026
DR   BCRC; 60104
DR   BCRJ; 0102
DR   BioSample; SAMN11397638
DR   ECACC; 95090613
DR   ICLC; ATL98016
DR   KCLB; 22026
DR   Lonza; 1224
DR   Wikidata; Q54882812
RX   PubMed=106390;
RX   PubMed=4362668;
RX   PubMed=6300048;
RX   PubMed=7462248;
RX   PubMed=18959748;
RX   PubMed=31220119;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 14,15
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 14
ST   Mouse STR 3-2: 10
ST   Mouse STR 4-2: 18.3,19.3
ST   Mouse STR 5-5: 17,18
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 15
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17.1
ST   Mouse STR 15-3: 17,18,19
ST   Mouse STR 17-2: 14
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 10,11
ST   Mouse STR X-1: 25
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S550 ! Hepa-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   Hepa-C12
AC   CVCL_0329
SY   Hepa-1c1c7-c12; Hepa 1c1c7 C12
DR   BTO; BTO_0004251
DR   MCCL; MCC:0000225
DR   Wikidata; Q54882813
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   Hepa-C4
AC   CVCL_0330
SY   Hepa-1c1c7-c4; Hepa 1c1c7 C4
DR   BTO; BTO_0004252
DR   MCCL; MCC:0000226
DR   Wikidata; Q54882814
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   Hepa-E1
AC   CVCL_4225
DR   CLO; CLO_0050003
DR   ECACC; 99072812
DR   RCB; RCB1155
DR   Wikidata; Q54882815
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   Hepa-RP3
AC   CVCL_FA15
SY   HepaRP3
DR   Wikidata; Q54882816
RX   Patent=US9765300;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_FA14 ! Hepa-SC
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 8
//
ID   Hepa-SC
AC   CVCL_FA14
SY   HepaSC
DR   Wikidata; Q54882817
RX   Patent=US9765300;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4980.
CC   Characteristics: Has stem-like cell properties. Can be differentiated/reprogrammed using mechanical stress and in the presence of at least one differentiation factor.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   Hepa-T1
AC   CVCL_4226
DR   CLO; CLO_0050270
DR   ECACC; 99072813
DR   RCB; RCB1156
DR   Wikidata; Q54882818
RX   DOI=10.1007/s12562-018-1215-4;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; RCB; -; https://web.archive.org/web/20230328160254/https://cell.brc.riken.jp/en/DNA_barcoding
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of tilapia origin (Oreochromis niloticus) but found to be from eel (DOI=10.1007/s12562-018-1215-4; RCB). Is probably identical to Hepa-E1.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00567.
CC   Discontinued: ECACC; 99072813; true.
CC   Discontinued: RCB; RCB1156; probable.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
HI   CVCL_4225 ! Hepa-E1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   Hepa/8F5
AC   CVCL_RI52
SY   Hepa/8F(#5); Hepa8F5
DR   ArrayExpress; E-MTAB-5770
DR   RCB; RCB4661
DR   Wikidata; Q54882819
RX   DOI=10.1016/j.bej.2011.10.004;
RX   PubMed=28847578;
RX   PubMed=34149171;
CC   Characteristics: When doxycycline-induced, overexpresses 8 liver-enriched transcription factors (LETFs).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99480; Cebpa.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88373; Cebpb.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104982; Cebpg.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1347476; Foxa2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98504; Hnf1a.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98505; Hnf1b.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:109128; Hnf4a.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1196423; Onecut1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 13
//
ID   Hepa/HS
AC   CVCL_B5ZG
DR   Wikidata; Q111733353
RX   PubMed=34149171;
CC   Characteristics: When doxycycline-induced, overexpresses 8 liver-enriched transcription factors (LETFs) (from parent cell line).
CC   Characteristics: The parent cell line was modified to enable switching between proliferation and expression of proteins for liver function in response to heat by introducing a new heat-inducible gene expression/amplification system (pHSP-tTA-TRE-tTA-pEF1a-Puro) which was transferred using a PiggyBac transposon vector (PubMed=34149171).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:99480; Cebpa.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88373; Cebpb.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104982; Cebpg.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1347476; Foxa2.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98504; Hnf1a.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98505; Hnf1b.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:109128; Hnf4a.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1196423; Onecut1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RI52 ! Hepa/8F5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 8
//
ID   Hepa1-3xFlag-AhR-HA-pCEP4(CAG)H12C1
AC   CVCL_AS15
DR   TKG; TKG 0721
DR   Wikidata; Q54882821
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:105043; Ahr (Note=With 3xFLAG and HA tags).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AS14 ! Hepa1-cl19E4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   Hepa1-6-eGFP-Puro
AC   CVCL_RA18
DR   Imanis; CL128
DR   Wikidata; Q54882822
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL128).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   Hepa1-6-Fluc-Neo
AC   CVCL_RA19
DR   Imanis; CL130
DR   Wikidata; Q54882823
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Neo vector encoding for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL130).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   Hepa1-6-Fluc-Neo/eGFP-Puro
AC   CVCL_RA20
DR   Imanis; CL133
DR   Wikidata; Q54882824
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL133).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   Hepa1-6-iRFP-Puro
AC   CVCL_RA21
DR   Imanis; CL131
DR   Wikidata; Q54882825
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Puro vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL131).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   Hepa1-cl19E4
AC   CVCL_AS14
DR   TKG; TKG 0719
DR   Wikidata; Q54882826
CC   Characteristics: Aryl hydrocarbon receptor deficient mutant (TKG=TKG 0719).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   Hepa1c1c7 BORIS C68
AC   CVCL_C1LX
DR   Wikidata; Q114311604
RX   PubMed=35813346;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16234; CTCFL (Note=Isoform C68).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   Hepa1c1c7 BORIS sf2
AC   CVCL_C1LY
DR   Wikidata; Q114311607
RX   PubMed=35813346;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16234; CTCFL (Note=Isoform sf2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   Hepa1c1c7-M4P2
AC   CVCL_DC15
DR   Wikidata; Q54882828
RX   Patent=US20050277142;
CC   Group: Patented cell line.
CC   Registration: Bioresource Collection and Research Center (BCRC) of Taiwan; BCRC 960208.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6090.
CC   Biotechnology: Can be used for bioassays to detect dioxin/TCDD-like compounds.
CC   Characteristics: Acts through the activation of a luciferase reporter gene which is under the control of dioxin-response elements (DREs) from mouse Cyp1a1 gene.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 13
//
ID   Hepa1c1c7-MP
AC   CVCL_DC14
DR   Wikidata; Q54882827
RX   Patent=US20050277142;
CC   Group: Patented cell line.
CC   Registration: Bioresource Collection and Research Center (BCRC) of Taiwan; BCRC 960207.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6089.
CC   Biotechnology: Can be used for bioassays to detect dioxin/TCDD-like compounds.
CC   Characteristics: Acts through the activation of a luciferase reporter gene which is under the control of dioxin-response elements (DREs) from mouse Cyp1a1 gene.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0328 ! Hepa-1c1c7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 13
//
ID   HepAD38
AC   CVCL_M177
SY   Hep AD38; HepG2 AD38; HepG2-AD38; Hep G2 AD 38; AD-38; AD38
DR   BTO; BTO_0006298
DR   ATCC; CRL-3561
DR   ATCC; CRL-12077
DR   cancercelllines; CVCL_M177
DR   Wikidata; Q54882829
RX   Patent=US5723319;
RX   PubMed=9257747;
RX   PubMed=9875378;
RX   PubMed=21331898;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12077.
CC   Population: Caucasian.
CC   Biotechnology: Used in a bioassay that permits the large-scale screening of compound libraries for inhibitors of HBV replication.
CC   Virology: Inducibly expresses a hepatitis B virus (HBV) genome under the control of a tet operator/CMV promoter. Upon removal of tetracycline the cell line produces viral RNA and secrete virus-like particles into the supernatant.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: ATCC; CRL-12077; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-3561
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 23
//
ID   HepAD43
AC   CVCL_DE22
SY   Hep AD43
DR   cancercelllines; CVCL_DE22
DR   Wikidata; Q54882830
RX   PubMed=21331898;
CC   Population: Caucasian.
CC   Biotechnology: Control cell line for the bioassay based on HepAD38 (Cellosaurus=CVCL_M177) or HepAD79 (Cellosaurus=CVCL_DE23).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   HepAD79
AC   CVCL_DE23
SY   Hep AD79; HepG2-AD79; AD-79; AD79
DR   cancercelllines; CVCL_DE23
DR   Wikidata; Q54882831
RX   PubMed=9875378;
CC   Population: Caucasian.
CC   Virology: Inducibly expresses a lamivudine-resistant hepatitis B virus (HBV) genome under the control of a tet operator/CMV promoter. Upon removal of tetracycline the cell line produces viral RNA and secrete virus-like particles into the supernatant (PubMed=9875378).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 17
//
ID   HepaFH3
AC   CVCL_ZG37
DR   Wikidata; Q98126683
RX   DOI=10.17169/refubium-1249;
RX   PubMed=26715207;
RX   PubMed=30347615;
RX   PubMed=31561354;
CC   Characteristics: Has an extended lifespan due to the lentiviral transfer of Upcyte(R) proliferation genes.
CC   Doubling time: ~28 hours (PubMed=26715207).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Hepama-1
AC   CVCL_IR43
SY   HP-1
DR   CCRID; 4201PAT-CCTCC00131
DR   CCRID; 4201PAT-CCTCC00145
DR   Wikidata; Q54882832
RX   Patent=CN1114619C;
RX   PubMed=1849045;
RX   PubMed=2424200;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C95013.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human antigen on hepatocellular carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   Hepama-18
AC   CVCL_WL29
SY   HP-18
DR   CCRID; 4201PAT-CCTCC00144
DR   Wikidata; Q94103034
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on hepatocellular carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   Hepama-2
AC   CVCL_IR44
DR   Wikidata; Q54882833
RX   PubMed=2424200;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on hepatocellular carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   HepaRG
AC   CVCL_9720
SY   Hepa-RG
DR   BTO; BTO_0005736
DR   EFO; EFO_0001186
DR   ChEMBL-Cells; CHEMBL4630773
DR   ChEMBL-Targets; CHEMBL4630781
DR   Cosmic; 2162524
DR   MetaboLights; MTBLS78
DR   MetaboLights; MTBLS4063
DR   Millipore; C103485
DR   PRIDE; PXD001107
DR   PRIDE; PXD004752
DR   PRIDE; PXD006267
DR   PRIDE; PXD010304
DR   PubChem_Cell_line; CVCL_9720
DR   Wikidata; Q54882834
RX   Patent=US7456018;
RX   PubMed=12432097;
RX   PubMed=17241619;
RX   PubMed=17393521;
RX   PubMed=20228232;
RX   PubMed=20645056;
RX   PubMed=21414303;
RX   PubMed=22568886;
RX   PubMed=22594799;
RX   PubMed=22643240;
RX   PubMed=22857383;
RX   PubMed=23887712;
RX   PubMed=26160117;
RX   PubMed=26694163;
RX   PubMed=27027780;
RX   PubMed=27169750;
RX   PubMed=27780834;
RX   PubMed=27975304;
RX   PubMed=28904299;
RX   PubMed=30795634;
RX   PubMed=31063779;
RX   PubMed=33441761;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/HepaRG
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HepaRG
WW   Provider; Biopredic; -; https://web.archive.org/web/20221228183303/http://www.heparg.com/
WW   Provider; Biopredic; -; https://www.biopredicadvancells.com/product/cryopreserved-heparg-116-cells/
WW   Provider; Thermo Fisher; HPRGC10; https://www.thermofisher.com/order/catalog/product/HPRGC10
WW   Provider; TRL; -; https://web.archive.org/web/20171123042648/http://triangleresearchlabs.net/products-hepatocytes/nospin-heparg/
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2652.
CC   Characteristics: Can be induced to differentiate into hepatocyte-like cells by exposure to DMSO.
CC   Characteristics: Cell line main applications are sugar and lipid metabolism, physiopathology; drug metabolism and toxicology and viral infection.
CC   Doubling time: 24 hours (PubMed=12432097).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Anecdotal: The 'RG' in the cell name stands for 'Rumin' and 'Gripon', the two scientists that were influential in the establishment of this cell line.
CC   Miscellaneous: This cell line is exclusively produced and controlled by Biopredic International and owned by Inserm. BioPredic sells undifferentiated cell line (HPR101) that can be expanded, passaged, and frozen in-house to prepare a cell bank and differentiated ready-to-use cells, HPR116 (Cellosaurus=CVCL_WL73) that can be used immediately or in a few days after thawing, as a single-use disposable product (Biopredic).
CC   Discontinued: Millipore; C103485; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 34
//
ID   HepaRG 5F
AC   CVCL_B6A6
SY   HepaRG 5F Control Cells
DR   Sigma-Aldrich; MTOX1010
DR   Wikidata; Q111733354
RX   PubMed=27713827;
CC   Characteristics: These cells were modified with the use of transfected mRNA encoding ZFNs targeting a specific site (Sigma-Aldrich=MTOX1010).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   HepaRG AHR KO
AC   CVCL_B6A7
SY   HepaRG Cells AHR (-/-); HepaRG AHR Knockout Cells
DR   Sigma-Aldrich; MTOX1013
DR   Wikidata; Q111733355
CC   Knockout cell: Method=ZFN; HGNC; HGNC:348; AHR.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG BCRP KO
AC   CVCL_B6A8
SY   HepaRG Cells BCRP (-/-); HepaRG BCRP Knockout Cells
DR   Sigma-Aldrich; MTOX1021
DR   Wikidata; Q111733356
CC   Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG BSEP KO
AC   CVCL_B6A9
SY   HepaRG Cells BSEP (-/-); HepaRG BSEP Knockout Cells
DR   Sigma-Aldrich; MTOX1018
DR   Wikidata; Q111733357
CC   Knockout cell: Method=ZFN; HGNC; HGNC:42; ABCB11.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG CAR KO
AC   CVCL_B6AA
SY   HepaRG Cells CAR (-/-); HepaRG CAR Knockout Cells
DR   Sigma-Aldrich; MTOX1012
DR   Wikidata; Q111733358
CC   Knockout cell: Method=ZFN; HGNC; HGNC:7969; NR1I3.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG CYP3A4 KO
AC   CVCL_B6AB
SY   HepaRG Cells CYP3A4 (-/-); HepaRG CYP3A4 Knockout Cells
DR   Sigma-Aldrich; MTOX1026
DR   Wikidata; Q111733359
CC   Knockout cell: Method=ZFN; HGNC; HGNC:2637; CYP3A4.
CC   Discontinued: Sigma-Aldrich; MTOX1026; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HepaRG CYP3A4G/7R clone 3
AC   CVCL_JJ68
SY   HepaRG C3; C3
DR   Wikidata; Q54882835
RX   PubMed=25101946;
CC   Characteristics: Transfected with a dual reporter that express RFP under the transcriptional regulation of CYP3A7 in the hepatoblast-like cell state and EGFP under the transcriptional regulation of CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   HepaRG FXR KO
AC   CVCL_B6AC
SY   HepaRG Cells FXR (-/-); HepaRG FXR Knockout Cells
DR   Sigma-Aldrich; MTOX1031
DR   Wikidata; Q111733360
CC   Knockout cell: Method=ZFN; HGNC; HGNC:7967; NR1H4.
CC   Discontinued: Sigma-Aldrich; MTOX1031; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG MATE1 KO
AC   CVCL_B6AD
SY   HepaRG Cells MATE1 (-/-); HepaRG MATE1 Knockout Cells
DR   Sigma-Aldrich; MTOX1022
DR   Wikidata; Q111733362
CC   Knockout cell: Method=ZFN; HGNC; HGNC:25588; SLC47A1.
CC   Discontinued: Sigma-Aldrich; MTOX1022; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG MDR1 KO
AC   CVCL_B6AE
SY   HepaRG Cells MDR1 (-/-); HepaRG MDR1 Knockout Cells
DR   Sigma-Aldrich; MTOX1019
DR   Wikidata; Q111733363
CC   Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG MDR3 KO
AC   CVCL_B6AF
SY   HepaRG Cells MDR3 (-/-); HepaRG MDR3 Knockout Cells
DR   Sigma-Aldrich; MTOX1029
DR   Wikidata; Q111733364
CC   Knockout cell: Method=ZFN; HGNC; HGNC:45; ABCB4.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   HepaRG MRP2 KO
AC   CVCL_B6AG
SY   HepaRG Cells MRP2 (-/-); HepaRG MRP2 Knockout Cells
DR   Sigma-Aldrich; MTOX1020
DR   Wikidata; Q111733365
CC   Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG MRP2/MRP4 KO
AC   CVCL_B6AH
SY   HepaRG MRP2/MRP4 DKO; HepaRG MRP2/MRP4 Double Knockout Cells
DR   Sigma-Aldrich; MTOX1103
DR   Wikidata; Q111733366
CC   Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4.
CC   Discontinued: Sigma-Aldrich; MTOX1103; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG MRP3 KO
AC   CVCL_B6AI
SY   HepaRG Cells MRP3 (-/-); HepaRG MRP3 Knockout Cells
DR   Sigma-Aldrich; MTOX1105
DR   Wikidata; Q111733367
CC   Knockout cell: Method=ZFN; HGNC; HGNC:54; ABCC3.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG MRP4 KO
AC   CVCL_B6AJ
SY   HepaRG Cells MRP4 (-/-); HepaRG MRP4 Knockout Cells
DR   Sigma-Aldrich; MTOX1106
DR   Wikidata; Q111733368
CC   Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4.
CC   Discontinued: Sigma-Aldrich; MTOX1106; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG MRP6 KO
AC   CVCL_B6AK
SY   HepaRG Cells MRP6 (-/-); HepaRG MRP6 Knockout Cells
DR   Sigma-Aldrich; MTOX1104
DR   Wikidata; Q111733371
CC   Knockout cell: Method=ZFN; HGNC; HGNC:57; ABCC6.
CC   Discontinued: Sigma-Aldrich; MTOX1104; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG OATP1B1 KO
AC   CVCL_B6AL
SY   HepaRG Cells OATP1B1 (-/-); HepaRG OATP1B1 Knockout Cells
DR   Sigma-Aldrich; MTOX1015
DR   Wikidata; Q111733372
CC   Knockout cell: Method=ZFN; HGNC; HGNC:10959; SLCO1B1.
CC   Discontinued: Sigma-Aldrich; MTOX1015; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG OATP1B1/OATP1B3 KO
AC   CVCL_B6AM
SY   HepaRG Cells OATP1B1 (-/-)/OATP1B3 (-/-); OATP1B1/OATP1B3 Knockout HepaRG Cells
DR   Sigma-Aldrich; MTOX1017
DR   Wikidata; Q111733373
CC   Knockout cell: Method=ZFN; HGNC; HGNC:10959; SLCO1B1.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:10961; SLCO1B3.
CC   Discontinued: Sigma-Aldrich; MTOX1017; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG OATP1B3 KO
AC   CVCL_B6AN
SY   HepaRG Cells OATP1B3 (-/-); HepaRG OATP1B3 Knockout Cells
DR   Sigma-Aldrich; MTOX1016
DR   Wikidata; Q111733374
CC   Knockout cell: Method=ZFN; HGNC; HGNC:10961; SLCO1B3.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG P66SHC KO
AC   CVCL_B6AP
SY   HepaRG Cells P66SHC (-/-); HepaRG P66SHC Knockout Cells
DR   Sigma-Aldrich; MTOX1023
DR   Wikidata; Q111733375
CC   Knockout cell: Method=ZFN; HGNC; HGNC:10840; SHC1.
CC   Discontinued: Sigma-Aldrich; MTOX1023; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG PERK KO
AC   CVCL_B6AQ
SY   HepaRG Cells PERK (-/-); HepaRG PERK Knockout Cells
DR   Sigma-Aldrich; MTOX1024
DR   Wikidata; Q111733376
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3255; EIF2AK3.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG POR KO
AC   CVCL_B6AR
SY   HepaRG Cells POR (-/-); HepaRG POR Knockout Cells
DR   Sigma-Aldrich; MTOX1025
DR   Wikidata; Q111733377
CC   Knockout cell: Method=ZFN; HGNC; HGNC:9208; POR.
CC   Discontinued: Sigma-Aldrich; MTOX1025; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG PXR KO
AC   CVCL_B6AS
SY   HepaRG Cells PXR (-/-); HepaRG PXR Knockout Cells
DR   Sigma-Aldrich; MTOX1011
DR   Wikidata; Q111733378
RX   PubMed=27713827;
CC   Knockout cell: Method=ZFN; HGNC; HGNC:7968; NR1I2.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HepaRG PXR/CAR KO
AC   CVCL_B6AT
SY   HepaRG PXR/CAR DKO; HepaRG PXR/CAR Double Knockout Cells
DR   Sigma-Aldrich; MTOX1014
DR   Wikidata; Q111733380
CC   Knockout cell: Method=ZFN; HGNC; HGNC:7968; NR1I2.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:7969; NR1I3.
CC   Discontinued: Sigma-Aldrich; MTOX1014; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG SOD2 KO
AC   CVCL_B6AU
SY   HepaRG Cells SOD2 (-/-); HepaRG SOD2 Knockout Cells
DR   Sigma-Aldrich; MTOX1027
DR   Wikidata; Q111733381
CC   Knockout cell: Method=ZFN; HGNC; HGNC:11180; SOD2.
CC   Discontinued: Sigma-Aldrich; MTOX1027; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6A6 ! HepaRG 5F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   HepaRG-CAR
AC   CVCL_XI49
DR   Wikidata; Q94103091
RX   Patent=US20190256822;
RX   PubMed=27780834;
RX   PubMed=32130581;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3291.
CC   Characteristics: Compared to the parent cell line, has improved liver functionality. Drug metabolism is highly improved. Culturing can be performed in serum-free conditions both in the presence or absence of DMSO.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HepaRG-hNTCP
AC   CVCL_JY39
SY   HepaRGhNTCP
DR   Wikidata; Q54882836
RX   PubMed=24361467;
RX   PubMed=27975304;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10905; SLC10A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   HepaRG-POR#1
AC   CVCL_C0R0
DR   Wikidata; Q112929712
RX   PubMed=33441761;
CC   Characteristics: Not completely KO for POR, can be considered as a POR knockdown cell line (PubMed=33441761).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0QZ ! HepaRG(VC)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepaRG-POR#2
AC   CVCL_C0R1
DR   Wikidata; Q112929713
RX   PubMed=33441761;
CC   Characteristics: Not completely KO for POR, can be considered as a POR knockdown cell line (PubMed=33441761).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0QZ ! HepaRG(VC)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepaRG(VC)
AC   CVCL_C0QZ
SY   HepaRGVC; HepaRG Vector Control
DR   Wikidata; Q112929714
RX   PubMed=33441761;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepBHAe82
AC   CVCL_DF32
SY   HepBHAe-82
DR   cancercelllines; CVCL_DF32
DR   Wikidata; Q54882837
RX   PubMed=27185623;
CC   Population: Caucasian.
CC   Biotechnology: Used for a bioassay to detect HBV covalently closed circular (ccc) DNA.
CC   Characteristics: Transfected with an in-frame influenza hemagglutinin (HA) epitope tag into the precore domain of hepatitis B virus (HBV) e antigen (HBeAg).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 17
//
ID   HEPC-CB.1
AC   CVCL_A1AV
SY   HucPEC 55.1; Human Endothelial Progenitor Cells-Cord Blood.1
DR   Wikidata; Q102114122
RX   Patent=US9631178;
RX   PubMed=21710642;
RX   PubMed=32705508;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4220.
CC   Characteristics: Expresses CD133 and CD271, markers specific for early stem/progenitor cells. Can undergo an in vitro pre-angiogenic process, forms pseudovessel structures and presents an accelerated angiogenesis in hypoxic conditions (PubMed=21710642).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Miscellaneous: Sex of donor from personal communication of Kieda, Claudine.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Endothelial progenitor cell; CL=CL_0002546.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1AW ! HEPC-CB.2
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   HEPC-CB.2
AC   CVCL_A1AW
SY   HucPEC 55.2; Human Endothelial Progenitor Cells-Cord Blood.2
DR   Wikidata; Q102114123
RX   Patent=US9631178;
RX   PubMed=21710642;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4221.
CC   Characteristics: Expresses CD133 and CD271, markers specific for early stem/progenitor cells. Can undergo an in vitro pre-angiogenic process, forms pseudovessel structures and presents an accelerated angiogenesis in hypoxic conditions (PubMed=21710642).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Miscellaneous: Sex of donor from personal communication of Kieda, Claudine.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Endothelial progenitor cell; CL=CL_0002546.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1AV ! HEPC-CB.1
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   Hepc/1A1.4
AC   CVCL_B5VV
DR   cancercelllines; CVCL_B5VV
DR   Wikidata; Q111733382
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/1A2.9
AC   CVCL_B5VW
DR   cancercelllines; CVCL_B5VW
DR   Wikidata; Q111733383
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/2A6L.14
AC   CVCL_B5VX
DR   cancercelllines; CVCL_B5VX
DR   Wikidata; Q111733384
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/2B6.68
AC   CVCL_B5VY
DR   cancercelllines; CVCL_B5VY
DR   Wikidata; Q111733385
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/2C19.12
AC   CVCL_B5VZ
DR   cancercelllines; CVCL_B5VZ
DR   Wikidata; Q111733386
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2621; CYP2C19.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/2C8.46
AC   CVCL_B5W0
DR   cancercelllines; CVCL_B5W0
DR   Wikidata; Q111733387
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2622; CYP2C8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/2C9.1
AC   CVCL_B5W1
DR   cancercelllines; CVCL_B5W1
DR   Wikidata; Q111733388
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/2D6.39
AC   CVCL_B5W2
DR   cancercelllines; CVCL_B5W2
DR   Wikidata; Q111733389
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2625; CYP2D6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/2E1.3-8
AC   CVCL_B5W3
DR   cancercelllines; CVCL_B5W3
DR   Wikidata; Q111733390
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepc/3A4.2-30
AC   CVCL_B5W4
DR   cancercelllines; CVCL_B5W4
DR   Wikidata; Q111733391
RX   PubMed=11377097;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Hepd
AC   CVCL_F0BF
RX   PubMed=2450630;
CC   Population: Japanese.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Hepd-uvBLMr
AC   CVCL_F0BG
RX   PubMed=2450630;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_22907; Bleomycin.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0BF ! Hepd
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HepDE19
AC   CVCL_M178
SY   DE19
DR   cancercelllines; CVCL_M178
DR   Wikidata; Q54882838
RX   PubMed=17804499;
RX   PubMed=17875990;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   HepDES19
AC   CVCL_M179
SY   DES19
DR   cancercelllines; CVCL_M179
DR   Wikidata; Q54882839
RX   PubMed=17804499;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   HepDT
AC   CVCL_C3PA
DR   Wikidata; Q116049311
RX   Patent=US20190345441;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.15590.
CC   Doubling time: 27-32 hours (Patent=US20190345441).
CC   Knockout cell: Method=KO pig; VGNC; VGNC:112761; GGTA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   20D
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HePe-01
AC   CVCL_VX31
SY   Hepe01
DR   IBRC; C10834
DR   Wikidata; Q94103190
RX   PubMed=29948549;
CC   Group: Reptilian cell line.
CC   Doubling time: 24 +- 0.5 hours (PubMed=29948549).
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=303590; ! Cyrtopodion scabrum (Rough-tailed gecko)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   HepF
AC   CVCL_TZ61
DR   ATCC; CRL-7925
DR   Wikidata; Q54882840
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7925; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   HEPFT
AC   CVCL_M185
DR   Wikidata; Q54882841
RX   PubMed=17949352;
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=17949352).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
DI   NCIt; C3867; Fallopian tube carcinoma
DI   ORDO; Orphanet_180242; Malignant tumor of fallopian tubes
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   HepG2 82FR-31NR
AC   CVCL_D5JJ
SY   82FR-31NR; 82 days Fractionated Radiation-31 days Non-Radiation
DR   TKG; TKG 0803
DR   Wikidata; Q127381750
RX   PubMed=23552696;
CC   Population: Caucasian.
CC   Characteristics: Radioresistant. Exposed to X-ray (0.5 Gy) fractionated radiation (FR) for 82 days and cessation of FR for 31 days (PubMed=23552696).
CC   Selected for resistance to: NCIt; C17262; X-Ray.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0803
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HepG2 AhR-CYP1A1 clone 10
AC   CVCL_C0V3
DR   cancercelllines; CVCL_C0V3
DR   Wikidata; Q112929715
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hAhR and pGLuc-CYP1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:348; AHR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 AhR-CYP1A1 clone 4
AC   CVCL_C0V1
DR   cancercelllines; CVCL_C0V1
DR   Wikidata; Q112929716
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hAhR and pGLuc-CYP1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:348; AHR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 AhR-CYP1A1 clone 9
AC   CVCL_C0V2
DR   cancercelllines; CVCL_C0V2
DR   Wikidata; Q112929717
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hAhR and pGLuc-CYP1A1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:348; AHR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 CAR-CYP2B6 clone 10
AC   CVCL_C0V6
DR   cancercelllines; CVCL_C0V6
DR   Wikidata; Q112929718
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hCAR and pGLuc-CYP2B6.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 CAR-CYP2B6 clone 6
AC   CVCL_C0V4
DR   cancercelllines; CVCL_C0V4
DR   Wikidata; Q112929719
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hCAR and pGLuc-CYP2B6.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 CAR-CYP2B6 clone 7
AC   CVCL_C0V5
DR   cancercelllines; CVCL_C0V5
DR   Wikidata; Q112929720
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hCAR and pGLuc-CYP2B6.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 CYP3A4G/7R clone 87
AC   CVCL_IX10
SY   HepG2 C87; C87
DR   cancercelllines; CVCL_IX10
DR   Wikidata; Q54882844
RX   PubMed=25101946;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a dual reporter that express RFP under the transcriptional regulation of CYP3A7 in the hepatoblast-like cell state and EGFP under the transcriptional regulation of CYP3A4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   HepG2 hALR
AC   CVCL_W371
DR   cancercelllines; CVCL_W371
DR   Wikidata; Q54882845
RX   PubMed=23797278;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4236; GFER.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   HepG2 PXR-CYP3A4 clone 1
AC   CVCL_C0V7
DR   cancercelllines; CVCL_C0V7
DR   Wikidata; Q112929721
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hPXR and pGLuc-CYP3A4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 PXR-CYP3A4 clone 3
AC   CVCL_C0V8
DR   cancercelllines; CVCL_C0V8
DR   Wikidata; Q112929723
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hPXR and pGLuc-CYP3A4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 PXR-CYP3A4 clone 8
AC   CVCL_C0V9
DR   cancercelllines; CVCL_C0V9
DR   Wikidata; Q112929724
RX   PubMed=33896369;
CC   Population: Caucasian.
CC   Characteristics: Transfected with both pcDNA3.1-hPXR and pGLuc-CYP3A4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9BLZ2; Gaussia princeps luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   HepG2 Tet-Off Advanced
AC   CVCL_KU36
DR   cancercelllines; CVCL_KU36
DR   Wikidata; Q54882846
CC   Population: Caucasian.
CC   Characteristics: Transfected with an advanced tetracycline transactivator (tTA2(S)-M2) protein, a fusion of a mutated E.coli tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 631151.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   HepG2 Tet-On
AC   CVCL_V331
DR   cancercelllines; CVCL_V331
DR   Wikidata; Q54882847
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 19
//
ID   HepG2 Tet-On Advanced
AC   CVCL_KT01
DR   cancercelllines; CVCL_KT01
DR   Wikidata; Q54882848
WW   Provider; Takara Bio; 630932; https://www.takarabio.com/documents/Components%20List/631150_071817.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with an advanced reverse tetracycline-controlled transactivator (rtTA2(S)-M2), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   HepG2-FVII
AC   CVCL_E3FN
SY   FVII-HepG2
RX   PubMed=31381603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3544; F7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HepG2.105
AC   CVCL_A5AW
SY   HepG2.TA2-7.105
DR   cancercelllines; CVCL_A5AW
DR   Wikidata; Q107115331
RX   PubMed=16935386;
CC   Population: Caucasian.
CC   Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16. Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HepG2.117
AC   CVCL_A5AX
SY   HepG2.TA2-7.117
DR   cancercelllines; CVCL_A5AX
DR   Wikidata; Q107115332
RX   PubMed=16935386;
RX   PubMed=21472112;
CC   Population: Caucasian.
CC   Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16. Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HepG2.A64
AC   CVCL_B0UH
SY   A64
DR   cancercelllines; CVCL_B0UH
DR   Wikidata; Q108820458
RX   PubMed=28382278;
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201163.
CC   Population: Caucasian.
CC   Virology: Transfected with a plasmid pTriexHBV1.1 containing 1.1 copies of hepatitis B virus (HBV) DNA (GenBank: HQ638218.1) (PubMed=28382278).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   HepG2-8960-R
AC   CVCL_A8FS
DR   cancercelllines; CVCL_A8FS
DR   TKG; TKG 0804
DR   Wikidata; Q107115333
RX   PubMed=19215227;
RX   PubMed=20410675;
RX   PubMed=21716292;
RX   PubMed=27681752;
CC   Population: Caucasian.
CC   Characteristics: Radioresistant. Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=19215227).
CC   Selected for resistance to: NCIt; C17262; X-Ray.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0804
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   HepG2-CAR
AC   CVCL_XI50
DR   cancercelllines; CVCL_XI50
DR   Wikidata; Q94103341
RX   Patent=US20190256822;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HepG2-CD81
AC   CVCL_C5RN
SY   HepG2/CD81+
DR   ChEMBL-Cells; CHEMBL4543855
DR   ChEMBL-Targets; CHEMBL4543887
DR   Wikidata; Q116049312
RX   PubMed=12913001;
RX   PubMed=16819966;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1701; CD81.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HepG2-CYP2B6-hCAR
AC   CVCL_XI69
DR   cancercelllines; CVCL_XI69
DR   Wikidata; Q94103346
RX   PubMed=25993555;
RX   PubMed=27518621;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HepG2-CYP2E1
AC   CVCL_A2HH
DR   cancercelllines; CVCL_A2HH
DR   Wikidata; Q105507643
RX   PubMed=14669323;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   HepG2-CYP3A29
AC   CVCL_A9JD
DR   cancercelllines; CVCL_A9JD
DR   Wikidata; Q108820459
RX   CelloPub=CLPUB00644;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:103556; Pig CYP3A29.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   HepG2-CYP3A22
AC   CVCL_E8Z3
RX   CelloPub=CLPUB00804;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:103554; Pig CYP3A22.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HepG2-CYP3A46
AC   CVCL_E8Z2
RX   CelloPub=CLPUB00803;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:103557; Pig CYP3A46.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HepG2-DM2
AC   CVCL_9874
DR   cancercelllines; CVCL_9874
DR   Wikidata; Q54882849
RX   PubMed=11083647;
CC   Population: Caucasian.
CC   Virology: Transfected with a hepatitis B virus (HBV) subtype adr genome with a DNA polymerase having p.Leu526Met and p.Met550Val mutations (PubMed=11083647).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   HepG2-DP
AC   CVCL_D5I8
SY   HepG2-DP clone No.4; DP-4; DNMT1/PKR double knockdowned HepG2
DR   JCRB; JCRB1978
DR   Wikidata; Q127381751
RX   PubMed=36476676;
CC   Population: Caucasian.
CC   Characteristics: Has improved hepatic function (PubMed=36476676).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:2976; DNMT1.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:9437; EIF2AK2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1978
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HepG2-Dual
AC   CVCL_A8BS
DR   cancercelllines; CVCL_A8BS
DR   InvivoGen; hepg2d-nfis
DR   Wikidata; Q107115334
CC   Population: Caucasian.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hepg2d-nfis).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HepG2-GS
AC   CVCL_H214
SY   GS-HepG2
DR   CLO; CLO_0050857
DR   BioSample; SAMN03472118
DR   cancercelllines; CVCL_H214
DR   RCB; RCB1681
DR   Wikidata; Q54882850
RX   DOI=10.1016/j.enzmictec.2004.08.027;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4341; GLUL.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): RCB=RCB1681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 23
//
ID   HepG2-GS-CYP3A4
AC   CVCL_8560
SY   GS-3A4-HepG2
DR   cancercelllines; CVCL_8560
DR   JCRB; JCRB1371
DR   JCRB; NIHS0617
DR   Wikidata; Q54882851
RX   PubMed=15903254;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4341; GLUL.
CC   Discontinued: JCRB; NIHS0617; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1371
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   HepG2-hNTCP
AC   CVCL_JY40
DR   cancercelllines; CVCL_JY40
DR   Wikidata; Q54882852
RX   PubMed=24361467;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10905; SLC10A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   HepG2-HSP
AC   CVCL_D3XE
DR   Wikidata; Q127381752
RX   PubMed=30962099;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a pQMSCV-pHSP70B-TRE-pCMVmin-EGFP-IRES-tTA construct. The heat-activated HSPA6/HSP70B' promoter drives bicistronic gene expression of EGFP and of the tetracycline-controlled transactivator (tTA), which is mediated by an internal ribosomal entry site (IRES). Then, the tTA protein binds to TRE and activates the cytomegalovirus minimum promoter (pCMVmin) upstream of EGFP, which in turn induces further expression of the EGFP and tTA genes, providing a transcriptional positive feedback loop (PubMed=30962099).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HepG2-Luc
AC   CVCL_JG47
SY   Hep G2-Luc
DR   cancercelllines; CVCL_JG47
DR   JCRB; JCRB1592
DR   Wikidata; Q54882853
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1592
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 17
//
ID   HepG2-luc2
AC   CVCL_5I95
DR   cancercelllines; CVCL_5I95
DR   Revvity/PerkinElmer; 134280
DR   Wikidata; Q54882854
WW   Provider; Revvity/PerkinElmer; 134280; https://web.archive.org/web/20150601084718/http://www.perkinelmer.com/catalog/product/id/134280
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 134280; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 20
//
ID   HepG2-Luc2-tdT
AC   CVCL_XD61
DR   cancercelllines; CVCL_XD61
DR   CCRID; 1101HUM-PUMC000802
DR   Wikidata; Q94103474
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 15
//
ID   HepG2-Lucia AhR
AC   CVCL_A8BT
DR   cancercelllines; CVCL_A8BT
DR   InvivoGen; hpgl-ahr
DR   Wikidata; Q107115335
CC   Population: Caucasian.
CC   Characteristics: Used for the study of aryl hydrocarbon receptor (AhR) genomic signaling induction (InvivoGen=hpgl-ahr).
CC   Characteristics: The Lucia luciferase reporter gene is under the control of a minimal promoter coupled with the human CYP1A1 gene entire regulatory sequence which contains 6 dioxin responsive elements (DRE) (InvivoGen=hpgl-ahr).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HepG2-N10
AC   CVCL_A8IF
SY   HepN10
DR   BTO; BTO_0006301
DR   cancercelllines; CVCL_A8IF
DR   Wikidata; Q107115336
RX   PubMed=18313149;
CC   From: Xia, Ning-Shao; Xiamen University; Xiamen; China.
CC   Population: Caucasian.
CC   Virology: Transfected with a hepatitis B virus (HBV) subtype adw2 genome.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   HepG2-NIAS
AC   CVCL_A7DQ
DR   cancercelllines; CVCL_A7DQ
DR   RCB; RCB4679
DR   Wikidata; Q107115337
RX   CelloPub=CLPUB00634;
CC   Population: Caucasian.
CC   Characteristics: Can not only rapidly activate hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity but also induce the formation of bile canaliculus-like structures by utilizing a collagen vitrigel membrane as a culture substratum (RCB=RCB4679).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   HepG2-NTCP1
AC   CVCL_C9B9
SY   HepG2-hNTCP
DR   Wikidata; Q123031638
RX   PubMed=26438841;
RX   PubMed=31801065;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10905; SLC10A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HepG2-NTCP1 HBV
AC   CVCL_C9BA
SY   HepG2-HBV
DR   Wikidata; Q123031639
RX   PubMed=26438841;
RX   PubMed=31801065;
CC   Population: Caucasian.
CC   Virology: Contains a stably integrated 1.3 mer copy of the Hepatitis B virus (HBV) subtype AYW genome (PubMed=26438841).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10905; SLC10A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9B9 ! HepG2-NTCP1
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HepG2-NTCP1 HBV Cas9
AC   CVCL_C9BB
SY   Cas9 HepG2-HBV
DR   BioGRID_ORCS_Cell_line; 1173
DR   Wikidata; Q123031640
RX   PubMed=31801065;
CC   Population: Caucasian.
CC   Virology: Contains a stably integrated 1.3 mer copy of the Hepatitis B virus (HBV) subtype AYW genome (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10905; SLC10A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9BA ! HepG2-NTCP1 HBV
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HepG2-R
AC   CVCL_A8FT
DR   cancercelllines; CVCL_A8FT
DR   TKG; TKG 0799
DR   Wikidata; Q107115339
RX   PubMed=21716292;
RX   PubMed=27681752;
CC   Population: Caucasian.
CC   Characteristics: Radioresistant. Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=21716292).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0799
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   HepG2-Red-FLuc
AC   CVCL_5I98
SY   Bioware Brite HepG2-Red-FLuc; IVISbrite HepG2 Red F-luc
DR   cancercelllines; CVCL_5I98
DR   Revvity/PerkinElmer; BW134280
DR   Wikidata; Q54882855
CC   Population: Caucasian.
CC   Doubling time: 30 hours (Revvity/PerkinElmer=BW134280).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   HepG2-RHBV
AC   CVCL_XB55
DR   cancercelllines; CVCL_XB55
DR   CCRID; 4201PAT-CCTCC00204
DR   Wikidata; Q94103497
RX   Patent=CN101016536A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200635.
CC   Population: Caucasian.
CC   Virology: Transfected with a wild-type hepatitis B virus (HBV) genome.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   HepG2-rNTCP-eGFP
AC   CVCL_JY38
SY   HepG2 FLAG-Ntcp-EGFP
DR   cancercelllines; CVCL_JY38
DR   Wikidata; Q54882856
RX   PubMed=20539008;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=RGD; 3681; Slc10a1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   HepG2-SM1
AC   CVCL_9873
DR   cancercelllines; CVCL_9873
DR   Wikidata; Q54882857
RX   PubMed=11083647;
CC   Population: Caucasian.
CC   Virology: Transfected with a hepatitis B virus (HBV) subtype adr genome with a DNA polymerase having a p.Leu526Met mutation (PubMed=11083647).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   HepG2-WT10
AC   CVCL_9872
DR   cancercelllines; CVCL_9872
DR   Wikidata; Q54882858
RX   PubMed=11083647;
CC   Population: Caucasian.
CC   Virology: Transfected with a hepatitis B virus (HBV) subtype adr genome (PubMed=11083647).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   HepG2/8F_HS
AC   CVCL_D3XF
DR   RCB; RCB5677
DR   Wikidata; Q127381753
RX   PubMed=35406758;
CC   Population: Caucasian.
CC   Characteristics: Could be useful as a new cell source for pharmacological studies and constructing bioartificial liver systems. When heat-stimulated it expresses 8 liver-specific transcription factor genes and thus many liver functions are induced upon heat treatment (PubMed=35406758).
CC   Characteristics: Transduced with a pQMSCV-pHSP70B-TRE-pCMVmin-EGFP-IRES-tTA construct. The heat-activated HSPA6/HSP70B' promoter drives bicistronic gene expression of EGFP and of the tetracycline-controlled transactivator (tTA), which is mediated by an internal ribosomal entry site (IRES). Then, the tTA protein binds to TRE and activates the cytomegalovirus minimum promoter (pCMVmin) upstream of EGFP, which in turn induces further expression of the EGFP and tTA genes, providing a transcriptional positive feedback loop (from parent cell line).
CC   Characteristics: The amplified tTA promotes the expression of 8 liver-enriched transcription factor (LETF) genes that were transduced using two constructs: PB513B-1/TRE-HNF1A-FOXA2/HNF3B-CEBPA-CEBPB-CEBPG-EF1a-PuroR and PB513B-1/TRE-HNF1B-HNF4A-ONECUT1-EF1a-Bla (PubMed=35406758).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1833; CEBPA.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1834; CEBPB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1837; CEBPG.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5022; FOXA2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11621; HNF1A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11630; HNF1B.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5024; HNF4A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8138; ONECUT1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3XE ! HepG2-HSP
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HepG2/Adm
AC   CVCL_M187
SY   HepG2/ADM; Hep-G2/ADM; Hep G2/ADM
DR   BTO; BTO_0006029
DR   cancercelllines; CVCL_M187
DR   ChEMBL-Cells; CHEMBL4482252
DR   PubChem_Cell_line; CVCL_M187
DR   Wikidata; Q54882859
RX   PubMed=14980111;
RX   PubMed=15087025;
RX   PubMed=17075973;
CC   Population: Caucasian.
CC   Doubling time: 30.1 hours (PubMed=15087025).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 20
//
ID   HepG2/C3A-2.5B1
AC   CVCL_1N69
SY   C3A clone 2.5B1; Clone 2.5 B1
DR   ATCC; CRL-3533
DR   cancercelllines; CVCL_1N69
DR   Wikidata; Q54808152
RX   Patent=US6653105;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12461.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1098 ! Hep-G2/C3A
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   HepG2/CD81++
AC   CVCL_C5RP
DR   Wikidata; Q116049313
RX   PubMed=16819966;
CC   Population: Caucasian.
CC   Characteristics: Expresses 4 times more CD81 than HepG2-CD81 (Cellosaurus=CVCL_C5RN) (PubMed=16819966).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1701; CD81.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 6
//
ID   HepG2/mdr1
AC   CVCL_M186
DR   cancercelllines; CVCL_M186
DR   Wikidata; Q54882860
RX   PubMed=17517188;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 19
//
ID   HepG2/STAT1
AC   CVCL_F1AH
RX   PubMed=37315652;
CC   Population: Caucasian.
CC   Characteristics: Used to monitor the activation of the STAT1 signaling pathway. Sensitive to interferon-alpha (PubMed=37315652).
CC   Characteristics: Transfected with the pGL4.45[luc2P/ISRE/Hygro] plasmid that contains a synthetic firefly luciferase (luc2P) gene under the control of five copies of an interferon-stimulated response element (ISRE) (PubMed=37315652).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression and a PEST sequence = Luc2P).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HepG2/STAT3
AC   CVCL_F1AI
RX   PubMed=37315652;
CC   Population: Caucasian.
CC   Characteristics: Used to monitor the activation of the STAT3 signaling pathway. Sensitive to interleukin-6 (IL6) (PubMed=37315652).
CC   Characteristics: Transfected with the pGL4.47[luc2P/SIE/Hygro] plasmid that contains a synthetic firefly luciferase (luc2P) gene under the control of five copies of the SIS-inducible element (SIE) (PubMed=37315652).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression and a PEST sequence = Luc2P).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HepG2/TC155
AC   CVCL_B0UI
DR   cancercelllines; CVCL_B0UI
DR   CCRID; 4201PAT-CCTCC00437
DR   Wikidata; Q108820460
RX   Patent=CN103667194B;
RX   PubMed=24373334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013191.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a hepatitis B virus capsid protein that contains a tetracysteine (TC) C-C-P-G-C-C insertion in position 115. The TC tag specifically reacts with a membrane-permeable biarsenical fluorescent dye (ReAsH) (PubMed=24373334).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03146; Hepatitis B virus genotype D subtype ayw capsid protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 9
//
ID   HepG2S1
AC   CVCL_4W42
DR   cancercelllines; CVCL_4W42
DR   Wikidata; Q54882861
RX   PubMed=23111106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   HepG2S2
AC   CVCL_4W43
DR   cancercelllines; CVCL_4W43
DR   Wikidata; Q54882862
RX   PubMed=23111106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   HepG2S3
AC   CVCL_4W44
DR   cancercelllines; CVCL_4W44
DR   Wikidata; Q54882863
RX   PubMed=23111106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   HepG2T14
AC   CVCL_HE77
SY   HepG2T-14
DR   cancercelllines; CVCL_HE77
DR   Wikidata; Q54882864
RX   PubMed=3019565;
RX   PubMed=9755253;
CC   Population: Caucasian.
CC   Virology: Transfected with a circular hepatitis B virus (HBV).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   HepG2T14.1
AC   CVCL_HE78
DR   cancercelllines; CVCL_HE78
DR   Wikidata; Q54882865
RX   PubMed=9247614;
CC   Population: Caucasian.
CC   Virology: Transfected with a circular hepatitis B virus (HBV).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HE77 ! HepG2T14
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   HepG3
AC   CVCL_Y479
DR   EFO; EFO_0005382
DR   cancercelllines; CVCL_Y479
DR   Wikidata; Q54882867
RX   PubMed=22912842;
WW   Info; Protocol Online; -; https://web.archive.org/web/20220814100156/http://www.protocol-online.org/forums/topic/27211-hepg3-cell-line-origin/
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Miscellaneous: It is not clear if there is a single HepG3 cell line or many differents ones. The one described in PubMed=22912842 is is said to be a Hep-G2 'derived stable cell line containing an integrated wild-type DHBV head-to-tail unit-length genomic DNA dimer', but there seem to be old papers (like PubMed 1828229) using this cell line as if it was obtained from ATCC.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 18
//
ID   HepHA-HBe4
AC   CVCL_DF33
DR   cancercelllines; CVCL_DF33
DR   Wikidata; Q54882868
RX   PubMed=27185623;
CC   Population: Caucasian.
CC   Virology: Transfected with the HA-tagged HBeAg expression vector. This cell line can be used as a counter-screen to cell line HepBHAe82 (Cellosaurus=CVCL_DF32) (PubMed=27185623).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 16
//
ID   HepJ5
AC   CVCL_RW48
SY   Hep-J5; Hep J5
DR   cancercelllines; CVCL_RW48
DR   Wikidata; Q54882869
RX   PubMed=19830497;
RX   PubMed=20087778;
CC   Population: Caucasian.
CC   Characteristics: GRP78-overexpressing.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   HepLi2
AC   CVCL_D532
SY   HepLi-2
DR   Wikidata; Q54882870
RX   DOI=10.3760/cma.j.issn.1000-6680.2009.07.003;
RX   PubMed=21134830;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   HepLi3
AC   CVCL_D533
DR   Wikidata; Q54882871
RX   DOI=10.3760/cma.j.issn.1000-6680.2009.07.003;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   HepLi4
AC   CVCL_D531
SY   HepLi-4
DR   Wikidata; Q54882872
RX   DOI=10.5897/AJB11.3411;
CC   Population: Chinese.
CC   Characteristics: Reversible immortalized. The cell line was obtained by transduction of a retrovirus containing SV40 LT flanked by a pair of LoxP recombination targets. The SV40 LT gene can be excised by Cre/Lox site-specific recombination.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   HepLi5
AC   CVCL_D530
DR   Wikidata; Q54882873
RX   PubMed=22930002;
CC   Population: Chinese.
CC   Doubling time: 8 hours (PubMed=22930002).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   HepLL
AC   CVCL_B6EJ
DR   Wikidata; Q111733392
RX   PubMed=15968957;
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HEPM
AC   CVCL_2486
SY   Human Embryonic Palatal Mesenchyme
DR   CLO; CLO_0003714
DR   CLDB; cl1662
DR   ATCC; CRL-1486
DR   BCRC; 60277
DR   BioSample; SAMN03471366
DR   ECACC; 90120505
DR   FANTOM5_SSTAR; 10813-111B3
DR   IZSLER; BS CL 163
DR   JCRB; JCRB9095
DR   Wikidata; Q54882874
RX   PubMed=1282915;
RX   PubMed=7017936;
RX   PubMed=7119095;
CC   Doubling time: 25-30 hours (PubMed=1282915).
CC   Derived from site: In situ; Fetal oral cavity, palate; UBERON=UBERON_0001716.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
ST   Source(s): ATCC=CRL-1486; IZSLER=BS CL 163; JCRB=JCRB9095
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   Penta D: 14
ST   Penta E: 13,19
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Hept-2
AC   CVCL_VH14
SY   LLNL-Hept2
DR   ATCC; HB-10623
DR   Wikidata; Q54882875
RX   Patent=US5334528;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10623.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_34785; Heptachlor.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 5
//
ID   HepT1
AC   CVCL_G003
DR   Cosmic; 869287
DR   Cosmic; 1237545
DR   Wikidata; Q54882877
RX   PubMed=8606490;
RX   PubMed=10934159;
RX   PubMed=12704668;
CC   Characteristics: Tumorigenic. Injection into nude mice gives rise to subcutaneous tumors (PubMed=8606490).
CC   Doubling time: 1-2 days (PubMed=8606490).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=8606490).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y10M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   HepT3
AC   CVCL_G004
DR   Cosmic; 869280
DR   Wikidata; Q54882878
RX   PubMed=10934159;
RX   PubMed=12704668;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   HepU1
AC   CVCL_M170
DR   Wikidata; Q54882879
RX   PubMed=12704668;
CC   Doubling time: ~10 days (PubMed=12704668).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M171 ! HepU2
SX   Male
AG   4Y5M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   HepU2
AC   CVCL_M171
DR   Wikidata; Q54882881
RX   PubMed=12704668;
CC   Doubling time: ~10 days (PubMed=12704668).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M170 ! HepU1
SX   Male
AG   4Y10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   HepZ
AC   CVCL_B6FC
DR   Wikidata; Q111733393
RX   Patent=US6046050;
RX   PubMed=10415582;
RX   PubMed=10699872;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2302.
CC   Characteristics: Transfected with albumin-promoter regulated antisense constructs against RB1 and TP53.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3113; E2F1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HER-Xho1-CC2
AC   CVCL_S623
DR   Wikidata; Q54882882
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=3011403;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   HER1-hiPSC1
AC   CVCL_C424
SY   HER.1.H.iPSC.1; RIi006-A
DR   hPSCreg; RIi006-A
DR   RSCB; RSCB0074
DR   SKIP; SKIP002401
DR   SKIP; SKIP005835
DR   Wikidata; Q54882883
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C425 ! HER1-hiPSC2
OI   CVCL_C426 ! HER1-hiPSC3
OI   CVCL_C427 ! HER1-hiPSC4
OI   CVCL_C428 ! HER1-hiPSC5
OI   CVCL_C429 ! HER1-hiPSC6
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   HER1-hiPSC2
AC   CVCL_C425
SY   HER.1.H.iPSC.2
DR   RSCB; RSCB0075
DR   Wikidata; Q54882884
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C424 ! HER1-hiPSC1
OI   CVCL_C426 ! HER1-hiPSC3
OI   CVCL_C427 ! HER1-hiPSC4
OI   CVCL_C428 ! HER1-hiPSC5
OI   CVCL_C429 ! HER1-hiPSC6
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HER1-hiPSC3
AC   CVCL_C426
SY   HER.1.H.iPSC.3
DR   RSCB; RSCB0076
DR   Wikidata; Q54882885
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C424 ! HER1-hiPSC1
OI   CVCL_C425 ! HER1-hiPSC2
OI   CVCL_C427 ! HER1-hiPSC4
OI   CVCL_C428 ! HER1-hiPSC5
OI   CVCL_C429 ! HER1-hiPSC6
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HER1-hiPSC4
AC   CVCL_C427
SY   HER.1.H.iPSC.4
DR   RSCB; RSCB0077
DR   Wikidata; Q54882886
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C424 ! HER1-hiPSC1
OI   CVCL_C425 ! HER1-hiPSC2
OI   CVCL_C426 ! HER1-hiPSC3
OI   CVCL_C428 ! HER1-hiPSC5
OI   CVCL_C429 ! HER1-hiPSC6
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HER1-hiPSC5
AC   CVCL_C428
SY   HER.1.H.iPSC.5
DR   RSCB; RSCB0078
DR   Wikidata; Q54882888
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C424 ! HER1-hiPSC1
OI   CVCL_C425 ! HER1-hiPSC2
OI   CVCL_C426 ! HER1-hiPSC3
OI   CVCL_C427 ! HER1-hiPSC4
OI   CVCL_C429 ! HER1-hiPSC6
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HER1-hiPSC6
AC   CVCL_C429
SY   HER.1.H.iPSC.6
DR   RSCB; RSCB0079
DR   Wikidata; Q54882889
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84453; Progressive familial intrahepatic cholestasis
DI   ORDO; Orphanet_172; Progressive familial intrahepatic cholestasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C424 ! HER1-hiPSC1
OI   CVCL_C425 ! HER1-hiPSC2
OI   CVCL_C426 ! HER1-hiPSC3
OI   CVCL_C427 ! HER1-hiPSC4
OI   CVCL_C428 ! HER1-hiPSC5
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HER14
AC   CVCL_D576
SY   NIH3T3-Her14; DHER14; HER 14
DR   BTO; BTO_0005263
DR   EFO; EFO_0022731
DR   Wikidata; Q54882890
RX   PubMed=1417788;
RX   PubMed=3501826;
CC   Characteristics: Expresses ~200000 EGFR (PubMed=1417788).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   HER4.10H1.1A1
AC   CVCL_A2JF
SY   4-1464
DR   Wikidata; Q105507645
RX   Patent=US7704498;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2828.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15303; Human ERBB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   HER4.1A6.5B3
AC   CVCL_A2JG
SY   4-1492
DR   Wikidata; Q105507648
RX   Patent=US7704498;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2827.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15303; Human ERBB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   HER4.1C6.A11
AC   CVCL_A2JH
SY   4-1440
DR   Wikidata; Q105507649
RX   Patent=US7704498;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2829.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15303; Human ERBB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   HER4.3B9.2C9
AC   CVCL_A2JI
SY   4-1460
DR   Wikidata; Q105507652
RX   Patent=US7704498;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2826.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15303; Human ERBB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   HER4.8B1.2H2
AC   CVCL_A2JJ
SY   4-1473
DR   Wikidata; Q105507655
RX   Patent=US7704498;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2825.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15303; Human ERBB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   HERLUF
AC   CVCL_E693
SY   HERLUF2; HERLUFF; Herluff; GM03160; GM3160
DR   CLO; CLO_0013515
DR   Coriell; GM03160
DR   dbMHC; 48889
DR   ECACC; 87031104
DR   IHW; IHW09299
DR   IPD-IMGT/HLA; 10728
DR   Wikidata; Q54882891
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Danish.
CC   HLA typing: A*02:01:01:01; B*44:02:01:01,35:03:01:01; C*05:01:01:02,04:01:01:01; DPA1*01,02; DPB1*04:01:01; DQA1*05:01; DQB1*03:01:01; DRB1*12:01:01/12:10; DRB3*02:02 (IPD-IMGT/HLA=10728).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   Hermes 1
AC   CVCL_VS06
SY   Hermes1; Human extended-replication melanocytes-1
DR   GEO; GSM555117
DR   GEO; GSM555169
DR   Wikidata; Q94104090
RX   PubMed=12759390;
RX   PubMed=21343389;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala76Cysfs*64 (c.225_243del19) (p.Arg90Valfs*76, c.268_286del19) (p16-Leiden); ClinVar=VCV000182411; Zygosity=Homozygous (PubMed=12759390).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS14 ! Hmel-p16-1
SX   Male
AG   24Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   Hermes 2A
AC   CVCL_VS07
SY   Hermes 2a; Hermes2A; Human extended-replication melanocytes-2A
DR   Wikidata; Q94104098
RX   PubMed=12759390;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met53Thr (c.158T>C); ClinVar=VCV001480737; Zygosity=Heterozygous (PubMed=12759390).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp108Asn (c.322G>A) (p.Arg122Gln, c.365G>A); ClinVar=VCV000216275; Zygosity=Heterozygous (PubMed=12759390).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS15 ! Hmel-p16-2
SX   Female
AG   28Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   Hermes 2B
AC   CVCL_VS08
SY   Hermes 2b; Hermes2B; Human extended-replication melanocytes-2B
DR   GEO; GSM555118
DR   GEO; GSM555170
DR   Wikidata; Q94104106
RX   PubMed=12759390;
RX   PubMed=21343389;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met53Thr (c.158T>C); ClinVar=VCV001480737; Zygosity=Heterozygous (PubMed=12759390).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp108Asn (c.322G>A) (p.Arg122Gln, c.365G>A); ClinVar=VCV000216275; Zygosity=Heterozygous (PubMed=12759390).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS15 ! Hmel-p16-2
SX   Female
AG   28Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   Hermes 2C
AC   CVCL_VS09
SY   Hermes 2c; Hermes2C; Human extended-replication melanocytes-2C
DR   Wikidata; Q94104113
RX   PubMed=12759390;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met53Thr (c.158T>C); ClinVar=VCV001480737; Zygosity=Heterozygous (PubMed=12759390).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp108Asn (c.322G>A) (p.Arg122Gln, c.365G>A); ClinVar=VCV000216275; Zygosity=Heterozygous (PubMed=12759390).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS15 ! Hmel-p16-2
SX   Female
AG   28Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   Hermes 3A
AC   CVCL_VS10
SY   Hermes3A; H3A; Human extended-replication melanocytes-3A
DR   Wikidata; Q94104119
RX   PubMed=16880792;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS17 ! Nohm-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   Hermes 3B
AC   CVCL_VS11
SY   Hermes3B; Human extended-replication melanocytes-3B
DR   Wikidata; Q94104125
RX   PubMed=16880792;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS17 ! Nohm-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   Hermes 3C
AC   CVCL_VS12
SY   Hermes3C; Human extended-replication melanocytes-3C
DR   Wikidata; Q94104133
RX   PubMed=16880792;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS17 ! Nohm-1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   Hermes 4A
AC   CVCL_VS19
SY   Hermes4A; Human extended-replication melanocytes-4A
DR   Wikidata; Q94104138
RX   PubMed=16880792;
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Arg160Trp (c.478C>T); ClinVar=VCV000014310; Zygosity=Heterozygous (PubMed=16880792).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Asp294His (c.880G>C); ClinVar=VCV000014307; Zygosity=Heterozygous (PubMed=16880792).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS18 ! 830-c
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   Hermes 4B
AC   CVCL_VS20
SY   Hermes4B; Human extended-replication melanocytes-4B
DR   Wikidata; Q94104147
RX   PubMed=16880792;
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Arg160Trp (c.478C>T); ClinVar=VCV000014310; Zygosity=Heterozygous (PubMed=16880792).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Asp294His (c.880G>C); ClinVar=VCV000014307; Zygosity=Heterozygous (PubMed=16880792).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS18 ! 830-c
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   Hermes 4C
AC   CVCL_VS21
SY   Hermes4C; Human extended-replication melanocytes-4C
DR   Wikidata; Q94104151
RX   PubMed=16880792;
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Arg160Trp (c.478C>T); ClinVar=VCV000014310; Zygosity=Heterozygous (PubMed=16880792).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Asp294His (c.880G>C); ClinVar=VCV000014307; Zygosity=Heterozygous (PubMed=16880792).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS18 ! 830-c
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   Hermes-1
AC   CVCL_KB74
DR   DSHB; Hermes-1
DR   Wikidata; Q54882892
RX   PubMed=2429846;
RX   PubMed=2646376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   Hermes-2
AC   CVCL_A7QL
DR   Wikidata; Q107115340
RX   PubMed=2646376;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Hermes-3
AC   CVCL_4525
SY   HERMES 3
DR   CLO; CLO_0003715
DR   Wikidata; Q54882893
RX   Patent=US5403919;
RX   PubMed=2442176;
RX   PubMed=2646376;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9480.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 8
//
ID   HeRo [Human glioblastoma]
AC   CVCL_W138
DR   Wikidata; Q54882894
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2988753;
RX   PubMed=3759084;
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   HeRo [Human Merkel cell carcinoma]
AC   CVCL_F000
DR   Cosmic; 1699820
DR   Wikidata; Q54882896
RX   PubMed=22363598;
RX   PubMed=23563200;
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   HeRo-SV
AC   CVCL_W139
SY   HeRo-SV1
DR   Wikidata; Q54882897
RX   PubMed=2988753;
RX   PubMed=3759084;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W138 ! HeRo [Human glioblastoma]
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   HES [Human contaminated endometrial epithelial]
AC   CVCL_W635
DR   BioSample; SAMN03151708
DR   Wikidata; Q54882899
RX   PubMed=7512055;
RX   PubMed=24520087;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a WISH derivative (PubMed=24520087). Originally thought to originate from an endometrium.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00461.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1909 ! WISH
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   HES [Human embryonic skin fibroblast]
AC   CVCL_XB12
SY   HSAS3; Human Embryonic Skin
DR   CCRID; 5301HUM-KCB0505SZJ
DR   KCB; KCB 200505SZJ
DR   Wikidata; Q94104278
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   HES [Human endometrial carcinoma]
AC   CVCL_W380
DR   Wikidata; Q54882900
RX   PubMed=18667022;
CC   Population: Japanese.
CC   Doubling time: ~16 hours (Note=At 113th passage) (PubMed=18667022).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18667022).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   hES 3.1
AC   CVCL_7159
SY   hES3.1; HES 3.1; ESIBIOe003-A-1; ESIBIe003-A-1
DR   CCRID; 4201PAT-CCTCC00176
DR   hPSCreg; ESIBIe003-A-1
DR   SKIP; SKIP002043
DR   Wikidata; Q54882901
RX   Patent=US20070160974;
RX   PubMed=16522163;
CC   Group: Patented cell line.
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200601.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   hES 3.2
AC   CVCL_7160
SY   hES3.2; HES 3.2; ESIBIOe003-A-2; ESIBIe003-A-2
DR   CCRID; 4201PAT-CCTCC00195
DR   hPSCreg; ESIBIe003-A-2
DR   SKIP; SKIP002044
DR   Wikidata; Q54882902
RX   Patent=US20070160974;
RX   PubMed=16522163;
CC   Group: Patented cell line.
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200624.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   hES 3.3
AC   CVCL_7161
SY   hES3.3; HES 3.3; ESIBIOe003-A-3; ESIBIe003-A-3
DR   CCRID; 4201PAT-CCTCC00196
DR   hPSCreg; ESIBIe003-A-3
DR   SKIP; SKIP002045
DR   Wikidata; Q54882903
RX   Patent=US20070160974;
RX   PubMed=16522163;
CC   Group: Patented cell line.
CC   From: Prince of Wales Hospital; Sidney; Australia.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200625.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   HES-1
AC   CVCL_D092
SY   HES 1; ES01; hES1; ESIBIOe001-A; ESIBIe001-A
DR   BioSample; SAMN03471888
DR   GEO; GSM856722
DR   GEO; GSM862725
DR   hPSCreg; ESIBIe001-A
DR   SKIP; SKIP001018
DR   SKIP; SKIP001941
DR   WiCell; es01
DR   Wikidata; Q54882904
RX   PubMed=10748519;
RX   PubMed=17572666;
RX   PubMed=23117585;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/28
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   From: Monash University; Melbourne; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-02.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=es01
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   HES-2
AC   CVCL_D093
SY   hES-2; HES 2; HES2; hES2; ES02; ESIBIOe002-A; ESIBIe002-A
DR   EFO; EFO_0003048
DR   BioSample; SAMN03471889
DR   GEO; GSM856723
DR   GEO; GSM862740
DR   hPSCreg; ESIBIe002-A
DR   SKIP; SKIP001942
DR   WiCell; es02
DR   Wikidata; Q54882906
RX   PubMed=10748519;
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=18772870;
RX   PubMed=23117585;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/affy/30
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/30
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   From: Monash University; Melbourne; Australia.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-02.
CC   HLA typing: A*02:03,02; B*46,48; C*01,08; DQB1*04,06; DRB1*04,15; DRB5*01 (PubMed=16919167).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=es02
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   HES-3
AC   CVCL_7158
SY   hES-3; HES 3; HES3; hES3; ESI-hES3; hES 3; ES03; ESIBIOe003-A; ESIBIe003-A
DR   BioSample; SAMN03471890
DR   GEO; GSM239976
DR   GEO; GSM288328
DR   GEO; GSM288330
DR   GEO; GSM288395
DR   GEO; GSM383880
DR   GEO; GSM384101
DR   GEO; GSM856724
DR   GEO; GSM862741
DR   GEO; GSM1040244
DR   GEO; GSM1040314
DR   GEO; GSM1084820
DR   GEO; GSM1084834
DR   GEO; GSM1084938
DR   GEO; GSM1084939
DR   GEO; GSM1084940
DR   GEO; GSM1084993
DR   GEO; GSM1085016
DR   GEO; GSM1589802
DR   GEO; GSM1589814
DR   GEO; GSM1589934
DR   GEO; GSM1589946
DR   hPSCreg; ESIBIe003-A
DR   PRIDE; PXD000134
DR   SKIP; SKIP001476
DR   SKIP; SKIP001943
DR   WiCell; es03
DR   Wikidata; Q54882907
RX   PubMed=16919167;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=22108792;
RX   PubMed=22802639;
RX   PubMed=23117585;
RX   PubMed=24259714;
RX   PubMed=27688775;
RX   PubMed=28090699;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/5
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0055.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-02.
CC   HLA typing: A*11:33; B*40,55; C*01,07; DQB1*06; DRB1*12,12; DRB3*01 (PubMed=16919167).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Misspelling: ESO3; PubMed=27688775.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=es03
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HES-3 INSGFP/w
AC   CVCL_XA15
SY   HES3 INS(GFP/w); HES3 INSGFP/w; INSULIN(GFP/w) HES3
DR   Wikidata; Q94104651
RX   PubMed=22120512;
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the INS locus (PubMed=22120512).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 7
//
ID   HES-3 MESP1mCherry/w NKX2-5eGFP/w
AC   CVCL_A8JT
DR   Wikidata; Q108820461
RX   PubMed=25187301;
CC   Registration: Swiss research registry; BAG-hES-IMP-0075.
CC   Characteristics: Useful for dissecting the molecular and cellular mechanisms related to the earliest steps in cardiac development in live cells (PubMed=25187301).
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced at the first exon of one allele of the NKX2.5 locus.
CC   Characteristics: Using homologous recombination a mCherry reporter gene was introduced at the first exon of one allele of the MESP1 locus.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8JS ! HES-3 NKX2.5eGFP/w
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HES-3 MIXL1GFP/w
AC   CVCL_E9D2
SY   HES3 MIXL1GFP/+; HES3(MIXL1GFP/w); HES3/MIXL1 GFP; HES3 MIXL1-GFP; MIXL1-GFP HES3
RX   PubMed=18032708;
CC   Registration: Swiss research registry; BAG-hES-IMP-0076.
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the MIXL1 locus (PubMed=18032708).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HES-3 NKX2.1GFP/w
AC   CVCL_A5HB
SY   NKX2.1GFP/w HES3; NKX2.1(GFP/w) HES3; HES3-NKX2.1-GFP
DR   Wikidata; Q107115341
RX   PubMed=21425409;
CC   Registration: Swiss research registry; BAG-hES-IMP-0067.
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the NKX2.1 locus.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   HES-3 NKX2.5eGFP/w
AC   CVCL_A8JS
SY   HES-3 NKX2.5(eGFP/w); H3 NKX2-5GFP
DR   Wikidata; Q108820462
RX   PubMed=22020065;
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced at the first exon of one allele of the NKX2.5 locus (PubMed=22020065).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7158 ! HES-3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   HES-4
AC   CVCL_D094
SY   HES 4; HES4; ES04; ESIBIOe004-A; ESIBIe004-A
DR   BioSample; SAMN03471891
DR   GEO; GSM288338
DR   GEO; GSM383881
DR   GEO; GSM384102
DR   GEO; GSM1040245
DR   GEO; GSM1040315
DR   hPSCreg; ESIBIe004-A
DR   SKIP; SKIP001477
DR   SKIP; SKIP001944
DR   WiCell; es04
DR   Wikidata; Q54882908
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=22802639;
RX   PubMed=23117585;
RX   PubMed=24259714;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/10
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0006.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-02.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=es04
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 9,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   HES-5
AC   CVCL_D095
SY   HES 5; ES05; hES5; ESIBIOe005-A; ESIBIe005-A
DR   GEO; GSM856725
DR   GEO; GSM862734
DR   hPSCreg; ESIBIe005-A
DR   SKIP; SKIP001478
DR   SKIP; SKIP001945
DR   WiCell; es05
DR   Wikidata; Q54882909
RX   PubMed=17572666;
RX   PubMed=23117585;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/31
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-02.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=es05
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 10,12
ST   D7S820: 9,13
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   HES-6
AC   CVCL_D096
SY   HES 6; ES06; hES6; ESIBIOe006-A; ESIBIe006-A
DR   BioSample; SAMN03471892
DR   GEO; GSM288342
DR   GEO; GSM856726
DR   GEO; GSM862735
DR   GEO; GSM1040246
DR   GEO; GSM1040316
DR   GEO; GSM1489294
DR   hPSCreg; ESIBIe006-A
DR   SKIP; SKIP001479
DR   SKIP; SKIP002000
DR   WiCell; es06
DR   Wikidata; Q54882910
RX   PubMed=22802639;
RX   PubMed=23117585;
RX   PubMed=24259714;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/33
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-02.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=es06
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   hES-NCL1 NANOG
AC   CVCL_F0SL
RX   PubMed=19139263;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20857; NANOG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A002 ! UNEWe001-A
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HESC-1
AC   CVCL_B0KR
SY   Human Endolymphatic Sac Cell line-1
DR   Wikidata; Q108820463
RX   Patent=US20120122716;
RX   PubMed=21901615;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ear, inner ear, endolymphatic sac; UBERON=UBERON_0002223.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   hESC-PRLY
AC   CVCL_XJ77
SY   hESC pPRL-YFP
DR   Wikidata; Q94105074
RX   PubMed=31501330;
CC   Characteristics: Allows a quantifiable visual readout of the decidualization response.
CC   Characteristics: YFP expression is under the control of a prolactin promoter (pPRL).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C464 ! T HESCs
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   hESderK/E6E7 clK
AC   CVCL_UZ63
SY   hESderK/E6E7 clone K
DR   Wikidata; Q94105080
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   hESM01
AC   CVCL_C643
SY   ESM01; RASe001-A
DR   hPSCreg; RASe001-A
DR   SKIP; SKIP001994
DR   Wikidata; Q54882911
RX   PubMed=20160486;
RX   PubMed=20178000;
RX   PubMed=29861859;
CC   From: Vavilov Institute of General Genetics; Moscow; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   hESM02
AC   CVCL_C644
SY   ESM02; RASe002-A
DR   hPSCreg; RASe002-A
DR   SKIP; SKIP001995
DR   Wikidata; Q54882912
RX   PubMed=20178000;
CC   From: Vavilov Institute of General Genetics; Moscow; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   hESM03
AC   CVCL_C645
SY   ESM03; RASe003-A
DR   hPSCreg; RASe003-A
DR   SKIP; SKIP001996
DR   Wikidata; Q54882913
RX   PubMed=20160486;
RX   PubMed=20178000;
RX   PubMed=29861859;
CC   From: Vavilov Institute of General Genetics; Moscow; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   hESM04
AC   CVCL_C646
DR   Wikidata; Q54882914
RX   PubMed=20160486;
RX   PubMed=20178000;
RX   PubMed=29861859;
CC   From: Vavilov Institute of General Genetics; Moscow; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   hESMK05
AC   CVCL_C647
DR   Wikidata; Q54882915
RX   PubMed=20160486;
RX   PubMed=20178000;
CC   From: Vavilov Institute of General Genetics; Moscow; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   hESO-ST2
AC   CVCL_H644
SY   HESO-ST2; HESO-ST-2
DR   Wikidata; Q54882916
RX   PubMed=23103867;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   hESO-ST3
AC   CVCL_H260
SY   HESO-ST3; HESO-ST-3
DR   Wikidata; Q54882917
RX   PubMed=23103867;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   hESO-ST4
AC   CVCL_H261
SY   HESO-ST4; HESO-ST-4
DR   Wikidata; Q54882918
RX   PubMed=23103867;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   hESO-ST5
AC   CVCL_H262
SY   HESO-ST5; HESO-ST-5
DR   Wikidata; Q54882919
RX   PubMed=23103867;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   hESO-ST6
AC   CVCL_H263
SY   HESO-ST6; HESO-ST-6
DR   Wikidata; Q54882920
RX   PubMed=23103867;
CC   Karyotypic information: Has a triploid karyotype.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   hESO-ST7
AC   CVCL_H264
SY   HESO-ST7; HESO-ST-7
DR   Wikidata; Q54882921
RX   PubMed=23103867;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   HESS-1 CL.3
AC   CVCL_6D83
DR   Wikidata; Q54882922
RX   PubMed=8656675;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C3H/HeN-Crj.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   HESS-5
AC   CVCL_5207
DR   Wikidata; Q54882923
RX   PubMed=8656675;
RX   PubMed=9454756;
RX   PubMed=10840071;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HESS-5
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C3H/HeN-Crj.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   HESS-M28
AC   CVCL_5208
DR   Wikidata; Q54882924
RX   PubMed=10680841;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   HEST
AC   CVCL_E6XE
RX   PubMed=12836015;
CC   From: Lindner, Matthias; University Hospital for Gynecology and Obstetrics; Heidelberg; Germany.
CC   HLA typing: A*02,02; B*27,27; DQB1*02,02; DRB1*07:01:01,07:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HET-1A
AC   CVCL_3702
SY   Het-1A; HET1A; Het1A
DR   BTO; BTO_0004433
DR   CLO; CLO_0003718
DR   EFO; EFO_0022693
DR   ATCC; CRL-2692
DR   BioSample; SAMN03471766
DR   ChEMBL-Cells; CHEMBL4295465
DR   ChEMBL-Targets; CHEMBL4296426
DR   CLS; 305270
DR   GEO; GSM1375723
DR   GEO; GSM1375724
DR   GEO; GSM1375725
DR   GEO; GSM1375726
DR   GEO; GSM1375735
DR   GEO; GSM1375736
DR   GEO; GSM1375737
DR   GEO; GSM1375738
DR   GEO; GSM1375747
DR   GEO; GSM1375748
DR   GEO; GSM1375749
DR   GEO; GSM1375750
DR   GEO; GSM1508954
DR   GEO; GSM1508958
DR   IARC_TP53; 21630
DR   IARC_TP53; 23555
DR   PubChem_Cell_line; CVCL_3702
DR   Wikidata; Q54882925
RX   CelloPub=CLPUB00265;
RX   DOI=10.1007/978-1-4612-0411-4_30;
RX   DOI=10.1155/2014/376541;
RX   Patent=WO1991005062A1;
RX   PubMed=1703038;
RX   PubMed=7972006;
RX   PubMed=8504475;
RX   PubMed=10078940;
RX   PubMed=20139130;
RX   PubMed=20843300;
RX   PubMed=21127259;
RX   PubMed=28224081;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10209.
CC   Population: African American.
CC   Doubling time: 27.4 +- 3.6 hours (PubMed=21127259).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Indicated as originating from a 25 year old male in ATCC, but said to be derived from autopsy specimen from a 74 year old male.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
ST   Source(s): ATCC=CRL-2692
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 28,31
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   HET-2A
AC   CVCL_4T83
DR   Wikidata; Q54882926
RX   CelloPub=CLPUB00265;
RX   Patent=WO1991005062A1;
RX   PubMed=1703038;
CC   Group: Patented cell line.
CC   Problematic cell line: Probably contaminated. Shown not to be originating from the normal human esophageal cell HE-451 as previously thought and to be of a female origin (PubMed=1703038).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10210.
CC   Karyotypic information: Hypotriploid karyotype (PubMed=1703038).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HET-37
AC   CVCL_A5YP
DR   Wikidata; Q107115342
RX   CelloPub=CLPUB00607;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A5YN ! C23/11
HI   CVCL_3940 ! NS0
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HET15
AC   CVCL_T953
DR   Wikidata; Q54882927
RX   PubMed=8494788;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T955 ! TGR-1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   HET16
AC   CVCL_T954
DR   Wikidata; Q54882928
RX   PubMed=8494788;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T955 ! TGR-1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   HET1AR
AC   CVCL_4T84
DR   Wikidata; Q54882929
RX   PubMed=21127259;
CC   Population: African American.
CC   Doubling time: 27.6 +- 4.6 hours (PubMed=21127259).
CC   Selected for resistance to: ChEBI; CHEBI_3098; Bile acids.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3702 ! HET-1A
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   HetA
AC   CVCL_5F69
DR   Wikidata; Q54882930
RX   CelloPub=CLPUB00276;
CC   Group: Fish cell line.
CC   Doubling time: ~28 hours (Note=At 32 Celsius) (CelloPub=CLPUB00276).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   HEV-NICPBP04
AC   CVCL_XC26
DR   CCRID; 4201PAT-CCTCC00172
DR   Wikidata; Q94106224
RX   Patent=CN101034090B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200519.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q81871; Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) secreted protein ORF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   HEV-NICPBP07
AC   CVCL_XC27
DR   CCRID; 4201PAT-CCTCC00173
DR   Wikidata; Q94106229
RX   Patent=CN101034090B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200520.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q81871; Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) secreted protein ORF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   HEV-NICPBP58
AC   CVCL_XC28
DR   CCRID; 4201PAT-CCTCC00174
DR   Wikidata; Q94106232
RX   Patent=CN101034090B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200521.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q81871; Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) secreted protein ORF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   HEV0011
AC   CVCL_T068
DR   CLO; CLO_0051212
DR   RCB; HEV0011
DR   Wikidata; Q54882932
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:06; B*39:01,40:02; C*03:04,07:02; DPB1*02:01,05:01; DQB1*03:01,03:02; DRB1*08:02,14:06 (RCB=HEV0011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0012
AC   CVCL_T069
DR   CLO; CLO_0051213
DR   RCB; HEV0012
DR   Wikidata; Q54882933
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*31:01,33:03; B*40:03,44:03; C*03:04,14:03; DPB1*05:01; DQB1*04:01,06:01; DRB1*04:05,08:03 (RCB=HEV0012).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0013
AC   CVCL_T070
DR   CLO; CLO_0051214
DR   RCB; HEV0013
DR   Wikidata; Q54882934
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,26:03; B*40:01,55:02; C*01:02,03:03; DPB1*02:01,05:01; DQB1*03:01,04:01; DRB1*04:05,11:01 (RCB=HEV0013).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0019
AC   CVCL_T071
DR   CLO; CLO_0051215
DR   RCB; HEV0019
DR   Wikidata; Q54882935
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:02; B*07:02,13:01; C*03:04,07:02; DPB1*02:02,04:02; DQB1*03:01,05:01; DRB1*01:01,12:02 (RCB=HEV0019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0022
AC   CVCL_T072
DR   CLO; CLO_0051216
DR   RCB; HEV0022
DR   Wikidata; Q54882936
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*48:01,52:01; C*08:03,12:02; DPB1*09:01,14:01; DQB1*05:02,06:01; DRB1*14:07,15:02 (RCB=HEV0022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0023
AC   CVCL_T073
DR   CLO; CLO_0051217
DR   RCB; HEV0023
DR   Wikidata; Q54882937
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:03; B*15:01,59:01; C*01:02,03:03; DPB1*02:01,04:02; DQB1*04:01,06:02; DRB1*04:05,15:01 (RCB=HEV0023).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0024
AC   CVCL_T074
DR   CLO; CLO_0051218
DR   RCB; HEV0024
DR   Wikidata; Q54882938
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*13:01,40:02; C*03:04; DPB1*05:01,13:01; DQB1*03:01,04:02; DRB1*04:10,12:02 (RCB=HEV0024).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0031
AC   CVCL_T075
DR   CLO; CLO_0051219
DR   RCB; HEV0031
DR   Wikidata; Q54882939
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:06,02:10; B*39:01,40:06; C*07:02,08:01; DPB1*02:01,05:01; DQB1*03:01,06:02; DRB1*14:03,15:01 (RCB=HEV0031).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0032
AC   CVCL_T076
DR   CLO; CLO_0051220
DR   RCB; HEV0032
DR   Wikidata; Q54882940
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; C*12:02; DPB1*02:01,14:01; DQB1*06:01,06:02; DRB1*15:01,15:02 (RCB=HEV0032).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0034
AC   CVCL_T077
DR   CLO; CLO_0051221
DR   RCB; HEV0034
DR   Wikidata; Q54882941
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka and Japanese.
CC   HLA typing: A*02:01,26:01; B*07:02,15:01; C*03:04,07:02; DPB1*05:01; DQB1*04:01,05:02; DRB1*04:05,14:01 (RCB=HEV0034).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0035
AC   CVCL_T078
DR   CLO; CLO_0051222
DR   RCB; HEV0035
DR   Wikidata; Q54882942
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*54:01,67:01; C*01:02,07:02; DPB1*05:01,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0035).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0036
AC   CVCL_T079
DR   CLO; CLO_0051223
DR   RCB; HEV0036
DR   Wikidata; Q54882943
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:03; B*15:01,40:06; C*03:03,15:02; DPB1*02:01; DQB1*03:03,04:02; DRB1*08:02,09:01 (RCB=HEV0036).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0037
AC   CVCL_T080
DR   CLO; CLO_0051224
DR   RCB; HEV0037
DR   Wikidata; Q54882944
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*54:01; C*01:02; DPB1*05:01; DQB1*04:01; DRB1*04:05 (RCB=HEV0037).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0038
AC   CVCL_T081
DR   CLO; CLO_0051225
DR   RCB; HEV0038
DR   Wikidata; Q54882945
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*13:01,51:01; C*03:04,15:02; DPB1*04:01,05:01; DQB1*03:01; DRB1*04:01,12:02 (RCB=HEV0038).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0039
AC   CVCL_T082
DR   CLO; CLO_0051226
DR   RCB; HEV0039
DR   Wikidata; Q54882946
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:03; B*15:01,51:01; C*03:03,14:02; DPB1*09:01,13:01; DQB1*03:01,06:01; DRB1*11:01,15:02 (RCB=HEV0039).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0040
AC   CVCL_T083
DR   CLO; CLO_0051227
DR   RCB; HEV0040
DR   Wikidata; Q54882947
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*35:01,51:01; C*04:01,14:02; DPB1*02:01,04:02; DQB1*03:03,04:01; DRB1*04:05,09:01 (RCB=HEV0040).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0041
AC   CVCL_T084
DR   CLO; CLO_0051228
DR   RCB; HEV0041
DR   Wikidata; Q54882948
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*07:02,35:01; C*03:03,07:02; DPB1*02:01,04:02; DQB1*04:02,05:01; DRB1*01:01,08:02 (RCB=HEV0041).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0042
AC   CVCL_T085
DR   CLO; CLO_0051229
DR   RCB; HEV0042
DR   Wikidata; Q54882949
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*40:01,40:03; C*03:04; DPB1*05:01; DQB1*04:01,06:03; DRB1*04:05,13:01 (RCB=HEV0042).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0043
AC   CVCL_T086
DR   CLO; CLO_0051230
DR   RCB; HEV0043
DR   Wikidata; Q54882950
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,02:07; B*07:02,46:01; C*01:02,07:02; DPB1*03:01,05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0045
AC   CVCL_T087
DR   CLO; CLO_0051231
DR   RCB; HEV0045
DR   Wikidata; Q54882951
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:07; B*40:01,46:01; C*01:02,03:04; DPB1*02:02,05:01; DQB1*06:01,06:02; DRB1*08:03,15:01 (RCB=HEV0045).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0046
AC   CVCL_T088
DR   CLO; CLO_0051232
DR   RCB; HEV0046
DR   Wikidata; Q54882953
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*40:02,59:01; C*01:02,03:03; DPB1*04:01,05:01; DQB1*03:01,06:04; DRB1*04:01,13:02 (RCB=HEV0046).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0047
AC   CVCL_T089
DR   CLO; CLO_0051233
DR   RCB; HEV0047
DR   Wikidata; Q54882954
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*46:01,55:02; C*01:02; DPB1*02:01,02:02; DQB1*06:01,06:02; DRB1*08:03,15:01 (RCB=HEV0047).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0048
AC   CVCL_T090
DR   CLO; CLO_0051234
DR   RCB; HEV0048
DR   Wikidata; Q54882955
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,33:03; B*44:03,59:01; C*01:02,14:03; DPB1*04:01,05:01; DQB1*04:01,06:04; DRB1*04:05,13:02 (RCB=HEV0048).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0049
AC   CVCL_T091
DR   CLO; CLO_0051235
DR   RCB; HEV0049
DR   Wikidata; Q54882956
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*51:01,52:01; C*12:02,14:02; DPB1*05:01,09:01; DQB1*03:01,06:01; DRB1*14:03,15:02 (RCB=HEV0049).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0050
AC   CVCL_T092
DR   CLO; CLO_0051236
DR   RCB; HEV0050
DR   Wikidata; Q54882957
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*35:01,54:01; C*01:02,08:01; DPB1*03:01,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0050).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0051
AC   CVCL_T093
DR   CLO; CLO_0051237
DR   RCB; HEV0051
DR   Wikidata; Q54882958
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:02,33:03; B*40:06,44:03; C*08:01,14:03; DPB1*03:01,05:01; DQB1*03:02,03:03; DRB1*08:02,09:01 (RCB=HEV0051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0052
AC   CVCL_T094
DR   CLO; CLO_0051238
DR   RCB; HEV0052
DR   Wikidata; Q54882959
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*40:02,51:01; C*03:04,14:02; DPB1*05:01; DQB1*03:01,03:02; DRB1*08:02,14:03 (RCB=HEV0052).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0053
AC   CVCL_T095
DR   CLO; CLO_0051343
DR   RCB; HEV0053
DR   Wikidata; Q54882960
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,33:03; B*35:01,44:03; C*03:03,14:03; DPB1*02:01,04:01; DQB1*04:01,06:04; DRB1*04:05,13:02 (RCB=HEV0053).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0054
AC   CVCL_T096
DR   CLO; CLO_0051342
DR   RCB; HEV0054
DR   Wikidata; Q54882961
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*11:01,33:03; B*35:01,44:03; C*03:03,14:03; DPB1*02:01,05:01; DQB1*03:02,06:04; DRB1*04:05,13:02 (RCB=HEV0054).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0055
AC   CVCL_T097
DR   CLO; CLO_0051239
DR   RCB; HEV0055
DR   Wikidata; Q54882962
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*39:01,48:01; C*03:03,07:02; DPB1*04:02,05:01; DQB1*05:03,06:01; DRB1*08:03,14:01 (RCB=HEV0055).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0056
AC   CVCL_DE58
DR   RCB; HEV0056
DR   Wikidata; Q54882963
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0057
AC   CVCL_T098
DR   CLO; CLO_0051240
DR   RCB; HEV0057
DR   Wikidata; Q54882964
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,31:01; B*15:11; C*03:03; DPB1*02:01,09:01; DQB1*03:03; DRB1*09:01 (RCB=HEV0057).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0058
AC   CVCL_T099
DR   CLO; CLO_0051241
DR   RCB; HEV0058
DR   Wikidata; Q54882965
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:03,33:03; B*15:01,44:03; C*03:03,14:03; DPB1*04:01,05:01; DQB1*03:01,06:04; DRB1*13:02,14:06 (RCB=HEV0058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0060
AC   CVCL_T100
DR   CLO; CLO_0051242
DR   RCB; HEV0060
DR   Wikidata; Q54882966
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*35:01,52:01; C*08:01,12:02; DPB1*04:02,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0060).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0063
AC   CVCL_T101
DR   CLO; CLO_0051243
DR   RCB; HEV0063
DR   Wikidata; Q54882967
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,33:03; B*39:01,44:03; C*07:02,14:03; DPB1*03:01,04:01; DQB1*04:01,06:04; DRB1*04:05,13:02 (RCB=HEV0063).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0064
AC   CVCL_T102
DR   CLO; CLO_0051190
DR   RCB; HEV0064
DR   Wikidata; Q54882968
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0065
AC   CVCL_T103
DR   RCB; HEV0065
DR   Wikidata; Q54882969
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0066
AC   CVCL_T104
DR   CLO; CLO_0051244
DR   RCB; HEV0066
DR   Wikidata; Q54882970
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*35:01,52:01; C*03:03,12:02; DPB1*05:01,06:01; DQB1*03:01,06:01; DRB1*12:01,15:02 (RCB=HEV0066).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0067
AC   CVCL_T105
DR   CLO; CLO_0051245
DR   RCB; HEV0067
DR   Wikidata; Q54882971
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,31:01; B*40:01,52:01; C*03:04,12:02; DPB1*05:01,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0067).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0068
AC   CVCL_T106
DR   CLO; CLO_0051246
DR   RCB; HEV0068
DR   Wikidata; Q54882972
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*07:02,56:01; C*04:01,07:02; DPB1*04:02,05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0068).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0069
AC   CVCL_DE59
DR   RCB; HEV0069
DR   Wikidata; Q54882979
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0070
AC   CVCL_T107
DR   CLO; CLO_0051247
DR   RCB; HEV0070
DR   Wikidata; Q54882980
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*39:04,54:01; C*01:02,07:02; DPB1*05:01; DQB1*03:02,04:01; DRB1*04:03,04:05 (RCB=HEV0070).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0071
AC   CVCL_T108
DR   CLO; CLO_0051248
DR   RCB; HEV0071
DR   Wikidata; Q54882981
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*39:01,52:01; C*07:02,12:02; DPB1*02:01,09:01; DQB1*04:02,06:01; DRB1*08:02,15:02 (RCB=HEV0071).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0073
AC   CVCL_T109
DR   CLO; CLO_0051249
DR   RCB; HEV0073
DR   Wikidata; Q54882983
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*07:02,51:01; C*07:02,14:02; DPB1*04:02,05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0073).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0074
AC   CVCL_T110
DR   CLO; CLO_0051191
DR   RCB; HEV0074
DR   Wikidata; Q54882984
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0077
AC   CVCL_T111
DR   CLO; CLO_0051257
DR   RCB; HEV0077
DR   Wikidata; Q54882985
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*07:02,48:01; C*07:02,08:01; DPB1*04:02,13:01; DQB1*03:01,05:01; DRB1*01:01,09:01 (RCB=HEV0077).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0078
AC   CVCL_T112
DR   CLO; CLO_0051192
DR   RCB; HEV0078
DR   Wikidata; Q54882986
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0079
AC   CVCL_T113
DR   CLO; CLO_0051250
DR   RCB; HEV0079
DR   Wikidata; Q54882987
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,33:03; B*40:02,44:03; C*03:04,14:03; DPB1*04:01,05:01; DQB1*06:01,06:04; DRB1*08:03,13:02 (RCB=HEV0079).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0080
AC   CVCL_DE60
DR   RCB; HEV0080
DR   Wikidata; Q54882988
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0082
AC   CVCL_T114
DR   CLO; CLO_0051251
DR   RCB; HEV0082
DR   Wikidata; Q54882989
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*44:03,52:01; C*12:02,14:03; DPB1*02:01,05:01; DQB1*06:02,06:04; DRB1*13:02,15:01 (RCB=HEV0082).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0083
AC   CVCL_T115
DR   CLO; CLO_0051353
DR   RCB; HEV0083
DR   Wikidata; Q54882990
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0085
AC   CVCL_T116
DR   CLO; CLO_0051252
DR   RCB; HEV0085
DR   Wikidata; Q54882991
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*07:02,55:02; C*03:03,07:02; DPB1*02:01,05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0085).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0086
AC   CVCL_T117
DR   CLO; CLO_0051253
DR   RCB; HEV0086
DR   Wikidata; Q54882992
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01,54:01; C*01:02,12:02; DPB1*05:01,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0086).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0089
AC   CVCL_T118
DR   CLO; CLO_0051254
DR   RCB; HEV0089
DR   Wikidata; Q54882993
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,02:07; B*15:18,46:01; C*01:03,08:01; DPB1*05:01; DQB1*03:01,03:03; DRB1*09:01,12:01 (RCB=HEV0089).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0090
AC   CVCL_T119
DR   RCB; HEV0090
DR   Wikidata; Q54882994
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0091
AC   CVCL_T120
DR   CLO; CLO_0051255
DR   RCB; HEV0091
DR   Wikidata; Q54882995
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,02:07; B*15:18,46:01; C*01:03,08:01; DPB1*05:01; DQB1*03:01,03:03; DRB1*09:01,12:01 (RCB=HEV0091).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0092
AC   CVCL_T121
DR   CLO; CLO_0051347
DR   RCB; HEV0092
DR   Wikidata; Q54882997
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02,13:01; C*03:03,07:02; DPB1*02:01,04:02; DQB1*03:01,05:01; DRB1*01:01,12:02 (RCB=HEV0092).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0093
AC   CVCL_T122
DR   CLO; CLO_0051354
DR   RCB; HEV0093
DR   Wikidata; Q54882998
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*35:01,40:01; C*03:03,03:04; DPB1*04:01,05:01; DQB1*03:02,05:03; DRB1*08:02,14:54 (RCB=HEV0093).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0095
AC   CVCL_T123
DR   CLO; CLO_0051256
DR   RCB; HEV0095
DR   Wikidata; Q54882999
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*54:01; C*01:02,03:04; DPB1*02:01,05:01; DQB1*04:01,05:02; DRB1*04:05,14:01 (RCB=HEV0095).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0096
AC   CVCL_T124
DR   CLO; CLO_0051204
DR   RCB; HEV0096
DR   Wikidata; Q54883000
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,26:03; B*51:01,54:01; C*03:04; DPB1*02:01,05:01; DQB1*04:01,05:02; DRB1*04:05,14:54 (RCB=HEV0096).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0097
AC   CVCL_DE61
DR   RCB; HEV0097
DR   Wikidata; Q54883001
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0098
AC   CVCL_T125
DR   RCB; HEV0098
DR   Wikidata; Q54883002
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*44:03,52:01; C*12:02,14:03; DPB1*02:01,05:01; DQB1*03:01,06:04; DRB1*13:02,15:01 (RCB=HEV0098).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0099
AC   CVCL_T126
DR   CLO; CLO_0051258
DR   RCB; HEV0099
DR   Wikidata; Q54883003
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,11:01; B*15:01,54:01; C*01:02,04:01; DPB1*02:01,03:01; DQB1*03:02,04:01; DRB1*04:05,04:06 (RCB=HEV0099).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0100
AC   CVCL_T127
DR   CLO; CLO_0051259
DR   RCB; HEV0100
DR   Wikidata; Q54883004
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*48:01,59:01; C*01:02,08:03; DPB1*02:01,19:01; DQB1*03:03,04:01; DRB1*04:05,09:01 (RCB=HEV0100).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0101
AC   CVCL_T128
DR   CLO; CLO_0051367
DR   RCB; HEV0101
DR   Wikidata; Q54883005
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*40:02,52:01; C*03:04,12:02; DPB1*02:01,05:01; DQB1*04:02,06:01; DRB1*04:10,15:02 (RCB=HEV0101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0102
AC   CVCL_T129
DR   RCB; HEV0102
DR   Wikidata; Q54883006
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0104
AC   CVCL_T130
DR   CLO; CLO_0051260
DR   RCB; HEV0104
DR   Wikidata; Q54883007
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*51:01,54:01; C*01:02,14:02; DPB1*02:01,05:01; DQB1*03:01,04:01; DRB1*04:05,11:01 (RCB=HEV0104).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0106
AC   CVCL_T131
DR   CLO; CLO_0051261
DR   RCB; HEV0106
DR   Wikidata; Q54883008
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,33:03; B*44:03,54:01; C*01:02,14:03; DPB1*05:01; DQB1*04:01,06:01; DRB1*04:05,08:03 (RCB=HEV0106).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0109
AC   CVCL_T132
DR   CLO; CLO_0051193
DR   RCB; HEV0109
DR   Wikidata; Q54883009
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0110
AC   CVCL_T133
DR   CLO; CLO_0051339
DR   RCB; HEV0110
DR   Wikidata; Q54883010
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*15:07,15:18; C*03:03,07:04:01; DPB1*02:01,05:01; DQB1*03:01,03:02; DRB1*04:01,04:03 (RCB=HEV0110).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0112
AC   CVCL_T134
DR   CLO; CLO_0051262
DR   RCB; HEV0112
DR   Wikidata; Q54883011
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*35:01,52:01; C*12:02,15:02; DPB1*05:01,09:01; DQB1*03:01,06:01; DRB1*14:06,15:02 (RCB=HEV0112).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0114
AC   CVCL_DE62
DR   RCB; HEV0114
DR   Wikidata; Q54883012
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*51:01,52:01; C*12:02,14:02; DPB1*02:01,09:01; DQB1*06:01,06:02; DRB1*15:01,15:02 (RCB=HEV0114).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   HEV0116
AC   CVCL_T135
DR   CLO; CLO_0051265
DR   RCB; HEV0116
DR   Wikidata; Q54883013
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:10,24:02; B*40:06,52:01; C*08:01,12:02; DPB1*02:02,09:01; DQB1*05:03,06:01; DRB1*14:05,15:02 (RCB=HEV0116).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0117
AC   CVCL_T136
DR   CLO; CLO_0051263
DR   RCB; HEV0117
DR   Wikidata; Q54883014
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,33:03; B*44:03,56:01; C*04:01,14:03; DPB1*02:02,05:01; DQB1*03:03,04:01; DRB1*04:05,09:01 (RCB=HEV0117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0118
AC   CVCL_DE63
DR   RCB; HEV0118
DR   Wikidata; Q54883015
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0120
AC   CVCL_T137
DR   CLO; CLO_0051264
DR   RCB; HEV0120
DR   Wikidata; Q54883016
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*01:01,26:01; B*37:01,39:01; C*06:02,07:02; DPB1*02:01,04:02; DQB1*05:01; DRB1*01:01,10:01 (RCB=HEV0120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0121
AC   CVCL_T138
DR   CLO; CLO_0051364
DR   RCB; HEV0121
DR   Wikidata; Q54883017
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*40:02,44:03; C*03:04,14:03; DPB1*02:01; DQB1*03:02,06:04; DRB1*04:06,13:02 (RCB=HEV0121).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0124
AC   CVCL_T139
DR   CLO; CLO_0051266
DR   RCB; HEV0124
DR   Wikidata; Q54883018
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*35:01,40:02; C*03:04,08:01; DPB1*02:01,05:01; DQB1*03:03,04:02; DRB1*04:10,09:01 (RCB=HEV0124).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0126
AC   CVCL_T140
DR   CLO; CLO_0051205
DR   RCB; HEV0126
DR   Wikidata; Q54883019
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*40:02,54:01; C*01:02,03:04; DPB1*05:01; DQB1*03:03,06:01; DRB1*08:03,09:01 (RCB=HEV0126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0127
AC   CVCL_T141
DR   CLO; CLO_0051355
DR   RCB; HEV0127
DR   Wikidata; Q54883020
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0128
AC   CVCL_T142
DR   RCB; HEV0128
DR   Wikidata; Q54883024
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0130
AC   CVCL_T143
DR   CLO; CLO_0051267
DR   RCB; HEV0130
DR   Wikidata; Q54883025
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*07:02,56:01; C*04:01,07:02; DPB1*04:02,05:01; DQB1*04:01,05:01; DRB1*01:01,04:05 (RCB=HEV0130).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0131
AC   CVCL_T144
DR   CLO; CLO_0051194
DR   RCB; HEV0131
DR   Wikidata; Q54883026
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0134
AC   CVCL_T145
DR   CLO; CLO_0051268
DR   RCB; HEV0134
DR   Wikidata; Q54883027
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*07:02,44:03; C*07:02,14:03; DPB1*04:01,04:02; DQB1*05:01,06:04; DRB1*01:01,13:02 (RCB=HEV0134).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0135
AC   CVCL_T146
DR   RCB; HEV0135
DR   Wikidata; Q54883028
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0136
AC   CVCL_DE64
DR   RCB; HEV0136
DR   Wikidata; Q54883029
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0137
AC   CVCL_T147
DR   CLO; CLO_0051269
DR   RCB; HEV0137
DR   Wikidata; Q54883030
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*46:01,67:01; C*01:02,07:02; DPB1*02:01,05:01; DQB1*03:03,06:01; DRB1*08:03,09:01 (RCB=HEV0137).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0139
AC   CVCL_T148
DR   CLO; CLO_0051270
DR   RCB; HEV0139
DR   Wikidata; Q54883031
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,26:01; B*40:02,54:01; C*01:02,03:04; DPB1*02:01,05:01; DQB1*03:03,06:02; DRB1*09:01,15:01 (RCB=HEV0139).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0140
AC   CVCL_T149
DR   RCB; HEV0140
DR   Wikidata; Q54883032
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0141
AC   CVCL_T150
DR   CLO; CLO_0051271
DR   RCB; HEV0141
DR   Wikidata; Q54883033
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*31:01,33:03; B*48:01,58:01; C*03:02,08:01; DPB1*03:01,04:02; DQB1*03:03,06:09; DRB1*09:01,13:02 (RCB=HEV0141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0144
AC   CVCL_T151
DR   CLO; CLO_0051272
DR   RCB; HEV0144
DR   Wikidata; Q54883034
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,26:02; B*07:02,52:01; C*07:02,12:02; DPB1*04:02,09:01; DQB1*05:01,06:01; DRB1*01:01,15:02 (RCB=HEV0144).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0145
AC   CVCL_T152
DR   CLO; CLO_0051273
DR   RCB; HEV0145
DR   Wikidata; Q54883035
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*40:01,40:06; C*07:02,08:01; DPB1*02:01; DQB1*03:02,03:03; DRB1*04:06,09:01 (RCB=HEV0145).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0146
AC   CVCL_DE65
DR   RCB; HEV0146
DR   Wikidata; Q54883036
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0149
AC   CVCL_T153
DR   CLO; CLO_0051274
DR   RCB; HEV0149
DR   Wikidata; Q54883037
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*26:01,31:01; B*07:02,51:01; C*07:02,14:02; DPB1*02:01,05:01; DQB1*03:01,05:01; DRB1*01:01,14:03 (RCB=HEV0149).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0150
AC   CVCL_T154
DR   CLO; CLO_0051275
DR   RCB; HEV0150
DR   Wikidata; Q54883038
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*15:18,52:01; C*08:01,12:02; DPB1*02:01,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0150).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0151
AC   CVCL_T155
DR   CLO; CLO_0051335
DR   RCB; HEV0151
DR   Wikidata; Q54883039
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:02,31:01; B*07:02,40:06; C*07:02,08:01; DPB1*04:02,05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0151).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0153
AC   CVCL_DE66
DR   RCB; HEV0153
DR   Wikidata; Q54883040
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0154
AC   CVCL_T156
DR   CLO; CLO_0051276
DR   RCB; HEV0154
DR   Wikidata; Q54883041
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,26:01; B*15:01,52:01; C*12:02,15:02; DPB1*03:01,09:01; DQB1*03:03,06:01; DRB1*09:01,15:02 (RCB=HEV0154).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0155
AC   CVCL_T157
DR   CLO; CLO_0051344
DR   RCB; HEV0155
DR   Wikidata; Q54883042
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*15:01,51:01; C*03:04,04:01; DPB1*02:01; DQB1*03:02,05:03; DRB1*04:06,14:54 (RCB=HEV0155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0156
AC   CVCL_T158
DR   CLO; CLO_0051366
DR   RCB; HEV0156
DR   Wikidata; Q54883043
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:01,26:03; B*35:01,40:02; C*03:03,03:04; DPB1*05:01; DQB1*03:01,06:02; DRB1*14:06,15:01 (RCB=HEV0156).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0157
AC   CVCL_T159
DR   RCB; HEV0157
DR   Wikidata; Q54883044
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0160
AC   CVCL_T160
DR   CLO; CLO_0051277
DR   RCB; HEV0160
DR   Wikidata; Q54883045
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*40:01,67:01; C*03:04,07:02; DPB1*02:01,05:01; DQB1*03:01,06:02; DRB1*12:01,15:01 (RCB=HEV0160).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0164
AC   CVCL_T161
DR   CLO; CLO_0051278
DR   RCB; HEV0164
DR   Wikidata; Q54883046
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*15:18,44:03; C*08:01,14:03; DPB1*04:01,05:01; DQB1*03:02,06:04; DRB1*04:03,13:02 (RCB=HEV0164).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0168
AC   CVCL_T162
DR   CLO; CLO_0051279
DR   RCB; HEV0168
DR   Wikidata; Q54883047
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*39:01,55:02; C*01:02,07:02; DPB1*05:01; DQB1*04:01,06:01; DRB1*04:05,08:03 (RCB=HEV0168).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0170
AC   CVCL_T163
DR   RCB; HEV0170
DR   Wikidata; Q54883048
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0171
AC   CVCL_T164
DR   CLO; CLO_0051280
DR   RCB; HEV0171
DR   Wikidata; Q54883049
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*40:02,59:01; C*01:02,03:04; DPB1*04:02,05:01; DQB1*03:03,04:01; DRB1*04:05,09:01 (RCB=HEV0171).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0174
AC   CVCL_T165
DR   CLO; CLO_0051281
DR   RCB; HEV0174
DR   Wikidata; Q54883050
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,33:03; B*35:01,44:03; C*03:03,14:03; DPB1*05:01; DQB1*04:01,06:02; DRB1*04:05,15:01 (RCB=HEV0174).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0177
AC   CVCL_T166
DR   CLO; CLO_0051282
DR   RCB; HEV0177
DR   Wikidata; Q54883051
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*54:01,59:01; C*01:02; DPB1*04:02,05:01; DQB1*04:01; DRB1*04:05 (RCB=HEV0177).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0178
AC   CVCL_T167
DR   RCB; HEV0178
DR   Wikidata; Q54883052
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*11:01,31:01; B*15:01,56:01; C*04:01; DPB1*04:01,05:01; DQB1*03:02,03:03; DRB1*04:06,09:01 (RCB=HEV0178).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0181
AC   CVCL_T168
DR   CLO; CLO_0051332
DR   RCB; HEV0181
DR   Wikidata; Q54883053
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*40:01,55:02; C*01:02,03:04; DPB1*05:01; DQB1*04:01; DRB1*04:05 (RCB=HEV0181).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0182
AC   CVCL_T169
DR   RCB; HEV0182
DR   Wikidata; Q54883054
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0183
AC   CVCL_LL60
DR   RCB; HEV0183
DR   Wikidata; Q54883055
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   HEV0186
AC   CVCL_T170
DR   CLO; CLO_0051283
DR   RCB; HEV0186
DR   Wikidata; Q54883056
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*39:04,40:02; C*03:04,07:02; DPB1*02:01; DQB1*03:02,03:03; DRB1*04:06,09:01 (RCB=HEV0186).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0188
AC   CVCL_T171
DR   CLO; CLO_0051284
DR   RCB; HEV0188
DR   Wikidata; Q54883057
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:20,33:03; B*44:03,51:01; C*14:02,14:03; DPB1*02:01,05:01; DQB1*03:02,03:03; DRB1*09:01,12:01 (RCB=HEV0188).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0190
AC   CVCL_T172
DR   CLO; CLO_0051285
DR   RCB; HEV0190
DR   Wikidata; Q54883058
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*15:28,52:01; C*03:03,12:02; DPB1*05:01,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0190).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0191
AC   CVCL_DE67
DR   RCB; HEV0191
DR   Wikidata; Q54883059
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0192
AC   CVCL_T173
DR   CLO; CLO_0051348
DR   RCB; HEV0192
DR   Wikidata; Q54883060
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:07,24:02; B*46:01,52:01; C*01:02,12:02; DPB1*02:01,09:01; DQB1*06:01; DRB1*08:03,15:02 (RCB=HEV0192).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0195
AC   CVCL_T174
DR   CLO; CLO_0051286
DR   RCB; HEV0195
DR   Wikidata; Q54883061
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*15:01,52:01; C*07:02,12:02; DPB1*02:01,09:01; DQB1*06:01,06:02; DRB1*15:01,15:02 (RCB=HEV0195).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0196
AC   CVCL_DE68
DR   RCB; HEV0196
DR   Wikidata; Q54883062
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0198
AC   CVCL_T175
DR   CLO; CLO_0051338
DR   RCB; HEV0198
DR   Wikidata; Q54883063
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*52:01,59:01; C*01:02,12:02; DPB1*04:02,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0198).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0199
AC   CVCL_DE69
DR   RCB; HEV0199
DR   Wikidata; Q54883066
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0201
AC   CVCL_T176
DR   CLO; CLO_0051287
DR   RCB; HEV0201
DR   Wikidata; Q54883067
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*01:01,11:01; B*07:02,54:01; C*01:02,07:02; DPB1*04:02,05:01; DQB1*03:03,05:01; DRB1*01:01,04:05 (RCB=HEV0201).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0203
AC   CVCL_T177
DR   CLO; CLO_0051195
DR   RCB; HEV0203
DR   Wikidata; Q54883068
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0207
AC   CVCL_T178
DR   CLO; CLO_0051288
DR   RCB; HEV0207
DR   Wikidata; Q54883069
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*07:02 X; C*03:03,07:02; DPB1*04:02,05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0207).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0208
AC   CVCL_T179
DR   RCB; HEV0208
DR   Wikidata; Q54883070
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:20; B*15:18,40:06; C*08:01; DPB1*05:01; DQB1*03:01; DRB1*12:01,14:06 (RCB=HEV0208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0209
AC   CVCL_DE70
DR   RCB; HEV0209
DR   Wikidata; Q54883071
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0213
AC   CVCL_T180
DR   CLO; CLO_0051289
DR   RCB; HEV0213
DR   Wikidata; Q54883072
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:18,33:03; B*44:03,46:01; C*01:02,14:03; DPB1*02:01,02:02; DQB1*04:01,06:01; DRB1*04:05,08:03 (RCB=HEV0213).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0217
AC   CVCL_T181
DR   CLO; CLO_0051290
DR   RCB; HEV0217
DR   Wikidata; Q54883073
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,11:01; B*15:01,35:01; C*03:03,04:01; DPB1*03:01,05:01; DQB1*03:02,06:02; DRB1*04:06,15:01 (RCB=HEV0217).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0218
AC   CVCL_T182
DR   CLO; CLO_0051363
DR   RCB; HEV0218
DR   Wikidata; Q54883074
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Chinese; Han and Japanese.
CC   HLA typing: A*11:01,24:02; B*15:07,44:02; C*03:03,05:01; DPB1*02:01,05:01; DQB1*03:02,06:03; DRB1*04:03,13:01 (RCB=HEV0218).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0220
AC   CVCL_T183
DR   CLO; CLO_0051291
DR   RCB; HEV0220
DR   Wikidata; Q54883075
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*54:01,55:02; C*01:02; DPB1*05:01,13:01; DQB1*03:01,03:03; DRB1*09:01,11:01 (RCB=HEV0220).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0221
AC   CVCL_T184
DR   CLO; CLO_0051292
DR   RCB; HEV0221
DR   Wikidata; Q54883076
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*39:02,40:06; C*07:02,08:01; DPB1*02:01,05:01; DQB1*03:01,03:03; DRB1*09:01,12:01 (RCB=HEV0221).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0224
AC   CVCL_T185
DR   CLO; CLO_0051346
DR   RCB; HEV0224
DR   Wikidata; Q54883077
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:07; B*40:01,46:01; C*01:02,15:02; DPB1*05:01; DQB1*05:03,06:01; DRB1*08:03,14:05 (RCB=HEV0224).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0227
AC   CVCL_T186
DR   CLO; CLO_0051293
DR   RCB; HEV0227
DR   Wikidata; Q54883078
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:03,31:01; B*35:01,51:01; C*03:03,14:02; DPB1*02:01,05:01; DQB1*03:02,06:01; DRB1*04:03,15:02 (RCB=HEV0227).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0229
AC   CVCL_T187
DR   RCB; HEV0229
DR   Wikidata; Q54883079
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0230
AC   CVCL_T188
DR   CLO; CLO_0051294
DR   RCB; HEV0230
DR   Wikidata; Q54883080
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:06; B*07:02,40:01; C*03:03,07:02; DPB1*03:01,05:01; DQB1*05:01,06:01; DRB1*01:01,08:03 (RCB=HEV0230).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0232
AC   CVCL_T189
DR   CLO; CLO_0051295
DR   RCB; HEV0232
DR   Wikidata; Q54883081
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*15:01,54:01; C*01:02,03:03; DPB1*05:01,09:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0234
AC   CVCL_T190
DR   CLO; CLO_0051296
DR   RCB; HEV0234
DR   Wikidata; Q54883082
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,33:03; B*40:01,44:03; C*03:04,14:03; DPB1*04:01,05:01; DQB1*05:03,06:04; DRB1*13:02,14:01 (RCB=HEV0234).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0236
AC   CVCL_T191
DR   RCB; HEV0236
DR   Wikidata; Q54883083
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*11:01,31:01; B*51:01,54:01; C*01:02,15:02; DPB1*05:01; DQB1*06:01,06:02; DRB1*08:03,15:01 (RCB=HEV0236).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0238
AC   CVCL_T192
DR   CLO; CLO_0051297
DR   RCB; HEV0238
DR   Wikidata; Q54883084
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*15:01,39:01; C*04:01,07:02; DPB1*02:01,05:01; DQB1*03:01,03:02; DRB1*04:06,12:01 (RCB=HEV0238).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0240
AC   CVCL_T193
DR   RCB; HEV0240
DR   Wikidata; Q54883085
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*24:02; B*48:01,52:01; C*08:01,12:02; DPB1*02:01,09:01; DQB1*06:01,06:02; DRB1*15:01,15:02 (RCB=HEV0240).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0244
AC   CVCL_T194
DR   CLO; CLO_0051298
DR   RCB; HEV0244
DR   Wikidata; Q54883086
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*35:01,44:02; C*05:01,08:01; DPB1*02:01,09:01; DQB1*03:03,04:02; DRB1*04:10,12:01 (RCB=HEV0244).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0245
AC   CVCL_T195
DR   RCB; HEV0245
DR   Wikidata; Q54883087
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0248
AC   CVCL_T196
DR   CLO; CLO_0051299
DR   RCB; HEV0248
DR   Wikidata; Q54883088
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,31:01; B*40:06,44:03; C*03:04,14:03; DPB1*02:01,05:01; DQB1*03:03,06:04; DRB1*09:01,13:02 (RCB=HEV0248).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0250
AC   CVCL_DE71
DR   RCB; HEV0250
DR   Wikidata; Q54883089
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0251
AC   CVCL_T197
DR   RCB; HEV0251
DR   Wikidata; Q54883090
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*24:02,26:01; B*40:06; C*08:01; DPB1*02:01,05:01; DQB1*03:03; DRB1*09:01 (RCB=HEV0251).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0256
AC   CVCL_T198
DR   CLO; CLO_0051300
DR   RCB; HEV0256
DR   Wikidata; Q54883091
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,33:03; B*15:01,44:03; C*03:03,14:03; DPB1*03:01,05:01; DQB1*03:01,06:01; DRB1*08:03,14:06 (RCB=HEV0256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0257
AC   CVCL_DE72
DR   RCB; HEV0257
DR   Wikidata; Q54883092
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0260
AC   CVCL_T199
DR   CLO; CLO_0051301
DR   RCB; HEV0260
DR   Wikidata; Q54883093
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*52:01,54:01; C*01:02,12:02; DPB1*05:01,14:01; DQB1*06:01,06:02; DRB1*08:03,15:01 (RCB=HEV0260).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0261
AC   CVCL_DE73
DR   RCB; HEV0261
DR   Wikidata; Q54883094
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0262
AC   CVCL_T200
DR   CLO; CLO_0051196
DR   RCB; HEV0262
DR   Wikidata; Q54883095
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0266
AC   CVCL_T201
DR   CLO; CLO_0051356
DR   RCB; HEV0266
DR   Wikidata; Q54883096
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,33:03; B*35:01,44:03; C*03:03,14:03; DPB1*03:01,04:01; DQB1*04:02,06:04; DRB1*04:10,13:02 (RCB=HEV0266).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0270
AC   CVCL_T202
DR   RCB; HEV0270
DR   Wikidata; Q54883097
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0271
AC   CVCL_T203
DR   CLO; CLO_0051302
DR   RCB; HEV0271
DR   Wikidata; Q54883098
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01; B*48:01,51:01; C*08:01,15:02; DPB1*04:02,05:01; DQB1*03:03; DRB1*09:01 (RCB=HEV0271).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0272
AC   CVCL_T204
DR   RCB; HEV0272
DR   Wikidata; Q54883099
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0277
AC   CVCL_T205
DR   CLO; CLO_0051303
DR   RCB; HEV0277
DR   Wikidata; Q54883100
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*31:01,33:03; B*44:03,51:01; C*14:02,14:03; DPB1*02:01,04:01; DQB1*03:01,06:04; DRB1*13:02,14:03 (RCB=HEV0277).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0283
AC   CVCL_DE74
DR   RCB; HEV0283
DR   Wikidata; Q54883101
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0284
AC   CVCL_T206
DR   CLO; CLO_0051206
DR   RCB; HEV0284
DR   Wikidata; Q54883102
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02,40:06; C*07:02,08:01; DPB1*05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0285
AC   CVCL_T207
DR   RCB; HEV0285
DR   Wikidata; Q54883103
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0288
AC   CVCL_T208
DR   CLO; CLO_0051304
DR   RCB; HEV0288
DR   Wikidata; Q54883104
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*07:02,44:03; C*07:02,14:03; DPB1*04:02,05:01; DQB1*05:01,06:04; DRB1*01:01,13:02 (RCB=HEV0288).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0290
AC   CVCL_DE75
DR   RCB; HEV0290
DR   Wikidata; Q54883105
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0292
AC   CVCL_T209
DR   CLO; CLO_0051305
DR   RCB; HEV0292
DR   Wikidata; Q54883108
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; C*12:02; DPB1*02:01,04:02; DQB1*06:01; DRB1*15:02 (RCB=HEV0292).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0293
AC   CVCL_DE76
DR   RCB; HEV0293
DR   Wikidata; Q54883109
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0295
AC   CVCL_T210
DR   RCB; HEV0295
DR   Wikidata; Q54883110
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:01,26:03; B*40:01,40:02; C*15:02; DPB1*02:01,04:02; DQB1*05:02,06:01; DRB1*08:03,14:54 (RCB=HEV0295).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0296
AC   CVCL_T211
DR   CLO; CLO_0051306
DR   RCB; HEV0296
DR   Wikidata; Q54883111
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*44:03,52:01; C*12:02,14:03; DPB1*04:01,05:01; DQB1*03:02,06:04; DRB1*04:06,13:02 (RCB=HEV0296).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0299
AC   CVCL_DE77
DR   RCB; HEV0299
DR   Wikidata; Q54883112
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0300
AC   CVCL_T212
DR   CLO; CLO_0051350
DR   RCB; HEV0300
DR   Wikidata; Q54883113
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*15:27,35:01; C*03:03,04:01; DPB1*02:01,05:01; DQB1*03:01,03:02; DRB1*04:03,12:01 (RCB=HEV0300).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0301
AC   CVCL_T213
DR   CLO; CLO_0051307
DR   RCB; HEV0301
DR   Wikidata; Q54883114
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:06; B*35:01,39:01; C*03:03,07:02; DPB1*05:01; DQB1*03:01,03:03; DRB1*09:01,14:06 (RCB=HEV0301).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0303
AC   CVCL_T214
DR   RCB; HEV0303
DR   Wikidata; Q54883115
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0304
AC   CVCL_T215
DR   CLO; CLO_0051308
DR   RCB; HEV0304
DR   Wikidata; Q54883116
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,31:01; B*40:02,44:03; C*03:04,14:03; DPB1*04:01,05:01; DQB1*03:03,06:04; DRB1*09:01,13:02 (RCB=HEV0304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0305
AC   CVCL_DE78
DR   RCB; HEV0305
DR   Wikidata; Q54883117
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0307
AC   CVCL_T216
DR   CLO; CLO_0051309
DR   RCB; HEV0307
DR   Wikidata; Q54883118
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*46:01,54:01; C*01:02; DPB1*05:01; DQB1*04:01,06:01; DRB1*04:05,08:03 (RCB=HEV0307).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0308
AC   CVCL_DE79
DR   RCB; HEV0308
DR   Wikidata; Q54883119
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0311
AC   CVCL_T217
DR   CLO; CLO_0051310
DR   RCB; HEV0311
DR   Wikidata; Q54883120
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:01; B*35:01,52:01; C*03:03,12:02; DPB1*02:01,09:01; DQB1*06:01,06:02; DRB1*15:01,15:02 (RCB=HEV0311).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0312
AC   CVCL_T218
DR   CLO; CLO_0051197
DR   RCB; HEV0312
DR   Wikidata; Q54883121
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0315
AC   CVCL_T219
DR   CLO; CLO_0051311
DR   RCB; HEV0315
DR   Wikidata; Q54883122
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:01,33:03; B*44:03,52:01; C*12:02,14:03; DPB1*04:01,09:01; DQB1*06:01,06:04; DRB1*13:02,15:02 (RCB=HEV0315).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0317
AC   CVCL_T220
DR   RCB; HEV0317
DR   Wikidata; Q54883123
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0322
AC   CVCL_LK58
DR   RCB; HEV0322
DR   Wikidata; Q54883124
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   HEV0324
AC   CVCL_T221
DR   CLO; CLO_0051312
DR   RCB; HEV0324
DR   Wikidata; Q54883126
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*51:01,52:01; C*12:02,14:02; DPB1*04:02,09:01; DQB1*04:02,06:01; DRB1*08:02,15:02 (RCB=HEV0324).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0325
AC   CVCL_T222
DR   RCB; HEV0325
DR   Wikidata; Q54883127
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Korean.
CC   HLA typing: A*11:01,24:02; B*35:01,51:01; C*03:03,15:02; DPB1*02:01,03:01; DQB1*04:01,04:02; DRB1*04:05,04:10 (RCB=HEV0325).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0327
AC   CVCL_T223
DR   CLO; CLO_0051313
DR   RCB; HEV0327
DR   Wikidata; Q54883129
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*07:02,46:01; C*03:04,07:02; DPB1*04:02,05:01; DQB1*05:01,06:01; DRB1*01:01,08:03 (RCB=HEV0327).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0330
AC   CVCL_T224
DR   CLO; CLO_0051207
DR   RCB; HEV0330
DR   Wikidata; Q54883130
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:03; B*15:01,52:01; C*03:03,12:02; DPB1*05:01,09:01; DQB1*06:01,06:04; DRB1*13:02,15:02 (RCB=HEV0330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0333
AC   CVCL_T225
DR   RCB; HEV0333
DR   Wikidata; Q54883131
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*40:01,48:01; C*03:03,03:04; DPB1*04:02,05:01; DQB1*03:01,05:03; DRB1*11:01,14:54 (RCB=HEV0333).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0336
AC   CVCL_T226
DR   CLO; CLO_0051208
DR   RCB; HEV0336
DR   Wikidata; Q54883132
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,31:01; B*40:02,55:02; C*01:02,03:04; DPB1*02:01,05:01; DQB1*03:02,06:02; DRB1*08:02,15:01 (RCB=HEV0336).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0337
AC   CVCL_T227
DR   RCB; HEV0337
DR   Wikidata; Q54883133
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0338
AC   CVCL_DE80
DR   RCB; HEV0338
DR   Wikidata; Q54883134
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0340
AC   CVCL_T228
DR   CLO; CLO_0051314
DR   RCB; HEV0340
DR   Wikidata; Q54883135
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*15:07,52:01; C*01:02,12:02; DPB1*02:01,05:01; DQB1*03:02,06:02; DRB1*04:03,15:01 (RCB=HEV0340).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0342
AC   CVCL_T229
DR   CLO; CLO_0051315
DR   RCB; HEV0342
DR   Wikidata; Q54883136
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*38:02,51:01; C*07:02,14:02; DPB1*05:01,14:01; DQB1*03:01,03:03; DRB1*08:03,09:01 (RCB=HEV0342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0343
AC   CVCL_DE81
DR   RCB; HEV0343
DR   Wikidata; Q54883137
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0345
AC   CVCL_T230
DR   CLO; CLO_0051198
DR   RCB; HEV0345
DR   Wikidata; Q54883138
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0349
AC   CVCL_T231
DR   CLO; CLO_0051316
DR   RCB; HEV0349
DR   Wikidata; Q54883139
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*07:02,39:01; C*07:02; DPB1*05:01; DQB1*04:01,05:01; DRB1*01:01,04:05 (RCB=HEV0349).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0350
AC   CVCL_T232
DR   CLO; CLO_0051357
DR   RCB; HEV0350
DR   Wikidata; Q54883140
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0351
AC   CVCL_T233
DR   CLO; CLO_0051351
DR   RCB; HEV0351
DR   Wikidata; Q54883141
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:53N,26:01; B*39:01,54:01; C*01:02,07:02; DPB1*04:02,05:01; DQB1*05:03,06:02; DRB1*14:05,15:01 (RCB=HEV0351).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0352
AC   CVCL_DE82
DR   RCB; HEV0352
DR   Wikidata; Q54883142
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0356
AC   CVCL_T234
DR   CLO; CLO_0051317
DR   RCB; HEV0356
DR   Wikidata; Q54883143
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*13:01,48:01; C*03:04,08:01; DPB1*02:01,04:02; DQB1*03:01,03:03; DRB1*09:01,12:02 (RCB=HEV0356).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0358
AC   CVCL_DE83
DR   RCB; HEV0358
DR   Wikidata; Q54883144
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0363
AC   CVCL_T235
DR   CLO; CLO_0051345
DR   RCB; HEV0363
DR   Wikidata; Q54883145
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:07,24:20; B*46:01,55:02; C*01:02,07:02; DPB1*02:01,05:01; DQB1*06:01; DRB1*08:03 (RCB=HEV0363).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0370
AC   CVCL_T236
DR   CLO; CLO_0051318
DR   RCB; HEV0370
DR   Wikidata; Q54883146
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:02; B*40:01,40:06; C*03:04,08:01; DPB1*04:01,05:01; DQB1*03:03,04:01; DRB1*04:05,09:01 (RCB=HEV0370).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0375
AC   CVCL_T237
DR   CLO; CLO_0051209
DR   RCB; HEV0375
DR   Wikidata; Q54883147
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*44:03,52:01; C*12:02,14:03; DPB1*02:01,05:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0375).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0377
AC   CVCL_DE84
DR   RCB; HEV0377
DR   Wikidata; Q54883148
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0378
AC   CVCL_T238
DR   RCB; HEV0378
DR   Wikidata; Q54883149
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0380
AC   CVCL_T239
DR   RCB; HEV0380
DR   Wikidata; Q54883155
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*02:06,24:02; B*35:01,52:01; C*03:03,12:02; DPB1*02:01,05:01; DQB1*05:03,06:02; DRB1*14:54,15:01 (RCB=HEV0380).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0384
AC   CVCL_T240
DR   CLO; CLO_0051319
DR   RCB; HEV0384
DR   Wikidata; Q54883156
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,26:01; B*40:02,51:02; C*03:04,08:01; DPB1*02:01,03:01; DQB1*03:03; DRB1*09:01 (RCB=HEV0384).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0386
AC   CVCL_T241
DR   CLO; CLO_0051320
DR   RCB; HEV0386
DR   Wikidata; Q54883157
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*01:01,02:01; B*15:01,40:06; C*06:02,08:01; DPB1*04:01,04:02; DQB1*03:03,04:01; DRB1*04:05,09:01 (RCB=HEV0386).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0388
AC   CVCL_T242
DR   RCB; HEV0388
DR   Wikidata; Q54883158
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*15:01,35:01; C*01:02,03:03; DPB1*03:01,19:01; DQB1*03:03,06:01; DRB1*08:03,09:01 (RCB=HEV0388).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0390
AC   CVCL_DE85
DR   RCB; HEV0390
DR   Wikidata; Q54883159
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0391
AC   CVCL_DE86
DR   RCB; HEV0391
DR   Wikidata; Q54883160
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0396
AC   CVCL_T243
DR   CLO; CLO_0051321
DR   RCB; HEV0396
DR   Wikidata; Q54883161
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*39:01,55:02; C*01:02,07:02; DPB1*02:02,03:01; DQB1*04:02,06:02; DRB1*04:10,15:01 (RCB=HEV0396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0399
AC   CVCL_T244
DR   CLO; CLO_0051199
DR   RCB; HEV0399
DR   Wikidata; Q54883162
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0400
AC   CVCL_T245
DR   CLO; CLO_0051330
DR   RCB; HEV0400
DR   Wikidata; Q54883163
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:01,33:03; B*35:01,44:03; C*03:03,14:03; DPB1*05:01,14:01; DQB1*03:01,03:03; DRB1*04:01,12:01 (RCB=HEV0400).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0401
AC   CVCL_T246
DR   CLO; CLO_0051210
DR   RCB; HEV0401
DR   Wikidata; Q54883164
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,33:03; B*40:02,44:03; C*03:04,14:03; DPB1*04:01,05:01; DQB1*03:03,06:04; DRB1*09:01,13:02 (RCB=HEV0401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0404
AC   CVCL_T247
DR   RCB; HEV0404
DR   Wikidata; Q54883165
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka and Japanese.
CC   HLA typing: A*24:02; B*07:02,51:01; C*07:02,14:02; DPB1*04:02,13:01; DQB1*03:02,05:01; DRB1*01:01,04:06 (RCB=HEV0404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0408
AC   CVCL_T248
DR   CLO; CLO_0051331
DR   RCB; HEV0408
DR   Wikidata; Q54883166
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*15:01,40:06; C*04:01,08:01; DPB1*05:01; DQB1*03:02,03:03; DRB1*04:06,09:01 (RCB=HEV0408).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0410
AC   CVCL_T249
DR   RCB; HEV0410
DR   Wikidata; Q54883167
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   HLA typing: A*02:01,11:01; B*44:03,67:01; C*07:02,14:03; DPB1*02:02,09:01; DQB1*05:02,06:01; DRB1*15:02,16:02 (RCB=HEV0410).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0415
AC   CVCL_T250
DR   CLO; CLO_0051358
DR   RCB; HEV0415
DR   Wikidata; Q54883168
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:06; B*51:01; C*14:02; DPB1*02:01,03:01; DQB1*03:01,04:02; DRB1*04:10,14:03 (RCB=HEV0415).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0421
AC   CVCL_T251
DR   RCB; HEV0421
DR   Wikidata; Q54883169
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   HLA typing: A*02:01,11:01; B*40:01,48:01; C*03:04,08:03; DPB1*02:01; DQB1*03:03,06:02; DRB1*09:01,15:01 (RCB=HEV0421).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0424
AC   CVCL_T252
DR   RCB; HEV0424
DR   Wikidata; Q54883170
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0425
AC   CVCL_DE87
DR   RCB; HEV0425
DR   Wikidata; Q54883171
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0428
AC   CVCL_T253
DR   CLO; CLO_0051322
DR   RCB; HEV0428
DR   Wikidata; Q54883172
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*40:02,52:01; C*03:04,12:02; DPB1*02:01,09:01; DQB1*03:02,06:01; DRB1*08:02,15:02 (RCB=HEV0428).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0430
AC   CVCL_T254
DR   RCB; HEV0430
DR   Wikidata; Q54883173
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0431
AC   CVCL_T255
DR   CLO; CLO_0051359
DR   RCB; HEV0431
DR   Wikidata; Q54883174
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0436
AC   CVCL_T256
DR   RCB; HEV0436
DR   Wikidata; Q54883175
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*35:01,46:01; C*01:02,03:03; DPB1*02:02,05:01; DQB1*06:01,06:02; DRB1*08:03,15:01 (RCB=HEV0436).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0438
AC   CVCL_DE88
DR   RCB; HEV0438
DR   Wikidata; Q54883176
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0440
AC   CVCL_T257
DR   CLO; CLO_0051323
DR   RCB; HEV0440
DR   Wikidata; Q54883177
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,26:01; B*40:02,54:01; C*01:02,03:04; DPB1*05:01; DQB1*03:03,05:01; DRB1*01:01,09:01 (RCB=HEV0440).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0442
AC   CVCL_T258
DR   CLO; CLO_0051349
DR   RCB; HEV0442
DR   Wikidata; Q54883178
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*15:11,59:01; C*01:02,03:03; DPB1*02:02,04:02; DQB1*03:01,04:01; DRB1*04:05,12:01 (RCB=HEV0442).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0444
AC   CVCL_T259
DR   CLO; CLO_0051360
DR   RCB; HEV0444
DR   Wikidata; Q54883179
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0445
AC   CVCL_DE57
DR   RCB; HEV0445
DR   Wikidata; Q54883180
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a vaginal cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0448
AC   CVCL_T260
DR   CLO; CLO_0051324
DR   RCB; HEV0448
DR   Wikidata; Q54883181
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,26:01; B*40:01,40:02; C*03:04,15:02; DPB1*04:01,13:01; DQB1*03:03,06:01; DRB1*08:03,09:01 (RCB=HEV0448).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0451
AC   CVCL_T261
DR   CLO; CLO_0051361
DR   RCB; HEV0451
DR   Wikidata; Q54883182
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0455
AC   CVCL_T262
DR   CLO; CLO_0051325
DR   RCB; HEV0455
DR   Wikidata; Q54883183
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,11:01; B*13:01,48:01; C*03:04,08:03; DPB1*02:01; DQB1*03:01; DRB1*12:02,15:01 (RCB=HEV0455).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0456
AC   CVCL_T263
DR   RCB; HEV0456
DR   Wikidata; Q54883184
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0459
AC   CVCL_T264
DR   RCB; HEV0459
DR   Wikidata; Q54883185
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0463
AC   CVCL_T265
DR   CLO; CLO_0051326
DR   RCB; HEV0463
DR   Wikidata; Q54883186
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*15:11,52:01; C*03:03,12:02; DPB1*05:01;09:01; DQB1*03:03,06:01; DRB1*09:01,15:02 (RCB=HEV0463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0465
AC   CVCL_T266
DR   RCB; HEV0465
DR   Wikidata; Q54883187
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0466
AC   CVCL_DE89
DR   RCB; HEV0466
DR   Wikidata; Q54883188
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0469
AC   CVCL_T267
DR   CLO; CLO_0051211
DR   RCB; HEV0469
DR   Wikidata; Q54883189
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*11:01,31:01; B*15:01; C*03:04,04:01; DPB1*02:01; DQB1*03:02; DRB1*04:06,11:01 (RCB=HEV0469).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0470
AC   CVCL_T268
DR   RCB; HEV0470
DR   Wikidata; Q54883190
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0477
AC   CVCL_T269
DR   CLO; CLO_0051365
DR   RCB; HEV0477
DR   Wikidata; Q54883191
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*26:01,31:01; B*48:01,51:01; C*03:03,14:02; DPB1*02:01,05:01; DQB1*04:02,06:01; DRB1*08:02,08:03 (RCB=HEV0477).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0482
AC   CVCL_T270
DR   CLO; CLO_0051327
DR   RCB; HEV0482
DR   Wikidata; Q54883192
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*15:11,52:01; C*03:03,12:02; DPB1*05:01,13:01; DQB1*03:01,06:01; DRB1*14:54,15:02 (RCB=HEV0482).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0485
AC   CVCL_T271
DR   CLO; CLO_0051352
DR   RCB; HEV0485
DR   Wikidata; Q54883193
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*39:01,48:01; C*07:02,08:01; DPB1*02:01,02:02; DQB1*03:01,04:01; DRB1*04:05,11:01 (RCB=HEV0485).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0487
AC   CVCL_T272
DR   CLO; CLO_0051362
DR   RCB; HEV0487
DR   Wikidata; Q54883194
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a breast cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HEV0492
AC   CVCL_T273
DR   CLO; CLO_0051328
DR   RCB; HEV0492
DR   Wikidata; Q54883201
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*35:01,52:01; C*04:01,12:02; DPB1*02:01,05:01; DQB1*03:03,06:01; DRB1*09:01,15:02 (RCB=HEV0492).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0496
AC   CVCL_T274
DR   CLO; CLO_0051329
DR   RCB; HEV0496
DR   Wikidata; Q54883202
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02; B*40:01,52:01; C*03:04,12:02; DPB1*02:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (RCB=HEV0496).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HEV0498
AC   CVCL_T275
DR   RCB; HEV0498
DR   Wikidata; Q54883203
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Chinese; Han and Japanese.
CC   HLA typing: A*24:02,26:02; B*07:43,40:02; C*03:04,07:02; DPB1*02:01; DQB1*02:02,05:03; DRB1*07:01,14:54 (RCB=HEV0498).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEV0499
AC   CVCL_DE90
DR   RCB; HEV0499
DR   Wikidata; Q54883205
RX   PubMed=16260175;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a cervical cancer patient.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   HEV0500
AC   CVCL_T276
DR   RCB; HEV0500
DR   Wikidata; Q54883206
RX   PubMed=16260175;
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka and Japanese.
CC   HLA typing: A*02:01,02:07; B*15:01,46:01; C*01:02,03:03; DPB1*02:02,05:01; DQB1*03:03,06:01; DRB1*08:03,09:01 (RCB=HEV0500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HEVE-II
AC   CVCL_Y193
DR   Cosmic; 1590841
DR   Wikidata; Q54883208
RX   CelloPub=CLPUB00412;
RX   PubMed=22038905;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 9
//
ID   HEW
AC   CVCL_R907
SY   Haddock Embryo Waterloo
DR   Wikidata; Q54883209
RX   PubMed=16909215;
RX   PubMed=24357037;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8056; ! Melanogrammus aeglefinus (Haddock)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   Hewga-CCS
AC   CVCL_0J32
DR   Wikidata; Q54883210
RX   PubMed=24946937;
RX   PubMed=28745431;
CC   Population: Japanese.
CC   Doubling time: ~44 hours (PubMed=24946937).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 2: EWSR1 exon 7 fused to ATF1 exon 5 (PubMed=24946937; PubMed=28745431).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   HEY
AC   CVCL_0297
SY   Hey
DR   BTO; BTO_0002590
DR   EFO; EFO_0006580
DR   MCCL; MCC:0000188
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 866
DR   BioSample; SAMN03473280
DR   cancercelllines; CVCL_0297
DR   Cell_Model_Passport; SIDM00968
DR   ChEMBL-Cells; CHEMBL3308082
DR   ChEMBL-Targets; CHEMBL613869
DR   CLS; 305017
DR   Cosmic; 1102812
DR   Cosmic; 1524358
DR   Cosmic-CLP; 1479988
DR   DepMap; ACH-002140
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1479988
DR   GEO; GSM659377
DR   GEO; GSM1340581
DR   GEO; GSM1669880
DR   IARC_TP53; 28489
DR   PharmacoDB; HEY_541_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_0297
DR   Wikidata; Q54883211
RX   PubMed=3731068;
RX   PubMed=4016745;
RX   PubMed=12960427;
RX   PubMed=19926575;
RX   PubMed=20204287;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Cedarlane; CLU302; https://www.cedarlanelabs.com/Products/Detail/CLU302?lob=AllProducts
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=4016745); 20.53 hours (JWGray panel).
CC   HLA typing: A*02:01,29:02; B*44:02,45:01; C*05:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (Cosmic-CLP=1479988; DepMap=ACH-002140).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=1479988; DepMap=ACH-002140).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.88%; Native American=0.22%; East Asian, North=0.66%; East Asian, South=0.27%; South Asian=0%; European, North=67.37%; European, South=30.59% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1479988; PubMed=22710073; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 11,12 (Cosmic-CLP=1479988; PubMed=22710073; PubMed=25877200)
ST   D5S818: 11,12,13 (PubMed=30485824)
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 9,13
ST   Penta E: 7,13
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4995 ! HX/62
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   HEY A4
AC   CVCL_L041
DR   cancercelllines; CVCL_L041
DR   Wikidata; Q54883212
RX   PubMed=2394835;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   HEY A8
AC   CVCL_8878
SY   HEY-A8; Hey-A8; Hey A8; HEYA8; HeyA8; Heya8
DR   BTO; BTO_0006454
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 715
DR   BioSample; SAMN10988247
DR   cancercelllines; CVCL_8878
DR   Cell_Model_Passport; SIDM01215
DR   Cosmic; 1305329
DR   DepMap; ACH-000542
DR   GEO; GSM851918
DR   GEO; GSM887080
DR   GEO; GSM888150
DR   IARC_TP53; 30038
DR   LiGeA; CCLE_702
DR   PharmacoDB; HeyA8_542_2019
DR   PRIDE; PXD003668
DR   Progenetix; CVCL_8878
DR   Wikidata; Q54883213
RX   PubMed=2394835;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=23839242;
RX   PubMed=25984343;
RX   PubMed=27235858;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 16 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (DepMap=ACH-000542).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000542).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.54%; Native American=0%; East Asian, North=2.65%; East Asian, South=0%; South Asian=0%; European, North=62.34%; European, South=33.46% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   HEY AS1
AC   CVCL_L040
DR   cancercelllines; CVCL_L040
DR   Wikidata; Q54883214
RX   PubMed=2394835;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   HEY C2
AC   CVCL_X009
SY   HEY-C2; Hey-C2; Hey C2; HEYC2; HeyC2
DR   cancercelllines; CVCL_X009
DR   Cell_Model_Passport; SIDM01216
DR   GEO; GSM659378
DR   GEO; GSM1340582
DR   Wikidata; Q54883215
RX   PubMed=22710073;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   HEY-1B
AC   CVCL_AZ64
SY   HEY1B; Hey1b
DR   BTO; BTO_0005706
DR   cancercelllines; CVCL_AZ64
DR   Wikidata; Q54883216
RX   PubMed=3731068;
RX   PubMed=10637068;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   HEY-T30
AC   CVCL_2Z96
DR   ATCC; CRL-3252
DR   cancercelllines; CVCL_2Z96
DR   Wikidata; Q54883217
RX   PubMed=20404007;
CC   Population: Caucasian.
CC   Doubling time: ~18-22 hours (ATCC=CRL-3252).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=CRL-3252
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   HEY/GFP
AC   CVCL_JZ11
DR   cancercelllines; CVCL_JZ11
DR   Cell_Biolabs; AKR-205
DR   Wikidata; Q54883218
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Cell_Biolabs; AKR-205; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0297 ! HEY
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   HeyA8-IP
AC   CVCL_IW34
SY   HEYA8IP
DR   cancercelllines; CVCL_IW34
DR   Wikidata; Q54883219
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Established from a passage from a mouse intra peritoneal injected tumor.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8878 ! HEY A8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 14
//
ID   HeyA8-MDR
AC   CVCL_8879
SY   HEYA8MDR
DR   cancercelllines; CVCL_8879
DR   Wikidata; Q54883220
RX   PubMed=16951177;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8878 ! HEY A8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   HF
AC   CVCL_UI84
DR   ATCC; CRL-3383
DR   Wikidata; Q94113023
RX   PubMed=20664054;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
CC   Population: Caucasian.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3383
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 6
//
ID   HF 277.Mu
AC   CVCL_S096
DR   ATCC; CRL-7699
DR   Wikidata; Q54883221
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7699; true.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   HF 282
AC   CVCL_S092
DR   ATCC; CRL-7700
DR   Wikidata; Q54883222
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7700; true.
CC   Derived from site: In situ; Fetal colon; UBERON=UBERON_0001155.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3703 ! HF 282.Sp
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   HF 282.Sp
AC   CVCL_3703
DR   CLO; CLO_0003720
DR   ATCC; CRL-7701
DR   Wikidata; Q54883223
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7701; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S092 ! HF 282
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   HF 322.Li
AC   CVCL_S094
DR   ATCC; CRL-7705
DR   Wikidata; Q54883224
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7705; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S093 ! HF 322.Lu
OI   CVCL_3704 ! HF 322.Sk
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   HF 322.Lu
AC   CVCL_S093
DR   ATCC; CRL-7704
DR   Wikidata; Q54883225
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7704; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S094 ! HF 322.Li
OI   CVCL_3704 ! HF 322.Sk
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   HF 322.Sk
AC   CVCL_3704
DR   CLO; CLO_0003721
DR   ATCC; CRL-7703
DR   BioSample; SAMN03472812
DR   Wikidata; Q54883226
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7703; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7703
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D5S818: 9,13,15
ST   D7S820: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S094 ! HF 322.Li
OI   CVCL_S093 ! HF 322.Lu
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   HF 333.We
AC   CVCL_3705
DR   CLO; CLO_0003722
DR   ATCC; CRL-7706
DR   BioSample; SAMN03471139
DR   Wikidata; Q54883227
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7706; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7706
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   HF 344.Ht
AC   CVCL_S095
DR   ATCC; CRL-7707
DR   Wikidata; Q54883228
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7707; true.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   HF 345.We
AC   CVCL_3706
DR   CLO; CLO_0003723
DR   ATCC; CRL-7708
DR   Wikidata; Q54883229
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7708; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   HF 358.We
AC   CVCL_3707
DR   CLO; CLO_0003724
DR   ATCC; CRL-7709
DR   BioSample; SAMN03471140
DR   Wikidata; Q54883230
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7709; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
ST   Source(s): ATCC=CRL-7709
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,15
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   HF-1 [Human follicular lymphoma]
AC   CVCL_M656
DR   Wikidata; Q54883231
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7631145;
RX   PubMed=7696202;
RX   PubMed=8119385;
RX   PubMed=26727417;
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, centroblastic-type.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 13
//
ID   HF-1 [Human foreskin]
AC   CVCL_QY01
SY   Human Foreskin-1
DR   ATCC; CRL-2867
DR   BioSample; SAMN03471806
DR   Wikidata; Q54883232
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-2867; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): ATCC=CRL-2867
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 8
//
ID   HF-1 [Paralichthys]
AC   CVCL_WZ22
SY   Hirame Fin-1
DR   Wikidata; Q94113332
RX   CelloPub=CLPUB00103;
RX   DOI=10.3354/dao001209;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 7
//
ID   HF-1.3.4
AC   CVCL_M661
DR   Wikidata; Q54883233
RX   PubMed=7631145;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M656 ! HF-1 [Human follicular lymphoma]
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   HF-1A3
AC   CVCL_M662
SY   HF1A3
DR   Wikidata; Q54883234
RX   PubMed=12791092;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M656 ! HF-1 [Human follicular lymphoma]
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   HF-28
AC   CVCL_M663
SY   HF28
DR   Wikidata; Q54883235
RX   PubMed=12791092;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   HF-4
AC   CVCL_B6CE
DR   Wikidata; Q111733394
RX   DOI=10.1080/00021369.1986.10867575;
RX   PubMed=3804938;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   HF-4.9
AC   CVCL_M664
SY   HF-4-9
DR   Wikidata; Q54883236
RX   PubMed=12791092;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M657 ! HF-4b
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   HF-4a
AC   CVCL_M660
SY   HF-9
DR   Wikidata; Q54883237
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7696202;
RX   PubMed=8119385;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M657 ! HF-4b
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   HF-4b
AC   CVCL_M657
SY   HF-4
DR   Wikidata; Q54883238
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7696202;
RX   PubMed=8119385;
RX   PubMed=12791092;
RX   PubMed=26727417;
CC   Miscellaneous: Originally assigned to be from a mantle cell lymphoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M660 ! HF-4a
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   HF-7
AC   CVCL_B6CF
DR   Wikidata; Q111733395
RX   DOI=10.1080/00021369.1986.10867575;
RX   PubMed=3804938;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   HF-99/5
AC   CVCL_C6K1
DR   Wikidata; Q116049314
RX   DOI=10.15496/publikation-48348;
CC   From: Neumann-Haefelin, Dieter & Kapper-Falcone, Valeria; Institute of Virology, Medical Center University of Freiburg; Freiburg; Germany.
CC   HLA typing: A*11:01,24:02; B*08:01,52:01; C*07:01,12:02 (DOI=10.15496/publikation-48348).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   HF-99/7
AC   CVCL_C6K0
DR   PRIDE; PXD013120
DR   Wikidata; Q116049315
RX   DOI=10.15496/publikation-48348;
RX   PubMed=31869419;
CC   From: Neumann-Haefelin, Dieter & Kapper-Falcone, Valeria; Institute of Virology, Medical Center University of Freiburg; Freiburg; Germany.
CC   HLA typing: A*01:01,03:01; B*08:01,51:01; C*01:02,07:01 (DOI=10.15496/publikation-48348).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   HF1
AC   CVCL_4227
DR   CLO; CLO_0003725
DR   CLDB; cl1666
DR   ECACC; 94101908
DR   Wikidata; Q54883239
RX   PubMed=6932027;
CC   Doubling time: 23 hours (PubMed=6932027).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
HI   CVCL_4212 ! H5
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 5
//
ID   HF1-5
AC   CVCL_4228
SY   HF1.5
DR   CLO; CLO_0003726
DR   CLDB; cl1665
DR   ECACC; 94101909
DR   Wikidata; Q54883240
RX   PubMed=6378929;
RX   PubMed=6932027;
CC   Characteristics: Selected for it's ability to grow in glucose free medium (ECACC=94101909).
CC   Doubling time: 34 hours (PubMed=6932027).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4227 ! HF1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 5
//
ID   HF1-H1
AC   CVCL_E2VR
RX   PubMed=5801069;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E2VS ! HF1-L2
SX   Male
AG   8FW
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HF1-L2
AC   CVCL_E2VS
RX   PubMed=5801069;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E2VR ! HF1-H1
SX   Male
AG   8FW
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HF10B4
AC   CVCL_C473
DR   CLO; CLO_0050276
DR   RCB; RCB0708
DR   Wikidata; Q54883241
RX   PubMed=1368811;
RX   PubMed=1369345;
RX   PubMed=3902783;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on lung cancer cell lines.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U821 ! NAT-30
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   HF10F7
AC   CVCL_4Y78
DR   Wikidata; Q54883242
RX   PubMed=3902783;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on lung cancer cell lines.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U821 ! NAT-30
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   HF19
AC   CVCL_2487
SY   HF 19; HF-19
DR   BTO; BTO_0006399
DR   CLO; CLO_0003719
DR   CLO; CLO_0003727
DR   CLO; CLO_0050054
DR   CLDB; cl1663
DR   CLDB; cl1664
DR   BioSample; SAMN03472346
DR   ECACC; 85011418
DR   RCB; RCB0210
DR   Wikidata; Q54883247
RX   PubMed=301865;
RX   PubMed=2973075;
RX   PubMed=6968735;
RX   PubMed=8609460;
RX   PubMed=8609461;
RX   PubMed=17395773;
CC   Senescence: Senesces at 16 PDL (PubMed=17395773).
CC   Doubling time: 24 hours (PubMed=8609460).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ECACC=85011418; RCB=RCB0210
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,13
ST   D16S539: 13,14
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HF2303
AC   CVCL_C8P8
SY   HF-2303
DR   BTO; BTO_0006543
DR   Wikidata; Q123031641
RX   PubMed=27564115;
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 179 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HF2381
AC   CVCL_C8P9
DR   Wikidata; Q123031642
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 153 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2414
AC   CVCL_C8PA
DR   Wikidata; Q123031643
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2476
AC   CVCL_C8PB
DR   Wikidata; Q123031645
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 122 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2485
AC   CVCL_C8PC
DR   Wikidata; Q123031646
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2561
AC   CVCL_C8PD
DR   Wikidata; Q123031647
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2562
AC   CVCL_C8PE
DR   Wikidata; Q123031648
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 165 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2575
AC   CVCL_C8PF
DR   Wikidata; Q123031649
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 87 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2609
AC   CVCL_C8PG
DR   Wikidata; Q123031650
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   HF2790
AC   CVCL_C8PH
DR   Wikidata; Q123031651
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 143 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HF2876
AC   CVCL_C8PI
DR   Wikidata; Q123031652
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 97 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2885
AC   CVCL_C8PJ
DR   Wikidata; Q123031653
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 173 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2906
AC   CVCL_C8PK
DR   Wikidata; Q123031655
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 226 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HF2941
AC   CVCL_C8PL
DR   Wikidata; Q123031656
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 85 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2998
AC   CVCL_C8PM
DR   Wikidata; Q123031657
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 87 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF2FF-PI 14
AC   CVCL_9W01
DR   NCBI_Iran; C190
DR   Wikidata; Q54883248
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HF2x653
AC   CVCL_2488
DR   CLO; CLO_0003728
DR   CLDB; cl1667
DR   ECACC; 90012609
DR   NCBI_Iran; C150
DR   Wikidata; Q54883249
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
HI   CVCL_6741 ! WI-L2-729HF2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   HF3013
AC   CVCL_C8PN
DR   Wikidata; Q123031658
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 91 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HF3019
AC   CVCL_C8PP
DR   Wikidata; Q123031659
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 77 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF3026
AC   CVCL_C8PQ
DR   Wikidata; Q123031660
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 84 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF3037
AC   CVCL_C8PR
DR   Wikidata; Q123031661
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 117 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF3177
AC   CVCL_C8PS
DR   Wikidata; Q123031662
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 185 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HF3216
AC   CVCL_C8PT
DR   Wikidata; Q123031663
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF3309
AC   CVCL_C8PU
DR   Wikidata; Q123031664
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 625 hours (PubMed=32064048).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HF3373
AC   CVCL_C8PV
DR   Wikidata; Q123031665
RX   PubMed=32064048;
CC   Group: Cancer stem cell line.
CC   Doubling time: 134 hours (PubMed=32064048).
CC   Miscellaneous: Established both as a cell culture and a neurosphere.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF5205
AC   CVCL_C8ZV
DR   Wikidata; Q123031666
RX   PubMed=38089093;
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Somatic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HF6
AC   CVCL_F0W7
RX   PubMed=6932027;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
HI   CVCL_4212 ! H5
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HF6562
AC   CVCL_C8ZT
DR   Wikidata; Q123031667
RX   PubMed=30995489;
RX   PubMed=38089093;
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Somatic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HF6562-Cas9
AC   CVCL_C8ZW
DR   BioGRID_ORCS_Cell_line; 1065
DR   Wikidata; Q123031668
RX   PubMed=30995489;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZT ! HF6562
AG   Fetus
CA   Somatic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HF7450
AC   CVCL_C8ZU
DR   Wikidata; Q123031669
RX   PubMed=30995489;
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Somatic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HF7450-Cas9
AC   CVCL_C8ZX
DR   BioGRID_ORCS_Cell_line; 1066
DR   Wikidata; Q123031670
RX   PubMed=30995489;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8ZU ! HF7450
AG   Fetus
CA   Somatic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HFAE-2
AC   CVCL_3437
SY   Human Femoral Artery Endothelial-2; WC00099
DR   CLO; CLO_0003729
DR   ATCC; CRL-2474
DR   Coriell; WC00099
DR   Wikidata; Q54883250
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2474; true.
CC   Discontinued: Coriell; WC00099; probable.
CC   Derived from site: In situ; Femoral artery; UBERON=UBERON_0002060.
CC   Cell type: Endothelial cell of artery; CL=CL_1000413.
ST   Source(s): ATCC=CRL-2474
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3693 ! HAAE-2
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HFB-1
AC   CVCL_6257
SY   HFB1; Human Fusion B cell-1
DR   Wikidata; Q54883251
RX   PubMed=3106068;
RX   PubMed=6126667;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HFB-1
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 10-12 hours (PubMed=6126667).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   HFB-ES
AC   CVCL_A8VQ
SY   Heteropneustes Fossilis Blastula-Embryonic Stem
DR   Wikidata; Q108820464
RX   PubMed=24574890;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=93621; ! Heteropneustes fossilis (Stinging catfish)
SX   Sex unspecified
AG   Blastula stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   HFb16d
AC   CVCL_2941
DR   BioSample; SAMN03472530
DR   JCRB; JCRB1008
DR   JCRB; NIHS0241
DR   Wikidata; Q54883252
CC   Doubling time: ~3 days (Note=Lot 12152003) (JCRB=JCRB1008).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0241; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): JCRB=JCRB1008
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HFE7A
AC   CVCL_E4S2
DR   ABCD; ABCD_AD823
RX   Patent=EP0909816A1;
RX   PubMed=10744657;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5828.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HFF
AC   CVCL_XB54
SY   Human Foreskin Fibroblast
DR   Wikidata; Q94113639
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000036). It was the sole source of information for this entry.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 22
ST   D3S1358: 15,16
ST   D5S818: 9,15
ST   D7S820: 8,11
ST   D8S1179: 12,16
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 9
//
ID   HFF Heart
AC   CVCL_9T06
SY   HFF HEART; Human Fetal Fibroblast from Heart
DR   IZSLER; BS CL 160
DR   Wikidata; Q54883253
CC   Discontinued: IZSLER; BS CL 160; probable.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 7
//
ID   HFF Liver
AC   CVCL_9T07
SY   HFF LIVER; Human Fetal Fibroblast from Liver
DR   IZSLER; BS CL 158
DR   Wikidata; Q54883254
CC   Discontinued: IZSLER; BS CL 158; probable.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HFF-1
AC   CVCL_3285
SY   HFF1
DR   BTO; BTO_0004784
DR   CLO; CLO_0003730
DR   ATCC; SCRC-1041
DR   BCRJ; 0275
DR   BioSample; SAMN03471935
DR   CCRID; 3101HUMSCSP109
DR   ChEMBL-Cells; CHEMBL4295455
DR   ChEMBL-Targets; CHEMBL4296427
DR   IARC_TP53; 28245
DR   Lonza; 1293
DR   PubChem_Cell_line; CVCL_3285
DR   Ubigene; YC-C069
DR   Wikidata; Q54883255
RX   PubMed=18415935;
CC   Donor information: Established from foreskin pooled from two individuals (ATCC=SCRC-1041).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=SCRC-1041
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11,12,13
ST   D13S317: 11,13
ST   D16S539: 10,12
ST   D18S51: 10,13,16
ST   D19S433: 13,14,15
ST   D21S11: 28,30,32.2
ST   D2S1338: 17,19,20
ST   D3S1358: 15,17,18
ST   D5S818: 11
ST   D7S820: 9,10,12
ST   D8S1179: 10,14,15
ST   FGA: 19,21,22,25
ST   Penta D: 9,12,13,16
ST   Penta E: 7,12,21
ST   TH01: 7,9,9.3
ST   TPOX: 8,11
ST   vWA: 14,15,17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   HFF-1 IRR
AC   CVCL_F285
DR   ATCC; SCRC-1041.1
DR   Wikidata; Q54883256
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 6000 rads.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=SCRC-1041.1
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11,12,13
ST   D13S317: 11,13
ST   D16S539: 10,12
ST   D18S51: 10,13,16
ST   D19S433: 13,14,15
ST   D21S11: 28,30,32.2
ST   D2S1338: 17,19,20
ST   D3S1358: 15,17,18
ST   D5S818: 11
ST   D7S820: 9,10,12
ST   D8S1179: 10,14,15
ST   FGA: 19,21,22,25
ST   Penta D: 9,12,13,16
ST   Penta E: 7,12,21
ST   TH01: 7,9,9.3
ST   TPOX: 8,11
ST   vWA: 14,15,17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 11
//
ID   HFF-1 MITC
AC   CVCL_F286
DR   ATCC; SCRC-1041.2
DR   Wikidata; Q54883257
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Discontinued: ATCC; SCRC-1041.2; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   HFF-2
AC   CVCL_3286
SY   HFF2
DR   CLO; CLO_0003731
DR   ATCC; SCRC-1042
DR   Wikidata; Q54883258
RX   PubMed=18415935;
CC   Donor information: Established from foreskin pooled from four individuals (ATCC=SCRC-1042).
CC   Discontinued: ATCC; SCRC-1042; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   HFF-2 IRR
AC   CVCL_A5UE
DR   ATCC; SCRC-1042.1
DR   Wikidata; Q107115343
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 6000 rads.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: ATCC; SCRC-1042.1; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3286 ! HFF-2
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   HFF-2 MITC
AC   CVCL_N793
DR   ATCC; SCRC-1042.2
DR   Wikidata; Q54883259
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Discontinued: ATCC; SCRC-1042.2; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3286 ! HFF-2
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 9
//
ID   HFF-3
AC   CVCL_DB29
DR   ATCC; SCRC-1043
DR   Wikidata; Q54883260
RX   PubMed=18415935;
CC   Discontinued: ATCC; SCRC-1043; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 7
//
ID   HFF-4
AC   CVCL_DB30
DR   ATCC; SCRC-1044
DR   Wikidata; Q54883261
RX   PubMed=18415935;
CC   Discontinued: ATCC; SCRC-1044; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 7
//
ID   HFF-6
AC   CVCL_C642
DR   Wikidata; Q54883262
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HFF-hTERT
AC   CVCL_VC40
DR   4DN; 4DNSRIX5KE1M
DR   Wikidata; Q54883263
RX   PubMed=15024073;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 7
//
ID   HFF-hTERT clone 6
AC   CVCL_VC41
SY   HFF-hTert-clone 6; HFFc6
DR   EFO; EFO_0009318
DR   4DN; 4DNSRC6ZVYVP
DR   ENCODE; ENCBS647URW
DR   ENCODE; ENCBS756WUB
DR   Wikidata; Q54883264
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VC40 ! HFF-hTERT
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   HFF-Myc
AC   CVCL_Y511
SY   HFF-cMyc; HFF-MYC
DR   EFO; EFO_0005710
DR   ENCODE; ENCBS411AMC
DR   ENCODE; ENCBS553ENC
DR   GEO; GSM824866
DR   GEO; GSM824867
DR   GEO; GSM945239
DR   GEO; GSM945281
DR   Wikidata; Q54883266
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/HFFMyc_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:43527; Dog MYC.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 16
//
ID   HFF-PI 34
AC   CVCL_9W13
DR   NCBI_Iran; C452
DR   Wikidata; Q54883267
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HFF2/T
AC   CVCL_C866
DR   BTO; BTO_0004826
DR   Wikidata; Q54883268
RX   PubMed=16835273;
RX   PubMed=18761675;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3286 ! HFF-2
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   HFFF-PI 6
AC   CVCL_9V94
SY   HFFF-PI6; HFFF
DR   NCBI_Iran; C170
DR   Wikidata; Q54883269
RX   CelloPub=CLPUB00310;
RX   PubMed=17254797;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D21S11: 30
ST   D3S1358: 17,20
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 24,28,31
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V33 ! HFLF-PI 4
OI   CVCL_9V95 ! HFLF-PI 5
OI   CVCL_9V96 ! HFSF-PI 3
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HFFF2
AC   CVCL_2489
SY   Human Fetal Foreskin Fibroblast 2
DR   CLO; CLO_0003732
DR   CLDB; cl1668
DR   CLDB; cl1669
DR   CCRID; 5301HUM-KCB15020YJ
DR   ECACC; 86031405
DR   ICLC; HL95002
DR   KCB; KCB 2015020YJ
DR   Lonza; 278
DR   NCBI_Iran; C163
DR   Wikidata; Q54883270
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-367.html
CC   Population: Caucasian.
CC   Senescence: Senesces at ~16 PDL (ECACC=86031405).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ECACC=86031405
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14-18FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   HFH(M)
AC   CVCL_UW63
DR   Wikidata; Q94113928
RX   PubMed=8120409;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS32 ! HFH-18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   HFH-14
AC   CVCL_GS31
SY   HFH14
DR   Wikidata; Q54883271
RX   PubMed=14234007;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_GS32 ! HFH-18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   HFH-18
AC   CVCL_GS32
SY   HFH 18; HFH18
DR   Wikidata; Q54883272
RX   PubMed=3467124;
RX   PubMed=5290290;
RX   PubMed=8120409;
RX   PubMed=14234007;
CC   Misspelling: HGH18; Note=Occasionally.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_GS31 ! HFH-14
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   HFH18-15
AC   CVCL_UW60
SY   HFH 18-(15)-C
DR   Wikidata; Q94113973
RX   PubMed=3467124;
RX   PubMed=3942687;
CC   Characteristics: Melanogenic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS32 ! HFH-18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   HFH18-T2
AC   CVCL_UW61
DR   Wikidata; Q94113979
RX   PubMed=3771439;
RX   PubMed=3942687;
CC   Characteristics: Melanogenic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS32 ! HFH-18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   HFH18/IL-6(+)
AC   CVCL_UW62
DR   Wikidata; Q94113985
RX   PubMed=8120409;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96559; Il6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS32 ! HFH-18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   hFIB2-iPS2
AC   CVCL_C968
SY   HFIB2-IPS2; hFib2-iPS2
DR   Wikidata; Q54883273
RX   PubMed=18157115;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C969 ! hFIB2-iPS4
OI   CVCL_C970 ! hFIB2-iPS5
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   hFIB2-iPS4
AC   CVCL_C969
SY   HFIB2-IPS4; hFib2 iPS4; HFib2 iPS4; HFib2 iPS 4; iPS_hFib2_iPS4; hFib2-iPS4; iPS-4
DR   EFO; EFO_0007951
DR   ENCODE; ENCBS554ENC
DR   GEO; GSM659049
DR   GEO; GSM659050
DR   Wikidata; Q54883274
RX   PubMed=18600223;
RX   PubMed=21654665;
RX   PubMed=23861493;
CC   Part of: ENCODE project common cell types; tier 3.
CC   From: Children's Hospital Boston; Boston; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C968 ! hFIB2-iPS2
OI   CVCL_C970 ! hFIB2-iPS5
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   hFIB2-iPS5
AC   CVCL_C970
SY   HFIB2-IPS5; HFib2 iPS5; HFib2 iPS 5; iPS_hFib2_iPS5; hFib2_iPS5; iPS-5
DR   EFO; EFO_0007111
DR   ENCODE; ENCBS555ENC
DR   Wikidata; Q54883275
RX   PubMed=23861493;
CC   Part of: ENCODE project common cell types; tier 3.
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C968 ! hFIB2-iPS2
OI   CVCL_C969 ! hFIB2-iPS4
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HFK-1
AC   CVCL_9U04
SY   Human Fetal Kidney-1
DR   Wikidata; Q54883276
RX   PubMed=9338139;
CC   Senescence: SV40-transformed but with a finite life span.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   HFL-AE-I
AC   CVCL_4636
DR   BioSample; SAMN03472283
DR   RCB; RCB0524
DR   Wikidata; Q54883277
CC   Population: Japanese.
CC   Karyotypic information: 46,XY,17p+ or 17ph+ (RCB=RCB0524).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB0524
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 10,12,13
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HFL-AE-II
AC   CVCL_4637
DR   BioSample; SAMN03472284
DR   KCB; KCB 94010YJ
DR   RCB; RCB0525
DR   Wikidata; Q54883278
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,inv(9p+,q-) (RCB=RCB0525).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB0525
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HFL-AE-III
AC   CVCL_4638
DR   BioSample; SAMN03472213
DR   RCB; RCB0684
DR   Wikidata; Q54883279
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 54 PDL (PubMed=17395773).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB0684
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   HFL-AE-VI
AC   CVCL_4659
DR   BioSample; SAMN03472108
DR   RCB; RCB1613
DR   Wikidata; Q54883280
RX   PubMed=38639832;
CC   Population: Korean.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB1613
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 13,14
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   HFL-AE-VII
AC   CVCL_4668
DR   BioSample; SAMN03472110
DR   RCB; RCB1617
DR   Wikidata; Q54883281
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB1617
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5512 ! HFLI-AE-VII
OI   CVCL_5514 ! HFSKF-AE-VII
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   HFL-I
AC   CVCL_K101
DR   BioSample; SAMN03472280
DR   RCB; RCB0521
DR   Wikidata; Q54883282
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 44 PDL (PubMed=17395773).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000200005). It was one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): CCRID; RCB=RCB0521
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 9,14
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 18,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 16
//
ID   HFL-II
AC   CVCL_K102
DR   BioSample; SAMN03472281
DR   RCB; RCB0522
DR   Wikidata; Q54883283
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   Senescence: Senesces at 40 PDL (PubMed=17395773).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB0522
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   HFL-III
AC   CVCL_K103
DR   BioSample; SAMN03472282
DR   RCB; RCB0523
DR   Wikidata; Q54883284
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka.
CC   Senescence: Senesces at 46 PDL (PubMed=17395773).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB0523
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   HFL
AC   CVCL_C0SC
SY   Human Fetal Lung
DR   CLO; CLO_0003733
DR   CLDB; cl5200
DR   IZSLER; BS CL 116
DR   Wikidata; Q123031671
CC   From: Istituto di Medicina Sperimentale, Consiglio Nazionale delle Ricerche; Roma; Italy.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): IZSLER=BS CL 116
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,14
ST   D21S11: 28,30
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 8,10
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   HFL1
AC   CVCL_0298
AS   CVCL_4526
SY   HFL-1; HFL 1; Human fetal lung fibroblast 1
DR   BTO; BTO_0002582
DR   CLO; CLO_0003734
DR   EFO; EFO_0005368
DR   MCCL; MCC:0000189
DR   CLDB; cl1670
DR   ATCC; CCL-153
DR   BCRC; 60299
DR   BioSample; SAMN01821558
DR   BioSample; SAMN01821728
DR   BioSample; SAMN03471457
DR   CCRID; 3101HUMGNHu28
DR   CCRID; 3101HUMSCSP5049
DR   ChEMBL-Cells; CHEMBL3307970
DR   ChEMBL-Targets; CHEMBL612547
DR   CLS; 305065
DR   ECACC; 89071902
DR   GEO; GSM2141963
DR   GEO; GSM2141966
DR   GEO; GSM2141970
DR   GEO; GSM2141971
DR   GEO; GSM2141977
DR   GEO; GSM2141978
DR   GEO; GSM2141981
DR   GEO; GSM2141982
DR   GEO; GSM2141983
DR   GEO; GSM2141989
DR   GEO; GSM2141991
DR   GEO; GSM2141994
DR   GEO; GSM2142007
DR   GEO; GSM2142013
DR   GEO; GSM2142014
DR   GEO; GSM2142022
DR   GEO; GSM2142032
DR   GEO; GSM2142040
DR   GEO; GSM2142041
DR   GEO; GSM2142051
DR   JCRB; IFO50074
DR   PubChem_Cell_line; CVCL_0298
DR   Wikidata; Q54883285
RX   PubMed=7065527;
RX   PubMed=7372635;
RX   PubMed=22481983;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/passage-limits-of-atcc-ccl-153-cells
CC   Population: Caucasian.
CC   Senescence: Capable of at least 57 PDL (JCRB=IFO50074).
CC   Doubling time: ~31 hours (Note=Lot 10092015) (JCRB=IFO50074).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-153; BCRC=60299; CLS=305065; ECACC=89071902; JCRB=IFO50074
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 20,21
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 18,19
ST   D19S433: 11,13
ST   D21S11: 27,30
ST   D2S1338: 17,25
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D6S1043: 11,18
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 2.2,9
ST   Penta E: 12,20
ST   TH01: 7,9
ST   TPOX: 6,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   HFL9t
AC   CVCL_B503
DR   BioSample; SAMN03472151
DR   RCB; RCB1541
DR   Wikidata; Q54883286
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB1541
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B504 ! HFSK9t
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HFLF-PI 4
AC   CVCL_9V33
SY   HFLF-PI4; HFLF
DR   NCBI_Iran; C168
DR   Wikidata; Q54883287
RX   CelloPub=CLPUB00310;
RX   PubMed=17254797;
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D21S11: 30
ST   D3S1358: 17,20
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 24,28,31
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V94 ! HFFF-PI 6
OI   CVCL_9V95 ! HFLF-PI 5
OI   CVCL_9V96 ! HFSF-PI 3
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HFLF-PI 5
AC   CVCL_9V95
SY   HFLF-PI5; HFLGF
DR   NCBI_Iran; C169
DR   Wikidata; Q54883294
RX   CelloPub=CLPUB00310;
RX   PubMed=17254797;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D21S11: 30
ST   D3S1358: 17,20
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 14,15
ST   FGA: 24,28,31
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V94 ! HFFF-PI 6
OI   CVCL_9V33 ! HFLF-PI 4
OI   CVCL_9V96 ! HFSF-PI 3
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HFLI-AE-VII
AC   CVCL_5512
DR   RCB; RCB1618
DR   Wikidata; Q54883295
CC   Population: Chinese/Asian ethnic group; Hakka.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB1618
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4668 ! HFL-AE-VII
OI   CVCL_5514 ! HFSKF-AE-VII
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   HFLT
AC   CVCL_BT03
SY   Human Fetal Lung Transformed
DR   Wikidata; Q54883297
RX   PubMed=3769747;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BT02 ! 2BS
SX   Female
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   HFLung
AC   CVCL_9T08
SY   Human Fetal Lung
DR   IZSLER; BS CL 159
DR   Wikidata; Q54883296
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): IZSLER=BS CL 159
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11,14
ST   D21S11: 30,31.2
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 8
//
ID   HFM-01
AC   CVCL_WB24
SY   Human Fetal Membrane-01
DR   IBRC; C10636
DR   Wikidata; Q94114213
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   HFM-02
AC   CVCL_WB25
SY   Human Fetal Membrane-02
DR   IBRC; C10637
DR   Wikidata; Q94114217
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   HFMG1
AC   CVCL_C7H7
SY   HFMG-1; 1.10.F3; 1-10-F3
DR   Wikidata; Q117704484
RX   PubMed=7309278;
RX   PubMed=7682986;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   HFN 36.3
AC   CVCL_E979
SY   HFN36.3
DR   CLO; CLO_0003735
DR   ATCC; CRL-1605
DR   ATCC; HB-40
DR   BCRJ; 0312
DR   ECACC; 89062006
DR   Wikidata; Q54883298
RX   PubMed=6208125;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
CC   Discontinued: ATCC; HB-40; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   HFN 7.1
AC   CVCL_E980
SY   HFN7.1
DR   CLO; CLO_0003736
DR   ATCC; CRL-1606
DR   ATCC; HB-39
DR   ECACC; 89062001
DR   Wikidata; Q54883299
RX   PubMed=6208125;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
CC   Discontinued: ATCC; HB-39; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   hFOB 1.19
AC   CVCL_3708
SY   hFOB1.19; hFOB
DR   BTO; BTO_0004827
DR   BTO; BTO_0005224
DR   CLO; CLO_0003737
DR   ABM; T0007
DR   AddexBio; T0004005/4973
DR   ATCC; CRL-3602
DR   ATCC; CRL-11372
DR   BCRC; 60357
DR   BioSample; SAMN03471334
DR   CCRID; 3101HUMGNHu14
DR   CLS; 305069
DR   GEO; GSM320833
DR   IZSLER; BS CL 198
DR   TOKU-E; 1462
DR   Wikidata; Q54883300
RX   Patent=US5693511;
RX   PubMed=7754797;
RX   PubMed=10719274;
RX   PubMed=12210717;
CC   Group: Patented cell line.
CC   Group: Space-flown cell line (cellonaut).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11372.
CC   Doubling time: 36 hours (Note=At permissive temperature of 33.5 Celsius) (ATCC=CRL-11372).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Anecdotal: Have been flown in space on shuttle flight STS-80 to study growth in microgravity (PubMed=10719274).
CC   Discontinued: ABM; T0007; true.
CC   Discontinued: ATCC; CRL-11372; true.
CC   Discontinued: CLS; 305069; true.
CC   Derived from site: In situ; Fetal bone, limb; UBERON=UBERON_0002428.
CC   Cell type: Osteoblast; CL=CL_0000062.
ST   Source(s): AddexBio=T0004005/4973; ATCC=CRL-3602; CCRID=3101HUMGNHu14
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 20,23
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 10,17
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 23,24
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D6S1043: 13,16
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 19,22
ST   Penta E: 8,11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   hFOB/ER9
AC   CVCL_DG20
DR   Wikidata; Q54883301
RX   PubMed=8904314;
RX   PubMed=12210717;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Fetal bone, limb; UBERON=UBERON_0002428.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3708 ! hFOB 1.19
SX   Female
AG   Fetus
CA   Conditionally immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   HFSF-PI 3
AC   CVCL_9V96
SY   HFSF-PI3; HFSF
DR   NCBI_Iran; C167
DR   Wikidata; Q54883302
RX   CelloPub=CLPUB00310;
RX   PubMed=17254797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D21S11: 31
ST   D3S1358: 17,20
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 24,28
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V94 ! HFFF-PI 6
OI   CVCL_9V33 ! HFLF-PI 4
OI   CVCL_9V95 ! HFLF-PI 5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HFSK9t
AC   CVCL_B504
DR   RCB; RCB1542
DR   Wikidata; Q54883303
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84282; Trisomy 9
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B503 ! HFL9t
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   HFSKF-AE-V
AC   CVCL_5513
DR   BioSample; SAMN03472158
DR   RCB; RCB1139
DR   Wikidata; Q54883304
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 30 PDL (PubMed=17395773).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB1139
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   HFSKF-AE-VII
AC   CVCL_5514
DR   BioSample; SAMN03472109
DR   RCB; RCB1615
DR   Wikidata; Q54883305
CC   Population: Chinese/Asian ethnic group; Hakka.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB1615
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4668 ! HFL-AE-VII
OI   CVCL_5512 ! HFLI-AE-VII
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HFSKF-II
AC   CVCL_3709
DR   BioSample; SAMN03472219
DR   RCB; RCB0698
DR   Wikidata; Q54883306
RX   PubMed=38639832;
CC   Population: Korean.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0698
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   11FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   HFT-8810
AC   CVCL_6951
SY   HFT 8810; HFT8810; Human Fetal Thymocyte-8810
DR   Wikidata; Q54883307
RX   PubMed=7781129;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
CC   Cell type: Fetal thymocyte; CL=CL_0002404.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HFTC-14
AC   CVCL_E9YH
SY   HFTC subclone 14
RX   PubMed=3459557;
CC   Characteristics: Produces EPO (PubMed=3459557).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E9YG ! HFTC-5
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HFTC-5
AC   CVCL_E9YG
SY   HFTC subclone 5
RX   PubMed=2660672;
RX   PubMed=3459557;
CC   Characteristics: Produces EPO (PubMed=2660672; PubMed=3459557).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_E9YH ! HFTC-14
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HFUA
AC   CVCL_VT01
DR   Wikidata; Q94114349
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3778323;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 27 hours (PubMed=10457904).
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   HFWT
AC   CVCL_8691
DR   CLO; CLO_0050899
DR   BioSample; SAMN03472268
DR   FANTOM5_SSTAR; 10597-108E3
DR   RCB; RCB0665
DR   Wikidata; Q54883308
RX   PubMed=1850701;
RX   PubMed=11927014;
CC   Population: Japanese.
CC   Doubling time: 48 hours (Note=At 5th passage), 41 hours (Note=At 20th passage), 40 hours (Note=At 50th passage) (PubMed=1850701).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB0665
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HG-261
AC   CVCL_2490
SY   HG 261; HG261; GM00062; GM62; GM 62
DR   CLO; CLO_0003738
DR   CLDB; cl1671
DR   CLDB; cl1672
DR   ATCC; CCL-122
DR   BioSample; SAMN03472702
DR   Coriell; GM00062
DR   ECACC; 90112603
DR   ECACC; 93120823
DR   IZSLER; BS TCL 24
DR   Wikidata; Q54883309
RX   PubMed=420857;
RX   PubMed=656543;
RX   PubMed=7374661;
RX   PubMed=7471105;
CC   Population: Caucasian.
CC   Discontinued: Coriell; GM00062; probable.
CC   Discontinued: ECACC; 90112603; true.
CC   Discontinued: ECACC; 93120823; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CCL-122; IZSLER=BS TCL 24
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D19S433: 12,13
ST   D21S11: 28
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 8,13
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 7
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   HG-3
AC   CVCL_Y547
SY   HG3
DR   ArrayExpress; E-MTAB-4527
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   Cell_Model_Passport; SIDM01817
DR   DepMap; ACH-001520
DR   DSMZ; ACC-765
DR   DSMZCellDive; ACC-765
DR   Wikidata; Q54883310
RX   PubMed=22720208;
RX   PubMed=23297799;
RX   PubMed=27566572;
RX   PubMed=28489572;
RX   PubMed=31160637;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Characteristics: Genetically heterogeneous, consists of 3 subclones (PubMed=27566572).
CC   Doubling time: ~50-70 hours (DSMZ=ACC-765).
CC   HLA typing: A*11:01:01,31:01:02; B*07:02:01,15:01:01; C*03:03:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,04:01:01; DQA1*01:02:01,01:04:01; DQB1*05:03:01,06:02:01; DRA*01:01:01,01:02:03; DRB1*14:54:01,15:01:01 (DSMZCellDive=ACC-765).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DepMap=ACH-001520; DSMZ=ACC-765
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 15,16
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,13
ST   D8S1179: 11,15
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 17,20
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 16
//
ID   HG-E
AC   CVCL_0C13
DR   Wikidata; Q54883311
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9815546;
RX   PubMed=10100721;
CC   Doubling time: 37.8 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HG00096
AC   CVCL_P676
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123268
DR   Coriell; HG00096
DR   GEO; GSM1718068
DR   IGSR; HG00096
DR   Wikidata; Q54883312
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00097
AC   CVCL_P677
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123267
DR   Coriell; HG00097
DR   GEO; GSM1718069
DR   IGSR; HG00097
DR   Wikidata; Q54883313
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00098
AC   CVCL_P678
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123272
DR   Coriell; HG00098
DR   IGSR; HG00098
DR   Wikidata; Q54883314
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00099
AC   CVCL_P679
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123271
DR   Coriell; HG00099
DR   GEO; GSM1718070
DR   IGSR; HG00099
DR   Wikidata; Q54883315
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00100
AC   CVCL_P680
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125154
DR   Coriell; HG00100
DR   GEO; GSM1718071
DR   IGSR; HG00100
DR   Wikidata; Q54883316
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00101
AC   CVCL_P681
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125153
DR   Coriell; HG00101
DR   GEO; GSM1718072
DR   IGSR; HG00101
DR   Wikidata; Q54883317
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00102
AC   CVCL_P682
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123945
DR   Coriell; HG00102
DR   GEO; GSM649514
DR   GEO; GSM1718073
DR   IGSR; HG00102
DR   Wikidata; Q54883318
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00103
AC   CVCL_P683
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125151
DR   Coriell; HG00103
DR   GEO; GSM649515
DR   GEO; GSM1718074
DR   IGSR; HG00103
DR   Wikidata; Q54883319
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00104
AC   CVCL_P684
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123950
DR   Coriell; HG00104
DR   GEO; GSM649516
DR   IGSR; HG00104
DR   Wikidata; Q54883320
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00105
AC   CVCL_P685
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   BioSamples; SAME123949
DR   Coriell; HG00105
DR   GEO; GSM649517
DR   GEO; GSM1718075
DR   IGSR; HG00105
DR   Wikidata; Q54883321
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00106
AC   CVCL_P686
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123948
DR   Coriell; HG00106
DR   GEO; GSM649518
DR   GEO; GSM1718076
DR   IGSR; HG00106
DR   Wikidata; Q54883322
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00107
AC   CVCL_P687
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123947
DR   Coriell; HG00107
DR   GEO; GSM649519
DR   GEO; GSM1718077
DR   IGSR; HG00107
DR   Wikidata; Q54883323
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00108
AC   CVCL_P688
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125161
DR   Coriell; HG00108
DR   GEO; GSM649520
DR   GEO; GSM1718078
DR   IGSR; HG00108
DR   Wikidata; Q54883324
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00109
AC   CVCL_P689
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125160
DR   Coriell; HG00109
DR   GEO; GSM649521
DR   GEO; GSM1718079
DR   IGSR; HG00109
DR   Wikidata; Q54883325
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00110
AC   CVCL_P690
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125339
DR   Coriell; HG00110
DR   GEO; GSM649522
DR   GEO; GSM1718080
DR   IGSR; HG00110
DR   Wikidata; Q54883326
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00111
AC   CVCL_P691
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125340
DR   Coriell; HG00111
DR   GEO; GSM649523
DR   GEO; GSM1718081
DR   IGSR; HG00111
DR   Wikidata; Q54883327
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00112
AC   CVCL_P692
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125341
DR   Coriell; HG00112
DR   GEO; GSM649524
DR   GEO; GSM1718082
DR   IGSR; HG00112
DR   Wikidata; Q54883328
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00113
AC   CVCL_P693
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125342
DR   Coriell; HG00113
DR   GEO; GSM649525
DR   GEO; GSM1718083
DR   IGSR; HG00113
DR   Wikidata; Q54883329
RX   PubMed=21397061;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00114
AC   CVCL_P694
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125343
DR   Coriell; HG00114
DR   GEO; GSM649526
DR   GEO; GSM1718084
DR   IGSR; HG00114
DR   Wikidata; Q54883331
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00115
AC   CVCL_P695
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125344
DR   Coriell; HG00115
DR   GEO; GSM649527
DR   GEO; GSM1718085
DR   IGSR; HG00115
DR   Wikidata; Q54883332
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00116
AC   CVCL_P696
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125345
DR   Coriell; HG00116
DR   GEO; GSM649528
DR   GEO; GSM1718086
DR   IGSR; HG00116
DR   Wikidata; Q54883333
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00117
AC   CVCL_P697
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125346
DR   Coriell; HG00117
DR   GEO; GSM649529
DR   GEO; GSM1718087
DR   IGSR; HG00117
DR   Wikidata; Q54883334
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00118
AC   CVCL_P698
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125347
DR   Coriell; HG00118
DR   GEO; GSM649530
DR   GEO; GSM1718088
DR   IGSR; HG00118
DR   Wikidata; Q54883337
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00119
AC   CVCL_P699
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME125348
DR   Coriell; HG00119
DR   GEO; GSM649531
DR   GEO; GSM1718089
DR   IGSR; HG00119
DR   Wikidata; Q54883338
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00120
AC   CVCL_P700
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122874
DR   Coriell; HG00120
DR   GEO; GSM649532
DR   GEO; GSM1718090
DR   IGSR; HG00120
DR   Wikidata; Q54883339
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00121
AC   CVCL_P701
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122873
DR   Coriell; HG00121
DR   GEO; GSM649533
DR   GEO; GSM1718091
DR   IGSR; HG00121
DR   Wikidata; Q54883340
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00122
AC   CVCL_P702
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122876
DR   Coriell; HG00122
DR   GEO; GSM649534
DR   GEO; GSM1718092
DR   IGSR; HG00122
DR   Wikidata; Q54883341
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00123
AC   CVCL_P703
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122875
DR   Coriell; HG00123
DR   GEO; GSM649535
DR   GEO; GSM1718093
DR   IGSR; HG00123
DR   Wikidata; Q54883342
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00124
AC   CVCL_P704
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122870
DR   Coriell; HG00124
DR   GEO; GSM649536
DR   GEO; GSM1718094
DR   IGSR; HG00124
DR   Wikidata; Q54883343
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00125
AC   CVCL_P705
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122869
DR   Coriell; HG00125
DR   GEO; GSM649537
DR   GEO; GSM1718095
DR   IGSR; HG00125
DR   Wikidata; Q54883344
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00126
AC   CVCL_P706
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122872
DR   Coriell; HG00126
DR   GEO; GSM649538
DR   GEO; GSM1718096
DR   IGSR; HG00126
DR   Wikidata; Q54883346
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00127
AC   CVCL_P707
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME122871
DR   Coriell; HG00127
DR   GEO; GSM649539
DR   GEO; GSM1718097
DR   IGSR; HG00127
DR   Wikidata; Q54883347
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00128
AC   CVCL_P708
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122868
DR   Coriell; HG00128
DR   GEO; GSM649540
DR   GEO; GSM1718098
DR   IGSR; HG00128
DR   Wikidata; Q54883348
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00129
AC   CVCL_P709
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME122867
DR   Coriell; HG00129
DR   GEO; GSM649541
DR   GEO; GSM1718099
DR   IGSR; HG00129
DR   Wikidata; Q54883349
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00130
AC   CVCL_P710
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123063
DR   Coriell; HG00130
DR   GEO; GSM649542
DR   GEO; GSM1718100
DR   IGSR; HG00130
DR   Wikidata; Q54883350
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00131
AC   CVCL_P711
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123064
DR   Coriell; HG00131
DR   GEO; GSM649543
DR   GEO; GSM1718101
DR   IGSR; HG00131
DR   Wikidata; Q54883351
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00132
AC   CVCL_P712
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123061
DR   Coriell; HG00132
DR   GEO; GSM649544
DR   GEO; GSM1718102
DR   IGSR; HG00132
DR   Wikidata; Q54883352
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00133
AC   CVCL_P713
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   BioSamples; SAME123062
DR   Coriell; HG00133
DR   GEO; GSM649545
DR   GEO; GSM1718103
DR   IGSR; HG00133
DR   Wikidata; Q54883353
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00134
AC   CVCL_P714
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123067
DR   Coriell; HG00134
DR   GEO; GSM649546
DR   IGSR; HG00134
DR   Wikidata; Q54883354
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00135
AC   CVCL_P715
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123068
DR   Coriell; HG00135
DR   GEO; GSM649547
DR   IGSR; HG00135
DR   Wikidata; Q54883355
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00136
AC   CVCL_P716
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123065
DR   Coriell; HG00136
DR   GEO; GSM649548
DR   GEO; GSM1718104
DR   IGSR; HG00136
DR   Wikidata; Q54883356
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00137
AC   CVCL_P717
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123066
DR   Coriell; HG00137
DR   GEO; GSM649549
DR   GEO; GSM1718105
DR   IGSR; HG00137
DR   Wikidata; Q54883358
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00138
AC   CVCL_P718
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123059
DR   Coriell; HG00138
DR   GEO; GSM649550
DR   GEO; GSM1718106
DR   IGSR; HG00138
DR   Wikidata; Q54883359
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00139
AC   CVCL_P719
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123060
DR   Coriell; HG00139
DR   GEO; GSM649551
DR   GEO; GSM1718107
DR   IGSR; HG00139
DR   Wikidata; Q54883360
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00140
AC   CVCL_P720
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124396
DR   Coriell; HG00140
DR   GEO; GSM649552
DR   GEO; GSM1718108
DR   IGSR; HG00140
DR   Wikidata; Q54883361
RX   PubMed=21397061;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00141
AC   CVCL_P721
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124395
DR   Coriell; HG00141
DR   GEO; GSM649553
DR   GEO; GSM1718109
DR   IGSR; HG00141
DR   Wikidata; Q54883362
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00142
AC   CVCL_P722
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124818
DR   Coriell; HG00142
DR   GEO; GSM649554
DR   GEO; GSM1718110
DR   IGSR; HG00142
DR   Wikidata; Q54883363
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00143
AC   CVCL_P723
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124393
DR   Coriell; HG00143
DR   GEO; GSM649555
DR   GEO; GSM1718111
DR   IGSR; HG00143
DR   Wikidata; Q54883364
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00145
AC   CVCL_P724
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124391
DR   Coriell; HG00145
DR   GEO; GSM649556
DR   GEO; GSM1718112
DR   IGSR; HG00145
DR   Wikidata; Q54883365
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00146
AC   CVCL_P725
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124390
DR   Coriell; HG00146
DR   GEO; GSM1718113
DR   IGSR; HG00146
DR   Wikidata; Q54883366
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00148
AC   CVCL_P726
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124388
DR   Coriell; HG00148
DR   GEO; GSM649557
DR   GEO; GSM1718114
DR   IGSR; HG00148
DR   Wikidata; Q54883367
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00149
AC   CVCL_P727
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124387
DR   Coriell; HG00149
DR   GEO; GSM649558
DR   GEO; GSM1718115
DR   IGSR; HG00149
DR   Wikidata; Q54883368
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00150
AC   CVCL_P728
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124591
DR   Coriell; HG00150
DR   GEO; GSM649559
DR   GEO; GSM1718116
DR   IGSR; HG00150
DR   Wikidata; Q54883369
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00151
AC   CVCL_P729
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124592
DR   Coriell; HG00151
DR   GEO; GSM1718117
DR   IGSR; HG00151
DR   Wikidata; Q54883370
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00152
AC   CVCL_P730
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124593
DR   Coriell; HG00152
DR   GEO; GSM649560
DR   IGSR; HG00152
DR   Wikidata; Q54883371
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00154
AC   CVCL_P731
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124587
DR   Coriell; HG00154
DR   GEO; GSM649561
DR   GEO; GSM1718118
DR   IGSR; HG00154
DR   Wikidata; Q54883372
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00155
AC   CVCL_P732
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124588
DR   Coriell; HG00155
DR   GEO; GSM1718119
DR   IGSR; HG00155
DR   Wikidata; Q54883373
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00156
AC   CVCL_P733
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123276
DR   Coriell; HG00156
DR   GEO; GSM649562
DR   IGSR; HG00156
DR   Wikidata; Q54883374
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HG00157
AC   CVCL_P734
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124590
DR   Coriell; HG00157
DR   GEO; GSM649563
DR   GEO; GSM1718120
DR   IGSR; HG00157
DR   Wikidata; Q54883375
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00158
AC   CVCL_P735
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124585
DR   Coriell; HG00158
DR   GEO; GSM1718121
DR   IGSR; HG00158
DR   Wikidata; Q54883376
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00159
AC   CVCL_P736
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124586
DR   Coriell; HG00159
DR   GEO; GSM649564
DR   GEO; GSM1718122
DR   IGSR; HG00159
DR   Wikidata; Q54883377
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00160
AC   CVCL_P737
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124780
DR   Coriell; HG00160
DR   GEO; GSM649565
DR   GEO; GSM1718123
DR   IGSR; HG00160
DR   Wikidata; Q54883378
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00171
AC   CVCL_P738
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124961
DR   Coriell; HG00171
DR   GEO; GSM1718124
DR   IGSR; HG00171
DR   Wikidata; Q54883380
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00173
AC   CVCL_P739
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124960
DR   Coriell; HG00173
DR   GEO; GSM649566
DR   GEO; GSM1718125
DR   IGSR; HG00173
DR   Wikidata; Q54883381
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00174
AC   CVCL_P740
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124958
DR   Coriell; HG00174
DR   GEO; GSM649567
DR   GEO; GSM1718126
DR   IGSR; HG00174
DR   Wikidata; Q54883382
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00176
AC   CVCL_P741
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124956
DR   Coriell; HG00176
DR   GEO; GSM649568
DR   GEO; GSM1718127
DR   IGSR; HG00176
DR   Wikidata; Q54883383
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00177
AC   CVCL_P742
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124957
DR   Coriell; HG00177
DR   GEO; GSM649569
DR   GEO; GSM1718128
DR   IGSR; HG00177
DR   Wikidata; Q54883384
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00178
AC   CVCL_P743
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124964
DR   Coriell; HG00178
DR   GEO; GSM649570
DR   GEO; GSM1718129
DR   IGSR; HG00178
DR   Wikidata; Q54883385
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00179
AC   CVCL_P744
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124965
DR   Coriell; HG00179
DR   GEO; GSM649571
DR   GEO; GSM1718130
DR   IGSR; HG00179
DR   Wikidata; Q54883386
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00180
AC   CVCL_P745
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123645
DR   Coriell; HG00180
DR   GEO; GSM649572
DR   GEO; GSM1718131
DR   IGSR; HG00180
DR   Wikidata; Q54883387
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00181
AC   CVCL_P746
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123644
DR   Coriell; HG00181
DR   GEO; GSM649573
DR   GEO; GSM1718132
DR   IGSR; HG00181
DR   Wikidata; Q54883388
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00182
AC   CVCL_P747
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123643
DR   Coriell; HG00182
DR   GEO; GSM649574
DR   GEO; GSM1718133
DR   IGSR; HG00182
DR   Wikidata; Q54883389
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00183
AC   CVCL_P748
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123642
DR   Coriell; HG00183
DR   GEO; GSM649575
DR   GEO; GSM1718134
DR   IGSR; HG00183
DR   Wikidata; Q54883390
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00185
AC   CVCL_P749
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123648
DR   Coriell; HG00185
DR   GEO; GSM649576
DR   GEO; GSM1718135
DR   IGSR; HG00185
DR   Wikidata; Q54883392
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00186
AC   CVCL_P750
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123647
DR   Coriell; HG00186
DR   GEO; GSM649577
DR   GEO; GSM1718136
DR   IGSR; HG00186
DR   Wikidata; Q54883393
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00187
AC   CVCL_P751
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123646
DR   Coriell; HG00187
DR   GEO; GSM649578
DR   GEO; GSM1718137
DR   IGSR; HG00187
DR   Wikidata; Q54883394
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00188
AC   CVCL_P752
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123641
DR   Coriell; HG00188
DR   GEO; GSM649579
DR   GEO; GSM1718138
DR   IGSR; HG00188
DR   Wikidata; Q54883395
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00189
AC   CVCL_R016
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123640
DR   Coriell; HG00189
DR   GEO; GSM649580
DR   GEO; GSM1718139
DR   IGSR; HG00189
DR   Wikidata; Q54883396
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00190
AC   CVCL_P753
DR   BioSamples; SAME123856
DR   Coriell; HG00190
DR   GEO; GSM649581
DR   GEO; GSM1718140
DR   IGSR; HG00190
DR   Wikidata; Q54883397
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00231
AC   CVCL_P754
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124126
DR   Coriell; HG00231
DR   GEO; GSM649582
DR   GEO; GSM1718141
DR   IGSR; HG00231
DR   Wikidata; Q54883398
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00232
AC   CVCL_P755
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124128
DR   Coriell; HG00232
DR   GEO; GSM649583
DR   GEO; GSM1718142
DR   IGSR; HG00232
DR   Wikidata; Q54883399
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00233
AC   CVCL_P756
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124127
DR   Coriell; HG00233
DR   GEO; GSM649584
DR   GEO; GSM1718143
DR   IGSR; HG00233
DR   Wikidata; Q54883401
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00234
AC   CVCL_P757
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124123
DR   Coriell; HG00234
DR   GEO; GSM649585
DR   GEO; GSM1718144
DR   IGSR; HG00234
DR   Wikidata; Q54883402
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00235
AC   CVCL_P758
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124122
DR   Coriell; HG00235
DR   GEO; GSM649586
DR   GEO; GSM1718145
DR   IGSR; HG00235
DR   Wikidata; Q54883403
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00236
AC   CVCL_P759
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123273
DR   Coriell; HG00236
DR   GEO; GSM649587
DR   GEO; GSM1718146
DR   IGSR; HG00236
DR   Wikidata; Q54883404
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00237
AC   CVCL_P760
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124124
DR   Coriell; HG00237
DR   GEO; GSM649588
DR   GEO; GSM1718147
DR   IGSR; HG00237
DR   Wikidata; Q54883405
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00238
AC   CVCL_P761
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124131
DR   Coriell; HG00238
DR   GEO; GSM649589
DR   GEO; GSM1718148
DR   IGSR; HG00238
DR   Wikidata; Q54883406
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00239
AC   CVCL_P762
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124130
DR   Coriell; HG00239
DR   GEO; GSM649590
DR   GEO; GSM1718149
DR   IGSR; HG00239
DR   Wikidata; Q54883407
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00240
AC   CVCL_P763
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123221
DR   Coriell; HG00240
DR   GEO; GSM649591
DR   GEO; GSM1718150
DR   IGSR; HG00240
DR   Wikidata; Q54883408
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00242
AC   CVCL_P764
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123223
DR   Coriell; HG00242
DR   GEO; GSM649592
DR   GEO; GSM1718151
DR   IGSR; HG00242
DR   Wikidata; Q54883409
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00243
AC   CVCL_P765
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123224
DR   Coriell; HG00243
DR   GEO; GSM649593
DR   GEO; GSM1718152
DR   IGSR; HG00243
DR   Wikidata; Q54883410
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00244
AC   CVCL_P766
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123217
DR   Coriell; HG00244
DR   GEO; GSM649594
DR   GEO; GSM1718153
DR   IGSR; HG00244
DR   Wikidata; Q54883411
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00245
AC   CVCL_P767
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123218
DR   Coriell; HG00245
DR   GEO; GSM649595
DR   GEO; GSM1718154
DR   IGSR; HG00245
DR   Wikidata; Q54883413
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00246
AC   CVCL_P768
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123219
DR   Coriell; HG00246
DR   GEO; GSM649596
DR   GEO; GSM1718155
DR   IGSR; HG00246
DR   Wikidata; Q54883414
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00247
AC   CVCL_P769
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123220
DR   Coriell; HG00247
DR   GEO; GSM649597
DR   IGSR; HG00247
DR   Wikidata; Q54883415
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00249
AC   CVCL_P770
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123227
DR   Coriell; HG00249
DR   GEO; GSM649598
DR   IGSR; HG00249
DR   Wikidata; Q54883416
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00250
AC   CVCL_P771
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123054
DR   Coriell; HG00250
DR   GEO; GSM649599
DR   GEO; GSM1718156
DR   IGSR; HG00250
DR   Wikidata; Q54883417
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00251
AC   CVCL_P772
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123053
DR   Coriell; HG00251
DR   GEO; GSM649600
DR   GEO; GSM1718157
DR   IGSR; HG00251
DR   Wikidata; Q54883418
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00252
AC   CVCL_P773
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123052
DR   Coriell; HG00252
DR   GEO; GSM649601
DR   GEO; GSM1718158
DR   IGSR; HG00252
DR   Wikidata; Q54883419
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00253
AC   CVCL_P774
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123051
DR   Coriell; HG00253
DR   GEO; GSM649602
DR   GEO; GSM1718159
DR   IGSR; HG00253
DR   Wikidata; Q54883420
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00254
AC   CVCL_P775
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123050
DR   Coriell; HG00254
DR   GEO; GSM649603
DR   GEO; GSM1718160
DR   IGSR; HG00254
DR   Wikidata; Q54883421
RX   PubMed=21397061;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00255
AC   CVCL_P776
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123049
DR   Coriell; HG00255
DR   GEO; GSM649604
DR   GEO; GSM1718161
DR   IGSR; HG00255
DR   Wikidata; Q54883422
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00256
AC   CVCL_P777
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123048
DR   Coriell; HG00256
DR   GEO; GSM649605
DR   GEO; GSM1718162
DR   IGSR; HG00256
DR   Wikidata; Q54883425
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00257
AC   CVCL_P778
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123047
DR   Coriell; HG00257
DR   GEO; GSM649606
DR   GEO; GSM1718163
DR   IGSR; HG00257
DR   Wikidata; Q54883427
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00258
AC   CVCL_P779
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123057
DR   Coriell; HG00258
DR   GEO; GSM649607
DR   GEO; GSM1718164
DR   IGSR; HG00258
DR   Wikidata; Q54883428
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00259
AC   CVCL_P780
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123056
DR   Coriell; HG00259
DR   GEO; GSM649608
DR   GEO; GSM1718165
DR   IGSR; HG00259
DR   Wikidata; Q54883429
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00260
AC   CVCL_P781
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123582
DR   Coriell; HG00260
DR   GEO; GSM649609
DR   GEO; GSM1718166
DR   IGSR; HG00260
DR   Wikidata; Q54883430
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00261
AC   CVCL_P782
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123583
DR   Coriell; HG00261
DR   GEO; GSM649610
DR   GEO; GSM1718167
DR   IGSR; HG00261
DR   Wikidata; Q54883431
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00262
AC   CVCL_P783
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123580
DR   Coriell; HG00262
DR   GEO; GSM649611
DR   GEO; GSM1718168
DR   IGSR; HG00262
DR   Wikidata; Q54883432
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00263
AC   CVCL_P784
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123581
DR   Coriell; HG00263
DR   GEO; GSM649612
DR   GEO; GSM1718169
DR   IGSR; HG00263
DR   Wikidata; Q54883433
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00264
AC   CVCL_P785
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123578
DR   Coriell; HG00264
DR   GEO; GSM649613
DR   GEO; GSM1718170
DR   IGSR; HG00264
DR   Wikidata; Q54883434
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00265
AC   CVCL_P786
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123579
DR   Coriell; HG00265
DR   GEO; GSM649614
DR   GEO; GSM1718171
DR   IGSR; HG00265
DR   Wikidata; Q54883435
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00266
AC   CVCL_P787
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123576
DR   Coriell; HG00266
DR   GEO; GSM649615
DR   GEO; GSM1718172
DR   IGSR; HG00266
DR   Wikidata; Q54883436
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00267
AC   CVCL_P788
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123577
DR   Coriell; HG00267
DR   GEO; GSM649616
DR   GEO; GSM1718173
DR   IGSR; HG00267
DR   Wikidata; Q54883437
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00268
AC   CVCL_P789
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123574
DR   Coriell; HG00268
DR   GEO; GSM649617
DR   GEO; GSM1718174
DR   IGSR; HG00268
DR   Wikidata; Q54883438
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00269
AC   CVCL_P790
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123575
DR   Coriell; HG00269
DR   GEO; GSM649618
DR   GEO; GSM1718175
DR   IGSR; HG00269
DR   Wikidata; Q54883439
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00270
AC   CVCL_P791
DR   BioSamples; SAME123418
DR   Coriell; HG00270
DR   GEO; GSM649619
DR   GEO; GSM1718176
DR   IGSR; HG00270
DR   Wikidata; Q54883440
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00271
AC   CVCL_P792
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123417
DR   Coriell; HG00271
DR   GEO; GSM649620
DR   IGSR; HG00271
DR   Wikidata; Q54883441
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00272
AC   CVCL_P793
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123420
DR   Coriell; HG00272
DR   GEO; GSM649621
DR   GEO; GSM1718177
DR   IGSR; HG00272
DR   Wikidata; Q54883442
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00273
AC   CVCL_P794
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123419
DR   Coriell; HG00273
DR   GEO; GSM649622
DR   GEO; GSM1718178
DR   IGSR; HG00273
DR   Wikidata; Q54883443
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00274
AC   CVCL_P795
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123422
DR   Coriell; HG00274
DR   GEO; GSM649623
DR   GEO; GSM1718179
DR   IGSR; HG00274
DR   Wikidata; Q54883444
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00275
AC   CVCL_P796
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123421
DR   Coriell; HG00275
DR   GEO; GSM649624
DR   GEO; GSM1718180
DR   IGSR; HG00275
DR   Wikidata; Q54883445
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00276
AC   CVCL_P797
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123424
DR   Coriell; HG00276
DR   GEO; GSM649625
DR   GEO; GSM1718181
DR   IGSR; HG00276
DR   Wikidata; Q54883446
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=26621101;
RX   PubMed=27617755;
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00277
AC   CVCL_P798
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123423
DR   Coriell; HG00277
DR   GEO; GSM649626
DR   GEO; GSM1718182
DR   IGSR; HG00277
DR   Wikidata; Q54883447
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00278
AC   CVCL_P799
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123425
DR   Coriell; HG00278
DR   GEO; GSM649627
DR   GEO; GSM1718183
DR   IGSR; HG00278
DR   Wikidata; Q54883448
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00280
AC   CVCL_P800
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME122831
DR   Coriell; HG00280
DR   GEO; GSM649628
DR   GEO; GSM1718184
DR   IGSR; HG00280
DR   Wikidata; Q54883449
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00281
AC   CVCL_P801
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME122832
DR   Coriell; HG00281
DR   GEO; GSM649629
DR   GEO; GSM1718185
DR   IGSR; HG00281
DR   Wikidata; Q54883450
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00282
AC   CVCL_P802
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME122833
DR   Coriell; HG00282
DR   GEO; GSM649630
DR   GEO; GSM1718186
DR   IGSR; HG00282
DR   Wikidata; Q54883452
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00284
AC   CVCL_P803
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME122835
DR   Coriell; HG00284
DR   GEO; GSM649631
DR   GEO; GSM1718187
DR   IGSR; HG00284
DR   Wikidata; Q54883453
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00285
AC   CVCL_P804
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME122836
DR   Coriell; HG00285
DR   GEO; GSM649632
DR   GEO; GSM1718188
DR   IGSR; HG00285
DR   Wikidata; Q54883454
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00288
AC   CVCL_GU05
DR   BioSamples; SAME1839246
DR   Coriell; HG00288
DR   GEO; GSM1718189
DR   IGSR; HG00288
DR   Wikidata; Q54883455
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG00290
AC   CVCL_GU06
DR   BioSamples; SAME1839057
DR   Coriell; HG00290
DR   GEO; GSM1718190
DR   IGSR; HG00290
DR   Wikidata; Q54883456
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG00304
AC   CVCL_GU07
DR   BioSamples; SAME1840118
DR   Coriell; HG00304
DR   GEO; GSM1718191
DR   IGSR; HG00304
DR   Wikidata; Q54883458
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   HG00306
AC   CVCL_P805
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124159
DR   Coriell; HG00306
DR   GEO; GSM649633
DR   GEO; GSM1718192
DR   IGSR; HG00306
DR   Wikidata; Q54883459
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00308
AC   CVCL_P806
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124161
DR   Coriell; HG00308
DR   GEO; GSM649634
DR   GEO; GSM1718193
DR   IGSR; HG00308
DR   Wikidata; Q54883460
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00309
AC   CVCL_P807
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124160
DR   Coriell; HG00309
DR   GEO; GSM649635
DR   GEO; GSM1718194
DR   IGSR; HG00309
DR   Wikidata; Q54883461
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00310
AC   CVCL_P808
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124338
DR   Coriell; HG00310
DR   GEO; GSM649636
DR   GEO; GSM1718195
DR   IGSR; HG00310
DR   Wikidata; Q54883462
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00311
AC   CVCL_P809
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124339
DR   Coriell; HG00311
DR   GEO; GSM649637
DR   GEO; GSM1718196
DR   IGSR; HG00311
DR   Wikidata; Q54883463
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00312
AC   CVCL_P810
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124336
DR   Coriell; HG00312
DR   GEO; GSM649638
DR   IGSR; HG00312
DR   Wikidata; Q54883464
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00313
AC   CVCL_P811
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124337
DR   Coriell; HG00313
DR   GEO; GSM649639
DR   GEO; GSM1718197
DR   IGSR; HG00313
DR   Wikidata; Q54883465
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00315
AC   CVCL_P812
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124335
DR   Coriell; HG00315
DR   GEO; GSM649640
DR   GEO; GSM1718198
DR   IGSR; HG00315
DR   Wikidata; Q54883466
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00318
AC   CVCL_P813
DR   BioSamples; SAME124333
DR   Coriell; HG00318
DR   GEO; GSM649641
DR   GEO; GSM1718199
DR   IGSR; HG00318
DR   Wikidata; Q54883467
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00319
AC   CVCL_P814
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124334
DR   Coriell; HG00319
DR   GEO; GSM649642
DR   GEO; GSM1718200
DR   IGSR; HG00319
DR   Wikidata; Q54883469
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00320
AC   CVCL_P815
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123797
DR   Coriell; HG00320
DR   GEO; GSM649643
DR   GEO; GSM1718201
DR   IGSR; HG00320
DR   Wikidata; Q54883470
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00321
AC   CVCL_P816
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123796
DR   Coriell; HG00321
DR   GEO; GSM649644
DR   GEO; GSM1718202
DR   IGSR; HG00321
DR   Wikidata; Q54883471
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00323
AC   CVCL_P817
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123795
DR   Coriell; HG00323
DR   GEO; GSM649645
DR   GEO; GSM1718203
DR   IGSR; HG00323
DR   Wikidata; Q54883472
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00324
AC   CVCL_P818
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123794
DR   Coriell; HG00324
DR   GEO; GSM649646
DR   GEO; GSM1718204
DR   IGSR; HG00324
DR   Wikidata; Q54883473
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00325
AC   CVCL_P819
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123793
DR   Coriell; HG00325
DR   GEO; GSM649647
DR   GEO; GSM1718205
DR   IGSR; HG00325
DR   Wikidata; Q54883474
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00326
AC   CVCL_P820
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123792
DR   Coriell; HG00326
DR   GEO; GSM649648
DR   GEO; GSM1718206
DR   IGSR; HG00326
DR   Wikidata; Q54883475
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00327
AC   CVCL_P821
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123791
DR   Coriell; HG00327
DR   GEO; GSM649649
DR   GEO; GSM1718207
DR   IGSR; HG00327
DR   Wikidata; Q54883476
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00328
AC   CVCL_P822
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123799
DR   Coriell; HG00328
DR   GEO; GSM649650
DR   GEO; GSM1718208
DR   IGSR; HG00328
DR   Wikidata; Q54883477
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00329
AC   CVCL_P823
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123798
DR   Coriell; HG00329
DR   GEO; GSM649651
DR   GEO; GSM1718209
DR   IGSR; HG00329
DR   Wikidata; Q54883478
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00330
AC   CVCL_P824
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123985
DR   Coriell; HG00330
DR   GEO; GSM649652
DR   GEO; GSM1718210
DR   IGSR; HG00330
DR   Wikidata; Q54883479
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00331
AC   CVCL_P825
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123986
DR   Coriell; HG00331
DR   GEO; GSM649653
DR   GEO; GSM1718211
DR   IGSR; HG00331
DR   Wikidata; Q54883480
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00332
AC   CVCL_P826
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123987
DR   Coriell; HG00332
DR   GEO; GSM649654
DR   GEO; GSM1718212
DR   IGSR; HG00332
DR   Wikidata; Q54883481
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00334
AC   CVCL_P827
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123981
DR   Coriell; HG00334
DR   GEO; GSM649655
DR   GEO; GSM1718213
DR   IGSR; HG00334
DR   Wikidata; Q54883482
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00335
AC   CVCL_P828
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123982
DR   Coriell; HG00335
DR   GEO; GSM649656
DR   GEO; GSM1718214
DR   IGSR; HG00335
DR   Wikidata; Q54883483
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00336
AC   CVCL_P829
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123983
DR   Coriell; HG00336
DR   GEO; GSM649657
DR   GEO; GSM1718215
DR   IGSR; HG00336
DR   Wikidata; Q54883484
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00337
AC   CVCL_P830
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123984
DR   Coriell; HG00337
DR   GEO; GSM649658
DR   GEO; GSM1718216
DR   IGSR; HG00337
DR   Wikidata; Q54883485
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00338
AC   CVCL_P831
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123990
DR   Coriell; HG00338
DR   GEO; GSM649659
DR   GEO; GSM1718217
DR   IGSR; HG00338
DR   Wikidata; Q54883486
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00339
AC   CVCL_P832
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123991
DR   Coriell; HG00339
DR   GEO; GSM649660
DR   GEO; GSM1718218
DR   IGSR; HG00339
DR   Wikidata; Q54883487
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00341
AC   CVCL_P833
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124922
DR   Coriell; HG00341
DR   GEO; GSM649661
DR   GEO; GSM1718219
DR   IGSR; HG00341
DR   Wikidata; Q54883488
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00342
AC   CVCL_P834
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124924
DR   Coriell; HG00342
DR   GEO; GSM649662
DR   GEO; GSM1718220
DR   IGSR; HG00342
DR   Wikidata; Q54883489
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00343
AC   CVCL_P835
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124923
DR   Coriell; HG00343
DR   GEO; GSM649663
DR   GEO; GSM1718221
DR   IGSR; HG00343
DR   Wikidata; Q54883490
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00344
AC   CVCL_P836
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125255
DR   Coriell; HG00344
DR   GEO; GSM649664
DR   GEO; GSM1718222
DR   IGSR; HG00344
DR   Wikidata; Q54883491
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00345
AC   CVCL_P837
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124919
DR   Coriell; HG00345
DR   GEO; GSM649665
DR   GEO; GSM1718223
DR   IGSR; HG00345
DR   Wikidata; Q54883492
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00346
AC   CVCL_P838
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125264
DR   Coriell; HG00346
DR   GEO; GSM649666
DR   GEO; GSM1718224
DR   IGSR; HG00346
DR   Wikidata; Q54883493
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00349
AC   CVCL_P839
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124925
DR   Coriell; HG00349
DR   GEO; GSM649667
DR   GEO; GSM1718225
DR   IGSR; HG00349
DR   Wikidata; Q54883494
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00350
AC   CVCL_P840
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125121
DR   Coriell; HG00350
DR   GEO; GSM649668
DR   GEO; GSM1718226
DR   IGSR; HG00350
DR   Wikidata; Q54883495
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00351
AC   CVCL_P841
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125122
DR   Coriell; HG00351
DR   GEO; GSM649669
DR   GEO; GSM1718227
DR   IGSR; HG00351
DR   Wikidata; Q54883496
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00353
AC   CVCL_P842
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125120
DR   Coriell; HG00353
DR   GEO; GSM649670
DR   GEO; GSM1718228
DR   IGSR; HG00353
DR   Wikidata; Q54883497
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00355
AC   CVCL_P843
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125125
DR   Coriell; HG00355
DR   GEO; GSM649671
DR   GEO; GSM1718229
DR   IGSR; HG00355
DR   Wikidata; Q54883498
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00356
AC   CVCL_P844
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125123
DR   Coriell; HG00356
DR   GEO; GSM649672
DR   GEO; GSM1718230
DR   IGSR; HG00356
DR   Wikidata; Q54883499
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00357
AC   CVCL_P845
DR   BioSamples; SAME125124
DR   Coriell; HG00357
DR   GEO; GSM649673
DR   GEO; GSM1718231
DR   IGSR; HG00357
DR   Wikidata; Q54883500
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00358
AC   CVCL_P846
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125126
DR   Coriell; HG00358
DR   GEO; GSM649674
DR   GEO; GSM1718232
DR   IGSR; HG00358
DR   Wikidata; Q54883501
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00359
AC   CVCL_P847
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME125127
DR   Coriell; HG00359
DR   GEO; GSM649675
DR   IGSR; HG00359
DR   Wikidata; Q54883502
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00360
AC   CVCL_P848
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124539
DR   Coriell; HG00360
DR   GEO; GSM649676
DR   GEO; GSM1718233
DR   IGSR; HG00360
DR   Wikidata; Q54883503
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00361
AC   CVCL_P849
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124538
DR   Coriell; HG00361
DR   GEO; GSM649677
DR   GEO; GSM1718234
DR   IGSR; HG00361
DR   Wikidata; Q54883504
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00362
AC   CVCL_P850
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124537
DR   Coriell; HG00362
DR   GEO; GSM649678
DR   GEO; GSM1718235
DR   IGSR; HG00362
DR   Wikidata; Q54883505
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00364
AC   CVCL_P851
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124543
DR   Coriell; HG00364
DR   GEO; GSM649679
DR   GEO; GSM1718236
DR   IGSR; HG00364
DR   Wikidata; Q54883506
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00365
AC   CVCL_P852
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124542
DR   Coriell; HG00365
DR   GEO; GSM649680
DR   GEO; GSM1718237
DR   IGSR; HG00365
DR   Wikidata; Q54883507
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00366
AC   CVCL_P853
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124541
DR   Coriell; HG00366
DR   GEO; GSM649681
DR   GEO; GSM1718238
DR   IGSR; HG00366
DR   Wikidata; Q54883508
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00367
AC   CVCL_P854
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124540
DR   Coriell; HG00367
DR   GEO; GSM649682
DR   GEO; GSM1718239
DR   IGSR; HG00367
DR   Wikidata; Q54883510
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00368
AC   CVCL_P855
DR   BioSamples; SAME124535
DR   Coriell; HG00368
DR   GEO; GSM649683
DR   GEO; GSM1718240
DR   IGSR; HG00368
DR   Wikidata; Q54883511
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00369
AC   CVCL_P856
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124534
DR   Coriell; HG00369
DR   GEO; GSM649684
DR   GEO; GSM1718241
DR   IGSR; HG00369
DR   Wikidata; Q54883512
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00371
AC   CVCL_P857
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124747
DR   Coriell; HG00371
DR   GEO; GSM649685
DR   GEO; GSM1718242
DR   IGSR; HG00371
DR   Wikidata; Q54883513
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00372
AC   CVCL_P858
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124748
DR   Coriell; HG00372
DR   GEO; GSM649686
DR   GEO; GSM1718243
DR   IGSR; HG00372
DR   Wikidata; Q54883515
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00373
AC   CVCL_P859
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124749
DR   Coriell; HG00373
DR   GEO; GSM649687
DR   GEO; GSM1718244
DR   IGSR; HG00373
DR   Wikidata; Q54883516
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00375
AC   CVCL_P860
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124750
DR   Coriell; HG00375
DR   GEO; GSM649688
DR   GEO; GSM1718245
DR   IGSR; HG00375
DR   Wikidata; Q54883517
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00376
AC   CVCL_P861
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124751
DR   Coriell; HG00376
DR   GEO; GSM649689
DR   GEO; GSM1718246
DR   IGSR; HG00376
DR   Wikidata; Q54883518
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00377
AC   CVCL_P862
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124752
DR   Coriell; HG00377
DR   GEO; GSM649690
DR   IGSR; HG00377
DR   Wikidata; Q54883519
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00378
AC   CVCL_P863
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124745
DR   Coriell; HG00378
DR   GEO; GSM649691
DR   GEO; GSM1718247
DR   IGSR; HG00378
DR   Wikidata; Q54883520
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00379
AC   CVCL_P864
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124746
DR   Coriell; HG00379
DR   GEO; GSM649692
DR   GEO; GSM1718248
DR   IGSR; HG00379
DR   Wikidata; Q54883521
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00380
AC   CVCL_P865
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123031
DR   Coriell; HG00380
DR   GEO; GSM649693
DR   GEO; GSM1718249
DR   IGSR; HG00380
DR   Wikidata; Q54883522
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00381
AC   CVCL_P866
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123030
DR   Coriell; HG00381
DR   GEO; GSM649694
DR   GEO; GSM1718250
DR   IGSR; HG00381
DR   Wikidata; Q54883523
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00382
AC   CVCL_P867
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123033
DR   Coriell; HG00382
DR   GEO; GSM649695
DR   GEO; GSM1718251
DR   IGSR; HG00382
DR   Wikidata; Q54883525
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00383
AC   CVCL_P868
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123032
DR   Coriell; HG00383
DR   GEO; GSM649696
DR   GEO; GSM1718252
DR   IGSR; HG00383
DR   Wikidata; Q54883526
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00384
AC   CVCL_P869
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123034
DR   Coriell; HG00384
DR   GEO; GSM649697
DR   GEO; GSM1718253
DR   IGSR; HG00384
DR   Wikidata; Q54883527
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Finnish in Finland (FIN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00403
AC   CVCL_P870
DR   BioSamples; SAME123160
DR   Coriell; HG00403
DR   GEO; GSM649698
DR   GEO; GSM1718254
DR   IGSR; HG00403
DR   Wikidata; Q54883528
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00404
AC   CVCL_P871
DR   BioSamples; SAME123158
DR   Coriell; HG00404
DR   GEO; GSM649699
DR   GEO; GSM1718255
DR   IGSR; HG00404
DR   Wikidata; Q54883529
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00405
AC   CVCL_P872
DR   BioSamples; SAME123159
DR   Coriell; HG00405
DR   GEO; GSM649700
DR   GEO; GSM1718256
DR   IGSR; HG00405
DR   Wikidata; Q54883530
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00406
AC   CVCL_P873
DR   BioSamples; SAME123156
DR   Coriell; HG00406
DR   GEO; GSM649701
DR   IGSR; HG00406
DR   Wikidata; Q54883531
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00407
AC   CVCL_P874
DR   BioSamples; SAME125106
DR   Coriell; HG00407
DR   GEO; GSM649702
DR   GEO; GSM1718257
DR   IGSR; HG00407
DR   Wikidata; Q54883532
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00408
AC   CVCL_P875
DR   BioSamples; SAME123155
DR   Coriell; HG00408
DR   GEO; GSM649703
DR   IGSR; HG00408
DR   Wikidata; Q54883533
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00409
AC   CVCL_P876
DR   BioSamples; SAME1840026
DR   Coriell; HG00409
DR   GEO; GSM1718258
DR   IGSR; HG00409
DR   Wikidata; Q54883534
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00410
AC   CVCL_P877
DR   BioSamples; SAME1839734
DR   Coriell; HG00410
DR   GEO; GSM1718259
DR   IGSR; HG00410
DR   Wikidata; Q54883535
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00418
AC   CVCL_P878
DR   BioSamples; SAME122992
DR   Coriell; HG00418
DR   GEO; GSM649704
DR   IGSR; HG00418
DR   Wikidata; Q54883536
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00419
AC   CVCL_P879
DR   BioSamples; SAME122991
DR   Coriell; HG00419
DR   GEO; GSM649705
DR   GEO; GSM1718260
DR   IGSR; HG00419
DR   Wikidata; Q54883537
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00420
AC   CVCL_P880
DR   BioSamples; SAME122807
DR   Coriell; HG00420
DR   GEO; GSM649706
DR   IGSR; HG00420
DR   Wikidata; Q54883538
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00421
AC   CVCL_P881
DR   BioSamples; SAME122808
DR   Coriell; HG00421
DR   GEO; GSM649707
DR   GEO; GSM1718261
DR   IGSR; HG00421
DR   Wikidata; Q54883539
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00422
AC   CVCL_P882
DR   BioSamples; SAME122809
DR   Coriell; HG00422
DR   GEO; GSM649708
DR   GEO; GSM1718262
DR   IGSR; HG00422
DR   Wikidata; Q54883540
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00423
AC   CVCL_P883
DR   BioSamples; SAME122810
DR   Coriell; HG00423
DR   GEO; GSM649709
DR   IGSR; HG00423
DR   Wikidata; Q54883541
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00427
AC   CVCL_P884
DR   BioSamples; SAME122806
DR   Coriell; HG00427
DR   GEO; GSM649710
DR   IGSR; HG00427
DR   Wikidata; Q54883542
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00428
AC   CVCL_P885
DR   BioSamples; SAME122811
DR   Coriell; HG00428
DR   GEO; GSM649711
DR   GEO; GSM1718263
DR   IGSR; HG00428
DR   Wikidata; Q54883543
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00429
AC   CVCL_P886
DR   BioSamples; SAME122812
DR   Coriell; HG00429
DR   GEO; GSM649712
DR   IGSR; HG00429
DR   Wikidata; Q54883544
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00436
AC   CVCL_P887
DR   BioSamples; SAME125262
DR   Coriell; HG00436
DR   GEO; GSM649713
DR   GEO; GSM1718264
DR   IGSR; HG00436
DR   Wikidata; Q54883545
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00437
AC   CVCL_P888
DR   BioSamples; SAME125261
DR   Coriell; HG00437
DR   GEO; GSM649714
DR   GEO; GSM1718265
DR   IGSR; HG00437
DR   Wikidata; Q54883546
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00438
AC   CVCL_P889
DR   BioSamples; SAME125267
DR   Coriell; HG00438
DR   GEO; GSM649715
DR   IGSR; HG00438
DR   Wikidata; Q54883547
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00442
AC   CVCL_P890
DR   BioSamples; SAME124912
DR   Coriell; HG00442
DR   GEO; GSM649716
DR   GEO; GSM1718266
DR   IGSR; HG00442
DR   Wikidata; Q54883548
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00443
AC   CVCL_P891
DR   BioSamples; SAME124920
DR   Coriell; HG00443
DR   GEO; GSM649717
DR   GEO; GSM1718267
DR   IGSR; HG00443
DR   Wikidata; Q54883549
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00444
AC   CVCL_P892
DR   BioSamples; SAME124190
DR   Coriell; HG00444
DR   GEO; GSM649718
DR   IGSR; HG00444
DR   Wikidata; Q54883550
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00445
AC   CVCL_P893
DR   BioSamples; SAME124975
DR   Coriell; HG00445
DR   GEO; GSM649719
DR   GEO; GSM1718268
DR   IGSR; HG00445
DR   Wikidata; Q54883551
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00446
AC   CVCL_P894
DR   BioSamples; SAME123880
DR   Coriell; HG00446
DR   GEO; GSM649720
DR   GEO; GSM1718269
DR   IGSR; HG00446
DR   Wikidata; Q54883553
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00447
AC   CVCL_P895
DR   BioSamples; SAME124953
DR   Coriell; HG00447
DR   GEO; GSM649721
DR   IGSR; HG00447
DR   Wikidata; Q54883554
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00448
AC   CVCL_P896
DR   BioSamples; SAME124200
DR   Coriell; HG00448
DR   GEO; GSM649722
DR   GEO; GSM1718270
DR   IGSR; HG00448
DR   Wikidata; Q54883555
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00449
AC   CVCL_P897
DR   BioSamples; SAME123885
DR   Coriell; HG00449
DR   GEO; GSM649723
DR   GEO; GSM1718271
DR   IGSR; HG00449
DR   Wikidata; Q54883556
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00450
AC   CVCL_P898
DR   BioSamples; SAME125167
DR   Coriell; HG00450
DR   GEO; GSM649724
DR   IGSR; HG00450
DR   Wikidata; Q54883557
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00451
AC   CVCL_P899
DR   BioSamples; SAME125159
DR   Coriell; HG00451
DR   GEO; GSM649725
DR   GEO; GSM1718272
DR   IGSR; HG00451
DR   Wikidata; Q54883558
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00452
AC   CVCL_P900
DR   BioSamples; SAME123115
DR   Coriell; HG00452
DR   GEO; GSM649726
DR   GEO; GSM1718273
DR   IGSR; HG00452
DR   Wikidata; Q54883559
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00453
AC   CVCL_P901
DR   BioSamples; SAME123113
DR   Coriell; HG00453
DR   GEO; GSM649727
DR   IGSR; HG00453
DR   Wikidata; Q54883560
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00457
AC   CVCL_P902
DR   BioSamples; SAME123095
DR   Coriell; HG00457
DR   GEO; GSM649728
DR   GEO; GSM1718274
DR   IGSR; HG00457
DR   Wikidata; Q54883561
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00458
AC   CVCL_P903
DR   BioSamples; SAME125278
DR   Coriell; HG00458
DR   GEO; GSM649729
DR   GEO; GSM1718275
DR   IGSR; HG00458
DR   Wikidata; Q54883562
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00459
AC   CVCL_P904
DR   BioSamples; SAME125269
DR   Coriell; HG00459
DR   GEO; GSM649730
DR   IGSR; HG00459
DR   Wikidata; Q54883563
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00463
AC   CVCL_P905
DR   BioSamples; SAME123496
DR   Coriell; HG00463
DR   GEO; GSM649731
DR   GEO; GSM1718276
DR   IGSR; HG00463
DR   Wikidata; Q54883564
RX   PubMed=21397061;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00464
AC   CVCL_P906
DR   BioSamples; SAME123497
DR   Coriell; HG00464
DR   GEO; GSM649732
DR   GEO; GSM1718277
DR   IGSR; HG00464
DR   Wikidata; Q54883565
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00465
AC   CVCL_P907
DR   BioSamples; SAME123498
DR   Coriell; HG00465
DR   GEO; GSM649733
DR   IGSR; HG00465
DR   Wikidata; Q54883566
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00472
AC   CVCL_P908
DR   BioSamples; SAME123339
DR   Coriell; HG00472
DR   GEO; GSM649734
DR   GEO; GSM1718278
DR   IGSR; HG00472
DR   Wikidata; Q54883567
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00473
AC   CVCL_P909
DR   BioSamples; SAME123338
DR   Coriell; HG00473
DR   GEO; GSM649735
DR   GEO; GSM1718279
DR   IGSR; HG00473
DR   Wikidata; Q54883568
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00474
AC   CVCL_P910
DR   BioSamples; SAME123343
DR   Coriell; HG00474
DR   GEO; GSM649736
DR   IGSR; HG00474
DR   Wikidata; Q54883569
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00475
AC   CVCL_P911
DR   BioSamples; SAME123342
DR   Coriell; HG00475
DR   GEO; GSM649737
DR   GEO; GSM1718280
DR   IGSR; HG00475
DR   Wikidata; Q54883570
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00476
AC   CVCL_P912
DR   BioSamples; SAME123341
DR   Coriell; HG00476
DR   GEO; GSM649738
DR   GEO; GSM1718281
DR   IGSR; HG00476
DR   Wikidata; Q54883571
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00477
AC   CVCL_P913
DR   BioSamples; SAME123340
DR   Coriell; HG00477
DR   GEO; GSM649739
DR   IGSR; HG00477
DR   Wikidata; Q54883572
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00478
AC   CVCL_P914
DR   BioSamples; SAME123335
DR   Coriell; HG00478
DR   GEO; GSM649740
DR   GEO; GSM1718282
DR   IGSR; HG00478
DR   Wikidata; Q54883573
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00479
AC   CVCL_P915
DR   BioSamples; SAME123334
DR   Coriell; HG00479
DR   GEO; GSM649741
DR   GEO; GSM1718283
DR   IGSR; HG00479
DR   Wikidata; Q54883574
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00480
AC   CVCL_P916
DR   BioSamples; SAME124617
DR   Coriell; HG00480
DR   GEO; GSM649742
DR   IGSR; HG00480
DR   Wikidata; Q54883575
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00500
AC   CVCL_P917
DR   BioSamples; SAME123363
DR   Coriell; HG00500
DR   GEO; GSM649743
DR   GEO; GSM1718284
DR   IGSR; HG00500
DR   Wikidata; Q54883576
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00501
AC   CVCL_P918
DR   BioSamples; SAME123362
DR   Coriell; HG00501
DR   GEO; GSM649744
DR   GEO; GSM1718285
DR   IGSR; HG00501
DR   Wikidata; Q54883577
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00502
AC   CVCL_P919
DR   BioSamples; SAME123361
DR   Coriell; HG00502
DR   GEO; GSM649745
DR   IGSR; HG00502
DR   Wikidata; Q54883578
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00512
AC   CVCL_P920
DR   4DN; 4DNSRLMHZQFT
DR   BioSamples; SAME123525
DR   Coriell; HG00512
DR   GEO; GSM649746
DR   IGSR; HG00512
DR   Wikidata; Q54883579
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00513
AC   CVCL_P921
DR   4DN; 4DNSREWJQFW7
DR   BioSamples; SAME123526
DR   Coriell; HG00513
DR   GEO; GSM649747
DR   GEO; GSM1718286
DR   IGSR; HG00513
DR   Wikidata; Q54883580
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00514
AC   CVCL_P922
DR   4DN; 4DNSR55ZF71Z
DR   BioSamples; SAME123522
DR   Coriell; HG00514
DR   GEO; GSM649748
DR   IGSR; HG00514
DR   Wikidata; Q54883581
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG00524
AC   CVCL_P923
DR   BioSamples; SAME123724
DR   Coriell; HG00524
DR   GEO; GSM649749
DR   GEO; GSM1718287
DR   IGSR; HG00524
DR   Wikidata; Q54883583
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00525
AC   CVCL_P924
DR   BioSamples; SAME123242
DR   Coriell; HG00525
DR   GEO; GSM649750
DR   GEO; GSM1718288
DR   IGSR; HG00525
DR   Wikidata; Q54883585
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00526
AC   CVCL_P925
DR   BioSamples; SAME123395
DR   Coriell; HG00526
DR   GEO; GSM649751
DR   IGSR; HG00526
DR   Wikidata; Q54883586
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00530
AC   CVCL_P926
DR   BioSamples; SAME124356
DR   Coriell; HG00530
DR   GEO; GSM649752
DR   GEO; GSM1718289
DR   IGSR; HG00530
DR   Wikidata; Q54883587
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00531
AC   CVCL_P927
DR   BioSamples; SAME125381
DR   Coriell; HG00531
DR   GEO; GSM649753
DR   GEO; GSM1718290
DR   IGSR; HG00531
DR   Wikidata; Q54883588
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00532
AC   CVCL_P928
DR   BioSamples; SAME125268
DR   Coriell; HG00532
DR   GEO; GSM649754
DR   IGSR; HG00532
DR   Wikidata; Q54883589
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00533
AC   CVCL_P929
DR   BioSamples; SAME124353
DR   Coriell; HG00533
DR   GEO; GSM649755
DR   GEO; GSM1718291
DR   IGSR; HG00533
DR   Wikidata; Q54883590
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00534
AC   CVCL_P930
DR   BioSamples; SAME123915
DR   Coriell; HG00534
DR   GEO; GSM649756
DR   GEO; GSM1718292
DR   IGSR; HG00534
DR   Wikidata; Q54883591
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00535
AC   CVCL_P931
DR   BioSamples; SAME124348
DR   Coriell; HG00535
DR   GEO; GSM649757
DR   IGSR; HG00535
DR   Wikidata; Q54883592
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00536
AC   CVCL_P932
DR   BioSamples; SAME124344
DR   Coriell; HG00536
DR   GEO; GSM649758
DR   GEO; GSM1718293
DR   IGSR; HG00536
DR   Wikidata; Q54883593
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00537
AC   CVCL_P933
DR   BioSamples; SAME124345
DR   Coriell; HG00537
DR   GEO; GSM649759
DR   GEO; GSM1718294
DR   IGSR; HG00537
DR   Wikidata; Q54883594
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00538
AC   CVCL_P934
DR   BioSamples; SAME124343
DR   Coriell; HG00538
DR   GEO; GSM649760
DR   IGSR; HG00538
DR   Wikidata; Q54883597
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00542
AC   CVCL_P935
DR   BioSamples; SAME124352
DR   Coriell; HG00542
DR   GEO; GSM649761
DR   GEO; GSM1718295
DR   IGSR; HG00542
DR   Wikidata; Q54883599
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00543
AC   CVCL_P936
DR   BioSamples; SAME122857
DR   Coriell; HG00543
DR   GEO; GSM649762
DR   GEO; GSM1718296
DR   IGSR; HG00543
DR   Wikidata; Q54883600
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00544
AC   CVCL_P937
DR   BioSamples; SAME124086
DR   Coriell; HG00544
DR   GEO; GSM649763
DR   IGSR; HG00544
DR   Wikidata; Q54883601
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00551
AC   CVCL_P938
DR   BioSamples; SAME124252
DR   Coriell; HG00551
DR   GEO; GSM1718297
DR   IGSR; HG00551
DR   Wikidata; Q54883602
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00552
AC   CVCL_P939
DR   BioSamples; SAME124253
DR   Coriell; HG00552
DR   IGSR; HG00552
DR   Wikidata; Q54883603
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00553
AC   CVCL_P940
DR   BioSamples; SAME124254
DR   Coriell; HG00553
DR   GEO; GSM1718298
DR   IGSR; HG00553
DR   Wikidata; Q54883604
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00554
AC   CVCL_P941
DR   BioSamples; SAME123969
DR   Coriell; HG00554
DR   GEO; GSM1718299
DR   IGSR; HG00554
DR   Wikidata; Q54883605
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00555
AC   CVCL_P942
DR   BioSamples; SAME122856
DR   Coriell; HG00555
DR   IGSR; HG00555
DR   Wikidata; Q54883606
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00556
AC   CVCL_P943
DR   BioSamples; SAME123971
DR   Coriell; HG00556
DR   GEO; GSM649764
DR   GEO; GSM1718300
DR   IGSR; HG00556
DR   Wikidata; Q54883607
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00557
AC   CVCL_P944
DR   BioSamples; SAME124258
DR   Coriell; HG00557
DR   GEO; GSM649765
DR   GEO; GSM1718301
DR   IGSR; HG00557
DR   Wikidata; Q54883608
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00558
AC   CVCL_P945
DR   BioSamples; SAME124247
DR   Coriell; HG00558
DR   GEO; GSM649766
DR   IGSR; HG00558
DR   Wikidata; Q54883609
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00559
AC   CVCL_P946
DR   BioSamples; SAME124248
DR   Coriell; HG00559
DR   GEO; GSM649767
DR   GEO; GSM1718302
DR   IGSR; HG00559
DR   Wikidata; Q54883610
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00560
AC   CVCL_P947
DR   BioSamples; SAME124456
DR   Coriell; HG00560
DR   GEO; GSM649768
DR   GEO; GSM1718303
DR   IGSR; HG00560
DR   Wikidata; Q54883611
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00561
AC   CVCL_P948
DR   BioSamples; SAME124455
DR   Coriell; HG00561
DR   GEO; GSM649769
DR   IGSR; HG00561
DR   Wikidata; Q54883612
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00565
AC   CVCL_P949
DR   BioSamples; SAME124452
DR   Coriell; HG00565
DR   GEO; GSM649770
DR   GEO; GSM1718304
DR   IGSR; HG00565
DR   Wikidata; Q54883613
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00566
AC   CVCL_P950
DR   BioSamples; SAME125048
DR   Coriell; HG00566
DR   GEO; GSM649771
DR   GEO; GSM1718305
DR   IGSR; HG00566
DR   Wikidata; Q54883614
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00567
AC   CVCL_P951
DR   BioSamples; SAME124453
DR   Coriell; HG00567
DR   GEO; GSM649772
DR   IGSR; HG00567
DR   Wikidata; Q54883615
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00577
AC   CVCL_P952
DR   BioSamples; SAME123516
DR   Coriell; HG00577
DR   GEO; GSM649773
DR   IGSR; HG00577
DR   Wikidata; Q54883616
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00578
AC   CVCL_P953
DR   BioSamples; SAME123528
DR   Coriell; HG00578
DR   GEO; GSM649774
DR   IGSR; HG00578
DR   Wikidata; Q54883617
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00579
AC   CVCL_P954
DR   BioSamples; SAME123530
DR   Coriell; HG00579
DR   GEO; GSM649775
DR   IGSR; HG00579
DR   Wikidata; Q54883618
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00580
AC   CVCL_P955
DR   BioSamples; SAME124832
DR   Coriell; HG00580
DR   GEO; GSM649776
DR   GEO; GSM1718306
DR   IGSR; HG00580
DR   Wikidata; Q54883619
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00581
AC   CVCL_P956
DR   BioSamples; SAME124831
DR   Coriell; HG00581
DR   GEO; GSM649777
DR   GEO; GSM1718307
DR   IGSR; HG00581
DR   Wikidata; Q54883620
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00582
AC   CVCL_P957
DR   BioSamples; SAME124830
DR   Coriell; HG00582
DR   GEO; GSM649778
DR   IGSR; HG00582
DR   Wikidata; Q54883621
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00583
AC   CVCL_P958
DR   BioSamples; SAME124829
DR   Coriell; HG00583
DR   GEO; GSM649779
DR   GEO; GSM1718308
DR   IGSR; HG00583
DR   Wikidata; Q54883622
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00584
AC   CVCL_P959
DR   BioSamples; SAME124663
DR   Coriell; HG00584
DR   GEO; GSM649780
DR   GEO; GSM1718309
DR   IGSR; HG00584
DR   Wikidata; Q54883623
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00585
AC   CVCL_P960
DR   BioSamples; SAME124722
DR   Coriell; HG00585
DR   GEO; GSM649781
DR   IGSR; HG00585
DR   Wikidata; Q54883624
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00589
AC   CVCL_P961
DR   BioSamples; SAME124824
DR   Coriell; HG00589
DR   GEO; GSM649782
DR   GEO; GSM1718310
DR   IGSR; HG00589
DR   Wikidata; Q54883625
RX   PubMed=21397061;
RX   PubMed=26621101;
RX   PubMed=31401124;
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   HG00590
AC   CVCL_P962
DR   BioSamples; SAME125009
DR   Coriell; HG00590
DR   GEO; GSM649783
DR   GEO; GSM1718311
DR   IGSR; HG00590
DR   Wikidata; Q54883627
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00591
AC   CVCL_P963
DR   BioSamples; SAME125010
DR   Coriell; HG00591
DR   GEO; GSM649784
DR   IGSR; HG00591
DR   Wikidata; Q54883628
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00592
AC   CVCL_P964
DR   BioSamples; SAME125011
DR   Coriell; HG00592
DR   GEO; GSM649785
DR   GEO; GSM1718312
DR   IGSR; HG00592
DR   Wikidata; Q54883629
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00593
AC   CVCL_P965
DR   BioSamples; SAME125012
DR   Coriell; HG00593
DR   GEO; GSM649786
DR   GEO; GSM1718313
DR   IGSR; HG00593
DR   Wikidata; Q54883630
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00594
AC   CVCL_P966
DR   BioSamples; SAME125005
DR   Coriell; HG00594
DR   GEO; GSM649787
DR   IGSR; HG00594
DR   Wikidata; Q54883631
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00595
AC   CVCL_P967
DR   BioSamples; SAME125006
DR   Coriell; HG00595
DR   GEO; GSM649788
DR   GEO; GSM1718314
DR   IGSR; HG00595
DR   Wikidata; Q54883632
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00596
AC   CVCL_P968
DR   BioSamples; SAME125007
DR   Coriell; HG00596
DR   GEO; GSM649789
DR   GEO; GSM1718315
DR   IGSR; HG00596
DR   Wikidata; Q54883633
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00597
AC   CVCL_P969
DR   BioSamples; SAME125008
DR   Coriell; HG00597
DR   GEO; GSM649790
DR   IGSR; HG00597
DR   Wikidata; Q54883634
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00598
AC   CVCL_P970
DR   BioSamples; SAME1839713
DR   Coriell; HG00598
DR   GEO; GSM1718316
DR   IGSR; HG00598
DR   Wikidata; Q54883635
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00599
AC   CVCL_P971
DR   BioSamples; SAME1839802
DR   Coriell; HG00599
DR   GEO; GSM1718317
DR   IGSR; HG00599
DR   Wikidata; Q54883636
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00607
AC   CVCL_P972
DR   BioSamples; SAME125373
DR   Coriell; HG00607
DR   GEO; GSM649791
DR   GEO; GSM1718318
DR   IGSR; HG00607
DR   Wikidata; Q54883637
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00608
AC   CVCL_P973
DR   BioSamples; SAME125369
DR   Coriell; HG00608
DR   GEO; GSM649792
DR   GEO; GSM1718319
DR   IGSR; HG00608
DR   Wikidata; Q54883638
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00609
AC   CVCL_P974
DR   BioSamples; SAME125370
DR   Coriell; HG00609
DR   GEO; GSM649793
DR   IGSR; HG00609
DR   Wikidata; Q54883643
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00610
AC   CVCL_P975
DR   BioSamples; SAME125199
DR   Coriell; HG00610
DR   GEO; GSM1718320
DR   IGSR; HG00610
DR   Wikidata; Q54883644
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00611
AC   CVCL_P976
DR   BioSamples; SAME125198
DR   Coriell; HG00611
DR   GEO; GSM1718321
DR   IGSR; HG00611
DR   Wikidata; Q54883645
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00612
AC   CVCL_P977
DR   BioSamples; SAME125197
DR   Coriell; HG00612
DR   GEO; GSM649794
DR   IGSR; HG00612
DR   Wikidata; Q54883646
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00613
AC   CVCL_P978
DR   BioSamples; SAME125196
DR   Coriell; HG00613
DR   GEO; GSM649795
DR   GEO; GSM1718322
DR   IGSR; HG00613
DR   Wikidata; Q54883647
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00614
AC   CVCL_P979
DR   BioSamples; SAME125195
DR   Coriell; HG00614
DR   GEO; GSM649796
DR   GEO; GSM1718323
DR   IGSR; HG00614
DR   Wikidata; Q54883648
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00615
AC   CVCL_P980
DR   BioSamples; SAME125194
DR   Coriell; HG00615
DR   GEO; GSM649797
DR   IGSR; HG00615
DR   Wikidata; Q54883649
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00619
AC   CVCL_P981
DR   BioSamples; SAME125193
DR   Coriell; HG00619
DR   GEO; GSM649798
DR   GEO; GSM1718324
DR   IGSR; HG00619
DR   Wikidata; Q54883650
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00620
AC   CVCL_P982
DR   BioSamples; SAME123081
DR   Coriell; HG00620
DR   GEO; GSM649799
DR   GEO; GSM1718325
DR   IGSR; HG00620
DR   Wikidata; Q54883651
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00621
AC   CVCL_P983
DR   BioSamples; SAME123082
DR   Coriell; HG00621
DR   GEO; GSM649800
DR   IGSR; HG00621
DR   Wikidata; Q54883652
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00622
AC   CVCL_P984
DR   BioSamples; SAME1839278
DR   Coriell; HG00622
DR   GEO; GSM1718326
DR   IGSR; HG00622
DR   Wikidata; Q54883653
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00623
AC   CVCL_P985
DR   BioSamples; SAME1839285
DR   Coriell; HG00623
DR   GEO; GSM1718327
DR   IGSR; HG00623
DR   Wikidata; Q54883654
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00625
AC   CVCL_P986
DR   BioSamples; SAME123080
DR   Coriell; HG00625
DR   GEO; GSM649801
DR   GEO; GSM1718328
DR   IGSR; HG00625
DR   Wikidata; Q54883655
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00626
AC   CVCL_P987
DR   BioSamples; SAME123078
DR   Coriell; HG00626
DR   GEO; GSM649802
DR   GEO; GSM1718329
DR   IGSR; HG00626
DR   Wikidata; Q54883656
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00627
AC   CVCL_P988
DR   BioSamples; SAME123079
DR   Coriell; HG00627
DR   GEO; GSM649803
DR   IGSR; HG00627
DR   Wikidata; Q54883657
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00628
AC   CVCL_P989
DR   BioSamples; SAME123085
DR   Coriell; HG00628
DR   GEO; GSM649804
DR   GEO; GSM1718330
DR   IGSR; HG00628
DR   Wikidata; Q54883658
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00629
AC   CVCL_P990
DR   BioSamples; SAME123086
DR   Coriell; HG00629
DR   GEO; GSM649805
DR   GEO; GSM1718331
DR   IGSR; HG00629
DR   Wikidata; Q54883659
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00630
AC   CVCL_P991
DR   BioSamples; SAME122901
DR   Coriell; HG00630
DR   GEO; GSM649806
DR   IGSR; HG00630
DR   Wikidata; Q54883660
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00631
AC   CVCL_P992
DR   BioSamples; SAME1839060
DR   Coriell; HG00631
DR   GEO; GSM1718332
DR   IGSR; HG00631
DR   Wikidata; Q54883661
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00632
AC   CVCL_P993
DR   BioSamples; SAME1839151
DR   Coriell; HG00632
DR   GEO; GSM1718333
DR   IGSR; HG00632
DR   Wikidata; Q54883662
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00634
AC   CVCL_P994
DR   BioSamples; SAME122903
DR   Coriell; HG00634
DR   GEO; GSM649807
DR   GEO; GSM1718334
DR   IGSR; HG00634
DR   Wikidata; Q54883663
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00635
AC   CVCL_P995
DR   BioSamples; SAME122902
DR   Coriell; HG00635
DR   GEO; GSM649808
DR   GEO; GSM1718335
DR   IGSR; HG00635
DR   Wikidata; Q54883664
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00636
AC   CVCL_P996
DR   BioSamples; SAME123711
DR   Coriell; HG00636
DR   GEO; GSM649809
DR   IGSR; HG00636
DR   Wikidata; Q54883665
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00637
AC   CVCL_P997
DR   BioSamples; SAME123710
DR   Coriell; HG00637
DR   GEO; GSM1718336
DR   IGSR; HG00637
DR   Wikidata; Q54883666
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00638
AC   CVCL_P998
DR   BioSamples; SAME123652
DR   Coriell; HG00638
DR   GEO; GSM1718337
DR   IGSR; HG00638
DR   Wikidata; Q54883667
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00639
AC   CVCL_P999
DR   BioSamples; SAME123650
DR   Coriell; HG00639
DR   IGSR; HG00639
DR   Wikidata; Q54883668
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00640
AC   CVCL_Q000
DR   BioSamples; SAME123434
DR   Coriell; HG00640
DR   GEO; GSM1718338
DR   IGSR; HG00640
DR   Wikidata; Q54883669
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00641
AC   CVCL_Q001
DR   BioSamples; SAME123435
DR   Coriell; HG00641
DR   GEO; GSM1718339
DR   IGSR; HG00641
DR   Wikidata; Q54883670
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00642
AC   CVCL_Q002
DR   BioSamples; SAME123436
DR   Coriell; HG00642
DR   IGSR; HG00642
DR   Wikidata; Q54883671
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00650
AC   CVCL_Q003
DR   BioSamples; SAME123254
DR   Coriell; HG00650
DR   GEO; GSM649810
DR   GEO; GSM1718340
DR   IGSR; HG00650
DR   Wikidata; Q54883672
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00651
AC   CVCL_Q004
DR   BioSamples; SAME123966
DR   Coriell; HG00651
DR   GEO; GSM649811
DR   GEO; GSM1718341
DR   IGSR; HG00651
DR   Wikidata; Q54883673
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00652
AC   CVCL_Q005
DR   BioSamples; SAME123252
DR   Coriell; HG00652
DR   GEO; GSM649812
DR   IGSR; HG00652
DR   Wikidata; Q54883674
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00653
AC   CVCL_Q006
DR   BioSamples; SAME123251
DR   Coriell; HG00653
DR   GEO; GSM649813
DR   GEO; GSM1718342
DR   IGSR; HG00653
DR   Wikidata; Q54883675
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00654
AC   CVCL_Q007
DR   BioSamples; SAME123234
DR   Coriell; HG00654
DR   GEO; GSM649814
DR   GEO; GSM1718343
DR   IGSR; HG00654
DR   Wikidata; Q54883676
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00655
AC   CVCL_Q008
DR   BioSamples; SAME123257
DR   Coriell; HG00655
DR   GEO; GSM649815
DR   IGSR; HG00655
DR   Wikidata; Q54883677
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00656
AC   CVCL_Q009
DR   BioSamples; SAME123233
DR   Coriell; HG00656
DR   GEO; GSM649816
DR   GEO; GSM1718344
DR   IGSR; HG00656
DR   Wikidata; Q54883678
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00657
AC   CVCL_Q010
DR   BioSamples; SAME123255
DR   Coriell; HG00657
DR   GEO; GSM649817
DR   GEO; GSM1718345
DR   IGSR; HG00657
DR   Wikidata; Q54883679
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00658
AC   CVCL_Q011
DR   BioSamples; SAME123241
DR   Coriell; HG00658
DR   GEO; GSM649818
DR   IGSR; HG00658
DR   Wikidata; Q54883680
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00662
AC   CVCL_Q012
DR   BioSamples; SAME123812
DR   Coriell; HG00662
DR   GEO; GSM649819
DR   GEO; GSM1718346
DR   IGSR; HG00662
DR   Wikidata; Q54883681
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00663
AC   CVCL_Q013
DR   BioSamples; SAME123813
DR   Coriell; HG00663
DR   GEO; GSM649820
DR   GEO; GSM1718347
DR   IGSR; HG00663
DR   Wikidata; Q54883682
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00664
AC   CVCL_Q014
DR   BioSamples; SAME123814
DR   Coriell; HG00664
DR   GEO; GSM649821
DR   IGSR; HG00664
DR   Wikidata; Q54883688
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00671
AC   CVCL_Q015
DR   BioSamples; SAME123604
DR   Coriell; HG00671
DR   GEO; GSM649822
DR   GEO; GSM1718348
DR   IGSR; HG00671
DR   Wikidata; Q54883689
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00672
AC   CVCL_Q016
DR   BioSamples; SAME123606
DR   Coriell; HG00672
DR   GEO; GSM649823
DR   GEO; GSM1718349
DR   IGSR; HG00672
DR   Wikidata; Q54883690
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00673
AC   CVCL_Q017
DR   BioSamples; SAME123605
DR   Coriell; HG00673
DR   GEO; GSM649824
DR   IGSR; HG00673
DR   Wikidata; Q54883691
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00674
AC   CVCL_Q018
DR   BioSamples; SAME1840080
DR   Coriell; HG00674
DR   GEO; GSM1718350
DR   IGSR; HG00674
DR   Wikidata; Q54883693
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00675
AC   CVCL_Q019
DR   BioSamples; SAME1840076
DR   Coriell; HG00675
DR   GEO; GSM1718351
DR   IGSR; HG00675
DR   Wikidata; Q54883695
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00683
AC   CVCL_Q020
DR   BioSamples; SAME123892
DR   Coriell; HG00683
DR   GEO; GSM649825
DR   GEO; GSM1718352
DR   IGSR; HG00683
DR   Wikidata; Q54883696
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00684
AC   CVCL_Q021
DR   BioSamples; SAME123890
DR   Coriell; HG00684
DR   GEO; GSM649826
DR   GEO; GSM1718353
DR   IGSR; HG00684
DR   Wikidata; Q54883697
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00685
AC   CVCL_Q022
DR   BioSamples; SAME123891
DR   Coriell; HG00685
DR   GEO; GSM649827
DR   IGSR; HG00685
DR   Wikidata; Q54883698
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00689
AC   CVCL_Q023
DR   BioSamples; SAME123893
DR   Coriell; HG00689
DR   GEO; GSM649828
DR   GEO; GSM1718354
DR   IGSR; HG00689
DR   Wikidata; Q54883699
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00690
AC   CVCL_Q024
DR   BioSamples; SAME123686
DR   Coriell; HG00690
DR   GEO; GSM649829
DR   GEO; GSM1718355
DR   IGSR; HG00690
DR   Wikidata; Q54883701
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00691
AC   CVCL_Q025
DR   BioSamples; SAME123161
DR   Coriell; HG00691
DR   GEO; GSM649830
DR   IGSR; HG00691
DR   Wikidata; Q54883702
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00692
AC   CVCL_Q026
DR   BioSamples; SAME123684
DR   Coriell; HG00692
DR   GEO; GSM649831
DR   GEO; GSM1718356
DR   IGSR; HG00692
DR   Wikidata; Q54883703
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00693
AC   CVCL_Q027
DR   BioSamples; SAME123683
DR   Coriell; HG00693
DR   GEO; GSM649832
DR   GEO; GSM1718357
DR   IGSR; HG00693
DR   Wikidata; Q54883704
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00694
AC   CVCL_Q028
DR   BioSamples; SAME123154
DR   Coriell; HG00694
DR   GEO; GSM649833
DR   IGSR; HG00694
DR   Wikidata; Q54883705
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00698
AC   CVCL_Q029
DR   BioSamples; SAME123693
DR   Coriell; HG00698
DR   GEO; GSM649834
DR   GEO; GSM1718358
DR   IGSR; HG00698
DR   Wikidata; Q54883706
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00699
AC   CVCL_Q030
DR   BioSamples; SAME123165
DR   Coriell; HG00699
DR   GEO; GSM649835
DR   GEO; GSM1718359
DR   IGSR; HG00699
DR   Wikidata; Q54883707
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00700
AC   CVCL_Q031
DR   BioSamples; SAME122932
DR   Coriell; HG00700
DR   GEO; GSM649836
DR   IGSR; HG00700
DR   Wikidata; Q54883708
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00701
AC   CVCL_Q032
DR   BioSamples; SAME122931
DR   Coriell; HG00701
DR   GEO; GSM649837
DR   GEO; GSM1718360
DR   IGSR; HG00701
DR   Wikidata; Q54883709
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00702
AC   CVCL_Q033
DR   BioSamples; SAME122934
DR   Coriell; HG00702
DR   GEO; GSM649838
DR   GEO; GSM1718361
DR   IGSR; HG00702
DR   Wikidata; Q54883710
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00703
AC   CVCL_Q034
DR   BioSamples; SAME122933
DR   Coriell; HG00703
DR   GEO; GSM649839
DR   IGSR; HG00703
DR   Wikidata; Q54883712
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00704
AC   CVCL_Q035
DR   BioSamples; SAME122928
DR   Coriell; HG00704
DR   GEO; GSM649840
DR   GEO; GSM1718362
DR   IGSR; HG00704
DR   Wikidata; Q54883713
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00705
AC   CVCL_Q036
DR   BioSamples; SAME122927
DR   Coriell; HG00705
DR   GEO; GSM649841
DR   GEO; GSM1718363
DR   IGSR; HG00705
DR   Wikidata; Q54883714
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00706
AC   CVCL_Q037
DR   BioSamples; SAME122930
DR   Coriell; HG00706
DR   GEO; GSM649842
DR   IGSR; HG00706
DR   Wikidata; Q54883715
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00707
AC   CVCL_Q038
DR   BioSamples; SAME122929
DR   Coriell; HG00707
DR   GEO; GSM649843
DR   GEO; GSM1718364
DR   IGSR; HG00707
DR   Wikidata; Q54883716
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00708
AC   CVCL_Q039
DR   BioSamples; SAME122940
DR   Coriell; HG00708
DR   GEO; GSM649844
DR   GEO; GSM1718365
DR   IGSR; HG00708
DR   Wikidata; Q54883717
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00709
AC   CVCL_Q040
DR   BioSamples; SAME125334
DR   Coriell; HG00709
DR   GEO; GSM649845
DR   IGSR; HG00709
DR   Wikidata; Q54883718
RX   PubMed=21397061;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00717
AC   CVCL_GU08
DR   BioSamples; SAME124926
DR   Coriell; HG00717
DR   GEO; GSM1718366
DR   IGSR; HG00717
DR   Wikidata; Q54883719
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG00728
AC   CVCL_Q041
DR   BioSamples; SAME1840267
DR   Coriell; HG00728
DR   GEO; GSM1718367
DR   IGSR; HG00728
DR   Wikidata; Q54883720
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00729
AC   CVCL_Q042
DR   BioSamples; SAME1840273
DR   Coriell; HG00729
DR   GEO; GSM1718368
DR   IGSR; HG00729
DR   Wikidata; Q54883721
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese; Han in the South (CHS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00731
AC   CVCL_Q043
DR   4DN; 4DNSR5JKFTEH
DR   BioSamples; SAME125390
DR   Coriell; HG00731
DR   GEO; GSM1718369
DR   IGSR; HG00731
DR   Wikidata; Q54883722
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00732
AC   CVCL_Q044
DR   4DN; 4DNSR35GW47J
DR   BioSamples; SAME125396
DR   Coriell; HG00732
DR   GEO; GSM1718370
DR   IGSR; HG00732
DR   Wikidata; Q54883723
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00733
AC   CVCL_Q045
DR   4DN; 4DNSRMW6MTYY
DR   BioSamples; SAME125399
DR   Coriell; HG00733
DR   GEO; GSM1718371
DR   IGSR; HG00733
DR   Wikidata; Q54883724
WW   Info; Complete Genomics; -; https://web.archive.org/web/20220626143727/http://www.completegenomics.com/documents/PublicGenomes.pdf
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00734
AC   CVCL_Q046
DR   BioSamples; SAME123016
DR   Coriell; HG00734
DR   GEO; GSM1718372
DR   IGSR; HG00734
DR   Wikidata; Q54883725
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00735
AC   CVCL_Q047
DR   BioSamples; SAME123042
DR   Coriell; HG00735
DR   IGSR; HG00735
DR   Wikidata; Q54883726
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00736
AC   CVCL_Q048
DR   BioSamples; SAME123058
DR   Coriell; HG00736
DR   GEO; GSM1718373
DR   IGSR; HG00736
DR   Wikidata; Q54883727
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00737
AC   CVCL_Q049
DR   BioSamples; SAME125416
DR   Coriell; HG00737
DR   GEO; GSM1718374
DR   IGSR; HG00737
DR   Wikidata; Q54883728
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00738
AC   CVCL_Q050
DR   BioSamples; SAME125368
DR   Coriell; HG00738
DR   IGSR; HG00738
DR   Wikidata; Q54883729
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00739
AC   CVCL_Q051
DR   BioSamples; SAME125113
DR   Coriell; HG00739
DR   GEO; GSM1718375
DR   IGSR; HG00739
DR   Wikidata; Q54883730
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00740
AC   CVCL_Q052
DR   BioSamples; SAME124834
DR   Coriell; HG00740
DR   GEO; GSM1718376
DR   IGSR; HG00740
DR   Wikidata; Q54883731
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00741
AC   CVCL_Q053
DR   BioSamples; SAME124833
DR   Coriell; HG00741
DR   IGSR; HG00741
DR   Wikidata; Q54883739
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG00742
AC   CVCL_GU09
DR   BioSamples; SAME1840188
DR   Coriell; HG00742
DR   GEO; GSM1718377
DR   IGSR; HG00742
DR   Wikidata; Q54883740
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG00743
AC   CVCL_GU10
DR   BioSamples; SAME1840184
DR   Coriell; HG00743
DR   GEO; GSM1718378
DR   IGSR; HG00743
DR   Wikidata; Q54883741
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG00759
AC   CVCL_Q054
DR   BioSamples; SAME125020
DR   Coriell; HG00759
DR   GEO; GSM1718379
DR   IGSR; HG00759
DR   Wikidata; Q54883742
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00766
AC   CVCL_Q055
DR   BioSamples; SAME124458
DR   Coriell; HG00766
DR   GEO; GSM1718380
DR   IGSR; HG00766
DR   Wikidata; Q54883743
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00844
AC   CVCL_Q056
DR   BioSamples; SAME123952
DR   Coriell; HG00844
DR   GEO; GSM1718381
DR   IGSR; HG00844
DR   Wikidata; Q54883744
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00851
AC   CVCL_Q057
DR   BioSamples; SAME123756
DR   Coriell; HG00851
DR   GEO; GSM1718382
DR   IGSR; HG00851
DR   Wikidata; Q54883745
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00864
AC   CVCL_Q058
DR   BioSamples; SAME123547
DR   Coriell; HG00864
DR   GEO; GSM1718383
DR   IGSR; HG00864
DR   Wikidata; Q54883746
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00866
AC   CVCL_Q059
DR   BioSamples; SAME123549
DR   Coriell; HG00866
DR   IGSR; HG00866
DR   Wikidata; Q54883747
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00867
AC   CVCL_Q060
DR   BioSamples; SAME123550
DR   Coriell; HG00867
DR   GEO; GSM1718384
DR   IGSR; HG00867
DR   Wikidata; Q54883748
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00879
AC   CVCL_Q061
DR   BioSamples; SAME123399
DR   Coriell; HG00879
DR   GEO; GSM1718385
DR   IGSR; HG00879
DR   Wikidata; Q54883749
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00881
AC   CVCL_Q062
DR   BioSamples; SAME123540
DR   Coriell; HG00881
DR   GEO; GSM1718386
DR   IGSR; HG00881
DR   Wikidata; Q54883750
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00956
AC   CVCL_Q063
DR   BioSamples; SAME124319
DR   Coriell; HG00956
DR   GEO; GSM1718387
DR   IGSR; HG00956
DR   Wikidata; Q54883751
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00978
AC   CVCL_Q064
DR   BioSamples; SAME124727
DR   Coriell; HG00978
DR   GEO; GSM1718388
DR   IGSR; HG00978
DR   Wikidata; Q54883752
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00982
AC   CVCL_Q065
DR   BioSamples; SAME123770
DR   Coriell; HG00982
DR   GEO; GSM1718389
DR   IGSR; HG00982
DR   Wikidata; Q54883753
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG00983
AC   CVCL_Q066
DR   BioSamples; SAME123769
DR   Coriell; HG00983
DR   IGSR; HG00983
DR   Wikidata; Q54883754
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01028
AC   CVCL_Q067
DR   BioSamples; SAME123524
DR   Coriell; HG01028
DR   GEO; GSM1718390
DR   IGSR; HG01028
DR   Wikidata; Q54883756
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01029
AC   CVCL_Q068
DR   BioSamples; SAME123523
DR   Coriell; HG01029
DR   GEO; GSM1718391
DR   IGSR; HG01029
DR   Wikidata; Q54883757
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01031
AC   CVCL_Q069
DR   BioSamples; SAME123728
DR   Coriell; HG01031
DR   GEO; GSM1718392
DR   IGSR; HG01031
DR   Wikidata; Q54883758
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01046
AC   CVCL_Q070
DR   BioSamples; SAME123167
DR   Coriell; HG01046
DR   GEO; GSM1718393
DR   IGSR; HG01046
DR   Wikidata; Q54883759
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01047
AC   CVCL_Q071
DR   BioSamples; SAME123166
DR   Coriell; HG01047
DR   GEO; GSM1718394
DR   IGSR; HG01047
DR   Wikidata; Q54883760
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01048
AC   CVCL_Q072
DR   BioSamples; SAME123169
DR   Coriell; HG01048
DR   GEO; GSM1718395
DR   IGSR; HG01048
DR   Wikidata; Q54883761
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01049
AC   CVCL_Q073
DR   BioSamples; SAME125248
DR   Coriell; HG01049
DR   GEO; GSM1718396
DR   IGSR; HG01049
DR   Wikidata; Q54883762
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01050
AC   CVCL_Q074
DR   BioSamples; SAME123180
DR   Coriell; HG01050
DR   IGSR; HG01050
DR   Wikidata; Q54883763
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01051
AC   CVCL_Q075
DR   BioSamples; SAME123712
DR   Coriell; HG01051
DR   GEO; GSM1718397
DR   IGSR; HG01051
DR   Wikidata; Q54883764
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01052
AC   CVCL_Q076
DR   BioSamples; SAME123368
DR   Coriell; HG01052
DR   GEO; GSM1718398
DR   IGSR; HG01052
DR   Wikidata; Q54883765
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01053
AC   CVCL_Q077
DR   BioSamples; SAME124866
DR   Coriell; HG01053
DR   IGSR; HG01053
DR   Wikidata; Q54883766
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01054
AC   CVCL_Q078
DR   BioSamples; SAME123663
DR   Coriell; HG01054
DR   GEO; GSM1718399
DR   IGSR; HG01054
DR   Wikidata; Q54883767
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01055
AC   CVCL_Q079
DR   BioSamples; SAME123638
DR   Coriell; HG01055
DR   GEO; GSM1718400
DR   IGSR; HG01055
DR   Wikidata; Q54883768
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01056
AC   CVCL_Q080
DR   BioSamples; SAME123658
DR   Coriell; HG01056
DR   IGSR; HG01056
DR   Wikidata; Q54883769
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01058
AC   CVCL_GU11
DR   BioSamples; SAME1840086
DR   Coriell; HG01058
DR   GEO; GSM1718401
DR   IGSR; HG01058
DR   Wikidata; Q54883770
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01060
AC   CVCL_Q081
DR   BioSamples; SAME123015
DR   Coriell; HG01060
DR   GEO; GSM1718402
DR   IGSR; HG01060
DR   Wikidata; Q54883771
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01061
AC   CVCL_Q082
DR   BioSamples; SAME122821
DR   Coriell; HG01061
DR   GEO; GSM1718403
DR   IGSR; HG01061
DR   Wikidata; Q54883772
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01062
AC   CVCL_Q083
DR   BioSamples; SAME123014
DR   Coriell; HG01062
DR   IGSR; HG01062
DR   Wikidata; Q54883773
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01063
AC   CVCL_GU12
DR   BioSamples; SAME1839767
DR   Coriell; HG01063
DR   GEO; GSM1718404
DR   IGSR; HG01063
DR   Wikidata; Q54883774
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01064
AC   CVCL_GU13
DR   BioSamples; SAME1839759
DR   Coriell; HG01064
DR   GEO; GSM1718405
DR   IGSR; HG01064
DR   Wikidata; Q54883775
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01066
AC   CVCL_Q084
DR   BioSamples; SAME124294
DR   Coriell; HG01066
DR   GEO; GSM1718406
DR   IGSR; HG01066
DR   Wikidata; Q54883776
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01067
AC   CVCL_Q085
DR   BioSamples; SAME122997
DR   Coriell; HG01067
DR   GEO; GSM1718407
DR   IGSR; HG01067
DR   Wikidata; Q54883777
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01068
AC   CVCL_Q086
DR   BioSamples; SAME122826
DR   Coriell; HG01068
DR   IGSR; HG01068
DR   Wikidata; Q54883778
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01069
AC   CVCL_Q087
DR   BioSamples; SAME122825
DR   Coriell; HG01069
DR   GEO; GSM1718408
DR   IGSR; HG01069
DR   Wikidata; Q54883779
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01070
AC   CVCL_Q088
DR   BioSamples; SAME123993
DR   Coriell; HG01070
DR   GEO; GSM1718409
DR   IGSR; HG01070
DR   Wikidata; Q54883787
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01071
AC   CVCL_Q089
DR   BioSamples; SAME123009
DR   Coriell; HG01071
DR   IGSR; HG01071
DR   Wikidata; Q54883788
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01072
AC   CVCL_Q090
DR   BioSamples; SAME124091
DR   Coriell; HG01072
DR   GEO; GSM1718410
DR   IGSR; HG01072
DR   Wikidata; Q54883789
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01073
AC   CVCL_Q091
DR   BioSamples; SAME124095
DR   Coriell; HG01073
DR   GEO; GSM1718411
DR   IGSR; HG01073
DR   Wikidata; Q54883790
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01074
AC   CVCL_Q092
DR   BioSamples; SAME124070
DR   Coriell; HG01074
DR   IGSR; HG01074
DR   Wikidata; Q54883791
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01075
AC   CVCL_Q093
DR   BioSamples; SAME124071
DR   Coriell; HG01075
DR   GEO; GSM1718412
DR   IGSR; HG01075
DR   Wikidata; Q54883792
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01077
AC   CVCL_GU14
DR   BioSamples; SAME1839581
DR   Coriell; HG01077
DR   GEO; GSM1718413
DR   IGSR; HG01077
DR   Wikidata; Q54883793
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01079
AC   CVCL_Q094
DR   BioSamples; SAME123013
DR   Coriell; HG01079
DR   GEO; GSM1718414
DR   IGSR; HG01079
DR   Wikidata; Q54883794
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01080
AC   CVCL_Q095
DR   BioSamples; SAME125333
DR   Coriell; HG01080
DR   GEO; GSM1718415
DR   IGSR; HG01080
DR   Wikidata; Q54883795
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01081
AC   CVCL_Q096
DR   BioSamples; SAME125395
DR   Coriell; HG01081
DR   IGSR; HG01081
DR   Wikidata; Q54883796
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01082
AC   CVCL_Q097
DR   BioSamples; SAME125398
DR   Coriell; HG01082
DR   GEO; GSM1718416
DR   IGSR; HG01082
DR   Wikidata; Q54883797
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01083
AC   CVCL_Q098
DR   BioSamples; SAME125397
DR   Coriell; HG01083
DR   GEO; GSM1718417
DR   IGSR; HG01083
DR   Wikidata; Q54883798
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01084
AC   CVCL_Q099
DR   BioSamples; SAME125392
DR   Coriell; HG01084
DR   IGSR; HG01084
DR   Wikidata; Q54883799
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01085
AC   CVCL_Q100
DR   BioSamples; SAME125391
DR   Coriell; HG01085
DR   GEO; GSM1718418
DR   IGSR; HG01085
DR   Wikidata; Q54883800
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01086
AC   CVCL_Q101
DR   BioSamples; SAME125394
DR   Coriell; HG01086
DR   GEO; GSM1718419
DR   IGSR; HG01086
DR   Wikidata; Q54883801
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01087
AC   CVCL_Q102
DR   BioSamples; SAME125393
DR   Coriell; HG01087
DR   IGSR; HG01087
DR   Wikidata; Q54883802
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01088
AC   CVCL_GU15
DR   BioSamples; SAME1839361
DR   Coriell; HG01088
DR   GEO; GSM1718420
DR   IGSR; HG01088
DR   Wikidata; Q54883803
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01089
AC   CVCL_GU16
DR   BioSamples; SAME1839432
DR   Coriell; HG01089
DR   GEO; GSM1718421
DR   IGSR; HG01089
DR   Wikidata; Q54883804
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01092
AC   CVCL_GU17
DR   BioSamples; SAME1839489
DR   Coriell; HG01092
DR   GEO; GSM1718422
DR   IGSR; HG01092
DR   Wikidata; Q54883805
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01094
AC   CVCL_Q103
DR   BioSamples; SAME122925
DR   Coriell; HG01094
DR   GEO; GSM1718423
DR   IGSR; HG01094
DR   Wikidata; Q54883807
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01095
AC   CVCL_Q104
DR   BioSamples; SAME122926
DR   Coriell; HG01095
DR   GEO; GSM1718424
DR   IGSR; HG01095
DR   Wikidata; Q54883808
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01096
AC   CVCL_Q105
DR   BioSamples; SAME123776
DR   Coriell; HG01096
DR   IGSR; HG01096
DR   Wikidata; Q54883809
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01097
AC   CVCL_Q106
DR   BioSamples; SAME122924
DR   Coriell; HG01097
DR   GEO; GSM1718425
DR   IGSR; HG01097
DR   Wikidata; Q54883810
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01098
AC   CVCL_Q107
DR   BioSamples; SAME123490
DR   Coriell; HG01098
DR   GEO; GSM1718426
DR   IGSR; HG01098
DR   Wikidata; Q54883811
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01099
AC   CVCL_Q108
DR   BioSamples; SAME123771
DR   Coriell; HG01099
DR   IGSR; HG01099
DR   Wikidata; Q54883812
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01100
AC   CVCL_Q109
DR   BioSamples; SAME123676
DR   Coriell; HG01100
DR   IGSR; HG01100
DR   Wikidata; Q54883813
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01101
AC   CVCL_Q110
DR   BioSamples; SAME123677
DR   Coriell; HG01101
DR   GEO; GSM1718427
DR   IGSR; HG01101
DR   Wikidata; Q54883814
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01102
AC   CVCL_Q111
DR   BioSamples; SAME123678
DR   Coriell; HG01102
DR   GEO; GSM1718428
DR   IGSR; HG01102
DR   Wikidata; Q54883815
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01103
AC   CVCL_Q112
DR   BioSamples; SAME123679
DR   Coriell; HG01103
DR   IGSR; HG01103
DR   Wikidata; Q54883816
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01104
AC   CVCL_Q113
DR   BioSamples; SAME123672
DR   Coriell; HG01104
DR   GEO; GSM1718429
DR   IGSR; HG01104
DR   Wikidata; Q54883817
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01105
AC   CVCL_Q114
DR   BioSamples; SAME123673
DR   Coriell; HG01105
DR   GEO; GSM1718430
DR   IGSR; HG01105
DR   Wikidata; Q54883818
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01106
AC   CVCL_Q115
DR   BioSamples; SAME123674
DR   Coriell; HG01106
DR   IGSR; HG01106
DR   Wikidata; Q54883819
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01107
AC   CVCL_Q116
DR   BioSamples; SAME123675
DR   Coriell; HG01107
DR   GEO; GSM1718431
DR   IGSR; HG01107
DR   Wikidata; Q54883820
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01108
AC   CVCL_Q117
DR   BioSamples; SAME123103
DR   Coriell; HG01108
DR   GEO; GSM1718432
DR   IGSR; HG01108
DR   Wikidata; Q54883821
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01109
AC   CVCL_Q118
DR   BioSamples; SAME123669
DR   Coriell; HG01109
DR   IGSR; HG01109
DR   Wikidata; Q54883822
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01110
AC   CVCL_Q119
DR   BioSamples; SAME123487
DR   Coriell; HG01110
DR   GEO; GSM1718433
DR   IGSR; HG01110
DR   Wikidata; Q54883823
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01111
AC   CVCL_Q120
DR   BioSamples; SAME123486
DR   Coriell; HG01111
DR   GEO; GSM1718434
DR   IGSR; HG01111
DR   Wikidata; Q54883824
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01112
AC   CVCL_Q121
DR   BioSamples; SAME123485
DR   Coriell; HG01112
DR   GEO; GSM1718435
DR   IGSR; HG01112
DR   Wikidata; Q54883825
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01113
AC   CVCL_Q122
DR   BioSamples; SAME123484
DR   Coriell; HG01113
DR   GEO; GSM1718436
DR   IGSR; HG01113
DR   Wikidata; Q54883826
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01114
AC   CVCL_Q123
DR   BioSamples; SAME123483
DR   Coriell; HG01114
DR   IGSR; HG01114
DR   Wikidata; Q54883827
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01119
AC   CVCL_GU18
DR   BioSamples; SAME1840402
DR   Coriell; HG01119
DR   GEO; GSM1718437
DR   IGSR; HG01119
DR   Wikidata; Q54883835
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01121
AC   CVCL_Q124
DR   BioSamples; SAME1840127
DR   Coriell; HG01121
DR   GEO; GSM1718438
DR   IGSR; HG01121
DR   Wikidata; Q54883836
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01122
AC   CVCL_Q125
DR   BioSamples; SAME1840203
DR   Coriell; HG01122
DR   GEO; GSM1718439
DR   IGSR; HG01122
DR   Wikidata; Q54883837
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01124
AC   CVCL_Q126
DR   BioSamples; SAME124053
DR   Coriell; HG01124
DR   GEO; GSM1718440
DR   IGSR; HG01124
DR   Wikidata; Q54883838
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01125
AC   CVCL_Q127
DR   BioSamples; SAME124054
DR   Coriell; HG01125
DR   GEO; GSM1718441
DR   IGSR; HG01125
DR   Wikidata; Q54883839
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01126
AC   CVCL_Q128
DR   BioSamples; SAME124052
DR   Coriell; HG01126
DR   IGSR; HG01126
DR   Wikidata; Q54883840
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01130
AC   CVCL_GU19
DR   BioSamples; SAME1839995
DR   Coriell; HG01130
DR   GEO; GSM1718442
DR   IGSR; HG01130
DR   Wikidata; Q54883841
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01131
AC   CVCL_GU20
DR   BioSamples; SAME1839985
DR   Coriell; HG01131
DR   GEO; GSM1718443
DR   IGSR; HG01131
DR   Wikidata; Q54883842
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01133
AC   CVCL_Q129
DR   BioSamples; SAME123884
DR   Coriell; HG01133
DR   GEO; GSM1718444
DR   IGSR; HG01133
DR   Wikidata; Q54883844
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01134
AC   CVCL_Q130
DR   BioSamples; SAME123887
DR   Coriell; HG01134
DR   GEO; GSM1718445
DR   IGSR; HG01134
DR   Wikidata; Q54883845
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01135
AC   CVCL_Q131
DR   BioSamples; SAME123886
DR   Coriell; HG01135
DR   IGSR; HG01135
DR   Wikidata; Q54883846
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01136
AC   CVCL_Q132
DR   BioSamples; SAME123889
DR   Coriell; HG01136
DR   GEO; GSM1718446
DR   IGSR; HG01136
DR   Wikidata; Q54883847
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01137
AC   CVCL_Q133
DR   BioSamples; SAME123888
DR   Coriell; HG01137
DR   GEO; GSM1718447
DR   IGSR; HG01137
DR   Wikidata; Q54883848
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01138
AC   CVCL_Q134
DR   BioSamples; SAME123877
DR   Coriell; HG01138
DR   IGSR; HG01138
DR   Wikidata; Q54883849
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01139
AC   CVCL_Q135
DR   BioSamples; SAME123876
DR   Coriell; HG01139
DR   GEO; GSM1718448
DR   IGSR; HG01139
DR   Wikidata; Q54883850
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01140
AC   CVCL_Q136
DR   BioSamples; SAME124422
DR   Coriell; HG01140
DR   GEO; GSM1718449
DR   IGSR; HG01140
DR   Wikidata; Q54883851
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01141
AC   CVCL_Q137
DR   BioSamples; SAME124423
DR   Coriell; HG01141
DR   IGSR; HG01141
DR   Wikidata; Q54883852
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01142
AC   CVCL_GU21
DR   BioSamples; SAME1839731
DR   Coriell; HG01142
DR   GEO; GSM1718450
DR   IGSR; HG01142
DR   Wikidata; Q54883853
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01148
AC   CVCL_Q138
DR   BioSamples; SAME124424
DR   Coriell; HG01148
DR   GEO; GSM1718451
DR   IGSR; HG01148
DR   Wikidata; Q54883854
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01149
AC   CVCL_Q139
DR   BioSamples; SAME124425
DR   Coriell; HG01149
DR   GEO; GSM1718452
DR   IGSR; HG01149
DR   Wikidata; Q54883855
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01150
AC   CVCL_Q140
DR   BioSamples; SAME124216
DR   Coriell; HG01150
DR   IGSR; HG01150
DR   Wikidata; Q54883856
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01161
AC   CVCL_GU22
DR   BioSamples; SAME1839615
DR   Coriell; HG01161
DR   GEO; GSM1718453
DR   IGSR; HG01161
DR   Wikidata; Q54883857
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01162
AC   CVCL_GU23
DR   BioSamples; SAME1839707
DR   Coriell; HG01162
DR   GEO; GSM1718454
DR   IGSR; HG01162
DR   Wikidata; Q54883858
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01164
AC   CVCL_GU24
DR   BioSamples; SAME1839690
DR   Coriell; HG01164
DR   GEO; GSM1718455
DR   IGSR; HG01164
DR   Wikidata; Q54883859
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01167
AC   CVCL_Q141
DR   BioSamples; SAME124798
DR   Coriell; HG01167
DR   GEO; GSM1718456
DR   IGSR; HG01167
DR   Wikidata; Q54883860
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01168
AC   CVCL_Q142
DR   BioSamples; SAME124796
DR   Coriell; HG01168
DR   GEO; GSM1718457
DR   IGSR; HG01168
DR   Wikidata; Q54883861
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01169
AC   CVCL_GU25
DR   BioSamples; SAME124797
DR   Coriell; HG01169
DR   IGSR; HG01169
DR   Wikidata; Q54883862
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01170
AC   CVCL_Q143
DR   BioSamples; SAME124623
DR   Coriell; HG01170
DR   GEO; GSM1718458
DR   IGSR; HG01170
DR   Wikidata; Q54883863
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01171
AC   CVCL_Q144
DR   BioSamples; SAME124622
DR   Coriell; HG01171
DR   GEO; GSM1718459
DR   IGSR; HG01171
DR   Wikidata; Q54883864
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01172
AC   CVCL_Q145
DR   BioSamples; SAME124625
DR   Coriell; HG01172
DR   IGSR; HG01172
DR   Wikidata; Q54883865
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01173
AC   CVCL_Q146
DR   BioSamples; SAME124624
DR   Coriell; HG01173
DR   GEO; GSM1718460
DR   IGSR; HG01173
DR   Wikidata; Q54883866
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01174
AC   CVCL_Q147
DR   BioSamples; SAME124619
DR   Coriell; HG01174
DR   GEO; GSM1718462
DR   IGSR; HG01174
DR   Wikidata; Q54883867
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01175
AC   CVCL_Q148
DR   BioSamples; SAME124618
DR   Coriell; HG01175
DR   IGSR; HG01175
DR   Wikidata; Q54883868
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01176
AC   CVCL_Q149
DR   BioSamples; SAME124621
DR   Coriell; HG01176
DR   IGSR; HG01176
DR   Wikidata; Q54883869
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01177
AC   CVCL_Q150
DR   BioSamples; SAME124620
DR   Coriell; HG01177
DR   GEO; GSM1718463
DR   IGSR; HG01177
DR   Wikidata; Q54883870
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01178
AC   CVCL_Q151
DR   BioSamples; SAME124616
DR   Coriell; HG01178
DR   IGSR; HG01178
DR   Wikidata; Q54883871
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01182
AC   CVCL_Q152
DR   BioSamples; SAME124789
DR   Coriell; HG01182
DR   GEO; GSM1718464
DR   IGSR; HG01182
DR   Wikidata; Q54883872
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01183
AC   CVCL_Q153
DR   BioSamples; SAME124792
DR   Coriell; HG01183
DR   GEO; GSM1718465
DR   IGSR; HG01183
DR   Wikidata; Q54883873
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01184
AC   CVCL_Q154
DR   BioSamples; SAME124321
DR   Coriell; HG01184
DR   IGSR; HG01184
DR   Wikidata; Q54883874
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01187
AC   CVCL_Q155
DR   BioSamples; SAME124783
DR   Coriell; HG01187
DR   GEO; GSM1718466
DR   IGSR; HG01187
DR   Wikidata; Q54883875
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01188
AC   CVCL_Q156
DR   BioSamples; SAME124927
DR   Coriell; HG01188
DR   GEO; GSM1718467
DR   IGSR; HG01188
DR   Wikidata; Q54883882
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01189
AC   CVCL_Q157
DR   BioSamples; SAME124878
DR   Coriell; HG01189
DR   IGSR; HG01189
DR   Wikidata; Q54883883
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01190
AC   CVCL_Q158
DR   BioSamples; SAME123654
DR   Coriell; HG01190
DR   GEO; GSM1718468
DR   IGSR; HG01190
DR   Wikidata; Q54883884
RX   PubMed=26621101;
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01191
AC   CVCL_Q159
DR   BioSamples; SAME123651
DR   Coriell; HG01191
DR   GEO; GSM1718469
DR   IGSR; HG01191
DR   Wikidata; Q54883885
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01192
AC   CVCL_Q160
DR   BioSamples; SAME124298
DR   Coriell; HG01192
DR   IGSR; HG01192
DR   Wikidata; Q54883887
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01197
AC   CVCL_Q161
DR   BioSamples; SAME124237
DR   Coriell; HG01197
DR   GEO; GSM1718470
DR   IGSR; HG01197
DR   Wikidata; Q54883888
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01198
AC   CVCL_Q162
DR   BioSamples; SAME125228
DR   Coriell; HG01198
DR   GEO; GSM1718471
DR   IGSR; HG01198
DR   Wikidata; Q54883889
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01199
AC   CVCL_Q163
DR   BioSamples; SAME124366
DR   Coriell; HG01199
DR   IGSR; HG01199
DR   Wikidata; Q54883890
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01200
AC   CVCL_GU26
DR   BioSamples; SAME1840109
DR   Coriell; HG01200
DR   GEO; GSM1718472
DR   IGSR; HG01200
DR   Wikidata; Q54883891
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01204
AC   CVCL_Q164
DR   BioSamples; SAME124297
DR   Coriell; HG01204
DR   GEO; GSM1718473
DR   IGSR; HG01204
DR   Wikidata; Q54883892
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01205
AC   CVCL_Q165
DR   BioSamples; SAME124296
DR   Coriell; HG01205
DR   GEO; GSM1718474
DR   IGSR; HG01205
DR   Wikidata; Q54883893
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01206
AC   CVCL_Q166
DR   BioSamples; SAME124295
DR   Coriell; HG01206
DR   IGSR; HG01206
DR   Wikidata; Q54883894
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01241
AC   CVCL_Q167
DR   BioSamples; SAME125065
DR   Coriell; HG01241
DR   GEO; GSM1718475
DR   IGSR; HG01241
DR   Wikidata; Q54883895
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01242
AC   CVCL_Q168
DR   BioSamples; SAME125064
DR   Coriell; HG01242
DR   GEO; GSM1718476
DR   IGSR; HG01242
DR   Wikidata; Q54883896
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01243
AC   CVCL_Q169
DR   BioSamples; SAME125063
DR   Coriell; HG01243
DR   IGSR; HG01243
DR   Wikidata; Q54883897
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01247
AC   CVCL_Q170
DR   BioSamples; SAME125067
DR   Coriell; HG01247
DR   GEO; GSM1718477
DR   IGSR; HG01247
DR   Wikidata; Q54883898
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01248
AC   CVCL_Q171
DR   BioSamples; SAME125058
DR   Coriell; HG01248
DR   GEO; GSM1718478
DR   IGSR; HG01248
DR   Wikidata; Q54883899
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01249
AC   CVCL_Q172
DR   BioSamples; SAME125057
DR   Coriell; HG01249
DR   IGSR; HG01249
DR   Wikidata; Q54883900
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01250
AC   CVCL_Q173
DR   BioSamples; SAME125281
DR   Coriell; HG01250
DR   GEO; GSM1718479
DR   IGSR; HG01250
DR   Wikidata; Q54883901
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01251
AC   CVCL_Q174
DR   BioSamples; SAME125282
DR   Coriell; HG01251
DR   GEO; GSM1718480
DR   IGSR; HG01251
DR   Wikidata; Q54883902
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01252
AC   CVCL_Q175
DR   BioSamples; SAME125283
DR   Coriell; HG01252
DR   IGSR; HG01252
DR   Wikidata; Q54883903
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01253
AC   CVCL_Q176
DR   BioSamples; SAME125284
DR   Coriell; HG01253
DR   GEO; GSM1718481
DR   IGSR; HG01253
DR   Wikidata; Q54883904
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01254
AC   CVCL_Q177
DR   BioSamples; SAME125285
DR   Coriell; HG01254
DR   GEO; GSM1718482
DR   IGSR; HG01254
DR   Wikidata; Q54883905
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01255
AC   CVCL_Q178
DR   BioSamples; SAME125286
DR   Coriell; HG01255
DR   IGSR; HG01255
DR   Wikidata; Q54883906
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01256
AC   CVCL_Q179
DR   BioSamples; SAME125287
DR   Coriell; HG01256
DR   GEO; GSM1718483
DR   IGSR; HG01256
DR   Wikidata; Q54883907
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01257
AC   CVCL_Q180
DR   BioSamples; SAME125288
DR   Coriell; HG01257
DR   GEO; GSM1718484
DR   IGSR; HG01257
DR   Wikidata; Q54883908
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01258
AC   CVCL_Q181
DR   BioSamples; SAME125279
DR   Coriell; HG01258
DR   IGSR; HG01258
DR   Wikidata; Q54883909
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01259
AC   CVCL_Q182
DR   BioSamples; SAME125280
DR   Coriell; HG01259
DR   GEO; GSM1718485
DR   IGSR; HG01259
DR   Wikidata; Q54883910
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01260
AC   CVCL_Q183
DR   BioSamples; SAME122815
DR   Coriell; HG01260
DR   GEO; GSM1718486
DR   IGSR; HG01260
DR   Wikidata; Q54883911
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01261
AC   CVCL_Q184
DR   BioSamples; SAME122814
DR   Coriell; HG01261
DR   IGSR; HG01261
DR   Wikidata; Q54883912
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01269
AC   CVCL_GU27
DR   BioSamples; SAME1839257
DR   Coriell; HG01269
DR   GEO; GSM1718487
DR   IGSR; HG01269
DR   Wikidata; Q54883913
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01271
AC   CVCL_Q185
DR   BioSamples; SAME122998
DR   Coriell; HG01271
DR   GEO; GSM1718488
DR   IGSR; HG01271
DR   Wikidata; Q54883914
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01272
AC   CVCL_Q186
DR   BioSamples; SAME122996
DR   Coriell; HG01272
DR   GEO; GSM1718489
DR   IGSR; HG01272
DR   Wikidata; Q54883915
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01273
AC   CVCL_Q187
DR   BioSamples; SAME124046
DR   Coriell; HG01273
DR   IGSR; HG01273
DR   Wikidata; Q54883916
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01274
AC   CVCL_Q188
DR   BioSamples; SAME123001
DR   Coriell; HG01274
DR   IGSR; HG01274
DR   Wikidata; Q54883917
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01275
AC   CVCL_Q189
DR   BioSamples; SAME123002
DR   Coriell; HG01275
DR   GEO; GSM1718490
DR   IGSR; HG01275
DR   Wikidata; Q54883918
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01276
AC   CVCL_Q190
DR   BioSamples; SAME122999
DR   Coriell; HG01276
DR   IGSR; HG01276
DR   Wikidata; Q54883919
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01277
AC   CVCL_Q191
DR   BioSamples; SAME123000
DR   Coriell; HG01277
DR   GEO; GSM1718491
DR   IGSR; HG01277
DR   Wikidata; Q54883920
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01278
AC   CVCL_Q192
DR   BioSamples; SAME123003
DR   Coriell; HG01278
DR   IGSR; HG01278
DR   Wikidata; Q54883921
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01279
AC   CVCL_Q193
DR   BioSamples; SAME123004
DR   Coriell; HG01279
DR   IGSR; HG01279
DR   Wikidata; Q54883922
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01280
AC   CVCL_GU28
DR   BioSamples; SAME1839113
DR   Coriell; HG01280
DR   GEO; GSM1718492
DR   IGSR; HG01280
DR   Wikidata; Q54883926
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01281
AC   CVCL_GU29
DR   BioSamples; SAME1839107
DR   Coriell; HG01281
DR   GEO; GSM1718493
DR   IGSR; HG01281
DR   Wikidata; Q54883927
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01284
AC   CVCL_GU30
DR   BioSamples; SAME1839191
DR   Coriell; HG01284
DR   GEO; GSM1718494
DR   IGSR; HG01284
DR   Wikidata; Q54883928
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01286
AC   CVCL_GU31
DR   BioSamples; SAME1839176
DR   Coriell; HG01286
DR   GEO; GSM1718495
DR   IGSR; HG01286
DR   Wikidata; Q54883929
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01302
AC   CVCL_GU32
DR   BioSamples; SAME1840038
DR   Coriell; HG01302
DR   GEO; GSM1718496
DR   IGSR; HG01302
DR   Wikidata; Q54883930
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01303
AC   CVCL_GU33
DR   BioSamples; SAME1840027
DR   Coriell; HG01303
DR   GEO; GSM1718497
DR   IGSR; HG01303
DR   Wikidata; Q54883931
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01305
AC   CVCL_GU34
DR   BioSamples; SAME1840020
DR   Coriell; HG01305
DR   GEO; GSM1718498
DR   IGSR; HG01305
DR   Wikidata; Q54883932
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01308
AC   CVCL_GU35
DR   BioSamples; SAME1840002
DR   Coriell; HG01308
DR   GEO; GSM1718499
DR   IGSR; HG01308
DR   Wikidata; Q54883933
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01311
AC   CVCL_GU36
DR   BioSamples; SAME1839796
DR   Coriell; HG01311
DR   GEO; GSM1718500
DR   IGSR; HG01311
DR   Wikidata; Q54883934
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01312
AC   CVCL_GU37
DR   BioSamples; SAME1839791
DR   Coriell; HG01312
DR   GEO; GSM1718501
DR   IGSR; HG01312
DR   Wikidata; Q54883935
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01323
AC   CVCL_GU38
DR   BioSamples; SAME1839534
DR   Coriell; HG01323
DR   GEO; GSM1718502
DR   IGSR; HG01323
DR   Wikidata; Q54883936
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01325
AC   CVCL_GU39
DR   BioSamples; SAME1839604
DR   Coriell; HG01325
DR   GEO; GSM1718503
DR   IGSR; HG01325
DR   Wikidata; Q54883937
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01326
AC   CVCL_GU40
DR   BioSamples; SAME1839598
DR   Coriell; HG01326
DR   GEO; GSM1718504
DR   IGSR; HG01326
DR   Wikidata; Q54883939
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01334
AC   CVCL_Q194
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME123533
DR   Coriell; HG01334
DR   GEO; GSM649846
DR   GEO; GSM1718505
DR   IGSR; HG01334
DR   Wikidata; Q54883940
RX   PubMed=21397061;
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG01341
AC   CVCL_Q195
DR   BioSamples; SAME124859
DR   Coriell; HG01341
DR   GEO; GSM1718506
DR   IGSR; HG01341
DR   Wikidata; Q54883941
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01342
AC   CVCL_Q196
DR   BioSamples; SAME124856
DR   Coriell; HG01342
DR   GEO; GSM1718507
DR   IGSR; HG01342
DR   Wikidata; Q54883942
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01343
AC   CVCL_Q197
DR   BioSamples; SAME124857
DR   Coriell; HG01343
DR   IGSR; HG01343
DR   Wikidata; Q54883943
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01344
AC   CVCL_Q198
DR   BioSamples; SAME124862
DR   Coriell; HG01344
DR   GEO; GSM1718508
DR   IGSR; HG01344
DR   Wikidata; Q54883945
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01345
AC   CVCL_Q199
DR   BioSamples; SAME124863
DR   Coriell; HG01345
DR   GEO; GSM1718509
DR   IGSR; HG01345
DR   Wikidata; Q54883946
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01346
AC   CVCL_Q200
DR   BioSamples; SAME124860
DR   Coriell; HG01346
DR   IGSR; HG01346
DR   Wikidata; Q54883947
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01347
AC   CVCL_Q201
DR   BioSamples; SAME124861
DR   Coriell; HG01347
DR   IGSR; HG01347
DR   Wikidata; Q54883948
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01348
AC   CVCL_Q202
DR   BioSamples; SAME124864
DR   Coriell; HG01348
DR   GEO; GSM1718510
DR   IGSR; HG01348
DR   Wikidata; Q54883949
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01349
AC   CVCL_Q203
DR   BioSamples; SAME124865
DR   Coriell; HG01349
DR   IGSR; HG01349
DR   Wikidata; Q54883950
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01350
AC   CVCL_Q204
DR   BioSamples; SAME124684
DR   Coriell; HG01350
DR   GEO; GSM1718511
DR   IGSR; HG01350
DR   Wikidata; Q54883951
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01351
AC   CVCL_Q205
DR   BioSamples; SAME124683
DR   Coriell; HG01351
DR   GEO; GSM1718512
DR   IGSR; HG01351
DR   Wikidata; Q54883952
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01352
AC   CVCL_Q206
DR   BioSamples; SAME124686
DR   Coriell; HG01352
DR   IGSR; HG01352
DR   Wikidata; Q54883953
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01353
AC   CVCL_Q207
DR   BioSamples; SAME124685
DR   Coriell; HG01353
DR   GEO; GSM1718513
DR   IGSR; HG01353
DR   Wikidata; Q54883954
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01354
AC   CVCL_Q208
DR   BioSamples; SAME124680
DR   Coriell; HG01354
DR   GEO; GSM1718514
DR   IGSR; HG01354
DR   Wikidata; Q54883955
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01355
AC   CVCL_Q209
DR   BioSamples; SAME124679
DR   Coriell; HG01355
DR   IGSR; HG01355
DR   Wikidata; Q54883956
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01356
AC   CVCL_Q210
DR   BioSamples; SAME124682
DR   Coriell; HG01356
DR   GEO; GSM1718515
DR   IGSR; HG01356
DR   Wikidata; Q54883957
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01357
AC   CVCL_Q211
DR   BioSamples; SAME124681
DR   Coriell; HG01357
DR   GEO; GSM1718516
DR   IGSR; HG01357
DR   Wikidata; Q54883958
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01358
AC   CVCL_Q212
DR   BioSamples; SAME124688
DR   Coriell; HG01358
DR   IGSR; HG01358
DR   Wikidata; Q54883959
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01359
AC   CVCL_Q213
DR   BioSamples; SAME124687
DR   Coriell; HG01359
DR   GEO; GSM1718517
DR   IGSR; HG01359
DR   Wikidata; Q54883960
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01360
AC   CVCL_Q214
DR   BioSamples; SAME122855
DR   Coriell; HG01360
DR   GEO; GSM1718518
DR   IGSR; HG01360
DR   Wikidata; Q54883961
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01361
AC   CVCL_Q215
DR   BioSamples; SAME124504
DR   Coriell; HG01361
DR   IGSR; HG01361
DR   Wikidata; Q54883962
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01362
AC   CVCL_Q216
DR   BioSamples; SAME1839066
DR   Coriell; HG01362
DR   GEO; GSM1718519
DR   IGSR; HG01362
DR   Wikidata; Q54883963
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01363
AC   CVCL_Q217
DR   BioSamples; SAME1839059
DR   Coriell; HG01363
DR   GEO; GSM1718520
DR   IGSR; HG01363
DR   Wikidata; Q54883964
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01365
AC   CVCL_Q218
DR   BioSamples; SAME124508
DR   Coriell; HG01365
DR   GEO; GSM1718521
DR   IGSR; HG01365
DR   Wikidata; Q54883966
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01366
AC   CVCL_Q219
DR   BioSamples; SAME125265
DR   Coriell; HG01366
DR   GEO; GSM1718522
DR   IGSR; HG01366
DR   Wikidata; Q54883967
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01367
AC   CVCL_Q220
DR   BioSamples; SAME125266
DR   Coriell; HG01367
DR   IGSR; HG01367
DR   Wikidata; Q54883968
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01369
AC   CVCL_GU41
DR   BioSamples; SAME1839124
DR   Coriell; HG01369
DR   GEO; GSM1718523
DR   IGSR; HG01369
DR   Wikidata; Q54883972
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01372
AC   CVCL_GU42
DR   BioSamples; SAME1840339
DR   Coriell; HG01372
DR   GEO; GSM1718524
DR   IGSR; HG01372
DR   Wikidata; Q54883973
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01374
AC   CVCL_Q221
DR   BioSamples; SAME124291
DR   Coriell; HG01374
DR   GEO; GSM1718525
DR   IGSR; HG01374
DR   Wikidata; Q54883974
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01375
AC   CVCL_Q222
DR   BioSamples; SAME124290
DR   Coriell; HG01375
DR   GEO; GSM1718526
DR   IGSR; HG01375
DR   Wikidata; Q54883975
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01376
AC   CVCL_Q223
DR   BioSamples; SAME124289
DR   Coriell; HG01376
DR   IGSR; HG01376
DR   Wikidata; Q54883976
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01377
AC   CVCL_Q224
DR   BioSamples; SAME124288
DR   Coriell; HG01377
DR   GEO; GSM1718527
DR   IGSR; HG01377
DR   Wikidata; Q54883977
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01378
AC   CVCL_Q225
DR   BioSamples; SAME124076
DR   Coriell; HG01378
DR   GEO; GSM1718528
DR   IGSR; HG01378
DR   Wikidata; Q54883978
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01379
AC   CVCL_Q226
DR   BioSamples; SAME124283
DR   Coriell; HG01379
DR   IGSR; HG01379
DR   Wikidata; Q54883979
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01383
AC   CVCL_Q227
DR   BioSamples; SAME122971
DR   Coriell; HG01383
DR   GEO; GSM1718529
DR   IGSR; HG01383
DR   Wikidata; Q54883980
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01384
AC   CVCL_Q228
DR   BioSamples; SAME122969
DR   Coriell; HG01384
DR   GEO; GSM1718530
DR   IGSR; HG01384
DR   Wikidata; Q54883981
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01385
AC   CVCL_Q229
DR   BioSamples; SAME122970
DR   Coriell; HG01385
DR   IGSR; HG01385
DR   Wikidata; Q54883982
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01389
AC   CVCL_Q230
DR   BioSamples; SAME122972
DR   Coriell; HG01389
DR   GEO; GSM1718531
DR   IGSR; HG01389
DR   Wikidata; Q54883983
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01390
AC   CVCL_Q231
DR   BioSamples; SAME122805
DR   Coriell; HG01390
DR   GEO; GSM1718532
DR   IGSR; HG01390
DR   Wikidata; Q54883984
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01391
AC   CVCL_Q232
DR   BioSamples; SAME122804
DR   Coriell; HG01391
DR   IGSR; HG01391
DR   Wikidata; Q54883985
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01392
AC   CVCL_GU43
DR   BioSamples; SAME1840234
DR   Coriell; HG01392
DR   GEO; GSM1718533
DR   IGSR; HG01392
DR   Wikidata; Q54883986
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01393
AC   CVCL_GU44
DR   BioSamples; SAME1840222
DR   Coriell; HG01393
DR   GEO; GSM1718534
DR   IGSR; HG01393
DR   Wikidata; Q54883987
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01395
AC   CVCL_GU45
DR   BioSamples; SAME1840207
DR   Coriell; HG01395
DR   GEO; GSM1718535
DR   IGSR; HG01395
DR   Wikidata; Q54883988
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01396
AC   CVCL_GU46
DR   BioSamples; SAME1839954
DR   Coriell; HG01396
DR   GEO; GSM1718536
DR   IGSR; HG01396
DR   Wikidata; Q54883989
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01398
AC   CVCL_GU47
DR   BioSamples; SAME1839950
DR   Coriell; HG01398
DR   GEO; GSM1718537
DR   IGSR; HG01398
DR   Wikidata; Q54883990
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01402
AC   CVCL_GU48
DR   BioSamples; SAME1839873
DR   Coriell; HG01402
DR   GEO; GSM1718538
DR   IGSR; HG01402
DR   Wikidata; Q54883991
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01403
AC   CVCL_GU49
DR   BioSamples; SAME1839867
DR   Coriell; HG01403
DR   GEO; GSM1718539
DR   IGSR; HG01403
DR   Wikidata; Q54883992
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01405
AC   CVCL_GU50
DR   BioSamples; SAME1839863
DR   Coriell; HG01405
DR   GEO; GSM1718540
DR   IGSR; HG01405
DR   Wikidata; Q54883993
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01412
AC   CVCL_GU51
DR   BioSamples; SAME1839619
DR   Coriell; HG01412
DR   GEO; GSM1718541
DR   IGSR; HG01412
DR   Wikidata; Q54883994
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01413
AC   CVCL_GU52
DR   BioSamples; SAME1839612
DR   Coriell; HG01413
DR   GEO; GSM1718542
DR   IGSR; HG01413
DR   Wikidata; Q54883995
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01414
AC   CVCL_GU53
DR   BioSamples; SAME1839703
DR   Coriell; HG01414
DR   GEO; GSM1718543
DR   IGSR; HG01414
DR   Wikidata; Q54883996
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Puerto Rican in Puerto Rico (PUR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG01431
AC   CVCL_Q233
DR   BioSamples; SAME1839260
DR   Coriell; HG01431
DR   GEO; GSM1718544
DR   IGSR; HG01431
DR   Wikidata; Q54883997
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01432
AC   CVCL_Q234
DR   BioSamples; SAME1839256
DR   Coriell; HG01432
DR   GEO; GSM1718545
DR   IGSR; HG01432
DR   Wikidata; Q54883998
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01433
AC   CVCL_GV08
DR   BioSamples; SAME1839252
DR   Coriell; HG01433
DR   IGSR; HG01433
DR   Wikidata; Q54883999
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG01434
AC   CVCL_GX95
DR   Coriell; HG01434
DR   Wikidata; Q54884000
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG01435
AC   CVCL_GU54
DR   BioSamples; SAME1839239
DR   Coriell; HG01435
DR   GEO; GSM1718546
DR   IGSR; HG01435
DR   Wikidata; Q54884001
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01437
AC   CVCL_Q235
DR   BioSamples; SAME124966
DR   Coriell; HG01437
DR   GEO; GSM1718547
DR   IGSR; HG01437
DR   Wikidata; Q54884002
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01438
AC   CVCL_Q236
DR   BioSamples; SAME124971
DR   Coriell; HG01438
DR   GEO; GSM1718548
DR   IGSR; HG01438
DR   Wikidata; Q54884003
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01439
AC   CVCL_Q237
DR   BioSamples; SAME124972
DR   Coriell; HG01439
DR   IGSR; HG01439
DR   Wikidata; Q54884004
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01440
AC   CVCL_Q238
DR   BioSamples; SAME123237
DR   Coriell; HG01440
DR   GEO; GSM1718549
DR   IGSR; HG01440
DR   Wikidata; Q54884005
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01441
AC   CVCL_Q239
DR   BioSamples; SAME123236
DR   Coriell; HG01441
DR   GEO; GSM1718550
DR   IGSR; HG01441
DR   Wikidata; Q54884006
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01442
AC   CVCL_Q240
DR   BioSamples; SAME123238
DR   Coriell; HG01442
DR   IGSR; HG01442
DR   Wikidata; Q54884007
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01443
AC   CVCL_Q241
DR   BioSamples; SAME1839032
DR   Coriell; HG01443
DR   GEO; GSM1718551
DR   IGSR; HG01443
DR   Wikidata; Q54884008
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01444
AC   CVCL_Q242
DR   BioSamples; SAME1839026
DR   Coriell; HG01444
DR   GEO; GSM1718552
DR   IGSR; HG01444
DR   Wikidata; Q54884009
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01447
AC   CVCL_GU55
DR   BioSamples; SAME1839099
DR   Coriell; HG01447
DR   GEO; GSM1718553
DR   IGSR; HG01447
DR   Wikidata; Q54884010
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01452
AC   CVCL_Q243
DR   BioSamples; SAME1839158
DR   Coriell; HG01452
DR   IGSR; HG01452
DR   Wikidata; Q54884011
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01453
AC   CVCL_Q244
DR   BioSamples; SAME1839159
DR   Coriell; HG01453
DR   IGSR; HG01453
DR   Wikidata; Q54884016
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01455
AC   CVCL_Q245
DR   BioSamples; SAME123429
DR   Coriell; HG01455
DR   GEO; GSM1718554
DR   IGSR; HG01455
DR   Wikidata; Q54884017
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01456
AC   CVCL_Q246
DR   BioSamples; SAME123427
DR   Coriell; HG01456
DR   GEO; GSM1718555
DR   IGSR; HG01456
DR   Wikidata; Q54884018
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01457
AC   CVCL_Q247
DR   BioSamples; SAME123428
DR   Coriell; HG01457
DR   IGSR; HG01457
DR   Wikidata; Q54884019
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01459
AC   CVCL_GU56
DR   BioSamples; SAME1840278
DR   Coriell; HG01459
DR   GEO; GSM1718556
DR   IGSR; HG01459
DR   Wikidata; Q54884020
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01461
AC   CVCL_Q248
DR   BioSamples; SAME122879
DR   Coriell; HG01461
DR   GEO; GSM1718557
DR   IGSR; HG01461
DR   Wikidata; Q54884021
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01462
AC   CVCL_Q249
DR   BioSamples; SAME123539
DR   Coriell; HG01462
DR   GEO; GSM1718558
DR   IGSR; HG01462
DR   Wikidata; Q54884022
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01463
AC   CVCL_Q250
DR   BioSamples; SAME123537
DR   Coriell; HG01463
DR   IGSR; HG01463
DR   Wikidata; Q54884023
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01464
AC   CVCL_Q251
DR   BioSamples; SAME122883
DR   Coriell; HG01464
DR   GEO; GSM1718559
DR   IGSR; HG01464
DR   Wikidata; Q54884024
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01465
AC   CVCL_Q252
DR   BioSamples; SAME122882
DR   Coriell; HG01465
DR   GEO; GSM1718560
DR   IGSR; HG01465
DR   Wikidata; Q54884026
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01466
AC   CVCL_Q253
DR   BioSamples; SAME122881
DR   Coriell; HG01466
DR   IGSR; HG01466
DR   Wikidata; Q54884027
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01468
AC   CVCL_GU57
DR   BioSamples; SAME1840382
DR   Coriell; HG01468
DR   GEO; GSM1718561
DR   IGSR; HG01468
DR   Wikidata; Q54884028
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01474
AC   CVCL_GU58
DR   BioSamples; SAME1840189
DR   Coriell; HG01474
DR   GEO; GSM1718562
DR   IGSR; HG01474
DR   Wikidata; Q54884029
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   HG01479
AC   CVCL_GU59
DR   BioSamples; SAME1840251
DR   Coriell; HG01479
DR   GEO; GSM1718563
DR   IGSR; HG01479
DR   Wikidata; Q54884030
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01485
AC   CVCL_GU60
DR   BioSamples; SAME1840047
DR   Coriell; HG01485
DR   GEO; GSM1718564
DR   IGSR; HG01485
DR   Wikidata; Q54884031
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01486
AC   CVCL_GU61
DR   BioSamples; SAME1840048
DR   Coriell; HG01486
DR   GEO; GSM1718565
DR   IGSR; HG01486
DR   Wikidata; Q54884032
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01488
AC   CVCL_Q254
DR   BioSamples; SAME123973
DR   Coriell; HG01488
DR   GEO; GSM1718566
DR   IGSR; HG01488
DR   Wikidata; Q54884033
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01489
AC   CVCL_Q255
DR   BioSamples; SAME123972
DR   Coriell; HG01489
DR   GEO; GSM1718567
DR   IGSR; HG01489
DR   Wikidata; Q54884034
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01490
AC   CVCL_Q256
DR   BioSamples; SAME124139
DR   Coriell; HG01490
DR   IGSR; HG01490
DR   Wikidata; Q54884035
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01491
AC   CVCL_Q257
DR   BioSamples; SAME124140
DR   Coriell; HG01491
DR   GEO; GSM1718568
DR   IGSR; HG01491
DR   Wikidata; Q54884036
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01492
AC   CVCL_Q258
DR   BioSamples; SAME124137
DR   Coriell; HG01492
DR   GEO; GSM1718569
DR   IGSR; HG01492
DR   Wikidata; Q54884037
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01493
AC   CVCL_Q259
DR   BioSamples; SAME124138
DR   Coriell; HG01493
DR   IGSR; HG01493
DR   Wikidata; Q54884039
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01494
AC   CVCL_Q260
DR   BioSamples; SAME124135
DR   Coriell; HG01494
DR   GEO; GSM1718570
DR   IGSR; HG01494
DR   Wikidata; Q54884040
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01495
AC   CVCL_Q261
DR   BioSamples; SAME124136
DR   Coriell; HG01495
DR   GEO; GSM1718571
DR   IGSR; HG01495
DR   Wikidata; Q54884041
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01496
AC   CVCL_Q262
DR   BioSamples; SAME124133
DR   Coriell; HG01496
DR   IGSR; HG01496
DR   Wikidata; Q54884042
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01497
AC   CVCL_Q263
DR   BioSamples; SAME124134
DR   Coriell; HG01497
DR   GEO; GSM1718572
DR   IGSR; HG01497
DR   Wikidata; Q54884043
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01498
AC   CVCL_Q264
DR   BioSamples; SAME124142
DR   Coriell; HG01498
DR   GEO; GSM1718573
DR   IGSR; HG01498
DR   Wikidata; Q54884044
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01499
AC   CVCL_Q265
DR   BioSamples; SAME124143
DR   Coriell; HG01499
DR   IGSR; HG01499
DR   Wikidata; Q54884045
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01500
AC   CVCL_Q266
DR   BioSamples; SAME124941
DR   Coriell; HG01500
DR   GEO; GSM1718574
DR   IGSR; HG01500
DR   Wikidata; Q54884046
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01501
AC   CVCL_Q267
DR   BioSamples; SAME124942
DR   Coriell; HG01501
DR   GEO; GSM1718575
DR   IGSR; HG01501
DR   Wikidata; Q54884047
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01502
AC   CVCL_Q268
DR   BioSamples; SAME124943
DR   Coriell; HG01502
DR   IGSR; HG01502
DR   Wikidata; Q54884048
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01503
AC   CVCL_Q269
DR   BioSamples; SAME124944
DR   Coriell; HG01503
DR   GEO; GSM1718576
DR   IGSR; HG01503
DR   Wikidata; Q54884049
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01504
AC   CVCL_Q270
DR   BioSamples; SAME124945
DR   Coriell; HG01504
DR   GEO; GSM1718577
DR   IGSR; HG01504
DR   Wikidata; Q54884050
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01505
AC   CVCL_Q271
DR   BioSamples; SAME124946
DR   Coriell; HG01505
DR   IGSR; HG01505
DR   Wikidata; Q54884051
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01506
AC   CVCL_Q272
DR   BioSamples; SAME124947
DR   Coriell; HG01506
DR   GEO; GSM1718578
DR   IGSR; HG01506
DR   Wikidata; Q54884052
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01507
AC   CVCL_Q273
DR   BioSamples; SAME124948
DR   Coriell; HG01507
DR   GEO; GSM1718579
DR   IGSR; HG01507
DR   Wikidata; Q54884053
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01508
AC   CVCL_R017
DR   BioSamples; SAME124939
DR   Coriell; HG01508
DR   IGSR; HG01508
DR   Wikidata; Q54884054
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01509
AC   CVCL_Q274
DR   BioSamples; SAME124940
DR   Coriell; HG01509
DR   GEO; GSM1718580
DR   IGSR; HG01509
DR   Wikidata; Q54884055
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01510
AC   CVCL_Q275
DR   BioSamples; SAME124771
DR   Coriell; HG01510
DR   GEO; GSM1718581
DR   IGSR; HG01510
DR   Wikidata; Q54884056
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01511
AC   CVCL_Q276
DR   BioSamples; SAME124770
DR   Coriell; HG01511
DR   IGSR; HG01511
DR   Wikidata; Q54884057
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01512
AC   CVCL_Q277
DR   BioSamples; SAME124769
DR   Coriell; HG01512
DR   GEO; GSM1718582
DR   IGSR; HG01512
DR   Wikidata; Q54884064
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01513
AC   CVCL_Q278
DR   BioSamples; SAME124768
DR   Coriell; HG01513
DR   GEO; GSM1718583
DR   IGSR; HG01513
DR   Wikidata; Q54884065
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01514
AC   CVCL_Q279
DR   BioSamples; SAME124775
DR   Coriell; HG01514
DR   IGSR; HG01514
DR   Wikidata; Q54884066
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01515
AC   CVCL_Q280
DR   BioSamples; SAME124774
DR   Coriell; HG01515
DR   GEO; GSM1718584
DR   IGSR; HG01515
DR   Wikidata; Q54884067
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01516
AC   CVCL_Q281
DR   BioSamples; SAME124773
DR   Coriell; HG01516
DR   GEO; GSM1718585
DR   IGSR; HG01516
DR   Wikidata; Q54884068
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01517
AC   CVCL_Q282
DR   BioSamples; SAME124772
DR   Coriell; HG01517
DR   IGSR; HG01517
DR   Wikidata; Q54884069
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01518
AC   CVCL_Q283
DR   BioSamples; SAME124766
DR   Coriell; HG01518
DR   GEO; GSM1718586
DR   IGSR; HG01518
DR   Wikidata; Q54884070
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01519
AC   CVCL_Q284
DR   BioSamples; SAME124765
DR   Coriell; HG01519
DR   GEO; GSM1718587
DR   IGSR; HG01519
DR   Wikidata; Q54884071
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01520
AC   CVCL_Q285
DR   BioSamples; SAME125323
DR   Coriell; HG01520
DR   IGSR; HG01520
DR   Wikidata; Q54884072
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01521
AC   CVCL_Q286
DR   BioSamples; SAME125324
DR   Coriell; HG01521
DR   GEO; GSM1718588
DR   IGSR; HG01521
DR   Wikidata; Q54884073
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01522
AC   CVCL_Q287
DR   BioSamples; SAME125321
DR   Coriell; HG01522
DR   GEO; GSM1718589
DR   IGSR; HG01522
DR   Wikidata; Q54884074
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01523
AC   CVCL_Q288
DR   BioSamples; SAME125322
DR   Coriell; HG01523
DR   IGSR; HG01523
DR   Wikidata; Q54884075
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01524
AC   CVCL_Q289
DR   BioSamples; SAME125327
DR   Coriell; HG01524
DR   GEO; GSM1718590
DR   IGSR; HG01524
DR   Wikidata; Q54884076
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01525
AC   CVCL_Q290
DR   BioSamples; SAME125328
DR   Coriell; HG01525
DR   GEO; GSM1718591
DR   IGSR; HG01525
DR   Wikidata; Q54884077
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01526
AC   CVCL_Q291
DR   BioSamples; SAME125325
DR   Coriell; HG01526
DR   IGSR; HG01526
DR   Wikidata; Q54884078
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01527
AC   CVCL_Q292
DR   BioSamples; SAME125326
DR   Coriell; HG01527
DR   GEO; GSM1718592
DR   IGSR; HG01527
DR   Wikidata; Q54884079
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01528
AC   CVCL_Q293
DR   BioSamples; SAME125329
DR   Coriell; HG01528
DR   GEO; GSM1718593
DR   IGSR; HG01528
DR   Wikidata; Q54884080
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01529
AC   CVCL_Q294
DR   BioSamples; SAME125330
DR   Coriell; HG01529
DR   IGSR; HG01529
DR   Wikidata; Q54884081
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01530
AC   CVCL_Q295
DR   BioSamples; SAME125137
DR   Coriell; HG01530
DR   GEO; GSM1718594
DR   IGSR; HG01530
DR   Wikidata; Q54884082
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01531
AC   CVCL_Q296
DR   BioSamples; SAME125136
DR   Coriell; HG01531
DR   GEO; GSM1718595
DR   IGSR; HG01531
DR   Wikidata; Q54884083
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01532
AC   CVCL_Q297
DR   BioSamples; SAME125138
DR   Coriell; HG01532
DR   IGSR; HG01532
DR   Wikidata; Q54884084
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01536
AC   CVCL_Q298
DR   BioSamples; SAME125135
DR   Coriell; HG01536
DR   GEO; GSM1718596
DR   IGSR; HG01536
DR   Wikidata; Q54884085
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01537
AC   CVCL_Q299
DR   BioSamples; SAME125134
DR   Coriell; HG01537
DR   GEO; GSM1718597
DR   IGSR; HG01537
DR   Wikidata; Q54884086
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01538
AC   CVCL_Q300
DR   BioSamples; SAME125141
DR   Coriell; HG01538
DR   IGSR; HG01538
DR   Wikidata; Q54884087
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01550
AC   CVCL_Q301
DR   BioSamples; SAME124009
DR   Coriell; HG01550
DR   GEO; GSM1718598
DR   IGSR; HG01550
DR   Wikidata; Q54884088
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01551
AC   CVCL_Q302
DR   BioSamples; SAME124008
DR   Coriell; HG01551
DR   GEO; GSM1718599
DR   IGSR; HG01551
DR   Wikidata; Q54884089
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01552
AC   CVCL_Q303
DR   BioSamples; SAME124007
DR   Coriell; HG01552
DR   IGSR; HG01552
DR   Wikidata; Q54884090
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01556
AC   CVCL_GU62
DR   BioSamples; SAME1840141
DR   Coriell; HG01556
DR   GEO; GSM1718600
DR   IGSR; HG01556
DR   Wikidata; Q54884091
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Colombian from Medellin (CLM).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01565
AC   CVCL_Q304
DR   BioSamples; SAME124566
DR   Coriell; HG01565
DR   GEO; GSM1718601
DR   IGSR; HG01565
DR   Wikidata; Q54884092
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01566
AC   CVCL_Q305
DR   BioSamples; SAME124564
DR   Coriell; HG01566
DR   GEO; GSM1718602
DR   IGSR; HG01566
DR   Wikidata; Q54884093
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01567
AC   CVCL_Q306
DR   BioSamples; SAME124565
DR   Coriell; HG01567
DR   IGSR; HG01567
DR   Wikidata; Q54884094
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01571
AC   CVCL_Q307
DR   BioSamples; SAME124346
DR   Coriell; HG01571
DR   GEO; GSM1718603
DR   IGSR; HG01571
DR   Wikidata; Q54884095
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01572
AC   CVCL_Q308
DR   BioSamples; SAME124705
DR   Coriell; HG01572
DR   GEO; GSM1718604
DR   IGSR; HG01572
DR   Wikidata; Q54884096
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01573
AC   CVCL_Q309
DR   BioSamples; SAME124347
DR   Coriell; HG01573
DR   IGSR; HG01573
DR   Wikidata; Q54884097
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01577
AC   CVCL_Q310
DR   BioSamples; SAME124349
DR   Coriell; HG01577
DR   GEO; GSM1718605
DR   IGSR; HG01577
DR   Wikidata; Q54884098
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01578
AC   CVCL_Q311
DR   BioSamples; SAME124351
DR   Coriell; HG01578
DR   GEO; GSM1718606
DR   IGSR; HG01578
DR   Wikidata; Q54884099
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01579
AC   CVCL_Q312
DR   BioSamples; SAME124350
DR   Coriell; HG01579
DR   IGSR; HG01579
DR   Wikidata; Q54884100
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01583
AC   CVCL_Q313
DR   BioSamples; SAME1839895
DR   Coriell; HG01583
DR   GEO; GSM1718607
DR   IGSR; HG01583
DR   Wikidata; Q54884101
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01586
AC   CVCL_Q314
DR   BioSamples; SAME1839879
DR   Coriell; HG01586
DR   GEO; GSM1718608
DR   IGSR; HG01586
DR   Wikidata; Q54884102
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01589
AC   CVCL_Q315
DR   BioSamples; SAME1839859
DR   Coriell; HG01589
DR   GEO; GSM1718609
DR   IGSR; HG01589
DR   Wikidata; Q54884103
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01590
AC   CVCL_Q316
DR   BioSamples; SAME1839651
DR   Coriell; HG01590
DR   IGSR; HG01590
DR   Wikidata; Q54884108
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01593
AC   CVCL_Q317
DR   BioSamples; SAME1839634
DR   Coriell; HG01593
DR   GEO; GSM1718610
DR   IGSR; HG01593
DR   Wikidata; Q54884109
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01594
AC   CVCL_GV09
DR   BioSamples; SAME1839631
DR   Coriell; HG01594
DR   IGSR; HG01594
DR   Wikidata; Q54884110
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG01595
AC   CVCL_Q318
DR   BioSamples; SAME123569
DR   Coriell; HG01595
DR   GEO; GSM1718611
DR   IGSR; HG01595
DR   Wikidata; Q54884111
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01596
AC   CVCL_Q319
DR   BioSamples; SAME125227
DR   Coriell; HG01596
DR   GEO; GSM1718612
DR   IGSR; HG01596
DR   Wikidata; Q54884112
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01597
AC   CVCL_Q320
DR   BioSamples; SAME125226
DR   Coriell; HG01597
DR   GEO; GSM1718613
DR   IGSR; HG01597
DR   Wikidata; Q54884113
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01598
AC   CVCL_Q321
DR   BioSamples; SAME125239
DR   Coriell; HG01598
DR   GEO; GSM1718614
DR   IGSR; HG01598
DR   Wikidata; Q54884114
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01599
AC   CVCL_Q322
DR   BioSamples; SAME125238
DR   Coriell; HG01599
DR   GEO; GSM1718615
DR   IGSR; HG01599
DR   Wikidata; Q54884115
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01600
AC   CVCL_Q323
DR   BioSamples; SAME123456
DR   Coriell; HG01600
DR   GEO; GSM1718616
DR   IGSR; HG01600
DR   Wikidata; Q54884116
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01601
AC   CVCL_Q324
DR   BioSamples; SAME123455
DR   Coriell; HG01601
DR   IGSR; HG01601
DR   Wikidata; Q54884117
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01602
AC   CVCL_Q325
DR   BioSamples; SAME123454
DR   Coriell; HG01602
DR   GEO; GSM1718617
DR   IGSR; HG01602
DR   Wikidata; Q54884118
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01603
AC   CVCL_Q326
DR   BioSamples; SAME123453
DR   Coriell; HG01603
DR   GEO; GSM1718618
DR   IGSR; HG01603
DR   Wikidata; Q54884119
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01604
AC   CVCL_Q327
DR   BioSamples; SAME123460
DR   Coriell; HG01604
DR   IGSR; HG01604
DR   Wikidata; Q54884120
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01605
AC   CVCL_Q328
DR   BioSamples; SAME123459
DR   Coriell; HG01605
DR   GEO; GSM1718619
DR   IGSR; HG01605
DR   Wikidata; Q54884121
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01606
AC   CVCL_Q329
DR   BioSamples; SAME123458
DR   Coriell; HG01606
DR   GEO; GSM1718620
DR   IGSR; HG01606
DR   Wikidata; Q54884122
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01607
AC   CVCL_Q330
DR   BioSamples; SAME123457
DR   Coriell; HG01607
DR   GEO; GSM1718621
DR   IGSR; HG01607
DR   Wikidata; Q54884123
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01608
AC   CVCL_Q331
DR   BioSamples; SAME123462
DR   Coriell; HG01608
DR   GEO; GSM1718622
DR   IGSR; HG01608
DR   Wikidata; Q54884124
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01609
AC   CVCL_Q332
DR   BioSamples; SAME123461
DR   Coriell; HG01609
DR   IGSR; HG01609
DR   Wikidata; Q54884125
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01610
AC   CVCL_Q333
DR   BioSamples; SAME123623
DR   Coriell; HG01610
DR   GEO; GSM1718623
DR   IGSR; HG01610
DR   Wikidata; Q54884126
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01611
AC   CVCL_Q334
DR   BioSamples; SAME123624
DR   Coriell; HG01611
DR   IGSR; HG01611
DR   Wikidata; Q54884127
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01612
AC   CVCL_Q335
DR   BioSamples; SAME123625
DR   Coriell; HG01612
DR   GEO; GSM1718624
DR   IGSR; HG01612
DR   Wikidata; Q54884128
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01613
AC   CVCL_Q336
DR   BioSamples; SAME123626
DR   Coriell; HG01613
DR   GEO; GSM1718625
DR   IGSR; HG01613
DR   Wikidata; Q54884129
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01614
AC   CVCL_Q337
DR   BioSamples; SAME123627
DR   Coriell; HG01614
DR   IGSR; HG01614
DR   Wikidata; Q54884130
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01615
AC   CVCL_Q338
DR   BioSamples; SAME123628
DR   Coriell; HG01615
DR   GEO; GSM1718626
DR   IGSR; HG01615
DR   Wikidata; Q54884131
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01616
AC   CVCL_Q339
DR   BioSamples; SAME123629
DR   Coriell; HG01616
DR   IGSR; HG01616
DR   Wikidata; Q54884132
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01617
AC   CVCL_Q340
DR   BioSamples; SAME123630
DR   Coriell; HG01617
DR   GEO; GSM1718627
DR   IGSR; HG01617
DR   Wikidata; Q54884133
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01618
AC   CVCL_Q341
DR   BioSamples; SAME123631
DR   Coriell; HG01618
DR   GEO; GSM1718628
DR   IGSR; HG01618
DR   Wikidata; Q54884134
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01619
AC   CVCL_Q342
DR   BioSamples; SAME123632
DR   Coriell; HG01619
DR   GEO; GSM1718629
DR   IGSR; HG01619
DR   Wikidata; Q54884135
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01620
AC   CVCL_Q343
DR   BioSamples; SAME123844
DR   Coriell; HG01620
DR   GEO; GSM1718630
DR   IGSR; HG01620
DR   Wikidata; Q54884136
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01621
AC   CVCL_Q344
DR   BioSamples; SAME123843
DR   Coriell; HG01621
DR   IGSR; HG01621
DR   Wikidata; Q54884137
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01622
AC   CVCL_Q345
DR   BioSamples; SAME123846
DR   Coriell; HG01622
DR   IGSR; HG01622
DR   Wikidata; Q54884138
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01623
AC   CVCL_Q346
DR   BioSamples; SAME123845
DR   Coriell; HG01623
DR   GEO; GSM1718631
DR   IGSR; HG01623
DR   Wikidata; Q54884139
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01624
AC   CVCL_Q347
DR   BioSamples; SAME123840
DR   Coriell; HG01624
DR   GEO; GSM1718632
DR   IGSR; HG01624
DR   Wikidata; Q54884140
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01625
AC   CVCL_Q348
DR   BioSamples; SAME123839
DR   Coriell; HG01625
DR   GEO; GSM1718633
DR   IGSR; HG01625
DR   Wikidata; Q54884141
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01626
AC   CVCL_Q349
DR   BioSamples; SAME123842
DR   Coriell; HG01626
DR   GEO; GSM1718634
DR   IGSR; HG01626
DR   Wikidata; Q54884142
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01627
AC   CVCL_Q350
DR   BioSamples; SAME123841
DR   Coriell; HG01627
DR   IGSR; HG01627
DR   Wikidata; Q54884143
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01628
AC   CVCL_Q351
DR   BioSamples; SAME123837
DR   Coriell; HG01628
DR   GEO; GSM1718635
DR   IGSR; HG01628
DR   Wikidata; Q54884145
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01629
AC   CVCL_Q352
DR   BioSamples; SAME123836
DR   Coriell; HG01629
DR   IGSR; HG01629
DR   Wikidata; Q54884146
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01630
AC   CVCL_Q353
DR   BioSamples; SAME124034
DR   Coriell; HG01630
DR   GEO; GSM1718636
DR   IGSR; HG01630
DR   Wikidata; Q54884147
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01631
AC   CVCL_Q354
DR   BioSamples; SAME124035
DR   Coriell; HG01631
DR   GEO; GSM1718637
DR   IGSR; HG01631
DR   Wikidata; Q54884148
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01632
AC   CVCL_Q355
DR   BioSamples; SAME124032
DR   Coriell; HG01632
DR   GEO; GSM1718638
DR   IGSR; HG01632
DR   Wikidata; Q54884151
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01633
AC   CVCL_Q356
DR   BioSamples; SAME124033
DR   Coriell; HG01633
DR   IGSR; HG01633
DR   Wikidata; Q54884152
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01667
AC   CVCL_Q357
DR   BioSamples; SAME123116
DR   Coriell; HG01667
DR   IGSR; HG01667
DR   Wikidata; Q54884153
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01668
AC   CVCL_Q358
DR   BioSamples; SAME123111
DR   Coriell; HG01668
DR   GEO; GSM1718639
DR   IGSR; HG01668
DR   Wikidata; Q54884154
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01669
AC   CVCL_Q359
DR   BioSamples; SAME123110
DR   Coriell; HG01669
DR   GEO; GSM1718640
DR   IGSR; HG01669
DR   Wikidata; Q54884155
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01670
AC   CVCL_Q360
DR   BioSamples; SAME123290
DR   Coriell; HG01670
DR   GEO; GSM1718641
DR   IGSR; HG01670
DR   Wikidata; Q54884156
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01671
AC   CVCL_Q361
DR   BioSamples; SAME123291
DR   Coriell; HG01671
DR   IGSR; HG01671
DR   Wikidata; Q54884157
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01672
AC   CVCL_Q362
DR   BioSamples; SAME123288
DR   Coriell; HG01672
DR   GEO; GSM1718642
DR   IGSR; HG01672
DR   Wikidata; Q54884158
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01673
AC   CVCL_Q363
DR   BioSamples; SAME123289
DR   Coriell; HG01673
DR   GEO; GSM1718643
DR   IGSR; HG01673
DR   Wikidata; Q54884159
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01674
AC   CVCL_Q364
DR   BioSamples; SAME123286
DR   Coriell; HG01674
DR   IGSR; HG01674
DR   Wikidata; Q54884160
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01675
AC   CVCL_Q365
DR   BioSamples; SAME123287
DR   Coriell; HG01675
DR   GEO; GSM1718644
DR   IGSR; HG01675
DR   Wikidata; Q54884161
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01676
AC   CVCL_Q366
DR   BioSamples; SAME123284
DR   Coriell; HG01676
DR   GEO; GSM1718645
DR   IGSR; HG01676
DR   Wikidata; Q54884162
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01677
AC   CVCL_Q367
DR   BioSamples; SAME123285
DR   Coriell; HG01677
DR   IGSR; HG01677
DR   Wikidata; Q54884163
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01678
AC   CVCL_Q368
DR   BioSamples; SAME123292
DR   Coriell; HG01678
DR   GEO; GSM1718646
DR   IGSR; HG01678
DR   Wikidata; Q54884164
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01679
AC   CVCL_Q369
DR   BioSamples; SAME123293
DR   Coriell; HG01679
DR   GEO; GSM1718647
DR   IGSR; HG01679
DR   Wikidata; Q54884165
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01680
AC   CVCL_Q370
DR   BioSamples; SAME124656
DR   Coriell; HG01680
DR   GEO; GSM1718648
DR   IGSR; HG01680
DR   Wikidata; Q54884166
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01681
AC   CVCL_Q371
DR   BioSamples; SAME124655
DR   Coriell; HG01681
DR   IGSR; HG01681
DR   Wikidata; Q54884167
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01682
AC   CVCL_Q372
DR   BioSamples; SAME124654
DR   Coriell; HG01682
DR   GEO; GSM1718649
DR   IGSR; HG01682
DR   Wikidata; Q54884168
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01683
AC   CVCL_Q373
DR   BioSamples; SAME124653
DR   Coriell; HG01683
DR   IGSR; HG01683
DR   Wikidata; Q54884169
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01684
AC   CVCL_Q374
DR   BioSamples; SAME124660
DR   Coriell; HG01684
DR   GEO; GSM1718650
DR   IGSR; HG01684
DR   Wikidata; Q54884170
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01685
AC   CVCL_Q375
DR   BioSamples; SAME124659
DR   Coriell; HG01685
DR   GEO; GSM1718651
DR   IGSR; HG01685
DR   Wikidata; Q54884171
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01686
AC   CVCL_Q376
DR   BioSamples; SAME124658
DR   Coriell; HG01686
DR   GEO; GSM1718652
DR   IGSR; HG01686
DR   Wikidata; Q54884172
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01687
AC   CVCL_Q377
DR   BioSamples; SAME124657
DR   Coriell; HG01687
DR   IGSR; HG01687
DR   Wikidata; Q54884173
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01694
AC   CVCL_Q378
DR   BioSamples; SAME124844
DR   Coriell; HG01694
DR   GEO; GSM1718653
DR   IGSR; HG01694
DR   Wikidata; Q54884174
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01695
AC   CVCL_Q379
DR   BioSamples; SAME124845
DR   Coriell; HG01695
DR   GEO; GSM1718654
DR   IGSR; HG01695
DR   Wikidata; Q54884175
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01696
AC   CVCL_Q380
DR   BioSamples; SAME124715
DR   Coriell; HG01696
DR   IGSR; HG01696
DR   Wikidata; Q54884176
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01697
AC   CVCL_Q381
DR   BioSamples; SAME1839223
DR   Coriell; HG01697
DR   GEO; GSM1718655
DR   IGSR; HG01697
DR   Wikidata; Q54884177
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01698
AC   CVCL_Q382
DR   BioSamples; SAME1839214
DR   Coriell; HG01698
DR   IGSR; HG01698
DR   Wikidata; Q54884178
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01699
AC   CVCL_Q383
DR   BioSamples; SAME1839210
DR   Coriell; HG01699
DR   GEO; GSM1718656
DR   IGSR; HG01699
DR   Wikidata; Q54884179
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01700
AC   CVCL_Q384
DR   BioSamples; SAME123261
DR   Coriell; HG01700
DR   GEO; GSM1718657
DR   IGSR; HG01700
DR   Wikidata; Q54884180
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01701
AC   CVCL_Q385
DR   BioSamples; SAME123262
DR   Coriell; HG01701
DR   IGSR; HG01701
DR   Wikidata; Q54884181
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01702
AC   CVCL_Q386
DR   BioSamples; SAME123259
DR   Coriell; HG01702
DR   GEO; GSM1718658
DR   IGSR; HG01702
DR   Wikidata; Q54884182
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01703
AC   CVCL_Q387
DR   BioSamples; SAME123260
DR   Coriell; HG01703
DR   IGSR; HG01703
DR   Wikidata; Q54884183
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01704
AC   CVCL_Q388
DR   BioSamples; SAME123265
DR   Coriell; HG01704
DR   GEO; GSM1718659
DR   IGSR; HG01704
DR   Wikidata; Q54884184
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01705
AC   CVCL_Q389
DR   BioSamples; SAME123266
DR   Coriell; HG01705
DR   GEO; GSM1718660
DR   IGSR; HG01705
DR   Wikidata; Q54884186
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01706
AC   CVCL_Q390
DR   BioSamples; SAME123263
DR   Coriell; HG01706
DR   IGSR; HG01706
DR   Wikidata; Q54884187
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01707
AC   CVCL_Q391
DR   BioSamples; SAME123264
DR   Coriell; HG01707
DR   GEO; GSM1718661
DR   IGSR; HG01707
DR   Wikidata; Q54884188
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01708
AC   CVCL_Q392
DR   BioSamples; SAME123253
DR   Coriell; HG01708
DR   GEO; GSM1718662
DR   IGSR; HG01708
DR   Wikidata; Q54884189
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01709
AC   CVCL_Q393
DR   BioSamples; SAME123229
DR   Coriell; HG01709
DR   GEO; GSM1718663
DR   IGSR; HG01709
DR   Wikidata; Q54884190
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01710
AC   CVCL_Q394
DR   BioSamples; SAME123084
DR   Coriell; HG01710
DR   GEO; GSM1718664
DR   IGSR; HG01710
DR   Wikidata; Q54884191
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01711
AC   CVCL_Q395
DR   BioSamples; SAME123083
DR   Coriell; HG01711
DR   IGSR; HG01711
DR   Wikidata; Q54884198
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01746
AC   CVCL_Q396
DR   BioSamples; SAME125180
DR   Coriell; HG01746
DR   GEO; GSM1718665
DR   IGSR; HG01746
DR   Wikidata; Q54884199
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01747
AC   CVCL_Q397
DR   BioSamples; SAME125181
DR   Coriell; HG01747
DR   GEO; GSM1718666
DR   IGSR; HG01747
DR   Wikidata; Q54884200
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01748
AC   CVCL_Q398
DR   BioSamples; SAME125191
DR   Coriell; HG01748
DR   IGSR; HG01748
DR   Wikidata; Q54884201
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01755
AC   CVCL_Q399
DR   BioSamples; SAME124986
DR   Coriell; HG01755
DR   IGSR; HG01755
DR   Wikidata; Q54884202
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01756
AC   CVCL_Q400
DR   BioSamples; SAME124988
DR   Coriell; HG01756
DR   GEO; GSM1718667
DR   IGSR; HG01756
DR   Wikidata; Q54884204
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01757
AC   CVCL_Q401
DR   BioSamples; SAME124987
DR   Coriell; HG01757
DR   GEO; GSM1718668
DR   IGSR; HG01757
DR   Wikidata; Q54884205
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01761
AC   CVCL_Q402
DR   BioSamples; SAME124810
DR   Coriell; HG01761
DR   GEO; GSM1718669
DR   IGSR; HG01761
DR   Wikidata; Q54884206
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01762
AC   CVCL_Q403
DR   BioSamples; SAME124811
DR   Coriell; HG01762
DR   GEO; GSM1718670
DR   IGSR; HG01762
DR   Wikidata; Q54884207
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01763
AC   CVCL_Q404
DR   BioSamples; SAME124812
DR   Coriell; HG01763
DR   IGSR; HG01763
DR   Wikidata; Q54884208
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01765
AC   CVCL_GU63
DR   BioSamples; SAME1839681
DR   Coriell; HG01765
DR   GEO; GSM1718671
DR   IGSR; HG01765
DR   Wikidata; Q54884209
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01766
AC   CVCL_GU64
DR   BioSamples; SAME1839673
DR   Coriell; HG01766
DR   GEO; GSM1718672
DR   IGSR; HG01766
DR   Wikidata; Q54884210
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01767
AC   CVCL_GU65
DR   BioSamples; SAME1839671
DR   Coriell; HG01767
DR   GEO; GSM1718673
DR   IGSR; HG01767
DR   Wikidata; Q54884211
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01768
AC   CVCL_GU66
DR   BioSamples; SAME1839665
DR   Coriell; HG01768
DR   GEO; GSM1718674
DR   IGSR; HG01768
DR   Wikidata; Q54884212
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01770
AC   CVCL_Q405
DR   BioSamples; SAME124638
DR   Coriell; HG01770
DR   GEO; GSM1718675
DR   IGSR; HG01770
DR   Wikidata; Q54884213
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01771
AC   CVCL_Q406
DR   BioSamples; SAME124637
DR   Coriell; HG01771
DR   GEO; GSM1718676
DR   IGSR; HG01771
DR   Wikidata; Q54884214
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01772
AC   CVCL_Q407
DR   BioSamples; SAME124636
DR   Coriell; HG01772
DR   IGSR; HG01772
DR   Wikidata; Q54884215
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01773
AC   CVCL_Q408
DR   BioSamples; SAME124635
DR   Coriell; HG01773
DR   GEO; GSM1718677
DR   IGSR; HG01773
DR   Wikidata; Q54884216
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=33197628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Heterozygous (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   HG01774
AC   CVCL_Q409
DR   BioSamples; SAME124634
DR   Coriell; HG01774
DR   IGSR; HG01774
DR   Wikidata; Q54884217
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01775
AC   CVCL_Q410
DR   BioSamples; SAME124633
DR   Coriell; HG01775
DR   GEO; GSM1718678
DR   IGSR; HG01775
DR   Wikidata; Q54884218
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01776
AC   CVCL_Q411
DR   BioSamples; SAME124632
DR   Coriell; HG01776
DR   GEO; GSM1718679
DR   IGSR; HG01776
DR   Wikidata; Q54884219
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01777
AC   CVCL_Q412
DR   BioSamples; SAME124631
DR   Coriell; HG01777
DR   GEO; GSM1718680
DR   IGSR; HG01777
DR   Wikidata; Q54884220
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01778
AC   CVCL_Q413
DR   BioSamples; SAME124630
DR   Coriell; HG01778
DR   IGSR; HG01778
DR   Wikidata; Q54884221
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01779
AC   CVCL_Q414
DR   BioSamples; SAME124629
DR   Coriell; HG01779
DR   GEO; GSM1718681
DR   IGSR; HG01779
DR   Wikidata; Q54884222
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01780
AC   CVCL_Q415
DR   BioSamples; SAME124428
DR   Coriell; HG01780
DR   IGSR; HG01780
DR   Wikidata; Q54884223
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01781
AC   CVCL_Q416
DR   BioSamples; SAME124921
DR   Coriell; HG01781
DR   GEO; GSM1718682
DR   IGSR; HG01781
DR   Wikidata; Q54884224
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01782
AC   CVCL_Q417
DR   BioSamples; SAME124426
DR   Coriell; HG01782
DR   IGSR; HG01782
DR   Wikidata; Q54884225
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01783
AC   CVCL_Q418
DR   BioSamples; SAME124427
DR   Coriell; HG01783
DR   GEO; GSM1718683
DR   IGSR; HG01783
DR   Wikidata; Q54884226
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01784
AC   CVCL_Q419
DR   BioSamples; SAME124431
DR   Coriell; HG01784
DR   GEO; GSM1718684
DR   IGSR; HG01784
DR   Wikidata; Q54884227
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01785
AC   CVCL_GU67
DR   BioSamples; SAME1839313
DR   Coriell; HG01785
DR   GEO; GSM1718685
DR   IGSR; HG01785
DR   Wikidata; Q54884228
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01786
AC   CVCL_GU68
DR   BioSamples; SAME1839312
DR   Coriell; HG01786
DR   GEO; GSM1718686
DR   IGSR; HG01786
DR   Wikidata; Q54884229
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01789
AC   CVCL_Q420
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124433
DR   Coriell; HG01789
DR   GEO; GSM1718687
DR   IGSR; HG01789
DR   Wikidata; Q54884230
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01790
AC   CVCL_Q421
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME124222
DR   Coriell; HG01790
DR   GEO; GSM1718688
DR   IGSR; HG01790
DR   Wikidata; Q54884231
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG01791
AC   CVCL_Q422
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   BioSamples; SAME124221
DR   Coriell; HG01791
DR   GEO; GSM1718689
DR   IGSR; HG01791
DR   Wikidata; Q54884232
RX   PubMed=24037378;
RX   PubMed=27617755;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG01794
AC   CVCL_Q423
DR   BioSamples; SAME124218
DR   Coriell; HG01794
DR   GEO; GSM1718690
DR   IGSR; HG01794
DR   Wikidata; Q54884233
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01795
AC   CVCL_Q424
DR   BioSamples; SAME124217
DR   Coriell; HG01795
DR   GEO; GSM1718691
DR   IGSR; HG01795
DR   Wikidata; Q54884235
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01796
AC   CVCL_Q425
DR   BioSamples; SAME124220
DR   Coriell; HG01796
DR   GEO; GSM1718692
DR   IGSR; HG01796
DR   Wikidata; Q54884236
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01797
AC   CVCL_Q426
DR   BioSamples; SAME124219
DR   Coriell; HG01797
DR   GEO; GSM1718693
DR   IGSR; HG01797
DR   Wikidata; Q54884237
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01798
AC   CVCL_Q427
DR   BioSamples; SAME124228
DR   Coriell; HG01798
DR   GEO; GSM1718694
DR   IGSR; HG01798
DR   Wikidata; Q54884238
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01799
AC   CVCL_Q428
DR   BioSamples; SAME124227
DR   Coriell; HG01799
DR   GEO; GSM1718695
DR   IGSR; HG01799
DR   Wikidata; Q54884239
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01800
AC   CVCL_Q429
DR   BioSamples; SAME124306
DR   Coriell; HG01800
DR   GEO; GSM1718696
DR   IGSR; HG01800
DR   Wikidata; Q54884242
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01801
AC   CVCL_Q430
DR   BioSamples; SAME124305
DR   Coriell; HG01801
DR   GEO; GSM1718697
DR   IGSR; HG01801
DR   Wikidata; Q54884243
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01802
AC   CVCL_Q431
DR   BioSamples; SAME124307
DR   Coriell; HG01802
DR   GEO; GSM1718698
DR   IGSR; HG01802
DR   Wikidata; Q54884244
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01804
AC   CVCL_Q432
DR   BioSamples; SAME124302
DR   Coriell; HG01804
DR   GEO; GSM1718699
DR   IGSR; HG01804
DR   Wikidata; Q54884245
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01805
AC   CVCL_Q433
DR   BioSamples; SAME124301
DR   Coriell; HG01805
DR   GEO; GSM1718700
DR   IGSR; HG01805
DR   Wikidata; Q54884246
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01806
AC   CVCL_Q434
DR   BioSamples; SAME124304
DR   Coriell; HG01806
DR   GEO; GSM1718701
DR   IGSR; HG01806
DR   Wikidata; Q54884247
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01807
AC   CVCL_Q435
DR   BioSamples; SAME124303
DR   Coriell; HG01807
DR   GEO; GSM1718702
DR   IGSR; HG01807
DR   Wikidata; Q54884248
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01808
AC   CVCL_Q436
DR   BioSamples; SAME124300
DR   Coriell; HG01808
DR   GEO; GSM1718703
DR   IGSR; HG01808
DR   Wikidata; Q54884249
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01809
AC   CVCL_Q437
DR   BioSamples; SAME124299
DR   Coriell; HG01809
DR   GEO; GSM1718704
DR   IGSR; HG01809
DR   Wikidata; Q54884250
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01810
AC   CVCL_Q438
DR   BioSamples; SAME124519
DR   Coriell; HG01810
DR   GEO; GSM1718705
DR   IGSR; HG01810
DR   Wikidata; Q54884251
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01811
AC   CVCL_Q439
DR   BioSamples; SAME125380
DR   Coriell; HG01811
DR   GEO; GSM1718706
DR   IGSR; HG01811
DR   Wikidata; Q54884252
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01812
AC   CVCL_Q440
DR   BioSamples; SAME124517
DR   Coriell; HG01812
DR   GEO; GSM1718707
DR   IGSR; HG01812
DR   Wikidata; Q54884253
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01813
AC   CVCL_Q441
DR   BioSamples; SAME124518
DR   Coriell; HG01813
DR   GEO; GSM1718708
DR   IGSR; HG01813
DR   Wikidata; Q54884254
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01815
AC   CVCL_Q442
DR   BioSamples; SAME124524
DR   Coriell; HG01815
DR   GEO; GSM1718709
DR   IGSR; HG01815
DR   Wikidata; Q54884255
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01816
AC   CVCL_Q443
DR   BioSamples; SAME124521
DR   Coriell; HG01816
DR   GEO; GSM1718710
DR   IGSR; HG01816
DR   Wikidata; Q54884256
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01817
AC   CVCL_Q444
DR   BioSamples; SAME124522
DR   Coriell; HG01817
DR   GEO; GSM1718711
DR   IGSR; HG01817
DR   Wikidata; Q54884257
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01840
AC   CVCL_Q445
DR   BioSamples; SAME123552
DR   Coriell; HG01840
DR   GEO; GSM1718712
DR   IGSR; HG01840
DR   Wikidata; Q54884258
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01841
AC   CVCL_Q446
DR   BioSamples; SAME123551
DR   Coriell; HG01841
DR   GEO; GSM1718713
DR   IGSR; HG01841
DR   Wikidata; Q54884259
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01842
AC   CVCL_Q447
DR   BioSamples; SAME123554
DR   Coriell; HG01842
DR   GEO; GSM1718714
DR   IGSR; HG01842
DR   Wikidata; Q54884260
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01843
AC   CVCL_Q448
DR   BioSamples; SAME123553
DR   Coriell; HG01843
DR   GEO; GSM1718715
DR   IGSR; HG01843
DR   Wikidata; Q54884261
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01844
AC   CVCL_Q449
DR   BioSamples; SAME123556
DR   Coriell; HG01844
DR   GEO; GSM1718716
DR   IGSR; HG01844
DR   Wikidata; Q54884262
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01845
AC   CVCL_Q450
DR   BioSamples; SAME123555
DR   Coriell; HG01845
DR   GEO; GSM1718717
DR   IGSR; HG01845
DR   Wikidata; Q54884263
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01846
AC   CVCL_Q451
DR   BioSamples; SAME123558
DR   Coriell; HG01846
DR   GEO; GSM1718718
DR   IGSR; HG01846
DR   Wikidata; Q54884264
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01847
AC   CVCL_Q452
DR   BioSamples; SAME123557
DR   Coriell; HG01847
DR   GEO; GSM1718719
DR   IGSR; HG01847
DR   Wikidata; Q54884265
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01848
AC   CVCL_Q453
DR   BioSamples; SAME123548
DR   Coriell; HG01848
DR   GEO; GSM1718720
DR   IGSR; HG01848
DR   Wikidata; Q54884266
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01849
AC   CVCL_Q454
DR   BioSamples; SAME125110
DR   Coriell; HG01849
DR   GEO; GSM1718721
DR   IGSR; HG01849
DR   Wikidata; Q54884267
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01850
AC   CVCL_Q455
DR   BioSamples; SAME123752
DR   Coriell; HG01850
DR   GEO; GSM1718722
DR   IGSR; HG01850
DR   Wikidata; Q54884268
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01851
AC   CVCL_Q456
DR   BioSamples; SAME123753
DR   Coriell; HG01851
DR   GEO; GSM1718723
DR   IGSR; HG01851
DR   Wikidata; Q54884269
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01852
AC   CVCL_Q457
DR   BioSamples; SAME123750
DR   Coriell; HG01852
DR   GEO; GSM1718724
DR   IGSR; HG01852
DR   Wikidata; Q54884270
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01853
AC   CVCL_Q458
DR   BioSamples; SAME123751
DR   Coriell; HG01853
DR   GEO; GSM1718725
DR   IGSR; HG01853
DR   Wikidata; Q54884271
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01855
AC   CVCL_Q459
DR   BioSamples; SAME123749
DR   Coriell; HG01855
DR   GEO; GSM1718726
DR   IGSR; HG01855
DR   Wikidata; Q54884272
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01857
AC   CVCL_Q460
DR   BioSamples; SAME123748
DR   Coriell; HG01857
DR   GEO; GSM1718727
DR   IGSR; HG01857
DR   Wikidata; Q54884273
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01858
AC   CVCL_Q461
DR   BioSamples; SAME123754
DR   Coriell; HG01858
DR   GEO; GSM1718728
DR   IGSR; HG01858
DR   Wikidata; Q54884274
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01859
AC   CVCL_Q462
DR   BioSamples; SAME123535
DR   Coriell; HG01859
DR   GEO; GSM1718729
DR   IGSR; HG01859
DR   Wikidata; Q54884275
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01860
AC   CVCL_Q463
DR   BioSamples; SAME123201
DR   Coriell; HG01860
DR   GEO; GSM1718730
DR   IGSR; HG01860
DR   Wikidata; Q54884276
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01861
AC   CVCL_Q464
DR   BioSamples; SAME123200
DR   Coriell; HG01861
DR   GEO; GSM1718731
DR   IGSR; HG01861
DR   Wikidata; Q54884277
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01862
AC   CVCL_Q465
DR   BioSamples; SAME123199
DR   Coriell; HG01862
DR   GEO; GSM1718732
DR   IGSR; HG01862
DR   Wikidata; Q54884278
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01863
AC   CVCL_Q466
DR   BioSamples; SAME123198
DR   Coriell; HG01863
DR   GEO; GSM1718733
DR   IGSR; HG01863
DR   Wikidata; Q54884279
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01864
AC   CVCL_Q467
DR   BioSamples; SAME123197
DR   Coriell; HG01864
DR   GEO; GSM1718734
DR   IGSR; HG01864
DR   Wikidata; Q54884280
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01865
AC   CVCL_Q468
DR   BioSamples; SAME123196
DR   Coriell; HG01865
DR   GEO; GSM1718735
DR   IGSR; HG01865
DR   Wikidata; Q54884281
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01866
AC   CVCL_Q469
DR   BioSamples; SAME123195
DR   Coriell; HG01866
DR   GEO; GSM1718736
DR   IGSR; HG01866
DR   Wikidata; Q54884289
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01867
AC   CVCL_Q470
DR   BioSamples; SAME123194
DR   Coriell; HG01867
DR   GEO; GSM1718737
DR   IGSR; HG01867
DR   Wikidata; Q54884290
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01868
AC   CVCL_Q471
DR   BioSamples; SAME123193
DR   Coriell; HG01868
DR   GEO; GSM1718738
DR   IGSR; HG01868
DR   Wikidata; Q54884291
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01869
AC   CVCL_Q472
DR   BioSamples; SAME123192
DR   Coriell; HG01869
DR   GEO; GSM1718739
DR   IGSR; HG01869
DR   Wikidata; Q54884292
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01870
AC   CVCL_Q473
DR   BioSamples; SAME123397
DR   Coriell; HG01870
DR   GEO; GSM1718740
DR   IGSR; HG01870
DR   Wikidata; Q54884293
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01871
AC   CVCL_Q474
DR   BioSamples; SAME123398
DR   Coriell; HG01871
DR   GEO; GSM1718741
DR   IGSR; HG01871
DR   Wikidata; Q54884294
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01872
AC   CVCL_Q475
DR   BioSamples; SAME123995
DR   Coriell; HG01872
DR   GEO; GSM1718742
DR   IGSR; HG01872
DR   Wikidata; Q54884295
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01873
AC   CVCL_Q476
DR   BioSamples; SAME123400
DR   Coriell; HG01873
DR   GEO; GSM1718743
DR   IGSR; HG01873
DR   Wikidata; Q54884296
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01874
AC   CVCL_Q477
DR   BioSamples; SAME123396
DR   Coriell; HG01874
DR   GEO; GSM1718744
DR   IGSR; HG01874
DR   Wikidata; Q54884297
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01878
AC   CVCL_Q478
DR   BioSamples; SAME123394
DR   Coriell; HG01878
DR   GEO; GSM1718745
DR   IGSR; HG01878
DR   Wikidata; Q54884298
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01879
AC   CVCL_Q479
DR   BioSamples; SAME1839037
DR   Coriell; HG01879
DR   GEO; GSM1718746
DR   IGSR; HG01879
DR   Wikidata; Q54884299
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01880
AC   CVCL_Q480
DR   BioSamples; SAME1839109
DR   Coriell; HG01880
DR   GEO; GSM1718747
DR   IGSR; HG01880
DR   Wikidata; Q54884300
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01881
AC   CVCL_Q481
DR   BioSamples; SAME1839193
DR   Coriell; HG01881
DR   IGSR; HG01881
DR   Wikidata; Q54884301
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01882
AC   CVCL_Q482
DR   BioSamples; SAME122849
DR   Coriell; HG01882
DR   GEO; GSM1718748
DR   IGSR; HG01882
DR   Wikidata; Q54884302
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01883
AC   CVCL_Q483
DR   BioSamples; SAME122848
DR   Coriell; HG01883
DR   GEO; GSM1718749
DR   IGSR; HG01883
DR   Wikidata; Q54884303
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01884
AC   CVCL_Q484
DR   BioSamples; SAME122845
DR   Coriell; HG01884
DR   IGSR; HG01884
DR   Wikidata; Q54884305
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01885
AC   CVCL_Q485
DR   BioSamples; SAME122844
DR   Coriell; HG01885
DR   GEO; GSM1718750
DR   IGSR; HG01885
DR   Wikidata; Q54884306
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01886
AC   CVCL_Q486
DR   BioSamples; SAME122847
DR   Coriell; HG01886
DR   GEO; GSM1718751
DR   IGSR; HG01886
DR   Wikidata; Q54884307
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01887
AC   CVCL_Q487
DR   BioSamples; SAME122846
DR   Coriell; HG01887
DR   IGSR; HG01887
DR   Wikidata; Q54884308
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01888
AC   CVCL_Q488
DR   BioSamples; SAME122852
DR   Coriell; HG01888
DR   IGSR; HG01888
DR   Wikidata; Q54884309
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01889
AC   CVCL_Q489
DR   BioSamples; SAME122851
DR   Coriell; HG01889
DR   GEO; GSM1718752
DR   IGSR; HG01889
DR   Wikidata; Q54884310
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01890
AC   CVCL_Q490
DR   BioSamples; SAME123028
DR   Coriell; HG01890
DR   GEO; GSM1718753
DR   IGSR; HG01890
DR   Wikidata; Q54884311
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01891
AC   CVCL_Q491
DR   BioSamples; SAME123029
DR   Coriell; HG01891
DR   IGSR; HG01891
DR   Wikidata; Q54884312
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01892
AC   CVCL_Q492
DR   BioSamples; SAME123026
DR   Coriell; HG01892
DR   GEO; GSM1718754
DR   IGSR; HG01892
DR   Wikidata; Q54884313
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01893
AC   CVCL_Q493
DR   BioSamples; SAME123027
DR   Coriell; HG01893
DR   GEO; GSM1718755
DR   IGSR; HG01893
DR   Wikidata; Q54884314
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01894
AC   CVCL_Q494
DR   BioSamples; SAME1840357
DR   Coriell; HG01894
DR   GEO; GSM1718756
DR   IGSR; HG01894
DR   Wikidata; Q54884315
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01895
AC   CVCL_Q495
DR   BioSamples; SAME1840349
DR   Coriell; HG01895
DR   IGSR; HG01895
DR   Wikidata; Q54884316
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01896
AC   CVCL_Q496
DR   BioSamples; SAME1840348
DR   Coriell; HG01896
DR   GEO; GSM1718757
DR   IGSR; HG01896
DR   Wikidata; Q54884317
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01897
AC   CVCL_Q497
DR   BioSamples; SAME1840343
DR   Coriell; HG01897
DR   IGSR; HG01897
DR   Wikidata; Q54884318
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01898
AC   CVCL_Q498
DR   BioSamples; SAME124383
DR   Coriell; HG01898
DR   IGSR; HG01898
DR   Wikidata; Q54884319
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01912
AC   CVCL_Q499
DR   BioSamples; SAME1839779
DR   Coriell; HG01912
DR   GEO; GSM1718758
DR   IGSR; HG01912
DR   Wikidata; Q54884320
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01914
AC   CVCL_Q500
DR   BioSamples; SAME1839768
DR   Coriell; HG01914
DR   GEO; GSM1718759
DR   IGSR; HG01914
DR   Wikidata; Q54884321
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01915
AC   CVCL_Q501
DR   BioSamples; SAME1839757
DR   Coriell; HG01915
DR   GEO; GSM1718760
DR   IGSR; HG01915
DR   Wikidata; Q54884322
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01916
AC   CVCL_Q502
DR   BioSamples; SAME1839853
DR   Coriell; HG01916
DR   IGSR; HG01916
DR   Wikidata; Q54884323
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01917
AC   CVCL_Q503
DR   BioSamples; SAME123235
DR   Coriell; HG01917
DR   GEO; GSM1718761
DR   IGSR; HG01917
DR   Wikidata; Q54884324
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01918
AC   CVCL_Q504
DR   BioSamples; SAME123240
DR   Coriell; HG01918
DR   GEO; GSM1718762
DR   IGSR; HG01918
DR   Wikidata; Q54884325
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01919
AC   CVCL_Q505
DR   BioSamples; SAME123239
DR   Coriell; HG01919
DR   IGSR; HG01919
DR   Wikidata; Q54884326
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01920
AC   CVCL_Q506
DR   BioSamples; SAME123789
DR   Coriell; HG01920
DR   GEO; GSM1718763
DR   IGSR; HG01920
DR   Wikidata; Q54884327
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01921
AC   CVCL_Q507
DR   BioSamples; SAME123790
DR   Coriell; HG01921
DR   GEO; GSM1718764
DR   IGSR; HG01921
DR   Wikidata; Q54884328
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01922
AC   CVCL_Q508
DR   BioSamples; SAME123787
DR   Coriell; HG01922
DR   IGSR; HG01922
DR   Wikidata; Q54884329
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01923
AC   CVCL_Q509
DR   BioSamples; SAME123788
DR   Coriell; HG01923
DR   GEO; GSM1718765
DR   IGSR; HG01923
DR   Wikidata; Q54884336
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01924
AC   CVCL_Q510
DR   BioSamples; SAME123785
DR   Coriell; HG01924
DR   GEO; GSM1718766
DR   IGSR; HG01924
DR   Wikidata; Q54884337
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01925
AC   CVCL_Q511
DR   BioSamples; SAME123786
DR   Coriell; HG01925
DR   IGSR; HG01925
DR   Wikidata; Q54884338
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01926
AC   CVCL_Q512
DR   BioSamples; SAME123783
DR   Coriell; HG01926
DR   GEO; GSM1718767
DR   IGSR; HG01926
DR   Wikidata; Q54884339
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01927
AC   CVCL_Q513
DR   BioSamples; SAME123784
DR   Coriell; HG01927
DR   GEO; GSM1718768
DR   IGSR; HG01927
DR   Wikidata; Q54884340
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01928
AC   CVCL_Q514
DR   BioSamples; SAME123782
DR   Coriell; HG01928
DR   IGSR; HG01928
DR   Wikidata; Q54884341
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01932
AC   CVCL_Q515
DR   BioSamples; SAME123587
DR   Coriell; HG01932
DR   GEO; GSM1718769
DR   IGSR; HG01932
DR   Wikidata; Q54884342
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01933
AC   CVCL_Q516
DR   BioSamples; SAME123586
DR   Coriell; HG01933
DR   GEO; GSM1718770
DR   IGSR; HG01933
DR   Wikidata; Q54884343
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01934
AC   CVCL_Q517
DR   BioSamples; SAME123589
DR   Coriell; HG01934
DR   IGSR; HG01934
DR   Wikidata; Q54884344
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01935
AC   CVCL_Q518
DR   BioSamples; SAME123588
DR   Coriell; HG01935
DR   GEO; GSM1718771
DR   IGSR; HG01935
DR   Wikidata; Q54884345
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01936
AC   CVCL_Q519
DR   BioSamples; SAME123591
DR   Coriell; HG01936
DR   GEO; GSM1718772
DR   IGSR; HG01936
DR   Wikidata; Q54884346
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01937
AC   CVCL_Q520
DR   BioSamples; SAME123590
DR   Coriell; HG01937
DR   IGSR; HG01937
DR   Wikidata; Q54884347
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01938
AC   CVCL_Q521
DR   BioSamples; SAME123593
DR   Coriell; HG01938
DR   GEO; GSM1718773
DR   IGSR; HG01938
DR   Wikidata; Q54884348
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01939
AC   CVCL_Q522
DR   BioSamples; SAME123592
DR   Coriell; HG01939
DR   GEO; GSM1718774
DR   IGSR; HG01939
DR   Wikidata; Q54884349
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01940
AC   CVCL_Q523
DR   BioSamples; SAME124148
DR   Coriell; HG01940
DR   IGSR; HG01940
DR   Wikidata; Q54884350
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01941
AC   CVCL_Q524
DR   BioSamples; SAME124149
DR   Coriell; HG01941
DR   GEO; GSM1718775
DR   IGSR; HG01941
DR   Wikidata; Q54884352
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01942
AC   CVCL_Q525
DR   BioSamples; SAME124150
DR   Coriell; HG01942
DR   GEO; GSM1718776
DR   IGSR; HG01942
DR   Wikidata; Q54884353
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01943
AC   CVCL_Q526
DR   BioSamples; SAME124151
DR   Coriell; HG01943
DR   IGSR; HG01943
DR   Wikidata; Q54884354
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01944
AC   CVCL_Q527
DR   BioSamples; SAME124152
DR   Coriell; HG01944
DR   GEO; GSM1718777
DR   IGSR; HG01944
DR   Wikidata; Q54884355
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01945
AC   CVCL_Q528
DR   BioSamples; SAME124153
DR   Coriell; HG01945
DR   GEO; GSM1718778
DR   IGSR; HG01945
DR   Wikidata; Q54884356
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01946
AC   CVCL_Q529
DR   BioSamples; SAME124154
DR   Coriell; HG01946
DR   IGSR; HG01946
DR   Wikidata; Q54884357
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01947
AC   CVCL_Q530
DR   BioSamples; SAME124155
DR   Coriell; HG01947
DR   GEO; GSM1718779
DR   IGSR; HG01947
DR   Wikidata; Q54884358
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01948
AC   CVCL_Q531
DR   BioSamples; SAME124144
DR   Coriell; HG01948
DR   GEO; GSM1718780
DR   IGSR; HG01948
DR   Wikidata; Q54884359
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01949
AC   CVCL_Q532
DR   BioSamples; SAME124145
DR   Coriell; HG01949
DR   IGSR; HG01949
DR   Wikidata; Q54884360
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01950
AC   CVCL_Q533
DR   BioSamples; SAME123977
DR   Coriell; HG01950
DR   GEO; GSM1718781
DR   IGSR; HG01950
DR   Wikidata; Q54884361
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01951
AC   CVCL_Q534
DR   BioSamples; SAME123976
DR   Coriell; HG01951
DR   GEO; GSM1718782
DR   IGSR; HG01951
DR   Wikidata; Q54884362
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01952
AC   CVCL_Q535
DR   BioSamples; SAME123975
DR   Coriell; HG01952
DR   IGSR; HG01952
DR   Wikidata; Q54884363
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01953
AC   CVCL_Q536
DR   BioSamples; SAME123974
DR   Coriell; HG01953
DR   GEO; GSM1718783
DR   IGSR; HG01953
DR   Wikidata; Q54884364
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01954
AC   CVCL_Q537
DR   BioSamples; SAME123980
DR   Coriell; HG01954
DR   GEO; GSM1718784
DR   IGSR; HG01954
DR   Wikidata; Q54884365
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01955
AC   CVCL_Q538
DR   BioSamples; SAME123979
DR   Coriell; HG01955
DR   IGSR; HG01955
DR   Wikidata; Q54884366
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01956
AC   CVCL_Q539
DR   BioSamples; SAME123978
DR   Coriell; HG01956
DR   GEO; GSM1718785
DR   IGSR; HG01956
DR   Wikidata; Q54884367
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01958
AC   CVCL_Q540
DR   BioSamples; SAME1839349
DR   Coriell; HG01958
DR   GEO; GSM1718786
DR   IGSR; HG01958
DR   Wikidata; Q54884368
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01959
AC   CVCL_Q541
DR   BioSamples; SAME1839343
DR   Coriell; HG01959
DR   IGSR; HG01959
DR   Wikidata; Q54884369
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01960
AC   CVCL_Q542
DR   BioSamples; SAME1839076
DR   Coriell; HG01960
DR   IGSR; HG01960
DR   Wikidata; Q54884370
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01961
AC   CVCL_GU69
DR   BioSamples; SAME1839067
DR   Coriell; HG01961
DR   GEO; GSM1718787
DR   IGSR; HG01961
DR   Wikidata; Q54884371
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01965
AC   CVCL_GU70
DR   BioSamples; SAME1839145
DR   Coriell; HG01965
DR   GEO; GSM1718788
DR   IGSR; HG01965
DR   Wikidata; Q54884372
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG01967
AC   CVCL_Q543
DR   BioSamples; SAME124530
DR   Coriell; HG01967
DR   GEO; GSM1718789
DR   IGSR; HG01967
DR   Wikidata; Q54884373
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01968
AC   CVCL_Q544
DR   BioSamples; SAME124532
DR   Coriell; HG01968
DR   GEO; GSM1718790
DR   IGSR; HG01968
DR   Wikidata; Q54884374
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01969
AC   CVCL_Q545
DR   BioSamples; SAME124533
DR   Coriell; HG01969
DR   IGSR; HG01969
DR   Wikidata; Q54884375
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01970
AC   CVCL_Q546
DR   BioSamples; SAME124327
DR   Coriell; HG01970
DR   GEO; GSM1718791
DR   IGSR; HG01970
DR   Wikidata; Q54884377
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01971
AC   CVCL_Q547
DR   BioSamples; SAME124326
DR   Coriell; HG01971
DR   GEO; GSM1718792
DR   IGSR; HG01971
DR   Wikidata; Q54884383
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01972
AC   CVCL_Q548
DR   BioSamples; SAME124329
DR   Coriell; HG01972
DR   IGSR; HG01972
DR   Wikidata; Q54884384
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01973
AC   CVCL_Q549
DR   BioSamples; SAME124328
DR   Coriell; HG01973
DR   GEO; GSM1718793
DR   IGSR; HG01973
DR   Wikidata; Q54884385
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01974
AC   CVCL_Q550
DR   BioSamples; SAME124323
DR   Coriell; HG01974
DR   GEO; GSM1718794
DR   IGSR; HG01974
DR   Wikidata; Q54884386
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01975
AC   CVCL_Q551
DR   BioSamples; SAME124322
DR   Coriell; HG01975
DR   IGSR; HG01975
DR   Wikidata; Q54884387
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01976
AC   CVCL_Q552
DR   BioSamples; SAME124325
DR   Coriell; HG01976
DR   GEO; GSM1718795
DR   IGSR; HG01976
DR   Wikidata; Q54884388
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01977
AC   CVCL_Q553
DR   BioSamples; SAME124324
DR   Coriell; HG01977
DR   GEO; GSM1718796
DR   IGSR; HG01977
DR   Wikidata; Q54884389
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01978
AC   CVCL_Q554
DR   BioSamples; SAME124332
DR   Coriell; HG01978
DR   IGSR; HG01978
DR   Wikidata; Q54884390
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01979
AC   CVCL_Q555
DR   BioSamples; SAME124331
DR   Coriell; HG01979
DR   GEO; GSM1718797
DR   IGSR; HG01979
DR   Wikidata; Q54884391
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01980
AC   CVCL_Q556
DR   BioSamples; SAME124917
DR   Coriell; HG01980
DR   GEO; GSM1718798
DR   IGSR; HG01980
DR   Wikidata; Q54884392
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01981
AC   CVCL_Q557
DR   BioSamples; SAME125247
DR   Coriell; HG01981
DR   IGSR; HG01981
DR   Wikidata; Q54884393
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01982
AC   CVCL_Q558
DR   BioSamples; SAME1840111
DR   Coriell; HG01982
DR   GEO; GSM1718799
DR   IGSR; HG01982
DR   Wikidata; Q54884394
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01983
AC   CVCL_Q559
DR   BioSamples; SAME1840106
DR   Coriell; HG01983
DR   GEO; GSM1718800
DR   IGSR; HG01983
DR   Wikidata; Q54884395
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01984
AC   CVCL_Q560
DR   BioSamples; SAME1840105
DR   Coriell; HG01984
DR   IGSR; HG01984
DR   Wikidata; Q54884397
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01985
AC   CVCL_Q561
DR   BioSamples; SAME1840099
DR   Coriell; HG01985
DR   GEO; GSM1718801
DR   IGSR; HG01985
DR   Wikidata; Q54884398
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01986
AC   CVCL_Q562
DR   BioSamples; SAME1840091
DR   Coriell; HG01986
DR   GEO; GSM1718802
DR   IGSR; HG01986
DR   Wikidata; Q54884399
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01987
AC   CVCL_Q563
DR   BioSamples; SAME1840089
DR   Coriell; HG01987
DR   IGSR; HG01987
DR   Wikidata; Q54884401
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01988
AC   CVCL_Q564
DR   BioSamples; SAME1840175
DR   Coriell; HG01988
DR   GEO; GSM1718803
DR   IGSR; HG01988
DR   Wikidata; Q54884402
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01989
AC   CVCL_Q565
DR   BioSamples; SAME1840166
DR   Coriell; HG01989
DR   GEO; GSM1718804
DR   IGSR; HG01989
DR   Wikidata; Q54884403
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01990
AC   CVCL_Q566
DR   BioSamples; SAME1840235
DR   Coriell; HG01990
DR   GEO; GSM1718805
DR   IGSR; HG01990
DR   Wikidata; Q54884404
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG01991
AC   CVCL_Q567
DR   BioSamples; SAME124743
DR   Coriell; HG01991
DR   GEO; GSM1718806
DR   IGSR; HG01991
DR   Wikidata; Q54884405
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01992
AC   CVCL_Q568
DR   BioSamples; SAME124742
DR   Coriell; HG01992
DR   GEO; GSM1718807
DR   IGSR; HG01992
DR   Wikidata; Q54884406
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01993
AC   CVCL_Q569
DR   BioSamples; SAME124741
DR   Coriell; HG01993
DR   IGSR; HG01993
DR   Wikidata; Q54884407
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01997
AC   CVCL_Q570
DR   BioSamples; SAME124740
DR   Coriell; HG01997
DR   GEO; GSM1718808
DR   IGSR; HG01997
DR   Wikidata; Q54884408
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG01998
AC   CVCL_Q571
DR   BioSamples; SAME124739
DR   Coriell; HG01998
DR   IGSR; HG01998
DR   Wikidata; Q54884409
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02002
AC   CVCL_Q572
DR   BioSamples; SAME123618
DR   Coriell; HG02002
DR   GEO; GSM1718809
DR   IGSR; HG02002
DR   Wikidata; Q54884410
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02003
AC   CVCL_Q573
DR   BioSamples; SAME123619
DR   Coriell; HG02003
DR   GEO; GSM1718810
DR   IGSR; HG02003
DR   Wikidata; Q54884411
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02004
AC   CVCL_Q574
DR   BioSamples; SAME123620
DR   Coriell; HG02004
DR   IGSR; HG02004
DR   Wikidata; Q54884412
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02006
AC   CVCL_GU71
DR   BioSamples; SAME1840279
DR   Coriell; HG02006
DR   GEO; GSM1718811
DR   IGSR; HG02006
DR   Wikidata; Q54884413
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02008
AC   CVCL_Q575
DR   BioSamples; SAME123621
DR   Coriell; HG02008
DR   GEO; GSM1718812
DR   IGSR; HG02008
DR   Wikidata; Q54884414
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02009
AC   CVCL_Q576
DR   BioSamples; SAME123622
DR   Coriell; HG02009
DR   GEO; GSM1718813
DR   IGSR; HG02009
DR   Wikidata; Q54884415
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02010
AC   CVCL_Q577
DR   BioSamples; SAME123444
DR   Coriell; HG02010
DR   GEO; GSM1718814
DR   IGSR; HG02010
DR   Wikidata; Q54884416
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02011
AC   CVCL_Q578
DR   BioSamples; SAME123443
DR   Coriell; HG02011
DR   IGSR; HG02011
DR   Wikidata; Q54884417
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02012
AC   CVCL_Q579
DR   BioSamples; SAME1840403
DR   Coriell; HG02012
DR   GEO; GSM1718815
DR   IGSR; HG02012
DR   Wikidata; Q54884418
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02013
AC   CVCL_Q580
DR   BioSamples; SAME1840396
DR   Coriell; HG02013
DR   GEO; GSM1718816
DR   IGSR; HG02013
DR   Wikidata; Q54884419
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02014
AC   CVCL_Q581
DR   BioSamples; SAME123448
DR   Coriell; HG02014
DR   GEO; GSM1718817
DR   IGSR; HG02014
DR   Wikidata; Q54884420
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02015
AC   CVCL_GV10
DR   BioSamples; SAME123447
DR   Coriell; HG02015
DR   IGSR; HG02015
DR   Wikidata; Q54884421
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02016
AC   CVCL_Q582
DR   BioSamples; SAME123446
DR   Coriell; HG02016
DR   GEO; GSM1718818
DR   IGSR; HG02016
DR   Wikidata; Q54884422
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02017
AC   CVCL_Q583
DR   BioSamples; SAME123445
DR   Coriell; HG02017
DR   GEO; GSM1718819
DR   IGSR; HG02017
DR   Wikidata; Q54884423
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02018
AC   CVCL_GV11
DR   BioSamples; SAME123451
DR   Coriell; HG02018
DR   IGSR; HG02018
DR   Wikidata; Q54884424
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02019
AC   CVCL_Q584
DR   BioSamples; SAME123450
DR   Coriell; HG02019
DR   GEO; GSM1718820
DR   IGSR; HG02019
DR   Wikidata; Q54884432
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02020
AC   CVCL_Q585
DR   BioSamples; SAME125168
DR   Coriell; HG02020
DR   GEO; GSM1718821
DR   IGSR; HG02020
DR   Wikidata; Q54884433
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02023
AC   CVCL_Q586
DR   BioSamples; SAME125307
DR   Coriell; HG02023
DR   GEO; GSM1718822
DR   IGSR; HG02023
DR   Wikidata; Q54884434
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02024
AC   CVCL_GU72
DR   BioSamples; SAME125182
DR   Coriell; HG02024
DR   GEO; GSM1718823
DR   IGSR; HG02024
DR   Wikidata; Q54884435
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02025
AC   CVCL_Q587
DR   BioSamples; SAME125335
DR   Coriell; HG02025
DR   GEO; GSM1718824
DR   IGSR; HG02025
DR   Wikidata; Q54884436
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02026
AC   CVCL_Q588
DR   BioSamples; SAME125315
DR   Coriell; HG02026
DR   GEO; GSM1718825
DR   IGSR; HG02026
DR   Wikidata; Q54884437
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02027
AC   CVCL_GV12
DR   BioSamples; SAME125318
DR   Coriell; HG02027
DR   IGSR; HG02027
DR   Wikidata; Q54884438
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02028
AC   CVCL_Q589
DR   BioSamples; SAME124020
DR   Coriell; HG02028
DR   GEO; GSM1718826
DR   IGSR; HG02028
DR   Wikidata; Q54884439
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02029
AC   CVCL_Q590
DR   BioSamples; SAME124021
DR   Coriell; HG02029
DR   GEO; GSM1718827
DR   IGSR; HG02029
DR   Wikidata; Q54884440
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02030
AC   CVCL_GV13
DR   BioSamples; SAME1839966
DR   Coriell; HG02030
DR   IGSR; HG02030
DR   Wikidata; Q54884441
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02031
AC   CVCL_Q591
DR   BioSamples; SAME1839964
DR   Coriell; HG02031
DR   GEO; GSM1718828
DR   IGSR; HG02031
DR   Wikidata; Q54884442
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02032
AC   CVCL_Q592
DR   BioSamples; SAME1839959
DR   Coriell; HG02032
DR   GEO; GSM1718829
DR   IGSR; HG02032
DR   Wikidata; Q54884444
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02035
AC   CVCL_Q593
DR   BioSamples; SAME1840035
DR   Coriell; HG02035
DR   GEO; GSM1718830
DR   IGSR; HG02035
DR   Wikidata; Q54884445
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02040
AC   CVCL_Q594
DR   BioSamples; SAME1839803
DR   Coriell; HG02040
DR   GEO; GSM1718831
DR   IGSR; HG02040
DR   Wikidata; Q54884446
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02045
AC   CVCL_GX96
DR   Coriell; HG02045
DR   Wikidata; Q54884447
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG02046
AC   CVCL_Q595
DR   BioSamples; SAME1839777
DR   Coriell; HG02046
DR   GEO; GSM1718832
DR   IGSR; HG02046
DR   Wikidata; Q54884448
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02047
AC   CVCL_Q596
DR   BioSamples; SAME1839772
DR   Coriell; HG02047
DR   GEO; GSM1718833
DR   IGSR; HG02047
DR   Wikidata; Q54884449
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02048
AC   CVCL_Q597
DR   BioSamples; SAME123772
DR   Coriell; HG02048
DR   GEO; GSM1718834
DR   IGSR; HG02048
DR   Wikidata; Q54884450
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02049
AC   CVCL_Q598
DR   BioSamples; SAME123773
DR   Coriell; HG02049
DR   GEO; GSM1718835
DR   IGSR; HG02049
DR   Wikidata; Q54884451
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02050
AC   CVCL_Q599
DR   BioSamples; SAME1839555
DR   Coriell; HG02050
DR   GEO; GSM1718836
DR   IGSR; HG02050
DR   Wikidata; Q54884452
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02051
AC   CVCL_Q600
DR   BioSamples; SAME1839549
DR   Coriell; HG02051
DR   GEO; GSM1718837
DR   IGSR; HG02051
DR   Wikidata; Q54884453
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02052
AC   CVCL_Q601
DR   BioSamples; SAME1839545
DR   Coriell; HG02052
DR   GEO; GSM1718838
DR   IGSR; HG02052
DR   Wikidata; Q54884454
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02053
AC   CVCL_Q602
DR   BioSamples; SAME1839543
DR   Coriell; HG02053
DR   GEO; GSM1718839
DR   IGSR; HG02053
DR   Wikidata; Q54884455
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02054
AC   CVCL_Q603
DR   BioSamples; SAME1839538
DR   Coriell; HG02054
DR   GEO; GSM1718840
DR   IGSR; HG02054
DR   Wikidata; Q54884456
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02055
AC   CVCL_Q604
DR   BioSamples; SAME1839531
DR   Coriell; HG02055
DR   IGSR; HG02055
DR   Wikidata; Q54884457
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02056
AC   CVCL_GV14
DR   BioSamples; SAME124162
DR   Coriell; HG02056
DR   IGSR; HG02056
DR   Wikidata; Q54884458
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02057
AC   CVCL_Q605
DR   BioSamples; SAME124146
DR   Coriell; HG02057
DR   GEO; GSM1718841
DR   IGSR; HG02057
DR   Wikidata; Q54884459
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02058
AC   CVCL_Q606
DR   BioSamples; SAME125319
DR   Coriell; HG02058
DR   GEO; GSM1718842
DR   IGSR; HG02058
DR   Wikidata; Q54884460
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02059
AC   CVCL_GV15
DR   BioSamples; SAME1839596
DR   Coriell; HG02059
DR   IGSR; HG02059
DR   Wikidata; Q54884461
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02060
AC   CVCL_Q607
DR   BioSamples; SAME1839679
DR   Coriell; HG02060
DR   GEO; GSM1718843
DR   IGSR; HG02060
DR   Wikidata; Q54884462
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02061
AC   CVCL_Q608
DR   BioSamples; SAME1839676
DR   Coriell; HG02061
DR   GEO; GSM1718844
DR   IGSR; HG02061
DR   Wikidata; Q54884463
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02064
AC   CVCL_Q609
DR   BioSamples; SAME1839658
DR   Coriell; HG02064
DR   GEO; GSM1718845
DR   IGSR; HG02064
DR   Wikidata; Q54884464
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02067
AC   CVCL_Q610
DR   BioSamples; SAME1839388
DR   Coriell; HG02067
DR   GEO; GSM1718846
DR   IGSR; HG02067
DR   Wikidata; Q54884465
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02068
AC   CVCL_GV16
DR   BioSamples; SAME123374
DR   Coriell; HG02068
DR   IGSR; HG02068
DR   Wikidata; Q54884466
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02069
AC   CVCL_Q611
DR   BioSamples; SAME123375
DR   Coriell; HG02069
DR   GEO; GSM1718847
DR   IGSR; HG02069
DR   Wikidata; Q54884467
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02070
AC   CVCL_Q612
DR   BioSamples; SAME124908
DR   Coriell; HG02070
DR   GEO; GSM1718848
DR   IGSR; HG02070
DR   Wikidata; Q54884468
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02071
AC   CVCL_GV17
DR   BioSamples; SAME123102
DR   Coriell; HG02071
DR   IGSR; HG02071
DR   Wikidata; Q54884469
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02072
AC   CVCL_Q613
DR   BioSamples; SAME123105
DR   Coriell; HG02072
DR   GEO; GSM1718849
DR   IGSR; HG02072
DR   Wikidata; Q54884471
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02073
AC   CVCL_Q614
DR   BioSamples; SAME123104
DR   Coriell; HG02073
DR   GEO; GSM1718850
DR   IGSR; HG02073
DR   Wikidata; Q54884472
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02074
AC   CVCL_GV18
DR   BioSamples; SAME123107
DR   Coriell; HG02074
DR   IGSR; HG02074
DR   Wikidata; Q54884473
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02075
AC   CVCL_Q615
DR   BioSamples; SAME123106
DR   Coriell; HG02075
DR   GEO; GSM1718851
DR   IGSR; HG02075
DR   Wikidata; Q54884479
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02076
AC   CVCL_Q616
DR   BioSamples; SAME124913
DR   Coriell; HG02076
DR   GEO; GSM1718852
DR   IGSR; HG02076
DR   Wikidata; Q54884480
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02077
AC   CVCL_GV19
DR   BioSamples; SAME123108
DR   Coriell; HG02077
DR   IGSR; HG02077
DR   Wikidata; Q54884481
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02078
AC   CVCL_Q617
DR   BioSamples; SAME123099
DR   Coriell; HG02078
DR   GEO; GSM1718853
DR   IGSR; HG02078
DR   Wikidata; Q54884482
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02079
AC   CVCL_Q618
DR   BioSamples; SAME123098
DR   Coriell; HG02079
DR   GEO; GSM1718854
DR   IGSR; HG02079
DR   Wikidata; Q54884483
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02080
AC   CVCL_GV20
DR   BioSamples; SAME124825
DR   Coriell; HG02080
DR   IGSR; HG02080
DR   Wikidata; Q54884484
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02081
AC   CVCL_Q619
DR   BioSamples; SAME124826
DR   Coriell; HG02081
DR   GEO; GSM1718855
DR   IGSR; HG02081
DR   Wikidata; Q54884485
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02082
AC   CVCL_Q620
DR   BioSamples; SAME124950
DR   Coriell; HG02082
DR   GEO; GSM1718856
DR   IGSR; HG02082
DR   Wikidata; Q54884487
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02083
AC   CVCL_GV21
DR   BioSamples; SAME124962
DR   Coriell; HG02083
DR   IGSR; HG02083
DR   Wikidata; Q54884488
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02084
AC   CVCL_Q621
DR   BioSamples; SAME124973
DR   Coriell; HG02084
DR   GEO; GSM1718857
DR   IGSR; HG02084
DR   Wikidata; Q54884489
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02085
AC   CVCL_Q622
DR   BioSamples; SAME124979
DR   Coriell; HG02085
DR   GEO; GSM1718858
DR   IGSR; HG02085
DR   Wikidata; Q54884490
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02086
AC   CVCL_Q623
DR   BioSamples; SAME124675
DR   Coriell; HG02086
DR   GEO; GSM1718859
DR   IGSR; HG02086
DR   Wikidata; Q54884491
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02087
AC   CVCL_Q624
DR   BioSamples; SAME124678
DR   Coriell; HG02087
DR   GEO; GSM1718860
DR   IGSR; HG02087
DR   Wikidata; Q54884492
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02088
AC   CVCL_Q625
DR   BioSamples; SAME124820
DR   Coriell; HG02088
DR   GEO; GSM1718861
DR   IGSR; HG02088
DR   Wikidata; Q54884493
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02089
AC   CVCL_Q626
DR   BioSamples; SAME124821
DR   Coriell; HG02089
DR   GEO; GSM1718862
DR   IGSR; HG02089
DR   Wikidata; Q54884494
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02090
AC   CVCL_Q627
DR   BioSamples; SAME124651
DR   Coriell; HG02090
DR   GEO; GSM1718863
DR   IGSR; HG02090
DR   Wikidata; Q54884495
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02091
AC   CVCL_Q628
DR   BioSamples; SAME124650
DR   Coriell; HG02091
DR   IGSR; HG02091
DR   Wikidata; Q54884496
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02095
AC   CVCL_Q629
DR   BioSamples; SAME1839064
DR   Coriell; HG02095
DR   GEO; GSM1718864
DR   IGSR; HG02095
DR   Wikidata; Q54884497
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02102
AC   CVCL_GU73
DR   BioSamples; SAME1840155
DR   Coriell; HG02102
DR   GEO; GSM1718865
DR   IGSR; HG02102
DR   Wikidata; Q54884498
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02104
AC   CVCL_Q630
DR   BioSamples; SAME123874
DR   Coriell; HG02104
DR   GEO; GSM1718866
DR   IGSR; HG02104
DR   Wikidata; Q54884499
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02105
AC   CVCL_Q631
DR   BioSamples; SAME123873
DR   Coriell; HG02105
DR   GEO; GSM1718867
DR   IGSR; HG02105
DR   Wikidata; Q54884500
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02106
AC   CVCL_Q632
DR   BioSamples; SAME123875
DR   Coriell; HG02106
DR   IGSR; HG02106
DR   Wikidata; Q54884501
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02107
AC   CVCL_Q633
DR   BioSamples; SAME1840206
DR   Coriell; HG02107
DR   GEO; GSM1718868
DR   IGSR; HG02107
DR   Wikidata; Q54884503
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02108
AC   CVCL_Q634
DR   BioSamples; SAME1840201
DR   Coriell; HG02108
DR   GEO; GSM1718869
DR   IGSR; HG02108
DR   Wikidata; Q54884504
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02109
AC   CVCL_Q635
DR   Coriell; HG02109
DR   Wikidata; Q54884505
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   HG02111
AC   CVCL_Q636
DR   BioSamples; SAME1839922
DR   Coriell; HG02111
DR   GEO; GSM1718870
DR   IGSR; HG02111
DR   Wikidata; Q54884506
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02113
AC   CVCL_Q637
DR   BioSamples; SAME124044
DR   Coriell; HG02113
DR   GEO; GSM1718871
DR   IGSR; HG02113
DR   Wikidata; Q54884507
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02116
AC   CVCL_Q638
DR   BioSamples; SAME1839990
DR   Coriell; HG02116
DR   GEO; GSM1718872
DR   IGSR; HG02116
DR   Wikidata; Q54884508
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02120
AC   CVCL_GV22
DR   BioSamples; SAME123480
DR   Coriell; HG02120
DR   IGSR; HG02120
DR   Wikidata; Q54884509
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02121
AC   CVCL_Q639
DR   BioSamples; SAME123479
DR   Coriell; HG02121
DR   GEO; GSM1718873
DR   IGSR; HG02121
DR   Wikidata; Q54884510
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02122
AC   CVCL_Q640
DR   BioSamples; SAME123478
DR   Coriell; HG02122
DR   GEO; GSM1718874
DR   IGSR; HG02122
DR   Wikidata; Q54884511
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02126
AC   CVCL_GV23
DR   BioSamples; SAME123477
DR   Coriell; HG02126
DR   IGSR; HG02126
DR   Wikidata; Q54884512
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02127
AC   CVCL_Q641
DR   BioSamples; SAME123476
DR   Coriell; HG02127
DR   GEO; GSM1718875
DR   IGSR; HG02127
DR   Wikidata; Q54884513
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02128
AC   CVCL_Q642
DR   BioSamples; SAME123475
DR   Coriell; HG02128
DR   GEO; GSM1718876
DR   IGSR; HG02128
DR   Wikidata; Q54884514
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02129
AC   CVCL_GV24
DR   BioSamples; SAME1839724
DR   Coriell; HG02129
DR   IGSR; HG02129
DR   Wikidata; Q54884515
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02130
AC   CVCL_Q643
DR   BioSamples; SAME1839904
DR   Coriell; HG02130
DR   GEO; GSM1718877
DR   IGSR; HG02130
DR   Wikidata; Q54884516
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02131
AC   CVCL_Q644
DR   BioSamples; SAME1839896
DR   Coriell; HG02131
DR   GEO; GSM1718878
DR   IGSR; HG02131
DR   Wikidata; Q54884518
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02132
AC   CVCL_GV25
DR   BioSamples; SAME1839889
DR   Coriell; HG02132
DR   IGSR; HG02132
DR   Wikidata; Q54884519
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02133
AC   CVCL_Q645
DR   BioSamples; SAME1839882
DR   Coriell; HG02133
DR   GEO; GSM1718879
DR   IGSR; HG02133
DR   Wikidata; Q54884520
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02134
AC   CVCL_Q646
DR   BioSamples; SAME1839875
DR   Coriell; HG02134
DR   GEO; GSM1718880
DR   IGSR; HG02134
DR   Wikidata; Q54884521
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02135
AC   CVCL_GV26
DR   BioSamples; SAME1839872
DR   Coriell; HG02135
DR   IGSR; HG02135
DR   Wikidata; Q54884528
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02136
AC   CVCL_Q647
DR   BioSamples; SAME1839865
DR   Coriell; HG02136
DR   GEO; GSM1718881
DR   IGSR; HG02136
DR   Wikidata; Q54884529
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02137
AC   CVCL_Q648
DR   BioSamples; SAME1839862
DR   Coriell; HG02137
DR   GEO; GSM1718882
DR   IGSR; HG02137
DR   Wikidata; Q54884530
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02138
AC   CVCL_Q649
DR   BioSamples; SAME123659
DR   Coriell; HG02138
DR   GEO; GSM1718883
DR   IGSR; HG02138
DR   Wikidata; Q54884531
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02139
AC   CVCL_Q650
DR   BioSamples; SAME123660
DR   Coriell; HG02139
DR   GEO; GSM1718884
DR   IGSR; HG02139
DR   Wikidata; Q54884532
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02140
AC   CVCL_Q651
DR   BioSamples; SAME124612
DR   Coriell; HG02140
DR   GEO; GSM1718885
DR   IGSR; HG02140
DR   Wikidata; Q54884533
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02141
AC   CVCL_Q652
DR   BioSamples; SAME124611
DR   Coriell; HG02141
DR   GEO; GSM1718886
DR   IGSR; HG02141
DR   Wikidata; Q54884534
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02142
AC   CVCL_Q653
DR   BioSamples; SAME124614
DR   Coriell; HG02142
DR   GEO; GSM1718887
DR   IGSR; HG02142
DR   Wikidata; Q54884536
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02143
AC   CVCL_Q654
DR   BioSamples; SAME1839628
DR   Coriell; HG02143
DR   GEO; GSM1718888
DR   IGSR; HG02143
DR   Wikidata; Q54884538
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02144
AC   CVCL_Q655
DR   BioSamples; SAME1839624
DR   Coriell; HG02144
DR   GEO; GSM1718889
DR   IGSR; HG02144
DR   Wikidata; Q54884539
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02145
AC   CVCL_Q656
DR   BioSamples; SAME1839616
DR   Coriell; HG02145
DR   IGSR; HG02145
DR   Wikidata; Q54884540
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02146
AC   CVCL_Q657
DR   BioSamples; SAME1839613
DR   Coriell; HG02146
DR   GEO; GSM1718890
DR   IGSR; HG02146
DR   Wikidata; Q54884541
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02147
AC   CVCL_Q658
DR   BioSamples; SAME1839700
DR   Coriell; HG02147
DR   GEO; GSM1718891
DR   IGSR; HG02147
DR   Wikidata; Q54884542
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02148
AC   CVCL_Q659
DR   BioSamples; SAME1839697
DR   Coriell; HG02148
DR   IGSR; HG02148
DR   Wikidata; Q54884543
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02150
AC   CVCL_GU74
DR   BioSamples; SAME1839407
DR   Coriell; HG02150
DR   GEO; GSM1718892
DR   IGSR; HG02150
DR   Wikidata; Q54884544
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02151
AC   CVCL_Q660
DR   BioSamples; SAME1839403
DR   Coriell; HG02151
DR   GEO; GSM1718893
DR   IGSR; HG02151
DR   Wikidata; Q54884545
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02152
AC   CVCL_Q661
DR   BioSamples; SAME124790
DR   Coriell; HG02152
DR   GEO; GSM1718894
DR   IGSR; HG02152
DR   Wikidata; Q54884546
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02153
AC   CVCL_Q662
DR   BioSamples; SAME124791
DR   Coriell; HG02153
DR   GEO; GSM1718895
DR   IGSR; HG02153
DR   Wikidata; Q54884547
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02154
AC   CVCL_Q663
DR   BioSamples; SAME124794
DR   Coriell; HG02154
DR   GEO; GSM1718896
DR   IGSR; HG02154
DR   Wikidata; Q54884548
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02155
AC   CVCL_Q664
DR   BioSamples; SAME124795
DR   Coriell; HG02155
DR   GEO; GSM1718897
DR   IGSR; HG02155
DR   Wikidata; Q54884549
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02156
AC   CVCL_Q665
DR   BioSamples; SAME124793
DR   Coriell; HG02156
DR   GEO; GSM1718898
DR   IGSR; HG02156
DR   Wikidata; Q54884550
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02164
AC   CVCL_Q666
DR   BioSamples; SAME124209
DR   Coriell; HG02164
DR   GEO; GSM1718899
DR   IGSR; HG02164
DR   Wikidata; Q54884551
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02165
AC   CVCL_Q667
DR   BioSamples; SAME124208
DR   Coriell; HG02165
DR   GEO; GSM1718900
DR   IGSR; HG02165
DR   Wikidata; Q54884552
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02166
AC   CVCL_Q668
DR   BioSamples; SAME124207
DR   Coriell; HG02166
DR   GEO; GSM1718901
DR   IGSR; HG02166
DR   Wikidata; Q54884553
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02178
AC   CVCL_Q669
DR   BioSamples; SAME124414
DR   Coriell; HG02178
DR   GEO; GSM1718902
DR   IGSR; HG02178
DR   Wikidata; Q54884554
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02179
AC   CVCL_Q670
DR   BioSamples; SAME124415
DR   Coriell; HG02179
DR   GEO; GSM1718903
DR   IGSR; HG02179
DR   Wikidata; Q54884555
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02180
AC   CVCL_Q671
DR   BioSamples; SAME123208
DR   Coriell; HG02180
DR   GEO; GSM1718904
DR   IGSR; HG02180
DR   Wikidata; Q54884556
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02181
AC   CVCL_Q672
DR   BioSamples; SAME123206
DR   Coriell; HG02181
DR   GEO; GSM1718905
DR   IGSR; HG02181
DR   Wikidata; Q54884558
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02182
AC   CVCL_Q673
DR   BioSamples; SAME125035
DR   Coriell; HG02182
DR   GEO; GSM1718906
DR   IGSR; HG02182
DR   Wikidata; Q54884559
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02184
AC   CVCL_Q674
DR   BioSamples; SAME123216
DR   Coriell; HG02184
DR   GEO; GSM1718907
DR   IGSR; HG02184
DR   Wikidata; Q54884560
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02185
AC   CVCL_Q675
DR   BioSamples; SAME123215
DR   Coriell; HG02185
DR   GEO; GSM1718908
DR   IGSR; HG02185
DR   Wikidata; Q54884561
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02186
AC   CVCL_Q676
DR   BioSamples; SAME125039
DR   Coriell; HG02186
DR   GEO; GSM1718909
DR   IGSR; HG02186
DR   Wikidata; Q54884562
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02187
AC   CVCL_Q677
DR   BioSamples; SAME125038
DR   Coriell; HG02187
DR   GEO; GSM1718910
DR   IGSR; HG02187
DR   Wikidata; Q54884563
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02188
AC   CVCL_Q678
DR   BioSamples; SAME122829
DR   Coriell; HG02188
DR   GEO; GSM1718911
DR   IGSR; HG02188
DR   Wikidata; Q54884564
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02189
AC   CVCL_Q679
DR   BioSamples; SAME125040
DR   Coriell; HG02189
DR   IGSR; HG02189
DR   Wikidata; Q54884565
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02190
AC   CVCL_Q680
DR   BioSamples; SAME125259
DR   Coriell; HG02190
DR   GEO; GSM1718912
DR   IGSR; HG02190
DR   Wikidata; Q54884566
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02215
AC   CVCL_Q681
DR   ArrayExpress; E-GEUV-1
DR   ArrayExpress; E-GEUV-2
DR   ArrayExpress; E-GEUV-3
DR   ArrayExpress; E-MTAB-3656
DR   ArrayExpress; E-MTAB-3657
DR   BioSamples; SAME123904
DR   Coriell; HG02215
DR   GEO; GSM1718913
DR   IGSR; HG02215
DR   Wikidata; Q54884568
RX   PubMed=24037378;
RX   PubMed=27617755;
RX   PubMed=31048460;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; British from England and Scotland (GBR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG02219
AC   CVCL_GU75
DR   BioSamples; SAME1839813
DR   Coriell; HG02219
DR   GEO; GSM1718914
DR   IGSR; HG02219
DR   Wikidata; Q54884569
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02220
AC   CVCL_Q682
DR   BioSamples; SAME123715
DR   Coriell; HG02220
DR   GEO; GSM1718915
DR   IGSR; HG02220
DR   Wikidata; Q54884570
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02221
AC   CVCL_Q683
DR   BioSamples; SAME123716
DR   Coriell; HG02221
DR   GEO; GSM1718916
DR   IGSR; HG02221
DR   Wikidata; Q54884571
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02222
AC   CVCL_Q684
DR   BioSamples; SAME123717
DR   Coriell; HG02222
DR   IGSR; HG02222
DR   Wikidata; Q54884581
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02223
AC   CVCL_Q685
DR   BioSamples; SAME1839584
DR   Coriell; HG02223
DR   GEO; GSM1718917
DR   IGSR; HG02223
DR   Wikidata; Q54884582
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02224
AC   CVCL_Q686
DR   BioSamples; SAME1839579
DR   Coriell; HG02224
DR   GEO; GSM1718918
DR   IGSR; HG02224
DR   Wikidata; Q54884583
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02225
AC   CVCL_Q687
DR   BioSamples; SAME1839576
DR   Coriell; HG02225
DR   IGSR; HG02225
DR   Wikidata; Q54884584
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02229
AC   CVCL_Q688
DR   BioSamples; SAME1839649
DR   Coriell; HG02229
DR   IGSR; HG02229
DR   Wikidata; Q54884585
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02230
AC   CVCL_Q689
DR   BioSamples; SAME1839383
DR   Coriell; HG02230
DR   GEO; GSM1718919
DR   IGSR; HG02230
DR   Wikidata; Q54884586
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02231
AC   CVCL_Q690
DR   BioSamples; SAME1839376
DR   Coriell; HG02231
DR   GEO; GSM1718920
DR   IGSR; HG02231
DR   Wikidata; Q54884587
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02232
AC   CVCL_Q691
DR   BioSamples; SAME1839374
DR   Coriell; HG02232
DR   GEO; GSM1718921
DR   IGSR; HG02232
DR   Wikidata; Q54884588
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02233
AC   CVCL_Q692
DR   BioSamples; SAME1839370
DR   Coriell; HG02233
DR   GEO; GSM1718922
DR   IGSR; HG02233
DR   Wikidata; Q54884589
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02234
AC   CVCL_Q693
DR   BioSamples; SAME1839367
DR   Coriell; HG02234
DR   IGSR; HG02234
DR   Wikidata; Q54884591
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02235
AC   CVCL_Q694
DR   BioSamples; SAME123521
DR   Coriell; HG02235
DR   GEO; GSM1718923
DR   IGSR; HG02235
DR   Wikidata; Q54884592
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02236
AC   CVCL_Q695
DR   BioSamples; SAME123520
DR   Coriell; HG02236
DR   GEO; GSM1718924
DR   IGSR; HG02236
DR   Wikidata; Q54884593
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02237
AC   CVCL_Q696
DR   BioSamples; SAME123519
DR   Coriell; HG02237
DR   IGSR; HG02237
DR   Wikidata; Q54884594
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02238
AC   CVCL_Q697
DR   BioSamples; SAME1839423
DR   Coriell; HG02238
DR   GEO; GSM1718925
DR   IGSR; HG02238
DR   Wikidata; Q54884595
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02239
AC   CVCL_Q698
DR   BioSamples; SAME1839420
DR   Coriell; HG02239
DR   GEO; GSM1718926
DR   IGSR; HG02239
DR   Wikidata; Q54884596
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02240
AC   CVCL_Q699
DR   BioSamples; SAME1839481
DR   Coriell; HG02240
DR   IGSR; HG02240
DR   Wikidata; Q54884597
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Caucasian; Iberian populations in Spain (IBS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02250
AC   CVCL_Q700
DR   BioSamples; SAME1839268
DR   Coriell; HG02250
DR   GEO; GSM1718927
DR   IGSR; HG02250
DR   Wikidata; Q54884598
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02252
AC   CVCL_GU76
DR   BioSamples; SAME1839354
DR   Coriell; HG02252
DR   GEO; GSM1718928
DR   IGSR; HG02252
DR   Wikidata; Q54884599
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02253
AC   CVCL_GU77
DR   BioSamples; SAME1839347
DR   Coriell; HG02253
DR   GEO; GSM1718929
DR   IGSR; HG02253
DR   Wikidata; Q54884600
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02255
AC   CVCL_Q701
DR   BioSamples; SAME1839337
DR   Coriell; HG02255
DR   GEO; GSM1718930
DR   IGSR; HG02255
DR   Wikidata; Q54884601
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02256
AC   CVCL_Q702
DR   BioSamples; SAME1839332
DR   Coriell; HG02256
DR   GEO; GSM1718931
DR   IGSR; HG02256
DR   Wikidata; Q54884602
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02257
AC   CVCL_Q703
DR   BioSamples; SAME1839326
DR   Coriell; HG02257
DR   IGSR; HG02257
DR   Wikidata; Q54884603
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02258
AC   CVCL_Q704
DR   BioSamples; SAME1839322
DR   Coriell; HG02258
DR   IGSR; HG02258
DR   Wikidata; Q54884604
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02259
AC   CVCL_Q705
DR   BioSamples; SAME1839319
DR   Coriell; HG02259
DR   GEO; GSM1718932
DR   IGSR; HG02259
DR   Wikidata; Q54884605
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02260
AC   CVCL_Q706
DR   BioSamples; SAME1839139
DR   Coriell; HG02260
DR   GEO; GSM1718933
DR   IGSR; HG02260
DR   Wikidata; Q54884606
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02261
AC   CVCL_Q707
DR   BioSamples; SAME1839134
DR   Coriell; HG02261
DR   IGSR; HG02261
DR   Wikidata; Q54884607
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02262
AC   CVCL_GU78
DR   BioSamples; SAME1839128
DR   Coriell; HG02262
DR   GEO; GSM1718934
DR   IGSR; HG02262
DR   Wikidata; Q54884608
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02265
AC   CVCL_GU79
DR   BioSamples; SAME1839117
DR   Coriell; HG02265
DR   GEO; GSM1718935
DR   IGSR; HG02265
DR   Wikidata; Q54884609
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02266
AC   CVCL_GU80
DR   BioSamples; SAME1839110
DR   Coriell; HG02266
DR   GEO; GSM1718936
DR   IGSR; HG02266
DR   Wikidata; Q54884610
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02271
AC   CVCL_Q708
DR   BioSamples; SAME1840319
DR   Coriell; HG02271
DR   GEO; GSM1718937
DR   IGSR; HG02271
DR   Wikidata; Q54884611
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02272
AC   CVCL_Q709
DR   BioSamples; SAME1840314
DR   Coriell; HG02272
DR   GEO; GSM1718938
DR   IGSR; HG02272
DR   Wikidata; Q54884612
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02273
AC   CVCL_Q710
DR   BioSamples; SAME1840309
DR   Coriell; HG02273
DR   IGSR; HG02273
DR   Wikidata; Q54884613
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02274
AC   CVCL_GU81
DR   BioSamples; SAME1840306
DR   Coriell; HG02274
DR   GEO; GSM1718939
DR   IGSR; HG02274
DR   Wikidata; Q54884614
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02275
AC   CVCL_GU82
DR   BioSamples; SAME1840376
DR   Coriell; HG02275
DR   GEO; GSM1718940
DR   IGSR; HG02275
DR   Wikidata; Q54884615
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02277
AC   CVCL_Q711
DR   BioSamples; SAME1840370
DR   Coriell; HG02277
DR   GEO; GSM1718941
DR   IGSR; HG02277
DR   Wikidata; Q54884616
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02278
AC   CVCL_Q712
DR   BioSamples; SAME1840367
DR   Coriell; HG02278
DR   GEO; GSM1718942
DR   IGSR; HG02278
DR   Wikidata; Q54884617
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02279
AC   CVCL_Q713
DR   BioSamples; SAME1840362
DR   Coriell; HG02279
DR   IGSR; HG02279
DR   Wikidata; Q54884618
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02280
AC   CVCL_Q714
DR   BioSamples; SAME1840096
DR   Coriell; HG02280
DR   IGSR; HG02280
DR   Wikidata; Q54884619
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02281
AC   CVCL_Q715
DR   BioSamples; SAME1840094
DR   Coriell; HG02281
DR   GEO; GSM1718943
DR   IGSR; HG02281
DR   Wikidata; Q54884621
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02282
AC   CVCL_Q716
DR   BioSamples; SAME1840177
DR   Coriell; HG02282
DR   GEO; GSM1718944
DR   IGSR; HG02282
DR   Wikidata; Q54884622
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02283
AC   CVCL_Q717
DR   BioSamples; SAME1840173
DR   Coriell; HG02283
DR   GEO; GSM1718945
DR   IGSR; HG02283
DR   Wikidata; Q54884629
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02284
AC   CVCL_Q718
DR   BioSamples; SAME1840168
DR   Coriell; HG02284
DR   GEO; GSM1718946
DR   IGSR; HG02284
DR   Wikidata; Q54884630
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02285
AC   CVCL_Q719
DR   BioSamples; SAME122914
DR   Coriell; HG02285
DR   GEO; GSM1718947
DR   IGSR; HG02285
DR   Wikidata; Q54884631
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02286
AC   CVCL_Q720
DR   BioSamples; SAME122912
DR   Coriell; HG02286
DR   GEO; GSM1718948
DR   IGSR; HG02286
DR   Wikidata; Q54884632
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02287
AC   CVCL_Q721
DR   BioSamples; SAME123755
DR   Coriell; HG02287
DR   IGSR; HG02287
DR   Wikidata; Q54884633
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02291
AC   CVCL_Q722
DR   BioSamples; SAME1839948
DR   Coriell; HG02291
DR   GEO; GSM1718949
DR   IGSR; HG02291
DR   Wikidata; Q54884634
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02292
AC   CVCL_Q723
DR   BioSamples; SAME1839943
DR   Coriell; HG02292
DR   GEO; GSM1718950
DR   IGSR; HG02292
DR   Wikidata; Q54884635
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02293
AC   CVCL_Q724
DR   BioSamples; SAME1839934
DR   Coriell; HG02293
DR   IGSR; HG02293
DR   Wikidata; Q54884636
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02298
AC   CVCL_Q725
DR   BioSamples; SAME1839913
DR   Coriell; HG02298
DR   GEO; GSM1718951
DR   IGSR; HG02298
DR   Wikidata; Q54884637
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02299
AC   CVCL_Q726
DR   BioSamples; SAME1839994
DR   Coriell; HG02299
DR   GEO; GSM1718952
DR   IGSR; HG02299
DR   Wikidata; Q54884638
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02300
AC   CVCL_Q727
DR   BioSamples; SAME1839856
DR   Coriell; HG02300
DR   IGSR; HG02300
DR   Wikidata; Q54884640
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02301
AC   CVCL_Q728
DR   BioSamples; SAME124280
DR   Coriell; HG02301
DR   GEO; GSM1718953
DR   IGSR; HG02301
DR   Wikidata; Q54884641
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02302
AC   CVCL_Q729
DR   BioSamples; SAME124279
DR   Coriell; HG02302
DR   IGSR; HG02302
DR   Wikidata; Q54884642
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02303
AC   CVCL_Q730
DR   BioSamples; SAME124278
DR   Coriell; HG02303
DR   IGSR; HG02303
DR   Wikidata; Q54884643
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02304
AC   CVCL_GU83
DR   BioSamples; SAME1839548
DR   Coriell; HG02304
DR   GEO; GSM1718954
DR   IGSR; HG02304
DR   Wikidata; Q54884644
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02307
AC   CVCL_Q731
DR   BioSamples; SAME1839535
DR   Coriell; HG02307
DR   GEO; GSM1718955
DR   IGSR; HG02307
DR   Wikidata; Q54884645
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02308
AC   CVCL_Q732
DR   BioSamples; SAME1839529
DR   Coriell; HG02308
DR   GEO; GSM1718956
DR   IGSR; HG02308
DR   Wikidata; Q54884646
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02309
AC   CVCL_Q733
DR   BioSamples; SAME1839525
DR   Coriell; HG02309
DR   GEO; GSM1718957
DR   IGSR; HG02309
DR   Wikidata; Q54884647
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02312
AC   CVCL_GU84
DR   BioSamples; SAME1839684
DR   Coriell; HG02312
DR   GEO; GSM1718958
DR   IGSR; HG02312
DR   Wikidata; Q54884648
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02314
AC   CVCL_Q734
DR   BioSamples; SAME1839674
DR   Coriell; HG02314
DR   GEO; GSM1718959
DR   IGSR; HG02314
DR   Wikidata; Q54884649
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02315
AC   CVCL_Q735
DR   BioSamples; SAME1839666
DR   Coriell; HG02315
DR   GEO; GSM1718960
DR   IGSR; HG02315
DR   Wikidata; Q54884650
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02316
AC   CVCL_Q736
DR   BioSamples; SAME1839661
DR   Coriell; HG02316
DR   IGSR; HG02316
DR   Wikidata; Q54884651
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02317
AC   CVCL_Q737
DR   BioSamples; SAME1839656
DR   Coriell; HG02317
DR   GEO; GSM1718961
DR   IGSR; HG02317
DR   Wikidata; Q54884652
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02318
AC   CVCL_Q738
DR   BioSamples; SAME1839391
DR   Coriell; HG02318
DR   GEO; GSM1718962
DR   IGSR; HG02318
DR   Wikidata; Q54884653
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02319
AC   CVCL_Q739
DR   Coriell; HG02319
DR   Wikidata; Q54884654
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   HG02321
AC   CVCL_Q740
DR   BioSamples; SAME1839446
DR   Coriell; HG02321
DR   IGSR; HG02321
DR   Wikidata; Q54884655
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02322
AC   CVCL_Q741
DR   BioSamples; SAME1839444
DR   Coriell; HG02322
DR   GEO; GSM1718963
DR   IGSR; HG02322
DR   Wikidata; Q54884656
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02323
AC   CVCL_Q742
DR   BioSamples; SAME1839440
DR   Coriell; HG02323
DR   GEO; GSM1718964
DR   IGSR; HG02323
DR   Wikidata; Q54884657
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02325
AC   CVCL_Q743
DR   BioSamples; SAME1839521
DR   Coriell; HG02325
DR   GEO; GSM1718965
DR   IGSR; HG02325
DR   Wikidata; Q54884658
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02330
AC   CVCL_Q744
DR   BioSamples; SAME1839237
DR   Coriell; HG02330
DR   GEO; GSM1718966
DR   IGSR; HG02330
DR   Wikidata; Q54884659
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02332
AC   CVCL_Q745
DR   BioSamples; SAME1839315
DR   Coriell; HG02332
DR   GEO; GSM1718967
DR   IGSR; HG02332
DR   Wikidata; Q54884660
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02334
AC   CVCL_Q746
DR   BioSamples; SAME1839307
DR   Coriell; HG02334
DR   GEO; GSM1718968
DR   IGSR; HG02334
DR   Wikidata; Q54884661
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02337
AC   CVCL_Q747
DR   BioSamples; SAME1839296
DR   Coriell; HG02337
DR   GEO; GSM1718969
DR   IGSR; HG02337
DR   Wikidata; Q54884662
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02339
AC   CVCL_Q748
DR   BioSamples; SAME1839288
DR   Coriell; HG02339
DR   GEO; GSM1718970
DR   IGSR; HG02339
DR   Wikidata; Q54884663
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02343
AC   CVCL_Q749
DR   BioSamples; SAME1839087
DR   BioSamples; SAME1839091
DR   Coriell; HG02343
DR   GEO; GSM1718971
DR   IGSR; HG02343
DR   Wikidata; Q54884664
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02345
AC   CVCL_GU85
DR   BioSamples; SAME1839081
DR   Coriell; HG02345
DR   GEO; GSM1718972
DR   IGSR; HG02345
DR   Wikidata; Q54884665
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02348
AC   CVCL_GU86
DR   BioSamples; SAME1839063
DR   Coriell; HG02348
DR   GEO; GSM1718973
DR   IGSR; HG02348
DR   Wikidata; Q54884666
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02351
AC   CVCL_Q750
DR   BioSamples; SAME1840284
DR   Coriell; HG02351
DR   GEO; GSM1718974
DR   IGSR; HG02351
DR   Wikidata; Q54884667
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02353
AC   CVCL_Q751
DR   BioSamples; SAME1840276
DR   Coriell; HG02353
DR   GEO; GSM1718975
DR   IGSR; HG02353
DR   Wikidata; Q54884668
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02355
AC   CVCL_Q752
DR   BioSamples; SAME1840269
DR   Coriell; HG02355
DR   GEO; GSM1718976
DR   IGSR; HG02355
DR   Wikidata; Q54884669
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02356
AC   CVCL_Q753
DR   BioSamples; SAME1840261
DR   Coriell; HG02356
DR   GEO; GSM1718977
DR   IGSR; HG02356
DR   Wikidata; Q54884677
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02360
AC   CVCL_Q754
DR   BioSamples; SAME1840391
DR   Coriell; HG02360
DR   GEO; GSM1718978
DR   IGSR; HG02360
DR   Wikidata; Q54884678
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02363
AC   CVCL_Q755
DR   BioSamples; SAME1840379
DR   Coriell; HG02363
DR   GEO; GSM1718979
DR   IGSR; HG02363
DR   Wikidata; Q54884679
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02364
AC   CVCL_Q756
DR   BioSamples; SAME1840125
DR   Coriell; HG02364
DR   GEO; GSM1718980
DR   IGSR; HG02364
DR   Wikidata; Q54884680
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02367
AC   CVCL_Q757
DR   BioSamples; SAME1840113
DR   Coriell; HG02367
DR   GEO; GSM1718981
DR   IGSR; HG02367
DR   Wikidata; Q54884681
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02371
AC   CVCL_Q758
DR   BioSamples; SAME1840180
DR   Coriell; HG02371
DR   GEO; GSM1718982
DR   IGSR; HG02371
DR   Wikidata; Q54884682
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02372
AC   CVCL_Q759
DR   BioSamples; SAME1840258
DR   Coriell; HG02372
DR   GEO; GSM1718983
DR   IGSR; HG02372
DR   Wikidata; Q54884683
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02373
AC   CVCL_Q760
DR   BioSamples; SAME124104
DR   Coriell; HG02373
DR   GEO; GSM1718984
DR   IGSR; HG02373
DR   Wikidata; Q54884684
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02374
AC   CVCL_Q761
DR   BioSamples; SAME1840247
DR   Coriell; HG02374
DR   GEO; GSM1718985
DR   IGSR; HG02374
DR   Wikidata; Q54884685
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02375
AC   CVCL_Q762
DR   BioSamples; SAME1840244
DR   Coriell; HG02375
DR   GEO; GSM1718986
DR   IGSR; HG02375
DR   Wikidata; Q54884686
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02377
AC   CVCL_Q763
DR   BioSamples; SAME1840228
DR   Coriell; HG02377
DR   GEO; GSM1718987
DR   IGSR; HG02377
DR   Wikidata; Q54884687
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02379
AC   CVCL_Q764
DR   BioSamples; SAME1840217
DR   Coriell; HG02379
DR   GEO; GSM1718988
DR   IGSR; HG02379
DR   Wikidata; Q54884688
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02380
AC   CVCL_Q765
DR   BioSamples; SAME1840045
DR   Coriell; HG02380
DR   GEO; GSM1718989
DR   IGSR; HG02380
DR   Wikidata; Q54884689
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02381
AC   CVCL_Q766
DR   BioSamples; SAME1840033
DR   Coriell; HG02381
DR   GEO; GSM1718990
DR   IGSR; HG02381
DR   Wikidata; Q54884691
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02382
AC   CVCL_Q767
DR   BioSamples; SAME1840025
DR   Coriell; HG02382
DR   GEO; GSM1718991
DR   IGSR; HG02382
DR   Wikidata; Q54884692
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02383
AC   CVCL_Q768
DR   BioSamples; SAME1840019
DR   Coriell; HG02383
DR   GEO; GSM1718992
DR   IGSR; HG02383
DR   Wikidata; Q54884693
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02384
AC   CVCL_Q769
DR   BioSamples; SAME1840011
DR   Coriell; HG02384
DR   GEO; GSM1718993
DR   IGSR; HG02384
DR   Wikidata; Q54884694
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02385
AC   CVCL_Q770
DR   BioSamples; SAME1840006
DR   Coriell; HG02385
DR   GEO; GSM1718994
DR   IGSR; HG02385
DR   Wikidata; Q54884695
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02386
AC   CVCL_Q771
DR   BioSamples; SAME1840001
DR   Coriell; HG02386
DR   GEO; GSM1718995
DR   IGSR; HG02386
DR   Wikidata; Q54884696
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02387
AC   CVCL_Q772
DR   BioSamples; SAME1839998
DR   Coriell; HG02387
DR   GEO; GSM1718996
DR   IGSR; HG02387
DR   Wikidata; Q54884697
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02388
AC   CVCL_Q773
DR   BioSamples; SAME1839997
DR   Coriell; HG02388
DR   GEO; GSM1718997
DR   IGSR; HG02388
DR   Wikidata; Q54884698
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02389
AC   CVCL_Q774
DR   BioSamples; SAME1840085
DR   Coriell; HG02389
DR   GEO; GSM1718998
DR   IGSR; HG02389
DR   Wikidata; Q54884699
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02390
AC   CVCL_Q775
DR   BioSamples; SAME1839788
DR   Coriell; HG02390
DR   GEO; GSM1718999
DR   IGSR; HG02390
DR   Wikidata; Q54884700
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02391
AC   CVCL_Q776
DR   BioSamples; SAME1839784
DR   Coriell; HG02391
DR   GEO; GSM1719000
DR   IGSR; HG02391
DR   Wikidata; Q54884701
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02392
AC   CVCL_Q777
DR   BioSamples; SAME1839776
DR   Coriell; HG02392
DR   GEO; GSM1719001
DR   IGSR; HG02392
DR   Wikidata; Q54884702
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02394
AC   CVCL_Q778
DR   BioSamples; SAME123305
DR   Coriell; HG02394
DR   GEO; GSM1719002
DR   IGSR; HG02394
DR   Wikidata; Q54884703
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02395
AC   CVCL_Q779
DR   BioSamples; SAME1839754
DR   Coriell; HG02395
DR   GEO; GSM1719003
DR   IGSR; HG02395
DR   Wikidata; Q54884704
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02396
AC   CVCL_Q780
DR   BioSamples; SAME125357
DR   Coriell; HG02396
DR   GEO; GSM1719004
DR   IGSR; HG02396
DR   Wikidata; Q54884705
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02397
AC   CVCL_Q781
DR   BioSamples; SAME123308
DR   Coriell; HG02397
DR   GEO; GSM1719005
DR   IGSR; HG02397
DR   Wikidata; Q54884706
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02398
AC   CVCL_Q782
DR   BioSamples; SAME1839845
DR   Coriell; HG02398
DR   GEO; GSM1719006
DR   IGSR; HG02398
DR   Wikidata; Q54884707
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02399
AC   CVCL_Q783
DR   BioSamples; SAME1839842
DR   Coriell; HG02399
DR   GEO; GSM1719007
DR   IGSR; HG02399
DR   Wikidata; Q54884708
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02401
AC   CVCL_Q784
DR   BioSamples; SAME1839415
DR   Coriell; HG02401
DR   GEO; GSM1719008
DR   IGSR; HG02401
DR   Wikidata; Q54884709
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02402
AC   CVCL_Q785
DR   BioSamples; SAME1839412
DR   Coriell; HG02402
DR   GEO; GSM1719009
DR   IGSR; HG02402
DR   Wikidata; Q54884710
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02406
AC   CVCL_Q786
DR   BioSamples; SAME1839394
DR   Coriell; HG02406
DR   GEO; GSM1719010
DR   IGSR; HG02406
DR   Wikidata; Q54884711
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02407
AC   CVCL_Q787
DR   BioSamples; SAME1839464
DR   Coriell; HG02407
DR   GEO; GSM1719011
DR   IGSR; HG02407
DR   Wikidata; Q54884712
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02408
AC   CVCL_Q788
DR   BioSamples; SAME1839461
DR   Coriell; HG02408
DR   GEO; GSM1719012
DR   IGSR; HG02408
DR   Wikidata; Q54884713
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02409
AC   CVCL_Q789
DR   BioSamples; SAME1839457
DR   Coriell; HG02409
DR   GEO; GSM1719013
DR   IGSR; HG02409
DR   Wikidata; Q54884714
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02410
AC   CVCL_Q790
DR   BioSamples; SAME1839207
DR   Coriell; HG02410
DR   GEO; GSM1719014
DR   IGSR; HG02410
DR   Wikidata; Q54884715
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Chinese/Asian ethnic group: Dai in Xishuangbanna, China (CDX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02419
AC   CVCL_Q791
DR   BioSamples; SAME1839244
DR   Coriell; HG02419
DR   GEO; GSM1719015
DR   IGSR; HG02419
DR   Wikidata; Q54884716
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02420
AC   CVCL_Q792
DR   BioSamples; SAME1839320
DR   Coriell; HG02420
DR   GEO; GSM1719016
DR   IGSR; HG02420
DR   Wikidata; Q54884718
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02425
AC   CVCL_GU87
DR   BioSamples; SAME1839043
DR   Coriell; HG02425
DR   GEO; GSM1719017
DR   IGSR; HG02425
DR   Wikidata; Q54884724
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Peruvian in Lima (PEL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02427
AC   CVCL_Q793
DR   BioSamples; SAME1839036
DR   Coriell; HG02427
DR   GEO; GSM1719018
DR   IGSR; HG02427
DR   Wikidata; Q54884725
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02429
AC   CVCL_Q794
DR   BioSamples; SAME1839021
DR   Coriell; HG02429
DR   GEO; GSM1719019
DR   IGSR; HG02429
DR   Wikidata; Q54884726
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02433
AC   CVCL_Q795
DR   BioSamples; SAME1839175
DR   Coriell; HG02433
DR   GEO; GSM1719020
DR   IGSR; HG02433
DR   Wikidata; Q54884727
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02436
AC   CVCL_Q796
DR   BioSamples; SAME1839164
DR   Coriell; HG02436
DR   IGSR; HG02436
DR   Wikidata; Q54884728
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02439
AC   CVCL_GU88
DR   BioSamples; SAME1840297
DR   Coriell; HG02439
DR   GEO; GSM1719021
DR   IGSR; HG02439
DR   Wikidata; Q54884729
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02442
AC   CVCL_Q797
DR   BioSamples; SAME1840352
DR   Coriell; HG02442
DR   GEO; GSM1719022
DR   IGSR; HG02442
DR   Wikidata; Q54884730
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02445
AC   CVCL_Q798
DR   BioSamples; SAME1840341
DR   Coriell; HG02445
DR   GEO; GSM1719023
DR   IGSR; HG02445
DR   Wikidata; Q54884731
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02449
AC   CVCL_Q799
DR   BioSamples; SAME1840404
DR   Coriell; HG02449
DR   GEO; GSM1719024
DR   IGSR; HG02449
DR   Wikidata; Q54884732
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02450
AC   CVCL_Q800
DR   BioSamples; SAME1840144
DR   Coriell; HG02450
DR   GEO; GSM1719025
DR   IGSR; HG02450
DR   Wikidata; Q54884733
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02451
AC   CVCL_Q801
DR   BioSamples; SAME1840138
DR   Coriell; HG02451
DR   IGSR; HG02451
DR   Wikidata; Q54884734
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02455
AC   CVCL_GU89
DR   BioSamples; SAME1840198
DR   Coriell; HG02455
DR   GEO; GSM1719026
DR   IGSR; HG02455
DR   Wikidata; Q54884735
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02461
AC   CVCL_Q802
DR   BioSamples; SAME1839993
DR   Coriell; HG02461
DR   GEO; GSM1719027
DR   IGSR; HG02461
DR   Wikidata; Q54884736
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02462
AC   CVCL_Q803
DR   BioSamples; SAME1839991
DR   Coriell; HG02462
DR   GEO; GSM1719028
DR   IGSR; HG02462
DR   Wikidata; Q54884737
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02463
AC   CVCL_GV27
DR   BioSamples; SAME1839983
DR   Coriell; HG02463
DR   IGSR; HG02463
DR   Wikidata; Q54884738
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02464
AC   CVCL_Q804
DR   BioSamples; SAME1839978
DR   Coriell; HG02464
DR   GEO; GSM1719029
DR   IGSR; HG02464
DR   Wikidata; Q54884739
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02465
AC   CVCL_Q805
DR   BioSamples; SAME1839973
DR   Coriell; HG02465
DR   GEO; GSM1719030
DR   IGSR; HG02465
DR   Wikidata; Q54884740
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02466
AC   CVCL_GV28
DR   BioSamples; SAME1839970
DR   Coriell; HG02466
DR   IGSR; HG02466
DR   Wikidata; Q54884741
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02470
AC   CVCL_Q806
DR   BioSamples; SAME1839744
DR   Coriell; HG02470
DR   GEO; GSM1719031
DR   IGSR; HG02470
DR   Wikidata; Q54884742
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02471
AC   CVCL_Q807
DR   BioSamples; SAME1839741
DR   Coriell; HG02471
DR   GEO; GSM1719032
DR   IGSR; HG02471
DR   Wikidata; Q54884743
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02476
AC   CVCL_GU90
DR   BioSamples; SAME1839717
DR   Coriell; HG02476
DR   GEO; GSM1719033
DR   IGSR; HG02476
DR   Wikidata; Q54884744
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02477
AC   CVCL_GU91
DR   BioSamples; SAME1839710
DR   Coriell; HG02477
DR   GEO; GSM1719034
DR   IGSR; HG02477
DR   Wikidata; Q54884745
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02478
AC   CVCL_Q808
DR   BioSamples; SAME1839801
DR   Coriell; HG02478
DR   IGSR; HG02478
DR   Wikidata; Q54884746
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02479
AC   CVCL_Q809
DR   BioSamples; SAME1839798
DR   Coriell; HG02479
DR   GEO; GSM1719035
DR   IGSR; HG02479
DR   Wikidata; Q54884747
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02481
AC   CVCL_GU92
DR   BioSamples; SAME1839870
DR   Coriell; HG02481
DR   GEO; GSM1719036
DR   IGSR; HG02481
DR   Wikidata; Q54884748
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02484
AC   CVCL_Q810
DR   BioSamples; SAME1839858
DR   Coriell; HG02484
DR   GEO; GSM1719037
DR   IGSR; HG02484
DR   Wikidata; Q54884749
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02485
AC   CVCL_Q811
DR   BioSamples; SAME1839564
DR   Coriell; HG02485
DR   GEO; GSM1719038
DR   IGSR; HG02485
DR   Wikidata; Q54884750
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02489
AC   CVCL_Q812
DR   BioSamples; SAME1839546
DR   Coriell; HG02489
DR   GEO; GSM1719039
DR   IGSR; HG02489
DR   Wikidata; Q54884751
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02490
AC   CVCL_Q813
DR   BioSamples; SAME1839625
DR   Coriell; HG02490
DR   GEO; GSM1719040
DR   IGSR; HG02490
DR   Wikidata; Q54884752
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02491
AC   CVCL_Q814
DR   BioSamples; SAME1839617
DR   Coriell; HG02491
DR   GEO; GSM1719041
DR   IGSR; HG02491
DR   Wikidata; Q54884753
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02492
AC   CVCL_GV29
DR   BioSamples; SAME1839610
DR   Coriell; HG02492
DR   IGSR; HG02492
DR   Wikidata; Q54884754
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02493
AC   CVCL_Q815
DR   BioSamples; SAME1839704
DR   Coriell; HG02493
DR   GEO; GSM1719042
DR   IGSR; HG02493
DR   Wikidata; Q54884755
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02494
AC   CVCL_Q816
DR   BioSamples; SAME1839698
DR   Coriell; HG02494
DR   GEO; GSM1719043
DR   IGSR; HG02494
DR   Wikidata; Q54884756
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02495
AC   CVCL_GV30
DR   BioSamples; SAME1839694
DR   Coriell; HG02495
DR   IGSR; HG02495
DR   Wikidata; Q54884757
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02496
AC   CVCL_Q817
DR   BioSamples; SAME1839688
DR   Coriell; HG02496
DR   GEO; GSM1719044
DR   IGSR; HG02496
DR   Wikidata; Q54884758
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02497
AC   CVCL_Q818
DR   BioSamples; SAME1839682
DR   Coriell; HG02497
DR   GEO; GSM1719045
DR   IGSR; HG02497
DR   Wikidata; Q54884759
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02501
AC   CVCL_GU93
DR   BioSamples; SAME1839281
DR   Coriell; HG02501
DR   GEO; GSM1719046
DR   IGSR; HG02501
DR   Wikidata; Q54884760
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02502
AC   CVCL_GU94
DR   BioSamples; SAME1839272
DR   Coriell; HG02502
DR   GEO; GSM1719047
DR   IGSR; HG02502
DR   Wikidata; Q54884761
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02505
AC   CVCL_GU95
DR   BioSamples; SAME1839351
DR   Coriell; HG02505
DR   GEO; GSM1719048
DR   IGSR; HG02505
DR   Wikidata; Q54884762
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02508
AC   CVCL_Q819
DR   BioSamples; SAME1839334
DR   Coriell; HG02508
DR   GEO; GSM1719049
DR   IGSR; HG02508
DR   Wikidata; Q54884764
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02511
AC   CVCL_Q820
DR   BioSamples; SAME1839150
DR   Coriell; HG02511
DR   GEO; GSM1719050
DR   IGSR; HG02511
DR   Wikidata; Q54884770
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02512
AC   CVCL_Q821
DR   BioSamples; SAME1839146
DR   Coriell; HG02512
DR   GEO; GSM1719051
DR   IGSR; HG02512
DR   Wikidata; Q54884771
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02513
AC   CVCL_Q822
DR   BioSamples; SAME1839138
DR   Coriell; HG02513
DR   GEO; GSM1719052
DR   IGSR; HG02513
DR   Wikidata; Q54884772
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02514
AC   CVCL_GV31
DR   BioSamples; SAME1839133
DR   Coriell; HG02514
DR   IGSR; HG02514
DR   Wikidata; Q54884773
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02521
AC   CVCL_Q823
DR   BioSamples; SAME1840327
DR   Coriell; HG02521
DR   GEO; GSM1719053
DR   IGSR; HG02521
DR   Wikidata; Q54884774
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02522
AC   CVCL_Q824
DR   BioSamples; SAME1840326
DR   Coriell; HG02522
DR   GEO; GSM1719054
DR   IGSR; HG02522
DR   Wikidata; Q54884775
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02523
AC   CVCL_GV32
DR   BioSamples; SAME1840322
DR   Coriell; HG02523
DR   IGSR; HG02523
DR   Wikidata; Q54884776
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02524
AC   CVCL_GV33
DR   BioSamples; SAME1840317
DR   Coriell; HG02524
DR   IGSR; HG02524
DR   Wikidata; Q54884777
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02525
AC   CVCL_GV34
DR   BioSamples; SAME1840313
DR   Coriell; HG02525
DR   IGSR; HG02525
DR   Wikidata; Q54884778
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02526
AC   CVCL_GV35
DR   BioSamples; SAME1840308
DR   Coriell; HG02526
DR   IGSR; HG02526
DR   Wikidata; Q54884779
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Southeast Asian; Kinh in Ho Chi Minh City, Vietnam (KHV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02536
AC   CVCL_GU96
DR   BioSamples; SAME1840172
DR   Coriell; HG02536
DR   GEO; GSM1719055
DR   IGSR; HG02536
DR   Wikidata; Q54884780
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02537
AC   CVCL_Q825
DR   BioSamples; SAME1840165
DR   Coriell; HG02537
DR   GEO; GSM1719056
DR   IGSR; HG02537
DR   Wikidata; Q54884781
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG02541
AC   CVCL_GU97
DR   BioSamples; SAME1840214
DR   Coriell; HG02541
DR   GEO; GSM1719057
DR   IGSR; HG02541
DR   Wikidata; Q54884782
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02545
AC   CVCL_GU98
DR   BioSamples; SAME1839939
DR   Coriell; HG02545
DR   GEO; GSM1719058
DR   IGSR; HG02545
DR   Wikidata; Q54884783
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02546
AC   CVCL_GU99
DR   BioSamples; SAME1839932
DR   Coriell; HG02546
DR   GEO; GSM1719059
DR   IGSR; HG02546
DR   Wikidata; Q54884784
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02549
AC   CVCL_GV00
DR   BioSamples; SAME1839917
DR   Coriell; HG02549
DR   GEO; GSM1719060
DR   IGSR; HG02549
DR   Wikidata; Q54884785
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02554
AC   CVCL_GV01
DR   BioSamples; SAME1840075
DR   Coriell; HG02554
DR   GEO; GSM1719061
DR   IGSR; HG02554
DR   Wikidata; Q54884786
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02555
AC   CVCL_GV02
DR   BioSamples; SAME1840070
DR   Coriell; HG02555
DR   GEO; GSM1719062
DR   IGSR; HG02555
DR   Wikidata; Q54884787
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02557
AC   CVCL_GV03
DR   BioSamples; SAME1840061
DR   Coriell; HG02557
DR   GEO; GSM1719063
DR   IGSR; HG02557
DR   Wikidata; Q54884788
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02558
AC   CVCL_GV04
DR   BioSamples; SAME1840057
DR   Coriell; HG02558
DR   GEO; GSM1719064
DR   IGSR; HG02558
DR   Wikidata; Q54884789
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02561
AC   CVCL_Q826
DR   BioSamples; SAME1839838
DR   Coriell; HG02561
DR   GEO; GSM1719065
DR   IGSR; HG02561
DR   Wikidata; Q54884790
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02562
AC   CVCL_Q827
DR   BioSamples; SAME1839832
DR   Coriell; HG02562
DR   GEO; GSM1719066
DR   IGSR; HG02562
DR   Wikidata; Q54884791
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02563
AC   CVCL_GV36
DR   BioSamples; SAME1839824
DR   Coriell; HG02563
DR   IGSR; HG02563
DR   Wikidata; Q54884792
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02567
AC   CVCL_Q828
DR   BioSamples; SAME1839905
DR   Coriell; HG02567
DR   IGSR; HG02567
DR   Wikidata; Q54884793
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02568
AC   CVCL_Q829
DR   BioSamples; SAME1839899
DR   Coriell; HG02568
DR   GEO; GSM1719067
DR   IGSR; HG02568
DR   Wikidata; Q54884794
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02569
AC   CVCL_GV37
DR   BioSamples; SAME1839892
DR   Coriell; HG02569
DR   IGSR; HG02569
DR   Wikidata; Q54884795
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02570
AC   CVCL_Q830
DR   BioSamples; SAME1839582
DR   Coriell; HG02570
DR   GEO; GSM1719068
DR   IGSR; HG02570
DR   Wikidata; Q54884796
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02571
AC   CVCL_Q831
DR   EFO; EFO_0010841
DR   BioSamples; SAME1839577
DR   Coriell; HG02571
DR   GEO; GSM1719069
DR   IGSR; HG02571
DR   Wikidata; Q54884797
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02572
AC   CVCL_GV38
DR   BioSamples; SAME1839570
DR   Coriell; HG02572
DR   IGSR; HG02572
DR   Wikidata; Q54884798
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02573
AC   CVCL_Q832
DR   BioSamples; SAME1839567
DR   Coriell; HG02573
DR   GEO; GSM1719070
DR   IGSR; HG02573
DR   Wikidata; Q54884799
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02574
AC   CVCL_Q833
DR   BioSamples; SAME1839652
DR   Coriell; HG02574
DR   GEO; GSM1719071
DR   IGSR; HG02574
DR   Wikidata; Q54884800
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02575
AC   CVCL_GV39
DR   BioSamples; SAME1839650
DR   Coriell; HG02575
DR   IGSR; HG02575
DR   Wikidata; Q54884801
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02577
AC   CVCL_GV05
DR   BioSamples; SAME1839642
DR   Coriell; HG02577
DR   GEO; GSM1719072
DR   IGSR; HG02577
DR   Wikidata; Q54884802
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02580
AC   CVCL_GV06
DR   BioSamples; SAME1839366
DR   Coriell; HG02580
DR   GEO; GSM1719073
DR   IGSR; HG02580
DR   Wikidata; Q54884803
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African Caribbean in Barbados (ACB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG02582
AC   CVCL_Q834
DR   BioSamples; SAME1839431
DR   Coriell; HG02582
DR   GEO; GSM1719074
DR   IGSR; HG02582
DR   Wikidata; Q54884804
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02583
AC   CVCL_Q835
DR   BioSamples; SAME1839429
DR   Coriell; HG02583
DR   GEO; GSM1719075
DR   IGSR; HG02583
DR   Wikidata; Q54884805
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02584
AC   CVCL_GV40
DR   BioSamples; SAME1839425
DR   Coriell; HG02584
DR   IGSR; HG02584
DR   Wikidata; Q54884806
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02585
AC   CVCL_Q836
DR   BioSamples; SAME1839418
DR   Coriell; HG02585
DR   GEO; GSM1719076
DR   IGSR; HG02585
DR   Wikidata; Q54884807
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02586
AC   CVCL_Q837
DR   BioSamples; SAME1839414
DR   Coriell; HG02586
DR   GEO; GSM1719077
DR   IGSR; HG02586
DR   Wikidata; Q54884808
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02587
AC   CVCL_GV41
DR   BioSamples; SAME1839409
DR   Coriell; HG02587
DR   IGSR; HG02587
DR   Wikidata; Q54884809
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02588
AC   CVCL_Q838
DR   EFO; EFO_0010842
DR   BioSamples; SAME1839404
DR   Coriell; HG02588
DR   GEO; GSM1719078
DR   IGSR; HG02588
DR   Wikidata; Q54884816
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02589
AC   CVCL_Q839
DR   BioSamples; SAME1839401
DR   Coriell; HG02589
DR   GEO; GSM1719079
DR   IGSR; HG02589
DR   Wikidata; Q54884817
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02590
AC   CVCL_GV42
DR   BioSamples; SAME1839222
DR   Coriell; HG02590
DR   IGSR; HG02590
DR   Wikidata; Q54884818
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02594
AC   CVCL_Q840
DR   BioSamples; SAME1839208
DR   Coriell; HG02594
DR   GEO; GSM1719080
DR   IGSR; HG02594
DR   Wikidata; Q54884819
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02595
AC   CVCL_Q841
DR   BioSamples; SAME1839204
DR   Coriell; HG02595
DR   GEO; GSM1719081
DR   IGSR; HG02595
DR   Wikidata; Q54884820
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02596
AC   CVCL_GV43
DR   BioSamples; SAME1839201
DR   Coriell; HG02596
DR   IGSR; HG02596
DR   Wikidata; Q54884821
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02597
AC   CVCL_Q842
DR   BioSamples; SAME1839199
DR   Coriell; HG02597
DR   GEO; GSM1719082
DR   IGSR; HG02597
DR   Wikidata; Q54884822
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02599
AC   CVCL_GV44
DR   BioSamples; SAME1839266
DR   Coriell; HG02599
DR   IGSR; HG02599
DR   Wikidata; Q54884823
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02600
AC   CVCL_Q843
DR   BioSamples; SAME1840302
DR   Coriell; HG02600
DR   GEO; GSM1719083
DR   IGSR; HG02600
DR   Wikidata; Q54884824
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02601
AC   CVCL_Q844
DR   BioSamples; SAME1840293
DR   Coriell; HG02601
DR   GEO; GSM1719084
DR   IGSR; HG02601
DR   Wikidata; Q54884825
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02602
AC   CVCL_GV45
DR   BioSamples; SAME1840290
DR   Coriell; HG02602
DR   IGSR; HG02602
DR   Wikidata; Q54884826
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02603
AC   CVCL_Q845
DR   BioSamples; SAME1840287
DR   Coriell; HG02603
DR   GEO; GSM1719085
DR   IGSR; HG02603
DR   Wikidata; Q54884827
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02604
AC   CVCL_Q846
DR   BioSamples; SAME1840282
DR   Coriell; HG02604
DR   GEO; GSM1719086
DR   IGSR; HG02604
DR   Wikidata; Q54884828
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02605
AC   CVCL_GV46
DR   BioSamples; SAME1840277
DR   Coriell; HG02605
DR   IGSR; HG02605
DR   Wikidata; Q54884829
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02610
AC   CVCL_Q847
DR   EFO; EFO_0010843
DR   BioSamples; SAME1840405
DR   Coriell; HG02610
DR   GEO; GSM1719087
DR   IGSR; HG02610
DR   Wikidata; Q54884830
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02611
AC   CVCL_Q848
DR   BioSamples; SAME1840401
DR   Coriell; HG02611
DR   GEO; GSM1719088
DR   IGSR; HG02611
DR   Wikidata; Q54884831
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02612
AC   CVCL_GV47
DR   BioSamples; SAME1840394
DR   Coriell; HG02612
DR   IGSR; HG02612
DR   Wikidata; Q54884832
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02613
AC   CVCL_Q849
DR   BioSamples; SAME1840390
DR   Coriell; HG02613
DR   GEO; GSM1719089
DR   IGSR; HG02613
DR   Wikidata; Q54884833
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02614
AC   CVCL_Q850
DR   BioSamples; SAME1840385
DR   Coriell; HG02614
DR   GEO; GSM1719090
DR   IGSR; HG02614
DR   Wikidata; Q54884834
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02615
AC   CVCL_GV48
DR   BioSamples; SAME1840380
DR   Coriell; HG02615
DR   IGSR; HG02615
DR   Wikidata; Q54884835
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02620
AC   CVCL_Q851
DR   BioSamples; SAME1840191
DR   Coriell; HG02620
DR   GEO; GSM1719091
DR   IGSR; HG02620
DR   Wikidata; Q54884836
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02621
AC   CVCL_Q852
DR   BioSamples; SAME1840187
DR   Coriell; HG02621
DR   GEO; GSM1719092
DR   IGSR; HG02621
DR   Wikidata; Q54884837
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02622
AC   CVCL_GV49
DR   BioSamples; SAME1840185
DR   Coriell; HG02622
DR   IGSR; HG02622
DR   Wikidata; Q54884838
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02623
AC   CVCL_Q853
DR   EFO; EFO_0010844
DR   BioSamples; SAME1840182
DR   Coriell; HG02623
DR   GEO; GSM1719093
DR   IGSR; HG02623
DR   Wikidata; Q54884839
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02624
AC   CVCL_Q854
DR   BioSamples; SAME1840259
DR   Coriell; HG02624
DR   GEO; GSM1719094
DR   IGSR; HG02624
DR   Wikidata; Q54884840
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02625
AC   CVCL_GV50
DR   BioSamples; SAME1840257
DR   Coriell; HG02625
DR   IGSR; HG02625
DR   Wikidata; Q54884841
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02628
AC   CVCL_Q855
DR   BioSamples; SAME1840238
DR   Coriell; HG02628
DR   GEO; GSM1719095
DR   IGSR; HG02628
DR   Wikidata; Q54884842
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02629
AC   CVCL_Q856
DR   BioSamples; SAME1840230
DR   Coriell; HG02629
DR   GEO; GSM1719096
DR   IGSR; HG02629
DR   Wikidata; Q54884843
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02630
AC   CVCL_GV51
DR   BioSamples; SAME1839963
DR   Coriell; HG02630
DR   IGSR; HG02630
DR   Wikidata; Q54884844
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02634
AC   CVCL_Q857
DR   BioSamples; SAME1840031
DR   Coriell; HG02634
DR   GEO; GSM1719097
DR   IGSR; HG02634
DR   Wikidata; Q54884845
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02635
AC   CVCL_Q858
DR   BioSamples; SAME1840023
DR   Coriell; HG02635
DR   GEO; GSM1719098
DR   IGSR; HG02635
DR   Wikidata; Q54884846
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02636
AC   CVCL_GV52
DR   BioSamples; SAME1840017
DR   Coriell; HG02636
DR   IGSR; HG02636
DR   Wikidata; Q54884847
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02642
AC   CVCL_Q859
DR   EFO; EFO_0010845
DR   BioSamples; SAME1839792
DR   Coriell; HG02642
DR   GEO; GSM1719099
DR   IGSR; HG02642
DR   Wikidata; Q54884848
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02643
AC   CVCL_Q860
DR   BioSamples; SAME1839785
DR   Coriell; HG02643
DR   GEO; GSM1719100
DR   IGSR; HG02643
DR   Wikidata; Q54884849
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02644
AC   CVCL_GV53
DR   BioSamples; SAME1839782
DR   Coriell; HG02644
DR   IGSR; HG02644
DR   Wikidata; Q54884850
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02645
AC   CVCL_Q861
DR   BioSamples; SAME1839774
DR   Coriell; HG02645
DR   GEO; GSM1719101
DR   IGSR; HG02645
DR   Wikidata; Q54884851
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02646
AC   CVCL_Q862
DR   BioSamples; SAME1839770
DR   Coriell; HG02646
DR   GEO; GSM1719102
DR   IGSR; HG02646
DR   Wikidata; Q54884852
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02647
AC   CVCL_GV54
DR   BioSamples; SAME1839762
DR   Coriell; HG02647
DR   IGSR; HG02647
DR   Wikidata; Q54884853
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02648
AC   CVCL_Q863
DR   BioSamples; SAME1839751
DR   Coriell; HG02648
DR   GEO; GSM1719103
DR   IGSR; HG02648
DR   Wikidata; Q54884854
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02649
AC   CVCL_Q864
DR   BioSamples; SAME1839852
DR   Coriell; HG02649
DR   GEO; GSM1719104
DR   IGSR; HG02649
DR   Wikidata; Q54884855
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02650
AC   CVCL_GV55
DR   BioSamples; SAME1839550
DR   Coriell; HG02650
DR   IGSR; HG02650
DR   Wikidata; Q54884860
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02651
AC   CVCL_Q865
DR   BioSamples; SAME1839544
DR   Coriell; HG02651
DR   GEO; GSM1719105
DR   IGSR; HG02651
DR   Wikidata; Q54884861
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02652
AC   CVCL_Q866
DR   BioSamples; SAME1839541
DR   Coriell; HG02652
DR   GEO; GSM1719106
DR   IGSR; HG02652
DR   Wikidata; Q54884862
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02653
AC   CVCL_GV56
DR   BioSamples; SAME1839537
DR   Coriell; HG02653
DR   IGSR; HG02653
DR   Wikidata; Q54884863
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02654
AC   CVCL_Q867
DR   BioSamples; SAME1839530
DR   Coriell; HG02654
DR   GEO; GSM1719107
DR   IGSR; HG02654
DR   Wikidata; Q54884864
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02655
AC   CVCL_Q868
DR   BioSamples; SAME1839526
DR   Coriell; HG02655
DR   GEO; GSM1719108
DR   IGSR; HG02655
DR   Wikidata; Q54884865
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02656
AC   CVCL_GV57
DR   BioSamples; SAME1839607
DR   Coriell; HG02656
DR   IGSR; HG02656
DR   Wikidata; Q54884866
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02657
AC   CVCL_Q869
DR   BioSamples; SAME1839600
DR   Coriell; HG02657
DR   GEO; GSM1719109
DR   IGSR; HG02657
DR   Wikidata; Q54884867
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02658
AC   CVCL_Q870
DR   BioSamples; SAME1839597
DR   Coriell; HG02658
DR   GEO; GSM1719110
DR   IGSR; HG02658
DR   Wikidata; Q54884868
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02659
AC   CVCL_GV58
DR   BioSamples; SAME1839590
DR   Coriell; HG02659
DR   IGSR; HG02659
DR   Wikidata; Q54884869
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02660
AC   CVCL_Q871
DR   BioSamples; SAME1839672
DR   Coriell; HG02660
DR   GEO; GSM1719111
DR   IGSR; HG02660
DR   Wikidata; Q54884870
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02661
AC   CVCL_Q872
DR   BioSamples; SAME1839667
DR   Coriell; HG02661
DR   GEO; GSM1719112
DR   IGSR; HG02661
DR   Wikidata; Q54884871
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02662
AC   CVCL_GV59
DR   BioSamples; SAME1839662
DR   Coriell; HG02662
DR   IGSR; HG02662
DR   Wikidata; Q54884872
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02666
AC   CVCL_Q873
DR   BioSamples; SAME1839386
DR   Coriell; HG02666
DR   GEO; GSM1719113
DR   IGSR; HG02666
DR   Wikidata; Q54884873
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02667
AC   CVCL_Q874
DR   BioSamples; SAME1839384
DR   Coriell; HG02667
DR   GEO; GSM1719114
DR   IGSR; HG02667
DR   Wikidata; Q54884874
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02668
AC   CVCL_GV60
DR   BioSamples; SAME1839377
DR   Coriell; HG02668
DR   IGSR; HG02668
DR   Wikidata; Q54884875
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02675
AC   CVCL_Q875
DR   BioSamples; SAME1839495
DR   Coriell; HG02675
DR   GEO; GSM1719115
DR   IGSR; HG02675
DR   Wikidata; Q54884876
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02676
AC   CVCL_Q876
DR   BioSamples; SAME1839491
DR   Coriell; HG02676
DR   GEO; GSM1719116
DR   IGSR; HG02676
DR   Wikidata; Q54884877
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02677
AC   CVCL_GV61
DR   BioSamples; SAME1839483
DR   Coriell; HG02677
DR   IGSR; HG02677
DR   Wikidata; Q54884878
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02678
AC   CVCL_Q877
DR   EFO; EFO_0010846
DR   BioSamples; SAME1839477
DR   Coriell; HG02678
DR   GEO; GSM1719117
DR   IGSR; HG02678
DR   Wikidata; Q54884879
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02679
AC   CVCL_Q878
DR   BioSamples; SAME1839471
DR   Coriell; HG02679
DR   GEO; GSM1719118
DR   IGSR; HG02679
DR   Wikidata; Q54884880
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02680
AC   CVCL_GV62
DR   BioSamples; SAME1839308
DR   Coriell; HG02680
DR   IGSR; HG02680
DR   Wikidata; Q54884881
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02681
AC   CVCL_Q879
DR   BioSamples; SAME1839304
DR   Coriell; HG02681
DR   GEO; GSM1719119
DR   IGSR; HG02681
DR   Wikidata; Q54884882
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02682
AC   CVCL_Q880
DR   BioSamples; SAME1839300
DR   Coriell; HG02682
DR   GEO; GSM1719120
DR   IGSR; HG02682
DR   Wikidata; Q54884883
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02683
AC   CVCL_GV63
DR   BioSamples; SAME1839298
DR   Coriell; HG02683
DR   IGSR; HG02683
DR   Wikidata; Q54884884
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02684
AC   CVCL_Q881
DR   BioSamples; SAME1839292
DR   Coriell; HG02684
DR   GEO; GSM1719121
DR   IGSR; HG02684
DR   Wikidata; Q54884885
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02685
AC   CVCL_Q882
DR   BioSamples; SAME1839286
DR   Coriell; HG02685
DR   GEO; GSM1719122
DR   IGSR; HG02685
DR   Wikidata; Q54884886
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02686
AC   CVCL_GV64
DR   BioSamples; SAME1839277
DR   Coriell; HG02686
DR   IGSR; HG02686
DR   Wikidata; Q54884887
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02687
AC   CVCL_Q883
DR   BioSamples; SAME1839270
DR   Coriell; HG02687
DR   GEO; GSM1719123
DR   IGSR; HG02687
DR   Wikidata; Q54884888
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02688
AC   CVCL_Q884
DR   BioSamples; SAME1839358
DR   Coriell; HG02688
DR   GEO; GSM1719124
DR   IGSR; HG02688
DR   Wikidata; Q54884889
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02689
AC   CVCL_GV65
DR   BioSamples; SAME1839355
DR   Coriell; HG02689
DR   IGSR; HG02689
DR   Wikidata; Q54884890
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02690
AC   CVCL_Q885
DR   BioSamples; SAME1839088
DR   Coriell; HG02690
DR   GEO; GSM1719125
DR   IGSR; HG02690
DR   Wikidata; Q54884891
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02691
AC   CVCL_Q886
DR   BioSamples; SAME1839084
DR   Coriell; HG02691
DR   GEO; GSM1719126
DR   IGSR; HG02691
DR   Wikidata; Q54884892
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02692
AC   CVCL_GV66
DR   BioSamples; SAME1839078
DR   Coriell; HG02692
DR   IGSR; HG02692
DR   Wikidata; Q54884893
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02694
AC   CVCL_Q887
DR   BioSamples; SAME1839065
DR   Coriell; HG02694
DR   GEO; GSM1719127
DR   IGSR; HG02694
DR   Wikidata; Q54884894
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02696
AC   CVCL_Q888
DR   BioSamples; SAME1839149
DR   Coriell; HG02696
DR   GEO; GSM1719128
DR   IGSR; HG02696
DR   Wikidata; Q54884895
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02697
AC   CVCL_Q889
DR   BioSamples; SAME1839142
DR   Coriell; HG02697
DR   GEO; GSM1719129
DR   IGSR; HG02697
DR   Wikidata; Q54884896
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02698
AC   CVCL_GV67
DR   BioSamples; SAME1839137
DR   Coriell; HG02698
DR   IGSR; HG02698
DR   Wikidata; Q54884897
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02699
AC   CVCL_Q890
DR   BioSamples; SAME1839129
DR   Coriell; HG02699
DR   GEO; GSM1719130
DR   IGSR; HG02699
DR   Wikidata; Q54884898
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02700
AC   CVCL_Q891
DR   BioSamples; SAME1840159
DR   Coriell; HG02700
DR   GEO; GSM1719131
DR   IGSR; HG02700
DR   Wikidata; Q54884899
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02701
AC   CVCL_GV68
DR   BioSamples; SAME1840152
DR   Coriell; HG02701
DR   IGSR; HG02701
DR   Wikidata; Q54884904
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02702
AC   CVCL_Q892
DR   BioSamples; SAME1840149
DR   Coriell; HG02702
DR   GEO; GSM1719132
DR   IGSR; HG02702
DR   Wikidata; Q54884905
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02703
AC   CVCL_Q893
DR   BioSamples; SAME1840142
DR   Coriell; HG02703
DR   GEO; GSM1719133
DR   IGSR; HG02703
DR   Wikidata; Q54884906
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02704
AC   CVCL_GV69
DR   BioSamples; SAME1840134
DR   Coriell; HG02704
DR   IGSR; HG02704
DR   Wikidata; Q54884907
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02715
AC   CVCL_Q894
DR   BioSamples; SAME1839987
DR   Coriell; HG02715
DR   GEO; GSM1719134
DR   IGSR; HG02715
DR   Wikidata; Q54884908
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02716
AC   CVCL_Q895
DR   BioSamples; SAME1839981
DR   Coriell; HG02716
DR   GEO; GSM1719135
DR   IGSR; HG02716
DR   Wikidata; Q54884909
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02717
AC   CVCL_GV70
DR   BioSamples; SAME1839976
DR   Coriell; HG02717
DR   IGSR; HG02717
DR   Wikidata; Q54884910
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02721
AC   CVCL_Q896
DR   BioSamples; SAME1839749
DR   Coriell; HG02721
DR   GEO; GSM1719136
DR   IGSR; HG02721
DR   Wikidata; Q54884911
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02722
AC   CVCL_Q897
DR   BioSamples; SAME1839747
DR   Coriell; HG02722
DR   GEO; GSM1719137
DR   IGSR; HG02722
DR   Wikidata; Q54884912
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02723
AC   CVCL_GV71
DR   BioSamples; SAME1839742
DR   Coriell; HG02723
DR   IGSR; HG02723
DR   Wikidata; Q54884913
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02724
AC   CVCL_Q898
DR   BioSamples; SAME1839740
DR   Coriell; HG02724
DR   GEO; GSM1719138
DR   IGSR; HG02724
DR   Wikidata; Q54884914
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02725
AC   CVCL_Q899
DR   BioSamples; SAME1839737
DR   Coriell; HG02725
DR   GEO; GSM1719139
DR   IGSR; HG02725
DR   Wikidata; Q54884915
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02726
AC   CVCL_GV72
DR   BioSamples; SAME1839732
DR   Coriell; HG02726
DR   IGSR; HG02726
DR   Wikidata; Q54884916
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02727
AC   CVCL_Q900
DR   BioSamples; SAME1839727
DR   Coriell; HG02727
DR   GEO; GSM1719140
DR   IGSR; HG02727
DR   Wikidata; Q54884917
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02728
AC   CVCL_Q901
DR   BioSamples; SAME1839722
DR   Coriell; HG02728
DR   GEO; GSM1719141
DR   IGSR; HG02728
DR   Wikidata; Q54884918
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02729
AC   CVCL_GV73
DR   BioSamples; SAME1839715
DR   Coriell; HG02729
DR   IGSR; HG02729
DR   Wikidata; Q54884919
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02731
AC   CVCL_Q902
DR   BioSamples; SAME1839886
DR   Coriell; HG02731
DR   GEO; GSM1719142
DR   IGSR; HG02731
DR   Wikidata; Q54884920
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02733
AC   CVCL_Q903
DR   BioSamples; SAME1839874
DR   Coriell; HG02733
DR   GEO; GSM1719143
DR   IGSR; HG02733
DR   Wikidata; Q54884921
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02734
AC   CVCL_Q904
DR   BioSamples; SAME1839869
DR   Coriell; HG02734
DR   GEO; GSM1719144
DR   IGSR; HG02734
DR   Wikidata; Q54884922
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02735
AC   CVCL_GV74
DR   BioSamples; SAME1839866
DR   Coriell; HG02735
DR   IGSR; HG02735
DR   Wikidata; Q54884923
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02736
AC   CVCL_Q905
DR   BioSamples; SAME1839860
DR   Coriell; HG02736
DR   GEO; GSM1719145
DR   IGSR; HG02736
DR   Wikidata; Q54884924
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02737
AC   CVCL_Q906
DR   BioSamples; SAME1839857
DR   Coriell; HG02737
DR   GEO; GSM1719146
DR   IGSR; HG02737
DR   Wikidata; Q54884925
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02738
AC   CVCL_GV75
DR   BioSamples; SAME1839560
DR   Coriell; HG02738
DR   IGSR; HG02738
DR   Wikidata; Q54884926
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02757
AC   CVCL_Q907
DR   BioSamples; SAME1839451
DR   Coriell; HG02757
DR   GEO; GSM1719147
DR   IGSR; HG02757
DR   Wikidata; Q54884927
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02758
AC   CVCL_GV76
DR   BioSamples; SAME1839448
DR   Coriell; HG02758
DR   IGSR; HG02758
DR   Wikidata; Q54884928
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02759
AC   CVCL_Q908
DR   EFO; EFO_0010847
DR   BioSamples; SAME1839445
DR   Coriell; HG02759
DR   GEO; GSM1719148
DR   IGSR; HG02759
DR   Wikidata; Q54884929
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02760
AC   CVCL_Q909
DR   BioSamples; SAME1839267
DR   Coriell; HG02760
DR   GEO; GSM1719149
DR   IGSR; HG02760
DR   Wikidata; Q54884930
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02761
AC   CVCL_GV77
DR   BioSamples; SAME1839262
DR   Coriell; HG02761
DR   IGSR; HG02761
DR   Wikidata; Q54884931
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02762
AC   CVCL_Q910
DR   BioSamples; SAME1839258
DR   Coriell; HG02762
DR   IGSR; HG02762
DR   Wikidata; Q54884932
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02763
AC   CVCL_Q911
DR   EFO; EFO_0010848
DR   BioSamples; SAME1839254
DR   Coriell; HG02763
DR   GEO; GSM1719150
DR   IGSR; HG02763
DR   Wikidata; Q54884933
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02764
AC   CVCL_GV78
DR   BioSamples; SAME1839250
DR   Coriell; HG02764
DR   IGSR; HG02764
DR   Wikidata; Q54884934
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02768
AC   CVCL_Q912
DR   BioSamples; SAME1839235
DR   Coriell; HG02768
DR   GEO; GSM1719151
DR   IGSR; HG02768
DR   Wikidata; Q54884935
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02769
AC   CVCL_Q913
DR   BioSamples; SAME1839231
DR   Coriell; HG02769
DR   GEO; GSM1719152
DR   IGSR; HG02769
DR   Wikidata; Q54884936
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02770
AC   CVCL_GV79
DR   BioSamples; SAME1839049
DR   Coriell; HG02770
DR   IGSR; HG02770
DR   Wikidata; Q54884937
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02771
AC   CVCL_Q914
DR   BioSamples; SAME1839045
DR   Coriell; HG02771
DR   GEO; GSM1719153
DR   IGSR; HG02771
DR   Wikidata; Q54884938
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02772
AC   CVCL_Q915
DR   BioSamples; SAME1839039
DR   Coriell; HG02772
DR   GEO; GSM1719154
DR   IGSR; HG02772
DR   Wikidata; Q54884939
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02773
AC   CVCL_GV80
DR   BioSamples; SAME1839034
DR   Coriell; HG02773
DR   IGSR; HG02773
DR   Wikidata; Q54884940
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02774
AC   CVCL_Q916
DR   BioSamples; SAME1839028
DR   Coriell; HG02774
DR   GEO; GSM1719155
DR   IGSR; HG02774
DR   Wikidata; Q54884941
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02775
AC   CVCL_Q917
DR   BioSamples; SAME1839022
DR   Coriell; HG02775
DR   GEO; GSM1719156
DR   IGSR; HG02775
DR   Wikidata; Q54884942
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02776
AC   CVCL_GV81
DR   BioSamples; SAME1839017
DR   Coriell; HG02776
DR   IGSR; HG02776
DR   Wikidata; Q54884943
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02778
AC   CVCL_Q918
DR   BioSamples; SAME1839100
DR   Coriell; HG02778
DR   GEO; GSM1719157
DR   IGSR; HG02778
DR   Wikidata; Q54884947
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02779
AC   CVCL_GV82
DR   BioSamples; SAME1839097
DR   Coriell; HG02779
DR   IGSR; HG02779
DR   Wikidata; Q54884948
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02780
AC   CVCL_Q919
DR   BioSamples; SAME1839169
DR   Coriell; HG02780
DR   GEO; GSM1719158
DR   IGSR; HG02780
DR   Wikidata; Q54884949
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02781
AC   CVCL_Q920
DR   BioSamples; SAME1839167
DR   Coriell; HG02781
DR   IGSR; HG02781
DR   Wikidata; Q54884950
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02783
AC   CVCL_Q921
DR   BioSamples; SAME1839162
DR   Coriell; HG02783
DR   GEO; GSM1719159
DR   IGSR; HG02783
DR   Wikidata; Q54884951
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02784
AC   CVCL_Q922
DR   BioSamples; SAME1839157
DR   Coriell; HG02784
DR   GEO; GSM1719160
DR   IGSR; HG02784
DR   Wikidata; Q54884952
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02785
AC   CVCL_GV83
DR   BioSamples; SAME1840298
DR   Coriell; HG02785
DR   IGSR; HG02785
DR   Wikidata; Q54884953
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02786
AC   CVCL_Q923
DR   BioSamples; SAME1840292
DR   Coriell; HG02786
DR   GEO; GSM1719161
DR   IGSR; HG02786
DR   Wikidata; Q54884954
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02787
AC   CVCL_Q924
DR   BioSamples; SAME1840288
DR   Coriell; HG02787
DR   GEO; GSM1719162
DR   IGSR; HG02787
DR   Wikidata; Q54884955
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02788
AC   CVCL_GV84
DR   BioSamples; SAME1840285
DR   Coriell; HG02788
DR   IGSR; HG02788
DR   Wikidata; Q54884956
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02789
AC   CVCL_Q925
DR   BioSamples; SAME1840280
DR   Coriell; HG02789
DR   GEO; GSM1719163
DR   IGSR; HG02789
DR   Wikidata; Q54884957
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02790
AC   CVCL_Q926
DR   BioSamples; SAME1840345
DR   Coriell; HG02790
DR   GEO; GSM1719164
DR   IGSR; HG02790
DR   Wikidata; Q54884958
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02791
AC   CVCL_GV85
DR   BioSamples; SAME1840342
DR   Coriell; HG02791
DR   IGSR; HG02791
DR   Wikidata; Q54884959
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG02792
AC   CVCL_Q927
DR   BioSamples; SAME1840416
DR   Coriell; HG02792
DR   GEO; GSM1719165
DR   IGSR; HG02792
DR   Wikidata; Q54884960
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02793
AC   CVCL_Q928
DR   BioSamples; SAME1840415
DR   Coriell; HG02793
DR   GEO; GSM1719166
DR   IGSR; HG02793
DR   Wikidata; Q54884961
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02794
AC   CVCL_GV86
DR   BioSamples; SAME1840410
DR   Coriell; HG02794
DR   IGSR; HG02794
DR   Wikidata; Q54884962
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02798
AC   CVCL_Q929
DR   EFO; EFO_0010849
DR   BioSamples; SAME1840387
DR   Coriell; HG02798
DR   GEO; GSM1719167
DR   IGSR; HG02798
DR   Wikidata; Q54884963
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02799
AC   CVCL_Q930
DR   BioSamples; SAME1840384
DR   Coriell; HG02799
DR   GEO; GSM1719168
DR   IGSR; HG02799
DR   Wikidata; Q54884964
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02800
AC   CVCL_GV87
DR   BioSamples; SAME1840000
DR   Coriell; HG02800
DR   IGSR; HG02800
DR   Wikidata; Q54884965
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02804
AC   CVCL_Q931
DR   BioSamples; SAME1840084
DR   Coriell; HG02804
DR   GEO; GSM1719169
DR   IGSR; HG02804
DR   Wikidata; Q54884966
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02805
AC   CVCL_Q932
DR   BioSamples; SAME1840081
DR   Coriell; HG02805
DR   GEO; GSM1719170
DR   IGSR; HG02805
DR   Wikidata; Q54884967
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02806
AC   CVCL_GV88
DR   BioSamples; SAME1840079
DR   Coriell; HG02806
DR   IGSR; HG02806
DR   Wikidata; Q54884968
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02807
AC   CVCL_Q933
DR   BioSamples; SAME1840073
DR   Coriell; HG02807
DR   GEO; GSM1719171
DR   IGSR; HG02807
DR   Wikidata; Q54884969
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02808
AC   CVCL_Q934
DR   BioSamples; SAME1840069
DR   Coriell; HG02808
DR   GEO; GSM1719172
DR   IGSR; HG02808
DR   Wikidata; Q54884970
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02809
AC   CVCL_GV89
DR   BioSamples; SAME1840067
DR   Coriell; HG02809
DR   IGSR; HG02809
DR   Wikidata; Q54884971
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02810
AC   CVCL_Q935
DR   BioSamples; SAME1839854
DR   Coriell; HG02810
DR   GEO; GSM1719173
DR   IGSR; HG02810
DR   Wikidata; Q54884972
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02811
AC   CVCL_Q936
DR   BioSamples; SAME1839849
DR   Coriell; HG02811
DR   GEO; GSM1719174
DR   IGSR; HG02811
DR   Wikidata; Q54884973
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02812
AC   CVCL_GV90
DR   BioSamples; SAME1839846
DR   Coriell; HG02812
DR   IGSR; HG02812
DR   Wikidata; Q54884974
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02813
AC   CVCL_Q937
DR   BioSamples; SAME1839841
DR   Coriell; HG02813
DR   GEO; GSM1719175
DR   IGSR; HG02813
DR   Wikidata; Q54884975
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02814
AC   CVCL_Q938
DR   BioSamples; SAME1839837
DR   Coriell; HG02814
DR   GEO; GSM1719176
DR   IGSR; HG02814
DR   Wikidata; Q54884976
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02815
AC   CVCL_GV91
DR   BioSamples; SAME1839829
DR   Coriell; HG02815
DR   IGSR; HG02815
DR   Wikidata; Q54884977
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02816
AC   CVCL_Q939
DR   BioSamples; SAME1839822
DR   Coriell; HG02816
DR   GEO; GSM1719177
DR   IGSR; HG02816
DR   Wikidata; Q54884978
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02817
AC   CVCL_Q940
DR   BioSamples; SAME1839819
DR   Coriell; HG02817
DR   GEO; GSM1719178
DR   IGSR; HG02817
DR   Wikidata; Q54884979
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02818
AC   CVCL_GV92
DR   BioSamples; SAME1839810
DR   Coriell; HG02818
DR   IGSR; HG02818
DR   Wikidata; Q54884980
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02819
AC   CVCL_Q941
DR   BioSamples; SAME1839804
DR   Coriell; HG02819
DR   GEO; GSM1719179
DR   IGSR; HG02819
DR   Wikidata; Q54884981
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02820
AC   CVCL_Q942
DR   BioSamples; SAME1839591
DR   Coriell; HG02820
DR   GEO; GSM1719180
DR   IGSR; HG02820
DR   Wikidata; Q54884982
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02821
AC   CVCL_GV93
DR   BioSamples; SAME1839588
DR   Coriell; HG02821
DR   IGSR; HG02821
DR   Wikidata; Q54884983
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02836
AC   CVCL_Q943
DR   BioSamples; SAME1839428
DR   Coriell; HG02836
DR   GEO; GSM1719181
DR   IGSR; HG02836
DR   Wikidata; Q54884984
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02837
AC   CVCL_Q944
DR   BioSamples; SAME1839422
DR   Coriell; HG02837
DR   GEO; GSM1719182
DR   IGSR; HG02837
DR   Wikidata; Q54884985
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02838
AC   CVCL_GV94
DR   BioSamples; SAME1839417
DR   Coriell; HG02838
DR   IGSR; HG02838
DR   Wikidata; Q54884986
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02839
AC   CVCL_Q945
DR   BioSamples; SAME1839413
DR   Coriell; HG02839
DR   GEO; GSM1719183
DR   IGSR; HG02839
DR   Wikidata; Q54884991
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02840
AC   CVCL_Q946
DR   EFO; EFO_0010850
DR   BioSamples; SAME1839475
DR   Coriell; HG02840
DR   GEO; GSM1719184
DR   IGSR; HG02840
DR   Wikidata; Q54884992
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02841
AC   CVCL_GV95
DR   BioSamples; SAME1839470
DR   Coriell; HG02841
DR   IGSR; HG02841
DR   Wikidata; Q54884993
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02851
AC   CVCL_Q947
DR   BioSamples; SAME1839352
DR   Coriell; HG02851
DR   GEO; GSM1719185
DR   IGSR; HG02851
DR   Wikidata; Q54884994
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02852
AC   CVCL_Q948
DR   EFO; EFO_0010851
DR   BioSamples; SAME1839346
DR   Coriell; HG02852
DR   GEO; GSM1719186
DR   IGSR; HG02852
DR   Wikidata; Q54884995
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02853
AC   CVCL_GV96
DR   BioSamples; SAME1839342
DR   Coriell; HG02853
DR   IGSR; HG02853
DR   Wikidata; Q54884996
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02854
AC   CVCL_Q949
DR   BioSamples; SAME1839336
DR   Coriell; HG02854
DR   GEO; GSM1719187
DR   IGSR; HG02854
DR   Wikidata; Q54884997
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02855
AC   CVCL_Q950
DR   BioSamples; SAME1839330
DR   Coriell; HG02855
DR   GEO; GSM1719188
DR   IGSR; HG02855
DR   Wikidata; Q54884998
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02856
AC   CVCL_GV97
DR   BioSamples; SAME1839327
DR   Coriell; HG02856
DR   IGSR; HG02856
DR   Wikidata; Q54884999
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02860
AC   CVCL_Q951
DR   BioSamples; SAME1839132
DR   Coriell; HG02860
DR   GEO; GSM1719189
DR   IGSR; HG02860
DR   Wikidata; Q54885000
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02861
AC   CVCL_Q952
DR   BioSamples; SAME1839125
DR   Coriell; HG02861
DR   GEO; GSM1719190
DR   IGSR; HG02861
DR   Wikidata; Q54885001
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02862
AC   CVCL_GV98
DR   BioSamples; SAME1839123
DR   Coriell; HG02862
DR   IGSR; HG02862
DR   Wikidata; Q54885002
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02869
AC   CVCL_Q953
DR   BioSamples; SAME1839184
DR   Coriell; HG02869
DR   IGSR; HG02869
DR   Wikidata; Q54885003
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02870
AC   CVCL_Q954
DR   EFO; EFO_0010852
DR   BioSamples; SAME1840320
DR   Coriell; HG02870
DR   GEO; GSM1719191
DR   IGSR; HG02870
DR   Wikidata; Q54885004
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02871
AC   CVCL_GV99
DR   BioSamples; SAME1840312
DR   Coriell; HG02871
DR   IGSR; HG02871
DR   Wikidata; Q54885005
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02878
AC   CVCL_Q955
DR   BioSamples; SAME1840363
DR   Coriell; HG02878
DR   GEO; GSM1719192
DR   IGSR; HG02878
DR   Wikidata; Q54885006
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02879
AC   CVCL_Q956
DR   BioSamples; SAME1840355
DR   Coriell; HG02879
DR   GEO; GSM1719193
DR   IGSR; HG02879
DR   Wikidata; Q54885008
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02880
AC   CVCL_GW00
DR   BioSamples; SAME1840090
DR   Coriell; HG02880
DR   IGSR; HG02880
DR   Wikidata; Q54885009
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02881
AC   CVCL_Q957
DR   BioSamples; SAME1840178
DR   Coriell; HG02881
DR   GEO; GSM1719194
DR   IGSR; HG02881
DR   Wikidata; Q54885010
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02882
AC   CVCL_Q958
DR   BioSamples; SAME1840171
DR   Coriell; HG02882
DR   GEO; GSM1719195
DR   IGSR; HG02882
DR   Wikidata; Q54885011
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02883
AC   CVCL_GW01
DR   BioSamples; SAME1840164
DR   Coriell; HG02883
DR   IGSR; HG02883
DR   Wikidata; Q54885012
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02884
AC   CVCL_Q959
DR   EFO; EFO_0010853
DR   BioSamples; SAME1840161
DR   Coriell; HG02884
DR   GEO; GSM1719196
DR   IGSR; HG02884
DR   Wikidata; Q54885013
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02885
AC   CVCL_Q960
DR   EFO; EFO_0010854
DR   BioSamples; SAME1840157
DR   Coriell; HG02885
DR   GEO; GSM1719197
DR   IGSR; HG02885
DR   Wikidata; Q54885014
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02886
AC   CVCL_GW02
DR   BioSamples; SAME1840151
DR   Coriell; HG02886
DR   IGSR; HG02886
DR   Wikidata; Q54885015
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02887
AC   CVCL_Q961
DR   BioSamples; SAME1840147
DR   Coriell; HG02887
DR   GEO; GSM1719198
DR   IGSR; HG02887
DR   Wikidata; Q54885016
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02888
AC   CVCL_Q962
DR   BioSamples; SAME1840139
DR   Coriell; HG02888
DR   GEO; GSM1719199
DR   IGSR; HG02888
DR   Wikidata; Q54885017
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02889
AC   CVCL_GW03
DR   BioSamples; SAME1840133
DR   Coriell; HG02889
DR   IGSR; HG02889
DR   Wikidata; Q54885018
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02890
AC   CVCL_Q963
DR   BioSamples; SAME1839947
DR   Coriell; HG02890
DR   GEO; GSM1719200
DR   IGSR; HG02890
DR   Wikidata; Q54885019
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02891
AC   CVCL_Q964
DR   BioSamples; SAME1839938
DR   Coriell; HG02891
DR   GEO; GSM1719201
DR   IGSR; HG02891
DR   Wikidata; Q54885020
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02892
AC   CVCL_GW04
DR   BioSamples; SAME1839935
DR   Coriell; HG02892
DR   IGSR; HG02892
DR   Wikidata; Q54885021
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02895
AC   CVCL_Q965
DR   BioSamples; SAME1839918
DR   Coriell; HG02895
DR   GEO; GSM1719202
DR   IGSR; HG02895
DR   Wikidata; Q54885022
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02896
AC   CVCL_Q966
DR   BioSamples; SAME1839916
DR   Coriell; HG02896
DR   GEO; GSM1719203
DR   IGSR; HG02896
DR   Wikidata; Q54885023
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02897
AC   CVCL_GW05
DR   BioSamples; SAME1839910
DR   Coriell; HG02897
DR   IGSR; HG02897
DR   Wikidata; Q54885024
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02922
AC   CVCL_Q967
DR   BioSamples; SAME1839441
DR   Coriell; HG02922
DR   GEO; GSM1719204
DR   IGSR; HG02922
DR   Wikidata; Q54885025
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02923
AC   CVCL_Q968
DR   BioSamples; SAME1839436
DR   Coriell; HG02923
DR   GEO; GSM1719205
DR   IGSR; HG02923
DR   Wikidata; Q54885026
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02924
AC   CVCL_GW06
DR   BioSamples; SAME1839516
DR   Coriell; HG02924
DR   IGSR; HG02924
DR   Wikidata; Q54885027
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02938
AC   CVCL_Q969
DR   EFO; EFO_0010855
DR   BioSamples; SAME1839284
DR   Coriell; HG02938
DR   GEO; GSM1719206
DR   IGSR; HG02938
DR   Wikidata; Q54885028
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02939
AC   CVCL_GW07
DR   BioSamples; SAME1839275
DR   Coriell; HG02939
DR   IGSR; HG02939
DR   Wikidata; Q54885029
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02941
AC   CVCL_Q970
DR   BioSamples; SAME1839096
DR   Coriell; HG02941
DR   GEO; GSM1719207
DR   IGSR; HG02941
DR   Wikidata; Q54885030
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02942
AC   CVCL_GW08
DR   BioSamples; SAME1839090
DR   Coriell; HG02942
DR   IGSR; HG02942
DR   Wikidata; Q54885031
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02943
AC   CVCL_Q971
DR   EFO; EFO_0010856
DR   BioSamples; SAME1839085
DR   Coriell; HG02943
DR   GEO; GSM1719208
DR   IGSR; HG02943
DR   Wikidata; Q54885036
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02944
AC   CVCL_Q972
DR   BioSamples; SAME1839082
DR   Coriell; HG02944
DR   GEO; GSM1719209
DR   IGSR; HG02944
DR   Wikidata; Q54885037
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02945
AC   CVCL_GW09
DR   BioSamples; SAME1839075
DR   Coriell; HG02945
DR   IGSR; HG02945
DR   Wikidata; Q54885039
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02946
AC   CVCL_Q973
DR   BioSamples; SAME1839068
DR   Coriell; HG02946
DR   GEO; GSM1719210
DR   IGSR; HG02946
DR   Wikidata; Q54885040
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02947
AC   CVCL_Q974
DR   BioSamples; SAME1839061
DR   Coriell; HG02947
DR   GEO; GSM1719211
DR   IGSR; HG02947
DR   Wikidata; Q54885041
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02948
AC   CVCL_GW10
DR   BioSamples; SAME1839153
DR   Coriell; HG02948
DR   IGSR; HG02948
DR   Wikidata; Q54885042
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02952
AC   CVCL_Q975
DR   BioSamples; SAME1840275
DR   Coriell; HG02952
DR   GEO; GSM1719212
DR   IGSR; HG02952
DR   Wikidata; Q54885043
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02953
AC   CVCL_Q976
DR   BioSamples; SAME1840271
DR   Coriell; HG02953
DR   GEO; GSM1719213
DR   IGSR; HG02953
DR   Wikidata; Q54885044
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02954
AC   CVCL_GW11
DR   BioSamples; SAME1840264
DR   Coriell; HG02954
DR   IGSR; HG02954
DR   Wikidata; Q54885045
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02964
AC   CVCL_Q977
DR   BioSamples; SAME1840122
DR   Coriell; HG02964
DR   IGSR; HG02964
DR   Wikidata; Q54885046
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02965
AC   CVCL_Q978
DR   BioSamples; SAME1840116
DR   Coriell; HG02965
DR   IGSR; HG02965
DR   Wikidata; Q54885047
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02966
AC   CVCL_GW12
DR   BioSamples; SAME1840114
DR   Coriell; HG02966
DR   IGSR; HG02966
DR   Wikidata; Q54885048
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02968
AC   CVCL_Q979
DR   BioSamples; SAME1840108
DR   Coriell; HG02968
DR   GEO; GSM1719214
DR   IGSR; HG02968
DR   Wikidata; Q54885049
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02969
AC   CVCL_GW13
DR   BioSamples; SAME1840103
DR   Coriell; HG02969
DR   IGSR; HG02969
DR   Wikidata; Q54885050
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02970
AC   CVCL_Q980
DR   EFO; EFO_0010857
DR   BioSamples; SAME1840260
DR   Coriell; HG02970
DR   GEO; GSM1719215
DR   IGSR; HG02970
DR   Wikidata; Q54885051
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02971
AC   CVCL_Q981
DR   BioSamples; SAME1840255
DR   Coriell; HG02971
DR   GEO; GSM1719216
DR   IGSR; HG02971
DR   Wikidata; Q54885052
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02972
AC   CVCL_GW14
DR   BioSamples; SAME1840250
DR   Coriell; HG02972
DR   IGSR; HG02972
DR   Wikidata; Q54885053
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02973
AC   CVCL_Q982
DR   EFO; EFO_0010858
DR   BioSamples; SAME1840246
DR   Coriell; HG02973
DR   GEO; GSM1719217
DR   IGSR; HG02973
DR   Wikidata; Q54885054
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02974
AC   CVCL_Q983
DR   BioSamples; SAME1840241
DR   Coriell; HG02974
DR   GEO; GSM1719218
DR   IGSR; HG02974
DR   Wikidata; Q54885055
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02975
AC   CVCL_GW15
DR   BioSamples; SAME1840232
DR   Coriell; HG02975
DR   IGSR; HG02975
DR   Wikidata; Q54885056
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02976
AC   CVCL_Q984
DR   BioSamples; SAME1840223
DR   Coriell; HG02976
DR   GEO; GSM1719219
DR   IGSR; HG02976
DR   Wikidata; Q54885057
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02977
AC   CVCL_Q985
DR   BioSamples; SAME1840221
DR   Coriell; HG02977
DR   GEO; GSM1719220
DR   IGSR; HG02977
DR   Wikidata; Q54885058
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02978
AC   CVCL_GW16
DR   BioSamples; SAME1840216
DR   Coriell; HG02978
DR   IGSR; HG02978
DR   Wikidata; Q54885059
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02979
AC   CVCL_Q986
DR   BioSamples; SAME1840209
DR   Coriell; HG02979
DR   GEO; GSM1719221
DR   IGSR; HG02979
DR   Wikidata; Q54885060
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02980
AC   CVCL_GW17
DR   BioSamples; SAME1840034
DR   Coriell; HG02980
DR   IGSR; HG02980
DR   Wikidata; Q54885061
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG02981
AC   CVCL_Q987
DR   EFO; EFO_0010859
DR   BioSamples; SAME1840024
DR   Coriell; HG02981
DR   GEO; GSM1719222
DR   IGSR; HG02981
DR   Wikidata; Q54885062
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG02982
AC   CVCL_Q988
DR   BioSamples; SAME1840015
DR   Coriell; HG02982
DR   GEO; GSM1719223
DR   IGSR; HG02982
DR   Wikidata; Q54885063
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02983
AC   CVCL_Q989
DR   BioSamples; SAME1840009
DR   Coriell; HG02983
DR   GEO; GSM1719224
DR   IGSR; HG02983
DR   Wikidata; Q54885064
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG02984
AC   CVCL_GW18
DR   BioSamples; SAME1840004
DR   Coriell; HG02984
DR   IGSR; HG02984
DR   Wikidata; Q54885065
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03006
AC   CVCL_Q990
DR   BioSamples; SAME1840242
DR   Coriell; HG03006
DR   GEO; GSM1719225
DR   IGSR; HG03006
DR   Wikidata; Q54885066
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03007
AC   CVCL_Q991
DR   BioSamples; SAME1840245
DR   Coriell; HG03007
DR   GEO; GSM1719226
DR   IGSR; HG03007
DR   Wikidata; Q54885067
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03008
AC   CVCL_GW19
DR   BioSamples; SAME1840253
DR   Coriell; HG03008
DR   IGSR; HG03008
DR   Wikidata; Q54885069
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03009
AC   CVCL_Q992
DR   BioSamples; SAME1840256
DR   Coriell; HG03009
DR   GEO; GSM1719227
DR   IGSR; HG03009
DR   Wikidata; Q54885070
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03012
AC   CVCL_Q993
DR   BioSamples; SAME1839924
DR   Coriell; HG03012
DR   GEO; GSM1719228
DR   IGSR; HG03012
DR   Wikidata; Q54885071
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03015
AC   CVCL_Q994
DR   BioSamples; SAME1839940
DR   Coriell; HG03015
DR   GEO; GSM1719229
DR   IGSR; HG03015
DR   Wikidata; Q54885072
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03016
AC   CVCL_Q995
DR   BioSamples; SAME1839952
DR   Coriell; HG03016
DR   GEO; GSM1719230
DR   IGSR; HG03016
DR   Wikidata; Q54885073
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03017
AC   CVCL_GW20
DR   BioSamples; SAME1839956
DR   Coriell; HG03017
DR   IGSR; HG03017
DR   Wikidata; Q54885074
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03018
AC   CVCL_Q996
DR   BioSamples; SAME1840053
DR   Coriell; HG03018
DR   GEO; GSM1719231
DR   IGSR; HG03018
DR   Wikidata; Q54885075
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03019
AC   CVCL_Q997
DR   BioSamples; SAME1840060
DR   Coriell; HG03019
DR   GEO; GSM1719232
DR   IGSR; HG03019
DR   Wikidata; Q54885076
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03021
AC   CVCL_Q998
DR   BioSamples; SAME1839789
DR   Coriell; HG03021
DR   GEO; GSM1719233
DR   IGSR; HG03021
DR   Wikidata; Q54885077
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03022
AC   CVCL_Q999
DR   BioSamples; SAME1839795
DR   Coriell; HG03022
DR   GEO; GSM1719234
DR   IGSR; HG03022
DR   Wikidata; Q54885082
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03023
AC   CVCL_GW21
DR   BioSamples; SAME1839797
DR   Coriell; HG03023
DR   IGSR; HG03023
DR   Wikidata; Q54885083
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03024
AC   CVCL_R000
DR   BioSamples; SAME1839799
DR   Coriell; HG03024
DR   GEO; GSM1719235
DR   IGSR; HG03024
DR   Wikidata; Q54885084
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03025
AC   CVCL_R001
DR   EFO; EFO_0010860
DR   BioSamples; SAME1839711
DR   Coriell; HG03025
DR   GEO; GSM1719236
DR   IGSR; HG03025
DR   Wikidata; Q54885085
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03026
AC   CVCL_GW22
DR   BioSamples; SAME1839714
DR   Coriell; HG03026
DR   IGSR; HG03026
DR   Wikidata; Q54885086
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03027
AC   CVCL_R002
DR   BioSamples; SAME1839725
DR   Coriell; HG03027
DR   GEO; GSM1719237
DR   IGSR; HG03027
DR   Wikidata; Q54885087
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03028
AC   CVCL_R003
DR   BioSamples; SAME1839729
DR   Coriell; HG03028
DR   GEO; GSM1719238
DR   IGSR; HG03028
DR   Wikidata; Q54885088
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03029
AC   CVCL_GW23
DR   BioSamples; SAME1839733
DR   Coriell; HG03029
DR   IGSR; HG03029
DR   Wikidata; Q54885089
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03033
AC   CVCL_R004
DR   BioSamples; SAME1839566
DR   Coriell; HG03033
DR   IGSR; HG03033
DR   Wikidata; Q54885090
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03034
AC   CVCL_R005
DR   BioSamples; SAME1839568
DR   Coriell; HG03034
DR   IGSR; HG03034
DR   Wikidata; Q54885092
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03035
AC   CVCL_GW24
DR   BioSamples; SAME1839573
DR   Coriell; HG03035
DR   IGSR; HG03035
DR   Wikidata; Q54885093
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03039
AC   CVCL_R006
DR   EFO; EFO_0010861
DR   BioSamples; SAME1839593
DR   Coriell; HG03039
DR   GEO; GSM1719239
DR   IGSR; HG03039
DR   Wikidata; Q54885094
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03040
AC   CVCL_R007
DR   BioSamples; SAME1839611
DR   Coriell; HG03040
DR   GEO; GSM1719240
DR   IGSR; HG03040
DR   Wikidata; Q54885095
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03041
AC   CVCL_GW25
DR   BioSamples; SAME1839620
DR   Coriell; HG03041
DR   IGSR; HG03041
DR   Wikidata; Q54885096
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03045
AC   CVCL_R008
DR   EFO; EFO_0010862
DR   BioSamples; SAME1839635
DR   Coriell; HG03045
DR   GEO; GSM1719241
DR   IGSR; HG03045
DR   Wikidata; Q54885097
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03046
AC   CVCL_R009
DR   BioSamples; SAME1839639
DR   Coriell; HG03046
DR   GEO; GSM1719242
DR   IGSR; HG03046
DR   Wikidata; Q54885098
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03047
AC   CVCL_GW26
DR   BioSamples; SAME1839644
DR   Coriell; HG03047
DR   IGSR; HG03047
DR   Wikidata; Q54885099
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03048
AC   CVCL_R010
DR   BioSamples; SAME1839647
DR   Coriell; HG03048
DR   GEO; GSM1719243
DR   IGSR; HG03048
DR   Wikidata; Q54885100
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03049
AC   CVCL_R011
DR   BioSamples; SAME1839653
DR   Coriell; HG03049
DR   GEO; GSM1719244
DR   IGSR; HG03049
DR   Wikidata; Q54885101
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03050
AC   CVCL_GW27
DR   BioSamples; SAME1839482
DR   Coriell; HG03050
DR   IGSR; HG03050
DR   Wikidata; Q54885102
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03052
AC   CVCL_R012
DR   BioSamples; SAME1839496
DR   Coriell; HG03052
DR   GEO; GSM1719245
DR   IGSR; HG03052
DR   Wikidata; Q54885103
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03053
AC   CVCL_GW28
DR   BioSamples; SAME1839502
DR   Coriell; HG03053
DR   IGSR; HG03053
DR   Wikidata; Q54885104
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03054
AC   CVCL_R013
DR   BioSamples; SAME1839507
DR   Coriell; HG03054
DR   GEO; GSM1719246
DR   IGSR; HG03054
DR   Wikidata; Q54885105
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03055
AC   CVCL_R014
DR   BioSamples; SAME1839514
DR   Coriell; HG03055
DR   GEO; GSM1719247
DR   IGSR; HG03055
DR   Wikidata; Q54885106
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03056
AC   CVCL_GW29
DR   BioSamples; SAME1839518
DR   Coriell; HG03056
DR   IGSR; HG03056
DR   Wikidata; Q54885107
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03057
AC   CVCL_R015
DR   BioSamples; SAME1839434
DR   Coriell; HG03057
DR   GEO; GSM1719248
DR   IGSR; HG03057
DR   Wikidata; Q54885108
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03058
AC   CVCL_R018
DR   BioSamples; SAME1839442
DR   Coriell; HG03058
DR   GEO; GSM1719249
DR   IGSR; HG03058
DR   Wikidata; Q54885109
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03059
AC   CVCL_GW30
DR   BioSamples; SAME1839443
DR   Coriell; HG03059
DR   IGSR; HG03059
DR   Wikidata; Q54885110
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03060
AC   CVCL_R019
DR   EFO; EFO_0010863
DR   BioSamples; SAME1839211
DR   Coriell; HG03060
DR   GEO; GSM1719250
DR   IGSR; HG03060
DR   Wikidata; Q54885111
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03061
AC   CVCL_R020
DR   BioSamples; SAME1839215
DR   Coriell; HG03061
DR   GEO; GSM1719251
DR   IGSR; HG03061
DR   Wikidata; Q54885112
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03062
AC   CVCL_GW31
DR   BioSamples; SAME1839220
DR   Coriell; HG03062
DR   IGSR; HG03062
DR   Wikidata; Q54885113
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03063
AC   CVCL_R021
DR   BioSamples; SAME1839226
DR   Coriell; HG03063
DR   GEO; GSM1719252
DR   IGSR; HG03063
DR   Wikidata; Q54885114
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03064
AC   CVCL_R022
DR   EFO; EFO_0010864
DR   BioSamples; SAME1839228
DR   Coriell; HG03064
DR   GEO; GSM1719253
DR   IGSR; HG03064
DR   Wikidata; Q54885115
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03065
AC   CVCL_GW32
DR   BioSamples; SAME1839318
DR   Coriell; HG03065
DR   IGSR; HG03065
DR   Wikidata; Q54885116
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03066
AC   CVCL_R023
DR   EFO; EFO_0010865
DR   BioSamples; SAME1839324
DR   Coriell; HG03066
DR   GEO; GSM1719254
DR   IGSR; HG03066
DR   Wikidata; Q54885117
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03069
AC   CVCL_R024
DR   BioSamples; SAME1839340
DR   Coriell; HG03069
DR   GEO; GSM1719255
DR   IGSR; HG03069
DR   Wikidata; Q54885118
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03072
AC   CVCL_R025
DR   BioSamples; SAME1839016
DR   Coriell; HG03072
DR   GEO; GSM1719256
DR   IGSR; HG03072
DR   Wikidata; Q54885119
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03073
AC   CVCL_R026
DR   BioSamples; SAME1839019
DR   Coriell; HG03073
DR   GEO; GSM1719257
DR   IGSR; HG03073
DR   Wikidata; Q54885120
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03074
AC   CVCL_R027
DR   BioSamples; SAME1839029
DR   Coriell; HG03074
DR   GEO; GSM1719258
DR   IGSR; HG03074
DR   Wikidata; Q54885121
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03076
AC   CVCL_R028
DR   BioSamples; SAME1839038
DR   Coriell; HG03076
DR   IGSR; HG03076
DR   Wikidata; Q54885122
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03077
AC   CVCL_R029
DR   BioSamples; SAME1839044
DR   Coriell; HG03077
DR   GEO; GSM1719259
DR   IGSR; HG03077
DR   Wikidata; Q54885127
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03078
AC   CVCL_R030
DR   BioSamples; SAME1839047
DR   Coriell; HG03078
DR   GEO; GSM1719260
DR   IGSR; HG03078
DR   Wikidata; Q54885128
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03079
AC   CVCL_R031
DR   BioSamples; SAME1839051
DR   Coriell; HG03079
DR   GEO; GSM1719261
DR   IGSR; HG03079
DR   Wikidata; Q54885129
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03080
AC   CVCL_GW33
DR   BioSamples; SAME1840307
DR   Coriell; HG03080
DR   IGSR; HG03080
DR   Wikidata; Q54885130
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03081
AC   CVCL_R032
DR   BioSamples; SAME1840310
DR   Coriell; HG03081
DR   GEO; GSM1719262
DR   IGSR; HG03081
DR   Wikidata; Q54885131
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03082
AC   CVCL_R033
DR   BioSamples; SAME1840316
DR   Coriell; HG03082
DR   GEO; GSM1719263
DR   IGSR; HG03082
DR   Wikidata; Q54885132
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03084
AC   CVCL_R034
DR   BioSamples; SAME1840324
DR   Coriell; HG03084
DR   GEO; GSM1719264
DR   IGSR; HG03084
DR   Wikidata; Q54885133
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03085
AC   CVCL_R035
DR   BioSamples; SAME1840328
DR   Coriell; HG03085
DR   GEO; GSM1719265
DR   IGSR; HG03085
DR   Wikidata; Q54885134
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03086
AC   CVCL_R036
DR   BioSamples; SAME1840331
DR   Coriell; HG03086
DR   GEO; GSM1719266
DR   IGSR; HG03086
DR   Wikidata; Q54885135
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03088
AC   CVCL_R037
DR   BioSamples; SAME1840338
DR   Coriell; HG03088
DR   GEO; GSM1719267
DR   IGSR; HG03088
DR   Wikidata; Q54885136
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03091
AC   CVCL_R038
DR   BioSamples; SAME1840360
DR   Coriell; HG03091
DR   GEO; GSM1719268
DR   IGSR; HG03091
DR   Wikidata; Q54885137
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03095
AC   CVCL_R039
DR   EFO; EFO_0010866
DR   BioSamples; SAME1840374
DR   Coriell; HG03095
DR   GEO; GSM1719269
DR   IGSR; HG03095
DR   Wikidata; Q54885138
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03096
AC   CVCL_R040
DR   BioSamples; SAME1840126
DR   Coriell; HG03096
DR   GEO; GSM1719270
DR   IGSR; HG03096
DR   Wikidata; Q54885139
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03097
AC   CVCL_R041
DR   EFO; EFO_0010867
DR   BioSamples; SAME1840130
DR   Coriell; HG03097
DR   GEO; GSM1719271
DR   IGSR; HG03097
DR   Wikidata; Q54885140
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03098
AC   CVCL_GW34
DR   BioSamples; SAME1840136
DR   Coriell; HG03098
DR   IGSR; HG03098
DR   Wikidata; Q54885141
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03099
AC   CVCL_R042
DR   BioSamples; SAME1840146
DR   Coriell; HG03099
DR   GEO; GSM1719272
DR   IGSR; HG03099
DR   Wikidata; Q54885142
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03100
AC   CVCL_R043
DR   BioSamples; SAME1840003
DR   Coriell; HG03100
DR   GEO; GSM1719273
DR   IGSR; HG03100
DR   Wikidata; Q54885143
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03101
AC   CVCL_GW35
DR   BioSamples; SAME1840008
DR   Coriell; HG03101
DR   IGSR; HG03101
DR   Wikidata; Q54885144
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03103
AC   CVCL_R044
DR   EFO; EFO_0010868
DR   BioSamples; SAME1840022
DR   Coriell; HG03103
DR   GEO; GSM1719274
DR   IGSR; HG03103
DR   Wikidata; Q54885145
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03104
AC   CVCL_GW36
DR   BioSamples; SAME1840037
DR   Coriell; HG03104
DR   IGSR; HG03104
DR   Wikidata; Q54885146
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03105
AC   CVCL_R045
DR   BioSamples; SAME1840041
DR   Coriell; HG03105
DR   GEO; GSM1719275
DR   IGSR; HG03105
DR   Wikidata; Q54885147
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03107
AC   CVCL_GW37
DR   BioSamples; SAME1839755
DR   Coriell; HG03107
DR   IGSR; HG03107
DR   Wikidata; Q54885148
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03108
AC   CVCL_R046
DR   EFO; EFO_0010869
DR   BioSamples; SAME1839760
DR   Coriell; HG03108
DR   GEO; GSM1719276
DR   IGSR; HG03108
DR   Wikidata; Q54885149
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03109
AC   CVCL_R047
DR   BioSamples; SAME1839765
DR   Coriell; HG03109
DR   GEO; GSM1719277
DR   IGSR; HG03109
DR   Wikidata; Q54885150
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03110
AC   CVCL_GW38
DR   BioSamples; SAME1839880
DR   Coriell; HG03110
DR   IGSR; HG03110
DR   Wikidata; Q54885152
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03111
AC   CVCL_R048
DR   BioSamples; SAME1839884
DR   Coriell; HG03111
DR   GEO; GSM1719278
DR   IGSR; HG03111
DR   Wikidata; Q54885153
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03112
AC   CVCL_R049
DR   BioSamples; SAME1839893
DR   Coriell; HG03112
DR   GEO; GSM1719279
DR   IGSR; HG03112
DR   Wikidata; Q54885154
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03113
AC   CVCL_GW39
DR   BioSamples; SAME1839901
DR   Coriell; HG03113
DR   IGSR; HG03113
DR   Wikidata; Q54885155
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03114
AC   CVCL_R050
DR   BioSamples; SAME1839907
DR   Coriell; HG03114
DR   GEO; GSM1719280
DR   IGSR; HG03114
DR   Wikidata; Q54885156
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03115
AC   CVCL_R051
DR   BioSamples; SAME1839812
DR   Coriell; HG03115
DR   GEO; GSM1719281
DR   IGSR; HG03115
DR   Wikidata; Q54885157
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03116
AC   CVCL_GW40
DR   BioSamples; SAME1839816
DR   Coriell; HG03116
DR   IGSR; HG03116
DR   Wikidata; Q54885158
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03117
AC   CVCL_R052
DR   BioSamples; SAME1839821
DR   Coriell; HG03117
DR   GEO; GSM1719282
DR   IGSR; HG03117
DR   Wikidata; Q54885159
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03118
AC   CVCL_R053
DR   BioSamples; SAME1839830
DR   Coriell; HG03118
DR   GEO; GSM1719283
DR   IGSR; HG03118
DR   Wikidata; Q54885160
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03119
AC   CVCL_GW41
DR   BioSamples; SAME1839833
DR   Coriell; HG03119
DR   IGSR; HG03119
DR   Wikidata; Q54885161
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03120
AC   CVCL_R054
DR   BioSamples; SAME1839557
DR   Coriell; HG03120
DR   GEO; GSM1719284
DR   IGSR; HG03120
DR   Wikidata; Q54885163
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03121
AC   CVCL_R055
DR   BioSamples; SAME1839563
DR   Coriell; HG03121
DR   GEO; GSM1719285
DR   IGSR; HG03121
DR   Wikidata; Q54885164
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03122
AC   CVCL_GW42
DR   BioSamples; SAME1839657
DR   Coriell; HG03122
DR   IGSR; HG03122
DR   Wikidata; Q54885165
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03123
AC   CVCL_R056
DR   BioSamples; SAME1839663
DR   Coriell; HG03123
DR   GEO; GSM1719286
DR   IGSR; HG03123
DR   Wikidata; Q54885166
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03124
AC   CVCL_R057
DR   BioSamples; SAME1839669
DR   Coriell; HG03124
DR   GEO; GSM1719287
DR   IGSR; HG03124
DR   Wikidata; Q54885167
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03125
AC   CVCL_GW43
DR   BioSamples; SAME1839675
DR   Coriell; HG03125
DR   IGSR; HG03125
DR   Wikidata; Q54885168
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03126
AC   CVCL_R058
DR   BioSamples; SAME1839683
DR   Coriell; HG03126
DR   GEO; GSM1719288
DR   IGSR; HG03126
DR   Wikidata; Q54885171
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03127
AC   CVCL_R059
DR   BioSamples; SAME1839686
DR   Coriell; HG03127
DR   GEO; GSM1719289
DR   IGSR; HG03127
DR   Wikidata; Q54885172
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03128
AC   CVCL_GW44
DR   BioSamples; SAME1839692
DR   Coriell; HG03128
DR   IGSR; HG03128
DR   Wikidata; Q54885173
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03129
AC   CVCL_R060
DR   BioSamples; SAME1839699
DR   Coriell; HG03129
DR   GEO; GSM1719290
DR   IGSR; HG03129
DR   Wikidata; Q54885174
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03130
AC   CVCL_R061
DR   BioSamples; SAME1839365
DR   Coriell; HG03130
DR   GEO; GSM1719291
DR   IGSR; HG03130
DR   Wikidata; Q54885175
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03131
AC   CVCL_GW45
DR   BioSamples; SAME1839368
DR   Coriell; HG03131
DR   IGSR; HG03131
DR   Wikidata; Q54885176
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03132
AC   CVCL_R062
DR   BioSamples; SAME1839373
DR   Coriell; HG03132
DR   GEO; GSM1719292
DR   IGSR; HG03132
DR   Wikidata; Q54885177
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03133
AC   CVCL_R063
DR   BioSamples; SAME1839375
DR   Coriell; HG03133
DR   GEO; GSM1719293
DR   IGSR; HG03133
DR   Wikidata; Q54885178
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03134
AC   CVCL_GW46
DR   BioSamples; SAME1839380
DR   Coriell; HG03134
DR   IGSR; HG03134
DR   Wikidata; Q54885179
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03135
AC   CVCL_R064
DR   EFO; EFO_0010870
DR   BioSamples; SAME1839385
DR   Coriell; HG03135
DR   GEO; GSM1719294
DR   IGSR; HG03135
DR   Wikidata; Q54885180
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03136
AC   CVCL_R065
DR   BioSamples; SAME1839387
DR   Coriell; HG03136
DR   GEO; GSM1719295
DR   IGSR; HG03136
DR   Wikidata; Q54885181
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03137
AC   CVCL_GW47
DR   BioSamples; SAME1839390
DR   Coriell; HG03137
DR   IGSR; HG03137
DR   Wikidata; Q54885182
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03139
AC   CVCL_R066
DR   EFO; EFO_0010871
DR   BioSamples; SAME1839468
DR   Coriell; HG03139
DR   GEO; GSM1719296
DR   IGSR; HG03139
DR   Wikidata; Q54885183
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03140
AC   CVCL_GW48
DR   BioSamples; SAME1839243
DR   Coriell; HG03140
DR   IGSR; HG03140
DR   Wikidata; Q54885184
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03157
AC   CVCL_R067
DR   BioSamples; SAME1839083
DR   Coriell; HG03157
DR   GEO; GSM1719297
DR   IGSR; HG03157
DR   Wikidata; Q54885185
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03158
AC   CVCL_GW49
DR   BioSamples; SAME1839086
DR   Coriell; HG03158
DR   IGSR; HG03158
DR   Wikidata; Q54885186
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03159
AC   CVCL_R068
DR   EFO; EFO_0010872
DR   BioSamples; SAME1839092
DR   Coriell; HG03159
DR   GEO; GSM1719298
DR   IGSR; HG03159
DR   Wikidata; Q54885187
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03160
AC   CVCL_R069
DR   BioSamples; SAME1839192
DR   Coriell; HG03160
DR   GEO; GSM1719299
DR   IGSR; HG03160
DR   Wikidata; Q54885188
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03161
AC   CVCL_GW50
DR   BioSamples; SAME1839104
DR   Coriell; HG03161
DR   IGSR; HG03161
DR   Wikidata; Q54885189
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03162
AC   CVCL_R070
DR   BioSamples; SAME1839112
DR   Coriell; HG03162
DR   GEO; GSM1719300
DR   IGSR; HG03162
DR   Wikidata; Q54885190
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03163
AC   CVCL_R071
DR   BioSamples; SAME1839118
DR   Coriell; HG03163
DR   GEO; GSM1719301
DR   IGSR; HG03163
DR   Wikidata; Q54885191
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03164
AC   CVCL_GW51
DR   BioSamples; SAME1839121
DR   Coriell; HG03164
DR   IGSR; HG03164
DR   Wikidata; Q54885192
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03166
AC   CVCL_R072
DR   BioSamples; SAME1839127
DR   Coriell; HG03166
DR   GEO; GSM1719302
DR   IGSR; HG03166
DR   Wikidata; Q54885193
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03167
AC   CVCL_GW52
DR   BioSamples; SAME1839135
DR   Coriell; HG03167
DR   IGSR; HG03167
DR   Wikidata; Q54885194
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03168
AC   CVCL_R073
DR   BioSamples; SAME1839143
DR   Coriell; HG03168
DR   GEO; GSM1719303
DR   IGSR; HG03168
DR   Wikidata; Q54885195
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03169
AC   CVCL_R074
DR   BioSamples; SAME1839148
DR   Coriell; HG03169
DR   GEO; GSM1719304
DR   IGSR; HG03169
DR   Wikidata; Q54885196
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03170
AC   CVCL_GW53
DR   BioSamples; SAME1840383
DR   Coriell; HG03170
DR   IGSR; HG03170
DR   Wikidata; Q54885197
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03171
AC   CVCL_R075
DR   BioSamples; SAME1840386
DR   Coriell; HG03171
DR   IGSR; HG03171
DR   Wikidata; Q54885198
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03172
AC   CVCL_R076
DR   BioSamples; SAME1840392
DR   Coriell; HG03172
DR   GEO; GSM1719305
DR   IGSR; HG03172
DR   Wikidata; Q54885199
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03173
AC   CVCL_GW54
DR   BioSamples; SAME1840397
DR   Coriell; HG03173
DR   IGSR; HG03173
DR   Wikidata; Q54885200
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03175
AC   CVCL_R077
DR   EFO; EFO_0010873
DR   BioSamples; SAME1840407
DR   Coriell; HG03175
DR   GEO; GSM1719306
DR   IGSR; HG03175
DR   Wikidata; Q54885201
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03176
AC   CVCL_GW55
DR   BioSamples; SAME1840414
DR   Coriell; HG03176
DR   IGSR; HG03176
DR   Wikidata; Q54885202
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03189
AC   CVCL_R078
DR   BioSamples; SAME1840226
DR   Coriell; HG03189
DR   GEO; GSM1719307
DR   IGSR; HG03189
DR   Wikidata; Q54885203
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03190
AC   CVCL_R079
DR   BioSamples; SAME1839984
DR   Coriell; HG03190
DR   GEO; GSM1719308
DR   IGSR; HG03190
DR   Wikidata; Q54885204
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03191
AC   CVCL_GW56
DR   BioSamples; SAME1839988
DR   Coriell; HG03191
DR   IGSR; HG03191
DR   Wikidata; Q54885205
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03193
AC   CVCL_R080
DR   BioSamples; SAME1839909
DR   Coriell; HG03193
DR   GEO; GSM1719309
DR   IGSR; HG03193
DR   Wikidata; Q54885206
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03194
AC   CVCL_GW57
DR   BioSamples; SAME1839914
DR   Coriell; HG03194
DR   IGSR; HG03194
DR   Wikidata; Q54885207
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03195
AC   CVCL_R081
DR   BioSamples; SAME1839919
DR   Coriell; HG03195
DR   GEO; GSM1719310
DR   IGSR; HG03195
DR   Wikidata; Q54885208
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03196
AC   CVCL_R082
DR   EFO; EFO_0010874
DR   BioSamples; SAME1839921
DR   Coriell; HG03196
DR   GEO; GSM1719311
DR   IGSR; HG03196
DR   Wikidata; Q54885209
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03197
AC   CVCL_GW58
DR   BioSamples; SAME1839926
DR   Coriell; HG03197
DR   IGSR; HG03197
DR   Wikidata; Q54885210
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03198
AC   CVCL_R083
DR   BioSamples; SAME1839933
DR   Coriell; HG03198
DR   GEO; GSM1719312
DR   IGSR; HG03198
DR   Wikidata; Q54885215
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03199
AC   CVCL_R084
DR   BioSamples; SAME1839937
DR   Coriell; HG03199
DR   GEO; GSM1719313
DR   IGSR; HG03199
DR   Wikidata; Q54885216
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03200
AC   CVCL_GW59
DR   BioSamples; SAME1839589
DR   Coriell; HG03200
DR   IGSR; HG03200
DR   Wikidata; Q54885217
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03202
AC   CVCL_R085
DR   BioSamples; SAME1839602
DR   Coriell; HG03202
DR   GEO; GSM1719314
DR   IGSR; HG03202
DR   Wikidata; Q54885219
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03203
AC   CVCL_GW60
DR   BioSamples; SAME1839609
DR   Coriell; HG03203
DR   IGSR; HG03203
DR   Wikidata; Q54885220
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03209
AC   CVCL_R086
DR   BioSamples; SAME1839551
DR   Coriell; HG03209
DR   GEO; GSM1719315
DR   IGSR; HG03209
DR   Wikidata; Q54885221
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03212
AC   CVCL_R087
DR   BioSamples; SAME1839399
DR   Coriell; HG03212
DR   GEO; GSM1719316
DR   IGSR; HG03212
DR   Wikidata; Q54885222
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03224
AC   CVCL_R088
DR   BioSamples; SAME1839455
DR   Coriell; HG03224
DR   GEO; GSM1719317
DR   IGSR; HG03224
DR   Wikidata; Q54885223
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03225
AC   CVCL_R089
DR   BioSamples; SAME1839460
DR   Coriell; HG03225
DR   GEO; GSM1719318
DR   IGSR; HG03225
DR   Wikidata; Q54885224
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03228
AC   CVCL_R090
DR   BioSamples; SAME1839232
DR   Coriell; HG03228
DR   GEO; GSM1719319
DR   IGSR; HG03228
DR   Wikidata; Q54885225
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03229
AC   CVCL_R091
DR   BioSamples; SAME1839234
DR   Coriell; HG03229
DR   GEO; GSM1719320
DR   IGSR; HG03229
DR   Wikidata; Q54885226
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03230
AC   CVCL_GW61
DR   BioSamples; SAME1839335
DR   Coriell; HG03230
DR   IGSR; HG03230
DR   Wikidata; Q54885227
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03234
AC   CVCL_R092
DR   BioSamples; SAME1839357
DR   Coriell; HG03234
DR   GEO; GSM1719321
DR   IGSR; HG03234
DR   Wikidata; Q54885228
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03235
AC   CVCL_R093
DR   BioSamples; SAME1839360
DR   Coriell; HG03235
DR   GEO; GSM1719322
DR   IGSR; HG03235
DR   Wikidata; Q54885229
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03236
AC   CVCL_GW62
DR   BioSamples; SAME1839276
DR   Coriell; HG03236
DR   IGSR; HG03236
DR   Wikidata; Q54885230
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03237
AC   CVCL_R094
DR   BioSamples; SAME1839282
DR   Coriell; HG03237
DR   GEO; GSM1719323
DR   IGSR; HG03237
DR   Wikidata; Q54885231
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03238
AC   CVCL_R095
DR   BioSamples; SAME1839289
DR   Coriell; HG03238
DR   GEO; GSM1719324
DR   IGSR; HG03238
DR   Wikidata; Q54885232
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03239
AC   CVCL_GW63
DR   BioSamples; SAME1839295
DR   Coriell; HG03239
DR   IGSR; HG03239
DR   Wikidata; Q54885233
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG03240
AC   CVCL_R096
DR   BioSamples; SAME1839050
DR   Coriell; HG03240
DR   GEO; GSM1719325
DR   IGSR; HG03240
DR   Wikidata; Q54885234
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03241
AC   CVCL_R097
DR   BioSamples; SAME1839053
DR   Coriell; HG03241
DR   GEO; GSM1719326
DR   IGSR; HG03241
DR   Wikidata; Q54885235
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03242
AC   CVCL_GW64
DR   BioSamples; SAME1839058
DR   Coriell; HG03242
DR   IGSR; HG03242
DR   Wikidata; Q54885236
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03246
AC   CVCL_R098
DR   BioSamples; SAME1839168
DR   Coriell; HG03246
DR   GEO; GSM1719327
DR   IGSR; HG03246
DR   Wikidata; Q54885237
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03247
AC   CVCL_R099
DR   BioSamples; SAME1839174
DR   Coriell; HG03247
DR   GEO; GSM1719328
DR   IGSR; HG03247
DR   Wikidata; Q54885238
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03248
AC   CVCL_GW65
DR   BioSamples; SAME1839180
DR   Coriell; HG03248
DR   IGSR; HG03248
DR   Wikidata; Q54885239
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03249
AC   CVCL_R100
DR   BioSamples; SAME1839183
DR   Coriell; HG03249
DR   IGSR; HG03249
DR   Wikidata; Q54885240
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03250
AC   CVCL_R101
DR   BioSamples; SAME1840262
DR   Coriell; HG03250
DR   IGSR; HG03250
DR   Wikidata; Q54885241
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03251
AC   CVCL_GW66
DR   BioSamples; SAME1840266
DR   Coriell; HG03251
DR   IGSR; HG03251
DR   Wikidata; Q54885242
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03258
AC   CVCL_R102
DR   BioSamples; SAME1840296
DR   Coriell; HG03258
DR   GEO; GSM1719329
DR   IGSR; HG03258
DR   Wikidata; Q54885243
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03259
AC   CVCL_R103
DR   BioSamples; SAME1840303
DR   Coriell; HG03259
DR   GEO; GSM1719330
DR   IGSR; HG03259
DR   Wikidata; Q54885244
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03260
AC   CVCL_GW67
DR   BioSamples; SAME1840140
DR   Coriell; HG03260
DR   IGSR; HG03260
DR   Wikidata; Q54885245
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03265
AC   CVCL_R104
DR   BioSamples; SAME1840167
DR   Coriell; HG03265
DR   GEO; GSM1719331
DR   IGSR; HG03265
DR   Wikidata; Q54885246
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03266
AC   CVCL_GW68
DR   BioSamples; SAME1840174
DR   Coriell; HG03266
DR   IGSR; HG03266
DR   Wikidata; Q54885247
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03267
AC   CVCL_R105
DR   BioSamples; SAME1840088
DR   Coriell; HG03267
DR   GEO; GSM1719332
DR   IGSR; HG03267
DR   Wikidata; Q54885248
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03268
AC   CVCL_R106
DR   BioSamples; SAME1840093
DR   Coriell; HG03268
DR   GEO; GSM1719333
DR   IGSR; HG03268
DR   Wikidata; Q54885249
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03269
AC   CVCL_GW69
DR   BioSamples; SAME1840100
DR   Coriell; HG03269
DR   IGSR; HG03269
DR   Wikidata; Q54885250
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03270
AC   CVCL_R107
DR   BioSamples; SAME1840194
DR   Coriell; HG03270
DR   GEO; GSM1719334
DR   IGSR; HG03270
DR   Wikidata; Q54885251
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03271
AC   CVCL_R108
DR   BioSamples; SAME1840195
DR   Coriell; HG03271
DR   GEO; GSM1719335
DR   IGSR; HG03271
DR   Wikidata; Q54885252
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03272
AC   CVCL_GW70
DR   BioSamples; SAME1840199
DR   Coriell; HG03272
DR   IGSR; HG03272
DR   Wikidata; Q54885253
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03279
AC   CVCL_R109
DR   BioSamples; SAME1839972
DR   Coriell; HG03279
DR   GEO; GSM1719336
DR   IGSR; HG03279
DR   Wikidata; Q54885254
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03280
AC   CVCL_R110
DR   EFO; EFO_0010875
DR   BioSamples; SAME1840083
DR   Coriell; HG03280
DR   GEO; GSM1719337
DR   IGSR; HG03280
DR   Wikidata; Q54885255
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03291
AC   CVCL_R111
DR   BioSamples; SAME1839861
DR   Coriell; HG03291
DR   GEO; GSM1719338
DR   IGSR; HG03291
DR   Wikidata; Q54885264
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03293
AC   CVCL_GW71
DR   BioSamples; SAME1839871
DR   Coriell; HG03293
DR   IGSR; HG03293
DR   Wikidata; Q54885265
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03294
AC   CVCL_R112
DR   BioSamples; SAME1839877
DR   Coriell; HG03294
DR   GEO; GSM1719339
DR   IGSR; HG03294
DR   Wikidata; Q54885266
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03295
AC   CVCL_R113
DR   BioSamples; SAME1839881
DR   Coriell; HG03295
DR   GEO; GSM1719340
DR   IGSR; HG03295
DR   Wikidata; Q54885267
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03296
AC   CVCL_GW72
DR   BioSamples; SAME1839887
DR   Coriell; HG03296
DR   IGSR; HG03296
DR   Wikidata; Q54885268
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03297
AC   CVCL_R114
DR   BioSamples; SAME1839900
DR   Coriell; HG03297
DR   GEO; GSM1719341
DR   IGSR; HG03297
DR   Wikidata; Q54885269
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03298
AC   CVCL_R115
DR   BioSamples; SAME1839903
DR   Coriell; HG03298
DR   GEO; GSM1719342
DR   IGSR; HG03298
DR   Wikidata; Q54885270
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03299
AC   CVCL_GW73
DR   BioSamples; SAME1839805
DR   Coriell; HG03299
DR   IGSR; HG03299
DR   Wikidata; Q54885271
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03300
AC   CVCL_R116
DR   BioSamples; SAME1839467
DR   Coriell; HG03300
DR   GEO; GSM1719343
DR   IGSR; HG03300
DR   Wikidata; Q54885272
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03301
AC   CVCL_R117
DR   BioSamples; SAME1839472
DR   Coriell; HG03301
DR   GEO; GSM1719344
DR   IGSR; HG03301
DR   Wikidata; Q54885273
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03302
AC   CVCL_GW74
DR   BioSamples; SAME1839479
DR   Coriell; HG03302
DR   IGSR; HG03302
DR   Wikidata; Q54885274
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03303
AC   CVCL_R118
DR   BioSamples; SAME1839485
DR   Coriell; HG03303
DR   GEO; GSM1719345
DR   IGSR; HG03303
DR   Wikidata; Q54885275
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03304
AC   CVCL_R119
DR   BioSamples; SAME1839490
DR   Coriell; HG03304
DR   GEO; GSM1719346
DR   IGSR; HG03304
DR   Wikidata; Q54885276
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03305
AC   CVCL_GW75
DR   BioSamples; SAME1839497
DR   Coriell; HG03305
DR   IGSR; HG03305
DR   Wikidata; Q54885277
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03306
AC   CVCL_R120
DR   BioSamples; SAME1839504
DR   Coriell; HG03306
DR   IGSR; HG03306
DR   Wikidata; Q54885278
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03307
AC   CVCL_R121
DR   BioSamples; SAME1839509
DR   Coriell; HG03307
DR   IGSR; HG03307
DR   Wikidata; Q54885279
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03308
AC   CVCL_GW76
DR   BioSamples; SAME1839515
DR   Coriell; HG03308
DR   IGSR; HG03308
DR   Wikidata; Q54885281
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03309
AC   CVCL_R122
DR   BioSamples; SAME1839520
DR   Coriell; HG03309
DR   IGSR; HG03309
DR   Wikidata; Q54885282
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03310
AC   CVCL_GW77
DR   BioSamples; SAME1839202
DR   Coriell; HG03310
DR   IGSR; HG03310
DR   Wikidata; Q54885283
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03311
AC   CVCL_R123
DR   BioSamples; SAME1839206
DR   Coriell; HG03311
DR   GEO; GSM1719347
DR   IGSR; HG03311
DR   Wikidata; Q54885284
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03312
AC   CVCL_R124
DR   BioSamples; SAME1839209
DR   Coriell; HG03312
DR   IGSR; HG03312
DR   Wikidata; Q54885285
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03313
AC   CVCL_R125
DR   BioSamples; SAME1839213
DR   Coriell; HG03313
DR   GEO; GSM1719348
DR   IGSR; HG03313
DR   Wikidata; Q54885286
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03314
AC   CVCL_GW78
DR   BioSamples; SAME1839217
DR   Coriell; HG03314
DR   IGSR; HG03314
DR   Wikidata; Q54885287
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03339
AC   CVCL_R126
DR   BioSamples; SAME1840332
DR   Coriell; HG03339
DR   IGSR; HG03339
DR   Wikidata; Q54885289
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03341
AC   CVCL_GW79
DR   BioSamples; SAME1840347
DR   Coriell; HG03341
DR   IGSR; HG03341
DR   Wikidata; Q54885290
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03342
AC   CVCL_R127
DR   EFO; EFO_0010876
DR   BioSamples; SAME1840350
DR   Coriell; HG03342
DR   GEO; GSM1719349
DR   IGSR; HG03342
DR   Wikidata; Q54885291
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03343
AC   CVCL_R128
DR   BioSamples; SAME1840354
DR   Coriell; HG03343
DR   GEO; GSM1719350
DR   IGSR; HG03343
DR   Wikidata; Q54885292
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03344
AC   CVCL_GW80
DR   BioSamples; SAME1840364
DR   Coriell; HG03344
DR   IGSR; HG03344
DR   Wikidata; Q54885293
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03350
AC   CVCL_GW81
DR   BioSamples; SAME1840225
DR   Coriell; HG03350
DR   IGSR; HG03350
DR   Wikidata; Q54885294
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03351
AC   CVCL_R129
DR   BioSamples; SAME1840231
DR   Coriell; HG03351
DR   GEO; GSM1719351
DR   IGSR; HG03351
DR   Wikidata; Q54885295
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03352
AC   CVCL_R130
DR   BioSamples; SAME1840243
DR   Coriell; HG03352
DR   GEO; GSM1719352
DR   IGSR; HG03352
DR   Wikidata; Q54885296
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03354
AC   CVCL_R131
DR   EFO; EFO_0010877
DR   BioSamples; SAME1840249
DR   Coriell; HG03354
DR   GEO; GSM1719353
DR   IGSR; HG03354
DR   Wikidata; Q54885297
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03361
AC   CVCL_R132
DR   BioSamples; SAME1839942
DR   Coriell; HG03361
DR   IGSR; HG03361
DR   Wikidata; Q54885298
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03362
AC   CVCL_GW82
DR   BioSamples; SAME1839949
DR   Coriell; HG03362
DR   IGSR; HG03362
DR   Wikidata; Q54885299
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03363
AC   CVCL_R133
DR   BioSamples; SAME1839957
DR   Coriell; HG03363
DR   GEO; GSM1719354
DR   IGSR; HG03363
DR   Wikidata; Q54885300
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03365
AC   CVCL_GW83
DR   BioSamples; SAME1840058
DR   Coriell; HG03365
DR   IGSR; HG03365
DR   Wikidata; Q54885301
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03366
AC   CVCL_R134
DR   BioSamples; SAME1840066
DR   Coriell; HG03366
DR   GEO; GSM1719355
DR   IGSR; HG03366
DR   Wikidata; Q54885302
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03367
AC   CVCL_R135
DR   BioSamples; SAME1840068
DR   Coriell; HG03367
DR   GEO; GSM1719356
DR   IGSR; HG03367
DR   Wikidata; Q54885303
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03368
AC   CVCL_GW84
DR   BioSamples; SAME1840074
DR   Coriell; HG03368
DR   IGSR; HG03368
DR   Wikidata; Q54885304
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03369
AC   CVCL_R136
DR   BioSamples; SAME1840078
DR   Coriell; HG03369
DR   GEO; GSM1719357
DR   IGSR; HG03369
DR   Wikidata; Q54885305
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03370
AC   CVCL_R137
DR   BioSamples; SAME1839800
DR   Coriell; HG03370
DR   GEO; GSM1719358
DR   IGSR; HG03370
DR   Wikidata; Q54885309
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03371
AC   CVCL_GW85
DR   BioSamples; SAME1839712
DR   Coriell; HG03371
DR   IGSR; HG03371
DR   Wikidata; Q54885310
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03372
AC   CVCL_R138
DR   BioSamples; SAME1839716
DR   Coriell; HG03372
DR   GEO; GSM1719359
DR   IGSR; HG03372
DR   Wikidata; Q54885311
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03373
AC   CVCL_R139
DR   BioSamples; SAME1839720
DR   Coriell; HG03373
DR   IGSR; HG03373
DR   Wikidata; Q54885312
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03374
AC   CVCL_GW86
DR   BioSamples; SAME1839730
DR   Coriell; HG03374
DR   IGSR; HG03374
DR   Wikidata; Q54885313
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03376
AC   CVCL_R140
DR   BioSamples; SAME1839736
DR   Coriell; HG03376
DR   GEO; GSM1719360
DR   IGSR; HG03376
DR   Wikidata; Q54885314
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03378
AC   CVCL_R141
DR   EFO; EFO_0010878
DR   BioSamples; SAME1839743
DR   Coriell; HG03378
DR   GEO; GSM1719361
DR   IGSR; HG03378
DR   Wikidata; Q54885315
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03380
AC   CVCL_R142
DR   BioSamples; SAME1839569
DR   Coriell; HG03380
DR   GEO; GSM1719362
DR   IGSR; HG03380
DR   Wikidata; Q54885316
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03381
AC   CVCL_GW87
DR   BioSamples; SAME1839574
DR   Coriell; HG03381
DR   IGSR; HG03381
DR   Wikidata; Q54885317
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03382
AC   CVCL_R143
DR   BioSamples; SAME1839580
DR   Coriell; HG03382
DR   GEO; GSM1719363
DR   IGSR; HG03382
DR   Wikidata; Q54885318
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03383
AC   CVCL_R144
DR   BioSamples; SAME1839583
DR   Coriell; HG03383
DR   IGSR; HG03383
DR   Wikidata; Q54885319
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03384
AC   CVCL_GW88
DR   BioSamples; SAME1839587
DR   Coriell; HG03384
DR   IGSR; HG03384
DR   Wikidata; Q54885320
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03385
AC   CVCL_R145
DR   BioSamples; SAME1839594
DR   Coriell; HG03385
DR   GEO; GSM1719364
DR   IGSR; HG03385
DR   Wikidata; Q54885321
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03388
AC   CVCL_R146
DR   BioSamples; SAME1839524
DR   Coriell; HG03388
DR   GEO; GSM1719365
DR   IGSR; HG03388
DR   Wikidata; Q54885322
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03390
AC   CVCL_GW89
DR   BioSamples; SAME1839632
DR   Coriell; HG03390
DR   IGSR; HG03390
DR   Wikidata; Q54885323
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03391
AC   CVCL_R147
DR   BioSamples; SAME1839636
DR   Coriell; HG03391
DR   GEO; GSM1719366
DR   IGSR; HG03391
DR   Wikidata; Q54885324
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03393
AC   CVCL_R148
DR   BioSamples; SAME1839645
DR   Coriell; HG03393
DR   IGSR; HG03393
DR   Wikidata; Q54885325
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03394
AC   CVCL_R149
DR   BioSamples; SAME1839648
DR   Coriell; HG03394
DR   GEO; GSM1719367
DR   IGSR; HG03394
DR   Wikidata; Q54885326
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03397
AC   CVCL_R150
DR   BioSamples; SAME1839400
DR   Coriell; HG03397
DR   GEO; GSM1719368
DR   IGSR; HG03397
DR   Wikidata; Q54885327
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03398
AC   CVCL_R151
DR   BioSamples; SAME1839402
DR   Coriell; HG03398
DR   IGSR; HG03398
DR   Wikidata; Q54885328
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03399
AC   CVCL_GW90
DR   BioSamples; SAME1839410
DR   Coriell; HG03399
DR   IGSR; HG03399
DR   Wikidata; Q54885329
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03401
AC   CVCL_R152
DR   BioSamples; SAME1839299
DR   Coriell; HG03401
DR   GEO; GSM1719369
DR   IGSR; HG03401
DR   Wikidata; Q54885330
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03402
AC   CVCL_GW91
DR   BioSamples; SAME1839301
DR   Coriell; HG03402
DR   IGSR; HG03402
DR   Wikidata; Q54885331
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03408
AC   CVCL_R153
DR   BioSamples; SAME1839071
DR   Coriell; HG03408
DR   IGSR; HG03408
DR   Wikidata; Q54885332
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03410
AC   CVCL_R154
DR   BioSamples; SAME1839182
DR   Coriell; HG03410
DR   GEO; GSM1719370
DR   IGSR; HG03410
DR   Wikidata; Q54885333
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03411
AC   CVCL_GW92
DR   BioSamples; SAME1839186
DR   Coriell; HG03411
DR   IGSR; HG03411
DR   Wikidata; Q54885334
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03419
AC   CVCL_R155
DR   BioSamples; SAME1839130
DR   Coriell; HG03419
DR   GEO; GSM1719371
DR   IGSR; HG03419
DR   Wikidata; Q54885335
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03428
AC   CVCL_R156
DR   BioSamples; SAME1840409
DR   Coriell; HG03428
DR   GEO; GSM1719372
DR   IGSR; HG03428
DR   Wikidata; Q54885336
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03431
AC   CVCL_R157
DR   BioSamples; SAME1840101
DR   Coriell; HG03431
DR   IGSR; HG03431
DR   Wikidata; Q54885337
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03432
AC   CVCL_R158
DR   EFO; EFO_0010879
DR   BioSamples; SAME1840107
DR   Coriell; HG03432
DR   GEO; GSM1719373
DR   IGSR; HG03432
DR   Wikidata; Q54885338
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03433
AC   CVCL_R159
DR   BioSamples; SAME1840110
DR   Coriell; HG03433
DR   GEO; GSM1719374
DR   IGSR; HG03433
DR   Wikidata; Q54885339
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03436
AC   CVCL_R160
DR   BioSamples; SAME1840120
DR   Coriell; HG03436
DR   GEO; GSM1719375
DR   IGSR; HG03436
DR   Wikidata; Q54885340
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03437
AC   CVCL_R161
DR   BioSamples; SAME1840123
DR   Coriell; HG03437
DR   GEO; GSM1719376
DR   IGSR; HG03437
DR   Wikidata; Q54885341
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03438
AC   CVCL_GW93
DR   BioSamples; SAME1840208
DR   Coriell; HG03438
DR   IGSR; HG03438
DR   Wikidata; Q54885342
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03439
AC   CVCL_R162
DR   EFO; EFO_0010880
DR   BioSamples; SAME1840213
DR   Coriell; HG03439
DR   GEO; GSM1719377
DR   IGSR; HG03439
DR   Wikidata; Q54885343
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03442
AC   CVCL_R163
DR   EFO; EFO_0010881
DR   BioSamples; SAME1839979
DR   Coriell; HG03442
DR   GEO; GSM1719378
DR   IGSR; HG03442
DR   Wikidata; Q54885344
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03445
AC   CVCL_R164
DR   BioSamples; SAME1839996
DR   Coriell; HG03445
DR   GEO; GSM1719379
DR   IGSR; HG03445
DR   Wikidata; Q54885345
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03446
AC   CVCL_R165
DR   BioSamples; SAME1839911
DR   Coriell; HG03446
DR   GEO; GSM1719380
DR   IGSR; HG03446
DR   Wikidata; Q54885346
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03449
AC   CVCL_R166
DR   BioSamples; SAME1839923
DR   Coriell; HG03449
DR   GEO; GSM1719381
DR   IGSR; HG03449
DR   Wikidata; Q54885347
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03450
AC   CVCL_GW94
DR   BioSamples; SAME1840030
DR   Coriell; HG03450
DR   IGSR; HG03450
DR   Wikidata; Q54885348
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03451
AC   CVCL_R167
DR   BioSamples; SAME1840043
DR   Coriell; HG03451
DR   GEO; GSM1719382
DR   IGSR; HG03451
DR   Wikidata; Q54885352
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03452
AC   CVCL_R168
DR   BioSamples; SAME1840046
DR   Coriell; HG03452
DR   GEO; GSM1719383
DR   IGSR; HG03452
DR   Wikidata; Q54885353
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03453
AC   CVCL_GW95
DR   BioSamples; SAME1839750
DR   Coriell; HG03453
DR   IGSR; HG03453
DR   Wikidata; Q54885354
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03454
AC   CVCL_R169
DR   BioSamples; SAME1839764
DR   Coriell; HG03454
DR   IGSR; HG03454
DR   Wikidata; Q54885355
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03455
AC   CVCL_R170
DR   BioSamples; SAME1839766
DR   Coriell; HG03455
DR   GEO; GSM1719384
DR   IGSR; HG03455
DR   Wikidata; Q54885356
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03456
AC   CVCL_GW96
DR   BioSamples; SAME1839778
DR   Coriell; HG03456
DR   IGSR; HG03456
DR   Wikidata; Q54885357
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03457
AC   CVCL_R171
DR   EFO; EFO_0010882
DR   BioSamples; SAME1839781
DR   Coriell; HG03457
DR   GEO; GSM1719385
DR   IGSR; HG03457
DR   Wikidata; Q54885358
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03458
AC   CVCL_R172
DR   BioSamples; SAME1839786
DR   Coriell; HG03458
DR   GEO; GSM1719386
DR   IGSR; HG03458
DR   Wikidata; Q54885359
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03459
AC   CVCL_GW97
DR   BioSamples; SAME1839793
DR   Coriell; HG03459
DR   IGSR; HG03459
DR   Wikidata; Q54885360
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03460
AC   CVCL_R173
DR   EFO; EFO_0010883
DR   BioSamples; SAME1839908
DR   Coriell; HG03460
DR   GEO; GSM1719387
DR   IGSR; HG03460
DR   Wikidata; Q54885361
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03461
AC   CVCL_R174
DR   BioSamples; SAME1839808
DR   Coriell; HG03461
DR   GEO; GSM1719388
DR   IGSR; HG03461
DR   Wikidata; Q54885362
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03462
AC   CVCL_R175
DR   BioSamples; SAME1839817
DR   Coriell; HG03462
DR   IGSR; HG03462
DR   Wikidata; Q54885363
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03464
AC   CVCL_R176
DR   BioSamples; SAME1839827
DR   Coriell; HG03464
DR   GEO; GSM1719389
DR   IGSR; HG03464
DR   Wikidata; Q54885364
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03465
AC   CVCL_GW98
DR   BioSamples; SAME1839836
DR   Coriell; HG03465
DR   IGSR; HG03465
DR   Wikidata; Q54885365
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03466
AC   CVCL_GW99
DR   BioSamples; SAME1839839
DR   Coriell; HG03466
DR   IGSR; HG03466
DR   Wikidata; Q54885366
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03468
AC   CVCL_GX00
DR   BioSamples; SAME1839848
DR   Coriell; HG03468
DR   IGSR; HG03468
DR   Wikidata; Q54885367
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03469
AC   CVCL_R177
DR   EFO; EFO_0010884
DR   BioSamples; SAME1839850
DR   Coriell; HG03469
DR   GEO; GSM1719390
DR   IGSR; HG03469
DR   Wikidata; Q54885368
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03470
AC   CVCL_R178
DR   BioSamples; SAME1839670
DR   Coriell; HG03470
DR   GEO; GSM1719391
DR   IGSR; HG03470
DR   Wikidata; Q54885369
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03471
AC   CVCL_GX01
DR   BioSamples; SAME1839677
DR   Coriell; HG03471
DR   IGSR; HG03471
DR   Wikidata; Q54885370
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03472
AC   CVCL_R179
DR   BioSamples; SAME1839678
DR   Coriell; HG03472
DR   GEO; GSM1719392
DR   IGSR; HG03472
DR   Wikidata; Q54885371
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03473
AC   CVCL_R180
DR   BioSamples; SAME1839687
DR   Coriell; HG03473
DR   GEO; GSM1719393
DR   IGSR; HG03473
DR   Wikidata; Q54885372
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03474
AC   CVCL_GX02
DR   BioSamples; SAME1839693
DR   Coriell; HG03474
DR   IGSR; HG03474
DR   Wikidata; Q54885373
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03476
AC   CVCL_R181
DR   BioSamples; SAME1839702
DR   Coriell; HG03476
DR   GEO; GSM1719394
DR   IGSR; HG03476
DR   Wikidata; Q54885374
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03477
AC   CVCL_GX03
DR   BioSamples; SAME1839706
DR   Coriell; HG03477
DR   IGSR; HG03477
DR   Wikidata; Q54885375
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03478
AC   CVCL_R182
DR   BioSamples; SAME1839618
DR   Coriell; HG03478
DR   GEO; GSM1719395
DR   IGSR; HG03478
DR   Wikidata; Q54885376
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03479
AC   CVCL_R183
DR   BioSamples; SAME1839623
DR   Coriell; HG03479
DR   GEO; GSM1719396
DR   IGSR; HG03479
DR   Wikidata; Q54885377
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03480
AC   CVCL_GX04
DR   BioSamples; SAME1839381
DR   Coriell; HG03480
DR   IGSR; HG03480
DR   Wikidata; Q54885378
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03484
AC   CVCL_R184
DR   BioSamples; SAME1839393
DR   Coriell; HG03484
DR   GEO; GSM1719397
DR   IGSR; HG03484
DR   Wikidata; Q54885379
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03485
AC   CVCL_R185
DR   BioSamples; SAME1839469
DR   Coriell; HG03485
DR   GEO; GSM1719398
DR   IGSR; HG03485
DR   Wikidata; Q54885380
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03486
AC   CVCL_GX05
DR   BioSamples; SAME1839474
DR   Coriell; HG03486
DR   IGSR; HG03486
DR   Wikidata; Q54885381
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG03487
AC   CVCL_R186
DR   BioSamples; SAME1839480
DR   Coriell; HG03487
DR   IGSR; HG03487
DR   Wikidata; Q54885382
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03488
AC   CVCL_R187
DR   BioSamples; SAME1839486
DR   Coriell; HG03488
DR   GEO; GSM1719399
DR   IGSR; HG03488
DR   Wikidata; Q54885383
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03489
AC   CVCL_GX06
DR   BioSamples; SAME1839494
DR   Coriell; HG03489
DR   IGSR; HG03489
DR   Wikidata; Q54885384
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03490
AC   CVCL_R188
DR   BioSamples; SAME1839259
DR   Coriell; HG03490
DR   GEO; GSM1719400
DR   IGSR; HG03490
DR   Wikidata; Q54885385
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03491
AC   CVCL_R189
DR   BioSamples; SAME1839264
DR   Coriell; HG03491
DR   GEO; GSM1719401
DR   IGSR; HG03491
DR   Wikidata; Q54885386
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03492
AC   CVCL_GX07
DR   BioSamples; SAME1839196
DR   Coriell; HG03492
DR   IGSR; HG03492
DR   Wikidata; Q54885387
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG03493
AC   CVCL_R190
DR   BioSamples; SAME1839198
DR   Coriell; HG03493
DR   IGSR; HG03493
DR   Wikidata; Q54885388
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03499
AC   CVCL_R191
DR   BioSamples; SAME1839219
DR   Coriell; HG03499
DR   GEO; GSM1719402
DR   IGSR; HG03499
DR   Wikidata; Q54885389
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03508
AC   CVCL_R192
DR   BioSamples; SAME1840286
DR   Coriell; HG03508
DR   IGSR; HG03508
DR   Wikidata; Q54885390
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03510
AC   CVCL_GX08
DR   BioSamples; SAME1840377
DR   Coriell; HG03510
DR   IGSR; HG03510
DR   Wikidata; Q54885391
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03511
AC   CVCL_R193
DR   BioSamples; SAME1840131
DR   Coriell; HG03511
DR   GEO; GSM1719403
DR   IGSR; HG03511
DR   Wikidata; Q54885395
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03513
AC   CVCL_GX09
DR   BioSamples; SAME1840143
DR   Coriell; HG03513
DR   IGSR; HG03513
DR   Wikidata; Q54885396
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03514
AC   CVCL_R194
DR   BioSamples; SAME1840150
DR   Coriell; HG03514
DR   GEO; GSM1719404
DR   IGSR; HG03514
DR   Wikidata; Q54885397
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03515
AC   CVCL_R195
DR   BioSamples; SAME1840154
DR   Coriell; HG03515
DR   GEO; GSM1719405
DR   IGSR; HG03515
DR   Wikidata; Q54885398
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03516
AC   CVCL_GX10
DR   BioSamples; SAME1840160
DR   Coriell; HG03516
DR   IGSR; HG03516
DR   Wikidata; Q54885399
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03517
AC   CVCL_R196
DR   BioSamples; SAME1840163
DR   Coriell; HG03517
DR   GEO; GSM1719406
DR   IGSR; HG03517
DR   Wikidata; Q54885400
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03518
AC   CVCL_R197
DR   BioSamples; SAME1840169
DR   Coriell; HG03518
DR   GEO; GSM1719407
DR   IGSR; HG03518
DR   Wikidata; Q54885401
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03519
AC   CVCL_GX11
DR   BioSamples; SAME1840176
DR   Coriell; HG03519
DR   IGSR; HG03519
DR   Wikidata; Q54885402
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03520
AC   CVCL_R198
DR   EFO; EFO_0010885
DR   BioSamples; SAME1840186
DR   Coriell; HG03520
DR   GEO; GSM1719408
DR   IGSR; HG03520
DR   Wikidata; Q54885403
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03521
AC   CVCL_R199
DR   EFO; EFO_0010886
DR   BioSamples; SAME1840190
DR   Coriell; HG03521
DR   GEO; GSM1719409
DR   IGSR; HG03521
DR   Wikidata; Q54885404
RX   PubMed=35931342;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG03522
AC   CVCL_GX12
DR   BioSamples; SAME1840193
DR   Coriell; HG03522
DR   IGSR; HG03522
DR   Wikidata; Q54885405
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Esan from Nigeria (ESN).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03538
AC   CVCL_R200
DR   BioSamples; SAME1840007
DR   Coriell; HG03538
DR   GEO; GSM1719410
DR   IGSR; HG03538
DR   Wikidata; Q54885406
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03539
AC   CVCL_R201
DR   BioSamples; SAME1840014
DR   Coriell; HG03539
DR   GEO; GSM1719411
DR   IGSR; HG03539
DR   Wikidata; Q54885407
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03540
AC   CVCL_GX13
DR   BioSamples; SAME1839745
DR   Coriell; HG03540
DR   IGSR; HG03540
DR   Wikidata; Q54885408
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Gambian in Western Division - Mandinka (GWD).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03547
AC   CVCL_R202
DR   BioSamples; SAME1839878
DR   Coriell; HG03547
DR   GEO; GSM1719412
DR   IGSR; HG03547
DR   Wikidata; Q54885409
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03548
AC   CVCL_R203
DR   BioSamples; SAME1839883
DR   Coriell; HG03548
DR   GEO; GSM1719413
DR   IGSR; HG03548
DR   Wikidata; Q54885410
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03549
AC   CVCL_R204
DR   BioSamples; SAME1839890
DR   Coriell; HG03549
DR   IGSR; HG03549
DR   Wikidata; Q54885411
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03556
AC   CVCL_R205
DR   BioSamples; SAME1839553
DR   Coriell; HG03556
DR   GEO; GSM1719414
DR   IGSR; HG03556
DR   Wikidata; Q54885412
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03557
AC   CVCL_R206
DR   BioSamples; SAME1839556
DR   Coriell; HG03557
DR   GEO; GSM1719415
DR   IGSR; HG03557
DR   Wikidata; Q54885413
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03558
AC   CVCL_R207
DR   EFO; EFO_0010887
DR   BioSamples; SAME1839561
DR   Coriell; HG03558
DR   GEO; GSM1719416
DR   IGSR; HG03558
DR   Wikidata; Q54885414
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03559
AC   CVCL_R208
DR   BioSamples; SAME1839654
DR   Coriell; HG03559
DR   GEO; GSM1719417
DR   IGSR; HG03559
DR   Wikidata; Q54885415
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03563
AC   CVCL_R209
DR   BioSamples; SAME1839421
DR   Coriell; HG03563
DR   GEO; GSM1719418
DR   IGSR; HG03563
DR   Wikidata; Q54885416
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03564
AC   CVCL_GX14
DR   BioSamples; SAME1839427
DR   Coriell; HG03564
DR   IGSR; HG03564
DR   Wikidata; Q54885417
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03565
AC   CVCL_R210
DR   EFO; EFO_0010888
DR   BioSamples; SAME1839430
DR   Coriell; HG03565
DR   GEO; GSM1719419
DR   IGSR; HG03565
DR   Wikidata; Q54885418
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03566
AC   CVCL_R211
DR   BioSamples; SAME1839433
DR   Coriell; HG03566
DR   IGSR; HG03566
DR   Wikidata; Q54885419
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03567
AC   CVCL_R212
DR   BioSamples; SAME1839364
DR   Coriell; HG03567
DR   GEO; GSM1719420
DR   IGSR; HG03567
DR   Wikidata; Q54885420
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03569
AC   CVCL_R213
DR   BioSamples; SAME1839371
DR   Coriell; HG03569
DR   IGSR; HG03569
DR   Wikidata; Q54885421
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03571
AC   CVCL_R214
DR   EFO; EFO_0010889
DR   BioSamples; SAME1839458
DR   Coriell; HG03571
DR   GEO; GSM1719421
DR   IGSR; HG03571
DR   Wikidata; Q54885422
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03572
AC   CVCL_R215
DR   BioSamples; SAME1839463
DR   Coriell; HG03572
DR   GEO; GSM1719422
DR   IGSR; HG03572
DR   Wikidata; Q54885423
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03574
AC   CVCL_R216
DR   BioSamples; SAME1839229
DR   Coriell; HG03574
DR   IGSR; HG03574
DR   Wikidata; Q54885424
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03575
AC   CVCL_R217
DR   EFO; EFO_0010890
DR   BioSamples; SAME1839236
DR   Coriell; HG03575
DR   GEO; GSM1719423
DR   IGSR; HG03575
DR   Wikidata; Q54885425
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03576
AC   CVCL_GX15
DR   BioSamples; SAME1839238
DR   Coriell; HG03576
DR   IGSR; HG03576
DR   Wikidata; Q54885426
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03577
AC   CVCL_R218
DR   BioSamples; SAME1839242
DR   Coriell; HG03577
DR   GEO; GSM1719424
DR   IGSR; HG03577
DR   Wikidata; Q54885427
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03578
AC   CVCL_R219
DR   BioSamples; SAME1839245
DR   Coriell; HG03578
DR   GEO; GSM1719425
DR   IGSR; HG03578
DR   Wikidata; Q54885428
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03579
AC   CVCL_GX16
DR   BioSamples; SAME1839247
DR   Coriell; HG03579
DR   IGSR; HG03579
DR   Wikidata; Q54885429
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03582
AC   CVCL_R220
DR   BioSamples; SAME1839271
DR   Coriell; HG03582
DR   IGSR; HG03582
DR   Wikidata; Q54885430
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03583
AC   CVCL_R221
DR   BioSamples; SAME1839283
DR   Coriell; HG03583
DR   GEO; GSM1719426
DR   IGSR; HG03583
DR   Wikidata; Q54885431
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03584
AC   CVCL_GX17
DR   BioSamples; SAME1839290
DR   Coriell; HG03584
DR   IGSR; HG03584
DR   Wikidata; Q54885432
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: African; Mende in Sierra Leone (MSL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   HG03585
AC   CVCL_R222
DR   BioSamples; SAME1839293
DR   Coriell; HG03585
DR   GEO; GSM1719427
DR   IGSR; HG03585
DR   Wikidata; Q54885433
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03587
AC   CVCL_GX18
DR   BioSamples; SAME1839302
DR   Coriell; HG03587
DR   IGSR; HG03587
DR   Wikidata; Q54885434
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03589
AC   CVCL_R223
DR   BioSamples; SAME1839311
DR   Coriell; HG03589
DR   GEO; GSM1719428
DR   IGSR; HG03589
DR   Wikidata; Q54885437
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03590
AC   CVCL_GX19
DR   BioSamples; SAME1839163
DR   Coriell; HG03590
DR   IGSR; HG03590
DR   Wikidata; Q54885438
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03593
AC   CVCL_R224
DR   BioSamples; SAME1839171
DR   Coriell; HG03593
DR   GEO; GSM1719429
DR   IGSR; HG03593
DR   Wikidata; Q54885439
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03594
AC   CVCL_R225
DR   BioSamples; SAME1839181
DR   Coriell; HG03594
DR   GEO; GSM1719430
DR   IGSR; HG03594
DR   Wikidata; Q54885440
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03595
AC   CVCL_R226
DR   BioSamples; SAME1839185
DR   Coriell; HG03595
DR   GEO; GSM1719431
DR   IGSR; HG03595
DR   Wikidata; Q54885441
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03596
AC   CVCL_GX20
DR   BioSamples; SAME1839188
DR   Coriell; HG03596
DR   IGSR; HG03596
DR   Wikidata; Q54885442
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03598
AC   CVCL_R227
DR   BioSamples; SAME1839194
DR   Coriell; HG03598
DR   GEO; GSM1719432
DR   IGSR; HG03598
DR   Wikidata; Q54885443
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03599
AC   CVCL_GX21
DR   BioSamples; SAME1839111
DR   Coriell; HG03599
DR   IGSR; HG03599
DR   Wikidata; Q54885444
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03600
AC   CVCL_R228
DR   BioSamples; SAME1840215
DR   Coriell; HG03600
DR   GEO; GSM1719433
DR   IGSR; HG03600
DR   Wikidata; Q54885445
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03602
AC   CVCL_GX22
DR   BioSamples; SAME1840220
DR   Coriell; HG03602
DR   IGSR; HG03602
DR   Wikidata; Q54885446
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03603
AC   CVCL_R229
DR   BioSamples; SAME1840229
DR   Coriell; HG03603
DR   GEO; GSM1719434
DR   IGSR; HG03603
DR   Wikidata; Q54885447
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03604
AC   CVCL_R230
DR   BioSamples; SAME1840236
DR   Coriell; HG03604
DR   GEO; GSM1719435
DR   IGSR; HG03604
DR   Wikidata; Q54885448
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03605
AC   CVCL_GX23
DR   BioSamples; SAME1840240
DR   Coriell; HG03605
DR   IGSR; HG03605
DR   Wikidata; Q54885449
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03606
AC   CVCL_R231
DR   BioSamples; SAME1840248
DR   Coriell; HG03606
DR   IGSR; HG03606
DR   Wikidata; Q54885450
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03607
AC   CVCL_R232
DR   BioSamples; SAME1840254
DR   Coriell; HG03607
DR   GEO; GSM1719436
DR   IGSR; HG03607
DR   Wikidata; Q54885451
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03611
AC   CVCL_R233
DR   BioSamples; SAME1839929
DR   Coriell; HG03611
DR   GEO; GSM1719437
DR   IGSR; HG03611
DR   Wikidata; Q54885452
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03615
AC   CVCL_R234
DR   BioSamples; SAME1839951
DR   Coriell; HG03615
DR   GEO; GSM1719438
DR   IGSR; HG03615
DR   Wikidata; Q54885453
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03616
AC   CVCL_R235
DR   BioSamples; SAME1839955
DR   Coriell; HG03616
DR   GEO; GSM1719439
DR   IGSR; HG03616
DR   Wikidata; Q54885454
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03617
AC   CVCL_GX24
DR   BioSamples; SAME1840056
DR   Coriell; HG03617
DR   IGSR; HG03617
DR   Wikidata; Q54885455
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03618
AC   CVCL_R236
DR   BioSamples; SAME1840062
DR   Coriell; HG03618
DR   IGSR; HG03618
DR   Wikidata; Q54885456
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03619
AC   CVCL_R237
DR   BioSamples; SAME1840064
DR   Coriell; HG03619
DR   GEO; GSM1719440
DR   IGSR; HG03619
DR   Wikidata; Q54885457
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03620
AC   CVCL_GX25
DR   BioSamples; SAME1839790
DR   Coriell; HG03620
DR   IGSR; HG03620
DR   Wikidata; Q54885458
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03621
AC   CVCL_R238
DR   BioSamples; SAME1839794
DR   Coriell; HG03621
DR   IGSR; HG03621
DR   Wikidata; Q54885459
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03624
AC   CVCL_R239
DR   BioSamples; SAME1839709
DR   Coriell; HG03624
DR   GEO; GSM1719441
DR   IGSR; HG03624
DR   Wikidata; Q54885460
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03625
AC   CVCL_R240
DR   BioSamples; SAME1839719
DR   Coriell; HG03625
DR   GEO; GSM1719442
DR   IGSR; HG03625
DR   Wikidata; Q54885461
RX   PubMed=33197628;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=33197628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   HG03626
AC   CVCL_GX26
DR   BioSamples; SAME1839723
DR   Coriell; HG03626
DR   IGSR; HG03626
DR   Wikidata; Q54885462
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03629
AC   CVCL_R241
DR   BioSamples; SAME1839738
DR   Coriell; HG03629
DR   GEO; GSM1719443
DR   IGSR; HG03629
DR   Wikidata; Q54885463
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03631
AC   CVCL_R242
DR   BioSamples; SAME1839855
DR   Coriell; HG03631
DR   GEO; GSM1719444
DR   IGSR; HG03631
DR   Wikidata; Q54885464
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03633
AC   CVCL_R243
DR   BioSamples; SAME1839571
DR   Coriell; HG03633
DR   IGSR; HG03633
DR   Wikidata; Q54885465
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03634
AC   CVCL_R244
DR   BioSamples; SAME1839575
DR   Coriell; HG03634
DR   GEO; GSM1719445
DR   IGSR; HG03634
DR   Wikidata; Q54885466
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03635
AC   CVCL_GX27
DR   BioSamples; SAME1839578
DR   Coriell; HG03635
DR   IGSR; HG03635
DR   Wikidata; Q54885467
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03636
AC   CVCL_R245
DR   BioSamples; SAME1839586
DR   Coriell; HG03636
DR   GEO; GSM1719446
DR   IGSR; HG03636
DR   Wikidata; Q54885468
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03638
AC   CVCL_GX28
DR   BioSamples; SAME1839592
DR   Coriell; HG03638
DR   IGSR; HG03638
DR   Wikidata; Q54885469
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03639
AC   CVCL_R246
DR   BioSamples; SAME1839603
DR   Coriell; HG03639
DR   IGSR; HG03639
DR   Wikidata; Q54885470
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03640
AC   CVCL_R247
DR   BioSamples; SAME1839621
DR   Coriell; HG03640
DR   GEO; GSM1719447
DR   IGSR; HG03640
DR   Wikidata; Q54885471
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03641
AC   CVCL_GX29
DR   BioSamples; SAME1839626
DR   Coriell; HG03641
DR   IGSR; HG03641
DR   Wikidata; Q54885472
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03642
AC   CVCL_R248
DR   BioSamples; SAME1839627
DR   Coriell; HG03642
DR   GEO; GSM1719448
DR   IGSR; HG03642
DR   Wikidata; Q54885473
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03643
AC   CVCL_R249
DR   BioSamples; SAME1839633
DR   Coriell; HG03643
DR   GEO; GSM1719449
DR   IGSR; HG03643
DR   Wikidata; Q54885474
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03644
AC   CVCL_R250
DR   BioSamples; SAME1839638
DR   Coriell; HG03644
DR   GEO; GSM1719450
DR   IGSR; HG03644
DR   Wikidata; Q54885475
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03645
AC   CVCL_R251
DR   BioSamples; SAME1839641
DR   Coriell; HG03645
DR   GEO; GSM1719451
DR   IGSR; HG03645
DR   Wikidata; Q54885476
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03646
AC   CVCL_R252
DR   BioSamples; SAME1839643
DR   Coriell; HG03646
DR   GEO; GSM1719452
DR   IGSR; HG03646
DR   Wikidata; Q54885481
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03649
AC   CVCL_R253
DR   BioSamples; SAME1839396
DR   Coriell; HG03649
DR   GEO; GSM1719453
DR   IGSR; HG03649
DR   Wikidata; Q54885482
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03650
AC   CVCL_R254
DR   BioSamples; SAME1839488
DR   Coriell; HG03650
DR   IGSR; HG03650
DR   Wikidata; Q54885483
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03651
AC   CVCL_GX30
DR   BioSamples; SAME1839498
DR   Coriell; HG03651
DR   IGSR; HG03651
DR   Wikidata; Q54885484
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03652
AC   CVCL_R255
DR   BioSamples; SAME1839505
DR   Coriell; HG03652
DR   GEO; GSM1719454
DR   IGSR; HG03652
DR   Wikidata; Q54885485
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03653
AC   CVCL_R256
DR   BioSamples; SAME1839508
DR   Coriell; HG03653
DR   GEO; GSM1719455
DR   IGSR; HG03653
DR   Wikidata; Q54885486
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03654
AC   CVCL_GX31
DR   BioSamples; SAME1839513
DR   Coriell; HG03654
DR   IGSR; HG03654
DR   Wikidata; Q54885487
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03656
AC   CVCL_R257
DR   BioSamples; SAME1839435
DR   Coriell; HG03656
DR   IGSR; HG03656
DR   Wikidata; Q54885488
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03657
AC   CVCL_GX32
DR   BioSamples; SAME1839439
DR   Coriell; HG03657
DR   IGSR; HG03657
DR   Wikidata; Q54885489
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03660
AC   CVCL_R258
DR   BioSamples; SAME1839218
DR   Coriell; HG03660
DR   GEO; GSM1719456
DR   IGSR; HG03660
DR   Wikidata; Q54885490
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03663
AC   CVCL_R259
DR   BioSamples; SAME1839317
DR   Coriell; HG03663
DR   GEO; GSM1719457
DR   IGSR; HG03663
DR   Wikidata; Q54885491
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03667
AC   CVCL_R260
DR   BioSamples; SAME1839331
DR   Coriell; HG03667
DR   GEO; GSM1719458
DR   IGSR; HG03667
DR   Wikidata; Q54885492
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03668
AC   CVCL_R261
DR   BioSamples; SAME1839338
DR   Coriell; HG03668
DR   GEO; GSM1719459
DR   IGSR; HG03668
DR   Wikidata; Q54885493
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03669
AC   CVCL_GX33
DR   BioSamples; SAME1839345
DR   Coriell; HG03669
DR   IGSR; HG03669
DR   Wikidata; Q54885494
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03672
AC   CVCL_R262
DR   BioSamples; SAME1839020
DR   Coriell; HG03672
DR   GEO; GSM1719460
DR   IGSR; HG03672
DR   Wikidata; Q54885495
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03673
AC   CVCL_R263
DR   BioSamples; SAME1839030
DR   Coriell; HG03673
DR   GEO; GSM1719461
DR   IGSR; HG03673
DR   Wikidata; Q54885496
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03679
AC   CVCL_R264
DR   BioSamples; SAME1839055
DR   Coriell; HG03679
DR   GEO; GSM1719462
DR   IGSR; HG03679
DR   Wikidata; Q54885497
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03680
AC   CVCL_R265
DR   BioSamples; SAME1840311
DR   Coriell; HG03680
DR   GEO; GSM1719463
DR   IGSR; HG03680
DR   Wikidata; Q54885498
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03681
AC   CVCL_R266
DR   BioSamples; SAME1840321
DR   Coriell; HG03681
DR   GEO; GSM1719464
DR   IGSR; HG03681
DR   Wikidata; Q54885499
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03682
AC   CVCL_R267
DR   BioSamples; SAME1840323
DR   Coriell; HG03682
DR   IGSR; HG03682
DR   Wikidata; Q54885500
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03683
AC   CVCL_GX34
DR   BioSamples; SAME1840325
DR   Coriell; HG03683
DR   IGSR; HG03683
DR   Wikidata; Q54885501
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03684
AC   CVCL_R268
DR   BioSamples; SAME1840329
DR   Coriell; HG03684
DR   GEO; GSM1719465
DR   IGSR; HG03684
DR   Wikidata; Q54885502
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03685
AC   CVCL_R269
DR   BioSamples; SAME1840333
DR   Coriell; HG03685
DR   GEO; GSM1719466
DR   IGSR; HG03685
DR   Wikidata; Q54885503
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03686
AC   CVCL_R270
DR   BioSamples; SAME1840335
DR   Coriell; HG03686
DR   GEO; GSM1719467
DR   IGSR; HG03686
DR   Wikidata; Q54885504
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03687
AC   CVCL_R271
DR   BioSamples; SAME1840337
DR   Coriell; HG03687
DR   GEO; GSM1719468
DR   IGSR; HG03687
DR   Wikidata; Q54885505
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03688
AC   CVCL_GX35
DR   BioSamples; SAME1840265
DR   Coriell; HG03688
DR   IGSR; HG03688
DR   Wikidata; Q54885506
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03689
AC   CVCL_R272
DR   BioSamples; SAME1840268
DR   Coriell; HG03689
DR   GEO; GSM1719469
DR   IGSR; HG03689
DR   Wikidata; Q54885507
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03690
AC   CVCL_R273
DR   BioSamples; SAME1840365
DR   Coriell; HG03690
DR   GEO; GSM1719470
DR   IGSR; HG03690
DR   Wikidata; Q54885508
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03691
AC   CVCL_R274
DR   BioSamples; SAME1840366
DR   Coriell; HG03691
DR   GEO; GSM1719471
DR   IGSR; HG03691
DR   Wikidata; Q54885509
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03692
AC   CVCL_R275
DR   BioSamples; SAME1840371
DR   Coriell; HG03692
DR   GEO; GSM1719472
DR   IGSR; HG03692
DR   Wikidata; Q54885510
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03693
AC   CVCL_R276
DR   BioSamples; SAME1840372
DR   Coriell; HG03693
DR   GEO; GSM1719473
DR   IGSR; HG03693
DR   Wikidata; Q54885511
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03694
AC   CVCL_R277
DR   BioSamples; SAME1840375
DR   Coriell; HG03694
DR   GEO; GSM1719474
DR   IGSR; HG03694
DR   Wikidata; Q54885512
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03695
AC   CVCL_R278
DR   BioSamples; SAME1840128
DR   Coriell; HG03695
DR   GEO; GSM1719475
DR   IGSR; HG03695
DR   Wikidata; Q54885513
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03696
AC   CVCL_R279
DR   BioSamples; SAME1840135
DR   Coriell; HG03696
DR   GEO; GSM1719476
DR   IGSR; HG03696
DR   Wikidata; Q54885514
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03697
AC   CVCL_R280
DR   BioSamples; SAME1840137
DR   Coriell; HG03697
DR   GEO; GSM1719477
DR   IGSR; HG03697
DR   Wikidata; Q54885515
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03698
AC   CVCL_R281
DR   BioSamples; SAME1840145
DR   Coriell; HG03698
DR   GEO; GSM1719478
DR   IGSR; HG03698
DR   Wikidata; Q54885516
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03699
AC   CVCL_R282
DR   BioSamples; SAME1840153
DR   Coriell; HG03699
DR   IGSR; HG03699
DR   Wikidata; Q54885517
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03700
AC   CVCL_R283
DR   BioSamples; SAME1840010
DR   Coriell; HG03700
DR   IGSR; HG03700
DR   Wikidata; Q54885518
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03701
AC   CVCL_GX36
DR   BioSamples; SAME1840016
DR   Coriell; HG03701
DR   IGSR; HG03701
DR   Wikidata; Q54885519
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03702
AC   CVCL_R284
DR   BioSamples; SAME1840029
DR   Coriell; HG03702
DR   GEO; GSM1719479
DR   IGSR; HG03702
DR   Wikidata; Q54885520
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03703
AC   CVCL_R285
DR   BioSamples; SAME1840032
DR   Coriell; HG03703
DR   GEO; GSM1719480
DR   IGSR; HG03703
DR   Wikidata; Q54885525
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03704
AC   CVCL_GX37
DR   BioSamples; SAME1840040
DR   Coriell; HG03704
DR   IGSR; HG03704
DR   Wikidata; Q54885526
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03705
AC   CVCL_R286
DR   BioSamples; SAME1840051
DR   Coriell; HG03705
DR   GEO; GSM1719481
DR   IGSR; HG03705
DR   Wikidata; Q54885527
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03706
AC   CVCL_R287
DR   BioSamples; SAME1839758
DR   Coriell; HG03706
DR   GEO; GSM1719482
DR   IGSR; HG03706
DR   Wikidata; Q54885528
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03707
AC   CVCL_GX38
DR   BioSamples; SAME1839761
DR   Coriell; HG03707
DR   IGSR; HG03707
DR   Wikidata; Q54885529
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03708
AC   CVCL_R288
DR   BioSamples; SAME1839773
DR   Coriell; HG03708
DR   GEO; GSM1719483
DR   IGSR; HG03708
DR   Wikidata; Q54885530
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03709
AC   CVCL_R289
DR   BioSamples; SAME1839780
DR   Coriell; HG03709
DR   GEO; GSM1719484
DR   IGSR; HG03709
DR   Wikidata; Q54885531
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03710
AC   CVCL_GX39
DR   BioSamples; SAME1839891
DR   Coriell; HG03710
DR   IGSR; HG03710
DR   Wikidata; Q54885533
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03711
AC   CVCL_R290
DR   BioSamples; SAME1839894
DR   Coriell; HG03711
DR   GEO; GSM1719485
DR   IGSR; HG03711
DR   Wikidata; Q54885534
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03713
AC   CVCL_R291
DR   BioSamples; SAME1839807
DR   Coriell; HG03713
DR   GEO; GSM1719486
DR   IGSR; HG03713
DR   Wikidata; Q54885535
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03714
AC   CVCL_R292
DR   BioSamples; SAME1839809
DR   Coriell; HG03714
DR   GEO; GSM1719487
DR   IGSR; HG03714
DR   Wikidata; Q54885536
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03715
AC   CVCL_R293
DR   BioSamples; SAME1839815
DR   Coriell; HG03715
DR   GEO; GSM1719488
DR   IGSR; HG03715
DR   Wikidata; Q54885537
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03716
AC   CVCL_R294
DR   BioSamples; SAME1839825
DR   Coriell; HG03716
DR   GEO; GSM1719489
DR   IGSR; HG03716
DR   Wikidata; Q54885538
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03717
AC   CVCL_R295
DR   BioSamples; SAME1839831
DR   Coriell; HG03717
DR   GEO; GSM1719490
DR   IGSR; HG03717
DR   Wikidata; Q54885539
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03718
AC   CVCL_R296
DR   BioSamples; SAME1839834
DR   Coriell; HG03718
DR   GEO; GSM1719491
DR   IGSR; HG03718
DR   Wikidata; Q54885540
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03719
AC   CVCL_GX40
DR   BioSamples; SAME1839843
DR   Coriell; HG03719
DR   IGSR; HG03719
DR   Wikidata; Q54885541
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03720
AC   CVCL_R297
DR   BioSamples; SAME1839562
DR   Coriell; HG03720
DR   GEO; GSM1719492
DR   IGSR; HG03720
DR   Wikidata; Q54885542
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03721
AC   CVCL_R298
DR   BioSamples; SAME1839659
DR   Coriell; HG03721
DR   IGSR; HG03721
DR   Wikidata; Q54885543
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03722
AC   CVCL_R299
DR   BioSamples; SAME1839664
DR   Coriell; HG03722
DR   GEO; GSM1719493
DR   IGSR; HG03722
DR   Wikidata; Q54885544
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03723
AC   CVCL_R300
DR   BioSamples; SAME1839668
DR   Coriell; HG03723
DR   IGSR; HG03723
DR   Wikidata; Q54885545
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03725
AC   CVCL_R301
DR   BioSamples; SAME1839680
DR   Coriell; HG03725
DR   IGSR; HG03725
DR   Wikidata; Q54885546
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03727
AC   CVCL_R302
DR   BioSamples; SAME1839695
DR   Coriell; HG03727
DR   GEO; GSM1719494
DR   IGSR; HG03727
DR   Wikidata; Q54885547
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03729
AC   CVCL_R303
DR   BioSamples; SAME1839701
DR   Coriell; HG03729
DR   GEO; GSM1719495
DR   IGSR; HG03729
DR   Wikidata; Q54885548
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03730
AC   CVCL_R304
DR   BioSamples; SAME1839369
DR   Coriell; HG03730
DR   GEO; GSM1719496
DR   IGSR; HG03730
DR   Wikidata; Q54885549
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03731
AC   CVCL_R305
DR   BioSamples; SAME1839372
DR   Coriell; HG03731
DR   GEO; GSM1719497
DR   IGSR; HG03731
DR   Wikidata; Q54885550
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03732
AC   CVCL_GX41
DR   BioSamples; SAME1839378
DR   Coriell; HG03732
DR   IGSR; HG03732
DR   Wikidata; Q54885551
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03733
AC   CVCL_R306
DR   BioSamples; SAME1839382
DR   Coriell; HG03733
DR   GEO; GSM1719498
DR   IGSR; HG03733
DR   Wikidata; Q54885552
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03736
AC   CVCL_R307
DR   BioSamples; SAME1839389
DR   Coriell; HG03736
DR   GEO; GSM1719499
DR   IGSR; HG03736
DR   Wikidata; Q54885553
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03738
AC   CVCL_R308
DR   BioSamples; SAME1839473
DR   Coriell; HG03738
DR   GEO; GSM1719500
DR   IGSR; HG03738
DR   Wikidata; Q54885554
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03740
AC   CVCL_R309
DR   BioSamples; SAME1839248
DR   Coriell; HG03740
DR   GEO; GSM1719501
DR   IGSR; HG03740
DR   Wikidata; Q54885555
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03741
AC   CVCL_R310
DR   BioSamples; SAME1839251
DR   Coriell; HG03741
DR   GEO; GSM1719502
DR   IGSR; HG03741
DR   Wikidata; Q54885556
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03742
AC   CVCL_R311
DR   BioSamples; SAME1839255
DR   Coriell; HG03742
DR   GEO; GSM1719503
DR   IGSR; HG03742
DR   Wikidata; Q54885557
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03743
AC   CVCL_R312
DR   BioSamples; SAME1839261
DR   Coriell; HG03743
DR   GEO; GSM1719504
DR   IGSR; HG03743
DR   Wikidata; Q54885558
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03744
AC   CVCL_R313
DR   BioSamples; SAME1839265
DR   Coriell; HG03744
DR   GEO; GSM1719505
DR   IGSR; HG03744
DR   Wikidata; Q54885559
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03745
AC   CVCL_R314
DR   BioSamples; SAME1839195
DR   Coriell; HG03745
DR   GEO; GSM1719506
DR   IGSR; HG03745
DR   Wikidata; Q54885560
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03746
AC   CVCL_R315
DR   BioSamples; SAME1839200
DR   Coriell; HG03746
DR   GEO; GSM1719507
DR   IGSR; HG03746
DR   Wikidata; Q54885561
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03750
AC   CVCL_R316
DR   BioSamples; SAME1839309
DR   Coriell; HG03750
DR   GEO; GSM1719508
DR   IGSR; HG03750
DR   Wikidata; Q54885562
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03752
AC   CVCL_R317
DR   BioSamples; SAME1839314
DR   Coriell; HG03752
DR   GEO; GSM1719509
DR   IGSR; HG03752
DR   Wikidata; Q54885563
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03753
AC   CVCL_R318
DR   BioSamples; SAME1839062
DR   Coriell; HG03753
DR   GEO; GSM1719510
DR   IGSR; HG03753
DR   Wikidata; Q54885564
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03754
AC   CVCL_R319
DR   BioSamples; SAME1839073
DR   Coriell; HG03754
DR   GEO; GSM1719511
DR   IGSR; HG03754
DR   Wikidata; Q54885565
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03755
AC   CVCL_R320
DR   BioSamples; SAME1839074
DR   Coriell; HG03755
DR   GEO; GSM1719512
DR   IGSR; HG03755
DR   Wikidata; Q54885570
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03756
AC   CVCL_R321
DR   BioSamples; SAME1839080
DR   Coriell; HG03756
DR   GEO; GSM1719513
DR   IGSR; HG03756
DR   Wikidata; Q54885571
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03757
AC   CVCL_R322
DR   BioSamples; SAME1839089
DR   Coriell; HG03757
DR   GEO; GSM1719514
DR   IGSR; HG03757
DR   Wikidata; Q54885572
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03760
AC   CVCL_R323
DR   BioSamples; SAME1839105
DR   Coriell; HG03760
DR   GEO; GSM1719515
DR   IGSR; HG03760
DR   Wikidata; Q54885573
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03761
AC   CVCL_R324
DR   BioSamples; SAME1839114
DR   Coriell; HG03761
DR   IGSR; HG03761
DR   Wikidata; Q54885574
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03762
AC   CVCL_R325
DR   BioSamples; SAME1839119
DR   Coriell; HG03762
DR   GEO; GSM1719516
DR   IGSR; HG03762
DR   Wikidata; Q54885575
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03763
AC   CVCL_GX42
DR   BioSamples; SAME1839122
DR   Coriell; HG03763
DR   IGSR; HG03763
DR   Wikidata; Q54885576
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03765
AC   CVCL_R326
DR   BioSamples; SAME1839131
DR   Coriell; HG03765
DR   GEO; GSM1719517
DR   IGSR; HG03765
DR   Wikidata; Q54885577
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03766
AC   CVCL_GX43
DR   BioSamples; SAME1839136
DR   Coriell; HG03766
DR   IGSR; HG03766
DR   Wikidata; Q54885578
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03767
AC   CVCL_R327
DR   BioSamples; SAME1839141
DR   Coriell; HG03767
DR   GEO; GSM1719518
DR   IGSR; HG03767
DR   Wikidata; Q54885579
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03769
AC   CVCL_GX44
DR   BioSamples; SAME1839154
DR   Coriell; HG03769
DR   IGSR; HG03769
DR   Wikidata; Q54885580
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Punjabi in Lahore (PJL).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03770
AC   CVCL_R328
DR   BioSamples; SAME1840388
DR   Coriell; HG03770
DR   GEO; GSM1719519
DR   IGSR; HG03770
DR   Wikidata; Q54885581
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03771
AC   CVCL_R329
DR   BioSamples; SAME1840393
DR   Coriell; HG03771
DR   GEO; GSM1719520
DR   IGSR; HG03771
DR   Wikidata; Q54885582
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03772
AC   CVCL_R330
DR   BioSamples; SAME1840398
DR   Coriell; HG03772
DR   GEO; GSM1719521
DR   IGSR; HG03772
DR   Wikidata; Q54885583
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03773
AC   CVCL_R331
DR   BioSamples; SAME1840406
DR   Coriell; HG03773
DR   GEO; GSM1719522
DR   IGSR; HG03773
DR   Wikidata; Q54885584
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03774
AC   CVCL_R332
DR   BioSamples; SAME1840408
DR   Coriell; HG03774
DR   GEO; GSM1719523
DR   IGSR; HG03774
DR   Wikidata; Q54885585
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03775
AC   CVCL_R333
DR   BioSamples; SAME1840413
DR   Coriell; HG03775
DR   GEO; GSM1719524
DR   IGSR; HG03775
DR   Wikidata; Q54885586
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03777
AC   CVCL_R334
DR   BioSamples; SAME1840340
DR   Coriell; HG03777
DR   GEO; GSM1719525
DR   IGSR; HG03777
DR   Wikidata; Q54885587
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03778
AC   CVCL_R335
DR   BioSamples; SAME1840344
DR   Coriell; HG03778
DR   GEO; GSM1719526
DR   IGSR; HG03778
DR   Wikidata; Q54885588
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03779
AC   CVCL_R336
DR   BioSamples; SAME1840351
DR   Coriell; HG03779
DR   GEO; GSM1719527
DR   IGSR; HG03779
DR   Wikidata; Q54885589
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03780
AC   CVCL_R337
DR   BioSamples; SAME1840112
DR   Coriell; HG03780
DR   GEO; GSM1719528
DR   IGSR; HG03780
DR   Wikidata; Q54885590
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03781
AC   CVCL_R338
DR   BioSamples; SAME1840117
DR   Coriell; HG03781
DR   GEO; GSM1719529
DR   IGSR; HG03781
DR   Wikidata; Q54885591
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03782
AC   CVCL_R339
DR   BioSamples; SAME1840119
DR   Coriell; HG03782
DR   GEO; GSM1719530
DR   IGSR; HG03782
DR   Wikidata; Q54885592
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03783
AC   CVCL_GX45
DR   BioSamples; SAME1840124
DR   Coriell; HG03783
DR   IGSR; HG03783
DR   Wikidata; Q54885593
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03784
AC   CVCL_R340
DR   BioSamples; SAME1840210
DR   Coriell; HG03784
DR   GEO; GSM1719531
DR   IGSR; HG03784
DR   Wikidata; Q54885594
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03785
AC   CVCL_R341
DR   BioSamples; SAME1840212
DR   Coriell; HG03785
DR   GEO; GSM1719532
DR   IGSR; HG03785
DR   Wikidata; Q54885595
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03786
AC   CVCL_R342
DR   BioSamples; SAME1840218
DR   Coriell; HG03786
DR   GEO; GSM1719533
DR   IGSR; HG03786
DR   Wikidata; Q54885596
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03787
AC   CVCL_R343
DR   BioSamples; SAME1840224
DR   Coriell; HG03787
DR   GEO; GSM1719534
DR   IGSR; HG03787
DR   Wikidata; Q54885597
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03788
AC   CVCL_R344
DR   BioSamples; SAME1840227
DR   Coriell; HG03788
DR   GEO; GSM1719535
DR   IGSR; HG03788
DR   Wikidata; Q54885598
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03789
AC   CVCL_R345
DR   BioSamples; SAME1840237
DR   Coriell; HG03789
DR   GEO; GSM1719536
DR   IGSR; HG03789
DR   Wikidata; Q54885599
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03790
AC   CVCL_R346
DR   BioSamples; SAME1839989
DR   Coriell; HG03790
DR   GEO; GSM1719537
DR   IGSR; HG03790
DR   Wikidata; Q54885600
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03792
AC   CVCL_R347
DR   BioSamples; SAME1839912
DR   Coriell; HG03792
DR   GEO; GSM1719538
DR   IGSR; HG03792
DR   Wikidata; Q54885601
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03793
AC   CVCL_R348
DR   BioSamples; SAME1839915
DR   Coriell; HG03793
DR   GEO; GSM1719539
DR   IGSR; HG03793
DR   Wikidata; Q54885603
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03794
AC   CVCL_R349
DR   BioSamples; SAME1839920
DR   Coriell; HG03794
DR   IGSR; HG03794
DR   Wikidata; Q54885604
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03795
AC   CVCL_GX46
DR   BioSamples; SAME1839925
DR   Coriell; HG03795
DR   IGSR; HG03795
DR   Wikidata; Q54885605
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03796
AC   CVCL_R350
DR   BioSamples; SAME1839928
DR   Coriell; HG03796
DR   GEO; GSM1719540
DR   IGSR; HG03796
DR   Wikidata; Q54885606
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03797
AC   CVCL_R351
DR   BioSamples; SAME1839931
DR   Coriell; HG03797
DR   IGSR; HG03797
DR   Wikidata; Q54885607
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03798
AC   CVCL_GX47
DR   BioSamples; SAME1839941
DR   Coriell; HG03798
DR   IGSR; HG03798
DR   Wikidata; Q54885608
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03799
AC   CVCL_R352
DR   BioSamples; SAME1839944
DR   Coriell; HG03799
DR   IGSR; HG03799
DR   Wikidata; Q54885609
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03800
AC   CVCL_R353
DR   BioSamples; SAME1839595
DR   Coriell; HG03800
DR   GEO; GSM1719541
DR   IGSR; HG03800
DR   Wikidata; Q54885610
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03801
AC   CVCL_GX48
DR   BioSamples; SAME1839606
DR   Coriell; HG03801
DR   IGSR; HG03801
DR   Wikidata; Q54885616
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03802
AC   CVCL_R354
DR   BioSamples; SAME1839608
DR   Coriell; HG03802
DR   GEO; GSM1719542
DR   IGSR; HG03802
DR   Wikidata; Q54885617
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03803
AC   CVCL_R355
DR   BioSamples; SAME1839527
DR   Coriell; HG03803
DR   GEO; GSM1719543
DR   IGSR; HG03803
DR   Wikidata; Q54885618
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03804
AC   CVCL_GX49
DR   BioSamples; SAME1839533
DR   Coriell; HG03804
DR   IGSR; HG03804
DR   Wikidata; Q54885619
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03805
AC   CVCL_R356
DR   BioSamples; SAME1839540
DR   Coriell; HG03805
DR   GEO; GSM1719544
DR   IGSR; HG03805
DR   Wikidata; Q54885620
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03806
AC   CVCL_R357
DR   BioSamples; SAME1839542
DR   Coriell; HG03806
DR   IGSR; HG03806
DR   Wikidata; Q54885621
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03807
AC   CVCL_GX50
DR   BioSamples; SAME1839547
DR   Coriell; HG03807
DR   IGSR; HG03807
DR   Wikidata; Q54885623
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03808
AC   CVCL_R358
DR   BioSamples; SAME1839552
DR   Coriell; HG03808
DR   GEO; GSM1719545
DR   IGSR; HG03808
DR   Wikidata; Q54885624
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03809
AC   CVCL_R359
DR   BioSamples; SAME1839554
DR   Coriell; HG03809
DR   GEO; GSM1719546
DR   IGSR; HG03809
DR   Wikidata; Q54885625
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03811
AC   CVCL_R360
DR   BioSamples; SAME1839397
DR   Coriell; HG03811
DR   IGSR; HG03811
DR   Wikidata; Q54885626
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03812
AC   CVCL_R361
DR   BioSamples; SAME1839405
DR   Coriell; HG03812
DR   GEO; GSM1719547
DR   IGSR; HG03812
DR   Wikidata; Q54885627
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03813
AC   CVCL_GX51
DR   BioSamples; SAME1839406
DR   Coriell; HG03813
DR   IGSR; HG03813
DR   Wikidata; Q54885628
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03814
AC   CVCL_R362
DR   BioSamples; SAME1839411
DR   Coriell; HG03814
DR   GEO; GSM1719548
DR   IGSR; HG03814
DR   Wikidata; Q54885629
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03815
AC   CVCL_R363
DR   BioSamples; SAME1839419
DR   Coriell; HG03815
DR   IGSR; HG03815
DR   Wikidata; Q54885630
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03816
AC   CVCL_GX52
DR   BioSamples; SAME1839424
DR   Coriell; HG03816
DR   IGSR; HG03816
DR   Wikidata; Q54885631
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03817
AC   CVCL_R364
DR   BioSamples; SAME1839426
DR   Coriell; HG03817
DR   GEO; GSM1719550
DR   IGSR; HG03817
DR   Wikidata; Q54885633
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03821
AC   CVCL_R365
DR   BioSamples; SAME1839449
DR   Coriell; HG03821
DR   GEO; GSM1719551
DR   IGSR; HG03821
DR   Wikidata; Q54885634
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03822
AC   CVCL_GX53
DR   BioSamples; SAME1839450
DR   Coriell; HG03822
DR   IGSR; HG03822
DR   Wikidata; Q54885635
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG03823
AC   CVCL_R366
DR   BioSamples; SAME1839456
DR   Coriell; HG03823
DR   GEO; GSM1719552
DR   IGSR; HG03823
DR   Wikidata; Q54885636
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03824
AC   CVCL_R367
DR   BioSamples; SAME1839459
DR   Coriell; HG03824
DR   GEO; GSM1719553
DR   IGSR; HG03824
DR   Wikidata; Q54885637
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03825
AC   CVCL_GX54
DR   BioSamples; SAME1839462
DR   Coriell; HG03825
DR   IGSR; HG03825
DR   Wikidata; Q54885638
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03826
AC   CVCL_R368
DR   BioSamples; SAME1839465
DR   Coriell; HG03826
DR   GEO; GSM1719554
DR   IGSR; HG03826
DR   Wikidata; Q54885639
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03829
AC   CVCL_R369
DR   BioSamples; SAME1839241
DR   Coriell; HG03829
DR   GEO; GSM1719555
DR   IGSR; HG03829
DR   Wikidata; Q54885640
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03830
AC   CVCL_R370
DR   BioSamples; SAME1839341
DR   Coriell; HG03830
DR   GEO; GSM1719556
DR   IGSR; HG03830
DR   Wikidata; Q54885641
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03831
AC   CVCL_GX55
DR   BioSamples; SAME1839348
DR   Coriell; HG03831
DR   IGSR; HG03831
DR   Wikidata; Q54885642
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03832
AC   CVCL_R371
DR   BioSamples; SAME1839353
DR   Coriell; HG03832
DR   GEO; GSM1719557
DR   IGSR; HG03832
DR   Wikidata; Q54885643
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03833
AC   CVCL_R372
DR   BioSamples; SAME1839356
DR   Coriell; HG03833
DR   GEO; GSM1719558
DR   IGSR; HG03833
DR   Wikidata; Q54885644
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03834
AC   CVCL_GX56
DR   BioSamples; SAME1839269
DR   Coriell; HG03834
DR   IGSR; HG03834
DR   Wikidata; Q54885645
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03835
AC   CVCL_GX57
DR   BioSamples; SAME1839273
DR   Coriell; HG03835
DR   IGSR; HG03835
DR   Wikidata; Q54885646
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03836
AC   CVCL_R373
DR   BioSamples; SAME1839280
DR   Coriell; HG03836
DR   GEO; GSM1719559
DR   IGSR; HG03836
DR   Wikidata; Q54885647
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03837
AC   CVCL_R374
DR   BioSamples; SAME1839291
DR   Coriell; HG03837
DR   GEO; GSM1719560
DR   IGSR; HG03837
DR   Wikidata; Q54885648
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03838
AC   CVCL_R375
DR   BioSamples; SAME1839297
DR   Coriell; HG03838
DR   GEO; GSM1719561
DR   IGSR; HG03838
DR   Wikidata; Q54885649
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03840
AC   CVCL_GX58
DR   BioSamples; SAME1839054
DR   Coriell; HG03840
DR   IGSR; HG03840
DR   Wikidata; Q54885650
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03842
AC   CVCL_R376
DR   BioSamples; SAME1839160
DR   Coriell; HG03842
DR   IGSR; HG03842
DR   Wikidata; Q54885651
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03844
AC   CVCL_R377
DR   BioSamples; SAME1839166
DR   Coriell; HG03844
DR   GEO; GSM1719562
DR   IGSR; HG03844
DR   Wikidata; Q54885652
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03845
AC   CVCL_R378
DR   BioSamples; SAME1839170
DR   Coriell; HG03845
DR   IGSR; HG03845
DR   Wikidata; Q54885653
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03846
AC   CVCL_R379
DR   BioSamples; SAME1839172
DR   Coriell; HG03846
DR   GEO; GSM1719563
DR   IGSR; HG03846
DR   Wikidata; Q54885654
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03847
AC   CVCL_R380
DR   BioSamples; SAME1839179
DR   Coriell; HG03847
DR   IGSR; HG03847
DR   Wikidata; Q54885655
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03848
AC   CVCL_R381
DR   BioSamples; SAME1839187
DR   Coriell; HG03848
DR   GEO; GSM1719564
DR   IGSR; HG03848
DR   Wikidata; Q54885656
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03849
AC   CVCL_R382
DR   BioSamples; SAME1839190
DR   Coriell; HG03849
DR   GEO; GSM1719565
DR   IGSR; HG03849
DR   Wikidata; Q54885657
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03850
AC   CVCL_R383
DR   BioSamples; SAME1840270
DR   Coriell; HG03850
DR   GEO; GSM1719566
DR   IGSR; HG03850
DR   Wikidata; Q54885663
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03851
AC   CVCL_R384
DR   BioSamples; SAME1840272
DR   Coriell; HG03851
DR   GEO; GSM1719567
DR   IGSR; HG03851
DR   Wikidata; Q54885664
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03854
AC   CVCL_R385
DR   BioSamples; SAME1840283
DR   Coriell; HG03854
DR   GEO; GSM1719568
DR   IGSR; HG03854
DR   Wikidata; Q54885665
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03856
AC   CVCL_R386
DR   BioSamples; SAME1840291
DR   Coriell; HG03856
DR   GEO; GSM1719569
DR   IGSR; HG03856
DR   Wikidata; Q54885666
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03857
AC   CVCL_R387
DR   BioSamples; SAME1840294
DR   Coriell; HG03857
DR   GEO; GSM1719570
DR   IGSR; HG03857
DR   Wikidata; Q54885667
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03858
AC   CVCL_R388
DR   BioSamples; SAME1840301
DR   Coriell; HG03858
DR   GEO; GSM1719571
DR   IGSR; HG03858
DR   Wikidata; Q54885668
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03861
AC   CVCL_R389
DR   BioSamples; SAME1840156
DR   Coriell; HG03861
DR   GEO; GSM1719572
DR   IGSR; HG03861
DR   Wikidata; Q54885669
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03862
AC   CVCL_R390
DR   BioSamples; SAME1840158
DR   Coriell; HG03862
DR   GEO; GSM1719573
DR   IGSR; HG03862
DR   Wikidata; Q54885670
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03863
AC   CVCL_R391
DR   BioSamples; SAME1840162
DR   Coriell; HG03863
DR   GEO; GSM1719574
DR   IGSR; HG03863
DR   Wikidata; Q54885671
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03864
AC   CVCL_R392
DR   BioSamples; SAME1840170
DR   Coriell; HG03864
DR   GEO; GSM1719575
DR   IGSR; HG03864
DR   Wikidata; Q54885672
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03866
AC   CVCL_R393
DR   BioSamples; SAME1840087
DR   Coriell; HG03866
DR   GEO; GSM1719576
DR   IGSR; HG03866
DR   Wikidata; Q54885673
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03867
AC   CVCL_R394
DR   BioSamples; SAME1840095
DR   Coriell; HG03867
DR   GEO; GSM1719577
DR   IGSR; HG03867
DR   Wikidata; Q54885674
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03868
AC   CVCL_R395
DR   BioSamples; SAME1840097
DR   Coriell; HG03868
DR   GEO; GSM1719578
DR   IGSR; HG03868
DR   Wikidata; Q54885675
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03869
AC   CVCL_R396
DR   BioSamples; SAME1840104
DR   Coriell; HG03869
DR   GEO; GSM1719579
DR   IGSR; HG03869
DR   Wikidata; Q54885676
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03870
AC   CVCL_R397
DR   BioSamples; SAME1840196
DR   Coriell; HG03870
DR   GEO; GSM1719580
DR   IGSR; HG03870
DR   Wikidata; Q54885677
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03871
AC   CVCL_R398
DR   BioSamples; SAME1840200
DR   Coriell; HG03871
DR   GEO; GSM1719581
DR   IGSR; HG03871
DR   Wikidata; Q54885678
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03872
AC   CVCL_R399
DR   BioSamples; SAME1840202
DR   Coriell; HG03872
DR   GEO; GSM1719582
DR   IGSR; HG03872
DR   Wikidata; Q54885679
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03873
AC   CVCL_R400
DR   BioSamples; SAME1840205
DR   Coriell; HG03873
DR   GEO; GSM1719583
DR   IGSR; HG03873
DR   Wikidata; Q54885680
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03874
AC   CVCL_R401
DR   BioSamples; SAME1839961
DR   Coriell; HG03874
DR   GEO; GSM1719584
DR   IGSR; HG03874
DR   Wikidata; Q54885681
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03875
AC   CVCL_R402
DR   BioSamples; SAME1839965
DR   Coriell; HG03875
DR   GEO; GSM1719585
DR   IGSR; HG03875
DR   Wikidata; Q54885682
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03876
AC   CVCL_GX59
DR   BioSamples; SAME1839967
DR   Coriell; HG03876
DR   IGSR; HG03876
DR   Wikidata; Q54885683
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03879
AC   CVCL_GX60
DR   BioSamples; SAME1839975
DR   Coriell; HG03879
DR   IGSR; HG03879
DR   Wikidata; Q54885684
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG03882
AC   CVCL_R403
DR   BioSamples; SAME1839999
DR   Coriell; HG03882
DR   GEO; GSM1719586
DR   IGSR; HG03882
DR   Wikidata; Q54885685
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG03884
AC   CVCL_R404
DR   BioSamples; SAME1840005
DR   Coriell; HG03884
DR   GEO; GSM1719587
DR   IGSR; HG03884
DR   Wikidata; Q54885686
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03885
AC   CVCL_R405
DR   BioSamples; SAME1840013
DR   Coriell; HG03885
DR   GEO; GSM1719588
DR   IGSR; HG03885
DR   Wikidata; Q54885687
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03886
AC   CVCL_R406
DR   BioSamples; SAME1840021
DR   Coriell; HG03886
DR   GEO; GSM1719589
DR   IGSR; HG03886
DR   Wikidata; Q54885688
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03887
AC   CVCL_R407
DR   BioSamples; SAME1840028
DR   Coriell; HG03887
DR   GEO; GSM1719590
DR   IGSR; HG03887
DR   Wikidata; Q54885689
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03888
AC   CVCL_R408
DR   BioSamples; SAME1840039
DR   Coriell; HG03888
DR   GEO; GSM1719591
DR   IGSR; HG03888
DR   Wikidata; Q54885690
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03890
AC   CVCL_R409
DR   BioSamples; SAME1839864
DR   Coriell; HG03890
DR   GEO; GSM1719592
DR   IGSR; HG03890
DR   Wikidata; Q54885691
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03894
AC   CVCL_R410
DR   BioSamples; SAME1839885
DR   Coriell; HG03894
DR   GEO; GSM1719593
DR   IGSR; HG03894
DR   Wikidata; Q54885692
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03895
AC   CVCL_R411
DR   BioSamples; SAME1839888
DR   Coriell; HG03895
DR   GEO; GSM1719594
DR   IGSR; HG03895
DR   Wikidata; Q54885693
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03896
AC   CVCL_R412
DR   BioSamples; SAME1839898
DR   Coriell; HG03896
DR   GEO; GSM1719595
DR   IGSR; HG03896
DR   Wikidata; Q54885694
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03897
AC   CVCL_R413
DR   BioSamples; SAME1839906
DR   Coriell; HG03897
DR   GEO; GSM1719596
DR   IGSR; HG03897
DR   Wikidata; Q54885695
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03898
AC   CVCL_R414
DR   BioSamples; SAME1839806
DR   Coriell; HG03898
DR   GEO; GSM1719597
DR   IGSR; HG03898
DR   Wikidata; Q54885696
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03899
AC   CVCL_R415
DR   BioSamples; SAME1839814
DR   Coriell; HG03899
DR   GEO; GSM1719598
DR   IGSR; HG03899
DR   Wikidata; Q54885697
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03900
AC   CVCL_R416
DR   BioSamples; SAME1839476
DR   Coriell; HG03900
DR   GEO; GSM1719599
DR   IGSR; HG03900
DR   Wikidata; Q54885698
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03901
AC   CVCL_R417
DR   BioSamples; SAME1839478
DR   Coriell; HG03901
DR   IGSR; HG03901
DR   Wikidata; Q54885699
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03902
AC   CVCL_R418
DR   BioSamples; SAME1839484
DR   Coriell; HG03902
DR   GEO; GSM1719600
DR   IGSR; HG03902
DR   Wikidata; Q54885700
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03903
AC   CVCL_GX61
DR   BioSamples; SAME1839493
DR   Coriell; HG03903
DR   IGSR; HG03903
DR   Wikidata; Q54885701
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03904
AC   CVCL_R419
DR   BioSamples; SAME1839501
DR   Coriell; HG03904
DR   IGSR; HG03904
DR   Wikidata; Q54885702
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03905
AC   CVCL_R420
DR   BioSamples; SAME1839503
DR   Coriell; HG03905
DR   GEO; GSM1719601
DR   IGSR; HG03905
DR   Wikidata; Q54885706
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03906
AC   CVCL_GX62
DR   BioSamples; SAME1839512
DR   Coriell; HG03906
DR   IGSR; HG03906
DR   Wikidata; Q54885707
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03907
AC   CVCL_R421
DR   BioSamples; SAME1839517
DR   Coriell; HG03907
DR   GEO; GSM1719602
DR   IGSR; HG03907
DR   Wikidata; Q54885708
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03908
AC   CVCL_R422
DR   BioSamples; SAME1839522
DR   Coriell; HG03908
DR   GEO; GSM1719603
DR   IGSR; HG03908
DR   Wikidata; Q54885709
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03909
AC   CVCL_GX63
DR   BioSamples; SAME1839438
DR   Coriell; HG03909
DR   IGSR; HG03909
DR   Wikidata; Q54885710
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03910
AC   CVCL_R423
DR   BioSamples; SAME1839205
DR   Coriell; HG03910
DR   GEO; GSM1719604
DR   IGSR; HG03910
DR   Wikidata; Q54885711
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03911
AC   CVCL_R424
DR   BioSamples; SAME1839212
DR   Coriell; HG03911
DR   GEO; GSM1719605
DR   IGSR; HG03911
DR   Wikidata; Q54885712
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03913
AC   CVCL_R425
DR   BioSamples; SAME1839216
DR   Coriell; HG03913
DR   GEO; GSM1719606
DR   IGSR; HG03913
DR   Wikidata; Q54885713
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03914
AC   CVCL_R426
DR   BioSamples; SAME1839224
DR   Coriell; HG03914
DR   GEO; GSM1719607
DR   IGSR; HG03914
DR   Wikidata; Q54885714
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03915
AC   CVCL_GX64
DR   BioSamples; SAME1839227
DR   Coriell; HG03915
DR   IGSR; HG03915
DR   Wikidata; Q54885715
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03916
AC   CVCL_R427
DR   BioSamples; SAME1839316
DR   Coriell; HG03916
DR   GEO; GSM1719608
DR   IGSR; HG03916
DR   Wikidata; Q54885716
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03917
AC   CVCL_R428
DR   BioSamples; SAME1839323
DR   Coriell; HG03917
DR   GEO; GSM1719609
DR   IGSR; HG03917
DR   Wikidata; Q54885717
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03919
AC   CVCL_R429
DR   BioSamples; SAME1839329
DR   Coriell; HG03919
DR   GEO; GSM1719610
DR   IGSR; HG03919
DR   Wikidata; Q54885718
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03920
AC   CVCL_R430
DR   BioSamples; SAME1839093
DR   Coriell; HG03920
DR   GEO; GSM1719611
DR   IGSR; HG03920
DR   Wikidata; Q54885719
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03922
AC   CVCL_R431
DR   BioSamples; SAME1839103
DR   Coriell; HG03922
DR   GEO; GSM1719612
DR   IGSR; HG03922
DR   Wikidata; Q54885720
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03924
AC   CVCL_GX65
DR   BioSamples; SAME1839018
DR   Coriell; HG03924
DR   IGSR; HG03924
DR   Wikidata; Q54885721
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03925
AC   CVCL_R432
DR   BioSamples; SAME1839025
DR   Coriell; HG03925
DR   GEO; GSM1719613
DR   IGSR; HG03925
DR   Wikidata; Q54885722
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03926
AC   CVCL_R433
DR   BioSamples; SAME1839033
DR   Coriell; HG03926
DR   GEO; GSM1719614
DR   IGSR; HG03926
DR   Wikidata; Q54885723
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03927
AC   CVCL_GX66
DR   BioSamples; SAME1839035
DR   Coriell; HG03927
DR   IGSR; HG03927
DR   Wikidata; Q54885724
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03928
AC   CVCL_R434
DR   BioSamples; SAME1839042
DR   Coriell; HG03928
DR   GEO; GSM1719615
DR   IGSR; HG03928
DR   Wikidata; Q54885725
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03929
AC   CVCL_R435
DR   BioSamples; SAME1839046
DR   Coriell; HG03929
DR   IGSR; HG03929
DR   Wikidata; Q54885726
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03930
AC   CVCL_GX67
DR   BioSamples; SAME1839156
DR   Coriell; HG03930
DR   IGSR; HG03930
DR   Wikidata; Q54885727
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03931
AC   CVCL_R436
DR   BioSamples; SAME1840305
DR   Coriell; HG03931
DR   GEO; GSM1719616
DR   IGSR; HG03931
DR   Wikidata; Q54885728
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03934
AC   CVCL_R437
DR   BioSamples; SAME1840318
DR   Coriell; HG03934
DR   GEO; GSM1719617
DR   IGSR; HG03934
DR   Wikidata; Q54885729
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03937
AC   CVCL_R438
DR   BioSamples; SAME1840330
DR   Coriell; HG03937
DR   GEO; GSM1719618
DR   IGSR; HG03937
DR   Wikidata; Q54885730
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03939
AC   CVCL_GX68
DR   BioSamples; SAME1840336
DR   Coriell; HG03939
DR   IGSR; HG03939
DR   Wikidata; Q54885731
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03940
AC   CVCL_R439
DR   BioSamples; SAME1840346
DR   Coriell; HG03940
DR   GEO; GSM1719619
DR   IGSR; HG03940
DR   Wikidata; Q54885732
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03941
AC   CVCL_R440
DR   BioSamples; SAME1840353
DR   Coriell; HG03941
DR   GEO; GSM1719620
DR   IGSR; HG03941
DR   Wikidata; Q54885733
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03942
AC   CVCL_GX69
DR   BioSamples; SAME1840356
DR   Coriell; HG03942
DR   IGSR; HG03942
DR   Wikidata; Q54885734
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03943
AC   CVCL_R441
DR   BioSamples; SAME1840361
DR   Coriell; HG03943
DR   GEO; GSM1719621
DR   IGSR; HG03943
DR   Wikidata; Q54885735
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03944
AC   CVCL_R442
DR   BioSamples; SAME1840368
DR   Coriell; HG03944
DR   GEO; GSM1719622
DR   IGSR; HG03944
DR   Wikidata; Q54885736
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03945
AC   CVCL_R443
DR   BioSamples; SAME1840369
DR   Coriell; HG03945
DR   GEO; GSM1719623
DR   IGSR; HG03945
DR   Wikidata; Q54885737
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03947
AC   CVCL_R444
DR   BioSamples; SAME1840378
DR   Coriell; HG03947
DR   GEO; GSM1719624
DR   IGSR; HG03947
DR   Wikidata; Q54885738
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03948
AC   CVCL_GV07
DR   BioSamples; SAME1840129
DR   Coriell; HG03948
DR   GEO; GSM1719625
DR   IGSR; HG03948
DR   Wikidata; Q54885740
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   HG03949
AC   CVCL_R445
DR   BioSamples; SAME1840132
DR   Coriell; HG03949
DR   GEO; GSM1719626
DR   IGSR; HG03949
DR   Wikidata; Q54885741
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03950
AC   CVCL_R446
DR   BioSamples; SAME1840233
DR   Coriell; HG03950
DR   GEO; GSM1719627
DR   IGSR; HG03950
DR   Wikidata; Q54885742
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03951
AC   CVCL_R447
DR   BioSamples; SAME1840239
DR   Coriell; HG03951
DR   GEO; GSM1719628
DR   IGSR; HG03951
DR   Wikidata; Q54885743
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03953
AC   CVCL_R448
DR   BioSamples; SAME1840252
DR   Coriell; HG03953
DR   GEO; GSM1719629
DR   IGSR; HG03953
DR   Wikidata; Q54885744
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03955
AC   CVCL_R449
DR   BioSamples; SAME1840181
DR   Coriell; HG03955
DR   GEO; GSM1719630
DR   IGSR; HG03955
DR   Wikidata; Q54885745
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03960
AC   CVCL_R450
DR   BioSamples; SAME1839945
DR   Coriell; HG03960
DR   GEO; GSM1719631
DR   IGSR; HG03960
DR   Wikidata; Q54885746
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03963
AC   CVCL_R451
DR   BioSamples; SAME1840055
DR   Coriell; HG03963
DR   GEO; GSM1719632
DR   IGSR; HG03963
DR   Wikidata; Q54885753
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03965
AC   CVCL_R452
DR   BioSamples; SAME1840063
DR   Coriell; HG03965
DR   GEO; GSM1719633
DR   IGSR; HG03965
DR   Wikidata; Q54885754
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03967
AC   CVCL_R453
DR   BioSamples; SAME1840072
DR   Coriell; HG03967
DR   GEO; GSM1719634
DR   IGSR; HG03967
DR   Wikidata; Q54885755
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03968
AC   CVCL_R454
DR   BioSamples; SAME1840077
DR   Coriell; HG03968
DR   GEO; GSM1719635
DR   IGSR; HG03968
DR   Wikidata; Q54885756
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03969
AC   CVCL_R455
DR   BioSamples; SAME1840082
DR   Coriell; HG03969
DR   GEO; GSM1719636
DR   IGSR; HG03969
DR   Wikidata; Q54885757
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03971
AC   CVCL_R456
DR   BioSamples; SAME1839718
DR   Coriell; HG03971
DR   GEO; GSM1719637
DR   IGSR; HG03971
DR   Wikidata; Q54885758
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03972
AC   CVCL_R457
DR   BioSamples; SAME1839721
DR   Coriell; HG03972
DR   IGSR; HG03972
DR   Wikidata; Q54885759
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03973
AC   CVCL_R458
DR   BioSamples; SAME1839728
DR   Coriell; HG03973
DR   GEO; GSM1719638
DR   IGSR; HG03973
DR   Wikidata; Q54885760
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03974
AC   CVCL_R459
DR   BioSamples; SAME1839735
DR   Coriell; HG03974
DR   GEO; GSM1719639
DR   IGSR; HG03974
DR   Wikidata; Q54885761
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03976
AC   CVCL_R460
DR   BioSamples; SAME1839739
DR   Coriell; HG03976
DR   GEO; GSM1719640
DR   IGSR; HG03976
DR   Wikidata; Q54885762
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03977
AC   CVCL_R461
DR   BioSamples; SAME1839746
DR   Coriell; HG03977
DR   GEO; GSM1719641
DR   IGSR; HG03977
DR   Wikidata; Q54885763
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03978
AC   CVCL_R462
DR   BioSamples; SAME1839748
DR   Coriell; HG03978
DR   GEO; GSM1719642
DR   IGSR; HG03978
DR   Wikidata; Q54885764
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG03982
AC   CVCL_R463
DR   BioSamples; SAME1839585
DR   Coriell; HG03982
DR   IGSR; HG03982
DR   Wikidata; Q54885765
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03985
AC   CVCL_R464
DR   BioSamples; SAME1839601
DR   Coriell; HG03985
DR   GEO; GSM1719643
DR   IGSR; HG03985
DR   Wikidata; Q54885766
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03986
AC   CVCL_R465
DR   BioSamples; SAME1839605
DR   Coriell; HG03986
DR   GEO; GSM1719644
DR   IGSR; HG03986
DR   Wikidata; Q54885767
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03988
AC   CVCL_R466
DR   BioSamples; SAME1839528
DR   Coriell; HG03988
DR   IGSR; HG03988
DR   Wikidata; Q54885768
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03989
AC   CVCL_R467
DR   BioSamples; SAME1839532
DR   Coriell; HG03989
DR   GEO; GSM1719645
DR   IGSR; HG03989
DR   Wikidata; Q54885769
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03990
AC   CVCL_R468
DR   BioSamples; SAME1839637
DR   Coriell; HG03990
DR   GEO; GSM1719646
DR   IGSR; HG03990
DR   Wikidata; Q54885770
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03991
AC   CVCL_R469
DR   BioSamples; SAME1839640
DR   Coriell; HG03991
DR   GEO; GSM1719647
DR   IGSR; HG03991
DR   Wikidata; Q54885771
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03992
AC   CVCL_GX70
DR   BioSamples; SAME1839646
DR   Coriell; HG03992
DR   IGSR; HG03992
DR   Wikidata; Q54885772
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG03995
AC   CVCL_R470
DR   BioSamples; SAME1839395
DR   Coriell; HG03995
DR   GEO; GSM1719648
DR   IGSR; HG03995
DR   Wikidata; Q54885773
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03998
AC   CVCL_R471
DR   BioSamples; SAME1839408
DR   Coriell; HG03998
DR   GEO; GSM1719649
DR   IGSR; HG03998
DR   Wikidata; Q54885774
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG03999
AC   CVCL_R472
DR   BioSamples; SAME1839416
DR   Coriell; HG03999
DR   GEO; GSM1719650
DR   IGSR; HG03999
DR   Wikidata; Q54885775
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04001
AC   CVCL_R473
DR   BioSamples; SAME1839752
DR   Coriell; HG04001
DR   GEO; GSM1719651
DR   IGSR; HG04001
DR   Wikidata; Q54885776
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04002
AC   CVCL_R474
DR   BioSamples; SAME1839769
DR   Coriell; HG04002
DR   GEO; GSM1719652
DR   IGSR; HG04002
DR   Wikidata; Q54885777
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04003
AC   CVCL_R475
DR   BioSamples; SAME1839775
DR   Coriell; HG04003
DR   GEO; GSM1719653
DR   IGSR; HG04003
DR   Wikidata; Q54885778
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04006
AC   CVCL_R476
DR   BioSamples; SAME1839787
DR   Coriell; HG04006
DR   GEO; GSM1719654
DR   IGSR; HG04006
DR   Wikidata; Q54885780
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04014
AC   CVCL_R477
DR   BioSamples; SAME1839844
DR   Coriell; HG04014
DR   GEO; GSM1719655
DR   IGSR; HG04014
DR   Wikidata; Q54885781
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04015
AC   CVCL_R478
DR   BioSamples; SAME1839847
DR   Coriell; HG04015
DR   GEO; GSM1719656
DR   IGSR; HG04015
DR   Wikidata; Q54885782
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04017
AC   CVCL_R479
DR   BioSamples; SAME1839851
DR   Coriell; HG04017
DR   GEO; GSM1719657
DR   IGSR; HG04017
DR   Wikidata; Q54885783
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04018
AC   CVCL_R480
DR   BioSamples; SAME1839565
DR   Coriell; HG04018
DR   GEO; GSM1719658
DR   IGSR; HG04018
DR   Wikidata; Q54885784
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04019
AC   CVCL_R481
DR   BioSamples; SAME1839572
DR   Coriell; HG04019
DR   GEO; GSM1719659
DR   IGSR; HG04019
DR   Wikidata; Q54885785
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04020
AC   CVCL_R482
DR   BioSamples; SAME1839685
DR   Coriell; HG04020
DR   GEO; GSM1719660
DR   IGSR; HG04020
DR   Wikidata; Q54885786
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04022
AC   CVCL_R483
DR   BioSamples; SAME1839691
DR   Coriell; HG04022
DR   GEO; GSM1719661
DR   IGSR; HG04022
DR   Wikidata; Q54885787
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04023
AC   CVCL_R484
DR   BioSamples; SAME1839696
DR   Coriell; HG04023
DR   GEO; GSM1719662
DR   IGSR; HG04023
DR   Wikidata; Q54885788
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04024
AC   CVCL_R485
DR   BioSamples; SAME1839708
DR   Coriell; HG04024
DR   IGSR; HG04024
DR   Wikidata; Q54885789
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04025
AC   CVCL_R486
DR   BioSamples; SAME1839614
DR   Coriell; HG04025
DR   GEO; GSM1719663
DR   IGSR; HG04025
DR   Wikidata; Q54885790
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04026
AC   CVCL_R487
DR   BioSamples; SAME1839622
DR   Coriell; HG04026
DR   GEO; GSM1719664
DR   IGSR; HG04026
DR   Wikidata; Q54885791
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04029
AC   CVCL_R488
DR   BioSamples; SAME1839630
DR   Coriell; HG04029
DR   GEO; GSM1719665
DR   IGSR; HG04029
DR   Wikidata; Q54885792
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04033
AC   CVCL_R489
DR   BioSamples; SAME1839466
DR   Coriell; HG04033
DR   GEO; GSM1719666
DR   IGSR; HG04033
DR   Wikidata; Q54885793
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04035
AC   CVCL_R490
DR   BioSamples; SAME1839487
DR   Coriell; HG04035
DR   GEO; GSM1719667
DR   IGSR; HG04035
DR   Wikidata; Q54885799
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04036
AC   CVCL_GX71
DR   BioSamples; SAME1839492
DR   Coriell; HG04036
DR   IGSR; HG04036
DR   Wikidata; Q54885800
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04037
AC   CVCL_R491
DR   BioSamples; SAME1839500
DR   Coriell; HG04037
DR   IGSR; HG04037
DR   Wikidata; Q54885801
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04038
AC   CVCL_R492
DR   BioSamples; SAME1839499
DR   Coriell; HG04038
DR   GEO; GSM1719668
DR   IGSR; HG04038
DR   Wikidata; Q54885802
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04039
AC   CVCL_R493
DR   BioSamples; SAME1839506
DR   Coriell; HG04039
DR   GEO; GSM1719669
DR   IGSR; HG04039
DR   Wikidata; Q54885803
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04040
AC   CVCL_GX72
DR   BioSamples; SAME1839197
DR   Coriell; HG04040
DR   IGSR; HG04040
DR   Wikidata; Q54885804
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04042
AC   CVCL_R494
DR   BioSamples; SAME1839203
DR   Coriell; HG04042
DR   GEO; GSM1719670
DR   IGSR; HG04042
DR   Wikidata; Q54885805
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04047
AC   CVCL_R495
DR   BioSamples; SAME1839221
DR   Coriell; HG04047
DR   GEO; GSM1719671
DR   IGSR; HG04047
DR   Wikidata; Q54885806
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04050
AC   CVCL_R496
DR   BioSamples; SAME1839079
DR   Coriell; HG04050
DR   IGSR; HG04050
DR   Wikidata; Q54885807
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04053
AC   CVCL_R497
DR   BioSamples; SAME1839095
DR   Coriell; HG04053
DR   IGSR; HG04053
DR   Wikidata; Q54885808
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04054
AC   CVCL_R498
DR   BioSamples; SAME1839094
DR   Coriell; HG04054
DR   GEO; GSM1719672
DR   IGSR; HG04054
DR   Wikidata; Q54885809
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04055
AC   CVCL_R499
DR   BioSamples; SAME1839098
DR   Coriell; HG04055
DR   IGSR; HG04055
DR   Wikidata; Q54885810
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04056
AC   CVCL_R500
DR   BioSamples; SAME1839102
DR   Coriell; HG04056
DR   GEO; GSM1719673
DR   IGSR; HG04056
DR   Wikidata; Q54885811
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04058
AC   CVCL_R501
DR   BioSamples; SAME1839023
DR   Coriell; HG04058
DR   IGSR; HG04058
DR   Wikidata; Q54885812
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04059
AC   CVCL_R502
DR   BioSamples; SAME1839031
DR   Coriell; HG04059
DR   GEO; GSM1719674
DR   IGSR; HG04059
DR   Wikidata; Q54885813
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04060
AC   CVCL_R503
DR   BioSamples; SAME1839126
DR   Coriell; HG04060
DR   GEO; GSM1719675
DR   IGSR; HG04060
DR   Wikidata; Q54885814
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04061
AC   CVCL_R504
DR   BioSamples; SAME1839140
DR   Coriell; HG04061
DR   GEO; GSM1719676
DR   IGSR; HG04061
DR   Wikidata; Q54885815
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04062
AC   CVCL_R505
DR   BioSamples; SAME1839147
DR   Coriell; HG04062
DR   GEO; GSM1719677
DR   IGSR; HG04062
DR   Wikidata; Q54885816
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04063
AC   CVCL_R506
DR   BioSamples; SAME1839155
DR   Coriell; HG04063
DR   GEO; GSM1719678
DR   IGSR; HG04063
DR   Wikidata; Q54885817
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04067
AC   CVCL_GX73
DR   BioSamples; SAME1840315
DR   Coriell; HG04067
DR   IGSR; HG04067
DR   Wikidata; Q54885818
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04070
AC   CVCL_R507
DR   BioSamples; SAME1840411
DR   Coriell; HG04070
DR   GEO; GSM1719679
DR   IGSR; HG04070
DR   Wikidata; Q54885819
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04075
AC   CVCL_R508
DR   BioSamples; SAME1840359
DR   Coriell; HG04075
DR   GEO; GSM1719680
DR   IGSR; HG04075
DR   Wikidata; Q54885820
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04076
AC   CVCL_R509
DR   BioSamples; SAME1840358
DR   Coriell; HG04076
DR   GEO; GSM1719681
DR   IGSR; HG04076
DR   Wikidata; Q54885821
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04080
AC   CVCL_R510
DR   BioSamples; SAME1840211
DR   Coriell; HG04080
DR   GEO; GSM1719682
DR   IGSR; HG04080
DR   Wikidata; Q54885822
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04090
AC   CVCL_R511
DR   BioSamples; SAME1839927
DR   Coriell; HG04090
DR   GEO; GSM1719683
DR   IGSR; HG04090
DR   Wikidata; Q54885823
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04093
AC   CVCL_R512
DR   BioSamples; SAME1839936
DR   Coriell; HG04093
DR   GEO; GSM1719684
DR   IGSR; HG04093
DR   Wikidata; Q54885824
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04094
AC   CVCL_R513
DR   BioSamples; SAME1839953
DR   Coriell; HG04094
DR   GEO; GSM1719685
DR   IGSR; HG04094
DR   Wikidata; Q54885825
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04096
AC   CVCL_R514
DR   BioSamples; SAME1840054
DR   Coriell; HG04096
DR   GEO; GSM1719686
DR   IGSR; HG04096
DR   Wikidata; Q54885826
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04098
AC   CVCL_R515
DR   BioSamples; SAME1840059
DR   Coriell; HG04098
DR   GEO; GSM1719687
DR   IGSR; HG04098
DR   Wikidata; Q54885827
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04099
AC   CVCL_R516
DR   BioSamples; SAME1840065
DR   Coriell; HG04099
DR   GEO; GSM1719688
DR   IGSR; HG04099
DR   Wikidata; Q54885828
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04100
AC   CVCL_R517
DR   BioSamples; SAME1839536
DR   Coriell; HG04100
DR   GEO; GSM1719689
DR   IGSR; HG04100
DR   Wikidata; Q54885829
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04106
AC   CVCL_R518
DR   BioSamples; SAME1839559
DR   Coriell; HG04106
DR   GEO; GSM1719690
DR   IGSR; HG04106
DR   Wikidata; Q54885830
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04107
AC   CVCL_R519
DR   BioSamples; SAME1839660
DR   Coriell; HG04107
DR   GEO; GSM1719691
DR   IGSR; HG04107
DR   Wikidata; Q54885831
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04114
AC   CVCL_R520
DR   BioSamples; SAME1839363
DR   Coriell; HG04114
DR   IGSR; HG04114
DR   Wikidata; Q54885832
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04115
AC   CVCL_GX74
DR   BioSamples; SAME1839362
DR   Coriell; HG04115
DR   IGSR; HG04115
DR   Wikidata; Q54885833
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04118
AC   CVCL_R521
DR   BioSamples; SAME1839379
DR   Coriell; HG04118
DR   GEO; GSM1719692
DR   IGSR; HG04118
DR   Wikidata; Q54885834
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04122
AC   CVCL_GX75
DR   BioSamples; SAME1839230
DR   Coriell; HG04122
DR   IGSR; HG04122
DR   Wikidata; Q54885835
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04127
AC   CVCL_R522
DR   BioSamples; SAME1839249
DR   Coriell; HG04127
DR   IGSR; HG04127
DR   Wikidata; Q54885836
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04128
AC   CVCL_R523
DR   BioSamples; SAME1839253
DR   Coriell; HG04128
DR   IGSR; HG04128
DR   Wikidata; Q54885838
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04131
AC   CVCL_R524
DR   BioSamples; SAME1839279
DR   Coriell; HG04131
DR   GEO; GSM1719693
DR   IGSR; HG04131
DR   Wikidata; Q54885839
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04132
AC   CVCL_R525
DR   BioSamples; SAME1839287
DR   Coriell; HG04132
DR   IGSR; HG04132
DR   Wikidata; Q54885845
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04133
AC   CVCL_GX76
DR   BioSamples; SAME1839294
DR   Coriell; HG04133
DR   IGSR; HG04133
DR   Wikidata; Q54885846
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04134
AC   CVCL_R526
DR   BioSamples; SAME1839303
DR   Coriell; HG04134
DR   GEO; GSM1719694
DR   IGSR; HG04134
DR   Wikidata; Q54885847
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04135
AC   CVCL_R527
DR   BioSamples; SAME1839305
DR   Coriell; HG04135
DR   IGSR; HG04135
DR   Wikidata; Q54885848
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04136
AC   CVCL_GX77
DR   BioSamples; SAME1839310
DR   Coriell; HG04136
DR   IGSR; HG04136
DR   Wikidata; Q54885849
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04140
AC   CVCL_R528
DR   BioSamples; SAME1839173
DR   Coriell; HG04140
DR   GEO; GSM1719695
DR   IGSR; HG04140
DR   Wikidata; Q54885850
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04141
AC   CVCL_R529
DR   BioSamples; SAME1839178
DR   Coriell; HG04141
DR   GEO; GSM1719696
DR   IGSR; HG04141
DR   Wikidata; Q54885851
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04142
AC   CVCL_GX78
DR   BioSamples; SAME1839177
DR   Coriell; HG04142
DR   IGSR; HG04142
DR   Wikidata; Q54885852
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04144
AC   CVCL_R530
DR   BioSamples; SAME1839189
DR   Coriell; HG04144
DR   GEO; GSM1719697
DR   IGSR; HG04144
DR   Wikidata; Q54885853
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04146
AC   CVCL_R531
DR   BioSamples; SAME1839108
DR   Coriell; HG04146
DR   GEO; GSM1719698
DR   IGSR; HG04146
DR   Wikidata; Q54885854
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04147
AC   CVCL_R532
DR   BioSamples; SAME1839116
DR   Coriell; HG04147
DR   IGSR; HG04147
DR   Wikidata; Q54885855
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04148
AC   CVCL_GX79
DR   BioSamples; SAME1839115
DR   Coriell; HG04148
DR   IGSR; HG04148
DR   Wikidata; Q54885856
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04149
AC   CVCL_R533
DR   BioSamples; SAME1839120
DR   Coriell; HG04149
DR   IGSR; HG04149
DR   Wikidata; Q54885857
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04150
AC   CVCL_R534
DR   BioSamples; SAME1840289
DR   Coriell; HG04150
DR   IGSR; HG04150
DR   Wikidata; Q54885858
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04151
AC   CVCL_GX80
DR   BioSamples; SAME1840295
DR   Coriell; HG04151
DR   IGSR; HG04151
DR   Wikidata; Q54885859
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04152
AC   CVCL_R535
DR   BioSamples; SAME1840300
DR   Coriell; HG04152
DR   GEO; GSM1719699
DR   IGSR; HG04152
DR   Wikidata; Q54885860
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04153
AC   CVCL_R536
DR   BioSamples; SAME1840299
DR   Coriell; HG04153
DR   GEO; GSM1719700
DR   IGSR; HG04153
DR   Wikidata; Q54885861
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04155
AC   CVCL_R537
DR   BioSamples; SAME1840381
DR   Coriell; HG04155
DR   GEO; GSM1719701
DR   IGSR; HG04155
DR   Wikidata; Q54885862
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04156
AC   CVCL_R538
DR   BioSamples; SAME1840389
DR   Coriell; HG04156
DR   GEO; GSM1719702
DR   IGSR; HG04156
DR   Wikidata; Q54885863
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04157
AC   CVCL_GX81
DR   BioSamples; SAME1840395
DR   Coriell; HG04157
DR   IGSR; HG04157
DR   Wikidata; Q54885865
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04158
AC   CVCL_R539
DR   BioSamples; SAME1840400
DR   Coriell; HG04158
DR   GEO; GSM1719703
DR   IGSR; HG04158
DR   Wikidata; Q54885866
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04159
AC   CVCL_R540
DR   BioSamples; SAME1840399
DR   Coriell; HG04159
DR   GEO; GSM1719704
DR   IGSR; HG04159
DR   Wikidata; Q54885867
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04160
AC   CVCL_GX82
DR   BioSamples; SAME1840179
DR   Coriell; HG04160
DR   IGSR; HG04160
DR   Wikidata; Q54885868
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04161
AC   CVCL_R541
DR   BioSamples; SAME1840092
DR   Coriell; HG04161
DR   GEO; GSM1719705
DR   IGSR; HG04161
DR   Wikidata; Q54885869
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04162
AC   CVCL_R542
DR   BioSamples; SAME1840098
DR   Coriell; HG04162
DR   GEO; GSM1719706
DR   IGSR; HG04162
DR   Wikidata; Q54885870
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04164
AC   CVCL_R543
DR   BioSamples; SAME1840102
DR   Coriell; HG04164
DR   GEO; GSM1719707
DR   IGSR; HG04164
DR   Wikidata; Q54885871
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04171
AC   CVCL_R544
DR   BioSamples; SAME1839968
DR   Coriell; HG04171
DR   GEO; GSM1719708
DR   IGSR; HG04171
DR   Wikidata; Q54885872
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04173
AC   CVCL_R545
DR   BioSamples; SAME1839977
DR   Coriell; HG04173
DR   GEO; GSM1719709
DR   IGSR; HG04173
DR   Wikidata; Q54885873
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04174
AC   CVCL_R546
DR   BioSamples; SAME1839982
DR   Coriell; HG04174
DR   IGSR; HG04174
DR   Wikidata; Q54885874
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04175
AC   CVCL_GX83
DR   BioSamples; SAME1839980
DR   Coriell; HG04175
DR   IGSR; HG04175
DR   Wikidata; Q54885875
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04176
AC   CVCL_R547
DR   BioSamples; SAME1839986
DR   Coriell; HG04176
DR   GEO; GSM1719710
DR   IGSR; HG04176
DR   Wikidata; Q54885876
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04177
AC   CVCL_R548
DR   BioSamples; SAME1839992
DR   Coriell; HG04177
DR   GEO; GSM1719711
DR   IGSR; HG04177
DR   Wikidata; Q54885877
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04180
AC   CVCL_R549
DR   BioSamples; SAME1840012
DR   Coriell; HG04180
DR   GEO; GSM1719712
DR   IGSR; HG04180
DR   Wikidata; Q54885878
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04181
AC   CVCL_GX84
DR   BioSamples; SAME1840018
DR   Coriell; HG04181
DR   IGSR; HG04181
DR   Wikidata; Q54885879
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04182
AC   CVCL_R550
DR   BioSamples; SAME1840036
DR   Coriell; HG04182
DR   GEO; GSM1719713
DR   IGSR; HG04182
DR   Wikidata; Q54885880
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04183
AC   CVCL_R551
DR   BioSamples; SAME1840044
DR   Coriell; HG04183
DR   GEO; GSM1719714
DR   IGSR; HG04183
DR   Wikidata; Q54885881
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04184
AC   CVCL_GX85
DR   BioSamples; SAME1840049
DR   Coriell; HG04184
DR   IGSR; HG04184
DR   Wikidata; Q54885882
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04185
AC   CVCL_R552
DR   BioSamples; SAME1839756
DR   Coriell; HG04185
DR   GEO; GSM1719715
DR   IGSR; HG04185
DR   Wikidata; Q54885883
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04186
AC   CVCL_R553
DR   BioSamples; SAME1839753
DR   Coriell; HG04186
DR   GEO; GSM1719716
DR   IGSR; HG04186
DR   Wikidata; Q54885884
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04187
AC   CVCL_GX86
DR   BioSamples; SAME1839763
DR   Coriell; HG04187
DR   IGSR; HG04187
DR   Wikidata; Q54885885
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04188
AC   CVCL_R554
DR   BioSamples; SAME1839771
DR   Coriell; HG04188
DR   GEO; GSM1719717
DR   IGSR; HG04188
DR   Wikidata; Q54885889
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04189
AC   CVCL_R555
DR   BioSamples; SAME1839783
DR   Coriell; HG04189
DR   GEO; GSM1719718
DR   IGSR; HG04189
DR   Wikidata; Q54885890
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04191
AC   CVCL_R556
DR   BioSamples; SAME1839897
DR   Coriell; HG04191
DR   IGSR; HG04191
DR   Wikidata; Q54885891
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04192
AC   CVCL_R557
DR   BioSamples; SAME1839902
DR   Coriell; HG04192
DR   IGSR; HG04192
DR   Wikidata; Q54885892
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04193
AC   CVCL_GX87
DR   BioSamples; SAME1839811
DR   Coriell; HG04193
DR   IGSR; HG04193
DR   Wikidata; Q54885893
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04194
AC   CVCL_R558
DR   BioSamples; SAME1839818
DR   Coriell; HG04194
DR   GEO; GSM1719719
DR   IGSR; HG04194
DR   Wikidata; Q54885894
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04195
AC   CVCL_R559
DR   BioSamples; SAME1839823
DR   Coriell; HG04195
DR   GEO; GSM1719720
DR   IGSR; HG04195
DR   Wikidata; Q54885895
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Bengali in Bangladesh (BEB).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04197
AC   CVCL_GX88
DR   BioSamples; SAME1839828
DR   Coriell; HG04197
DR   IGSR; HG04197
DR   Wikidata; Q54885896
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04198
AC   CVCL_R560
DR   BioSamples; SAME1839835
DR   Coriell; HG04198
DR   GEO; GSM1719721
DR   IGSR; HG04198
DR   Wikidata; Q54885897
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04199
AC   CVCL_GX89
DR   BioSamples; SAME1839840
DR   Coriell; HG04199
DR   IGSR; HG04199
DR   Wikidata; Q54885898
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04200
AC   CVCL_R561
DR   BioSamples; SAME1839511
DR   Coriell; HG04200
DR   GEO; GSM1719722
DR   IGSR; HG04200
DR   Wikidata; Q54885899
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04202
AC   CVCL_R562
DR   BioSamples; SAME1839519
DR   Coriell; HG04202
DR   GEO; GSM1719723
DR   IGSR; HG04202
DR   Wikidata; Q54885900
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04204
AC   CVCL_GX90
DR   BioSamples; SAME1839437
DR   Coriell; HG04204
DR   IGSR; HG04204
DR   Wikidata; Q54885901
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04206
AC   CVCL_R563
DR   BioSamples; SAME1839447
DR   Coriell; HG04206
DR   GEO; GSM1719724
DR   IGSR; HG04206
DR   Wikidata; Q54885902
RX   PubMed=31401124;
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   HG04208
AC   CVCL_GX91
DR   BioSamples; SAME1839453
DR   Coriell; HG04208
DR   IGSR; HG04208
DR   Wikidata; Q54885903
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04209
AC   CVCL_R564
DR   BioSamples; SAME1839452
DR   Coriell; HG04209
DR   GEO; GSM1719725
DR   IGSR; HG04209
DR   Wikidata; Q54885904
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04210
AC   CVCL_R565
DR   BioSamples; SAME1839225
DR   Coriell; HG04210
DR   GEO; GSM1719726
DR   IGSR; HG04210
DR   Wikidata; Q54885905
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04211
AC   CVCL_R566
DR   BioSamples; SAME1839321
DR   Coriell; HG04211
DR   GEO; GSM1719727
DR   IGSR; HG04211
DR   Wikidata; Q54885906
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04212
AC   CVCL_R567
DR   BioSamples; SAME1839325
DR   Coriell; HG04212
DR   GEO; GSM1719728
DR   IGSR; HG04212
DR   Wikidata; Q54885907
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04214
AC   CVCL_R568
DR   BioSamples; SAME1839328
DR   Coriell; HG04214
DR   GEO; GSM1719729
DR   IGSR; HG04214
DR   Wikidata; Q54885908
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04215
AC   CVCL_GX92
DR   BioSamples; SAME1839333
DR   Coriell; HG04215
DR   IGSR; HG04215
DR   Wikidata; Q54885909
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04216
AC   CVCL_R569
DR   BioSamples; SAME1839339
DR   Coriell; HG04216
DR   GEO; GSM1719730
DR   IGSR; HG04216
DR   Wikidata; Q54885910
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04217
AC   CVCL_GX93
DR   BioSamples; SAME1839350
DR   Coriell; HG04217
DR   IGSR; HG04217
DR   Wikidata; Q54885911
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HG04219
AC   CVCL_R570
DR   BioSamples; SAME1839359
DR   Coriell; HG04219
DR   GEO; GSM1719731
DR   IGSR; HG04219
DR   Wikidata; Q54885912
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04222
AC   CVCL_R571
DR   BioSamples; SAME1839040
DR   Coriell; HG04222
DR   GEO; GSM1719732
DR   IGSR; HG04222
DR   Wikidata; Q54885913
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04225
AC   CVCL_R572
DR   BioSamples; SAME1839048
DR   Coriell; HG04225
DR   GEO; GSM1719733
DR   IGSR; HG04225
DR   Wikidata; Q54885914
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04227
AC   CVCL_R573
DR   BioSamples; SAME1839056
DR   Coriell; HG04227
DR   GEO; GSM1719734
DR   IGSR; HG04227
DR   Wikidata; Q54885916
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04228
AC   CVCL_GX94
DR   BioSamples; SAME1839161
DR   Coriell; HG04228
DR   IGSR; HG04228
DR   Wikidata; Q54885917
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   HG04229
AC   CVCL_R574
DR   BioSamples; SAME1839165
DR   Coriell; HG04229
DR   GEO; GSM1719735
DR   IGSR; HG04229
DR   Wikidata; Q54885918
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Sri Lankan Tamil in the UK (STU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   HG04235
AC   CVCL_R575
DR   BioSamples; SAME1840263
DR   Coriell; HG04235
DR   GEO; GSM1719736
DR   IGSR; HG04235
DR   Wikidata; Q54885920
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04238
AC   CVCL_R576
DR   BioSamples; SAME1840274
DR   Coriell; HG04238
DR   GEO; GSM1719737
DR   IGSR; HG04238
DR   Wikidata; Q54885921
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG04239
AC   CVCL_R577
DR   BioSamples; SAME1840281
DR   Coriell; HG04239
DR   GEO; GSM1719738
DR   IGSR; HG04239
DR   Wikidata; Q54885922
CC   Part of: International Genome Sample Resource (1000 genomes project) cell lines.
CC   Population: Indian; Telugu in the UK (ITU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   HG06799
AC   CVCL_E3T8
DR   Coriell; HG06799
CC   Population: African American.
CC   Karyotypic information: 46,XY,t(1;6)(6qter->6q13::1p13->1qter;6pter->6q13::1p13->1pter [5]; 46,XY [15] (Coriell=HG06799).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06800 iPSC
AC   CVCL_E3T9
SY   HG06800*J; CIMRi005-A
DR   Coriell; HG06800
DR   hPSCreg; CIMRi005-A
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3TA ! HG06800 LCL
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06800 LCL
AC   CVCL_E3TA
DR   Coriell; HG06800
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06801 iPSC
AC   CVCL_E3TB
SY   HG06801*J; CIMRi006-A
DR   Coriell; HG06801
DR   hPSCreg; CIMRi006-A
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3TC ! HG06801 LCL
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06801 LCL
AC   CVCL_E3TC
DR   Coriell; HG06801
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06802 iPSC
AC   CVCL_E3TD
SY   CIMRi007-A
DR   Coriell; HG06802
DR   hPSCreg; CIMRi007-A
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3TE ! HG06802 LCL
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06802 LCL
AC   CVCL_E3TE
DR   Coriell; HG06802
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06803 iPSC
AC   CVCL_E3TF
SY   HG06800*H; CIMRi008-A
DR   Coriell; HG06803
DR   hPSCreg; CIMRi008-A
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3TG ! HG06803 LCL
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06803 LCL
AC   CVCL_E3TG
DR   Coriell; HG06803
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06804 iPSC
AC   CVCL_E3TH
SY   HG06804*H; CIMRi009-A
DR   Coriell; HG06804
DR   hPSCreg; CIMRi009-A
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3TI ! HG06804 LCL
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06804 LCL
AC   CVCL_E3TI
DR   Coriell; HG06804
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06805
AC   CVCL_E3TJ
DR   Coriell; HG06805
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06807
AC   CVCL_E3TK
DR   Coriell; HG06807
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG06808
AC   CVCL_E3TL
DR   Coriell; HG06808
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HG1052
AC   CVCL_WX83
DR   Wikidata; Q94192496
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Unexplicit; Ex22-22Fdel; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 50(JeBl) (BSR50).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG12
AC   CVCL_E5QN
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HG1321
AC   CVCL_WX85
DR   Wikidata; Q94192500
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln700Ter (c.2098C>T); ClinVar=VCV000042067; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 59(FrFi) (BSR59).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U713 ! GM16886
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1374
AC   CVCL_WX80
DR   Wikidata; Q94192503
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser186_Lys187delinsTer (c.557_559delCAA) (S186*); ClinVar=VCV000005455; Zygosity=Homozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 128(YaWa) (BSR128).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG1435
AC   CVCL_WX81
DR   Wikidata; Q94192509
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gly891Glu (c.2672G>A); ClinVar=VCV000524780; Zygosity=Heterozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 54(AlTu) (BSR54).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WY09 ! HG2709
SX   Male
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG149
AC   CVCL_WX57
DR   Wikidata; Q94192513
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln700Ter (c.2098C>T); ClinVar=VCV000042067; Zygosity=Homozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 5(JaOa) (BSR5).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-32Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1514
AC   CVCL_WX82
DR   Wikidata; Q94192518
RX   PubMed=908169;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=7585968; PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 15(MaRo) (BSR15).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1542
AC   CVCL_WX77
DR   Wikidata; Q94192522
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 11(IaTh) (BSR11).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX78 ! HG1544
OI   CVCL_WX79 ! HG1547
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1544
AC   CVCL_WX78
DR   Wikidata; Q94192528
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 11(IaTh) (BSR11).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX77 ! HG1542
OI   CVCL_WX79 ! HG1547
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1547
AC   CVCL_WX79
DR   Wikidata; Q94192534
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 11(IaTh) (BSR11).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX77 ! HG1542
OI   CVCL_WX78 ! HG1544
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1584
AC   CVCL_WX86
DR   Wikidata; Q94192540
RX   PubMed=6705251;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ile770fs (c.2308-953_2555+4719del6126) (Ex11-12fdel); Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 92(VaBia) (BSR92).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1624
AC   CVCL_WX87
DR   Wikidata; Q94192543
RX   PubMed=2647324;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Ser (c.3164G>C); ClinVar=VCV000042078; Zygosity=Homozygous (PubMed=7585968; PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 113(DaDem) (BSR113).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1626
AC   CVCL_WX55
DR   Wikidata; Q94192547
RX   PubMed=6705251;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (PubMed=7585968; PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 93(YoYa) (BSR93).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W042 ! BS2KA
OI   CVCL_2869 ! BSL2KA
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   HG1647
AC   CVCL_WX88
DR   Wikidata; Q94192552
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 32(MiKo) (BSR32).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1742
AC   CVCL_WX89
DR   Wikidata; Q94192558
RX   PubMed=2647324;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi/Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 107(MyAsa) (BSR107).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U708 ! GM16859
OI   CVCL_WX72 ! HG2654
SX   Female
AG   >40Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1751
AC   CVCL_WX90
DR   Wikidata; Q94192563
RX   PubMed=2647324;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi/Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; c.98+1G>T; ClinVar=VCV000370200; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 126(BrNa) (BSR126).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG1782
AC   CVCL_WX91
DR   Wikidata; Q94192566
RX   PubMed=2647324;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser186_Lys187delinsTer (c.557_559delCAA) (S186*); ClinVar=VCV000005455; Zygosity=Homozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 110(MaKur) (BSR110).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG1783
AC   CVCL_WX92
DR   Wikidata; Q94192570
RX   PubMed=2647324;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 129(MaWat) (BSR129).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1785
AC   CVCL_WX93
DR   Wikidata; Q94192574
RX   PubMed=6705251;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser186_Lys187delinsTer (c.557_559delCAA) (S186*); ClinVar=VCV000005455; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 100(YuMat) (BSR100).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1805
AC   CVCL_WX76
DR   Wikidata; Q94192579
RX   PubMed=6705251;
RX   PubMed=17407155;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 86(NoKi) (BSR86).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L951 ! BS1KA
OI   CVCL_ZS84 ! EB-BS-NoKi-1
OI   CVCL_ZS85 ! EB-BS-NoKi-2
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1926
AC   CVCL_WX94
DR   Wikidata; Q94192585
RX   PubMed=6705251;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser186_Lys187delinsTer (c.557_559delCAA) (S186*); ClinVar=VCV000005455; Zygosity=Homozygous (PubMed=7585968; PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 97(AsOk) (BSR97).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG1929
AC   CVCL_WX95
DR   Wikidata; Q94192589
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Lys657Glufs*5 (c.1968dupG); ClinVar=VCV000495425; Zygosity=Homozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 17(ChSm) (BSR17).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG1943
AC   CVCL_WX53
DR   Wikidata; Q94192592
RX   PubMed=7585968;
RX   PubMed=10521302;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   HG1947
AC   CVCL_WX73
DR   Wikidata; Q94192598
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 53(StAs) (BSR53).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JD73 ! GM01620
OI   CVCL_U703 ! GM02085
SX   Female
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1972
AC   CVCL_WX96
DR   Wikidata; Q94192603
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Population: Jewish; Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 140(DrKas) (BSR140).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
//
ID   HG1974
AC   CVCL_WX97
DR   Wikidata; Q94192605
RX   PubMed=2647324;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 121(NiRos) (BSR121).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG1987
AC   CVCL_WX98
DR   Wikidata; Q94192610
RX   PubMed=908169;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Arg899Ter (c.2695C>T); ClinVar=VCV000127491; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asp1010Metfs*24 (c.3028delG); ClinVar=VCV000189048; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 30(MaKa) (BSR30).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2045
AC   CVCL_WX99
DR   Wikidata; Q94192615
RX   PubMed=2647324;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ile770fs (c.2308-117_2555+7420del7811) (Ex11-12fdel); Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Arg899Ter (c.2695C>T); ClinVar=VCV000127491; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 111(JaKir) (BSR111).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG2118
AC   CVCL_WY00
DR   Wikidata; Q94192618
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Thr830Asnfs*5 (c.2488dupA); ClinVar=VCV000042178; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Lys1227Asnfs*52 (c.3681delA); Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 65(AnPa) (BSR65).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG2122
AC   CVCL_WY01
DR   Wikidata; Q94192622
RX   PubMed=908169;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 61(DoHop) (BSR61).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG2162
AC   CVCL_WX54
DR   Wikidata; Q94192627
RX   PubMed=7585968;
RX   PubMed=10521302;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   HG2166
AC   CVCL_WX75
DR   Wikidata; Q94192631
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Phe1087Leufs*11 (c.3261delT); ClinVar=VCV000454132; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 26(SaTi) (BSR26).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U711 ! GM16882
SX   Female
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG2169
AC   CVCL_WY02
DR   Wikidata; Q94192636
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys901Tyr (c.2702G>A); dbSNP=rs758311406; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 40(DoRoe) (BSR40).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2193
AC   CVCL_WY03
DR   Wikidata; Q94192641
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Phe1087Leufs*11 (c.3261delT); ClinVar=VCV000454132; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 170 (BSR170).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2225
AC   CVCL_WY04
DR   Wikidata; Q94192644
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Phe1087Leufs*11 (c.3261delT); ClinVar=VCV000454132; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 22(ElHa) (BSR22).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG2231
AC   CVCL_WY05
DR   Wikidata; Q94192649
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln672Arg (c.2015A>G) (2089A>G); ClinVar=VCV000188963; Zygosity=Heterozygous (PubMed=7585968; PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Arg (c.3163T>C); ClinVar=VCV000549904; Zygosity=Heterozygous (PubMed=7585968; PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 139(ViKre) (BSR139).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2252
AC   CVCL_WY06
DR   Wikidata; Q94192653
RX   PubMed=436333;
RX   PubMed=17407155;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser104Ter (c.311C>A); ClinVar=VCV001683330; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Ser (c.3164G>C); ClinVar=VCV000042078; Zygosity=Heterozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 80(ErPal) (BSR80).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   HG23
AC   CVCL_RW46
DR   cancercelllines; CVCL_RW46
DR   GEO; GSM388886
DR   GEO; GSM388887
DR   GEO; GSM388888
DR   Wikidata; Q54885923
RX   PubMed=16843517;
RX   PubMed=19515767;
CC   Population: Japanese.
CC   Virology: Stably transfected with plasmid NV101, which contains a cloned cDNA consensus sequence of the RNA genome of Norwalk virus.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   HG2508
AC   CVCL_WY07
DR   Wikidata; Q94192672
RX   PubMed=2647324;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln909Ter (c.2725C>T); ClinVar=VCV001454098; Zygosity=Heterozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 105(ShWo) (BSR105).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG2510
AC   CVCL_WY08
DR   Wikidata; Q94192677
RX   PubMed=2647324;
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Lys272Ter (c.814A>T) (888A>T); Zygosity=Heterozygous (PubMed=7585968; PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ala363fs (c.1220+3A>G); ClinVar=VCV000949363; Zygosity=Heterozygous (PubMed=7585968; PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 112(NaSch) (BSR112).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   HG2619
AC   CVCL_WY19
DR   Wikidata; Q94192680
RX   PubMed=10521302;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   HG2620
AC   CVCL_WY20
DR   Wikidata; Q94192686
RX   PubMed=7585968;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   HG2654
AC   CVCL_WX72
DR   Wikidata; Q94192690
RX   PubMed=2647324;
RX   PubMed=7585968;
CC   Population: Jewish; Ashkenazi/Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=7585968).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 107(MyAsa) (BSR107).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U708 ! GM16859
OI   CVCL_WX89 ! HG1742
SX   Female
AG   >40Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG2703
AC   CVCL_WX52
DR   Wikidata; Q94192696
RX   PubMed=7585968;
RX   PubMed=10521302;
RX   PubMed=17407155;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=10521302; PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 171 (BSR171) (Nr2(CrSPe)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX74 ! HG2727
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG2709
AC   CVCL_WY09
DR   Wikidata; Q94192700
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 54(AlTu) (BSR54).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX81 ! HG1435
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2721
AC   CVCL_WY10
DR   Wikidata; Q94192705
RX   PubMed=17407155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln645Ter (c.1933C>T); ClinVar=VCV000454091; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Arg899Ter (c.2695C>T); ClinVar=VCV000127491; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 177 (BSR177).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HG2726
AC   CVCL_WY11
DR   Wikidata; Q94192711
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Population: Lebanese.
CC   Donor information: From Bloom Syndrome Registry patient 70(DY) (BSR70).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   HG2727
AC   CVCL_WX74
DR   Wikidata; Q94192715
RX   PubMed=7585968;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (from autologous cell line HG2703).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 171 (BSR171) (Nr2(CrSPe)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX52 ! HG2703
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG2820
AC   CVCL_WY12
DR   Wikidata; Q94192721
RX   PubMed=7585968;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 142(MaMatu) (BSR142).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG2829
AC   CVCL_WY13
DR   Wikidata; Q94192726
RX   PubMed=6705251;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Arg364Ter (c.1090A>T); ClinVar=VCV000632671; Zygosity=Homozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Trp567Ter (c.1701G>A); ClinVar=VCV000819865; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 98(RoMo) (BSR98).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2830
AC   CVCL_WY14
DR   Wikidata; Q94192731
RX   PubMed=908169;
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln700Ter (c.2098C>T); ClinVar=VCV000042067; Zygosity=Homozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 51(KeMc) (BSR51).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   HG2912
AC   CVCL_WY15
DR   Wikidata; Q94192737
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Leu751Lysfs*25 (c.2250_2251insAAAT); ClinVar=VCV000188790; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Phe1087Leufs*11 (c.3261delT); ClinVar=VCV000454132; Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 193 (BSR193).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2915
AC   CVCL_WY16
DR   Wikidata; Q94192743
RX   PubMed=17407155;
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (PubMed=17407155).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1066Tyr (c.3197G>A); Zygosity=Heterozygous (PubMed=17407155).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 197 (BSR197).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2917
AC   CVCL_WY17
DR   Wikidata; Q94192748
RX   PubMed=17407155;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: From Bloom Syndrome Registry patient 175 (BSR175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   HG2940
AC   CVCL_WY18
DR   Wikidata; Q94192752
RX   PubMed=17407155;
CC   Population: Ecuadorian and El Salvadoran.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Phe194Leufs*11 (c.582delT); ClinVar=VCV001878278; Zygosity=Homozygous (PubMed=17407155).
CC   Donor information: From Bloom Syndrome Registry patient 232 (BSR232).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   HG2L1.1c3
AC   CVCL_DC29
DR   cancercelllines; CVCL_DC29
DR   Wikidata; Q54885924
RX   Patent=US5854010;
RX   PubMed=8812265;
CC   Population: Caucasian.
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 20
//
ID   HG2L6.1c1
AC   CVCL_DC30
DR   cancercelllines; CVCL_DC30
DR   Wikidata; Q54885925
RX   PubMed=26366531;
WW   Provider; XDSI; -; http://www.dioxins.com/products/
CC   Population: Caucasian.
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 21
//
ID   HG2L6.1c3
AC   CVCL_DC31
DR   cancercelllines; CVCL_DC31
DR   Wikidata; Q54885926
RX   PubMed=21394221;
CC   Population: Caucasian.
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 20
//
ID   HG2L7.5c1
AC   CVCL_DC32
DR   cancercelllines; CVCL_DC32
DR   Wikidata; Q54885927
RX   PubMed=26366531;
CC   Population: Caucasian.
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 20
//
ID   HGADFN001
AC   CVCL_2A25
DR   Wikidata; Q54885928
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   HGADFN003
AC   CVCL_1Y86
SY   HGADFN 003; HGP 003; P01
DR   Wikidata; Q54885929
RX   PubMed=12714972;
RX   PubMed=16126733;
RX   PubMed=19958786;
RX   PubMed=23213444;
RX   PubMed=36139359;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF; PubMed=12714972).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z47 ! HGALBV073
SX   Male
AG   2Y0M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 17
//
ID   HGADFN003 hTERT
AC   CVCL_C3PB
DR   Wikidata; Q116049316
RX   PubMed=36139359;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y86 ! HGADFN003
SX   Male
AG   2Y0M
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HGADFN003 iPS1B
AC   CVCL_2A08
DR   Wikidata; Q54885930
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y86 ! HGADFN003
SX   Male
AG   2Y0M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN003 iPS1C
AC   CVCL_2A09
DR   Wikidata; Q54885937
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y86 ! HGADFN003
SX   Male
AG   2Y0M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN003 iPS1D
AC   CVCL_2A10
DR   Wikidata; Q54885938
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y86 ! HGADFN003
SX   Male
AG   2Y0M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN004
AC   CVCL_2A32
DR   Wikidata; Q54885939
RX   PubMed=16126733;
CC   Part of: Progeria Research Foundation cell lines.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGADFN005
AC   CVCL_2A26
DR   Wikidata; Q54885940
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGADFN008
AC   CVCL_2A27
DR   Wikidata; Q54885941
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   HGADFN014
AC   CVCL_2A28
DR   Wikidata; Q54885942
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PubMed=12714972).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   HGADFN122
AC   CVCL_1Y87
DR   GEO; GSM3124700
DR   Wikidata; Q54885943
RX   PubMed=30567591;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z52 ! HGALBV097
SX   Female
AG   5Y0M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN127
AC   CVCL_1Y88
SY   HGADFN 127; HGP 127
DR   GEO; GSM3124696
DR   Wikidata; Q54885944
RX   PubMed=30567591;
RX   PubMed=36139359;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z37 ! HGALBV039
SX   Female
AG   3Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGADFN127 hTERT
AC   CVCL_C3PC
DR   Wikidata; Q116049317
RX   PubMed=36139359;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y88 ! HGADFN127
SX   Female
AG   3Y9M
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HGADFN136
AC   CVCL_2A35
DR   Wikidata; Q54885945
RX   PubMed=16126733;
CC   Part of: Progeria Research Foundation cell lines.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGADFN143
AC   CVCL_1Y89
DR   GEO; GSM3124701
DR   Wikidata; Q54885946
RX   PubMed=30567591;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z31 ! HGALBV011
SX   Male
AG   8Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN155
AC   CVCL_1Y90
DR   Wikidata; Q54885947
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN164
AC   CVCL_1Y91
SY   HGADFN 164; HGP 164
DR   GEO; GSM3124697
DR   Wikidata; Q54885948
RX   PubMed=23213444;
RX   PubMed=30567591;
RX   PubMed=36139359;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGADFN164 hTERT
AC   CVCL_C3PD
DR   Wikidata; Q116049318
RX   PubMed=36139359;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y91 ! HGADFN164
SX   Female
AG   4Y8M
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HGADFN167
AC   CVCL_1Y92
SY   HGPS; PRF167
DR   EFO; EFO_0005909
DR   ENCODE; ENCBS381ENC
DR   GEO; GSM1023616
DR   GEO; GSM1023617
DR   GEO; GSM1023618
DR   GEO; GSM1023619
DR   GEO; GSM1023624
DR   GEO; GSM1023625
DR   GEO; GSM1023626
DR   GEO; GSM1023627
DR   GEO; GSM3124694
DR   Wikidata; Q54885949
RX   PubMed=19958786;
RX   PubMed=23027899;
RX   PubMed=23325432;
RX   PubMed=28855503;
RX   PubMed=30567591;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/progeria_Crawford_protocol.pdf
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z28 ! HGALBV009
SX   Male
AG   8Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 16
//
ID   HGADFN167 iPS1J
AC   CVCL_2A11
DR   Wikidata; Q54885950
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y92 ! HGADFN167
SX   Male
AG   8Y5M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN167 iPS1Q
AC   CVCL_2A12
DR   Wikidata; Q54885951
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y92 ! HGADFN167
SX   Male
AG   8Y5M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN169
AC   CVCL_1Y95
DR   GEO; GSM3124698
DR   Wikidata; Q54885952
RX   PubMed=23213444;
RX   PubMed=30567591;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN178
AC   CVCL_1Y96
SY   HGADFN 178; HGP 178
DR   GEO; GSM3124699
DR   Wikidata; Q54885953
RX   PubMed=23213444;
RX   PubMed=30567591;
RX   PubMed=36139359;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z55 ! HGALBV110
SX   Female
AG   6Y11M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGADFN178 hTERT
AC   CVCL_C3PE
DR   Wikidata; Q116049319
RX   PubMed=36139359;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y96 ! HGADFN178
SX   Female
AG   6Y11M
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HGADFN188
AC   CVCL_1Y97
SY   HGADFN 188; HGP 188
DR   GEO; GSM3124695
DR   Wikidata; Q54885954
RX   PubMed=23213444;
RX   PubMed=30567591;
RX   PubMed=36139359;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z63 ! HGALBV152
SX   Female
AG   2Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGADFN188 hTERT
AC   CVCL_C3PF
DR   Wikidata; Q116049320
RX   PubMed=36139359;
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y97 ! HGADFN188
SX   Female
AG   2Y3M
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HGADFN271
AC   CVCL_1Y98
DR   Wikidata; Q54885955
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN367
AC   CVCL_1Y99
DR   GEO; GSM3124702
DR   Wikidata; Q54885956
RX   PubMed=30567591;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y0M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   HGADFN370
AC   CVCL_1Z02
DR   Wikidata; Q54885957
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   HGADFN496
AC   CVCL_YU38
DR   Wikidata; Q94193200
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y7M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   HGADFSV40T367
AC   CVCL_DP43
SY   HGADFNSV40T367
DR   Wikidata; Q54885958
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y99 ! HGADFN367
SX   Female
AG   3Y0M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   HGALBV009
AC   CVCL_1Z28
DR   Wikidata; Q54885959
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF; PubMed=12714972).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y92 ! HGADFN167
SX   Male
AG   8Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV011
AC   CVCL_1Z31
DR   Wikidata; Q54885960
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF; PubMed=12714972).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y89 ! HGADFN143
SX   Male
AG   6Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV016
AC   CVCL_1Z34
DR   Wikidata; Q54885961
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV039
AC   CVCL_1Z37
DR   Wikidata; Q54885962
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y88 ! HGADFN127
SX   Female
AG   3Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV040
AC   CVCL_1Z38
DR   Wikidata; Q54885963
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV055
AC   CVCL_1Z41
DR   Wikidata; Q54885964
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV057
AC   CVCL_1Z43
DR   Wikidata; Q54885965
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF; PubMed=12714972).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV071
AC   CVCL_1Z46
DR   Wikidata; Q54885966
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF; PubMed=12714972).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y0M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV073
AC   CVCL_1Z47
DR   Wikidata; Q54885967
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y86 ! HGADFN003
SX   Male
AG   2Y0M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV074
AC   CVCL_1Z48
DR   Wikidata; Q54885968
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV097
AC   CVCL_1Z52
DR   Wikidata; Q54885969
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y87 ! HGADFN122
SX   Female
AG   2Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV110
AC   CVCL_1Z55
DR   Wikidata; Q54885970
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y96 ! HGADFN178
SX   Female
AG   5Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV113
AC   CVCL_1Z56
DR   Wikidata; Q54885971
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV132
AC   CVCL_1Z57
DR   Wikidata; Q54885972
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV145
AC   CVCL_1Z60
DR   Wikidata; Q54885973
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y0M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV146
AC   CVCL_1Z61
DR   Wikidata; Q54885974
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV150
AC   CVCL_1Z62
DR   Wikidata; Q54885975
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y0M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV152
AC   CVCL_1Z63
DR   Wikidata; Q54885976
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y97 ! HGADFN188
SX   Female
AG   11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV162
AC   CVCL_1Z64
DR   Wikidata; Q54885978
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV172
AC   CVCL_1Z65
DR   Wikidata; Q54885979
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV186
AC   CVCL_1Z66
DR   Wikidata; Q54885980
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y0M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV234
AC   CVCL_1Z80
DR   Wikidata; Q54885981
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV236
AC   CVCL_1Z67
DR   Wikidata; Q54885982
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV237
AC   CVCL_1Z68
DR   Wikidata; Q54885983
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV240
AC   CVCL_1Z69
DR   Wikidata; Q54885984
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV255
AC   CVCL_1Z70
DR   Wikidata; Q54885985
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV304
AC   CVCL_1Z71
DR   Wikidata; Q54885986
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   HGALBV314
AC   CVCL_1Z72
DR   Wikidata; Q54885987
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV331
AC   CVCL_1Z75
DR   Wikidata; Q54885988
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV338
AC   CVCL_1Z76
DR   Wikidata; Q54885989
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV351
AC   CVCL_1Z77
DR   Wikidata; Q54885990
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV378
AC   CVCL_1Z78
DR   Wikidata; Q54885991
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV389
AC   CVCL_1Z79
DR   Wikidata; Q54885992
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV395
AC   CVCL_1Z81
DR   Wikidata; Q54885993
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV408
AC   CVCL_1Z82
DR   Wikidata; Q54885994
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV419
AC   CVCL_1Z83
DR   Wikidata; Q54885995
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV424
AC   CVCL_1Z84
DR   Wikidata; Q54885996
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV437
AC   CVCL_1Z85
DR   Wikidata; Q54885997
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV439
AC   CVCL_1Z86
DR   Wikidata; Q54885998
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   HGALBV451
AC   CVCL_DP32
DR   Wikidata; Q54885999
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y7M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HGALBV452
AC   CVCL_DP33
DR   Wikidata; Q54886000
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HGALBV462
AC   CVCL_DP34
DR   Wikidata; Q54886001
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y2M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HGALBV471
AC   CVCL_LK55
DR   Wikidata; Q54886002
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y4M
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HGC-25
AC   CVCL_C827
SY   HGC 25
DR   cancercelllines; CVCL_C827
DR   GEO; GSM784700
DR   Progenetix; CVCL_C827
DR   Wikidata; Q54886003
RX   PubMed=851032;
RX   PubMed=3518877;
CC   Population: Japanese.
CC   Doubling time: 15.6 hours (PubMed=851032).
CC   Misspelling: HCG-25; Note=Occasionally.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 12
//
ID   HGC-27
AC   CVCL_1279
SY   HGC 27; HGC27
DR   BTO; BTO_0004828
DR   CLO; CLO_0003739
DR   CLO; CLO_0050799
DR   EFO; EFO_0006581
DR   CLDB; cl1673
DR   CLDB; cl1674
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0310
DR   BioGRID_ORCS_Cell_line; 658
DR   BioSample; SAMN03472940
DR   BioSample; SAMN10987863
DR   cancercelllines; CVCL_1279
DR   CCRID; 1101HUM-PUMC000279
DR   CCRID; 3101HUMTCHu22
DR   CCRID; 5301HUM-KCB16001YJ
DR   Cell_Model_Passport; SIDM00290
DR   ChEMBL-Cells; CHEMBL3308741
DR   ChEMBL-Targets; CHEMBL1075463
DR   CLS; 300436
DR   Cosmic; 907055
DR   Cosmic; 1001653
DR   Cosmic; 1007604
DR   Cosmic; 1187274
DR   Cosmic; 1518247
DR   Cosmic; 1995440
DR   Cosmic; 2484952
DR   Cosmic; 2807625
DR   Cosmic-CLP; 907055
DR   DepMap; ACH-000847
DR   ECACC; 94042256
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907055
DR   GEO; GSM552358
DR   GEO; GSM827366
DR   GEO; GSM844558
DR   GEO; GSM887081
DR   GEO; GSM888151
DR   GEO; GSM1374533
DR   GEO; GSM1374534
DR   GEO; GSM1669881
DR   GEO; GSM2983069
DR   GEO; GSM2983070
DR   GEO; GSM2983071
DR   GEO; GSM2983072
DR   IARC_TP53; 21370
DR   ICLC; HTL95028
DR   KCB; KCB 2016001YJ
DR   LiGeA; CCLE_106
DR   LINCS_LDP; LCL-1882
DR   PharmacoDB; HGC27_543_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1279
DR   PubChem_Cell_line; CVCL_1279
DR   RCB; RCB0500
DR   Ubigene; YC-C079
DR   Wikidata; Q54886004
RX   PubMed=136873;
RX   PubMed=3986962;
RX   PubMed=11314020;
RX   PubMed=11416159;
RX   PubMed=15767549;
RX   PubMed=15901131;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34466148;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~17 hours (Note=At 21th passage) (PubMed=136873).
CC   HLA typing: A*24:02:24:02; B*55:02,55:02; C*03:03,03:03 (PubMed=26589293).
CC   HLA typing: A*24:02:01; B*55:02:01; C*03:03:01; DPB1*05:01:01; DQA1*01:01:01; DQB1*05:01:01; DRB1*01:01:01 (CLS=300436).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (Cosmic-CLP=907055; DepMap=ACH-000847).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (Cosmic-CLP=907055; DepMap=ACH-000847).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (Cosmic-CLP=907055; DepMap=ACH-000847).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.61%; East Asian, South=21.46%; South Asian=0.22%; European, North=0%; European, South=0.7% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID; CLS=300436; Cosmic-CLP=907055; ECACC=94042256; PubMed=11416159; PubMed=25877200; RCB=RCB0500
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 16 (PubMed=11416159)
ST   D18S51: 16,17 (CCRID; CLS=300436; PubMed=25877200)
ST   D19S433: 14
ST   D21S11: 30,33,34
ST   D2S1338: 22,24
ST   D3S1358: 17 (CLS=300436; PubMed=25877200)
ST   D3S1358: 17,17.3 (CCRID)
ST   D5S818: 12
ST   D7S820: 11,12,13
ST   D8S1179: 7,11,16 (CLS=300436)
ST   D8S1179: 8.2,10,11,16 (CCRID)
ST   D8S1179: 11 (PubMed=11416159; PubMed=25877200)
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   HGC27-EGFP
AC   CVCL_XB28
DR   cancercelllines; CVCL_XB28
DR   Wikidata; Q94193781
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000648). It was the sole source of information for this entry.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 14
ST   D21S11: 30,33,34
ST   D2S1338: 22,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 18
ST   D7S820: 11,12,13
ST   D8S1179: 10,11,16
ST   FGA: 22
ST   Penta E: 18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   HGC27-mCherry-2
AC   CVCL_XD65
DR   cancercelllines; CVCL_XD65
DR   CCRID; 1101HUM-PUMC000647
DR   Wikidata; Q94193785
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000647
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 14
ST   D21S11: 30,33
ST   D2S1338: 22,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 18
ST   D7S820: 11,12,13
ST   D8S1179: 11,16
ST   FGA: 22
ST   Penta E: 18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   HGC27-tdT
AC   CVCL_XB29
DR   cancercelllines; CVCL_XB29
DR   CCRID; 1101HUM-PUMC000646
DR   Wikidata; Q94193791
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000646
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 14
ST   D21S11: 30,33,34
ST   D2S1338: 22,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 18
ST   D7S820: 11,12,13
ST   D8S1179: 10,11,16
ST   FGA: 22
ST   Penta E: 18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 13
//
ID   HGDP00001
AC   CVCL_I001
DR   Wikidata; Q54886005
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00003
AC   CVCL_I003
DR   Wikidata; Q54886006
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00005
AC   CVCL_I005
DR   Wikidata; Q54886007
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00007
AC   CVCL_I007
DR   Wikidata; Q54886009
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00009
AC   CVCL_I009
DR   Wikidata; Q54886010
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00011
AC   CVCL_I011
DR   Wikidata; Q54886011
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00013
AC   CVCL_I013
DR   Wikidata; Q54886012
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00015
AC   CVCL_I015
DR   Wikidata; Q54886013
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00017
AC   CVCL_I017
DR   Wikidata; Q54886014
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00019
AC   CVCL_I019
DR   Wikidata; Q54886015
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00021
AC   CVCL_I021
DR   Wikidata; Q54886016
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00023
AC   CVCL_I023
DR   Wikidata; Q54886017
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00025
AC   CVCL_I025
DR   Wikidata; Q54886018
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00027
AC   CVCL_I027
DR   Wikidata; Q54886022
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00029
AC   CVCL_I029
DR   Wikidata; Q54886023
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00031
AC   CVCL_I031
DR   Wikidata; Q54886024
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00033
AC   CVCL_I033
DR   Wikidata; Q54886025
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00035
AC   CVCL_I035
DR   Wikidata; Q54886026
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00037
AC   CVCL_I037
DR   Wikidata; Q54886027
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00039
AC   CVCL_I039
DR   Wikidata; Q54886028
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00041
AC   CVCL_I041
DR   Wikidata; Q54886029
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00043
AC   CVCL_I043
DR   Wikidata; Q54886030
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00045
AC   CVCL_I045
DR   Wikidata; Q54886031
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00047
AC   CVCL_I047
DR   Wikidata; Q54886032
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00049
AC   CVCL_I049
DR   Wikidata; Q54886033
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Brahui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00052
AC   CVCL_I052
DR   Wikidata; Q54886034
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00054
AC   CVCL_I054
DR   Wikidata; Q54886035
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00056
AC   CVCL_I056
DR   Wikidata; Q54886036
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00057
AC   CVCL_I057
DR   Wikidata; Q54886037
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00058
AC   CVCL_I058
DR   Wikidata; Q54886038
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00060
AC   CVCL_I060
DR   Wikidata; Q54886039
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00062
AC   CVCL_I062
DR   Wikidata; Q54886040
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00064
AC   CVCL_I064
DR   Wikidata; Q54886041
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00066
AC   CVCL_I066
DR   Wikidata; Q54886042
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00068
AC   CVCL_I068
DR   Wikidata; Q54886043
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00070
AC   CVCL_I070
DR   Wikidata; Q54886044
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00072
AC   CVCL_I072
DR   Wikidata; Q54886045
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00074
AC   CVCL_I074
DR   Wikidata; Q54886046
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00076
AC   CVCL_I076
DR   Wikidata; Q54886047
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00078
AC   CVCL_I078
DR   Wikidata; Q54886048
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00080
AC   CVCL_I080
DR   Wikidata; Q54886050
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00082
AC   CVCL_I082
DR   Wikidata; Q54886051
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00084
AC   CVCL_I084
DR   Wikidata; Q54886052
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00086
AC   CVCL_I086
DR   Wikidata; Q54886053
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00088
AC   CVCL_I088
DR   Wikidata; Q54886054
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00090
AC   CVCL_I090
DR   Wikidata; Q54886055
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00092
AC   CVCL_I092
DR   Wikidata; Q54886056
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00094
AC   CVCL_I094
DR   Wikidata; Q54886057
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00096
AC   CVCL_I096
DR   Wikidata; Q54886058
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00098
AC   CVCL_I098
DR   Wikidata; Q54886059
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Balochi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00099
AC   CVCL_I099
DR   Wikidata; Q54886060
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00100
AC   CVCL_I100
DR   Wikidata; Q54886061
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00102
AC   CVCL_I102
DR   Wikidata; Q54886062
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00103
AC   CVCL_I103
DR   Wikidata; Q54886069
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00104
AC   CVCL_I104
DR   Wikidata; Q54886070
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00105
AC   CVCL_I105
DR   Wikidata; Q54886071
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00106
AC   CVCL_I106
DR   Wikidata; Q54886072
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00108
AC   CVCL_I108
DR   Wikidata; Q54886073
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00109
AC   CVCL_I109
DR   Wikidata; Q54886074
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00110
AC   CVCL_I110
DR   Wikidata; Q54886075
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00111
AC   CVCL_I111
DR   Wikidata; Q54886076
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara (but could be Pathan).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I220 ! HGDP00220
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00112
AC   CVCL_I112
DR   Wikidata; Q54886077
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00113
AC   CVCL_I113
DR   Wikidata; Q54886078
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00115
AC   CVCL_I115
DR   Wikidata; Q54886079
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00116
AC   CVCL_I116
DR   Wikidata; Q54886080
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00118
AC   CVCL_I118
DR   Wikidata; Q54886081
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00119
AC   CVCL_I119
DR   Wikidata; Q54886082
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00120
AC   CVCL_I120
DR   Wikidata; Q54886083
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00121
AC   CVCL_I121
DR   Wikidata; Q54886084
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00122
AC   CVCL_I122
DR   Wikidata; Q54886085
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00124
AC   CVCL_I124
DR   Wikidata; Q54886086
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00125
AC   CVCL_I125
DR   Wikidata; Q54886087
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00127
AC   CVCL_I127
DR   Wikidata; Q54886088
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00128
AC   CVCL_I128
DR   Wikidata; Q54886089
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00129
AC   CVCL_I129
DR   Wikidata; Q54886090
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00130
AC   CVCL_I130
DR   Wikidata; Q54886091
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00131
AC   CVCL_I131
DR   Wikidata; Q54886092
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00133
AC   CVCL_I133
DR   Wikidata; Q54886093
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00134
AC   CVCL_I134
DR   Wikidata; Q54886094
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00135
AC   CVCL_I135
DR   Wikidata; Q54886095
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00136
AC   CVCL_I136
DR   Wikidata; Q54886096
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00137
AC   CVCL_I137
DR   Wikidata; Q54886098
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00139
AC   CVCL_I139
DR   Wikidata; Q54886099
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00140
AC   CVCL_I140
DR   Wikidata; Q54886101
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00141
AC   CVCL_I141
DR   Wikidata; Q54886102
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00143
AC   CVCL_I143
DR   Wikidata; Q54886103
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00144
AC   CVCL_I144
DR   Wikidata; Q54886104
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00145
AC   CVCL_I145
DR   Wikidata; Q54886105
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00146
AC   CVCL_I146
DR   Wikidata; Q54886106
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00148
AC   CVCL_I148
DR   Wikidata; Q54886107
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00149
AC   CVCL_I149
DR   Wikidata; Q54886108
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00150
AC   CVCL_I150
DR   Wikidata; Q54886109
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00151
AC   CVCL_I151
DR   Wikidata; Q54886110
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00153
AC   CVCL_I153
DR   Wikidata; Q54886117
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00154
AC   CVCL_I154
DR   Wikidata; Q54886118
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00155
AC   CVCL_I155
DR   Wikidata; Q54886119
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00157
AC   CVCL_I157
DR   Wikidata; Q54886120
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00158
AC   CVCL_I158
DR   Wikidata; Q54886121
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00160
AC   CVCL_I160
DR   Wikidata; Q54886122
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00161
AC   CVCL_I161
DR   Wikidata; Q54886123
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Makrani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00163
AC   CVCL_I163
DR   Wikidata; Q54886124
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00165
AC   CVCL_I165
DR   Wikidata; Q54886125
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00167
AC   CVCL_I167
DR   Wikidata; Q54886126
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00169
AC   CVCL_I169
DR   Wikidata; Q54886127
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00171
AC   CVCL_I171
DR   Wikidata; Q54886128
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00173
AC   CVCL_I173
DR   Wikidata; Q54886129
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00175
AC   CVCL_I175
DR   Wikidata; Q54886131
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00177
AC   CVCL_I177
DR   Wikidata; Q54886132
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00179
AC   CVCL_I179
DR   Wikidata; Q54886133
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00181
AC   CVCL_I181
DR   Wikidata; Q54886134
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00183
AC   CVCL_I183
DR   Wikidata; Q54886135
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00185
AC   CVCL_I185
DR   Wikidata; Q54886136
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00187
AC   CVCL_I187
DR   Wikidata; Q54886137
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00189
AC   CVCL_I189
DR   Wikidata; Q54886138
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00191
AC   CVCL_I191
DR   Wikidata; Q54886139
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00192
AC   CVCL_I192
DR   Wikidata; Q54886140
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00195
AC   CVCL_I195
DR   Wikidata; Q54886141
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00197
AC   CVCL_I197
DR   Wikidata; Q54886142
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00199
AC   CVCL_I199
DR   Wikidata; Q54886143
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00201
AC   CVCL_I201
DR   Wikidata; Q54886144
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00203
AC   CVCL_I203
DR   Wikidata; Q54886145
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00205
AC   CVCL_I205
DR   Wikidata; Q54886146
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00206
AC   CVCL_I206
DR   Wikidata; Q54886147
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00208
AC   CVCL_I208
DR   Wikidata; Q54886148
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00210
AC   CVCL_I210
DR   Wikidata; Q54886149
RX   PubMed=11954565;
RX   PubMed=27995740;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Indian; Sindhi.
CC   Sequence variation: Gene deletion; HGNC; HGNC:3620; FCGR3B; Zygosity=Homozygous (PubMed=27995740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   HGDP00213
AC   CVCL_I213
DR   Wikidata; Q54886150
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00214
AC   CVCL_I214
DR   Wikidata; Q54886151
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00216
AC   CVCL_I216
DR   Wikidata; Q54886152
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00218
AC   CVCL_I218
DR   Wikidata; Q54886153
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00220
AC   CVCL_I220
DR   Wikidata; Q54886154
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Hazara (but could be Pathan).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I111 ! HGDP00111
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00222
AC   CVCL_I222
DR   Wikidata; Q54886155
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00224
AC   CVCL_I224
DR   Wikidata; Q54886156
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00226
AC   CVCL_I226
DR   Wikidata; Q54886157
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00228
AC   CVCL_I228
DR   Wikidata; Q54886160
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00230
AC   CVCL_I230
DR   Wikidata; Q54886161
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00232
AC   CVCL_I232
DR   Wikidata; Q54886162
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00234
AC   CVCL_I234
DR   Wikidata; Q54886163
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00237
AC   CVCL_I237
DR   Wikidata; Q54886165
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00239
AC   CVCL_I239
DR   Wikidata; Q54886166
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00241
AC   CVCL_I241
DR   Wikidata; Q54886167
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00243
AC   CVCL_I243
DR   Wikidata; Q54886168
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00244
AC   CVCL_I244
DR   Wikidata; Q54886169
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00247
AC   CVCL_I247
DR   Wikidata; Q54886170
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00248
AC   CVCL_I248
DR   Wikidata; Q54886171
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00251
AC   CVCL_I251
DR   Wikidata; Q54886172
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00254
AC   CVCL_I254
DR   Wikidata; Q54886173
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00258
AC   CVCL_I258
DR   Wikidata; Q54886174
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00259
AC   CVCL_I259
DR   Wikidata; Q54886175
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00262
AC   CVCL_I262
DR   Wikidata; Q54886176
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00264
AC   CVCL_I264
DR   Wikidata; Q54886177
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pashtun.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00267
AC   CVCL_I267
DR   Wikidata; Q54886178
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00274
AC   CVCL_I274
DR   Wikidata; Q54886179
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00277
AC   CVCL_I277
DR   Wikidata; Q54886180
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00279
AC   CVCL_I279
DR   Wikidata; Q54886181
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00281
AC   CVCL_I281
DR   Wikidata; Q54886182
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00285
AC   CVCL_I285
DR   Wikidata; Q54886183
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00286
AC   CVCL_I286
DR   Wikidata; Q54886184
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00288
AC   CVCL_I288
DR   Wikidata; Q54886185
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00290
AC   CVCL_I290
DR   Wikidata; Q54886186
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00292
AC   CVCL_I292
DR   Wikidata; Q54886187
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00298
AC   CVCL_I298
DR   Wikidata; Q54886188
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00302
AC   CVCL_I302
DR   Wikidata; Q54886189
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00304
AC   CVCL_I304
DR   Wikidata; Q54886190
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00307
AC   CVCL_I307
DR   Wikidata; Q54886191
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00309
AC   CVCL_I309
DR   Wikidata; Q54886192
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00311
AC   CVCL_I311
DR   Wikidata; Q54886193
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00313
AC   CVCL_I313
DR   Wikidata; Q54886194
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00315
AC   CVCL_I315
DR   Wikidata; Q54886195
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00319
AC   CVCL_I319
DR   Wikidata; Q54886197
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00321
AC   CVCL_I321
DR   Wikidata; Q54886198
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00323
AC   CVCL_I323
DR   Wikidata; Q54886199
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00326
AC   CVCL_I326
DR   Wikidata; Q54886200
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00328
AC   CVCL_I328
DR   Wikidata; Q54886201
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00330
AC   CVCL_I330
DR   Wikidata; Q54886203
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00333
AC   CVCL_I333
DR   Wikidata; Q54886204
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Kalash.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00336
AC   CVCL_I336
DR   Wikidata; Q54886205
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00338
AC   CVCL_I338
DR   Wikidata; Q54886206
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00341
AC   CVCL_I341
DR   Wikidata; Q54886207
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00346
AC   CVCL_I346
DR   Wikidata; Q54886208
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00351
AC   CVCL_I351
DR   Wikidata; Q54886209
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00356
AC   CVCL_I356
DR   Wikidata; Q54886210
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00359
AC   CVCL_I359
DR   Wikidata; Q54886211
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00364
AC   CVCL_I364
DR   Wikidata; Q54886212
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00371
AC   CVCL_I371
DR   Wikidata; Q54886213
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00372
AC   CVCL_I372
DR   Wikidata; Q54886214
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00376
AC   CVCL_I376
DR   Wikidata; Q54886215
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00382
AC   CVCL_I382
DR   Wikidata; Q54886216
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00388
AC   CVCL_I388
DR   Wikidata; Q54886217
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00392
AC   CVCL_I392
DR   Wikidata; Q54886218
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00397
AC   CVCL_I397
DR   Wikidata; Q54886219
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00402
AC   CVCL_I402
DR   Wikidata; Q54886220
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00407
AC   CVCL_I407
DR   Wikidata; Q54886221
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00412
AC   CVCL_I412
DR   Wikidata; Q54886222
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00417
AC   CVCL_I417
DR   Wikidata; Q54886223
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00423
AC   CVCL_I423
DR   Wikidata; Q54886224
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00428
AC   CVCL_I428
DR   Wikidata; Q54886225
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00433
AC   CVCL_I433
DR   Wikidata; Q54886226
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00438
AC   CVCL_I438
DR   Wikidata; Q54886227
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00444
AC   CVCL_I444
DR   Wikidata; Q54886228
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00445
AC   CVCL_I445
DR   Wikidata; Q54886229
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Burusho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00448
AC   CVCL_I448
DR   Wikidata; Q54886230
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00449
AC   CVCL_I449
DR   Wikidata; Q54886231
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00450
AC   CVCL_I450
DR   Wikidata; Q54886232
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00451
AC   CVCL_I451
DR   Wikidata; Q54886233
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00452
AC   CVCL_I452
DR   Wikidata; Q54886234
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I202 ! HGDP01087
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00453
AC   CVCL_I453
DR   Wikidata; Q54886235
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00454
AC   CVCL_I454
DR   Wikidata; Q54886236
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00455
AC   CVCL_I455
DR   Wikidata; Q54886237
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00456
AC   CVCL_I456
DR   Wikidata; Q54886238
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00457
AC   CVCL_I457
DR   Wikidata; Q54886239
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I212 ! HGDP01092
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00458
AC   CVCL_I458
DR   Wikidata; Q54886240
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00459
AC   CVCL_I459
DR   Wikidata; Q54886241
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00460
AC   CVCL_I460
DR   Wikidata; Q54886242
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00461
AC   CVCL_I461
DR   Wikidata; Q54886246
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00462
AC   CVCL_I462
DR   Wikidata; Q54886247
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00463
AC   CVCL_I463
DR   Wikidata; Q54886248
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00464
AC   CVCL_I464
DR   Wikidata; Q54886249
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00465
AC   CVCL_I465
DR   Wikidata; Q54886250
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00466
AC   CVCL_I466
DR   Wikidata; Q54886251
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00467
AC   CVCL_I467
DR   Wikidata; Q54886252
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00468
AC   CVCL_I468
DR   Wikidata; Q54886253
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00469
AC   CVCL_I469
DR   Wikidata; Q54886254
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00470
AC   CVCL_I470
DR   Wikidata; Q54886255
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00471
AC   CVCL_I471
DR   Wikidata; Q54886257
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00472
AC   CVCL_I472
DR   Wikidata; Q54886259
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I981 ! HGDP00981
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00473
AC   CVCL_I473
DR   Wikidata; Q54886260
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00474
AC   CVCL_I474
DR   Wikidata; Q54886262
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00475
AC   CVCL_I475
DR   Wikidata; Q54886264
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00476
AC   CVCL_I476
DR   Wikidata; Q54886265
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00477
AC   CVCL_I477
DR   Wikidata; Q54886267
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00478
AC   CVCL_I478
DR   Wikidata; Q54886268
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00479
AC   CVCL_I479
DR   Wikidata; Q54886271
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00490
AC   CVCL_I490
DR   Wikidata; Q54886273
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00491
AC   CVCL_I491
DR   Wikidata; Q54886274
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00511
AC   CVCL_I511
DR   Wikidata; Q54886276
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00512
AC   CVCL_I512
DR   Wikidata; Q54886278
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00513
AC   CVCL_I513
DR   Wikidata; Q54886279
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00514
AC   CVCL_I514
DR   Wikidata; Q54886281
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00515
AC   CVCL_I515
DR   Wikidata; Q54886283
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00516
AC   CVCL_I516
DR   Wikidata; Q54886284
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00517
AC   CVCL_I517
DR   Wikidata; Q54886285
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00518
AC   CVCL_I518
DR   Wikidata; Q54886286
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00519
AC   CVCL_I519
DR   Wikidata; Q54886287
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00520
AC   CVCL_I520
DR   Wikidata; Q54886288
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00521
AC   CVCL_I521
DR   Wikidata; Q54886289
RX   PubMed=11954565;
RX   PubMed=20448178;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   HGDP00522
AC   CVCL_I522
DR   Wikidata; Q54886290
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00523
AC   CVCL_I523
DR   Wikidata; Q54886291
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00524
AC   CVCL_I524
DR   Wikidata; Q54886292
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00525
AC   CVCL_I525
DR   Wikidata; Q54886295
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00526
AC   CVCL_I526
DR   Wikidata; Q54886297
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00527
AC   CVCL_I527
DR   Wikidata; Q54886299
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00528
AC   CVCL_I528
DR   Wikidata; Q54886300
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00529
AC   CVCL_I529
DR   Wikidata; Q54886301
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00530
AC   CVCL_I530
DR   Wikidata; Q54886313
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00531
AC   CVCL_I531
DR   Wikidata; Q54886315
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00532
AC   CVCL_I532
DR   Wikidata; Q54886317
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00533
AC   CVCL_I533
DR   Wikidata; Q54886319
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00534
AC   CVCL_I534
DR   Wikidata; Q54886320
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00535
AC   CVCL_I535
DR   Wikidata; Q54886322
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00536
AC   CVCL_I536
DR   Wikidata; Q54886323
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00537
AC   CVCL_I537
DR   Wikidata; Q54886324
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00538
AC   CVCL_I538
DR   Wikidata; Q54886325
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00539
AC   CVCL_I539
DR   Wikidata; Q54886326
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP00540
AC   CVCL_I540
DR   Wikidata; Q54886327
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00541
AC   CVCL_I541
DR   Wikidata; Q54886328
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00542
AC   CVCL_I542
DR   Wikidata; Q54886329
RX   PubMed=11954565;
RX   PubMed=20448178;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   HGDP00543
AC   CVCL_I543
DR   Wikidata; Q54886330
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00544
AC   CVCL_I544
DR   Wikidata; Q54886331
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00545
AC   CVCL_I545
DR   Wikidata; Q54886332
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00546
AC   CVCL_I546
DR   Wikidata; Q54886333
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00547
AC   CVCL_I547
DR   Wikidata; Q54886334
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00548
AC   CVCL_I548
DR   Wikidata; Q54886335
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00549
AC   CVCL_I549
DR   Wikidata; Q54886336
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00550
AC   CVCL_I550
DR   Wikidata; Q54886337
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00551
AC   CVCL_I551
DR   Wikidata; Q54886338
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00552
AC   CVCL_I552
DR   Wikidata; Q54886339
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00553
AC   CVCL_I553
DR   Wikidata; Q54886340
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00554
AC   CVCL_I554
DR   Wikidata; Q54886341
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00555
AC   CVCL_I555
DR   Wikidata; Q54886342
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00556
AC   CVCL_I556
DR   Wikidata; Q54886343
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00557
AC   CVCL_I557
DR   Wikidata; Q54886344
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00558
AC   CVCL_I558
DR   Wikidata; Q54886345
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00559
AC   CVCL_I559
DR   Wikidata; Q54886346
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00560
AC   CVCL_I560
DR   Wikidata; Q54886347
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00561
AC   CVCL_I561
DR   Wikidata; Q54886349
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00562
AC   CVCL_I562
DR   Wikidata; Q54886350
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00563
AC   CVCL_I563
DR   Wikidata; Q54886351
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00564
AC   CVCL_I564
DR   Wikidata; Q54886352
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00565
AC   CVCL_I565
DR   Wikidata; Q54886353
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00566
AC   CVCL_I566
DR   Wikidata; Q54886354
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00567
AC   CVCL_I567
DR   Wikidata; Q54886355
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00568
AC   CVCL_I568
DR   Wikidata; Q54886356
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00569
AC   CVCL_I569
DR   Wikidata; Q54886357
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00570
AC   CVCL_I570
DR   Wikidata; Q54886362
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00571
AC   CVCL_I571
DR   Wikidata; Q54886363
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00572
AC   CVCL_I572
DR   Wikidata; Q54886364
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00573
AC   CVCL_I573
DR   Wikidata; Q54886365
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00574
AC   CVCL_I574
DR   Wikidata; Q54886366
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00575
AC   CVCL_I575
DR   Wikidata; Q54886367
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00576
AC   CVCL_I576
DR   Wikidata; Q54886368
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00577
AC   CVCL_I577
DR   Wikidata; Q54886369
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00578
AC   CVCL_I578
DR   Wikidata; Q54886370
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00579
AC   CVCL_I579
DR   Wikidata; Q54886371
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00580
AC   CVCL_I580
DR   Wikidata; Q54886372
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00581
AC   CVCL_I581
DR   Wikidata; Q54886373
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00582
AC   CVCL_I582
DR   Wikidata; Q54886374
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00583
AC   CVCL_I583
DR   Wikidata; Q54886375
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I589 ! HGDP00589
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00584
AC   CVCL_I584
DR   Wikidata; Q54886376
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00585
AC   CVCL_I585
DR   Wikidata; Q54886377
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00586
AC   CVCL_I586
DR   Wikidata; Q54886378
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00587
AC   CVCL_I587
DR   Wikidata; Q54886379
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00588
AC   CVCL_I588
DR   Wikidata; Q54886380
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00589
AC   CVCL_I589
DR   Wikidata; Q54886381
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I583 ! HGDP00583
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00590
AC   CVCL_I590
DR   Wikidata; Q54886382
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00591
AC   CVCL_I591
DR   Wikidata; Q54886383
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00592
AC   CVCL_I592
DR   Wikidata; Q54886384
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00594
AC   CVCL_I594
DR   Wikidata; Q54886385
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00595
AC   CVCL_I595
DR   Wikidata; Q54886386
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00597
AC   CVCL_I597
DR   Wikidata; Q54886387
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00598
AC   CVCL_I598
DR   Wikidata; Q54886388
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00599
AC   CVCL_I599
DR   Wikidata; Q54886389
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00600
AC   CVCL_I600
DR   Wikidata; Q54886390
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00601
AC   CVCL_I601
DR   Wikidata; Q54886391
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00602
AC   CVCL_I602
DR   Wikidata; Q54886392
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00603
AC   CVCL_I603
DR   Wikidata; Q54886393
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00604
AC   CVCL_I604
DR   Wikidata; Q54886394
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00605
AC   CVCL_I605
DR   Wikidata; Q54886395
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00606
AC   CVCL_I606
DR   Wikidata; Q54886396
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Druze.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00607
AC   CVCL_I607
DR   Wikidata; Q54886397
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00608
AC   CVCL_I608
DR   Wikidata; Q54886398
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00609
AC   CVCL_I609
DR   Wikidata; Q54886399
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00610
AC   CVCL_I610
DR   Wikidata; Q54886400
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00611
AC   CVCL_I611
DR   Wikidata; Q54886401
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00612
AC   CVCL_I612
DR   Wikidata; Q54886407
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00613
AC   CVCL_I613
DR   Wikidata; Q54886408
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00614
AC   CVCL_I614
DR   Wikidata; Q54886409
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00615
AC   CVCL_I615
DR   Wikidata; Q54886410
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00616
AC   CVCL_I616
DR   Wikidata; Q54886411
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00617
AC   CVCL_I617
DR   Wikidata; Q54886412
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00618
AC   CVCL_I618
DR   Wikidata; Q54886413
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00619
AC   CVCL_I619
DR   Wikidata; Q54886414
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00620
AC   CVCL_I620
DR   Wikidata; Q54886415
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00621
AC   CVCL_I621
DR   Wikidata; Q54886416
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00622
AC   CVCL_I622
DR   Wikidata; Q54886417
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00623
AC   CVCL_I623
DR   Wikidata; Q54886418
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00624
AC   CVCL_I624
DR   Wikidata; Q54886419
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00625
AC   CVCL_I625
DR   Wikidata; Q54886420
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00626
AC   CVCL_I626
DR   Wikidata; Q54886421
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00627
AC   CVCL_I627
DR   Wikidata; Q54886422
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00628
AC   CVCL_I628
SY   CEPH-HGDP00628
DR   Wikidata; Q54886423
RX   PubMed=11954565;
RX   PubMed=24057213;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Virology: Contains a chromosomally integrated human herpesvirus 6A (CI-HHV-6A).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   HGDP00629
AC   CVCL_I629
DR   Wikidata; Q54886424
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00630
AC   CVCL_I630
DR   Wikidata; Q54886425
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00631
AC   CVCL_I631
DR   Wikidata; Q54886426
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00632
AC   CVCL_I632
DR   Wikidata; Q54886427
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00633
AC   CVCL_I633
DR   Wikidata; Q54886428
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00634
AC   CVCL_I634
DR   Wikidata; Q54886429
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00635
AC   CVCL_I635
DR   Wikidata; Q54886430
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00636
AC   CVCL_I636
DR   Wikidata; Q54886431
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00637
AC   CVCL_I637
DR   Wikidata; Q54886432
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00638
AC   CVCL_I638
DR   Wikidata; Q54886433
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00639
AC   CVCL_I639
DR   Wikidata; Q54886434
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00640
AC   CVCL_I640
DR   Wikidata; Q54886435
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00641
AC   CVCL_I641
DR   Wikidata; Q54886436
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00642
AC   CVCL_I642
DR   Wikidata; Q54886437
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00643
AC   CVCL_I643
DR   Wikidata; Q54886438
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00644
AC   CVCL_I644
DR   Wikidata; Q54886439
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00645
AC   CVCL_I645
DR   Wikidata; Q54886440
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00646
AC   CVCL_I646
DR   Wikidata; Q54886441
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00647
AC   CVCL_I647
DR   Wikidata; Q54886442
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00648
AC   CVCL_I648
DR   Wikidata; Q54886443
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00649
AC   CVCL_I649
DR   Wikidata; Q54886444
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00650
AC   CVCL_I650
DR   Wikidata; Q54886445
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I652 ! HGDP00652
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00651
AC   CVCL_I651
DR   Wikidata; Q54886446
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00652
AC   CVCL_I652
DR   Wikidata; Q54886450
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I650 ! HGDP00650
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00653
AC   CVCL_I653
DR   Wikidata; Q54886451
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00654
AC   CVCL_I654
DR   Wikidata; Q54886454
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00655
AC   CVCL_I655
DR   Wikidata; Q54886455
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00656
AC   CVCL_I656
DR   Wikidata; Q54886456
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00657
AC   CVCL_I657
DR   Wikidata; Q54886457
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I826 ! HGDP00826
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00658
AC   CVCL_I658
DR   Wikidata; Q54886458
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I659 ! HGDP00659
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00659
AC   CVCL_I659
DR   Wikidata; Q54886459
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I658 ! HGDP00658
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00660
AC   CVCL_I660
DR   Wikidata; Q54886460
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I979 ! HGDP00979
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00661
AC   CVCL_I661
DR   Wikidata; Q54886461
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00662
AC   CVCL_I662
DR   Wikidata; Q54886462
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00663
AC   CVCL_I663
DR   Wikidata; Q54886463
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00664
AC   CVCL_I664
DR   Wikidata; Q54886464
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00665
AC   CVCL_I665
DR   Wikidata; Q54886465
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00666
AC   CVCL_I666
DR   Wikidata; Q54886466
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00667
AC   CVCL_I667
DR   Wikidata; Q54886467
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00668
AC   CVCL_I668
DR   Wikidata; Q54886468
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00669
AC   CVCL_I669
DR   Wikidata; Q54886469
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00670
AC   CVCL_I670
DR   Wikidata; Q54886470
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00671
AC   CVCL_I671
DR   Wikidata; Q54886471
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00672
AC   CVCL_I672
DR   Wikidata; Q54886472
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00673
AC   CVCL_I673
DR   Wikidata; Q54886473
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00674
AC   CVCL_I674
DR   Wikidata; Q54886474
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00675
AC   CVCL_I675
DR   Wikidata; Q54886475
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00676
AC   CVCL_I676
DR   Wikidata; Q54886476
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00677
AC   CVCL_I677
DR   Wikidata; Q54886477
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00678
AC   CVCL_I678
DR   Wikidata; Q54886478
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00679
AC   CVCL_I679
DR   Wikidata; Q54886479
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00680
AC   CVCL_I680
DR   Wikidata; Q54886480
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00681
AC   CVCL_I681
DR   Wikidata; Q54886481
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00682
AC   CVCL_I682
DR   Wikidata; Q54886483
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00683
AC   CVCL_I683
DR   Wikidata; Q54886484
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00684
AC   CVCL_I684
DR   Wikidata; Q54886485
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00685
AC   CVCL_I685
DR   Wikidata; Q54886486
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00686
AC   CVCL_I686
DR   Wikidata; Q54886487
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00687
AC   CVCL_I687
DR   Wikidata; Q54886488
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00688
AC   CVCL_I688
DR   Wikidata; Q54886489
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00689
AC   CVCL_I689
DR   Wikidata; Q54886490
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00690
AC   CVCL_I690
DR   Wikidata; Q54886491
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00691
AC   CVCL_I691
DR   Wikidata; Q54886492
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00692
AC   CVCL_I692
DR   Wikidata; Q54886497
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00693
AC   CVCL_I693
DR   Wikidata; Q54886498
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00694
AC   CVCL_I694
DR   Wikidata; Q54886499
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00695
AC   CVCL_I695
DR   Wikidata; Q54886500
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00696
AC   CVCL_I696
DR   Wikidata; Q54886501
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00697
AC   CVCL_I697
DR   Wikidata; Q54886502
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00698
AC   CVCL_I698
DR   Wikidata; Q54886503
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00699
AC   CVCL_I699
DR   Wikidata; Q54886504
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00700
AC   CVCL_I700
DR   Wikidata; Q54886505
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00701
AC   CVCL_I701
DR   Wikidata; Q54886506
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Bedouin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00702
AC   CVCL_I702
DR   Wikidata; Q54886507
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00703
AC   CVCL_I703
DR   Wikidata; Q54886508
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00704
AC   CVCL_I704
DR   Wikidata; Q54886509
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00705
AC   CVCL_I705
DR   Wikidata; Q54886510
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00706
AC   CVCL_I706
DR   Wikidata; Q54886511
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00707
AC   CVCL_I707
DR   Wikidata; Q54886512
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00708
AC   CVCL_I708
DR   Wikidata; Q54886513
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00709
AC   CVCL_I709
DR   Wikidata; Q54886514
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00710
AC   CVCL_I710
DR   Wikidata; Q54886515
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00711
AC   CVCL_I711
DR   Wikidata; Q54886517
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00712
AC   CVCL_I712
DR   Wikidata; Q54886518
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00713
AC   CVCL_I713
DR   Wikidata; Q54886519
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00714
AC   CVCL_I714
DR   Wikidata; Q54886520
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00715
AC   CVCL_I715
DR   Wikidata; Q54886521
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00716
AC   CVCL_I716
DR   Wikidata; Q54886522
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00717
AC   CVCL_I717
DR   Wikidata; Q54886523
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00718
AC   CVCL_I718
DR   Wikidata; Q54886524
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00719
AC   CVCL_I719
DR   Wikidata; Q54886525
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00720
AC   CVCL_I720
DR   Wikidata; Q54886526
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00721
AC   CVCL_I721
DR   Wikidata; Q54886527
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Southeast Asian; Cambodian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00722
AC   CVCL_I722
DR   Wikidata; Q54886528
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00723
AC   CVCL_I723
DR   Wikidata; Q54886529
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00724
AC   CVCL_I724
DR   Wikidata; Q54886530
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00725
AC   CVCL_I725
DR   Wikidata; Q54886531
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00726
AC   CVCL_I726
DR   Wikidata; Q54886532
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00727
AC   CVCL_I727
DR   Wikidata; Q54886533
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00728
AC   CVCL_I728
DR   Wikidata; Q54886534
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00729
AC   CVCL_I729
DR   Wikidata; Q54886535
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00730
AC   CVCL_I730
DR   Wikidata; Q54886536
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00731
AC   CVCL_I731
DR   Wikidata; Q54886537
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00732
AC   CVCL_I732
DR   Wikidata; Q54886544
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00733
AC   CVCL_I733
DR   Wikidata; Q54886545
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00734
AC   CVCL_I734
DR   Wikidata; Q54886546
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00735
AC   CVCL_I735
DR   Wikidata; Q54886547
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00736
AC   CVCL_I736
DR   Wikidata; Q54886549
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00737
AC   CVCL_I737
DR   Wikidata; Q54886550
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00738
AC   CVCL_I738
DR   Wikidata; Q54886551
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00739
AC   CVCL_I739
DR   Wikidata; Q54886552
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00740
AC   CVCL_I740
DR   Wikidata; Q54886553
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00741
AC   CVCL_I741
DR   Wikidata; Q54886554
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00742
AC   CVCL_I742
DR   Wikidata; Q54886555
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00743
AC   CVCL_I743
DR   Wikidata; Q54886556
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00744
AC   CVCL_I744
DR   Wikidata; Q54886557
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00745
AC   CVCL_I745
DR   Wikidata; Q54886558
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00746
AC   CVCL_I746
DR   Wikidata; Q54886559
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00747
AC   CVCL_I747
DR   Wikidata; Q54886560
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00748
AC   CVCL_I748
DR   Wikidata; Q54886561
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00749
AC   CVCL_I749
DR   Wikidata; Q54886562
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00750
AC   CVCL_I750
DR   Wikidata; Q54886563
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00751
AC   CVCL_I751
DR   Wikidata; Q54886564
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00752
AC   CVCL_I752
DR   Wikidata; Q54886565
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00753
AC   CVCL_I753
DR   Wikidata; Q54886566
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00754
AC   CVCL_I754
DR   Wikidata; Q54886567
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00755
AC   CVCL_I755
DR   Wikidata; Q54886568
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00756
AC   CVCL_I756
DR   Wikidata; Q54886569
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00757
AC   CVCL_I757
DR   Wikidata; Q54886570
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00758
AC   CVCL_I758
DR   Wikidata; Q54886571
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00759
AC   CVCL_I759
DR   Wikidata; Q54886573
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00760
AC   CVCL_I760
DR   Wikidata; Q54886574
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00761
AC   CVCL_I761
DR   Wikidata; Q54886575
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00762
AC   CVCL_I762
DR   Wikidata; Q54886576
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I048 ! HGDP01025
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00763
AC   CVCL_I763
DR   Wikidata; Q54886577
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00764
AC   CVCL_I764
DR   Wikidata; Q54886578
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00765
AC   CVCL_I765
DR   Wikidata; Q54886579
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00766
AC   CVCL_I766
DR   Wikidata; Q54886580
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00767
AC   CVCL_I767
DR   Wikidata; Q54886581
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00768
AC   CVCL_I768
DR   Wikidata; Q54886582
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00769
AC   CVCL_I769
DR   Wikidata; Q54886583
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00770
AC   CVCL_I770
DR   Wikidata; Q54886584
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native American (was originally classified as Japanese).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00771
AC   CVCL_I771
DR   Wikidata; Q54886585
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00772
AC   CVCL_I772
DR   Wikidata; Q54886589
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00773
AC   CVCL_I773
DR   Wikidata; Q54886590
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00774
AC   CVCL_I774
DR   Wikidata; Q54886591
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00775
AC   CVCL_I775
DR   Wikidata; Q54886592
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00776
AC   CVCL_I776
DR   Wikidata; Q54886593
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00777
AC   CVCL_I777
DR   Wikidata; Q54886594
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00778
AC   CVCL_I778
DR   Wikidata; Q54886595
RX   PubMed=11954565;
RX   PubMed=20448178;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   HGDP00779
AC   CVCL_I779
DR   Wikidata; Q54886596
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00780
AC   CVCL_I780
DR   Wikidata; Q54886597
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00781
AC   CVCL_I781
DR   Wikidata; Q54886598
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00782
AC   CVCL_I782
DR   Wikidata; Q54886599
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00783
AC   CVCL_I783
DR   Wikidata; Q54886600
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00784
AC   CVCL_I784
DR   Wikidata; Q54886601
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00785
AC   CVCL_I785
DR   Wikidata; Q54886602
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00786
AC   CVCL_I786
DR   Wikidata; Q54886603
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00787
AC   CVCL_I787
DR   Wikidata; Q54886604
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00788
AC   CVCL_I788
DR   Wikidata; Q54886605
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00789
AC   CVCL_I789
DR   Wikidata; Q54886606
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00790
AC   CVCL_I790
DR   Wikidata; Q54886607
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00791
AC   CVCL_I791
DR   Wikidata; Q54886608
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00792
AC   CVCL_I792
DR   Wikidata; Q54886609
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00793
AC   CVCL_I793
DR   Wikidata; Q54886610
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00794
AC   CVCL_I794
DR   Wikidata; Q54886611
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00795
AC   CVCL_I795
DR   Wikidata; Q54886612
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00796
AC   CVCL_I796
DR   Wikidata; Q54886613
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00797
AC   CVCL_I797
DR   Wikidata; Q54886614
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00798
AC   CVCL_I798
DR   Wikidata; Q54886615
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00799
AC   CVCL_I799
DR   Wikidata; Q54886616
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00800
AC   CVCL_I800
DR   Wikidata; Q54886617
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00801
AC   CVCL_I801
DR   Wikidata; Q54886618
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00802
AC   CVCL_I802
DR   Wikidata; Q54886619
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00803
AC   CVCL_I803
DR   Wikidata; Q54886621
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00804
AC   CVCL_I804
DR   Wikidata; Q54886623
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00805
AC   CVCL_I805
DR   Wikidata; Q54886624
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00806
AC   CVCL_I806
DR   Wikidata; Q54886625
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00807
AC   CVCL_I807
DR   Wikidata; Q54886626
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00808
AC   CVCL_I808
DR   Wikidata; Q54886627
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00810
AC   CVCL_I810
DR   Wikidata; Q54886629
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Orcadian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00811
AC   CVCL_I811
DR   Wikidata; Q54886630
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00812
AC   CVCL_I812
DR   Wikidata; Q54886631
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00813
AC   CVCL_I813
DR   Wikidata; Q54886637
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I042 ! HGDP01022
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00814
AC   CVCL_I814
DR   Wikidata; Q54886638
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00815
AC   CVCL_I815
DR   Wikidata; Q54886639
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00817
AC   CVCL_I817
DR   Wikidata; Q54886640
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00818
AC   CVCL_I818
DR   Wikidata; Q54886641
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00819
AC   CVCL_I819
DR   Wikidata; Q54886642
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00820
AC   CVCL_I820
DR   Wikidata; Q54886643
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00821
AC   CVCL_I821
DR   Wikidata; Q54886644
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00822
AC   CVCL_I822
DR   Wikidata; Q54886645
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00823
AC   CVCL_I823
DR   Wikidata; Q54886646
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00824
AC   CVCL_I824
DR   Wikidata; Q54886647
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00825
AC   CVCL_I825
DR   Wikidata; Q54886648
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00826
AC   CVCL_I826
DR   Wikidata; Q54886649
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I657 ! HGDP00657
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00827
AC   CVCL_I827
DR   Wikidata; Q54886650
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00828
AC   CVCL_I828
DR   Wikidata; Q54886651
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00830
AC   CVCL_I830
DR   Wikidata; Q54886652
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00832
AC   CVCL_I832
DR   Wikidata; Q54886653
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00833
AC   CVCL_I833
DR   Wikidata; Q54886654
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00834
AC   CVCL_I834
DR   Wikidata; Q54886655
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00835
AC   CVCL_I835
DR   Wikidata; Q54886656
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00837
AC   CVCL_I837
DR   Wikidata; Q54886657
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00838
AC   CVCL_I838
DR   Wikidata; Q54886658
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00839
AC   CVCL_I839
DR   Wikidata; Q54886659
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00840
AC   CVCL_I840
DR   Wikidata; Q54886660
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00841
AC   CVCL_I841
DR   Wikidata; Q54886661
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00842
AC   CVCL_I842
DR   Wikidata; Q54886662
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00843
AC   CVCL_I843
DR   Wikidata; Q54886663
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00844
AC   CVCL_I844
DR   Wikidata; Q54886664
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00845
AC   CVCL_I845
DR   Wikidata; Q54886665
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00846
AC   CVCL_I846
DR   Wikidata; Q54886666
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00847
AC   CVCL_I847
DR   Wikidata; Q54886667
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00848
AC   CVCL_I848
DR   Wikidata; Q54886668
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00849
AC   CVCL_I849
DR   Wikidata; Q54886669
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00850
AC   CVCL_I850
DR   Wikidata; Q54886670
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00851
AC   CVCL_I851
DR   Wikidata; Q54886671
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00852
AC   CVCL_I852
DR   Wikidata; Q54886672
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Surui.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00854
AC   CVCL_I854
DR   Wikidata; Q54886673
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00855
AC   CVCL_I855
DR   Wikidata; Q54886675
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00856
AC   CVCL_I856
DR   Wikidata; Q54886676
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00857
AC   CVCL_I857
DR   Wikidata; Q54886677
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00858
AC   CVCL_I858
DR   Wikidata; Q54886680
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00859
AC   CVCL_I859
DR   Wikidata; Q54886681
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00860
AC   CVCL_I860
DR   Wikidata; Q54886682
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00861
AC   CVCL_I861
DR   Wikidata; Q54886683
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00862
AC   CVCL_I862
DR   Wikidata; Q54886684
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00863
AC   CVCL_I863
DR   Wikidata; Q54886685
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00864
AC   CVCL_I864
DR   Wikidata; Q54886686
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00865
AC   CVCL_I865
DR   Wikidata; Q54886687
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00866
AC   CVCL_I866
DR   Wikidata; Q54886688
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00867
AC   CVCL_I867
DR   Wikidata; Q54886689
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00868
AC   CVCL_I868
DR   Wikidata; Q54886690
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00869
AC   CVCL_I869
DR   Wikidata; Q54886691
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00870
AC   CVCL_I870
DR   Wikidata; Q54886692
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00871
AC   CVCL_I871
DR   Wikidata; Q54886693
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00872
AC   CVCL_I872
DR   Wikidata; Q54886694
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00873
AC   CVCL_I873
DR   Wikidata; Q54886695
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00874
AC   CVCL_I874
DR   Wikidata; Q54886696
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00875
AC   CVCL_I875
DR   Wikidata; Q54886697
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00876
AC   CVCL_I876
DR   Wikidata; Q54886698
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00877
AC   CVCL_I877
DR   Wikidata; Q54886699
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00878
AC   CVCL_I878
DR   Wikidata; Q54886700
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Mayan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00879
AC   CVCL_I879
DR   Wikidata; Q54886701
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00880
AC   CVCL_I880
DR   Wikidata; Q54886703
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00881
AC   CVCL_I881
DR   Wikidata; Q54886704
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00882
AC   CVCL_I882
DR   Wikidata; Q54886705
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00883
AC   CVCL_I883
DR   Wikidata; Q54886706
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00884
AC   CVCL_I884
DR   Wikidata; Q54886707
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00885
AC   CVCL_I885
DR   Wikidata; Q54886708
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00886
AC   CVCL_I886
DR   Wikidata; Q54886709
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00887
AC   CVCL_I887
DR   Wikidata; Q54886710
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00888
AC   CVCL_I888
DR   Wikidata; Q54886711
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00889
AC   CVCL_I889
DR   Wikidata; Q54886712
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00890
AC   CVCL_I890
DR   Wikidata; Q54886713
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00891
AC   CVCL_I891
DR   Wikidata; Q54886715
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00892
AC   CVCL_I892
DR   Wikidata; Q54886716
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00893
AC   CVCL_I893
DR   Wikidata; Q54886717
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00894
AC   CVCL_I894
DR   Wikidata; Q54886718
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00895
AC   CVCL_I895
DR   Wikidata; Q54886719
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00896
AC   CVCL_I896
DR   Wikidata; Q54886720
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00897
AC   CVCL_I897
DR   Wikidata; Q54886721
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00898
AC   CVCL_I898
DR   Wikidata; Q54886729
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00899
AC   CVCL_I899
DR   Wikidata; Q54886730
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00900
AC   CVCL_I900
DR   Wikidata; Q54886731
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00901
AC   CVCL_I901
DR   Wikidata; Q54886732
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00902
AC   CVCL_I902
DR   Wikidata; Q54886733
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00903
AC   CVCL_I903
DR   Wikidata; Q54886734
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 16
//
ID   HGDP00904
AC   CVCL_I904
DR   Wikidata; Q54886735
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00905
AC   CVCL_I905
DR   Wikidata; Q54886736
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00906
AC   CVCL_I906
DR   Wikidata; Q54886737
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00907
AC   CVCL_I907
DR   Wikidata; Q54886738
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00908
AC   CVCL_I908
DR   Wikidata; Q54886739
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00909
AC   CVCL_I909
DR   Wikidata; Q54886740
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00910
AC   CVCL_I910
DR   Wikidata; Q54886741
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00911
AC   CVCL_I911
DR   Wikidata; Q54886742
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00912
AC   CVCL_I912
DR   Wikidata; Q54886743
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00913
AC   CVCL_I913
DR   Wikidata; Q54886744
RX   PubMed=11954565;
RX   PubMed=27995740;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Sequence variation: Gene deletion; HGNC; HGNC:3620; FCGR3B; Zygosity=Homozygous (PubMed=27995740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   HGDP00914
AC   CVCL_I914
DR   Wikidata; Q54886745
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00915
AC   CVCL_I915
DR   Wikidata; Q54886746
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00916
AC   CVCL_I916
DR   Wikidata; Q54886747
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00917
AC   CVCL_I917
DR   Wikidata; Q54886748
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00918
AC   CVCL_I918
DR   Wikidata; Q54886749
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00919
AC   CVCL_I919
DR   Wikidata; Q54886750
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00920
AC   CVCL_I920
DR   Wikidata; Q54886751
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00921
AC   CVCL_I921
DR   Wikidata; Q54886752
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00922
AC   CVCL_I922
DR   Wikidata; Q54886753
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00923
AC   CVCL_I923
DR   Wikidata; Q54886754
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00924
AC   CVCL_I924
DR   Wikidata; Q54886755
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00925
AC   CVCL_I925
DR   Wikidata; Q54886756
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00926
AC   CVCL_I926
DR   Wikidata; Q54886757
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00927
AC   CVCL_I927
DR   Wikidata; Q54886758
RX   PubMed=11954565;
RX   PubMed=20448178;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   HGDP00928
AC   CVCL_I928
DR   Wikidata; Q54886759
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00929
AC   CVCL_I929
DR   Wikidata; Q54886760
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00930
AC   CVCL_I930
DR   Wikidata; Q54886761
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00931
AC   CVCL_I931
DR   Wikidata; Q54886762
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00932
AC   CVCL_I932
DR   Wikidata; Q54886763
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00933
AC   CVCL_I933
DR   Wikidata; Q54886764
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00934
AC   CVCL_I934
DR   Wikidata; Q54886765
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00935
AC   CVCL_I935
DR   Wikidata; Q54886766
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00936
AC   CVCL_I936
DR   Wikidata; Q54886767
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00937
AC   CVCL_I937
DR   Wikidata; Q54886769
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00938
AC   CVCL_I938
DR   Wikidata; Q54886773
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00939
AC   CVCL_I939
DR   Wikidata; Q54886774
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00940
AC   CVCL_I940
DR   Wikidata; Q54886775
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00941
AC   CVCL_I941
DR   Wikidata; Q54886776
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00942
AC   CVCL_I942
DR   Wikidata; Q54886777
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00943
AC   CVCL_I943
DR   Wikidata; Q54886779
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00944
AC   CVCL_I944
DR   Wikidata; Q54886781
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Yoruba.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00945
AC   CVCL_I945
DR   Wikidata; Q54886782
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00946
AC   CVCL_I946
DR   Wikidata; Q54886783
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00947
AC   CVCL_I947
DR   Wikidata; Q54886784
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00948
AC   CVCL_I948
DR   Wikidata; Q54886785
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00949
AC   CVCL_I949
DR   Wikidata; Q54886786
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00950
AC   CVCL_I950
DR   Wikidata; Q54886787
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00951
AC   CVCL_I951
DR   Wikidata; Q54886788
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00952
AC   CVCL_I952
DR   Wikidata; Q54886789
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00953
AC   CVCL_I953
DR   Wikidata; Q54886790
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00954
AC   CVCL_I954
DR   Wikidata; Q54886791
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00955
AC   CVCL_I955
DR   Wikidata; Q54886792
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00956
AC   CVCL_I956
DR   Wikidata; Q54886793
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00957
AC   CVCL_I957
DR   Wikidata; Q54886794
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00958
AC   CVCL_I958
DR   Wikidata; Q54886795
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00959
AC   CVCL_I959
DR   Wikidata; Q54886796
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00960
AC   CVCL_I960
DR   Wikidata; Q54886797
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00961
AC   CVCL_I961
DR   Wikidata; Q54886798
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00962
AC   CVCL_I962
DR   Wikidata; Q54886799
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00963
AC   CVCL_I963
DR   Wikidata; Q54886800
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00964
AC   CVCL_I964
DR   Wikidata; Q54886801
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00965
AC   CVCL_I965
DR   Wikidata; Q54886802
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00966
AC   CVCL_I966
DR   Wikidata; Q54886803
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00967
AC   CVCL_I967
DR   Wikidata; Q54886804
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00968
AC   CVCL_I968
DR   Wikidata; Q54886805
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00969
AC   CVCL_I969
DR   Wikidata; Q54886806
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Yakut.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00970
AC   CVCL_I970
DR   Wikidata; Q54886807
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Colombian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00971
AC   CVCL_I971
DR   Wikidata; Q54886808
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00972
AC   CVCL_I972
DR   Wikidata; Q54886809
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00973
AC   CVCL_I973
DR   Wikidata; Q54886810
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00974
AC   CVCL_I974
DR   Wikidata; Q54886811
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00975
AC   CVCL_I975
DR   Wikidata; Q54886812
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00976
AC   CVCL_I976
DR   Wikidata; Q54886813
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00977
AC   CVCL_I977
DR   Wikidata; Q54886814
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00978
AC   CVCL_I978
DR   Wikidata; Q54886819
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00979
AC   CVCL_I979
DR   Wikidata; Q54886820
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I660 ! HGDP00660
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00980
AC   CVCL_I980
DR   Wikidata; Q54886821
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Eurasian (was originally classified as Biaka pygmies).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00981
AC   CVCL_I981
DR   Wikidata; Q54886822
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I472 ! HGDP00472
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00982
AC   CVCL_I982
DR   Wikidata; Q54886823
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00983
AC   CVCL_I983
DR   Wikidata; Q54886824
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00984
AC   CVCL_I984
DR   Wikidata; Q54886825
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00985
AC   CVCL_I985
DR   Wikidata; Q54886826
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00986
AC   CVCL_I986
DR   Wikidata; Q54886827
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00987
AC   CVCL_I987
DR   Wikidata; Q54886828
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; San.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00988
AC   CVCL_I988
DR   Wikidata; Q54886829
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; San.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00991
AC   CVCL_I991
DR   Wikidata; Q54886830
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; San.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00992
AC   CVCL_I992
DR   Wikidata; Q54886831
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; San.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00993
AC   CVCL_I993
DR   Wikidata; Q54886832
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.E. Pedi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00994
AC   CVCL_I994
DR   Wikidata; Q54886833
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.E. S.Sotho.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00995
AC   CVCL_I995
DR   Wikidata; Q54886834
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00996
AC   CVCL_I996
DR   Wikidata; Q54886835
RX   PubMed=11954565;
RX   PubMed=27995740;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Sequence variation: Gene deletion; HGNC; HGNC:3620; FCGR3B; Zygosity=Homozygous (PubMed=27995740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   HGDP00997
AC   CVCL_I997
DR   Wikidata; Q54886836
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00998
AC   CVCL_I998
DR   Wikidata; Q54886837
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP00999
AC   CVCL_I999
DR   Wikidata; Q54886838
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01000
AC   CVCL_I002
DR   Wikidata; Q54886839
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01001
AC   CVCL_I004
DR   Wikidata; Q54886840
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01003
AC   CVCL_I006
DR   Wikidata; Q54886841
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01004
AC   CVCL_I008
DR   Wikidata; Q54886843
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01005
AC   CVCL_I010
DR   Wikidata; Q54886844
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01006
AC   CVCL_I012
DR   Wikidata; Q54886845
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01007
AC   CVCL_I014
DR   Wikidata; Q54886846
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01008
AC   CVCL_I016
DR   Wikidata; Q54886848
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01009
AC   CVCL_I018
DR   Wikidata; Q54886849
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01010
AC   CVCL_I020
DR   Wikidata; Q54886850
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01011
AC   CVCL_I022
DR   Wikidata; Q54886851
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01012
AC   CVCL_I024
DR   Wikidata; Q54886852
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01013
AC   CVCL_I026
DR   Wikidata; Q54886853
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01014
AC   CVCL_I028
DR   Wikidata; Q54886854
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01015
AC   CVCL_I030
DR   Wikidata; Q54886855
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01016
AC   CVCL_I032
DR   Wikidata; Q54886856
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01017
AC   CVCL_I034
DR   Wikidata; Q54886857
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01018
AC   CVCL_I036
DR   Wikidata; Q54886858
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01019
AC   CVCL_I038
DR   Wikidata; Q54886859
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native South American; Karitiana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01021
AC   CVCL_I040
DR   Wikidata; Q54886860
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01022
AC   CVCL_I042
DR   Wikidata; Q54886863
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I813 ! HGDP00813
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01023
AC   CVCL_I044
DR   Wikidata; Q54886864
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01024
AC   CVCL_I046
DR   Wikidata; Q54886865
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01025
AC   CVCL_I048
DR   Wikidata; Q54886866
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I762 ! HGDP00762
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01026
AC   CVCL_H337
DR   Wikidata; Q54886867
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01027
AC   CVCL_I050
DR   Wikidata; Q54886868
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Pacific; NAN Melanesian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01028
AC   CVCL_I051
DR   Wikidata; Q54886869
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.W. Herero.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01029
AC   CVCL_I053
DR   Wikidata; Q54886870
RX   PubMed=11954565;
RX   PubMed=20448178;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; San.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   HGDP01030
AC   CVCL_I055
DR   Wikidata; Q54886871
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.E. Tswana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01031
AC   CVCL_I059
DR   Wikidata; Q54886872
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.W. Ovambo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01032
AC   CVCL_I061
DR   Wikidata; Q54886873
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; San.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01033
AC   CVCL_I063
DR   Wikidata; Q54886874
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.E. Zulu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01034
AC   CVCL_I065
DR   Wikidata; Q54886875
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.E. Tswana.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01035
AC   CVCL_I067
DR   Wikidata; Q54886876
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu S.W. Herero.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01036
AC   CVCL_I069
DR   Wikidata; Q54886877
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; San.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01037
AC   CVCL_I071
DR   Wikidata; Q54886878
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01038
AC   CVCL_I073
DR   Wikidata; Q54886879
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01039
AC   CVCL_I075
DR   Wikidata; Q54886880
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01040
AC   CVCL_I077
DR   Wikidata; Q54886881
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01041
AC   CVCL_I079
DR   Wikidata; Q54886883
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01042
AC   CVCL_I081
DR   Wikidata; Q54886884
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01043
AC   CVCL_I083
DR   Wikidata; Q54886885
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01044
AC   CVCL_I085
DR   Wikidata; Q54886886
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01045
AC   CVCL_I087
DR   Wikidata; Q54886887
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01046
AC   CVCL_I089
DR   Wikidata; Q54886888
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01047
AC   CVCL_I091
DR   Wikidata; Q54886889
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01048
AC   CVCL_I093
DR   Wikidata; Q54886890
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01049
AC   CVCL_I095
DR   Wikidata; Q54886891
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01050
AC   CVCL_I097
DR   Wikidata; Q54886892
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01051
AC   CVCL_I101
DR   Wikidata; Q54886894
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01052
AC   CVCL_I107
DR   Wikidata; Q54886895
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01053
AC   CVCL_I114
DR   Wikidata; Q54886896
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01054
AC   CVCL_I117
DR   Wikidata; Q54886897
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01055
AC   CVCL_I123
DR   Wikidata; Q54886899
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01056
AC   CVCL_I126
DR   Wikidata; Q54886900
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01057
AC   CVCL_I132
DR   Wikidata; Q54886901
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01058
AC   CVCL_I138
DR   Wikidata; Q54886902
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01059
AC   CVCL_I142
DR   Wikidata; Q54886903
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01060
AC   CVCL_I147
DR   Wikidata; Q54886904
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01061
AC   CVCL_I152
DR   Wikidata; Q54886906
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Native Central American; Pima.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01062
AC   CVCL_I156
DR   Wikidata; Q54886911
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01063
AC   CVCL_I159
DR   Wikidata; Q54886912
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01064
AC   CVCL_I162
DR   Wikidata; Q54886913
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01065
AC   CVCL_I164
DR   Wikidata; Q54886914
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01066
AC   CVCL_I166
DR   Wikidata; Q54886915
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01067
AC   CVCL_I168
DR   Wikidata; Q54886916
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01068
AC   CVCL_I170
DR   Wikidata; Q54886918
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01069
AC   CVCL_I172
DR   Wikidata; Q54886919
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01070
AC   CVCL_I174
DR   Wikidata; Q54886920
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01071
AC   CVCL_I176
DR   Wikidata; Q54886921
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01072
AC   CVCL_I178
DR   Wikidata; Q54886922
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01073
AC   CVCL_I180
DR   Wikidata; Q54886923
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01074
AC   CVCL_I182
DR   Wikidata; Q54886924
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01075
AC   CVCL_I184
DR   Wikidata; Q54886925
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01076
AC   CVCL_I186
DR   Wikidata; Q54886926
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01077
AC   CVCL_I188
DR   Wikidata; Q54886927
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01078
AC   CVCL_I190
DR   Wikidata; Q54886928
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01079
AC   CVCL_I193
DR   Wikidata; Q54886929
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01081
AC   CVCL_I194
DR   Wikidata; Q54886930
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mbuti Pygmy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01084
AC   CVCL_I196
DR   Wikidata; Q54886931
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01085
AC   CVCL_I198
DR   Wikidata; Q54886932
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01086
AC   CVCL_I200
DR   Wikidata; Q54886933
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01087
AC   CVCL_I202
DR   Wikidata; Q54886934
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I452 ! HGDP00452
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01088
AC   CVCL_I204
DR   Wikidata; Q54886935
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01089
AC   CVCL_I207
DR   Wikidata; Q54886936
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01090
AC   CVCL_I209
DR   Wikidata; Q54886937
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01091
AC   CVCL_I211
DR   Wikidata; Q54886938
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01092
AC   CVCL_I212
DR   Wikidata; Q54886939
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I457 ! HGDP00457
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01093
AC   CVCL_I215
DR   Wikidata; Q54886940
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01094
AC   CVCL_I217
DR   Wikidata; Q54886941
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Biaka pygmies.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01095
AC   CVCL_I219
DR   Wikidata; Q54886942
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01096
AC   CVCL_I221
DR   Wikidata; Q54886943
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01097
AC   CVCL_I223
DR   Wikidata; Q54886944
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01098
AC   CVCL_I225
DR   Wikidata; Q54886945
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01099
AC   CVCL_I227
DR   Wikidata; Q54886946
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01100
AC   CVCL_I229
DR   Wikidata; Q54886947
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01101
AC   CVCL_I231
DR   Wikidata; Q54886948
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01102
AC   CVCL_I233
DR   Wikidata; Q54886949
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01103
AC   CVCL_I235
DR   Wikidata; Q54886950
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01104
AC   CVCL_I236
DR   Wikidata; Q54886951
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tujia.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01147
AC   CVCL_I238
DR   Wikidata; Q54886959
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01149
AC   CVCL_I240
DR   Wikidata; Q54886960
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I249 ! HGDP01154
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01151
AC   CVCL_I242
DR   Wikidata; Q54886961
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01152
AC   CVCL_I245
DR   Wikidata; Q54886962
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01153
AC   CVCL_I246
DR   Wikidata; Q54886963
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01154
AC   CVCL_I249
DR   Wikidata; Q54886964
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I240 ! HGDP01149
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01155
AC   CVCL_I250
DR   Wikidata; Q54886965
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01156
AC   CVCL_I252
DR   Wikidata; Q54886966
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01157
AC   CVCL_I253
DR   Wikidata; Q54886967
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01161
AC   CVCL_I255
DR   Wikidata; Q54886968
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01162
AC   CVCL_I256
DR   Wikidata; Q54886969
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01163
AC   CVCL_I257
DR   Wikidata; Q54886970
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01164
AC   CVCL_I260
DR   Wikidata; Q54886971
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01166
AC   CVCL_I261
DR   Wikidata; Q54886972
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01167
AC   CVCL_I263
DR   Wikidata; Q54886973
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01168
AC   CVCL_I265
DR   Wikidata; Q54886974
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01169
AC   CVCL_I266
DR   Wikidata; Q54886975
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Tuscan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01171
AC   CVCL_I268
DR   Wikidata; Q54886976
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01172
AC   CVCL_I269
DR   Wikidata; Q54886977
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01173
AC   CVCL_I270
DR   Wikidata; Q54886978
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01174
AC   CVCL_I271
DR   Wikidata; Q54886979
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01177
AC   CVCL_I272
DR   Wikidata; Q54886980
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; North Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01179
AC   CVCL_I273
DR   Wikidata; Q54886981
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01180
AC   CVCL_I275
DR   Wikidata; Q54886982
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01181
AC   CVCL_I276
DR   Wikidata; Q54886983
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01182
AC   CVCL_I278
DR   Wikidata; Q54886984
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01183
AC   CVCL_I280
DR   Wikidata; Q54886985
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01184
AC   CVCL_I282
DR   Wikidata; Q54886986
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01185
AC   CVCL_I283
DR   Wikidata; Q54886987
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01186
AC   CVCL_I284
DR   Wikidata; Q54886988
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01187
AC   CVCL_I287
DR   Wikidata; Q54886989
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01188
AC   CVCL_I289
DR   Wikidata; Q54886990
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01189
AC   CVCL_I291
DR   Wikidata; Q54886991
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01190
AC   CVCL_I293
DR   Wikidata; Q54886992
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01191
AC   CVCL_I294
DR   Wikidata; Q54886993
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01192
AC   CVCL_I295
DR   Wikidata; Q54886994
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01193
AC   CVCL_I296
DR   Wikidata; Q54886995
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01194
AC   CVCL_I297
DR   Wikidata; Q54886996
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01195
AC   CVCL_I299
DR   Wikidata; Q54886997
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01196
AC   CVCL_I300
DR   Wikidata; Q54886998
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01197
AC   CVCL_I301
DR   Wikidata; Q54887002
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01198
AC   CVCL_I303
DR   Wikidata; Q54887003
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Miaozu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01199
AC   CVCL_I305
DR   Wikidata; Q54887004
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01200
AC   CVCL_I306
DR   Wikidata; Q54887005
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01201
AC   CVCL_I308
DR   Wikidata; Q54887006
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01202
AC   CVCL_I310
DR   Wikidata; Q54887007
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01203
AC   CVCL_I312
DR   Wikidata; Q54887008
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01204
AC   CVCL_I314
DR   Wikidata; Q54887009
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01205
AC   CVCL_I316
DR   Wikidata; Q54887010
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01206
AC   CVCL_I317
DR   Wikidata; Q54887011
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01207
AC   CVCL_I318
DR   Wikidata; Q54887012
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01208
AC   CVCL_I320
DR   Wikidata; Q54887013
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01209
AC   CVCL_I322
DR   Wikidata; Q54887014
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01210
AC   CVCL_I324
DR   Wikidata; Q54887015
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01211
AC   CVCL_I325
DR   Wikidata; Q54887016
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01212
AC   CVCL_I327
DR   Wikidata; Q54887017
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Oroqen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01213
AC   CVCL_I329
DR   Wikidata; Q54887018
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01214
AC   CVCL_I331
DR   Wikidata; Q54887019
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01215
AC   CVCL_I332
DR   Wikidata; Q54887020
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01216
AC   CVCL_I334
DR   Wikidata; Q54887021
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01217
AC   CVCL_I335
DR   Wikidata; Q54887022
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01218
AC   CVCL_I337
DR   Wikidata; Q54887023
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01219
AC   CVCL_I339
DR   Wikidata; Q54887024
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01220
AC   CVCL_I340
DR   Wikidata; Q54887025
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01221
AC   CVCL_I342
DR   Wikidata; Q54887026
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01222
AC   CVCL_I343
DR   Wikidata; Q54887027
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Daur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01223
AC   CVCL_I344
DR   Wikidata; Q54887028
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01224
AC   CVCL_I345
DR   Wikidata; Q54887029
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01225
AC   CVCL_I347
DR   Wikidata; Q54887030
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01226
AC   CVCL_I348
DR   Wikidata; Q54887031
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01227
AC   CVCL_I349
DR   Wikidata; Q54887033
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01228
AC   CVCL_I350
DR   Wikidata; Q54887034
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01229
AC   CVCL_I352
DR   Wikidata; Q54887035
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01230
AC   CVCL_I353
DR   Wikidata; Q54887036
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01231
AC   CVCL_I354
DR   Wikidata; Q54887037
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01232
AC   CVCL_I355
DR   Wikidata; Q54887038
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mongolian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01233
AC   CVCL_I357
DR   Wikidata; Q54887039
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I360 ! HGDP01235
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01234
AC   CVCL_I358
DR   Wikidata; Q54887040
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01235
AC   CVCL_I360
DR   Wikidata; Q54887041
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_I357 ! HGDP01233
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01236
AC   CVCL_I361
DR   Wikidata; Q54887042
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01237
AC   CVCL_I362
DR   Wikidata; Q54887045
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01238
AC   CVCL_I363
DR   Wikidata; Q54887046
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01239
AC   CVCL_I365
DR   Wikidata; Q54887047
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01240
AC   CVCL_I366
DR   Wikidata; Q54887048
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01241
AC   CVCL_I367
DR   Wikidata; Q54887049
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01242
AC   CVCL_I368
DR   Wikidata; Q54887050
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Hezhen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01243
AC   CVCL_I369
DR   Wikidata; Q54887051
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01244
AC   CVCL_I370
DR   Wikidata; Q54887052
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01245
AC   CVCL_I373
DR   Wikidata; Q54887053
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01246
AC   CVCL_I374
DR   Wikidata; Q54887054
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01247
AC   CVCL_I375
DR   Wikidata; Q54887055
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01248
AC   CVCL_I377
DR   Wikidata; Q54887056
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01249
AC   CVCL_I378
DR   Wikidata; Q54887057
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01250
AC   CVCL_I379
DR   Wikidata; Q54887058
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01251
AC   CVCL_I380
DR   Wikidata; Q54887059
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Xibo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01253
AC   CVCL_I381
DR   Wikidata; Q54887060
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01254
AC   CVCL_I383
DR   Wikidata; Q54887061
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01255
AC   CVCL_I384
DR   Wikidata; Q54887062
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01256
AC   CVCL_I385
DR   Wikidata; Q54887063
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01257
AC   CVCL_I386
DR   Wikidata; Q54887064
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01258
AC   CVCL_I387
DR   Wikidata; Q54887065
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01259
AC   CVCL_I389
DR   Wikidata; Q54887066
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01260
AC   CVCL_I390
DR   Wikidata; Q54887067
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01261
AC   CVCL_I391
DR   Wikidata; Q54887068
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01262
AC   CVCL_I393
DR   Wikidata; Q54887069
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01263
AC   CVCL_I394
DR   Wikidata; Q54887071
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01264
AC   CVCL_I395
DR   Wikidata; Q54887073
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01265
AC   CVCL_I396
DR   Wikidata; Q54887074
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01266
AC   CVCL_I398
DR   Wikidata; Q54887075
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01267
AC   CVCL_I399
DR   Wikidata; Q54887076
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01268
AC   CVCL_I400
DR   Wikidata; Q54887077
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01269
AC   CVCL_I401
DR   Wikidata; Q54887078
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01270
AC   CVCL_I403
DR   Wikidata; Q54887079
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01271
AC   CVCL_I404
DR   Wikidata; Q54887081
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01272
AC   CVCL_I405
DR   Wikidata; Q54887082
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01273
AC   CVCL_I406
DR   Wikidata; Q54887083
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01274
AC   CVCL_I408
DR   Wikidata; Q54887084
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01275
AC   CVCL_I409
DR   Wikidata; Q54887085
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01276
AC   CVCL_I410
DR   Wikidata; Q54887086
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01277
AC   CVCL_I411
DR   Wikidata; Q54887087
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01278
AC   CVCL_I413
DR   Wikidata; Q54887093
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01279
AC   CVCL_I414
DR   Wikidata; Q54887094
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01280
AC   CVCL_I415
DR   Wikidata; Q54887095
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01281
AC   CVCL_I416
DR   Wikidata; Q54887096
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01282
AC   CVCL_I418
DR   Wikidata; Q54887097
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Mozabite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01283
AC   CVCL_I419
DR   Wikidata; Q54887098
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01284
AC   CVCL_I420
DR   Wikidata; Q54887099
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01285
AC   CVCL_I421
DR   Wikidata; Q54887100
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01286
AC   CVCL_I422
DR   Wikidata; Q54887101
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Mandenka.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01287
AC   CVCL_I424
DR   Wikidata; Q54887102
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01288
AC   CVCL_I425
DR   Wikidata; Q54887103
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01289
AC   CVCL_I426
DR   Wikidata; Q54887104
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01290
AC   CVCL_I427
DR   Wikidata; Q54887105
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01291
AC   CVCL_I429
DR   Wikidata; Q54887106
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01292
AC   CVCL_I430
DR   Wikidata; Q54887107
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01293
AC   CVCL_I431
DR   Wikidata; Q54887108
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01294
AC   CVCL_I432
DR   Wikidata; Q54887109
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01295
AC   CVCL_I434
DR   Wikidata; Q54887110
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01296
AC   CVCL_I435
DR   Wikidata; Q54887111
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese; Han.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01297
AC   CVCL_I436
DR   Wikidata; Q54887112
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01298
AC   CVCL_I437
DR   Wikidata; Q54887113
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01299
AC   CVCL_I439
DR   Wikidata; Q54887114
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01300
AC   CVCL_I440
DR   Wikidata; Q54887115
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01301
AC   CVCL_I441
DR   Wikidata; Q54887116
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01302
AC   CVCL_I442
DR   Wikidata; Q54887117
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01303
AC   CVCL_I443
DR   Wikidata; Q54887118
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01304
AC   CVCL_I446
DR   Wikidata; Q54887119
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01305
AC   CVCL_I447
DR   Wikidata; Q54887120
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01306
AC   CVCL_I480
DR   Wikidata; Q54887121
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HGDP01307
AC   CVCL_I481
DR   Wikidata; Q54887122
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01308
AC   CVCL_I482
DR   Wikidata; Q54887123
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01309
AC   CVCL_I483
DR   Wikidata; Q54887124
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01310
AC   CVCL_I484
DR   Wikidata; Q54887125
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01311
AC   CVCL_I485
DR   Wikidata; Q54887126
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01312
AC   CVCL_I486
DR   Wikidata; Q54887127
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01313
AC   CVCL_I487
DR   Wikidata; Q54887128
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01314
AC   CVCL_I488
DR   Wikidata; Q54887129
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01315
AC   CVCL_I489
DR   Wikidata; Q54887130
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01316
AC   CVCL_I492
DR   Wikidata; Q54887131
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Dai.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01317
AC   CVCL_I493
DR   Wikidata; Q54887132
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01318
AC   CVCL_I494
DR   Wikidata; Q54887137
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01319
AC   CVCL_I495
DR   Wikidata; Q54887138
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01320
AC   CVCL_I496
DR   Wikidata; Q54887139
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01321
AC   CVCL_I497
DR   Wikidata; Q54887140
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01322
AC   CVCL_I498
DR   Wikidata; Q54887141
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01323
AC   CVCL_I499
DR   Wikidata; Q54887142
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01324
AC   CVCL_I500
DR   Wikidata; Q54887143
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01325
AC   CVCL_I501
DR   Wikidata; Q54887144
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01326
AC   CVCL_I502
DR   Wikidata; Q54887145
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Lahu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01327
AC   CVCL_I503
DR   Wikidata; Q54887146
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01328
AC   CVCL_I504
DR   Wikidata; Q54887147
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01329
AC   CVCL_I505
DR   Wikidata; Q54887148
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01330
AC   CVCL_I506
DR   Wikidata; Q54887150
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01331
AC   CVCL_I507
DR   Wikidata; Q54887151
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01332
AC   CVCL_I508
DR   Wikidata; Q54887152
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01333
AC   CVCL_I509
DR   Wikidata; Q54887153
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01334
AC   CVCL_I510
DR   Wikidata; Q54887154
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01335
AC   CVCL_I593
DR   Wikidata; Q54887155
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01336
AC   CVCL_I596
DR   Wikidata; Q54887156
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; She.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01337
AC   CVCL_I809
DR   Wikidata; Q54887157
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01338
AC   CVCL_I816
DR   Wikidata; Q54887159
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01339
AC   CVCL_I829
DR   Wikidata; Q54887160
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01340
AC   CVCL_I831
DR   Wikidata; Q54887161
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01341
AC   CVCL_I836
DR   Wikidata; Q54887162
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01342
AC   CVCL_I853
DR   Wikidata; Q54887163
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01343
AC   CVCL_I989
DR   Wikidata; Q54887164
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01344
AC   CVCL_I990
DR   Wikidata; Q54887165
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01345
AC   CVCL_H272
DR   Wikidata; Q54887166
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01346
AC   CVCL_H273
DR   Wikidata; Q54887167
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Naxi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01347
AC   CVCL_H274
DR   Wikidata; Q54887168
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01348
AC   CVCL_H275
DR   Wikidata; Q54887169
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01349
AC   CVCL_H276
DR   Wikidata; Q54887170
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01350
AC   CVCL_H277
DR   Wikidata; Q54887171
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01351
AC   CVCL_H278
DR   Wikidata; Q54887172
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01352
AC   CVCL_H279
DR   Wikidata; Q54887173
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01353
AC   CVCL_H280
DR   Wikidata; Q54887174
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01354
AC   CVCL_H281
DR   Wikidata; Q54887175
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01355
AC   CVCL_H282
DR   Wikidata; Q54887177
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01356
AC   CVCL_H283
DR   Wikidata; Q54887178
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Chinese/Asian ethnic group; Tu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01357
AC   CVCL_H284
DR   Wikidata; Q54887179
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01358
AC   CVCL_H285
DR   Wikidata; Q54887181
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01359
AC   CVCL_H286
DR   Wikidata; Q54887182
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01360
AC   CVCL_H287
DR   Wikidata; Q54887183
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01361
AC   CVCL_H288
DR   Wikidata; Q54887184
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01362
AC   CVCL_H289
DR   Wikidata; Q54887185
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01363
AC   CVCL_H290
DR   Wikidata; Q54887186
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01364
AC   CVCL_H291
DR   Wikidata; Q54887187
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01365
AC   CVCL_H292
DR   Wikidata; Q54887188
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01366
AC   CVCL_H293
DR   Wikidata; Q54887189
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01367
AC   CVCL_H294
DR   Wikidata; Q54887190
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01368
AC   CVCL_H295
DR   Wikidata; Q54887191
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01369
AC   CVCL_H296
DR   Wikidata; Q54887192
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01370
AC   CVCL_H297
DR   Wikidata; Q54887193
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01371
AC   CVCL_H298
DR   Wikidata; Q54887194
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01372
AC   CVCL_H299
DR   Wikidata; Q54887195
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01373
AC   CVCL_H300
DR   Wikidata; Q54887196
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01374
AC   CVCL_H301
DR   Wikidata; Q54887198
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01375
AC   CVCL_H302
DR   Wikidata; Q54887199
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01376
AC   CVCL_H303
DR   Wikidata; Q54887200
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01377
AC   CVCL_H304
DR   Wikidata; Q54887201
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01378
AC   CVCL_H305
DR   Wikidata; Q54887202
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01379
AC   CVCL_H306
DR   Wikidata; Q54887203
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01380
AC   CVCL_H307
DR   Wikidata; Q54887204
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Basque.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01381
AC   CVCL_H308
DR   Wikidata; Q54887205
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01382
AC   CVCL_H309
DR   Wikidata; Q54887206
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01383
AC   CVCL_H310
DR   Wikidata; Q54887207
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01384
AC   CVCL_H311
DR   Wikidata; Q54887208
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01385
AC   CVCL_H312
DR   Wikidata; Q54887209
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01386
AC   CVCL_H313
DR   Wikidata; Q54887210
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01387
AC   CVCL_H314
DR   Wikidata; Q54887211
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01388
AC   CVCL_H315
DR   Wikidata; Q54887212
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01396
AC   CVCL_H316
DR   Wikidata; Q54887213
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01397
AC   CVCL_H317
DR   Wikidata; Q54887214
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01398
AC   CVCL_H318
DR   Wikidata; Q54887215
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01399
AC   CVCL_H319
DR   Wikidata; Q54887216
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01400
AC   CVCL_H320
DR   Wikidata; Q54887217
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01401
AC   CVCL_H321
DR   Wikidata; Q54887218
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01402
AC   CVCL_H322
DR   Wikidata; Q54887219
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01403
AC   CVCL_H323
DR   Wikidata; Q54887220
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01404
AC   CVCL_H324
DR   Wikidata; Q54887221
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Caucasian; Adyghean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01405
AC   CVCL_H325
DR   Wikidata; Q54887228
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01406
AC   CVCL_H326
DR   Wikidata; Q54887229
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01408
AC   CVCL_H327
DR   Wikidata; Q54887230
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01410
AC   CVCL_H338
DR   Wikidata; Q54887231
RX   PubMed=11954565;
RX   PubMed=17044859;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: Nilote.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01411
AC   CVCL_H328
DR   Wikidata; Q54887232
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01412
AC   CVCL_H329
DR   Wikidata; Q54887233
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01413
AC   CVCL_H330
DR   Wikidata; Q54887234
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01414
AC   CVCL_H331
DR   Wikidata; Q54887235
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01415
AC   CVCL_H332
DR   Wikidata; Q54887236
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01416
AC   CVCL_H333
DR   Wikidata; Q54887237
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01417
AC   CVCL_H334
DR   Wikidata; Q54887238
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01418
AC   CVCL_H335
DR   Wikidata; Q54887239
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGDP01419
AC   CVCL_H336
DR   Wikidata; Q54887240
RX   PubMed=11954565;
WW   Info; CEPH; -; https://www.cephb.fr/en/hgdp_panel.php
CC   Part of: Human genome diversity (HGDP-CEPH) cell line panel.
CC   Population: African; Bantu N.E.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HGELN
AC   CVCL_WI90
SY   HeLa GAL4RE-ERE Luciferase-Neo
DR   Wikidata; Q94204125
RX   PubMed=10492897;
CC   Population: African American.
CC   Biotechnology: Used in a bioluminescent bioassay to quantitatively measure estrogenic compounds.
CC   Characteristics: The luciferase reporter gene is under the control of an estrogen-responsive element from the beta-globin promoter.
CC   Characteristics: Transfected with the DNA-binding domain (DBD) of GAL4 fused to the ligand-binding domain (LBD) of ESR1 (GAL4-ER).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   HGF [Epinephelus]
AC   CVCL_6E26
SY   Honeycomb Grouper Fin
DR   Wikidata; Q54887241
RX   DOI=10.56093/ijans.v82i9.23682;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=215346; ! Epinephelus merra (Honeycomb grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   HGF [Human gingival]
AC   CVCL_3989
DR   BTO; BTO_0003579
DR   CLO; CLO_0003740
DR   EFO; EFO_0002792
DR   CLDB; cl1675
DR   Wikidata; Q54887243
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   HGF 1
AC   CVCL_B5XD
DR   Wikidata; Q111733396
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 10
AC   CVCL_B5XM
DR   Wikidata; Q111733397
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 11
AC   CVCL_B5XN
DR   Wikidata; Q111733398
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 12
AC   CVCL_B5XP
DR   Wikidata; Q111733399
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 13
AC   CVCL_B5XQ
DR   Wikidata; Q111733400
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 2
AC   CVCL_B5XE
DR   Wikidata; Q111733401
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 3
AC   CVCL_B5XF
DR   Wikidata; Q111733402
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 4
AC   CVCL_B5XG
DR   Wikidata; Q111733403
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 5
AC   CVCL_B5XH
DR   Wikidata; Q111733404
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 6
AC   CVCL_B5XI
DR   Wikidata; Q111733405
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 7
AC   CVCL_B5XJ
DR   Wikidata; Q111733406
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 8
AC   CVCL_B5XK
DR   Wikidata; Q111733407
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF 9
AC   CVCL_B5XL
DR   Wikidata; Q111733408
RX   PubMed=16297161;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF-1
AC   CVCL_3710
SY   Human Gingival Fibroblast-1
DR   CLO; CLO_0003742
DR   ATCC; CRL-2014
DR   BioSample; SAMN03471276
DR   IZSLER; BS CL 166
DR   KCLB; 22014
DR   Wikidata; Q54887245
RX   PubMed=8396328;
CC   Population: Caucasian.
CC   Senescence: Senesces at ~22 PDL (ATCC=CRL-2014).
CC   Discontinued: KCLB; 22014; probable.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
ST   Source(s): ATCC=CRL-2014; IZSLER=BS CL 166
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 16,20
ST   D19S433: 12,14
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 24,24.1
ST   Penta D: 13
ST   Penta E: 17,20
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   HGF1
AC   CVCL_B5X4
SY   F1; Human Gingival Fibroblast 1
DR   Wikidata; Q111733409
RX   PubMed=682592;
RX   PubMed=4053560;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF1-PI 1
AC   CVCL_9V97
DR   NCBI_Iran; C165
DR   Wikidata; Q54887246
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HGF10
AC   CVCL_B5X6
SY   F10; Human Gingival Fibroblast 10
DR   Wikidata; Q111733410
RX   PubMed=682592;
RX   PubMed=3733638;
RX   PubMed=4053560;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF11
AC   CVCL_B5X7
SY   Human Gingival Fibroblast 11
DR   Wikidata; Q111733411
RX   PubMed=682592;
RX   PubMed=3733638;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF12
AC   CVCL_B5Y9
SY   Human Gingival Fibroblast 12
DR   Wikidata; Q111733412
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   37Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF13
AC   CVCL_B5X8
SY   F13; Human Gingival Fibroblast 13
DR   Wikidata; Q111733413
RX   PubMed=682592;
RX   PubMed=3733638;
RX   PubMed=4053560;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF15
AC   CVCL_B5YA
SY   Human Gingival Fibroblast 15
DR   Wikidata; Q111733414
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF16
AC   CVCL_B5YB
SY   Human Gingival Fibroblast 16
DR   Wikidata; Q111733415
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF2
AC   CVCL_B5Y3
SY   Human Gingival Fibroblast 2
DR   Wikidata; Q111733416
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF2-PI 2
AC   CVCL_9V98
SY   HGF2 PI 2; HGF2
DR   NCBI_Iran; C166
DR   Wikidata; Q54887247
RX   PubMed=15016018;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HGF22
AC   CVCL_B5X9
SY   F22; Human Gingival Fibroblast 22
DR   Wikidata; Q111733417
RX   PubMed=4053560;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF24
AC   CVCL_4527
SY   HGF 24; F24; Human Gingival Fibroblast 24
DR   CLO; CLO_0003741
DR   CLDB; cl5201
DR   IZSLER; BS CL 138
DR   Wikidata; Q54887244
RX   PubMed=3733638;
RX   PubMed=3805152;
RX   PubMed=4053560;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
ST   Source(s): IZSLER=BS CL 138
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 29,32.2
ST   D5S818: 9,14
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 8
//
ID   HGF25
AC   CVCL_B5XA
SY   Human Gingival Fibroblast 25
DR   Wikidata; Q111733418
RX   PubMed=3733638;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF27
AC   CVCL_B5XB
SY   Human Gingival Fibroblast 27
DR   Wikidata; Q111733419
RX   PubMed=3733638;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF3
AC   CVCL_B5X5
SY   F3; Human Gingival Fibroblast 3
DR   Wikidata; Q111733420
RX   PubMed=682592;
RX   PubMed=4053560;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5Y6 ! HGF6
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF3-PI 53
AC   CVCL_9V99
DR   NCBI_Iran; C502
DR   Wikidata; Q54887248
RX   PubMed=17254797;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D21S11: 30,32
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HGF4
AC   CVCL_B5Y4
SY   Human Gingival Fibroblast 4
DR   Wikidata; Q111733421
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF42
AC   CVCL_B5XC
SY   Human Gingival Fibroblast 42
DR   Wikidata; Q111733423
RX   PubMed=3805152;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF5
AC   CVCL_B5Y5
SY   Human Gingival Fibroblast 5
DR   Wikidata; Q111733424
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF6
AC   CVCL_B5Y6
SY   Human Gingival Fibroblast 6
DR   Wikidata; Q111733425
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5X5 ! HGF3
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF7
AC   CVCL_B5Y7
SY   Human Gingival Fibroblast 7
DR   Wikidata; Q111733426
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGF9
AC   CVCL_B5Y8
SY   Human Gingival Fibroblast 9
DR   Wikidata; Q111733427
RX   PubMed=682592;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HGFDFN168
AC   CVCL_1Y93
DR   GEO; GSM1023610
DR   GEO; GSM1023611
DR   GEO; GSM1023612
DR   GEO; GSM1023613
DR   GEO; GSM1023620
DR   GEO; GSM1023621
DR   GEO; GSM1023622
DR   GEO; GSM1023623
DR   Wikidata; Q54887249
RX   PubMed=19958786;
RX   PubMed=28855503;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z30 ! HGFLBV021
SX   Male
AG   40Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGFDFN168 iPS1D2
AC   CVCL_2A15
DR   Wikidata; Q54887250
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y93 ! HGFDFN168
SX   Male
AG   40Y5M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   HGFDFN168 iPS1P
AC   CVCL_2A16
DR   Wikidata; Q54887251
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y93 ! HGFDFN168
SX   Male
AG   40Y5M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   HGFDFN369
AC   CVCL_1Z01
DR   Wikidata; Q54887252
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   HGFDFN372
AC   CVCL_1Z04
DR   Wikidata; Q54887253
CC   Part of: Progeria Research Foundation cell lines.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HGFDFSV40T168
AC   CVCL_DP42
DR   Wikidata; Q54887254
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y93 ! HGFDFN168
SX   Male
AG   40Y5M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   HGFDFSV40T369
AC   CVCL_DP45
DR   Wikidata; Q54887255
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z01 ! HGFDFN369
SX   Male
AG   33Y9M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   HGFLBV021
AC   CVCL_1Z30
DR   Wikidata; Q54887256
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y93 ! HGFDFN168
SX   Male
AG   37Y0M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGFLBV031
AC   CVCL_1Z33
DR   Wikidata; Q54887257
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGFLBV042
AC   CVCL_1Z40
DR   Wikidata; Q54887258
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGFLBV050
AC   CVCL_2A17
DR   Wikidata; Q54887259
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGFLBV067
AC   CVCL_1Z45
DR   Wikidata; Q54887260
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGFLBV079
AC   CVCL_2A18
DR   Wikidata; Q54887261
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGFLBV082
AC   CVCL_2A19
DR   Wikidata; Q54887262
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGFLBV099
AC   CVCL_1Z54
DR   Wikidata; Q54887263
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGFLBV134
AC   CVCL_1Z59
DR   Wikidata; Q54887264
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGFu
AC   CVCL_S892
SY   Hgfu
DR   Wikidata; Q54887265
RX   PubMed=6184607;
RX   PubMed=6343228;
CC   Doubling time: 18 hours (Note=In 10% FBS), 25.5 hours (Note=In 5% FBS), 31 hours (Note=In 2.5% FBS), 39 hours (Note=With 1% FBS) (PubMed=6343228).
CC   Derived from site: In situ; Testis, epididymis, epididymal fat pad; UBERON=UBERON_0010412.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   HGG-02
AC   CVCL_IR54
DR   cancercelllines; CVCL_IR54
DR   IARC_TP53; 28524
DR   Wikidata; Q54887266
RX   PubMed=20195615;
RX   PubMed=24270553;
CC   Sequence variation: Gene deletion; HGNC; HGNC:3236; EGFR; Zygosity=Heterozygous (PubMed=20195615).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=20195615).
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14-15Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   hGH-12
AC   CVCL_F1AJ
RX   Patent=WO1997036929A1;
RX   PubMed=8636376;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1 (Note=Recognizes both the 20 kDa variant (hGH 20K) and the 22 Kda variant (hGH 22K)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   hGH-25
AC   CVCL_F1AK
RX   Patent=WO1997036929A1;
RX   PubMed=8636376;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1 (Note=Recognizes specifically the 22 kDa variant = hGH 21K).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   hGH-26
AC   CVCL_F1AL
RX   Patent=WO1997036929A1;
RX   PubMed=8636376;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1 (Note=Recognizes specifically the 22 kDa variant = hGH 21K).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   hGH-33
AC   CVCL_F1AM
RX   Patent=WO1997036929A1;
RX   PubMed=8636376;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2254.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1 (Note=Recognizes specifically the 20 kDa variant = hGH 20K).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HGH-B
AC   CVCL_J685
DR   CLO; CLO_0003743
DR   ATCC; HB-10596
DR   Wikidata; Q54887267
RX   Patent=US5210017;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10596.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 8
//
ID   HGH1.1.3
AC   CVCL_J453
SY   HGH 1.1.3
DR   JCRB; JCRB1222.01
DR   Wikidata; Q54887268
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.11.1
AC   CVCL_J454
SY   HGH 1.11.1
DR   JCRB; JCRB1222.08
DR   Wikidata; Q54887271
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.15.3
AC   CVCL_J455
SY   HGH 1.15.3
DR   JCRB; JCRB1222.09
DR   Wikidata; Q54887273
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.17.2
AC   CVCL_J456
SY   HGH 1.17.2
DR   JCRB; JCRB1222.03
DR   Wikidata; Q54887274
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.31.3
AC   CVCL_J457
SY   HGH 1.31.3
DR   JCRB; JCRB1222.12
DR   Wikidata; Q54887275
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.32.4
AC   CVCL_J458
SY   HGH 1.32.4
DR   JCRB; JCRB1222.13
DR   Wikidata; Q54887276
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.35.2
AC   CVCL_J459
SY   HGH 1.35.2
DR   JCRB; JCRB1222.04
DR   Wikidata; Q54887277
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.37.3
AC   CVCL_J460
SY   HGH 1.37.3
DR   JCRB; JCRB1222.14
DR   Wikidata; Q54887278
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.41.1
AC   CVCL_J461
SY   HGH 1.41.1
DR   JCRB; JCRB1222.10
DR   Wikidata; Q54887279
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.46.1
AC   CVCL_J462
SY   HGH 1.46.1
DR   JCRB; JCRB1222.11
DR   Wikidata; Q54887280
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.6.5
AC   CVCL_J463
SY   HGH 1.6.5
DR   JCRB; JCRB1222.02
DR   Wikidata; Q54887281
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.8.1
AC   CVCL_J464
SY   HGH 1.8.1
DR   JCRB; JCRB1222.07
DR   Wikidata; Q54887282
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH1.9.3
AC   CVCL_J465
SY   HGH 1.9.3
DR   JCRB; JCRB1222.06
DR   Wikidata; Q54887283
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH2.15.4
AC   CVCL_J466
SY   HGH 2.15.4
DR   JCRB; JCRB1222.16
DR   Wikidata; Q54887284
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH2.4.2
AC   CVCL_J467
SY   HGH 2.4.2
DR   JCRB; JCRB1222.15
DR   Wikidata; Q54887285
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGH2.6.1
AC   CVCL_J468
SY   HGH 2.6.1
DR   JCRB; JCRB1222.05
DR   Wikidata; Q54887286
RX   PubMed=2427940;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01241; Human GH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HGL5
AC   CVCL_6644
SY   HGL-5
DR   ABM; T0650
DR   Wikidata; Q54887287
RX   PubMed=8126145;
RX   PubMed=15541573;
RX   PubMed=22949596;
RX   PubMed=34888112;
CC   Doubling time: 96 hours (Note=At 75th passage) (PubMed=8126145).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from an IVF patient undergoing oocyte retrieval procedure (PubMed=8126145).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   HGL5-MXIV
AC   CVCL_E3DF
RX   PubMed=34888112;
CC   Characteristics: Control cell line for HGL5-YAP(S127A) (Cellosaurus=CVCL_E3DG). Transduced with an empty vector (PubMed=34888112).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from an IVF patient undergoing oocyte retrieval procedure (from parent cell line).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6644 ! HGL5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HGL5-YAP(S127A)
AC   CVCL_E3DG
SY   HGL5-YAPS127A
RX   PubMed=34888112;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser127Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from an IVF patient undergoing oocyte retrieval procedure (from parent cell line).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6644 ! HGL5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HGMDFN090
AC   CVCL_1Y94
DR   Wikidata; Q54887288
RX   PubMed=16126733;
RX   PubMed=19958786;
CC   Part of: Progeria Research Foundation cell lines.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YU37 ! HGMDFN717
OI   CVCL_1Z29 ! HGMLBV010
SX   Female
AG   37Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HGMDFN090 iPS1B
AC   CVCL_2A13
DR   Wikidata; Q54887289
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y94 ! HGMDFN090
SX   Female
AG   37Y10M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   HGMDFN090 iPS1C
AC   CVCL_2A14
DR   Wikidata; Q54887290
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y94 ! HGMDFN090
SX   Female
AG   37Y10M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   HGMDFN368
AC   CVCL_1Z00
DR   Wikidata; Q54887291
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   HGMDFN371
AC   CVCL_1Z03
DR   Wikidata; Q54887292
CC   Part of: Progeria Research Foundation cell lines.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HGMDFN717
AC   CVCL_YU37
DR   Wikidata; Q94204615
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y94 ! HGMDFN090
OI   CVCL_1Z29 ! HGMLBV010
SX   Female
AG   53Y3M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   HGMDFN718
AC   CVCL_YU39
DR   Wikidata; Q94204619
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y0M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   HGMDFSV40T090
AC   CVCL_DP41
DR   Wikidata; Q54887293
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y94 ! HGMDFN090
SX   Female
AG   37Y10M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   HGMDFSV40T368
AC   CVCL_DP44
SY   HGMDFSV40TN368
DR   Wikidata; Q54887294
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z00 ! HGMDFN368
SX   Female
AG   31Y7M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   HGMLBV010
AC   CVCL_1Z29
DR   Wikidata; Q54887295
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y94 ! HGMDFN090
OI   CVCL_YU37 ! HGMDFN717
SX   Female
AG   36Y11M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   HGMLBV013
AC   CVCL_2A20
DR   Wikidata; Q54887296
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGMLBV017
AC   CVCL_1Z35
DR   Wikidata; Q54887297
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGMLBV023
AC   CVCL_1Z32
DR   Wikidata; Q54887298
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGMLBV041
AC   CVCL_1Z39
DR   Wikidata; Q54887299
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGMLBV058
AC   CVCL_2A21
DR   Wikidata; Q54887300
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGMLBV065
AC   CVCL_1Z42
DR   Wikidata; Q54887301
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y0M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGMLBV066
AC   CVCL_1Z44
DR   Wikidata; Q54887302
RX   PubMed=12714972;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGMLBV076
AC   CVCL_1Z49
DR   Wikidata; Q54887303
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGMLBV078
AC   CVCL_2A22
DR   Wikidata; Q54887304
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGMLBV081
AC   CVCL_2A23
DR   Wikidata; Q54887305
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HGMLBV098
AC   CVCL_1Z53
DR   Wikidata; Q54887306
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGMLBV133
AC   CVCL_1Z58
DR   Wikidata; Q54887307
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGOM
AC   CVCL_G032
DR   IPD-IMGT/HLA; 10731
DR   Wikidata; Q54887308
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*39:05; DPB1*04:02 (IPD-IMGT/HLA=10731).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   hGP 5C4
AC   CVCL_IQ42
DR   Wikidata; Q54887309
RX   Patent=EP1538165A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2631.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   HGP53
AC   CVCL_6645
SY   HGP53-110
DR   Wikidata; Q54887310
RX   PubMed=11756569;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala132Val).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   HGPS-iPSC#1
AC   CVCL_L655
SY   HGPS-iPSC_1
DR   GEO; GSM603052
DR   GEO; GSM603053
DR   Wikidata; Q54887311
RX   PubMed=21346760;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F261 ! GM01972
SX   Female
AG   13Y10M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   HGPS-iPSC#2
AC   CVCL_L656
DR   Wikidata; Q54887317
RX   PubMed=21346760;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F261 ! GM01972
SX   Female
AG   13Y10M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   HGPS-iPSC#3
AC   CVCL_L657
DR   Wikidata; Q54887318
RX   PubMed=21346760;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F261 ! GM01972
SX   Female
AG   13Y10M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   HGPS-iPSC#4
AC   CVCL_L658
DR   Wikidata; Q54887319
RX   PubMed=21346760;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F261 ! GM01972
SX   Female
AG   13Y10M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   HGPS-iPSC#5
AC   CVCL_L659
DR   Wikidata; Q54887320
RX   PubMed=21346760;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F261 ! GM01972
SX   Female
AG   13Y10M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   HGPS-iPSC#6
AC   CVCL_L660
DR   Wikidata; Q54887321
RX   PubMed=21346760;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F261 ! GM01972
SX   Female
AG   13Y10M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   HGrC1
AC   CVCL_KB28
SY   hGrC1
DR   Wikidata; Q54887322
RX   PubMed=22467494;
RX   PubMed=31079267;
RX   PubMed=34888112;
CC   Characteristics: Has FSH-responsive aromatase activity, inducible FSHR expression and responsiveness to the TGF-beta superfamily (PubMed=22467494).
CC   Doubling time: ~40 hours (PubMed=22467494).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HGrC1-MXIV
AC   CVCL_E3DE
RX   PubMed=34888112;
CC   Characteristics: Control cell line for HGrC1-TP53(R175H) (Cellosaurus=CVCL_E3DD), HGrC1-YAP (Cellosaurus=CVCL_A0TX) and HGrC1-YAP(S127A) (Cellosaurus=CVCL_A0TY). Transduced with an empty vector (PubMed=34888112).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB28 ! HGrC1
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HGrC1-TP53(R175H)
AC   CVCL_E3DD
SY   HGrC1-TP53R175H
RX   PubMed=34888112;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg175His).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB28 ! HGrC1
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HGrC1-YAP
AC   CVCL_A0TX
DR   Wikidata; Q108820465
RX   PubMed=34888112;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB28 ! HGrC1
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   HGrC1-YAP(S127A)
AC   CVCL_A0TY
SY   HGrC1-YAPS127A
DR   Wikidata; Q108820466
RX   PubMed=34888112;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser127Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB28 ! HGrC1
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   HGRT
AC   CVCL_H733
DR   CLO; CLO_0050118
DR   BioSample; SAMN03472190
DR   FANTOM5_SSTAR; 10694-109G1
DR   RCB; RCB0966
DR   Wikidata; Q54887323
CC   Population: Japanese.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): RCB=RCB0966
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C5260; Mature gastric teratoma
DI   ORDO; Orphanet_883; Extragonadal teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   HGS1
AC   CVCL_B5GV
DR   CancerTools; 160537
DR   Wikidata; Q110432892
DR   Ximbio; 160537
RX   PubMed=31940494;
CC   Characteristics: When injected i.p. produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl.
DI   NCIt; C33903; Mouse ovarian serous adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HGS2
AC   CVCL_B5GW
DR   CancerTools; 160538
DR   Wikidata; Q110432893
DR   Ximbio; 160538
RX   PubMed=31940494;
CC   Characteristics: When injected i.p. produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl.
DI   NCIt; C33903; Mouse ovarian serous adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   HGS3
AC   CVCL_B5GX
DR   CancerTools; 160539
DR   Wikidata; Q110432894
DR   Ximbio; 160539
RX   PubMed=31940494;
CC   Characteristics: When injected i.p. produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2 (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl.
DI   NCIt; C33903; Mouse ovarian serous adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HGS4
AC   CVCL_B5GY
DR   CancerTools; 160540
DR   Wikidata; Q110432895
DR   Ximbio; 160540
RX   PubMed=31940494;
CC   Characteristics: When injected i.p. produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2 (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Mesentery; UBERON=UBERON_0002095.
CC   Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl.
DI   NCIt; C33903; Mouse ovarian serous adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   HGSLBV019
AC   CVCL_1Z36
DR   Wikidata; Q54887324
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGSLBV059
AC   CVCL_2A24
DR   Wikidata; Q54887325
RX   PubMed=12714972;
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HGSLBV075
AC   CVCL_1Z50
DR   Wikidata; Q54887326
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGSLBV077
AC   CVCL_1Z51
DR   Wikidata; Q54887327
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGSLBV353
AC   CVCL_1Z73
DR   Wikidata; Q54887328
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGSLBV359
AC   CVCL_1Z74
DR   Wikidata; Q54887329
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HGT-1
AC   CVCL_A609
SY   HGT1
DR   ABM; T8210
DR   Cosmic; 887254
DR   Millipore; SCC199
DR   Wikidata; Q54887330
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=6277484;
CC   Population: Moroccan.
CC   Characteristics: Tumorgenic in nude mice (PubMed=6277484).
CC   Doubling time: 27.86 +- 2.71 hours (Note=At 40th passage), 19.48 +- 1.20 hours (Note=At 59th passage) (PubMed=6277484).
CC   Karyotypic information: Hyperdiploid karyotype with a modal number of 57 chromosomes (PubMed=6277484).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): Millipore=SCC199
ST   Amelogenin: X,Y
ST   CSF1PO: 8,13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D21S11: 29,33.2
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 22,23
ST   Penta D: 11,13
ST   Penta E: 10,11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   HGTC-8
AC   CVCL_1D70
DR   Wikidata; Q54887331
RX   PubMed=15170695;
WW   Provider; NIH OTT; E-038-2009/0-147; https://web.archive.org/web/20150922071442/http://www.ott.nih.gov/erma/one-vial-frozen-hgtc-8-or-other-similar-cells
WW   Provider; NIH OTT; E-038-2009/0-147; https://www.genome.gov/Pages/About/Organization/DIR/TTO/Schwartzberg_Murine_Embryonic_Stem_Cell_Line-1.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   HGUE-C-1
AC   CVCL_1J99
SY   Hospital General Universitario de Elche-Colon-1
DR   Wikidata; Q54887332
RX   PubMed=25885658;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=25885658).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (PubMed=25885658).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; None_reported; -; Zygosity=- (PubMed=25885658).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=25885658).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 8
//
ID   HGVEC.SV1
AC   CVCL_WW27
SY   Human Glomerular Visceral Epithelial Cells.SV40 transformed 1
DR   Wikidata; Q94205053
RX   PubMed=1354670;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVHB1).
CC   Derived from site: In situ; Kidney, glomerular visceral epithelium; UBERON=UBERON_0005751.
CC   Cell type: Glomerular epithelial cell; CL=CL_1000510.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   HGVEC.SV1A4
AC   CVCL_WW28
SY   HGVEC.SV1 clone A4; HGVEC; Human Glomerular Visceral Epithelial Cells.SV40 transformed 1 clone A4
DR   Wikidata; Q94205056
RX   PubMed=1354670;
RX   PubMed=8995744;
CC   Doubling time: ~36 hours (PubMed=1354670).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVHB1).
CC   Derived from site: In situ; Kidney, glomerular visceral epithelium; UBERON=UBERON_0005751.
CC   Cell type: Glomerular epithelial cell; CL=CL_1000510.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WW27 ! HGVEC.SV1
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   HGY
AC   CVCL_XY39
DR   Wikidata; Q94205061
RX   Patent=CN1312182C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200416.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   HH [Bovine]
AC   CVCL_2942
DR   JCRB; JCRB0099
DR   Wikidata; Q54887333
RX   PubMed=6538703;
CC   Senescence: Can undergo 60-70 PDL (JCRB=JCRB0099).
CC   Derived from site: In situ; Carotid artery, endothelium; UBERON=UBERON_0019189.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   HH [Human lymphoma]
AC   CVCL_1280
DR   CLO; CLO_0003744
DR   EFO; EFO_0002194
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2105
DR   BCRC; 60248
DR   BioSample; SAMN03472543
DR   BioSample; SAMN10987897
DR   cancercelllines; CVCL_1280
DR   Cell_Model_Passport; SIDM00671
DR   ChEMBL-Cells; CHEMBL3308142
DR   ChEMBL-Targets; CHEMBL2366310
DR   Cosmic; 687843
DR   Cosmic; 907056
DR   Cosmic; 1551452
DR   Cosmic; 2153071
DR   Cosmic; 2402471
DR   Cosmic-CLP; 907056
DR   DepMap; ACH-000061
DR   DSMZ; ACC-707
DR   DSMZCellDive; ACC-707
DR   EGA; EGAS00001000978
DR   GDSC; 907056
DR   GEO; GSM887082
DR   GEO; GSM888152
DR   GEO; GSM1669882
DR   IARC_TP53; 21371
DR   IGRhCellID; HH
DR   LiGeA; CCLE_426
DR   LINCS_LDP; LCL-1141
DR   PharmacoDB; HH_544_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1280
DR   PubChem_Cell_line; CVCL_1280
DR   Wikidata; Q54887334
RX   PubMed=1879969;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~50-70 hours (DSMZ=ACC-707).
CC   HLA typing: A*01:01,01:01; B*08:01,37:01; C*06:02,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,01:01:01; B*08:01:01,37:01:01; C*06:02:01,07:01:01; DPA1*02:01:02,02:01:02; DPB1*01:01:01,01:01:01; DQA1*01:02:01,01:02:01; DQB1*06:02:01,06:02:01; DRA*01:02:03,01:02:03; DRB1*15:01:01,15:01:01 (DSMZCellDive=ACC-707).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6036; FOXK2 + HGNC; HGNC:15979; TP63; Name(s)=FOXK2-TP63 (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=907056; DepMap=ACH-000061).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.42%; Native American=0%; East Asian, North=3.69%; East Asian, South=0%; South Asian=0%; European, North=61.06%; European, South=32.82% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2105; Cosmic-CLP=907056; DSMZ=ACC-707
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12 (ATCC=CRL-2105; Cosmic-CLP=907056)
ST   D13S317: 11,13 (DSMZ=ACC-707)
ST   D16S539: 12
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 30,32.2
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   HH-01
AC   CVCL_G288
DR   CCRID; 5301HUM-KCB10050ZJ
DR   KCB; KCB 2010050ZJ
DR   Wikidata; Q54887335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   HH-1
AC   CVCL_B6D4
DR   Wikidata; Q111733428
RX   Patent=EP0336405B1;
RX   PubMed=1369279;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1811.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50162.
CC   Characteristics: Tridoma obtained by the biological fusion of an hybridoma (AGC-78) with an EBV-transformed LCL cell line.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cell line A431.
CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6D3 ! AGC-78
HI   CVCL_B6D1 ! PEA7-1-6D
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   HH-16
AC   CVCL_G289
DR   CCRID; 5301HUM-KCB10095ZJ
DR   KCB; KCB 2010095ZJ
DR   Wikidata; Q54887336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   HH-16 cl.2/1
AC   CVCL_2068
DR   CLO; CLO_0003745
DR   DSMZ; ACC-485
DR   DSMZCellDive; ACC-485
DR   Wikidata; Q54887337
RX   PubMed=22253826;
CC   Doubling time: ~40 hours (DSMZ=ACC-485).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_2069 ! HH-16 cl.4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   HH-16 cl.4
AC   CVCL_2069
SY   HH-16.cl.4
DR   CLO; CLO_0003746
DR   DSMZ; ACC-358
DR   DSMZCellDive; ACC-358
DR   Wikidata; Q54887338
RX   PubMed=22253826;
CC   Doubling time: ~50-80 hours (DSMZ=ACC-358).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_2068 ! HH-16 cl.2/1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   HH-29
AC   CVCL_G290
DR   CCRID; 5301HUM-KCB10139ZJ
DR   KCB; KCB 2010139ZJ
DR   Wikidata; Q54887340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   HH-8
AC   CVCL_2491
SY   HH8; H-H8
DR   CCRID; 5301HUM-KCB15022YJ
DR   ECACC; 99090226
DR   KCB; KCB 2015022YJ
DR   Wikidata; Q54887341
RX   PubMed=9053739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1390; CACNA1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ECACC; 99090226; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   HH-B2
AC   CVCL_DF85
SY   HHB2
DR   cancercelllines; CVCL_DF85
DR   GEO; GSM634738
DR   Progenetix; CVCL_DF85
DR   Wikidata; Q54887342
RX   PubMed=10846108;
RX   PubMed=21685375;
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   HH0004
AC   CVCL_8W59
DR   ECACC; 910430171
DR   Wikidata; Q54887343
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,Y,Xp- (ECACC=910430171).
CC   Discontinued: ECACC; 910430171; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HH0005
AC   CVCL_8W60
DR   ECACC; 89030635
DR   Wikidata; Q54887344
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030635; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0006
AC   CVCL_8W61
DR   ECACC; 89030662
DR   Wikidata; Q54887345
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030662; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0007
AC   CVCL_8W62
DR   ECACC; 89030661
DR   Wikidata; Q54887346
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030661; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0008
AC   CVCL_8W63
DR   ECACC; 89030660
DR   Wikidata; Q54887347
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030660; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0009
AC   CVCL_8W64
DR   ECACC; 89030659
DR   Wikidata; Q54887348
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030659; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0010
AC   CVCL_8W65
DR   ECACC; 89030658
DR   Wikidata; Q54887349
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0011
AC   CVCL_8W66
DR   ECACC; 89030653
DR   Wikidata; Q54887350
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61420; Gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0012
AC   CVCL_8W67
DR   ECACC; 89030650
DR   Wikidata; Q54887351
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030650; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0013
AC   CVCL_8W68
DR   ECACC; 89030649
DR   Wikidata; Q54887352
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030649; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0015
AC   CVCL_8W69
DR   ECACC; 89030647
DR   Wikidata; Q54887353
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030647; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0018
AC   CVCL_8W70
DR   ECACC; 89030642
DR   Wikidata; Q54887354
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030642; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0019
AC   CVCL_8W71
DR   ECACC; 89030641
DR   Wikidata; Q54887355
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(9) (ECACC=89030641).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030641; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0020
AC   CVCL_8W72
DR   ECACC; 89030640
DR   Wikidata; Q54887356
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030640; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0021
AC   CVCL_8W73
DR   ECACC; 89030639
DR   Wikidata; Q54887357
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(9) (ECACC=89030639).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0023
AC   CVCL_8W74
DR   ECACC; 89030631
DR   Wikidata; Q54887360
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0024
AC   CVCL_8W75
DR   ECACC; 89030630
DR   Wikidata; Q54887361
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030630; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0025
AC   CVCL_8W76
DR   ECACC; 89030628
DR   Wikidata; Q54887362
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,-18,+i(18q); 47,XX,-18,+i(18q)+i(18p) (ECACC=89030628).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030628; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0027
AC   CVCL_8W77
DR   ECACC; 89030625
DR   Wikidata; Q54887363
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,inv dup(15)(q11.2) (ECACC=89030625).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030625; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0029
AC   CVCL_8W78
DR   ECACC; 89030621
DR   Wikidata; Q54887364
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(21) (ECACC=89030621).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030621; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0030
AC   CVCL_8W79
DR   ECACC; 89030619
DR   Wikidata; Q54887365
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030619; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0033
AC   CVCL_8W80
DR   ECACC; 89030604
DR   Wikidata; Q54887366
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(3;6)(q27;q25) (ECACC=89030604).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030604; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0035
AC   CVCL_8W81
DR   ECACC; 89030203
DR   Wikidata; Q54887367
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,t(X;Y) (ECACC=89030203).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030203; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0039
AC   CVCL_8W82
DR   ECACC; 89030274
DR   Wikidata; Q54887369
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030274; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0040
AC   CVCL_8W83
DR   ECACC; 89030288
DR   Wikidata; Q54887370
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030288; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0041
AC   CVCL_8W84
DR   ECACC; 89030291
DR   Wikidata; Q54887371
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030291; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0050
AC   CVCL_8W85
DR   ECACC; 87052062
DR   Wikidata; Q54887372
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 87052062; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0052
AC   CVCL_8W86
DR   ECACC; 88042807
DR   Wikidata; Q54887373
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;13)(q31;q32) (ECACC=88042807).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 88042807; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0055
AC   CVCL_8W87
DR   ECACC; 89022424
DR   Wikidata; Q54887374
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(3;5;12)(q12;q11;p11),t(6;17)(p21;q21) (ECACC=89022424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0056
AC   CVCL_8W88
DR   ECACC; 89022837
DR   Wikidata; Q54887375
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+i(Xq) (ECACC=89022837).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89022837; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0057
AC   CVCL_8W89
DR   ECACC; 89022838
DR   Wikidata; Q54887376
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 45,X (ECACC=89022838).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89022838; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0059
AC   CVCL_8W90
DR   ECACC; 89022840
DR   Wikidata; Q54887377
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,18p- (ECACC=89022840).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89022840; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0061
AC   CVCL_8W91
DR   ECACC; 89030272
DR   Wikidata; Q54887378
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,dir ins(2;18)(q2.1;q11.2 q21.3) (ECACC=89030272).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030272; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0063
AC   CVCL_8W92
DR   ECACC; 89030275
DR   Wikidata; Q54887379
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX; 47,XX,+mar (ECACC=89030275).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030275; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0066
AC   CVCL_8W93
DR   ECACC; 89030279
DR   Wikidata; Q54887380
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(22) (ECACC=89030279).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030279; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179702; Ring chromosome 22 syndrome
DI   ORDO; Orphanet_1446; Ring chromosome 22 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0068
AC   CVCL_8W94
DR   ECACC; 89030281
DR   Wikidata; Q54887381
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX; 47,XX,+18 (ECACC=89030281).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89030281; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0073
AC   CVCL_8W95
DR   ECACC; 89030287
DR   Wikidata; Q54887382
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY; 46,XY,5p- (ECACC=89030287).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0085
AC   CVCL_8W96
DR   ECACC; 89041102
DR   Wikidata; Q54887383
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 89041102; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HH0091
AC   CVCL_8W97
DR   ECACC; 89041119
DR   Wikidata; Q54887384
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,-15,+der(15) (ECACC=89041119).
CC   Discontinued: ECACC; 89041119; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HH0092
AC   CVCL_8W98
DR   ECACC; 89041120
DR   Wikidata; Q54887385
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,inv(X)(p11;q28) (ECACC=89041120).
CC   Discontinued: ECACC; 89041120; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   HH0093
AC   CVCL_8W99
DR   ECACC; 89041121
DR   Wikidata; Q54887386
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+13 (ECACC=89041121).
CC   Discontinued: ECACC; 89041121; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0094
AC   CVCL_8X00
DR   ECACC; 89061910
DR   Wikidata; Q54887387
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+i(12p) (ECACC=89061910).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   HH0095
AC   CVCL_8X01
DR   ECACC; 89041125
DR   Wikidata; Q54887388
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY; 46,XY,inv(21) (ECACC=89041125).
CC   Discontinued: ECACC; 89041125; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0096
AC   CVCL_8X02
DR   ECACC; 89041130
DR   Wikidata; Q54887389
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(2;14)(p11.2;11.2) (ECACC=89041130).
CC   Discontinued: ECACC; 89041130; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0098
AC   CVCL_8X03
DR   ECACC; 89041133
DR   Wikidata; Q54887390
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,+f (ECACC=89041133).
CC   Discontinued: ECACC; 89041133; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH01
AC   CVCL_4Z97
DR   Wikidata; Q54887391
RX   PubMed=7514562;
RX   PubMed=8095227;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   HH0102
AC   CVCL_8X04
DR   ECACC; 89041144
DR   Wikidata; Q54887392
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 48,XX,+i(Yq)+i(Yq) (ECACC=89041144).
CC   Discontinued: ECACC; 89041144; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0103
AC   CVCL_8X05
DR   ECACC; 89041145
DR   Wikidata; Q54887393
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+mar (ECACC=89041145).
CC   Discontinued: ECACC; 89041145; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0104
AC   CVCL_8X06
DR   ECACC; 89041146
DR   Wikidata; Q54887394
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(9;22) (ECACC=89041146).
CC   Discontinued: ECACC; 89041146; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0105
AC   CVCL_8X07
DR   ECACC; 89041150
DR   Wikidata; Q54887395
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY; 46,XY,del(5p) (ECACC=89041150).
CC   Discontinued: ECACC; 89041150; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0106
AC   CVCL_8X08
DR   ECACC; 89041151
DR   Wikidata; Q54887396
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,dup(Xq) (ECACC=89041151).
CC   Discontinued: ECACC; 89041151; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0107
AC   CVCL_8X09
DR   ECACC; 89041152
DR   Wikidata; Q54887398
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(7)(q11;q34) (ECACC=89041152).
CC   Discontinued: ECACC; 89041152; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0108
AC   CVCL_8X10
DR   ECACC; 89041153
DR   Wikidata; Q54887399
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;14)(q21;q32) (ECACC=89041153).
CC   Discontinued: ECACC; 89041153; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0110
AC   CVCL_8X11
DR   ECACC; 89042116
DR   Wikidata; Q54887400
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX; 47,XX,+2; 47,XX,+21 (ECACC=89042116).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0113
AC   CVCL_8X12
DR   ECACC; 89041157
DR   Wikidata; Q54887401
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;4) (ECACC=89041157).
CC   Discontinued: ECACC; 89041157; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0115
AC   CVCL_8X13
DR   ECACC; 89041159
DR   Wikidata; Q54887406
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(2q) (ECACC=89041159).
CC   Discontinued: ECACC; 89041159; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0117
AC   CVCL_8X14
DR   ECACC; 89042115
DR   Wikidata; Q54887407
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(2;9)(p11.2;p13) (ECACC=89042115).
CC   Discontinued: ECACC; 89042115; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0118
AC   CVCL_8X15
DR   ECACC; 89042121
DR   Wikidata; Q54887408
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+13 (ECACC=89042121).
CC   Discontinued: ECACC; 89042121; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0119
AC   CVCL_8X16
DR   ECACC; 89042122
DR   Wikidata; Q54887409
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+22 (ECACC=89042122).
CC   Discontinued: ECACC; 89042122; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0121
AC   CVCL_8X17
DR   ECACC; 89042124
DR   Wikidata; Q54887410
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+21 (ECACC=89042124).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0122
AC   CVCL_8X18
DR   ECACC; 89042125
DR   Wikidata; Q54887411
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(1)(q31) (ECACC=89042125).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0123
AC   CVCL_8X19
DR   ECACC; 89042126
DR   Wikidata; Q54887412
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+f (ECACC=89042126).
CC   Discontinued: ECACC; 89042126; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0127
AC   CVCL_8X20
DR   ECACC; 89042137
DR   Wikidata; Q54887413
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,dup(X)(q26->q27) (ECACC=89042137).
CC   Discontinued: ECACC; 89042137; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0128
AC   CVCL_8X21
DR   ECACC; 89042138
DR   Wikidata; Q54887414
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX; 47,XX,+f (ECACC=89042138).
CC   Discontinued: ECACC; 89042138; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0129
AC   CVCL_8X22
DR   ECACC; 89042139
DR   Wikidata; Q54887415
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XX,+18 (ECACC=89042139).
CC   Discontinued: ECACC; 89042139; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0130
AC   CVCL_8X23
DR   ECACC; 89061404
DR   Wikidata; Q54887416
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+13 (ECACC=89061404).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0131
AC   CVCL_8X24
DR   ECACC; 89041416
DR   Wikidata; Q54887417
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+(16) (ECACC=89041416).
CC   Discontinued: ECACC; 89041416; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0132
AC   CVCL_8X25
DR   ECACC; 89061423
DR   Wikidata; Q54887418
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XYY (ECACC=89061423).
CC   Discontinued: ECACC; 89061423; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0133
AC   CVCL_8X26
DR   ECACC; 89061425
DR   Wikidata; Q54887419
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+22 (ECACC=89061425).
CC   Discontinued: ECACC; 89061425; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0134
AC   CVCL_8X27
DR   ECACC; 89061429
DR   Wikidata; Q54887420
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 89061429; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   HH0135
AC   CVCL_8X28
DR   ECACC; 89061432
DR   Wikidata; Q54887421
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(4;18)(q25;p11.2) (ECACC=89061432).
CC   Discontinued: ECACC; 89061432; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0139
AC   CVCL_8X29
DR   ECACC; 89061906
DR   Wikidata; Q54887422
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX; 47,XX,+i(12p) (ECACC=89061906).
CC   Discontinued: ECACC; 89061906; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH02
AC   CVCL_4Z98
DR   Wikidata; Q54887423
RX   PubMed=7514562;
RX   PubMed=8095227;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   HH0244
AC   CVCL_8X30
DR   ECACC; 89042114
DR   Wikidata; Q54887424
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0273
AC   CVCL_8X31
DR   ECACC; 89061426
DR   Wikidata; Q54887425
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0279
AC   CVCL_8X32
DR   ECACC; 89061903
DR   Wikidata; Q54887426
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(1)(q25;q32) (ECACC=89061903).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0295
AC   CVCL_8X33
DR   ECACC; 92022702
DR   Wikidata; Q54887427
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(7)(q34) (ECACC=92022702).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0297
AC   CVCL_8X34
DR   ECACC; 92022704
DR   Wikidata; Q54887428
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(7)(q34) (ECACC=92022704).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0299
AC   CVCL_8X35
DR   ECACC; 89022802
DR   Wikidata; Q54887429
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XYY (ECACC=89022802).
CC   Discontinued: ECACC; 89022802; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85237; 47,XYY syndrome
DI   ORDO; Orphanet_8; 47,XYY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0301
AC   CVCL_8X36
DR   ECACC; 93111903
DR   Wikidata; Q54887430
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93111903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0302
AC   CVCL_8X37
DR   ECACC; 890306072
DR   Wikidata; Q54887431
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 890306072; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0304
AC   CVCL_8X38
DR   ECACC; 89091406
DR   Wikidata; Q54887432
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(11;22)(q23;q11.2) (ECACC=89091406).
CC   Discontinued: ECACC; 89091406; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0305
AC   CVCL_8X39
DR   ECACC; 92090701
DR   Wikidata; Q54887433
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;5)(p32;q35)mat (ECACC=92090701).
CC   Discontinued: ECACC; 92090701; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0307
AC   CVCL_8X40
DR   ECACC; 93011409
DR   Wikidata; Q54887434
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;2)(q32;p25) (ECACC=93011409).
CC   Discontinued: ECACC; 93011409; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0309
AC   CVCL_8X41
DR   ECACC; 93011411
DR   Wikidata; Q54887435
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,-18,+der(18)t(4;18)(q33;p11.2)mat (ECACC=93011411).
CC   Discontinued: ECACC; 93011411; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0310
AC   CVCL_8X42
DR   ECACC; 93021014
DR   Wikidata; Q54887436
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;16)(p32;q22) (ECACC=93021014).
CC   Discontinued: ECACC; 93021014; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0311
AC   CVCL_8X43
DR   ECACC; 93021015
DR   Wikidata; Q54887437
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+der(22)t(11;22) (ECACC=93021015).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C87069; Cleft palate
DI   ORDO; Orphanet_2014; Cleft palate
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HH0312
AC   CVCL_8X44
DR   ECACC; 93021717
DR   Wikidata; Q54887438
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(4;6)(q35;q15) (ECACC=93021717).
CC   Discontinued: ECACC; 93021717; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0313
AC   CVCL_8X45
DR   ECACC; 93021718
DR   Wikidata; Q54887439
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,-15,+(15),t(15;Y)(p12;q12) (ECACC=93021718).
CC   Discontinued: ECACC; 93021718; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0314
AC   CVCL_8X46
DR   ECACC; 93040109
DR   Wikidata; Q54887440
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(4)(p15.2->pter) (ECACC=93040109).
CC   Discontinued: ECACC; 93040109; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0315
AC   CVCL_8X47
DR   ECACC; 93041404
DR   Wikidata; Q54887441
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(1;21)(q11;p11.2) (ECACC=93041404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93041404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0316
AC   CVCL_8X48
DR   ECACC; 93052625
DR   Wikidata; Q54887442
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+18,t(1;6)(p32;q25) (ECACC=93052625).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0317
AC   CVCL_8X49
DR   ECACC; 93081117
DR   Wikidata; Q54887443
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,del(13)(q12;q14) (ECACC=93081117).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0318
AC   CVCL_8X50
DR   ECACC; 93081118
DR   Wikidata; Q54887444
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93081118; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0319
AC   CVCL_8X51
DR   ECACC; 93081119
DR   Wikidata; Q54887445
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93081119; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0320
AC   CVCL_8X52
DR   ECACC; 93081120
DR   Wikidata; Q54887452
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93081120; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0321
AC   CVCL_8X53
DR   ECACC; 93081121
DR   Wikidata; Q54887453
CC   Part of: ECACC chromosomal abnormality collection.
CC   Discontinued: ECACC; 93081121; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0332
AC   CVCL_8X54
DR   ECACC; 93120812
DR   Wikidata; Q54887454
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93120812; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0333
AC   CVCL_8X55
DR   ECACC; 93120813
DR   Wikidata; Q54887455
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93120813; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0334
AC   CVCL_8X56
DR   ECACC; 93120814
DR   Wikidata; Q54887456
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35261; Congenital adrenal gland hypoplasia
DI   ORDO; Orphanet_595337; Adrenal hypoplasia congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HH0335
AC   CVCL_8X57
DR   ECACC; 93122005
DR   Wikidata; Q54887457
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,r(4)(p15;q33) (ECACC=93122005).
CC   Discontinued: ECACC; 93122005; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C99041; Renal agenesis
DI   ORDO; Orphanet_411709; Renal agenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0341
AC   CVCL_8X58
DR   ECACC; 94120104
DR   Wikidata; Q54887458
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+i(12p) (ECACC=94120104).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0354
AC   CVCL_8X59
DR   ECACC; 95110822
DR   Wikidata; Q54887460
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,-18+der(18)t(2;18)(q29:q21.33)mat (ECACC=95110822).
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0356
AC   CVCL_8X60
DR   ECACC; 96012414
DR   Wikidata; Q54887461
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,inv(12)(q15;q24.1) (ECACC=96012414).
CC   Discontinued: ECACC; 96012414; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   HH0365
AC   CVCL_8X61
DR   ECACC; 97082809
DR   Wikidata; Q54887462
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(8;20)(q24.1;p13)mat (ECACC=97082809).
CC   Discontinued: ECACC; 97082809; true.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0370
AC   CVCL_8X62
DR   ECACC; 97092508
DR   Wikidata; Q54887463
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,der(X),t(X;17)(p22.1;q23)mat (ECACC=97092508).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0375
AC   CVCL_8X63
DR   ECACC; 98022709
DR   Wikidata; Q54887464
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,inv(12)(q15;q24.1)mat (ECACC=98022709).
CC   Discontinued: ECACC; 98022709; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   HH0377
AC   CVCL_8X64
DR   ECACC; 98091011
DR   Wikidata; Q54887465
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,inv(8)(p23;q11.2),+18 (ECACC=98091011).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HH0378
AC   CVCL_8X65
DR   ECACC; 01042409
DR   Wikidata; Q54887466
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   HH050
AC   CVCL_X531
DR   Wikidata; Q54887467
RX   PubMed=18704411;
CC   HLA typing: A*02,03; B*62,35; C*03,04 (PubMed=18704411).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   HH09
AC   CVCL_4Z99
DR   Wikidata; Q54887468
RX   PubMed=7514562;
RX   PubMed=8095227;
CC   Donor information: Established from the normal liver from a patient suffering from hepatoblastoma.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   HH09A2
AC   CVCL_A6HX
DR   Wikidata; Q107115345
RX   Patent=US4594325;
RX   PubMed=6699402;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6741 ! WI-L2-729HF2
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HH09A3
AC   CVCL_A6HY
DR   Wikidata; Q107115346
RX   Patent=US4594325;
RX   PubMed=6699402;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6741 ! WI-L2-729HF2
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HH13-1
AC   CVCL_U188
DR   CLO; CLO_0050296
DR   RCB; RCB0959
DR   Wikidata; Q54887469
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P17931; Human LGALS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   HH17-4
AC   CVCL_U189
DR   CLO; CLO_0050297
DR   RCB; RCB0960
DR   Wikidata; Q54887470
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P17931; Human LGALS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   HH244
AC   CVCL_X532
DR   Wikidata; Q54887471
RX   PubMed=18704411;
CC   HLA typing: A*01,24; B*08,35; C*04,07 (PubMed=18704411).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   HH25
AC   CVCL_5A00
DR   Wikidata; Q54887472
RX   PubMed=7493648;
RX   PubMed=7514562;
RX   PubMed=10475252;
RX   PubMed=10580581;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   HH28-3-1
AC   CVCL_C6JF
DR   Wikidata; Q116049321
RX   PubMed=1368752;
CC   Characteristics: Tetradoma obtained by the biological fusion of two hybridomas.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Monoclonal antibody target: UniProtKB; P0A3R9; Streptomyces carzinostaticus neocarzinostatin (ncsA).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6JE ! MH161H
HI   CVCL_C5Z0 ! YK136HNT56
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HH29
AC   CVCL_5A01
DR   Wikidata; Q54887473
RX   PubMed=8607815;
RX   PubMed=9495533;
RX   PubMed=10580581;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   HH2a
AC   CVCL_HG40
SY   HH2A
DR   Wikidata; Q54887474
RX   PubMed=7535635;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 7
//
ID   HH315
AC   CVCL_Y513
DR   Wikidata; Q54887475
RX   PubMed=10777059;
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Note=At 18th passage) (PubMed=10777059).
CC   Derived from site: Metastatic; Gastro-omental lymph node; UBERON=UBERON_0038746.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 7
//
ID   HH332
AC   CVCL_X533
DR   Wikidata; Q54887476
RX   PubMed=18704411;
CC   HLA typing: A*24,24; B*51,58; C*07,14 (PubMed=18704411).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   HH375
AC   CVCL_Y514
DR   Wikidata; Q54887477
RX   PubMed=10777059;
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Note=At 13th passage) (PubMed=10777059).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 7
//
ID   HH4
AC   CVCL_X906
DR   Wikidata; Q54887478
RX   Patent=US4302535;
RX   PubMed=214074;
RX   PubMed=6810168;
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, does not require a feeder layer in order to form colonies in soft agarose.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 13
//
ID   HH514-16
AC   CVCL_W740
SY   HH514; HR-1 clone 16; P3JHR-1 cl 16
DR   cancercelllines; CVCL_W740
DR   PRIDE; PXD001838
DR   Wikidata; Q54887479
RX   PubMed=6302703;
CC   Population: African; Nigerian.
CC   Characteristics: Does not exhibit spontaneous EBV lytic replication, but high levels of EBV lytic cycle gene expression can be induced following chemical treatment (PubMed=6302703).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 17
//
ID   HH543-5
AC   CVCL_W741
DR   cancercelllines; CVCL_W741
DR   Wikidata; Q54887480
RX   PubMed=6302703;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 17
//
ID   HH870
AC   CVCL_4839
DR   Wikidata; Q28872936
RX   PubMed=15468172;
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=15468172); 29.33 hours (JWGray panel).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=15468172
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 9
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 15,16
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HHC6548 T1 M1
AC   CVCL_1U94
DR   cancercelllines; CVCL_1U94
DR   CLS; 300832
DR   Wikidata; Q54887481
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 26 hours (CLS=300832).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (CLS=300832).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300832; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 9,10
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   HHCL-PI 48
AC   CVCL_9V82
DR   NCBI_Iran; C479
DR   Wikidata; Q54887482
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V81 ! HTHCL-PI 47
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HHF35
AC   CVCL_C3RZ
SY   HHF-35
DR   Wikidata; Q116049322
RX   PubMed=3544852;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P68133; Human ACTA1 (Note=Also reacts with many other mammalian species, with chicken and with zebrafish).
CC   Monoclonal antibody target: UniProtKB; P63267; Human ACTG2 (Note=Also reacts with many other mammalian species, with chicken and with zebrafish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HHKB
AC   CVCL_E694
SY   HHK; GM06818
DR   CLO; CLO_0036528
DR   Coriell; GM06818
DR   dbMHC; 48890
DR   ECACC; 85022806
DR   IHW; IHW09065
DR   IPD-IMGT/HLA; 10735
DR   Wikidata; Q54887483
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=6417008;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01; DPB1*04:01:01; DQA1*01:03; DQB1*06:03:01; DRA*01:02; DRB1*13:01:01; DRB3*01:01:02:01 (IPD-IMGT/HLA=10735).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 20
//
ID   HHL-16
AC   CVCL_S955
SY   HHL16; Human Hepatocyte Line 16
DR   Wikidata; Q54887485
RX   PubMed=15780065;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S956 ! HHL-5
OI   CVCL_S957 ! HHL-7
OI   CVCL_WX19 ! HHL-17
SX   Male
AG   <19Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   HHL-17
AC   CVCL_WX19
SY   HHL17; Human Hepatocyte Line 17
DR   Wikidata; Q94206969
RX   PubMed=10521302;
RX   PubMed=15780065;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: Not directly described in PubMed=15780065.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S956 ! HHL-5
OI   CVCL_S957 ! HHL-7
OI   CVCL_S955 ! HHL-16
SX   Male
AG   <19Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   HHL-5
AC   CVCL_S956
SY   HHL5; Human Hepatocyte Line 5
DR   BTO; BTO_0006455
DR   Wikidata; Q54887486
RX   PubMed=15780065;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S957 ! HHL-7
OI   CVCL_S955 ! HHL-16
OI   CVCL_WX19 ! HHL-17
SX   Male
AG   <19Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 17
//
ID   HHL-7
AC   CVCL_S957
SY   HHL7; Human Hepatocyte Line 7
DR   Wikidata; Q54887487
RX   PubMed=15780065;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S956 ! HHL-5
OI   CVCL_S955 ! HHL-16
OI   CVCL_WX19 ! HHL-17
SX   Male
AG   <19Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   HHP-16
AC   CVCL_M339
DR   Wikidata; Q54887488
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HHP-40
AC   CVCL_M340
DR   Wikidata; Q54887489
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Karyotypic information: Hypotetraploid; 76 chromosomes.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HHS-20
AC   CVCL_M341
DR   Wikidata; Q54887490
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   HHS-25
AC   CVCL_LJ90
DR   Wikidata; Q54887491
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   HHS-26
AC   CVCL_M342
DR   Wikidata; Q54887492
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   HHS-56
AC   CVCL_M343
DR   Wikidata; Q54887493
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Misspelling: HHP-56; DOI=10.1007/978-4-431-68349-0_4.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HHS-85
AC   CVCL_M344
DR   Wikidata; Q54887497
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Misspelling: HHP-85; DOI=10.1007/978-4-431-68349-0_4.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HHS-85Nu
AC   CVCL_LJ91
SY   HHS-85 Nu
DR   Wikidata; Q54887498
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Established after one tumor passage of HHS-85 in nude mice.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M344 ! HHS-85
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   HHS-89
AC   CVCL_M345
DR   Wikidata; Q54887499
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=2578738;
CC   Population: Southeast Asian; Thai.
CC   Misspelling: HHP-89; DOI=10.1007/978-4-431-68349-0_4.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HHT3
AC   CVCL_A9Z2
DR   Wikidata; Q102114124
RX   PubMed=20017137;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HHT4
AC   CVCL_A9Z1
SY   HHT-4
DR   Wikidata; Q102114125
RX   PubMed=17404395;
RX   PubMed=20017137;
RX   PubMed=32899426;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HHUA
AC   CVCL_3866
SY   HHUA-1
DR   CLO; CLO_0050885
DR   BioSample; SAMN03472264
DR   cancercelllines; CVCL_3866
DR   Cosmic; 713497
DR   Cosmic; 735333
DR   Cosmic; 1177619
DR   Cosmic; 1223488
DR   Cosmic; 1241346
DR   Cosmic; 1622898
DR   Cosmic; 1696758
DR   Cosmic; 2030474
DR   DepMap; ACH-002026
DR   IARC_TP53; 2377
DR   RCB; RCB0658
DR   TOKU-E; 4122
DR   Wikidata; Q54887500
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=6532401;
RX   PubMed=6706228;
RX   PubMed=8105795;
RX   PubMed=9436037;
RX   PubMed=9573483;
RX   PubMed=10457904;
RX   PubMed=15901131;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; RCB; -; https://cell.brc.riken.jp/en/wp-content/uploads/pdf/announcement/RCB0658_en.pdf
CC   Problematic cell line: Possibly contaminated. HHUA (distributed by RCB) and SNG-M (distributed by JCRB) share similar STR profiles and have been established by the same research group. While HHUA was described in 1984 and SNG-M in 1977 it has not been possible to establish which of the two cell lines are derived from each other. Thus it has been decided to consider them as being sister cell lines originating from the same donor.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00628.
CC   Population: Japanese.
CC   Doubling time: 34 hours (Note=At 5th passage), 30 hours (Note=At 15th passage) (PubMed=6706228); 30 hours (PubMed=6532401); 28 hours (PubMed=10457904).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala138Val (c.413C>T); ClinVar=VCV000184863; Zygosity=Unspecified (PubMed=8105795).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): DepMap=ACH-002026; RCB=RCB0658
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 12,18,19
ST   D21S11: 29,30
ST   D3S1358: 14,15
ST   D5S818: 9,12,13,14 (DepMap=ACH-002026)
ST   D5S818: 9,13,14 (RCB=RCB0658)
ST   D7S820: 10,13 (RCB=RCB0658)
ST   D7S820: 10,13,14 (DepMap=ACH-002026)
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 8,11
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17,18,19 (RCB=RCB0658)
ST   vWA: 17,19,20,21 (DepMap=ACH-002026)
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1707 ! SNG-M
OI   CVCL_S914 ! SNG-P
SX   Female
AG   52-54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   HHUABM
AC   CVCL_W446
DR   Wikidata; Q54887501
RX   PubMed=10834108;
CC   Population: Japanese.
CC   Doubling time: 70 hours (Note=At 10th passage), 28 hours (Note=At 40th passage) (PubMed=10834108).
CC   Derived from site: Metastatic; Left Bartholin gland; UBERON=UBERON_0000460.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   HHUi003-A
AC   CVCL_C1T8
SY   A4_M1
DR   hPSCreg; HHUi003-A
DR   Wikidata; Q114311609
CC   From: Universitatsklinikum Dusseldorf, Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (from autologous cell lines HHUi003-A; HHUi003-B).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1T9 ! HHUi003-B
OI   CVCL_C1TA ! HHUi003-C
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HHUi003-B
AC   CVCL_C1T9
SY   A4_C1
DR   BioSamples; SAMEA110696885
DR   hPSCreg; HHUi003-B
DR   Wikidata; Q114311612
RX   PubMed=36137325;
CC   From: Universitatsklinikum Dusseldorf, Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=36137325).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1T8 ! HHUi003-A
OI   CVCL_C1TA ! HHUi003-C
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HHUi003-C
AC   CVCL_C1TA
SY   A4_W1
DR   BioSamples; SAMEA110696886
DR   hPSCreg; HHUi003-C
DR   Wikidata; Q114311615
RX   PubMed=36137325;
CC   From: Universitatsklinikum Dusseldorf, Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=36137325).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1T8 ! HHUi003-A
OI   CVCL_C1T9 ! HHUi003-B
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HHUi006-A
AC   CVCL_C1TB
SY   11656_H
DR   BioSamples; SAMEA110696887
DR   hPSCreg; HHUi006-A
DR   Wikidata; Q114311617
RX   PubMed=36137325;
CC   From: Universitatsklinikum Dusseldorf, Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Heteroplasmic; Note=In about 4% of cells (PubMed=36137325).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TC ! HHUi006-B
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HHUi006-B
AC   CVCL_C1TC
SY   11656_K
DR   BioSamples; SAMEA110696888
DR   hPSCreg; HHUi006-B
DR   Wikidata; Q114311618
RX   PubMed=36137325;
CC   From: Universitatsklinikum Dusseldorf, Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Heteroplasmic; Note=In about 4% of cells (PubMed=36137325).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TB ! HHUi006-A
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HHUS
AC   CVCL_U340
DR   Wikidata; Q54887502
RX   PubMed=10937347;
RX   PubMed=15859161;
RX   PubMed=35692560;
CC   Population: Japanese.
CC   Doubling time: 92 hours (Note=At 10th passage), 67 hours (Note=At 30th passage) (PubMed=15859161).
CC   Transformant: NCBI_TaxID; 37115; Human papillomavirus type 59 (HPV59).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C40187; Cervical keratinizing squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 11
//
ID   HHUUKDi001-A
AC   CVCL_QX81
SY   ISRM-UM51; UM51
DR   BioSamples; SAMEA14016224
DR   hPSCreg; HHUUKDi001-A
DR   Wikidata; Q54887503
RX   PubMed=29035842;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: African.
CC   HLA typing: A*03:01,33:01; B*08:01,53:01; C*04:01/09N,07:02; DQB1*02:02,06:03; DRB1*07:01,13:01 (PubMed=29035842).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 8
//
ID   HHUUKDi002-A
AC   CVCL_RL76
SY   ISRM-CON9
DR   hPSCreg; HHUUKDi002-A
DR   SKIP; SKIP003085
DR   Wikidata; Q54887504
RX   PubMed=29268155;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VE87 ! CON9
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   HHUUKDi003-A
AC   CVCL_VE83
SY   AD-TREM2-1; AD TREM2-1
DR   hPSCreg; HHUUKDi003-A
DR   SKIP; SKIP003218
DR   Wikidata; Q54887505
RX   PubMed=29602048;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (PubMed=29602048).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   HHUUKDi004-A
AC   CVCL_VN16
SY   AD-TREM2-3; ISRM AD TREM2-3
DR   hPSCreg; HHUUKDi004-A
DR   Wikidata; Q94207196
RX   PubMed=29902745;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (PubMed=29902745).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   HHUUKDi005-A
AC   CVCL_WJ48
SY   CNS705
DR   hPSCreg; HHUUKDi005-A
DR   Wikidata; Q94207200
RX   PubMed=33485181;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:12530; UGT1A1; Simple; p.Tyr293Metfs*69 (c.877_890delTACATTAATGCTTCinsA) (p.Tyr292Metfs, c.874_887delTACATTAATGCTTCinsA) (879 del 13); ClinVar=VCV000012266; Zygosity=Homozygous; Note=Allele UGT1A1*2 (PubMed=33485181).
CC   Caution: The parent fibroblast seem to contain both male and female cells but the iPSC cells seem to be derived from the male cells (PubMed=33485181).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84656; Crigler-Najjar syndrome
DI   ORDO; Orphanet_205; Crigler-Najjar syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AA86 ! GM09705
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   HHUUKDi006-A
AC   CVCL_UK17
SY   ISRM-NBS1
DR   hPSCreg; HHUUKDi006-A
DR   Wikidata; Q94207203
RX   PubMed=30616142;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (PubMed=30616142).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   HHUUKDi007-A
AC   CVCL_VN15
SY   S11
DR   hPSCreg; HHUUKDi007-A
DR   Wikidata; Q94207205
RX   PubMed=30081348;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18590; PNPLA3; Simple; p.Ile148Met (c.444C>G); ClinVar=VCV000341932; Zygosity=Homozygous (PubMed=30081348).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   HHUUKDi008-A
AC   CVCL_VN14
SY   S18
DR   hPSCreg; HHUUKDi008-A
DR   Wikidata; Q94207209
RX   PubMed=30071394;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18590; PNPLA3; Simple; p.Ile148Met (c.444C>G); ClinVar=VCV000341932; Zygosity=Homozygous (PubMed=30071394).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84444; Nonalcoholic fatty liver disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   HHUUKDi009-A
AC   CVCL_B3T9
SY   TFBJ
DR   BioSamples; SAMEA13795056
DR   hPSCreg; HHUUKDi009-A
DR   Wikidata; Q110432896
RX   PubMed=28132834;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   HHUUKDi011-A
AC   CVCL_C1PU
SY   AATD iPSC-1; ISRM-AATD-iPSC-1
DR   BioSamples; SAMEA13944731
DR   hPSCreg; HHUUKDi011-A
DR   Wikidata; Q114311619
RX   PubMed=37506509;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=37506509).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Urine-derived renal progenitor cell.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   HHUUKDi012-A
AC   CVCL_C1PV
SY   AATD iPSC-2; ISRM-AATD-iPSC-2
DR   BioSamples; SAMEA13944732
DR   hPSCreg; HHUUKDi012-A
DR   Wikidata; Q114311620
RX   PubMed=37506509;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=37506509).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Urine-derived renal progenitor cell.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   HHUUKDi013-A
AC   CVCL_F0RH
SY   ISRM-AATD-iPSC-3
DR   BioSamples; SAMEA118769832
DR   hPSCreg; HHUUKDi013-A
RX   PubMed=40602288;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=40602288).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Urine-derived renal progenitor cell.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HHUUKDi014-A
AC   CVCL_F0RG
SY   ISRM-BS3-UM18-iPSC; ISRM-BS3-iPSC
DR   hPSCreg; HHUUKDi014-A
RX   PubMed=40609324;
RX   PubMed=40818270;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Population: Asian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:2027; CLCNKB; Zygosity=Homozygous (PubMed=40609324).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Urine-derived renal progenitor cell.
DI   NCIt; C222346; Bartter syndrome, type 3
DI   ORDO; Orphanet_93605; Bartter syndrome type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HHW105
AC   CVCL_0F84
SY   HHW 105; GM10114
DR   CLO; CLO_0029904
DR   Coriell; GM10114
DR   Wikidata; Q54887506
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=2884625;
RX   PubMed=3459254;
RX   PubMed=6346061;
RX   PubMed=7782085;
RX   PubMed=8314568;
RX   PubMed=9732752;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping. Contains a complete copy of chromosome 5.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 11
//
ID   HHW1064
AC   CVCL_5U13
SY   HHW 1064; GM11434
DR   CLO; CLO_0020837
DR   Coriell; GM11434
DR   Wikidata; Q54887507
RX   PubMed=7782085;
RX   PubMed=8188230;
RX   PubMed=8508678;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   HHW1099
AC   CVCL_0G17
SY   HHW 1099; GM50003
DR   CLO; CLO_0014811
DR   Coriell; GM50003
DR   Wikidata; Q54887508
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   HHW1107
AC   CVCL_DE40
SY   HHW 1107; GM11446
DR   CLO; CLO_0020934
DR   Coriell; GM11446
DR   Wikidata; Q54887509
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   HHW1113
AC   CVCL_DE41
SY   HHW 1113; GM11443
DR   CLO; CLO_0020935
DR   Coriell; GM11443
DR   Wikidata; Q54887510
RX   CelloPub=CLPUB00447;
RX   PubMed=7782085;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 7
//
ID   HHW1118
AC   CVCL_5U14
SY   HHW 1118; GM14229
DR   CLO; CLO_0034264
DR   Coriell; GM14229
DR   Wikidata; Q54887511
RX   PubMed=7782085;
RX   PubMed=8188230;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5Q44 ! GM14230
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   HHW1124
AC   CVCL_DE42
SY   HHW 1124; GM11444
DR   CLO; CLO_0020937
DR   Coriell; GM11444
DR   Wikidata; Q54887512
RX   CelloPub=CLPUB00447;
RX   PubMed=7782085;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 7
//
ID   HHW1126
AC   CVCL_GP91
SY   HHW 1126; GM14216
DR   CLO; CLO_0034280
DR   Coriell; GM14216
DR   Wikidata; Q54887513
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4E11 ! GM14217
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW1138
AC   CVCL_DE43
SY   HHW 1138; GM11445
DR   CLO; CLO_0020932
DR   Coriell; GM11445
DR   Wikidata; Q54887514
RX   PubMed=7782085;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 6
//
ID   HHW1185
AC   CVCL_GP92
SY   HHW 1185; GM14248
DR   CLO; CLO_0031112
DR   Coriell; GM14248
DR   Wikidata; Q54887515
RX   PubMed=7726173;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW1249
AC   CVCL_DE44
SY   HHW 1249; GM11440
DR   CLO; CLO_0020827
DR   Coriell; GM11440
DR   Wikidata; Q54887516
RX   CelloPub=CLPUB00447;
RX   PubMed=7726173;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 7
//
ID   HHW1273
AC   CVCL_0G18
SY   HHW 1273; GM50049
DR   CLO; CLO_0014827
DR   Coriell; GM50049
DR   Wikidata; Q54887517
RX   PubMed=7726173;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   HHW1296
AC   CVCL_GP93
SY   HHW 1296; GM16590
DR   CLO; CLO_0017396
DR   Coriell; GM16590
DR   Wikidata; Q54887518
RX   PubMed=7726173;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW1372
AC   CVCL_GP94
SY   HHW 1372; GM14221
DR   CLO; CLO_0034277
DR   Coriell; GM14221
DR   Wikidata; Q54887519
RX   PubMed=8103757;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1N68 ! GM11025
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 5
//
ID   HHW1405
AC   CVCL_5P57
SY   HHW 1405; GM14231
DR   CLO; CLO_0034262
DR   Coriell; GM14231
DR   Wikidata; Q54887520
RX   PubMed=7782085;
RX   PubMed=8188230;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2T79 ! GM10308
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   HHW1421
AC   CVCL_5U15
SY   HHW 1421; GM14233
DR   CLO; CLO_0034261
DR   Coriell; GM14233
DR   Wikidata; Q54887521
RX   PubMed=7782085;
RX   PubMed=8188230;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5P59 ! GM11571
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   HHW1452
AC   CVCL_GP95
SY   HHW 1452; GM14237
DR   CLO; CLO_0034257
DR   Coriell; GM14237
DR   Wikidata; Q54887522
RX   PubMed=7782085;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5Q46 ! GM14238
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW1499
AC   CVCL_5U16
SY   HHW 1499; GM13332
DR   CLO; CLO_0013256
DR   Coriell; GM13332
DR   Wikidata; Q54887523
RX   PubMed=7782085;
RX   PubMed=8188230;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 4 and 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   HHW1600
AC   CVCL_5U17
SY   HHW 1600; GM14235
DR   CLO; CLO_0034259
DR   Coriell; GM14235
DR   Wikidata; Q54887524
RX   PubMed=7782085;
RX   PubMed=8188230;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2U40 ! GM14236
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   HHW1796
AC   CVCL_GP96
DR   Wikidata; Q54887525
RX   PubMed=7726173;
CC   Population: Caucasian; Danish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   HHW1798
AC   CVCL_GP97
DR   Wikidata; Q54887526
RX   PubMed=7726173;
CC   Population: Caucasian; Danish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   HHW1799
AC   CVCL_GP98
DR   Wikidata; Q54887527
RX   PubMed=7726173;
CC   Population: Caucasian; Danish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   HHW339
AC   CVCL_AV70
SY   HHW 339; GM14204
DR   CLO; CLO_0034301
DR   Coriell; GM14204
DR   Wikidata; Q54887528
RX   PubMed=2884625;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HHW342
AC   CVCL_AV71
SY   HHW 342; GM11442
DR   CLO; CLO_0020832
DR   Coriell; GM11442
DR   Wikidata; Q54887529
RX   CelloPub=CLPUB00447;
RX   PubMed=2884625;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 7
//
ID   HHW416
AC   CVCL_0G19
SY   HHW 416; GM10115
DR   CLO; CLO_0029906
DR   Coriell; GM10115
DR   Wikidata; Q54887530
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=2557612;
RX   PubMed=8103757;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping. Contains a complete copy of chromosome 4.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 11
//
ID   HHW441
AC   CVCL_AV72
SY   HHW 441; GM14205
DR   CLO; CLO_0034300
DR   Coriell; GM14205
DR   Wikidata; Q54889475
RX   PubMed=2884625;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HHW484
AC   CVCL_0G20
SY   HHW 484; GM10629
DR   CLO; CLO_0024546
DR   Coriell; GM10629
DR   Wikidata; Q54889476
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=3459254;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 6 mapping. Contains a complete copy of chromosome 6.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 10
//
ID   HHW582
AC   CVCL_DE36
SY   HHW 582; GM11449
DR   CLO; CLO_0020925
DR   Coriell; GM11449
DR   Wikidata; Q54889477
RX   CelloPub=CLPUB00447;
RX   PubMed=8103757;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 7
//
ID   HHW631
AC   CVCL_0G21
SY   HHW 631; GM10897
DR   CLO; CLO_0023411
DR   Coriell; GM10897
DR   Wikidata; Q54889478
RX   CelloPub=CLPUB00447;
RX   PubMed=3459254;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   HHW659
AC   CVCL_0H43
SY   HHW 659; GM14225
DR   CLO; CLO_0034285
DR   Coriell; GM14225
DR   Wikidata; Q54889479
RX   PubMed=1577474;
RX   PubMed=2884625;
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   HHW661
AC   CVCL_5U04
SY   HHW 661; GM11436
DR   CLO; CLO_0020840
DR   Coriell; GM11436
DR   Wikidata; Q54889480
RX   CelloPub=CLPUB00447;
RX   PubMed=1663488;
RX   PubMed=2884625;
RX   PubMed=2945430;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 4 and 5 mapping (PubMed=9441767).
CC   Miscellaneous: Indicated in PubMed=2945430 to be derived from UCW 56, but in PubMed=1663488 it is said to be derived from UCW 113 (Cellosaurus=CVCL_5T99).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   HHW686
AC   CVCL_AV73
SY   HHW 686; GM14195
DR   CLO; CLO_0034325
DR   Coriell; GM14195
DR   Wikidata; Q54889481
RX   PubMed=2884625;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HHW690
AC   CVCL_DE37
SY   HHW 690; GM11441
DR   CLO; CLO_0020830
DR   Coriell; GM11441
DR   Wikidata; Q54889482
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   HHW693
AC   CVCL_5U05
SY   HHW 693; GM14190
DR   CLO; CLO_0034318
DR   Coriell; GM14190
DR   Wikidata; Q54889483
RX   PubMed=2557612;
RX   PubMed=2884625;
RX   PubMed=2945430;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping.
CC   Anecdotal: Was used to identify HTT, the Huntington disease causing gene.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U04 ! HHW661
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HHW711
AC   CVCL_AV74
SY   HHW 711; GM14201
DR   CLO; CLO_0034302
DR   Coriell; GM14201
DR   Wikidata; Q54889484
RX   PubMed=2884625;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HHW720
AC   CVCL_AV75
SY   HHW 720; GM11435
DR   CLO; CLO_0020838
DR   Coriell; GM11435
DR   Wikidata; Q54889485
RX   CelloPub=CLPUB00447;
RX   PubMed=2884625;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 18 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 7
//
ID   HHW725
AC   CVCL_0G22
SY   HHW 725; GM10898
DR   CLO; CLO_0023410
DR   Coriell; GM10898
DR   Wikidata; Q54889486
RX   CelloPub=CLPUB00447;
RX   PubMed=8314568;
RX   PubMed=8314575;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   HHW740
AC   CVCL_AV76
SY   HHW 740; GM14207
DR   CLO; CLO_0034305
DR   Coriell; GM14207
DR   Wikidata; Q54889487
RX   PubMed=2884625;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HHW750
AC   CVCL_AV77
SY   HHW 750; GM14196
DR   CLO; CLO_0034324
DR   Coriell; GM14196
DR   Wikidata; Q54889488
RX   PubMed=2884625;
RX   PubMed=7726173;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   HHW764
AC   CVCL_AV78
SY   HHW 764; GM11437
DR   CLO; CLO_0020842
DR   Coriell; GM11437
DR   Wikidata; Q54889489
RX   CelloPub=CLPUB00447;
RX   PubMed=2884625;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 7
//
ID   HHW778
AC   CVCL_0H44
SY   HHW 778; GM14227
DR   CLO; CLO_0034284
DR   Coriell; GM14227
DR   Wikidata; Q54889490
RX   PubMed=1577474;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H46 ! GM14228
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   HHW786
AC   CVCL_GP84
SY   HHW 786; GM14224
DR   CLO; CLO_0034278
DR   Coriell; GM14224
DR   Wikidata; Q54889492
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW792
AC   CVCL_AV79
SY   HHW 792; GM14198
DR   CLO; CLO_0034298
DR   Coriell; GM14198
DR   Wikidata; Q54889493
RX   PubMed=2884625;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HHW805
AC   CVCL_DE38
SY   HHW 805; GM11438
DR   CLO; CLO_0020844
DR   Coriell; GM11438
DR   Wikidata; Q54889494
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   HHW813
AC   CVCL_0H45
SY   HHW 813; GM14214
DR   CLO; CLO_0034303
DR   Coriell; GM14214
DR   Wikidata; Q54889495
RX   PubMed=1577474;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F85 ! UCW 206
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   HHW832
AC   CVCL_5U06
SY   HHW 832; GM14193
DR   CLO; CLO_0034323
DR   Coriell; GM14193
DR   Wikidata; Q54889496
RX   PubMed=2963539;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   HHW842
AC   CVCL_5U07
SY   HHW 842; GM11447
DR   CLO; CLO_0020929
DR   Coriell; GM11447
DR   Wikidata; Q54889497
RX   PubMed=2963539;
RX   PubMed=8103757;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   HHW847
AC   CVCL_5U08
SY   HHW 847
DR   Wikidata; Q54889498
RX   PubMed=2963539;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   HHW848
AC   CVCL_AV80
SY   HHW 848; GM11439
DR   CLO; CLO_0020846
DR   Coriell; GM11439
DR   Wikidata; Q54889499
RX   CelloPub=CLPUB00447;
RX   PubMed=2884625;
RX   PubMed=8103757;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosomes 4 and 5 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 8
//
ID   HHW878
AC   CVCL_5U09
SY   HHW 878; GM14192
DR   CLO; CLO_0034320
DR   Coriell; GM14192
DR   Wikidata; Q54889500
RX   PubMed=2963539;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   HHW882
AC   CVCL_5U10
SY   HHW 882; GM11448
DR   CLO; CLO_0020931
DR   Coriell; GM11448
DR   Wikidata; Q54889501
RX   PubMed=2963539;
RX   PubMed=9441767;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping (PubMed=9441767).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 7
//
ID   HHW886
AC   CVCL_5U11
SY   HHW 886; GM14191
DR   CLO; CLO_0034321
DR   Coriell; GM14191
DR   Wikidata; Q54889502
RX   PubMed=2963539;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   HHW890
AC   CVCL_DE39
SY   HHW 890
DR   Wikidata; Q54889503
RX   PubMed=1765380;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   HHW892
AC   CVCL_5U12
SY   HHW 892; GM14194
DR   CLO; CLO_0034322
DR   Coriell; GM14194
DR   Wikidata; Q54889504
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U08 ! HHW847
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   HHW909
AC   CVCL_AV81
SY   HHW 909; GM14200
DR   CLO; CLO_0034296
DR   Coriell; GM14200
DR   Wikidata; Q54889505
RX   PubMed=2884625;
RX   PubMed=7726173;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   HHW939
AC   CVCL_0G23
SY   HHW 939; GM14223
DR   CLO; CLO_0034279
DR   Coriell; GM14223
DR   Wikidata; Q54889506
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   HHW950
AC   CVCL_GP85
SY   HHW 950
DR   Wikidata; Q54889507
RX   PubMed=7726173;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW962
AC   CVCL_GP86
SY   HHW 962; GM14199
DR   CLO; CLO_0034297
DR   Coriell; GM14199
DR   Wikidata; Q54889508
RX   PubMed=7726173;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW965
AC   CVCL_GP87
SY   HHW 965; GM14206
DR   CLO; CLO_0034299
DR   Coriell; GM14206
DR   Wikidata; Q54889509
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U18 ! GM14213
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW972
AC   CVCL_5M66
SY   HHW 972; GM16592
DR   CLO; CLO_0017397
DR   Coriell; GM16592
DR   Wikidata; Q54889510
RX   PubMed=8004090;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   HHW980
AC   CVCL_GP88
SY   HHW 980; GM14462
DR   CLO; CLO_0031277
DR   Coriell; GM14462
DR   Wikidata; Q54889511
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHW983
AC   CVCL_0G24
SY   HHW 983; GM11584
DR   CLO; CLO_0021217
DR   Coriell; GM11584
DR   Wikidata; Q54889512
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F83 ! UCW 56
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   HHW986
AC   CVCL_GP89
SY   HHW 986; GM14218
DR   CLO; CLO_0034282
DR   Coriell; GM14218
DR   Wikidata; Q54889513
RX   PubMed=8103757;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 4 mapping.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 5
//
ID   HHW996
AC   CVCL_GP90
SY   HHW 996; GM14215
DR   CLO; CLO_0034281
DR   Coriell; GM14215
DR   Wikidata; Q54889514
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   HHY-B
AC   CVCL_HA38
DR   Wikidata; Q54889515
RX   Patent=EP1045024A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 4981CB.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   HHY41
AC   CVCL_C868
DR   Wikidata; Q54889517
RX   PubMed=7493648;
RX   PubMed=8607815;
RX   PubMed=9495533;
RX   PubMed=10580581;
CC   Doubling time: 39 hours (Note=At high density), 34 hours (Note=At low density) (PubMed=7493648).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HI
AC   CVCL_A1GY
DR   Wikidata; Q102114126
RX   DOI=10.5282/edoc.3898;
RX   PubMed=9384677;
RX   PubMed=15706405;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   Hi-5 Rix4446
AC   CVCL_RW20
SY   Hi-5 Rix 4446; Rix4446
DR   ICLDB; hi-5-rix4446
DR   Wikidata; Q54889518
RX   PubMed=22265860;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Group: Vaccine production cell line.
CC   Biotechnology: Used for the production of the papilloma vaccine Cervarix. The C-terminally truncated proteins L1 of HPV-16 and HPV-18 are separately produced in this cell line using a recombinant baculovirus expression system.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   HIAE-101
AC   CVCL_3287
SY   Human Iliac Artery Endothelial-101; AG10769; AG10769A
DR   CLO; CLO_0003747
DR   CLO; CLO_0021513
DR   ATCC; CRL-2478
DR   BioSample; SAMN03471590
DR   Coriell; AG10769
DR   Wikidata; Q54889519
RX   CelloPub=CLPUB00597;
RX   PubMed=1309825;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2478; true.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
ST   Source(s): ATCC=CRL-2478
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 9,13
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6776 ! HIVE-101
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   HIAE-109
AC   CVCL_0E17
SY   Human Iliac Artery Endothelial-109; AG10767
DR   CLO; CLO_0021526
DR   Coriell; AG10767
DR   Wikidata; Q54889520
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E18 ! HIVE-109
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIAE-24
AC   CVCL_0F58
SY   Human Iliac Artery Endothelial-24; AG10464; AG10464A
DR   Coriell; AG10464
DR   Wikidata; Q54889521
RX   CelloPub=CLPUB00597;
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: Coriell; AG10464; probable.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0F59 ! HIVE-24
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HIAE-25
AC   CVCL_A2CZ
SY   AG10504; AG10504A; Human Iliac Artery Endothelial-25
DR   Coriell; AG10504
DR   Wikidata; Q105507658
RX   CelloPub=CLPUB00597;
RX   PubMed=3156882;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: Coriell; AG10504; probable.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HIAE-27
AC   CVCL_0E13
SY   Human Iliac Artery Endothelial-27
DR   ATCC; CRL-2604
DR   BioSample; SAMN03471689
DR   Wikidata; Q54889522
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2604; true.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
ST   Source(s): ATCC=CRL-2604
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E14 ! HAAE-27
OI   CVCL_0F02 ! HIVE-27
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   HIAE-32
AC   CVCL_0E23
SY   Human Iliac Artery Endothelial-32; AG11180
DR   CLO; CLO_0021609
DR   Coriell; AG11180
DR   Wikidata; Q54889523
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIAE-35
AC   CVCL_WN98
SY   Human Iliac Artery Endothelial-35
DR   Wikidata; Q94208018
RX   PubMed=2777882;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E24 ! HIVE-35
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HIAE-36/7-1
AC   CVCL_IV55
SY   Human Iliac Artery Endothelial-36/7-1
DR   Wikidata; Q54889524
RX   PubMed=1309825;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E25 ! HIVE-36
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   HIAE-38
AC   CVCL_3288
SY   Human Iliac Artery Endothelial-38; WC00108
DR   CLO; CLO_0003748
DR   ATCC; CRL-2599
DR   BioSample; SAMN03471688
DR   Coriell; WC00108
DR   Wikidata; Q54889525
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2599; true.
CC   Discontinued: Coriell; WC00108; probable.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
ST   Source(s): ATCC=CRL-2599
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6777 ! HIVE-38
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HIAE-43/7-12
AC   CVCL_0E15
SY   Human Iliac Artery Endothelial-43/7-12; HIAE-43; AG09872; AG09872A; AG09872D
DR   CLO; CLO_0021940
DR   Coriell; AG09872
DR   Wikidata; Q54889526
RX   CelloPub=CLPUB00597;
RX   PubMed=1309825;
RX   PubMed=2777882;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E09 ! HIVE-43
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HIAE-55
AC   CVCL_3289
SY   Human Iliac Artery Endothelial-55
DR   CLO; CLO_0003749
DR   ATCC; CRL-2608
DR   BioSample; SAMN03471691
DR   Wikidata; Q54889527
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 37 PDL (ATCC=CRL-2608).
CC   Discontinued: ATCC; CRL-2608; true.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
ST   Source(s): ATCC=CRL-2608
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3293 ! HIVE-55
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HIAE-65
AC   CVCL_3290
SY   Human Iliac Artery Endothelial-65; WC00114
DR   CLO; CLO_0003750
DR   ATCC; CRL-2606
DR   BioSample; SAMN03471690
DR   Coriell; WC00114
DR   Wikidata; Q54889528
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2606; true.
CC   Discontinued: Coriell; WC00114; probable.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
ST   Source(s): ATCC=CRL-2606
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3294 ! HIVE-65
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HIAE-78
AC   CVCL_3291
SY   Human Iliac Artery Endothelial-78; WC00100
DR   CLO; CLO_0003751
DR   ATCC; CRL-2475
DR   BioSample; SAMN03471589
DR   Coriell; WC00100
DR   Wikidata; Q54889529
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 36 PDL (ATCC=CRL-2475).
CC   Discontinued: ATCC; CRL-2475; true.
CC   Discontinued: Coriell; WC00100; probable.
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
ST   Source(s): ATCC=CRL-2475
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 9,13
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3295 ! HIVE-78
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   HIAS-117C
AC   CVCL_2Q17
SY   Human Iliac Artery Smooth muscle-117C; AG11545
DR   CLO; CLO_0022600
DR   Coriell; AG11545
DR   Wikidata; Q54889530
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac artery, smooth muscle; UBERON=UBERON_8480003.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HIAS-126
AC   CVCL_6775
SY   Human Iliac Artery Smooth muscle-126; WC00106
DR   ATCC; CRL-2483
DR   BioSample; SAMN03471595
DR   Coriell; WC00106
DR   Wikidata; Q54889531
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Misspelling: NIAS-126; BioSample=SAMN03471595.
CC   Discontinued: ATCC; CRL-2483; true.
CC   Discontinued: Coriell; WC00106; probable.
CC   Derived from site: In situ; Iliac artery, smooth muscle; UBERON=UBERON_8480003.
ST   Source(s): ATCC=CRL-2483
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,14
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HIAS-130T
AC   CVCL_0N50
SY   Human Iliac Artery Smooth muscle-130T; AG11548
DR   CLO; CLO_0022596
DR   Coriell; AG11548
DR   Wikidata; Q54889532
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac artery, smooth muscle; UBERON=UBERON_8480003.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N51 ! HIVS-130T
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIB 1B
AC   CVCL_0299
SY   HIB-1B; HIB1B
DR   BTO; BTO_0005964
DR   EFO; EFO_0022808
DR   MCCL; MCC:0000190
DR   Lonza; 279
DR   Wikidata; Q54889533
RX   PubMed=1323843;
RX   PubMed=8175918;
WW   Info; Wikipedia; -; https://ca.wikipedia.org/wiki/C%C3%A8l%C2%B7lules_HIB_1B
CC   Characteristics: Expresses UCP. Differentiates into adipocyte-like cells (PubMed=1323843).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: aP2-TAg transgenic.
DI   NCIt; C21634; Mouse hibernoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   HiB5
AC   CVCL_XF91
DR   Wikidata; Q94208147
RX   PubMed=1878969;
RX   PubMed=12112642;
RX   PubMed=22457755;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-61.html
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Differentiates at the restrictive temperature (37 Celsius).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16FD
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HiB5.LV-BA8
AC   CVCL_XF92
DR   Wikidata; Q94208151
RX   PubMed=12112642;
CC   Characteristics: Expresses eGFP under the control of the CMV promoter.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_XF91 ! HiB5
SX   Sex unspecified
AG   16FD
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   HiB5.pNS-6
AC   CVCL_XF93
DR   Wikidata; Q94208155
RX   PubMed=12112642;
RX   PubMed=15881422;
CC   Characteristics: Expresses eGFP under the control of the CMV promoter.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_XF91 ! HiB5
SX   Sex unspecified
AG   16FD
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   HiB5.pUbi-11
AC   CVCL_XF94
DR   Wikidata; Q94208160
RX   PubMed=12112642;
CC   Characteristics: Expresses eGFP under the control of the ubiquitin (UbC) promoter.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_XF91 ! HiB5
SX   Sex unspecified
AG   16FD
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   HIBCPP
AC   CVCL_U566
DR   Wikidata; Q54889534
RX   PubMed=16130902;
RX   PubMed=29949606;
CC   Population: Japanese.
CC   Doubling time: 69 hours (Note=At 5th passage), 62 hours (Note=At 20th passage), 53 hours (Note=At 50th passage) (PubMed=16130902).
CC   Derived from site: In situ; Brain, right lateral ventricle; UBERON=UBERON_0013162.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3698; Choroid plexus papilloma
DI   ORDO; Orphanet_2807; Papilloma of choroid plexus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 10
//
ID   HIC
AC   CVCL_WJ24
SY   Human Intestinal Cancer
DR   CCRID; 4201HUM-CCTCC00043
DR   CCTCC; GDC0043
DR   Wikidata; Q94208172
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   HID
AC   CVCL_E695
DR   dbMHC; 48891
DR   ECACC; 88052703
DR   IHW; IHW09074
DR   IPD-IMGT/HLA; 11632
DR   Wikidata; Q54889535
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:01:01:01,02:06:01:01; B*40:01:02:01,40:06:01:01; C*03:04:01:02,08:01:01; DPA1*01; DPB1*02:01:02/02:01:19,05:01:01; DQA1*03; DQB1*03:03:02; DRB1*09:01:02/09:21 (IPD-IMGT/HLA=11632).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HiDEP-1
AC   CVCL_VI03
SY   Human iPS cell-Derived Erythroid Progenitor-1
DR   RCB; RCB4554
DR   Wikidata; Q54889536
RX   Patent=US8975072;
RX   PubMed=23533656;
CC   Population: Japanese.
CC   Characteristics: After in vitro induction of differentiation, will produce enucleated red blood cells. Expresses embryonic and fetal hemoglobin.
CC   Characteristics: Expression of the HPV16 E6 and E7 genes is induced by tetracycline (PubMed=23533656).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VI02 ! HiPS-RIKEN-4A-TAL1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   HiDEP-2
AC   CVCL_VI04
SY   Human iPS cell-Derived Erythroid Progenitor-2
DR   RCB; RCB4555
DR   Wikidata; Q54889537
RX   Patent=US8975072;
RX   PubMed=23533656;
CC   Population: Japanese.
CC   Characteristics: After in vitro induction of differentiation, will produce enucleated red blood cells.
CC   Characteristics: Expression of the HPV16 E6 and E7 genes is induced by tetracycline (PubMed=23533656).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VI01 ! HiPS-RIKEN-3A-TAL1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   HIE-18
AC   CVCL_YJ10
SY   HIE18; Haematobia Irritans Embryonic-18
DR   Wikidata; Q94208211
RX   PubMed=32058670;
CC   Group: Insect cell line.
CC   Characteristics: Susceptible to infection by Wolbachia wAlbB native to mosquitoes and wMel and wMelPop native to Drosophila melanogaster.
CC   Characteristics: Optimal growth temperature is 30 Celsius (PubMed=32058670).
CC   Doubling time: ~67 hours (PubMed=32058670).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7368; ! Haematobia irritans (Horn fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   HIE1
AC   CVCL_C0IA
DR   Wikidata; Q112929725
RX   PubMed=11876951;
CC   Population: Chinese.
CC   Doubling time: 22-24 hours (PubMed=11876951).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=11876951).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   HIEC-6
AC   CVCL_6C21
SY   HIEC6; Human Intestinal Epithelial Cell-6
DR   ATCC; CRL-3266
DR   Wikidata; Q54889538
RX   PubMed=8612712;
RX   PubMed=9827699;
RX   PubMed=20444515;
RX   PubMed=28239090;
CC   Doubling time: ~96 hours (ATCC=CRL-3266).
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
ST   Source(s): ATCC=CRL-3266; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14,16
ST   D12S391: 18,20
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D19S433: 14,16
ST   D1S1656: 14,18.3
ST   D21S11: 31.2
ST   D22S1045: 11,18
ST   D2S1338: 17
ST   D2S441: 10,15
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,15 (Technion Genomics Center)
ST   vWA: 15 (ATCC=CRL-3266)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17-19FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   HIG
AC   CVCL_X933
DR   CGH-DB; 9208-4
DR   Wikidata; Q54889539
RX   PubMed=14704036;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3519; Atypical chronic myeloid leukemia, BCR-ABL1 negative
DI   ORDO; Orphanet_98824; Atypical chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   HIG-82
AC   CVCL_3439
SY   HIG82
DR   BTO; BTO_0003903
DR   CLO; CLO_0003752
DR   ATCC; CRL-1832
DR   BCRC; 60242
DR   Wikidata; Q54889540
RX   PubMed=1651386;
RX   PubMed=2844284;
RX   PubMed=2846503;
CC   Doubling time: ~24 hours (PubMed=2846503).
CC   Derived from site: In situ; Knee joint, synovium; UBERON=UBERON_0001485+UBERON_0007616.
CC   Cell type: Synoviocyte; CL=CL_0000214.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   HIgE-01
AC   CVCL_WB26
SY   Hyper IgE-01
DR   IBRC; C10370
DR   Wikidata; Q94208260
RX   PubMed=32358742;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3144; Hyperimmunoglobulin E syndrome
DI   ORDO; Orphanet_2314; Autosomal dominant hyper-IgE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HIgE-02
AC   CVCL_WB27
SY   Hyper IgE-02
DR   IBRC; C10761
DR   Wikidata; Q94208265
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3144; Hyperimmunoglobulin E syndrome
DI   ORDO; Orphanet_2314; Autosomal dominant hyper-IgE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   High5-ht33
AC   CVCL_UF19
DR   ICLDB; high5-ht33
DR   Wikidata; Q94208270
RX   PubMed=21667340;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Adapted to growth at 33 Celsius.
CC   Doubling time: 24 hours (PubMed=21667340).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   High5-ht35
AC   CVCL_UF20
DR   ICLDB; high5-ht35
DR   Wikidata; Q94208275
RX   PubMed=21667340;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Adapted to growth at 35 Celsius.
CC   Doubling time: 23 hours (PubMed=21667340).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   HighMan-S2
AC   CVCL_A8PY
DR   Wikidata; Q108820467
WW   Provider; ExpreS2ion; -; https://web.archive.org/web/20240602174613/https://expres2ionbio.com/platform/about-s2-cells/
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Using CRISPR/Cas9 the parent cell line was engineered to produce proteins with high-mannose N-glycan structures.
CC   Doubling time: 18-24 hours (ExpreS2ion).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   HIHCNi001-A
AC   CVCL_VG85
SY   iPSC-STUB1
DR   hPSCreg; HIHCNi001-A
DR   Wikidata; Q54889541
RX   PubMed=29679845;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11427; STUB1; Simple; p.Arg119Ter (c.355C>T); Zygosity=Heterozygous (PubMed=29679845).
CC   Sequence variation: Mutation; HGNC; HGNC:11427; STUB1; Simple; p.Ile294Phe (c.880A>T); Zygosity=Heterozygous (PubMed=29679845).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150250; Spinocerebellar ataxia type 16
DI   ORDO; Orphanet_412057; Autosomal recessive cerebellar ataxia due to STUB1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   HIHCNi002-A
AC   CVCL_VL41
SY   iPSC-SCA3
DR   hPSCreg; HIHCNi002-A
DR   Wikidata; Q94208294
RX   PubMed=29936336;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[73]; Zygosity=Heterozygous; Note=The other allele has 24 repeats (PubMed=29936336).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   HIHCNi003-A
AC   CVCL_VL40
SY   iPSC-ALSP
DR   hPSCreg; HIHCNi003-A
DR   Wikidata; Q94208301
RX   PubMed=29980109;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:2433; CSF1R; Simple; p.Val838Leu (c.2512G>C); ClinVar=VCV000162121; Zygosity=Heterozygous (PubMed=29980109).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   HIHCNi004-A
AC   CVCL_UL59
SY   iPSC-CO
DR   hPSCreg; HIHCNi004-A
DR   Wikidata; Q94208305
RX   PubMed=30605842;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HIHCNi004-A-1
AC   CVCL_UL60
SY   iPSC-STUB1_KO
DR   hPSCreg; HIHCNi004-A-1
DR   Wikidata; Q94208310
RX   PubMed=30605842;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11427; STUB1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150250; Spinocerebellar ataxia type 16
DI   ORDO; Orphanet_412057; Autosomal recessive cerebellar ataxia due to STUB1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL59 ! HIHCNi004-A
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HIHCNi005-A
AC   CVCL_ZA49
SY   iPSC-FIG4_1
DR   hPSCreg; HIHCNi005-A
DR   Wikidata; Q98126684
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   HIHCNi006-A
AC   CVCL_B7BQ
SY   iPSC-CO2
DR   hPSCreg; HIHCNi006-A
DR   Wikidata; Q112929726
RX   PubMed=35248878;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 6
//
ID   HIHCNi006-A-1
AC   CVCL_B7BR
SY   HIHCNi006-B; iPSC-SPAST_hetKO
DR   hPSCreg; HIHCNi006-A-1
DR   Wikidata; Q112929727
RX   PubMed=35248878;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129981; Spastic paraplegia 4
DI   ORDO; Orphanet_100985; Autosomal dominant spastic paraplegia type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BQ ! HIHCNi006-A
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 8
//
ID   HIHCNi006-A-2
AC   CVCL_B7BS
SY   HIHCNi006-C; iPSC-SPAST_homKO
DR   hPSCreg; HIHCNi006-A-2
DR   Wikidata; Q112929728
RX   PubMed=35248878;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129981; Spastic paraplegia 4
DI   ORDO; Orphanet_100985; Autosomal dominant spastic paraplegia type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BQ ! HIHCNi006-A
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   HIHCNi007-A
AC   CVCL_C3RF
SY   iPSC-CO3
DR   hPSCreg; HIHCNi007-A
DR   Wikidata; Q116049323
RX   PubMed=36947995;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 3
//
ID   HIHCNi007-A-1
AC   CVCL_C3RG
SY   iPSC-CSF1R_homKO; iPSC-CSF1R-/-
DR   hPSCreg; HIHCNi007-A-1
DR   Wikidata; Q116049324
RX   PubMed=36947995;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3RF ! HIHCNi007-A
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HIHCNi007-A-2
AC   CVCL_C3RH
SY   iPSC-CSF1R_hetKO; iPSC-CSF1R+/-
DR   hPSCreg; HIHCNi007-A-2
DR   Wikidata; Q116049325
RX   PubMed=36947995;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3RF ! HIHCNi007-A
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HIHCNi008-A
AC   CVCL_C3RI
SY   iPSC-CO4
DR   BioSamples; SAMEA115164120
DR   hPSCreg; HIHCNi008-A
DR   Wikidata; Q116049327
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   HIHCNi008-A-1
AC   CVCL_C3RJ
SY   iPSC-SPAST_hetKO2
DR   hPSCreg; HIHCNi008-A-1
DR   Wikidata; Q116049328
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3RI ! HIHCNi008-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   HIHCNi008-A-2
AC   CVCL_C3RK
SY   iPSC-SPAST_homKO2
DR   hPSCreg; HIHCNi008-A-2
DR   Wikidata; Q116049329
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3RI ! HIHCNi008-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HIHCNi008-A-3
AC   CVCL_D5H9
SY   iPSC-REEP1_homKO
DR   hPSCreg; HIHCNi008-A-3
DR   Wikidata; Q127381754
RX   PubMed=38479332;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25786; REEP1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C189921; Spastic paraplegia 31
DI   ORDO; Orphanet_101011; Autosomal dominant spastic paraplegia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BQ ! HIHCNi006-A
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HIHCNi008-A-4
AC   CVCL_D5HA
SY   iPSC-REEP1_hetKO
DR   hPSCreg; HIHCNi008-A-4
DR   Wikidata; Q127381755
RX   PubMed=38479332;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25786; REEP1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C189921; Spastic paraplegia 31
DI   ORDO; Orphanet_101011; Autosomal dominant spastic paraplegia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7BQ ! HIHCNi006-A
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HIHCNi009-A
AC   CVCL_C3RL
SY   iPSC-SPAST1
DR   hPSCreg; HIHCNi009-A
DR   Wikidata; Q116049330
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HIHCNi010-A
AC   CVCL_C3RM
SY   iPSC-SPAST2
DR   hPSCreg; HIHCNi010-A
DR   Wikidata; Q116049331
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HIHDNDi001-A
AC   CVCL_YR02
SY   A30P-3; SNCA3; Tue_020_A
DR   BioSamples; SAMEA6611426
DR   hPSCreg; HIHDNDi001-A
DR   Wikidata; Q94208315
RX   PubMed=32798915;
CC   From: Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Heterozygous (PubMed=32798915).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR03 ! HIHDNDi001-B
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   HIHDNDi001-B
AC   CVCL_YR03
SY   A30P-4; SNCA4; Tue_020_B
DR   BioSamples; SAMEA6724116
DR   hPSCreg; HIHDNDi001-B
DR   Wikidata; Q94208320
RX   PubMed=32798915;
CC   From: Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Heterozygous (PubMed=32798915).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR02 ! HIHDNDi001-A
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   HIHDNEi001-A
AC   CVCL_UD88
SY   iPSC-KCNA2-P3
DR   hPSCreg; HIHDNEi001-A
DR   Wikidata; Q94208325
RX   PubMed=30292882;
CC   From: Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:6220; KCNA2; Simple; p.Leu328Val (c.982T>G); Zygosity=Heterozygous (PubMed=30292882).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155998; Developmental and epileptic encephalopathy 32
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   HIHDNEi002-A
AC   CVCL_WN13
SY   iPSC-KCNA2-P4
DR   hPSCreg; HIHDNEi002-A
DR   Wikidata; Q94208329
RX   PubMed=31075689;
CC   From: Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:6220; KCNA2; Simple; p.Arg297Gln (c.890G>A); ClinVar=VCV000190328; Zygosity=Heterozygous (PubMed=31075689).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155998; Developmental and epileptic encephalopathy 32
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   HIHDNEi003-A
AC   CVCL_WN14
DR   hPSCreg; HIHDNEi003-A
DR   Wikidata; Q94208333
RX   PubMed=31465893;
CC   From: Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6220; KCNA2; Simple; p.Thr374Ala (c.1120A>G); ClinVar=VCV000559647; Zygosity=Heterozygous (PubMed=31465893).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155998; Developmental and epileptic encephalopathy 32
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   HIHDNEi004-A
AC   CVCL_C1TD
SY   iPSC-STX1B-P8
DR   hPSCreg; HIHDNEi004-A
DR   Wikidata; Q114311621
RX   PubMed=36652844;
CC   From: Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18539; STX1B; Simple; p.Lys45delinsArgMetCysIleGlu (c.133_134insGGATGTGCATTG); ClinVar=VCV000162396; Zygosity=Heterozygous (PubMed=36652844).
CC   Sequence variation: Mutation; HGNC; HGNC:18539; STX1B; Simple; p.Leu46Met (c.135_136delinsGA) (c.135_136AC>GA); ClinVar=VCV002627888; Zygosity=Heterozygous (PubMed=36652844).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192201; Generalized epilepsy with febrile seizures plus, type 9
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   HIHRSi001-A
AC   CVCL_UL52
SY   iPSC-GBA-1
DR   hPSCreg; HIHRSi001-A
DR   Wikidata; Q94208338
RX   PubMed=30606667;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=30606667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HIHRSi002-A
AC   CVCL_UL53
SY   iPSC-GBA-2
DR   hPSCreg; HIHRSi002-A
DR   Wikidata; Q94208343
RX   PubMed=30606667;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Trp223Arg (c.667T>C) (W184R); ClinVar=VCV000093457; Zygosity=Heterozygous (PubMed=30606667).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=30606667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   HIHRSi003-A
AC   CVCL_A4EI
SY   iPSC-CO
DR   hPSCreg; HIHRSi003-A
DR   Wikidata; Q105507661
RX   PubMed=33161238;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   HIHRSi003-A-1
AC   CVCL_A4EJ
SY   iPSC-KIF1C-/-
DR   hPSCreg; HIHRSi003-A-1
DR   Wikidata; Q105507664
RX   PubMed=33161238;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6317; KIF1C; Simple_edited; p.Asp53Alafs*83 (c.158_227del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33161238).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177252; Autosomal recessive spastic ataxia-2
DI   ORDO; Orphanet_397946; Autosomal spastic paraplegia type 58
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4EI ! HIHRSi003-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HIHRSi004-A
AC   CVCL_D6ID
SY   iPSC SP-184 4.1
DR   BioSamples; SAMEA115084270
DR   hPSCreg; HIHRSi004-A
DR   Wikidata; Q127381756
RX   PubMed=38437768;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Tyr637Cysfs*14 (c.1909+22G>A); ClinVar=VCV000445922; Zygosity=Heterozygous (PubMed=38437768).
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Val1315Alafs*7 (c.3944_3945delTG); ClinVar=VCV000986804; Zygosity=Heterozygous (PubMed=38437768).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206117; POLR3A-related spastic ataxia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HIHRSi005-A
AC   CVCL_D6IE
SY   iPSC LD-12 5.3
DR   BioSamples; SAMEA115090590
DR   hPSCreg; HIHRSi005-A
DR   Wikidata; Q127381757
RX   PubMed=38437768;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Gln511Ter (c.1531C>T); Zygosity=Heterozygous (PubMed=38437768).
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Tyr637Cysfs*14 (c.1909+22G>A); ClinVar=VCV000445922; Zygosity=Heterozygous (PubMed=38437768).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206117; POLR3A-related spastic ataxia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HIHRSi006-A
AC   CVCL_D6IF
SY   iPSC SP-76 1.3
DR   BioSamples; SAMEA115090592
DR   hPSCreg; HIHRSi006-A
DR   Wikidata; Q127381758
RX   PubMed=38437768;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Tyr637Cysfs*14 (c.1909+22G>A); ClinVar=VCV000445922; Zygosity=Heterozygous (PubMed=38437768).
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Ser825Glnfs*18 (c.2472delC); Zygosity=Heterozygous (PubMed=38437768).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206117; POLR3A-related spastic ataxia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HIHTFi001-A
AC   CVCL_A0ZL
SY   RHOT1 R272Q
DR   hPSCreg; HIHTFi001-A
DR   Wikidata; Q108820468
RX   PubMed=34359002;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_edited; p.Ser156Ala (c.466T>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34359002).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4ML ! ID 16423 iPSC
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HIHTFi001-B
AC   CVCL_A0ZM
SY   RHOT1 S156A
DR   hPSCreg; HIHTFi001-B
DR   Wikidata; Q108820469
RX   PubMed=34359002;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_edited; p.Arg272Gln (c.815G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34359002).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4ML ! ID 16423 iPSC
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HIHTFi001-C
AC   CVCL_A0ZN
SY   RHOT1 K572R
DR   hPSCreg; HIHTFi001-C
DR   Wikidata; Q108820470
RX   PubMed=34359002;
CC   From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_edited; p.Lys572Arg (c.1714_1716AAA>CGG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34359002).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4ML ! ID 16423 iPSC
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HII3
AC   CVCL_V080
DR   CLO; CLO_0003753
DR   CLDB; cl1676
DR   IHW; 11w 8028
DR   Wikidata; Q54889542
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   HIL-12F3-16F2
AC   CVCL_DB51
SY   16F2
DR   Wikidata; Q54889544
RX   Patent=US6225117;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12447.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P29459; Human IL12A.
CC   Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   HIL-12F3-16G2
AC   CVCL_DB53
SY   16G2
DR   Wikidata; Q54889545
RX   Patent=US6225117;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12449.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P29459; Human IL12A.
CC   Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   HIL-12F3-20E11
AC   CVCL_DB52
SY   20E11
DR   Wikidata; Q54889546
RX   Patent=US6225117;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12448.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P29459; Human IL12A.
CC   Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   HIL-12F3-5F2
AC   CVCL_DB50
SY   5F2
DR   ATCC; HB-12446
DR   Wikidata; Q54889547
RX   Patent=US6225117;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12446.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P29459; Human IL12A.
CC   Monoclonal antibody target: UniProtKB; P29460; Human IL12B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   hIL-15-M110
AC   CVCL_J686
SY   M110
DR   CLO; CLO_0003756
DR   ATCC; HB-12061
DR   Wikidata; Q54889548
RX   Patent=US6177079;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12061.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P40933; Human IL15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   hIL-15-M111
AC   CVCL_J687
SY   M111
DR   CLO; CLO_0003757
DR   ATCC; HB-12062
DR   Wikidata; Q54889549
RX   Patent=US6177079;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12062.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P40933; Human IL15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   hIL-15-M112
AC   CVCL_J688
SY   M112; HIL-15-M112
DR   ATCC; HB-12063
DR   Wikidata; Q54889550
RX   Patent=US6177079;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12063.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P40933; Human IL15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   HIL12R1.2B10
AC   CVCL_9180
SY   HIL12R1.2B10.C5.D11; 2B10
DR   CLO; CLO_0003755
DR   ATCC; CRL-2359
DR   Wikidata; Q54889551
RX   PubMed=8617302;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P42701; Human IL12RB1/CD212.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   hIL1Rm10
AC   CVCL_A0DU
DR   Wikidata; Q108820471
RX   Patent=US6511665;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10556.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14778; Human IL1R1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HIME
AC   CVCL_WY70
DR   Wikidata; Q94208489
RX   CelloPub=CLPUB00103;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8023; ! Oncorhynchus nerka (Sockeye salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   HIMeg-1
AC   CVCL_8439
SY   HIMEG-1
DR   BioSample; SAMN03151774
DR   cancercelllines; CVCL_8439
DR   Wikidata; Q54889552
RX   PubMed=7543177;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00208.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   HIMRi001-A
AC   CVCL_D0F8
SY   p.Q1662X FLNC hiPSCs
DR   BioSamples; SAMEA113971216
DR   hPSCreg; HIMRi001-A
DR   Wikidata; Q123031672
RX   PubMed=37748332;
CC   From: Heimer Institute for Muscle Research; Bochum; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Gln1662Ter (c.4984C>T); ClinVar=VCV000852214; Zygosity=Heterozygous (PubMed=37748332).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HIMRi002-A
AC   CVCL_D0F9
SY   p.A46T CAV3 hiPSCs #1
DR   BioSamples; SAMEA114267276
DR   hPSCreg; HIMRi002-A
DR   Wikidata; Q123031673
RX   PubMed=37839261;
CC   From: Heimer Institute for Muscle Research; Bochum; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1529; CAV3; Simple; p.Ala46Thr (c.136G>A) (p.A47T); ClinVar=VCV000008281; Zygosity=Heterozygous (PubMed=37839261).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148325; Rippling muscle disease 2
DI   ORDO; Orphanet_97238; Rippling muscle disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HIMRi003-A
AC   CVCL_D0FA
SY   p.A46T CAV3 hiPSCs #2
DR   BioSamples; SAMEA114267275
DR   hPSCreg; HIMRi003-A
DR   Wikidata; Q123031674
RX   PubMed=37839261;
CC   From: Heimer Institute for Muscle Research; Bochum; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1529; CAV3; Simple; p.Ala46Thr (c.136G>A) (p.A47T); ClinVar=VCV000008281; Zygosity=Heterozygous (PubMed=37839261).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=37839261
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D8S1179: 13
ST   FGA: 24.2
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C148325; Rippling muscle disease 2
DI   ORDO; Orphanet_97238; Rippling muscle disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HIMRi004-A
AC   CVCL_D6NZ
SY   FLNC p.W2710X hiPSC
DR   BioSamples; SAMEA114710073
DR   hPSCreg; HIMRi004-A
RX   PubMed=38309149;
CC   From: Heimer Institute for Muscle Research; Bochum; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Trp2710Ter (c.8129G>A); ClinVar=VCV000694402; Zygosity=Heterozygous (PubMed=38309149).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206670; Myofibrillar myopathy 5
DI   ORDO; Orphanet_171445; Muscle filaminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HIMRi005-A
AC   CVCL_D6P0
SY   FLNC p.Y2704X hiPSC
DR   BioSamples; SAMEA114710075
DR   hPSCreg; HIMRi005-A
RX   PubMed=38309149;
CC   From: Heimer Institute for Muscle Research; Bochum; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Asp2703_Tyr2704insTer (c.8112delC); ClinVar=VCV002580944; Zygosity=Heterozygous (PubMed=38309149).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206670; Myofibrillar myopathy 5
DI   ORDO; Orphanet_171445; Muscle filaminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HIMRi006-A
AC   CVCL_D6P1
SY   GAA c.307T>G hiPSC
DR   BioSamples; SAMEA114758323
DR   hPSCreg; HIMRi006-A
RX   PubMed=38896971;
CC   From: Heimer Institute for Muscle Research; Bochum; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Cys103Gly (c.307T>G); ClinVar=VCV000092483; Zygosity=Homozygous (PubMed=38896971).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HIMRi007-A
AC   CVCL_D6P2
SY   GAA c.-32-13T>G, c.1716C>G hiPSC
DR   BioSamples; SAMEA114760681
DR   hPSCreg; HIMRi007-A
RX   PubMed=38896971;
CC   From: Heimer Institute for Muscle Research; Bochum; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (PubMed=38896971).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.His572Gln (c.1716C>G); ClinVar=VCV000929167; Zygosity=Heterozygous (PubMed=38896971).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HIN,JP
AC   CVCL_E696
SY   HIN, JP
DR   dbMHC; 48892
DR   ECACC; 94082263
DR   IHW; IHW09163
DR   IPD-IMGT/HLA; 11706
DR   Wikidata; Q54889553
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*08,51; C*07,14:02; DPB1*03:01,04:01; DQA1*06:01,05:01; DQB1*03:01,02:01; DRB1*03:01,08:03; DRB3*01:01 (IPD-IMGT/HLA=11706).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HIN,K
AC   CVCL_E697
SY   HIN, K
DR   dbMHC; 48893
DR   ECACC; 94082262
DR   IHW; IHW09162
DR   IPD-IMGT/HLA; 11705
DR   Wikidata; Q54889554
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,03; B*44:02; C*05,07; DPB1*02:02,17:01; DQA1*01:02,05:01; DQB1*02:01,06:04; DRB1*03:01,13:02; DRB3*02:02,03:01 (IPD-IMGT/HLA=11705).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HIN,R
AC   CVCL_E698
SY   HIN, R
DR   dbMHC; 48894
DR   ECACC; 94082264
DR   IHW; IHW09164
DR   IPD-IMGT/HLA; 11707
DR   Wikidata; Q54889555
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,03; B*07,08; C*07; DPB1*04:01,09:01; DQA1*01:02,05:01; DQB1*02:01,06:04; DRB1*03:01,13:02; DRB3*01:01,03:01 (IPD-IMGT/HLA=11707).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HIN,S
AC   CVCL_E699
SY   HIN, S
DR   dbMHC; 48895
DR   ECACC; 94082265
DR   IHW; IHW09165
DR   IPD-IMGT/HLA; 11708
DR   Wikidata; Q54889556
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02; B*44:02; C*01; DPB1*02:02,03:01; DQA1*05:01,06:01; DQB1*02:01,03:01; DRB1*03:01,08:03; DRB3*02:02 (IPD-IMGT/HLA=11708).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HINAE
AC   CVCL_R908
SY   HIrame NAtural Embryo
DR   Wikidata; Q54889561
RX   CelloPub=CLPUB00030;
RX   PubMed=15325525;
CC   Group: Fish cell line.
CC   Doubling time: 9 days (CelloPub=CLPUB00030).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HindIIIG-1
AC   CVCL_B7J1
DR   Wikidata; Q112929729
RX   DOI=10.1134/S1990519X2104009X;
RX   PubMed=24626185;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03246; Human adenovirus C serotype 5 E1B 19 kDa protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HIO102
AC   CVCL_E243
SY   HIO-102; Human Immortal OSE 102
DR   Wikidata; Q54889562
RX   CelloPub=CLPUB00795;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   HIO103
AC   CVCL_E244
SY   HIO-103; Human Immortal OSE 103
DR   Wikidata; Q54889563
RX   PubMed=12365030;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   HIO104
AC   CVCL_E245
SY   HIO-104; Human Immortal OSE 104
DR   Wikidata; Q54889564
RX   CelloPub=CLPUB00795;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   HIO105
AC   CVCL_E246
SY   HIO-105; Human Immortal OSE 105
DR   Wikidata; Q54889565
RX   PubMed=12365030;
RX   PubMed=14973065;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   HIO106
AC   CVCL_E256
SY   HIO-106; Human Immortal OSE 106
DR   Wikidata; Q54889566
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HIO107
AC   CVCL_E247
SY   HIO-107; Human Immortal OSE 107
DR   Wikidata; Q54889567
RX   CelloPub=CLPUB00795;
RX   PubMed=11082050;
RX   PubMed=11555632;
RX   PubMed=12365030;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (PubMed=11082050).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   HIO107C6
AC   CVCL_6E47
SY   HIO 107 C6
DR   Wikidata; Q54889568
RX   PubMed=11555632;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E247 ! HIO107
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   HIO108
AC   CVCL_E257
SY   HIO-108; Human Immortal OSE 108
DR   Wikidata; Q54889569
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   HIO113
AC   CVCL_E248
SY   HIO-113; Human Immortal OSE 113
DR   Wikidata; Q54889570
RX   CelloPub=CLPUB00795;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   HIO114
AC   CVCL_E249
SY   HIO-114; Human Immortal OSE 114
DR   Wikidata; Q54889571
RX   CelloPub=CLPUB00795;
RX   PubMed=11082050;
RX   PubMed=12365030;
RX   PubMed=14973065;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   HIO115
AC   CVCL_E258
SY   HIO-115; Human Immortal OSE 115
DR   Wikidata; Q54889573
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HIO117
AC   CVCL_E250
SY   HIO-117; HIO 117; Human Immortal OSE 117
DR   Wikidata; Q54889574
RX   CelloPub=CLPUB00795;
RX   PubMed=11082050;
RX   PubMed=19926575;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (PubMed=11082050).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   HIO118
AC   CVCL_E251
SY   HIO-118; Human Immortal OSE 118
DR   Wikidata; Q54889575
RX   CelloPub=CLPUB00795;
RX   PubMed=11082050;
RX   PubMed=11555632;
RX   PubMed=12365030;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (PubMed=11082050).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   HIO118A5
AC   CVCL_6E48
SY   HIO 118 A5
DR   Wikidata; Q54889576
RX   PubMed=11555632;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E251 ! HIO118
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   HIO118D6
AC   CVCL_6E49
DR   Wikidata; Q54889577
RX   PubMed=11555632;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E251 ! HIO118
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   HIO120
AC   CVCL_E259
SY   HIO-120; Human Immortal OSE 120
DR   Wikidata; Q54889578
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HIO121
AC   CVCL_E252
SY   HIO-121; Human Immortal OSE 121
DR   Wikidata; Q54889579
RX   CelloPub=CLPUB00795;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   HIO135
AC   CVCL_E253
SY   HIO-135; Human Immortal OSE 135
DR   Wikidata; Q54889580
RX   CelloPub=CLPUB00795;
RX   PubMed=19926575;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   HIO166
AC   CVCL_E254
SY   HIO-166; Human Immortal OSE 166
DR   Wikidata; Q54889581
RX   CelloPub=CLPUB00795;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   HIO180
AC   CVCL_DG83
SY   HIO 180; Human Immortal OSE 180
DR   Wikidata; Q54889582
RX   PubMed=23415752;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   HIO3173-11
AC   CVCL_E255
DR   Wikidata; Q54889583
RX   PubMed=19926575;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   HIO80
AC   CVCL_E274
SY   HIO-80; Human Immortal OSE 80
DR   Wikidata; Q54889584
RX   PubMed=14973065;
CC   From: Fox Chase Cancer Center; Philadelphia; USA.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   HIOAnu
AC   CVCL_X937
SY   HIOA
DR   CGH-DB; 379-2
DR   CGH-DB; 9354-4
DR   Wikidata; Q54889585
RX   CelloPub=CLPUB00153;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft produced in a BALB-c/nu nude mouse.
CC   Doubling time: 34 hours (CelloPub=CLPUB00153).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   HIOAnu2
AC   CVCL_X941
DR   CGH-DB; 384-2
DR   Wikidata; Q54889586
CC   Population: Japanese.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X937 ! HIOAnu
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   HIOEC
AC   CVCL_6E43
SY   Human Immortalized Oral Epithelial Cells
DR   Wikidata; Q54889587
RX   Patent=CN1730663A;
RX   PubMed=16513324;
RX   PubMed=16685356;
RX   PubMed=18206853;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   HIOEC-B(a)P-56
AC   CVCL_C1LE
SY   HB56
DR   Wikidata; Q114311622
RX   PubMed=18206853;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E43 ! HIOEC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HIOEC-B(a)P-96
AC   CVCL_6E44
SY   HB96
DR   Wikidata; Q54889588
RX   PubMed=18206853;
RX   PubMed=20464641;
CC   Characteristics: Tumorigenic (PubMed=18206853).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E43 ! HIOEC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   HIOEC-B(a)P-TPA
AC   CVCL_C1LG
DR   Wikidata; Q114311623
RX   Patent=CN1730663A;
RX   PubMed=16685356;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E43 ! HIOEC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HipaLu/24
AC   CVCL_RX54
SY   HipaLu-24
DR   Wikidata; Q54889589
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=249020; ! Hipposideros abae (Aba leaf-nosed bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   HipaLu/27
AC   CVCL_RX55
SY   HipaLu-27
DR   Wikidata; Q54889590
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=249020; ! Hipposideros abae (Aba leaf-nosed bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   HIPEC-65
AC   CVCL_L783
SY   HIPEC 65; HIPEC65; Human Invasive, Proliferative Extravillous Cytotrophoblast-65
DR   BTO; BTO_0006209
DR   Wikidata; Q54889591
RX   PubMed=12807721;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=HuVim [830]-T/t).
CC   Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   HipEm/28
AC   CVCL_RX52
SY   HipEm-28
DR   Wikidata; Q54889592
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=302402; ! Hipposideros caffer (Sundevall's leaf-nosed bat)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   HipEm/5
AC   CVCL_RX53
SY   HipEm-5
DR   Wikidata; Q54889593
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=302402; ! Hipposideros caffer (Sundevall's leaf-nosed bat)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   HIPS #1
AC   CVCL_C648
DR   Wikidata; Q54889594
RX   PubMed=18782754;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HIPS #11
AC   CVCL_C649
DR   Wikidata; Q54889595
RX   PubMed=18782754;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HIPS #14
AC   CVCL_C650
DR   Wikidata; Q54889596
RX   PubMed=18782754;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HIPS #3
AC   CVCL_C651
DR   Wikidata; Q54889597
RX   PubMed=18782754;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HIPS #7
AC   CVCL_C652
DR   Wikidata; Q54889598
RX   PubMed=18782754;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HIPS #8
AC   CVCL_C653
DR   Wikidata; Q54889599
RX   PubMed=18782754;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   HIPS #9
AC   CVCL_C654
DR   Wikidata; Q54889600
RX   PubMed=18782754;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   hiPS 1-8
AC   CVCL_IN12
SY   Human iPS clone 1-8
DR   GEO; GSM245339
DR   GEO; GSM245342
DR   GEO; GSM248216
DR   GEO; GSM248217
DR   GEO; GSM257570
DR   Wikidata; Q54889601
RX   PubMed=19383391;
CC   Doubling time: ~48.5 hours (PubMed=19383391).
CC   HLA typing: A*01:01,02:06; B*38:01/09,39:05; C*06:02,07:02; DPB1*04:02,05:01; DQB1*03:01,04:02; DRB1*08:02,11:04/43 (PubMed=19383391).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN14 ! hiPS 3-2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   hiPS 2-4
AC   CVCL_IN13
SY   Human iPS clone 2-4
DR   GEO; GSM257521
DR   GEO; GSM257522
DR   GEO; GSM257572
DR   Wikidata; Q54889610
RX   PubMed=19383391;
CC   HLA typing: A*02:01; B*15:01,51:01; C*03:03,04:01; DPB1*02:01,03:01; DQB1*03:02,04:02; DRB1*04:01/33/38,08:01/26 (PubMed=19383391).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   hiPS 3-2
AC   CVCL_IN14
SY   Human iPS clone 3-2
DR   GEO; GSM257523
DR   GEO; GSM257574
DR   Wikidata; Q54889611
RX   PubMed=19383391;
CC   HLA typing: A*01:01,02:06; B*38:01/09,39:05; C*06:02;07:02; DPB1*04:02,05:01; DQB1*03:01,04:02; DRB1*08:02,11:04/43 (PubMed=19383391).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN12 ! hiPS 1-8
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   HiPS-1A
AC   CVCL_B505
DR   Wikidata; Q54889612
RX   PubMed=19774082;
CC   From: Stanford University; Stanford; USA.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX95 ! HUF1
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   HiPS-1C
AC   CVCL_B506
DR   Wikidata; Q54889613
RX   PubMed=19774082;
CC   From: Stanford University; Stanford; USA.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX95 ! HUF1
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   HiPS-1D
AC   CVCL_B507
DR   Wikidata; Q54889614
RX   PubMed=19774082;
CC   From: Stanford University; Stanford; USA.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX95 ! HUF1
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   hiPS-201B7-Rm
AC   CVCL_WI46
SY   B7Rm
DR   SKIP; SKIP001134
DR   Wikidata; Q94209221
RX   PubMed=24935155;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple_edited; p.Glu181Lys (c.541G>A); ClinVar=VCV000196282; Zygosity=Heterozygous; Note=By helper-dependent adenoviral vector (PubMed=24935155).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A324 ! 201B7
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   HiPS-2C
AC   CVCL_B508
DR   Wikidata; Q54889615
RX   PubMed=19774082;
CC   From: Stanford University; Stanford; USA.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX95 ! HUF1
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   HiPS-3D
AC   CVCL_B509
DR   Wikidata; Q54889616
RX   PubMed=19774082;
CC   From: Stanford University; Stanford; USA.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX95 ! HUF1
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   hiPS-drg13
AC   CVCL_V194
DR   Wikidata; Q54889617
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS-drg13-MB.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-hiPS-drg13.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   hiPS-drg9
AC   CVCL_V195
DR   Wikidata; Q54889618
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS-drg9-MB.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Annex-BNCL-drg9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   HiPS-RIKEN-10A
AC   CVCL_Y914
SY   HPS0055
DR   RCB; HPS0055
DR   Wikidata; Q54889619
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4729 ! NCU-F4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-10B
AC   CVCL_Y915
SY   HPS0056
DR   RCB; HPS0056
DR   Wikidata; Q54889620
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4729 ! NCU-F4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-11A
AC   CVCL_1Q61
DR   SKIP; SKIP000649
DR   Wikidata; Q54889622
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D00 ! HiPS-RIKEN-11B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   HiPS-RIKEN-11B
AC   CVCL_6D00
DR   SKIP; SKIP000650
DR   Wikidata; Q54889623
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q61 ! HiPS-RIKEN-11A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   HiPS-RIKEN-12A
AC   CVCL_B510
SY   HPS0029
DR   RCB; HPS0029
DR   SKIP; SKIP000222
DR   Wikidata; Q54889624
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZH ! HUC-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   HiPS-RIKEN-12B
AC   CVCL_6C98
DR   SKIP; SKIP000646
DR   Wikidata; Q54889625
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZH ! HUC-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HiPS-RIKEN-13A
AC   CVCL_1Q62
DR   SKIP; SKIP000647
DR   Wikidata; Q54889626
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZH ! HUC-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   HiPS-RIKEN-13B
AC   CVCL_6C99
DR   SKIP; SKIP000648
DR   Wikidata; Q54889627
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZH ! HUC-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HiPS-RIKEN-1A
AC   CVCL_B511
SY   HPS0003
DR   RCB; HPS0003
DR   SKIP; SKIP000220
DR   Wikidata; Q54889628
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4682 ! HUC-F2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HiPS-RIKEN-1B
AC   CVCL_6C89
DR   SKIP; SKIP000637
DR   Wikidata; Q54889629
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4682 ! HUC-F2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-1C
AC   CVCL_6C90
DR   SKIP; SKIP000638
DR   Wikidata; Q54889630
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4682 ! HUC-F2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-1D
AC   CVCL_6C91
DR   SKIP; SKIP000639
DR   Wikidata; Q54889631
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4682 ! HUC-F2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-1E
AC   CVCL_6C92
DR   SKIP; SKIP000640
DR   Wikidata; Q54889632
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4682 ! HUC-F2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-1F
AC   CVCL_6C93
DR   SKIP; SKIP000641
DR   Wikidata; Q54889633
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4682 ! HUC-F2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-2A
AC   CVCL_B512
SY   HPS0009
DR   RCB; HPS0009
DR   SKIP; SKIP000221
DR   Wikidata; Q54889634
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2524 ! HUC-Fm
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HiPS-RIKEN-2B
AC   CVCL_6C94
DR   SKIP; SKIP000642
DR   Wikidata; Q54889635
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2524 ! HUC-Fm
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-2C
AC   CVCL_6C95
DR   SKIP; SKIP000643
DR   Wikidata; Q54889636
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2524 ! HUC-Fm
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-2D
AC   CVCL_6C96
DR   SKIP; SKIP000644
DR   Wikidata; Q54889637
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2524 ! HUC-Fm
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-2E
AC   CVCL_6C97
DR   SKIP; SKIP000645
DR   Wikidata; Q54889638
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2524 ! HUC-Fm
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-2F
AC   CVCL_1Q63
SY   HPS0014
DR   RCB; HPS0014
DR   SKIP; SKIP000636
DR   Wikidata; Q54889639
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2524 ! HUC-Fm
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   HiPS-RIKEN-3A
AC   CVCL_6D01
DR   SKIP; SKIP000651
DR   Wikidata; Q54889640
RX   PubMed=20973836;
RX   PubMed=23533656;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   HiPS-RIKEN-3A-TAL1
AC   CVCL_VI01
DR   Wikidata; Q54889641
RX   PubMed=23533656;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6D01 ! HiPS-RIKEN-3A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HiPS-RIKEN-3D
AC   CVCL_6D02
DR   SKIP; SKIP000652
DR   Wikidata; Q54889643
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-3E
AC   CVCL_6D03
DR   SKIP; SKIP000653
DR   Wikidata; Q54889644
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-4A
AC   CVCL_6D04
DR   SKIP; SKIP000654
DR   Wikidata; Q54889645
RX   PubMed=20973836;
RX   PubMed=23533656;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   HiPS-RIKEN-4A-TAL1
AC   CVCL_VI02
DR   Wikidata; Q54889646
RX   PubMed=23533656;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6D04 ! HiPS-RIKEN-4A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HiPS-RIKEN-4B
AC   CVCL_6D05
DR   SKIP; SKIP000655
DR   Wikidata; Q54889647
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-4C
AC   CVCL_6D06
DR   SKIP; SKIP000656
DR   Wikidata; Q54889648
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-4D
AC   CVCL_6D07
DR   SKIP; SKIP000657
DR   Wikidata; Q54889649
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-4E
AC   CVCL_6D08
DR   SKIP; SKIP000658
DR   Wikidata; Q54889650
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-4F
AC   CVCL_6D09
DR   SKIP; SKIP000659
DR   Wikidata; Q54889651
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D10 ! HiPS-RIKEN-4G
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-4G
AC   CVCL_6D10
DR   SKIP; SKIP000660
DR   Wikidata; Q54889658
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D11 ! HiPS-RIKEN-4H
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-4H
AC   CVCL_6D11
DR   SKIP; SKIP000661
DR   Wikidata; Q54889659
RX   PubMed=20973836;
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6D01 ! HiPS-RIKEN-3A
OI   CVCL_6D02 ! HiPS-RIKEN-3D
OI   CVCL_6D03 ! HiPS-RIKEN-3E
OI   CVCL_6D04 ! HiPS-RIKEN-4A
OI   CVCL_6D05 ! HiPS-RIKEN-4B
OI   CVCL_6D06 ! HiPS-RIKEN-4C
OI   CVCL_6D07 ! HiPS-RIKEN-4D
OI   CVCL_6D08 ! HiPS-RIKEN-4E
OI   CVCL_6D09 ! HiPS-RIKEN-4F
OI   CVCL_6D10 ! HiPS-RIKEN-4G
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   HiPS-RIKEN-5A
AC   CVCL_B519
SY   HPS0045
DR   RCB; HPS0045
DR   SKIP; SKIP000170
DR   Wikidata; Q54889660
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4732 ! NCU-F8
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   HiPS-RIKEN-5B
AC   CVCL_Y967
SY   HPS0046
DR   RCB; HPS0046
DR   Wikidata; Q54889661
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4732 ! NCU-F8
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HiPS-RIKEN-6A
AC   CVCL_Y692
SY   HPS0047
DR   RCB; HPS0047
DR   Wikidata; Q54889662
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4732 ! NCU-F8
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HiPS-RIKEN-6B
AC   CVCL_Y693
SY   HPS0048
DR   RCB; HPS0048
DR   Wikidata; Q54889663
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4732 ! NCU-F8
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HiPS-RIKEN-7A
AC   CVCL_T829
SY   HPS0049
DR   RCB; HPS0049
DR   SKIP; SKIP000278
DR   Wikidata; Q54889664
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4728 ! NCU-F3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HiPS-RIKEN-7B
AC   CVCL_Y694
SY   HPS0050
DR   RCB; HPS0050
DR   Wikidata; Q54889665
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4728 ! NCU-F3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-8A
AC   CVCL_Y962
SY   HPS0051
DR   RCB; HPS0051
DR   Wikidata; Q54889666
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4728 ! NCU-F3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-8B
AC   CVCL_Y932
SY   HPS0052
DR   RCB; HPS0052
DR   Wikidata; Q54889667
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4728 ! NCU-F3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-9A
AC   CVCL_Y517
SY   HPS0053
DR   RCB; HPS0053
DR   SKIP; SKIP000378
DR   Wikidata; Q54889668
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4729 ! NCU-F4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   HiPS-RIKEN-9B
AC   CVCL_Y699
DR   RCB; HPS0054
DR   Wikidata; Q54889669
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4729 ! NCU-F4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   hiPS-RP#5
AC   CVCL_WI44
SY   RP#5
DR   SKIP; SKIP001132
DR   Wikidata; Q94209700
RX   PubMed=24935155;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Glu181Lys (c.541G>A); ClinVar=VCV000196282; Zygosity=Heterozygous (PubMed=24935155).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   hiPS-RP#5Rw
AC   CVCL_WI45
SY   RP#5Rw; #5Rw
DR   SKIP; SKIP001133
DR   Wikidata; Q94209705
RX   PubMed=24935155;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple_corrected; p.Glu181Lys (c.541G>A); ClinVar=VCV000196282; Zygosity=Heterozygous; Note=By helper-dependent adenoviral vector (PubMed=24935155).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WI44 ! hiPS-RP#5
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   hiPSC clone 1
AC   CVCL_V196
DR   Wikidata; Q54889670
RX   PubMed=20073085;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+hiPSC_clone_1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=20073085
ST   Amelogenin: X
ST   D16S539: 9,10
ST   D18S51: 14,15
ST   D19S433: 15
ST   D21S11: 27,28
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D8S1179: 11,15
ST   FGA: 22,26
ST   TH01: 6,7
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V197 ! hiPSC clone 4
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   hiPSC clone 4
AC   CVCL_V197
DR   Wikidata; Q54889671
RX   PubMed=20073085;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/hiPSC_clone_4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=20073085
ST   Amelogenin: X
ST   D16S539: 9,10
ST   D18S51: 14,15
ST   D19S433: 15
ST   D21S11: 27,28
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D8S1179: 11,15
ST   FGA: 22,26
ST   TH01: 6,7
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V196 ! hiPSC clone 1
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   hiPSC DFNA41 patient II-1
AC   CVCL_E7GD
RX   PubMed=30819013;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:15459; P2RX2; Simple; p.Val60Leu) (c.178G>T); ClinVar= VCV000155762; Zygosity=Heterozygous (PubMed=30819013).
DI   NCIt; C175700; Deafness, autosomal dominant 41
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   hiPSC DFNA41 patient II-2
AC   CVCL_E7GE
RX   PubMed=30819013;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:15459; P2RX2; Simple; p.Val60Leu) (c.178G>T); ClinVar= VCV000155762; Zygosity=Heterozygous (PubMed=30819013).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C175700; Deafness, autosomal dominant 41
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   hiPSC DFNA41 patient III-1
AC   CVCL_E7GF
RX   PubMed=30819013;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:15459; P2RX2; Simple; p.Val60Leu) (c.178G>T); ClinVar= VCV000155762; Zygosity=Heterozygous (PubMed=30819013).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C175700; Deafness, autosomal dominant 41
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   hIPSC-Di21-C2-4-3
AC   CVCL_D1FC
SY   Di C2-4-3; C2-4-3
DR   WiCell; hipsc-di21-c2-4-2
DR   Wikidata; Q127381759
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: This cell line has lot one copy of chromosome 21. Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 of the parent cell line. The parent cell line was cultured in the absence of G418 selection for three passages to allow chromosome loss to take place, and then were cultured in the presence of ganciclovir (GCV) to select a clone without the presence of the TK-neo construct (PubMed=23084023).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1F9 ! hIPSC-Tri21-C2-4
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   hIPSC-Di21-C2-4-4
AC   CVCL_D1FD
SY   Di C2-4-4; C2-4-4
DR   WiCell; hipsc-di21-c2-4-4
DR   Wikidata; Q127381760
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: This cell line has lot one copy of chromosome 21. Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 of the parent cell line. The parent cell line was cultured in the absence of G418 selection for three passages to allow chromosome loss to take place, and then were cultured in the presence of ganciclovir (GCV) to select a clone without the presence of the TK-neo construct (PubMed=23084023).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1F9 ! hIPSC-Tri21-C2-4
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   hIPSC-Di21-C3-1-1
AC   CVCL_D1FE
SY   Di C3-1-1; C3-1-1
DR   Wikidata; Q127381761
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: This cell line has lot one copy of chromosome 21. Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 of the parent cell line. The parent cell line was cultured in the absence of G418 selection for three passages to allow chromosome loss to take place, and then were cultured in the presence of ganciclovir (GCV) to select a clone without the presence of the TK-neo construct (PubMed=23084023).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1FA ! hIPSC-Tri21-C3-1
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   hIPSC-Di21-C3-1-2
AC   CVCL_D1FF
SY   Di C3-1-2; C3-1-2
DR   Wikidata; Q127381762
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 (PubMed=23084023).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1FA ! hIPSC-Tri21-C3-1
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   hIPSC-Di21-C3-5-11
AC   CVCL_D1FG
SY   Di C3-5-11; C3-5-11
DR   Wikidata; Q127381763
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: This cell line has lot one copy of chromosome 21. Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 of the parent cell line. The parent cell line was cultured in the absence of G418 selection for three passages to allow chromosome loss to take place, and then were cultured in the presence of ganciclovir (GCV) to select a clone without the presence of the TK-neo construct (PubMed=23084023).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1FB ! hIPSC-Tri21-C3-5
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   hIPSC-Di21-C3-5-13
AC   CVCL_D1FH
SY   Di C3-5-13; C3-5-13
DR   Wikidata; Q127381764
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: This cell line has lot one copy of chromosome 21. Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 of the parent cell line. The parent cell line was cultured in the absence of G418 selection for three passages to allow chromosome loss to take place, and then were cultured in the presence of ganciclovir (GCV) to select a clone without the presence of the TK-neo construct (PubMed=23084023).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1FB ! hIPSC-Tri21-C3-5
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   hIPSC-Tri21-C2-4
AC   CVCL_D1F9
SY   Tri C2-4; C2-4
DR   WiCell; hipsc-tri21-c2-4
DR   Wikidata; Q127381765
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 (PubMed=23084023).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   hIPSC-Tri21-C3-1
AC   CVCL_D1FA
SY   Tri C3-1; C3-1
DR   Wikidata; Q127381767
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 (PubMed=23084023).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   hIPSC-Tri21-C3-5
AC   CVCL_D1FB
SY   Tri C3-5; C3-5
DR   Wikidata; Q127381768
RX   PubMed=23084023;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a IRES-TK-Neo-polyA site cassette was introduced in one allele of exon 3 of APP on chromosome 21 (PubMed=23084023).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   hiPSC117
AC   CVCL_C971
SY   HIPSC117
DR   Wikidata; Q54889672
RX   PubMed=19252477;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C972 ! hiPSC121
OI   CVCL_C973 ! hiPSC122
SX   Sex unspecified
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   hiPSC121
AC   CVCL_C972
SY   HIPSC121
DR   Wikidata; Q54889673
RX   PubMed=19252477;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C971 ! hiPSC117
OI   CVCL_C973 ! hiPSC122
SX   Sex unspecified
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   hiPSC122
AC   CVCL_C973
SY   HIPSC122
DR   Wikidata; Q54889674
RX   PubMed=19252477;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C971 ! hiPSC117
OI   CVCL_C972 ! hiPSC121
SX   Sex unspecified
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   HIRcB
AC   CVCL_0300
SY   HIRc-B
DR   EFO; EFO_0022834
DR   MCCL; MCC:0000191
DR   Wikidata; Q54889675
RX   PubMed=3312193;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   HIRO-294
AC   CVCL_ZF29
DR   Wikidata; Q98126685
RX   PubMed=25180691;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13336; Human SLC14A1 (Note=Recognizes the Jka/Jkb polymorphic site).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZF27 ! JMS-3
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   HIRO-305
AC   CVCL_ZF30
DR   Wikidata; Q98126686
RX   PubMed=32358867;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Thr31Pro. Recognizes SUMI blood group antigen).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZF27 ! JMS-3
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   HIRS-BM
AC   CVCL_E060
SY   HIRSBM
DR   CLO; CLO_0051382
DR   BioSample; SAMN03472192
DR   FANTOM5_SSTAR; 10696-109G3
DR   RCB; RCB0978
DR   Wikidata; Q54889676
RX   PubMed=3019754;
RX   PubMed=6328089;
CC   Population: Japanese.
CC   Doubling time: 38.4 hours (Note=At 30th passage), 35.2 hours (Note=At 40th passage), 33.5 hours (Note=At 60th passage) (PubMed=6328089); 35 hours (PubMed=3019754).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): RCB=RCB0978
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E061 ! HIRS-PB
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   HIRS-BMA
AC   CVCL_VS99
SY   HIRSBMA
DR   Wikidata; Q94209809
RX   PubMed=3019754;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=3019754).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E060 ! HIRS-BM
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HIRS-BMS
AC   CVCL_VT00
SY   HIRSBMS
DR   Wikidata; Q94209810
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3019754;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=3019754).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E060 ! HIRS-BM
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   HIRS-PB
AC   CVCL_E061
DR   Wikidata; Q54889677
RX   PubMed=6328089;
CC   Population: Japanese.
CC   Doubling time: 46.1 hours (Note=At 28th passage), 45.8 hours (Note=At 34th passage), 40.2 hours (Note=At 60th passage) (PubMed=6328089).
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E060 ! HIRS-BM
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   HISM
AC   CVCL_F640
SY   Human Intestinal Smooth Muscle
DR   ATCC; CRL-1692
DR   BioSample; SAMN03472822
DR   Wikidata; Q54889678
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/hism-atcc-crl-1692
CC   Senescence: Senesces at ~25 PDL (ATCC=CRL-1692). Has been discontinued from ATCC because the cells senesced.
CC   Discontinued: ATCC; CRL-1692; true.
CC   Derived from site: In situ; Small intestine, jejunum, smooth muscle; UBERON=UBERON_0012377.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
ST   Source(s): ATCC=CRL-1692
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HIT-T15
AC   CVCL_0301
SY   HIT T15; HIT.T15; HIT T-15; HITT15; HIT clone T15; Hamster Islet Transformed-Tioguanine resistant clone 15; HIT
DR   BTO; BTO_0000627
DR   CLO; CLO_0003758
DR   MCCL; MCC:0000192
DR   ATCC; CRL-1777
DR   IZSLER; BS TCL 188
DR   KCB; KCB 200828YJ
DR   KCLB; 21777
DR   Wikidata; Q54889679
RX   PubMed=2569024;
RX   PubMed=3535793;
RX   PubMed=6270673;
RX   PubMed=8697299;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-502.html
CC   Characteristics: Secretes insulin. Maximal stimulation is obtained with glucose, arginine and leucine (PubMed=3535793).
CC   Doubling time: 33-34 hours (PubMed=6270673).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HITA1
AC   CVCL_D363
SY   Human Internal Thoracic A1
DR   Wikidata; Q54889680
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITA2
AC   CVCL_D364
SY   Human Internal Thoracic A2
DR   Wikidata; Q54889681
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITA4
AC   CVCL_D365
SY   Human Internal Thoracic A4
DR   Wikidata; Q54889683
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITA5
AC   CVCL_D366
SY   Human Internal Thoracic A5
DR   Wikidata; Q54889684
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITB2
AC   CVCL_D367
SY   Human Internal Thoracic B2
DR   Wikidata; Q54889685
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITB5
AC   CVCL_D368
SY   Human Internal Thoracic B5
DR   Wikidata; Q54889686
RX   PubMed=10455062;
RX   PubMed=11557739;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-465.html
WW   Provider; Cedarlane; CLU-L-305; https://www.cedarlanelabs.com/Products/Detail/CLU-L-305?lob=AllProducts
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   HITC1
AC   CVCL_D369
SY   Human Internal Thoracic C1
DR   Wikidata; Q54889687
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITC6
AC   CVCL_D370
SY   Human Internal Thoracic C6
DR   BTO; BTO_0004118
DR   Wikidata; Q54889688
RX   PubMed=11557739;
WW   Provider; Cedarlane; CLU-L-306; https://www.cedarlanelabs.com/Products/Detail/CLU-L-306?lob=AllProducts
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   HITD1
AC   CVCL_D371
SY   Human Internal Thoracic D1
DR   Wikidata; Q54889689
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITD4
AC   CVCL_D372
SY   Human Internal Thoracic D4
DR   Wikidata; Q54889690
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D373 ! HITD5
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITD5
AC   CVCL_D373
SY   Human Internal Thoracic D5
DR   Wikidata; Q54889691
RX   PubMed=11557739;
WW   Provider; Cedarlane; CLU-L-307; https://www.cedarlanelabs.com/Products/Detail/CLU-L-307?lob=AllProducts
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D374 ! HITD6
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   HITD6
AC   CVCL_D374
SY   Human Internal Thoracic D6
DR   Wikidata; Q54889692
RX   PubMed=11557739;
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D363 ! HITA1
OI   CVCL_D364 ! HITA2
OI   CVCL_D365 ! HITA4
OI   CVCL_D366 ! HITA5
OI   CVCL_D367 ! HITB2
OI   CVCL_D368 ! HITB5
OI   CVCL_D369 ! HITC1
OI   CVCL_D370 ! HITC6
OI   CVCL_D371 ! HITD1
OI   CVCL_D372 ! HITD4
OI   CVCL_D373 ! HITD5
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   HITS glioma
AC   CVCL_WL46
DR   Wikidata; Q94210016
RX   CelloPub=CLPUB00506;
RX   PubMed=8164056;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6-9M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HIUML
AC   CVCL_W383
DR   Wikidata; Q54889693
RX   PubMed=16130900;
CC   Population: Japanese.
CC   Doubling time: ~32 hours (PubMed=16130900).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   HIVCE-17
AC   CVCL_A2DC
SY   Human Inferior Vena Cava Endothelial-17
DR   Wikidata; Q105507667
RX   PubMed=3156882;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Inferior vena cava, endothelium; UBERON=UBERON_0001072+UBERON_0004698.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HIVE-101
AC   CVCL_6776
SY   Human Iliac Vein Endothelial-101; AG10770; AG10770A
DR   CLO; CLO_0021516
DR   ATCC; CRL-2479
DR   Coriell; AG10770
DR   Coriell; WC00102
DR   Wikidata; Q54889694
RX   CelloPub=CLPUB00597;
RX   PubMed=1309825;
RX   PubMed=2777882;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2479; true.
CC   Discontinued: Coriell; WC00102; probable.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
ST   Source(s): ATCC=CRL-2479
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 9,13
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3287 ! HIAE-101
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HIVE-109
AC   CVCL_0E18
SY   Human Iliac Vein Endothelial-109; AG10768
DR   CLO; CLO_0021514
DR   Coriell; AG10768
DR   Wikidata; Q54889696
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E17 ! HIAE-109
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIVE-24
AC   CVCL_0F59
SY   Human Iliac Vein Endothelial-24; AG09874; AG09874B; AG10451
DR   CLO; CLO_0021550
DR   CLO; CLO_0021939
DR   Coriell; AG09874
DR   Coriell; AG10451
DR   Wikidata; Q54889697
RX   CelloPub=CLPUB00597;
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0F58 ! HIAE-24
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   HIVE-26
AC   CVCL_3292
SY   Human Iliac Vein Endothelial-26; WC00110
DR   CLO; CLO_0003759
DR   ATCC; CRL-2603
DR   Coriell; WC00110
DR   Wikidata; Q54889698
RX   PubMed=2777882;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 67 PDL (ATCC=CRL-2603).
CC   Discontinued: ATCC; CRL-2603; true.
CC   Discontinued: Coriell; WC00110; probable.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
ST   Source(s): ATCC=CRL-2603
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13,14
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E12 ! HAAE-26
OI   CVCL_3716 ! HPAE-26
OI   CVCL_3718 ! HPVE-26
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   HIVE-27
AC   CVCL_0F02
SY   Human Iliac Vein Endothelial-27
DR   ATCC; CRL-2600
DR   Wikidata; Q54889699
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2600; true.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E14 ! HAAE-27
OI   CVCL_0E13 ! HIAE-27
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HIVE-35
AC   CVCL_0E24
SY   Human Iliac Vein Endothelial-35; AG11182
DR   CLO; CLO_0021610
DR   Coriell; AG11182
DR   Wikidata; Q54889703
RX   CelloPub=CLPUB00597;
RX   PubMed=2777882;
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WN98 ! HIAE-35
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HIVE-36
AC   CVCL_0E25
SY   Human Iliac Vein Endothelial-36; AG11184; AG11184A
DR   CLO; CLO_0021611
DR   Coriell; AG11184
DR   Wikidata; Q54889704
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV55 ! HIAE-36/7-1
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIVE-38
AC   CVCL_6777
SY   Human Iliac Vein Endothelial-38; WC00109
DR   ATCC; CRL-2601
DR   Coriell; WC00109
DR   Wikidata; Q54889705
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2601; true.
CC   Discontinued: Coriell; WC00109; probable.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
ST   Source(s): ATCC=CRL-2601
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3288 ! HIAE-38
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HIVE-43
AC   CVCL_0E09
SY   Human Iliac Vein Endothelial-43
DR   ATCC; CRL-2477
DR   Wikidata; Q54889706
RX   PubMed=2777882;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2477; true.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E15 ! HIAE-43/7-12
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIVE-46
AC   CVCL_0E26
SY   Human Iliac Vein Endothelial-46; AG11188
DR   CLO; CLO_0021612
DR   Coriell; AG11188
DR   Wikidata; Q54889707
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIVE-54/7-2
AC   CVCL_IV53
SY   Human Iliac Vein Endothelial-54/7-2
DR   Wikidata; Q54889708
RX   PubMed=1309825;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   HIVE-55
AC   CVCL_3293
SY   Human Iliac Vein Endothelial-55; WC00113
DR   CLO; CLO_0003760
DR   ATCC; CRL-2609
DR   Coriell; WC00113
DR   Wikidata; Q54889709
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 24 PDL (ATCC=CRL-2609).
CC   Discontinued: ATCC; CRL-2609; true.
CC   Discontinued: Coriell; WC00113; probable.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
ST   Source(s): ATCC=CRL-2609
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3289 ! HIAE-55
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HIVE-65
AC   CVCL_3294
SY   Human Iliac Vein Endothelial-65; WC00111
DR   CLO; CLO_0003761
DR   ATCC; CRL-2605
DR   Coriell; WC00111
DR   Wikidata; Q54889710
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 39 PDL (ATCC=CRL-2605).
CC   Discontinued: ATCC; CRL-2605; true.
CC   Discontinued: Coriell; WC00111; probable.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
ST   Source(s): ATCC=CRL-2605
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3290 ! HIAE-65
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   HIVE-78
AC   CVCL_3295
SY   Human Iliac Vein Endothelial-78; WC00101
DR   CLO; CLO_0003762
DR   ATCC; CRL-2476
DR   Coriell; WC00101
DR   Wikidata; Q54889711
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 27 PDL (ATCC=CRL-2476).
CC   Discontinued: ATCC; CRL-2476; true.
CC   Discontinued: Coriell; WC00101; probable.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3291 ! HIAE-78
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HIVE-79/7-2
AC   CVCL_IV52
SY   Human Iliac Vein Endothelial-79/7-2
DR   Wikidata; Q54889712
RX   PubMed=1309825;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   HIVE-81/7-2
AC   CVCL_IV54
SY   Human Iliac Vein Endothelial-81/7-2
DR   Wikidata; Q54889713
RX   PubMed=1309825;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   HIVE-86
AC   CVCL_0E19
SY   Human Iliac Vein Endothelial-86; AG10773
DR   CLO; CLO_0021515
DR   Coriell; AG10773
DR   Wikidata; Q54889714
RX   CelloPub=CLPUB00597;
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Anecdotal: Have been flown in space on shuttle flight STS-89/Mir to study growth in microgravity (Coriell=AG10773).
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HIVE-87
AC   CVCL_0E20
SY   Human Iliac Vein Endothelial-87; AG10774
DR   CLO; CLO_0021510
DR   Coriell; AG10774
DR   Wikidata; Q54889715
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIVE-98/7-1
AC   CVCL_0E16
SY   Human Iliac Vein Endothelial-98/7-1; AG09897
DR   CLO; CLO_0021935
DR   Coriell; AG09897
DR   Wikidata; Q54889716
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, endothelium; UBERON=UBERON_8480004.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HIVS-121T
AC   CVCL_2Q18
SY   Human Iliac Vein Smooth muscle-121T; AG11546
DR   CLO; CLO_0022603
DR   Coriell; AG11546
DR   Wikidata; Q54889717
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, smooth muscle; UBERON=UBERON_8480000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HIVS-125
AC   CVCL_6399
SY   Human Iliac Vein Smooth muscle-125; WC00105
DR   CLO; CLO_0003763
DR   ATCC; CRL-2482
DR   BioSample; SAMN03471593
DR   Coriell; WC00105
DR   Wikidata; Q54889718
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 40 PDL (ATCC=CRL-2482).
CC   Misspelling: NIVS-125; BioSample=SAMN03471593.
CC   Discontinued: ATCC; CRL-2482; true.
CC   Discontinued: Coriell; WC00105; probable.
CC   Derived from site: In situ; Iliac vein, smooth muscle; UBERON=UBERON_8480000.
ST   Source(s): ATCC=CRL-2482
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D5S818: 10
ST   D7S820: 9,11
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   HIVS-130T
AC   CVCL_0N51
SY   Human Iliac Vein Smooth muscle-130T; AG11549
DR   CLO; CLO_0022598
DR   Coriell; AG11549
DR   Wikidata; Q54889719
RX   CelloPub=CLPUB00597;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Iliac vein, smooth muscle; UBERON=UBERON_8480000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0N50 ! HIAS-130T
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HJ1.K
AC   CVCL_S171
SY   HJ1K
DR   ATCC; CRL-6271
DR   Wikidata; Q54889720
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6271; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S172 ! HJ1.Ln
OI   CVCL_S173 ! HJ1.Lu
OI   CVCL_6400 ! HJ1.Ov
OI   CVCL_S174 ! HJ1.Th
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HJ1.Ln
AC   CVCL_S172
SY   HJ1LN
DR   ATCC; CRL-6272
DR   Wikidata; Q54889721
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6272; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S171 ! HJ1.K
OI   CVCL_S173 ! HJ1.Lu
OI   CVCL_6400 ! HJ1.Ov
OI   CVCL_S174 ! HJ1.Th
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   HJ1.Lu
AC   CVCL_S173
SY   HJ1LU
DR   ATCC; CRL-6273
DR   Wikidata; Q54889722
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6273; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S171 ! HJ1.K
OI   CVCL_S172 ! HJ1.Ln
OI   CVCL_6400 ! HJ1.Ov
OI   CVCL_S174 ! HJ1.Th
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HJ1.Ov
AC   CVCL_6400
DR   CLO; CLO_0003764
DR   ATCC; CRL-6274
DR   Wikidata; Q54889723
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/hj1ov/hj1ovcells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6274; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S171 ! HJ1.K
OI   CVCL_S172 ! HJ1.Ln
OI   CVCL_S173 ! HJ1.Lu
OI   CVCL_S174 ! HJ1.Th
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   HJ1.Th
AC   CVCL_S174
SY   HJ1th
DR   ATCC; CRL-6275
DR   Wikidata; Q54889724
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6275; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S171 ! HJ1.K
OI   CVCL_S172 ! HJ1.Ln
OI   CVCL_S173 ! HJ1.Lu
OI   CVCL_6400 ! HJ1.Ov
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HJ2.K
AC   CVCL_S175
SY   HJ2K
DR   ATCC; CRL-6276
DR   Wikidata; Q54889725
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6276; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_6401 ! HJ2.Lu
OI   CVCL_S176 ! HJ2.Sp
OI   CVCL_S177 ! HJ2.Tes
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HJ2.Lu
AC   CVCL_6401
DR   CLO; CLO_0003765
DR   ATCC; CRL-6277
DR   Wikidata; Q54889726
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6277; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S175 ! HJ2.K
OI   CVCL_S176 ! HJ2.Sp
OI   CVCL_S177 ! HJ2.Tes
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HJ2.Sp
AC   CVCL_S176
SY   HJ2Sp
DR   ATCC; CRL-6278
DR   Wikidata; Q54889727
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6278; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S175 ! HJ2.K
OI   CVCL_6401 ! HJ2.Lu
OI   CVCL_S177 ! HJ2.Tes
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HJ2.Tes
AC   CVCL_S177
DR   ATCC; CRL-6279
DR   Wikidata; Q54889728
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6279; true.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=37179; ! Hemitragus jemlahicus (Himalayan tahr)
OI   CVCL_S175 ! HJ2.K
OI   CVCL_6401 ! HJ2.Lu
OI   CVCL_S176 ! HJ2.Sp
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   HJS-1
AC   CVCL_SA76
SY   HJS1
DR   Wikidata; Q54889729
RX   PubMed=11683350;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   HK
AC   CVCL_L805
DR   Wikidata; Q54889730
RX   PubMed=2827813;
CC   Doubling time: 36 hours (PubMed=2827813).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   HK-1
AC   CVCL_7047
SY   HK1
DR   Wikidata; Q54889731
RX   PubMed=1851672;
CC   Population: Mongolian.
CC   Doubling time: ~24 hours (PubMed=1851672).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   HK-2 [Human kidney]
AC   CVCL_0302
SY   Hk-2; HK2; Human Kidney-2
DR   BTO; BTO_0003575
DR   CLO; CLO_0003771
DR   EFO; EFO_0022529
DR   MCCL; MCC:0000193
DR   AddexBio; T0011004/4929
DR   ATCC; CRL-2190
DR   BCRC; 60097
DR   BioGRID_ORCS_Cell_line; 1711
DR   BioSample; SAMN03472562
DR   cancercelllines; CVCL_0302
DR   CCRID; 3101HUMSCSP511
DR   CCRID; 4201HUM-CCTCC00152
DR   CCTCC; GDC0152
DR   Cell_Model_Passport; SIDM01818
DR   ChEMBL-Cells; CHEMBL4295396
DR   ChEMBL-Targets; CHEMBL4296428
DR   CLS; 305021
DR   Cosmic; 2520628
DR   DepMap; ACH-001087
DR   ENCODE; ENCBS188NWH
DR   GEO; GSM827261
DR   GEO; GSM4009069
DR   GEO; GSM4009073
DR   KCB; KCB 200815YJ
DR   KCLB; 22190
DR   Lonza; 769
DR   PharmacoDB; HK2_545_2019
DR   Progenetix; CVCL_0302
DR   PubChem_Cell_line; CVCL_0302
DR   Ubigene; YC-C140
DR   Wikidata; Q54889732
RX   PubMed=8127021;
RX   PubMed=20215515;
RX   PubMed=20555413;
RX   PubMed=22949125;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=33122286;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.63%; Native American=0%; East Asian, North=3.68%; East Asian, South=0%; South Asian=0%; European, North=62.77%; European, South=29.92% (PubMed=30894373).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): AddexBio=T0011004/4929; ATCC=CRL-2190; CCRID; KCLB=22190
ST   Amelogenin: X (CCRID)
ST   Amelogenin: X,Y (AddexBio=T0011004/4929; ATCC=CRL-2190; KCLB=22190)
ST   CSF1PO: 13
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 15,15.2
ST   D21S11: 28,30
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   HK-2 [Human lung carcinoma]
AC   CVCL_7048
DR   Wikidata; Q54889734
RX   PubMed=1851672;
CC   Population: Mongolian.
CC   Characteristics: Established from a rat xenograft of the HK-1 cell line.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7047 ! HK-1
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   HK-2 LPL(p.464K_del)
AC   CVCL_F1YE
SY   HK-2-hLPL(p.464K_del)
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6677; LPL; Simple_edited; p.Lys464del (c.1390_1392delAAA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: Cell line information from personal communication of Zhang, Ai-Hua.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HK-2-KIM-1
AC   CVCL_UC05
DR   Wikidata; Q94210556
RX   PubMed=30260998;
CC   Population: Caucasian.
CC   Characteristics: CRISPR/Cas9-mediated knock-in of eGFP-T2A-luciferase construct at the C-terminal end of HAVCR1/KIM-1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HK-2xCRISPR-CAP-D2-mEGFP no.272-78
AC   CVCL_UR42
SY   HK-2xCRISPR-CAP-D2-mEGFP #272-78; HK CRISPR CAP-D2-mEGFP
DR   CLS; 301572
DR   Wikidata; Q94210561
RX   PubMed=29632028;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NCAPD2 (CAP-D2) has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   HK-2xZFN-mEGFP-Nup107
AC   CVCL_VL12
DR   CLS; 300676
DR   Wikidata; Q94210567
RX   PubMed=27630123;
CC   Population: African American.
CC   Characteristics: Using ZFN NUP107 has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=ZFN; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
ID   HK-2xZFN-Smc4-mEGFP no.82-68
AC   CVCL_B7FT
SY   HK-2xZFN-Smc4-mEGFP Clone 82-68
DR   CLS; 301576
DR   Wikidata; Q112929730
CC   Population: African American.
CC   Characteristics: Using ZFN SMC4 has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=ZFN; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   HK-CRISPR-CAP-D3-mEGFP no.16
AC   CVCL_UR44
SY   HK-CRISPR-CAP-D3-mEGFP #16; HK CRISPR CAP-D3-mEGFP
DR   CLS; 301573
DR   Wikidata; Q94210571
RX   PubMed=29632028;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NCAPD3 (CAP-D3) has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   HK-CRISPR-CAP-H-mEGFP no.86
AC   CVCL_UR43
SY   HK-CRISPR-CAP-H-mEGFP #86; HK CRISPR CAP-H-mEGFP
DR   CLS; 301568
DR   Wikidata; Q94210577
RX   PubMed=29632028;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NCAPH (CAP-H) has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   HK-CRISPR-CAP-H2-mEGFP no.67
AC   CVCL_UR45
SY   HK-CRISPR-CAP-H2-mEGFP #67; HK CRISPR CAP-H2-mEGFP
DR   CLS; 301569
DR   Wikidata; Q94210582
RX   PubMed=29632028;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NCAPH2 (CAP-H2) has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   HK-CRISPR-CEP250-mEGFP no.1A-142
AC   CVCL_E6A0
SY   HK-CRISPR-CEP250-mEGFP #1A-142; HK CRISPR CEP250-mEGFP #1A-142
RX   PubMed=30202089;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A CEP250 has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-mEGFP-CAP-H2 no.1
AC   CVCL_UR46
SY   HK CRISPR mEGFP-CAP-H2; HK CRISPR mEGFP-NCAPH2 #1
DR   Wikidata; Q94210587
RX   PubMed=29632028;
RX   PubMed=30202089;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NCAPH2 (CAP-H2) has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   HK-CRISPR-mEGFP-KIF4A no.173
AC   CVCL_E6A1
SY   HK CRISPR mEGFP-KIF4A #173
RX   PubMed=30202089;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A KIF4A has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-mEGFP-NUP153 no.90
AC   CVCL_E6A3
SY   HK-CRISPR-mEGFP-Nup153 #90
DR   CLS; 300656
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NUP153 has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-mEGFP-NUP214 no.2-12
AC   CVCL_E6A4
SY   HK-CRISPR-mEGFP-Nup214 #2-12; HK CRISPR mEGFP-NUP214 #2-12
DR   CLS; 300671
RX   PubMed=30202089;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NUP214 has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-mEGFP-NUP358 no.97
AC   CVCL_B7FS
SY   HK-CRISPR-mEGFP-Nup358 #97; HK CRISPR mEGFP Nup358 #97
DR   CLS; 301575
DR   Wikidata; Q112929731
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NUP358 has been endogenously tagged in both alleles at the N-terminus with mEGFP (CLS=301575).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   HK-CRISPR-mEGFP-RANBP2/NUP358 no.97
AC   CVCL_E6A5
SY   HK-CRISPR-mEGFP-RanBP2/Nup358 #97; HK CRISPR mEGFP-NUP358/RANBP2 #97
DR   CLS; 300660
RX   PubMed=30202089;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A RANBP2 has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-mEGFP-SEH1 no.76-2
AC   CVCL_E6AV
SY   HK-CRISPR-mEGFP-Seh1 #76-2
DR   CLS; 300669
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A SEH1L has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-mEGFP-TOP2A no.102
AC   CVCL_E6A6
SY   HK CRISPR mEGFP-TOP2A #102
RX   PubMed=30202089;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A TOP2A has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-NUP188-mEGFP no.11-092
AC   CVCL_E6A7
SY   HK-CRISPR-Nup188-mEGFP #11-092
DR   CLS; 300657
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NUP188 has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-NUP205-mEGFP no.81
AC   CVCL_UR49
SY   HK-CRISPR-NUP205-mEGFP #81; HK CRISPR NUP205-mEGFP #81
DR   CLS; 301574
DR   Wikidata; Q94210591
RX   PubMed=29323269;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NUP205 has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   HK-CRISPR-NUP62-mEGFP no.199
AC   CVCL_E6A8
SY   HK-CRISPR-Nup62-mEGFP #199
DR   CLS; 300659
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NUP62 has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-Nup93-mEGFP no.79
AC   CVCL_E6A9
SY   HK-CRISPR-Nup93-mEGFP #79
DR   CLS; 300655
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A NUP93 has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-POM121-mCherry no.32
AC   CVCL_E6AA
SY   HK-CRISPR-Pom121-mCherry #32
DR   CLS; 300658
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A POM121 has been endogenously tagged in both alleles at the C-terminus with mCherry.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-CRISPR-TPR-mEGFP no.171
AC   CVCL_E6AB
SY   HK-CRISPR-Tpr-mEGFP #171; HK CRISPR TPR-mEGFP #171
DR   CLS; 300662
RX   PubMed=30202089;
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9D10A TPR has been endogenously tagged in both alleles at the C-terminus with mCherry.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HK-PEG-1
AC   CVCL_3441
SY   PEG-1-6; PEG 1-6
DR   CLO; CLO_0003766
DR   CLO; CLO_0003773
DR   CLO; CLO_0008417
DR   CLDB; cl5247
DR   ATCC; CCL-189
DR   BCRC; 60188
DR   ECACC; 90112229
DR   IZSLER; BS Hy 31
DR   Wikidata; Q54889736
RX   PubMed=268647;
RX   PubMed=23430347;
CC   Monoclonal antibody isotype: IgG1+IgG3.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Miscellaneous: STR profile from personal communication of Almeida, Jamie L.; PubMed=23430347 has a different value for STR 6-4 (17,18) than that submitted (18,19,20) due to a change in the marker motif and stutter rules.
CC   Discontinued: ATCC; CCL-189; true.
ST   Source(s): Direct_author_submission; PubMed=23430347
ST   Mouse STR 1-1: 15,16,17
ST   Mouse STR 1-2: 16,17,18
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 18,19,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 24.2,25.2,26.2,28.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 16,18
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 13,14
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   HK-ZFN-AURKB-mEGFP
AC   CVCL_VL13
DR   CLS; 300173
DR   Wikidata; Q94210613
CC   Population: African American.
CC   Characteristics: Edited by ZFN at the AURKB locus to insert a mEGFP construct at the N-terminus of the gene.
CC   Genetic integration: Method=ZFN; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
ID   HK-ZFN-AURKB-mEGFP/ZFN-INCENP-mCherry
AC   CVCL_VL14
SY   HK-ZFN-AURKB-mEGFP,ZFN-INCENP-mCherry
DR   CLS; 300270
DR   Wikidata; Q94210615
CC   Population: African American.
CC   Characteristics: Edited by ZFN at the AURKB locus to insert a mEGFP construct at the N-terminus of both alleles of the gene and at the INCENP locus to insert a mCherry construct at the N-terminus of one allele of the gene.
CC   Genetic integration: Method=ZFN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=ZFN; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Misspelling: HK-ZFN-AURKB-mEGFP, ZFN-INCEMP-mCherry; CLS=300270; Note=Until July 2018.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   HK-ZFN-mEGFP-CAP-H
AC   CVCL_UR47
SY   HK ZFN mEGFP-CAP-H
DR   Wikidata; Q94210621
RX   PubMed=29632028;
CC   Population: African American.
CC   Characteristics: Using ZFN NCAPH (CAP-H) has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=ZFN; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   HK-ZFN-SMC4-mEGFP
AC   CVCL_UR48
SY   HK ZFN SMC4-mEGFP
DR   Wikidata; Q94210625
RX   PubMed=29632028;
CC   Population: African American.
CC   Characteristics: Using ZFN SMC4 has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=ZFN; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   HK1
AC   CVCL_YE27
SY   Head Kidney 1
DR   Wikidata; Q94210632
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK10
AC   CVCL_YE36
SY   Head Kidney 10
DR   Wikidata; Q94210637
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK10 s10
AC   CVCL_YE39
SY   Head Kidney 10 s10
DR   Wikidata; Q94210644
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 70.3 +- 15.9 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE36 ! HK10
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK10 s7
AC   CVCL_YE37
SY   Head Kidney 10 s7
DR   Wikidata; Q94210647
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 50.2 +- 8.2 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE36 ! HK10
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK10 s8
AC   CVCL_YE38
SY   Head Kidney 10 s8
DR   Wikidata; Q94210653
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 101.4 +- 6.9 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE36 ! HK10
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK13
AC   CVCL_B7MY
SY   Head Kidney 13
DR   Wikidata; Q112929732
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Virology: Derived from a piscine orthoreovirus-1 (PRV-1) infected fish.
CC   Miscellaneous: Age at sampling from personal communication of Pham, Phuc H.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   1Y6M
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   HK1532
AC   CVCL_KB50
SY   Head Kidney 1532
DR   Wikidata; Q54889737
RX   PubMed=27053758;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Characteristics: IL15 dependent.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 7
//
ID   HK1A523
AC   CVCL_A0BK
SY   HK1 A523; hK2-A523; A523
DR   Wikidata; Q108820472
RX   Patent=WO1998021365A2;
RX   PubMed=8889697;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11876.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20151; Human KLK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HK1D106.4
AC   CVCL_A0BL
SY   HK1D 106.4
DR   Wikidata; Q108820473
RX   Patent=WO1998002748A1;
RX   Patent=WO1998021365A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11937.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P20151; Human KLK2.
CC   Misspelling: HKD106.4; Patent=WO1998021365A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HK1G464.3
AC   CVCL_A0BM
SY   HK1G 464.3
DR   Wikidata; Q108820474
RX   Patent=WO1998002748A1;
RX   Patent=WO1998021365A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11983.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P20151; Human KLK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HK1G586.1
AC   CVCL_A0BN
SY   HK1G 586.1; hK2-G586; G586
DR   Wikidata; Q108820475
RX   Patent=WO1998002748A1;
RX   Patent=WO1998021365A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12026.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P20151; Human KLK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HK1H247
AC   CVCL_A0BP
DR   Wikidata; Q108820476
RX   Patent=WO1998002748A1;
RX   Patent=WO1998021365A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12162.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P20151; Human KLK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HK2
AC   CVCL_YE28
SY   Head Kidney 2
DR   Wikidata; Q94210676
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK2/Cas9-hyg
AC   CVCL_C9F4
DR   GeneCopoeia; SL566
DR   Wikidata; Q123031675
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL566).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HK3
AC   CVCL_YE29
SY   Head Kidney 3
DR   Wikidata; Q94210681
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK4
AC   CVCL_YE30
SY   Head Kidney 4
DR   Wikidata; Q94210687
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK42/1
AC   CVCL_WS17
DR   Wikidata; Q94210691
RX   PubMed=12667817;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 05-10-23; Version: 7
//
ID   HK5
AC   CVCL_YE31
SY   Head Kidney 5
DR   Wikidata; Q94210697
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK6
AC   CVCL_YE32
SY   Head Kidney 6
DR   Wikidata; Q94210705
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK7
AC   CVCL_YE33
SY   Head Kidney 7
DR   Wikidata; Q94210708
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK7 s1
AC   CVCL_YE40
SY   Head Kidney 7 s1
DR   Wikidata; Q94210713
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 34.5 +- 2.9 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE33 ! HK7
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK7 s2
AC   CVCL_YE41
SY   Head Kidney 7 s2
DR   Wikidata; Q94210718
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 38.4 +- 3.4 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE33 ! HK7
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK7 s4
AC   CVCL_YE42
SY   Head Kidney 7 s4
DR   Wikidata; Q94210722
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 47.0 +- 2.5 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE33 ! HK7
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK7 s6
AC   CVCL_YE43
SY   Head Kidney 7 s6
DR   Wikidata; Q94210726
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 38.9 +- 3.2 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE33 ! HK7
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK7 s7
AC   CVCL_YE44
SY   Head Kidney 7 s7
DR   Wikidata; Q94210730
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Doubling time: 32.2 +- 5.7 hours (PubMed=29532473).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
HI   CVCL_YE33 ! HK7
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK8
AC   CVCL_YE34
SY   Head Kidney 8
DR   Wikidata; Q94210734
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HK9
AC   CVCL_YE35
SY   Head Kidney 9
DR   Wikidata; Q94210737
RX   PubMed=29532473;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   HKA-1
AC   CVCL_2943
SY   HKA1
DR   BioSample; SAMN03472533
DR   cancercelllines; CVCL_2943
DR   Cell_Model_Passport; SIDM01620
DR   DepMap; ACH-001521
DR   FANTOM5_SSTAR; 10791-110H8
DR   JCRB; JCRB1017
DR   JCRB; NIHS0251
DR   Wikidata; Q54889738
RX   CelloPub=CLPUB00048;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~34 hours (Note=At 37th passage) (CelloPub=CLPUB00048).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (DepMap=ACH-001521).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: JCRB; NIHS0251; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): DepMap=ACH-001521; JCRB=JCRB1017
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10
ST   D18S51: 13,16
ST   D21S11: 30,30.2
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 7,12
ST   D8S1179: 10
ST   FGA: 19,20
ST   Penta D: 9,13
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3146; Skin keratoacanthoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HKB-1
AC   CVCL_5290
DR   BioSample; SAMN03152013
DR   Wikidata; Q54889739
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9722894;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=29533902;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HKB-1
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misclassified. Originally though to be a Hodgkin lymphoma cell line, but its real origin is not clear (PubMed=12592342; PubMed=20143388; PubMed=29533902).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00209.
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HKB-11
AC   CVCL_3712
SY   HKB11; Hybrid of Kidney and B cells-11
DR   CLO; CLO_0003772
DR   EFO; EFO_0022587
DR   ATCC; CRL-12568
DR   BioSample; SAMN03473641
DR   FCS-free; 175-2-331-1-4-3
DR   Wikidata; Q27555063
RX   Patent=US6136599;
RX   Patent=US6358703;
RX   PubMed=12432229;
RX   PubMed=25822314;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12568.
CC   Doubling time: 41.0 +- 15.9 hours (Note=In serum-containing medium), 57.6 hours (Note=In FreeStyle medium), 48.1 hours (Note=In CDM4 medium) (PubMed=25822314).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-12568; true.
ST   Source(s): ATCC=CRL-12568
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 12,14
ST   D16S539: 9,10
ST   D5S818: 8,9,12
ST   D7S820: 10,11,12
ST   TH01: 7,9,9.3
ST   TPOX: 6,11
ST   vWA: 15,16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6354 ! 2B8 [Human Burkitt lymphoma]
HI   CVCL_A784 ! HEK293S
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   HKb20
AC   CVCL_E065
DR   CLO; CLO_0050900
DR   BioSample; SAMN03471986
DR   RCB; RCB2253
DR   Wikidata; Q54889740
RX   PubMed=12403648;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9NDN4; Bombyx mori BtR175b.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB2253
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   HKBML
AC   CVCL_8161
DR   CLO; CLO_0050638
DR   BioSample; SAMN03472185
DR   RCB; RCB0820
DR   Wikidata; Q54889741
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): RCB=RCB0820
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HKBMM
AC   CVCL_8162
DR   CLO; CLO_0050633
DR   BioSample; SAMN03472212
DR   DepMap; ACH-002070
DR   FANTOM5_SSTAR; 10691-109F7
DR   RCB; RCB0680
DR   Wikidata; Q54889742
RX   PubMed=16035506;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 28 hours (Note=At 50th passage) (PubMed=16035506).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (DepMap=ACH-002070).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro177Leu (c.530C>T); ClinVar=VCV000406583; Zygosity=Homozygous (DepMap=ACH-002070).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): RCB=RCB0680
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HKC
AC   CVCL_WZ51
DR   CCRID; 1101HUM-PUMC000160
DR   Wikidata; Q94210822
CC   Problematic cell line: Contaminated. Shown to be a HK-2 derivative (CCRID). Originally thought to be a renal tubular epithelial cell line.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): CCRID=1101HUM-PUMC000160
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 15,15.2
ST   D21S11: 28,30
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 20,22
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   hKC hTERT
AC   CVCL_A8UR
DR   Wikidata; Q108820477
RX   PubMed=33689065;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: Age/sex of donor from personal communication of Gurskaya, Nadya G.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D10S1248: 14
ST   D12S391: 19,21,22
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D1S1656: 15,17.3
ST   D21S11: 28,29.2
ST   D22S1045: 16,17
ST   D2S441: 11,15
ST   D3S1358: 15,16,17
ST   D5S818: 8,9
ST   D7S820: 10,11
ST   D8S1179: 11,12,14
ST   FGA: 23
ST   SE33: 19,20,21
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HKC-11
AC   CVCL_Y911
SY   HKC11
DR   GEO; GSM4009070
DR   GEO; GSM4009071
DR   GEO; GSM4009072
DR   Wikidata; Q54889743
RX   PubMed=9042817;
RX   PubMed=33122286;
CC   Doubling time: 20 hours (PubMed=9042817).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y909 ! HKC-5
OI   CVCL_Y910 ! HKC-8
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   HKC-5
AC   CVCL_Y909
SY   HKC5
DR   Wikidata; Q54889744
RX   PubMed=9042817;
RX   PubMed=17158639;
CC   Doubling time: 40 hours (PubMed=9042817).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y910 ! HKC-8
OI   CVCL_Y911 ! HKC-11
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HKC-8
AC   CVCL_Y910
SY   HKC8; HKC clone 8
DR   GEO; GSM4009067
DR   GEO; GSM4009068
DR   GEO; GSM4009077
DR   Wikidata; Q54889747
RX   PubMed=9042817;
RX   PubMed=11007312;
RX   PubMed=19937734;
RX   PubMed=31267758;
RX   PubMed=33122286;
CC   Doubling time: 20 hours (PubMed=9042817).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y909 ! HKC-5
OI   CVCL_Y911 ! HKC-11
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   HKCI-1
AC   CVCL_E308
DR   cancercelllines; CVCL_E308
DR   Wikidata; Q54889748
RX   PubMed=10958934;
RX   PubMed=11793441;
RX   PubMed=15645427;
RX   PubMed=15709204;
RX   PubMed=19003983;
RX   PubMed=24582836;
CC   Population: Chinese.
CC   Doubling time: ~60 hours (PubMed=10958934).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=10958934).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Indicated as originating from a 44 year old male in material methods of PubMed=10958934 and from a 58 year old male in table 1 of the same publication.
CC   Misspelling: HCKI-1; PubMed=10958934; Note=In table 1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   HKCI-10
AC   CVCL_SA08
DR   Wikidata; Q54889750
RX   PubMed=19003983;
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   HKCI-11
AC   CVCL_SA10
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889751
RX   PubMed=24582836;
CC   Population: Chinese.
CC   Virology: Expresses chimeric hepatitis B virus (HBV)-human transcripts (PubMed=24582836).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-2
AC   CVCL_M173
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889752
RX   DOI=10.1385/CP:1:3-4:313;
RX   PubMed=11793441;
RX   PubMed=15645427;
RX   PubMed=15709204;
RX   PubMed=15765123;
RX   PubMed=19003983;
CC   Population: Chinese.
CC   Karyotypic information: Has lost chromosome Y.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   HKCI-3
AC   CVCL_M174
DR   Wikidata; Q54889753
RX   DOI=10.1385/CP:1:3-4:313;
RX   PubMed=11793441;
RX   PubMed=15645427;
RX   PubMed=15709204;
RX   PubMed=15765123;
RX   PubMed=19003983;
CC   Population: Chinese.
CC   Karyotypic information: Has lost chromosome Y.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   HKCI-4
AC   CVCL_M175
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889754
RX   DOI=10.1385/CP:1:3-4:313;
RX   PubMed=11793441;
RX   PubMed=15645427;
RX   PubMed=15709204;
RX   PubMed=15765123;
RX   PubMed=19003983;
RX   PubMed=23376363;
RX   PubMed=24582836;
CC   Population: Chinese.
CC   Virology: Expresses chimeric hepatitis B virus (HBV)-human transcripts (PubMed=24582836).
CC   Karyotypic information: Has lost chromosome Y.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   HKCI-5
AC   CVCL_SA02
DR   Wikidata; Q54889755
RX   PubMed=15645427;
RX   PubMed=19003983;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   HKCI-5A
AC   CVCL_SA13
SY   HKCI-5a; HKCI5a
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889756
RX   PubMed=23314323;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SA02 ! HKCI-5
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-5B
AC   CVCL_SA09
DR   Wikidata; Q54889757
RX   PubMed=24582836;
CC   Population: Chinese.
CC   Virology: Expresses chimeric hepatitis B virus (HBV)-human transcripts (PubMed=24582836).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SA02 ! HKCI-5
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-6
AC   CVCL_SA04
DR   Wikidata; Q54889758
RX   PubMed=16680155;
RX   PubMed=19003983;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   HKCI-7
AC   CVCL_SA05
DR   Wikidata; Q54889759
RX   PubMed=19003983;
RX   PubMed=24582836;
CC   Population: Chinese.
CC   Virology: Expresses chimeric hepatitis B virus (HBV)-human transcripts (PubMed=24582836).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-8
AC   CVCL_SA06
DR   Wikidata; Q54889760
RX   PubMed=19003983;
RX   PubMed=23376363;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-9
AC   CVCL_SA07
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889761
RX   PubMed=19003983;
RX   PubMed=24582836;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-C1
AC   CVCL_SA00
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889762
RX   PubMed=15645427;
RX   PubMed=15709204;
RX   PubMed=15765123;
RX   PubMed=19003983;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-C2
AC   CVCL_SA01
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889763
RX   PubMed=15645427;
RX   PubMed=15709204;
RX   PubMed=15765123;
RX   PubMed=19003983;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKCI-C3
AC   CVCL_SA03
DR   EGA; EGAD00001004475
DR   Wikidata; Q54889764
RX   PubMed=15645427;
RX   PubMed=15709204;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   HKe-3
AC   CVCL_9796
SY   HKE-3; Hke-3; HKE3; Hke3
DR   BTO; BTO_0003469
DR   EFO; EFO_0022707
DR   cancercelllines; CVCL_9796
DR   Wikidata; Q54889765
RX   PubMed=8465203;
RX   PubMed=9354428;
RX   PubMed=28192450;
CC   Population: Caucasian.
CC   Characteristics: In HCT 116 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   HKESC-1
AC   CVCL_D568
SY   HKESC1; Hong Kong Esophageal Squamous Carcinoma-1
DR   BTO; BTO_0005164
DR   AddexBio; C0013002/47
DR   Wikidata; Q54889766
RX   PubMed=10748291;
CC   Population: Chinese.
CC   Doubling time: 46 hours (PubMed=10748291).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   HKESC-1/cis
AC   CVCL_S525
DR   Wikidata; Q54889767
RX   PubMed=21177414;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D568 ! HKESC-1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   HKESC-2
AC   CVCL_D571
SY   HKESC2; Hong Kong Esophageal Squamous Carcinoma-2
DR   BTO; BTO_0005165
DR   Wikidata; Q54889768
RX   PubMed=12127396;
RX   PubMed=15885884;
CC   Population: Chinese.
CC   Doubling time: 24 hours (PubMed=12127396).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   HKESC-3
AC   CVCL_D572
SY   HKESC3; Hong Kong Esophageal Squamous Carcinoma-3
DR   BTO; BTO_0005166
DR   Wikidata; Q54889770
RX   PubMed=12127396;
CC   Population: Chinese.
CC   Doubling time: 48 hours (PubMed=12127396).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   HKESC-4
AC   CVCL_E304
SY   HKESC4; Hong Kong Esophageal Squamous Carcinoma-4
DR   Wikidata; Q54889771
RX   PubMed=17889704;
CC   Population: Chinese.
CC   Characteristics: Established from a xenograft produced in BALB/c nude mice.
CC   Doubling time: 63 hours (PubMed=17889704).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   HKGZ-CC
AC   CVCL_E329
SY   HKGZCC
DR   cancercelllines; CVCL_E329
DR   Cell_Model_Passport; SIDM01819
DR   DepMap; ACH-001852
DR   Wikidata; Q54889772
RX   CelloPub=CLPUB00275;
RX   PubMed=17914572;
RX   PubMed=27231123;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Chinese.
CC   Doubling time: ~48 hours (PubMed=17914572).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (DepMap=ACH-001852).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001852
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 15
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   HKh-2
AC   CVCL_9797
SY   HKH-2; HKH2; Hkh2
DR   cancercelllines; CVCL_9797
DR   GEO; GSM3591763
DR   Wikidata; Q54889773
RX   PubMed=8465203;
RX   PubMed=9354428;
CC   Population: Caucasian.
CC   Characteristics: In HCT 116 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6407; KRAS (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   HKh-2_6244R
AC   CVCL_C3GJ
SY   HKH2_6244R
DR   cancercelllines; CVCL_C3GJ
DR   GEO; GSM3591764
DR   Wikidata; Q114311624
CC   Population: Caucasian.
CC   Characteristics: In HCT 116 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9797 ! HKh-2
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Hki-8
AC   CVCL_A5BV
DR   Wikidata; Q107115348
RX   PubMed=10585270;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8022; NT5C2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   HKiG2
AC   CVCL_A5BU
SY   Hkig-2
DR   BTO; BTO_0006320
DR   Wikidata; Q107115349
RX   PubMed=10585270;
RX   PubMed=25857773;
CC   Characteristics: Transfected with a NT5C2 fused to EGFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8022; NT5C2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HKM
AC   CVCL_A8VR
SY   Head Kidney Macrophages
DR   Wikidata; Q108820478
RX   PubMed=25204072;
CC   Group: Fish cell line.
CC   Characteristics: Can grow between 25 to 37 Celsius, with an optimal growth temperature of 28 Celsius (PubMed=25204072).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   HKMFH
AC   CVCL_W460
SY   HKMFH-nu
DR   Wikidata; Q54889774
RX   PubMed=2562089;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   HKMS
AC   CVCL_W524
DR   Wikidata; Q54889775
RX   PubMed=2519215;
CC   Population: Japanese.
CC   Doubling time: 42 hours (Note=At 10th passage), 37 hours (Note=At 30th passage), 38 hours (Note=At 50th passage) (PubMed=2519215).
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   HKMUS
AC   CVCL_8776
DR   BioSample; SAMN03151914
DR   Cell_Model_Passport; SIDM01930
DR   Wikidata; Q54889776
RX   PubMed=1698374;
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=9436037;
RX   PubMed=10457904;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SKG-II-SF derivative (PubMed=20143388). Originally thought to originate from a 50 year old female patient with an uterine large cell non-keratinizing squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00311.
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=10457904).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8159 ! SKG-II-SF
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HKMUS-SF
AC   CVCL_8230
DR   BioSample; SAMN03151915
DR   RCB; RCB0686
DR   Wikidata; Q54889777
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HKMUS) has been shown to be a SKG-II-SF derivative (PubMed=16643607; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00210.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0686; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8776 ! HKMUS
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   HKNM-2
AC   CVCL_H684
SY   HKNM2
DR   Wikidata; Q54889778
RX   PubMed=20831825;
RX   PubMed=21454801;
CC   From: Popper, Helmut H.; University of Graz; Graz; Austria.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 8
//
ID   HKOA
AC   CVCL_VT02
DR   Wikidata; Q94211201
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3593088;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=3593088).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HKRT-II
AC   CVCL_M686
DR   Wikidata; Q54889779
RX   PubMed=10834109;
CC   Population: Japanese.
CC   Doubling time: 42 hours (Note=At 50th passage) (PubMed=10834109).
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C7733; Testicular choriocarcinoma
DI   ORDO; Orphanet_363504; Germ cell tumor of testis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   HKT-1097
AC   CVCL_2070
SY   Hamster Kidney Tumor-1097
DR   CLO; CLO_0003774
DR   DSMZ; ACC-445
DR   DSMZCellDive; ACC-445
DR   ECACC; 98061003
DR   Wikidata; Q54889780
RX   PubMed=10476921;
CC   Doubling time: 15 hours (PubMed=10476921); ~19 hours (DSMZ=ACC-445); 36 hours (ECACC=98061003).
CC   Transformant: ChEBI; CHEBI_41922; Diethylstilbestrol.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C134775; Hamster kidney tumor
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HKT-2
AC   CVCL_Y024
DR   Wikidata; Q54889781
RX   PubMed=2224863;
CC   Population: Japanese.
CC   Doubling time: 43.6 hours (PubMed=2224863).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   HKT-3
AC   CVCL_Y025
DR   Wikidata; Q54889782
RX   PubMed=2224863;
CC   Population: Japanese.
CC   Doubling time: 63.7 hours (PubMed=2224863).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   HKT-5
AC   CVCL_Y026
DR   Wikidata; Q54889783
RX   PubMed=2224863;
CC   Population: Japanese.
CC   Doubling time: 86.7 hours (PubMed=2224863).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   HKT-6
AC   CVCL_Y027
DR   Wikidata; Q54889785
RX   PubMed=2224863;
CC   Population: Japanese.
CC   Doubling time: 79.5 hours (PubMed=2224863).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   HKT-7
AC   CVCL_Y028
DR   Wikidata; Q54889786
RX   PubMed=2224863;
CC   Population: Japanese.
CC   Doubling time: 95.3 hours (PubMed=2224863).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   HKT-8
AC   CVCL_Y029
DR   Wikidata; Q54889787
RX   PubMed=2224863;
CC   Population: Japanese.
CC   Doubling time: 40.0 hours (PubMed=2224863).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   HKTN-2
AC   CVCL_W669
DR   IZSLER; BS CL 167
DR   Wikidata; Q54889788
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (STR profile). Was originally thought to originate from TERT immortalized keratinocytes.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00635.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): IZSLER=BS CL 167
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,14
ST   D16S539: 9,10
ST   D21S11: 27,28
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HKUA
AC   CVCL_VT03
DR   Wikidata; Q94211328
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3778323;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=10457904).
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   HKUi001-A
AC   CVCL_ZA50
SY   PCSK9 KO
DR   hPSCreg; HKUi001-A
DR   Wikidata; Q98126687
CC   From: Department of Paediatrics and Adolescent Medicine, University of Hong Kong; Hong Kong; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   HKUi002-A
AC   CVCL_ZA51
SY   HKUi002-A-AYC12; AYC12
DR   BioSamples; SAMEA6880596
DR   hPSCreg; HKUi002-A
DR   Wikidata; Q98126688
RX   PubMed=33099108;
CC   From: Department of Paediatrics and Adolescent Medicine, University of Hong Kong; Hong Kong; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.31+1G>A; ClinVar=VCV001070319; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=33099108).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   HKULC 1
AC   CVCL_A392
SY   HKULC1; Hong Kong University Lung Cancer 1
DR   Cosmic; 1053059
DR   Wikidata; Q54889789
RX   PubMed=17409975;
CC   Population: Chinese.
CC   Doubling time: ~25 hours (PubMed=17409975).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   HKULC 2
AC   CVCL_A393
SY   HKULC2; Hong Kong University Lung Cancer 2
DR   Cosmic; 1053060
DR   Wikidata; Q54889791
RX   PubMed=17409975;
CC   Population: Chinese.
CC   Doubling time: ~25 hours (PubMed=17409975).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   HKULC 3
AC   CVCL_A394
SY   HKULC3; Hong Kong University Lung Cancer 3
DR   Cosmic; 1053061
DR   Wikidata; Q54889792
RX   PubMed=17409975;
CC   Population: Chinese.
CC   Doubling time: ~25 hours (PubMed=17409975).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn756_Leu760del; Zygosity=Unspecified (PubMed=17409975).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   HKULC 4
AC   CVCL_A395
SY   HKULC4; Hong Kong University Lung Cancer 4
DR   Cosmic; 1053062
DR   Wikidata; Q54889793
RX   PubMed=17409975;
CC   Population: Chinese.
CC   Doubling time: 33.5 hours (PubMed=17409975).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   HKUS
AC   CVCL_X942
DR   Wikidata; Q54889794
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=2838556;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 24 hours (Note=At 200th passage) (PubMed=2838556).
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   HL
AC   CVCL_2492
SY   Human Lung
DR   CCRID; 4201HUM-CCTCC00082
DR   CCTCC; GDC0082
DR   ChEMBL-Cells; CHEMBL3307999
DR   ChEMBL-Targets; CHEMBL612594
DR   ECACC; 96121720
DR   PubChem_Cell_line; CVCL_2492
DR   Wikidata; Q54889795
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ECACC=96121720
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   HL-1
AC   CVCL_0303
SY   HL1; HL-1 F2 P76
DR   BTO; BTO_0003264
DR   EFO; EFO_0022835
DR   MCCL; MCC:0000194
DR   Lonza; 740
DR   Millipore; SCC065
DR   Ubigene; YC-C100
DR   Wikidata; Q29838237
RX   Patent=US6316207;
RX   PubMed=9501201;
RX   PubMed=10908350;
RX   PubMed=14766671;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-549.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12197.
CC   Characteristics: Spontaneously contract while maintaining a differentiated cardiac phenotype (Millipore=SCC065).
CC   Characteristics: From transgenic mice expressing a fusion gene comprised of the atrial natriuretic factor promoter and the SV40 early region.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: The STR profile of HL-1 as distributed from Ubigene shows that the cell line that what they distribute is not HL-1 but C2C12 (Cellosaurus=CVCL_0188) or a derivative of that cell line (Ubigene=YC-C100).
CC   Derived from site: In situ; Heart, left atrium; UBERON=UBERON_0002079.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: C3HeB/FeJ transgenic.
ST   Source(s): Millipore=SCC065
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17,18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 21.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_JK52 ! AT-1 [Mouse cardiomyocyte]
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   HL-1 Friendly Myeloma-653
AC   CVCL_D145
SY   HL-1 Friendly Myeloma 653; HL-1 Friendly-653; HL-1 Friendly myeloma; HL1 Friendly myeloma; HL-1 myeloma; HL-1; F.653
DR   Wikidata; Q54889796
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Miscellaneous: Cell line probably no longer available; was distributed by Ventrex Bioventures Group which was later acquired by Hycor Biomedical.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   HL-2
AC   CVCL_N700
SY   H-L2
DR   Wikidata; Q54889797
RX   PubMed=9053739;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1390; CACNA1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   HL-259
AC   CVCL_B6CH
DR   Wikidata; Q111733429
RX   DOI=10.1080/00021369.1986.10867575;
RX   PubMed=3804938;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   HL-321
AC   CVCL_B6CC
DR   Wikidata; Q111733430
RX   PubMed=3804938;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Nucleic acids: poly(dT), poly(I) and poly(dU).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   HL-349
AC   CVCL_B6CD
DR   Wikidata; Q111733431
RX   DOI=10.1080/00021369.1986.10867575;
RX   PubMed=3804938;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA.
CC   Monoclonal antibody target: ChEBI; CHEBI_33697; RNA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   HL-60
AC   CVCL_0002
SY   HL 60; HL.60; HL60; Human Leukemia-60
DR   BTO; BTO_0000738
DR   CLO; CLO_0003775
DR   CLO; CLO_0050972
DR   EFO; EFO_0002793
DR   MCCL; MCC:0000195
DR   CLDB; cl1682
DR   CLDB; cl1684
DR   CLDB; cl1685
DR   CLDB; cl1686
DR   CLDB; cl1687
DR   CLDB; cl1688
DR   CLDB; cl1689
DR   CLDB; cl1690
DR   CLDB; cl1691
DR   CLDB; cl1693
DR   Abcam; ab282204
DR   AddexBio; C0003023/4977
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CCL-240
DR   BCRC; 60027
DR   BCRJ; 0104
DR   BioGRID_ORCS_Cell_line; 42
DR   BioSample; SAMN01821559
DR   BioSample; SAMN01821682
DR   BioSample; SAMN03472768
DR   BioSample; SAMN03473174
DR   BioSample; SAMN10988245
DR   cancercelllines; CVCL_0002
DR   CCRID; 1101HUM-PUMC000037
DR   CCRID; 1102HUM-NIFDC00098
DR   CCRID; 3101HUMTCHu23
DR   CCRID; 4201HUM-CCTCC00028
DR   CCTCC; GDC0027
DR   CCTCC; GDC0028
DR   Cell_Model_Passport; SIDM00829
DR   ChEMBL-Cells; CHEMBL3307654
DR   ChEMBL-Targets; CHEMBL383
DR   CLS; 300209
DR   Cosmic; 716179
DR   Cosmic; 716190
DR   Cosmic; 724817
DR   Cosmic; 787433
DR   Cosmic; 798224
DR   Cosmic; 798665
DR   Cosmic; 808506
DR   Cosmic; 821043
DR   Cosmic; 850380
DR   Cosmic; 851996
DR   Cosmic; 875866
DR   Cosmic; 905938
DR   Cosmic; 919116
DR   Cosmic; 922161
DR   Cosmic; 922683
DR   Cosmic; 924049
DR   Cosmic; 932769
DR   Cosmic; 947366
DR   Cosmic; 949099
DR   Cosmic; 975252
DR   Cosmic; 981578
DR   Cosmic; 991557
DR   Cosmic; 994170
DR   Cosmic; 999724
DR   Cosmic; 1012068
DR   Cosmic; 1019836
DR   Cosmic; 1037661
DR   Cosmic; 1070693
DR   Cosmic; 1078724
DR   Cosmic; 1089519
DR   Cosmic; 1092602
DR   Cosmic; 1107177
DR   Cosmic; 1127250
DR   Cosmic; 1130234
DR   Cosmic; 1168468
DR   Cosmic; 1176580
DR   Cosmic; 1181599
DR   Cosmic; 1191695
DR   Cosmic; 1192826
DR   Cosmic; 1226863
DR   Cosmic; 1281315
DR   Cosmic; 1305337
DR   Cosmic; 1308224
DR   Cosmic; 1319549
DR   Cosmic; 1451845
DR   Cosmic; 1465966
DR   Cosmic; 1523825
DR   Cosmic; 1524830
DR   Cosmic; 1582390
DR   Cosmic; 1601062
DR   Cosmic; 1604861
DR   Cosmic; 1998444
DR   Cosmic; 2036678
DR   Cosmic; 2089652
DR   Cosmic; 2131539
DR   Cosmic; 2301565
DR   Cosmic; 2306208
DR   Cosmic; 2651387
DR   Cosmic-CLP; 905938
DR   DepMap; ACH-000002
DR   DSMZ; ACC-3
DR   DSMZCellDive; ACC-3
DR   ECACC; 98070106
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS069ENC
DR   ENCODE; ENCBS070ENC
DR   ENCODE; ENCBS215JQI
DR   ENCODE; ENCBS308XSW
DR   ENCODE; ENCBS373UEY
DR   ENCODE; ENCBS482VCU
DR   ENCODE; ENCBS698WLF
DR   ENCODE; ENCBS869DKF
DR   ENCODE; ENCBS880XNW
DR   FANTOM5_SSTAR; 10829-111D1
DR   GDSC; 905938
DR   GEO; GSM50194
DR   GEO; GSM50258
DR   GEO; GSM213809
DR   GEO; GSM236782
DR   GEO; GSM236818
DR   GEO; GSM472908
DR   GEO; GSM472942
DR   GEO; GSM482507
DR   GEO; GSM545496
DR   GEO; GSM545497
DR   GEO; GSM743458
DR   GEO; GSM749688
DR   GEO; GSM749775
DR   GEO; GSM750812
DR   GEO; GSM799346
DR   GEO; GSM799409
DR   GEO; GSM838428
DR   GEO; GSM838429
DR   GEO; GSM838430
DR   GEO; GSM838431
DR   GEO; GSM887083
DR   GEO; GSM888153
DR   GEO; GSM945222
DR   GEO; GSM945255
DR   GEO; GSM1153417
DR   GEO; GSM1181331
DR   GEO; GSM1181348
DR   GEO; GSM1374535
DR   GEO; GSM1374536
DR   GEO; GSM1446736
DR   GEO; GSM1669883
DR   GEO; GSM2716740
DR   GEO; GSM2716741
DR   GEO; GSM2716742
DR   GEO; GSM2716743
DR   GEO; GSM7701378
DR   GEO; GSM7701379
DR   IARC_TP53; 21372
DR   IARC_TP53; 21731
DR   ICLC; HTL95010
DR   IGRhCellID; HL60
DR   IZSLER; BS TCL 25
DR   JCRB; IFO50022
DR   JCRB; JCRB0085
DR   JCRB; NIHS0086
DR   KCB; KCB 2014051YJ
DR   KCLB; 10240
DR   LiGeA; CCLE_789
DR   LINCS_LDP; LCL-1054
DR   Lonza; 64
DR   MeSH; D018922
DR   NCBI_Iran; C217
DR   PharmacoDB; HL60_546_2019
DR   PRIDE; PRD000345
DR   PRIDE; PXD000589
DR   PRIDE; PXD003539
DR   PRIDE; PXD006421
DR   PRIDE; PXD030304
DR   PRIDE; PXD032942
DR   Progenetix; CVCL_0002
DR   PubChem_Cell_line; CVCL_0002
DR   RCB; RCB0041
DR   RCB; RCB3683
DR   SKY/M-FISH/CGH; 5609
DR   TKG; TKG 0345
DR   TOKU-E; 1488
DR   Ubigene; YC-C058
DR   Wikidata; Q5630035
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.1159/000415060;
RX   PubMed=271272;
RX   PubMed=288488;
RX   PubMed=1368402;
RX   PubMed=1574572;
RX   PubMed=1970118;
RX   PubMed=2140233;
RX   PubMed=2545346;
RX   PubMed=2858093;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3311197;
RX   PubMed=3335022;
RX   PubMed=3422031;
RX   PubMed=3860286;
RX   PubMed=3874327;
RX   PubMed=6091813;
RX   PubMed=6255959;
RX   PubMed=6582512;
RX   PubMed=6945469;
RX   PubMed=6954533;
RX   PubMed=6996765;
RX   PubMed=7630190;
RX   PubMed=8316623;
RX   PubMed=8343448;
RX   PubMed=8558913;
RX   PubMed=8562479;
RX   PubMed=9434637;
RX   PubMed=9510473;
RX   PubMed=9557624;
RX   PubMed=9607592;
RX   PubMed=9737686;
RX   PubMed=9738977;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=12661003;
RX   PubMed=15843827;
RX   PubMed=16120335;
RX   PubMed=16408098;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22032829;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22460905;
RX   PubMed=22944676;
RX   PubMed=23955599;
RX   PubMed=24368162;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28109323;
RX   PubMed=28196595;
RX   PubMed=29491412;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30670178;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31733513;
RX   PubMed=33389257;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HL-60
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/hl60/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/HL-60_Stam_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=32
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-132.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HL60
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/leukemia-xenograft-model/hl60-xenograft-model/
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I.
CC   Population: Caucasian.
CC   Biotechnology: Used a source of mitochondrial DNA for USA forensic testing.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 16 hours (PubMed=8343448); 28 hours (PubMed=25984343); ~40 hours (DSMZ=ACC-3).
CC   HLA typing: A*01:01,24:15; B*57:01,57:01; C*06:02,06:02 (PubMed=26589293).
CC   HLA typing: B*57:01:01,57:01:01; C*06:02:01,06:02:01 (DSMZCellDive=ACC-3).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; PubMed=12661003; Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=2858093).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=17088437; Cosmic-CLP=905938; DepMap=ACH-000002).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; Cosmic-CLP=905938; DepMap=ACH-000002).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.15%; Native American=0.42%; East Asian, North=0.4%; East Asian, South=0%; South Asian=0%; European, North=71.71%; European, South=26.32% (PubMed=30894373).
CC   Anecdotal: Established at the 60th attempt to culture human leukemia biopsies in Gallo's lab. All the preceding attempts having failed.
CC   Misspelling: IIL-60; Note=Occasionally.
CC   Discontinued: Abcam; ab282204; true.
CC   Discontinued: JCRB; NIHS0086; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003023/4977; ATCC=CCL-240; CCRID; CLS=300209; COG; Cosmic-CLP=905938; DSMZ=ACC-3; ECACC=98070106; JCRB=IFO50022; JCRB=JCRB0085; KCLB=10240; PubMed=11416159; PubMed=25877200; RCB=RCB0041; TKG=TKG 0345
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14 (CLS=300209)
ST   D18S51: 14,15 (ATCC=CCL-240; CCRID; DSMZ=ACC-3; PubMed=11416159; PubMed=25877200)
ST   D19S433: 14
ST   D21S11: 29,30 (ATCC=CCL-240; CCRID; COG; DSMZ=ACC-3; PubMed=25877200)
ST   D21S11: 30 (CLS=300209; PubMed=11416159)
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12 (DSMZ=ACC-3)
ST   D8S1179: 12,13 (ATCC=CCL-240; CCRID; PubMed=11416159; PubMed=25877200)
ST   D8S1179: 13 (CLS=300209)
ST   FGA: 22,24
ST   Penta D: 10,11 (DSMZ=ACC-3)
ST   Penta D: 10,12 (ATCC=CCL-240; CLS=300209; PubMed=25877200)
ST   Penta E: 13 (CLS=300209)
ST   Penta E: 13,14 (ATCC=CCL-240; DSMZ=ACC-3; PubMed=25877200)
ST   TH01: 7,8 (AddexBio=C0003023/4977; ATCC=CCL-240; CCRID; CLS=300209; COG; Cosmic-CLP=905938; DSMZ=ACC-3; JCRB=JCRB0085; KCLB=10240; PubMed=11416159; PubMed=25877200; RCB=RCB0041; TKG=TKG 0345)
ST   TH01: 8 (ECACC=98070106; JCRB=IFO50022)
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 53
//
ID   HL-60 248
AC   CVCL_UM46
SY   HL60 248; 248
DR   cancercelllines; CVCL_UM46
DR   Wikidata; Q94211454
RX   PubMed=8562479;
RX   PubMed=9607592;
CC   Population: Caucasian.
CC   Characteristics: The TP53 null parental cell line was transfected with a mutated TP53 sequence.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg248Trp).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   HL-60 blast
AC   CVCL_VK43
SY   HL-60 Blast; HL-60_blast; HL60 blast
DR   cancercelllines; CVCL_VK43
DR   Cosmic; 850383
DR   Wikidata; Q94211458
RX   PubMed=6945469;
RX   PubMed=10966170;
CC   Population: Caucasian.
CC   Characteristics: Subclone of HL-60 resistant to the growth and differentiation effects of various compounds.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=10966170).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 14
//
ID   HL-60 clone 15
AC   CVCL_2493
SY   HL-60 clone15; HL60 clone 15; Clone 15 HL-60; HC15
DR   CLO; CLO_0002499
DR   CLDB; cl5151
DR   ATCC; CRL-1964
DR   BCRC; 60273
DR   cancercelllines; CVCL_2493
DR   ECACC; 98052918
DR   LINCS_LDP; LCL-1081
DR   PRIDE; PXD057747
DR   Wikidata; Q54889798
RX   PubMed=3184985;
RX   PubMed=40496865;
CC   Population: Caucasian.
CC   Characteristics: When cultured in slightly alkaline conditions for 2 months the cells gain the potential to differentiate into eosinophils if stimulated with sodium butyrate for 5-7 days (PubMed=40496865).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-1964; ECACC=98052918
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 33
//
ID   HL-60 clone 15-12
AC   CVCL_2494
SY   HL60 15-12
DR   CLO; CLO_0003776
DR   CLDB; cl1694
DR   cancercelllines; CVCL_2494
DR   ECACC; 88120805
DR   Wikidata; Q54889799
RX   PubMed=3165665;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2493 ! HL-60 clone 15
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   HL-60 clone F8
AC   CVCL_B6DR
SY   F8
DR   cancercelllines; CVCL_B6DR
DR   Wikidata; Q111733432
RX   PubMed=1368402;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_16134; Ammonia.
CC   Selected for resistance to: ChEBI; CHEBI_24996; Lactate.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HL-60 clone H6
AC   CVCL_B6DS
SY   H6
DR   cancercelllines; CVCL_B6DS
DR   Wikidata; Q111733433
RX   PubMed=1368402;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_16134; Ammonia.
CC   Selected for resistance to: ChEBI; CHEBI_24996; Lactate.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HL-60 DeltaF508-CF
AC   CVCL_WZ17
SY   DeltaF508-CF HL-60
DR   cancercelllines; CVCL_WZ17
DR   Millipore; SCC251
DR   Wikidata; Q94211494
RX   PubMed=30670178;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_edited; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=30670178).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Millipore=SCC251
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   HL-60 eosinophilic subline No. 3
AC   CVCL_F0CQ
RX   PubMed=3486011;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HL-60 eosinophilic subline No. 3(4)
AC   CVCL_F0CR
RX   PubMed=3486011;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CQ ! HL-60 eosinophilic subline No. 3
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HL-60 eosinophilic subline No. 3(5)
AC   CVCL_F0CS
RX   PubMed=3486011;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CQ ! HL-60 eosinophilic subline No. 3
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HL-60 neutrophilic subline No. 14
AC   CVCL_F0CU
RX   PubMed=3486011;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HL-60 neutrophilic subline No. 8
AC   CVCL_F0CT
RX   PubMed=3486011;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HL-60 SCX3
AC   CVCL_UM47
SY   HL60 SCX3; SCX3
DR   cancercelllines; CVCL_UM47
DR   Wikidata; Q94211499
RX   PubMed=8562479;
RX   PubMed=9607592;
CC   Population: Caucasian.
CC   Characteristics: The TP53 null parental cell line was transfected with a mutated TP53 sequence.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   HL-60 SN3
AC   CVCL_UM48
SY   HL-60-SN3; HL60 SN3; HL60/SN3; SN3
DR   cancercelllines; CVCL_UM48
DR   Wikidata; Q94211503
RX   PubMed=8562479;
RX   PubMed=9607592;
CC   Population: Caucasian.
CC   Characteristics: The TP53 null parental cell line was transfected with a wild type TP53 sequence.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   HL-60(Cas9)
AC   CVCL_E7J6
WW   Provider; BRICS; ECC3043; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3977
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HL-60(DM)
AC   CVCL_C8HP
SY   HL-60 (DM)
DR   Wikidata; Q123031676
RX   PubMed=3475162;
CC   Population: Caucasian.
CC   Karyotypic information: Contains a variable number (from 1 to 37) of double minute chromosomes (PubMed=3475162).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   HL-60(TB)
AC   CVCL_A794
SY   HL-60 (TB); HL-60-TB; HL-60TB; HL-60 TB
DR   BTO; BTO_0004119
DR   cancercelllines; CVCL_A794
DR   ChEMBL-Cells; CHEMBL4106363
DR   ChEMBL-Targets; CHEMBL4296429
DR   Cosmic; 974252
DR   Cosmic; 1175855
DR   Cosmic; 1312323
DR   GEO; GSM2173
DR   GEO; GSM1178186
DR   GEO; GSM1178187
DR   GEO; GSM1178188
DR   GEO; GSM1178189
DR   GEO; GSM1178190
DR   GEO; GSM2124666
DR   NCI-DTP; HL-60
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PubChem_Cell_line; CVCL_A794
DR   SKY/M-FISH/CGH; 2738
DR   Wikidata; Q54889812
RX   PubMed=2041050;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=27377824;
RX   PubMed=27807467;
RX   PubMed=38861359;
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 28.6 hours (NCI-DTP=HL-60).
CC   HLA typing: A*01:01:01; B*57:01:01; C*06:02; DPB1*04:01,13:01; DQB1*03:03:02 (PubMed=15748285).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=17088437).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 35
//
ID   HL-60-79B
AC   CVCL_C8HN
SY   HL-60(8q+)
DR   Wikidata; Q123031677
RX   PubMed=3475162;
RX   PubMed=6580529;
CC   Population: Caucasian.
CC   Karyotypic information: Has an abnormally banded region on chromosome 8 (PubMed=3475162; PubMed=6580529).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   HL-60-Luc2
AC   CVCL_A4BY
DR   ATCC; CCL-240-LUC2
DR   cancercelllines; CVCL_A4BY
DR   Wikidata; Q105507671
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-240-LUC2).
CC   Doubling time: ~19 hours (ATCC=CCL-240-LUC2).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CCL-240-LUC2
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   HL-60-R2
AC   CVCL_4635
DR   CLO; CLO_0051006
DR   cancercelllines; CVCL_4635
DR   RCB; RCB1550
DR   Wikidata; Q54889811
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27300; Vitamin D.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1550
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   HL-60-Y3
AC   CVCL_WW75
DR   cancercelllines; CVCL_WW75
DR   Wikidata; Q94211534
RX   PubMed=8343448;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=8343448).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HL-60/5FU
AC   CVCL_YP33
DR   cancercelllines; CVCL_YP33
DR   Wikidata; Q94211538
RX   PubMed=31741260;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   HL-60/ADR
AC   CVCL_0304
SY   HL60/ADR; HL60/Adr; HL60-ADR
DR   BTO; BTO_0003572
DR   MCCL; MCC:0000196
DR   cancercelllines; CVCL_0304
DR   ChEMBL-Cells; CHEMBL3833762
DR   ChEMBL-Targets; CHEMBL4296430
DR   PubChem_Cell_line; CVCL_0304
DR   Wikidata; Q54889800
RX   PubMed=2425939;
RX   PubMed=2573357;
RX   PubMed=2886122;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   HL-60/AMSA
AC   CVCL_IP18
DR   cancercelllines; CVCL_IP18
DR   Wikidata; Q54889801
RX   PubMed=1311390;
RX   PubMed=1651812;
RX   PubMed=2550442;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2687; Amsacrine.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11989; TOP2A; Simple; p.Arg487Lys (c.1460G>A); ClinVar=VCV000016772; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=1311390).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 19
//
ID   HL-60/AR
AC   CVCL_WR44
DR   cancercelllines; CVCL_WR44
DR   Wikidata; Q94211566
RX   PubMed=2545346;
RX   PubMed=3860286;
RX   PubMed=9434637;
CC   Group: Space-flown cell line (cellonaut).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_48120; Anthracycline.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Anecdotal: Have been flown in space on shuttle flight STS-67 to study the effect of microgravity on multidrug resistance (PubMed=9434637).
CC   Caution: Not to be confused with HL60/AR (Cellosaurus=CVCL_WI27) which is an 5-azacytidine resistant subline of HL-60.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 12
//
ID   HL-60/ara-C [Japan 2011]
AC   CVCL_4V19
DR   cancercelllines; CVCL_4V19
DR   Wikidata; Q54889802
RX   PubMed=21290089;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 19
//
ID   HL-60/ara-C [USA 1984]
AC   CVCL_Z938
DR   cancercelllines; CVCL_Z938
DR   Wikidata; Q54889803
RX   PubMed=6091869;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 20
//
ID   HL-60/CDDP
AC   CVCL_C3M3
DR   Wikidata; Q116049332
RX   DOI=10.7546/CRABS.2022.07.13;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   HL-60/DNR
AC   CVCL_4458
SY   HL60/DNR; HL60-DNR
DR   BTO; BTO_0003573
DR   cancercelllines; CVCL_4458
DR   Wikidata; Q54889804
RX   PubMed=9557624;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   HL-60/LRARa403SN D.2
AC   CVCL_D1L6
DR   Wikidata; Q127381769
RX   PubMed=1334022;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HL-60/LRARa403SN D.5
AC   CVCL_D1L7
DR   Wikidata; Q127381770
RX   PubMed=1334022;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   HL-60/MX1
AC   CVCL_3332
SY   HL 60/MX1; HL-60/MX-1; HL60/MX1; HL60MX1
DR   CLO; CLO_0003781
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2258
DR   BioSample; SAMN03471850
DR   cancercelllines; CVCL_3332
DR   IGRhCellID; HL60MX1
DR   NCBI_Iran; C553
DR   Progenetix; CVCL_3332
DR   Wikidata; Q54889805
RX   PubMed=2568172;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2258
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   HL-60/MX2
AC   CVCL_3333
SY   HL-60/MX-2; HL60/MX2
DR   BTO; BTO_0003571
DR   CLO; CLO_0003782
DR   ATCC; CRL-2257
DR   cancercelllines; CVCL_3333
DR   ChEMBL-Cells; CHEMBL4295458
DR   ChEMBL-Targets; CHEMBL4296431
DR   LINCS_LDP; LCL-1083
DR   PubChem_Cell_line; CVCL_3333
DR   Wikidata; Q54889806
RX   PubMed=2568172;
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (ATCC=CRL-2257).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2257
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3332 ! HL-60/MX1
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   HL-60/R3
AC   CVCL_II78
DR   cancercelllines; CVCL_II78
DR   Wikidata; Q54889807
RX   PubMed=1737356;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 18
//
ID   HL-60/RS
AC   CVCL_XE38
DR   cancercelllines; CVCL_XE38
DR   CCRID; 4201PAT-CCTCC00581
DR   Wikidata; Q94211650
RX   Patent=CN104004715B;
RX   PubMed=29399180;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201430.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   HL-60/S4
AC   CVCL_II77
DR   ATCC; CRL-3306
DR   cancercelllines; CVCL_II77
DR   Wikidata; Q54889808
RX   PubMed=1737356;
RX   PubMed=31988093;
CC   Population: Caucasian.
CC   Characteristics: Differentiation to a granulocyte-like state can be induced by retinoic acid (RA).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3306
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 20
//
ID   HL-60/VCR
AC   CVCL_0305
SY   HL60/VCR
DR   MCCL; MCC:0000197
DR   cancercelllines; CVCL_0305
DR   Wikidata; Q54889809
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   HL-60/Vinc
AC   CVCL_4967
SY   HL60/Vinc
DR   BTO; BTO_0002591
DR   cancercelllines; CVCL_4967
DR   Wikidata; Q54889810
RX   PubMed=2573357;
RX   PubMed=2886122;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   HL-60R
AC   CVCL_YT56
DR   cancercelllines; CVCL_YT56
DR   Wikidata; Q94211690
RX   PubMed=1327285;
RX   PubMed=1970118;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln411Ter (c.1231C>T); Zygosity=Heterozygous; Note=Responsible for retinoic acid resistance (PubMed=1327285).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   HL-60rARA-C2mug/ML
AC   CVCL_RS49
DR   cancercelllines; CVCL_RS49
DR   Wikidata; Q54889813
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 17
//
ID   HL-7702BaPT
AC   CVCL_WN40
DR   CCRID; 4201PAT-CCTCC00571
DR   Wikidata; Q94211708
RX   Patent=CN105802915B;
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014243.
CC   Population: African American.
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6926 ! L-02
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   HL-CZ
AC   CVCL_WU73
DR   BCRC; 60043
DR   Wikidata; Q94211712
RX   CelloPub=CLPUB00514;
RX   CelloPub=CLPUB00515;
RX   CelloPub=CLPUB00516;
RX   PubMed=1913629;
RX   PubMed=2063953;
RX   PubMed=25073113;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (BCRC=60043). Originally thought to originate from a 50 year old male patient with a acute T-cell leukemia.
CC   Population: Caucasian.
CC   Doubling time: 22-26 hours (CelloPub=CLPUB00515).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: BCRC; 60043; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 14
//
ID   HL/CAFdA20
AC   CVCL_4V55
DR   cancercelllines; CVCL_4V55
DR   Wikidata; Q54889814
RX   PubMed=23421409;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_681569; Clofarabine (CAFdA).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   HL/CAFdA80
AC   CVCL_4V56
DR   cancercelllines; CVCL_4V56
DR   Wikidata; Q54889815
RX   PubMed=23421409;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_681569; Clofarabine (CAFdA).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V55 ! HL/CAFdA20
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   HL111783
AC   CVCL_8231
SY   HL-111783
DR   BioSample; SAMN03151709
DR   RCB; RCB0111
DR   Wikidata; Q54889816
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00211.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0111; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   HL116
AC   CVCL_RW47
DR   cancercelllines; CVCL_RW47
DR   Wikidata; Q54889817
RX   PubMed=7932753;
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of a IFN-alpha inducible IFI6 (6-16) promoter.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HL130C2.3C5
AC   CVCL_A2IL
SY   MB47
DR   ATCC; HB-8746
DR   Wikidata; Q105507673
RX   Patent=US4828986;
RX   PubMed=3524903;
RX   PubMed=3954672;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8746.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 5
//
ID   HL165
AC   CVCL_X144
DR   Wikidata; Q54889818
RX   PubMed=6386741;
CC   Population: Caucasian.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   HL1C
AC   CVCL_D052
DR   BTO; BTO_0003565
DR   Wikidata; Q54889819
RX   PubMed=2172798;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0284 ! H4-II-E
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 14
//
ID   HL2/3
AC   CVCL_X685
DR   CLO; CLO_0037218
DR   BEI_Resources; ARP-1294
DR   Wikidata; Q54889820
RX   PubMed=2078409;
CC   Population: African American.
CC   Virology: Contains stably integrated copies of HIV-1 clone HXB2/3gpt.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 15
//
ID   HL2368
AC   CVCL_E8BB
RX   PubMed=27424005;
WW   Provider; UF Innovate; MP17454_1; https://ufinnovate.technologypublisher.com/tech/Panel_of_Monoclonal_Antibodies_for_Characterization_of_AAV8_and_AAV9_Capsids_to_Improve_Therapeutic_Efficacy_of_AAV_Gene-Based_Therapy
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q6JC40; Adeno-associated virus 9 (AAV-9) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HL2370
AC   CVCL_E8BC
RX   PubMed=27424005;
WW   Provider; UF Innovate; MP17454_1; https://ufinnovate.technologypublisher.com/tech/Panel_of_Monoclonal_Antibodies_for_Characterization_of_AAV8_and_AAV9_Capsids_to_Improve_Therapeutic_Efficacy_of_AAV_Gene-Based_Therapy
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6JC40; Adeno-associated virus 9 (AAV-9) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HL2372
AC   CVCL_E8BD
RX   PubMed=27424005;
WW   Provider; UF Innovate; MP17454_1; https://ufinnovate.technologypublisher.com/tech/Panel_of_Monoclonal_Antibodies_for_Characterization_of_AAV8_and_AAV9_Capsids_to_Improve_Therapeutic_Efficacy_of_AAV_Gene-Based_Therapy
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6JC40; Adeno-associated virus 9 (AAV-9) capsid protein VP1 (Note=Also recognizes AAV-8).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HL2374
AC   CVCL_E8BE
RX   PubMed=27424005;
WW   Provider; UF Innovate; MP17454_1; https://ufinnovate.technologypublisher.com/tech/Panel_of_Monoclonal_Antibodies_for_Characterization_of_AAV8_and_AAV9_Capsids_to_Improve_Therapeutic_Efficacy_of_AAV_Gene-Based_Therapy
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q6JC40; Adeno-associated virus 9 (AAV-9) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HL2381
AC   CVCL_E8BF
RX   PubMed=27424005;
WW   Provider; UF Innovate; MP17454_1; https://ufinnovate.technologypublisher.com/tech/Panel_of_Monoclonal_Antibodies_for_Characterization_of_AAV8_and_AAV9_Capsids_to_Improve_Therapeutic_Efficacy_of_AAV_Gene-Based_Therapy
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q8JQF8; Adeno-associated virus 8 (AAV-8) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HL2383
AC   CVCL_E8BG
RX   PubMed=27424005;
WW   Provider; UF Innovate; MP17454_1; https://ufinnovate.technologypublisher.com/tech/Panel_of_Monoclonal_Antibodies_for_Characterization_of_AAV8_and_AAV9_Capsids_to_Improve_Therapeutic_Efficacy_of_AAV_Gene-Based_Therapy
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q8JQF8; Adeno-associated virus 8 (AAV-8) capsid protein VP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HL3
AC   CVCL_B6DV
DR   Wikidata; Q111733434
RX   PubMed=7686026;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: FOS+HRAS.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Lymphocyte; CL=CL_0000542.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HL3T1
AC   CVCL_8232
SY   HeLa-HL3T1
DR   BTO; BTO_0006091
DR   BEI_Resources; ARP-1115
DR   TOKU-E; 4003
DR   Wikidata; Q54889821
RX   PubMed=3422113;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HL407
AC   CVCL_M510
SY   HL 407
DR   Wikidata; Q54889822
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1518305;
RX   PubMed=10936422;
CC   Characteristics: Produces IgA lambda.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   HL461
AC   CVCL_M511
SY   UCD-HL461; HL 461
DR   Wikidata; Q54889823
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1700238;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG4 kappa.
CC   Doubling time: 50 hours (PubMed=1700238).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   HL60 Ast.1
AC   CVCL_AR88
SY   HL60 Ast1
DR   cancercelllines; CVCL_AR88
DR   Wikidata; Q54889824
RX   PubMed=6641827;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129638; Astatine-211 alpha radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 19
//
ID   HL60 Ast.25
AC   CVCL_AR85
SY   HL60 Ast25
DR   cancercelllines; CVCL_AR85
DR   Wikidata; Q54889825
RX   PubMed=6641827;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129638; Astatine-211 alpha radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 19
//
ID   HL60 Ast.3
AC   CVCL_2495
SY   HL60 Ast 3; HL60 Ast3
DR   CLO; CLO_0003777
DR   CLDB; cl1695
DR   cancercelllines; CVCL_2495
DR   ECACC; 88120801
DR   Wikidata; Q54889826
RX   PubMed=3165665;
RX   PubMed=6641827;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129638; Astatine-211 alpha radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=88120801
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   HL60 Ast.4
AC   CVCL_2496
SY   HL60 Ast 4; HL60 Ast4
DR   CLO; CLO_0003778
DR   CLDB; cl1696
DR   cancercelllines; CVCL_2496
DR   ECACC; 88120802
DR   Wikidata; Q54889827
RX   PubMed=3165665;
RX   PubMed=6641827;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129638; Astatine-211 alpha radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=88120802
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   HL60 M2
AC   CVCL_2497
SY   HL60 m2; HL60M2; HL60m2
DR   CLO; CLO_0003779
DR   CLDB; cl1697
DR   cancercelllines; CVCL_2497
DR   ECACC; 88120803
DR   Wikidata; Q54889828
RX   PubMed=3165665;
RX   PubMed=6641827;
RX   PubMed=6958930;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   HL60 M4
AC   CVCL_2498
SY   HL60 m4; HL60M4; HL60m4
DR   CLO; CLO_0003780
DR   CLDB; cl1698
DR   cancercelllines; CVCL_2498
DR   ECACC; 88120804
DR   Wikidata; Q54889829
RX   PubMed=3165665;
RX   PubMed=6641827;
RX   PubMed=6958930;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   HL60 Sp1
AC   CVCL_AR89
SY   HL60Sp1
DR   cancercelllines; CVCL_AR89
DR   Wikidata; Q54889831
RX   PubMed=6641827;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 18
//
ID   HL60(S)
AC   CVCL_2944
SY   HL-60/S
DR   BTO; BTO_0006261
DR   CLO; CLO_0037170
DR   cancercelllines; CVCL_2944
DR   JCRB; JCRB0163
DR   JCRB; NIHS0248
DR   LINCS_LDP; LCL-1082
DR   Wikidata; Q54889834
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0248; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0163
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   HL60-CDR
AC   CVCL_C1LK
DR   cancercelllines; CVCL_C1LK
DR   Wikidata; Q114311625
RX   PubMed=35822500;
CC   Population: Caucasian.
CC   Characteristics: Resistant to doxorubicin, cisplatin, etoposide and daunorubicin (PubMed=35822500).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   HL60/AR
AC   CVCL_WI27
SY   HAR
DR   cancercelllines; CVCL_WI27
DR   Wikidata; Q94211961
RX   PubMed=24368162;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Caution: Not to be confused with HL-60/AR (Cellosaurus=CVCL_WR44) which is an anthracycline resistant subline of HL-60.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   HL60/MRI
AC   CVCL_A0ST
SY   MRI
DR   cancercelllines; CVCL_A0ST
DR   Wikidata; Q108820479
RX   PubMed=3469018;
CC   Population: Caucasian.
CC   Characteristics: Cell line established from the transplantable tumor of the same name.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   HL60RG
AC   CVCL_2945
SY   HL60-RG
DR   CLO; CLO_0037171
DR   cancercelllines; CVCL_2945
DR   GEO; GSM254145
DR   JCRB; JCRB0006
DR   LINCS_LDP; LCL-2056
DR   Progenetix; CVCL_2945
DR   Wikidata; Q54889835
RX   PubMed=9290701;
RX   PubMed=11416159;
RX   PubMed=22032829;
CC   Population: Caucasian.
CC   Doubling time: ~20 hours (PubMed=22032829); ~2 days (Note=Lot 12182006) (JCRB=JCRB0006).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0006; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,22,24
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   HL7
AC   CVCL_B6DW
DR   Wikidata; Q111733435
RX   PubMed=7686026;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: FOS+HRAS.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Lymphocyte; CL=CL_0000542.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HL8
AC   CVCL_B6DX
DR   Wikidata; Q111733436
RX   PubMed=7686026;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: FOS+HRAS.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Lymphocyte; CL=CL_0000542.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HL9
AC   CVCL_B6DY
DR   Wikidata; Q111733437
RX   PubMed=7686026;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: FOS+HRAS.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Lymphocyte; CL=CL_0000542.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HLaC-78
AC   CVCL_6647
SY   HLaC 78; HLac 78; HLAC78; HLaC'78; HLa-C-78
DR   BTO; BTO_0004020
DR   Wikidata; Q54889836
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=548013;
RX   PubMed=3138611;
RX   PubMed=6837290;
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HLaC-79
AC   CVCL_6648
SY   HLaC 79; HLac 79; HLAC79; HLaC'79; HlaC79
DR   BTO; BTO_0004021
DR   Cosmic; 932294
DR   Wikidata; Q54889837
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3138611;
RX   PubMed=6837290;
RX   PubMed=7543833;
RX   PubMed=8679156;
RX   PubMed=15495191;
RX   PubMed=20947470;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   HLaC-82
AC   CVCL_6649
SY   HLaC 82; HLac 82; HLAC82; HLaC'82
DR   Wikidata; Q54889838
RX   PubMed=7543833;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   HLB
AC   CVCL_LC11
DR   Wikidata; Q54889839
RX   PubMed=3201749;
RX   PubMed=3266096;
CC   Virology: Infected by squirrel monkey retrovirus (SMRV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   HLB-B1
AC   CVCL_LC20
DR   Wikidata; Q54889840
RX   PubMed=6292115;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   HLB-R1
AC   CVCL_LC19
DR   Wikidata; Q54889841
RX   PubMed=6292115;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   HLC-1
AC   CVCL_5529
SY   HLC1
DR   CLO; CLO_0050024
DR   BioSample; SAMN03472335
DR   cancercelllines; CVCL_5529
DR   Cell_Model_Passport; SIDM01805
DR   Cosmic; 1154601
DR   DepMap; ACH-001088
DR   GEO; GSM784262
DR   PharmacoDB; HLC1_547_2019
DR   Progenetix; CVCL_5529
DR   RCB; RCB0083
DR   Wikidata; Q54889842
RX   PubMed=140093;
RX   PubMed=3518877;
RX   PubMed=3986962;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~33 hours (Note=At 29th passage) (PubMed=140093).
CC   Genome ancestry: African=4.37%; Native American=0%; East Asian, North=90.08%; East Asian, South=3.53%; South Asian=0%; European, North=0%; European, South=2.02% (PubMed=30894373).
CC   Caution: Indicated by Riken to originate from Okabe T. but with no reference provided. Therefore it is not certain that HLC-1 from Riken and HLC-1 originating from Akagi T. and Kimoto T. (PubMed=140093) are identical.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB0083
ST   Amelogenin: X
ST   CSF1PO: 7,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 9,10
ST   D7S820: 11,13
ST   TH01: 7,9
ST   TPOX: 12
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 24
//
ID   HLC-1-Luc
AC   CVCL_4Y14
DR   JCRB; NIHS0711
DR   Wikidata; Q54889843
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0711; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5529 ! HLC-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   HLC-2
AC   CVCL_WZ42
DR   Wikidata; Q94212077
RX   CelloPub=CLPUB00527;
RX   PubMed=7508905;
RX   PubMed=8407567;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   HLCD4-CAT
AC   CVCL_X686
DR   BEI_Resources; ARP-1299
DR   Wikidata; Q54889844
RX   PubMed=2078409;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S495 ! HeLa-T4+
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 16
//
ID   HLCL-1
AC   CVCL_2946
DR   BioSample; SAMN03472809
DR   JCRB; JCRB0041
DR   Wikidata; Q54889845
RX   PubMed=29892436;
CC   Doubling time: 4-5 days (Note=Lot 102497) (JCRB=JCRB0041).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0041
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   HLCZ01
AC   CVCL_1J92
DR   Wikidata; Q54889846
RX   Patent=US9989520;
RX   PubMed=24616513;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201309.
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   HLD18 FiPS4379-Ep6F-2
AC   CVCL_E7AA
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+HLD18+FiPS4379-Ep6F-2+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/HLD18%2520FiPS4379-Ep6F-2%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D21S11: 30,31
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C215053; Hypomyelinating leukodystrophy-18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HLE
AC   CVCL_1281
DR   BTO; BTO_0005987
DR   CLO; CLO_0009986
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473204
DR   cancercelllines; CVCL_1281
DR   Cell_Model_Passport; SIDM00064
DR   CGH-DB; 9075-4
DR   ChEMBL-Cells; CHEMBL3308108
DR   ChEMBL-Targets; CHEMBL1075464
DR   Cosmic; 907057
DR   Cosmic; 945156
DR   Cosmic; 1518230
DR   Cosmic; 2023859
DR   Cosmic; 2162526
DR   Cosmic-CLP; 907057
DR   DepMap; ACH-001089
DR   EGA; EGAS00001000978
DR   GDSC; 907057
DR   GEO; GSM827170
DR   GEO; GSM887084
DR   GEO; GSM888154
DR   GEO; GSM936757
DR   GEO; GSM1374537
DR   GEO; GSM1669884
DR   GEO; GSM2551566
DR   IARC_TP53; 2008
DR   IARC_TP53; 21373
DR   JCRB; JCRB0404
DR   LIMORE; HLE
DR   LINCS_LDP; LCL-1939
DR   PharmacoDB; HLE_548_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1281
DR   PubChem_Cell_line; CVCL_1281
DR   TOKU-E; 3605
DR   Wikidata; Q54889847
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   DOI=10.11418/jtca1981.12.3_221;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=52570;
RX   PubMed=1778766;
RX   PubMed=7874267;
RX   PubMed=8389256;
RX   PubMed=8835345;
RX   PubMed=9290701;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=12029633;
RX   PubMed=12679910;
RX   PubMed=15767549;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20937217;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=32899426;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/HLE
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 40 hours (PubMed=52570); 21.82 hours (PubMed=31378681).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ala (c.731G>C); ClinVar=VCV000458560; Zygosity=Unspecified (PubMed=31378681; DepMap=ACH-001089).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.86%; Native American=0%; East Asian, North=85.81%; East Asian, South=8.43%; South Asian=0%; European, North=0%; European, South=3.89% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at c.747G>T in PubMed=8389256.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): Cosmic-CLP=907057; JCRB=JCRB0404; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 15
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2947 ! HLF
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   HLE-LUC
AC   CVCL_JF92
DR   cancercelllines; CVCL_JF92
DR   JCRB; JCRB1610
DR   Wikidata; Q54889848
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ala (c.731G>C); ClinVar=VCV000458560; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): JCRB=JCRB1610
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1281 ! HLE
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 17
//
ID   HLE/2E1
AC   CVCL_X149
DR   cancercelllines; CVCL_X149
DR   Wikidata; Q54889849
RX   PubMed=11212141;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ala (c.731G>C); ClinVar=VCV000458560; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1281 ! HLE
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   HLE/LULS42
AC   CVCL_C1GQ
DR   Wikidata; Q114311626
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=49205; ! Hyalomma lusitanicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   HLE/LULS43
AC   CVCL_C1GR
DR   Wikidata; Q114311627
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=49205; ! Hyalomma lusitanicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   HLE/LULS48
AC   CVCL_C1GS
DR   Wikidata; Q114311628
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=49205; ! Hyalomma lusitanicum (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   HLF
AC   CVCL_2947
DR   CLO; CLO_0009987
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 657
DR   BioSample; SAMN10987769
DR   cancercelllines; CVCL_2947
DR   Cell_Model_Passport; SIDM00065
DR   CGH-DB; 9076-4
DR   Cosmic; 945157
DR   Cosmic; 1187332
DR   Cosmic; 1518229
DR   Cosmic; 2023860
DR   Cosmic; 2162527
DR   DepMap; ACH-000393
DR   GEO; GSM887086
DR   GEO; GSM888156
DR   GEO; GSM936758
DR   GEO; GSM1374538
DR   GEO; GSM1669885
DR   GEO; GSM2551567
DR   IARC_TP53; 2009
DR   JCRB; JCRB0405
DR   LiGeA; CCLE_520
DR   LIMORE; HLF
DR   LINCS_HMS; 50015
DR   LINCS_LDP; LCL-1938
DR   PharmacoDB; HLF_549_2019
DR   Progenetix; CVCL_2947
DR   Wikidata; Q54889850
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   DOI=10.11418/jtca1981.12.3_221;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=52570;
RX   PubMed=1778766;
RX   PubMed=7874267;
RX   PubMed=8389256;
RX   PubMed=9290701;
RX   PubMed=10523694;
RX   PubMed=12029633;
RX   PubMed=15767549;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31978347;
RX   PubMed=32899426;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/HLF
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 53 hours (PubMed=52570); 27 hours (PubMed=25984343); 22.98 hours (PubMed=31378681).
CC   HLA typing: A*02:06,24:02; B*15:01,15:01; C*01:02,03:03; DQB1*03:04,03:04; DRB1*04:05,11:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ala (c.731G>C); ClinVar=VCV000458560; Zygosity=Unspecified (PubMed=8389256; PubMed=31378681).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=85.67%; East Asian, South=14.33%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB0405; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1281 ! HLE
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   HLF-a
AC   CVCL_2255
SY   HLFa; HLFA
DR   CLO; CLO_0003783
DR   CLDB; cl1699
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-199
DR   BioSample; SAMN03471463
DR   BioSample; SAMN10988274
DR   cancercelllines; CVCL_2255
DR   Cell_Model_Passport; SIDM01710
DR   DepMap; ACH-000797
DR   ECACC; 90112703
DR   GEO; GSM206505
DR   GEO; GSM274805
DR   GEO; GSM274806
DR   GEO; GSM887085
DR   GEO; GSM888155
DR   IARC_TP53; 30040
DR   LiGeA; CCLE_508
DR   PharmacoDB; HLFa_550_2019
DR   Progenetix; CVCL_2255
DR   Wikidata; Q54889851
RX   DOI=10.1101/166199;
RX   PubMed=7065527;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a lung squamous cell carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000797).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=90.86%; Native American=0%; East Asian, North=2.07%; East Asian, South=0%; South Asian=0%; European, North=1.99%; European, South=5.07% (PubMed=30894373).
CC   Discontinued: ECACC; 90112703; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-199
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D19S433: 14,14.2
ST   D21S11: 29,34
ST   D2S1338: 18,25
ST   D3S1358: 15
ST   D5S818: 8,12
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 19
ST   Penta D: 7,11
ST   Penta E: 8,9
ST   TH01: 6,9.3
ST   TPOX: 6,8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   HLF-Luc
AC   CVCL_JG48
DR   cancercelllines; CVCL_JG48
DR   JCRB; JCRB1591
DR   Wikidata; Q54889852
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ala (c.731G>C); ClinVar=VCV000458560; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1591
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2947 ! HLF
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 16
//
ID   HLF-R10
AC   CVCL_M180
DR   cancercelllines; CVCL_M180
DR   Wikidata; Q54889853
RX   PubMed=22179686;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ala (c.731G>C); ClinVar=VCV000458560; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2947 ! HLF
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   HLF-R4
AC   CVCL_M181
DR   cancercelllines; CVCL_M181
DR   Wikidata; Q54889854
RX   PubMed=22179686;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ala (c.731G>C); ClinVar=VCV000458560; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2947 ! HLF
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   HLfB
AC   CVCL_X688
DR   BEI_Resources; ARP-1300
DR   Wikidata; Q54889855
RX   PubMed=2186373;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 12
//
ID   HLHL-1
AC   CVCL_VJ06
SY   Human Lymphocyte-Human Lymphocyte 1
DR   Wikidata; Q94212243
RX   PubMed=4368696;
CC   Karyotypic information: Tetraploid karyotype.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VJ01 ! UM-1-6TGr
HI   CVCL_VJ02 ! UM-21-5
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   HLM1
AC   CVCL_X699
DR   BEI_Resources; ARP-2090
DR   Wikidata; Q54889856
RX   PubMed=1981148;
CC   Population: African American.
CC   Virology: Transfected with a HIV proviral DNA (pHXB2gpt) that contains a tat-defective mutant pMtat1 which has a Tat p.Met1Ter (c.1_3ATG>TGA) mutation.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S495 ! HeLa-T4+
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 18
//
ID   HLM107
AC   CVCL_X700
DR   BEI_Resources; ARP-2092
DR   Wikidata; Q54889857
CC   Population: African American.
CC   Virology: Transfected with a HIV proviral DNA (pHXB2gpt) that contains a rev-defective mutant pMrev- which has a Rev p.Gly6Ter (c.16G>T) mutation.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S495 ! HeLa-T4+
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 17
//
ID   HLM30
AC   CVCL_X701
DR   BEI_Resources; ARP-2091
DR   Wikidata; Q54889858
RX   PubMed=1981148;
CC   Population: African American.
CC   Virology: Transfected with a HIV proviral DNA (pHXB2gpt) that contains a tat-defective mutant pMtat34 which has a Tat p.Cys30Gly (c.88T>G) mutation.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S495 ! HeLa-T4+
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 18
//
ID   HLM34
AC   CVCL_WN04
DR   Wikidata; Q94212291
RX   PubMed=1981148;
CC   Population: African American.
CC   Virology: Transfected with a HIV proviral DNA (pHXB2gpt) that contains a tat-defective mutant pMtat34 which has a Tat p.Cys34Gly (c.100T>G) mutation.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S495 ! HeLa-T4+
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   HLN-ATL-O
AC   CVCL_VN75
SY   HLN-ATL-0; LN-ATL-O
DR   Wikidata; Q94212296
RX   PubMed=2140233;
RX   PubMed=15871724;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VN76 ! HPB-ATL-O
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 10
//
ID   HLN-GAC-5
AC   CVCL_WT56
SY   GAC-5
DR   Wikidata; Q94212301
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 6
//
ID   HLN-Ret-1
AC   CVCL_WT64
SY   Ret-1
DR   Wikidata; Q94212306
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from 'reticulum cell sarcoma'.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 7
//
ID   HLN-Ret-2
AC   CVCL_WT65
SY   Ret-2
DR   Wikidata; Q94212312
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from 'reticulum cell sarcoma'.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 7
//
ID   HLN-STL-C
AC   CVCL_X751
SY   STL-C
DR   Wikidata; Q54889859
RX   PubMed=2551312;
RX   PubMed=8263111;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 9
//
ID   hLp1
AC   CVCL_A8GE
DR   TKG; TKG 0788
DR   Wikidata; Q107115350
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P18428; Human LBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   hLp4
AC   CVCL_A8GF
DR   TKG; TKG 0789
DR   Wikidata; Q107115351
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P18428; Human LBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HLR
AC   CVCL_KB15
SY   Hlr; PathDetect HLR; HeLa Luciferase Reporter
DR   Wikidata; Q54889860
RX   PubMed=11355349;
WW   Provider; Agilent; 800050; https://www.chem-agilent.com/pdf/strata/800050.pdf
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene expression is under the control of a synthetic promoter containing 5 direct repeats of the 17-mer GAL4-binding site.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Agilent/Stratagene; Catalog number 800050.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HLR-CHOP
AC   CVCL_KB17
SY   PathDetect HLR-CHOP
DR   Wikidata; Q54889861
WW   Provider; Agilent; 800060; https://www.chem-agilent.com/pdf/strata/800050.pdf
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene expression is under the control of a synthetic promoter containing 5 direct repeats of the 17-mer GAL4-binding site.
CC   Characteristics: Transfected with the activation domain of DDIT3 fused to the yeast GAL4 DNA-binding domain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2726; DDIT3 (Note=With p.Thr102_Ala169del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Agilent/Stratagene; Catalog number 800060.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB15 ! HLR
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   HLR-cJun
AC   CVCL_KB16
SY   HLR-c-Jun; PathDetect HLR-cJun
DR   Wikidata; Q54889862
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene expression is under the control of a synthetic promoter containing 5 direct repeats of the 17-mer GAL4-binding site.
CC   Characteristics: Transfected with the activation domain of JUN fused to the yeast GAL4 DNA-binding domain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6204; JUN (Note=With del ?-331).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Agilent/Stratagene; Catalog number 800070.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB15 ! HLR
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HLR-CREB
AC   CVCL_KB18
SY   PathDetect HLR-CREB
DR   Wikidata; Q54889863
RX   PubMed=11355349;
WW   Provider; Agilent; 800065; https://www.chem-agilent.com/pdf/strata/800050.pdf
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene expression is under the control of a synthetic promoter containing 5 direct repeats of the 17-mer GAL4-binding site.
CC   Characteristics: Transfected with the activation domain of CREB1 fused to the yeast GAL4 DNA-binding domain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2345; CREB1 (Note=With del 281-341).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Agilent/Stratagene; Catalog number 800065.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB15 ! HLR
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   HLR-Elk1
AC   CVCL_KB19
SY   HLR-ELK1; PathDetect HLR-Elk1
DR   Wikidata; Q54889864
RX   PubMed=11355349;
WW   Provider; Agilent; 800055; https://www.chem-agilent.com/pdf/strata/800050.pdf
CC   Population: African American.
CC   Characteristics: The luciferase reporter gene expression is under the control of a synthetic promoter containing 5 direct repeats of the 17-mer GAL4-binding site.
CC   Characteristics: Transfected with the activation domain of ELK1 fused to the yeast GAL4 DNA-binding domain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3321; ELK1 (Note=With p.Met1_Ile307del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Agilent/Stratagene; Catalog number 800055.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KB15 ! HLR
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   HLSC
AC   CVCL_AS77
SY   Human Lung Stem Cell line
DR   Wikidata; Q54889865
DR   Ximbio; 152715
RX   PubMed=22828869;
CC   Discontinued: Ximbio; 152715; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 6
//
ID   HLSC PGK-EGFP
AC   CVCL_AS80
DR   Wikidata; Q54889866
DR   Ximbio; 152718
RX   PubMed=22828869;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Ximbio; 152718; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AS77 ! HLSC
SX   Sex unspecified
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 7
//
ID   HLSC SH2
AC   CVCL_AS79
DR   Wikidata; Q54889867
DR   Ximbio; 152717
RX   PubMed=22828869;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:6876; MAPK14.
CC   Discontinued: Ximbio; 152717; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AS77 ! HLSC
SX   Sex unspecified
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 7
//
ID   HLSC SH3
AC   CVCL_AS78
DR   Wikidata; Q54889868
DR   Ximbio; 152716
RX   PubMed=22828869;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:6876; MAPK14.
CC   Discontinued: Ximbio; 152716; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AS77 ! HLSC
SX   Sex unspecified
AG   Age unspecified
CA   Somatic stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 7
//
ID   HLT-Oat-1
AC   CVCL_WT50
DR   Wikidata; Q94212441
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HLT-Oat-2
AC   CVCL_WT51
DR   Wikidata; Q94212444
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HLtat
AC   CVCL_8164
DR   CLO; CLO_0050935
DR   BEI_Resources; ARP-1293
DR   RCB; RCB2358
DR   Wikidata; Q54889869
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB2358
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HLY-1
AC   CVCL_H207
SY   HLY1
DR   Cosmic; 1486589
DR   GEO; GSM1035337
DR   GEO; GSM1374539
DR   Wikidata; Q54889870
RX   PubMed=15122589;
RX   PubMed=18077790;
RX   PubMed=21179087;
CC   From: Al Saati, Talal; Hopital de Purpan, Centre Hospitalier Universitaire de Toulouse; Toulouse; France.
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Ser206Cys (c.617C>G) (p.Ser219Cys, c.656C>G) (S219C); Zygosity=Heterozygous (PubMed=21179087).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   HLY-1 eIF4E1
AC   CVCL_IN94
DR   GEO; GSM1511349
DR   GEO; GSM1511350
DR   GEO; GSM1511351
DR   GEO; GSM1511361
DR   GEO; GSM1511362
DR   GEO; GSM1511363
DR   Wikidata; Q54889871
RX   PubMed=25403230;
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Ser206Cys (c.617C>G) (p.Ser219Cys, c.656C>G) (S219C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3287; EIF4E.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H207 ! HLY-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   HLY-1 eIF4E3
AC   CVCL_IN95
DR   GEO; GSM1511352
DR   GEO; GSM1511353
DR   GEO; GSM1511354
DR   GEO; GSM1511364
DR   GEO; GSM1511365
DR   GEO; GSM1511366
DR   Wikidata; Q54889872
RX   PubMed=25403230;
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Ser206Cys (c.617C>G) (p.Ser219Cys, c.656C>G) (S219C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:31837; EIF4E3.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H207 ! HLY-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   HM [Human breast carcinoma]
AC   CVCL_E6XF
RX   PubMed=12836015;
CC   HLA typing: A*01,01; B*08,08; DQB1*02,06:02; DRB1*03:01:01,15:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HM [Human gestational choriocarcinoma]
AC   CVCL_M679
DR   Wikidata; Q54889873
RX   PubMed=6190712;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=6190712).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   HM [Human mesothelioma]
AC   CVCL_IW97
DR   Wikidata; Q54889875
RX   PubMed=11485930;
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HM 1
AC   CVCL_L696
SY   HM1
DR   ATCC; HB-8586
DR   Wikidata; Q54889877
RX   Patent=US4665032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8586.
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L699 ! KE 37.3.2
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   HM 162
AC   CVCL_W442
SY   HM162
DR   Wikidata; Q54889879
RX   DOI=10.5794/jjoms.37.1797;
RX   PubMed=1882124;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   HM 2
AC   CVCL_3713
SY   HM2
DR   CLO; CLO_0003784
DR   ATCC; HB-8587
DR   Wikidata; Q54889880
RX   Patent=US4665032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8587.
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L699 ! KE 37.3.2
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   HM-1 [Hamster]
AC   CVCL_D6D7
SY   HM1
DR   Wikidata; Q127381771
RX   PubMed=631215;
RX   PubMed=986876;
RX   PubMed=4856336;
RX   PubMed=4856409;
RX   PubMed=6182621;
RX   PubMed=6499947;
RX   PubMed=6826652;
CC   From: KAM Laboratories, Inc.; St. Joseph; USA.
CC   Doubling time: 20 hours (Note=At 33 Celsius), 12 hours (Note=At 39 Celsius) (PubMed=4856409); 19 hours (Note=At 33 Celsius), 13 hours (Note=At 39 Celsius) (PubMed=631215).
CC   Miscellaneous: This is not the HM-1 hamster macrophage cell line (Cellosaurus=CVCL_2948) as it was established in Japan at least 4 years after this cell line was first mentionned. Not can it be the HM1/HM-1 hamster melanomas cell line (Cellosaurus=CVCL_D6D3) which was also established long after this one.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   HM-1 [Hamster macrophage]
AC   CVCL_2948
SY   Hamster Macrophage-1
DR   JCRB; JCRB1208
DR   Wikidata; Q54889881
RX   PubMed=657122;
CC   Doubling time: 114 hours (PubMed=657122).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Macrophage; CL=CL_0000235.
DI   NCIt; C134776; Hamster lymphoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   HM-1 [Human cervical carcinoma]
AC   CVCL_VI96
DR   Wikidata; Q94212585
RX   PubMed=24723343;
RX   PubMed=28484083;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 35 hours (PubMed=28484083).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=28484083
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D21S11: 29,32.2
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C128045; Cervical neuroendocrine carcinoma
DI   ORDO; Orphanet_213777; High-grade neuroendocrine carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   HM-1 [Pig/mouse heteromyeloma]
AC   CVCL_9V22
DR   Wikidata; Q54889882
RX   PubMed=2264287;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of pig lymphocytes with P3X63Ag8.653 (PubMed=2264287).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 5
//
ID   HM-1 ES
AC   CVCL_C315
SY   HM-1
DR   BTO; BTO_0002896
DR   Wikidata; Q54889883
RX   PubMed=1440055;
RX   PubMed=1641353;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-543.html
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/OlaHsd-Hprt<b-m3>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   HM-2 [Hamster macrophage]
AC   CVCL_W885
SY   Hamster Macrophage-2
DR   Wikidata; Q54889884
RX   PubMed=657122;
CC   Doubling time: 90 hours (PubMed=657122).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Macrophage; CL=CL_0000235.
DI   NCIt; C134776; Hamster lymphoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   HM-2 [Pig/mouse/bovine heteromyeloma]
AC   CVCL_9V23
DR   Wikidata; Q54889885
RX   PubMed=2264287;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of pig lymphocytes with 7E2 (PubMed=2264287).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_9V27 ! 7E2
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 5
//
ID   HM-3 [Pig/mouse/bovine heteromyeloma]
AC   CVCL_9V24
DR   Wikidata; Q54889886
RX   PubMed=2264287;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of pig lymphocytes with HM-2 (PubMed=2264287).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_9V23 ! HM-2 [Pig/mouse/bovine heteromyeloma]
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 6
//
ID   HM-3 [Human mesothelia]
AC   CVCL_UZ40
SY   HM3
DR   Wikidata; Q94212653
RX   PubMed=9382953;
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 43 PDL (PubMed=12077343).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   HM-3/p53DD
AC   CVCL_UZ41
DR   Wikidata; Q94212655
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ40 ! HM-3 [Human mesothelia]
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   HM-3/TERT
AC   CVCL_UZ42
DR   Wikidata; Q94212660
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ40 ! HM-3 [Human mesothelia]
SX   Female
AG   29Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   HM-4
AC   CVCL_9V25
DR   Wikidata; Q54889887
RX   PubMed=2264287;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of pig lymphocytes with HM-3 (PubMed=2264287).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_9V24 ! HM-3 [Pig/mouse/bovine heteromyeloma]
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 6
//
ID   HM-5 [Human/mouse heteromyeloma]
AC   CVCL_9V73
DR   Wikidata; Q54889888
RX   PubMed=2408619;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   HM-5 [Pig/mouse/bovine heteromyeloma]
AC   CVCL_9V26
DR   Wikidata; Q54889889
RX   PubMed=2264287;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of pig lymphocytes with HM-3 (PubMed=2264287).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_9V24 ! HM-3 [Pig/mouse/bovine heteromyeloma]
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 6
//
ID   HM02
AC   CVCL_RX75
DR   Wikidata; Q54889890
RX   PubMed=7831386;
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   HM1
AC   CVCL_D6D3
SY   HM-1; Hamster Melanoma 1
DR   Wikidata; Q127381772
RX   PubMed=3098410;
RX   PubMed=3607776;
CC   Characteristics: Originates from a transplantable tumor (MM1) (PubMed=3098410; PubMed=3607776).
CC   Doubling time: 36 hours (PubMed=3607776).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_D6D4 ! HM2 [Hamster melanoma]
OI   CVCL_D6D5 ! HM3
OI   CVCL_D6D6 ! HM4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HM1-SV40
AC   CVCL_6258
DR   Wikidata; Q54889891
RX   PubMed=14767565;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HM1-SV40
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   HM2 [Hamster melanoma]
AC   CVCL_D6D4
SY   HM-2; Hamster Melanoma 2
DR   Wikidata; Q127381773
RX   PubMed=3098410;
CC   Characteristics: Originates from a transplantable tumor (MM1) (PubMed=3098410).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_D6D3 ! HM1
OI   CVCL_D6D5 ! HM3
OI   CVCL_D6D6 ! HM4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HM2 [Mouse hybridoma against human GPC1]
AC   CVCL_E8DD
DR   ABCD; ABCD_BF007
RX   Patent=US12122843;
RX   PubMed=32623934;
WW   Provider; NCI TTC; TAB-4107/E-028-2019-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4107
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P35052; Human GPC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HM2-SV40
AC   CVCL_6259
DR   Wikidata; Q54889892
RX   PubMed=14767565;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HM2-SV40
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   HM2C1
AC   CVCL_RB03
DR   Wikidata; Q54889893
RX   PubMed=1116142;
RX   PubMed=1260765;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Sex unspecified
AG   38FD
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   HM3
AC   CVCL_D6D5
SY   HM-3; Hamster Melanoma 3
DR   Wikidata; Q127381774
RX   PubMed=3607776;
CC   Characteristics: Originates from a transplantable tumor (MM1) (PubMed=3098410).
CC   Doubling time: 44 hours (PubMed=3607776).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_D6D3 ! HM1
OI   CVCL_D6D4 ! HM2 [Hamster melanoma]
OI   CVCL_D6D6 ! HM4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HM3KO
AC   CVCL_5620
SY   HM 3 KO
DR   Wikidata; Q54889894
RX   PubMed=2513567;
RX   PubMed=12839565;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   HM4
AC   CVCL_D6D6
SY   HM-4; Hamster Melanoma 4
DR   Wikidata; Q127381775
RX   PubMed=3607776;
CC   Characteristics: Originates from a transplantable tumor (MM1) (PubMed=3098410).
CC   Doubling time: 56 hours (PubMed=3607776).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_D6D3 ! HM1
OI   CVCL_D6D4 ! HM2 [Hamster melanoma]
OI   CVCL_D6D5 ! HM3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HM4C1
AC   CVCL_RB04
DR   Wikidata; Q54889895
RX   PubMed=1116142;
RX   PubMed=1260765;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Sex unspecified
AG   49FD
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   HM4KO
AC   CVCL_A1SA
SY   HM 4 KO
DR   Wikidata; Q105507676
RX   PubMed=2513567;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   HM51
AC   CVCL_RX76
DR   Cosmic; 1460711
DR   Wikidata; Q54889896
RX   PubMed=7831386;
DI   NCIt; C5476; Gastric undifferentiated carcinoma
DI   ORDO; Orphanet_423786; Undifferentiated carcinoma of stomach
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   HM5KO
AC   CVCL_A1SB
SY   HM 5 KO
DR   Wikidata; Q105507679
RX   PubMed=2513567;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   HM6KO
AC   CVCL_A1SC
SY   HM 6 KO
DR   Wikidata; Q105507683
RX   PubMed=2513567;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   HMA-1
AC   CVCL_M378
DR   Wikidata; Q54889897
RX   PubMed=1750037;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=1750037).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   HMab-1
AC   CVCL_D3E0
DR   Wikidata; Q127381776
RX   PubMed=22396072;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132His).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   HMab-2
AC   CVCL_D3E1
DR   Wikidata; Q127381777
RX   PubMed=26381180;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132His).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   HMAM4A
AC   CVCL_JY09
DR   Wikidata; Q54889898
RX   PubMed=21893382;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C135723; Hamster mammary carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_JY10 ! HMAM4B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   HMAM4B
AC   CVCL_JY10
DR   Wikidata; Q54889899
RX   PubMed=21893382;
CC   Doubling time: ~24 hours (PubMed=21893382).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C135723; Hamster mammary carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_JY09 ! HMAM4A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   HMAM5
AC   CVCL_JY11
DR   ABM; T8099
DR   Wikidata; Q54889900
RX   PubMed=21893382;
CC   Characteristics: Produced from a tumor derived from HMAM4B cells implanted into a syngeneic hamster.
CC   Doubling time: ~24 hours (PubMed=21893382).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C135723; Hamster mammary carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_JY10 ! HMAM4B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 8
//
ID   HMB-2
AC   CVCL_6646
SY   HMB2; Human Melanoma Bratislava-2
DR   BTO; BTO_0001667
DR   Cosmic; 1132586
DR   Wikidata; Q54889901
RX   PubMed=3065655;
RX   PubMed=6819484;
CC   Doubling time: 36-49 hours (PubMed=3065655); 47.3 hours (PubMed=6819484).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   HMB-45
AC   CVCL_B3XR
SY   HMB 45; HMB45
DR   Wikidata; Q110432897
RX   PubMed=3518473;
RX   PubMed=3766867;
RX   PubMed=7504884;
RX   PubMed=8624261;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HMB-45
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P40967; Human PMEL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 4
//
ID   HMB-50
AC   CVCL_B3XS
SY   HMB 50; HMB50
DR   Wikidata; Q110432899
RX   PubMed=3342407;
RX   PubMed=3518473;
RX   PubMed=3766867;
RX   PubMed=7504884;
RX   PubMed=8624261;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P40967; Human PMEL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   HMB2-5
AC   CVCL_S514
SY   HMB2-MIA5
DR   Wikidata; Q54889902
RX   PubMed=15208686;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6646 ! HMB-2
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   HMB2-8
AC   CVCL_S515
SY   HMB2-MIA8
DR   Wikidata; Q54889903
RX   PubMed=15208686;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6646 ! HMB-2
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   HMB2-LacZ
AC   CVCL_S516
SY   HMB2 LacZ; HMB2lacZ
DR   Wikidata; Q54889904
RX   PubMed=15208686;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6646 ! HMB-2
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   hMBL1.2
AC   CVCL_B0JY
SY   1.2
DR   Wikidata; Q108820480
RX   Patent=WO2000035483A1;
RX   PubMed=10793066;
RX   PubMed=11991814;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12619.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11226; Human MBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   hMC
AC   CVCL_9Q61
SY   human Myogenic Cell line
DR   Wikidata; Q54889905
RX   PubMed=25380573;
CC   Miscellaneous: Cell line name from personal communication of Trapecar, Martin.
CC   Derived from site: In situ; Semitendinosus tendon; UBERON=UBERON_8480009.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Somatic stem cell
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   HMC-1
AC   CVCL_0003
SY   HMC1
DR   BTO; BTO_0001669
DR   MCCL; MCC:0000199
DR   BioSample; SAMN03473342
DR   cancercelllines; CVCL_0003
DR   ChEMBL-Cells; CHEMBL4295401
DR   ChEMBL-Targets; CHEMBL4296432
DR   Cosmic; 821806
DR   Cosmic; 821913
DR   Cosmic; 822147
DR   Cosmic; 1122161
DR   DSMZ; ACC-283
DR   DSMZCellDive; ACC-283
DR   GEO; GSM7701425
DR   GEO; GSM7701438
DR   Lonza; 502
DR   PubChem_Cell_line; CVCL_0003
DR   TOKU-E; 3534
DR   Wikidata; Q54889906
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3131594;
RX   PubMed=7691885;
RX   PubMed=8191224;
RX   PubMed=8950460;
RX   PubMed=16957166;
RX   PubMed=25149487;
WW   Info; CIL; 50934; https://www.cellimagelibrary.org/groups/50934
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: 3-4 days (PubMed=3131594).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560Gly (c.1679T>G); ClinVar=VCV000375916; Zygosity=Heterozygous (PubMed=7691885).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=7691885).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: DSMZ; ACC-283; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
ST   Source(s): DSMZ=ACC-283
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D18S51: 14,20
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 18,20
ST   Penta D: 11
ST   Penta E: 9,19
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3169; Mast cell leukemia
DI   ORDO; Orphanet_98851; Mast cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   HMC-1 5C6
AC   CVCL_4T80
SY   HMC-1(5C6); HMC1-5C6; 5C6
DR   cancercelllines; CVCL_4T80
DR   Wikidata; Q54889907
RX   PubMed=8950460;
RX   PubMed=22363102;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560Gly (c.1679T>G); ClinVar=VCV000375916; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
DI   NCIt; C3169; Mast cell leukemia
DI   ORDO; Orphanet_98851; Mast cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0003 ! HMC-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   HMC-1-8
AC   CVCL_2949
SY   HMC18
DR   CLO; CLO_0037257
DR   EFO; EFO_0022456
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 656
DR   BioSample; SAMN03470817
DR   BioSample; SAMN10987868
DR   cancercelllines; CVCL_2949
DR   Cell_Model_Passport; SIDM01622
DR   DepMap; ACH-000721
DR   IARC_TP53; 28374
DR   JCRB; FDSC0048
DR   JCRB; JCRB0166
DR   LiGeA; CCLE_562
DR   PharmacoDB; HMC18_552_2019
DR   Progenetix; CVCL_2949
DR   SLKBase; 3552
DR   Wikidata; Q54889908
RX   DOI=10.15114/tr.22.27;
RX   PubMed=3488124;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 26 hours (DOI=10.15114/tr.22.27).
CC   HLA typing: A*24:02,31:01; B*07:13,35:08; C*01:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (DepMap=ACH-000721).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (DepMap=ACH-000721).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.08%; East Asian, South=16.92%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0048; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB0166
ST   Amelogenin: X
ST   CSF1PO: 7,12
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H204 ! TcHMC-1
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HMC-1.1
AC   CVCL_H206
SY   HMC-1_1; HMC1.1; HMC-1(560); HMC-1-560
DR   cancercelllines; CVCL_H206
DR   Cosmic; 819947
DR   Cosmic; 1476309
DR   Cosmic; 1476421
DR   Cosmic; 1498491
DR   GEO; GSM6674134
DR   GEO; GSM6674135
DR   GEO; GSM6674136
DR   Millipore; SCC067
DR   Wikidata; Q54889909
RX   PubMed=11861291;
RX   PubMed=12519307;
RX   PubMed=20814942;
RX   PubMed=25149487;
RX   PubMed=37025992;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560Gly (c.1679T>G); ClinVar=VCV000375916; Zygosity=Heterozygous (PubMed=12519307).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
ST   Source(s): Millipore=SCC067
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 14,20
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 18,20
ST   Penta D: 11
ST   Penta E: 9,19
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3169; Mast cell leukemia
DI   ORDO; Orphanet_98851; Mast cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0003 ! HMC-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   HMC-1.2
AC   CVCL_H205
SY   HMC-1_2; HMC1_2; HMC1.2; HMC-1(560,816); HMC-1-560_816
DR   cancercelllines; CVCL_H205
DR   Cosmic; 819945
DR   Cosmic; 1476310
DR   Cosmic; 1476422
DR   Cosmic; 1498492
DR   GEO; GSM6674137
DR   GEO; GSM6674138
DR   GEO; GSM6674139
DR   Millipore; SCC062
DR   Wikidata; Q54889910
RX   DOI=10.57844/arcadia-3207-4695;
RX   PubMed=11861291;
RX   PubMed=12519307;
RX   PubMed=20814942;
RX   PubMed=25149487;
RX   PubMed=37025992;
WW   Info; protocols.io; -; https://dx.doi.org/10.17504/protocols.io.261ger8xwl47/v1
CC   Characteristics: Compound 48/80 which is used to promote mast cell degranulation is toxic to this cell line (DOI=10.57844/arcadia-3207-4695).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560Gly (c.1679T>G); ClinVar=VCV000375916; Zygosity=Heterozygous (PubMed=12519307).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=12519307).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
ST   Source(s): Millipore=SCC062
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 14,20
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 18,20
ST   Penta D: 11
ST   Penta E: 9,19
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3169; Mast cell leukemia
DI   ORDO; Orphanet_98851; Mast cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0003 ! HMC-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   HMC-1.3 clone 1H9
AC   CVCL_E8DV
DR   ABM; T8388
DR   GEO; GSM6674143
DR   GEO; GSM6674144
DR   GEO; GSM6674145
RX   PubMed=37025992;
CC   Characteristics: Compared to the parent cell line has reduced activity in pathways involved in survival, cell-to-cell adhesion, and neoplasia with differences in expression of molecular components and cell surface markers (PubMed=37025992).
CC   Characteristics: Produces significantly smaller tumors than the parent cell line when subcutaneously inoculated in mice (PubMed=37025992).
CC   Doubling time: 24 hours (ABM=T8388).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple_corrected; p.Val560Gly (c.1679T>G); ClinVar=VCV000375916; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37025992).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=37025992).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
DI   NCIt; C3169; Mast cell leukemia
DI   ORDO; Orphanet_98851; Mast cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H205 ! HMC-1.2
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HMC-1.3 clone 2E2
AC   CVCL_E8DW
DR   ABM; T8389
DR   GEO; GSM6674140
DR   GEO; GSM6674141
DR   GEO; GSM6674142
RX   PubMed=37025992;
CC   Characteristics: Compared to the parent cell line has reduced activity in pathways involved in survival, cell-to-cell adhesion, and neoplasia with differences in expression of molecular components and cell surface markers (PubMed=37025992).
CC   Characteristics: Produces significantly smaller tumors than the parent cell line when subcutaneously inoculated in mice (PubMed=37025992).
CC   Doubling time: 36-48 hours (ABM=T8389).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple_corrected; p.Val560Gly (c.1679T>G); ClinVar=VCV000375916; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37025992).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=37025992).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
DI   NCIt; C3169; Mast cell leukemia
DI   ORDO; Orphanet_98851; Mast cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H205 ! HMC-1.2
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HMC-2-1
AC   CVCL_WW77
DR   Wikidata; Q94212938
RX   DOI=10.15114/tr.22.27;
CC   Population: Japanese.
CC   Doubling time: 22 hours (DOI=10.15114/tr.22.27).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   HMC3
AC   CVCL_II76
SY   Human Microglia Clone 3; CHME-3; CHME3
DR   ATCC; CRL-3304
DR   CLS; 300102
DR   Ubigene; YC-C131
DR   Wikidata; Q54889911
RX   PubMed=7478261;
RX   PubMed=16371321;
RX   PubMed=20375612;
RX   PubMed=30200996;
RX   PubMed=35352315;
CC   Virology: Susceptible to infection by Chikungunya virus. Supports viral replication with no signifcant loss in cell viability until 72 hours post infection (PubMed=35352315).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
ST   Source(s): ATCC=CRL-3304; CLS=300102
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 16,21
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 15,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 17,25
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 10,14
ST   Penta E: 7,13
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   8-10FW
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   HMCa
AC   CVCL_B402
SY   Human Medullary Carcinoma
DR   Wikidata; Q54889912
RX   PubMed=2891216;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=2891216).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   HMCB
AC   CVCL_3317
SY   Human Melanoma Cell Bowes; Bowes melanoma cells; BOWES
DR   BTO; BTO_0001998
DR   CLO; CLO_0003785
DR   EFO; EFO_0002195
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-9607
DR   BioSample; SAMN10988240
DR   cancercelllines; CVCL_3317
DR   Cell_Model_Passport; SIDM00914
DR   ChEMBL-Cells; CHEMBL3308385
DR   ChEMBL-Targets; CHEMBL614824
DR   Cosmic; 724822
DR   DepMap; ACH-000931
DR   GEO; GSM827473
DR   GEO; GSM887087
DR   GEO; GSM888157
DR   IARC_TP53; 21374
DR   IGRhCellID; HMCB
DR   LiGeA; CCLE_295
DR   NCBI_Iran; C524
DR   PharmacoDB; HMCB_553_2019
DR   Progenetix; CVCL_3317
DR   PubChem_Cell_line; CVCL_3317
DR   Wikidata; Q54889913
RX   Patent=US5010002;
RX   PubMed=1970678;
RX   PubMed=12068308;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-379.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-109.html
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9607.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07:02,57:01; C*06:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (DepMap=ACH-000931).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (DepMap=ACH-000931).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.21%; Native American=0%; East Asian, North=1.87%; East Asian, South=0%; South Asian=0%; European, North=63.92%; European, South=33.99% (PubMed=30894373).
CC   Anecdotal: The Bowes cell line is famous for its use in the identification and purification of tissue-type plasminogen activator, tPA.
CC   Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
ST   Source(s): ATCC=CRL-9607
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 11,12
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 10,13
ST   FGA: 23,25
ST   Penta D: 12,14
ST   Penta E: 10,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   HMCL-7304
AC   CVCL_T053
DR   Wikidata; Q54889914
RX   PubMed=23905709;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   HMCL-I
AC   CVCL_F1B4
SY   Human Muller Cell Line-I
RX   PubMed=17251490;
RX   PubMed=17962478;
CC   Doubling time: 76 hours (PubMed=17251490).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HMCL-II
AC   CVCL_F1B5
SY   Human Muller Cell Line-II
RX   PubMed=17251490;
RX   PubMed=17962478;
CC   Doubling time: 39 hours (PubMed=17251490).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HME348
AC   CVCL_VG05
DR   Wikidata; Q54889915
RX   PubMed=16541310;
CC   Senescence: Senesces at 65 PDL.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr2215Serfs*13 (c.6644_6647delACTC) (6872del4); ClinVar=VCV000038060; Zygosity=Heterozygous (PubMed=16541310).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   HME348 cdk4
AC   CVCL_VG06
SY   HME348cdk4; 348hTERT
DR   Wikidata; Q54889916
RX   PubMed=16541310;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr2215Serfs*13 (c.6644_6647delACTC) (6872del4); ClinVar=VCV000038060; Zygosity=Heterozygous (PubMed=16541310).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VG05 ! HME348
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   HME348 cdk4/hTERT
AC   CVCL_VG08
SY   348cdk4hTERT
DR   Wikidata; Q54889919
RX   PubMed=16541310;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr2215Serfs*13 (c.6644_6647delACTC) (6872del4); ClinVar=VCV000038060; Zygosity=Heterozygous (PubMed=16541310).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VG06 ! HME348 cdk4
SX   Female
AG   44Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   HME348 hTERT
AC   CVCL_VG07
SY   HME348hTERT
DR   Wikidata; Q54889920
RX   PubMed=16541310;
RX   PubMed=22019625;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr2215Serfs*13 (c.6644_6647delACTC) (6872del4); ClinVar=VCV000038060; Zygosity=Heterozygous (PubMed=16541310).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VG05 ! HME348
SX   Female
AG   44Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   HME50
AC   CVCL_C7T1
DR   GEO; GSM383844
DR   GEO; GSM384086
DR   Wikidata; Q117704485
RX   PubMed=7799951;
RX   PubMed=17968319;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (PubMed=7799951).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7T2 ! HMS50
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   HME50-3
AC   CVCL_C7ST
DR   Wikidata; Q117704486
RX   PubMed=7799951;
RX   PubMed=17968319;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T1 ! HME50
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HME50-5
AC   CVCL_C7SU
DR   Wikidata; Q117704487
RX   PubMed=7799951;
RX   PubMed=17968319;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T1 ! HME50
SX   Female
AG   31Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HME50-6
AC   CVCL_C7SV
DR   Wikidata; Q117704488
RX   PubMed=7799951;
RX   PubMed=17968319;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T1 ! HME50
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HME50-7
AC   CVCL_C7SW
DR   Wikidata; Q117704489
RX   PubMed=7799951;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T1 ! HME50
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HME50-8
AC   CVCL_C7SX
DR   Wikidata; Q117704490
RX   PubMed=7799951;
RX   PubMed=17968319;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T1 ! HME50
SX   Female
AG   31Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HME50-8R
AC   CVCL_C7T3
DR   Wikidata; Q117704491
RX   PubMed=17968319;
CC   Characteristics: Treated with resveratrol (PubMed=17968319).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7SX ! HME50-8
SX   Female
AG   31Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HME50-9
AC   CVCL_C7SY
DR   Wikidata; Q117704492
RX   PubMed=7799951;
RX   PubMed=17968319;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (PubMed=7799951).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T1 ! HME50
SX   Female
AG   31Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HME50-9R
AC   CVCL_C7T4
DR   Wikidata; Q117704493
RX   PubMed=17968319;
CC   Characteristics: Treated with resveratrol (PubMed=17968319).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7SX ! HME50-8
SX   Female
AG   31Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   HMEC 2.6
AC   CVCL_B0CI
SY   HMEC2.6
DR   ABM; T0454
DR   Wikidata; Q108820481
RX   PubMed=29022488;
CC   Doubling time: ~3 days (PubMed=29022488).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Donor information: Established from a patient undergoing reduction mammoplasty with no known breast pathology (PubMed=29022488).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   HMEC-1
AC   CVCL_0307
SY   Hmec-1; HMEC1; CDC/EU.HMEC-1; Human Microvascular Endothelial Cell line-1
DR   BTO; BTO_0002828
DR   EFO; EFO_0005383
DR   MCCL; MCC:0000200
DR   ATCC; CRL-3243
DR   ChEMBL-Cells; CHEMBL4295409
DR   ChEMBL-Targets; CHEMBL4296433
DR   CLS; 304064
DR   Lonza; 736
DR   PubChem_Cell_line; CVCL_0307
DR   Wikidata; Q54889921
RX   Patent=WO1992017569A1;
RX   PubMed=1361507;
RX   PubMed=12453433;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-159.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10636.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVT).
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): ATCC=CRL-3243
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   HMEC-1330
AC   CVCL_UW69
SY   HMEC 1330; HMEC1330; N1330 HMEC
DR   BTO; BTO_0004434
DR   Wikidata; Q94213018
RX   PubMed=17440060;
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HMEEC-1
AC   CVCL_0E44
SY   HEI-HMEEC-1; HEI-HMEEC; Human Middle Ear Epithelial Cell line-1
DR   ATCC; CRL-13012
DR   BioSample; SAMN03471351
DR   Wikidata; Q54889922
RX   Patent=US6358688;
RX   PubMed=12090706;
RX   PubMed=21901615;
RX   PubMed=32433794;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-81.
CC   Doubling time: 23.8 hours (PubMed=12090706).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-13012; true.
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-13012
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   HMEL
AC   CVCL_IZ34
DR   BioSample; SAMN10988390
DR   Cell_Model_Passport; SIDM01708
DR   DepMap; ACH-000642
DR   PharmacoDB; HMEL_554_2019
DR   Progenetix; CVCL_IZ34
DR   Wikidata; Q54889923
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=74.68%; Native American=1.37%; East Asian, North=1.09%; East Asian, South=0%; South Asian=0%; European, North=12.54%; European, South=10.33% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   Hmel-p16-1
AC   CVCL_VS14
SY   Human melanocytes lacking p16-1
DR   Wikidata; Q94213050
RX   PubMed=12759390;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala76Cysfs*64 (c.225_243del19) (p.Arg90Valfs*76, c.268_286del19) (p16-Leiden); ClinVar=VCV000182411; Zygosity=Homozygous (PubMed=12759390).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   Hmel-p16-2
AC   CVCL_VS15
SY   Human melanocytes lacking p16-2
DR   Wikidata; Q94213052
RX   PubMed=12759390;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met53Thr (c.158T>C); ClinVar=VCV001480737; Zygosity=Heterozygous (PubMed=12759390).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp108Asn (c.322G>A) (p.Arg122Gln, c.365G>A); ClinVar=VCV000216275; Zygosity=Heterozygous (PubMed=12759390).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS16 ! Q34
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   hmel1
AC   CVCL_D722
SY   Hmel1; Hmel-1
DR   cancercelllines; CVCL_D722
DR   Cosmic; 1676366
DR   Cosmic; 2051675
DR   Wikidata; Q54889924
RX   DOI=10.1186/1479-5876-12-S1-P7;
RX   PubMed=21880213;
RX   PubMed=23489693;
RX   PubMed=25623468;
RX   PubMed=27540956;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=21880213; PubMed=23489693).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Trp383Cys (c.1149G>T); Zygosity=Unspecified (PubMed=23489693).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   hmel1R
AC   CVCL_A2GA
SY   Hmel1R; Hmel-1R
DR   cancercelllines; CVCL_A2GA
DR   Wikidata; Q105507686
RX   DOI=10.1186/1479-5876-12-S1-P7;
RX   PubMed=25623468;
CC   Population: Caucasian; Italian.
CC   Selected for resistance to: ChEBI; CHEBI_91367; Barasertib-HQPA (AZD1152-HQPA).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Trp383Cys (c.1149G>T); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D722 ! hmel1
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   hmel11
AC   CVCL_M576
DR   cancercelllines; CVCL_M576
DR   Cosmic; 2051677
DR   Wikidata; Q54889925
RX   PubMed=23489693;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (PubMed=23489693).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   hmel9
AC   CVCL_D723
DR   cancercelllines; CVCL_D723
DR   Cosmic; 1676367
DR   Cosmic; 2051676
DR   Wikidata; Q54889926
RX   PubMed=21880213;
RX   PubMed=23489693;
RX   PubMed=27540956;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Homozygous (PubMed=21880213; PubMed=23489693).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   HMF3A
AC   CVCL_4U96
DR   Wikidata; Q54889927
RX   PubMed=11209060;
RX   PubMed=15574883;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U97 ! HMF3B
OI   CVCL_4U98 ! HMF3C
OI   CVCL_4U99 ! HMF3D
OI   CVCL_4V00 ! HMF3Dwt
SX   Female
AG   19Y
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   HMF3B
AC   CVCL_4U97
DR   Wikidata; Q54889928
RX   PubMed=11209060;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U96 ! HMF3A
OI   CVCL_4U98 ! HMF3C
OI   CVCL_4U99 ! HMF3D
OI   CVCL_4V00 ! HMF3Dwt
SX   Female
AG   19Y
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HMF3C
AC   CVCL_4U98
DR   Wikidata; Q54889929
RX   PubMed=11209060;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U96 ! HMF3A
OI   CVCL_4U97 ! HMF3B
OI   CVCL_4U99 ! HMF3D
OI   CVCL_4V00 ! HMF3Dwt
SX   Female
AG   19Y
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HMF3D
AC   CVCL_4U99
DR   Wikidata; Q54889930
RX   PubMed=11209060;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U96 ! HMF3A
OI   CVCL_4U97 ! HMF3B
OI   CVCL_4U98 ! HMF3C
OI   CVCL_4V00 ! HMF3Dwt
SX   Female
AG   19Y
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HMF3Dwt
AC   CVCL_4V00
DR   Wikidata; Q54889931
RX   PubMed=15574883;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U96 ! HMF3A
OI   CVCL_4U97 ! HMF3B
OI   CVCL_4U98 ! HMF3C
OI   CVCL_4U99 ! HMF3D
SX   Female
AG   19Y
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HMG
AC   CVCL_W288
SY   Human malignant Melanoma Gingiva origin
DR   Wikidata; Q54889932
RX   PubMed=6807872;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=6807872).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   HMGEC
AC   CVCL_VF64
SY   IHMGEC; Human Meibomian Gland Epithelial Cells
DR   ATCC; CRL-3472
DR   Wikidata; Q54889933
RX   PubMed=20335607;
RX   PubMed=26042605;
RX   PubMed=28363775;
RX   PubMed=29625457;
RX   PubMed=29787296;
CC   Doubling time: 27.39 hours (PubMed=20335607); ~3-7 days (ATCC=CRL-3472).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Meibomian gland; UBERON=UBERON_0001818.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=29787296
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,14
ST   D16S539: 8,11
ST   D18S51: 12,16
ST   D21S11: 29,30.2
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   Penta D: 8,12
ST   Penta E: 5,14
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   HMGUi001-A
AC   CVCL_WJ49
SY   XM001; BIHi043-A
DR   BioSamples; SAMEA5727779
DR   GEO; GSM2850662
DR   GEO; GSM2850663
DR   hPSCreg; HMGUi001-A
DR   Wikidata; Q94213145
RX   PubMed=29396371;
RX   PubMed=32361463;
RX   PubMed=32544857;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HMGUi001-A-1
AC   CVCL_WJ50
SY   HMGUi001-A hINS-T2A-H2B-Cherry (+/-)
DR   BioSamples; SAMEA5696687
DR   hPSCreg; HMGUi001-A-1
DR   Wikidata; Q94213147
RX   PubMed=32361463;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a T2A-H2B-Cherry construct was integrated in one allele of INS exon 3 (PubMed=32361463).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ49 ! HMGUi001-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   HMGUi001-A-2
AC   CVCL_ZA40
SY   iXM001Cas9v1 Clone 10; BIHi043-A-1; BIHi268-A-2
DR   hPSCreg; HMGUi001-A-2
DR   Wikidata; Q98126690
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ49 ! HMGUi001-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   HMGUi001-A-22
AC   CVCL_D6KM
SY   NCS1-KO Clone 19; MDCi053-A-22
DR   BioSamples; SAMEA114562334
DR   hPSCreg; HMGUi001-A-22
DR   Wikidata; Q127381778
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3953; NCS1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ49 ! HMGUi001-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HMGUi001-A-3
AC   CVCL_A9YJ
SY   iXM001Cas9v5c bid.Prom.RFP Clone 16; BIHi043-A-2; BIHi268-A-3
DR   hPSCreg; HMGUi001-A-3
DR   Wikidata; Q102114127
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ49 ! HMGUi001-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   HMGUi001-A-4
AC   CVCL_ZZ82
SY   hiPSC-ARX-T2A-H2B-CFP-Flag; IDRi002-A-4
DR   BioSamples; SAMEA7002448
DR   hPSCreg; HMGUi001-A-4
DR   Wikidata; Q102114128
RX   PubMed=32544857;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a T2A-H2B-CFP-FLAG construct was integrated at the C-terminus of both alleles of ARX (PubMed=32544857).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:4761; H2BC11.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ49 ! HMGUi001-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 12
//
ID   HMGUi001-A-5
AC   CVCL_ZW13
SY   DeltaINK4 T2D risk region hiPSC; IDRi002-A-5
DR   BioSamples; SAMEA7178021
DR   hPSCreg; HMGUi001-A-5
DR   Wikidata; Q102114129
RX   PubMed=32739881;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a large non-coding genomic DNA at INK4 locus was homozygously deleted (PubMed=32739881).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ49 ! HMGUi001-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   HMGUi001-A-8
AC   CVCL_A1DA
SY   C-PEP-mCherry-hiPSC; C-peptide-mCherry-hiPSC; IDRi002-A-8
DR   BioSamples; SAMEA7249858
DR   hPSCreg; HMGUi001-A-8
DR   Wikidata; Q102114130
RX   PubMed=33373890;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a mCherry construct was fused to the C-terminus of INS C-peptide in one allele (PubMed=33373890).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ49 ! HMGUi001-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   HMGUi002-A
AC   CVCL_XC36
SY   XM002
DR   BioSamples; SAMEA5945657
DR   hPSCreg; HMGUi002-A
DR   Wikidata; Q94213151
RX   PubMed=31419739;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   HMGUi003-A
AC   CVCL_C0HS
SY   95595; PPCS-Cl2
DR   BioSamples; SAMEA11371739
DR   hPSCreg; HMGUi003-A
DR   Wikidata; Q112929733
RX   PubMed=35397396;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:25686; PPCS; Simple; p.Pro107_Ala111del (c.320_334del); ClinVar=VCV000590784; Zygosity=Heterozygous (PubMed=35397396).
CC   Sequence variation: Mutation; HGNC; HGNC:25686; PPCS; Simple; p.Ala180Pro (c.538G>C); ClinVar=VCV000590783; Zygosity=Heterozygous (PubMed=35397396).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C186785; Dilated cardiomyopathy-2C
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   HMGUi004-A
AC   CVCL_C9D6
SY   106300
DR   BioSamples; SAMEA113476113
DR   hPSCreg; HMGUi004-A
DR   Wikidata; Q123031678
RX   PubMed=37689041;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:25443; C19orf12; Simple; p.Gly54Val (c.161G>T); ClinVar=VCV000402183; Zygosity=Homozygous (PubMed=37689041).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175707; Neurodegeneration with brain iron accumulation 4
DI   ORDO; Orphanet_289560; Mitochondrial membrane protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HMKOA
AC   CVCL_X938
DR   CGH-DB; 345-2
DR   CGH-DB; 9350-4
DR   Wikidata; Q54889934
RX   CelloPub=CLPUB00154;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   HML
AC   CVCL_RL96
DR   Wikidata; Q54889935
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9444944;
RX   PubMed=9488639;
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HML-1
AC   CVCL_A8KB
DR   Wikidata; Q108820482
RX   PubMed=1730254;
RX   PubMed=3498635;
RX   PubMed=7522169;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103.
CC   Monoclonal antibody target: UniProtKB; P26010; Human ITGB7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HML-2 [Human leukemia]
AC   CVCL_RL97
DR   Cosmic; 787434
DR   Wikidata; Q54889936
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9444944;
CC   Population: Japanese.
CC   Characteristics: CSF2 and KITLG dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL96 ! HML
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   HML-2 [Mouse hybridoma against human ITGAE/ITGB7]
AC   CVCL_A8KC
SY   F3F7
DR   Wikidata; Q108820483
RX   PubMed=1730254;
RX   PubMed=7522169;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103.
CC   Monoclonal antibody target: UniProtKB; P26010; Human ITGB7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HML-3
AC   CVCL_A8KD
SY   F4F1
DR   Wikidata; Q108820484
RX   PubMed=1730254;
RX   PubMed=7522169;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103.
CC   Monoclonal antibody target: UniProtKB; P26010; Human ITGB7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HML-4
AC   CVCL_A8KE
SY   6E7
DR   Wikidata; Q108820485
RX   PubMed=7522169;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103.
CC   Monoclonal antibody target: UniProtKB; P26010; Human ITGB7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HML-5
AC   CVCL_A8KF
SY   7C8
DR   Wikidata; Q108820486
RX   PubMed=7522169;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103.
CC   Monoclonal antibody target: UniProtKB; P26010; Human ITGB7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HML-Gb3
AC   CVCL_U968
DR   BTO; BTO_0004898
DR   Wikidata; Q54889937
RX   PubMed=19674101;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18149; A4GALT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   HML/SE
AC   CVCL_RL98
DR   Wikidata; Q54889938
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9642254;
CC   Population: Japanese.
CC   Characteristics: CSF2 and KITLG dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL96 ! HML
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HmLu-1
AC   CVCL_E3B0
SY   Hmlu1
RX   CelloPub=CLPUB00778;
RX   PubMed=1186910;
RX   PubMed=1368677;
CC   Characteristics: Tumorigenic (CelloPub=CLPUB00778).
CC   Virology: Susceptible to infection by Akabane virus OBE-1, bovine ephemeral fever virus (BEFV), Ibaraki virus No.2 and Chuzan virus K-478 (PubMed=1368677).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Mixed sex
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HmLu-2
AC   CVCL_E3FL
RX   CelloPub=CLPUB00778;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Mixed sex
AG   5D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HMMA2.11TG/0
AC   CVCL_VG39
SY   HMMA2.11TG/O; HMMA 2.11TG/0
DR   Wikidata; Q54889939
RX   PubMed=3436625;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Does not secretes IgG, IgM, nor IgA immunoglobulins (PubMed=3436625).
CC   Doubling time: 20-26 hours (PubMed=3436625).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 6
//
ID   HMMA2.5
AC   CVCL_VG40
DR   Wikidata; Q54889940
RX   PubMed=18514220;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Subclone of the parent cell line that was selected by passaging the line in 6-thioguanosine, cloning by limiting dilution and selecting a clone with optimal fusion efficiency (PubMed=18514220).
CC   Characteristics: Does not secretes IgG, IgM, nor IgA immunoglobulins (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VG39 ! HMMA2.11TG/0
CA   Hybrid cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 5
//
ID   HMME7
AC   CVCL_E3FD
RX   PubMed=11209060;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mammary microvascular endothelial cell; CL=CL_2000071.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Conditionally immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HMMME
AC   CVCL_8163
DR   CLO; CLO_0050866
DR   BioSample; SAMN03472184
DR   Cosmic; 1481547
DR   RCB; RCB0819
DR   Wikidata; Q47478630
RX   PubMed=9573483;
RX   PubMed=15147043;
RX   PubMed=18667024;
RX   PubMed=25902174;
CC   Population: Japanese.
CC   Doubling time: 45 hours (Note=At 20th passage), 42 hours (Note=At 50th passage) (PubMed=15147043).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB0819
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 9
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W379 ! HMMMF
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   HMMMF
AC   CVCL_W379
DR   Wikidata; Q47478704
RX   PubMed=18667024;
CC   Population: Japanese.
CC   Doubling time: ~62 hours (PubMed=18667024).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8163 ! HMMME
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   HMN-1
AC   CVCL_U508
SY   HMN 1; HMN1; Hybrid Motor Neuron-1; MN1; 2F1.10.14
DR   EFO; EFO_0007601
DR   ENCODE; ENCBS258GWZ
DR   ENCODE; ENCBS389RBU
DR   ENCODE; ENCBS861BIB
DR   ENCODE; ENCBS880XXF
DR   Wikidata; Q54889942
RX   PubMed=1751804;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-184.html
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   HMO6
AC   CVCL_5G94
SY   HMO6.A1; HM06.A1
DR   GEO; GSE28642
DR   Wikidata; Q54889943
RX   Patent=US6780641;
RX   PubMed=11741401;
RX   PubMed=15957187;
RX   PubMed=22651808;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Human_Microglia_Cell_Line
CC   Group: Patented cell line.
CC   Doubling time: 34.5 hours (PubMed=11741401).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   HMOA
AC   CVCL_A610
DR   CGH-DB; 380-2
DR   CGH-DB; 9348-4
DR   Cosmic; 877483
DR   Cosmic; 1152563
DR   Wikidata; Q54889944
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3593088;
RX   PubMed=3732924;
RX   PubMed=9436037;
RX   PubMed=10457904;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=3593088).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   HMOCC-1
AC   CVCL_F0KX
SY   Human Monoclonal antibody for Ovarian Clear cell Carcinoma-1
RX   PubMed=15491748;
RX   PubMed=22194598;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Disulfated oligosaccharide SO(3)->3Gal(beta1)->4GlcNAc(beta1)-3(+-SO(3)->6)Gal(beta1)-4GlcNAc(beta1).
CC   Miscellaneous: As the immunized splenic B-cells are from KM mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HMOS-1
AC   CVCL_A2BF
SY   Human Mandibular OsteoSarcoma-1
DR   Wikidata; Q105507690
RX   PubMed=9307724;
CC   Population: Japanese.
CC   Doubling time: 18 hours (PubMed=9307724).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HMOS-A
AC   CVCL_6E82
SY   Human Multicentric OsteoSarcoma-Anterior lesion
DR   Wikidata; Q54889945
RX   DOI=10.11418/jtca.27.161;
RX   PubMed=20440512;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone, left ilium; UBERON=UBERON_0001273.
DI   NCIt; C6470; Multifocal osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E83 ! HMOS-P
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HMOS-P
AC   CVCL_6E83
SY   Human Multicentric OsteoSarcoma-Posterior lesion
DR   Wikidata; Q54889946
RX   DOI=10.11418/jtca.27.161;
RX   PubMed=20440512;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C6470; Multifocal osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E82 ! HMOS-A
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HMP1-LE
AC   CVCL_F0XH
SY   Hanemann Meningioma Primary 1 - LE
CC   Characteristics: Does not express NF2 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ile391Met (c.1173A>G); ClinVar=VCV000135038; Zygosity=Heterozygous (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Miscellaneous: Cell line information from personal communication of de Assis, Leandro Jose.
CC   Derived from site: In situ; Brain, subarachnoid space; UBERON=UBERON_0039175.
DI   NCIt; C4331; Psammomatous meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   hMPL-32D
AC   CVCL_D6I2
DR   Wikidata; Q127381779
RX   PubMed=32417303;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7217; MPL (Note=With a N-terminal HA tag).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6G54 ! 32Dcl23
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HMPOS
AC   CVCL_L355
SY   Highly Metastasizing POS cells
DR   BTO; BTO_0005369
DR   GEO; GSM1974790
DR   PRIDE; PXD008986
DR   Wikidata; Q54889947
RX   PubMed=10342286;
RX   PubMed=21801068;
RX   PubMed=23758893;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
RX   PubMed=31959767;
RX   PubMed=33446089;
RX   PubMed=36099278;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 20 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Arg164His (c.491G>A); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235,239
ST   Dog FHC2054: 151,156
ST   Dog FHC2079: 275
ST   Dog PEZ1: 111,123
ST   Dog PEZ3: 124,127
ST   Dog PEZ5: 103,107
ST   Dog PEZ6: 179
ST   Dog PEZ8: 232,240
ST   Dog PEZ12: 270,297
ST   Dog PEZ20: 172,184
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L413 ! POS [Dog osteosarcoma]
SX   Male
AG   1-2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 21
//
ID   HMR0921
AC   CVCL_ZF26
DR   Wikidata; Q98126691
RX   PubMed=8146983;
RX   PubMed=22246505;
CC   Monoclonal antibody isotype: IgG3, lambda.
CC   Monoclonal antibody target: UniProtKB; Q9UNQ0; Human ABCG2/CD338.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   HMR10-3
AC   CVCL_A5AY
DR   Wikidata; Q107115352
RX   PubMed=7820600;
CC   Characteristics: Grows at the permissive temperature (33 Celsius). Differentiates to a neuronal phenotype at the nonpermissive temperature (39 Celsius) (PubMed=7820600).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsa).
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Cell type: Hippocampal neuron; CL=CL_0002608.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   HMS-1
AC   CVCL_UD56
DR   Wikidata; Q94213294
RX   PubMed=8606488;
RX   PubMed=8946227;
RX   PubMed=9815584;
CC   Doubling time: 24-36 hours (PubMed=8946227).
CC   Derived from site: In situ; Salivary gland, parotid gland, myoepithelium; UBERON=UBERON_0035076.
DI   NCIt; C5941; Parotid gland adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UD57 ! HMS-XC
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   HMS-3
AC   CVCL_UD59
DR   Wikidata; Q94213299
RX   PubMed=8946227;
RX   PubMed=9815584;
CC   Characteristics: Established from a ninth generation nude mouse xenograft (HMS-3X) of the original tumor.
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 3
//
ID   HMS-4
AC   CVCL_UD68
DR   Wikidata; Q94213304
RX   PubMed=8606488;
RX   PubMed=9815584;
CC   Characteristics: Established from a nude mouse xenograft (HMS-4X) of the original tumor.
DI   NCIt; C40395; Breast malignant myoepithelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   HMS-XC
AC   CVCL_UD57
DR   Wikidata; Q94213307
RX   PubMed=8946227;
CC   Characteristics: Established from a fifth generation nude mouse xenograft (HMS-X) of the original tumor.
CC   Derived from site: In situ; Salivary gland, parotid gland, myoepithelium; UBERON=UBERON_0035076.
DI   NCIt; C5941; Parotid gland adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UD56 ! HMS-1
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   HMS001
AC   CVCL_UH26
SY   HMS-001
DR   Wikidata; Q94213311
RX   PubMed=24201445;
RX   PubMed=29156801;
CC   Virology: Contains from 1 to 2 copies of the HPV16 genome (PubMed=24201445).
CC   Doubling time: 5 days (PubMed=29156801).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tonsil, tonsillar fossa; UBERON=UBERON_0035228.
ST   Source(s): PubMed=29156801
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   HMS50
AC   CVCL_C7T2
DR   Wikidata; Q117704494
RX   PubMed=7799951;
CC   Senescence: Capable of 40-50 PDL. One clone senesced at 68 PDL (PubMed=7799951).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (PubMed=7799951).
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7T1 ! HME50
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   HMS50-E6/E7-2
AC   CVCL_C7SZ
DR   Wikidata; Q117704495
RX   PubMed=7799951;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (PubMed=7799951).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T2 ! HMS50
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   HMS50-E7-5
AC   CVCL_C7T0
DR   Wikidata; Q117704496
RX   PubMed=7799951;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Thr (c.398T>C); ClinVar=VCV000012357; Zygosity=Heterozygous (PubMed=7799951).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Breast, interlobular stroma; UBERON=UBERON_8480033.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7T2 ! HMS50
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   hMSC-AT
AC   CVCL_Y509
DR   ENCODE; ENCBS457ENC
DR   ENCODE; ENCBS458ENC
DR   Wikidata; Q54889948
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/hMSCAT0102604.12_Gingeras_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Somatic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 8
//
ID   hMSC-BM
AC   CVCL_Y510
DR   ENCODE; ENCBS459ENC
DR   ENCODE; ENCBS460ENC
DR   Wikidata; Q54889957
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/hMSCBM0050602.11_Gingeras_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Somatic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 8
//
ID   hMSC-hTERT
AC   CVCL_A2JN
SY   human Mesenchymal Stem Cells-hTERT-immortalized
DR   Wikidata; Q105507692
RX   PubMed=12150956;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2JP ! hMSC-hTERT-E6/E7
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   hMSC-hTERT-E6/E7
AC   CVCL_A2JP
SY   human Mesenchymal Stem Cells-hTERT-immortalized HPV16 E6/E7 transformed
DR   Wikidata; Q105507697
RX   PubMed=12150956;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2JN ! hMSC-hTERT
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   hMSC-TERT
AC   CVCL_Z015
DR   Wikidata; Q54889958
RX   PubMed=12042863;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
ID   hMSC-TERT2
AC   CVCL_Z016
DR   Wikidata; Q54889959
RX   PubMed=15596132;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z015 ! hMSC-TERT
SX   Male
AG   33Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
ID   hMSC-TERT20
AC   CVCL_Z018
SY   TERT20
DR   Wikidata; Q54889962
RX   PubMed=15596132;
RX   PubMed=18578522;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z015 ! hMSC-TERT
SX   Male
AG   33Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   hMSC-TERT4
AC   CVCL_Z017
DR   Wikidata; Q54889963
RX   PubMed=15596132;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z015 ! hMSC-TERT
SX   Male
AG   33Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
ID   hMSC-UC
AC   CVCL_Y483
DR   ENCODE; ENCBS461ENC
DR   ENCODE; ENCBS462ENC
DR   Wikidata; Q54889964
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/hMSCUC0081101.7_Gingeras_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Somatic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 8
//
ID   HMSC.AD
AC   CVCL_1D52
AS   CVCL_1D53
SY   HMSC-AD; HMSC.AD-100; HMSC.AD-500
DR   CLS; 300645
DR   Wikidata; Q54889949
WW   Provider; CET; CR1004-500; https://cet.bio/product/human-adipose-derived-mesenchymal-stem-cells/
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Somatic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   HMSC.AM
AC   CVCL_1D54
AS   CVCL_1D55
SY   HMSC-AM; HMSC.AM-100; HMSC.AM-500
DR   CLS; 300644
DR   Wikidata; Q54889951
WW   Provider; CET; CR1006-500; https://cet.bio/product/human-amniotic-membrane-derived-mesenchymal-stem-cells/
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Somatic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 9
//
ID   HMSC.BM
AC   CVCL_1D56
AS   CVCL_1D57
SY   HMSC-BM; HMSC.BM-100; HMSC.BM-500
DR   CLS; 300661
DR   CLS; 300665
DR   Wikidata; Q54889953
WW   Provider; CET; CR1005-500; https://cet.bio/product/human-bone-marrow-derived-mesenchymal-stem-cells/
CC   Discontinued: CLS; 300661; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Somatic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   HMSC.WJ
AC   CVCL_1D58
AS   CVCL_1D59
SY   HMSC-WJ; HMSC.WJ-100; HMSC.WJ-500
DR   CLS; 300685
DR   Wikidata; Q54889955
WW   Provider; CET; CR1019-500; https://cet.bio/product/human-whartons-jelly-derived-mesenchymal-stem-cells-wj-mscs/
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
CC   Cell type: Mesenchymal stem cell of Wharton's jelly; CL=CL_0002568.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Somatic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 9
//
ID   HMSc1
AC   CVCL_AX71
DR   Wikidata; Q54889965
RX   PubMed=22136931;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   HMSc2
AC   CVCL_AX72
DR   Wikidata; Q54889966
RX   PubMed=22136931;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   HMSCATi001-A
AC   CVCL_B0PR
DR   BioSamples; SAMEA9873209
DR   hPSCreg; HMSCATi001-A
DR   Wikidata; Q108820487
RX   PubMed=36113356;
CC   From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China.
CC   Population: Chinese.
CC   Misspelling: HMSCASTi001-A; PubMed=36113356; Note=In title of paper.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HMSCATi002-A
AC   CVCL_B0PS
DR   BioSamples; SAMEA9903725
DR   hPSCreg; HMSCATi002-A
DR   Wikidata; Q108820488
RX   PubMed=36099765;
CC   From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China.
CC   Population: Chinese.
CC   Misspelling: HMSCASTi002-A; PubMed=36099765; Note=In title of paper.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HMSCATi003-A
AC   CVCL_B0PT
DR   BioSamples; SAMEA9908054
DR   hPSCreg; HMSCATi003-A
DR   Wikidata; Q108820489
RX   PubMed=38820865;
CC   From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HMSCATi004-A
AC   CVCL_C1PW
SY   LHK-PD
DR   BioSamples; SAMEA14088256
DR   hPSCreg; HMSCATi004-A
DR   Wikidata; Q114311629
RX   PubMed=39405989;
CC   From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=39405989).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex2-4 del; Zygosity=Heterozygous (PubMed=39405989).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   HMSCATi005-A
AC   CVCL_C1PX
DR   BioSamples; SAMEA115169991
DR   hPSCreg; HMSCATi005-A
DR   Wikidata; Q114311631
CC   From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   HMSCATi006-A
AC   CVCL_E4GA
DR   BioSamples; SAMEA115633941
DR   hPSCreg; HMSCATi006-A
CC   From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147070; Developmental and epileptic encephalopathy 2
DI   ORDO; Orphanet_505652; CDKL5-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HMSCATi007-A
AC   CVCL_E4GB
DR   hPSCreg; HMSCATi007-A
CC   From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HMT-3522
AC   CVCL_6855
SY   HMT3522
DR   BTO; BTO_0003884
DR   Wikidata; Q54889967
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=3558253;
RX   PubMed=7495986;
RX   PubMed=7828152;
RX   PubMed=7982476;
CC   Population: Caucasian.
CC   Characteristics: EGF dependent.
CC   Donor information: Established from a nontumorigenic fibrocystic breast lesion (PubMed=3558253).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HMT-3522 S1
AC   CVCL_2499
SY   HMT-3522-S1; HMT3522 S1; HMT-3522S1; HMT3522S1; S1; S-1; HMT-3522/wt; HMEC S1
DR   BTO; BTO_0006484
DR   EFO; EFO_0001191
DR   ArrayExpress; E-TABM-244
DR   Cosmic; 889085
DR   ECACC; 98102210
DR   GEO; GSM200612
DR   GEO; GSM200739
DR   GEO; GSM200740
DR   GEO; GSM200741
DR   GEO; GSM200742
DR   GEO; GSM200743
DR   GEO; GSM1219374
DR   GEO; GSM1219375
DR   GEO; GSM1219376
DR   GEO; GSM1219377
DR   GEO; GSM1219378
DR   LINCS_HMS; 51119
DR   PharmacoDB; S1_1340_2019
DR   PRIDE; PXD000309
DR   Wikidata; Q54889968
RX   PubMed=7982476;
RX   PubMed=8616848;
RX   PubMed=16849555;
RX   PubMed=18316601;
RX   PubMed=18516279;
RX   PubMed=22414580;
RX   PubMed=24176112;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 40.14 hours (JWGray panel).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a nontumorigenic fibrocystic breast lesion (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6855 ! HMT-3522
SX   Female
AG   50Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   HMT-3522 S2
AC   CVCL_2500
SY   HMT-3522-S2; HMT-3522S2; HMT3522S2; S2; S-2; HMT-3522/gt-1; gt-1; HMT-3522/growth-transformed-1
DR   cancercelllines; CVCL_2500
DR   Cosmic; 889086
DR   Cosmic; 1066170
DR   ECACC; 98102211
DR   Wikidata; Q54889969
RX   PubMed=7982476;
RX   PubMed=8616848;
RX   PubMed=18316601;
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line by permanent ommission of EGF in culture medium.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Unspecified (PubMed=7982476).
CC   Donor information: Established from a nontumorigenic fibrocystic breast lesion (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
ST   Source(s): ECACC=98102211
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 9
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6855 ! HMT-3522
SX   Female
AG   50Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   HMT-3522 T4-2
AC   CVCL_2501
SY   T4-2; T4; HMT-3522/mt-1; mt-1; HMT-3522/massive tumor-1
DR   BTO; BTO_0006210
DR   ArrayExpress; E-TABM-244
DR   cancercelllines; CVCL_2501
DR   ECACC; 98102212
DR   GEO; GSM1172999
DR   GEO; GSM1219379
DR   GEO; GSM1219380
DR   GEO; GSM1219381
DR   GEO; GSM1219382
DR   GEO; GSM1219383
DR   GEO; GSM1219384
DR   GEO; GSM1219385
DR   GEO; GSM1219386
DR   GEO; GSM1219387
DR   GEO; GSM1219388
DR   GEO; GSM1219389
DR   GEO; GSM1219390
DR   GEO; GSM1219391
DR   GEO; GSM1219392
DR   GEO; GSM1219393
DR   GEO; GSM1219394
DR   GEO; GSM1219395
DR   GEO; GSM1219396
DR   GEO; GSM1219397
DR   LINCS_HMS; 51123
DR   PharmacoDB; T4_1558_2019
DR   Wikidata; Q54889970
RX   PubMed=8616848;
RX   PubMed=18316601;
RX   PubMed=18516279;
RX   PubMed=24176112;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 32.94 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Unspecified (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a nontumorigenic fibrocystic breast lesion (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
ST   Source(s): ECACC=98102212
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 8,9
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2500 ! HMT-3522 S2
SX   Female
AG   50Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   HMT-3909
AC   CVCL_6858
SY   HMT3909
DR   cancercelllines; CVCL_6858
DR   IARC_TP53; 4042
DR   Wikidata; Q54889971
RX   PubMed=2153455;
RX   PubMed=7786603;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (PubMed=7786603).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   HMT-3909S1
AC   CVCL_6856
SY   HMT-3909-S1; HMT-3909 S1; HMT3909S1; HMT-3909 subline S1
DR   cancercelllines; CVCL_6856
DR   Wikidata; Q54889972
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2153455;
RX   PubMed=7786603;
CC   Group: Serum/protein free medium cell line.
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Non-tumorigenic.
CC   Doubling time: 55 hours (PubMed=7786603).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (PubMed=7786603).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6858 ! HMT-3909
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HMT-3909S13
AC   CVCL_UW65
SY   HMT3909S13; HMT-3909/S13; HMT-3909 subline S13
DR   cancercelllines; CVCL_UW65
DR   Wikidata; Q94213575
RX   PubMed=11801722;
RX   PubMed=16807805;
RX   PubMed=22692575;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Appears to be a progenitor cell line. Produces myoepithelial cells at the stromal-epithelial junction in tumors generated in nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6857 ! HMT-3909S8
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HMT-3909S13 clone A4
AC   CVCL_UW66
SY   HMT3909S13 clone A4
DR   cancercelllines; CVCL_UW66
DR   Wikidata; Q94213578
RX   PubMed=22692575;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UW65 ! HMT-3909S13
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HMT-3909S13 clone G4
AC   CVCL_UW67
SY   HMT3909S13 clone G4
DR   cancercelllines; CVCL_UW67
DR   Wikidata; Q94213582
RX   PubMed=22692575;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UW65 ! HMT-3909S13
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HMT-3909S16
AC   CVCL_UW68
SY   HMT3909S16; HMT-3909 subline S16
DR   cancercelllines; CVCL_UW68
DR   Wikidata; Q94213584
RX   PubMed=11801722;
RX   PubMed=16807805;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Purified myoepithelial cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UW65 ! HMT-3909S13
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HMT-3909S8
AC   CVCL_6857
SY   HMT-3909-S8; HMT-3909 S8; HMT3909S8; HMT-3909 subline S8
DR   cancercelllines; CVCL_6857
DR   Wikidata; Q54889973
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2153455;
RX   PubMed=7786603;
CC   Group: Serum/protein free medium cell line.
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Tumorigenic.
CC   Doubling time: 38 hours (PubMed=7786603).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (PubMed=7786603).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6858 ! HMT-3909
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HMUi001-A
AC   CVCL_WU21
SY   HCSiPSCs
DR   hPSCreg; HMUi001-A
DR   Wikidata; Q94213597
RX   PubMed=31121475;
CC   From: Eye Hospital, Harbin Medical University; Harbin; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HMUi002-A
AC   CVCL_C1PY
SY   Han CCM1
DR   BioSamples; SAMEA12859073
DR   hPSCreg; HMUi002-A
DR   Wikidata; Q114311632
CC   From: Eye Hospital, Harbin Medical University; Harbin; China.
CC   Population: Chinese; Han.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   HMV-I
AC   CVCL_8233
SY   HMV-1
DR   BioSample; SAMN03151710
DR   CGH-DB; 9288-4
DR   ChEMBL-Cells; CHEMBL3308666
DR   ChEMBL-Targets; CHEMBL614825
DR   Cosmic; 874382
DR   Cosmic; 905202
DR   Cosmic; 1007154
DR   PubChem_Cell_line; CVCL_8233
DR   RCB; RCB0004
DR   TKG; TKG 0302
DR   Wikidata; Q54889974
RX   PubMed=3361142;
RX   PubMed=10508494;
RX   PubMed=11416159;
RX   PubMed=15467732;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from female 65 year old patient with vaginal melanoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00126.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0004; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=11416159; TKG=TKG 0302
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9
ST   D18S51: 16
ST   D21S11: 27,28
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   HMV-II
AC   CVCL_1282
SY   HMV-2; HMVII; Human Melanoma Vagina-II
DR   BTO; BTO_0002918
DR   CLO; CLO_0003786
DR   CLO; CLO_0050086
DR   CLDB; cl1700
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0316
DR   BioSample; SAMN03472908
DR   cancercelllines; CVCL_1282
DR   Cell_Model_Passport; SIDM00291
DR   CGH-DB; 9289-4
DR   ChEMBL-Cells; CHEMBL3308667
DR   ChEMBL-Targets; CHEMBL614826
DR   Cosmic; 688044
DR   Cosmic; 874383
DR   Cosmic; 905203
DR   Cosmic; 907058
DR   Cosmic; 1007155
DR   Cosmic; 1477417
DR   Cosmic; 2230117
DR   Cosmic-CLP; 907058
DR   DepMap; ACH-002040
DR   ECACC; 92042701
DR   EGA; EGAS00001000978
DR   GDSC; 907058
DR   GEO; GSM827367
DR   GEO; GSM1669886
DR   IARC_TP53; 21375
DR   LINCS_LDP; LCL-1285
DR   PharmacoDB; HMVII_555_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1282
DR   PubChem_Cell_line; CVCL_1282
DR   RCB; RCB0777
DR   RCB; RCB3685
DR   TKG; TKG 0318
DR   Wikidata; Q54889975
RX   CelloPub=CLPUB00585;
RX   PubMed=2166075;
RX   PubMed=3361142;
RX   PubMed=12068308;
RX   PubMed=15467732;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Pigmented.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Val (c.1406G>T); ClinVar=VCV000044803; Zygosity=Heterozygous (Cosmic-CLP=907058; DepMap=ACH-002040).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; PubMed=15467732; Cosmic-CLP=907058; DepMap=ACH-002040).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn268Ile (c.803A>T); Zygosity=Heterozygous (Cosmic-CLP=907058; DepMap=ACH-002040).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.4%; Native American=0%; East Asian, North=76.31%; East Asian, South=21.9%; South Asian=0.25%; European, North=0.78%; European, South=0.36% (PubMed=30894373).
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
ST   Source(s): Cosmic-CLP=907058; ECACC=92042701; PubMed=25877200; RCB=RCB0777; TKG=TKG 0318
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,14
ST   D8S1179: 10
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 5,21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C27394; Vaginal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   HMVC
AC   CVCL_S803
DR   Wikidata; Q54889977
RX   CelloPub=CLPUB00526;
RX   PubMed=12889856;
CC   Population: Japanese.
CC   Doubling time: 28-32 hours (PubMed=12889856).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HMY-1
AC   CVCL_2950
SY   HMY1
DR   EFO; EFO_0006582
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472869
DR   cancercelllines; CVCL_2950
DR   Cell_Model_Passport; SIDM01623
DR   CLS; 305145
DR   DepMap; ACH-001522
DR   EGA; EGAS00001000610
DR   JCRB; JCRB1018
DR   JCRB; NIHS0252
DR   PharmacoDB; HMY1_556_2019
DR   Wikidata; Q54889978
RX   PubMed=6239887;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=6239887).
CC   HLA typing: A*02:06,24:02; B*39:01,52:01; C*07:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001522).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0252; true.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): DepMap=ACH-001522; JCRB=JCRB1018; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 10
ST   D18S51: 14,17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,14
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 14
ST   Penta E: 17,20
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   HMY-2
AC   CVCL_D850
DR   Wikidata; Q54889979
RX   PubMed=6239887;
CC   Population: Japanese.
CC   Miscellaneous: Cell line has been lost (PubMed=6239887).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   HMy.2 B
AC   CVCL_8119
SY   LICR-Lon-HMy-2; LICR-LON-HMy2; LICR.LON.HMy2; Licr.Lon.Hmy2; LICRLON/My2; Hmy2; LICR-2
DR   CLS; 302008
DR   IPD-IMGT/HLA; 10744
DR   TKG; TKG 0221
DR   Wikidata; Q54889980
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   Patent=US4695538;
RX   PubMed=6350451;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=7140810;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (Patent=US4695538).
CC   HLA typing: A*02:01; B*35:03; C*04:01 (IPD-IMGT/HLA=10744).
CC   HLA typing: A*02:01:01,03:01:01; B*15:01:01,35:03:01; C*03:04:01,04:01:01; DPB1*03:01:01,04:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRB1*04:01:01,12:01:01 (CLS=302008).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302008; TKG=TKG 0221
ST   Amelogenin: X
ST   CSF1PO: 6,10
ST   D13S317: 11,13
ST   D16S539: 9,13 (TKG=TKG 0221)
ST   D16S539: 13 (CLS=302008)
ST   D18S51: 4,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,12
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1072 ! ARH-77
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   HMy2.A3m
AC   CVCL_F825
DR   Wikidata; Q54889981
RX   PubMed=2212658;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8119 ! HMy.2 B
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   HMy2.C1R
AC   CVCL_3714
AS   CVCL_E511
SY   Hmy.2 CIR; HMy2.CIR; C1R
DR   BTO; BTO_0003699
DR   CLO; CLO_0003787
DR   ATCC; CRL-1993
DR   CCRID; 3101HUMGNHu21
DR   ChEMBL-Cells; CHEMBL4295449
DR   ChEMBL-Targets; CHEMBL4296434
DR   CLS; 305126
DR   dbMHC; 48526
DR   ECACC; 94050320
DR   IHW; IHW09208
DR   IPD-IMGT/HLA; 10372
DR   Lonza; 1264
DR   PubChem_Cell_line; CVCL_3714
DR   Wikidata; Q54889982
RX   PubMed=1541831;
RX   PubMed=2784569;
RX   PubMed=3819393;
RX   PubMed=30844424;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-408.html
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01; B*35:03; C*04:01:01; DPB1*04:01,04:02 (IPD-IMGT/HLA=10372).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1993
ST   Amelogenin: X
ST   CSF1PO: 6,10
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,12
ST   D8S1179: 15
ST   FGA: 20,21
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8119 ! HMy.2 B
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HMy2.DRN
AC   CVCL_F826
DR   Wikidata; Q54889983
RX   PubMed=2212658;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F825 ! HMy2.A3m
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   HN
AC   CVCL_1283
DR   BTO; BTO_0004589
DR   CLO; CLO_0003788
DR   CLDB; cl1701
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473149
DR   cancercelllines; CVCL_1283
DR   Cell_Model_Passport; SIDM01061
DR   ChEMBL-Cells; CHEMBL3308742
DR   ChEMBL-Targets; CHEMBL1075465
DR   Cosmic; 907059
DR   Cosmic-CLP; 907059
DR   DepMap; ACH-001090
DR   DSMZ; ACC-417
DR   DSMZCellDive; ACC-417
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907059
DR   GEO; GSM888158
DR   GEO; GSM1669887
DR   IARC_TP53; 21376
DR   IARC_TP53; 25037
DR   LINCS_LDP; LCL-1209
DR   PharmacoDB; HN_557_2019
DR   Progenetix; CVCL_1283
DR   PubChem_Cell_line; CVCL_1283
DR   Wikidata; Q54889984
RX   PubMed=8985100;
RX   PubMed=17390010;
RX   PubMed=17719389;
RX   PubMed=18423281;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~50 hours (DSMZ=ACC-417).
CC   HLA typing: A*24:02,31:01; B*07:02,51:01; C*07:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (PubMed=17390010).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly279Glu (c.836G>A); ClinVar=VCV000419454; Zygosity=Unspecified (PubMed=17390010).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.89%; Native American=0%; East Asian, North=79.15%; East Asian, South=18.39%; South Asian=0%; European, North=0%; European, South=1.57% (PubMed=30894373).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=907059; DSMZ=ACC-417; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,11
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   HN-1
AC   CVCL_8123
SY   HN1; LICR-LON-HN1; LICR (LON) HN1; LICR(Lond)-HN 1
DR   Wikidata; Q54889985
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1992541;
RX   PubMed=2427339;
RX   PubMed=2605456;
RX   PubMed=2777647;
RX   PubMed=6387708;
RX   PubMed=7195729;
CC   Doubling time: 36 hours (PubMed=7195729).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   HN-10
AC   CVCL_8124
SY   HN10; LICR-LON-HN10
DR   Cosmic; 706677
DR   Wikidata; Q54889986
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2183872;
RX   PubMed=7195729;
CC   Doubling time: 60 hours (PubMed=7195729).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   HN-11
AC   CVCL_W944
SY   HN11; LICR-LON-HN11
DR   Cosmic; 706688
DR   Cosmic; 2043884
DR   Wikidata; Q54889987
RX   PubMed=2183872;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   HN-15
AC   CVCL_W297
SY   HN15; LICR-LON-HN15; LICR-HN-15
DR   Cosmic; 686976
DR   Wikidata; Q54889988
RX   PubMed=10760816;
RX   PubMed=12124801;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   HN-16
AC   CVCL_EJ04
SY   HN16; LICR-LON-HN16
DR   Cosmic; 706699
DR   Wikidata; Q54889989
RX   PubMed=2183872;
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   HN-2
AC   CVCL_8125
SY   HN2; LICR-LON-HN2; LICR (LON) HN2; LICR(Lond)-HN 2; LICR-HN2
DR   Wikidata; Q54889990
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2427339;
RX   PubMed=6387708;
RX   PubMed=7195729;
RX   PubMed=26032726;
RX   PubMed=26269754;
CC   Doubling time: 48 hours (PubMed=7195729).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   HN-3
AC   CVCL_8126
SY   HN3; LICR-LON-HN3; LICR (LON) HN3; LICR (LON) HN-3; LICR-HN-3; LICR-HN3
DR   Wikidata; Q54889991
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2427339;
RX   PubMed=7195729;
CC   Doubling time: 38 hours (PubMed=7195729).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   HN-4
AC   CVCL_8127
SY   HN4; LICR-LON-HN4; LICR (LON) HN4; LICR-HN-4
DR   Wikidata; Q54889992
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2427339;
RX   PubMed=7195729;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 100 hours (PubMed=7195729).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HN-5
AC   CVCL_8128
SY   HN5; LICR-LON-HN5; LICR (LON) HN5; LICR-HN5; LICR-HN-5; LICR HN-5
DR   EFO; EFO_0022405
DR   ChEMBL-Cells; CHEMBL3308481
DR   ChEMBL-Targets; CHEMBL614828
DR   Cosmic; 686977
DR   Cosmic; 706622
DR   Cosmic; 916365
DR   Cosmic; 1339911
DR   Cosmic; 1530740
DR   Cosmic; 2131847
DR   Cosmic; 2439753
DR   GEO; GSM1374540
DR   GEO; GSM1374541
DR   NCBI_Iran; C196
DR   PubChem_Cell_line; CVCL_8128
DR   Wikidata; Q54889993
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2183872;
RX   PubMed=2427339;
RX   PubMed=7195729;
RX   PubMed=10760816;
RX   PubMed=12124801;
RX   PubMed=17254797;
RX   PubMed=21868764;
RX   PubMed=26032726;
RX   PubMed=26269754;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 34 hours (PubMed=7195729).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: HNS; Cosmic=1530740.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=17254797; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11 (PubMed=17254797)
ST   CSF1PO: 11,13 (PubMed=21868764)
ST   D13S317: 11
ST   D16S539: 10,12 (PubMed=17254797)
ST   D16S539: 11,13 (PubMed=21868764)
ST   D18S51: 12,14
ST   D21S11: 27,31
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,18,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   HN-6
AC   CVCL_8129
SY   HN6; LICR-LON-HN6; LICR (LON) HN6; LICR-HN-6; LICR-HN6; LICR (Lond) HN-6; LICR(Lond)-HN 6
DR   ChEMBL-Cells; CHEMBL4879547
DR   Cosmic; 706633
DR   Cosmic; 916366
DR   Wikidata; Q54889994
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2183872;
RX   PubMed=2427339;
RX   PubMed=6387708;
RX   PubMed=7195729;
RX   PubMed=7284233;
RX   PubMed=10760816;
RX   PubMed=12124801;
CC   Doubling time: 32 hours (PubMed=7195729).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ03 ! HN-6n1
OI   CVCL_A1TI ! HN-6n2
OI   CVCL_A1TJ ! HN-6Rr
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   HN-6n1
AC   CVCL_EJ03
SY   HN-6SM; HN6-SM; LICR-LON-HN6-SM; LICR (Lond) HN-6n1
DR   Cosmic; 706644
DR   Wikidata; Q54889995
RX   PubMed=2183872;
RX   PubMed=7284233;
CC   Doubling time: 30 hours (PubMed=7284233).
CC   Derived from site: Metastatic; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8129 ! HN-6
OI   CVCL_A1TI ! HN-6n2
OI   CVCL_A1TJ ! HN-6Rr
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   HN-6n2
AC   CVCL_A1TI
SY   LICR (Lond) HN-6n2
DR   Wikidata; Q105507699
RX   PubMed=7284233;
CC   Doubling time: 72 hours (PubMed=7284233).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8129 ! HN-6
OI   CVCL_EJ03 ! HN-6n1
OI   CVCL_A1TJ ! HN-6Rr
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HN-6Rr
AC   CVCL_A1TJ
SY   LICR-LON-HN6-R; LICR (Lond) HN-6Rr
DR   Wikidata; Q105507702
RX   PubMed=2183872;
RX   PubMed=7284233;
CC   Doubling time: 30 hours (PubMed=7284233).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8129 ! HN-6
OI   CVCL_EJ03 ! HN-6n1
OI   CVCL_A1TI ! HN-6n2
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HN-7
AC   CVCL_8130
SY   HN7; LICR-LON-HN7
DR   Wikidata; Q54889996
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=7195729;
CC   Doubling time: 72 hours (PubMed=7195729).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   HN-8
AC   CVCL_8131
SY   HN8; LICR-LON-HN8
DR   cancercelllines; CVCL_8131
DR   Cosmic; 706655
DR   Wikidata; Q54889997
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2183872;
RX   PubMed=7195729;
CC   Doubling time: 170 hours (PubMed=7195729).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=2183872).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   HN-9
AC   CVCL_8132
SY   HN9; LICR-LON-HN9
DR   Cosmic; 706666
DR   Wikidata; Q54889998
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2183872;
RX   PubMed=7195729;
CC   Doubling time: 70 hours (PubMed=7195729).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   HN-R
AC   CVCL_0I56
DR   CCLV; CCLV-RIE 1001
DR   Wikidata; Q54889999
RX   PubMed=19941903;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9983; ! Lepus europaeus (European hare)
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   HN-SCC-104
AC   CVCL_RK49
SY   HNSCC 104
DR   Wikidata; Q54890000
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=8339273;
CC   Derived from site: In situ; Pharynx, hypopharynx, pyriform sinus; UBERON=UBERON_8480022.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   HN-SCC-109A
AC   CVCL_RK50
DR   Wikidata; Q54890001
RX   PubMed=1574572;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HN-SCC-131
AC   CVCL_RK51
SY   HNSCC 131
DR   IARC_TP53; 6393
DR   Wikidata; Q54890002
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Ser (c.614A>C); ClinVar=VCV000376683; Zygosity=Unspecified (PubMed=8339273).
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   HN-SCC-135
AC   CVCL_RK52
SY   HNSCC 135
DR   cancercelllines; CVCL_RK52
DR   IARC_TP53; 6394
DR   Wikidata; Q54890004
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2394610;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Unspecified (PubMed=8339273).
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   HN-SCC-143
AC   CVCL_RK53
SY   HNSCC 143
DR   Wikidata; Q54890005
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2394610;
RX   PubMed=8339273;
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   HN-SCC-147
AC   CVCL_RK54
DR   Wikidata; Q54890006
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
CC   Derived from site: In situ; Bone, jaw, left mandible; UBERON=UBERON_0001684.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   HN-SCC-151
AC   CVCL_RK55
SY   HNSCC-151; SCC 151
DR   IARC_TP53; 6404
DR   Wikidata; Q54890007
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2380097;
RX   PubMed=2394610;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Unspecified (PubMed=8339273).
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   HN-SCC-152
AC   CVCL_RK56
SY   HNSCC 152
DR   IARC_TP53; 6395
DR   Wikidata; Q54890008
RX   PubMed=1574572;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val203Trpfs*44 (c.607delG); Zygosity=Unspecified (PubMed=8339273).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   HN-SCC-153
AC   CVCL_RK57
DR   Wikidata; Q54890009
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HN-SCC-161
AC   CVCL_RK58
DR   Wikidata; Q54890010
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2394610;
CC   Derived from site: In situ; Oral cavity, tongue, base; UBERON=UBERON_0010033.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   HN-SCC-166
AC   CVCL_RK59
SY   HNSCC 166
DR   Wikidata; Q54890011
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2394610;
RX   PubMed=8339273;
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
CC   Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   HN-SCC-170A
AC   CVCL_RK60
DR   Wikidata; Q54890012
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2394610;
CC   Derived from site: In situ; Larynx, subglottis; UBERON=UBERON_0036068.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK61 ! HN-SCC-170B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HN-SCC-170B
AC   CVCL_RK61
DR   Wikidata; Q54890013
RX   PubMed=1574572;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK60 ! HN-SCC-170A
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   HN-SCC-19
AC   CVCL_RK44
DR   Wikidata; Q54890014
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   HN-SCC-257
AC   CVCL_UT88
SY   HNSCC 257
DR   Wikidata; Q94214112
RX   PubMed=8339273;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   HN-SCC-28
AC   CVCL_RK45
SY   HNSCC 28
DR   Wikidata; Q54890015
RX   PubMed=2573646;
RX   PubMed=8339273;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   HN-SCC-288B
AC   CVCL_RK62
DR   Wikidata; Q54890016
RX   DOI=10.1007/978-1-4615-2023-8_7;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HN-SCC-29
AC   CVCL_V279
SY   HNSCC 29
DR   cancercelllines; CVCL_V279
DR   IARC_TP53; 6396
DR   Wikidata; Q54890017
RX   PubMed=1574572;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Asp (c.613T>G); ClinVar=VCV000376686; Zygosity=Unspecified (PubMed=8339273).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   HN-SCC-294
AC   CVCL_RK63
SY   HNSCC 294
DR   IARC_TP53; 6397
DR   Wikidata; Q54890018
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Leu (c.736A>T); ClinVar=VCV000406586; Zygosity=Unspecified (PubMed=8339273).
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   HN-SCC-296A
AC   CVCL_RK64
SY   HNSCC 296A
DR   Wikidata; Q54890019
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=8339273;
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   HN-SCC-3
AC   CVCL_RK43
DR   Wikidata; Q54890020
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
CC   Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HN-SCC-301B
AC   CVCL_UT89
SY   HNSCC 301B
DR   cancercelllines; CVCL_UT89
DR   IARC_TP53; 6399
DR   Wikidata; Q94214181
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=8339273).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   HN-SCC-42
AC   CVCL_RK46
SY   HNSCC 42
DR   cancercelllines; CVCL_RK46
DR   IARC_TP53; 6400
DR   Wikidata; Q54890021
RX   PubMed=1574572;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=8339273).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   HN-SCC-58
AC   CVCL_RK47
SY   HNSCC 58
DR   Wikidata; Q54890022
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=1574572;
RX   PubMed=2394610;
RX   PubMed=8339273;
CC   Derived from site: In situ; Oral cavity, tongue, base; UBERON=UBERON_0010033.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   HN-SCC-68
AC   CVCL_V280
SY   HNSCC-68
DR   Wikidata; Q54890023
RX   PubMed=1574572;
RX   PubMed=2380097;
RX   PubMed=2573646;
RX   PubMed=3417487;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   HN-SCC-80
AC   CVCL_RK48
SY   HNSCC 80
DR   IARC_TP53; 6401
DR   Wikidata; Q54890024
RX   PubMed=1574572;
RX   PubMed=8339273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919_934del16; Zygosity=Unspecified (PubMed=8339273).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   HN0124
AC   CVCL_LB90
DR   Wikidata; Q54890025
RX   PubMed=25723285;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_138017; 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 4
//
ID   HN4
AC   CVCL_IS30
SY   HN 4
DR   Wikidata; Q54890026
RX   PubMed=8603355;
CC   Population: Caucasian.
CC   Doubling time: 63 hours (PubMed=8603355).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   HN51
AC   CVCL_IS31
SY   HN 51
DR   Wikidata; Q54890027
RX   PubMed=8603355;
RX   PubMed=10723130;
CC   Population: Caucasian.
CC   Doubling time: 75 hours (PubMed=8603355).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   HN9-10
AC   CVCL_E2TS
SY   HN9 - 10
RX   PubMed=9592861;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of Sp2/0-Ag14 with human mononuclear cells (PubMed=9592861).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HN9.10e
AC   CVCL_LN31
DR   BTO; BTO_0002873
DR   Wikidata; Q54890028
RX   PubMed=2113086;
CC   Characteristics: Somatic fusion product of hippocampal cells from embryonic day 18 C57BL/6 mice and N18TG2.
CC   Characteristics: Has morphological and cytoskeletal features similar to their neuronal precursors.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 4
//
ID   HNC PC1
AC   CVCL_C8X8
SY   PC1
DR   Wikidata; Q123031679
RX   PubMed=31321735;
CC   Population: Caucasian.
CC   Characteristics: This is a primary cell culture (PubMed=31321735).
CC   Karyotypic information: Near triploid karyotype (PubMed=31321735).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HNC PC2
AC   CVCL_C8X9
SY   PC2
DR   Wikidata; Q123031680
RX   PubMed=31321735;
CC   Population: Caucasian.
CC   Characteristics: This is a primary cell culture (PubMed=31321735).
CC   Karyotypic information: Near triploid karyotype (PubMed=31321735).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HNC PC3
AC   CVCL_C8XA
SY   PC3
DR   Wikidata; Q123031681
RX   PubMed=31321735;
CC   Population: Caucasian.
CC   Characteristics: This is a primary cell culture (PubMed=31321735).
CC   Karyotypic information: Near triploid karyotype (PubMed=31321735).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HNCEC/HL-008
AC   CVCL_B6Z8
SY   Human Normal Corneal Epithelial Cell/HL-008
DR   CCRID; 4201PAT-CCTCC00677
DR   Wikidata; Q111733438
RX   Patent=CN106591216B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201550.
CC   Population: Chinese.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
ST   Source(s): Patent=CN106591216B
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 13,15
ST   D12S391: 18,20
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 18,25
ST   D2S441: 10,11
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D6S1043: 14,21.3
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   Penta D: 10,11
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HNCEC/HL-043
AC   CVCL_B6Z6
SY   Human Normal Conjunctival Epithelial Cell/HL-043
DR   CCRID; 4201PAT-CCTCC00999
DR   Wikidata; Q111733439
RX   Patent=CN108285887B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201676.
CC   Population: Chinese.
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
ST   Source(s): Patent=CN108285887B
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 15
ST   D12S391: 19,20
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 13,22
ST   D19S433: 13,15.2
ST   D21S11: 32.2,33.2
ST   D2S1338: 23,25
ST   D2S441: 11,14
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D6S1043: 12,14
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 16,22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HNCF-PI 52
AC   CVCL_9V83
SY   HNCF-pi52
DR   NCBI_Iran; C491
DR   Wikidata; Q54890029
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HNE-1
AC   CVCL_0308
SY   HNE1
DR   BTO; BTO_0006135
DR   MCCL; MCC:0000201
DR   BioSample; SAMN03472440
DR   Wikidata; Q54890030
RX   CelloPub=CLPUB00484;
RX   PubMed=2556716;
RX   PubMed=18196576;
RX   PubMed=25877200;
CC   Problematic cell line: Possibly contaminated. The STR profile is very similar to that of the HeLa cell line and almost identical to that of HNE-2 (Cellosaurus=CVCL_FA07).
CC   Virology: EBV-negative in established line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=18196576; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10 (PubMed=18196576)
ST   D16S539: 9,10,11 (PubMed=25877200)
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,16 (PubMed=18196576)
ST   D8S1179: 12,17 (PubMed=25877200)
ST   FGA: 18,21
ST   Penta D: 9,12
ST   Penta E: 17,20
ST   TH01: 6,7,9 (PubMed=18196576)
ST   TH01: 6,9 (PubMed=25877200)
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HNE-2
AC   CVCL_FA07
SY   HNE2
DR   Wikidata; Q54890031
RX   CelloPub=CLPUB00484;
RX   PubMed=18196576;
CC   Problematic cell line: Possibly contaminated. The STR profile is very similar to that of the HeLa cell line and almost identical to that of HNE-1 (Cellosaurus=CVCL_0308).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=18196576
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,16
ST   FGA: 18,21
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   HNE-3
AC   CVCL_FA08
SY   HNE3
DR   Wikidata; Q54890033
RX   PubMed=2556716;
CC   Population: Chinese.
CC   Virology: EBV-negative.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 8
//
ID   HNEEC/HL-014
AC   CVCL_C0MI
SY   Human Normal Eyelid Epithelial Cell/HL-014
DR   CCRID; 4201PAT-CCTCC00679
DR   Wikidata; Q112929734
RX   Patent=CN106591220A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015180.
CC   Population: Chinese.
CC   Derived from site: In situ; Eye lid, skin; UBERON=UBERON_0001457.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): Patent=CN106591220A
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 17,18
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 17,23
ST   D2S441: 10,11
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   FGA: 24
ST   Penta D: 12,13
ST   Penta E: 5,21
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   HNEEC/HL-015
AC   CVCL_C0MJ
SY   Human Normal Eyelid Epithelial Cell/HL-015
DR   CCRID; 4201PAT-CCTCC00680
DR   Wikidata; Q112929735
RX   Patent=CN106591220A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015181.
CC   Population: Chinese.
CC   Derived from site: In situ; Eye lid, skin; UBERON=UBERON_0001457.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): Patent=CN106591220A
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 13
ST   D12S391: 19,21
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,21
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 19,20
ST   D2S441: 10,11
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D6S1043: 12,19
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   Penta D: 8,9
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   HNES1 GATA3:mKO2
AC   CVCL_C2VL
SY   HNES1_GATA3mKO2
DR   Wikidata; Q114311634
RX   PubMed=33831366;
CC   Characteristics: Using CRISPR/Cas9 a IRES-mKO2-FRT-PGKp-Neo-PA construct was integrated following the stop codon of GATA3 (PubMed=33831366).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 134NN; mKusabira-Orange2 (Note=mKO2, orange fluorescent protein derived from F.concinna Kusabira-Orange (KO)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9R98 ! CAMe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   HNES2
AC   CVCL_UI95
SY   hNES2; Human Naive Embryonic Stem cells 2
DR   ArrayExpress; E-MTAB-4461
DR   Wikidata; Q94214312
RX   PubMed=26947977;
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC21-35.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   HNES4
AC   CVCL_UI96
SY   hNES4; Human Naive Embryonic Stem cells 4
DR   Wikidata; Q94214315
RX   PubMed=26947977;
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC16-07.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   HNFF-PI 8
AC   CVCL_9V45
DR   NCBI_Iran; C172
DR   Wikidata; Q54890034
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HNGA
AC   CVCL_WT61
DR   Wikidata; Q94214329
RX   CelloPub=CLPUB00513;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
CC   Population: Japanese.
CC   Doubling time: 35 hours (CelloPub=CLPUB00513).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HNK-1
AC   CVCL_D293
SY   HNK1; Leu7; Leu-7
DR   CLO; CLO_0003789
DR   ATCC; TIB-200
DR   BCRJ; 0105
DR   NCBI_Iran; H163
DR   Wikidata; Q54890035
RX   PubMed=6790607;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   HNL1
AC   CVCL_QX15
DR   SKIP; SKIP000901
DR   Wikidata; Q54890036
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   HNL2
AC   CVCL_RL51
DR   SKIP; SKIP000902
DR   Wikidata; Q54890037
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HNL4
AC   CVCL_RL52
DR   SKIP; SKIP000903
DR   Wikidata; Q54890038
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HNL5
AC   CVCL_RL53
DR   SKIP; SKIP000904
DR   Wikidata; Q54890039
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HNL6
AC   CVCL_RL54
DR   SKIP; SKIP000905
DR   Wikidata; Q54890040
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HNLp
AC   CVCL_RL55
DR   SKIP; SKIP000906
DR   Wikidata; Q54890041
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HNMUi001-A
AC   CVCL_ZE86
SY   iPS-CV002
DR   hPSCreg; HNMUi001-A
DR   SKIP; SKIP005789
DR   Wikidata; Q98126692
RX   PubMed=32361311;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
ST   Source(s): PubMed=32361311
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 18,19
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 12,15.2
ST   D1S1656: 13,16
ST   D21S11: 31.2,32.2
ST   D2S1338: 23,24
ST   D2S441: 11,12
ST   D3S1358: 16
ST   D5S818: 7,12
ST   D6S1043: 11,18
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 8,14
ST   Penta E: 11,19
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11FW
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   HNMUi002-A
AC   CVCL_A1BY
SY   iPS-UC1291
DR   BioSamples; SAMEA7366526
DR   hPSCreg; HNMUi002-A
DR   Wikidata; Q102114131
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Unexplicit; 4.2 kb deletion (alpha4.2 del); ClinVar=VCV000375752; Zygosity=Heterozygous (PubMed=33039806).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Heterozygous (PubMed=33039806).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34368; Alpha thalassemia
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   HNMUi003-A
AC   CVCL_A1BZ
SY   iPS-UC1290
DR   BioSamples; SAMEA7484332
DR   hPSCreg; HNMUi003-A
DR   Wikidata; Q102114132
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Heterozygous (PubMed=33039806).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   HNMUi004-A
AC   CVCL_A1CA
SY   iPS-AF717
DR   BioSamples; SAMEA7484334
DR   hPSCreg; HNMUi004-A
DR   Wikidata; Q102114133
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Unexplicit; 4.2 kb deletion (alpha4.2 del); ClinVar=VCV000375752; Zygosity=Heterozygous (PubMed=33039806).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=33039806).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C34368; Alpha thalassemia
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   HNMUi005-A
AC   CVCL_A1CB
SY   iPS-UC1056
DR   BioSamples; SAMEA7484336
DR   hPSCreg; HNMUi005-A
DR   Wikidata; Q102114135
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; chr16:g.223300_227103del (3.7 kb deletion) (alpha3.7 del); ClinVar=VCV000038636; Zygosity=Heterozygous (PubMed=33039806).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Heterozygous (PubMed=33039806).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34368; Alpha thalassemia
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   HNMUi006-A
AC   CVCL_A1CC
SY   iPS-UC1055
DR   BioSamples; SAMEA7484338
DR   hPSCreg; HNMUi006-A
DR   Wikidata; Q102114137
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=33039806).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   HNMUi007-A
AC   CVCL_A1CD
SY   iPS-AF0442
DR   BioSamples; SAMEA7484340
DR   hPSCreg; HNMUi007-A
DR   Wikidata; Q102114138
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; chr16:g.223300_227103del (3.7 kb deletion) (alpha3.7 del); ClinVar=VCV000038636; Zygosity=Heterozygous (PubMed=33039806).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Heterozygous (PubMed=33039806).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C34368; Alpha thalassemia
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   HNMUi008-A
AC   CVCL_A1CE
SY   iPS-UC2419
DR   BioSamples; SAMEA7484342
DR   hPSCreg; HNMUi008-A
DR   Wikidata; Q102114139
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Heterozygous (PubMed=33039806).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   HNMUi009-A
AC   CVCL_A1CF
SY   iPS-UC1171
DR   BioSamples; SAMEA7484344
DR   hPSCreg; HNMUi009-A
DR   Wikidata; Q102114140
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Heterozygous (PubMed=33039806).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   HNMUi010-A
AC   CVCL_A1CG
SY   iPS-AF091
DR   BioSamples; SAMEA7484346
DR   hPSCreg; HNMUi010-A
DR   Wikidata; Q102114141
RX   PubMed=33039806;
CC   From: Hainan Medical University; Haikou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=33039806).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   HNO124
AC   CVCL_D207
DR   Wikidata; Q54890042
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HNO136
AC   CVCL_D208
DR   Wikidata; Q54890043
RX   PubMed=12794754;
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   HNO147
AC   CVCL_D209
DR   Wikidata; Q54890044
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   HNO150
AC   CVCL_D210
DR   Wikidata; Q54890048
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HNO160
AC   CVCL_D211
DR   Wikidata; Q54890049
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HNO180
AC   CVCL_D212
DR   Wikidata; Q54890050
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Caution: From hypopharynx according to PubMed=12794754 but from oropharynx according to PubMed=20149059.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   HNO199
AC   CVCL_D213
DR   ChEMBL-Cells; CHEMBL3307792
DR   ChEMBL-Targets; CHEMBL612257
DR   PubChem_Cell_line; CVCL_D213
DR   Wikidata; Q54890052
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   HNO206
AC   CVCL_D214
DR   Wikidata; Q54890053
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   HNO210
AC   CVCL_D215
DR   CLS; 300134
DR   Wikidata; Q54890054
RX   PubMed=12794754;
RX   PubMed=17557286;
RX   PubMed=19223422;
RX   PubMed=20149059;
CC   Population: Caucasian.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): CLS=300134
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 20,25
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D1S1656: 12,16.3
ST   D21S11: 29
ST   D2S1338: 18
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D6S1043: 13,14
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20,22
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 8.3,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   HNO211
AC   CVCL_D216
DR   Wikidata; Q54890055
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   HNO212
AC   CVCL_D217
DR   Wikidata; Q54890056
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HNO222
AC   CVCL_D218
DR   Wikidata; Q54890057
RX   PubMed=19223422;
RX   PubMed=20149059;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   HNO223
AC   CVCL_D219
DR   CLS; 300142
DR   Wikidata; Q54890058
RX   PubMed=19223422;
RX   PubMed=20149059;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): CLS=300142
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20,22
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 14
ST   D1S1656: 15,16.3
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 14
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   Penta D: 12
ST   Penta E: 5
ST   TH01: 6,8
ST   TPOX: 9
ST   vWA: 18,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
ID   HNO237
AC   CVCL_D220
DR   Wikidata; Q54890059
RX   PubMed=19223422;
RX   PubMed=20149059;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   HNO258
AC   CVCL_D221
DR   CLS; 300146
DR   Wikidata; Q54890060
RX   PubMed=20149059;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
ST   Source(s): CLS=300146
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19,20
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 19
ST   D19S433: 14
ST   D1S1656: 12,16.3
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 10
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 12,14
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
ID   HNO268
AC   CVCL_D222
DR   Wikidata; Q54890061
RX   PubMed=20149059;
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   HNO306
AC   CVCL_D223
DR   Wikidata; Q54890062
RX   PubMed=20149059;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   HNO41
AC   CVCL_D224
DR   CLS; 300126
DR   Wikidata; Q54890063
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Population: Caucasian.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
ST   Source(s): CLS=300126
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 16,20
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 14
ST   D1S1656: 16.3,17
ST   D21S11: 30
ST   D2S1338: 27
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 17
//
ID   HNO89
AC   CVCL_D225
DR   Wikidata; Q54890064
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HNO91
AC   CVCL_D226
DR   Wikidata; Q54890065
RX   PubMed=12794754;
RX   PubMed=20149059;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HNO97
AC   CVCL_D227
SY   HNO 97
DR   ChEMBL-Cells; CHEMBL3308658
DR   ChEMBL-Targets; CHEMBL614808
DR   CLS; 300129
DR   PubChem_Cell_line; CVCL_D227
DR   Wikidata; Q54890066
RX   PubMed=12794754;
RX   PubMed=19223422;
RX   PubMed=20149059;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): CLS=300129
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 19
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 22
ST   D19S433: 14
ST   D1S1656: 12,13
ST   D21S11: 28,32.2
ST   D2S1338: 19
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D6S1043: 13,18
ST   D7S820: 11,13
ST   D8S1179: 8,14
ST   FGA: 25
ST   Penta D: 12,13
ST   Penta E: 7,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   HNOA
AC   CVCL_S919
DR   CGH-DB; 381-2
DR   CGH-DB; 9352-4
DR   Wikidata; Q54890067
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3593088;
RX   PubMed=3732924;
RX   PubMed=9436037;
RX   PubMed=10457904;
RX   PubMed=11330945;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Characteristics: Established from a nude mouse xenograft (PubMed=3593088).
CC   Doubling time: 26 hours (PubMed=3593088).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HNOS
AC   CVCL_M838
DR   JCRB; JCRB1023
DR   JCRB; NIHS0256
DR   Wikidata; Q54890068
RX   PubMed=10601556;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://web.archive.org/web/20240619205041/https://cellbank.nibiohn.go.jp/legacy/information/safety/report/general/20021001.htm
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (ICLAC; JCRB). Originally thought to originate from a oral cavity squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00580.
CC   Doubling time: 20 hours (PubMed=10601556).
CC   Miscellaneous: A sample of HNOS was supplied to ICLAC for STR profiling by JCRB (Kohara A.) and tested by Labcorp Cell Line Testing (Ladd M.).
CC   Discontinued: JCRB; JCRB1023; true.
CC   Discontinued: JCRB; NIHS0256; true.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,16
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3,25.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   Hnp-SWN-14O
AC   CVCL_JM61
DR   Wikidata; Q54890069
RX   PubMed=26657314;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C6557; Schwannomatosis
DI   ORDO; Orphanet_93921; Schwannomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   HNPSV-1
AC   CVCL_B0BI
SY   Human Nucleus Pulposus SV40-transformed-1
DR   Wikidata; Q108820490
RX   PubMed=15247572;
RX   PubMed=16102816;
RX   PubMed=19598131;
CC   Population: Japanese.
CC   Senescence: Transformed but with a finite life span. Senesces at 60-100 PDL (PubMed=15247572).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HNPSV-5
AC   CVCL_B0BJ
SY   Human Nucleus Pulposus SV40-transformed-5
DR   Wikidata; Q108820491
RX   PubMed=16688029;
CC   Population: Japanese.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HNROA
AC   CVCL_WY81
DR   Wikidata; Q94214679
RX   CelloPub=CLPUB00525;
CC   Population: Japanese.
CC   Doubling time: 83 hours (CelloPub=CLPUB00525).
DI   NCIt; C40206; Cervical mucinous adenocarcinoma, minimal deviation type
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   HNS1A
AC   CVCL_6650
DR   RCB; RCB0591
DR   Wikidata; Q54890070
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=294368; ! Hynobius nebulosus (Mitsjama salamander)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HNS2
AC   CVCL_6651
DR   RCB; RCB0592
DR   Wikidata; Q54890071
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=294368; ! Hynobius nebulosus (Mitsjama salamander)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HNS3
AC   CVCL_6652
DR   RCB; RCB0593
DR   Wikidata; Q54890072
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=294368; ! Hynobius nebulosus (Mitsjama salamander)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HNS4
AC   CVCL_6653
DR   RCB; RCB0594
DR   Wikidata; Q54890073
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=294368; ! Hynobius nebulosus (Mitsjama salamander)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HNS5
AC   CVCL_6654
DR   RCB; RCB0595
DR   Wikidata; Q54890074
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=294368; ! Hynobius nebulosus (Mitsjama salamander)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HNSC.100
AC   CVCL_B6QU
SY   Human Neural Stem Cells.100
DR   Wikidata; Q111733441
RX   PubMed=10683274;
CC   Doubling time: 1.7 +- 0.08 days (PubMed=10683274).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, diencephalon; UBERON=UBERON_0006222.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10-11FW
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HNT-34
AC   CVCL_2071
SY   HNT34
DR   CLO; CLO_0050982
DR   EFO; EFO_0006583
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN01821631
DR   BioSample; SAMN03472915
DR   BioSample; SAMN10989583
DR   cancercelllines; CVCL_2071
DR   Cell_Model_Passport; SIDM01621
DR   Cosmic; 787435
DR   Cosmic; 975253
DR   Cosmic; 1012069
DR   Cosmic; 1281316
DR   Cosmic; 2306209
DR   Cosmic; 2378086
DR   DepMap; ACH-000299
DR   DSMZ; ACC-600
DR   DSMZCellDive; ACC-600
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10831-111D3
DR   GEO; GSM1446757
DR   PharmacoDB; HNT34_558_2019
DR   RCB; RCB1296
DR   Wikidata; Q54890075
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9266939;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10637496;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=16408098;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 26-27 hours (PubMed=9266939); 34 hours (PubMed=25984343); ~40 hours (DSMZ=ACC-600).
CC   HLA typing: A*02:06,02:06; B*40:06,67:02; C*07:02,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=25485619; DepMap=ACH-000299).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.86%; Native American=0%; East Asian, North=80.82%; East Asian, South=13.41%; South Asian=0%; European, North=0%; European, South=3.91% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-600; PubMed=25877200; RCB=RCB1296
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 18,24
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20,26
ST   Penta D: 10
ST   Penta E: 11,14
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   HNTB-2K
AC   CVCL_A6IP
SY   Human Normal Thyroid B-2K
DR   Wikidata; Q107115353
RX   PubMed=8090760;
CC   Doubling time: 69 hours (Note=At 45th passage) (PubMed=8090760).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   hntES
AC   CVCL_4J67
DR   Wikidata; Q54890076
RX   Patent=US9476064;
WW   Info; -; -; https://www.ipscell.com/2014/02/jeanne-lorings-take-on-hwangs-approved-us-patent-of-scnt-embryonic-stem-cells/
WW   Info; -; -; https://www.ipscell.com/2015/02/mitalipov-hwang/
WW   Info; New Scientist; -; https://www.newscientist.com/article/dn8601
CC   Group: Patented cell line.
CC   Problematic cell line: As this cell line is reported in a patent originating from authors who have retracted their papers based on the same type of techniques, this cell line origin is doubtful.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00092.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   HNU-Ha-MG1
AC   CVCL_HF52
DR   ICLDB; hnu-ha-mg1
DR   Wikidata; Q54890077
RX   PubMed=25678461;
CC   Group: Insect cell line.
CC   Doubling time: 58.6 +- 7 hours (PubMed=25678461).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Fourth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   HNU-Tn-FB1
AC   CVCL_0A12
SY   FB1
DR   ICLDB; hnu-tn-fb1
DR   Wikidata; Q54890078
RX   DOI=10.16380/j.kcxb.2001.03.004;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 22.9 hours (DOI=10.16380/j.kcxb.2001.03.004).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   HNVEC/HL-016
AC   CVCL_C0MK
SY   Human Normal Vaginal Epithelial Cell/HL-016
DR   CCRID; 4201PAT-CCTCC00681
DR   Wikidata; Q112929736
RX   Patent=CN106497866A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015113.
CC   Population: Chinese.
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): Patent=CN106497866A
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 19,22
ST   D13S317: 12,14
ST   D16S539: 9
ST   D18S51: 13,18
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 24
ST   D2S441: 9.1,11
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D6S1043: 18,20.3
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 21,24,25
ST   Penta D: 9
ST   Penta E: 14,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   Ho
AC   CVCL_M698
SY   HO; Holden
DR   Wikidata; Q54890079
RX   PubMed=2468595;
RX   PubMed=2602651;
RX   PubMed=29533902;
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   HO #1
AC   CVCL_1E42
SY   HO 1; HO-1
DR   BTO; BTO_0002942
DR   Wikidata; Q54890080
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=2624919;
RX   PubMed=3518877;
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 9
//
ID   HO(6)
AC   CVCL_Y444
DR   ATCC; CRL-6267
DR   Wikidata; Q54890081
CC   Group: Amphibian cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6267; true.
OX   NCBI_TaxID=8400; ! Aquarana catesbeiana (American bullfrog)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 8
//
ID   HO-1-N-1
AC   CVCL_1284
SY   Ho-1-N-1; Ho-1-n-1; HO1-N-1; HO1-N1; HO1N1; Nakata-1
DR   BTO; BTO_0005771
DR   CLO; CLO_0009945
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472524
DR   cancercelllines; CVCL_1284
DR   Cell_Model_Passport; SIDM00592
DR   CGH-DB; 372-2
DR   ChEMBL-Cells; CHEMBL3308743
DR   ChEMBL-Targets; CHEMBL1075466
DR   Cosmic; 924111
DR   Cosmic; 1118793
DR   Cosmic; 1120708
DR   Cosmic; 1530741
DR   Cosmic; 1571801
DR   Cosmic; 2266787
DR   Cosmic-CLP; 924111
DR   DepMap; ACH-002244
DR   EGA; EGAS00001000978
DR   GDSC; 924111
DR   GEO; GSM827187
DR   GEO; GSM1669888
DR   IARC_TP53; 27171
DR   JCRB; JCRB0831
DR   LINCS_LDP; LCL-1204
DR   PharmacoDB; HO1N1_559_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1284
DR   PubChem_Cell_line; CVCL_1284
DR   Wikidata; Q54890082
RX   CelloPub=CLPUB00049;
RX   DOI=10.5794/jjoms.34.7;
RX   PubMed=9290701;
RX   PubMed=12738951;
RX   PubMed=17599052;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~31 hours (Note=Lot 08212015) (JCRB=JCRB0831).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.796G>C); ClinVar=VCV000376605; Zygosity=Heterozygous (Cosmic-CLP=924111; DepMap=ACH-002244).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.94%; East Asian, South=20.55%; South Asian=0.47%; European, North=1.04%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=924111; JCRB=JCRB0831
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 9
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   HO-1-u-1
AC   CVCL_2784
SY   HO-1-U-1; Ho-1-u-1; HO1-U-1; HO1-U1; Ho-1U1; HO1U1; HO1u1; Ho1u1; Ueda-1
DR   BTO; BTO_0005948
DR   CLO; CLO_0051384
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 864
DR   BioSample; SAMN01821683
DR   BioSample; SAMN03472521
DR   cancercelllines; CVCL_2784
DR   Cell_Model_Passport; SIDM00591
DR   Cosmic; 753561
DR   Cosmic; 1118792
DR   Cosmic; 1120707
DR   Cosmic; 1530742
DR   Cosmic; 1571800
DR   Cosmic; 1995441
DR   Cosmic; 2266788
DR   Cosmic; 2546834
DR   Cosmic-CLP; 753561
DR   DepMap; ACH-002045
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10550-107I1
DR   GDSC; 753561
DR   GEO; GSM827216
DR   GEO; GSM850381
DR   GEO; GSM1669889
DR   JCRB; JCRB0828
DR   LINCS_LDP; LCL-1202
DR   PharmacoDB; HO1u1_560_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2784
DR   RCB; RCB2102
DR   TKG; TKG 0455
DR   Wikidata; Q54890083
RX   DOI=10.5794/jjoms.31.1347;
RX   PubMed=9290701;
RX   PubMed=12738951;
RX   PubMed=17079100;
RX   PubMed=17325662;
RX   PubMed=19071203;
RX   PubMed=20215515;
RX   PubMed=25448555;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=32990596;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Suitable for in vitro sublingual drug delivery screening involving passive diffusion (PubMed=17079100; PubMed=19071203).
CC   Doubling time: ~23 hours (DOI=10.5794/jjoms.31.1347).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.54%; Native American=0%; East Asian, North=76.45%; East Asian, South=19.98%; South Asian=0.41%; European, North=1.61%; European, South=0% (PubMed=30894373).
CC   Misspelling: HO1-UI; Cosmic=2546834.
CC   Derived from site: In situ; Salivary gland, sublingual gland; UBERON=UBERON_0001832.
ST   Source(s): Cosmic-CLP=753561; JCRB=JCRB0828; RCB=RCB2102; TKG=TKG 0455
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 10
ST   vWA: 17,19
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   HO-13-4
AC   CVCL_2502
DR   CLO; CLO_0003790
DR   ATCC; TIB-99
DR   Wikidata; Q54890084
RX   PubMed=87465;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (Note=Allotype 1.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   Ho-15
AC   CVCL_HG32
SY   HO-15
DR   TOKU-E; 3611
DR   Wikidata; Q54890085
RX   PubMed=10764804;
CC   Knockout cell: Method=KO mouse; MGI; MGI:95607; G6pc.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   Ho-15-D3
AC   CVCL_B5YC
DR   Wikidata; Q111733442
RX   PubMed=10764804;
CC   Knockout cell: Method=KO mouse; MGI; MGI:95607; G6pc.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95607; G6pc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG32 ! Ho-15
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   HO-2.2
AC   CVCL_2503
DR   CLO; CLO_0003791
DR   ATCC; TIB-150
DR   Wikidata; Q54890086
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   HO-22-1
AC   CVCL_2504
DR   CLO; CLO_0003792
DR   ATCC; TIB-100
DR   Wikidata; Q54890087
RX   PubMed=87465;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (Note=Allotype 1.1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   HO-23
AC   CVCL_0309
SY   HO23
DR   MCCL; MCC:0000202
DR   Wikidata; Q54890088
RX   PubMed=9794480;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala132Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   HO-323
AC   CVCL_Z045
SY   HO 323/WIL2.NS; HO323
DR   Wikidata; Q54890090
RX   PubMed=3485476;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2761 ! WIL2 NS
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   HO-323-3
AC   CVCL_B6C9
DR   Wikidata; Q111733443
RX   PubMed=1368811;
RX   PubMed=22359119;
RX   PubMed=22359170;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   HO-8910
AC   CVCL_6868
SY   Ho-8910; HO8910; Ho8910
DR   BTO; BTO_0005438
DR   Wikidata; Q38151529
RX   PubMed=8082435;
RX   PubMed=11930655;
RX   PubMed=25502083;
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706; CCRID). Originally thought to originate from the ascites of a 51 year old female patient with ovarian serous cystadenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00606.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3111C0001CCC000280, 3131C0001000700024). They were one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10 (PubMed=26116706)
ST   CSF1PO: 10 (CCRID)
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16 (CCRID)
ST   D18S51: 16,17 (PubMed=26116706)
ST   D19S433: 13 (CCRID)
ST   D19S433: 13,14 (PubMed=26116706)
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12 (PubMed=26116706)
ST   D5S818: 12 (CCRID)
ST   D6S1043: 18
ST   D7S820: 8,12 (PubMed=26116706)
ST   D7S820: 12 (CCRID)
ST   D8S1179: 12 (CCRID)
ST   D8S1179: 12,13 (PubMed=26116706)
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12 (PubMed=26116706)
ST   TPOX: 12 (CCRID)
ST   vWA: 16,17,18 (CCRID)
ST   vWA: 16,18 (PubMed=26116706)
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HO-8910PM
AC   CVCL_0310
SY   HO-8910 PM; HO8910-PM; HO8910-pm; HO8910/PM; HO8910PM; HO8910pm
DR   BTO; BTO_0005772
DR   MCCL; MCC:0000203
DR   Wikidata; Q38151257
RX   PubMed=10464713;
RX   PubMed=11930655;
RX   PubMed=25502083;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative (CCRID).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00607.
CC   Population: African American.
CC   Characteristics: Established from a 7th generation nude mice xenograft originating from HO-8910.
CC   Doubling time: 34.5 hours (PubMed=10464713).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3111C0001CCC000281, 3131C0001000700025). They were the sole source for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,17,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6868 ! HO-8910
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HO1
AC   CVCL_A2CK
DR   Wikidata; Q105507705
RX   PubMed=10025895;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   HO104
AC   CVCL_E700
SY   H0104; HO 104
DR   dbMHC; 48896
DR   ECACC; 88052082
DR   IHW; IHW09082
DR   IPD-IMGT/HLA; 11633
DR   Wikidata; Q54890091
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01; DPB1*04:01:01; DQA1*01:02:01; DQB1*06:02:01; DRA*01:02; DRB1*15:01:01; DRB5*01:01; DRB6*02:01 (IPD-IMGT/HLA=11633).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   HO11
AC   CVCL_ZT81
DR   Wikidata; Q98126693
RX   PubMed=8794843;
RX   PubMed=9018113;
RX   PubMed=9649131;
CC   Senescence: Senesces at 63 PDL (PubMed=9649131).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   HO15.19
AC   CVCL_0311
SY   Ho15.19
DR   MCCL; MCC:0000204
DR   ChEMBL-Cells; CHEMBL4483153
DR   ChEMBL-Targets; CHEMBL4483245
DR   PubChem_Cell_line; CVCL_0311
DR   Wikidata; Q54890092
RX   PubMed=9342182;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T953 ! HET15
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   HO16.4C
AC   CVCL_T952
SY   HO16.4c
DR   Wikidata; Q54890093
RX   PubMed=9342182;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T954 ! HET16
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   HO275
AC   CVCL_W086
DR   BioSamples; SAMEA100933
DR   cancercelllines; CVCL_W086
DR   Cosmic; 1522771
DR   GEO; GSM726270
DR   Progenetix; CVCL_W086
DR   Wikidata; Q54890094
RX   PubMed=21642991;
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: NCI-H0275; Cosmic=1522771.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   HO301
AC   CVCL_E701
SY   H0301; HO 301
DR   dbMHC; 48876
DR   ECACC; 88052055
DR   IHW; IHW09055
DR   IPD-IMGT/HLA; 10751
DR   Wikidata; Q54890095
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*03:01:01:01; B*14:02:01:01; C*08:02:01:01; DPA1*02:01:01; DPB1*05:01:01; DQA1*01:02:01; DQB1*06:09:01; DRA*01:02; DRB1*13:02:01; DRB3*03:01 (IPD-IMGT/HLA=10751).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   HO8910-TAX/CBP
AC   CVCL_B0WD
DR   Wikidata; Q108820493
RX   PubMed=34535163;
CC   Problematic cell line: Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6868 ! HO-8910
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   HOB-01-C1
AC   CVCL_WN88
DR   Wikidata; Q94215049
RX   PubMed=8895322;
CC   Characteristics: Proliferates at the permissive temperature (34 Celsius). Stop dividing at the restrictive temperature (39-40 Celsius).
CC   Doubling time: 4-6 days (PubMed=8895322).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Bone, femoral neck; UBERON=UBERON_0007119.
CC   Cell type: Osteocyte; CL=CL_0000137.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Conditionally immortalized cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 7
//
ID   HOB-02-C1
AC   CVCL_F757
DR   Wikidata; Q54890096
RX   PubMed=8725178;
CC   Characteristics: Proliferates at the permissive temperature (34 Celsius). Stop dividing at the restrictive temperature (40 Celsius).
CC   Doubling time: ~2 days (PubMed=8725178).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   HOB1
AC   CVCL_J391
DR   Wikidata; Q54890097
RX   PubMed=2159767;
RX   PubMed=7786033;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 22 hours (PubMed=2159767).
DI   NCIt; C7873; Adult immunoblastic lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   HOB1/ADR2.0
AC   CVCL_J392
DR   Wikidata; Q54890098
RX   PubMed=1360209;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
DI   NCIt; C7873; Adult immunoblastic lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J391 ! HOB1
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   HOB1/VCR0.1
AC   CVCL_J393
DR   Wikidata; Q54890099
RX   PubMed=1360209;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
DI   NCIt; C7873; Adult immunoblastic lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J391 ! HOB1
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   HOB1/VCR0.5
AC   CVCL_II74
DR   Wikidata; Q54890100
RX   PubMed=7786033;
RX   PubMed=7903440;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
DI   NCIt; C7873; Adult immunoblastic lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J391 ! HOB1
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   HOB1/VCR1.0
AC   CVCL_II75
DR   Wikidata; Q54890101
RX   PubMed=7786033;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
DI   NCIt; C7873; Adult immunoblastic lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J391 ! HOB1
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   HOBIT
AC   CVCL_W632
SY   Human OsteoBlast-like Initial Transfectant
DR   Wikidata; Q54890102
RX   PubMed=1373929;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   HOC-1
AC   CVCL_5454
SY   HOC1
DR   Cosmic; 877478
DR   Cosmic; 1152558
DR   Wikidata; Q54890103
RX   PubMed=4016745;
RX   PubMed=23415752;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 36 hours (PubMed=4016745); 24.87 hours (JWGray panel).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5455 ! HOC-7
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HOC-21
AC   CVCL_8692
SY   Human Ovarian Cancer-21
DR   ChEMBL-Cells; CHEMBL3308669
DR   ChEMBL-Targets; CHEMBL614829
DR   Cosmic; 877479
DR   Cosmic; 1152559
DR   PubChem_Cell_line; CVCL_8692
DR   Wikidata; Q54890104
RX   PubMed=4436993;
RX   PubMed=6163305;
RX   PubMed=6174649;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=4436993).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   HOC-7
AC   CVCL_5455
SY   HOC7
DR   cancercelllines; CVCL_5455
DR   Cosmic; 923105
DR   GEO; GSM1291141
DR   Wikidata; Q54890105
RX   PubMed=4016745;
RX   PubMed=23415752;
RX   PubMed=25230021;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Doubling time: 16.4 hours (PubMed=4016745); 26.68 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Phe (c.824G>T); ClinVar=VCV000376582; Zygosity=Unspecified (PubMed=25230021).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5454 ! HOC-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   HOC-8
AC   CVCL_5456
SY   HOC8
DR   Wikidata; Q54890106
RX   PubMed=3756872;
RX   PubMed=11416159;
RX   PubMed=23415752;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 72.06 hours (JWGray panel).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 13,17
ST   D21S11: 28,32.2
ST   D8S1179: 10,12
ST   FGA: 22
ST   TH01: 6,9.3
ST   vWA: 16,18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   HOC-I
AC   CVCL_A5HC
DR   Wikidata; Q107115354
RX   PubMed=2723484;
CC   Population: Japanese.
CC   Doubling time: ~75 hours (PubMed=2723484).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HOC1119
AC   CVCL_S689
SY   HOC 1119
DR   Wikidata; Q54890107
RX   DOI=10.11277/stomatology1952.44.47;
CC   Population: Japanese.
CC   Doubling time: 17.5 hours (DOI=10.11277/stomatology1952.44.47).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HOC119
AC   CVCL_8693
SY   HOC-119; HOC 119; HOC 1-19
DR   Cosmic; 1120709
DR   Wikidata; Q54890108
RX   DOI=10.11277/stomatology1952.44.47;
RX   PubMed=10705089;
CC   Population: Japanese.
CC   Doubling time: 20.4 hours (DOI=10.11277/stomatology1952.44.47).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   HOC119PF
AC   CVCL_A1KH
SY   HOC 1-19 PF HOC119 Protein Free
DR   Wikidata; Q102114143
RX   DOI=10.11277/stomatology1952.44.47;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8693 ! HOC119
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   HOC1208
AC   CVCL_8694
DR   Wikidata; Q54890109
RX   PubMed=10705089;
WW   Info; -; -; https://inhibitorlibraries.com/we-unearthed-that-the-development-of-oral-scc-cells-was-inhi
CC   Population: Japanese.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   HOC1A
AC   CVCL_JK56
SY   HOC1a; Hoc1a; BUPH:OVSC; BUPH:OVSC-1
DR   Wikidata; Q54890110
RX   PubMed=16174236;
RX   PubMed=25180175;
CC   Population: Chinese.
CC   Doubling time: 39.5 hours (PubMed=16174236).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C4512; Ovarian mucinous cystadenoma
DI   NCIt; C27004; Sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   HOC313
AC   CVCL_8695
SY   Hoc313; HOC-313
DR   BTO; BTO_0006030
DR   cancercelllines; CVCL_8695
DR   CGH-DB; 363-2
DR   Cosmic; 930340
DR   Cosmic; 1046030
DR   Cosmic; 1123030
DR   IARC_TP53; 1096
DR   Wikidata; Q54890111
RX   PubMed=1570156;
RX   PubMed=2654810;
RX   PubMed=10069537;
RX   PubMed=11120485;
RX   PubMed=12632084;
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Unspecified (PubMed=18097548).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=1570156).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   HOC512
AC   CVCL_8696
SY   HOC 512
DR   Wikidata; Q54890112
RX   DOI=10.11277/stomatology1952.44.47;
RX   PubMed=10705089;
CC   Population: Japanese.
CC   Doubling time: 16.7 hours (DOI=10.11277/stomatology1952.44.47).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   HOC519
AC   CVCL_8697
SY   HOC 519
DR   Wikidata; Q54890113
RX   DOI=10.11277/stomatology1952.44.47;
RX   PubMed=10705089;
CC   Population: Japanese.
CC   Doubling time: 28.1 hours (DOI=10.11277/stomatology1952.44.47).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   HOC519PF
AC   CVCL_A1KG
SY   HOC 519 PF; HOC519 Protein Free
DR   Wikidata; Q102114144
RX   DOI=10.11277/stomatology1952.44.47;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8697 ! HOC519
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   HOC605
AC   CVCL_8698
DR   cancercelllines; CVCL_8698
DR   Cosmic; 1123033
DR   IARC_TP53; 1097
DR   Wikidata; Q54890114
RX   PubMed=1570156;
RX   PubMed=1624295;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Unspecified (PubMed=1570156).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HOC621
AC   CVCL_8699
DR   Cosmic; 1120710
DR   Wikidata; Q54890115
RX   PubMed=10705089;
WW   Info; -; -; https://inhibitorlibraries.com/we-unearthed-that-the-development-of-oral-scc-cells-was-inhi
CC   Population: Japanese.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   HOC719
AC   CVCL_8700
DR   Cosmic; 1123034
DR   IARC_TP53; 1098
DR   Wikidata; Q54890116
RX   PubMed=1570156;
RX   PubMed=11120485;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Met1043Val (c.3127A>G); ClinVar=VCV000376485; Zygosity=Homozygous (PubMed=18097548).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Glu (c.843C>G); ClinVar=VCV000376587; Zygosity=Unspecified (PubMed=1570156).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HOC719-NE
AC   CVCL_8701
SY   HOC719-Negative E-cadherin
DR   Wikidata; Q54890117
RX   PubMed=11120485;
RX   PubMed=12632084;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Met1043Val (c.3127A>G); ClinVar=VCV000376485; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Glu (c.843C>G); ClinVar=VCV000376587; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8700 ! HOC719
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HOC719-PE
AC   CVCL_8702
SY   HOC719-Positive E-cadherin
DR   Wikidata; Q54890118
RX   PubMed=11120485;
RX   PubMed=12632084;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Met1043Val (c.3127A>G); ClinVar=VCV000376485; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Glu (c.843C>G); ClinVar=VCV000376587; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8700 ! HOC719
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HOC815
AC   CVCL_8703
SY   Hoc815; HOC-815
DR   CGH-DB; 357-2
DR   Cosmic; 930341
DR   Cosmic; 1046031
DR   Cosmic; 1123031
DR   IARC_TP53; 1099
DR   Wikidata; Q54890120
RX   PubMed=1570156;
RX   PubMed=1624295;
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Unspecified (PubMed=1570156).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   HOC927
AC   CVCL_8704
DR   cancercelllines; CVCL_8704
DR   Cosmic; 1123035
DR   IARC_TP53; 24377
DR   Wikidata; Q54890121
RX   PubMed=1570156;
RX   PubMed=1624295;
RX   PubMed=10069537;
RX   PubMed=18097548;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Homozygous (PubMed=18097548).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1570156).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   HOCC
AC   CVCL_M684
DR   Wikidata; Q54890123
RX   PubMed=15369135;
CC   Population: Japanese.
CC   Doubling time: ~32 hours (PubMed=15369135).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   HOCE
AC   CVCL_4840
DR   CLO; CLO_0050152
DR   BioSample; SAMN03472148
DR   RCB; RCB1514
DR   Wikidata; Q54890124
RX   PubMed=9573483;
CC   Population: Japanese.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): RCB=RCB1514
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   HOE6V
AC   CVCL_4J71
DR   cancercelllines; CVCL_4J71
DR   Wikidata; Q54890125
RX   Patent=US8835164;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00218.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=Variant form).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1094 ! C-33 A
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 19
//
ID   HOEF
AC   CVCL_4841
DR   CLO; CLO_0050883
DR   BioSample; SAMN03472199
DR   RCB; RCB1010
DR   Wikidata; Q54890126
CC   Population: Japanese.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1010
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HOF
AC   CVCL_YE18
SY   Hexagrammos Otakii Fin
DR   Wikidata; Q94215372
RX   DOI=10.3724/SP.J.1231.2013.38314;
RX   Patent=CN102492650A;
CC   Group: Fish cell line.
CC   Doubling time: 58.7 hours (DOI=10.3724/SP.J.1231.2013.38314).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=72450; ! Hexagrammos otakii (Fat greenling)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 6
//
ID   HOFPAEC
AC   CVCL_6G14
SY   HPV16-transformed Ovine Fetal Pulmonary Artery Endothelial Cell line
DR   Wikidata; Q54890127
RX   PubMed=10409236;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the transformation method, the species of origin and the primary cell type name.
CC   Derived from site: In situ; Fetal lung, artery, endothelium; UBERON=UBERON_0005597+UBERON_0005317.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   125-135FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   HOG
AC   CVCL_D354
SY   Human OligodendroGlioma
DR   Millipore; SCC163
DR   Wikidata; Q54890128
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1315720;
RX   PubMed=1329795;
RX   PubMed=8416742;
RX   PubMed=14618099;
CC   Characteristics: Useful model to study signal transduction pathways of oligodendrocyte metabolism and the role of oligodendrocytes in neurodegenerative diseases (Millipore=SCC163).
CC   Doubling time: 2 days (PubMed=1329795); 18 hours (PubMed=8416742).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
ST   Source(s): Millipore=SCC163
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 19
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10,12
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 14
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 13
//
ID   HOG-1
AC   CVCL_JF79
SY   HOG-I
DR   Wikidata; Q54890129
RX   PubMed=1387868;
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HOGT
AC   CVCL_A1IK
SY   HOGT clonal strain
DR   Wikidata; Q102114145
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=2408913;
CC   Population: Japanese.
CC   Doubling time: 48 hours (Note=At 5th passage), 40 hours (Note=At 24th passage), 38 hours (Note=At 40th passage) (PubMed=2408913).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5260; Mature gastric teratoma
DI   ORDO; Orphanet_883; Extragonadal teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   HOK
AC   CVCL_YE19
SY   Hexagrammos Otakii Kidney
DR   Wikidata; Q94215408
RX   DOI=10.3724/SP.J.1231.2013.38314;
RX   Patent=CN102492650A;
CC   Group: Fish cell line.
CC   Doubling time: 32.9 hours (DOI=10.3724/SP.J.1231.2013.38314).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=72450; ! Hexagrammos otakii (Fat greenling)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 6
//
ID   HOK-1
AC   CVCL_B403
SY   HOK-I
DR   Wikidata; Q54890130
RX   PubMed=1714884;
CC   Population: Caucasian.
CC   Doubling time: 29.6 hours (PubMed=1714884).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HOK-16A
AC   CVCL_B404
SY   HOK16A; Human Oral Keratinocytes-16A
DR   Wikidata; Q54890131
RX   PubMed=1330348;
RX   PubMed=1654226;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B405 ! HOK-16B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HOK-16A-BaP
AC   CVCL_6G58
DR   Wikidata; Q54890133
RX   PubMed=1330348;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B404 ! HOK-16A
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   HOK-16A-MSEE
AC   CVCL_6G59
DR   Wikidata; Q54890134
RX   PubMed=1330348;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B404 ! HOK-16A
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   HOK-16B
AC   CVCL_B405
SY   HOK16B; Human Oral Keratinocytes-16B
DR   Wikidata; Q54890135
RX   PubMed=1330348;
RX   PubMed=1654226;
RX   PubMed=10675494;
RX   PubMed=12907203;
RX   PubMed=21868764;
RX   PubMed=32574978;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 9,10
ST   D7S820: 12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B404 ! HOK-16A
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   HOK-16B-BaP
AC   CVCL_B406
DR   Wikidata; Q54890136
RX   PubMed=1330348;
RX   PubMed=7784058;
RX   PubMed=10675494;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B405 ! HOK-16B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   HOK-16B-BaP-T1
AC   CVCL_B407
DR   Wikidata; Q54890137
RX   PubMed=7784058;
RX   PubMed=10675494;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B406 ! HOK-16B-BaP
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   HOK-16B-MSEE
AC   CVCL_6G60
DR   Wikidata; Q54890138
RX   PubMed=1330348;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B405 ! HOK-16B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   HOKKAIDO
AC   CVCL_E702
DR   dbMHC; 48897
DR   ECACC; 94082241
DR   IHW; IHW09141
DR   IPD-IMGT/HLA; 11684
DR   Wikidata; Q54890139
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*24; B*54; C*01; DPB1*05:01; DQA1*03; DQB1*04:01; DRB1*04:05; DRB4*01:01 (IPD-IMGT/HLA=11684).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   HOKN9
AC   CVCL_X902
SY   HOKN-9
DR   Wikidata; Q54890140
RX   PubMed=10761702;
RX   PubMed=18704411;
CC   Population: Japanese.
CC   HLA typing: A*04,24(9); B*35,46; C*01,03 (PubMed=18704411).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   HOKUG
AC   CVCL_8705
DR   CLO; CLO_0050937
DR   BioSample; SAMN03472263
DR   cancercelllines; CVCL_8705
DR   Cosmic; 877465
DR   Cosmic; 1152545
DR   DepMap; ACH-002019
DR   FANTOM5_SSTAR; 10688-109F4
DR   RCB; RCB0657
DR   Wikidata; Q54890141
RX   PubMed=1698374;
RX   PubMed=10937347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 57 hours (Note=At 5th passage), 45 hours (Note=At 20th passage), 44 hours (Note=At 50th passage) (PubMed=1698374).
CC   Transformant: NCBI_TaxID; 10596; Human papillomavirus type 56 (HPV56).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DepMap=ACH-002019; RCB=RCB0657
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 9,11 (DepMap=ACH-002019)
ST   D5S818: 11 (RCB=RCB0657)
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 8,12
ST   Penta E: 12,16
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
DI   ORDO; Orphanet_213833; Glassy cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   HOL
AC   CVCL_YE20
SY   Hexagrammos Otakii Lip
DR   Wikidata; Q94215526
RX   DOI=10.3724/SP.J.1231.2013.38314;
RX   Patent=CN102492650A;
CC   Group: Fish cell line.
CC   Doubling time: 50.4 hours (DOI=10.3724/SP.J.1231.2013.38314).
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=72450; ! Hexagrammos otakii (Fat greenling)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 6
//
ID   HOM-1
AC   CVCL_A611
SY   HOM 1; HOM1
DR   Wikidata; Q54890142
RX   PubMed=158761;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   HOM-2
AC   CVCL_A612
SY   HOM 2; HOM2
DR   BTO; BTO_0003106
DR   EFO; EFO_0022657
DR   dbMHC; 48898
DR   ECACC; 98092902
DR   IHW; IHW09005
DR   IPD-IMGT/HLA; 10755
DR   Wikidata; Q54890143
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=158761;
RX   PubMed=7614994;
RX   PubMed=8813743;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*03:01:01:01; B*27:05:02; C*01:02:01:06; DPA1*01; DPB1*04:01:01; DQA1*01:01; DQB1*05:01:01; DRA*01:01; DRB1*01:01:01; DRB6*01:01 (IPD-IMGT/HLA=10755).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   HOMC-A4
AC   CVCL_B7AX
DR   GEO; GSM3684944
DR   Wikidata; Q111733444
RX   PubMed=34663305;
CC   Population: Japanese.
CC   Karyotypic information: 46,XY,-14,-20,+2mar [45%] (PubMed=34663305).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Greater omentum mesothelium; UBERON=UBERON_0005670.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
ST   Source(s): PubMed=34663305
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 12,19
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7AY ! HOMC-B1
OI   CVCL_B7AZ ! HOMC-D4
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   HOMC-B1
AC   CVCL_B7AY
DR   GEO; GSM3684945
DR   Wikidata; Q111733445
RX   PubMed=34663305;
CC   Population: Japanese.
CC   Karyotypic information: 45,XY,-13 [80%] (PubMed=34663305).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Greater omentum mesothelium; UBERON=UBERON_0005670.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
ST   Source(s): PubMed=34663305
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 12,19
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7AX ! HOMC-A4
OI   CVCL_B7AZ ! HOMC-D4
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   HOMC-D4
AC   CVCL_B7AZ
DR   GEO; GSM3684946
DR   Wikidata; Q111733446
RX   PubMed=34663305;
CC   Population: Japanese.
CC   Karyotypic information: 45,XY,-13,-22,+mar [55%] (PubMed=34663305).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Greater omentum mesothelium; UBERON=UBERON_0005670.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
ST   Source(s): PubMed=34663305
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 12,19
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7AX ! HOMC-A4
OI   CVCL_B7AY ! HOMC-B1
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   HoMel-A1
AC   CVCL_T050
DR   Wikidata; Q54890144
RX   PubMed=23982913;
CC   Doubling time: 42 hours (PubMed=23982913).
CC   Derived from site: Metastatic; Tail, skin; UBERON=UBERON_0003534.
CC   Breed/subspecies: Arabian; VBO=VBO_0000905.
DI   NCIt; C134569; Horse melanoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 14
//
ID   HoMel-L1
AC   CVCL_T051
DR   Wikidata; Q54890145
RX   PubMed=23982913;
CC   Doubling time: 90 hours (PubMed=23982913).
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Breed/subspecies: Lipizzan; VBO=VBO_0011535.
DI   NCIt; C134569; Horse melanoma
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   HOMM
AC   CVCL_4842
SY   Human Okuno Malignant Melanoma
DR   CLO; CLO_0050928
DR   BioSample; SAMN03472147
DR   RCB; RCB1513
DR   Wikidata; Q54890146
RX   PubMed=9777403;
CC   Population: Japanese.
CC   Doubling time: 48 hours (Note=At 5th passage), 37 hours (Note=At 15th passage) (PubMed=9777403).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB1513
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C40239; Cervical melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   HONE-1
AC   CVCL_8706
SY   Hone-1; HONE1; Hone1
DR   BTO; BTO_0006136
DR   BioSample; SAMN03472391
DR   cancercelllines; CVCL_8706
DR   ChEMBL-Cells; CHEMBL3308670
DR   ChEMBL-Targets; CHEMBL614830
DR   Cosmic; 755506
DR   Cosmic; 944908
DR   Cosmic; 1017620
DR   Cosmic; 1300998
DR   Cosmic; 1322948
DR   Cosmic; 2366881
DR   GEO; GSM375844
DR   GEO; GSM378801
DR   GEO; GSM378802
DR   Progenetix; CVCL_8706
DR   PubChem_Cell_line; CVCL_8706
DR   TOKU-E; 3587
DR   Wikidata; Q54890147
RX   CelloPub=CLPUB00484;
RX   PubMed=2556716;
RX   PubMed=12097280;
RX   PubMed=24991015;
RX   PubMed=25877200;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Seems to bear part of the HeLa genomic sequence; may be a derivative of HeLa and another cell of unknown origin (PubMed=24991015).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00496.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: HOME-1; Note=Occasionally.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,10,11
ST   D18S51: 13,16
ST   D21S11: 27,30
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 9,12
ST   Penta E: 17,20
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   HONE-1/CPT30
AC   CVCL_M595
SY   CPT30
DR   cancercelllines; CVCL_M595
DR   ChEMBL-Cells; CHEMBL3307934
DR   ChEMBL-Targets; CHEMBL614470
DR   PubChem_Cell_line; CVCL_M595
DR   Wikidata; Q54890148
RX   PubMed=12097280;
CC   Problematic cell line: Parent cell line (HONE-1) seems to bear part of the HeLa genomic sequence and may be a derivative of HeLa and another cell of unknown origin.
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu418Lys (c.1252G>A); ClinVar=VCV000016774; Zygosity=Unspecified (PubMed=12097280).
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8706 ! HONE-1
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   HONE-1/CPT30R
AC   CVCL_M596
SY   CPT30R
DR   cancercelllines; CVCL_M596
DR   Wikidata; Q54890149
RX   PubMed=12097280;
CC   Problematic cell line: Parent cell line (HONE-1) seems to bear part of the HeLa genomic sequence and may be a derivative of HeLa and another cell of unknown origin.
CC   Characteristics: Partial revertant of the CPT30 camptothecin-resistant subline.
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu418Lys (c.1252G>A); ClinVar=VCV000016774; Zygosity=Unspecified (PubMed=12097280).
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M595 ! HONE-1/CPT30
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   HOON
AC   CVCL_IN52
DR   Wikidata; Q54890150
RX   PubMed=3262645;
RX   PubMed=6230491;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=6230491).
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 7
//
ID   HOP-1
AC   CVCL_J127
SY   Human Oligodendroglial Progenitor-1
DR   Wikidata; Q54890151
RX   Patent=US5830651;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11881.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Oligodendrocyte precursor cell; CL=CL_0002453.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10-14FW
CA   Somatic stem cell
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   HOP-18
AC   CVCL_H642
SY   HOP 18; Hop 18; HOP18; Hop18; Hopkins-18
DR   BioSample; SAMN03472883
DR   ChEMBL-Cells; CHEMBL3307783
DR   ChEMBL-Targets; CHEMBL614809
DR   GEO; GSM206506
DR   GEO; GSM274801
DR   GEO; GSM274802
DR   NCI-DTP; HOP-18
DR   PubChem_Cell_line; CVCL_H642
DR   Wikidata; Q54890153
RX   CelloPub=CLPUB00545;
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=2536293;
RX   PubMed=25877200;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 18,19
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   HOP-19
AC   CVCL_H643
SY   Hop 19; Hopkins-19
DR   ChEMBL-Cells; CHEMBL3308671
DR   ChEMBL-Targets; CHEMBL614832
DR   PubChem_Cell_line; CVCL_H643
DR   Wikidata; Q54890154
RX   CelloPub=CLPUB00545;
RX   PubMed=2388294;
RX   PubMed=2536293;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 10
//
ID   HOP-27
AC   CVCL_YA86
SY   Hop 27; Hopkins-27
DR   Wikidata; Q94215696
RX   CelloPub=CLPUB00545;
RX   PubMed=2388294;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   HOP-62
AC   CVCL_1285
SY   HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62
DR   BTO; BTO_0004080
DR   CLO; CLO_0037016
DR   EFO; EFO_0006439
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 418
DR   BioSample; SAMN03471402
DR   BioSample; SAMN10989587
DR   cancercelllines; CVCL_1285
DR   Cell_Model_Passport; SIDM00133
DR   ChEMBL-Cells; CHEMBL3307671
DR   ChEMBL-Targets; CHEMBL614643
DR   Cosmic; 875855
DR   Cosmic; 905972
DR   Cosmic; 974289
DR   Cosmic; 1092603
DR   Cosmic; 1146945
DR   Cosmic; 1175861
DR   Cosmic; 1305344
DR   Cosmic; 1995442
DR   Cosmic; 1998445
DR   Cosmic-CLP; 905972
DR   DepMap; ACH-000861
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905972
DR   GEO; GSM2105
DR   GEO; GSM50211
DR   GEO; GSM50274
DR   GEO; GSM206507
DR   GEO; GSM274784
DR   GEO; GSM274816
DR   GEO; GSM434275
DR   GEO; GSM743450
DR   GEO; GSM750804
DR   GEO; GSM794404
DR   GEO; GSM799338
DR   GEO; GSM799401
DR   GEO; GSM846357
DR   GEO; GSM1153408
DR   GEO; GSM1178204
DR   GEO; GSM1178205
DR   GEO; GSM1178206
DR   GEO; GSM1181256
DR   GEO; GSM1181314
DR   GEO; GSM1374542
DR   GEO; GSM2124640
DR   IARC_TP53; 21113
DR   IGRhCellID; HOP-62_02GEO
DR   LiGeA; CCLE_548
DR   LINCS_LDP; LCL-1666
DR   NCI-DTP; HOP-62
DR   PharmacoDB; HOP62_561_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1285
DR   PubChem_Cell_line; CVCL_1285
DR   SKY/M-FISH/CGH; 2896
DR   Wikidata; Q54890155
RX   CelloPub=CLPUB00545;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=2536293;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12068308;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=13
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30.3 hours (PubMed=29681454); 39 hours (NCI-DTP=HOP-62).
CC   HLA typing: A*03:01:01; B*07,44; C*05,07:02:01; DPB1*04:02; DQB1*06,06; DRB1*13,15 (PubMed=15748285).
CC   HLA typing: A*03:01,11:01; B*40:01,56:01; C*01:02,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; Cosmic-CLP=905972; DepMap=ACH-000861).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=905972; DepMap=ACH-000861).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.83%; Native American=0.13%; East Asian, North=2.13%; East Asian, South=0%; South Asian=0.11%; European, North=63.51%; European, South=33.3% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=905972; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 9,13
ST   Penta E: 10,19
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   HOP-92
AC   CVCL_1286
SY   HOP 92; HOP.92; HOP92; Hop92; Hopkins-92
DR   BTO; BTO_0004085
DR   EFO; EFO_0006440
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471631
DR   BioSample; SAMN10989594
DR   cancercelllines; CVCL_1286
DR   Cell_Model_Passport; SIDM00134
DR   ChEMBL-Cells; CHEMBL3308091
DR   ChEMBL-Targets; CHEMBL613889
DR   Cosmic; 687783
DR   Cosmic; 875856
DR   Cosmic; 897510
DR   Cosmic; 905973
DR   Cosmic; 974290
DR   Cosmic; 1044247
DR   Cosmic; 1092604
DR   Cosmic; 1146946
DR   Cosmic; 1175862
DR   Cosmic; 1305345
DR   Cosmic; 1312330
DR   Cosmic; 1995443
DR   Cosmic; 1998446
DR   Cosmic-CLP; 905973
DR   DepMap; ACH-000825
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905973
DR   GEO; GSM2125
DR   GEO; GSM50212
DR   GEO; GSM50275
DR   GEO; GSM206508
DR   GEO; GSM274792
DR   GEO; GSM274826
DR   GEO; GSM434299
DR   GEO; GSM743451
DR   GEO; GSM750805
DR   GEO; GSM794405
DR   GEO; GSM799339
DR   GEO; GSM799402
DR   GEO; GSM846358
DR   GEO; GSM1153409
DR   GEO; GSM1153410
DR   GEO; GSM1178221
DR   GEO; GSM1178222
DR   GEO; GSM1178223
DR   GEO; GSM1181257
DR   GEO; GSM1181315
DR   GEO; GSM1669890
DR   GEO; GSM2124657
DR   IARC_TP53; 18068
DR   IGRhCellID; HOP-92_02GEO
DR   LiGeA; CCLE_870
DR   NCI-DTP; HOP-92
DR   PharmacoDB; HOP92_562_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1286
DR   PubChem_Cell_line; CVCL_1286
DR   SKY/M-FISH/CGH; 2810
DR   Wikidata; Q54890156
RX   PubMed=2041050;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=14
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 62.3 hours (PubMed=22628656); 79.5 hours (NCI-DTP=HOP-92).
CC   HLA typing: A*03,24; B*27,47:01:01; C*01,06; DPB1*04:01,04:02; DQB1*05:01:01,06:02; DRB1*01,15:01_01 (PubMed=15748285).
CC   HLA typing: A*03:01,24:02; B*27:05,47:01; C*01:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Heterozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=1.34%; East Asian, South=0%; South Asian=0%; European, North=74.13%; European, South=24.16% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=905973; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,18
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 9,14 (PubMed=25877200)
ST   D8S1179: 14 (PubMed=19372543)
ST   FGA: 19,21
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 41
//
ID   HOPC 1F/12
AC   CVCL_3515
SY   HOPC-1F/12
DR   CLO; CLO_0003793
DR   ATCC; TIB-13
DR   Wikidata; Q54890157
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   HOR
AC   CVCL_E703
DR   dbMHC; 48899
DR   ECACC; 88052053
DR   IHW; IHW09053
DR   IPD-IMGT/HLA; 10757
DR   Wikidata; Q54890158
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*33:03:01:01,33:03:01:02; B*44:03:01:01; C*14:03; DPB1*04:01:01; DQA1*01:02; DQB1*06:04:01; DRB1*13:02:01; DRB3*03:01:01 (IPD-IMGT/HLA=10757).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   Horse
AC   CVCL_9124
DR   CLO; CLO_0003794
DR   ATCC; CRL-6583
DR   Wikidata; Q54890159
RX   CelloPub=CLPUB00758;
CC   Problematic cell line: Misidentified. Originally thought to be of horse origin but found to be from hamster (CelloPub=CLPUB00758).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6583; true.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 10
//
ID   HOS
AC   CVCL_0312
DR   BTO; BTO_0003904
DR   CLO; CLO_0003795
DR   CLO; CLO_0050810
DR   EFO; EFO_0002196
DR   MCCL; MCC:0000205
DR   CLDB; cl1702
DR   CLDB; cl1706
DR   CLDB; cl7155
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1543
DR   BCRC; 60308
DR   BCRJ; 0339
DR   BioSample; SAMN01821560
DR   BioSample; SAMN01821729
DR   BioSample; SAMN03471393
DR   BioSample; SAMN10987602
DR   cancercelllines; CVCL_0312
DR   CCRID; 1101HUM-PUMC000038
DR   CCRID; 4201HUM-CCTCC00333
DR   CCRID; 5301HUM-KCB15015YJ
DR   CCTCC; GDC0251
DR   CCTCC; GDC0333
DR   Cell_Model_Passport; SIDM00806
DR   ChEMBL-Cells; CHEMBL3308811
DR   ChEMBL-Targets; CHEMBL614173
DR   ChEMBL-Targets; CHEMBL614736
DR   CLS; 300449
DR   CLS; 300468
DR   Cosmic; 687928
DR   Cosmic; 759899
DR   Cosmic; 907060
DR   Cosmic; 931037
DR   Cosmic; 931910
DR   Cosmic; 1044082
DR   Cosmic; 1070840
DR   Cosmic; 1074391
DR   Cosmic; 1176621
DR   Cosmic; 1529902
DR   Cosmic; 2816208
DR   Cosmic-CLP; 907060
DR   DepMap; ACH-000613
DR   ECACC; 87070202
DR   EGA; EGAS00001000978
DR   GDSC; 907060
DR   GEO; GSM170248
DR   GEO; GSM185087
DR   GEO; GSM185088
DR   GEO; GSM320827
DR   GEO; GSM827319
DR   GEO; GSM879208
DR   GEO; GSM887088
DR   GEO; GSM888159
DR   GEO; GSM1669891
DR   GEO; GSM1676300
DR   GEO; GSM1701635
DR   GEO; GSM1914984
DR   GEO; GSM1914985
DR   GEO; GSM1914986
DR   GEO; GSM1914987
DR   GEO; GSM1915023
DR   GEO; GSM1915024
DR   GEO; GSM2635315
DR   GEO; GSM2635316
DR   GEO; GSM5087472
DR   GEO; GSM5087473
DR   GEO; GSM5087474
DR   GEO; GSM5087475
DR   GEO; GSM5087476
DR   GEO; GSM5087477
DR   IARC_TP53; 27020
DR   ICLC; HTL04003
DR   IGRhCellID; HOS
DR   IZSLER; BS TCL 69
DR   JCRB; IFO50106
DR   KCB; KCB 2015015YJ
DR   LiGeA; CCLE_703
DR   LINCS_LDP; LCL-1421
DR   PharmacoDB; HOS_563_2019
DR   PRIDE; PXD022868
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0312
DR   PubChem_Cell_line; CVCL_0312
DR   RCB; RCB0992
DR   Wikidata; Q54890160
RX   PubMed=1385192;
RX   PubMed=2233717;
RX   PubMed=2463881;
RX   PubMed=2823272;
RX   PubMed=6954533;
RX   PubMed=12645653;
RX   PubMed=15150091;
RX   PubMed=15289353;
RX   PubMed=17981215;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21519327;
RX   PubMed=22460905;
RX   PubMed=23144859;
RX   PubMed=26320182;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-420.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=21519327).
CC   HLA typing: A*02:11; B*52:01; C*12:02 (PubMed=15289353).
CC   HLA typing: A*02:11,02:11; B*52:01,52:01; C*12:02,12:02; DQA1*02:01,02:01; DRB1*15:02,13:60 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (PubMed=19787792; Cosmic-CLP=907060; DepMap=ACH-000613).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.17%; East Asian, South=3.52%; South Asian=35.51%; European, North=0%; European, South=59.79% (PubMed=30894373).
CC   Discontinued: CLS; 300468; true.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-1543; CCRID; CLS=300449; Cosmic-CLP=907060; ECACC=87070202; JCRB=IFO50106; PubMed=19787792; RCB=RCB0992
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D2S441: 10
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   SE33: 21
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   HOS [Dog osteosarcoma]
AC   CVCL_L356
DR   Wikidata; Q54890161
RX   PubMed=9673952;
RX   PubMed=28283079;
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: 42.0 +- 0.1 hours (PubMed=9673952).
CC   Derived from site: In situ; Bone, scapula; UBERON=UBERON_0006849.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   HOS-143B/CISR8
AC   CVCL_C6V0
DR   Wikidata; Q117704497
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   HOS-143B/DOXR8
AC   CVCL_C6V1
DR   Wikidata; Q117704498
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   HOS-143B/MTXR8
AC   CVCL_C6V2
DR   Wikidata; Q117704499
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   HOS-143B/TRIR8
AC   CVCL_C6V3
DR   Wikidata; Q117704500
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   HOS-B55
AC   CVCL_WK80
DR   cancercelllines; CVCL_WK80
DR   Wikidata; Q94215802
RX   PubMed=15289353;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*55:02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   HOS-CCR5
AC   CVCL_1H19
SY   HOS.CCR5
DR   BEI_Resources; ARP-3519
DR   cancercelllines; CVCL_1H19
DR   Wikidata; Q54890162
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H17 ! HOS-pBABE-puro
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-CD4
AC   CVCL_W650
SY   HOS.CD4
DR   BEI_Resources; ARP-3313
DR   cancercelllines; CVCL_W650
DR   Wikidata; Q54890163
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   HOS-CD4-CCR1
AC   CVCL_1D94
SY   HOS-CD4-CCR-1; HOS-CD4.CCR-1; HOS.CD4.CCR1; HOS.CD4.CKR-1
DR   BEI_Resources; ARP-3314
DR   cancercelllines; CVCL_1D94
DR   Wikidata; Q54890164
RX   PubMed=8649511;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1602; CCR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W650 ! HOS-CD4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-CD4-CCR2b
AC   CVCL_1D95
SY   HOS-CD4-CCR-2B; HOS-CD4.CCR-2B; HOS.CD4.CCR2b
DR   BEI_Resources; ARP-3315
DR   cancercelllines; CVCL_1D95
DR   Wikidata; Q54890165
RX   PubMed=8649511;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1603; CCR2 (Note=Isoform B).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W650 ! HOS-CD4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-CD4-CCR3
AC   CVCL_1D96
SY   HOS.CD4.CCR3; HOS.CD4.CKR-3
DR   BEI_Resources; ARP-3316
DR   cancercelllines; CVCL_1D96
DR   Wikidata; Q54890166
RX   PubMed=8649511;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W650 ! HOS-CD4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-CD4-CCR4
AC   CVCL_1D97
SY   HOS.CD4.CCR4
DR   BEI_Resources; ARP-3317
DR   cancercelllines; CVCL_1D97
DR   Wikidata; Q54890167
RX   PubMed=8649511;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1605; CCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W650 ! HOS-CD4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-CD4-CCR5
AC   CVCL_1D98
SY   HOS-CD4.CCR5; HOS.CD4.CCR5; HOS.CD4-CKR5
DR   BEI_Resources; ARP-3318
DR   cancercelllines; CVCL_1D98
DR   Wikidata; Q54890168
RX   PubMed=8649511;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W650 ! HOS-CD4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-CD4-Fusin
AC   CVCL_1D99
SY   HOS-CD4.Fusin
DR   BEI_Resources; ARP-3319
DR   cancercelllines; CVCL_1D99
DR   Wikidata; Q54890169
RX   PubMed=8649511;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W650 ! HOS-CD4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-CD4-pBABE-puro
AC   CVCL_1E00
SY   HOS-CD4.pBABE-puro; HOS.CD4.pBABE-puro
DR   BEI_Resources; ARP-3320
DR   cancercelllines; CVCL_1E00
DR   Wikidata; Q54890170
RX   PubMed=8649511;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W650 ! HOS-CD4
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 17
//
ID   HOS-CXCR4
AC   CVCL_1H18
SY   HOS.CXCR4
DR   BEI_Resources; ARP-3518
DR   cancercelllines; CVCL_1H18
DR   Wikidata; Q54890171
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H17 ! HOS-pBABE-puro
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   HOS-Luc2-tdT
AC   CVCL_XD62
DR   cancercelllines; CVCL_XD62
DR   CCRID; 1101HUM-PUMC000641
DR   Wikidata; Q94215916
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): CCRID=1101HUM-PUMC000641
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 24
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 15
//
ID   HOS-mCherry
AC   CVCL_XD63
DR   cancercelllines; CVCL_XD63
DR   CCRID; 1101HUM-PUMC000640
DR   Wikidata; Q94215920
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): CCRID=1101HUM-PUMC000640
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 24
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   HOS-O
AC   CVCL_C7SI
DR   Wikidata; Q117704501
RX   CelloPub=CLPUB00733;
CC   Population: Japanese.
CC   Doubling time: 12.0-16.8 hours (CelloPub=CLPUB00733).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   HOS-pBABE-puro
AC   CVCL_1H17
SY   HOS.p.BABE-puro
DR   BEI_Resources; ARP-3517
DR   cancercelllines; CVCL_1H17
DR   Wikidata; Q54890172
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 16
//
ID   HOS-SL
AC   CVCL_A9AN
DR   cancercelllines; CVCL_A9AN
DR   IARC_TP53; 230
DR   Wikidata; Q108820494
RX   PubMed=2531855;
RX   PubMed=2978869;
CC   Population: Caucasian.
CC   Characteristics: Non-tumorigenic.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (PubMed=2531855).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2544 ! KHOS-240S
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   HOS-tdT
AC   CVCL_XD64
DR   cancercelllines; CVCL_XD64
DR   CCRID; 1101HUM-PUMC000639
DR   Wikidata; Q94215936
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): CCRID=1101HUM-PUMC000639
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 24
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 13
//
ID   HOS/CMV-Luc#2(c-1)
AC   CVCL_JG33
DR   cancercelllines; CVCL_JG33
DR   JCRB; JCRB1674
DR   Wikidata; Q54890174
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1674).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 15
//
ID   HOS/GFP
AC   CVCL_A9JG
DR   cancercelllines; CVCL_A9JG
DR   CCRID; 5301HUM-KCB17028YJ
DR   KCB; KCB 2017028YJ
DR   Wikidata; Q108820495
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   HOSC1
AC   CVCL_IW50
DR   Wikidata; Q54890178
RX   PubMed=25193510;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 5
//
ID   HOSE 11-12
AC   CVCL_7671
SY   HOSE11-12; Human Ovarian Surface Epithelial cells 11-12
DR   BTO; BTO_0004435
DR   Wikidata; Q54890179
RX   PubMed=11675135;
RX   PubMed=15489894;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   HOSE 11-24-96
AC   CVCL_UW71
SY   HOSE-B; HOSE B; Human Ovarian Surface Epithelial cells-B
DR   BTO; BTO_0002557
DR   Wikidata; Q94215974
RX   PubMed=9769148;
RX   PubMed=11675135;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   HOSE 17-1
AC   CVCL_7672
SY   HOSE17-1; Human Ovarian Surface Epithelial cells 17-1
DR   BTO; BTO_0004437
DR   Wikidata; Q54890180
RX   PubMed=11675135;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   HOSE 6-3
AC   CVCL_7673
SY   HOSE6-3; Human Ovarian Surface Epithelial cells 6-3
DR   BTO; BTO_0004436
DR   Wikidata; Q54890181
RX   PubMed=7796885;
RX   PubMed=11675135;
RX   PubMed=15489894;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   HOSE 96-9-98
AC   CVCL_UW70
SY   HOSE-A; HOSE A; Human Ovarian Surface Epithelial cells-A
DR   BTO; BTO_0002556
DR   Wikidata; Q94216004
RX   PubMed=9769148;
RX   PubMed=11675135;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   HOSE1-E6/hTERT
AC   CVCL_E3DK
RX   PubMed=15956975;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a postmenopausal patient undergoing abdominal total hysterectomy and bilateral salpingooophorectomy for endometrial cancer (PubMed=15956975).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3DL ! HOSE1-E6/E7/hTERT
OI   CVCL_E232 ! HOSE1-E7/hTERT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HOSE1-E6/E7/hTERT
AC   CVCL_E3DL
RX   PubMed=15956975;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a postmenopausal patient undergoing abdominal total hysterectomy and bilateral salpingooophorectomy for endometrial cancer (PubMed=15956975).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3DK ! HOSE1-E6/hTERT
OI   CVCL_E232 ! HOSE1-E7/hTERT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HOSE1-E7/hTERT
AC   CVCL_E232
SY   hTERT7
DR   Wikidata; Q54890182
RX   PubMed=15956975;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a postmenopausal patient undergoing abdominal total hysterectomy and bilateral salpingooophorectomy for endometrial cancer (PubMed=15956975).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3DK ! HOSE1-E6/hTERT
OI   CVCL_E3DL ! HOSE1-E6/E7/hTERT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   HOSE2089
AC   CVCL_ZL28
DR   Wikidata; Q98126694
RX   PubMed=16380993;
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   HOSM-1
AC   CVCL_A2BI
SY   Human OsteoSarcoma from Mandible-1
DR   Wikidata; Q105507710
RX   CelloPub=CLPUB00595;
RX   PubMed=9307724;
RX   PubMed=12782945;
RX   PubMed=19878029;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2BJ ! HOSM-2
OI   CVCL_A2BK ! HOSMN-1C
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HOSM-2
AC   CVCL_A2BJ
SY   Human OsteoSarcoma from Mandible-2
DR   cancercelllines; CVCL_A2BJ
DR   IARC_TP53; 20215
DR   Wikidata; Q105507713
RX   CelloPub=CLPUB00596;
RX   PubMed=15172645;
RX   PubMed=19878029;
CC   Population: Japanese.
CC   Doubling time: 74.8 hours (CelloPub=CLPUB00596); 70.6 hours (PubMed=15172645).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=15172645).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2BI ! HOSM-1
OI   CVCL_A2BK ! HOSMN-1C
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HOSMN-1C
AC   CVCL_A2BK
SY   Human OsteoSarcoma from Mandible in Nude mouse-1 Cell
DR   Wikidata; Q105507716
RX   DOI=10.11277/stomatology1952.38.1007;
CC   Population: Japanese.
CC   Characteristics: Established from a nude mouse xenograft (HOSMN-1).
CC   Doubling time: 30.75 hours (DOI=10.11277/stomatology1952.38.1007).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2BI ! HOSM-1
OI   CVCL_A2BJ ! HOSM-2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HOSONUMA
AC   CVCL_E704
SY   HOSONUM
DR   dbMHC; 48900
DR   ECACC; 94082229
DR   IHW; IHW09130
DR   IPD-IMGT/HLA; 11673
DR   Wikidata; Q54890183
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01; B*07:02:01; C*07; DPB1*04:02; DQA1*01:01; DQB1*05:01:01; DRB1*01:01:01 (IPD-IMGT/HLA=11673).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: HONOSUMA; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 19
//
ID   HOT
AC   CVCL_A8UN
DR   Wikidata; Q108820496
RX   PubMed=7671230;
CC   From: Sato, Noriyuki; Sapporo Medical College; Sapporo; Japan.
CC   Population: Japanese.
CC   HLA typing: A*26; B*35,60; C*07 (PubMed=7671230).
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   HOT-1
AC   CVCL_A2BN
DR   Wikidata; Q105507718
RX   DOI=10.11277/stomatology1952.42.48;
CC   Population: Japanese.
CC   Doubling time: ~31.2 hours (Note=At 20th passage) (DOI=10.11277/stomatology1952.42.48).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HOTC-3
AC   CVCL_8707
SY   HOTC 3; HOTC3; Human Ovarian Teratocarcinoma Cell line-3
DR   Wikidata; Q54890184
RX   CelloPub=CLPUB00050;
RX   PubMed=6174649;
CC   Population: Japanese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C39995; Malignant ovarian teratoma
DI   ORDO; Orphanet_398987; Malignant teratoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   HOTHC
AC   CVCL_8708
DR   CLO; CLO_0050950
DR   BioSample; SAMN03472267
DR   cancercelllines; CVCL_8708
DR   DepMap; ACH-002041
DR   RCB; RCB0662
DR   Wikidata; Q54890185
RX   PubMed=10457904;
RX   PubMed=17022149;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=10457904); 24-28 hours (PubMed=17022149).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): RCB=RCB0662
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
ID   HOTHC-SF
AC   CVCL_8709
SY   HOTHC-Serum Free
DR   CLO; CLO_0050947
DR   RCB; RCB0690
DR   Wikidata; Q54890186
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): RCB=RCB0690
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8708 ! HOTHC
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   HOUA-I
AC   CVCL_3867
SY   HOUA-1; HOUAI; HOUA
DR   CLO; CLO_0050886
DR   BioSample; SAMN03472265
DR   cancercelllines; CVCL_3867
DR   Cosmic; 713498
DR   Cosmic; 1241348
DR   Cosmic; 1622897
DR   DepMap; ACH-002027
DR   IARC_TP53; 2378
DR   RCB; RCB0659
DR   Wikidata; Q54890187
RX   CelloPub=CLPUB00051;
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=8105795;
RX   PubMed=9436037;
RX   PubMed=10457904;
RX   PubMed=15901131;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~50 hours (CelloPub=CLPUB00051); 56 hours (PubMed=10457904).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=8105795).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=8105795).
CC   Misspelling: HOOUA; Cosmic=1241348.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): DepMap=ACH-002027; RCB=RCB0659
ST   Amelogenin: X
ST   CSF1PO: 13,14,15 (DepMap=ACH-002027)
ST   CSF1PO: 14,15 (RCB=RCB0659)
ST   D13S317: 13,14,15
ST   D16S539: 9,13,14 (RCB=RCB0659)
ST   D16S539: 9,13,14,15 (DepMap=ACH-002027)
ST   D18S51: 17,18,19,23,24,25
ST   D21S11: 31,32
ST   D3S1358: 16,17
ST   D5S818: 12,13,14,15 (DepMap=ACH-002027)
ST   D5S818: 12,14,15 (RCB=RCB0659)
ST   D7S820: 10,11,12
ST   D8S1179: 12,13,15
ST   FGA: 17,21
ST   Penta D: 11
ST   Penta E: 13,15,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 18,19,20
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A778 ! HOUA-II
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   HOUA-II
AC   CVCL_A778
DR   Wikidata; Q54890188
RX   CelloPub=CLPUB00051;
CC   Population: Japanese.
CC   Doubling time: 60 hours (CelloPub=CLPUB00051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3867 ! HOUA-I
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   HOUFXXX
AC   CVCL_E957
DR   CLO; CLO_0051368
DR   BioSample; SAMN03472166
DR   RCB; RCB1171
DR   Wikidata; Q54890189
CC   Population: Japanese.
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
ST   Source(s): RCB=RCB1171
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 10,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C129718; 47,XXX syndrome
DI   ORDO; Orphanet_3375; Trisomy X
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 11
//
ID   HOV
AC   CVCL_0B90
DR   cancercelllines; CVCL_0B90
DR   Cosmic; 2239133
DR   IARC_TP53; 11277
DR   Wikidata; Q54890190
RX   PubMed=9559344;
RX   PubMed=10408787;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (PubMed=10408787).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   HOVTAX2
AC   CVCL_AV53
SY   HOV Tax2
DR   ABM; T8248
DR   Wikidata; Q54890191
RX   PubMed=22115851;
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=22115851
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 13,14
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   HOVTAX2-paclitaxel resistant
AC   CVCL_AV60
DR   Wikidata; Q54890192
RX   PubMed=22115851;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AV53 ! HOVTAX2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   HOZOT
AC   CVCL_A5ZV
SY   HOZO-derived T cell line
DR   Wikidata; Q107115355
RX   PubMed=17258077;
RX   PubMed=20348186;
RX   PubMed=27901098;
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   HP
AC   CVCL_3715
SY   HT1080 poly
DR   CLO; CLO_0003797
DR   ATCC; CRL-12012
DR   cancercelllines; CVCL_3715
DR   Cell_Model_Passport; SIDM01214
DR   Wikidata; Q54890193
RX   Patent=US5591624;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12012.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-12012; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ATCC=CRL-12012
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   HP PER.C6
AC   CVCL_A9E7
SY   Higher passage PER.C6
DR   Wikidata; Q102114146
RX   PubMed=18052336;
CC   Group: Vaccine production cell line.
CC   Characteristics: Has a greater capacity for adenovirus production than the parent cell line and is better adapted to suspension culture growth (PubMed=18052336).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
CC   Cell type: Retinoblast; CL=CL_4023129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G704 ! PER.C6
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   HP-1
AC   CVCL_C309
DR   Cosmic; 1032369
DR   Wikidata; Q54890194
RX   PubMed=7695406;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HP-13b
AC   CVCL_E2TA
RX   PubMed=23245717;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-13b antibodies (PubMed=23245717).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6137; ITGA2 (Note=With p.Thr828Met = HPA-13b/Sit(a)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-15a
AC   CVCL_E2TB
RX   PubMed=20812998;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-15a antibodies (PubMed=20812998).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21685; CD109 (Note=With p.Tyr703Ser = HPA-15a/Gov(b)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-15b
AC   CVCL_E2TC
RX   PubMed=20812998;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-15b antibodies (PubMed=20812998).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21685; CD109.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-18b
AC   CVCL_E2TD
RX   PubMed=23245717;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-18b antibodies (PubMed=23245717).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6137; ITGA2 (Note=With p.Gln735His = HPA-18b/Cab(a)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-1b
AC   CVCL_E2TE
RX   PubMed=21208305;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-1b antibodies (PubMed=21208305).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6138; ITGA2B.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6156; ITGB3 (Note=With p.Leu59Pro = HPA-1b/Zw(B)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-2
AC   CVCL_C310
DR   Cosmic; 1032392
DR   Wikidata; Q54890195
RX   PubMed=7695406;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HP-3
AC   CVCL_C311
DR   Cosmic; 1032377
DR   Wikidata; Q54890196
RX   PubMed=7695406;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   HP-3b
AC   CVCL_E2TF
RX   PubMed=21208305;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-3b antibodies (PubMed=21208305).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6138; ITGA2B (Note=With p.Ile874Ser = HPA-3b/Bak(B)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6156; ITGB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-4b
AC   CVCL_E2TG
RX   PubMed=21286877;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-4b antibodies (PubMed=21286877).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6138; ITGA2B.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6156; ITGB3 (Note=With p.Arg169Gln = HPA-4b/Yuk(b)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-5b
AC   CVCL_E2TH
RX   PubMed=23245717;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-5b antibodies (PubMed=23245717).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6137; ITGA2 (Note=With p.Glu534Lys = HPA-5b).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-6b
AC   CVCL_E2TI
RX   PubMed=21208305;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-6b antibodies (PubMed=21208305).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6138; ITGA2B.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6156; ITGB3 (Note=With p.Arg515Gln = HPA-6b/Ca(+)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-7 variant
AC   CVCL_E2TJ
RX   PubMed=21208305;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-7 variant antibodies (PubMed=21208305).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6138; ITGA2B.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6156; ITGB3 (Note=With p.Pro433Ser = HPA-7 variant).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-7b
AC   CVCL_E2TK
RX   PubMed=21208305;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-7b antibodies (PubMed=21208305).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6138; ITGA2B.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6156; ITGB3 (Note=With p.Pro433Ala = HPA-7b/Mo(+)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-A1
AC   CVCL_6G10
DR   Wikidata; Q54890197
RX   PubMed=1318503;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G11 ! HP-A2
OI   CVCL_6G12 ! HP-W
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   HP-A2
AC   CVCL_6G11
DR   Wikidata; Q54890198
RX   PubMed=1318503;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G10 ! HP-A1
OI   CVCL_6G12 ! HP-W
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   HP-alphaIIbbeta3
AC   CVCL_E2T9
RX   PubMed=21208305;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of HPA-1a, HPA-3a, HPA-6a and HPA-7a antibodies (PubMed=21208305).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6138; ITGA2B.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6156; ITGB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Hp-E-1
AC   CVCL_HF43
DR   Wikidata; Q54890199
RX   PubMed=27083164;
CC   Group: Insect cell line.
CC   Doubling time: 136.7 hours (PubMed=27083164).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=93412; ! Holotrichia parallela (Dark black chafer beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   HP-mock (neo/puro)
AC   CVCL_E2T8
RX   PubMed=21208305;
RX   PubMed=21286877;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for many anti-HPA antibodies cell lines.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   HP-mock (puro)
AC   CVCL_C0UQ
SY   HP-mock
DR   Wikidata; Q112929738
RX   PubMed=19389219;
RX   PubMed=20812998;
RX   PubMed=23245717;
RX   PubMed=24387678;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for many anti-HPA antibodies cell lines.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   HP-Nak
AC   CVCL_C0UP
SY   HP-CD36
DR   Wikidata; Q112929737
RX   PubMed=19389219;
RX   PubMed=24387678;
CC   Population: Caucasian.
CC   Biotechnology: Used in assay systems for the detection of CD36 antibodies (PubMed=19389219; PubMed=24387678).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1663; CD36.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   Hp-SWN-14F
AC   CVCL_JM62
DR   Wikidata; Q54890200
RX   PubMed=26657314;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=26657314
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D21S11: 30,31
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C6557; Schwannomatosis
DI   ORDO; Orphanet_93921; Schwannomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   HP-W
AC   CVCL_6G12
DR   Wikidata; Q54890201
RX   PubMed=1318503;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G10 ! HP-A1
OI   CVCL_6G11 ! HP-A2
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HP100-1
AC   CVCL_8710
SY   HL60 HP100-1
DR   CLO; CLO_0050987
DR   cancercelllines; CVCL_8710
DR   RCB; RCB0769
DR   Wikidata; Q54890202
RX   PubMed=2796382;
RX   PubMed=9290701;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_16240; Hydrogen peroxide.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB0769
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   HP121D7
AC   CVCL_F1HW
SY   121D7
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HP123E4
AC   CVCL_F1HX
SY   123E4
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HP123E6
AC   CVCL_F1HY
SY   123E6
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HP124E1
AC   CVCL_F1HZ
SY   124E1
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HP50-2
AC   CVCL_8711
SY   HL60 HP50-2
DR   CLO; CLO_0050977
DR   cancercelllines; CVCL_8711
DR   RCB; RCB0768
DR   Wikidata; Q54890203
RX   PubMed=2796382;
RX   PubMed=9290701;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_16240; Hydrogen peroxide.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB0768
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   HP6000
AC   CVCL_C481
DR   CLO; CLO_0003798
DR   ATCC; CRL-1754
DR   Wikidata; Q54890204
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human IgG (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6001
AC   CVCL_C482
DR   CLO; CLO_0003799
DR   ATCC; CRL-1755
DR   Wikidata; Q54890205
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human IgG1 (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6002
AC   CVCL_C483
DR   CLO; CLO_0003800
DR   ATCC; CRL-1788
DR   Wikidata; Q54890206
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG2 (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6003
AC   CVCL_C484
DR   CLO; CLO_0003801
DR   ATCC; CRL-1756
DR   Wikidata; Q54890207
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG3 (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6014
AC   CVCL_C485
DR   CLO; CLO_0003802
DR   ATCC; CRL-1752
DR   Wikidata; Q54890208
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG2 (Fd).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6016
AC   CVCL_C486
DR   CLO; CLO_0003803
DR   ATCC; CRL-1787
DR   Wikidata; Q54890209
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6017
AC   CVCL_C487
DR   CLO; CLO_0003804
DR   ATCC; CRL-1753
DR   Wikidata; Q54890210
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human IgG (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6020
AC   CVCL_C488
DR   CLO; CLO_0003805
DR   ATCC; CRL-1789
DR   Wikidata; Q54890211
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human IgG4 (Fab).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6023
AC   CVCL_C489
DR   CLO; CLO_0003806
DR   ATCC; CRL-1776
DR   Wikidata; Q54890212
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human IgG4 (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6025
AC   CVCL_C490
DR   CLO; CLO_0003807
DR   ATCC; CRL-1775
DR   Wikidata; Q54890213
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG4 (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6045
AC   CVCL_C491
DR   CLO; CLO_0003808
DR   ATCC; CRL-1757
DR   Wikidata; Q54890214
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6047
AC   CVCL_C492
DR   CLO; CLO_0003809
DR   ATCC; CRL-1774
DR   Wikidata; Q54890215
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG3 (hinge).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6050
AC   CVCL_C493
DR   CLO; CLO_0003810
DR   ATCC; CRL-1768
DR   Wikidata; Q54890216
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG3 (hinge).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP6053
AC   CVCL_C494
SY   HP 6053
DR   CLO; CLO_0003811
DR   ATCC; CRL-1758
DR   ECACC; 94050510
DR   Wikidata; Q54890217
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   HP6054
AC   CVCL_C495
SY   HP 6054
DR   CLO; CLO_0003812
DR   ATCC; CRL-1763
DR   ECACC; 93092704
DR   Wikidata; Q54890220
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human Ig lambda light chains.
CC   Discontinued: ECACC; 93092704; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   HP6058
AC   CVCL_C496
DR   CLO; CLO_0003813
DR   ATCC; CRL-1786
DR   Wikidata; Q54890221
RX   PubMed=6209201;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgG (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   HP75
AC   CVCL_3516
SY   HP-75
DR   ATCC; CRL-2506
DR   BioSample; SAMN03471601
DR   Wikidata; Q54890222
RX   DOI=10.1007/BF02782609;
RX   PubMed=15541569;
RX   PubMed=15734994;
CC   Doubling time: ~2 days (DOI=10.1007/BF02782609).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=AD-SVR4).
CC   Discontinued: ATCC; CRL-2506; true.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
ST   Source(s): ATCC=CRL-2506
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 7,8
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C3329; Pituitary gland adenoma
DI   ORDO; Orphanet_99408; Pituitary adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   HP91A3
AC   CVCL_F1I0
SY   91A3
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HP92D5
AC   CVCL_F1I1
SY   92D5
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HP93G7
AC   CVCL_F1G2
SY   93G7
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HP94B10
AC   CVCL_F1I2
SY   94B10
RX   PubMed=6341819;
RX   PubMed=6768828;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53554; 4,4'-azodibenzenearsonic acid (p-Azobenzenearsonate).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HPA [Human oral cavity adenoma]
AC   CVCL_W418
DR   Wikidata; Q54890223
RX   PubMed=6243244;
CC   Population: Japanese.
CC   Derived from site: In situ; Salivary gland, palatine gland; UBERON=UBERON_0002447.
DI   NCIt; C6242; Oral cavity pleomorphic adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   HPA [Human pituitary adenoma]
AC   CVCL_ZV97
SY   Human Pituitary Adenoma
DR   Wikidata; Q102114147
RX   PubMed=4053045;
RX   PubMed=31728905;
CC   Population: Japanese.
CC   Characteristics: Secretes prolactin.
CC   Doubling time: 14 hours (PubMed=4053045).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
DI   NCIt; C3329; Pituitary gland adenoma
DI   ORDO; Orphanet_99408; Pituitary adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   HPa 33
AC   CVCL_Z875
SY   HPa-33; H Pa 33
DR   Wikidata; Q54890224
RX   DOI=10.1016/0022-1910(75)90074-8;
RX   PubMed=4810369;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=6978; ! Periplaneta americana (American cockroach)
SX   Male
AG   Nymph
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPa 34
AC   CVCL_Z876
SY   HPa-34
DR   Wikidata; Q54890225
RX   DOI=10.1016/0022-1910(75)90074-8;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=6978; ! Periplaneta americana (American cockroach)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPAC
AC   CVCL_3517
SY   Hpac
DR   BTO; BTO_0004121
DR   CLO; CLO_0003814
DR   EFO; EFO_0002197
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2119
DR   BCRC; 60495
DR   BioSample; SAMN03472247
DR   BioSample; SAMN10987698
DR   cancercelllines; CVCL_3517
DR   CCRID; 1101HUM-PUMC000189
DR   Cell_Model_Passport; SIDM00670
DR   ChEMBL-Cells; CHEMBL3308388
DR   ChEMBL-Targets; CHEMBL612595
DR   Cosmic; 913306
DR   Cosmic; 1571784
DR   Cosmic; 1995444
DR   Cosmic; 2434094
DR   Cosmic-CLP; 1298136
DR   DepMap; ACH-000270
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298136
DR   GEO; GSM206509
DR   GEO; GSM621897
DR   GEO; GSM784701
DR   GEO; GSM887089
DR   GEO; GSM888160
DR   GEO; GSM1024401
DR   GEO; GSM1374545
DR   GEO; GSM1669892
DR   IARC_TP53; 21070
DR   IGRhCellID; HPAC
DR   LiGeA; CCLE_795
DR   LINCS_LDP; LCL-1735
DR   PharmacoDB; HPAC_564_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   PRIDE; PXD032263
DR   Progenetix; CVCL_3517
DR   PubChem_Cell_line; CVCL_3517
DR   Wikidata; Q54890226
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=15367885;
RX   PubMed=20215515;
RX   PubMed=20418756;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25939163;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Characteristics: Established from a nude mouse xenograft (ATCC=CRL-2119).
CC   Doubling time: 38 +- 6 hours (Note=At 5th passage), 41 +- 2 hours (Note=At 90th passage) (PubMed=25939163); 23 hours (PubMed=25984343).
CC   HLA typing: A*03:01,03:01; B*14:02,14:02; C*08:02,08:02; DQA1*03:02,03:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (PubMed=15367885).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=15367885).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15367885).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.23%; Native American=0.7%; East Asian, North=2.44%; East Asian, South=0%; South Asian=0%; European, North=62.15%; European, South=34.47% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): ATCC=CRL-2119; CCRID=1101HUM-PUMC000189; Cosmic-CLP=1298136; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 15,17
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 15,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   HPaC-79
AC   CVCL_M121
SY   HPaC 79; HPaC79
DR   Wikidata; Q54890228
RX   PubMed=3138611;
RX   PubMed=6837290;
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5942; Parotid gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   HPAE-26
AC   CVCL_3716
SY   Human Pulmonary Artery Endothelial-26; WC00107
DR   CLO; CLO_0003815
DR   ATCC; CRL-2598
DR   BioSample; SAMN03471687
DR   Coriell; WC00107
DR   Wikidata; Q54890229
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least 29 PDL (ATCC=CRL-2598).
CC   Discontinued: ATCC; CRL-2598; true.
CC   Discontinued: Coriell; WC00107; probable.
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
ST   Source(s): ATCC=CRL-2598
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13,14
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E12 ! HAAE-26
OI   CVCL_3292 ! HIVE-26
OI   CVCL_3718 ! HPVE-26
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   HPAF
AC   CVCL_B284
SY   HPAF-I
DR   cancercelllines; CVCL_B284
DR   Cosmic; 724640
DR   Cosmic; 736274
DR   Cosmic; 808174
DR   Cosmic; 872999
DR   Cosmic; 922245
DR   Cosmic; 933527
DR   Cosmic; 948376
DR   Cosmic; 948735
DR   IARC_TP53; 28521
DR   Wikidata; Q54890230
RX   PubMed=7034925;
RX   PubMed=8026879;
RX   PubMed=8194712;
RX   PubMed=8426738;
RX   PubMed=11169957;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=8026879; PubMed=8426738).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Homozygous (PubMed=8026879; PubMed=8194712; PubMed=8426738).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   HPAF-II
AC   CVCL_0313
SY   HPAF II; HPAFII; HPAF-2; HPAF2; HPAF/CD18; CD18/HPAF; HPAF-II/CD18; CD-18; CD18; CD 18
DR   BTO; BTO_0003266
DR   CLO; CLO_0003816
DR   EFO; EFO_0002198
DR   MCCL; MCC:0000206
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1997
DR   BioGRID_ORCS_Cell_line; 236
DR   BioSample; SAMN03471950
DR   BioSample; SAMN10987875
DR   cancercelllines; CVCL_0313
DR   CCRID; 3101HUMSCSP5011
DR   Cell_Model_Passport; SIDM00669
DR   CGH-DB; 165-1
DR   CGH-DB; 9274-4
DR   ChEMBL-Cells; CHEMBL3308744
DR   ChEMBL-Targets; CHEMBL1075467
DR   CLS; 305088
DR   Cosmic; 710858
DR   Cosmic; 724869
DR   Cosmic; 868241
DR   Cosmic; 913304
DR   Cosmic; 922247
DR   Cosmic; 1108343
DR   Cosmic; 1299299
DR   Cosmic; 1320467
DR   Cosmic; 1571777
DR   Cosmic; 2046534
DR   Cosmic; 2434099
DR   Cosmic-CLP; 724869
DR   DepMap; ACH-000094
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724869
DR   GEO; GSM206510
DR   GEO; GSM385517
DR   GEO; GSM385528
DR   GEO; GSM621899
DR   GEO; GSM784696
DR   GEO; GSM827289
DR   GEO; GSM887090
DR   GEO; GSM888161
DR   GEO; GSM1024402
DR   GEO; GSM1374546
DR   GEO; GSM1374547
DR   GEO; GSM1669893
DR   IARC_TP53; 944
DR   IGRhCellID; HPAFII
DR   IZSLER; BS TCL 170
DR   LiGeA; CCLE_028
DR   LINCS_LDP; LCL-1736
DR   MetaboLights; MTBLS812
DR   PharmacoDB; HPAFII_565_2019
DR   PRIDE; PXD003198
DR   Progenetix; CVCL_0313
DR   PubChem_Cell_line; CVCL_0313
DR   TOKU-E; 4028
DR   Wikidata; Q54890231
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=1764370;
RX   PubMed=2734279;
RX   PubMed=11787853;
RX   PubMed=12068308;
RX   PubMed=12692724;
RX   PubMed=15126341;
RX   PubMed=15367885;
RX   PubMed=15367897;
RX   PubMed=18380791;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20418756;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31037374;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=2734279); 70 hours (PubMed=25984343).
CC   HLA typing: A*01:01,26:01; B*08:01,55:01; C*03:03,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg29_Ala34del (c.85_102del18); Zygosity=Heterozygous (PubMed=11787853; PubMed=15367885; Cosmic-CLP=724869; DepMap=ACH-000094).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=11787853; PubMed=12068308; PubMed=15367885; Cosmic-CLP=724869; DepMap=ACH-000094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Homozygous (PubMed=11787853; PubMed=15367885; Cosmic-CLP=724869; DepMap=ACH-000094).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.96%; Native American=0.23%; East Asian, North=0.7%; East Asian, South=0%; South Asian=0%; European, North=64.61%; European, South=33.49% (PubMed=30894373).
CC   Caution: Could not find proof that the CD18 subline of HPAF is really HPAF-II but many indirect evidences points in this direction. If someone read this comment and can help us, please do.
CC   Caution: TP53 mutation indicated incorrectly as being at c.452C>T in PubMed=1764370.
CC   Misspelling: HPAF11; PubMed=25984343.
CC   Misspelling: Hapaf-II; Note=Occasionally.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-1997; Cosmic-CLP=724869; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 12
ST   D21S11: 30,31
ST   D2S1338: 16,19
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 11,12
ST   F13A01: 5,17
ST   F13B: 8,10
ST   FESFPS: 11,12
ST   FGA: 21,24
ST   LPL: 10
ST   Penta D: 9,13
ST   Penta E: 10,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B284 ! HPAF
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   HPAF-II/Cas9-hyg
AC   CVCL_C9DQ
DR   GeneCopoeia; SL528
DR   Wikidata; Q123031683
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL528).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg29_Ala34del (c.85_102del18); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B284 ! HPAF
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HPAF/CD11
AC   CVCL_B285
SY   HPAF-CD11; CD11/HPAF; CD11; CD-11; CD 11
DR   cancercelllines; CVCL_B285
DR   Cosmic; 922246
DR   Wikidata; Q54890232
RX   PubMed=2734279;
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=2734279).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B284 ! HPAF
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   HPAF1
AC   CVCL_1Y72
DR   EFO; EFO_0006279
DR   Wikidata; Q54890233
RX   Patent=US5462870;
RX   PubMed=7713331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11707.
CC   Doubling time: ~43 hours (PubMed=7713331).
CC   Derived from site: In situ; Salivary gland, parotid gland, epithelium; UBERON=UBERON_0003360.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   HPAM1
AC   CVCL_1Y73
DR   EFO; EFO_0006280
DR   Wikidata; Q54890234
RX   Patent=US5462870;
RX   PubMed=7713331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11706.
CC   Doubling time: ~41 hours (PubMed=7713331).
CC   Derived from site: In situ; Salivary gland, parotid gland, epithelium; UBERON=UBERON_0003360.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   HPB-ALL
AC   CVCL_1820
SY   HPB/ALL; HPBALL; FCCH1018
DR   BTO; BTO_0001952
DR   CLO; CLO_0003817
DR   CLO; CLO_0050988
DR   EFO; EFO_0022458
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN01821632
DR   BioSample; SAMN03473562
DR   BioSample; SAMN10988462
DR   cancercelllines; CVCL_1820
DR   Cell_Model_Passport; SIDM01618
DR   ChEMBL-Cells; CHEMBL4295419
DR   ChEMBL-Targets; CHEMBL4296435
DR   Cosmic; 801726
DR   Cosmic; 913406
DR   Cosmic; 919159
DR   Cosmic; 933550
DR   Cosmic; 998736
DR   Cosmic; 999754
DR   Cosmic; 1037689
DR   Cosmic; 1115583
DR   Cosmic; 1130235
DR   Cosmic; 1151779
DR   Cosmic; 1224373
DR   Cosmic; 1281368
DR   Cosmic; 1330499
DR   Cosmic; 1524796
DR   Cosmic; 1641378
DR   Cosmic; 1664521
DR   Cosmic; 1760522
DR   Cosmic; 2165711
DR   Cosmic; 2602914
DR   DepMap; ACH-000942
DR   DSMZ; ACC-483
DR   DSMZCellDive; ACC-483
DR   FANTOM5_SSTAR; 10429-106D6
DR   GEO; GSM887091
DR   GEO; GSM888162
DR   GEO; GSM5137717
DR   IARC_TP53; 21703
DR   LiGeA; CCLE_898
DR   Lonza; 250
DR   NCBI_Iran; C213
DR   PharmacoDB; HPBALL_566_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_1820
DR   PubChem_Cell_line; CVCL_1820
DR   RCB; RCB1935
DR   TKG; TKG 0199
DR   Wikidata; Q54890235
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=203546;
RX   PubMed=1373528;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6181032;
RX   PubMed=6582512;
RX   PubMed=6749281;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=8957066;
RX   PubMed=9510473;
RX   PubMed=9738977;
RX   PubMed=9933131;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12661009;
RX   PubMed=15472075;
RX   PubMed=16142349;
RX   PubMed=17170727;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35354797;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/hpb-all/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-55.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~50 hours (DSMZ=ACC-483).
CC   HLA typing: A*24:02,24:02; B*15:07,52:01; C*03:03,12:02 (PubMed=26589293).
CC   HLA typing: A*24:02:01,24:02:01; B*15:07:01,52:01:01; C*03:03:01,12:02:02 (DSMZCellDive=ACC-483).
CC   Microsatellite instability: Instable (MSI) (PubMed=10739008; PubMed=11226526; PubMed=31068700).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Ala134Ser (c.400G>T); Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg159Ser (c.477G>T); ClinVar=VCV000375959; Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (PubMed=16142349; DepMap=ACH-000942).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=22675565).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser121Ter (c.362C>A); Zygosity=Unspecified (PubMed=22675565).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.04%; East Asian, South=20.81%; South Asian=1.14%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-483; RCB=RCB1935; TKG=TKG 0199
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 15,19
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 19,23
ST   Penta D: 9,11
ST   Penta E: 10,15
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 18,20
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   HPB-ATL-2
AC   CVCL_VN78
SY   ATL-2
DR   Wikidata; Q94216609
RX   PubMed=2140233;
RX   PubMed=2874115;
RX   PubMed=10849313;
RX   PubMed=15871724;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   HPB-ATL-O
AC   CVCL_VN76
SY   HPB-ATL-0; PB-ATL-O
DR   Wikidata; Q94216613
RX   PubMed=2140233;
RX   PubMed=15871724;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VN75 ! HLN-ATL-O
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   HPB-ATL-T
AC   CVCL_VN77
SY   ATL-T
DR   Wikidata; Q94216616
RX   PubMed=2140233;
RX   PubMed=2874115;
RX   PubMed=15871724;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   HPB-CTL-I
AC   CVCL_VN79
SY   HPB-CTL-1; CTL-I; CTL-1
DR   Wikidata; Q94216621
RX   PubMed=2140233;
RX   PubMed=2874115;
RX   PubMed=15871724;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   HPB-Ma
AC   CVCL_E8AT
RX   PubMed=8392185;
CC   Population: Japanese.
CC   Virology: Infected with Moloney murine leukemia virus (MoMuLV) from MiCl1 (S+L-) (Cellosaurus=CVCL_3405) cells (PubMed=8392185).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1820 ! HPB-ALL
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HPB-Ma clone 10-2
AC   CVCL_E8AU
RX   PubMed=8392185;
CC   Population: Japanese.
CC   Virology: Infected with Moloney murine leukemia virus (MoMuLV) from MiCl1 (S+L-) (Cellosaurus=CVCL_3405) cells (from parent cell line).
CC   Virology: Supports replication of hepatitis C virus genome. Can persist up to 76 days (PubMed=8392185).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AT ! HPB-Ma
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HPB-MB
AC   CVCL_WL85
DR   ICLDB; hpb-mb
DR   Wikidata; Q94216626
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MB 17S
AC   CVCL_WL89
DR   ICLDB; hpb-mb-17s
DR   Wikidata; Q94216630
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_WL85 ! HPB-MB
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MB 18E
AC   CVCL_WL90
DR   ICLDB; hpb-mb-18e
DR   Wikidata; Q94216632
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_WL85 ! HPB-MB
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MB 18M
AC   CVCL_WL91
DR   ICLDB; hpb-mb-18m
DR   Wikidata; Q94216638
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_WL85 ! HPB-MB
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MB 18S
AC   CVCL_WL92
DR   ICLDB; hpb-mb-18s
DR   Wikidata; Q94216642
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
RX   DOI=10.1111/j.1439-0418.1981.tb04445.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_WL85 ! HPB-MB
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MB 19E
AC   CVCL_WL93
DR   ICLDB; hpb-mb-19e
DR   Wikidata; Q94216646
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_WL85 ! HPB-MB
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MB 19S
AC   CVCL_WL94
DR   ICLDB; hpb-mb-19s
DR   Wikidata; Q94216649
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_WL85 ! HPB-MB
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MLp-2
AC   CVCL_WU13
DR   Wikidata; Q94216653
RX   DOI=10.1159/000415060;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPB-MLp-W
AC   CVCL_RL83
DR   Wikidata; Q54890236
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2046390;
CC   Population: Japanese.
CC   Doubling time: 72-96 hours (PubMed=2046390).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   HPB-MLT
AC   CVCL_7959
SY   FCCH1019
DR   BioSample; SAMN03151780
DR   cancercelllines; CVCL_7959
DR   Cosmic; 721703
DR   Cosmic; 801733
DR   Cosmic; 998731
DR   RCB; RCB1937
DR   TKG; TKG 0361
DR   Wikidata; Q54890237
RX   PubMed=203546;
RX   PubMed=1370437;
RX   PubMed=1373528;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6198871;
RX   PubMed=6749281;
RX   PubMed=8099376;
RX   PubMed=10071127;
RX   PubMed=10849313;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HPB-ALL derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 62 year old female patient with a T-cell lymphoid malignancy.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00212.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: MPB-MLT; PubMed=10071127.
CC   Discontinued: RCB; RCB1937; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): TKG=TKG 0361
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 18,20
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1820 ! HPB-ALL
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   HPB-Null
AC   CVCL_7960
SY   HPB-NULL; HPB-null; HPB/Null; HPB Null; HPB null
DR   Cosmic; 998711
DR   Cosmic; 999750
DR   Cosmic; 1037727
DR   Cosmic; 2491080
DR   Wikidata; Q54890238
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   HPB-SL
AC   CVCL_WL95
DR   ICLDB; hpb-sl
DR   Wikidata; Q94216689
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   HPB-SL 24E
AC   CVCL_WL96
DR   ICLDB; hpb-sl-24e
DR   Wikidata; Q94216693
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
HI   CVCL_WL95 ! HPB-SL
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   HPB-SL 24S
AC   CVCL_WL97
DR   ICLDB; hpb-sl-24s
DR   Wikidata; Q94216696
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
HI   CVCL_WL95 ! HPB-SL
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   HPB-SL 25S
AC   CVCL_WL98
DR   ICLDB; hpb-sl-25s
DR   Wikidata; Q94216701
RX   DOI=10.1111/j.1439-0418.1978.tb02444.x;
RX   DOI=10.1111/j.1439-0418.1981.tb04445.x;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
HI   CVCL_WL97 ! HPB-SL 24S
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   HPB-SL 26M
AC   CVCL_WM02
SY   HPB-SL 26 M
DR   ICLDB; hpb-sl-26m
DR   Wikidata; Q94216706
RX   DOI=10.1111/j.1439-0418.1979.tb02499.x;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
HI   CVCL_WL95 ! HPB-SL
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   HPB/ADR
AC   CVCL_UJ09
DR   cancercelllines; CVCL_UJ09
DR   Wikidata; Q94216710
RX   PubMed=1370437;
RX   PubMed=8099376;
CC   Problematic cell line: Contaminated. Parent cell line (HPB-MLT) has been shown to be a HPB-ALL derivative.
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7959 ! HPB-MLT
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   HPB/VP-16
AC   CVCL_UJ10
DR   cancercelllines; CVCL_UJ10
DR   Wikidata; Q94216712
RX   PubMed=1370437;
RX   PubMed=8099376;
CC   Problematic cell line: Contaminated. Parent cell line (HPB-MLT) has been shown to be a HPB-ALL derivative.
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7959 ! HPB-MLT
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   HPC-1
AC   CVCL_6C64
DR   Wikidata; Q54890239
RX   DOI=10.15114/tr.20.33;
CC   Population: Japanese.
CC   Doubling time: 26 hours (DOI=10.15114/tr.20.33).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HPC-1H5
AC   CVCL_6C65
DR   Wikidata; Q54890240
RX   PubMed=12198767;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6C64 ! HPC-1
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPC-1P5
AC   CVCL_6C66
DR   Wikidata; Q54890241
RX   PubMed=12198767;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6C64 ! HPC-1
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPC-3
AC   CVCL_6C67
DR   Wikidata; Q54890242
RX   DOI=10.15114/tr.21.9;
CC   Population: Japanese.
CC   Doubling time: ~21 hours (DOI=10.15114/tr.21.9).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HPC-36
AC   CVCL_M169
DR   Wikidata; Q54890243
RX   PubMed=571046;
RX   PubMed=6244232;
RX   PubMed=15643172;
CC   Miscellaneous: Cell line has been lost (PubMed=15643172).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   HPC-36M
AC   CVCL_8446
SY   HPC36M
DR   BioSample; SAMN03151711
DR   Wikidata; Q54890244
RX   PubMed=8612713;
RX   PubMed=10754530;
RX   PubMed=11416159;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00213.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Caution: Was reported to derive from HPC-36 (Cellosaurus=CVCL_M169).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16
ST   D21S11: 27,28
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   TH01: 7
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HPC-3H4
AC   CVCL_6C68
DR   Wikidata; Q54890245
RX   PubMed=10385366;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6C67 ! HPC-3
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPC-3P4a
AC   CVCL_6C69
DR   Wikidata; Q54890246
RX   PubMed=11345134;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6C67 ! HPC-3
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPC-4
AC   CVCL_6C70
DR   Wikidata; Q54890247
RX   DOI=10.15114/tr.21.9;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (DOI=10.15114/tr.21.9).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HPC-4H4
AC   CVCL_6C71
DR   Wikidata; Q54890248
RX   PubMed=11893931;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6C70 ! HPC-4
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPC-4P4a
AC   CVCL_6C72
DR   Wikidata; Q54890249
RX   PubMed=11893931;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6C70 ! HPC-4
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPC-7
AC   CVCL_RB19
SY   HPC7; Hematopoietic precursor cell-7
DR   GEO; GSM397032
DR   GEO; GSM397033
DR   Wikidata; Q54890250
RX   PubMed=9755174;
RX   PubMed=19346495;
CC   Characteristics: KITLG dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96785; Lhx2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C313 ! CCE
SX   Male
AG   Blastocyst stage
CA   Factor-dependent cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   HPC-92Y
AC   CVCL_C7SM
SY   HPC 92Y; HPC92Y
DR   Wikidata; Q117704502
RX   PubMed=21344157;
CC   From: Yanoma, Shunsuke; Kanagawa Cancer Center; Yokohama; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   HPC-Y0
AC   CVCL_6912
AS   CVCL_A067
SY   HPC-YO; HPCY0
DR   cancercelllines; CVCL_6912
DR   Cosmic; 730529
DR   Wikidata; Q54890252
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=7961102).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C7977; Pancreatic acinar cell carcinoma
DI   ORDO; Orphanet_424046; Acinar cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   HPC-Y1
AC   CVCL_6913
DR   cancercelllines; CVCL_6913
DR   Cosmic; 730518
DR   Wikidata; Q54890253
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HPC-Y11
AC   CVCL_6914
DR   cancercelllines; CVCL_6914
DR   Cosmic; 730521
DR   Wikidata; Q54890254
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=7961102).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   HPC-Y15
AC   CVCL_6915
DR   Wikidata; Q54890255
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=2208167).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   HPC-Y19
AC   CVCL_6916
DR   cancercelllines; CVCL_6916
DR   Cosmic; 730522
DR   Wikidata; Q54890256
RX   PubMed=2208167;
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Unspecified (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HPC-Y21
AC   CVCL_A069
DR   cancercelllines; CVCL_A069
DR   Cosmic; 730524
DR   Wikidata; Q54890257
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=7961102).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   HPC-Y23
AC   CVCL_A068
DR   cancercelllines; CVCL_A068
DR   Cosmic; 730525
DR   Wikidata; Q54890258
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   HPC-Y25
AC   CVCL_6917
DR   cancercelllines; CVCL_6917
DR   Cosmic; 730526
DR   Wikidata; Q54890259
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Doubling time: 41 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HPC-Y3
AC   CVCL_A066
DR   cancercelllines; CVCL_A066
DR   Cosmic; 730519
DR   Wikidata; Q54890260
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7961102).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   HPC-Y5
AC   CVCL_6918
DR   cancercelllines; CVCL_6918
DR   CCRID; 4201PAT-CCTCC00102
DR   Cosmic; 730520
DR   Wikidata; Q54890261
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
RX   PubMed=7961102;
RX   PubMed=8288629;
CC   Population: Japanese.
CC   Doubling time: 33 hours (PubMed=2208167).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7961102).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   HPC-Y9
AC   CVCL_6919
DR   Wikidata; Q54890265
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
CC   Population: Japanese.
CC   Doubling time: 35 hours (PubMed=2208167).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   HPC-YP
AC   CVCL_6920
DR   Wikidata; Q54890266
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
CC   Population: Japanese.
CC   Doubling time: 34 hours (PubMed=2208167).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   HPC-YS
AC   CVCL_6921
DR   Wikidata; Q54890267
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2208167;
CC   Population: Japanese.
CC   Doubling time: 31 hours (PubMed=2208167).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   HPC-YT
AC   CVCL_A070
DR   Cosmic; 730530
DR   Wikidata; Q54890268
RX   PubMed=7961102;
CC   Population: Japanese.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   HPC0A07
AC   CVCL_9T02
SY   HPCOA07
DR   Wikidata; Q54890269
RX   Patent=US7666672;
RX   PubMed=18635871;
CC   Group: Patented cell line.
CC   From: ReNeuron, Ltd; Pencoed; United Kingdom.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 04092302.
CC   Doubling time: ~2 days (Patent=US7666672).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Fetal brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   HPCASRi002-A
AC   CVCL_A8WH
SY   hiPSC-casr2
DR   Wikidata; Q108820497
RX   PubMed=34111698;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1514; CASR; Simple; p.Ile554Serfs*73 (c.1656delA); Zygosity=Heterozygous (PubMed=34111698).
CC   Sequence variation: Mutation; HGNC; HGNC:1514; CASR; Simple; p.Cys739Ter (c.2217T>A); Zygosity=Heterozygous (PubMed=34111698).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131853; Neonatal severe primary hyperparathyroidism
DI   ORDO; Orphanet_417; Neonatal severe primary hyperparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   HPCASRi002-Ae4
AC   CVCL_E4C7
RX   PubMed=39446198;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1514; CASR; Simple_corrected; p.Ile554Serfs*73 (c.1656delA); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39446198).
CC   Sequence variation: Mutation; HGNC; HGNC:1514; CASR; Simple; p.Cys739Ter (c.2217T>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131853; Neonatal severe primary hyperparathyroidism
DI   ORDO; Orphanet_417; Neonatal severe primary hyperparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8WH ! HPCASRi002-A
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HPCT-03-ts
AC   CVCL_9W32
SY   Human Proximal Convoluted Tubule-03-ts
DR   ABM; T0748
DR   Wikidata; Q54890270
RX   PubMed=14748622;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, proximal convoluted tubule; UBERON=UBERON_0001287.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   HPCT-05-wt
AC   CVCL_9W33
SY   Human Proximal Convoluted Tubule-05-wt
DR   ABM; T0747
DR   ECACC; 12020703
DR   Wikidata; Q54890271
RX   PubMed=14748622;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal convoluted tubule; UBERON=UBERON_0001287.
ST   Source(s): ECACC=12020703
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   HPCT-06-wt
AC   CVCL_9W34
SY   Human Proximal Convoluted Tubule-06-wt
DR   Wikidata; Q54890272
RX   PubMed=14748622;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal convoluted tubule; UBERON=UBERON_0001287.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPCT-1E3
AC   CVCL_DG56
SY   HPCT 1E3; HPCT clone 1E3
DR   Wikidata; Q54890273
RX   PubMed=7813520;
RX   PubMed=7813521;
RX   PubMed=8738419;
RX   PubMed=24329745;
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   HPCT-1F9
AC   CVCL_ER20
SY   HPCT 1F9; HPCT clone 1F9
DR   Wikidata; Q54890274
RX   PubMed=7813520;
RX   PubMed=7813521;
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   HPCT-2E9
AC   CVCL_ER21
SY   HPCT 2E9; HPCT clone 2E9
DR   Wikidata; Q54890275
RX   PubMed=7813520;
RX   PubMed=7813521;
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
CA   Hybrid cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   HPD-1NR
AC   CVCL_2072
SY   HPD1NR
DR   CLO; CLO_0003818
DR   DSMZ; ACC-314
DR   DSMZCellDive; ACC-314
DR   TKG; TKG 0722
DR   Wikidata; Q54890276
RX   PubMed=7868943;
CC   Doubling time: ~60-70 hours (DSMZ=ACC-314).
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_2073 ! HPD-2NR
OI   CVCL_T289 ! HPD-3NR
SX   Female
AG   6W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HPD-2NR
AC   CVCL_2073
SY   HPD2NR
DR   CLO; CLO_0003819
DR   DSMZ; ACC-293
DR   DSMZCellDive; ACC-293
DR   TKG; TKG 0723
DR   Wikidata; Q54890277
RX   PubMed=7868943;
CC   Doubling time: ~40 hours (DSMZ=ACC-293).
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_2072 ! HPD-1NR
OI   CVCL_T289 ! HPD-3NR
SX   Female
AG   6W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HPD-3NR
AC   CVCL_T289
SY   HPD3NR
DR   TKG; TKG 0724
DR   Wikidata; Q54890278
RX   PubMed=7868943;
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_2072 ! HPD-1NR
OI   CVCL_2073 ! HPD-2NR
SX   Female
AG   6W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   HPDE
AC   CVCL_4376
SY   Human Pancreatic Duct Epithelial
DR   Wikidata; Q54890279
RX   PubMed=22585861;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): PubMed=22585861
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   HPDE-1/E6E7
AC   CVCL_S973
SY   HPDE1/E6E7; Human Pancreatic Duct Epithelial-1 E6E7 immortalized
DR   Wikidata; Q54890280
RX   PubMed=8669463;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from ampulla of Vater adenocarcinoma.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   HPDE-4/E6E7
AC   CVCL_S974
SY   HPDE4/E6E7; HPDE4; Human Pancreatic Duct Epithelial-4 E6E7 immortalized
DR   Wikidata; Q54890281
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=8669463;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics; 2DE-MS.
CC   Donor information: Established from a patient suffering from acute and chronic pancreatitis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 17
//
ID   HPDE-5/E6E7
AC   CVCL_S975
SY   HPDE5/E6E7; Human Pancreatic Duct Epithelial-5 E6E7 immortalized
DR   Wikidata; Q54890282
RX   PubMed=8669463;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from multiloculated cystadenoma of pancreas.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   HPDE-6/E6E7
AC   CVCL_S972
SY   HPDE6/E6E7; HPDE6-E6E7; HPDE6E6E7; Human Pancreatic Duct Epithelial-6 E6E7 immortalized
DR   EFO; EFO_0005711
DR   ENCODE; ENCBS224AAA
DR   GEO; GSM621854
DR   GEO; GSM816639
DR   Wikidata; Q54890283
RX   PubMed=8669463;
RX   PubMed=11073822;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/HPDE6-E6E7_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a cystadenocarcinoma in the tail of her pancreas.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4376 ! HPDE
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 20
//
ID   HPDE-iKRAS(G12D)
AC   CVCL_YY28
SY   HPDE-iKRASG12D
DR   Wikidata; Q98126697
RX   PubMed=26806015;
CC   Characteristics: Expression the KRAS gene is under the control of doxycycline.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Asp (c.35G>A)).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a cystadenocarcinoma in the tail of her pancreas.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P37 ! HPDE6c11
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 13
//
ID   HPDE-iKRASwt
AC   CVCL_YY29
DR   Wikidata; Q98126698
RX   PubMed=26806015;
CC   Characteristics: Expression the KRAS gene is under the control of doxycycline.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6407; KRAS.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a cystadenocarcinoma in the tail of her pancreas.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P37 ! HPDE6c11
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 13
//
ID   HPDE6c11
AC   CVCL_0P37
DR   Wikidata; Q54890284
RX   PubMed=11073822;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a cystadenocarcinoma in the tail of her pancreas.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S972 ! HPDE-6/E6E7
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   HPDE6c7
AC   CVCL_0P38
SY   HPDE6-C7; H6c7; H6C7; HPDEC
DR   BTO; BTO_0006456
DR   AddexBio; T0018001/74
DR   Kerafast; ECA001-FP
DR   Millipore; SCC442
DR   PRIDE; PXD032263
DR   Wikidata; Q54890285
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=11073822;
RX   PubMed=12499933;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics; 2DE-MS.
CC   Donor information: Established from a patient suffering from a cystadenocarcinoma in the tail of her pancreas.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): Millipore=SCC442
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 13,18
ST   D21S11: 30,33
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 14,16
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 5,10
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S972 ! HPDE-6/E6E7
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 21
//
ID   HPE-15
AC   CVCL_WL66
SY   Human Prostate Epithelial-15
DR   Wikidata; Q94217176
RX   PubMed=31020641;
CC   Doubling time: ~31 hours (PubMed=31020641).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): PubMed=31020641
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   Penta D: 12,13
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL64 ! HPS-14
OI   CVCL_WL65 ! HPS-15
SX   Male
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   HPE-GAC-2
AC   CVCL_WT53
SY   GAC-2
DR   Wikidata; Q94217182
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=3181664;
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPE-GAC-3
AC   CVCL_WT54
SY   GAC-3
DR   Wikidata; Q94217187
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=3181664;
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPE-GAC-4
AC   CVCL_WT55
SY   GAC-4
DR   Wikidata; Q94217190
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPE-GAC-T
AC   CVCL_WT57
SY   GAC-T
DR   Wikidata; Q94217193
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=3181664;
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPE-MLp-K
AC   CVCL_WT69
SY   MLp-K
DR   Wikidata; Q94217198
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=7550995;
RX   PubMed=10849313;
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HPE-MLp-M
AC   CVCL_WT70
SY   MLp-M
DR   Wikidata; Q94217204
RX   PubMed=7550995;
RX   PubMed=10849313;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 6
//
ID   HPE-Ret-3
AC   CVCL_WT66
SY   Ret-3
DR   Wikidata; Q94217208
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=7550995;
CC   Population: Japanese.
CC   Donor information: Established from a patient suffering from 'reticulum cell sarcoma'.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HPET-1
AC   CVCL_EQ24
SY   HPET1; Human Prostate Epithelial/hTERT-1
DR   Wikidata; Q54890286
RX   PubMed=17510410;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HPET-11
AC   CVCL_EQ26
SY   HPET11; Human Prostate Epithelial/hTERT-11
DR   GEO; GSM844559
DR   Wikidata; Q54890287
RX   PubMed=17510410;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   HPET-13
AC   CVCL_EQ27
SY   HPET13; Human Prostate Epithelial/hTERT-13
DR   GEO; GSM844560
DR   GEO; GSM844561
DR   Wikidata; Q54890288
RX   PubMed=17510410;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   HPET-5
AC   CVCL_EQ25
SY   HPET5; Human Prostate Epithelial/hTERT-5
DR   GEO; GSM844562
DR   Wikidata; Q54890289
RX   PubMed=17510410;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   HPh1
AC   CVCL_D7EI
RX   CelloPub=CLPUB00771;
CC   Derived from site: In situ; Pharynx; UBERON=UBERON_0006562.
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   hPheo1
AC   CVCL_IY88
DR   Wikidata; Q54890291
RX   PubMed=23785438;
RX   PubMed=35008989;
CC   Doubling time: ~1.2 days (PubMed=23785438).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): PubMed=23785438
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3326; Adrenal gland pheochromocytoma
DI   ORDO; Orphanet_276621; Sporadic pheochromocytoma/secreting paraganglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   hPheo1 KD-SDHB
AC   CVCL_C6JR
SY   KD-SDHB hPheo1
DR   Wikidata; Q116049333
RX   PubMed=35008989;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10681; SDHB (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C3326; Adrenal gland pheochromocytoma
DI   ORDO; Orphanet_276621; Sporadic pheochromocytoma/secreting paraganglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY88 ! hPheo1
SX   Female
AG   39Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   HPIi001-A
AC   CVCL_A5FA
SY   iPS-6303-C6B3
DR   BioSamples; SAMEA114558319
DR   hPSCreg; HPIi001-A
DR   Wikidata; Q107115356
RX   PubMed=33740643;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Arg185Ser (c.553C>A); ClinVar=VCV000420099; Zygosity=Heterozygous (PubMed=33740643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FB ! HPIi001-B
SX   Female
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   HPIi001-B
AC   CVCL_A5FB
SY   iPS-6303-R12
DR   BioSamples; SAMEA114562355
DR   hPSCreg; HPIi001-B
DR   Wikidata; Q107115358
RX   PubMed=33740643;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Arg185Ser (c.553C>A); ClinVar=VCV000420099; Zygosity=Heterozygous (PubMed=33740643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FA ! HPIi001-A
SX   Female
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   HPIi002-A
AC   CVCL_A5FC
SY   iPS-789-C1
DR   BioSamples; SAMEA114562536
DR   hPSCreg; HPIi002-A
DR   Wikidata; Q107115359
RX   PubMed=34388489;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Asp179Asn (c.541G>A); Zygosity=Heterozygous (PubMed=34388489).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FD ! HPIi002-B
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   HPIi002-B
AC   CVCL_A5FD
SY   iPS-789-C2
DR   BioSamples; SAMEA114562538
DR   hPSCreg; HPIi002-B
DR   Wikidata; Q107115360
RX   PubMed=34388489;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Asp179Asn (c.541G>A); Zygosity=Heterozygous (PubMed=34388489).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FC ! HPIi002-A
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   HPIi003-A
AC   CVCL_C0ZE
SY   iPS-7247-C5
DR   hPSCreg; HPIi003-A
DR   Wikidata; Q114311635
RX   PubMed=35728439;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Ala172Glu (c.515C>A); ClinVar=VCV000128261; Zygosity=Heterozygous (PubMed=35728439).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   HPIi004-A
AC   CVCL_C0ZF
SY   iPS-5964-R3
DR   hPSCreg; HPIi004-A
DR   Wikidata; Q114311636
RX   PubMed=35728440;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian; Romani.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Arg39Ter (c.121C>T); Zygosity=Homozygous (PubMed=35728440).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0ZG ! HPIi004-B
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   HPIi004-B
AC   CVCL_C0ZG
SY   iPS-5964-R6
DR   hPSCreg; HPIi004-B
DR   Wikidata; Q114311637
RX   PubMed=35728440;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian; Romani.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Arg39Ter (c.121C>T); Zygosity=Homozygous (PubMed=35728440).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0ZF ! HPIi004-A
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   HPIi005-A
AC   CVCL_D0FB
SY   RYR1-5-9214-iPSC clone R5
DR   BioSamples; SAMEA114562801
DR   hPSCreg; HPIi005-A
DR   Wikidata; Q123031684
RX   PubMed=38029555;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Asn4715_Asp4718del (c.14145_14156delCTACTGGGACAA); Zygosity=Heterozygous (PubMed=38029555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FC ! HPIi005-B
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HPIi005-B
AC   CVCL_D0FC
SY   RYR1-5-9214-iPSC clone R11
DR   BioSamples; SAMEA114563044
DR   hPSCreg; HPIi005-B
DR   Wikidata; Q123031685
RX   PubMed=38029555;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Asn4715_Asp4718del (c.14145_14156delCTACTGGGACAA); Zygosity=Heterozygous (PubMed=38029555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FB ! HPIi005-A
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HPIi006-A
AC   CVCL_D6KF
SY   RYR1-3278-R2A
DR   BioSamples; SAMEA115133461
DR   hPSCreg; HPIi006-A
DR   Wikidata; Q127381780
RX   PubMed=38583293;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Arg2508Cys (c.7522C>T); ClinVar=VCV000065981; Zygosity=Heterozygous (PubMed=38583293).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   NCIt; C84869; Malignant hyperthermia syndrome
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HPIi007-A
AC   CVCL_D6KG
SY   RYR1-6546-R3B
DR   BioSamples; SAMEA115133462
DR   hPSCreg; HPIi007-A
DR   Wikidata; Q127381782
RX   PubMed=38583293;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Val2168Met (c.6502G>A); ClinVar=VCV000012976; Zygosity=Heterozygous (PubMed=38583293).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   NCIt; C84869; Malignant hyperthermia syndrome
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HPIi008-A
AC   CVCL_D6KH
SY   RYR1-4833-R7
DR   BioSamples; SAMEA115133463
DR   hPSCreg; HPIi008-A
DR   Wikidata; Q127381783
RX   PubMed=38582058;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.His4813Tyr (c.14437C>T); ClinVar=VCV001180698; Zygosity=Heterozygous (PubMed=38582058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HPIi009-A
AC   CVCL_D6KI
SY   RYR1-15377-R1B
DR   BioSamples; SAMEA115133464
DR   hPSCreg; HPIi009-A
DR   Wikidata; Q127381784
RX   PubMed=38582058;
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Asn1346Lys (c.4038C>A); ClinVar=VCV000290117; Zygosity=Heterozygous (PubMed=38582058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C83010; Central core disease
DI   ORDO; Orphanet_597; Central core disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HPIi010-A
AC   CVCL_D6KJ
SY   MYH7-17773-R4A
DR   BioSamples; SAMEA115133465
DR   hPSCreg; HPIi010-A
DR   Wikidata; Q127381785
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: African; Angolan.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Lys1617del (c.4850_4852delAGA) (c.4844AGA[2]); ClinVar=VCV000190401; Zygosity=Heterozygous (hPSCreg=HPIi010-A).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206090; Autosomal dominant myosin storage congenital myopathy 7A
DI   ORDO; Orphanet_53698; Myosin storage myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HPIi011-A
AC   CVCL_D6KK
SY   MYH7-18681-R1A
DR   BioSamples; SAMEA115133466
DR   hPSCreg; HPIi011-A
DR   Wikidata; Q127381786
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Afghanistan; Persian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Lys1617del (c.4850_4852delAGA) (c.4844AGA[2]); ClinVar=VCV000190401; Zygosity=Heterozygous (hPSCreg=HPIi011-A).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206090; Autosomal dominant myosin storage congenital myopathy 7A
DI   ORDO; Orphanet_53698; Myosin storage myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HPIi012-A
AC   CVCL_D6KL
SY   MYH7-19203-R1D
DR   BioSamples; SAMEA115133467
DR   hPSCreg; HPIi012-A
DR   Wikidata; Q127381787
CC   From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Lys1617del (c.4850_4852delAGA) (c.4844AGA[2]); ClinVar=VCV000190401; Zygosity=Heterozygous (hPSCreg=HPIi012-A).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206090; Autosomal dominant myosin storage congenital myopathy 7A
DI   ORDO; Orphanet_53698; Myosin storage myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HPK-1A
AC   CVCL_D890
SY   HPK1A; HPK IA; HPKIA
DR   BTO; BTO_0005276
DR   Wikidata; Q54890290
RX   DOI=10.1007/978-1-4612-0411-4_3;
RX   PubMed=1618864;
RX   PubMed=1742725;
RX   PubMed=2556855;
RX   PubMed=2838778;
RX   PubMed=21439369;
CC   Virology: Contains 2 to 3 copies of the complete HPV16 genomes arranged in a head-to-tail fashion and integrated at a single chromosomal site.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   HPK-1A-ras
AC   CVCL_D891
SY   HPK-1A/ras; HPK1A-ras; KiMSV/HPK-1A; K-ras/HPK-1A
DR   BTO; BTO_0005275
DR   Wikidata; Q54890292
RX   DOI=10.1007/978-1-4612-0411-4_3;
RX   PubMed=1742725;
RX   PubMed=2556855;
CC   Virology: Contains several complete HPV16 genomes arranged in a head-to-tail fashion and integrated at a single chromosomal site.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D890 ! HPK-1A
SX   Male
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   HPK1A-AS
AC   CVCL_C8BL
DR   Wikidata; Q123031686
RX   PubMed=1618864;
CC   Genetic integration: Method=Transduction; Gene=RGD; 3441; Pthlh (Note=In antisense orientation).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D890 ! HPK-1A
SX   Male
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   HPL-Ad-K
AC   CVCL_WT47
SY   Ad-K
DR   Wikidata; Q94217322
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPL-GCC-1
AC   CVCL_WT48
DR   Wikidata; Q94217325
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPL-GCC-2
AC   CVCL_WT49
DR   Wikidata; Q94217330
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   HPL-Hod-1
AC   CVCL_WT62
SY   HPL-HOD-1; Hod-1
DR   Wikidata; Q94217335
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=6749281;
RX   PubMed=10849313;
RX   PubMed=11380694;
RX   PubMed=29533902;
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HPL-Hod-2
AC   CVCL_WT63
SY   Hod-2
DR   Wikidata; Q94217339
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=6749281;
WW   Info; KAKEN; 10670159; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-10670159/
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   HPL-MmC
AC   CVCL_WT58
DR   Wikidata; Q94217342
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HPL-Oat-3
AC   CVCL_WT52
DR   Wikidata; Q94217344
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   HPL1A
AC   CVCL_9863
DR   EFO; EFO_0006907
DR   RCB; RCB5661
DR   Wikidata; Q54890293
RX   PubMed=9354455;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, parenchyma; UBERON=UBERON_0008946.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9864 ! HPL1B
OI   CVCL_9865 ! HPL1C
OI   CVCL_8880 ! HPL1D
OI   CVCL_9866 ! HPL1E
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 12
//
ID   HPL1B
AC   CVCL_9864
DR   EFO; EFO_0002705
DR   Wikidata; Q54890294
RX   PubMed=9354455;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, parenchyma; UBERON=UBERON_0008946.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9863 ! HPL1A
OI   CVCL_9865 ! HPL1C
OI   CVCL_8880 ! HPL1D
OI   CVCL_9866 ! HPL1E
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 12
//
ID   HPL1C
AC   CVCL_9865
DR   EFO; EFO_0006908
DR   Wikidata; Q54890295
RX   PubMed=9354455;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, parenchyma; UBERON=UBERON_0008946.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9863 ! HPL1A
OI   CVCL_9864 ! HPL1B
OI   CVCL_8880 ! HPL1D
OI   CVCL_9866 ! HPL1E
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 12
//
ID   HPL1D
AC   CVCL_8880
DR   BTO; BTO_0003214
DR   EFO; EFO_0006909
DR   RCB; RCB5662
DR   Wikidata; Q54890296
RX   PubMed=9354455;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, parenchyma; UBERON=UBERON_0008946.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9863 ! HPL1A
OI   CVCL_9864 ! HPL1B
OI   CVCL_9865 ! HPL1C
OI   CVCL_9866 ! HPL1E
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   HPL1E
AC   CVCL_9866
DR   EFO; EFO_0006910
DR   Wikidata; Q54890297
RX   PubMed=9354455;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, parenchyma; UBERON=UBERON_0008946.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9863 ! HPL1A
OI   CVCL_9864 ! HPL1B
OI   CVCL_9865 ! HPL1C
OI   CVCL_8880 ! HPL1D
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 12
//
ID   HPLA-A3
AC   CVCL_6G77
DR   cancercelllines; CVCL_6G77
DR   Wikidata; Q54890298
RX   PubMed=22687401;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 17
//
ID   HPM clone #3
AC   CVCL_E7FW
SY   HP proMastocyte clone #3
RX   DOI=10.1016/j.jaci.2012.12.1081;
RX   PubMed=27459687;
CC   Doubling time: 3-4 days (DOI=10.1016/j.jaci.2012.12.1081; PubMed=27459687).
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.His497Glnfs*90 (c.1472_1487dup16); ClinVar=VCV000005277; Zygosity=Homozygous (DOI=10.1016/j.jaci.2012.12.1081).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7FX ! HPM clone #4
SX   Male
AG   24-47Y
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HPM clone #4
AC   CVCL_E7FX
SY   HP proMastocyte clone #4
RX   DOI=10.1016/j.jaci.2012.12.1081;
RX   PubMed=27459687;
CC   Doubling time: 3-4 days (DOI=10.1016/j.jaci.2012.12.1081; PubMed=27459687).
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.His497Glnfs*90 (c.1472_1487dup16); ClinVar=VCV000005277; Zygosity=Homozygous (DOI=10.1016/j.jaci.2012.12.1081).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7FW ! HPM clone #3
SX   Male
AG   24-47Y
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HPM clone #4-HPS1
AC   CVCL_E7FY
RX   PubMed=27459687;
CC   Characteristics: Transduction of HPS1 reduces and nearly normalizes the secretion of IL6 and IL8, but not CSF2 or TNF (PubMed=27459687).
CC   Sequence variation: Mutation; HGNC; HGNC:5163; HPS1; Simple; p.His497Glnfs*90 (c.1472_1487dup16); ClinVar=VCV000005277; Zygosity=Homozygous (DOI=10.1016/j.jaci.2012.12.1081).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5163; HPS1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
DI   NCIt; C150367; Hermansky-Pudlak syndrome 1
DI   ORDO; Orphanet_231500; Hermansky-Pudlak syndrome with pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7FX ! HPM clone #4
SX   Male
AG   24-47Y
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HPME
AC   CVCL_3717
SY   High Passage Mouse Embryo
DR   CLO; CLO_0003820
DR   ATCC; CRL-6589
DR   Wikidata; Q54890299
RX   PubMed=4332936;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6589; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   HPMEC-ST1.6R
AC   CVCL_8712
DR   Wikidata; Q54890300
RX   PubMed=11742042;
RX   PubMed=12453433;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   hPOB-tert
AC   CVCL_HA41
DR   Wikidata; Q54890301
RX   PubMed=11864909;
CC   Doubling time: 20.8 hours (PubMed=11864909).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, femur, periosteum; UBERON=UBERON_0016896.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 10
//
ID   HPr-1
AC   CVCL_B7J3
DR   EFO; EFO_0022591
DR   Wikidata; Q112929741
RX   PubMed=10398276;
RX   PubMed=11431162;
CC   Population: Hispanic.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   HPr-1-AR
AC   CVCL_B7J4
DR   Wikidata; Q112929744
RX   PubMed=11431162;
RX   PubMed=27203692;
RX   PubMed=30865707;
CC   Population: Hispanic.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7J3 ! HPr-1
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   Hpr-4
AC   CVCL_4706
DR   CLO; CLO_0051572
DR   RCB; RCB1728
DR   Wikidata; Q54890303
RX   PubMed=8205225;
CC   Selected for resistance to: ChEBI; CHEBI_16240; Hydrogen peroxide.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HPR116
AC   CVCL_WL73
DR   Wikidata; Q94217445
WW   Provider; Biopredic; -; https://web.archive.org/web/20230106012420/https://www.heparg.com/rubrique-differentiated-heparg-cells-hpr116
CC   Characteristics: HepaRG cells cryopreserved after differentiation (Biopredic=.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   HPR600
AC   CVCL_9U05
SY   HPR-600
DR   Wikidata; Q54890304
RX   PubMed=8895552;
RX   PubMed=11414198;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   26Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   hPrEC-T-deltaN2A, clone 1
AC   CVCL_A2EM
SY   T-deltaN2A, clone 1
DR   Wikidata; Q105507721
RX   PubMed=32873916;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2EN ! hPrEC-T-deltaN2A, clone 2
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   hPrEC-T-deltaN2A, clone 2
AC   CVCL_A2EN
SY   T-deltaN2A, clone 2
DR   Wikidata; Q105507724
RX   PubMed=32873916;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2EM ! hPrEC-T-deltaN2A, clone 1
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   HPRS-1
AC   CVCL_8447
SY   HPRS line 1; MDCC-HP1; HP1
DR   Wikidata; Q54890305
RX   PubMed=69431;
RX   PubMed=797387;
RX   PubMed=4547318;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   HPRS-2
AC   CVCL_8448
SY   HPRS line 2; MDCC-HP2; HP2
DR   Wikidata; Q54890309
RX   PubMed=69431;
RX   PubMed=797387;
RX   PubMed=3273463;
RX   PubMed=4547318;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 13.4 hours (PubMed=3273463).
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   HPS-10
AC   CVCL_WL60
SY   Human Prostate Stromal-10
DR   Wikidata; Q94217483
RX   PubMed=20383666;
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL61 ! HPS-11
SX   Male
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPS-11
AC   CVCL_WL61
SY   Human Prostate Stromal-11
DR   Wikidata; Q94217488
RX   PubMed=20383666;
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL60 ! HPS-10
SX   Male
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPS-12
AC   CVCL_WL62
SY   Human Prostate Stromal-12
DR   Wikidata; Q94217494
RX   PubMed=20383666;
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL63 ! HPS-13
SX   Male
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPS-13
AC   CVCL_WL63
SY   Human Prostate Stromal-13
DR   Wikidata; Q94217499
RX   PubMed=20383666;
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL62 ! HPS-12
SX   Male
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPS-14
AC   CVCL_WL64
SY   Human Prostate Stromal-14
DR   Wikidata; Q94217505
RX   PubMed=20383666;
RX   PubMed=31020641;
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
ST   Source(s): PubMed=31020641
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL66 ! HPE-15
OI   CVCL_WL65 ! HPS-15
SX   Male
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPS-15
AC   CVCL_WL65
SY   Human Prostate Stromal-15
DR   Wikidata; Q94217509
RX   PubMed=20383666;
RX   PubMed=31020641;
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
ST   Source(s): PubMed=31020641
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL66 ! HPE-15
OI   CVCL_WL64 ! HPS-14
SX   Male
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0059
AC   CVCL_6C74
DR   RCB; HPS0059
DR   SKIP; SKIP000806
DR   Wikidata; Q54890310
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0060
AC   CVCL_6C75
DR   RCB; HPS0060
DR   SKIP; SKIP000807
DR   Wikidata; Q54890311
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM51 ! HPS0812
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0078
AC   CVCL_T927
DR   RCB; HPS0078
DR   SKIP; SKIP000223
DR   Wikidata; Q54890312
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84595; Bernard-Soulier syndrome
DI   ORDO; Orphanet_274; Bernard-Soulier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G87 ! HPS0191
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0097
AC   CVCL_T964
DR   RCB; HPS0097
DR   SKIP; SKIP000617
DR   Wikidata; Q54890313
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS0097).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   HPS0112
AC   CVCL_A3YG
DR   RCB; HPS0112
DR   Wikidata; Q105507729
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 5
//
ID   HPS0128
AC   CVCL_Y980
SY   A000005#1
DR   SKIP; SKIP000031
DR   Wikidata; Q54890314
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T969 ! HPS0129
OI   CVCL_Y518 ! HPS0130
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0129
AC   CVCL_T969
SY   A000005#2
DR   RCB; HPS0129
DR   SKIP; SKIP000032
DR   SKIP; SKIP000272
DR   Wikidata; Q54890315
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y980 ! HPS0128
OI   CVCL_Y518 ! HPS0130
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HPS0130
AC   CVCL_Y518
SY   A000005#7
DR   RCB; HPS0130
DR   SKIP; SKIP000033
DR   SKIP; SKIP000379
DR   Wikidata; Q54890316
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y980 ! HPS0128
OI   CVCL_T969 ! HPS0129
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0131
AC   CVCL_Y952
SY   A000006#4-2
DR   SKIP; SKIP000037
DR   Wikidata; Q54890317
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y953 ! HPS0132
OI   CVCL_T973 ! HPS0133
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0132
AC   CVCL_Y953
SY   A000006#4-3
DR   SKIP; SKIP000038
DR   Wikidata; Q54890318
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y952 ! HPS0131
OI   CVCL_T973 ! HPS0133
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0133
AC   CVCL_T973
SY   A000006#6-1
DR   RCB; HPS0133
DR   SKIP; SKIP000039
DR   SKIP; SKIP000273
DR   Wikidata; Q54890319
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y952 ! HPS0131
OI   CVCL_Y953 ! HPS0132
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   HPS0134
AC   CVCL_T970
SY   A000007#5
DR   RCB; HPS0134
DR   SKIP; SKIP000040
DR   Wikidata; Q54890320
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y974 ! HPS0135
OI   CVCL_Y975 ! HPS0136
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0135
AC   CVCL_Y974
SY   A000007#6
DR   SKIP; SKIP000041
DR   Wikidata; Q54890321
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T970 ! HPS0134
OI   CVCL_Y975 ! HPS0136
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0136
AC   CVCL_Y975
SY   A000007#7
DR   RCB; HPS0136
DR   SKIP; SKIP000042
DR   SKIP; SKIP000808
DR   Wikidata; Q54890322
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T970 ! HPS0134
OI   CVCL_Y974 ! HPS0135
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0140
AC   CVCL_T967
SY   A000010#1-8
DR   RCB; HPS0140
DR   SKIP; SKIP000046
DR   SKIP; SKIP000613
DR   Wikidata; Q54890324
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y978 ! HPS0141
OI   CVCL_Y979 ! HPS0142
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0141
AC   CVCL_Y978
SY   A000010#3-3
DR   RCB; HPS0141
DR   SKIP; SKIP000047
DR   Wikidata; Q54890325
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T967 ! HPS0140
OI   CVCL_Y979 ! HPS0142
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0142
AC   CVCL_Y979
SY   A000010#3-4
DR   RCB; HPS0142
DR   SKIP; SKIP000048
DR   SKIP; SKIP000614
DR   Wikidata; Q54890326
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T967 ! HPS0140
OI   CVCL_Y978 ! HPS0141
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0143
AC   CVCL_T966
DR   RCB; HPS0143
DR   SKIP; SKIP000274
DR   Wikidata; Q54890327
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C120046; Congenital fiber-type disproportion
DI   ORDO; Orphanet_2020; Congenital fiber-type disproportion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM52 ! HPS0144
OI   CVCL_1Q64 ! HPS0145
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0144
AC   CVCL_VM52
DR   RCB; HPS0144
DR   Wikidata; Q94217694
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C120046; Congenital fiber-type disproportion
DI   ORDO; Orphanet_2020; Congenital fiber-type disproportion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T966 ! HPS0143
OI   CVCL_1Q64 ! HPS0145
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0145
AC   CVCL_1Q64
DR   RCB; HPS0145
DR   SKIP; SKIP000624
DR   Wikidata; Q54890328
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C120046; Congenital fiber-type disproportion
DI   ORDO; Orphanet_2020; Congenital fiber-type disproportion myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T966 ! HPS0143
OI   CVCL_VM52 ! HPS0144
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0146
AC   CVCL_T968
SY   A000023#7
DR   RCB; HPS0146
DR   SKIP; SKIP000052
DR   SKIP; SKIP000275
DR   Wikidata; Q54890329
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y976 ! HPS0147
OI   CVCL_Y977 ! HPS0148
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0147
AC   CVCL_Y976
SY   A000023#10
DR   RCB; HPS0147
DR   SKIP; SKIP000053
DR   SKIP; SKIP000615
DR   Wikidata; Q54890330
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T968 ! HPS0146
OI   CVCL_Y977 ! HPS0148
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0148
AC   CVCL_Y977
SY   A000023#11
DR   RCB; HPS0148
DR   SKIP; SKIP000054
DR   SKIP; SKIP000809
DR   Wikidata; Q54890331
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T968 ! HPS0146
OI   CVCL_Y976 ! HPS0147
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0152
AC   CVCL_Y921
SY   A000074#1
DR   SKIP; SKIP000058
DR   Wikidata; Q54606179
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y922 ! HPS0153
OI   CVCL_Y923 ! HPS0154
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0153
AC   CVCL_Y922
SY   A000074#2
DR   SKIP; SKIP000059
DR   Wikidata; Q54606180
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y921 ! HPS0152
OI   CVCL_Y923 ! HPS0154
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0154
AC   CVCL_Y923
SY   A000074#3
DR   SKIP; SKIP000060
DR   Wikidata; Q54606182
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y921 ! HPS0152
OI   CVCL_Y922 ! HPS0153
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0155
AC   CVCL_Y691
SY   A000088#8
DR   SKIP; SKIP000061
DR   Wikidata; Q54890332
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T928 ! HPS0156
OI   CVCL_Y519 ! HPS0157
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0156
AC   CVCL_T928
SY   A000088#10
DR   RCB; HPS0156
DR   SKIP; SKIP000062
DR   SKIP; SKIP000264
DR   Wikidata; Q54890333
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y691 ! HPS0155
OI   CVCL_Y519 ! HPS0157
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   HPS0157
AC   CVCL_Y519
SY   A000088#12
DR   RCB; HPS0157
DR   SKIP; SKIP000063
DR   SKIP; SKIP000380
DR   Wikidata; Q54890334
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y691 ! HPS0155
OI   CVCL_T928 ! HPS0156
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0158
AC   CVCL_VM59
DR   RCB; HPS0158
DR   Wikidata; Q94217816
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP72 ! HPS0159
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0159
AC   CVCL_UP72
DR   RCB; HPS0159
DR   Wikidata; Q94217820
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM59 ! HPS0158
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0164
AC   CVCL_T929
SY   Riken51
DR   RCB; HPS0164
DR   SKIP; SKIP000245
DR   Wikidata; Q54890335
RX   PubMed=28439558;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex48-50del; Zygosity=Hemizygous (PubMed=28439558).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   HPS0169
AC   CVCL_T930
DR   RCB; HPS0169
DR   SKIP; SKIP000244
DR   Wikidata; Q54890336
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q65 ! HPS0171
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0171
AC   CVCL_1Q65
DR   RCB; HPS0171
DR   SKIP; SKIP000625
DR   Wikidata; Q54890337
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T930 ! HPS0169
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0172
AC   CVCL_Y919
SY   A000009#2
DR   SKIP; SKIP000064
DR   Wikidata; Q54890338
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y920 ! HPS0173
OI   CVCL_T931 ! HPS0174
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0173
AC   CVCL_Y920
SY   A000009#6
DR   SKIP; SKIP000065
DR   Wikidata; Q54890339
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y919 ! HPS0172
OI   CVCL_T931 ! HPS0174
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0174
AC   CVCL_T931
SY   A000009#7
DR   RCB; HPS0174
DR   SKIP; SKIP000066
DR   SKIP; SKIP000243
DR   Wikidata; Q54890340
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y919 ! HPS0172
OI   CVCL_Y920 ! HPS0173
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0175
AC   CVCL_T932
SY   A000027#32-1; iPSC Pompe1
DR   RCB; HPS0175
DR   SKIP; SKIP000079
DR   SKIP; SKIP000249
DR   Wikidata; Q54890341
RX   PubMed=26199952;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Pro266Ser (c.796C>T); ClinVar=VCV000556117; Zygosity=Heterozygous (PubMed=26199952).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Met439Lys (c.1316T>A); ClinVar=VCV000371305; Zygosity=Heterozygous (PubMed=26199952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T933 ! HPS0176
OI   CVCL_T934 ! HPS0177
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   HPS0176
AC   CVCL_T933
SY   A000027#33-1; iPSC Pompe2
DR   RCB; HPS0176
DR   SKIP; SKIP000080
DR   SKIP; SKIP000250
DR   Wikidata; Q54890342
RX   PubMed=26199952;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Pro266Ser (c.796C>T); ClinVar=VCV000556117; Zygosity=Heterozygous (PubMed=26199952).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Met439Lys (c.1316T>A); ClinVar=VCV000371305; Zygosity=Heterozygous (PubMed=26199952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T932 ! HPS0175
OI   CVCL_T934 ! HPS0177
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   HPS0177
AC   CVCL_T934
SY   A000027#34-2; iPSC Pompe3
DR   RCB; HPS0177
DR   SKIP; SKIP000081
DR   SKIP; SKIP000251
DR   Wikidata; Q54890343
RX   PubMed=26199952;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Pro266Ser (c.796C>T); ClinVar=VCV000556117; Zygosity=Heterozygous (PubMed=26199952).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Met439Lys (c.1316T>A); ClinVar=VCV000371305; Zygosity=Heterozygous (PubMed=26199952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T932 ! HPS0175
OI   CVCL_T933 ! HPS0176
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   HPS0178
AC   CVCL_T935
SY   A000032#2
DR   RCB; HPS0178
DR   SKIP; SKIP000082
DR   SKIP; SKIP000242
DR   Wikidata; Q54890344
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM53 ! HPS0179
OI   CVCL_6C76 ! HPS0180
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HPS0179
AC   CVCL_VM53
SY   A000032#3
DR   RCB; HPS0179
DR   SKIP; SKIP000083
DR   Wikidata; Q94217932
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T935 ! HPS0178
OI   CVCL_6C76 ! HPS0180
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0180
AC   CVCL_6C76
SY   A000032#4
DR   RCB; HPS0180
DR   SKIP; SKIP000084
DR   SKIP; SKIP000810
DR   Wikidata; Q54890345
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T935 ! HPS0178
OI   CVCL_VM53 ! HPS0179
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HPS0181
AC   CVCL_Y924
SY   A000066#2
DR   SKIP; SKIP000085
DR   Wikidata; Q54890346
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84786; Inclusion body myositis
DI   ORDO; Orphanet_611; Inclusion body myositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y925 ! HPS0182
OI   CVCL_T936 ! HPS0183
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0182
AC   CVCL_Y925
SY   A000066#3
DR   SKIP; SKIP000086
DR   Wikidata; Q54890347
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84786; Inclusion body myositis
DI   ORDO; Orphanet_611; Inclusion body myositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y924 ! HPS0181
OI   CVCL_T936 ! HPS0183
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0183
AC   CVCL_T936
SY   A000066#5
DR   RCB; HPS0183
DR   SKIP; SKIP000087
DR   SKIP; SKIP000241
DR   Wikidata; Q54890348
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84786; Inclusion body myositis
DI   ORDO; Orphanet_611; Inclusion body myositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y924 ! HPS0181
OI   CVCL_Y925 ! HPS0182
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0184
AC   CVCL_T937
SY   A000095#2-3
DR   RCB; HPS0184
DR   SKIP; SKIP000088
DR   SKIP; SKIP000240
DR   Wikidata; Q54890349
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C77 ! HPS0185
OI   CVCL_IP64 ! HPS0186
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HPS0185
AC   CVCL_6C77
SY   A000095#3-6
DR   RCB; HPS0185
DR   SKIP; SKIP000090
DR   SKIP; SKIP000811
DR   Wikidata; Q54890352
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T937 ! HPS0184
OI   CVCL_IP64 ! HPS0186
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HPS0186
AC   CVCL_IP64
SY   A000095#2-10
DR   RCB; HPS0186
DR   SKIP; SKIP000089
DR   SKIP; SKIP001283
DR   Wikidata; Q54890353
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T937 ! HPS0184
OI   CVCL_6C77 ! HPS0185
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   HPS0191
AC   CVCL_0G87
DR   RCB; HPS0191
DR   SKIP; SKIP000555
DR   Wikidata; Q54890354
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84595; Bernard-Soulier syndrome
DI   ORDO; Orphanet_274; Bernard-Soulier syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T927 ! HPS0078
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0192
AC   CVCL_T971
DR   RCB; HPS0192
DR   SKIP; SKIP000279
DR   Wikidata; Q54890355
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C79532; Allergic rhinitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   HPS0193
AC   CVCL_A3YB
DR   RCB; HPS0193
DR   Wikidata; Q105507731
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J712 ! WS2TKB
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HPS0198
AC   CVCL_Y946
SY   A000014#3-6
DR   SKIP; SKIP000091
DR   Wikidata; Q54606105
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84828; Limb-girdle muscular dystrophy
DI   ORDO; Orphanet_263; Limb-girdle muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y947 ! HPS0199
OI   CVCL_Y948 ! HPS0200
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0199
AC   CVCL_Y947
SY   A000014#4-5
DR   SKIP; SKIP000092
DR   Wikidata; Q54606106
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84828; Limb-girdle muscular dystrophy
DI   ORDO; Orphanet_263; Limb-girdle muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y946 ! HPS0198
OI   CVCL_Y948 ! HPS0200
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0200
AC   CVCL_Y948
SY   A000014#5-4
DR   RCB; HPS0200
DR   SKIP; SKIP000093
DR   SKIP; SKIP000556
DR   Wikidata; Q54606108
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84828; Limb-girdle muscular dystrophy
DI   ORDO; Orphanet_263; Limb-girdle muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y946 ! HPS0198
OI   CVCL_Y947 ! HPS0199
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0204
AC   CVCL_Y916
SY   A000055#3
DR   SKIP; SKIP000097
DR   Wikidata; Q54606118
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103968; Pyruvate dehydrogenase deficiency
DI   ORDO; Orphanet_765; Pyruvate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L558 ! AT-PDH1TKB
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0205
AC   CVCL_Y917
SY   A000055#4
DR   SKIP; SKIP000098
DR   Wikidata; Q54606120
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103968; Pyruvate dehydrogenase deficiency
DI   ORDO; Orphanet_765; Pyruvate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L558 ! AT-PDH1TKB
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0206
AC   CVCL_Y918
SY   A000055#5
DR   SKIP; SKIP000099
DR   Wikidata; Q54606122
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103968; Pyruvate dehydrogenase deficiency
DI   ORDO; Orphanet_765; Pyruvate dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L558 ! AT-PDH1TKB
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0207
AC   CVCL_Y522
SY   A000126#1
DR   RCB; HPS0207
DR   SKIP; SKIP000100
DR   SKIP; SKIP000388
DR   Wikidata; Q54890356
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y968 ! HPS0208
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 27-11-25; Version: 8
//
ID   HPS0208
AC   CVCL_Y968
SY   A000126#2
DR   RCB; HPS0208
DR   SKIP; SKIP000101
DR   Wikidata; Q54890357
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y522 ! HPS0207
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 7
//
ID   HPS0209
AC   CVCL_T974
SY   A000145#3-1
DR   RCB; HPS0209
DR   SKIP; SKIP000102
DR   SKIP; SKIP000280
DR   Wikidata; Q54890358
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3120; Pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y933 ! HPS0210
OI   CVCL_Y934 ! HPS0211
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   HPS0210
AC   CVCL_Y933
SY   A000145#3-2
DR   RCB; HPS0210
DR   SKIP; SKIP000103
DR   Wikidata; Q54890359
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3120; Pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T974 ! HPS0209
OI   CVCL_Y934 ! HPS0211
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0211
AC   CVCL_Y934
SY   A000145#3-4
DR   RCB; HPS0211
DR   SKIP; SKIP000104
DR   SKIP; SKIP000865
DR   Wikidata; Q54890360
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3120; Pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T974 ! HPS0209
OI   CVCL_Y933 ! HPS0210
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0214
AC   CVCL_T938
DR   RCB; HPS0214
DR   SKIP; SKIP000239
DR   Wikidata; Q54890361
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168975; Ehlers-Danlos syndrome, musculocontractural type 1
DI   ORDO; Orphanet_2953; Musculocontractural Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   HPS0215
AC   CVCL_T972
SY   A000182#1
DR   RCB; HPS0215
DR   SKIP; SKIP000128
DR   SKIP; SKIP000281
DR   Wikidata; Q54890362
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM54 ! HPS0216
OI   CVCL_IP65 ! HPS0217
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HPS0216
AC   CVCL_VM54
SY   A000182#4
DR   RCB; HPS0216
DR   SKIP; SKIP000129
DR   Wikidata; Q94218165
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T972 ! HPS0215
OI   CVCL_IP65 ! HPS0217
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0217
AC   CVCL_IP65
SY   A000182#6
DR   RCB; HPS0217
DR   SKIP; SKIP000130
DR   Wikidata; Q54890363
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T972 ! HPS0215
OI   CVCL_VM54 ! HPS0216
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   HPS0224
AC   CVCL_T939
SY   A000002#2-1
DR   RCB; HPS0224
DR   SKIP; SKIP000111
DR   SKIP; SKIP000238
DR   Wikidata; Q54890364
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y972 ! HPS0225
OI   CVCL_Y973 ! HPS0226
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0225
AC   CVCL_Y972
SY   A000002#2-2
DR   RCB; HPS0225
DR   SKIP; SKIP000112
DR   Wikidata; Q54890365
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T939 ! HPS0224
OI   CVCL_Y973 ! HPS0226
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0226
AC   CVCL_Y973
SY   A000002#2-5
DR   RCB; HPS0226
DR   SKIP; SKIP000113
DR   SKIP; SKIP000864
DR   Wikidata; Q54890366
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T939 ! HPS0224
OI   CVCL_Y972 ! HPS0225
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0227
AC   CVCL_Y516
SY   A000003#3-6
DR   RCB; HPS0227
DR   SKIP; SKIP000114
DR   SKIP; SKIP000389
DR   Wikidata; Q54890367
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y971 ! HPS0228
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0228
AC   CVCL_Y971
DR   RCB; HPS0228
DR   SKIP; SKIP000115
DR   SKIP; SKIP001124
DR   Wikidata; Q54890368
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y516 ! HPS0227
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0229
AC   CVCL_Y943
SY   A000013#1
DR   SKIP; SKIP000116
DR   Wikidata; Q54606098
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y944 ! HPS0230
OI   CVCL_Y945 ! HPS0231
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0230
AC   CVCL_Y944
SY   A000013#2
DR   SKIP; SKIP000117
DR   Wikidata; Q54606100
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y943 ! HPS0229
OI   CVCL_Y945 ! HPS0231
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0231
AC   CVCL_Y945
SY   A000013#3
DR   SKIP; SKIP000118
DR   Wikidata; Q54606103
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y943 ! HPS0229
OI   CVCL_Y944 ! HPS0230
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0232
AC   CVCL_Y929
SY   A000018#18-12-2
DR   SKIP; SKIP000119
DR   Wikidata; Q54890369
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y520 ! HPS0233
OI   CVCL_Y931 ! HPS0234
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0233
AC   CVCL_Y520
SY   A000018#18-12-25
DR   RCB; HPS0233
DR   SKIP; SKIP000120
DR   SKIP; SKIP000381
DR   Wikidata; Q54890370
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y929 ! HPS0232
OI   CVCL_Y931 ! HPS0234
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0234
AC   CVCL_Y931
SY   A000018#18-15-8
DR   RCB; HPS0234
DR   SKIP; SKIP000121
DR   SKIP; SKIP001125
DR   Wikidata; Q54890371
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y929 ! HPS0232
OI   CVCL_Y520 ! HPS0233
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0235
AC   CVCL_Y940
SY   A000026#1
DR   SKIP; SKIP000122
DR   Wikidata; Q54606111
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y941 ! HPS0236
OI   CVCL_Y942 ! HPS0237
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0236
AC   CVCL_Y941
SY   A000026#2
DR   SKIP; SKIP000123
DR   Wikidata; Q54606113
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y940 ! HPS0235
OI   CVCL_Y942 ! HPS0237
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0237
AC   CVCL_Y942
SY   A000026#3
DR   SKIP; SKIP000124
DR   Wikidata; Q54606116
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y940 ! HPS0235
OI   CVCL_Y941 ! HPS0236
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   HPS0238
AC   CVCL_Y926
SY   A000069#14-7
DR   SKIP; SKIP000125
DR   Wikidata; Q54606123
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y927 ! HPS0239
OI   CVCL_Y928 ! HPS0240
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0239
AC   CVCL_Y927
SY   A000069#15-1
DR   SKIP; SKIP000126
DR   Wikidata; Q54606126
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y926 ! HPS0238
OI   CVCL_Y928 ! HPS0240
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0240
AC   CVCL_Y928
SY   A000069#15-4
DR   RCB; HPS0240
DR   SKIP; SKIP000127
DR   Wikidata; Q54606127
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y926 ! HPS0238
OI   CVCL_Y927 ! HPS0239
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0244
AC   CVCL_Y521
SY   A000196#1
DR   SKIP; SKIP000131
DR   SKIP; SKIP000382
DR   Wikidata; Q54890372
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y969 ! HPS0245
OI   CVCL_Y970 ! HPS0246
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 27-11-25; Version: 10
//
ID   HPS0245
AC   CVCL_Y969
SY   A000196#5
DR   SKIP; SKIP000132
DR   Wikidata; Q54890373
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y521 ! HPS0244
OI   CVCL_Y970 ! HPS0246
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   HPS0246
AC   CVCL_Y970
SY   A000196#6
DR   SKIP; SKIP000133
DR   Wikidata; Q54890374
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y521 ! HPS0244
OI   CVCL_Y969 ! HPS0245
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   HPS0247
AC   CVCL_6C78
DR   RCB; HPS0247
DR   SKIP; SKIP001126
DR   Wikidata; Q54890375
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0248
AC   CVCL_6C79
DR   RCB; HPS0248
DR   SKIP; SKIP001127
DR   Wikidata; Q54890376
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0249
AC   CVCL_6C80
DR   RCB; HPS0249
DR   SKIP; SKIP000853
DR   Wikidata; Q54890377
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0251
AC   CVCL_VM60
DR   RCB; HPS0251
DR   Wikidata; Q94218514
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0252
AC   CVCL_VM63
DR   RCB; HPS0252
DR   Wikidata; Q94218519
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0253
AC   CVCL_VM64
DR   RCB; HPS0253
DR   Wikidata; Q94218526
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0254
AC   CVCL_6C81
DR   RCB; HPS0254
DR   SKIP; SKIP000854
DR   Wikidata; Q54890378
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM55 ! CiRA00455
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0255
AC   CVCL_6C82
DR   RCB; HPS0255
DR   SKIP; SKIP000855
DR   Wikidata; Q54890379
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0256
AC   CVCL_6C83
DR   RCB; HPS0256
DR   SKIP; SKIP000856
DR   Wikidata; Q54890380
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HPS0258
AC   CVCL_VM65
DR   RCB; HPS0258
DR   Wikidata; Q94218573
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0263
AC   CVCL_6C84
SY   BRCi006-A
DR   hPSCreg; BRCi006-A
DR   RCB; HPS0263
DR   SKIP; SKIP000828
DR   Wikidata; Q54890381
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HPS0264
AC   CVCL_T944
SY   CiRA-PD00021
DR   RCB; HPS0264
DR   SKIP; SKIP000265
DR   Wikidata; Q54890382
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   HPS0265
AC   CVCL_T940
DR   RCB; HPS0265
DR   SKIP; SKIP000237
DR   Wikidata; Q54890383
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C85 ! HPS0266
OI   CVCL_VM56 ! HPS0267
OI   CVCL_A3YE ! HPS0268
OI   CVCL_A3YF ! HPS0269
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HPS0266
AC   CVCL_6C85
DR   RCB; HPS0266
DR   SKIP; SKIP000820
DR   Wikidata; Q54890384
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T940 ! HPS0265
OI   CVCL_VM56 ! HPS0267
OI   CVCL_A3YE ! HPS0268
OI   CVCL_A3YF ! HPS0269
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HPS0267
AC   CVCL_VM56
DR   RCB; HPS0267
DR   Wikidata; Q94218633
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T940 ! HPS0265
OI   CVCL_6C85 ! HPS0266
OI   CVCL_A3YE ! HPS0268
OI   CVCL_A3YF ! HPS0269
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0268
AC   CVCL_A3YE
DR   RCB; HPS0268
DR   Wikidata; Q105507734
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T940 ! HPS0265
OI   CVCL_6C85 ! HPS0266
OI   CVCL_VM56 ! HPS0267
OI   CVCL_A3YF ! HPS0269
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS0269
AC   CVCL_A3YF
DR   RCB; HPS0269
DR   Wikidata; Q105507738
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T940 ! HPS0265
OI   CVCL_6C85 ! HPS0266
OI   CVCL_VM56 ! HPS0267
OI   CVCL_A3YE ! HPS0268
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS0270
AC   CVCL_T941
DR   RCB; HPS0270
DR   SKIP; SKIP000235
DR   Wikidata; Q54890385
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3001; Eczema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T942 ! HPS0271
OI   CVCL_T943 ! HPS0272
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0271
AC   CVCL_T942
DR   RCB; HPS0271
DR   SKIP; SKIP000236
DR   Wikidata; Q54890386
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3001; Eczema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T941 ! HPS0270
OI   CVCL_T943 ! HPS0272
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   HPS0272
AC   CVCL_T943
DR   RCB; HPS0272
DR   SKIP; SKIP000282
DR   Wikidata; Q54890387
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3001; Eczema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T941 ! HPS0270
OI   CVCL_T942 ! HPS0271
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   HPS0284
AC   CVCL_A3YC
DR   RCB; HPS0284
DR   Wikidata; Q105507742
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J712 ! WS2TKB
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HPS0285
AC   CVCL_A3YD
DR   RCB; HPS0285
DR   Wikidata; Q105507745
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J712 ! WS2TKB
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HPS0287
AC   CVCL_UR14
DR   RCB; HPS0287
DR   Wikidata; Q94218672
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J712 ! WS2TKB
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0288
AC   CVCL_VM66
SY   iPS-WS2-C5
DR   RCB; HPS0288
DR   Wikidata; Q94218676
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J712 ! WS2TKB
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0312
AC   CVCL_6C86
DR   RCB; HPS0312
DR   SKIP; SKIP000827
DR   Wikidata; Q54890388
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50dup; Zygosity=Hemizygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM57 ! HPS0313
OI   CVCL_VM58 ! HPS0314
OI   CVCL_UP82 ! HPS0315
OI   CVCL_UP83 ! HPS0316
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   HPS0313
AC   CVCL_VM57
DR   RCB; HPS0313
DR   Wikidata; Q94218697
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50dup; Zygosity=Hemizygous (from autologous cell line HPS0312).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C86 ! HPS0312
OI   CVCL_VM58 ! HPS0314
OI   CVCL_UP82 ! HPS0315
OI   CVCL_UP83 ! HPS0316
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   HPS0314
AC   CVCL_VM58
SY   401-7
DR   RCB; HPS0314
DR   Wikidata; Q94218699
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50dup; Zygosity=Hemizygous (from autologous cell line HPS0312).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C86 ! HPS0312
OI   CVCL_VM57 ! HPS0313
OI   CVCL_UP82 ! HPS0315
OI   CVCL_UP83 ! HPS0316
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   HPS0315
AC   CVCL_UP82
DR   RCB; HPS0315
DR   Wikidata; Q94218705
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50dup; Zygosity=Hemizygous (from autologous cell line HPS0312).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C86 ! HPS0312
OI   CVCL_VM57 ! HPS0313
OI   CVCL_VM58 ! HPS0314
OI   CVCL_UP83 ! HPS0316
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS0316
AC   CVCL_UP83
DR   RCB; HPS0316
DR   Wikidata; Q94218710
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50dup; Zygosity=Hemizygous (from autologous cell line HPS0312).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C86 ! HPS0312
OI   CVCL_VM57 ! HPS0313
OI   CVCL_VM58 ! HPS0314
OI   CVCL_UP82 ! HPS0315
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   HPS0317
AC   CVCL_1Q66
DR   RCB; HPS0317
DR   SKIP; SKIP000618
DR   Wikidata; Q54890389
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP84 ! HPS0318
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP85 ! HPS0320
OI   CVCL_UP86 ! HPS0321
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP87 ! HPS0324
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   HPS0318
AC   CVCL_UP84
DR   RCB; HPS0318
DR   Wikidata; Q94218729
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP85 ! HPS0320
OI   CVCL_UP86 ! HPS0321
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP87 ! HPS0324
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS0319
AC   CVCL_VM49
SY   609-5
DR   RCB; HPS0319
DR   Wikidata; Q94218731
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_UP84 ! HPS0318
OI   CVCL_UP85 ! HPS0320
OI   CVCL_UP86 ! HPS0321
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP87 ! HPS0324
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   HPS0320
AC   CVCL_UP85
DR   RCB; HPS0320
DR   Wikidata; Q94218737
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_UP84 ! HPS0318
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP86 ! HPS0321
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP87 ! HPS0324
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS0321
AC   CVCL_UP86
DR   RCB; HPS0321
DR   Wikidata; Q94218743
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_UP84 ! HPS0318
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP85 ! HPS0320
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP87 ! HPS0324
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS0322
AC   CVCL_1Q67
DR   RCB; HPS0322
DR   SKIP; SKIP000619
DR   Wikidata; Q54890390
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_UP84 ! HPS0318
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP85 ! HPS0320
OI   CVCL_UP86 ! HPS0321
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP87 ! HPS0324
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   HPS0323
AC   CVCL_VM50
DR   RCB; HPS0323
DR   Wikidata; Q94218763
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_UP84 ! HPS0318
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP85 ! HPS0320
OI   CVCL_UP86 ! HPS0321
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_UP87 ! HPS0324
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   HPS0324
AC   CVCL_UP87
DR   RCB; HPS0324
DR   Wikidata; Q94218766
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_UP84 ! HPS0318
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP85 ! HPS0320
OI   CVCL_UP86 ! HPS0321
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP88 ! HPS0325
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS0325
AC   CVCL_UP88
DR   RCB; HPS0325
DR   Wikidata; Q94218771
RX   PubMed=28491099;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex42-43del; Zygosity=Heterozygous (PubMed=28491099).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Q66 ! HPS0317
OI   CVCL_UP84 ! HPS0318
OI   CVCL_VM49 ! HPS0319
OI   CVCL_UP85 ! HPS0320
OI   CVCL_UP86 ! HPS0321
OI   CVCL_1Q67 ! HPS0322
OI   CVCL_VM50 ! HPS0323
OI   CVCL_UP87 ! HPS0324
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS0332
AC   CVCL_1R58
DR   RCB; HPS0332
DR   SKIP; SKIP000627
DR   Wikidata; Q54890391
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0333
AC   CVCL_1R59
DR   RCB; HPS0333
DR   SKIP; SKIP000628
DR   Wikidata; Q54890396
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   HPS0334
AC   CVCL_1R65
DR   RCB; HPS0334
DR   SKIP; SKIP000629
DR   Wikidata; Q54890397
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154314; Autosomal recessive cytochrome b-positive chronic granulomatous disease type I
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1R66 ! HPS0335
OI   CVCL_1R67 ! HPS0336
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0335
AC   CVCL_1R66
DR   RCB; HPS0335
DR   SKIP; SKIP000630
DR   Wikidata; Q54890398
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154314; Autosomal recessive cytochrome b-positive chronic granulomatous disease type I
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1R65 ! HPS0334
OI   CVCL_1R67 ! HPS0336
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0336
AC   CVCL_1R67
DR   RCB; HPS0336
DR   SKIP; SKIP000631
DR   Wikidata; Q54890399
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154314; Autosomal recessive cytochrome b-positive chronic granulomatous disease type I
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1R65 ! HPS0334
OI   CVCL_1R66 ! HPS0335
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0337
AC   CVCL_1T00
DR   RCB; HPS0337
DR   SKIP; SKIP000632
DR   Wikidata; Q54890400
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154315; X-linked chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T01 ! HPS0338
OI   CVCL_1T02 ! HPS0339
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0338
AC   CVCL_1T01
DR   RCB; HPS0338
DR   SKIP; SKIP000633
DR   Wikidata; Q54890401
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154315; X-linked chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T00 ! HPS0337
OI   CVCL_1T02 ! HPS0339
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0339
AC   CVCL_1T02
DR   RCB; HPS0339
DR   SKIP; SKIP000634
DR   Wikidata; Q54890402
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154315; X-linked chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T00 ! HPS0337
OI   CVCL_1T01 ! HPS0338
SX   Male
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   HPS0388
AC   CVCL_VM84
DR   RCB; HPS0388
DR   Wikidata; Q94218897
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR05 ! HPS0389
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0389
AC   CVCL_UR05
DR   RCB; HPS0389
DR   Wikidata; Q94218900
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM84 ! HPS0388
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0390
AC   CVCL_VM85
DR   RCB; HPS0390
DR   Wikidata; Q94218907
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR15 ! HPS0391
OI   CVCL_UR16 ! HPS0392
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0391
AC   CVCL_UR15
DR   RCB; HPS0391
DR   Wikidata; Q94218911
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM85 ! HPS0390
OI   CVCL_UR16 ! HPS0392
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0392
AC   CVCL_UR16
DR   RCB; HPS0392
DR   Wikidata; Q94218916
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM85 ! HPS0390
OI   CVCL_UR15 ! HPS0391
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0393
AC   CVCL_VM86
DR   RCB; HPS0393
DR   Wikidata; Q94218923
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP89 ! HPS0394
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0394
AC   CVCL_UP89
DR   RCB; HPS0394
DR   Wikidata; Q94218929
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM86 ! HPS0393
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0395
AC   CVCL_VM87
DR   RCB; HPS0395
DR   Wikidata; Q94218934
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP90 ! HPS0396
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0396
AC   CVCL_UP90
DR   RCB; HPS0396
DR   Wikidata; Q94218938
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM87 ! HPS0395
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0397
AC   CVCL_VM88
DR   RCB; HPS0397
DR   Wikidata; Q94218944
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR17 ! HPS0398
OI   CVCL_UR18 ! HPS0399
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0398
AC   CVCL_UR17
DR   RCB; HPS0398
DR   Wikidata; Q94218948
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM88 ! HPS0397
OI   CVCL_UR18 ! HPS0399
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0399
AC   CVCL_UR18
DR   RCB; HPS0399
DR   Wikidata; Q94218951
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM88 ! HPS0397
OI   CVCL_UR17 ! HPS0398
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0407
AC   CVCL_VM89
DR   RCB; HPS0407
DR   Wikidata; Q94218955
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM90 ! HPS1010
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   HPS0408
AC   CVCL_VM91
DR   RCB; HPS0408
DR   Wikidata; Q94218958
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR19 ! HPS0409
OI   CVCL_UR20 ! HPS0410
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   HPS0409
AC   CVCL_UR19
DR   RCB; HPS0409
DR   Wikidata; Q94218962
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM91 ! HPS0408
OI   CVCL_UR20 ! HPS0410
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0410
AC   CVCL_UR20
DR   RCB; HPS0410
DR   Wikidata; Q94218966
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM91 ! HPS0408
OI   CVCL_UR19 ! HPS0409
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0414
AC   CVCL_IP66
DR   RCB; HPS0414
DR   SKIP; SKIP001190
DR   Wikidata; Q54890403
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP73 ! HPS0415
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   HPS0415
AC   CVCL_UP73
DR   RCB; HPS0415
DR   Wikidata; Q94218982
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP66 ! HPS0414
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0417
AC   CVCL_VM92
DR   RCB; HPS0417
DR   Wikidata; Q94218986
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP74 ! HPS0418
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0418
AC   CVCL_UP74
DR   RCB; HPS0418
DR   Wikidata; Q94218993
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM92 ! HPS0417
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0419
AC   CVCL_VM76
DR   RCB; HPS0419
DR   Wikidata; Q94218996
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP64 ! HPS0420
OI   CVCL_UP65 ! HPS0421
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0420
AC   CVCL_UP64
DR   RCB; HPS0420
DR   Wikidata; Q94219001
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM76 ! HPS0419
OI   CVCL_UP65 ! HPS0421
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0421
AC   CVCL_UP65
DR   RCB; HPS0421
DR   Wikidata; Q94219003
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM76 ! HPS0419
OI   CVCL_UP64 ! HPS0420
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0424
AC   CVCL_A3FK
DR   RCB; HPS0424
DR   Wikidata; Q105507748
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS0425
AC   CVCL_A3FL
DR   RCB; HPS0425
DR   Wikidata; Q105507751
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS0433
AC   CVCL_VM93
DR   RCB; HPS0433
DR   Wikidata; Q94219007
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP77 ! HPS0434
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0434
AC   CVCL_UP77
DR   RCB; HPS0434
DR   Wikidata; Q94219011
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM93 ! HPS0433
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0437
AC   CVCL_VM94
DR   RCB; HPS0437
DR   Wikidata; Q94219013
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26883; Sjogren syndrome
DI   ORDO; Orphanet_289390; Primary Sjogren syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN89 ! HPS0438
OI   CVCL_UP56 ! HPS0439
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0438
AC   CVCL_UN89
DR   RCB; HPS0438
DR   Wikidata; Q94219019
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26883; Sjogren syndrome
DI   ORDO; Orphanet_289390; Primary Sjogren syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM94 ! HPS0437
OI   CVCL_UP56 ! HPS0439
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0439
AC   CVCL_UP56
DR   RCB; HPS0439
DR   Wikidata; Q94219024
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26883; Sjogren syndrome
DI   ORDO; Orphanet_289390; Primary Sjogren syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM94 ! HPS0437
OI   CVCL_UN89 ! HPS0438
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0446
AC   CVCL_ZB54
SY   BRCi010-C
DR   hPSCreg; BRCi010-C
DR   RCB; HPS0446
DR   Wikidata; Q98126699
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7905; NPHP1; Zygosity=Homozygous (from autologous cell line HPS0447).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74998; Nephronophthisis 1
DI   ORDO; Orphanet_655; Nephronophthisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB55 ! HPS0447
OI   CVCL_ZB56 ! HPS0448
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   HPS0447
AC   CVCL_ZB55
SY   BRCi010-A; CiRA-j-0004-B
DR   hPSCreg; BRCi010-A
DR   RCB; HPS0447
DR   SKIP; SKIP005803
DR   Wikidata; Q98126700
RX   PubMed=32361464;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7905; NPHP1; Zygosity=Homozygous (PubMed=32361464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74998; Nephronophthisis 1
DI   ORDO; Orphanet_655; Nephronophthisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB54 ! HPS0446
OI   CVCL_ZB56 ! HPS0448
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   HPS0448
AC   CVCL_ZB56
SY   BRCi010-B
DR   hPSCreg; BRCi010-B
DR   RCB; HPS0448
DR   Wikidata; Q98126701
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7905; NPHP1; Zygosity=Homozygous (from autologous cell line HPS0447).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74998; Nephronophthisis 1
DI   ORDO; Orphanet_655; Nephronophthisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB54 ! HPS0446
OI   CVCL_ZB55 ! HPS0447
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   HPS0449
AC   CVCL_ZE68
DR   RCB; HPS0449
DR   Wikidata; Q98126704
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7905; NPHP1; Zygosity=Homozygous (from autologous cell line HPS0450).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74998; Nephronophthisis 1
DI   ORDO; Orphanet_655; Nephronophthisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE69 ! HPS0450
OI   CVCL_ZE70 ! HPS0451
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   HPS0450
AC   CVCL_ZE69
SY   BRCi011-A
DR   hPSCreg; BRCi011-A
DR   RCB; HPS0450
DR   SKIP; SKIP005802
DR   Wikidata; Q98126705
RX   PubMed=32361464;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7905; NPHP1; Zygosity=Homozygous (PubMed=32361464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74998; Nephronophthisis 1
DI   ORDO; Orphanet_655; Nephronophthisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE68 ! HPS0449
OI   CVCL_ZE70 ! HPS0451
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   HPS0451
AC   CVCL_ZE70
DR   RCB; HPS0451
DR   Wikidata; Q98126706
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7905; NPHP1; Zygosity=Homozygous (from autologous cell line HPS0450).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74998; Nephronophthisis 1
DI   ORDO; Orphanet_655; Nephronophthisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE68 ! HPS0449
OI   CVCL_ZE69 ! HPS0450
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   HPS0458
AC   CVCL_VM77
DR   RCB; HPS0458
DR   Wikidata; Q94219028
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP57 ! HPS0459
OI   CVCL_UP58 ! HPS0460
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0459
AC   CVCL_UP57
DR   RCB; HPS0459
DR   Wikidata; Q94219032
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM77 ! HPS0458
OI   CVCL_UP58 ! HPS0460
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0460
AC   CVCL_UP58
DR   RCB; HPS0460
DR   Wikidata; Q94219036
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM77 ! HPS0458
OI   CVCL_UP57 ! HPS0459
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0461
AC   CVCL_UN33
DR   RCB; HPS0461
DR   Wikidata; Q94219040
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP59 ! HPS0462
OI   CVCL_UP60 ! HPS0463
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0462
AC   CVCL_UP59
DR   RCB; HPS0462
DR   Wikidata; Q94219044
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN33 ! HPS0461
OI   CVCL_UP60 ! HPS0463
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0463
AC   CVCL_UP60
DR   RCB; HPS0463
DR   Wikidata; Q94219048
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN33 ! HPS0461
OI   CVCL_UP59 ! HPS0462
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0470
AC   CVCL_RY10
DR   RCB; HPS0470
DR   Wikidata; Q54890404
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP94 ! HPS0471
OI   CVCL_UP95 ! HPS0472
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0471
AC   CVCL_UP94
DR   RCB; HPS0471
DR   Wikidata; Q94219063
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY10 ! HPS0470
OI   CVCL_UP95 ! HPS0472
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0472
AC   CVCL_UP95
DR   RCB; HPS0472
DR   Wikidata; Q94219068
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY10 ! HPS0470
OI   CVCL_UP94 ! HPS0471
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0473
AC   CVCL_VM67
DR   RCB; HPS0473
DR   Wikidata; Q94219072
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP66 ! HPS0474
OI   CVCL_UP67 ! HPS0475
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0474
AC   CVCL_UP66
DR   RCB; HPS0474
DR   Wikidata; Q94219075
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM67 ! HPS0473
OI   CVCL_UP67 ! HPS0475
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0475
AC   CVCL_UP67
DR   RCB; HPS0475
DR   Wikidata; Q94219080
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM67 ! HPS0473
OI   CVCL_UP66 ! HPS0474
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0476
AC   CVCL_VM68
DR   RCB; HPS0476
DR   Wikidata; Q94219086
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP68 ! HPS0477
OI   CVCL_UP69 ! HPS0478
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0477
AC   CVCL_UP68
DR   RCB; HPS0477
DR   Wikidata; Q94219091
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM68 ! HPS0476
OI   CVCL_UP69 ! HPS0478
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0478
AC   CVCL_UP69
DR   RCB; HPS0478
DR   Wikidata; Q94219096
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM68 ! HPS0476
OI   CVCL_UP68 ! HPS0477
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0479
AC   CVCL_VM95
DR   RCB; HPS0479
DR   Wikidata; Q94219098
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP61 ! HPS0480
OI   CVCL_UP62 ! HPS0481
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0480
AC   CVCL_UP61
DR   RCB; HPS0480
DR   Wikidata; Q94219102
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM95 ! HPS0479
OI   CVCL_UP62 ! HPS0481
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0481
AC   CVCL_UP62
DR   RCB; HPS0481
DR   Wikidata; Q94219106
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM95 ! HPS0479
OI   CVCL_UP61 ! HPS0480
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0482
AC   CVCL_VM69
DR   RCB; HPS0482
DR   Wikidata; Q94219110
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP63 ! HPS0483
OI   CVCL_UR21 ! HPS0484
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0483
AC   CVCL_UP63
DR   RCB; HPS0483
DR   Wikidata; Q94219112
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM69 ! HPS0482
OI   CVCL_UR21 ! HPS0484
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0484
AC   CVCL_UR21
DR   RCB; HPS0484
DR   Wikidata; Q94219117
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM69 ! HPS0482
OI   CVCL_UP63 ! HPS0483
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0485
AC   CVCL_VM70
DR   RCB; HPS0485
DR   Wikidata; Q94219121
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP70 ! HPS0486
OI   CVCL_UP71 ! HPS0487
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0486
AC   CVCL_UP70
DR   RCB; HPS0486
DR   Wikidata; Q94219125
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM70 ! HPS0485
OI   CVCL_UP71 ! HPS0487
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0487
AC   CVCL_UP71
DR   RCB; HPS0487
DR   Wikidata; Q94219129
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM70 ! HPS0485
OI   CVCL_UP70 ! HPS0486
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0488
AC   CVCL_RY11
DR   RCB; HPS0488
DR   Wikidata; Q54890405
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61269; Niemann-Pick disease
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY12 ! HPS0489
OI   CVCL_RY13 ! HPS0490
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   HPS0489
AC   CVCL_RY12
DR   RCB; HPS0489
DR   Wikidata; Q54890406
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61269; Niemann-Pick disease
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY11 ! HPS0488
OI   CVCL_RY13 ! HPS0490
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   HPS0490
AC   CVCL_RY13
DR   RCB; HPS0490
DR   Wikidata; Q54890407
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61269; Niemann-Pick disease
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY11 ! HPS0488
OI   CVCL_RY12 ! HPS0489
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   HPS0491
AC   CVCL_VM96
DR   RCB; HPS0491
DR   Wikidata; Q94219187
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP75 ! HPS0492
OI   CVCL_UP76 ! HPS0493
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   HPS0492
AC   CVCL_UP75
DR   RCB; HPS0492
DR   Wikidata; Q94219190
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM96 ! HPS0491
OI   CVCL_UP76 ! HPS0493
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   HPS0493
AC   CVCL_UP76
DR   RCB; HPS0493
DR   Wikidata; Q94219196
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM96 ! HPS0491
OI   CVCL_UP75 ! HPS0492
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   HPS0510
AC   CVCL_UP35
DR   RCB; HPS0510
DR   Wikidata; Q94219200
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   HPS0515
AC   CVCL_UP36
DR   RCB; HPS0515
DR   Wikidata; Q94219205
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0525
AC   CVCL_UP97
DR   RCB; HPS0525
DR   Wikidata; Q94219209
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP98 ! HPS0527
OI   CVCL_UP99 ! HPS0528
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0527
AC   CVCL_UP98
DR   RCB; HPS0527
DR   Wikidata; Q94219214
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP97 ! HPS0525
OI   CVCL_UP99 ! HPS0528
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0528
AC   CVCL_UP99
DR   RCB; HPS0528
DR   Wikidata; Q94219218
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP97 ! HPS0525
OI   CVCL_UP98 ! HPS0527
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0540
AC   CVCL_UP91
DR   RCB; HPS0540
DR   Wikidata; Q94219222
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP92 ! HPS0541
OI   CVCL_UP93 ! HPS0542
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0541
AC   CVCL_UP92
DR   RCB; HPS0541
DR   Wikidata; Q94219227
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP91 ! HPS0540
OI   CVCL_UP93 ! HPS0542
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0542
AC   CVCL_UP93
DR   RCB; HPS0542
DR   Wikidata; Q94219230
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP91 ! HPS0540
OI   CVCL_UP92 ! HPS0541
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0546
AC   CVCL_VM78
DR   RCB; HPS0546
DR   Wikidata; Q94219235
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-9Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   HPS0549
AC   CVCL_UN31
DR   RCB; HPS0549
DR   Wikidata; Q94219239
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0552
AC   CVCL_YR39
DR   RCB; HPS0552
DR   Wikidata; Q94219245
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR40 ! HPS0553
OI   CVCL_YR41 ! HPS0554
OI   CVCL_YR42 ! HPS0555
OI   CVCL_YR43 ! HPS0556
OI   CVCL_YR44 ! HPS0557
OI   CVCL_YR45 ! HPS1047
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS0553
AC   CVCL_YR40
DR   RCB; HPS0553
DR   Wikidata; Q94219250
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR39 ! HPS0552
OI   CVCL_YR41 ! HPS0554
OI   CVCL_YR42 ! HPS0555
OI   CVCL_YR43 ! HPS0556
OI   CVCL_YR44 ! HPS0557
OI   CVCL_YR45 ! HPS1047
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS0554
AC   CVCL_YR41
DR   RCB; HPS0554
DR   Wikidata; Q94219255
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR39 ! HPS0552
OI   CVCL_YR40 ! HPS0553
OI   CVCL_YR42 ! HPS0555
OI   CVCL_YR43 ! HPS0556
OI   CVCL_YR44 ! HPS0557
OI   CVCL_YR45 ! HPS1047
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS0555
AC   CVCL_YR42
DR   RCB; HPS0555
DR   Wikidata; Q94219260
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR39 ! HPS0552
OI   CVCL_YR40 ! HPS0553
OI   CVCL_YR41 ! HPS0554
OI   CVCL_YR43 ! HPS0556
OI   CVCL_YR44 ! HPS0557
OI   CVCL_YR45 ! HPS1047
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS0556
AC   CVCL_YR43
DR   RCB; HPS0556
DR   Wikidata; Q94219265
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR39 ! HPS0552
OI   CVCL_YR40 ! HPS0553
OI   CVCL_YR41 ! HPS0554
OI   CVCL_YR42 ! HPS0555
OI   CVCL_YR44 ! HPS0557
OI   CVCL_YR45 ! HPS1047
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS0557
AC   CVCL_YR44
DR   RCB; HPS0557
DR   Wikidata; Q94219271
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR39 ! HPS0552
OI   CVCL_YR40 ! HPS0553
OI   CVCL_YR41 ! HPS0554
OI   CVCL_YR42 ! HPS0555
OI   CVCL_YR43 ! HPS0556
OI   CVCL_YR45 ! HPS1047
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS0582
AC   CVCL_C5ZD
DR   RCB; HPS0582
DR   Wikidata; Q116049334
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZE ! HPS0583
OI   CVCL_C5ZF ! HPS0584
OI   CVCL_C5ZG ! HPS0585
OI   CVCL_C5ZH ! HPS0586
OI   CVCL_C5ZI ! HPS0587
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0583
AC   CVCL_C5ZE
DR   RCB; HPS0583
DR   Wikidata; Q116049335
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZD ! HPS0582
OI   CVCL_C5ZF ! HPS0584
OI   CVCL_C5ZG ! HPS0585
OI   CVCL_C5ZH ! HPS0586
OI   CVCL_C5ZI ! HPS0587
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0584
AC   CVCL_C5ZF
DR   RCB; HPS0584
DR   Wikidata; Q116049336
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZD ! HPS0582
OI   CVCL_C5ZE ! HPS0583
OI   CVCL_C5ZG ! HPS0585
OI   CVCL_C5ZH ! HPS0586
OI   CVCL_C5ZI ! HPS0587
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0585
AC   CVCL_C5ZG
DR   RCB; HPS0585
DR   Wikidata; Q116049337
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZD ! HPS0582
OI   CVCL_C5ZE ! HPS0583
OI   CVCL_C5ZF ! HPS0584
OI   CVCL_C5ZH ! HPS0586
OI   CVCL_C5ZI ! HPS0587
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0586
AC   CVCL_C5ZH
DR   RCB; HPS0586
DR   Wikidata; Q116049338
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZD ! HPS0582
OI   CVCL_C5ZE ! HPS0583
OI   CVCL_C5ZF ! HPS0584
OI   CVCL_C5ZG ! HPS0585
OI   CVCL_C5ZI ! HPS0587
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0587
AC   CVCL_C5ZI
DR   RCB; HPS0587
DR   Wikidata; Q116049339
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZD ! HPS0582
OI   CVCL_C5ZE ! HPS0583
OI   CVCL_C5ZF ! HPS0584
OI   CVCL_C5ZG ! HPS0585
OI   CVCL_C5ZH ! HPS0586
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0588
AC   CVCL_C5ZJ
DR   RCB; HPS0588
DR   Wikidata; Q116049340
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZK ! HPS0589
OI   CVCL_C5ZL ! HPS0590
OI   CVCL_C5ZM ! HPS0591
OI   CVCL_C5ZN ! HPS0592
OI   CVCL_C5ZP ! HPS0593
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0589
AC   CVCL_C5ZK
DR   RCB; HPS0589
DR   Wikidata; Q116049341
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZJ ! HPS0588
OI   CVCL_C5ZL ! HPS0590
OI   CVCL_C5ZM ! HPS0591
OI   CVCL_C5ZN ! HPS0592
OI   CVCL_C5ZP ! HPS0593
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0590
AC   CVCL_C5ZL
DR   RCB; HPS0590
DR   Wikidata; Q116049342
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZJ ! HPS0588
OI   CVCL_C5ZK ! HPS0589
OI   CVCL_C5ZM ! HPS0591
OI   CVCL_C5ZN ! HPS0592
OI   CVCL_C5ZP ! HPS0593
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0591
AC   CVCL_C5ZM
DR   RCB; HPS0591
DR   Wikidata; Q116049343
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZJ ! HPS0588
OI   CVCL_C5ZK ! HPS0589
OI   CVCL_C5ZL ! HPS0590
OI   CVCL_C5ZN ! HPS0592
OI   CVCL_C5ZP ! HPS0593
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0592
AC   CVCL_C5ZN
DR   RCB; HPS0592
DR   Wikidata; Q116049344
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZJ ! HPS0588
OI   CVCL_C5ZK ! HPS0589
OI   CVCL_C5ZL ! HPS0590
OI   CVCL_C5ZM ! HPS0591
OI   CVCL_C5ZP ! HPS0593
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0593
AC   CVCL_C5ZP
DR   RCB; HPS0593
DR   Wikidata; Q116049345
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZJ ! HPS0588
OI   CVCL_C5ZK ! HPS0589
OI   CVCL_C5ZL ! HPS0590
OI   CVCL_C5ZM ! HPS0591
OI   CVCL_C5ZN ! HPS0592
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0594
AC   CVCL_C5ZQ
DR   RCB; HPS0594
DR   Wikidata; Q116049346
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZR ! HPS0595
OI   CVCL_C5ZS ! HPS0596
OI   CVCL_C5ZT ! HPS0597
OI   CVCL_C5ZU ! HPS0598
OI   CVCL_C5ZV ! HPS0599
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0595
AC   CVCL_C5ZR
DR   RCB; HPS0595
DR   Wikidata; Q116049347
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZQ ! HPS0594
OI   CVCL_C5ZS ! HPS0596
OI   CVCL_C5ZT ! HPS0597
OI   CVCL_C5ZU ! HPS0598
OI   CVCL_C5ZV ! HPS0599
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0596
AC   CVCL_C5ZS
DR   RCB; HPS0596
DR   Wikidata; Q116049348
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZQ ! HPS0594
OI   CVCL_C5ZR ! HPS0595
OI   CVCL_C5ZT ! HPS0597
OI   CVCL_C5ZU ! HPS0598
OI   CVCL_C5ZV ! HPS0599
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0597
AC   CVCL_C5ZT
DR   RCB; HPS0597
DR   Wikidata; Q116049349
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZQ ! HPS0594
OI   CVCL_C5ZR ! HPS0595
OI   CVCL_C5ZS ! HPS0596
OI   CVCL_C5ZU ! HPS0598
OI   CVCL_C5ZV ! HPS0599
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0598
AC   CVCL_C5ZU
DR   RCB; HPS0598
DR   Wikidata; Q116049350
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZQ ! HPS0594
OI   CVCL_C5ZR ! HPS0595
OI   CVCL_C5ZS ! HPS0596
OI   CVCL_C5ZT ! HPS0597
OI   CVCL_C5ZV ! HPS0599
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0599
AC   CVCL_C5ZV
DR   RCB; HPS0599
DR   Wikidata; Q116049351
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZQ ! HPS0594
OI   CVCL_C5ZR ! HPS0595
OI   CVCL_C5ZS ! HPS0596
OI   CVCL_C5ZT ! HPS0597
OI   CVCL_C5ZU ! HPS0598
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0600
AC   CVCL_C5ZW
DR   RCB; HPS0600
DR   Wikidata; Q116049352
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZX ! HPS0601
OI   CVCL_C5ZY ! HPS0602
OI   CVCL_C5ZZ ! HPS0603
OI   CVCL_C6A0 ! HPS0604
OI   CVCL_C6A1 ! HPS0605
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0601
AC   CVCL_C5ZX
DR   RCB; HPS0601
DR   Wikidata; Q116049353
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZW ! HPS0600
OI   CVCL_C5ZY ! HPS0602
OI   CVCL_C5ZZ ! HPS0603
OI   CVCL_C6A0 ! HPS0604
OI   CVCL_C6A1 ! HPS0605
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0602
AC   CVCL_C5ZY
DR   RCB; HPS0602
DR   Wikidata; Q116049354
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZW ! HPS0600
OI   CVCL_C5ZX ! HPS0601
OI   CVCL_C5ZZ ! HPS0603
OI   CVCL_C6A0 ! HPS0604
OI   CVCL_C6A1 ! HPS0605
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0603
AC   CVCL_C5ZZ
DR   RCB; HPS0603
DR   Wikidata; Q116049355
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZW ! HPS0600
OI   CVCL_C5ZX ! HPS0601
OI   CVCL_C5ZY ! HPS0602
OI   CVCL_C6A0 ! HPS0604
OI   CVCL_C6A1 ! HPS0605
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0604
AC   CVCL_C6A0
DR   RCB; HPS0604
DR   Wikidata; Q116049356
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZW ! HPS0600
OI   CVCL_C5ZX ! HPS0601
OI   CVCL_C5ZY ! HPS0602
OI   CVCL_C5ZZ ! HPS0603
OI   CVCL_C6A1 ! HPS0605
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0605
AC   CVCL_C6A1
DR   RCB; HPS0605
DR   Wikidata; Q116049357
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5ZW ! HPS0600
OI   CVCL_C5ZX ! HPS0601
OI   CVCL_C5ZY ! HPS0602
OI   CVCL_C5ZZ ! HPS0603
OI   CVCL_C6A0 ! HPS0604
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0606
AC   CVCL_C6A2
DR   RCB; HPS0606
DR   Wikidata; Q116049358
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A3 ! HPS0607
OI   CVCL_C6A4 ! HPS0608
OI   CVCL_C6A5 ! HPS0609
OI   CVCL_C6A6 ! HPS0610
OI   CVCL_C6A7 ! HPS0611
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0607
AC   CVCL_C6A3
DR   RCB; HPS0607
DR   Wikidata; Q116049359
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A2 ! HPS0606
OI   CVCL_C6A4 ! HPS0608
OI   CVCL_C6A5 ! HPS0609
OI   CVCL_C6A6 ! HPS0610
OI   CVCL_C6A7 ! HPS0611
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0608
AC   CVCL_C6A4
DR   RCB; HPS0608
DR   Wikidata; Q116049360
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A2 ! HPS0606
OI   CVCL_C6A3 ! HPS0607
OI   CVCL_C6A5 ! HPS0609
OI   CVCL_C6A6 ! HPS0610
OI   CVCL_C6A7 ! HPS0611
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0609
AC   CVCL_C6A5
DR   RCB; HPS0609
DR   Wikidata; Q116049361
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A2 ! HPS0606
OI   CVCL_C6A3 ! HPS0607
OI   CVCL_C6A4 ! HPS0608
OI   CVCL_C6A6 ! HPS0610
OI   CVCL_C6A7 ! HPS0611
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0610
AC   CVCL_C6A6
DR   RCB; HPS0610
DR   Wikidata; Q116049362
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A2 ! HPS0606
OI   CVCL_C6A3 ! HPS0607
OI   CVCL_C6A4 ! HPS0608
OI   CVCL_C6A5 ! HPS0609
OI   CVCL_C6A7 ! HPS0611
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0611
AC   CVCL_C6A7
DR   RCB; HPS0611
DR   Wikidata; Q116049363
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A2 ! HPS0606
OI   CVCL_C6A3 ! HPS0607
OI   CVCL_C6A4 ! HPS0608
OI   CVCL_C6A5 ! HPS0609
OI   CVCL_C6A6 ! HPS0610
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0654
AC   CVCL_UN29
DR   RCB; HPS0654
DR   Wikidata; Q94219277
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS0660
AC   CVCL_UN30
SY   BRCi001-A
DR   BioSamples; SAMEA5141620
DR   hPSCreg; BRCi001-A
DR   RCB; HPS0660
DR   SKIP; SKIP005526
DR   Wikidata; Q94219283
RX   PubMed=30849633;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Arg89Gln (c.266G>A); ClinVar=VCV000011922; Zygosity=Homozygous (PubMed=30849633).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS0666
AC   CVCL_C6A8
DR   RCB; HPS0666
DR   Wikidata; Q116049364
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A9 ! HPS0667
OI   CVCL_C6AA ! HPS0668
OI   CVCL_C6AB ! HPS0669
OI   CVCL_C6AC ! HPS0670
OI   CVCL_C6AD ! HPS0671
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0667
AC   CVCL_C6A9
DR   RCB; HPS0667
DR   Wikidata; Q116049365
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A8 ! HPS0666
OI   CVCL_C6AA ! HPS0668
OI   CVCL_C6AB ! HPS0669
OI   CVCL_C6AC ! HPS0670
OI   CVCL_C6AD ! HPS0671
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0668
AC   CVCL_C6AA
DR   RCB; HPS0668
DR   Wikidata; Q116049366
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A8 ! HPS0666
OI   CVCL_C6A9 ! HPS0667
OI   CVCL_C6AB ! HPS0669
OI   CVCL_C6AC ! HPS0670
OI   CVCL_C6AD ! HPS0671
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0669
AC   CVCL_C6AB
DR   RCB; HPS0669
DR   Wikidata; Q116049367
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A8 ! HPS0666
OI   CVCL_C6A9 ! HPS0667
OI   CVCL_C6AA ! HPS0668
OI   CVCL_C6AC ! HPS0670
OI   CVCL_C6AD ! HPS0671
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0670
AC   CVCL_C6AC
DR   RCB; HPS0670
DR   Wikidata; Q116049368
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A8 ! HPS0666
OI   CVCL_C6A9 ! HPS0667
OI   CVCL_C6AA ! HPS0668
OI   CVCL_C6AB ! HPS0669
OI   CVCL_C6AD ! HPS0671
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0671
AC   CVCL_C6AD
DR   RCB; HPS0671
DR   Wikidata; Q116049369
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6A8 ! HPS0666
OI   CVCL_C6A9 ! HPS0667
OI   CVCL_C6AA ! HPS0668
OI   CVCL_C6AB ! HPS0669
OI   CVCL_C6AC ! HPS0670
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0678
AC   CVCL_C6AE
DR   RCB; HPS0678
DR   Wikidata; Q116049370
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AF ! HPS0679
OI   CVCL_C6AG ! HPS0680
OI   CVCL_C6AH ! HPS0681
OI   CVCL_C6AI ! HPS0682
OI   CVCL_C6AJ ! HPS0683
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0679
AC   CVCL_C6AF
DR   RCB; HPS0679
DR   Wikidata; Q116049371
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AE ! HPS0678
OI   CVCL_C6AG ! HPS0680
OI   CVCL_C6AH ! HPS0681
OI   CVCL_C6AI ! HPS0682
OI   CVCL_C6AJ ! HPS0683
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0680
AC   CVCL_C6AG
DR   RCB; HPS0680
DR   Wikidata; Q116049372
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AE ! HPS0678
OI   CVCL_C6AF ! HPS0679
OI   CVCL_C6AH ! HPS0681
OI   CVCL_C6AI ! HPS0682
OI   CVCL_C6AJ ! HPS0683
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0681
AC   CVCL_C6AH
DR   RCB; HPS0681
DR   Wikidata; Q116049373
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AE ! HPS0678
OI   CVCL_C6AF ! HPS0679
OI   CVCL_C6AG ! HPS0680
OI   CVCL_C6AI ! HPS0682
OI   CVCL_C6AJ ! HPS0683
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0682
AC   CVCL_C6AI
DR   RCB; HPS0682
DR   Wikidata; Q116049374
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AE ! HPS0678
OI   CVCL_C6AF ! HPS0679
OI   CVCL_C6AG ! HPS0680
OI   CVCL_C6AH ! HPS0681
OI   CVCL_C6AJ ! HPS0683
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0683
AC   CVCL_C6AJ
DR   RCB; HPS0683
DR   Wikidata; Q116049375
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AE ! HPS0678
OI   CVCL_C6AF ! HPS0679
OI   CVCL_C6AG ! HPS0680
OI   CVCL_C6AH ! HPS0681
OI   CVCL_C6AI ! HPS0682
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0718
AC   CVCL_C6AX
DR   RCB; HPS0718
DR   Wikidata; Q116049376
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AY ! HPS0719
OI   CVCL_C6AZ ! HPS0720
OI   CVCL_C6B0 ! HPS0721
OI   CVCL_C6B1 ! HPS0722
OI   CVCL_C6B2 ! HPS0723
OI   CVCL_A3FG ! HPS1044
OI   CVCL_C6B3 ! HPS1749
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0719
AC   CVCL_C6AY
DR   RCB; HPS0719
DR   Wikidata; Q116049377
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AX ! HPS0718
OI   CVCL_C6AZ ! HPS0720
OI   CVCL_C6B0 ! HPS0721
OI   CVCL_C6B1 ! HPS0722
OI   CVCL_C6B2 ! HPS0723
OI   CVCL_A3FG ! HPS1044
OI   CVCL_C6B3 ! HPS1749
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0720
AC   CVCL_C6AZ
DR   RCB; HPS0720
DR   Wikidata; Q116049378
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AX ! HPS0718
OI   CVCL_C6AY ! HPS0719
OI   CVCL_C6B0 ! HPS0721
OI   CVCL_C6B1 ! HPS0722
OI   CVCL_C6B2 ! HPS0723
OI   CVCL_A3FG ! HPS1044
OI   CVCL_C6B3 ! HPS1749
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0721
AC   CVCL_C6B0
DR   RCB; HPS0721
DR   Wikidata; Q116049379
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AX ! HPS0718
OI   CVCL_C6AY ! HPS0719
OI   CVCL_C6AZ ! HPS0720
OI   CVCL_C6B1 ! HPS0722
OI   CVCL_C6B2 ! HPS0723
OI   CVCL_A3FG ! HPS1044
OI   CVCL_C6B3 ! HPS1749
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0722
AC   CVCL_C6B1
DR   RCB; HPS0722
DR   Wikidata; Q116049380
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AX ! HPS0718
OI   CVCL_C6AY ! HPS0719
OI   CVCL_C6AZ ! HPS0720
OI   CVCL_C6B0 ! HPS0721
OI   CVCL_C6B2 ! HPS0723
OI   CVCL_A3FG ! HPS1044
OI   CVCL_C6B3 ! HPS1749
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0723
AC   CVCL_C6B2
DR   RCB; HPS0723
DR   Wikidata; Q116049381
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AX ! HPS0718
OI   CVCL_C6AY ! HPS0719
OI   CVCL_C6AZ ! HPS0720
OI   CVCL_C6B0 ! HPS0721
OI   CVCL_C6B1 ! HPS0722
OI   CVCL_A3FG ! HPS1044
OI   CVCL_C6B3 ! HPS1749
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS0772
AC   CVCL_VM79
DR   RCB; HPS0772
DR   Wikidata; Q94219288
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DS ! HPS0773
OI   CVCL_C6DT ! HPS0774
OI   CVCL_C6DU ! HPS0775
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 8
//
ID   HPS0773
AC   CVCL_C6DS
DR   RCB; HPS0773
DR   Wikidata; Q116049382
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM79 ! HPS0772
OI   CVCL_C6DT ! HPS0774
OI   CVCL_C6DU ! HPS0775
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   HPS0774
AC   CVCL_C6DT
DR   RCB; HPS0774
DR   Wikidata; Q116049383
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM79 ! HPS0772
OI   CVCL_C6DS ! HPS0773
OI   CVCL_C6DU ! HPS0775
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   HPS0775
AC   CVCL_C6DU
DR   RCB; HPS0775
DR   Wikidata; Q116049384
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM79 ! HPS0772
OI   CVCL_C6DS ! HPS0773
OI   CVCL_C6DT ! HPS0774
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   HPS0800
AC   CVCL_C6AK
DR   RCB; HPS0800
DR   Wikidata; Q116049385
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AL ! HPS0801
OI   CVCL_C6AM ! HPS0802
OI   CVCL_C6AN ! HPS0803
OI   CVCL_C6AP ! HPS0804
OI   CVCL_C6AQ ! HPS0805
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0801
AC   CVCL_C6AL
DR   RCB; HPS0801
DR   Wikidata; Q116049386
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AK ! HPS0800
OI   CVCL_C6AM ! HPS0802
OI   CVCL_C6AN ! HPS0803
OI   CVCL_C6AP ! HPS0804
OI   CVCL_C6AQ ! HPS0805
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0802
AC   CVCL_C6AM
DR   RCB; HPS0802
DR   Wikidata; Q116049387
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AK ! HPS0800
OI   CVCL_C6AL ! HPS0801
OI   CVCL_C6AN ! HPS0803
OI   CVCL_C6AP ! HPS0804
OI   CVCL_C6AQ ! HPS0805
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0803
AC   CVCL_C6AN
DR   RCB; HPS0803
DR   Wikidata; Q116049388
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AK ! HPS0800
OI   CVCL_C6AL ! HPS0801
OI   CVCL_C6AM ! HPS0802
OI   CVCL_C6AP ! HPS0804
OI   CVCL_C6AQ ! HPS0805
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0804
AC   CVCL_C6AP
DR   RCB; HPS0804
DR   Wikidata; Q116049390
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AK ! HPS0800
OI   CVCL_C6AL ! HPS0801
OI   CVCL_C6AM ! HPS0802
OI   CVCL_C6AN ! HPS0803
OI   CVCL_C6AQ ! HPS0805
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0805
AC   CVCL_C6AQ
DR   RCB; HPS0805
DR   Wikidata; Q116049392
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AK ! HPS0800
OI   CVCL_C6AL ! HPS0801
OI   CVCL_C6AM ! HPS0802
OI   CVCL_C6AN ! HPS0803
OI   CVCL_C6AP ! HPS0804
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0812
AC   CVCL_VM51
DR   RCB; HPS0812
DR   Wikidata; Q94219295
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6C75 ! HPS0060
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS0818
AC   CVCL_UN41
DR   RCB; HPS0818
DR   Wikidata; Q94219298
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0830
AC   CVCL_UN28
DR   RCB; HPS0830
DR   Wikidata; Q94219305
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   HPS0842
AC   CVCL_C6AR
DR   RCB; HPS0842
DR   Wikidata; Q116049393
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AS ! HPS0843
OI   CVCL_C6AT ! HPS0844
OI   CVCL_C6AU ! HPS0845
OI   CVCL_C6AV ! HPS0846
OI   CVCL_C6AW ! HPS0847
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0843
AC   CVCL_C6AS
DR   RCB; HPS0843
DR   Wikidata; Q116049394
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AR ! HPS0842
OI   CVCL_C6AT ! HPS0844
OI   CVCL_C6AU ! HPS0845
OI   CVCL_C6AV ! HPS0846
OI   CVCL_C6AW ! HPS0847
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0844
AC   CVCL_C6AT
DR   RCB; HPS0844
DR   Wikidata; Q116049395
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AR ! HPS0842
OI   CVCL_C6AS ! HPS0843
OI   CVCL_C6AU ! HPS0845
OI   CVCL_C6AV ! HPS0846
OI   CVCL_C6AW ! HPS0847
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0845
AC   CVCL_C6AU
DR   RCB; HPS0845
DR   Wikidata; Q116049396
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AR ! HPS0842
OI   CVCL_C6AS ! HPS0843
OI   CVCL_C6AT ! HPS0844
OI   CVCL_C6AV ! HPS0846
OI   CVCL_C6AW ! HPS0847
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0846
AC   CVCL_C6AV
DR   RCB; HPS0846
DR   Wikidata; Q116049397
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AR ! HPS0842
OI   CVCL_C6AS ! HPS0843
OI   CVCL_C6AT ! HPS0844
OI   CVCL_C6AU ! HPS0845
OI   CVCL_C6AW ! HPS0847
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0847
AC   CVCL_C6AW
DR   RCB; HPS0847
DR   Wikidata; Q116049398
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AR ! HPS0842
OI   CVCL_C6AS ! HPS0843
OI   CVCL_C6AT ! HPS0844
OI   CVCL_C6AU ! HPS0845
OI   CVCL_C6AV ! HPS0846
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   HPS0848
AC   CVCL_UN27
DR   RCB; HPS0848
DR   Wikidata; Q94219309
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   HPS0854
AC   CVCL_UN26
DR   RCB; HPS0854
DR   Wikidata; Q94219313
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0939
AC   CVCL_UR09
DR   RCB; HPS0939
DR   Wikidata; Q94219318
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR10 ! HPS0940
OI   CVCL_UR11 ! HPS0941
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0940
AC   CVCL_UR10
DR   RCB; HPS0940
DR   Wikidata; Q94219324
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR09 ! HPS0939
OI   CVCL_UR11 ! HPS0941
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0941
AC   CVCL_UR11
DR   RCB; HPS0941
DR   Wikidata; Q94219329
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR09 ! HPS0939
OI   CVCL_UR10 ! HPS0940
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0945
AC   CVCL_UR00
DR   RCB; HPS0945
DR   Wikidata; Q94219334
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR01 ! HPS0946
OI   CVCL_UR02 ! HPS0947
OI   CVCL_UR03 ! HPS0948
OI   CVCL_UR04 ! HPS0949
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0946
AC   CVCL_UR01
DR   RCB; HPS0946
DR   Wikidata; Q94219339
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR00 ! HPS0945
OI   CVCL_UR02 ! HPS0947
OI   CVCL_UR03 ! HPS0948
OI   CVCL_UR04 ! HPS0949
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0947
AC   CVCL_UR02
DR   RCB; HPS0947
DR   Wikidata; Q94219344
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR00 ! HPS0945
OI   CVCL_UR01 ! HPS0946
OI   CVCL_UR03 ! HPS0948
OI   CVCL_UR04 ! HPS0949
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0948
AC   CVCL_UR03
DR   RCB; HPS0948
DR   Wikidata; Q94219348
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR00 ! HPS0945
OI   CVCL_UR01 ! HPS0946
OI   CVCL_UR02 ! HPS0947
OI   CVCL_UR04 ! HPS0949
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0949
AC   CVCL_UR04
DR   RCB; HPS0949
DR   Wikidata; Q94219354
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR00 ! HPS0945
OI   CVCL_UR01 ! HPS0946
OI   CVCL_UR02 ! HPS0947
OI   CVCL_UR03 ! HPS0948
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0953
AC   CVCL_UR12
DR   RCB; HPS0953
DR   Wikidata; Q94219361
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR13 ! HPS0954
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS0954
AC   CVCL_UR13
DR   RCB; HPS0954
DR   Wikidata; Q94219365
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR12 ! HPS0953
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1010
AC   CVCL_VM90
DR   RCB; HPS1010
DR   Wikidata; Q94219369
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM89 ! HPS0407
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   HPS1011
AC   CVCL_VM97
DR   RCB; HPS1011
DR   Wikidata; Q94219375
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129736; Autosomal dominant neurohypophyseal diabetes insipidus
DI   ORDO; Orphanet_30925; Hereditary central diabetes insipidus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   HPS1012
AC   CVCL_VN08
SY   BRCi005-A
DR   hPSCreg; BRCi005-A
DR   RCB; HPS1012
DR   SKIP; SKIP005775
DR   Wikidata; Q94219381
RX   PubMed=32416576;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12703; BEST1; Simple; p.Arg218His (c.653G>A); ClinVar=VCV000099736; Zygosity=Heterozygous (PubMed=32416576).
CC   Sequence variation: Mutation; HGNC; HGNC:12703; BEST1; Simple; p.Ala357Val (c.1070C>T); ClinVar=VCV000305125; Zygosity=Heterozygous (PubMed=32416576).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118788; Vitelliform macular dystrophy
DI   ORDO; Orphanet_1243; Best vitelliform macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   HPS1013
AC   CVCL_RH07
DR   RCB; HPS1013
DR   Wikidata; Q54890408
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142805; Gelatinous drop-like corneal dystrophy
DI   ORDO; Orphanet_98957; Gelatinous drop-like corneal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   HPS1032
AC   CVCL_UN54
DR   RCB; HPS1032
DR   Wikidata; Q94219399
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1033
AC   CVCL_UN55
DR   RCB; HPS1033
DR   Wikidata; Q94219403
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1037
AC   CVCL_A1SY
DR   RCB; HPS1037
DR   Wikidata; Q105507753
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1SZ ! HPS1708
OI   CVCL_A1TA ! HPS1709
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1038
AC   CVCL_A1TB
DR   RCB; HPS1038
DR   Wikidata; Q105507756
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1TC ! HPS1710
OI   CVCL_A1TD ! HPS1711
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1042
AC   CVCL_UN17
DR   RCB; HPS1042
DR   Wikidata; Q94219407
RX   PubMed=28918022;
CC   Population: Japanese.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   HPS1043
AC   CVCL_UN18
DR   RCB; HPS1043
DR   Wikidata; Q94219413
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1044
AC   CVCL_A3FG
DR   RCB; HPS1044
DR   Wikidata; Q105507760
RX   PubMed=28918022;
CC   Population: Japanese.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AX ! HPS0718
OI   CVCL_C6AY ! HPS0719
OI   CVCL_C6AZ ! HPS0720
OI   CVCL_C6B0 ! HPS0721
OI   CVCL_C6B1 ! HPS0722
OI   CVCL_C6B2 ! HPS0723
OI   CVCL_C6B3 ! HPS1749
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   HPS1046
AC   CVCL_UN19
SY   hc6 NOR-B
DR   RCB; HPS1046
DR   Wikidata; Q94219417
RX   PubMed=28918022;
CC   Population: Japanese.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   HPS1047
AC   CVCL_YR45
DR   RCB; HPS1047
DR   Wikidata; Q94219423
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR39 ! HPS0552
OI   CVCL_YR40 ! HPS0553
OI   CVCL_YR41 ! HPS0554
OI   CVCL_YR42 ! HPS0555
OI   CVCL_YR43 ! HPS0556
OI   CVCL_YR44 ! HPS0557
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1048
AC   CVCL_YR46
DR   RCB; HPS1048
DR   Wikidata; Q94219429
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1049
AC   CVCL_YR47
DR   RCB; HPS1049
DR   Wikidata; Q94219435
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR50 ! HPS1718
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1050
AC   CVCL_YR51
DR   RCB; HPS1050
DR   Wikidata; Q94219439
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1051
AC   CVCL_YR52
DR   RCB; HPS1051
DR   Wikidata; Q94219445
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR53 ! HPS1703
OI   CVCL_YR54 ! HPS1704
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1052
AC   CVCL_UN56
DR   RCB; HPS1052
DR   Wikidata; Q94219449
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1053
AC   CVCL_YR55
DR   RCB; HPS1053
DR   Wikidata; Q94219454
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1054
AC   CVCL_YR56
DR   RCB; HPS1054
DR   Wikidata; Q94219459
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LS ! HPS3842
OI   CVCL_A3LT ! HPS3843
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS1066
AC   CVCL_UN57
DR   RCB; HPS1066
DR   Wikidata; Q94219464
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP78 ! HPS1067
OI   CVCL_UP79 ! HPS1068
OI   CVCL_UP80 ! HPS1069
OI   CVCL_UP81 ! HPS1070
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1067
AC   CVCL_UP78
DR   RCB; HPS1067
DR   Wikidata; Q94219466
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN57 ! HPS1066
OI   CVCL_UP79 ! HPS1068
OI   CVCL_UP80 ! HPS1069
OI   CVCL_UP81 ! HPS1070
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1068
AC   CVCL_UP79
DR   RCB; HPS1068
DR   Wikidata; Q94219471
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN57 ! HPS1066
OI   CVCL_UP78 ! HPS1067
OI   CVCL_UP80 ! HPS1069
OI   CVCL_UP81 ! HPS1070
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1069
AC   CVCL_UP80
DR   RCB; HPS1069
DR   Wikidata; Q94219476
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN57 ! HPS1066
OI   CVCL_UP78 ! HPS1067
OI   CVCL_UP79 ! HPS1068
OI   CVCL_UP81 ! HPS1070
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1070
AC   CVCL_UP81
DR   RCB; HPS1070
DR   Wikidata; Q94219481
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN57 ! HPS1066
OI   CVCL_UP78 ! HPS1067
OI   CVCL_UP79 ! HPS1068
OI   CVCL_UP80 ! HPS1069
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1071
AC   CVCL_UN58
DR   RCB; HPS1071
DR   Wikidata; Q94219484
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1072
AC   CVCL_UP96
SY   BRCi004-A
DR   hPSCreg; BRCi004-A
DR   RCB; HPS1072
DR   Wikidata; Q94219489
RX   PubMed=32416577;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3TC ! HPS1756
SX   Male
AG   90-99Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   HPS1074
AC   CVCL_UN59
DR   RCB; HPS1074
DR   Wikidata; Q94219495
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171269; Spinocerebellar ataxia type 42
DI   ORDO; Orphanet_458803; Spinocerebellar ataxia type 42
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3UL ! HPS1772
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1075
AC   CVCL_UN60
DR   RCB; HPS1075
DR   Wikidata; Q94219499
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1090
AC   CVCL_UP33
SY   BRCi012-A; CiRA-j-0042-A
DR   hPSCreg; BRCi012-A
DR   RCB; HPS1090
DR   Wikidata; Q94219502
RX   PubMed=33901816;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Arg401Trp (c.1201C>T); ClinVar=VCV000488393; Zygosity=Hemizygous (PubMed=33901816).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3SS ! HPS1091
OI   CVCL_A3ST ! HPS1092
OI   CVCL_A3SU ! HPS1093
OI   CVCL_A3SV ! HPS1094
OI   CVCL_A3SW ! HPS1095
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   HPS1091
AC   CVCL_A3SS
SY   BRCi012-B
DR   hPSCreg; BRCi012-B
DR   RCB; HPS1091
DR   Wikidata; Q105507763
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Arg401Trp (c.1201C>T); ClinVar=VCV000488393; Zygosity=Hemizygous (from autologous cell line HPS1090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP33 ! HPS1090
OI   CVCL_A3ST ! HPS1092
OI   CVCL_A3SU ! HPS1093
OI   CVCL_A3SV ! HPS1094
OI   CVCL_A3SW ! HPS1095
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1092
AC   CVCL_A3ST
SY   BRCi012-C
DR   hPSCreg; BRCi012-C
DR   RCB; HPS1092
DR   Wikidata; Q105507767
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Arg401Trp (c.1201C>T); ClinVar=VCV000488393; Zygosity=Hemizygous (from autologous cell line HPS1090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP33 ! HPS1090
OI   CVCL_A3SS ! HPS1091
OI   CVCL_A3SU ! HPS1093
OI   CVCL_A3SV ! HPS1094
OI   CVCL_A3SW ! HPS1095
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1093
AC   CVCL_A3SU
SY   BRCi012-D
DR   hPSCreg; BRCi012-D
DR   RCB; HPS1093
DR   Wikidata; Q105507768
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Arg401Trp (c.1201C>T); ClinVar=VCV000488393; Zygosity=Hemizygous (from autologous cell line HPS1090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP33 ! HPS1090
OI   CVCL_A3SS ! HPS1091
OI   CVCL_A3ST ! HPS1092
OI   CVCL_A3SV ! HPS1094
OI   CVCL_A3SW ! HPS1095
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1094
AC   CVCL_A3SV
SY   BRCi012-E
DR   hPSCreg; BRCi012-E
DR   RCB; HPS1094
DR   Wikidata; Q105507773
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Arg401Trp (c.1201C>T); ClinVar=VCV000488393; Zygosity=Hemizygous (from autologous cell line HPS1090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP33 ! HPS1090
OI   CVCL_A3SS ! HPS1091
OI   CVCL_A3ST ! HPS1092
OI   CVCL_A3SU ! HPS1093
OI   CVCL_A3SW ! HPS1095
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1095
AC   CVCL_A3SW
SY   BRCi012-F
DR   hPSCreg; BRCi012-F
DR   RCB; HPS1095
DR   Wikidata; Q105507776
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Arg401Trp (c.1201C>T); ClinVar=VCV000488393; Zygosity=Hemizygous (from autologous cell line HPS1090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP33 ! HPS1090
OI   CVCL_A3SS ! HPS1091
OI   CVCL_A3ST ! HPS1092
OI   CVCL_A3SU ! HPS1093
OI   CVCL_A3SV ! HPS1094
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1096
AC   CVCL_UP34
SY   BRCi013-A; CiRA-j-0043-A
DR   hPSCreg; BRCi013-A
DR   RCB; HPS1096
DR   Wikidata; Q94219507
RX   PubMed=33901816;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Leu670Phefs*63 (c.2010_2014delinsTAT); Zygosity=Hemizygous (PubMed=33901816).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3SX ! HPS1097
OI   CVCL_A3SY ! HPS1098
OI   CVCL_A3SZ ! HPS1099
OI   CVCL_A3TA ! HPS1100
OI   CVCL_A3TB ! HPS1101
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   HPS1097
AC   CVCL_A3SX
SY   BRCi013-B
DR   hPSCreg; BRCi013-B
DR   RCB; HPS1097
DR   Wikidata; Q105507780
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Leu670Phefs*63 (c.2010_2014delinsTAT); Zygosity=Hemizygous (from autologous cell line HPS1096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP34 ! HPS1096
OI   CVCL_A3SY ! HPS1098
OI   CVCL_A3SZ ! HPS1099
OI   CVCL_A3TA ! HPS1100
OI   CVCL_A3TB ! HPS1101
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1098
AC   CVCL_A3SY
SY   BRCi013-C
DR   hPSCreg; BRCi013-C
DR   RCB; HPS1098
DR   Wikidata; Q105507782
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Leu670Phefs*63 (c.2010_2014delinsTAT); Zygosity=Hemizygous (from autologous cell line HPS1096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP34 ! HPS1096
OI   CVCL_A3SX ! HPS1097
OI   CVCL_A3SZ ! HPS1099
OI   CVCL_A3TA ! HPS1100
OI   CVCL_A3TB ! HPS1101
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1099
AC   CVCL_A3SZ
SY   BRCi013-D
DR   hPSCreg; BRCi013-D
DR   RCB; HPS1099
DR   Wikidata; Q105507785
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Leu670Phefs*63 (c.2010_2014delinsTAT); Zygosity=Hemizygous (from autologous cell line HPS1096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP34 ! HPS1096
OI   CVCL_A3SX ! HPS1097
OI   CVCL_A3SY ! HPS1098
OI   CVCL_A3TA ! HPS1100
OI   CVCL_A3TB ! HPS1101
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1100
AC   CVCL_A3TA
SY   BRCi013-E
DR   hPSCreg; BRCi013-E
DR   RCB; HPS1100
DR   Wikidata; Q105507788
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Leu670Phefs*63 (c.2010_2014delinsTAT); Zygosity=Hemizygous (from autologous cell line HPS1096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP34 ! HPS1096
OI   CVCL_A3SX ! HPS1097
OI   CVCL_A3SY ! HPS1098
OI   CVCL_A3SZ ! HPS1099
OI   CVCL_A3TB ! HPS1101
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1101
AC   CVCL_A3TB
SY   BRCi013-F
DR   hPSCreg; BRCi013-F
DR   RCB; HPS1101
DR   Wikidata; Q105507792
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Leu670Phefs*63 (c.2010_2014delinsTAT); Zygosity=Hemizygous (from autologous cell line HPS1096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP34 ! HPS1096
OI   CVCL_A3SX ! HPS1097
OI   CVCL_A3SY ! HPS1098
OI   CVCL_A3SZ ! HPS1099
OI   CVCL_A3TA ! HPS1100
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS1126
AC   CVCL_UN20
DR   RCB; HPS1126
DR   Wikidata; Q94219512
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN21 ! HPS1127
OI   CVCL_UN22 ! HPS1128
OI   CVCL_UN23 ! HPS1132
OI   CVCL_UN24 ! HPS1133
OI   CVCL_UN25 ! HPS1134
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1127
AC   CVCL_UN21
DR   RCB; HPS1127
DR   Wikidata; Q94219516
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN20 ! HPS1126
OI   CVCL_UN22 ! HPS1128
OI   CVCL_UN23 ! HPS1132
OI   CVCL_UN24 ! HPS1133
OI   CVCL_UN25 ! HPS1134
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1128
AC   CVCL_UN22
DR   RCB; HPS1128
DR   Wikidata; Q94219521
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN20 ! HPS1126
OI   CVCL_UN21 ! HPS1127
OI   CVCL_UN23 ! HPS1132
OI   CVCL_UN24 ! HPS1133
OI   CVCL_UN25 ! HPS1134
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1132
AC   CVCL_UN23
DR   RCB; HPS1132
DR   Wikidata; Q94219527
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN20 ! HPS1126
OI   CVCL_UN21 ! HPS1127
OI   CVCL_UN22 ! HPS1128
OI   CVCL_UN24 ! HPS1133
OI   CVCL_UN25 ! HPS1134
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   HPS1133
AC   CVCL_UN24
DR   RCB; HPS1133
DR   Wikidata; Q94219530
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN20 ! HPS1126
OI   CVCL_UN21 ! HPS1127
OI   CVCL_UN22 ! HPS1128
OI   CVCL_UN23 ! HPS1132
OI   CVCL_UN25 ! HPS1134
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   HPS1134
AC   CVCL_UN25
DR   RCB; HPS1134
DR   Wikidata; Q94219534
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN20 ! HPS1126
OI   CVCL_UN21 ! HPS1127
OI   CVCL_UN22 ! HPS1128
OI   CVCL_UN23 ! HPS1132
OI   CVCL_UN24 ! HPS1133
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   HPS1174
AC   CVCL_C9T8
DR   RCB; HPS1174
DR   Wikidata; Q123031687
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T9 ! HPS1175
OI   CVCL_C9TA ! HPS1176
OI   CVCL_C9TB ! HPS1177
OI   CVCL_C9TC ! HPS1178
OI   CVCL_C9TD ! HPS1179
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1175
AC   CVCL_C9T9
DR   RCB; HPS1175
DR   Wikidata; Q123031688
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T8 ! HPS1174
OI   CVCL_C9TA ! HPS1176
OI   CVCL_C9TB ! HPS1177
OI   CVCL_C9TC ! HPS1178
OI   CVCL_C9TD ! HPS1179
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1176
AC   CVCL_C9TA
DR   RCB; HPS1176
DR   Wikidata; Q123031689
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T8 ! HPS1174
OI   CVCL_C9T9 ! HPS1175
OI   CVCL_C9TB ! HPS1177
OI   CVCL_C9TC ! HPS1178
OI   CVCL_C9TD ! HPS1179
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1177
AC   CVCL_C9TB
DR   RCB; HPS1177
DR   Wikidata; Q123031690
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T8 ! HPS1174
OI   CVCL_C9T9 ! HPS1175
OI   CVCL_C9TA ! HPS1176
OI   CVCL_C9TC ! HPS1178
OI   CVCL_C9TD ! HPS1179
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1178
AC   CVCL_C9TC
DR   RCB; HPS1178
DR   Wikidata; Q123031691
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T8 ! HPS1174
OI   CVCL_C9T9 ! HPS1175
OI   CVCL_C9TA ! HPS1176
OI   CVCL_C9TB ! HPS1177
OI   CVCL_C9TD ! HPS1179
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1179
AC   CVCL_C9TD
DR   RCB; HPS1179
DR   Wikidata; Q123031692
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T8 ! HPS1174
OI   CVCL_C9T9 ! HPS1175
OI   CVCL_C9TA ! HPS1176
OI   CVCL_C9TB ! HPS1177
OI   CVCL_C9TC ! HPS1178
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1180
AC   CVCL_C9T2
DR   RCB; HPS1180
DR   Wikidata; Q123031693
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T3 ! HPS1181
OI   CVCL_C9T4 ! HPS1182
OI   CVCL_C9T5 ! HPS1183
OI   CVCL_C9T6 ! HPS1184
OI   CVCL_C9T7 ! HPS1185
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1181
AC   CVCL_C9T3
DR   RCB; HPS1181
DR   Wikidata; Q123031694
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T2 ! HPS1180
OI   CVCL_C9T4 ! HPS1182
OI   CVCL_C9T5 ! HPS1183
OI   CVCL_C9T6 ! HPS1184
OI   CVCL_C9T7 ! HPS1185
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1182
AC   CVCL_C9T4
DR   RCB; HPS1182
DR   Wikidata; Q123031695
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T2 ! HPS1180
OI   CVCL_C9T3 ! HPS1181
OI   CVCL_C9T5 ! HPS1183
OI   CVCL_C9T6 ! HPS1184
OI   CVCL_C9T7 ! HPS1185
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1183
AC   CVCL_C9T5
DR   RCB; HPS1183
DR   Wikidata; Q123031696
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T2 ! HPS1180
OI   CVCL_C9T3 ! HPS1181
OI   CVCL_C9T4 ! HPS1182
OI   CVCL_C9T6 ! HPS1184
OI   CVCL_C9T7 ! HPS1185
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1184
AC   CVCL_C9T6
DR   RCB; HPS1184
DR   Wikidata; Q123031697
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T2 ! HPS1180
OI   CVCL_C9T3 ! HPS1181
OI   CVCL_C9T4 ! HPS1182
OI   CVCL_C9T5 ! HPS1183
OI   CVCL_C9T7 ! HPS1185
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1185
AC   CVCL_C9T7
DR   RCB; HPS1185
DR   Wikidata; Q123031698
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9T2 ! HPS1180
OI   CVCL_C9T3 ! HPS1181
OI   CVCL_C9T4 ! HPS1182
OI   CVCL_C9T5 ! HPS1183
OI   CVCL_C9T6 ! HPS1184
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1186
AC   CVCL_C9SW
DR   RCB; HPS1186
DR   Wikidata; Q123031699
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SX ! HPS1187
OI   CVCL_C9SY ! HPS1188
OI   CVCL_C9SZ ! HPS1189
OI   CVCL_C9T0 ! HPS1190
OI   CVCL_C9T1 ! HPS1191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1187
AC   CVCL_C9SX
DR   RCB; HPS1187
DR   Wikidata; Q123031700
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SW ! HPS1186
OI   CVCL_C9SY ! HPS1188
OI   CVCL_C9SZ ! HPS1189
OI   CVCL_C9T0 ! HPS1190
OI   CVCL_C9T1 ! HPS1191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1188
AC   CVCL_C9SY
DR   RCB; HPS1188
DR   Wikidata; Q123031701
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SW ! HPS1186
OI   CVCL_C9SX ! HPS1187
OI   CVCL_C9SZ ! HPS1189
OI   CVCL_C9T0 ! HPS1190
OI   CVCL_C9T1 ! HPS1191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1189
AC   CVCL_C9SZ
DR   RCB; HPS1189
DR   Wikidata; Q123031702
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SW ! HPS1186
OI   CVCL_C9SX ! HPS1187
OI   CVCL_C9SY ! HPS1188
OI   CVCL_C9T0 ! HPS1190
OI   CVCL_C9T1 ! HPS1191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1190
AC   CVCL_C9T0
DR   RCB; HPS1190
DR   Wikidata; Q123031703
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SW ! HPS1186
OI   CVCL_C9SX ! HPS1187
OI   CVCL_C9SY ! HPS1188
OI   CVCL_C9SZ ! HPS1189
OI   CVCL_C9T1 ! HPS1191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1191
AC   CVCL_C9T1
DR   RCB; HPS1191
DR   Wikidata; Q123031704
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SW ! HPS1186
OI   CVCL_C9SX ! HPS1187
OI   CVCL_C9SY ! HPS1188
OI   CVCL_C9SZ ! HPS1189
OI   CVCL_C9T0 ! HPS1190
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1198
AC   CVCL_C6B4
DR   RCB; HPS1198
DR   Wikidata; Q116049399
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   NCIt; C72069; Localized scleroderma
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6B5 ! HPS1199
OI   CVCL_C6B6 ! HPS1200
OI   CVCL_C6B7 ! HPS1201
OI   CVCL_C6B8 ! HPS1202
OI   CVCL_C6B9 ! HPS1203
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   HPS1199
AC   CVCL_C6B5
DR   RCB; HPS1199
DR   Wikidata; Q116049400
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   NCIt; C72069; Localized scleroderma
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6B4 ! HPS1198
OI   CVCL_C6B6 ! HPS1200
OI   CVCL_C6B7 ! HPS1201
OI   CVCL_C6B8 ! HPS1202
OI   CVCL_C6B9 ! HPS1203
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   HPS1200
AC   CVCL_C6B6
DR   RCB; HPS1200
DR   Wikidata; Q116049402
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   NCIt; C72069; Localized scleroderma
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6B4 ! HPS1198
OI   CVCL_C6B5 ! HPS1199
OI   CVCL_C6B7 ! HPS1201
OI   CVCL_C6B8 ! HPS1202
OI   CVCL_C6B9 ! HPS1203
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   HPS1201
AC   CVCL_C6B7
DR   RCB; HPS1201
DR   Wikidata; Q116049403
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   NCIt; C72069; Localized scleroderma
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6B4 ! HPS1198
OI   CVCL_C6B5 ! HPS1199
OI   CVCL_C6B6 ! HPS1200
OI   CVCL_C6B8 ! HPS1202
OI   CVCL_C6B9 ! HPS1203
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   HPS1202
AC   CVCL_C6B8
DR   RCB; HPS1202
DR   Wikidata; Q116049404
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   NCIt; C72069; Localized scleroderma
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6B4 ! HPS1198
OI   CVCL_C6B5 ! HPS1199
OI   CVCL_C6B6 ! HPS1200
OI   CVCL_C6B7 ! HPS1201
OI   CVCL_C6B9 ! HPS1203
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   HPS1203
AC   CVCL_C6B9
DR   RCB; HPS1203
DR   Wikidata; Q116049405
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   NCIt; C72069; Localized scleroderma
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6B4 ! HPS1198
OI   CVCL_C6B5 ! HPS1199
OI   CVCL_C6B6 ! HPS1200
OI   CVCL_C6B7 ! HPS1201
OI   CVCL_C6B8 ! HPS1202
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   HPS1204
AC   CVCL_A3FM
DR   RCB; HPS1204
DR   Wikidata; Q105507795
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FN ! HPS1205
OI   CVCL_A3FP ! HPS1206
OI   CVCL_A3FQ ! HPS1207
OI   CVCL_A3FR ! HPS1208
OI   CVCL_A3FS ! HPS1209
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1205
AC   CVCL_A3FN
DR   RCB; HPS1205
DR   Wikidata; Q105507801
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FM ! HPS1204
OI   CVCL_A3FP ! HPS1206
OI   CVCL_A3FQ ! HPS1207
OI   CVCL_A3FR ! HPS1208
OI   CVCL_A3FS ! HPS1209
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1206
AC   CVCL_A3FP
DR   RCB; HPS1206
DR   Wikidata; Q105507805
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FM ! HPS1204
OI   CVCL_A3FN ! HPS1205
OI   CVCL_A3FQ ! HPS1207
OI   CVCL_A3FR ! HPS1208
OI   CVCL_A3FS ! HPS1209
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1207
AC   CVCL_A3FQ
DR   RCB; HPS1207
DR   Wikidata; Q105507810
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FM ! HPS1204
OI   CVCL_A3FN ! HPS1205
OI   CVCL_A3FP ! HPS1206
OI   CVCL_A3FR ! HPS1208
OI   CVCL_A3FS ! HPS1209
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1208
AC   CVCL_A3FR
DR   RCB; HPS1208
DR   Wikidata; Q105507812
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FM ! HPS1204
OI   CVCL_A3FN ! HPS1205
OI   CVCL_A3FP ! HPS1206
OI   CVCL_A3FQ ! HPS1207
OI   CVCL_A3FS ! HPS1209
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1209
AC   CVCL_A3FS
DR   RCB; HPS1209
DR   Wikidata; Q105507814
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FM ! HPS1204
OI   CVCL_A3FN ! HPS1205
OI   CVCL_A3FP ! HPS1206
OI   CVCL_A3FQ ! HPS1207
OI   CVCL_A3FR ! HPS1208
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1210
AC   CVCL_UN61
DR   RCB; HPS1210
DR   Wikidata; Q94219539
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3TT ! HPS1211
OI   CVCL_A3TU ! HPS1212
OI   CVCL_A3TV ! HPS1213
OI   CVCL_A3TW ! HPS1214
OI   CVCL_A3TX ! HPS1215
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1211
AC   CVCL_A3TT
DR   RCB; HPS1211
DR   Wikidata; Q105507819
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN61 ! HPS1210
OI   CVCL_A3TU ! HPS1212
OI   CVCL_A3TV ! HPS1213
OI   CVCL_A3TW ! HPS1214
OI   CVCL_A3TX ! HPS1215
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1212
AC   CVCL_A3TU
DR   RCB; HPS1212
DR   Wikidata; Q105507821
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN61 ! HPS1210
OI   CVCL_A3TT ! HPS1211
OI   CVCL_A3TV ! HPS1213
OI   CVCL_A3TW ! HPS1214
OI   CVCL_A3TX ! HPS1215
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1213
AC   CVCL_A3TV
DR   RCB; HPS1213
DR   Wikidata; Q105507826
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN61 ! HPS1210
OI   CVCL_A3TT ! HPS1211
OI   CVCL_A3TU ! HPS1212
OI   CVCL_A3TW ! HPS1214
OI   CVCL_A3TX ! HPS1215
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1214
AC   CVCL_A3TW
DR   RCB; HPS1214
DR   Wikidata; Q105507830
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN61 ! HPS1210
OI   CVCL_A3TT ! HPS1211
OI   CVCL_A3TU ! HPS1212
OI   CVCL_A3TV ! HPS1213
OI   CVCL_A3TX ! HPS1215
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1215
AC   CVCL_A3TX
DR   RCB; HPS1215
DR   Wikidata; Q105507834
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN61 ! HPS1210
OI   CVCL_A3TT ! HPS1211
OI   CVCL_A3TU ! HPS1212
OI   CVCL_A3TV ! HPS1213
OI   CVCL_A3TW ! HPS1214
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1216
AC   CVCL_C6BA
DR   RCB; HPS1216
DR   Wikidata; Q116049406
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BB ! HPS1217
OI   CVCL_C6BC ! HPS1218
OI   CVCL_C6BD ! HPS1219
OI   CVCL_C6BE ! HPS1220
OI   CVCL_C6BF ! HPS1221
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1217
AC   CVCL_C6BB
DR   RCB; HPS1217
DR   Wikidata; Q116049407
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BA ! HPS1216
OI   CVCL_C6BC ! HPS1218
OI   CVCL_C6BD ! HPS1219
OI   CVCL_C6BE ! HPS1220
OI   CVCL_C6BF ! HPS1221
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1218
AC   CVCL_C6BC
DR   RCB; HPS1218
DR   Wikidata; Q116049408
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BA ! HPS1216
OI   CVCL_C6BB ! HPS1217
OI   CVCL_C6BD ! HPS1219
OI   CVCL_C6BE ! HPS1220
OI   CVCL_C6BF ! HPS1221
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1219
AC   CVCL_C6BD
DR   RCB; HPS1219
DR   Wikidata; Q116049409
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BA ! HPS1216
OI   CVCL_C6BB ! HPS1217
OI   CVCL_C6BC ! HPS1218
OI   CVCL_C6BE ! HPS1220
OI   CVCL_C6BF ! HPS1221
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1220
AC   CVCL_C6BE
DR   RCB; HPS1220
DR   Wikidata; Q116049410
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BA ! HPS1216
OI   CVCL_C6BB ! HPS1217
OI   CVCL_C6BC ! HPS1218
OI   CVCL_C6BD ! HPS1219
OI   CVCL_C6BF ! HPS1221
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1221
AC   CVCL_C6BF
DR   RCB; HPS1221
DR   Wikidata; Q116049411
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BA ! HPS1216
OI   CVCL_C6BB ! HPS1217
OI   CVCL_C6BC ! HPS1218
OI   CVCL_C6BD ! HPS1219
OI   CVCL_C6BE ! HPS1220
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1222
AC   CVCL_C9P5
DR   RCB; HPS1222
DR   Wikidata; Q123031705
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9P6 ! HPS1223
OI   CVCL_C9P7 ! HPS1224
OI   CVCL_C9P8 ! HPS1225
OI   CVCL_C9P9 ! HPS1226
OI   CVCL_C9PA ! HPS1227
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1223
AC   CVCL_C9P6
DR   RCB; HPS1223
DR   Wikidata; Q123031706
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9P5 ! HPS1222
OI   CVCL_C9P7 ! HPS1224
OI   CVCL_C9P8 ! HPS1225
OI   CVCL_C9P9 ! HPS1226
OI   CVCL_C9PA ! HPS1227
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1224
AC   CVCL_C9P7
DR   RCB; HPS1224
DR   Wikidata; Q123031707
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9P5 ! HPS1222
OI   CVCL_C9P6 ! HPS1223
OI   CVCL_C9P8 ! HPS1225
OI   CVCL_C9P9 ! HPS1226
OI   CVCL_C9PA ! HPS1227
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1225
AC   CVCL_C9P8
DR   RCB; HPS1225
DR   Wikidata; Q123031708
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9P5 ! HPS1222
OI   CVCL_C9P6 ! HPS1223
OI   CVCL_C9P7 ! HPS1224
OI   CVCL_C9P9 ! HPS1226
OI   CVCL_C9PA ! HPS1227
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1226
AC   CVCL_C9P9
DR   RCB; HPS1226
DR   Wikidata; Q123031709
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9P5 ! HPS1222
OI   CVCL_C9P6 ! HPS1223
OI   CVCL_C9P7 ! HPS1224
OI   CVCL_C9P8 ! HPS1225
OI   CVCL_C9PA ! HPS1227
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1227
AC   CVCL_C9PA
DR   RCB; HPS1227
DR   Wikidata; Q123031710
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9P5 ! HPS1222
OI   CVCL_C9P6 ! HPS1223
OI   CVCL_C9P7 ! HPS1224
OI   CVCL_C9P8 ! HPS1225
OI   CVCL_C9P9 ! HPS1226
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1228
AC   CVCL_UN62
DR   RCB; HPS1228
DR   Wikidata; Q94219542
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3TY ! HPS1229
OI   CVCL_A3TZ ! HPS1230
OI   CVCL_A3UA ! HPS1231
OI   CVCL_A3UB ! HPS1232
OI   CVCL_A3UC ! HPS1233
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1229
AC   CVCL_A3TY
DR   RCB; HPS1229
DR   Wikidata; Q105507838
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN62 ! HPS1228
OI   CVCL_A3TZ ! HPS1230
OI   CVCL_A3UA ! HPS1231
OI   CVCL_A3UB ! HPS1232
OI   CVCL_A3UC ! HPS1233
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1230
AC   CVCL_A3TZ
DR   RCB; HPS1230
DR   Wikidata; Q105507844
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN62 ! HPS1228
OI   CVCL_A3TY ! HPS1229
OI   CVCL_A3UA ! HPS1231
OI   CVCL_A3UB ! HPS1232
OI   CVCL_A3UC ! HPS1233
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1231
AC   CVCL_A3UA
DR   RCB; HPS1231
DR   Wikidata; Q105507848
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN62 ! HPS1228
OI   CVCL_A3TY ! HPS1229
OI   CVCL_A3TZ ! HPS1230
OI   CVCL_A3UB ! HPS1232
OI   CVCL_A3UC ! HPS1233
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1232
AC   CVCL_A3UB
DR   RCB; HPS1232
DR   Wikidata; Q105507850
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN62 ! HPS1228
OI   CVCL_A3TY ! HPS1229
OI   CVCL_A3TZ ! HPS1230
OI   CVCL_A3UA ! HPS1231
OI   CVCL_A3UC ! HPS1233
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1233
AC   CVCL_A3UC
DR   RCB; HPS1233
DR   Wikidata; Q105507852
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN62 ! HPS1228
OI   CVCL_A3TY ! HPS1229
OI   CVCL_A3TZ ! HPS1230
OI   CVCL_A3UA ! HPS1231
OI   CVCL_A3UB ! HPS1232
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1234
AC   CVCL_C9TE
DR   RCB; HPS1234
DR   Wikidata; Q123031711
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TF ! HPS1235
OI   CVCL_C9TG ! HPS1236
OI   CVCL_C9TH ! HPS1237
OI   CVCL_C9TI ! HPS1238
OI   CVCL_C9TJ ! HPS1239
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1235
AC   CVCL_C9TF
DR   RCB; HPS1235
DR   Wikidata; Q123031712
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TE ! HPS1234
OI   CVCL_C9TG ! HPS1236
OI   CVCL_C9TH ! HPS1237
OI   CVCL_C9TI ! HPS1238
OI   CVCL_C9TJ ! HPS1239
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1236
AC   CVCL_C9TG
DR   RCB; HPS1236
DR   Wikidata; Q123031713
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TE ! HPS1234
OI   CVCL_C9TF ! HPS1235
OI   CVCL_C9TH ! HPS1237
OI   CVCL_C9TI ! HPS1238
OI   CVCL_C9TJ ! HPS1239
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1237
AC   CVCL_C9TH
DR   RCB; HPS1237
DR   Wikidata; Q123031714
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TE ! HPS1234
OI   CVCL_C9TF ! HPS1235
OI   CVCL_C9TG ! HPS1236
OI   CVCL_C9TI ! HPS1238
OI   CVCL_C9TJ ! HPS1239
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1238
AC   CVCL_C9TI
DR   RCB; HPS1238
DR   Wikidata; Q123031715
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TE ! HPS1234
OI   CVCL_C9TF ! HPS1235
OI   CVCL_C9TG ! HPS1236
OI   CVCL_C9TH ! HPS1237
OI   CVCL_C9TJ ! HPS1239
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1239
AC   CVCL_C9TJ
DR   RCB; HPS1239
DR   Wikidata; Q123031716
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TE ! HPS1234
OI   CVCL_C9TF ! HPS1235
OI   CVCL_C9TG ! HPS1236
OI   CVCL_C9TH ! HPS1237
OI   CVCL_C9TI ! HPS1238
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1240
AC   CVCL_C9ML
DR   RCB; HPS1240
DR   Wikidata; Q123031717
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MM ! HPS1241
OI   CVCL_C9MN ! HPS1242
OI   CVCL_C9MP ! HPS1243
OI   CVCL_C9MQ ! HPS1244
OI   CVCL_C9MR ! HPS1245
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1241
AC   CVCL_C9MM
DR   RCB; HPS1241
DR   Wikidata; Q123031718
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ML ! HPS1240
OI   CVCL_C9MN ! HPS1242
OI   CVCL_C9MP ! HPS1243
OI   CVCL_C9MQ ! HPS1244
OI   CVCL_C9MR ! HPS1245
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1242
AC   CVCL_C9MN
DR   RCB; HPS1242
DR   Wikidata; Q123031719
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ML ! HPS1240
OI   CVCL_C9MM ! HPS1241
OI   CVCL_C9MP ! HPS1243
OI   CVCL_C9MQ ! HPS1244
OI   CVCL_C9MR ! HPS1245
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1243
AC   CVCL_C9MP
DR   RCB; HPS1243
DR   Wikidata; Q123031720
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ML ! HPS1240
OI   CVCL_C9MM ! HPS1241
OI   CVCL_C9MN ! HPS1242
OI   CVCL_C9MQ ! HPS1244
OI   CVCL_C9MR ! HPS1245
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1244
AC   CVCL_C9MQ
DR   RCB; HPS1244
DR   Wikidata; Q123031721
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ML ! HPS1240
OI   CVCL_C9MM ! HPS1241
OI   CVCL_C9MN ! HPS1242
OI   CVCL_C9MP ! HPS1243
OI   CVCL_C9MR ! HPS1245
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1245
AC   CVCL_C9MR
DR   RCB; HPS1245
DR   Wikidata; Q123031722
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9ML ! HPS1240
OI   CVCL_C9MM ! HPS1241
OI   CVCL_C9MN ! HPS1242
OI   CVCL_C9MP ! HPS1243
OI   CVCL_C9MQ ! HPS1244
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1246
AC   CVCL_C9TK
DR   RCB; HPS1246
DR   Wikidata; Q123031723
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TL ! HPS1247
OI   CVCL_C9TM ! HPS1248
OI   CVCL_C9TN ! HPS1249
OI   CVCL_C9TP ! HPS1250
OI   CVCL_C9TQ ! HPS1251
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1247
AC   CVCL_C9TL
DR   RCB; HPS1247
DR   Wikidata; Q123031725
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TK ! HPS1246
OI   CVCL_C9TM ! HPS1248
OI   CVCL_C9TN ! HPS1249
OI   CVCL_C9TP ! HPS1250
OI   CVCL_C9TQ ! HPS1251
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1248
AC   CVCL_C9TM
DR   RCB; HPS1248
DR   Wikidata; Q123031726
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TK ! HPS1246
OI   CVCL_C9TL ! HPS1247
OI   CVCL_C9TN ! HPS1249
OI   CVCL_C9TP ! HPS1250
OI   CVCL_C9TQ ! HPS1251
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1249
AC   CVCL_C9TN
DR   RCB; HPS1249
DR   Wikidata; Q123031727
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TK ! HPS1246
OI   CVCL_C9TL ! HPS1247
OI   CVCL_C9TM ! HPS1248
OI   CVCL_C9TP ! HPS1250
OI   CVCL_C9TQ ! HPS1251
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1250
AC   CVCL_C9TP
DR   RCB; HPS1250
DR   Wikidata; Q123031728
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TK ! HPS1246
OI   CVCL_C9TL ! HPS1247
OI   CVCL_C9TM ! HPS1248
OI   CVCL_C9TN ! HPS1249
OI   CVCL_C9TQ ! HPS1251
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1251
AC   CVCL_C9TQ
DR   RCB; HPS1251
DR   Wikidata; Q123031729
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TK ! HPS1246
OI   CVCL_C9TL ! HPS1247
OI   CVCL_C9TM ! HPS1248
OI   CVCL_C9TN ! HPS1249
OI   CVCL_C9TP ! HPS1250
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1252
AC   CVCL_UN63
DR   RCB; HPS1252
DR   Wikidata; Q94219546
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR57 ! HPS1253
OI   CVCL_YR58 ! HPS1254
OI   CVCL_YR59 ! HPS1255
OI   CVCL_YR60 ! HPS1256
OI   CVCL_YR61 ! HPS1257
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1253
AC   CVCL_YR57
DR   RCB; HPS1253
DR   Wikidata; Q94219551
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN63 ! HPS1252
OI   CVCL_YR58 ! HPS1254
OI   CVCL_YR59 ! HPS1255
OI   CVCL_YR60 ! HPS1256
OI   CVCL_YR61 ! HPS1257
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1254
AC   CVCL_YR58
DR   RCB; HPS1254
DR   Wikidata; Q94219556
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN63 ! HPS1252
OI   CVCL_YR57 ! HPS1253
OI   CVCL_YR59 ! HPS1255
OI   CVCL_YR60 ! HPS1256
OI   CVCL_YR61 ! HPS1257
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1255
AC   CVCL_YR59
DR   RCB; HPS1255
DR   Wikidata; Q94219561
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN63 ! HPS1252
OI   CVCL_YR57 ! HPS1253
OI   CVCL_YR58 ! HPS1254
OI   CVCL_YR60 ! HPS1256
OI   CVCL_YR61 ! HPS1257
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1256
AC   CVCL_YR60
DR   RCB; HPS1256
DR   Wikidata; Q94219565
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN63 ! HPS1252
OI   CVCL_YR57 ! HPS1253
OI   CVCL_YR58 ! HPS1254
OI   CVCL_YR59 ! HPS1255
OI   CVCL_YR61 ! HPS1257
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1257
AC   CVCL_YR61
DR   RCB; HPS1257
DR   Wikidata; Q94219572
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3107; Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN63 ! HPS1252
OI   CVCL_YR57 ! HPS1253
OI   CVCL_YR58 ! HPS1254
OI   CVCL_YR59 ! HPS1255
OI   CVCL_YR60 ! HPS1256
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1258
AC   CVCL_C9MS
DR   RCB; HPS1258
DR   Wikidata; Q123031730
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MT ! HPS1259
OI   CVCL_C9MU ! HPS1260
OI   CVCL_C9MV ! HPS1261
OI   CVCL_C9MW ! HPS1262
OI   CVCL_C9MX ! HPS1263
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1259
AC   CVCL_C9MT
DR   RCB; HPS1259
DR   Wikidata; Q123031731
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MS ! HPS1258
OI   CVCL_C9MU ! HPS1260
OI   CVCL_C9MV ! HPS1261
OI   CVCL_C9MW ! HPS1262
OI   CVCL_C9MX ! HPS1263
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1260
AC   CVCL_C9MU
DR   RCB; HPS1260
DR   Wikidata; Q123031732
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MS ! HPS1258
OI   CVCL_C9MT ! HPS1259
OI   CVCL_C9MV ! HPS1261
OI   CVCL_C9MW ! HPS1262
OI   CVCL_C9MX ! HPS1263
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1261
AC   CVCL_C9MV
DR   RCB; HPS1261
DR   Wikidata; Q123031733
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MS ! HPS1258
OI   CVCL_C9MT ! HPS1259
OI   CVCL_C9MU ! HPS1260
OI   CVCL_C9MW ! HPS1262
OI   CVCL_C9MX ! HPS1263
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1262
AC   CVCL_C9MW
DR   RCB; HPS1262
DR   Wikidata; Q123031734
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MS ! HPS1258
OI   CVCL_C9MT ! HPS1259
OI   CVCL_C9MU ! HPS1260
OI   CVCL_C9MV ! HPS1261
OI   CVCL_C9MX ! HPS1263
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1263
AC   CVCL_C9MX
DR   RCB; HPS1263
DR   Wikidata; Q123031735
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MS ! HPS1258
OI   CVCL_C9MT ! HPS1259
OI   CVCL_C9MU ! HPS1260
OI   CVCL_C9MV ! HPS1261
OI   CVCL_C9MW ! HPS1262
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1264
AC   CVCL_YS24
DR   RCB; HPS1264
DR   Wikidata; Q94219576
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75464; Polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS25 ! HPS1265
OI   CVCL_YS26 ! HPS1266
OI   CVCL_YS27 ! HPS1267
OI   CVCL_YS28 ! HPS1268
OI   CVCL_YS29 ! HPS1269
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS1265
AC   CVCL_YS25
DR   RCB; HPS1265
DR   Wikidata; Q94219580
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75464; Polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS24 ! HPS1264
OI   CVCL_YS26 ! HPS1266
OI   CVCL_YS27 ! HPS1267
OI   CVCL_YS28 ! HPS1268
OI   CVCL_YS29 ! HPS1269
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1266
AC   CVCL_YS26
DR   RCB; HPS1266
DR   Wikidata; Q94219584
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75464; Polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS24 ! HPS1264
OI   CVCL_YS25 ! HPS1265
OI   CVCL_YS27 ! HPS1267
OI   CVCL_YS28 ! HPS1268
OI   CVCL_YS29 ! HPS1269
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1267
AC   CVCL_YS27
DR   RCB; HPS1267
DR   Wikidata; Q94219588
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75464; Polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS24 ! HPS1264
OI   CVCL_YS25 ! HPS1265
OI   CVCL_YS26 ! HPS1266
OI   CVCL_YS28 ! HPS1268
OI   CVCL_YS29 ! HPS1269
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1268
AC   CVCL_YS28
DR   RCB; HPS1268
DR   Wikidata; Q94219593
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75464; Polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS24 ! HPS1264
OI   CVCL_YS25 ! HPS1265
OI   CVCL_YS26 ! HPS1266
OI   CVCL_YS27 ! HPS1267
OI   CVCL_YS29 ! HPS1269
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1269
AC   CVCL_YS29
DR   RCB; HPS1269
DR   Wikidata; Q94219598
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75464; Polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS24 ! HPS1264
OI   CVCL_YS25 ! HPS1265
OI   CVCL_YS26 ! HPS1266
OI   CVCL_YS27 ! HPS1267
OI   CVCL_YS28 ! HPS1268
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1270
AC   CVCL_D0ZQ
DR   RCB; HPS1270
DR   Wikidata; Q123031736
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZR ! HPS1271
OI   CVCL_D0ZS ! HPS1272
OI   CVCL_D0ZT ! HPS1273
OI   CVCL_D0ZU ! HPS1274
OI   CVCL_D0ZV ! HPS1275
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1271
AC   CVCL_D0ZR
DR   RCB; HPS1271
DR   Wikidata; Q123031737
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZQ ! HPS1270
OI   CVCL_D0ZS ! HPS1272
OI   CVCL_D0ZT ! HPS1273
OI   CVCL_D0ZU ! HPS1274
OI   CVCL_D0ZV ! HPS1275
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1272
AC   CVCL_D0ZS
DR   RCB; HPS1272
DR   Wikidata; Q123031738
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZQ ! HPS1270
OI   CVCL_D0ZR ! HPS1271
OI   CVCL_D0ZT ! HPS1273
OI   CVCL_D0ZU ! HPS1274
OI   CVCL_D0ZV ! HPS1275
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1273
AC   CVCL_D0ZT
DR   RCB; HPS1273
DR   Wikidata; Q123031739
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZQ ! HPS1270
OI   CVCL_D0ZR ! HPS1271
OI   CVCL_D0ZS ! HPS1272
OI   CVCL_D0ZU ! HPS1274
OI   CVCL_D0ZV ! HPS1275
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1274
AC   CVCL_D0ZU
DR   RCB; HPS1274
DR   Wikidata; Q123031740
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZQ ! HPS1270
OI   CVCL_D0ZR ! HPS1271
OI   CVCL_D0ZS ! HPS1272
OI   CVCL_D0ZT ! HPS1273
OI   CVCL_D0ZV ! HPS1275
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1275
AC   CVCL_D0ZV
DR   RCB; HPS1275
DR   Wikidata; Q123031741
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZQ ! HPS1270
OI   CVCL_D0ZR ! HPS1271
OI   CVCL_D0ZS ! HPS1272
OI   CVCL_D0ZT ! HPS1273
OI   CVCL_D0ZU ! HPS1274
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1276
AC   CVCL_C9TR
DR   RCB; HPS1276
DR   Wikidata; Q123031742
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TS ! HPS1277
OI   CVCL_C9TT ! HPS1278
OI   CVCL_C9TU ! HPS1279
OI   CVCL_C9TV ! HPS1280
OI   CVCL_C9TW ! HPS1281
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1277
AC   CVCL_C9TS
DR   RCB; HPS1277
DR   Wikidata; Q123031743
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TR ! HPS1276
OI   CVCL_C9TT ! HPS1278
OI   CVCL_C9TU ! HPS1279
OI   CVCL_C9TV ! HPS1280
OI   CVCL_C9TW ! HPS1281
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1278
AC   CVCL_C9TT
DR   RCB; HPS1278
DR   Wikidata; Q123031744
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TR ! HPS1276
OI   CVCL_C9TS ! HPS1277
OI   CVCL_C9TU ! HPS1279
OI   CVCL_C9TV ! HPS1280
OI   CVCL_C9TW ! HPS1281
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1279
AC   CVCL_C9TU
DR   RCB; HPS1279
DR   Wikidata; Q123031745
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TR ! HPS1276
OI   CVCL_C9TS ! HPS1277
OI   CVCL_C9TT ! HPS1278
OI   CVCL_C9TV ! HPS1280
OI   CVCL_C9TW ! HPS1281
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1280
AC   CVCL_C9TV
DR   RCB; HPS1280
DR   Wikidata; Q123031746
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TR ! HPS1276
OI   CVCL_C9TS ! HPS1277
OI   CVCL_C9TT ! HPS1278
OI   CVCL_C9TU ! HPS1279
OI   CVCL_C9TW ! HPS1281
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1281
AC   CVCL_C9TW
DR   RCB; HPS1281
DR   Wikidata; Q123031747
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TR ! HPS1276
OI   CVCL_C9TS ! HPS1277
OI   CVCL_C9TT ! HPS1278
OI   CVCL_C9TU ! HPS1279
OI   CVCL_C9TV ! HPS1280
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1282
AC   CVCL_C9MY
DR   RCB; HPS1282
DR   Wikidata; Q123031748
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MZ ! HPS1283
OI   CVCL_C9N0 ! HPS1284
OI   CVCL_C9N1 ! HPS1285
OI   CVCL_C9N2 ! HPS1286
OI   CVCL_C9N3 ! HPS1287
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1283
AC   CVCL_C9MZ
DR   RCB; HPS1283
DR   Wikidata; Q123031749
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MY ! HPS1282
OI   CVCL_C9N0 ! HPS1284
OI   CVCL_C9N1 ! HPS1285
OI   CVCL_C9N2 ! HPS1286
OI   CVCL_C9N3 ! HPS1287
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1284
AC   CVCL_C9N0
DR   RCB; HPS1284
DR   Wikidata; Q123031750
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MY ! HPS1282
OI   CVCL_C9MZ ! HPS1283
OI   CVCL_C9N1 ! HPS1285
OI   CVCL_C9N2 ! HPS1286
OI   CVCL_C9N3 ! HPS1287
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1285
AC   CVCL_C9N1
DR   RCB; HPS1285
DR   Wikidata; Q123031752
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MY ! HPS1282
OI   CVCL_C9MZ ! HPS1283
OI   CVCL_C9N0 ! HPS1284
OI   CVCL_C9N2 ! HPS1286
OI   CVCL_C9N3 ! HPS1287
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1286
AC   CVCL_C9N2
DR   RCB; HPS1286
DR   Wikidata; Q123031753
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MY ! HPS1282
OI   CVCL_C9MZ ! HPS1283
OI   CVCL_C9N0 ! HPS1284
OI   CVCL_C9N1 ! HPS1285
OI   CVCL_C9N3 ! HPS1287
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1287
AC   CVCL_C9N3
DR   RCB; HPS1287
DR   Wikidata; Q123031754
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MY ! HPS1282
OI   CVCL_C9MZ ! HPS1283
OI   CVCL_C9N0 ! HPS1284
OI   CVCL_C9N1 ! HPS1285
OI   CVCL_C9N2 ! HPS1286
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1288
AC   CVCL_C9N4
DR   RCB; HPS1288
DR   Wikidata; Q123031755
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84892; Mixed connective tissue disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9N5 ! HPS1289
OI   CVCL_C9N6 ! HPS1290
OI   CVCL_C9N7 ! HPS1291
OI   CVCL_C9N8 ! HPS1292
OI   CVCL_C9N9 ! HPS1293
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1289
AC   CVCL_C9N5
DR   RCB; HPS1289
DR   Wikidata; Q123031756
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84892; Mixed connective tissue disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9N4 ! HPS1288
OI   CVCL_C9N6 ! HPS1290
OI   CVCL_C9N7 ! HPS1291
OI   CVCL_C9N8 ! HPS1292
OI   CVCL_C9N9 ! HPS1293
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1290
AC   CVCL_C9N6
DR   RCB; HPS1290
DR   Wikidata; Q123031757
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84892; Mixed connective tissue disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9N4 ! HPS1288
OI   CVCL_C9N5 ! HPS1289
OI   CVCL_C9N7 ! HPS1291
OI   CVCL_C9N8 ! HPS1292
OI   CVCL_C9N9 ! HPS1293
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1291
AC   CVCL_C9N7
DR   RCB; HPS1291
DR   Wikidata; Q123031758
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84892; Mixed connective tissue disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9N4 ! HPS1288
OI   CVCL_C9N5 ! HPS1289
OI   CVCL_C9N6 ! HPS1290
OI   CVCL_C9N8 ! HPS1292
OI   CVCL_C9N9 ! HPS1293
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1292
AC   CVCL_C9N8
DR   RCB; HPS1292
DR   Wikidata; Q123031759
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84892; Mixed connective tissue disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9N4 ! HPS1288
OI   CVCL_C9N5 ! HPS1289
OI   CVCL_C9N6 ! HPS1290
OI   CVCL_C9N7 ! HPS1291
OI   CVCL_C9N9 ! HPS1293
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1293
AC   CVCL_C9N9
DR   RCB; HPS1293
DR   Wikidata; Q123031760
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84892; Mixed connective tissue disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9N4 ! HPS1288
OI   CVCL_C9N5 ! HPS1289
OI   CVCL_C9N6 ! HPS1290
OI   CVCL_C9N7 ! HPS1291
OI   CVCL_C9N8 ! HPS1292
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1294
AC   CVCL_C6BG
DR   RCB; HPS1294
DR   Wikidata; Q116049412
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BH ! HPS1295
OI   CVCL_C6BI ! HPS1296
OI   CVCL_C6BJ ! HPS1297
OI   CVCL_C6BK ! HPS1298
OI   CVCL_C6BL ! HPS1299
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1295
AC   CVCL_C6BH
DR   RCB; HPS1295
DR   Wikidata; Q116049413
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BG ! HPS1294
OI   CVCL_C6BI ! HPS1296
OI   CVCL_C6BJ ! HPS1297
OI   CVCL_C6BK ! HPS1298
OI   CVCL_C6BL ! HPS1299
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1296
AC   CVCL_C6BI
DR   RCB; HPS1296
DR   Wikidata; Q116049414
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BG ! HPS1294
OI   CVCL_C6BH ! HPS1295
OI   CVCL_C6BJ ! HPS1297
OI   CVCL_C6BK ! HPS1298
OI   CVCL_C6BL ! HPS1299
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1297
AC   CVCL_C6BJ
DR   RCB; HPS1297
DR   Wikidata; Q116049415
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BG ! HPS1294
OI   CVCL_C6BH ! HPS1295
OI   CVCL_C6BI ! HPS1296
OI   CVCL_C6BK ! HPS1298
OI   CVCL_C6BL ! HPS1299
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1298
AC   CVCL_C6BK
DR   RCB; HPS1298
DR   Wikidata; Q116049416
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BG ! HPS1294
OI   CVCL_C6BH ! HPS1295
OI   CVCL_C6BI ! HPS1296
OI   CVCL_C6BJ ! HPS1297
OI   CVCL_C6BL ! HPS1299
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1299
AC   CVCL_C6BL
DR   RCB; HPS1299
DR   Wikidata; Q116049417
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BG ! HPS1294
OI   CVCL_C6BH ! HPS1295
OI   CVCL_C6BI ! HPS1296
OI   CVCL_C6BJ ! HPS1297
OI   CVCL_C6BK ! HPS1298
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1306
AC   CVCL_C9TX
DR   RCB; HPS1306
DR   Wikidata; Q123031761
CC   Donor information: Patient suffering from polyarteritis nodosa, MPO-ANCA(+).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TY ! HPS1307
OI   CVCL_C9TZ ! HPS1308
OI   CVCL_C9U0 ! HPS1309
OI   CVCL_C9U1 ! HPS1310
OI   CVCL_C9U2 ! HPS1311
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1307
AC   CVCL_C9TY
DR   RCB; HPS1307
DR   Wikidata; Q123031762
CC   Donor information: Patient suffering from polyarteritis nodosa, MPO-ANCA(+).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TX ! HPS1306
OI   CVCL_C9TZ ! HPS1308
OI   CVCL_C9U0 ! HPS1309
OI   CVCL_C9U1 ! HPS1310
OI   CVCL_C9U2 ! HPS1311
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1308
AC   CVCL_C9TZ
DR   RCB; HPS1308
DR   Wikidata; Q123031763
CC   Donor information: Patient suffering from polyarteritis nodosa, MPO-ANCA(+).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TX ! HPS1306
OI   CVCL_C9TY ! HPS1307
OI   CVCL_C9U0 ! HPS1309
OI   CVCL_C9U1 ! HPS1310
OI   CVCL_C9U2 ! HPS1311
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1309
AC   CVCL_C9U0
DR   RCB; HPS1309
DR   Wikidata; Q123031764
CC   Donor information: Patient suffering from polyarteritis nodosa, MPO-ANCA(+).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TX ! HPS1306
OI   CVCL_C9TY ! HPS1307
OI   CVCL_C9TZ ! HPS1308
OI   CVCL_C9U1 ! HPS1310
OI   CVCL_C9U2 ! HPS1311
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1310
AC   CVCL_C9U1
DR   RCB; HPS1310
DR   Wikidata; Q123031765
CC   Donor information: Patient suffering from polyarteritis nodosa, MPO-ANCA(+).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TX ! HPS1306
OI   CVCL_C9TY ! HPS1307
OI   CVCL_C9TZ ! HPS1308
OI   CVCL_C9U0 ! HPS1309
OI   CVCL_C9U2 ! HPS1311
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1311
AC   CVCL_C9U2
DR   RCB; HPS1311
DR   Wikidata; Q123031766
CC   Donor information: Patient suffering from polyarteritis nodosa, MPO-ANCA(+).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9TX ! HPS1306
OI   CVCL_C9TY ! HPS1307
OI   CVCL_C9TZ ! HPS1308
OI   CVCL_C9U0 ! HPS1309
OI   CVCL_C9U1 ! HPS1310
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1312
AC   CVCL_UN64
DR   RCB; HPS1312
DR   Wikidata; Q94219602
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3UD ! HPS1313
OI   CVCL_A3UE ! HPS1314
OI   CVCL_A3UF ! HPS1315
OI   CVCL_A3UG ! HPS1316
OI   CVCL_A3UH ! HPS1317
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1313
AC   CVCL_A3UD
DR   RCB; HPS1313
DR   Wikidata; Q105507858
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN64 ! HPS1312
OI   CVCL_A3UE ! HPS1314
OI   CVCL_A3UF ! HPS1315
OI   CVCL_A3UG ! HPS1316
OI   CVCL_A3UH ! HPS1317
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1314
AC   CVCL_A3UE
DR   RCB; HPS1314
DR   Wikidata; Q105507861
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN64 ! HPS1312
OI   CVCL_A3UD ! HPS1313
OI   CVCL_A3UF ! HPS1315
OI   CVCL_A3UG ! HPS1316
OI   CVCL_A3UH ! HPS1317
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1315
AC   CVCL_A3UF
DR   RCB; HPS1315
DR   Wikidata; Q105507863
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN64 ! HPS1312
OI   CVCL_A3UD ! HPS1313
OI   CVCL_A3UE ! HPS1314
OI   CVCL_A3UG ! HPS1316
OI   CVCL_A3UH ! HPS1317
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1316
AC   CVCL_A3UG
DR   RCB; HPS1316
DR   Wikidata; Q105507866
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN64 ! HPS1312
OI   CVCL_A3UD ! HPS1313
OI   CVCL_A3UE ! HPS1314
OI   CVCL_A3UF ! HPS1315
OI   CVCL_A3UH ! HPS1317
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1317
AC   CVCL_A3UH
DR   RCB; HPS1317
DR   Wikidata; Q105507871
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN64 ! HPS1312
OI   CVCL_A3UD ! HPS1313
OI   CVCL_A3UE ! HPS1314
OI   CVCL_A3UF ! HPS1315
OI   CVCL_A3UG ! HPS1316
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1318
AC   CVCL_UN65
DR   RCB; HPS1318
DR   Wikidata; Q94219609
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN66 ! HPS1319
OI   CVCL_UN67 ! HPS1320
OI   CVCL_A3UI ! HPS1321
OI   CVCL_A3UJ ! HPS1322
OI   CVCL_A3UK ! HPS1323
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1319
AC   CVCL_UN66
DR   RCB; HPS1319
DR   Wikidata; Q94219614
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN65 ! HPS1318
OI   CVCL_UN67 ! HPS1320
OI   CVCL_A3UI ! HPS1321
OI   CVCL_A3UJ ! HPS1322
OI   CVCL_A3UK ! HPS1323
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1320
AC   CVCL_UN67
DR   RCB; HPS1320
DR   Wikidata; Q94219619
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN65 ! HPS1318
OI   CVCL_UN66 ! HPS1319
OI   CVCL_A3UI ! HPS1321
OI   CVCL_A3UJ ! HPS1322
OI   CVCL_A3UK ! HPS1323
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1321
AC   CVCL_A3UI
DR   RCB; HPS1321
DR   Wikidata; Q105507875
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN65 ! HPS1318
OI   CVCL_UN66 ! HPS1319
OI   CVCL_UN67 ! HPS1320
OI   CVCL_A3UJ ! HPS1322
OI   CVCL_A3UK ! HPS1323
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1322
AC   CVCL_A3UJ
DR   RCB; HPS1322
DR   Wikidata; Q105507879
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN65 ! HPS1318
OI   CVCL_UN66 ! HPS1319
OI   CVCL_UN67 ! HPS1320
OI   CVCL_A3UI ! HPS1321
OI   CVCL_A3UK ! HPS1323
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1323
AC   CVCL_A3UK
DR   RCB; HPS1323
DR   Wikidata; Q105507882
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN65 ! HPS1318
OI   CVCL_UN66 ! HPS1319
OI   CVCL_UN67 ! HPS1320
OI   CVCL_A3UI ! HPS1321
OI   CVCL_A3UJ ! HPS1322
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1324
AC   CVCL_UN68
DR   RCB; HPS1324
DR   Wikidata; Q94219623
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1325
AC   CVCL_UN69
DR   RCB; HPS1325
DR   Wikidata; Q94219627
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34909; Pemphigus
DI   ORDO; Orphanet_79481; Pemphigus foliaceus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3SM ! HPS1326
OI   CVCL_A3SN ! HPS1327
OI   CVCL_A3SP ! HPS1328
OI   CVCL_A3SQ ! HPS1329
OI   CVCL_A3SR ! HPS1330
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1326
AC   CVCL_A3SM
DR   RCB; HPS1326
DR   Wikidata; Q105507885
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34909; Pemphigus
DI   ORDO; Orphanet_79481; Pemphigus foliaceus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN69 ! HPS1325
OI   CVCL_A3SN ! HPS1327
OI   CVCL_A3SP ! HPS1328
OI   CVCL_A3SQ ! HPS1329
OI   CVCL_A3SR ! HPS1330
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1327
AC   CVCL_A3SN
DR   RCB; HPS1327
DR   Wikidata; Q105507888
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34909; Pemphigus
DI   ORDO; Orphanet_79481; Pemphigus foliaceus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN69 ! HPS1325
OI   CVCL_A3SM ! HPS1326
OI   CVCL_A3SP ! HPS1328
OI   CVCL_A3SQ ! HPS1329
OI   CVCL_A3SR ! HPS1330
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1328
AC   CVCL_A3SP
DR   RCB; HPS1328
DR   Wikidata; Q105507892
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34909; Pemphigus
DI   ORDO; Orphanet_79481; Pemphigus foliaceus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN69 ! HPS1325
OI   CVCL_A3SM ! HPS1326
OI   CVCL_A3SN ! HPS1327
OI   CVCL_A3SQ ! HPS1329
OI   CVCL_A3SR ! HPS1330
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1329
AC   CVCL_A3SQ
DR   RCB; HPS1329
DR   Wikidata; Q105507895
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34909; Pemphigus
DI   ORDO; Orphanet_79481; Pemphigus foliaceus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN69 ! HPS1325
OI   CVCL_A3SM ! HPS1326
OI   CVCL_A3SN ! HPS1327
OI   CVCL_A3SP ! HPS1328
OI   CVCL_A3SR ! HPS1330
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1330
AC   CVCL_A3SR
DR   RCB; HPS1330
DR   Wikidata; Q105507899
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34909; Pemphigus
DI   ORDO; Orphanet_79481; Pemphigus foliaceus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN69 ! HPS1325
OI   CVCL_A3SM ! HPS1326
OI   CVCL_A3SN ! HPS1327
OI   CVCL_A3SP ! HPS1328
OI   CVCL_A3SQ ! HPS1329
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1331
AC   CVCL_C9NA
DR   RCB; HPS1331
DR   Wikidata; Q123031767
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34908; Pemphigoid
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NB ! HPS1332
OI   CVCL_C9NC ! HPS1333
OI   CVCL_C9ND ! HPS1334
OI   CVCL_C9NE ! HPS1335
OI   CVCL_C9NF ! HPS1336
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1332
AC   CVCL_C9NB
DR   RCB; HPS1332
DR   Wikidata; Q123031768
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34908; Pemphigoid
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NA ! HPS1331
OI   CVCL_C9NC ! HPS1333
OI   CVCL_C9ND ! HPS1334
OI   CVCL_C9NE ! HPS1335
OI   CVCL_C9NF ! HPS1336
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1333
AC   CVCL_C9NC
DR   RCB; HPS1333
DR   Wikidata; Q123031769
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34908; Pemphigoid
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NA ! HPS1331
OI   CVCL_C9NB ! HPS1332
OI   CVCL_C9ND ! HPS1334
OI   CVCL_C9NE ! HPS1335
OI   CVCL_C9NF ! HPS1336
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1334
AC   CVCL_C9ND
DR   RCB; HPS1334
DR   Wikidata; Q123031770
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34908; Pemphigoid
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NA ! HPS1331
OI   CVCL_C9NB ! HPS1332
OI   CVCL_C9NC ! HPS1333
OI   CVCL_C9NE ! HPS1335
OI   CVCL_C9NF ! HPS1336
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1335
AC   CVCL_C9NE
DR   RCB; HPS1335
DR   Wikidata; Q123031771
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34908; Pemphigoid
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NA ! HPS1331
OI   CVCL_C9NB ! HPS1332
OI   CVCL_C9NC ! HPS1333
OI   CVCL_C9ND ! HPS1334
OI   CVCL_C9NF ! HPS1336
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1336
AC   CVCL_C9NF
DR   RCB; HPS1336
DR   Wikidata; Q123031772
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34908; Pemphigoid
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NA ! HPS1331
OI   CVCL_C9NB ! HPS1332
OI   CVCL_C9NC ! HPS1333
OI   CVCL_C9ND ! HPS1334
OI   CVCL_C9NE ! HPS1335
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1337
AC   CVCL_UN70
DR   RCB; HPS1337
DR   Wikidata; Q94219632
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1337).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3SH ! HPS1338
OI   CVCL_A3SI ! HPS1339
OI   CVCL_A3SJ ! HPS1340
OI   CVCL_A3SK ! HPS1341
OI   CVCL_A3SL ! HPS1342
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   HPS1338
AC   CVCL_A3SH
DR   RCB; HPS1338
DR   Wikidata; Q105507901
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1338).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN70 ! HPS1337
OI   CVCL_A3SI ! HPS1339
OI   CVCL_A3SJ ! HPS1340
OI   CVCL_A3SK ! HPS1341
OI   CVCL_A3SL ! HPS1342
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1339
AC   CVCL_A3SI
DR   RCB; HPS1339
DR   Wikidata; Q105507907
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1339).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN70 ! HPS1337
OI   CVCL_A3SH ! HPS1338
OI   CVCL_A3SJ ! HPS1340
OI   CVCL_A3SK ! HPS1341
OI   CVCL_A3SL ! HPS1342
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1340
AC   CVCL_A3SJ
DR   RCB; HPS1340
DR   Wikidata; Q105507911
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1340).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN70 ! HPS1337
OI   CVCL_A3SH ! HPS1338
OI   CVCL_A3SI ! HPS1339
OI   CVCL_A3SK ! HPS1341
OI   CVCL_A3SL ! HPS1342
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1341
AC   CVCL_A3SK
DR   RCB; HPS1341
DR   Wikidata; Q105507914
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1341).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN70 ! HPS1337
OI   CVCL_A3SH ! HPS1338
OI   CVCL_A3SI ! HPS1339
OI   CVCL_A3SJ ! HPS1340
OI   CVCL_A3SL ! HPS1342
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1342
AC   CVCL_A3SL
DR   RCB; HPS1342
DR   Wikidata; Q105507917
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1342).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN70 ! HPS1337
OI   CVCL_A3SH ! HPS1338
OI   CVCL_A3SI ! HPS1339
OI   CVCL_A3SJ ! HPS1340
OI   CVCL_A3SK ! HPS1341
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1343
AC   CVCL_UN71
DR   RCB; HPS1343
DR   Wikidata; Q94219634
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (RCB=HPS1343).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ57 ! HPS1344
OI   CVCL_YQ58 ! HPS1345
OI   CVCL_YQ59 ! HPS1346
OI   CVCL_YQ60 ! HPS1347
OI   CVCL_YQ61 ! HPS1348
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HPS1344
AC   CVCL_YQ57
DR   RCB; HPS1344
DR   Wikidata; Q94219638
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (RCB=HPS1344).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN71 ! HPS1343
OI   CVCL_YQ58 ! HPS1345
OI   CVCL_YQ59 ! HPS1346
OI   CVCL_YQ60 ! HPS1347
OI   CVCL_YQ61 ! HPS1348
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1345
AC   CVCL_YQ58
DR   RCB; HPS1345
DR   Wikidata; Q94219643
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (RCB=HPS1345).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN71 ! HPS1343
OI   CVCL_YQ57 ! HPS1344
OI   CVCL_YQ59 ! HPS1346
OI   CVCL_YQ60 ! HPS1347
OI   CVCL_YQ61 ! HPS1348
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1346
AC   CVCL_YQ59
DR   RCB; HPS1346
DR   Wikidata; Q94219647
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (RCB=HPS1346).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN71 ! HPS1343
OI   CVCL_YQ57 ! HPS1344
OI   CVCL_YQ58 ! HPS1345
OI   CVCL_YQ60 ! HPS1347
OI   CVCL_YQ61 ! HPS1348
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1347
AC   CVCL_YQ60
DR   RCB; HPS1347
DR   Wikidata; Q94219649
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (RCB=HPS1347).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN71 ! HPS1343
OI   CVCL_YQ57 ! HPS1344
OI   CVCL_YQ58 ! HPS1345
OI   CVCL_YQ59 ! HPS1346
OI   CVCL_YQ61 ! HPS1348
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1348
AC   CVCL_YQ61
DR   RCB; HPS1348
DR   Wikidata; Q94219654
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (RCB=HPS1348).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN71 ! HPS1343
OI   CVCL_YQ57 ! HPS1344
OI   CVCL_YQ58 ! HPS1345
OI   CVCL_YQ59 ! HPS1346
OI   CVCL_YQ60 ! HPS1347
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1349
AC   CVCL_UN72
DR   RCB; HPS1349
DR   Wikidata; Q94219658
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1349).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ62 ! HPS1350
OI   CVCL_YQ63 ! HPS1351
OI   CVCL_YQ64 ! HPS1352
OI   CVCL_YQ65 ! HPS1353
OI   CVCL_YQ66 ! HPS1354
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HPS1350
AC   CVCL_YQ62
DR   RCB; HPS1350
DR   Wikidata; Q94219662
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1350).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN72 ! HPS1349
OI   CVCL_YQ63 ! HPS1351
OI   CVCL_YQ64 ! HPS1352
OI   CVCL_YQ65 ! HPS1353
OI   CVCL_YQ66 ! HPS1354
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1351
AC   CVCL_YQ63
DR   RCB; HPS1351
DR   Wikidata; Q94219665
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1351).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN72 ! HPS1349
OI   CVCL_YQ62 ! HPS1350
OI   CVCL_YQ64 ! HPS1352
OI   CVCL_YQ65 ! HPS1353
OI   CVCL_YQ66 ! HPS1354
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1352
AC   CVCL_YQ64
DR   RCB; HPS1352
DR   Wikidata; Q94219669
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1352).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN72 ! HPS1349
OI   CVCL_YQ62 ! HPS1350
OI   CVCL_YQ63 ! HPS1351
OI   CVCL_YQ65 ! HPS1353
OI   CVCL_YQ66 ! HPS1354
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1353
AC   CVCL_YQ65
DR   RCB; HPS1353
DR   Wikidata; Q94219672
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1353).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN72 ! HPS1349
OI   CVCL_YQ62 ! HPS1350
OI   CVCL_YQ63 ! HPS1351
OI   CVCL_YQ64 ! HPS1352
OI   CVCL_YQ66 ! HPS1354
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1354
AC   CVCL_YQ66
DR   RCB; HPS1354
DR   Wikidata; Q94219675
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex47-52del; Zygosity=Hemizygous (RCB=HPS1354).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN72 ! HPS1349
OI   CVCL_YQ62 ! HPS1350
OI   CVCL_YQ63 ! HPS1351
OI   CVCL_YQ64 ! HPS1352
OI   CVCL_YQ65 ! HPS1353
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1355
AC   CVCL_UN73
DR   RCB; HPS1355
DR   Wikidata; Q94219680
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Hemizygous (RCB=HPS1355).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ67 ! HPS1356
OI   CVCL_YQ68 ! HPS1357
OI   CVCL_YQ69 ! HPS1358
OI   CVCL_YQ70 ! HPS1359
OI   CVCL_YQ71 ! HPS1360
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HPS1356
AC   CVCL_YQ67
DR   RCB; HPS1356
DR   Wikidata; Q94219684
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Hemizygous (RCB=HPS1356).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN73 ! HPS1355
OI   CVCL_YQ68 ! HPS1357
OI   CVCL_YQ69 ! HPS1358
OI   CVCL_YQ70 ! HPS1359
OI   CVCL_YQ71 ! HPS1360
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1357
AC   CVCL_YQ68
DR   RCB; HPS1357
DR   Wikidata; Q94219688
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Hemizygous (RCB=HPS1357).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN73 ! HPS1355
OI   CVCL_YQ67 ! HPS1356
OI   CVCL_YQ69 ! HPS1358
OI   CVCL_YQ70 ! HPS1359
OI   CVCL_YQ71 ! HPS1360
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1358
AC   CVCL_YQ69
DR   RCB; HPS1358
DR   Wikidata; Q94219690
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Hemizygous (RCB=HPS1358).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN73 ! HPS1355
OI   CVCL_YQ67 ! HPS1356
OI   CVCL_YQ68 ! HPS1357
OI   CVCL_YQ70 ! HPS1359
OI   CVCL_YQ71 ! HPS1360
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1359
AC   CVCL_YQ70
DR   RCB; HPS1359
DR   Wikidata; Q94219694
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Hemizygous (RCB=HPS1359).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN73 ! HPS1355
OI   CVCL_YQ67 ! HPS1356
OI   CVCL_YQ68 ! HPS1357
OI   CVCL_YQ69 ! HPS1358
OI   CVCL_YQ71 ! HPS1360
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1360
AC   CVCL_YQ71
DR   RCB; HPS1360
DR   Wikidata; Q94219698
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-52del; Zygosity=Hemizygous (RCB=HPS1360).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN73 ! HPS1355
OI   CVCL_YQ67 ! HPS1356
OI   CVCL_YQ68 ! HPS1357
OI   CVCL_YQ69 ! HPS1358
OI   CVCL_YQ70 ! HPS1359
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS1361
AC   CVCL_C9NG
DR   RCB; HPS1361
DR   Wikidata; Q123031773
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C152105; Inborn error of immunity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NH ! HPS1362
OI   CVCL_C9NI ! HPS1363
OI   CVCL_C9NJ ! HPS1364
OI   CVCL_C9NK ! HPS1365
OI   CVCL_C9NL ! HPS1366
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HPS1362
AC   CVCL_C9NH
DR   RCB; HPS1362
DR   Wikidata; Q123031774
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C152105; Inborn error of immunity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NG ! HPS1361
OI   CVCL_C9NI ! HPS1363
OI   CVCL_C9NJ ! HPS1364
OI   CVCL_C9NK ! HPS1365
OI   CVCL_C9NL ! HPS1366
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HPS1363
AC   CVCL_C9NI
DR   RCB; HPS1363
DR   Wikidata; Q123031775
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C152105; Inborn error of immunity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NG ! HPS1361
OI   CVCL_C9NH ! HPS1362
OI   CVCL_C9NJ ! HPS1364
OI   CVCL_C9NK ! HPS1365
OI   CVCL_C9NL ! HPS1366
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HPS1364
AC   CVCL_C9NJ
DR   RCB; HPS1364
DR   Wikidata; Q123031776
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C152105; Inborn error of immunity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NG ! HPS1361
OI   CVCL_C9NH ! HPS1362
OI   CVCL_C9NI ! HPS1363
OI   CVCL_C9NK ! HPS1365
OI   CVCL_C9NL ! HPS1366
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HPS1365
AC   CVCL_C9NK
DR   RCB; HPS1365
DR   Wikidata; Q123031777
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C152105; Inborn error of immunity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NG ! HPS1361
OI   CVCL_C9NH ! HPS1362
OI   CVCL_C9NI ! HPS1363
OI   CVCL_C9NJ ! HPS1364
OI   CVCL_C9NL ! HPS1366
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HPS1366
AC   CVCL_C9NL
DR   RCB; HPS1366
DR   Wikidata; Q123031778
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C152105; Inborn error of immunity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NG ! HPS1361
OI   CVCL_C9NH ! HPS1362
OI   CVCL_C9NI ! HPS1363
OI   CVCL_C9NJ ! HPS1364
OI   CVCL_C9NK ! HPS1365
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   HPS1367
AC   CVCL_UN74
DR   RCB; HPS1367
DR   Wikidata; Q94219702
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-7del; Zygosity=Hemizygous (RCB=HPS1367).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3TD ! HPS1368
OI   CVCL_A3TE ! HPS1369
OI   CVCL_A3TF ! HPS1370
OI   CVCL_A3TG ! HPS1371
OI   CVCL_A3TH ! HPS1372
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   HPS1368
AC   CVCL_A3TD
DR   RCB; HPS1368
DR   Wikidata; Q105507922
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-7del; Zygosity=Hemizygous (RCB=HPS1368).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN74 ! HPS1367
OI   CVCL_A3TE ! HPS1369
OI   CVCL_A3TF ! HPS1370
OI   CVCL_A3TG ! HPS1371
OI   CVCL_A3TH ! HPS1372
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1369
AC   CVCL_A3TE
DR   RCB; HPS1369
DR   Wikidata; Q105507924
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-7del; Zygosity=Hemizygous (RCB=HPS1369).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN74 ! HPS1367
OI   CVCL_A3TD ! HPS1368
OI   CVCL_A3TF ! HPS1370
OI   CVCL_A3TG ! HPS1371
OI   CVCL_A3TH ! HPS1372
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1370
AC   CVCL_A3TF
DR   RCB; HPS1370
DR   Wikidata; Q105507928
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-7del; Zygosity=Hemizygous (RCB=HPS1370).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN74 ! HPS1367
OI   CVCL_A3TD ! HPS1368
OI   CVCL_A3TE ! HPS1369
OI   CVCL_A3TG ! HPS1371
OI   CVCL_A3TH ! HPS1372
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1371
AC   CVCL_A3TG
DR   RCB; HPS1371
DR   Wikidata; Q105507931
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-7del; Zygosity=Hemizygous (RCB=HPS1371).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN74 ! HPS1367
OI   CVCL_A3TD ! HPS1368
OI   CVCL_A3TE ! HPS1369
OI   CVCL_A3TF ! HPS1370
OI   CVCL_A3TH ! HPS1372
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1372
AC   CVCL_A3TH
DR   RCB; HPS1372
DR   Wikidata; Q105507936
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-7del; Zygosity=Hemizygous (RCB=HPS1372).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN74 ! HPS1367
OI   CVCL_A3TD ! HPS1368
OI   CVCL_A3TE ! HPS1369
OI   CVCL_A3TF ! HPS1370
OI   CVCL_A3TG ! HPS1371
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS1373
AC   CVCL_UN75
DR   RCB; HPS1373
DR   Wikidata; Q94219705
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3TI ! HPS1374
OI   CVCL_A3TJ ! HPS1375
OI   CVCL_A3TK ! HPS1376
OI   CVCL_A3TL ! HPS1377
OI   CVCL_A3TM ! HPS1378
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1374
AC   CVCL_A3TI
DR   RCB; HPS1374
DR   Wikidata; Q105507939
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN75 ! HPS1373
OI   CVCL_A3TJ ! HPS1375
OI   CVCL_A3TK ! HPS1376
OI   CVCL_A3TL ! HPS1377
OI   CVCL_A3TM ! HPS1378
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1375
AC   CVCL_A3TJ
DR   RCB; HPS1375
DR   Wikidata; Q105507943
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN75 ! HPS1373
OI   CVCL_A3TI ! HPS1374
OI   CVCL_A3TK ! HPS1376
OI   CVCL_A3TL ! HPS1377
OI   CVCL_A3TM ! HPS1378
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1376
AC   CVCL_A3TK
DR   RCB; HPS1376
DR   Wikidata; Q105507944
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN75 ! HPS1373
OI   CVCL_A3TI ! HPS1374
OI   CVCL_A3TJ ! HPS1375
OI   CVCL_A3TL ! HPS1377
OI   CVCL_A3TM ! HPS1378
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1377
AC   CVCL_A3TL
DR   RCB; HPS1377
DR   Wikidata; Q105507948
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN75 ! HPS1373
OI   CVCL_A3TI ! HPS1374
OI   CVCL_A3TJ ! HPS1375
OI   CVCL_A3TK ! HPS1376
OI   CVCL_A3TM ! HPS1378
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1378
AC   CVCL_A3TM
DR   RCB; HPS1378
DR   Wikidata; Q105507954
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN75 ! HPS1373
OI   CVCL_A3TI ! HPS1374
OI   CVCL_A3TJ ! HPS1375
OI   CVCL_A3TK ! HPS1376
OI   CVCL_A3TL ! HPS1377
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1379
AC   CVCL_C9NM
DR   RCB; HPS1379
DR   Wikidata; Q123031779
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NN ! HPS1380
OI   CVCL_C9NP ! HPS1381
OI   CVCL_C9NQ ! HPS1382
OI   CVCL_C9NR ! HPS1383
OI   CVCL_C9NS ! HPS1384
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1380
AC   CVCL_C9NN
DR   RCB; HPS1380
DR   Wikidata; Q123031780
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NM ! HPS1379
OI   CVCL_C9NP ! HPS1381
OI   CVCL_C9NQ ! HPS1382
OI   CVCL_C9NR ! HPS1383
OI   CVCL_C9NS ! HPS1384
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1381
AC   CVCL_C9NP
DR   RCB; HPS1381
DR   Wikidata; Q123031781
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NM ! HPS1379
OI   CVCL_C9NN ! HPS1380
OI   CVCL_C9NQ ! HPS1382
OI   CVCL_C9NR ! HPS1383
OI   CVCL_C9NS ! HPS1384
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1382
AC   CVCL_C9NQ
DR   RCB; HPS1382
DR   Wikidata; Q123031782
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NM ! HPS1379
OI   CVCL_C9NN ! HPS1380
OI   CVCL_C9NP ! HPS1381
OI   CVCL_C9NR ! HPS1383
OI   CVCL_C9NS ! HPS1384
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1383
AC   CVCL_C9NR
DR   RCB; HPS1383
DR   Wikidata; Q123031783
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NM ! HPS1379
OI   CVCL_C9NN ! HPS1380
OI   CVCL_C9NP ! HPS1381
OI   CVCL_C9NQ ! HPS1382
OI   CVCL_C9NS ! HPS1384
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1384
AC   CVCL_C9NS
DR   RCB; HPS1384
DR   Wikidata; Q123031784
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NM ! HPS1379
OI   CVCL_C9NN ! HPS1380
OI   CVCL_C9NP ! HPS1381
OI   CVCL_C9NQ ! HPS1382
OI   CVCL_C9NR ! HPS1383
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1385
AC   CVCL_UN76
DR   RCB; HPS1385
DR   Wikidata; Q94219710
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3TN ! HPS1386
OI   CVCL_A3TP ! HPS1387
OI   CVCL_A3TQ ! HPS1388
OI   CVCL_A3TR ! HPS1389
OI   CVCL_A3TS ! HPS1390
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1386
AC   CVCL_A3TN
DR   RCB; HPS1386
DR   Wikidata; Q105507957
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN76 ! HPS1385
OI   CVCL_A3TP ! HPS1387
OI   CVCL_A3TQ ! HPS1388
OI   CVCL_A3TR ! HPS1389
OI   CVCL_A3TS ! HPS1390
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1387
AC   CVCL_A3TP
DR   RCB; HPS1387
DR   Wikidata; Q105507960
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN76 ! HPS1385
OI   CVCL_A3TN ! HPS1386
OI   CVCL_A3TQ ! HPS1388
OI   CVCL_A3TR ! HPS1389
OI   CVCL_A3TS ! HPS1390
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1388
AC   CVCL_A3TQ
DR   RCB; HPS1388
DR   Wikidata; Q105507963
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN76 ! HPS1385
OI   CVCL_A3TN ! HPS1386
OI   CVCL_A3TP ! HPS1387
OI   CVCL_A3TR ! HPS1389
OI   CVCL_A3TS ! HPS1390
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1389
AC   CVCL_A3TR
DR   RCB; HPS1389
DR   Wikidata; Q105507966
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN76 ! HPS1385
OI   CVCL_A3TN ! HPS1386
OI   CVCL_A3TP ! HPS1387
OI   CVCL_A3TQ ! HPS1388
OI   CVCL_A3TS ! HPS1390
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1390
AC   CVCL_A3TS
DR   RCB; HPS1390
DR   Wikidata; Q105507969
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN76 ! HPS1385
OI   CVCL_A3TN ! HPS1386
OI   CVCL_A3TP ! HPS1387
OI   CVCL_A3TQ ! HPS1388
OI   CVCL_A3TR ! HPS1389
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1391
AC   CVCL_UN77
DR   RCB; HPS1391
DR   Wikidata; Q94219715
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ50 ! HPS1392
OI   CVCL_YQ51 ! HPS1393
OI   CVCL_YQ52 ! HPS1394
OI   CVCL_YQ53 ! HPS1395
OI   CVCL_YQ54 ! HPS1396
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1392
AC   CVCL_YQ50
DR   RCB; HPS1392
DR   Wikidata; Q94219717
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN77 ! HPS1391
OI   CVCL_YQ51 ! HPS1393
OI   CVCL_YQ52 ! HPS1394
OI   CVCL_YQ53 ! HPS1395
OI   CVCL_YQ54 ! HPS1396
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1393
AC   CVCL_YQ51
DR   RCB; HPS1393
DR   Wikidata; Q94219721
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN77 ! HPS1391
OI   CVCL_YQ50 ! HPS1392
OI   CVCL_YQ52 ! HPS1394
OI   CVCL_YQ53 ! HPS1395
OI   CVCL_YQ54 ! HPS1396
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1394
AC   CVCL_YQ52
DR   RCB; HPS1394
DR   Wikidata; Q94219724
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN77 ! HPS1391
OI   CVCL_YQ50 ! HPS1392
OI   CVCL_YQ51 ! HPS1393
OI   CVCL_YQ53 ! HPS1395
OI   CVCL_YQ54 ! HPS1396
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1395
AC   CVCL_YQ53
DR   RCB; HPS1395
DR   Wikidata; Q94219727
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN77 ! HPS1391
OI   CVCL_YQ50 ! HPS1392
OI   CVCL_YQ51 ! HPS1393
OI   CVCL_YQ52 ! HPS1394
OI   CVCL_YQ54 ! HPS1396
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1396
AC   CVCL_YQ54
DR   RCB; HPS1396
DR   Wikidata; Q94219731
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN77 ! HPS1391
OI   CVCL_YQ50 ! HPS1392
OI   CVCL_YQ51 ! HPS1393
OI   CVCL_YQ52 ! HPS1394
OI   CVCL_YQ53 ! HPS1395
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1397
AC   CVCL_C9NT
DR   RCB; HPS1397
DR   Wikidata; Q123031785
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NU ! HPS1398
OI   CVCL_C9NV ! HPS1399
OI   CVCL_C9NW ! HPS1400
OI   CVCL_C9NX ! HPS1401
OI   CVCL_C9NY ! HPS1402
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1398
AC   CVCL_C9NU
DR   RCB; HPS1398
DR   Wikidata; Q123031786
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NT ! HPS1397
OI   CVCL_C9NV ! HPS1399
OI   CVCL_C9NW ! HPS1400
OI   CVCL_C9NX ! HPS1401
OI   CVCL_C9NY ! HPS1402
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1399
AC   CVCL_C9NV
DR   RCB; HPS1399
DR   Wikidata; Q123031787
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NT ! HPS1397
OI   CVCL_C9NU ! HPS1398
OI   CVCL_C9NW ! HPS1400
OI   CVCL_C9NX ! HPS1401
OI   CVCL_C9NY ! HPS1402
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1400
AC   CVCL_C9NW
DR   RCB; HPS1400
DR   Wikidata; Q123031788
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NT ! HPS1397
OI   CVCL_C9NU ! HPS1398
OI   CVCL_C9NV ! HPS1399
OI   CVCL_C9NX ! HPS1401
OI   CVCL_C9NY ! HPS1402
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1401
AC   CVCL_C9NX
DR   RCB; HPS1401
DR   Wikidata; Q123031789
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NT ! HPS1397
OI   CVCL_C9NU ! HPS1398
OI   CVCL_C9NV ! HPS1399
OI   CVCL_C9NW ! HPS1400
OI   CVCL_C9NY ! HPS1402
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1402
AC   CVCL_C9NY
DR   RCB; HPS1402
DR   Wikidata; Q123031790
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9NT ! HPS1397
OI   CVCL_C9NU ! HPS1398
OI   CVCL_C9NV ! HPS1399
OI   CVCL_C9NW ! HPS1400
OI   CVCL_C9NX ! HPS1401
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1403
AC   CVCL_UN78
DR   RCB; HPS1403
DR   Wikidata; Q94219734
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3UM ! HPS1404
OI   CVCL_A3UN ! HPS1405
OI   CVCL_A3UP ! HPS1406
OI   CVCL_A3UQ ! HPS1407
OI   CVCL_A3UR ! HPS1408
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1404
AC   CVCL_A3UM
DR   RCB; HPS1404
DR   Wikidata; Q105507973
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN78 ! HPS1403
OI   CVCL_A3UN ! HPS1405
OI   CVCL_A3UP ! HPS1406
OI   CVCL_A3UQ ! HPS1407
OI   CVCL_A3UR ! HPS1408
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1405
AC   CVCL_A3UN
DR   RCB; HPS1405
DR   Wikidata; Q105507977
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN78 ! HPS1403
OI   CVCL_A3UM ! HPS1404
OI   CVCL_A3UP ! HPS1406
OI   CVCL_A3UQ ! HPS1407
OI   CVCL_A3UR ! HPS1408
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1406
AC   CVCL_A3UP
DR   RCB; HPS1406
DR   Wikidata; Q105507982
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN78 ! HPS1403
OI   CVCL_A3UM ! HPS1404
OI   CVCL_A3UN ! HPS1405
OI   CVCL_A3UQ ! HPS1407
OI   CVCL_A3UR ! HPS1408
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1407
AC   CVCL_A3UQ
DR   RCB; HPS1407
DR   Wikidata; Q105507985
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN78 ! HPS1403
OI   CVCL_A3UM ! HPS1404
OI   CVCL_A3UN ! HPS1405
OI   CVCL_A3UP ! HPS1406
OI   CVCL_A3UR ! HPS1408
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1408
AC   CVCL_A3UR
DR   RCB; HPS1408
DR   Wikidata; Q105507988
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN78 ! HPS1403
OI   CVCL_A3UM ! HPS1404
OI   CVCL_A3UN ! HPS1405
OI   CVCL_A3UP ! HPS1406
OI   CVCL_A3UQ ! HPS1407
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1421
AC   CVCL_YS30
DR   RCB; HPS1421
DR   Wikidata; Q94219737
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS31 ! HPS1422
OI   CVCL_YS32 ! HPS1423
OI   CVCL_YS33 ! HPS1424
OI   CVCL_YS34 ! HPS1425
OI   CVCL_YS35 ! HPS1426
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1422
AC   CVCL_YS31
DR   RCB; HPS1422
DR   Wikidata; Q94219740
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS30 ! HPS1421
OI   CVCL_YS32 ! HPS1423
OI   CVCL_YS33 ! HPS1424
OI   CVCL_YS34 ! HPS1425
OI   CVCL_YS35 ! HPS1426
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1423
AC   CVCL_YS32
DR   RCB; HPS1423
DR   Wikidata; Q94219744
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS30 ! HPS1421
OI   CVCL_YS31 ! HPS1422
OI   CVCL_YS33 ! HPS1424
OI   CVCL_YS34 ! HPS1425
OI   CVCL_YS35 ! HPS1426
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1424
AC   CVCL_YS33
DR   RCB; HPS1424
DR   Wikidata; Q94219748
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS30 ! HPS1421
OI   CVCL_YS31 ! HPS1422
OI   CVCL_YS32 ! HPS1423
OI   CVCL_YS34 ! HPS1425
OI   CVCL_YS35 ! HPS1426
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1425
AC   CVCL_YS34
DR   RCB; HPS1425
DR   Wikidata; Q94219749
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS30 ! HPS1421
OI   CVCL_YS31 ! HPS1422
OI   CVCL_YS32 ! HPS1423
OI   CVCL_YS33 ! HPS1424
OI   CVCL_YS35 ! HPS1426
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1426
AC   CVCL_YS35
DR   RCB; HPS1426
DR   Wikidata; Q94219752
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS30 ! HPS1421
OI   CVCL_YS31 ! HPS1422
OI   CVCL_YS32 ! HPS1423
OI   CVCL_YS33 ! HPS1424
OI   CVCL_YS34 ! HPS1425
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1427
AC   CVCL_UN79
DR   RCB; HPS1427
DR   Wikidata; Q94219754
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2976; Cystinosis
DI   ORDO; Orphanet_213; Cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ55 ! HPS1428
OI   CVCL_YQ56 ! HPS1429
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1428
AC   CVCL_YQ55
DR   RCB; HPS1428
DR   Wikidata; Q94219756
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2976; Cystinosis
DI   ORDO; Orphanet_213; Cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN79 ! HPS1427
OI   CVCL_YQ56 ! HPS1429
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1429
AC   CVCL_YQ56
DR   RCB; HPS1429
DR   Wikidata; Q94219759
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2976; Cystinosis
DI   ORDO; Orphanet_213; Cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN79 ! HPS1427
OI   CVCL_YQ55 ! HPS1428
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1430
AC   CVCL_C9MF
DR   RCB; HPS1430
DR   Wikidata; Q123031791
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MG ! HPS1431
OI   CVCL_C9MH ! HPS1432
OI   CVCL_C9MI ! HPS1433
OI   CVCL_C9MJ ! HPS1434
OI   CVCL_C9MK ! HPS1435
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1431
AC   CVCL_C9MG
DR   RCB; HPS1431
DR   Wikidata; Q123031792
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MF ! HPS1430
OI   CVCL_C9MH ! HPS1432
OI   CVCL_C9MI ! HPS1433
OI   CVCL_C9MJ ! HPS1434
OI   CVCL_C9MK ! HPS1435
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1432
AC   CVCL_C9MH
DR   RCB; HPS1432
DR   Wikidata; Q123031793
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MF ! HPS1430
OI   CVCL_C9MG ! HPS1431
OI   CVCL_C9MI ! HPS1433
OI   CVCL_C9MJ ! HPS1434
OI   CVCL_C9MK ! HPS1435
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1433
AC   CVCL_C9MI
DR   RCB; HPS1433
DR   Wikidata; Q123031794
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MF ! HPS1430
OI   CVCL_C9MG ! HPS1431
OI   CVCL_C9MH ! HPS1432
OI   CVCL_C9MJ ! HPS1434
OI   CVCL_C9MK ! HPS1435
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1434
AC   CVCL_C9MJ
DR   RCB; HPS1434
DR   Wikidata; Q123031795
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MF ! HPS1430
OI   CVCL_C9MG ! HPS1431
OI   CVCL_C9MH ! HPS1432
OI   CVCL_C9MI ! HPS1433
OI   CVCL_C9MK ! HPS1435
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1435
AC   CVCL_C9MK
DR   RCB; HPS1435
DR   Wikidata; Q123031797
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9MF ! HPS1430
OI   CVCL_C9MG ! HPS1431
OI   CVCL_C9MH ! HPS1432
OI   CVCL_C9MI ! HPS1433
OI   CVCL_C9MJ ! HPS1434
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1436
AC   CVCL_A3FT
DR   RCB; HPS1436
DR   Wikidata; Q105507991
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FU ! HPS1437
OI   CVCL_A3FV ! HPS1438
OI   CVCL_A3FW ! HPS1439
OI   CVCL_A3FX ! HPS1440
OI   CVCL_A3FY ! HPS1441
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1437
AC   CVCL_A3FU
DR   RCB; HPS1437
DR   Wikidata; Q105507994
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FT ! HPS1436
OI   CVCL_A3FV ! HPS1438
OI   CVCL_A3FW ! HPS1439
OI   CVCL_A3FX ! HPS1440
OI   CVCL_A3FY ! HPS1441
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1438
AC   CVCL_A3FV
DR   RCB; HPS1438
DR   Wikidata; Q105507997
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FT ! HPS1436
OI   CVCL_A3FU ! HPS1437
OI   CVCL_A3FW ! HPS1439
OI   CVCL_A3FX ! HPS1440
OI   CVCL_A3FY ! HPS1441
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1439
AC   CVCL_A3FW
DR   RCB; HPS1439
DR   Wikidata; Q105508003
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FT ! HPS1436
OI   CVCL_A3FU ! HPS1437
OI   CVCL_A3FV ! HPS1438
OI   CVCL_A3FX ! HPS1440
OI   CVCL_A3FY ! HPS1441
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1440
AC   CVCL_A3FX
DR   RCB; HPS1440
DR   Wikidata; Q105508006
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FT ! HPS1436
OI   CVCL_A3FU ! HPS1437
OI   CVCL_A3FV ! HPS1438
OI   CVCL_A3FW ! HPS1439
OI   CVCL_A3FY ! HPS1441
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1441
AC   CVCL_A3FY
DR   RCB; HPS1441
DR   Wikidata; Q105508010
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FT ! HPS1436
OI   CVCL_A3FU ! HPS1437
OI   CVCL_A3FV ! HPS1438
OI   CVCL_A3FW ! HPS1439
OI   CVCL_A3FX ! HPS1440
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1442
AC   CVCL_A3MG
DR   RCB; HPS1442
DR   Wikidata; Q105508014
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1442).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MH ! HPS1443
OI   CVCL_A3MI ! HPS1444
OI   CVCL_A3MJ ! HPS1445
OI   CVCL_A3MK ! HPS1446
OI   CVCL_A3ML ! HPS1447
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS1443
AC   CVCL_A3MH
DR   RCB; HPS1443
DR   Wikidata; Q105508018
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1443).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MG ! HPS1442
OI   CVCL_A3MI ! HPS1444
OI   CVCL_A3MJ ! HPS1445
OI   CVCL_A3MK ! HPS1446
OI   CVCL_A3ML ! HPS1447
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS1444
AC   CVCL_A3MI
DR   RCB; HPS1444
DR   Wikidata; Q105508021
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1444).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MG ! HPS1442
OI   CVCL_A3MH ! HPS1443
OI   CVCL_A3MJ ! HPS1445
OI   CVCL_A3MK ! HPS1446
OI   CVCL_A3ML ! HPS1447
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS1445
AC   CVCL_A3MJ
DR   RCB; HPS1445
DR   Wikidata; Q105508026
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1445).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MG ! HPS1442
OI   CVCL_A3MH ! HPS1443
OI   CVCL_A3MI ! HPS1444
OI   CVCL_A3MK ! HPS1446
OI   CVCL_A3ML ! HPS1447
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS1446
AC   CVCL_A3MK
DR   RCB; HPS1446
DR   Wikidata; Q105508028
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1446).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MG ! HPS1442
OI   CVCL_A3MH ! HPS1443
OI   CVCL_A3MI ! HPS1444
OI   CVCL_A3MJ ! HPS1445
OI   CVCL_A3ML ! HPS1447
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS1447
AC   CVCL_A3ML
DR   RCB; HPS1447
DR   Wikidata; Q105508033
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1447).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MG ! HPS1442
OI   CVCL_A3MH ! HPS1443
OI   CVCL_A3MI ! HPS1444
OI   CVCL_A3MJ ! HPS1445
OI   CVCL_A3MK ! HPS1446
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS1448
AC   CVCL_C9NZ
DR   RCB; HPS1448
DR   Wikidata; Q123031798
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1449
AC   CVCL_C9P0
DR   RCB; HPS1449
DR   Wikidata; Q123031799
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1450
AC   CVCL_C9P1
DR   RCB; HPS1450
DR   Wikidata; Q123031800
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1451
AC   CVCL_C9P2
DR   RCB; HPS1451
DR   Wikidata; Q123031801
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1452
AC   CVCL_C9P3
DR   RCB; HPS1452
DR   Wikidata; Q123031802
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1453
AC   CVCL_C9P4
DR   RCB; HPS1453
DR   Wikidata; Q123031803
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1454
AC   CVCL_UN80
DR   RCB; HPS1454
DR   Wikidata; Q94219761
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3US ! HPS1455
OI   CVCL_A3UT ! HPS1456
OI   CVCL_A3UU ! HPS1457
OI   CVCL_A3UV ! HPS1458
OI   CVCL_A3UW ! HPS1459
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1455
AC   CVCL_A3US
DR   RCB; HPS1455
DR   Wikidata; Q105508037
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN80 ! HPS1454
OI   CVCL_A3UT ! HPS1456
OI   CVCL_A3UU ! HPS1457
OI   CVCL_A3UV ! HPS1458
OI   CVCL_A3UW ! HPS1459
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1456
AC   CVCL_A3UT
DR   RCB; HPS1456
DR   Wikidata; Q105508041
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN80 ! HPS1454
OI   CVCL_A3US ! HPS1455
OI   CVCL_A3UU ! HPS1457
OI   CVCL_A3UV ! HPS1458
OI   CVCL_A3UW ! HPS1459
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1457
AC   CVCL_A3UU
DR   RCB; HPS1457
DR   Wikidata; Q105508048
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN80 ! HPS1454
OI   CVCL_A3US ! HPS1455
OI   CVCL_A3UT ! HPS1456
OI   CVCL_A3UV ! HPS1458
OI   CVCL_A3UW ! HPS1459
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1458
AC   CVCL_A3UV
DR   RCB; HPS1458
DR   Wikidata; Q105508052
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN80 ! HPS1454
OI   CVCL_A3US ! HPS1455
OI   CVCL_A3UT ! HPS1456
OI   CVCL_A3UU ! HPS1457
OI   CVCL_A3UW ! HPS1459
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1459
AC   CVCL_A3UW
DR   RCB; HPS1459
DR   Wikidata; Q105508055
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN80 ! HPS1454
OI   CVCL_A3US ! HPS1455
OI   CVCL_A3UT ! HPS1456
OI   CVCL_A3UU ! HPS1457
OI   CVCL_A3UV ! HPS1458
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1460
AC   CVCL_UN81
DR   RCB; HPS1460
DR   Wikidata; Q94219763
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Heterozygous (RCB=HPS1460).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR62 ! HPS1461
OI   CVCL_YR63 ! HPS1462
OI   CVCL_YR64 ! HPS1463
OI   CVCL_YR65 ! HPS1464
OI   CVCL_YR66 ! HPS1465
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS1461
AC   CVCL_YR62
DR   RCB; HPS1461
DR   Wikidata; Q94219767
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Heterozygous (RCB=HPS1461).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN81 ! HPS1460
OI   CVCL_YR63 ! HPS1462
OI   CVCL_YR64 ! HPS1463
OI   CVCL_YR65 ! HPS1464
OI   CVCL_YR66 ! HPS1465
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS1462
AC   CVCL_YR63
DR   RCB; HPS1462
DR   Wikidata; Q94219770
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Heterozygous (RCB=HPS1462).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN81 ! HPS1460
OI   CVCL_YR62 ! HPS1461
OI   CVCL_YR64 ! HPS1463
OI   CVCL_YR65 ! HPS1464
OI   CVCL_YR66 ! HPS1465
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS1463
AC   CVCL_YR64
DR   RCB; HPS1463
DR   Wikidata; Q94219773
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Heterozygous (RCB=HPS1463).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN81 ! HPS1460
OI   CVCL_YR62 ! HPS1461
OI   CVCL_YR63 ! HPS1462
OI   CVCL_YR65 ! HPS1464
OI   CVCL_YR66 ! HPS1465
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS1464
AC   CVCL_YR65
DR   RCB; HPS1464
DR   Wikidata; Q94219776
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Heterozygous (RCB=HPS1464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN81 ! HPS1460
OI   CVCL_YR62 ! HPS1461
OI   CVCL_YR63 ! HPS1462
OI   CVCL_YR64 ! HPS1463
OI   CVCL_YR66 ! HPS1465
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS1465
AC   CVCL_YR66
DR   RCB; HPS1465
DR   Wikidata; Q94219780
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Heterozygous (RCB=HPS1465).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN81 ! HPS1460
OI   CVCL_YR62 ! HPS1461
OI   CVCL_YR63 ! HPS1462
OI   CVCL_YR64 ! HPS1463
OI   CVCL_YR65 ! HPS1464
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS1466
AC   CVCL_UN82
DR   RCB; HPS1466
DR   Wikidata; Q94219783
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3PI ! HPS1467
OI   CVCL_A3PJ ! HPS1468
OI   CVCL_A3PK ! HPS1469
OI   CVCL_A3PL ! HPS1470
OI   CVCL_A3PM ! HPS1471
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1467
AC   CVCL_A3PI
DR   RCB; HPS1467
DR   Wikidata; Q105508059
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN82 ! HPS1466
OI   CVCL_A3PJ ! HPS1468
OI   CVCL_A3PK ! HPS1469
OI   CVCL_A3PL ! HPS1470
OI   CVCL_A3PM ! HPS1471
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1468
AC   CVCL_A3PJ
DR   RCB; HPS1468
DR   Wikidata; Q105508062
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN82 ! HPS1466
OI   CVCL_A3PI ! HPS1467
OI   CVCL_A3PK ! HPS1469
OI   CVCL_A3PL ! HPS1470
OI   CVCL_A3PM ! HPS1471
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1469
AC   CVCL_A3PK
DR   RCB; HPS1469
DR   Wikidata; Q105508065
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN82 ! HPS1466
OI   CVCL_A3PI ! HPS1467
OI   CVCL_A3PJ ! HPS1468
OI   CVCL_A3PL ! HPS1470
OI   CVCL_A3PM ! HPS1471
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1470
AC   CVCL_A3PL
DR   RCB; HPS1470
DR   Wikidata; Q105508069
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN82 ! HPS1466
OI   CVCL_A3PI ! HPS1467
OI   CVCL_A3PJ ! HPS1468
OI   CVCL_A3PK ! HPS1469
OI   CVCL_A3PM ! HPS1471
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1471
AC   CVCL_A3PM
DR   RCB; HPS1471
DR   Wikidata; Q105508071
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN82 ! HPS1466
OI   CVCL_A3PI ! HPS1467
OI   CVCL_A3PJ ! HPS1468
OI   CVCL_A3PK ! HPS1469
OI   CVCL_A3PL ! HPS1470
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1472
AC   CVCL_UN83
DR   RCB; HPS1472
DR   Wikidata; Q94219785
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3PN ! HPS1473
OI   CVCL_A3PP ! HPS1474
OI   CVCL_A3PQ ! HPS1475
OI   CVCL_A3PR ! HPS1476
OI   CVCL_A3PS ! HPS1477
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1473
AC   CVCL_A3PN
DR   RCB; HPS1473
DR   Wikidata; Q105508074
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN83 ! HPS1472
OI   CVCL_A3PP ! HPS1474
OI   CVCL_A3PQ ! HPS1475
OI   CVCL_A3PR ! HPS1476
OI   CVCL_A3PS ! HPS1477
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1474
AC   CVCL_A3PP
DR   RCB; HPS1474
DR   Wikidata; Q105508077
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN83 ! HPS1472
OI   CVCL_A3PN ! HPS1473
OI   CVCL_A3PQ ! HPS1475
OI   CVCL_A3PR ! HPS1476
OI   CVCL_A3PS ! HPS1477
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1475
AC   CVCL_A3PQ
DR   RCB; HPS1475
DR   Wikidata; Q105508079
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN83 ! HPS1472
OI   CVCL_A3PN ! HPS1473
OI   CVCL_A3PP ! HPS1474
OI   CVCL_A3PR ! HPS1476
OI   CVCL_A3PS ! HPS1477
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1476
AC   CVCL_A3PR
DR   RCB; HPS1476
DR   Wikidata; Q105508082
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN83 ! HPS1472
OI   CVCL_A3PN ! HPS1473
OI   CVCL_A3PP ! HPS1474
OI   CVCL_A3PQ ! HPS1475
OI   CVCL_A3PS ! HPS1477
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1477
AC   CVCL_A3PS
DR   RCB; HPS1477
DR   Wikidata; Q105508085
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN83 ! HPS1472
OI   CVCL_A3PN ! HPS1473
OI   CVCL_A3PP ! HPS1474
OI   CVCL_A3PQ ! HPS1475
OI   CVCL_A3PR ! HPS1476
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1478
AC   CVCL_VM80
DR   RCB; HPS1478
DR   Wikidata; Q94219789
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3PT ! HPS1479
OI   CVCL_A3PU ! HPS1480
OI   CVCL_A3PV ! HPS1481
OI   CVCL_A3PW ! HPS1482
OI   CVCL_A3PX ! HPS1483
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS1479
AC   CVCL_A3PT
DR   RCB; HPS1479
DR   Wikidata; Q105508088
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM80 ! HPS1478
OI   CVCL_A3PU ! HPS1480
OI   CVCL_A3PV ! HPS1481
OI   CVCL_A3PW ! HPS1482
OI   CVCL_A3PX ! HPS1483
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1480
AC   CVCL_A3PU
DR   RCB; HPS1480
DR   Wikidata; Q105508091
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM80 ! HPS1478
OI   CVCL_A3PT ! HPS1479
OI   CVCL_A3PV ! HPS1481
OI   CVCL_A3PW ! HPS1482
OI   CVCL_A3PX ! HPS1483
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1481
AC   CVCL_A3PV
DR   RCB; HPS1481
DR   Wikidata; Q105508094
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM80 ! HPS1478
OI   CVCL_A3PT ! HPS1479
OI   CVCL_A3PU ! HPS1480
OI   CVCL_A3PW ! HPS1482
OI   CVCL_A3PX ! HPS1483
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1482
AC   CVCL_A3PW
DR   RCB; HPS1482
DR   Wikidata; Q105508097
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM80 ! HPS1478
OI   CVCL_A3PT ! HPS1479
OI   CVCL_A3PU ! HPS1480
OI   CVCL_A3PV ! HPS1481
OI   CVCL_A3PX ! HPS1483
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1483
AC   CVCL_A3PX
DR   RCB; HPS1483
DR   Wikidata; Q105508102
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM80 ! HPS1478
OI   CVCL_A3PT ! HPS1479
OI   CVCL_A3PU ! HPS1480
OI   CVCL_A3PV ! HPS1481
OI   CVCL_A3PW ! HPS1482
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1490
AC   CVCL_D1EM
DR   RCB; HPS1490
DR   Wikidata; Q123031804
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EN ! HPS1491
OI   CVCL_D1EP ! HPS1492
OI   CVCL_D1EQ ! HPS1493
OI   CVCL_D1ER ! HPS1494
OI   CVCL_D1ES ! HPS1495
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1491
AC   CVCL_D1EN
DR   RCB; HPS1491
DR   Wikidata; Q123031805
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EM ! HPS1490
OI   CVCL_D1EP ! HPS1492
OI   CVCL_D1EQ ! HPS1493
OI   CVCL_D1ER ! HPS1494
OI   CVCL_D1ES ! HPS1495
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1492
AC   CVCL_D1EP
DR   RCB; HPS1492
DR   Wikidata; Q123031806
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EM ! HPS1490
OI   CVCL_D1EN ! HPS1491
OI   CVCL_D1EQ ! HPS1493
OI   CVCL_D1ER ! HPS1494
OI   CVCL_D1ES ! HPS1495
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1493
AC   CVCL_D1EQ
DR   RCB; HPS1493
DR   Wikidata; Q123031807
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EM ! HPS1490
OI   CVCL_D1EN ! HPS1491
OI   CVCL_D1EP ! HPS1492
OI   CVCL_D1ER ! HPS1494
OI   CVCL_D1ES ! HPS1495
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1494
AC   CVCL_D1ER
DR   RCB; HPS1494
DR   Wikidata; Q123031808
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EM ! HPS1490
OI   CVCL_D1EN ! HPS1491
OI   CVCL_D1EP ! HPS1492
OI   CVCL_D1EQ ! HPS1493
OI   CVCL_D1ES ! HPS1495
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1495
AC   CVCL_D1ES
DR   RCB; HPS1495
DR   Wikidata; Q123031809
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27167; Primary biliary cirrhosis
DI   ORDO; Orphanet_186; Primary biliary cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EM ! HPS1490
OI   CVCL_D1EN ! HPS1491
OI   CVCL_D1EP ! HPS1492
OI   CVCL_D1EQ ! HPS1493
OI   CVCL_D1ER ! HPS1494
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1496
AC   CVCL_C9U3
DR   RCB; HPS1496
DR   Wikidata; Q123031810
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U4 ! HPS1497
OI   CVCL_C9U5 ! HPS1498
OI   CVCL_C9U6 ! HPS1499
OI   CVCL_C9U7 ! HPS1500
OI   CVCL_C9U8 ! HPS1501
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1497
AC   CVCL_C9U4
DR   RCB; HPS1497
DR   Wikidata; Q123031811
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U3 ! HPS1496
OI   CVCL_C9U5 ! HPS1498
OI   CVCL_C9U6 ! HPS1499
OI   CVCL_C9U7 ! HPS1500
OI   CVCL_C9U8 ! HPS1501
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1498
AC   CVCL_C9U5
DR   RCB; HPS1498
DR   Wikidata; Q123031812
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U3 ! HPS1496
OI   CVCL_C9U4 ! HPS1497
OI   CVCL_C9U6 ! HPS1499
OI   CVCL_C9U7 ! HPS1500
OI   CVCL_C9U8 ! HPS1501
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1499
AC   CVCL_C9U6
DR   RCB; HPS1499
DR   Wikidata; Q123031813
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U3 ! HPS1496
OI   CVCL_C9U4 ! HPS1497
OI   CVCL_C9U5 ! HPS1498
OI   CVCL_C9U7 ! HPS1500
OI   CVCL_C9U8 ! HPS1501
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1500
AC   CVCL_C9U7
DR   RCB; HPS1500
DR   Wikidata; Q123031814
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U3 ! HPS1496
OI   CVCL_C9U4 ! HPS1497
OI   CVCL_C9U5 ! HPS1498
OI   CVCL_C9U6 ! HPS1499
OI   CVCL_C9U8 ! HPS1501
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1501
AC   CVCL_C9U8
DR   RCB; HPS1501
DR   Wikidata; Q123031815
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U3 ! HPS1496
OI   CVCL_C9U4 ! HPS1497
OI   CVCL_C9U5 ! HPS1498
OI   CVCL_C9U6 ! HPS1499
OI   CVCL_C9U7 ! HPS1500
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1502
AC   CVCL_C9PB
DR   RCB; HPS1502
DR   Wikidata; Q123031816
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PC ! HPS1503
OI   CVCL_C9PD ! HPS1504
OI   CVCL_C9PE ! HPS1505
OI   CVCL_C9PF ! HPS1506
OI   CVCL_C9PG ! HPS1507
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1503
AC   CVCL_C9PC
DR   RCB; HPS1503
DR   Wikidata; Q123031817
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PB ! HPS1502
OI   CVCL_C9PD ! HPS1504
OI   CVCL_C9PE ! HPS1505
OI   CVCL_C9PF ! HPS1506
OI   CVCL_C9PG ! HPS1507
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1504
AC   CVCL_C9PD
DR   RCB; HPS1504
DR   Wikidata; Q123031818
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PB ! HPS1502
OI   CVCL_C9PC ! HPS1503
OI   CVCL_C9PE ! HPS1505
OI   CVCL_C9PF ! HPS1506
OI   CVCL_C9PG ! HPS1507
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1505
AC   CVCL_C9PE
DR   RCB; HPS1505
DR   Wikidata; Q123031819
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PB ! HPS1502
OI   CVCL_C9PC ! HPS1503
OI   CVCL_C9PD ! HPS1504
OI   CVCL_C9PF ! HPS1506
OI   CVCL_C9PG ! HPS1507
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1506
AC   CVCL_C9PF
DR   RCB; HPS1506
DR   Wikidata; Q123031820
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PB ! HPS1502
OI   CVCL_C9PC ! HPS1503
OI   CVCL_C9PD ! HPS1504
OI   CVCL_C9PE ! HPS1505
OI   CVCL_C9PG ! HPS1507
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1507
AC   CVCL_C9PG
DR   RCB; HPS1507
DR   Wikidata; Q123031821
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PB ! HPS1502
OI   CVCL_C9PC ! HPS1503
OI   CVCL_C9PD ! HPS1504
OI   CVCL_C9PE ! HPS1505
OI   CVCL_C9PF ! HPS1506
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1508
AC   CVCL_A3FZ
DR   RCB; HPS1508
DR   Wikidata; Q105508105
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GA ! HPS1509
OI   CVCL_A3GB ! HPS1510
OI   CVCL_A3GC ! HPS1511
OI   CVCL_A3GD ! HPS1512
OI   CVCL_A3GE ! HPS1513
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1509
AC   CVCL_A3GA
DR   RCB; HPS1509
DR   Wikidata; Q105508111
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FZ ! HPS1508
OI   CVCL_A3GB ! HPS1510
OI   CVCL_A3GC ! HPS1511
OI   CVCL_A3GD ! HPS1512
OI   CVCL_A3GE ! HPS1513
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1510
AC   CVCL_A3GB
DR   RCB; HPS1510
DR   Wikidata; Q105508114
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FZ ! HPS1508
OI   CVCL_A3GA ! HPS1509
OI   CVCL_A3GC ! HPS1511
OI   CVCL_A3GD ! HPS1512
OI   CVCL_A3GE ! HPS1513
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1511
AC   CVCL_A3GC
DR   RCB; HPS1511
DR   Wikidata; Q105508117
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FZ ! HPS1508
OI   CVCL_A3GA ! HPS1509
OI   CVCL_A3GB ! HPS1510
OI   CVCL_A3GD ! HPS1512
OI   CVCL_A3GE ! HPS1513
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1512
AC   CVCL_A3GD
DR   RCB; HPS1512
DR   Wikidata; Q105508121
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FZ ! HPS1508
OI   CVCL_A3GA ! HPS1509
OI   CVCL_A3GB ! HPS1510
OI   CVCL_A3GC ! HPS1511
OI   CVCL_A3GE ! HPS1513
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1513
AC   CVCL_A3GE
DR   RCB; HPS1513
DR   Wikidata; Q105508124
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3FZ ! HPS1508
OI   CVCL_A3GA ! HPS1509
OI   CVCL_A3GB ! HPS1510
OI   CVCL_A3GC ! HPS1511
OI   CVCL_A3GD ! HPS1512
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1514
AC   CVCL_C9U9
DR   RCB; HPS1514
DR   Wikidata; Q123031822
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UA ! HPS1515
OI   CVCL_C9UB ! HPS1516
OI   CVCL_C9UC ! HPS1517
OI   CVCL_C9UD ! HPS1518
OI   CVCL_C9UE ! HPS1519
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1515
AC   CVCL_C9UA
DR   RCB; HPS1515
DR   Wikidata; Q123031823
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U9 ! HPS1514
OI   CVCL_C9UB ! HPS1516
OI   CVCL_C9UC ! HPS1517
OI   CVCL_C9UD ! HPS1518
OI   CVCL_C9UE ! HPS1519
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1516
AC   CVCL_C9UB
DR   RCB; HPS1516
DR   Wikidata; Q123031824
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U9 ! HPS1514
OI   CVCL_C9UA ! HPS1515
OI   CVCL_C9UC ! HPS1517
OI   CVCL_C9UD ! HPS1518
OI   CVCL_C9UE ! HPS1519
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1517
AC   CVCL_C9UC
DR   RCB; HPS1517
DR   Wikidata; Q123031825
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U9 ! HPS1514
OI   CVCL_C9UA ! HPS1515
OI   CVCL_C9UB ! HPS1516
OI   CVCL_C9UD ! HPS1518
OI   CVCL_C9UE ! HPS1519
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1518
AC   CVCL_C9UD
DR   RCB; HPS1518
DR   Wikidata; Q123031826
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U9 ! HPS1514
OI   CVCL_C9UA ! HPS1515
OI   CVCL_C9UB ! HPS1516
OI   CVCL_C9UC ! HPS1517
OI   CVCL_C9UE ! HPS1519
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1519
AC   CVCL_C9UE
DR   RCB; HPS1519
DR   Wikidata; Q123031827
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84796; Juvenile myoclonic epilepsy
DI   ORDO; Orphanet_307; Juvenile myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9U9 ! HPS1514
OI   CVCL_C9UA ! HPS1515
OI   CVCL_C9UB ! HPS1516
OI   CVCL_C9UC ! HPS1517
OI   CVCL_C9UD ! HPS1518
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1520
AC   CVCL_C9UF
DR   RCB; HPS1520
DR   Wikidata; Q123031828
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UG ! HPS1521
OI   CVCL_C9UH ! HPS1522
OI   CVCL_C9UI ! HPS1523
OI   CVCL_C9UJ ! HPS1524
OI   CVCL_C9UK ! HPS1525
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1521
AC   CVCL_C9UG
DR   RCB; HPS1521
DR   Wikidata; Q123031829
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UF ! HPS1520
OI   CVCL_C9UH ! HPS1522
OI   CVCL_C9UI ! HPS1523
OI   CVCL_C9UJ ! HPS1524
OI   CVCL_C9UK ! HPS1525
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1522
AC   CVCL_C9UH
DR   RCB; HPS1522
DR   Wikidata; Q123031830
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UF ! HPS1520
OI   CVCL_C9UG ! HPS1521
OI   CVCL_C9UI ! HPS1523
OI   CVCL_C9UJ ! HPS1524
OI   CVCL_C9UK ! HPS1525
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1523
AC   CVCL_C9UI
DR   RCB; HPS1523
DR   Wikidata; Q123031831
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UF ! HPS1520
OI   CVCL_C9UG ! HPS1521
OI   CVCL_C9UH ! HPS1522
OI   CVCL_C9UJ ! HPS1524
OI   CVCL_C9UK ! HPS1525
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1524
AC   CVCL_C9UJ
DR   RCB; HPS1524
DR   Wikidata; Q123031832
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UF ! HPS1520
OI   CVCL_C9UG ! HPS1521
OI   CVCL_C9UH ! HPS1522
OI   CVCL_C9UI ! HPS1523
OI   CVCL_C9UK ! HPS1525
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1525
AC   CVCL_C9UK
DR   RCB; HPS1525
DR   Wikidata; Q123031834
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UF ! HPS1520
OI   CVCL_C9UG ! HPS1521
OI   CVCL_C9UH ! HPS1522
OI   CVCL_C9UI ! HPS1523
OI   CVCL_C9UJ ! HPS1524
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1526
AC   CVCL_UN84
DR   RCB; HPS1526
DR   Wikidata; Q94219792
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3UX ! HPS1527
OI   CVCL_A3UY ! HPS1528
OI   CVCL_A3UZ ! HPS1529
OI   CVCL_A3VA ! HPS1530
OI   CVCL_A3VB ! HPS1531
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1527
AC   CVCL_A3UX
DR   RCB; HPS1527
DR   Wikidata; Q105508126
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN84 ! HPS1526
OI   CVCL_A3UY ! HPS1528
OI   CVCL_A3UZ ! HPS1529
OI   CVCL_A3VA ! HPS1530
OI   CVCL_A3VB ! HPS1531
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1528
AC   CVCL_A3UY
DR   RCB; HPS1528
DR   Wikidata; Q105508129
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN84 ! HPS1526
OI   CVCL_A3UX ! HPS1527
OI   CVCL_A3UZ ! HPS1529
OI   CVCL_A3VA ! HPS1530
OI   CVCL_A3VB ! HPS1531
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1529
AC   CVCL_A3UZ
DR   RCB; HPS1529
DR   Wikidata; Q105508133
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN84 ! HPS1526
OI   CVCL_A3UX ! HPS1527
OI   CVCL_A3UY ! HPS1528
OI   CVCL_A3VA ! HPS1530
OI   CVCL_A3VB ! HPS1531
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1530
AC   CVCL_A3VA
DR   RCB; HPS1530
DR   Wikidata; Q105508135
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN84 ! HPS1526
OI   CVCL_A3UX ! HPS1527
OI   CVCL_A3UY ! HPS1528
OI   CVCL_A3UZ ! HPS1529
OI   CVCL_A3VB ! HPS1531
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1531
AC   CVCL_A3VB
DR   RCB; HPS1531
DR   Wikidata; Q105508138
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN84 ! HPS1526
OI   CVCL_A3UX ! HPS1527
OI   CVCL_A3UY ! HPS1528
OI   CVCL_A3UZ ! HPS1529
OI   CVCL_A3VA ! HPS1530
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1532
AC   CVCL_UN85
DR   RCB; HPS1532
DR   Wikidata; Q94219794
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3QN ! HPS1533
OI   CVCL_A3QP ! HPS1534
OI   CVCL_A3QQ ! HPS1535
OI   CVCL_A3QR ! HPS1536
OI   CVCL_A3QS ! HPS1537
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1533
AC   CVCL_A3QN
DR   RCB; HPS1533
DR   Wikidata; Q105508144
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN85 ! HPS1532
OI   CVCL_A3QP ! HPS1534
OI   CVCL_A3QQ ! HPS1535
OI   CVCL_A3QR ! HPS1536
OI   CVCL_A3QS ! HPS1537
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1534
AC   CVCL_A3QP
DR   RCB; HPS1534
DR   Wikidata; Q105508147
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN85 ! HPS1532
OI   CVCL_A3QN ! HPS1533
OI   CVCL_A3QQ ! HPS1535
OI   CVCL_A3QR ! HPS1536
OI   CVCL_A3QS ! HPS1537
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1535
AC   CVCL_A3QQ
DR   RCB; HPS1535
DR   Wikidata; Q105508150
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN85 ! HPS1532
OI   CVCL_A3QN ! HPS1533
OI   CVCL_A3QP ! HPS1534
OI   CVCL_A3QR ! HPS1536
OI   CVCL_A3QS ! HPS1537
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1536
AC   CVCL_A3QR
DR   RCB; HPS1536
DR   Wikidata; Q105508155
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN85 ! HPS1532
OI   CVCL_A3QN ! HPS1533
OI   CVCL_A3QP ! HPS1534
OI   CVCL_A3QQ ! HPS1535
OI   CVCL_A3QS ! HPS1537
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1537
AC   CVCL_A3QS
DR   RCB; HPS1537
DR   Wikidata; Q105508162
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN85 ! HPS1532
OI   CVCL_A3QN ! HPS1533
OI   CVCL_A3QP ! HPS1534
OI   CVCL_A3QQ ! HPS1535
OI   CVCL_A3QR ! HPS1536
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1544
AC   CVCL_D1DS
DR   RCB; HPS1544
DR   Wikidata; Q123031835
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), motor-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DT ! HPS1545
OI   CVCL_D1DU ! HPS1546
OI   CVCL_D1DV ! HPS1547
OI   CVCL_D1DW ! HPS1548
OI   CVCL_D1DX ! HPS1549
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1545
AC   CVCL_D1DT
DR   RCB; HPS1545
DR   Wikidata; Q123031836
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), motor-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DS ! HPS1544
OI   CVCL_D1DU ! HPS1546
OI   CVCL_D1DV ! HPS1547
OI   CVCL_D1DW ! HPS1548
OI   CVCL_D1DX ! HPS1549
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1546
AC   CVCL_D1DU
DR   RCB; HPS1546
DR   Wikidata; Q123031837
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), motor-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DS ! HPS1544
OI   CVCL_D1DT ! HPS1545
OI   CVCL_D1DV ! HPS1547
OI   CVCL_D1DW ! HPS1548
OI   CVCL_D1DX ! HPS1549
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1547
AC   CVCL_D1DV
DR   RCB; HPS1547
DR   Wikidata; Q123031838
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), motor-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DS ! HPS1544
OI   CVCL_D1DT ! HPS1545
OI   CVCL_D1DU ! HPS1546
OI   CVCL_D1DW ! HPS1548
OI   CVCL_D1DX ! HPS1549
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1548
AC   CVCL_D1DW
DR   RCB; HPS1548
DR   Wikidata; Q123031839
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), motor-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DS ! HPS1544
OI   CVCL_D1DT ! HPS1545
OI   CVCL_D1DU ! HPS1546
OI   CVCL_D1DV ! HPS1547
OI   CVCL_D1DX ! HPS1549
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1549
AC   CVCL_D1DX
DR   RCB; HPS1549
DR   Wikidata; Q123031840
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), motor-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DS ! HPS1544
OI   CVCL_D1DT ! HPS1545
OI   CVCL_D1DU ! HPS1546
OI   CVCL_D1DV ! HPS1547
OI   CVCL_D1DW ! HPS1548
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1550
AC   CVCL_C9UL
DR   RCB; HPS1550
DR   Wikidata; Q123031842
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UM ! HPS1551
OI   CVCL_C9UN ! HPS1552
OI   CVCL_C9UP ! HPS1553
OI   CVCL_C9UQ ! HPS1554
OI   CVCL_C9UR ! HPS1555
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1551
AC   CVCL_C9UM
DR   RCB; HPS1551
DR   Wikidata; Q123031843
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UL ! HPS1550
OI   CVCL_C9UN ! HPS1552
OI   CVCL_C9UP ! HPS1553
OI   CVCL_C9UQ ! HPS1554
OI   CVCL_C9UR ! HPS1555
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1552
AC   CVCL_C9UN
DR   RCB; HPS1552
DR   Wikidata; Q123031844
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UL ! HPS1550
OI   CVCL_C9UM ! HPS1551
OI   CVCL_C9UP ! HPS1553
OI   CVCL_C9UQ ! HPS1554
OI   CVCL_C9UR ! HPS1555
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1553
AC   CVCL_C9UP
DR   RCB; HPS1553
DR   Wikidata; Q123031845
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UL ! HPS1550
OI   CVCL_C9UM ! HPS1551
OI   CVCL_C9UN ! HPS1552
OI   CVCL_C9UQ ! HPS1554
OI   CVCL_C9UR ! HPS1555
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1554
AC   CVCL_C9UQ
DR   RCB; HPS1554
DR   Wikidata; Q123031846
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UL ! HPS1550
OI   CVCL_C9UM ! HPS1551
OI   CVCL_C9UN ! HPS1552
OI   CVCL_C9UP ! HPS1553
OI   CVCL_C9UR ! HPS1555
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1555
AC   CVCL_C9UR
DR   RCB; HPS1555
DR   Wikidata; Q123031848
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75469; Smith-Magenis syndrome
DI   ORDO; Orphanet_819; Smith-Magenis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UL ! HPS1550
OI   CVCL_C9UM ! HPS1551
OI   CVCL_C9UN ! HPS1552
OI   CVCL_C9UP ! HPS1553
OI   CVCL_C9UQ ! HPS1554
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1556
AC   CVCL_C9US
DR   RCB; HPS1556
DR   Wikidata; Q123031849
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UT ! HPS1557
OI   CVCL_C9UU ! HPS1558
OI   CVCL_C9UV ! HPS1559
OI   CVCL_C9UW ! HPS1560
OI   CVCL_C9UX ! HPS1561
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1557
AC   CVCL_C9UT
DR   RCB; HPS1557
DR   Wikidata; Q123031850
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9US ! HPS1556
OI   CVCL_C9UU ! HPS1558
OI   CVCL_C9UV ! HPS1559
OI   CVCL_C9UW ! HPS1560
OI   CVCL_C9UX ! HPS1561
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1558
AC   CVCL_C9UU
DR   RCB; HPS1558
DR   Wikidata; Q123031851
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9US ! HPS1556
OI   CVCL_C9UT ! HPS1557
OI   CVCL_C9UV ! HPS1559
OI   CVCL_C9UW ! HPS1560
OI   CVCL_C9UX ! HPS1561
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1559
AC   CVCL_C9UV
DR   RCB; HPS1559
DR   Wikidata; Q123031852
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9US ! HPS1556
OI   CVCL_C9UT ! HPS1557
OI   CVCL_C9UU ! HPS1558
OI   CVCL_C9UW ! HPS1560
OI   CVCL_C9UX ! HPS1561
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1560
AC   CVCL_C9UW
DR   RCB; HPS1560
DR   Wikidata; Q123031853
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9US ! HPS1556
OI   CVCL_C9UT ! HPS1557
OI   CVCL_C9UU ! HPS1558
OI   CVCL_C9UV ! HPS1559
OI   CVCL_C9UX ! HPS1561
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1561
AC   CVCL_C9UX
DR   RCB; HPS1561
DR   Wikidata; Q123031854
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9US ! HPS1556
OI   CVCL_C9UT ! HPS1557
OI   CVCL_C9UU ! HPS1558
OI   CVCL_C9UV ! HPS1559
OI   CVCL_C9UW ! HPS1560
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1568
AC   CVCL_UN86
DR   RCB; HPS1568
DR   Wikidata; Q94219796
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LX ! HPS1569
OI   CVCL_A3LY ! HPS1570
OI   CVCL_A3LZ ! HPS1571
OI   CVCL_A3MA ! HPS1572
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1569
AC   CVCL_A3LX
DR   RCB; HPS1569
DR   Wikidata; Q105508164
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN86 ! HPS1568
OI   CVCL_A3LY ! HPS1570
OI   CVCL_A3LZ ! HPS1571
OI   CVCL_A3MA ! HPS1572
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1570
AC   CVCL_A3LY
DR   RCB; HPS1570
DR   Wikidata; Q105508169
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN86 ! HPS1568
OI   CVCL_A3LX ! HPS1569
OI   CVCL_A3LZ ! HPS1571
OI   CVCL_A3MA ! HPS1572
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1571
AC   CVCL_A3LZ
DR   RCB; HPS1571
DR   Wikidata; Q105508173
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN86 ! HPS1568
OI   CVCL_A3LX ! HPS1569
OI   CVCL_A3LY ! HPS1570
OI   CVCL_A3MA ! HPS1572
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1572
AC   CVCL_A3MA
DR   RCB; HPS1572
DR   Wikidata; Q105508176
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN86 ! HPS1568
OI   CVCL_A3LX ! HPS1569
OI   CVCL_A3LY ! HPS1570
OI   CVCL_A3LZ ! HPS1571
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1573
AC   CVCL_D1A8
DR   RCB; HPS1573
DR   Wikidata; Q123031855
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A9 ! HPS1574
OI   CVCL_D1AA ! HPS1575
OI   CVCL_D1AB ! HPS1576
OI   CVCL_D1AC ! HPS1577
OI   CVCL_D1AD ! HPS1578
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1574
AC   CVCL_D1A9
DR   RCB; HPS1574
DR   Wikidata; Q123031856
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A8 ! HPS1573
OI   CVCL_D1AA ! HPS1575
OI   CVCL_D1AB ! HPS1576
OI   CVCL_D1AC ! HPS1577
OI   CVCL_D1AD ! HPS1578
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1575
AC   CVCL_D1AA
DR   RCB; HPS1575
DR   Wikidata; Q123031857
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A8 ! HPS1573
OI   CVCL_D1A9 ! HPS1574
OI   CVCL_D1AB ! HPS1576
OI   CVCL_D1AC ! HPS1577
OI   CVCL_D1AD ! HPS1578
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1576
AC   CVCL_D1AB
DR   RCB; HPS1576
DR   Wikidata; Q123031858
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A8 ! HPS1573
OI   CVCL_D1A9 ! HPS1574
OI   CVCL_D1AA ! HPS1575
OI   CVCL_D1AC ! HPS1577
OI   CVCL_D1AD ! HPS1578
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1577
AC   CVCL_D1AC
DR   RCB; HPS1577
DR   Wikidata; Q123031859
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A8 ! HPS1573
OI   CVCL_D1A9 ! HPS1574
OI   CVCL_D1AA ! HPS1575
OI   CVCL_D1AB ! HPS1576
OI   CVCL_D1AD ! HPS1578
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1578
AC   CVCL_D1AD
DR   RCB; HPS1578
DR   Wikidata; Q123031860
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34643; IgA nephropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A8 ! HPS1573
OI   CVCL_D1A9 ! HPS1574
OI   CVCL_D1AA ! HPS1575
OI   CVCL_D1AB ! HPS1576
OI   CVCL_D1AC ! HPS1577
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1579
AC   CVCL_D1A2
DR   RCB; HPS1579
DR   Wikidata; Q123031861
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35065; Temporal arteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A3 ! HPS1580
OI   CVCL_D1A4 ! HPS1581
OI   CVCL_D1A5 ! HPS1582
OI   CVCL_D1A6 ! HPS1583
OI   CVCL_D1A7 ! HPS1584
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1580
AC   CVCL_D1A3
DR   RCB; HPS1580
DR   Wikidata; Q123031862
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35065; Temporal arteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A2 ! HPS1579
OI   CVCL_D1A4 ! HPS1581
OI   CVCL_D1A5 ! HPS1582
OI   CVCL_D1A6 ! HPS1583
OI   CVCL_D1A7 ! HPS1584
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1581
AC   CVCL_D1A4
DR   RCB; HPS1581
DR   Wikidata; Q123031863
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35065; Temporal arteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A2 ! HPS1579
OI   CVCL_D1A3 ! HPS1580
OI   CVCL_D1A5 ! HPS1582
OI   CVCL_D1A6 ! HPS1583
OI   CVCL_D1A7 ! HPS1584
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1582
AC   CVCL_D1A5
DR   RCB; HPS1582
DR   Wikidata; Q123031864
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35065; Temporal arteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A2 ! HPS1579
OI   CVCL_D1A3 ! HPS1580
OI   CVCL_D1A4 ! HPS1581
OI   CVCL_D1A6 ! HPS1583
OI   CVCL_D1A7 ! HPS1584
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1583
AC   CVCL_D1A6
DR   RCB; HPS1583
DR   Wikidata; Q123031865
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35065; Temporal arteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A2 ! HPS1579
OI   CVCL_D1A3 ! HPS1580
OI   CVCL_D1A4 ! HPS1581
OI   CVCL_D1A5 ! HPS1582
OI   CVCL_D1A7 ! HPS1584
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1584
AC   CVCL_D1A7
DR   RCB; HPS1584
DR   Wikidata; Q123031866
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35065; Temporal arteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1A2 ! HPS1579
OI   CVCL_D1A3 ! HPS1580
OI   CVCL_D1A4 ! HPS1581
OI   CVCL_D1A5 ! HPS1582
OI   CVCL_D1A6 ! HPS1583
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1585
AC   CVCL_C6BM
DR   RCB; HPS1585
DR   Wikidata; Q116049418
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BN ! HPS1586
OI   CVCL_C6BP ! HPS1587
OI   CVCL_C6BQ ! HPS1588
OI   CVCL_C6BR ! HPS1589
OI   CVCL_C6BS ! HPS1590
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1586
AC   CVCL_C6BN
DR   RCB; HPS1586
DR   Wikidata; Q116049419
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BM ! HPS1585
OI   CVCL_C6BP ! HPS1587
OI   CVCL_C6BQ ! HPS1588
OI   CVCL_C6BR ! HPS1589
OI   CVCL_C6BS ! HPS1590
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1587
AC   CVCL_C6BP
DR   RCB; HPS1587
DR   Wikidata; Q116049420
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BM ! HPS1585
OI   CVCL_C6BN ! HPS1586
OI   CVCL_C6BQ ! HPS1588
OI   CVCL_C6BR ! HPS1589
OI   CVCL_C6BS ! HPS1590
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1588
AC   CVCL_C6BQ
DR   RCB; HPS1588
DR   Wikidata; Q116049422
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BM ! HPS1585
OI   CVCL_C6BN ! HPS1586
OI   CVCL_C6BP ! HPS1587
OI   CVCL_C6BR ! HPS1589
OI   CVCL_C6BS ! HPS1590
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1589
AC   CVCL_C6BR
DR   RCB; HPS1589
DR   Wikidata; Q116049423
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BM ! HPS1585
OI   CVCL_C6BN ! HPS1586
OI   CVCL_C6BP ! HPS1587
OI   CVCL_C6BQ ! HPS1588
OI   CVCL_C6BS ! HPS1590
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1590
AC   CVCL_C6BS
DR   RCB; HPS1590
DR   Wikidata; Q116049424
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BM ! HPS1585
OI   CVCL_C6BN ! HPS1586
OI   CVCL_C6BP ! HPS1587
OI   CVCL_C6BQ ! HPS1588
OI   CVCL_C6BR ! HPS1589
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1591
AC   CVCL_C9UY
DR   RCB; HPS1591
DR   Wikidata; Q123031867
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201592; Focal cortical dysplasia
DI   ORDO; Orphanet_65683; Isolated focal cortical dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UZ ! HPS1592
OI   CVCL_C9V0 ! HPS1593
OI   CVCL_C9V1 ! HPS1594
OI   CVCL_C9V2 ! HPS1595
OI   CVCL_C9V3 ! HPS1596
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1592
AC   CVCL_C9UZ
DR   RCB; HPS1592
DR   Wikidata; Q123031868
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201592; Focal cortical dysplasia
DI   ORDO; Orphanet_65683; Isolated focal cortical dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UY ! HPS1591
OI   CVCL_C9V0 ! HPS1593
OI   CVCL_C9V1 ! HPS1594
OI   CVCL_C9V2 ! HPS1595
OI   CVCL_C9V3 ! HPS1596
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1593
AC   CVCL_C9V0
DR   RCB; HPS1593
DR   Wikidata; Q123031869
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201592; Focal cortical dysplasia
DI   ORDO; Orphanet_65683; Isolated focal cortical dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UY ! HPS1591
OI   CVCL_C9UZ ! HPS1592
OI   CVCL_C9V1 ! HPS1594
OI   CVCL_C9V2 ! HPS1595
OI   CVCL_C9V3 ! HPS1596
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1594
AC   CVCL_C9V1
DR   RCB; HPS1594
DR   Wikidata; Q123031870
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201592; Focal cortical dysplasia
DI   ORDO; Orphanet_65683; Isolated focal cortical dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UY ! HPS1591
OI   CVCL_C9UZ ! HPS1592
OI   CVCL_C9V0 ! HPS1593
OI   CVCL_C9V2 ! HPS1595
OI   CVCL_C9V3 ! HPS1596
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1595
AC   CVCL_C9V2
DR   RCB; HPS1595
DR   Wikidata; Q123031871
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201592; Focal cortical dysplasia
DI   ORDO; Orphanet_65683; Isolated focal cortical dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UY ! HPS1591
OI   CVCL_C9UZ ! HPS1592
OI   CVCL_C9V0 ! HPS1593
OI   CVCL_C9V1 ! HPS1594
OI   CVCL_C9V3 ! HPS1596
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1596
AC   CVCL_C9V3
DR   RCB; HPS1596
DR   Wikidata; Q123031872
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201592; Focal cortical dysplasia
DI   ORDO; Orphanet_65683; Isolated focal cortical dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9UY ! HPS1591
OI   CVCL_C9UZ ! HPS1592
OI   CVCL_C9V0 ! HPS1593
OI   CVCL_C9V1 ! HPS1594
OI   CVCL_C9V2 ! HPS1595
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1597
AC   CVCL_A3GF
DR   RCB; HPS1597
DR   Wikidata; Q105508179
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GG ! HPS1598
OI   CVCL_A3GH ! HPS1599
OI   CVCL_A3GI ! HPS1600
OI   CVCL_A3GJ ! HPS1601
OI   CVCL_A3GK ! HPS1602
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1598
AC   CVCL_A3GG
DR   RCB; HPS1598
DR   Wikidata; Q105508184
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GF ! HPS1597
OI   CVCL_A3GH ! HPS1599
OI   CVCL_A3GI ! HPS1600
OI   CVCL_A3GJ ! HPS1601
OI   CVCL_A3GK ! HPS1602
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1599
AC   CVCL_A3GH
DR   RCB; HPS1599
DR   Wikidata; Q105508186
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GF ! HPS1597
OI   CVCL_A3GG ! HPS1598
OI   CVCL_A3GI ! HPS1600
OI   CVCL_A3GJ ! HPS1601
OI   CVCL_A3GK ! HPS1602
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1600
AC   CVCL_A3GI
DR   RCB; HPS1600
DR   Wikidata; Q105508190
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GF ! HPS1597
OI   CVCL_A3GG ! HPS1598
OI   CVCL_A3GH ! HPS1599
OI   CVCL_A3GJ ! HPS1601
OI   CVCL_A3GK ! HPS1602
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1601
AC   CVCL_A3GJ
DR   RCB; HPS1601
DR   Wikidata; Q105508195
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GF ! HPS1597
OI   CVCL_A3GG ! HPS1598
OI   CVCL_A3GH ! HPS1599
OI   CVCL_A3GI ! HPS1600
OI   CVCL_A3GK ! HPS1602
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1602
AC   CVCL_A3GK
DR   RCB; HPS1602
DR   Wikidata; Q105508198
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GF ! HPS1597
OI   CVCL_A3GG ! HPS1598
OI   CVCL_A3GH ! HPS1599
OI   CVCL_A3GI ! HPS1600
OI   CVCL_A3GJ ! HPS1601
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1603
AC   CVCL_A3GL
DR   RCB; HPS1603
DR   Wikidata; Q105508201
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GM ! HPS1604
OI   CVCL_A3GN ! HPS1605
OI   CVCL_A3GP ! HPS1606
OI   CVCL_A3GQ ! HPS1607
OI   CVCL_A3GR ! HPS1608
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1604
AC   CVCL_A3GM
DR   RCB; HPS1604
DR   Wikidata; Q105508206
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GL ! HPS1603
OI   CVCL_A3GN ! HPS1605
OI   CVCL_A3GP ! HPS1606
OI   CVCL_A3GQ ! HPS1607
OI   CVCL_A3GR ! HPS1608
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1605
AC   CVCL_A3GN
DR   RCB; HPS1605
DR   Wikidata; Q105508211
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GL ! HPS1603
OI   CVCL_A3GM ! HPS1604
OI   CVCL_A3GP ! HPS1606
OI   CVCL_A3GQ ! HPS1607
OI   CVCL_A3GR ! HPS1608
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1606
AC   CVCL_A3GP
DR   RCB; HPS1606
DR   Wikidata; Q105508214
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GL ! HPS1603
OI   CVCL_A3GM ! HPS1604
OI   CVCL_A3GN ! HPS1605
OI   CVCL_A3GQ ! HPS1607
OI   CVCL_A3GR ! HPS1608
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1607
AC   CVCL_A3GQ
DR   RCB; HPS1607
DR   Wikidata; Q105508219
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GL ! HPS1603
OI   CVCL_A3GM ! HPS1604
OI   CVCL_A3GN ! HPS1605
OI   CVCL_A3GP ! HPS1606
OI   CVCL_A3GR ! HPS1608
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1608
AC   CVCL_A3GR
DR   RCB; HPS1608
DR   Wikidata; Q105508223
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GL ! HPS1603
OI   CVCL_A3GM ! HPS1604
OI   CVCL_A3GN ! HPS1605
OI   CVCL_A3GP ! HPS1606
OI   CVCL_A3GQ ! HPS1607
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1609
AC   CVCL_C9PH
DR   RCB; HPS1609
DR   Wikidata; Q123031873
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PI ! HPS1610
OI   CVCL_C9PJ ! HPS1611
OI   CVCL_C9PK ! HPS1612
OI   CVCL_C9PL ! HPS1613
OI   CVCL_C9PM ! HPS1614
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1610
AC   CVCL_C9PI
DR   RCB; HPS1610
DR   Wikidata; Q123031874
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PH ! HPS1609
OI   CVCL_C9PJ ! HPS1611
OI   CVCL_C9PK ! HPS1612
OI   CVCL_C9PL ! HPS1613
OI   CVCL_C9PM ! HPS1614
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1611
AC   CVCL_C9PJ
DR   RCB; HPS1611
DR   Wikidata; Q123031875
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PH ! HPS1609
OI   CVCL_C9PI ! HPS1610
OI   CVCL_C9PK ! HPS1612
OI   CVCL_C9PL ! HPS1613
OI   CVCL_C9PM ! HPS1614
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1612
AC   CVCL_C9PK
DR   RCB; HPS1612
DR   Wikidata; Q123031877
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PH ! HPS1609
OI   CVCL_C9PI ! HPS1610
OI   CVCL_C9PJ ! HPS1611
OI   CVCL_C9PL ! HPS1613
OI   CVCL_C9PM ! HPS1614
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1613
AC   CVCL_C9PL
DR   RCB; HPS1613
DR   Wikidata; Q123031878
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PH ! HPS1609
OI   CVCL_C9PI ! HPS1610
OI   CVCL_C9PJ ! HPS1611
OI   CVCL_C9PK ! HPS1612
OI   CVCL_C9PM ! HPS1614
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1614
AC   CVCL_C9PM
DR   RCB; HPS1614
DR   Wikidata; Q123031879
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PH ! HPS1609
OI   CVCL_C9PI ! HPS1610
OI   CVCL_C9PJ ! HPS1611
OI   CVCL_C9PK ! HPS1612
OI   CVCL_C9PL ! HPS1613
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1615
AC   CVCL_C9PN
DR   RCB; HPS1615
DR   Wikidata; Q123031880
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99056; Schizencephaly
DI   ORDO; Orphanet_799; Schizencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PP ! HPS1616
OI   CVCL_C9PQ ! HPS1617
OI   CVCL_C9PR ! HPS1618
OI   CVCL_C9PS ! HPS1619
OI   CVCL_C9PT ! HPS1620
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1616
AC   CVCL_C9PP
DR   RCB; HPS1616
DR   Wikidata; Q123031881
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99056; Schizencephaly
DI   ORDO; Orphanet_799; Schizencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PN ! HPS1615
OI   CVCL_C9PQ ! HPS1617
OI   CVCL_C9PR ! HPS1618
OI   CVCL_C9PS ! HPS1619
OI   CVCL_C9PT ! HPS1620
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1617
AC   CVCL_C9PQ
DR   RCB; HPS1617
DR   Wikidata; Q123031882
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99056; Schizencephaly
DI   ORDO; Orphanet_799; Schizencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PN ! HPS1615
OI   CVCL_C9PP ! HPS1616
OI   CVCL_C9PR ! HPS1618
OI   CVCL_C9PS ! HPS1619
OI   CVCL_C9PT ! HPS1620
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1618
AC   CVCL_C9PR
DR   RCB; HPS1618
DR   Wikidata; Q123031884
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99056; Schizencephaly
DI   ORDO; Orphanet_799; Schizencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PN ! HPS1615
OI   CVCL_C9PP ! HPS1616
OI   CVCL_C9PQ ! HPS1617
OI   CVCL_C9PS ! HPS1619
OI   CVCL_C9PT ! HPS1620
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1619
AC   CVCL_C9PS
DR   RCB; HPS1619
DR   Wikidata; Q123031885
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99056; Schizencephaly
DI   ORDO; Orphanet_799; Schizencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PN ! HPS1615
OI   CVCL_C9PP ! HPS1616
OI   CVCL_C9PQ ! HPS1617
OI   CVCL_C9PR ! HPS1618
OI   CVCL_C9PT ! HPS1620
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1620
AC   CVCL_C9PT
DR   RCB; HPS1620
DR   Wikidata; Q123031886
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99056; Schizencephaly
DI   ORDO; Orphanet_799; Schizencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PN ! HPS1615
OI   CVCL_C9PP ! HPS1616
OI   CVCL_C9PQ ! HPS1617
OI   CVCL_C9PR ! HPS1618
OI   CVCL_C9PS ! HPS1619
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1621
AC   CVCL_C9PU
DR   RCB; HPS1621
DR   Wikidata; Q123031887
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PV ! HPS1622
OI   CVCL_C9PW ! HPS1623
OI   CVCL_C9PX ! HPS1624
OI   CVCL_C9PY ! HPS1625
OI   CVCL_C9PZ ! HPS1626
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1622
AC   CVCL_C9PV
DR   RCB; HPS1622
DR   Wikidata; Q123031888
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PU ! HPS1621
OI   CVCL_C9PW ! HPS1623
OI   CVCL_C9PX ! HPS1624
OI   CVCL_C9PY ! HPS1625
OI   CVCL_C9PZ ! HPS1626
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1623
AC   CVCL_C9PW
DR   RCB; HPS1623
DR   Wikidata; Q123031889
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PU ! HPS1621
OI   CVCL_C9PV ! HPS1622
OI   CVCL_C9PX ! HPS1624
OI   CVCL_C9PY ! HPS1625
OI   CVCL_C9PZ ! HPS1626
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1624
AC   CVCL_C9PX
DR   RCB; HPS1624
DR   Wikidata; Q123031890
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PU ! HPS1621
OI   CVCL_C9PV ! HPS1622
OI   CVCL_C9PW ! HPS1623
OI   CVCL_C9PY ! HPS1625
OI   CVCL_C9PZ ! HPS1626
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1625
AC   CVCL_C9PY
DR   RCB; HPS1625
DR   Wikidata; Q123031891
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PU ! HPS1621
OI   CVCL_C9PV ! HPS1622
OI   CVCL_C9PW ! HPS1623
OI   CVCL_C9PX ! HPS1624
OI   CVCL_C9PZ ! HPS1626
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1626
AC   CVCL_C9PZ
DR   RCB; HPS1626
DR   Wikidata; Q123031892
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9PU ! HPS1621
OI   CVCL_C9PV ! HPS1622
OI   CVCL_C9PW ! HPS1623
OI   CVCL_C9PX ! HPS1624
OI   CVCL_C9PY ! HPS1625
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1627
AC   CVCL_YS36
AS   CVCL_C0HH
SY   BRCi019-A
DR   hPSCreg; BRCi019-A
DR   RCB; HPS1627
DR   Wikidata; Q94219799
RX   PubMed=35292424;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS37 ! HPS1628
OI   CVCL_YS38 ! HPS1629
OI   CVCL_YS39 ! HPS1630
OI   CVCL_YS40 ! HPS1631
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   HPS1628
AC   CVCL_YS37
SY   BRCi019-B
DR   hPSCreg; BRCi019-B
DR   RCB; HPS1628
DR   Wikidata; Q94219801
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS36 ! HPS1627
OI   CVCL_YS38 ! HPS1629
OI   CVCL_YS39 ! HPS1630
OI   CVCL_YS40 ! HPS1631
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS1629
AC   CVCL_YS38
SY   BRCi019-C
DR   hPSCreg; BRCi019-C
DR   RCB; HPS1629
DR   Wikidata; Q94219803
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS36 ! HPS1627
OI   CVCL_YS37 ! HPS1628
OI   CVCL_YS39 ! HPS1630
OI   CVCL_YS40 ! HPS1631
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS1630
AC   CVCL_YS39
SY   BRCi019-D
DR   hPSCreg; BRCi019-D
DR   RCB; HPS1630
DR   Wikidata; Q94219806
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS36 ! HPS1627
OI   CVCL_YS37 ! HPS1628
OI   CVCL_YS38 ! HPS1629
OI   CVCL_YS40 ! HPS1631
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS1631
AC   CVCL_YS40
SY   BRCi019-E
DR   hPSCreg; BRCi019-E
DR   RCB; HPS1631
DR   Wikidata; Q94219809
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS36 ! HPS1627
OI   CVCL_YS37 ! HPS1628
OI   CVCL_YS38 ! HPS1629
OI   CVCL_YS39 ! HPS1630
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS1632
AC   CVCL_UN87
DR   RCB; HPS1632
DR   Wikidata; Q94219810
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3RX ! HPS1633
OI   CVCL_A3RY ! HPS1634
OI   CVCL_A3RZ ! HPS1635
OI   CVCL_A3SA ! HPS1636
OI   CVCL_A3SB ! HPS1637
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1633
AC   CVCL_A3RX
DR   RCB; HPS1633
DR   Wikidata; Q105508225
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN87 ! HPS1632
OI   CVCL_A3RY ! HPS1634
OI   CVCL_A3RZ ! HPS1635
OI   CVCL_A3SA ! HPS1636
OI   CVCL_A3SB ! HPS1637
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1634
AC   CVCL_A3RY
DR   RCB; HPS1634
DR   Wikidata; Q105508231
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN87 ! HPS1632
OI   CVCL_A3RX ! HPS1633
OI   CVCL_A3RZ ! HPS1635
OI   CVCL_A3SA ! HPS1636
OI   CVCL_A3SB ! HPS1637
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1635
AC   CVCL_A3RZ
DR   RCB; HPS1635
DR   Wikidata; Q105508235
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN87 ! HPS1632
OI   CVCL_A3RX ! HPS1633
OI   CVCL_A3RY ! HPS1634
OI   CVCL_A3SA ! HPS1636
OI   CVCL_A3SB ! HPS1637
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1636
AC   CVCL_A3SA
DR   RCB; HPS1636
DR   Wikidata; Q105508239
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN87 ! HPS1632
OI   CVCL_A3RX ! HPS1633
OI   CVCL_A3RY ! HPS1634
OI   CVCL_A3RZ ! HPS1635
OI   CVCL_A3SB ! HPS1637
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1637
AC   CVCL_A3SB
DR   RCB; HPS1637
DR   Wikidata; Q105508242
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN87 ! HPS1632
OI   CVCL_A3RX ! HPS1633
OI   CVCL_A3RY ! HPS1634
OI   CVCL_A3RZ ! HPS1635
OI   CVCL_A3SA ! HPS1636
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1638
AC   CVCL_C9RD
DR   RCB; HPS1638
DR   Wikidata; Q123031893
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RE ! HPS1639
OI   CVCL_C9RF ! HPS1640
OI   CVCL_C9RG ! HPS1641
OI   CVCL_C9RH ! HPS1642
OI   CVCL_C9RI ! HPS1643
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1639
AC   CVCL_C9RE
DR   RCB; HPS1639
DR   Wikidata; Q123031894
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RD ! HPS1638
OI   CVCL_C9RF ! HPS1640
OI   CVCL_C9RG ! HPS1641
OI   CVCL_C9RH ! HPS1642
OI   CVCL_C9RI ! HPS1643
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1640
AC   CVCL_C9RF
DR   RCB; HPS1640
DR   Wikidata; Q123031895
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RD ! HPS1638
OI   CVCL_C9RE ! HPS1639
OI   CVCL_C9RG ! HPS1641
OI   CVCL_C9RH ! HPS1642
OI   CVCL_C9RI ! HPS1643
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1641
AC   CVCL_C9RG
DR   RCB; HPS1641
DR   Wikidata; Q123031896
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RD ! HPS1638
OI   CVCL_C9RE ! HPS1639
OI   CVCL_C9RF ! HPS1640
OI   CVCL_C9RH ! HPS1642
OI   CVCL_C9RI ! HPS1643
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1642
AC   CVCL_C9RH
DR   RCB; HPS1642
DR   Wikidata; Q123031897
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RD ! HPS1638
OI   CVCL_C9RE ! HPS1639
OI   CVCL_C9RF ! HPS1640
OI   CVCL_C9RG ! HPS1641
OI   CVCL_C9RI ! HPS1643
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1643
AC   CVCL_C9RI
DR   RCB; HPS1643
DR   Wikidata; Q123031898
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RD ! HPS1638
OI   CVCL_C9RE ! HPS1639
OI   CVCL_C9RF ! HPS1640
OI   CVCL_C9RG ! HPS1641
OI   CVCL_C9RH ! HPS1642
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1644
AC   CVCL_C9RJ
DR   RCB; HPS1644
DR   Wikidata; Q123031899
CC   Donor information: Patient suffering from epilepsy with continuous spikes and waves during slow sleep of unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RK ! HPS1645
OI   CVCL_C9RL ! HPS1646
OI   CVCL_C9RM ! HPS1647
OI   CVCL_C9RN ! HPS1648
OI   CVCL_C9RP ! HPS1649
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1645
AC   CVCL_C9RK
DR   RCB; HPS1645
DR   Wikidata; Q123031900
CC   Donor information: Patient suffering from epilepsy with continuous spikes and waves during slow sleep of unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RJ ! HPS1644
OI   CVCL_C9RL ! HPS1646
OI   CVCL_C9RM ! HPS1647
OI   CVCL_C9RN ! HPS1648
OI   CVCL_C9RP ! HPS1649
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1646
AC   CVCL_C9RL
DR   RCB; HPS1646
DR   Wikidata; Q123031901
CC   Donor information: Patient suffering from epilepsy with continuous spikes and waves during slow sleep of unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RJ ! HPS1644
OI   CVCL_C9RK ! HPS1645
OI   CVCL_C9RM ! HPS1647
OI   CVCL_C9RN ! HPS1648
OI   CVCL_C9RP ! HPS1649
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1647
AC   CVCL_C9RM
DR   RCB; HPS1647
DR   Wikidata; Q123031902
CC   Donor information: Patient suffering from epilepsy with continuous spikes and waves during slow sleep of unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RJ ! HPS1644
OI   CVCL_C9RK ! HPS1645
OI   CVCL_C9RL ! HPS1646
OI   CVCL_C9RN ! HPS1648
OI   CVCL_C9RP ! HPS1649
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1648
AC   CVCL_C9RN
DR   RCB; HPS1648
DR   Wikidata; Q123031903
CC   Donor information: Patient suffering from epilepsy with continuous spikes and waves during slow sleep of unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RJ ! HPS1644
OI   CVCL_C9RK ! HPS1645
OI   CVCL_C9RL ! HPS1646
OI   CVCL_C9RM ! HPS1647
OI   CVCL_C9RP ! HPS1649
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1649
AC   CVCL_C9RP
DR   RCB; HPS1649
DR   Wikidata; Q123031904
CC   Donor information: Patient suffering from epilepsy with continuous spikes and waves during slow sleep of unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RJ ! HPS1644
OI   CVCL_C9RK ! HPS1645
OI   CVCL_C9RL ! HPS1646
OI   CVCL_C9RM ! HPS1647
OI   CVCL_C9RN ! HPS1648
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1650
AC   CVCL_C9RQ
DR   RCB; HPS1650
DR   Wikidata; Q123031905
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RR ! HPS1651
OI   CVCL_C9RS ! HPS1652
OI   CVCL_C9RT ! HPS1653
OI   CVCL_C9RU ! HPS1654
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1651
AC   CVCL_C9RR
DR   RCB; HPS1651
DR   Wikidata; Q123031906
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RQ ! HPS1650
OI   CVCL_C9RS ! HPS1652
OI   CVCL_C9RT ! HPS1653
OI   CVCL_C9RU ! HPS1654
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1652
AC   CVCL_C9RS
DR   RCB; HPS1652
DR   Wikidata; Q123031907
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RQ ! HPS1650
OI   CVCL_C9RR ! HPS1651
OI   CVCL_C9RT ! HPS1653
OI   CVCL_C9RU ! HPS1654
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1653
AC   CVCL_C9RT
DR   RCB; HPS1653
DR   Wikidata; Q123031908
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RQ ! HPS1650
OI   CVCL_C9RR ! HPS1651
OI   CVCL_C9RS ! HPS1652
OI   CVCL_C9RU ! HPS1654
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1654
AC   CVCL_C9RU
DR   RCB; HPS1654
DR   Wikidata; Q123031910
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RQ ! HPS1650
OI   CVCL_C9RR ! HPS1651
OI   CVCL_C9RS ! HPS1652
OI   CVCL_C9RT ! HPS1653
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1655
AC   CVCL_C9RV
DR   RCB; HPS1655
DR   Wikidata; Q123031911
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1655).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RW ! HPS1656
OI   CVCL_C9RX ! HPS1657
OI   CVCL_C9RY ! HPS1658
OI   CVCL_C9RZ ! HPS1659
OI   CVCL_C9S0 ! HPS1660
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1656
AC   CVCL_C9RW
DR   RCB; HPS1656
DR   Wikidata; Q123031912
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1656).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RV ! HPS1655
OI   CVCL_C9RX ! HPS1657
OI   CVCL_C9RY ! HPS1658
OI   CVCL_C9RZ ! HPS1659
OI   CVCL_C9S0 ! HPS1660
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1657
AC   CVCL_C9RX
DR   RCB; HPS1657
DR   Wikidata; Q123031913
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1657).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RV ! HPS1655
OI   CVCL_C9RW ! HPS1656
OI   CVCL_C9RY ! HPS1658
OI   CVCL_C9RZ ! HPS1659
OI   CVCL_C9S0 ! HPS1660
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1658
AC   CVCL_C9RY
DR   RCB; HPS1658
DR   Wikidata; Q123031914
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1658).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RV ! HPS1655
OI   CVCL_C9RW ! HPS1656
OI   CVCL_C9RX ! HPS1657
OI   CVCL_C9RZ ! HPS1659
OI   CVCL_C9S0 ! HPS1660
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1659
AC   CVCL_C9RZ
DR   RCB; HPS1659
DR   Wikidata; Q123031915
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1659).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RV ! HPS1655
OI   CVCL_C9RW ! HPS1656
OI   CVCL_C9RX ! HPS1657
OI   CVCL_C9RY ! HPS1658
OI   CVCL_C9S0 ! HPS1660
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1660
AC   CVCL_C9S0
DR   RCB; HPS1660
DR   Wikidata; Q123031916
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1660).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9RV ! HPS1655
OI   CVCL_C9RW ! HPS1656
OI   CVCL_C9RX ! HPS1657
OI   CVCL_C9RY ! HPS1658
OI   CVCL_C9RZ ! HPS1659
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1661
AC   CVCL_C9S1
DR   RCB; HPS1661
DR   Wikidata; Q123031917
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3391; Sturge-Weber syndrome
DI   ORDO; Orphanet_3205; Sturge-Weber syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S2 ! HPS1662
OI   CVCL_C9S3 ! HPS1663
OI   CVCL_C9S4 ! HPS1664
OI   CVCL_C9S5 ! HPS1665
OI   CVCL_C9S6 ! HPS1666
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1662
AC   CVCL_C9S2
DR   RCB; HPS1662
DR   Wikidata; Q123031918
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3391; Sturge-Weber syndrome
DI   ORDO; Orphanet_3205; Sturge-Weber syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S1 ! HPS1661
OI   CVCL_C9S3 ! HPS1663
OI   CVCL_C9S4 ! HPS1664
OI   CVCL_C9S5 ! HPS1665
OI   CVCL_C9S6 ! HPS1666
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1663
AC   CVCL_C9S3
DR   RCB; HPS1663
DR   Wikidata; Q123031919
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3391; Sturge-Weber syndrome
DI   ORDO; Orphanet_3205; Sturge-Weber syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S1 ! HPS1661
OI   CVCL_C9S2 ! HPS1662
OI   CVCL_C9S4 ! HPS1664
OI   CVCL_C9S5 ! HPS1665
OI   CVCL_C9S6 ! HPS1666
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1664
AC   CVCL_C9S4
DR   RCB; HPS1664
DR   Wikidata; Q123031920
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3391; Sturge-Weber syndrome
DI   ORDO; Orphanet_3205; Sturge-Weber syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S1 ! HPS1661
OI   CVCL_C9S2 ! HPS1662
OI   CVCL_C9S3 ! HPS1663
OI   CVCL_C9S5 ! HPS1665
OI   CVCL_C9S6 ! HPS1666
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1665
AC   CVCL_C9S5
DR   RCB; HPS1665
DR   Wikidata; Q123031921
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3391; Sturge-Weber syndrome
DI   ORDO; Orphanet_3205; Sturge-Weber syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S1 ! HPS1661
OI   CVCL_C9S2 ! HPS1662
OI   CVCL_C9S3 ! HPS1663
OI   CVCL_C9S4 ! HPS1664
OI   CVCL_C9S6 ! HPS1666
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1666
AC   CVCL_C9S6
DR   RCB; HPS1666
DR   Wikidata; Q123031922
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3391; Sturge-Weber syndrome
DI   ORDO; Orphanet_3205; Sturge-Weber syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S1 ! HPS1661
OI   CVCL_C9S2 ! HPS1662
OI   CVCL_C9S3 ! HPS1663
OI   CVCL_C9S4 ! HPS1664
OI   CVCL_C9S5 ! HPS1665
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1667
AC   CVCL_C9S7
DR   RCB; HPS1667
DR   Wikidata; Q123031923
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S8 ! HPS1668
OI   CVCL_C9S9 ! HPS1669
OI   CVCL_C9SA ! HPS1670
OI   CVCL_C9SB ! HPS1671
OI   CVCL_C9SC ! HPS1672
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1668
AC   CVCL_C9S8
DR   RCB; HPS1668
DR   Wikidata; Q123031925
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S7 ! HPS1667
OI   CVCL_C9S9 ! HPS1669
OI   CVCL_C9SA ! HPS1670
OI   CVCL_C9SB ! HPS1671
OI   CVCL_C9SC ! HPS1672
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1669
AC   CVCL_C9S9
DR   RCB; HPS1669
DR   Wikidata; Q123031926
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S7 ! HPS1667
OI   CVCL_C9S8 ! HPS1668
OI   CVCL_C9SA ! HPS1670
OI   CVCL_C9SB ! HPS1671
OI   CVCL_C9SC ! HPS1672
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1670
AC   CVCL_C9SA
DR   RCB; HPS1670
DR   Wikidata; Q123031927
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S7 ! HPS1667
OI   CVCL_C9S8 ! HPS1668
OI   CVCL_C9S9 ! HPS1669
OI   CVCL_C9SB ! HPS1671
OI   CVCL_C9SC ! HPS1672
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1671
AC   CVCL_C9SB
DR   RCB; HPS1671
DR   Wikidata; Q123031928
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S7 ! HPS1667
OI   CVCL_C9S8 ! HPS1668
OI   CVCL_C9S9 ! HPS1669
OI   CVCL_C9SA ! HPS1670
OI   CVCL_C9SC ! HPS1672
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1672
AC   CVCL_C9SC
DR   RCB; HPS1672
DR   Wikidata; Q123031929
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9S7 ! HPS1667
OI   CVCL_C9S8 ! HPS1668
OI   CVCL_C9S9 ! HPS1669
OI   CVCL_C9SA ! HPS1670
OI   CVCL_C9SB ! HPS1671
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1673
AC   CVCL_C9SD
DR   RCB; HPS1673
DR   Wikidata; Q123031930
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1673).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SE ! HPS1674
OI   CVCL_C9SF ! HPS1675
OI   CVCL_C9SG ! HPS1676
OI   CVCL_C9SH ! HPS1677
OI   CVCL_C9SI ! HPS1678
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1674
AC   CVCL_C9SE
DR   RCB; HPS1674
DR   Wikidata; Q123031931
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1674).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SD ! HPS1673
OI   CVCL_C9SF ! HPS1675
OI   CVCL_C9SG ! HPS1676
OI   CVCL_C9SH ! HPS1677
OI   CVCL_C9SI ! HPS1678
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1675
AC   CVCL_C9SF
DR   RCB; HPS1675
DR   Wikidata; Q123031932
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1675).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SD ! HPS1673
OI   CVCL_C9SE ! HPS1674
OI   CVCL_C9SG ! HPS1676
OI   CVCL_C9SH ! HPS1677
OI   CVCL_C9SI ! HPS1678
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1676
AC   CVCL_C9SG
DR   RCB; HPS1676
DR   Wikidata; Q123031933
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1676).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SD ! HPS1673
OI   CVCL_C9SE ! HPS1674
OI   CVCL_C9SF ! HPS1675
OI   CVCL_C9SH ! HPS1677
OI   CVCL_C9SI ! HPS1678
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1677
AC   CVCL_C9SH
DR   RCB; HPS1677
DR   Wikidata; Q123031934
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1677).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SD ! HPS1673
OI   CVCL_C9SE ! HPS1674
OI   CVCL_C9SF ! HPS1675
OI   CVCL_C9SG ! HPS1676
OI   CVCL_C9SI ! HPS1678
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1678
AC   CVCL_C9SI
DR   RCB; HPS1678
DR   Wikidata; Q123031935
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1678).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SD ! HPS1673
OI   CVCL_C9SE ! HPS1674
OI   CVCL_C9SF ! HPS1675
OI   CVCL_C9SG ! HPS1676
OI   CVCL_C9SH ! HPS1677
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1679
AC   CVCL_UN88
DR   RCB; HPS1679
DR   Wikidata; Q94219812
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3SC ! HPS1680
OI   CVCL_A3SD ! HPS1681
OI   CVCL_A3SE ! HPS1682
OI   CVCL_A3SF ! HPS1683
OI   CVCL_A3SG ! HPS1684
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1680
AC   CVCL_A3SC
DR   RCB; HPS1680
DR   Wikidata; Q105508246
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN88 ! HPS1679
OI   CVCL_A3SD ! HPS1681
OI   CVCL_A3SE ! HPS1682
OI   CVCL_A3SF ! HPS1683
OI   CVCL_A3SG ! HPS1684
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1681
AC   CVCL_A3SD
DR   RCB; HPS1681
DR   Wikidata; Q105508250
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN88 ! HPS1679
OI   CVCL_A3SC ! HPS1680
OI   CVCL_A3SE ! HPS1682
OI   CVCL_A3SF ! HPS1683
OI   CVCL_A3SG ! HPS1684
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1682
AC   CVCL_A3SE
DR   RCB; HPS1682
DR   Wikidata; Q105508253
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN88 ! HPS1679
OI   CVCL_A3SC ! HPS1680
OI   CVCL_A3SD ! HPS1681
OI   CVCL_A3SF ! HPS1683
OI   CVCL_A3SG ! HPS1684
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1683
AC   CVCL_A3SF
DR   RCB; HPS1683
DR   Wikidata; Q105508256
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN88 ! HPS1679
OI   CVCL_A3SC ! HPS1680
OI   CVCL_A3SD ! HPS1681
OI   CVCL_A3SE ! HPS1682
OI   CVCL_A3SG ! HPS1684
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1684
AC   CVCL_A3SG
DR   RCB; HPS1684
DR   Wikidata; Q105508260
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN88 ! HPS1679
OI   CVCL_A3SC ! HPS1680
OI   CVCL_A3SD ! HPS1681
OI   CVCL_A3SE ! HPS1682
OI   CVCL_A3SF ! HPS1683
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1685
AC   CVCL_C9SJ
DR   RCB; HPS1685
DR   Wikidata; Q123031936
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SK ! HPS1686
OI   CVCL_C9SL ! HPS1687
OI   CVCL_C9SM ! HPS1688
OI   CVCL_C9SN ! HPS1689
OI   CVCL_C9SP ! HPS1690
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1686
AC   CVCL_C9SK
DR   RCB; HPS1686
DR   Wikidata; Q123031937
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SJ ! HPS1685
OI   CVCL_C9SL ! HPS1687
OI   CVCL_C9SM ! HPS1688
OI   CVCL_C9SN ! HPS1689
OI   CVCL_C9SP ! HPS1690
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1687
AC   CVCL_C9SL
DR   RCB; HPS1687
DR   Wikidata; Q123031938
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SJ ! HPS1685
OI   CVCL_C9SK ! HPS1686
OI   CVCL_C9SM ! HPS1688
OI   CVCL_C9SN ! HPS1689
OI   CVCL_C9SP ! HPS1690
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1688
AC   CVCL_C9SM
DR   RCB; HPS1688
DR   Wikidata; Q123031939
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SJ ! HPS1685
OI   CVCL_C9SK ! HPS1686
OI   CVCL_C9SL ! HPS1687
OI   CVCL_C9SN ! HPS1689
OI   CVCL_C9SP ! HPS1690
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1689
AC   CVCL_C9SN
DR   RCB; HPS1689
DR   Wikidata; Q123031940
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SJ ! HPS1685
OI   CVCL_C9SK ! HPS1686
OI   CVCL_C9SL ! HPS1687
OI   CVCL_C9SM ! HPS1688
OI   CVCL_C9SP ! HPS1690
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1690
AC   CVCL_C9SP
DR   RCB; HPS1690
DR   Wikidata; Q123031941
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SJ ! HPS1685
OI   CVCL_C9SK ! HPS1686
OI   CVCL_C9SL ! HPS1687
OI   CVCL_C9SM ! HPS1688
OI   CVCL_C9SN ! HPS1689
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1691
AC   CVCL_C9SQ
DR   RCB; HPS1691
DR   Wikidata; Q123031942
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SR ! HPS1692
OI   CVCL_C9SS ! HPS1693
OI   CVCL_C9ST ! HPS1694
OI   CVCL_C9SU ! HPS1695
OI   CVCL_C9SV ! HPS1696
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1692
AC   CVCL_C9SR
DR   RCB; HPS1692
DR   Wikidata; Q123031943
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SQ ! HPS1691
OI   CVCL_C9SS ! HPS1693
OI   CVCL_C9ST ! HPS1694
OI   CVCL_C9SU ! HPS1695
OI   CVCL_C9SV ! HPS1696
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1693
AC   CVCL_C9SS
DR   RCB; HPS1693
DR   Wikidata; Q123031944
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SQ ! HPS1691
OI   CVCL_C9SR ! HPS1692
OI   CVCL_C9ST ! HPS1694
OI   CVCL_C9SU ! HPS1695
OI   CVCL_C9SV ! HPS1696
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1694
AC   CVCL_C9ST
DR   RCB; HPS1694
DR   Wikidata; Q123031945
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SQ ! HPS1691
OI   CVCL_C9SR ! HPS1692
OI   CVCL_C9SS ! HPS1693
OI   CVCL_C9SU ! HPS1695
OI   CVCL_C9SV ! HPS1696
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1695
AC   CVCL_C9SU
DR   RCB; HPS1695
DR   Wikidata; Q123031946
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SQ ! HPS1691
OI   CVCL_C9SR ! HPS1692
OI   CVCL_C9SS ! HPS1693
OI   CVCL_C9ST ! HPS1694
OI   CVCL_C9SV ! HPS1696
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1696
AC   CVCL_C9SV
DR   RCB; HPS1696
DR   Wikidata; Q123031947
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9SQ ! HPS1691
OI   CVCL_C9SR ! HPS1692
OI   CVCL_C9SS ! HPS1693
OI   CVCL_C9ST ! HPS1694
OI   CVCL_C9SU ! HPS1695
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1703
AC   CVCL_YR53
DR   RCB; HPS1703
DR   Wikidata; Q94219816
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR52 ! HPS1051
OI   CVCL_YR54 ! HPS1704
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1704
AC   CVCL_YR54
DR   RCB; HPS1704
DR   Wikidata; Q94219822
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR52 ! HPS1051
OI   CVCL_YR53 ! HPS1703
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1705
AC   CVCL_A1SX
DR   RCB; HPS1705
DR   Wikidata; Q105508265
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:10947; SLC20A2; Simple; p.Trp616Ter (c.1848G>A); ClinVar=VCV003704396; Zygosity=Heterozygous (from autologous cell line CIRAi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX86 ! CIRAi003-A
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   HPS1706
AC   CVCL_A3GS
DR   RCB; HPS1706
DR   Wikidata; Q105508269
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GT ! HPS1707
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1707
AC   CVCL_A3GT
DR   RCB; HPS1707
DR   Wikidata; Q105508273
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GS ! HPS1706
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1708
AC   CVCL_A1SZ
DR   RCB; HPS1708
DR   Wikidata; Q105508275
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1SY ! HPS1037
OI   CVCL_A1TA ! HPS1709
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1709
AC   CVCL_A1TA
DR   RCB; HPS1709
DR   Wikidata; Q105508283
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1SY ! HPS1037
OI   CVCL_A1SZ ! HPS1708
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1710
AC   CVCL_A1TC
DR   RCB; HPS1710
DR   Wikidata; Q105508286
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1TB ! HPS1038
OI   CVCL_A1TD ! HPS1711
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1711
AC   CVCL_A1TD
DR   RCB; HPS1711
DR   Wikidata; Q105508291
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1TB ! HPS1038
OI   CVCL_A1TC ! HPS1710
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1718
AC   CVCL_YR50
DR   RCB; HPS1718
DR   Wikidata; Q94219824
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR47 ! HPS1049
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS1725
AC   CVCL_VM81
DR   RCB; HPS1725
DR   Wikidata; Q94219828
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   HPS1728
AC   CVCL_VM82
DR   RCB; HPS1728
DR   Wikidata; Q94219833
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GV ! HPS1729
OI   CVCL_A3GW ! HPS1730
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS1729
AC   CVCL_A3GV
DR   RCB; HPS1729
DR   Wikidata; Q105508295
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM82 ! HPS1728
OI   CVCL_A3GW ! HPS1730
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1730
AC   CVCL_A3GW
DR   RCB; HPS1730
DR   Wikidata; Q105508299
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM82 ! HPS1728
OI   CVCL_A3GV ! HPS1729
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1749
AC   CVCL_C6B3
DR   RCB; HPS1749
DR   Wikidata; Q116049425
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6AX ! HPS0718
OI   CVCL_C6AY ! HPS0719
OI   CVCL_C6AZ ! HPS0720
OI   CVCL_C6B0 ! HPS0721
OI   CVCL_C6B1 ! HPS0722
OI   CVCL_C6B2 ! HPS0723
OI   CVCL_A3FG ! HPS1044
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS1756
AC   CVCL_A3TC
DR   RCB; HPS1756
DR   Wikidata; Q105508302
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP96 ! HPS1072
SX   Male
AG   90-99Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1772
AC   CVCL_A3UL
DR   RCB; HPS1772
DR   Wikidata; Q105508305
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171269; Spinocerebellar ataxia type 42
DI   ORDO; Orphanet_458803; Spinocerebellar ataxia type 42
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN59 ! HPS1074
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1776
AC   CVCL_UN90
DR   RCB; HPS1776
DR   Wikidata; Q94219838
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7459; MT-ND4; Simple; p.Arg340His (m.11778G>A); ClinVar=VCV000009708; Zygosity=Unspecified (RCB=HPS1776).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   HPS1898
AC   CVCL_A3VC
DR   RCB; HPS1898
DR   Wikidata; Q105508308
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176901; Spinocerebellar ataxia type 31
DI   ORDO; Orphanet_217012; Spinocerebellar ataxia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GU ! HPS1899
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1899
AC   CVCL_A3GU
DR   RCB; HPS1899
DR   Wikidata; Q105508312
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176901; Spinocerebellar ataxia type 31
DI   ORDO; Orphanet_217012; Spinocerebellar ataxia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3VC ! HPS1898
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1900
AC   CVCL_UN91
DR   RCB; HPS1900
DR   Wikidata; Q94219840
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS1906
AC   CVCL_UN92
DR   RCB; HPS1906
DR   Wikidata; Q94219845
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MB ! HPS1907
OI   CVCL_A3MC ! HPS1908
OI   CVCL_A3MD ! HPS1909
OI   CVCL_A3ME ! HPS1910
OI   CVCL_A3MF ! HPS1911
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1907
AC   CVCL_A3MB
DR   RCB; HPS1907
DR   Wikidata; Q105508315
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN92 ! HPS1906
OI   CVCL_A3MC ! HPS1908
OI   CVCL_A3MD ! HPS1909
OI   CVCL_A3ME ! HPS1910
OI   CVCL_A3MF ! HPS1911
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1908
AC   CVCL_A3MC
DR   RCB; HPS1908
DR   Wikidata; Q105508318
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN92 ! HPS1906
OI   CVCL_A3MB ! HPS1907
OI   CVCL_A3MD ! HPS1909
OI   CVCL_A3ME ! HPS1910
OI   CVCL_A3MF ! HPS1911
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1909
AC   CVCL_A3MD
DR   RCB; HPS1909
DR   Wikidata; Q105508321
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN92 ! HPS1906
OI   CVCL_A3MB ! HPS1907
OI   CVCL_A3MC ! HPS1908
OI   CVCL_A3ME ! HPS1910
OI   CVCL_A3MF ! HPS1911
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1910
AC   CVCL_A3ME
DR   RCB; HPS1910
DR   Wikidata; Q105508325
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN92 ! HPS1906
OI   CVCL_A3MB ! HPS1907
OI   CVCL_A3MC ! HPS1908
OI   CVCL_A3MD ! HPS1909
OI   CVCL_A3MF ! HPS1911
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1911
AC   CVCL_A3MF
DR   RCB; HPS1911
DR   Wikidata; Q105508330
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN92 ! HPS1906
OI   CVCL_A3MB ! HPS1907
OI   CVCL_A3MC ! HPS1908
OI   CVCL_A3MD ! HPS1909
OI   CVCL_A3ME ! HPS1910
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1912
AC   CVCL_C9Q0
DR   RCB; HPS1912
DR   Wikidata; Q123031948
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q1 ! HPS1913
OI   CVCL_C9Q2 ! HPS1914
OI   CVCL_C9Q3 ! HPS1915
OI   CVCL_C9Q4 ! HPS1916
OI   CVCL_C9Q5 ! HPS1917
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1913
AC   CVCL_C9Q1
DR   RCB; HPS1913
DR   Wikidata; Q123031949
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q0 ! HPS1912
OI   CVCL_C9Q2 ! HPS1914
OI   CVCL_C9Q3 ! HPS1915
OI   CVCL_C9Q4 ! HPS1916
OI   CVCL_C9Q5 ! HPS1917
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1914
AC   CVCL_C9Q2
DR   RCB; HPS1914
DR   Wikidata; Q123031951
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q0 ! HPS1912
OI   CVCL_C9Q1 ! HPS1913
OI   CVCL_C9Q3 ! HPS1915
OI   CVCL_C9Q4 ! HPS1916
OI   CVCL_C9Q5 ! HPS1917
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1915
AC   CVCL_C9Q3
DR   RCB; HPS1915
DR   Wikidata; Q123031952
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q0 ! HPS1912
OI   CVCL_C9Q1 ! HPS1913
OI   CVCL_C9Q2 ! HPS1914
OI   CVCL_C9Q4 ! HPS1916
OI   CVCL_C9Q5 ! HPS1917
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1916
AC   CVCL_C9Q4
DR   RCB; HPS1916
DR   Wikidata; Q123031953
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q0 ! HPS1912
OI   CVCL_C9Q1 ! HPS1913
OI   CVCL_C9Q2 ! HPS1914
OI   CVCL_C9Q3 ! HPS1915
OI   CVCL_C9Q5 ! HPS1917
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1917
AC   CVCL_C9Q5
DR   RCB; HPS1917
DR   Wikidata; Q123031954
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74983; 1p36 deletion syndrome
DI   ORDO; Orphanet_1606; 1p36 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q0 ! HPS1912
OI   CVCL_C9Q1 ! HPS1913
OI   CVCL_C9Q2 ! HPS1914
OI   CVCL_C9Q3 ! HPS1915
OI   CVCL_C9Q4 ! HPS1916
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1918
AC   CVCL_D1AK
DR   RCB; HPS1918
DR   Wikidata; Q123031955
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AL ! HPS1919
OI   CVCL_D1AM ! HPS1920
OI   CVCL_D1AN ! HPS1921
OI   CVCL_D1AP ! HPS1922
OI   CVCL_D1AQ ! HPS1923
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1919
AC   CVCL_D1AL
DR   RCB; HPS1919
DR   Wikidata; Q123031957
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AK ! HPS1918
OI   CVCL_D1AM ! HPS1920
OI   CVCL_D1AN ! HPS1921
OI   CVCL_D1AP ! HPS1922
OI   CVCL_D1AQ ! HPS1923
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1920
AC   CVCL_D1AM
DR   RCB; HPS1920
DR   Wikidata; Q123031958
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AK ! HPS1918
OI   CVCL_D1AL ! HPS1919
OI   CVCL_D1AN ! HPS1921
OI   CVCL_D1AP ! HPS1922
OI   CVCL_D1AQ ! HPS1923
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1921
AC   CVCL_D1AN
DR   RCB; HPS1921
DR   Wikidata; Q123031959
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AK ! HPS1918
OI   CVCL_D1AL ! HPS1919
OI   CVCL_D1AM ! HPS1920
OI   CVCL_D1AP ! HPS1922
OI   CVCL_D1AQ ! HPS1923
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1922
AC   CVCL_D1AP
DR   RCB; HPS1922
DR   Wikidata; Q123031960
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AK ! HPS1918
OI   CVCL_D1AL ! HPS1919
OI   CVCL_D1AM ! HPS1920
OI   CVCL_D1AN ! HPS1921
OI   CVCL_D1AQ ! HPS1923
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1923
AC   CVCL_D1AQ
DR   RCB; HPS1923
DR   Wikidata; Q123031961
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AK ! HPS1918
OI   CVCL_D1AL ! HPS1919
OI   CVCL_D1AM ! HPS1920
OI   CVCL_D1AN ! HPS1921
OI   CVCL_D1AP ! HPS1922
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1924
AC   CVCL_C9Q6
DR   RCB; HPS1924
DR   Wikidata; Q123031962
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202017; Acute encephalopathy with biphasic seizures and late reduced diffusion
DI   ORDO; Orphanet_363549; Acute encephalopathy with biphasic seizures and late reduced diffusion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q7 ! HPS1925
OI   CVCL_C9Q8 ! HPS1926
OI   CVCL_C9Q9 ! HPS1927
OI   CVCL_C9QA ! HPS1928
OI   CVCL_C9QB ! HPS1929
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1925
AC   CVCL_C9Q7
DR   RCB; HPS1925
DR   Wikidata; Q123031963
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202017; Acute encephalopathy with biphasic seizures and late reduced diffusion
DI   ORDO; Orphanet_363549; Acute encephalopathy with biphasic seizures and late reduced diffusion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q6 ! HPS1924
OI   CVCL_C9Q8 ! HPS1926
OI   CVCL_C9Q9 ! HPS1927
OI   CVCL_C9QA ! HPS1928
OI   CVCL_C9QB ! HPS1929
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1926
AC   CVCL_C9Q8
DR   RCB; HPS1926
DR   Wikidata; Q123031964
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202017; Acute encephalopathy with biphasic seizures and late reduced diffusion
DI   ORDO; Orphanet_363549; Acute encephalopathy with biphasic seizures and late reduced diffusion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q6 ! HPS1924
OI   CVCL_C9Q7 ! HPS1925
OI   CVCL_C9Q9 ! HPS1927
OI   CVCL_C9QA ! HPS1928
OI   CVCL_C9QB ! HPS1929
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1927
AC   CVCL_C9Q9
DR   RCB; HPS1927
DR   Wikidata; Q123031965
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202017; Acute encephalopathy with biphasic seizures and late reduced diffusion
DI   ORDO; Orphanet_363549; Acute encephalopathy with biphasic seizures and late reduced diffusion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q6 ! HPS1924
OI   CVCL_C9Q7 ! HPS1925
OI   CVCL_C9Q8 ! HPS1926
OI   CVCL_C9QA ! HPS1928
OI   CVCL_C9QB ! HPS1929
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1928
AC   CVCL_C9QA
DR   RCB; HPS1928
DR   Wikidata; Q123031966
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202017; Acute encephalopathy with biphasic seizures and late reduced diffusion
DI   ORDO; Orphanet_363549; Acute encephalopathy with biphasic seizures and late reduced diffusion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q6 ! HPS1924
OI   CVCL_C9Q7 ! HPS1925
OI   CVCL_C9Q8 ! HPS1926
OI   CVCL_C9Q9 ! HPS1927
OI   CVCL_C9QB ! HPS1929
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1929
AC   CVCL_C9QB
DR   RCB; HPS1929
DR   Wikidata; Q123031967
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202017; Acute encephalopathy with biphasic seizures and late reduced diffusion
DI   ORDO; Orphanet_363549; Acute encephalopathy with biphasic seizures and late reduced diffusion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Q6 ! HPS1924
OI   CVCL_C9Q7 ! HPS1925
OI   CVCL_C9Q8 ! HPS1926
OI   CVCL_C9Q9 ! HPS1927
OI   CVCL_C9QA ! HPS1928
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1930
AC   CVCL_C6BT
DR   RCB; HPS1930
DR   Wikidata; Q116049426
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165674; Myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BU ! HPS1931
OI   CVCL_C6BV ! HPS1932
OI   CVCL_C6BW ! HPS1933
OI   CVCL_C6BX ! HPS1934
OI   CVCL_C6BY ! HPS1935
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HPS1931
AC   CVCL_C6BU
DR   RCB; HPS1931
DR   Wikidata; Q116049427
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165674; Myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BT ! HPS1930
OI   CVCL_C6BV ! HPS1932
OI   CVCL_C6BW ! HPS1933
OI   CVCL_C6BX ! HPS1934
OI   CVCL_C6BY ! HPS1935
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HPS1932
AC   CVCL_C6BV
DR   RCB; HPS1932
DR   Wikidata; Q116049428
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165674; Myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BT ! HPS1930
OI   CVCL_C6BU ! HPS1931
OI   CVCL_C6BW ! HPS1933
OI   CVCL_C6BX ! HPS1934
OI   CVCL_C6BY ! HPS1935
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HPS1933
AC   CVCL_C6BW
DR   RCB; HPS1933
DR   Wikidata; Q116049429
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165674; Myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BT ! HPS1930
OI   CVCL_C6BU ! HPS1931
OI   CVCL_C6BV ! HPS1932
OI   CVCL_C6BX ! HPS1934
OI   CVCL_C6BY ! HPS1935
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HPS1934
AC   CVCL_C6BX
DR   RCB; HPS1934
DR   Wikidata; Q116049430
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165674; Myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BT ! HPS1930
OI   CVCL_C6BU ! HPS1931
OI   CVCL_C6BV ! HPS1932
OI   CVCL_C6BW ! HPS1933
OI   CVCL_C6BY ! HPS1935
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HPS1935
AC   CVCL_C6BY
DR   RCB; HPS1935
DR   Wikidata; Q116049431
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165674; Myoclonic-atonic epilepsy
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BT ! HPS1930
OI   CVCL_C6BU ! HPS1931
OI   CVCL_C6BV ! HPS1932
OI   CVCL_C6BW ! HPS1933
OI   CVCL_C6BX ! HPS1934
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   HPS1936
AC   CVCL_UN93
DR   RCB; HPS1936
DR   Wikidata; Q94219851
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3VD ! HPS1937
OI   CVCL_A3VE ! HPS1938
OI   CVCL_A3VF ! HPS1939
OI   CVCL_A3VG ! HPS1940
OI   CVCL_A3VH ! HPS1941
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1937
AC   CVCL_A3VD
DR   RCB; HPS1937
DR   Wikidata; Q105508333
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN93 ! HPS1936
OI   CVCL_A3VE ! HPS1938
OI   CVCL_A3VF ! HPS1939
OI   CVCL_A3VG ! HPS1940
OI   CVCL_A3VH ! HPS1941
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1938
AC   CVCL_A3VE
DR   RCB; HPS1938
DR   Wikidata; Q105508338
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN93 ! HPS1936
OI   CVCL_A3VD ! HPS1937
OI   CVCL_A3VF ! HPS1939
OI   CVCL_A3VG ! HPS1940
OI   CVCL_A3VH ! HPS1941
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1939
AC   CVCL_A3VF
DR   RCB; HPS1939
DR   Wikidata; Q105508342
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN93 ! HPS1936
OI   CVCL_A3VD ! HPS1937
OI   CVCL_A3VE ! HPS1938
OI   CVCL_A3VG ! HPS1940
OI   CVCL_A3VH ! HPS1941
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1940
AC   CVCL_A3VG
DR   RCB; HPS1940
DR   Wikidata; Q105508346
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN93 ! HPS1936
OI   CVCL_A3VD ! HPS1937
OI   CVCL_A3VE ! HPS1938
OI   CVCL_A3VF ! HPS1939
OI   CVCL_A3VH ! HPS1941
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1941
AC   CVCL_A3VH
DR   RCB; HPS1941
DR   Wikidata; Q105508352
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129928; Galactosialidosis
DI   ORDO; Orphanet_351; Galactosialidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN93 ! HPS1936
OI   CVCL_A3VD ! HPS1937
OI   CVCL_A3VE ! HPS1938
OI   CVCL_A3VF ! HPS1939
OI   CVCL_A3VG ! HPS1940
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1942
AC   CVCL_C9QC
DR   RCB; HPS1942
DR   Wikidata; Q123031968
CC   Sequence variation: Mutation; HGNC; HGNC:10808; SGCE; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1942).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201596; Dystonia 11, myoclonic
DI   ORDO; Orphanet_36899; Myoclonus-dystonia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QD ! HPS1943
OI   CVCL_C9QE ! HPS1944
OI   CVCL_C9QF ! HPS1945
OI   CVCL_C9QG ! HPS1946
OI   CVCL_C9QH ! HPS1947
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1943
AC   CVCL_C9QD
DR   RCB; HPS1943
DR   Wikidata; Q123031969
CC   Sequence variation: Mutation; HGNC; HGNC:10808; SGCE; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1943).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201596; Dystonia 11, myoclonic
DI   ORDO; Orphanet_36899; Myoclonus-dystonia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QC ! HPS1942
OI   CVCL_C9QE ! HPS1944
OI   CVCL_C9QF ! HPS1945
OI   CVCL_C9QG ! HPS1946
OI   CVCL_C9QH ! HPS1947
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1944
AC   CVCL_C9QE
DR   RCB; HPS1944
DR   Wikidata; Q123031970
CC   Sequence variation: Mutation; HGNC; HGNC:10808; SGCE; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1944).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201596; Dystonia 11, myoclonic
DI   ORDO; Orphanet_36899; Myoclonus-dystonia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QC ! HPS1942
OI   CVCL_C9QD ! HPS1943
OI   CVCL_C9QF ! HPS1945
OI   CVCL_C9QG ! HPS1946
OI   CVCL_C9QH ! HPS1947
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1945
AC   CVCL_C9QF
DR   RCB; HPS1945
DR   Wikidata; Q123031971
CC   Sequence variation: Mutation; HGNC; HGNC:10808; SGCE; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1945).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201596; Dystonia 11, myoclonic
DI   ORDO; Orphanet_36899; Myoclonus-dystonia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QC ! HPS1942
OI   CVCL_C9QD ! HPS1943
OI   CVCL_C9QE ! HPS1944
OI   CVCL_C9QG ! HPS1946
OI   CVCL_C9QH ! HPS1947
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1946
AC   CVCL_C9QG
DR   RCB; HPS1946
DR   Wikidata; Q123031972
CC   Sequence variation: Mutation; HGNC; HGNC:10808; SGCE; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1946).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201596; Dystonia 11, myoclonic
DI   ORDO; Orphanet_36899; Myoclonus-dystonia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QC ! HPS1942
OI   CVCL_C9QD ! HPS1943
OI   CVCL_C9QE ! HPS1944
OI   CVCL_C9QF ! HPS1945
OI   CVCL_C9QH ! HPS1947
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1947
AC   CVCL_C9QH
DR   RCB; HPS1947
DR   Wikidata; Q123031973
CC   Sequence variation: Mutation; HGNC; HGNC:10808; SGCE; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS1947).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201596; Dystonia 11, myoclonic
DI   ORDO; Orphanet_36899; Myoclonus-dystonia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QC ! HPS1942
OI   CVCL_C9QD ! HPS1943
OI   CVCL_C9QE ! HPS1944
OI   CVCL_C9QF ! HPS1945
OI   CVCL_C9QG ! HPS1946
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS1948
AC   CVCL_C9QI
DR   RCB; HPS1948
DR   Wikidata; Q123031974
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202071; Ossification of the ligamentum flavum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QJ ! HPS1949
OI   CVCL_C9QK ! HPS1950
OI   CVCL_C9QL ! HPS1951
OI   CVCL_C9QM ! HPS1952
OI   CVCL_C9QN ! HPS1953
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1949
AC   CVCL_C9QJ
DR   RCB; HPS1949
DR   Wikidata; Q123031975
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202071; Ossification of the ligamentum flavum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QI ! HPS1948
OI   CVCL_C9QK ! HPS1950
OI   CVCL_C9QL ! HPS1951
OI   CVCL_C9QM ! HPS1952
OI   CVCL_C9QN ! HPS1953
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1950
AC   CVCL_C9QK
DR   RCB; HPS1950
DR   Wikidata; Q123031976
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202071; Ossification of the ligamentum flavum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QI ! HPS1948
OI   CVCL_C9QJ ! HPS1949
OI   CVCL_C9QL ! HPS1951
OI   CVCL_C9QM ! HPS1952
OI   CVCL_C9QN ! HPS1953
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1951
AC   CVCL_C9QL
DR   RCB; HPS1951
DR   Wikidata; Q123031977
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202071; Ossification of the ligamentum flavum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QI ! HPS1948
OI   CVCL_C9QJ ! HPS1949
OI   CVCL_C9QK ! HPS1950
OI   CVCL_C9QM ! HPS1952
OI   CVCL_C9QN ! HPS1953
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1952
AC   CVCL_C9QM
DR   RCB; HPS1952
DR   Wikidata; Q123031978
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202071; Ossification of the ligamentum flavum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QI ! HPS1948
OI   CVCL_C9QJ ! HPS1949
OI   CVCL_C9QK ! HPS1950
OI   CVCL_C9QL ! HPS1951
OI   CVCL_C9QN ! HPS1953
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1953
AC   CVCL_C9QN
DR   RCB; HPS1953
DR   Wikidata; Q123031979
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202071; Ossification of the ligamentum flavum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QI ! HPS1948
OI   CVCL_C9QJ ! HPS1949
OI   CVCL_C9QK ! HPS1950
OI   CVCL_C9QL ! HPS1951
OI   CVCL_C9QM ! HPS1952
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1966
AC   CVCL_C9QP
DR   RCB; HPS1966
DR   Wikidata; Q123031981
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78797; Thrombotic thrombocytopenic purpura
DI   ORDO; Orphanet_54057; Thrombotic thrombocytopenic purpura
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QQ ! HPS1967
OI   CVCL_C9QR ! HPS1968
OI   CVCL_C9QS ! HPS1969
OI   CVCL_C9QT ! HPS1970
OI   CVCL_C9QU ! HPS1971
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1967
AC   CVCL_C9QQ
DR   RCB; HPS1967
DR   Wikidata; Q123031982
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78797; Thrombotic thrombocytopenic purpura
DI   ORDO; Orphanet_54057; Thrombotic thrombocytopenic purpura
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QP ! HPS1966
OI   CVCL_C9QR ! HPS1968
OI   CVCL_C9QS ! HPS1969
OI   CVCL_C9QT ! HPS1970
OI   CVCL_C9QU ! HPS1971
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1968
AC   CVCL_C9QR
DR   RCB; HPS1968
DR   Wikidata; Q123031983
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78797; Thrombotic thrombocytopenic purpura
DI   ORDO; Orphanet_54057; Thrombotic thrombocytopenic purpura
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QP ! HPS1966
OI   CVCL_C9QQ ! HPS1967
OI   CVCL_C9QS ! HPS1969
OI   CVCL_C9QT ! HPS1970
OI   CVCL_C9QU ! HPS1971
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1969
AC   CVCL_C9QS
DR   RCB; HPS1969
DR   Wikidata; Q123031984
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78797; Thrombotic thrombocytopenic purpura
DI   ORDO; Orphanet_54057; Thrombotic thrombocytopenic purpura
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QP ! HPS1966
OI   CVCL_C9QQ ! HPS1967
OI   CVCL_C9QR ! HPS1968
OI   CVCL_C9QT ! HPS1970
OI   CVCL_C9QU ! HPS1971
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1970
AC   CVCL_C9QT
DR   RCB; HPS1970
DR   Wikidata; Q123031985
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78797; Thrombotic thrombocytopenic purpura
DI   ORDO; Orphanet_54057; Thrombotic thrombocytopenic purpura
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QP ! HPS1966
OI   CVCL_C9QQ ! HPS1967
OI   CVCL_C9QR ! HPS1968
OI   CVCL_C9QS ! HPS1969
OI   CVCL_C9QU ! HPS1971
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1971
AC   CVCL_C9QU
DR   RCB; HPS1971
DR   Wikidata; Q123031986
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78797; Thrombotic thrombocytopenic purpura
DI   ORDO; Orphanet_54057; Thrombotic thrombocytopenic purpura
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QP ! HPS1966
OI   CVCL_C9QQ ! HPS1967
OI   CVCL_C9QR ! HPS1968
OI   CVCL_C9QS ! HPS1969
OI   CVCL_C9QT ! HPS1970
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1972
AC   CVCL_D1D9
DR   RCB; HPS1972
DR   Wikidata; Q123031987
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4828; Primary sclerosing cholangitis
DI   ORDO; Orphanet_171; Primary sclerosing cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DA ! HPS1973
OI   CVCL_D1DB ! HPS1974
OI   CVCL_D1DC ! HPS1975
OI   CVCL_D1DD ! HPS1976
OI   CVCL_D1DE ! HPS1977
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1973
AC   CVCL_D1DA
DR   RCB; HPS1973
DR   Wikidata; Q123031988
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4828; Primary sclerosing cholangitis
DI   ORDO; Orphanet_171; Primary sclerosing cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D9 ! HPS1972
OI   CVCL_D1DB ! HPS1974
OI   CVCL_D1DC ! HPS1975
OI   CVCL_D1DD ! HPS1976
OI   CVCL_D1DE ! HPS1977
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1974
AC   CVCL_D1DB
DR   RCB; HPS1974
DR   Wikidata; Q123031989
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4828; Primary sclerosing cholangitis
DI   ORDO; Orphanet_171; Primary sclerosing cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D9 ! HPS1972
OI   CVCL_D1DA ! HPS1973
OI   CVCL_D1DC ! HPS1975
OI   CVCL_D1DD ! HPS1976
OI   CVCL_D1DE ! HPS1977
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1975
AC   CVCL_D1DC
DR   RCB; HPS1975
DR   Wikidata; Q123031990
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4828; Primary sclerosing cholangitis
DI   ORDO; Orphanet_171; Primary sclerosing cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D9 ! HPS1972
OI   CVCL_D1DA ! HPS1973
OI   CVCL_D1DB ! HPS1974
OI   CVCL_D1DD ! HPS1976
OI   CVCL_D1DE ! HPS1977
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1976
AC   CVCL_D1DD
DR   RCB; HPS1976
DR   Wikidata; Q123031991
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4828; Primary sclerosing cholangitis
DI   ORDO; Orphanet_171; Primary sclerosing cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D9 ! HPS1972
OI   CVCL_D1DA ! HPS1973
OI   CVCL_D1DB ! HPS1974
OI   CVCL_D1DC ! HPS1975
OI   CVCL_D1DE ! HPS1977
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1977
AC   CVCL_D1DE
DR   RCB; HPS1977
DR   Wikidata; Q123031992
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4828; Primary sclerosing cholangitis
DI   ORDO; Orphanet_171; Primary sclerosing cholangitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D9 ! HPS1972
OI   CVCL_D1DA ! HPS1973
OI   CVCL_D1DB ! HPS1974
OI   CVCL_D1DC ! HPS1975
OI   CVCL_D1DD ! HPS1976
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1978
AC   CVCL_D1AR
DR   RCB; HPS1978
DR   Wikidata; Q123031993
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177444; Spinal stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AS ! HPS1979
OI   CVCL_D1AT ! HPS1980
OI   CVCL_D1AU ! HPS1981
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1979
AC   CVCL_D1AS
DR   RCB; HPS1979
DR   Wikidata; Q123031994
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177444; Spinal stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AR ! HPS1978
OI   CVCL_D1AT ! HPS1980
OI   CVCL_D1AU ! HPS1981
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1980
AC   CVCL_D1AT
DR   RCB; HPS1980
DR   Wikidata; Q123031995
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177444; Spinal stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AR ! HPS1978
OI   CVCL_D1AS ! HPS1979
OI   CVCL_D1AU ! HPS1981
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1981
AC   CVCL_D1AU
DR   RCB; HPS1981
DR   Wikidata; Q123031996
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177444; Spinal stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AR ! HPS1978
OI   CVCL_D1AS ! HPS1979
OI   CVCL_D1AT ! HPS1980
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1988
AC   CVCL_UN94
DR   RCB; HPS1988
DR   Wikidata; Q94219856
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157268; Relapsing polychondritis
DI   ORDO; Orphanet_728; Relapsing polychondritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3VI ! HPS1989
OI   CVCL_A3VJ ! HPS1990
OI   CVCL_A3VK ! HPS1991
OI   CVCL_A3VL ! HPS1992
OI   CVCL_A3VM ! HPS1993
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS1989
AC   CVCL_A3VI
DR   RCB; HPS1989
DR   Wikidata; Q105508354
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157268; Relapsing polychondritis
DI   ORDO; Orphanet_728; Relapsing polychondritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN94 ! HPS1988
OI   CVCL_A3VJ ! HPS1990
OI   CVCL_A3VK ! HPS1991
OI   CVCL_A3VL ! HPS1992
OI   CVCL_A3VM ! HPS1993
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1990
AC   CVCL_A3VJ
DR   RCB; HPS1990
DR   Wikidata; Q105508360
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157268; Relapsing polychondritis
DI   ORDO; Orphanet_728; Relapsing polychondritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN94 ! HPS1988
OI   CVCL_A3VI ! HPS1989
OI   CVCL_A3VK ! HPS1991
OI   CVCL_A3VL ! HPS1992
OI   CVCL_A3VM ! HPS1993
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1991
AC   CVCL_A3VK
DR   RCB; HPS1991
DR   Wikidata; Q105508365
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157268; Relapsing polychondritis
DI   ORDO; Orphanet_728; Relapsing polychondritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN94 ! HPS1988
OI   CVCL_A3VI ! HPS1989
OI   CVCL_A3VJ ! HPS1990
OI   CVCL_A3VL ! HPS1992
OI   CVCL_A3VM ! HPS1993
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1992
AC   CVCL_A3VL
DR   RCB; HPS1992
DR   Wikidata; Q105508370
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157268; Relapsing polychondritis
DI   ORDO; Orphanet_728; Relapsing polychondritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN94 ! HPS1988
OI   CVCL_A3VI ! HPS1989
OI   CVCL_A3VJ ! HPS1990
OI   CVCL_A3VK ! HPS1991
OI   CVCL_A3VM ! HPS1993
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1993
AC   CVCL_A3VM
DR   RCB; HPS1993
DR   Wikidata; Q105508373
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157268; Relapsing polychondritis
DI   ORDO; Orphanet_728; Relapsing polychondritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN94 ! HPS1988
OI   CVCL_A3VI ! HPS1989
OI   CVCL_A3VJ ! HPS1990
OI   CVCL_A3VK ! HPS1991
OI   CVCL_A3VL ! HPS1992
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS1994
AC   CVCL_C9QV
DR   RCB; HPS1994
DR   Wikidata; Q123031997
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34378; Autoimmune hemolytic anemia
DI   ORDO; Orphanet_90033; Autoimmune hemolytic anemia, warm type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QW ! HPS1995
OI   CVCL_C9QX ! HPS1996
OI   CVCL_C9QY ! HPS1997
OI   CVCL_C9QZ ! HPS1998
OI   CVCL_C9R0 ! HPS1999
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1995
AC   CVCL_C9QW
DR   RCB; HPS1995
DR   Wikidata; Q123031998
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34378; Autoimmune hemolytic anemia
DI   ORDO; Orphanet_90033; Autoimmune hemolytic anemia, warm type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QV ! HPS1994
OI   CVCL_C9QX ! HPS1996
OI   CVCL_C9QY ! HPS1997
OI   CVCL_C9QZ ! HPS1998
OI   CVCL_C9R0 ! HPS1999
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1996
AC   CVCL_C9QX
DR   RCB; HPS1996
DR   Wikidata; Q123031999
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34378; Autoimmune hemolytic anemia
DI   ORDO; Orphanet_90033; Autoimmune hemolytic anemia, warm type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QV ! HPS1994
OI   CVCL_C9QW ! HPS1995
OI   CVCL_C9QY ! HPS1997
OI   CVCL_C9QZ ! HPS1998
OI   CVCL_C9R0 ! HPS1999
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1997
AC   CVCL_C9QY
DR   RCB; HPS1997
DR   Wikidata; Q123032000
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34378; Autoimmune hemolytic anemia
DI   ORDO; Orphanet_90033; Autoimmune hemolytic anemia, warm type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QV ! HPS1994
OI   CVCL_C9QW ! HPS1995
OI   CVCL_C9QX ! HPS1996
OI   CVCL_C9QZ ! HPS1998
OI   CVCL_C9R0 ! HPS1999
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1998
AC   CVCL_C9QZ
DR   RCB; HPS1998
DR   Wikidata; Q123032001
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34378; Autoimmune hemolytic anemia
DI   ORDO; Orphanet_90033; Autoimmune hemolytic anemia, warm type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QV ! HPS1994
OI   CVCL_C9QW ! HPS1995
OI   CVCL_C9QX ! HPS1996
OI   CVCL_C9QY ! HPS1997
OI   CVCL_C9R0 ! HPS1999
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS1999
AC   CVCL_C9R0
DR   RCB; HPS1999
DR   Wikidata; Q123032002
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34378; Autoimmune hemolytic anemia
DI   ORDO; Orphanet_90033; Autoimmune hemolytic anemia, warm type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9QV ! HPS1994
OI   CVCL_C9QW ! HPS1995
OI   CVCL_C9QX ! HPS1996
OI   CVCL_C9QY ! HPS1997
OI   CVCL_C9QZ ! HPS1998
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2000
AC   CVCL_UN95
DR   RCB; HPS2000
DR   Wikidata; Q94219860
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2000).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR67 ! HPS2001
OI   CVCL_YR68 ! HPS2002
OI   CVCL_YR69 ! HPS2003
OI   CVCL_YR70 ! HPS2004
OI   CVCL_YR71 ! HPS2005
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   HPS2001
AC   CVCL_YR67
DR   RCB; HPS2001
DR   Wikidata; Q94219865
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2001).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN95 ! HPS2000
OI   CVCL_YR68 ! HPS2002
OI   CVCL_YR69 ! HPS2003
OI   CVCL_YR70 ! HPS2004
OI   CVCL_YR71 ! HPS2005
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS2002
AC   CVCL_YR68
DR   RCB; HPS2002
DR   Wikidata; Q94219869
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2002).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN95 ! HPS2000
OI   CVCL_YR67 ! HPS2001
OI   CVCL_YR69 ! HPS2003
OI   CVCL_YR70 ! HPS2004
OI   CVCL_YR71 ! HPS2005
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS2003
AC   CVCL_YR69
DR   RCB; HPS2003
DR   Wikidata; Q94219873
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2003).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN95 ! HPS2000
OI   CVCL_YR67 ! HPS2001
OI   CVCL_YR68 ! HPS2002
OI   CVCL_YR70 ! HPS2004
OI   CVCL_YR71 ! HPS2005
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS2004
AC   CVCL_YR70
DR   RCB; HPS2004
DR   Wikidata; Q94219878
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2004).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN95 ! HPS2000
OI   CVCL_YR67 ! HPS2001
OI   CVCL_YR68 ! HPS2002
OI   CVCL_YR69 ! HPS2003
OI   CVCL_YR71 ! HPS2005
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS2005
AC   CVCL_YR71
DR   RCB; HPS2005
DR   Wikidata; Q94219882
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2005).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN95 ! HPS2000
OI   CVCL_YR67 ! HPS2001
OI   CVCL_YR68 ! HPS2002
OI   CVCL_YR69 ! HPS2003
OI   CVCL_YR70 ! HPS2004
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   HPS2006
AC   CVCL_C9R1
DR   RCB; HPS2006
DR   Wikidata; Q123032003
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R2 ! HPS2007
OI   CVCL_C9R3 ! HPS2008
OI   CVCL_C9R4 ! HPS2009
OI   CVCL_C9R5 ! HPS2010
OI   CVCL_C9R6 ! HPS2011
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2007
AC   CVCL_C9R2
DR   RCB; HPS2007
DR   Wikidata; Q123032004
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R1 ! HPS2006
OI   CVCL_C9R3 ! HPS2008
OI   CVCL_C9R4 ! HPS2009
OI   CVCL_C9R5 ! HPS2010
OI   CVCL_C9R6 ! HPS2011
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2008
AC   CVCL_C9R3
DR   RCB; HPS2008
DR   Wikidata; Q123032005
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R1 ! HPS2006
OI   CVCL_C9R2 ! HPS2007
OI   CVCL_C9R4 ! HPS2009
OI   CVCL_C9R5 ! HPS2010
OI   CVCL_C9R6 ! HPS2011
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2009
AC   CVCL_C9R4
DR   RCB; HPS2009
DR   Wikidata; Q123032006
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R1 ! HPS2006
OI   CVCL_C9R2 ! HPS2007
OI   CVCL_C9R3 ! HPS2008
OI   CVCL_C9R5 ! HPS2010
OI   CVCL_C9R6 ! HPS2011
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2010
AC   CVCL_C9R5
DR   RCB; HPS2010
DR   Wikidata; Q123032007
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R1 ! HPS2006
OI   CVCL_C9R2 ! HPS2007
OI   CVCL_C9R3 ! HPS2008
OI   CVCL_C9R4 ! HPS2009
OI   CVCL_C9R6 ! HPS2011
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2011
AC   CVCL_C9R6
DR   RCB; HPS2011
DR   Wikidata; Q123032008
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_183435; Inherited ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R1 ! HPS2006
OI   CVCL_C9R2 ! HPS2007
OI   CVCL_C9R3 ! HPS2008
OI   CVCL_C9R4 ! HPS2009
OI   CVCL_C9R5 ! HPS2010
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2012
AC   CVCL_A3HD
DR   RCB; HPS2012
DR   Wikidata; Q105508378
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HE ! HPS2013
OI   CVCL_A3HF ! HPS2014
OI   CVCL_A3HG ! HPS2015
OI   CVCL_A3HH ! HPS2016
OI   CVCL_A3HI ! HPS2017
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2013
AC   CVCL_A3HE
DR   RCB; HPS2013
DR   Wikidata; Q105508381
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HD ! HPS2012
OI   CVCL_A3HF ! HPS2014
OI   CVCL_A3HG ! HPS2015
OI   CVCL_A3HH ! HPS2016
OI   CVCL_A3HI ! HPS2017
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2014
AC   CVCL_A3HF
DR   RCB; HPS2014
DR   Wikidata; Q105508384
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HD ! HPS2012
OI   CVCL_A3HE ! HPS2013
OI   CVCL_A3HG ! HPS2015
OI   CVCL_A3HH ! HPS2016
OI   CVCL_A3HI ! HPS2017
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2015
AC   CVCL_A3HG
DR   RCB; HPS2015
DR   Wikidata; Q105508387
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HD ! HPS2012
OI   CVCL_A3HE ! HPS2013
OI   CVCL_A3HF ! HPS2014
OI   CVCL_A3HH ! HPS2016
OI   CVCL_A3HI ! HPS2017
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2016
AC   CVCL_A3HH
DR   RCB; HPS2016
DR   Wikidata; Q105508393
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HD ! HPS2012
OI   CVCL_A3HE ! HPS2013
OI   CVCL_A3HF ! HPS2014
OI   CVCL_A3HG ! HPS2015
OI   CVCL_A3HI ! HPS2017
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2017
AC   CVCL_A3HI
DR   RCB; HPS2017
DR   Wikidata; Q105508396
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HD ! HPS2012
OI   CVCL_A3HE ! HPS2013
OI   CVCL_A3HF ! HPS2014
OI   CVCL_A3HG ! HPS2015
OI   CVCL_A3HH ! HPS2016
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2018
AC   CVCL_C9R7
DR   RCB; HPS2018
DR   Wikidata; Q123032009
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R8 ! HPS2019
OI   CVCL_C9R9 ! HPS2020
OI   CVCL_C9RA ! HPS2021
OI   CVCL_C9RB ! HPS2022
OI   CVCL_C9RC ! HPS2023
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2019
AC   CVCL_C9R8
DR   RCB; HPS2019
DR   Wikidata; Q123032010
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R7 ! HPS2018
OI   CVCL_C9R9 ! HPS2020
OI   CVCL_C9RA ! HPS2021
OI   CVCL_C9RB ! HPS2022
OI   CVCL_C9RC ! HPS2023
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2020
AC   CVCL_C9R9
DR   RCB; HPS2020
DR   Wikidata; Q123032011
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R7 ! HPS2018
OI   CVCL_C9R8 ! HPS2019
OI   CVCL_C9RA ! HPS2021
OI   CVCL_C9RB ! HPS2022
OI   CVCL_C9RC ! HPS2023
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2021
AC   CVCL_C9RA
DR   RCB; HPS2021
DR   Wikidata; Q123032012
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R7 ! HPS2018
OI   CVCL_C9R8 ! HPS2019
OI   CVCL_C9R9 ! HPS2020
OI   CVCL_C9RB ! HPS2022
OI   CVCL_C9RC ! HPS2023
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2022
AC   CVCL_C9RB
DR   RCB; HPS2022
DR   Wikidata; Q123032013
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R7 ! HPS2018
OI   CVCL_C9R8 ! HPS2019
OI   CVCL_C9R9 ! HPS2020
OI   CVCL_C9RA ! HPS2021
OI   CVCL_C9RC ! HPS2023
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2023
AC   CVCL_C9RC
DR   RCB; HPS2023
DR   Wikidata; Q123032014
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84555; Familial amyloidosis
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9R7 ! HPS2018
OI   CVCL_C9R8 ! HPS2019
OI   CVCL_C9R9 ! HPS2020
OI   CVCL_C9RA ! HPS2021
OI   CVCL_C9RB ! HPS2022
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2024
AC   CVCL_C9V4
DR   RCB; HPS2024
DR   Wikidata; Q123032015
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158963; AL amyloidosis
DI   ORDO; Orphanet_85443; AL amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9V5 ! HPS2025
OI   CVCL_C9V6 ! HPS2026
OI   CVCL_C9V7 ! HPS2027
OI   CVCL_C9V8 ! HPS2028
OI   CVCL_C9V9 ! HPS2029
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2025
AC   CVCL_C9V5
DR   RCB; HPS2025
DR   Wikidata; Q123032016
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158963; AL amyloidosis
DI   ORDO; Orphanet_85443; AL amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9V4 ! HPS2024
OI   CVCL_C9V6 ! HPS2026
OI   CVCL_C9V7 ! HPS2027
OI   CVCL_C9V8 ! HPS2028
OI   CVCL_C9V9 ! HPS2029
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2026
AC   CVCL_C9V6
DR   RCB; HPS2026
DR   Wikidata; Q123032017
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158963; AL amyloidosis
DI   ORDO; Orphanet_85443; AL amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9V4 ! HPS2024
OI   CVCL_C9V5 ! HPS2025
OI   CVCL_C9V7 ! HPS2027
OI   CVCL_C9V8 ! HPS2028
OI   CVCL_C9V9 ! HPS2029
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2027
AC   CVCL_C9V7
DR   RCB; HPS2027
DR   Wikidata; Q123032018
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158963; AL amyloidosis
DI   ORDO; Orphanet_85443; AL amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9V4 ! HPS2024
OI   CVCL_C9V5 ! HPS2025
OI   CVCL_C9V6 ! HPS2026
OI   CVCL_C9V8 ! HPS2028
OI   CVCL_C9V9 ! HPS2029
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2028
AC   CVCL_C9V8
DR   RCB; HPS2028
DR   Wikidata; Q123032019
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158963; AL amyloidosis
DI   ORDO; Orphanet_85443; AL amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9V4 ! HPS2024
OI   CVCL_C9V5 ! HPS2025
OI   CVCL_C9V6 ! HPS2026
OI   CVCL_C9V7 ! HPS2027
OI   CVCL_C9V9 ! HPS2029
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2029
AC   CVCL_C9V9
DR   RCB; HPS2029
DR   Wikidata; Q123032020
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C158963; AL amyloidosis
DI   ORDO; Orphanet_85443; AL amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9V4 ! HPS2024
OI   CVCL_C9V5 ! HPS2025
OI   CVCL_C9V6 ! HPS2026
OI   CVCL_C9V7 ! HPS2027
OI   CVCL_C9V8 ! HPS2028
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2030
AC   CVCL_C9VA
DR   RCB; HPS2030
DR   Wikidata; Q123032021
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2030).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VB ! HPS2031
OI   CVCL_C9VC ! HPS2032
OI   CVCL_C9VD ! HPS2033
OI   CVCL_C9VE ! HPS2034
OI   CVCL_C9VF ! HPS2035
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2031
AC   CVCL_C9VB
DR   RCB; HPS2031
DR   Wikidata; Q123032022
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2031).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VA ! HPS2030
OI   CVCL_C9VC ! HPS2032
OI   CVCL_C9VD ! HPS2033
OI   CVCL_C9VE ! HPS2034
OI   CVCL_C9VF ! HPS2035
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2032
AC   CVCL_C9VC
DR   RCB; HPS2032
DR   Wikidata; Q123032023
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2032).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VA ! HPS2030
OI   CVCL_C9VB ! HPS2031
OI   CVCL_C9VD ! HPS2033
OI   CVCL_C9VE ! HPS2034
OI   CVCL_C9VF ! HPS2035
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2033
AC   CVCL_C9VD
DR   RCB; HPS2033
DR   Wikidata; Q123032024
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2033).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VA ! HPS2030
OI   CVCL_C9VB ! HPS2031
OI   CVCL_C9VC ! HPS2032
OI   CVCL_C9VE ! HPS2034
OI   CVCL_C9VF ! HPS2035
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2034
AC   CVCL_C9VE
DR   RCB; HPS2034
DR   Wikidata; Q123032025
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2034).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VA ! HPS2030
OI   CVCL_C9VB ! HPS2031
OI   CVCL_C9VC ! HPS2032
OI   CVCL_C9VD ! HPS2033
OI   CVCL_C9VF ! HPS2035
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2035
AC   CVCL_C9VF
DR   RCB; HPS2035
DR   Wikidata; Q123032026
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2035).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VA ! HPS2030
OI   CVCL_C9VB ! HPS2031
OI   CVCL_C9VC ! HPS2032
OI   CVCL_C9VD ! HPS2033
OI   CVCL_C9VE ! HPS2034
SX   Female
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2036
AC   CVCL_A3HJ
DR   RCB; HPS2036
DR   Wikidata; Q105508402
CC   Sequence variation: Mutation; HGNC; HGNC:1037; CFB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2036).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176902; Atypical hemolytic uremic syndrome-4
DI   ORDO; Orphanet_2134; Atypical hemolytic uremic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HK ! HPS2037
OI   CVCL_A3HL ! HPS2038
OI   CVCL_A3HM ! HPS2039
OI   CVCL_A3HN ! HPS2040
OI   CVCL_A3HP ! HPS2041
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2037
AC   CVCL_A3HK
DR   RCB; HPS2037
DR   Wikidata; Q105508405
CC   Sequence variation: Mutation; HGNC; HGNC:1037; CFB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2037).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176902; Atypical hemolytic uremic syndrome-4
DI   ORDO; Orphanet_2134; Atypical hemolytic uremic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HJ ! HPS2036
OI   CVCL_A3HL ! HPS2038
OI   CVCL_A3HM ! HPS2039
OI   CVCL_A3HN ! HPS2040
OI   CVCL_A3HP ! HPS2041
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2038
AC   CVCL_A3HL
DR   RCB; HPS2038
DR   Wikidata; Q105508408
CC   Sequence variation: Mutation; HGNC; HGNC:1037; CFB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2038).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176902; Atypical hemolytic uremic syndrome-4
DI   ORDO; Orphanet_2134; Atypical hemolytic uremic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HJ ! HPS2036
OI   CVCL_A3HK ! HPS2037
OI   CVCL_A3HM ! HPS2039
OI   CVCL_A3HN ! HPS2040
OI   CVCL_A3HP ! HPS2041
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2039
AC   CVCL_A3HM
DR   RCB; HPS2039
DR   Wikidata; Q105508413
CC   Sequence variation: Mutation; HGNC; HGNC:1037; CFB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2039).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176902; Atypical hemolytic uremic syndrome-4
DI   ORDO; Orphanet_2134; Atypical hemolytic uremic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HJ ! HPS2036
OI   CVCL_A3HK ! HPS2037
OI   CVCL_A3HL ! HPS2038
OI   CVCL_A3HN ! HPS2040
OI   CVCL_A3HP ! HPS2041
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2040
AC   CVCL_A3HN
DR   RCB; HPS2040
DR   Wikidata; Q105508416
CC   Sequence variation: Mutation; HGNC; HGNC:1037; CFB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2040).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176902; Atypical hemolytic uremic syndrome-4
DI   ORDO; Orphanet_2134; Atypical hemolytic uremic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HJ ! HPS2036
OI   CVCL_A3HK ! HPS2037
OI   CVCL_A3HL ! HPS2038
OI   CVCL_A3HM ! HPS2039
OI   CVCL_A3HP ! HPS2041
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2041
AC   CVCL_A3HP
DR   RCB; HPS2041
DR   Wikidata; Q105508419
CC   Sequence variation: Mutation; HGNC; HGNC:1037; CFB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2041).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176902; Atypical hemolytic uremic syndrome-4
DI   ORDO; Orphanet_2134; Atypical hemolytic uremic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HJ ! HPS2036
OI   CVCL_A3HK ! HPS2037
OI   CVCL_A3HL ! HPS2038
OI   CVCL_A3HM ! HPS2039
OI   CVCL_A3HN ! HPS2040
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2048
AC   CVCL_C9VG
DR   RCB; HPS2048
DR   Wikidata; Q123032027
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VH ! HPS2049
OI   CVCL_C9VI ! HPS2050
OI   CVCL_C9VJ ! HPS2051
OI   CVCL_C9VK ! HPS2052
OI   CVCL_C9VL ! HPS2053
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2049
AC   CVCL_C9VH
DR   RCB; HPS2049
DR   Wikidata; Q123032028
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VG ! HPS2048
OI   CVCL_C9VI ! HPS2050
OI   CVCL_C9VJ ! HPS2051
OI   CVCL_C9VK ! HPS2052
OI   CVCL_C9VL ! HPS2053
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2050
AC   CVCL_C9VI
DR   RCB; HPS2050
DR   Wikidata; Q123032029
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VG ! HPS2048
OI   CVCL_C9VH ! HPS2049
OI   CVCL_C9VJ ! HPS2051
OI   CVCL_C9VK ! HPS2052
OI   CVCL_C9VL ! HPS2053
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2051
AC   CVCL_C9VJ
DR   RCB; HPS2051
DR   Wikidata; Q123032030
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VG ! HPS2048
OI   CVCL_C9VH ! HPS2049
OI   CVCL_C9VI ! HPS2050
OI   CVCL_C9VK ! HPS2052
OI   CVCL_C9VL ! HPS2053
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2052
AC   CVCL_C9VK
DR   RCB; HPS2052
DR   Wikidata; Q123032031
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VG ! HPS2048
OI   CVCL_C9VH ! HPS2049
OI   CVCL_C9VI ! HPS2050
OI   CVCL_C9VJ ! HPS2051
OI   CVCL_C9VL ! HPS2053
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2053
AC   CVCL_C9VL
DR   RCB; HPS2053
DR   Wikidata; Q123032032
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VG ! HPS2048
OI   CVCL_C9VH ! HPS2049
OI   CVCL_C9VI ! HPS2050
OI   CVCL_C9VJ ! HPS2051
OI   CVCL_C9VK ! HPS2052
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2054
AC   CVCL_A3HQ
DR   RCB; HPS2054
DR   Wikidata; Q105508422
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HR ! HPS2055
OI   CVCL_A3HS ! HPS2056
OI   CVCL_A3HT ! HPS2057
OI   CVCL_A3HU ! HPS2058
OI   CVCL_A3HV ! HPS2059
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2055
AC   CVCL_A3HR
DR   RCB; HPS2055
DR   Wikidata; Q105508425
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HQ ! HPS2054
OI   CVCL_A3HS ! HPS2056
OI   CVCL_A3HT ! HPS2057
OI   CVCL_A3HU ! HPS2058
OI   CVCL_A3HV ! HPS2059
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2056
AC   CVCL_A3HS
DR   RCB; HPS2056
DR   Wikidata; Q105508428
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HQ ! HPS2054
OI   CVCL_A3HR ! HPS2055
OI   CVCL_A3HT ! HPS2057
OI   CVCL_A3HU ! HPS2058
OI   CVCL_A3HV ! HPS2059
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2057
AC   CVCL_A3HT
DR   RCB; HPS2057
DR   Wikidata; Q105508432
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HQ ! HPS2054
OI   CVCL_A3HR ! HPS2055
OI   CVCL_A3HS ! HPS2056
OI   CVCL_A3HU ! HPS2058
OI   CVCL_A3HV ! HPS2059
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2058
AC   CVCL_A3HU
DR   RCB; HPS2058
DR   Wikidata; Q105508436
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HQ ! HPS2054
OI   CVCL_A3HR ! HPS2055
OI   CVCL_A3HS ! HPS2056
OI   CVCL_A3HT ! HPS2057
OI   CVCL_A3HV ! HPS2059
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2059
AC   CVCL_A3HV
DR   RCB; HPS2059
DR   Wikidata; Q105508438
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HQ ! HPS2054
OI   CVCL_A3HR ! HPS2055
OI   CVCL_A3HS ! HPS2056
OI   CVCL_A3HT ! HPS2057
OI   CVCL_A3HU ! HPS2058
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2060
AC   CVCL_C6BZ
DR   RCB; HPS2060
DR   Wikidata; Q116049432
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6C0 ! HPS2061
OI   CVCL_C6C1 ! HPS2062
OI   CVCL_C6C2 ! HPS2063
OI   CVCL_C6C3 ! HPS2064
OI   CVCL_C6C4 ! HPS2065
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2061
AC   CVCL_C6C0
DR   RCB; HPS2061
DR   Wikidata; Q116049433
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BZ ! HPS2060
OI   CVCL_C6C1 ! HPS2062
OI   CVCL_C6C2 ! HPS2063
OI   CVCL_C6C3 ! HPS2064
OI   CVCL_C6C4 ! HPS2065
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2062
AC   CVCL_C6C1
DR   RCB; HPS2062
DR   Wikidata; Q116049434
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BZ ! HPS2060
OI   CVCL_C6C0 ! HPS2061
OI   CVCL_C6C2 ! HPS2063
OI   CVCL_C6C3 ! HPS2064
OI   CVCL_C6C4 ! HPS2065
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2063
AC   CVCL_C6C2
DR   RCB; HPS2063
DR   Wikidata; Q116049435
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BZ ! HPS2060
OI   CVCL_C6C0 ! HPS2061
OI   CVCL_C6C1 ! HPS2062
OI   CVCL_C6C3 ! HPS2064
OI   CVCL_C6C4 ! HPS2065
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2064
AC   CVCL_C6C3
DR   RCB; HPS2064
DR   Wikidata; Q116049436
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BZ ! HPS2060
OI   CVCL_C6C0 ! HPS2061
OI   CVCL_C6C1 ! HPS2062
OI   CVCL_C6C2 ! HPS2063
OI   CVCL_C6C4 ! HPS2065
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2065
AC   CVCL_C6C4
DR   RCB; HPS2065
DR   Wikidata; Q116049437
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6BZ ! HPS2060
OI   CVCL_C6C0 ! HPS2061
OI   CVCL_C6C1 ! HPS2062
OI   CVCL_C6C2 ! HPS2063
OI   CVCL_C6C3 ! HPS2064
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2084
AC   CVCL_UN96
DR   RCB; HPS2084
DR   Wikidata; Q94219886
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR72 ! HPS2085
OI   CVCL_YR73 ! HPS2086
OI   CVCL_YR74 ! HPS2087
OI   CVCL_YR75 ! HPS2088
OI   CVCL_YR76 ! HPS2089
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS2085
AC   CVCL_YR72
DR   RCB; HPS2085
DR   Wikidata; Q94219891
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN96 ! HPS2084
OI   CVCL_YR73 ! HPS2086
OI   CVCL_YR74 ! HPS2087
OI   CVCL_YR75 ! HPS2088
OI   CVCL_YR76 ! HPS2089
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2086
AC   CVCL_YR73
DR   RCB; HPS2086
DR   Wikidata; Q94219896
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN96 ! HPS2084
OI   CVCL_YR72 ! HPS2085
OI   CVCL_YR74 ! HPS2087
OI   CVCL_YR75 ! HPS2088
OI   CVCL_YR76 ! HPS2089
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2087
AC   CVCL_YR74
DR   RCB; HPS2087
DR   Wikidata; Q94219900
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN96 ! HPS2084
OI   CVCL_YR72 ! HPS2085
OI   CVCL_YR73 ! HPS2086
OI   CVCL_YR75 ! HPS2088
OI   CVCL_YR76 ! HPS2089
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2088
AC   CVCL_YR75
DR   RCB; HPS2088
DR   Wikidata; Q94219905
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN96 ! HPS2084
OI   CVCL_YR72 ! HPS2085
OI   CVCL_YR73 ! HPS2086
OI   CVCL_YR74 ! HPS2087
OI   CVCL_YR76 ! HPS2089
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2089
AC   CVCL_YR76
DR   RCB; HPS2089
DR   Wikidata; Q94219909
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN96 ! HPS2084
OI   CVCL_YR72 ! HPS2085
OI   CVCL_YR73 ! HPS2086
OI   CVCL_YR74 ! HPS2087
OI   CVCL_YR75 ! HPS2088
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2090
AC   CVCL_D1CX
DR   RCB; HPS2090
DR   Wikidata; Q123032033
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CY ! HPS2091
OI   CVCL_D1CZ ! HPS2092
OI   CVCL_D1D0 ! HPS2093
OI   CVCL_D1D1 ! HPS2094
OI   CVCL_D1D2 ! HPS2095
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2091
AC   CVCL_D1CY
DR   RCB; HPS2091
DR   Wikidata; Q123032034
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CX ! HPS2090
OI   CVCL_D1CZ ! HPS2092
OI   CVCL_D1D0 ! HPS2093
OI   CVCL_D1D1 ! HPS2094
OI   CVCL_D1D2 ! HPS2095
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2092
AC   CVCL_D1CZ
DR   RCB; HPS2092
DR   Wikidata; Q123032035
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CX ! HPS2090
OI   CVCL_D1CY ! HPS2091
OI   CVCL_D1D0 ! HPS2093
OI   CVCL_D1D1 ! HPS2094
OI   CVCL_D1D2 ! HPS2095
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2093
AC   CVCL_D1D0
DR   RCB; HPS2093
DR   Wikidata; Q123032036
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CX ! HPS2090
OI   CVCL_D1CY ! HPS2091
OI   CVCL_D1CZ ! HPS2092
OI   CVCL_D1D1 ! HPS2094
OI   CVCL_D1D2 ! HPS2095
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2094
AC   CVCL_D1D1
DR   RCB; HPS2094
DR   Wikidata; Q123032037
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CX ! HPS2090
OI   CVCL_D1CY ! HPS2091
OI   CVCL_D1CZ ! HPS2092
OI   CVCL_D1D0 ! HPS2093
OI   CVCL_D1D2 ! HPS2095
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2095
AC   CVCL_D1D2
DR   RCB; HPS2095
DR   Wikidata; Q123032038
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34995; Sarcoidosis
DI   ORDO; Orphanet_797; Sarcoidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CX ! HPS2090
OI   CVCL_D1CY ! HPS2091
OI   CVCL_D1CZ ! HPS2092
OI   CVCL_D1D0 ! HPS2093
OI   CVCL_D1D1 ! HPS2094
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2096
AC   CVCL_UN97
DR   RCB; HPS2096
DR   Wikidata; Q94219912
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2096).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR77 ! HPS2097
OI   CVCL_YR78 ! HPS2098
OI   CVCL_YR79 ! HPS2099
OI   CVCL_YR80 ! HPS2100
OI   CVCL_YR81 ! HPS2101
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS2097
AC   CVCL_YR77
DR   RCB; HPS2097
DR   Wikidata; Q94219917
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2097).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN97 ! HPS2096
OI   CVCL_YR78 ! HPS2098
OI   CVCL_YR79 ! HPS2099
OI   CVCL_YR80 ! HPS2100
OI   CVCL_YR81 ! HPS2101
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2098
AC   CVCL_YR78
DR   RCB; HPS2098
DR   Wikidata; Q94219920
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2098).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN97 ! HPS2096
OI   CVCL_YR77 ! HPS2097
OI   CVCL_YR79 ! HPS2099
OI   CVCL_YR80 ! HPS2100
OI   CVCL_YR81 ! HPS2101
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2099
AC   CVCL_YR79
DR   RCB; HPS2099
DR   Wikidata; Q94219924
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2099).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN97 ! HPS2096
OI   CVCL_YR77 ! HPS2097
OI   CVCL_YR78 ! HPS2098
OI   CVCL_YR80 ! HPS2100
OI   CVCL_YR81 ! HPS2101
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2100
AC   CVCL_YR80
DR   RCB; HPS2100
DR   Wikidata; Q94219929
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2100).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN97 ! HPS2096
OI   CVCL_YR77 ! HPS2097
OI   CVCL_YR78 ! HPS2098
OI   CVCL_YR79 ! HPS2099
OI   CVCL_YR81 ! HPS2101
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2101
AC   CVCL_YR81
DR   RCB; HPS2101
DR   Wikidata; Q94219932
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2101).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN97 ! HPS2096
OI   CVCL_YR77 ! HPS2097
OI   CVCL_YR78 ! HPS2098
OI   CVCL_YR79 ! HPS2099
OI   CVCL_YR80 ! HPS2100
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2102
AC   CVCL_C9VM
DR   RCB; HPS2102
DR   Wikidata; Q123032039
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VN ! HPS2103
OI   CVCL_C9VP ! HPS2104
OI   CVCL_C9VQ ! HPS2105
OI   CVCL_C9VR ! HPS2106
OI   CVCL_C9VS ! HPS2107
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2103
AC   CVCL_C9VN
DR   RCB; HPS2103
DR   Wikidata; Q123032041
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VM ! HPS2102
OI   CVCL_C9VP ! HPS2104
OI   CVCL_C9VQ ! HPS2105
OI   CVCL_C9VR ! HPS2106
OI   CVCL_C9VS ! HPS2107
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2104
AC   CVCL_C9VP
DR   RCB; HPS2104
DR   Wikidata; Q123032042
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VM ! HPS2102
OI   CVCL_C9VN ! HPS2103
OI   CVCL_C9VQ ! HPS2105
OI   CVCL_C9VR ! HPS2106
OI   CVCL_C9VS ! HPS2107
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2105
AC   CVCL_C9VQ
DR   RCB; HPS2105
DR   Wikidata; Q123032043
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VM ! HPS2102
OI   CVCL_C9VN ! HPS2103
OI   CVCL_C9VP ! HPS2104
OI   CVCL_C9VR ! HPS2106
OI   CVCL_C9VS ! HPS2107
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2106
AC   CVCL_C9VR
DR   RCB; HPS2106
DR   Wikidata; Q123032044
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VM ! HPS2102
OI   CVCL_C9VN ! HPS2103
OI   CVCL_C9VP ! HPS2104
OI   CVCL_C9VQ ! HPS2105
OI   CVCL_C9VS ! HPS2107
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2107
AC   CVCL_C9VS
DR   RCB; HPS2107
DR   Wikidata; Q123032045
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35070; Buerger disease
DI   ORDO; Orphanet_36258; Buerger disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VM ! HPS2102
OI   CVCL_C9VN ! HPS2103
OI   CVCL_C9VP ! HPS2104
OI   CVCL_C9VQ ! HPS2105
OI   CVCL_C9VR ! HPS2106
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2108
AC   CVCL_UN98
DR   RCB; HPS2108
DR   Wikidata; Q94219937
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR82 ! HPS2109
OI   CVCL_YR83 ! HPS2110
OI   CVCL_YR84 ! HPS2111
OI   CVCL_YR85 ! HPS2112
OI   CVCL_YR86 ! HPS2113
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS2109
AC   CVCL_YR82
DR   RCB; HPS2109
DR   Wikidata; Q94219941
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN98 ! HPS2108
OI   CVCL_YR83 ! HPS2110
OI   CVCL_YR84 ! HPS2111
OI   CVCL_YR85 ! HPS2112
OI   CVCL_YR86 ! HPS2113
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2110
AC   CVCL_YR83
DR   RCB; HPS2110
DR   Wikidata; Q94219945
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN98 ! HPS2108
OI   CVCL_YR82 ! HPS2109
OI   CVCL_YR84 ! HPS2111
OI   CVCL_YR85 ! HPS2112
OI   CVCL_YR86 ! HPS2113
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2111
AC   CVCL_YR84
DR   RCB; HPS2111
DR   Wikidata; Q94219949
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN98 ! HPS2108
OI   CVCL_YR82 ! HPS2109
OI   CVCL_YR83 ! HPS2110
OI   CVCL_YR85 ! HPS2112
OI   CVCL_YR86 ! HPS2113
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2112
AC   CVCL_YR85
DR   RCB; HPS2112
DR   Wikidata; Q94219954
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN98 ! HPS2108
OI   CVCL_YR82 ! HPS2109
OI   CVCL_YR83 ! HPS2110
OI   CVCL_YR84 ! HPS2111
OI   CVCL_YR86 ! HPS2113
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2113
AC   CVCL_YR86
DR   RCB; HPS2113
DR   Wikidata; Q94219960
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN98 ! HPS2108
OI   CVCL_YR82 ! HPS2109
OI   CVCL_YR83 ! HPS2110
OI   CVCL_YR84 ! HPS2111
OI   CVCL_YR85 ! HPS2112
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2114
AC   CVCL_UN99
DR   RCB; HPS2114
DR   Wikidata; Q94219964
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR87 ! HPS2115
OI   CVCL_YR88 ! HPS2116
OI   CVCL_A3VN ! HPS2117
OI   CVCL_A3VP ! HPS2118
OI   CVCL_A3VQ ! HPS2119
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2115
AC   CVCL_YR87
DR   RCB; HPS2115
DR   Wikidata; Q94219968
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN99 ! HPS2114
OI   CVCL_YR88 ! HPS2116
OI   CVCL_A3VN ! HPS2117
OI   CVCL_A3VP ! HPS2118
OI   CVCL_A3VQ ! HPS2119
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS2116
AC   CVCL_YR88
DR   RCB; HPS2116
DR   Wikidata; Q94219973
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN99 ! HPS2114
OI   CVCL_YR87 ! HPS2115
OI   CVCL_A3VN ! HPS2117
OI   CVCL_A3VP ! HPS2118
OI   CVCL_A3VQ ! HPS2119
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   HPS2117
AC   CVCL_A3VN
DR   RCB; HPS2117
DR   Wikidata; Q105508445
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN99 ! HPS2114
OI   CVCL_YR87 ! HPS2115
OI   CVCL_YR88 ! HPS2116
OI   CVCL_A3VP ! HPS2118
OI   CVCL_A3VQ ! HPS2119
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2118
AC   CVCL_A3VP
DR   RCB; HPS2118
DR   Wikidata; Q105508449
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN99 ! HPS2114
OI   CVCL_YR87 ! HPS2115
OI   CVCL_YR88 ! HPS2116
OI   CVCL_A3VN ! HPS2117
OI   CVCL_A3VQ ! HPS2119
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2119
AC   CVCL_A3VQ
DR   RCB; HPS2119
DR   Wikidata; Q105508452
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN99 ! HPS2114
OI   CVCL_YR87 ! HPS2115
OI   CVCL_YR88 ! HPS2116
OI   CVCL_A3VN ! HPS2117
OI   CVCL_A3VP ! HPS2118
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2120
AC   CVCL_A3HW
DR   RCB; HPS2120
DR   Wikidata; Q105508455
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HX ! HPS2121
OI   CVCL_A3HY ! HPS2122
OI   CVCL_A3HZ ! HPS2123
OI   CVCL_A3IA ! HPS2124
OI   CVCL_A3IB ! HPS2125
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2121
AC   CVCL_A3HX
DR   RCB; HPS2121
DR   Wikidata; Q105508460
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HW ! HPS2120
OI   CVCL_A3HY ! HPS2122
OI   CVCL_A3HZ ! HPS2123
OI   CVCL_A3IA ! HPS2124
OI   CVCL_A3IB ! HPS2125
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2122
AC   CVCL_A3HY
DR   RCB; HPS2122
DR   Wikidata; Q105508464
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HW ! HPS2120
OI   CVCL_A3HX ! HPS2121
OI   CVCL_A3HZ ! HPS2123
OI   CVCL_A3IA ! HPS2124
OI   CVCL_A3IB ! HPS2125
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2123
AC   CVCL_A3HZ
DR   RCB; HPS2123
DR   Wikidata; Q105508468
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HW ! HPS2120
OI   CVCL_A3HX ! HPS2121
OI   CVCL_A3HY ! HPS2122
OI   CVCL_A3IA ! HPS2124
OI   CVCL_A3IB ! HPS2125
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2124
AC   CVCL_A3IA
DR   RCB; HPS2124
DR   Wikidata; Q105508469
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HW ! HPS2120
OI   CVCL_A3HX ! HPS2121
OI   CVCL_A3HY ! HPS2122
OI   CVCL_A3HZ ! HPS2123
OI   CVCL_A3IB ! HPS2125
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2125
AC   CVCL_A3IB
DR   RCB; HPS2125
DR   Wikidata; Q105508472
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84816; Lennox-Gastaut syndrome
DI   ORDO; Orphanet_2382; Lennox-Gastaut syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3HW ! HPS2120
OI   CVCL_A3HX ! HPS2121
OI   CVCL_A3HY ! HPS2122
OI   CVCL_A3HZ ! HPS2123
OI   CVCL_A3IA ! HPS2124
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2126
AC   CVCL_C9VT
DR   RCB; HPS2126
DR   Wikidata; Q123032046
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VU ! HPS2127
OI   CVCL_C9VV ! HPS2128
OI   CVCL_C9VW ! HPS2129
OI   CVCL_C9VX ! HPS2130
OI   CVCL_C9VY ! HPS2131
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2127
AC   CVCL_C9VU
DR   RCB; HPS2127
DR   Wikidata; Q123032047
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VT ! HPS2126
OI   CVCL_C9VV ! HPS2128
OI   CVCL_C9VW ! HPS2129
OI   CVCL_C9VX ! HPS2130
OI   CVCL_C9VY ! HPS2131
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2128
AC   CVCL_C9VV
DR   RCB; HPS2128
DR   Wikidata; Q123032048
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VT ! HPS2126
OI   CVCL_C9VU ! HPS2127
OI   CVCL_C9VW ! HPS2129
OI   CVCL_C9VX ! HPS2130
OI   CVCL_C9VY ! HPS2131
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2129
AC   CVCL_C9VW
DR   RCB; HPS2129
DR   Wikidata; Q123032049
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VT ! HPS2126
OI   CVCL_C9VU ! HPS2127
OI   CVCL_C9VV ! HPS2128
OI   CVCL_C9VX ! HPS2130
OI   CVCL_C9VY ! HPS2131
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2130
AC   CVCL_C9VX
DR   RCB; HPS2130
DR   Wikidata; Q123032050
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VT ! HPS2126
OI   CVCL_C9VU ! HPS2127
OI   CVCL_C9VV ! HPS2128
OI   CVCL_C9VW ! HPS2129
OI   CVCL_C9VY ! HPS2131
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2131
AC   CVCL_C9VY
DR   RCB; HPS2131
DR   Wikidata; Q123032052
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176900; Nonaka myopathy
DI   ORDO; Orphanet_602; GNE myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VT ! HPS2126
OI   CVCL_C9VU ! HPS2127
OI   CVCL_C9VV ! HPS2128
OI   CVCL_C9VW ! HPS2129
OI   CVCL_C9VX ! HPS2130
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2138
AC   CVCL_YS41
DR   RCB; HPS2138
DR   Wikidata; Q94219977
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS42 ! HPS2139
OI   CVCL_YS43 ! HPS2140
OI   CVCL_YS44 ! HPS2141
OI   CVCL_YS45 ! HPS2142
OI   CVCL_YS46 ! HPS2143
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2139
AC   CVCL_YS42
DR   RCB; HPS2139
DR   Wikidata; Q94219982
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS41 ! HPS2138
OI   CVCL_YS43 ! HPS2140
OI   CVCL_YS44 ! HPS2141
OI   CVCL_YS45 ! HPS2142
OI   CVCL_YS46 ! HPS2143
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2140
AC   CVCL_YS43
DR   RCB; HPS2140
DR   Wikidata; Q94219986
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS41 ! HPS2138
OI   CVCL_YS42 ! HPS2139
OI   CVCL_YS44 ! HPS2141
OI   CVCL_YS45 ! HPS2142
OI   CVCL_YS46 ! HPS2143
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2141
AC   CVCL_YS44
DR   RCB; HPS2141
DR   Wikidata; Q94219990
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS41 ! HPS2138
OI   CVCL_YS42 ! HPS2139
OI   CVCL_YS43 ! HPS2140
OI   CVCL_YS45 ! HPS2142
OI   CVCL_YS46 ! HPS2143
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2142
AC   CVCL_YS45
DR   RCB; HPS2142
DR   Wikidata; Q94219994
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS41 ! HPS2138
OI   CVCL_YS42 ! HPS2139
OI   CVCL_YS43 ! HPS2140
OI   CVCL_YS44 ! HPS2141
OI   CVCL_YS46 ! HPS2143
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2143
AC   CVCL_YS46
DR   RCB; HPS2143
DR   Wikidata; Q94219998
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169001; Ring chromosome 20 syndrome
DI   ORDO; Orphanet_1444; Ring chromosome 20 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS41 ! HPS2138
OI   CVCL_YS42 ! HPS2139
OI   CVCL_YS43 ! HPS2140
OI   CVCL_YS44 ! HPS2141
OI   CVCL_YS45 ! HPS2142
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2150
AC   CVCL_UP00
DR   RCB; HPS2150
DR   Wikidata; Q94220003
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3VW ! HPS2151
OI   CVCL_A3VX ! HPS2152
OI   CVCL_A3VY ! HPS2153
OI   CVCL_A3VZ ! HPS2154
OI   CVCL_A3WA ! HPS2155
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2151
AC   CVCL_A3VW
DR   RCB; HPS2151
DR   Wikidata; Q105508476
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP00 ! HPS2150
OI   CVCL_A3VX ! HPS2152
OI   CVCL_A3VY ! HPS2153
OI   CVCL_A3VZ ! HPS2154
OI   CVCL_A3WA ! HPS2155
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2152
AC   CVCL_A3VX
DR   RCB; HPS2152
DR   Wikidata; Q105508481
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP00 ! HPS2150
OI   CVCL_A3VW ! HPS2151
OI   CVCL_A3VY ! HPS2153
OI   CVCL_A3VZ ! HPS2154
OI   CVCL_A3WA ! HPS2155
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2153
AC   CVCL_A3VY
DR   RCB; HPS2153
DR   Wikidata; Q105508485
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP00 ! HPS2150
OI   CVCL_A3VW ! HPS2151
OI   CVCL_A3VX ! HPS2152
OI   CVCL_A3VZ ! HPS2154
OI   CVCL_A3WA ! HPS2155
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2154
AC   CVCL_A3VZ
DR   RCB; HPS2154
DR   Wikidata; Q105508487
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP00 ! HPS2150
OI   CVCL_A3VW ! HPS2151
OI   CVCL_A3VX ! HPS2152
OI   CVCL_A3VY ! HPS2153
OI   CVCL_A3WA ! HPS2155
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2155
AC   CVCL_A3WA
DR   RCB; HPS2155
DR   Wikidata; Q105508491
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34481; Eosinophilic granulomatosis with polyangiitis
DI   ORDO; Orphanet_183; Eosinophilic granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP00 ! HPS2150
OI   CVCL_A3VW ! HPS2151
OI   CVCL_A3VX ! HPS2152
OI   CVCL_A3VY ! HPS2153
OI   CVCL_A3VZ ! HPS2154
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2156
AC   CVCL_C9VZ
DR   RCB; HPS2156
DR   Wikidata; Q123032053
CC   Donor information: Patient suffering from a neuronal migration disorder and polymicrogyria, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9W0 ! HPS2157
OI   CVCL_C9W1 ! HPS2158
OI   CVCL_C9W2 ! HPS2159
OI   CVCL_C9W3 ! HPS2160
OI   CVCL_C9W4 ! HPS2161
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2157
AC   CVCL_C9W0
DR   RCB; HPS2157
DR   Wikidata; Q123032054
CC   Donor information: Patient suffering from a neuronal migration disorder and polymicrogyria, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VZ ! HPS2156
OI   CVCL_C9W1 ! HPS2158
OI   CVCL_C9W2 ! HPS2159
OI   CVCL_C9W3 ! HPS2160
OI   CVCL_C9W4 ! HPS2161
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2158
AC   CVCL_C9W1
DR   RCB; HPS2158
DR   Wikidata; Q123032055
CC   Donor information: Patient suffering from a neuronal migration disorder and polymicrogyria, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VZ ! HPS2156
OI   CVCL_C9W0 ! HPS2157
OI   CVCL_C9W2 ! HPS2159
OI   CVCL_C9W3 ! HPS2160
OI   CVCL_C9W4 ! HPS2161
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2159
AC   CVCL_C9W2
DR   RCB; HPS2159
DR   Wikidata; Q123032056
CC   Donor information: Patient suffering from a neuronal migration disorder and polymicrogyria, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VZ ! HPS2156
OI   CVCL_C9W0 ! HPS2157
OI   CVCL_C9W1 ! HPS2158
OI   CVCL_C9W3 ! HPS2160
OI   CVCL_C9W4 ! HPS2161
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2160
AC   CVCL_C9W3
DR   RCB; HPS2160
DR   Wikidata; Q123032057
CC   Donor information: Patient suffering from a neuronal migration disorder and polymicrogyria, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VZ ! HPS2156
OI   CVCL_C9W0 ! HPS2157
OI   CVCL_C9W1 ! HPS2158
OI   CVCL_C9W2 ! HPS2159
OI   CVCL_C9W4 ! HPS2161
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2161
AC   CVCL_C9W4
DR   RCB; HPS2161
DR   Wikidata; Q123032059
CC   Donor information: Patient suffering from a neuronal migration disorder and polymicrogyria, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9VZ ! HPS2156
OI   CVCL_C9W0 ! HPS2157
OI   CVCL_C9W1 ! HPS2158
OI   CVCL_C9W2 ! HPS2159
OI   CVCL_C9W3 ! HPS2160
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2174
AC   CVCL_C9W5
DR   RCB; HPS2174
DR   Wikidata; Q123032061
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), sensory-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9W6 ! HPS2175
OI   CVCL_C9W7 ! HPS2176
OI   CVCL_C9W8 ! HPS2177
OI   CVCL_C9W9 ! HPS2178
OI   CVCL_C9WA ! HPS2179
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2175
AC   CVCL_C9W6
DR   RCB; HPS2175
DR   Wikidata; Q123032062
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), sensory-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9W5 ! HPS2174
OI   CVCL_C9W7 ! HPS2176
OI   CVCL_C9W8 ! HPS2177
OI   CVCL_C9W9 ! HPS2178
OI   CVCL_C9WA ! HPS2179
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2176
AC   CVCL_C9W7
DR   RCB; HPS2176
DR   Wikidata; Q123032063
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), sensory-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9W5 ! HPS2174
OI   CVCL_C9W6 ! HPS2175
OI   CVCL_C9W8 ! HPS2177
OI   CVCL_C9W9 ! HPS2178
OI   CVCL_C9WA ! HPS2179
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2177
AC   CVCL_C9W8
DR   RCB; HPS2177
DR   Wikidata; Q123032066
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), sensory-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9W5 ! HPS2174
OI   CVCL_C9W6 ! HPS2175
OI   CVCL_C9W7 ! HPS2176
OI   CVCL_C9W9 ! HPS2178
OI   CVCL_C9WA ! HPS2179
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2178
AC   CVCL_C9W9
DR   RCB; HPS2178
DR   Wikidata; Q123032067
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), sensory-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9W5 ! HPS2174
OI   CVCL_C9W6 ! HPS2175
OI   CVCL_C9W7 ! HPS2176
OI   CVCL_C9W8 ! HPS2177
OI   CVCL_C9WA ! HPS2179
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2179
AC   CVCL_C9WA
DR   RCB; HPS2179
DR   Wikidata; Q123032069
CC   Donor information: Patient suffering from chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (MMN), sensory-predominant.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84636; Chronic inflammatory demyelinating polyneuropathy
DI   ORDO; Orphanet_2932; Chronic inflammatory demyelinating polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9W5 ! HPS2174
OI   CVCL_C9W6 ! HPS2175
OI   CVCL_C9W7 ! HPS2176
OI   CVCL_C9W8 ! HPS2177
OI   CVCL_C9W9 ! HPS2178
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2180
AC   CVCL_D1AE
DR   RCB; HPS2180
DR   Wikidata; Q123032070
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AF ! HPS2181
OI   CVCL_D1AG ! HPS2182
OI   CVCL_D1AH ! HPS2183
OI   CVCL_D1AI ! HPS2184
OI   CVCL_D1AJ ! HPS2185
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2181
AC   CVCL_D1AF
DR   RCB; HPS2181
DR   Wikidata; Q123032071
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AE ! HPS2180
OI   CVCL_D1AG ! HPS2182
OI   CVCL_D1AH ! HPS2183
OI   CVCL_D1AI ! HPS2184
OI   CVCL_D1AJ ! HPS2185
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2182
AC   CVCL_D1AG
DR   RCB; HPS2182
DR   Wikidata; Q123032072
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AE ! HPS2180
OI   CVCL_D1AF ! HPS2181
OI   CVCL_D1AH ! HPS2183
OI   CVCL_D1AI ! HPS2184
OI   CVCL_D1AJ ! HPS2185
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2183
AC   CVCL_D1AH
DR   RCB; HPS2183
DR   Wikidata; Q123032074
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AE ! HPS2180
OI   CVCL_D1AF ! HPS2181
OI   CVCL_D1AG ! HPS2182
OI   CVCL_D1AI ! HPS2184
OI   CVCL_D1AJ ! HPS2185
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2184
AC   CVCL_D1AI
DR   RCB; HPS2184
DR   Wikidata; Q123032075
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AE ! HPS2180
OI   CVCL_D1AF ! HPS2181
OI   CVCL_D1AG ! HPS2182
OI   CVCL_D1AH ! HPS2183
OI   CVCL_D1AJ ! HPS2185
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2185
AC   CVCL_D1AJ
DR   RCB; HPS2185
DR   Wikidata; Q123032076
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125384; Rasmussen subacute encephalitis
DI   ORDO; Orphanet_1929; Rasmussen subacute encephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AE ! HPS2180
OI   CVCL_D1AF ! HPS2181
OI   CVCL_D1AG ! HPS2182
OI   CVCL_D1AH ! HPS2183
OI   CVCL_D1AI ! HPS2184
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2186
AC   CVCL_UP01
DR   RCB; HPS2186
DR   Wikidata; Q94220008
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3VR ! HPS2187
OI   CVCL_A3VS ! HPS2188
OI   CVCL_A3VT ! HPS2189
OI   CVCL_A3VU ! HPS2190
OI   CVCL_A3VV ! HPS2191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2187
AC   CVCL_A3VR
DR   RCB; HPS2187
DR   Wikidata; Q105508495
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP01 ! HPS2186
OI   CVCL_A3VS ! HPS2188
OI   CVCL_A3VT ! HPS2189
OI   CVCL_A3VU ! HPS2190
OI   CVCL_A3VV ! HPS2191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2188
AC   CVCL_A3VS
DR   RCB; HPS2188
DR   Wikidata; Q105508499
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP01 ! HPS2186
OI   CVCL_A3VR ! HPS2187
OI   CVCL_A3VT ! HPS2189
OI   CVCL_A3VU ! HPS2190
OI   CVCL_A3VV ! HPS2191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2189
AC   CVCL_A3VT
DR   RCB; HPS2189
DR   Wikidata; Q105508501
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP01 ! HPS2186
OI   CVCL_A3VR ! HPS2187
OI   CVCL_A3VS ! HPS2188
OI   CVCL_A3VU ! HPS2190
OI   CVCL_A3VV ! HPS2191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2190
AC   CVCL_A3VU
DR   RCB; HPS2190
DR   Wikidata; Q105508505
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP01 ! HPS2186
OI   CVCL_A3VR ! HPS2187
OI   CVCL_A3VS ! HPS2188
OI   CVCL_A3VT ! HPS2189
OI   CVCL_A3VV ! HPS2191
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2191
AC   CVCL_A3VV
DR   RCB; HPS2191
DR   Wikidata; Q105508508
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP01 ! HPS2186
OI   CVCL_A3VR ! HPS2187
OI   CVCL_A3VS ! HPS2188
OI   CVCL_A3VT ! HPS2189
OI   CVCL_A3VU ! HPS2190
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2192
AC   CVCL_YS47
DR   RCB; HPS2192
DR   Wikidata; Q94220012
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS48 ! HPS2193
OI   CVCL_YS49 ! HPS2194
OI   CVCL_YS50 ! HPS2195
OI   CVCL_YS51 ! HPS2196
OI   CVCL_YS52 ! HPS2197
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2193
AC   CVCL_YS48
DR   RCB; HPS2193
DR   Wikidata; Q94220017
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS47 ! HPS2192
OI   CVCL_YS49 ! HPS2194
OI   CVCL_YS50 ! HPS2195
OI   CVCL_YS51 ! HPS2196
OI   CVCL_YS52 ! HPS2197
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2194
AC   CVCL_YS49
DR   RCB; HPS2194
DR   Wikidata; Q94220021
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS47 ! HPS2192
OI   CVCL_YS48 ! HPS2193
OI   CVCL_YS50 ! HPS2195
OI   CVCL_YS51 ! HPS2196
OI   CVCL_YS52 ! HPS2197
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2195
AC   CVCL_YS50
DR   RCB; HPS2195
DR   Wikidata; Q94220025
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS47 ! HPS2192
OI   CVCL_YS48 ! HPS2193
OI   CVCL_YS49 ! HPS2194
OI   CVCL_YS51 ! HPS2196
OI   CVCL_YS52 ! HPS2197
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2196
AC   CVCL_YS51
DR   RCB; HPS2196
DR   Wikidata; Q94220029
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS47 ! HPS2192
OI   CVCL_YS48 ! HPS2193
OI   CVCL_YS49 ! HPS2194
OI   CVCL_YS50 ! HPS2195
OI   CVCL_YS52 ! HPS2197
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2197
AC   CVCL_YS52
DR   RCB; HPS2197
DR   Wikidata; Q94220033
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS47 ! HPS2192
OI   CVCL_YS48 ! HPS2193
OI   CVCL_YS49 ! HPS2194
OI   CVCL_YS50 ! HPS2195
OI   CVCL_YS51 ! HPS2196
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2198
AC   CVCL_UP02
DR   RCB; HPS2198
DR   Wikidata; Q94220037
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3RR ! HPS2199
OI   CVCL_A3RS ! HPS2200
OI   CVCL_A3RT ! HPS2201
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2199
AC   CVCL_A3RR
DR   RCB; HPS2199
DR   Wikidata; Q105508509
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP02 ! HPS2198
OI   CVCL_A3RS ! HPS2200
OI   CVCL_A3RT ! HPS2201
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2200
AC   CVCL_A3RS
DR   RCB; HPS2200
DR   Wikidata; Q105508514
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP02 ! HPS2198
OI   CVCL_A3RR ! HPS2199
OI   CVCL_A3RT ! HPS2201
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2201
AC   CVCL_A3RT
DR   RCB; HPS2201
DR   Wikidata; Q105508518
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP02 ! HPS2198
OI   CVCL_A3RR ! HPS2199
OI   CVCL_A3RS ! HPS2200
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2208
AC   CVCL_D0ZW
DR   RCB; HPS2208
DR   Wikidata; Q123032077
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZX ! HPS2209
OI   CVCL_D0ZY ! HPS2210
OI   CVCL_D0ZZ ! HPS2211
OI   CVCL_D1A0 ! HPS2212
OI   CVCL_D1A1 ! HPS2213
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2209
AC   CVCL_D0ZX
DR   RCB; HPS2209
DR   Wikidata; Q123032078
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZW ! HPS2208
OI   CVCL_D0ZY ! HPS2210
OI   CVCL_D0ZZ ! HPS2211
OI   CVCL_D1A0 ! HPS2212
OI   CVCL_D1A1 ! HPS2213
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2210
AC   CVCL_D0ZY
DR   RCB; HPS2210
DR   Wikidata; Q123032079
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZW ! HPS2208
OI   CVCL_D0ZX ! HPS2209
OI   CVCL_D0ZZ ! HPS2211
OI   CVCL_D1A0 ! HPS2212
OI   CVCL_D1A1 ! HPS2213
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2211
AC   CVCL_D0ZZ
DR   RCB; HPS2211
DR   Wikidata; Q123032080
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZW ! HPS2208
OI   CVCL_D0ZX ! HPS2209
OI   CVCL_D0ZY ! HPS2210
OI   CVCL_D1A0 ! HPS2212
OI   CVCL_D1A1 ! HPS2213
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2212
AC   CVCL_D1A0
DR   RCB; HPS2212
DR   Wikidata; Q123032081
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZW ! HPS2208
OI   CVCL_D0ZX ! HPS2209
OI   CVCL_D0ZY ! HPS2210
OI   CVCL_D0ZZ ! HPS2211
OI   CVCL_D1A1 ! HPS2213
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2213
AC   CVCL_D1A1
DR   RCB; HPS2213
DR   Wikidata; Q123032082
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZW ! HPS2208
OI   CVCL_D0ZX ! HPS2209
OI   CVCL_D0ZY ! HPS2210
OI   CVCL_D0ZZ ! HPS2211
OI   CVCL_D1A0 ! HPS2212
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2214
AC   CVCL_UN42
DR   RCB; HPS2214
DR   Wikidata; Q94220041
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3PY ! HPS2215
OI   CVCL_A3PZ ! HPS2216
OI   CVCL_A3QA ! HPS2217
OI   CVCL_A3QB ! HPS2218
OI   CVCL_A3QC ! HPS2219
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2215
AC   CVCL_A3PY
DR   RCB; HPS2215
DR   Wikidata; Q105508522
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN42 ! HPS2214
OI   CVCL_A3PZ ! HPS2216
OI   CVCL_A3QA ! HPS2217
OI   CVCL_A3QB ! HPS2218
OI   CVCL_A3QC ! HPS2219
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2216
AC   CVCL_A3PZ
DR   RCB; HPS2216
DR   Wikidata; Q105508526
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN42 ! HPS2214
OI   CVCL_A3PY ! HPS2215
OI   CVCL_A3QA ! HPS2217
OI   CVCL_A3QB ! HPS2218
OI   CVCL_A3QC ! HPS2219
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2217
AC   CVCL_A3QA
DR   RCB; HPS2217
DR   Wikidata; Q105508528
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN42 ! HPS2214
OI   CVCL_A3PY ! HPS2215
OI   CVCL_A3PZ ! HPS2216
OI   CVCL_A3QB ! HPS2218
OI   CVCL_A3QC ! HPS2219
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2218
AC   CVCL_A3QB
DR   RCB; HPS2218
DR   Wikidata; Q105508531
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN42 ! HPS2214
OI   CVCL_A3PY ! HPS2215
OI   CVCL_A3PZ ! HPS2216
OI   CVCL_A3QA ! HPS2217
OI   CVCL_A3QC ! HPS2219
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2219
AC   CVCL_A3QC
DR   RCB; HPS2219
DR   Wikidata; Q105508537
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN42 ! HPS2214
OI   CVCL_A3PY ! HPS2215
OI   CVCL_A3PZ ! HPS2216
OI   CVCL_A3QA ! HPS2217
OI   CVCL_A3QB ! HPS2218
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2220
AC   CVCL_VM83
DR   RCB; HPS2220
DR   Wikidata; Q94220046
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3QD ! HPS2221
OI   CVCL_A3QE ! HPS2222
OI   CVCL_A3QF ! HPS2223
OI   CVCL_A3QG ! HPS2224
OI   CVCL_A3QH ! HPS2225
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   HPS2221
AC   CVCL_A3QD
DR   RCB; HPS2221
DR   Wikidata; Q105508542
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM83 ! HPS2220
OI   CVCL_A3QE ! HPS2222
OI   CVCL_A3QF ! HPS2223
OI   CVCL_A3QG ! HPS2224
OI   CVCL_A3QH ! HPS2225
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2222
AC   CVCL_A3QE
DR   RCB; HPS2222
DR   Wikidata; Q105508544
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM83 ! HPS2220
OI   CVCL_A3QD ! HPS2221
OI   CVCL_A3QF ! HPS2223
OI   CVCL_A3QG ! HPS2224
OI   CVCL_A3QH ! HPS2225
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2223
AC   CVCL_A3QF
DR   RCB; HPS2223
DR   Wikidata; Q105508547
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM83 ! HPS2220
OI   CVCL_A3QD ! HPS2221
OI   CVCL_A3QE ! HPS2222
OI   CVCL_A3QG ! HPS2224
OI   CVCL_A3QH ! HPS2225
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2224
AC   CVCL_A3QG
DR   RCB; HPS2224
DR   Wikidata; Q105508552
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM83 ! HPS2220
OI   CVCL_A3QD ! HPS2221
OI   CVCL_A3QE ! HPS2222
OI   CVCL_A3QF ! HPS2223
OI   CVCL_A3QH ! HPS2225
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2225
AC   CVCL_A3QH
DR   RCB; HPS2225
DR   Wikidata; Q105508557
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM83 ! HPS2220
OI   CVCL_A3QD ! HPS2221
OI   CVCL_A3QE ! HPS2222
OI   CVCL_A3QF ! HPS2223
OI   CVCL_A3QG ! HPS2224
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2226
AC   CVCL_UP03
DR   RCB; HPS2226
DR   Wikidata; Q94220050
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3QI ! HPS2227
OI   CVCL_A3QJ ! HPS2228
OI   CVCL_A3QK ! HPS2229
OI   CVCL_A3QL ! HPS2230
OI   CVCL_A3QM ! HPS2231
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2227
AC   CVCL_A3QI
DR   RCB; HPS2227
DR   Wikidata; Q105508560
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP03 ! HPS2226
OI   CVCL_A3QJ ! HPS2228
OI   CVCL_A3QK ! HPS2229
OI   CVCL_A3QL ! HPS2230
OI   CVCL_A3QM ! HPS2231
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2228
AC   CVCL_A3QJ
DR   RCB; HPS2228
DR   Wikidata; Q105508562
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP03 ! HPS2226
OI   CVCL_A3QI ! HPS2227
OI   CVCL_A3QK ! HPS2229
OI   CVCL_A3QL ! HPS2230
OI   CVCL_A3QM ! HPS2231
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2229
AC   CVCL_A3QK
DR   RCB; HPS2229
DR   Wikidata; Q105508567
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP03 ! HPS2226
OI   CVCL_A3QI ! HPS2227
OI   CVCL_A3QJ ! HPS2228
OI   CVCL_A3QL ! HPS2230
OI   CVCL_A3QM ! HPS2231
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2230
AC   CVCL_A3QL
DR   RCB; HPS2230
DR   Wikidata; Q105508569
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP03 ! HPS2226
OI   CVCL_A3QI ! HPS2227
OI   CVCL_A3QJ ! HPS2228
OI   CVCL_A3QK ! HPS2229
OI   CVCL_A3QM ! HPS2231
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2231
AC   CVCL_A3QM
DR   RCB; HPS2231
DR   Wikidata; Q105508573
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP03 ! HPS2226
OI   CVCL_A3QI ! HPS2227
OI   CVCL_A3QJ ! HPS2228
OI   CVCL_A3QK ! HPS2229
OI   CVCL_A3QL ! HPS2230
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2238
AC   CVCL_C9WB
DR   RCB; HPS2238
DR   Wikidata; Q123032083
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202012; Isaacs syndrome
DI   ORDO; Orphanet_84142; Isaacs syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WC ! HPS2239
OI   CVCL_C9WD ! HPS2240
OI   CVCL_C9WE ! HPS2241
OI   CVCL_C9WF ! HPS2242
OI   CVCL_C9WG ! HPS2243
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2239
AC   CVCL_C9WC
DR   RCB; HPS2239
DR   Wikidata; Q123032084
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202012; Isaacs syndrome
DI   ORDO; Orphanet_84142; Isaacs syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WB ! HPS2238
OI   CVCL_C9WD ! HPS2240
OI   CVCL_C9WE ! HPS2241
OI   CVCL_C9WF ! HPS2242
OI   CVCL_C9WG ! HPS2243
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2240
AC   CVCL_C9WD
DR   RCB; HPS2240
DR   Wikidata; Q123032085
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202012; Isaacs syndrome
DI   ORDO; Orphanet_84142; Isaacs syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WB ! HPS2238
OI   CVCL_C9WC ! HPS2239
OI   CVCL_C9WE ! HPS2241
OI   CVCL_C9WF ! HPS2242
OI   CVCL_C9WG ! HPS2243
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2241
AC   CVCL_C9WE
DR   RCB; HPS2241
DR   Wikidata; Q123032086
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202012; Isaacs syndrome
DI   ORDO; Orphanet_84142; Isaacs syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WB ! HPS2238
OI   CVCL_C9WC ! HPS2239
OI   CVCL_C9WD ! HPS2240
OI   CVCL_C9WF ! HPS2242
OI   CVCL_C9WG ! HPS2243
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2242
AC   CVCL_C9WF
DR   RCB; HPS2242
DR   Wikidata; Q123032087
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202012; Isaacs syndrome
DI   ORDO; Orphanet_84142; Isaacs syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WB ! HPS2238
OI   CVCL_C9WC ! HPS2239
OI   CVCL_C9WD ! HPS2240
OI   CVCL_C9WE ! HPS2241
OI   CVCL_C9WG ! HPS2243
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2243
AC   CVCL_C9WG
DR   RCB; HPS2243
DR   Wikidata; Q123032088
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202012; Isaacs syndrome
DI   ORDO; Orphanet_84142; Isaacs syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WB ! HPS2238
OI   CVCL_C9WC ! HPS2239
OI   CVCL_C9WD ! HPS2240
OI   CVCL_C9WE ! HPS2241
OI   CVCL_C9WF ! HPS2242
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2250
AC   CVCL_UP04
DR   RCB; HPS2250
DR   Wikidata; Q94220054
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3RL ! HPS2251
OI   CVCL_A3RM ! HPS2252
OI   CVCL_A3RN ! HPS2253
OI   CVCL_A3RP ! HPS2254
OI   CVCL_A3RQ ! HPS2255
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2251
AC   CVCL_A3RL
DR   RCB; HPS2251
DR   Wikidata; Q105508577
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP04 ! HPS2250
OI   CVCL_A3RM ! HPS2252
OI   CVCL_A3RN ! HPS2253
OI   CVCL_A3RP ! HPS2254
OI   CVCL_A3RQ ! HPS2255
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2252
AC   CVCL_A3RM
DR   RCB; HPS2252
DR   Wikidata; Q105508580
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP04 ! HPS2250
OI   CVCL_A3RL ! HPS2251
OI   CVCL_A3RN ! HPS2253
OI   CVCL_A3RP ! HPS2254
OI   CVCL_A3RQ ! HPS2255
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2253
AC   CVCL_A3RN
DR   RCB; HPS2253
DR   Wikidata; Q105508583
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP04 ! HPS2250
OI   CVCL_A3RL ! HPS2251
OI   CVCL_A3RM ! HPS2252
OI   CVCL_A3RP ! HPS2254
OI   CVCL_A3RQ ! HPS2255
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2254
AC   CVCL_A3RP
DR   RCB; HPS2254
DR   Wikidata; Q105508588
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP04 ! HPS2250
OI   CVCL_A3RL ! HPS2251
OI   CVCL_A3RM ! HPS2252
OI   CVCL_A3RN ! HPS2253
OI   CVCL_A3RQ ! HPS2255
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2255
AC   CVCL_A3RQ
DR   RCB; HPS2255
DR   Wikidata; Q105508589
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP04 ! HPS2250
OI   CVCL_A3RL ! HPS2251
OI   CVCL_A3RM ! HPS2252
OI   CVCL_A3RN ! HPS2253
OI   CVCL_A3RP ! HPS2254
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2256
AC   CVCL_D1DY
DR   RCB; HPS2256
DR   Wikidata; Q123032089
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DZ ! HPS2257
OI   CVCL_D1E0 ! HPS2258
OI   CVCL_D1E1 ! HPS2259
OI   CVCL_D1E2 ! HPS2260
OI   CVCL_D1E3 ! HPS2261
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2257
AC   CVCL_D1DZ
DR   RCB; HPS2257
DR   Wikidata; Q123032090
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DY ! HPS2256
OI   CVCL_D1E0 ! HPS2258
OI   CVCL_D1E1 ! HPS2259
OI   CVCL_D1E2 ! HPS2260
OI   CVCL_D1E3 ! HPS2261
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2258
AC   CVCL_D1E0
DR   RCB; HPS2258
DR   Wikidata; Q123032091
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DY ! HPS2256
OI   CVCL_D1DZ ! HPS2257
OI   CVCL_D1E1 ! HPS2259
OI   CVCL_D1E2 ! HPS2260
OI   CVCL_D1E3 ! HPS2261
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2259
AC   CVCL_D1E1
DR   RCB; HPS2259
DR   Wikidata; Q123032092
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DY ! HPS2256
OI   CVCL_D1DZ ! HPS2257
OI   CVCL_D1E0 ! HPS2258
OI   CVCL_D1E2 ! HPS2260
OI   CVCL_D1E3 ! HPS2261
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2260
AC   CVCL_D1E2
DR   RCB; HPS2260
DR   Wikidata; Q123032093
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DY ! HPS2256
OI   CVCL_D1DZ ! HPS2257
OI   CVCL_D1E0 ! HPS2258
OI   CVCL_D1E1 ! HPS2259
OI   CVCL_D1E3 ! HPS2261
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2261
AC   CVCL_D1E3
DR   RCB; HPS2261
DR   Wikidata; Q123032094
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26847; Polyarteritis nodosa
DI   ORDO; Orphanet_767; Polyarteritis nodosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DY ! HPS2256
OI   CVCL_D1DZ ! HPS2257
OI   CVCL_D1E0 ! HPS2258
OI   CVCL_D1E1 ! HPS2259
OI   CVCL_D1E2 ! HPS2260
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2262
AC   CVCL_D1AV
DR   RCB; HPS2262
DR   Wikidata; Q123032095
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AW ! HPS2263
OI   CVCL_D1AX ! HPS2264
OI   CVCL_D1AY ! HPS2265
OI   CVCL_D1AZ ! HPS2266
OI   CVCL_D1B0 ! HPS2267
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2263
AC   CVCL_D1AW
DR   RCB; HPS2263
DR   Wikidata; Q123032096
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AV ! HPS2262
OI   CVCL_D1AX ! HPS2264
OI   CVCL_D1AY ! HPS2265
OI   CVCL_D1AZ ! HPS2266
OI   CVCL_D1B0 ! HPS2267
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2264
AC   CVCL_D1AX
DR   RCB; HPS2264
DR   Wikidata; Q123032097
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AV ! HPS2262
OI   CVCL_D1AW ! HPS2263
OI   CVCL_D1AY ! HPS2265
OI   CVCL_D1AZ ! HPS2266
OI   CVCL_D1B0 ! HPS2267
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2265
AC   CVCL_D1AY
DR   RCB; HPS2265
DR   Wikidata; Q123032098
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AV ! HPS2262
OI   CVCL_D1AW ! HPS2263
OI   CVCL_D1AX ! HPS2264
OI   CVCL_D1AZ ! HPS2266
OI   CVCL_D1B0 ! HPS2267
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2266
AC   CVCL_D1AZ
DR   RCB; HPS2266
DR   Wikidata; Q123032099
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AV ! HPS2262
OI   CVCL_D1AW ! HPS2263
OI   CVCL_D1AX ! HPS2264
OI   CVCL_D1AY ! HPS2265
OI   CVCL_D1B0 ! HPS2267
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2267
AC   CVCL_D1B0
DR   RCB; HPS2267
DR   Wikidata; Q123032100
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122796; Idiopathic nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1AV ! HPS2262
OI   CVCL_D1AW ! HPS2263
OI   CVCL_D1AX ! HPS2264
OI   CVCL_D1AY ! HPS2265
OI   CVCL_D1AZ ! HPS2266
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2268
AC   CVCL_D1DL
DR   RCB; HPS2268
DR   Wikidata; Q123032101
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35330; Eosinophilic gastroenteritis
DI   ORDO; Orphanet_2070; Eosinophilic gastroenteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DM ! HPS2269
OI   CVCL_D1DN ! HPS2270
OI   CVCL_D1DP ! HPS2271
OI   CVCL_D1DQ ! HPS2272
OI   CVCL_D1DR ! HPS2273
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2269
AC   CVCL_D1DM
DR   RCB; HPS2269
DR   Wikidata; Q123032102
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35330; Eosinophilic gastroenteritis
DI   ORDO; Orphanet_2070; Eosinophilic gastroenteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DL ! HPS2268
OI   CVCL_D1DN ! HPS2270
OI   CVCL_D1DP ! HPS2271
OI   CVCL_D1DQ ! HPS2272
OI   CVCL_D1DR ! HPS2273
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2270
AC   CVCL_D1DN
DR   RCB; HPS2270
DR   Wikidata; Q123032104
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35330; Eosinophilic gastroenteritis
DI   ORDO; Orphanet_2070; Eosinophilic gastroenteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DL ! HPS2268
OI   CVCL_D1DM ! HPS2269
OI   CVCL_D1DP ! HPS2271
OI   CVCL_D1DQ ! HPS2272
OI   CVCL_D1DR ! HPS2273
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2271
AC   CVCL_D1DP
DR   RCB; HPS2271
DR   Wikidata; Q123032106
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35330; Eosinophilic gastroenteritis
DI   ORDO; Orphanet_2070; Eosinophilic gastroenteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DL ! HPS2268
OI   CVCL_D1DM ! HPS2269
OI   CVCL_D1DN ! HPS2270
OI   CVCL_D1DQ ! HPS2272
OI   CVCL_D1DR ! HPS2273
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2272
AC   CVCL_D1DQ
DR   RCB; HPS2272
DR   Wikidata; Q123032107
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35330; Eosinophilic gastroenteritis
DI   ORDO; Orphanet_2070; Eosinophilic gastroenteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DL ! HPS2268
OI   CVCL_D1DM ! HPS2269
OI   CVCL_D1DN ! HPS2270
OI   CVCL_D1DP ! HPS2271
OI   CVCL_D1DR ! HPS2273
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2273
AC   CVCL_D1DR
DR   RCB; HPS2273
DR   Wikidata; Q123032108
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35330; Eosinophilic gastroenteritis
DI   ORDO; Orphanet_2070; Eosinophilic gastroenteritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DL ! HPS2268
OI   CVCL_D1DM ! HPS2269
OI   CVCL_D1DN ! HPS2270
OI   CVCL_D1DP ! HPS2271
OI   CVCL_D1DQ ! HPS2272
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2274
AC   CVCL_UP05
DR   RCB; HPS2274
DR   Wikidata; Q94220060
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3RG ! HPS2275
OI   CVCL_A3RH ! HPS2276
OI   CVCL_A3RI ! HPS2277
OI   CVCL_A3RJ ! HPS2278
OI   CVCL_A3RK ! HPS2279
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2275
AC   CVCL_A3RG
DR   RCB; HPS2275
DR   Wikidata; Q105508596
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP05 ! HPS2274
OI   CVCL_A3RH ! HPS2276
OI   CVCL_A3RI ! HPS2277
OI   CVCL_A3RJ ! HPS2278
OI   CVCL_A3RK ! HPS2279
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2276
AC   CVCL_A3RH
DR   RCB; HPS2276
DR   Wikidata; Q105508599
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP05 ! HPS2274
OI   CVCL_A3RG ! HPS2275
OI   CVCL_A3RI ! HPS2277
OI   CVCL_A3RJ ! HPS2278
OI   CVCL_A3RK ! HPS2279
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2277
AC   CVCL_A3RI
DR   RCB; HPS2277
DR   Wikidata; Q105508604
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP05 ! HPS2274
OI   CVCL_A3RG ! HPS2275
OI   CVCL_A3RH ! HPS2276
OI   CVCL_A3RJ ! HPS2278
OI   CVCL_A3RK ! HPS2279
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2278
AC   CVCL_A3RJ
DR   RCB; HPS2278
DR   Wikidata; Q105508608
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP05 ! HPS2274
OI   CVCL_A3RG ! HPS2275
OI   CVCL_A3RH ! HPS2276
OI   CVCL_A3RI ! HPS2277
OI   CVCL_A3RK ! HPS2279
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2279
AC   CVCL_A3RK
DR   RCB; HPS2279
DR   Wikidata; Q105508610
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP05 ! HPS2274
OI   CVCL_A3RG ! HPS2275
OI   CVCL_A3RH ! HPS2276
OI   CVCL_A3RI ! HPS2277
OI   CVCL_A3RJ ! HPS2278
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2280
AC   CVCL_C9WH
DR   RCB; HPS2280
DR   Wikidata; Q123032109
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26815; Progressive multifocal leukoencephalopathy
DI   ORDO; Orphanet_217260; Progressive multifocal leukoencephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WI ! HPS2281
OI   CVCL_C9WJ ! HPS2282
OI   CVCL_C9WK ! HPS2283
OI   CVCL_C9WL ! HPS2284
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2281
AC   CVCL_C9WI
DR   RCB; HPS2281
DR   Wikidata; Q123032110
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26815; Progressive multifocal leukoencephalopathy
DI   ORDO; Orphanet_217260; Progressive multifocal leukoencephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WH ! HPS2280
OI   CVCL_C9WJ ! HPS2282
OI   CVCL_C9WK ! HPS2283
OI   CVCL_C9WL ! HPS2284
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2282
AC   CVCL_C9WJ
DR   RCB; HPS2282
DR   Wikidata; Q123032111
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26815; Progressive multifocal leukoencephalopathy
DI   ORDO; Orphanet_217260; Progressive multifocal leukoencephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WH ! HPS2280
OI   CVCL_C9WI ! HPS2281
OI   CVCL_C9WK ! HPS2283
OI   CVCL_C9WL ! HPS2284
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2283
AC   CVCL_C9WK
DR   RCB; HPS2283
DR   Wikidata; Q123032112
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26815; Progressive multifocal leukoencephalopathy
DI   ORDO; Orphanet_217260; Progressive multifocal leukoencephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WH ! HPS2280
OI   CVCL_C9WI ! HPS2281
OI   CVCL_C9WJ ! HPS2282
OI   CVCL_C9WL ! HPS2284
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2284
AC   CVCL_C9WL
DR   RCB; HPS2284
DR   Wikidata; Q123032114
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26815; Progressive multifocal leukoencephalopathy
DI   ORDO; Orphanet_217260; Progressive multifocal leukoencephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WH ! HPS2280
OI   CVCL_C9WI ! HPS2281
OI   CVCL_C9WJ ! HPS2282
OI   CVCL_C9WK ! HPS2283
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2285
AC   CVCL_C9WM
DR   RCB; HPS2285
DR   Wikidata; Q123032116
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85179; Syringomyelia
DI   ORDO; Orphanet_3280; Syringomyelia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WN ! HPS2286
OI   CVCL_C9WP ! HPS2287
OI   CVCL_C9WQ ! HPS2288
OI   CVCL_C9WR ! HPS2289
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2286
AC   CVCL_C9WN
DR   RCB; HPS2286
DR   Wikidata; Q123032117
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85179; Syringomyelia
DI   ORDO; Orphanet_3280; Syringomyelia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WM ! HPS2285
OI   CVCL_C9WP ! HPS2287
OI   CVCL_C9WQ ! HPS2288
OI   CVCL_C9WR ! HPS2289
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2287
AC   CVCL_C9WP
DR   RCB; HPS2287
DR   Wikidata; Q123032118
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85179; Syringomyelia
DI   ORDO; Orphanet_3280; Syringomyelia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WM ! HPS2285
OI   CVCL_C9WN ! HPS2286
OI   CVCL_C9WQ ! HPS2288
OI   CVCL_C9WR ! HPS2289
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2288
AC   CVCL_C9WQ
DR   RCB; HPS2288
DR   Wikidata; Q123032119
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85179; Syringomyelia
DI   ORDO; Orphanet_3280; Syringomyelia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WM ! HPS2285
OI   CVCL_C9WN ! HPS2286
OI   CVCL_C9WP ! HPS2287
OI   CVCL_C9WR ! HPS2289
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2289
AC   CVCL_C9WR
DR   RCB; HPS2289
DR   Wikidata; Q123032120
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85179; Syringomyelia
DI   ORDO; Orphanet_3280; Syringomyelia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WM ! HPS2285
OI   CVCL_C9WN ! HPS2286
OI   CVCL_C9WP ! HPS2287
OI   CVCL_C9WQ ! HPS2288
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2296
AC   CVCL_YS53
SY   BRCi020-A
DR   hPSCreg; BRCi020-A
DR   RCB; HPS2296
DR   Wikidata; Q94220064
RX   PubMed=35292424;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS54 ! HPS2297
OI   CVCL_YS55 ! HPS2298
OI   CVCL_YS56 ! HPS2299
OI   CVCL_YS57 ! HPS2300
SX   Male
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 6
//
ID   HPS2297
AC   CVCL_YS54
SY   BRCi020-B
DR   hPSCreg; BRCi020-B
DR   RCB; HPS2297
DR   Wikidata; Q94220068
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS53 ! HPS2296
OI   CVCL_YS55 ! HPS2298
OI   CVCL_YS56 ! HPS2299
OI   CVCL_YS57 ! HPS2300
SX   Male
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 7
//
ID   HPS2298
AC   CVCL_YS55
SY   BRCi020-C
DR   hPSCreg; BRCi020-C
DR   RCB; HPS2298
DR   Wikidata; Q94220073
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS53 ! HPS2296
OI   CVCL_YS54 ! HPS2297
OI   CVCL_YS56 ! HPS2299
OI   CVCL_YS57 ! HPS2300
SX   Male
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 6
//
ID   HPS2299
AC   CVCL_YS56
SY   BRCi020-D
DR   hPSCreg; BRCi020-D
DR   RCB; HPS2299
DR   Wikidata; Q94220079
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS53 ! HPS2296
OI   CVCL_YS54 ! HPS2297
OI   CVCL_YS55 ! HPS2298
OI   CVCL_YS57 ! HPS2300
SX   Male
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 6
//
ID   HPS2300
AC   CVCL_YS57
SY   BRCi020-E
DR   hPSCreg; BRCi020-E
DR   RCB; HPS2300
DR   Wikidata; Q94220083
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS53 ! HPS2296
OI   CVCL_YS54 ! HPS2297
OI   CVCL_YS55 ! HPS2298
OI   CVCL_YS56 ! HPS2299
SX   Male
AG   1-5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 6
//
ID   HPS2301
AC   CVCL_C9WS
DR   RCB; HPS2301
DR   Wikidata; Q123032121
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2301).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WT ! HPS2302
OI   CVCL_C9WU ! HPS2303
OI   CVCL_C9WV ! HPS2304
OI   CVCL_C9WW ! HPS2305
OI   CVCL_C9WX ! HPS2306
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2302
AC   CVCL_C9WT
DR   RCB; HPS2302
DR   Wikidata; Q123032122
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2302).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WS ! HPS2301
OI   CVCL_C9WU ! HPS2303
OI   CVCL_C9WV ! HPS2304
OI   CVCL_C9WW ! HPS2305
OI   CVCL_C9WX ! HPS2306
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2303
AC   CVCL_C9WU
DR   RCB; HPS2303
DR   Wikidata; Q123032123
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2303).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WS ! HPS2301
OI   CVCL_C9WT ! HPS2302
OI   CVCL_C9WV ! HPS2304
OI   CVCL_C9WW ! HPS2305
OI   CVCL_C9WX ! HPS2306
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2304
AC   CVCL_C9WV
DR   RCB; HPS2304
DR   Wikidata; Q123032124
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2304).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WS ! HPS2301
OI   CVCL_C9WT ! HPS2302
OI   CVCL_C9WU ! HPS2303
OI   CVCL_C9WW ! HPS2305
OI   CVCL_C9WX ! HPS2306
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2305
AC   CVCL_C9WW
DR   RCB; HPS2305
DR   Wikidata; Q123032125
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2305).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WS ! HPS2301
OI   CVCL_C9WT ! HPS2302
OI   CVCL_C9WU ! HPS2303
OI   CVCL_C9WV ! HPS2304
OI   CVCL_C9WX ! HPS2306
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2306
AC   CVCL_C9WX
DR   RCB; HPS2306
DR   Wikidata; Q123032126
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2306).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WS ! HPS2301
OI   CVCL_C9WT ! HPS2302
OI   CVCL_C9WU ! HPS2303
OI   CVCL_C9WV ! HPS2304
OI   CVCL_C9WW ! HPS2305
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2307
AC   CVCL_UP06
DR   RCB; HPS2307
DR   Wikidata; Q94220086
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP07 ! HPS2308
OI   CVCL_UP08 ! HPS2309
OI   CVCL_A3RU ! HPS2310
OI   CVCL_A3RV ! HPS2311
OI   CVCL_A3RW ! HPS2312
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2308
AC   CVCL_UP07
DR   RCB; HPS2308
DR   Wikidata; Q94220091
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP06 ! HPS2307
OI   CVCL_UP08 ! HPS2309
OI   CVCL_A3RU ! HPS2310
OI   CVCL_A3RV ! HPS2311
OI   CVCL_A3RW ! HPS2312
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2309
AC   CVCL_UP08
DR   RCB; HPS2309
DR   Wikidata; Q94220095
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP06 ! HPS2307
OI   CVCL_UP07 ! HPS2308
OI   CVCL_A3RU ! HPS2310
OI   CVCL_A3RV ! HPS2311
OI   CVCL_A3RW ! HPS2312
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2310
AC   CVCL_A3RU
DR   RCB; HPS2310
DR   Wikidata; Q105508615
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP06 ! HPS2307
OI   CVCL_UP07 ! HPS2308
OI   CVCL_UP08 ! HPS2309
OI   CVCL_A3RV ! HPS2311
OI   CVCL_A3RW ! HPS2312
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2311
AC   CVCL_A3RV
DR   RCB; HPS2311
DR   Wikidata; Q105508617
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP06 ! HPS2307
OI   CVCL_UP07 ! HPS2308
OI   CVCL_UP08 ! HPS2309
OI   CVCL_A3RU ! HPS2310
OI   CVCL_A3RW ! HPS2312
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2312
AC   CVCL_A3RW
DR   RCB; HPS2312
DR   Wikidata; Q105508620
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3446; Idiopathic thrombocytopenic purpura
DI   ORDO; Orphanet_3002; Immune thrombocytopenic purpur
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP06 ! HPS2307
OI   CVCL_UP07 ! HPS2308
OI   CVCL_UP08 ! HPS2309
OI   CVCL_A3RU ! HPS2310
OI   CVCL_A3RV ! HPS2311
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2313
AC   CVCL_C9WY
DR   RCB; HPS2313
DR   Wikidata; Q123032127
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2313).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WZ ! HPS2314
OI   CVCL_C9X0 ! HPS2315
OI   CVCL_C9X1 ! HPS2316
OI   CVCL_C9X2 ! HPS2317
OI   CVCL_C9X3 ! HPS2318
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2314
AC   CVCL_C9WZ
DR   RCB; HPS2314
DR   Wikidata; Q123032128
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2314).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WY ! HPS2313
OI   CVCL_C9X0 ! HPS2315
OI   CVCL_C9X1 ! HPS2316
OI   CVCL_C9X2 ! HPS2317
OI   CVCL_C9X3 ! HPS2318
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2315
AC   CVCL_C9X0
DR   RCB; HPS2315
DR   Wikidata; Q123032129
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2315).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WY ! HPS2313
OI   CVCL_C9WZ ! HPS2314
OI   CVCL_C9X1 ! HPS2316
OI   CVCL_C9X2 ! HPS2317
OI   CVCL_C9X3 ! HPS2318
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2316
AC   CVCL_C9X1
DR   RCB; HPS2316
DR   Wikidata; Q123032130
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2316).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WY ! HPS2313
OI   CVCL_C9WZ ! HPS2314
OI   CVCL_C9X0 ! HPS2315
OI   CVCL_C9X2 ! HPS2317
OI   CVCL_C9X3 ! HPS2318
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2317
AC   CVCL_C9X2
DR   RCB; HPS2317
DR   Wikidata; Q123032131
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2317).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WY ! HPS2313
OI   CVCL_C9WZ ! HPS2314
OI   CVCL_C9X0 ! HPS2315
OI   CVCL_C9X1 ! HPS2316
OI   CVCL_C9X3 ! HPS2318
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2318
AC   CVCL_C9X3
DR   RCB; HPS2318
DR   Wikidata; Q123032132
CC   Sequence variation: Mutation; HGNC; HGNC:14270; PCDH19; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2318).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201590; Developmental and epileptic encephalopathy 9
DI   ORDO; Orphanet_101039; Female restricted epilepsy with intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9WY ! HPS2313
OI   CVCL_C9WZ ! HPS2314
OI   CVCL_C9X0 ! HPS2315
OI   CVCL_C9X1 ! HPS2316
OI   CVCL_C9X2 ! HPS2317
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2319
AC   CVCL_C9X4
DR   RCB; HPS2319
DR   Wikidata; Q123032133
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9X5 ! HPS2320
OI   CVCL_C9X6 ! HPS2321
OI   CVCL_C9X7 ! HPS2322
OI   CVCL_C9X8 ! HPS2323
OI   CVCL_C9X9 ! HPS2324
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2320
AC   CVCL_C9X5
DR   RCB; HPS2320
DR   Wikidata; Q123032134
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9X4 ! HPS2319
OI   CVCL_C9X6 ! HPS2321
OI   CVCL_C9X7 ! HPS2322
OI   CVCL_C9X8 ! HPS2323
OI   CVCL_C9X9 ! HPS2324
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2321
AC   CVCL_C9X6
DR   RCB; HPS2321
DR   Wikidata; Q123032135
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9X4 ! HPS2319
OI   CVCL_C9X5 ! HPS2320
OI   CVCL_C9X7 ! HPS2322
OI   CVCL_C9X8 ! HPS2323
OI   CVCL_C9X9 ! HPS2324
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2322
AC   CVCL_C9X7
DR   RCB; HPS2322
DR   Wikidata; Q123032136
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9X4 ! HPS2319
OI   CVCL_C9X5 ! HPS2320
OI   CVCL_C9X6 ! HPS2321
OI   CVCL_C9X8 ! HPS2323
OI   CVCL_C9X9 ! HPS2324
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2323
AC   CVCL_C9X8
DR   RCB; HPS2323
DR   Wikidata; Q123032137
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9X4 ! HPS2319
OI   CVCL_C9X5 ! HPS2320
OI   CVCL_C9X6 ! HPS2321
OI   CVCL_C9X7 ! HPS2322
OI   CVCL_C9X9 ! HPS2324
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2324
AC   CVCL_C9X9
DR   RCB; HPS2324
DR   Wikidata; Q123032138
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9X4 ! HPS2319
OI   CVCL_C9X5 ! HPS2320
OI   CVCL_C9X6 ! HPS2321
OI   CVCL_C9X7 ! HPS2322
OI   CVCL_C9X8 ! HPS2323
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2337
AC   CVCL_UP09
DR   RCB; HPS2337
DR   Wikidata; Q94220099
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3QT ! HPS2338
OI   CVCL_A3QU ! HPS2339
OI   CVCL_A3QV ! HPS2340
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2338
AC   CVCL_A3QT
DR   RCB; HPS2338
DR   Wikidata; Q105508624
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP09 ! HPS2337
OI   CVCL_A3QU ! HPS2339
OI   CVCL_A3QV ! HPS2340
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2339
AC   CVCL_A3QU
DR   RCB; HPS2339
DR   Wikidata; Q105508628
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP09 ! HPS2337
OI   CVCL_A3QT ! HPS2338
OI   CVCL_A3QV ! HPS2340
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2340
AC   CVCL_A3QV
DR   RCB; HPS2340
DR   Wikidata; Q105508631
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP09 ! HPS2337
OI   CVCL_A3QT ! HPS2338
OI   CVCL_A3QU ! HPS2339
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2341
AC   CVCL_C9XA
DR   RCB; HPS2341
DR   Wikidata; Q123032139
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XB ! HPS2342
OI   CVCL_C9XC ! HPS2343
OI   CVCL_C9XD ! HPS2344
OI   CVCL_C9XE ! HPS2345
OI   CVCL_C9XF ! HPS2346
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2342
AC   CVCL_C9XB
DR   RCB; HPS2342
DR   Wikidata; Q123032140
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XA ! HPS2341
OI   CVCL_C9XC ! HPS2343
OI   CVCL_C9XD ! HPS2344
OI   CVCL_C9XE ! HPS2345
OI   CVCL_C9XF ! HPS2346
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2343
AC   CVCL_C9XC
DR   RCB; HPS2343
DR   Wikidata; Q123032141
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XA ! HPS2341
OI   CVCL_C9XB ! HPS2342
OI   CVCL_C9XD ! HPS2344
OI   CVCL_C9XE ! HPS2345
OI   CVCL_C9XF ! HPS2346
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2344
AC   CVCL_C9XD
DR   RCB; HPS2344
DR   Wikidata; Q123032142
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XA ! HPS2341
OI   CVCL_C9XB ! HPS2342
OI   CVCL_C9XC ! HPS2343
OI   CVCL_C9XE ! HPS2345
OI   CVCL_C9XF ! HPS2346
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2345
AC   CVCL_C9XE
DR   RCB; HPS2345
DR   Wikidata; Q123032143
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XA ! HPS2341
OI   CVCL_C9XB ! HPS2342
OI   CVCL_C9XC ! HPS2343
OI   CVCL_C9XD ! HPS2344
OI   CVCL_C9XF ! HPS2346
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2346
AC   CVCL_C9XF
DR   RCB; HPS2346
DR   Wikidata; Q123032144
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XA ! HPS2341
OI   CVCL_C9XB ! HPS2342
OI   CVCL_C9XC ! HPS2343
OI   CVCL_C9XD ! HPS2344
OI   CVCL_C9XE ! HPS2345
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2347
AC   CVCL_C6C5
DR   RCB; HPS2347
DR   Wikidata; Q116049438
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6C6 ! HPS2348
OI   CVCL_C6C7 ! HPS2349
OI   CVCL_C6C8 ! HPS2350
OI   CVCL_C6C9 ! HPS2351
OI   CVCL_C6CA ! HPS2352
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2348
AC   CVCL_C6C6
DR   RCB; HPS2348
DR   Wikidata; Q116049439
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6C5 ! HPS2347
OI   CVCL_C6C7 ! HPS2349
OI   CVCL_C6C8 ! HPS2350
OI   CVCL_C6C9 ! HPS2351
OI   CVCL_C6CA ! HPS2352
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2349
AC   CVCL_C6C7
DR   RCB; HPS2349
DR   Wikidata; Q116049440
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6C5 ! HPS2347
OI   CVCL_C6C6 ! HPS2348
OI   CVCL_C6C8 ! HPS2350
OI   CVCL_C6C9 ! HPS2351
OI   CVCL_C6CA ! HPS2352
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2350
AC   CVCL_C6C8
DR   RCB; HPS2350
DR   Wikidata; Q116049441
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6C5 ! HPS2347
OI   CVCL_C6C6 ! HPS2348
OI   CVCL_C6C7 ! HPS2349
OI   CVCL_C6C9 ! HPS2351
OI   CVCL_C6CA ! HPS2352
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2351
AC   CVCL_C6C9
DR   RCB; HPS2351
DR   Wikidata; Q116049442
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6C5 ! HPS2347
OI   CVCL_C6C6 ! HPS2348
OI   CVCL_C6C7 ! HPS2349
OI   CVCL_C6C8 ! HPS2350
OI   CVCL_C6CA ! HPS2352
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2352
AC   CVCL_C6CA
DR   RCB; HPS2352
DR   Wikidata; Q116049443
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80303; POEMS syndrome
DI   ORDO; Orphanet_2905; POEMS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6C5 ! HPS2347
OI   CVCL_C6C6 ! HPS2348
OI   CVCL_C6C7 ! HPS2349
OI   CVCL_C6C8 ! HPS2350
OI   CVCL_C6C9 ! HPS2351
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2353
AC   CVCL_C9XG
DR   RCB; HPS2353
DR   Wikidata; Q123032145
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XH ! HPS2354
OI   CVCL_C9XI ! HPS2355
OI   CVCL_C9XJ ! HPS2356
OI   CVCL_C9XK ! HPS2357
OI   CVCL_C9XL ! HPS2358
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2354
AC   CVCL_C9XH
DR   RCB; HPS2354
DR   Wikidata; Q123032146
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XG ! HPS2353
OI   CVCL_C9XI ! HPS2355
OI   CVCL_C9XJ ! HPS2356
OI   CVCL_C9XK ! HPS2357
OI   CVCL_C9XL ! HPS2358
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2355
AC   CVCL_C9XI
DR   RCB; HPS2355
DR   Wikidata; Q123032147
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XG ! HPS2353
OI   CVCL_C9XH ! HPS2354
OI   CVCL_C9XJ ! HPS2356
OI   CVCL_C9XK ! HPS2357
OI   CVCL_C9XL ! HPS2358
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2356
AC   CVCL_C9XJ
DR   RCB; HPS2356
DR   Wikidata; Q123032148
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XG ! HPS2353
OI   CVCL_C9XH ! HPS2354
OI   CVCL_C9XI ! HPS2355
OI   CVCL_C9XK ! HPS2357
OI   CVCL_C9XL ! HPS2358
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2357
AC   CVCL_C9XK
DR   RCB; HPS2357
DR   Wikidata; Q123032149
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XG ! HPS2353
OI   CVCL_C9XH ! HPS2354
OI   CVCL_C9XI ! HPS2355
OI   CVCL_C9XJ ! HPS2356
OI   CVCL_C9XL ! HPS2358
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2358
AC   CVCL_C9XL
DR   RCB; HPS2358
DR   Wikidata; Q123032150
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XG ! HPS2353
OI   CVCL_C9XH ! HPS2354
OI   CVCL_C9XI ! HPS2355
OI   CVCL_C9XJ ! HPS2356
OI   CVCL_C9XK ! HPS2357
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2359
AC   CVCL_UP10
DR   RCB; HPS2359
DR   Wikidata; Q94220103
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MT ! HPS2360
OI   CVCL_A3MU ! HPS2361
OI   CVCL_A3MV ! HPS2362
OI   CVCL_A3MW ! HPS2363
OI   CVCL_A3MX ! HPS2364
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2360
AC   CVCL_A3MT
DR   RCB; HPS2360
DR   Wikidata; Q105508634
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP10 ! HPS2359
OI   CVCL_A3MU ! HPS2361
OI   CVCL_A3MV ! HPS2362
OI   CVCL_A3MW ! HPS2363
OI   CVCL_A3MX ! HPS2364
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2361
AC   CVCL_A3MU
DR   RCB; HPS2361
DR   Wikidata; Q105508638
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP10 ! HPS2359
OI   CVCL_A3MT ! HPS2360
OI   CVCL_A3MV ! HPS2362
OI   CVCL_A3MW ! HPS2363
OI   CVCL_A3MX ! HPS2364
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2362
AC   CVCL_A3MV
DR   RCB; HPS2362
DR   Wikidata; Q105508641
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP10 ! HPS2359
OI   CVCL_A3MT ! HPS2360
OI   CVCL_A3MU ! HPS2361
OI   CVCL_A3MW ! HPS2363
OI   CVCL_A3MX ! HPS2364
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2363
AC   CVCL_A3MW
DR   RCB; HPS2363
DR   Wikidata; Q105508644
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP10 ! HPS2359
OI   CVCL_A3MT ! HPS2360
OI   CVCL_A3MU ! HPS2361
OI   CVCL_A3MV ! HPS2362
OI   CVCL_A3MX ! HPS2364
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2364
AC   CVCL_A3MX
DR   RCB; HPS2364
DR   Wikidata; Q105508646
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP10 ! HPS2359
OI   CVCL_A3MT ! HPS2360
OI   CVCL_A3MU ! HPS2361
OI   CVCL_A3MV ! HPS2362
OI   CVCL_A3MW ! HPS2363
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2365
AC   CVCL_D1B1
DR   RCB; HPS2365
DR   Wikidata; Q123032151
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B2 ! HPS2366
OI   CVCL_D1B3 ! HPS2367
OI   CVCL_D1B4 ! HPS2368
OI   CVCL_D1B5 ! HPS2369
OI   CVCL_D1B6 ! HPS2370
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2366
AC   CVCL_D1B2
DR   RCB; HPS2366
DR   Wikidata; Q123032152
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B1 ! HPS2365
OI   CVCL_D1B3 ! HPS2367
OI   CVCL_D1B4 ! HPS2368
OI   CVCL_D1B5 ! HPS2369
OI   CVCL_D1B6 ! HPS2370
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2367
AC   CVCL_D1B3
DR   RCB; HPS2367
DR   Wikidata; Q123032153
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B1 ! HPS2365
OI   CVCL_D1B2 ! HPS2366
OI   CVCL_D1B4 ! HPS2368
OI   CVCL_D1B5 ! HPS2369
OI   CVCL_D1B6 ! HPS2370
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2368
AC   CVCL_D1B4
DR   RCB; HPS2368
DR   Wikidata; Q123032154
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B1 ! HPS2365
OI   CVCL_D1B2 ! HPS2366
OI   CVCL_D1B3 ! HPS2367
OI   CVCL_D1B5 ! HPS2369
OI   CVCL_D1B6 ! HPS2370
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2369
AC   CVCL_D1B5
DR   RCB; HPS2369
DR   Wikidata; Q123032155
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B1 ! HPS2365
OI   CVCL_D1B2 ! HPS2366
OI   CVCL_D1B3 ! HPS2367
OI   CVCL_D1B4 ! HPS2368
OI   CVCL_D1B6 ! HPS2370
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2370
AC   CVCL_D1B6
DR   RCB; HPS2370
DR   Wikidata; Q123032156
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2884; Rheumatoid arthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B1 ! HPS2365
OI   CVCL_D1B2 ! HPS2366
OI   CVCL_D1B3 ! HPS2367
OI   CVCL_D1B4 ! HPS2368
OI   CVCL_D1B5 ! HPS2369
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2371
AC   CVCL_C9XM
DR   RCB; HPS2371
DR   Wikidata; Q123032157
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202011; Autoimmune pulmonary alveolar proteinosis
DI   ORDO; Orphanet_747; Autoimmune pulmonary alveolar proteinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XN ! HPS2372
OI   CVCL_C9XP ! HPS2373
OI   CVCL_C9XQ ! HPS2374
OI   CVCL_C9XR ! HPS2375
OI   CVCL_C9XS ! HPS2376
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2372
AC   CVCL_C9XN
DR   RCB; HPS2372
DR   Wikidata; Q123032158
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202011; Autoimmune pulmonary alveolar proteinosis
DI   ORDO; Orphanet_747; Autoimmune pulmonary alveolar proteinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XM ! HPS2371
OI   CVCL_C9XP ! HPS2373
OI   CVCL_C9XQ ! HPS2374
OI   CVCL_C9XR ! HPS2375
OI   CVCL_C9XS ! HPS2376
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2373
AC   CVCL_C9XP
DR   RCB; HPS2373
DR   Wikidata; Q123032160
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202011; Autoimmune pulmonary alveolar proteinosis
DI   ORDO; Orphanet_747; Autoimmune pulmonary alveolar proteinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XM ! HPS2371
OI   CVCL_C9XN ! HPS2372
OI   CVCL_C9XQ ! HPS2374
OI   CVCL_C9XR ! HPS2375
OI   CVCL_C9XS ! HPS2376
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2374
AC   CVCL_C9XQ
DR   RCB; HPS2374
DR   Wikidata; Q123032161
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202011; Autoimmune pulmonary alveolar proteinosis
DI   ORDO; Orphanet_747; Autoimmune pulmonary alveolar proteinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XM ! HPS2371
OI   CVCL_C9XN ! HPS2372
OI   CVCL_C9XP ! HPS2373
OI   CVCL_C9XR ! HPS2375
OI   CVCL_C9XS ! HPS2376
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2375
AC   CVCL_C9XR
DR   RCB; HPS2375
DR   Wikidata; Q123032162
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202011; Autoimmune pulmonary alveolar proteinosis
DI   ORDO; Orphanet_747; Autoimmune pulmonary alveolar proteinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XM ! HPS2371
OI   CVCL_C9XN ! HPS2372
OI   CVCL_C9XP ! HPS2373
OI   CVCL_C9XQ ! HPS2374
OI   CVCL_C9XS ! HPS2376
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2376
AC   CVCL_C9XS
DR   RCB; HPS2376
DR   Wikidata; Q123032163
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202011; Autoimmune pulmonary alveolar proteinosis
DI   ORDO; Orphanet_747; Autoimmune pulmonary alveolar proteinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XM ! HPS2371
OI   CVCL_C9XN ! HPS2372
OI   CVCL_C9XP ! HPS2373
OI   CVCL_C9XQ ! HPS2374
OI   CVCL_C9XR ! HPS2375
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2377
AC   CVCL_UP11
DR   RCB; HPS2377
DR   Wikidata; Q94220107
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2377).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3RB ! HPS2378
OI   CVCL_A3RC ! HPS2379
OI   CVCL_A3RD ! HPS2380
OI   CVCL_A3RE ! HPS2381
OI   CVCL_A3RF ! HPS2382
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   HPS2378
AC   CVCL_A3RB
DR   RCB; HPS2378
DR   Wikidata; Q105508650
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2378).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP11 ! HPS2377
OI   CVCL_A3RC ! HPS2379
OI   CVCL_A3RD ! HPS2380
OI   CVCL_A3RE ! HPS2381
OI   CVCL_A3RF ! HPS2382
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2379
AC   CVCL_A3RC
DR   RCB; HPS2379
DR   Wikidata; Q105508653
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2379).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP11 ! HPS2377
OI   CVCL_A3RB ! HPS2378
OI   CVCL_A3RD ! HPS2380
OI   CVCL_A3RE ! HPS2381
OI   CVCL_A3RF ! HPS2382
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2380
AC   CVCL_A3RD
DR   RCB; HPS2380
DR   Wikidata; Q105508656
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2380).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP11 ! HPS2377
OI   CVCL_A3RB ! HPS2378
OI   CVCL_A3RC ! HPS2379
OI   CVCL_A3RE ! HPS2381
OI   CVCL_A3RF ! HPS2382
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2381
AC   CVCL_A3RE
DR   RCB; HPS2381
DR   Wikidata; Q105508659
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2381).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP11 ! HPS2377
OI   CVCL_A3RB ! HPS2378
OI   CVCL_A3RC ! HPS2379
OI   CVCL_A3RD ! HPS2380
OI   CVCL_A3RF ! HPS2382
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2382
AC   CVCL_A3RF
DR   RCB; HPS2382
DR   Wikidata; Q105508662
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2382).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP11 ! HPS2377
OI   CVCL_A3RB ! HPS2378
OI   CVCL_A3RC ! HPS2379
OI   CVCL_A3RD ! HPS2380
OI   CVCL_A3RE ! HPS2381
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2383
AC   CVCL_UP12
DR   RCB; HPS2383
DR   Wikidata; Q94220112
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2383).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3QW ! HPS2384
OI   CVCL_A3QX ! HPS2385
OI   CVCL_A3QY ! HPS2386
OI   CVCL_A3QZ ! HPS2387
OI   CVCL_A3RA ! HPS2388
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   HPS2384
AC   CVCL_A3QW
DR   RCB; HPS2384
DR   Wikidata; Q105508664
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2384).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP12 ! HPS2383
OI   CVCL_A3QX ! HPS2385
OI   CVCL_A3QY ! HPS2386
OI   CVCL_A3QZ ! HPS2387
OI   CVCL_A3RA ! HPS2388
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2385
AC   CVCL_A3QX
DR   RCB; HPS2385
DR   Wikidata; Q105508667
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2385).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP12 ! HPS2383
OI   CVCL_A3QW ! HPS2384
OI   CVCL_A3QY ! HPS2386
OI   CVCL_A3QZ ! HPS2387
OI   CVCL_A3RA ! HPS2388
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2386
AC   CVCL_A3QY
DR   RCB; HPS2386
DR   Wikidata; Q105508670
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2386).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP12 ! HPS2383
OI   CVCL_A3QW ! HPS2384
OI   CVCL_A3QX ! HPS2385
OI   CVCL_A3QZ ! HPS2387
OI   CVCL_A3RA ! HPS2388
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2387
AC   CVCL_A3QZ
DR   RCB; HPS2387
DR   Wikidata; Q105508673
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2387).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP12 ! HPS2383
OI   CVCL_A3QW ! HPS2384
OI   CVCL_A3QX ! HPS2385
OI   CVCL_A3QY ! HPS2386
OI   CVCL_A3RA ! HPS2388
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2388
AC   CVCL_A3RA
DR   RCB; HPS2388
DR   Wikidata; Q105508676
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2388).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP12 ! HPS2383
OI   CVCL_A3QW ! HPS2384
OI   CVCL_A3QX ! HPS2385
OI   CVCL_A3QY ! HPS2386
OI   CVCL_A3QZ ! HPS2387
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   HPS2389
AC   CVCL_A3MM
DR   RCB; HPS2389
DR   Wikidata; Q105508681
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MN ! HPS2390
OI   CVCL_A3MP ! HPS2391
OI   CVCL_A3MQ ! HPS2392
OI   CVCL_A3MR ! HPS2393
OI   CVCL_A3MS ! HPS2394
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2390
AC   CVCL_A3MN
DR   RCB; HPS2390
DR   Wikidata; Q105508688
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MM ! HPS2389
OI   CVCL_A3MP ! HPS2391
OI   CVCL_A3MQ ! HPS2392
OI   CVCL_A3MR ! HPS2393
OI   CVCL_A3MS ! HPS2394
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2391
AC   CVCL_A3MP
DR   RCB; HPS2391
DR   Wikidata; Q105508690
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MM ! HPS2389
OI   CVCL_A3MN ! HPS2390
OI   CVCL_A3MQ ! HPS2392
OI   CVCL_A3MR ! HPS2393
OI   CVCL_A3MS ! HPS2394
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2392
AC   CVCL_A3MQ
DR   RCB; HPS2392
DR   Wikidata; Q105508694
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MM ! HPS2389
OI   CVCL_A3MN ! HPS2390
OI   CVCL_A3MP ! HPS2391
OI   CVCL_A3MR ! HPS2393
OI   CVCL_A3MS ! HPS2394
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2393
AC   CVCL_A3MR
DR   RCB; HPS2393
DR   Wikidata; Q105508700
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MM ! HPS2389
OI   CVCL_A3MN ! HPS2390
OI   CVCL_A3MP ! HPS2391
OI   CVCL_A3MQ ! HPS2392
OI   CVCL_A3MS ! HPS2394
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2394
AC   CVCL_A3MS
DR   RCB; HPS2394
DR   Wikidata; Q105508703
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MM ! HPS2389
OI   CVCL_A3MN ! HPS2390
OI   CVCL_A3MP ! HPS2391
OI   CVCL_A3MQ ! HPS2392
OI   CVCL_A3MR ! HPS2393
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2395
AC   CVCL_A3IC
DR   RCB; HPS2395
DR   Wikidata; Q105508706
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3424; Tuberous sclerosis
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ID ! HPS2396
OI   CVCL_A3IE ! HPS2397
OI   CVCL_A3IF ! HPS2398
OI   CVCL_A3IG ! HPS2399
OI   CVCL_A3IH ! HPS2400
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2396
AC   CVCL_A3ID
DR   RCB; HPS2396
DR   Wikidata; Q105508709
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3424; Tuberous sclerosis
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IC ! HPS2395
OI   CVCL_A3IE ! HPS2397
OI   CVCL_A3IF ! HPS2398
OI   CVCL_A3IG ! HPS2399
OI   CVCL_A3IH ! HPS2400
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2397
AC   CVCL_A3IE
DR   RCB; HPS2397
DR   Wikidata; Q105508711
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3424; Tuberous sclerosis
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IC ! HPS2395
OI   CVCL_A3ID ! HPS2396
OI   CVCL_A3IF ! HPS2398
OI   CVCL_A3IG ! HPS2399
OI   CVCL_A3IH ! HPS2400
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2398
AC   CVCL_A3IF
DR   RCB; HPS2398
DR   Wikidata; Q105508714
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3424; Tuberous sclerosis
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IC ! HPS2395
OI   CVCL_A3ID ! HPS2396
OI   CVCL_A3IE ! HPS2397
OI   CVCL_A3IG ! HPS2399
OI   CVCL_A3IH ! HPS2400
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2399
AC   CVCL_A3IG
DR   RCB; HPS2399
DR   Wikidata; Q105508717
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3424; Tuberous sclerosis
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IC ! HPS2395
OI   CVCL_A3ID ! HPS2396
OI   CVCL_A3IE ! HPS2397
OI   CVCL_A3IF ! HPS2398
OI   CVCL_A3IH ! HPS2400
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2400
AC   CVCL_A3IH
DR   RCB; HPS2400
DR   Wikidata; Q105508721
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3424; Tuberous sclerosis
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IC ! HPS2395
OI   CVCL_A3ID ! HPS2396
OI   CVCL_A3IE ! HPS2397
OI   CVCL_A3IF ! HPS2398
OI   CVCL_A3IG ! HPS2399
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2401
AC   CVCL_UP13
DR   RCB; HPS2401
DR   Wikidata; Q94220116
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3YH ! HPS2402
OI   CVCL_A3YI ! HPS2403
OI   CVCL_A3YJ ! HPS2404
OI   CVCL_A3YK ! HPS2405
OI   CVCL_A3YL ! HPS2406
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2402
AC   CVCL_A3YH
DR   RCB; HPS2402
DR   Wikidata; Q105508724
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP13 ! HPS2401
OI   CVCL_A3YI ! HPS2403
OI   CVCL_A3YJ ! HPS2404
OI   CVCL_A3YK ! HPS2405
OI   CVCL_A3YL ! HPS2406
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2403
AC   CVCL_A3YI
DR   RCB; HPS2403
DR   Wikidata; Q105508727
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP13 ! HPS2401
OI   CVCL_A3YH ! HPS2402
OI   CVCL_A3YJ ! HPS2404
OI   CVCL_A3YK ! HPS2405
OI   CVCL_A3YL ! HPS2406
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2404
AC   CVCL_A3YJ
DR   RCB; HPS2404
DR   Wikidata; Q105508731
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP13 ! HPS2401
OI   CVCL_A3YH ! HPS2402
OI   CVCL_A3YI ! HPS2403
OI   CVCL_A3YK ! HPS2405
OI   CVCL_A3YL ! HPS2406
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2405
AC   CVCL_A3YK
DR   RCB; HPS2405
DR   Wikidata; Q105508735
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP13 ! HPS2401
OI   CVCL_A3YH ! HPS2402
OI   CVCL_A3YI ! HPS2403
OI   CVCL_A3YJ ! HPS2404
OI   CVCL_A3YL ! HPS2406
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2406
AC   CVCL_A3YL
DR   RCB; HPS2406
DR   Wikidata; Q105508738
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP13 ! HPS2401
OI   CVCL_A3YH ! HPS2402
OI   CVCL_A3YI ! HPS2403
OI   CVCL_A3YJ ! HPS2404
OI   CVCL_A3YK ! HPS2405
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2407
AC   CVCL_UP14
DR   RCB; HPS2407
DR   Wikidata; Q94220122
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3II ! HPS2408
OI   CVCL_A3IJ ! HPS2409
OI   CVCL_A3IK ! HPS2410
OI   CVCL_A3IL ! HPS2411
OI   CVCL_A3IM ! HPS2412
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2408
AC   CVCL_A3II
DR   RCB; HPS2408
DR   Wikidata; Q105508741
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP14 ! HPS2407
OI   CVCL_A3IJ ! HPS2409
OI   CVCL_A3IK ! HPS2410
OI   CVCL_A3IL ! HPS2411
OI   CVCL_A3IM ! HPS2412
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2409
AC   CVCL_A3IJ
DR   RCB; HPS2409
DR   Wikidata; Q105508744
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP14 ! HPS2407
OI   CVCL_A3II ! HPS2408
OI   CVCL_A3IK ! HPS2410
OI   CVCL_A3IL ! HPS2411
OI   CVCL_A3IM ! HPS2412
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2410
AC   CVCL_A3IK
DR   RCB; HPS2410
DR   Wikidata; Q105508746
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP14 ! HPS2407
OI   CVCL_A3II ! HPS2408
OI   CVCL_A3IJ ! HPS2409
OI   CVCL_A3IL ! HPS2411
OI   CVCL_A3IM ! HPS2412
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2411
AC   CVCL_A3IL
DR   RCB; HPS2411
DR   Wikidata; Q105508748
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP14 ! HPS2407
OI   CVCL_A3II ! HPS2408
OI   CVCL_A3IJ ! HPS2409
OI   CVCL_A3IK ! HPS2410
OI   CVCL_A3IM ! HPS2412
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2412
AC   CVCL_A3IM
DR   RCB; HPS2412
DR   Wikidata; Q105508751
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP14 ! HPS2407
OI   CVCL_A3II ! HPS2408
OI   CVCL_A3IJ ! HPS2409
OI   CVCL_A3IK ! HPS2410
OI   CVCL_A3IL ! HPS2411
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2413
AC   CVCL_C9XT
DR   RCB; HPS2413
DR   Wikidata; Q123032164
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2413).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XU ! HPS2414
OI   CVCL_C9XV ! HPS2415
OI   CVCL_C9XW ! HPS2416
OI   CVCL_C9XX ! HPS2417
OI   CVCL_C9XY ! HPS2418
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2414
AC   CVCL_C9XU
DR   RCB; HPS2414
DR   Wikidata; Q123032165
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2414).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XT ! HPS2413
OI   CVCL_C9XV ! HPS2415
OI   CVCL_C9XW ! HPS2416
OI   CVCL_C9XX ! HPS2417
OI   CVCL_C9XY ! HPS2418
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2415
AC   CVCL_C9XV
DR   RCB; HPS2415
DR   Wikidata; Q123032166
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2415).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XT ! HPS2413
OI   CVCL_C9XU ! HPS2414
OI   CVCL_C9XW ! HPS2416
OI   CVCL_C9XX ! HPS2417
OI   CVCL_C9XY ! HPS2418
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2416
AC   CVCL_C9XW
DR   RCB; HPS2416
DR   Wikidata; Q123032167
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2416).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XT ! HPS2413
OI   CVCL_C9XU ! HPS2414
OI   CVCL_C9XV ! HPS2415
OI   CVCL_C9XX ! HPS2417
OI   CVCL_C9XY ! HPS2418
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2417
AC   CVCL_C9XX
DR   RCB; HPS2417
DR   Wikidata; Q123032168
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2417).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XT ! HPS2413
OI   CVCL_C9XU ! HPS2414
OI   CVCL_C9XV ! HPS2415
OI   CVCL_C9XW ! HPS2416
OI   CVCL_C9XY ! HPS2418
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2418
AC   CVCL_C9XY
DR   RCB; HPS2418
DR   Wikidata; Q123032169
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2418).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XT ! HPS2413
OI   CVCL_C9XU ! HPS2414
OI   CVCL_C9XV ! HPS2415
OI   CVCL_C9XW ! HPS2416
OI   CVCL_C9XX ! HPS2417
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2424
AC   CVCL_D1CR
DR   RCB; HPS2424
DR   Wikidata; Q123032170
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CS ! HPS2425
OI   CVCL_D1CT ! HPS2426
OI   CVCL_D1CU ! HPS2427
OI   CVCL_D1CV ! HPS2428
OI   CVCL_D1CW ! HPS2429
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2425
AC   CVCL_D1CS
DR   RCB; HPS2425
DR   Wikidata; Q123032171
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CR ! HPS2424
OI   CVCL_D1CT ! HPS2426
OI   CVCL_D1CU ! HPS2427
OI   CVCL_D1CV ! HPS2428
OI   CVCL_D1CW ! HPS2429
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2426
AC   CVCL_D1CT
DR   RCB; HPS2426
DR   Wikidata; Q123032173
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CR ! HPS2424
OI   CVCL_D1CS ! HPS2425
OI   CVCL_D1CU ! HPS2427
OI   CVCL_D1CV ! HPS2428
OI   CVCL_D1CW ! HPS2429
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2427
AC   CVCL_D1CU
DR   RCB; HPS2427
DR   Wikidata; Q123032174
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CR ! HPS2424
OI   CVCL_D1CS ! HPS2425
OI   CVCL_D1CT ! HPS2426
OI   CVCL_D1CV ! HPS2428
OI   CVCL_D1CW ! HPS2429
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2428
AC   CVCL_D1CV
DR   RCB; HPS2428
DR   Wikidata; Q123032175
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CR ! HPS2424
OI   CVCL_D1CS ! HPS2425
OI   CVCL_D1CT ! HPS2426
OI   CVCL_D1CU ! HPS2427
OI   CVCL_D1CW ! HPS2429
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2429
AC   CVCL_D1CW
DR   RCB; HPS2429
DR   Wikidata; Q123032176
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26744; Dermatomyositis
DI   ORDO; Orphanet_221; Dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CR ! HPS2424
OI   CVCL_D1CS ! HPS2425
OI   CVCL_D1CT ! HPS2426
OI   CVCL_D1CU ! HPS2427
OI   CVCL_D1CV ! HPS2428
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2430
AC   CVCL_D1E4
DR   RCB; HPS2430
DR   Wikidata; Q123032177
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1E5 ! HPS2431
OI   CVCL_D1E6 ! HPS2432
OI   CVCL_D1E7 ! HPS2433
OI   CVCL_D1E8 ! HPS2434
OI   CVCL_D1E9 ! HPS2435
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2431
AC   CVCL_D1E5
DR   RCB; HPS2431
DR   Wikidata; Q123032178
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1E4 ! HPS2430
OI   CVCL_D1E6 ! HPS2432
OI   CVCL_D1E7 ! HPS2433
OI   CVCL_D1E8 ! HPS2434
OI   CVCL_D1E9 ! HPS2435
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2432
AC   CVCL_D1E6
DR   RCB; HPS2432
DR   Wikidata; Q123032179
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1E4 ! HPS2430
OI   CVCL_D1E5 ! HPS2431
OI   CVCL_D1E7 ! HPS2433
OI   CVCL_D1E8 ! HPS2434
OI   CVCL_D1E9 ! HPS2435
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2433
AC   CVCL_D1E7
DR   RCB; HPS2433
DR   Wikidata; Q123032180
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1E4 ! HPS2430
OI   CVCL_D1E5 ! HPS2431
OI   CVCL_D1E6 ! HPS2432
OI   CVCL_D1E8 ! HPS2434
OI   CVCL_D1E9 ! HPS2435
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2434
AC   CVCL_D1E8
DR   RCB; HPS2434
DR   Wikidata; Q123032181
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1E4 ! HPS2430
OI   CVCL_D1E5 ! HPS2431
OI   CVCL_D1E6 ! HPS2432
OI   CVCL_D1E7 ! HPS2433
OI   CVCL_D1E9 ! HPS2435
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2435
AC   CVCL_D1E9
DR   RCB; HPS2435
DR   Wikidata; Q123032182
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85171; Subacute sclerosing panencephalitis
DI   ORDO; Orphanet_2806; Subacute sclerosing leukoencephalitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1E4 ! HPS2430
OI   CVCL_D1E5 ! HPS2431
OI   CVCL_D1E6 ! HPS2432
OI   CVCL_D1E7 ! HPS2433
OI   CVCL_D1E8 ! HPS2434
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2436
AC   CVCL_C9XZ
DR   RCB; HPS2436
DR   Wikidata; Q123032183
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Y0 ! HPS2437
OI   CVCL_C9Y1 ! HPS2438
OI   CVCL_C9Y2 ! HPS2439
OI   CVCL_C9Y3 ! HPS2440
OI   CVCL_C9Y4 ! HPS2441
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2437
AC   CVCL_C9Y0
DR   RCB; HPS2437
DR   Wikidata; Q123032185
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XZ ! HPS2436
OI   CVCL_C9Y1 ! HPS2438
OI   CVCL_C9Y2 ! HPS2439
OI   CVCL_C9Y3 ! HPS2440
OI   CVCL_C9Y4 ! HPS2441
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2438
AC   CVCL_C9Y1
DR   RCB; HPS2438
DR   Wikidata; Q123032186
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XZ ! HPS2436
OI   CVCL_C9Y0 ! HPS2437
OI   CVCL_C9Y2 ! HPS2439
OI   CVCL_C9Y3 ! HPS2440
OI   CVCL_C9Y4 ! HPS2441
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2439
AC   CVCL_C9Y2
DR   RCB; HPS2439
DR   Wikidata; Q123032187
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XZ ! HPS2436
OI   CVCL_C9Y0 ! HPS2437
OI   CVCL_C9Y1 ! HPS2438
OI   CVCL_C9Y3 ! HPS2440
OI   CVCL_C9Y4 ! HPS2441
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2440
AC   CVCL_C9Y3
DR   RCB; HPS2440
DR   Wikidata; Q123032188
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XZ ! HPS2436
OI   CVCL_C9Y0 ! HPS2437
OI   CVCL_C9Y1 ! HPS2438
OI   CVCL_C9Y2 ! HPS2439
OI   CVCL_C9Y4 ! HPS2441
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2441
AC   CVCL_C9Y4
DR   RCB; HPS2441
DR   Wikidata; Q123032189
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177244; Temporal lobe epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9XZ ! HPS2436
OI   CVCL_C9Y0 ! HPS2437
OI   CVCL_C9Y1 ! HPS2438
OI   CVCL_C9Y2 ! HPS2439
OI   CVCL_C9Y3 ! HPS2440
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2442
AC   CVCL_C9Y5
DR   RCB; HPS2442
DR   Wikidata; Q123032190
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201593; Focal cortical dysplasia type 2
DI   ORDO; Orphanet_269001; Isolated focal cortical dysplasia type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Y6 ! HPS2443
OI   CVCL_C9Y7 ! HPS2444
OI   CVCL_C9Y8 ! HPS2445
OI   CVCL_C9Y9 ! HPS2446
OI   CVCL_C9YA ! HPS2447
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2443
AC   CVCL_C9Y6
DR   RCB; HPS2443
DR   Wikidata; Q123032191
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201593; Focal cortical dysplasia type 2
DI   ORDO; Orphanet_269001; Isolated focal cortical dysplasia type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Y5 ! HPS2442
OI   CVCL_C9Y7 ! HPS2444
OI   CVCL_C9Y8 ! HPS2445
OI   CVCL_C9Y9 ! HPS2446
OI   CVCL_C9YA ! HPS2447
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2444
AC   CVCL_C9Y7
DR   RCB; HPS2444
DR   Wikidata; Q123032192
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201593; Focal cortical dysplasia type 2
DI   ORDO; Orphanet_269001; Isolated focal cortical dysplasia type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Y5 ! HPS2442
OI   CVCL_C9Y6 ! HPS2443
OI   CVCL_C9Y8 ! HPS2445
OI   CVCL_C9Y9 ! HPS2446
OI   CVCL_C9YA ! HPS2447
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2445
AC   CVCL_C9Y8
DR   RCB; HPS2445
DR   Wikidata; Q123032193
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201593; Focal cortical dysplasia type 2
DI   ORDO; Orphanet_269001; Isolated focal cortical dysplasia type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Y5 ! HPS2442
OI   CVCL_C9Y6 ! HPS2443
OI   CVCL_C9Y7 ! HPS2444
OI   CVCL_C9Y9 ! HPS2446
OI   CVCL_C9YA ! HPS2447
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2446
AC   CVCL_C9Y9
DR   RCB; HPS2446
DR   Wikidata; Q123032194
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201593; Focal cortical dysplasia type 2
DI   ORDO; Orphanet_269001; Isolated focal cortical dysplasia type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Y5 ! HPS2442
OI   CVCL_C9Y6 ! HPS2443
OI   CVCL_C9Y7 ! HPS2444
OI   CVCL_C9Y8 ! HPS2445
OI   CVCL_C9YA ! HPS2447
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2447
AC   CVCL_C9YA
DR   RCB; HPS2447
DR   Wikidata; Q123032196
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201593; Focal cortical dysplasia type 2
DI   ORDO; Orphanet_269001; Isolated focal cortical dysplasia type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9Y5 ! HPS2442
OI   CVCL_C9Y6 ! HPS2443
OI   CVCL_C9Y7 ! HPS2444
OI   CVCL_C9Y8 ! HPS2445
OI   CVCL_C9Y9 ! HPS2446
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2448
AC   CVCL_C9YB
DR   RCB; HPS2448
DR   Wikidata; Q123032197
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2448).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YC ! HPS2449
OI   CVCL_C9YD ! HPS2450
OI   CVCL_C9YE ! HPS2451
OI   CVCL_C9YF ! HPS2452
OI   CVCL_C9YG ! HPS2453
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2449
AC   CVCL_C9YC
DR   RCB; HPS2449
DR   Wikidata; Q123032198
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2449).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YB ! HPS2448
OI   CVCL_C9YD ! HPS2450
OI   CVCL_C9YE ! HPS2451
OI   CVCL_C9YF ! HPS2452
OI   CVCL_C9YG ! HPS2453
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2450
AC   CVCL_C9YD
DR   RCB; HPS2450
DR   Wikidata; Q123032199
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2450).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YB ! HPS2448
OI   CVCL_C9YC ! HPS2449
OI   CVCL_C9YE ! HPS2451
OI   CVCL_C9YF ! HPS2452
OI   CVCL_C9YG ! HPS2453
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2451
AC   CVCL_C9YE
DR   RCB; HPS2451
DR   Wikidata; Q123032200
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2451).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YB ! HPS2448
OI   CVCL_C9YC ! HPS2449
OI   CVCL_C9YD ! HPS2450
OI   CVCL_C9YF ! HPS2452
OI   CVCL_C9YG ! HPS2453
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2452
AC   CVCL_C9YF
DR   RCB; HPS2452
DR   Wikidata; Q123032201
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2452).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YB ! HPS2448
OI   CVCL_C9YC ! HPS2449
OI   CVCL_C9YD ! HPS2450
OI   CVCL_C9YE ! HPS2451
OI   CVCL_C9YG ! HPS2453
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2453
AC   CVCL_C9YG
DR   RCB; HPS2453
DR   Wikidata; Q123032202
CC   Sequence variation: Mutation; HGNC; HGNC:11799; THRB; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2453).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131816; Generalized thyroid hormone resistance
DI   ORDO; Orphanet_3221; Generalized resistance to thyroid hormone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YB ! HPS2448
OI   CVCL_C9YC ! HPS2449
OI   CVCL_C9YD ! HPS2450
OI   CVCL_C9YE ! HPS2451
OI   CVCL_C9YF ! HPS2452
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2460
AC   CVCL_D1DF
DR   RCB; HPS2460
DR   Wikidata; Q123032203
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DG ! HPS2461
OI   CVCL_D1DH ! HPS2462
OI   CVCL_D1DI ! HPS2463
OI   CVCL_D1DJ ! HPS2464
OI   CVCL_D1DK ! HPS2465
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2461
AC   CVCL_D1DG
DR   RCB; HPS2461
DR   Wikidata; Q123032204
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DF ! HPS2460
OI   CVCL_D1DH ! HPS2462
OI   CVCL_D1DI ! HPS2463
OI   CVCL_D1DJ ! HPS2464
OI   CVCL_D1DK ! HPS2465
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2462
AC   CVCL_D1DH
DR   RCB; HPS2462
DR   Wikidata; Q123032205
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DF ! HPS2460
OI   CVCL_D1DG ! HPS2461
OI   CVCL_D1DI ! HPS2463
OI   CVCL_D1DJ ! HPS2464
OI   CVCL_D1DK ! HPS2465
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2463
AC   CVCL_D1DI
DR   RCB; HPS2463
DR   Wikidata; Q123032206
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DF ! HPS2460
OI   CVCL_D1DG ! HPS2461
OI   CVCL_D1DH ! HPS2462
OI   CVCL_D1DJ ! HPS2464
OI   CVCL_D1DK ! HPS2465
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2464
AC   CVCL_D1DJ
DR   RCB; HPS2464
DR   Wikidata; Q123032207
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DF ! HPS2460
OI   CVCL_D1DG ! HPS2461
OI   CVCL_D1DH ! HPS2462
OI   CVCL_D1DI ! HPS2463
OI   CVCL_D1DK ! HPS2465
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2465
AC   CVCL_D1DK
DR   RCB; HPS2465
DR   Wikidata; Q123032208
CC   Donor information: Patient suffering from hemiconvulsion-hemiplegia-epilepsy syndrome, unknown genetic etiology.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1DF ! HPS2460
OI   CVCL_D1DG ! HPS2461
OI   CVCL_D1DH ! HPS2462
OI   CVCL_D1DI ! HPS2463
OI   CVCL_D1DJ ! HPS2464
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2466
AC   CVCL_C9YH
DR   RCB; HPS2466
DR   Wikidata; Q123032209
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YI ! HPS2467
OI   CVCL_C9YJ ! HPS2468
OI   CVCL_C9YK ! HPS2469
OI   CVCL_C9YL ! HPS2470
OI   CVCL_C9YM ! HPS2471
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2467
AC   CVCL_C9YI
DR   RCB; HPS2467
DR   Wikidata; Q123032210
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YH ! HPS2466
OI   CVCL_C9YJ ! HPS2468
OI   CVCL_C9YK ! HPS2469
OI   CVCL_C9YL ! HPS2470
OI   CVCL_C9YM ! HPS2471
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2468
AC   CVCL_C9YJ
DR   RCB; HPS2468
DR   Wikidata; Q123032212
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YH ! HPS2466
OI   CVCL_C9YI ! HPS2467
OI   CVCL_C9YK ! HPS2469
OI   CVCL_C9YL ! HPS2470
OI   CVCL_C9YM ! HPS2471
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2469
AC   CVCL_C9YK
DR   RCB; HPS2469
DR   Wikidata; Q123032213
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YH ! HPS2466
OI   CVCL_C9YI ! HPS2467
OI   CVCL_C9YJ ! HPS2468
OI   CVCL_C9YL ! HPS2470
OI   CVCL_C9YM ! HPS2471
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2470
AC   CVCL_C9YL
DR   RCB; HPS2470
DR   Wikidata; Q123032214
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YH ! HPS2466
OI   CVCL_C9YI ! HPS2467
OI   CVCL_C9YJ ! HPS2468
OI   CVCL_C9YK ! HPS2469
OI   CVCL_C9YM ! HPS2471
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2471
AC   CVCL_C9YM
DR   RCB; HPS2471
DR   Wikidata; Q123032215
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34416; Behcet syndrome
DI   ORDO; Orphanet_117; Behcet disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YH ! HPS2466
OI   CVCL_C9YI ! HPS2467
OI   CVCL_C9YJ ! HPS2468
OI   CVCL_C9YK ! HPS2469
OI   CVCL_C9YL ! HPS2470
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2472
AC   CVCL_C9YN
DR   RCB; HPS2472
DR   Wikidata; Q123032216
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YP ! HPS2473
OI   CVCL_C9YQ ! HPS2474
OI   CVCL_C9YR ! HPS2475
OI   CVCL_C9YS ! HPS2476
OI   CVCL_C9YT ! HPS2477
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2473
AC   CVCL_C9YP
DR   RCB; HPS2473
DR   Wikidata; Q123032217
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YN ! HPS2472
OI   CVCL_C9YQ ! HPS2474
OI   CVCL_C9YR ! HPS2475
OI   CVCL_C9YS ! HPS2476
OI   CVCL_C9YT ! HPS2477
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2474
AC   CVCL_C9YQ
DR   RCB; HPS2474
DR   Wikidata; Q123032218
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YN ! HPS2472
OI   CVCL_C9YP ! HPS2473
OI   CVCL_C9YR ! HPS2475
OI   CVCL_C9YS ! HPS2476
OI   CVCL_C9YT ! HPS2477
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2475
AC   CVCL_C9YR
DR   RCB; HPS2475
DR   Wikidata; Q123032219
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YN ! HPS2472
OI   CVCL_C9YP ! HPS2473
OI   CVCL_C9YQ ! HPS2474
OI   CVCL_C9YS ! HPS2476
OI   CVCL_C9YT ! HPS2477
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2476
AC   CVCL_C9YS
DR   RCB; HPS2476
DR   Wikidata; Q123032220
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YN ! HPS2472
OI   CVCL_C9YP ! HPS2473
OI   CVCL_C9YQ ! HPS2474
OI   CVCL_C9YR ! HPS2475
OI   CVCL_C9YT ! HPS2477
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2477
AC   CVCL_C9YT
DR   RCB; HPS2477
DR   Wikidata; Q123032221
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27029; Autoimmune hepatitis
DI   ORDO; Orphanet_2137; Autoimmune hepatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9YN ! HPS2472
OI   CVCL_C9YP ! HPS2473
OI   CVCL_C9YQ ! HPS2474
OI   CVCL_C9YR ! HPS2475
OI   CVCL_C9YS ! HPS2476
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2478
AC   CVCL_UN32
DR   RCB; HPS2478
DR   Wikidata; Q94220125
CC   HLA typing: A*24:02:01:01,33:03:01; B*40:06:01:01,44:03:01:01New; C*08:01:01:01,14:03; DPB1*04:01:01:26,05:01:01:04; DQB1*03:03:02,06:04; DRB1*09:01:02,13:02:01:02 (RCB=HPS2478).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3NI ! HPS2479
OI   CVCL_A3NJ ! HPS2480
OI   CVCL_A3NK ! HPS2481
OI   CVCL_A3NL ! HPS2482
OI   CVCL_A3NM ! HPS2483
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2479
AC   CVCL_A3NI
DR   RCB; HPS2479
DR   Wikidata; Q105508757
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN32 ! HPS2478
OI   CVCL_A3NJ ! HPS2480
OI   CVCL_A3NK ! HPS2481
OI   CVCL_A3NL ! HPS2482
OI   CVCL_A3NM ! HPS2483
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2480
AC   CVCL_A3NJ
DR   RCB; HPS2480
DR   Wikidata; Q105508761
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN32 ! HPS2478
OI   CVCL_A3NI ! HPS2479
OI   CVCL_A3NK ! HPS2481
OI   CVCL_A3NL ! HPS2482
OI   CVCL_A3NM ! HPS2483
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2481
AC   CVCL_A3NK
DR   RCB; HPS2481
DR   Wikidata; Q105508764
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN32 ! HPS2478
OI   CVCL_A3NI ! HPS2479
OI   CVCL_A3NJ ! HPS2480
OI   CVCL_A3NL ! HPS2482
OI   CVCL_A3NM ! HPS2483
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2482
AC   CVCL_A3NL
DR   RCB; HPS2482
DR   Wikidata; Q105508768
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN32 ! HPS2478
OI   CVCL_A3NI ! HPS2479
OI   CVCL_A3NJ ! HPS2480
OI   CVCL_A3NK ! HPS2481
OI   CVCL_A3NM ! HPS2483
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2483
AC   CVCL_A3NM
DR   RCB; HPS2483
DR   Wikidata; Q105508770
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN32 ! HPS2478
OI   CVCL_A3NI ! HPS2479
OI   CVCL_A3NJ ! HPS2480
OI   CVCL_A3NK ! HPS2481
OI   CVCL_A3NL ! HPS2482
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2484
AC   CVCL_UP37
DR   RCB; HPS2484
DR   Wikidata; Q94220130
CC   HLA typing: A*24:02:01:01; B*40:02:01:01,59:01:01:01; C*01:02:01,03:04:01; DPB1*02:01:02; DQB1*03:02:01,05:03:01New; DRB1*08:02:01,14:54:01:02New (RCB=HPS2484).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ND ! HPS2485
OI   CVCL_A3NE ! HPS2486
OI   CVCL_A3NF ! HPS2487
OI   CVCL_A3NG ! HPS2488
OI   CVCL_A3NH ! HPS2489
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2485
AC   CVCL_A3ND
DR   RCB; HPS2485
DR   Wikidata; Q105508772
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP37 ! HPS2484
OI   CVCL_A3NE ! HPS2486
OI   CVCL_A3NF ! HPS2487
OI   CVCL_A3NG ! HPS2488
OI   CVCL_A3NH ! HPS2489
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2486
AC   CVCL_A3NE
DR   RCB; HPS2486
DR   Wikidata; Q105508774
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP37 ! HPS2484
OI   CVCL_A3ND ! HPS2485
OI   CVCL_A3NF ! HPS2487
OI   CVCL_A3NG ! HPS2488
OI   CVCL_A3NH ! HPS2489
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2487
AC   CVCL_A3NF
DR   RCB; HPS2487
DR   Wikidata; Q105508778
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP37 ! HPS2484
OI   CVCL_A3ND ! HPS2485
OI   CVCL_A3NE ! HPS2486
OI   CVCL_A3NG ! HPS2488
OI   CVCL_A3NH ! HPS2489
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2488
AC   CVCL_A3NG
DR   RCB; HPS2488
DR   Wikidata; Q105508781
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP37 ! HPS2484
OI   CVCL_A3ND ! HPS2485
OI   CVCL_A3NE ! HPS2486
OI   CVCL_A3NF ! HPS2487
OI   CVCL_A3NH ! HPS2489
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2489
AC   CVCL_A3NH
DR   RCB; HPS2489
DR   Wikidata; Q105508784
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP37 ! HPS2484
OI   CVCL_A3ND ! HPS2485
OI   CVCL_A3NE ! HPS2486
OI   CVCL_A3NF ! HPS2487
OI   CVCL_A3NG ! HPS2488
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2490
AC   CVCL_A3IT
DR   RCB; HPS2490
DR   Wikidata; Q105508787
CC   HLA typing: A*11:01:01:01,24:02:01:01; B*40:02:01:01,51:01:01; C*03:04:01:02,15:02:01:01; DPB1*04:02:01,09:01:01; DQB1*03:01:01,06:01; DRB1*04:01:01:01,08:03:02 (RCB=HPS2490).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IU ! HPS2491
OI   CVCL_A3IV ! HPS2492
OI   CVCL_A3IW ! HPS2493
OI   CVCL_A3IX ! HPS2494
OI   CVCL_A3IY ! HPS2495
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2491
AC   CVCL_A3IU
DR   RCB; HPS2491
DR   Wikidata; Q105508792
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IT ! HPS2490
OI   CVCL_A3IV ! HPS2492
OI   CVCL_A3IW ! HPS2493
OI   CVCL_A3IX ! HPS2494
OI   CVCL_A3IY ! HPS2495
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2492
AC   CVCL_A3IV
DR   RCB; HPS2492
DR   Wikidata; Q105508795
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IT ! HPS2490
OI   CVCL_A3IU ! HPS2491
OI   CVCL_A3IW ! HPS2493
OI   CVCL_A3IX ! HPS2494
OI   CVCL_A3IY ! HPS2495
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2493
AC   CVCL_A3IW
DR   RCB; HPS2493
DR   Wikidata; Q105508797
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IT ! HPS2490
OI   CVCL_A3IU ! HPS2491
OI   CVCL_A3IV ! HPS2492
OI   CVCL_A3IX ! HPS2494
OI   CVCL_A3IY ! HPS2495
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2494
AC   CVCL_A3IX
DR   RCB; HPS2494
DR   Wikidata; Q105508801
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IT ! HPS2490
OI   CVCL_A3IU ! HPS2491
OI   CVCL_A3IV ! HPS2492
OI   CVCL_A3IW ! HPS2493
OI   CVCL_A3IY ! HPS2495
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2495
AC   CVCL_A3IY
DR   RCB; HPS2495
DR   Wikidata; Q105508802
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IT ! HPS2490
OI   CVCL_A3IU ! HPS2491
OI   CVCL_A3IV ! HPS2492
OI   CVCL_A3IW ! HPS2493
OI   CVCL_A3IX ! HPS2494
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2496
AC   CVCL_A3IZ
DR   RCB; HPS2496
DR   Wikidata; Q105508806
CC   HLA typing: A*11:01:01:01,24:02:01:01; B*15:01:01:01,52:01:01:02; C*03:03:01:01,12:02:02:01; DPB1*05:01:01,09:01:01; DQB1*04:01:01:02,06:01; DRB1*04:05:01:02,15:02:01:01 (RCB=HPS2496).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JA ! HPS2497
OI   CVCL_A3JB ! HPS2498
OI   CVCL_A3JC ! HPS2499
OI   CVCL_A3JD ! HPS2500
OI   CVCL_A3JE ! HPS2501
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2497
AC   CVCL_A3JA
DR   RCB; HPS2497
DR   Wikidata; Q105508809
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IZ ! HPS2496
OI   CVCL_A3JB ! HPS2498
OI   CVCL_A3JC ! HPS2499
OI   CVCL_A3JD ! HPS2500
OI   CVCL_A3JE ! HPS2501
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2498
AC   CVCL_A3JB
DR   RCB; HPS2498
DR   Wikidata; Q105508814
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IZ ! HPS2496
OI   CVCL_A3JA ! HPS2497
OI   CVCL_A3JC ! HPS2499
OI   CVCL_A3JD ! HPS2500
OI   CVCL_A3JE ! HPS2501
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2499
AC   CVCL_A3JC
DR   RCB; HPS2499
DR   Wikidata; Q105508817
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IZ ! HPS2496
OI   CVCL_A3JA ! HPS2497
OI   CVCL_A3JB ! HPS2498
OI   CVCL_A3JD ! HPS2500
OI   CVCL_A3JE ! HPS2501
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2500
AC   CVCL_A3JD
DR   RCB; HPS2500
DR   Wikidata; Q105508819
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IZ ! HPS2496
OI   CVCL_A3JA ! HPS2497
OI   CVCL_A3JB ! HPS2498
OI   CVCL_A3JC ! HPS2499
OI   CVCL_A3JE ! HPS2501
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2501
AC   CVCL_A3JE
DR   RCB; HPS2501
DR   Wikidata; Q105508823
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IZ ! HPS2496
OI   CVCL_A3JA ! HPS2497
OI   CVCL_A3JB ! HPS2498
OI   CVCL_A3JC ! HPS2499
OI   CVCL_A3JD ! HPS2500
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2502
AC   CVCL_D1ET
DR   RCB; HPS2502
DR   Wikidata; Q123032222
CC   HLA typing: A*24:02:01:01,24:02:01:01; B*52:01:01:02,55:02:01:01; C*01:02:01:01,12:02:02:01; DPB1*09:01:01,13:01:01New; DQB1*06:01,06:02:01:01; DRB1*15:01:01,15:02:01:03 (RCB=HPS2502).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EU ! HPS2503
OI   CVCL_D1EV ! HPS2504
OI   CVCL_D1EW ! HPS2505
OI   CVCL_D1EX ! HPS2506
OI   CVCL_D1EY ! HPS2507
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2503
AC   CVCL_D1EU
DR   RCB; HPS2503
DR   Wikidata; Q123032223
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1ET ! HPS2502
OI   CVCL_D1EV ! HPS2504
OI   CVCL_D1EW ! HPS2505
OI   CVCL_D1EX ! HPS2506
OI   CVCL_D1EY ! HPS2507
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2504
AC   CVCL_D1EV
DR   RCB; HPS2504
DR   Wikidata; Q123032224
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1ET ! HPS2502
OI   CVCL_D1EU ! HPS2503
OI   CVCL_D1EW ! HPS2505
OI   CVCL_D1EX ! HPS2506
OI   CVCL_D1EY ! HPS2507
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2505
AC   CVCL_D1EW
DR   RCB; HPS2505
DR   Wikidata; Q123032225
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1ET ! HPS2502
OI   CVCL_D1EU ! HPS2503
OI   CVCL_D1EV ! HPS2504
OI   CVCL_D1EX ! HPS2506
OI   CVCL_D1EY ! HPS2507
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2506
AC   CVCL_D1EX
DR   RCB; HPS2506
DR   Wikidata; Q123032226
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1ET ! HPS2502
OI   CVCL_D1EU ! HPS2503
OI   CVCL_D1EV ! HPS2504
OI   CVCL_D1EW ! HPS2505
OI   CVCL_D1EY ! HPS2507
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2507
AC   CVCL_D1EY
DR   RCB; HPS2507
DR   Wikidata; Q123032227
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1ET ! HPS2502
OI   CVCL_D1EU ! HPS2503
OI   CVCL_D1EV ! HPS2504
OI   CVCL_D1EW ! HPS2505
OI   CVCL_D1EX ! HPS2506
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2508
AC   CVCL_UN34
DR   RCB; HPS2508
DR   Wikidata; Q94220134
CC   HLA typing: A*24:02:01:01,24:02:01:01; B*07:02:01:01,54:01:01; C*01:02:01,07:02:01; DPB1*05:01:01; DQB1*03:03:02,04:01:01:01; DRB1*04:05:01:01,09:01:02 (RCB=HPS2508).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3NN ! HPS2509
OI   CVCL_A3NP ! HPS2510
OI   CVCL_A3NQ ! HPS2511
OI   CVCL_A3NR ! HPS2512
OI   CVCL_A3NS ! HPS2513
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2509
AC   CVCL_A3NN
DR   RCB; HPS2509
DR   Wikidata; Q105508827
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN34 ! HPS2508
OI   CVCL_A3NP ! HPS2510
OI   CVCL_A3NQ ! HPS2511
OI   CVCL_A3NR ! HPS2512
OI   CVCL_A3NS ! HPS2513
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2510
AC   CVCL_A3NP
DR   RCB; HPS2510
DR   Wikidata; Q105508831
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN34 ! HPS2508
OI   CVCL_A3NN ! HPS2509
OI   CVCL_A3NQ ! HPS2511
OI   CVCL_A3NR ! HPS2512
OI   CVCL_A3NS ! HPS2513
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2511
AC   CVCL_A3NQ
DR   RCB; HPS2511
DR   Wikidata; Q105508833
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN34 ! HPS2508
OI   CVCL_A3NN ! HPS2509
OI   CVCL_A3NP ! HPS2510
OI   CVCL_A3NR ! HPS2512
OI   CVCL_A3NS ! HPS2513
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2512
AC   CVCL_A3NR
DR   RCB; HPS2512
DR   Wikidata; Q105508837
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN34 ! HPS2508
OI   CVCL_A3NN ! HPS2509
OI   CVCL_A3NP ! HPS2510
OI   CVCL_A3NQ ! HPS2511
OI   CVCL_A3NS ! HPS2513
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2513
AC   CVCL_A3NS
DR   RCB; HPS2513
DR   Wikidata; Q105508839
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN34 ! HPS2508
OI   CVCL_A3NN ! HPS2509
OI   CVCL_A3NP ! HPS2510
OI   CVCL_A3NQ ! HPS2511
OI   CVCL_A3NR ! HPS2512
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2550
AC   CVCL_C6CB
DR   RCB; HPS2550
DR   Wikidata; Q116049444
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CC ! HPS2551
OI   CVCL_C6CD ! HPS2552
OI   CVCL_C6CE ! HPS2553
OI   CVCL_C6CF ! HPS2554
OI   CVCL_C6CG ! HPS2555
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2551
AC   CVCL_C6CC
DR   RCB; HPS2551
DR   Wikidata; Q116049446
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CB ! HPS2550
OI   CVCL_C6CD ! HPS2552
OI   CVCL_C6CE ! HPS2553
OI   CVCL_C6CF ! HPS2554
OI   CVCL_C6CG ! HPS2555
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2552
AC   CVCL_C6CD
DR   RCB; HPS2552
DR   Wikidata; Q116049447
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CB ! HPS2550
OI   CVCL_C6CC ! HPS2551
OI   CVCL_C6CE ! HPS2553
OI   CVCL_C6CF ! HPS2554
OI   CVCL_C6CG ! HPS2555
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2553
AC   CVCL_C6CE
DR   RCB; HPS2553
DR   Wikidata; Q116049449
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CB ! HPS2550
OI   CVCL_C6CC ! HPS2551
OI   CVCL_C6CD ! HPS2552
OI   CVCL_C6CF ! HPS2554
OI   CVCL_C6CG ! HPS2555
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2554
AC   CVCL_C6CF
DR   RCB; HPS2554
DR   Wikidata; Q116049450
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CB ! HPS2550
OI   CVCL_C6CC ! HPS2551
OI   CVCL_C6CD ! HPS2552
OI   CVCL_C6CE ! HPS2553
OI   CVCL_C6CG ! HPS2555
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2555
AC   CVCL_C6CG
DR   RCB; HPS2555
DR   Wikidata; Q116049451
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CB ! HPS2550
OI   CVCL_C6CC ! HPS2551
OI   CVCL_C6CD ! HPS2552
OI   CVCL_C6CE ! HPS2553
OI   CVCL_C6CF ! HPS2554
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2556
AC   CVCL_A3JF
DR   RCB; HPS2556
DR   Wikidata; Q105508845
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JG ! HPS2557
OI   CVCL_A3JH ! HPS2558
OI   CVCL_A3JI ! HPS2559
OI   CVCL_A3JJ ! HPS2560
OI   CVCL_A3JK ! HPS2561
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2557
AC   CVCL_A3JG
DR   RCB; HPS2557
DR   Wikidata; Q105508848
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JF ! HPS2556
OI   CVCL_A3JH ! HPS2558
OI   CVCL_A3JI ! HPS2559
OI   CVCL_A3JJ ! HPS2560
OI   CVCL_A3JK ! HPS2561
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2558
AC   CVCL_A3JH
DR   RCB; HPS2558
DR   Wikidata; Q105508850
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JF ! HPS2556
OI   CVCL_A3JG ! HPS2557
OI   CVCL_A3JI ! HPS2559
OI   CVCL_A3JJ ! HPS2560
OI   CVCL_A3JK ! HPS2561
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2559
AC   CVCL_A3JI
DR   RCB; HPS2559
DR   Wikidata; Q105508853
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JF ! HPS2556
OI   CVCL_A3JG ! HPS2557
OI   CVCL_A3JH ! HPS2558
OI   CVCL_A3JJ ! HPS2560
OI   CVCL_A3JK ! HPS2561
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2560
AC   CVCL_A3JJ
DR   RCB; HPS2560
DR   Wikidata; Q105508859
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JF ! HPS2556
OI   CVCL_A3JG ! HPS2557
OI   CVCL_A3JH ! HPS2558
OI   CVCL_A3JI ! HPS2559
OI   CVCL_A3JK ! HPS2561
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2561
AC   CVCL_A3JK
DR   RCB; HPS2561
DR   Wikidata; Q105508862
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JF ! HPS2556
OI   CVCL_A3JG ! HPS2557
OI   CVCL_A3JH ! HPS2558
OI   CVCL_A3JI ! HPS2559
OI   CVCL_A3JJ ! HPS2560
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2562
AC   CVCL_D0R7
DR   RCB; HPS2562
DR   Wikidata; Q123032229
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R8 ! HPS2563
OI   CVCL_D0R9 ! HPS2564
OI   CVCL_D0RA ! HPS2565
OI   CVCL_D0RB ! HPS2566
OI   CVCL_D0RC ! HPS2567
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2563
AC   CVCL_D0R8
DR   RCB; HPS2563
DR   Wikidata; Q123032230
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R7 ! HPS2562
OI   CVCL_D0R9 ! HPS2564
OI   CVCL_D0RA ! HPS2565
OI   CVCL_D0RB ! HPS2566
OI   CVCL_D0RC ! HPS2567
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2564
AC   CVCL_D0R9
DR   RCB; HPS2564
DR   Wikidata; Q123032231
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R7 ! HPS2562
OI   CVCL_D0R8 ! HPS2563
OI   CVCL_D0RA ! HPS2565
OI   CVCL_D0RB ! HPS2566
OI   CVCL_D0RC ! HPS2567
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2565
AC   CVCL_D0RA
DR   RCB; HPS2565
DR   Wikidata; Q123032232
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R7 ! HPS2562
OI   CVCL_D0R8 ! HPS2563
OI   CVCL_D0R9 ! HPS2564
OI   CVCL_D0RB ! HPS2566
OI   CVCL_D0RC ! HPS2567
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2566
AC   CVCL_D0RB
DR   RCB; HPS2566
DR   Wikidata; Q123032233
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R7 ! HPS2562
OI   CVCL_D0R8 ! HPS2563
OI   CVCL_D0R9 ! HPS2564
OI   CVCL_D0RA ! HPS2565
OI   CVCL_D0RC ! HPS2567
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2567
AC   CVCL_D0RC
DR   RCB; HPS2567
DR   Wikidata; Q123032234
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0R7 ! HPS2562
OI   CVCL_D0R8 ! HPS2563
OI   CVCL_D0R9 ! HPS2564
OI   CVCL_D0RA ! HPS2565
OI   CVCL_D0RB ! HPS2566
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2574
AC   CVCL_D0RD
DR   RCB; HPS2574
DR   Wikidata; Q123032235
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RE ! HPS2575
OI   CVCL_D0RF ! HPS2576
OI   CVCL_D0RG ! HPS2577
OI   CVCL_D0RH ! HPS2578
OI   CVCL_D0RI ! HPS2579
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2575
AC   CVCL_D0RE
DR   RCB; HPS2575
DR   Wikidata; Q123032236
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RD ! HPS2574
OI   CVCL_D0RF ! HPS2576
OI   CVCL_D0RG ! HPS2577
OI   CVCL_D0RH ! HPS2578
OI   CVCL_D0RI ! HPS2579
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2576
AC   CVCL_D0RF
DR   RCB; HPS2576
DR   Wikidata; Q123032237
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RD ! HPS2574
OI   CVCL_D0RE ! HPS2575
OI   CVCL_D0RG ! HPS2577
OI   CVCL_D0RH ! HPS2578
OI   CVCL_D0RI ! HPS2579
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2577
AC   CVCL_D0RG
DR   RCB; HPS2577
DR   Wikidata; Q123032238
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RD ! HPS2574
OI   CVCL_D0RE ! HPS2575
OI   CVCL_D0RF ! HPS2576
OI   CVCL_D0RH ! HPS2578
OI   CVCL_D0RI ! HPS2579
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2578
AC   CVCL_D0RH
DR   RCB; HPS2578
DR   Wikidata; Q123032239
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RD ! HPS2574
OI   CVCL_D0RE ! HPS2575
OI   CVCL_D0RF ! HPS2576
OI   CVCL_D0RG ! HPS2577
OI   CVCL_D0RI ! HPS2579
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2579
AC   CVCL_D0RI
DR   RCB; HPS2579
DR   Wikidata; Q123032240
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RD ! HPS2574
OI   CVCL_D0RE ! HPS2575
OI   CVCL_D0RF ! HPS2576
OI   CVCL_D0RG ! HPS2577
OI   CVCL_D0RH ! HPS2578
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2580
AC   CVCL_C6CH
DR   RCB; HPS2580
DR   Wikidata; Q116049452
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CI ! HPS2581
OI   CVCL_C6CJ ! HPS2582
OI   CVCL_C6CK ! HPS2583
OI   CVCL_C6CL ! HPS2584
OI   CVCL_C6CM ! HPS2585
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2581
AC   CVCL_C6CI
DR   RCB; HPS2581
DR   Wikidata; Q116049453
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CH ! HPS2580
OI   CVCL_C6CJ ! HPS2582
OI   CVCL_C6CK ! HPS2583
OI   CVCL_C6CL ! HPS2584
OI   CVCL_C6CM ! HPS2585
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2582
AC   CVCL_C6CJ
DR   RCB; HPS2582
DR   Wikidata; Q116049455
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CH ! HPS2580
OI   CVCL_C6CI ! HPS2581
OI   CVCL_C6CK ! HPS2583
OI   CVCL_C6CL ! HPS2584
OI   CVCL_C6CM ! HPS2585
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2583
AC   CVCL_C6CK
DR   RCB; HPS2583
DR   Wikidata; Q116049456
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CH ! HPS2580
OI   CVCL_C6CI ! HPS2581
OI   CVCL_C6CJ ! HPS2582
OI   CVCL_C6CL ! HPS2584
OI   CVCL_C6CM ! HPS2585
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2584
AC   CVCL_C6CL
DR   RCB; HPS2584
DR   Wikidata; Q116049457
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CH ! HPS2580
OI   CVCL_C6CI ! HPS2581
OI   CVCL_C6CJ ! HPS2582
OI   CVCL_C6CK ! HPS2583
OI   CVCL_C6CM ! HPS2585
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2585
AC   CVCL_C6CM
DR   RCB; HPS2585
DR   Wikidata; Q116049458
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CH ! HPS2580
OI   CVCL_C6CI ! HPS2581
OI   CVCL_C6CJ ! HPS2582
OI   CVCL_C6CK ! HPS2583
OI   CVCL_C6CL ! HPS2584
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2592
AC   CVCL_C6CN
DR   RCB; HPS2592
DR   Wikidata; Q116049459
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CP ! HPS2593
OI   CVCL_C6CQ ! HPS2594
OI   CVCL_C6CR ! HPS2595
OI   CVCL_C6CS ! HPS2596
OI   CVCL_C6CT ! HPS2597
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2593
AC   CVCL_C6CP
DR   RCB; HPS2593
DR   Wikidata; Q116049460
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CN ! HPS2592
OI   CVCL_C6CQ ! HPS2594
OI   CVCL_C6CR ! HPS2595
OI   CVCL_C6CS ! HPS2596
OI   CVCL_C6CT ! HPS2597
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2594
AC   CVCL_C6CQ
DR   RCB; HPS2594
DR   Wikidata; Q116049461
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CN ! HPS2592
OI   CVCL_C6CP ! HPS2593
OI   CVCL_C6CR ! HPS2595
OI   CVCL_C6CS ! HPS2596
OI   CVCL_C6CT ! HPS2597
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2595
AC   CVCL_C6CR
DR   RCB; HPS2595
DR   Wikidata; Q116049462
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CN ! HPS2592
OI   CVCL_C6CP ! HPS2593
OI   CVCL_C6CQ ! HPS2594
OI   CVCL_C6CS ! HPS2596
OI   CVCL_C6CT ! HPS2597
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2596
AC   CVCL_C6CS
DR   RCB; HPS2596
DR   Wikidata; Q116049463
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CN ! HPS2592
OI   CVCL_C6CP ! HPS2593
OI   CVCL_C6CQ ! HPS2594
OI   CVCL_C6CR ! HPS2595
OI   CVCL_C6CT ! HPS2597
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2597
AC   CVCL_C6CT
DR   RCB; HPS2597
DR   Wikidata; Q116049465
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CN ! HPS2592
OI   CVCL_C6CP ! HPS2593
OI   CVCL_C6CQ ! HPS2594
OI   CVCL_C6CR ! HPS2595
OI   CVCL_C6CS ! HPS2596
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2612
AC   CVCL_D0RJ
DR   RCB; HPS2612
DR   Wikidata; Q123032241
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RK ! HPS2613
OI   CVCL_D0RL ! HPS2614
OI   CVCL_D0RM ! HPS2615
OI   CVCL_D0RN ! HPS2616
OI   CVCL_D0RP ! HPS2617
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2613
AC   CVCL_D0RK
DR   RCB; HPS2613
DR   Wikidata; Q123032242
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RJ ! HPS2612
OI   CVCL_D0RL ! HPS2614
OI   CVCL_D0RM ! HPS2615
OI   CVCL_D0RN ! HPS2616
OI   CVCL_D0RP ! HPS2617
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2614
AC   CVCL_D0RL
DR   RCB; HPS2614
DR   Wikidata; Q123032243
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RJ ! HPS2612
OI   CVCL_D0RK ! HPS2613
OI   CVCL_D0RM ! HPS2615
OI   CVCL_D0RN ! HPS2616
OI   CVCL_D0RP ! HPS2617
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2615
AC   CVCL_D0RM
DR   RCB; HPS2615
DR   Wikidata; Q123032244
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RJ ! HPS2612
OI   CVCL_D0RK ! HPS2613
OI   CVCL_D0RL ! HPS2614
OI   CVCL_D0RN ! HPS2616
OI   CVCL_D0RP ! HPS2617
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2616
AC   CVCL_D0RN
DR   RCB; HPS2616
DR   Wikidata; Q123032245
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RJ ! HPS2612
OI   CVCL_D0RK ! HPS2613
OI   CVCL_D0RL ! HPS2614
OI   CVCL_D0RM ! HPS2615
OI   CVCL_D0RP ! HPS2617
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2617
AC   CVCL_D0RP
DR   RCB; HPS2617
DR   Wikidata; Q123032246
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RJ ! HPS2612
OI   CVCL_D0RK ! HPS2613
OI   CVCL_D0RL ! HPS2614
OI   CVCL_D0RM ! HPS2615
OI   CVCL_D0RN ! HPS2616
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2636
AC   CVCL_YS58
DR   RCB; HPS2636
DR   Wikidata; Q94220137
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS59 ! HPS2637
OI   CVCL_YS60 ! HPS2638
OI   CVCL_YS61 ! HPS2639
OI   CVCL_YS62 ! HPS2640
OI   CVCL_YS63 ! HPS2641
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2637
AC   CVCL_YS59
DR   RCB; HPS2637
DR   Wikidata; Q94220142
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS58 ! HPS2636
OI   CVCL_YS60 ! HPS2638
OI   CVCL_YS61 ! HPS2639
OI   CVCL_YS62 ! HPS2640
OI   CVCL_YS63 ! HPS2641
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2638
AC   CVCL_YS60
DR   RCB; HPS2638
DR   Wikidata; Q94220147
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS58 ! HPS2636
OI   CVCL_YS59 ! HPS2637
OI   CVCL_YS61 ! HPS2639
OI   CVCL_YS62 ! HPS2640
OI   CVCL_YS63 ! HPS2641
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2639
AC   CVCL_YS61
DR   RCB; HPS2639
DR   Wikidata; Q94220152
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS58 ! HPS2636
OI   CVCL_YS59 ! HPS2637
OI   CVCL_YS60 ! HPS2638
OI   CVCL_YS62 ! HPS2640
OI   CVCL_YS63 ! HPS2641
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2640
AC   CVCL_YS62
DR   RCB; HPS2640
DR   Wikidata; Q94220155
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS58 ! HPS2636
OI   CVCL_YS59 ! HPS2637
OI   CVCL_YS60 ! HPS2638
OI   CVCL_YS61 ! HPS2639
OI   CVCL_YS63 ! HPS2641
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2641
AC   CVCL_YS63
DR   RCB; HPS2641
DR   Wikidata; Q94220160
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS58 ! HPS2636
OI   CVCL_YS59 ! HPS2637
OI   CVCL_YS60 ! HPS2638
OI   CVCL_YS61 ! HPS2639
OI   CVCL_YS62 ! HPS2640
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2642
AC   CVCL_D1EG
DR   RCB; HPS2642
DR   Wikidata; Q123032247
CC   Donor information: Patient suffering from primary aldosteronism.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EH ! HPS2643
OI   CVCL_D1EI ! HPS2644
OI   CVCL_D1EJ ! HPS2645
OI   CVCL_D1EK ! HPS2646
OI   CVCL_D1EL ! HPS2647
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2643
AC   CVCL_D1EH
DR   RCB; HPS2643
DR   Wikidata; Q123032248
CC   Donor information: Patient suffering from primary aldosteronism.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EG ! HPS2642
OI   CVCL_D1EI ! HPS2644
OI   CVCL_D1EJ ! HPS2645
OI   CVCL_D1EK ! HPS2646
OI   CVCL_D1EL ! HPS2647
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2644
AC   CVCL_D1EI
DR   RCB; HPS2644
DR   Wikidata; Q123032249
CC   Donor information: Patient suffering from primary aldosteronism.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EG ! HPS2642
OI   CVCL_D1EH ! HPS2643
OI   CVCL_D1EJ ! HPS2645
OI   CVCL_D1EK ! HPS2646
OI   CVCL_D1EL ! HPS2647
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2645
AC   CVCL_D1EJ
DR   RCB; HPS2645
DR   Wikidata; Q123032250
CC   Donor information: Patient suffering from primary aldosteronism.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EG ! HPS2642
OI   CVCL_D1EH ! HPS2643
OI   CVCL_D1EI ! HPS2644
OI   CVCL_D1EK ! HPS2646
OI   CVCL_D1EL ! HPS2647
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2646
AC   CVCL_D1EK
DR   RCB; HPS2646
DR   Wikidata; Q123032251
CC   Donor information: Patient suffering from primary aldosteronism.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EG ! HPS2642
OI   CVCL_D1EH ! HPS2643
OI   CVCL_D1EI ! HPS2644
OI   CVCL_D1EJ ! HPS2645
OI   CVCL_D1EL ! HPS2647
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2647
AC   CVCL_D1EL
DR   RCB; HPS2647
DR   Wikidata; Q123032253
CC   Donor information: Patient suffering from primary aldosteronism.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EG ! HPS2642
OI   CVCL_D1EH ! HPS2643
OI   CVCL_D1EI ! HPS2644
OI   CVCL_D1EJ ! HPS2645
OI   CVCL_D1EK ! HPS2646
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2648
AC   CVCL_D1D3
DR   RCB; HPS2648
DR   Wikidata; Q123032255
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D4 ! HPS2649
OI   CVCL_D1D5 ! HPS2650
OI   CVCL_D1D6 ! HPS2651
OI   CVCL_D1D7 ! HPS2652
OI   CVCL_D1D8 ! HPS2653
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2649
AC   CVCL_D1D4
DR   RCB; HPS2649
DR   Wikidata; Q123032256
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D3 ! HPS2648
OI   CVCL_D1D5 ! HPS2650
OI   CVCL_D1D6 ! HPS2651
OI   CVCL_D1D7 ! HPS2652
OI   CVCL_D1D8 ! HPS2653
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2650
AC   CVCL_D1D5
DR   RCB; HPS2650
DR   Wikidata; Q123032257
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D3 ! HPS2648
OI   CVCL_D1D4 ! HPS2649
OI   CVCL_D1D6 ! HPS2651
OI   CVCL_D1D7 ! HPS2652
OI   CVCL_D1D8 ! HPS2653
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2651
AC   CVCL_D1D6
DR   RCB; HPS2651
DR   Wikidata; Q123032259
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D3 ! HPS2648
OI   CVCL_D1D4 ! HPS2649
OI   CVCL_D1D5 ! HPS2650
OI   CVCL_D1D7 ! HPS2652
OI   CVCL_D1D8 ! HPS2653
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2652
AC   CVCL_D1D7
DR   RCB; HPS2652
DR   Wikidata; Q123032261
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D3 ! HPS2648
OI   CVCL_D1D4 ! HPS2649
OI   CVCL_D1D5 ! HPS2650
OI   CVCL_D1D6 ! HPS2651
OI   CVCL_D1D8 ! HPS2653
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2653
AC   CVCL_D1D8
DR   RCB; HPS2653
DR   Wikidata; Q123032263
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34910; Pemphigus vulgaris
DI   ORDO; Orphanet_704; Pemphigus vulgaris
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1D3 ! HPS2648
OI   CVCL_D1D4 ! HPS2649
OI   CVCL_D1D5 ! HPS2650
OI   CVCL_D1D6 ! HPS2651
OI   CVCL_D1D7 ! HPS2652
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2660
AC   CVCL_D0RQ
DR   RCB; HPS2660
DR   Wikidata; Q123032264
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RR ! HPS2661
OI   CVCL_D0RS ! HPS2662
OI   CVCL_D0RT ! HPS2663
OI   CVCL_D0RU ! HPS2664
OI   CVCL_D0RV ! HPS2665
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2661
AC   CVCL_D0RR
DR   RCB; HPS2661
DR   Wikidata; Q123032265
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RQ ! HPS2660
OI   CVCL_D0RS ! HPS2662
OI   CVCL_D0RT ! HPS2663
OI   CVCL_D0RU ! HPS2664
OI   CVCL_D0RV ! HPS2665
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2662
AC   CVCL_D0RS
DR   RCB; HPS2662
DR   Wikidata; Q123032266
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RQ ! HPS2660
OI   CVCL_D0RR ! HPS2661
OI   CVCL_D0RT ! HPS2663
OI   CVCL_D0RU ! HPS2664
OI   CVCL_D0RV ! HPS2665
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2663
AC   CVCL_D0RT
DR   RCB; HPS2663
DR   Wikidata; Q123032268
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RQ ! HPS2660
OI   CVCL_D0RR ! HPS2661
OI   CVCL_D0RS ! HPS2662
OI   CVCL_D0RU ! HPS2664
OI   CVCL_D0RV ! HPS2665
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2664
AC   CVCL_D0RU
DR   RCB; HPS2664
DR   Wikidata; Q123032269
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RQ ! HPS2660
OI   CVCL_D0RR ! HPS2661
OI   CVCL_D0RS ! HPS2662
OI   CVCL_D0RT ! HPS2663
OI   CVCL_D0RV ! HPS2665
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2665
AC   CVCL_D0RV
DR   RCB; HPS2665
DR   Wikidata; Q123032270
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RQ ! HPS2660
OI   CVCL_D0RR ! HPS2661
OI   CVCL_D0RS ! HPS2662
OI   CVCL_D0RT ! HPS2663
OI   CVCL_D0RU ! HPS2664
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2666
AC   CVCL_D1CE
DR   RCB; HPS2666
DR   Wikidata; Q123032272
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35264; Rapidly progressive glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CF ! HPS2667
OI   CVCL_D1CG ! HPS2668
OI   CVCL_D1CH ! HPS2669
OI   CVCL_D1CI ! HPS2670
OI   CVCL_D1CJ ! HPS2671
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2667
AC   CVCL_D1CF
DR   RCB; HPS2667
DR   Wikidata; Q123032275
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35264; Rapidly progressive glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CE ! HPS2666
OI   CVCL_D1CG ! HPS2668
OI   CVCL_D1CH ! HPS2669
OI   CVCL_D1CI ! HPS2670
OI   CVCL_D1CJ ! HPS2671
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2668
AC   CVCL_D1CG
DR   RCB; HPS2668
DR   Wikidata; Q123032276
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35264; Rapidly progressive glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CE ! HPS2666
OI   CVCL_D1CF ! HPS2667
OI   CVCL_D1CH ! HPS2669
OI   CVCL_D1CI ! HPS2670
OI   CVCL_D1CJ ! HPS2671
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2669
AC   CVCL_D1CH
DR   RCB; HPS2669
DR   Wikidata; Q123032278
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35264; Rapidly progressive glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CE ! HPS2666
OI   CVCL_D1CF ! HPS2667
OI   CVCL_D1CG ! HPS2668
OI   CVCL_D1CI ! HPS2670
OI   CVCL_D1CJ ! HPS2671
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2670
AC   CVCL_D1CI
DR   RCB; HPS2670
DR   Wikidata; Q123032279
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35264; Rapidly progressive glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CE ! HPS2666
OI   CVCL_D1CF ! HPS2667
OI   CVCL_D1CG ! HPS2668
OI   CVCL_D1CH ! HPS2669
OI   CVCL_D1CJ ! HPS2671
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2671
AC   CVCL_D1CJ
DR   RCB; HPS2671
DR   Wikidata; Q123032282
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35264; Rapidly progressive glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CE ! HPS2666
OI   CVCL_D1CF ! HPS2667
OI   CVCL_D1CG ! HPS2668
OI   CVCL_D1CH ! HPS2669
OI   CVCL_D1CI ! HPS2670
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2672
AC   CVCL_D0RW
DR   RCB; HPS2672
DR   Wikidata; Q123032284
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95992; IgG4-related disease
DI   ORDO; Orphanet_284264; IgG4-related disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RX ! HPS2673
OI   CVCL_D0RY ! HPS2674
OI   CVCL_D0RZ ! HPS2675
OI   CVCL_D0S0 ! HPS2676
OI   CVCL_D0S1 ! HPS2677
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2673
AC   CVCL_D0RX
DR   RCB; HPS2673
DR   Wikidata; Q123032286
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95992; IgG4-related disease
DI   ORDO; Orphanet_284264; IgG4-related disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RW ! HPS2672
OI   CVCL_D0RY ! HPS2674
OI   CVCL_D0RZ ! HPS2675
OI   CVCL_D0S0 ! HPS2676
OI   CVCL_D0S1 ! HPS2677
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2674
AC   CVCL_D0RY
DR   RCB; HPS2674
DR   Wikidata; Q123032287
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95992; IgG4-related disease
DI   ORDO; Orphanet_284264; IgG4-related disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RW ! HPS2672
OI   CVCL_D0RX ! HPS2673
OI   CVCL_D0RZ ! HPS2675
OI   CVCL_D0S0 ! HPS2676
OI   CVCL_D0S1 ! HPS2677
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2675
AC   CVCL_D0RZ
DR   RCB; HPS2675
DR   Wikidata; Q123032288
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95992; IgG4-related disease
DI   ORDO; Orphanet_284264; IgG4-related disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RW ! HPS2672
OI   CVCL_D0RX ! HPS2673
OI   CVCL_D0RY ! HPS2674
OI   CVCL_D0S0 ! HPS2676
OI   CVCL_D0S1 ! HPS2677
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2676
AC   CVCL_D0S0
DR   RCB; HPS2676
DR   Wikidata; Q123032289
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95992; IgG4-related disease
DI   ORDO; Orphanet_284264; IgG4-related disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RW ! HPS2672
OI   CVCL_D0RX ! HPS2673
OI   CVCL_D0RY ! HPS2674
OI   CVCL_D0RZ ! HPS2675
OI   CVCL_D0S1 ! HPS2677
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2677
AC   CVCL_D0S1
DR   RCB; HPS2677
DR   Wikidata; Q123032290
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95992; IgG4-related disease
DI   ORDO; Orphanet_284264; IgG4-related disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0RW ! HPS2672
OI   CVCL_D0RX ! HPS2673
OI   CVCL_D0RY ! HPS2674
OI   CVCL_D0RZ ! HPS2675
OI   CVCL_D0S0 ! HPS2676
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2678
AC   CVCL_D0S2
DR   RCB; HPS2678
DR   Wikidata; Q123032291
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S3 ! HPS2679
OI   CVCL_D0S4 ! HPS2680
OI   CVCL_D0S5 ! HPS2681
OI   CVCL_D0S6 ! HPS2682
OI   CVCL_D0S7 ! HPS2683
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2679
AC   CVCL_D0S3
DR   RCB; HPS2679
DR   Wikidata; Q123032292
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S2 ! HPS2678
OI   CVCL_D0S4 ! HPS2680
OI   CVCL_D0S5 ! HPS2681
OI   CVCL_D0S6 ! HPS2682
OI   CVCL_D0S7 ! HPS2683
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2680
AC   CVCL_D0S4
DR   RCB; HPS2680
DR   Wikidata; Q123032293
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S2 ! HPS2678
OI   CVCL_D0S3 ! HPS2679
OI   CVCL_D0S5 ! HPS2681
OI   CVCL_D0S6 ! HPS2682
OI   CVCL_D0S7 ! HPS2683
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2681
AC   CVCL_D0S5
DR   RCB; HPS2681
DR   Wikidata; Q123032295
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S2 ! HPS2678
OI   CVCL_D0S3 ! HPS2679
OI   CVCL_D0S4 ! HPS2680
OI   CVCL_D0S6 ! HPS2682
OI   CVCL_D0S7 ! HPS2683
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2682
AC   CVCL_D0S6
DR   RCB; HPS2682
DR   Wikidata; Q123032297
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S2 ! HPS2678
OI   CVCL_D0S3 ! HPS2679
OI   CVCL_D0S4 ! HPS2680
OI   CVCL_D0S5 ! HPS2681
OI   CVCL_D0S7 ! HPS2683
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2683
AC   CVCL_D0S7
DR   RCB; HPS2683
DR   Wikidata; Q123032299
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2952; Ulcerative colitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S2 ! HPS2678
OI   CVCL_D0S3 ! HPS2679
OI   CVCL_D0S4 ! HPS2680
OI   CVCL_D0S5 ! HPS2681
OI   CVCL_D0S6 ! HPS2682
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2684
AC   CVCL_D0S8
DR   RCB; HPS2684
DR   Wikidata; Q123032300
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S9 ! HPS2685
OI   CVCL_D0SA ! HPS2686
OI   CVCL_D0SB ! HPS2687
OI   CVCL_D0SC ! HPS2688
OI   CVCL_D0SD ! HPS2689
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2685
AC   CVCL_D0S9
DR   RCB; HPS2685
DR   Wikidata; Q123032301
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S8 ! HPS2684
OI   CVCL_D0SA ! HPS2686
OI   CVCL_D0SB ! HPS2687
OI   CVCL_D0SC ! HPS2688
OI   CVCL_D0SD ! HPS2689
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2686
AC   CVCL_D0SA
DR   RCB; HPS2686
DR   Wikidata; Q123032302
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S8 ! HPS2684
OI   CVCL_D0S9 ! HPS2685
OI   CVCL_D0SB ! HPS2687
OI   CVCL_D0SC ! HPS2688
OI   CVCL_D0SD ! HPS2689
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2687
AC   CVCL_D0SB
DR   RCB; HPS2687
DR   Wikidata; Q123032303
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S8 ! HPS2684
OI   CVCL_D0S9 ! HPS2685
OI   CVCL_D0SA ! HPS2686
OI   CVCL_D0SC ! HPS2688
OI   CVCL_D0SD ! HPS2689
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2688
AC   CVCL_D0SC
DR   RCB; HPS2688
DR   Wikidata; Q123032304
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S8 ! HPS2684
OI   CVCL_D0S9 ! HPS2685
OI   CVCL_D0SA ! HPS2686
OI   CVCL_D0SB ! HPS2687
OI   CVCL_D0SD ! HPS2689
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2689
AC   CVCL_D0SD
DR   RCB; HPS2689
DR   Wikidata; Q123032305
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0S8 ! HPS2684
OI   CVCL_D0S9 ! HPS2685
OI   CVCL_D0SA ! HPS2686
OI   CVCL_D0SB ! HPS2687
OI   CVCL_D0SC ! HPS2688
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2690
AC   CVCL_UP15
DR   RCB; HPS2690
DR   Wikidata; Q94220165
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_88; Idiopathic aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP16 ! HPS2691
OI   CVCL_UP17 ! HPS2692
OI   CVCL_A3WB ! HPS2693
OI   CVCL_A3WC ! HPS2694
OI   CVCL_A3WD ! HPS2695
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2691
AC   CVCL_UP16
DR   RCB; HPS2691
DR   Wikidata; Q94220170
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_88; Idiopathic aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP15 ! HPS2690
OI   CVCL_UP17 ! HPS2692
OI   CVCL_A3WB ! HPS2693
OI   CVCL_A3WC ! HPS2694
OI   CVCL_A3WD ! HPS2695
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2692
AC   CVCL_UP17
DR   RCB; HPS2692
DR   Wikidata; Q94220174
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_88; Idiopathic aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP15 ! HPS2690
OI   CVCL_UP16 ! HPS2691
OI   CVCL_A3WB ! HPS2693
OI   CVCL_A3WC ! HPS2694
OI   CVCL_A3WD ! HPS2695
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2693
AC   CVCL_A3WB
DR   RCB; HPS2693
DR   Wikidata; Q105508866
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_88; Idiopathic aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP15 ! HPS2690
OI   CVCL_UP16 ! HPS2691
OI   CVCL_UP17 ! HPS2692
OI   CVCL_A3WC ! HPS2694
OI   CVCL_A3WD ! HPS2695
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2694
AC   CVCL_A3WC
DR   RCB; HPS2694
DR   Wikidata; Q105508871
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_88; Idiopathic aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP15 ! HPS2690
OI   CVCL_UP16 ! HPS2691
OI   CVCL_UP17 ! HPS2692
OI   CVCL_A3WB ! HPS2693
OI   CVCL_A3WD ! HPS2695
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2695
AC   CVCL_A3WD
DR   RCB; HPS2695
DR   Wikidata; Q105508875
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_88; Idiopathic aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP15 ! HPS2690
OI   CVCL_UP16 ! HPS2691
OI   CVCL_UP17 ! HPS2692
OI   CVCL_A3WB ! HPS2693
OI   CVCL_A3WC ! HPS2694
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2696
AC   CVCL_D0SE
DR   RCB; HPS2696
DR   Wikidata; Q123032306
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SF ! HPS2697
OI   CVCL_D0SG ! HPS2698
OI   CVCL_D0SH ! HPS2699
OI   CVCL_D0SI ! HPS2700
OI   CVCL_D0SJ ! HPS2701
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2697
AC   CVCL_D0SF
DR   RCB; HPS2697
DR   Wikidata; Q123032307
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SE ! HPS2696
OI   CVCL_D0SG ! HPS2698
OI   CVCL_D0SH ! HPS2699
OI   CVCL_D0SI ! HPS2700
OI   CVCL_D0SJ ! HPS2701
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2698
AC   CVCL_D0SG
DR   RCB; HPS2698
DR   Wikidata; Q123032308
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SE ! HPS2696
OI   CVCL_D0SF ! HPS2697
OI   CVCL_D0SH ! HPS2699
OI   CVCL_D0SI ! HPS2700
OI   CVCL_D0SJ ! HPS2701
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2699
AC   CVCL_D0SH
DR   RCB; HPS2699
DR   Wikidata; Q123032310
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SE ! HPS2696
OI   CVCL_D0SF ! HPS2697
OI   CVCL_D0SG ! HPS2698
OI   CVCL_D0SI ! HPS2700
OI   CVCL_D0SJ ! HPS2701
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2700
AC   CVCL_D0SI
DR   RCB; HPS2700
DR   Wikidata; Q123032312
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SE ! HPS2696
OI   CVCL_D0SF ! HPS2697
OI   CVCL_D0SG ! HPS2698
OI   CVCL_D0SH ! HPS2699
OI   CVCL_D0SJ ! HPS2701
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2701
AC   CVCL_D0SJ
DR   RCB; HPS2701
DR   Wikidata; Q123032313
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SE ! HPS2696
OI   CVCL_D0SF ! HPS2697
OI   CVCL_D0SG ! HPS2698
OI   CVCL_D0SH ! HPS2699
OI   CVCL_D0SI ! HPS2700
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2702
AC   CVCL_D0SK
DR   RCB; HPS2702
DR   Wikidata; Q123032314
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84975; Ossification of posterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SL ! HPS2703
OI   CVCL_D0SM ! HPS2704
OI   CVCL_D0SN ! HPS2705
OI   CVCL_D0SP ! HPS2706
OI   CVCL_D0SQ ! HPS2707
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2703
AC   CVCL_D0SL
DR   RCB; HPS2703
DR   Wikidata; Q123032317
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84975; Ossification of posterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SK ! HPS2702
OI   CVCL_D0SM ! HPS2704
OI   CVCL_D0SN ! HPS2705
OI   CVCL_D0SP ! HPS2706
OI   CVCL_D0SQ ! HPS2707
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2704
AC   CVCL_D0SM
DR   RCB; HPS2704
DR   Wikidata; Q123032318
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84975; Ossification of posterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SK ! HPS2702
OI   CVCL_D0SL ! HPS2703
OI   CVCL_D0SN ! HPS2705
OI   CVCL_D0SP ! HPS2706
OI   CVCL_D0SQ ! HPS2707
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2705
AC   CVCL_D0SN
DR   RCB; HPS2705
DR   Wikidata; Q123032319
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84975; Ossification of posterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SK ! HPS2702
OI   CVCL_D0SL ! HPS2703
OI   CVCL_D0SM ! HPS2704
OI   CVCL_D0SP ! HPS2706
OI   CVCL_D0SQ ! HPS2707
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2706
AC   CVCL_D0SP
DR   RCB; HPS2706
DR   Wikidata; Q123032320
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84975; Ossification of posterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SK ! HPS2702
OI   CVCL_D0SL ! HPS2703
OI   CVCL_D0SM ! HPS2704
OI   CVCL_D0SN ! HPS2705
OI   CVCL_D0SQ ! HPS2707
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2707
AC   CVCL_D0SQ
DR   RCB; HPS2707
DR   Wikidata; Q123032321
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84975; Ossification of posterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SK ! HPS2702
OI   CVCL_D0SL ! HPS2703
OI   CVCL_D0SM ! HPS2704
OI   CVCL_D0SN ! HPS2705
OI   CVCL_D0SP ! HPS2706
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2708
AC   CVCL_D0SR
DR   RCB; HPS2708
DR   Wikidata; Q123032322
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SS ! HPS2709
OI   CVCL_D0ST ! HPS2710
OI   CVCL_D0SU ! HPS2711
OI   CVCL_D0SV ! HPS2712
OI   CVCL_D0SW ! HPS2713
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2709
AC   CVCL_D0SS
DR   RCB; HPS2709
DR   Wikidata; Q123032323
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SR ! HPS2708
OI   CVCL_D0ST ! HPS2710
OI   CVCL_D0SU ! HPS2711
OI   CVCL_D0SV ! HPS2712
OI   CVCL_D0SW ! HPS2713
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2710
AC   CVCL_D0ST
DR   RCB; HPS2710
DR   Wikidata; Q123032324
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SR ! HPS2708
OI   CVCL_D0SS ! HPS2709
OI   CVCL_D0SU ! HPS2711
OI   CVCL_D0SV ! HPS2712
OI   CVCL_D0SW ! HPS2713
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2711
AC   CVCL_D0SU
DR   RCB; HPS2711
DR   Wikidata; Q123032325
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SR ! HPS2708
OI   CVCL_D0SS ! HPS2709
OI   CVCL_D0ST ! HPS2710
OI   CVCL_D0SV ! HPS2712
OI   CVCL_D0SW ! HPS2713
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2712
AC   CVCL_D0SV
DR   RCB; HPS2712
DR   Wikidata; Q123032326
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SR ! HPS2708
OI   CVCL_D0SS ! HPS2709
OI   CVCL_D0ST ! HPS2710
OI   CVCL_D0SU ! HPS2711
OI   CVCL_D0SW ! HPS2713
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2713
AC   CVCL_D0SW
DR   RCB; HPS2713
DR   Wikidata; Q123032327
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C197832; Adult-onset Still's disease
DI   ORDO; Orphanet_829; Adult-onset Still disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SR ! HPS2708
OI   CVCL_D0SS ! HPS2709
OI   CVCL_D0ST ! HPS2710
OI   CVCL_D0SU ! HPS2711
OI   CVCL_D0SV ! HPS2712
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2714
AC   CVCL_D0SX
DR   RCB; HPS2714
DR   Wikidata; Q123032329
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SY ! HPS2715
OI   CVCL_D0SZ ! HPS2716
OI   CVCL_D0T0 ! HPS2717
OI   CVCL_D0T1 ! HPS2718
OI   CVCL_D0T2 ! HPS2719
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2715
AC   CVCL_D0SY
DR   RCB; HPS2715
DR   Wikidata; Q123032330
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SX ! HPS2714
OI   CVCL_D0SZ ! HPS2716
OI   CVCL_D0T0 ! HPS2717
OI   CVCL_D0T1 ! HPS2718
OI   CVCL_D0T2 ! HPS2719
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2716
AC   CVCL_D0SZ
DR   RCB; HPS2716
DR   Wikidata; Q123032332
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SX ! HPS2714
OI   CVCL_D0SY ! HPS2715
OI   CVCL_D0T0 ! HPS2717
OI   CVCL_D0T1 ! HPS2718
OI   CVCL_D0T2 ! HPS2719
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2717
AC   CVCL_D0T0
DR   RCB; HPS2717
DR   Wikidata; Q123032334
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SX ! HPS2714
OI   CVCL_D0SY ! HPS2715
OI   CVCL_D0SZ ! HPS2716
OI   CVCL_D0T1 ! HPS2718
OI   CVCL_D0T2 ! HPS2719
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2718
AC   CVCL_D0T1
DR   RCB; HPS2718
DR   Wikidata; Q123032335
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SX ! HPS2714
OI   CVCL_D0SY ! HPS2715
OI   CVCL_D0SZ ! HPS2716
OI   CVCL_D0T0 ! HPS2717
OI   CVCL_D0T2 ! HPS2719
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2719
AC   CVCL_D0T2
DR   RCB; HPS2719
DR   Wikidata; Q123032336
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0SX ! HPS2714
OI   CVCL_D0SY ! HPS2715
OI   CVCL_D0SZ ! HPS2716
OI   CVCL_D0T0 ! HPS2717
OI   CVCL_D0T1 ! HPS2718
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2720
AC   CVCL_D0T3
DR   RCB; HPS2720
DR   Wikidata; Q123032337
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T4 ! HPS2721
OI   CVCL_D0T5 ! HPS2722
OI   CVCL_D0T6 ! HPS2723
OI   CVCL_D0T7 ! HPS2724
OI   CVCL_D0T8 ! HPS2725
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HPS2721
AC   CVCL_D0T4
DR   RCB; HPS2721
DR   Wikidata; Q123032338
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T3 ! HPS2720
OI   CVCL_D0T5 ! HPS2722
OI   CVCL_D0T6 ! HPS2723
OI   CVCL_D0T7 ! HPS2724
OI   CVCL_D0T8 ! HPS2725
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HPS2722
AC   CVCL_D0T5
DR   RCB; HPS2722
DR   Wikidata; Q123032339
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T3 ! HPS2720
OI   CVCL_D0T4 ! HPS2721
OI   CVCL_D0T6 ! HPS2723
OI   CVCL_D0T7 ! HPS2724
OI   CVCL_D0T8 ! HPS2725
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HPS2723
AC   CVCL_D0T6
DR   RCB; HPS2723
DR   Wikidata; Q123032340
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T3 ! HPS2720
OI   CVCL_D0T4 ! HPS2721
OI   CVCL_D0T5 ! HPS2722
OI   CVCL_D0T7 ! HPS2724
OI   CVCL_D0T8 ! HPS2725
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HPS2724
AC   CVCL_D0T7
DR   RCB; HPS2724
DR   Wikidata; Q123032341
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T3 ! HPS2720
OI   CVCL_D0T4 ! HPS2721
OI   CVCL_D0T5 ! HPS2722
OI   CVCL_D0T6 ! HPS2723
OI   CVCL_D0T8 ! HPS2725
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HPS2725
AC   CVCL_D0T8
DR   RCB; HPS2725
DR   Wikidata; Q123032342
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220611; Hemimegalencephaly
DI   ORDO; Orphanet_99802; Hemimegalencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T3 ! HPS2720
OI   CVCL_D0T4 ! HPS2721
OI   CVCL_D0T5 ! HPS2722
OI   CVCL_D0T6 ! HPS2723
OI   CVCL_D0T7 ! HPS2724
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   HPS2726
AC   CVCL_D0T9
DR   RCB; HPS2726
DR   Wikidata; Q123032345
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C113814; Autoimmune primary adrenal insufficiency
DI   ORDO; Orphanet_3143; Autoimmune polyendocrinopathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TA ! HPS2727
OI   CVCL_D0TB ! HPS2728
OI   CVCL_D0TC ! HPS2729
OI   CVCL_D0TD ! HPS2730
OI   CVCL_D0TE ! HPS2731
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2727
AC   CVCL_D0TA
DR   RCB; HPS2727
DR   Wikidata; Q123032346
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C113814; Autoimmune primary adrenal insufficiency
DI   ORDO; Orphanet_3143; Autoimmune polyendocrinopathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T9 ! HPS2726
OI   CVCL_D0TB ! HPS2728
OI   CVCL_D0TC ! HPS2729
OI   CVCL_D0TD ! HPS2730
OI   CVCL_D0TE ! HPS2731
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2728
AC   CVCL_D0TB
DR   RCB; HPS2728
DR   Wikidata; Q123032348
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C113814; Autoimmune primary adrenal insufficiency
DI   ORDO; Orphanet_3143; Autoimmune polyendocrinopathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T9 ! HPS2726
OI   CVCL_D0TA ! HPS2727
OI   CVCL_D0TC ! HPS2729
OI   CVCL_D0TD ! HPS2730
OI   CVCL_D0TE ! HPS2731
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2729
AC   CVCL_D0TC
DR   RCB; HPS2729
DR   Wikidata; Q123032350
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C113814; Autoimmune primary adrenal insufficiency
DI   ORDO; Orphanet_3143; Autoimmune polyendocrinopathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T9 ! HPS2726
OI   CVCL_D0TA ! HPS2727
OI   CVCL_D0TB ! HPS2728
OI   CVCL_D0TD ! HPS2730
OI   CVCL_D0TE ! HPS2731
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2730
AC   CVCL_D0TD
DR   RCB; HPS2730
DR   Wikidata; Q123032351
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C113814; Autoimmune primary adrenal insufficiency
DI   ORDO; Orphanet_3143; Autoimmune polyendocrinopathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T9 ! HPS2726
OI   CVCL_D0TA ! HPS2727
OI   CVCL_D0TB ! HPS2728
OI   CVCL_D0TC ! HPS2729
OI   CVCL_D0TE ! HPS2731
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2731
AC   CVCL_D0TE
DR   RCB; HPS2731
DR   Wikidata; Q123032352
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C113814; Autoimmune primary adrenal insufficiency
DI   ORDO; Orphanet_3143; Autoimmune polyendocrinopathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0T9 ! HPS2726
OI   CVCL_D0TA ! HPS2727
OI   CVCL_D0TB ! HPS2728
OI   CVCL_D0TC ! HPS2729
OI   CVCL_D0TD ! HPS2730
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2732
AC   CVCL_D0TF
DR   RCB; HPS2732
DR   Wikidata; Q123032353
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84806; Landau-Kleffner syndrome
DI   ORDO; Orphanet_98818; Landau-Kleffner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TG ! HPS2733
OI   CVCL_D0TH ! HPS2734
OI   CVCL_D0TI ! HPS2735
OI   CVCL_D0TJ ! HPS2736
OI   CVCL_D0TK ! HPS2737
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2733
AC   CVCL_D0TG
DR   RCB; HPS2733
DR   Wikidata; Q123032354
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84806; Landau-Kleffner syndrome
DI   ORDO; Orphanet_98818; Landau-Kleffner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TF ! HPS2732
OI   CVCL_D0TH ! HPS2734
OI   CVCL_D0TI ! HPS2735
OI   CVCL_D0TJ ! HPS2736
OI   CVCL_D0TK ! HPS2737
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2734
AC   CVCL_D0TH
DR   RCB; HPS2734
DR   Wikidata; Q123032357
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84806; Landau-Kleffner syndrome
DI   ORDO; Orphanet_98818; Landau-Kleffner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TF ! HPS2732
OI   CVCL_D0TG ! HPS2733
OI   CVCL_D0TI ! HPS2735
OI   CVCL_D0TJ ! HPS2736
OI   CVCL_D0TK ! HPS2737
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2735
AC   CVCL_D0TI
DR   RCB; HPS2735
DR   Wikidata; Q123032358
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84806; Landau-Kleffner syndrome
DI   ORDO; Orphanet_98818; Landau-Kleffner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TF ! HPS2732
OI   CVCL_D0TG ! HPS2733
OI   CVCL_D0TH ! HPS2734
OI   CVCL_D0TJ ! HPS2736
OI   CVCL_D0TK ! HPS2737
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2736
AC   CVCL_D0TJ
DR   RCB; HPS2736
DR   Wikidata; Q123032359
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84806; Landau-Kleffner syndrome
DI   ORDO; Orphanet_98818; Landau-Kleffner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TF ! HPS2732
OI   CVCL_D0TG ! HPS2733
OI   CVCL_D0TH ! HPS2734
OI   CVCL_D0TI ! HPS2735
OI   CVCL_D0TK ! HPS2737
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2737
AC   CVCL_D0TK
DR   RCB; HPS2737
DR   Wikidata; Q123032361
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84806; Landau-Kleffner syndrome
DI   ORDO; Orphanet_98818; Landau-Kleffner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TF ! HPS2732
OI   CVCL_D0TG ! HPS2733
OI   CVCL_D0TH ! HPS2734
OI   CVCL_D0TI ! HPS2735
OI   CVCL_D0TJ ! HPS2736
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2738
AC   CVCL_D0TL
DR   RCB; HPS2738
DR   Wikidata; Q123032362
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35540; Nephrotic syndrome with lesion of minimal change glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TM ! HPS2739
OI   CVCL_D0TN ! HPS2740
OI   CVCL_D0TP ! HPS2741
OI   CVCL_D0TQ ! HPS2742
OI   CVCL_D0TR ! HPS2743
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2739
AC   CVCL_D0TM
DR   RCB; HPS2739
DR   Wikidata; Q123032364
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35540; Nephrotic syndrome with lesion of minimal change glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TL ! HPS2738
OI   CVCL_D0TN ! HPS2740
OI   CVCL_D0TP ! HPS2741
OI   CVCL_D0TQ ! HPS2742
OI   CVCL_D0TR ! HPS2743
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2740
AC   CVCL_D0TN
DR   RCB; HPS2740
DR   Wikidata; Q123032365
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35540; Nephrotic syndrome with lesion of minimal change glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TL ! HPS2738
OI   CVCL_D0TM ! HPS2739
OI   CVCL_D0TP ! HPS2741
OI   CVCL_D0TQ ! HPS2742
OI   CVCL_D0TR ! HPS2743
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2741
AC   CVCL_D0TP
DR   RCB; HPS2741
DR   Wikidata; Q123032367
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35540; Nephrotic syndrome with lesion of minimal change glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TL ! HPS2738
OI   CVCL_D0TM ! HPS2739
OI   CVCL_D0TN ! HPS2740
OI   CVCL_D0TQ ! HPS2742
OI   CVCL_D0TR ! HPS2743
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2742
AC   CVCL_D0TQ
DR   RCB; HPS2742
DR   Wikidata; Q123032369
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35540; Nephrotic syndrome with lesion of minimal change glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TL ! HPS2738
OI   CVCL_D0TM ! HPS2739
OI   CVCL_D0TN ! HPS2740
OI   CVCL_D0TP ! HPS2741
OI   CVCL_D0TR ! HPS2743
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2743
AC   CVCL_D0TR
DR   RCB; HPS2743
DR   Wikidata; Q123032370
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35540; Nephrotic syndrome with lesion of minimal change glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TL ! HPS2738
OI   CVCL_D0TM ! HPS2739
OI   CVCL_D0TN ! HPS2740
OI   CVCL_D0TP ! HPS2741
OI   CVCL_D0TQ ! HPS2742
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2744
AC   CVCL_YS64
DR   RCB; HPS2744
DR   Wikidata; Q94220178
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS65 ! HPS2745
OI   CVCL_YS66 ! HPS2746
OI   CVCL_YS67 ! HPS2747
OI   CVCL_YS68 ! HPS2748
OI   CVCL_YS69 ! HPS2749
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2745
AC   CVCL_YS65
DR   RCB; HPS2745
DR   Wikidata; Q94220183
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS64 ! HPS2744
OI   CVCL_YS66 ! HPS2746
OI   CVCL_YS67 ! HPS2747
OI   CVCL_YS68 ! HPS2748
OI   CVCL_YS69 ! HPS2749
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2746
AC   CVCL_YS66
DR   RCB; HPS2746
DR   Wikidata; Q94220187
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS64 ! HPS2744
OI   CVCL_YS65 ! HPS2745
OI   CVCL_YS67 ! HPS2747
OI   CVCL_YS68 ! HPS2748
OI   CVCL_YS69 ! HPS2749
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2747
AC   CVCL_YS67
DR   RCB; HPS2747
DR   Wikidata; Q94220191
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS64 ! HPS2744
OI   CVCL_YS65 ! HPS2745
OI   CVCL_YS66 ! HPS2746
OI   CVCL_YS68 ! HPS2748
OI   CVCL_YS69 ! HPS2749
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2748
AC   CVCL_YS68
DR   RCB; HPS2748
DR   Wikidata; Q94220196
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS64 ! HPS2744
OI   CVCL_YS65 ! HPS2745
OI   CVCL_YS66 ! HPS2746
OI   CVCL_YS67 ! HPS2747
OI   CVCL_YS69 ! HPS2749
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2749
AC   CVCL_YS69
DR   RCB; HPS2749
DR   Wikidata; Q94220201
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS64 ! HPS2744
OI   CVCL_YS65 ! HPS2745
OI   CVCL_YS66 ! HPS2746
OI   CVCL_YS67 ! HPS2747
OI   CVCL_YS68 ! HPS2748
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2750
AC   CVCL_D0TS
DR   RCB; HPS2750
DR   Wikidata; Q123032371
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35798; Anti-basement membrane glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TT ! HPS2751
OI   CVCL_D0TU ! HPS2752
OI   CVCL_D0TV ! HPS2753
OI   CVCL_D0TW ! HPS2754
OI   CVCL_D0TX ! HPS2755
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2751
AC   CVCL_D0TT
DR   RCB; HPS2751
DR   Wikidata; Q123032372
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35798; Anti-basement membrane glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TS ! HPS2750
OI   CVCL_D0TU ! HPS2752
OI   CVCL_D0TV ! HPS2753
OI   CVCL_D0TW ! HPS2754
OI   CVCL_D0TX ! HPS2755
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2752
AC   CVCL_D0TU
DR   RCB; HPS2752
DR   Wikidata; Q123032373
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35798; Anti-basement membrane glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TS ! HPS2750
OI   CVCL_D0TT ! HPS2751
OI   CVCL_D0TV ! HPS2753
OI   CVCL_D0TW ! HPS2754
OI   CVCL_D0TX ! HPS2755
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2753
AC   CVCL_D0TV
DR   RCB; HPS2753
DR   Wikidata; Q123032374
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35798; Anti-basement membrane glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TS ! HPS2750
OI   CVCL_D0TT ! HPS2751
OI   CVCL_D0TU ! HPS2752
OI   CVCL_D0TW ! HPS2754
OI   CVCL_D0TX ! HPS2755
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2754
AC   CVCL_D0TW
DR   RCB; HPS2754
DR   Wikidata; Q123032375
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35798; Anti-basement membrane glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TS ! HPS2750
OI   CVCL_D0TT ! HPS2751
OI   CVCL_D0TU ! HPS2752
OI   CVCL_D0TV ! HPS2753
OI   CVCL_D0TX ! HPS2755
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2755
AC   CVCL_D0TX
DR   RCB; HPS2755
DR   Wikidata; Q123032376
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35798; Anti-basement membrane glomerulonephritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TS ! HPS2750
OI   CVCL_D0TT ! HPS2751
OI   CVCL_D0TU ! HPS2752
OI   CVCL_D0TV ! HPS2753
OI   CVCL_D0TW ! HPS2754
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2756
AC   CVCL_D0TY
DR   RCB; HPS2756
DR   Wikidata; Q123032377
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35447; Avascular necrosis of femoral head
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TZ ! HPS2757
OI   CVCL_D0U0 ! HPS2758
OI   CVCL_D0U1 ! HPS2759
OI   CVCL_D0U2 ! HPS2760
OI   CVCL_D0U3 ! HPS2761
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2757
AC   CVCL_D0TZ
DR   RCB; HPS2757
DR   Wikidata; Q123032378
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35447; Avascular necrosis of femoral head
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TY ! HPS2756
OI   CVCL_D0U0 ! HPS2758
OI   CVCL_D0U1 ! HPS2759
OI   CVCL_D0U2 ! HPS2760
OI   CVCL_D0U3 ! HPS2761
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2758
AC   CVCL_D0U0
DR   RCB; HPS2758
DR   Wikidata; Q123032379
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35447; Avascular necrosis of femoral head
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TY ! HPS2756
OI   CVCL_D0TZ ! HPS2757
OI   CVCL_D0U1 ! HPS2759
OI   CVCL_D0U2 ! HPS2760
OI   CVCL_D0U3 ! HPS2761
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2759
AC   CVCL_D0U1
DR   RCB; HPS2759
DR   Wikidata; Q123032380
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35447; Avascular necrosis of femoral head
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TY ! HPS2756
OI   CVCL_D0TZ ! HPS2757
OI   CVCL_D0U0 ! HPS2758
OI   CVCL_D0U2 ! HPS2760
OI   CVCL_D0U3 ! HPS2761
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2760
AC   CVCL_D0U2
DR   RCB; HPS2760
DR   Wikidata; Q123032381
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35447; Avascular necrosis of femoral head
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TY ! HPS2756
OI   CVCL_D0TZ ! HPS2757
OI   CVCL_D0U0 ! HPS2758
OI   CVCL_D0U1 ! HPS2759
OI   CVCL_D0U3 ! HPS2761
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2761
AC   CVCL_D0U3
DR   RCB; HPS2761
DR   Wikidata; Q123032382
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35447; Avascular necrosis of femoral head
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0TY ! HPS2756
OI   CVCL_D0TZ ! HPS2757
OI   CVCL_D0U0 ! HPS2758
OI   CVCL_D0U1 ! HPS2759
OI   CVCL_D0U2 ! HPS2760
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2762
AC   CVCL_D0U4
DR   RCB; HPS2762
DR   Wikidata; Q123032383
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95437; Acute pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0U5 ! HPS2763
OI   CVCL_D0U6 ! HPS2764
OI   CVCL_D0U7 ! HPS2765
OI   CVCL_D0U8 ! HPS2766
OI   CVCL_D0U9 ! HPS2767
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2763
AC   CVCL_D0U5
DR   RCB; HPS2763
DR   Wikidata; Q123032384
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95437; Acute pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0U4 ! HPS2762
OI   CVCL_D0U6 ! HPS2764
OI   CVCL_D0U7 ! HPS2765
OI   CVCL_D0U8 ! HPS2766
OI   CVCL_D0U9 ! HPS2767
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2764
AC   CVCL_D0U6
DR   RCB; HPS2764
DR   Wikidata; Q123032385
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95437; Acute pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0U4 ! HPS2762
OI   CVCL_D0U5 ! HPS2763
OI   CVCL_D0U7 ! HPS2765
OI   CVCL_D0U8 ! HPS2766
OI   CVCL_D0U9 ! HPS2767
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2765
AC   CVCL_D0U7
DR   RCB; HPS2765
DR   Wikidata; Q123032386
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95437; Acute pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0U4 ! HPS2762
OI   CVCL_D0U5 ! HPS2763
OI   CVCL_D0U6 ! HPS2764
OI   CVCL_D0U8 ! HPS2766
OI   CVCL_D0U9 ! HPS2767
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2766
AC   CVCL_D0U8
DR   RCB; HPS2766
DR   Wikidata; Q123032387
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95437; Acute pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0U4 ! HPS2762
OI   CVCL_D0U5 ! HPS2763
OI   CVCL_D0U6 ! HPS2764
OI   CVCL_D0U7 ! HPS2765
OI   CVCL_D0U9 ! HPS2767
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2767
AC   CVCL_D0U9
DR   RCB; HPS2767
DR   Wikidata; Q123032388
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95437; Acute pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0U4 ! HPS2762
OI   CVCL_D0U5 ! HPS2763
OI   CVCL_D0U6 ! HPS2764
OI   CVCL_D0U7 ! HPS2765
OI   CVCL_D0U8 ! HPS2766
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2780
AC   CVCL_D0UA
DR   RCB; HPS2780
DR   Wikidata; Q123032389
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UB ! HPS2781
OI   CVCL_D0UC ! HPS2782
OI   CVCL_D0UD ! HPS2783
OI   CVCL_D0UE ! HPS2784
OI   CVCL_D0UF ! HPS2785
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2781
AC   CVCL_D0UB
DR   RCB; HPS2781
DR   Wikidata; Q123032390
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UA ! HPS2780
OI   CVCL_D0UC ! HPS2782
OI   CVCL_D0UD ! HPS2783
OI   CVCL_D0UE ! HPS2784
OI   CVCL_D0UF ! HPS2785
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2782
AC   CVCL_D0UC
DR   RCB; HPS2782
DR   Wikidata; Q123032391
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UA ! HPS2780
OI   CVCL_D0UB ! HPS2781
OI   CVCL_D0UD ! HPS2783
OI   CVCL_D0UE ! HPS2784
OI   CVCL_D0UF ! HPS2785
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2783
AC   CVCL_D0UD
DR   RCB; HPS2783
DR   Wikidata; Q123032392
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UA ! HPS2780
OI   CVCL_D0UB ! HPS2781
OI   CVCL_D0UC ! HPS2782
OI   CVCL_D0UE ! HPS2784
OI   CVCL_D0UF ! HPS2785
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2784
AC   CVCL_D0UE
DR   RCB; HPS2784
DR   Wikidata; Q123032393
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UA ! HPS2780
OI   CVCL_D0UB ! HPS2781
OI   CVCL_D0UC ! HPS2782
OI   CVCL_D0UD ! HPS2783
OI   CVCL_D0UF ! HPS2785
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2785
AC   CVCL_D0UF
DR   RCB; HPS2785
DR   Wikidata; Q123032394
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UA ! HPS2780
OI   CVCL_D0UB ! HPS2781
OI   CVCL_D0UC ! HPS2782
OI   CVCL_D0UD ! HPS2783
OI   CVCL_D0UE ! HPS2784
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2786
AC   CVCL_D0UG
DR   RCB; HPS2786
DR   Wikidata; Q123032395
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2786).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UH ! HPS2787
OI   CVCL_D0UI ! HPS2788
OI   CVCL_D0UJ ! HPS2789
OI   CVCL_D0UK ! HPS2790
OI   CVCL_D0UL ! HPS2791
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2787
AC   CVCL_D0UH
DR   RCB; HPS2787
DR   Wikidata; Q123032396
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2787).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UG ! HPS2786
OI   CVCL_D0UI ! HPS2788
OI   CVCL_D0UJ ! HPS2789
OI   CVCL_D0UK ! HPS2790
OI   CVCL_D0UL ! HPS2791
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2788
AC   CVCL_D0UI
DR   RCB; HPS2788
DR   Wikidata; Q123032397
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2788).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UG ! HPS2786
OI   CVCL_D0UH ! HPS2787
OI   CVCL_D0UJ ! HPS2789
OI   CVCL_D0UK ! HPS2790
OI   CVCL_D0UL ! HPS2791
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2789
AC   CVCL_D0UJ
DR   RCB; HPS2789
DR   Wikidata; Q123032398
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2789).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UG ! HPS2786
OI   CVCL_D0UH ! HPS2787
OI   CVCL_D0UI ! HPS2788
OI   CVCL_D0UK ! HPS2790
OI   CVCL_D0UL ! HPS2791
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2790
AC   CVCL_D0UK
DR   RCB; HPS2790
DR   Wikidata; Q123032399
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2790).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UG ! HPS2786
OI   CVCL_D0UH ! HPS2787
OI   CVCL_D0UI ! HPS2788
OI   CVCL_D0UJ ! HPS2789
OI   CVCL_D0UL ! HPS2791
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2791
AC   CVCL_D0UL
DR   RCB; HPS2791
DR   Wikidata; Q123032400
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2791).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UG ! HPS2786
OI   CVCL_D0UH ! HPS2787
OI   CVCL_D0UI ! HPS2788
OI   CVCL_D0UJ ! HPS2789
OI   CVCL_D0UK ! HPS2790
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2792
AC   CVCL_D0UM
DR   RCB; HPS2792
DR   Wikidata; Q123032401
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2792).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UN ! HPS2793
OI   CVCL_D0UP ! HPS2794
OI   CVCL_D0UQ ! HPS2795
OI   CVCL_D0UR ! HPS2796
OI   CVCL_D0US ! HPS2797
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2793
AC   CVCL_D0UN
DR   RCB; HPS2793
DR   Wikidata; Q123032402
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2793).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UM ! HPS2792
OI   CVCL_D0UP ! HPS2794
OI   CVCL_D0UQ ! HPS2795
OI   CVCL_D0UR ! HPS2796
OI   CVCL_D0US ! HPS2797
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2794
AC   CVCL_D0UP
DR   RCB; HPS2794
DR   Wikidata; Q123032403
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2794).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UM ! HPS2792
OI   CVCL_D0UN ! HPS2793
OI   CVCL_D0UQ ! HPS2795
OI   CVCL_D0UR ! HPS2796
OI   CVCL_D0US ! HPS2797
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2795
AC   CVCL_D0UQ
DR   RCB; HPS2795
DR   Wikidata; Q123032404
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2795).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UM ! HPS2792
OI   CVCL_D0UN ! HPS2793
OI   CVCL_D0UP ! HPS2794
OI   CVCL_D0UR ! HPS2796
OI   CVCL_D0US ! HPS2797
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2796
AC   CVCL_D0UR
DR   RCB; HPS2796
DR   Wikidata; Q123032405
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2796).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UM ! HPS2792
OI   CVCL_D0UN ! HPS2793
OI   CVCL_D0UP ! HPS2794
OI   CVCL_D0UQ ! HPS2795
OI   CVCL_D0US ! HPS2797
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2797
AC   CVCL_D0US
DR   RCB; HPS2797
DR   Wikidata; Q123032406
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2797).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UM ! HPS2792
OI   CVCL_D0UN ! HPS2793
OI   CVCL_D0UP ! HPS2794
OI   CVCL_D0UQ ! HPS2795
OI   CVCL_D0UR ! HPS2796
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2798
AC   CVCL_UP18
DR   RCB; HPS2798
DR   Wikidata; Q94220204
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR89 ! HPS2799
OI   CVCL_YR90 ! HPS2800
OI   CVCL_YR91 ! HPS2801
OI   CVCL_YR92 ! HPS2802
OI   CVCL_YR93 ! HPS2803
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   HPS2799
AC   CVCL_YR89
DR   RCB; HPS2799
DR   Wikidata; Q94220209
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP18 ! HPS2798
OI   CVCL_YR90 ! HPS2800
OI   CVCL_YR91 ! HPS2801
OI   CVCL_YR92 ! HPS2802
OI   CVCL_YR93 ! HPS2803
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2800
AC   CVCL_YR90
DR   RCB; HPS2800
DR   Wikidata; Q94220213
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP18 ! HPS2798
OI   CVCL_YR89 ! HPS2799
OI   CVCL_YR91 ! HPS2801
OI   CVCL_YR92 ! HPS2802
OI   CVCL_YR93 ! HPS2803
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2801
AC   CVCL_YR91
DR   RCB; HPS2801
DR   Wikidata; Q94220217
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP18 ! HPS2798
OI   CVCL_YR89 ! HPS2799
OI   CVCL_YR90 ! HPS2800
OI   CVCL_YR92 ! HPS2802
OI   CVCL_YR93 ! HPS2803
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2802
AC   CVCL_YR92
DR   RCB; HPS2802
DR   Wikidata; Q94220221
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP18 ! HPS2798
OI   CVCL_YR89 ! HPS2799
OI   CVCL_YR90 ! HPS2800
OI   CVCL_YR91 ! HPS2801
OI   CVCL_YR93 ! HPS2803
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2803
AC   CVCL_YR93
DR   RCB; HPS2803
DR   Wikidata; Q94220226
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP18 ! HPS2798
OI   CVCL_YR89 ! HPS2799
OI   CVCL_YR90 ! HPS2800
OI   CVCL_YR91 ! HPS2801
OI   CVCL_YR92 ! HPS2802
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2804
AC   CVCL_YS70
DR   RCB; HPS2804
DR   Wikidata; Q94220230
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS71 ! HPS2805
OI   CVCL_YS72 ! HPS2806
OI   CVCL_YS73 ! HPS2807
OI   CVCL_YS74 ! HPS2808
OI   CVCL_YS75 ! HPS2809
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2805
AC   CVCL_YS71
DR   RCB; HPS2805
DR   Wikidata; Q94220235
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS70 ! HPS2804
OI   CVCL_YS72 ! HPS2806
OI   CVCL_YS73 ! HPS2807
OI   CVCL_YS74 ! HPS2808
OI   CVCL_YS75 ! HPS2809
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2806
AC   CVCL_YS72
DR   RCB; HPS2806
DR   Wikidata; Q94220239
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS70 ! HPS2804
OI   CVCL_YS71 ! HPS2805
OI   CVCL_YS73 ! HPS2807
OI   CVCL_YS74 ! HPS2808
OI   CVCL_YS75 ! HPS2809
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2807
AC   CVCL_YS73
DR   RCB; HPS2807
DR   Wikidata; Q94220242
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS70 ! HPS2804
OI   CVCL_YS71 ! HPS2805
OI   CVCL_YS72 ! HPS2806
OI   CVCL_YS74 ! HPS2808
OI   CVCL_YS75 ! HPS2809
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2808
AC   CVCL_YS74
DR   RCB; HPS2808
DR   Wikidata; Q94220247
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS70 ! HPS2804
OI   CVCL_YS71 ! HPS2805
OI   CVCL_YS72 ! HPS2806
OI   CVCL_YS73 ! HPS2807
OI   CVCL_YS75 ! HPS2809
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2809
AC   CVCL_YS75
DR   RCB; HPS2809
DR   Wikidata; Q94220252
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS70 ! HPS2804
OI   CVCL_YS71 ! HPS2805
OI   CVCL_YS72 ! HPS2806
OI   CVCL_YS73 ! HPS2807
OI   CVCL_YS74 ! HPS2808
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2810
AC   CVCL_D0UT
DR   RCB; HPS2810
DR   Wikidata; Q123032407
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116345; Guillain-Barre syndrome
DI   ORDO; Orphanet_2103; Guillain-Barre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UU ! HPS2811
OI   CVCL_D0UV ! HPS2812
OI   CVCL_D0UW ! HPS2813
OI   CVCL_D0UX ! HPS2814
OI   CVCL_D0UY ! HPS2815
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2811
AC   CVCL_D0UU
DR   RCB; HPS2811
DR   Wikidata; Q123032408
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116345; Guillain-Barre syndrome
DI   ORDO; Orphanet_2103; Guillain-Barre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UT ! HPS2810
OI   CVCL_D0UV ! HPS2812
OI   CVCL_D0UW ! HPS2813
OI   CVCL_D0UX ! HPS2814
OI   CVCL_D0UY ! HPS2815
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2812
AC   CVCL_D0UV
DR   RCB; HPS2812
DR   Wikidata; Q123032409
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116345; Guillain-Barre syndrome
DI   ORDO; Orphanet_2103; Guillain-Barre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UT ! HPS2810
OI   CVCL_D0UU ! HPS2811
OI   CVCL_D0UW ! HPS2813
OI   CVCL_D0UX ! HPS2814
OI   CVCL_D0UY ! HPS2815
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2813
AC   CVCL_D0UW
DR   RCB; HPS2813
DR   Wikidata; Q123032410
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116345; Guillain-Barre syndrome
DI   ORDO; Orphanet_2103; Guillain-Barre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UT ! HPS2810
OI   CVCL_D0UU ! HPS2811
OI   CVCL_D0UV ! HPS2812
OI   CVCL_D0UX ! HPS2814
OI   CVCL_D0UY ! HPS2815
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2814
AC   CVCL_D0UX
DR   RCB; HPS2814
DR   Wikidata; Q123032411
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116345; Guillain-Barre syndrome
DI   ORDO; Orphanet_2103; Guillain-Barre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UT ! HPS2810
OI   CVCL_D0UU ! HPS2811
OI   CVCL_D0UV ! HPS2812
OI   CVCL_D0UW ! HPS2813
OI   CVCL_D0UY ! HPS2815
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2815
AC   CVCL_D0UY
DR   RCB; HPS2815
DR   Wikidata; Q123032412
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116345; Guillain-Barre syndrome
DI   ORDO; Orphanet_2103; Guillain-Barre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UT ! HPS2810
OI   CVCL_D0UU ! HPS2811
OI   CVCL_D0UV ! HPS2812
OI   CVCL_D0UW ! HPS2813
OI   CVCL_D0UX ! HPS2814
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2816
AC   CVCL_A3JL
DR   RCB; HPS2816
DR   Wikidata; Q105508878
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JM ! HPS2817
OI   CVCL_A3JN ! HPS2818
OI   CVCL_A3JP ! HPS2819
OI   CVCL_A3JQ ! HPS2820
OI   CVCL_A3JR ! HPS2821
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2817
AC   CVCL_A3JM
DR   RCB; HPS2817
DR   Wikidata; Q105508880
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JL ! HPS2816
OI   CVCL_A3JN ! HPS2818
OI   CVCL_A3JP ! HPS2819
OI   CVCL_A3JQ ! HPS2820
OI   CVCL_A3JR ! HPS2821
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2818
AC   CVCL_A3JN
DR   RCB; HPS2818
DR   Wikidata; Q105508882
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JL ! HPS2816
OI   CVCL_A3JM ! HPS2817
OI   CVCL_A3JP ! HPS2819
OI   CVCL_A3JQ ! HPS2820
OI   CVCL_A3JR ! HPS2821
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2819
AC   CVCL_A3JP
DR   RCB; HPS2819
DR   Wikidata; Q105508886
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JL ! HPS2816
OI   CVCL_A3JM ! HPS2817
OI   CVCL_A3JN ! HPS2818
OI   CVCL_A3JQ ! HPS2820
OI   CVCL_A3JR ! HPS2821
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2820
AC   CVCL_A3JQ
DR   RCB; HPS2820
DR   Wikidata; Q105508890
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JL ! HPS2816
OI   CVCL_A3JM ! HPS2817
OI   CVCL_A3JN ! HPS2818
OI   CVCL_A3JP ! HPS2819
OI   CVCL_A3JR ! HPS2821
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2821
AC   CVCL_A3JR
DR   RCB; HPS2821
DR   Wikidata; Q105508893
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JL ! HPS2816
OI   CVCL_A3JM ! HPS2817
OI   CVCL_A3JN ! HPS2818
OI   CVCL_A3JP ! HPS2819
OI   CVCL_A3JQ ! HPS2820
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2822
AC   CVCL_D0UZ
DR   RCB; HPS2822
DR   Wikidata; Q123032413
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2822).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0V0 ! HPS2823
OI   CVCL_D0V1 ! HPS2824
OI   CVCL_D0V2 ! HPS2825
OI   CVCL_D0V3 ! HPS2826
OI   CVCL_D0V4 ! HPS2827
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2823
AC   CVCL_D0V0
DR   RCB; HPS2823
DR   Wikidata; Q123032414
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2823).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UZ ! HPS2822
OI   CVCL_D0V1 ! HPS2824
OI   CVCL_D0V2 ! HPS2825
OI   CVCL_D0V3 ! HPS2826
OI   CVCL_D0V4 ! HPS2827
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2824
AC   CVCL_D0V1
DR   RCB; HPS2824
DR   Wikidata; Q123032415
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2824).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UZ ! HPS2822
OI   CVCL_D0V0 ! HPS2823
OI   CVCL_D0V2 ! HPS2825
OI   CVCL_D0V3 ! HPS2826
OI   CVCL_D0V4 ! HPS2827
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2825
AC   CVCL_D0V2
DR   RCB; HPS2825
DR   Wikidata; Q123032416
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2825).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UZ ! HPS2822
OI   CVCL_D0V0 ! HPS2823
OI   CVCL_D0V1 ! HPS2824
OI   CVCL_D0V3 ! HPS2826
OI   CVCL_D0V4 ! HPS2827
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2826
AC   CVCL_D0V3
DR   RCB; HPS2826
DR   Wikidata; Q123032417
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2826).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UZ ! HPS2822
OI   CVCL_D0V0 ! HPS2823
OI   CVCL_D0V1 ! HPS2824
OI   CVCL_D0V2 ! HPS2825
OI   CVCL_D0V4 ! HPS2827
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2827
AC   CVCL_D0V4
DR   RCB; HPS2827
DR   Wikidata; Q123032418
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2827).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0UZ ! HPS2822
OI   CVCL_D0V0 ! HPS2823
OI   CVCL_D0V1 ! HPS2824
OI   CVCL_D0V2 ! HPS2825
OI   CVCL_D0V3 ! HPS2826
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2828
AC   CVCL_UP19
DR   RCB; HPS2828
DR   Wikidata; Q94220256
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C79484; Stevens-Johnson syndrome
DI   ORDO; Orphanet_36426; Stevens-Johnson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3WE ! HPS2829
OI   CVCL_A3WF ! HPS2830
OI   CVCL_A3WG ! HPS2831
OI   CVCL_A3WH ! HPS2832
OI   CVCL_A3WI ! HPS2833
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2829
AC   CVCL_A3WE
DR   RCB; HPS2829
DR   Wikidata; Q105508896
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C79484; Stevens-Johnson syndrome
DI   ORDO; Orphanet_36426; Stevens-Johnson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP19 ! HPS2828
OI   CVCL_A3WF ! HPS2830
OI   CVCL_A3WG ! HPS2831
OI   CVCL_A3WH ! HPS2832
OI   CVCL_A3WI ! HPS2833
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2830
AC   CVCL_A3WF
DR   RCB; HPS2830
DR   Wikidata; Q105508899
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C79484; Stevens-Johnson syndrome
DI   ORDO; Orphanet_36426; Stevens-Johnson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP19 ! HPS2828
OI   CVCL_A3WE ! HPS2829
OI   CVCL_A3WG ! HPS2831
OI   CVCL_A3WH ! HPS2832
OI   CVCL_A3WI ! HPS2833
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2831
AC   CVCL_A3WG
DR   RCB; HPS2831
DR   Wikidata; Q105508902
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C79484; Stevens-Johnson syndrome
DI   ORDO; Orphanet_36426; Stevens-Johnson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP19 ! HPS2828
OI   CVCL_A3WE ! HPS2829
OI   CVCL_A3WF ! HPS2830
OI   CVCL_A3WH ! HPS2832
OI   CVCL_A3WI ! HPS2833
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2832
AC   CVCL_A3WH
DR   RCB; HPS2832
DR   Wikidata; Q105508905
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C79484; Stevens-Johnson syndrome
DI   ORDO; Orphanet_36426; Stevens-Johnson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP19 ! HPS2828
OI   CVCL_A3WE ! HPS2829
OI   CVCL_A3WF ! HPS2830
OI   CVCL_A3WG ! HPS2831
OI   CVCL_A3WI ! HPS2833
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2833
AC   CVCL_A3WI
DR   RCB; HPS2833
DR   Wikidata; Q105508910
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C79484; Stevens-Johnson syndrome
DI   ORDO; Orphanet_36426; Stevens-Johnson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP19 ! HPS2828
OI   CVCL_A3WE ! HPS2829
OI   CVCL_A3WF ! HPS2830
OI   CVCL_A3WG ! HPS2831
OI   CVCL_A3WH ! HPS2832
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2834
AC   CVCL_UP20
DR   RCB; HPS2834
DR   Wikidata; Q94220263
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2834).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR94 ! HPS2835
OI   CVCL_YR95 ! HPS2836
OI   CVCL_YR96 ! HPS2837
OI   CVCL_YR97 ! HPS2838
OI   CVCL_YR98 ! HPS2839
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   HPS2835
AC   CVCL_YR94
DR   RCB; HPS2835
DR   Wikidata; Q94220269
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2835).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP20 ! HPS2834
OI   CVCL_YR95 ! HPS2836
OI   CVCL_YR96 ! HPS2837
OI   CVCL_YR97 ! HPS2838
OI   CVCL_YR98 ! HPS2839
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2836
AC   CVCL_YR95
DR   RCB; HPS2836
DR   Wikidata; Q94220275
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2836).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP20 ! HPS2834
OI   CVCL_YR94 ! HPS2835
OI   CVCL_YR96 ! HPS2837
OI   CVCL_YR97 ! HPS2838
OI   CVCL_YR98 ! HPS2839
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2837
AC   CVCL_YR96
DR   RCB; HPS2837
DR   Wikidata; Q94220278
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2837).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP20 ! HPS2834
OI   CVCL_YR94 ! HPS2835
OI   CVCL_YR95 ! HPS2836
OI   CVCL_YR97 ! HPS2838
OI   CVCL_YR98 ! HPS2839
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2838
AC   CVCL_YR97
DR   RCB; HPS2838
DR   Wikidata; Q94220283
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2838).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP20 ! HPS2834
OI   CVCL_YR94 ! HPS2835
OI   CVCL_YR95 ! HPS2836
OI   CVCL_YR96 ! HPS2837
OI   CVCL_YR98 ! HPS2839
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2839
AC   CVCL_YR98
DR   RCB; HPS2839
DR   Wikidata; Q94220287
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2839).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP20 ! HPS2834
OI   CVCL_YR94 ! HPS2835
OI   CVCL_YR95 ! HPS2836
OI   CVCL_YR96 ! HPS2837
OI   CVCL_YR97 ! HPS2838
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS2840
AC   CVCL_D0V5
DR   RCB; HPS2840
DR   Wikidata; Q123032419
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26838; Osteomalacia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0V6 ! HPS2841
OI   CVCL_D0V7 ! HPS2842
OI   CVCL_D0V8 ! HPS2843
OI   CVCL_D0V9 ! HPS2844
OI   CVCL_D0VA ! HPS2845
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2841
AC   CVCL_D0V6
DR   RCB; HPS2841
DR   Wikidata; Q123032421
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26838; Osteomalacia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0V5 ! HPS2840
OI   CVCL_D0V7 ! HPS2842
OI   CVCL_D0V8 ! HPS2843
OI   CVCL_D0V9 ! HPS2844
OI   CVCL_D0VA ! HPS2845
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2842
AC   CVCL_D0V7
DR   RCB; HPS2842
DR   Wikidata; Q123032422
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26838; Osteomalacia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0V5 ! HPS2840
OI   CVCL_D0V6 ! HPS2841
OI   CVCL_D0V8 ! HPS2843
OI   CVCL_D0V9 ! HPS2844
OI   CVCL_D0VA ! HPS2845
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2843
AC   CVCL_D0V8
DR   RCB; HPS2843
DR   Wikidata; Q123032424
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26838; Osteomalacia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0V5 ! HPS2840
OI   CVCL_D0V6 ! HPS2841
OI   CVCL_D0V7 ! HPS2842
OI   CVCL_D0V9 ! HPS2844
OI   CVCL_D0VA ! HPS2845
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2844
AC   CVCL_D0V9
DR   RCB; HPS2844
DR   Wikidata; Q123032425
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26838; Osteomalacia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0V5 ! HPS2840
OI   CVCL_D0V6 ! HPS2841
OI   CVCL_D0V7 ! HPS2842
OI   CVCL_D0V8 ! HPS2843
OI   CVCL_D0VA ! HPS2845
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2845
AC   CVCL_D0VA
DR   RCB; HPS2845
DR   Wikidata; Q123032426
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26838; Osteomalacia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0V5 ! HPS2840
OI   CVCL_D0V6 ! HPS2841
OI   CVCL_D0V7 ! HPS2842
OI   CVCL_D0V8 ! HPS2843
OI   CVCL_D0V9 ! HPS2844
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2846
AC   CVCL_UP21
DR   RCB; HPS2846
DR   Wikidata; Q94220291
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR99 ! HPS2847
OI   CVCL_YS00 ! HPS2848
OI   CVCL_YS01 ! HPS2849
OI   CVCL_YS02 ! HPS2850
OI   CVCL_YS03 ! HPS2851
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   HPS2847
AC   CVCL_YR99
DR   RCB; HPS2847
DR   Wikidata; Q94220294
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP21 ! HPS2846
OI   CVCL_YS00 ! HPS2848
OI   CVCL_YS01 ! HPS2849
OI   CVCL_YS02 ! HPS2850
OI   CVCL_YS03 ! HPS2851
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2848
AC   CVCL_YS00
DR   RCB; HPS2848
DR   Wikidata; Q94220298
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP21 ! HPS2846
OI   CVCL_YR99 ! HPS2847
OI   CVCL_YS01 ! HPS2849
OI   CVCL_YS02 ! HPS2850
OI   CVCL_YS03 ! HPS2851
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2849
AC   CVCL_YS01
DR   RCB; HPS2849
DR   Wikidata; Q94220302
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP21 ! HPS2846
OI   CVCL_YR99 ! HPS2847
OI   CVCL_YS00 ! HPS2848
OI   CVCL_YS02 ! HPS2850
OI   CVCL_YS03 ! HPS2851
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2850
AC   CVCL_YS02
DR   RCB; HPS2850
DR   Wikidata; Q94220307
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP21 ! HPS2846
OI   CVCL_YR99 ! HPS2847
OI   CVCL_YS00 ! HPS2848
OI   CVCL_YS01 ! HPS2849
OI   CVCL_YS03 ! HPS2851
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2851
AC   CVCL_YS03
DR   RCB; HPS2851
DR   Wikidata; Q94220311
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP21 ! HPS2846
OI   CVCL_YR99 ! HPS2847
OI   CVCL_YS00 ! HPS2848
OI   CVCL_YS01 ! HPS2849
OI   CVCL_YS02 ! HPS2850
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 5
//
ID   HPS2852
AC   CVCL_D0VT
DR   RCB; HPS2852
DR   Wikidata; Q123032427
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99026; Protein S deficiency disease
DI   ORDO; Orphanet_743; Severe hereditary thrombophilia due to congenital protein S deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VU ! HPS2853
OI   CVCL_D0VV ! HPS2854
OI   CVCL_D0VW ! HPS2855
OI   CVCL_D0VX ! HPS2856
OI   CVCL_D0VY ! HPS2857
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2853
AC   CVCL_D0VU
DR   RCB; HPS2853
DR   Wikidata; Q123032428
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99026; Protein S deficiency disease
DI   ORDO; Orphanet_743; Severe hereditary thrombophilia due to congenital protein S deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VT ! HPS2852
OI   CVCL_D0VV ! HPS2854
OI   CVCL_D0VW ! HPS2855
OI   CVCL_D0VX ! HPS2856
OI   CVCL_D0VY ! HPS2857
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2854
AC   CVCL_D0VV
DR   RCB; HPS2854
DR   Wikidata; Q123032429
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99026; Protein S deficiency disease
DI   ORDO; Orphanet_743; Severe hereditary thrombophilia due to congenital protein S deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VT ! HPS2852
OI   CVCL_D0VU ! HPS2853
OI   CVCL_D0VW ! HPS2855
OI   CVCL_D0VX ! HPS2856
OI   CVCL_D0VY ! HPS2857
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2855
AC   CVCL_D0VW
DR   RCB; HPS2855
DR   Wikidata; Q123032430
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99026; Protein S deficiency disease
DI   ORDO; Orphanet_743; Severe hereditary thrombophilia due to congenital protein S deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VT ! HPS2852
OI   CVCL_D0VU ! HPS2853
OI   CVCL_D0VV ! HPS2854
OI   CVCL_D0VX ! HPS2856
OI   CVCL_D0VY ! HPS2857
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2856
AC   CVCL_D0VX
DR   RCB; HPS2856
DR   Wikidata; Q123032431
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99026; Protein S deficiency disease
DI   ORDO; Orphanet_743; Severe hereditary thrombophilia due to congenital protein S deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VT ! HPS2852
OI   CVCL_D0VU ! HPS2853
OI   CVCL_D0VV ! HPS2854
OI   CVCL_D0VW ! HPS2855
OI   CVCL_D0VY ! HPS2857
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2857
AC   CVCL_D0VY
DR   RCB; HPS2857
DR   Wikidata; Q123032432
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99026; Protein S deficiency disease
DI   ORDO; Orphanet_743; Severe hereditary thrombophilia due to congenital protein S deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VT ! HPS2852
OI   CVCL_D0VU ! HPS2853
OI   CVCL_D0VV ! HPS2854
OI   CVCL_D0VW ! HPS2855
OI   CVCL_D0VX ! HPS2856
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2858
AC   CVCL_D0VZ
DR   RCB; HPS2858
DR   Wikidata; Q123032433
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0W0 ! HPS2859
OI   CVCL_D0W1 ! HPS2860
OI   CVCL_D0W2 ! HPS2861
OI   CVCL_D0W3 ! HPS2862
OI   CVCL_D0W4 ! HPS2863
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2859
AC   CVCL_D0W0
DR   RCB; HPS2859
DR   Wikidata; Q123032434
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VZ ! HPS2858
OI   CVCL_D0W1 ! HPS2860
OI   CVCL_D0W2 ! HPS2861
OI   CVCL_D0W3 ! HPS2862
OI   CVCL_D0W4 ! HPS2863
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2860
AC   CVCL_D0W1
DR   RCB; HPS2860
DR   Wikidata; Q123032435
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VZ ! HPS2858
OI   CVCL_D0W0 ! HPS2859
OI   CVCL_D0W2 ! HPS2861
OI   CVCL_D0W3 ! HPS2862
OI   CVCL_D0W4 ! HPS2863
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2861
AC   CVCL_D0W2
DR   RCB; HPS2861
DR   Wikidata; Q123032437
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VZ ! HPS2858
OI   CVCL_D0W0 ! HPS2859
OI   CVCL_D0W1 ! HPS2860
OI   CVCL_D0W3 ! HPS2862
OI   CVCL_D0W4 ! HPS2863
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2862
AC   CVCL_D0W3
DR   RCB; HPS2862
DR   Wikidata; Q123032438
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VZ ! HPS2858
OI   CVCL_D0W0 ! HPS2859
OI   CVCL_D0W1 ! HPS2860
OI   CVCL_D0W2 ! HPS2861
OI   CVCL_D0W4 ! HPS2863
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2863
AC   CVCL_D0W4
DR   RCB; HPS2863
DR   Wikidata; Q123032439
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0VZ ! HPS2858
OI   CVCL_D0W0 ! HPS2859
OI   CVCL_D0W1 ! HPS2860
OI   CVCL_D0W2 ! HPS2861
OI   CVCL_D0W3 ! HPS2862
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2864
AC   CVCL_UP22
DR   RCB; HPS2864
DR   Wikidata; Q94220315
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3WJ ! HPS2865
OI   CVCL_A3WK ! HPS2866
OI   CVCL_A3WL ! HPS2867
OI   CVCL_A3WM ! HPS2868
OI   CVCL_A3WN ! HPS2869
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2865
AC   CVCL_A3WJ
DR   RCB; HPS2865
DR   Wikidata; Q105508913
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP22 ! HPS2864
OI   CVCL_A3WK ! HPS2866
OI   CVCL_A3WL ! HPS2867
OI   CVCL_A3WM ! HPS2868
OI   CVCL_A3WN ! HPS2869
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2866
AC   CVCL_A3WK
DR   RCB; HPS2866
DR   Wikidata; Q105508915
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP22 ! HPS2864
OI   CVCL_A3WJ ! HPS2865
OI   CVCL_A3WL ! HPS2867
OI   CVCL_A3WM ! HPS2868
OI   CVCL_A3WN ! HPS2869
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2867
AC   CVCL_A3WL
DR   RCB; HPS2867
DR   Wikidata; Q105508920
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP22 ! HPS2864
OI   CVCL_A3WJ ! HPS2865
OI   CVCL_A3WK ! HPS2866
OI   CVCL_A3WM ! HPS2868
OI   CVCL_A3WN ! HPS2869
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2868
AC   CVCL_A3WM
DR   RCB; HPS2868
DR   Wikidata; Q105508922
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP22 ! HPS2864
OI   CVCL_A3WJ ! HPS2865
OI   CVCL_A3WK ! HPS2866
OI   CVCL_A3WL ! HPS2867
OI   CVCL_A3WN ! HPS2869
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2869
AC   CVCL_A3WN
DR   RCB; HPS2869
DR   Wikidata; Q105508925
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP22 ! HPS2864
OI   CVCL_A3WJ ! HPS2865
OI   CVCL_A3WK ! HPS2866
OI   CVCL_A3WL ! HPS2867
OI   CVCL_A3WM ! HPS2868
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2870
AC   CVCL_UP23
DR   RCB; HPS2870
DR   Wikidata; Q94220320
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2870).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3MY ! HPS2871
OI   CVCL_A3MZ ! HPS2872
OI   CVCL_A3NA ! HPS2873
OI   CVCL_A3NB ! HPS2874
OI   CVCL_A3NC ! HPS2875
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   HPS2871
AC   CVCL_A3MY
DR   RCB; HPS2871
DR   Wikidata; Q105508928
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2871).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP23 ! HPS2870
OI   CVCL_A3MZ ! HPS2872
OI   CVCL_A3NA ! HPS2873
OI   CVCL_A3NB ! HPS2874
OI   CVCL_A3NC ! HPS2875
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2872
AC   CVCL_A3MZ
DR   RCB; HPS2872
DR   Wikidata; Q105508931
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2872).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP23 ! HPS2870
OI   CVCL_A3MY ! HPS2871
OI   CVCL_A3NA ! HPS2873
OI   CVCL_A3NB ! HPS2874
OI   CVCL_A3NC ! HPS2875
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2873
AC   CVCL_A3NA
DR   RCB; HPS2873
DR   Wikidata; Q105508936
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2873).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP23 ! HPS2870
OI   CVCL_A3MY ! HPS2871
OI   CVCL_A3MZ ! HPS2872
OI   CVCL_A3NB ! HPS2874
OI   CVCL_A3NC ! HPS2875
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2874
AC   CVCL_A3NB
DR   RCB; HPS2874
DR   Wikidata; Q105508939
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2874).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP23 ! HPS2870
OI   CVCL_A3MY ! HPS2871
OI   CVCL_A3MZ ! HPS2872
OI   CVCL_A3NA ! HPS2873
OI   CVCL_A3NC ! HPS2875
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2875
AC   CVCL_A3NC
DR   RCB; HPS2875
DR   Wikidata; Q105508942
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2875).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP23 ! HPS2870
OI   CVCL_A3MY ! HPS2871
OI   CVCL_A3MZ ! HPS2872
OI   CVCL_A3NA ! HPS2873
OI   CVCL_A3NB ! HPS2874
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2876
AC   CVCL_A3JS
DR   RCB; HPS2876
DR   Wikidata; Q105508946
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2876).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JT ! HPS2877
OI   CVCL_A3JU ! HPS2878
OI   CVCL_A3JV ! HPS2879
OI   CVCL_A3JW ! HPS2880
OI   CVCL_A3JX ! HPS2881
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2877
AC   CVCL_A3JT
DR   RCB; HPS2877
DR   Wikidata; Q105508950
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2877).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JS ! HPS2876
OI   CVCL_A3JU ! HPS2878
OI   CVCL_A3JV ! HPS2879
OI   CVCL_A3JW ! HPS2880
OI   CVCL_A3JX ! HPS2881
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2878
AC   CVCL_A3JU
DR   RCB; HPS2878
DR   Wikidata; Q105508953
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2878).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JS ! HPS2876
OI   CVCL_A3JT ! HPS2877
OI   CVCL_A3JV ! HPS2879
OI   CVCL_A3JW ! HPS2880
OI   CVCL_A3JX ! HPS2881
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2879
AC   CVCL_A3JV
DR   RCB; HPS2879
DR   Wikidata; Q105508957
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2879).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JS ! HPS2876
OI   CVCL_A3JT ! HPS2877
OI   CVCL_A3JU ! HPS2878
OI   CVCL_A3JW ! HPS2880
OI   CVCL_A3JX ! HPS2881
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2880
AC   CVCL_A3JW
DR   RCB; HPS2880
DR   Wikidata; Q105508960
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2880).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JS ! HPS2876
OI   CVCL_A3JT ! HPS2877
OI   CVCL_A3JU ! HPS2878
OI   CVCL_A3JV ! HPS2879
OI   CVCL_A3JX ! HPS2881
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2881
AC   CVCL_A3JX
DR   RCB; HPS2881
DR   Wikidata; Q105508961
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2881).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JS ! HPS2876
OI   CVCL_A3JT ! HPS2877
OI   CVCL_A3JU ! HPS2878
OI   CVCL_A3JV ! HPS2879
OI   CVCL_A3JW ! HPS2880
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2882
AC   CVCL_A3JY
DR   RCB; HPS2882
DR   Wikidata; Q105508964
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Unexplicit; Not described; Zygosity=Hemizygous (RCB=HPS2882).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JZ ! HPS2883
OI   CVCL_A3KA ! HPS2884
OI   CVCL_A3KB ! HPS2885
OI   CVCL_A3KC ! HPS2886
OI   CVCL_A3KD ! HPS2887
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2883
AC   CVCL_A3JZ
DR   RCB; HPS2883
DR   Wikidata; Q105508967
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Unexplicit; Not described; Zygosity=Hemizygous (RCB=HPS2883).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JY ! HPS2882
OI   CVCL_A3KA ! HPS2884
OI   CVCL_A3KB ! HPS2885
OI   CVCL_A3KC ! HPS2886
OI   CVCL_A3KD ! HPS2887
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2884
AC   CVCL_A3KA
DR   RCB; HPS2884
DR   Wikidata; Q105508969
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Unexplicit; Not described; Zygosity=Hemizygous (RCB=HPS2884).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JY ! HPS2882
OI   CVCL_A3JZ ! HPS2883
OI   CVCL_A3KB ! HPS2885
OI   CVCL_A3KC ! HPS2886
OI   CVCL_A3KD ! HPS2887
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2885
AC   CVCL_A3KB
DR   RCB; HPS2885
DR   Wikidata; Q105508970
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Unexplicit; Not described; Zygosity=Hemizygous (RCB=HPS2885).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JY ! HPS2882
OI   CVCL_A3JZ ! HPS2883
OI   CVCL_A3KA ! HPS2884
OI   CVCL_A3KC ! HPS2886
OI   CVCL_A3KD ! HPS2887
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2886
AC   CVCL_A3KC
DR   RCB; HPS2886
DR   Wikidata; Q105508973
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Unexplicit; Not described; Zygosity=Hemizygous (RCB=HPS2886).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JY ! HPS2882
OI   CVCL_A3JZ ! HPS2883
OI   CVCL_A3KA ! HPS2884
OI   CVCL_A3KB ! HPS2885
OI   CVCL_A3KD ! HPS2887
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2887
AC   CVCL_A3KD
DR   RCB; HPS2887
DR   Wikidata; Q105508976
CC   Sequence variation: Mutation; HGNC; HGNC:7448; MTM1; Unexplicit; Not described; Zygosity=Hemizygous (RCB=HPS2887).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3JY ! HPS2882
OI   CVCL_A3JZ ! HPS2883
OI   CVCL_A3KA ! HPS2884
OI   CVCL_A3KB ! HPS2885
OI   CVCL_A3KC ! HPS2886
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2888
AC   CVCL_D0W5
DR   RCB; HPS2888
DR   Wikidata; Q123032440
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98893; Congenital diaphragmatic hernia
DI   ORDO; Orphanet_2140; Congenital diaphragmatic hernia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0W6 ! HPS2889
OI   CVCL_D0W7 ! HPS2890
OI   CVCL_D0W8 ! HPS2891
OI   CVCL_D0W9 ! HPS2892
OI   CVCL_D0WA ! HPS2893
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2889
AC   CVCL_D0W6
DR   RCB; HPS2889
DR   Wikidata; Q123032441
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98893; Congenital diaphragmatic hernia
DI   ORDO; Orphanet_2140; Congenital diaphragmatic hernia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0W5 ! HPS2888
OI   CVCL_D0W7 ! HPS2890
OI   CVCL_D0W8 ! HPS2891
OI   CVCL_D0W9 ! HPS2892
OI   CVCL_D0WA ! HPS2893
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2890
AC   CVCL_D0W7
DR   RCB; HPS2890
DR   Wikidata; Q123032444
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98893; Congenital diaphragmatic hernia
DI   ORDO; Orphanet_2140; Congenital diaphragmatic hernia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0W5 ! HPS2888
OI   CVCL_D0W6 ! HPS2889
OI   CVCL_D0W8 ! HPS2891
OI   CVCL_D0W9 ! HPS2892
OI   CVCL_D0WA ! HPS2893
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2891
AC   CVCL_D0W8
DR   RCB; HPS2891
DR   Wikidata; Q123032445
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98893; Congenital diaphragmatic hernia
DI   ORDO; Orphanet_2140; Congenital diaphragmatic hernia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0W5 ! HPS2888
OI   CVCL_D0W6 ! HPS2889
OI   CVCL_D0W7 ! HPS2890
OI   CVCL_D0W9 ! HPS2892
OI   CVCL_D0WA ! HPS2893
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2892
AC   CVCL_D0W9
DR   RCB; HPS2892
DR   Wikidata; Q123032446
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98893; Congenital diaphragmatic hernia
DI   ORDO; Orphanet_2140; Congenital diaphragmatic hernia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0W5 ! HPS2888
OI   CVCL_D0W6 ! HPS2889
OI   CVCL_D0W7 ! HPS2890
OI   CVCL_D0W8 ! HPS2891
OI   CVCL_D0WA ! HPS2893
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2893
AC   CVCL_D0WA
DR   RCB; HPS2893
DR   Wikidata; Q123032447
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98893; Congenital diaphragmatic hernia
DI   ORDO; Orphanet_2140; Congenital diaphragmatic hernia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0W5 ! HPS2888
OI   CVCL_D0W6 ! HPS2889
OI   CVCL_D0W7 ! HPS2890
OI   CVCL_D0W8 ! HPS2891
OI   CVCL_D0W9 ! HPS2892
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2894
AC   CVCL_UP24
DR   RCB; HPS2894
DR   Wikidata; Q94220326
CC   Sequence variation: Mutation; HGNC; HGNC:4241; GFPT1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2894).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168997; Congenital myasthenic syndrome 12
DI   ORDO; Orphanet_353327; Congenital myasthenic syndromes with glycosylation defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3WP ! HPS2895
OI   CVCL_A3WQ ! HPS2896
OI   CVCL_A3WR ! HPS2897
OI   CVCL_A3WS ! HPS2898
OI   CVCL_A3WT ! HPS2899
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   HPS2895
AC   CVCL_A3WP
DR   RCB; HPS2895
DR   Wikidata; Q105508978
CC   Sequence variation: Mutation; HGNC; HGNC:4241; GFPT1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2895).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168997; Congenital myasthenic syndrome 12
DI   ORDO; Orphanet_353327; Congenital myasthenic syndromes with glycosylation defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP24 ! HPS2894
OI   CVCL_A3WQ ! HPS2896
OI   CVCL_A3WR ! HPS2897
OI   CVCL_A3WS ! HPS2898
OI   CVCL_A3WT ! HPS2899
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2896
AC   CVCL_A3WQ
DR   RCB; HPS2896
DR   Wikidata; Q105508982
CC   Sequence variation: Mutation; HGNC; HGNC:4241; GFPT1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2896).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168997; Congenital myasthenic syndrome 12
DI   ORDO; Orphanet_353327; Congenital myasthenic syndromes with glycosylation defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP24 ! HPS2894
OI   CVCL_A3WP ! HPS2895
OI   CVCL_A3WR ! HPS2897
OI   CVCL_A3WS ! HPS2898
OI   CVCL_A3WT ! HPS2899
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2897
AC   CVCL_A3WR
DR   RCB; HPS2897
DR   Wikidata; Q105508987
CC   Sequence variation: Mutation; HGNC; HGNC:4241; GFPT1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2897).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168997; Congenital myasthenic syndrome 12
DI   ORDO; Orphanet_353327; Congenital myasthenic syndromes with glycosylation defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP24 ! HPS2894
OI   CVCL_A3WP ! HPS2895
OI   CVCL_A3WQ ! HPS2896
OI   CVCL_A3WS ! HPS2898
OI   CVCL_A3WT ! HPS2899
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2898
AC   CVCL_A3WS
DR   RCB; HPS2898
DR   Wikidata; Q105508990
CC   Sequence variation: Mutation; HGNC; HGNC:4241; GFPT1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2898).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168997; Congenital myasthenic syndrome 12
DI   ORDO; Orphanet_353327; Congenital myasthenic syndromes with glycosylation defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP24 ! HPS2894
OI   CVCL_A3WP ! HPS2895
OI   CVCL_A3WQ ! HPS2896
OI   CVCL_A3WR ! HPS2897
OI   CVCL_A3WT ! HPS2899
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2899
AC   CVCL_A3WT
DR   RCB; HPS2899
DR   Wikidata; Q105508995
CC   Sequence variation: Mutation; HGNC; HGNC:4241; GFPT1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2899).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168997; Congenital myasthenic syndrome 12
DI   ORDO; Orphanet_353327; Congenital myasthenic syndromes with glycosylation defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP24 ! HPS2894
OI   CVCL_A3WP ! HPS2895
OI   CVCL_A3WQ ! HPS2896
OI   CVCL_A3WR ! HPS2897
OI   CVCL_A3WS ! HPS2898
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HPS2900
AC   CVCL_D0WB
DR   RCB; HPS2900
DR   Wikidata; Q123032448
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202118; Ossification of anterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WC ! HPS2901
OI   CVCL_D0WD ! HPS2902
OI   CVCL_D0WE ! HPS2903
OI   CVCL_D0WF ! HPS2904
OI   CVCL_D0WG ! HPS2905
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2901
AC   CVCL_D0WC
DR   RCB; HPS2901
DR   Wikidata; Q123032449
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202118; Ossification of anterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WB ! HPS2900
OI   CVCL_D0WD ! HPS2902
OI   CVCL_D0WE ! HPS2903
OI   CVCL_D0WF ! HPS2904
OI   CVCL_D0WG ! HPS2905
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2902
AC   CVCL_D0WD
DR   RCB; HPS2902
DR   Wikidata; Q123032450
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202118; Ossification of anterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WB ! HPS2900
OI   CVCL_D0WC ! HPS2901
OI   CVCL_D0WE ! HPS2903
OI   CVCL_D0WF ! HPS2904
OI   CVCL_D0WG ! HPS2905
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2903
AC   CVCL_D0WE
DR   RCB; HPS2903
DR   Wikidata; Q123032451
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202118; Ossification of anterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WB ! HPS2900
OI   CVCL_D0WC ! HPS2901
OI   CVCL_D0WD ! HPS2902
OI   CVCL_D0WF ! HPS2904
OI   CVCL_D0WG ! HPS2905
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2904
AC   CVCL_D0WF
DR   RCB; HPS2904
DR   Wikidata; Q123032452
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202118; Ossification of anterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WB ! HPS2900
OI   CVCL_D0WC ! HPS2901
OI   CVCL_D0WD ! HPS2902
OI   CVCL_D0WE ! HPS2903
OI   CVCL_D0WG ! HPS2905
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2905
AC   CVCL_D0WG
DR   RCB; HPS2905
DR   Wikidata; Q123032453
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202118; Ossification of anterior longitudinal ligament
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WB ! HPS2900
OI   CVCL_D0WC ! HPS2901
OI   CVCL_D0WD ! HPS2902
OI   CVCL_D0WE ! HPS2903
OI   CVCL_D0WF ! HPS2904
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2906
AC   CVCL_UP25
DR   RCB; HPS2906
DR   Wikidata; Q94220328
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LM ! HPS2907
OI   CVCL_A3LN ! HPS2908
OI   CVCL_A3LP ! HPS2909
OI   CVCL_A3LQ ! HPS2910
OI   CVCL_A3LR ! HPS2911
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2907
AC   CVCL_A3LM
DR   RCB; HPS2907
DR   Wikidata; Q105508997
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP25 ! HPS2906
OI   CVCL_A3LN ! HPS2908
OI   CVCL_A3LP ! HPS2909
OI   CVCL_A3LQ ! HPS2910
OI   CVCL_A3LR ! HPS2911
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2908
AC   CVCL_A3LN
DR   RCB; HPS2908
DR   Wikidata; Q105509002
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP25 ! HPS2906
OI   CVCL_A3LM ! HPS2907
OI   CVCL_A3LP ! HPS2909
OI   CVCL_A3LQ ! HPS2910
OI   CVCL_A3LR ! HPS2911
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2909
AC   CVCL_A3LP
DR   RCB; HPS2909
DR   Wikidata; Q105509004
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP25 ! HPS2906
OI   CVCL_A3LM ! HPS2907
OI   CVCL_A3LN ! HPS2908
OI   CVCL_A3LQ ! HPS2910
OI   CVCL_A3LR ! HPS2911
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2910
AC   CVCL_A3LQ
DR   RCB; HPS2910
DR   Wikidata; Q105509006
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP25 ! HPS2906
OI   CVCL_A3LM ! HPS2907
OI   CVCL_A3LN ! HPS2908
OI   CVCL_A3LP ! HPS2909
OI   CVCL_A3LR ! HPS2911
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2911
AC   CVCL_A3LR
DR   RCB; HPS2911
DR   Wikidata; Q105509009
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP25 ! HPS2906
OI   CVCL_A3LM ! HPS2907
OI   CVCL_A3LN ! HPS2908
OI   CVCL_A3LP ! HPS2909
OI   CVCL_A3LQ ! HPS2910
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2912
AC   CVCL_UP26
DR   RCB; HPS2912
DR   Wikidata; Q94220333
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3WU ! HPS2913
OI   CVCL_A3WV ! HPS2914
OI   CVCL_A3WW ! HPS2915
OI   CVCL_A3WX ! HPS2916
OI   CVCL_A3WY ! HPS2917
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS2913
AC   CVCL_A3WU
DR   RCB; HPS2913
DR   Wikidata; Q105509013
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP26 ! HPS2912
OI   CVCL_A3WV ! HPS2914
OI   CVCL_A3WW ! HPS2915
OI   CVCL_A3WX ! HPS2916
OI   CVCL_A3WY ! HPS2917
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2914
AC   CVCL_A3WV
DR   RCB; HPS2914
DR   Wikidata; Q105509016
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP26 ! HPS2912
OI   CVCL_A3WU ! HPS2913
OI   CVCL_A3WW ! HPS2915
OI   CVCL_A3WX ! HPS2916
OI   CVCL_A3WY ! HPS2917
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2915
AC   CVCL_A3WW
DR   RCB; HPS2915
DR   Wikidata; Q105509018
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP26 ! HPS2912
OI   CVCL_A3WU ! HPS2913
OI   CVCL_A3WV ! HPS2914
OI   CVCL_A3WX ! HPS2916
OI   CVCL_A3WY ! HPS2917
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2916
AC   CVCL_A3WX
DR   RCB; HPS2916
DR   Wikidata; Q105509021
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP26 ! HPS2912
OI   CVCL_A3WU ! HPS2913
OI   CVCL_A3WV ! HPS2914
OI   CVCL_A3WW ! HPS2915
OI   CVCL_A3WY ! HPS2917
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2917
AC   CVCL_A3WY
DR   RCB; HPS2917
DR   Wikidata; Q105509024
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP26 ! HPS2912
OI   CVCL_A3WU ! HPS2913
OI   CVCL_A3WV ! HPS2914
OI   CVCL_A3WW ! HPS2915
OI   CVCL_A3WX ! HPS2916
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS2918
AC   CVCL_D0WH
DR   RCB; HPS2918
DR   Wikidata; Q123032454
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35151; Chronic sinusitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WI ! HPS2919
OI   CVCL_D0WJ ! HPS2920
OI   CVCL_D0WK ! HPS2921
OI   CVCL_D0WL ! HPS2922
OI   CVCL_D0WM ! HPS2923
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2919
AC   CVCL_D0WI
DR   RCB; HPS2919
DR   Wikidata; Q123032455
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35151; Chronic sinusitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WH ! HPS2918
OI   CVCL_D0WJ ! HPS2920
OI   CVCL_D0WK ! HPS2921
OI   CVCL_D0WL ! HPS2922
OI   CVCL_D0WM ! HPS2923
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2920
AC   CVCL_D0WJ
DR   RCB; HPS2920
DR   Wikidata; Q123032456
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35151; Chronic sinusitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WH ! HPS2918
OI   CVCL_D0WI ! HPS2919
OI   CVCL_D0WK ! HPS2921
OI   CVCL_D0WL ! HPS2922
OI   CVCL_D0WM ! HPS2923
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2921
AC   CVCL_D0WK
DR   RCB; HPS2921
DR   Wikidata; Q123032457
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35151; Chronic sinusitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WH ! HPS2918
OI   CVCL_D0WI ! HPS2919
OI   CVCL_D0WJ ! HPS2920
OI   CVCL_D0WL ! HPS2922
OI   CVCL_D0WM ! HPS2923
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2922
AC   CVCL_D0WL
DR   RCB; HPS2922
DR   Wikidata; Q123032458
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35151; Chronic sinusitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WH ! HPS2918
OI   CVCL_D0WI ! HPS2919
OI   CVCL_D0WJ ! HPS2920
OI   CVCL_D0WK ! HPS2921
OI   CVCL_D0WM ! HPS2923
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2923
AC   CVCL_D0WM
DR   RCB; HPS2923
DR   Wikidata; Q123032459
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35151; Chronic sinusitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WH ! HPS2918
OI   CVCL_D0WI ! HPS2919
OI   CVCL_D0WJ ! HPS2920
OI   CVCL_D0WK ! HPS2921
OI   CVCL_D0WL ! HPS2922
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2924
AC   CVCL_C6CU
DR   RCB; HPS2924
DR   Wikidata; Q116049466
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CV ! HPS2925
OI   CVCL_C6CW ! HPS2926
OI   CVCL_C6CX ! HPS2927
OI   CVCL_C6CY ! HPS2928
OI   CVCL_C6CZ ! HPS2929
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2925
AC   CVCL_C6CV
DR   RCB; HPS2925
DR   Wikidata; Q116049467
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CU ! HPS2924
OI   CVCL_C6CW ! HPS2926
OI   CVCL_C6CX ! HPS2927
OI   CVCL_C6CY ! HPS2928
OI   CVCL_C6CZ ! HPS2929
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2926
AC   CVCL_C6CW
DR   RCB; HPS2926
DR   Wikidata; Q116049468
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CU ! HPS2924
OI   CVCL_C6CV ! HPS2925
OI   CVCL_C6CX ! HPS2927
OI   CVCL_C6CY ! HPS2928
OI   CVCL_C6CZ ! HPS2929
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2927
AC   CVCL_C6CX
DR   RCB; HPS2927
DR   Wikidata; Q116049469
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CU ! HPS2924
OI   CVCL_C6CV ! HPS2925
OI   CVCL_C6CW ! HPS2926
OI   CVCL_C6CY ! HPS2928
OI   CVCL_C6CZ ! HPS2929
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2928
AC   CVCL_C6CY
DR   RCB; HPS2928
DR   Wikidata; Q116049471
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CU ! HPS2924
OI   CVCL_C6CV ! HPS2925
OI   CVCL_C6CW ! HPS2926
OI   CVCL_C6CX ! HPS2927
OI   CVCL_C6CZ ! HPS2929
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2929
AC   CVCL_C6CZ
DR   RCB; HPS2929
DR   Wikidata; Q116049472
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6CU ! HPS2924
OI   CVCL_C6CV ! HPS2925
OI   CVCL_C6CW ! HPS2926
OI   CVCL_C6CX ! HPS2927
OI   CVCL_C6CY ! HPS2928
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2936
AC   CVCL_D0WN
DR   RCB; HPS2936
DR   Wikidata; Q123032460
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2936).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202114; Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome-1
DI   ORDO; Orphanet_83473; Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WP ! HPS2937
OI   CVCL_D0WQ ! HPS2938
OI   CVCL_D0WR ! HPS2939
OI   CVCL_D0WS ! HPS2940
OI   CVCL_D0WT ! HPS2941
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2937
AC   CVCL_D0WP
DR   RCB; HPS2937
DR   Wikidata; Q123032461
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2937).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202114; Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome-1
DI   ORDO; Orphanet_83473; Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WN ! HPS2936
OI   CVCL_D0WQ ! HPS2938
OI   CVCL_D0WR ! HPS2939
OI   CVCL_D0WS ! HPS2940
OI   CVCL_D0WT ! HPS2941
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2938
AC   CVCL_D0WQ
DR   RCB; HPS2938
DR   Wikidata; Q123032462
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2938).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202114; Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome-1
DI   ORDO; Orphanet_83473; Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WN ! HPS2936
OI   CVCL_D0WP ! HPS2937
OI   CVCL_D0WR ! HPS2939
OI   CVCL_D0WS ! HPS2940
OI   CVCL_D0WT ! HPS2941
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2939
AC   CVCL_D0WR
DR   RCB; HPS2939
DR   Wikidata; Q123032463
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2939).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202114; Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome-1
DI   ORDO; Orphanet_83473; Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WN ! HPS2936
OI   CVCL_D0WP ! HPS2937
OI   CVCL_D0WQ ! HPS2938
OI   CVCL_D0WS ! HPS2940
OI   CVCL_D0WT ! HPS2941
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2940
AC   CVCL_D0WS
DR   RCB; HPS2940
DR   Wikidata; Q123032464
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2940).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202114; Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome-1
DI   ORDO; Orphanet_83473; Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WN ! HPS2936
OI   CVCL_D0WP ! HPS2937
OI   CVCL_D0WQ ! HPS2938
OI   CVCL_D0WR ! HPS2939
OI   CVCL_D0WT ! HPS2941
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2941
AC   CVCL_D0WT
DR   RCB; HPS2941
DR   Wikidata; Q123032465
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS2941).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202114; Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome-1
DI   ORDO; Orphanet_83473; Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WN ! HPS2936
OI   CVCL_D0WP ! HPS2937
OI   CVCL_D0WQ ! HPS2938
OI   CVCL_D0WR ! HPS2939
OI   CVCL_D0WS ! HPS2940
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS2942
AC   CVCL_D0WU
DR   RCB; HPS2942
DR   Wikidata; Q123032466
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114688; Urolithiasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WV ! HPS2943
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2943
AC   CVCL_D0WV
DR   RCB; HPS2943
DR   Wikidata; Q123032467
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114688; Urolithiasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WU ! HPS2942
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2944
AC   CVCL_YS76
DR   RCB; HPS2944
DR   Wikidata; Q94220339
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS77 ! HPS2945
OI   CVCL_YS78 ! HPS2946
OI   CVCL_YS79 ! HPS2947
OI   CVCL_YS80 ! HPS2948
OI   CVCL_YS81 ! HPS2949
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2945
AC   CVCL_YS77
DR   RCB; HPS2945
DR   Wikidata; Q94220343
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS76 ! HPS2944
OI   CVCL_YS78 ! HPS2946
OI   CVCL_YS79 ! HPS2947
OI   CVCL_YS80 ! HPS2948
OI   CVCL_YS81 ! HPS2949
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2946
AC   CVCL_YS78
DR   RCB; HPS2946
DR   Wikidata; Q94220346
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS76 ! HPS2944
OI   CVCL_YS77 ! HPS2945
OI   CVCL_YS79 ! HPS2947
OI   CVCL_YS80 ! HPS2948
OI   CVCL_YS81 ! HPS2949
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2947
AC   CVCL_YS79
DR   RCB; HPS2947
DR   Wikidata; Q94220351
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS76 ! HPS2944
OI   CVCL_YS77 ! HPS2945
OI   CVCL_YS78 ! HPS2946
OI   CVCL_YS80 ! HPS2948
OI   CVCL_YS81 ! HPS2949
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2948
AC   CVCL_YS80
DR   RCB; HPS2948
DR   Wikidata; Q94220355
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS76 ! HPS2944
OI   CVCL_YS77 ! HPS2945
OI   CVCL_YS78 ! HPS2946
OI   CVCL_YS79 ! HPS2947
OI   CVCL_YS81 ! HPS2949
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2949
AC   CVCL_YS81
DR   RCB; HPS2949
DR   Wikidata; Q94220360
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS76 ! HPS2944
OI   CVCL_YS77 ! HPS2945
OI   CVCL_YS78 ! HPS2946
OI   CVCL_YS79 ! HPS2947
OI   CVCL_YS80 ! HPS2948
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS2965
AC   CVCL_D0WW
DR   RCB; HPS2965
DR   Wikidata; Q123032468
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WX ! HPS2966
OI   CVCL_D0WY ! HPS2967
OI   CVCL_D0WZ ! HPS2968
OI   CVCL_D0X0 ! HPS2969
OI   CVCL_D0X1 ! HPS2970
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2966
AC   CVCL_D0WX
DR   RCB; HPS2966
DR   Wikidata; Q123032469
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WW ! HPS2965
OI   CVCL_D0WY ! HPS2967
OI   CVCL_D0WZ ! HPS2968
OI   CVCL_D0X0 ! HPS2969
OI   CVCL_D0X1 ! HPS2970
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2967
AC   CVCL_D0WY
DR   RCB; HPS2967
DR   Wikidata; Q123032470
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WW ! HPS2965
OI   CVCL_D0WX ! HPS2966
OI   CVCL_D0WZ ! HPS2968
OI   CVCL_D0X0 ! HPS2969
OI   CVCL_D0X1 ! HPS2970
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2968
AC   CVCL_D0WZ
DR   RCB; HPS2968
DR   Wikidata; Q123032471
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WW ! HPS2965
OI   CVCL_D0WX ! HPS2966
OI   CVCL_D0WY ! HPS2967
OI   CVCL_D0X0 ! HPS2969
OI   CVCL_D0X1 ! HPS2970
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2969
AC   CVCL_D0X0
DR   RCB; HPS2969
DR   Wikidata; Q123032472
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WW ! HPS2965
OI   CVCL_D0WX ! HPS2966
OI   CVCL_D0WY ! HPS2967
OI   CVCL_D0WZ ! HPS2968
OI   CVCL_D0X1 ! HPS2970
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2970
AC   CVCL_D0X1
DR   RCB; HPS2970
DR   Wikidata; Q123032473
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0WW ! HPS2965
OI   CVCL_D0WX ! HPS2966
OI   CVCL_D0WY ! HPS2967
OI   CVCL_D0WZ ! HPS2968
OI   CVCL_D0X0 ! HPS2969
SX   Female
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2971
AC   CVCL_C6D5
DR   RCB; HPS2971
DR   Wikidata; Q116049473
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D0 ! HPS2972
OI   CVCL_C6D1 ! HPS2973
OI   CVCL_C6D2 ! HPS2974
OI   CVCL_C6D3 ! HPS2975
OI   CVCL_C6D4 ! HPS2976
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2972
AC   CVCL_C6D0
DR   RCB; HPS2972
DR   Wikidata; Q116049474
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D5 ! HPS2971
OI   CVCL_C6D1 ! HPS2973
OI   CVCL_C6D2 ! HPS2974
OI   CVCL_C6D3 ! HPS2975
OI   CVCL_C6D4 ! HPS2976
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2973
AC   CVCL_C6D1
DR   RCB; HPS2973
DR   Wikidata; Q116049476
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D5 ! HPS2971
OI   CVCL_C6D0 ! HPS2972
OI   CVCL_C6D2 ! HPS2974
OI   CVCL_C6D3 ! HPS2975
OI   CVCL_C6D4 ! HPS2976
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2974
AC   CVCL_C6D2
DR   RCB; HPS2974
DR   Wikidata; Q116049477
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D5 ! HPS2971
OI   CVCL_C6D0 ! HPS2972
OI   CVCL_C6D1 ! HPS2973
OI   CVCL_C6D3 ! HPS2975
OI   CVCL_C6D4 ! HPS2976
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2975
AC   CVCL_C6D3
DR   RCB; HPS2975
DR   Wikidata; Q116049478
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D5 ! HPS2971
OI   CVCL_C6D0 ! HPS2972
OI   CVCL_C6D1 ! HPS2973
OI   CVCL_C6D2 ! HPS2974
OI   CVCL_C6D4 ! HPS2976
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2976
AC   CVCL_C6D4
DR   RCB; HPS2976
DR   Wikidata; Q116049479
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118846; Miyoshi muscular dystrophy 1
DI   ORDO; Orphanet_45448; Miyoshi myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D5 ! HPS2971
OI   CVCL_C6D0 ! HPS2972
OI   CVCL_C6D1 ! HPS2973
OI   CVCL_C6D2 ! HPS2974
OI   CVCL_C6D3 ! HPS2975
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS2977
AC   CVCL_D0X2
DR   RCB; HPS2977
DR   Wikidata; Q123032474
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202129; Chronic non-specific multiple ulcers of the small intestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X3 ! HPS2978
OI   CVCL_D0X4 ! HPS2979
OI   CVCL_D0X5 ! HPS2980
OI   CVCL_D0X6 ! HPS2981
OI   CVCL_D0X7 ! HPS2982
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2978
AC   CVCL_D0X3
DR   RCB; HPS2978
DR   Wikidata; Q123032475
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202129; Chronic non-specific multiple ulcers of the small intestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X2 ! HPS2977
OI   CVCL_D0X4 ! HPS2979
OI   CVCL_D0X5 ! HPS2980
OI   CVCL_D0X6 ! HPS2981
OI   CVCL_D0X7 ! HPS2982
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2979
AC   CVCL_D0X4
DR   RCB; HPS2979
DR   Wikidata; Q123032476
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202129; Chronic non-specific multiple ulcers of the small intestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X2 ! HPS2977
OI   CVCL_D0X3 ! HPS2978
OI   CVCL_D0X5 ! HPS2980
OI   CVCL_D0X6 ! HPS2981
OI   CVCL_D0X7 ! HPS2982
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2980
AC   CVCL_D0X5
DR   RCB; HPS2980
DR   Wikidata; Q123032477
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202129; Chronic non-specific multiple ulcers of the small intestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X2 ! HPS2977
OI   CVCL_D0X3 ! HPS2978
OI   CVCL_D0X4 ! HPS2979
OI   CVCL_D0X6 ! HPS2981
OI   CVCL_D0X7 ! HPS2982
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2981
AC   CVCL_D0X6
DR   RCB; HPS2981
DR   Wikidata; Q123032478
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202129; Chronic non-specific multiple ulcers of the small intestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X2 ! HPS2977
OI   CVCL_D0X3 ! HPS2978
OI   CVCL_D0X4 ! HPS2979
OI   CVCL_D0X5 ! HPS2980
OI   CVCL_D0X7 ! HPS2982
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS2982
AC   CVCL_D0X7
DR   RCB; HPS2982
DR   Wikidata; Q123032479
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202129; Chronic non-specific multiple ulcers of the small intestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X2 ! HPS2977
OI   CVCL_D0X3 ! HPS2978
OI   CVCL_D0X4 ! HPS2979
OI   CVCL_D0X5 ! HPS2980
OI   CVCL_D0X6 ! HPS2981
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3001
AC   CVCL_YS82
DR   RCB; HPS3001
DR   Wikidata; Q94220364
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141398; Loss of chromosome 4p
DI   ORDO; Orphanet_261884; Partial deletion of the short arm of chromosome 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS83 ! HPS3002
OI   CVCL_YS84 ! HPS3003
OI   CVCL_YS85 ! HPS3004
OI   CVCL_YS86 ! HPS3005
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3002
AC   CVCL_YS83
DR   RCB; HPS3002
DR   Wikidata; Q94220368
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141398; Loss of chromosome 4p
DI   ORDO; Orphanet_261884; Partial deletion of the short arm of chromosome 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS82 ! HPS3001
OI   CVCL_YS84 ! HPS3003
OI   CVCL_YS85 ! HPS3004
OI   CVCL_YS86 ! HPS3005
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3003
AC   CVCL_YS84
DR   RCB; HPS3003
DR   Wikidata; Q94220373
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141398; Loss of chromosome 4p
DI   ORDO; Orphanet_261884; Partial deletion of the short arm of chromosome 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS82 ! HPS3001
OI   CVCL_YS83 ! HPS3002
OI   CVCL_YS85 ! HPS3004
OI   CVCL_YS86 ! HPS3005
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3004
AC   CVCL_YS85
DR   RCB; HPS3004
DR   Wikidata; Q94220377
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141398; Loss of chromosome 4p
DI   ORDO; Orphanet_261884; Partial deletion of the short arm of chromosome 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS82 ! HPS3001
OI   CVCL_YS83 ! HPS3002
OI   CVCL_YS84 ! HPS3003
OI   CVCL_YS86 ! HPS3005
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3005
AC   CVCL_YS86
DR   RCB; HPS3005
DR   Wikidata; Q94220382
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141398; Loss of chromosome 4p
DI   ORDO; Orphanet_261884; Partial deletion of the short arm of chromosome 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS82 ! HPS3001
OI   CVCL_YS83 ! HPS3002
OI   CVCL_YS84 ! HPS3003
OI   CVCL_YS85 ! HPS3004
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3006
AC   CVCL_UP27
DR   RCB; HPS3006
DR   Wikidata; Q94220385
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3IN ! HPS3007
OI   CVCL_A3IP ! HPS3008
OI   CVCL_A3IQ ! HPS3009
OI   CVCL_A3IR ! HPS3010
OI   CVCL_A3IS ! HPS3011
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3007
AC   CVCL_A3IN
DR   RCB; HPS3007
DR   Wikidata; Q105509027
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP27 ! HPS3006
OI   CVCL_A3IP ! HPS3008
OI   CVCL_A3IQ ! HPS3009
OI   CVCL_A3IR ! HPS3010
OI   CVCL_A3IS ! HPS3011
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3008
AC   CVCL_A3IP
DR   RCB; HPS3008
DR   Wikidata; Q105509030
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP27 ! HPS3006
OI   CVCL_A3IN ! HPS3007
OI   CVCL_A3IQ ! HPS3009
OI   CVCL_A3IR ! HPS3010
OI   CVCL_A3IS ! HPS3011
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3009
AC   CVCL_A3IQ
DR   RCB; HPS3009
DR   Wikidata; Q105509033
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP27 ! HPS3006
OI   CVCL_A3IN ! HPS3007
OI   CVCL_A3IP ! HPS3008
OI   CVCL_A3IR ! HPS3010
OI   CVCL_A3IS ! HPS3011
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3010
AC   CVCL_A3IR
DR   RCB; HPS3010
DR   Wikidata; Q105509037
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP27 ! HPS3006
OI   CVCL_A3IN ! HPS3007
OI   CVCL_A3IP ! HPS3008
OI   CVCL_A3IQ ! HPS3009
OI   CVCL_A3IS ! HPS3011
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3011
AC   CVCL_A3IS
DR   RCB; HPS3011
DR   Wikidata; Q105509038
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP27 ! HPS3006
OI   CVCL_A3IN ! HPS3007
OI   CVCL_A3IP ! HPS3008
OI   CVCL_A3IQ ! HPS3009
OI   CVCL_A3IR ! HPS3010
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3018
AC   CVCL_D0X8
DR   RCB; HPS3018
DR   Wikidata; Q123032480
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X9 ! HPS3019
OI   CVCL_D0XA ! HPS3020
OI   CVCL_D0XB ! HPS3021
OI   CVCL_D0XC ! HPS3022
OI   CVCL_D0XD ! HPS3023
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3019
AC   CVCL_D0X9
DR   RCB; HPS3019
DR   Wikidata; Q123032481
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X8 ! HPS3018
OI   CVCL_D0XA ! HPS3020
OI   CVCL_D0XB ! HPS3021
OI   CVCL_D0XC ! HPS3022
OI   CVCL_D0XD ! HPS3023
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3020
AC   CVCL_D0XA
DR   RCB; HPS3020
DR   Wikidata; Q123032482
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X8 ! HPS3018
OI   CVCL_D0X9 ! HPS3019
OI   CVCL_D0XB ! HPS3021
OI   CVCL_D0XC ! HPS3022
OI   CVCL_D0XD ! HPS3023
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3021
AC   CVCL_D0XB
DR   RCB; HPS3021
DR   Wikidata; Q123032483
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X8 ! HPS3018
OI   CVCL_D0X9 ! HPS3019
OI   CVCL_D0XA ! HPS3020
OI   CVCL_D0XC ! HPS3022
OI   CVCL_D0XD ! HPS3023
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3022
AC   CVCL_D0XC
DR   RCB; HPS3022
DR   Wikidata; Q123032484
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X8 ! HPS3018
OI   CVCL_D0X9 ! HPS3019
OI   CVCL_D0XA ! HPS3020
OI   CVCL_D0XB ! HPS3021
OI   CVCL_D0XD ! HPS3023
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3023
AC   CVCL_D0XD
DR   RCB; HPS3023
DR   Wikidata; Q123032485
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0X8 ! HPS3018
OI   CVCL_D0X9 ! HPS3019
OI   CVCL_D0XA ! HPS3020
OI   CVCL_D0XB ! HPS3021
OI   CVCL_D0XC ! HPS3022
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3036
AC   CVCL_UP28
DR   RCB; HPS3036
DR   Wikidata; Q94220388
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS04 ! HPS3037
OI   CVCL_YS05 ! HPS3038
OI   CVCL_YS06 ! HPS3039
OI   CVCL_YS07 ! HPS3040
OI   CVCL_YS08 ! HPS3041
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS3037
AC   CVCL_YS04
DR   RCB; HPS3037
DR   Wikidata; Q94220392
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP28 ! HPS3036
OI   CVCL_YS05 ! HPS3038
OI   CVCL_YS06 ! HPS3039
OI   CVCL_YS07 ! HPS3040
OI   CVCL_YS08 ! HPS3041
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3038
AC   CVCL_YS05
DR   RCB; HPS3038
DR   Wikidata; Q94220395
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP28 ! HPS3036
OI   CVCL_YS04 ! HPS3037
OI   CVCL_YS06 ! HPS3039
OI   CVCL_YS07 ! HPS3040
OI   CVCL_YS08 ! HPS3041
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3039
AC   CVCL_YS06
DR   RCB; HPS3039
DR   Wikidata; Q94220399
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP28 ! HPS3036
OI   CVCL_YS04 ! HPS3037
OI   CVCL_YS05 ! HPS3038
OI   CVCL_YS07 ! HPS3040
OI   CVCL_YS08 ! HPS3041
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3040
AC   CVCL_YS07
DR   RCB; HPS3040
DR   Wikidata; Q94220401
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP28 ! HPS3036
OI   CVCL_YS04 ! HPS3037
OI   CVCL_YS05 ! HPS3038
OI   CVCL_YS06 ! HPS3039
OI   CVCL_YS08 ! HPS3041
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3041
AC   CVCL_YS08
DR   RCB; HPS3041
DR   Wikidata; Q94220405
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP28 ! HPS3036
OI   CVCL_YS04 ! HPS3037
OI   CVCL_YS05 ! HPS3038
OI   CVCL_YS06 ! HPS3039
OI   CVCL_YS07 ! HPS3040
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3042
AC   CVCL_UP29
DR   RCB; HPS3042
DR   Wikidata; Q94220409
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS09 ! HPS3043
OI   CVCL_YS10 ! HPS3044
OI   CVCL_YS11 ! HPS3045
OI   CVCL_YS12 ! HPS3046
OI   CVCL_YS13 ! HPS3047
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS3043
AC   CVCL_YS09
DR   RCB; HPS3043
DR   Wikidata; Q94220412
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP29 ! HPS3042
OI   CVCL_YS10 ! HPS3044
OI   CVCL_YS11 ! HPS3045
OI   CVCL_YS12 ! HPS3046
OI   CVCL_YS13 ! HPS3047
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3044
AC   CVCL_YS10
DR   RCB; HPS3044
DR   Wikidata; Q94220416
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP29 ! HPS3042
OI   CVCL_YS09 ! HPS3043
OI   CVCL_YS11 ! HPS3045
OI   CVCL_YS12 ! HPS3046
OI   CVCL_YS13 ! HPS3047
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3045
AC   CVCL_YS11
DR   RCB; HPS3045
DR   Wikidata; Q94220420
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP29 ! HPS3042
OI   CVCL_YS09 ! HPS3043
OI   CVCL_YS10 ! HPS3044
OI   CVCL_YS12 ! HPS3046
OI   CVCL_YS13 ! HPS3047
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3046
AC   CVCL_YS12
DR   RCB; HPS3046
DR   Wikidata; Q94220425
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP29 ! HPS3042
OI   CVCL_YS09 ! HPS3043
OI   CVCL_YS10 ! HPS3044
OI   CVCL_YS11 ! HPS3045
OI   CVCL_YS13 ! HPS3047
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3047
AC   CVCL_YS13
DR   RCB; HPS3047
DR   Wikidata; Q94220429
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP29 ! HPS3042
OI   CVCL_YS09 ! HPS3043
OI   CVCL_YS10 ! HPS3044
OI   CVCL_YS11 ! HPS3045
OI   CVCL_YS12 ! HPS3046
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3048
AC   CVCL_UP30
DR   RCB; HPS3048
DR   Wikidata; Q94220434
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS14 ! HPS3049
OI   CVCL_YS15 ! HPS3050
OI   CVCL_YS16 ! HPS3051
OI   CVCL_YS17 ! HPS3052
OI   CVCL_YS18 ! HPS3053
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS3049
AC   CVCL_YS14
DR   RCB; HPS3049
DR   Wikidata; Q94220438
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP30 ! HPS3048
OI   CVCL_YS15 ! HPS3050
OI   CVCL_YS16 ! HPS3051
OI   CVCL_YS17 ! HPS3052
OI   CVCL_YS18 ! HPS3053
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3050
AC   CVCL_YS15
DR   RCB; HPS3050
DR   Wikidata; Q94220448
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP30 ! HPS3048
OI   CVCL_YS14 ! HPS3049
OI   CVCL_YS16 ! HPS3051
OI   CVCL_YS17 ! HPS3052
OI   CVCL_YS18 ! HPS3053
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3051
AC   CVCL_YS16
DR   RCB; HPS3051
DR   Wikidata; Q94220451
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP30 ! HPS3048
OI   CVCL_YS14 ! HPS3049
OI   CVCL_YS15 ! HPS3050
OI   CVCL_YS17 ! HPS3052
OI   CVCL_YS18 ! HPS3053
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3052
AC   CVCL_YS17
DR   RCB; HPS3052
DR   Wikidata; Q94220456
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP30 ! HPS3048
OI   CVCL_YS14 ! HPS3049
OI   CVCL_YS15 ! HPS3050
OI   CVCL_YS16 ! HPS3051
OI   CVCL_YS18 ! HPS3053
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3053
AC   CVCL_YS18
DR   RCB; HPS3053
DR   Wikidata; Q94220460
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP30 ! HPS3048
OI   CVCL_YS14 ! HPS3049
OI   CVCL_YS15 ! HPS3050
OI   CVCL_YS16 ! HPS3051
OI   CVCL_YS17 ! HPS3052
SX   Female
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3054
AC   CVCL_D0XE
DR   RCB; HPS3054
DR   Wikidata; Q123032486
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XF ! HPS3055
OI   CVCL_D0XG ! HPS3056
OI   CVCL_D0XH ! HPS3057
OI   CVCL_D0XI ! HPS3058
OI   CVCL_D0XJ ! HPS3059
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3055
AC   CVCL_D0XF
DR   RCB; HPS3055
DR   Wikidata; Q123032487
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XE ! HPS3054
OI   CVCL_D0XG ! HPS3056
OI   CVCL_D0XH ! HPS3057
OI   CVCL_D0XI ! HPS3058
OI   CVCL_D0XJ ! HPS3059
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3056
AC   CVCL_D0XG
DR   RCB; HPS3056
DR   Wikidata; Q123032489
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XE ! HPS3054
OI   CVCL_D0XF ! HPS3055
OI   CVCL_D0XH ! HPS3057
OI   CVCL_D0XI ! HPS3058
OI   CVCL_D0XJ ! HPS3059
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3057
AC   CVCL_D0XH
DR   RCB; HPS3057
DR   Wikidata; Q123032490
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XE ! HPS3054
OI   CVCL_D0XF ! HPS3055
OI   CVCL_D0XG ! HPS3056
OI   CVCL_D0XI ! HPS3058
OI   CVCL_D0XJ ! HPS3059
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3058
AC   CVCL_D0XI
DR   RCB; HPS3058
DR   Wikidata; Q123032491
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XE ! HPS3054
OI   CVCL_D0XF ! HPS3055
OI   CVCL_D0XG ! HPS3056
OI   CVCL_D0XH ! HPS3057
OI   CVCL_D0XJ ! HPS3059
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3059
AC   CVCL_D0XJ
DR   RCB; HPS3059
DR   Wikidata; Q123032492
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XE ! HPS3054
OI   CVCL_D0XF ! HPS3055
OI   CVCL_D0XG ! HPS3056
OI   CVCL_D0XH ! HPS3057
OI   CVCL_D0XI ! HPS3058
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3084
AC   CVCL_C6D6
DR   RCB; HPS3084
DR   Wikidata; Q116049481
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Unspecified (RCB=HPS3084).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D7 ! HPS3085
OI   CVCL_C6D8 ! HPS3086
OI   CVCL_C6D9 ! HPS3087
OI   CVCL_C6DA ! HPS3088
OI   CVCL_C6DB ! HPS3089
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3085
AC   CVCL_C6D7
DR   RCB; HPS3085
DR   Wikidata; Q116049482
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Unspecified (RCB=HPS3085).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D6 ! HPS3084
OI   CVCL_C6D8 ! HPS3086
OI   CVCL_C6D9 ! HPS3087
OI   CVCL_C6DA ! HPS3088
OI   CVCL_C6DB ! HPS3089
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3086
AC   CVCL_C6D8
DR   RCB; HPS3086
DR   Wikidata; Q116049483
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Unspecified (RCB=HPS3086).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D6 ! HPS3084
OI   CVCL_C6D7 ! HPS3085
OI   CVCL_C6D9 ! HPS3087
OI   CVCL_C6DA ! HPS3088
OI   CVCL_C6DB ! HPS3089
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3087
AC   CVCL_C6D9
DR   RCB; HPS3087
DR   Wikidata; Q116049485
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Unspecified (RCB=HPS3087).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D6 ! HPS3084
OI   CVCL_C6D7 ! HPS3085
OI   CVCL_C6D8 ! HPS3086
OI   CVCL_C6DA ! HPS3088
OI   CVCL_C6DB ! HPS3089
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3088
AC   CVCL_C6DA
DR   RCB; HPS3088
DR   Wikidata; Q116049486
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Unspecified (RCB=HPS3088).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D6 ! HPS3084
OI   CVCL_C6D7 ! HPS3085
OI   CVCL_C6D8 ! HPS3086
OI   CVCL_C6D9 ! HPS3087
OI   CVCL_C6DB ! HPS3089
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3089
AC   CVCL_C6DB
DR   RCB; HPS3089
DR   Wikidata; Q116049487
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg294Ter (c.880C>T) (p.Arg306Ter, c.916C>T); ClinVar=VCV000011819; Zygosity=Unspecified (RCB=HPS3089).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6D6 ! HPS3084
OI   CVCL_C6D7 ! HPS3085
OI   CVCL_C6D8 ! HPS3086
OI   CVCL_C6D9 ! HPS3087
OI   CVCL_C6DA ! HPS3088
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3090
AC   CVCL_C6DC
DR   RCB; HPS3090
DR   Wikidata; Q116049488
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DD ! HPS3091
OI   CVCL_C6DE ! HPS3092
OI   CVCL_C6DF ! HPS3093
OI   CVCL_C6DG ! HPS3094
OI   CVCL_C6DH ! HPS3095
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3091
AC   CVCL_C6DD
DR   RCB; HPS3091
DR   Wikidata; Q116049489
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DC ! HPS3090
OI   CVCL_C6DE ! HPS3092
OI   CVCL_C6DF ! HPS3093
OI   CVCL_C6DG ! HPS3094
OI   CVCL_C6DH ! HPS3095
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3092
AC   CVCL_C6DE
DR   RCB; HPS3092
DR   Wikidata; Q116049490
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DC ! HPS3090
OI   CVCL_C6DD ! HPS3091
OI   CVCL_C6DF ! HPS3093
OI   CVCL_C6DG ! HPS3094
OI   CVCL_C6DH ! HPS3095
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3093
AC   CVCL_C6DF
DR   RCB; HPS3093
DR   Wikidata; Q116049491
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DC ! HPS3090
OI   CVCL_C6DD ! HPS3091
OI   CVCL_C6DE ! HPS3092
OI   CVCL_C6DG ! HPS3094
OI   CVCL_C6DH ! HPS3095
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3094
AC   CVCL_C6DG
DR   RCB; HPS3094
DR   Wikidata; Q116049492
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DC ! HPS3090
OI   CVCL_C6DD ! HPS3091
OI   CVCL_C6DE ! HPS3092
OI   CVCL_C6DF ! HPS3093
OI   CVCL_C6DH ! HPS3095
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3095
AC   CVCL_C6DH
DR   RCB; HPS3095
DR   Wikidata; Q116049493
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DC ! HPS3090
OI   CVCL_C6DD ! HPS3091
OI   CVCL_C6DE ! HPS3092
OI   CVCL_C6DF ! HPS3093
OI   CVCL_C6DG ! HPS3094
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3096
AC   CVCL_D0XN
DR   RCB; HPS3096
DR   Wikidata; Q123032493
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XP ! HPS3097
OI   CVCL_D0XQ ! HPS3098
OI   CVCL_D0XR ! HPS3099
OI   CVCL_D0XS ! HPS3100
OI   CVCL_D0XT ! HPS3101
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3097
AC   CVCL_D0XP
DR   RCB; HPS3097
DR   Wikidata; Q123032494
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XN ! HPS3096
OI   CVCL_D0XQ ! HPS3098
OI   CVCL_D0XR ! HPS3099
OI   CVCL_D0XS ! HPS3100
OI   CVCL_D0XT ! HPS3101
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3098
AC   CVCL_D0XQ
DR   RCB; HPS3098
DR   Wikidata; Q123032495
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XN ! HPS3096
OI   CVCL_D0XP ! HPS3097
OI   CVCL_D0XR ! HPS3099
OI   CVCL_D0XS ! HPS3100
OI   CVCL_D0XT ! HPS3101
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3099
AC   CVCL_D0XR
DR   RCB; HPS3099
DR   Wikidata; Q123032497
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XN ! HPS3096
OI   CVCL_D0XP ! HPS3097
OI   CVCL_D0XQ ! HPS3098
OI   CVCL_D0XS ! HPS3100
OI   CVCL_D0XT ! HPS3101
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3100
AC   CVCL_D0XS
DR   RCB; HPS3100
DR   Wikidata; Q123032498
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XN ! HPS3096
OI   CVCL_D0XP ! HPS3097
OI   CVCL_D0XQ ! HPS3098
OI   CVCL_D0XR ! HPS3099
OI   CVCL_D0XT ! HPS3101
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3101
AC   CVCL_D0XT
DR   RCB; HPS3101
DR   Wikidata; Q123032499
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XN ! HPS3096
OI   CVCL_D0XP ! HPS3097
OI   CVCL_D0XQ ! HPS3098
OI   CVCL_D0XR ! HPS3099
OI   CVCL_D0XS ! HPS3100
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3119
AC   CVCL_UN35
DR   RCB; HPS3119
DR   Wikidata; Q94220463
CC   HLA typing: A*24:02:01:01,24:02:01:01; B*40:02:01:01,54:01:01; C*01:02:01,03:04:01; DPB1*02:01:02,05:01:01; DQB1*03:01:01,05:01:01; DRB1*01:01:01,11:01:01:01New (RCB=HPS3119).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3WZ ! HPS3120
OI   CVCL_A3XA ! HPS3121
OI   CVCL_A3XB ! HPS3122
OI   CVCL_A3XC ! HPS3123
OI   CVCL_A3XD ! HPS3124
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3120
AC   CVCL_A3WZ
DR   RCB; HPS3120
DR   Wikidata; Q105509041
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN35 ! HPS3119
OI   CVCL_A3XA ! HPS3121
OI   CVCL_A3XB ! HPS3122
OI   CVCL_A3XC ! HPS3123
OI   CVCL_A3XD ! HPS3124
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3121
AC   CVCL_A3XA
DR   RCB; HPS3121
DR   Wikidata; Q105509046
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN35 ! HPS3119
OI   CVCL_A3WZ ! HPS3120
OI   CVCL_A3XB ! HPS3122
OI   CVCL_A3XC ! HPS3123
OI   CVCL_A3XD ! HPS3124
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3122
AC   CVCL_A3XB
DR   RCB; HPS3122
DR   Wikidata; Q105509049
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN35 ! HPS3119
OI   CVCL_A3WZ ! HPS3120
OI   CVCL_A3XA ! HPS3121
OI   CVCL_A3XC ! HPS3123
OI   CVCL_A3XD ! HPS3124
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3123
AC   CVCL_A3XC
DR   RCB; HPS3123
DR   Wikidata; Q105509052
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN35 ! HPS3119
OI   CVCL_A3WZ ! HPS3120
OI   CVCL_A3XA ! HPS3121
OI   CVCL_A3XB ! HPS3122
OI   CVCL_A3XD ! HPS3124
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3124
AC   CVCL_A3XD
DR   RCB; HPS3124
DR   Wikidata; Q105509057
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN35 ! HPS3119
OI   CVCL_A3WZ ! HPS3120
OI   CVCL_A3XA ! HPS3121
OI   CVCL_A3XB ! HPS3122
OI   CVCL_A3XC ! HPS3123
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3125
AC   CVCL_UN36
DR   RCB; HPS3125
DR   Wikidata; Q94220468
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*54:01:01; C*01:02:01; DPB1*04:02:01,05:01:01; DQB1*04:01:01:01,06:02:01:01; DRB1*04:05:01:01,15:01:01 (RCB=HPS3125).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3NT ! HPS3126
OI   CVCL_A3NU ! HPS3127
OI   CVCL_A3NV ! HPS3128
OI   CVCL_A3NW ! HPS3129
OI   CVCL_A3NX ! HPS3130
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 7
//
ID   HPS3126
AC   CVCL_A3NT
DR   RCB; HPS3126
DR   Wikidata; Q105509059
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN36 ! HPS3125
OI   CVCL_A3NU ! HPS3127
OI   CVCL_A3NV ! HPS3128
OI   CVCL_A3NW ! HPS3129
OI   CVCL_A3NX ! HPS3130
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3127
AC   CVCL_A3NU
DR   RCB; HPS3127
DR   Wikidata; Q105509062
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN36 ! HPS3125
OI   CVCL_A3NT ! HPS3126
OI   CVCL_A3NV ! HPS3128
OI   CVCL_A3NW ! HPS3129
OI   CVCL_A3NX ! HPS3130
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3128
AC   CVCL_A3NV
DR   RCB; HPS3128
DR   Wikidata; Q105509064
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN36 ! HPS3125
OI   CVCL_A3NT ! HPS3126
OI   CVCL_A3NU ! HPS3127
OI   CVCL_A3NW ! HPS3129
OI   CVCL_A3NX ! HPS3130
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3129
AC   CVCL_A3NW
DR   RCB; HPS3129
DR   Wikidata; Q105509069
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN36 ! HPS3125
OI   CVCL_A3NT ! HPS3126
OI   CVCL_A3NU ! HPS3127
OI   CVCL_A3NV ! HPS3128
OI   CVCL_A3NX ! HPS3130
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3130
AC   CVCL_A3NX
DR   RCB; HPS3130
DR   Wikidata; Q105509073
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN36 ! HPS3125
OI   CVCL_A3NT ! HPS3126
OI   CVCL_A3NU ! HPS3127
OI   CVCL_A3NV ! HPS3128
OI   CVCL_A3NW ! HPS3129
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3131
AC   CVCL_UN37
DR   RCB; HPS3131
DR   Wikidata; Q94220471
CC   HLA typing: A*02:01:01:01,24:20:01:01New; B*35:01:01:02,51:01:01; C*01:02:01,03:03:01; DPB1*02:01:02,05:01:01; DQB1*03:01:01,03:02:01; DRB1*08:02:01,12:01:01:03/12:10 (RCB=HPS3131).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3NY ! HPS3132
OI   CVCL_A3NZ ! HPS3133
OI   CVCL_A3PA ! HPS3134
OI   CVCL_A3PB ! HPS3135
OI   CVCL_A3PC ! HPS3136
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3132
AC   CVCL_A3NY
DR   RCB; HPS3132
DR   Wikidata; Q105509075
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN37 ! HPS3131
OI   CVCL_A3NZ ! HPS3133
OI   CVCL_A3PA ! HPS3134
OI   CVCL_A3PB ! HPS3135
OI   CVCL_A3PC ! HPS3136
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3133
AC   CVCL_A3NZ
DR   RCB; HPS3133
DR   Wikidata; Q105509079
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN37 ! HPS3131
OI   CVCL_A3NY ! HPS3132
OI   CVCL_A3PA ! HPS3134
OI   CVCL_A3PB ! HPS3135
OI   CVCL_A3PC ! HPS3136
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3134
AC   CVCL_A3PA
DR   RCB; HPS3134
DR   Wikidata; Q105509081
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN37 ! HPS3131
OI   CVCL_A3NY ! HPS3132
OI   CVCL_A3NZ ! HPS3133
OI   CVCL_A3PB ! HPS3135
OI   CVCL_A3PC ! HPS3136
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3135
AC   CVCL_A3PB
DR   RCB; HPS3135
DR   Wikidata; Q105509084
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN37 ! HPS3131
OI   CVCL_A3NY ! HPS3132
OI   CVCL_A3NZ ! HPS3133
OI   CVCL_A3PA ! HPS3134
OI   CVCL_A3PC ! HPS3136
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3136
AC   CVCL_A3PC
DR   RCB; HPS3136
DR   Wikidata; Q105509087
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN37 ! HPS3131
OI   CVCL_A3NY ! HPS3132
OI   CVCL_A3NZ ! HPS3133
OI   CVCL_A3PA ! HPS3134
OI   CVCL_A3PB ! HPS3135
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3137
AC   CVCL_C6DI
DR   RCB; HPS3137
DR   Wikidata; Q116049494
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DJ ! HPS3138
OI   CVCL_C6DK ! HPS3139
OI   CVCL_C6DL ! HPS3140
OI   CVCL_C6DM ! HPS3141
OI   CVCL_C6DN ! HPS3142
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3138
AC   CVCL_C6DJ
DR   RCB; HPS3138
DR   Wikidata; Q116049495
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DI ! HPS3137
OI   CVCL_C6DK ! HPS3139
OI   CVCL_C6DL ! HPS3140
OI   CVCL_C6DM ! HPS3141
OI   CVCL_C6DN ! HPS3142
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3139
AC   CVCL_C6DK
DR   RCB; HPS3139
DR   Wikidata; Q116049496
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DI ! HPS3137
OI   CVCL_C6DJ ! HPS3138
OI   CVCL_C6DL ! HPS3140
OI   CVCL_C6DM ! HPS3141
OI   CVCL_C6DN ! HPS3142
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3140
AC   CVCL_C6DL
DR   RCB; HPS3140
DR   Wikidata; Q116049497
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DI ! HPS3137
OI   CVCL_C6DJ ! HPS3138
OI   CVCL_C6DK ! HPS3139
OI   CVCL_C6DM ! HPS3141
OI   CVCL_C6DN ! HPS3142
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3141
AC   CVCL_C6DM
DR   RCB; HPS3141
DR   Wikidata; Q116049498
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DI ! HPS3137
OI   CVCL_C6DJ ! HPS3138
OI   CVCL_C6DK ! HPS3139
OI   CVCL_C6DL ! HPS3140
OI   CVCL_C6DN ! HPS3142
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3142
AC   CVCL_C6DN
DR   RCB; HPS3142
DR   Wikidata; Q116049499
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
DI   NCIt; C84934; Neuromyelitis optica
DI   ORDO; Orphanet_71211; Neuromyelitis optica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DI ! HPS3137
OI   CVCL_C6DJ ! HPS3138
OI   CVCL_C6DK ! HPS3139
OI   CVCL_C6DL ! HPS3140
OI   CVCL_C6DM ! HPS3141
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HPS3143
AC   CVCL_UP31
DR   RCB; HPS3143
DR   Wikidata; Q94220476
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3PD ! HPS3144
OI   CVCL_A3PE ! HPS3145
OI   CVCL_A3PF ! HPS3146
OI   CVCL_A3PG ! HPS3147
OI   CVCL_A3PH ! HPS3148
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3144
AC   CVCL_A3PD
DR   RCB; HPS3144
DR   Wikidata; Q105509090
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP31 ! HPS3143
OI   CVCL_A3PE ! HPS3145
OI   CVCL_A3PF ! HPS3146
OI   CVCL_A3PG ! HPS3147
OI   CVCL_A3PH ! HPS3148
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3145
AC   CVCL_A3PE
DR   RCB; HPS3145
DR   Wikidata; Q105509092
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP31 ! HPS3143
OI   CVCL_A3PD ! HPS3144
OI   CVCL_A3PF ! HPS3146
OI   CVCL_A3PG ! HPS3147
OI   CVCL_A3PH ! HPS3148
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3146
AC   CVCL_A3PF
DR   RCB; HPS3146
DR   Wikidata; Q105509095
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP31 ! HPS3143
OI   CVCL_A3PD ! HPS3144
OI   CVCL_A3PE ! HPS3145
OI   CVCL_A3PG ! HPS3147
OI   CVCL_A3PH ! HPS3148
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3147
AC   CVCL_A3PG
DR   RCB; HPS3147
DR   Wikidata; Q105509099
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP31 ! HPS3143
OI   CVCL_A3PD ! HPS3144
OI   CVCL_A3PE ! HPS3145
OI   CVCL_A3PF ! HPS3146
OI   CVCL_A3PH ! HPS3148
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3148
AC   CVCL_A3PH
DR   RCB; HPS3148
DR   Wikidata; Q105509102
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP31 ! HPS3143
OI   CVCL_A3PD ! HPS3144
OI   CVCL_A3PE ! HPS3145
OI   CVCL_A3PF ! HPS3146
OI   CVCL_A3PG ! HPS3147
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3149
AC   CVCL_D0XU
DR   RCB; HPS3149
DR   Wikidata; Q123032500
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XV ! HPS3150
OI   CVCL_D0XW ! HPS3151
OI   CVCL_D0XX ! HPS3152
OI   CVCL_D0XY ! HPS3153
OI   CVCL_D0XZ ! HPS3154
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3150
AC   CVCL_D0XV
DR   RCB; HPS3150
DR   Wikidata; Q123032501
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XU ! HPS3149
OI   CVCL_D0XW ! HPS3151
OI   CVCL_D0XX ! HPS3152
OI   CVCL_D0XY ! HPS3153
OI   CVCL_D0XZ ! HPS3154
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3151
AC   CVCL_D0XW
DR   RCB; HPS3151
DR   Wikidata; Q123032503
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XU ! HPS3149
OI   CVCL_D0XV ! HPS3150
OI   CVCL_D0XX ! HPS3152
OI   CVCL_D0XY ! HPS3153
OI   CVCL_D0XZ ! HPS3154
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3152
AC   CVCL_D0XX
DR   RCB; HPS3152
DR   Wikidata; Q123032504
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XU ! HPS3149
OI   CVCL_D0XV ! HPS3150
OI   CVCL_D0XW ! HPS3151
OI   CVCL_D0XY ! HPS3153
OI   CVCL_D0XZ ! HPS3154
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3153
AC   CVCL_D0XY
DR   RCB; HPS3153
DR   Wikidata; Q123032505
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XU ! HPS3149
OI   CVCL_D0XV ! HPS3150
OI   CVCL_D0XW ! HPS3151
OI   CVCL_D0XX ! HPS3152
OI   CVCL_D0XZ ! HPS3154
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3154
AC   CVCL_D0XZ
DR   RCB; HPS3154
DR   Wikidata; Q123032506
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0XU ! HPS3149
OI   CVCL_D0XV ! HPS3150
OI   CVCL_D0XW ! HPS3151
OI   CVCL_D0XX ! HPS3152
OI   CVCL_D0XY ! HPS3153
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3155
AC   CVCL_D0Y0
DR   RCB; HPS3155
DR   Wikidata; Q123032507
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y1 ! HPS3156
OI   CVCL_D0Y2 ! HPS3157
OI   CVCL_D0Y3 ! HPS3158
OI   CVCL_D0Y4 ! HPS3159
OI   CVCL_D0Y5 ! HPS3160
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3156
AC   CVCL_D0Y1
DR   RCB; HPS3156
DR   Wikidata; Q123032508
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y0 ! HPS3155
OI   CVCL_D0Y2 ! HPS3157
OI   CVCL_D0Y3 ! HPS3158
OI   CVCL_D0Y4 ! HPS3159
OI   CVCL_D0Y5 ! HPS3160
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3157
AC   CVCL_D0Y2
DR   RCB; HPS3157
DR   Wikidata; Q123032509
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y0 ! HPS3155
OI   CVCL_D0Y1 ! HPS3156
OI   CVCL_D0Y3 ! HPS3158
OI   CVCL_D0Y4 ! HPS3159
OI   CVCL_D0Y5 ! HPS3160
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3158
AC   CVCL_D0Y3
DR   RCB; HPS3158
DR   Wikidata; Q123032510
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y0 ! HPS3155
OI   CVCL_D0Y1 ! HPS3156
OI   CVCL_D0Y2 ! HPS3157
OI   CVCL_D0Y4 ! HPS3159
OI   CVCL_D0Y5 ! HPS3160
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3159
AC   CVCL_D0Y4
DR   RCB; HPS3159
DR   Wikidata; Q123032511
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y0 ! HPS3155
OI   CVCL_D0Y1 ! HPS3156
OI   CVCL_D0Y2 ! HPS3157
OI   CVCL_D0Y3 ! HPS3158
OI   CVCL_D0Y5 ! HPS3160
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3160
AC   CVCL_D0Y5
DR   RCB; HPS3160
DR   Wikidata; Q123032512
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y0 ! HPS3155
OI   CVCL_D0Y1 ! HPS3156
OI   CVCL_D0Y2 ! HPS3157
OI   CVCL_D0Y3 ! HPS3158
OI   CVCL_D0Y4 ! HPS3159
SX   Female
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3161
AC   CVCL_D0Y6
DR   RCB; HPS3161
DR   Wikidata; Q123032513
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3161).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y7 ! HPS3162
OI   CVCL_D0Y8 ! HPS3163
OI   CVCL_D0Y9 ! HPS3164
OI   CVCL_D0YA ! HPS3165
OI   CVCL_D0YB ! HPS3166
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3162
AC   CVCL_D0Y7
DR   RCB; HPS3162
DR   Wikidata; Q123032514
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3162).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y6 ! HPS3161
OI   CVCL_D0Y8 ! HPS3163
OI   CVCL_D0Y9 ! HPS3164
OI   CVCL_D0YA ! HPS3165
OI   CVCL_D0YB ! HPS3166
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HPS3163
AC   CVCL_D0Y8
DR   RCB; HPS3163
DR   Wikidata; Q123032515
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3163).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y6 ! HPS3161
OI   CVCL_D0Y7 ! HPS3162
OI   CVCL_D0Y9 ! HPS3164
OI   CVCL_D0YA ! HPS3165
OI   CVCL_D0YB ! HPS3166
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HPS3164
AC   CVCL_D0Y9
DR   RCB; HPS3164
DR   Wikidata; Q123032516
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3164).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y6 ! HPS3161
OI   CVCL_D0Y7 ! HPS3162
OI   CVCL_D0Y8 ! HPS3163
OI   CVCL_D0YA ! HPS3165
OI   CVCL_D0YB ! HPS3166
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HPS3165
AC   CVCL_D0YA
DR   RCB; HPS3165
DR   Wikidata; Q123032517
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3165).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y6 ! HPS3161
OI   CVCL_D0Y7 ! HPS3162
OI   CVCL_D0Y8 ! HPS3163
OI   CVCL_D0Y9 ! HPS3164
OI   CVCL_D0YB ! HPS3166
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HPS3166
AC   CVCL_D0YB
DR   RCB; HPS3166
DR   Wikidata; Q123032518
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3166).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Y6 ! HPS3161
OI   CVCL_D0Y7 ! HPS3162
OI   CVCL_D0Y8 ! HPS3163
OI   CVCL_D0Y9 ! HPS3164
OI   CVCL_D0YA ! HPS3165
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   HPS3167
AC   CVCL_D0YC
DR   RCB; HPS3167
DR   Wikidata; Q123032519
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78350; Hypoparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YD ! HPS3168
OI   CVCL_D0YE ! HPS3169
OI   CVCL_D0YF ! HPS3170
OI   CVCL_D0YG ! HPS3171
OI   CVCL_D0YH ! HPS3172
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3168
AC   CVCL_D0YD
DR   RCB; HPS3168
DR   Wikidata; Q123032521
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78350; Hypoparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YC ! HPS3167
OI   CVCL_D0YE ! HPS3169
OI   CVCL_D0YF ! HPS3170
OI   CVCL_D0YG ! HPS3171
OI   CVCL_D0YH ! HPS3172
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3169
AC   CVCL_D0YE
DR   RCB; HPS3169
DR   Wikidata; Q123032522
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78350; Hypoparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YC ! HPS3167
OI   CVCL_D0YD ! HPS3168
OI   CVCL_D0YF ! HPS3170
OI   CVCL_D0YG ! HPS3171
OI   CVCL_D0YH ! HPS3172
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3170
AC   CVCL_D0YF
DR   RCB; HPS3170
DR   Wikidata; Q123032523
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78350; Hypoparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YC ! HPS3167
OI   CVCL_D0YD ! HPS3168
OI   CVCL_D0YE ! HPS3169
OI   CVCL_D0YG ! HPS3171
OI   CVCL_D0YH ! HPS3172
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3171
AC   CVCL_D0YG
DR   RCB; HPS3171
DR   Wikidata; Q123032524
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78350; Hypoparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YC ! HPS3167
OI   CVCL_D0YD ! HPS3168
OI   CVCL_D0YE ! HPS3169
OI   CVCL_D0YF ! HPS3170
OI   CVCL_D0YH ! HPS3172
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3172
AC   CVCL_D0YH
DR   RCB; HPS3172
DR   Wikidata; Q123032525
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C78350; Hypoparathyroidism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YC ! HPS3167
OI   CVCL_D0YD ! HPS3168
OI   CVCL_D0YE ! HPS3169
OI   CVCL_D0YF ! HPS3170
OI   CVCL_D0YG ! HPS3171
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3173
AC   CVCL_D0YI
DR   RCB; HPS3173
DR   Wikidata; Q123032526
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3096; Hepatitis A infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YJ ! HPS3174
OI   CVCL_D0YK ! HPS3175
OI   CVCL_D0YL ! HPS3176
OI   CVCL_D0YM ! HPS3177
OI   CVCL_D0YN ! HPS3178
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3174
AC   CVCL_D0YJ
DR   RCB; HPS3174
DR   Wikidata; Q123032527
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3096; Hepatitis A infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YI ! HPS3173
OI   CVCL_D0YK ! HPS3175
OI   CVCL_D0YL ! HPS3176
OI   CVCL_D0YM ! HPS3177
OI   CVCL_D0YN ! HPS3178
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3175
AC   CVCL_D0YK
DR   RCB; HPS3175
DR   Wikidata; Q123032528
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3096; Hepatitis A infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YI ! HPS3173
OI   CVCL_D0YJ ! HPS3174
OI   CVCL_D0YL ! HPS3176
OI   CVCL_D0YM ! HPS3177
OI   CVCL_D0YN ! HPS3178
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3176
AC   CVCL_D0YL
DR   RCB; HPS3176
DR   Wikidata; Q123032529
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3096; Hepatitis A infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YI ! HPS3173
OI   CVCL_D0YJ ! HPS3174
OI   CVCL_D0YK ! HPS3175
OI   CVCL_D0YM ! HPS3177
OI   CVCL_D0YN ! HPS3178
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3177
AC   CVCL_D0YM
DR   RCB; HPS3177
DR   Wikidata; Q123032530
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3096; Hepatitis A infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YI ! HPS3173
OI   CVCL_D0YJ ! HPS3174
OI   CVCL_D0YK ! HPS3175
OI   CVCL_D0YL ! HPS3176
OI   CVCL_D0YN ! HPS3178
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3178
AC   CVCL_D0YN
DR   RCB; HPS3178
DR   Wikidata; Q123032531
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3096; Hepatitis A infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YI ! HPS3173
OI   CVCL_D0YJ ! HPS3174
OI   CVCL_D0YK ! HPS3175
OI   CVCL_D0YL ! HPS3176
OI   CVCL_D0YM ! HPS3177
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3179
AC   CVCL_A3KE
DR   RCB; HPS3179
DR   Wikidata; Q105509105
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3179).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KF ! HPS3180
OI   CVCL_A3KG ! HPS3181
OI   CVCL_A3KH ! HPS3182
OI   CVCL_A3KI ! HPS3183
OI   CVCL_A3KJ ! HPS3184
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS3180
AC   CVCL_A3KF
DR   RCB; HPS3180
DR   Wikidata; Q105509106
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3180).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KE ! HPS3179
OI   CVCL_A3KG ! HPS3181
OI   CVCL_A3KH ! HPS3182
OI   CVCL_A3KI ! HPS3183
OI   CVCL_A3KJ ! HPS3184
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS3181
AC   CVCL_A3KG
DR   RCB; HPS3181
DR   Wikidata; Q105509109
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3181).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KE ! HPS3179
OI   CVCL_A3KF ! HPS3180
OI   CVCL_A3KH ! HPS3182
OI   CVCL_A3KI ! HPS3183
OI   CVCL_A3KJ ! HPS3184
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS3182
AC   CVCL_A3KH
DR   RCB; HPS3182
DR   Wikidata; Q105509112
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3182).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KE ! HPS3179
OI   CVCL_A3KF ! HPS3180
OI   CVCL_A3KG ! HPS3181
OI   CVCL_A3KI ! HPS3183
OI   CVCL_A3KJ ! HPS3184
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS3183
AC   CVCL_A3KI
DR   RCB; HPS3183
DR   Wikidata; Q105509114
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3183).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KE ! HPS3179
OI   CVCL_A3KF ! HPS3180
OI   CVCL_A3KG ! HPS3181
OI   CVCL_A3KH ! HPS3182
OI   CVCL_A3KJ ! HPS3184
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS3184
AC   CVCL_A3KJ
DR   RCB; HPS3184
DR   Wikidata; Q105509116
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3184).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KE ! HPS3179
OI   CVCL_A3KF ! HPS3180
OI   CVCL_A3KG ! HPS3181
OI   CVCL_A3KH ! HPS3182
OI   CVCL_A3KI ! HPS3183
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HPS3185
AC   CVCL_D0YP
DR   RCB; HPS3185
DR   Wikidata; Q123032532
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YQ ! HPS3186
OI   CVCL_D0YR ! HPS3187
OI   CVCL_D0YS ! HPS3188
OI   CVCL_D0YT ! HPS3189
OI   CVCL_D0YU ! HPS3190
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3186
AC   CVCL_D0YQ
DR   RCB; HPS3186
DR   Wikidata; Q123032533
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YP ! HPS3185
OI   CVCL_D0YR ! HPS3187
OI   CVCL_D0YS ! HPS3188
OI   CVCL_D0YT ! HPS3189
OI   CVCL_D0YU ! HPS3190
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3187
AC   CVCL_D0YR
DR   RCB; HPS3187
DR   Wikidata; Q123032535
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YP ! HPS3185
OI   CVCL_D0YQ ! HPS3186
OI   CVCL_D0YS ! HPS3188
OI   CVCL_D0YT ! HPS3189
OI   CVCL_D0YU ! HPS3190
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3188
AC   CVCL_D0YS
DR   RCB; HPS3188
DR   Wikidata; Q123032536
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YP ! HPS3185
OI   CVCL_D0YQ ! HPS3186
OI   CVCL_D0YR ! HPS3187
OI   CVCL_D0YT ! HPS3189
OI   CVCL_D0YU ! HPS3190
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3189
AC   CVCL_D0YT
DR   RCB; HPS3189
DR   Wikidata; Q123032537
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YP ! HPS3185
OI   CVCL_D0YQ ! HPS3186
OI   CVCL_D0YR ! HPS3187
OI   CVCL_D0YS ! HPS3188
OI   CVCL_D0YU ! HPS3190
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3190
AC   CVCL_D0YU
DR   RCB; HPS3190
DR   Wikidata; Q123032538
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YP ! HPS3185
OI   CVCL_D0YQ ! HPS3186
OI   CVCL_D0YR ! HPS3187
OI   CVCL_D0YS ! HPS3188
OI   CVCL_D0YT ! HPS3189
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3191
AC   CVCL_D0YV
DR   RCB; HPS3191
DR   Wikidata; Q123032539
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   NCIt; C34908; Pemphigoid
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YW ! HPS3192
OI   CVCL_D0YX ! HPS3193
OI   CVCL_D0YY ! HPS3194
OI   CVCL_D0YZ ! HPS3195
OI   CVCL_D0Z0 ! HPS3196
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3192
AC   CVCL_D0YW
DR   RCB; HPS3192
DR   Wikidata; Q123032540
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   NCIt; C34908; Pemphigoid
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YV ! HPS3191
OI   CVCL_D0YX ! HPS3193
OI   CVCL_D0YY ! HPS3194
OI   CVCL_D0YZ ! HPS3195
OI   CVCL_D0Z0 ! HPS3196
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3193
AC   CVCL_D0YX
DR   RCB; HPS3193
DR   Wikidata; Q123032541
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   NCIt; C34908; Pemphigoid
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YV ! HPS3191
OI   CVCL_D0YW ! HPS3192
OI   CVCL_D0YY ! HPS3194
OI   CVCL_D0YZ ! HPS3195
OI   CVCL_D0Z0 ! HPS3196
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3194
AC   CVCL_D0YY
DR   RCB; HPS3194
DR   Wikidata; Q123032542
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   NCIt; C34908; Pemphigoid
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YV ! HPS3191
OI   CVCL_D0YW ! HPS3192
OI   CVCL_D0YX ! HPS3193
OI   CVCL_D0YZ ! HPS3195
OI   CVCL_D0Z0 ! HPS3196
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3195
AC   CVCL_D0YZ
DR   RCB; HPS3195
DR   Wikidata; Q123032543
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   NCIt; C34908; Pemphigoid
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YV ! HPS3191
OI   CVCL_D0YW ! HPS3192
OI   CVCL_D0YX ! HPS3193
OI   CVCL_D0YY ! HPS3194
OI   CVCL_D0Z0 ! HPS3196
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3196
AC   CVCL_D0Z0
DR   RCB; HPS3196
DR   Wikidata; Q123032544
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61283; Antiphospholipid syndrome
DI   NCIt; C34908; Pemphigoid
DI   ORDO; Orphanet_80; Antiphospholipid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0YV ! HPS3191
OI   CVCL_D0YW ! HPS3192
OI   CVCL_D0YX ! HPS3193
OI   CVCL_D0YY ! HPS3194
OI   CVCL_D0YZ ! HPS3195
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3197
AC   CVCL_D0Z1
DR   RCB; HPS3197
DR   Wikidata; Q123032545
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z2 ! HPS3198
OI   CVCL_D0Z3 ! HPS3199
OI   CVCL_D0Z4 ! HPS3200
OI   CVCL_D0Z5 ! HPS3201
OI   CVCL_D0Z6 ! HPS3202
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3198
AC   CVCL_D0Z2
DR   RCB; HPS3198
DR   Wikidata; Q123032546
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z1 ! HPS3197
OI   CVCL_D0Z3 ! HPS3199
OI   CVCL_D0Z4 ! HPS3200
OI   CVCL_D0Z5 ! HPS3201
OI   CVCL_D0Z6 ! HPS3202
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3199
AC   CVCL_D0Z3
DR   RCB; HPS3199
DR   Wikidata; Q123032547
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z1 ! HPS3197
OI   CVCL_D0Z2 ! HPS3198
OI   CVCL_D0Z4 ! HPS3200
OI   CVCL_D0Z5 ! HPS3201
OI   CVCL_D0Z6 ! HPS3202
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3200
AC   CVCL_D0Z4
DR   RCB; HPS3200
DR   Wikidata; Q123032548
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z1 ! HPS3197
OI   CVCL_D0Z2 ! HPS3198
OI   CVCL_D0Z3 ! HPS3199
OI   CVCL_D0Z5 ! HPS3201
OI   CVCL_D0Z6 ! HPS3202
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3201
AC   CVCL_D0Z5
DR   RCB; HPS3201
DR   Wikidata; Q123032549
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z1 ! HPS3197
OI   CVCL_D0Z2 ! HPS3198
OI   CVCL_D0Z3 ! HPS3199
OI   CVCL_D0Z4 ! HPS3200
OI   CVCL_D0Z6 ! HPS3202
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3202
AC   CVCL_D0Z6
DR   RCB; HPS3202
DR   Wikidata; Q123032550
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z1 ! HPS3197
OI   CVCL_D0Z2 ! HPS3198
OI   CVCL_D0Z3 ! HPS3199
OI   CVCL_D0Z4 ! HPS3200
OI   CVCL_D0Z5 ! HPS3201
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3209
AC   CVCL_D0Z7
DR   RCB; HPS3209
DR   Wikidata; Q123032551
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3209).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z8 ! HPS3210
OI   CVCL_D0Z9 ! HPS3211
OI   CVCL_D0ZA ! HPS3212
OI   CVCL_D0ZB ! HPS3213
OI   CVCL_D0ZC ! HPS3214
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3210
AC   CVCL_D0Z8
DR   RCB; HPS3210
DR   Wikidata; Q123032552
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3210).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z7 ! HPS3209
OI   CVCL_D0Z9 ! HPS3211
OI   CVCL_D0ZA ! HPS3212
OI   CVCL_D0ZB ! HPS3213
OI   CVCL_D0ZC ! HPS3214
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3211
AC   CVCL_D0Z9
DR   RCB; HPS3211
DR   Wikidata; Q123032553
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3211).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z7 ! HPS3209
OI   CVCL_D0Z8 ! HPS3210
OI   CVCL_D0ZA ! HPS3212
OI   CVCL_D0ZB ! HPS3213
OI   CVCL_D0ZC ! HPS3214
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3212
AC   CVCL_D0ZA
DR   RCB; HPS3212
DR   Wikidata; Q123032555
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3212).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z7 ! HPS3209
OI   CVCL_D0Z8 ! HPS3210
OI   CVCL_D0Z9 ! HPS3211
OI   CVCL_D0ZB ! HPS3213
OI   CVCL_D0ZC ! HPS3214
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3213
AC   CVCL_D0ZB
DR   RCB; HPS3213
DR   Wikidata; Q123032556
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3213).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z7 ! HPS3209
OI   CVCL_D0Z8 ! HPS3210
OI   CVCL_D0Z9 ! HPS3211
OI   CVCL_D0ZA ! HPS3212
OI   CVCL_D0ZC ! HPS3214
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3214
AC   CVCL_D0ZC
DR   RCB; HPS3214
DR   Wikidata; Q123032558
CC   Sequence variation: Mutation; HGNC; HGNC:2211; COL6A1; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3214).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126688; Bethlem myopathy 1
DI   ORDO; Orphanet_610; Bethlem myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0Z7 ! HPS3209
OI   CVCL_D0Z8 ! HPS3210
OI   CVCL_D0Z9 ! HPS3211
OI   CVCL_D0ZA ! HPS3212
OI   CVCL_D0ZB ! HPS3213
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3215
AC   CVCL_C6DP
DR   RCB; HPS3215
DR   Wikidata; Q116049500
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3215).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DQ ! HPS3216
OI   CVCL_C6DR ! HPS3217
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3216
AC   CVCL_C6DQ
DR   RCB; HPS3216
DR   Wikidata; Q116049501
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3216).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DP ! HPS3215
OI   CVCL_C6DR ! HPS3217
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3217
AC   CVCL_C6DR
DR   RCB; HPS3217
DR   Wikidata; Q116049502
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Unexplicit; Not described; Zygosity=Unspecified (RCB=HPS3217).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6DP ! HPS3215
OI   CVCL_C6DQ ! HPS3216
SX   Female
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HPS3218
AC   CVCL_D0ZD
DR   RCB; HPS3218
DR   Wikidata; Q123032559
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202116; Diffuse panbronchiolitis
DI   ORDO; Orphanet_171700; Diffuse panbronchiolitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZE ! HPS3219
OI   CVCL_D0ZF ! HPS3220
OI   CVCL_D0ZG ! HPS3221
OI   CVCL_D0ZH ! HPS3222
OI   CVCL_D0ZI ! HPS3223
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3219
AC   CVCL_D0ZE
DR   RCB; HPS3219
DR   Wikidata; Q123032560
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202116; Diffuse panbronchiolitis
DI   ORDO; Orphanet_171700; Diffuse panbronchiolitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZD ! HPS3218
OI   CVCL_D0ZF ! HPS3220
OI   CVCL_D0ZG ! HPS3221
OI   CVCL_D0ZH ! HPS3222
OI   CVCL_D0ZI ! HPS3223
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3220
AC   CVCL_D0ZF
DR   RCB; HPS3220
DR   Wikidata; Q123032561
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202116; Diffuse panbronchiolitis
DI   ORDO; Orphanet_171700; Diffuse panbronchiolitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZD ! HPS3218
OI   CVCL_D0ZE ! HPS3219
OI   CVCL_D0ZG ! HPS3221
OI   CVCL_D0ZH ! HPS3222
OI   CVCL_D0ZI ! HPS3223
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3221
AC   CVCL_D0ZG
DR   RCB; HPS3221
DR   Wikidata; Q123032562
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202116; Diffuse panbronchiolitis
DI   ORDO; Orphanet_171700; Diffuse panbronchiolitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZD ! HPS3218
OI   CVCL_D0ZE ! HPS3219
OI   CVCL_D0ZF ! HPS3220
OI   CVCL_D0ZH ! HPS3222
OI   CVCL_D0ZI ! HPS3223
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3222
AC   CVCL_D0ZH
DR   RCB; HPS3222
DR   Wikidata; Q123032563
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202116; Diffuse panbronchiolitis
DI   ORDO; Orphanet_171700; Diffuse panbronchiolitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZD ! HPS3218
OI   CVCL_D0ZE ! HPS3219
OI   CVCL_D0ZF ! HPS3220
OI   CVCL_D0ZG ! HPS3221
OI   CVCL_D0ZI ! HPS3223
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3223
AC   CVCL_D0ZI
DR   RCB; HPS3223
DR   Wikidata; Q123032564
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202116; Diffuse panbronchiolitis
DI   ORDO; Orphanet_171700; Diffuse panbronchiolitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZD ! HPS3218
OI   CVCL_D0ZE ! HPS3219
OI   CVCL_D0ZF ! HPS3220
OI   CVCL_D0ZG ! HPS3221
OI   CVCL_D0ZH ! HPS3222
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3224
AC   CVCL_A3KK
DR   RCB; HPS3224
DR   Wikidata; Q105509119
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84788; West syndrome
DI   ORDO; Orphanet_3451; Infantile spasms syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KL ! HPS3225
OI   CVCL_A3KM ! HPS3226
OI   CVCL_A3KN ! HPS3227
OI   CVCL_A3KP ! HPS3228
OI   CVCL_A3KQ ! HPS3229
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   HPS3225
AC   CVCL_A3KL
DR   RCB; HPS3225
DR   Wikidata; Q105509121
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84788; West syndrome
DI   ORDO; Orphanet_3451; Infantile spasms syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KK ! HPS3224
OI   CVCL_A3KM ! HPS3226
OI   CVCL_A3KN ! HPS3227
OI   CVCL_A3KP ! HPS3228
OI   CVCL_A3KQ ! HPS3229
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   HPS3226
AC   CVCL_A3KM
DR   RCB; HPS3226
DR   Wikidata; Q105509124
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84788; West syndrome
DI   ORDO; Orphanet_3451; Infantile spasms syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KK ! HPS3224
OI   CVCL_A3KL ! HPS3225
OI   CVCL_A3KN ! HPS3227
OI   CVCL_A3KP ! HPS3228
OI   CVCL_A3KQ ! HPS3229
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   HPS3227
AC   CVCL_A3KN
DR   RCB; HPS3227
DR   Wikidata; Q105509128
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84788; West syndrome
DI   ORDO; Orphanet_3451; Infantile spasms syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KK ! HPS3224
OI   CVCL_A3KL ! HPS3225
OI   CVCL_A3KM ! HPS3226
OI   CVCL_A3KP ! HPS3228
OI   CVCL_A3KQ ! HPS3229
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   HPS3228
AC   CVCL_A3KP
DR   RCB; HPS3228
DR   Wikidata; Q105509131
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84788; West syndrome
DI   ORDO; Orphanet_3451; Infantile spasms syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KK ! HPS3224
OI   CVCL_A3KL ! HPS3225
OI   CVCL_A3KM ! HPS3226
OI   CVCL_A3KN ! HPS3227
OI   CVCL_A3KQ ! HPS3229
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   HPS3229
AC   CVCL_A3KQ
DR   RCB; HPS3229
DR   Wikidata; Q105509134
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84788; West syndrome
DI   ORDO; Orphanet_3451; Infantile spasms syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KK ! HPS3224
OI   CVCL_A3KL ! HPS3225
OI   CVCL_A3KM ! HPS3226
OI   CVCL_A3KN ! HPS3227
OI   CVCL_A3KP ! HPS3228
SX   Male
AG   6-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   HPS3236
AC   CVCL_D0ZJ
DR   RCB; HPS3236
DR   Wikidata; Q123032565
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Unspecified (RCB=HPS3236).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZK ! HPS3237
OI   CVCL_D0ZL ! HPS3238
OI   CVCL_D0ZM ! HPS3239
OI   CVCL_D0ZN ! HPS3240
OI   CVCL_D0ZP ! HPS3241
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3237
AC   CVCL_D0ZK
DR   RCB; HPS3237
DR   Wikidata; Q123032566
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Unspecified (RCB=HPS3237).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZJ ! HPS3236
OI   CVCL_D0ZL ! HPS3238
OI   CVCL_D0ZM ! HPS3239
OI   CVCL_D0ZN ! HPS3240
OI   CVCL_D0ZP ! HPS3241
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3238
AC   CVCL_D0ZL
DR   RCB; HPS3238
DR   Wikidata; Q123032567
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Unspecified (RCB=HPS3238).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZJ ! HPS3236
OI   CVCL_D0ZK ! HPS3237
OI   CVCL_D0ZM ! HPS3239
OI   CVCL_D0ZN ! HPS3240
OI   CVCL_D0ZP ! HPS3241
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3239
AC   CVCL_D0ZM
DR   RCB; HPS3239
DR   Wikidata; Q123032568
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Unspecified (RCB=HPS3239).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZJ ! HPS3236
OI   CVCL_D0ZK ! HPS3237
OI   CVCL_D0ZL ! HPS3238
OI   CVCL_D0ZN ! HPS3240
OI   CVCL_D0ZP ! HPS3241
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3240
AC   CVCL_D0ZN
DR   RCB; HPS3240
DR   Wikidata; Q123032569
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Unspecified (RCB=HPS3240).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZJ ! HPS3236
OI   CVCL_D0ZK ! HPS3237
OI   CVCL_D0ZL ! HPS3238
OI   CVCL_D0ZM ! HPS3239
OI   CVCL_D0ZP ! HPS3241
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3241
AC   CVCL_D0ZP
DR   RCB; HPS3241
DR   Wikidata; Q123032570
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Unspecified (RCB=HPS3241).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ZJ ! HPS3236
OI   CVCL_D0ZK ! HPS3237
OI   CVCL_D0ZL ! HPS3238
OI   CVCL_D0ZM ! HPS3239
OI   CVCL_D0ZN ! HPS3240
SX   Male
AG   20-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HPS3242
AC   CVCL_YS87
DR   RCB; HPS3242
DR   Wikidata; Q94220480
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS88 ! HPS3243
OI   CVCL_YS89 ! HPS3244
OI   CVCL_YS90 ! HPS3245
OI   CVCL_YS91 ! HPS3246
OI   CVCL_YS92 ! HPS3247
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3243
AC   CVCL_YS88
DR   RCB; HPS3243
DR   Wikidata; Q94220483
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS87 ! HPS3242
OI   CVCL_YS89 ! HPS3244
OI   CVCL_YS90 ! HPS3245
OI   CVCL_YS91 ! HPS3246
OI   CVCL_YS92 ! HPS3247
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3244
AC   CVCL_YS89
DR   RCB; HPS3244
DR   Wikidata; Q94220489
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS87 ! HPS3242
OI   CVCL_YS88 ! HPS3243
OI   CVCL_YS90 ! HPS3245
OI   CVCL_YS91 ! HPS3246
OI   CVCL_YS92 ! HPS3247
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3245
AC   CVCL_YS90
DR   RCB; HPS3245
DR   Wikidata; Q94220493
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS87 ! HPS3242
OI   CVCL_YS88 ! HPS3243
OI   CVCL_YS89 ! HPS3244
OI   CVCL_YS91 ! HPS3246
OI   CVCL_YS92 ! HPS3247
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3246
AC   CVCL_YS91
DR   RCB; HPS3246
DR   Wikidata; Q94220497
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS87 ! HPS3242
OI   CVCL_YS88 ! HPS3243
OI   CVCL_YS89 ! HPS3244
OI   CVCL_YS90 ! HPS3245
OI   CVCL_YS92 ! HPS3247
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3247
AC   CVCL_YS92
DR   RCB; HPS3247
DR   Wikidata; Q94220501
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS87 ! HPS3242
OI   CVCL_YS88 ! HPS3243
OI   CVCL_YS89 ! HPS3244
OI   CVCL_YS90 ! HPS3245
OI   CVCL_YS91 ! HPS3246
SX   Male
AG   <10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3248
AC   CVCL_D1B7
DR   RCB; HPS3248
DR   Wikidata; Q123032571
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B8 ! HPS3249
OI   CVCL_D1B9 ! HPS3250
OI   CVCL_D1BA ! HPS3251
OI   CVCL_D1BB ! HPS3252
OI   CVCL_D1BC ! HPS3253
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3249
AC   CVCL_D1B8
DR   RCB; HPS3249
DR   Wikidata; Q123032572
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B7 ! HPS3248
OI   CVCL_D1B9 ! HPS3250
OI   CVCL_D1BA ! HPS3251
OI   CVCL_D1BB ! HPS3252
OI   CVCL_D1BC ! HPS3253
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3250
AC   CVCL_D1B9
DR   RCB; HPS3250
DR   Wikidata; Q123032573
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B7 ! HPS3248
OI   CVCL_D1B8 ! HPS3249
OI   CVCL_D1BA ! HPS3251
OI   CVCL_D1BB ! HPS3252
OI   CVCL_D1BC ! HPS3253
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3251
AC   CVCL_D1BA
DR   RCB; HPS3251
DR   Wikidata; Q123032574
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B7 ! HPS3248
OI   CVCL_D1B8 ! HPS3249
OI   CVCL_D1B9 ! HPS3250
OI   CVCL_D1BB ! HPS3252
OI   CVCL_D1BC ! HPS3253
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3252
AC   CVCL_D1BB
DR   RCB; HPS3252
DR   Wikidata; Q123032576
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B7 ! HPS3248
OI   CVCL_D1B8 ! HPS3249
OI   CVCL_D1B9 ! HPS3250
OI   CVCL_D1BA ! HPS3251
OI   CVCL_D1BC ! HPS3253
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3253
AC   CVCL_D1BC
DR   RCB; HPS3253
DR   Wikidata; Q123032577
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1B7 ! HPS3248
OI   CVCL_D1B8 ! HPS3249
OI   CVCL_D1B9 ! HPS3250
OI   CVCL_D1BA ! HPS3251
OI   CVCL_D1BB ! HPS3252
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3254
AC   CVCL_D1BD
DR   RCB; HPS3254
DR   Wikidata; Q123032578
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BE ! HPS3255
OI   CVCL_D1BF ! HPS3256
OI   CVCL_D1BG ! HPS3257
OI   CVCL_D1BH ! HPS3258
OI   CVCL_D1BI ! HPS3259
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3255
AC   CVCL_D1BE
DR   RCB; HPS3255
DR   Wikidata; Q123032579
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BD ! HPS3254
OI   CVCL_D1BF ! HPS3256
OI   CVCL_D1BG ! HPS3257
OI   CVCL_D1BH ! HPS3258
OI   CVCL_D1BI ! HPS3259
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3256
AC   CVCL_D1BF
DR   RCB; HPS3256
DR   Wikidata; Q123032580
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BD ! HPS3254
OI   CVCL_D1BE ! HPS3255
OI   CVCL_D1BG ! HPS3257
OI   CVCL_D1BH ! HPS3258
OI   CVCL_D1BI ! HPS3259
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3257
AC   CVCL_D1BG
DR   RCB; HPS3257
DR   Wikidata; Q123032581
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BD ! HPS3254
OI   CVCL_D1BE ! HPS3255
OI   CVCL_D1BF ! HPS3256
OI   CVCL_D1BH ! HPS3258
OI   CVCL_D1BI ! HPS3259
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3258
AC   CVCL_D1BH
DR   RCB; HPS3258
DR   Wikidata; Q123032582
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BD ! HPS3254
OI   CVCL_D1BE ! HPS3255
OI   CVCL_D1BF ! HPS3256
OI   CVCL_D1BG ! HPS3257
OI   CVCL_D1BI ! HPS3259
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3259
AC   CVCL_D1BI
DR   RCB; HPS3259
DR   Wikidata; Q123032583
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BD ! HPS3254
OI   CVCL_D1BE ! HPS3255
OI   CVCL_D1BF ! HPS3256
OI   CVCL_D1BG ! HPS3257
OI   CVCL_D1BH ! HPS3258
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3260
AC   CVCL_D1BJ
DR   RCB; HPS3260
DR   Wikidata; Q123032584
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179057; Primary hypertrophic osteoarthropathy, autosomal recessive type 1
DI   ORDO; Orphanet_2796; Pachydermoperiostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BK ! HPS3261
OI   CVCL_D1BL ! HPS3262
OI   CVCL_D1BM ! HPS3263
OI   CVCL_D1BN ! HPS3264
OI   CVCL_D1BP ! HPS3265
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3261
AC   CVCL_D1BK
DR   RCB; HPS3261
DR   Wikidata; Q123032585
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179057; Primary hypertrophic osteoarthropathy, autosomal recessive type 1
DI   ORDO; Orphanet_2796; Pachydermoperiostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BJ ! HPS3260
OI   CVCL_D1BL ! HPS3262
OI   CVCL_D1BM ! HPS3263
OI   CVCL_D1BN ! HPS3264
OI   CVCL_D1BP ! HPS3265
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3262
AC   CVCL_D1BL
DR   RCB; HPS3262
DR   Wikidata; Q123032586
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179057; Primary hypertrophic osteoarthropathy, autosomal recessive type 1
DI   ORDO; Orphanet_2796; Pachydermoperiostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BJ ! HPS3260
OI   CVCL_D1BK ! HPS3261
OI   CVCL_D1BM ! HPS3263
OI   CVCL_D1BN ! HPS3264
OI   CVCL_D1BP ! HPS3265
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3263
AC   CVCL_D1BM
DR   RCB; HPS3263
DR   Wikidata; Q123032587
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179057; Primary hypertrophic osteoarthropathy, autosomal recessive type 1
DI   ORDO; Orphanet_2796; Pachydermoperiostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BJ ! HPS3260
OI   CVCL_D1BK ! HPS3261
OI   CVCL_D1BL ! HPS3262
OI   CVCL_D1BN ! HPS3264
OI   CVCL_D1BP ! HPS3265
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3264
AC   CVCL_D1BN
DR   RCB; HPS3264
DR   Wikidata; Q123032588
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179057; Primary hypertrophic osteoarthropathy, autosomal recessive type 1
DI   ORDO; Orphanet_2796; Pachydermoperiostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BJ ! HPS3260
OI   CVCL_D1BK ! HPS3261
OI   CVCL_D1BL ! HPS3262
OI   CVCL_D1BM ! HPS3263
OI   CVCL_D1BP ! HPS3265
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3265
AC   CVCL_D1BP
DR   RCB; HPS3265
DR   Wikidata; Q123032589
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179057; Primary hypertrophic osteoarthropathy, autosomal recessive type 1
DI   ORDO; Orphanet_2796; Pachydermoperiostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BJ ! HPS3260
OI   CVCL_D1BK ! HPS3261
OI   CVCL_D1BL ! HPS3262
OI   CVCL_D1BM ! HPS3263
OI   CVCL_D1BN ! HPS3264
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3266
AC   CVCL_D1BQ
DR   RCB; HPS3266
DR   Wikidata; Q123032590
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202121; Generalized pustular psoriasis
DI   ORDO; Orphanet_247353; Generalized pustular psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BR ! HPS3267
OI   CVCL_D1BS ! HPS3268
OI   CVCL_D1BT ! HPS3269
OI   CVCL_D1BU ! HPS3270
OI   CVCL_D1BV ! HPS3271
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3267
AC   CVCL_D1BR
DR   RCB; HPS3267
DR   Wikidata; Q123032591
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202121; Generalized pustular psoriasis
DI   ORDO; Orphanet_247353; Generalized pustular psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BQ ! HPS3266
OI   CVCL_D1BS ! HPS3268
OI   CVCL_D1BT ! HPS3269
OI   CVCL_D1BU ! HPS3270
OI   CVCL_D1BV ! HPS3271
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3268
AC   CVCL_D1BS
DR   RCB; HPS3268
DR   Wikidata; Q123032593
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202121; Generalized pustular psoriasis
DI   ORDO; Orphanet_247353; Generalized pustular psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BQ ! HPS3266
OI   CVCL_D1BR ! HPS3267
OI   CVCL_D1BT ! HPS3269
OI   CVCL_D1BU ! HPS3270
OI   CVCL_D1BV ! HPS3271
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3269
AC   CVCL_D1BT
DR   RCB; HPS3269
DR   Wikidata; Q123032594
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202121; Generalized pustular psoriasis
DI   ORDO; Orphanet_247353; Generalized pustular psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BQ ! HPS3266
OI   CVCL_D1BR ! HPS3267
OI   CVCL_D1BS ! HPS3268
OI   CVCL_D1BU ! HPS3270
OI   CVCL_D1BV ! HPS3271
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3270
AC   CVCL_D1BU
DR   RCB; HPS3270
DR   Wikidata; Q123032595
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202121; Generalized pustular psoriasis
DI   ORDO; Orphanet_247353; Generalized pustular psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BQ ! HPS3266
OI   CVCL_D1BR ! HPS3267
OI   CVCL_D1BS ! HPS3268
OI   CVCL_D1BT ! HPS3269
OI   CVCL_D1BV ! HPS3271
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3271
AC   CVCL_D1BV
DR   RCB; HPS3271
DR   Wikidata; Q123032596
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202121; Generalized pustular psoriasis
DI   ORDO; Orphanet_247353; Generalized pustular psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BQ ! HPS3266
OI   CVCL_D1BR ! HPS3267
OI   CVCL_D1BS ! HPS3268
OI   CVCL_D1BT ! HPS3269
OI   CVCL_D1BU ! HPS3270
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3272
AC   CVCL_D1BW
DR   RCB; HPS3272
DR   Wikidata; Q123032597
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BX ! HPS3273
OI   CVCL_D1BY ! HPS3274
OI   CVCL_D1BZ ! HPS3275
OI   CVCL_D1C0 ! HPS3276
OI   CVCL_D1C1 ! HPS3277
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3273
AC   CVCL_D1BX
DR   RCB; HPS3273
DR   Wikidata; Q123032598
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BW ! HPS3272
OI   CVCL_D1BY ! HPS3274
OI   CVCL_D1BZ ! HPS3275
OI   CVCL_D1C0 ! HPS3276
OI   CVCL_D1C1 ! HPS3277
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3274
AC   CVCL_D1BY
DR   RCB; HPS3274
DR   Wikidata; Q123032599
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BW ! HPS3272
OI   CVCL_D1BX ! HPS3273
OI   CVCL_D1BZ ! HPS3275
OI   CVCL_D1C0 ! HPS3276
OI   CVCL_D1C1 ! HPS3277
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3275
AC   CVCL_D1BZ
DR   RCB; HPS3275
DR   Wikidata; Q123032600
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BW ! HPS3272
OI   CVCL_D1BX ! HPS3273
OI   CVCL_D1BY ! HPS3274
OI   CVCL_D1C0 ! HPS3276
OI   CVCL_D1C1 ! HPS3277
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3276
AC   CVCL_D1C0
DR   RCB; HPS3276
DR   Wikidata; Q123032601
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BW ! HPS3272
OI   CVCL_D1BX ! HPS3273
OI   CVCL_D1BY ! HPS3274
OI   CVCL_D1BZ ! HPS3275
OI   CVCL_D1C1 ! HPS3277
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3277
AC   CVCL_D1C1
DR   RCB; HPS3277
DR   Wikidata; Q123032602
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1BW ! HPS3272
OI   CVCL_D1BX ! HPS3273
OI   CVCL_D1BY ! HPS3274
OI   CVCL_D1BZ ! HPS3275
OI   CVCL_D1C0 ! HPS3276
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3278
AC   CVCL_D1C2
DR   RCB; HPS3278
DR   Wikidata; Q123032604
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C3 ! HPS3279
OI   CVCL_D1C4 ! HPS3280
OI   CVCL_D1C5 ! HPS3281
OI   CVCL_D1C6 ! HPS3282
OI   CVCL_D1C7 ! HPS3283
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3279
AC   CVCL_D1C3
DR   RCB; HPS3279
DR   Wikidata; Q123032605
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C2 ! HPS3278
OI   CVCL_D1C4 ! HPS3280
OI   CVCL_D1C5 ! HPS3281
OI   CVCL_D1C6 ! HPS3282
OI   CVCL_D1C7 ! HPS3283
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3280
AC   CVCL_D1C4
DR   RCB; HPS3280
DR   Wikidata; Q123032606
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C2 ! HPS3278
OI   CVCL_D1C3 ! HPS3279
OI   CVCL_D1C5 ! HPS3281
OI   CVCL_D1C6 ! HPS3282
OI   CVCL_D1C7 ! HPS3283
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3281
AC   CVCL_D1C5
DR   RCB; HPS3281
DR   Wikidata; Q123032607
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C2 ! HPS3278
OI   CVCL_D1C3 ! HPS3279
OI   CVCL_D1C4 ! HPS3280
OI   CVCL_D1C6 ! HPS3282
OI   CVCL_D1C7 ! HPS3283
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3282
AC   CVCL_D1C6
DR   RCB; HPS3282
DR   Wikidata; Q123032608
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C2 ! HPS3278
OI   CVCL_D1C3 ! HPS3279
OI   CVCL_D1C4 ! HPS3280
OI   CVCL_D1C5 ! HPS3281
OI   CVCL_D1C7 ! HPS3283
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3283
AC   CVCL_D1C7
DR   RCB; HPS3283
DR   Wikidata; Q123032609
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C2 ! HPS3278
OI   CVCL_D1C3 ! HPS3279
OI   CVCL_D1C4 ! HPS3280
OI   CVCL_D1C5 ! HPS3281
OI   CVCL_D1C6 ! HPS3282
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3284
AC   CVCL_UP32
DR   RCB; HPS3284
DR   Wikidata; Q94220506
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YS19 ! HPS3285
OI   CVCL_YS20 ! HPS3286
OI   CVCL_YS21 ! HPS3287
OI   CVCL_YS22 ! HPS3288
OI   CVCL_YS23 ! HPS3289
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   HPS3285
AC   CVCL_YS19
DR   RCB; HPS3285
DR   Wikidata; Q94220509
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP32 ! HPS3284
OI   CVCL_YS20 ! HPS3286
OI   CVCL_YS21 ! HPS3287
OI   CVCL_YS22 ! HPS3288
OI   CVCL_YS23 ! HPS3289
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3286
AC   CVCL_YS20
DR   RCB; HPS3286
DR   Wikidata; Q94220515
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP32 ! HPS3284
OI   CVCL_YS19 ! HPS3285
OI   CVCL_YS21 ! HPS3287
OI   CVCL_YS22 ! HPS3288
OI   CVCL_YS23 ! HPS3289
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3287
AC   CVCL_YS21
DR   RCB; HPS3287
DR   Wikidata; Q94220519
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP32 ! HPS3284
OI   CVCL_YS19 ! HPS3285
OI   CVCL_YS20 ! HPS3286
OI   CVCL_YS22 ! HPS3288
OI   CVCL_YS23 ! HPS3289
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3288
AC   CVCL_YS22
DR   RCB; HPS3288
DR   Wikidata; Q94220524
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP32 ! HPS3284
OI   CVCL_YS19 ! HPS3285
OI   CVCL_YS20 ! HPS3286
OI   CVCL_YS21 ! HPS3287
OI   CVCL_YS23 ! HPS3289
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3289
AC   CVCL_YS23
DR   RCB; HPS3289
DR   Wikidata; Q94220529
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UP32 ! HPS3284
OI   CVCL_YS19 ! HPS3285
OI   CVCL_YS20 ! HPS3286
OI   CVCL_YS21 ! HPS3287
OI   CVCL_YS22 ! HPS3288
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HPS3290
AC   CVCL_D1C8
DR   RCB; HPS3290
DR   Wikidata; Q123032610
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C9 ! HPS3291
OI   CVCL_D1CA ! HPS3292
OI   CVCL_D1CB ! HPS3293
OI   CVCL_D1CC ! HPS3294
OI   CVCL_D1CD ! HPS3295
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3291
AC   CVCL_D1C9
DR   RCB; HPS3291
DR   Wikidata; Q123032611
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C8 ! HPS3290
OI   CVCL_D1CA ! HPS3292
OI   CVCL_D1CB ! HPS3293
OI   CVCL_D1CC ! HPS3294
OI   CVCL_D1CD ! HPS3295
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3292
AC   CVCL_D1CA
DR   RCB; HPS3292
DR   Wikidata; Q123032612
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C8 ! HPS3290
OI   CVCL_D1C9 ! HPS3291
OI   CVCL_D1CB ! HPS3293
OI   CVCL_D1CC ! HPS3294
OI   CVCL_D1CD ! HPS3295
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3293
AC   CVCL_D1CB
DR   RCB; HPS3293
DR   Wikidata; Q123032613
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C8 ! HPS3290
OI   CVCL_D1C9 ! HPS3291
OI   CVCL_D1CA ! HPS3292
OI   CVCL_D1CC ! HPS3294
OI   CVCL_D1CD ! HPS3295
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3294
AC   CVCL_D1CC
DR   RCB; HPS3294
DR   Wikidata; Q123032614
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C8 ! HPS3290
OI   CVCL_D1C9 ! HPS3291
OI   CVCL_D1CA ! HPS3292
OI   CVCL_D1CB ! HPS3293
OI   CVCL_D1CD ! HPS3295
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3295
AC   CVCL_D1CD
DR   RCB; HPS3295
DR   Wikidata; Q123032615
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3725; Lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1C8 ! HPS3290
OI   CVCL_D1C9 ! HPS3291
OI   CVCL_D1CA ! HPS3292
OI   CVCL_D1CB ! HPS3293
OI   CVCL_D1CC ! HPS3294
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3302
AC   CVCL_D1CK
DR   RCB; HPS3302
DR   Wikidata; Q123032616
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CL ! HPS3303
OI   CVCL_D1CM ! HPS3304
OI   CVCL_D1CN ! HPS3305
OI   CVCL_D1CP ! HPS3306
OI   CVCL_D1CQ ! HPS3307
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3303
AC   CVCL_D1CL
DR   RCB; HPS3303
DR   Wikidata; Q123032617
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CK ! HPS3302
OI   CVCL_D1CM ! HPS3304
OI   CVCL_D1CN ! HPS3305
OI   CVCL_D1CP ! HPS3306
OI   CVCL_D1CQ ! HPS3307
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3304
AC   CVCL_D1CM
DR   RCB; HPS3304
DR   Wikidata; Q123032618
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CK ! HPS3302
OI   CVCL_D1CL ! HPS3303
OI   CVCL_D1CN ! HPS3305
OI   CVCL_D1CP ! HPS3306
OI   CVCL_D1CQ ! HPS3307
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3305
AC   CVCL_D1CN
DR   RCB; HPS3305
DR   Wikidata; Q123032619
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CK ! HPS3302
OI   CVCL_D1CL ! HPS3303
OI   CVCL_D1CM ! HPS3304
OI   CVCL_D1CP ! HPS3306
OI   CVCL_D1CQ ! HPS3307
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3306
AC   CVCL_D1CP
DR   RCB; HPS3306
DR   Wikidata; Q123032620
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CK ! HPS3302
OI   CVCL_D1CL ! HPS3303
OI   CVCL_D1CM ! HPS3304
OI   CVCL_D1CN ! HPS3305
OI   CVCL_D1CQ ! HPS3307
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3307
AC   CVCL_D1CQ
DR   RCB; HPS3307
DR   Wikidata; Q123032621
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1CK ! HPS3302
OI   CVCL_D1CL ! HPS3303
OI   CVCL_D1CM ! HPS3304
OI   CVCL_D1CN ! HPS3305
OI   CVCL_D1CP ! HPS3306
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3314
AC   CVCL_D1EA
DR   RCB; HPS3314
DR   Wikidata; Q123032622
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EB ! HPS3315
OI   CVCL_D1EC ! HPS3316
OI   CVCL_D1ED ! HPS3317
OI   CVCL_D1EE ! HPS3318
OI   CVCL_D1EF ! HPS3319
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3315
AC   CVCL_D1EB
DR   RCB; HPS3315
DR   Wikidata; Q123032623
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EA ! HPS3314
OI   CVCL_D1EC ! HPS3316
OI   CVCL_D1ED ! HPS3317
OI   CVCL_D1EE ! HPS3318
OI   CVCL_D1EF ! HPS3319
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3316
AC   CVCL_D1EC
DR   RCB; HPS3316
DR   Wikidata; Q123032625
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EA ! HPS3314
OI   CVCL_D1EB ! HPS3315
OI   CVCL_D1ED ! HPS3317
OI   CVCL_D1EE ! HPS3318
OI   CVCL_D1EF ! HPS3319
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3317
AC   CVCL_D1ED
DR   RCB; HPS3317
DR   Wikidata; Q123032626
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EA ! HPS3314
OI   CVCL_D1EB ! HPS3315
OI   CVCL_D1EC ! HPS3316
OI   CVCL_D1EE ! HPS3318
OI   CVCL_D1EF ! HPS3319
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3318
AC   CVCL_D1EE
DR   RCB; HPS3318
DR   Wikidata; Q123032627
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EA ! HPS3314
OI   CVCL_D1EB ! HPS3315
OI   CVCL_D1EC ! HPS3316
OI   CVCL_D1ED ! HPS3317
OI   CVCL_D1EF ! HPS3319
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3319
AC   CVCL_D1EF
DR   RCB; HPS3319
DR   Wikidata; Q123032628
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EA ! HPS3314
OI   CVCL_D1EB ! HPS3315
OI   CVCL_D1EC ! HPS3316
OI   CVCL_D1ED ! HPS3317
OI   CVCL_D1EE ! HPS3318
SX   Male
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS3338
AC   CVCL_UN38
DR   RCB; HPS3338
DR   Wikidata; Q94220533
CC   HLA typing: A*02:06:01:04,24:02:01:01; B*40:02:01:01,48:01:01; C*03:04:01New,08:03:01; DPB1*05:01:0; DQB1*03:03:02,05:03:01New; DRB1*09:01:02,14:54:01:02New (RCB=HPS3338).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3XE ! HPS3339
OI   CVCL_A3XF ! HPS3340
OI   CVCL_A3XG ! HPS3341
OI   CVCL_A3XH ! HPS3342
OI   CVCL_A3XI ! HPS3343
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3339
AC   CVCL_A3XE
DR   RCB; HPS3339
DR   Wikidata; Q105509137
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN38 ! HPS3338
OI   CVCL_A3XF ! HPS3340
OI   CVCL_A3XG ! HPS3341
OI   CVCL_A3XH ! HPS3342
OI   CVCL_A3XI ! HPS3343
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3340
AC   CVCL_A3XF
DR   RCB; HPS3340
DR   Wikidata; Q105509140
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN38 ! HPS3338
OI   CVCL_A3XE ! HPS3339
OI   CVCL_A3XG ! HPS3341
OI   CVCL_A3XH ! HPS3342
OI   CVCL_A3XI ! HPS3343
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3341
AC   CVCL_A3XG
DR   RCB; HPS3341
DR   Wikidata; Q105509144
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN38 ! HPS3338
OI   CVCL_A3XE ! HPS3339
OI   CVCL_A3XF ! HPS3340
OI   CVCL_A3XH ! HPS3342
OI   CVCL_A3XI ! HPS3343
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3342
AC   CVCL_A3XH
DR   RCB; HPS3342
DR   Wikidata; Q105509147
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN38 ! HPS3338
OI   CVCL_A3XE ! HPS3339
OI   CVCL_A3XF ! HPS3340
OI   CVCL_A3XG ! HPS3341
OI   CVCL_A3XI ! HPS3343
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3343
AC   CVCL_A3XI
DR   RCB; HPS3343
DR   Wikidata; Q105509150
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN38 ! HPS3338
OI   CVCL_A3XE ! HPS3339
OI   CVCL_A3XF ! HPS3340
OI   CVCL_A3XG ! HPS3341
OI   CVCL_A3XH ! HPS3342
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3344
AC   CVCL_UN39
DR   RCB; HPS3344
DR   Wikidata; Q94220538
CC   HLA typing: A*02:01:01:01; B*40:06:01:01,54:01:01; C*01:02:01:05,08:01:01:01; DPB1*02:01:02,05:01:01; DQB1*03:03:02,04:01:01:02; DRB1*04:05:01:01,09:01:02 (RCB=HPS3344).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3XJ ! HPS3345
OI   CVCL_A3XK ! HPS3346
OI   CVCL_A3XL ! HPS3347
OI   CVCL_A3XM ! HPS3720
OI   CVCL_A3XN ! HPS3721
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3345
AC   CVCL_A3XJ
DR   RCB; HPS3345
DR   Wikidata; Q105509151
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN39 ! HPS3344
OI   CVCL_A3XK ! HPS3346
OI   CVCL_A3XL ! HPS3347
OI   CVCL_A3XM ! HPS3720
OI   CVCL_A3XN ! HPS3721
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3346
AC   CVCL_A3XK
DR   RCB; HPS3346
DR   Wikidata; Q105509154
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN39 ! HPS3344
OI   CVCL_A3XJ ! HPS3345
OI   CVCL_A3XL ! HPS3347
OI   CVCL_A3XM ! HPS3720
OI   CVCL_A3XN ! HPS3721
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3347
AC   CVCL_A3XL
DR   RCB; HPS3347
DR   Wikidata; Q105509158
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN39 ! HPS3344
OI   CVCL_A3XJ ! HPS3345
OI   CVCL_A3XK ! HPS3346
OI   CVCL_A3XM ! HPS3720
OI   CVCL_A3XN ! HPS3721
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3348
AC   CVCL_A3KU
DR   RCB; HPS3348
DR   Wikidata; Q105509162
CC   HLA typing: A*24:02:01:01,26:03:01; B*07:02:01:01,15:01:01:01; C*03:03:01:01,07:02:01:03; DPB1*02:01:02New,04:02:01New; DQB1*03:03:02,05:01:01; DRB1*01:01:01,09:01:02 (RCB=HPS3348).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KV ! HPS3349
OI   CVCL_A3KW ! HPS3350
OI   CVCL_A3KX ! HPS3351
OI   CVCL_A3KY ! HPS3352
OI   CVCL_A3KZ ! HPS3353
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3349
AC   CVCL_A3KV
DR   RCB; HPS3349
DR   Wikidata; Q105509164
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KU ! HPS3348
OI   CVCL_A3KW ! HPS3350
OI   CVCL_A3KX ! HPS3351
OI   CVCL_A3KY ! HPS3352
OI   CVCL_A3KZ ! HPS3353
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3350
AC   CVCL_A3KW
DR   RCB; HPS3350
DR   Wikidata; Q105509166
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KU ! HPS3348
OI   CVCL_A3KV ! HPS3349
OI   CVCL_A3KX ! HPS3351
OI   CVCL_A3KY ! HPS3352
OI   CVCL_A3KZ ! HPS3353
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3351
AC   CVCL_A3KX
DR   RCB; HPS3351
DR   Wikidata; Q105509169
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KU ! HPS3348
OI   CVCL_A3KV ! HPS3349
OI   CVCL_A3KW ! HPS3350
OI   CVCL_A3KY ! HPS3352
OI   CVCL_A3KZ ! HPS3353
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3352
AC   CVCL_A3KY
DR   RCB; HPS3352
DR   Wikidata; Q105509172
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KU ! HPS3348
OI   CVCL_A3KV ! HPS3349
OI   CVCL_A3KW ! HPS3350
OI   CVCL_A3KX ! HPS3351
OI   CVCL_A3KZ ! HPS3353
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3353
AC   CVCL_A3KZ
DR   RCB; HPS3353
DR   Wikidata; Q105509175
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3KU ! HPS3348
OI   CVCL_A3KV ! HPS3349
OI   CVCL_A3KW ! HPS3350
OI   CVCL_A3KX ! HPS3351
OI   CVCL_A3KY ! HPS3352
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3354
AC   CVCL_A3LA
DR   RCB; HPS3354
DR   Wikidata; Q105509178
CC   HLA typing: A*02:06:01:01,24:20:01:01New; B*35:01:01:02,39:01:01:03; C*03:03:01:01,03:04:01:02; DPB1*02:01:02,05:01:01; DQB1*03:01:01,06:02:01:01; DRB1*11:01:01:01,15:01:01New (RCB=HPS3354).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LB ! HPS3355
OI   CVCL_A3LC ! HPS3356
OI   CVCL_A3LD ! HPS3357
OI   CVCL_A3LE ! HPS3358
OI   CVCL_A3LF ! HPS3359
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3355
AC   CVCL_A3LB
DR   RCB; HPS3355
DR   Wikidata; Q105509180
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LA ! HPS3354
OI   CVCL_A3LC ! HPS3356
OI   CVCL_A3LD ! HPS3357
OI   CVCL_A3LE ! HPS3358
OI   CVCL_A3LF ! HPS3359
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3356
AC   CVCL_A3LC
DR   RCB; HPS3356
DR   Wikidata; Q105509184
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LA ! HPS3354
OI   CVCL_A3LB ! HPS3355
OI   CVCL_A3LD ! HPS3357
OI   CVCL_A3LE ! HPS3358
OI   CVCL_A3LF ! HPS3359
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3357
AC   CVCL_A3LD
DR   RCB; HPS3357
DR   Wikidata; Q105509189
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LA ! HPS3354
OI   CVCL_A3LB ! HPS3355
OI   CVCL_A3LC ! HPS3356
OI   CVCL_A3LE ! HPS3358
OI   CVCL_A3LF ! HPS3359
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3358
AC   CVCL_A3LE
DR   RCB; HPS3358
DR   Wikidata; Q105509191
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LA ! HPS3354
OI   CVCL_A3LB ! HPS3355
OI   CVCL_A3LC ! HPS3356
OI   CVCL_A3LD ! HPS3357
OI   CVCL_A3LF ! HPS3359
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3359
AC   CVCL_A3LF
DR   RCB; HPS3359
DR   Wikidata; Q105509195
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LA ! HPS3354
OI   CVCL_A3LB ! HPS3355
OI   CVCL_A3LC ! HPS3356
OI   CVCL_A3LD ! HPS3357
OI   CVCL_A3LE ! HPS3358
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3382
AC   CVCL_A3GX
DR   RCB; HPS3382
DR   Wikidata; Q105509198
CC   HLA typing: A*01:01:01:01New,26:01:01:01; B*37:01:01,40:02:01:01; C*03:04:01,06:02:01:01; DPB1*02:01:02,05:01:01; DQB1*03:03:02,05:01:01New; DRB1*09:01:02,10:01:01:03 (RCB=HPS3382).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GY ! HPS3383
OI   CVCL_A3GZ ! HPS3384
OI   CVCL_A3HA ! HPS3385
OI   CVCL_A3HB ! HPS3747
OI   CVCL_A3HC ! HPS3748
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3383
AC   CVCL_A3GY
DR   RCB; HPS3383
DR   Wikidata; Q105509201
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GX ! HPS3382
OI   CVCL_A3GZ ! HPS3384
OI   CVCL_A3HA ! HPS3385
OI   CVCL_A3HB ! HPS3747
OI   CVCL_A3HC ! HPS3748
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3384
AC   CVCL_A3GZ
DR   RCB; HPS3384
DR   Wikidata; Q105509205
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GX ! HPS3382
OI   CVCL_A3GY ! HPS3383
OI   CVCL_A3HA ! HPS3385
OI   CVCL_A3HB ! HPS3747
OI   CVCL_A3HC ! HPS3748
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3385
AC   CVCL_A3HA
DR   RCB; HPS3385
DR   Wikidata; Q105509207
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GX ! HPS3382
OI   CVCL_A3GY ! HPS3383
OI   CVCL_A3GZ ! HPS3384
OI   CVCL_A3HB ! HPS3747
OI   CVCL_A3HC ! HPS3748
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3386
AC   CVCL_A3LG
DR   RCB; HPS3386
DR   Wikidata; Q105509209
CC   HLA typing: A*24:02:01:01; B*52:01:01:02,54:01:01; C*01:02:01,12:02:02:01; DPB1*05:01:01,09:01:01; DQB1*04:01:01:01,06:01; DRB1*04:05:01:02,15:02:01:01 (RCB=HPS3386).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LH ! HPS3387
OI   CVCL_A3LI ! HPS3388
OI   CVCL_A3LJ ! HPS3389
OI   CVCL_A3LK ! HPS3390
OI   CVCL_A3LL ! HPS3391
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3387
AC   CVCL_A3LH
DR   RCB; HPS3387
DR   Wikidata; Q105509212
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LG ! HPS3386
OI   CVCL_A3LI ! HPS3388
OI   CVCL_A3LJ ! HPS3389
OI   CVCL_A3LK ! HPS3390
OI   CVCL_A3LL ! HPS3391
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3388
AC   CVCL_A3LI
DR   RCB; HPS3388
DR   Wikidata; Q105509215
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LG ! HPS3386
OI   CVCL_A3LH ! HPS3387
OI   CVCL_A3LJ ! HPS3389
OI   CVCL_A3LK ! HPS3390
OI   CVCL_A3LL ! HPS3391
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3389
AC   CVCL_A3LJ
DR   RCB; HPS3389
DR   Wikidata; Q105509218
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LG ! HPS3386
OI   CVCL_A3LH ! HPS3387
OI   CVCL_A3LI ! HPS3388
OI   CVCL_A3LK ! HPS3390
OI   CVCL_A3LL ! HPS3391
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3390
AC   CVCL_A3LK
DR   RCB; HPS3390
DR   Wikidata; Q105509221
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LG ! HPS3386
OI   CVCL_A3LH ! HPS3387
OI   CVCL_A3LI ! HPS3388
OI   CVCL_A3LJ ! HPS3389
OI   CVCL_A3LL ! HPS3391
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3391
AC   CVCL_A3LL
DR   RCB; HPS3391
DR   Wikidata; Q105509224
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LG ! HPS3386
OI   CVCL_A3LH ! HPS3387
OI   CVCL_A3LI ! HPS3388
OI   CVCL_A3LJ ! HPS3389
OI   CVCL_A3LK ! HPS3390
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3392
AC   CVCL_D2VD
DR   RCB; HPS3392
DR   Wikidata; Q127381788
CC   HLA typing: A*02:01:01:01,11:01:01:01; B*40:01:02,54:01:01; C*01:02:01,03:04:01; DPB1*02:01:02,03:01:01; DQB1*04:01:01:01,06:01; DRB1*04:05:01:01,08:03:02 (RCB=HPS3392).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VE ! HPS3393
OI   CVCL_D2VF ! HPS3394
OI   CVCL_D2VG ! HPS3395
OI   CVCL_D2VH ! HPS3396
OI   CVCL_D2XM ! HPS3749
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3393
AC   CVCL_D2VE
DR   RCB; HPS3393
DR   Wikidata; Q127381789
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VD ! HPS3392
OI   CVCL_D2VF ! HPS3394
OI   CVCL_D2VG ! HPS3395
OI   CVCL_D2VH ! HPS3396
OI   CVCL_D2XM ! HPS3749
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3394
AC   CVCL_D2VF
DR   RCB; HPS3394
DR   Wikidata; Q127381790
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VD ! HPS3392
OI   CVCL_D2VE ! HPS3393
OI   CVCL_D2VG ! HPS3395
OI   CVCL_D2VH ! HPS3396
OI   CVCL_D2XM ! HPS3749
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3395
AC   CVCL_D2VG
DR   RCB; HPS3395
DR   Wikidata; Q127381791
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VD ! HPS3392
OI   CVCL_D2VE ! HPS3393
OI   CVCL_D2VF ! HPS3394
OI   CVCL_D2VH ! HPS3396
OI   CVCL_D2XM ! HPS3749
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3396
AC   CVCL_D2VH
DR   RCB; HPS3396
DR   Wikidata; Q127381792
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VD ! HPS3392
OI   CVCL_D2VE ! HPS3393
OI   CVCL_D2VF ! HPS3394
OI   CVCL_D2VG ! HPS3395
OI   CVCL_D2XM ! HPS3749
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3397
AC   CVCL_D2VI
DR   RCB; HPS3397
DR   Wikidata; Q127381794
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VJ ! HPS3750
OI   CVCL_D2VK ! HPS3751
OI   CVCL_D2VL ! HPS3752
OI   CVCL_D2VM ! HPS3753
OI   CVCL_D2VN ! HPS3754
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3410
AC   CVCL_A3ED
DR   RCB; HPS3410
DR   Wikidata; Q105509227
CC   HLA typing: A*02:01:01:01,24:02:01:01; B*15:01:01:01New,40:01:02; C*03:04:01,08:03:01; DPB1*02:01:02,05:01:01; DQB1*03:01:01,05:03:01; DRB1*14:06:01,14:54:01:02 (RCB=HPS3410).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EE ! HPS3767
OI   CVCL_A3EF ! HPS3768
OI   CVCL_A3EG ! HPS3769
OI   CVCL_A3EH ! HPS3770
OI   CVCL_A3EI ! HPS3771
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3417
AC   CVCL_A3EJ
DR   RCB; HPS3417
DR   Wikidata; Q105509229
CC   HLA typing: A*24:02:01:01,26:01:01:01; B*40:02:01:01,54:01:01; C*01:02:01:05,03:29; DPB1*02:01:02,04:02:01; DQB1*05:02:01:01,06:01; DRB1*08:03:02,14:54:01:02New (RCB=HPS3417).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EK ! HPS3418
OI   CVCL_A3EL ! HPS3772
OI   CVCL_A3EM ! HPS3773
OI   CVCL_A3EN ! HPS3774
OI   CVCL_A3EP ! HPS3775
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3418
AC   CVCL_A3EK
DR   RCB; HPS3418
DR   Wikidata; Q105509233
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EJ ! HPS3417
OI   CVCL_A3EL ! HPS3772
OI   CVCL_A3EM ! HPS3773
OI   CVCL_A3EN ! HPS3774
OI   CVCL_A3EP ! HPS3775
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3419
AC   CVCL_A3EQ
DR   RCB; HPS3419
DR   Wikidata; Q105509236
CC   HLA typing: A*02:01:01:01,02:06:01:04; B*39:01:03,40:02:01:01; C*01:02:01New,07:02:01:01; DPB1*02:01:02,05:01:01; DQB1*04:02,06:03:01:01; DRB1*08:02:01,13:01:01:01 (RCB=HPS3419).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ER ! HPS3420
OI   CVCL_A3ES ! HPS3421
OI   CVCL_A3ET ! HPS3422
OI   CVCL_A3EU ! HPS3423
OI   CVCL_A3EV ! HPS3424
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3420
AC   CVCL_A3ER
DR   RCB; HPS3420
DR   Wikidata; Q105509240
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EQ ! HPS3419
OI   CVCL_A3ES ! HPS3421
OI   CVCL_A3ET ! HPS3422
OI   CVCL_A3EU ! HPS3423
OI   CVCL_A3EV ! HPS3424
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3421
AC   CVCL_A3ES
DR   RCB; HPS3421
DR   Wikidata; Q105509243
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EQ ! HPS3419
OI   CVCL_A3ER ! HPS3420
OI   CVCL_A3ET ! HPS3422
OI   CVCL_A3EU ! HPS3423
OI   CVCL_A3EV ! HPS3424
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3422
AC   CVCL_A3ET
DR   RCB; HPS3422
DR   Wikidata; Q105509248
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EQ ! HPS3419
OI   CVCL_A3ER ! HPS3420
OI   CVCL_A3ES ! HPS3421
OI   CVCL_A3EU ! HPS3423
OI   CVCL_A3EV ! HPS3424
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3423
AC   CVCL_A3EU
DR   RCB; HPS3423
DR   Wikidata; Q105509250
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EQ ! HPS3419
OI   CVCL_A3ER ! HPS3420
OI   CVCL_A3ES ! HPS3421
OI   CVCL_A3ET ! HPS3422
OI   CVCL_A3EV ! HPS3424
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3424
AC   CVCL_A3EV
DR   RCB; HPS3424
DR   Wikidata; Q105509254
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EQ ! HPS3419
OI   CVCL_A3ER ! HPS3420
OI   CVCL_A3ES ! HPS3421
OI   CVCL_A3ET ! HPS3422
OI   CVCL_A3EU ! HPS3423
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3425
AC   CVCL_A3EW
DR   RCB; HPS3425
DR   Wikidata; Q105509257
CC   HLA typing: A*24:02:01:01,26:03:01; B*35:01:01:02NEW,52:01:01:02; C*03:03:01,12:02:02:01; DPB1*05:01:01,09:01:01; DQB1*03:02:01,06:01; DRB1*04:03:01,15:02:01:01 (RCB=HPS3425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EX ! HPS3426
OI   CVCL_A3EY ! HPS3427
OI   CVCL_A3EZ ! HPS3428
OI   CVCL_A3FA ! HPS3776
OI   CVCL_A3FB ! HPS3777
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3426
AC   CVCL_A3EX
DR   RCB; HPS3426
DR   Wikidata; Q105509260
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EW ! HPS3425
OI   CVCL_A3EY ! HPS3427
OI   CVCL_A3EZ ! HPS3428
OI   CVCL_A3FA ! HPS3776
OI   CVCL_A3FB ! HPS3777
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3427
AC   CVCL_A3EY
DR   RCB; HPS3427
DR   Wikidata; Q105509264
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EW ! HPS3425
OI   CVCL_A3EX ! HPS3426
OI   CVCL_A3EZ ! HPS3428
OI   CVCL_A3FA ! HPS3776
OI   CVCL_A3FB ! HPS3777
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3428
AC   CVCL_A3EZ
DR   RCB; HPS3428
DR   Wikidata; Q105509267
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EW ! HPS3425
OI   CVCL_A3EX ! HPS3426
OI   CVCL_A3EY ! HPS3427
OI   CVCL_A3FA ! HPS3776
OI   CVCL_A3FB ! HPS3777
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3429
AC   CVCL_D2VP
DR   RCB; HPS3429
DR   Wikidata; Q127381796
CC   HLA typing: A*24:02:01:01; B*40:06:01:01,52:01:01:02; C*01:02:01,12:02:02:01; DPB1*05:01:01,09:01:01; DQB1*03:03:02,06:01; DRB1*09:01:02,15:02:01:01 (RCB=HPS3429).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VQ ! HPS3430
OI   CVCL_D2VR ! HPS3778
OI   CVCL_D2VS ! HPS3779
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3430
AC   CVCL_D2VQ
DR   RCB; HPS3430
DR   Wikidata; Q127381797
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VP ! HPS3429
OI   CVCL_D2VR ! HPS3778
OI   CVCL_D2VS ! HPS3779
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3431
AC   CVCL_D2VT
DR   RCB; HPS3431
DR   Wikidata; Q127381798
CC   HLA typing: A*24:02:01:01,26:03:01; B*15:01:01:01; C*03:03:01,04:01:01; DPB1*02:01:02,05:01:01; DQB1*03:02:01,04:01:01:01; DRB1*04:05:01:03,04:06:01 (RCB=HPS3431).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VU ! HPS3432
OI   CVCL_D2VV ! HPS3433
OI   CVCL_D2VW ! HPS3434
OI   CVCL_D2VX ! HPS3780
OI   CVCL_D2VY ! HPS3781
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3432
AC   CVCL_D2VU
DR   RCB; HPS3432
DR   Wikidata; Q127381799
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VT ! HPS3431
OI   CVCL_D2VV ! HPS3433
OI   CVCL_D2VW ! HPS3434
OI   CVCL_D2VX ! HPS3780
OI   CVCL_D2VY ! HPS3781
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3433
AC   CVCL_D2VV
DR   RCB; HPS3433
DR   Wikidata; Q127381800
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VT ! HPS3431
OI   CVCL_D2VU ! HPS3432
OI   CVCL_D2VW ! HPS3434
OI   CVCL_D2VX ! HPS3780
OI   CVCL_D2VY ! HPS3781
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3434
AC   CVCL_D2VW
DR   RCB; HPS3434
DR   Wikidata; Q127381801
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VT ! HPS3431
OI   CVCL_D2VU ! HPS3432
OI   CVCL_D2VV ! HPS3433
OI   CVCL_D2VX ! HPS3780
OI   CVCL_D2VY ! HPS3781
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3435
AC   CVCL_D2VZ
DR   RCB; HPS3435
DR   Wikidata; Q127381802
CC   HLA typing: A*02:06:01:01,02:07:01; B*40:06:01:01,46:01:01; C*01:02:01,08:01:01:01; DPB1*02:01:02,02:01:02:11; DQB1*03:03:02,06:01; DRB1*08:03:02;09:01:02 (RCB=HPS3435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2W0 ! HPS3436
OI   CVCL_D2W1 ! HPS3437
OI   CVCL_D2W2 ! HPS3438
OI   CVCL_D2W3 ! HPS3787
OI   CVCL_D2W4 ! HPS3788
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3436
AC   CVCL_D2W0
DR   RCB; HPS3436
DR   Wikidata; Q127381803
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VZ ! HPS3435
OI   CVCL_D2W1 ! HPS3437
OI   CVCL_D2W2 ! HPS3438
OI   CVCL_D2W3 ! HPS3787
OI   CVCL_D2W4 ! HPS3788
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3437
AC   CVCL_D2W1
DR   RCB; HPS3437
DR   Wikidata; Q127381804
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VZ ! HPS3435
OI   CVCL_D2W0 ! HPS3436
OI   CVCL_D2W2 ! HPS3438
OI   CVCL_D2W3 ! HPS3787
OI   CVCL_D2W4 ! HPS3788
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3438
AC   CVCL_D2W2
DR   RCB; HPS3438
DR   Wikidata; Q127381806
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VZ ! HPS3435
OI   CVCL_D2W0 ! HPS3436
OI   CVCL_D2W1 ! HPS3437
OI   CVCL_D2W3 ! HPS3787
OI   CVCL_D2W4 ! HPS3788
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3439
AC   CVCL_D2W5
DR   RCB; HPS3439
DR   Wikidata; Q127381807
CC   HLA typing: A*24:02:01:01,31:01:02:01; B*15:11:01,52:01:01:02; C*03:03:01,12:02:02:01; DPB1*02:01:02; DQB1*04:01:01:01,06:04; DRB1*04:05:01:01,15:02:01:01 (RCB=HPS3439).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2W6 ! HPS3440
OI   CVCL_D2W7 ! HPS3441
OI   CVCL_D2W8 ! HPS3442
OI   CVCL_D2W9 ! HPS3443
OI   CVCL_D2WA ! HPS3789
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3440
AC   CVCL_D2W6
DR   RCB; HPS3440
DR   Wikidata; Q127381808
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2W5 ! HPS3439
OI   CVCL_D2W7 ! HPS3441
OI   CVCL_D2W8 ! HPS3442
OI   CVCL_D2W9 ! HPS3443
OI   CVCL_D2WA ! HPS3789
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3441
AC   CVCL_D2W7
DR   RCB; HPS3441
DR   Wikidata; Q127381809
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2W5 ! HPS3439
OI   CVCL_D2W6 ! HPS3440
OI   CVCL_D2W8 ! HPS3442
OI   CVCL_D2W9 ! HPS3443
OI   CVCL_D2WA ! HPS3789
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3442
AC   CVCL_D2W8
DR   RCB; HPS3442
DR   Wikidata; Q127381810
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2W5 ! HPS3439
OI   CVCL_D2W6 ! HPS3440
OI   CVCL_D2W7 ! HPS3441
OI   CVCL_D2W9 ! HPS3443
OI   CVCL_D2WA ! HPS3789
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3443
AC   CVCL_D2W9
DR   RCB; HPS3443
DR   Wikidata; Q127381811
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2W5 ! HPS3439
OI   CVCL_D2W6 ! HPS3440
OI   CVCL_D2W7 ! HPS3441
OI   CVCL_D2W8 ! HPS3442
OI   CVCL_D2WA ! HPS3789
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3676
AC   CVCL_A3DP
DR   RCB; HPS3676
DR   Wikidata; Q105509271
CC   HLA typing: A*24:02:01:01; B*40:06:01:01,52:01:01:02; C*03:03:01,12:02:02:01; DPB1*05:01:01,09:01:01; DQB1*06:01New,06:04; DRB1*13:02:01:02,15:02:01:01 (RCB=HPS3676).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DR ! HPS3678
OI   CVCL_A3DS ! HPS3679
OI   CVCL_A3DT ! HPS3680
OI   CVCL_A3DU ! HPS3799
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3678
AC   CVCL_A3DR
DR   RCB; HPS3678
DR   Wikidata; Q105509276
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DP ! HPS3676
OI   CVCL_A3DS ! HPS3679
OI   CVCL_A3DT ! HPS3680
OI   CVCL_A3DU ! HPS3799
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3679
AC   CVCL_A3DS
DR   RCB; HPS3679
DR   Wikidata; Q105509279
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DP ! HPS3676
OI   CVCL_A3DR ! HPS3678
OI   CVCL_A3DT ! HPS3680
OI   CVCL_A3DU ! HPS3799
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3680
AC   CVCL_A3DT
DR   RCB; HPS3680
DR   Wikidata; Q105509282
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DP ! HPS3676
OI   CVCL_A3DR ! HPS3678
OI   CVCL_A3DS ! HPS3679
OI   CVCL_A3DU ! HPS3799
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3681
AC   CVCL_A3DI
DR   RCB; HPS3681
DR   Wikidata; Q105509286
CC   HLA typing: A*02:06:01:01,24:02:01:01; B*40:02:01:01,54:01:01; C*01:02:01,03:04:01; DPB1*02:01:02,02:01:02:11; DQB1*06:01,06:02:01:01; DRB1*08:03:02,15:01:01 (RCB=HPS3681).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DJ ! HPS3682
OI   CVCL_A3DK ! HPS3683
OI   CVCL_A3DL ! HPS3684
OI   CVCL_A3DM ! HPS3685
OI   CVCL_A3DN ! HPS3800
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3682
AC   CVCL_A3DJ
DR   RCB; HPS3682
DR   Wikidata; Q105509288
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DI ! HPS3681
OI   CVCL_A3DK ! HPS3683
OI   CVCL_A3DL ! HPS3684
OI   CVCL_A3DM ! HPS3685
OI   CVCL_A3DN ! HPS3800
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3683
AC   CVCL_A3DK
DR   RCB; HPS3683
DR   Wikidata; Q105509292
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DI ! HPS3681
OI   CVCL_A3DJ ! HPS3682
OI   CVCL_A3DL ! HPS3684
OI   CVCL_A3DM ! HPS3685
OI   CVCL_A3DN ! HPS3800
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3684
AC   CVCL_A3DL
DR   RCB; HPS3684
DR   Wikidata; Q105509296
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DI ! HPS3681
OI   CVCL_A3DJ ! HPS3682
OI   CVCL_A3DK ! HPS3683
OI   CVCL_A3DM ! HPS3685
OI   CVCL_A3DN ! HPS3800
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3685
AC   CVCL_A3DM
DR   RCB; HPS3685
DR   Wikidata; Q105509299
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DI ! HPS3681
OI   CVCL_A3DJ ! HPS3682
OI   CVCL_A3DK ! HPS3683
OI   CVCL_A3DL ! HPS3684
OI   CVCL_A3DN ! HPS3800
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3686
AC   CVCL_A3DC
DR   RCB; HPS3686
DR   Wikidata; Q105509303
CC   HLA typing: A*11:01:01:01,26:01:01:01; B*15:01:01:01,40:02:01:01; C*01:02:01,03:04:01; DPB1*05:01:01,09:01:01; DQB1*05:03:01,06:01; DRB1*14:05:01:01,15:02:01:01 (RCB=HPS3686).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DD ! HPS3687
OI   CVCL_A3DE ! HPS3688
OI   CVCL_A3DF ! HPS3689
OI   CVCL_A3DG ! HPS3690
OI   CVCL_A3DH ! HPS3691
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3687
AC   CVCL_A3DD
DR   RCB; HPS3687
DR   Wikidata; Q105509307
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DC ! HPS3686
OI   CVCL_A3DE ! HPS3688
OI   CVCL_A3DF ! HPS3689
OI   CVCL_A3DG ! HPS3690
OI   CVCL_A3DH ! HPS3691
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3688
AC   CVCL_A3DE
DR   RCB; HPS3688
DR   Wikidata; Q105509309
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DC ! HPS3686
OI   CVCL_A3DD ! HPS3687
OI   CVCL_A3DF ! HPS3689
OI   CVCL_A3DG ! HPS3690
OI   CVCL_A3DH ! HPS3691
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3689
AC   CVCL_A3DF
DR   RCB; HPS3689
DR   Wikidata; Q105509311
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DC ! HPS3686
OI   CVCL_A3DD ! HPS3687
OI   CVCL_A3DE ! HPS3688
OI   CVCL_A3DG ! HPS3690
OI   CVCL_A3DH ! HPS3691
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3690
AC   CVCL_A3DG
DR   RCB; HPS3690
DR   Wikidata; Q105509314
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DC ! HPS3686
OI   CVCL_A3DD ! HPS3687
OI   CVCL_A3DE ! HPS3688
OI   CVCL_A3DF ! HPS3689
OI   CVCL_A3DH ! HPS3691
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3691
AC   CVCL_A3DH
DR   RCB; HPS3691
DR   Wikidata; Q105509316
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DC ! HPS3686
OI   CVCL_A3DD ! HPS3687
OI   CVCL_A3DE ! HPS3688
OI   CVCL_A3DF ! HPS3689
OI   CVCL_A3DG ! HPS3690
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3692
AC   CVCL_A3CQ
DR   RCB; HPS3692
DR   Wikidata; Q105509318
CC   HLA typing: A*24:02:01:01,31:01:02:01; B*51:01:01:03,52:01:01:02; C*12:02:02:01,14:02:01; DPB1*02:01:02,09:01:01; DQB1*03:01:01,06:01; DRB1*11:01:01:03,15:02:01:01 (RCB=HPS3692).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CR ! HPS3693
OI   CVCL_A3CS ! HPS3694
OI   CVCL_A3CT ! HPS3695
OI   CVCL_A3DA ! HPS3801
OI   CVCL_A3DB ! HPS3802
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3693
AC   CVCL_A3CR
DR   RCB; HPS3693
DR   Wikidata; Q105509321
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CQ ! HPS3692
OI   CVCL_A3CS ! HPS3694
OI   CVCL_A3CT ! HPS3695
OI   CVCL_A3DA ! HPS3801
OI   CVCL_A3DB ! HPS3802
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3694
AC   CVCL_A3CS
DR   RCB; HPS3694
DR   Wikidata; Q105509326
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CQ ! HPS3692
OI   CVCL_A3CR ! HPS3693
OI   CVCL_A3CT ! HPS3695
OI   CVCL_A3DA ! HPS3801
OI   CVCL_A3DB ! HPS3802
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3695
AC   CVCL_A3CT
DR   RCB; HPS3695
DR   Wikidata; Q105509329
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CQ ! HPS3692
OI   CVCL_A3CR ! HPS3693
OI   CVCL_A3CS ! HPS3694
OI   CVCL_A3DA ! HPS3801
OI   CVCL_A3DB ! HPS3802
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3696
AC   CVCL_A3CU
DR   RCB; HPS3696
DR   Wikidata; Q105509332
CC   HLA typing: A*11:01:01:01; B*39:04,48:01:01; C*07:02:01:01,08:01:01:01; DPB1*02:01:02; DQB1*03:01:01,03:03:02; DRB1*09:01:02,11:01:01:04 (RCB=HPS3696).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CV ! HPS3697
OI   CVCL_A3CW ! HPS3698
OI   CVCL_A3CX ! HPS3699
OI   CVCL_A3CY ! HPS3700
OI   CVCL_A3CZ ! HPS3701
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3697
AC   CVCL_A3CV
DR   RCB; HPS3697
DR   Wikidata; Q105509336
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CU ! HPS3696
OI   CVCL_A3CW ! HPS3698
OI   CVCL_A3CX ! HPS3699
OI   CVCL_A3CY ! HPS3700
OI   CVCL_A3CZ ! HPS3701
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3698
AC   CVCL_A3CW
DR   RCB; HPS3698
DR   Wikidata; Q105509337
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CU ! HPS3696
OI   CVCL_A3CV ! HPS3697
OI   CVCL_A3CX ! HPS3699
OI   CVCL_A3CY ! HPS3700
OI   CVCL_A3CZ ! HPS3701
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3699
AC   CVCL_A3CX
DR   RCB; HPS3699
DR   Wikidata; Q105509340
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CU ! HPS3696
OI   CVCL_A3CV ! HPS3697
OI   CVCL_A3CW ! HPS3698
OI   CVCL_A3CY ! HPS3700
OI   CVCL_A3CZ ! HPS3701
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3700
AC   CVCL_A3CY
DR   RCB; HPS3700
DR   Wikidata; Q105509343
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CU ! HPS3696
OI   CVCL_A3CV ! HPS3697
OI   CVCL_A3CW ! HPS3698
OI   CVCL_A3CX ! HPS3699
OI   CVCL_A3CZ ! HPS3701
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3701
AC   CVCL_A3CZ
DR   RCB; HPS3701
DR   Wikidata; Q105509347
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CU ! HPS3696
OI   CVCL_A3CV ! HPS3697
OI   CVCL_A3CW ! HPS3698
OI   CVCL_A3CX ! HPS3699
OI   CVCL_A3CY ! HPS3700
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3702
AC   CVCL_A3DV
DR   RCB; HPS3702
DR   Wikidata; Q105509350
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DW ! HPS3810
OI   CVCL_A3DX ! HPS3811
OI   CVCL_A3DY ! HPS3812
OI   CVCL_A3DZ ! HPS3813
OI   CVCL_A3EA ! HPS3814
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3704
AC   CVCL_UN40
DR   RCB; HPS3704
DR   Wikidata; Q94220545
CC   HLA typing: A*11:01:01:01,31:01:02:01; B*51:01:01:01,67:01:01; C*07:02:01,14:02:01; DPB1*05:01:01; DRB1*04:05:01:01,15:01:01; DQB1*04:01:01:01,06:02:01:01 (RCB=HPS3704).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3XP ! HPS3705
OI   CVCL_A3XQ ! HPS3706
OI   CVCL_A3XR ! HPS3707
OI   CVCL_A3XS ! HPS3708
OI   CVCL_A3XT ! HPS3709
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3705
AC   CVCL_A3XP
DR   RCB; HPS3705
DR   Wikidata; Q105509353
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN40 ! HPS3704
OI   CVCL_A3XQ ! HPS3706
OI   CVCL_A3XR ! HPS3707
OI   CVCL_A3XS ! HPS3708
OI   CVCL_A3XT ! HPS3709
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3706
AC   CVCL_A3XQ
DR   RCB; HPS3706
DR   Wikidata; Q105509354
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN40 ! HPS3704
OI   CVCL_A3XP ! HPS3705
OI   CVCL_A3XR ! HPS3707
OI   CVCL_A3XS ! HPS3708
OI   CVCL_A3XT ! HPS3709
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3707
AC   CVCL_A3XR
DR   RCB; HPS3707
DR   Wikidata; Q105509357
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN40 ! HPS3704
OI   CVCL_A3XP ! HPS3705
OI   CVCL_A3XQ ! HPS3706
OI   CVCL_A3XS ! HPS3708
OI   CVCL_A3XT ! HPS3709
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3708
AC   CVCL_A3XS
DR   RCB; HPS3708
DR   Wikidata; Q105509360
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN40 ! HPS3704
OI   CVCL_A3XP ! HPS3705
OI   CVCL_A3XQ ! HPS3706
OI   CVCL_A3XR ! HPS3707
OI   CVCL_A3XT ! HPS3709
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3709
AC   CVCL_A3XT
DR   RCB; HPS3709
DR   Wikidata; Q105509364
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN40 ! HPS3704
OI   CVCL_A3XP ! HPS3705
OI   CVCL_A3XQ ! HPS3706
OI   CVCL_A3XR ! HPS3707
OI   CVCL_A3XS ! HPS3708
SX   Male
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3720
AC   CVCL_A3XM
DR   RCB; HPS3720
DR   Wikidata; Q105509368
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN39 ! HPS3344
OI   CVCL_A3XJ ! HPS3345
OI   CVCL_A3XK ! HPS3346
OI   CVCL_A3XL ! HPS3347
OI   CVCL_A3XN ! HPS3721
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3721
AC   CVCL_A3XN
DR   RCB; HPS3721
DR   Wikidata; Q105509369
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UN39 ! HPS3344
OI   CVCL_A3XJ ! HPS3345
OI   CVCL_A3XK ! HPS3346
OI   CVCL_A3XL ! HPS3347
OI   CVCL_A3XM ! HPS3720
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3747
AC   CVCL_A3HB
DR   RCB; HPS3747
DR   Wikidata; Q105509374
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GX ! HPS3382
OI   CVCL_A3GY ! HPS3383
OI   CVCL_A3GZ ! HPS3384
OI   CVCL_A3HA ! HPS3385
OI   CVCL_A3HC ! HPS3748
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3748
AC   CVCL_A3HC
DR   RCB; HPS3748
DR   Wikidata; Q105509378
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3GX ! HPS3382
OI   CVCL_A3GY ! HPS3383
OI   CVCL_A3GZ ! HPS3384
OI   CVCL_A3HA ! HPS3385
OI   CVCL_A3HB ! HPS3747
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3749
AC   CVCL_D2XM
DR   RCB; HPS3749
DR   Wikidata; Q127381812
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VD ! HPS3392
OI   CVCL_D2VE ! HPS3393
OI   CVCL_D2VF ! HPS3394
OI   CVCL_D2VG ! HPS3395
OI   CVCL_D2VH ! HPS3396
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3750
AC   CVCL_D2VJ
DR   RCB; HPS3750
DR   Wikidata; Q127381813
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VI ! HPS3397
OI   CVCL_D2VK ! HPS3751
OI   CVCL_D2VL ! HPS3752
OI   CVCL_D2VM ! HPS3753
OI   CVCL_D2VN ! HPS3754
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3751
AC   CVCL_D2VK
DR   RCB; HPS3751
DR   Wikidata; Q127381814
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VI ! HPS3397
OI   CVCL_D2VJ ! HPS3750
OI   CVCL_D2VL ! HPS3752
OI   CVCL_D2VM ! HPS3753
OI   CVCL_D2VN ! HPS3754
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3752
AC   CVCL_D2VL
DR   RCB; HPS3752
DR   Wikidata; Q127381815
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VI ! HPS3397
OI   CVCL_D2VJ ! HPS3750
OI   CVCL_D2VK ! HPS3751
OI   CVCL_D2VM ! HPS3753
OI   CVCL_D2VN ! HPS3754
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3753
AC   CVCL_D2VM
DR   RCB; HPS3753
DR   Wikidata; Q127381816
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VI ! HPS3397
OI   CVCL_D2VJ ! HPS3750
OI   CVCL_D2VK ! HPS3751
OI   CVCL_D2VL ! HPS3752
OI   CVCL_D2VN ! HPS3754
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3754
AC   CVCL_D2VN
DR   RCB; HPS3754
DR   Wikidata; Q127381817
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VI ! HPS3397
OI   CVCL_D2VJ ! HPS3750
OI   CVCL_D2VK ! HPS3751
OI   CVCL_D2VL ! HPS3752
OI   CVCL_D2VM ! HPS3753
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3767
AC   CVCL_A3EE
DR   RCB; HPS3767
DR   Wikidata; Q105509381
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ED ! HPS3410
OI   CVCL_A3EF ! HPS3768
OI   CVCL_A3EG ! HPS3769
OI   CVCL_A3EH ! HPS3770
OI   CVCL_A3EI ! HPS3771
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3768
AC   CVCL_A3EF
DR   RCB; HPS3768
DR   Wikidata; Q105509384
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ED ! HPS3410
OI   CVCL_A3EE ! HPS3767
OI   CVCL_A3EG ! HPS3769
OI   CVCL_A3EH ! HPS3770
OI   CVCL_A3EI ! HPS3771
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3769
AC   CVCL_A3EG
DR   RCB; HPS3769
DR   Wikidata; Q105509386
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ED ! HPS3410
OI   CVCL_A3EE ! HPS3767
OI   CVCL_A3EF ! HPS3768
OI   CVCL_A3EH ! HPS3770
OI   CVCL_A3EI ! HPS3771
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3770
AC   CVCL_A3EH
DR   RCB; HPS3770
DR   Wikidata; Q105509390
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ED ! HPS3410
OI   CVCL_A3EE ! HPS3767
OI   CVCL_A3EF ! HPS3768
OI   CVCL_A3EG ! HPS3769
OI   CVCL_A3EI ! HPS3771
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3771
AC   CVCL_A3EI
DR   RCB; HPS3771
DR   Wikidata; Q105509392
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3ED ! HPS3410
OI   CVCL_A3EE ! HPS3767
OI   CVCL_A3EF ! HPS3768
OI   CVCL_A3EG ! HPS3769
OI   CVCL_A3EH ! HPS3770
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3772
AC   CVCL_A3EL
DR   RCB; HPS3772
DR   Wikidata; Q105509398
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EJ ! HPS3417
OI   CVCL_A3EK ! HPS3418
OI   CVCL_A3EM ! HPS3773
OI   CVCL_A3EN ! HPS3774
OI   CVCL_A3EP ! HPS3775
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3773
AC   CVCL_A3EM
DR   RCB; HPS3773
DR   Wikidata; Q105509400
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EJ ! HPS3417
OI   CVCL_A3EK ! HPS3418
OI   CVCL_A3EL ! HPS3772
OI   CVCL_A3EN ! HPS3774
OI   CVCL_A3EP ! HPS3775
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3774
AC   CVCL_A3EN
DR   RCB; HPS3774
DR   Wikidata; Q105509404
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EJ ! HPS3417
OI   CVCL_A3EK ! HPS3418
OI   CVCL_A3EL ! HPS3772
OI   CVCL_A3EM ! HPS3773
OI   CVCL_A3EP ! HPS3775
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3775
AC   CVCL_A3EP
DR   RCB; HPS3775
DR   Wikidata; Q105509407
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EJ ! HPS3417
OI   CVCL_A3EK ! HPS3418
OI   CVCL_A3EL ! HPS3772
OI   CVCL_A3EM ! HPS3773
OI   CVCL_A3EN ! HPS3774
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3776
AC   CVCL_A3FA
DR   RCB; HPS3776
DR   Wikidata; Q105509409
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EW ! HPS3425
OI   CVCL_A3EX ! HPS3426
OI   CVCL_A3EY ! HPS3427
OI   CVCL_A3EZ ! HPS3428
OI   CVCL_A3FB ! HPS3777
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3777
AC   CVCL_A3FB
DR   RCB; HPS3777
DR   Wikidata; Q105509412
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3EW ! HPS3425
OI   CVCL_A3EX ! HPS3426
OI   CVCL_A3EY ! HPS3427
OI   CVCL_A3EZ ! HPS3428
OI   CVCL_A3FA ! HPS3776
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3778
AC   CVCL_D2VR
DR   RCB; HPS3778
DR   Wikidata; Q127381818
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VP ! HPS3429
OI   CVCL_D2VQ ! HPS3430
OI   CVCL_D2VS ! HPS3779
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3779
AC   CVCL_D2VS
DR   RCB; HPS3779
DR   Wikidata; Q127381819
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VP ! HPS3429
OI   CVCL_D2VQ ! HPS3430
OI   CVCL_D2VR ! HPS3778
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3780
AC   CVCL_D2VX
DR   RCB; HPS3780
DR   Wikidata; Q127381820
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VT ! HPS3431
OI   CVCL_D2VU ! HPS3432
OI   CVCL_D2VV ! HPS3433
OI   CVCL_D2VW ! HPS3434
OI   CVCL_D2VY ! HPS3781
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3781
AC   CVCL_D2VY
DR   RCB; HPS3781
DR   Wikidata; Q127381821
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VT ! HPS3431
OI   CVCL_D2VU ! HPS3432
OI   CVCL_D2VV ! HPS3433
OI   CVCL_D2VW ! HPS3434
OI   CVCL_D2VX ! HPS3780
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3787
AC   CVCL_D2W3
DR   RCB; HPS3787
DR   Wikidata; Q127381822
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VZ ! HPS3435
OI   CVCL_D2W0 ! HPS3436
OI   CVCL_D2W1 ! HPS3437
OI   CVCL_D2W2 ! HPS3438
OI   CVCL_D2W4 ! HPS3788
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3788
AC   CVCL_D2W4
DR   RCB; HPS3788
DR   Wikidata; Q127381824
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2VZ ! HPS3435
OI   CVCL_D2W0 ! HPS3436
OI   CVCL_D2W1 ! HPS3437
OI   CVCL_D2W2 ! HPS3438
OI   CVCL_D2W3 ! HPS3787
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3789
AC   CVCL_D2WA
DR   RCB; HPS3789
DR   Wikidata; Q127381825
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D2W5 ! HPS3439
OI   CVCL_D2W6 ! HPS3440
OI   CVCL_D2W7 ! HPS3441
OI   CVCL_D2W8 ! HPS3442
OI   CVCL_D2W9 ! HPS3443
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   HPS3799
AC   CVCL_A3DU
DR   RCB; HPS3799
DR   Wikidata; Q105509416
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DP ! HPS3676
OI   CVCL_A3DR ! HPS3678
OI   CVCL_A3DS ! HPS3679
OI   CVCL_A3DT ! HPS3680
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3800
AC   CVCL_A3DN
DR   RCB; HPS3800
DR   Wikidata; Q105509418
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DI ! HPS3681
OI   CVCL_A3DJ ! HPS3682
OI   CVCL_A3DK ! HPS3683
OI   CVCL_A3DL ! HPS3684
OI   CVCL_A3DM ! HPS3685
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3801
AC   CVCL_A3DA
DR   RCB; HPS3801
DR   Wikidata; Q105509421
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CQ ! HPS3692
OI   CVCL_A3CR ! HPS3693
OI   CVCL_A3CS ! HPS3694
OI   CVCL_A3CT ! HPS3695
OI   CVCL_A3DB ! HPS3802
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3802
AC   CVCL_A3DB
DR   RCB; HPS3802
DR   Wikidata; Q105509424
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3CQ ! HPS3692
OI   CVCL_A3CR ! HPS3693
OI   CVCL_A3CS ! HPS3694
OI   CVCL_A3CT ! HPS3695
OI   CVCL_A3DA ! HPS3801
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3810
AC   CVCL_A3DW
DR   RCB; HPS3810
DR   SKIP; SKIP005869
DR   Wikidata; Q105509425
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DV ! HPS3702
OI   CVCL_A3DX ! HPS3811
OI   CVCL_A3DY ! HPS3812
OI   CVCL_A3DZ ! HPS3813
OI   CVCL_A3EA ! HPS3814
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3811
AC   CVCL_A3DX
DR   RCB; HPS3811
DR   Wikidata; Q105509428
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DV ! HPS3702
OI   CVCL_A3DW ! HPS3810
OI   CVCL_A3DY ! HPS3812
OI   CVCL_A3DZ ! HPS3813
OI   CVCL_A3EA ! HPS3814
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3812
AC   CVCL_A3DY
DR   RCB; HPS3812
DR   Wikidata; Q105509432
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DV ! HPS3702
OI   CVCL_A3DW ! HPS3810
OI   CVCL_A3DX ! HPS3811
OI   CVCL_A3DZ ! HPS3813
OI   CVCL_A3EA ! HPS3814
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3813
AC   CVCL_A3DZ
DR   RCB; HPS3813
DR   Wikidata; Q105509433
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DV ! HPS3702
OI   CVCL_A3DW ! HPS3810
OI   CVCL_A3DX ! HPS3811
OI   CVCL_A3DY ! HPS3812
OI   CVCL_A3EA ! HPS3814
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3814
AC   CVCL_A3EA
DR   RCB; HPS3814
DR   Wikidata; Q105509436
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3DV ! HPS3702
OI   CVCL_A3DW ! HPS3810
OI   CVCL_A3DX ! HPS3811
OI   CVCL_A3DY ! HPS3812
OI   CVCL_A3DZ ! HPS3813
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3842
AC   CVCL_A3LS
DR   RCB; HPS3842
DR   Wikidata; Q105509439
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR56 ! HPS1054
OI   CVCL_A3LT ! HPS3843
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3843
AC   CVCL_A3LT
DR   RCB; HPS3843
DR   Wikidata; Q105509444
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR56 ! HPS1054
OI   CVCL_A3LS ! HPS3842
SX   Female
AG   10-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3844
AC   CVCL_A3LU
DR   RCB; HPS3844
DR   Wikidata; Q105509447
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LV ! HPS3845
OI   CVCL_A3LW ! HPS3846
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3845
AC   CVCL_A3LV
DR   RCB; HPS3845
DR   Wikidata; Q105509450
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LU ! HPS3844
OI   CVCL_A3LW ! HPS3846
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3846
AC   CVCL_A3LW
DR   RCB; HPS3846
DR   Wikidata; Q105509453
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A3LU ! HPS3844
OI   CVCL_A3LV ! HPS3845
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HPS3887
AC   CVCL_ZE14
SY   BRCi008-A
DR   hPSCreg; BRCi008-A
DR   SKIP; SKIP005798
DR   Wikidata; Q98126707
RX   PubMed=32413791;
CC   Population: Japanese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Duplication; Zygosity=Heterozygous (PubMed=32413791).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   HPS3900
AC   CVCL_YB91
SY   BRCi007-A
DR   hPSCreg; BRCi007-A
DR   Wikidata; Q94220551
RX   PubMed=33714066;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179297; Idiopathic basal ganglia calcification
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   HPS3918
AC   CVCL_B0GQ
SY   BRCi015-A
DR   hPSCreg; BRCi015-A
DR   Wikidata; Q108820498
RX   PubMed=34419750;
CC   Population: Japanese.
CC   Donor information: Established from dizygotic twin of HPS3920 (Cellosaurus=CVCL_UP53).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HPS3920
AC   CVCL_UP53
SY   BRCi003-A
DR   hPSCreg; BRCi003-A
DR   Wikidata; Q94220554
RX   PubMed=34419750;
CC   Population: Japanese.
CC   Donor information: Established from dizygotic twin of HPS3918 (Cellosaurus=CVCL_B0GQ).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HPS3926
AC   CVCL_YS98
SY   BRCi009-A
DR   hPSCreg; BRCi009-A
DR   RCB; HPS3926
DR   Wikidata; Q94220561
RX   PubMed=33291009;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Leu216Leu (c.648G>T); ClinVar=VCV000012003; Zygosity=Homozygous; Note=Produces an aberrant transcript (PubMed=33291009).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   HPS4014
AC   CVCL_C1DH
DR   RCB; HPS4014
DR   Wikidata; Q114311638
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DI ! HPS4015
OI   CVCL_A3EB ! HPS4016
OI   CVCL_C1DJ ! HPS4017
OI   CVCL_C1DK ! HPS4018
OI   CVCL_C1DL ! HPS4019
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4015
AC   CVCL_C1DI
DR   RCB; HPS4015
DR   Wikidata; Q114311639
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DH ! HPS4014
OI   CVCL_A3EB ! HPS4016
OI   CVCL_C1DJ ! HPS4017
OI   CVCL_C1DK ! HPS4018
OI   CVCL_C1DL ! HPS4019
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4016
AC   CVCL_A3EB
DR   RCB; HPS4016
DR   Wikidata; Q105509456
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DH ! HPS4014
OI   CVCL_C1DI ! HPS4015
OI   CVCL_C1DJ ! HPS4017
OI   CVCL_C1DK ! HPS4018
OI   CVCL_C1DL ! HPS4019
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HPS4017
AC   CVCL_C1DJ
DR   RCB; HPS4017
DR   Wikidata; Q114311641
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DH ! HPS4014
OI   CVCL_C1DI ! HPS4015
OI   CVCL_A3EB ! HPS4016
OI   CVCL_C1DK ! HPS4018
OI   CVCL_C1DL ! HPS4019
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4018
AC   CVCL_C1DK
DR   RCB; HPS4018
DR   Wikidata; Q114311643
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DH ! HPS4014
OI   CVCL_C1DI ! HPS4015
OI   CVCL_A3EB ! HPS4016
OI   CVCL_C1DJ ! HPS4017
OI   CVCL_C1DL ! HPS4019
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4019
AC   CVCL_C1DL
DR   RCB; HPS4019
DR   Wikidata; Q114311644
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DH ! HPS4014
OI   CVCL_C1DI ! HPS4015
OI   CVCL_A3EB ! HPS4016
OI   CVCL_C1DJ ! HPS4017
OI   CVCL_C1DK ! HPS4018
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4046
AC   CVCL_C1D9
DR   RCB; HPS4046
DR   Wikidata; Q114311645
RX   PubMed=35754715;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4110
AC   CVCL_C1D4
DR   RCB; HPS4110
DR   Wikidata; Q114311647
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1D5 ! HPS4111
OI   CVCL_C1D6 ! HPS4112
OI   CVCL_C1D7 ! HPS4113
OI   CVCL_C1D8 ! HPS4114
OI   CVCL_A3EC ! HPS4115
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4111
AC   CVCL_C1D5
DR   RCB; HPS4111
DR   Wikidata; Q114311649
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1D4 ! HPS4110
OI   CVCL_C1D6 ! HPS4112
OI   CVCL_C1D7 ! HPS4113
OI   CVCL_C1D8 ! HPS4114
OI   CVCL_A3EC ! HPS4115
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4112
AC   CVCL_C1D6
DR   RCB; HPS4112
DR   Wikidata; Q114311650
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1D4 ! HPS4110
OI   CVCL_C1D5 ! HPS4111
OI   CVCL_C1D7 ! HPS4113
OI   CVCL_C1D8 ! HPS4114
OI   CVCL_A3EC ! HPS4115
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4113
AC   CVCL_C1D7
DR   RCB; HPS4113
DR   Wikidata; Q114311651
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1D4 ! HPS4110
OI   CVCL_C1D5 ! HPS4111
OI   CVCL_C1D6 ! HPS4112
OI   CVCL_C1D8 ! HPS4114
OI   CVCL_A3EC ! HPS4115
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4114
AC   CVCL_C1D8
DR   RCB; HPS4114
DR   Wikidata; Q114311652
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1D4 ! HPS4110
OI   CVCL_C1D5 ! HPS4111
OI   CVCL_C1D6 ! HPS4112
OI   CVCL_C1D7 ! HPS4113
OI   CVCL_A3EC ! HPS4115
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4115
AC   CVCL_A3EC
DR   RCB; HPS4115
DR   Wikidata; Q105509459
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1D4 ! HPS4110
OI   CVCL_C1D5 ! HPS4111
OI   CVCL_C1D6 ! HPS4112
OI   CVCL_C1D7 ! HPS4113
OI   CVCL_C1D8 ! HPS4114
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HPS4122
AC   CVCL_D1EZ
DR   RCB; HPS4122
DR   Wikidata; Q123032629
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1F0 ! HPS4123
OI   CVCL_D1F1 ! HPS4124
OI   CVCL_D1F2 ! HPS4125
OI   CVCL_D1F3 ! HPS4126
OI   CVCL_D1F4 ! HPS4127
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS4123
AC   CVCL_D1F0
DR   RCB; HPS4123
DR   Wikidata; Q123032630
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EZ ! HPS4122
OI   CVCL_D1F1 ! HPS4124
OI   CVCL_D1F2 ! HPS4125
OI   CVCL_D1F3 ! HPS4126
OI   CVCL_D1F4 ! HPS4127
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS4124
AC   CVCL_D1F1
DR   RCB; HPS4124
DR   Wikidata; Q123032631
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EZ ! HPS4122
OI   CVCL_D1F0 ! HPS4123
OI   CVCL_D1F2 ! HPS4125
OI   CVCL_D1F3 ! HPS4126
OI   CVCL_D1F4 ! HPS4127
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS4125
AC   CVCL_D1F2
DR   RCB; HPS4125
DR   Wikidata; Q123032632
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EZ ! HPS4122
OI   CVCL_D1F0 ! HPS4123
OI   CVCL_D1F1 ! HPS4124
OI   CVCL_D1F3 ! HPS4126
OI   CVCL_D1F4 ! HPS4127
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS4126
AC   CVCL_D1F3
DR   RCB; HPS4126
DR   Wikidata; Q123032633
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EZ ! HPS4122
OI   CVCL_D1F0 ! HPS4123
OI   CVCL_D1F1 ! HPS4124
OI   CVCL_D1F2 ! HPS4125
OI   CVCL_D1F4 ! HPS4127
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS4127
AC   CVCL_D1F4
DR   RCB; HPS4127
DR   Wikidata; Q123032634
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1EZ ! HPS4122
OI   CVCL_D1F0 ! HPS4123
OI   CVCL_D1F1 ! HPS4124
OI   CVCL_D1F2 ! HPS4125
OI   CVCL_D1F3 ! HPS4126
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   HPS4134
AC   CVCL_C1DA
DR   RCB; HPS4134
DR   Wikidata; Q114311653
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DB ! HPS4135
OI   CVCL_C1DC ! HPS4136
OI   CVCL_C1DD ! HPS4137
OI   CVCL_C1DE ! HPS4138
OI   CVCL_C1DF ! HPS4139
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4135
AC   CVCL_C1DB
DR   RCB; HPS4135
DR   Wikidata; Q114311654
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DA ! HPS4134
OI   CVCL_C1DC ! HPS4136
OI   CVCL_C1DD ! HPS4137
OI   CVCL_C1DE ! HPS4138
OI   CVCL_C1DF ! HPS4139
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4136
AC   CVCL_C1DC
DR   RCB; HPS4136
DR   Wikidata; Q114311655
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DA ! HPS4134
OI   CVCL_C1DB ! HPS4135
OI   CVCL_C1DD ! HPS4137
OI   CVCL_C1DE ! HPS4138
OI   CVCL_C1DF ! HPS4139
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4137
AC   CVCL_C1DD
DR   RCB; HPS4137
DR   Wikidata; Q114311656
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DA ! HPS4134
OI   CVCL_C1DB ! HPS4135
OI   CVCL_C1DC ! HPS4136
OI   CVCL_C1DE ! HPS4138
OI   CVCL_C1DF ! HPS4139
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4138
AC   CVCL_C1DE
DR   RCB; HPS4138
DR   Wikidata; Q114311657
RX   PubMed=35754715;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DA ! HPS4134
OI   CVCL_C1DB ! HPS4135
OI   CVCL_C1DC ! HPS4136
OI   CVCL_C1DD ! HPS4137
OI   CVCL_C1DF ! HPS4139
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4139
AC   CVCL_C1DF
DR   RCB; HPS4139
DR   Wikidata; Q114311658
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DA ! HPS4134
OI   CVCL_C1DB ! HPS4135
OI   CVCL_C1DC ! HPS4136
OI   CVCL_C1DD ! HPS4137
OI   CVCL_C1DE ! HPS4138
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HPS4234
AC   CVCL_C1DG
DR   RCB; HPS4234
DR   Wikidata; Q114311659
RX   PubMed=35754715;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   hPSC-1
AC   CVCL_T767
SY   human Pancreatic Stellate Cells-1
DR   RCB; RCB3586
DR   Wikidata; Q54890409
CC   Population: Japanese.
CC   Senescence: Senesces at 50 PDL (RCB=RCB3586).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   hPSC-14
AC   CVCL_T768
SY   human Pancreatic Stellate Cells-14
DR   RCB; RCB3589
DR   Wikidata; Q54890410
CC   Population: Japanese.
CC   Senescence: Senesces at 50 PDL (RCB=RCB3589).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   hPSC-5
AC   CVCL_T769
SY   human Pancreatic Stellate Cells-6
DR   RCB; RCB3588
DR   Wikidata; Q54890411
CC   Population: Japanese.
CC   Senescence: Senesces at 50 PDL (RCB=RCB3588).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   hpSC-Hhom-1
AC   CVCL_XI35
DR   Wikidata; Q94220604
RX   PubMed=18092905;
CC   Characteristics: Established from parthenogenetically activated oocytes.
CC   HLA typing: A*25; B*18; DRB1*15 (PubMed=18092905).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   hpSC-Hhom-2
AC   CVCL_XI36
DR   Wikidata; Q94220608
RX   PubMed=18092905;
CC   Characteristics: Established from parthenogenetically activated oocytes.
CC   HLA typing: A*68; B*18; DRB1*13 (PubMed=18092905).
CC   Donor information: Embryo is sibling to that giving rise to hpSC-Hhom-3 (Cellosaurus=CVCL_XI37).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   hpSC-Hhom-3
AC   CVCL_XI37
DR   Wikidata; Q94220615
RX   PubMed=18092905;
CC   Characteristics: Established from parthenogenetically activated oocytes.
CC   HLA typing: A*02; B*13; DRB1*07 (PubMed=18092905).
CC   Donor information: Embryo is sibling to that giving rise to hpSC-Hhom-2 (Cellosaurus=CVCL_XI36).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   hpSC-Hhom-4
AC   CVCL_XI38
DR   Wikidata; Q94220619
RX   PubMed=18092905;
CC   Characteristics: Established from parthenogenetically activated oocytes.
CC   HLA typing: A*01; B*08; DRB1*03 (PubMed=18092905).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   HPSC-TAg
AC   CVCL_SA57
SY   Human Pancreatic Stellate Cells-T Antigen immortalized
DR   Wikidata; Q54890412
RX   PubMed=18245495;
CC   Doubling time: 42 hours (PubMed=18245495).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA59 ! HPSC-TAg-TERT
OI   CVCL_SA58 ! HPSC-TERT
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   HPSC-TAg-TERT
AC   CVCL_SA59
SY   Human Pancreatic Stellate Cells-T Antigen-TERT immortalized
DR   Wikidata; Q54890413
RX   PubMed=18245495;
CC   Doubling time: 12 hours (PubMed=18245495).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA57 ! HPSC-TAg
OI   CVCL_SA58 ! HPSC-TERT
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   HPSC-TERT
AC   CVCL_SA58
SY   HPSC-T; Human Pancreatic Stellate Cells-TERT immortalized
DR   Wikidata; Q54890414
RX   PubMed=18245495;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA57 ! HPSC-TAg
OI   CVCL_SA59 ! HPSC-TAg-TERT
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   HPSI0114i-bezi_1
AC   CVCL_AE24
SY   WTSIi041-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518325
DR   EBiSC; WTSIi041-A
DR   ECACC; 66540037
DR   ECACC; 77650042
DR   HipSci; HPSI0114i-bezi_1
DR   hPSCreg; WTSIi041-A
DR   SKIP; SKIP002600
DR   Wikidata; Q54890415
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540037; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE25 ! HPSI0114i-bezi_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-bezi_3
AC   CVCL_AE25
SY   WTSIi041-B; WTSIi306-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518324
DR   ECACC; 77650041
DR   HipSci; HPSI0114i-bezi_3
DR   hPSCreg; WTSIi041-B
DR   Wikidata; Q54890416
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE24 ! HPSI0114i-bezi_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-eipl_1
AC   CVCL_AE06
SY   WTSIi020-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536417
DR   EBiSC; WTSIi020-A
DR   ECACC; 66540090
DR   ECACC; 77650081
DR   HipSci; HPSI0114i-eipl_1
DR   hPSCreg; WTSIi020-A
DR   PRIDE; PXD005506
DR   SKIP; SKIP002533
DR   Wikidata; Q54890417
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540090; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM63 ! HPSI0114i-eipl_2
OI   CVCL_AE21 ! HPSI0114i-eipl_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-eipl_2
AC   CVCL_JM63
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536414
DR   HipSci; HPSI0114i-eipl_2
DR   PRIDE; PXD005506
DR   Wikidata; Q54890418
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE06 ! HPSI0114i-eipl_1
OI   CVCL_AE21 ! HPSI0114i-eipl_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-eipl_3
AC   CVCL_AE21
SY   WTSIi020-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536405
DR   EBiSC; WTSIi020-B
DR   ECACC; 66540239
DR   ECACC; 77650198
DR   HipSci; HPSI0114i-eipl_3
DR   hPSCreg; WTSIi020-B
DR   SKIP; SKIP002764
DR   Wikidata; Q54890419
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540239; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE06 ! HPSI0114i-eipl_1
OI   CVCL_JM63 ! HPSI0114i-eipl_2
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-fikt_1
AC   CVCL_JM69
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547629
DR   HipSci; HPSI0114i-fikt_1
DR   Wikidata; Q54890420
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE26 ! HPSI0114i-fikt_2
OI   CVCL_AE27 ! HPSI0114i-fikt_3
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-fikt_2
AC   CVCL_AE26
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547610
DR   HipSci; HPSI0114i-fikt_2
DR   Wikidata; Q54890421
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM69 ! HPSI0114i-fikt_1
OI   CVCL_AE27 ! HPSI0114i-fikt_3
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0114i-fikt_3
AC   CVCL_AE27
SY   WTSIi072-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547619
DR   EBiSC; WTSIi072-A
DR   ECACC; 66540184
DR   ECACC; 77650106
DR   HipSci; HPSI0114i-fikt_3
DR   hPSCreg; WTSIi072-A
DR   SKIP; SKIP002661
DR   Wikidata; Q54890422
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540184; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM69 ! HPSI0114i-fikt_1
OI   CVCL_AE26 ! HPSI0114i-fikt_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-iisa_1
AC   CVCL_AE22
SY   WTSIi019-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536412
DR   EBiSC; WTSIi019-B
DR   ECACC; 66540129
DR   ECACC; 77650096
DR   HipSci; HPSI0114i-iisa_1
DR   hPSCreg; WTSIi019-B
DR   SKIP; SKIP002636
DR   Wikidata; Q54890423
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540129; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM70 ! HPSI0114i-iisa_2
OI   CVCL_AE05 ! HPSI0114i-iisa_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-iisa_2
AC   CVCL_JM70
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536409
DR   HipSci; HPSI0114i-iisa_2
DR   Wikidata; Q54890425
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE22 ! HPSI0114i-iisa_1
OI   CVCL_AE05 ! HPSI0114i-iisa_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-iisa_3
AC   CVCL_AE05
SY   WTSIi019-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536410
DR   EBiSC; WTSIi019-A
DR   ECACC; 66540089
DR   ECACC; 77650082
DR   HipSci; HPSI0114i-iisa_3
DR   hPSCreg; WTSIi019-A
DR   SKIP; SKIP002532
DR   Wikidata; Q54890426
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540089; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE22 ! HPSI0114i-iisa_1
OI   CVCL_JM70 ! HPSI0114i-iisa_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-joxm_1
AC   CVCL_AE28
SY   WTSIi074-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547637
DR   EBiSC; WTSIi074-A
DR   ECACC; 66540186
DR   ECACC; 77650047
DR   HipSci; HPSI0114i-joxm_1
DR   hPSCreg; WTSIi074-A
DR   SKIP; SKIP002689
DR   Wikidata; Q54890427
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540186; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM71 ! HPSI0114i-joxm_2
OI   CVCL_JM72 ! HPSI0114i-joxm_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-joxm_2
AC   CVCL_JM71
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547645
DR   HipSci; HPSI0114i-joxm_2
DR   Wikidata; Q54890428
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE28 ! HPSI0114i-joxm_1
OI   CVCL_JM72 ! HPSI0114i-joxm_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-joxm_3
AC   CVCL_JM72
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547620
DR   HipSci; HPSI0114i-joxm_3
DR   Wikidata; Q54890429
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE28 ! HPSI0114i-joxm_1
OI   CVCL_JM71 ! HPSI0114i-joxm_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-kolf_1
AC   CVCL_JM73
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547634
DR   HipSci; HPSI0114i-kolf_1
DR   Wikidata; Q54890430
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE29 ! HPSI0114i-kolf_2
OI   CVCL_AE30 ! HPSI0114i-kolf_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-kolf_2
AC   CVCL_AE29
SY   WTSIi018-B; KOLF2
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547615
DR   ECACC; 77650100
DR   HipSci; HPSI0114i-kolf_2
DR   hPSCreg; WTSIi018-B
DR   SKIP; SKIP002605
DR   Wikidata; Q54890431
RX   PubMed=28489815;
RX   PubMed=31216442;
RX   PubMed=31813827;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous (PubMed=31216442; PubMed=31813827).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31216442; PubMed=31813827).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (PubMed=31216442; PubMed=31813827).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM73 ! HPSI0114i-kolf_1
OI   CVCL_AE30 ! HPSI0114i-kolf_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-kolf_2-C1
AC   CVCL_9S58
SY   HPSI0114i-Kolf_2-C1; KOLF2-C1; WTSIi018-B-1; WTSIi018-C; WTSIi043-A
DR   EFO; EFO_0010976
DR   BioSamples; SAMEA7996638
DR   hPSCreg; WTSIi018-B-1
DR   SKIP; SKIP002606
DR   Wikidata; Q54890432
RX   PubMed=31216442;
RX   PubMed=36459969;
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous (PubMed=31216442).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31216442).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (PubMed=31216442).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AE29 ! HPSI0114i-kolf_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0114i-kolf_3
AC   CVCL_AE30
SY   WTSIi018-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547644
DR   EBiSC; WTSIi018-A
DR   ECACC; 66540088
DR   ECACC; 77650048
DR   HipSci; HPSI0114i-kolf_3
DR   hPSCreg; WTSIi018-A
DR   SKIP; SKIP002531
DR   Wikidata; Q54890433
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540088; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM73 ! HPSI0114i-kolf_1
OI   CVCL_AE29 ! HPSI0114i-kolf_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-lexy_1
AC   CVCL_AE31
SY   WTSIi017-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536416
DR   EBiSC; WTSIi017-B
DR   ECACC; 66540187
DR   ECACC; 77650054
DR   HipSci; HPSI0114i-lexy_1
DR   hPSCreg; WTSIi017-B
DR   SKIP; SKIP002690
DR   Wikidata; Q54890434
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540187; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE32 ! HPSI0114i-lexy_2
OI   CVCL_JM74 ! HPSI0114i-lexy_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-lexy_2
AC   CVCL_AE32
SY   WTSIi017-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536404
DR   EBiSC; WTSIi017-A
DR   ECACC; 66540087
DR   ECACC; 77650034
DR   HipSci; HPSI0114i-lexy_2
DR   hPSCreg; WTSIi017-A
DR   SKIP; SKIP002530
DR   Wikidata; Q54890435
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540087; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE31 ! HPSI0114i-lexy_1
OI   CVCL_JM74 ! HPSI0114i-lexy_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-lexy_3
AC   CVCL_JM74
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536406
DR   HipSci; HPSI0114i-lexy_3
DR   Wikidata; Q54890436
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE31 ! HPSI0114i-lexy_1
OI   CVCL_AE32 ! HPSI0114i-lexy_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-oevr_2
AC   CVCL_JM75
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2570421
DR   HipSci; HPSI0114i-oevr_2
DR   Wikidata; Q54890441
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE04 ! HPSI0114i-oevr_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-oevr_3
AC   CVCL_AE04
SY   WTSIi016-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2570435
DR   EBiSC; WTSIi016-A
DR   ECACC; 66540086
DR   ECACC; 77650072
DR   HipSci; HPSI0114i-oevr_3
DR   hPSCreg; WTSIi016-A
DR   SKIP; SKIP002529
DR   Wikidata; Q54890442
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540086; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM75 ! HPSI0114i-oevr_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-posc_1
AC   CVCL_JM76
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547621
DR   HipSci; HPSI0114i-posc_1
DR   Wikidata; Q54890443
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM77 ! HPSI0114i-posc_2
OI   CVCL_JM78 ! HPSI0114i-posc_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0114i-posc_2
AC   CVCL_JM77
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547630
DR   HipSci; HPSI0114i-posc_2
DR   Wikidata; Q54890444
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM76 ! HPSI0114i-posc_1
OI   CVCL_JM78 ! HPSI0114i-posc_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0114i-posc_3
AC   CVCL_JM78
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547614
DR   HipSci; HPSI0114i-posc_3
DR   Wikidata; Q54890445
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM76 ! HPSI0114i-posc_1
OI   CVCL_JM77 ! HPSI0114i-posc_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0114i-rozh_3
AC   CVCL_JM79
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547893
DR   HipSci; HPSI0114i-rozh_3
DR   Wikidata; Q54890446
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE33 ! HPSI0114i-rozh_4
OI   CVCL_AE34 ! HPSI0114i-rozh_5
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-rozh_4
AC   CVCL_AE33
SY   WTSIi015-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2555017
DR   EBiSC; WTSIi015-B
DR   ECACC; 66540113
DR   ECACC; 77650050
DR   HipSci; HPSI0114i-rozh_4
DR   hPSCreg; WTSIi015-B
DR   SKIP; SKIP002607
DR   Wikidata; Q54890447
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540113; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM79 ! HPSI0114i-rozh_3
OI   CVCL_AE34 ! HPSI0114i-rozh_5
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-rozh_5
AC   CVCL_AE34
SY   WTSIi015-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2555012
DR   EBiSC; WTSIi015-A
DR   ECACC; 66540085
DR   ECACC; 77650043
DR   HipSci; HPSI0114i-rozh_5
DR   hPSCreg; WTSIi015-A
DR   SKIP; SKIP002528
DR   Wikidata; Q54890448
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540085; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM79 ! HPSI0114i-rozh_3
OI   CVCL_AE33 ! HPSI0114i-rozh_4
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-vabj_1
AC   CVCL_JM80
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2595434
DR   HipSci; HPSI0114i-vabj_1
DR   Wikidata; Q54890449
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM81 ! HPSI0114i-vabj_2
OI   CVCL_AE35 ! HPSI0114i-vabj_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-vabj_2
AC   CVCL_JM81
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2595428
DR   HipSci; HPSI0114i-vabj_2
DR   Wikidata; Q54890450
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM80 ! HPSI0114i-vabj_1
OI   CVCL_AE35 ! HPSI0114i-vabj_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-vabj_3
AC   CVCL_AE35
SY   WTSIi024-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2595426
DR   EBiSC; WTSIi024-A
DR   ECACC; 66540094
DR   ECACC; 77650053
DR   HipSci; HPSI0114i-vabj_3
DR   hPSCreg; WTSIi024-A
DR   SKIP; SKIP002554
DR   Wikidata; Q54890451
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540094; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM80 ! HPSI0114i-vabj_1
OI   CVCL_JM81 ! HPSI0114i-vabj_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-vass_1
AC   CVCL_AE36
SY   WTSIi075-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627141
DR   EBiSC; WTSIi075-A
DR   ECACC; 66540188
DR   ECACC; 77650044
DR   HipSci; HPSI0114i-vass_1
DR   hPSCreg; WTSIi075-A
DR   SKIP; SKIP002691
DR   Wikidata; Q54890452
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540188; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0114i-veui_3
AC   CVCL_AE37
SY   WTSIi148-A
DR   BioSamples; SAMEA2464772
DR   ECACC; 77650267
DR   HipSci; HPSI0114i-veui_3
DR   hPSCreg; WTSIi148-A
DR   SKIP; SKIP002801
DR   Wikidata; Q54890453
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0114i-wegi_1
AC   CVCL_AE38
SY   WTSIi144-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547631
DR   EBiSC; WTSIi144-A
DR   ECACC; 66540254
DR   ECACC; 77650197
DR   HipSci; HPSI0114i-wegi_1
DR   hPSCreg; WTSIi144-A
DR   SKIP; SKIP002778
DR   Wikidata; Q54890454
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540254; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM82 ! HPSI0114i-wegi_2
OI   CVCL_WK07 ! HPSI0114i-wegi_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-wegi_2
AC   CVCL_JM82
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547613
DR   HipSci; HPSI0114i-wegi_2
DR   Wikidata; Q54890455
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE38 ! HPSI0114i-wegi_1
OI   CVCL_WK07 ! HPSI0114i-wegi_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-wegi_3
AC   CVCL_WK07
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547617
DR   HipSci; HPSI0114i-wegi_3
DR   Wikidata; Q94221073
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE38 ! HPSI0114i-wegi_1
OI   CVCL_JM82 ! HPSI0114i-wegi_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0114i-zapk_1
AC   CVCL_JM83
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2570424
DR   HipSci; HPSI0114i-zapk_1
DR   Wikidata; Q54890456
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE39 ! HPSI0114i-zapk_2
OI   CVCL_AE40 ! HPSI0114i-zapk_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-zapk_2
AC   CVCL_AE39
SY   WTSIi023-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2570426
DR   EBiSC; WTSIi023-B
DR   ECACC; 66540261
DR   ECACC; 77650195
DR   HipSci; HPSI0114i-zapk_2
DR   hPSCreg; WTSIi023-B
DR   SKIP; SKIP002782
DR   Wikidata; Q54890457
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540261; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM83 ! HPSI0114i-zapk_1
OI   CVCL_AE40 ! HPSI0114i-zapk_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0114i-zapk_3
AC   CVCL_AE40
SY   WTSIi023-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2570432
DR   EBiSC; WTSIi023-A
DR   ECACC; 66540093
DR   ECACC; 77650156
DR   HipSci; HPSI0114i-zapk_3
DR   hPSCreg; WTSIi023-A
DR   SKIP; SKIP002553
DR   Wikidata; Q54890458
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540093; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM83 ! HPSI0114i-zapk_1
OI   CVCL_AE39 ! HPSI0114i-zapk_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0114i-zoxy_1
AC   CVCL_JM84
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536411
DR   HipSci; HPSI0114i-zoxy_1
DR   Wikidata; Q54890459
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM85 ! HPSI0114i-zoxy_2
OI   CVCL_AE41 ! HPSI0114i-zoxy_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-zoxy_2
AC   CVCL_JM85
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536408
DR   HipSci; HPSI0114i-zoxy_2
DR   Wikidata; Q54890460
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM84 ! HPSI0114i-zoxy_1
OI   CVCL_AE41 ! HPSI0114i-zoxy_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0114i-zoxy_3
AC   CVCL_AE41
SY   WTSIi037-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2536413
DR   ECACC; 77650164
DR   HipSci; HPSI0114i-zoxy_3
DR   hPSCreg; WTSIi037-A
DR   SKIP; SKIP002596
DR   Wikidata; Q54890461
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM84 ! HPSI0114i-zoxy_1
OI   CVCL_JM85 ! HPSI0114i-zoxy_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0115i-aion_2
AC   CVCL_EE75
SY   WTSIi255-B; WTSIi278-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3754202
DR   ECACC; 77650400
DR   HipSci; HPSI0115i-aion_2
DR   hPSCreg; WTSIi255-B
DR   Wikidata; Q54890462
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE76 ! HPSI0115i-aion_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-aion_3
AC   CVCL_EE76
SY   WTSIi255-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3754203
DR   ECACC; 77650434
DR   HipSci; HPSI0115i-aion_3
DR   hPSCreg; WTSIi255-A
DR   Wikidata; Q54890463
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE75 ! HPSI0115i-aion_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-aoxv_1
AC   CVCL_IY09
SY   WTSIi594-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4451655
DR   ECACC; 77650452
DR   HipSci; HPSI0115i-aoxv_1
DR   hPSCreg; WTSIi594-A
DR   Wikidata; Q54890464
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY10 ! HPSI0115i-aoxv_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-aoxv_3
AC   CVCL_IY10
SY   WTSIi594-B; WTSIi604-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4451657
DR   ECACC; 77650453
DR   HipSci; HPSI0115i-aoxv_3
DR   hPSCreg; WTSIi594-B
DR   Wikidata; Q54890465
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY09 ! HPSI0115i-aoxv_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-bimq_4
AC   CVCL_LK97
SY   WTSIi727-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011280
DR   ECACC; 77650686
DR   HipSci; HPSI0115i-bimq_4
DR   hPSCreg; WTSIi727-A
DR   Wikidata; Q54890466
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ82 ! HPSI0115i-bimq_5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-bimq_5
AC   CVCL_WJ82
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011279
DR   HipSci; HPSI0115i-bimq_5
DR   Wikidata; Q94221230
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LK97 ! HPSI0115i-bimq_4
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-boqx_1
AC   CVCL_WK08
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104130215
DR   HipSci; HPSI0115i-boqx_1
DR   Wikidata; Q94221235
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LK98 ! HPSI0115i-boqx_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-boqx_2
AC   CVCL_LK98
SY   WTSIi726-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104130216
DR   ECACC; 77650742
DR   HipSci; HPSI0115i-boqx_2
DR   hPSCreg; WTSIi726-A
DR   Wikidata; Q54890467
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK08 ! HPSI0115i-boqx_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-gifk_1
AC   CVCL_AJ81
SY   WTSIi266-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3753601
DR   ECACC; 77650562
DR   HipSci; HPSI0115i-gifk_1
DR   hPSCreg; WTSIi266-A
DR   Wikidata; Q54890468
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-gost_2
AC   CVCL_IY11
SY   WTSIi590-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4454941
DR   ECACC; 77650454
DR   HipSci; HPSI0115i-gost_2
DR   hPSCreg; WTSIi590-A
DR   Wikidata; Q54890469
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-hecn_3
AC   CVCL_EE77
SY   WTSIi269-B; WTSIi340-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853173
DR   ECACC; 77650412
DR   HipSci; HPSI0115i-hecn_3
DR   hPSCreg; WTSIi269-B
DR   Wikidata; Q54890470
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE78 ! HPSI0115i-hecn_6
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-hecn_6
AC   CVCL_EE78
SY   WTSIi269-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853180
DR   ECACC; 77650415
DR   HipSci; HPSI0115i-hecn_6
DR   hPSCreg; WTSIi269-A
DR   Wikidata; Q54890471
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE77 ! HPSI0115i-hecn_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-iinu_3
AC   CVCL_IX19
SY   WTSIi457-A
DR   BioSamples; SAMEA3976982
DR   ECACC; 77650529
DR   HipSci; HPSI0115i-iinu_3
DR   hPSCreg; WTSIi457-A
DR   Wikidata; Q54890472
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Pakistani.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX20 ! HPSI0115i-iinu_5
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-iinu_5
AC   CVCL_IX20
SY   WTSIi457-B; WTSIi489-A
DR   BioSamples; SAMEA3976980
DR   ECACC; 77650530
DR   HipSci; HPSI0115i-iinu_5
DR   hPSCreg; WTSIi457-B
DR   Wikidata; Q54890473
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Pakistani.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX19 ! HPSI0115i-iinu_3
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-iiyk_2
AC   CVCL_EE79
SY   WTSIi267-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4303610
DR   ECACC; 77650421
DR   HipSci; HPSI0115i-iiyk_2
DR   hPSCreg; WTSIi267-A
DR   Wikidata; Q54890474
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE80 ! HPSI0115i-iiyk_4
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-iiyk_4
AC   CVCL_EE80
SY   WTSIi267-B; WTSIi319-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4303613
DR   ECACC; 77650422
DR   HipSci; HPSI0115i-iiyk_4
DR   hPSCreg; WTSIi267-B
DR   Wikidata; Q54890475
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE79 ! HPSI0115i-iiyk_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-iuad_2
AC   CVCL_LK99
SY   WTSIi700-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103886060
DR   ECACC; 77650694
DR   HipSci; HPSI0115i-iuad_2
DR   hPSCreg; WTSIi700-A
DR   Wikidata; Q54890476
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL00 ! HPSI0115i-iuad_3
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-iuad_3
AC   CVCL_LL00
SY   WTSIi700-B; WTSIi723-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103887419
DR   ECACC; 77650695
DR   HipSci; HPSI0115i-iuad_3
DR   hPSCreg; WTSIi700-B
DR   Wikidata; Q54890477
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LK99 ! HPSI0115i-iuad_2
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-jakt_1
AC   CVCL_LL01
SY   WTSIi722-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4455484
DR   ECACC; 77650678
DR   HipSci; HPSI0115i-jakt_1
DR   hPSCreg; WTSIi722-A
DR   Wikidata; Q54890478
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0115i-jotn_2
AC   CVCL_LL02
SY   WTSIi690-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA17511418
DR   ECACC; 77650755
DR   HipSci; HPSI0115i-jotn_2
DR   hPSCreg; WTSIi690-A
DR   Wikidata; Q54890479
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL03 ! HPSI0115i-jotn_4
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-jotn_4
AC   CVCL_LL03
SY   WTSIi690-B; WTSIi730-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104237550
DR   ECACC; 77650756
DR   HipSci; HPSI0115i-jotn_4
DR   hPSCreg; WTSIi690-B
DR   Wikidata; Q54890480
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL02 ! HPSI0115i-jotn_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-kozf_1
AC   CVCL_LL04
SY   WTSIi619-B; WTSIi651-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011286
DR   ECACC; 77650700
DR   HipSci; HPSI0115i-kozf_1
DR   hPSCreg; WTSIi619-B
DR   Wikidata; Q54890487
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL05 ! HPSI0115i-kozf_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-kozf_2
AC   CVCL_LL05
SY   WTSIi619-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011285
DR   ECACC; 77650701
DR   HipSci; HPSI0115i-kozf_2
DR   hPSCreg; WTSIi619-A
DR   Wikidata; Q54890488
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL04 ! HPSI0115i-kozf_1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-melw_1
AC   CVCL_AJ82
SY   WTSIi250-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3754205
DR   ECACC; 77650563
DR   HipSci; HPSI0115i-melw_1
DR   hPSCreg; WTSIi250-A
DR   Wikidata; Q54890490
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ83 ! HPSI0115i-melw_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-melw_2
AC   CVCL_AJ83
SY   WTSIi250-B; WTSIi264-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3754201
DR   ECACC; 77650564
DR   HipSci; HPSI0115i-melw_2
DR   hPSCreg; WTSIi250-B
DR   Wikidata; Q54890491
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ82 ! HPSI0115i-melw_1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-paim_1
AC   CVCL_IY12
SY   WTSIi388-B; WTSIi397-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4448538
DR   ECACC; 77650445
DR   HipSci; HPSI0115i-paim_1
DR   hPSCreg; WTSIi388-B
DR   Wikidata; Q54890492
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY13 ! HPSI0115i-paim_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0115i-paim_3
AC   CVCL_IY13
SY   WTSIi388-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4448539
DR   ECACC; 77650446
DR   HipSci; HPSI0115i-paim_3
DR   hPSCreg; WTSIi388-A
DR   Wikidata; Q54890493
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY12 ! HPSI0115i-paim_1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0115i-payf_1
AC   CVCL_LL06
SY   WTSIi715-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011289
DR   ECACC; 77650858
DR   HipSci; HPSI0115i-payf_1
DR   hPSCreg; WTSIi715-A
DR   Wikidata; Q54890494
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ83 ! HPSI0115i-payf_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-payf_2
AC   CVCL_WJ83
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011290
DR   ECACC; 77650798
DR   HipSci; HPSI0115i-payf_2
DR   Wikidata; Q94221528
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL06 ! HPSI0115i-payf_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-pitg_2
AC   CVCL_WJ84
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103992851
DR   ECACC; 77650817
DR   HipSci; HPSI0115i-pitg_2
DR   Wikidata; Q94221532
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-qaqp_4
AC   CVCL_IX21
SY   WTSIi573-A
DR   BioSamples; SAMEA3976880
DR   ECACC; 77650512
DR   HipSci; HPSI0115i-qaqp_4
DR   hPSCreg; WTSIi573-A
DR   Wikidata; Q54890495
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Pakistani.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ33 ! HPSI0115i-qaqp_5
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-qaqp_5
AC   CVCL_IZ33
SY   WTSIi573-B; WTSIi581-A
DR   BioSamples; SAMEA3976881
DR   ECACC; 77650513
DR   HipSci; HPSI0115i-qaqp_5
DR   hPSCreg; WTSIi573-B
DR   Wikidata; Q54890497
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Pakistani.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX21 ! HPSI0115i-qaqp_4
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-qecv_1
AC   CVCL_WK00
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103992843
DR   ECACC; 77650813
DR   HipSci; HPSI0115i-qecv_1
DR   Wikidata; Q94221559
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK01 ! HPSI0115i-qecv_2
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-qecv_2
AC   CVCL_WK01
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103992842
DR   ECACC; 77650814
DR   HipSci; HPSI0115i-qecv_2
DR   Wikidata; Q94221562
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK00 ! HPSI0115i-qecv_1
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-qoog_4
AC   CVCL_EE81
SY   WTSIi281-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4090533
DR   ECACC; 77650431
DR   HipSci; HPSI0115i-qoog_4
DR   hPSCreg; WTSIi281-A
DR   Wikidata; Q54890498
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE82 ! HPSI0115i-qoog_6
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-qoog_6
AC   CVCL_EE82
SY   WTSIi281-B; WTSIi332-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4090531
DR   ECACC; 77650384
DR   HipSci; HPSI0115i-qoog_6
DR   hPSCreg; WTSIi281-B
DR   Wikidata; Q54890499
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE81 ! HPSI0115i-qoog_4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-quze_4
AC   CVCL_WK09
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104132470
DR   HipSci; HPSI0115i-quze_4
DR   Wikidata; Q94221583
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK02 ! HPSI0115i-quze_6
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-quze_6
AC   CVCL_WK02
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104132471
DR   ECACC; 77650808
DR   HipSci; HPSI0115i-quze_6
DR   Wikidata; Q94221587
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK09 ! HPSI0115i-quze_4
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-rakq_1
AC   CVCL_LL07
SY   WTSIi615-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103884675
DR   ECACC; 77650626
DR   HipSci; HPSI0115i-rakq_1
DR   hPSCreg; WTSIi615-A
DR   Wikidata; Q54890500
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL08 ! HPSI0115i-rakq_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-rakq_3
AC   CVCL_LL08
SY   WTSIi615-B; WTSIi629-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103884673
DR   ECACC; 77650627
DR   HipSci; HPSI0115i-rakq_3
DR   hPSCreg; WTSIi615-B
DR   Wikidata; Q54890501
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL07 ! HPSI0115i-rakq_1
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-rakz_6
AC   CVCL_WJ85
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104009798
DR   ECACC; 77650799
DR   HipSci; HPSI0115i-rakz_6
DR   Wikidata; Q94221613
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-rehy_2
AC   CVCL_WJ86
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103885514
DR   ECACC; 77650800
DR   HipSci; HPSI0115i-rehy_2
DR   Wikidata; Q94221618
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ87 ! HPSI0115i-rehy_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-rehy_3
AC   CVCL_WJ87
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103885513
DR   HipSci; HPSI0115i-rehy_3
DR   Wikidata; Q94221622
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ86 ! HPSI0115i-rehy_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-roka_1
AC   CVCL_LL09
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011277
DR   HipSci; HPSI0115i-roka_1
DR   Wikidata; Q54890502
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL10 ! HPSI0115i-roka_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0115i-roka_3
AC   CVCL_LL10
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011278
DR   HipSci; HPSI0115i-roka_3
DR   Wikidata; Q54890503
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL09 ! HPSI0115i-roka_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0115i-sehp_2
AC   CVCL_LL11
SY   WTSIi644-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4562183
DR   ECACC; 77650717
DR   HipSci; HPSI0115i-sehp_2
DR   hPSCreg; WTSIi644-A
DR   Wikidata; Q54890504
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL12 ! HPSI0115i-sehp_3
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-sehp_3
AC   CVCL_LL12
SY   WTSIi644-B; WTSIi656-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA7417918
DR   ECACC; 77650671
DR   HipSci; HPSI0115i-sehp_3
DR   hPSCreg; WTSIi644-B
DR   Wikidata; Q54890505
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL11 ! HPSI0115i-sehp_2
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-tiku_1
AC   CVCL_LL13
SY   WTSIi660-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104237551
DR   ECACC; 77650770
DR   HipSci; HPSI0115i-tiku_1
DR   hPSCreg; WTSIi660-A
DR   Wikidata; Q54890506
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL14 ! HPSI0115i-tiku_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-tiku_3
AC   CVCL_LL14
SY   WTSIi660-B; WTSIi692-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104237552
DR   ECACC; 77650771
DR   HipSci; HPSI0115i-tiku_3
DR   hPSCreg; WTSIi660-B
DR   Wikidata; Q54890507
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL13 ! HPSI0115i-tiku_1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-timk_2
AC   CVCL_WK10
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103988282
DR   HipSci; HPSI0115i-timk_2
DR   Wikidata; Q94221694
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL15 ! HPSI0115i-timk_4
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-timk_4
AC   CVCL_LL15
SY   WTSIi634-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103988283
DR   ECACC; 77650728
DR   HipSci; HPSI0115i-timk_4
DR   hPSCreg; WTSIi634-A
DR   Wikidata; Q54890508
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK10 ! HPSI0115i-timk_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-uolo_1
AC   CVCL_JM86
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3753588
DR   HipSci; HPSI0115i-uolo_1
DR   Wikidata; Q54890509
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE42 ! HPSI0115i-uolo_5
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-uolo_5
AC   CVCL_AE42
SY   WTSIi275-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3755284
DR   ECACC; 77650615
DR   HipSci; HPSI0115i-uolo_5
DR   hPSCreg; WTSIi275-A
DR   Wikidata; Q54890510
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM86 ! HPSI0115i-uolo_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-uupc_2
AC   CVCL_LL16
SY   WTSIi654-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103884677
DR   ECACC; 77650727
DR   HipSci; HPSI0115i-uupc_2
DR   hPSCreg; WTSIi654-A
DR   Wikidata; Q54890511
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-vazt_1
AC   CVCL_EE83
SY   WTSIi252-B; WTSIi321-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4089843
DR   ECACC; 77650425
DR   HipSci; HPSI0115i-vazt_1
DR   hPSCreg; WTSIi252-B
DR   Wikidata; Q54890512
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE84 ! HPSI0115i-vazt_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-vazt_2
AC   CVCL_EE84
SY   WTSIi252-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4089842
DR   ECACC; 77650403
DR   HipSci; HPSI0115i-vazt_2
DR   hPSCreg; WTSIi252-A
DR   Wikidata; Q54890513
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE83 ! HPSI0115i-vazt_1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-vehl_2
AC   CVCL_WK11
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103988284
DR   HipSci; HPSI0115i-vehl_2
DR   Wikidata; Q94221769
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK12 ! HPSI0115i-vehl_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-vehl_3
AC   CVCL_WK12
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103988275
DR   HipSci; HPSI0115i-vehl_3
DR   Wikidata; Q94221775
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK11 ! HPSI0115i-vehl_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-womt_1
AC   CVCL_WK03
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103992896
DR   ECACC; 77650812
DR   HipSci; HPSI0115i-womt_1
DR   Wikidata; Q94221777
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-xaka_1
AC   CVCL_IZ32
SY   WTSIi452-B; WTSIi542-A
DR   BioSamples; SAMEA4340443
DR   ECACC; 77650527
DR   HipSci; HPSI0115i-xaka_1
DR   hPSCreg; WTSIi452-B
DR   Wikidata; Q54890515
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Pakistani.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX22 ! HPSI0115i-xaka_2
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-xaka_2
AC   CVCL_IX22
SY   WTSIi452-A
DR   BioSamples; SAMEA4340444
DR   ECACC; 77650528
DR   HipSci; HPSI0115i-xaka_2
DR   hPSCreg; WTSIi452-A
DR   Wikidata; Q54890516
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Pakistani.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ32 ! HPSI0115i-xaka_1
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0115i-yaqw_1
AC   CVCL_WK13
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104134591
DR   HipSci; HPSI0115i-yaqw_1
DR   Wikidata; Q94221809
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK14 ! HPSI0115i-yaqw_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-yaqw_3
AC   CVCL_WK14
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104134592
DR   HipSci; HPSI0115i-yaqw_3
DR   Wikidata; Q94221816
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK13 ! HPSI0115i-yaqw_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-zagk_3
AC   CVCL_WK15
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011218
DR   HipSci; HPSI0115i-zagk_3
DR   Wikidata; Q94221821
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK16 ! HPSI0115i-zagk_4
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-zagk_4
AC   CVCL_WK16
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011219
DR   HipSci; HPSI0115i-zagk_4
DR   Wikidata; Q94221826
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK15 ! HPSI0115i-zagk_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0115i-zihe_1
AC   CVCL_AJ84
SY   WTSIi308-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3735470
DR   ECACC; 77650561
DR   HipSci; HPSI0115i-zihe_1
DR   hPSCreg; WTSIi308-A
DR   Wikidata; Q54890517
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0115i-zuer_1
AC   CVCL_LL17
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104243063
DR   HipSci; HPSI0115i-zuer_1
DR   Wikidata; Q54890518
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL18 ! HPSI0115i-zuer_4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0115i-zuer_4
AC   CVCL_LL18
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103884172
DR   HipSci; HPSI0115i-zuer_4
DR   Wikidata; Q54890519
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL17 ! HPSI0115i-zuer_1
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0213i-koun_2
AC   CVCL_AE43
SY   WTSIi248-A
DR   BioSamples; SAMEA2398494
DR   ECACC; 77650435
DR   HipSci; HPSI0213i-koun_2
DR   hPSCreg; WTSIi248-A
DR   Wikidata; Q54890520
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE44 ! HPSI0213i-koun_4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0213i-koun_4
AC   CVCL_AE44
SY   WTSIi248-B
DR   BioSamples; SAMEA2399269
DR   HipSci; HPSI0213i-koun_4
DR   hPSCreg; WTSIi248-B
DR   Wikidata; Q54890521
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE43 ! HPSI0213i-koun_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0213i-nawk_44
AC   CVCL_JM87
DR   BioSamples; SAMEA2398161
DR   HipSci; HPSI0213i-nawk_44
DR   Wikidata; Q54890522
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE45 ! HPSI0213i-nawk_5
OI   CVCL_AE46 ! HPSI0213i-nawk_55
OI   CVCL_JM88 ! HPSI0213i-nawk_66
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0213i-nawk_5
AC   CVCL_AE45
DR   BioSamples; SAMEA2397827
DR   HipSci; HPSI0213i-nawk_5
DR   Wikidata; Q54890523
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM87 ! HPSI0213i-nawk_44
OI   CVCL_AE46 ! HPSI0213i-nawk_55
OI   CVCL_JM88 ! HPSI0213i-nawk_66
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0213i-nawk_55
AC   CVCL_AE46
SY   WTSIi299-A
DR   BioSamples; SAMEA2398515
DR   ECACC; 77650172
DR   HipSci; HPSI0213i-nawk_55
DR   hPSCreg; WTSIi299-A
DR   Wikidata; Q54890524
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM87 ! HPSI0213i-nawk_44
OI   CVCL_AE45 ! HPSI0213i-nawk_5
OI   CVCL_JM88 ! HPSI0213i-nawk_66
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0213i-nawk_66
AC   CVCL_JM88
DR   BioSamples; SAMEA2398321
DR   HipSci; HPSI0213i-nawk_66
DR   Wikidata; Q54890525
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE45 ! HPSI0213i-nawk_5
OI   CVCL_JM87 ! HPSI0213i-nawk_44
OI   CVCL_AE46 ! HPSI0213i-nawk_55
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0213i-xeaw_1
AC   CVCL_AE47
DR   BioSamples; SAMEA2398145
DR   HipSci; HPSI0213i-xeaw_1
DR   Wikidata; Q54890526
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   HPSI0214i-bute_2
AC   CVCL_AE48
SY   WTSIi560-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2682666
DR   HipSci; HPSI0214i-bute_2
DR   hPSCreg; WTSIi560-A
DR   Wikidata; Q54890527
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0214i-datg_1
AC   CVCL_JM89
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2632905
DR   HipSci; HPSI0214i-datg_1
DR   Wikidata; Q54890528
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE49 ! HPSI0214i-datg_2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0214i-datg_2
AC   CVCL_AE49
SY   WTSIi048-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2632921
DR   EBiSC; WTSIi048-A
DR   ECACC; 66540127
DR   ECACC; 77650205
DR   HipSci; HPSI0214i-datg_2
DR   hPSCreg; WTSIi048-A
DR   SKIP; SKIP002620
DR   Wikidata; Q54890529
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540127; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM89 ! HPSI0214i-datg_1
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0214i-eiwy_1
AC   CVCL_AE50
SY   WTSIi044-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2645805
DR   EBiSC; WTSIi044-A
DR   ECACC; 66540118
DR   ECACC; 77650165
DR   HipSci; HPSI0214i-eiwy_1
DR   hPSCreg; WTSIi044-A
DR   SKIP; SKIP002612
DR   Wikidata; Q54890534
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540118; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-feec_2
AC   CVCL_AE51
SY   WTSIi135-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2612471
DR   EBiSC; WTSIi135-A
DR   ECACC; 66540240
DR   ECACC; 77650191
DR   HipSci; HPSI0214i-feec_2
DR   hPSCreg; WTSIi135-A
DR   SKIP; SKIP002765
DR   Wikidata; Q54890535
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540240; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE52 ! HPSI0214i-feec_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0214i-feec_3
AC   CVCL_AE52
SY   WTSIi135-B; WTSIi320-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2612483
DR   ECACC; 77650080
DR   HipSci; HPSI0214i-feec_3
DR   hPSCreg; WTSIi135-B
DR   Wikidata; Q54890536
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE51 ! HPSI0214i-feec_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0214i-fiau_1
AC   CVCL_AE53
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627574
DR   HipSci; HPSI0214i-fiau_1
DR   Wikidata; Q54890537
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM90 ! HPSI0214i-fiau_2
OI   CVCL_JM91 ! HPSI0214i-fiau_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0214i-fiau_2
AC   CVCL_JM90
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627575
DR   HipSci; HPSI0214i-fiau_2
DR   Wikidata; Q54890538
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE53 ! HPSI0214i-fiau_1
OI   CVCL_JM91 ! HPSI0214i-fiau_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0214i-fiau_3
AC   CVCL_JM91
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627579
DR   HipSci; HPSI0214i-fiau_3
DR   Wikidata; Q54890539
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE53 ! HPSI0214i-fiau_1
OI   CVCL_JM90 ! HPSI0214i-fiau_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0214i-giju_2
AC   CVCL_AE54
SY   WTSIi296-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3460678
DR   ECACC; 77650603
DR   HipSci; HPSI0214i-giju_2
DR   hPSCreg; WTSIi296-A
DR   Wikidata; Q54890540
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE55 ! HPSI0214i-giju_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0214i-giju_3
AC   CVCL_AE55
SY   WTSIi296-B; WTSIi315-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3460677
DR   ECACC; 77650604
DR   HipSci; HPSI0214i-giju_3
DR   hPSCreg; WTSIi296-B
DR   Wikidata; Q54890541
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE54 ! HPSI0214i-giju_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0214i-heja_1
AC   CVCL_AE56
SY   WTSIi014-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627577
DR   EBiSC; WTSIi014-B
DR   ECACC; 66540112
DR   ECACC; 77650124
DR   HipSci; HPSI0214i-heja_1
DR   hPSCreg; WTSIi014-B
DR   SKIP; SKIP002608
DR   Wikidata; Q54890542
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540112; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE57 ! HPSI0214i-heja_2
OI   CVCL_JM92 ! HPSI0214i-heja_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-heja_2
AC   CVCL_AE57
SY   WTSIi014-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627578
DR   EBiSC; WTSIi014-A
DR   ECACC; 66540084
DR   ECACC; 77650085
DR   HipSci; HPSI0214i-heja_2
DR   hPSCreg; WTSIi014-A
DR   SKIP; SKIP002527
DR   Wikidata; Q54890543
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540084; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE56 ! HPSI0214i-heja_1
OI   CVCL_JM92 ! HPSI0214i-heja_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-heja_3
AC   CVCL_JM92
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627570
DR   HipSci; HPSI0214i-heja_3
DR   Wikidata; Q54890544
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE56 ! HPSI0214i-heja_1
OI   CVCL_AE57 ! HPSI0214i-heja_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0214i-heth_1
AC   CVCL_AE58
SY   WTSIi045-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2658090
DR   EBiSC; WTSIi045-A
DR   ECACC; 66540119
DR   ECACC; 77650139
DR   HipSci; HPSI0214i-heth_1
DR   hPSCreg; WTSIi045-A
DR   SKIP; SKIP002613
DR   Wikidata; Q54890545
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540119; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-kehc_2
AC   CVCL_AE59
SY   WTSIi076-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2658107
DR   EBiSC; WTSIi076-A
DR   ECACC; 66540189
DR   ECACC; 77650052
DR   HipSci; HPSI0214i-kehc_2
DR   hPSCreg; WTSIi076-A
DR   SKIP; SKIP002692
DR   Wikidata; Q54890546
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540189; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-kucg_2
AC   CVCL_AE60
SY   WTSIi013-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2645814
DR   EBiSC; WTSIi013-A
DR   ECACC; 66540083
DR   ECACC; 77650065
DR   HipSci; HPSI0214i-kucg_2
DR   hPSCreg; WTSIi013-A
DR   SKIP; SKIP002526
DR   Wikidata; Q54890547
RX   PubMed=28489815;
RX   PubMed=31813827;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540083; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7TX ! HPSI0214i-kucg_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-kucg_3
AC   CVCL_C7TX
SY   KUCG3
DR   BioSamples; SAMEA2645816
DR   HipSci; HPSI0214i-kucg_3
DR   Wikidata; Q117704503
RX   PubMed=36459969;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE60 ! HPSI0214i-kucg_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 3
//
ID   HPSI0214i-pelm_1
AC   CVCL_AE61
SY   WTSIi030-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2678742
DR   EBiSC; WTSIi030-B
DR   ECACC; 66540128
DR   ECACC; 77650089
DR   HipSci; HPSI0214i-pelm_1
DR   hPSCreg; WTSIi030-B
DR   SKIP; SKIP002637
DR   Wikidata; Q54890548
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540128; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM93 ! HPSI0214i-pelm_2
OI   CVCL_AE62 ! HPSI0214i-pelm_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-pelm_2
AC   CVCL_JM93
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2678741
DR   HipSci; HPSI0214i-pelm_2
DR   Wikidata; Q54890549
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE61 ! HPSI0214i-pelm_1
OI   CVCL_AE62 ! HPSI0214i-pelm_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0214i-pelm_3
AC   CVCL_AE62
SY   WTSIi030-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2678738
DR   EBiSC; WTSIi030-A
DR   ECACC; 66540100
DR   ECACC; 77650070
DR   HipSci; HPSI0214i-pelm_3
DR   hPSCreg; WTSIi030-A
DR   SKIP; SKIP002560
DR   Wikidata; Q54890550
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540100; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE61 ! HPSI0214i-pelm_1
OI   CVCL_JM93 ! HPSI0214i-pelm_2
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-poih_2
AC   CVCL_EE42
SY   WTSIi168-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3968761
DR   ECACC; 77650304
DR   HipSci; HPSI0214i-poih_2
DR   hPSCreg; WTSIi168-B
DR   SKIP; SKIP002869
DR   Wikidata; Q54890551
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE43 ! HPSI0214i-poih_4
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0214i-poih_4
AC   CVCL_EE43
SY   WTSIi168-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3969686
DR   EBiSC; WTSIi168-A
DR   ECACC; 66540336
DR   ECACC; 77650305
DR   HipSci; HPSI0214i-poih_4
DR   hPSCreg; WTSIi168-A
DR   SKIP; SKIP002833
DR   Wikidata; Q54890552
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540336; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE42 ! HPSI0214i-poih_2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0214i-rayr_1
AC   CVCL_AE63
SY   WTSIi143-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2649534
DR   EBiSC; WTSIi143-A
DR   ECACC; 66540252
DR   ECACC; 77650196
DR   HipSci; HPSI0214i-rayr_1
DR   hPSCreg; WTSIi143-A
DR   Wikidata; Q54890553
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540252; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0214i-wibj_1
AC   CVCL_AE64
SY   WTSIi046-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627566
DR   EBiSC; WTSIi046-B
DR   ECACC; 66540255
DR   ECACC; 77650257
DR   HipSci; HPSI0214i-wibj_1
DR   hPSCreg; WTSIi046-B
DR   SKIP; SKIP002779
DR   Wikidata; Q54890554
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540255; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE65 ! HPSI0214i-wibj_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0214i-wibj_2
AC   CVCL_AE65
SY   WTSIi046-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627567
DR   EBiSC; WTSIi046-A
DR   ECACC; 66540120
DR   ECACC; 77650057
DR   HipSci; HPSI0214i-wibj_2
DR   hPSCreg; WTSIi046-A
DR   SKIP; SKIP002616
DR   Wikidata; Q54890555
RX   PubMed=28489815;
RX   PubMed=31813827;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540120; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE64 ! HPSI0214i-wibj_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0215i-deyz_2
AC   CVCL_AJ85
SY   WTSIi293-B; WTSIi312-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3847037
DR   ECACC; 77650565
DR   HipSci; HPSI0215i-deyz_2
DR   hPSCreg; WTSIi293-B
DR   Wikidata; Q54890556
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ86 ! HPSI0215i-deyz_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0215i-deyz_3
AC   CVCL_AJ86
SY   WTSIi293-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3847036
DR   ECACC; 77650585
DR   HipSci; HPSI0215i-deyz_3
DR   hPSCreg; WTSIi293-A
DR   Wikidata; Q54890558
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ85 ! HPSI0215i-deyz_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0215i-fawm_2
AC   CVCL_EE55
SY   WTSIi178-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3735541
DR   EBiSC; WTSIi178-A
DR   ECACC; 66540350
DR   ECACC; 77650288
DR   HipSci; HPSI0215i-fawm_2
DR   hPSCreg; WTSIi178-A
DR   SKIP; SKIP002845
DR   Wikidata; Q54890559
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540350; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE56 ! HPSI0215i-fawm_4
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0215i-fawm_4
AC   CVCL_EE56
SY   WTSIi178-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3754916
DR   EBiSC; WTSIi178-B
DR   ECACC; 66540351
DR   ECACC; 77650289
DR   HipSci; HPSI0215i-fawm_4
DR   hPSCreg; WTSIi178-B
DR   SKIP; SKIP002848
DR   Wikidata; Q54890560
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540351; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE55 ! HPSI0215i-fawm_2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0215i-hipn_1
AC   CVCL_AE66
SY   WTSIi311-B; WTSIi326-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3483998
DR   ECACC; 77650616
DR   HipSci; HPSI0215i-hipn_1
DR   hPSCreg; WTSIi311-B
DR   Wikidata; Q54890561
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE67 ! HPSI0215i-hipn_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0215i-hipn_2
AC   CVCL_AE67
SY   WTSIi311-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3483996
DR   ECACC; 77650617
DR   HipSci; HPSI0215i-hipn_2
DR   hPSCreg; WTSIi311-A
DR   Wikidata; Q54890562
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE66 ! HPSI0215i-hipn_1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0215i-oilg_1
AC   CVCL_AX08
SY   WTSIi191-B; WTSIi239-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3485963
DR   ECACC; 77650300
DR   HipSci; HPSI0215i-oilg_1
DR   hPSCreg; WTSIi191-B
DR   PRIDE; PXD005506
DR   Wikidata; Q54890563
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE41 ! HPSI0215i-oilg_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0215i-oilg_3
AC   CVCL_EE41
SY   WTSIi191-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3485962
DR   EBiSC; WTSIi191-A
DR   ECACC; 66540417
DR   ECACC; 77650301
DR   HipSci; HPSI0215i-oilg_3
DR   hPSCreg; WTSIi191-A
DR   PRIDE; PXD005506
DR   SKIP; SKIP002890
DR   Wikidata; Q54890564
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540417; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX08 ! HPSI0215i-oilg_1
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0215i-qenw_1
AC   CVCL_LL19
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104236711
DR   HipSci; HPSI0215i-qenw_1
DR   Wikidata; Q54890565
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL20 ! HPSI0215i-qenw_5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0215i-qenw_5
AC   CVCL_LL20
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104236710
DR   HipSci; HPSI0215i-qenw_5
DR   Wikidata; Q54890566
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL19 ! HPSI0215i-qenw_1
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0215i-romx_1
AC   CVCL_LL21
SY   WTSIi740-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104009795
DR   ECACC; 77650716
DR   HipSci; HPSI0215i-romx_1
DR   hPSCreg; WTSIi740-A
DR   Wikidata; Q54890567
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650716; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ88 ! HPSI0215i-romx_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0215i-romx_2
AC   CVCL_WJ88
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104009794
DR   ECACC; 77650801
DR   HipSci; HPSI0215i-romx_2
DR   Wikidata; Q94222315
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL21 ! HPSI0215i-romx_1
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0215i-uiao_1
AC   CVCL_LL22
SY   WTSIi617-B; WTSIi625-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104009787
DR   ECACC; 77650733
DR   HipSci; HPSI0215i-uiao_1
DR   hPSCreg; WTSIi617-B
DR   Wikidata; Q54890568
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL23 ! HPSI0215i-uiao_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0215i-uiao_2
AC   CVCL_LL23
SY   WTSIi617-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104009786
DR   ECACC; 77650734
DR   HipSci; HPSI0215i-uiao_2
DR   hPSCreg; WTSIi617-A
DR   Wikidata; Q54890569
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL22 ! HPSI0215i-uiao_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0215i-yoch_6
AC   CVCL_EE85
SY   WTSIi291-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3847031
DR   ECACC; 77650413
DR   HipSci; HPSI0215i-yoch_6
DR   hPSCreg; WTSIi291-A
DR   Wikidata; Q54890570
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0215i-zett_5
AC   CVCL_IY14
SY   WTSIi530-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853129
DR   ECACC; 77650496
DR   HipSci; HPSI0215i-zett_5
DR   hPSCreg; WTSIi530-A
DR   Wikidata; Q54890571
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-aiid_1
AC   CVCL_IX83
SY   WTSIi450-A
DR   BioSamples; SAMEA4447140
DR   ECACC; 77650469
DR   HipSci; HPSI0216i-aiid_1
DR   hPSCreg; WTSIi450-A
DR   Wikidata; Q54890572
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX84 ! HPSI0216i-aiid_6
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-aiid_6
AC   CVCL_IX84
SY   WTSIi450-B; WTSIi451-A
DR   BioSamples; SAMEA4447143
DR   ECACC; 77650470
DR   HipSci; HPSI0216i-aiid_6
DR   hPSCreg; WTSIi450-B
DR   Wikidata; Q54890573
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX83 ! HPSI0216i-aiid_1
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0216i-boho_3
AC   CVCL_IX72
SY   WTSIi502-A
DR   BioSamples; SAMEA4447052
DR   ECACC; 77650471
DR   HipSci; HPSI0216i-boho_3
DR   hPSCreg; WTSIi502-A
DR   Wikidata; Q54890574
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0216i-dacv_6
AC   CVCL_IX73
SY   WTSIi554-A
DR   BioSamples; SAMEA4451172
DR   ECACC; 77650472
DR   HipSci; HPSI0216i-dacv_6
DR   hPSCreg; WTSIi554-A
DR   Wikidata; Q54890577
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0216i-dewh_4
AC   CVCL_IX85
SY   WTSIi474-B; WTSIi535-A
DR   BioSamples; SAMEA4343058
DR   ECACC; 77650531
DR   HipSci; HPSI0216i-dewh_4
DR   hPSCreg; WTSIi474-B
DR   Wikidata; Q54890578
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX86 ! HPSI0216i-dewh_6
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-dewh_6
AC   CVCL_IX86
SY   WTSIi474-A
DR   BioSamples; SAMEA4343060
DR   ECACC; 77650546
DR   HipSci; HPSI0216i-dewh_6
DR   hPSCreg; WTSIi474-A
DR   Wikidata; Q54890579
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX85 ! HPSI0216i-dewh_4
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-feht_1
AC   CVCL_LF21
SY   WTSIi576-A
DR   BioSamples; SAMEA4453879
DR   ECACC; 77650630
DR   HipSci; HPSI0216i-feht_1
DR   hPSCreg; WTSIi576-A
DR   Wikidata; Q54890580
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0216i-heub_1
AC   CVCL_IX87
SY   WTSIi527-A
DR   BioSamples; SAMEA4453691
DR   ECACC; 77650631
DR   HipSci; HPSI0216i-heub_1
DR   hPSCreg; WTSIi527-A
DR   Wikidata; Q54890581
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX88 ! HPSI0216i-heub_6
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-heub_6
AC   CVCL_IX88
SY   WTSIi527-B; WTSIi528-A
DR   BioSamples; SAMEA4453760
DR   ECACC; 77650498
DR   HipSci; HPSI0216i-heub_6
DR   hPSCreg; WTSIi527-B
DR   Wikidata; Q54890582
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX87 ! HPSI0216i-heub_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-iogu_5
AC   CVCL_IX89
SY   WTSIi516-A
DR   BioSamples; SAMEA4453868
DR   ECACC; 77650499
DR   HipSci; HPSI0216i-iogu_5
DR   hPSCreg; WTSIi516-A
DR   Wikidata; Q54890583
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX90 ! HPSI0216i-iogu_6
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-iogu_6
AC   CVCL_IX90
SY   WTSIi516-B; WTSIi550-A
DR   BioSamples; SAMEA4453876
DR   ECACC; 77650628
DR   HipSci; HPSI0216i-iogu_6
DR   hPSCreg; WTSIi516-B
DR   Wikidata; Q54890584
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX89 ! HPSI0216i-iogu_5
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-puxp_1
AC   CVCL_IX67
SY   WTSIi449-A
DR   BioSamples; SAMEA4448207
DR   ECACC; 77650511
DR   HipSci; HPSI0216i-puxp_1
DR   hPSCreg; WTSIi449-A
DR   Wikidata; Q54890585
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0216i-rihx_4
AC   CVCL_IX74
SY   WTSIi568-A
DR   BioSamples; SAMEA4447136
DR   ECACC; 77650545
DR   HipSci; HPSI0216i-rihx_4
DR   hPSCreg; WTSIi568-A
DR   Wikidata; Q54890586
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650545; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   HPSI0216i-tony_5
AC   CVCL_IX68
SY   WTSIi471-A
DR   BioSamples; SAMEA4448542
DR   ECACC; 77650490
DR   HipSci; HPSI0216i-tony_5
DR   hPSCreg; WTSIi471-A
DR   Wikidata; Q54890587
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0216i-vieg_3
AC   CVCL_IX75
SY   WTSIi472-B; WTSIi547-A
DR   BioSamples; SAMEA4453872
DR   ECACC; 77650491
DR   HipSci; HPSI0216i-vieg_3
DR   hPSCreg; WTSIi472-B
DR   Wikidata; Q54890588
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX76 ! HPSI0216i-vieg_5
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0216i-vieg_5
AC   CVCL_IX76
SY   WTSIi472-A
DR   BioSamples; SAMEA4453874
DR   ECACC; 77650492
DR   HipSci; HPSI0216i-vieg_5
DR   hPSCreg; WTSIi472-A
DR   Wikidata; Q54890589
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX75 ! HPSI0216i-vieg_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0216i-xanu_5
AC   CVCL_IX91
SY   WTSIi510-A
DR   BioSamples; SAMEA4447133
DR   ECACC; 77650443
DR   HipSci; HPSI0216i-xanu_5
DR   hPSCreg; WTSIi510-A
DR   Wikidata; Q54890590
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX92 ! HPSI0216i-xanu_6
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0216i-xanu_6
AC   CVCL_IX92
SY   WTSIi510-B; WTSIi539-A
DR   BioSamples; SAMEA4447132
DR   ECACC; 77650444
DR   HipSci; HPSI0216i-xanu_6
DR   hPSCreg; WTSIi510-B
DR   Wikidata; Q54890591
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX91 ! HPSI0216i-xanu_5
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0313i-airc_1
AC   CVCL_JM94
DR   BioSamples; SAMEA2399175
DR   HipSci; HPSI0313i-airc_1
DR   Wikidata; Q54890592
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE68 ! HPSI0313i-airc_2
OI   CVCL_JM95 ! HPSI0313i-airc_3
OI   CVCL_AE69 ! HPSI0313i-airc_6
OI   CVCL_JM96 ! HPSI0313i-airc_44
OI   CVCL_JM97 ! HPSI0313i-airc_55
OI   CVCL_AE70 ! HPSI0313i-airc_66
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0313i-airc_2
AC   CVCL_AE68
SY   WTSIi105-A
DR   BioSamples; SAMEA2398371
DR   ECACC; 77650008
DR   HipSci; HPSI0313i-airc_2
DR   hPSCreg; WTSIi105-A
DR   SKIP; SKIP002720
DR   Wikidata; Q54890593
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650008; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM94 ! HPSI0313i-airc_1
OI   CVCL_JM95 ! HPSI0313i-airc_3
OI   CVCL_AE69 ! HPSI0313i-airc_6
OI   CVCL_JM96 ! HPSI0313i-airc_44
OI   CVCL_JM97 ! HPSI0313i-airc_55
OI   CVCL_AE70 ! HPSI0313i-airc_66
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   HPSI0313i-airc_3
AC   CVCL_JM95
DR   BioSamples; SAMEA2398723
DR   HipSci; HPSI0313i-airc_3
DR   Wikidata; Q54890594
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM94 ! HPSI0313i-airc_1
OI   CVCL_AE68 ! HPSI0313i-airc_2
OI   CVCL_AE69 ! HPSI0313i-airc_6
OI   CVCL_JM96 ! HPSI0313i-airc_44
OI   CVCL_JM97 ! HPSI0313i-airc_55
OI   CVCL_AE70 ! HPSI0313i-airc_66
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0313i-airc_44
AC   CVCL_JM96
DR   BioSamples; SAMEA2398695
DR   HipSci; HPSI0313i-airc_44
DR   Wikidata; Q54890595
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM94 ! HPSI0313i-airc_1
OI   CVCL_AE68 ! HPSI0313i-airc_2
OI   CVCL_JM95 ! HPSI0313i-airc_3
OI   CVCL_AE69 ! HPSI0313i-airc_6
OI   CVCL_JM97 ! HPSI0313i-airc_55
OI   CVCL_AE70 ! HPSI0313i-airc_66
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0313i-airc_55
AC   CVCL_JM97
DR   BioSamples; SAMEA2398986
DR   HipSci; HPSI0313i-airc_55
DR   Wikidata; Q54890596
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM94 ! HPSI0313i-airc_1
OI   CVCL_AE68 ! HPSI0313i-airc_2
OI   CVCL_JM95 ! HPSI0313i-airc_3
OI   CVCL_AE69 ! HPSI0313i-airc_6
OI   CVCL_JM96 ! HPSI0313i-airc_44
OI   CVCL_AE70 ! HPSI0313i-airc_66
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0313i-airc_6
AC   CVCL_AE69
SY   WTSIi105-D; WTSIi589-A
DR   BioSamples; SAMEA2398072
DR   HipSci; HPSI0313i-airc_6
DR   hPSCreg; WTSIi105-D
DR   Wikidata; Q54890597
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM94 ! HPSI0313i-airc_1
OI   CVCL_AE68 ! HPSI0313i-airc_2
OI   CVCL_JM95 ! HPSI0313i-airc_3
OI   CVCL_JM96 ! HPSI0313i-airc_44
OI   CVCL_JM97 ! HPSI0313i-airc_55
OI   CVCL_AE70 ! HPSI0313i-airc_66
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0313i-airc_66
AC   CVCL_AE70
SY   WTSIi105-B
DR   BioSamples; SAMEA2399089
DR   ECACC; 77650171
DR   HipSci; HPSI0313i-airc_66
DR   hPSCreg; WTSIi105-B
DR   SKIP; SKIP002757
DR   Wikidata; Q54890599
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650171; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM94 ! HPSI0313i-airc_1
OI   CVCL_AE68 ! HPSI0313i-airc_2
OI   CVCL_JM95 ! HPSI0313i-airc_3
OI   CVCL_AE69 ! HPSI0313i-airc_6
OI   CVCL_JM96 ! HPSI0313i-airc_44
OI   CVCL_JM97 ! HPSI0313i-airc_55
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI0313i-cesj_1
AC   CVCL_AE71
SY   WTSIi108-A
DR   BioSamples; SAMEA2398465
DR   ECACC; 77650127
DR   HipSci; HPSI0313i-cesj_1
DR   hPSCreg; WTSIi108-A
DR   SKIP; SKIP002723
DR   Wikidata; Q54890600
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650127; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI0313i-fecs_1
AC   CVCL_AE72
DR   BioSamples; SAMEA2398470
DR   HipSci; HPSI0313i-fecs_1
DR   Wikidata; Q54890601
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM98 ! HPSI0313i-fecs_2
OI   CVCL_AE73 ! HPSI0313i-fecs_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0313i-fecs_2
AC   CVCL_JM98
SY   WTSIi564-A
DR   BioSamples; SAMEA2398405
DR   HipSci; HPSI0313i-fecs_2
DR   hPSCreg; WTSIi564-A
DR   Wikidata; Q54890602
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE72 ! HPSI0313i-fecs_1
OI   CVCL_AE73 ! HPSI0313i-fecs_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0313i-fecs_3
AC   CVCL_AE73
DR   BioSamples; SAMEA2398356
DR   HipSci; HPSI0313i-fecs_3
DR   Wikidata; Q54890603
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE72 ! HPSI0313i-fecs_1
OI   CVCL_JM98 ! HPSI0313i-fecs_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0313i-xovo_1
AC   CVCL_AE74
DR   BioSamples; SAMEA2398521
DR   HipSci; HPSI0313i-xovo_1
DR   Wikidata; Q54890604
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE75 ! HPSI0313i-xovo_2
OI   CVCL_JM99 ! HPSI0313i-xovo_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0313i-xovo_2
AC   CVCL_AE75
SY   WTSIi565-A
DR   BioSamples; SAMEA2398754
DR   HipSci; HPSI0313i-xovo_2
DR   hPSCreg; WTSIi565-A
DR   Wikidata; Q54890605
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE74 ! HPSI0313i-xovo_1
OI   CVCL_JM99 ! HPSI0313i-xovo_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0313i-xovo_3
AC   CVCL_JM99
DR   BioSamples; SAMEA2398376
DR   HipSci; HPSI0313i-xovo_3
DR   Wikidata; Q54890606
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE74 ! HPSI0313i-xovo_1
OI   CVCL_AE75 ! HPSI0313i-xovo_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0314i-bipt_1
AC   CVCL_AE76
SY   WTSIi031-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2719619
DR   EBiSC; WTSIi031-A
DR   ECACC; 66540101
DR   HipSci; HPSI0314i-bipt_1
DR   hPSCreg; WTSIi031-A
DR   SKIP; SKIP002561
DR   Wikidata; Q54890607
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540101; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0314i-bubh_1
AC   CVCL_AE77
SY   WTSIi012-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2675459
DR   EBiSC; WTSIi012-A
DR   ECACC; 66540082
DR   ECACC; 77650062
DR   HipSci; HPSI0314i-bubh_1
DR   hPSCreg; WTSIi012-A
DR   SKIP; SKIP002525
DR   Wikidata; Q54890608
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540082; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN00 ! HPSI0314i-bubh_2
OI   CVCL_AE78 ! HPSI0314i-bubh_3
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-bubh_2
AC   CVCL_JN00
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2675457
DR   HipSci; HPSI0314i-bubh_2
DR   Wikidata; Q54890609
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE77 ! HPSI0314i-bubh_1
OI   CVCL_AE78 ! HPSI0314i-bubh_3
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0314i-bubh_3
AC   CVCL_AE78
SY   WTSIi012-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2698309
DR   EBiSC; WTSIi012-B
DR   ECACC; 66540181
DR   ECACC; 77650077
DR   HipSci; HPSI0314i-bubh_3
DR   hPSCreg; WTSIi012-B
DR   SKIP; SKIP002687
DR   Wikidata; Q54890610
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540181; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE77 ! HPSI0314i-bubh_1
OI   CVCL_JN00 ! HPSI0314i-bubh_2
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-cuhk_1
AC   CVCL_AE79
SY   WTSIi077-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2682671
DR   EBiSC; WTSIi077-A
DR   ECACC; 66540190
DR   ECACC; 77650049
DR   HipSci; HPSI0314i-cuhk_1
DR   hPSCreg; WTSIi077-A
DR   SKIP; SKIP002693
DR   Wikidata; Q54890611
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540190; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE80 ! HPSI0314i-cuhk_2
OI   CVCL_JN01 ! HPSI0314i-cuhk_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-cuhk_2
AC   CVCL_AE80
SY   WTSIi077-B; WTSIi289-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2682670
DR   ECACC; 77650058
DR   HipSci; HPSI0314i-cuhk_2
DR   hPSCreg; WTSIi077-B
DR   Wikidata; Q54890612
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE79 ! HPSI0314i-cuhk_1
OI   CVCL_JN01 ! HPSI0314i-cuhk_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0314i-cuhk_3
AC   CVCL_JN01
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2708114
DR   HipSci; HPSI0314i-cuhk_3
DR   Wikidata; Q54890613
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE79 ! HPSI0314i-cuhk_1
OI   CVCL_AE80 ! HPSI0314i-cuhk_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0314i-fafq_1
AC   CVCL_AE81
SY   WTSIi078-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2711371
DR   EBiSC; WTSIi078-A
DR   ECACC; 66540191
DR   ECACC; 77650090
DR   HipSci; HPSI0314i-fafq_1
DR   hPSCreg; WTSIi078-A
DR   SKIP; SKIP002694
DR   Wikidata; Q54890614
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540191; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-hoik_1
AC   CVCL_AE82
SY   WTSIi026-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2698315
DR   EBiSC; WTSIi026-A
DR   ECACC; 66540096
DR   ECACC; 77650129
DR   HipSci; HPSI0314i-hoik_1
DR   hPSCreg; WTSIi026-A
DR   SKIP; SKIP002556
DR   Wikidata; Q54890615
RX   PubMed=28489815;
RX   PubMed=31813827;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540096; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN02 ! HPSI0314i-hoik_2
OI   CVCL_JN03 ! HPSI0314i-hoik_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-hoik_2
AC   CVCL_JN02
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2698312
DR   HipSci; HPSI0314i-hoik_2
DR   Wikidata; Q54890616
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE82 ! HPSI0314i-hoik_1
OI   CVCL_JN03 ! HPSI0314i-hoik_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0314i-hoik_3
AC   CVCL_JN03
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2698313
DR   HipSci; HPSI0314i-hoik_3
DR   Wikidata; Q54890617
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE82 ! HPSI0314i-hoik_1
OI   CVCL_JN02 ! HPSI0314i-hoik_2
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0314i-kujn_2
AC   CVCL_IX23
SY   WTSIi495-A
DR   BioSamples; SAMEA4448211
DR   ECACC; 77650459
DR   HipSci; HPSI0314i-kujn_2
DR   hPSCreg; WTSIi495-A
DR   Wikidata; Q54890620
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX24 ! HPSI0314i-kujn_5
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0314i-kujn_5
AC   CVCL_IX24
SY   WTSIi495-B; WTSIi540-A
DR   BioSamples; SAMEA4448547
DR   ECACC; 77650460
DR   HipSci; HPSI0314i-kujn_5
DR   hPSCreg; WTSIi495-B
DR   Wikidata; Q54890621
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX23 ! HPSI0314i-kujn_2
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0314i-qaqx_1
AC   CVCL_AE83
SY   WTSIi040-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2658084
DR   EBiSC; WTSIi040-A
DR   ECACC; 66540036
DR   ECACC; 77650146
DR   HipSci; HPSI0314i-qaqx_1
DR   hPSCreg; WTSIi040-A
DR   SKIP; SKIP002599
DR   Wikidata; Q54890622
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540036; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-qonc_1
AC   CVCL_AE84
SY   WTSIi011-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2707499
DR   EBiSC; WTSIi011-B
DR   ECACC; 66540192
DR   ECACC; 77650084
DR   HipSci; HPSI0314i-qonc_1
DR   hPSCreg; WTSIi011-B
DR   SKIP; SKIP002695
DR   Wikidata; Q54890623
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540192; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE85 ! HPSI0314i-qonc_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-qonc_2
AC   CVCL_AE85
SY   WTSIi011-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2707507
DR   EBiSC; WTSIi011-A
DR   ECACC; 66540081
DR   ECACC; 77650074
DR   HipSci; HPSI0314i-qonc_2
DR   hPSCreg; WTSIi011-A
DR   SKIP; SKIP002524
DR   Wikidata; Q54890624
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540081; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE84 ! HPSI0314i-qonc_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-sojd_1
AC   CVCL_JN04
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627573
DR   HipSci; HPSI0314i-sojd_1
DR   Wikidata; Q54890625
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE86 ! HPSI0314i-sojd_2
OI   CVCL_AE87 ! HPSI0314i-sojd_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0314i-sojd_2
AC   CVCL_AE86
SY   WTSIi073-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627571
DR   EBiSC; WTSIi073-B
DR   ECACC; 66540253
DR   ECACC; 77650184
DR   HipSci; HPSI0314i-sojd_2
DR   hPSCreg; WTSIi073-B
DR   SKIP; SKIP002777
DR   Wikidata; Q54890626
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540253; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN04 ! HPSI0314i-sojd_1
OI   CVCL_AE87 ! HPSI0314i-sojd_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0314i-sojd_3
AC   CVCL_AE87
SY   WTSIi073-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2627569
DR   EBiSC; WTSIi073-A
DR   ECACC; 66540185
DR   ECACC; 77650126
DR   HipSci; HPSI0314i-sojd_3
DR   hPSCreg; WTSIi073-A
DR   SKIP; SKIP002662
DR   Wikidata; Q54890627
RX   PubMed=28489815;
RX   PubMed=31813827;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Gln348Ter (c.1042C>T); Zygosity=Heterozygous (PubMed=31813827).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; WTSIi073-A; true.
CC   Discontinued: ECACC; 66540185; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN04 ! HPSI0314i-sojd_1
OI   CVCL_AE86 ! HPSI0314i-sojd_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0314i-uict_1
AC   CVCL_WJ94
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103885511
DR   ECACC; 77650815
DR   HipSci; HPSI0314i-uict_1
DR   Wikidata; Q94223155
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ95 ! HPSI0314i-uict_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0314i-uict_3
AC   CVCL_WJ95
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103885510
DR   ECACC; 77650816
DR   HipSci; HPSI0314i-uict_3
DR   Wikidata; Q94223161
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ94 ! HPSI0314i-uict_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0314i-wigw_2
AC   CVCL_EE57
SY   WTSIi179-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3969710
DR   EBiSC; WTSIi179-A
DR   ECACC; 66540352
DR   ECACC; 77650315
DR   HipSci; HPSI0314i-wigw_2
DR   hPSCreg; WTSIi179-A
DR   SKIP; SKIP002846
DR   Wikidata; Q54890628
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540352; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-xagu_1
AC   CVCL_LL24
SY   WTSIi705-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4452626
DR   ECACC; 77650680
DR   HipSci; HPSI0314i-xagu_1
DR   hPSCreg; WTSIi705-A
DR   Wikidata; Q54890629
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650680; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0314i-xugn_1
AC   CVCL_AE88
SY   WTSIi010-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2645811
DR   EBiSC; WTSIi010-A
DR   ECACC; 66540080
DR   ECACC; 77650055
DR   HipSci; HPSI0314i-xugn_1
DR   hPSCreg; WTSIi010-A
DR   SKIP; SKIP002523
DR   Wikidata; Q54890630
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540080; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE89 ! HPSI0314i-xugn_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0314i-xugn_2
AC   CVCL_AE89
SY   WTSIi010-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2645809
DR   EBiSC; WTSIi010-B
DR   ECACC; 66540111
DR   ECACC; 77650144
DR   HipSci; HPSI0314i-xugn_2
DR   hPSCreg; WTSIi010-B
DR   SKIP; SKIP002609
DR   Wikidata; Q54890631
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540111; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE88 ! HPSI0314i-xugn_1
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0316i-aask_4
AC   CVCL_IX49
SY   WTSIi580-A
DR   BioSamples; SAMEA4446777
DR   ECACC; 77650553
DR   HipSci; HPSI0316i-aask_4
DR   hPSCreg; WTSIi580-A
DR   Wikidata; Q54890632
CC   From: University of Manchester; Manchester; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0316i-beqm_12
AC   CVCL_WJ60
DR   BioSamples; SAMEA104242355
DR   ECACC; 77650845
DR   HipSci; HPSI0316i-beqm_12
DR   Wikidata; Q94223232
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ61 ! HPSI0316i-beqm_9
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0316i-beqm_9
AC   CVCL_WJ61
DR   BioSamples; SAMEA104242350
DR   ECACC; 77650844
DR   HipSci; HPSI0316i-beqm_9
DR   Wikidata; Q94223236
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ60 ! HPSI0316i-beqm_12
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0316i-circ_2
AC   CVCL_LF09
SY   WTSIi501-A
DR   BioSamples; SAMEA4453729
DR   ECACC; 77650640
DR   HipSci; HPSI0316i-circ_2
DR   hPSCreg; WTSIi501-A
DR   Wikidata; Q54890633
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF10 ! HPSI0316i-circ_4
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0316i-circ_4
AC   CVCL_LF10
SY   WTSIi501-B; WTSIi583-A
DR   BioSamples; SAMEA4453727
DR   ECACC; 77650664
DR   HipSci; HPSI0316i-circ_4
DR   hPSCreg; WTSIi501-B
DR   Wikidata; Q54890634
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF09 ! HPSI0316i-circ_2
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0316i-eoko_3
AC   CVCL_LF00
SY   WTSIi461-B; WTSIi500-A
DR   BioSamples; SAMEA4453829
DR   ECACC; 77650642
DR   HipSci; HPSI0316i-eoko_3
DR   hPSCreg; WTSIi461-B
DR   Wikidata; Q54890635
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF01 ! HPSI0316i-eoko_5
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0316i-eoko_5
AC   CVCL_LF01
SY   WTSIi461-A
DR   BioSamples; SAMEA4453826
DR   ECACC; 77650641
DR   HipSci; HPSI0316i-eoko_5
DR   hPSCreg; WTSIi461-A
DR   Wikidata; Q54890636
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF00 ! HPSI0316i-eoko_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0316i-ierp_4
AC   CVCL_IX50
SY   WTSIi469-A
DR   BioSamples; SAMEA4447303
DR   ECACC; 77650474
DR   HipSci; HPSI0316i-ierp_4
DR   hPSCreg; WTSIi469-A
DR   Wikidata; Q54890637
CC   From: University of Manchester; Manchester; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0316i-miov_1
AC   CVCL_LF02
SY   WTSIi462-A
DR   BioSamples; SAMEA4453822
DR   ECACC; 77650643
DR   HipSci; HPSI0316i-miov_1
DR   hPSCreg; WTSIi462-A
DR   Wikidata; Q54890638
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0316i-muwv_3
AC   CVCL_IX77
SY   WTSIi448-A
DR   BioSamples; SAMEA4448534
DR   ECACC; 77650502
DR   HipSci; HPSI0316i-muwv_3
DR   hPSCreg; WTSIi448-A
DR   Wikidata; Q54890639
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX78 ! HPSI0316i-muwv_6
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0316i-muwv_6
AC   CVCL_IX78
SY   WTSIi448-B; WTSIi492-A
DR   BioSamples; SAMEA4448528
DR   ECACC; 77650503
DR   HipSci; HPSI0316i-muwv_6
DR   hPSCreg; WTSIi448-B
DR   Wikidata; Q54890640
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX77 ! HPSI0316i-muwv_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0316i-pecz_2
AC   CVCL_LL25
SY   WTSIi684-A
DR   BioSamples; SAMEA4453735
DR   ECACC; 77650765
DR   HipSci; HPSI0316i-pecz_2
DR   hPSCreg; WTSIi684-A
DR   Wikidata; Q54890641
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: African; Sudanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0316i-ponl_2
AC   CVCL_LF03
SY   WTSIi679-A
DR   BioSamples; SAMEA4562364
DR   ECACC; 77650711
DR   HipSci; HPSI0316i-ponl_2
DR   hPSCreg; WTSIi679-A
DR   Wikidata; Q54890642
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF04 ! HPSI0316i-ponl_4
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0316i-ponl_4
AC   CVCL_LF04
SY   WTSIi679-B; WTSIi739-A
DR   BioSamples; SAMEA4562358
DR   ECACC; 77650747
DR   HipSci; HPSI0316i-ponl_4
DR   hPSCreg; WTSIi679-B
DR   Wikidata; Q54890643
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF03 ! HPSI0316i-ponl_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0316i-qeti_1
AC   CVCL_IX51
SY   WTSIi526-B; WTSIi543-A
DR   BioSamples; SAMEA4453779
DR   ECACC; 77650486
DR   HipSci; HPSI0316i-qeti_1
DR   hPSCreg; WTSIi526-B
DR   Wikidata; Q54890644
CC   From: University of Manchester; Manchester; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX52 ! HPSI0316i-qeti_2
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0316i-qeti_2
AC   CVCL_IX52
SY   WTSIi526-A
DR   BioSamples; SAMEA4453781
DR   ECACC; 77650487
DR   HipSci; HPSI0316i-qeti_2
DR   hPSCreg; WTSIi526-A
DR   Wikidata; Q54890645
CC   From: University of Manchester; Manchester; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX51 ! HPSI0316i-qeti_1
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0316i-tezs_6
AC   CVCL_IX69
SY   WTSIi520-A
DR   BioSamples; SAMEA4453864
DR   ECACC; 77650624
DR   HipSci; HPSI0316i-tezs_6
DR   hPSCreg; WTSIi520-A
DR   Wikidata; Q54890646
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0316i-vats_2
AC   CVCL_LF11
SY   WTSIi632-A
DR   BioSamples; SAMEA4563365
DR   ECACC; 77650723
DR   HipSci; HPSI0316i-vats_2
DR   hPSCreg; WTSIi632-A
DR   Wikidata; Q54890647
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF12 ! HPSI0316i-vats_4
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0316i-vats_4
AC   CVCL_LF12
SY   WTSIi632-B; WTSIi671-A
DR   BioSamples; SAMEA4563367
DR   ECACC; 77650855
DR   HipSci; HPSI0316i-vats_4
DR   hPSCreg; WTSIi632-B
DR   Wikidata; Q54890648
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF11 ! HPSI0316i-vats_2
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0316i-xaqm_4
AC   CVCL_IX70
SY   WTSIi490-B; WTSIi555-A
DR   BioSamples; SAMEA4453836
DR   ECACC; 77650534
DR   HipSci; HPSI0316i-xaqm_4
DR   hPSCreg; WTSIi490-B
DR   Wikidata; Q54890649
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Bahraini.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX71 ! HPSI0316i-xaqm_6
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0316i-xaqm_6
AC   CVCL_IX71
SY   WTSIi490-A
DR   BioSamples; SAMEA4453885
DR   ECACC; 77650535
DR   HipSci; HPSI0316i-xaqm_6
DR   hPSCreg; WTSIi490-A
DR   Wikidata; Q54890650
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Bahraini.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX70 ! HPSI0316i-xaqm_4
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0316i-zuik_6
AC   CVCL_LL26
SY   WTSIi663-A
DR   BioSamples; SAMEA4453772
DR   ECACC; 77650788
DR   HipSci; HPSI0316i-zuik_6
DR   hPSCreg; WTSIi663-A
DR   Wikidata; Q54890651
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caribbean.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131425; Congenital hyperinsulinism
DI   ORDO; Orphanet_276525; Familial hyperinsulinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0413i-bupo_4
AC   CVCL_AE90
DR   BioSamples; SAMEA2398801
DR   HipSci; HPSI0413i-bupo_4
DR   Wikidata; Q54890652
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN05 ! HPSI0413i-bupo_5
OI   CVCL_JN06 ! HPSI0413i-bupo_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0413i-bupo_5
AC   CVCL_JN05
DR   BioSamples; SAMEA2398648
DR   HipSci; HPSI0413i-bupo_5
DR   Wikidata; Q54890653
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE90 ! HPSI0413i-bupo_4
OI   CVCL_JN06 ! HPSI0413i-bupo_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0413i-bupo_6
AC   CVCL_JN06
DR   BioSamples; SAMEA2398698
DR   HipSci; HPSI0413i-bupo_6
DR   Wikidata; Q54890654
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE90 ! HPSI0413i-bupo_4
OI   CVCL_JN05 ! HPSI0413i-bupo_5
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0413i-corn_1
AC   CVCL_AE91
SY   WTSIi053-A
DR   BioSamples; SAMEA2677117
DR   EBiSC; WTSIi053-A
DR   ECACC; 66540150
DR   ECACC; 77650219
DR   HipSci; HPSI0413i-corn_1
DR   hPSCreg; WTSIi053-A
DR   SKIP; SKIP002642
DR   Wikidata; Q54890655
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540150; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0413i-coxy_2
AC   CVCL_JN07
DR   BioSamples; SAMEA2399029
DR   HipSci; HPSI0413i-coxy_2
DR   Wikidata; Q54890656
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE92 ! HPSI0413i-coxy_3
OI   CVCL_AE93 ! HPSI0413i-coxy_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-coxy_3
AC   CVCL_AE92
SY   WTSIi109-A
DR   BioSamples; SAMEA2399264
DR   ECACC; 77650015
DR   HipSci; HPSI0413i-coxy_3
DR   hPSCreg; WTSIi109-A
DR   SKIP; SKIP002725
DR   Wikidata; Q54890657
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN07 ! HPSI0413i-coxy_2
OI   CVCL_AE93 ! HPSI0413i-coxy_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-coxy_33
AC   CVCL_AE93
SY   WTSIi109-B
DR   BioSamples; SAMEA2398219
DR   EBiSC; WTSIi109-B
DR   ECACC; 66540234
DR   ECACC; 77650220
DR   HipSci; HPSI0413i-coxy_33
DR   hPSCreg; WTSIi109-B
DR   SKIP; SKIP002759
DR   Wikidata; Q54890658
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540234; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN07 ! HPSI0413i-coxy_2
OI   CVCL_AE92 ! HPSI0413i-coxy_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0413i-gomv_2
AC   CVCL_JN08
DR   BioSamples; SAMEA2398939
DR   HipSci; HPSI0413i-gomv_2
DR   Wikidata; Q54890659
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE94 ! HPSI0413i-gomv_3
OI   CVCL_JN09 ! HPSI0413i-gomv_4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0413i-gomv_3
AC   CVCL_AE94
DR   BioSamples; SAMEA2399172
DR   ECACC; 77650588
DR   HipSci; HPSI0413i-gomv_3
DR   Wikidata; Q54890663
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 77650588; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN08 ! HPSI0413i-gomv_2
OI   CVCL_JN09 ! HPSI0413i-gomv_4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   HPSI0413i-gomv_4
AC   CVCL_JN09
DR   BioSamples; SAMEA2398101
DR   HipSci; HPSI0413i-gomv_4
DR   Wikidata; Q54890664
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE94 ! HPSI0413i-gomv_3
OI   CVCL_JN08 ! HPSI0413i-gomv_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0413i-iakz_1
AC   CVCL_AE95
SY   WTSIi102-B
DR   BioSamples; SAMEA2398858
DR   ECACC; 77650023
DR   HipSci; HPSI0413i-iakz_1
DR   hPSCreg; WTSIi102-B
DR   SKIP; SKIP002730
DR   Wikidata; Q54890665
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE96 ! HPSI0413i-iakz_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-iakz_2
AC   CVCL_AE96
SY   WTSIi102-A
DR   BioSamples; SAMEA2397889
DR   ECACC; 77650231
DR   HipSci; HPSI0413i-iakz_2
DR   hPSCreg; WTSIi102-A
DR   SKIP; SKIP002717
DR   Wikidata; Q54890666
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE95 ! HPSI0413i-iakz_1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-nudd_1
AC   CVCL_AE97
SY   WTSIi054-A
DR   BioSamples; SAMEA2399199
DR   EBiSC; WTSIi054-A
DR   ECACC; 66540149
DR   ECACC; 77650188
DR   HipSci; HPSI0413i-nudd_1
DR   hPSCreg; WTSIi054-A
DR   SKIP; SKIP002643
DR   Wikidata; Q54890667
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540149; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN10 ! HPSI0413i-nudd_2
OI   CVCL_AE98 ! HPSI0413i-nudd_6
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0413i-nudd_2
AC   CVCL_JN10
DR   BioSamples; SAMEA2399092
DR   HipSci; HPSI0413i-nudd_2
DR   Wikidata; Q54890668
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE97 ! HPSI0413i-nudd_1
OI   CVCL_AE98 ! HPSI0413i-nudd_6
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-nudd_6
AC   CVCL_AE98
SY   WTSIi054-B
DR   BioSamples; SAMEA2398822
DR   EBiSC; WTSIi054-B
DR   ECACC; 66540247
DR   ECACC; 77650169
DR   HipSci; HPSI0413i-nudd_6
DR   hPSCreg; WTSIi054-B
DR   SKIP; SKIP002772
DR   Wikidata; Q54890669
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; WTSIi054-B; true.
CC   Discontinued: ECACC; 66540247; true.
CC   Discontinued: ECACC; 77650169; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE97 ! HPSI0413i-nudd_1
OI   CVCL_JN10 ! HPSI0413i-nudd_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0413i-ougl_1
AC   CVCL_AE99
SY   WTSIi121-A
DR   BioSamples; SAMEA2398316
DR   ECACC; 77650110
DR   HipSci; HPSI0413i-ougl_1
DR   hPSCreg; WTSIi121-A
DR   PRIDE; PXD003903
DR   SKIP; SKIP002744
DR   Wikidata; Q54890670
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN11 ! HPSI0413i-ougl_2
OI   CVCL_AF00 ! HPSI0413i-ougl_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0413i-ougl_2
AC   CVCL_JN11
DR   BioSamples; SAMEA2399179
DR   HipSci; HPSI0413i-ougl_2
DR   Wikidata; Q54890671
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE99 ! HPSI0413i-ougl_1
OI   CVCL_AF00 ! HPSI0413i-ougl_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-ougl_3
AC   CVCL_AF00
SY   WTSIi121-B
DR   BioSamples; SAMEA2398428
DR   ECACC; 77650117
DR   HipSci; HPSI0413i-ougl_3
DR   hPSCreg; WTSIi121-B
DR   PRIDE; PXD003903
DR   SKIP; SKIP002745
DR   Wikidata; Q54890672
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE99 ! HPSI0413i-ougl_1
OI   CVCL_JN11 ! HPSI0413i-ougl_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0413i-peop_1
AC   CVCL_JN12
DR   BioSamples; SAMEA2399024
DR   HipSci; HPSI0413i-peop_1
DR   Wikidata; Q54890673
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF01 ! HPSI0413i-peop_2
OI   CVCL_JN13 ! HPSI0413i-peop_3
OI   CVCL_AF02 ! HPSI0413i-peop_4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-peop_2
AC   CVCL_AF01
SY   WTSIi122-A
DR   BioSamples; SAMEA2399200
DR   ECACC; 77650021
DR   HipSci; HPSI0413i-peop_2
DR   hPSCreg; WTSIi122-A
DR   SKIP; SKIP002746
DR   Wikidata; Q54890674
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN12 ! HPSI0413i-peop_1
OI   CVCL_JN13 ! HPSI0413i-peop_3
OI   CVCL_AF02 ! HPSI0413i-peop_4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0413i-peop_3
AC   CVCL_JN13
DR   BioSamples; SAMEA2398388
DR   HipSci; HPSI0413i-peop_3
DR   Wikidata; Q54890675
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN12 ! HPSI0413i-peop_1
OI   CVCL_AF01 ! HPSI0413i-peop_2
OI   CVCL_AF02 ! HPSI0413i-peop_4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-peop_4
AC   CVCL_AF02
SY   WTSIi122-B; WTSIi352-A
DR   BioSamples; SAMEA2398297
DR   ECACC; 77650243
DR   HipSci; HPSI0413i-peop_4
DR   hPSCreg; WTSIi122-B
DR   Wikidata; Q54890676
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN12 ! HPSI0413i-peop_1
OI   CVCL_AF01 ! HPSI0413i-peop_2
OI   CVCL_JN13 ! HPSI0413i-peop_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0413i-sukz_1
AC   CVCL_AF03
SY   WTSIi093-A
DR   BioSamples; SAMEA2398007
DR   EBiSC; WTSIi093-A
DR   ECACC; 66540208
DR   ECACC; 77650118
DR   HipSci; HPSI0413i-sukz_1
DR   hPSCreg; WTSIi093-A
DR   SKIP; SKIP002709
DR   Wikidata; Q54890677
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540208; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN14 ! HPSI0413i-sukz_2
OI   CVCL_JN15 ! HPSI0413i-sukz_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-sukz_2
AC   CVCL_JN14
DR   BioSamples; SAMEA2398826
DR   HipSci; HPSI0413i-sukz_2
DR   Wikidata; Q54890678
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF03 ! HPSI0413i-sukz_1
OI   CVCL_JN15 ! HPSI0413i-sukz_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-sukz_3
AC   CVCL_JN15
DR   BioSamples; SAMEA2398673
DR   HipSci; HPSI0413i-sukz_3
DR   Wikidata; Q54890679
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF03 ! HPSI0413i-sukz_1
OI   CVCL_JN14 ! HPSI0413i-sukz_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-uahf_1
AC   CVCL_JN16
DR   BioSamples; SAMEA2399072
DR   HipSci; HPSI0413i-uahf_1
DR   Wikidata; Q54890680
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN17 ! HPSI0413i-uahf_2
OI   CVCL_AF04 ! HPSI0413i-uahf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-uahf_2
AC   CVCL_JN17
DR   BioSamples; SAMEA2397878
DR   HipSci; HPSI0413i-uahf_2
DR   Wikidata; Q54890681
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN16 ! HPSI0413i-uahf_1
OI   CVCL_AF04 ! HPSI0413i-uahf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-uahf_3
AC   CVCL_AF04
SY   WTSIi125-A
DR   BioSamples; SAMEA2397812
DR   ECACC; 77650007
DR   HipSci; HPSI0413i-uahf_3
DR   hPSCreg; WTSIi125-A
DR   SKIP; SKIP002750
DR   Wikidata; Q54890682
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN16 ! HPSI0413i-uahf_1
OI   CVCL_JN17 ! HPSI0413i-uahf_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-xekf_1
AC   CVCL_AF05
SY   WTSIi127-A
DR   BioSamples; SAMEA2399123
DR   ECACC; 77650010
DR   HipSci; HPSI0413i-xekf_1
DR   hPSCreg; WTSIi127-A
DR   SKIP; SKIP002752
DR   Wikidata; Q54890683
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN18 ! HPSI0413i-xekf_2
OI   CVCL_JN19 ! HPSI0413i-xekf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-xekf_2
AC   CVCL_JN18
DR   BioSamples; SAMEA2397932
DR   HipSci; HPSI0413i-xekf_2
DR   Wikidata; Q54890684
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF05 ! HPSI0413i-xekf_1
OI   CVCL_JN19 ! HPSI0413i-xekf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-xekf_3
AC   CVCL_JN19
DR   BioSamples; SAMEA2398920
DR   HipSci; HPSI0413i-xekf_3
DR   Wikidata; Q54890685
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF05 ! HPSI0413i-xekf_1
OI   CVCL_JN18 ! HPSI0413i-xekf_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-xisg_1
AC   CVCL_JN20
DR   BioSamples; SAMEA2398077
DR   HipSci; HPSI0413i-xisg_1
DR   Wikidata; Q54890686
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF06 ! HPSI0413i-xisg_2
OI   CVCL_JN21 ! HPSI0413i-xisg_3
OI   CVCL_JN22 ! HPSI0413i-xisg_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0413i-xisg_2
AC   CVCL_AF06
DR   BioSamples; SAMEA2397966
DR   HipSci; HPSI0413i-xisg_2
DR   Wikidata; Q54890687
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN20 ! HPSI0413i-xisg_1
OI   CVCL_JN21 ! HPSI0413i-xisg_3
OI   CVCL_JN22 ! HPSI0413i-xisg_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0413i-xisg_3
AC   CVCL_JN21
DR   BioSamples; SAMEA2397828
DR   HipSci; HPSI0413i-xisg_3
DR   Wikidata; Q54890688
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN20 ! HPSI0413i-xisg_1
OI   CVCL_AF06 ! HPSI0413i-xisg_2
OI   CVCL_JN22 ! HPSI0413i-xisg_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0413i-xisg_33
AC   CVCL_JN22
DR   BioSamples; SAMEA2397817
DR   HipSci; HPSI0413i-xisg_33
DR   Wikidata; Q54890689
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN20 ! HPSI0413i-xisg_1
OI   CVCL_AF06 ! HPSI0413i-xisg_2
OI   CVCL_JN21 ! HPSI0413i-xisg_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0413i-yotv_2
AC   CVCL_AF07
SY   WTSIi355-A
DR   BioSamples; SAMEA2399165
DR   ECACC; 77650153
DR   HipSci; HPSI0413i-yotv_2
DR   hPSCreg; WTSIi355-A
DR   Wikidata; Q54890690
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF08 ! HPSI0413i-yotv_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-yotv_3
AC   CVCL_AF08
SY   WTSIi355-B; WTSIi386-A
DR   BioSamples; SAMEA2397911
DR   ECACC; 77650590
DR   HipSci; HPSI0413i-yotv_3
DR   hPSCreg; WTSIi355-B
DR   Wikidata; Q54890691
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF07 ! HPSI0413i-yotv_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0413i-yuze_1
AC   CVCL_AF09
SY   WTSIi128-A
DR   BioSamples; SAMEA2397955
DR   ECACC; 77650011
DR   HipSci; HPSI0413i-yuze_1
DR   hPSCreg; WTSIi128-A
DR   SKIP; SKIP002753
DR   Wikidata; Q54890692
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN23 ! HPSI0413i-yuze_2
OI   CVCL_JN24 ! HPSI0413i-yuze_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0413i-yuze_2
AC   CVCL_JN23
DR   BioSamples; SAMEA2398805
DR   HipSci; HPSI0413i-yuze_2
DR   Wikidata; Q54890693
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF09 ! HPSI0413i-yuze_1
OI   CVCL_JN24 ! HPSI0413i-yuze_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0413i-yuze_3
AC   CVCL_JN24
DR   BioSamples; SAMEA2397869
DR   HipSci; HPSI0413i-yuze_3
DR   Wikidata; Q54890694
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF09 ! HPSI0413i-yuze_1
OI   CVCL_JN23 ! HPSI0413i-yuze_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0414i-biiw_1
AC   CVCL_AF10
SY   WTSIi192-A
DR   BioSamples; SAMEA2733282
DR   EBiSC; WTSIi192-A
DR   ECACC; 66540426
DR   ECACC; 77650333
DR   HipSci; HPSI0414i-biiw_1
DR   hPSCreg; WTSIi192-A
DR   Wikidata; Q54890695
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540426; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-ceik_1
AC   CVCL_AF11
SY   WTSIi243-B; WTSIi328-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3470396
DR   ECACC; 77650608
DR   HipSci; HPSI0414i-ceik_1
DR   hPSCreg; WTSIi243-B
DR   Wikidata; Q54890696
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF12 ! HPSI0414i-ceik_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-ceik_2
AC   CVCL_AF12
SY   WTSIi243-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3474016
DR   ECACC; 77650609
DR   HipSci; HPSI0414i-ceik_2
DR   hPSCreg; WTSIi243-A
DR   Wikidata; Q54890697
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF11 ! HPSI0414i-ceik_1
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-cekz_1
AC   CVCL_AF13
SY   WTSIi193-A
DR   BioSamples; SAMEA2698314
DR   EBiSC; WTSIi193-A
DR   ECACC; 66540427
DR   ECACC; 77650334
DR   HipSci; HPSI0414i-cekz_1
DR   hPSCreg; WTSIi193-A
DR   Wikidata; Q54890698
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; German.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540427; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-eafb_1
AC   CVCL_AF14
SY   WTSIi152-A
DR   BioSamples; SAMEA2769874
DR   EBiSC; WTSIi152-A
DR   ECACC; 66540306
DR   ECACC; 77650269
DR   HipSci; HPSI0414i-eafb_1
DR   hPSCreg; WTSIi152-A
DR   SKIP; SKIP002805
DR   Wikidata; Q54890699
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540306; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-eevy_6
AC   CVCL_AJ87
SY   WTSIi195-A
DR   BioSamples; SAMEA3848091
DR   EBiSC; WTSIi195-A
DR   ECACC; 66540429
DR   ECACC; 77650353
DR   HipSci; HPSI0414i-eevy_6
DR   hPSCreg; WTSIi195-A
DR   Wikidata; Q54890700
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540429; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ88 ! HPSI0414i-eevy_7
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-eevy_7
AC   CVCL_AJ88
SY   WTSIi195-B
DR   BioSamples; SAMEA3848092
DR   ECACC; 77650354
DR   HipSci; HPSI0414i-eevy_7
DR   hPSCreg; WTSIi195-B
DR   Wikidata; Q54890701
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ87 ! HPSI0414i-eevy_6
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0414i-fixm_2
AC   CVCL_AF15
SY   WTSIi151-A
DR   BioSamples; SAMEA2757093
DR   EBiSC; WTSIi151-A
DR   ECACC; 66540305
DR   ECACC; 77650272
DR   HipSci; HPSI0414i-fixm_2
DR   hPSCreg; WTSIi151-A
DR   SKIP; SKIP002804
DR   Wikidata; Q54890702
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540305; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-fuai_1
AC   CVCL_AF16
SY   WTSIi198-A
DR   BioSamples; SAMEA2796155
DR   EBiSC; WTSIi198-A
DR   ECACC; 66540433
DR   ECACC; 77650336
DR   HipSci; HPSI0414i-fuai_1
DR   hPSCreg; WTSIi198-A
DR   Wikidata; Q54890706
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian and Cuban.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540433; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-gesg_2
AC   CVCL_AJ89
SY   WTSIi271-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854130
DR   ECACC; 77650569
DR   HipSci; HPSI0414i-gesg_2
DR   hPSCreg; WTSIi271-A
DR   Wikidata; Q54890707
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-hutq_1
AC   CVCL_AF17
SY   WTSIi155-A
DR   BioSamples; SAMEA2777391
DR   EBiSC; WTSIi155-A
DR   ECACC; 66540309
DR   ECACC; 77650273
DR   HipSci; HPSI0414i-hutq_1
DR   hPSCreg; WTSIi155-A
DR   SKIP; SKIP002808
DR   Wikidata; Q54890708
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540309; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-jetz_1
AC   CVCL_AF18
SY   WTSIi150-A
DR   BioSamples; SAMEA2729778
DR   EBiSC; WTSIi150-A
DR   ECACC; 66540304
DR   ECACC; 77650268
DR   HipSci; HPSI0414i-jetz_1
DR   hPSCreg; WTSIi150-A
DR   SKIP; SKIP002803
DR   Wikidata; Q54890709
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Discontinued: ECACC; 66540304; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-kefk_2
AC   CVCL_AF19
SY   WTSIi200-A
DR   BioSamples; SAMEA2733285
DR   EBiSC; WTSIi200-A
DR   ECACC; 66540435
DR   ECACC; 77650335
DR   HipSci; HPSI0414i-kefk_2
DR   hPSCreg; WTSIi200-A
DR   Wikidata; Q54890710
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Bulgarian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540435; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-kodf_2
AC   CVCL_AF20
SY   WTSIi396-A
DR   BioSamples; SAMEA2708758
DR   ECACC; 77650556
DR   HipSci; HPSI0414i-kodf_2
DR   hPSCreg; WTSIi396-A
DR   Wikidata; Q54890711
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0414i-lavd_2
AC   CVCL_AF21
SY   WTSIi154-A
DR   BioSamples; SAMEA2777396
DR   EBiSC; WTSIi154-A
DR   ECACC; 66540308
DR   ECACC; 77650274
DR   HipSci; HPSI0414i-lavd_2
DR   hPSCreg; WTSIi154-A
DR   SKIP; SKIP002807
DR   Wikidata; Q54890712
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540308; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-mita_1
AC   CVCL_JN25
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2724746
DR   HipSci; HPSI0414i-mita_1
DR   Wikidata; Q54890714
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF22 ! HPSI0414i-mita_2
OI   CVCL_JN26 ! HPSI0414i-mita_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0414i-mita_2
AC   CVCL_AF22
SY   WTSIi138-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2724743
DR   EBiSC; WTSIi138-A
DR   ECACC; 66540246
DR   ECACC; 77650194
DR   HipSci; HPSI0414i-mita_2
DR   hPSCreg; WTSIi138-A
DR   SKIP; SKIP002771
DR   Wikidata; Q54890715
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540246; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN25 ! HPSI0414i-mita_1
OI   CVCL_JN26 ! HPSI0414i-mita_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0414i-mita_3
AC   CVCL_JN26
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2724753
DR   HipSci; HPSI0414i-mita_3
DR   Wikidata; Q54890716
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN25 ! HPSI0414i-mita_1
OI   CVCL_AF22 ! HPSI0414i-mita_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0414i-naju_1
AC   CVCL_EE48
SY   WTSIi173-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962372
DR   EBiSC; WTSIi173-A
DR   ECACC; 66540344
DR   ECACC; 77650297
DR   HipSci; HPSI0414i-naju_1
DR   hPSCreg; WTSIi173-A
DR   SKIP; SKIP002840
DR   Wikidata; Q54890717
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540344; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0414i-niim_3
AC   CVCL_EE86
SY   WTSIi408-A
DR   BioSamples; SAMEA4088907
DR   ECACC; 77650406
DR   HipSci; HPSI0414i-niim_3
DR   hPSCreg; WTSIi408-A
DR   Wikidata; Q54890719
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE87 ! HPSI0414i-niim_5
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0414i-niim_5
AC   CVCL_EE87
SY   WTSIi408-B; WTSIi441-A
DR   BioSamples; SAMEA4092259
DR   ECACC; 77650369
DR   HipSci; HPSI0414i-niim_5
DR   hPSCreg; WTSIi408-B
DR   Wikidata; Q54890720
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE86 ! HPSI0414i-niim_3
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0414i-nolz_4
AC   CVCL_IX25
SY   WTSIi478-A
DR   BioSamples; SAMEA3976872
DR   ECACC; 77650504
DR   HipSci; HPSI0414i-nolz_4
DR   hPSCreg; WTSIi478-A
DR   Wikidata; Q54890721
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0414i-oaqd_2
AC   CVCL_EE61
SY   WTSIi183-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854308
DR   EBiSC; WTSIi183-A
DR   ECACC; 66540380
DR   ECACC; 77650298
DR   HipSci; HPSI0414i-oaqd_2
DR   hPSCreg; WTSIi183-A
DR   SKIP; SKIP002867
DR   Wikidata; Q54890722
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540380; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE62 ! HPSI0414i-oaqd_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0414i-oaqd_3
AC   CVCL_EE62
SY   WTSIi183-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3965164
DR   EBiSC; WTSIi183-B
DR   ECACC; 66540381
DR   ECACC; 77650299
DR   HipSci; HPSI0414i-oaqd_3
DR   hPSCreg; WTSIi183-B
DR   SKIP; SKIP002872
DR   Wikidata; Q54890723
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540381; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE61 ! HPSI0414i-oaqd_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0414i-oikd_2
AC   CVCL_EE88
SY   WTSIi260-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4446772
DR   ECACC; 77650380
DR   HipSci; HPSI0414i-oikd_2
DR   hPSCreg; WTSIi260-A
DR   Wikidata; Q54890724
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE89 ! HPSI0414i-oikd_5
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-oikd_5
AC   CVCL_EE89
SY   WTSIi260-B; WTSIi333-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4446953
DR   ECACC; 77650385
DR   HipSci; HPSI0414i-oikd_5
DR   hPSCreg; WTSIi260-B
DR   Wikidata; Q54890725
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE88 ! HPSI0414i-oikd_2
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-oulr_2
AC   CVCL_AJ90
SY   WTSIi204-A
DR   BioSamples; SAMEA3847989
DR   EBiSC; WTSIi204-A
DR   ECACC; 66540439
DR   ECACC; 77650355
DR   HipSci; HPSI0414i-oulr_2
DR   hPSCreg; WTSIi204-A
DR   Wikidata; Q54890726
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540439; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ91 ! HPSI0414i-oulr_4
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-oulr_4
AC   CVCL_AJ91
SY   WTSIi204-B; WTSIi440-A
DR   BioSamples; SAMEA3847991
DR   ECACC; 77650356
DR   HipSci; HPSI0414i-oulr_4
DR   hPSCreg; WTSIi204-B
DR   Wikidata; Q54890727
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ90 ! HPSI0414i-oulr_2
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0414i-puvg_1
AC   CVCL_AF23
SY   WTSIi153-A
DR   BioSamples; SAMEA2769876
DR   EBiSC; WTSIi153-A
DR   ECACC; 66540307
DR   ECACC; 77650270
DR   HipSci; HPSI0414i-puvg_1
DR   hPSCreg; WTSIi153-A
DR   SKIP; SKIP002806
DR   Wikidata; Q54890728
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540307; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-rauj_1
AC   CVCL_AF24
SY   WTSIi398-A
DR   BioSamples; SAMEA2733286
DR   ECACC; 77650332
DR   HipSci; HPSI0414i-rauj_1
DR   hPSCreg; WTSIi398-A
DR   Wikidata; Q54890729
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0414i-reng_4
AC   CVCL_AF25
SY   WTSIi165-A
DR   BioSamples; SAMEA3358976
DR   EBiSC; WTSIi165-A
DR   ECACC; 66540319
DR   ECACC; 77650279
DR   HipSci; HPSI0414i-reng_4
DR   hPSCreg; WTSIi165-A
DR   SKIP; SKIP002817
DR   Wikidata; Q54890730
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540319; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-sebn_3
AC   CVCL_AJ92
SY   WTSIi285-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962525
DR   ECACC; 77650571
DR   HipSci; HPSI0414i-sebn_3
DR   hPSCreg; WTSIi285-A
DR   Wikidata; Q54890731
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ93 ! HPSI0414i-sebn_4
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-sebn_4
AC   CVCL_AJ93
SY   WTSIi285-B; WTSIi309-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962524
DR   ECACC; 77650587
DR   HipSci; HPSI0414i-sebn_4
DR   hPSCreg; WTSIi285-B
DR   Wikidata; Q54890732
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ92 ! HPSI0414i-sebn_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-seru_1
AC   CVCL_EE71
SY   WTSIi185-B; WTSIi246-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962568
DR   ECACC; 77650322
DR   HipSci; HPSI0414i-seru_1
DR   hPSCreg; WTSIi185-B
DR   Wikidata; Q54890733
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE65 ! HPSI0414i-seru_7
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-seru_7
AC   CVCL_EE65
SY   WTSIi185-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3965165
DR   EBiSC; WTSIi185-A
DR   ECACC; 66540383
DR   ECACC; 77650323
DR   HipSci; HPSI0414i-seru_7
DR   hPSCreg; WTSIi185-A
DR   SKIP; SKIP002871
DR   Wikidata; Q54890734
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540383; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE71 ! HPSI0414i-seru_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0414i-tout_1
AC   CVCL_AF26
SY   WTSIi400-A
DR   BioSamples; SAMEA2777398
DR   ECACC; 77650337
DR   HipSci; HPSI0414i-tout_1
DR   hPSCreg; WTSIi400-A
DR   Wikidata; Q54890735
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-uawq_2
AC   CVCL_IY96
SY   WTSIi597-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4343046
DR   ECACC; 77650436
DR   HipSci; HPSI0414i-uawq_2
DR   hPSCreg; WTSIi597-A
DR   Wikidata; Q54890736
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0414i-uugp_2
AC   CVCL_LL27
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104236471
DR   HipSci; HPSI0414i-uugp_2
DR   Wikidata; Q54890737
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL28 ! HPSI0414i-uugp_3
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0414i-uugp_3
AC   CVCL_LL28
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104236470
DR   HipSci; HPSI0414i-uugp_3
DR   Wikidata; Q54890738
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL27 ! HPSI0414i-uugp_2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0414i-voqc_2
AC   CVCL_LL29
SY   WTSIi627-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4455482
DR   ECACC; 77650667
DR   HipSci; HPSI0414i-voqc_2
DR   hPSCreg; WTSIi627-A
DR   Wikidata; Q54890739
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0414i-walu_1
AC   CVCL_AF27
SY   WTSIi409-A
DR   BioSamples; SAMEA3292102
DR   ECACC; 77650351
DR   HipSci; HPSI0414i-walu_1
DR   hPSCreg; WTSIi409-A
DR   Wikidata; Q54890740
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-wize_1
AC   CVCL_AF28
SY   WTSIi166-A
DR   BioSamples; SAMEA3374096
DR   EBiSC; WTSIi166-A
DR   ECACC; 66540320
DR   ECACC; 77650281
DR   HipSci; HPSI0414i-wize_1
DR   hPSCreg; WTSIi166-A
DR   SKIP; SKIP002818
DR   Wikidata; Q54890741
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540320; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0414i-xojn_3
AC   CVCL_EE54
SY   WTSIi177-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854068
DR   EBiSC; WTSIi177-A
DR   ECACC; 66540349
DR   ECACC; 77650316
DR   HipSci; HPSI0414i-xojn_3
DR   hPSCreg; WTSIi177-A
DR   SKIP; SKIP002844
DR   Wikidata; Q54890742
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540349; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0414i-xugr_2
AC   CVCL_AF29
SY   WTSIi156-A
DR   BioSamples; SAMEA2794309
DR   EBiSC; WTSIi156-A
DR   ECACC; 66540310
DR   ECACC; 77650271
DR   HipSci; HPSI0414i-xugr_2
DR   hPSCreg; WTSIi156-A
DR   SKIP; SKIP002809
DR   Wikidata; Q54890743
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540310; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-zabk_4
AC   CVCL_LL30
SY   WTSIi635-A
DR   BioSamples; SAMEA3847988
DR   ECACC; 77650676
DR   HipSci; HPSI0414i-zabk_4
DR   hPSCreg; WTSIi635-A
DR   Wikidata; Q54890744
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0414i-zazi_4
AC   CVCL_EE72
SY   WTSIi422-A
DR   BioSamples; SAMEA3976800
DR   ECACC; 77650318
DR   HipSci; HPSI0414i-zazi_4
DR   hPSCreg; WTSIi422-A
DR   Wikidata; Q54890745
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX02 ! HPSI0414i-zazi_5
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0414i-zazi_5
AC   CVCL_AX02
SY   WTSIi422-B; WTSIi429-A
DR   BioSamples; SAMEA3976801
DR   ECACC; 77650319
DR   HipSci; HPSI0414i-zazi_5
DR   hPSCreg; WTSIi422-B
DR   Wikidata; Q54890746
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE72 ! HPSI0414i-zazi_4
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0416i-aicq_1
AC   CVCL_IX55
SY   WTSIi466-A
DR   BioSamples; SAMEA4753918
DR   ECACC; 77650550
DR   HipSci; HPSI0416i-aicq_1
DR   hPSCreg; WTSIi466-A
DR   Wikidata; Q54890747
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX56 ! HPSI0416i-aicq_4
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0416i-aicq_4
AC   CVCL_IX56
SY   WTSIi466-B; WTSIi537-A
DR   BioSamples; SAMEA4754668
DR   ECACC; 77650549
DR   HipSci; HPSI0416i-aicq_4
DR   hPSCreg; WTSIi466-B
DR   Wikidata; Q54890753
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX55 ! HPSI0416i-aicq_1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0416i-bife_2
AC   CVCL_IX42
SY   WTSIi515-A
DR   BioSamples; SAMEA4563405
DR   ECACC; 77650552
DR   HipSci; HPSI0416i-bife_2
DR   hPSCreg; WTSIi515-A
DR   Wikidata; Q54890754
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-cihd_4
AC   CVCL_IZ29
SY   WTSIi518-A
DR   BioSamples; SAMEA4700668
DR   ECACC; 77650540
DR   HipSci; HPSI0416i-cihd_4
DR   hPSCreg; WTSIi518-A
DR   Wikidata; Q54890755
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-eapo_2
AC   CVCL_IZ31
SY   WTSIi545-A
DR   BioSamples; SAMEA4563375
DR   ECACC; 77650551
DR   HipSci; HPSI0416i-eapo_2
DR   hPSCreg; WTSIi545-A
DR   Wikidata; Q54890756
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-fiwt_3
AC   CVCL_IX93
SY   WTSIi453-A
DR   BioSamples; SAMEA4453687
DR   ECACC; 77650473
DR   HipSci; HPSI0416i-fiwt_3
DR   hPSCreg; WTSIi453-A
DR   Wikidata; Q54890757
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0416i-iazw_4
AC   CVCL_WK04
DR   BioSamples; SAMEA4563372
DR   ECACC; 77650811
DR   HipSci; HPSI0416i-iazw_4
DR   Wikidata; Q94225021
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0416i-iooi_1
AC   CVCL_IX57
SY   WTSIi514-A
DR   BioSamples; SAMEA4562345
DR   ECACC; 77650521
DR   HipSci; HPSI0416i-iooi_1
DR   hPSCreg; WTSIi514-A
DR   Wikidata; Q54890758
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX58 ! HPSI0416i-iooi_6
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-iooi_6
AC   CVCL_IX58
SY   WTSIi514-B; WTSIi575-A
DR   BioSamples; SAMEA4562347
DR   ECACC; 77650522
DR   HipSci; HPSI0416i-iooi_6
DR   hPSCreg; WTSIi514-B
DR   Wikidata; Q54890759
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650522; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX57 ! HPSI0416i-iooi_1
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0416i-ioys_5
AC   CVCL_LL31
SY   WTSIi685-A
DR   BioSamples; SAMEA4562172
DR   ECACC; 77650753
DR   HipSci; HPSI0416i-ioys_5
DR   hPSCreg; WTSIi685-A
DR   Wikidata; Q54890760
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL32 ! HPSI0416i-ioys_6
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0416i-ioys_6
AC   CVCL_LL32
SY   WTSIi685-B; WTSIi708-A
DR   BioSamples; SAMEA4562173
DR   ECACC; 77650754
DR   HipSci; HPSI0416i-ioys_6
DR   hPSCreg; WTSIi685-B
DR   Wikidata; Q54890761
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL31 ! HPSI0416i-ioys_5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0416i-jewl_5
AC   CVCL_IX59
SY   WTSIi508-A
DR   BioSamples; SAMEA6864418
DR   ECACC; 77650543
DR   HipSci; HPSI0416i-jewl_5
DR   hPSCreg; WTSIi508-A
DR   Wikidata; Q54890762
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX60 ! HPSI0416i-jewl_6
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0416i-jewl_6
AC   CVCL_IX60
SY   WTSIi508-B; WTSIi536-A
DR   BioSamples; SAMEA6865168
DR   ECACC; 77650544
DR   HipSci; HPSI0416i-jewl_6
DR   hPSCreg; WTSIi508-B
DR   Wikidata; Q54890763
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX59 ! HPSI0416i-jewl_5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0416i-mapx_1
AC   CVCL_LF13
SY   WTSIi503-B; WTSIi578-A
DR   BioSamples; SAMEA4682668
DR   ECACC; 77650639
DR   HipSci; HPSI0416i-mapx_1
DR   hPSCreg; WTSIi503-B
DR   Wikidata; Q54890764
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1232Asp (c.3695G>A); Zygosity=Heterozygous (from autologous cell line HPSI0416i-mapx_5).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF14 ! HPSI0416i-mapx_5
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-mapx_5
AC   CVCL_LF14
SY   WTSIi503-A
DR   BioSamples; SAMEA4679668
DR   ECACC; 77650638
DR   HipSci; HPSI0416i-mapx_5
DR   hPSCreg; WTSIi503-A
DR   Wikidata; Q54890766
RX   PubMed=35076391;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1232Asp (c.3695G>A); Zygosity=Heterozygous (PubMed=35076391).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF13 ! HPSI0416i-mapx_1
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-mefc_1
AC   CVCL_IX94
SY   WTSIi548-B; WTSIi574-A
DR   BioSamples; SAMEA4453893
DR   ECACC; 77650479
DR   HipSci; HPSI0416i-mefc_1
DR   hPSCreg; WTSIi548-B
DR   Wikidata; Q54890767
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX95 ! HPSI0416i-mefc_2
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0416i-mefc_2
AC   CVCL_IX95
SY   WTSIi548-A
DR   BioSamples; SAMEA4453894
DR   ECACC; 77650480
DR   HipSci; HPSI0416i-mefc_2
DR   hPSCreg; WTSIi548-A
DR   Wikidata; Q54890768
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX94 ! HPSI0416i-mefc_1
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0416i-ourj_1
AC   CVCL_IX61
SY   WTSIi483-A
DR   BioSamples; SAMEA4761418
DR   ECACC; 77650507
DR   HipSci; HPSI0416i-ourj_1
DR   hPSCreg; WTSIi483-A
DR   Wikidata; Q54890769
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Bangladeshi.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX62 ! HPSI0416i-ourj_2
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0416i-ourj_2
AC   CVCL_IX62
SY   WTSIi483-B; WTSIi509-A
DR   BioSamples; SAMEA4762168
DR   ECACC; 77650508
DR   HipSci; HPSI0416i-ourj_2
DR   hPSCreg; WTSIi483-B
DR   Wikidata; Q54890770
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Bangladeshi.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX61 ! HPSI0416i-ourj_1
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0416i-ruah_4
AC   CVCL_IX63
SY   WTSIi493-A
DR   BioSamples; SAMEA4561634
DR   ECACC; 77650515
DR   HipSci; HPSI0416i-ruah_4
DR   hPSCreg; WTSIi493-A
DR   Wikidata; Q54890771
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX64 ! HPSI0416i-ruah_5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-ruah_5
AC   CVCL_IX64
SY   WTSIi493-B; WTSIi512-A
DR   BioSamples; SAMEA4561637
DR   ECACC; 77650514
DR   HipSci; HPSI0416i-ruah_5
DR   hPSCreg; WTSIi493-B
DR   Wikidata; Q54890772
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX63 ! HPSI0416i-ruah_4
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-sevr_1
AC   CVCL_IX43
SY   WTSIi519-A
DR   BioSamples; SAMEA4562350
DR   ECACC; 77650516
DR   HipSci; HPSI0416i-sevr_1
DR   hPSCreg; WTSIi519-A
DR   Wikidata; Q54890773
RX   PubMed=35076391;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2206; COL4A4; Simple; p.Pro1096Ser (c.3286C>T); Zygosity=Heterozygous (PubMed=35076391).
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1232Asp (c.3695G>A); Zygosity=Heterozygous (PubMed=35076391).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX44 ! HPSI0416i-sevr_2
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0416i-sevr_2
AC   CVCL_IX44
SY   WTSIi519-B; WTSIi546-A
DR   BioSamples; SAMEA4562351
DR   ECACC; 77650517
DR   HipSci; HPSI0416i-sevr_2
DR   hPSCreg; WTSIi519-B
DR   Wikidata; Q54890774
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2206; COL4A4; Simple; p.Pro1096Ser (c.3286C>T); Zygosity=Heterozygous (from autologous cell line HPSI0416i-sevr_1).
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1232Asp (c.3695G>A); Zygosity=Heterozygous (from autologous cell line HPSI0416i-sevr_1).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX43 ! HPSI0416i-sevr_1
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0416i-xutl_2
AC   CVCL_LE93
SY   WTSIi499-A
DR   BioSamples; SAMEA4562178
DR   ECACC; 77650665
DR   HipSci; HPSI0416i-xutl_2
DR   hPSCreg; WTSIi499-A
DR   Wikidata; Q54890775
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0416i-zige_2
AC   CVCL_IX96
SY   WTSIi447-B; WTSIi491-A
DR   BioSamples; SAMEA4453756
DR   ECACC; 77650523
DR   HipSci; HPSI0416i-zige_2
DR   hPSCreg; WTSIi447-B
DR   Wikidata; Q54890776
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX97 ! HPSI0416i-zige_5
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0416i-zige_5
AC   CVCL_IX97
SY   WTSIi447-A
DR   BioSamples; SAMEA4453863
DR   ECACC; 77650524
DR   HipSci; HPSI0416i-zige_5
DR   hPSCreg; WTSIi447-A
DR   Wikidata; Q54890777
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX96 ! HPSI0416i-zige_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0513i-aipt_1
AC   CVCL_JN27
DR   BioSamples; SAMEA2398340
DR   HipSci; HPSI0513i-aipt_1
DR   Wikidata; Q54890778
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN28 ! HPSI0513i-aipt_2
OI   CVCL_AF30 ! HPSI0513i-aipt_3
OI   CVCL_AF31 ! HPSI0513i-aipt_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-aipt_2
AC   CVCL_JN28
DR   BioSamples; SAMEA2398762
DR   HipSci; HPSI0513i-aipt_2
DR   Wikidata; Q54890779
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN27 ! HPSI0513i-aipt_1
OI   CVCL_AF30 ! HPSI0513i-aipt_3
OI   CVCL_AF31 ! HPSI0513i-aipt_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-aipt_3
AC   CVCL_AF30
SY   WTSIi131-B; WTSIi348-A
DR   BioSamples; SAMEA2398519
DR   ECACC; 77650192
DR   HipSci; HPSI0513i-aipt_3
DR   hPSCreg; WTSIi131-B
DR   Wikidata; Q54890780
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN27 ! HPSI0513i-aipt_1
OI   CVCL_JN28 ! HPSI0513i-aipt_2
OI   CVCL_AF31 ! HPSI0513i-aipt_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-aipt_33
AC   CVCL_AF31
SY   WTSIi131-A
DR   BioSamples; SAMEA2398868
DR   EBiSC; WTSIi131-A
DR   ECACC; 66540231
DR   ECACC; 77650173
DR   HipSci; HPSI0513i-aipt_33
DR   hPSCreg; WTSIi131-A
DR   SKIP; SKIP002756
DR   Wikidata; Q54890781
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540231; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN27 ! HPSI0513i-aipt_1
OI   CVCL_JN28 ! HPSI0513i-aipt_2
OI   CVCL_AF30 ! HPSI0513i-aipt_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0513i-bicb_1
AC   CVCL_JN29
DR   BioSamples; SAMEA2398622
DR   HipSci; HPSI0513i-bicb_1
DR   Wikidata; Q54890782
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF32 ! HPSI0513i-bicb_3
OI   CVCL_JN30 ! HPSI0513i-bicb_4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-bicb_3
AC   CVCL_AF32
SY   WTSIi467-A
DR   BioSamples; SAMEA2398512
DR   ECACC; 77650619
DR   HipSci; HPSI0513i-bicb_3
DR   hPSCreg; WTSIi467-A
DR   Wikidata; Q54890783
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN29 ! HPSI0513i-bicb_1
OI   CVCL_JN30 ! HPSI0513i-bicb_4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0513i-bicb_4
AC   CVCL_JN30
DR   BioSamples; SAMEA2398601
DR   HipSci; HPSI0513i-bicb_4
DR   Wikidata; Q54890784
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN29 ! HPSI0513i-bicb_1
OI   CVCL_AF32 ! HPSI0513i-bicb_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-cehw_1
AC   CVCL_JN31
DR   BioSamples; SAMEA2399085
DR   HipSci; HPSI0513i-cehw_1
DR   Wikidata; Q54890785
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN32 ! HPSI0513i-cehw_2
OI   CVCL_AF33 ! HPSI0513i-cehw_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-cehw_2
AC   CVCL_JN32
DR   BioSamples; SAMEA2398364
DR   HipSci; HPSI0513i-cehw_2
DR   Wikidata; Q54890787
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN31 ! HPSI0513i-cehw_1
OI   CVCL_AF33 ! HPSI0513i-cehw_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-cehw_3
AC   CVCL_AF33
SY   WTSIi233-A
DR   BioSamples; SAMEA2398560
DR   ECACC; 77650217
DR   HipSci; HPSI0513i-cehw_3
DR   hPSCreg; WTSIi233-A
DR   Wikidata; Q54890788
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN31 ! HPSI0513i-cehw_1
OI   CVCL_JN32 ! HPSI0513i-cehw_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-coio_1
AC   CVCL_AF34
SY   WTSIi104-B
DR   BioSamples; SAMEA2398024
DR   ECACC; 77650155
DR   HipSci; HPSI0513i-coio_1
DR   hPSCreg; WTSIi104-B
DR   PRIDE; PXD003903
DR   SKIP; SKIP002731
DR   Wikidata; Q54890789
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF35 ! HPSI0513i-coio_2
OI   CVCL_JN33 ! HPSI0513i-coio_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-coio_2
AC   CVCL_AF35
SY   WTSIi104-A
DR   BioSamples; SAMEA2398916
DR   ECACC; 77650218
DR   HipSci; HPSI0513i-coio_2
DR   hPSCreg; WTSIi104-A
DR   PRIDE; PXD003903
DR   SKIP; SKIP002719
DR   Wikidata; Q54890790
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF34 ! HPSI0513i-coio_1
OI   CVCL_JN33 ! HPSI0513i-coio_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-coio_3
AC   CVCL_JN33
DR   BioSamples; SAMEA2398472
DR   HipSci; HPSI0513i-coio_3
DR   Wikidata; Q54890791
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF34 ! HPSI0513i-coio_1
OI   CVCL_AF35 ! HPSI0513i-coio_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-cuau_1
AC   CVCL_AF36
SY   WTSIi217-A
DR   BioSamples; SAMEA2398553
DR   ECACC; 77650221
DR   HipSci; HPSI0513i-cuau_1
DR   hPSCreg; WTSIi217-A
DR   PRIDE; PXD003903
DR   Wikidata; Q54890792
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF37 ! HPSI0513i-cuau_2
OI   CVCL_JN34 ! HPSI0513i-cuau_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-cuau_2
AC   CVCL_AF37
SY   WTSIi217-B; WTSIi220-A
DR   BioSamples; SAMEA2399112
DR   ECACC; 77650222
DR   HipSci; HPSI0513i-cuau_2
DR   hPSCreg; WTSIi217-B
DR   PRIDE; PXD003903
DR   Wikidata; Q54890793
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF36 ! HPSI0513i-cuau_1
OI   CVCL_JN34 ! HPSI0513i-cuau_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-cuau_3
AC   CVCL_JN34
DR   BioSamples; SAMEA2398348
DR   HipSci; HPSI0513i-cuau_3
DR   Wikidata; Q54890794
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF36 ! HPSI0513i-cuau_1
OI   CVCL_AF37 ! HPSI0513i-cuau_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0513i-debk_7
AC   CVCL_AF38
SY   WTSIi055-B; WTSIi215-A
DR   BioSamples; SAMEA2398966
DR   ECACC; 77650225
DR   HipSci; HPSI0513i-debk_7
DR   hPSCreg; WTSIi055-B
DR   Wikidata; Q54890801
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN35 ! HPSI0513i-debk_8
OI   CVCL_AF39 ! HPSI0513i-debk_9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-debk_8
AC   CVCL_JN35
DR   BioSamples; SAMEA2398511
DR   HipSci; HPSI0513i-debk_8
DR   Wikidata; Q54890802
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF38 ! HPSI0513i-debk_7
OI   CVCL_AF39 ! HPSI0513i-debk_9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-debk_9
AC   CVCL_AF39
SY   WTSIi055-A
DR   BioSamples; SAMEA2399146
DR   EBiSC; WTSIi055-A
DR   ECACC; 66540148
DR   ECACC; 77650207
DR   HipSci; HPSI0513i-debk_9
DR   hPSCreg; WTSIi055-A
DR   SKIP; SKIP002644
DR   Wikidata; Q54890803
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540148; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF38 ! HPSI0513i-debk_7
OI   CVCL_JN35 ! HPSI0513i-debk_8
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0513i-dipe_1
AC   CVCL_AF40
SY   WTSIi056-A
DR   BioSamples; SAMEA2398050
DR   EBiSC; WTSIi056-A
DR   ECACC; 66540147
DR   ECACC; 77650204
DR   HipSci; HPSI0513i-dipe_1
DR   hPSCreg; WTSIi056-A
DR   SKIP; SKIP002645
DR   Wikidata; Q54890804
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540147; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN36 ! HPSI0513i-dipe_2
OI   CVCL_JN37 ! HPSI0513i-dipe_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0513i-dipe_2
AC   CVCL_JN36
DR   BioSamples; SAMEA2398008
DR   HipSci; HPSI0513i-dipe_2
DR   Wikidata; Q54890805
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF40 ! HPSI0513i-dipe_1
OI   CVCL_JN37 ! HPSI0513i-dipe_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-dipe_3
AC   CVCL_JN37
DR   BioSamples; SAMEA2399110
DR   HipSci; HPSI0513i-dipe_3
DR   Wikidata; Q54890806
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF40 ! HPSI0513i-dipe_1
OI   CVCL_JN36 ! HPSI0513i-dipe_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-dovq_3
AC   CVCL_AF41
SY   WTSIi387-A
DR   BioSamples; SAMEA2398899
DR   ECACC; 77650593
DR   HipSci; HPSI0513i-dovq_3
DR   hPSCreg; WTSIi387-A
DR   Wikidata; Q54890807
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF42 ! HPSI0513i-dovq_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0513i-dovq_33
AC   CVCL_AF42
DR   BioSamples; SAMEA2398210
DR   HipSci; HPSI0513i-dovq_33
DR   Wikidata; Q54890808
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF41 ! HPSI0513i-dovq_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0513i-dulv_1
AC   CVCL_AF43
SY   WTSIi134-A
DR   BioSamples; SAMEA2398925
DR   EBiSC; WTSIi134-A
DR   ECACC; 66540237
DR   ECACC; 77650190
DR   HipSci; HPSI0513i-dulv_1
DR   hPSCreg; WTSIi134-A
DR   SKIP; SKIP002762
DR   Wikidata; Q54890809
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540237; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF44 ! HPSI0513i-dulv_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0513i-dulv_2
AC   CVCL_AF44
SY   WTSIi134-B
DR   BioSamples; SAMEA2398957
DR   EBiSC; WTSIi134-B
DR   ECACC; 66540238
DR   ECACC; 77650168
DR   HipSci; HPSI0513i-dulv_2
DR   hPSCreg; WTSIi134-B
DR   SKIP; SKIP002763
DR   Wikidata; Q54890810
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540238; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF43 ! HPSI0513i-dulv_1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0513i-euir_1
AC   CVCL_AF45
SY   WTSIi111-A
DR   BioSamples; SAMEA2398167
DR   ECACC; 77650095
DR   HipSci; HPSI0513i-euir_1
DR   hPSCreg; WTSIi111-A
DR   PRIDE; PXD003903
DR   SKIP; SKIP002733
DR   Wikidata; Q54890811
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF46 ! HPSI0513i-euir_2
OI   CVCL_JN38 ! HPSI0513i-euir_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-euir_2
AC   CVCL_AF46
SY   WTSIi111-B; WTSIi221-A
DR   BioSamples; SAMEA2398821
DR   ECACC; 77650227
DR   HipSci; HPSI0513i-euir_2
DR   hPSCreg; WTSIi111-B
DR   PRIDE; PXD003903
DR   Wikidata; Q54890812
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN38 ! HPSI0513i-euir_3
OI   CVCL_AF45 ! HPSI0513i-euir_1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-euir_3
AC   CVCL_JN38
DR   BioSamples; SAMEA2398582
DR   HipSci; HPSI0513i-euir_3
DR   Wikidata; Q54890813
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF45 ! HPSI0513i-euir_1
OI   CVCL_AF46 ! HPSI0513i-euir_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-fejf_1
AC   CVCL_JN39
DR   BioSamples; SAMEA2398696
DR   HipSci; HPSI0513i-fejf_1
DR   Wikidata; Q54890814
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF47 ! HPSI0513i-fejf_2
OI   CVCL_AF48 ! HPSI0513i-fejf_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-fejf_2
AC   CVCL_AF47
SY   WTSIi101-A
DR   BioSamples; SAMEA2398812
DR   EBiSC; WTSIi101-A
DR   ECACC; 66540216
DR   ECACC; 77650141
DR   HipSci; HPSI0513i-fejf_2
DR   hPSCreg; WTSIi101-A
DR   SKIP; SKIP002716
DR   Wikidata; Q54890815
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540216; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN39 ! HPSI0513i-fejf_1
OI   CVCL_AF48 ! HPSI0513i-fejf_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0513i-fejf_3
AC   CVCL_AF48
DR   BioSamples; SAMEA2398361
DR   HipSci; HPSI0513i-fejf_3
DR   Wikidata; Q54890816
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN39 ! HPSI0513i-fejf_1
OI   CVCL_AF47 ! HPSI0513i-fejf_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0513i-giuf_1
AC   CVCL_AF49
SY   WTSIi057-B
DR   BioSamples; SAMEA2398296
DR   EBiSC; WTSIi057-B
DR   ECACC; 66540242
DR   ECACC; 77650181
DR   HipSci; HPSI0513i-giuf_1
DR   hPSCreg; WTSIi057-B
DR   SKIP; SKIP002767
DR   Wikidata; Q54890817
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540242; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN40 ! HPSI0513i-giuf_2
OI   CVCL_AF50 ! HPSI0513i-giuf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0513i-giuf_2
AC   CVCL_JN40
DR   BioSamples; SAMEA2397960
DR   HipSci; HPSI0513i-giuf_2
DR   Wikidata; Q54890818
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF49 ! HPSI0513i-giuf_1
OI   CVCL_AF50 ! HPSI0513i-giuf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-giuf_3
AC   CVCL_AF50
SY   WTSIi057-A
DR   BioSamples; SAMEA2398005
DR   EBiSC; WTSIi057-A
DR   ECACC; 66540146
DR   ECACC; 77650193
DR   HipSci; HPSI0513i-giuf_3
DR   hPSCreg; WTSIi057-A
DR   Wikidata; Q54890819
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540146; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF49 ! HPSI0513i-giuf_1
OI   CVCL_JN40 ! HPSI0513i-giuf_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0513i-golb_1
AC   CVCL_AF51
SY   WTSIi114-A
DR   BioSamples; SAMEA2398240
DR   ECACC; 77650012
DR   HipSci; HPSI0513i-golb_1
DR   hPSCreg; WTSIi114-A
DR   SKIP; SKIP002737
DR   Wikidata; Q54890821
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN41 ! HPSI0513i-golb_2
OI   CVCL_JN42 ! HPSI0513i-golb_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-golb_2
AC   CVCL_JN41
DR   BioSamples; SAMEA2398847
DR   HipSci; HPSI0513i-golb_2
DR   Wikidata; Q54890822
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF51 ! HPSI0513i-golb_1
OI   CVCL_JN42 ! HPSI0513i-golb_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-golb_3
AC   CVCL_JN42
DR   BioSamples; SAMEA2398408
DR   HipSci; HPSI0513i-golb_3
DR   Wikidata; Q54890823
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF51 ! HPSI0513i-golb_1
OI   CVCL_JN41 ! HPSI0513i-golb_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-huls_1
AC   CVCL_AF52
SY   WTSIi211-A
DR   BioSamples; SAMEA2398865
DR   ECACC; 77650230
DR   HipSci; HPSI0513i-huls_1
DR   hPSCreg; WTSIi211-A
DR   Wikidata; Q54890824
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN43 ! HPSI0513i-huls_2
OI   CVCL_JN44 ! HPSI0513i-huls_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-huls_2
AC   CVCL_JN43
DR   BioSamples; SAMEA2398684
DR   HipSci; HPSI0513i-huls_2
DR   Wikidata; Q54890825
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF52 ! HPSI0513i-huls_1
OI   CVCL_JN44 ! HPSI0513i-huls_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-huls_3
AC   CVCL_JN44
DR   BioSamples; SAMEA2399252
DR   HipSci; HPSI0513i-huls_3
DR   Wikidata; Q54890826
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF52 ! HPSI0513i-huls_1
OI   CVCL_JN43 ! HPSI0513i-huls_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-iasn_1
AC   CVCL_JN45
DR   BioSamples; SAMEA2397874
DR   HipSci; HPSI0513i-iasn_1
DR   Wikidata; Q54890827
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF53 ! HPSI0513i-iasn_2
OI   CVCL_AF54 ! HPSI0513i-iasn_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-iasn_2
AC   CVCL_AF53
DR   BioSamples; SAMEA2398263
DR   HipSci; HPSI0513i-iasn_2
DR   Wikidata; Q54890828
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN45 ! HPSI0513i-iasn_1
OI   CVCL_AF54 ! HPSI0513i-iasn_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0513i-iasn_3
AC   CVCL_AF54
SY   WTSIi115-A
DR   BioSamples; SAMEA2397877
DR   ECACC; 77650025
DR   HipSci; HPSI0513i-iasn_3
DR   hPSCreg; WTSIi115-A
DR   SKIP; SKIP002738
DR   Wikidata; Q54890829
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN45 ! HPSI0513i-iasn_1
OI   CVCL_AF53 ! HPSI0513i-iasn_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-kesz_1
AC   CVCL_AF55
SY   WTSIi208-A
DR   BioSamples; SAMEA2399236
DR   ECACC; 77650235
DR   HipSci; HPSI0513i-kesz_1
DR   hPSCreg; WTSIi208-A
DR   Wikidata; Q54890830
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF56 ! HPSI0513i-kesz_2
OI   CVCL_JN46 ! HPSI0513i-kesz_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0513i-kesz_2
AC   CVCL_AF56
SY   WTSIi208-B; WTSIi566-A
DR   BioSamples; SAMEA2398230
DR   HipSci; HPSI0513i-kesz_2
DR   hPSCreg; WTSIi208-B
DR   Wikidata; Q54890831
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF55 ! HPSI0513i-kesz_1
OI   CVCL_JN46 ! HPSI0513i-kesz_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0513i-kesz_3
AC   CVCL_JN46
DR   BioSamples; SAMEA2399217
DR   HipSci; HPSI0513i-kesz_3
DR   Wikidata; Q54890832
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF55 ! HPSI0513i-kesz_1
OI   CVCL_AF56 ! HPSI0513i-kesz_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-leeh_1
AC   CVCL_JN47
DR   BioSamples; SAMEA2398722
DR   HipSci; HPSI0513i-leeh_1
DR   Wikidata; Q54890833
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF57 ! HPSI0513i-leeh_2
OI   CVCL_AF58 ! HPSI0513i-leeh_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-leeh_2
AC   CVCL_AF57
SY   WTSIi214-B; WTSIi230-A
DR   BioSamples; SAMEA2398347
DR   ECACC; 77650236
DR   HipSci; HPSI0513i-leeh_2
DR   hPSCreg; WTSIi214-B
DR   Wikidata; Q54890834
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN47 ! HPSI0513i-leeh_1
OI   CVCL_AF58 ! HPSI0513i-leeh_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-leeh_3
AC   CVCL_AF58
SY   WTSIi214-A
DR   BioSamples; SAMEA2398586
DR   ECACC; 77650237
DR   HipSci; HPSI0513i-leeh_3
DR   hPSCreg; WTSIi214-A
DR   Wikidata; Q54890835
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN47 ! HPSI0513i-leeh_1
OI   CVCL_AF57 ! HPSI0513i-leeh_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-momt_2
AC   CVCL_AF59
SY   WTSIi350-A
DR   BioSamples; SAMEA2399161
DR   ECACC; 77650595
DR   HipSci; HPSI0513i-momt_2
DR   hPSCreg; WTSIi350-A
DR   Wikidata; Q54890837
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN48 ! HPSI0513i-momt_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0513i-momt_3
AC   CVCL_JN48
DR   BioSamples; SAMEA2397998
DR   HipSci; HPSI0513i-momt_3
DR   Wikidata; Q54890838
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF59 ! HPSI0513i-momt_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-netf_1
AC   CVCL_JN49
DR   BioSamples; SAMEA2469768
DR   HipSci; HPSI0513i-netf_1
DR   Wikidata; Q54890839
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF60 ! HPSI0513i-netf_2
OI   CVCL_JN50 ! HPSI0513i-netf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-netf_2
AC   CVCL_AF60
SY   WTSIi354-A
DR   BioSamples; SAMEA2469773
DR   ECACC; 77650151
DR   HipSci; HPSI0513i-netf_2
DR   hPSCreg; WTSIi354-A
DR   Wikidata; Q54890840
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN49 ! HPSI0513i-netf_1
OI   CVCL_JN50 ! HPSI0513i-netf_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-netf_3
AC   CVCL_JN50
DR   BioSamples; SAMEA2469771
DR   HipSci; HPSI0513i-netf_3
DR   Wikidata; Q54890842
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN49 ! HPSI0513i-netf_1
OI   CVCL_AF60 ! HPSI0513i-netf_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-oarz_1
AC   CVCL_JN51
DR   BioSamples; SAMEA2397898
DR   HipSci; HPSI0513i-oarz_1
DR   Wikidata; Q54890843
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF61 ! HPSI0513i-oarz_2
OI   CVCL_JN52 ! HPSI0513i-oarz_3
OI   CVCL_AF62 ! HPSI0513i-oarz_22
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-oarz_2
AC   CVCL_AF61
SY   WTSIi362-B; WTSIi384-A
DR   BioSamples; SAMEA2398593
DR   ECACC; 77650240
DR   HipSci; HPSI0513i-oarz_2
DR   hPSCreg; WTSIi362-B
DR   Wikidata; Q54890847
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650240; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN51 ! HPSI0513i-oarz_1
OI   CVCL_JN52 ! HPSI0513i-oarz_3
OI   CVCL_AF62 ! HPSI0513i-oarz_22
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   HPSI0513i-oarz_22
AC   CVCL_AF62
SY   WTSIi362-A
DR   BioSamples; SAMEA2398471
DR   ECACC; 77650162
DR   HipSci; HPSI0513i-oarz_22
DR   hPSCreg; WTSIi362-A
DR   Wikidata; Q54890848
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN51 ! HPSI0513i-oarz_1
OI   CVCL_AF61 ! HPSI0513i-oarz_2
OI   CVCL_JN52 ! HPSI0513i-oarz_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-oarz_3
AC   CVCL_JN52
DR   BioSamples; SAMEA2398213
DR   HipSci; HPSI0513i-oarz_3
DR   Wikidata; Q54890850
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN51 ! HPSI0513i-oarz_1
OI   CVCL_AF61 ! HPSI0513i-oarz_2
OI   CVCL_AF62 ! HPSI0513i-oarz_22
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-oeoo_1
AC   CVCL_JN53
DR   BioSamples; SAMEA2398846
DR   HipSci; HPSI0513i-oeoo_1
DR   Wikidata; Q54890851
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF63 ! HPSI0513i-oeoo_2
OI   CVCL_JN54 ! HPSI0513i-oeoo_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-oeoo_2
AC   CVCL_AF63
SY   WTSIi120-A
DR   BioSamples; SAMEA2398634
DR   ECACC; 77650022
DR   HipSci; HPSI0513i-oeoo_2
DR   hPSCreg; WTSIi120-A
DR   SKIP; SKIP002743
DR   Wikidata; Q54890852
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN53 ! HPSI0513i-oeoo_1
OI   CVCL_JN54 ! HPSI0513i-oeoo_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-oeoo_3
AC   CVCL_JN54
DR   BioSamples; SAMEA2398628
DR   HipSci; HPSI0513i-oeoo_3
DR   Wikidata; Q54890853
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN53 ! HPSI0513i-oeoo_1
OI   CVCL_AF63 ! HPSI0513i-oeoo_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-oibg_1
AC   CVCL_AF64
SY   WTSIi351-A
DR   BioSamples; SAMEA2399265
DR   ECACC; 77650149
DR   HipSci; HPSI0513i-oibg_1
DR   hPSCreg; WTSIi351-A
DR   Wikidata; Q54890854
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN55 ! HPSI0513i-oibg_2
OI   CVCL_JN56 ! HPSI0513i-oibg_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-oibg_2
AC   CVCL_JN55
DR   BioSamples; SAMEA2398229
DR   HipSci; HPSI0513i-oibg_2
DR   Wikidata; Q54890855
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF64 ! HPSI0513i-oibg_1
OI   CVCL_JN56 ! HPSI0513i-oibg_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-oibg_3
AC   CVCL_JN56
DR   BioSamples; SAMEA2399054
DR   HipSci; HPSI0513i-oibg_3
DR   Wikidata; Q54890856
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF64 ! HPSI0513i-oibg_1
OI   CVCL_JN55 ! HPSI0513i-oibg_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-oogu_1
AC   CVCL_JN57
DR   BioSamples; SAMEA2397833
DR   HipSci; HPSI0513i-oogu_1
DR   Wikidata; Q54890857
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF65 ! HPSI0513i-oogu_2
OI   CVCL_JN58 ! HPSI0513i-oogu_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-oogu_2
AC   CVCL_AF65
DR   BioSamples; SAMEA2398298
DR   ECACC; 77650241
DR   HipSci; HPSI0513i-oogu_2
DR   Wikidata; Q54890858
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650241; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN57 ! HPSI0513i-oogu_1
OI   CVCL_JN58 ! HPSI0513i-oogu_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI0513i-oogu_3
AC   CVCL_JN58
DR   BioSamples; SAMEA2398417
DR   HipSci; HPSI0513i-oogu_3
DR   Wikidata; Q54890859
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN57 ! HPSI0513i-oogu_1
OI   CVCL_AF65 ! HPSI0513i-oogu_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-pedc_1
AC   CVCL_AF66
SY   WTSIi571-A
DR   BioSamples; SAMEA2397927
DR   ECACC; 77650618
DR   HipSci; HPSI0513i-pedc_1
DR   hPSCreg; WTSIi571-A
DR   Wikidata; Q54890860
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0513i-sucd_1
AC   CVCL_JN59
DR   BioSamples; SAMEA2398110
DR   HipSci; HPSI0513i-sucd_1
DR   Wikidata; Q54890861
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN60 ! HPSI0513i-sucd_2
OI   CVCL_AF67 ! HPSI0513i-sucd_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-sucd_2
AC   CVCL_JN60
DR   BioSamples; SAMEA2397982
DR   HipSci; HPSI0513i-sucd_2
DR   Wikidata; Q54890862
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN59 ! HPSI0513i-sucd_1
OI   CVCL_AF67 ! HPSI0513i-sucd_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0513i-sucd_3
AC   CVCL_AF67
SY   WTSIi392-A
DR   BioSamples; SAMEA2398792
DR   ECACC; 77650589
DR   HipSci; HPSI0513i-sucd_3
DR   hPSCreg; WTSIi392-A
DR   Wikidata; Q54890863
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN59 ! HPSI0513i-sucd_1
OI   CVCL_JN60 ! HPSI0513i-sucd_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-suzg_1
AC   CVCL_JN61
DR   BioSamples; SAMEA2398366
DR   HipSci; HPSI0513i-suzg_1
DR   Wikidata; Q54890864
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN62 ! HPSI0513i-suzg_2
OI   CVCL_AF68 ! HPSI0513i-suzg_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-suzg_2
AC   CVCL_JN62
DR   BioSamples; SAMEA2398468
DR   HipSci; HPSI0513i-suzg_2
DR   Wikidata; Q54890865
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN61 ! HPSI0513i-suzg_1
OI   CVCL_AF68 ! HPSI0513i-suzg_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-suzg_3
AC   CVCL_AF68
SY   WTSIi058-A
DR   BioSamples; SAMEA2399150
DR   EBiSC; WTSIi058-A
DR   ECACC; 66540145
DR   ECACC; 77650122
DR   HipSci; HPSI0513i-suzg_3
DR   hPSCreg; WTSIi058-A
DR   SKIP; SKIP002646
DR   Wikidata; Q54890866
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540145; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN61 ! HPSI0513i-suzg_1
OI   CVCL_JN62 ! HPSI0513i-suzg_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-uilw_1
AC   CVCL_AF69
SY   WTSIi059-A
DR   BioSamples; SAMEA2398838
DR   ECACC; 77650183
DR   HipSci; HPSI0513i-uilw_1
DR   hPSCreg; WTSIi059-A
DR   SKIP; SKIP002647
DR   Wikidata; Q54890867
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN63 ! HPSI0513i-uilw_2
OI   CVCL_JN64 ! HPSI0513i-uilw_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0513i-uilw_2
AC   CVCL_JN63
DR   BioSamples; SAMEA2398578
DR   HipSci; HPSI0513i-uilw_2
DR   Wikidata; Q54890868
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF69 ! HPSI0513i-uilw_1
OI   CVCL_JN64 ! HPSI0513i-uilw_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-uilw_3
AC   CVCL_JN64
DR   BioSamples; SAMEA2398740
DR   HipSci; HPSI0513i-uilw_3
DR   Wikidata; Q54890869
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF69 ! HPSI0513i-uilw_1
OI   CVCL_JN63 ! HPSI0513i-uilw_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-uoxz_4
AC   CVCL_AF70
SY   WTSIi235-B; WTSIi367-A
DR   BioSamples; SAMEA2398350
DR   ECACC; 77650158
DR   HipSci; HPSI0513i-uoxz_4
DR   hPSCreg; WTSIi235-B
DR   Wikidata; Q54890870
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF71 ! HPSI0513i-uoxz_5
OI   CVCL_JN65 ! HPSI0513i-uoxz_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-uoxz_5
AC   CVCL_AF71
SY   WTSIi235-A
DR   BioSamples; SAMEA2398124
DR   ECACC; 77650253
DR   HipSci; HPSI0513i-uoxz_5
DR   hPSCreg; WTSIi235-A
DR   Wikidata; Q54890871
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF70 ! HPSI0513i-uoxz_4
OI   CVCL_JN65 ! HPSI0513i-uoxz_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-uoxz_6
AC   CVCL_JN65
DR   BioSamples; SAMEA2399117
DR   HipSci; HPSI0513i-uoxz_6
DR   Wikidata; Q54890872
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF70 ! HPSI0513i-uoxz_4
OI   CVCL_AF71 ! HPSI0513i-uoxz_5
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-veqz_4
AC   CVCL_AF72
DR   BioSamples; SAMEA2398324
DR   HipSci; HPSI0513i-veqz_4
DR   Wikidata; Q54890873
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN66 ! HPSI0513i-veqz_5
OI   CVCL_AF73 ! HPSI0513i-veqz_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0513i-veqz_5
AC   CVCL_JN66
DR   BioSamples; SAMEA2398400
DR   HipSci; HPSI0513i-veqz_5
DR   Wikidata; Q54890874
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF72 ! HPSI0513i-veqz_4
OI   CVCL_AF73 ! HPSI0513i-veqz_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-veqz_6
AC   CVCL_AF73
SY   WTSIi060-A
DR   BioSamples; SAMEA2398734
DR   EBiSC; WTSIi060-A
DR   ECACC; 66540143
DR   ECACC; 77650199
DR   HipSci; HPSI0513i-veqz_6
DR   hPSCreg; WTSIi060-A
DR   SKIP; SKIP002648
DR   Wikidata; Q54890875
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540143; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF72 ! HPSI0513i-veqz_4
OI   CVCL_JN66 ! HPSI0513i-veqz_5
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-veve_1
AC   CVCL_JN67
DR   BioSamples; SAMEA2398181
DR   HipSci; HPSI0513i-veve_1
DR   Wikidata; Q54890876
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF74 ! HPSI0513i-veve_2
OI   CVCL_JN68 ! HPSI0513i-veve_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-veve_2
AC   CVCL_AF74
SY   WTSIi061-A
DR   BioSamples; SAMEA2397967
DR   EBiSC; WTSIi061-A
DR   ECACC; 66540142
DR   ECACC; 77650143
DR   HipSci; HPSI0513i-veve_2
DR   hPSCreg; WTSIi061-A
DR   SKIP; SKIP002649
DR   Wikidata; Q54890877
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540142; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN67 ! HPSI0513i-veve_1
OI   CVCL_JN68 ! HPSI0513i-veve_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-veve_3
AC   CVCL_JN68
DR   BioSamples; SAMEA2398061
DR   HipSci; HPSI0513i-veve_3
DR   Wikidata; Q54890878
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN67 ! HPSI0513i-veve_1
OI   CVCL_AF74 ! HPSI0513i-veve_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-xegx_1
AC   CVCL_AF75
SY   WTSIi225-B; WTSIi356-A
DR   BioSamples; SAMEA2398343
DR   ECACC; 77650163
DR   HipSci; HPSI0513i-xegx_1
DR   hPSCreg; WTSIi225-B
DR   Wikidata; Q54890879
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF76 ! HPSI0513i-xegx_2
OI   CVCL_JN69 ! HPSI0513i-xegx_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-xegx_2
AC   CVCL_AF76
SY   WTSIi225-A
DR   BioSamples; SAMEA2398128
DR   ECACC; 77650259
DR   HipSci; HPSI0513i-xegx_2
DR   hPSCreg; WTSIi225-A
DR   Wikidata; Q54890880
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF75 ! HPSI0513i-xegx_1
OI   CVCL_JN69 ! HPSI0513i-xegx_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0513i-xegx_3
AC   CVCL_JN69
DR   BioSamples; SAMEA2399093
DR   HipSci; HPSI0513i-xegx_3
DR   Wikidata; Q54890881
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF75 ! HPSI0513i-xegx_1
OI   CVCL_AF76 ! HPSI0513i-xegx_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-zaui_1
AC   CVCL_JN70
DR   BioSamples; SAMEA2459965
DR   HipSci; HPSI0513i-zaui_1
DR   Wikidata; Q54890882
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN71 ! HPSI0513i-zaui_2
OI   CVCL_AF77 ! HPSI0513i-zaui_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-zaui_2
AC   CVCL_JN71
DR   BioSamples; SAMEA2459972
DR   HipSci; HPSI0513i-zaui_2
DR   Wikidata; Q54890883
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN70 ! HPSI0513i-zaui_1
OI   CVCL_AF77 ! HPSI0513i-zaui_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0513i-zaui_3
AC   CVCL_AF77
SY   WTSIi062-A
DR   BioSamples; SAMEA2459960
DR   EBiSC; WTSIi062-A
DR   ECACC; 66540141
DR   ECACC; 77650260
DR   HipSci; HPSI0513i-zaui_3
DR   hPSCreg; WTSIi062-A
DR   SKIP; SKIP002650
DR   Wikidata; Q54890884
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540141; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN70 ! HPSI0513i-zaui_1
OI   CVCL_JN71 ! HPSI0513i-zaui_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-aecv_2
AC   CVCL_EE90
SY   WTSIi430-A
DR   BioSamples; SAMEA4091786
DR   ECACC; 77650397
DR   HipSci; HPSI0514i-aecv_2
DR   hPSCreg; WTSIi430-A
DR   Wikidata; Q54890885
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE91 ! HPSI0514i-aecv_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0514i-aecv_3
AC   CVCL_EE91
SY   WTSIi430-B; WTSIi442-A
DR   BioSamples; SAMEA4091787
DR   ECACC; 77650372
DR   HipSci; HPSI0514i-aecv_3
DR   hPSCreg; WTSIi430-B
DR   Wikidata; Q54890886
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE90 ! HPSI0514i-aecv_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0514i-aomr_5
AC   CVCL_EE92
SY   WTSIi416-A
DR   BioSamples; SAMEA4085307
DR   ECACC; 77650398
DR   HipSci; HPSI0514i-aomr_5
DR   hPSCreg; WTSIi416-A
DR   Wikidata; Q54890887
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE93 ! HPSI0514i-aomr_6
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0514i-aomr_6
AC   CVCL_EE93
SY   WTSIi416-B; WTSIi437-A
DR   BioSamples; SAMEA4085304
DR   ECACC; 77650416
DR   HipSci; HPSI0514i-aomr_6
DR   hPSCreg; WTSIi416-B
DR   Wikidata; Q54890894
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE92 ! HPSI0514i-aomr_5
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0514i-eoxi_6
AC   CVCL_AF78
SY   WTSIi196-A
DR   BioSamples; SAMEA3355542
DR   EBiSC; WTSIi196-A
DR   ECACC; 66540431
DR   ECACC; 77650348
DR   HipSci; HPSI0514i-eoxi_6
DR   hPSCreg; WTSIi196-A
DR   Wikidata; Q54890895
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540431; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0514i-fiaj_1
AC   CVCL_AF79
SY   WTSIi270-B; WTSIi301-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3463756
DR   ECACC; 77650613
DR   HipSci; HPSI0514i-fiaj_1
DR   hPSCreg; WTSIi270-B
DR   Wikidata; Q54890896
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF80 ! HPSI0514i-fiaj_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-fiaj_3
AC   CVCL_AF80
SY   WTSIi270-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3469236
DR   ECACC; 77650614
DR   HipSci; HPSI0514i-fiaj_3
DR   hPSCreg; WTSIi270-A
DR   Wikidata; Q54890897
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF79 ! HPSI0514i-fiaj_1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-kidt_1
AC   CVCL_AF81
SY   WTSIi419-A
DR   BioSamples; SAMEA3374093
DR   ECACC; 77650677
DR   HipSci; HPSI0514i-kidt_1
DR   hPSCreg; WTSIi419-A
DR   Wikidata; Q54890898
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-kooz_5
AC   CVCL_IX32
SY   WTSIi477-A
DR   BioSamples; SAMEA4085271
DR   ECACC; 77650442
DR   HipSci; HPSI0514i-kooz_5
DR   hPSCreg; WTSIi477-A
DR   Wikidata; Q54890899
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-kuco_1
AC   CVCL_AJ94
SY   WTSIi316-B; WTSIi360-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3967041
DR   ECACC; 77650575
DR   HipSci; HPSI0514i-kuco_1
DR   hPSCreg; WTSIi316-B
DR   Wikidata; Q54890900
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ95 ! HPSI0514i-kuco_5
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-kuco_5
AC   CVCL_AJ95
SY   WTSIi316-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3969693
DR   ECACC; 77650578
DR   HipSci; HPSI0514i-kuco_5
DR   hPSCreg; WTSIi316-A
DR   Wikidata; Q54890901
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ94 ! HPSI0514i-kuco_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-lako_1
AC   CVCL_AJ96
SY   WTSIi287-B; WTSIi313-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3970237
DR   ECACC; 77650580
DR   HipSci; HPSI0514i-lako_1
DR   hPSCreg; WTSIi287-B
DR   Wikidata; Q54890902
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ97 ! HPSI0514i-lako_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-lako_2
AC   CVCL_AJ97
SY   WTSIi287-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3970239
DR   ECACC; 77650579
DR   HipSci; HPSI0514i-lako_2
DR   hPSCreg; WTSIi287-A
DR   Wikidata; Q54890903
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ96 ! HPSI0514i-lako_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-letw_1
AC   CVCL_EE94
SY   WTSIi253-B; WTSIi323-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962566
DR   ECACC; 77650394
DR   HipSci; HPSI0514i-letw_1
DR   hPSCreg; WTSIi253-B
DR   Wikidata; Q54890904
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Arg402Gln (c.1205G>A); ClinVar=VCV000003779; Zygosity=Homozygous (from autologous cell line HPSI0514i-letw_5).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE95 ! HPSI0514i-letw_5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0514i-letw_5
AC   CVCL_EE95
SY   WTSIi253-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3967410
DR   ECACC; 77650396
DR   HipSci; HPSI0514i-letw_5
DR   hPSCreg; WTSIi253-A
DR   Wikidata; Q54890905
RX   PubMed=28489815;
RX   PubMed=35933957;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Arg402Gln (c.1205G>A); ClinVar=VCV000003779; Zygosity=Homozygous (PubMed=35933957).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE94 ! HPSI0514i-letw_1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0514i-mure_4
AC   CVCL_EE96
SY   WTSIi424-B; WTSIi425-A
DR   BioSamples; SAMEA4092057
DR   ECACC; 77650390
DR   HipSci; HPSI0514i-mure_4
DR   hPSCreg; WTSIi424-B
DR   Wikidata; Q54890906
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE97 ! HPSI0514i-mure_9
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0514i-mure_9
AC   CVCL_EE97
SY   WTSIi424-A
DR   BioSamples; SAMEA4093128
DR   ECACC; 77650432
DR   HipSci; HPSI0514i-mure_9
DR   hPSCreg; WTSIi424-A
DR   Wikidata; Q54890907
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE96 ! HPSI0514i-mure_4
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0514i-naah_2
AC   CVCL_EE98
SY   WTSIi322-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962620
DR   ECACC; 77650410
DR   HipSci; HPSI0514i-naah_2
DR   hPSCreg; WTSIi322-A
DR   Wikidata; Q54890908
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE99 ! HPSI0514i-naah_4
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-naah_4
AC   CVCL_EE99
SY   WTSIi322-B; WTSIi338-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962619
DR   ECACC; 77650383
DR   HipSci; HPSI0514i-naah_4
DR   hPSCreg; WTSIi322-B
DR   Wikidata; Q54890909
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE98 ! HPSI0514i-naah_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-oekw_2
AC   CVCL_IY50
SY   WTSIi596-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3966033
DR   ECACC; 77650457
DR   HipSci; HPSI0514i-oekw_2
DR   hPSCreg; WTSIi596-A
DR   Wikidata; Q54890912
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-oupf_5
AC   CVCL_IY51
SY   WTSIi591-B; WTSIi592-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4451100
DR   ECACC; 77650484
DR   HipSci; HPSI0514i-oupf_5
DR   hPSCreg; WTSIi591-B
DR   Wikidata; Q54890913
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY52 ! HPSI0514i-oupf_6
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-oupf_6
AC   CVCL_IY52
SY   WTSIi591-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4451098
DR   ECACC; 77650485
DR   HipSci; HPSI0514i-oupf_6
DR   hPSCreg; WTSIi591-A
DR   Wikidata; Q54890914
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY51 ! HPSI0514i-oupf_5
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-puie_4
AC   CVCL_EE58
SY   WTSIi180-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962563
DR   EBiSC; WTSIi180-A
DR   ECACC; 66540353
DR   ECACC; 77650306
DR   HipSci; HPSI0514i-puie_4
DR   hPSCreg; WTSIi180-A
DR   SKIP; SKIP002849
DR   Wikidata; Q54890915
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540353; true.
CC   Discontinued: ECACC; 77650306; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE59 ! HPSI0514i-puie_5
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 17
//
ID   HPSI0514i-puie_5
AC   CVCL_EE59
SY   WTSIi180-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962560
DR   EBiSC; WTSIi180-B
DR   ECACC; 66540409
DR   ECACC; 77650307
DR   HipSci; HPSI0514i-puie_5
DR   hPSCreg; WTSIi180-B
DR   SKIP; SKIP002887
DR   Wikidata; Q54890916
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540409; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE58 ! HPSI0514i-puie_4
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0514i-pulk_1
AC   CVCL_AF82
SY   WTSIi205-A
DR   BioSamples; SAMEA3282740
DR   EBiSC; WTSIi205-A
DR   ECACC; 66540440
DR   ECACC; 77650349
DR   HipSci; HPSI0514i-pulk_1
DR   hPSCreg; WTSIi205-A
DR   Wikidata; Q54890917
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540440; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0514i-qajt_2
AC   CVCL_IX33
SY   WTSIi475-B; WTSIi541-A
DR   BioSamples; SAMEA4085311
DR   ECACC; 77650438
DR   HipSci; HPSI0514i-qajt_2
DR   hPSCreg; WTSIi475-B
DR   Wikidata; Q54890918
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX34 ! HPSI0514i-qajt_5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-qajt_5
AC   CVCL_IX34
SY   WTSIi475-A
DR   BioSamples; SAMEA4085309
DR   ECACC; 77650437
DR   HipSci; HPSI0514i-qajt_5
DR   hPSCreg; WTSIi475-A
DR   Wikidata; Q54890919
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX33 ! HPSI0514i-qajt_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-qihv_1
AC   CVCL_AF83
SY   WTSIi228-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3466477
DR   ECACC; 77650605
DR   HipSci; HPSI0514i-qihv_1
DR   hPSCreg; WTSIi228-A
DR   Wikidata; Q54890920
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-rutc_2
AC   CVCL_AX03
SY   WTSIi181-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974014
DR   EBiSC; WTSIi181-A
DR   ECACC; 66540354
DR   ECACC; 77650311
DR   HipSci; HPSI0514i-rutc_2
DR   hPSCreg; WTSIi181-A
DR   SKIP; SKIP002850
DR   Wikidata; Q54890922
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540354; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0514i-sohd_2
AC   CVCL_IY60
SY   HPSI0514pf-sohd_2; WTSIi262-B; WTSIi336-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4446780
DR   ECACC; 77650381
DR   HipSci; HPSI0514i-sohd_2
DR   hPSCreg; WTSIi262-B
DR   Wikidata; Q54890923
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650381; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF00 ! HPSI0514i-sohd_3
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0514i-sohd_3
AC   CVCL_EF00
SY   WTSIi262-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4446956
DR   ECACC; 77650386
DR   HipSci; HPSI0514i-sohd_3
DR   hPSCreg; WTSIi262-A
DR   Wikidata; Q54890924
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY60 ! HPSI0514i-sohd_2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-suul_1
AC   CVCL_LL33
SY   WTSIi643-B; WTSIi652-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011282
DR   ECACC; 77650718
DR   HipSci; HPSI0514i-suul_1
DR   hPSCreg; WTSIi643-B
DR   Wikidata; Q54890925
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL34 ! HPSI0514i-suul_2
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-suul_2
AC   CVCL_LL34
SY   WTSIi643-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011281
DR   ECACC; 77650719
DR   HipSci; HPSI0514i-suul_2
DR   hPSCreg; WTSIi643-A
DR   Wikidata; Q54890926
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL33 ! HPSI0514i-suul_1
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-tavh_2
AC   CVCL_AX01
SY   WTSIi431-A
DR   BioSamples; SAMEA4085319
DR   ECACC; 77650357
DR   HipSci; HPSI0514i-tavh_2
DR   hPSCreg; WTSIi431-A
DR   Wikidata; Q54890927
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-tert_1
AC   CVCL_IY61
SY   WTSIi593-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4454942
DR   ECACC; 77650465
DR   HipSci; HPSI0514i-tert_1
DR   hPSCreg; WTSIi593-A
DR   Wikidata; Q54890928
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY62 ! HPSI0514i-tert_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-tert_3
AC   CVCL_IY62
SY   WTSIi593-B; WTSIi608-A
DR   BioSamples; SAMEA4454944
DR   ECACC; 77650466
DR   HipSci; HPSI0514i-tert_3
DR   hPSCreg; WTSIi593-B
DR   Wikidata; Q54890929
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Discontinued: ECACC; 77650466; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY61 ! HPSI0514i-tert_1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   HPSI0514i-toco_5
AC   CVCL_AJ98
SY   WTSIi283-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3311872
DR   ECACC; 77650621
DR   HipSci; HPSI0514i-toco_5
DR   hPSCreg; WTSIi283-A
DR   Wikidata; Q54890930
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-uenn_3
AC   CVCL_EF01
SY   WTSIi369-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4339634
DR   ECACC; 77650364
DR   HipSci; HPSI0514i-uenn_3
DR   hPSCreg; WTSIi369-A
DR   Wikidata; Q54890931
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-vuna_2
AC   CVCL_JN72
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3448739
DR   HipSci; HPSI0514i-vuna_2
DR   Wikidata; Q54890932
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF84 ! HPSI0514i-vuna_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-vuna_3
AC   CVCL_AF84
SY   WTSIi259-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3448738
DR   ECACC; 77650602
DR   HipSci; HPSI0514i-vuna_3
DR   hPSCreg; WTSIi259-A
DR   Wikidata; Q54890933
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN72 ! HPSI0514i-vuna_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-wiii_2
AC   CVCL_AF85
SY   WTSIi049-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3312840
DR   EBiSC; WTSIi049-A
DR   ECACC; 66540126
DR   ECACC; 77650177
DR   HipSci; HPSI0514i-wiii_2
DR   hPSCreg; WTSIi049-A
DR   SKIP; SKIP002635
DR   Wikidata; Q54890934
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540126; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF86 ! HPSI0514i-wiii_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0514i-wiii_3
AC   CVCL_AF86
SY   WTSIi049-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3316296
DR   EBiSC; WTSIi049-B
DR   ECACC; 66540125
DR   ECACC; 77650211
DR   HipSci; HPSI0514i-wiii_3
DR   hPSCreg; WTSIi049-B
DR   SKIP; SKIP002638
DR   Wikidata; Q54890935
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540125; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF85 ! HPSI0514i-wiii_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0514i-xayd_4
AC   CVCL_IY63
SY   WTSIi666-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4564805
DR   ECACC; 77650493
DR   HipSci; HPSI0514i-xayd_4
DR   hPSCreg; WTSIi666-A
DR   Wikidata; Q54890936
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Discontinued: ECACC; 77650493; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY64 ! HPSI0514i-xayd_5
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   HPSI0514i-xayd_5
AC   CVCL_IY64
SY   WTSIi666-B; WTSIi734-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4564806
DR   ECACC; 77650494
DR   HipSci; HPSI0514i-xayd_5
DR   hPSCreg; WTSIi666-B
DR   Wikidata; Q54890944
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Discontinued: ECACC; 77650494; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY63 ! HPSI0514i-xayd_4
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   HPSI0514i-xufp_1
AC   CVCL_LL35
SY   WTSIi645-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104026891
DR   ECACC; 77650731
DR   HipSci; HPSI0514i-xufp_1
DR   hPSCreg; WTSIi645-A
DR   Wikidata; Q54890945
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ89 ! HPSI0514i-xufp_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-xufp_2
AC   CVCL_WJ89
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104026892
DR   ECACC; 77650804
DR   HipSci; HPSI0514i-xufp_2
DR   Wikidata; Q94226955
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL35 ! HPSI0514i-xufp_1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0514i-yafr_3
AC   CVCL_WJ81
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4451652
DR   ECACC; 77650818
DR   HipSci; HPSI0514i-yafr_3
DR   Wikidata; Q94226961
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0514i-yelp_3
AC   CVCL_AF87
SY   WTSIi365-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3282737
DR   ECACC; 77650596
DR   HipSci; HPSI0514i-yelp_3
DR   hPSCreg; WTSIi365-A
DR   Wikidata; Q54890946
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN73 ! HPSI0514i-yelp_4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0514i-yelp_4
AC   CVCL_JN73
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3282738
DR   HipSci; HPSI0514i-yelp_4
DR   Wikidata; Q54890947
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF87 ! HPSI0514i-yelp_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0514i-yewo_4
AC   CVCL_LL36
SY   WTSIi636-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103884170
DR   ECACC; 77650625
DR   HipSci; HPSI0514i-yewo_4
DR   hPSCreg; WTSIi636-A
DR   Wikidata; Q54890948
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-aaun_5
AC   CVCL_LF24
SY   WTSIi641-B; WTSIi738-A
DR   BioSamples; SAMEA103884148
DR   ECACC; 77650745
DR   HipSci; HPSI0516i-aaun_5
DR   hPSCreg; WTSIi641-B
DR   Wikidata; Q54890949
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Czechoslovakian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF25 ! HPSI0516i-aaun_6
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-aaun_6
AC   CVCL_LF25
SY   WTSIi641-A
DR   BioSamples; SAMEA103884146
DR   ECACC; 77650681
DR   HipSci; HPSI0516i-aaun_6
DR   hPSCreg; WTSIi641-A
DR   Wikidata; Q54890950
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Czechoslovakian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF24 ! HPSI0516i-aaun_5
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-dewa_2
AC   CVCL_LF26
SY   WTSIi697-A
DR   BioSamples; SAMEA104011559
DR   ECACC; 77650687
DR   HipSci; HPSI0516i-dewa_2
DR   hPSCreg; WTSIi697-A
DR   Wikidata; Q54890951
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF27 ! HPSI0516i-dewa_5
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-dewa_5
AC   CVCL_LF27
SY   WTSIi697-B; WTSIi737-A
DR   BioSamples; SAMEA104011562
DR   ECACC; 77650688
DR   HipSci; HPSI0516i-dewa_5
DR   hPSCreg; WTSIi697-B
DR   Wikidata; Q54890952
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF26 ! HPSI0516i-dewa_2
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-eitu_3
AC   CVCL_IX98
SY   WTSIi464-A
DR   BioSamples; SAMEA4856668
DR   ECACC; 77650497
DR   HipSci; HPSI0516i-eitu_3
DR   hPSCreg; WTSIi464-A
DR   Wikidata; Q54890953
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX99 ! HPSI0516i-eitu_4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-eitu_4
AC   CVCL_IX99
SY   WTSIi464-B; WTSIi553-A
DR   BioSamples; SAMEA4857418
DR   ECACC; 77650629
DR   HipSci; HPSI0516i-eitu_4
DR   hPSCreg; WTSIi464-B
DR   Wikidata; Q54890954
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX98 ! HPSI0516i-eitu_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-eosr_1
AC   CVCL_IZ30
SY   WTSIi455-A
DR   BioSamples; SAMEA17599168
DR   ECACC; 77650548
DR   HipSci; HPSI0516i-eosr_1
DR   hPSCreg; WTSIi455-A
DR   Wikidata; Q54890955
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-goek_4
AC   CVCL_IY00
SY   WTSIi487-A
DR   BioSamples; SAMEA4563413
DR   ECACC; 77650547
DR   HipSci; HPSI0516i-goek_4
DR   hPSCreg; WTSIi487-A
DR   Wikidata; Q54890956
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-hapz_2
AC   CVCL_IY01
SY   WTSIi486-B; WTSIi521-A
DR   BioSamples; SAMEA7594168
DR   ECACC; 77650536
DR   HipSci; HPSI0516i-hapz_2
DR   hPSCreg; WTSIi486-B
DR   Wikidata; Q54890957
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY02 ! HPSI0516i-hapz_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-hapz_3
AC   CVCL_IY02
SY   WTSIi486-A
DR   BioSamples; SAMEA7593418
DR   ECACC; 77650537
DR   HipSci; HPSI0516i-hapz_3
DR   hPSCreg; WTSIi486-A
DR   Wikidata; Q54890958
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY01 ! HPSI0516i-hapz_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-iool_4
AC   CVCL_IY03
SY   WTSIi454-B; WTSIi505-A
DR   BioSamples; SAMEA7864168
DR   ECACC; 77650532
DR   HipSci; HPSI0516i-iool_4
DR   hPSCreg; WTSIi454-B
DR   Wikidata; Q54890959
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY04 ! HPSI0516i-iool_6
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-iool_6
AC   CVCL_IY04
SY   WTSIi454-A
DR   BioSamples; SAMEA7867168
DR   ECACC; 77650533
DR   HipSci; HPSI0516i-iool_6
DR   hPSCreg; WTSIi454-A
DR   Wikidata; Q54890960
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY03 ! HPSI0516i-iool_4
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-iuoc_2
AC   CVCL_LE95
SY   WTSIi480-B; WTSIi556-A
DR   BioSamples; SAMEA8013418
DR   ECACC; 77650663
DR   HipSci; HPSI0516i-iuoc_2
DR   hPSCreg; WTSIi480-B
DR   Wikidata; Q54890961
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE94 ! HPSI0516i-iuoc_5
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-iuoc_5
AC   CVCL_LE94
SY   WTSIi480-A
DR   BioSamples; SAMEA8012668
DR   ECACC; 77650662
DR   HipSci; HPSI0516i-iuoc_5
DR   hPSCreg; WTSIi480-A
DR   Wikidata; Q54890962
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LE95 ! HPSI0516i-iuoc_2
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-jepf_3
AC   CVCL_IX65
SY   WTSIi460-B; WTSIi494-A
DR   BioSamples; SAMEA4563411
DR   ECACC; 77650500
DR   HipSci; HPSI0516i-jepf_3
DR   hPSCreg; WTSIi460-B
DR   Wikidata; Q54890963
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX66 ! HPSI0516i-jepf_5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-jepf_5
AC   CVCL_IX66
SY   WTSIi460-A
DR   BioSamples; SAMEA4563408
DR   ECACC; 77650501
DR   HipSci; HPSI0516i-jepf_5
DR   hPSCreg; WTSIi460-A
DR   Wikidata; Q54890964
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX65 ! HPSI0516i-jepf_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-jory_10
AC   CVCL_IX82
SY   WTSIi470-B; WTSIi557-A
DR   BioSamples; SAMEA4562370
DR   ECACC; 77650539
DR   HipSci; HPSI0516i-jory_10
DR   hPSCreg; WTSIi470-B
DR   Wikidata; Q54890965
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: African.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX79 ! HPSI0516i-jory_9
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0516i-jory_9
AC   CVCL_IX79
SY   WTSIi470-A
DR   BioSamples; SAMEA4562374
DR   ECACC; 77650538
DR   HipSci; HPSI0516i-jory_9
DR   hPSCreg; WTSIi470-A
DR   Wikidata; Q54890966
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: African.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX82 ! HPSI0516i-jory_10
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0516i-kumr_11
AC   CVCL_LL52
SY   WTSIi709-A
DR   BioSamples; SAMEA104012236
DR   ECACC; 77650758
DR   HipSci; HPSI0516i-kumr_11
DR   hPSCreg; WTSIi709-A
DR   Wikidata; Q54890967
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Portuguese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 11
//
ID   HPSI0516i-menz_3
AC   CVCL_LF28
SY   WTSIi622-B; WTSIi630-A
DR   BioSamples; SAMEA103884813
DR   ECACC; 77650702
DR   HipSci; HPSI0516i-menz_3
DR   hPSCreg; WTSIi622-B
DR   Wikidata; Q54890968
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF29 ! HPSI0516i-menz_4
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-menz_4
AC   CVCL_LF29
SY   WTSIi622-A
DR   BioSamples; SAMEA103884812
DR   ECACC; 77650703
DR   HipSci; HPSI0516i-menz_4
DR   hPSCreg; WTSIi622-A
DR   Wikidata; Q54890969
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF28 ! HPSI0516i-menz_3
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-oadp_4
AC   CVCL_IX53
SY   WTSIi558-A
DR   BioSamples; SAMEA4564044
DR   ECACC; 77650541
DR   HipSci; HPSI0516i-oadp_4
DR   hPSCreg; WTSIi558-A
DR   Wikidata; Q54890970
CC   From: University of Manchester; Manchester; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX54 ! HPSI0516i-oadp_5
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-oadp_5
AC   CVCL_IX54
SY   WTSIi558-B; WTSIi572-A
DR   BioSamples; SAMEA4564046
DR   ECACC; 77650542
DR   HipSci; HPSI0516i-oadp_5
DR   hPSCreg; WTSIi558-B
DR   Wikidata; Q54890971
CC   From: University of Manchester; Manchester; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX53 ! HPSI0516i-oadp_4
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-oazw_3
AC   CVCL_IY05
SY   WTSIi488-B; WTSIi517-A
DR   BioSamples; SAMEA4563397
DR   ECACC; 77650505
DR   HipSci; HPSI0516i-oazw_3
DR   hPSCreg; WTSIi488-B
DR   Wikidata; Q54890972
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY06 ! HPSI0516i-oazw_4
SX   Female
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-oazw_4
AC   CVCL_IY06
SY   WTSIi488-A
DR   BioSamples; SAMEA4563396
DR   ECACC; 77650506
DR   HipSci; HPSI0516i-oazw_4
DR   hPSCreg; WTSIi488-A
DR   Wikidata; Q54890973
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY05 ! HPSI0516i-oazw_3
SX   Female
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-peoo_1
AC   CVCL_LM06
SY   WTSIi680-B; WTSIi701-A
DR   BioSamples; SAMEA104008223
DR   ECACC; 77650709
DR   HipSci; HPSI0516i-peoo_1
DR   hPSCreg; WTSIi680-B
DR   Wikidata; Q54890974
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM07 ! HPSI0516i-peoo_2
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0516i-peoo_2
AC   CVCL_LM07
SY   WTSIi680-A
DR   BioSamples; SAMEA104008224
DR   ECACC; 77650710
DR   HipSci; HPSI0516i-peoo_2
DR   hPSCreg; WTSIi680-A
DR   Wikidata; Q54890975
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM06 ! HPSI0516i-peoo_1
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0516i-pews_2
AC   CVCL_IY07
SY   WTSIi522-B; WTSIi544-A
DR   BioSamples; SAMEA4563382
DR   ECACC; 77650509
DR   HipSci; HPSI0516i-pews_2
DR   hPSCreg; WTSIi522-B
DR   Wikidata; Q54890976
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY08 ! HPSI0516i-pews_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-pews_3
AC   CVCL_IY08
SY   WTSIi522-A
DR   BioSamples; SAMEA4563383
DR   ECACC; 77650510
DR   HipSci; HPSI0516i-pews_3
DR   hPSCreg; WTSIi522-A
DR   Wikidata; Q54890977
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY07 ! HPSI0516i-pews_2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-quqp_4
AC   CVCL_LF30
SY   WTSIi672-B; WTSIi704-A
DR   BioSamples; SAMEA104011303
DR   ECACC; 77650856
DR   HipSci; HPSI0516i-quqp_4
DR   hPSCreg; WTSIi672-B
DR   Wikidata; Q54890978
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF31 ! HPSI0516i-quqp_6
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-quqp_6
AC   CVCL_LF31
SY   WTSIi672-A
DR   BioSamples; SAMEA104011304
DR   ECACC; 77650857
DR   HipSci; HPSI0516i-quqp_6
DR   hPSCreg; WTSIi672-A
DR   Wikidata; Q54890979
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF30 ! HPSI0516i-quqp_4
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   HPSI0516i-raet_4
AC   CVCL_WJ62
DR   BioSamples; SAMEA104132159
DR   ECACC; 77650842
DR   HipSci; HPSI0516i-raet_4
DR   Wikidata; Q94227589
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ63 ! HPSI0516i-raet_6
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI0516i-raet_6
AC   CVCL_WJ63
DR   BioSamples; SAMEA104132157
DR   ECACC; 77650843
DR   HipSci; HPSI0516i-raet_6
DR   Wikidata; Q94227592
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ62 ! HPSI0516i-raet_4
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI0516i-suqd_3
AC   CVCL_LF05
SY   WTSIi609-A
DR   BioSamples; SAMEA4860418
DR   ECACC; 77650672
DR   HipSci; HPSI0516i-suqd_3
DR   hPSCreg; WTSIi609-A
DR   Wikidata; Q54890980
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF06 ! HPSI0516i-suqd_6
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0516i-suqd_6
AC   CVCL_LF06
SY   WTSIi609-B; WTSIi628-A
DR   BioSamples; SAMEA4861168
DR   ECACC; 77650673
DR   HipSci; HPSI0516i-suqd_6
DR   hPSCreg; WTSIi609-B
DR   Wikidata; Q54890981
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF05 ! HPSI0516i-suqd_3
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0516i-suyj_1
AC   CVCL_WJ53
DR   BioSamples; SAMEA104242929
DR   ECACC; 77650852
DR   HipSci; HPSI0516i-suyj_1
DR   Wikidata; Q94227628
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Portuguese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ54 ! HPSI0516i-suyj_2
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI0516i-suyj_2
AC   CVCL_WJ54
DR   BioSamples; SAMEA104242928
DR   ECACC; 77650851
DR   HipSci; HPSI0516i-suyj_2
DR   Wikidata; Q94227634
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Portuguese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ53 ! HPSI0516i-suyj_1
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI0516i-vebd_2
AC   CVCL_WJ58
DR   BioSamples; SAMEA104132054
DR   ECACC; 77650846
DR   HipSci; HPSI0516i-vebd_2
DR   Wikidata; Q94227639
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ59 ! HPSI0516i-vebd_4
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI0516i-vebd_4
AC   CVCL_WJ59
DR   BioSamples; SAMEA104132053
DR   ECACC; 77650847
DR   HipSci; HPSI0516i-vebd_4
DR   Wikidata; Q94227645
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ58 ! HPSI0516i-vebd_2
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI0516i-yibc_4
AC   CVCL_LE96
SY   WTSIi496-A
DR   BioSamples; SAMEA17641168
DR   ECACC; 77650661
DR   HipSci; HPSI0516i-yibc_4
DR   hPSCreg; WTSIi496-A
DR   Wikidata; Q54890982
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Czechoslovakian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0516i-yist_1
AC   CVCL_LF15
SY   WTSIi623-B; WTSIi639-A
DR   BioSamples; SAMEA4675918
DR   ECACC; 77650675
DR   HipSci; HPSI0516i-yist_1
DR   hPSCreg; WTSIi623-B
DR   Wikidata; Q54890983
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2206; COL4A4; Simple; p.Pro1096Ser (c.3286C>T); Zygosity=Heterozygous (from autologous cell line HPSI0516i-yist_3).
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1232Asp (c.3695G>A); Zygosity=Hemizygous (from autologous cell line HPSI0516i-yist_3).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF16 ! HPSI0516i-yist_3
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   HPSI0516i-yist_3
AC   CVCL_LF16
SY   WTSIi623-A
DR   BioSamples; SAMEA4673668
DR   ECACC; 77650724
DR   HipSci; HPSI0516i-yist_3
DR   hPSCreg; WTSIi623-A
DR   Wikidata; Q54890987
RX   PubMed=35076391;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2206; COL4A4; Simple; p.Pro1096Ser (c.3286C>T); Zygosity=Heterozygous (PubMed=35076391).
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1232Asp (c.3695G>A); Zygosity=Hemizygous (PubMed=35076391).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF15 ! HPSI0516i-yist_1
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   HPSI0516i-zujs_5
AC   CVCL_LF32
SY   WTSIi563-A
DR   BioSamples; SAMEA17647918
DR   ECACC; 77650666
DR   HipSci; HPSI0516i-zujs_5
DR   hPSCreg; WTSIi563-A
DR   Wikidata; Q54890988
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Portuguese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650666; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0516i-zukb_2
AC   CVCL_IX80
SY   WTSIi459-A
DR   BioSamples; SAMEA4561629
DR   ECACC; 77650525
DR   HipSci; HPSI0516i-zukb_2
DR   hPSCreg; WTSIi459-A
DR   Wikidata; Q54890989
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX81 ! HPSI0516i-zukb_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0516i-zukb_3
AC   CVCL_IX81
SY   WTSIi459-B; WTSIi549-A
DR   BioSamples; SAMEA4561630
DR   ECACC; 77650526
DR   HipSci; HPSI0516i-zukb_3
DR   hPSCreg; WTSIi459-B
DR   Wikidata; Q54890990
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX80 ! HPSI0516i-zukb_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-aaeh_3
AC   CVCL_JN74
DR   BioSamples; SAMEA2398596
DR   HipSci; HPSI0613i-aaeh_3
DR   Wikidata; Q54890991
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0613i-aevs_1
AC   CVCL_AF88
SY   WTSIi063-A
DR   BioSamples; SAMEA2398691
DR   EBiSC; WTSIi063-A
DR   ECACC; 66540140
DR   ECACC; 77650203
DR   HipSci; HPSI0613i-aevs_1
DR   hPSCreg; WTSIi063-A
DR   SKIP; SKIP002651
DR   Wikidata; Q54890992
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540140; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF89 ! HPSI0613i-aevs_2
OI   CVCL_JN75 ! HPSI0613i-aevs_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-aevs_2
AC   CVCL_AF89
DR   BioSamples; SAMEA2398693
DR   HipSci; HPSI0613i-aevs_2
DR   Wikidata; Q54890993
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF88 ! HPSI0613i-aevs_1
OI   CVCL_JN75 ! HPSI0613i-aevs_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-aevs_3
AC   CVCL_JN75
DR   BioSamples; SAMEA2398432
DR   HipSci; HPSI0613i-aevs_3
DR   Wikidata; Q54890995
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF88 ! HPSI0613i-aevs_1
OI   CVCL_AF89 ! HPSI0613i-aevs_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-auim_1
AC   CVCL_JN76
DR   BioSamples; SAMEA2398333
DR   HipSci; HPSI0613i-auim_1
DR   Wikidata; Q54890996
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF90 ! HPSI0613i-auim_2
OI   CVCL_AF91 ! HPSI0613i-auim_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-auim_2
AC   CVCL_AF90
SY   WTSIi212-A
DR   BioSamples; SAMEA2398656
DR   ECACC; 77650214
DR   HipSci; HPSI0613i-auim_2
DR   hPSCreg; WTSIi212-A
DR   PRIDE; PXD003903
DR   Wikidata; Q54890997
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN76 ! HPSI0613i-auim_1
OI   CVCL_AF91 ! HPSI0613i-auim_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-auim_3
AC   CVCL_AF91
SY   WTSIi212-B; WTSIi231-A
DR   BioSamples; SAMEA2397959
DR   ECACC; 77650215
DR   HipSci; HPSI0613i-auim_3
DR   hPSCreg; WTSIi212-B
DR   PRIDE; PXD003903
DR   Wikidata; Q54890998
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN76 ! HPSI0613i-auim_1
OI   CVCL_AF90 ! HPSI0613i-auim_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-bawa_1
AC   CVCL_AF92
SY   WTSIi132-A
DR   BioSamples; SAMEA2493816
DR   EBiSC; WTSIi132-A
DR   ECACC; 66540233
DR   ECACC; 77650180
DR   HipSci; HPSI0613i-bawa_1
DR   hPSCreg; WTSIi132-A
DR   SKIP; SKIP002758
DR   Wikidata; Q54890999
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540233; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN77 ! HPSI0613i-bawa_2
OI   CVCL_JN78 ! HPSI0613i-bawa_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0613i-bawa_2
AC   CVCL_JN77
DR   BioSamples; SAMEA2493810
DR   HipSci; HPSI0613i-bawa_2
DR   Wikidata; Q54891000
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF92 ! HPSI0613i-bawa_1
OI   CVCL_JN78 ! HPSI0613i-bawa_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-bawa_3
AC   CVCL_JN78
DR   BioSamples; SAMEA2493814
DR   HipSci; HPSI0613i-bawa_3
DR   Wikidata; Q54891001
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF92 ! HPSI0613i-bawa_1
OI   CVCL_JN77 ! HPSI0613i-bawa_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-bohf_1
AC   CVCL_AF93
SY   WTSIi064-A
DR   BioSamples; SAMEA2398251
DR   EBiSC; WTSIi064-A
DR   ECACC; 66540139
DR   ECACC; 77650137
DR   HipSci; HPSI0613i-bohf_1
DR   hPSCreg; WTSIi064-A
DR   SKIP; SKIP002652
DR   Wikidata; Q54891002
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540139; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN79 ! HPSI0613i-bohf_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-bohf_2
AC   CVCL_JN79
DR   BioSamples; SAMEA2399118
DR   HipSci; HPSI0613i-bohf_2
DR   Wikidata; Q54891003
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF93 ! HPSI0613i-bohf_1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-dium_1
AC   CVCL_AF94
SY   WTSIi209-A
DR   BioSamples; SAMEA2398412
DR   ECACC; 77650226
DR   HipSci; HPSI0613i-dium_1
DR   hPSCreg; WTSIi209-A
DR   Wikidata; Q54891004
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN80 ! HPSI0613i-dium_2
OI   CVCL_JN81 ! HPSI0613i-dium_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-dium_2
AC   CVCL_JN80
DR   BioSamples; SAMEA2398484
DR   HipSci; HPSI0613i-dium_2
DR   Wikidata; Q54891005
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF94 ! HPSI0613i-dium_1
OI   CVCL_JN81 ! HPSI0613i-dium_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-dium_3
AC   CVCL_JN81
DR   BioSamples; SAMEA2399019
DR   HipSci; HPSI0613i-dium_3
DR   Wikidata; Q54891006
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF94 ! HPSI0613i-dium_1
OI   CVCL_JN80 ! HPSI0613i-dium_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-eojr_1
AC   CVCL_JN82
DR   BioSamples; SAMEA2398944
DR   HipSci; HPSI0613i-eojr_1
DR   Wikidata; Q54891007
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF95 ! HPSI0613i-eojr_2
OI   CVCL_AF96 ! HPSI0613i-eojr_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-eojr_2
AC   CVCL_AF95
SY   WTSIi065-A
DR   BioSamples; SAMEA2399151
DR   EBiSC; WTSIi065-A
DR   ECACC; 66540138
DR   ECACC; 77650134
DR   HipSci; HPSI0613i-eojr_2
DR   hPSCreg; WTSIi065-A
DR   SKIP; SKIP002653
DR   Wikidata; Q54891008
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540138; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN82 ! HPSI0613i-eojr_1
OI   CVCL_AF96 ! HPSI0613i-eojr_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-eojr_3
AC   CVCL_AF96
SY   WTSIi065-B
DR   BioSamples; SAMEA2398291
DR   EBiSC; WTSIi065-B
DR   ECACC; 66540137
DR   ECACC; 77650093
DR   HipSci; HPSI0613i-eojr_3
DR   hPSCreg; WTSIi065-B
DR   SKIP; SKIP002663
DR   Wikidata; Q54891009
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540137; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN82 ! HPSI0613i-eojr_1
OI   CVCL_AF95 ! HPSI0613i-eojr_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-febc_1
AC   CVCL_AF97
SY   WTSIi066-A
DR   BioSamples; SAMEA2398252
DR   EBiSC; WTSIi066-A
DR   ECACC; 66540136
DR   ECACC; 77650208
DR   HipSci; HPSI0613i-febc_1
DR   hPSCreg; WTSIi066-A
DR   SKIP; SKIP002654
DR   Wikidata; Q54891010
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540136; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF98 ! HPSI0613i-febc_2
OI   CVCL_JN83 ! HPSI0613i-febc_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0613i-febc_2
AC   CVCL_AF98
SY   WTSIi066-B
DR   BioSamples; SAMEA2399014
DR   EBiSC; WTSIi066-B
DR   ECACC; 66540135
DR   ECACC; 77650228
DR   HipSci; HPSI0613i-febc_2
DR   hPSCreg; WTSIi066-B
DR   SKIP; SKIP002664
DR   Wikidata; Q54891011
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540135; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF97 ! HPSI0613i-febc_1
OI   CVCL_JN83 ! HPSI0613i-febc_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-febc_3
AC   CVCL_JN83
DR   BioSamples; SAMEA2398269
DR   HipSci; HPSI0613i-febc_3
DR   Wikidata; Q54891012
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF97 ! HPSI0613i-febc_1
OI   CVCL_AF98 ! HPSI0613i-febc_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-focm_1
AC   CVCL_AF99
SY   WTSIi232-A
DR   BioSamples; SAMEA2398725
DR   ECACC; 77650229
DR   HipSci; HPSI0613i-focm_1
DR   hPSCreg; WTSIi232-A
DR   Wikidata; Q54891013
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN84 ! HPSI0613i-focm_2
OI   CVCL_JN85 ! HPSI0613i-focm_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-focm_2
AC   CVCL_JN84
DR   BioSamples; SAMEA2397822
DR   HipSci; HPSI0613i-focm_2
DR   Wikidata; Q54891015
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF99 ! HPSI0613i-focm_1
OI   CVCL_JN85 ! HPSI0613i-focm_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-focm_3
AC   CVCL_JN85
DR   BioSamples; SAMEA2398687
DR   HipSci; HPSI0613i-focm_3
DR   Wikidata; Q54891016
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AF99 ! HPSI0613i-focm_1
OI   CVCL_JN84 ! HPSI0613i-focm_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-funp_1
AC   CVCL_JN86
DR   BioSamples; SAMEA2398012
DR   HipSci; HPSI0613i-funp_1
DR   Wikidata; Q54891017
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG00 ! HPSI0613i-funp_2
OI   CVCL_AG01 ! HPSI0613i-funp_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-funp_2
AC   CVCL_AG00
SY   WTSIi112-B; WTSIi372-A
DR   BioSamples; SAMEA2398478
DR   ECACC; 77650189
DR   HipSci; HPSI0613i-funp_2
DR   hPSCreg; WTSIi112-B
DR   Wikidata; Q54891018
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN86 ! HPSI0613i-funp_1
OI   CVCL_AG01 ! HPSI0613i-funp_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-funp_3
AC   CVCL_AG01
SY   WTSIi112-A
DR   BioSamples; SAMEA2398046
DR   ECACC; 77650018
DR   HipSci; HPSI0613i-funp_3
DR   hPSCreg; WTSIi112-A
DR   SKIP; SKIP002734
DR   Wikidata; Q54891019
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN86 ! HPSI0613i-funp_1
OI   CVCL_AG00 ! HPSI0613i-funp_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-giuo_4
AC   CVCL_AG02
SY   WTSIi068-B
DR   BioSamples; SAMEA2398834
DR   ECACC; 77650024
DR   HipSci; HPSI0613i-giuo_4
DR   hPSCreg; WTSIi068-B
DR   SKIP; SKIP002736
DR   Wikidata; Q54891020
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG03 ! HPSI0613i-giuo_5
OI   CVCL_JN87 ! HPSI0613i-giuo_6
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-giuo_5
AC   CVCL_AG03
SY   WTSIi068-A
DR   BioSamples; SAMEA2399222
DR   EBiSC; WTSIi068-A
DR   ECACC; 66540132
DR   ECACC; 77650202
DR   HipSci; HPSI0613i-giuo_5
DR   hPSCreg; WTSIi068-A
DR   SKIP; SKIP002657
DR   Wikidata; Q54891021
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540132; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG02 ! HPSI0613i-giuo_4
OI   CVCL_JN87 ! HPSI0613i-giuo_6
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0613i-giuo_6
AC   CVCL_JN87
DR   BioSamples; SAMEA2398362
DR   HipSci; HPSI0613i-giuo_6
DR   Wikidata; Q54891022
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG02 ! HPSI0613i-giuo_4
OI   CVCL_AG03 ! HPSI0613i-giuo_5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-hegp_1
AC   CVCL_JN88
DR   BioSamples; SAMEA2398033
DR   HipSci; HPSI0613i-hegp_1
DR   Wikidata; Q54891023
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN89 ! HPSI0613i-hegp_2
OI   CVCL_AG04 ! HPSI0613i-hegp_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-hegp_2
AC   CVCL_JN89
DR   BioSamples; SAMEA2399008
DR   HipSci; HPSI0613i-hegp_2
DR   Wikidata; Q54891025
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN88 ! HPSI0613i-hegp_1
OI   CVCL_AG04 ! HPSI0613i-hegp_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-hegp_3
AC   CVCL_AG04
SY   WTSIi069-A
DR   BioSamples; SAMEA2398257
DR   EBiSC; WTSIi069-A
DR   ECACC; 66540153
DR   ECACC; 77650201
DR   HipSci; HPSI0613i-hegp_3
DR   hPSCreg; WTSIi069-A
DR   SKIP; SKIP002658
DR   Wikidata; Q54891026
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540153; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN88 ! HPSI0613i-hegp_1
OI   CVCL_JN89 ! HPSI0613i-hegp_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0613i-hikj_1
AC   CVCL_AG05
SY   WTSIi106-B
DR   BioSamples; SAMEA2398534
DR   ECACC; 77650166
DR   HipSci; HPSI0613i-hikj_1
DR   hPSCreg; WTSIi106-B
DR   SKIP; SKIP002724
DR   Wikidata; Q54891027
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG06 ! HPSI0613i-hikj_2
OI   CVCL_JN90 ! HPSI0613i-hikj_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-hikj_2
AC   CVCL_AG06
SY   WTSIi106-A
DR   BioSamples; SAMEA2398233
DR   EBiSC; WTSIi106-A
DR   ECACC; 66540221
DR   ECACC; 77650209
DR   HipSci; HPSI0613i-hikj_2
DR   hPSCreg; WTSIi106-A
DR   SKIP; SKIP002721
DR   Wikidata; Q54891028
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540221; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG05 ! HPSI0613i-hikj_1
OI   CVCL_JN90 ! HPSI0613i-hikj_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-hikj_3
AC   CVCL_JN90
DR   BioSamples; SAMEA2398421
DR   HipSci; HPSI0613i-hikj_3
DR   Wikidata; Q54891029
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG05 ! HPSI0613i-hikj_1
OI   CVCL_AG06 ! HPSI0613i-hikj_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-iurx_1
AC   CVCL_AG07
DR   BioSamples; SAMEA2398135
DR   HipSci; HPSI0613i-iurx_1
DR   Wikidata; Q54891033
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN91 ! HPSI0613i-iurx_2
OI   CVCL_JN92 ! HPSI0613i-iurx_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-iurx_2
AC   CVCL_JN91
DR   BioSamples; SAMEA2398260
DR   HipSci; HPSI0613i-iurx_2
DR   Wikidata; Q54891034
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG07 ! HPSI0613i-iurx_1
OI   CVCL_JN92 ! HPSI0613i-iurx_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-iurx_3
AC   CVCL_JN92
DR   BioSamples; SAMEA2398738
DR   HipSci; HPSI0613i-iurx_3
DR   Wikidata; Q54891035
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG07 ! HPSI0613i-iurx_1
OI   CVCL_JN91 ! HPSI0613i-iurx_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-jorr_1
AC   CVCL_AG08
SY   WTSIi219-A
DR   BioSamples; SAMEA2397944
DR   ECACC; 77650232
DR   HipSci; HPSI0613i-jorr_1
DR   hPSCreg; WTSIi219-A
DR   Wikidata; Q54891036
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-kewt_1
AC   CVCL_JN93
DR   BioSamples; SAMEA2399227
DR   HipSci; HPSI0613i-kewt_1
DR   Wikidata; Q54891037
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN94 ! HPSI0613i-kewt_2
OI   CVCL_AG09 ! HPSI0613i-kewt_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-kewt_2
AC   CVCL_JN94
DR   BioSamples; SAMEA2398588
DR   HipSci; HPSI0613i-kewt_2
DR   Wikidata; Q54891038
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN93 ! HPSI0613i-kewt_1
OI   CVCL_AG09 ! HPSI0613i-kewt_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-kewt_3
AC   CVCL_AG09
DR   BioSamples; SAMEA2398244
DR   HipSci; HPSI0613i-kewt_3
DR   Wikidata; Q54891040
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN93 ! HPSI0613i-kewt_1
OI   CVCL_JN94 ! HPSI0613i-kewt_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0613i-lavp_2
AC   CVCL_JN95
DR   BioSamples; SAMEA2399220
DR   HipSci; HPSI0613i-lavp_2
DR   Wikidata; Q54891041
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG10 ! HPSI0613i-lavp_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-lavp_3
AC   CVCL_AG10
DR   BioSamples; SAMEA2397832
DR   HipSci; HPSI0613i-lavp_3
DR   Wikidata; Q54891042
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN95 ! HPSI0613i-lavp_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-liun_1
AC   CVCL_JN96
DR   BioSamples; SAMEA2398558
DR   HipSci; HPSI0613i-liun_1
DR   Wikidata; Q54891043
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG11 ! HPSI0613i-liun_2
OI   CVCL_JN97 ! HPSI0613i-liun_3
OI   CVCL_AG12 ! HPSI0613i-liun_22
OI   CVCL_JN98 ! HPSI0613i-liun_59
OI   CVCL_JN99 ! HPSI0613i-liun_60
OI   CVCL_JP00 ! HPSI0613i-liun_62
OI   CVCL_JP01 ! HPSI0613i-liun_64
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-liun_2
AC   CVCL_AG11
SY   WTSIi117-A
DR   BioSamples; SAMEA2398043
DR   ECACC; 77650013
DR   HipSci; HPSI0613i-liun_2
DR   hPSCreg; WTSIi117-A
DR   SKIP; SKIP002740
DR   Wikidata; Q54891044
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN96 ! HPSI0613i-liun_1
OI   CVCL_JN97 ! HPSI0613i-liun_3
OI   CVCL_AG12 ! HPSI0613i-liun_22
OI   CVCL_JN98 ! HPSI0613i-liun_59
OI   CVCL_JN99 ! HPSI0613i-liun_60
OI   CVCL_JP00 ! HPSI0613i-liun_62
OI   CVCL_JP01 ! HPSI0613i-liun_64
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-liun_22
AC   CVCL_AG12
SY   WTSIi117-B; WTSIi383-A
DR   BioSamples; SAMEA2398884
DR   ECACC; 77650016
DR   HipSci; HPSI0613i-liun_22
DR   hPSCreg; WTSIi117-B
DR   Wikidata; Q54891046
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650016; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN96 ! HPSI0613i-liun_1
OI   CVCL_AG11 ! HPSI0613i-liun_2
OI   CVCL_JN97 ! HPSI0613i-liun_3
OI   CVCL_JN98 ! HPSI0613i-liun_59
OI   CVCL_JN99 ! HPSI0613i-liun_60
OI   CVCL_JP00 ! HPSI0613i-liun_62
OI   CVCL_JP01 ! HPSI0613i-liun_64
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   HPSI0613i-liun_3
AC   CVCL_JN97
DR   BioSamples; SAMEA2397859
DR   HipSci; HPSI0613i-liun_3
DR   Wikidata; Q54891047
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN96 ! HPSI0613i-liun_1
OI   CVCL_AG11 ! HPSI0613i-liun_2
OI   CVCL_AG12 ! HPSI0613i-liun_22
OI   CVCL_JN98 ! HPSI0613i-liun_59
OI   CVCL_JN99 ! HPSI0613i-liun_60
OI   CVCL_JP00 ! HPSI0613i-liun_62
OI   CVCL_JP01 ! HPSI0613i-liun_64
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-liun_59
AC   CVCL_JN98
DR   BioSamples; SAMEA2629776
DR   HipSci; HPSI0613i-liun_59
DR   Wikidata; Q54891048
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN96 ! HPSI0613i-liun_1
OI   CVCL_AG11 ! HPSI0613i-liun_2
OI   CVCL_JN97 ! HPSI0613i-liun_3
OI   CVCL_AG12 ! HPSI0613i-liun_22
OI   CVCL_JN99 ! HPSI0613i-liun_60
OI   CVCL_JP00 ! HPSI0613i-liun_62
OI   CVCL_JP01 ! HPSI0613i-liun_64
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0613i-liun_60
AC   CVCL_JN99
DR   BioSamples; SAMEA2629789
DR   HipSci; HPSI0613i-liun_60
DR   Wikidata; Q54891049
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN96 ! HPSI0613i-liun_1
OI   CVCL_AG11 ! HPSI0613i-liun_2
OI   CVCL_JN97 ! HPSI0613i-liun_3
OI   CVCL_AG12 ! HPSI0613i-liun_22
OI   CVCL_JN98 ! HPSI0613i-liun_59
OI   CVCL_JP00 ! HPSI0613i-liun_62
OI   CVCL_JP01 ! HPSI0613i-liun_64
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0613i-liun_62
AC   CVCL_JP00
DR   BioSamples; SAMEA2649523
DR   HipSci; HPSI0613i-liun_62
DR   Wikidata; Q54891050
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN96 ! HPSI0613i-liun_1
OI   CVCL_AG11 ! HPSI0613i-liun_2
OI   CVCL_JN97 ! HPSI0613i-liun_3
OI   CVCL_AG12 ! HPSI0613i-liun_22
OI   CVCL_JN98 ! HPSI0613i-liun_59
OI   CVCL_JN99 ! HPSI0613i-liun_60
OI   CVCL_JP01 ! HPSI0613i-liun_64
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0613i-liun_64
AC   CVCL_JP01
DR   BioSamples; SAMEA2649528
DR   HipSci; HPSI0613i-liun_64
DR   Wikidata; Q54891051
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JN96 ! HPSI0613i-liun_1
OI   CVCL_AG11 ! HPSI0613i-liun_2
OI   CVCL_JN97 ! HPSI0613i-liun_3
OI   CVCL_AG12 ! HPSI0613i-liun_22
OI   CVCL_JN98 ! HPSI0613i-liun_59
OI   CVCL_JN99 ! HPSI0613i-liun_60
OI   CVCL_JP00 ! HPSI0613i-liun_62
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0613i-lizq_1
AC   CVCL_AG13
SY   WTSIi137-A
DR   BioSamples; SAMEA2398446
DR   EBiSC; WTSIi137-A
DR   ECACC; 66540244
DR   ECACC; 77650174
DR   HipSci; HPSI0613i-lizq_1
DR   hPSCreg; WTSIi137-A
DR   SKIP; SKIP002769
DR   Wikidata; Q54891052
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540244; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP02 ! HPSI0613i-lizq_2
OI   CVCL_AG14 ! HPSI0613i-lizq_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-lizq_2
AC   CVCL_JP02
DR   BioSamples; SAMEA2398716
DR   HipSci; HPSI0613i-lizq_2
DR   Wikidata; Q54891053
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG13 ! HPSI0613i-lizq_1
OI   CVCL_AG14 ! HPSI0613i-lizq_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-lizq_3
AC   CVCL_AG14
SY   WTSIi137-B
DR   BioSamples; SAMEA2399088
DR   EBiSC; WTSIi137-B
DR   ECACC; 66540245
DR   ECACC; 77650170
DR   HipSci; HPSI0613i-lizq_3
DR   hPSCreg; WTSIi137-B
DR   SKIP; SKIP002770
DR   Wikidata; Q54891054
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540245; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG13 ! HPSI0613i-lizq_1
OI   CVCL_JP02 ! HPSI0613i-lizq_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-lula_1
AC   CVCL_JP03
DR   BioSamples; SAMEA2777397
DR   HipSci; HPSI0613i-lula_1
DR   Wikidata; Q54891055
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP04 ! HPSI0613i-lula_2
OI   CVCL_AG15 ! HPSI0613i-lula_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-lula_2
AC   CVCL_JP04
DR   BioSamples; SAMEA2777400
DR   HipSci; HPSI0613i-lula_2
DR   Wikidata; Q54891056
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP03 ! HPSI0613i-lula_1
OI   CVCL_AG15 ! HPSI0613i-lula_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-lula_3
AC   CVCL_AG15
DR   BioSamples; SAMEA2777402
DR   HipSci; HPSI0613i-lula_3
DR   Wikidata; Q54891057
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP03 ! HPSI0613i-lula_1
OI   CVCL_JP04 ! HPSI0613i-lula_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0613i-nukw_1
AC   CVCL_AG16
SY   WTSIi370-A
DR   BioSamples; SAMEA2399224
DR   ECACC; 77650239
DR   HipSci; HPSI0613i-nukw_1
DR   hPSCreg; WTSIi370-A
DR   Wikidata; Q54891058
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP05 ! HPSI0613i-nukw_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-nukw_3
AC   CVCL_JP05
DR   BioSamples; SAMEA2398963
DR   HipSci; HPSI0613i-nukw_3
DR   Wikidata; Q54891059
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG16 ! HPSI0613i-nukw_1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-oefg_1
AC   CVCL_JP06
DR   BioSamples; SAMEA2397873
DR   HipSci; HPSI0613i-oefg_1
DR   Wikidata; Q54891060
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG17 ! HPSI0613i-oefg_2
OI   CVCL_JP07 ! HPSI0613i-oefg_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-oefg_2
AC   CVCL_AG17
SY   WTSIi119-A
DR   BioSamples; SAMEA2397854
DR   ECACC; 77650112
DR   HipSci; HPSI0613i-oefg_2
DR   hPSCreg; WTSIi119-A
DR   SKIP; SKIP002742
DR   Wikidata; Q54891061
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP06 ! HPSI0613i-oefg_1
OI   CVCL_JP07 ! HPSI0613i-oefg_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-oefg_3
AC   CVCL_JP07
DR   BioSamples; SAMEA2398794
DR   HipSci; HPSI0613i-oefg_3
DR   Wikidata; Q54891062
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP06 ! HPSI0613i-oefg_1
OI   CVCL_AG17 ! HPSI0613i-oefg_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-oesx_3
AC   CVCL_IY65
SY   WTSIi582-A
DR   BioSamples; SAMEA4451488
DR   ECACC; 77650483
DR   HipSci; HPSI0613i-oesx_3
DR   hPSCreg; WTSIi582-A
DR   Wikidata; Q54891063
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650483; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   HPSI0613i-oomz_1
AC   CVCL_JP08
DR   BioSamples; SAMEA2397951
DR   HipSci; HPSI0613i-oomz_1
DR   Wikidata; Q54891064
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP09 ! HPSI0613i-oomz_2
OI   CVCL_JP10 ! HPSI0613i-oomz_3
OI   CVCL_II88 ! HPSI0613i-oomz_22
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-oomz_2
AC   CVCL_JP09
SY   WTSIi140-B; WTSIi237-A
DR   BioSamples; SAMEA2398345
DR   ECACC; 77650242
DR   HipSci; HPSI0613i-oomz_2
DR   hPSCreg; WTSIi140-B
DR   Wikidata; Q54891065
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP08 ! HPSI0613i-oomz_1
OI   CVCL_JP10 ! HPSI0613i-oomz_3
OI   CVCL_II88 ! HPSI0613i-oomz_22
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0613i-oomz_22
AC   CVCL_II88
SY   WTSIi140-A
DR   BioSamples; SAMEA2398841
DR   EBiSC; WTSIi140-A
DR   ECACC; 66540249
DR   ECACC; 77650175
DR   HipSci; HPSI0613i-oomz_22
DR   hPSCreg; WTSIi140-A
DR   SKIP; SKIP002774
DR   Wikidata; Q54891066
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540249; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP08 ! HPSI0613i-oomz_1
OI   CVCL_JP09 ! HPSI0613i-oomz_2
OI   CVCL_JP10 ! HPSI0613i-oomz_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-oomz_3
AC   CVCL_JP10
DR   BioSamples; SAMEA2398498
DR   HipSci; HPSI0613i-oomz_3
DR   Wikidata; Q54891067
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP08 ! HPSI0613i-oomz_1
OI   CVCL_JP09 ! HPSI0613i-oomz_2
OI   CVCL_II88 ! HPSI0613i-oomz_22
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-pasj_1
AC   CVCL_JP11
DR   BioSamples; SAMEA2398594
DR   HipSci; HPSI0613i-pasj_1
DR   Wikidata; Q54891068
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG18 ! HPSI0613i-pasj_2
OI   CVCL_AG19 ! HPSI0613i-pasj_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-pasj_2
AC   CVCL_AG18
DR   BioSamples; SAMEA2398463
DR   HipSci; HPSI0613i-pasj_2
DR   Wikidata; Q54891069
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP11 ! HPSI0613i-pasj_1
OI   CVCL_AG19 ! HPSI0613i-pasj_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-pasj_3
AC   CVCL_AG19
DR   BioSamples; SAMEA2399140
DR   HipSci; HPSI0613i-pasj_3
DR   Wikidata; Q54891070
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP11 ! HPSI0613i-pasj_1
OI   CVCL_AG18 ! HPSI0613i-pasj_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-qanu_1
AC   CVCL_AG20
SY   WTSIi141-A
DR   BioSamples; SAMEA2399142
DR   ECACC; 77650245
DR   HipSci; HPSI0613i-qanu_1
DR   hPSCreg; WTSIi141-A
DR   SKIP; SKIP002775
DR   Wikidata; Q54891071
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG21 ! HPSI0613i-qanu_2
OI   CVCL_JP12 ! HPSI0613i-qanu_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-qanu_2
AC   CVCL_AG21
SY   WTSIi141-B; WTSIi210-A
DR   BioSamples; SAMEA2398295
DR   ECACC; 77650246
DR   HipSci; HPSI0613i-qanu_2
DR   hPSCreg; WTSIi141-B
DR   Wikidata; Q54891072
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG20 ! HPSI0613i-qanu_1
OI   CVCL_JP12 ! HPSI0613i-qanu_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-qanu_3
AC   CVCL_JP12
DR   BioSamples; SAMEA2398010
DR   HipSci; HPSI0613i-qanu_3
DR   Wikidata; Q54891073
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG20 ! HPSI0613i-qanu_1
OI   CVCL_AG21 ! HPSI0613i-qanu_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-qonr_1
AC   CVCL_AG22
SY   WTSIi569-B; WTSIi588-A
DR   BioSamples; SAMEA2398813
DR   HipSci; HPSI0613i-qonr_1
DR   hPSCreg; WTSIi569-B
DR   Wikidata; Q54891074
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG23 ! HPSI0613i-qonr_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-qonr_2
AC   CVCL_AG23
SY   WTSIi569-A
DR   BioSamples; SAMEA2399177
DR   HipSci; HPSI0613i-qonr_2
DR   hPSCreg; WTSIi569-A
DR   Wikidata; Q54891080
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG22 ! HPSI0613i-qonr_1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-qony_1
AC   CVCL_AG24
SY   WTSIi142-A
DR   BioSamples; SAMEA2398374
DR   EBiSC; WTSIi142-A
DR   ECACC; 66540251
DR   ECACC; 77650248
DR   HipSci; HPSI0613i-qony_1
DR   hPSCreg; WTSIi142-A
DR   SKIP; SKIP002776
DR   Wikidata; Q54891081
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540251; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG25 ! HPSI0613i-qony_2
OI   CVCL_JP13 ! HPSI0613i-qony_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-qony_2
AC   CVCL_AG25
SY   WTSIi142-B; WTSIi343-A
DR   BioSamples; SAMEA2398680
DR   ECACC; 77650249
DR   HipSci; HPSI0613i-qony_2
DR   hPSCreg; WTSIi142-B
DR   Wikidata; Q54891082
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG24 ! HPSI0613i-qony_1
OI   CVCL_JP13 ! HPSI0613i-qony_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-qony_3
AC   CVCL_JP13
DR   BioSamples; SAMEA2398045
DR   HipSci; HPSI0613i-qony_3
DR   Wikidata; Q54891083
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG24 ! HPSI0613i-qony_1
OI   CVCL_AG25 ! HPSI0613i-qony_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-riiv_1
AC   CVCL_AG26
SY   WTSIi216-A
DR   BioSamples; SAMEA2469777
DR   ECACC; 77650250
DR   HipSci; HPSI0613i-riiv_1
DR   hPSCreg; WTSIi216-A
DR   PRIDE; PXD003903
DR   Wikidata; Q54891084
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG27 ! HPSI0613i-riiv_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-riiv_3
AC   CVCL_AG27
SY   WTSIi216-B; WTSIi229-A
DR   BioSamples; SAMEA2469778
DR   ECACC; 77650251
DR   HipSci; HPSI0613i-riiv_3
DR   hPSCreg; WTSIi216-B
DR   PRIDE; PXD003903
DR   Wikidata; Q54891086
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG26 ! HPSI0613i-riiv_1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-sucu_1
AC   CVCL_AG28
DR   BioSamples; SAMEA2398671
DR   HipSci; HPSI0613i-sucu_1
DR   Wikidata; Q54891087
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP14 ! HPSI0613i-sucu_2
OI   CVCL_JP15 ! HPSI0613i-sucu_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0613i-sucu_2
AC   CVCL_JP14
DR   BioSamples; SAMEA2398873
DR   HipSci; HPSI0613i-sucu_2
DR   Wikidata; Q54891088
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG28 ! HPSI0613i-sucu_1
OI   CVCL_JP15 ! HPSI0613i-sucu_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-sucu_3
AC   CVCL_JP15
DR   BioSamples; SAMEA2398064
DR   HipSci; HPSI0613i-sucu_3
DR   Wikidata; Q54891090
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG28 ! HPSI0613i-sucu_1
OI   CVCL_JP14 ! HPSI0613i-sucu_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-uait_6
AC   CVCL_JP16
DR   BioSamples; SAMEA2398717
DR   HipSci; HPSI0613i-uait_6
DR   Wikidata; Q54891091
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-ueah_1
AC   CVCL_AG29
SY   WTSIi342-B; WTSIi366-A
DR   BioSamples; SAMEA2397921
DR   ECACC; 77650176
DR   HipSci; HPSI0613i-ueah_1
DR   hPSCreg; WTSIi342-B
DR   Wikidata; Q54891092
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP17 ! HPSI0613i-ueah_2
OI   CVCL_AG30 ! HPSI0613i-ueah_4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-ueah_2
AC   CVCL_JP17
DR   BioSamples; SAMEA2399079
DR   HipSci; HPSI0613i-ueah_2
DR   Wikidata; Q54891093
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG29 ! HPSI0613i-ueah_1
OI   CVCL_AG30 ! HPSI0613i-ueah_4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-ueah_4
AC   CVCL_AG30
SY   WTSIi342-A
DR   BioSamples; SAMEA2398322
DR   ECACC; 77650185
DR   HipSci; HPSI0613i-ueah_4
DR   hPSCreg; WTSIi342-A
DR   Wikidata; Q54891094
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG29 ! HPSI0613i-ueah_1
OI   CVCL_JP17 ! HPSI0613i-ueah_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-uexy_2
AC   CVCL_AG31
DR   BioSamples; SAMEA2398342
DR   HipSci; HPSI0613i-uexy_2
DR   Wikidata; Q54891095
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-vorx_1
AC   CVCL_AG32
SY   WTSIi222-A
DR   BioSamples; SAMEA2398071
DR   ECACC; 77650255
DR   HipSci; HPSI0613i-vorx_1
DR   hPSCreg; WTSIi222-A
DR   Wikidata; Q54891096
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP18 ! HPSI0613i-vorx_2
OI   CVCL_AG33 ! HPSI0613i-vorx_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-vorx_2
AC   CVCL_JP18
DR   BioSamples; SAMEA2398435
DR   HipSci; HPSI0613i-vorx_2
DR   Wikidata; Q54891097
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG32 ! HPSI0613i-vorx_1
OI   CVCL_AG33 ! HPSI0613i-vorx_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0613i-vorx_3
AC   CVCL_AG33
SY   WTSIi222-B; WTSIi344-A
DR   BioSamples; SAMEA2398098
DR   ECACC; 77650256
DR   HipSci; HPSI0613i-vorx_3
DR   hPSCreg; WTSIi222-B
DR   Wikidata; Q54891098
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG32 ! HPSI0613i-vorx_1
OI   CVCL_JP18 ! HPSI0613i-vorx_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-xavk_1
AC   CVCL_JP19
DR   BioSamples; SAMEA2398026
DR   HipSci; HPSI0613i-xavk_1
DR   Wikidata; Q54891099
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP20 ! HPSI0613i-xavk_2
OI   CVCL_AG34 ! HPSI0613i-xavk_3
OI   CVCL_AG35 ! HPSI0613i-xavk_33
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-xavk_2
AC   CVCL_JP20
DR   BioSamples; SAMEA2398303
DR   HipSci; HPSI0613i-xavk_2
DR   Wikidata; Q54891100
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP19 ! HPSI0613i-xavk_1
OI   CVCL_AG34 ! HPSI0613i-xavk_3
OI   CVCL_AG35 ! HPSI0613i-xavk_33
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-xavk_3
AC   CVCL_AG34
SY   WTSIi089-A
DR   BioSamples; SAMEA2397946
DR   EBiSC; WTSIi089-A
DR   ECACC; 66540204
DR   ECACC; 77650115
DR   HipSci; HPSI0613i-xavk_3
DR   hPSCreg; WTSIi089-A
DR   Wikidata; Q54891101
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540204; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP19 ! HPSI0613i-xavk_1
OI   CVCL_JP20 ! HPSI0613i-xavk_2
OI   CVCL_AG35 ! HPSI0613i-xavk_33
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-xavk_33
AC   CVCL_AG35
SY   WTSIi089-B; WTSIi587-A
DR   BioSamples; SAMEA2398113
DR   ECACC; 77650744
DR   HipSci; HPSI0613i-xavk_33
DR   hPSCreg; WTSIi089-B
DR   Wikidata; Q54891102
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP19 ! HPSI0613i-xavk_1
OI   CVCL_JP20 ! HPSI0613i-xavk_2
OI   CVCL_AG34 ! HPSI0613i-xavk_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0613i-xosg_2
AC   CVCL_AG36
SY   WTSIi146-A
DR   BioSamples; SAMEA2678739
DR   EBiSC; WTSIi146-A
DR   ECACC; 66540257
DR   ECACC; 77650179
DR   HipSci; HPSI0613i-xosg_2
DR   hPSCreg; WTSIi146-A
DR   SKIP; SKIP002781
DR   Wikidata; Q54891103
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540257; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP21 ! HPSI0613i-xosg_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0613i-xosg_3
AC   CVCL_JP21
DR   BioSamples; SAMEA2678743
DR   HipSci; HPSI0613i-xosg_3
DR   Wikidata; Q54891104
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG36 ! HPSI0613i-xosg_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-xucm_1
AC   CVCL_JP22
DR   BioSamples; SAMEA2469775
DR   HipSci; HPSI0613i-xucm_1
DR   Wikidata; Q54891105
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP23 ! HPSI0613i-xucm_2
OI   CVCL_AG37 ! HPSI0613i-xucm_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-xucm_2
AC   CVCL_JP23
DR   BioSamples; SAMEA2469766
DR   HipSci; HPSI0613i-xucm_2
DR   Wikidata; Q54891106
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP22 ! HPSI0613i-xucm_1
OI   CVCL_AG37 ! HPSI0613i-xucm_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-xucm_3
AC   CVCL_AG37
SY   WTSIi094-A
DR   BioSamples; SAMEA2469776
DR   EBiSC; WTSIi094-A
DR   ECACC; 66540209
DR   ECACC; 77650119
DR   HipSci; HPSI0613i-xucm_3
DR   hPSCreg; WTSIi094-A
DR   SKIP; SKIP002710
DR   Wikidata; Q54891107
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540209; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP22 ! HPSI0613i-xucm_1
OI   CVCL_JP23 ! HPSI0613i-xucm_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0613i-zisa_1
AC   CVCL_JP24
DR   BioSamples; SAMEA2398391
DR   HipSci; HPSI0613i-zisa_1
DR   Wikidata; Q54891108
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP25 ! HPSI0613i-zisa_2
OI   CVCL_AG38 ! HPSI0613i-zisa_3
OI   CVCL_EE73 ! HPSI0613i-zisa_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-zisa_2
AC   CVCL_JP25
DR   BioSamples; SAMEA2399271
DR   HipSci; HPSI0613i-zisa_2
DR   Wikidata; Q54891109
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP24 ! HPSI0613i-zisa_1
OI   CVCL_AG38 ! HPSI0613i-zisa_3
OI   CVCL_EE73 ! HPSI0613i-zisa_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0613i-zisa_3
AC   CVCL_AG38
SY   WTSIi129-A
DR   BioSamples; SAMEA2398851
DR   ECACC; 77650017
DR   HipSci; HPSI0613i-zisa_3
DR   hPSCreg; WTSIi129-A
DR   SKIP; SKIP002754
DR   Wikidata; Q54891110
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP24 ! HPSI0613i-zisa_1
OI   CVCL_JP25 ! HPSI0613i-zisa_2
OI   CVCL_EE73 ! HPSI0613i-zisa_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0613i-zisa_33
AC   CVCL_EE73
SY   WTSIi129-B; WTSIi339-A
DR   BioSamples; SAMEA2399080
DR   ECACC; 77650679
DR   HipSci; HPSI0613i-zisa_33
DR   hPSCreg; WTSIi129-B
DR   Wikidata; Q54891111
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650679; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP24 ! HPSI0613i-zisa_1
OI   CVCL_JP25 ! HPSI0613i-zisa_2
OI   CVCL_AG38 ! HPSI0613i-zisa_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI0614i-ciwj_1
AC   CVCL_AJ99
SY   WTSIi310-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3484001
DR   ECACC; 77650559
DR   HipSci; HPSI0614i-ciwj_1
DR   hPSCreg; WTSIi310-A
DR   Wikidata; Q54891112
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK00 ! HPSI0614i-ciwj_2
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-ciwj_2
AC   CVCL_AK00
SY   WTSIi310-B; WTSIi325-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3483999
DR   ECACC; 77650560
DR   HipSci; HPSI0614i-ciwj_2
DR   hPSCreg; WTSIi310-B
DR   Wikidata; Q54891113
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AJ99 ! HPSI0614i-ciwj_1
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-denw_6
AC   CVCL_EF02
SY   WTSIi382-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854232
DR   ECACC; 77650401
DR   HipSci; HPSI0614i-denw_6
DR   hPSCreg; WTSIi382-A
DR   Wikidata; Q54891114
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-dixh_2
AC   CVCL_AG39
SY   WTSIi194-A
DR   BioSamples; SAMEA3283000
DR   EBiSC; WTSIi194-A
DR   ECACC; 66540428
DR   ECACC; 77650344
DR   HipSci; HPSI0614i-dixh_2
DR   hPSCreg; WTSIi194-A
DR   Wikidata; Q54891115
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540428; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0614i-eavo_1
AC   CVCL_AG40
SY   WTSIi157-A
DR   BioSamples; SAMEA3271659
DR   EBiSC; WTSIi157-A
DR   ECACC; 66540311
DR   ECACC; 77650277
DR   HipSci; HPSI0614i-eavo_1
DR   hPSCreg; WTSIi157-A
DR   Wikidata; Q54891116
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540311; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0614i-eisk_3
AC   CVCL_EF03
SY   WTSIi414-A
DR   BioSamples; SAMEA3976893
DR   ECACC; 77650409
DR   HipSci; HPSI0614i-eisk_3
DR   hPSCreg; WTSIi414-A
DR   Wikidata; Q54891117
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF04 ! HPSI0614i-eisk_6
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-eisk_6
AC   CVCL_EF04
SY   WTSIi414-B; WTSIi435-A
DR   BioSamples; SAMEA3976890
DR   ECACC; 77650363
DR   HipSci; HPSI0614i-eisk_6
DR   hPSCreg; WTSIi414-B
DR   Wikidata; Q54891118
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF03 ! HPSI0614i-eisk_3
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-fovu_2
AC   CVCL_EE74
SY   WTSIi405-A
DR   BioSamples; SAMEA3974867
DR   ECACC; 77650320
DR   HipSci; HPSI0614i-fovu_2
DR   hPSCreg; WTSIi405-A
DR   Wikidata; Q54891119
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX09 ! HPSI0614i-fovu_5
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-fovu_5
AC   CVCL_AX09
SY   WTSIi405-B; WTSIi433-A
DR   BioSamples; SAMEA3974872
DR   ECACC; 77650321
DR   HipSci; HPSI0614i-fovu_5
DR   hPSCreg; WTSIi405-B
DR   Wikidata; Q54891120
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE74 ! HPSI0614i-fovu_2
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-foyj_1
AC   CVCL_AG41
SY   WTSIi164-A
DR   BioSamples; SAMEA3355547
DR   EBiSC; WTSIi164-A
DR   ECACC; 66540318
DR   ECACC; 77650275
DR   HipSci; HPSI0614i-foyj_1
DR   hPSCreg; WTSIi164-A
DR   SKIP; SKIP002816
DR   Wikidata; Q54891121
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; WTSIi164-A; true.
CC   Discontinued: ECACC; 66540318; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0614i-gawh_12
AC   CVCL_EF05
SY   WTSIi399-B; WTSIi413-A
DR   BioSamples; SAMEA4091784
DR   ECACC; 77650378
DR   HipSci; HPSI0614i-gawh_12
DR   hPSCreg; WTSIi399-B
DR   Wikidata; Q54891128
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF06 ! HPSI0614i-gawh_7
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-gawh_7
AC   CVCL_EF06
SY   WTSIi399-A
DR   BioSamples; SAMEA4091775
DR   ECACC; 77650411
DR   HipSci; HPSI0614i-gawh_7
DR   hPSCreg; WTSIi399-A
DR   Wikidata; Q54891129
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF05 ! HPSI0614i-gawh_12
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-guyj_2
AC   CVCL_AG42
SY   WTSIi199-A
DR   BioSamples; SAMEA3292099
DR   EBiSC; WTSIi199-A
DR   ECACC; 66540434
DR   ECACC; 77650342
DR   HipSci; HPSI0614i-guyj_2
DR   hPSCreg; WTSIi199-A
DR   Wikidata; Q54891130
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540434; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0614i-juzt_4
AC   CVCL_LL66
SY   WTSIi670-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962528
DR   ECACC; 77650699
DR   HipSci; HPSI0614i-juzt_4
DR   hPSCreg; WTSIi670-A
DR   Wikidata; Q54891131
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-kecw_3
AC   CVCL_IX26
SY   WTSIi485-A
DR   BioSamples; SAMEA3976884
DR   ECACC; 77650440
DR   HipSci; HPSI0614i-kecw_3
DR   hPSCreg; WTSIi485-A
DR   Wikidata; Q54891132
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX27 ! HPSI0614i-kecw_4
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0614i-kecw_4
AC   CVCL_IX27
SY   WTSIi485-B; WTSIi513-A
DR   BioSamples; SAMEA3976886
DR   ECACC; 77650441
DR   HipSci; HPSI0614i-kecw_4
DR   hPSCreg; WTSIi485-B
DR   Wikidata; Q54891133
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX26 ! HPSI0614i-kecw_3
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0614i-kegd_2
AC   CVCL_EE60
SY   WTSIi182-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3977051
DR   EBiSC; WTSIi182-A
DR   ECACC; 66540355
DR   ECACC; 77650292
DR   HipSci; HPSI0614i-kegd_2
DR   hPSCreg; WTSIi182-A
DR   SKIP; SKIP002851
DR   Wikidata; Q54891134
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540355; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0614i-koqx_1
AC   CVCL_AG43
SY   WTSIi201-A
DR   BioSamples; SAMEA3283863
DR   EBiSC; WTSIi201-A
DR   ECACC; 66540436
DR   ECACC; 77650352
DR   HipSci; HPSI0614i-koqx_1
DR   hPSCreg; WTSIi201-A
DR   Wikidata; Q54891135
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540436; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0614i-laig_1
AC   CVCL_EF07
SY   WTSIi415-A
DR   BioSamples; SAMEA3977535
DR   ECACC; 77650366
DR   HipSci; HPSI0614i-laig_1
DR   hPSCreg; WTSIi415-A
DR   Wikidata; Q54891136
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF08 ! HPSI0614i-laig_2
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-laig_2
AC   CVCL_EF08
SY   WTSIi415-B; WTSIi443-A
DR   BioSamples; SAMEA3977532
DR   ECACC; 77650365
DR   HipSci; HPSI0614i-laig_2
DR   hPSCreg; WTSIi415-B
DR   Wikidata; Q54891137
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF07 ! HPSI0614i-laig_1
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-lepk_1
AC   CVCL_EF09
SY   WTSIi263-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962624
DR   ECACC; 77650367
DR   HipSci; HPSI0614i-lepk_1
DR   hPSCreg; WTSIi263-A
DR   Wikidata; Q54891138
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF10 ! HPSI0614i-lepk_4
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-lepk_4
AC   CVCL_EF10
SY   WTSIi263-B; WTSIi329-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3964256
DR   ECACC; 77650414
DR   HipSci; HPSI0614i-lepk_4
DR   hPSCreg; WTSIi263-B
DR   Wikidata; Q54891139
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF09 ! HPSI0614i-lepk_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-lipl_2
AC   CVCL_IX28
SY   WTSIi458-A
DR   BioSamples; SAMEA3974877
DR   ECACC; 77650475
DR   HipSci; HPSI0614i-lipl_2
DR   hPSCreg; WTSIi458-A
DR   Wikidata; Q54891141
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX29 ! HPSI0614i-lipl_5
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0614i-lipl_5
AC   CVCL_IX29
SY   WTSIi458-B; WTSIi511-A
DR   BioSamples; SAMEA3974874
DR   ECACC; 77650476
DR   HipSci; HPSI0614i-lipl_5
DR   hPSCreg; WTSIi458-B
DR   Wikidata; Q54891142
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX28 ! HPSI0614i-lipl_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0614i-liqa_1
AC   CVCL_AK01
SY   WTSIi284-B; WTSIi295-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3968753
DR   ECACC; 77650577
DR   HipSci; HPSI0614i-liqa_1
DR   hPSCreg; WTSIi284-B
DR   Wikidata; Q54891143
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK02 ! HPSI0614i-liqa_6
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-liqa_6
AC   CVCL_AK02
SY   WTSIi284-AW
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974236
DR   ECACC; 77650558
DR   HipSci; HPSI0614i-liqa_6
DR   hPSCreg; WTSIi284-A
DR   Wikidata; Q54891144
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK01 ! HPSI0614i-liqa_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-lirf_5
AC   CVCL_IY75
SY   WTSIi599-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4085297
DR   ECACC; 77650477
DR   HipSci; HPSI0614i-lirf_5
DR   hPSCreg; WTSIi599-A
DR   Wikidata; Q54891145
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY76 ! HPSI0614i-lirf_6
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-lirf_6
AC   CVCL_IY76
SY   WTSIi599-B; WTSIi600-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4085299
DR   ECACC; 77650478
DR   HipSci; HPSI0614i-lirf_6
DR   hPSCreg; WTSIi599-B
DR   Wikidata; Q54891146
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY75 ! HPSI0614i-lirf_5
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-mesr_4
AC   CVCL_EF11
SY   WTSIi406-A
DR   BioSamples; SAMEA4091953
DR   ECACC; 77650392
DR   HipSci; HPSI0614i-mesr_4
DR   hPSCreg; WTSIi406-A
DR   Wikidata; Q54891147
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-miaj_4
AC   CVCL_EE39
SY   WTSIi169-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854313
DR   EBiSC; WTSIi169-B
DR   ECACC; 66540408
DR   ECACC; 77650295
DR   HipSci; HPSI0614i-miaj_4
DR   hPSCreg; WTSIi169-B
DR   SKIP; SKIP002889
DR   Wikidata; Q54891148
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540408; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX05 ! HPSI0614i-miaj_6
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0614i-miaj_6
AC   CVCL_AX05
SY   WTSIi169-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962387
DR   EBiSC; WTSIi169-A
DR   ECACC; 66540337
DR   ECACC; 77650296
DR   HipSci; HPSI0614i-miaj_6
DR   hPSCreg; WTSIi169-A
DR   SKIP; SKIP002834
DR   Wikidata; Q54891149
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540337; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE39 ! HPSI0614i-miaj_4
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0614i-oicx_2
AC   CVCL_EF12
SY   WTSIi247-B; WTSIi273-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3968774
DR   ECACC; 77650429
DR   HipSci; HPSI0614i-oicx_2
DR   hPSCreg; WTSIi247-B
DR   Wikidata; Q54891150
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF13 ! HPSI0614i-oicx_6
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-oicx_6
AC   CVCL_EF13
SY   WTSIi247-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3968772
DR   ECACC; 77650395
DR   HipSci; HPSI0614i-oicx_6
DR   hPSCreg; WTSIi247-A
DR   Wikidata; Q54891151
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF12 ! HPSI0614i-oicx_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-paab_3
AC   CVCL_EE49
SY   WTSIi174-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962561
DR   EBiSC; WTSIi174-B
DR   ECACC; 66540379
DR   ECACC; 77650302
DR   HipSci; HPSI0614i-paab_3
DR   hPSCreg; WTSIi174-B
DR   SKIP; SKIP002868
DR   Wikidata; Q54891152
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540379; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE50 ! HPSI0614i-paab_4
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0614i-paab_4
AC   CVCL_EE50
SY   WTSIi174-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962562
DR   EBiSC; WTSIi174-A
DR   ECACC; 66540345
DR   ECACC; 77650303
DR   HipSci; HPSI0614i-paab_4
DR   hPSCreg; WTSIi174-A
DR   SKIP; SKIP002841
DR   Wikidata; Q54891153
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540345; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE49 ! HPSI0614i-paab_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0614i-puhk_2
AC   CVCL_IY77
SY   WTSIi602-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3967414
DR   ECACC; 77650461
DR   HipSci; HPSI0614i-puhk_2
DR   hPSCreg; WTSIi602-A
DR   Wikidata; Q54891154
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY78 ! HPSI0614i-puhk_5
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-puhk_5
AC   CVCL_IY78
SY   WTSIi602-B; WTSIi606-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974502
DR   ECACC; 77650462
DR   HipSci; HPSI0614i-puhk_5
DR   hPSCreg; WTSIi602-B
DR   Wikidata; Q54891156
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650462; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY77 ! HPSI0614i-puhk_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0614i-qunz_2
AC   CVCL_IY79
SY   WTSIi603-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4458545
DR   ECACC; 77650488
DR   HipSci; HPSI0614i-qunz_2
DR   hPSCreg; WTSIi603-A
DR   Wikidata; Q54891157
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY80 ! HPSI0614i-qunz_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-qunz_3
AC   CVCL_IY80
SY   WTSIi603-B; WTSIi616-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4458546
DR   ECACC; 77650489
DR   HipSci; HPSI0614i-qunz_3
DR   hPSCreg; WTSIi603-B
DR   Wikidata; Q54891158
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY79 ! HPSI0614i-qunz_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-uevq_4
AC   CVCL_IY81
SY   WTSIi507-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4451109
DR   ECACC; 77650519
DR   HipSci; HPSI0614i-uevq_4
DR   hPSCreg; WTSIi507-A
DR   Wikidata; Q54891159
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY82 ! HPSI0614i-uevq_6
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-uevq_6
AC   CVCL_IY82
SY   WTSIi507-B; WTSIi538-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4451111
DR   ECACC; 77650518
DR   HipSci; HPSI0614i-uevq_6
DR   hPSCreg; WTSIi507-B
DR   Wikidata; Q54891160
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY81 ! HPSI0614i-uevq_4
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-uilk_2
AC   CVCL_AG44
SY   WTSIi249-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3485958
DR   ECACC; 77650606
DR   HipSci; HPSI0614i-uilk_2
DR   hPSCreg; WTSIi249-A
DR   Wikidata; Q54891161
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG45 ! HPSI0614i-uilk_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-uilk_3
AC   CVCL_AG45
SY   WTSIi249-B; WTSIi272-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3485957
DR   ECACC; 77650607
DR   HipSci; HPSI0614i-uilk_3
DR   hPSCreg; WTSIi249-B
DR   Wikidata; Q54891162
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG44 ! HPSI0614i-uilk_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0614i-voce_1
AC   CVCL_IY83
SY   WTSIi389-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4339548
DR   ECACC; 77650448
DR   HipSci; HPSI0614i-voce_1
DR   hPSCreg; WTSIi389-A
DR   Wikidata; Q54891163
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY84 ! HPSI0614i-voce_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-voce_2
AC   CVCL_IY84
SY   WTSIi389-B; WTSIi391-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4339550
DR   ECACC; 77650449
DR   HipSci; HPSI0614i-voce_2
DR   hPSCreg; WTSIi389-B
DR   Wikidata; Q54891164
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY83 ! HPSI0614i-voce_1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-voxu_1
AC   CVCL_EF14
SY   WTSIi417-A
DR   BioSamples; SAMEA3271656
DR   ECACC; 77650427
DR   HipSci; HPSI0614i-voxu_1
DR   hPSCreg; WTSIi417-A
DR   Wikidata; Q54891165
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF15 ! HPSI0614i-voxu_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-voxu_2
AC   CVCL_EF15
SY   WTSIi417-B; WTSIi423-A
DR   BioSamples; SAMEA3281296
DR   ECACC; 77650407
DR   HipSci; HPSI0614i-voxu_2
DR   hPSCreg; WTSIi417-B
DR   Wikidata; Q54891166
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF14 ! HPSI0614i-voxu_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-wihj_1
AC   CVCL_IY85
SY   WTSIi412-B; WTSIi421-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4339705
DR   ECACC; 77650450
DR   HipSci; HPSI0614i-wihj_1
DR   hPSCreg; WTSIi412-B
DR   Wikidata; Q54891167
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY86 ! HPSI0614i-wihj_4
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-wihj_4
AC   CVCL_IY86
SY   WTSIi412-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4339703
DR   ECACC; 77650451
DR   HipSci; HPSI0614i-wihj_4
DR   hPSCreg; WTSIi412-A
DR   Wikidata; Q54891168
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY85 ! HPSI0614i-wihj_1
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-xubw_1
AC   CVCL_LL67
SY   WTSIi661-B; WTSIi706-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104241751
DR   ECACC; 77650783
DR   HipSci; HPSI0614i-xubw_1
DR   hPSCreg; WTSIi661-B
DR   Wikidata; Q54891169
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL68 ! HPSI0614i-xubw_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-xubw_3
AC   CVCL_LL68
SY   WTSIi661-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104241752
DR   ECACC; 77650782
DR   HipSci; HPSI0614i-xubw_3
DR   hPSCreg; WTSIi661-A
DR   Wikidata; Q54891181
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL67 ! HPSI0614i-xubw_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0614i-zoio_1
AC   CVCL_EF16
SY   WTSIi410-B; WTSIi434-A
DR   BioSamples; SAMEA4085324
DR   ECACC; 77650358
DR   HipSci; HPSI0614i-zoio_1
DR   hPSCreg; WTSIi410-B
DR   Wikidata; Q54891182
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF17 ! HPSI0614i-zoio_2
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0614i-zoio_2
AC   CVCL_EF17
SY   WTSIi410-A
DR   BioSamples; SAMEA4085325
DR   ECACC; 77650359
DR   HipSci; HPSI0614i-zoio_2
DR   hPSCreg; WTSIi410-A
DR   Wikidata; Q54891183
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF16 ! HPSI0614i-zoio_1
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0616i-aauq_1
AC   CVCL_WK05
DR   BioSamples; SAMEA104130214
DR   HipSci; HPSI0616i-aauq_1
DR   Wikidata; Q94230292
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK06 ! HPSI0616i-aauq_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0616i-aauq_2
AC   CVCL_WK06
DR   BioSamples; SAMEA104130213
DR   ECACC; 77650802
DR   HipSci; HPSI0616i-aauq_2
DR   Wikidata; Q94230295
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK05 ! HPSI0616i-aauq_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0616i-baxr_5
AC   CVCL_LM08
SY   WTSIi686-A
DR   BioSamples; SAMEA103884199
DR   ECACC; 77650748
DR   HipSci; HPSI0616i-baxr_5
DR   hPSCreg; WTSIi686-A
DR   Wikidata; Q54891184
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM09 ! HPSI0616i-baxr_6
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-baxr_6
AC   CVCL_LM09
SY   WTSIi686-B; WTSIi710-A
DR   BioSamples; SAMEA103884198
DR   ECACC; 77650749
DR   HipSci; HPSI0616i-baxr_6
DR   hPSCreg; WTSIi686-B
DR   Wikidata; Q54891185
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM08 ! HPSI0616i-baxr_5
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-beyk_2
AC   CVCL_LM10
SY   WTSIi479-B; WTSIi504-A
DR   BioSamples; SAMEA103887417
DR   ECACC; 77650636
DR   HipSci; HPSI0616i-beyk_2
DR   hPSCreg; WTSIi479-B
DR   Wikidata; Q54891186
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM11 ! HPSI0616i-beyk_6
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-beyk_6
AC   CVCL_LM11
SY   WTSIi479-A
DR   BioSamples; SAMEA103887415
DR   ECACC; 77650637
DR   HipSci; HPSI0616i-beyk_6
DR   hPSCreg; WTSIi479-A
DR   Wikidata; Q54891187
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Indian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM10 ! HPSI0616i-beyk_2
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-biln_1
AC   CVCL_LM12
SY   WTSIi498-B; WTSIi562-A
DR   BioSamples; SAMEA103884670
DR   ECACC; 77650633
DR   HipSci; HPSI0616i-biln_1
DR   hPSCreg; WTSIi498-B
DR   Wikidata; Q54891188
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM13 ! HPSI0616i-biln_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-biln_2
AC   CVCL_LM13
SY   WTSIi498-A
DR   BioSamples; SAMEA103884671
DR   ECACC; 77650632
DR   HipSci; HPSI0616i-biln_2
DR   hPSCreg; WTSIi498-A
DR   Wikidata; Q54891189
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM12 ! HPSI0616i-biln_1
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-bury_5
AC   CVCL_LM14
SY   WTSIi525-A
DR   BioSamples; SAMEA103887514
DR   ECACC; 77650649
DR   HipSci; HPSI0616i-bury_5
DR   hPSCreg; WTSIi525-A
DR   Wikidata; Q54891190
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Bangladeshi.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM15 ! HPSI0616i-bury_6
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-bury_6
AC   CVCL_LM15
SY   WTSIi525-B; WTSIi584-A
DR   BioSamples; SAMEA103887513
DR   ECACC; 77650650
DR   HipSci; HPSI0616i-bury_6
DR   hPSCreg; WTSIi525-B
DR   Wikidata; Q54891191
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Bangladeshi.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM14 ! HPSI0616i-bury_5
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-duve_2
AC   CVCL_LM16
SY   WTSIi718-B; WTSIi736-A
DR   BioSamples; SAMEA104011269
DR   ECACC; 77650668
DR   HipSci; HPSI0616i-duve_2
DR   hPSCreg; WTSIi718-B
DR   Wikidata; Q54891192
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM17 ! HPSI0616i-duve_6
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-duve_6
AC   CVCL_LM17
SY   WTSIi718-A
DR   BioSamples; SAMEA104011271
DR   ECACC; 77650689
DR   HipSci; HPSI0616i-duve_6
DR   hPSCreg; WTSIi718-A
DR   Wikidata; Q54891193
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM16 ! HPSI0616i-duve_2
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-eomr_5
AC   CVCL_LL69
SY   WTSIi534-A
DR   BioSamples; SAMEA103884568
DR   ECACC; 77650652
DR   HipSci; HPSI0616i-eomr_5
DR   hPSCreg; WTSIi534-A
DR   Wikidata; Q54891194
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-euia_7
AC   CVCL_LM18
SY   WTSIi665-A
DR   BioSamples; SAMEA104011431
DR   ECACC; 77650751
DR   HipSci; HPSI0616i-euia_7
DR   hPSCreg; WTSIi665-A
DR   Wikidata; Q54891195
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-fayz_2
AC   CVCL_WJ52
DR   BioSamples; SAMEA103887421
DR   ECACC; 77650853
DR   HipSci; HPSI0616i-fayz_2
DR   Wikidata; Q94230475
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0616i-gayk_3
AC   CVCL_LL70
SY   WTSIi482-B; WTSIi585-A
DR   BioSamples; SAMEA103884205
DR   ECACC; 77650655
DR   HipSci; HPSI0616i-gayk_3
DR   hPSCreg; WTSIi482-B
DR   Wikidata; Q54891196
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL71 ! HPSI0616i-gayk_5
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-gayk_5
AC   CVCL_LL71
SY   WTSIi482-A
DR   BioSamples; SAMEA103884207
DR   ECACC; 77650651
DR   HipSci; HPSI0616i-gayk_5
DR   hPSCreg; WTSIi482-A
DR   Wikidata; Q54891197
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL70 ! HPSI0616i-gayk_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-giql_1
AC   CVCL_LL72
SY   WTSIi506-B; WTSIi577-A
DR   BioSamples; SAMEA103884210
DR   ECACC; 77650653
DR   HipSci; HPSI0616i-giql_1
DR   hPSCreg; WTSIi506-B
DR   Wikidata; Q54891198
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL73 ! HPSI0616i-giql_5
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0616i-giql_5
AC   CVCL_LL73
SY   WTSIi506-A
DR   BioSamples; SAMEA103884214
DR   ECACC; 77650654
DR   HipSci; HPSI0616i-giql_5
DR   hPSCreg; WTSIi506-A
DR   Wikidata; Q54891199
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL72 ! HPSI0616i-giql_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0616i-heba_11
AC   CVCL_LL74
SY   WTSIi676-A
DR   BioSamples; SAMEA104011420
DR   ECACC; 77650690
DR   HipSci; HPSI0616i-heba_11
DR   hPSCreg; WTSIi676-A
DR   Wikidata; Q54891200
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL75 ! HPSI0616i-heba_9
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0616i-heba_9
AC   CVCL_LL75
SY   WTSIi676-B; WTSIi677-A
DR   BioSamples; SAMEA104011428
DR   ECACC; 77650691
DR   HipSci; HPSI0616i-heba_9
DR   hPSCreg; WTSIi676-B
DR   Wikidata; Q54891201
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL74 ! HPSI0616i-heba_11
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0616i-iuse_5
AC   CVCL_LM19
SY   WTSIi675-A
DR   BioSamples; SAMEA103887519
DR   ECACC; 77650696
DR   HipSci; HPSI0616i-iuse_5
DR   hPSCreg; WTSIi675-A
DR   Wikidata; Q54891203
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM20 ! HPSI0616i-iuse_6
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-iuse_6
AC   CVCL_LM20
SY   WTSIi675-B; WTSIi696-A
DR   BioSamples; SAMEA103887518
DR   ECACC; 77650697
DR   HipSci; HPSI0616i-iuse_6
DR   hPSCreg; WTSIi675-B
DR   Wikidata; Q54891204
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM19 ! HPSI0616i-iuse_5
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-kalo_6
AC   CVCL_LL76
SY   WTSIi732-A
DR   BioSamples; SAMEA103887297
DR   ECACC; 77650757
DR   HipSci; HPSI0616i-kalo_6
DR   hPSCreg; WTSIi732-A
DR   Wikidata; Q54891205
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-kayf_5
AC   CVCL_LM21
SY   WTSIi531-A
DR   BioSamples; SAMEA103887527
DR   ECACC; 77650634
DR   HipSci; HPSI0616i-kayf_5
DR   hPSCreg; WTSIi531-A
DR   Wikidata; Q54891206
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM22 ! HPSI0616i-kayf_6
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0616i-kayf_6
AC   CVCL_LM22
SY   WTSIi531-B; WTSIi559-A
DR   BioSamples; SAMEA103887530
DR   ECACC; 77650635
DR   HipSci; HPSI0616i-kayf_6
DR   hPSCreg; WTSIi531-B
DR   Wikidata; Q54891207
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM21 ! HPSI0616i-kayf_5
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0616i-kulz_3
AC   CVCL_IZ27
SY   WTSIi456-A
DR   BioSamples; SAMEA17509168
DR   ECACC; 77650581
DR   HipSci; HPSI0616i-kulz_3
DR   hPSCreg; WTSIi456-A
DR   Wikidata; Q54891208
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ28 ! HPSI0616i-kulz_6
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-kulz_6
AC   CVCL_IZ28
SY   WTSIi456-B; WTSIi523-A
DR   BioSamples; SAMEA17506918
DR   ECACC; 77650582
DR   HipSci; HPSI0616i-kulz_6
DR   hPSCreg; WTSIi456-B
DR   Wikidata; Q54891209
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ27 ! HPSI0616i-kulz_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-mesv_4
AC   CVCL_LM23
SY   WTSIi648-A
DR   BioSamples; SAMEA104012022
DR   ECACC; 77650669
DR   HipSci; HPSI0616i-mesv_4
DR   hPSCreg; WTSIi648-A
DR   Wikidata; Q54891211
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM24 ! HPSI0616i-mesv_5
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-mesv_5
AC   CVCL_LM24
SY   WTSIi648-B; WTSIi668-A
DR   BioSamples; SAMEA104012025
DR   ECACC; 77650746
DR   HipSci; HPSI0616i-mesv_5
DR   hPSCreg; WTSIi648-B
DR   Wikidata; Q54891212
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM23 ! HPSI0616i-mesv_4
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-mifg_2
AC   CVCL_LM25
SY   WTSIi612-A
DR   BioSamples; SAMEA104008493
DR   ECACC; 77650670
DR   HipSci; HPSI0616i-mifg_2
DR   hPSCreg; WTSIi612-A
DR   Wikidata; Q54891213
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM26 ! HPSI0616i-mifg_5
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-mifg_5
AC   CVCL_LM26
SY   WTSIi612-B; WTSIi637-A
DR   BioSamples; SAMEA104008496
DR   ECACC; 77650704
DR   HipSci; HPSI0616i-mifg_5
DR   hPSCreg; WTSIi612-B
DR   Wikidata; Q54891214
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM25 ! HPSI0616i-mifg_2
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-newl_6
AC   CVCL_LL77
SY   WTSIi689-A
DR   BioSamples; SAMEA17605168
DR   ECACC; 77650763
DR   HipSci; HPSI0616i-newl_6
DR   hPSCreg; WTSIi689-A
DR   Wikidata; Q54891215
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0616i-oajt_3
AC   CVCL_LM27
SY   WTSIi497-B; WTSIi551-A
DR   BioSamples; SAMEA103992702
DR   ECACC; 77650647
DR   HipSci; HPSI0616i-oajt_3
DR   hPSCreg; WTSIi497-B
DR   Wikidata; Q54891216
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM28 ! HPSI0616i-oajt_6
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-oajt_6
AC   CVCL_LM28
SY   WTSIi497-A
DR   BioSamples; SAMEA103992803
DR   ECACC; 77650648
DR   HipSci; HPSI0616i-oajt_6
DR   hPSCreg; WTSIi497-A
DR   Wikidata; Q54891217
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM27 ! HPSI0616i-oajt_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0616i-rily_1
AC   CVCL_LM29
SY   WTSIi614-B; WTSIi721-A
DR   BioSamples; SAMEA103988278
DR   ECACC; 77650714
DR   HipSci; HPSI0616i-rily_1
DR   hPSCreg; WTSIi614-B
DR   Wikidata; Q54891218
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Moroccan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM30 ! HPSI0616i-rily_3
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-rily_3
AC   CVCL_LM30
SY   WTSIi614-A
DR   BioSamples; SAMEA103988276
DR   ECACC; 77650715
DR   HipSci; HPSI0616i-rily_3
DR   hPSCreg; WTSIi614-A
DR   Wikidata; Q54891219
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Moroccan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM29 ! HPSI0616i-rily_1
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-rurd_3
AC   CVCL_WK20
DR   BioSamples; SAMEA104012240
DR   ECACC; 77650836
DR   HipSci; HPSI0616i-rurd_3
DR   Wikidata; Q94230703
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   HPSI0616i-uegn_1
AC   CVCL_LM31
SY   WTSIi620-B; WTSIi647-A
DR   BioSamples; SAMEA103884190
DR   ECACC; 77650674
DR   HipSci; HPSI0616i-uegn_1
DR   hPSCreg; WTSIi620-B
DR   Wikidata; Q54891220
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM32 ! HPSI0616i-uegn_3
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-uegn_3
AC   CVCL_LM32
SY   WTSIi620-A
DR   BioSamples; SAMEA103884192
DR   ECACC; 77650720
DR   HipSci; HPSI0616i-uegn_3
DR   hPSCreg; WTSIi620-A
DR   Wikidata; Q54891221
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM31 ! HPSI0616i-uegn_1
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-uofs_2
AC   CVCL_LM33
SY   WTSIi624-B; WTSIi640-A
DR   BioSamples; SAMEA103884777
DR   ECACC; 77650721
DR   HipSci; HPSI0616i-uofs_2
DR   hPSCreg; WTSIi624-B
DR   Wikidata; Q54891222
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM34 ! HPSI0616i-uofs_5
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-uofs_5
AC   CVCL_LM34
SY   WTSIi624-A
DR   BioSamples; SAMEA103884780
DR   ECACC; 77650722
DR   HipSci; HPSI0616i-uofs_5
DR   hPSCreg; WTSIi624-A
DR   Wikidata; Q54891227
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM33 ! HPSI0616i-uofs_2
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-vaqr_4
AC   CVCL_WJ55
DR   BioSamples; SAMEA103884771
DR   ECACC; 77650850
DR   HipSci; HPSI0616i-vaqr_4
DR   Wikidata; Q94230752
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0616i-vaqx_2
AC   CVCL_LL78
SY   WTSIi673-B; WTSIi731-A
DR   BioSamples; SAMEA104012230
DR   ECACC; 77650789
DR   HipSci; HPSI0616i-vaqx_2
DR   hPSCreg; WTSIi673-B
DR   Wikidata; Q54891228
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL79 ! HPSI0616i-vaqx_4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-vaqx_4
AC   CVCL_LL79
SY   WTSIi673-A
DR   BioSamples; SAMEA104012233
DR   ECACC; 77650790
DR   HipSci; HPSI0616i-vaqx_4
DR   hPSCreg; WTSIi673-A
DR   Wikidata; Q54891229
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C103172; Congenital bleeding disorder
DI   ORDO; Orphanet_248308; Rare hemorrhagic disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL78 ! HPSI0616i-vaqx_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0616i-xuvy_6
AC   CVCL_LM35
SY   WTSIi524-A
DR   BioSamples; SAMEA17593168
DR   ECACC; 77650646
DR   HipSci; HPSI0616i-xuvy_6
DR   hPSCreg; WTSIi524-A
DR   Wikidata; Q54891230
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0713i-aehn_1
AC   CVCL_JP26
DR   BioSamples; SAMEA2398733
DR   HipSci; HPSI0713i-aehn_1
DR   Wikidata; Q54891231
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG46 ! HPSI0713i-aehn_2
OI   CVCL_II87 ! HPSI0713i-aehn_22
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-aehn_2
AC   CVCL_AG46
SY   WTSIi130-B; WTSIi359-A
DR   BioSamples; SAMEA2398224
DR   ECACC; 77650213
DR   HipSci; HPSI0713i-aehn_2
DR   hPSCreg; WTSIi130-B
DR   Wikidata; Q54891232
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP26 ! HPSI0713i-aehn_1
OI   CVCL_II87 ! HPSI0713i-aehn_22
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-aehn_22
AC   CVCL_II87
SY   WTSIi130-A
DR   BioSamples; SAMEA2398712
DR   EBiSC; WTSIi130-A
DR   ECACC; 66540230
DR   ECACC; 77650182
DR   HipSci; HPSI0713i-aehn_22
DR   hPSCreg; WTSIi130-A
DR   SKIP; SKIP002755
DR   Wikidata; Q54891233
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540230; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP26 ! HPSI0713i-aehn_1
OI   CVCL_AG46 ! HPSI0713i-aehn_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-cicb_1
AC   CVCL_JP27
DR   BioSamples; SAMEA2399060
DR   HipSci; HPSI0713i-cicb_1
DR   Wikidata; Q54891234
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG47 ! HPSI0713i-cicb_2
OI   CVCL_AG48 ! HPSI0713i-cicb_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-cicb_2
AC   CVCL_AG47
SY   WTSIi084-B
DR   BioSamples; SAMEA2398319
DR   EBiSC; WTSIi084-B
DR   ECACC; 66540200
DR   ECACC; 77650104
DR   HipSci; HPSI0713i-cicb_2
DR   hPSCreg; WTSIi084-B
DR   SKIP; SKIP002728
DR   Wikidata; Q54891235
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540200; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP27 ! HPSI0713i-cicb_1
OI   CVCL_AG48 ! HPSI0713i-cicb_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-cicb_3
AC   CVCL_AG48
SY   WTSIi084-A
DR   BioSamples; SAMEA2398485
DR   EBiSC; WTSIi084-A
DR   ECACC; 66540199
DR   ECACC; 77650103
DR   HipSci; HPSI0713i-cicb_3
DR   hPSCreg; WTSIi084-A
DR   SKIP; SKIP002702
DR   Wikidata; Q54891236
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540199; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP27 ! HPSI0713i-cicb_1
OI   CVCL_AG47 ! HPSI0713i-cicb_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-dard_1
AC   CVCL_AG49
SY   WTSIi133-A
DR   BioSamples; SAMEA2398125
DR   ECACC; 77650178
DR   HipSci; HPSI0713i-dard_1
DR   hPSCreg; WTSIi133-A
DR   SKIP; SKIP002760
DR   Wikidata; Q54891237
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG50 ! HPSI0713i-dard_2
OI   CVCL_JP28 ! HPSI0713i-dard_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-dard_2
AC   CVCL_AG50
SY   WTSIi133-B
DR   BioSamples; SAMEA2397935
DR   EBiSC; WTSIi133-B
DR   ECACC; 66540236
DR   ECACC; 77650223
DR   HipSci; HPSI0713i-dard_2
DR   hPSCreg; WTSIi133-B
DR   SKIP; SKIP002761
DR   Wikidata; Q54891238
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540236; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG49 ! HPSI0713i-dard_1
OI   CVCL_JP28 ! HPSI0713i-dard_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0713i-dard_3
AC   CVCL_JP28
DR   BioSamples; SAMEA2398287
DR   HipSci; HPSI0713i-dard_3
DR   Wikidata; Q54891239
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG49 ! HPSI0713i-dard_1
OI   CVCL_AG50 ! HPSI0713i-dard_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-darw_1
AC   CVCL_AG51
SY   WTSIi110-A
DR   BioSamples; SAMEA2397999
DR   ECACC; 77650107
DR   HipSci; HPSI0713i-darw_1
DR   hPSCreg; WTSIi110-A
DR   PRIDE; PXD003903
DR   SKIP; SKIP002726
DR   Wikidata; Q54891240
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG52 ! HPSI0713i-darw_2
OI   CVCL_JP29 ! HPSI0713i-darw_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-darw_2
AC   CVCL_AG52
SY   WTSIi110-B; WTSIi226-A
DR   BioSamples; SAMEA2398450
DR   ECACC; 77650224
DR   HipSci; HPSI0713i-darw_2
DR   hPSCreg; WTSIi110-B
DR   PRIDE; PXD003903
DR   Wikidata; Q54891241
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG51 ! HPSI0713i-darw_1
OI   CVCL_JP29 ! HPSI0713i-darw_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-darw_3
AC   CVCL_JP29
DR   BioSamples; SAMEA2398844
DR   HipSci; HPSI0713i-darw_3
DR   Wikidata; Q54891242
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG51 ! HPSI0713i-darw_1
OI   CVCL_AG52 ! HPSI0713i-darw_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-fett_1
AC   CVCL_JP30
DR   BioSamples; SAMEA2398676
DR   HipSci; HPSI0713i-fett_1
DR   Wikidata; Q54891243
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP31 ! HPSI0713i-fett_2
OI   CVCL_AG53 ! HPSI0713i-fett_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0713i-fett_2
AC   CVCL_JP31
DR   BioSamples; SAMEA2398481
DR   HipSci; HPSI0713i-fett_2
DR   Wikidata; Q54891244
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP30 ! HPSI0713i-fett_1
OI   CVCL_AG53 ! HPSI0713i-fett_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0713i-fett_3
AC   CVCL_AG53
SY   WTSIi385-A
DR   BioSamples; SAMEA2398365
DR   ECACC; 77650592
DR   HipSci; HPSI0713i-fett_3
DR   hPSCreg; WTSIi385-A
DR   Wikidata; Q54891245
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP30 ! HPSI0713i-fett_1
OI   CVCL_JP31 ! HPSI0713i-fett_2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-foop_1
AC   CVCL_AG54
SY   WTSIi067-A
DR   BioSamples; SAMEA2399242
DR   EBiSC; WTSIi067-A
DR   ECACC; 66540133
DR   ECACC; 77650097
DR   HipSci; HPSI0713i-foop_1
DR   hPSCreg; WTSIi067-A
DR   SKIP; SKIP002655
DR   Wikidata; Q54891246
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540133; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG55 ! HPSI0713i-foop_2
OI   CVCL_JP32 ! HPSI0713i-foop_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-foop_2
AC   CVCL_AG55
SY   WTSIi067-B
DR   BioSamples; SAMEA2398732
DR   EBiSC; WTSIi067-B
DR   ECACC; 66540134
DR   ECACC; 77650099
DR   HipSci; HPSI0713i-foop_2
DR   hPSCreg; WTSIi067-B
DR   SKIP; SKIP002656
DR   Wikidata; Q54891247
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540134; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG54 ! HPSI0713i-foop_1
OI   CVCL_JP32 ! HPSI0713i-foop_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-foop_3
AC   CVCL_JP32
DR   BioSamples; SAMEA2398629
DR   HipSci; HPSI0713i-foop_3
DR   Wikidata; Q54891248
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG54 ! HPSI0713i-foop_1
OI   CVCL_AG55 ! HPSI0713i-foop_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-gaab_1
AC   CVCL_AG56
DR   BioSamples; SAMEA2399176
DR   HipSci; HPSI0713i-gaab_1
DR   Wikidata; Q54891249
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP33 ! HPSI0713i-gaab_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   HPSI0713i-gaab_2
AC   CVCL_JP33
DR   BioSamples; SAMEA2398156
DR   HipSci; HPSI0713i-gaab_2
DR   Wikidata; Q54891250
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG56 ! HPSI0713i-gaab_1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-javm_1
AC   CVCL_AG57
DR   BioSamples; SAMEA2399148
DR   HipSci; HPSI0713i-javm_1
DR   Wikidata; Q54891251
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP34 ! HPSI0713i-javm_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0713i-javm_2
AC   CVCL_JP34
DR   BioSamples; SAMEA2397816
DR   HipSci; HPSI0713i-javm_2
DR   Wikidata; Q54891252
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG57 ! HPSI0713i-javm_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0713i-kaks_1
AC   CVCL_JP35
DR   BioSamples; SAMEA2398159
DR   HipSci; HPSI0713i-kaks_1
DR   Wikidata; Q54891253
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG58 ! HPSI0713i-kaks_2
OI   CVCL_AG59 ! HPSI0713i-kaks_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-kaks_2
AC   CVCL_AG58
SY   WTSIi213-B; WTSIi240-A
DR   BioSamples; SAMEA2399037
DR   ECACC; 77650233
DR   HipSci; HPSI0713i-kaks_2
DR   hPSCreg; WTSIi213-B
DR   PRIDE; PXD003903
DR   Wikidata; Q54891254
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP35 ! HPSI0713i-kaks_1
OI   CVCL_AG59 ! HPSI0713i-kaks_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0713i-kaks_3
AC   CVCL_AG59
SY   WTSIi213-A
DR   BioSamples; SAMEA2397948
DR   ECACC; 77650234
DR   HipSci; HPSI0713i-kaks_3
DR   hPSCreg; WTSIi213-A
DR   PRIDE; PXD003903
DR   Wikidata; Q54891255
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP35 ! HPSI0713i-kaks_1
OI   CVCL_AG58 ! HPSI0713i-kaks_2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0713i-nemb_1
AC   CVCL_AG60
SY   WTSIi092-A
DR   BioSamples; SAMEA2398231
DR   EBiSC; WTSIi092-A
DR   ECACC; 66540207
DR   ECACC; 77650098
DR   HipSci; HPSI0713i-nemb_1
DR   hPSCreg; WTSIi092-A
DR   SKIP; SKIP002708
DR   Wikidata; Q54891256
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540207; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP36 ! HPSI0713i-nemb_2
OI   CVCL_JP37 ! HPSI0713i-nemb_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-nemb_2
AC   CVCL_JP36
DR   BioSamples; SAMEA2398761
DR   HipSci; HPSI0713i-nemb_2
DR   Wikidata; Q54891257
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG60 ! HPSI0713i-nemb_1
OI   CVCL_JP37 ! HPSI0713i-nemb_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-nemb_3
AC   CVCL_JP37
DR   BioSamples; SAMEA2399084
DR   HipSci; HPSI0713i-nemb_3
DR   Wikidata; Q54891258
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG60 ! HPSI0713i-nemb_1
OI   CVCL_JP36 ! HPSI0713i-nemb_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-nocf_1
AC   CVCL_JP38
DR   BioSamples; SAMEA2399196
DR   HipSci; HPSI0713i-nocf_1
DR   Wikidata; Q54891259
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG61 ! HPSI0713i-nocf_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-nocf_2
AC   CVCL_AG61
SY   WTSIi378-A
DR   BioSamples; SAMEA2397806
DR   ECACC; 77650150
DR   HipSci; HPSI0713i-nocf_2
DR   hPSCreg; WTSIi378-A
DR   Wikidata; Q54891260
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP38 ! HPSI0713i-nocf_1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-pusf_1
AC   CVCL_JP39
DR   BioSamples; SAMEA2604127
DR   HipSci; HPSI0713i-pusf_1
DR   Wikidata; Q54891261
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP40 ! HPSI0713i-pusf_2
OI   CVCL_AG62 ! HPSI0713i-pusf_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-pusf_2
AC   CVCL_JP40
DR   BioSamples; SAMEA2604129
DR   HipSci; HPSI0713i-pusf_2
DR   Wikidata; Q54891262
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP39 ! HPSI0713i-pusf_1
OI   CVCL_AG62 ! HPSI0713i-pusf_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-pusf_3
AC   CVCL_AG62
SY   WTSIi380-A
DR   BioSamples; SAMEA2604130
DR   ECACC; 77650152
DR   HipSci; HPSI0713i-pusf_3
DR   hPSCreg; WTSIi380-A
DR   Wikidata; Q54891263
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP39 ! HPSI0713i-pusf_1
OI   CVCL_JP40 ! HPSI0713i-pusf_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-qimz_1
AC   CVCL_AG63
SY   WTSIi123-A
DR   BioSamples; SAMEA2398442
DR   ECACC; 77650019
DR   HipSci; HPSI0713i-qimz_1
DR   hPSCreg; WTSIi123-A
DR   PRIDE; PXD003903
DR   SKIP; SKIP002747
DR   Wikidata; Q54891264
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650019; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG64 ! HPSI0713i-qimz_2
OI   CVCL_JP41 ! HPSI0713i-qimz_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   HPSI0713i-qimz_2
AC   CVCL_AG64
SY   WTSIi123-B; WTSIi224-A
DR   BioSamples; SAMEA2399257
DR   ECACC; 77650247
DR   HipSci; HPSI0713i-qimz_2
DR   hPSCreg; WTSIi123-B
DR   PRIDE; PXD003903
DR   Wikidata; Q54891265
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG63 ! HPSI0713i-qimz_1
OI   CVCL_JP41 ! HPSI0713i-qimz_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-qimz_3
AC   CVCL_JP41
DR   BioSamples; SAMEA2398372
DR   HipSci; HPSI0713i-qimz_3
DR   Wikidata; Q54891266
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG63 ! HPSI0713i-qimz_1
OI   CVCL_AG64 ! HPSI0713i-qimz_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-ruyl_1
AC   CVCL_JP42
DR   BioSamples; SAMEA2397912
DR   HipSci; HPSI0713i-ruyl_1
DR   Wikidata; Q54891271
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP45 ! HPSI0713i-ruyl_2
OI   CVCL_JP46 ! HPSI0713i-ruyl_3
OI   CVCL_JP43 ! HPSI0713i-ruyl_10
OI   CVCL_JP44 ! HPSI0713i-ruyl_11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-ruyl_10
AC   CVCL_JP43
DR   BioSamples; SAMEA2658097
DR   HipSci; HPSI0713i-ruyl_10
DR   Wikidata; Q54891272
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP42 ! HPSI0713i-ruyl_1
OI   CVCL_JP45 ! HPSI0713i-ruyl_2
OI   CVCL_JP46 ! HPSI0713i-ruyl_3
OI   CVCL_JP44 ! HPSI0713i-ruyl_11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0713i-ruyl_11
AC   CVCL_JP44
DR   BioSamples; SAMEA2658099
DR   HipSci; HPSI0713i-ruyl_11
DR   Wikidata; Q54891273
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP42 ! HPSI0713i-ruyl_1
OI   CVCL_JP45 ! HPSI0713i-ruyl_2
OI   CVCL_JP46 ! HPSI0713i-ruyl_3
OI   CVCL_JP43 ! HPSI0713i-ruyl_10
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 9
//
ID   HPSI0713i-ruyl_2
AC   CVCL_JP45
DR   BioSamples; SAMEA2398518
DR   HipSci; HPSI0713i-ruyl_2
DR   Wikidata; Q54891274
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP42 ! HPSI0713i-ruyl_1
OI   CVCL_JP46 ! HPSI0713i-ruyl_3
OI   CVCL_JP43 ! HPSI0713i-ruyl_10
OI   CVCL_JP44 ! HPSI0713i-ruyl_11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-ruyl_3
AC   CVCL_JP46
DR   BioSamples; SAMEA2397913
DR   HipSci; HPSI0713i-ruyl_3
DR   Wikidata; Q54891275
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP42 ! HPSI0713i-ruyl_1
OI   CVCL_JP45 ! HPSI0713i-ruyl_2
OI   CVCL_JP43 ! HPSI0713i-ruyl_10
OI   CVCL_JP44 ! HPSI0713i-ruyl_11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-ruyv_1
AC   CVCL_AG65
SY   WTSIi124-A
DR   BioSamples; SAMEA2398137
DR   ECACC; 77650111
DR   HipSci; HPSI0713i-ruyv_1
DR   hPSCreg; WTSIi124-A
DR   SKIP; SKIP002748
DR   Wikidata; Q54891276
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP47 ! HPSI0713i-ruyv_2
OI   CVCL_AG66 ! HPSI0713i-ruyv_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-ruyv_2
AC   CVCL_JP47
DR   BioSamples; SAMEA2398447
DR   HipSci; HPSI0713i-ruyv_2
DR   Wikidata; Q54891277
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG65 ! HPSI0713i-ruyv_1
OI   CVCL_AG66 ! HPSI0713i-ruyv_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-ruyv_3
AC   CVCL_AG66
SY   WTSIi124-B
DR   BioSamples; SAMEA2399040
DR   ECACC; 77650109
DR   HipSci; HPSI0713i-ruyv_3
DR   hPSCreg; WTSIi124-B
DR   SKIP; SKIP002749
DR   Wikidata; Q54891278
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG65 ! HPSI0713i-ruyv_1
OI   CVCL_JP47 ! HPSI0713i-ruyv_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-tadm_1
AC   CVCL_JP48
DR   BioSamples; SAMEA2399025
DR   HipSci; HPSI0713i-tadm_1
DR   Wikidata; Q54891280
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG67 ! HPSI0713i-tadm_2
OI   CVCL_JP49 ! HPSI0713i-tadm_3
OI   CVCL_JP50 ! HPSI0713i-tadm_4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-tadm_2
AC   CVCL_AG67
DR   BioSamples; SAMEA2398082
DR   HipSci; HPSI0713i-tadm_2
DR   Wikidata; Q54891281
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP48 ! HPSI0713i-tadm_1
OI   CVCL_JP49 ! HPSI0713i-tadm_3
OI   CVCL_JP50 ! HPSI0713i-tadm_4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0713i-tadm_3
AC   CVCL_JP49
DR   BioSamples; SAMEA2398955
DR   HipSci; HPSI0713i-tadm_3
DR   Wikidata; Q54891282
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP48 ! HPSI0713i-tadm_1
OI   CVCL_AG67 ! HPSI0713i-tadm_2
OI   CVCL_JP50 ! HPSI0713i-tadm_4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-tadm_4
AC   CVCL_JP50
DR   BioSamples; SAMEA2397809
DR   HipSci; HPSI0713i-tadm_4
DR   Wikidata; Q54891283
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP48 ! HPSI0713i-tadm_1
OI   CVCL_AG67 ! HPSI0713i-tadm_2
OI   CVCL_JP49 ! HPSI0713i-tadm_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-terl_1
AC   CVCL_AG68
SY   WTSIi070-A
DR   BioSamples; SAMEA2397851
DR   EBiSC; WTSIi070-A
DR   ECACC; 66540131
DR   ECACC; 77650136
DR   HipSci; HPSI0713i-terl_1
DR   hPSCreg; WTSIi070-A
DR   SKIP; SKIP002659
DR   Wikidata; Q54891284
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540131; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG69 ! HPSI0713i-terl_2
OI   CVCL_JP51 ! HPSI0713i-terl_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0713i-terl_2
AC   CVCL_AG69
SY   WTSIi070-B
DR   BioSamples; SAMEA2398335
DR   EBiSC; WTSIi070-B
DR   ECACC; 66540130
DR   ECACC; 77650135
DR   HipSci; HPSI0713i-terl_2
DR   hPSCreg; WTSIi070-B
DR   SKIP; SKIP002665
DR   Wikidata; Q54891285
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540130; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG68 ! HPSI0713i-terl_1
OI   CVCL_JP51 ! HPSI0713i-terl_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0713i-terl_3
AC   CVCL_JP51
DR   BioSamples; SAMEA2397883
DR   HipSci; HPSI0713i-terl_3
DR   Wikidata; Q54891286
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG68 ! HPSI0713i-terl_1
OI   CVCL_AG69 ! HPSI0713i-terl_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-uimo_1
AC   CVCL_AG70
SY   WTSIi376-A
DR   BioSamples; SAMEA2448270
DR   ECACC; 77650252
DR   HipSci; HPSI0713i-uimo_1
DR   hPSCreg; WTSIi376-A
DR   Wikidata; Q54891287
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0713i-veku_1
AC   CVCL_JP52
DR   BioSamples; SAMEA2482136
DR   HipSci; HPSI0713i-veku_1
DR   Wikidata; Q54891288
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG71 ! HPSI0713i-veku_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-veku_2
AC   CVCL_AG71
SY   WTSIi377-A
DR   BioSamples; SAMEA2482140
DR   ECACC; 77650148
DR   HipSci; HPSI0713i-veku_2
DR   hPSCreg; WTSIi377-A
DR   Wikidata; Q54891289
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP52 ! HPSI0713i-veku_1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0713i-wiol_1
AC   CVCL_AG72
SY   WTSIi357-A
DR   BioSamples; SAMEA2399149
DR   ECACC; 77650147
DR   HipSci; HPSI0713i-wiol_1
DR   hPSCreg; WTSIi357-A
DR   Wikidata; Q54891290
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP53 ! HPSI0713i-wiol_2
OI   CVCL_JP54 ! HPSI0713i-wiol_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0713i-wiol_2
AC   CVCL_JP53
DR   BioSamples; SAMEA2398502
DR   HipSci; HPSI0713i-wiol_2
DR   Wikidata; Q54891291
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG72 ! HPSI0713i-wiol_1
OI   CVCL_JP54 ! HPSI0713i-wiol_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-wiol_3
AC   CVCL_JP54
DR   BioSamples; SAMEA2398436
DR   HipSci; HPSI0713i-wiol_3
DR   Wikidata; Q54891292
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG72 ! HPSI0713i-wiol_1
OI   CVCL_JP53 ! HPSI0713i-wiol_2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   HPSI0713i-yezj_1
AC   CVCL_JP55
DR   BioSamples; SAMEA2469765
DR   HipSci; HPSI0713i-yezj_1
DR   Wikidata; Q54891293
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP56 ! HPSI0713i-yezj_2
OI   CVCL_AG73 ! HPSI0713i-yezj_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-yezj_2
AC   CVCL_JP56
DR   BioSamples; SAMEA2469770
DR   HipSci; HPSI0713i-yezj_2
DR   Wikidata; Q54891294
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP55 ! HPSI0713i-yezj_1
OI   CVCL_AG73 ! HPSI0713i-yezj_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0713i-yezj_3
AC   CVCL_AG73
DR   BioSamples; SAMEA2469764
DR   HipSci; HPSI0713i-yezj_3
DR   Wikidata; Q54891295
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP55 ! HPSI0713i-yezj_1
OI   CVCL_JP56 ! HPSI0713i-yezj_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0714i-burb_1
AC   CVCL_AG74
SY   WTSIi257-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3460681
DR   ECACC; 77650599
DR   HipSci; HPSI0714i-burb_1
DR   hPSCreg; WTSIi257-A
DR   Wikidata; Q54891296
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG75 ! HPSI0714i-burb_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-burb_3
AC   CVCL_AG75
SY   WTSIi257-B; WTSIi305-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3466481
DR   ECACC; 77650600
DR   HipSci; HPSI0714i-burb_3
DR   hPSCreg; WTSIi257-B
DR   Wikidata; Q54891297
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG74 ! HPSI0714i-burb_1
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-fasu_2
AC   CVCL_AG76
SY   WTSIi197-A
DR   BioSamples; SAMEA3355537
DR   EBiSC; WTSIi197-A
DR   ECACC; 66540432
DR   ECACC; 77650345
DR   HipSci; HPSI0714i-fasu_2
DR   hPSCreg; WTSIi197-A
DR   Wikidata; Q54891298
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540432; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0714i-gibe_2
AC   CVCL_AG77
SY   WTSIi159-A
DR   BioSamples; SAMEA3336930
DR   EBiSC; WTSIi159-A
DR   ECACC; 66540313
DR   ECACC; 77650278
DR   HipSci; HPSI0714i-gibe_2
DR   hPSCreg; WTSIi159-A
DR   SKIP; SKIP002811
DR   Wikidata; Q54891299
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540313; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0714i-iudw_1
AC   CVCL_EE52
SY   WTSIi176-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3851971
DR   EBiSC; WTSIi176-A
DR   ECACC; 66540347
DR   ECACC; 77650290
DR   HipSci; HPSI0714i-iudw_1
DR   hPSCreg; WTSIi176-A
DR   SKIP; SKIP002843
DR   Wikidata; Q54891300
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540347; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE53 ! HPSI0714i-iudw_4
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0714i-iudw_4
AC   CVCL_EE53
SY   WTSIi176-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3851966
DR   EBiSC; WTSIi176-B
DR   ECACC; 66540348
DR   ECACC; 77650291
DR   HipSci; HPSI0714i-iudw_4
DR   hPSCreg; WTSIi176-B
DR   SKIP; SKIP002847
DR   Wikidata; Q54891301
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540348; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE52 ! HPSI0714i-iudw_1
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0714i-jilk_3
AC   CVCL_AK03
SY   WTSIi274-B; WTSIi286-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853136
DR   ECACC; 77650568
DR   HipSci; HPSI0714i-jilk_3
DR   hPSCreg; WTSIi274-B
DR   Wikidata; Q54891302
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK04 ! HPSI0714i-jilk_4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-jilk_4
AC   CVCL_AK04
SY   WTSIi274-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853137
DR   ECACC; 77650567
DR   HipSci; HPSI0714i-jilk_4
DR   hPSCreg; WTSIi274-A
DR   Wikidata; Q54891303
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK03 ! HPSI0714i-jilk_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-keui_1
AC   CVCL_EF18
SY   WTSIi245-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962382
DR   ECACC; 77650402
DR   HipSci; HPSI0714i-keui_1
DR   hPSCreg; WTSIi245-A
DR   Wikidata; Q54891304
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF19 ! HPSI0714i-keui_4
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-keui_4
AC   CVCL_EF19
SY   WTSIi245-B; WTSIi292-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962381
DR   ECACC; 77650361
DR   HipSci; HPSI0714i-keui_4
DR   hPSCreg; WTSIi245-B
DR   Wikidata; Q54891305
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF18 ! HPSI0714i-keui_1
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-kute_4
AC   CVCL_EF20
SY   WTSIi300-B; WTSIi324-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974246
DR   ECACC; 77650426
DR   HipSci; HPSI0714i-kute_4
DR   hPSCreg; WTSIi300-B
DR   Wikidata; Q54891306
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF21 ! HPSI0714i-kute_5
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-kute_5
AC   CVCL_EF21
SY   WTSIi300-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974247
DR   ECACC; 77650430
DR   HipSci; HPSI0714i-kute_5
DR   hPSCreg; WTSIi300-A
DR   Wikidata; Q54891307
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF20 ! HPSI0714i-kute_4
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-lutt_6
AC   CVCL_AG78
SY   WTSIi428-A
DR   BioSamples; SAMEA3355552
DR   ECACC; 77650338
DR   HipSci; HPSI0714i-lutt_6
DR   hPSCreg; WTSIi428-A
DR   Wikidata; Q54891308
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0714i-meet_3
AC   CVCL_EF22
SY   WTSIi401-A
DR   BioSamples; SAMEA4085328
DR   ECACC; 77650376
DR   HipSci; HPSI0714i-meet_3
DR   hPSCreg; WTSIi401-A
DR   Wikidata; Q54891309
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0714i-mejk_1
AC   CVCL_EF23
SY   WTSIi426-A
DR   BioSamples; SAMEA4085207
DR   ECACC; 77650328
DR   HipSci; HPSI0714i-mejk_1
DR   hPSCreg; WTSIi426-A
DR   Wikidata; Q54891310
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-mitg_4
AC   CVCL_AG79
SY   WTSIi439-A
DR   BioSamples; SAMEA3310759
DR   ECACC; 77650339
DR   HipSci; HPSI0714i-mitg_4
DR   hPSCreg; WTSIi439-A
DR   Wikidata; Q54891311
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0714i-nufh_3
AC   CVCL_EF24
SY   WTSIi268-B; WTSIi290-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3973288
DR   ECACC; 77650428
DR   HipSci; HPSI0714i-nufh_3
DR   hPSCreg; WTSIi268-B
DR   Wikidata; Q54891318
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF25 ! HPSI0714i-nufh_4
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-nufh_4
AC   CVCL_EF25
SY   WTSIi268-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974015
DR   ECACC; 77650377
DR   HipSci; HPSI0714i-nufh_4
DR   hPSCreg; WTSIi268-A
DR   Wikidata; Q54891319
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF24 ! HPSI0714i-nufh_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-oatm_1
AC   CVCL_LL80
SY   WTSIi633-B; WTSIi642-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853140
DR   ECACC; 77650707
DR   HipSci; HPSI0714i-oatm_1
DR   hPSCreg; WTSIi633-B
DR   Wikidata; Q54891320
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL81 ! HPSI0714i-oatm_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0714i-oatm_2
AC   CVCL_LL81
SY   WTSIi633-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853143
DR   ECACC; 77650708
DR   HipSci; HPSI0714i-oatm_2
DR   hPSCreg; WTSIi633-A
DR   Wikidata; Q54891321
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL80 ! HPSI0714i-oatm_1
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0714i-oebj_1
AC   CVCL_AG80
SY   WTSIi202-A
DR   BioSamples; SAMEA3355551
DR   EBiSC; WTSIi202-A
DR   ECACC; 66540437
DR   ECACC; 77650350
DR   HipSci; HPSI0714i-oebj_1
DR   hPSCreg; WTSIi202-A
DR   Wikidata; Q54891322
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Middle Eastern.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540437; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0714i-oojs_1
AC   CVCL_AG81
SY   WTSIi203-A
DR   BioSamples; SAMEA3339626
DR   EBiSC; WTSIi203-A
DR   ECACC; 66540438
DR   ECACC; 77650340
DR   HipSci; HPSI0714i-oojs_1
DR   hPSCreg; WTSIi203-A
DR   Wikidata; Q54891323
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: EBiSC; WTSIi203-A; true.
CC   Discontinued: ECACC; 66540438; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0714i-ouzk_4
AC   CVCL_EF26
SY   WTSIi402-B; WTSIi404-A
DR   BioSamples; SAMEA3976868
DR   ECACC; 77650399
DR   HipSci; HPSI0714i-ouzk_4
DR   hPSCreg; WTSIi402-B
DR   Wikidata; Q54891324
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF27 ! HPSI0714i-ouzk_5
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0714i-ouzk_5
AC   CVCL_EF27
SY   WTSIi402-A
DR   BioSamples; SAMEA3976870
DR   ECACC; 77650360
DR   HipSci; HPSI0714i-ouzk_5
DR   hPSCreg; WTSIi402-A
DR   Wikidata; Q54891325
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF26 ! HPSI0714i-ouzk_4
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0714i-pipw_4
AC   CVCL_AK05
SY   WTSIi265-B; WTSIi280-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3964247
DR   ECACC; 77650574
DR   HipSci; HPSI0714i-pipw_4
DR   hPSCreg; WTSIi265-B
DR   Wikidata; Q54891326
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK06 ! HPSI0714i-pipw_5
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-pipw_5
AC   CVCL_AK06
SY   WTSIi265-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3964246
DR   ECACC; 77650573
DR   HipSci; HPSI0714i-pipw_5
DR   hPSCreg; WTSIi265-A
DR   Wikidata; Q54891327
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK05 ! HPSI0714i-pipw_4
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0714i-pirs_1
AC   CVCL_AG82
SY   WTSIi438-A
DR   BioSamples; SAMEA3340808
DR   ECACC; 77650343
DR   HipSci; HPSI0714i-pirs_1
DR   hPSCreg; WTSIi438-A
DR   Wikidata; Q54891328
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0714i-rajk_1
AC   CVCL_AG83
SY   WTSIi161-A
DR   BioSamples; SAMEA3355533
DR   EBiSC; WTSIi161-A
DR   ECACC; 66540315
DR   ECACC; 77650284
DR   HipSci; HPSI0714i-rajk_1
DR   hPSCreg; WTSIi161-A
DR   SKIP; SKIP002813
DR   Wikidata; Q54891329
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540315; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0714i-riya_2
AC   CVCL_AG84
SY   WTSIi444-A
DR   BioSamples; SAMEA3340819
DR   ECACC; 77650346
DR   HipSci; HPSI0714i-riya_2
DR   hPSCreg; WTSIi444-A
DR   Wikidata; Q54891330
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Bulgarian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0714i-tosj_3
AC   CVCL_WK23
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104132710
DR   HipSci; HPSI0714i-tosj_3
DR   Wikidata; Q94231960
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK24 ! HPSI0714i-tosj_4
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0714i-tosj_4
AC   CVCL_WK24
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA7417168
DR   HipSci; HPSI0714i-tosj_4
DR   Wikidata; Q94231964
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK23 ! HPSI0714i-tosj_3
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0714i-wipe_3
AC   CVCL_JP57
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3322801
DR   HipSci; HPSI0714i-wipe_3
DR   Wikidata; Q54891331
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0714i-xebt_2
AC   CVCL_AG85
SY   WTSIi445-A
DR   BioSamples; SAMEA3340815
DR   ECACC; 77650347
DR   HipSci; HPSI0714i-xebt_2
DR   hPSCreg; WTSIi445-A
DR   Wikidata; Q54891332
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0714i-xiry_1
AC   CVCL_IX30
SY   WTSIi465-B; WTSIi586-A
DR   BioSamples; SAMEA3977536
DR   ECACC; 77650467
DR   HipSci; HPSI0714i-xiry_1
DR   hPSCreg; WTSIi465-B
DR   Wikidata; Q54891333
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650467; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX31 ! HPSI0714i-xiry_5
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0714i-xiry_5
AC   CVCL_IX31
SY   WTSIi465-A
DR   BioSamples; SAMEA3977540
DR   ECACC; 77650468
DR   HipSci; HPSI0714i-xiry_5
DR   hPSCreg; WTSIi465-A
DR   Wikidata; Q54891334
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX30 ! HPSI0714i-xiry_1
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0714i-zaos_1
AC   CVCL_AG86
SY   WTSIi436-A
DR   BioSamples; SAMEA3340805
DR   ECACC; 77650341
DR   HipSci; HPSI0714i-zaos_1
DR   hPSCreg; WTSIi436-A
DR   Wikidata; Q54891335
CC   From: University of Exeter Medical School; Exeter; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Pakistani.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0715i-aowh_2
AC   CVCL_EF28
SY   WTSIi345-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3973284
DR   ECACC; 77650417
DR   HipSci; HPSI0715i-aowh_2
DR   hPSCreg; WTSIi345-A
DR   Wikidata; Q54891336
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0715i-meue_4
AC   CVCL_EF29
SY   WTSIi288-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3973848
DR   ECACC; 77650368
DR   HipSci; HPSI0715i-meue_4
DR   hPSCreg; WTSIi288-A
DR   Wikidata; Q54891337
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF30 ! HPSI0715i-meue_5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0715i-meue_5
AC   CVCL_EF30
SY   WTSIi288-B; WTSIi307-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3973851
DR   ECACC; 77650408
DR   HipSci; HPSI0715i-meue_5
DR   hPSCreg; WTSIi288-B
DR   Wikidata; Q54891338
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF29 ! HPSI0715i-meue_4
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0715i-zaie_1
AC   CVCL_EF31
SY   WTSIi327-B; WTSIi335-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3966782
DR   ECACC; 77650388
DR   HipSci; HPSI0715i-zaie_1
DR   hPSCreg; WTSIi327-B
DR   Wikidata; Q54891339
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF32 ! HPSI0715i-zaie_5
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0715i-zaie_5
AC   CVCL_EF32
SY   WTSIi327-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3973871
DR   ECACC; 77650405
DR   HipSci; HPSI0715i-zaie_5
DR   hPSCreg; WTSIi327-A
DR   Wikidata; Q54891340
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF31 ! HPSI0715i-zaie_1
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0716i-bakv_4
AC   CVCL_LF07
SY   WTSIi484-B; WTSIi579-A
DR   BioSamples; SAMEA103997233
DR   ECACC; 77650645
DR   HipSci; HPSI0716i-bakv_4
DR   hPSCreg; WTSIi484-B
DR   Wikidata; Q54891341
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF08 ! HPSI0716i-bakv_6
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0716i-bakv_6
AC   CVCL_LF08
SY   WTSIi484-A
DR   BioSamples; SAMEA103997234
DR   ECACC; 77650644
DR   HipSci; HPSI0716i-bakv_6
DR   hPSCreg; WTSIi484-A
DR   Wikidata; Q54891342
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF07 ! HPSI0716i-bakv_4
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0716i-toba_1
AC   CVCL_LM36
SY   WTSIi481-A
DR   BioSamples; SAMEA103887535
DR   ECACC; 77650656
DR   HipSci; HPSI0716i-toba_1
DR   hPSCreg; WTSIi481-A
DR   Wikidata; Q54891343
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0716i-yibs_1
AC   CVCL_LF33
SY   WTSIi463-A
DR   BioSamples; SAMEA103887411
DR   ECACC; 77650660
DR   HipSci; HPSI0716i-yibs_1
DR   hPSCreg; WTSIi463-A
DR   Wikidata; Q54891344
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF34 ! HPSI0716i-yibs_3
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0716i-yibs_3
AC   CVCL_LF34
SY   WTSIi463-B; WTSIi533-A
DR   BioSamples; SAMEA103988286
DR   ECACC; 77650659
DR   HipSci; HPSI0716i-yibs_3
DR   hPSCreg; WTSIi463-B
DR   Wikidata; Q54891345
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF33 ! HPSI0716i-yibs_1
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0716i-yipp_2
AC   CVCL_LM37
SY   WTSIi529-A
DR   BioSamples; SAMEA103885916
DR   ECACC; 77650658
DR   HipSci; HPSI0716i-yipp_2
DR   hPSCreg; WTSIi529-A
DR   Wikidata; Q54891346
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM38 ! HPSI0716i-yipp_6
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0716i-yipp_6
AC   CVCL_LM38
SY   WTSIi529-B; WTSIi552-A
DR   BioSamples; SAMEA103885920
DR   ECACC; 77650657
DR   HipSci; HPSI0716i-yipp_6
DR   hPSCreg; WTSIi529-B
DR   Wikidata; Q54891347
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM37 ! HPSI0716i-yipp_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0813i-aizi_1
AC   CVCL_AG87
SY   WTSIi097-B
DR   BioSamples; SAMEA2420642
DR   EBiSC; WTSIi097-B
DR   ECACC; 66540213
DR   ECACC; 77650157
DR   HipSci; HPSI0813i-aizi_1
DR   hPSCreg; WTSIi097-B
DR   SKIP; SKIP002729
DR   Wikidata; Q54891348
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540213; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP58 ! HPSI0813i-aizi_2
OI   CVCL_AG88 ! HPSI0813i-aizi_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0813i-aizi_2
AC   CVCL_JP58
DR   BioSamples; SAMEA2420647
DR   HipSci; HPSI0813i-aizi_2
DR   Wikidata; Q54891349
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG87 ! HPSI0813i-aizi_1
OI   CVCL_AG88 ! HPSI0813i-aizi_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-aizi_3
AC   CVCL_AG88
SY   WTSIi097-A
DR   BioSamples; SAMEA2420639
DR   EBiSC; WTSIi097-A
DR   ECACC; 66540212
DR   ECACC; 77650128
DR   HipSci; HPSI0813i-aizi_3
DR   hPSCreg; WTSIi097-A
DR   SKIP; SKIP002712
DR   Wikidata; Q54891350
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540212; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG87 ! HPSI0813i-aizi_1
OI   CVCL_JP58 ! HPSI0813i-aizi_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0813i-aomg_2
AC   CVCL_AG89
SY   WTSIi561-A
DR   BioSamples; SAMEA2398885
DR   HipSci; HPSI0813i-aomg_2
DR   hPSCreg; WTSIi561-A
DR   Wikidata; Q54891351
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG90 ! HPSI0813i-aomg_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0813i-aomg_3
AC   CVCL_AG90
DR   BioSamples; SAMEA2398185
DR   HipSci; HPSI0813i-aomg_3
DR   Wikidata; Q54891352
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG89 ! HPSI0813i-aomg_2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0813i-civh_1
AC   CVCL_AG91
SY   WTSIi099-A
DR   BioSamples; SAMEA2397802
DR   EBiSC; WTSIi099-A
DR   ECACC; 66540214
DR   ECACC; 77650130
DR   HipSci; HPSI0813i-civh_1
DR   hPSCreg; WTSIi099-A
DR   SKIP; SKIP002714
DR   Wikidata; Q54891353
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540214; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP59 ! HPSI0813i-civh_2
OI   CVCL_AG92 ! HPSI0813i-civh_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-civh_2
AC   CVCL_JP59
DR   BioSamples; SAMEA2399186
DR   HipSci; HPSI0813i-civh_2
DR   Wikidata; Q54891354
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG91 ! HPSI0813i-civh_1
OI   CVCL_AG92 ! HPSI0813i-civh_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-civh_3
AC   CVCL_AG92
SY   WTSIi099-B; WTSIi393-A
DR   BioSamples; SAMEA2398123
DR   ECACC; 77650591
DR   HipSci; HPSI0813i-civh_3
DR   hPSCreg; WTSIi099-B
DR   Wikidata; Q54891355
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG91 ! HPSI0813i-civh_1
OI   CVCL_JP59 ! HPSI0813i-civh_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0813i-eiqh_1
AC   CVCL_JP60
DR   BioSamples; SAMEA2399153
DR   HipSci; HPSI0813i-eiqh_1
DR   Wikidata; Q54891356
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP61 ! HPSI0813i-eiqh_2
OI   CVCL_AG93 ! HPSI0813i-eiqh_3
OI   CVCL_AG94 ! HPSI0813i-eiqh_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-eiqh_2
AC   CVCL_JP61
DR   BioSamples; SAMEA2399059
DR   HipSci; HPSI0813i-eiqh_2
DR   Wikidata; Q54891357
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP60 ! HPSI0813i-eiqh_1
OI   CVCL_AG93 ! HPSI0813i-eiqh_3
OI   CVCL_AG94 ! HPSI0813i-eiqh_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-eiqh_3
AC   CVCL_AG93
SY   WTSIi567-A
DR   BioSamples; SAMEA2397899
DR   HipSci; HPSI0813i-eiqh_3
DR   hPSCreg; WTSIi567-A
DR   Wikidata; Q54891365
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP60 ! HPSI0813i-eiqh_1
OI   CVCL_JP61 ! HPSI0813i-eiqh_2
OI   CVCL_AG94 ! HPSI0813i-eiqh_6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0813i-eiqh_6
AC   CVCL_AG94
DR   BioSamples; SAMEA2399245
DR   HipSci; HPSI0813i-eiqh_6
DR   Wikidata; Q54891366
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP60 ! HPSI0813i-eiqh_1
OI   CVCL_JP61 ! HPSI0813i-eiqh_2
OI   CVCL_AG93 ! HPSI0813i-eiqh_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0813i-ffdc_1
AC   CVCL_AG95
SY   WTSIi091-B; WTSIi381-A
DR   BioSamples; SAMEA2398883
DR   ECACC; 77650002
DR   HipSci; HPSI0813i-ffdc_1
DR   hPSCreg; WTSIi091-B
DR   Wikidata; Q54891367
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650002; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG96 ! HPSI0813i-ffdc_11
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   HPSI0813i-ffdc_11
AC   CVCL_AG96
SY   WTSIi091-A
DR   BioSamples; SAMEA2398313
DR   EBiSC; WTSIi091-A
DR   ECACC; 66540206
DR   ECACC; 77650014
DR   HipSci; HPSI0813i-ffdc_11
DR   hPSCreg; WTSIi091-A
DR   SKIP; SKIP002707
DR   Wikidata; Q54891368
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540206; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG95 ! HPSI0813i-ffdc_1
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0813i-ffdj_1
AC   CVCL_AG97
SY   WTSIi279-A
DR   BioSamples; SAMEA2398530
DR   ECACC; 77650009
DR   HipSci; HPSI0813i-ffdj_1
DR   hPSCreg; WTSIi279-A
DR   Wikidata; Q54891369
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH01 ! HPSI0813i-fpdj_3
OI   CVCL_JQ22 ! HPSI1113i-nibo_1
OI   CVCL_AH95 ! HPSI1113i-nibo_2
OI   CVCL_AH96 ! HPSI1113i-nibo_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0813i-ffdk_3
AC   CVCL_AG98
DR   BioSamples; SAMEA2398134
DR   HipSci; HPSI0813i-ffdk_3
DR   Wikidata; Q54891370
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH02 ! HPSI0813i-fpdk_2
OI   CVCL_AI07 ! HPSI1113i-zuta_1
OI   CVCL_JQ31 ! HPSI1113i-zuta_2
OI   CVCL_AI08 ! HPSI1113i-zuta_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0813i-ffdm_3
AC   CVCL_AG99
DR   BioSamples; SAMEA2399249
DR   HipSci; HPSI0813i-ffdm_3
DR   Wikidata; Q54891371
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH05 ! HPSI0813i-fpdm_2
OI   CVCL_JQ32 ! HPSI1114i-qibk_1
OI   CVCL_AI09 ! HPSI1114i-qibk_2
OI   CVCL_AI10 ! HPSI1114i-qibk_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0813i-ffdr_3
AC   CVCL_AH00
SY   WTSIi207-A
DR   BioSamples; SAMEA2201451
DR   ECACC; 77650001
DR   HipSci; HPSI0813i-ffdr_3
DR   hPSCreg; WTSIi207-A
DR   Wikidata; Q54891372
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH06 ! HPSI0813i-fpdr_2
OI   CVCL_AH91 ! HPSI1113i-fumb_2
OI   CVCL_JQ17 ! HPSI1113i-fumb_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0813i-fpdj_3
AC   CVCL_AH01
DR   BioSamples; SAMEA2201446
DR   HipSci; HPSI0813i-fpdj_3
DR   Wikidata; Q54891373
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG97 ! HPSI0813i-ffdj_1
OI   CVCL_JQ22 ! HPSI1113i-nibo_1
OI   CVCL_AH95 ! HPSI1113i-nibo_2
OI   CVCL_AH96 ! HPSI1113i-nibo_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0813i-fpdk_2
AC   CVCL_AH02
SY   WTSIi206-A
DR   BioSamples; SAMEA2201448
DR   ECACC; 77650003
DR   HipSci; HPSI0813i-fpdk_2
DR   hPSCreg; WTSIi206-A
DR   Wikidata; Q54891374
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG98 ! HPSI0813i-ffdk_3
OI   CVCL_AI07 ! HPSI1113i-zuta_1
OI   CVCL_JQ31 ! HPSI1113i-zuta_2
OI   CVCL_AI08 ! HPSI1113i-zuta_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0813i-fpdl_1
AC   CVCL_AH03
SY   WTSIi297-D; WTSIi375-A
DR   BioSamples; SAMEA2399182
DR   ECACC; 77650004
DR   HipSci; HPSI0813i-fpdl_1
DR   hPSCreg; WTSIi297-D
DR   Wikidata; Q54891375
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH04 ! HPSI0813i-fpdl_2
OI   CVCL_AH33 ! HPSI0913i-ffdl_1
OI   CVCL_WV05 ! HPSI0913i-ffdl_2
OI   CVCL_AH36 ! HPSI0913i-ffdz_2
OI   CVCL_AI15 ! HPSI1213i-foqj_1
OI   CVCL_AI16 ! HPSI1213i-foqj_2
OI   CVCL_JQ37 ! HPSI1213i-foqj_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0813i-fpdl_2
AC   CVCL_AH04
SY   WTSIi297-A
DR   BioSamples; SAMEA2201450
DR   ECACC; 77650005
DR   HipSci; HPSI0813i-fpdl_2
DR   hPSCreg; WTSIi297-A
DR   Wikidata; Q54891376
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH03 ! HPSI0813i-fpdl_1
OI   CVCL_AH33 ! HPSI0913i-ffdl_1
OI   CVCL_WV05 ! HPSI0913i-ffdl_2
OI   CVCL_AH36 ! HPSI0913i-ffdz_2
OI   CVCL_AI15 ! HPSI1213i-foqj_1
OI   CVCL_AI16 ! HPSI1213i-foqj_2
OI   CVCL_JQ37 ! HPSI1213i-foqj_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0813i-fpdm_2
AC   CVCL_AH05
DR   BioSamples; SAMEA2201447
DR   ECACC; 77650622
DR   HipSci; HPSI0813i-fpdm_2
DR   Wikidata; Q54891377
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650622; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG99 ! HPSI0813i-ffdm_3
OI   CVCL_JQ32 ! HPSI1114i-qibk_1
OI   CVCL_AI09 ! HPSI1114i-qibk_2
OI   CVCL_AI10 ! HPSI1114i-qibk_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   HPSI0813i-fpdr_2
AC   CVCL_AH06
DR   BioSamples; SAMEA2201445
DR   HipSci; HPSI0813i-fpdr_2
DR   Wikidata; Q54891378
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH00 ! HPSI0813i-ffdr_3
OI   CVCL_AH91 ! HPSI1113i-fumb_2
OI   CVCL_JQ17 ! HPSI1113i-fumb_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0813i-guss_1
AC   CVCL_AH07
SY   WTSIi096-A
DR   BioSamples; SAMEA2697659
DR   EBiSC; WTSIi096-A
DR   ECACC; 66540211
DR   ECACC; 77650125
DR   HipSci; HPSI0813i-guss_1
DR   hPSCreg; WTSIi096-A
DR   SKIP; SKIP002711
DR   Wikidata; Q54891379
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540211; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0813i-iicq_1
AC   CVCL_AH08
SY   WTSIi116-A
DR   BioSamples; SAMEA2398866
DR   ECACC; 77650094
DR   HipSci; HPSI0813i-iicq_1
DR   hPSCreg; WTSIi116-A
DR   SKIP; SKIP002739
DR   Wikidata; Q54891380
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP62 ! HPSI0813i-iicq_2
OI   CVCL_AH09 ! HPSI0813i-iicq_3
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-iicq_2
AC   CVCL_JP62
DR   BioSamples; SAMEA2398067
DR   HipSci; HPSI0813i-iicq_2
DR   Wikidata; Q54891381
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH08 ! HPSI0813i-iicq_1
OI   CVCL_AH09 ! HPSI0813i-iicq_3
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-iicq_3
AC   CVCL_AH09
SY   WTSIi116-B; WTSIi358-A
DR   BioSamples; SAMEA2398900
DR   ECACC; 77650159
DR   HipSci; HPSI0813i-iicq_3
DR   hPSCreg; WTSIi116-B
DR   Wikidata; Q54891382
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH08 ! HPSI0813i-iicq_1
OI   CVCL_JP62 ! HPSI0813i-iicq_2
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-iill_1
AC   CVCL_AH10
SY   WTSIi107-A
DR   BioSamples; SAMEA2398643
DR   EBiSC; WTSIi107-A
DR   ECACC; 66540222
DR   ECACC; 77650075
DR   HipSci; HPSI0813i-iill_1
DR   hPSCreg; WTSIi107-A
DR   SKIP; SKIP002722
DR   Wikidata; Q54891383
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540222; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP63 ! HPSI0813i-iill_2
OI   CVCL_AH11 ! HPSI0813i-iill_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-iill_2
AC   CVCL_JP63
DR   BioSamples; SAMEA2397825
DR   HipSci; HPSI0813i-iill_2
DR   Wikidata; Q54891384
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH10 ! HPSI0813i-iill_1
OI   CVCL_AH11 ! HPSI0813i-iill_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-iill_3
AC   CVCL_AH11
SY   WTSIi107-B
DR   BioSamples; SAMEA2399058
DR   EBiSC; WTSIi107-B
DR   ECACC; 66540223
DR   ECACC; 77650132
DR   HipSci; HPSI0813i-iill_3
DR   hPSCreg; WTSIi107-B
DR   SKIP; SKIP002732
DR   Wikidata; Q54891385
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540223; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH10 ! HPSI0813i-iill_1
OI   CVCL_JP63 ! HPSI0813i-iill_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0813i-meqo_1
AC   CVCL_JP64
DR   BioSamples; SAMEA2399462
DR   HipSci; HPSI0813i-meqo_1
DR   Wikidata; Q54891386
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH12 ! HPSI0813i-meqo_2
OI   CVCL_AH13 ! HPSI0813i-meqo_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-meqo_2
AC   CVCL_AH12
SY   WTSIi118-A
DR   BioSamples; SAMEA2399460
DR   ECACC; 77650092
DR   HipSci; HPSI0813i-meqo_2
DR   hPSCreg; WTSIi118-A
DR   SKIP; SKIP002741
DR   Wikidata; Q54891387
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP64 ! HPSI0813i-meqo_1
OI   CVCL_AH13 ! HPSI0813i-meqo_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-meqo_3
AC   CVCL_AH13
SY   WTSIi118-B; WTSIi234-A
DR   BioSamples; SAMEA2399459
DR   ECACC; 77650238
DR   HipSci; HPSI0813i-meqo_3
DR   hPSCreg; WTSIi118-B
DR   Wikidata; Q54891388
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP64 ! HPSI0813i-meqo_1
OI   CVCL_AH12 ! HPSI0813i-meqo_2
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-mioj_1
AC   CVCL_IY91
SY   WTSIi473-A
DR   BioSamples; SAMEA4449169
DR   ECACC; 77650481
DR   HipSci; HPSI0813i-mioj_1
DR   hPSCreg; WTSIi473-A
DR   Wikidata; Q54891389
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY92 ! HPSI0813i-mioj_4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0813i-mioj_4
AC   CVCL_IY92
SY   WTSIi473-B; WTSIi532-A
DR   BioSamples; SAMEA4449172
DR   ECACC; 77650482
DR   HipSci; HPSI0813i-mioj_4
DR   hPSCreg; WTSIi473-B
DR   Wikidata; Q54891390
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY91 ! HPSI0813i-mioj_1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0813i-peoj_1
AC   CVCL_IY93
SY   WTSIi476-A
DR   BioSamples; SAMEA4451496
DR   ECACC; 77650458
DR   HipSci; HPSI0813i-peoj_1
DR   hPSCreg; WTSIi476-A
DR   Wikidata; Q54891391
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0813i-piun_1
AC   CVCL_JP65
DR   BioSamples; SAMEA2400643
DR   HipSci; HPSI0813i-piun_1
DR   Wikidata; Q54891392
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP66 ! HPSI0813i-piun_2
OI   CVCL_AH14 ! HPSI0813i-piun_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-piun_2
AC   CVCL_JP66
DR   BioSamples; SAMEA2400644
DR   HipSci; HPSI0813i-piun_2
DR   Wikidata; Q54891393
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP65 ! HPSI0813i-piun_1
OI   CVCL_AH14 ! HPSI0813i-piun_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-piun_3
AC   CVCL_AH14
SY   WTSIi223-A
DR   BioSamples; SAMEA2400645
DR   ECACC; 77650244
DR   HipSci; HPSI0813i-piun_3
DR   hPSCreg; WTSIi223-A
DR   Wikidata; Q54891394
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP65 ! HPSI0813i-piun_1
OI   CVCL_JP66 ! HPSI0813i-piun_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-raki_1
AC   CVCL_AH15
DR   BioSamples; SAMEA2518335
DR   HipSci; HPSI0813i-raki_1
DR   Wikidata; Q54891395
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP67 ! HPSI0813i-raki_2
OI   CVCL_JP68 ! HPSI0813i-raki_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0813i-raki_2
AC   CVCL_JP67
DR   BioSamples; SAMEA2518321
DR   HipSci; HPSI0813i-raki_2
DR   Wikidata; Q54891397
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH15 ! HPSI0813i-raki_1
OI   CVCL_JP68 ! HPSI0813i-raki_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0813i-raki_3
AC   CVCL_JP68
DR   BioSamples; SAMEA2518333
DR   HipSci; HPSI0813i-raki_3
DR   Wikidata; Q54891398
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH15 ! HPSI0813i-raki_1
OI   CVCL_JP67 ! HPSI0813i-raki_2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0813i-robp_2
AC   CVCL_JP69
DR   BioSamples; SAMEA2398773
DR   HipSci; HPSI0813i-robp_2
DR   Wikidata; Q54891399
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH16 ! HPSI0813i-robp_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-robp_3
AC   CVCL_AH16
SY   WTSIi090-A
DR   BioSamples; SAMEA2398670
DR   EBiSC; WTSIi090-A
DR   ECACC; 66540205
DR   ECACC; 77650116
DR   HipSci; HPSI0813i-robp_3
DR   hPSCreg; WTSIi090-A
DR   Wikidata; Q54891400
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540205; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP69 ! HPSI0813i-robp_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0813i-uaqe_1
AC   CVCL_AH17
SY   WTSIi087-A
DR   BioSamples; SAMEA2398377
DR   EBiSC; WTSIi087-A
DR   ECACC; 66540202
DR   ECACC; 77650113
DR   HipSci; HPSI0813i-uaqe_1
DR   hPSCreg; WTSIi087-A
DR   SKIP; SKIP002705
DR   Wikidata; Q54891401
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540202; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP70 ! HPSI0813i-uaqe_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0813i-uaqe_2
AC   CVCL_JP70
DR   BioSamples; SAMEA2398947
DR   HipSci; HPSI0813i-uaqe_2
DR   Wikidata; Q54891402
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH17 ! HPSI0813i-uaqe_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-vajx_1
AC   CVCL_JP71
DR   BioSamples; SAMEA2555018
DR   HipSci; HPSI0813i-vajx_1
DR   Wikidata; Q54891403
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH18 ! HPSI0813i-vajx_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-vajx_2
AC   CVCL_AH18
SY   WTSIi095-A
DR   BioSamples; SAMEA2555015
DR   EBiSC; WTSIi095-A
DR   ECACC; 66540210
DR   ECACC; 77650120
DR   HipSci; HPSI0813i-vajx_2
DR   hPSCreg; WTSIi095-A
DR   Wikidata; Q54891404
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540210; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP71 ! HPSI0813i-vajx_1
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0813i-voas_1
AC   CVCL_JP72
DR   BioSamples; SAMEA2402584
DR   HipSci; HPSI0813i-voas_1
DR   Wikidata; Q54891405
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH19 ! HPSI0813i-voas_2
OI   CVCL_JP73 ! HPSI0813i-voas_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-voas_2
AC   CVCL_AH19
SY   WTSIi236-A
DR   BioSamples; SAMEA2402582
DR   ECACC; 77650254
DR   HipSci; HPSI0813i-voas_2
DR   hPSCreg; WTSIi236-A
DR   Wikidata; Q54891411
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP72 ! HPSI0813i-voas_1
OI   CVCL_JP73 ! HPSI0813i-voas_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0813i-voas_3
AC   CVCL_JP73
DR   BioSamples; SAMEA2402583
DR   HipSci; HPSI0813i-voas_3
DR   Wikidata; Q54891412
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP72 ! HPSI0813i-voas_1
OI   CVCL_AH19 ! HPSI0813i-voas_2
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-wots_1
AC   CVCL_JP74
DR   BioSamples; SAMEA2697662
DR   HipSci; HPSI0813i-wots_1
DR   Wikidata; Q54891413
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP75 ! HPSI0813i-wots_2
OI   CVCL_AH20 ! HPSI0813i-wots_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-wots_2
AC   CVCL_JP75
DR   BioSamples; SAMEA2697661
DR   HipSci; HPSI0813i-wots_2
DR   Wikidata; Q54891415
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP74 ! HPSI0813i-wots_1
OI   CVCL_AH20 ! HPSI0813i-wots_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-wots_3
AC   CVCL_AH20
SY   WTSIi145-A
DR   BioSamples; SAMEA2697658
DR   EBiSC; WTSIi145-A
DR   ECACC; 66540256
DR   ECACC; 77650258
DR   HipSci; HPSI0813i-wots_3
DR   hPSCreg; WTSIi145-A
DR   SKIP; SKIP002780
DR   Wikidata; Q54891416
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540256; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP74 ! HPSI0813i-wots_1
OI   CVCL_JP75 ! HPSI0813i-wots_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0813i-zexw_1
AC   CVCL_JP76
DR   BioSamples; SAMEA2625597
DR   HipSci; HPSI0813i-zexw_1
DR   Wikidata; Q54891417
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP77 ! HPSI0813i-zexw_2
OI   CVCL_AH21 ! HPSI0813i-zexw_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-zexw_2
AC   CVCL_JP77
DR   BioSamples; SAMEA2625590
DR   HipSci; HPSI0813i-zexw_2
DR   Wikidata; Q54891418
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP76 ! HPSI0813i-zexw_1
OI   CVCL_AH21 ! HPSI0813i-zexw_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0813i-zexw_3
AC   CVCL_AH21
SY   WTSIi100-A
DR   BioSamples; SAMEA2625596
DR   EBiSC; WTSIi100-A
DR   ECACC; 66540215
DR   ECACC; 77650133
DR   HipSci; HPSI0813i-zexw_3
DR   hPSCreg; WTSIi100-A
DR   SKIP; SKIP002715
DR   Wikidata; Q54891419
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540215; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP76 ! HPSI0813i-zexw_1
OI   CVCL_JP77 ! HPSI0813i-zexw_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0814i-bokz_5
AC   CVCL_AH22
SY   WTSIi047-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3355549
DR   EBiSC; WTSIi047-A
DR   ECACC; 66540121
DR   ECACC; 77650200
DR   HipSci; HPSI0814i-bokz_5
DR   hPSCreg; WTSIi047-A
DR   SKIP; SKIP002618
DR   Wikidata; Q54891420
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540121; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH23 ! HPSI0814i-bokz_6
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0814i-bokz_6
AC   CVCL_AH23
SY   WTSIi047-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3355550
DR   EBiSC; WTSIi047-B
DR   ECACC; 66540122
DR   ECACC; 77650210
DR   HipSci; HPSI0814i-bokz_6
DR   hPSCreg; WTSIi047-B
DR   SKIP; SKIP002621
DR   Wikidata; Q54891421
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540122; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH22 ! HPSI0814i-bokz_5
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI0814i-doao_1
AC   CVCL_AH24
SY   WTSIi347-B; WTSIi379-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3443156
DR   ECACC; 77650597
DR   HipSci; HPSI0814i-doao_1
DR   hPSCreg; WTSIi347-B
DR   Wikidata; Q54891422
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH25 ! HPSI0814i-doao_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0814i-doao_2
AC   CVCL_AH25
SY   WTSIi347-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3448741
DR   ECACC; 77650598
DR   HipSci; HPSI0814i-doao_2
DR   hPSCreg; WTSIi347-A
DR   Wikidata; Q54891423
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH24 ! HPSI0814i-doao_1
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0814i-siqu_11
AC   CVCL_IY94
SY   WTSIi595-B; WTSIi605-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4092051
DR   ECACC; 77650464
DR   HipSci; HPSI0814i-siqu_11
DR   hPSCreg; WTSIi595-B
DR   Wikidata; Q54891424
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650464; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY95 ! HPSI0814i-siqu_4
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI0814i-siqu_4
AC   CVCL_IY95
SY   WTSIi595-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4091336
DR   ECACC; 77650463
DR   HipSci; HPSI0814i-siqu_4
DR   hPSCreg; WTSIi595-A
DR   Wikidata; Q54891426
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY94 ! HPSI0814i-siqu_11
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0814i-uepz_3
AC   CVCL_WK17
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103887416
DR   HipSci; HPSI0814i-uepz_3
DR   Wikidata; Q94233001
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK18 ! HPSI0814i-uepz_4
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0814i-uepz_4
AC   CVCL_WK18
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104130212
DR   HipSci; HPSI0814i-uepz_4
DR   Wikidata; Q94233007
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK17 ! HPSI0814i-uepz_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI0816i-aorf_1
AC   CVCL_LF22
SY   WTSIi669-A
DR   BioSamples; SAMEA104011440
DR   ECACC; 77650684
DR   HipSci; HPSI0816i-aorf_1
DR   hPSCreg; WTSIi669-A
DR   Wikidata; Q54891427
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF23 ! HPSI0816i-aorf_2
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-aorf_2
AC   CVCL_LF23
SY   WTSIi669-B; WTSIi678-A
DR   BioSamples; SAMEA104011444
DR   ECACC; 77650685
DR   HipSci; HPSI0816i-aorf_2
DR   hPSCreg; WTSIi669-B
DR   Wikidata; Q54891428
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF22 ! HPSI0816i-aorf_1
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-daah_1
AC   CVCL_WJ79
DR   BioSamples; SAMEA103887431
DR   ECACC; 77650819
DR   HipSci; HPSI0816i-daah_1
DR   Wikidata; Q94233027
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ80 ! HPSI0816i-daah_6
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-daah_6
AC   CVCL_WJ80
DR   BioSamples; SAMEA103887426
DR   ECACC; 77650820
DR   HipSci; HPSI0816i-daah_6
DR   Wikidata; Q94233032
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ79 ! HPSI0816i-daah_1
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-fuuy_3
AC   CVCL_LM39
SY   WTSIi658-A
DR   BioSamples; SAMEA104236472
DR   ECACC; 77650752
DR   HipSci; HPSI0816i-fuuy_3
DR   hPSCreg; WTSIi658-A
DR   Wikidata; Q54891429
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-hizl_3
AC   CVCL_LM40
SY   WTSIi703-A
DR   BioSamples; SAMEA104132903
DR   HipSci; HPSI0816i-hizl_3
DR   hPSCreg; WTSIi703-A
DR   Wikidata; Q54891430
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM41 ! HPSI0816i-hizl_4
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-hizl_4
AC   CVCL_LM41
SY   WTSIi703-B; WTSIi716-A
DR   BioSamples; SAMEA104132415
DR   HipSci; HPSI0816i-hizl_4
DR   hPSCreg; WTSIi703-B
DR   Wikidata; Q54891431
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM40 ! HPSI0816i-hizl_3
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-keha_2
AC   CVCL_WJ72
DR   BioSamples; SAMEA104241750
DR   ECACC; 77650830
DR   HipSci; HPSI0816i-keha_2
DR   Wikidata; Q94233063
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ73 ! HPSI0816i-keha_5
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 9
//
ID   HPSI0816i-keha_5
AC   CVCL_WJ73
DR   BioSamples; SAMEA104241748
DR   ECACC; 77650831
DR   HipSci; HPSI0816i-keha_5
DR   Wikidata; Q94233067
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ72 ! HPSI0816i-keha_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-keit_1
AC   CVCL_WJ96
DR   BioSamples; SAMEA104011301
DR   ECACC; 77650806
DR   HipSci; HPSI0816i-keit_1
DR   Wikidata; Q94233070
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ97 ! HPSI0816i-keit_2
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-keit_2
AC   CVCL_WJ97
DR   BioSamples; SAMEA104011302
DR   ECACC; 77650807
DR   HipSci; HPSI0816i-keit_2
DR   Wikidata; Q94233072
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ96 ! HPSI0816i-keit_1
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-kije_1
AC   CVCL_WJ65
DR   BioSamples; SAMEA104009780
DR   ECACC; 77650839
DR   HipSci; HPSI0816i-kije_1
DR   Wikidata; Q94233077
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ66 ! HPSI0816i-kije_4
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-kije_4
AC   CVCL_WJ66
DR   BioSamples; SAMEA104009781
DR   ECACC; 77650840
DR   HipSci; HPSI0816i-kije_4
DR   Wikidata; Q94233082
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ65 ! HPSI0816i-kije_1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-neow_5
AC   CVCL_LF17
SY   WTSIi611-A
DR   BioSamples; SAMEA104011308
DR   ECACC; 77650705
DR   HipSci; HPSI0816i-neow_5
DR   hPSCreg; WTSIi611-A
DR   Wikidata; Q54891432
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF18 ! HPSI0816i-neow_7
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-neow_7
AC   CVCL_LF18
SY   WTSIi611-B; WTSIi631-A
DR   BioSamples; SAMEA104011453
DR   ECACC; 77650706
DR   HipSci; HPSI0816i-neow_7
DR   hPSCreg; WTSIi611-B
DR   Wikidata; Q54891433
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF17 ! HPSI0816i-neow_5
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-oemk_6
AC   CVCL_LL82
SY   WTSIi694-A
DR   BioSamples; SAMEA104012028
DR   ECACC; 77650764
DR   HipSci; HPSI0816i-oemk_6
DR   hPSCreg; WTSIi694-A
DR   Wikidata; Q54891434
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Moroccan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0816i-oexh_2
AC   CVCL_WJ74
DR   BioSamples; SAMEA104012018
DR   ECACC; 77650828
DR   HipSci; HPSI0816i-oexh_2
DR   Wikidata; Q94233112
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ75 ! HPSI0816i-oexh_5
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-oexh_5
AC   CVCL_WJ75
DR   BioSamples; SAMEA104012017
DR   ECACC; 77650829
DR   HipSci; HPSI0816i-oexh_5
DR   Wikidata; Q94233116
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ74 ! HPSI0816i-oexh_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-uixy_1
AC   CVCL_WJ77
DR   BioSamples; SAMEA104132474
DR   ECACC; 77650821
DR   HipSci; HPSI0816i-uixy_1
DR   Wikidata; Q94233120
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ78 ! HPSI0816i-uixy_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-uixy_2
AC   CVCL_WJ78
DR   BioSamples; SAMEA104132473
DR   ECACC; 77650822
DR   HipSci; HPSI0816i-uixy_2
DR   Wikidata; Q94233125
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ77 ! HPSI0816i-uixy_1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-uosa_6
AC   CVCL_WJ51
DR   BioSamples; SAMEA104276930
DR   ECACC; 77650854
DR   HipSci; HPSI0816i-uosa_6
DR   Wikidata; Q94233126
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Moroccan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   HPSI0816i-xoga_12
AC   CVCL_LL83
SY   WTSIi713-B; WTSIi728-A
DR   BioSamples; SAMEA104132636
DR   ECACC; 77650791
DR   HipSci; HPSI0816i-xoga_12
DR   hPSCreg; WTSIi713-B
DR   Wikidata; Q54891435
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL84 ! HPSI0816i-xoga_7
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0816i-xoga_7
AC   CVCL_LL84
SY   WTSIi713-A
DR   BioSamples; SAMEA104132637
DR   ECACC; 77650792
DR   HipSci; HPSI0816i-xoga_7
DR   hPSCreg; WTSIi713-A
DR   Wikidata; Q54891436
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL83 ! HPSI0816i-xoga_12
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0816i-youd_6
AC   CVCL_WJ98
DR   BioSamples; SAMEA104011448
DR   ECACC; 77650809
DR   HipSci; HPSI0816i-youd_6
DR   Wikidata; Q94233145
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ99 ! HPSI0816i-youd_8
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0816i-youd_8
AC   CVCL_WJ99
DR   BioSamples; SAMEA104011450
DR   ECACC; 77650810
DR   HipSci; HPSI0816i-youd_8
DR   Wikidata; Q94233147
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ98 ! HPSI0816i-youd_6
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI0913i-bulb_1
AC   CVCL_AH26
SY   WTSIi258-A
DR   BioSamples; SAMEA2501466
DR   ECACC; 77650216
DR   HipSci; HPSI0913i-bulb_1
DR   hPSCreg; WTSIi258-A
DR   Wikidata; Q54891437
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP78 ! HPSI0913i-bulb_2
OI   CVCL_JP79 ! HPSI0913i-bulb_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0913i-bulb_2
AC   CVCL_JP78
DR   BioSamples; SAMEA2501468
DR   HipSci; HPSI0913i-bulb_2
DR   Wikidata; Q54891438
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH26 ! HPSI0913i-bulb_1
OI   CVCL_JP79 ! HPSI0913i-bulb_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-bulb_3
AC   CVCL_JP79
DR   BioSamples; SAMEA2501465
DR   HipSci; HPSI0913i-bulb_3
DR   Wikidata; Q54891439
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH26 ! HPSI0913i-bulb_1
OI   CVCL_JP78 ! HPSI0913i-bulb_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-coyi_1
AC   CVCL_JP80
DR   BioSamples; SAMEA2398170
DR   HipSci; HPSI0913i-coyi_1
DR   Wikidata; Q54891440
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP81 ! HPSI0913i-coyi_2
OI   CVCL_AH27 ! HPSI0913i-coyi_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-coyi_2
AC   CVCL_JP81
DR   BioSamples; SAMEA2399106
DR   HipSci; HPSI0913i-coyi_2
DR   Wikidata; Q54891441
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP80 ! HPSI0913i-coyi_1
OI   CVCL_AH27 ! HPSI0913i-coyi_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-coyi_3
AC   CVCL_AH27
SY   WTSIi086-A
DR   BioSamples; SAMEA2397914
DR   ECACC; 77650102
DR   HipSci; HPSI0913i-coyi_3
DR   hPSCreg; WTSIi086-A
DR   SKIP; SKIP002704
DR   Wikidata; Q54891442
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP80 ! HPSI0913i-coyi_1
OI   CVCL_JP81 ! HPSI0913i-coyi_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-diku_1
AC   CVCL_AH28
SY   WTSIi009-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2593858
DR   EBiSC; WTSIi009-A
DR   ECACC; 66540079
DR   ECACC; 77650088
DR   EGA; EGAS00001002755
DR   HipSci; HPSI0913i-diku_1
DR   hPSCreg; WTSIi009-A
DR   SKIP; SKIP002522
DR   Wikidata; Q54891443
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540079; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP82 ! HPSI0913i-diku_2
OI   CVCL_JP83 ! HPSI0913i-diku_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0913i-diku_2
AC   CVCL_JP82
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2593857
DR   HipSci; HPSI0913i-diku_2
DR   Wikidata; Q54891444
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH28 ! HPSI0913i-diku_1
OI   CVCL_JP83 ! HPSI0913i-diku_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0913i-diku_3
AC   CVCL_JP83
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2593862
DR   HipSci; HPSI0913i-diku_3
DR   Wikidata; Q54891445
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH28 ! HPSI0913i-diku_1
OI   CVCL_JP82 ! HPSI0913i-diku_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0913i-duuy_1
AC   CVCL_AH29
DR   BioSamples; SAMEA2398084
DR   HipSci; HPSI0913i-duuy_1
DR   Wikidata; Q54891446
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-eika_1
AC   CVCL_JP84
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2590625
DR   HipSci; HPSI0913i-eika_1
DR   Wikidata; Q54891447
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH30 ! HPSI0913i-eika_2
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0913i-eika_2
AC   CVCL_AH30
SY   WTSIi002-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2590621
DR   EBiSC; WTSIi002-A
DR   ECACC; 66540072
DR   ECACC; 77650059
DR   HipSci; HPSI0913i-eika_2
DR   hPSCreg; WTSIi002-A
DR   SKIP; SKIP002515
DR   Wikidata; Q54891448
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540072; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP84 ! HPSI0913i-eika_1
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0913i-eorc_2
AC   CVCL_AH31
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3735540
DR   HipSci; HPSI0913i-eorc_2
DR   Wikidata; Q54891449
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH32 ! HPSI0913i-eorc_4
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-eorc_4
AC   CVCL_AH32
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3735538
DR   HipSci; HPSI0913i-eorc_4
DR   Wikidata; Q54891450
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH31 ! HPSI0913i-eorc_2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-ffdl_1
AC   CVCL_AH33
SY   WTSIi297-C; WTSIi361-A
DR   BioSamples; SAMEA2397979
DR   ECACC; 77650105
DR   HipSci; HPSI0913i-ffdl_1
DR   hPSCreg; WTSIi297-C
DR   Wikidata; Q54891451
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH03 ! HPSI0813i-fpdl_1
OI   CVCL_AH04 ! HPSI0813i-fpdl_2
OI   CVCL_WV05 ! HPSI0913i-ffdl_2
OI   CVCL_AH36 ! HPSI0913i-ffdz_2
OI   CVCL_AI15 ! HPSI1213i-foqj_1
OI   CVCL_AI16 ! HPSI1213i-foqj_2
OI   CVCL_JQ37 ! HPSI1213i-foqj_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-ffdl_2
AC   CVCL_WV05
DR   BioSamples; SAMEA2398880
DR   HipSci; HPSI0913i-ffdl_2
DR   Wikidata; Q94233289
RX   PubMed=30784590;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH03 ! HPSI0813i-fpdl_1
OI   CVCL_AH04 ! HPSI0813i-fpdl_2
OI   CVCL_AH33 ! HPSI0913i-ffdl_1
OI   CVCL_AH36 ! HPSI0913i-ffdz_2
OI   CVCL_AI15 ! HPSI1213i-foqj_1
OI   CVCL_AI16 ! HPSI1213i-foqj_2
OI   CVCL_JQ37 ! HPSI1213i-foqj_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   HPSI0913i-ffdp_3
AC   CVCL_AH34
DR   BioSamples; SAMEA2397794
DR   HipSci; HPSI0913i-ffdp_3
DR   Wikidata; Q54891453
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH35 ! HPSI0913i-ffdp_33
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0913i-ffdp_33
AC   CVCL_AH35
DR   BioSamples; SAMEA2397840
DR   HipSci; HPSI0913i-ffdp_33
DR   Wikidata; Q54891458
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH34 ! HPSI0913i-ffdp_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0913i-ffdz_2
AC   CVCL_AH36
DR   BioSamples; SAMEA2398073
DR   ECACC; 77650160
DR   HipSci; HPSI0913i-ffdz_2
DR   Wikidata; Q54891459
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650160; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH03 ! HPSI0813i-fpdl_1
OI   CVCL_AH04 ! HPSI0813i-fpdl_2
OI   CVCL_AH33 ! HPSI0913i-ffdl_1
OI   CVCL_WV05 ! HPSI0913i-ffdl_2
OI   CVCL_AI15 ! HPSI1213i-foqj_1
OI   CVCL_AI16 ! HPSI1213i-foqj_2
OI   CVCL_JQ37 ! HPSI1213i-foqj_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   HPSI0913i-gedo_3
AC   CVCL_AH37
SY   WTSIi113-A
DR   BioSamples; SAMEA2398496
DR   ECACC; 77650006
DR   HipSci; HPSI0913i-gedo_3
DR   hPSCreg; WTSIi113-A
DR   SKIP; SKIP002735
DR   Wikidata; Q54891460
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650006; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH38 ! HPSI0913i-gedo_33
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI0913i-gedo_33
AC   CVCL_AH38
SY   WTSIi113-B
DR   BioSamples; SAMEA2398982
DR   ECACC; 77650167
DR   HipSci; HPSI0913i-gedo_33
DR   hPSCreg; WTSIi113-B
DR   SKIP; SKIP002766
DR   Wikidata; Q54891461
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650167; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH37 ! HPSI0913i-gedo_3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI0913i-gooj_1
AC   CVCL_AH39
SY   WTSIi035-A
DR   BioSamples; SAMEA2398905
DR   EBiSC; WTSIi035-A
DR   ECACC; 66540105
DR   ECACC; 77650263
DR   HipSci; HPSI0913i-gooj_1
DR   hPSCreg; WTSIi035-A
DR   SKIP; SKIP002580
DR   Wikidata; Q54891462
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540105; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0913i-iuqb_1
AC   CVCL_AH40
SY   WTSIi136-A
DR   BioSamples; SAMEA2399071
DR   EBiSC; WTSIi136-A
DR   ECACC; 66540243
DR   ECACC; 77650186
DR   HipSci; HPSI0913i-iuqb_1
DR   hPSCreg; WTSIi136-A
DR   SKIP; SKIP002768
DR   Wikidata; Q54891463
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540243; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP85 ! HPSI0913i-iuqb_2
OI   CVCL_JP86 ! HPSI0913i-iuqb_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0913i-iuqb_2
AC   CVCL_JP85
DR   BioSamples; SAMEA2398909
DR   HipSci; HPSI0913i-iuqb_2
DR   Wikidata; Q54891464
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH40 ! HPSI0913i-iuqb_1
OI   CVCL_JP86 ! HPSI0913i-iuqb_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-iuqb_3
AC   CVCL_JP86
DR   BioSamples; SAMEA2398160
DR   HipSci; HPSI0913i-iuqb_3
DR   Wikidata; Q54891465
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH40 ! HPSI0913i-iuqb_1
OI   CVCL_JP85 ! HPSI0913i-iuqb_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-kojv_2
AC   CVCL_AH41
SY   WTSIi034-A
DR   BioSamples; SAMEA2397798
DR   EBiSC; WTSIi034-A
DR   ECACC; 66540104
DR   ECACC; 77650265
DR   HipSci; HPSI0913i-kojv_2
DR   hPSCreg; WTSIi034-A
DR   SKIP; SKIP002579
DR   Wikidata; Q54891466
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540104; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0913i-laia_4
AC   CVCL_AH42
SY   WTSIi149-A
DR   BioSamples; SAMEA3356002
DR   EBiSC; WTSIi149-A
DR   ECACC; 66540303
DR   ECACC; 77650283
DR   HipSci; HPSI0913i-laia_4
DR   hPSCreg; WTSIi149-A
DR   SKIP; SKIP002802
DR   Wikidata; Q54891467
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Afghan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540303; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0913i-lise_1
AC   CVCL_AH43
SY   WTSIi071-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2625592
DR   EBiSC; WTSIi071-A
DR   ECACC; 66540183
DR   ECACC; 77650064
DR   HipSci; HPSI0913i-lise_1
DR   hPSCreg; WTSIi071-A
DR   SKIP; SKIP002660
DR   Wikidata; Q54891468
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540183; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP87 ! HPSI0913i-lise_2
OI   CVCL_AH44 ! HPSI0913i-lise_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0913i-lise_2
AC   CVCL_JP87
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2625598
DR   HipSci; HPSI0913i-lise_2
DR   Wikidata; Q54891469
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH43 ! HPSI0913i-lise_1
OI   CVCL_AH44 ! HPSI0913i-lise_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0913i-lise_3
AC   CVCL_AH44
SY   WTSIi071-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2625589
DR   EBiSC; WTSIi071-B
DR   ECACC; 66540193
DR   ECACC; 77650086
DR   HipSci; HPSI0913i-lise_3
DR   hPSCreg; WTSIi071-B
DR   SKIP; SKIP002696
DR   Wikidata; Q54891470
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540193; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH43 ! HPSI0913i-lise_1
OI   CVCL_JP87 ! HPSI0913i-lise_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0913i-lofv_3
AC   CVCL_AH45
SY   WTSIi241-A
DR   BioSamples; SAMEA2399275
DR   HipSci; HPSI0913i-lofv_3
DR   hPSCreg; WTSIi241-A
DR   Wikidata; Q54891471
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH46 ! HPSI0913i-lofv_33
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-lofv_33
AC   CVCL_AH46
SY   WTSIi241-B; WTSIi667-A
DR   BioSamples; SAMEA2201449
DR   HipSci; HPSI0913i-lofv_33
DR   hPSCreg; WTSIi241-B
DR   Wikidata; Q54891472
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH45 ! HPSI0913i-lofv_3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 12
//
ID   HPSI0913i-oapg_4
AC   CVCL_JP88
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547894
DR   HipSci; HPSI0913i-oapg_4
DR   Wikidata; Q54891473
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH47 ! HPSI0913i-oapg_5
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0913i-oapg_5
AC   CVCL_AH47
SY   WTSIi027-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547899
DR   EBiSC; WTSIi027-A
DR   ECACC; 66540097
DR   ECACC; 77650038
DR   HipSci; HPSI0913i-oapg_5
DR   hPSCreg; WTSIi027-A
DR   SKIP; SKIP002557
DR   Wikidata; Q54891474
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540097; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP88 ! HPSI0913i-oapg_4
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI0913i-qiea_1
AC   CVCL_JP89
DR   BioSamples; SAMEA2398065
DR   HipSci; HPSI0913i-qiea_1
DR   Wikidata; Q54891475
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH48 ! HPSI0913i-qiea_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI0913i-qiea_2
AC   CVCL_AH48
DR   BioSamples; SAMEA2398202
DR   HipSci; HPSI0913i-qiea_2
DR   Wikidata; Q54891476
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP89 ! HPSI0913i-qiea_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-rufg_3
AC   CVCL_EF33
SY   WTSIi403-B; WTSIi432-A
DR   BioSamples; SAMEA3974565
DR   ECACC; 77650393
DR   HipSci; HPSI0913i-rufg_3
DR   hPSCreg; WTSIi403-B
DR   Wikidata; Q54891477
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF34 ! HPSI0913i-rufg_4
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0913i-rufg_4
AC   CVCL_EF34
SY   WTSIi403-A
DR   BioSamples; SAMEA3974569
DR   ECACC; 77650362
DR   HipSci; HPSI0913i-rufg_4
DR   hPSCreg; WTSIi403-A
DR   Wikidata; Q54891478
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF33 ! HPSI0913i-rufg_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI0913i-ruql_1
AC   CVCL_JP90
DR   BioSamples; SAMEA2518329
DR   HipSci; HPSI0913i-ruql_1
DR   Wikidata; Q54891479
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP91 ! HPSI0913i-ruql_2
OI   CVCL_AH49 ! HPSI0913i-ruql_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-ruql_2
AC   CVCL_JP91
DR   BioSamples; SAMEA2518323
DR   HipSci; HPSI0913i-ruql_2
DR   Wikidata; Q54891480
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP90 ! HPSI0913i-ruql_1
OI   CVCL_AH49 ! HPSI0913i-ruql_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-ruql_3
AC   CVCL_AH49
SY   WTSIi088-A
DR   BioSamples; SAMEA2518336
DR   EBiSC; WTSIi088-A
DR   ECACC; 66540203
DR   ECACC; 77650114
DR   HipSci; HPSI0913i-ruql_3
DR   hPSCreg; WTSIi088-A
DR   SKIP; SKIP002706
DR   Wikidata; Q54891482
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540203; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP90 ! HPSI0913i-ruql_1
OI   CVCL_JP91 ! HPSI0913i-ruql_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0913i-tozk_1
AC   CVCL_AH50
DR   BioSamples; SAMEA2399012
DR   HipSci; HPSI0913i-tozk_1
DR   Wikidata; Q54891483
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP92 ! HPSI0913i-tozk_2
OI   CVCL_AH51 ! HPSI0913i-tozk_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-tozk_2
AC   CVCL_JP92
DR   BioSamples; SAMEA2398176
DR   HipSci; HPSI0913i-tozk_2
DR   Wikidata; Q54891484
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH50 ! HPSI0913i-tozk_1
OI   CVCL_AH51 ! HPSI0913i-tozk_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI0913i-tozk_3
AC   CVCL_AH51
DR   BioSamples; SAMEA2398793
DR   HipSci; HPSI0913i-tozk_3
DR   Wikidata; Q54891485
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH50 ! HPSI0913i-tozk_1
OI   CVCL_JP92 ! HPSI0913i-tozk_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-vopm_1
AC   CVCL_JP93
DR   BioSamples; SAMEA2398490
DR   HipSci; HPSI0913i-vopm_1
DR   Wikidata; Q54891486
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH52 ! HPSI0913i-vopm_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI0913i-vopm_2
AC   CVCL_AH52
SY   WTSIi126-A
DR   BioSamples; SAMEA2399121
DR   ECACC; 77650020
DR   HipSci; HPSI0913i-vopm_2
DR   hPSCreg; WTSIi126-A
DR   SKIP; SKIP002751
DR   Wikidata; Q54891487
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP93 ! HPSI0913i-vopm_1
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0913i-xomm_1
AC   CVCL_JP94
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2399226
DR   HipSci; HPSI0913i-xomm_1
DR   Wikidata; Q54891488
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH53 ! HPSI0913i-xomm_2
OI   CVCL_AH54 ! HPSI0913i-xomm_3
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0913i-xomm_2
AC   CVCL_AH53
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2397900
DR   HipSci; HPSI0913i-xomm_2
DR   Wikidata; Q54891489
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP94 ! HPSI0913i-xomm_1
OI   CVCL_AH54 ! HPSI0913i-xomm_3
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0913i-xomm_3
AC   CVCL_AH54
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398954
DR   HipSci; HPSI0913i-xomm_3
DR   Wikidata; Q54891490
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP94 ! HPSI0913i-xomm_1
OI   CVCL_AH53 ! HPSI0913i-xomm_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-euts_1
AC   CVCL_JP95
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3735543
DR   HipSci; HPSI0914i-euts_1
DR   Wikidata; Q54891491
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH55 ! HPSI0914i-euts_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0914i-euts_3
AC   CVCL_AH55
SY   WTSIi218-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3755280
DR   ECACC; 77650612
DR   HipSci; HPSI0914i-euts_3
DR   hPSCreg; WTSIi218-A
DR   Wikidata; Q54891492
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP95 ! HPSI0914i-euts_1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-fuhz_1
AC   CVCL_AH56
SY   WTSIi158-A
DR   BioSamples; SAMEA3313418
DR   EBiSC; WTSIi158-A
DR   ECACC; 66540312
DR   ECACC; 77650276
DR   HipSci; HPSI0914i-fuhz_1
DR   hPSCreg; WTSIi158-A
DR   SKIP; SKIP002810
DR   Wikidata; Q54891493
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540312; true.
CC   Discontinued: ECACC; 77650276; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   HPSI0914i-gine_2
AC   CVCL_EF35
SY   WTSIi349-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3847979
DR   ECACC; 77650387
DR   HipSci; HPSI0914i-gine_2
DR   hPSCreg; WTSIi349-A
DR   Wikidata; Q54891494
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-hidy_3
AC   CVCL_AK07
SY   WTSIi407-B; WTSIi418-A
DR   BioSamples; SAMEA3374095
DR   ECACC; 77650286
DR   HipSci; HPSI0914i-hidy_3
DR   hPSCreg; WTSIi407-B
DR   Wikidata; Q54891496
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK08 ! HPSI0914i-hidy_4
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-hidy_4
AC   CVCL_AK08
SY   WTSIi407-A
DR   BioSamples; SAMEA3381721
DR   ECACC; 77650287
DR   HipSci; HPSI0914i-hidy_4
DR   hPSCreg; WTSIi407-A
DR   Wikidata; Q54891497
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK07 ! HPSI0914i-hidy_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-iezw_2
AC   CVCL_EF36
SY   WTSIi368-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962530
DR   ECACC; 77650404
DR   HipSci; HPSI0914i-iezw_2
DR   hPSCreg; WTSIi368-A
DR   Wikidata; Q54891498
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-jejf_2
AC   CVCL_AK14
SY   WTSIi254-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854309
DR   ECACC; 77650570
DR   HipSci; HPSI0914i-jejf_2
DR   hPSCreg; WTSIi254-A
DR   Wikidata; Q54891499
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK15 ! HPSI0914i-jejf_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-jejf_3
AC   CVCL_AK15
SY   WTSIi254-B; WTSIi330-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962529
DR   ECACC; 77650572
DR   HipSci; HPSI0914i-jejf_3
DR   hPSCreg; WTSIi254-B
DR   Wikidata; Q54891504
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK14 ! HPSI0914i-jejf_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-kajh_2
AC   CVCL_EE69
SY   WTSIi190-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853122
DR   EBiSC; WTSIi190-B
DR   ECACC; 66540416
DR   ECACC; 77650324
DR   HipSci; HPSI0914i-kajh_2
DR   hPSCreg; WTSIi190-B
DR   SKIP; SKIP002888
DR   Wikidata; Q54891505
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540416; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE70 ! HPSI0914i-kajh_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0914i-kajh_3
AC   CVCL_EE70
SY   WTSIi190-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854215
DR   EBiSC; WTSIi190-A
DR   ECACC; 66540415
DR   ECACC; 77650325
DR   HipSci; HPSI0914i-kajh_3
DR   hPSCreg; WTSIi190-A
DR   SKIP; SKIP002886
DR   Wikidata; Q54891506
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540415; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE69 ! HPSI0914i-kajh_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0914i-laey_4
AC   CVCL_EE46
SY   WTSIi172-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853157
DR   EBiSC; WTSIi172-B
DR   ECACC; 66540343
DR   ECACC; 77650293
DR   HipSci; HPSI0914i-laey_4
DR   hPSCreg; WTSIi172-B
DR   SKIP; SKIP002852
DR   Wikidata; Q54891507
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540343; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE47 ! HPSI0914i-laey_6
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0914i-laey_6
AC   CVCL_EE47
SY   WTSIi172-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853161
DR   EBiSC; WTSIi172-A
DR   ECACC; 66540342
DR   ECACC; 77650294
DR   HipSci; HPSI0914i-laey_6
DR   hPSCreg; WTSIi172-A
DR   SKIP; SKIP002839
DR   Wikidata; Q54891508
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540342; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE46 ! HPSI0914i-laey_4
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0914i-lopq_1
AC   CVCL_AH57
SY   WTSIi162-A
DR   BioSamples; SAMEA3355534
DR   EBiSC; WTSIi162-A
DR   ECACC; 66540316
DR   ECACC; 77650285
DR   HipSci; HPSI0914i-lopq_1
DR   hPSCreg; WTSIi162-A
DR   SKIP; SKIP002814
DR   Wikidata; Q54891509
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540316; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI0914i-ouvb_2
AC   CVCL_EF37
SY   WTSIi353-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3968781
DR   ECACC; 77650379
DR   HipSci; HPSI0914i-ouvb_2
DR   hPSCreg; WTSIi353-A
DR   Wikidata; Q54891510
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-qehq_3
AC   CVCL_AK09
SY   WTSIi303-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3967411
DR   ECACC; 77650576
DR   HipSci; HPSI0914i-qehq_3
DR   hPSCreg; WTSIi303-A
DR   Wikidata; Q54891511
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK10 ! HPSI0914i-qehq_7
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-qehq_7
AC   CVCL_AK10
SY   WTSIi303-B; WTSIi331-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3968755
DR   ECACC; 77650584
DR   HipSci; HPSI0914i-qehq_7
DR   hPSCreg; WTSIi303-B
DR   Wikidata; Q54891512
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK09 ! HPSI0914i-qehq_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-rejf_2
AC   CVCL_IZ20
SY   WTSIi411-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962628
DR   ECACC; 77650439
DR   HipSci; HPSI0914i-rejf_2
DR   hPSCreg; WTSIi411-A
DR   Wikidata; Q54891513
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0914i-suop_2
AC   CVCL_EF38
SY   WTSIi238-B; WTSIi242-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4343049
DR   ECACC; 77650374
DR   HipSci; HPSI0914i-suop_2
DR   hPSCreg; WTSIi238-B
DR   PRIDE; PXD005506
DR   Wikidata; Q54891514
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF39 ! HPSI0914i-suop_5
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-suop_5
AC   CVCL_EF39
SY   WTSIi238-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4343052
DR   ECACC; 77650391
DR   HipSci; HPSI0914i-suop_5
DR   hPSCreg; WTSIi238-A
DR   PRIDE; PXD005506
DR   Wikidata; Q54891515
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF38 ! HPSI0914i-suop_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-tifo_1
AC   CVCL_EF40
SY   WTSIi420-B; WTSIi427-A
DR   BioSamples; SAMEA3847028
DR   ECACC; 77650433
DR   HipSci; HPSI0914i-tifo_1
DR   hPSCreg; WTSIi420-B
DR   Wikidata; Q54891516
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF41 ! HPSI0914i-tifo_2
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0914i-tifo_2
AC   CVCL_EF41
SY   WTSIi420-A
DR   BioSamples; SAMEA3847027
DR   ECACC; 77650375
DR   HipSci; HPSI0914i-tifo_2
DR   hPSCreg; WTSIi420-A
DR   Wikidata; Q54891517
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF40 ! HPSI0914i-tifo_1
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   HPSI0914i-vaka_5
AC   CVCL_IZ21
SY   WTSIi394-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853165
DR   ECACC; 77650447
DR   HipSci; HPSI0914i-vaka_5
DR   hPSCreg; WTSIi394-A
DR   Wikidata; Q54891519
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   HPSI0914i-verf_1
AC   CVCL_AH58
SY   WTSIi160-A
DR   BioSamples; SAMEA3340804
DR   EBiSC; WTSIi160-A
DR   ECACC; 66540314
DR   ECACC; 77650280
DR   HipSci; HPSI0914i-verf_1
DR   hPSCreg; WTSIi160-A
DR   SKIP; SKIP002812
DR   Wikidata; Q54891520
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540314; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI0914i-yuvg_2
AC   CVCL_LL85
SY   WTSIi626-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104009796
DR   ECACC; 77650732
DR   HipSci; HPSI0914i-yuvg_2
DR   hPSCreg; WTSIi626-A
DR   Wikidata; Q54891521
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI0914i-zerv_7
AC   CVCL_EE44
SY   WTSIi171-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4089453
DR   EBiSC; WTSIi171-A
DR   ECACC; 66540340
DR   ECACC; 77650326
DR   HipSci; HPSI0914i-zerv_7
DR   hPSCreg; WTSIi171-A
DR   SKIP; SKIP002837
DR   Wikidata; Q54891522
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540340; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE45 ! HPSI0914i-zerv_8
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0914i-zerv_8
AC   CVCL_EE45
SY   WTSIi171-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4089454
DR   EBiSC; WTSIi171-B
DR   ECACC; 66540341
DR   ECACC; 77650327
DR   HipSci; HPSI0914i-zerv_8
DR   hPSCreg; WTSIi171-B
DR   SKIP; SKIP002838
DR   Wikidata; Q54891523
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540341; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE44 ! HPSI0914i-zerv_7
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI0916i-helh_1
AC   CVCL_LM42
SY   WTSIi717-B; WTSIi719-A
DR   BioSamples; SAMEA104012323
DR   ECACC; 77650737
DR   HipSci; HPSI0916i-helh_1
DR   hPSCreg; WTSIi717-B
DR   Wikidata; Q54891524
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caribbean.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM43 ! HPSI0916i-helh_6
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-helh_6
AC   CVCL_LM43
SY   WTSIi717-A
DR   BioSamples; SAMEA104012320
DR   ECACC; 77650738
DR   HipSci; HPSI0916i-helh_6
DR   hPSCreg; WTSIi717-A
DR   Wikidata; Q54891525
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caribbean.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM42 ! HPSI0916i-helh_1
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-hikt_1
AC   CVCL_LM44
SY   WTSIi699-B; WTSIi724-A
DR   BioSamples; SAMEA104008491
DR   ECACC; 77650692
DR   HipSci; HPSI0916i-hikt_1
DR   hPSCreg; WTSIi699-B
DR   Wikidata; Q54891526
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM45 ! HPSI0916i-hikt_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-hikt_2
AC   CVCL_LM45
SY   WTSIi699-A
DR   BioSamples; SAMEA104008492
DR   ECACC; 77650693
DR   HipSci; HPSI0916i-hikt_2
DR   hPSCreg; WTSIi699-A
DR   Wikidata; Q54891527
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM44 ! HPSI0916i-hikt_1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-jejm_4
AC   CVCL_LM46
SY   WTSIi720-A
DR   BioSamples; SAMEA103887294
DR   ECACC; 77650698
DR   HipSci; HPSI0916i-jejm_4
DR   hPSCreg; WTSIi720-A
DR   Wikidata; Q54891528
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-moyn_1
AC   CVCL_LM47
SY   WTSIi657-B; WTSIi711-A
DR   BioSamples; SAMEA104130575
DR   ECACC; 77650761
DR   HipSci; HPSI0916i-moyn_1
DR   hPSCreg; WTSIi657-B
DR   Wikidata; Q54891529
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM48 ! HPSI0916i-moyn_4
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-moyn_4
AC   CVCL_LM48
SY   WTSIi657-A
DR   BioSamples; SAMEA104130574
DR   ECACC; 77650762
DR   HipSci; HPSI0916i-moyn_4
DR   hPSCreg; WTSIi657-A
DR   Wikidata; Q54891530
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM47 ! HPSI0916i-moyn_1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-vajy_4
AC   CVCL_LM49
SY   WTSIi687-B; WTSIi714-A
DR   BioSamples; SAMEA104012543
DR   ECACC; 77650774
DR   HipSci; HPSI0916i-vajy_4
DR   hPSCreg; WTSIi687-B
DR   Wikidata; Q54891531
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM50 ! HPSI0916i-vajy_5
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-vajy_5
AC   CVCL_LM50
SY   WTSIi687-A
DR   BioSamples; SAMEA104012545
DR   ECACC; 77650775
DR   HipSci; HPSI0916i-vajy_5
DR   hPSCreg; WTSIi687-A
DR   Wikidata; Q54891532
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM49 ! HPSI0916i-vajy_4
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-vorn_2
AC   CVCL_LM51
SY   WTSIi621-B; WTSIi650-A
DR   BioSamples; SAMEA104012394
DR   ECACC; 77650739
DR   HipSci; HPSI0916i-vorn_2
DR   hPSCreg; WTSIi621-B
DR   Wikidata; Q54891533
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM52 ! HPSI0916i-vorn_5
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-vorn_5
AC   CVCL_LM52
SY   WTSIi621-A
DR   BioSamples; SAMEA104012397
DR   ECACC; 77650740
DR   HipSci; HPSI0916i-vorn_5
DR   hPSCreg; WTSIi621-A
DR   Wikidata; Q54891534
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM51 ! HPSI0916i-vorn_2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-zaue_2
AC   CVCL_WJ76
DR   BioSamples; SAMEA104134261
DR   ECACC; 77650825
DR   HipSci; HPSI0916i-zaue_2
DR   Wikidata; Q94234210
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   HPSI0916i-zipi_1
AC   CVCL_LM53
SY   WTSIi638-A
DR   BioSamples; SAMEA103997877
DR   ECACC; 77650725
DR   HipSci; HPSI0916i-zipi_1
DR   hPSCreg; WTSIi638-A
DR   Wikidata; Q54891535
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM54 ! HPSI0916i-zipi_5
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI0916i-zipi_5
AC   CVCL_LM54
SY   WTSIi638-B; WTSIi649-A
DR   BioSamples; SAMEA103997878
DR   ECACC; 77650726
DR   HipSci; HPSI0916i-zipi_5
DR   hPSCreg; WTSIi638-B
DR   Wikidata; Q54891536
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140268; Hereditary cerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM53 ! HPSI0916i-zipi_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI1013i-aetc_1
AC   CVCL_AH59
SY   WTSIi033-A
DR   BioSamples; SAMEA2398632
DR   EBiSC; WTSIi033-A
DR   ECACC; 66540103
DR   ECACC; 77650261
DR   HipSci; HPSI1013i-aetc_1
DR   hPSCreg; WTSIi033-A
DR   SKIP; SKIP002578
DR   Wikidata; Q54891537
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540103; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-cups_1
AC   CVCL_JP96
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2498699
DR   HipSci; HPSI1013i-cups_1
DR   Wikidata; Q54891539
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP97 ! HPSI1013i-cups_2
OI   CVCL_AH60 ! HPSI1013i-cups_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-cups_2
AC   CVCL_JP97
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2498701
DR   HipSci; HPSI1013i-cups_2
DR   Wikidata; Q54891540
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP96 ! HPSI1013i-cups_1
OI   CVCL_AH60 ! HPSI1013i-cups_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-cups_3
AC   CVCL_AH60
SY   WTSIi082-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2498700
DR   ECACC; 77650031
DR   HipSci; HPSI1013i-cups_3
DR   hPSCreg; WTSIi082-A
DR   SKIP; SKIP002700
DR   Wikidata; Q54891541
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP96 ! HPSI1013i-cups_1
OI   CVCL_JP97 ! HPSI1013i-cups_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1013i-funy_1
AC   CVCL_AH61
SY   WTSIi167-A
DR   BioSamples; SAMEA2398081
DR   EBiSC; WTSIi167-A
DR   ECACC; 66540321
DR   ECACC; 77650262
DR   HipSci; HPSI1013i-funy_1
DR   hPSCreg; WTSIi167-A
DR   SKIP; SKIP002819
DR   Wikidata; Q54891542
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540321; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH62 ! HPSI1013i-funy_3
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1013i-funy_3
AC   CVCL_AH62
DR   BioSamples; SAMEA2399004
DR   HipSci; HPSI1013i-funy_3
DR   Wikidata; Q54891543
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH61 ! HPSI1013i-funy_1
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   HPSI1013i-garx_1
AC   CVCL_JP98
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398188
DR   HipSci; HPSI1013i-garx_1
DR   Wikidata; Q54891544
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH63 ! HPSI1013i-garx_2
OI   CVCL_JP99 ! HPSI1013i-garx_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-garx_2
AC   CVCL_AH63
SY   WTSIi029-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398552
DR   EBiSC; WTSIi029-A
DR   ECACC; 66540099
DR   ECACC; 77650138
DR   HipSci; HPSI1013i-garx_2
DR   hPSCreg; WTSIi029-A
DR   SKIP; SKIP002559
DR   Wikidata; Q54891545
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540099; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP98 ! HPSI1013i-garx_1
OI   CVCL_JP99 ! HPSI1013i-garx_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-garx_3
AC   CVCL_JP99
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398004
DR   HipSci; HPSI1013i-garx_3
DR   Wikidata; Q54891551
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JP98 ! HPSI1013i-garx_1
OI   CVCL_AH63 ! HPSI1013i-garx_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-hiaf_1
AC   CVCL_AH64
SY   WTSIi079-B; WTSIi395-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2609968
DR   ECACC; 77650594
DR   HipSci; HPSI1013i-hiaf_1
DR   hPSCreg; WTSIi079-B
DR   Wikidata; Q54891552
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH65 ! HPSI1013i-hiaf_2
OI   CVCL_JQ00 ! HPSI1013i-hiaf_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1013i-hiaf_2
AC   CVCL_AH65
SY   WTSIi079-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2609971
DR   EBiSC; WTSIi079-A
DR   ECACC; 66540194
DR   ECACC; 77650040
DR   HipSci; HPSI1013i-hiaf_2
DR   hPSCreg; WTSIi079-A
DR   SKIP; SKIP002697
DR   Wikidata; Q54891553
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540194; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH64 ! HPSI1013i-hiaf_1
OI   CVCL_JQ00 ! HPSI1013i-hiaf_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-hiaf_3
AC   CVCL_JQ00
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2609963
DR   HipSci; HPSI1013i-hiaf_3
DR   Wikidata; Q54891554
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH64 ! HPSI1013i-hiaf_1
OI   CVCL_AH65 ! HPSI1013i-hiaf_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-jogf_1
AC   CVCL_AH66
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2397990
DR   HipSci; HPSI1013i-jogf_1
DR   Wikidata; Q54891555
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH67 ! HPSI1013i-jogf_2
OI   CVCL_JQ01 ! HPSI1013i-jogf_3
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1013i-jogf_2
AC   CVCL_AH67
SY   WTSIi373-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398028
DR   ECACC; 77650142
DR   HipSci; HPSI1013i-jogf_2
DR   hPSCreg; WTSIi373-A
DR   Wikidata; Q54891556
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH66 ! HPSI1013i-jogf_1
OI   CVCL_JQ01 ! HPSI1013i-jogf_3
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1013i-jogf_3
AC   CVCL_JQ01
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398737
DR   HipSci; HPSI1013i-jogf_3
DR   Wikidata; Q54891557
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH66 ! HPSI1013i-jogf_1
OI   CVCL_AH67 ! HPSI1013i-jogf_2
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-jufd_1
AC   CVCL_JQ02
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2399465
DR   HipSci; HPSI1013i-jufd_1
DR   Wikidata; Q54891558
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH68 ! HPSI1013i-jufd_2
OI   CVCL_AH69 ! HPSI1013i-jufd_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-jufd_2
AC   CVCL_AH68
SY   WTSIi042-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2399463
DR   EBiSC; WTSIi042-A
DR   ECACC; 66540038
DR   ECACC; 77650154
DR   HipSci; HPSI1013i-jufd_2
DR   hPSCreg; WTSIi042-A
DR   SKIP; SKIP002601
DR   Wikidata; Q54891559
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540038; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ02 ! HPSI1013i-jufd_1
OI   CVCL_AH69 ! HPSI1013i-jufd_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-jufd_3
AC   CVCL_AH69
SY   WTSIi042-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2399461
DR   EBiSC; WTSIi042-B
DR   ECACC; 66540182
DR   ECACC; 77650091
DR   HipSci; HPSI1013i-jufd_3
DR   hPSCreg; WTSIi042-B
DR   SKIP; SKIP002688
DR   Wikidata; Q54891560
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540182; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ02 ! HPSI1013i-jufd_1
OI   CVCL_AH68 ! HPSI1013i-jufd_2
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-kuxp_1
AC   CVCL_AH70
SY   WTSIi008-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547622
DR   EBiSC; WTSIi008-A
DR   ECACC; 66540078
DR   ECACC; 77650039
DR   HipSci; HPSI1013i-kuxp_1
DR   hPSCreg; WTSIi008-A
DR   SKIP; SKIP002521
DR   Wikidata; Q54891561
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540078; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-mijn_2
AC   CVCL_AH71
SY   WTSIi147-A
DR   BioSamples; SAMEA2398395
DR   EBiSC; WTSIi147-A
DR   ECACC; 66540301
DR   ECACC; 77650266
DR   HipSci; HPSI1013i-mijn_2
DR   hPSCreg; WTSIi147-A
DR   SKIP; SKIP002800
DR   Wikidata; Q54891562
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540301; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1013i-pamv_1
AC   CVCL_AH72
SY   WTSIi025-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2474458
DR   EBiSC; WTSIi025-A
DR   ECACC; 66540095
DR   ECACC; 77650051
DR   HipSci; HPSI1013i-pamv_1
DR   hPSCreg; WTSIi025-A
DR   SKIP; SKIP002555
DR   Wikidata; Q54891563
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540095; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ03 ! HPSI1013i-pamv_2
OI   CVCL_AH73 ! HPSI1013i-pamv_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-pamv_2
AC   CVCL_JQ03
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2474451
DR   HipSci; HPSI1013i-pamv_2
DR   Wikidata; Q54891564
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH72 ! HPSI1013i-pamv_1
OI   CVCL_AH73 ! HPSI1013i-pamv_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-pamv_3
AC   CVCL_AH73
SY   WTSIi025-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2474454
DR   EBiSC; WTSIi025-B
DR   ECACC; 66540116
DR   ECACC; 77650037
DR   HipSci; HPSI1013i-pamv_3
DR   hPSCreg; WTSIi025-B
DR   SKIP; SKIP002610
DR   Wikidata; Q54891565
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540116; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH72 ! HPSI1013i-pamv_1
OI   CVCL_JQ03 ! HPSI1013i-pamv_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-sebz_1
AC   CVCL_AH74
SY   WTSIi080-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2420640
DR   EBiSC; WTSIi080-A
DR   ECACC; 66540195
DR   ECACC; 77650045
DR   HipSci; HPSI1013i-sebz_1
DR   hPSCreg; WTSIi080-A
DR   SKIP; SKIP002698
DR   Wikidata; Q54891566
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540195; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ04 ! HPSI1013i-sebz_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-sebz_3
AC   CVCL_JQ04
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2420636
DR   HipSci; HPSI1013i-sebz_3
DR   Wikidata; Q54891567
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH74 ! HPSI1013i-sebz_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-sita_1
AC   CVCL_EE66
SY   WTSIi187-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3848359
DR   EBiSC; WTSIi187-A
DR   ECACC; 66540412
DR   ECACC; 77650331
DR   HipSci; HPSI1013i-sita_1
DR   hPSCreg; WTSIi187-A
DR   SKIP; SKIP002883
DR   Wikidata; Q54891568
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540412; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-woci_1
AC   CVCL_AH75
SY   WTSIi468-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2399090
DR   ECACC; 77650620
DR   HipSci; HPSI1013i-woci_1
DR   hPSCreg; WTSIi468-A
DR   Wikidata; Q54891569
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH76 ! HPSI1013i-woci_2
OI   CVCL_JQ05 ! HPSI1013i-woci_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1013i-woci_2
AC   CVCL_AH76
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2399043
DR   HipSci; HPSI1013i-woci_2
DR   Wikidata; Q54891570
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH75 ! HPSI1013i-woci_1
OI   CVCL_JQ05 ! HPSI1013i-woci_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1013i-woci_3
AC   CVCL_JQ05
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398983
DR   HipSci; HPSI1013i-woci_3
DR   Wikidata; Q54891571
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH75 ! HPSI1013i-woci_1
OI   CVCL_AH76 ! HPSI1013i-woci_2
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1013i-wopl_1
AC   CVCL_AH77
SY   WTSIi039-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2398080
DR   EBiSC; WTSIi039-A
DR   ECACC; 66540035
DR   ECACC; 77650140
DR   HipSci; HPSI1013i-wopl_1
DR   hPSCreg; WTSIi039-A
DR   SKIP; SKIP002598
DR   Wikidata; Q54891572
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540035; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ06 ! HPSI1013i-wopl_2
OI   CVCL_JQ07 ! HPSI1013i-wopl_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-wopl_2
AC   CVCL_JQ06
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2397823
DR   HipSci; HPSI1013i-wopl_2
DR   Wikidata; Q54891573
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH77 ! HPSI1013i-wopl_1
OI   CVCL_JQ07 ! HPSI1013i-wopl_3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-wopl_3
AC   CVCL_JQ07
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2397890
DR   HipSci; HPSI1013i-wopl_3
DR   Wikidata; Q54891574
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH77 ! HPSI1013i-wopl_1
OI   CVCL_JQ06 ! HPSI1013i-wopl_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-wuye_1
AC   CVCL_JQ08
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518326
DR   HipSci; HPSI1013i-wuye_1
DR   Wikidata; Q54891575
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH78 ! HPSI1013i-wuye_2
OI   CVCL_AH79 ! HPSI1013i-wuye_3
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-wuye_2
AC   CVCL_AH78
SY   WTSIi021-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518332
DR   EBiSC; WTSIi021-A
DR   ECACC; 66540091
DR   ECACC; 77650073
DR   HipSci; HPSI1013i-wuye_2
DR   hPSCreg; WTSIi021-A
DR   SKIP; SKIP002551
DR   Wikidata; Q54891576
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540091; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ08 ! HPSI1013i-wuye_1
OI   CVCL_AH79 ! HPSI1013i-wuye_3
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-wuye_3
AC   CVCL_AH79
SY   WTSIi021-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518334
DR   EBiSC; WTSIi021-B
DR   ECACC; 66540114
DR   ECACC; 77650131
DR   HipSci; HPSI1013i-wuye_3
DR   hPSCreg; WTSIi021-B
DR   SKIP; SKIP002611
DR   Wikidata; Q54891577
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540114; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ08 ! HPSI1013i-wuye_1
OI   CVCL_AH78 ! HPSI1013i-wuye_2
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-yemz_1
AC   CVCL_AH80
SY   WTSIi022-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2613912
DR   EBiSC; WTSIi022-A
DR   ECACC; 66540092
DR   ECACC; 77650060
DR   HipSci; HPSI1013i-yemz_1
DR   hPSCreg; WTSIi022-A
DR   SKIP; SKIP002552
DR   Wikidata; Q54891578
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540092; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ09 ! HPSI1013i-yemz_2
OI   CVCL_AH81 ! HPSI1013i-yemz_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1013i-yemz_2
AC   CVCL_JQ09
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2613906
DR   HipSci; HPSI1013i-yemz_2
DR   Wikidata; Q54891579
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH80 ! HPSI1013i-yemz_1
OI   CVCL_AH81 ! HPSI1013i-yemz_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1013i-yemz_3
AC   CVCL_AH81
SY   WTSIi022-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2613897
DR   EBiSC; WTSIi022-B
DR   ECACC; 66540115
DR   ECACC; 77650066
DR   HipSci; HPSI1013i-yemz_3
DR   hPSCreg; WTSIi022-B
DR   SKIP; SKIP002617
DR   Wikidata; Q54891580
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540115; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH80 ! HPSI1013i-yemz_1
OI   CVCL_JQ09 ! HPSI1013i-yemz_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1013i-zagm_1
AC   CVCL_EF42
SY   WTSIi364-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4303619
DR   ECACC; 77650424
DR   HipSci; HPSI1013i-zagm_1
DR   hPSCreg; WTSIi364-A
DR   Wikidata; Q54891581
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-babz_3
AC   CVCL_AX04
SY   WTSIi186-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854226
DR   EBiSC; WTSIi186-A
DR   ECACC; 66540411
DR   ECACC; 77650330
DR   HipSci; HPSI1014i-babz_3
DR   hPSCreg; WTSIi186-A
DR   SKIP; SKIP002882
DR   Wikidata; Q54891582
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540411; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1014i-bilx_1
AC   CVCL_AH82
SY   WTSIi294-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3374091
DR   ECACC; 77650610
DR   HipSci; HPSI1014i-bilx_1
DR   hPSCreg; WTSIi294-A
DR   Wikidata; Q54891583
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH83 ! HPSI1014i-bilx_2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-bilx_2
AC   CVCL_AH83
SY   WTSIi294-B; WTSIi304-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3374092
DR   ECACC; 77650611
DR   HipSci; HPSI1014i-bilx_2
DR   hPSCreg; WTSIi294-B
DR   Wikidata; Q54891584
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH82 ! HPSI1014i-bilx_1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-boss_1
AC   CVCL_IZ22
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3312841
DR   ECACC; 77650623
DR   HipSci; HPSI1014i-boss_1
DR   Wikidata; Q54891585
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 77650623; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ10 ! HPSI1014i-boss_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   HPSI1014i-boss_2
AC   CVCL_JQ10
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3325332
DR   HipSci; HPSI1014i-boss_2
DR   Wikidata; Q54891586
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ22 ! HPSI1014i-boss_1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1014i-eesb_1
AC   CVCL_AH84
SY   WTSIi317-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3470401
DR   ECACC; 77650601
DR   HipSci; HPSI1014i-eesb_1
DR   hPSCreg; WTSIi317-A
DR   Wikidata; Q54891587
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-juuy_2
AC   CVCL_AK11
SY   WTSIi276-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853131
DR   ECACC; 77650566
DR   HipSci; HPSI1014i-juuy_2
DR   hPSCreg; WTSIi276-A
DR   Wikidata; Q54891588
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-kefb_1
AC   CVCL_EE67
SY   WTSIi188-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853038
DR   ECACC; 77650317
DR   HipSci; HPSI1014i-kefb_1
DR   hPSCreg; WTSIi188-A
DR   SKIP; SKIP002884
DR   Wikidata; Q54891589
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1014i-nosn_1
AC   CVCL_EF43
SY   WTSIi302-B; WTSIi314-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3964907
DR   ECACC; 77650382
DR   HipSci; HPSI1014i-nosn_1
DR   hPSCreg; WTSIi302-B
DR   Wikidata; Q54891590
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF44 ! HPSI1014i-nosn_6
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-nosn_6
AC   CVCL_EF44
SY   WTSIi302-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3964906
DR   ECACC; 77650420
DR   HipSci; HPSI1014i-nosn_6
DR   hPSCreg; WTSIi302-A
DR   Wikidata; Q54891595
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF43 ! HPSI1014i-nosn_1
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-qayj_3
AC   CVCL_EE63
SY   WTSIi184-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3963885
DR   EBiSC; WTSIi184-A
DR   ECACC; 66540382
DR   ECACC; 77650308
DR   HipSci; HPSI1014i-qayj_3
DR   hPSCreg; WTSIi184-A
DR   SKIP; SKIP002870
DR   Wikidata; Q54891596
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540382; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE64 ! HPSI1014i-qayj_4
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1014i-qayj_4
AC   CVCL_EE64
SY   WTSIi184-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3963884
DR   EBiSC; WTSIi184-B
DR   ECACC; 66540410
DR   ECACC; 77650309
DR   HipSci; HPSI1014i-qayj_4
DR   hPSCreg; WTSIi184-B
DR   SKIP; SKIP002881
DR   Wikidata; Q54891597
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540410; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE63 ! HPSI1014i-qayj_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1014i-quls_2
AC   CVCL_EE68
SY   WTSIi189-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3966392
DR   EBiSC; WTSIi189-A
DR   ECACC; 66540414
DR   ECACC; 77650329
DR   HipSci; HPSI1014i-quls_2
DR   hPSCreg; WTSIi189-A
DR   SKIP; SKIP002885
DR   Wikidata; Q54891598
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540414; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1014i-riun_1
AC   CVCL_EF45
SY   WTSIi341-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3477720
DR   ECACC; 77650310
DR   HipSci; HPSI1014i-riun_1
DR   hPSCreg; WTSIi341-A
DR   Wikidata; Q54891599
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650310; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI1014i-roug_3
AC   CVCL_EF46
SY   WTSIi374-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3854239
DR   ECACC; 77650370
DR   HipSci; HPSI1014i-roug_3
DR   hPSCreg; WTSIi374-A
DR   Wikidata; Q54891600
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-sehl_6
AC   CVCL_EF47
SY   WTSIi318-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974064
DR   ECACC; 77650371
DR   HipSci; HPSI1014i-sehl_6
DR   hPSCreg; WTSIi318-A
DR   Wikidata; Q54891601
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-suok_3
AC   CVCL_AH85
SY   WTSIi163-A
DR   BioSamples; SAMEA3355538
DR   EBiSC; WTSIi163-A
DR   ECACC; 66540317
DR   ECACC; 77650282
DR   HipSci; HPSI1014i-suok_3
DR   hPSCreg; WTSIi163-A
DR   SKIP; SKIP002815
DR   Wikidata; Q54891602
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540317; true.
CC   Discontinued: ECACC; 77650282; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV23 ! HPSI1014i-suok_4
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 17
//
ID   HPSI1014i-suok_4
AC   CVCL_WV23
DR   BioSamples; SAMEA3355535
DR   HipSci; HPSI1014i-suok_4
DR   Wikidata; Q94235493
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH85 ! HPSI1014i-suok_3
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI1014i-tixi_4
AC   CVCL_EE51
SY   WTSIi175-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3962389
DR   EBiSC; WTSIi175-A
DR   ECACC; 66540346
DR   ECACC; 77650312
DR   HipSci; HPSI1014i-tixi_4
DR   hPSCreg; WTSIi175-A
DR   SKIP; SKIP002842
DR   Wikidata; Q54891603
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540346; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1014i-toss_1
AC   CVCL_JQ11
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3321229
DR   HipSci; HPSI1014i-toss_1
DR   Wikidata; Q54891604
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH86 ! HPSI1014i-toss_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1014i-toss_3
AC   CVCL_AH86
SY   WTSIi050-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3335591
DR   EBiSC; WTSIi050-A
DR   ECACC; 66540152
DR   ECACC; 77650212
DR   HipSci; HPSI1014i-toss_3
DR   hPSCreg; WTSIi050-A
DR   SKIP; SKIP002639
DR   Wikidata; Q54891605
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540152; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ11 ! HPSI1014i-toss_1
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI1014i-tuju_1
AC   CVCL_AK12
SY   WTSIi256-B; WTSIi282-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853121
DR   ECACC; 77650583
DR   HipSci; HPSI1014i-tuju_1
DR   hPSCreg; WTSIi256-B
DR   Wikidata; Q54891606
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK13 ! HPSI1014i-tuju_4
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-tuju_4
AC   CVCL_AK13
SY   WTSIi256-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3853119
DR   ECACC; 77650586
DR   HipSci; HPSI1014i-tuju_4
DR   hPSCreg; WTSIi256-A
DR   Wikidata; Q54891607
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK12 ! HPSI1014i-tuju_1
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-vils_1
AC   CVCL_EF48
SY   WTSIi363-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4303614
DR   ECACC; 77650423
DR   HipSci; HPSI1014i-vils_1
DR   hPSCreg; WTSIi363-A
DR   Wikidata; Q54891608
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1014i-xejd_1
AC   CVCL_WJ90
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103992846
DR   ECACC; 77650803
DR   HipSci; HPSI1014i-xejd_1
DR   Wikidata; Q94235587
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WK19 ! HPSI1014i-xejd_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI1014i-xejd_2
AC   CVCL_WK19
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103992847
DR   HipSci; HPSI1014i-xejd_2
DR   Wikidata; Q94235591
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ90 ! HPSI1014i-xejd_1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI1014i-xiyh_3
AC   CVCL_LK96
SY   WTSIi607-B; WTSIi702-A
DR   BioSamples; SAMEA4678168
DR   HipSci; HPSI1014i-xiyh_3
DR   hPSCreg; WTSIi607-B
DR   Wikidata; Q54891609
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ23 ! HPSI1014i-xiyh_4
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1014i-xiyh_4
AC   CVCL_IZ23
SY   WTSIi607-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4677418
DR   ECACC; 77650495
DR   HipSci; HPSI1014i-xiyh_4
DR   hPSCreg; WTSIi607-A
DR   Wikidata; Q54891610
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Discontinued: ECACC; 77650495; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LK96 ! HPSI1014i-xiyh_3
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HPSI1016i-eoxu_2
AC   CVCL_YU05
DR   BioSamples; SAMEA104134232
DR   ECACC; 77650826
DR   HipSci; HPSI1016i-eoxu_2
DR   Wikidata; Q94235624
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; British.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YU06 ! HPSI1016i-eoxu_6
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   HPSI1016i-eoxu_6
AC   CVCL_YU06
DR   BioSamples; SAMEA104134230
DR   ECACC; 77650827
DR   HipSci; HPSI1016i-eoxu_6
DR   Wikidata; Q94235630
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; British.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YU05 ! HPSI1016i-eoxu_2
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   HPSI1016i-livl_2
AC   CVCL_LM55
SY   WTSIi664-B; WTSIi682-A
DR   BioSamples; SAMEA104132164
DR   ECACC; 77650793
DR   HipSci; HPSI1016i-livl_2
DR   hPSCreg; WTSIi664-B
DR   Wikidata; Q54891611
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; British.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM56 ! HPSI1016i-livl_5
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1016i-livl_5
AC   CVCL_LM56
SY   WTSIi664-A
DR   BioSamples; SAMEA104132163
DR   ECACC; 77650794
DR   HipSci; HPSI1016i-livl_5
DR   hPSCreg; WTSIi664-A
DR   Wikidata; Q54891613
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; British.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM55 ! HPSI1016i-livl_2
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1016i-riwg_2
AC   CVCL_LM57
SY   WTSIi681-A
DR   BioSamples; SAMEA104132412
DR   ECACC; 77650795
DR   HipSci; HPSI1016i-riwg_2
DR   hPSCreg; WTSIi681-A
DR   Wikidata; Q54891614
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; Irish.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM58 ! HPSI1016i-riwg_8
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1016i-riwg_8
AC   CVCL_LM58
SY   WTSIi681-B; WTSIi712-A
DR   BioSamples; SAMEA104132682
DR   ECACC; 77650796
DR   HipSci; HPSI1016i-riwg_8
DR   hPSCreg; WTSIi681-B
DR   Wikidata; Q54891615
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; Irish.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM57 ! HPSI1016i-riwg_2
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1113i-bima_1
AC   CVCL_AH87
SY   WTSIi032-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2433568
DR   EBiSC; WTSIi032-A
DR   ECACC; 66540102
DR   ECACC; 77650068
DR   HipSci; HPSI1113i-bima_1
DR   hPSCreg; WTSIi032-A
DR   SKIP; SKIP002562
DR   Wikidata; Q54891616
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540102; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH88 ! HPSI1113i-bima_2
OI   CVCL_JQ12 ! HPSI1113i-bima_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-bima_2
AC   CVCL_AH88
SY   WTSIi032-B; WTSIi244-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2433566
DR   ECACC; 77650027
DR   HipSci; HPSI1113i-bima_2
DR   hPSCreg; WTSIi032-B
DR   Wikidata; Q54891618
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH87 ! HPSI1113i-bima_1
OI   CVCL_JQ12 ! HPSI1113i-bima_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1113i-bima_3
AC   CVCL_JQ12
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2433567
DR   HipSci; HPSI1113i-bima_3
DR   Wikidata; Q54891619
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH87 ! HPSI1113i-bima_1
OI   CVCL_AH88 ! HPSI1113i-bima_2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-dons_1
AC   CVCL_AH89
SY   WTSIi007-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459961
DR   EBiSC; WTSIi007-A
DR   ECACC; 66540077
DR   ECACC; 77650108
DR   HipSci; HPSI1113i-dons_1
DR   hPSCreg; WTSIi007-A
DR   SKIP; SKIP002520
DR   Wikidata; Q54891620
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540077; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ13 ! HPSI1113i-dons_2
OI   CVCL_JQ14 ! HPSI1113i-dons_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-dons_2
AC   CVCL_JQ13
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459963
DR   HipSci; HPSI1113i-dons_2
DR   Wikidata; Q54891621
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH89 ! HPSI1113i-dons_1
OI   CVCL_JQ14 ! HPSI1113i-dons_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-dons_3
AC   CVCL_JQ14
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459971
DR   HipSci; HPSI1113i-dons_3
DR   Wikidata; Q54891622
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH89 ! HPSI1113i-dons_1
OI   CVCL_JQ13 ! HPSI1113i-dons_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-eofe_1
AC   CVCL_AH90
SY   WTSIi085-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2474456
DR   ECACC; 77650029
DR   HipSci; HPSI1113i-eofe_1
DR   hPSCreg; WTSIi085-A
DR   SKIP; SKIP002703
DR   Wikidata; Q54891623
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ15 ! HPSI1113i-eofe_2
OI   CVCL_JQ16 ! HPSI1113i-eofe_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-eofe_2
AC   CVCL_JQ15
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2474459
DR   HipSci; HPSI1113i-eofe_2
DR   Wikidata; Q54891624
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH90 ! HPSI1113i-eofe_1
OI   CVCL_JQ16 ! HPSI1113i-eofe_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-eofe_3
AC   CVCL_JQ16
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2474449
DR   HipSci; HPSI1113i-eofe_3
DR   Wikidata; Q54891625
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH90 ! HPSI1113i-eofe_1
OI   CVCL_JQ15 ! HPSI1113i-eofe_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-fumb_2
AC   CVCL_AH91
DR   BioSamples; SAMEA2397860
DR   ECACC; 77650161
DR   HipSci; HPSI1113i-fumb_2
DR   Wikidata; Q54891626
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650161; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH00 ! HPSI0813i-ffdr_3
OI   CVCL_AH06 ! HPSI0813i-fpdr_2
OI   CVCL_JQ17 ! HPSI1113i-fumb_3
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   HPSI1113i-fumb_3
AC   CVCL_JQ17
DR   BioSamples; SAMEA2398912
DR   HipSci; HPSI1113i-fumb_3
DR   Wikidata; Q54891627
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH00 ! HPSI0813i-ffdr_3
OI   CVCL_AH06 ! HPSI0813i-fpdr_2
OI   CVCL_AH91 ! HPSI1113i-fumb_2
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-hajc_1
AC   CVCL_AH92
SY   WTSIi390-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459962
DR   ECACC; 77650557
DR   HipSci; HPSI1113i-hajc_1
DR   hPSCreg; WTSIi390-A
DR   Wikidata; Q54891628
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ18 ! HPSI1113i-hajc_2
OI   CVCL_JQ19 ! HPSI1113i-hajc_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1113i-hajc_2
AC   CVCL_JQ18
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459969
DR   HipSci; HPSI1113i-hajc_2
DR   Wikidata; Q54891629
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH92 ! HPSI1113i-hajc_1
OI   CVCL_JQ19 ! HPSI1113i-hajc_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1113i-hajc_3
AC   CVCL_JQ19
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459964
DR   HipSci; HPSI1113i-hajc_3
DR   Wikidata; Q54891630
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH92 ! HPSI1113i-hajc_1
OI   CVCL_JQ18 ! HPSI1113i-hajc_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1113i-hayt_1
AC   CVCL_AE23
SY   WTSIi006-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445790
DR   EBiSC; WTSIi006-A
DR   ECACC; 66540076
DR   ECACC; 77650071
DR   HipSci; HPSI1113i-hayt_1
DR   hPSCreg; WTSIi006-A
DR   SKIP; SKIP002519
DR   Wikidata; Q54891631
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540076; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ20 ! HPSI1113i-hayt_2
OI   CVCL_AE03 ! HPSI1113i-hayt_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-hayt_2
AC   CVCL_JQ20
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445791
DR   HipSci; HPSI1113i-hayt_2
DR   Wikidata; Q54891632
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE23 ! HPSI1113i-hayt_1
OI   CVCL_AE03 ! HPSI1113i-hayt_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-hayt_3
AC   CVCL_AE03
SY   WTSIi006-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445784
DR   EBiSC; WTSIi006-B
DR   ECACC; 66540110
DR   ECACC; 77650076
DR   HipSci; HPSI1113i-hayt_3
DR   hPSCreg; WTSIi006-B
DR   SKIP; SKIP002622
DR   Wikidata; Q54891633
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540110; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE23 ! HPSI1113i-hayt_1
OI   CVCL_JQ20 ! HPSI1113i-hayt_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-ieki_1
AC   CVCL_JQ21
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445781
DR   HipSci; HPSI1113i-ieki_1
DR   Wikidata; Q54891634
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH93 ! HPSI1113i-ieki_2
OI   CVCL_AH94 ! HPSI1113i-ieki_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-ieki_2
AC   CVCL_AH93
SY   WTSIi038-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445779
DR   EBiSC; WTSIi038-B
DR   ECACC; 66540117
DR   ECACC; 77650061
DR   HipSci; HPSI1113i-ieki_2
DR   hPSCreg; WTSIi038-B
DR   SKIP; SKIP002619
DR   Wikidata; Q54891635
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540117; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ21 ! HPSI1113i-ieki_1
OI   CVCL_AH94 ! HPSI1113i-ieki_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-ieki_3
AC   CVCL_AH94
SY   WTSIi038-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445787
DR   EBiSC; WTSIi038-A
DR   ECACC; 66540034
DR   ECACC; 77650743
DR   HipSci; HPSI1113i-ieki_3
DR   hPSCreg; WTSIi038-A
DR   SKIP; SKIP002597
DR   Wikidata; Q54891636
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540034; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ21 ! HPSI1113i-ieki_1
OI   CVCL_AH93 ! HPSI1113i-ieki_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-nibo_1
AC   CVCL_JQ22
DR   BioSamples; SAMEA2398745
DR   HipSci; HPSI1113i-nibo_1
DR   Wikidata; Q54891643
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG97 ! HPSI0813i-ffdj_1
OI   CVCL_AH01 ! HPSI0813i-fpdj_3
OI   CVCL_AH95 ! HPSI1113i-nibo_2
OI   CVCL_AH96 ! HPSI1113i-nibo_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI1113i-nibo_2
AC   CVCL_AH95
DR   BioSamples; SAMEA2397920
DR   HipSci; HPSI1113i-nibo_2
DR   Wikidata; Q54891644
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG97 ! HPSI0813i-ffdj_1
OI   CVCL_AH01 ! HPSI0813i-fpdj_3
OI   CVCL_JQ22 ! HPSI1113i-nibo_1
OI   CVCL_AH96 ! HPSI1113i-nibo_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1113i-nibo_3
AC   CVCL_AH96
DR   BioSamples; SAMEA2398294
DR   ECACC; 77650123
DR   HipSci; HPSI1113i-nibo_3
DR   Wikidata; Q54891645
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650123; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG97 ! HPSI0813i-ffdj_1
OI   CVCL_AH01 ! HPSI0813i-fpdj_3
OI   CVCL_JQ22 ! HPSI1113i-nibo_1
OI   CVCL_AH95 ! HPSI1113i-nibo_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI1113i-oaaz_1
AC   CVCL_JQ23
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459967
DR   HipSci; HPSI1113i-oaaz_1
DR   Wikidata; Q54891647
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH97 ! HPSI1113i-oaaz_2
OI   CVCL_AH98 ! HPSI1113i-oaaz_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-oaaz_2
AC   CVCL_AH97
SY   WTSIi139-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459970
DR   EBiSC; WTSIi139-A
DR   ECACC; 66540248
DR   ECACC; 77650187
DR   HipSci; HPSI1113i-oaaz_2
DR   hPSCreg; WTSIi139-A
DR   SKIP; SKIP002773
DR   Wikidata; Q54891648
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540248; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ23 ! HPSI1113i-oaaz_1
OI   CVCL_AH98 ! HPSI1113i-oaaz_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI1113i-oaaz_3
AC   CVCL_AH98
SY   WTSIi139-B; WTSIi371-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459968
DR   ECACC; 77650554
DR   HipSci; HPSI1113i-oaaz_3
DR   hPSCreg; WTSIi139-B
DR   Wikidata; Q54891649
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ23 ! HPSI1113i-oaaz_1
OI   CVCL_AH97 ! HPSI1113i-oaaz_2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1113i-podx_1
AC   CVCL_AH99
SY   WTSIi005-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2533339
DR   EBiSC; WTSIi005-A
DR   ECACC; 66540075
DR   ECACC; 77650036
DR   HipSci; HPSI1113i-podx_1
DR   hPSCreg; WTSIi005-A
DR   SKIP; SKIP002518
DR   Wikidata; Q54891650
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540075; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI00 ! HPSI1113i-podx_2
OI   CVCL_JQ24 ! HPSI1113i-podx_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-podx_2
AC   CVCL_AI00
SY   WTSIi005-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2533336
DR   EBiSC; WTSIi005-B
DR   ECACC; 66540109
DR   ECACC; 77650121
DR   HipSci; HPSI1113i-podx_2
DR   hPSCreg; WTSIi005-B
DR   SKIP; SKIP002614
DR   Wikidata; Q54891651
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540109; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH99 ! HPSI1113i-podx_1
OI   CVCL_JQ24 ! HPSI1113i-podx_3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-podx_3
AC   CVCL_JQ24
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2533338
DR   HipSci; HPSI1113i-podx_3
DR   Wikidata; Q54891652
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH99 ! HPSI1113i-podx_1
OI   CVCL_AI00 ! HPSI1113i-podx_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-qolg_1
AC   CVCL_AI01
SY   WTSIi004-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464797
DR   EBiSC; WTSIi004-B
DR   ECACC; 66540108
DR   ECACC; 77650145
DR   HipSci; HPSI1113i-qolg_1
DR   hPSCreg; WTSIi004-B
DR   SKIP; SKIP002615
DR   Wikidata; Q54891653
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540108; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ25 ! HPSI1113i-qolg_2
OI   CVCL_AI02 ! HPSI1113i-qolg_3
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-qolg_2
AC   CVCL_JQ25
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464798
DR   HipSci; HPSI1113i-qolg_2
DR   Wikidata; Q54891654
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI01 ! HPSI1113i-qolg_1
OI   CVCL_AI02 ! HPSI1113i-qolg_3
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-qolg_3
AC   CVCL_AI02
SY   WTSIi004-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464810
DR   EBiSC; WTSIi004-A
DR   ECACC; 66540074
DR   ECACC; 77650030
DR   HipSci; HPSI1113i-qolg_3
DR   hPSCreg; WTSIi004-A
DR   SKIP; SKIP002517
DR   Wikidata; Q54891655
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540074; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI01 ! HPSI1113i-qolg_1
OI   CVCL_JQ25 ! HPSI1113i-qolg_2
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-qorq_1
AC   CVCL_AI03
SY   WTSIi081-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2609972
DR   EBiSC; WTSIi081-B
DR   ECACC; 66540197
DR   ECACC; 77650056
DR   HipSci; HPSI1113i-qorq_1
DR   hPSCreg; WTSIi081-B
DR   SKIP; SKIP002727
DR   Wikidata; Q54891656
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540197; true.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI04 ! HPSI1113i-qorq_2
OI   CVCL_JQ26 ! HPSI1113i-qorq_3
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-qorq_2
AC   CVCL_AI04
SY   WTSIi081-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2609965
DR   EBiSC; WTSIi081-A
DR   ECACC; 66540196
DR   ECACC; 77650063
DR   HipSci; HPSI1113i-qorq_2
DR   hPSCreg; WTSIi081-A
DR   SKIP; SKIP002699
DR   Wikidata; Q54891657
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540196; true.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI03 ! HPSI1113i-qorq_1
OI   CVCL_JQ26 ! HPSI1113i-qorq_3
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1113i-qorq_3
AC   CVCL_JQ26
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2609964
DR   HipSci; HPSI1113i-qorq_3
DR   Wikidata; Q54891658
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI03 ! HPSI1113i-qorq_1
OI   CVCL_AI04 ! HPSI1113i-qorq_2
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1113i-uofv_1
AC   CVCL_AE07
SY   WTSIi051-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464819
DR   EBiSC; WTSIi051-A
DR   ECACC; 66540151
DR   ECACC; 77650078
DR   HipSci; HPSI1113i-uofv_1
DR   hPSCreg; WTSIi051-A
DR   SKIP; SKIP002640
DR   Wikidata; Q54891659
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540151; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ27 ! HPSI1113i-uofv_2
OI   CVCL_JQ28 ! HPSI1113i-uofv_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-uofv_2
AC   CVCL_JQ27
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464803
DR   HipSci; HPSI1113i-uofv_2
DR   Wikidata; Q54891660
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE07 ! HPSI1113i-uofv_1
OI   CVCL_JQ28 ! HPSI1113i-uofv_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-uofv_3
AC   CVCL_JQ28
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464828
DR   HipSci; HPSI1113i-uofv_3
DR   Wikidata; Q54891661
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AE07 ! HPSI1113i-uofv_1
OI   CVCL_JQ27 ! HPSI1113i-uofv_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1113i-vuud_2
AC   CVCL_IZ24
SY   WTSIi446-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4342379
DR   ECACC; 77650520
DR   HipSci; HPSI1113i-vuud_2
DR   hPSCreg; WTSIi446-A
DR   Wikidata; Q54891662
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1113i-wahn_1
AC   CVCL_EF49
SY   WTSIi261-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4303618
DR   ECACC; 77650418
DR   HipSci; HPSI1113i-wahn_1
DR   hPSCreg; WTSIi261-A
DR   Wikidata; Q54891663
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF50 ! HPSI1113i-wahn_2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1113i-wahn_2
AC   CVCL_EF50
SY   WTSIi261-B; WTSIi337-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4303617
DR   ECACC; 77650419
DR   HipSci; HPSI1113i-wahn_2
DR   hPSCreg; WTSIi261-B
DR   Wikidata; Q54891664
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 77650419; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF49 ! HPSI1113i-wahn_1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   HPSI1113i-waus_1
AC   CVCL_AI05
SY   WTSIi036-A
DR   BioSamples; SAMEA2469767
DR   ECACC; 77650264
DR   HipSci; HPSI1113i-waus_1
DR   hPSCreg; WTSIi036-A
DR   SKIP; SKIP002581
DR   Wikidata; Q54891665
RX   PubMed=30784590;
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1113i-wetu_1
AC   CVCL_JQ29
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464785
DR   HipSci; HPSI1113i-wetu_1
DR   Wikidata; Q54891666
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI06 ! HPSI1113i-wetu_2
OI   CVCL_JQ30 ! HPSI1113i-wetu_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1113i-wetu_2
AC   CVCL_AI06
SY   WTSIi227-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464814
DR   ECACC; 77650026
DR   HipSci; HPSI1113i-wetu_2
DR   hPSCreg; WTSIi227-A
DR   Wikidata; Q54891667
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ29 ! HPSI1113i-wetu_1
OI   CVCL_JQ30 ! HPSI1113i-wetu_3
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-wetu_3
AC   CVCL_JQ30
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464792
DR   HipSci; HPSI1113i-wetu_3
DR   Wikidata; Q54891668
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ29 ! HPSI1113i-wetu_1
OI   CVCL_AI06 ! HPSI1113i-wetu_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1113i-zuta_1
AC   CVCL_AI07
DR   BioSamples; SAMEA2398133
DR   HipSci; HPSI1113i-zuta_1
DR   Wikidata; Q54891669
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG98 ! HPSI0813i-ffdk_3
OI   CVCL_AH02 ! HPSI0813i-fpdk_2
OI   CVCL_JQ31 ! HPSI1113i-zuta_2
OI   CVCL_AI08 ! HPSI1113i-zuta_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1113i-zuta_2
AC   CVCL_JQ31
DR   BioSamples; SAMEA2398545
DR   HipSci; HPSI1113i-zuta_2
DR   Wikidata; Q54891671
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG98 ! HPSI0813i-ffdk_3
OI   CVCL_AH02 ! HPSI0813i-fpdk_2
OI   CVCL_AI07 ! HPSI1113i-zuta_1
OI   CVCL_AI08 ! HPSI1113i-zuta_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1113i-zuta_3
AC   CVCL_AI08
DR   BioSamples; SAMEA2399032
DR   HipSci; HPSI1113i-zuta_3
DR   Wikidata; Q54891672
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG98 ! HPSI0813i-ffdk_3
OI   CVCL_AH02 ! HPSI0813i-fpdk_2
OI   CVCL_AI07 ! HPSI1113i-zuta_1
OI   CVCL_JQ31 ! HPSI1113i-zuta_2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1114i-kuul_1
AC   CVCL_IZ25
SY   WTSIi598-B; WTSIi601-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4447178
DR   ECACC; 77650455
DR   HipSci; HPSI1114i-kuul_1
DR   hPSCreg; WTSIi598-B
DR   Wikidata; Q54891673
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ26 ! HPSI1114i-kuul_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1114i-kuul_2
AC   CVCL_IZ26
SY   WTSIi598-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA4448549
DR   ECACC; 77650456
DR   HipSci; HPSI1114i-kuul_2
DR   hPSCreg; WTSIi598-A
DR   Wikidata; Q54891674
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ25 ! HPSI1114i-kuul_1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1114i-qibk_1
AC   CVCL_JQ32
DR   BioSamples; SAMEA3143054
DR   HipSci; HPSI1114i-qibk_1
DR   Wikidata; Q54891675
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG99 ! HPSI0813i-ffdm_3
OI   CVCL_AH05 ! HPSI0813i-fpdm_2
OI   CVCL_AI09 ! HPSI1114i-qibk_2
OI   CVCL_AI10 ! HPSI1114i-qibk_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   HPSI1114i-qibk_2
AC   CVCL_AI09
DR   BioSamples; SAMEA3143053
DR   HipSci; HPSI1114i-qibk_2
DR   Wikidata; Q54891676
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG99 ! HPSI0813i-ffdm_3
OI   CVCL_AH05 ! HPSI0813i-fpdm_2
OI   CVCL_JQ32 ! HPSI1114i-qibk_1
OI   CVCL_AI10 ! HPSI1114i-qibk_3
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   HPSI1114i-qibk_3
AC   CVCL_AI10
DR   BioSamples; SAMEA3143055
DR   HipSci; HPSI1114i-qibk_3
DR   Wikidata; Q54891678
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AG99 ! HPSI0813i-ffdm_3
OI   CVCL_AH05 ! HPSI0813i-fpdm_2
OI   CVCL_JQ32 ! HPSI1114i-qibk_1
OI   CVCL_AI09 ! HPSI1114i-qibk_2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   HPSI1114i-ualf_2
AC   CVCL_EF51
SY   WTSIi277-B; WTSIi334-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3973854
DR   ECACC; 77650373
DR   HipSci; HPSI1114i-ualf_2
DR   hPSCreg; WTSIi277-B
DR   Wikidata; Q54891679
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF52 ! HPSI1114i-ualf_6
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1114i-ualf_6
AC   CVCL_EF52
SY   WTSIi277-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3973852
DR   ECACC; 77650389
DR   HipSci; HPSI1114i-ualf_6
DR   hPSCreg; WTSIi277-A
DR   Wikidata; Q54891680
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EF51 ! HPSI1114i-ualf_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1114i-xiby_4
AC   CVCL_LL86
SY   WTSIi618-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011287
DR   ECACC; 77650729
DR   HipSci; HPSI1114i-xiby_4
DR   hPSCreg; WTSIi618-A
DR   Wikidata; Q54891681
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL87 ! HPSI1114i-xiby_5
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1114i-xiby_5
AC   CVCL_LL87
SY   WTSIi618-B; WTSIi653-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104011288
DR   ECACC; 77650730
DR   HipSci; HPSI1114i-xiby_5
DR   hPSCreg; WTSIi618-B
DR   Wikidata; Q54891682
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL86 ! HPSI1114i-xiby_4
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1114i-yair_2
AC   CVCL_WJ91
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA103884850
DR   ECACC; 77650805
DR   HipSci; HPSI1114i-yair_2
DR   Wikidata; Q94236454
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HPSI1114i-ziyn_5
AC   CVCL_JQ33
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3311868
DR   HipSci; HPSI1114i-ziyn_5
DR   Wikidata; Q54891683
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI11 ! HPSI1114i-ziyn_6
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1114i-ziyn_6
AC   CVCL_AI11
SY   WTSIi052-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3311866
DR   EBiSC; WTSIi052-A
DR   ECACC; 66540046
DR   ECACC; 77650206
DR   HipSci; HPSI1114i-ziyn_6
DR   hPSCreg; WTSIi052-A
DR   SKIP; SKIP002641
DR   Wikidata; Q54891684
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540046; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ33 ! HPSI1114i-ziyn_5
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   HPSI1114i-zuuy_4
AC   CVCL_LL88
SY   WTSIi646-B; WTSIi655-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104130211
DR   ECACC; 77650735
DR   HipSci; HPSI1114i-zuuy_4
DR   hPSCreg; WTSIi646-B
DR   Wikidata; Q54891685
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL89 ! HPSI1114i-zuuy_5
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1114i-zuuy_5
AC   CVCL_LL89
SY   WTSIi646-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA104130210
DR   ECACC; 77650736
DR   HipSci; HPSI1114i-zuuy_5
DR   hPSCreg; WTSIi646-A
DR   Wikidata; Q54891689
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL88 ! HPSI1114i-zuuy_4
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1116i-aimh_3
AC   CVCL_LF35
SY   WTSIi698-B; WTSIi735-A
DR   BioSamples; SAMEA104012527
DR   ECACC; 77650682
DR   HipSci; HPSI1116i-aimh_3
DR   hPSCreg; WTSIi698-B
DR   Wikidata; Q54891690
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF36 ! HPSI1116i-aimh_5
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-aimh_5
AC   CVCL_LF36
SY   WTSIi698-A
DR   BioSamples; SAMEA104012528
DR   ECACC; 77650683
DR   HipSci; HPSI1116i-aimh_5
DR   hPSCreg; WTSIi698-A
DR   Wikidata; Q54891691
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF35 ! HPSI1116i-aimh_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-eiyy_1
AC   CVCL_LL90
SY   WTSIi691-A
DR   BioSamples; SAMEA104134251
DR   ECACC; 77650750
DR   HipSci; HPSI1116i-eiyy_1
DR   hPSCreg; WTSIi691-A
DR   Wikidata; Q54891692
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-geve_3
AC   CVCL_WJ56
DR   BioSamples; SAMEA104236890
DR   ECACC; 77650848
DR   HipSci; HPSI1116i-geve_3
DR   Wikidata; Q94236560
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ57 ! HPSI1116i-geve_4
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI1116i-geve_4
AC   CVCL_WJ57
DR   BioSamples; SAMEA104236891
DR   ECACC; 77650849
DR   HipSci; HPSI1116i-geve_4
DR   Wikidata; Q94236566
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ56 ! HPSI1116i-geve_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI1116i-mebq_1
AC   CVCL_LL91
SY   WTSIi662-A
DR   BioSamples; SAMEA104012540
DR   ECACC; 77650759
DR   HipSci; HPSI1116i-mebq_1
DR   hPSCreg; WTSIi662-A
DR   Wikidata; Q54891693
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL92 ! HPSI1116i-mebq_7
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 10
//
ID   HPSI1116i-mebq_7
AC   CVCL_LL92
SY   WTSIi662-B; WTSIi733-A
DR   BioSamples; SAMEA104026897
DR   ECACC; 77650760
DR   HipSci; HPSI1116i-mebq_7
DR   hPSCreg; WTSIi662-B
DR   Wikidata; Q54891694
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL91 ! HPSI1116i-mebq_1
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 10
//
ID   HPSI1116i-naum_5
AC   CVCL_LF37
SY   WTSIi610-A
DR   BioSamples; SAMEA104012695
DR   ECACC; 77650741
DR   HipSci; HPSI1116i-naum_5
DR   hPSCreg; WTSIi610-A
DR   Wikidata; Q54891695
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI1116i-peru_4
AC   CVCL_WJ70
DR   BioSamples; SAMEA104241736
DR   ECACC; 77650834
DR   HipSci; HPSI1116i-peru_4
DR   Wikidata; Q94236613
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Greek.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI1116i-rafd_1
AC   CVCL_LF38
SY   WTSIi613-B; WTSIi725-A
DR   BioSamples; SAMEA104012672
DR   ECACC; 77650712
DR   HipSci; HPSI1116i-rafd_1
DR   hPSCreg; WTSIi613-B
DR   Wikidata; Q54891696
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF39 ! HPSI1116i-rafd_4
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-rafd_4
AC   CVCL_LF39
SY   WTSIi613-A
DR   BioSamples; SAMEA104012675
DR   ECACC; 77650713
DR   HipSci; HPSI1116i-rafd_4
DR   hPSCreg; WTSIi613-A
DR   Wikidata; Q54891697
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF38 ! HPSI1116i-rafd_1
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 11
//
ID   HPSI1116i-sozw_2
AC   CVCL_WJ69
DR   BioSamples; SAMEA104135334
DR   ECACC; 77650835
DR   HipSci; HPSI1116i-sozw_2
DR   Wikidata; Q94236646
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Italian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-4Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI1116i-uabf_6
AC   CVCL_WJ71
DR   BioSamples; SAMEA104012605
DR   ECACC; 77650832
DR   HipSci; HPSI1116i-uabf_6
DR   Wikidata; Q94236651
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI1116i-uacs_3
AC   CVCL_WK26
DR   BioSamples; SAMEA104012374
DR   ECACC; 77650833
DR   HipSci; HPSI1116i-uacs_3
DR   Wikidata; Q94236658
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; French.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C140264; Genetic macular dystrophy
DI   ORDO; Orphanet_522574; Rare genetic macular disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI1116i-vozo_2
AC   CVCL_LL93
SY   WTSIi674-B; WTSIi683-A
DR   BioSamples; SAMEA104132910
DR   ECACC; 77650776
DR   HipSci; HPSI1116i-vozo_2
DR   hPSCreg; WTSIi674-B
DR   Wikidata; Q54891698
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL94 ! HPSI1116i-vozo_3
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-vozo_3
AC   CVCL_LL94
SY   WTSIi674-A
DR   BioSamples; SAMEA104132909
DR   ECACC; 77650777
DR   HipSci; HPSI1116i-vozo_3
DR   hPSCreg; WTSIi674-A
DR   Wikidata; Q54891699
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL93 ! HPSI1116i-vozo_2
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-wakr_3
AC   CVCL_LL95
SY   WTSIi659-A
DR   BioSamples; SAMEA104132155
DR   ECACC; 77650778
DR   HipSci; HPSI1116i-wakr_3
DR   hPSCreg; WTSIi659-A
DR   Wikidata; Q54891700
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL96 ! HPSI1116i-wakr_6
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-wakr_6
AC   CVCL_LL96
SY   WTSIi659-B; WTSIi695-A
DR   BioSamples; SAMEA104132150
DR   ECACC; 77650779
DR   HipSci; HPSI1116i-wakr_6
DR   hPSCreg; WTSIi659-B
DR   Wikidata; Q54891701
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL95 ! HPSI1116i-wakr_3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-wiau_1
AC   CVCL_LL97
SY   WTSIi688-A
DR   BioSamples; SAMEA104132890
DR   ECACC; 77650780
DR   HipSci; HPSI1116i-wiau_1
DR   hPSCreg; WTSIi688-A
DR   Wikidata; Q54891702
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL98 ! HPSI1116i-wiau_4
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-wiau_4
AC   CVCL_LL98
SY   WTSIi688-B; WTSIi729-A
DR   BioSamples; SAMEA104132896
DR   ECACC; 77650781
DR   HipSci; HPSI1116i-wiau_4
DR   hPSCreg; WTSIi688-B
DR   Wikidata; Q54891703
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL97 ! HPSI1116i-wiau_1
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-yiek_2
AC   CVCL_WJ67
DR   BioSamples; SAMEA104132891
DR   ECACC; 77650837
DR   HipSci; HPSI1116i-yiek_2
DR   Wikidata; Q94236753
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Romani.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ68 ! HPSI1116i-yiek_6
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI1116i-yiek_6
AC   CVCL_WJ68
DR   BioSamples; SAMEA104132897
DR   ECACC; 77650838
DR   HipSci; HPSI1116i-yiek_6
DR   Wikidata; Q94236759
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; Romani.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61258; Neuronal ceroid lipofuscinosis type 3
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ67 ! HPSI1116i-yiek_2
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   HPSI1116i-zalc_1
AC   CVCL_WJ64
DR   BioSamples; SAMEA104012368
DR   ECACC; 77650841
DR   HipSci; HPSI1116i-zalc_1
DR   Wikidata; Q94236763
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HPSI1116i-zehh_3
AC   CVCL_YU07
DR   BioSamples; SAMEA104134252
DR   ECACC; 77650823
DR   HipSci; HPSI1016i-zehh_3
DR   Wikidata; Q94236770
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; British.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YU08 ! HPSI1116i-zehh_4
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   HPSI1116i-zehh_4
AC   CVCL_YU08
DR   BioSamples; SAMEA104134253
DR   ECACC; 77650824
DR   HipSci; HPSI1016i-zehh_4
DR   Wikidata; Q94236773
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   Population: Caucasian; British.
CC   Donor information: Donor is said to be suffering from a 'rare genetic neurological disorder'.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26835; Nervous system disorder
DI   ORDO; Orphanet_71859; Rare genetic neurological disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YU07 ! HPSI1116i-zehh_3
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   HPSI1116i-zies_2
AC   CVCL_LL99
SY   WTSIi693-A
DR   BioSamples; SAMEA104236993
DR   ECACC; 77650784
DR   HipSci; HPSI1116i-zies_2
DR   hPSCreg; WTSIi693-A
DR   Wikidata; Q54891704
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM00 ! HPSI1116i-zies_6
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1116i-zies_6
AC   CVCL_LM00
SY   WTSIi693-B; WTSIi707-A
DR   BioSamples; SAMEA104236996
DR   ECACC; 77650785
DR   HipSci; HPSI1116i-zies_6
DR   hPSCreg; WTSIi693-B
DR   Wikidata; Q54891706
CC   From: University College London; London; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LL99 ! HPSI1116i-zies_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 10
//
ID   HPSI1213i-aegt_1
AC   CVCL_JQ34
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464813
DR   HipSci; HPSI1213i-aegt_1
DR   Wikidata; Q54891707
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI12 ! HPSI1213i-aegt_2
OI   CVCL_AI13 ! HPSI1213i-aegt_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1213i-aegt_2
AC   CVCL_AI12
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464818
DR   HipSci; HPSI1213i-aegt_2
DR   Wikidata; Q54891708
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ34 ! HPSI1213i-aegt_1
OI   CVCL_AI13 ! HPSI1213i-aegt_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1213i-aegt_3
AC   CVCL_AI13
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464791
DR   HipSci; HPSI1213i-aegt_3
DR   Wikidata; Q54891709
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ34 ! HPSI1213i-aegt_1
OI   CVCL_AI12 ! HPSI1213i-aegt_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   HPSI1213i-babk_1
AC   CVCL_JQ35
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459966
DR   HipSci; HPSI1213i-babk_1
DR   Wikidata; Q54891710
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI14 ! HPSI1213i-babk_2
OI   CVCL_JQ36 ! HPSI1213i-babk_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-babk_2
AC   CVCL_AI14
SY   WTSIi028-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459959
DR   EBiSC; WTSIi028-A
DR   ECACC; 66540098
DR   ECACC; 77650032
DR   HipSci; HPSI1213i-babk_2
DR   hPSCreg; WTSIi028-A
DR   SKIP; SKIP002558
DR   Wikidata; Q54891711
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540098; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ35 ! HPSI1213i-babk_1
OI   CVCL_JQ36 ! HPSI1213i-babk_3
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1213i-babk_3
AC   CVCL_JQ36
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2459973
DR   HipSci; HPSI1213i-babk_3
DR   Wikidata; Q54891712
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ35 ! HPSI1213i-babk_1
OI   CVCL_AI14 ! HPSI1213i-babk_2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-foqj_1
AC   CVCL_AI15
DR   BioSamples; SAMEA2399173
DR   HipSci; HPSI1213i-foqj_1
DR   Wikidata; Q54891713
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH03 ! HPSI0813i-fpdl_1
OI   CVCL_AH04 ! HPSI0813i-fpdl_2
OI   CVCL_AH33 ! HPSI0913i-ffdl_1
OI   CVCL_WV05 ! HPSI0913i-ffdl_2
OI   CVCL_AH36 ! HPSI0913i-ffdz_2
OI   CVCL_AI16 ! HPSI1213i-foqj_2
OI   CVCL_JQ37 ! HPSI1213i-foqj_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1213i-foqj_2
AC   CVCL_AI16
SY   WTSIi297-B; WTSIi298-A
DR   BioSamples; SAMEA2399194
DR   ECACC; 77650101
DR   HipSci; HPSI1213i-foqj_2
DR   hPSCreg; WTSIi297-B
DR   Wikidata; Q54891715
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH03 ! HPSI0813i-fpdl_1
OI   CVCL_AH04 ! HPSI0813i-fpdl_2
OI   CVCL_AH33 ! HPSI0913i-ffdl_1
OI   CVCL_WV05 ! HPSI0913i-ffdl_2
OI   CVCL_AH36 ! HPSI0913i-ffdz_2
OI   CVCL_AI15 ! HPSI1213i-foqj_1
OI   CVCL_JQ37 ! HPSI1213i-foqj_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1213i-foqj_3
AC   CVCL_JQ37
DR   BioSamples; SAMEA2398665
DR   HipSci; HPSI1213i-foqj_3
DR   Wikidata; Q54891716
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AH03 ! HPSI0813i-fpdl_1
OI   CVCL_AH04 ! HPSI0813i-fpdl_2
OI   CVCL_AH33 ! HPSI0913i-ffdl_1
OI   CVCL_WV05 ! HPSI0913i-ffdl_2
OI   CVCL_AH36 ! HPSI0913i-ffdz_2
OI   CVCL_AI15 ! HPSI1213i-foqj_1
OI   CVCL_AI16 ! HPSI1213i-foqj_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-hehd_1
AC   CVCL_AI17
SY   WTSIi003-B; WTSIi346-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518338
DR   ECACC; 77650555
DR   HipSci; HPSI1213i-hehd_1
DR   hPSCreg; WTSIi003-B
DR   Wikidata; Q54891717
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI18 ! HPSI1213i-hehd_2
OI   CVCL_JQ38 ! HPSI1213i-hehd_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1213i-hehd_2
AC   CVCL_AI18
SY   WTSIi003-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518322
DR   EBiSC; WTSIi003-A
DR   ECACC; 66540073
DR   ECACC; 77650083
DR   HipSci; HPSI1213i-hehd_2
DR   hPSCreg; WTSIi003-A
DR   SKIP; SKIP002516
DR   Wikidata; Q54891718
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540073; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI17 ! HPSI1213i-hehd_1
OI   CVCL_JQ38 ! HPSI1213i-hehd_3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1213i-hehd_3
AC   CVCL_JQ38
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2518327
DR   HipSci; HPSI1213i-hehd_3
DR   Wikidata; Q54891719
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI17 ! HPSI1213i-hehd_1
OI   CVCL_AI18 ! HPSI1213i-hehd_2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-nekd_1
AC   CVCL_AI19
SY   WTSIi098-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445783
DR   ECACC; 77650028
DR   HipSci; HPSI1213i-nekd_1
DR   hPSCreg; WTSIi098-A
DR   SKIP; SKIP002713
DR   Wikidata; Q54891720
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Cellular features.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ39 ! HPSI1213i-nekd_2
OI   CVCL_JQ40 ! HPSI1213i-nekd_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1213i-nekd_2
AC   CVCL_JQ39
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445785
DR   HipSci; HPSI1213i-nekd_2
DR   Wikidata; Q54891721
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI19 ! HPSI1213i-nekd_1
OI   CVCL_JQ40 ! HPSI1213i-nekd_3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1213i-nekd_3
AC   CVCL_JQ40
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2445774
DR   HipSci; HPSI1213i-nekd_3
DR   Wikidata; Q54891722
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI19 ! HPSI1213i-nekd_1
OI   CVCL_JQ39 ! HPSI1213i-nekd_2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   HPSI1213i-nusw_1
AC   CVCL_JQ41
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464796
DR   HipSci; HPSI1213i-nusw_1
DR   Wikidata; Q54891723
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI20 ! HPSI1213i-nusw_2
OI   CVCL_JQ42 ! HPSI1213i-nusw_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-nusw_2
AC   CVCL_AI20
SY   WTSIi103-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464779
DR   ECACC; 77650035
DR   HipSci; HPSI1213i-nusw_2
DR   hPSCreg; WTSIi103-A
DR   SKIP; SKIP002718
DR   Wikidata; Q54891724
RX   PubMed=28489815;
RX   PubMed=30784590;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ41 ! HPSI1213i-nusw_1
OI   CVCL_JQ42 ! HPSI1213i-nusw_3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1213i-nusw_3
AC   CVCL_JQ42
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2464815
DR   HipSci; HPSI1213i-nusw_3
DR   Wikidata; Q54891725
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ41 ! HPSI1213i-nusw_1
OI   CVCL_AI20 ! HPSI1213i-nusw_2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-pahc_4
AC   CVCL_AI21
SY   WTSIi001-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547633
DR   ECACC; 77650046
DR   HipSci; HPSI1213i-pahc_4
DR   hPSCreg; WTSIi001-A
DR   SKIP; SKIP002514
DR   Wikidata; Q54891726
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI22 ! HPSI1213i-pahc_5
OI   CVCL_JQ43 ! HPSI1213i-pahc_6
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1213i-pahc_5
AC   CVCL_AI22
SY   WTSIi001-B; WTSIi251-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547616
DR   ECACC; 77650033
DR   HipSci; HPSI1213i-pahc_5
DR   hPSCreg; WTSIi001-B
DR   Wikidata; Q54891727
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI21 ! HPSI1213i-pahc_4
OI   CVCL_JQ43 ! HPSI1213i-pahc_6
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   HPSI1213i-pahc_6
AC   CVCL_JQ43
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2547625
DR   HipSci; HPSI1213i-pahc_6
DR   Wikidata; Q54891728
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI21 ! HPSI1213i-pahc_4
OI   CVCL_AI22 ! HPSI1213i-pahc_5
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-tolg_4
AC   CVCL_EE40
SY   WTSIi170-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974244
DR   EBiSC; WTSIi170-A
DR   ECACC; 66540338
DR   ECACC; 77650313
DR   HipSci; HPSI1213i-tolg_4
DR   hPSCreg; WTSIi170-A
DR   SKIP; SKIP002835
DR   Wikidata; Q54891729
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540338; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX10 ! HPSI1213i-tolg_6
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   HPSI1213i-tolg_6
AC   CVCL_AX10
SY   WTSIi170-B
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA3974241
DR   EBiSC; WTSIi170-B
DR   ECACC; 66540339
DR   ECACC; 77650314
DR   HipSci; HPSI1213i-tolg_6
DR   hPSCreg; WTSIi170-B
DR   SKIP; SKIP002836
DR   Wikidata; Q54891730
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540339; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE40 ! HPSI1213i-tolg_4
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1213i-xuja_1
AC   CVCL_JQ44
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2494987
DR   HipSci; HPSI1213i-xuja_1
DR   Wikidata; Q54891732
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AI23 ! HPSI1213i-xuja_2
OI   CVCL_JQ45 ! HPSI1213i-xuja_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HPSI1213i-xuja_2
AC   CVCL_AI23
SY   WTSIi083-A
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2494988
DR   EBiSC; WTSIi083-A
DR   ECACC; 66540198
DR   ECACC; 77650087
DR   HipSci; HPSI1213i-xuja_2
DR   hPSCreg; WTSIi083-A
DR   SKIP; SKIP002701
DR   Wikidata; Q54891734
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 66540198; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ44 ! HPSI1213i-xuja_1
OI   CVCL_JQ45 ! HPSI1213i-xuja_3
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   HPSI1213i-xuja_3
AC   CVCL_JQ45
DR   ArrayExpress; E-MTAB-4057
DR   BioSamples; SAMEA2494986
DR   HipSci; HPSI1213i-xuja_3
DR   Wikidata; Q54891735
RX   PubMed=28489815;
CC   From: Cambridge BioResource; Cambridge; United Kingdom.
CC   From: Wellcome Trust Sanger Institute; Hinxton; United Kingdom.
CC   Population: Caucasian; British.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ44 ! HPSI1213i-xuja_1
OI   CVCL_AI23 ! HPSI1213i-xuja_2
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   HpSV Cl1
AC   CVCL_C4ML
DR   Wikidata; Q116049503
RX   PubMed=6141846;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   HPSV178-4-3
AC   CVCL_J292
DR   JCRB; JCRB1314
DR   Wikidata; Q54891736
RX   PubMed=18445040;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04156; Human PRNP (Note=GPI-anchorless splice variant).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 6
//
ID   HPT-8
AC   CVCL_A9QW
DR   Wikidata; Q102114148
RX   PubMed=21596708;
CC   Population: Chinese.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   HPT-8-HBV
AC   CVCL_A9QX
DR   Wikidata; Q102114149
RX   PubMed=21596708;
CC   Population: Chinese.
CC   Virology: Transfected with a hepatitis B virus (HBV) subtype adr genome.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9QW ! HPT-8
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   hPTC
AC   CVCL_8224
SY   HPTC; human Papillary Thyroid Carcinoma
DR   BioSample; SAMN03152014
DR   Wikidata; Q54891737
RX   PubMed=7787432;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin and originate from a 27 year old female patient with papillary carcinoma but found to be from pig (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00127.
CC   Doubling time: 18 hours (Note=In HAM + 10% FBS) (PubMed=7787432).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 18
//
ID   HPV-18-A2
AC   CVCL_4843
SY   HPV-18 A-2; HPE(HPV-18 A2); HPV-18 transfected HPE clone A-2
DR   Wikidata; Q54891738
RX   PubMed=7991549;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4844 ! HPV-18-C1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   HPV-18-C1
AC   CVCL_4844
SY   HPV-18 C-1; HPE(HPV-18 C1); HPV-18 transfected HPE clone C-1
DR   Wikidata; Q54891739
RX   PubMed=7991549;
RX   PubMed=9772298;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4843 ! HPV-18-A2
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   HPV-18 C-1/Ki-ras
AC   CVCL_F0TQ
SY   Ki-ras/HPV-18 C-1
RX   PubMed=7991549;
RX   PubMed=9772298;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4844 ! HPV-18-C1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HPV-BIEC
AC   CVCL_UZ23
DR   Wikidata; Q94237239
RX   PubMed=30600465;
CC   Doubling time: 13.26 hours (PubMed=30600465).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_UZ22 ! BIEC-c4
SX   Male
AG   2D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   HPVE-26
AC   CVCL_3718
SY   Human Pulmonary Vein Endothelial-26
DR   CLO; CLO_0003821
DR   ATCC; CRL-2607
DR   Wikidata; Q54891740
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Senescence: Capable of at least ~30 PDL (ATCC=CRL-2607).
CC   Discontinued: ATCC; CRL-2607; true.
CC   Derived from site: In situ; Lung, vein; UBERON=UBERON_0002016.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
ST   Source(s): ATCC=CRL-2607
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13,14
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E12 ! HAAE-26
OI   CVCL_3292 ! HIVE-26
OI   CVCL_3716 ! HPAE-26
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HQ00001
AC   CVCL_3A00
DR   CLO; CLO_0012517
DR   BioSamples; SAME52935
DR   Coriell; HQ00001
DR   Wikidata; Q54891741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00002
AC   CVCL_3A01
DR   CLO; CLO_0012516
DR   BioSamples; SAME52943
DR   Coriell; HQ00002
DR   Wikidata; Q54891742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00003
AC   CVCL_3A02
DR   CLO; CLO_0012534
DR   BioSamples; SAME52944
DR   Coriell; HQ00003
DR   Wikidata; Q54891743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00004
AC   CVCL_3A03
DR   CLO; CLO_0012538
DR   BioSamples; SAME52938
DR   Coriell; HQ00004
DR   Wikidata; Q54891745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00005
AC   CVCL_3A04
DR   CLO; CLO_0012537
DR   BioSamples; SAME52939
DR   Coriell; HQ00005
DR   Wikidata; Q54891746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00006
AC   CVCL_3A05
DR   CLO; CLO_0012540
DR   BioSamples; SAME52940
DR   Coriell; HQ00006
DR   Wikidata; Q54891747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00007
AC   CVCL_3A06
DR   CLO; CLO_0012539
DR   BioSamples; SAME52941
DR   Coriell; HQ00007
DR   Wikidata; Q54891748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00008
AC   CVCL_3A07
DR   CLO; CLO_0012542
DR   BioSamples; SAME52936
DR   Coriell; HQ00008
DR   Wikidata; Q54891749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00009
AC   CVCL_3A08
DR   CLO; CLO_0012541
DR   BioSamples; SAME52937
DR   Coriell; HQ00009
DR   Wikidata; Q54891750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00010
AC   CVCL_3A09
DR   CLO; CLO_0012546
DR   BioSamples; SAME52719
DR   Coriell; HQ00010
DR   Wikidata; Q54891751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00011
AC   CVCL_3A10
DR   CLO; CLO_0012543
DR   BioSamples; SAME52704
DR   Coriell; HQ00011
DR   Wikidata; Q54891752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00012
AC   CVCL_3A11
DR   CLO; CLO_0012536
DR   BioSamples; SAME52703
DR   Coriell; HQ00012
DR   Wikidata; Q54891753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00013
AC   CVCL_3A12
DR   Coriell; HQ00013
DR   Wikidata; Q54891754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00014
AC   CVCL_3A13
DR   CLO; CLO_0012549
DR   BioSamples; SAME52701
DR   Coriell; HQ00014
DR   Wikidata; Q54891755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00015
AC   CVCL_3A14
DR   CLO; CLO_0012550
DR   BioSamples; SAME52353
DR   Coriell; HQ00015
DR   Wikidata; Q54891756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00016
AC   CVCL_3A15
DR   CLO; CLO_0012576
DR   BioSamples; SAME52699
DR   Coriell; HQ00016
DR   Wikidata; Q54891757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00017
AC   CVCL_3A16
DR   CLO; CLO_0012574
DR   BioSamples; SAME52630
DR   Coriell; HQ00017
DR   Wikidata; Q54891758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00018
AC   CVCL_3A17
DR   CLO; CLO_0012572
DR   BioSamples; SAME52933
DR   Coriell; HQ00018
DR   Wikidata; Q54891759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00019
AC   CVCL_3A18
DR   Coriell; HQ00019
DR   Wikidata; Q54891760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00020
AC   CVCL_3A19
DR   CLO; CLO_0012570
DR   BioSamples; SAME52554
DR   Coriell; HQ00020
DR   Wikidata; Q54891761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00021
AC   CVCL_3A20
DR   CLO; CLO_0012567
DR   BioSamples; SAME52555
DR   Coriell; HQ00021
DR   Wikidata; Q54891762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00022
AC   CVCL_3A21
DR   CLO; CLO_0012566
DR   BioSamples; SAME52552
DR   Coriell; HQ00022
DR   Wikidata; Q54891763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00023
AC   CVCL_3A22
DR   CLO; CLO_0012564
DR   BioSamples; SAME52354
DR   Coriell; HQ00023
DR   Wikidata; Q54891764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00024
AC   CVCL_3A23
DR   CLO; CLO_0012561
DR   BioSamples; SAME52550
DR   Coriell; HQ00024
DR   Wikidata; Q54891766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00025
AC   CVCL_3A24
DR   CLO; CLO_0012579
DR   BioSamples; SAME52551
DR   Coriell; HQ00025
DR   Wikidata; Q54891767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00026
AC   CVCL_3A25
DR   CLO; CLO_0012581
DR   BioSamples; SAME52548
DR   Coriell; HQ00026
DR   Wikidata; Q54891768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00027
AC   CVCL_3A26
DR   CLO; CLO_0012583
DR   BioSamples; SAME52549
DR   Coriell; HQ00027
DR   Wikidata; Q54891769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00028
AC   CVCL_3A27
DR   CLO; CLO_0012602
DR   BioSamples; SAME52562
DR   Coriell; HQ00028
DR   Wikidata; Q54891770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00029
AC   CVCL_3A28
DR   CLO; CLO_0012599
DR   BioSamples; SAME52563
DR   Coriell; HQ00029
DR   Wikidata; Q54891771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00030
AC   CVCL_3A29
DR   CLO; CLO_0012606
DR   BioSamples; SAME52322
DR   Coriell; HQ00030
DR   Wikidata; Q54891772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00031
AC   CVCL_3A30
DR   CLO; CLO_0012603
DR   BioSamples; SAME52321
DR   Coriell; HQ00031
DR   Wikidata; Q54891773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00032
AC   CVCL_3A31
DR   CLO; CLO_0012595
DR   BioSamples; SAME52324
DR   Coriell; HQ00032
DR   Wikidata; Q54891774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00033
AC   CVCL_3A32
DR   CLO; CLO_0012592
DR   BioSamples; SAME52323
DR   Coriell; HQ00033
DR   Wikidata; Q54891781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00034
AC   CVCL_3A33
DR   CLO; CLO_0012597
DR   BioSamples; SAME52326
DR   Coriell; HQ00034
DR   Wikidata; Q54891782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00035
AC   CVCL_3A34
DR   CLO; CLO_0012610
DR   BioSamples; SAME52325
DR   Coriell; HQ00035
DR   Wikidata; Q54891783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00036
AC   CVCL_3A35
DR   CLO; CLO_0012609
DR   BioSamples; SAME52328
DR   Coriell; HQ00036
DR   Wikidata; Q54891784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00037
AC   CVCL_3A36
DR   CLO; CLO_0012608
DR   BioSamples; SAME52327
DR   Coriell; HQ00037
DR   Wikidata; Q54891785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00038
AC   CVCL_3A37
DR   CLO; CLO_0012607
DR   BioSamples; SAME52320
DR   Coriell; HQ00038
DR   Wikidata; Q54891786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00039
AC   CVCL_3A38
DR   Coriell; HQ00039
DR   Wikidata; Q54891787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ0004
AC   CVCL_8X66
DR   ECACC; 97031221
DR   Wikidata; Q54891788
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(14),(q11.2;q13). Interstitial deletion of chromosome 14 long arm (ECACC=97031221).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   HQ00040
AC   CVCL_3A39
DR   Coriell; HQ00040
DR   Wikidata; Q54891789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00041
AC   CVCL_3A40
DR   CLO; CLO_0012613
DR   BioSamples; SAME52191
DR   Coriell; HQ00041
DR   Wikidata; Q54891790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00042
AC   CVCL_3A41
DR   CLO; CLO_0012614
DR   BioSamples; SAME52192
DR   Coriell; HQ00042
DR   Wikidata; Q54891791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00043
AC   CVCL_3A42
DR   CLO; CLO_0012611
DR   BioSamples; SAME52193
DR   Coriell; HQ00043
DR   Wikidata; Q54891792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00044
AC   CVCL_3A43
DR   CLO; CLO_0012612
DR   BioSamples; SAME52194
DR   Coriell; HQ00044
DR   Wikidata; Q54891793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00045
AC   CVCL_3A44
DR   CLO; CLO_0012615
DR   BioSamples; SAME52195
DR   Coriell; HQ00045
DR   Wikidata; Q54891794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00046
AC   CVCL_3A45
DR   CLO; CLO_0012616
DR   BioSamples; SAME52196
DR   Coriell; HQ00046
DR   Wikidata; Q54891795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00047
AC   CVCL_3A46
DR   CLO; CLO_0012621
DR   BioSamples; SAME52197
DR   Coriell; HQ00047
DR   Wikidata; Q54891796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00048
AC   CVCL_3A47
DR   CLO; CLO_0012627
DR   BioSamples; SAME52198
DR   Coriell; HQ00048
DR   Wikidata; Q54891797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00049
AC   CVCL_3A48
DR   CLO; CLO_0012625
DR   BioSamples; SAME52199
DR   Coriell; HQ00049
DR   Wikidata; Q54891798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00050
AC   CVCL_3A49
DR   CLO; CLO_0012631
DR   BioSamples; SAME52784
DR   Coriell; HQ00050
DR   Wikidata; Q54891799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00051
AC   CVCL_3A50
DR   CLO; CLO_0012629
DR   BioSamples; SAME52783
DR   Coriell; HQ00051
DR   Wikidata; Q54891800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00052
AC   CVCL_3A51
DR   CLO; CLO_0012632
DR   BioSamples; SAME52915
DR   Coriell; HQ00052
DR   Wikidata; Q54891801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00053
AC   CVCL_3A52
DR   CLO; CLO_0012633
DR   BioSamples; SAME52781
DR   Coriell; HQ00053
DR   Wikidata; Q54891802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00054
AC   CVCL_3A53
DR   CLO; CLO_0012634
DR   BioSamples; SAME52934
DR   Coriell; HQ00054
DR   Wikidata; Q54891803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00055
AC   CVCL_3A54
DR   Coriell; HQ00055
DR   Wikidata; Q54891804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; HQ00055; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00056
AC   CVCL_3A55
DR   Coriell; HQ00056
DR   Wikidata; Q54891805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; HQ00056; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00057
AC   CVCL_3A56
DR   CLO; CLO_0012635
DR   BioSamples; SAME52785
DR   Coriell; HQ00057
DR   Wikidata; Q54891806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00058
AC   CVCL_3A57
DR   CLO; CLO_0012636
DR   BioSamples; SAME52789
DR   Coriell; HQ00058
DR   Wikidata; Q54891807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00059
AC   CVCL_3A58
DR   Coriell; HQ00059
DR   Wikidata; Q54891808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; HQ00059; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00060
AC   CVCL_3A59
DR   CLO; CLO_0012642
DR   BioSamples; SAME52667
DR   Coriell; HQ00060
DR   Wikidata; Q54891809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00061
AC   CVCL_3A60
DR   CLO; CLO_0012641
DR   BioSamples; SAME52668
DR   Coriell; HQ00061
DR   Wikidata; Q54891811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00062
AC   CVCL_3A61
DR   CLO; CLO_0012640
DR   BioSamples; SAME52665
DR   Coriell; HQ00062
DR   Wikidata; Q54891812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00063
AC   CVCL_3A62
DR   CLO; CLO_0012639
DR   BioSamples; SAME52666
DR   Coriell; HQ00063
DR   Wikidata; Q54891813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00064
AC   CVCL_3A63
DR   CLO; CLO_0012638
DR   BioSamples; SAME52671
DR   Coriell; HQ00064
DR   Wikidata; Q54891814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00065
AC   CVCL_3A64
DR   CLO; CLO_0012637
DR   BioSamples; SAME52672
DR   Coriell; HQ00065
DR   Wikidata; Q54891815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00066
AC   CVCL_3A65
DR   CLO; CLO_0012649
DR   BioSamples; SAME52669
DR   Coriell; HQ00066
DR   Wikidata; Q54891816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00067
AC   CVCL_3A66
DR   CLO; CLO_0012652
DR   BioSamples; SAME52670
DR   Coriell; HQ00067
DR   Wikidata; Q54891817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00068
AC   CVCL_3A67
DR   CLO; CLO_0012647
DR   BioSamples; SAME52474
DR   Coriell; HQ00068
DR   Wikidata; Q54891818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00069
AC   CVCL_3A68
DR   CLO; CLO_0012648
DR   BioSamples; SAME52660
DR   Coriell; HQ00069
DR   Wikidata; Q54891819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00070
AC   CVCL_3A69
DR   CLO; CLO_0012661
DR   BioSamples; SAME52421
DR   Coriell; HQ00070
DR   Wikidata; Q54891820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00071
AC   CVCL_3A70
DR   CLO; CLO_0012663
DR   BioSamples; SAME52420
DR   Coriell; HQ00071
DR   Wikidata; Q54891821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00072
AC   CVCL_3A71
DR   CLO; CLO_0012662
DR   BioSamples; SAME52423
DR   Coriell; HQ00072
DR   Wikidata; Q54891825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00073
AC   CVCL_3A72
DR   CLO; CLO_0012658
DR   BioSamples; SAME52422
DR   Coriell; HQ00073
DR   Wikidata; Q54891826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00074
AC   CVCL_3A73
DR   CLO; CLO_0012657
DR   BioSamples; SAME52417
DR   Coriell; HQ00074
DR   Wikidata; Q54891827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00075
AC   CVCL_3A74
DR   CLO; CLO_0012660
DR   BioSamples; SAME52416
DR   Coriell; HQ00075
DR   Wikidata; Q54891828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00076
AC   CVCL_3A75
DR   CLO; CLO_0012659
DR   BioSamples; SAME52419
DR   Coriell; HQ00076
DR   Wikidata; Q54891829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00077
AC   CVCL_3A76
DR   CLO; CLO_0012668
DR   BioSamples; SAME52418
DR   Coriell; HQ00077
DR   Wikidata; Q54891830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00078
AC   CVCL_3A77
DR   CLO; CLO_0012670
DR   BioSamples; SAME52414
DR   Coriell; HQ00078
DR   Wikidata; Q54891831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00079
AC   CVCL_3A78
DR   CLO; CLO_0012671
DR   BioSamples; SAME52388
DR   Coriell; HQ00079
DR   Wikidata; Q54891832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00080
AC   CVCL_3A79
DR   CLO; CLO_0012784
DR   BioSamples; SAME52683
DR   Coriell; HQ00080
DR   Wikidata; Q54891833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00081
AC   CVCL_3A80
DR   CLO; CLO_0012775
DR   BioSamples; SAME52684
DR   Coriell; HQ00081
DR   Wikidata; Q54891834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00082
AC   CVCL_3A81
DR   CLO; CLO_0012778
DR   BioSamples; SAME52685
DR   Coriell; HQ00082
DR   Wikidata; Q54891835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00083
AC   CVCL_3A82
DR   CLO; CLO_0012779
DR   BioSamples; SAME52236
DR   Coriell; HQ00083
DR   Wikidata; Q54891836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00084
AC   CVCL_3A83
DR   CLO; CLO_0012781
DR   BioSamples; SAME52679
DR   Coriell; HQ00084
DR   Wikidata; Q54891837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00085
AC   CVCL_3A84
DR   CLO; CLO_0012786
DR   BioSamples; SAME52680
DR   Coriell; HQ00085
DR   Wikidata; Q54891838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00086
AC   CVCL_3A85
DR   CLO; CLO_0012787
DR   BioSamples; SAME52227
DR   Coriell; HQ00086
DR   Wikidata; Q54891839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00087
AC   CVCL_3A86
DR   CLO; CLO_0012788
DR   BioSamples; SAME52682
DR   Coriell; HQ00087
DR   Wikidata; Q54891840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00088
AC   CVCL_3A87
DR   CLO; CLO_0012789
DR   BioSamples; SAME52254
DR   Coriell; HQ00088
DR   Wikidata; Q54891841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00089
AC   CVCL_3A88
DR   CLO; CLO_0012785
DR   BioSamples; SAME52257
DR   Coriell; HQ00089
DR   Wikidata; Q54891842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00090
AC   CVCL_3A89
DR   CLO; CLO_0012763
DR   BioSamples; SAME52437
DR   Coriell; HQ00090
DR   Wikidata; Q54891843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00091
AC   CVCL_3A90
DR   Coriell; HQ00091
DR   Wikidata; Q54891844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00092
AC   CVCL_3A91
DR   CLO; CLO_0012766
DR   BioSamples; SAME52435
DR   Coriell; HQ00092
DR   Wikidata; Q54891845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00093
AC   CVCL_3A92
DR   CLO; CLO_0012759
DR   BioSamples; SAME52434
DR   Coriell; HQ00093
DR   Wikidata; Q54891846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00094
AC   CVCL_3A93
DR   CLO; CLO_0012762
DR   BioSamples; SAME52433
DR   Coriell; HQ00094
DR   Wikidata; Q54891847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00095
AC   CVCL_3A94
DR   CLO; CLO_0012756
DR   BioSamples; SAME52432
DR   Coriell; HQ00095
DR   Wikidata; Q54891848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00096
AC   CVCL_3A95
DR   CLO; CLO_0012757
DR   BioSamples; SAME52431
DR   Coriell; HQ00096
DR   Wikidata; Q54891849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00097
AC   CVCL_3A96
DR   Coriell; HQ00097
DR   Wikidata; Q54891850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; HQ00097; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00098
AC   CVCL_3A97
DR   CLO; CLO_0012769
DR   BioSamples; SAME52444
DR   Coriell; HQ00098
DR   Wikidata; Q54891851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00099
AC   CVCL_3A98
DR   CLO; CLO_0012770
DR   BioSamples; SAME52443
DR   Coriell; HQ00099
DR   Wikidata; Q54891853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00100
AC   CVCL_3A99
DR   CLO; CLO_0012767
DR   BioSamples; SAME52360
DR   Coriell; HQ00100
DR   Wikidata; Q54891854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00101
AC   CVCL_3B00
DR   CLO; CLO_0012768
DR   BioSamples; SAME52359
DR   Coriell; HQ00101
DR   Wikidata; Q54891855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00102
AC   CVCL_3B01
DR   CLO; CLO_0012815
DR   BioSamples; SAME52362
DR   Coriell; HQ00102
DR   Wikidata; Q54891856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00103
AC   CVCL_3B02
DR   CLO; CLO_0012816
DR   BioSamples; SAME52361
DR   Coriell; HQ00103
DR   Wikidata; Q54891857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00104
AC   CVCL_3B03
DR   CLO; CLO_0012817
DR   BioSamples; SAME52356
DR   Coriell; HQ00104
DR   Wikidata; Q54891859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00105
AC   CVCL_3B04
DR   CLO; CLO_0012818
DR   BioSamples; SAME52355
DR   Coriell; HQ00105
DR   Wikidata; Q54891860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00106
AC   CVCL_3B05
DR   CLO; CLO_0012820
DR   BioSamples; SAME52358
DR   Coriell; HQ00106
DR   Wikidata; Q54891861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00107
AC   CVCL_3B06
DR   CLO; CLO_0012821
DR   BioSamples; SAME52357
DR   Coriell; HQ00107
DR   Wikidata; Q54891862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00108
AC   CVCL_3B07
DR   CLO; CLO_0012824
DR   BioSamples; SAME52368
DR   Coriell; HQ00108
DR   Wikidata; Q54891863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00109
AC   CVCL_3B08
DR   CLO; CLO_0012825
DR   BioSamples; SAME52367
DR   Coriell; HQ00109
DR   Wikidata; Q54891864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00110
AC   CVCL_3B09
DR   CLO; CLO_0012826
DR   BioSamples; SAME52619
DR   Coriell; HQ00110
DR   Wikidata; Q54891865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00111
AC   CVCL_3B10
DR   CLO; CLO_0012827
DR   BioSamples; SAME52695
DR   Coriell; HQ00111
DR   Wikidata; Q54891867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00112
AC   CVCL_3B11
DR   CLO; CLO_0012797
DR   BioSamples; SAME52595
DR   Coriell; HQ00112
DR   Wikidata; Q54891869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00113
AC   CVCL_3B12
DR   CLO; CLO_0012798
DR   BioSamples; SAME52596
DR   Coriell; HQ00113
DR   Wikidata; Q54891870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00114
AC   CVCL_3B13
DR   CLO; CLO_0012795
DR   BioSamples; SAME52601
DR   Coriell; HQ00114
DR   Wikidata; Q54891871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00116
AC   CVCL_3B14
DR   CLO; CLO_0012796
DR   BioSamples; SAME52599
DR   Coriell; HQ00116
DR   Wikidata; Q54891873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00117
AC   CVCL_3B15
DR   CLO; CLO_0012803
DR   BioSamples; SAME52600
DR   Coriell; HQ00117
DR   Wikidata; Q54891874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00118
AC   CVCL_3B16
DR   CLO; CLO_0012805
DR   BioSamples; SAME52605
DR   Coriell; HQ00118
DR   Wikidata; Q54891875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00119
AC   CVCL_3B17
DR   CLO; CLO_0012799
DR   BioSamples; SAME52780
DR   Coriell; HQ00119
DR   Wikidata; Q54891876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00120
AC   CVCL_3B18
DR   CLO; CLO_0012801
DR   BioSamples; SAME52689
DR   Coriell; HQ00120
DR   Wikidata; Q54891877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00121
AC   CVCL_3B19
DR   CLO; CLO_0012807
DR   BioSamples; SAME52688
DR   Coriell; HQ00121
DR   Wikidata; Q54891878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00122
AC   CVCL_3B20
DR   CLO; CLO_0012808
DR   BioSamples; SAME52687
DR   Coriell; HQ00122
DR   Wikidata; Q54891879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00123
AC   CVCL_3B21
DR   Coriell; HQ00123
DR   Wikidata; Q54891880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; HQ00123; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00124
AC   CVCL_3B22
DR   CLO; CLO_0013396
DR   BioSamples; SAME52693
DR   Coriell; HQ00124
DR   Wikidata; Q54891881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00125
AC   CVCL_3B23
DR   CLO; CLO_0013403
DR   BioSamples; SAME52692
DR   Coriell; HQ00125
DR   Wikidata; Q54891882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00126
AC   CVCL_3B24
DR   CLO; CLO_0013402
DR   BioSamples; SAME52691
DR   Coriell; HQ00126
DR   Wikidata; Q54891883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00127
AC   CVCL_3B25
DR   CLO; CLO_0013401
DR   BioSamples; SAME52690
DR   Coriell; HQ00127
DR   Wikidata; Q54891884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00128
AC   CVCL_3B26
DR   Coriell; HQ00128
DR   Wikidata; Q54891885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; HQ00128; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00129
AC   CVCL_3B27
DR   CLO; CLO_0013400
DR   BioSamples; SAME52681
DR   Coriell; HQ00129
DR   Wikidata; Q54891886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00130
AC   CVCL_3B28
DR   CLO; CLO_0013407
DR   BioSamples; SAME52916
DR   Coriell; HQ00130
DR   Wikidata; Q54891887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00131
AC   CVCL_3B29
DR   CLO; CLO_0013406
DR   BioSamples; SAME52917
DR   Coriell; HQ00131
DR   Wikidata; Q54891888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00132
AC   CVCL_3B30
DR   CLO; CLO_0013405
DR   BioSamples; SAME52918
DR   Coriell; HQ00132
DR   Wikidata; Q54891889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00133
AC   CVCL_3B31
DR   CLO; CLO_0013404
DR   BioSamples; SAME52919
DR   Coriell; HQ00133
DR   Wikidata; Q54891890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00134
AC   CVCL_3B32
DR   CLO; CLO_0013408
DR   BioSamples; SAME52920
DR   Coriell; HQ00134
DR   Wikidata; Q54891891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00135
AC   CVCL_3B33
DR   Coriell; HQ00135
DR   Wikidata; Q54891892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00136
AC   CVCL_3B34
DR   Coriell; HQ00136
DR   Wikidata; Q54891893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00137
AC   CVCL_3B35
DR   Coriell; HQ00137
DR   Wikidata; Q54891894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00138
AC   CVCL_3B36
DR   CLO; CLO_0013417
DR   BioSamples; SAME52913
DR   Coriell; HQ00138
DR   Wikidata; Q54891895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00139
AC   CVCL_3B37
DR   CLO; CLO_0013418
DR   BioSamples; SAME52914
DR   Coriell; HQ00139
DR   Wikidata; Q54891896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00140
AC   CVCL_3B38
DR   CLO; CLO_0013421
DR   BioSamples; SAME52217
DR   Coriell; HQ00140
DR   Wikidata; Q54891897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00141
AC   CVCL_3B39
DR   CLO; CLO_0013420
DR   BioSamples; SAME52743
DR   Coriell; HQ00141
DR   Wikidata; Q54891898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00142
AC   CVCL_3B40
DR   CLO; CLO_0013423
DR   BioSamples; SAME52219
DR   Coriell; HQ00142
DR   Wikidata; Q54891899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00143
AC   CVCL_3B41
DR   CLO; CLO_0013422
DR   BioSamples; SAME52218
DR   Coriell; HQ00143
DR   Wikidata; Q54891900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00144
AC   CVCL_3B42
DR   CLO; CLO_0013425
DR   BioSamples; SAME52221
DR   Coriell; HQ00144
DR   Wikidata; Q54891901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00145
AC   CVCL_3B43
DR   CLO; CLO_0013424
DR   BioSamples; SAME52220
DR   Coriell; HQ00145
DR   Wikidata; Q54891902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00148
AC   CVCL_3B44
DR   CLO; CLO_0013427
DR   BioSamples; SAME52756
DR   Coriell; HQ00148
DR   Wikidata; Q54891903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00149
AC   CVCL_3B45
DR   CLO; CLO_0013426
DR   BioSamples; SAME52754
DR   Coriell; HQ00149
DR   Wikidata; Q54891904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00150
AC   CVCL_3B46
DR   CLO; CLO_0013361
DR   BioSamples; SAME52505
DR   Coriell; HQ00150
DR   Wikidata; Q54891905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00151
AC   CVCL_3B47
DR   CLO; CLO_0013359
DR   BioSamples; SAME52509
DR   Coriell; HQ00151
DR   Wikidata; Q54891906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00152
AC   CVCL_3B48
DR   CLO; CLO_0013360
DR   BioSamples; SAME52441
DR   Coriell; HQ00152
DR   Wikidata; Q54891907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00153
AC   CVCL_3B49
DR   CLO; CLO_0013368
DR   BioSamples; SAME52442
DR   Coriell; HQ00153
DR   Wikidata; Q54891908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00154
AC   CVCL_3B50
DR   CLO; CLO_0013367
DR   BioSamples; SAME52439
DR   Coriell; HQ00154
DR   Wikidata; Q54891909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00155
AC   CVCL_3B51
DR   CLO; CLO_0013366
DR   BioSamples; SAME52440
DR   Coriell; HQ00155
DR   Wikidata; Q54891913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00156
AC   CVCL_3B52
DR   CLO; CLO_0013365
DR   BioSamples; SAME52438
DR   Coriell; HQ00156
DR   Wikidata; Q54891914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00157
AC   CVCL_3B53
DR   Coriell; HQ00157
DR   Wikidata; Q54891915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00158
AC   CVCL_3B54
DR   CLO; CLO_0013364
DR   BioSamples; SAME52436
DR   Coriell; HQ00158
DR   Wikidata; Q54891916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00159
AC   CVCL_3B55
DR   CLO; CLO_0013363
DR   BioSamples; SAME52480
DR   Coriell; HQ00159
DR   Wikidata; Q54891917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00160
AC   CVCL_3B56
DR   CLO; CLO_0013362
DR   BioSamples; SAME52579
DR   Coriell; HQ00160
DR   Wikidata; Q54891918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00161
AC   CVCL_3B57
DR   CLO; CLO_0013372
DR   BioSamples; SAME52578
DR   Coriell; HQ00161
DR   Wikidata; Q54891919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00162
AC   CVCL_3B58
DR   CLO; CLO_0013375
DR   BioSamples; SAME52577
DR   Coriell; HQ00162
DR   Wikidata; Q54891920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00163
AC   CVCL_3B59
DR   CLO; CLO_0013376
DR   BioSamples; SAME52576
DR   Coriell; HQ00163
DR   Wikidata; Q54891921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00164
AC   CVCL_3B60
DR   CLO; CLO_0013379
DR   BioSamples; SAME52575
DR   Coriell; HQ00164
DR   Wikidata; Q54891922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00165
AC   CVCL_3B61
DR   CLO; CLO_0013386
DR   BioSamples; SAME52574
DR   Coriell; HQ00165
DR   Wikidata; Q54891924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00166
AC   CVCL_3B62
DR   CLO; CLO_0013385
DR   BioSamples; SAME52573
DR   Coriell; HQ00166
DR   Wikidata; Q54891925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00167
AC   CVCL_3B63
DR   CLO; CLO_0013388
DR   BioSamples; SAME52572
DR   Coriell; HQ00167
DR   Wikidata; Q54891926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00168
AC   CVCL_3B64
DR   CLO; CLO_0013387
DR   BioSamples; SAME52585
DR   Coriell; HQ00168
DR   Wikidata; Q54891927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00169
AC   CVCL_3B65
DR   CLO; CLO_0013384
DR   BioSamples; SAME52584
DR   Coriell; HQ00169
DR   Wikidata; Q54891928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00170
AC   CVCL_3B66
DR   CLO; CLO_0013383
DR   BioSamples; SAME52812
DR   Coriell; HQ00170
DR   Wikidata; Q54891929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00171
AC   CVCL_3B67
DR   CLO; CLO_0013439
DR   BioSamples; SAME52813
DR   Coriell; HQ00171
DR   Wikidata; Q54891930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00172
AC   CVCL_3B68
DR   Coriell; HQ00172
DR   Wikidata; Q54891931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00173
AC   CVCL_3B69
DR   CLO; CLO_0013443
DR   BioSamples; SAME52814
DR   Coriell; HQ00173
DR   Wikidata; Q54891932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00174
AC   CVCL_3B70
DR   CLO; CLO_0013442
DR   BioSamples; SAME52808
DR   Coriell; HQ00174
DR   Wikidata; Q54891933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00175
AC   CVCL_3B71
DR   CLO; CLO_0013441
DR   BioSamples; SAME52809
DR   Coriell; HQ00175
DR   Wikidata; Q54891934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00176
AC   CVCL_3B72
DR   CLO; CLO_0013440
DR   BioSamples; SAME52639
DR   Coriell; HQ00176
DR   Wikidata; Q54891935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00177
AC   CVCL_3B73
DR   CLO; CLO_0013446
DR   BioSamples; SAME52811
DR   Coriell; HQ00177
DR   Wikidata; Q54891936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00178
AC   CVCL_3B74
DR   Coriell; HQ00178
DR   Wikidata; Q54891937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00179
AC   CVCL_3B75
DR   CLO; CLO_0013447
DR   BioSamples; SAME52820
DR   Coriell; HQ00179
DR   Wikidata; Q54891938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00180
AC   CVCL_3B76
DR   CLO; CLO_0013444
DR   BioSamples; SAME52561
DR   Coriell; HQ00180
DR   Wikidata; Q54891939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00181
AC   CVCL_3B77
DR   CLO; CLO_0013445
DR   BioSamples; SAME52560
DR   Coriell; HQ00181
DR   Wikidata; Q54891940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00182
AC   CVCL_3B78
DR   CLO; CLO_0013448
DR   BioSamples; SAME52373
DR   Coriell; HQ00182
DR   Wikidata; Q54891941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00183
AC   CVCL_3B79
DR   CLO; CLO_0013450
DR   BioSamples; SAME52371
DR   Coriell; HQ00183
DR   Wikidata; Q54891942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00184
AC   CVCL_3B80
DR   CLO; CLO_0013449
DR   BioSamples; SAME52557
DR   Coriell; HQ00184
DR   Wikidata; Q54891943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00185
AC   CVCL_3B81
DR   CLO; CLO_0013452
DR   BioSamples; SAME52556
DR   Coriell; HQ00185
DR   Wikidata; Q54891944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00186
AC   CVCL_3B82
DR   CLO; CLO_0013451
DR   BioSamples; SAME52559
DR   Coriell; HQ00186
DR   Wikidata; Q54891946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00187
AC   CVCL_3B83
DR   CLO; CLO_0013454
DR   BioSamples; SAME52558
DR   Coriell; HQ00187
DR   Wikidata; Q54891947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00188
AC   CVCL_3B84
DR   CLO; CLO_0013453
DR   BioSamples; SAME52553
DR   Coriell; HQ00188
DR   Wikidata; Q54891948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00189
AC   CVCL_3B85
DR   Coriell; HQ00189
DR   Wikidata; Q54891949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00190
AC   CVCL_3B86
DR   CLO; CLO_0013455
DR   BioSamples; SAME52942
DR   Coriell; HQ00190
DR   Wikidata; Q54891950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00191
AC   CVCL_3B87
DR   Coriell; HQ00191
DR   Wikidata; Q54891951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00192
AC   CVCL_3B88
DR   Coriell; HQ00192
DR   Wikidata; Q54891952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00193
AC   CVCL_3B89
DR   CLO; CLO_0013456
DR   BioSamples; SAME52787
DR   Coriell; HQ00193
DR   Wikidata; Q54891953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00194
AC   CVCL_3B90
DR   CLO; CLO_0013457
DR   BioSamples; SAME52792
DR   Coriell; HQ00194
DR   Wikidata; Q54891954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00195
AC   CVCL_3B91
DR   CLO; CLO_0013458
DR   BioSamples; SAME52793
DR   Coriell; HQ00195
DR   Wikidata; Q54891958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00196
AC   CVCL_3B92
DR   CLO; CLO_0013484
DR   BioSamples; SAME52790
DR   Coriell; HQ00196
DR   Wikidata; Q54891959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00197
AC   CVCL_3B93
DR   CLO; CLO_0013482
DR   BioSamples; SAME52791
DR   Coriell; HQ00197
DR   Wikidata; Q54891960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00198
AC   CVCL_3B94
DR   CLO; CLO_0013488
DR   BioSamples; SAME52921
DR   Coriell; HQ00198
DR   Wikidata; Q54891961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00199
AC   CVCL_3B95
DR   CLO; CLO_0013485
DR   BioSamples; SAME52923
DR   Coriell; HQ00199
DR   Wikidata; Q54891962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00200
AC   CVCL_3B96
DR   CLO; CLO_0013490
DR   BioSamples; SAME52445
DR   Coriell; HQ00200
DR   Wikidata; Q54891963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00201
AC   CVCL_3B97
DR   CLO; CLO_0013489
DR   BioSamples; SAME52447
DR   Coriell; HQ00201
DR   Wikidata; Q54891964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00202
AC   CVCL_3B98
DR   Coriell; HQ00202
DR   Wikidata; Q54891965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00203
AC   CVCL_3B99
DR   CLO; CLO_0013492
DR   BioSamples; SAME52583
DR   Coriell; HQ00203
DR   Wikidata; Q54891966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00204
AC   CVCL_3C00
DR   CLO; CLO_0013491
DR   BioSamples; SAME52581
DR   Coriell; HQ00204
DR   Wikidata; Q54891967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00205
AC   CVCL_3C01
DR   CLO; CLO_0013494
DR   BioSamples; SAME52582
DR   Coriell; HQ00205
DR   Wikidata; Q54891968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00206
AC   CVCL_3C02
DR   Coriell; HQ00206
DR   Wikidata; Q54891969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00207
AC   CVCL_3C03
DR   CLO; CLO_0013493
DR   BioSamples; SAME52580
DR   Coriell; HQ00207
DR   Wikidata; Q54891970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00208
AC   CVCL_3C04
DR   CLO; CLO_0013460
DR   BioSamples; SAME52258
DR   Coriell; HQ00208
DR   Wikidata; Q54891971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00209
AC   CVCL_3C05
DR   CLO; CLO_0013470
DR   BioSamples; SAME52158
DR   Coriell; HQ00209
DR   Wikidata; Q54891972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00210
AC   CVCL_3C06
DR   CLO; CLO_0013467
DR   BioSamples; SAME52330
DR   Coriell; HQ00210
DR   Wikidata; Q54891973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00211
AC   CVCL_3C07
DR   CLO; CLO_0013466
DR   BioSamples; SAME52329
DR   Coriell; HQ00211
DR   Wikidata; Q54891974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00212
AC   CVCL_3C08
DR   CLO; CLO_0013463
DR   BioSamples; SAME52332
DR   Coriell; HQ00212
DR   Wikidata; Q54891975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00213
AC   CVCL_3C09
DR   CLO; CLO_0013474
DR   BioSamples; SAME52331
DR   Coriell; HQ00213
DR   Wikidata; Q54891976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00214
AC   CVCL_3C10
DR   CLO; CLO_0013473
DR   BioSamples; SAME52334
DR   Coriell; HQ00214
DR   Wikidata; Q54891977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00215
AC   CVCL_3C11
DR   CLO; CLO_0013472
DR   BioSamples; SAME52333
DR   Coriell; HQ00215
DR   Wikidata; Q54891978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00216
AC   CVCL_3C12
DR   CLO; CLO_0013471
DR   BioSamples; SAME52336
DR   Coriell; HQ00216
DR   Wikidata; Q54891979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00217
AC   CVCL_3C13
DR   CLO; CLO_0013475
DR   BioSamples; SAME52335
DR   Coriell; HQ00217
DR   Wikidata; Q54891980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00218
AC   CVCL_3C14
DR   CLO; CLO_0013581
DR   BioSamples; SAME52338
DR   Coriell; HQ00218
DR   Wikidata; Q54891981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00219
AC   CVCL_3C15
DR   Coriell; HQ00219
DR   Wikidata; Q54891982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00220
AC   CVCL_3C16
DR   Coriell; HQ00220
DR   Wikidata; Q54891983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00221
AC   CVCL_3C17
DR   CLO; CLO_0013582
DR   BioSamples; SAME52132
DR   Coriell; HQ00221
DR   Wikidata; Q54891984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00222
AC   CVCL_3C18
DR   Coriell; HQ00222
DR   Wikidata; Q54891985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00224
AC   CVCL_3C19
DR   CLO; CLO_0013574
DR   BioSamples; SAME52128
DR   Coriell; HQ00224
DR   Wikidata; Q54891986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00225
AC   CVCL_3C20
DR   CLO; CLO_0013576
DR   BioSamples; SAME52129
DR   Coriell; HQ00225
DR   Wikidata; Q54891987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00226
AC   CVCL_3C21
DR   CLO; CLO_0013578
DR   BioSamples; SAME52130
DR   Coriell; HQ00226
DR   Wikidata; Q54891988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00227
AC   CVCL_3C22
DR   CLO; CLO_0013580
DR   BioSamples; SAME52131
DR   Coriell; HQ00227
DR   Wikidata; Q54891989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00228
AC   CVCL_3C23
DR   CLO; CLO_0013569
DR   BioSamples; SAME52137
DR   Coriell; HQ00228
DR   Wikidata; Q54891990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00229
AC   CVCL_3C24
DR   CLO; CLO_0013570
DR   BioSamples; SAME52138
DR   Coriell; HQ00229
DR   Wikidata; Q54891991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00230
AC   CVCL_3C25
DR   CLO; CLO_0013571
DR   BioSamples; SAME52380
DR   Coriell; HQ00230
DR   Wikidata; Q54891992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00231
AC   CVCL_3C26
DR   CLO; CLO_0013572
DR   BioSamples; SAME52378
DR   Coriell; HQ00231
DR   Wikidata; Q54891993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00232
AC   CVCL_3C27
DR   CLO; CLO_0013563
DR   BioSamples; SAME52710
DR   Coriell; HQ00232
DR   Wikidata; Q54891994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00233
AC   CVCL_3C28
DR   CLO; CLO_0013560
DR   BioSamples; SAME52709
DR   Coriell; HQ00233
DR   Wikidata; Q54891995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00234
AC   CVCL_3C29
DR   CLO; CLO_0013562
DR   BioSamples; SAME52708
DR   Coriell; HQ00234
DR   Wikidata; Q54891996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00235
AC   CVCL_3C30
DR   CLO; CLO_0013557
DR   BioSamples; SAME52707
DR   Coriell; HQ00235
DR   Wikidata; Q54891997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00237
AC   CVCL_3C31
DR   CLO; CLO_0013558
DR   BioSamples; SAME52706
DR   Coriell; HQ00237
DR   Wikidata; Q54891999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00238
AC   CVCL_3C32
DR   CLO; CLO_0013552
DR   BioSamples; SAME52389
DR   Coriell; HQ00238
DR   Wikidata; Q54892000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00239
AC   CVCL_3C33
DR   CLO; CLO_0013555
DR   BioSamples; SAME52387
DR   Coriell; HQ00239
DR   Wikidata; Q54892001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00240
AC   CVCL_3C34
DR   Coriell; HQ00240
DR   Wikidata; Q54892002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00241
AC   CVCL_3C35
DR   Coriell; HQ00241
DR   Wikidata; Q54892003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00242
AC   CVCL_3C36
DR   CLO; CLO_0013550
DR   BioSamples; SAME52732
DR   Coriell; HQ00242
DR   Wikidata; Q54892004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00243
AC   CVCL_3C37
DR   CLO; CLO_0013551
DR   BioSamples; SAME52733
DR   Coriell; HQ00243
DR   Wikidata; Q54892005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00244
AC   CVCL_3C38
DR   CLO; CLO_0013549
DR   BioSamples; SAME52738
DR   Coriell; HQ00244
DR   Wikidata; Q54892006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00245
AC   CVCL_3C39
DR   CLO; CLO_0013531
DR   BioSamples; SAME52739
DR   Coriell; HQ00245
DR   Wikidata; Q54892007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00246
AC   CVCL_3C40
DR   CLO; CLO_0013532
DR   BioSamples; SAME52736
DR   Coriell; HQ00246
DR   Wikidata; Q54892008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00247
AC   CVCL_3C41
DR   CLO; CLO_0013533
DR   BioSamples; SAME52737
DR   Coriell; HQ00247
DR   Wikidata; Q54892009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00248
AC   CVCL_3C42
DR   Coriell; HQ00248
DR   Wikidata; Q54892010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00249
AC   CVCL_3C43
DR   CLO; CLO_0013534
DR   BioSamples; SAME52740
DR   Coriell; HQ00249
DR   Wikidata; Q54892011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00250
AC   CVCL_3C44
DR   CLO; CLO_0013535
DR   BioSamples; SAME52862
DR   Coriell; HQ00250
DR   Wikidata; Q54892012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00251
AC   CVCL_3C45
DR   CLO; CLO_0013536
DR   BioSamples; SAME52489
DR   Coriell; HQ00251
DR   Wikidata; Q54892013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00252
AC   CVCL_3C46
DR   CLO; CLO_0013537
DR   BioSamples; SAME52492
DR   Coriell; HQ00252
DR   Wikidata; Q54892014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00253
AC   CVCL_3C47
DR   CLO; CLO_0013539
DR   BioSamples; SAME52491
DR   Coriell; HQ00253
DR   Wikidata; Q54892015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00254
AC   CVCL_3C48
DR   CLO; CLO_0013529
DR   BioSamples; SAME52486
DR   Coriell; HQ00254
DR   Wikidata; Q54892016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00255
AC   CVCL_3C49
DR   CLO; CLO_0013530
DR   BioSamples; SAME52485
DR   Coriell; HQ00255
DR   Wikidata; Q54892017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00256
AC   CVCL_3C50
DR   CLO; CLO_0013525
DR   BioSamples; SAME52826
DR   Coriell; HQ00256
DR   Wikidata; Q54892018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00257
AC   CVCL_3C51
DR   CLO; CLO_0013512
DR   BioSamples; SAME52487
DR   Coriell; HQ00257
DR   Wikidata; Q54892019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00258
AC   CVCL_3C52
DR   CLO; CLO_0013513
DR   BioSamples; SAME52498
DR   Coriell; HQ00258
DR   Wikidata; Q54892020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00259
AC   CVCL_3C53
DR   CLO; CLO_0013510
DR   BioSamples; SAME52774
DR   Coriell; HQ00259
DR   Wikidata; Q54892021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00260
AC   CVCL_3C54
DR   CLO; CLO_0013511
DR   BioSamples; SAME52223
DR   Coriell; HQ00260
DR   Wikidata; Q54892022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00261
AC   CVCL_3C55
DR   CLO; CLO_0013518
DR   BioSamples; SAME52224
DR   Coriell; HQ00261
DR   Wikidata; Q54892023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00262
AC   CVCL_3C56
DR   CLO; CLO_0013520
DR   BioSamples; SAME52225
DR   Coriell; HQ00262
DR   Wikidata; Q54892024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00263
AC   CVCL_3C57
DR   CLO; CLO_0013514
DR   BioSamples; SAME52226
DR   Coriell; HQ00263
DR   Wikidata; Q54892025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00264
AC   CVCL_3C58
DR   Coriell; HQ00264
DR   Wikidata; Q54892026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00265
AC   CVCL_3C59
DR   Coriell; HQ00265
DR   Wikidata; Q54892027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00266
AC   CVCL_3C60
DR   CLO; CLO_0013516
DR   BioSamples; SAME52228
DR   Coriell; HQ00266
DR   Wikidata; Q54892028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00267
AC   CVCL_3C61
DR   CLO; CLO_0013509
DR   BioSamples; SAME52229
DR   Coriell; HQ00267
DR   Wikidata; Q54892029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00268
AC   CVCL_3C62
DR   CLO; CLO_0011721
DR   BioSamples; SAME52216
DR   Coriell; HQ00268
DR   Wikidata; Q54892030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00269
AC   CVCL_3C63
DR   Coriell; HQ00269
DR   Wikidata; Q54892031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00270
AC   CVCL_3C64
DR   CLO; CLO_0011720
DR   BioSamples; SAME52818
DR   Coriell; HQ00270
DR   Wikidata; Q54892032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00271
AC   CVCL_3C65
DR   CLO; CLO_0011702
DR   BioSamples; SAME52817
DR   Coriell; HQ00271
DR   Wikidata; Q54892033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00272
AC   CVCL_3C66
DR   CLO; CLO_0011705
DR   BioSamples; SAME52816
DR   Coriell; HQ00272
DR   Wikidata; Q54892034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00273
AC   CVCL_3C67
DR   CLO; CLO_0011707
DR   BioSamples; SAME52815
DR   Coriell; HQ00273
DR   Wikidata; Q54892035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00274
AC   CVCL_3C68
DR   CLO; CLO_0011709
DR   BioSamples; SAME52821
DR   Coriell; HQ00274
DR   Wikidata; Q54892036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00275
AC   CVCL_3C69
DR   Coriell; HQ00275
DR   Wikidata; Q54892037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00276
AC   CVCL_3C70
DR   Coriell; HQ00276
DR   Wikidata; Q54892038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00277
AC   CVCL_3C71
DR   CLO; CLO_0011710
DR   BioSamples; SAME52819
DR   Coriell; HQ00277
DR   Wikidata; Q54892040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00278
AC   CVCL_3C72
DR   Coriell; HQ00278
DR   Wikidata; Q54892041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00279
AC   CVCL_3C73
DR   CLO; CLO_0011713
DR   BioSamples; SAME52810
DR   Coriell; HQ00279
DR   Wikidata; Q54892042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00280
AC   CVCL_3C74
DR   Coriell; HQ00280
DR   Wikidata; Q54892043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00281
AC   CVCL_3C75
DR   Coriell; HQ00281
DR   Wikidata; Q54892044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00282
AC   CVCL_3C76
DR   CLO; CLO_0011715
DR   BioSamples; SAME52831
DR   Coriell; HQ00282
DR   Wikidata; Q54892045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00283
AC   CVCL_3C77
DR   CLO; CLO_0011716
DR   BioSamples; SAME52832
DR   Coriell; HQ00283
DR   Wikidata; Q54892046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00284
AC   CVCL_3C78
DR   Coriell; HQ00284
DR   Wikidata; Q54892047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00285
AC   CVCL_3C79
DR   CLO; CLO_0011701
DR   BioSamples; SAME52830
DR   Coriell; HQ00285
DR   Wikidata; Q54892048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00286
AC   CVCL_3C80
DR   CLO; CLO_0011700
DR   BioSamples; SAME52829
DR   Coriell; HQ00286
DR   Wikidata; Q54892049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00287
AC   CVCL_3C81
DR   Coriell; HQ00287
DR   Wikidata; Q54892050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00288
AC   CVCL_3C82
DR   CLO; CLO_0011699
DR   BioSamples; SAME52834
DR   Coriell; HQ00288
DR   Wikidata; Q54892051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00289
AC   CVCL_3C83
DR   CLO; CLO_0011687
DR   BioSamples; SAME52860
DR   Coriell; HQ00289
DR   Wikidata; Q54892052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00290
AC   CVCL_3C84
DR   CLO; CLO_0011689
DR   BioSamples; SAME52720
DR   Coriell; HQ00290
DR   Wikidata; Q54892053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00291
AC   CVCL_3C85
DR   Coriell; HQ00291
DR   Wikidata; Q54892054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00292
AC   CVCL_3C86
DR   Coriell; HQ00292
DR   Wikidata; Q54892055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00293
AC   CVCL_3C87
DR   CLO; CLO_0011684
DR   BioSamples; SAME52788
DR   Coriell; HQ00293
DR   Wikidata; Q54892056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00294
AC   CVCL_3C88
DR   Coriell; HQ00294
DR   Wikidata; Q54892058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00295
AC   CVCL_2Y33
DR   CLO; CLO_0011685
DR   BioSamples; SAME52755
DR   Coriell; HQ00295
DR   Wikidata; Q54892059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; HQ00295; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00296
AC   CVCL_3C89
DR   Coriell; HQ00296
DR   Wikidata; Q54892060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00297
AC   CVCL_3C90
DR   CLO; CLO_0011694
DR   BioSamples; SAME52609
DR   Coriell; HQ00297
DR   Wikidata; Q54892061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00298
AC   CVCL_3C91
DR   CLO; CLO_0011696
DR   BioSamples; SAME52175
DR   Coriell; HQ00298
DR   Wikidata; Q54892062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00299
AC   CVCL_3C92
DR   CLO; CLO_0011691
DR   BioSamples; SAME52610
DR   Coriell; HQ00299
DR   Wikidata; Q54892063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00300
AC   CVCL_3C93
DR   CLO; CLO_0011679
DR   BioSamples; SAME52859
DR   Coriell; HQ00300
DR   Wikidata; Q54892064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00301
AC   CVCL_3C94
DR   CLO; CLO_0011678
DR   BioSamples; SAME52858
DR   Coriell; HQ00301
DR   Wikidata; Q54892065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00302
AC   CVCL_3C95
DR   CLO; CLO_0011681
DR   BioSamples; SAME52857
DR   Coriell; HQ00302
DR   Wikidata; Q54892066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00303
AC   CVCL_3C96
DR   CLO; CLO_0011680
DR   BioSamples; SAME52856
DR   Coriell; HQ00303
DR   Wikidata; Q54892067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00304
AC   CVCL_3C97
DR   CLO; CLO_0011670
DR   BioSamples; SAME52855
DR   Coriell; HQ00304
DR   Wikidata; Q54892068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00305
AC   CVCL_3C98
DR   CLO; CLO_0011672
DR   BioSamples; SAME52854
DR   Coriell; HQ00305
DR   Wikidata; Q54892069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00306
AC   CVCL_3C99
DR   CLO; CLO_0011674
DR   BioSamples; SAME52853
DR   Coriell; HQ00306
DR   Wikidata; Q54892071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00307
AC   CVCL_3D00
DR   CLO; CLO_0011677
DR   BioSamples; SAME52852
DR   Coriell; HQ00307
DR   Wikidata; Q54892073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00308
AC   CVCL_3D01
DR   CLO; CLO_0011664
DR   BioSamples; SAME52861
DR   Coriell; HQ00308
DR   Wikidata; Q54892074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00309
AC   CVCL_3D02
DR   Coriell; HQ00309
DR   Wikidata; Q54892075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00310
AC   CVCL_3D03
DR   Coriell; HQ00310
DR   Wikidata; Q54892076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00311
AC   CVCL_3D04
DR   Coriell; HQ00311
DR   Wikidata; Q54892077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00312
AC   CVCL_3D05
DR   CLO; CLO_0011666
DR   BioSamples; SAME52252
DR   Coriell; HQ00312
DR   Wikidata; Q54892078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00313
AC   CVCL_3D06
DR   CLO; CLO_0011661
DR   BioSamples; SAME52253
DR   Coriell; HQ00313
DR   Wikidata; Q54892079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00314
AC   CVCL_3D07
DR   CLO; CLO_0011660
DR   BioSamples; SAME52248
DR   Coriell; HQ00314
DR   Wikidata; Q54892080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00315
AC   CVCL_3D08
DR   CLO; CLO_0011659
DR   BioSamples; SAME52249
DR   Coriell; HQ00315
DR   Wikidata; Q54892081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00316
AC   CVCL_3D09
DR   CLO; CLO_0011658
DR   BioSamples; SAME52250
DR   Coriell; HQ00316
DR   Wikidata; Q54892082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00317
AC   CVCL_3D10
DR   CLO; CLO_0011657
DR   BioSamples; SAME52251
DR   Coriell; HQ00317
DR   Wikidata; Q54892086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00318
AC   CVCL_3D11
DR   CLO; CLO_0011653
DR   BioSamples; SAME52255
DR   Coriell; HQ00318
DR   Wikidata; Q54892087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00319
AC   CVCL_3D12
DR   CLO; CLO_0011656
DR   BioSamples; SAME52256
DR   Coriell; HQ00319
DR   Wikidata; Q54892088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00320
AC   CVCL_3D13
DR   CLO; CLO_0011650
DR   BioSamples; SAME52466
DR   Coriell; HQ00320
DR   Wikidata; Q54892089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00321
AC   CVCL_3D14
DR   CLO; CLO_0011652
DR   BioSamples; SAME52465
DR   Coriell; HQ00321
DR   Wikidata; Q54892090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00322
AC   CVCL_3D15
DR   Coriell; HQ00322
DR   Wikidata; Q54892091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00323
AC   CVCL_3D16
DR   CLO; CLO_0011647
DR   BioSamples; SAME52467
DR   Coriell; HQ00323
DR   Wikidata; Q54892093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00324
AC   CVCL_3D17
DR   CLO; CLO_0011580
DR   BioSamples; SAME52468
DR   Coriell; HQ00324
DR   Wikidata; Q54892094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00325
AC   CVCL_3D18
DR   Coriell; HQ00325
DR   Wikidata; Q54892095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00326
AC   CVCL_3D19
DR   Coriell; HQ00326
DR   Wikidata; Q54892096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00327
AC   CVCL_3D20
DR   Coriell; HQ00327
DR   Wikidata; Q54892098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00328
AC   CVCL_3D21
DR   CLO; CLO_0011578
DR   BioSamples; SAME52471
DR   Coriell; HQ00328
DR   Wikidata; Q54892099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00329
AC   CVCL_3D22
DR   CLO; CLO_0011579
DR   BioSamples; SAME52470
DR   Coriell; HQ00329
DR   Wikidata; Q54892100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00330
AC   CVCL_3D23
DR   CLO; CLO_0011574
DR   BioSamples; SAME52717
DR   Coriell; HQ00330
DR   Wikidata; Q54892101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00331
AC   CVCL_3D24
DR   CLO; CLO_0011577
DR   BioSamples; SAME52718
DR   Coriell; HQ00331
DR   Wikidata; Q54892102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00332
AC   CVCL_3D25
DR   CLO; CLO_0011571
DR   BioSamples; SAME52716
DR   Coriell; HQ00332
DR   Wikidata; Q54892103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00333
AC   CVCL_3D26
DR   Coriell; HQ00333
DR   Wikidata; Q54892104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00334
AC   CVCL_3D27
DR   Coriell; HQ00334
DR   Wikidata; Q54892105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00335
AC   CVCL_3D28
DR   CLO; CLO_0011572
DR   BioSamples; SAME52715
DR   Coriell; HQ00335
DR   Wikidata; Q54892107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00336
AC   CVCL_3D29
DR   CLO; CLO_0011567
DR   BioSamples; SAME52713
DR   Coriell; HQ00336
DR   Wikidata; Q54892108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00337
AC   CVCL_3D30
DR   CLO; CLO_0011568
DR   BioSamples; SAME52714
DR   Coriell; HQ00337
DR   Wikidata; Q54892109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00338
AC   CVCL_3D31
DR   CLO; CLO_0011564
DR   BioSamples; SAME52711
DR   Coriell; HQ00338
DR   Wikidata; Q54892110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00339
AC   CVCL_3D32
DR   CLO; CLO_0011598
DR   BioSamples; SAME52712
DR   Coriell; HQ00339
DR   Wikidata; Q54892111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00340
AC   CVCL_3D33
DR   CLO; CLO_0011599
DR   BioSamples; SAME52136
DR   Coriell; HQ00340
DR   Wikidata; Q54892112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00341
AC   CVCL_3D34
DR   CLO; CLO_0011600
DR   BioSamples; SAME52135
DR   Coriell; HQ00341
DR   Wikidata; Q54892114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00342
AC   CVCL_3D35
DR   CLO; CLO_0011601
DR   BioSamples; SAME52134
DR   Coriell; HQ00342
DR   Wikidata; Q54892115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00343
AC   CVCL_3D36
DR   CLO; CLO_0011591
DR   BioSamples; SAME52133
DR   Coriell; HQ00343
DR   Wikidata; Q54892116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00344
AC   CVCL_3D37
DR   CLO; CLO_0011592
DR   BioSamples; SAME52140
DR   Coriell; HQ00344
DR   Wikidata; Q54892118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00345
AC   CVCL_3D38
DR   CLO; CLO_0011594
DR   BioSamples; SAME52139
DR   Coriell; HQ00345
DR   Wikidata; Q54892119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00346
AC   CVCL_3D39
DR   CLO; CLO_0011596
DR   BioSamples; SAME52159
DR   Coriell; HQ00346
DR   Wikidata; Q54892121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00347
AC   CVCL_3D40
DR   CLO; CLO_0011586
DR   BioSamples; SAME52157
DR   Coriell; HQ00347
DR   Wikidata; Q54892122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00348
AC   CVCL_3D41
DR   CLO; CLO_0011588
DR   BioSamples; SAME52143
DR   Coriell; HQ00348
DR   Wikidata; Q54892123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00349
AC   CVCL_3D42
DR   CLO; CLO_0011534
DR   BioSamples; SAME52641
DR   Coriell; HQ00349
DR   Wikidata; Q54892124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00350
AC   CVCL_3D43
DR   CLO; CLO_0011537
DR   BioSamples; SAME52337
DR   Coriell; HQ00350
DR   Wikidata; Q54892125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00351
AC   CVCL_3D44
DR   CLO; CLO_0011538
DR   BioSamples; SAME52697
DR   Coriell; HQ00351
DR   Wikidata; Q54892126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00352
AC   CVCL_3D45
DR   CLO; CLO_0011535
DR   BioSamples; SAME52339
DR   Coriell; HQ00352
DR   Wikidata; Q54892128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00353
AC   CVCL_3D46
DR   CLO; CLO_0011536
DR   BioSamples; SAME52340
DR   Coriell; HQ00353
DR   Wikidata; Q54892129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00354
AC   CVCL_3D47
DR   CLO; CLO_0011527
DR   BioSamples; SAME52341
DR   Coriell; HQ00354
DR   Wikidata; Q54892130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00355
AC   CVCL_3D48
DR   CLO; CLO_0011528
DR   BioSamples; SAME52342
DR   Coriell; HQ00355
DR   Wikidata; Q54892131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00356
AC   CVCL_3D49
DR   CLO; CLO_0011523
DR   BioSamples; SAME52343
DR   Coriell; HQ00356
DR   Wikidata; Q54892132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00357
AC   CVCL_3D50
DR   CLO; CLO_0011526
DR   BioSamples; SAME52344
DR   Coriell; HQ00357
DR   Wikidata; Q54892136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00358
AC   CVCL_3D51
DR   CLO; CLO_0011532
DR   BioSamples; SAME52372
DR   Coriell; HQ00358
DR   Wikidata; Q54892137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00359
AC   CVCL_3D52
DR   CLO; CLO_0011554
DR   BioSamples; SAME52686
DR   Coriell; HQ00359
DR   Wikidata; Q54892139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00360
AC   CVCL_3D53
DR   CLO; CLO_0011555
DR   BioSamples; SAME52625
DR   Coriell; HQ00360
DR   Wikidata; Q54892140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00361
AC   CVCL_3D54
DR   CLO; CLO_0011556
DR   BioSamples; SAME52624
DR   Coriell; HQ00361
DR   Wikidata; Q54892141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00362
AC   CVCL_3D55
DR   CLO; CLO_0011557
DR   BioSamples; SAME52627
DR   Coriell; HQ00362
DR   Wikidata; Q54892142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00363
AC   CVCL_3D56
DR   CLO; CLO_0011558
DR   BioSamples; SAME52626
DR   Coriell; HQ00363
DR   Wikidata; Q54892143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00364
AC   CVCL_3D57
DR   Coriell; HQ00364
DR   Wikidata; Q54892144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00365
AC   CVCL_3D58
DR   Coriell; HQ00365
DR   Wikidata; Q54892146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00366
AC   CVCL_3D59
DR   CLO; CLO_0011559
DR   BioSamples; SAME52623
DR   Coriell; HQ00366
DR   Wikidata; Q54892147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00367
AC   CVCL_3D60
DR   CLO; CLO_0011545
DR   BioSamples; SAME52622
DR   Coriell; HQ00367
DR   Wikidata; Q54892148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00368
AC   CVCL_3D61
DR   CLO; CLO_0011546
DR   BioSamples; SAME52822
DR   Coriell; HQ00368
DR   Wikidata; Q54892149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00369
AC   CVCL_3D62
DR   CLO; CLO_0011547
DR   BioSamples; SAME52628
DR   Coriell; HQ00369
DR   Wikidata; Q54892150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00370
AC   CVCL_3D63
DR   CLO; CLO_0011548
DR   BioSamples; SAME52873
DR   Coriell; HQ00370
DR   Wikidata; Q54892151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00371
AC   CVCL_3D64
DR   CLO; CLO_0011475
DR   BioSamples; SAME52874
DR   Coriell; HQ00371
DR   Wikidata; Q54892152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00372
AC   CVCL_3D65
DR   Coriell; HQ00372
DR   Wikidata; Q54892153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00373
AC   CVCL_3D66
DR   CLO; CLO_0011473
DR   BioSamples; SAME52872
DR   Coriell; HQ00373
DR   Wikidata; Q54892154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00374
AC   CVCL_3D67
DR   Coriell; HQ00374
DR   Wikidata; Q54892155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00375
AC   CVCL_3D68
DR   CLO; CLO_0011470
DR   BioSamples; SAME52875
DR   Coriell; HQ00375
DR   Wikidata; Q54892156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00376
AC   CVCL_3D69
DR   Coriell; HQ00376
DR   Wikidata; Q54892157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00377
AC   CVCL_3D70
DR   Coriell; HQ00377
DR   Wikidata; Q54892158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00378
AC   CVCL_3D71
DR   Coriell; HQ00378
DR   Wikidata; Q54892159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00379
AC   CVCL_3D72
DR   CLO; CLO_0011469
DR   BioSamples; SAME52876
DR   Coriell; HQ00379
DR   Wikidata; Q54892160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00380
AC   CVCL_3D73
DR   CLO; CLO_0011466
DR   BioSamples; SAME52276
DR   Coriell; HQ00380
DR   Wikidata; Q54892161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00381
AC   CVCL_3D74
DR   CLO; CLO_0011465
DR   BioSamples; SAME52275
DR   Coriell; HQ00381
DR   Wikidata; Q54892163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00382
AC   CVCL_3D75
DR   CLO; CLO_0011463
DR   BioSamples; SAME52200
DR   Coriell; HQ00382
DR   Wikidata; Q54892164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00383
AC   CVCL_3D76
DR   CLO; CLO_0011486
DR   BioSamples; SAME52273
DR   Coriell; HQ00383
DR   Wikidata; Q54892165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00384
AC   CVCL_3D77
DR   CLO; CLO_0011485
DR   BioSamples; SAME52272
DR   Coriell; HQ00384
DR   Wikidata; Q54892166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00385
AC   CVCL_3D78
DR   CLO; CLO_0011484
DR   BioSamples; SAME52271
DR   Coriell; HQ00385
DR   Wikidata; Q54892167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00386
AC   CVCL_3D79
DR   CLO; CLO_0011503
DR   BioSamples; SAME52270
DR   Coriell; HQ00386
DR   Wikidata; Q54892168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00387
AC   CVCL_3D80
DR   CLO; CLO_0011501
DR   BioSamples; SAME52269
DR   Coriell; HQ00387
DR   Wikidata; Q54892169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00388
AC   CVCL_3D81
DR   Coriell; HQ00388
DR   Wikidata; Q54892170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00389
AC   CVCL_3D82
DR   CLO; CLO_0011507
DR   BioSamples; SAME52267
DR   Coriell; HQ00389
DR   Wikidata; Q54892171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00390
AC   CVCL_3D83
DR   CLO; CLO_0011506
DR   BioSamples; SAME52497
DR   Coriell; HQ00390
DR   Wikidata; Q54892172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00391
AC   CVCL_3D84
DR   CLO; CLO_0011497
DR   BioSamples; SAME52776
DR   Coriell; HQ00391
DR   Wikidata; Q54892173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00392
AC   CVCL_3D85
DR   CLO; CLO_0011496
DR   BioSamples; SAME52499
DR   Coriell; HQ00392
DR   Wikidata; Q54892175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00393
AC   CVCL_3D86
DR   CLO; CLO_0011500
DR   BioSamples; SAME52779
DR   Coriell; HQ00393
DR   Wikidata; Q54892176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00394
AC   CVCL_3D87
DR   CLO; CLO_0011499
DR   BioSamples; SAME52493
DR   Coriell; HQ00394
DR   Wikidata; Q54892177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00395
AC   CVCL_3D88
DR   CLO; CLO_0011517
DR   BioSamples; SAME52494
DR   Coriell; HQ00395
DR   Wikidata; Q54892178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00396
AC   CVCL_3D89
DR   CLO; CLO_0011516
DR   BioSamples; SAME52495
DR   Coriell; HQ00396
DR   Wikidata; Q54892179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00397
AC   CVCL_3D90
DR   CLO; CLO_0011423
DR   BioSamples; SAME52496
DR   Coriell; HQ00397
DR   Wikidata; Q54892185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00398
AC   CVCL_3D91
DR   CLO; CLO_0011427
DR   BioSamples; SAME52868
DR   Coriell; HQ00398
DR   Wikidata; Q54892186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00399
AC   CVCL_3D92
DR   CLO; CLO_0011426
DR   BioSamples; SAME52759
DR   Coriell; HQ00399
DR   Wikidata; Q54892187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00400
AC   CVCL_3D93
DR   CLO; CLO_0011425
DR   BioSamples; SAME52698
DR   Coriell; HQ00400
DR   Wikidata; Q54892189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00401
AC   CVCL_3D94
DR   Coriell; HQ00401
DR   Wikidata; Q54892190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00402
AC   CVCL_3D95
DR   CLO; CLO_0011424
DR   BioSamples; SAME52700
DR   Coriell; HQ00402
DR   Wikidata; Q54892191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00403
AC   CVCL_3D96
DR   Coriell; HQ00403
DR   Wikidata; Q54892192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00404
AC   CVCL_3D97
DR   CLO; CLO_0011431
DR   BioSamples; SAME52702
DR   Coriell; HQ00404
DR   Wikidata; Q54892193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00405
AC   CVCL_3D98
DR   Coriell; HQ00405
DR   Wikidata; Q54892194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of HQ00406 (Cellosaurus=CVCL_3D99).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   HQ00406
AC   CVCL_3D99
DR   Coriell; HQ00406
DR   Wikidata; Q54892195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of HQ00405 (Cellosaurus=CVCL_3D98).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   HQ00407
AC   CVCL_3E00
DR   CLO; CLO_0011430
DR   BioSamples; SAME52705
DR   Coriell; HQ00407
DR   Wikidata; Q54892197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00408
AC   CVCL_3E01
DR   Coriell; HQ00408
DR   Wikidata; Q54892199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00409
AC   CVCL_3E02
DR   Coriell; HQ00409
DR   Wikidata; Q54892200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00410
AC   CVCL_3E03
DR   CLO; CLO_0011429
DR   BioSamples; SAME52460
DR   Coriell; HQ00410
DR   Wikidata; Q54892201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00411
AC   CVCL_3E04
DR   CLO; CLO_0011428
DR   BioSamples; SAME52459
DR   Coriell; HQ00411
DR   Wikidata; Q54892203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00412
AC   CVCL_3E05
DR   Coriell; HQ00412
DR   Wikidata; Q54892204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00413
AC   CVCL_3E06
DR   Coriell; HQ00413
DR   Wikidata; Q54892205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00414
AC   CVCL_3E07
DR   CLO; CLO_0011432
DR   BioSamples; SAME52464
DR   Coriell; HQ00414
DR   Wikidata; Q54892206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00415
AC   CVCL_3E08
DR   CLO; CLO_0011445
DR   BioSamples; SAME52463
DR   Coriell; HQ00415
DR   Wikidata; Q54892207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00416
AC   CVCL_3E09
DR   CLO; CLO_0011446
DR   BioSamples; SAME52462
DR   Coriell; HQ00416
DR   Wikidata; Q54892209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00417
AC   CVCL_3E10
DR   CLO; CLO_0011448
DR   BioSamples; SAME52461
DR   Coriell; HQ00417
DR   Wikidata; Q54892210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00418
AC   CVCL_3E11
DR   CLO; CLO_0011447
DR   BioSamples; SAME52458
DR   Coriell; HQ00418
DR   Wikidata; Q54892211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00419
AC   CVCL_3E12
DR   CLO; CLO_0011450
DR   BioSamples; SAME52457
DR   Coriell; HQ00419
DR   Wikidata; Q54892212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00420
AC   CVCL_3E13
DR   CLO; CLO_0011449
DR   BioSamples; SAME52308
DR   Coriell; HQ00420
DR   Wikidata; Q54892213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00421
AC   CVCL_3E14
DR   CLO; CLO_0011452
DR   BioSamples; SAME52309
DR   Coriell; HQ00421
DR   Wikidata; Q54892215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00422
AC   CVCL_3E15
DR   CLO; CLO_0011451
DR   BioSamples; SAME52306
DR   Coriell; HQ00422
DR   Wikidata; Q54892216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00423
AC   CVCL_3E16
DR   CLO; CLO_0011454
DR   BioSamples; SAME52307
DR   Coriell; HQ00423
DR   Wikidata; Q54892217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00424
AC   CVCL_3E17
DR   CLO; CLO_0011453
DR   BioSamples; SAME52312
DR   Coriell; HQ00424
DR   Wikidata; Q54892218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00425
AC   CVCL_3E18
DR   Coriell; HQ00425
DR   Wikidata; Q54892219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00426
AC   CVCL_3E19
DR   CLO; CLO_0012141
DR   BioSamples; SAME52310
DR   Coriell; HQ00426
DR   Wikidata; Q54892220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00427
AC   CVCL_3E20
DR   CLO; CLO_0012143
DR   BioSamples; SAME52311
DR   Coriell; HQ00427
DR   Wikidata; Q54892221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00428
AC   CVCL_3E21
DR   CLO; CLO_0012142
DR   BioSamples; SAME52629
DR   Coriell; HQ00428
DR   Wikidata; Q54892222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00429
AC   CVCL_3E22
DR   Coriell; HQ00429
DR   Wikidata; Q54892223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00430
AC   CVCL_3E23
DR   CLO; CLO_0012124
DR   BioSamples; SAME52930
DR   Coriell; HQ00430
DR   Wikidata; Q54892226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00431
AC   CVCL_3E24
DR   CLO; CLO_0012125
DR   BioSamples; SAME52929
DR   Coriell; HQ00431
DR   Wikidata; Q54892227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00432
AC   CVCL_3E25
DR   CLO; CLO_0012127
DR   BioSamples; SAME52932
DR   Coriell; HQ00432
DR   Wikidata; Q54892228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00433
AC   CVCL_3E26
DR   CLO; CLO_0012129
DR   BioSamples; SAME52931
DR   Coriell; HQ00433
DR   Wikidata; Q54892229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00434
AC   CVCL_3E27
DR   CLO; CLO_0012131
DR   BioSamples; SAME52926
DR   Coriell; HQ00434
DR   Wikidata; Q54892230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00435
AC   CVCL_3E28
DR   CLO; CLO_0012133
DR   BioSamples; SAME52925
DR   Coriell; HQ00435
DR   Wikidata; Q54892231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00436
AC   CVCL_3E29
DR   CLO; CLO_0012135
DR   BioSamples; SAME52928
DR   Coriell; HQ00436
DR   Wikidata; Q54892232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00437
AC   CVCL_3E30
DR   CLO; CLO_0012123
DR   BioSamples; SAME52927
DR   Coriell; HQ00437
DR   Wikidata; Q54892236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00438
AC   CVCL_3E31
DR   Coriell; HQ00438
DR   Wikidata; Q54892237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00439
AC   CVCL_3E32
DR   Coriell; HQ00439
DR   Wikidata; Q54892238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00440
AC   CVCL_3E33
DR   Coriell; HQ00440
DR   Wikidata; Q54892239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00441
AC   CVCL_3E34
DR   CLO; CLO_0012122
DR   BioSamples; SAME52536
DR   Coriell; HQ00441
DR   Wikidata; Q54892240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00442
AC   CVCL_3E35
DR   CLO; CLO_0012121
DR   BioSamples; SAME52537
DR   Coriell; HQ00442
DR   Wikidata; Q54892241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00443
AC   CVCL_3E36
DR   CLO; CLO_0012120
DR   BioSamples; SAME52602
DR   Coriell; HQ00443
DR   Wikidata; Q54892242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00444
AC   CVCL_3E37
DR   Coriell; HQ00444
DR   Wikidata; Q54892243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00445
AC   CVCL_3E38
DR   Coriell; HQ00445
DR   Wikidata; Q54892244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00446
AC   CVCL_3E39
DR   CLO; CLO_0012109
DR   BioSamples; SAME52597
DR   Coriell; HQ00446
DR   Wikidata; Q54892246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00447
AC   CVCL_3E40
DR   CLO; CLO_0012111
DR   BioSamples; SAME52598
DR   Coriell; HQ00447
DR   Wikidata; Q54892247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00448
AC   CVCL_3E41
DR   CLO; CLO_0012105
DR   BioSamples; SAME52382
DR   Coriell; HQ00448
DR   Wikidata; Q54892248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00449
AC   CVCL_3E42
DR   CLO; CLO_0012106
DR   BioSamples; SAME52608
DR   Coriell; HQ00449
DR   Wikidata; Q54892249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00450
AC   CVCL_3E43
DR   Coriell; HQ00450
DR   Wikidata; Q54892252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00451
AC   CVCL_3E44
DR   Coriell; HQ00451
DR   Wikidata; Q54892253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00452
AC   CVCL_3E45
DR   CLO; CLO_0012114
DR   BioSamples; SAME52807
DR   Coriell; HQ00452
DR   Wikidata; Q54892254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00453
AC   CVCL_3E46
DR   CLO; CLO_0012117
DR   BioSamples; SAME52803
DR   Coriell; HQ00453
DR   Wikidata; Q54892255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00454
AC   CVCL_3E47
DR   CLO; CLO_0011831
DR   BioSamples; SAME52797
DR   Coriell; HQ00454
DR   Wikidata; Q54892256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00455
AC   CVCL_3E48
DR   CLO; CLO_0011830
DR   BioSamples; SAME52512
DR   Coriell; HQ00455
DR   Wikidata; Q54892257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00456
AC   CVCL_3E49
DR   CLO; CLO_0011823
DR   BioSamples; SAME52786
DR   Coriell; HQ00456
DR   Wikidata; Q54892258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00457
AC   CVCL_3E50
DR   CLO; CLO_0011822
DR   BioSamples; SAME52782
DR   Coriell; HQ00457
DR   Wikidata; Q54892259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00458
AC   CVCL_3E51
DR   CLO; CLO_0011825
DR   BioSamples; SAME52370
DR   Coriell; HQ00458
DR   Wikidata; Q54892260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00459
AC   CVCL_3E52
DR   CLO; CLO_0011824
DR   BioSamples; SAME52369
DR   Coriell; HQ00459
DR   Wikidata; Q54892262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00460
AC   CVCL_3E53
DR   CLO; CLO_0011827
DR   BioSamples; SAME52246
DR   Coriell; HQ00460
DR   Wikidata; Q54892263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00461
AC   CVCL_3E54
DR   CLO; CLO_0011826
DR   BioSamples; SAME52247
DR   Coriell; HQ00461
DR   Wikidata; Q54892264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00462
AC   CVCL_3E55
DR   CLO; CLO_0011829
DR   BioSamples; SAME52244
DR   Coriell; HQ00462
DR   Wikidata; Q54892265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00463
AC   CVCL_3E56
DR   CLO; CLO_0011828
DR   BioSamples; SAME52245
DR   Coriell; HQ00463
DR   Wikidata; Q54892266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00464
AC   CVCL_3E57
DR   CLO; CLO_0011841
DR   BioSamples; SAME52242
DR   Coriell; HQ00464
DR   Wikidata; Q54892267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00465
AC   CVCL_3E58
DR   CLO; CLO_0011840
DR   BioSamples; SAME52243
DR   Coriell; HQ00465
DR   Wikidata; Q54892268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00466
AC   CVCL_3E59
DR   Coriell; HQ00466
DR   Wikidata; Q54892269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00467
AC   CVCL_3E60
DR   CLO; CLO_0011839
DR   BioSamples; SAME52241
DR   Coriell; HQ00467
DR   Wikidata; Q54892270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00468
AC   CVCL_3E61
DR   CLO; CLO_0011835
DR   BioSamples; SAME52239
DR   Coriell; HQ00468
DR   Wikidata; Q54892271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00469
AC   CVCL_3E62
DR   CLO; CLO_0011834
DR   BioSamples; SAME52240
DR   Coriell; HQ00469
DR   Wikidata; Q54892272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00470
AC   CVCL_3E63
DR   CLO; CLO_0011833
DR   BioSamples; SAME52837
DR   Coriell; HQ00470
DR   Wikidata; Q54892273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00471
AC   CVCL_3E64
DR   CLO; CLO_0011832
DR   BioSamples; SAME52836
DR   Coriell; HQ00471
DR   Wikidata; Q54892274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00472
AC   CVCL_3E65
DR   CLO; CLO_0011838
DR   BioSamples; SAME52839
DR   Coriell; HQ00472
DR   Wikidata; Q54892276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00473
AC   CVCL_3E66
DR   CLO; CLO_0011837
DR   BioSamples; SAME52838
DR   Coriell; HQ00473
DR   Wikidata; Q54892277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00474
AC   CVCL_3E67
DR   CLO; CLO_0011836
DR   BioSamples; SAME52841
DR   Coriell; HQ00474
DR   Wikidata; Q54892278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00475
AC   CVCL_3E68
DR   CLO; CLO_0011999
DR   BioSamples; SAME52840
DR   Coriell; HQ00475
DR   Wikidata; Q54892279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00476
AC   CVCL_3E69
DR   CLO; CLO_0012000
DR   BioSamples; SAME52843
DR   Coriell; HQ00476
DR   Wikidata; Q54892280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00477
AC   CVCL_3E70
DR   CLO; CLO_0011997
DR   BioSamples; SAME52842
DR   Coriell; HQ00477
DR   Wikidata; Q54892286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00478
AC   CVCL_3E71
DR   CLO; CLO_0011998
DR   BioSamples; SAME52845
DR   Coriell; HQ00478
DR   Wikidata; Q54892287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00479
AC   CVCL_3E72
DR   CLO; CLO_0012005
DR   BioSamples; SAME52844
DR   Coriell; HQ00479
DR   Wikidata; Q54892288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00480
AC   CVCL_3E73
DR   CLO; CLO_0012006
DR   BioSamples; SAME52890
DR   Coriell; HQ00480
DR   Wikidata; Q54892289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00481
AC   CVCL_3E74
DR   CLO; CLO_0012003
DR   BioSamples; SAME52891
DR   Coriell; HQ00481
DR   Wikidata; Q54892290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00482
AC   CVCL_3E75
DR   CLO; CLO_0012004
DR   BioSamples; SAME52892
DR   Coriell; HQ00482
DR   Wikidata; Q54892291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00483
AC   CVCL_3E76
DR   CLO; CLO_0012001
DR   BioSamples; SAME52893
DR   Coriell; HQ00483
DR   Wikidata; Q54892292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00484
AC   CVCL_3E77
DR   Coriell; HQ00484
DR   Wikidata; Q54892293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00485
AC   CVCL_3E78
DR   Coriell; HQ00485
DR   Wikidata; Q54892294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00486
AC   CVCL_3E79
DR   Coriell; HQ00486
DR   Wikidata; Q54892295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00487
AC   CVCL_3E80
DR   CLO; CLO_0012002
DR   BioSamples; SAME52894
DR   Coriell; HQ00487
DR   Wikidata; Q54892296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00488
AC   CVCL_3E81
DR   Coriell; HQ00488
DR   Wikidata; Q54892297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00489
AC   CVCL_3E82
DR   CLO; CLO_0012014
DR   BioSamples; SAME52895
DR   Coriell; HQ00489
DR   Wikidata; Q54892298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00490
AC   CVCL_3E83
DR   CLO; CLO_0012010
DR   BioSamples; SAME52650
DR   Coriell; HQ00490
DR   Wikidata; Q54892299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00491
AC   CVCL_3E84
DR   CLO; CLO_0012011
DR   BioSamples; SAME52649
DR   Coriell; HQ00491
DR   Wikidata; Q54892300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00492
AC   CVCL_3E85
DR   CLO; CLO_0012012
DR   BioSamples; SAME52648
DR   Coriell; HQ00492
DR   Wikidata; Q54892301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00493
AC   CVCL_3E86
DR   CLO; CLO_0012013
DR   BioSamples; SAME52647
DR   Coriell; HQ00493
DR   Wikidata; Q54892302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00494
AC   CVCL_3E87
DR   CLO; CLO_0012016
DR   BioSamples; SAME52654
DR   Coriell; HQ00494
DR   Wikidata; Q54892303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00495
AC   CVCL_3E88
DR   CLO; CLO_0012017
DR   BioSamples; SAME52653
DR   Coriell; HQ00495
DR   Wikidata; Q54892304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00496
AC   CVCL_3E89
DR   CLO; CLO_0012018
DR   BioSamples; SAME52652
DR   Coriell; HQ00496
DR   Wikidata; Q54892305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00497
AC   CVCL_3E90
DR   CLO; CLO_0012019
DR   BioSamples; SAME52651
DR   Coriell; HQ00497
DR   Wikidata; Q54892306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00498
AC   CVCL_3E91
DR   CLO; CLO_0012015
DR   BioSamples; SAME52656
DR   Coriell; HQ00498
DR   Wikidata; Q54892307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00499
AC   CVCL_3E92
DR   CLO; CLO_0012024
DR   BioSamples; SAME52655
DR   Coriell; HQ00499
DR   Wikidata; Q54892308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00501
AC   CVCL_3E93
DR   CLO; CLO_0012025
DR   BioSamples; SAME52149
DR   Coriell; HQ00501
DR   Wikidata; Q54892309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00502
AC   CVCL_3E94
DR   CLO; CLO_0012028
DR   BioSamples; SAME52151
DR   Coriell; HQ00502
DR   Wikidata; Q54892310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00503
AC   CVCL_3E95
DR   CLO; CLO_0012029
DR   BioSamples; SAME52150
DR   Coriell; HQ00503
DR   Wikidata; Q54892311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00504
AC   CVCL_3E96
DR   CLO; CLO_0012026
DR   BioSamples; SAME52153
DR   Coriell; HQ00504
DR   Wikidata; Q54892312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00505
AC   CVCL_3E97
DR   CLO; CLO_0012027
DR   BioSamples; SAME52152
DR   Coriell; HQ00505
DR   Wikidata; Q54892313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00506
AC   CVCL_3E98
DR   Coriell; HQ00506
DR   Wikidata; Q54892314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00507
AC   CVCL_3E99
DR   Coriell; HQ00507
DR   Wikidata; Q54892315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00508
AC   CVCL_3F00
DR   Coriell; HQ00508
DR   Wikidata; Q54892316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00509
AC   CVCL_3F01
DR   CLO; CLO_0012034
DR   BioSamples; SAME52154
DR   Coriell; HQ00509
DR   Wikidata; Q54892317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00510
AC   CVCL_3F02
DR   CLO; CLO_0012035
DR   BioSamples; SAME52611
DR   Coriell; HQ00510
DR   Wikidata; Q54892318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00511
AC   CVCL_3F03
DR   CLO; CLO_0012030
DR   BioSamples; SAME52847
DR   Coriell; HQ00511
DR   Wikidata; Q54892319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00512
AC   CVCL_3F04
DR   CLO; CLO_0012032
DR   BioSamples; SAME52833
DR   Coriell; HQ00512
DR   Wikidata; Q54892320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00513
AC   CVCL_3F05
DR   CLO; CLO_0012046
DR   BioSamples; SAME52835
DR   Coriell; HQ00513
DR   Wikidata; Q54892321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00514
AC   CVCL_3F06
DR   CLO; CLO_0012047
DR   BioSamples; SAME52365
DR   Coriell; HQ00514
DR   Wikidata; Q54892322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00515
AC   CVCL_3F07
DR   CLO; CLO_0012048
DR   BioSamples; SAME52366
DR   Coriell; HQ00515
DR   Wikidata; Q54892323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00516
AC   CVCL_3F08
DR   CLO; CLO_0012049
DR   BioSamples; SAME52363
DR   Coriell; HQ00516
DR   Wikidata; Q54892324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00517
AC   CVCL_3F09
DR   CLO; CLO_0012050
DR   BioSamples; SAME52364
DR   Coriell; HQ00517
DR   Wikidata; Q54892325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00518
AC   CVCL_3F10
DR   CLO; CLO_0012051
DR   BioSamples; SAME52510
DR   Coriell; HQ00518
DR   Wikidata; Q54892328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00519
AC   CVCL_3F11
DR   CLO; CLO_0012052
DR   BioSamples; SAME52516
DR   Coriell; HQ00519
DR   Wikidata; Q54892329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00520
AC   CVCL_3F12
DR   CLO; CLO_0012053
DR   BioSamples; SAME52762
DR   Coriell; HQ00520
DR   Wikidata; Q54892330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00521
AC   CVCL_3F13
DR   Coriell; HQ00521
DR   Wikidata; Q54892331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00522
AC   CVCL_3F14
DR   CLO; CLO_0012054
DR   BioSamples; SAME52490
DR   Coriell; HQ00522
DR   Wikidata; Q54892332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00523
AC   CVCL_3F15
DR   CLO; CLO_0012055
DR   BioSamples; SAME52758
DR   Coriell; HQ00523
DR   Wikidata; Q54892333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00524
AC   CVCL_3F16
DR   CLO; CLO_0011902
DR   BioSamples; SAME52488
DR   Coriell; HQ00524
DR   Wikidata; Q54892334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00525
AC   CVCL_3F17
DR   CLO; CLO_0011900
DR   BioSamples; SAME52753
DR   Coriell; HQ00525
DR   Wikidata; Q54892335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00526
AC   CVCL_3F18
DR   CLO; CLO_0011899
DR   BioSamples; SAME52752
DR   Coriell; HQ00526
DR   Wikidata; Q54892336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00527
AC   CVCL_3F19
DR   CLO; CLO_0011897
DR   BioSamples; SAME52751
DR   Coriell; HQ00527
DR   Wikidata; Q54892337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00528
AC   CVCL_3F20
DR   CLO; CLO_0011894
DR   BioSamples; SAME52500
DR   Coriell; HQ00528
DR   Wikidata; Q54892338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00529
AC   CVCL_3F21
DR   CLO; CLO_0011893
DR   BioSamples; SAME52777
DR   Coriell; HQ00529
DR   Wikidata; Q54892339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00530
AC   CVCL_3F22
DR   CLO; CLO_0011891
DR   BioSamples; SAME52174
DR   Coriell; HQ00530
DR   Wikidata; Q54892340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00531
AC   CVCL_3F23
DR   CLO; CLO_0011889
DR   BioSamples; SAME52469
DR   Coriell; HQ00531
DR   Wikidata; Q54892341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00532
AC   CVCL_3F24
DR   CLO; CLO_0011887
DR   BioSamples; SAME52501
DR   Coriell; HQ00532
DR   Wikidata; Q54892342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00533
AC   CVCL_3F25
DR   CLO; CLO_0011886
DR   BioSamples; SAME52502
DR   Coriell; HQ00533
DR   Wikidata; Q54892343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00534
AC   CVCL_3F26
DR   CLO; CLO_0011904
DR   BioSamples; SAME52176
DR   Coriell; HQ00534
DR   Wikidata; Q54892344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00535
AC   CVCL_3F27
DR   CLO; CLO_0011929
DR   BioSamples; SAME52477
DR   Coriell; HQ00535
DR   Wikidata; Q54892345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00536
AC   CVCL_3F28
DR   CLO; CLO_0011927
DR   BioSamples; SAME52734
DR   Coriell; HQ00536
DR   Wikidata; Q54892346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00537
AC   CVCL_3F29
DR   CLO; CLO_0011933
DR   BioSamples; SAME52735
DR   Coriell; HQ00537
DR   Wikidata; Q54892347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00538
AC   CVCL_3F30
DR   CLO; CLO_0011931
DR   BioSamples; SAME52741
DR   Coriell; HQ00538
DR   Wikidata; Q54892348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00539
AC   CVCL_3F31
DR   CLO; CLO_0011923
DR   BioSamples; SAME52742
DR   Coriell; HQ00539
DR   Wikidata; Q54892349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00540
AC   CVCL_3F32
DR   CLO; CLO_0011921
DR   BioSamples; SAME52233
DR   Coriell; HQ00540
DR   Wikidata; Q54892350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00541
AC   CVCL_3F33
DR   CLO; CLO_0011926
DR   BioSamples; SAME52232
DR   Coriell; HQ00541
DR   Wikidata; Q54892351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00542
AC   CVCL_3F34
DR   CLO; CLO_0011924
DR   BioSamples; SAME52235
DR   Coriell; HQ00542
DR   Wikidata; Q54892352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00543
AC   CVCL_3F35
DR   CLO; CLO_0011919
DR   BioSamples; SAME52234
DR   Coriell; HQ00543
DR   Wikidata; Q54892353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00544
AC   CVCL_3F36
DR   CLO; CLO_0011935
DR   BioSamples; SAME52231
DR   Coriell; HQ00544
DR   Wikidata; Q54892354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00545
AC   CVCL_3F37
DR   CLO; CLO_0011936
DR   BioSamples; SAME52230
DR   Coriell; HQ00545
DR   Wikidata; Q54892355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00546
AC   CVCL_3F38
DR   Coriell; HQ00546
DR   Wikidata; Q54892356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00548
AC   CVCL_3F39
DR   CLO; CLO_0011959
DR   BioSamples; SAME52238
DR   Coriell; HQ00548
DR   Wikidata; Q54892357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00549
AC   CVCL_3F40
DR   CLO; CLO_0011956
DR   BioSamples; SAME52237
DR   Coriell; HQ00549
DR   Wikidata; Q54892358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00550
AC   CVCL_3F41
DR   CLO; CLO_0011954
DR   BioSamples; SAME52450
DR   Coriell; HQ00550
DR   Wikidata; Q54892359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00551
AC   CVCL_3F42
DR   CLO; CLO_0011953
DR   BioSamples; SAME52451
DR   Coriell; HQ00551
DR   Wikidata; Q54892360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00552
AC   CVCL_3F43
DR   CLO; CLO_0011964
DR   BioSamples; SAME52449
DR   Coriell; HQ00552
DR   Wikidata; Q54892361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00553
AC   CVCL_3F44
DR   Coriell; HQ00553
DR   Wikidata; Q54892362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00554
AC   CVCL_3F45
DR   CLO; CLO_0011963
DR   BioSamples; SAME52454
DR   Coriell; HQ00554
DR   Wikidata; Q54892363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00555
AC   CVCL_3F46
DR   Coriell; HQ00555
DR   Wikidata; Q54892364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00556
AC   CVCL_3F47
DR   CLO; CLO_0011961
DR   BioSamples; SAME52452
DR   Coriell; HQ00556
DR   Wikidata; Q54892365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00557
AC   CVCL_3F48
DR   CLO; CLO_0011960
DR   BioSamples; SAME52453
DR   Coriell; HQ00557
DR   Wikidata; Q54892366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00558
AC   CVCL_3F49
DR   CLO; CLO_0011967
DR   BioSamples; SAME52455
DR   Coriell; HQ00558
DR   Wikidata; Q54892367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00559
AC   CVCL_3F50
DR   CLO; CLO_0011968
DR   BioSamples; SAME52456
DR   Coriell; HQ00559
DR   Wikidata; Q54892371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00560
AC   CVCL_3F51
DR   CLO; CLO_0011969
DR   BioSamples; SAME52606
DR   Coriell; HQ00560
DR   Wikidata; Q54892372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00561
AC   CVCL_3F52
DR   CLO; CLO_0011988
DR   BioSamples; SAME52545
DR   Coriell; HQ00561
DR   Wikidata; Q54892373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00562
AC   CVCL_3F53
DR   CLO; CLO_0011985
DR   BioSamples; SAME52604
DR   Coriell; HQ00562
DR   Wikidata; Q54892374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00563
AC   CVCL_3F54
DR   CLO; CLO_0011992
DR   BioSamples; SAME52603
DR   Coriell; HQ00563
DR   Wikidata; Q54892375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00564
AC   CVCL_3F55
DR   Coriell; HQ00564
DR   Wikidata; Q54892376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00565
AC   CVCL_3F56
DR   Coriell; HQ00565
DR   Wikidata; Q54892377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00566
AC   CVCL_3F57
DR   CLO; CLO_0011989
DR   BioSamples; SAME52346
DR   Coriell; HQ00566
DR   Wikidata; Q54892378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00567
AC   CVCL_3F58
DR   CLO; CLO_0011995
DR   BioSamples; SAME52607
DR   Coriell; HQ00567
DR   Wikidata; Q54892379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00568
AC   CVCL_3F59
DR   CLO; CLO_0011993
DR   BioSamples; SAME52535
DR   Coriell; HQ00568
DR   Wikidata; Q54892380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00569
AC   CVCL_3F60
DR   CLO; CLO_0011996
DR   BioSamples; SAME52222
DR   Coriell; HQ00569
DR   Wikidata; Q54892381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00570
AC   CVCL_3F61
DR   CLO; CLO_0010693
DR   BioSamples; SAME52287
DR   Coriell; HQ00570
DR   Wikidata; Q54892383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00571
AC   CVCL_3F62
DR   CLO; CLO_0010699
DR   BioSamples; SAME52288
DR   Coriell; HQ00571
DR   Wikidata; Q54892384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00572
AC   CVCL_3F63
DR   CLO; CLO_0010698
DR   BioSamples; SAME52846
DR   Coriell; HQ00572
DR   Wikidata; Q54892385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00573
AC   CVCL_3F64
DR   CLO; CLO_0010701
DR   BioSamples; SAME52903
DR   Coriell; HQ00573
DR   Wikidata; Q54892386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00574
AC   CVCL_3F65
DR   CLO; CLO_0010700
DR   BioSamples; SAME52848
DR   Coriell; HQ00574
DR   Wikidata; Q54892388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00575
AC   CVCL_3F66
DR   CLO; CLO_0010695
DR   BioSamples; SAME52849
DR   Coriell; HQ00575
DR   Wikidata; Q54892389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00576
AC   CVCL_3F67
DR   CLO; CLO_0010694
DR   BioSamples; SAME52850
DR   Coriell; HQ00576
DR   Wikidata; Q54892390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00577
AC   CVCL_3F68
DR   CLO; CLO_0010697
DR   BioSamples; SAME52851
DR   Coriell; HQ00577
DR   Wikidata; Q54892391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00578
AC   CVCL_3F69
DR   CLO; CLO_0010696
DR   BioSamples; SAME52284
DR   Coriell; HQ00578
DR   Wikidata; Q54892392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00579
AC   CVCL_3F70
DR   CLO; CLO_0010702
DR   BioSamples; SAME52286
DR   Coriell; HQ00579
DR   Wikidata; Q54892393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00580
AC   CVCL_3F71
DR   CLO; CLO_0010704
DR   BioSamples; SAME52314
DR   Coriell; HQ00580
DR   Wikidata; Q54892394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00581
AC   CVCL_3F72
DR   CLO; CLO_0010703
DR   BioSamples; SAME52313
DR   Coriell; HQ00581
DR   Wikidata; Q54892395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00582
AC   CVCL_3F73
DR   CLO; CLO_0010712
DR   BioSamples; SAME52316
DR   Coriell; HQ00582
DR   Wikidata; Q54892396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00583
AC   CVCL_3F74
DR   CLO; CLO_0010711
DR   BioSamples; SAME52315
DR   Coriell; HQ00583
DR   Wikidata; Q54892397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00584
AC   CVCL_3F75
DR   CLO; CLO_0010710
DR   BioSamples; SAME52318
DR   Coriell; HQ00584
DR   Wikidata; Q54892398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00585
AC   CVCL_3F76
DR   CLO; CLO_0010709
DR   BioSamples; SAME52317
DR   Coriell; HQ00585
DR   Wikidata; Q54892399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00586
AC   CVCL_3F77
DR   CLO; CLO_0010708
DR   BioSamples; SAME52319
DR   Coriell; HQ00586
DR   Wikidata; Q54892400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00587
AC   CVCL_3F78
DR   Coriell; HQ00587
DR   Wikidata; Q54892401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00588
AC   CVCL_3F79
DR   Coriell; HQ00588
DR   Wikidata; Q54892402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00589
AC   CVCL_3F80
DR   Coriell; HQ00589
DR   Wikidata; Q54892403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00590
AC   CVCL_3F81
DR   CLO; CLO_0010707
DR   BioSamples; SAME52543
DR   Coriell; HQ00590
DR   Wikidata; Q54892404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00591
AC   CVCL_3F82
DR   CLO; CLO_0010706
DR   BioSamples; SAME52544
DR   Coriell; HQ00591
DR   Wikidata; Q54892405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00592
AC   CVCL_3F83
DR   CLO; CLO_0010705
DR   BioSamples; SAME52541
DR   Coriell; HQ00592
DR   Wikidata; Q54892406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00593
AC   CVCL_3F84
DR   CLO; CLO_0010663
DR   BioSamples; SAME52542
DR   Coriell; HQ00593
DR   Wikidata; Q54892407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00594
AC   CVCL_3F85
DR   CLO; CLO_0010665
DR   BioSamples; SAME52539
DR   Coriell; HQ00594
DR   Wikidata; Q54892408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00595
AC   CVCL_3F86
DR   CLO; CLO_0010664
DR   BioSamples; SAME52540
DR   Coriell; HQ00595
DR   Wikidata; Q54892409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00596
AC   CVCL_3F87
DR   Coriell; HQ00596
DR   Wikidata; Q54892410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00597
AC   CVCL_3F88
DR   CLO; CLO_0010667
DR   BioSamples; SAME52538
DR   Coriell; HQ00597
DR   Wikidata; Q54892411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00598
AC   CVCL_3F89
DR   CLO; CLO_0010666
DR   BioSamples; SAME52546
DR   Coriell; HQ00598
DR   Wikidata; Q54892412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00599
AC   CVCL_3F90
DR   CLO; CLO_0010669
DR   BioSamples; SAME52547
DR   Coriell; HQ00599
DR   Wikidata; Q54892418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00600
AC   CVCL_3F91
DR   CLO; CLO_0010668
DR   BioSamples; SAME52394
DR   Coriell; HQ00600
DR   Wikidata; Q54892419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00601
AC   CVCL_3F92
DR   CLO; CLO_0010671
DR   BioSamples; SAME52395
DR   Coriell; HQ00601
DR   Wikidata; Q54892420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00602
AC   CVCL_3F93
DR   Coriell; HQ00602
DR   Wikidata; Q54892421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00603
AC   CVCL_3F94
DR   CLO; CLO_0010670
DR   BioSamples; SAME52393
DR   Coriell; HQ00603
DR   Wikidata; Q54892422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00604
AC   CVCL_3F95
DR   Coriell; HQ00604
DR   Wikidata; Q54892423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00605
AC   CVCL_3F96
DR   CLO; CLO_0010672
DR   BioSamples; SAME52398
DR   Coriell; HQ00605
DR   Wikidata; Q54892425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00606
AC   CVCL_3F97
DR   CLO; CLO_0010676
DR   BioSamples; SAME52396
DR   Coriell; HQ00606
DR   Wikidata; Q54892426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00607
AC   CVCL_3F98
DR   Coriell; HQ00607
DR   Wikidata; Q54892427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00608
AC   CVCL_3F99
DR   CLO; CLO_0010675
DR   BioSamples; SAME52390
DR   Coriell; HQ00608
DR   Wikidata; Q54892428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00609
AC   CVCL_3G00
DR   CLO; CLO_0010674
DR   BioSamples; SAME52391
DR   Coriell; HQ00609
DR   Wikidata; Q54892429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00610
AC   CVCL_3G01
DR   CLO; CLO_0010673
DR   BioSamples; SAME52184
DR   Coriell; HQ00610
DR   Wikidata; Q54892430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00611
AC   CVCL_3G02
DR   CLO; CLO_0010680
DR   BioSamples; SAME52183
DR   Coriell; HQ00611
DR   Wikidata; Q54892431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00612
AC   CVCL_3G03
DR   CLO; CLO_0010679
DR   BioSamples; SAME52186
DR   Coriell; HQ00612
DR   Wikidata; Q54892432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00613
AC   CVCL_3G04
DR   CLO; CLO_0010678
DR   BioSamples; SAME52185
DR   Coriell; HQ00613
DR   Wikidata; Q54892433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00614
AC   CVCL_3G05
DR   CLO; CLO_0010677
DR   BioSamples; SAME52181
DR   Coriell; HQ00614
DR   Wikidata; Q54892434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00615
AC   CVCL_3G06
DR   CLO; CLO_0010682
DR   BioSamples; SAME52180
DR   Coriell; HQ00615
DR   Wikidata; Q54892435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00616
AC   CVCL_3G07
DR   CLO; CLO_0010681
DR   BioSamples; SAME52182
DR   Coriell; HQ00616
DR   Wikidata; Q54892436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00617
AC   CVCL_3G08
DR   Coriell; HQ00617
DR   Wikidata; Q54892437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00618
AC   CVCL_3G09
DR   CLO; CLO_0010754
DR   BioSamples; SAME52178
DR   Coriell; HQ00618
DR   Wikidata; Q54892438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00619
AC   CVCL_3G10
DR   CLO; CLO_0010749
DR   BioSamples; SAME52177
DR   Coriell; HQ00619
DR   Wikidata; Q54892439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00620
AC   CVCL_3G11
DR   CLO; CLO_0010751
DR   BioSamples; SAME52765
DR   Coriell; HQ00620
DR   Wikidata; Q54892440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00621
AC   CVCL_3G12
DR   CLO; CLO_0010747
DR   BioSamples; SAME52766
DR   Coriell; HQ00621
DR   Wikidata; Q54892441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00622
AC   CVCL_3G13
DR   CLO; CLO_0010748
DR   BioSamples; SAME52767
DR   Coriell; HQ00622
DR   Wikidata; Q54892442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00623
AC   CVCL_3G14
DR   CLO; CLO_0010745
DR   BioSamples; SAME52768
DR   Coriell; HQ00623
DR   Wikidata; Q54892443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00624
AC   CVCL_3G15
DR   CLO; CLO_0010746
DR   BioSamples; SAME52769
DR   Coriell; HQ00624
DR   Wikidata; Q54892444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00625
AC   CVCL_3G16
DR   Coriell; HQ00625
DR   Wikidata; Q54892445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00626
AC   CVCL_3G17
DR   Coriell; HQ00626
DR   Wikidata; Q54892446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00627
AC   CVCL_3G18
DR   Coriell; HQ00627
DR   Wikidata; Q54892447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00628
AC   CVCL_3G19
DR   CLO; CLO_0010742
DR   BioSamples; SAME52773
DR   Coriell; HQ00628
DR   Wikidata; Q54892448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00629
AC   CVCL_3G20
DR   CLO; CLO_0010744
DR   BioSamples; SAME52778
DR   Coriell; HQ00629
DR   Wikidata; Q54892449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00630
AC   CVCL_3G21
DR   CLO; CLO_0010740
DR   BioSamples; SAME52522
DR   Coriell; HQ00630
DR   Wikidata; Q54892450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00631
AC   CVCL_3G22
DR   CLO; CLO_0010774
DR   BioSamples; SAME52188
DR   Coriell; HQ00631
DR   Wikidata; Q54892451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00632
AC   CVCL_3G23
DR   CLO; CLO_0010776
DR   BioSamples; SAME52187
DR   Coriell; HQ00632
DR   Wikidata; Q54892452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00633
AC   CVCL_3G24
DR   CLO; CLO_0010767
DR   BioSamples; SAME52519
DR   Coriell; HQ00633
DR   Wikidata; Q54892453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00634
AC   CVCL_3G25
DR   CLO; CLO_0010768
DR   BioSamples; SAME52526
DR   Coriell; HQ00634
DR   Wikidata; Q54892454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00635
AC   CVCL_3G26
DR   CLO; CLO_0010769
DR   BioSamples; SAME52525
DR   Coriell; HQ00635
DR   Wikidata; Q54892455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00636
AC   CVCL_3G27
DR   Coriell; HQ00636
DR   Wikidata; Q54892456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00637
AC   CVCL_3G28
DR   CLO; CLO_0010770
DR   BioSamples; SAME52523
DR   Coriell; HQ00637
DR   Wikidata; Q54892457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00638
AC   CVCL_3G29
DR   CLO; CLO_0010761
DR   BioSamples; SAME52534
DR   Coriell; HQ00638
DR   Wikidata; Q54892458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00639
AC   CVCL_3G30
DR   CLO; CLO_0010762
DR   BioSamples; SAME52529
DR   Coriell; HQ00639
DR   Wikidata; Q54892461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00640
AC   CVCL_3G31
DR   Coriell; HQ00640
DR   Wikidata; Q54892462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00641
AC   CVCL_3G32
DR   CLO; CLO_0010763
DR   BioSamples; SAME52295
DR   Coriell; HQ00641
DR   Wikidata; Q54892463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00642
AC   CVCL_3G33
DR   CLO; CLO_0010765
DR   BioSamples; SAME52293
DR   Coriell; HQ00642
DR   Wikidata; Q54892464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00643
AC   CVCL_3G34
DR   CLO; CLO_0010718
DR   BioSamples; SAME52294
DR   Coriell; HQ00643
DR   Wikidata; Q54892465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00644
AC   CVCL_3G35
DR   CLO; CLO_0010716
DR   BioSamples; SAME52291
DR   Coriell; HQ00644
DR   Wikidata; Q54892466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00645
AC   CVCL_3G36
DR   CLO; CLO_0010717
DR   BioSamples; SAME52292
DR   Coriell; HQ00645
DR   Wikidata; Q54892467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00646
AC   CVCL_3G37
DR   CLO; CLO_0010721
DR   BioSamples; SAME52289
DR   Coriell; HQ00646
DR   Wikidata; Q54892468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00647
AC   CVCL_3G38
DR   CLO; CLO_0010722
DR   BioSamples; SAME52290
DR   Coriell; HQ00647
DR   Wikidata; Q54892469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00648
AC   CVCL_3G39
DR   CLO; CLO_0010719
DR   BioSamples; SAME52302
DR   Coriell; HQ00648
DR   Wikidata; Q54892470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00649
AC   CVCL_3G40
DR   CLO; CLO_0010720
DR   BioSamples; SAME52303
DR   Coriell; HQ00649
DR   Wikidata; Q54892471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00650
AC   CVCL_3G41
DR   CLO; CLO_0010714
DR   BioSamples; SAME52907
DR   Coriell; HQ00650
DR   Wikidata; Q54892472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00651
AC   CVCL_3G42
DR   CLO; CLO_0010715
DR   BioSamples; SAME52906
DR   Coriell; HQ00651
DR   Wikidata; Q54892473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00652
AC   CVCL_3G43
DR   CLO; CLO_0010713
DR   BioSamples; SAME52909
DR   Coriell; HQ00652
DR   Wikidata; Q54892474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00653
AC   CVCL_3G44
DR   CLO; CLO_0010725
DR   BioSamples; SAME52908
DR   Coriell; HQ00653
DR   Wikidata; Q54892475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00654
AC   CVCL_3G45
DR   CLO; CLO_0010726
DR   BioSamples; SAME52911
DR   Coriell; HQ00654
DR   Wikidata; Q54892476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00655
AC   CVCL_3G46
DR   CLO; CLO_0010727
DR   BioSamples; SAME52910
DR   Coriell; HQ00655
DR   Wikidata; Q54892477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00656
AC   CVCL_3G47
DR   CLO; CLO_0010728
DR   BioSamples; SAME52912
DR   Coriell; HQ00656
DR   Wikidata; Q54892478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00657
AC   CVCL_3G48
DR   Coriell; HQ00657
DR   Wikidata; Q54892479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00658
AC   CVCL_3G49
DR   Coriell; HQ00658
DR   Wikidata; Q54892480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00659
AC   CVCL_3G50
DR   Coriell; HQ00659
DR   Wikidata; Q54892481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00660
AC   CVCL_3G51
DR   CLO; CLO_0010729
DR   BioSamples; SAME52675
DR   Coriell; HQ00660
DR   Wikidata; Q54892482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00661
AC   CVCL_3G52
DR   CLO; CLO_0010730
DR   BioSamples; SAME52676
DR   Coriell; HQ00661
DR   Wikidata; Q54892483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00662
AC   CVCL_3G53
DR   CLO; CLO_0010731
DR   BioSamples; SAME52677
DR   Coriell; HQ00662
DR   Wikidata; Q54892484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00663
AC   CVCL_3G54
DR   CLO; CLO_0010732
DR   BioSamples; SAME52678
DR   Coriell; HQ00663
DR   Wikidata; Q54892485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00664
AC   CVCL_3G55
DR   Coriell; HQ00664
DR   Wikidata; Q54892486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00665
AC   CVCL_3G56
DR   Coriell; HQ00665
DR   Wikidata; Q54892487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00666
AC   CVCL_3G57
DR   Coriell; HQ00666
DR   Wikidata; Q54892488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00667
AC   CVCL_3G58
DR   Coriell; HQ00667
DR   Wikidata; Q54892489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00668
AC   CVCL_3G59
DR   CLO; CLO_0010723
DR   BioSamples; SAME52673
DR   Coriell; HQ00668
DR   Wikidata; Q54892491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00669
AC   CVCL_3G60
DR   CLO; CLO_0010724
DR   BioSamples; SAME52674
DR   Coriell; HQ00669
DR   Wikidata; Q54892492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00670
AC   CVCL_3G61
DR   Coriell; HQ00670
DR   Wikidata; Q54892493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00671
AC   CVCL_3G62
DR   CLO; CLO_0010848
DR   BioSamples; SAME52430
DR   Coriell; HQ00671
DR   Wikidata; Q54892494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00672
AC   CVCL_3G63
DR   Coriell; HQ00672
DR   Wikidata; Q54892495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00673
AC   CVCL_3G64
DR   CLO; CLO_0010834
DR   BioSamples; SAME52429
DR   Coriell; HQ00673
DR   Wikidata; Q54892496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00674
AC   CVCL_3G65
DR   CLO; CLO_0010831
DR   BioSamples; SAME52428
DR   Coriell; HQ00674
DR   Wikidata; Q54892497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00675
AC   CVCL_3G66
DR   CLO; CLO_0010830
DR   BioSamples; SAME52427
DR   Coriell; HQ00675
DR   Wikidata; Q54892498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00676
AC   CVCL_3G67
DR   CLO; CLO_0010828
DR   BioSamples; SAME52426
DR   Coriell; HQ00676
DR   Wikidata; Q54892499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00677
AC   CVCL_3G68
DR   CLO; CLO_0010825
DR   BioSamples; SAME52425
DR   Coriell; HQ00677
DR   Wikidata; Q54892501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00678
AC   CVCL_3G69
DR   Coriell; HQ00678
DR   Wikidata; Q54892502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00679
AC   CVCL_3G70
DR   CLO; CLO_0010823
DR   BioSamples; SAME52424
DR   Coriell; HQ00679
DR   Wikidata; Q54892505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00680
AC   CVCL_3G71
DR   CLO; CLO_0010822
DR   BioSamples; SAME52203
DR   Coriell; HQ00680
DR   Wikidata; Q54892506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00681
AC   CVCL_3G72
DR   CLO; CLO_0010820
DR   BioSamples; SAME52204
DR   Coriell; HQ00681
DR   Wikidata; Q54892507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00682
AC   CVCL_3G73
DR   CLO; CLO_0010842
DR   BioSamples; SAME52201
DR   Coriell; HQ00682
DR   Wikidata; Q54892508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00683
AC   CVCL_3G74
DR   CLO; CLO_0010879
DR   BioSamples; SAME52202
DR   Coriell; HQ00683
DR   Wikidata; Q54892509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00684
AC   CVCL_3G75
DR   CLO; CLO_0010880
DR   BioSamples; SAME52207
DR   Coriell; HQ00684
DR   Wikidata; Q54892510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00685
AC   CVCL_3G76
DR   CLO; CLO_0010860
DR   BioSamples; SAME52208
DR   Coriell; HQ00685
DR   Wikidata; Q54892511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00686
AC   CVCL_3G77
DR   CLO; CLO_0010859
DR   BioSamples; SAME52205
DR   Coriell; HQ00686
DR   Wikidata; Q54892512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00687
AC   CVCL_3G78
DR   CLO; CLO_0010864
DR   BioSamples; SAME52206
DR   Coriell; HQ00687
DR   Wikidata; Q54892513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00688
AC   CVCL_3G79
DR   CLO; CLO_0010862
DR   BioSamples; SAME52210
DR   Coriell; HQ00688
DR   Wikidata; Q54892514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00689
AC   CVCL_3G80
DR   CLO; CLO_0010853
DR   BioSamples; SAME52211
DR   Coriell; HQ00689
DR   Wikidata; Q54892515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00690
AC   CVCL_3G81
DR   CLO; CLO_0010850
DR   BioSamples; SAME52799
DR   Coriell; HQ00690
DR   Wikidata; Q54892516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00691
AC   CVCL_3G82
DR   CLO; CLO_0010857
DR   BioSamples; SAME52798
DR   Coriell; HQ00691
DR   Wikidata; Q54892517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00692
AC   CVCL_3G83
DR   CLO; CLO_0010854
DR   BioSamples; SAME52801
DR   Coriell; HQ00692
DR   Wikidata; Q54892518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00693
AC   CVCL_3G84
DR   CLO; CLO_0032236
DR   BioSamples; SAME52800
DR   Coriell; HQ00693
DR   Wikidata; Q54892519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00694
AC   CVCL_3G85
DR   CLO; CLO_0032237
DR   BioSamples; SAME52795
DR   Coriell; HQ00694
DR   Wikidata; Q54892520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00695
AC   CVCL_3G86
DR   CLO; CLO_0032238
DR   BioSamples; SAME52794
DR   Coriell; HQ00695
DR   Wikidata; Q54892521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00696
AC   CVCL_3G87
DR   CLO; CLO_0032233
DR   BioSamples; SAME52757
DR   Coriell; HQ00696
DR   Wikidata; Q54892522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00697
AC   CVCL_3G88
DR   CLO; CLO_0032232
DR   BioSamples; SAME52796
DR   Coriell; HQ00697
DR   Wikidata; Q54892523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00698
AC   CVCL_3G89
DR   CLO; CLO_0032235
DR   BioSamples; SAME52805
DR   Coriell; HQ00698
DR   Wikidata; Q54892524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00699
AC   CVCL_3G90
DR   Coriell; HQ00699
DR   Wikidata; Q54892525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00700
AC   CVCL_3G91
DR   CLO; CLO_0032234
DR   BioSamples; SAME52305
DR   Coriell; HQ00700
DR   Wikidata; Q54892526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00701
AC   CVCL_3G92
DR   CLO; CLO_0032230
DR   BioSamples; SAME52659
DR   Coriell; HQ00701
DR   Wikidata; Q54892527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00702
AC   CVCL_3G93
DR   CLO; CLO_0032229
DR   BioSamples; SAME52658
DR   Coriell; HQ00702
DR   Wikidata; Q54892528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00703
AC   CVCL_3G94
DR   CLO; CLO_0032231
DR   BioSamples; SAME52657
DR   Coriell; HQ00703
DR   Wikidata; Q54892529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00704
AC   CVCL_3G95
DR   CLO; CLO_0032257
DR   BioSamples; SAME52664
DR   Coriell; HQ00704
DR   Wikidata; Q54892531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00705
AC   CVCL_3G96
DR   CLO; CLO_0032258
DR   BioSamples; SAME52663
DR   Coriell; HQ00705
DR   Wikidata; Q54892532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00706
AC   CVCL_3G97
DR   CLO; CLO_0032255
DR   BioSamples; SAME52662
DR   Coriell; HQ00706
DR   Wikidata; Q54892533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00707
AC   CVCL_3G98
DR   CLO; CLO_0032256
DR   BioSamples; SAME52661
DR   Coriell; HQ00707
DR   Wikidata; Q54892534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00708
AC   CVCL_3G99
DR   CLO; CLO_0032252
DR   BioSamples; SAME52173
DR   Coriell; HQ00708
DR   Wikidata; Q54892535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00709
AC   CVCL_3H00
DR   CLO; CLO_0032250
DR   BioSamples; SAME52172
DR   Coriell; HQ00709
DR   Wikidata; Q54892536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00710
AC   CVCL_3H01
DR   CLO; CLO_0032247
DR   BioSamples; SAME52896
DR   Coriell; HQ00710
DR   Wikidata; Q54892537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00711
AC   CVCL_3H02
DR   CLO; CLO_0032245
DR   BioSamples; SAME52897
DR   Coriell; HQ00711
DR   Wikidata; Q54892538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00712
AC   CVCL_3H03
DR   CLO; CLO_0032254
DR   BioSamples; SAME52898
DR   Coriell; HQ00712
DR   Wikidata; Q54892539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00713
AC   CVCL_3H04
DR   CLO; CLO_0032253
DR   BioSamples; SAME52899
DR   Coriell; HQ00713
DR   Wikidata; Q54892540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00714
AC   CVCL_3H05
DR   CLO; CLO_0032274
DR   BioSamples; SAME52900
DR   Coriell; HQ00714
DR   Wikidata; Q54892541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00715
AC   CVCL_3H06
DR   CLO; CLO_0032275
DR   BioSamples; SAME52721
DR   Coriell; HQ00715
DR   Wikidata; Q54892544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00716
AC   CVCL_3H07
DR   CLO; CLO_0032276
DR   BioSamples; SAME52902
DR   Coriell; HQ00716
DR   Wikidata; Q54892545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00717
AC   CVCL_3H08
DR   CLO; CLO_0032277
DR   BioSamples; SAME52304
DR   Coriell; HQ00717
DR   Wikidata; Q54892546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00718
AC   CVCL_3H09
DR   CLO; CLO_0032278
DR   BioSamples; SAME52904
DR   Coriell; HQ00718
DR   Wikidata; Q54892548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00719
AC   CVCL_3H10
DR   CLO; CLO_0032268
DR   BioSamples; SAME52905
DR   Coriell; HQ00719
DR   Wikidata; Q54892553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00720
AC   CVCL_3H11
DR   CLO; CLO_0032266
DR   BioSamples; SAME52301
DR   Coriell; HQ00720
DR   Wikidata; Q54892554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00721
AC   CVCL_3H12
DR   CLO; CLO_0032272
DR   BioSamples; SAME52300
DR   Coriell; HQ00721
DR   Wikidata; Q54892555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00722
AC   CVCL_3H13
DR   Coriell; HQ00722
DR   Wikidata; Q54892556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00723
AC   CVCL_3H14
DR   CLO; CLO_0032271
DR   BioSamples; SAME52473
DR   Coriell; HQ00723
DR   Wikidata; Q54892557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00724
AC   CVCL_3H15
DR   CLO; CLO_0032273
DR   BioSamples; SAME52297
DR   Coriell; HQ00724
DR   Wikidata; Q54892558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00725
AC   CVCL_3H16
DR   CLO; CLO_0032148
DR   BioSamples; SAME52296
DR   Coriell; HQ00725
DR   Wikidata; Q54892559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00726
AC   CVCL_3H17
DR   CLO; CLO_0032147
DR   BioSamples; SAME52299
DR   Coriell; HQ00726
DR   Wikidata; Q54892560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00727
AC   CVCL_3H18
DR   CLO; CLO_0032146
DR   BioSamples; SAME52298
DR   Coriell; HQ00727
DR   Wikidata; Q54892561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00728
AC   CVCL_3H19
DR   CLO; CLO_0032143
DR   BioSamples; SAME52448
DR   Coriell; HQ00728
DR   Wikidata; Q54892562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00729
AC   CVCL_3H20
DR   CLO; CLO_0032142
DR   BioSamples; SAME52446
DR   Coriell; HQ00729
DR   Wikidata; Q54892563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00730
AC   CVCL_3H21
DR   CLO; CLO_0032140
DR   BioSamples; SAME52472
DR   Coriell; HQ00730
DR   Wikidata; Q54892564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00731
AC   CVCL_3H22
DR   CLO; CLO_0032125
DR   BioSamples; SAME52530
DR   Coriell; HQ00731
DR   Wikidata; Q54892565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00732
AC   CVCL_3H23
DR   CLO; CLO_0032127
DR   BioSamples; SAME52527
DR   Coriell; HQ00732
DR   Wikidata; Q54892566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00733
AC   CVCL_3H24
DR   CLO; CLO_0032122
DR   BioSamples; SAME52528
DR   Coriell; HQ00733
DR   Wikidata; Q54892567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00734
AC   CVCL_3H25
DR   Coriell; HQ00734
DR   Wikidata; Q54892568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00735
AC   CVCL_3H26
DR   CLO; CLO_0032124
DR   BioSamples; SAME52533
DR   Coriell; HQ00735
DR   Wikidata; Q54892569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00736
AC   CVCL_3H27
DR   CLO; CLO_0032166
DR   BioSamples; SAME52531
DR   Coriell; HQ00736
DR   Wikidata; Q54892570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00737
AC   CVCL_3H28
DR   Coriell; HQ00737
DR   Wikidata; Q54892571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00738
AC   CVCL_3H29
DR   CLO; CLO_0032168
DR   BioSamples; SAME52881
DR   Coriell; HQ00738
DR   Wikidata; Q54892572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00739
AC   CVCL_3H30
DR   CLO; CLO_0032167
DR   BioSamples; SAME52189
DR   Coriell; HQ00739
DR   Wikidata; Q54892573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00740
AC   CVCL_3H31
DR   CLO; CLO_0032163
DR   BioSamples; SAME52571
DR   Coriell; HQ00740
DR   Wikidata; Q54892574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00741
AC   CVCL_3H32
DR   CLO; CLO_0032162
DR   BioSamples; SAME52570
DR   Coriell; HQ00741
DR   Wikidata; Q54892575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00742
AC   CVCL_3H33
DR   CLO; CLO_0032165
DR   BioSamples; SAME52569
DR   Coriell; HQ00742
DR   Wikidata; Q54892577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00743
AC   CVCL_3H34
DR   CLO; CLO_0032164
DR   BioSamples; SAME52568
DR   Coriell; HQ00743
DR   Wikidata; Q54892578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00744
AC   CVCL_3H35
DR   Coriell; HQ00744
DR   Wikidata; Q54892579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00745
AC   CVCL_3H36
DR   CLO; CLO_0032151
DR   BioSamples; SAME52567
DR   Coriell; HQ00745
DR   Wikidata; Q54892580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00746
AC   CVCL_3H37
DR   Coriell; HQ00746
DR   Wikidata; Q54892581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00747
AC   CVCL_3H38
DR   CLO; CLO_0032153
DR   BioSamples; SAME52566
DR   Coriell; HQ00747
DR   Wikidata; Q54892582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00748
AC   CVCL_3H39
DR   CLO; CLO_0032154
DR   BioSamples; SAME52565
DR   Coriell; HQ00748
DR   Wikidata; Q54892583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00749
AC   CVCL_3H40
DR   CLO; CLO_0032190
DR   BioSamples; SAME52564
DR   Coriell; HQ00749
DR   Wikidata; Q54892584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00750
AC   CVCL_3H41
DR   CLO; CLO_0032187
DR   BioSamples; SAME52804
DR   Coriell; HQ00750
DR   Wikidata; Q54892586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00751
AC   CVCL_3H42
DR   CLO; CLO_0032186
DR   BioSamples; SAME52169
DR   Coriell; HQ00751
DR   Wikidata; Q54892587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00752
AC   CVCL_3H43
DR   CLO; CLO_0032185
DR   BioSamples; SAME52806
DR   Coriell; HQ00752
DR   Wikidata; Q54892588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00753
AC   CVCL_3H44
DR   CLO; CLO_0032198
DR   BioSamples; SAME52171
DR   Coriell; HQ00753
DR   Wikidata; Q54892589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00754
AC   CVCL_3H45
DR   CLO; CLO_0032196
DR   BioSamples; SAME52802
DR   Coriell; HQ00754
DR   Wikidata; Q54892590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00755
AC   CVCL_3H46
DR   CLO; CLO_0032193
DR   BioSamples; SAME52162
DR   Coriell; HQ00755
DR   Wikidata; Q54892591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00756
AC   CVCL_3H47
DR   Coriell; HQ00756
DR   Wikidata; Q54892592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00757
AC   CVCL_3H48
DR   Coriell; HQ00757
DR   Wikidata; Q54892593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00758
AC   CVCL_3H49
DR   CLO; CLO_0032191
DR   BioSamples; SAME52155
DR   Coriell; HQ00758
DR   Wikidata; Q54892595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00759
AC   CVCL_3H50
DR   CLO; CLO_0032171
DR   BioSamples; SAME52156
DR   Coriell; HQ00759
DR   Wikidata; Q54892600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00760
AC   CVCL_3H51
DR   CLO; CLO_0032173
DR   BioSamples; SAME52209
DR   Coriell; HQ00760
DR   Wikidata; Q54892601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00761
AC   CVCL_3H52
DR   Coriell; HQ00761
DR   Wikidata; Q54892602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00762
AC   CVCL_3H53
DR   CLO; CLO_0032214
DR   BioSamples; SAME52724
DR   Coriell; HQ00762
DR   Wikidata; Q54892603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00763
AC   CVCL_3H54
DR   Coriell; HQ00763
DR   Wikidata; Q54892604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00764
AC   CVCL_3H55
DR   CLO; CLO_0032218
DR   BioSamples; SAME52213
DR   Coriell; HQ00764
DR   Wikidata; Q54892605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00765
AC   CVCL_3H56
DR   CLO; CLO_0032217
DR   BioSamples; SAME52212
DR   Coriell; HQ00765
DR   Wikidata; Q54892606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00766
AC   CVCL_3H57
DR   CLO; CLO_0032220
DR   BioSamples; SAME52215
DR   Coriell; HQ00766
DR   Wikidata; Q54892607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00767
AC   CVCL_3H58
DR   CLO; CLO_0032219
DR   BioSamples; SAME52214
DR   Coriell; HQ00767
DR   Wikidata; Q54892608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00768
AC   CVCL_3H59
DR   CLO; CLO_0032224
DR   BioSamples; SAME52696
DR   Coriell; HQ00768
DR   Wikidata; Q54892609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00769
AC   CVCL_3H60
DR   CLO; CLO_0032221
DR   BioSamples; SAME52694
DR   Coriell; HQ00769
DR   Wikidata; Q54892610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00770
AC   CVCL_3H61
DR   Coriell; HQ00770
DR   Wikidata; Q54892611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00771
AC   CVCL_3H62
DR   CLO; CLO_0032227
DR   BioSamples; SAME52415
DR   Coriell; HQ00771
DR   Wikidata; Q54892612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00772
AC   CVCL_3H63
DR   CLO; CLO_0032225
DR   BioSamples; SAME52413
DR   Coriell; HQ00772
DR   Wikidata; Q54892613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00773
AC   CVCL_3H64
DR   Coriell; HQ00773
DR   Wikidata; Q54892614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00774
AC   CVCL_3H65
DR   CLO; CLO_0032200
DR   BioSamples; SAME52412
DR   Coriell; HQ00774
DR   Wikidata; Q54892615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00775
AC   CVCL_3H66
DR   Coriell; HQ00775
DR   Wikidata; Q54892616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00776
AC   CVCL_3H67
DR   CLO; CLO_0031838
DR   BioSamples; SAME52410
DR   Coriell; HQ00776
DR   Wikidata; Q54892617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00777
AC   CVCL_3H68
DR   CLO; CLO_0031839
DR   BioSamples; SAME52411
DR   Coriell; HQ00777
DR   Wikidata; Q54892618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00778
AC   CVCL_3H69
DR   CLO; CLO_0031829
DR   BioSamples; SAME52408
DR   Coriell; HQ00778
DR   Wikidata; Q54892619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00779
AC   CVCL_3H70
DR   CLO; CLO_0031831
DR   BioSamples; SAME52409
DR   Coriell; HQ00779
DR   Wikidata; Q54892620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00780
AC   CVCL_3H71
DR   CLO; CLO_0031832
DR   BioSamples; SAME52404
DR   Coriell; HQ00780
DR   Wikidata; Q54892621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00781
AC   CVCL_3H72
DR   CLO; CLO_0031833
DR   BioSamples; SAME52403
DR   Coriell; HQ00781
DR   Wikidata; Q54892622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00782
AC   CVCL_3H73
DR   CLO; CLO_0031834
DR   BioSamples; SAME52402
DR   Coriell; HQ00782
DR   Wikidata; Q54892623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00783
AC   CVCL_3H74
DR   CLO; CLO_0031835
DR   BioSamples; SAME52401
DR   Coriell; HQ00783
DR   Wikidata; Q54892624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00784
AC   CVCL_3H75
DR   CLO; CLO_0031836
DR   BioSamples; SAME52407
DR   Coriell; HQ00784
DR   Wikidata; Q54892625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00785
AC   CVCL_3H76
DR   CLO; CLO_0031837
DR   BioSamples; SAME52406
DR   Coriell; HQ00785
DR   Wikidata; Q54892626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00786
AC   CVCL_3H77
DR   CLO; CLO_0031818
DR   BioSamples; SAME52405
DR   Coriell; HQ00786
DR   Wikidata; Q54892627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00787
AC   CVCL_3H78
DR   Coriell; HQ00787
DR   Wikidata; Q54892628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00788
AC   CVCL_3H79
DR   CLO; CLO_0031816
DR   BioSamples; SAME52400
DR   Coriell; HQ00788
DR   Wikidata; Q54892629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00789
AC   CVCL_3H80
DR   CLO; CLO_0031817
DR   BioSamples; SAME52399
DR   Coriell; HQ00789
DR   Wikidata; Q54892630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00790
AC   CVCL_3H81
DR   CLO; CLO_0031811
DR   BioSamples; SAME52642
DR   Coriell; HQ00790
DR   Wikidata; Q54892631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00791
AC   CVCL_3H82
DR   Coriell; HQ00791
DR   Wikidata; Q54892632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00792
AC   CVCL_3H83
DR   CLO; CLO_0031812
DR   BioSamples; SAME52643
DR   Coriell; HQ00792
DR   Wikidata; Q54892633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00793
AC   CVCL_3H84
DR   CLO; CLO_0031809
DR   BioSamples; SAME52644
DR   Coriell; HQ00793
DR   Wikidata; Q54892634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00794
AC   CVCL_3H85
DR   Coriell; HQ00794
DR   Wikidata; Q54892635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00795
AC   CVCL_3H86
DR   Coriell; HQ00795
DR   Wikidata; Q54892636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00796
AC   CVCL_3H87
DR   CLO; CLO_0031810
DR   BioSamples; SAME52645
DR   Coriell; HQ00796
DR   Wikidata; Q54892637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00797
AC   CVCL_3H88
DR   CLO; CLO_0031814
DR   BioSamples; SAME52646
DR   Coriell; HQ00797
DR   Wikidata; Q54892638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00798
AC   CVCL_3H89
DR   CLO; CLO_0031815
DR   BioSamples; SAME52640
DR   Coriell; HQ00798
DR   Wikidata; Q54892639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00799
AC   CVCL_3H90
DR   Coriell; HQ00799
DR   Wikidata; Q54892648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00800
AC   CVCL_3H91
DR   CLO; CLO_0031813
DR   BioSamples; SAME52616
DR   Coriell; HQ00800
DR   Wikidata; Q54892650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00801
AC   CVCL_3H92
DR   CLO; CLO_0031872
DR   BioSamples; SAME52617
DR   Coriell; HQ00801
DR   Wikidata; Q54892651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00802
AC   CVCL_3H93
DR   CLO; CLO_0031874
DR   BioSamples; SAME52618
DR   Coriell; HQ00802
DR   Wikidata; Q54892652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00803
AC   CVCL_3H94
DR   Coriell; HQ00803
DR   Wikidata; Q54892653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00804
AC   CVCL_3H95
DR   CLO; CLO_0031876
DR   BioSamples; SAME52612
DR   Coriell; HQ00804
DR   Wikidata; Q54892654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00805
AC   CVCL_3H96
DR   CLO; CLO_0031879
DR   BioSamples; SAME52613
DR   Coriell; HQ00805
DR   Wikidata; Q54892655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00806
AC   CVCL_3H97
DR   CLO; CLO_0031861
DR   BioSamples; SAME52614
DR   Coriell; HQ00806
DR   Wikidata; Q54892656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00807
AC   CVCL_3H98
DR   CLO; CLO_0031865
DR   BioSamples; SAME52615
DR   Coriell; HQ00807
DR   Wikidata; Q54892657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00808
AC   CVCL_3H99
DR   CLO; CLO_0031867
DR   BioSamples; SAME52620
DR   Coriell; HQ00808
DR   Wikidata; Q54892658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00809
AC   CVCL_3I00
DR   CLO; CLO_0031870
DR   BioSamples; SAME52621
DR   Coriell; HQ00809
DR   Wikidata; Q54892659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00810
AC   CVCL_3I01
DR   CLO; CLO_0031859
DR   BioSamples; SAME52379
DR   Coriell; HQ00810
DR   Wikidata; Q54892660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00811
AC   CVCL_3I02
DR   Coriell; HQ00811
DR   Wikidata; Q54892661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00812
AC   CVCL_3I03
DR   CLO; CLO_0031860
DR   BioSamples; SAME52924
DR   Coriell; HQ00812
DR   Wikidata; Q54892662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00813
AC   CVCL_3I04
DR   CLO; CLO_0028750
DR   BioSamples; SAME52377
DR   Coriell; HQ00813
DR   Wikidata; Q54892663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00814
AC   CVCL_3I05
DR   CLO; CLO_0028752
DR   BioSamples; SAME52376
DR   Coriell; HQ00814
DR   Wikidata; Q54892664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00815
AC   CVCL_3I06
DR   CLO; CLO_0028743
DR   BioSamples; SAME52375
DR   Coriell; HQ00815
DR   Wikidata; Q54892665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00816
AC   CVCL_3I07
DR   CLO; CLO_0028741
DR   BioSamples; SAME52374
DR   Coriell; HQ00816
DR   Wikidata; Q54892666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00819
AC   CVCL_3I08
DR   CLO; CLO_0028746
DR   BioSamples; SAME52381
DR   Coriell; HQ00819
DR   Wikidata; Q54892667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00820
AC   CVCL_3I09
DR   CLO; CLO_0028745
DR   BioSamples; SAME52265
DR   Coriell; HQ00820
DR   Wikidata; Q54892668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00821
AC   CVCL_3I10
DR   CLO; CLO_0028736
DR   BioSamples; SAME52266
DR   Coriell; HQ00821
DR   Wikidata; Q54892669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00822
AC   CVCL_3I11
DR   CLO; CLO_0028732
DR   BioSamples; SAME52263
DR   Coriell; HQ00822
DR   Wikidata; Q54892670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00823
AC   CVCL_3I12
DR   CLO; CLO_0028740
DR   BioSamples; SAME52264
DR   Coriell; HQ00823
DR   Wikidata; Q54892671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00824
AC   CVCL_3I13
DR   Coriell; HQ00824
DR   Wikidata; Q54892672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00825
AC   CVCL_3I14
DR   Coriell; HQ00825
DR   Wikidata; Q54892673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00826
AC   CVCL_3I15
DR   CLO; CLO_0028738
DR   BioSamples; SAME52261
DR   Coriell; HQ00826
DR   Wikidata; Q54892674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00827
AC   CVCL_3I16
DR   CLO; CLO_0028611
DR   BioSamples; SAME52262
DR   Coriell; HQ00827
DR   Wikidata; Q54892675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00828
AC   CVCL_3I17
DR   CLO; CLO_0028614
DR   BioSamples; SAME52259
DR   Coriell; HQ00828
DR   Wikidata; Q54892677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00829
AC   CVCL_3I18
DR   CLO; CLO_0028613
DR   BioSamples; SAME52260
DR   Coriell; HQ00829
DR   Wikidata; Q54892678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00830
AC   CVCL_3I19
DR   CLO; CLO_0028615
DR   BioSamples; SAME52864
DR   Coriell; HQ00830
DR   Wikidata; Q54892679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00831
AC   CVCL_3I20
DR   CLO; CLO_0028616
DR   BioSamples; SAME52863
DR   Coriell; HQ00831
DR   Wikidata; Q54892680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00832
AC   CVCL_3I21
DR   CLO; CLO_0028618
DR   BioSamples; SAME52865
DR   Coriell; HQ00832
DR   Wikidata; Q54892681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00833
AC   CVCL_3I22
DR   Coriell; HQ00833
DR   Wikidata; Q54892682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00834
AC   CVCL_3I23
DR   CLO; CLO_0028619
DR   BioSamples; SAME52867
DR   Coriell; HQ00834
DR   Wikidata; Q54892683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00835
AC   CVCL_3I24
DR   CLO; CLO_0028620
DR   BioSamples; SAME52866
DR   Coriell; HQ00835
DR   Wikidata; Q54892684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00836
AC   CVCL_3I25
DR   CLO; CLO_0028622
DR   BioSamples; SAME52869
DR   Coriell; HQ00836
DR   Wikidata; Q54892685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00837
AC   CVCL_3I26
DR   Coriell; HQ00837
DR   Wikidata; Q54892686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00838
AC   CVCL_3I27
DR   CLO; CLO_0028624
DR   BioSamples; SAME52871
DR   Coriell; HQ00838
DR   Wikidata; Q54892687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00839
AC   CVCL_3I28
DR   CLO; CLO_0028582
DR   BioSamples; SAME52870
DR   Coriell; HQ00839
DR   Wikidata; Q54892688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00840
AC   CVCL_3I29
DR   CLO; CLO_0028580
DR   BioSamples; SAME52725
DR   Coriell; HQ00840
DR   Wikidata; Q54892690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00841
AC   CVCL_3I30
DR   CLO; CLO_0028579
DR   BioSamples; SAME52726
DR   Coriell; HQ00841
DR   Wikidata; Q54892695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00842
AC   CVCL_3I31
DR   CLO; CLO_0028578
DR   BioSamples; SAME52727
DR   Coriell; HQ00842
DR   Wikidata; Q54892696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00843
AC   CVCL_3I32
DR   CLO; CLO_0028588
DR   BioSamples; SAME52728
DR   Coriell; HQ00843
DR   Wikidata; Q54892697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00844
AC   CVCL_3I33
DR   Coriell; HQ00844
DR   Wikidata; Q54892698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00845
AC   CVCL_3I34
DR   CLO; CLO_0028589
DR   BioSamples; SAME52729
DR   Coriell; HQ00845
DR   Wikidata; Q54892699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00846
AC   CVCL_3I35
DR   CLO; CLO_0028584
DR   BioSamples; SAME52730
DR   Coriell; HQ00846
DR   Wikidata; Q54892700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00847
AC   CVCL_3I36
DR   CLO; CLO_0028587
DR   BioSamples; SAME52731
DR   Coriell; HQ00847
DR   Wikidata; Q54892701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00848
AC   CVCL_3I37
DR   CLO; CLO_0028592
DR   BioSamples; SAME52722
DR   Coriell; HQ00848
DR   Wikidata; Q54892702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00849
AC   CVCL_3I38
DR   CLO; CLO_0028595
DR   BioSamples; SAME52723
DR   Coriell; HQ00849
DR   Wikidata; Q54892705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00850
AC   CVCL_3I39
DR   Coriell; HQ00850
DR   Wikidata; Q54892706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00851
AC   CVCL_3I40
DR   CLO; CLO_0028678
DR   BioSamples; SAME52479
DR   Coriell; HQ00851
DR   Wikidata; Q54892707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00852
AC   CVCL_3I41
DR   CLO; CLO_0028665
DR   BioSamples; SAME52478
DR   Coriell; HQ00852
DR   Wikidata; Q54892708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00853
AC   CVCL_3I42
DR   Coriell; HQ00853
DR   Wikidata; Q54892709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00854
AC   CVCL_3I43
DR   CLO; CLO_0028663
DR   BioSamples; SAME52484
DR   Coriell; HQ00854
DR   Wikidata; Q54892710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00855
AC   CVCL_3I44
DR   CLO; CLO_0028671
DR   BioSamples; SAME52483
DR   Coriell; HQ00855
DR   Wikidata; Q54892711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00856
AC   CVCL_3I45
DR   CLO; CLO_0028669
DR   BioSamples; SAME52482
DR   Coriell; HQ00856
DR   Wikidata; Q54892712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00857
AC   CVCL_3I46
DR   CLO; CLO_0028685
DR   BioSamples; SAME52481
DR   Coriell; HQ00857
DR   Wikidata; Q54892713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00858
AC   CVCL_3I47
DR   CLO; CLO_0028686
DR   BioSamples; SAME52476
DR   Coriell; HQ00858
DR   Wikidata; Q54892714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00859
AC   CVCL_3I48
DR   CLO; CLO_0028687
DR   BioSamples; SAME52475
DR   Coriell; HQ00859
DR   Wikidata; Q54892715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00860
AC   CVCL_3I49
DR   Coriell; HQ00860
DR   Wikidata; Q54892716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00861
AC   CVCL_3I50
DR   CLO; CLO_0028688
DR   BioSamples; SAME52347
DR   Coriell; HQ00861
DR   Wikidata; Q54892717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00862
AC   CVCL_3I51
DR   CLO; CLO_0028681
DR   BioSamples; SAME52345
DR   Coriell; HQ00862
DR   Wikidata; Q54892718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00863
AC   CVCL_3I52
DR   Coriell; HQ00863
DR   Wikidata; Q54892719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00864
AC   CVCL_3I53
DR   Coriell; HQ00864
DR   Wikidata; Q54892720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00865
AC   CVCL_3I54
DR   CLO; CLO_0028644
DR   BioSamples; SAME52350
DR   Coriell; HQ00865
DR   Wikidata; Q54892721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00866
AC   CVCL_3I55
DR   CLO; CLO_0028641
DR   BioSamples; SAME52348
DR   Coriell; HQ00866
DR   Wikidata; Q54892722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00867
AC   CVCL_3I56
DR   CLO; CLO_0028639
DR   BioSamples; SAME52349
DR   Coriell; HQ00867
DR   Wikidata; Q54892723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00868
AC   CVCL_3I57
DR   CLO; CLO_0028636
DR   BioSamples; SAME52351
DR   Coriell; HQ00868
DR   Wikidata; Q54892724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00869
AC   CVCL_3I58
DR   CLO; CLO_0028633
DR   BioSamples; SAME52352
DR   Coriell; HQ00869
DR   Wikidata; Q54892725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00870
AC   CVCL_3I59
DR   CLO; CLO_0028630
DR   BioSamples; SAME52145
DR   Coriell; HQ00870
DR   Wikidata; Q54892726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00871
AC   CVCL_3I60
DR   CLO; CLO_0028656
DR   BioSamples; SAME52144
DR   Coriell; HQ00871
DR   Wikidata; Q54892727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00872
AC   CVCL_3I61
DR   CLO; CLO_0028657
DR   BioSamples; SAME52147
DR   Coriell; HQ00872
DR   Wikidata; Q54892728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00873
AC   CVCL_3I62
DR   CLO; CLO_0028654
DR   BioSamples; SAME52146
DR   Coriell; HQ00873
DR   Wikidata; Q54892729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00874
AC   CVCL_3I63
DR   CLO; CLO_0028655
DR   BioSamples; SAME52142
DR   Coriell; HQ00874
DR   Wikidata; Q54892730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00875
AC   CVCL_3I64
DR   CLO; CLO_0028506
DR   BioSamples; SAME52141
DR   Coriell; HQ00875
DR   Wikidata; Q54892731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00876
AC   CVCL_3I65
DR   CLO; CLO_0028511
DR   BioSamples; SAME52170
DR   Coriell; HQ00876
DR   Wikidata; Q54892732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00878
AC   CVCL_3I66
DR   Coriell; HQ00878
DR   Wikidata; Q54892733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00879
AC   CVCL_3I67
DR   CLO; CLO_0028512
DR   BioSamples; SAME52148
DR   Coriell; HQ00879
DR   Wikidata; Q54892734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00880
AC   CVCL_3I68
DR   CLO; CLO_0028517
DR   BioSamples; SAME52825
DR   Coriell; HQ00880
DR   Wikidata; Q54892735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00881
AC   CVCL_3I69
DR   Coriell; HQ00881
DR   Wikidata; Q54892736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00882
AC   CVCL_3I70
DR   CLO; CLO_0028518
DR   BioSamples; SAME52827
DR   Coriell; HQ00882
DR   Wikidata; Q54892739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00883
AC   CVCL_3I71
DR   CLO; CLO_0028522
DR   BioSamples; SAME52828
DR   Coriell; HQ00883
DR   Wikidata; Q54892740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00884
AC   CVCL_3I72
DR   Coriell; HQ00884
DR   Wikidata; Q54892741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00885
AC   CVCL_3I73
DR   CLO; CLO_0028524
DR   BioSamples; SAME52824
DR   Coriell; HQ00885
DR   Wikidata; Q54892743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00886
AC   CVCL_3I74
DR   Coriell; HQ00886
DR   Wikidata; Q54892744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00887
AC   CVCL_3I75
DR   Coriell; HQ00887
DR   Wikidata; Q54892745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00888
AC   CVCL_3I76
DR   CLO; CLO_0028532
DR   BioSamples; SAME52823
DR   Coriell; HQ00888
DR   Wikidata; Q54892746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00889
AC   CVCL_3I77
DR   Coriell; HQ00889
DR   Wikidata; Q54892747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00890
AC   CVCL_3I78
DR   CLO; CLO_0028531
DR   BioSamples; SAME52594
DR   Coriell; HQ00890
DR   Wikidata; Q54892748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00891
AC   CVCL_3I79
DR   CLO; CLO_0028533
DR   BioSamples; SAME52593
DR   Coriell; HQ00891
DR   Wikidata; Q54892749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00892
AC   CVCL_3I80
DR   CLO; CLO_0028481
DR   BioSamples; SAME52592
DR   Coriell; HQ00892
DR   Wikidata; Q54892750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00893
AC   CVCL_3I81
DR   CLO; CLO_0028483
DR   BioSamples; SAME52591
DR   Coriell; HQ00893
DR   Wikidata; Q54892751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00894
AC   CVCL_3I82
DR   CLO; CLO_0028473
DR   BioSamples; SAME52590
DR   Coriell; HQ00894
DR   Wikidata; Q54892752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00895
AC   CVCL_3I83
DR   CLO; CLO_0028476
DR   BioSamples; SAME52589
DR   Coriell; HQ00895
DR   Wikidata; Q54892753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00896
AC   CVCL_3I84
DR   CLO; CLO_0028492
DR   BioSamples; SAME52588
DR   Coriell; HQ00896
DR   Wikidata; Q54892754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00897
AC   CVCL_3I85
DR   Coriell; HQ00897
DR   Wikidata; Q54892755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00898
AC   CVCL_3I86
DR   CLO; CLO_0028496
DR   BioSamples; SAME52587
DR   Coriell; HQ00898
DR   Wikidata; Q54892756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00899
AC   CVCL_3I87
DR   CLO; CLO_0028487
DR   BioSamples; SAME52586
DR   Coriell; HQ00899
DR   Wikidata; Q54892757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00900
AC   CVCL_3I88
DR   Coriell; HQ00900
DR   Wikidata; Q54892758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00901
AC   CVCL_3I89
DR   Coriell; HQ00901
DR   Wikidata; Q54892759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00902
AC   CVCL_3I90
DR   CLO; CLO_0028488
DR   BioSamples; SAME52750
DR   Coriell; HQ00902
DR   Wikidata; Q54892760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00903
AC   CVCL_3I91
DR   CLO; CLO_0028500
DR   BioSamples; SAME52749
DR   Coriell; HQ00903
DR   Wikidata; Q54892761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00904
AC   CVCL_3I92
DR   CLO; CLO_0028499
DR   BioSamples; SAME52746
DR   Coriell; HQ00904
DR   Wikidata; Q54892762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00905
AC   CVCL_3I93
DR   CLO; CLO_0028563
DR   BioSamples; SAME52745
DR   Coriell; HQ00905
DR   Wikidata; Q54892763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00906
AC   CVCL_3I94
DR   CLO; CLO_0028559
DR   BioSamples; SAME52748
DR   Coriell; HQ00906
DR   Wikidata; Q54892764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00907
AC   CVCL_3I95
DR   CLO; CLO_0028560
DR   BioSamples; SAME52747
DR   Coriell; HQ00907
DR   Wikidata; Q54892765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00908
AC   CVCL_3I96
DR   Coriell; HQ00908
DR   Wikidata; Q54892766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00909
AC   CVCL_3I97
DR   CLO; CLO_0028561
DR   BioSamples; SAME52744
DR   Coriell; HQ00909
DR   Wikidata; Q54892767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00910
AC   CVCL_3I98
DR   CLO; CLO_0028562
DR   BioSamples; SAME52165
DR   Coriell; HQ00910
DR   Wikidata; Q54892768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00911
AC   CVCL_3I99
DR   CLO; CLO_0028555
DR   BioSamples; SAME52166
DR   Coriell; HQ00911
DR   Wikidata; Q54892769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00912
AC   CVCL_3J00
DR   CLO; CLO_0028556
DR   BioSamples; SAME52163
DR   Coriell; HQ00912
DR   Wikidata; Q54892770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00913
AC   CVCL_3J01
DR   CLO; CLO_0028557
DR   BioSamples; SAME52164
DR   Coriell; HQ00913
DR   Wikidata; Q54892771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00914
AC   CVCL_3J02
DR   Coriell; HQ00914
DR   Wikidata; Q54892772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00915
AC   CVCL_3J03
DR   CLO; CLO_0028558
DR   BioSamples; SAME52168
DR   Coriell; HQ00915
DR   Wikidata; Q54892773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00916
AC   CVCL_3J04
DR   CLO; CLO_0028564
DR   BioSamples; SAME52167
DR   Coriell; HQ00916
DR   Wikidata; Q54892774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00917
AC   CVCL_3J05
DR   Coriell; HQ00917
DR   Wikidata; Q54892775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00918
AC   CVCL_3J06
DR   CLO; CLO_0028550
DR   BioSamples; SAME52160
DR   Coriell; HQ00918
DR   Wikidata; Q54892776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00919
AC   CVCL_3J07
DR   CLO; CLO_0028551
DR   BioSamples; SAME52161
DR   Coriell; HQ00919
DR   Wikidata; Q54892777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00920
AC   CVCL_3J08
DR   CLO; CLO_0028547
DR   BioSamples; SAME52281
DR   Coriell; HQ00920
DR   Wikidata; Q54892778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00921
AC   CVCL_3J09
DR   CLO; CLO_0028549
DR   BioSamples; SAME52280
DR   Coriell; HQ00921
DR   Wikidata; Q54892779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00922
AC   CVCL_3J10
DR   CLO; CLO_0028544
DR   BioSamples; SAME52279
DR   Coriell; HQ00922
DR   Wikidata; Q54892782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00923
AC   CVCL_3J11
DR   CLO; CLO_0028546
DR   BioSamples; SAME52278
DR   Coriell; HQ00923
DR   Wikidata; Q54892784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00924
AC   CVCL_3J12
DR   Coriell; HQ00924
DR   Wikidata; Q54892785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00925
AC   CVCL_3J13
DR   Coriell; HQ00925
DR   Wikidata; Q54892786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00926
AC   CVCL_3J14
DR   Coriell; HQ00926
DR   Wikidata; Q54892787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00927
AC   CVCL_3J15
DR   CLO; CLO_0028539
DR   BioSamples; SAME52282
DR   Coriell; HQ00927
DR   Wikidata; Q54892788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00928
AC   CVCL_3J16
DR   CLO; CLO_0028541
DR   BioSamples; SAME52285
DR   Coriell; HQ00928
DR   Wikidata; Q54892789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00929
AC   CVCL_3J17
DR   Coriell; HQ00929
DR   Wikidata; Q54892790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00930
AC   CVCL_3J18
DR   Coriell; HQ00930
DR   Wikidata; Q54892791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00931
AC   CVCL_3J19
DR   Coriell; HQ00931
DR   Wikidata; Q54892792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00932
AC   CVCL_3J20
DR   CLO; CLO_0028536
DR   BioSamples; SAME52503
DR   Coriell; HQ00932
DR   Wikidata; Q54892793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00933
AC   CVCL_3J21
DR   CLO; CLO_0028538
DR   BioSamples; SAME52504
DR   Coriell; HQ00933
DR   Wikidata; Q54892794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00934
AC   CVCL_3J22
DR   Coriell; HQ00934
DR   Wikidata; Q54892795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00935
AC   CVCL_3J23
DR   CLO; CLO_0029125
DR   BioSamples; SAME52922
DR   Coriell; HQ00935
DR   Wikidata; Q54892796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00936
AC   CVCL_3J24
DR   CLO; CLO_0029124
DR   BioSamples; SAME52506
DR   Coriell; HQ00936
DR   Wikidata; Q54892797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00937
AC   CVCL_3J25
DR   Coriell; HQ00937
DR   Wikidata; Q54892798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00938
AC   CVCL_3J26
DR   CLO; CLO_0029123
DR   BioSamples; SAME52507
DR   Coriell; HQ00938
DR   Wikidata; Q54892799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00939
AC   CVCL_3J27
DR   CLO; CLO_0029132
DR   BioSamples; SAME52508
DR   Coriell; HQ00939
DR   Wikidata; Q54892800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00940
AC   CVCL_3J28
DR   CLO; CLO_0029131
DR   BioSamples; SAME52633
DR   Coriell; HQ00940
DR   Wikidata; Q54892801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00941
AC   CVCL_3J29
DR   Coriell; HQ00941
DR   Wikidata; Q54892802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00943
AC   CVCL_3J30
DR   CLO; CLO_0029130
DR   BioSamples; SAME52634
DR   Coriell; HQ00943
DR   Wikidata; Q54892803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00944
AC   CVCL_3J31
DR   CLO; CLO_0029129
DR   BioSamples; SAME52636
DR   Coriell; HQ00944
DR   Wikidata; Q54892804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00945
AC   CVCL_3J32
DR   CLO; CLO_0029128
DR   BioSamples; SAME52635
DR   Coriell; HQ00945
DR   Wikidata; Q54892805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00946
AC   CVCL_3J33
DR   CLO; CLO_0029127
DR   BioSamples; SAME52638
DR   Coriell; HQ00946
DR   Wikidata; Q54892806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00947
AC   CVCL_3J34
DR   CLO; CLO_0029126
DR   BioSamples; SAME52637
DR   Coriell; HQ00947
DR   Wikidata; Q54892807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00948
AC   CVCL_3J35
DR   CLO; CLO_0029427
DR   BioSamples; SAME52632
DR   Coriell; HQ00948
DR   Wikidata; Q54892808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00949
AC   CVCL_3J36
DR   Coriell; HQ00949
DR   Wikidata; Q54892809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00950
AC   CVCL_3J37
DR   CLO; CLO_0029412
DR   BioSamples; SAME52887
DR   Coriell; HQ00950
DR   Wikidata; Q54892810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00951
AC   CVCL_3J38
DR   CLO; CLO_0029409
DR   BioSamples; SAME52888
DR   Coriell; HQ00951
DR   Wikidata; Q54892812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00952
AC   CVCL_3J39
DR   CLO; CLO_0029415
DR   BioSamples; SAME52885
DR   Coriell; HQ00952
DR   Wikidata; Q54892813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00953
AC   CVCL_3J40
DR   CLO; CLO_0029414
DR   BioSamples; SAME52886
DR   Coriell; HQ00953
DR   Wikidata; Q54892815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00954
AC   CVCL_3J41
DR   CLO; CLO_0029420
DR   BioSamples; SAME52884
DR   Coriell; HQ00954
DR   Wikidata; Q54892816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00955
AC   CVCL_3J42
DR   Coriell; HQ00955
DR   Wikidata; Q54892817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00956
AC   CVCL_3J43
DR   CLO; CLO_0029417
DR   BioSamples; SAME52882
DR   Coriell; HQ00956
DR   Wikidata; Q54892818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00957
AC   CVCL_3J44
DR   CLO; CLO_0029423
DR   BioSamples; SAME52883
DR   Coriell; HQ00957
DR   Wikidata; Q54892819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00958
AC   CVCL_3J45
DR   CLO; CLO_0029421
DR   BioSamples; SAME52889
DR   Coriell; HQ00958
DR   Wikidata; Q54892820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00959
AC   CVCL_3J46
DR   Coriell; HQ00959
DR   Wikidata; Q54892821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00960
AC   CVCL_3J47
DR   Coriell; HQ00960
DR   Wikidata; Q54892822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00961
AC   CVCL_3J48
DR   CLO; CLO_0029425
DR   BioSamples; SAME52518
DR   Coriell; HQ00961
DR   Wikidata; Q54892823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00962
AC   CVCL_3J49
DR   CLO; CLO_0029406
DR   BioSamples; SAME52517
DR   Coriell; HQ00962
DR   Wikidata; Q54892824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00963
AC   CVCL_3J50
DR   CLO; CLO_0029408
DR   BioSamples; SAME52515
DR   Coriell; HQ00963
DR   Wikidata; Q54892829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00964
AC   CVCL_3J51
DR   CLO; CLO_0029404
DR   BioSamples; SAME52514
DR   Coriell; HQ00964
DR   Wikidata; Q54892830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00965
AC   CVCL_3J52
DR   Coriell; HQ00965
DR   Wikidata; Q54892831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00966
AC   CVCL_3J53
DR   CLO; CLO_0029401
DR   BioSamples; SAME52513
DR   Coriell; HQ00966
DR   Wikidata; Q54892832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00967
AC   CVCL_3J54
DR   CLO; CLO_0029400
DR   BioSamples; SAME52511
DR   Coriell; HQ00967
DR   Wikidata; Q54892833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00968
AC   CVCL_3J55
DR   CLO; CLO_0029398
DR   BioSamples; SAME52179
DR   Coriell; HQ00968
DR   Wikidata; Q54892834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00969
AC   CVCL_3J56
DR   Coriell; HQ00969
DR   Wikidata; Q54892835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00970
AC   CVCL_3J57
DR   Coriell; HQ00970
DR   Wikidata; Q54892836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00971
AC   CVCL_3J58
DR   Coriell; HQ00971
DR   Wikidata; Q54892838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00972
AC   CVCL_3J59
DR   CLO; CLO_0029395
DR   BioSamples; SAME52397
DR   Coriell; HQ00972
DR   Wikidata; Q54892839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00973
AC   CVCL_3J60
DR   CLO; CLO_0029394
DR   BioSamples; SAME52283
DR   Coriell; HQ00973
DR   Wikidata; Q54892840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00974
AC   CVCL_3J61
DR   CLO; CLO_0029392
DR   BioSamples; SAME52392
DR   Coriell; HQ00974
DR   Wikidata; Q54892841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00975
AC   CVCL_3J62
DR   CLO; CLO_0029389
DR   BioSamples; SAME52268
DR   Coriell; HQ00975
DR   Wikidata; Q54892842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00976
AC   CVCL_3J63
DR   CLO; CLO_0029386
DR   BioSamples; SAME52274
DR   Coriell; HQ00976
DR   Wikidata; Q54892843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00977
AC   CVCL_3J64
DR   CLO; CLO_0029387
DR   BioSamples; SAME52277
DR   Coriell; HQ00977
DR   Wikidata; Q54892844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00978
AC   CVCL_3J65
DR   Coriell; HQ00978
DR   Wikidata; Q54892845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00979
AC   CVCL_3J66
DR   Coriell; HQ00979
DR   Wikidata; Q54892846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00980
AC   CVCL_3J67
DR   CLO; CLO_0029388
DR   BioSamples; SAME52524
DR   Coriell; HQ00980
DR   Wikidata; Q54892847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00981
AC   CVCL_3J68
DR   CLO; CLO_0029379
DR   BioSamples; SAME52190
DR   Coriell; HQ00981
DR   Wikidata; Q54892848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00982
AC   CVCL_3J69
DR   Coriell; HQ00982
DR   Wikidata; Q54892849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ00983
AC   CVCL_3J70
DR   Coriell; HQ00983
DR   Wikidata; Q54892850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00984
AC   CVCL_3J71
DR   CLO; CLO_0029377
DR   BioSamples; SAME52520
DR   Coriell; HQ00984
DR   Wikidata; Q54892852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00985
AC   CVCL_3J72
DR   Coriell; HQ00985
DR   Wikidata; Q54892853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00986
AC   CVCL_3J73
DR   CLO; CLO_0029383
DR   BioSamples; SAME52877
DR   Coriell; HQ00986
DR   Wikidata; Q54892854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00987
AC   CVCL_3J74
DR   CLO; CLO_0029381
DR   BioSamples; SAME52521
DR   Coriell; HQ00987
DR   Wikidata; Q54892855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00988
AC   CVCL_3J75
DR   CLO; CLO_0029371
DR   BioSamples; SAME52532
DR   Coriell; HQ00988
DR   Wikidata; Q54892856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00989
AC   CVCL_3J76
DR   CLO; CLO_0029369
DR   BioSamples; SAME52901
DR   Coriell; HQ00989
DR   Wikidata; Q54892857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00990
AC   CVCL_3J77
DR   CLO; CLO_0029374
DR   BioSamples; SAME52763
DR   Coriell; HQ00990
DR   Wikidata; Q54892858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00991
AC   CVCL_3J78
DR   CLO; CLO_0029347
DR   BioSamples; SAME52764
DR   Coriell; HQ00991
DR   Wikidata; Q54892859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00992
AC   CVCL_3J79
DR   CLO; CLO_0029346
DR   BioSamples; SAME52760
DR   Coriell; HQ00992
DR   Wikidata; Q54892860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00993
AC   CVCL_3J80
DR   CLO; CLO_0029351
DR   BioSamples; SAME52761
DR   Coriell; HQ00993
DR   Wikidata; Q54892861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00994
AC   CVCL_3J81
DR   CLO; CLO_0029349
DR   BioSamples; SAME52771
DR   Coriell; HQ00994
DR   Wikidata; Q54892862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00995
AC   CVCL_3J82
DR   CLO; CLO_0029359
DR   BioSamples; SAME52772
DR   Coriell; HQ00995
DR   Wikidata; Q54892863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ00996
AC   CVCL_3J83
DR   Coriell; HQ00996
DR   Wikidata; Q54892864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ00997
AC   CVCL_3J84
DR   CLO; CLO_0029360
DR   BioSamples; SAME52770
DR   Coriell; HQ00997
DR   Wikidata; Q54892865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00998
AC   CVCL_3J85
DR   CLO; CLO_0029361
DR   BioSamples; SAME52775
DR   Coriell; HQ00998
DR   Wikidata; Q54892866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ00999
AC   CVCL_3J86
DR   Coriell; HQ00999
DR   Wikidata; Q54892867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01000
AC   CVCL_3J87
DR   Coriell; HQ01000
DR   Wikidata; Q54892868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01001
AC   CVCL_3J88
DR   Coriell; HQ01001
DR   Wikidata; Q54892869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01002
AC   CVCL_3J89
DR   CLO; CLO_0029362
DR   BioSamples; SAME52385
DR   Coriell; HQ01002
DR   Wikidata; Q54892870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ01003
AC   CVCL_3J90
DR   Coriell; HQ01003
DR   Wikidata; Q54892874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01004
AC   CVCL_3J91
DR   Coriell; HQ01004
DR   Wikidata; Q54892875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01005
AC   CVCL_3J92
DR   CLO; CLO_0029364
DR   BioSamples; SAME52384
DR   Coriell; HQ01005
DR   Wikidata; Q54892876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ01006
AC   CVCL_3J93
DR   Coriell; HQ01006
DR   Wikidata; Q54892877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01007
AC   CVCL_3J94
DR   CLO; CLO_0029366
DR   BioSamples; SAME52383
DR   Coriell; HQ01007
DR   Wikidata; Q54892878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ01008
AC   CVCL_3J95
DR   Coriell; HQ01008
DR   Wikidata; Q54892879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01009
AC   CVCL_3J96
DR   CLO; CLO_0029308
DR   BioSamples; SAME52386
DR   Coriell; HQ01009
DR   Wikidata; Q54892880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ01010
AC   CVCL_3J97
DR   CLO; CLO_0029320
DR   BioSamples; SAME52631
DR   Coriell; HQ01010
DR   Wikidata; Q54892881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ01011
AC   CVCL_3J98
DR   Coriell; HQ01011
DR   Wikidata; Q54892883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01012
AC   CVCL_3J99
DR   Coriell; HQ01012
DR   Wikidata; Q54892884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01013
AC   CVCL_3K00
DR   Coriell; HQ01013
DR   Wikidata; Q54892885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01014
AC   CVCL_3K01
DR   Coriell; HQ01014
DR   Wikidata; Q54892886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01015
AC   CVCL_3K02
DR   Coriell; HQ01015
DR   Wikidata; Q54892887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01016
AC   CVCL_3K03
DR   Coriell; HQ01016
DR   Wikidata; Q54892888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01017
AC   CVCL_3K04
DR   Coriell; HQ01017
DR   Wikidata; Q54892889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01018
AC   CVCL_3K05
DR   Coriell; HQ01018
DR   Wikidata; Q54892890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01019
AC   CVCL_3K06
DR   Coriell; HQ01019
DR   Wikidata; Q54892891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01020
AC   CVCL_3K07
DR   Coriell; HQ01020
DR   Wikidata; Q54892892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01021
AC   CVCL_3K08
DR   Coriell; HQ01021
DR   Wikidata; Q54892893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01022
AC   CVCL_3K09
DR   Coriell; HQ01022
DR   Wikidata; Q54892894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01023
AC   CVCL_3K10
DR   Coriell; HQ01023
DR   Wikidata; Q54892895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01024
AC   CVCL_3K11
DR   CLO; CLO_0029319
DR   BioSamples; SAME52879
DR   Coriell; HQ01024
DR   Wikidata; Q54892896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ01025
AC   CVCL_3K12
DR   CLO; CLO_0029317
DR   BioSamples; SAME52878
DR   Coriell; HQ01025
DR   Wikidata; Q54892897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   HQ01026
AC   CVCL_3K13
DR   Coriell; HQ01026
DR   Wikidata; Q54892898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01027
AC   CVCL_3K14
DR   CLO; CLO_0029316
DR   BioSamples; SAME52880
DR   Coriell; HQ01027
DR   Wikidata; Q54892899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ01028
AC   CVCL_3K15
DR   Coriell; HQ01028
DR   Wikidata; Q54892900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01029
AC   CVCL_3K16
DR   Coriell; HQ01029
DR   Wikidata; Q54892901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01030
AC   CVCL_3K17
DR   Coriell; HQ01030
DR   Wikidata; Q54892902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01031
AC   CVCL_3K18
DR   Coriell; HQ01031
DR   Wikidata; Q54892903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01032
AC   CVCL_3K19
DR   Coriell; HQ01032
DR   Wikidata; Q54892904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01033
AC   CVCL_3K20
DR   Coriell; HQ01033
DR   Wikidata; Q54892905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01034
AC   CVCL_3K21
DR   Coriell; HQ01034
DR   Wikidata; Q54892906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01035
AC   CVCL_3K22
DR   Coriell; HQ01035
DR   Wikidata; Q54892907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01036
AC   CVCL_3K23
DR   Coriell; HQ01036
DR   Wikidata; Q54892908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01037
AC   CVCL_3K24
DR   Coriell; HQ01037
DR   Wikidata; Q54892909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01038
AC   CVCL_3K25
DR   Coriell; HQ01038
DR   Wikidata; Q54892910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01039
AC   CVCL_3K26
DR   Coriell; HQ01039
DR   Wikidata; Q54892912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01040
AC   CVCL_3K27
DR   Coriell; HQ01040
DR   Wikidata; Q54892913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01042
AC   CVCL_3K28
DR   Coriell; HQ01042
DR   Wikidata; Q54892914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01043
AC   CVCL_3K29
DR   Coriell; HQ01043
DR   Wikidata; Q54892915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01044
AC   CVCL_3K30
DR   Coriell; HQ01044
DR   Wikidata; Q54892918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01045
AC   CVCL_3K31
DR   Coriell; HQ01045
DR   Wikidata; Q54892919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01046
AC   CVCL_3K32
DR   Coriell; HQ01046
DR   Wikidata; Q54892921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01047
AC   CVCL_3K33
DR   Coriell; HQ01047
DR   Wikidata; Q54892922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01048
AC   CVCL_3K34
DR   Coriell; HQ01048
DR   Wikidata; Q54892923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01049
AC   CVCL_3K35
DR   Coriell; HQ01049
DR   Wikidata; Q54892924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01050
AC   CVCL_3K36
DR   Coriell; HQ01050
DR   Wikidata; Q54892925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01051
AC   CVCL_3K37
DR   Coriell; HQ01051
DR   Wikidata; Q54892926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01052
AC   CVCL_3K38
DR   Coriell; HQ01052
DR   Wikidata; Q54892927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01053
AC   CVCL_3K39
DR   Coriell; HQ01053
DR   Wikidata; Q54892928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01054
AC   CVCL_3K40
DR   Coriell; HQ01054
DR   Wikidata; Q54892929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01055
AC   CVCL_3K41
DR   Coriell; HQ01055
DR   Wikidata; Q54892930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01056
AC   CVCL_3K42
DR   Coriell; HQ01056
DR   Wikidata; Q54892931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01057
AC   CVCL_3K43
DR   Coriell; HQ01057
DR   Wikidata; Q54892932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01058
AC   CVCL_3K44
DR   Coriell; HQ01058
DR   Wikidata; Q54892933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01059
AC   CVCL_3K45
DR   Coriell; HQ01059
DR   Wikidata; Q54892934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01060
AC   CVCL_3K46
DR   Coriell; HQ01060
DR   Wikidata; Q54892935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01061
AC   CVCL_3K47
DR   Coriell; HQ01061
DR   Wikidata; Q54892936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01062
AC   CVCL_3K48
DR   Coriell; HQ01062
DR   Wikidata; Q54892937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01063
AC   CVCL_3K49
DR   Coriell; HQ01063
DR   Wikidata; Q54892938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01064
AC   CVCL_3K50
DR   Coriell; HQ01064
DR   Wikidata; Q54892939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01065
AC   CVCL_3K51
DR   Coriell; HQ01065
DR   Wikidata; Q54892940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01066
AC   CVCL_3K52
DR   Coriell; HQ01066
DR   Wikidata; Q54892941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01067
AC   CVCL_3K53
DR   Coriell; HQ01067
DR   Wikidata; Q54892942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01068
AC   CVCL_3K54
DR   Coriell; HQ01068
DR   Wikidata; Q54892943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01069
AC   CVCL_3K55
DR   Coriell; HQ01069
DR   Wikidata; Q54892944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01070
AC   CVCL_3K56
DR   Coriell; HQ01070
DR   Wikidata; Q54892945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01071
AC   CVCL_3K57
DR   Coriell; HQ01071
DR   Wikidata; Q54892946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01072
AC   CVCL_3K58
DR   Coriell; HQ01072
DR   Wikidata; Q54892947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01073
AC   CVCL_3K59
DR   Coriell; HQ01073
DR   Wikidata; Q54892948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01074
AC   CVCL_3K60
DR   Coriell; HQ01074
DR   Wikidata; Q54892949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01075
AC   CVCL_3K61
DR   Coriell; HQ01075
DR   Wikidata; Q54892951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01076
AC   CVCL_3K62
DR   Coriell; HQ01076
DR   Wikidata; Q54892952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01077
AC   CVCL_3K63
DR   Coriell; HQ01077
DR   Wikidata; Q54892953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01078
AC   CVCL_3K64
DR   Coriell; HQ01078
DR   Wikidata; Q54892954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01079
AC   CVCL_3K65
DR   Coriell; HQ01079
DR   Wikidata; Q54892955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01080
AC   CVCL_3K66
DR   Coriell; HQ01080
DR   Wikidata; Q54892956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01081
AC   CVCL_3K67
DR   Coriell; HQ01081
DR   Wikidata; Q54892957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01082
AC   CVCL_3K68
DR   Coriell; HQ01082
DR   Wikidata; Q54892958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01083
AC   CVCL_3K69
DR   Coriell; HQ01083
DR   Wikidata; Q54892959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01084
AC   CVCL_3K70
DR   Coriell; HQ01084
DR   Wikidata; Q54892983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01085
AC   CVCL_3K71
DR   Coriell; HQ01085
DR   Wikidata; Q54892985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01086
AC   CVCL_3K72
DR   Coriell; HQ01086
DR   Wikidata; Q54892986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01087
AC   CVCL_3K73
DR   Coriell; HQ01087
DR   Wikidata; Q54892987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01088
AC   CVCL_3K74
DR   Coriell; HQ01088
DR   Wikidata; Q54892988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01089
AC   CVCL_3K75
DR   Coriell; HQ01089
DR   Wikidata; Q54892989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01090
AC   CVCL_3K76
DR   Coriell; HQ01090
DR   Wikidata; Q54892991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01091
AC   CVCL_3K77
DR   Coriell; HQ01091
DR   Wikidata; Q54892992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01092
AC   CVCL_3K78
DR   Coriell; HQ01092
DR   Wikidata; Q54892993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01093
AC   CVCL_3K79
DR   Coriell; HQ01093
DR   Wikidata; Q54892994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01094
AC   CVCL_3K80
DR   Coriell; HQ01094
DR   Wikidata; Q54892996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01095
AC   CVCL_3K81
DR   Coriell; HQ01095
DR   Wikidata; Q54892997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01096
AC   CVCL_3K82
DR   Coriell; HQ01096
DR   Wikidata; Q54892998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01097
AC   CVCL_3K83
DR   Coriell; HQ01097
DR   Wikidata; Q54892999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01098
AC   CVCL_3K84
DR   Coriell; HQ01098
DR   Wikidata; Q54893000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01099
AC   CVCL_3K85
DR   Coriell; HQ01099
DR   Wikidata; Q54893002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01100
AC   CVCL_3K86
DR   Coriell; HQ01100
DR   Wikidata; Q54893003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01101
AC   CVCL_3K87
DR   Coriell; HQ01101
DR   Wikidata; Q54893004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01102
AC   CVCL_3K88
DR   Coriell; HQ01102
DR   Wikidata; Q54893006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01103
AC   CVCL_3K89
DR   Coriell; HQ01103
DR   Wikidata; Q54893007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01104
AC   CVCL_3K90
DR   Coriell; HQ01104
DR   Wikidata; Q54893008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01105
AC   CVCL_3K91
DR   Coriell; HQ01105
DR   Wikidata; Q54893009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01106
AC   CVCL_3K92
DR   Coriell; HQ01106
DR   Wikidata; Q54893010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01107
AC   CVCL_3K93
DR   Coriell; HQ01107
DR   Wikidata; Q54893012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01108
AC   CVCL_3K94
DR   Coriell; HQ01108
DR   Wikidata; Q54893013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01109
AC   CVCL_3K95
DR   Coriell; HQ01109
DR   Wikidata; Q54893014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01110
AC   CVCL_3K96
DR   Coriell; HQ01110
DR   Wikidata; Q54893015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01111
AC   CVCL_3K97
DR   Coriell; HQ01111
DR   Wikidata; Q54893016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01112
AC   CVCL_3K98
DR   Coriell; HQ01112
DR   Wikidata; Q54893018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01113
AC   CVCL_3K99
DR   Coriell; HQ01113
DR   Wikidata; Q54893019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01114
AC   CVCL_3L00
DR   Coriell; HQ01114
DR   Wikidata; Q54893020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01115
AC   CVCL_3L01
DR   Coriell; HQ01115
DR   Wikidata; Q54893022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01116
AC   CVCL_3L02
DR   Coriell; HQ01116
DR   Wikidata; Q54893023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01117
AC   CVCL_3L03
DR   Coriell; HQ01117
DR   Wikidata; Q54893025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01118
AC   CVCL_3L04
DR   Coriell; HQ01118
DR   Wikidata; Q54893026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01119
AC   CVCL_3L05
DR   Coriell; HQ01119
DR   Wikidata; Q54893027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01120
AC   CVCL_3L06
DR   Coriell; HQ01120
DR   Wikidata; Q54893028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01121
AC   CVCL_3L07
DR   Coriell; HQ01121
DR   Wikidata; Q54893030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01122
AC   CVCL_3L08
DR   Coriell; HQ01122
DR   Wikidata; Q54893032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01123
AC   CVCL_3L09
DR   Coriell; HQ01123
DR   Wikidata; Q54893033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01124
AC   CVCL_3L10
DR   Coriell; HQ01124
DR   Wikidata; Q54893046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01125
AC   CVCL_3L11
DR   Coriell; HQ01125
DR   Wikidata; Q54893047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01126
AC   CVCL_3L12
DR   Coriell; HQ01126
DR   Wikidata; Q54893048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01127
AC   CVCL_3L13
DR   Coriell; HQ01127
DR   Wikidata; Q54893049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01128
AC   CVCL_3L14
DR   Coriell; HQ01128
DR   Wikidata; Q54893050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01129
AC   CVCL_3L15
DR   Coriell; HQ01129
DR   Wikidata; Q54893051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01130
AC   CVCL_3L16
DR   Coriell; HQ01130
DR   Wikidata; Q54893053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01131
AC   CVCL_3L17
DR   Coriell; HQ01131
DR   Wikidata; Q54893054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01132
AC   CVCL_3L18
DR   Coriell; HQ01132
DR   Wikidata; Q54893055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01133
AC   CVCL_3L19
DR   Coriell; HQ01133
DR   Wikidata; Q54893056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01134
AC   CVCL_3L20
DR   Coriell; HQ01134
DR   Wikidata; Q54893057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01135
AC   CVCL_3L21
DR   Coriell; HQ01135
DR   Wikidata; Q54893058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01136
AC   CVCL_3L22
DR   Coriell; HQ01136
DR   Wikidata; Q54893059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01137
AC   CVCL_3L23
DR   Coriell; HQ01137
DR   Wikidata; Q54893060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01138
AC   CVCL_3L24
DR   Coriell; HQ01138
DR   Wikidata; Q54893061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01139
AC   CVCL_3L25
DR   Coriell; HQ01139
DR   Wikidata; Q54893062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01140
AC   CVCL_3L26
DR   Coriell; HQ01140
DR   Wikidata; Q54893063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01141
AC   CVCL_3L27
DR   Coriell; HQ01141
DR   Wikidata; Q54893064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01142
AC   CVCL_3L28
DR   Coriell; HQ01142
DR   Wikidata; Q54893065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01143
AC   CVCL_3L29
DR   Coriell; HQ01143
DR   Wikidata; Q54893066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01144
AC   CVCL_3L30
DR   Coriell; HQ01144
DR   Wikidata; Q54893067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01145
AC   CVCL_3L31
DR   Coriell; HQ01145
DR   Wikidata; Q54893068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01146
AC   CVCL_3L32
DR   Coriell; HQ01146
DR   Wikidata; Q54893069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01147
AC   CVCL_3L33
DR   Coriell; HQ01147
DR   Wikidata; Q54893070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01148
AC   CVCL_3L34
DR   Coriell; HQ01148
DR   Wikidata; Q54893071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01149
AC   CVCL_3L35
DR   Coriell; HQ01149
DR   Wikidata; Q54893072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01150
AC   CVCL_3L36
DR   Coriell; HQ01150
DR   Wikidata; Q54893073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01151
AC   CVCL_3L37
DR   Coriell; HQ01151
DR   Wikidata; Q54893074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01152
AC   CVCL_3L38
DR   Coriell; HQ01152
DR   Wikidata; Q54893075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01153
AC   CVCL_3L39
DR   Coriell; HQ01153
DR   Wikidata; Q54893076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01154
AC   CVCL_3L40
DR   Coriell; HQ01154
DR   Wikidata; Q54893077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01155
AC   CVCL_3L41
DR   Coriell; HQ01155
DR   Wikidata; Q54893078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01156
AC   CVCL_3L42
DR   Coriell; HQ01156
DR   Wikidata; Q54893079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01157
AC   CVCL_3L43
DR   Coriell; HQ01157
DR   Wikidata; Q54893080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01158
AC   CVCL_3L44
DR   Coriell; HQ01158
DR   Wikidata; Q54893081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01159
AC   CVCL_3L45
DR   Coriell; HQ01159
DR   Wikidata; Q54893082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01160
AC   CVCL_3L46
DR   Coriell; HQ01160
DR   Wikidata; Q54893083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01161
AC   CVCL_3L47
DR   Coriell; HQ01161
DR   Wikidata; Q54893084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01162
AC   CVCL_3L48
DR   Coriell; HQ01162
DR   Wikidata; Q54893085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01163
AC   CVCL_3L49
DR   Coriell; HQ01163
DR   Wikidata; Q54893086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01164
AC   CVCL_3L50
DR   Coriell; HQ01164
DR   Wikidata; Q54893099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01165
AC   CVCL_3L51
DR   Coriell; HQ01165
DR   Wikidata; Q54893100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01166
AC   CVCL_3L52
DR   Coriell; HQ01166
DR   Wikidata; Q54893101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01167
AC   CVCL_3L53
DR   Coriell; HQ01167
DR   Wikidata; Q54893102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01168
AC   CVCL_3L54
DR   Coriell; HQ01168
DR   Wikidata; Q54893103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01169
AC   CVCL_3L55
DR   Coriell; HQ01169
DR   Wikidata; Q54893104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01170
AC   CVCL_3L56
DR   Coriell; HQ01170
DR   Wikidata; Q54893105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01171
AC   CVCL_3L57
DR   Coriell; HQ01171
DR   Wikidata; Q54893106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01172
AC   CVCL_3L58
DR   Coriell; HQ01172
DR   Wikidata; Q54893107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01173
AC   CVCL_3L59
DR   Coriell; HQ01173
DR   Wikidata; Q54893108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01174
AC   CVCL_3L60
DR   Coriell; HQ01174
DR   Wikidata; Q54893109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01175
AC   CVCL_3L61
DR   Coriell; HQ01175
DR   Wikidata; Q54893110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01176
AC   CVCL_3L62
DR   Coriell; HQ01176
DR   Wikidata; Q54893111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01177
AC   CVCL_3L63
DR   Coriell; HQ01177
DR   Wikidata; Q54893112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01178
AC   CVCL_3L64
DR   Coriell; HQ01178
DR   Wikidata; Q54893113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01179
AC   CVCL_3L65
DR   Coriell; HQ01179
DR   Wikidata; Q54893114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01180
AC   CVCL_3L66
DR   Coriell; HQ01180
DR   Wikidata; Q54893115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01181
AC   CVCL_3L67
DR   Coriell; HQ01181
DR   Wikidata; Q54893116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01182
AC   CVCL_3L68
DR   Coriell; HQ01182
DR   Wikidata; Q54893117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01183
AC   CVCL_3L69
DR   Coriell; HQ01183
DR   Wikidata; Q54893118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01184
AC   CVCL_3L70
DR   Coriell; HQ01184
DR   Wikidata; Q54893119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01185
AC   CVCL_3L71
DR   Coriell; HQ01185
DR   Wikidata; Q54893120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01186
AC   CVCL_3L72
DR   Coriell; HQ01186
DR   Wikidata; Q54893121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01187
AC   CVCL_3L73
DR   Coriell; HQ01187
DR   Wikidata; Q54893122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01188
AC   CVCL_3L74
DR   Coriell; HQ01188
DR   Wikidata; Q54893123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01189
AC   CVCL_3L75
DR   Coriell; HQ01189
DR   Wikidata; Q54893124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01190
AC   CVCL_3L76
DR   Coriell; HQ01190
DR   Wikidata; Q54893125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01191
AC   CVCL_3L77
DR   Coriell; HQ01191
DR   Wikidata; Q54893126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01192
AC   CVCL_3L78
DR   Coriell; HQ01192
DR   Wikidata; Q54893127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01193
AC   CVCL_3L79
DR   Coriell; HQ01193
DR   Wikidata; Q54893128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01194
AC   CVCL_3L80
DR   Coriell; HQ01194
DR   Wikidata; Q54893129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01195
AC   CVCL_3L81
DR   Coriell; HQ01195
DR   Wikidata; Q54893130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01196
AC   CVCL_3L82
DR   Coriell; HQ01196
DR   Wikidata; Q54893131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01197
AC   CVCL_3L83
DR   Coriell; HQ01197
DR   Wikidata; Q54893132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01198
AC   CVCL_3L84
DR   Coriell; HQ01198
DR   Wikidata; Q54893133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01199
AC   CVCL_3L85
DR   Coriell; HQ01199
DR   Wikidata; Q54893134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01200
AC   CVCL_3L86
DR   Coriell; HQ01200
DR   Wikidata; Q54893135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01201
AC   CVCL_3L87
DR   Coriell; HQ01201
DR   Wikidata; Q54893136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01202
AC   CVCL_3L88
DR   Coriell; HQ01202
DR   Wikidata; Q54893137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01203
AC   CVCL_3L89
DR   Coriell; HQ01203
DR   Wikidata; Q54893138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01204
AC   CVCL_3L90
DR   Coriell; HQ01204
DR   Wikidata; Q54893141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01205
AC   CVCL_3L91
DR   Coriell; HQ01205
DR   Wikidata; Q54893142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01206
AC   CVCL_3L92
DR   Coriell; HQ01206
DR   Wikidata; Q54893143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01207
AC   CVCL_3L93
DR   Coriell; HQ01207
DR   Wikidata; Q54893144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01208
AC   CVCL_3L94
DR   Coriell; HQ01208
DR   Wikidata; Q54893145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01209
AC   CVCL_3L95
DR   Coriell; HQ01209
DR   Wikidata; Q54893146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01210
AC   CVCL_3L96
DR   Coriell; HQ01210
DR   Wikidata; Q54893147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01211
AC   CVCL_3L97
DR   Coriell; HQ01211
DR   Wikidata; Q54893148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01212
AC   CVCL_3L98
DR   Coriell; HQ01212
DR   Wikidata; Q54893149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01213
AC   CVCL_3L99
DR   Coriell; HQ01213
DR   Wikidata; Q54893150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01214
AC   CVCL_3M00
DR   Coriell; HQ01214
DR   Wikidata; Q54893151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01215
AC   CVCL_3M01
DR   Coriell; HQ01215
DR   Wikidata; Q54893152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01216
AC   CVCL_3M02
DR   Coriell; HQ01216
DR   Wikidata; Q54893153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01217
AC   CVCL_3M03
DR   Coriell; HQ01217
DR   Wikidata; Q54893154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01218
AC   CVCL_3M04
DR   Coriell; HQ01218
DR   Wikidata; Q54893155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01219
AC   CVCL_3M05
DR   Coriell; HQ01219
DR   Wikidata; Q54893156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01220
AC   CVCL_3M06
DR   Coriell; HQ01220
DR   Wikidata; Q54893157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01221
AC   CVCL_3M07
DR   Coriell; HQ01221
DR   Wikidata; Q54893158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01222
AC   CVCL_3M08
DR   Coriell; HQ01222
DR   Wikidata; Q54893159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01223
AC   CVCL_3M09
DR   Coriell; HQ01223
DR   Wikidata; Q54893161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01224
AC   CVCL_3M10
DR   Coriell; HQ01224
DR   Wikidata; Q54893162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01225
AC   CVCL_3M11
DR   Coriell; HQ01225
DR   Wikidata; Q54893163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01226
AC   CVCL_3M12
DR   Coriell; HQ01226
DR   Wikidata; Q54893164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01227
AC   CVCL_3M13
DR   Coriell; HQ01227
DR   Wikidata; Q54893165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01228
AC   CVCL_3M14
DR   Coriell; HQ01228
DR   Wikidata; Q54893167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01229
AC   CVCL_3M15
DR   Coriell; HQ01229
DR   Wikidata; Q54893168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01230
AC   CVCL_3M16
DR   Coriell; HQ01230
DR   Wikidata; Q54893169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01231
AC   CVCL_3M17
DR   Coriell; HQ01231
DR   Wikidata; Q54893170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01232
AC   CVCL_3M18
DR   Coriell; HQ01232
DR   Wikidata; Q54893171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01233
AC   CVCL_3M19
DR   Coriell; HQ01233
DR   Wikidata; Q54893172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01234
AC   CVCL_3M20
DR   Coriell; HQ01234
DR   Wikidata; Q54893174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01235
AC   CVCL_3M21
DR   Coriell; HQ01235
DR   Wikidata; Q54893175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01236
AC   CVCL_3M22
DR   Coriell; HQ01236
DR   Wikidata; Q54893176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01237
AC   CVCL_3M23
DR   Coriell; HQ01237
DR   Wikidata; Q54893177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01238
AC   CVCL_3M24
DR   Coriell; HQ01238
DR   Wikidata; Q54893178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01239
AC   CVCL_3M25
DR   Coriell; HQ01239
DR   Wikidata; Q54893179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01240
AC   CVCL_3M26
DR   Coriell; HQ01240
DR   Wikidata; Q54893180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01241
AC   CVCL_3M27
DR   Coriell; HQ01241
DR   Wikidata; Q54893181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01242
AC   CVCL_3M28
DR   Coriell; HQ01242
DR   Wikidata; Q54893182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01243
AC   CVCL_3M29
DR   Coriell; HQ01243
DR   Wikidata; Q54893183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01244
AC   CVCL_3M30
DR   Coriell; HQ01244
DR   Wikidata; Q54893193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01245
AC   CVCL_3M31
DR   Coriell; HQ01245
DR   Wikidata; Q54893194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01246
AC   CVCL_3M32
DR   Coriell; HQ01246
DR   Wikidata; Q54893195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01247
AC   CVCL_3M33
DR   Coriell; HQ01247
DR   Wikidata; Q54893196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01248
AC   CVCL_3M34
DR   Coriell; HQ01248
DR   Wikidata; Q54893197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01249
AC   CVCL_3M35
DR   Coriell; HQ01249
DR   Wikidata; Q54893198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01250
AC   CVCL_3M36
DR   Coriell; HQ01250
DR   Wikidata; Q54893199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01251
AC   CVCL_3M37
DR   Coriell; HQ01251
DR   Wikidata; Q54893200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01252
AC   CVCL_3M38
DR   Coriell; HQ01252
DR   Wikidata; Q54893201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01253
AC   CVCL_3M39
DR   Coriell; HQ01253
DR   Wikidata; Q54893202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01254
AC   CVCL_3M40
DR   Coriell; HQ01254
DR   Wikidata; Q54893203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01255
AC   CVCL_3M41
DR   Coriell; HQ01255
DR   Wikidata; Q54893204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01256
AC   CVCL_3M42
DR   Coriell; HQ01256
DR   Wikidata; Q54893205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01257
AC   CVCL_3M43
DR   Coriell; HQ01257
DR   Wikidata; Q54893206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01258
AC   CVCL_3M44
DR   Coriell; HQ01258
DR   Wikidata; Q54893207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01259
AC   CVCL_3M45
DR   Coriell; HQ01259
DR   Wikidata; Q54893208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01260
AC   CVCL_3M46
DR   Coriell; HQ01260
DR   Wikidata; Q54893209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01261
AC   CVCL_3M47
DR   Coriell; HQ01261
DR   Wikidata; Q54893210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01262
AC   CVCL_3M48
DR   Coriell; HQ01262
DR   Wikidata; Q54893211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01263
AC   CVCL_3M49
DR   Coriell; HQ01263
DR   Wikidata; Q54893212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01264
AC   CVCL_3M50
DR   Coriell; HQ01264
DR   Wikidata; Q54893213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01265
AC   CVCL_3M51
DR   Coriell; HQ01265
DR   Wikidata; Q54893214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01266
AC   CVCL_3M52
DR   Coriell; HQ01266
DR   Wikidata; Q54893215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01268
AC   CVCL_3M53
DR   Coriell; HQ01268
DR   Wikidata; Q54893216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01269
AC   CVCL_3M54
DR   Coriell; HQ01269
DR   Wikidata; Q54893217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01270
AC   CVCL_3M55
DR   Coriell; HQ01270
DR   Wikidata; Q54893218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01271
AC   CVCL_3M56
DR   Coriell; HQ01271
DR   Wikidata; Q54893219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01272
AC   CVCL_3M57
DR   Coriell; HQ01272
DR   Wikidata; Q54893220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01273
AC   CVCL_3M58
DR   Coriell; HQ01273
DR   Wikidata; Q54893221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01274
AC   CVCL_3M59
DR   Coriell; HQ01274
DR   Wikidata; Q54893222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01275
AC   CVCL_3M60
DR   Coriell; HQ01275
DR   Wikidata; Q54893223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01276
AC   CVCL_3M61
DR   Coriell; HQ01276
DR   Wikidata; Q54893224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01277
AC   CVCL_3M62
DR   Coriell; HQ01277
DR   Wikidata; Q54893225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01278
AC   CVCL_3M63
DR   Coriell; HQ01278
DR   Wikidata; Q54893227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01279
AC   CVCL_3M64
DR   Coriell; HQ01279
DR   Wikidata; Q54893228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01280
AC   CVCL_3M65
DR   Coriell; HQ01280
DR   Wikidata; Q54893229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01281
AC   CVCL_3M66
DR   Coriell; HQ01281
DR   Wikidata; Q54893230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01282
AC   CVCL_3M67
DR   Coriell; HQ01282
DR   Wikidata; Q54893231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01283
AC   CVCL_3M68
DR   Coriell; HQ01283
DR   Wikidata; Q54893232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01284
AC   CVCL_3M69
DR   Coriell; HQ01284
DR   Wikidata; Q54893233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01285
AC   CVCL_3M70
DR   Coriell; HQ01285
DR   Wikidata; Q54893238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01286
AC   CVCL_3M71
DR   Coriell; HQ01286
DR   Wikidata; Q54893239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01287
AC   CVCL_3M72
DR   Coriell; HQ01287
DR   Wikidata; Q54893240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01288
AC   CVCL_3M73
DR   Coriell; HQ01288
DR   Wikidata; Q54893241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01289
AC   CVCL_3M74
DR   Coriell; HQ01289
DR   Wikidata; Q54893242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01290
AC   CVCL_3M75
DR   Coriell; HQ01290
DR   Wikidata; Q54893243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01291
AC   CVCL_3M76
DR   Coriell; HQ01291
DR   Wikidata; Q54893244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01292
AC   CVCL_3M77
DR   Coriell; HQ01292
DR   Wikidata; Q54893245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01293
AC   CVCL_3M78
DR   Coriell; HQ01293
DR   Wikidata; Q54893246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01294
AC   CVCL_3M79
DR   Coriell; HQ01294
DR   Wikidata; Q54893247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01295
AC   CVCL_3M80
DR   Coriell; HQ01295
DR   Wikidata; Q54893248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01296
AC   CVCL_3M81
DR   Coriell; HQ01296
DR   Wikidata; Q54893249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01297
AC   CVCL_3M82
DR   Coriell; HQ01297
DR   Wikidata; Q54893250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01298
AC   CVCL_3M83
DR   Coriell; HQ01298
DR   Wikidata; Q54893251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01299
AC   CVCL_3M84
DR   Coriell; HQ01299
DR   Wikidata; Q54893252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01300
AC   CVCL_3M85
DR   Coriell; HQ01300
DR   Wikidata; Q54893253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01301
AC   CVCL_3M86
DR   Coriell; HQ01301
DR   Wikidata; Q54893254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01302
AC   CVCL_3M87
DR   Coriell; HQ01302
DR   Wikidata; Q54893255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01303
AC   CVCL_3M88
DR   Coriell; HQ01303
DR   Wikidata; Q54893256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01304
AC   CVCL_3M89
DR   Coriell; HQ01304
DR   Wikidata; Q54893257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01305
AC   CVCL_3M90
DR   Coriell; HQ01305
DR   Wikidata; Q54893258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01306
AC   CVCL_3M91
DR   Coriell; HQ01306
DR   Wikidata; Q54893259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01307
AC   CVCL_3M92
DR   Coriell; HQ01307
DR   Wikidata; Q54893260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01308
AC   CVCL_3M93
DR   Coriell; HQ01308
DR   Wikidata; Q54893261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01309
AC   CVCL_3M94
DR   Coriell; HQ01309
DR   Wikidata; Q54893263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01310
AC   CVCL_3M95
DR   Coriell; HQ01310
DR   Wikidata; Q54893264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01311
AC   CVCL_3M96
DR   Coriell; HQ01311
DR   Wikidata; Q54893265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01312
AC   CVCL_3M97
DR   Coriell; HQ01312
DR   Wikidata; Q54893266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01313
AC   CVCL_3M98
DR   Coriell; HQ01313
DR   Wikidata; Q54893267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01314
AC   CVCL_3M99
DR   Coriell; HQ01314
DR   Wikidata; Q54893268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01315
AC   CVCL_3N00
DR   Coriell; HQ01315
DR   Wikidata; Q54893269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01316
AC   CVCL_3N01
DR   Coriell; HQ01316
DR   Wikidata; Q54893270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01317
AC   CVCL_3N02
DR   Coriell; HQ01317
DR   Wikidata; Q54893271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01318
AC   CVCL_3N03
DR   Coriell; HQ01318
DR   Wikidata; Q54893272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01319
AC   CVCL_3N04
DR   Coriell; HQ01319
DR   Wikidata; Q54893273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01320
AC   CVCL_3N05
DR   Coriell; HQ01320
DR   Wikidata; Q54893274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01321
AC   CVCL_3N06
DR   Coriell; HQ01321
DR   Wikidata; Q54893275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01322
AC   CVCL_3N07
DR   Coriell; HQ01322
DR   Wikidata; Q54893276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01323
AC   CVCL_3N08
DR   Coriell; HQ01323
DR   Wikidata; Q54893277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01324
AC   CVCL_3N09
DR   Coriell; HQ01324
DR   Wikidata; Q54893278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01325
AC   CVCL_3N10
DR   Coriell; HQ01325
DR   Wikidata; Q54893283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01326
AC   CVCL_3N11
DR   Coriell; HQ01326
DR   Wikidata; Q54893284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01327
AC   CVCL_3N12
DR   Coriell; HQ01327
DR   Wikidata; Q54893285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01328
AC   CVCL_3N13
DR   Coriell; HQ01328
DR   Wikidata; Q54893286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01329
AC   CVCL_3N14
DR   Coriell; HQ01329
DR   Wikidata; Q54893287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01330
AC   CVCL_3N15
DR   Coriell; HQ01330
DR   Wikidata; Q54893288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01331
AC   CVCL_3N16
DR   Coriell; HQ01331
DR   Wikidata; Q54893289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01332
AC   CVCL_3N17
DR   Coriell; HQ01332
DR   Wikidata; Q54893290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01333
AC   CVCL_3N18
DR   Coriell; HQ01333
DR   Wikidata; Q54893291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01334
AC   CVCL_3N19
DR   Coriell; HQ01334
DR   Wikidata; Q54893292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01335
AC   CVCL_3N20
DR   Coriell; HQ01335
DR   Wikidata; Q54893293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01336
AC   CVCL_3N21
DR   Coriell; HQ01336
DR   Wikidata; Q54893294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01337
AC   CVCL_3N22
DR   Coriell; HQ01337
DR   Wikidata; Q54893295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01338
AC   CVCL_3N23
DR   Coriell; HQ01338
DR   Wikidata; Q54893296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01339
AC   CVCL_3N24
DR   Coriell; HQ01339
DR   Wikidata; Q54893297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01340
AC   CVCL_3N25
DR   Coriell; HQ01340
DR   Wikidata; Q54893298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01341
AC   CVCL_3N26
DR   Coriell; HQ01341
DR   Wikidata; Q54893299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01342
AC   CVCL_3N27
DR   Coriell; HQ01342
DR   Wikidata; Q54893300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01343
AC   CVCL_3N28
DR   Coriell; HQ01343
DR   Wikidata; Q54893301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01344
AC   CVCL_3N29
DR   Coriell; HQ01344
DR   Wikidata; Q54893302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01345
AC   CVCL_3N30
DR   Coriell; HQ01345
DR   Wikidata; Q54893304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01346
AC   CVCL_3N31
DR   Coriell; HQ01346
DR   Wikidata; Q54893305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01347
AC   CVCL_3N32
DR   Coriell; HQ01347
DR   Wikidata; Q54893306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01348
AC   CVCL_3N33
DR   Coriell; HQ01348
DR   Wikidata; Q54893307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01349
AC   CVCL_3N34
DR   Coriell; HQ01349
DR   Wikidata; Q54893308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01350
AC   CVCL_3N35
DR   Coriell; HQ01350
DR   Wikidata; Q54893309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01351
AC   CVCL_3N36
DR   Coriell; HQ01351
DR   Wikidata; Q54893310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01352
AC   CVCL_3N37
DR   Coriell; HQ01352
DR   Wikidata; Q54893311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01353
AC   CVCL_3N38
DR   Coriell; HQ01353
DR   Wikidata; Q54893312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01354
AC   CVCL_3N39
DR   Coriell; HQ01354
DR   Wikidata; Q54893313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01355
AC   CVCL_3N40
DR   Coriell; HQ01355
DR   Wikidata; Q54893314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01356
AC   CVCL_3N41
DR   Coriell; HQ01356
DR   Wikidata; Q54893315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01357
AC   CVCL_3N42
DR   Coriell; HQ01357
DR   Wikidata; Q54893316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01358
AC   CVCL_3N43
DR   Coriell; HQ01358
DR   Wikidata; Q54893317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01359
AC   CVCL_3N44
DR   Coriell; HQ01359
DR   Wikidata; Q54893318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01360
AC   CVCL_3N45
DR   Coriell; HQ01360
DR   Wikidata; Q54893319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01361
AC   CVCL_3N46
DR   Coriell; HQ01361
DR   Wikidata; Q54893321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01363
AC   CVCL_3N47
DR   Coriell; HQ01363
DR   Wikidata; Q54893322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01364
AC   CVCL_3N48
DR   Coriell; HQ01364
DR   Wikidata; Q54893323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01365
AC   CVCL_3N49
DR   Coriell; HQ01365
DR   Wikidata; Q54893324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01366
AC   CVCL_3N50
DR   Coriell; HQ01366
DR   Wikidata; Q54893331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01367
AC   CVCL_3N51
DR   Coriell; HQ01367
DR   Wikidata; Q54893332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01368
AC   CVCL_3N52
DR   Coriell; HQ01368
DR   Wikidata; Q54893333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01369
AC   CVCL_3N53
DR   Coriell; HQ01369
DR   Wikidata; Q54893334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01370
AC   CVCL_3N54
DR   Coriell; HQ01370
DR   Wikidata; Q54893335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01371
AC   CVCL_3N55
DR   Coriell; HQ01371
DR   Wikidata; Q54893336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01372
AC   CVCL_3N56
DR   Coriell; HQ01372
DR   Wikidata; Q54893337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01373
AC   CVCL_3N57
DR   Coriell; HQ01373
DR   Wikidata; Q54893338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01374
AC   CVCL_3N58
DR   Coriell; HQ01374
DR   Wikidata; Q54893339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01375
AC   CVCL_3N59
DR   Coriell; HQ01375
DR   Wikidata; Q54893340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01376
AC   CVCL_3N60
DR   Coriell; HQ01376
DR   Wikidata; Q54893341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01377
AC   CVCL_3N61
DR   Coriell; HQ01377
DR   Wikidata; Q54893342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01378
AC   CVCL_3N62
DR   Coriell; HQ01378
DR   Wikidata; Q54893343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01379
AC   CVCL_3N63
DR   Coriell; HQ01379
DR   Wikidata; Q54893344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01380
AC   CVCL_3N64
DR   Coriell; HQ01380
DR   Wikidata; Q54893345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01381
AC   CVCL_3N65
DR   Coriell; HQ01381
DR   Wikidata; Q54893346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01382
AC   CVCL_3N66
DR   Coriell; HQ01382
DR   Wikidata; Q54893347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01383
AC   CVCL_3N67
DR   Coriell; HQ01383
DR   Wikidata; Q54893348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01384
AC   CVCL_3N68
DR   Coriell; HQ01384
DR   Wikidata; Q54893349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01385
AC   CVCL_3N69
DR   Coriell; HQ01385
DR   Wikidata; Q54893350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01386
AC   CVCL_3N70
DR   Coriell; HQ01386
DR   Wikidata; Q54893351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01387
AC   CVCL_3N71
DR   Coriell; HQ01387
DR   Wikidata; Q54893352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01388
AC   CVCL_3N72
DR   Coriell; HQ01388
DR   Wikidata; Q54893353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01389
AC   CVCL_3N73
DR   Coriell; HQ01389
DR   Wikidata; Q54893354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01390
AC   CVCL_3N74
DR   Coriell; HQ01390
DR   Wikidata; Q54893355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01391
AC   CVCL_3N75
DR   Coriell; HQ01391
DR   Wikidata; Q54893356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01392
AC   CVCL_3N76
DR   Coriell; HQ01392
DR   Wikidata; Q54893357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01394
AC   CVCL_3N77
DR   Coriell; HQ01394
DR   Wikidata; Q54893358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01395
AC   CVCL_3N78
DR   Coriell; HQ01395
DR   Wikidata; Q54893359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01396
AC   CVCL_3N79
DR   Coriell; HQ01396
DR   Wikidata; Q54893360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01397
AC   CVCL_3N80
DR   Coriell; HQ01397
DR   Wikidata; Q54893361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01398
AC   CVCL_3N81
DR   Coriell; HQ01398
DR   Wikidata; Q54893362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01399
AC   CVCL_3N82
DR   Coriell; HQ01399
DR   Wikidata; Q54893363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01400
AC   CVCL_3N83
DR   Coriell; HQ01400
DR   Wikidata; Q54893364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01401
AC   CVCL_3N84
DR   Coriell; HQ01401
DR   Wikidata; Q54893365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01402
AC   CVCL_3N85
DR   Coriell; HQ01402
DR   Wikidata; Q54893366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01403
AC   CVCL_3N86
DR   Coriell; HQ01403
DR   Wikidata; Q54893367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01404
AC   CVCL_3N87
DR   Coriell; HQ01404
DR   Wikidata; Q54893368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01405
AC   CVCL_3N88
DR   Coriell; HQ01405
DR   Wikidata; Q54893369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01406
AC   CVCL_3N89
DR   Coriell; HQ01406
DR   Wikidata; Q54893370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01407
AC   CVCL_3N90
DR   Coriell; HQ01407
DR   Wikidata; Q54893375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01408
AC   CVCL_3N91
DR   Coriell; HQ01408
DR   Wikidata; Q54893376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01409
AC   CVCL_3N92
DR   Coriell; HQ01409
DR   Wikidata; Q54893377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01410
AC   CVCL_3N93
DR   Coriell; HQ01410
DR   Wikidata; Q54893378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01411
AC   CVCL_3N94
DR   Coriell; HQ01411
DR   Wikidata; Q54893379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01412
AC   CVCL_3N95
DR   Coriell; HQ01412
DR   Wikidata; Q54893380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01413
AC   CVCL_3N96
DR   Coriell; HQ01413
DR   Wikidata; Q54893381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01414
AC   CVCL_3N97
DR   Coriell; HQ01414
DR   Wikidata; Q54893382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01415
AC   CVCL_3N98
DR   Coriell; HQ01415
DR   Wikidata; Q54893383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01416
AC   CVCL_3N99
DR   Coriell; HQ01416
DR   Wikidata; Q54893384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01417
AC   CVCL_3P00
DR   Coriell; HQ01417
DR   Wikidata; Q54893385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01418
AC   CVCL_3P01
DR   Coriell; HQ01418
DR   Wikidata; Q54893386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01419
AC   CVCL_3P02
DR   Coriell; HQ01419
DR   Wikidata; Q54893387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01420
AC   CVCL_3P03
DR   Coriell; HQ01420
DR   Wikidata; Q54893389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01421
AC   CVCL_3P04
DR   Coriell; HQ01421
DR   Wikidata; Q54893390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01422
AC   CVCL_3P05
DR   Coriell; HQ01422
DR   Wikidata; Q54893392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01423
AC   CVCL_3P06
DR   Coriell; HQ01423
DR   Wikidata; Q54893393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01424
AC   CVCL_3P07
DR   Coriell; HQ01424
DR   Wikidata; Q54893394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01425
AC   CVCL_3P08
DR   Coriell; HQ01425
DR   Wikidata; Q54893395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01426
AC   CVCL_3P09
DR   Coriell; HQ01426
DR   Wikidata; Q54893396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01427
AC   CVCL_3P10
DR   Coriell; HQ01427
DR   Wikidata; Q54893397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01428
AC   CVCL_3P11
DR   Coriell; HQ01428
DR   Wikidata; Q54893398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01429
AC   CVCL_3P12
DR   Coriell; HQ01429
DR   Wikidata; Q54893399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01430
AC   CVCL_3P13
DR   Coriell; HQ01430
DR   Wikidata; Q54893400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01431
AC   CVCL_3P14
DR   Coriell; HQ01431
DR   Wikidata; Q54893401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01432
AC   CVCL_3P15
DR   Coriell; HQ01432
DR   Wikidata; Q54893402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01433
AC   CVCL_3P16
DR   Coriell; HQ01433
DR   Wikidata; Q54893403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01434
AC   CVCL_3P17
DR   Coriell; HQ01434
DR   Wikidata; Q54893404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01435
AC   CVCL_3P18
DR   Coriell; HQ01435
DR   Wikidata; Q54893405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01436
AC   CVCL_3P19
DR   Coriell; HQ01436
DR   Wikidata; Q54893406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01437
AC   CVCL_3P20
DR   Coriell; HQ01437
DR   Wikidata; Q54893407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01438
AC   CVCL_3P21
DR   Coriell; HQ01438
DR   Wikidata; Q54893408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01439
AC   CVCL_3P22
DR   Coriell; HQ01439
DR   Wikidata; Q54893409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01440
AC   CVCL_3P23
DR   Coriell; HQ01440
DR   Wikidata; Q54893410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01441
AC   CVCL_3P24
DR   Coriell; HQ01441
DR   Wikidata; Q54893411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01442
AC   CVCL_3P25
DR   Coriell; HQ01442
DR   Wikidata; Q54893412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01443
AC   CVCL_3P26
DR   Coriell; HQ01443
DR   Wikidata; Q54893413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01444
AC   CVCL_3P27
DR   Coriell; HQ01444
DR   Wikidata; Q54893414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01445
AC   CVCL_3P28
DR   Coriell; HQ01445
DR   Wikidata; Q54893415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01446
AC   CVCL_3P29
DR   Coriell; HQ01446
DR   Wikidata; Q54893416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01447
AC   CVCL_3P30
DR   Coriell; HQ01447
DR   Wikidata; Q54893424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01448
AC   CVCL_3P31
DR   Coriell; HQ01448
DR   Wikidata; Q54893425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01449
AC   CVCL_3P32
DR   Coriell; HQ01449
DR   Wikidata; Q54893426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01450
AC   CVCL_3P33
DR   Coriell; HQ01450
DR   Wikidata; Q54893427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01451
AC   CVCL_3P34
DR   Coriell; HQ01451
DR   Wikidata; Q54893428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01452
AC   CVCL_3P35
DR   Coriell; HQ01452
DR   Wikidata; Q54893429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01453
AC   CVCL_3P36
DR   Coriell; HQ01453
DR   Wikidata; Q54893430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01454
AC   CVCL_3P37
DR   Coriell; HQ01454
DR   Wikidata; Q54893431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01455
AC   CVCL_3P38
DR   Coriell; HQ01455
DR   Wikidata; Q54893432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01456
AC   CVCL_3P39
DR   Coriell; HQ01456
DR   Wikidata; Q54893433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01457
AC   CVCL_3P40
DR   Coriell; HQ01457
DR   Wikidata; Q54893434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01458
AC   CVCL_3P41
DR   Coriell; HQ01458
DR   Wikidata; Q54893435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01459
AC   CVCL_3P42
DR   Coriell; HQ01459
DR   Wikidata; Q54893436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01460
AC   CVCL_3P43
DR   Coriell; HQ01460
DR   Wikidata; Q54893437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01461
AC   CVCL_3P44
DR   Coriell; HQ01461
DR   Wikidata; Q54893438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01462
AC   CVCL_3P45
DR   Coriell; HQ01462
DR   Wikidata; Q54893439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Patient indicated as not affected with HD in HQ01462, but as affected in ND30626.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y896 ! ND30626
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   HQ01463
AC   CVCL_3P46
DR   Coriell; HQ01463
DR   Wikidata; Q54893440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01464
AC   CVCL_3P47
DR   Coriell; HQ01464
DR   Wikidata; Q54893441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01465
AC   CVCL_3P48
DR   Coriell; HQ01465
DR   Wikidata; Q54893442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01466
AC   CVCL_3P49
DR   Coriell; HQ01466
DR   Wikidata; Q54893443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01467
AC   CVCL_3P50
DR   Coriell; HQ01467
DR   Wikidata; Q54893444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01468
AC   CVCL_3P51
DR   Coriell; HQ01468
DR   Wikidata; Q54893445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01469
AC   CVCL_3P52
DR   Coriell; HQ01469
DR   Wikidata; Q54893446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01470
AC   CVCL_3P53
DR   Coriell; HQ01470
DR   Wikidata; Q54893447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01471
AC   CVCL_3P54
DR   Coriell; HQ01471
DR   Wikidata; Q54893448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01472
AC   CVCL_3P55
DR   Coriell; HQ01472
DR   Wikidata; Q54893449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01473
AC   CVCL_3P56
DR   Coriell; HQ01473
DR   Wikidata; Q54893450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01474
AC   CVCL_3P57
DR   Coriell; HQ01474
DR   Wikidata; Q54893451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01475
AC   CVCL_3P58
DR   Coriell; HQ01475
DR   Wikidata; Q54893452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01476
AC   CVCL_3P59
DR   Coriell; HQ01476
DR   Wikidata; Q54893453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01477
AC   CVCL_3P60
DR   Coriell; HQ01477
DR   Wikidata; Q54893454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01478
AC   CVCL_3P61
DR   Coriell; HQ01478
DR   Wikidata; Q54893455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01479
AC   CVCL_3P62
DR   Coriell; HQ01479
DR   Wikidata; Q54893456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01480
AC   CVCL_3P63
DR   Coriell; HQ01480
DR   Wikidata; Q54893457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01481
AC   CVCL_3P64
DR   Coriell; HQ01481
DR   Wikidata; Q54893458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01482
AC   CVCL_3P65
DR   Coriell; HQ01482
DR   Wikidata; Q54893459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01483
AC   CVCL_3P66
DR   Coriell; HQ01483
DR   Wikidata; Q54893460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01484
AC   CVCL_3P67
DR   Coriell; HQ01484
DR   Wikidata; Q54893461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01485
AC   CVCL_3P68
DR   Coriell; HQ01485
DR   Wikidata; Q54893462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01486
AC   CVCL_3P69
DR   Coriell; HQ01486
DR   Wikidata; Q54893463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01487
AC   CVCL_3P70
DR   Coriell; HQ01487
DR   Wikidata; Q54893472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01488
AC   CVCL_3P71
DR   Coriell; HQ01488
DR   Wikidata; Q54893473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01489
AC   CVCL_3P72
DR   Coriell; HQ01489
DR   Wikidata; Q54893474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01490
AC   CVCL_3P73
DR   Coriell; HQ01490
DR   Wikidata; Q54893475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01491
AC   CVCL_3P74
DR   Coriell; HQ01491
DR   Wikidata; Q54893476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01492
AC   CVCL_3P75
DR   Coriell; HQ01492
DR   Wikidata; Q54893477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01493
AC   CVCL_3P76
DR   Coriell; HQ01493
DR   Wikidata; Q54893478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01494
AC   CVCL_3P77
DR   Coriell; HQ01494
DR   Wikidata; Q54893479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01495
AC   CVCL_3P78
DR   Coriell; HQ01495
DR   Wikidata; Q54893480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01496
AC   CVCL_3P79
DR   Coriell; HQ01496
DR   Wikidata; Q54893481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01497
AC   CVCL_3P80
DR   Coriell; HQ01497
DR   Wikidata; Q54893482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01498
AC   CVCL_3P81
DR   Coriell; HQ01498
DR   Wikidata; Q54893483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01499
AC   CVCL_3P82
DR   Coriell; HQ01499
DR   Wikidata; Q54893484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01500
AC   CVCL_3P83
DR   Coriell; HQ01500
DR   Wikidata; Q54893486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01501
AC   CVCL_3P84
DR   Coriell; HQ01501
DR   Wikidata; Q54893488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01502
AC   CVCL_3P85
DR   Coriell; HQ01502
DR   Wikidata; Q54893489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01503
AC   CVCL_3P86
DR   Coriell; HQ01503
DR   Wikidata; Q54893490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01504
AC   CVCL_3P87
DR   Coriell; HQ01504
DR   Wikidata; Q54893491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01505
AC   CVCL_3P88
DR   Coriell; HQ01505
DR   Wikidata; Q54893492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01506
AC   CVCL_3P89
DR   Coriell; HQ01506
DR   Wikidata; Q54893493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01507
AC   CVCL_3P90
DR   Coriell; HQ01507
DR   Wikidata; Q54893494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01508
AC   CVCL_3P91
DR   Coriell; HQ01508
DR   Wikidata; Q54893495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01509
AC   CVCL_3P92
DR   Coriell; HQ01509
DR   Wikidata; Q54893496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01510
AC   CVCL_3P93
DR   Coriell; HQ01510
DR   Wikidata; Q54893497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01511
AC   CVCL_3P94
DR   Coriell; HQ01511
DR   Wikidata; Q54893498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01512
AC   CVCL_3P95
DR   Coriell; HQ01512
DR   Wikidata; Q54893499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01513
AC   CVCL_3P96
DR   Coriell; HQ01513
DR   Wikidata; Q54893500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01514
AC   CVCL_3P97
DR   Coriell; HQ01514
DR   Wikidata; Q54893501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01515
AC   CVCL_3P98
DR   Coriell; HQ01515
DR   Wikidata; Q54893502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01516
AC   CVCL_3P99
DR   Coriell; HQ01516
DR   Wikidata; Q54893503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01517
AC   CVCL_3Q00
DR   Coriell; HQ01517
DR   Wikidata; Q54893504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01518
AC   CVCL_3Q01
DR   Coriell; HQ01518
DR   Wikidata; Q54893505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01519
AC   CVCL_3Q02
DR   Coriell; HQ01519
DR   Wikidata; Q54893506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01520
AC   CVCL_3Q03
DR   Coriell; HQ01520
DR   Wikidata; Q54893507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01521
AC   CVCL_3Q04
DR   Coriell; HQ01521
DR   Wikidata; Q54893508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01522
AC   CVCL_3Q05
DR   Coriell; HQ01522
DR   Wikidata; Q54893509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01524
AC   CVCL_3Q06
DR   Coriell; HQ01524
DR   Wikidata; Q54893510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01525
AC   CVCL_3Q07
DR   Coriell; HQ01525
DR   Wikidata; Q54893511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01526
AC   CVCL_3Q08
DR   Coriell; HQ01526
DR   Wikidata; Q54893512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01527
AC   CVCL_3Q09
DR   Coriell; HQ01527
DR   Wikidata; Q54893513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01528
AC   CVCL_3Q10
DR   Coriell; HQ01528
DR   Wikidata; Q54893522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01529
AC   CVCL_3Q11
DR   Coriell; HQ01529
DR   Wikidata; Q54893523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01530
AC   CVCL_3Q12
DR   Coriell; HQ01530
DR   Wikidata; Q54893524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01531
AC   CVCL_3Q13
DR   Coriell; HQ01531
DR   Wikidata; Q54893525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01532
AC   CVCL_3Q14
DR   Coriell; HQ01532
DR   Wikidata; Q54893526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01533
AC   CVCL_3Q15
DR   Coriell; HQ01533
DR   Wikidata; Q54893527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01534
AC   CVCL_3Q16
DR   Coriell; HQ01534
DR   Wikidata; Q54893528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01535
AC   CVCL_3Q17
DR   Coriell; HQ01535
DR   Wikidata; Q54893529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01536
AC   CVCL_3Q18
DR   Coriell; HQ01536
DR   Wikidata; Q54893530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01537
AC   CVCL_3Q19
DR   Coriell; HQ01537
DR   Wikidata; Q54893531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01538
AC   CVCL_3Q20
DR   Coriell; HQ01538
DR   Wikidata; Q54893532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01539
AC   CVCL_3Q21
DR   Coriell; HQ01539
DR   Wikidata; Q54893533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01540
AC   CVCL_3Q22
DR   Coriell; HQ01540
DR   Wikidata; Q54893534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01541
AC   CVCL_3Q23
DR   Coriell; HQ01541
DR   Wikidata; Q54893535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01542
AC   CVCL_3Q24
DR   Coriell; HQ01542
DR   Wikidata; Q54893536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01543
AC   CVCL_3Q25
DR   Coriell; HQ01543
DR   Wikidata; Q54893537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01544
AC   CVCL_3Q26
DR   Coriell; HQ01544
DR   Wikidata; Q54893538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01545
AC   CVCL_3Q27
DR   Coriell; HQ01545
DR   Wikidata; Q54893539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01546
AC   CVCL_3Q28
DR   Coriell; HQ01546
DR   Wikidata; Q54893540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01547
AC   CVCL_3Q29
DR   Coriell; HQ01547
DR   Wikidata; Q54893541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01548
AC   CVCL_3Q30
DR   Coriell; HQ01548
DR   Wikidata; Q54893542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01549
AC   CVCL_3Q31
DR   Coriell; HQ01549
DR   Wikidata; Q54893543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01550
AC   CVCL_3Q32
DR   Coriell; HQ01550
DR   Wikidata; Q54893544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01551
AC   CVCL_3Q33
DR   Coriell; HQ01551
DR   Wikidata; Q54893545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01552
AC   CVCL_3Q34
DR   Coriell; HQ01552
DR   Wikidata; Q54893546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01553
AC   CVCL_3Q35
DR   Coriell; HQ01553
DR   Wikidata; Q54893547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01554
AC   CVCL_3Q36
DR   Coriell; HQ01554
DR   Wikidata; Q54893548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01555
AC   CVCL_3Q37
DR   Coriell; HQ01555
DR   Wikidata; Q54893549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01556
AC   CVCL_3Q38
DR   Coriell; HQ01556
DR   Wikidata; Q54893550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01557
AC   CVCL_3Q39
DR   Coriell; HQ01557
DR   Wikidata; Q54893551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01558
AC   CVCL_3Q40
DR   Coriell; HQ01558
DR   Wikidata; Q54893552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01559
AC   CVCL_3Q41
DR   Coriell; HQ01559
DR   Wikidata; Q54893553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01560
AC   CVCL_3Q42
DR   Coriell; HQ01560
DR   Wikidata; Q54893554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01561
AC   CVCL_3Q43
DR   Coriell; HQ01561
DR   Wikidata; Q54893556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01562
AC   CVCL_3Q44
DR   Coriell; HQ01562
DR   Wikidata; Q54893559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01563
AC   CVCL_3Q45
DR   Coriell; HQ01563
DR   Wikidata; Q54893560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01564
AC   CVCL_3Q46
DR   Coriell; HQ01564
DR   Wikidata; Q54893561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01565
AC   CVCL_3Q47
DR   Coriell; HQ01565
DR   Wikidata; Q54893562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01566
AC   CVCL_3Q48
DR   Coriell; HQ01566
DR   Wikidata; Q54893563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01567
AC   CVCL_3Q49
DR   Coriell; HQ01567
DR   Wikidata; Q54893564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01568
AC   CVCL_3Q50
DR   Coriell; HQ01568
DR   Wikidata; Q54893577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01569
AC   CVCL_3Q51
DR   Coriell; HQ01569
DR   Wikidata; Q54893578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01570
AC   CVCL_3Q52
DR   Coriell; HQ01570
DR   Wikidata; Q54893579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01571
AC   CVCL_3Q53
DR   Coriell; HQ01571
DR   Wikidata; Q54893580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01572
AC   CVCL_3Q54
DR   Coriell; HQ01572
DR   Wikidata; Q54893581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01573
AC   CVCL_3Q55
DR   Coriell; HQ01573
DR   Wikidata; Q54893582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01574
AC   CVCL_3Q56
DR   Coriell; HQ01574
DR   Wikidata; Q54893583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01575
AC   CVCL_3Q57
DR   Coriell; HQ01575
DR   Wikidata; Q54893584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01576
AC   CVCL_3Q58
DR   Coriell; HQ01576
DR   Wikidata; Q54893585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01577
AC   CVCL_3Q59
DR   Coriell; HQ01577
DR   Wikidata; Q54893586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01578
AC   CVCL_3Q60
DR   Coriell; HQ01578
DR   Wikidata; Q54893587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01579
AC   CVCL_3Q61
DR   Coriell; HQ01579
DR   Wikidata; Q54893588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01580
AC   CVCL_3Q62
DR   Coriell; HQ01580
DR   Wikidata; Q54893589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01581
AC   CVCL_3Q63
DR   Coriell; HQ01581
DR   Wikidata; Q54893590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01582
AC   CVCL_3Q64
DR   Coriell; HQ01582
DR   Wikidata; Q54893591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01583
AC   CVCL_3Q65
DR   Coriell; HQ01583
DR   Wikidata; Q54893592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01584
AC   CVCL_3Q66
DR   Coriell; HQ01584
DR   Wikidata; Q54893593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01585
AC   CVCL_3Q67
DR   Coriell; HQ01585
DR   Wikidata; Q54893594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01586
AC   CVCL_3Q68
DR   Coriell; HQ01586
DR   Wikidata; Q54893595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01587
AC   CVCL_3Q69
DR   Coriell; HQ01587
DR   Wikidata; Q54893596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01588
AC   CVCL_3Q70
DR   Coriell; HQ01588
DR   Wikidata; Q54893597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01589
AC   CVCL_3Q71
DR   Coriell; HQ01589
DR   Wikidata; Q54893598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01590
AC   CVCL_3Q72
DR   Coriell; HQ01590
DR   Wikidata; Q54893599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01591
AC   CVCL_3Q73
DR   Coriell; HQ01591
DR   Wikidata; Q54893600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01592
AC   CVCL_3Q74
DR   Coriell; HQ01592
DR   Wikidata; Q54893601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01593
AC   CVCL_3Q75
DR   Coriell; HQ01593
DR   Wikidata; Q54893602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01594
AC   CVCL_3Q76
DR   Coriell; HQ01594
DR   Wikidata; Q54893603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01595
AC   CVCL_3Q77
DR   Coriell; HQ01595
DR   Wikidata; Q54893604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01596
AC   CVCL_3Q78
DR   Coriell; HQ01596
DR   Wikidata; Q54893605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01597
AC   CVCL_3Q79
DR   Coriell; HQ01597
DR   Wikidata; Q54893606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01598
AC   CVCL_3Q80
DR   Coriell; HQ01598
DR   Wikidata; Q54893607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01599
AC   CVCL_3Q81
DR   Coriell; HQ01599
DR   Wikidata; Q54893608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01600
AC   CVCL_3Q82
DR   Coriell; HQ01600
DR   Wikidata; Q54893609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01601
AC   CVCL_3Q83
DR   Coriell; HQ01601
DR   Wikidata; Q54893610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01602
AC   CVCL_3Q84
DR   Coriell; HQ01602
DR   Wikidata; Q54893611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01603
AC   CVCL_3Q85
DR   Coriell; HQ01603
DR   Wikidata; Q54893613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01604
AC   CVCL_3Q86
DR   Coriell; HQ01604
DR   Wikidata; Q54893615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01605
AC   CVCL_3Q87
DR   Coriell; HQ01605
DR   Wikidata; Q54893616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01606
AC   CVCL_3Q88
DR   Coriell; HQ01606
DR   Wikidata; Q54893617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01607
AC   CVCL_3Q89
DR   Coriell; HQ01607
DR   Wikidata; Q54893618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01608
AC   CVCL_3Q90
DR   Coriell; HQ01608
DR   Wikidata; Q54893624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01609
AC   CVCL_3Q91
DR   Coriell; HQ01609
DR   Wikidata; Q54893625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01610
AC   CVCL_3Q92
DR   Coriell; HQ01610
DR   Wikidata; Q54893626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01611
AC   CVCL_3Q93
DR   Coriell; HQ01611
DR   Wikidata; Q54893627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01612
AC   CVCL_3Q94
DR   Coriell; HQ01612
DR   Wikidata; Q54893628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01613
AC   CVCL_3Q95
DR   Coriell; HQ01613
DR   Wikidata; Q54893629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01614
AC   CVCL_3Q96
DR   Coriell; HQ01614
DR   Wikidata; Q54893630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01615
AC   CVCL_3Q97
DR   Coriell; HQ01615
DR   Wikidata; Q54893631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01616
AC   CVCL_3Q98
DR   Coriell; HQ01616
DR   Wikidata; Q54893632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01617
AC   CVCL_3Q99
DR   Coriell; HQ01617
DR   Wikidata; Q54893633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01618
AC   CVCL_3R00
DR   Coriell; HQ01618
DR   Wikidata; Q54893634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01619
AC   CVCL_3R01
DR   Coriell; HQ01619
DR   Wikidata; Q54893635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01620
AC   CVCL_3R02
DR   Coriell; HQ01620
DR   Wikidata; Q54893636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01621
AC   CVCL_3R03
DR   Coriell; HQ01621
DR   Wikidata; Q54893638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01622
AC   CVCL_3R04
DR   Coriell; HQ01622
DR   Wikidata; Q54893639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01623
AC   CVCL_3R05
DR   Coriell; HQ01623
DR   Wikidata; Q54893640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01624
AC   CVCL_3R06
DR   Coriell; HQ01624
DR   Wikidata; Q54893641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01625
AC   CVCL_3R07
DR   Coriell; HQ01625
DR   Wikidata; Q54893642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01626
AC   CVCL_3R08
DR   Coriell; HQ01626
DR   Wikidata; Q54893643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01627
AC   CVCL_3R09
DR   Coriell; HQ01627
DR   Wikidata; Q54893644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01628
AC   CVCL_3R10
DR   Coriell; HQ01628
DR   Wikidata; Q54893645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01629
AC   CVCL_3R11
DR   Coriell; HQ01629
DR   Wikidata; Q54893646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01630
AC   CVCL_3R12
DR   Coriell; HQ01630
DR   Wikidata; Q54893647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01631
AC   CVCL_3R13
DR   Coriell; HQ01631
DR   Wikidata; Q54893648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01632
AC   CVCL_3R14
DR   Coriell; HQ01632
DR   Wikidata; Q54893649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01634
AC   CVCL_3R15
DR   Coriell; HQ01634
DR   Wikidata; Q54893650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01636
AC   CVCL_3R16
DR   Coriell; HQ01636
DR   Wikidata; Q54893651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01637
AC   CVCL_3R17
DR   Coriell; HQ01637
DR   Wikidata; Q54893652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01638
AC   CVCL_3R18
DR   Coriell; HQ01638
DR   Wikidata; Q54893653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01639
AC   CVCL_3R19
DR   Coriell; HQ01639
DR   Wikidata; Q54893654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01640
AC   CVCL_3R20
DR   Coriell; HQ01640
DR   Wikidata; Q54893655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01641
AC   CVCL_3R21
DR   Coriell; HQ01641
DR   Wikidata; Q54893656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01642
AC   CVCL_3R22
DR   Coriell; HQ01642
DR   Wikidata; Q54893657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01643
AC   CVCL_3R23
DR   Coriell; HQ01643
DR   Wikidata; Q54893658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01644
AC   CVCL_3R24
DR   Coriell; HQ01644
DR   Wikidata; Q54893659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01645
AC   CVCL_3R25
DR   Coriell; HQ01645
DR   Wikidata; Q54893660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01646
AC   CVCL_3R26
DR   Coriell; HQ01646
DR   Wikidata; Q54893661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01647
AC   CVCL_3R27
DR   Coriell; HQ01647
DR   Wikidata; Q54893662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01648
AC   CVCL_3R28
DR   Coriell; HQ01648
DR   Wikidata; Q54893663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01649
AC   CVCL_3R29
DR   Coriell; HQ01649
DR   Wikidata; Q54893664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01650
AC   CVCL_3R30
DR   Coriell; HQ01650
DR   Wikidata; Q54893671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01651
AC   CVCL_3R31
DR   Coriell; HQ01651
DR   Wikidata; Q54893672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01652
AC   CVCL_3R32
DR   Coriell; HQ01652
DR   Wikidata; Q54893673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01654
AC   CVCL_3R33
DR   Coriell; HQ01654
DR   Wikidata; Q54893674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01656
AC   CVCL_3R34
DR   Coriell; HQ01656
DR   Wikidata; Q54893675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01657
AC   CVCL_3R35
DR   Coriell; HQ01657
DR   Wikidata; Q54893676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01659
AC   CVCL_3R36
DR   Coriell; HQ01659
DR   Wikidata; Q54893677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01660
AC   CVCL_3R37
DR   Coriell; HQ01660
DR   Wikidata; Q54893678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01661
AC   CVCL_3R38
DR   Coriell; HQ01661
DR   Wikidata; Q54893679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01662
AC   CVCL_3R39
DR   Coriell; HQ01662
DR   Wikidata; Q54893680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01663
AC   CVCL_3R40
DR   Coriell; HQ01663
DR   Wikidata; Q54893681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01664
AC   CVCL_3R41
DR   Coriell; HQ01664
DR   Wikidata; Q54893682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01666
AC   CVCL_3R42
DR   Coriell; HQ01666
DR   Wikidata; Q54893683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01667
AC   CVCL_3R43
DR   Coriell; HQ01667
DR   Wikidata; Q54893686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01668
AC   CVCL_3R44
DR   Coriell; HQ01668
DR   Wikidata; Q54893687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01669
AC   CVCL_3R45
DR   Coriell; HQ01669
DR   Wikidata; Q54893688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01670
AC   CVCL_3R46
DR   Coriell; HQ01670
DR   Wikidata; Q54893689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01671
AC   CVCL_3R47
DR   Coriell; HQ01671
DR   Wikidata; Q54893691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01672
AC   CVCL_3R48
DR   Coriell; HQ01672
DR   Wikidata; Q54893693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01673
AC   CVCL_3R49
DR   Coriell; HQ01673
DR   Wikidata; Q54893694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01674
AC   CVCL_3R50
DR   Coriell; HQ01674
DR   Wikidata; Q54893695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01675
AC   CVCL_3R51
DR   Coriell; HQ01675
DR   Wikidata; Q54893696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01676
AC   CVCL_3R52
DR   Coriell; HQ01676
DR   Wikidata; Q54893697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01677
AC   CVCL_3R53
DR   Coriell; HQ01677
DR   Wikidata; Q54893698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01678
AC   CVCL_3R54
DR   Coriell; HQ01678
DR   Wikidata; Q54893699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01679
AC   CVCL_3R55
DR   Coriell; HQ01679
DR   Wikidata; Q54893700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01680
AC   CVCL_3R56
DR   Coriell; HQ01680
DR   Wikidata; Q54893701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01681
AC   CVCL_3R57
DR   Coriell; HQ01681
DR   Wikidata; Q54893702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01683
AC   CVCL_3R58
DR   Coriell; HQ01683
DR   Wikidata; Q54893703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01684
AC   CVCL_3R59
DR   Coriell; HQ01684
DR   Wikidata; Q54893704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01685
AC   CVCL_3R60
DR   Coriell; HQ01685
DR   Wikidata; Q54893705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01686
AC   CVCL_3R61
DR   Coriell; HQ01686
DR   Wikidata; Q54893707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01687
AC   CVCL_3R62
DR   Coriell; HQ01687
DR   Wikidata; Q54893708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01688
AC   CVCL_3R63
DR   Coriell; HQ01688
DR   Wikidata; Q54893709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01689
AC   CVCL_3R64
DR   Coriell; HQ01689
DR   Wikidata; Q54893710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01690
AC   CVCL_3R65
DR   Coriell; HQ01690
DR   Wikidata; Q54893711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01691
AC   CVCL_3R66
DR   Coriell; HQ01691
DR   Wikidata; Q54893712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01692
AC   CVCL_3R67
DR   Coriell; HQ01692
DR   Wikidata; Q54893713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01693
AC   CVCL_3R68
DR   Coriell; HQ01693
DR   Wikidata; Q54893714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01694
AC   CVCL_3R69
DR   Coriell; HQ01694
DR   Wikidata; Q54893715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01695
AC   CVCL_3R70
DR   Coriell; HQ01695
DR   Wikidata; Q54893720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01696
AC   CVCL_3R71
DR   Coriell; HQ01696
DR   Wikidata; Q54893721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01697
AC   CVCL_3R72
DR   Coriell; HQ01697
DR   Wikidata; Q54893722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01698
AC   CVCL_3R73
DR   Coriell; HQ01698
DR   Wikidata; Q54893723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01699
AC   CVCL_3R74
DR   Coriell; HQ01699
DR   Wikidata; Q54893724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01700
AC   CVCL_3R75
DR   Coriell; HQ01700
DR   Wikidata; Q54893725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01701
AC   CVCL_3R76
DR   Coriell; HQ01701
DR   Wikidata; Q54893726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01702
AC   CVCL_3R77
DR   Coriell; HQ01702
DR   Wikidata; Q54893727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01703
AC   CVCL_3R78
DR   Coriell; HQ01703
DR   Wikidata; Q54893728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01704
AC   CVCL_3R79
DR   Coriell; HQ01704
DR   Wikidata; Q54893729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01705
AC   CVCL_3R80
DR   Coriell; HQ01705
DR   Wikidata; Q54893730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01706
AC   CVCL_3R81
DR   Coriell; HQ01706
DR   Wikidata; Q54893731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01707
AC   CVCL_3R82
DR   Coriell; HQ01707
DR   Wikidata; Q54893732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01708
AC   CVCL_3R83
DR   Coriell; HQ01708
DR   Wikidata; Q54893733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01709
AC   CVCL_3R84
DR   Coriell; HQ01709
DR   Wikidata; Q54893734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01710
AC   CVCL_3R85
DR   Coriell; HQ01710
DR   Wikidata; Q54893735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01711
AC   CVCL_3R86
DR   Coriell; HQ01711
DR   Wikidata; Q54893736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01712
AC   CVCL_3R87
DR   Coriell; HQ01712
DR   Wikidata; Q54893737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01713
AC   CVCL_3R88
DR   Coriell; HQ01713
DR   Wikidata; Q54893738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01714
AC   CVCL_3R89
DR   Coriell; HQ01714
DR   Wikidata; Q54893740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01715
AC   CVCL_3R90
DR   Coriell; HQ01715
DR   Wikidata; Q54893741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01716
AC   CVCL_3R91
DR   Coriell; HQ01716
DR   Wikidata; Q54893742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01717
AC   CVCL_3R92
DR   Coriell; HQ01717
DR   Wikidata; Q54893743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01718
AC   CVCL_3R93
DR   Coriell; HQ01718
DR   Wikidata; Q54893744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01719
AC   CVCL_3R94
DR   Coriell; HQ01719
DR   Wikidata; Q54893745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01720
AC   CVCL_3R95
DR   Coriell; HQ01720
DR   Wikidata; Q54893746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01721
AC   CVCL_3R96
DR   Coriell; HQ01721
DR   Wikidata; Q54893747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01722
AC   CVCL_3R97
DR   Coriell; HQ01722
DR   Wikidata; Q54893748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01723
AC   CVCL_3R98
DR   Coriell; HQ01723
DR   Wikidata; Q54893749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01724
AC   CVCL_3R99
DR   Coriell; HQ01724
DR   Wikidata; Q54893750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01725
AC   CVCL_3S00
DR   Coriell; HQ01725
DR   Wikidata; Q54893751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01726
AC   CVCL_3S01
DR   Coriell; HQ01726
DR   Wikidata; Q54893752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01727
AC   CVCL_3S02
DR   Coriell; HQ01727
DR   Wikidata; Q54893753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01728
AC   CVCL_3S03
DR   Coriell; HQ01728
DR   Wikidata; Q54893754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01729
AC   CVCL_3S04
DR   Coriell; HQ01729
DR   Wikidata; Q54893755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01730
AC   CVCL_3S05
DR   Coriell; HQ01730
DR   Wikidata; Q54893756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01731
AC   CVCL_3S06
DR   Coriell; HQ01731
DR   Wikidata; Q54893757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01732
AC   CVCL_3S07
DR   Coriell; HQ01732
DR   Wikidata; Q54893758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01733
AC   CVCL_3S08
DR   Coriell; HQ01733
DR   Wikidata; Q54893759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01734
AC   CVCL_3S09
DR   Coriell; HQ01734
DR   Wikidata; Q54893760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01735
AC   CVCL_3S10
DR   Coriell; HQ01735
DR   Wikidata; Q54893763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01736
AC   CVCL_3S11
DR   Coriell; HQ01736
DR   Wikidata; Q54893764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01737
AC   CVCL_3S12
DR   Coriell; HQ01737
DR   Wikidata; Q54893765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01738
AC   CVCL_3S13
DR   Coriell; HQ01738
DR   Wikidata; Q54893766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01739
AC   CVCL_3S14
DR   Coriell; HQ01739
DR   Wikidata; Q54893767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01740
AC   CVCL_3S15
DR   Coriell; HQ01740
DR   Wikidata; Q54893768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01741
AC   CVCL_3S16
DR   Coriell; HQ01741
DR   Wikidata; Q54893770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01742
AC   CVCL_3S17
DR   Coriell; HQ01742
DR   Wikidata; Q54893771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01743
AC   CVCL_3S18
DR   Coriell; HQ01743
DR   Wikidata; Q54893772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01744
AC   CVCL_3S19
DR   Coriell; HQ01744
DR   Wikidata; Q54893773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01745
AC   CVCL_3S20
DR   Coriell; HQ01745
DR   Wikidata; Q54893774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01746
AC   CVCL_3S21
DR   Coriell; HQ01746
DR   Wikidata; Q54893775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01747
AC   CVCL_3S22
DR   Coriell; HQ01747
DR   Wikidata; Q54893776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01748
AC   CVCL_3S23
DR   Coriell; HQ01748
DR   Wikidata; Q54893777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01749
AC   CVCL_3S24
DR   Coriell; HQ01749
DR   Wikidata; Q54893778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01750
AC   CVCL_3S25
DR   Coriell; HQ01750
DR   Wikidata; Q54893779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01751
AC   CVCL_3S26
DR   Coriell; HQ01751
DR   Wikidata; Q54893780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01752
AC   CVCL_3S27
DR   Coriell; HQ01752
DR   Wikidata; Q54893781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01753
AC   CVCL_3S28
DR   Coriell; HQ01753
DR   Wikidata; Q54893782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01754
AC   CVCL_3S29
DR   Coriell; HQ01754
DR   Wikidata; Q54893783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01755
AC   CVCL_3S30
DR   Coriell; HQ01755
DR   Wikidata; Q54893785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01757
AC   CVCL_3S31
DR   Coriell; HQ01757
DR   Wikidata; Q54893786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01758
AC   CVCL_3S32
DR   Coriell; HQ01758
DR   Wikidata; Q54893787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01759
AC   CVCL_3S33
DR   Coriell; HQ01759
DR   Wikidata; Q54893788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01760
AC   CVCL_3S34
DR   Coriell; HQ01760
DR   Wikidata; Q54893789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01761
AC   CVCL_3S35
DR   Coriell; HQ01761
DR   Wikidata; Q54893790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01763
AC   CVCL_3S36
DR   Coriell; HQ01763
DR   Wikidata; Q54893791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01764
AC   CVCL_3S37
DR   Coriell; HQ01764
DR   Wikidata; Q54893792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01766
AC   CVCL_3S38
DR   Coriell; HQ01766
DR   Wikidata; Q54893793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01767
AC   CVCL_3S39
DR   Coriell; HQ01767
DR   Wikidata; Q54893794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01768
AC   CVCL_3S40
DR   Coriell; HQ01768
DR   Wikidata; Q54893795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01769
AC   CVCL_3S41
DR   Coriell; HQ01769
DR   Wikidata; Q54893796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01770
AC   CVCL_3S42
DR   Coriell; HQ01770
DR   Wikidata; Q54893797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01771
AC   CVCL_3S43
DR   Coriell; HQ01771
DR   Wikidata; Q54893798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01772
AC   CVCL_3S44
DR   Coriell; HQ01772
DR   Wikidata; Q54893799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01773
AC   CVCL_3S45
DR   Coriell; HQ01773
DR   Wikidata; Q54893800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01774
AC   CVCL_3S46
DR   Coriell; HQ01774
DR   Wikidata; Q54893801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01776
AC   CVCL_3S47
DR   Coriell; HQ01776
DR   Wikidata; Q54893802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01777
AC   CVCL_3S48
DR   Coriell; HQ01777
DR   Wikidata; Q54893803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01778
AC   CVCL_3S49
DR   Coriell; HQ01778
DR   Wikidata; Q54893804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01779
AC   CVCL_3S50
DR   Coriell; HQ01779
DR   Wikidata; Q54893815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01780
AC   CVCL_3S51
DR   Coriell; HQ01780
DR   Wikidata; Q54893816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01781
AC   CVCL_3S52
DR   Coriell; HQ01781
DR   Wikidata; Q54893817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01782
AC   CVCL_3S53
DR   Coriell; HQ01782
DR   Wikidata; Q54893818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01783
AC   CVCL_3S54
DR   Coriell; HQ01783
DR   Wikidata; Q54893819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01784
AC   CVCL_3S55
DR   Coriell; HQ01784
DR   Wikidata; Q54893820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01785
AC   CVCL_3S56
DR   Coriell; HQ01785
DR   Wikidata; Q54893821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01786
AC   CVCL_3S57
DR   Coriell; HQ01786
DR   Wikidata; Q54893822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01787
AC   CVCL_3S58
DR   Coriell; HQ01787
DR   Wikidata; Q54893824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01788
AC   CVCL_3S59
DR   Coriell; HQ01788
DR   Wikidata; Q54893825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01789
AC   CVCL_3S60
DR   Coriell; HQ01789
DR   Wikidata; Q54893826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01790
AC   CVCL_3S61
DR   Coriell; HQ01790
DR   Wikidata; Q54893827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01791
AC   CVCL_3S62
DR   Coriell; HQ01791
DR   Wikidata; Q54893828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01792
AC   CVCL_3S63
DR   Coriell; HQ01792
DR   Wikidata; Q54893829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01793
AC   CVCL_3S64
DR   Coriell; HQ01793
DR   Wikidata; Q54893830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01794
AC   CVCL_3S65
DR   Coriell; HQ01794
DR   Wikidata; Q54893831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01795
AC   CVCL_3S66
DR   Coriell; HQ01795
DR   Wikidata; Q54893832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01796
AC   CVCL_3S67
DR   Coriell; HQ01796
DR   Wikidata; Q54893833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01799
AC   CVCL_3S68
DR   Coriell; HQ01799
DR   Wikidata; Q54893834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01800
AC   CVCL_3S69
DR   Coriell; HQ01800
DR   Wikidata; Q54893835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01801
AC   CVCL_3S70
DR   Coriell; HQ01801
DR   Wikidata; Q54893836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01802
AC   CVCL_3S71
DR   Coriell; HQ01802
DR   Wikidata; Q54893837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01803
AC   CVCL_3S72
DR   Coriell; HQ01803
DR   Wikidata; Q54893838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01804
AC   CVCL_3S73
DR   Coriell; HQ01804
DR   Wikidata; Q54893839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01805
AC   CVCL_3S74
DR   Coriell; HQ01805
DR   Wikidata; Q54893840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01806
AC   CVCL_3S75
DR   Coriell; HQ01806
DR   Wikidata; Q54893841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01807
AC   CVCL_3S76
DR   Coriell; HQ01807
DR   Wikidata; Q54893843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01808
AC   CVCL_3S77
DR   Coriell; HQ01808
DR   Wikidata; Q54893844
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line ND30013).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Patient indicated as not affected with HD in HQ01808, but as affected in ND30013.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y899 ! ND30013
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   HQ01809
AC   CVCL_3S78
DR   Coriell; HQ01809
DR   Wikidata; Q54893845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01810
AC   CVCL_3S79
DR   Coriell; HQ01810
DR   Wikidata; Q54893846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01811
AC   CVCL_3S80
DR   Coriell; HQ01811
DR   Wikidata; Q54893847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01812
AC   CVCL_3S81
DR   Coriell; HQ01812
DR   Wikidata; Q54893848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01813
AC   CVCL_3S82
DR   Coriell; HQ01813
DR   Wikidata; Q54893849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01814
AC   CVCL_3S83
DR   Coriell; HQ01814
DR   Wikidata; Q54893850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01815
AC   CVCL_3S84
DR   Coriell; HQ01815
DR   Wikidata; Q54893851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01817
AC   CVCL_3S85
DR   Coriell; HQ01817
DR   Wikidata; Q54893852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01818
AC   CVCL_3S86
DR   Coriell; HQ01818
DR   Wikidata; Q54893854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01819
AC   CVCL_3S87
DR   Coriell; HQ01819
DR   Wikidata; Q54893855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01820
AC   CVCL_3S88
DR   Coriell; HQ01820
DR   Wikidata; Q54893856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01821
AC   CVCL_3S89
DR   Coriell; HQ01821
DR   Wikidata; Q54893857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01822
AC   CVCL_3S90
DR   Coriell; HQ01822
DR   Wikidata; Q54893865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01823
AC   CVCL_3S91
DR   Coriell; HQ01823
DR   Wikidata; Q54893866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01824
AC   CVCL_3S92
DR   Coriell; HQ01824
DR   Wikidata; Q54893867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01825
AC   CVCL_3S93
DR   Coriell; HQ01825
DR   Wikidata; Q54893868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01826
AC   CVCL_3S94
DR   Coriell; HQ01826
DR   Wikidata; Q54893869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01827
AC   CVCL_3S95
DR   Coriell; HQ01827
DR   Wikidata; Q54893870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01828
AC   CVCL_3S96
DR   Coriell; HQ01828
DR   Wikidata; Q54893871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01829
AC   CVCL_3S97
DR   Coriell; HQ01829
DR   Wikidata; Q54893872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01830
AC   CVCL_3S98
DR   Coriell; HQ01830
DR   Wikidata; Q54893873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01831
AC   CVCL_3S99
DR   Coriell; HQ01831
DR   Wikidata; Q54893874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01832
AC   CVCL_3T00
DR   Coriell; HQ01832
DR   Wikidata; Q54893876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01833
AC   CVCL_3T01
DR   Coriell; HQ01833
DR   Wikidata; Q54893877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01834
AC   CVCL_3T02
DR   Coriell; HQ01834
DR   Wikidata; Q54893878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01835
AC   CVCL_3T03
DR   Coriell; HQ01835
DR   Wikidata; Q54893879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01837
AC   CVCL_3T04
DR   Coriell; HQ01837
DR   Wikidata; Q54893880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01838
AC   CVCL_3T05
DR   Coriell; HQ01838
DR   Wikidata; Q54893881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01839
AC   CVCL_3T06
DR   Coriell; HQ01839
DR   Wikidata; Q54893882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01840
AC   CVCL_3T07
DR   Coriell; HQ01840
DR   Wikidata; Q54893883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01841
AC   CVCL_3T08
DR   Coriell; HQ01841
DR   Wikidata; Q54893884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01842
AC   CVCL_3T09
DR   Coriell; HQ01842
DR   Wikidata; Q54893885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01843
AC   CVCL_3T10
DR   Coriell; HQ01843
DR   Wikidata; Q54893886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01844
AC   CVCL_3T11
DR   Coriell; HQ01844
DR   Wikidata; Q54893887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01845
AC   CVCL_3T12
DR   Coriell; HQ01845
DR   Wikidata; Q54893888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01847
AC   CVCL_3T13
DR   Coriell; HQ01847
DR   Wikidata; Q54893889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01848
AC   CVCL_3T14
DR   Coriell; HQ01848
DR   Wikidata; Q54893890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01849
AC   CVCL_3T15
DR   Coriell; HQ01849
DR   Wikidata; Q54893891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01851
AC   CVCL_3T16
DR   Coriell; HQ01851
DR   Wikidata; Q54893892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01852
AC   CVCL_3T17
DR   Coriell; HQ01852
DR   Wikidata; Q54893893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01853
AC   CVCL_3T18
DR   Coriell; HQ01853
DR   Wikidata; Q54893894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01854
AC   CVCL_3T19
DR   Coriell; HQ01854
DR   Wikidata; Q54893895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01855
AC   CVCL_3T20
DR   Coriell; HQ01855
DR   Wikidata; Q54893896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01856
AC   CVCL_3T21
DR   Coriell; HQ01856
DR   Wikidata; Q54893898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01857
AC   CVCL_3T22
DR   Coriell; HQ01857
DR   Wikidata; Q54893899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01858
AC   CVCL_3T23
DR   Coriell; HQ01858
DR   Wikidata; Q54893900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01859
AC   CVCL_3T24
DR   Coriell; HQ01859
DR   Wikidata; Q54893901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01860
AC   CVCL_3T25
DR   Coriell; HQ01860
DR   Wikidata; Q54893903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01861
AC   CVCL_3T26
DR   Coriell; HQ01861
DR   Wikidata; Q54893904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01862
AC   CVCL_3T27
DR   Coriell; HQ01862
DR   Wikidata; Q54893905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01863
AC   CVCL_3T28
DR   Coriell; HQ01863
DR   Wikidata; Q54893906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01864
AC   CVCL_3T29
DR   Coriell; HQ01864
DR   Wikidata; Q54893907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01865
AC   CVCL_3T30
DR   Coriell; HQ01865
DR   Wikidata; Q54893912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01866
AC   CVCL_3T31
DR   Coriell; HQ01866
DR   Wikidata; Q54893913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01867
AC   CVCL_3T32
DR   Coriell; HQ01867
DR   Wikidata; Q54893914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01868
AC   CVCL_3T33
DR   Coriell; HQ01868
DR   Wikidata; Q54893915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01869
AC   CVCL_3T34
DR   Coriell; HQ01869
DR   Wikidata; Q54893916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01870
AC   CVCL_3T35
DR   Coriell; HQ01870
DR   Wikidata; Q54893917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01871
AC   CVCL_3T36
DR   Coriell; HQ01871
DR   Wikidata; Q54893918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01872
AC   CVCL_3T37
DR   Coriell; HQ01872
DR   Wikidata; Q54893919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01873
AC   CVCL_3T38
DR   Coriell; HQ01873
DR   Wikidata; Q54893920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01874
AC   CVCL_3T39
DR   Coriell; HQ01874
DR   Wikidata; Q54893921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01875
AC   CVCL_3T40
DR   Coriell; HQ01875
DR   Wikidata; Q54893922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01876
AC   CVCL_3T41
DR   Coriell; HQ01876
DR   Wikidata; Q54893923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01877
AC   CVCL_3T42
DR   Coriell; HQ01877
DR   Wikidata; Q54893925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01878
AC   CVCL_3T43
DR   Coriell; HQ01878
DR   Wikidata; Q54893926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01880
AC   CVCL_3T44
DR   Coriell; HQ01880
DR   Wikidata; Q54893927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01881
AC   CVCL_3T45
DR   Coriell; HQ01881
DR   Wikidata; Q54893928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01882
AC   CVCL_3T46
DR   Coriell; HQ01882
DR   Wikidata; Q54893929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01883
AC   CVCL_3T47
DR   Coriell; HQ01883
DR   Wikidata; Q54893930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01884
AC   CVCL_3T48
DR   Coriell; HQ01884
DR   Wikidata; Q54893931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01885
AC   CVCL_3T49
DR   Coriell; HQ01885
DR   Wikidata; Q54893932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01886
AC   CVCL_3T50
DR   Coriell; HQ01886
DR   Wikidata; Q54893933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01887
AC   CVCL_3T51
DR   Coriell; HQ01887
DR   Wikidata; Q54893934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01888
AC   CVCL_3T52
DR   Coriell; HQ01888
DR   Wikidata; Q54893935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01889
AC   CVCL_3T53
DR   Coriell; HQ01889
DR   Wikidata; Q54893936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01890
AC   CVCL_3T54
DR   Coriell; HQ01890
DR   Wikidata; Q54893937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01891
AC   CVCL_3T55
DR   Coriell; HQ01891
DR   Wikidata; Q54893938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01892
AC   CVCL_3T56
DR   Coriell; HQ01892
DR   Wikidata; Q54893939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01893
AC   CVCL_3T57
DR   Coriell; HQ01893
DR   Wikidata; Q54893940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01894
AC   CVCL_3T58
DR   Coriell; HQ01894
DR   Wikidata; Q54893941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01895
AC   CVCL_3T59
DR   Coriell; HQ01895
DR   Wikidata; Q54893942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01896
AC   CVCL_3T60
DR   Coriell; HQ01896
DR   Wikidata; Q54893943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01897
AC   CVCL_3T61
DR   Coriell; HQ01897
DR   Wikidata; Q54893944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01898
AC   CVCL_3T62
DR   Coriell; HQ01898
DR   Wikidata; Q54893945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01899
AC   CVCL_3T63
DR   Coriell; HQ01899
DR   Wikidata; Q54893946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01900
AC   CVCL_3T64
DR   Coriell; HQ01900
DR   Wikidata; Q54893947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01901
AC   CVCL_3T65
DR   Coriell; HQ01901
DR   Wikidata; Q54893948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01903
AC   CVCL_3T66
DR   Coriell; HQ01903
DR   Wikidata; Q54893949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01904
AC   CVCL_3T67
DR   Coriell; HQ01904
DR   Wikidata; Q54893950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01905
AC   CVCL_3T68
DR   Coriell; HQ01905
DR   Wikidata; Q54893951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01906
AC   CVCL_3T69
DR   Coriell; HQ01906
DR   Wikidata; Q54893952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01907
AC   CVCL_3T70
DR   Coriell; HQ01907
DR   Wikidata; Q54893959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01908
AC   CVCL_3T71
DR   Coriell; HQ01908
DR   Wikidata; Q54893960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01909
AC   CVCL_3T72
DR   Coriell; HQ01909
DR   Wikidata; Q54893961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01910
AC   CVCL_3T73
DR   Coriell; HQ01910
DR   Wikidata; Q54893962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01911
AC   CVCL_3T74
DR   Coriell; HQ01911
DR   Wikidata; Q54893963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01912
AC   CVCL_3T75
DR   Coriell; HQ01912
DR   Wikidata; Q54893964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01913
AC   CVCL_3T76
DR   Coriell; HQ01913
DR   Wikidata; Q54893965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01914
AC   CVCL_3T77
DR   Coriell; HQ01914
DR   Wikidata; Q54893966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01916
AC   CVCL_3T78
DR   Coriell; HQ01916
DR   Wikidata; Q54893967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01917
AC   CVCL_3T79
DR   Coriell; HQ01917
DR   Wikidata; Q54893968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01918
AC   CVCL_3T80
DR   Coriell; HQ01918
DR   Wikidata; Q54893969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01919
AC   CVCL_3T81
DR   Coriell; HQ01919
DR   Wikidata; Q54893970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01920
AC   CVCL_3T82
DR   Coriell; HQ01920
DR   Wikidata; Q54893971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01921
AC   CVCL_3T83
DR   Coriell; HQ01921
DR   Wikidata; Q54893972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01922
AC   CVCL_3T84
DR   Coriell; HQ01922
DR   Wikidata; Q54893973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01923
AC   CVCL_3T85
DR   Coriell; HQ01923
DR   Wikidata; Q54893974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01924
AC   CVCL_3T86
DR   Coriell; HQ01924
DR   Wikidata; Q54893975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01925
AC   CVCL_3T87
DR   Coriell; HQ01925
DR   Wikidata; Q54893976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01926
AC   CVCL_3T88
DR   Coriell; HQ01926
DR   Wikidata; Q54893977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01927
AC   CVCL_3T89
DR   Coriell; HQ01927
DR   Wikidata; Q54893978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01928
AC   CVCL_3T90
DR   Coriell; HQ01928
DR   Wikidata; Q54893979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01929
AC   CVCL_3T91
DR   Coriell; HQ01929
DR   Wikidata; Q54893980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01930
AC   CVCL_3T92
DR   Coriell; HQ01930
DR   Wikidata; Q54893981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01931
AC   CVCL_3T93
DR   Coriell; HQ01931
DR   Wikidata; Q54893982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01932
AC   CVCL_3T94
DR   Coriell; HQ01932
DR   Wikidata; Q54893984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01933
AC   CVCL_3T95
DR   Coriell; HQ01933
DR   Wikidata; Q54893985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01934
AC   CVCL_3T96
DR   Coriell; HQ01934
DR   Wikidata; Q54893986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01935
AC   CVCL_3T97
DR   Coriell; HQ01935
DR   Wikidata; Q54893987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01936
AC   CVCL_3T98
DR   Coriell; HQ01936
DR   Wikidata; Q54893988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01937
AC   CVCL_3T99
DR   Coriell; HQ01937
DR   Wikidata; Q54893989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01938
AC   CVCL_3U00
DR   Coriell; HQ01938
DR   Wikidata; Q54893990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01939
AC   CVCL_3U01
DR   Coriell; HQ01939
DR   Wikidata; Q54893991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01940
AC   CVCL_3U02
DR   Coriell; HQ01940
DR   Wikidata; Q54893992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01941
AC   CVCL_3U03
DR   Coriell; HQ01941
DR   Wikidata; Q54893993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01942
AC   CVCL_3U04
DR   Coriell; HQ01942
DR   Wikidata; Q54893994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01943
AC   CVCL_3U05
DR   Coriell; HQ01943
DR   Wikidata; Q54893995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01944
AC   CVCL_3U06
DR   Coriell; HQ01944
DR   Wikidata; Q54893996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01945
AC   CVCL_3U07
DR   Coriell; HQ01945
DR   Wikidata; Q54893997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01946
AC   CVCL_3U08
DR   Coriell; HQ01946
DR   Wikidata; Q54893998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01947
AC   CVCL_3U09
DR   Coriell; HQ01947
DR   Wikidata; Q54893999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01948
AC   CVCL_3U10
DR   Coriell; HQ01948
DR   Wikidata; Q54894007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01949
AC   CVCL_3U11
DR   Coriell; HQ01949
DR   Wikidata; Q54894008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01950
AC   CVCL_3U12
DR   Coriell; HQ01950
DR   Wikidata; Q54894009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01951
AC   CVCL_3U13
DR   Coriell; HQ01951
DR   Wikidata; Q54894010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01952
AC   CVCL_3U14
DR   Coriell; HQ01952
DR   Wikidata; Q54894011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01953
AC   CVCL_3U15
DR   Coriell; HQ01953
DR   Wikidata; Q54894012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01954
AC   CVCL_3U16
DR   Coriell; HQ01954
DR   Wikidata; Q54894014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01955
AC   CVCL_3U17
DR   Coriell; HQ01955
DR   Wikidata; Q54894015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01956
AC   CVCL_3U18
DR   Coriell; HQ01956
DR   Wikidata; Q54894016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01957
AC   CVCL_3U19
DR   Coriell; HQ01957
DR   Wikidata; Q54894017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01958
AC   CVCL_3U20
DR   Coriell; HQ01958
DR   Wikidata; Q54894018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01959
AC   CVCL_3U21
DR   Coriell; HQ01959
DR   Wikidata; Q54894019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01960
AC   CVCL_3U22
DR   Coriell; HQ01960
DR   Wikidata; Q54894021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01961
AC   CVCL_3U23
DR   Coriell; HQ01961
DR   Wikidata; Q54894022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01962
AC   CVCL_3U24
DR   Coriell; HQ01962
DR   Wikidata; Q54894023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01963
AC   CVCL_3U25
DR   Coriell; HQ01963
DR   Wikidata; Q54894024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01964
AC   CVCL_3U26
DR   Coriell; HQ01964
DR   Wikidata; Q54894025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01965
AC   CVCL_3U27
DR   Coriell; HQ01965
DR   Wikidata; Q54894026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01966
AC   CVCL_3U28
DR   Coriell; HQ01966
DR   Wikidata; Q54894027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01967
AC   CVCL_3U29
DR   Coriell; HQ01967
DR   Wikidata; Q54894028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01968
AC   CVCL_3U30
DR   Coriell; HQ01968
DR   Wikidata; Q54894029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01970
AC   CVCL_3U31
DR   Coriell; HQ01970
DR   Wikidata; Q54894030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01971
AC   CVCL_3U32
DR   Coriell; HQ01971
DR   Wikidata; Q54894031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01972
AC   CVCL_3U33
DR   Coriell; HQ01972
DR   Wikidata; Q54894032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01974
AC   CVCL_3U34
DR   Coriell; HQ01974
DR   Wikidata; Q54894033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01975
AC   CVCL_3U35
DR   Coriell; HQ01975
DR   Wikidata; Q54894034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01976
AC   CVCL_3U36
DR   Coriell; HQ01976
DR   Wikidata; Q54894035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01977
AC   CVCL_3U37
DR   Coriell; HQ01977
DR   Wikidata; Q54894037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01978
AC   CVCL_3U38
DR   Coriell; HQ01978
DR   Wikidata; Q54894038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01979
AC   CVCL_3U39
DR   Coriell; HQ01979
DR   Wikidata; Q54894039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01980
AC   CVCL_3U40
DR   Coriell; HQ01980
DR   Wikidata; Q54894040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01981
AC   CVCL_3U41
DR   Coriell; HQ01981
DR   Wikidata; Q54894041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01982
AC   CVCL_3U42
DR   Coriell; HQ01982
DR   Wikidata; Q54894042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01983
AC   CVCL_3U43
DR   Coriell; HQ01983
DR   Wikidata; Q54894043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01984
AC   CVCL_3U44
DR   Coriell; HQ01984
DR   Wikidata; Q54894044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01985
AC   CVCL_3U45
DR   Coriell; HQ01985
DR   Wikidata; Q54894045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01986
AC   CVCL_3U46
DR   Coriell; HQ01986
DR   Wikidata; Q54894046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01987
AC   CVCL_3U47
DR   Coriell; HQ01987
DR   Wikidata; Q54894047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01988
AC   CVCL_3U48
DR   Coriell; HQ01988
DR   Wikidata; Q54894048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01989
AC   CVCL_3U49
DR   Coriell; HQ01989
DR   Wikidata; Q54894049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ01990
AC   CVCL_3U50
DR   Coriell; HQ01990
DR   Wikidata; Q54894054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01991
AC   CVCL_3U51
DR   Coriell; HQ01991
DR   Wikidata; Q54894055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01992
AC   CVCL_3U52
DR   Coriell; HQ01992
DR   Wikidata; Q54894056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01993
AC   CVCL_3U53
DR   Coriell; HQ01993
DR   Wikidata; Q54894057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01994
AC   CVCL_3U54
DR   Coriell; HQ01994
DR   Wikidata; Q54894058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01995
AC   CVCL_3U55
DR   Coriell; HQ01995
DR   Wikidata; Q54894059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01996
AC   CVCL_3U56
DR   Coriell; HQ01996
DR   Wikidata; Q54894060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01997
AC   CVCL_3U57
DR   Coriell; HQ01997
DR   Wikidata; Q54894062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01998
AC   CVCL_3U58
DR   Coriell; HQ01998
DR   Wikidata; Q54894063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ01999
AC   CVCL_3U59
DR   Coriell; HQ01999
DR   Wikidata; Q54894064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02000
AC   CVCL_3U60
DR   Coriell; HQ02000
DR   Wikidata; Q54894065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02001
AC   CVCL_3U61
DR   Coriell; HQ02001
DR   Wikidata; Q54894066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02002
AC   CVCL_3U62
DR   Coriell; HQ02002
DR   Wikidata; Q54894067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02003
AC   CVCL_3U63
DR   Coriell; HQ02003
DR   Wikidata; Q54894068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02004
AC   CVCL_3U64
DR   Coriell; HQ02004
DR   Wikidata; Q54894069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02005
AC   CVCL_3U65
DR   Coriell; HQ02005
DR   Wikidata; Q54894070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02006
AC   CVCL_3U66
DR   Coriell; HQ02006
DR   Wikidata; Q54894071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02007
AC   CVCL_3U67
DR   Coriell; HQ02007
DR   Wikidata; Q54894072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02008
AC   CVCL_3U68
DR   Coriell; HQ02008
DR   Wikidata; Q54894073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02009
AC   CVCL_3U69
DR   Coriell; HQ02009
DR   Wikidata; Q54894074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02010
AC   CVCL_3U70
DR   Coriell; HQ02010
DR   Wikidata; Q54894075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02011
AC   CVCL_3U71
DR   Coriell; HQ02011
DR   Wikidata; Q54894076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02012
AC   CVCL_3U72
DR   Coriell; HQ02012
DR   Wikidata; Q54894077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02013
AC   CVCL_3U73
DR   Coriell; HQ02013
DR   Wikidata; Q54894078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02015
AC   CVCL_3U74
DR   Coriell; HQ02015
DR   Wikidata; Q54894079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02016
AC   CVCL_3U75
DR   Coriell; HQ02016
DR   Wikidata; Q54894080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02017
AC   CVCL_3U76
DR   Coriell; HQ02017
DR   Wikidata; Q54894081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02018
AC   CVCL_3U77
DR   Coriell; HQ02018
DR   Wikidata; Q54894082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02019
AC   CVCL_3U78
DR   Coriell; HQ02019
DR   Wikidata; Q54894083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02020
AC   CVCL_3U79
DR   Coriell; HQ02020
DR   Wikidata; Q54894084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02021
AC   CVCL_3U80
DR   Coriell; HQ02021
DR   Wikidata; Q54894085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02022
AC   CVCL_3U81
DR   Coriell; HQ02022
DR   Wikidata; Q54894086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02023
AC   CVCL_3U82
DR   Coriell; HQ02023
DR   Wikidata; Q54894087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02024
AC   CVCL_3U83
DR   Coriell; HQ02024
DR   Wikidata; Q54894088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02025
AC   CVCL_3U84
DR   Coriell; HQ02025
DR   Wikidata; Q54894089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02026
AC   CVCL_3U85
DR   Coriell; HQ02026
DR   Wikidata; Q54894090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02027
AC   CVCL_3U86
DR   Coriell; HQ02027
DR   Wikidata; Q54894091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02028
AC   CVCL_3U87
DR   Coriell; HQ02028
DR   Wikidata; Q54894092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02029
AC   CVCL_3U88
DR   Coriell; HQ02029
DR   Wikidata; Q54894093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02030
AC   CVCL_3U89
DR   Coriell; HQ02030
DR   Wikidata; Q54894094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02031
AC   CVCL_3U90
DR   Coriell; HQ02031
DR   Wikidata; Q54894097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02032
AC   CVCL_3U91
DR   Coriell; HQ02032
DR   Wikidata; Q54894098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02033
AC   CVCL_3U92
DR   Coriell; HQ02033
DR   Wikidata; Q54894099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02034
AC   CVCL_3U93
DR   Coriell; HQ02034
DR   Wikidata; Q54894100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02035
AC   CVCL_3U94
DR   Coriell; HQ02035
DR   Wikidata; Q54894101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02036
AC   CVCL_3U95
DR   Coriell; HQ02036
DR   Wikidata; Q54894102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02037
AC   CVCL_3U96
DR   Coriell; HQ02037
DR   Wikidata; Q54894103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02038
AC   CVCL_3U97
DR   Coriell; HQ02038
DR   Wikidata; Q54894104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02039
AC   CVCL_3U98
DR   Coriell; HQ02039
DR   Wikidata; Q54894105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02040
AC   CVCL_3U99
DR   Coriell; HQ02040
DR   Wikidata; Q54894106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02041
AC   CVCL_3V00
DR   Coriell; HQ02041
DR   Wikidata; Q54894107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02042
AC   CVCL_3V01
DR   Coriell; HQ02042
DR   Wikidata; Q54894108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02043
AC   CVCL_3V02
DR   Coriell; HQ02043
DR   Wikidata; Q54894109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02044
AC   CVCL_3V03
DR   Coriell; HQ02044
DR   Wikidata; Q54894110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02045
AC   CVCL_3V04
DR   Coriell; HQ02045
DR   Wikidata; Q54894111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02046
AC   CVCL_3V05
DR   Coriell; HQ02046
DR   Wikidata; Q54894112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02047
AC   CVCL_3V06
DR   Coriell; HQ02047
DR   Wikidata; Q54894113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02048
AC   CVCL_3V07
DR   Coriell; HQ02048
DR   Wikidata; Q54894114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02049
AC   CVCL_3V08
DR   Coriell; HQ02049
DR   Wikidata; Q54894115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02050
AC   CVCL_3V09
DR   Coriell; HQ02050
DR   Wikidata; Q54894116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02051
AC   CVCL_3V10
DR   Coriell; HQ02051
DR   Wikidata; Q54894117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02052
AC   CVCL_3V11
DR   Coriell; HQ02052
DR   Wikidata; Q54894118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02053
AC   CVCL_3V12
DR   Coriell; HQ02053
DR   Wikidata; Q54894119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02054
AC   CVCL_3V13
DR   Coriell; HQ02054
DR   Wikidata; Q54894120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02055
AC   CVCL_3V14
DR   Coriell; HQ02055
DR   Wikidata; Q54894121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02056
AC   CVCL_3V15
DR   Coriell; HQ02056
DR   Wikidata; Q54894122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02057
AC   CVCL_3V16
DR   Coriell; HQ02057
DR   Wikidata; Q54894123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02058
AC   CVCL_3V17
DR   Coriell; HQ02058
DR   Wikidata; Q54894124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02059
AC   CVCL_3V18
DR   Coriell; HQ02059
DR   Wikidata; Q54894125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02061
AC   CVCL_3V19
DR   Coriell; HQ02061
DR   Wikidata; Q54894126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02062
AC   CVCL_3V20
DR   Coriell; HQ02062
DR   Wikidata; Q54894127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02063
AC   CVCL_3V21
DR   Coriell; HQ02063
DR   Wikidata; Q54894128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02064
AC   CVCL_3V22
DR   Coriell; HQ02064
DR   Wikidata; Q54894129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02065
AC   CVCL_3V23
DR   Coriell; HQ02065
DR   Wikidata; Q54894130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02066
AC   CVCL_3V24
DR   Coriell; HQ02066
DR   Wikidata; Q54894131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02069
AC   CVCL_3V25
DR   Coriell; HQ02069
DR   Wikidata; Q54894132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02070
AC   CVCL_3V26
DR   Coriell; HQ02070
DR   Wikidata; Q54894133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02071
AC   CVCL_3V27
DR   Coriell; HQ02071
DR   Wikidata; Q54894134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02072
AC   CVCL_3V28
DR   Coriell; HQ02072
DR   Wikidata; Q54894135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02074
AC   CVCL_3V29
DR   Coriell; HQ02074
DR   Wikidata; Q54894136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02075
AC   CVCL_3V30
DR   Coriell; HQ02075
DR   Wikidata; Q54894140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02076
AC   CVCL_3V31
DR   Coriell; HQ02076
DR   Wikidata; Q54894141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02077
AC   CVCL_3V32
DR   Coriell; HQ02077
DR   Wikidata; Q54894142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02078
AC   CVCL_3V33
DR   Coriell; HQ02078
DR   Wikidata; Q54894143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02079
AC   CVCL_3V34
DR   Coriell; HQ02079
DR   Wikidata; Q54894144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02082
AC   CVCL_3V35
DR   Coriell; HQ02082
DR   Wikidata; Q54894145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02083
AC   CVCL_3V36
DR   Coriell; HQ02083
DR   Wikidata; Q54894146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02084
AC   CVCL_3V37
DR   Coriell; HQ02084
DR   Wikidata; Q54894147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02085
AC   CVCL_3V38
DR   Coriell; HQ02085
DR   Wikidata; Q54894148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02086
AC   CVCL_3V39
DR   Coriell; HQ02086
DR   Wikidata; Q54894149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02087
AC   CVCL_3V40
DR   Coriell; HQ02087
DR   Wikidata; Q54894150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02088
AC   CVCL_3V41
DR   Coriell; HQ02088
DR   Wikidata; Q54894151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02089
AC   CVCL_3V42
DR   Coriell; HQ02089
DR   Wikidata; Q54894152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02090
AC   CVCL_3V43
DR   Coriell; HQ02090
DR   Wikidata; Q54894153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02091
AC   CVCL_3V44
DR   Coriell; HQ02091
DR   Wikidata; Q54894154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02092
AC   CVCL_3V45
DR   Coriell; HQ02092
DR   Wikidata; Q54894155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02093
AC   CVCL_3V46
DR   Coriell; HQ02093
DR   Wikidata; Q54894156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02094
AC   CVCL_3V47
DR   Coriell; HQ02094
DR   Wikidata; Q54894157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02095
AC   CVCL_3V48
DR   Coriell; HQ02095
DR   Wikidata; Q54894158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02096
AC   CVCL_3V49
DR   Coriell; HQ02096
DR   Wikidata; Q54894159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02097
AC   CVCL_3V50
DR   Coriell; HQ02097
DR   Wikidata; Q54894160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02098
AC   CVCL_3V51
DR   Coriell; HQ02098
DR   Wikidata; Q54894161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02099
AC   CVCL_3V52
DR   Coriell; HQ02099
DR   Wikidata; Q54894162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02100
AC   CVCL_3V53
DR   Coriell; HQ02100
DR   Wikidata; Q54894163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02101
AC   CVCL_3V54
DR   Coriell; HQ02101
DR   Wikidata; Q54894164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02102
AC   CVCL_3V55
DR   Coriell; HQ02102
DR   Wikidata; Q54894165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02103
AC   CVCL_3V56
DR   Coriell; HQ02103
DR   Wikidata; Q54894166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02104
AC   CVCL_3V57
DR   Coriell; HQ02104
DR   Wikidata; Q54894167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02105
AC   CVCL_3V58
DR   Coriell; HQ02105
DR   Wikidata; Q54894168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02106
AC   CVCL_3V59
DR   Coriell; HQ02106
DR   Wikidata; Q54894169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02107
AC   CVCL_3V60
DR   Coriell; HQ02107
DR   Wikidata; Q54894170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02108
AC   CVCL_3V61
DR   Coriell; HQ02108
DR   Wikidata; Q54894171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02109
AC   CVCL_3V62
DR   Coriell; HQ02109
DR   Wikidata; Q54894172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02110
AC   CVCL_3V63
DR   Coriell; HQ02110
DR   Wikidata; Q54894173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02111
AC   CVCL_3V64
DR   Coriell; HQ02111
DR   Wikidata; Q54894174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02112
AC   CVCL_3V65
DR   Coriell; HQ02112
DR   Wikidata; Q54894175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02113
AC   CVCL_3V66
DR   Coriell; HQ02113
DR   Wikidata; Q54894176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02114
AC   CVCL_3V67
DR   Coriell; HQ02114
DR   Wikidata; Q54894177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02115
AC   CVCL_3V68
DR   Coriell; HQ02115
DR   Wikidata; Q54894178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02116
AC   CVCL_3V69
DR   Coriell; HQ02116
DR   Wikidata; Q54894179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02117
AC   CVCL_3V70
DR   Coriell; HQ02117
DR   Wikidata; Q54894185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02118
AC   CVCL_3V71
DR   Coriell; HQ02118
DR   Wikidata; Q54894186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02120
AC   CVCL_3V72
DR   Coriell; HQ02120
DR   Wikidata; Q54894187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02121
AC   CVCL_3V73
DR   Coriell; HQ02121
DR   Wikidata; Q54894188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02122
AC   CVCL_3V74
DR   Coriell; HQ02122
DR   Wikidata; Q54894189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02123
AC   CVCL_3V75
DR   Coriell; HQ02123
DR   Wikidata; Q54894190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02124
AC   CVCL_3V76
DR   Coriell; HQ02124
DR   Wikidata; Q54894191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02125
AC   CVCL_3V77
DR   Coriell; HQ02125
DR   Wikidata; Q54894192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02126
AC   CVCL_3V78
DR   Coriell; HQ02126
DR   Wikidata; Q54894193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02127
AC   CVCL_3V79
DR   Coriell; HQ02127
DR   Wikidata; Q54894194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02128
AC   CVCL_3V80
DR   Coriell; HQ02128
DR   Wikidata; Q54894195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02129
AC   CVCL_3V81
DR   Coriell; HQ02129
DR   Wikidata; Q54894196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02130
AC   CVCL_3V82
DR   Coriell; HQ02130
DR   Wikidata; Q54894197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02131
AC   CVCL_3V83
DR   Coriell; HQ02131
DR   Wikidata; Q54894198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02132
AC   CVCL_3V84
DR   Coriell; HQ02132
DR   Wikidata; Q54894199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02133
AC   CVCL_3V85
DR   Coriell; HQ02133
DR   Wikidata; Q54894200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02134
AC   CVCL_3V86
DR   Coriell; HQ02134
DR   Wikidata; Q54894201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02135
AC   CVCL_3V87
DR   Coriell; HQ02135
DR   Wikidata; Q54894202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02136
AC   CVCL_3V88
DR   Coriell; HQ02136
DR   Wikidata; Q54894204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02137
AC   CVCL_3V89
DR   Coriell; HQ02137
DR   Wikidata; Q54894205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02138
AC   CVCL_3V90
DR   Coriell; HQ02138
DR   Wikidata; Q54894206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02139
AC   CVCL_3V91
DR   Coriell; HQ02139
DR   Wikidata; Q54894207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02140
AC   CVCL_3V92
DR   Coriell; HQ02140
DR   Wikidata; Q54894208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02141
AC   CVCL_3V93
DR   Coriell; HQ02141
DR   Wikidata; Q54894209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02142
AC   CVCL_3V94
DR   Coriell; HQ02142
DR   Wikidata; Q54894210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02143
AC   CVCL_3V95
DR   Coriell; HQ02143
DR   Wikidata; Q54894211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02144
AC   CVCL_3V96
DR   Coriell; HQ02144
DR   Wikidata; Q54894212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02145
AC   CVCL_3V97
DR   Coriell; HQ02145
DR   Wikidata; Q54894213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02146
AC   CVCL_3V98
DR   Coriell; HQ02146
DR   Wikidata; Q54894215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02147
AC   CVCL_3V99
DR   Coriell; HQ02147
DR   Wikidata; Q54894216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02148
AC   CVCL_3W00
DR   Coriell; HQ02148
DR   Wikidata; Q54894218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02149
AC   CVCL_3W01
DR   Coriell; HQ02149
DR   Wikidata; Q54894219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02150
AC   CVCL_3W02
DR   Coriell; HQ02150
DR   Wikidata; Q54894220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02151
AC   CVCL_3W03
DR   Coriell; HQ02151
DR   Wikidata; Q54894221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02152
AC   CVCL_3W04
DR   Coriell; HQ02152
DR   Wikidata; Q54894222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02153
AC   CVCL_3W05
DR   Coriell; HQ02153
DR   Wikidata; Q54894223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02154
AC   CVCL_3W06
DR   Coriell; HQ02154
DR   Wikidata; Q54894224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02155
AC   CVCL_3W07
DR   Coriell; HQ02155
DR   Wikidata; Q54894225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02156
AC   CVCL_3W08
DR   Coriell; HQ02156
DR   Wikidata; Q54894226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02157
AC   CVCL_3W09
DR   Coriell; HQ02157
DR   Wikidata; Q54894227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02158
AC   CVCL_3W10
DR   Coriell; HQ02158
DR   Wikidata; Q54894233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02159
AC   CVCL_3W11
DR   Coriell; HQ02159
DR   Wikidata; Q54894234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02160
AC   CVCL_3W12
DR   Coriell; HQ02160
DR   Wikidata; Q54894235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02161
AC   CVCL_3W13
DR   Coriell; HQ02161
DR   Wikidata; Q54894236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02162
AC   CVCL_3W14
DR   Coriell; HQ02162
DR   Wikidata; Q54894238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02163
AC   CVCL_3W15
DR   Coriell; HQ02163
DR   Wikidata; Q54894239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02164
AC   CVCL_3W16
DR   Coriell; HQ02164
DR   Wikidata; Q54894240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02165
AC   CVCL_3W17
DR   Coriell; HQ02165
DR   Wikidata; Q54894241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02166
AC   CVCL_3W18
DR   Coriell; HQ02166
DR   Wikidata; Q54894242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02167
AC   CVCL_3W19
DR   Coriell; HQ02167
DR   Wikidata; Q54894243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02168
AC   CVCL_3W20
DR   Coriell; HQ02168
DR   Wikidata; Q54894244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02169
AC   CVCL_3W21
DR   Coriell; HQ02169
DR   Wikidata; Q54894245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02170
AC   CVCL_3W22
DR   Coriell; HQ02170
DR   Wikidata; Q54894246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02171
AC   CVCL_3W23
DR   Coriell; HQ02171
DR   Wikidata; Q54894247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02172
AC   CVCL_3W24
DR   Coriell; HQ02172
DR   Wikidata; Q54894248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02173
AC   CVCL_3W25
DR   Coriell; HQ02173
DR   Wikidata; Q54894249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02174
AC   CVCL_3W26
DR   Coriell; HQ02174
DR   Wikidata; Q54894250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02175
AC   CVCL_3W27
DR   Coriell; HQ02175
DR   Wikidata; Q54894251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02176
AC   CVCL_3W28
DR   Coriell; HQ02176
DR   Wikidata; Q54894252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02177
AC   CVCL_3W29
DR   Coriell; HQ02177
DR   Wikidata; Q54894253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02178
AC   CVCL_3W30
DR   Coriell; HQ02178
DR   Wikidata; Q54894254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02179
AC   CVCL_3W31
DR   Coriell; HQ02179
DR   Wikidata; Q54894255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02180
AC   CVCL_3W32
DR   Coriell; HQ02180
DR   Wikidata; Q54894257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02181
AC   CVCL_3W33
DR   Coriell; HQ02181
DR   Wikidata; Q54894258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02182
AC   CVCL_3W34
DR   Coriell; HQ02182
DR   Wikidata; Q54894259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02183
AC   CVCL_3W35
DR   Coriell; HQ02183
DR   Wikidata; Q54894260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02184
AC   CVCL_3W36
DR   Coriell; HQ02184
DR   Wikidata; Q54894261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02185
AC   CVCL_3W37
DR   Coriell; HQ02185
DR   Wikidata; Q54894262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02186
AC   CVCL_3W38
DR   Coriell; HQ02186
DR   Wikidata; Q54894263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02187
AC   CVCL_3W39
DR   Coriell; HQ02187
DR   Wikidata; Q54894264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02188
AC   CVCL_3W40
DR   Coriell; HQ02188
DR   Wikidata; Q54894265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02189
AC   CVCL_3W41
DR   Coriell; HQ02189
DR   Wikidata; Q54894266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02190
AC   CVCL_3W42
DR   Coriell; HQ02190
DR   Wikidata; Q54894267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02191
AC   CVCL_3W43
DR   Coriell; HQ02191
DR   Wikidata; Q54894268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02192
AC   CVCL_3W44
DR   Coriell; HQ02192
DR   Wikidata; Q54894269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02193
AC   CVCL_3W45
DR   Coriell; HQ02193
DR   Wikidata; Q54894270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02194
AC   CVCL_3W46
DR   Coriell; HQ02194
DR   Wikidata; Q54894271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02195
AC   CVCL_3W47
DR   Coriell; HQ02195
DR   Wikidata; Q54894272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02196
AC   CVCL_3W48
DR   Coriell; HQ02196
DR   Wikidata; Q54894273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02198
AC   CVCL_3W49
DR   Coriell; HQ02198
DR   Wikidata; Q54894274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02199
AC   CVCL_3W50
DR   Coriell; HQ02199
DR   Wikidata; Q54894280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02200
AC   CVCL_3W51
DR   Coriell; HQ02200
DR   Wikidata; Q54894281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02201
AC   CVCL_3W52
DR   Coriell; HQ02201
DR   Wikidata; Q54894282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02202
AC   CVCL_3W53
DR   Coriell; HQ02202
DR   Wikidata; Q54894283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02203
AC   CVCL_3W54
DR   Coriell; HQ02203
DR   Wikidata; Q54894284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02204
AC   CVCL_3W55
DR   Coriell; HQ02204
DR   Wikidata; Q54894285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02205
AC   CVCL_3W56
DR   Coriell; HQ02205
DR   Wikidata; Q54894286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02206
AC   CVCL_3W57
DR   Coriell; HQ02206
DR   Wikidata; Q54894287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02208
AC   CVCL_3W58
DR   Coriell; HQ02208
DR   Wikidata; Q54894288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02209
AC   CVCL_3W59
DR   Coriell; HQ02209
DR   Wikidata; Q54894289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02210
AC   CVCL_3W60
DR   Coriell; HQ02210
DR   Wikidata; Q54894290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02211
AC   CVCL_3W61
DR   Coriell; HQ02211
DR   Wikidata; Q54894291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02212
AC   CVCL_3W62
DR   Coriell; HQ02212
DR   Wikidata; Q54894292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02214
AC   CVCL_3W63
DR   Coriell; HQ02214
DR   Wikidata; Q54894293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02215
AC   CVCL_3W64
DR   Coriell; HQ02215
DR   Wikidata; Q54894295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02216
AC   CVCL_3W65
DR   Coriell; HQ02216
DR   Wikidata; Q54894296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02217
AC   CVCL_3W66
DR   Coriell; HQ02217
DR   Wikidata; Q54894297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02218
AC   CVCL_3W67
DR   Coriell; HQ02218
DR   Wikidata; Q54894298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02220
AC   CVCL_3W68
DR   Coriell; HQ02220
DR   Wikidata; Q54894299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02222
AC   CVCL_3W69
DR   Coriell; HQ02222
DR   Wikidata; Q54894300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02223
AC   CVCL_3W70
DR   Coriell; HQ02223
DR   Wikidata; Q54894301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02224
AC   CVCL_3W71
DR   Coriell; HQ02224
DR   Wikidata; Q54894302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02225
AC   CVCL_3W72
DR   Coriell; HQ02225
DR   Wikidata; Q54894303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02226
AC   CVCL_3W73
DR   Coriell; HQ02226
DR   Wikidata; Q54894304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02227
AC   CVCL_3W74
DR   Coriell; HQ02227
DR   Wikidata; Q54894305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02228
AC   CVCL_3W75
DR   Coriell; HQ02228
DR   Wikidata; Q54894306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02229
AC   CVCL_3W76
DR   Coriell; HQ02229
DR   Wikidata; Q54894307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02231
AC   CVCL_3W77
DR   Coriell; HQ02231
DR   Wikidata; Q54894308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02232
AC   CVCL_3W78
DR   Coriell; HQ02232
DR   Wikidata; Q54894310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02233
AC   CVCL_3W79
DR   Coriell; HQ02233
DR   Wikidata; Q54894312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02234
AC   CVCL_3W80
DR   Coriell; HQ02234
DR   Wikidata; Q54894313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02235
AC   CVCL_3W81
DR   Coriell; HQ02235
DR   Wikidata; Q54894314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02236
AC   CVCL_3W82
DR   Coriell; HQ02236
DR   Wikidata; Q54894315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02237
AC   CVCL_3W83
DR   Coriell; HQ02237
DR   Wikidata; Q54894316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02238
AC   CVCL_3W84
DR   Coriell; HQ02238
DR   Wikidata; Q54894317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02239
AC   CVCL_3W85
DR   Coriell; HQ02239
DR   Wikidata; Q54894318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02240
AC   CVCL_3W86
DR   Coriell; HQ02240
DR   Wikidata; Q54894319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02241
AC   CVCL_3W87
DR   Coriell; HQ02241
DR   Wikidata; Q54894320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02243
AC   CVCL_3W88
DR   Coriell; HQ02243
DR   Wikidata; Q54894321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02244
AC   CVCL_3W89
DR   Coriell; HQ02244
DR   Wikidata; Q54894322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02245
AC   CVCL_3W90
DR   Coriell; HQ02245
DR   Wikidata; Q54894335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02246
AC   CVCL_3W91
DR   Coriell; HQ02246
DR   Wikidata; Q54894336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02247
AC   CVCL_3W92
DR   Coriell; HQ02247
DR   Wikidata; Q54894337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02249
AC   CVCL_3W93
DR   Coriell; HQ02249
DR   Wikidata; Q54894338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02250
AC   CVCL_3W94
DR   Coriell; HQ02250
DR   Wikidata; Q54894339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02251
AC   CVCL_3W95
DR   Coriell; HQ02251
DR   Wikidata; Q54894340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02252
AC   CVCL_3W96
DR   Coriell; HQ02252
DR   Wikidata; Q54894341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02254
AC   CVCL_3W97
DR   Coriell; HQ02254
DR   Wikidata; Q54894342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02255
AC   CVCL_3W98
DR   Coriell; HQ02255
DR   Wikidata; Q54894343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02256
AC   CVCL_3W99
DR   Coriell; HQ02256
DR   Wikidata; Q54894344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02257
AC   CVCL_3X00
DR   Coriell; HQ02257
DR   Wikidata; Q54894345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02258
AC   CVCL_3X01
DR   Coriell; HQ02258
DR   Wikidata; Q54894346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02259
AC   CVCL_3X02
DR   Coriell; HQ02259
DR   Wikidata; Q54894347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02260
AC   CVCL_3X03
DR   Coriell; HQ02260
DR   Wikidata; Q54894348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02262
AC   CVCL_3X04
DR   Coriell; HQ02262
DR   Wikidata; Q54894349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02263
AC   CVCL_3X05
DR   Coriell; HQ02263
DR   Wikidata; Q54894350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02264
AC   CVCL_3X06
DR   Coriell; HQ02264
DR   Wikidata; Q54894351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02265
AC   CVCL_3X07
DR   Coriell; HQ02265
DR   Wikidata; Q54894352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02267
AC   CVCL_3X08
DR   Coriell; HQ02267
DR   Wikidata; Q54894353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02268
AC   CVCL_3X09
DR   Coriell; HQ02268
DR   Wikidata; Q54894354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02271
AC   CVCL_3X10
DR   Coriell; HQ02271
DR   Wikidata; Q54894355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02272
AC   CVCL_3X11
DR   Coriell; HQ02272
DR   Wikidata; Q54894356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02273
AC   CVCL_3X12
DR   Coriell; HQ02273
DR   Wikidata; Q54894357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02274
AC   CVCL_3X13
DR   Coriell; HQ02274
DR   Wikidata; Q54894358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02276
AC   CVCL_3X14
DR   Coriell; HQ02276
DR   Wikidata; Q54894359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02277
AC   CVCL_3X15
DR   Coriell; HQ02277
DR   Wikidata; Q54894360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02278
AC   CVCL_3X16
DR   Coriell; HQ02278
DR   Wikidata; Q54894361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02279
AC   CVCL_3X17
DR   Coriell; HQ02279
DR   Wikidata; Q54894362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02280
AC   CVCL_3X18
DR   Coriell; HQ02280
DR   Wikidata; Q54894363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02281
AC   CVCL_3X19
DR   Coriell; HQ02281
DR   Wikidata; Q54894364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02282
AC   CVCL_3X20
DR   Coriell; HQ02282
DR   Wikidata; Q54894365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02283
AC   CVCL_3X21
DR   Coriell; HQ02283
DR   Wikidata; Q54894366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02284
AC   CVCL_3X22
DR   Coriell; HQ02284
DR   Wikidata; Q54894367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02285
AC   CVCL_3X23
DR   Coriell; HQ02285
DR   Wikidata; Q54894368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02286
AC   CVCL_3X24
DR   Coriell; HQ02286
DR   Wikidata; Q54894369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02288
AC   CVCL_3X25
DR   Coriell; HQ02288
DR   Wikidata; Q54894370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02289
AC   CVCL_3X26
DR   Coriell; HQ02289
DR   Wikidata; Q54894371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02290
AC   CVCL_3X27
DR   Coriell; HQ02290
DR   Wikidata; Q54894372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02291
AC   CVCL_3X28
DR   Coriell; HQ02291
DR   Wikidata; Q54894373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02293
AC   CVCL_3X29
DR   Coriell; HQ02293
DR   Wikidata; Q54894374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02295
AC   CVCL_3X30
DR   Coriell; HQ02295
DR   Wikidata; Q54894378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02296
AC   CVCL_3X31
DR   Coriell; HQ02296
DR   Wikidata; Q54894379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02297
AC   CVCL_3X32
DR   Coriell; HQ02297
DR   Wikidata; Q54894380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02298
AC   CVCL_3X33
DR   Coriell; HQ02298
DR   Wikidata; Q54894381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02299
AC   CVCL_3X34
DR   Coriell; HQ02299
DR   Wikidata; Q54894382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02300
AC   CVCL_3X35
DR   Coriell; HQ02300
DR   Wikidata; Q54894383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02303
AC   CVCL_3X36
DR   Coriell; HQ02303
DR   Wikidata; Q54894384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02304
AC   CVCL_3X37
DR   Coriell; HQ02304
DR   Wikidata; Q54894385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02305
AC   CVCL_3X38
DR   Coriell; HQ02305
DR   Wikidata; Q54894386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02306
AC   CVCL_3X39
DR   Coriell; HQ02306
DR   Wikidata; Q54894387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02307
AC   CVCL_3X40
DR   Coriell; HQ02307
DR   Wikidata; Q54894388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02308
AC   CVCL_3X41
DR   Coriell; HQ02308
DR   Wikidata; Q54894389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02311
AC   CVCL_3X42
DR   Coriell; HQ02311
DR   Wikidata; Q54894390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02312
AC   CVCL_3X43
DR   Coriell; HQ02312
DR   Wikidata; Q54894391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02313
AC   CVCL_3X44
DR   Coriell; HQ02313
DR   Wikidata; Q54894392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02315
AC   CVCL_3X45
DR   Coriell; HQ02315
DR   Wikidata; Q54894393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02316
AC   CVCL_3X46
DR   Coriell; HQ02316
DR   Wikidata; Q54894394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02317
AC   CVCL_3X47
DR   Coriell; HQ02317
DR   Wikidata; Q54894395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02318
AC   CVCL_3X48
DR   Coriell; HQ02318
DR   Wikidata; Q54894396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02319
AC   CVCL_3X49
DR   Coriell; HQ02319
DR   Wikidata; Q54894397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02321
AC   CVCL_3X50
DR   Coriell; HQ02321
DR   Wikidata; Q54894398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02322
AC   CVCL_3X51
DR   Coriell; HQ02322
DR   Wikidata; Q54894399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02324
AC   CVCL_3X52
DR   Coriell; HQ02324
DR   Wikidata; Q54894400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02325
AC   CVCL_3X53
DR   Coriell; HQ02325
DR   Wikidata; Q54894401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02326
AC   CVCL_3X54
DR   Coriell; HQ02326
DR   Wikidata; Q54894402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02327
AC   CVCL_3X55
DR   Coriell; HQ02327
DR   Wikidata; Q54894403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02328
AC   CVCL_3X56
DR   Coriell; HQ02328
DR   Wikidata; Q54894404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02329
AC   CVCL_3X57
DR   Coriell; HQ02329
DR   Wikidata; Q54894405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02330
AC   CVCL_3X58
DR   Coriell; HQ02330
DR   Wikidata; Q54894406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02331
AC   CVCL_3X59
DR   Coriell; HQ02331
DR   Wikidata; Q54894407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02332
AC   CVCL_3X60
DR   Coriell; HQ02332
DR   Wikidata; Q54894408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02333
AC   CVCL_3X61
DR   Coriell; HQ02333
DR   Wikidata; Q54894409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02335
AC   CVCL_3X62
DR   Coriell; HQ02335
DR   Wikidata; Q54894410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02336
AC   CVCL_3X63
DR   Coriell; HQ02336
DR   Wikidata; Q54894411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02337
AC   CVCL_3X64
DR   Coriell; HQ02337
DR   Wikidata; Q54894412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02338
AC   CVCL_3X65
DR   Coriell; HQ02338
DR   Wikidata; Q54894413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02339
AC   CVCL_3X66
DR   Coriell; HQ02339
DR   Wikidata; Q54894414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02340
AC   CVCL_3X67
DR   Coriell; HQ02340
DR   Wikidata; Q54894415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02341
AC   CVCL_3X68
DR   Coriell; HQ02341
DR   Wikidata; Q54894416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02342
AC   CVCL_3X69
DR   Coriell; HQ02342
DR   Wikidata; Q54894417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02343
AC   CVCL_3X70
DR   Coriell; HQ02343
DR   Wikidata; Q54894432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02346
AC   CVCL_3X71
DR   Coriell; HQ02346
DR   Wikidata; Q54894433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02347
AC   CVCL_3X72
DR   Coriell; HQ02347
DR   Wikidata; Q54894434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02349
AC   CVCL_3X73
DR   Coriell; HQ02349
DR   Wikidata; Q54894435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02350
AC   CVCL_3X74
DR   Coriell; HQ02350
DR   Wikidata; Q54894436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02351
AC   CVCL_3X75
DR   Coriell; HQ02351
DR   Wikidata; Q54894437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02352
AC   CVCL_3X76
DR   Coriell; HQ02352
DR   Wikidata; Q54894439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02353
AC   CVCL_3X77
DR   Coriell; HQ02353
DR   Wikidata; Q54894440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02355
AC   CVCL_3X78
DR   Coriell; HQ02355
DR   Wikidata; Q54894441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02356
AC   CVCL_3X79
DR   Coriell; HQ02356
DR   Wikidata; Q54894442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02357
AC   CVCL_3X80
DR   Coriell; HQ02357
DR   Wikidata; Q54894443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02358
AC   CVCL_3X81
DR   Coriell; HQ02358
DR   Wikidata; Q54894444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02359
AC   CVCL_3X82
DR   Coriell; HQ02359
DR   Wikidata; Q54894445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02360
AC   CVCL_3X83
DR   Coriell; HQ02360
DR   Wikidata; Q54894446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02361
AC   CVCL_3X84
DR   Coriell; HQ02361
DR   Wikidata; Q54894447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02362
AC   CVCL_3X85
DR   Coriell; HQ02362
DR   Wikidata; Q54894449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02363
AC   CVCL_3X86
DR   Coriell; HQ02363
DR   Wikidata; Q54894450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02364
AC   CVCL_3X87
DR   Coriell; HQ02364
DR   Wikidata; Q54894451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02368
AC   CVCL_3X88
DR   Coriell; HQ02368
DR   Wikidata; Q54894452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02369
AC   CVCL_3X89
DR   Coriell; HQ02369
DR   Wikidata; Q54894453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02370
AC   CVCL_3X90
DR   Coriell; HQ02370
DR   Wikidata; Q54894454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02371
AC   CVCL_3X91
DR   Coriell; HQ02371
DR   Wikidata; Q54894455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02372
AC   CVCL_3X92
DR   Coriell; HQ02372
DR   Wikidata; Q54894456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02373
AC   CVCL_3X93
DR   Coriell; HQ02373
DR   Wikidata; Q54894457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02374
AC   CVCL_3X94
DR   Coriell; HQ02374
DR   Wikidata; Q54894459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02375
AC   CVCL_3X95
DR   Coriell; HQ02375
DR   Wikidata; Q54894460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02376
AC   CVCL_3X96
DR   Coriell; HQ02376
DR   Wikidata; Q54894461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02378
AC   CVCL_3X97
DR   Coriell; HQ02378
DR   Wikidata; Q54894462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02380
AC   CVCL_3X98
DR   Coriell; HQ02380
DR   Wikidata; Q54894463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02381
AC   CVCL_3X99
DR   Coriell; HQ02381
DR   Wikidata; Q54894465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02382
AC   CVCL_3Y00
DR   Coriell; HQ02382
DR   Wikidata; Q54894466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02383
AC   CVCL_3Y01
DR   Coriell; HQ02383
DR   Wikidata; Q54894467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02384
AC   CVCL_3Y02
DR   Coriell; HQ02384
DR   Wikidata; Q54894468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02385
AC   CVCL_3Y03
DR   Coriell; HQ02385
DR   Wikidata; Q54894469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02386
AC   CVCL_3Y04
DR   Coriell; HQ02386
DR   Wikidata; Q54894470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02389
AC   CVCL_3Y05
DR   Coriell; HQ02389
DR   Wikidata; Q54894471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02390
AC   CVCL_3Y06
DR   Coriell; HQ02390
DR   Wikidata; Q54894473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02391
AC   CVCL_3Y07
DR   Coriell; HQ02391
DR   Wikidata; Q54894474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02392
AC   CVCL_3Y08
DR   Coriell; HQ02392
DR   Wikidata; Q54894475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02393
AC   CVCL_3Y09
DR   Coriell; HQ02393
DR   Wikidata; Q54894476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02394
AC   CVCL_3Y10
DR   Coriell; HQ02394
DR   Wikidata; Q54894493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02395
AC   CVCL_3Y11
DR   Coriell; HQ02395
DR   Wikidata; Q54894494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02396
AC   CVCL_3Y12
DR   Coriell; HQ02396
DR   Wikidata; Q54894495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02397
AC   CVCL_3Y13
DR   Coriell; HQ02397
DR   Wikidata; Q54894496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02398
AC   CVCL_3Y14
DR   Coriell; HQ02398
DR   Wikidata; Q54894498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02399
AC   CVCL_3Y15
DR   Coriell; HQ02399
DR   Wikidata; Q54894499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02401
AC   CVCL_3Y16
DR   Coriell; HQ02401
DR   Wikidata; Q54894500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02403
AC   CVCL_3Y17
DR   Coriell; HQ02403
DR   Wikidata; Q54894501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02404
AC   CVCL_3Y18
DR   Coriell; HQ02404
DR   Wikidata; Q54894502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02405
AC   CVCL_3Y19
DR   Coriell; HQ02405
DR   Wikidata; Q54894503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02406
AC   CVCL_3Y20
DR   Coriell; HQ02406
DR   Wikidata; Q54894504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02408
AC   CVCL_3Y21
DR   Coriell; HQ02408
DR   Wikidata; Q54894505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02410
AC   CVCL_3Y22
DR   Coriell; HQ02410
DR   Wikidata; Q54894506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02411
AC   CVCL_3Y23
DR   Coriell; HQ02411
DR   Wikidata; Q54894507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02412
AC   CVCL_3Y24
DR   Coriell; HQ02412
DR   Wikidata; Q54894508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02413
AC   CVCL_3Y25
DR   Coriell; HQ02413
DR   Wikidata; Q54894509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02415
AC   CVCL_3Y26
DR   Coriell; HQ02415
DR   Wikidata; Q54894510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02416
AC   CVCL_3Y27
DR   Coriell; HQ02416
DR   Wikidata; Q54894511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02417
AC   CVCL_3Y28
DR   Coriell; HQ02417
DR   Wikidata; Q54894513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02418
AC   CVCL_3Y29
DR   Coriell; HQ02418
DR   Wikidata; Q54894515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02419
AC   CVCL_3Y30
DR   Coriell; HQ02419
DR   Wikidata; Q54894516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02421
AC   CVCL_3Y31
DR   Coriell; HQ02421
DR   Wikidata; Q54894517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02422
AC   CVCL_3Y32
DR   Coriell; HQ02422
DR   Wikidata; Q54894518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02423
AC   CVCL_3Y33
DR   Coriell; HQ02423
DR   Wikidata; Q54894519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02424
AC   CVCL_3Y34
DR   Coriell; HQ02424
DR   Wikidata; Q54894521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02427
AC   CVCL_3Y35
DR   Coriell; HQ02427
DR   Wikidata; Q54894522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02428
AC   CVCL_3Y36
DR   Coriell; HQ02428
DR   Wikidata; Q54894523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02431
AC   CVCL_3Y37
DR   Coriell; HQ02431
DR   Wikidata; Q54894524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02432
AC   CVCL_3Y38
DR   Coriell; HQ02432
DR   Wikidata; Q54894526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02433
AC   CVCL_3Y39
DR   Coriell; HQ02433
DR   Wikidata; Q54894527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02435
AC   CVCL_3Y40
DR   Coriell; HQ02435
DR   Wikidata; Q54894528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02436
AC   CVCL_3Y41
DR   Coriell; HQ02436
DR   Wikidata; Q54894529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02437
AC   CVCL_3Y42
DR   Coriell; HQ02437
DR   Wikidata; Q54894530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02438
AC   CVCL_3Y43
DR   Coriell; HQ02438
DR   Wikidata; Q54894531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02439
AC   CVCL_3Y44
DR   Coriell; HQ02439
DR   Wikidata; Q54894532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02441
AC   CVCL_3Y45
DR   Coriell; HQ02441
DR   Wikidata; Q54894534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02443
AC   CVCL_3Y46
DR   Coriell; HQ02443
DR   Wikidata; Q54894535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02444
AC   CVCL_3Y47
DR   Coriell; HQ02444
DR   Wikidata; Q54894537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02445
AC   CVCL_3Y48
DR   Coriell; HQ02445
DR   Wikidata; Q54894538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02446
AC   CVCL_3Y49
DR   Coriell; HQ02446
DR   Wikidata; Q54894539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02447
AC   CVCL_3Y50
DR   Coriell; HQ02447
DR   Wikidata; Q54894554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02449
AC   CVCL_3Y51
DR   Coriell; HQ02449
DR   Wikidata; Q54894556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02450
AC   CVCL_3Y52
DR   Coriell; HQ02450
DR   Wikidata; Q54894557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02451
AC   CVCL_3Y53
DR   Coriell; HQ02451
DR   Wikidata; Q54894559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02452
AC   CVCL_3Y54
DR   Coriell; HQ02452
DR   Wikidata; Q54894560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02454
AC   CVCL_3Y55
DR   Coriell; HQ02454
DR   Wikidata; Q54894561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02455
AC   CVCL_3Y56
DR   Coriell; HQ02455
DR   Wikidata; Q54894562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02456
AC   CVCL_3Y57
DR   Coriell; HQ02456
DR   Wikidata; Q54894563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02457
AC   CVCL_3Y58
DR   Coriell; HQ02457
DR   Wikidata; Q54894564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02458
AC   CVCL_3Y59
DR   Coriell; HQ02458
DR   Wikidata; Q54894565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02459
AC   CVCL_3Y60
DR   Coriell; HQ02459
DR   Wikidata; Q54894567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02460
AC   CVCL_3Y61
DR   Coriell; HQ02460
DR   Wikidata; Q54894568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02462
AC   CVCL_3Y62
DR   Coriell; HQ02462
DR   Wikidata; Q54894569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02463
AC   CVCL_3Y63
DR   Coriell; HQ02463
DR   Wikidata; Q54894570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02464
AC   CVCL_3Y64
DR   Coriell; HQ02464
DR   Wikidata; Q54894571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02465
AC   CVCL_3Y65
DR   Coriell; HQ02465
DR   Wikidata; Q54894572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02466
AC   CVCL_3Y66
DR   Coriell; HQ02466
DR   Wikidata; Q54894573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02467
AC   CVCL_3Y67
DR   Coriell; HQ02467
DR   Wikidata; Q54894574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02468
AC   CVCL_3Y68
DR   Coriell; HQ02468
DR   Wikidata; Q54894575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02469
AC   CVCL_3Y69
DR   Coriell; HQ02469
DR   Wikidata; Q54894576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02470
AC   CVCL_3Y70
DR   Coriell; HQ02470
DR   Wikidata; Q54894577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02471
AC   CVCL_3Y71
DR   Coriell; HQ02471
DR   Wikidata; Q54894578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02472
AC   CVCL_3Y72
DR   Coriell; HQ02472
DR   Wikidata; Q54894579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02473
AC   CVCL_3Y73
DR   Coriell; HQ02473
DR   Wikidata; Q54894581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02477
AC   CVCL_3Y74
DR   Coriell; HQ02477
DR   Wikidata; Q54894582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02478
AC   CVCL_3Y75
DR   Coriell; HQ02478
DR   Wikidata; Q54894583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02479
AC   CVCL_3Y76
DR   Coriell; HQ02479
DR   Wikidata; Q54894584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02482
AC   CVCL_3Y77
DR   Coriell; HQ02482
DR   Wikidata; Q54894585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02483
AC   CVCL_3Y78
DR   Coriell; HQ02483
DR   Wikidata; Q54894586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02486
AC   CVCL_3Y79
DR   Coriell; HQ02486
DR   Wikidata; Q54894587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02487
AC   CVCL_3Y80
DR   Coriell; HQ02487
DR   Wikidata; Q54894588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02488
AC   CVCL_3Y81
DR   Coriell; HQ02488
DR   Wikidata; Q54894589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02489
AC   CVCL_3Y82
DR   Coriell; HQ02489
DR   Wikidata; Q54894591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02490
AC   CVCL_3Y83
DR   Coriell; HQ02490
DR   Wikidata; Q54894592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02491
AC   CVCL_3Y84
DR   Coriell; HQ02491
DR   Wikidata; Q54894593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02492
AC   CVCL_3Y85
DR   Coriell; HQ02492
DR   Wikidata; Q54894594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02493
AC   CVCL_3Y86
DR   Coriell; HQ02493
DR   Wikidata; Q54894596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02494
AC   CVCL_3Y87
DR   Coriell; HQ02494
DR   Wikidata; Q54894597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02495
AC   CVCL_3Y88
DR   Coriell; HQ02495
DR   Wikidata; Q54894598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02496
AC   CVCL_3Y89
DR   Coriell; HQ02496
DR   Wikidata; Q54894599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02497
AC   CVCL_3Y90
DR   Coriell; HQ02497
DR   Wikidata; Q54894605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02498
AC   CVCL_3Y91
DR   Coriell; HQ02498
DR   Wikidata; Q54894606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02500
AC   CVCL_3Y92
DR   Coriell; HQ02500
DR   Wikidata; Q54894607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02501
AC   CVCL_3Y93
DR   Coriell; HQ02501
DR   Wikidata; Q54894608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02502
AC   CVCL_3Y94
DR   Coriell; HQ02502
DR   Wikidata; Q54894609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02503
AC   CVCL_3Y95
DR   Coriell; HQ02503
DR   Wikidata; Q54894611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02504
AC   CVCL_3Y96
DR   Coriell; HQ02504
DR   Wikidata; Q54894612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02506
AC   CVCL_3Y97
DR   Coriell; HQ02506
DR   Wikidata; Q54894613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02507
AC   CVCL_3Y98
DR   Coriell; HQ02507
DR   Wikidata; Q54894614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02508
AC   CVCL_3Y99
DR   Coriell; HQ02508
DR   Wikidata; Q54894615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02509
AC   CVCL_3Z00
DR   Coriell; HQ02509
DR   Wikidata; Q54894616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02510
AC   CVCL_3Z01
DR   Coriell; HQ02510
DR   Wikidata; Q54894617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02512
AC   CVCL_3Z02
DR   Coriell; HQ02512
DR   Wikidata; Q54894618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02513
AC   CVCL_3Z03
DR   Coriell; HQ02513
DR   Wikidata; Q54894619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02514
AC   CVCL_3Z04
DR   Coriell; HQ02514
DR   Wikidata; Q54894620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02515
AC   CVCL_3Z05
DR   Coriell; HQ02515
DR   Wikidata; Q54894622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02517
AC   CVCL_3Z06
DR   Coriell; HQ02517
DR   Wikidata; Q54894623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02518
AC   CVCL_3Z07
DR   Coriell; HQ02518
DR   Wikidata; Q54894624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02519
AC   CVCL_3Z08
DR   Coriell; HQ02519
DR   Wikidata; Q54894626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02521
AC   CVCL_3Z09
DR   Coriell; HQ02521
DR   Wikidata; Q54894627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02522
AC   CVCL_3Z10
DR   Coriell; HQ02522
DR   Wikidata; Q54894628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02524
AC   CVCL_3Z11
DR   Coriell; HQ02524
DR   Wikidata; Q54894629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02525
AC   CVCL_3Z12
DR   Coriell; HQ02525
DR   Wikidata; Q54894630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02526
AC   CVCL_3Z13
DR   Coriell; HQ02526
DR   Wikidata; Q54894631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02527
AC   CVCL_3Z14
DR   Coriell; HQ02527
DR   Wikidata; Q54894632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02528
AC   CVCL_3Z15
DR   Coriell; HQ02528
DR   Wikidata; Q54894633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02529
AC   CVCL_3Z16
DR   Coriell; HQ02529
DR   Wikidata; Q54894634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02531
AC   CVCL_3Z17
DR   Coriell; HQ02531
DR   Wikidata; Q54894635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02532
AC   CVCL_3Z18
DR   Coriell; HQ02532
DR   Wikidata; Q54894637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02533
AC   CVCL_3Z19
DR   Coriell; HQ02533
DR   Wikidata; Q54894638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02534
AC   CVCL_3Z20
DR   Coriell; HQ02534
DR   Wikidata; Q54894639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02535
AC   CVCL_3Z21
DR   Coriell; HQ02535
DR   Wikidata; Q54894640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02540
AC   CVCL_3Z22
DR   Coriell; HQ02540
DR   Wikidata; Q54894641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02541
AC   CVCL_3Z23
DR   Coriell; HQ02541
DR   Wikidata; Q54894642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02542
AC   CVCL_3Z24
DR   Coriell; HQ02542
DR   Wikidata; Q54894644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02543
AC   CVCL_3Z25
DR   Coriell; HQ02543
DR   Wikidata; Q54894645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02544
AC   CVCL_3Z26
DR   Coriell; HQ02544
DR   Wikidata; Q54894646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02546
AC   CVCL_3Z27
DR   Coriell; HQ02546
DR   Wikidata; Q54894647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02547
AC   CVCL_3Z28
DR   Coriell; HQ02547
DR   Wikidata; Q54894649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02548
AC   CVCL_3Z29
DR   Coriell; HQ02548
DR   Wikidata; Q54894650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02549
AC   CVCL_3Z30
DR   Coriell; HQ02549
DR   Wikidata; Q54894660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02551
AC   CVCL_3Z31
DR   Coriell; HQ02551
DR   Wikidata; Q54894661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02552
AC   CVCL_3Z32
DR   Coriell; HQ02552
DR   Wikidata; Q54894662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02553
AC   CVCL_3Z33
DR   Coriell; HQ02553
DR   Wikidata; Q54894663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02554
AC   CVCL_3Z34
DR   Coriell; HQ02554
DR   Wikidata; Q54894665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02556
AC   CVCL_3Z35
DR   Coriell; HQ02556
DR   Wikidata; Q54894666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02557
AC   CVCL_3Z36
DR   Coriell; HQ02557
DR   Wikidata; Q54894668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02558
AC   CVCL_3Z37
DR   Coriell; HQ02558
DR   Wikidata; Q54894669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02559
AC   CVCL_3Z38
DR   Coriell; HQ02559
DR   Wikidata; Q54894670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02560
AC   CVCL_3Z39
DR   Coriell; HQ02560
DR   Wikidata; Q54894671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02561
AC   CVCL_3Z40
DR   Coriell; HQ02561
DR   Wikidata; Q54894672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02562
AC   CVCL_3Z41
DR   Coriell; HQ02562
DR   Wikidata; Q54894673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02564
AC   CVCL_3Z42
DR   Coriell; HQ02564
DR   Wikidata; Q54894674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02565
AC   CVCL_3Z43
DR   Coriell; HQ02565
DR   Wikidata; Q54894675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02566
AC   CVCL_3Z44
DR   Coriell; HQ02566
DR   Wikidata; Q54894676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02568
AC   CVCL_3Z45
DR   Coriell; HQ02568
DR   Wikidata; Q54894677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02571
AC   CVCL_3Z46
DR   Coriell; HQ02571
DR   Wikidata; Q54894678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02574
AC   CVCL_3Z47
DR   Coriell; HQ02574
DR   Wikidata; Q54894679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02575
AC   CVCL_3Z48
DR   Coriell; HQ02575
DR   Wikidata; Q54894680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02576
AC   CVCL_3Z49
DR   Coriell; HQ02576
DR   Wikidata; Q54894681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02577
AC   CVCL_3Z50
DR   Coriell; HQ02577
DR   Wikidata; Q54894682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02578
AC   CVCL_3Z51
DR   Coriell; HQ02578
DR   Wikidata; Q54894683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02579
AC   CVCL_3Z52
DR   Coriell; HQ02579
DR   Wikidata; Q54894684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02581
AC   CVCL_3Z53
DR   Coriell; HQ02581
DR   Wikidata; Q54894685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02582
AC   CVCL_3Z54
DR   Coriell; HQ02582
DR   Wikidata; Q54894686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02583
AC   CVCL_3Z55
DR   Coriell; HQ02583
DR   Wikidata; Q54894687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02584
AC   CVCL_3Z56
DR   Coriell; HQ02584
DR   Wikidata; Q54894688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y36 ! ND31008
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02585
AC   CVCL_3Z57
DR   Coriell; HQ02585
DR   Wikidata; Q54894689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Y35 ! ND31009
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02586
AC   CVCL_3Z58
DR   Coriell; HQ02586
DR   Wikidata; Q54894690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02588
AC   CVCL_3Z59
DR   Coriell; HQ02588
DR   Wikidata; Q54894691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02589
AC   CVCL_3Z60
DR   Coriell; HQ02589
DR   Wikidata; Q54894692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02590
AC   CVCL_3Z61
DR   Coriell; HQ02590
DR   Wikidata; Q54894693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02591
AC   CVCL_3Z62
DR   Coriell; HQ02591
DR   Wikidata; Q54894694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02592
AC   CVCL_3Z63
DR   Coriell; HQ02592
DR   Wikidata; Q54894695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02593
AC   CVCL_3Z64
DR   Coriell; HQ02593
DR   Wikidata; Q54894696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02598
AC   CVCL_3Z65
DR   Coriell; HQ02598
DR   Wikidata; Q54894697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02599
AC   CVCL_3Z66
DR   Coriell; HQ02599
DR   Wikidata; Q54894698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02600
AC   CVCL_3Z67
DR   Coriell; HQ02600
DR   Wikidata; Q54894699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02601
AC   CVCL_3Z68
DR   Coriell; HQ02601
DR   Wikidata; Q54894700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02602
AC   CVCL_3Z69
DR   Coriell; HQ02602
DR   Wikidata; Q54894701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02605
AC   CVCL_3Z70
DR   Coriell; HQ02605
DR   Wikidata; Q54894717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02607
AC   CVCL_3Z71
DR   Coriell; HQ02607
DR   Wikidata; Q54894718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02608
AC   CVCL_3Z72
DR   Coriell; HQ02608
DR   Wikidata; Q54894720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02609
AC   CVCL_3Z73
DR   Coriell; HQ02609
DR   Wikidata; Q54894721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02610
AC   CVCL_3Z74
DR   Coriell; HQ02610
DR   Wikidata; Q54894722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02611
AC   CVCL_3Z75
DR   Coriell; HQ02611
DR   Wikidata; Q54894723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02612
AC   CVCL_3Z76
DR   Coriell; HQ02612
DR   Wikidata; Q54894724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02613
AC   CVCL_3Z77
DR   Coriell; HQ02613
DR   Wikidata; Q54894725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02615
AC   CVCL_3Z78
DR   Coriell; HQ02615
DR   Wikidata; Q54894726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02616
AC   CVCL_3Z79
DR   Coriell; HQ02616
DR   Wikidata; Q54894727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02617
AC   CVCL_3Z80
DR   Coriell; HQ02617
DR   Wikidata; Q54894728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02618
AC   CVCL_3Z81
DR   Coriell; HQ02618
DR   Wikidata; Q54894730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02619
AC   CVCL_3Z82
DR   Coriell; HQ02619
DR   Wikidata; Q54894731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02621
AC   CVCL_3Z83
DR   Coriell; HQ02621
DR   Wikidata; Q54894732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02622
AC   CVCL_3Z84
DR   Coriell; HQ02622
DR   Wikidata; Q54894733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02623
AC   CVCL_3Z85
DR   Coriell; HQ02623
DR   Wikidata; Q54894734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02626
AC   CVCL_3Z86
DR   Coriell; HQ02626
DR   Wikidata; Q54894736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02627
AC   CVCL_3Z87
DR   Coriell; HQ02627
DR   Wikidata; Q54894737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02629
AC   CVCL_3Z88
DR   Coriell; HQ02629
DR   Wikidata; Q54894738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02632
AC   CVCL_3Z89
DR   Coriell; HQ02632
DR   Wikidata; Q54894739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02633
AC   CVCL_3Z90
DR   Coriell; HQ02633
DR   Wikidata; Q54894740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02634
AC   CVCL_3Z91
DR   Coriell; HQ02634
DR   Wikidata; Q54894741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02636
AC   CVCL_3Z92
DR   Coriell; HQ02636
DR   Wikidata; Q54894742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02637
AC   CVCL_3Z93
DR   Coriell; HQ02637
DR   Wikidata; Q54894743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02638
AC   CVCL_3Z94
DR   Coriell; HQ02638
DR   Wikidata; Q54894744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02641
AC   CVCL_3Z95
DR   Coriell; HQ02641
DR   Wikidata; Q54894745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02643
AC   CVCL_3Z96
DR   Coriell; HQ02643
DR   Wikidata; Q54894747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02644
AC   CVCL_3Z97
DR   Coriell; HQ02644
DR   Wikidata; Q54894748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02645
AC   CVCL_3Z98
DR   Coriell; HQ02645
DR   Wikidata; Q54894749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02648
AC   CVCL_3Z99
DR   Coriell; HQ02648
DR   Wikidata; Q54894750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02649
AC   CVCL_4A00
DR   Coriell; HQ02649
DR   Wikidata; Q54894751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02650
AC   CVCL_4A01
DR   Coriell; HQ02650
DR   Wikidata; Q54894752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02651
AC   CVCL_4A02
DR   Coriell; HQ02651
DR   Wikidata; Q54894754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02652
AC   CVCL_4A03
DR   Coriell; HQ02652
DR   Wikidata; Q54894755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02653
AC   CVCL_4A04
DR   Coriell; HQ02653
DR   Wikidata; Q54894756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02654
AC   CVCL_4A05
DR   Coriell; HQ02654
DR   Wikidata; Q54894758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02655
AC   CVCL_4A06
DR   Coriell; HQ02655
DR   Wikidata; Q54894759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02657
AC   CVCL_4A07
DR   Coriell; HQ02657
DR   Wikidata; Q54894760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02659
AC   CVCL_4A08
DR   Coriell; HQ02659
DR   Wikidata; Q54894761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02662
AC   CVCL_4A09
DR   Coriell; HQ02662
DR   Wikidata; Q54894762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02663
AC   CVCL_4A10
DR   Coriell; HQ02663
DR   Wikidata; Q54894777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02667
AC   CVCL_4A11
DR   Coriell; HQ02667
DR   Wikidata; Q54894778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02668
AC   CVCL_4A12
DR   Coriell; HQ02668
DR   Wikidata; Q54894779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02670
AC   CVCL_4A13
DR   Coriell; HQ02670
DR   Wikidata; Q54894780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02672
AC   CVCL_4A14
DR   Coriell; HQ02672
DR   Wikidata; Q54894781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02673
AC   CVCL_4A15
DR   Coriell; HQ02673
DR   Wikidata; Q54894782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02674
AC   CVCL_4A16
DR   Coriell; HQ02674
DR   Wikidata; Q54894784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02675
AC   CVCL_4A17
DR   Coriell; HQ02675
DR   Wikidata; Q54894785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02676
AC   CVCL_4A18
DR   Coriell; HQ02676
DR   Wikidata; Q54894786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02677
AC   CVCL_4A19
DR   Coriell; HQ02677
DR   Wikidata; Q54894787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02678
AC   CVCL_4A20
DR   Coriell; HQ02678
DR   Wikidata; Q54894788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02679
AC   CVCL_4A21
DR   Coriell; HQ02679
DR   Wikidata; Q54894789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02680
AC   CVCL_4A22
DR   Coriell; HQ02680
DR   Wikidata; Q54894790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02681
AC   CVCL_4A23
DR   Coriell; HQ02681
DR   Wikidata; Q54894791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02683
AC   CVCL_4A24
DR   Coriell; HQ02683
DR   Wikidata; Q54894792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02684
AC   CVCL_4A25
DR   Coriell; HQ02684
DR   Wikidata; Q54894794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02685
AC   CVCL_4A26
DR   Coriell; HQ02685
DR   Wikidata; Q54894795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02686
AC   CVCL_4A27
DR   Coriell; HQ02686
DR   Wikidata; Q54894796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02687
AC   CVCL_4A28
DR   Coriell; HQ02687
DR   Wikidata; Q54894797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02690
AC   CVCL_4A29
DR   Coriell; HQ02690
DR   Wikidata; Q54894798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02691
AC   CVCL_4A30
DR   Coriell; HQ02691
DR   Wikidata; Q54894799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02692
AC   CVCL_4A31
DR   Coriell; HQ02692
DR   Wikidata; Q54894800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02693
AC   CVCL_4A32
DR   Coriell; HQ02693
DR   Wikidata; Q54894801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02694
AC   CVCL_4A33
DR   Coriell; HQ02694
DR   Wikidata; Q54894802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02695
AC   CVCL_4A34
DR   Coriell; HQ02695
DR   Wikidata; Q54894803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02696
AC   CVCL_4A35
DR   Coriell; HQ02696
DR   Wikidata; Q54894805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02697
AC   CVCL_4A36
DR   Coriell; HQ02697
DR   Wikidata; Q54894806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02698
AC   CVCL_4A37
DR   Coriell; HQ02698
DR   Wikidata; Q54894807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02699
AC   CVCL_4A38
DR   Coriell; HQ02699
DR   Wikidata; Q54894808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02701
AC   CVCL_4A39
DR   Coriell; HQ02701
DR   Wikidata; Q54894809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02705
AC   CVCL_4A40
DR   Coriell; HQ02705
DR   Wikidata; Q54894810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02708
AC   CVCL_4A41
DR   Coriell; HQ02708
DR   Wikidata; Q54894811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02709
AC   CVCL_4A42
DR   Coriell; HQ02709
DR   Wikidata; Q54894812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02710
AC   CVCL_4A43
DR   Coriell; HQ02710
DR   Wikidata; Q54894813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02711
AC   CVCL_4A44
DR   Coriell; HQ02711
DR   Wikidata; Q54894814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02713
AC   CVCL_4A45
DR   Coriell; HQ02713
DR   Wikidata; Q54894815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02714
AC   CVCL_4A46
DR   Coriell; HQ02714
DR   Wikidata; Q54894817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02715
AC   CVCL_4A47
DR   Coriell; HQ02715
DR   Wikidata; Q54894818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02716
AC   CVCL_4A48
DR   Coriell; HQ02716
DR   Wikidata; Q54894819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02717
AC   CVCL_4A49
DR   Coriell; HQ02717
DR   Wikidata; Q54894820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02718
AC   CVCL_4A50
DR   Coriell; HQ02718
DR   Wikidata; Q54894834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02719
AC   CVCL_4A51
DR   Coriell; HQ02719
DR   Wikidata; Q54894835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02720
AC   CVCL_4A52
DR   Coriell; HQ02720
DR   Wikidata; Q54894836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02721
AC   CVCL_4A53
DR   Coriell; HQ02721
DR   Wikidata; Q54894837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02725
AC   CVCL_4A54
DR   Coriell; HQ02725
DR   Wikidata; Q54894838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02726
AC   CVCL_4A55
DR   Coriell; HQ02726
DR   Wikidata; Q54894839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02728
AC   CVCL_4A56
DR   Coriell; HQ02728
DR   Wikidata; Q54894841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02729
AC   CVCL_4A57
DR   Coriell; HQ02729
DR   Wikidata; Q54894842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02730
AC   CVCL_4A58
DR   Coriell; HQ02730
DR   Wikidata; Q54894843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02731
AC   CVCL_4A59
DR   Coriell; HQ02731
DR   Wikidata; Q54894844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02732
AC   CVCL_4A60
DR   Coriell; HQ02732
DR   Wikidata; Q54894845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02733
AC   CVCL_4A61
DR   Coriell; HQ02733
DR   Wikidata; Q54894846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02735
AC   CVCL_4A62
DR   Coriell; HQ02735
DR   Wikidata; Q54894847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02736
AC   CVCL_4A63
DR   Coriell; HQ02736
DR   Wikidata; Q54894848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02737
AC   CVCL_4A64
DR   Coriell; HQ02737
DR   Wikidata; Q54894849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02739
AC   CVCL_4A65
DR   Coriell; HQ02739
DR   Wikidata; Q54894850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02741
AC   CVCL_4A66
DR   Coriell; HQ02741
DR   Wikidata; Q54894852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02742
AC   CVCL_4A67
DR   Coriell; HQ02742
DR   Wikidata; Q54894853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02743
AC   CVCL_4A68
DR   Coriell; HQ02743
DR   Wikidata; Q54894854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02744
AC   CVCL_4A69
DR   Coriell; HQ02744
DR   Wikidata; Q54894855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02745
AC   CVCL_4A70
DR   Coriell; HQ02745
DR   Wikidata; Q54894856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02746
AC   CVCL_4A71
DR   Coriell; HQ02746
DR   Wikidata; Q54894857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02750
AC   CVCL_4A72
DR   Coriell; HQ02750
DR   Wikidata; Q54894858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02751
AC   CVCL_4A73
DR   Coriell; HQ02751
DR   Wikidata; Q54894859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02752
AC   CVCL_4A74
DR   Coriell; HQ02752
DR   Wikidata; Q54894860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02753
AC   CVCL_4A75
DR   Coriell; HQ02753
DR   Wikidata; Q54894862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02754
AC   CVCL_4A76
DR   Coriell; HQ02754
DR   Wikidata; Q54894863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02756
AC   CVCL_4A77
DR   Coriell; HQ02756
DR   Wikidata; Q54894864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02757
AC   CVCL_4A78
DR   Coriell; HQ02757
DR   Wikidata; Q54894865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02758
AC   CVCL_4A79
DR   Coriell; HQ02758
DR   Wikidata; Q54894866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02759
AC   CVCL_4A80
DR   Coriell; HQ02759
DR   Wikidata; Q54894867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02760
AC   CVCL_4A81
DR   Coriell; HQ02760
DR   Wikidata; Q54894868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02764
AC   CVCL_4A82
DR   Coriell; HQ02764
DR   Wikidata; Q54894870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02765
AC   CVCL_4A83
DR   Coriell; HQ02765
DR   Wikidata; Q54894871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02766
AC   CVCL_4A84
DR   Coriell; HQ02766
DR   Wikidata; Q54894873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02767
AC   CVCL_4A85
DR   Coriell; HQ02767
DR   Wikidata; Q54894874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02769
AC   CVCL_4A86
DR   Coriell; HQ02769
DR   Wikidata; Q54894875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02770
AC   CVCL_4A87
DR   Coriell; HQ02770
DR   Wikidata; Q54894876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02772
AC   CVCL_4A88
DR   Coriell; HQ02772
DR   Wikidata; Q54894877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02773
AC   CVCL_4A89
DR   Coriell; HQ02773
DR   Wikidata; Q54894878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02774
AC   CVCL_4A90
DR   Coriell; HQ02774
DR   Wikidata; Q54894886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02776
AC   CVCL_4A91
DR   Coriell; HQ02776
DR   Wikidata; Q54894887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02777
AC   CVCL_4A92
DR   Coriell; HQ02777
DR   Wikidata; Q54894888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02778
AC   CVCL_4A93
DR   Coriell; HQ02778
DR   Wikidata; Q54894889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02779
AC   CVCL_4A94
DR   Coriell; HQ02779
DR   Wikidata; Q54894890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02781
AC   CVCL_4A95
DR   Coriell; HQ02781
DR   Wikidata; Q54894892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02784
AC   CVCL_4A96
DR   Coriell; HQ02784
DR   Wikidata; Q54894893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02785
AC   CVCL_4A97
DR   Coriell; HQ02785
DR   Wikidata; Q54894894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02788
AC   CVCL_4A98
DR   Coriell; HQ02788
DR   Wikidata; Q54894897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02791
AC   CVCL_4A99
DR   Coriell; HQ02791
DR   Wikidata; Q54894898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02792
AC   CVCL_4B00
DR   Coriell; HQ02792
DR   Wikidata; Q54894899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02793
AC   CVCL_4B01
DR   Coriell; HQ02793
DR   Wikidata; Q54894901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02794
AC   CVCL_4B02
DR   Coriell; HQ02794
DR   Wikidata; Q54894902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02798
AC   CVCL_4B03
DR   Coriell; HQ02798
DR   Wikidata; Q54894903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02800
AC   CVCL_4B04
DR   Coriell; HQ02800
DR   Wikidata; Q54894904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02807
AC   CVCL_4B05
DR   Coriell; HQ02807
DR   Wikidata; Q54894905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02808
AC   CVCL_4B06
DR   Coriell; HQ02808
DR   Wikidata; Q54894906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02811
AC   CVCL_4B07
DR   Coriell; HQ02811
DR   Wikidata; Q54894907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02812
AC   CVCL_4B08
DR   Coriell; HQ02812
DR   Wikidata; Q54894909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02813
AC   CVCL_4B09
DR   Coriell; HQ02813
DR   Wikidata; Q54894910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02814
AC   CVCL_4B10
DR   Coriell; HQ02814
DR   Wikidata; Q54894911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02816
AC   CVCL_4B11
DR   Coriell; HQ02816
DR   Wikidata; Q54894912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02817
AC   CVCL_4B12
DR   Coriell; HQ02817
DR   Wikidata; Q54894913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02820
AC   CVCL_4B13
DR   Coriell; HQ02820
DR   Wikidata; Q54894914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02821
AC   CVCL_4B14
DR   Coriell; HQ02821
DR   Wikidata; Q54894915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02822
AC   CVCL_4B15
DR   Coriell; HQ02822
DR   Wikidata; Q54894916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02823
AC   CVCL_4B16
DR   Coriell; HQ02823
DR   Wikidata; Q54894917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02824
AC   CVCL_4B17
DR   Coriell; HQ02824
DR   Wikidata; Q54894919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02825
AC   CVCL_4B18
DR   Coriell; HQ02825
DR   Wikidata; Q54894920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02826
AC   CVCL_4B19
DR   Coriell; HQ02826
DR   Wikidata; Q54894921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02827
AC   CVCL_4B20
DR   Coriell; HQ02827
DR   Wikidata; Q54894922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02828
AC   CVCL_4B21
DR   Coriell; HQ02828
DR   Wikidata; Q54894923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02829
AC   CVCL_4B22
DR   Coriell; HQ02829
DR   Wikidata; Q54894924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02831
AC   CVCL_4B23
DR   Coriell; HQ02831
DR   Wikidata; Q54894925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02832
AC   CVCL_4B24
DR   Coriell; HQ02832
DR   Wikidata; Q54894926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02833
AC   CVCL_4B25
DR   Coriell; HQ02833
DR   Wikidata; Q54894928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02834
AC   CVCL_4B26
DR   Coriell; HQ02834
DR   Wikidata; Q54894929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02835
AC   CVCL_4B27
DR   Coriell; HQ02835
DR   Wikidata; Q54894931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02838
AC   CVCL_4B28
DR   Coriell; HQ02838
DR   Wikidata; Q54894932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02839
AC   CVCL_4B29
DR   Coriell; HQ02839
DR   Wikidata; Q54894933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02840
AC   CVCL_4B30
DR   Coriell; HQ02840
DR   Wikidata; Q54894946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02844
AC   CVCL_4B31
DR   Coriell; HQ02844
DR   Wikidata; Q54894947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02846
AC   CVCL_4B32
DR   Coriell; HQ02846
DR   Wikidata; Q54894948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02847
AC   CVCL_4B33
DR   Coriell; HQ02847
DR   Wikidata; Q54894950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02848
AC   CVCL_4B34
DR   Coriell; HQ02848
DR   Wikidata; Q54894951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02849
AC   CVCL_4B35
DR   Coriell; HQ02849
DR   Wikidata; Q54894952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02850
AC   CVCL_4B36
DR   Coriell; HQ02850
DR   Wikidata; Q54894953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02851
AC   CVCL_4B37
DR   Coriell; HQ02851
DR   Wikidata; Q54894955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02852
AC   CVCL_4B38
DR   Coriell; HQ02852
DR   Wikidata; Q54894956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02853
AC   CVCL_4B39
DR   Coriell; HQ02853
DR   Wikidata; Q54894957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02855
AC   CVCL_4B40
DR   Coriell; HQ02855
DR   Wikidata; Q54894958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02856
AC   CVCL_4B41
DR   Coriell; HQ02856
DR   Wikidata; Q54894959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02857
AC   CVCL_4B42
DR   Coriell; HQ02857
DR   Wikidata; Q54894961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02858
AC   CVCL_4B43
DR   Coriell; HQ02858
DR   Wikidata; Q54894962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02859
AC   CVCL_4B44
DR   Coriell; HQ02859
DR   Wikidata; Q54894963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02860
AC   CVCL_4B45
DR   Coriell; HQ02860
DR   Wikidata; Q54894964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02861
AC   CVCL_4B46
DR   Coriell; HQ02861
DR   Wikidata; Q54894965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02862
AC   CVCL_4B47
DR   Coriell; HQ02862
DR   Wikidata; Q54894966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02864
AC   CVCL_4B48
DR   Coriell; HQ02864
DR   Wikidata; Q54894967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02865
AC   CVCL_4B49
DR   Coriell; HQ02865
DR   Wikidata; Q54894968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02869
AC   CVCL_4B50
DR   Coriell; HQ02869
DR   Wikidata; Q54894969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02872
AC   CVCL_4B51
DR   Coriell; HQ02872
DR   Wikidata; Q54894970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02873
AC   CVCL_4B52
DR   Coriell; HQ02873
DR   Wikidata; Q54894972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02874
AC   CVCL_4B53
DR   Coriell; HQ02874
DR   Wikidata; Q54894973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02876
AC   CVCL_4B54
DR   Coriell; HQ02876
DR   Wikidata; Q54894975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02877
AC   CVCL_4B55
DR   Coriell; HQ02877
DR   Wikidata; Q54894976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02878
AC   CVCL_4B56
DR   Coriell; HQ02878
DR   Wikidata; Q54894977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02879
AC   CVCL_4B57
DR   Coriell; HQ02879
DR   Wikidata; Q54894978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02880
AC   CVCL_4B58
DR   Coriell; HQ02880
DR   Wikidata; Q54894979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02881
AC   CVCL_4B59
DR   Coriell; HQ02881
DR   Wikidata; Q54894980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02882
AC   CVCL_4B60
DR   Coriell; HQ02882
DR   Wikidata; Q54894981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02883
AC   CVCL_4B61
DR   Coriell; HQ02883
DR   Wikidata; Q54894982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02884
AC   CVCL_4B62
DR   Coriell; HQ02884
DR   Wikidata; Q54894983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02885
AC   CVCL_4B63
DR   Coriell; HQ02885
DR   Wikidata; Q54894984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02886
AC   CVCL_4B64
DR   Coriell; HQ02886
DR   Wikidata; Q54894986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02888
AC   CVCL_4B65
DR   Coriell; HQ02888
DR   Wikidata; Q54894987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02889
AC   CVCL_4B66
DR   Coriell; HQ02889
DR   Wikidata; Q54894988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02890
AC   CVCL_4B67
DR   Coriell; HQ02890
DR   Wikidata; Q54894990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02891
AC   CVCL_4B68
DR   Coriell; HQ02891
DR   Wikidata; Q54894991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02892
AC   CVCL_4B69
DR   Coriell; HQ02892
DR   Wikidata; Q54894992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02897
AC   CVCL_4B70
DR   Coriell; HQ02897
DR   Wikidata; Q54895017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02898
AC   CVCL_4B71
DR   Coriell; HQ02898
DR   Wikidata; Q54895018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02899
AC   CVCL_4B72
DR   Coriell; HQ02899
DR   Wikidata; Q54895019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02900
AC   CVCL_4B73
DR   Coriell; HQ02900
DR   Wikidata; Q54895022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02903
AC   CVCL_4B74
DR   Coriell; HQ02903
DR   Wikidata; Q54895023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02904
AC   CVCL_4B75
DR   Coriell; HQ02904
DR   Wikidata; Q54895024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02907
AC   CVCL_4B76
DR   Coriell; HQ02907
DR   Wikidata; Q54895025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02908
AC   CVCL_4B77
DR   Coriell; HQ02908
DR   Wikidata; Q54895026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02910
AC   CVCL_4B78
DR   Coriell; HQ02910
DR   Wikidata; Q54895027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02912
AC   CVCL_4B79
DR   Coriell; HQ02912
DR   Wikidata; Q54895028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02913
AC   CVCL_4B80
DR   Coriell; HQ02913
DR   Wikidata; Q54895030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02918
AC   CVCL_4B81
DR   Coriell; HQ02918
DR   Wikidata; Q54895031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02919
AC   CVCL_4B82
DR   Coriell; HQ02919
DR   Wikidata; Q54895032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02921
AC   CVCL_4B83
DR   Coriell; HQ02921
DR   Wikidata; Q54895034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02922
AC   CVCL_4B84
DR   Coriell; HQ02922
DR   Wikidata; Q54895035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02923
AC   CVCL_4B85
DR   Coriell; HQ02923
DR   Wikidata; Q54895036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02924
AC   CVCL_4B86
DR   Coriell; HQ02924
DR   Wikidata; Q54895037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02925
AC   CVCL_4B87
DR   Coriell; HQ02925
DR   Wikidata; Q54895038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02926
AC   CVCL_4B88
DR   Coriell; HQ02926
DR   Wikidata; Q54895039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02927
AC   CVCL_4B89
DR   Coriell; HQ02927
DR   Wikidata; Q54895040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02928
AC   CVCL_4B90
DR   Coriell; HQ02928
DR   Wikidata; Q54895041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02929
AC   CVCL_4B91
DR   Coriell; HQ02929
DR   Wikidata; Q54895042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02930
AC   CVCL_4B92
DR   Coriell; HQ02930
DR   Wikidata; Q54895044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02933
AC   CVCL_4B93
DR   Coriell; HQ02933
DR   Wikidata; Q54895045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02934
AC   CVCL_4B94
DR   Coriell; HQ02934
DR   Wikidata; Q54895046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02935
AC   CVCL_4B95
DR   Coriell; HQ02935
DR   Wikidata; Q54895047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02936
AC   CVCL_4B96
DR   Coriell; HQ02936
DR   Wikidata; Q54895048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02937
AC   CVCL_4B97
DR   Coriell; HQ02937
DR   Wikidata; Q54895049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02938
AC   CVCL_4B98
DR   Coriell; HQ02938
DR   Wikidata; Q54895050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02939
AC   CVCL_4B99
DR   Coriell; HQ02939
DR   Wikidata; Q54895051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02940
AC   CVCL_4C00
DR   Coriell; HQ02940
DR   Wikidata; Q54895052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02942
AC   CVCL_4C01
DR   Coriell; HQ02942
DR   Wikidata; Q54895054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02944
AC   CVCL_4C02
DR   Coriell; HQ02944
DR   Wikidata; Q54895055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02947
AC   CVCL_4C03
DR   Coriell; HQ02947
DR   Wikidata; Q54895056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02948
AC   CVCL_4C04
DR   Coriell; HQ02948
DR   Wikidata; Q54895057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02949
AC   CVCL_4C05
DR   Coriell; HQ02949
DR   Wikidata; Q54895058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02950
AC   CVCL_4C06
DR   Coriell; HQ02950
DR   Wikidata; Q54895060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02952
AC   CVCL_4C07
DR   Coriell; HQ02952
DR   Wikidata; Q54895061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02954
AC   CVCL_4C08
DR   Coriell; HQ02954
DR   Wikidata; Q54895062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02955
AC   CVCL_4C09
DR   Coriell; HQ02955
DR   Wikidata; Q54895063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02956
AC   CVCL_4C10
DR   Coriell; HQ02956
DR   Wikidata; Q54895079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02958
AC   CVCL_4C11
DR   Coriell; HQ02958
DR   Wikidata; Q54895080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02959
AC   CVCL_4C12
DR   Coriell; HQ02959
DR   Wikidata; Q54895081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02960
AC   CVCL_4C13
DR   Coriell; HQ02960
DR   Wikidata; Q54895082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02961
AC   CVCL_4C14
DR   Coriell; HQ02961
DR   Wikidata; Q54895083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02962
AC   CVCL_4C15
DR   Coriell; HQ02962
DR   Wikidata; Q54895085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02963
AC   CVCL_4C16
DR   Coriell; HQ02963
DR   Wikidata; Q54895086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02965
AC   CVCL_4C17
DR   Coriell; HQ02965
DR   Wikidata; Q54895087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02966
AC   CVCL_4C18
DR   Coriell; HQ02966
DR   Wikidata; Q54895088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02967
AC   CVCL_4C19
DR   Coriell; HQ02967
DR   Wikidata; Q54895089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02968
AC   CVCL_4C20
DR   Coriell; HQ02968
DR   Wikidata; Q54895091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02973
AC   CVCL_4C21
DR   Coriell; HQ02973
DR   Wikidata; Q54895092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02975
AC   CVCL_4C22
DR   Coriell; HQ02975
DR   Wikidata; Q54895093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02976
AC   CVCL_4C23
DR   Coriell; HQ02976
DR   Wikidata; Q54895094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02977
AC   CVCL_4C24
DR   Coriell; HQ02977
DR   Wikidata; Q54895096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02978
AC   CVCL_4C25
DR   Coriell; HQ02978
DR   Wikidata; Q54895097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ02979
AC   CVCL_4C26
DR   Coriell; HQ02979
DR   Wikidata; Q54895098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02980
AC   CVCL_4C27
DR   Coriell; HQ02980
DR   Wikidata; Q54895099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02981
AC   CVCL_4C28
DR   Coriell; HQ02981
DR   Wikidata; Q54895100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02986
AC   CVCL_4C29
DR   Coriell; HQ02986
DR   Wikidata; Q54895101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02988
AC   CVCL_4C30
DR   Coriell; HQ02988
DR   Wikidata; Q54895102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02996
AC   CVCL_4C31
DR   Coriell; HQ02996
DR   Wikidata; Q54895103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02997
AC   CVCL_4C32
DR   Coriell; HQ02997
DR   Wikidata; Q54895104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02998
AC   CVCL_4C33
DR   Coriell; HQ02998
DR   Wikidata; Q54895105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ02999
AC   CVCL_4C34
DR   Coriell; HQ02999
DR   Wikidata; Q54895107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03001
AC   CVCL_4C35
DR   Coriell; HQ03001
DR   Wikidata; Q54895108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03002
AC   CVCL_4C36
DR   Coriell; HQ03002
DR   Wikidata; Q54895109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03004
AC   CVCL_4C37
DR   Coriell; HQ03004
DR   Wikidata; Q54895110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03005
AC   CVCL_4C38
DR   Coriell; HQ03005
DR   Wikidata; Q54895111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03006
AC   CVCL_4C39
DR   Coriell; HQ03006
DR   Wikidata; Q54895112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03007
AC   CVCL_4C40
DR   Coriell; HQ03007
DR   Wikidata; Q54895113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03008
AC   CVCL_4C41
DR   Coriell; HQ03008
DR   Wikidata; Q54895114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03009
AC   CVCL_4C42
DR   Coriell; HQ03009
DR   Wikidata; Q54895115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03010
AC   CVCL_4C43
DR   Coriell; HQ03010
DR   Wikidata; Q54895116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03014
AC   CVCL_4C44
DR   Coriell; HQ03014
DR   Wikidata; Q54895117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03015
AC   CVCL_4C45
DR   Coriell; HQ03015
DR   Wikidata; Q54895118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03016
AC   CVCL_4C46
DR   Coriell; HQ03016
DR   Wikidata; Q54895119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03020
AC   CVCL_4C47
DR   Coriell; HQ03020
DR   Wikidata; Q54895120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03021
AC   CVCL_4C48
DR   Coriell; HQ03021
DR   Wikidata; Q54895122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03025
AC   CVCL_4C49
DR   Coriell; HQ03025
DR   Wikidata; Q54895123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03027
AC   CVCL_4C50
DR   Coriell; HQ03027
DR   Wikidata; Q54895132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03031
AC   CVCL_4C51
DR   Coriell; HQ03031
DR   Wikidata; Q54895133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03032
AC   CVCL_4C52
DR   Coriell; HQ03032
DR   Wikidata; Q54895134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03033
AC   CVCL_4C53
DR   Coriell; HQ03033
DR   Wikidata; Q54895135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03034
AC   CVCL_4C54
DR   Coriell; HQ03034
DR   Wikidata; Q54895136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03035
AC   CVCL_4C55
DR   Coriell; HQ03035
DR   Wikidata; Q54895137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03036
AC   CVCL_4C56
DR   Coriell; HQ03036
DR   Wikidata; Q54895138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03037
AC   CVCL_4C57
DR   Coriell; HQ03037
DR   Wikidata; Q54895139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03038
AC   CVCL_4C58
DR   Coriell; HQ03038
DR   Wikidata; Q54895140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03040
AC   CVCL_4C59
DR   Coriell; HQ03040
DR   Wikidata; Q54895141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03043
AC   CVCL_4C60
DR   Coriell; HQ03043
DR   Wikidata; Q54895142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03045
AC   CVCL_4C61
DR   Coriell; HQ03045
DR   Wikidata; Q54895143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03046
AC   CVCL_4C62
DR   Coriell; HQ03046
DR   Wikidata; Q54895144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03047
AC   CVCL_4C63
DR   Coriell; HQ03047
DR   Wikidata; Q54895145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03048
AC   CVCL_4C64
DR   Coriell; HQ03048
DR   Wikidata; Q54895146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03050
AC   CVCL_4C65
DR   Coriell; HQ03050
DR   Wikidata; Q54895147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03052
AC   CVCL_4C66
DR   Coriell; HQ03052
DR   Wikidata; Q54895148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03053
AC   CVCL_4C67
DR   Coriell; HQ03053
DR   Wikidata; Q54895149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03054
AC   CVCL_4C68
DR   Coriell; HQ03054
DR   Wikidata; Q54895150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03056
AC   CVCL_4C69
DR   Coriell; HQ03056
DR   Wikidata; Q54895151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03057
AC   CVCL_4C70
DR   Coriell; HQ03057
DR   Wikidata; Q54895152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03058
AC   CVCL_4C71
DR   Coriell; HQ03058
DR   Wikidata; Q54895153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03059
AC   CVCL_4C72
DR   Coriell; HQ03059
DR   Wikidata; Q54895154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03060
AC   CVCL_4C73
DR   Coriell; HQ03060
DR   Wikidata; Q54895155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03061
AC   CVCL_4C74
DR   Coriell; HQ03061
DR   Wikidata; Q54895156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03062
AC   CVCL_4C75
DR   Coriell; HQ03062
DR   Wikidata; Q54895157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03063
AC   CVCL_4C76
DR   Coriell; HQ03063
DR   Wikidata; Q54895158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03064
AC   CVCL_4C77
DR   Coriell; HQ03064
DR   Wikidata; Q54895159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03065
AC   CVCL_4C78
DR   Coriell; HQ03065
DR   Wikidata; Q54895160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03066
AC   CVCL_4C79
DR   Coriell; HQ03066
DR   Wikidata; Q54895161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03067
AC   CVCL_4C80
DR   Coriell; HQ03067
DR   Wikidata; Q54895162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03069
AC   CVCL_4C81
DR   Coriell; HQ03069
DR   Wikidata; Q54895163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03070
AC   CVCL_4C82
DR   Coriell; HQ03070
DR   Wikidata; Q54895164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03071
AC   CVCL_4C83
DR   Coriell; HQ03071
DR   Wikidata; Q54895165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03072
AC   CVCL_4C84
DR   Coriell; HQ03072
DR   Wikidata; Q54895166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03073
AC   CVCL_4C85
DR   Coriell; HQ03073
DR   Wikidata; Q54895167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03074
AC   CVCL_4C86
DR   Coriell; HQ03074
DR   Wikidata; Q54895168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03075
AC   CVCL_4C87
DR   Coriell; HQ03075
DR   Wikidata; Q54895169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03076
AC   CVCL_4C88
DR   Coriell; HQ03076
DR   Wikidata; Q54895170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03077
AC   CVCL_4C89
DR   Coriell; HQ03077
DR   Wikidata; Q54895171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03078
AC   CVCL_4C90
DR   Coriell; HQ03078
DR   Wikidata; Q54895181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03080
AC   CVCL_4C91
DR   Coriell; HQ03080
DR   Wikidata; Q54895182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03082
AC   CVCL_4C92
DR   Coriell; HQ03082
DR   Wikidata; Q54895183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03084
AC   CVCL_4C93
DR   Coriell; HQ03084
DR   Wikidata; Q54895184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03085
AC   CVCL_4C94
DR   Coriell; HQ03085
DR   Wikidata; Q54895185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03086
AC   CVCL_4C95
DR   Coriell; HQ03086
DR   Wikidata; Q54895186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03088
AC   CVCL_4C96
DR   Coriell; HQ03088
DR   Wikidata; Q54895187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03090
AC   CVCL_4C97
DR   Coriell; HQ03090
DR   Wikidata; Q54895188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03092
AC   CVCL_4C98
DR   Coriell; HQ03092
DR   Wikidata; Q54895189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03093
AC   CVCL_4C99
DR   Coriell; HQ03093
DR   Wikidata; Q54895190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HQ03096
AC   CVCL_4D00
DR   Coriell; HQ03096
DR   Wikidata; Q54895191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03097
AC   CVCL_4D01
DR   Coriell; HQ03097
DR   Wikidata; Q54895192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   HQ03103
AC   CVCL_4D02
DR   Coriell; HQ03103
DR   Wikidata; Q54895193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   HR
AC   CVCL_ZE74
DR   Wikidata; Q98126708
RX   PubMed=3791243;
RX   PubMed=6541042;
CC   Population: Japanese.
CC   Doubling time: 13.2 hours (PubMed=3791243); 19 hours (PubMed=6541042).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   HR-1
AC   CVCL_ZE75
DR   Wikidata; Q98126709
RX   PubMed=3791243;
CC   Population: Japanese.
CC   Doubling time: 17.6 hours (PubMed=3791243).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE74 ! HR
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   HR-3Y1-1
AC   CVCL_8096
DR   BTO; BTO_0002369
DR   RCB; RCB0356
DR   Wikidata; Q54895194
RX   PubMed=2961438;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: v-Ha-Ras.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   HR-3Y1-2
AC   CVCL_8097
DR   BTO; BTO_0002369
DR   JCRB; JCRB0743
DR   RCB; RCB0357
DR   Wikidata; Q54895195
RX   PubMed=2961438;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: v-Ha-Ras.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   HR-3Y1-3
AC   CVCL_6E96
DR   Wikidata; Q54895196
RX   PubMed=2961438;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: v-Ha-Ras.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   HR-8348
AC   CVCL_W821
SY   HR8348
DR   Wikidata; Q54895197
RX   PubMed=3672101;
CC   Population: Chinese.
CC   Doubling time: 36.05 hours (PubMed=3672101).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   HR/+ A.Sp
AC   CVCL_6319
DR   CLO; CLO_0003822
DR   ATCC; CRL-6347
DR   Wikidata; Q54895198
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6347; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/+ B.Sp
AC   CVCL_6325
SY   HR/+B.Sp
DR   CLO; CLO_0003828
DR   ATCC; CRL-6348
DR   Wikidata; Q54895199
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6348; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/+ C.Sp
AC   CVCL_6320
DR   CLO; CLO_0003823
DR   ATCC; CRL-6349
DR   Wikidata; Q54895200
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6349; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/+ D.Sp
AC   CVCL_6321
DR   CLO; CLO_0003824
DR   ATCC; CRL-6350
DR   Wikidata; Q54895201
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6350; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/+ E.Sp
AC   CVCL_6322
DR   CLO; CLO_0003825
DR   ATCC; CRL-6351
DR   Wikidata; Q54895202
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6351; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/+ F.Sp
AC   CVCL_6323
DR   CLO; CLO_0003826
DR   ATCC; CRL-6352
DR   Wikidata; Q54895203
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6352; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/+ G.Sp
AC   CVCL_6324
DR   CLO; CLO_0003827
DR   ATCC; CRL-6353
DR   Wikidata; Q54895204
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6353; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/HR 1.Sp
AC   CVCL_6328
DR   CLO; CLO_0003831
DR   ATCC; CRL-6354
DR   Wikidata; Q54895205
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6354; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/HR 2.Sp
AC   CVCL_6329
DR   CLO; CLO_0003832
DR   ATCC; CRL-6355
DR   Wikidata; Q54895206
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6355; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/HR 3.Sp
AC   CVCL_6330
DR   CLO; CLO_0003833
DR   ATCC; CRL-6356
DR   Wikidata; Q54895207
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6356; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   41D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   HR/HRA.We
AC   CVCL_6326
SY   hr/hr (WE) A
DR   CLO; CLO_0003829
DR   ATCC; CRL-6357
DR   Wikidata; Q54895208
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6357; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   HR/HRB.We
AC   CVCL_6327
SY   hr/hr (WE) B
DR   CLO; CLO_0003830
DR   ATCC; CRL-6358
DR   Wikidata; Q54895209
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6358; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   HR5
AC   CVCL_2505
SY   HeLa rtTA HR5; HeLa HR5
DR   CLO; CLO_0003834
DR   CLDB; cl1708
DR   BioSample; SAMN03470982
DR   ECACC; 95091409
DR   Wikidata; Q54895210
RX   PubMed=7792603;
RX   PubMed=25877200;
CC   Population: African American.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10,11
ST   D13S317: 12,13.3
ST   D16S539: 9,10,13
ST   D18S51: 13,16
ST   D19S433: 13,14,16
ST   D21S11: 27,29
ST   D2S1338: 17
ST   D3S1358: 15,16,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   HR5-CL11
AC   CVCL_2506
DR   CLO; CLO_0003835
DR   CLDB; cl1709
DR   BioSample; SAMN03470975
DR   ECACC; 95091411
DR   Wikidata; Q54895211
RX   PubMed=7792603;
RX   PubMed=25877200;
CC   Population: African American.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2505 ! HR5
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   HR78
AC   CVCL_E3ZG
DR   ABCD; ABCD_AN113
RX   Patent=EP0368466B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9760.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16412; Lipopolysaccharide.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6741 ! WI-L2-729HF2
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HR89
AC   CVCL_E3ZH
RX   Patent=EP0368466B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9759.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16412; Lipopolysaccharide.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6741 ! WI-L2-729HF2
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HRA
AC   CVCL_U986
DR   BTO; BTO_0004925
DR   Wikidata; Q54895212
RX   PubMed=3791243;
RX   PubMed=10381137;
RX   PubMed=12019149;
RX   PubMed=18720132;
CC   Population: Japanese.
CC   Doubling time: 15.6 hours (PubMed=3791243).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE74 ! HR
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 8
//
ID   HRA-16
AC   CVCL_2507
SY   HRA 16; HRA16
DR   ECACC; 06061905
DR   GEO; GSM1448117
DR   Wikidata; Q54895213
DR   Ximbio; 152464
RX   PubMed=3718830;
RX   PubMed=25926053;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Ximbio; 152464; probable.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 10,13
ST   D21S11: 28
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   HRA-19
AC   CVCL_2508
SY   HRA 19; HRA19
DR   cancercelllines; CVCL_2508
DR   ColonAtlas; HRA19
DR   Cosmic; 876723
DR   Cosmic; 948851
DR   Cosmic; 986014
DR   Cosmic; 995408
DR   Cosmic; 1043816
DR   Cosmic; 1312302
DR   Cosmic; 2301986
DR   Cosmic; 2760063
DR   Cosmic; 2800564
DR   ECACC; 10012802
DR   GEO; GSM1346842
DR   GEO; GSM1374548
DR   IARC_TP53; 21738
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54895214
DR   Ximbio; 152465
RX   PubMed=3569697;
RX   PubMed=3718830;
RX   PubMed=8197130;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg405Ter (c.1213C>T); ClinVar=VCV000127275; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.42_45delTCTT); Zygosity=Heterozygous (PubMed=8197130).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=16418264; PubMed=24755471).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Ximbio; 152465; probable.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ECACC=10012802
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   HRA-19a1.1
AC   CVCL_2509
DR   cancercelllines; CVCL_2509
DR   ECACC; 09071517
DR   Wikidata; Q54895215
DR   Ximbio; 152466
RX   PubMed=2449944;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg405Ter (c.1213C>T); ClinVar=VCV000127275; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.42_45delTCTT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Ximbio; 152466; probable.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ECACC=09071517
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2508 ! HRA-19
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   HRA-19a1.1 Alpha2 B
AC   CVCL_2512
DR   cancercelllines; CVCL_2512
DR   ECACC; 09071522
DR   Wikidata; Q54895216
DR   Ximbio; 152468
RX   PubMed=18664572;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg405Ter (c.1213C>T); ClinVar=VCV000127275; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.42_45delTCTT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6137; ITGA2.
CC   Discontinued: Ximbio; 152468; probable.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ECACC=09071522
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2509 ! HRA-19a1.1
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   HRA-19a1.1 Alpha2 F
AC   CVCL_2513
SY   HRA-19a1.1 Alpha 2F
DR   cancercelllines; CVCL_2513
DR   ECACC; 09071520
DR   Wikidata; Q54895217
DR   Ximbio; 152469
RX   PubMed=18664572;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg405Ter (c.1213C>T); ClinVar=VCV000127275; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.42_45delTCTT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6137; ITGA2.
CC   Discontinued: Ximbio; 152469; probable.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ECACC=09071520
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2509 ! HRA-19a1.1
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   HRA-19a1.1 Alpha2Alpha1 B
AC   CVCL_2510
DR   cancercelllines; CVCL_2510
DR   ECACC; 09071524
DR   Wikidata; Q54895218
DR   Ximbio; 152467
RX   PubMed=18664572;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg405Ter (c.1213C>T); ClinVar=VCV000127275; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.42_45delTCTT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6137; ITGA2 (Note=Chimeric extracellular and TM domain of ITGA2 and the cytoplasmic domain of ITGA1).
CC   Discontinued: Ximbio; 152467; probable.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ECACC=09071524
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2509 ! HRA-19a1.1
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   HRA-19a1.1 Alpha2Alpha1 E
AC   CVCL_2511
DR   cancercelllines; CVCL_2511
DR   ECACC; 09071527
DR   Wikidata; Q54895219
RX   PubMed=18664572;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg405Ter (c.1213C>T); ClinVar=VCV000127275; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.42_45delTCTT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6137; ITGA2 (Note=Chimeric extracellular and TM domain of ITGA2 and the cytoplasmic domain of ITGA1).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ECACC=09071527
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2509 ! HRA-19a1.1
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   HRC-17
AC   CVCL_C474
DR   CLO; CLO_0050277
DR   RCB; RCB1294
DR   Wikidata; Q54895220
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   HRC-99
AC   CVCL_IR28
DR   Wikidata; Q54895225
RX   DOI=10.11569/wcjd.v13.i13.1510;
CC   Population: Chinese.
CC   Doubling time: 24.8 hours (DOI=10.11569/wcjd.v13.i13.1510).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   HRC24
AC   CVCL_IS22
SY   HRC-24
DR   Wikidata; Q54895226
RX   PubMed=21854714;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   HRC31
AC   CVCL_IS23
SY   HRC-31
DR   Wikidata; Q54895227
RX   PubMed=21854714;
RX   PubMed=23657944;
RX   PubMed=27993170;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   HRC45
AC   CVCL_IS24
SY   HRC-45
DR   Wikidata; Q54895228
RX   PubMed=21854714;
RX   PubMed=23657944;
RX   PubMed=27993170;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   HRC63
AC   CVCL_IS25
SY   HRC-63
DR   Wikidata; Q54895229
RX   PubMed=23657944;
RX   PubMed=27993170;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   HRC78
AC   CVCL_IS26
SY   HRC-78
DR   Wikidata; Q54895230
RX   PubMed=21854714;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   HRE-H9
AC   CVCL_U408
DR   Wikidata; Q54895231
RX   PubMed=2555129;
RX   PubMed=11589618;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-174.html
CC   Characteristics: At the permissive temperature (33 Celsius) has a spindle shape morphology. At the restrictive temperature (40 Celsius) has a round shape morphology.
CC   Doubling time: ~48 hours (Note=At 33 Celsius) (PubMed=2555129).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   HREC24T
AC   CVCL_WN16
SY   Human Renal Epithelial Cell 24TERT
DR   Wikidata; Q94286803
RX   PubMed=31078587;
CC   Characteristics: CD133-/CD24+ subpopulation of parent cell line that is not capable of tubulogenic, adipogenic and osteogenic differentiation (PubMed=31078587).
CC   Doubling time: 108.3 hours (PubMed=31078587).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   HRI +2
AC   CVCL_E4CV
SY   HRI + 2
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: While this cell line was obtained by Benjamin, David from Gerber, Paul, there is no indication in how it differs from the parent cell line or even if it is identical to P3HR-1.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HRL9
AC   CVCL_GZ13
SY   HRL9 HeLa
DR   TOKU-E; 4131
DR   Wikidata; Q54895232
RX   PubMed=10738580;
CC   Population: African American.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2505 ! HR5
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   HRMSDUi001-A
AC   CVCL_A0ME
DR   hPSCreg; HRMSDUi001-A
DR   Wikidata; Q108820499
RX   PubMed=34284274;
CC   From: Hospital for Reproductive Medicine Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Karyotypic information: 45,XY,der(13;14)(q10;q10) (PubMed=34284274).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   HROBMC01
AC   CVCL_1D08
DR   CLS; 300800
DR   Wikidata; Q54895233
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (CLS=300800).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): CLS=300800; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10.3
ST   D13S317: 12
ST   D16S539: 9,13
ST   D21S11: 29,32.2
ST   D5S818: 11
ST   D7S820: 8,9,11 (CLS=300800)
ST   D7S820: 8,11 (Direct_author_submission)
ST   TH01: 7,9.3
ST   TPOX: 7.3,9.3 (Direct_author_submission)
ST   TPOX: 8,10 (CLS=300800)
ST   vWA: 18,19 (CLS=300800)
ST   vWA: 18.1,19.1 (Direct_author_submission)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LP00 ! HROBMC01 T0 M4
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 16
//
ID   HROBMC01 T0 M4
AC   CVCL_LP00
DR   Wikidata; Q94286844
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D08 ! HROBMC01
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   HROBML01
AC   CVCL_2U69
DR   Wikidata; Q54895234
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HROBML03
AC   CVCL_1D09
DR   cancercelllines; CVCL_1D09
DR   CLS; 300801
DR   Wikidata; Q54895235
RX   PubMed=25069049;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. The STR profile is identical to that of the NCI-H460 cell line. Contamination confirmed from personal communication of Linnebacher, Michael. Originally thought to originate from the resection of the brain metastasis of a 47 year old female Caucasian patient with a non-small cell lung carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00587.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: CLS; 300801; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300801
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 21
ST   D13S317: 13
ST   D16S539: 9
ST   D18S51: 13,15
ST   D19S433: 14
ST   D1S1656: 11,14.3
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 15,18
ST   D5S818: 9,10
ST   D6S1043: 11,14
ST   D7S820: 9,12
ST   D8S1179: 12
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 24
//
ID   HROC103 T0 M1
AC   CVCL_1D10
SY   HROC103
DR   CLS; 300802
DR   Wikidata; Q54895236
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): CLS=300802; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 9
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7FE ! B-LCL-HROC103
OI   CVCL_1V01 ! HROC103Met
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
ID   HROC103Met
AC   CVCL_1V01
SY   HROC103Met1
DR   Wikidata; Q54895237
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7FE ! B-LCL-HROC103
OI   CVCL_1D10 ! HROC103 T0 M1
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 14
//
ID   HROC107 cT0 M2
AC   CVCL_1D11
SY   HROC107
DR   CLS; 300845
DR   Wikidata; Q54895238
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): CLS=300845; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 14
//
ID   HROC111 T4 M1
AC   CVCL_VQ90
DR   Wikidata; Q94286931
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9.2
ST   TPOX: 8,8.3
ST   vWA: 16
DI   NCIt; C43584; Rectosigmoid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ91 ! HROC111Met1 T0 M2
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 9
//
ID   HROC111Met1 T0 M2
AC   CVCL_VQ91
DR   Wikidata; Q94286938
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Characteristics: Established from a patient-derived xenograft established in male NSG mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 7.3,8.3
ST   vWA: 16,18.1
DI   NCIt; C43584; Rectosigmoid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ90 ! HROC111 T4 M1
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   HROC112Met T0 M2
AC   CVCL_1U83
SY   HROC112 Met T0 M2; HROC112Met
DR   CLS; 300846
DR   Wikidata; Q54895239
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Caution: B-LCL-HROC112 (Cellosaurus=CVCL_C8Z4) and HROC112Met T0 M2 (Cellosaurus=CVCL_1U83) are from 2 different donors.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9.3,11.3
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 7.3
ST   vWA: 13.2,17.1
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   HROC113
AC   CVCL_S852
SY   HROC113P
DR   CLS; 300803
DR   Wikidata; Q54895240
RX   PubMed=23300683;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 23 hours (CLS=300803).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300803; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12,14
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD52 ! B-LCL-HROC113
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 21
//
ID   HROC113 cT0 M1
AC   CVCL_AN12
DR   Wikidata; Q54895242
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S852 ! HROC113
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 12
//
ID   HROC126
AC   CVCL_1D12
DR   CLS; 300804
DR   Wikidata; Q54895243
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): CLS=300804; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
ID   HROC131 T0 M3
AC   CVCL_1D13
SY   HROC131; HROC131X
DR   CLS; 300805
DR   Wikidata; Q54895244
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300805; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 8,12
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 16
//
ID   HROC147 T0 M1
AC   CVCL_1G09
SY   HROC147
DR   CLS; 300856
DR   Wikidata; Q54895245
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   HLA typing: A*02:01,11:01; B*07:02,15:01; C*03:04,07:02; DQB1*03:02,06:02; DRB1*04:01,15:01 (Direct_author_submission).
CC   Microsatellite instability: Instable (MSI-low) (Direct_author_submission).
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): CLS=300856; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D14 ! HROC147Met
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
ID   HROC147Met
AC   CVCL_1D14
DR   CLS; 300806
DR   Wikidata; Q54895246
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,11:01; B*07:02,15:01; C*03:04,07:02; DQB1*03:02,06:02; DRB1*04:01,15:01 (Direct_author_submission).
CC   Microsatellite instability: Instable (MSI-low) (Direct_author_submission).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): CLS=300806; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 7,9
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G09 ! HROC147 T0 M1
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
ID   HROC173
AC   CVCL_1D15
DR   CLS; 300807
DR   Wikidata; Q54895247
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300807; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6AX ! B-LCL-HROC173
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   HROC18
AC   CVCL_0B45
SY   HROC 18
DR   CLS; 300808
DR   Cosmic; 2151360
DR   Cosmic; 2324288
DR   GEO; GSM1448095
DR   Wikidata; Q54895248
RX   PubMed=24647592;
RX   PubMed=25309914;
RX   PubMed=25574089;
RX   PubMed=25926053;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 35 +- 7.2 hours (PubMed=25574089).
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,15:24:01; C*07:01:01; DPB1*01:01,04:01; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,13:03:01 (CLS=300808).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): CLS=300808; Direct_author_submission; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D21S11: 30,33.2
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0UD ! B-LCL-HROC18
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 20
//
ID   HROC183
AC   CVCL_1D16
SY   HROC183P
DR   CLS; 300809
DR   Wikidata; Q54895249
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (CLS=300809).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300809; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D17 ! HROC183 T0 M2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
ID   HROC183 T0 M2
AC   CVCL_1D17
SY   HROC183X
DR   CLS; 300810
DR   Wikidata; Q54895250
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 29 hours (CLS=300810).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300810
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D16 ! HROC183
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 14
//
ID   HROC212
AC   CVCL_1U84
SY   HROC212P
DR   CLS; 300811
DR   Wikidata; Q54895251
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (CLS=300811).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U85 ! HROC212 T0 M1
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 13
//
ID   HROC212 T0 M1
AC   CVCL_1U85
SY   HROC212X
DR   Wikidata; Q54895252
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U84 ! HROC212
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   HROC217 T1 M2
AC   CVCL_VQ92
DR   Wikidata; Q94287189
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   HROC222 T1 M2
AC   CVCL_VQ93
DR   CLS; 300859
DR   Wikidata; Q94287195
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in male NSG mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 10
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11.3
ST   TH01: 6,7
ST   TPOX: 7.3
ST   vWA: 17.1,18.1
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 9
//
ID   HROC239 T0 M1
AC   CVCL_1U93
SY   HROC239
DR   CLS; 300857
DR   Wikidata; Q54895253
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 29 hours (CLS=300857).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9.3,12
ST   D13S317: 7,8
ST   D16S539: 11
ST   D5S818: 9,10
ST   D7S820: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   HROC24
AC   CVCL_S853
SY   HROC24P
DR   CLS; 300812
DR   GEO; GSM1448071
DR   Wikidata; Q54895254
RX   PubMed=23300683;
RX   PubMed=25309914;
RX   PubMed=25926053;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,30:02; B*18:01,38:01; C*05:01,12:03; DQB1*02:01,06:01; DRB1*03:01,13:01 (Direct_author_submission).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300812; Direct_author_submission; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11 (Direct_author_submission)
ST   CSF1PO: 11,12 (CLS=300812; PubMed=25926053)
ST   D13S317: 7 (Direct_author_submission)
ST   D13S317: 7,13 (CLS=300812; PubMed=25926053)
ST   D16S539: 9,11
ST   D21S11: 27,28
ST   D5S818: 10,11 (CLS=300812; PubMed=25926053)
ST   D5S818: 10,12 (Direct_author_submission)
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,20 (CLS=300812; PubMed=25926053)
ST   vWA: 16,21 (Direct_author_submission)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD57 ! B-LCL-HROC24
OI   CVCL_1U80 ! HROC24 T1 M1
OI   CVCL_AN14 ! HROC24 T3 M1 #2
SX   Male
AG   98Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 23
//
ID   HROC24 T1 M1
AC   CVCL_1U80
SY   HROC24X
DR   CLS; 300813
DR   Wikidata; Q54895255
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NOD SCID mice.
CC   Doubling time: 20 hours (CLS=300813).
CC   HLA typing: A*02:01,30:02; B*18:01,38:01; C*05:01,12:03; DQB1*02:01,06:01; DRB1*03:01,13:01 (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300813; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 7,8 (Direct_author_submission)
ST   D13S317: 7,13 (CLS=300813)
ST   D16S539: 9,11
ST   D21S11: 27,28
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD57 ! B-LCL-HROC24
OI   CVCL_S853 ! HROC24
OI   CVCL_AN14 ! HROC24 T3 M1 #2
SX   Male
AG   98Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
ID   HROC24 T3 M1 #2
AC   CVCL_AN14
DR   CLS; 300858
DR   Wikidata; Q54895256
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in NMRI nu/nu mice.
CC   HLA typing: A*02:01,30:02; B*18:01,38:01; C*05:01,12:03; DQB1*02:01,06:01; DRB1*03:01,13:01 (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300858
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 7,13,14
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D21S11: 27,28
ST   D3S1358: 16,17,18
ST   D5S818: 10,11
ST   D7S820: 11,13,14
ST   D8S1179: 10,11
ST   FGA: 18,20
ST   Penta D: 11
ST   Penta E: 5,10
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,20,21
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD57 ! B-LCL-HROC24
OI   CVCL_S853 ! HROC24
OI   CVCL_1U80 ! HROC24 T1 M1
SX   Male
AG   98Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 14
//
ID   HROC257
AC   CVCL_1U96
SY   HROC257P
DR   CLS; 300814
DR   Wikidata; Q54895257
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (CLS=300814).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300814
ST   Amelogenin: X
ST   CSF1PO: 8.3,11
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 13
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U97 ! HROC257 T0 M1
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 14
//
ID   HROC257 T0 M1
AC   CVCL_1U97
SY   HROC257X
DR   CLS; 300815
DR   Wikidata; Q54895258
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300815; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 8.3,11
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 13
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U96 ! HROC257
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
ID   HROC277 T0 M1
AC   CVCL_1U86
SY   HROC277
DR   CLS; 300834
DR   Wikidata; Q54895259
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   HLA typing: A*02:01,32:01; B*15:17,35:03; C*0:401,07:01; DQB1*03:01,06:04; DRB1*11:01,13:02 (Direct_author_submission).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Miscellaneous: STR profile from personal communication of Linnebacher, Michael.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): CLS=300834; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD54 ! B-LCL-HROC277
OI   CVCL_1U87 ! HROC277Met1 T0 M2
OI   CVCL_1U88 ! HROC277Met2
OI   CVCL_AP59 ! HROC277Met2 T0 M1
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
ID   HROC277Met1 T0 M2
AC   CVCL_1U87
SY   HROC277Met1
DR   Wikidata; Q54895261
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
CC   HLA typing: A*02:01,32:01; B*15:17,35:03; C*0:401,07:01; DQB1*03:01,06:04; DRB1*11:01,13:02 (Direct_author_submission).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD54 ! B-LCL-HROC277
OI   CVCL_1U86 ! HROC277 T0 M1
OI   CVCL_1U88 ! HROC277Met2
OI   CVCL_AP59 ! HROC277Met2 T0 M1
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 14
//
ID   HROC277Met2
AC   CVCL_1U88
DR   CLS; 300848
DR   Wikidata; Q54895262
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (CLS=300848).
CC   HLA typing: A*02:01,32:01; B*15:17,35:03; C*0:401,07:01; DQB1*03:01,06:04; DRB1*11:01,13:02 (Direct_author_submission).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD54 ! B-LCL-HROC277
OI   CVCL_1U86 ! HROC277 T0 M1
OI   CVCL_1U87 ! HROC277Met1 T0 M2
OI   CVCL_AP59 ! HROC277Met2 T0 M1
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 16
//
ID   HROC277Met2 T0 M1
AC   CVCL_AP59
DR   CLS; 300840
DR   Wikidata; Q54895263
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
CC   HLA typing: A*02:01,32:01; B*15:17,35:03; C*0:401,07:01; DQB1*03:01,06:04; DRB1*11:01,13:02 (Direct_author_submission).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD54 ! B-LCL-HROC277
OI   CVCL_1U86 ! HROC277 T0 M1
OI   CVCL_1U87 ! HROC277Met1 T0 M2
OI   CVCL_1U88 ! HROC277Met2
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   HROC278 T0 M1
AC   CVCL_1U89
SY   HROC278
DR   CLS; 300835
DR   Wikidata; Q54895264
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 43 hours (CLS=300835).
CC   HLA typing: A*03:01,25:01; B*07:02,18:01; C*07:02,12:03; DQB1*03:02,03:02; DRB1*04:01,04:01 (Direct_author_submission).
CC   HLA typing: A*03:01:01,01:01:01; B*07:02:01,18:01:01; C*07:02:01,12:03:01; DPB1*02:01; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:01:01 (CLS=300835).
CC   Microsatellite instability: Instable (MSI-low) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300835; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UL ! B-LCL-HROC278
OI   CVCL_1U90 ! HROC278Met T2 M2
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 18
//
ID   HROC278Met T2 M2
AC   CVCL_1U90
SY   HROC278Met
DR   CLS; 300836
DR   Wikidata; Q54895265
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in mice.
CC   HLA typing: A*03:01,25:01; B*07:02,18:01; C*07:02,12:03; DQB1*03:02,03:02; DRB1*04:01,04:01 (Direct_author_submission).
CC   Microsatellite instability: Instable (MSI-low) (Direct_author_submission).
CC   Miscellaneous: STR profile from personal communication of Linnebacher, Michael.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): CLS=300836; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 13
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UL ! B-LCL-HROC278
OI   CVCL_1U89 ! HROC278 T0 M1
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 19
//
ID   HROC284Met
AC   CVCL_1U91
DR   CLS; 300816
DR   Wikidata; Q54895266
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (CLS=300816).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): CLS=300816
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 9,13
ST   D18S51: 16
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 20,25
ST   Penta D: 9,12
ST   Penta E: 11,13
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 13
//
ID   HROC285 T0 M2
AC   CVCL_1U92
SY   HROC285
DR   CLS; 300817
DR   Wikidata; Q54895277
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 29 hours (CLS=300817).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6AW ! B-LCL-HROC285
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   HROC296
AC   CVCL_1V02
DR   CLS; 300853
DR   Wikidata; Q54895278
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (CLS=300853).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   HROC300 T2 M1
AC   CVCL_VQ94
DR   CLS; 300866
DR   Wikidata; Q94287511
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): CLS=300866
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 13.1
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,8.3
ST   vWA: 17.1
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ95 ! HROC300Met T3 M4
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 10
//
ID   HROC300Met T3 M4
AC   CVCL_VQ95
DR   Wikidata; Q94287516
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in male NMRI nu/nu mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ94 ! HROC300 T2 M1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   HROC309
AC   CVCL_1U95
DR   CLS; 300837
DR   Wikidata; Q54895279
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
ST   Source(s): CLS=300837
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 19,20
ST   Penta D: 9,10
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   HROC313Met
AC   CVCL_1U98
SY   HROC313Met1
DR   CLS; 300849
DR   Wikidata; Q54895280
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8RL ! B-LCL-HROC313
OI   CVCL_AP60 ! HROC313Met1 T0 M1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 14
//
ID   HROC313Met1 T0 M1
AC   CVCL_AP60
DR   Wikidata; Q54895281
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in male NSG mice.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8RL ! B-LCL-HROC313
OI   CVCL_1U98 ! HROC313Met
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 11
//
ID   HROC32
AC   CVCL_1D06
SY   HROC32P
DR   cancercelllines; CVCL_1D06
DR   CLS; 300818
DR   Cosmic; 2324290
DR   GEO; GSM1448079
DR   Wikidata; Q54895282
RX   PubMed=25574089;
RX   PubMed=25926053;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 32 +- 10.6 hours (PubMed=25574089); 30 hours (CLS=300818).
CC   HLA typing: A*01:01,02:01; B*08:01,03:01; C*07:01,14:02; DPB1*01:01,02:01; DQA1*01:02,05:01; DQB1*02:01,03:01; DRB1*03:01,11:01 (CLS=300818).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (CLS=300818).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (CLS=300818).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300818; Direct_author_submission; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 11,12 (Direct_author_submission)
ST   D13S317: 12 (CLS=300818; PubMed=25926053)
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 31
ST   D3S1358: 15,17
ST   D5S818: 11,12 (CLS=300818; Direct_author_submission)
ST   D5S818: 12 (PubMed=25926053)
ST   D7S820: 8,11
ST   D8S1179: 12
ST   FGA: 18,19
ST   Penta D: 12
ST   Penta E: 10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD55 ! B-LCL-HROC32
OI   CVCL_1D07 ! HROC32 T3 M1
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 24
//
ID   HROC32 T3 M1
AC   CVCL_1D07
SY   HROC32X
DR   cancercelllines; CVCL_1D07
DR   CLS; 300819
DR   Cosmic; 2324291
DR   Wikidata; Q54895284
RX   PubMed=25574089;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NOD SCID mice.
CC   Doubling time: 33.8 +- 5.4 hours (PubMed=25574089).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (CLS=300819).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (CLS=300819).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300819
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 31
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD55 ! B-LCL-HROC32
OI   CVCL_1D06 ! HROC32
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   HROC324
AC   CVCL_1V00
DR   CLS; 300838
DR   Wikidata; Q54895285
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01; B*07:02:01; C*07:02:01; DPB1*02:01:02; DQA1*01:02:01; DQB1*06:04:01G; DRB1*13:02:01G (CLS=300838).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): CLS=300838; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C5543; Cecum adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
ID   HROC334
AC   CVCL_1D18
DR   CLS; 300850
DR   Wikidata; Q54895286
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): CLS=300850; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
ID   HROC348
AC   CVCL_AN13
DR   Wikidata; Q54895288
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1U99 ! HROC348Met
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 9
//
ID   HROC348Met
AC   CVCL_1U99
DR   CLS; 300871
DR   Wikidata; Q54895289
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): CLS=300871
ST   Amelogenin: X,Y
ST   CSF1PO: 8.3,9.3
ST   D13S317: 12
ST   D5S818: 11,12
ST   TH01: 8.3
ST   TPOX: 7.3,8.3
ST   vWA: 18.1
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AN13 ! HROC348
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   HROC357
AC   CVCL_AP61
DR   CLS; 300851
DR   Wikidata; Q54895290
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC02 ! HROC357 T0 M1
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 9
//
ID   HROC357 T0 M1
AC   CVCL_UC02
DR   Wikidata; Q94287631
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP61 ! HROC357
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   HROC364
AC   CVCL_AP62
DR   CLS; 300855
DR   Wikidata; Q54895291
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (CLS=300855).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 9
//
ID   HROC370
AC   CVCL_VQ96
DR   CLS; 300872
DR   Wikidata; Q94287656
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
ST   Source(s): CLS=300872
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,10
ST   D16S539: 12,14.1
ST   D5S818: 8.2,11.2
ST   D7S820: 7
ST   TH01: 8
ST   TPOX: 15
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ97 ! HROC370 T0 M2
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   HROC370 T0 M2
AC   CVCL_VQ97
DR   Wikidata; Q94287661
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ96 ! HROC370
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   HROC374
AC   CVCL_VQ98
DR   CLS; 300852
DR   Wikidata; Q94287665
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 9
//
ID   HROC383
AC   CVCL_VQ99
DR   CLS; 300873
DR   Wikidata; Q94287670
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
ST   Source(s): CLS=300873
ST   Amelogenin: X
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D21S11: 28
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 13,17
ST   FGA: 19
ST   Penta D: 11
ST   Penta E: 7,9
ST   TH01: 9.3
ST   TPOX: 8,11
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR00 ! HROC383 T0 M2
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 11
//
ID   HROC383 T0 M2
AC   CVCL_VR00
DR   Wikidata; Q94287675
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ99 ! HROC383
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 9
//
ID   HROC385Met1
AC   CVCL_VR01
DR   Wikidata; Q94287678
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   HROC39
AC   CVCL_1U81
SY   HROC39P
DR   CLS; 300820
DR   GEO; GSM1448083
DR   Wikidata; Q54895292
RX   PubMed=25926053;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300820; Direct_author_submission; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 11,12 (CLS=300820; Direct_author_submission)
ST   D16S539: 12 (PubMed=25926053)
ST   D21S11: 29
ST   D5S818: 12,13 (CLS=300820; Direct_author_submission)
ST   D5S818: 13 (PubMed=25926053)
ST   D7S820: 12
ST   TH01: 7,9.3 (PubMed=25926053)
ST   TH01: 7,10 (CLS=300820; Direct_author_submission)
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD56 ! B-LCL-HROC39
OI   CVCL_1U82 ! HROC39 T0 M2
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 21
//
ID   HROC39 T0 M2
AC   CVCL_1U82
SY   HROC39X
DR   CLS; 300821
DR   Wikidata; Q54895293
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NOD SCID mice.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300821
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD56 ! B-LCL-HROC39
OI   CVCL_1U81 ! HROC39
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 16
//
ID   HROC40
AC   CVCL_1G01
DR   CLS; 300822
DR   Wikidata; Q54895294
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
ST   Source(s): CLS=300822; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D21S11: 30
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
ID   HROC43
AC   CVCL_1D20
DR   CLS; 300823
DR   Wikidata; Q54895295
RX   PubMed=25309914;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300823; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D21S11: 31.2
ST   D5S818: 11,12
ST   D7S820: 13
ST   TH01: 10
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UN ! B-LCL-HROC43
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 16
//
ID   HROC46 T0 M1
AC   CVCL_1D21
SY   HROC46
DR   CLS; 300824
DR   GEO; GSM1448084
DR   Wikidata; Q54895296
RX   PubMed=25309914;
RX   PubMed=25926053;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NOD SCID mice.
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): Direct_author_submission; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 28,32.2
ST   D5S818: 11,13 (Direct_author_submission)
ST   D5S818: 13 (PubMed=25926053)
ST   D7S820: 8,11
ST   TH01: 6,9.3 (PubMed=25926053)
ST   TH01: 6,10 (Direct_author_submission)
ST   TPOX: 8,11 (Direct_author_submission)
ST   TPOX: 8,12 (PubMed=25926053)
ST   vWA: 15,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UP ! B-LCL-HROC46
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 18
//
ID   HROC50 T1 M5
AC   CVCL_1G02
SY   HROC50
DR   CLS; 300839
DR   Wikidata; Q54895297
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
CC   Doubling time: 25-40 hours (CLS=300839).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 8.3
ST   D13S317: 12,13
ST   D16S539: 12,14
ST   D5S818: 11,12,13.1
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 7.3,10.3
ST   vWA: 16,17.1
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UQ ! B-LCL-HROC50
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
ID   HROC57
AC   CVCL_1G03
DR   cancercelllines; CVCL_1G03
DR   CLS; 300825
DR   Wikidata; Q54895298
RX   PubMed=30197480;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 26.13 hours (PubMed=30197480).
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=30197480).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300825; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 30
ST   D5S818: 11,12 (Direct_author_submission)
ST   D5S818: 12 (CLS=300825)
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C96157; Colorectal large cell neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UR ! B-LCL-HROC57
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   HROC59 T1 M1
AC   CVCL_1G04
SY   HROC59
DR   CLS; 300826
DR   Wikidata; Q54895299
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in NMRI nu/nu mice.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300826; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 29,31.2
ST   D5S818: 11,12 (Direct_author_submission)
ST   D5S818: 12 (CLS=300826)
ST   D7S820: 10,13
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7US ! B-LCL-HROC59
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
ID   HROC60
AC   CVCL_1G05
DR   CLS; 300827
DR   Wikidata; Q54895300
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300827; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D21S11: 28
ST   D5S818: 11,12 (Direct_author_submission)
ST   D5S818: 12 (CLS=300827)
ST   D7S820: 10,12
ST   TH01: 6,8 (Direct_author_submission)
ST   TH01: 8 (CLS=300827)
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UT ! B-LCL-HROC60
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 17
//
ID   HROC69
AC   CVCL_1G06
SY   HROC69P
DR   cancercelllines; CVCL_1G06
DR   CLS; 300828
DR   Cosmic; 2795028
DR   GEO; GSM1448080
DR   Wikidata; Q54895301
RX   PubMed=25926053;
RX   PubMed=27087592;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*26:01,33:01; B*18:01,52:01; C*12:02,12:03; DQB1*03:01,06:01; DRB1*11:04,15:02 (Direct_author_submission).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=27087592).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu7Ter (c.19G>T); ClinVar=VCV000493079; Zygosity=Unspecified (PubMed=27087592).
CC   Sequence variation: Mutation; HGNC; HGNC:6769; SMAD3; Simple; p.Ala382Val (c.1145C>T); ClinVar=VCV001677493; Zygosity=Unspecified (PubMed=27087592).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=27087592).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300828; PubMed=25926053; PubMed=27087592
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12,13 (PubMed=25926053)
ST   D13S317: 12 (CLS=300828; PubMed=27087592)
ST   D16S539: 11,12 (CLS=300828; PubMed=27087592)
ST   D16S539: 12,13 (PubMed=25926053)
ST   D21S11: 29,33.2
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7,9.3 (CLS=300828; PubMed=25926053)
ST   TH01: 7,10 (PubMed=27087592)
ST   TPOX: 8,12
ST   vWA: 17,19 (CLS=300828; PubMed=25926053)
ST   vWA: 17,20 (PubMed=27087592)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD53 ! B-LCL-HROC69
OI   CVCL_1G07 ! HROC69 T0 M2
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 24
//
ID   HROC69 T0 M2
AC   CVCL_1G07
SY   HROC69X
DR   cancercelllines; CVCL_1G07
DR   CLS; 300829
DR   Cosmic; 2795027
DR   Wikidata; Q54895302
RX   PubMed=27087592;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   HLA typing: A*26:01,33:01; B*18:01,52:01; C*12:02,12:03; DQB1*03:01,06:01; DRB1*11:04,15:02 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=27087592).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu7Ter (c.19G>T); ClinVar=VCV000493079; Zygosity=Unspecified (PubMed=27087592).
CC   Sequence variation: Mutation; HGNC; HGNC:6769; SMAD3; Simple; p.Ala382Val (c.1145C>T); ClinVar=VCV001677493; Zygosity=Unspecified (PubMed=27087592).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=27087592).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300829; PubMed=27087592
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7,10
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD53 ! B-LCL-HROC69
OI   CVCL_1G06 ! HROC69
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 21
//
ID   HROC80 T1 M1
AC   CVCL_1G08
SY   HROC80
DR   CLS; 300830
DR   GEO; GSM1448093
DR   Wikidata; Q54895303
RX   PubMed=25926053;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 24 hours (CLS=300830).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300830; Direct_author_submission; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10 (CLS=300830; PubMed=25926053)
ST   D16S539: 10,15 (Direct_author_submission)
ST   D21S11: 30,30.2
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 18
//
ID   HROC85
AC   CVCL_0B46
SY   HROC 85
DR   Cosmic; 2151371
DR   Wikidata; Q54895304
RX   PubMed=24647592;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Caution: While reported as a cell line in PubMed=24647592 (and thus Cosmic 2151371) this is a patient-derived xenograft. Personal communication of Linnebacher, Michael.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   HROC86
AC   CVCL_0B47
SY   HROC 86
DR   Cosmic; 2151372
DR   Wikidata; Q54895305
RX   PubMed=24647592;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Caution: While reported as a cell line in PubMed=24647592 (and thus Cosmic 2151372) this is a patient-derived xenograft. Personal communication of Linnebacher, Michael.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   HROC87 T0 M2
AC   CVCL_S854
SY   HROC87; HROC87X
DR   cancercelllines; CVCL_S854
DR   CLS; 300831
DR   GEO; GSM1448072
DR   Wikidata; Q54895306
RX   PubMed=23300683;
RX   PubMed=25926053;
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 26 hours (CLS=300831).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23300683).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300831; Direct_author_submission; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10 (Direct_author_submission)
ST   D13S317: 10,14 (CLS=300831; PubMed=25926053)
ST   D16S539: 11,13
ST   D21S11: 28,29
ST   D5S818: 9,11
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 11,13
ST   vWA: 16,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 26
//
ID   HROG02
AC   CVCL_4U38
DR   cancercelllines; CVCL_4U38
DR   CLS; 300931
DR   PRIDE; PXD020079
DR   Wikidata; Q54895307
RX   PubMed=23951083;
RX   PubMed=33592498;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 36-54 hours (PubMed=23951083).
CC   HLA typing: A*01:01,02:01; B*08:01,13:02; C*06:02,07:01; DPA1*01:03; DPB1*04:01; DQA1*02:01,05:01; DQB1*02:01,02:02; DRB1*03:01,07:01; DRB3*01:01; DRB4*01:03 (PubMed=33592498).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=23951083).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 19
//
ID   HROG02-CIITA
AC   CVCL_C6JW
DR   PRIDE; PXD020079
DR   Wikidata; Q116049504
RX   PubMed=33592498;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7067; CIITA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U38 ! HROG02
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   HROG04
AC   CVCL_4U39
DR   cancercelllines; CVCL_4U39
DR   CLS; 300932
DR   Wikidata; Q54895308
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*01,02 (Direct_author_submission).
CC   HLA typing: A*01:01:01,05:35; B*08:01,03:01:01; C*07:01:01,15:02:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01,05:05:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,11:01:01 (CLS=300932).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Leu (c.821G>T); ClinVar=VCV000427600; Zygosity=Unspecified (CLS=300932).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): CLS=300932
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18.3,19
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 15,20
ST   D19S433: 14,15.2
ST   D1S1656: 15.3,16
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D6S1043: 11,12
ST   D7S820: 7,10
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 12,18
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7GY ! B-LCL-HROG04
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   HROG05
AC   CVCL_4U40
DR   cancercelllines; CVCL_4U40
DR   CLS; 300940
DR   Wikidata; Q54895310
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 44-48 hours (PubMed=23951083).
CC   HLA typing: A*02 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=23951083).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): CLS=300940
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 23
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D1S1656: 14,15.3
ST   D21S11: 30,31.2
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D6S1043: 12,19
ST   D7S820: 7,11
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 8,13
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 17
//
ID   HROG06
AC   CVCL_4U41
DR   cancercelllines; CVCL_4U41
DR   CLS; 300933
DR   Wikidata; Q54895311
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 57-59 hours (PubMed=23951083).
CC   HLA typing: A*01:01:01,03:01:01; B*08:01:01,11:01:01; C*04:01:01,07:01:01; DPB1*03:01,04:02; DQA1*01:01:01,01:02:01; DQB1*05:01:01,06:04:01; DRB1*01:01:01,13:02:01 (CLS=300933).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=23951083).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=23951083).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): CLS=300933
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 17.3,18
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 14,15.2
ST   D1S1656: 17.3
ST   D21S11: 28
ST   D2S1338: 22,25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 10,20
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7FP ! HROG06 T0 M2
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 19
//
ID   HROG06 T0 M2
AC   CVCL_B7FP
DR   CLS; 300883
DR   Wikidata; Q112929749
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U41 ! HROG06
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   HROG07
AC   CVCL_4U42
DR   CLS; 300934
DR   Wikidata; Q54895312
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,02:01:01; B*15:01:01,03:05:02; C*03:03:01,07:04:01; DPB1*04:01:01G,05:01:01G; DQA1*01:03:01,04:01:01; DQB1*04:02:01,06:01:01; DRB1*08:01:01,15:02:01 (CLS=300934).
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): CLS=300934
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 19,21
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,14
ST   D1S1656: 14,18.3
ST   D21S11: 31.2,33.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D6S1043: 12
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 22,25
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   HROG10
AC   CVCL_4U43
DR   CLS; 300935
DR   Wikidata; Q54895313
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,23:01:01; B*15:01:01,20:03:01; C*01:02:01,04:01:01; DPB1*02:01,04:01; DQA1*02:01:01,03:02:01; DQB1*02:02:01,03:03:02; DRB1*07:01:01,09:01:02 (CLS=300935).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): CLS=300935
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17,18
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D19S433: 15.2,16
ST   D1S1656: 14
ST   D21S11: 28,30
ST   D2S1338: 21,25
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,24
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   HROG12 T0 M1
AC   CVCL_B7FR
DR   CLS; 300882
DR   Wikidata; Q112929752
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Derived from site: In situ; Brain, right fronto-parietal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   HROG13
AC   CVCL_4U44
DR   CLS; 300936
DR   Wikidata; Q54895314
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01; B*15:01:01,20:02:01; C*03:03:01,05:01:01; DPB1*01:01,19:01; DQA1*01:03:01,03:03:01; DQB1*03:01:01,06:03:01; DRB1*04:01:01,13:01:01 (CLS=300936).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): CLS=300936
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18.3,23
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 13,18
ST   D19S433: 12,13
ST   D1S1656: 16,17
ST   D21S11: 30,30.2
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 12,19
ST   D7S820: 9,12
ST   D8S1179: 10,14
ST   FGA: 20,25
ST   Penta D: 9,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 12
//
ID   HROG15
AC   CVCL_LD58
DR   cancercelllines; CVCL_LD58
DR   CLS; 300937
DR   Wikidata; Q54895315
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,03:01:01; B*15:01:01,11:03:01; C*03:03:01,04:01:01; DPB1*01:01:01,02:01:02; DQA1*01:03:01,05:01:01; DQB1*02:01:01,06:03:01; DRB1*03:01:01,13:01:01 (CLS=300937).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ser170Asn (c.509G>A); ClinVar=VCV000951765; Zygosity=Unspecified (CLS=300937).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (CLS=300937).
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): CLS=300937
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 22,23
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 16
ST   D19S433: 12
ST   D1S1656: 17,17.3
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D6S1043: 12,14
ST   D7S820: 7,8
ST   D8S1179: 15,16
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 9,16
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   HROG16
AC   CVCL_LD59
DR   Wikidata; Q54895316
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   HROG17
AC   CVCL_4U45
DR   cancercelllines; CVCL_4U45
DR   CLS; 300938
DR   PRIDE; PXD020079
DR   Wikidata; Q54895317
RX   PubMed=23951083;
RX   PubMed=33592498;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 32-43 hours (PubMed=23951083).
CC   HLA typing: A*11:01,66:01; B*14:02,40:02; C*01:02,08:02; DPA1*01:03,02:01; DPB1*04:01,11:01; DQA1*01:01,05:05; DQB1*03:01,05:01; DRB1*01:02,12:01; DRB3*02:02 (PubMed=33592498).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Unspecified (CLS=300938).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
ST   Source(s): CLS=300938
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 17,19.3
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 16,17
ST   D19S433: 12,15
ST   D1S1656: 15,16
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D6S1043: 12,17
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 25
ST   Penta D: 9,15
ST   Penta E: 7,20
ST   TH01: 9,9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7FQ ! HROG17 T1 M1
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 18
//
ID   HROG17 T1 M1
AC   CVCL_B7FQ
DR   CLS; 300875
DR   Wikidata; Q112929753
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U45 ! HROG17
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   HROG17-CIITA
AC   CVCL_C6JX
DR   PRIDE; PXD020079
DR   Wikidata; Q116049505
RX   PubMed=33592498;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7067; CIITA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U45 ! HROG17
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   HROG24
AC   CVCL_4U46
DR   CLS; 300876
DR   Wikidata; Q54895318
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 70 hours (CLS=300876).
CC   Derived from site: In situ; Brain, left occipital lobe; UBERON=UBERON_0002806.
ST   Source(s): CLS=300876
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17.1
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   HROG33
AC   CVCL_4U47
DR   CLS; 300877
DR   Wikidata; Q54895319
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left temporo-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U48 ! HROG33 T0 M1
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HROG33 T0 M1
AC   CVCL_4U48
SY   HROG33 fT0 M1
DR   CLS; 300878
DR   Wikidata; Q54895325
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left temporo-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4U47 ! HROG33
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HROG36
AC   CVCL_4U49
DR   CLS; 300939
DR   Wikidata; Q54895326
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 35-40 hours (PubMed=23951083).
CC   HLA typing: A*02:01:01,01:01:01; B*40:01:02,55:01:01; C*03:03:01,03:04:01; DPB1*04:01:01G,06:01:01G; DQA1*01:04:01,03:01:01; DQB1*03:02:01,05:03:01; DRB1*04:04:01,14:54:01 (CLS=300939).
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): CLS=300939
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 20,23
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 16
ST   D19S433: 15
ST   D1S1656: 12,17.3
ST   D21S11: 29,30
ST   D2S1338: 17,23
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D6S1043: 12,14
ST   D7S820: 9,12
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 5,10
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 12
//
ID   HROG38
AC   CVCL_4U50
DR   cancercelllines; CVCL_4U50
DR   CLS; 300879
DR   Wikidata; Q54895327
RX   PubMed=23951083;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Doubling time: 63 hours (CLS=300879).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile224Met (c.672A>G); ClinVar=VCV000189505; Zygosity=Unspecified (CLS=300879).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg234Trp (c.700C>T); ClinVar=VCV000184844; Zygosity=Unspecified (CLS=300879).
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
ST   Source(s): CLS=300879
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D5S818: 12,13.1
ST   D7S820: 10,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17.1,18.1
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   HROG59
AC   CVCL_4U51
DR   CLS; 300880
DR   Wikidata; Q54895328
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HROG63
AC   CVCL_4U52
DR   CLS; 300881
DR   Wikidata; Q54895330
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HROGas03
AC   CVCL_2U70
DR   CLS; 300437
DR   Wikidata; Q54895331
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HROGas16
AC   CVCL_2U71
DR   Wikidata; Q54895332
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 8
//
ID   HROHep03
AC   CVCL_2U72
DR   CLS; 300197
DR   Wikidata; Q54895333
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CLS=300197
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,17
ST   D19S433: 14,14.2
ST   D21S11: 30
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   HROP04 T0 M1
AC   CVCL_VQ81
DR   Wikidata; Q94288267
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Characteristics: Established from a patient-derived xenograft established in mice.
CC   Derived from site: In situ; Pancreas, head; UBERON=UBERON_0001069.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   HRP 16-1
AC   CVCL_A9EN
DR   Wikidata; Q108820500
RX   Patent=CS276080B6;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute of Virology of the Slovak Academy of Sciences; Number_not_reported.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   HRP-1
AC   CVCL_F0FZ
RX   PubMed=2444478;
RX   PubMed=9223380;
CC   Derived from site: In situ; Placenta labyrinth; UBERON=UBERON_0003946.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   11-12FD
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HRPE-2S
AC   CVCL_IQ82
SY   Human Retinal Pigment Epithelium-2S
DR   Wikidata; Q54895335
RX   PubMed=27943290;
CC   Doubling time: 26.6 +- 3.3 hours (Note=At 6th passage), 25.7 +- 2.5 hours (Note=At 15th passage), 23.1 +- 2.1 hours (Note=At 26th passage), 22.7 +- 2.1 hours (Note=At 34th passage), 22.2 +- 1.7 hours (Note=At 40th passage), 22.3 +- 2.3 hours (Note=At 55th passage), 22.3 +- 1.9 hours (Note=At 65th passage) (PubMed=27943290).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   HRRT
AC   CVCL_JA35
SY   Hereditary Renal Rat Tumor
DR   Wikidata; Q54895336
RX   PubMed=2784762;
RX   PubMed=6307857;
CC   Doubling time: 21 hours (Note=In 10% serum), 42 hours (Note=In serum-free medium) (PubMed=6307857).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HRT-18
AC   CVCL_2514
SY   HRT18; Human Rectal Tumor-18
DR   BTO; BTO_0001947
DR   CLO; CLO_0003668
DR   CLO; CLO_0003836
DR   CLDB; cl1710
DR   CLDB; cl1711
DR   ATCC; CCL-244
DR   BCRJ; 0106
DR   BioSample; SAMN03471480
DR   BioSample; SAMN10989582
DR   cancercelllines; CVCL_2514
DR   CCLV; CCLV-RIE 0108
DR   Cell_Model_Passport; SIDM00788
DR   ChEMBL-Cells; CHEMBL3308672
DR   ChEMBL-Targets; CHEMBL614834
DR   CLS; 300230
DR   ColonAtlas; HRT18
DR   Cosmic; 724841
DR   DepMap; ACH-001091
DR   ECACC; 86040306
DR   GEO; GSM827431
DR   IZSLER; BS TCL 26
DR   LINCS_LDP; LCL-1289
DR   PharmacoDB; HRT18_567_2019
DR   Progenetix; CVCL_2514
DR   PubChem_Cell_line; CVCL_2514
DR   Wikidata; Q54895337
RX   PubMed=3349466;
RX   PubMed=9809040;
RX   PubMed=12068308;
RX   PubMed=20215515;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,24:02:01; B*08:01:01,35:01:01; C*04:01:01,07:01:01; DPB1*01:01:01,04:01:01; DQA1*01:04:01,05:01:01; DQB1*02:01:01,05:03:01G; DRB1*03:01:01,14:54:01 (CLS=300230).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-001091).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (DepMap=ACH-001091).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.15%; East Asian, North=0.34%; East Asian, South=1.05%; South Asian=1.84%; European, North=63.7%; European, South=32.91% (PubMed=30894373).
CC   Discontinued: CLS; 300230; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): ATCC=CCL-244; CLS=300230; ECACC=86040306; IZSLER=BS TCL 26
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 11,17
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,11.3,12 (ATCC=CCL-244)
ST   D7S820: 10,12 (CLS=300230; ECACC=86040306; IZSLER=BS TCL 26)
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 9,14
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3449 ! __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   HRT-18G
AC   CVCL_2515
DR   CLO; CLO_0003837
DR   ATCC; CRL-3609
DR   ATCC; CRL-11663
DR   cancercelllines; CVCL_2515
DR   Wikidata; Q54895338
RX   Patent=US5580778;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11663.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-11663; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): ATCC=CRL-3609
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2514 ! HRT-18
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   HRTPT
AC   CVCL_WN15
SY   Human Renal Tubular Precursor TERT
DR   Wikidata; Q94288355
RX   PubMed=31078587;
CC   Characteristics: CD133+/CD24+ subpopulation of parent cell line that shows tubulogenic, adipogenic and osteogenic differentiation (PubMed=31078587).
CC   Doubling time: 79.2 hours (PubMed=31078587).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   Hs
AC   CVCL_W404
SY   HS
DR   CGH-DB; 9-1
DR   CGH-DB; 9161-4
DR   Wikidata; Q54895339
RX   PubMed=7530506;
RX   PubMed=10936422;
RX   PubMed=15215163;
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   Hs 1.Int
AC   CVCL_0638
DR   CLO; CLO_0003838
DR   ATCC; CRL-7820
DR   Wikidata; Q54895340
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
ST   Source(s): ATCC=CRL-7820
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D2S1338: 19,23
ST   D3S1358: 13,15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S292 ! Hs 1.Li
OI   CVCL_0639 ! Hs 1.Lu
OI   CVCL_0640 ! Hs 1.Sk/Mu
OI   CVCL_0641 ! Hs 1.Tes
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 1.Li
AC   CVCL_S292
DR   ATCC; CRL-7821
DR   Wikidata; Q54895341
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7821; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0638 ! Hs 1.Int
OI   CVCL_0639 ! Hs 1.Lu
OI   CVCL_0640 ! Hs 1.Sk/Mu
OI   CVCL_0641 ! Hs 1.Tes
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 6
//
ID   Hs 1.Lu
AC   CVCL_0639
SY   Hs 1
DR   CLO; CLO_0003839
DR   ATCC; CRL-7000
DR   BioSample; SAMN03472634
DR   Wikidata; Q54895342
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7000
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D2S1338: 19,23
ST   D3S1358: 13,15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0638 ! Hs 1.Int
OI   CVCL_S292 ! Hs 1.Li
OI   CVCL_0640 ! Hs 1.Sk/Mu
OI   CVCL_0641 ! Hs 1.Tes
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 1.Sk/Mu
AC   CVCL_0640
DR   CLO; CLO_0003840
DR   ATCC; CRL-7001
DR   Wikidata; Q54895343
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7001; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D10S1248: 13,15
ST   D12S391: 17,18
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D1S1656: 12,16
ST   D21S11: 29
ST   D22S1045: 15,17
ST   D2S1338: 19,23
ST   D2S441: 10,12
ST   D3S1358: 13,15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   DYS391: 11
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0638 ! Hs 1.Int
OI   CVCL_S292 ! Hs 1.Li
OI   CVCL_0639 ! Hs 1.Lu
OI   CVCL_0641 ! Hs 1.Tes
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   Hs 1.Tes
AC   CVCL_0641
SY   Hs1.Tes
DR   CLO; CLO_0003841
DR   CLO; CLO_0004249
DR   ATCC; CRL-7002
DR   ECACC; 97123004
DR   Wikidata; Q54895344
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
ST   Source(s): ATCC=CRL-7002
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D2S1338: 19,23
ST   D3S1358: 13,15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0638 ! Hs 1.Int
OI   CVCL_S292 ! Hs 1.Li
OI   CVCL_0639 ! Hs 1.Lu
OI   CVCL_0640 ! Hs 1.Sk/Mu
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 101.K
AC   CVCL_N605
DR   ATCC; CRL-7066
DR   Wikidata; Q54895345
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7066; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N606 ! Hs 101.T
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 101.T
AC   CVCL_N606
DR   ATCC; CRL-7067
DR   Wikidata; Q54895346
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7067; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N605 ! Hs 101.K
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 103.Sp/Th
AC   CVCL_0642
DR   CLO; CLO_0003842
DR   ATCC; CRL-7068
DR   BioSample; SAMN03472662
DR   Wikidata; Q54895347
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7068; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
ST   Source(s): ATCC=CRL-7068
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,13
ST   D5S818: 9,11
ST   D7S820: 10,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 104.Bl
AC   CVCL_N492
DR   ATCC; CRL-7069
DR   Wikidata; Q54895348
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7069; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0643 ! Hs 104.Sp/Th
SX   Female
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 104.Sp/Th
AC   CVCL_0643
DR   CLO; CLO_0003843
DR   ATCC; CRL-7070
DR   Wikidata; Q54895349
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7070; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N492 ! Hs 104.Bl
SX   Female
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 111.Bl
AC   CVCL_S090
DR   ATCC; CRL-7697
DR   Wikidata; Q54895350
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7697; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 112.Bl
AC   CVCL_N493
DR   ATCC; CRL-7071
DR   Wikidata; Q54895351
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7071; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N607 ! Hs 112.K
OI   CVCL_N608 ! Hs 112.Rt
OI   CVCL_0644 ! Hs 112.Sk
OI   CVCL_N609 ! Hs 112.Tes
OI   CVCL_N610 ! Hs 112.Tr
SX   Male
AG   >24FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 112.K
AC   CVCL_N607
DR   ATCC; CRL-7072
DR   Wikidata; Q54895352
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7072; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N493 ! Hs 112.Bl
OI   CVCL_N608 ! Hs 112.Rt
OI   CVCL_0644 ! Hs 112.Sk
OI   CVCL_N609 ! Hs 112.Tes
OI   CVCL_N610 ! Hs 112.Tr
SX   Male
AG   >24FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 112.Rt
AC   CVCL_N608
DR   ATCC; CRL-7073
DR   Wikidata; Q54895353
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7073; true.
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N493 ! Hs 112.Bl
OI   CVCL_N607 ! Hs 112.K
OI   CVCL_0644 ! Hs 112.Sk
OI   CVCL_N609 ! Hs 112.Tes
OI   CVCL_N610 ! Hs 112.Tr
SX   Male
AG   >24FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 112.Sk
AC   CVCL_0644
DR   CLO; CLO_0003844
DR   ATCC; CRL-7074
DR   BioSample; SAMN03472663
DR   Wikidata; Q54895354
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7074; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7074
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N493 ! Hs 112.Bl
OI   CVCL_N607 ! Hs 112.K
OI   CVCL_N608 ! Hs 112.Rt
OI   CVCL_N609 ! Hs 112.Tes
OI   CVCL_N610 ! Hs 112.Tr
SX   Male
AG   >24FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 112.Tes
AC   CVCL_N609
DR   ATCC; CRL-7075
DR   Wikidata; Q54895355
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7075; true.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N493 ! Hs 112.Bl
OI   CVCL_N607 ! Hs 112.K
OI   CVCL_N608 ! Hs 112.Rt
OI   CVCL_0644 ! Hs 112.Sk
OI   CVCL_N610 ! Hs 112.Tr
SX   Male
AG   >24FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 112.Tr
AC   CVCL_N610
DR   ATCC; CRL-7076
DR   Wikidata; Q54895356
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7076; true.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N493 ! Hs 112.Bl
OI   CVCL_N607 ! Hs 112.K
OI   CVCL_N608 ! Hs 112.Rt
OI   CVCL_0644 ! Hs 112.Sk
OI   CVCL_N609 ! Hs 112.Tes
SX   Male
AG   >24FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 115.Lu
AC   CVCL_0645
DR   CLO; CLO_0003845
DR   ATCC; CRL-7077
DR   BioSample; SAMN03472664
DR   Wikidata; Q54895357
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7077; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7077
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9.3,10
ST   TPOX: 10,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 124.Sg
AC   CVCL_N497
DR   ATCC; CRL-7078
DR   Wikidata; Q54895358
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7078; true.
CC   Derived from site: In situ; Fetal salivary gland, sublingual gland; UBERON=UBERON_0006297.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N498 ! Hs 124.Tg
SX   Female
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 124.Tg
AC   CVCL_N498
DR   ATCC; CRL-7079
DR   Wikidata; Q54895359
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7079; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N497 ! Hs 124.Sg
SX   Female
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 126.T
AC   CVCL_N499
SY   HS 126KT
DR   ATCC; CRL-7080
DR   Wikidata; Q54895360
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7080; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 127.T
AC   CVCL_0646
SY   HS 127T
DR   CLO; CLO_0003846
DR   ATCC; CRL-7081
DR   BioSample; SAMN03472665
DR   Wikidata; Q54895361
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7081; true.
ST   Source(s): ATCC=CRL-7081
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 128.Br
AC   CVCL_N630
DR   ATCC; CRL-7082
DR   Wikidata; Q54895362
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7082; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   Hs 129.Br
AC   CVCL_N631
DR   ATCC; CRL-7083
DR   Wikidata; Q54895363
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7083; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   Hs 13.Sk
AC   CVCL_0647
DR   CLO; CLO_0003847
DR   ATCC; CRL-7011
DR   BioSample; SAMN03472639
DR   Wikidata; Q54895364
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7011; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7011
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 6,8
ST   vWA: 16,22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N305 ! Hs 13.T
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 13.T
AC   CVCL_N305
DR   ATCC; CRL-7010
DR   Wikidata; Q54895365
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7010; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0647 ! Hs 13.Sk
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 130.Br
AC   CVCL_N632
DR   ATCC; CRL-7084
DR   Wikidata; Q54895367
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7084; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   Hs 132.T
AC   CVCL_0648
DR   CLO; CLO_0003848
DR   ATCC; CRL-7085
DR   BioSample; SAMN03472666
DR   FANTOM5_SSTAR; 10737-110B8
DR   GEO; GSM1676364
DR   GEO; GSM1701693
DR   Wikidata; Q54895376
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7085
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 15,19
ST   D19S433: 12,15
ST   D21S11: 27,30
ST   D2S1338: 20,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   Penta D: 7,11
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C27005; Spindle cell sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   Hs 133.Br
AC   CVCL_N633
DR   ATCC; CRL-7086
DR   Wikidata; Q54895377
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7086; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   Hs 137.Fs
AC   CVCL_0649
DR   CLO; CLO_0003849
DR   ATCC; CRL-7087
DR   Wikidata; Q54895378
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7087; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 139.Br
AC   CVCL_N634
DR   ATCC; CRL-7088
DR   Wikidata; Q54895379
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7088; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   Hs 14.Mu
AC   CVCL_N519
DR   ATCC; CRL-7012
DR   Wikidata; Q54895380
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7012; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0650 ! Hs 14.T
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 14.T
AC   CVCL_0650
SY   HS 14T
DR   CLO; CLO_0003850
DR   ATCC; CRL-7823
DR   BioSample; SAMN03471103
DR   Wikidata; Q54895381
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7823; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7823
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N519 ! Hs 14.Mu
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 140.T
AC   CVCL_S296
DR   ATCC; CRL-7830
DR   Wikidata; Q54895382
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7830; true.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 141.T
AC   CVCL_N635
DR   ATCC; CRL-7089
DR   Wikidata; Q54895383
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7089; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 142.Sp
AC   CVCL_0651
DR   CLO; CLO_0003851
DR   ATCC; CRL-7090
DR   BioSample; SAMN03472667
DR   Wikidata; Q54895384
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7090; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-7090
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0652 ! Hs 142.Th
SX   Female
AG   12D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 142.Th
AC   CVCL_0652
DR   CLO; CLO_0003852
DR   ATCC; CRL-7091
DR   Wikidata; Q54895385
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7091; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
ST   Source(s): ATCC=CRL-7091
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0651 ! Hs 142.Sp
SX   Female
AG   12D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 143.We
AC   CVCL_0653
SY   Hs143We
DR   CLO; CLO_0003853
DR   ATCC; CRL-7092
DR   BioSample; SAMN03472669
DR   Wikidata; Q54895386
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7092
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 10,17
ST   Penta E: 7,15
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 144.We
AC   CVCL_0654
DR   CLO; CLO_0003854
DR   ATCC; CRL-7093
DR   BioSample; SAMN03472670
DR   Wikidata; Q54895387
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7093; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7093
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 146.Fs
AC   CVCL_N636
DR   ATCC; CRL-7094
DR   Wikidata; Q54895388
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7094; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 148.T
AC   CVCL_N637
DR   ATCC; CRL-7095
DR   Wikidata; Q54895389
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7095; true.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 15.Mu
AC   CVCL_N520
DR   ATCC; CRL-7013
DR   Wikidata; Q54895390
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7013; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0655 ! Hs 15.T
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 15.T
AC   CVCL_0655
DR   CLO; CLO_0003855
DR   ATCC; CRL-7824
DR   Wikidata; Q54895391
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7824; true.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N520 ! Hs 15.Mu
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 150.Bl
AC   CVCL_N638
DR   ATCC; CRL-7096
DR   Wikidata; Q54895392
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7096; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N639 ! Hs 150.K
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 150.K
AC   CVCL_N639
DR   ATCC; CRL-7097
DR   Wikidata; Q54895393
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7097; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N638 ! Hs 150.Bl
SX   Female
AG   18FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 151.K
AC   CVCL_S297
DR   ATCC; CRL-7831
DR   Wikidata; Q54895394
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7831; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S298 ! Hs 151.Pan
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 151.Pan
AC   CVCL_S298
DR   ATCC; CRL-7832
DR   Wikidata; Q54895395
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7832; true.
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S297 ! Hs 151.K
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 154.Fs
AC   CVCL_0656
DR   CLO; CLO_0003856
DR   ATCC; CRL-7098
DR   Wikidata; Q54895396
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7098; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 155.Pan
AC   CVCL_N546
DR   ATCC; CRL-7099
DR   Wikidata; Q54895397
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7099; true.
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N547 ! Hs 155.Pg
OI   CVCL_N548 ! Hs 155.Smg
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 155.Pg
AC   CVCL_N547
DR   ATCC; CRL-7100
DR   Wikidata; Q54895398
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7100; true.
CC   Derived from site: In situ; Fetal salivary gland, parotid gland; UBERON=UBERON_0008801.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N546 ! Hs 155.Pan
OI   CVCL_N548 ! Hs 155.Smg
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 155.Smg
AC   CVCL_N548
DR   ATCC; CRL-7101
DR   Wikidata; Q54895399
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7101; true.
CC   Derived from site: In situ; Fetal salivary gland, sublingual gland; UBERON=UBERON_0006297.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N546 ! Hs 155.Pan
OI   CVCL_N547 ! Hs 155.Pg
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 156.T
AC   CVCL_0657
DR   CLO; CLO_0003857
DR   ATCC; CRL-7102
DR   BioSample; SAMN03472671
DR   Wikidata; Q54895400
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7102; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7102
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 157.Br
AC   CVCL_N549
DR   ATCC; CRL-7103
DR   Wikidata; Q54895401
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7103; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N550 ! Hs 157.Int
OI   CVCL_N551 ! Hs 157.K
OI   CVCL_N552 ! Hs 157.Li
OI   CVCL_N553 ! Hs 157.Tg
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   Hs 157.Int
AC   CVCL_N550
DR   ATCC; CRL-7104
DR   Wikidata; Q54895402
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7104; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N549 ! Hs 157.Br
OI   CVCL_N551 ! Hs 157.K
OI   CVCL_N552 ! Hs 157.Li
OI   CVCL_N553 ! Hs 157.Tg
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 157.K
AC   CVCL_N551
DR   ATCC; CRL-7105
DR   Wikidata; Q54895403
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7105; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N549 ! Hs 157.Br
OI   CVCL_N550 ! Hs 157.Int
OI   CVCL_N552 ! Hs 157.Li
OI   CVCL_N553 ! Hs 157.Tg
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 157.Li
AC   CVCL_N552
DR   ATCC; CRL-7106
DR   Wikidata; Q54895404
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7106; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N549 ! Hs 157.Br
OI   CVCL_N550 ! Hs 157.Int
OI   CVCL_N551 ! Hs 157.K
OI   CVCL_N553 ! Hs 157.Tg
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 157.Tg
AC   CVCL_N553
DR   ATCC; CRL-7107
DR   Wikidata; Q54895405
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7107; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N549 ! Hs 157.Br
OI   CVCL_N550 ! Hs 157.Int
OI   CVCL_N551 ! Hs 157.K
OI   CVCL_N552 ! Hs 157.Li
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 158.Sk
AC   CVCL_N554
DR   ATCC; CRL-7108
DR   Wikidata; Q54895406
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7108; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 159.Fs
AC   CVCL_N555
DR   ATCC; CRL-7109
DR   Wikidata; Q54895407
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7109; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 160.Ht
AC   CVCL_N556
DR   ATCC; CRL-7110
DR   Wikidata; Q54895408
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7110; true.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N557 ! Hs 160.K
OI   CVCL_N558 ! Hs 160.Lu
OI   CVCL_N559 ! Hs 160.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 160.K
AC   CVCL_N557
DR   ATCC; CRL-7111
DR   Wikidata; Q54895409
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7111; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N556 ! Hs 160.Ht
OI   CVCL_N558 ! Hs 160.Lu
OI   CVCL_N559 ! Hs 160.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 160.Lu
AC   CVCL_N558
DR   ATCC; CRL-7112
DR   Wikidata; Q54895410
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7112; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N556 ! Hs 160.Ht
OI   CVCL_N557 ! Hs 160.K
OI   CVCL_N559 ! Hs 160.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 160.Tes
AC   CVCL_N559
DR   ATCC; CRL-7113
DR   Wikidata; Q54895411
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7113; true.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N556 ! Hs 160.Ht
OI   CVCL_N557 ! Hs 160.K
OI   CVCL_N558 ! Hs 160.Lu
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 161.Cn
AC   CVCL_N560
DR   ATCC; CRL-7114
DR   Wikidata; Q54895412
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7114; true.
CC   Derived from site: In situ; Fetal eye, cornea; UBERON=UBERON_0005427.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N561 ! Hs 161.Ht
OI   CVCL_N562 ! Hs 161.Sk
OI   CVCL_N563 ! Hs 161.Tg
SX   Sex unspecified
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 161.Ht
AC   CVCL_N561
DR   ATCC; CRL-7115
DR   Wikidata; Q54895413
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7115; true.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N560 ! Hs 161.Cn
OI   CVCL_N562 ! Hs 161.Sk
OI   CVCL_N563 ! Hs 161.Tg
SX   Sex unspecified
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 161.Sk
AC   CVCL_N562
DR   ATCC; CRL-7116
DR   Wikidata; Q54895414
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7116; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N560 ! Hs 161.Cn
OI   CVCL_N561 ! Hs 161.Ht
OI   CVCL_N563 ! Hs 161.Tg
SX   Sex unspecified
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 161.Tg
AC   CVCL_N563
DR   ATCC; CRL-7117
DR   Wikidata; Q54895415
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7117; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N560 ! Hs 161.Cn
OI   CVCL_N561 ! Hs 161.Ht
OI   CVCL_N562 ! Hs 161.Sk
SX   Sex unspecified
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 165.Fs
AC   CVCL_0658
DR   CLO; CLO_0003858
DR   ATCC; CRL-7118
DR   Wikidata; Q54895422
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7118; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 166.Bl
AC   CVCL_N564
DR   ATCC; CRL-7119
DR   Wikidata; Q54895423
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7119; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N565 ! Hs 166.Li
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 166.Li
AC   CVCL_N565
DR   ATCC; CRL-7120
DR   Wikidata; Q54895424
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7120; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N564 ! Hs 166.Bl
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 167.Fs
AC   CVCL_N566
DR   ATCC; CRL-7121
DR   Wikidata; Q54895425
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7121; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 168.Fs
AC   CVCL_0659
DR   CLO; CLO_0003859
DR   ATCC; CRL-7122
DR   BioSample; SAMN03472672
DR   Wikidata; Q54895426
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7122; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7122
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 172.T
AC   CVCL_0660
SY   Hs-172-T; Hs172T; HS172T
DR   CLO; CLO_0003860
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7833
DR   BioSample; SAMN03471104
DR   BioSample; SAMN10988444
DR   cancercelllines; CVCL_0660
DR   Cell_Model_Passport; SIDM01616
DR   DepMap; ACH-000088
DR   GEO; GSM136248
DR   GEO; GSM887092
DR   GEO; GSM888163
DR   IARC_TP53; 30042
DR   LiGeA; CCLE_707
DR   PharmacoDB; Hs172_T_568_2019
DR   Progenetix; CVCL_0660
DR   Wikidata; Q54895427
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a urinary bladder carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000088).
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.56%; Native American=0.85%; East Asian, North=1.69%; East Asian, South=0%; South Asian=0%; European, North=67.59%; European, South=29.31% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7833; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7833
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 18,21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Hs 173.Sp
AC   CVCL_0661
DR   CLO; CLO_0003861
DR   ATCC; CRL-7123
DR   BioSample; SAMN03472673
DR   Wikidata; Q54895428
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7123; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7123
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0662 ! Hs 173.We
OI   CVCL_3308 ! FHs 173We
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 173.We
AC   CVCL_0662
DR   CLO; CLO_0003862
DR   ATCC; CRL-7834
DR   Wikidata; Q54895429
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7834; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0661 ! Hs 173.Sp
OI   CVCL_3308 ! FHs 173We
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 174.We
AC   CVCL_0663
DR   CLO; CLO_0003863
DR   ATCC; CRL-7124
DR   BioSample; SAMN03472674
DR   Wikidata; Q54895430
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7124; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7124
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 12,14
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 175.T
AC   CVCL_N567
DR   ATCC; CRL-7125
DR   Wikidata; Q54895431
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7125; true.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 18.Fs
AC   CVCL_0664
DR   CLO; CLO_0003864
DR   ATCC; CRL-7014
DR   BioSample; SAMN03472640
DR   Wikidata; Q54895432
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7014; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7014
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 13,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 181.Bm
AC   CVCL_N568
SY   181BM
DR   ATCC; CRL-7126
DR   Wikidata; Q54895433
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7126; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N569 ! Hs 181.Gb
OI   CVCL_N570 ! Hs 181.Li
OI   CVCL_N571 ! Hs 181.St
OI   CVCL_0665 ! Hs 181.Sk
OI   CVCL_0666 ! Hs 181.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 181.Gb
AC   CVCL_N569
DR   AddexBio; P0037001/4963
DR   ATCC; CRL-7127
DR   Wikidata; Q54895435
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7127; true.
CC   Derived from site: In situ; Fetal gallbladder; UBERON=UBERON_0006242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N568 ! Hs 181.Bm
OI   CVCL_N570 ! Hs 181.Li
OI   CVCL_N571 ! Hs 181.St
OI   CVCL_0665 ! Hs 181.Sk
OI   CVCL_0666 ! Hs 181.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 181.Li
AC   CVCL_N570
DR   ATCC; CRL-7128
DR   Wikidata; Q54895436
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7128; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N568 ! Hs 181.Bm
OI   CVCL_N569 ! Hs 181.Gb
OI   CVCL_N571 ! Hs 181.St
OI   CVCL_0665 ! Hs 181.Sk
OI   CVCL_0666 ! Hs 181.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 181.Sk
AC   CVCL_0665
DR   CLO; CLO_0003865
DR   ATCC; CRL-7129
DR   BioSample; SAMN03472675
DR   Wikidata; Q54895437
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7129; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7129
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,13
ST   D16S539: 12
ST   D5S818: 8,12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N568 ! Hs 181.Bm
OI   CVCL_N569 ! Hs 181.Gb
OI   CVCL_N570 ! Hs 181.Li
OI   CVCL_N571 ! Hs 181.St
OI   CVCL_0666 ! Hs 181.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 181.St
AC   CVCL_N571
DR   ATCC; CRL-7130
DR   Wikidata; Q54895438
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7130; true.
CC   Derived from site: In situ; Fetal stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N568 ! Hs 181.Bm
OI   CVCL_N569 ! Hs 181.Gb
OI   CVCL_N570 ! Hs 181.Li
OI   CVCL_0665 ! Hs 181.Sk
OI   CVCL_0666 ! Hs 181.Tes
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 181.Tes
AC   CVCL_0666
DR   CLO; CLO_0003866
DR   ATCC; CRL-7131
DR   BCRC; 60317
DR   Lonza; 1403
DR   Wikidata; Q54895439
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7131
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,13
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 8,12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 15,16
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N568 ! Hs 181.Bm
OI   CVCL_N569 ! Hs 181.Gb
OI   CVCL_N570 ! Hs 181.Li
OI   CVCL_0665 ! Hs 181.Sk
OI   CVCL_N571 ! Hs 181.St
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 183.T
AC   CVCL_S299
DR   ATCC; CRL-7835
DR   Wikidata; Q54895440
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7835; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3756; Mixed embryonal carcinoma and teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 184.Mu
AC   CVCL_N572
DR   ATCC; CRL-7132
DR   Wikidata; Q54895441
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7132; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0667 ! Hs 184.Sk
OI   CVCL_0668 ! Hs 184.T
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 184.Sk
AC   CVCL_0667
DR   CLO; CLO_0003867
DR   ATCC; CRL-7133
DR   BioSample; SAMN03472676
DR   Wikidata; Q54895442
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7133; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7133
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N572 ! Hs 184.Mu
OI   CVCL_0668 ! Hs 184.T
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 184.T
AC   CVCL_0668
DR   CLO; CLO_0003868
DR   ATCC; CRL-7134
DR   Wikidata; Q54895443
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7134
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,18
ST   D19S433: 13,16
ST   D21S11: 31.2,32.2
ST   D2S1338: 18,19
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,12
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 12
ST   vWA: 15,16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N572 ! Hs 184.Mu
OI   CVCL_0667 ! Hs 184.Sk
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 185.T
AC   CVCL_N466
DR   ATCC; CRL-7135
DR   Wikidata; Q54895444
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7135; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 186.Int
AC   CVCL_N573
DR   ATCC; CRL-7136
DR   Wikidata; Q54895445
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7136; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N574 ! Hs 186.Li
OI   CVCL_0669 ! Hs 186.Sk
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 186.Li
AC   CVCL_N574
DR   ATCC; CRL-7137
DR   Wikidata; Q54895446
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7137; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N573 ! Hs 186.Int
OI   CVCL_0669 ! Hs 186.Sk
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 186.Sk
AC   CVCL_0669
DR   CLO; CLO_0003869
DR   ATCC; CRL-7138
DR   Wikidata; Q54895447
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7138; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N573 ! Hs 186.Int
OI   CVCL_N574 ! Hs 186.Li
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 187.T
AC   CVCL_N467
SY   Hs-187-T; Hs187T
DR   ATCC; CRL-7139
DR   Cosmic; 1609547
DR   Wikidata; Q54895448
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7139; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 188.T
AC   CVCL_0670
DR   CLO; CLO_0003870
DR   ATCC; CRL-7140
DR   BioSample; SAMN03472677
DR   Wikidata; Q54895449
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7140; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7140
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 189.Bl
AC   CVCL_N575
DR   ATCC; CRL-7141
DR   Wikidata; Q54895450
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7141; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S300 ! Hs 189.Int
OI   CVCL_N576 ! Hs 189.K
OI   CVCL_N577 ! Hs 189.Tes
OI   CVCL_N578 ! Hs 189.Tg
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 189.Int
AC   CVCL_S300
DR   ATCC; CRL-7836
DR   Wikidata; Q54895451
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7836; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N575 ! Hs 189.Bl
OI   CVCL_N576 ! Hs 189.K
OI   CVCL_N577 ! Hs 189.Tes
OI   CVCL_N578 ! Hs 189.Tg
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 189.K
AC   CVCL_N576
DR   ATCC; CRL-7142
DR   Wikidata; Q54895452
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7142; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N575 ! Hs 189.Bl
OI   CVCL_S300 ! Hs 189.Int
OI   CVCL_N577 ! Hs 189.Tes
OI   CVCL_N578 ! Hs 189.Tg
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 189.Tes
AC   CVCL_N577
DR   ATCC; CRL-7143
DR   Wikidata; Q54895453
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7143; true.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N575 ! Hs 189.Bl
OI   CVCL_S300 ! Hs 189.Int
OI   CVCL_N576 ! Hs 189.K
OI   CVCL_N578 ! Hs 189.Tg
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 189.Tg
AC   CVCL_N578
DR   ATCC; CRL-7144
DR   Wikidata; Q54895454
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7144; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N575 ! Hs 189.Bl
OI   CVCL_S300 ! Hs 189.Int
OI   CVCL_N576 ! Hs 189.K
OI   CVCL_N577 ! Hs 189.Tes
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 190.T
AC   CVCL_0671
DR   CLO; CLO_0003871
DR   ATCC; CRL-7145
DR   Wikidata; Q54895455
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7145; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 191.T
AC   CVCL_N579
DR   ATCC; CRL-7146
DR   Wikidata; Q54895456
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7146; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 192.T
AC   CVCL_N580
DR   ATCC; CRL-7147
DR   Wikidata; Q54895457
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7147; true.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 193.Li
AC   CVCL_S091
DR   ATCC; CRL-7698
DR   Wikidata; Q54895458
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7698; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0672 ! Hs 193.Sp
OI   CVCL_N581 ! Hs 193.Th
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 193.Sp
AC   CVCL_0672
DR   CLO; CLO_0003872
DR   ATCC; CRL-7148
DR   BioSample; SAMN03472678
DR   Wikidata; Q54895459
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7148; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7148
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S091 ! Hs 193.Li
OI   CVCL_N581 ! Hs 193.Th
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 193.Th
AC   CVCL_N581
DR   ATCC; CRL-7149
DR   Wikidata; Q54895460
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7149; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S091 ! Hs 193.Li
OI   CVCL_0672 ! Hs 193.Sp
SX   Male
AG   24FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 195.T
AC   CVCL_0673
SY   HS 195T
DR   CLO; CLO_0003873
DR   ATCC; CRL-7150
DR   BioSample; SAMN03472680
DR   Wikidata; Q54895461
RX   PubMed=6500159;
RX   PubMed=29732388;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7150; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-7150
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 9,13
ST   D7S820: 11,14
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 14,15
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 197.T
AC   CVCL_N582
DR   ATCC; CRL-7151
DR   Wikidata; Q54895462
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7151; true.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 198.Bl
AC   CVCL_N640
DR   ATCC; CRL-7152
DR   Wikidata; Q54895470
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7152; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N641 ! Hs 198.Bm
OI   CVCL_N642 ! Hs 198.Li
OI   CVCL_N643 ! Hs 198.St
OI   CVCL_0674 ! Hs 198.Ton
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 198.Bm
AC   CVCL_N641
DR   ATCC; CRL-7153
DR   Wikidata; Q54895471
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7153; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N640 ! Hs 198.Bl
OI   CVCL_N642 ! Hs 198.Li
OI   CVCL_N643 ! Hs 198.St
OI   CVCL_0674 ! Hs 198.Ton
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 198.Li
AC   CVCL_N642
DR   ATCC; CRL-7154
DR   Wikidata; Q54895472
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7154; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N640 ! Hs 198.Bl
OI   CVCL_N641 ! Hs 198.Bm
OI   CVCL_N643 ! Hs 198.St
OI   CVCL_0674 ! Hs 198.Ton
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 198.St
AC   CVCL_N643
DR   ATCC; CRL-7155
DR   Wikidata; Q54895473
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7155; true.
CC   Derived from site: In situ; Fetal stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N640 ! Hs 198.Bl
OI   CVCL_N641 ! Hs 198.Bm
OI   CVCL_N642 ! Hs 198.Li
OI   CVCL_0674 ! Hs 198.Ton
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 198.Ton
AC   CVCL_0674
DR   CLO; CLO_0003874
DR   ATCC; CRL-7156
DR   BioSample; SAMN03472681
DR   Wikidata; Q54895474
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7156; true.
CC   Derived from site: In situ; Fetal oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): ATCC=CRL-7156
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N640 ! Hs 198.Bl
OI   CVCL_N641 ! Hs 198.Bm
OI   CVCL_N642 ! Hs 198.Li
OI   CVCL_N643 ! Hs 198.St
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 199.Ad
AC   CVCL_N644
DR   ATCC; CRL-7157
DR   Wikidata; Q54895475
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7157; true.
CC   Derived from site: In situ; Fetal adrenal gland; UBERON=UBERON_0002369.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N645 ! Hs 199.Sk
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 199.Sk
AC   CVCL_N645
DR   ATCC; CRL-7158
DR   Wikidata; Q54895476
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7158; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N644 ! Hs 199.Ad
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 2.Li
AC   CVCL_N515
DR   ATCC; CRL-7004
DR   Wikidata; Q54895477
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7004; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0675 ! Hs 2.We
SX   Male
AG   <12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 2.We
AC   CVCL_0675
DR   CLO; CLO_0003875
DR   ATCC; CRL-7003
DR   BioSample; SAMN03472636
DR   Wikidata; Q54895478
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7003; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7003
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N515 ! Hs 2.Li
SX   Male
AG   <12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 200.T
AC   CVCL_0676
DR   CLO; CLO_0003876
DR   ATCC; CRL-7159
DR   Wikidata; Q54895479
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7159; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   Hs 201.Mu
AC   CVCL_N646
DR   ATCC; CRL-7160
DR   Wikidata; Q54895480
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7160; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0677 ! Hs 201.Sk
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 201.Sk
AC   CVCL_0677
DR   CLO; CLO_0003877
DR   ATCC; CRL-7161
DR   Wikidata; Q54895481
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7161; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N646 ! Hs 201.Mu
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 202.Sp
AC   CVCL_0678
DR   CLO; CLO_0003878
DR   ATCC; CRL-7162
DR   BioSample; SAMN03472682
DR   Wikidata; Q54895482
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7162; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7162
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0679 ! Hs 202.Th
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 202.Th
AC   CVCL_0679
DR   CLO; CLO_0003879
DR   ATCC; CRL-7163
DR   Wikidata; Q54895483
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
ST   Source(s): ATCC=CRL-7163
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 12,14
ST   D21S11: 29,30.2
ST   D2S1338: 18,19
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 21,23
ST   Penta D: 9,10
ST   Penta E: 15,19
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0678 ! Hs 202.Sp
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 203.Sp
AC   CVCL_0680
DR   CLO; CLO_0003880
DR   ATCC; CRL-7164
DR   BioSample; SAMN03472683
DR   Wikidata; Q54895484
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7164; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7164
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0681 ! Hs 203.Th
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 203.Th
AC   CVCL_0681
DR   CLO; CLO_0003881
DR   ATCC; CRL-7165
DR   Wikidata; Q54895485
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7165; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
ST   Source(s): ATCC=CRL-7165
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0680 ! Hs 203.Sp
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 204.Sp
AC   CVCL_0682
DR   CLO; CLO_0003882
DR   ATCC; CRL-7166
DR   BioSample; SAMN03472684
DR   Wikidata; Q54895486
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7166; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7166
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 205.T
AC   CVCL_N460
DR   ATCC; CRL-7167
DR   Wikidata; Q54895488
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7167; true.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 206.T
AC   CVCL_S445
DR   ATCC; CRL-7837
DR   Wikidata; Q54895489
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7837; true.
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 207.T
AC   CVCL_3519
SY   Hs-207-T; Hs 207 T; Hs207T
DR   ATCC; CRL-7168
DR   BioSample; SAMN03472685
DR   Cosmic; 1609490
DR   Wikidata; Q54895490
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7168; true.
ST   Source(s): ATCC=CRL-7168
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C43584; Rectosigmoid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 208.Sp
AC   CVCL_0683
DR   CLO; CLO_0003883
DR   ATCC; CRL-7169
DR   BioSample; SAMN03472686
DR   Wikidata; Q54895491
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7169; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7169
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 10,12
ST   D5S818: 7,9
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0684 ! Hs 208.Th
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 208.Th
AC   CVCL_0684
DR   CLO; CLO_0003884
DR   ATCC; CRL-7170
DR   Wikidata; Q54895492
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7170; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0683 ! Hs 208.Sp
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 209.Sp
AC   CVCL_0685
DR   CLO; CLO_0003885
DR   ATCC; CRL-7171
DR   BioSample; SAMN03472687
DR   Wikidata; Q54895493
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7171; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7171
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 12,13
ST   D16S539: 8,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 21.Fs
AC   CVCL_0686
DR   CLO; CLO_0003886
DR   ATCC; CRL-7015
DR   BioSample; SAMN03472641
DR   Wikidata; Q54895494
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7015; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7015
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11,13
ST   TH01: 6,7
ST   TPOX: 10,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 210.T
AC   CVCL_N468
DR   ATCC; CRL-7172
DR   Wikidata; Q54895495
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7172; true.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 212.M
AC   CVCL_6402
DR   ATCC; CRL-7173
DR   BioSample; SAMN03472688
DR   Wikidata; Q54895496
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7173; true.
CC   Derived from site: In situ; Fascia; UBERON=UBERON_0008982.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7173
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 13,15
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 214.T
AC   CVCL_N647
DR   ATCC; CRL-7174
DR   Wikidata; Q54895497
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7174; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   Hs 215.Ln
AC   CVCL_0687
DR   CLO; CLO_0003887
DR   ATCC; CRL-7175
DR   Wikidata; Q54895498
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7175; true.
CC   Derived from site: In situ; Mesenteric lymph node; UBERON=UBERON_0002509.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0688 ! Hs 215.Sp
OI   CVCL_0689 ! Hs 215.Th
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 215.Sp
AC   CVCL_0688
DR   CLO; CLO_0003888
DR   ATCC; CRL-7176
DR   BioSample; SAMN03472689
DR   Wikidata; Q54895499
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7176; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-7176
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0687 ! Hs 215.Ln
OI   CVCL_0689 ! Hs 215.Th
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 215.Th
AC   CVCL_0689
DR   CLO; CLO_0003889
DR   ATCC; CRL-7177
DR   Wikidata; Q54895500
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7177; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
ST   Source(s): ATCC=CRL-7177
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0687 ! Hs 215.Ln
OI   CVCL_0688 ! Hs 215.Sp
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 216.We
AC   CVCL_0690
DR   CLO; CLO_0003890
DR   ATCC; CRL-7178
DR   BioSample; SAMN03471524
DR   Wikidata; Q54895501
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7178; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7178
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 217.T
AC   CVCL_N469
DR   ATCC; CRL-7179
DR   Wikidata; Q54895502
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7179; true.
CC   Derived from site: Metastatic; Colon; UBERON=UBERON_0001155.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 7
//
ID   Hs 218.Lu
AC   CVCL_0691
DR   CLO; CLO_0003891
DR   ATCC; CRL-7180
DR   BioSample; SAMN03471525
DR   Wikidata; Q54895503
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7180; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7180
ST   Amelogenin: X
ST   CSF1PO: 7,13
ST   D13S317: 8,11
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N648 ! Hs 218.Sk
OI   CVCL_N649 ! Hs 218.Sp
OI   CVCL_N650 ! Hs 218.Th
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 218.Sk
AC   CVCL_N648
DR   ATCC; CRL-7181
DR   Wikidata; Q54895504
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7181; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0691 ! Hs 218.Lu
OI   CVCL_N649 ! Hs 218.Sp
OI   CVCL_N650 ! Hs 218.Th
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 218.Sp
AC   CVCL_N649
DR   ATCC; CRL-7182
DR   Wikidata; Q54895505
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7182; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0691 ! Hs 218.Lu
OI   CVCL_N648 ! Hs 218.Sk
OI   CVCL_N650 ! Hs 218.Th
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 218.Th
AC   CVCL_N650
DR   ATCC; CRL-7183
DR   Wikidata; Q54895506
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7183; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0691 ! Hs 218.Lu
OI   CVCL_N648 ! Hs 218.Sk
OI   CVCL_N649 ! Hs 218.Sp
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 219.T
AC   CVCL_0692
DR   CLO; CLO_0003892
DR   ATCC; CRL-7184
DR   Wikidata; Q54895507
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7184; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 220.Sp
AC   CVCL_N651
DR   ATCC; CRL-7185
DR   Wikidata; Q54895508
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7185; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N652 ! Hs 220.Th
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 220.Th
AC   CVCL_N652
DR   ATCC; CRL-7186
DR   Wikidata; Q54895509
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7186; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N651 ! Hs 220.Sp
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 221.Sp
AC   CVCL_0693
DR   CLO; CLO_0003893
DR   ATCC; CRL-7187
DR   Wikidata; Q54895510
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7187; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0694 ! Hs 221.Th
SX   Sex unspecified
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 221.Th
AC   CVCL_0694
DR   CLO; CLO_0003894
DR   ATCC; CRL-7188
DR   Wikidata; Q54895518
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7188; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0693 ! Hs 221.Sp
SX   Sex unspecified
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 222.Sp
AC   CVCL_0695
DR   CLO; CLO_0003895
DR   ATCC; CRL-7189
DR   BioSample; SAMN03471526
DR   Wikidata; Q54895519
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7189; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7189
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   11FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 224.T
AC   CVCL_N653
SY   HS 224T; Hs 224
DR   ATCC; CRL-7190
DR   Wikidata; Q54895520
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7190; true.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 225.Th
AC   CVCL_0696
DR   CLO; CLO_0003896
DR   ATCC; CRL-7191
DR   BioSample; SAMN03471527
DR   Wikidata; Q54895521
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
ST   Source(s): ATCC=CRL-7191
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 10,14
ST   D19S433: 14
ST   D21S11: 27,30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 8,14
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 8,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 227.T
AC   CVCL_N470
DR   ATCC; CRL-7192
DR   Wikidata; Q54895522
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7192; true.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 228.T
AC   CVCL_0697
SY   Hs228
DR   CLO; CLO_0003897
DR   ATCC; CRL-7193
DR   BioSample; SAMN03471529
DR   cancercelllines; CVCL_0697
DR   GEO; GSM136245
DR   GEO; GSM827357
DR   Progenetix; CVCL_0697
DR   Wikidata; Q54895523
RX   PubMed=20215515;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-7193
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 12,15
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 7,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Hs 229.T
AC   CVCL_0698
SY   Hs-229-T; Hs229T; HS229T
DR   CLO; CLO_0003898
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7194
DR   BioSample; SAMN03471528
DR   BioSample; SAMN10988156
DR   cancercelllines; CVCL_0698
DR   Cell_Model_Passport; SIDM01615
DR   DepMap; ACH-000131
DR   GEO; GSM887093
DR   GEO; GSM888164
DR   IARC_TP53; 30043
DR   LiGeA; CCLE_389
DR   PharmacoDB; Hs229_T_569_2019
DR   Progenetix; CVCL_0698
DR   Wikidata; Q54895525
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a lung adenocarcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000131).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.3%; East Asian, North=0%; East Asian, South=1.25%; South Asian=0.49%; European, North=68.77%; European, South=29.18% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7194; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-7194
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 14
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 230.Sp
AC   CVCL_0699
DR   CLO; CLO_0003899
DR   ATCC; CRL-7196
DR   Wikidata; Q54895526
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7196; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0700 ! Hs 230.Th
SX   Female
AG   17FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 230.Th
AC   CVCL_0700
DR   CLO; CLO_0003900
DR   ATCC; CRL-7195
DR   Wikidata; Q54895527
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7195; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0699 ! Hs 230.Sp
SX   Female
AG   17FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 232.Sp
AC   CVCL_0701
DR   CLO; CLO_0003901
DR   ATCC; CRL-7198
DR   Wikidata; Q54895528
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7198; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0702 ! Hs 232.Th
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 232.Th
AC   CVCL_0702
DR   CLO; CLO_0003902
DR   ATCC; CRL-7197
DR   Wikidata; Q54895529
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7197; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0701 ! Hs 232.Sp
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   Hs 234.Sp
AC   CVCL_N654
DR   ATCC; CRL-7199
DR   Wikidata; Q54895530
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7199; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0703 ! Hs 234.Th
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 234.Th
AC   CVCL_0703
DR   CLO; CLO_0003903
DR   ATCC; CRL-7200
DR   Wikidata; Q54895531
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7200; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N654 ! Hs 234.Sp
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 235.Sk
AC   CVCL_0704
DR   CLO; CLO_0003904
DR   ATCC; CRL-7201
DR   BioSample; SAMN03471530
DR   Wikidata; Q54895532
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7201
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 11,13
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D19S433: 14,14.2
ST   D21S11: 30,35
ST   D2S1338: 18
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 8,10
ST   Penta E: 7,15
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 237.T
AC   CVCL_M903
SY   Hs-237-T; Hs237T; Hs237
DR   ATCC; CRL-7202
DR   Cosmic; 1609507
DR   Wikidata; Q54895533
RX   PubMed=22282976;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7202; true.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 238.Sk
AC   CVCL_0705
DR   CLO; CLO_0003905
DR   ATCC; CRL-7203
DR   BioSample; SAMN03471531
DR   Wikidata; Q54895534
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7203; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7203
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D5S818: 10,13
ST   D7S820: 11,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M899 ! Hs 238.T
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 238.T
AC   CVCL_M899
DR   ATCC; CRL-7204
DR   Wikidata; Q54895535
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7204; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0705 ! Hs 238.Sk
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 239.Pe
AC   CVCL_M901
DR   ATCC; CRL-7205
DR   Wikidata; Q54895536
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7205; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   Hs 24.Fs
AC   CVCL_0706
DR   CLO; CLO_0003906
DR   ATCC; CRL-7016
DR   Wikidata; Q54895537
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7016; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 240.Pe
AC   CVCL_M902
DR   ATCC; CRL-7206
DR   Wikidata; Q54895538
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7206; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 241.T
AC   CVCL_N471
SY   Hs-241-T; Hs241T
DR   ATCC; CRL-7207
DR   Cosmic; 1609510
DR   Wikidata; Q54895539
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7207; true.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 242T
AC   CVCL_N618
DR   ATCC; HTB-145
DR   BioSample; SAMN03472719
DR   Wikidata; Q54895540
CC   Discontinued: ATCC; HTB-145; true.
ST   Source(s): ATCC=HTB-145
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 5,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 243.T
AC   CVCL_M900
DR   ATCC; CRL-7208
DR   Wikidata; Q54895541
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7208; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 246.T
AC   CVCL_N277
DR   ATCC; CRL-7209
DR   Wikidata; Q54895542
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7209; true.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 248.T
AC   CVCL_N655
DR   ATCC; CRL-7210
DR   Wikidata; Q54895543
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7210; true.
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 249.T
AC   CVCL_N304
SY   HS-249-T
DR   ATCC; CRL-7211
DR   Cosmic; 1303038
DR   Wikidata; Q54895544
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7211; true.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 25.T
AC   CVCL_N521
DR   ATCC; CRL-7017
DR   Wikidata; Q54895545
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7017; true.
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 252.T
AC   CVCL_N472
DR   ATCC; CRL-7212
DR   Wikidata; Q54895546
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7212; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 254.T
AC   CVCL_S447
DR   ATCC; CRL-7838
DR   Wikidata; Q54895547
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7838; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 255.T
AC   CVCL_0707
SY   Hs-255-T; Hs255T; HS255T; Hs255
DR   CLO; CLO_0003907
DR   EFO; EFO_0006584
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7213
DR   BioSample; SAMN03472961
DR   BioSample; SAMN10987994
DR   Cell_Model_Passport; SIDM01613
DR   ColonAtlas; Hs%20255.T
DR   Cosmic; 1609482
DR   DepMap; ACH-000199
DR   EGA; EGAS00001000610
DR   IARC_TP53; 30044
DR   LiGeA; CCLE_372
DR   PharmacoDB; Hs255_T_570_2019
DR   Wikidata; Q54895548
RX   DOI=10.1101/166199;
RX   PubMed=22282976;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a colorectal carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000199).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,29:02; B*14:02,44:02; C*05:01,05:01; DQB1*04:01,04:01; DRB1*03:08,14:06 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7213; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,14
ST   D18S51: 13
ST   D19S433: 13.2,14
ST   D21S11: 28,32.2
ST   D2S1338: 19,27
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8,14
ST   D8S1179: 16,17
ST   FGA: 24,27
ST   Penta D: 11,13
ST   Penta E: 11,12
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   Hs 257.T
AC   CVCL_0708
DR   CLO; CLO_0003908
DR   ATCC; CRL-7214
DR   BioSample; SAMN03471532
DR   LINCS_LDP; LCL-1179
DR   Wikidata; Q54895549
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-7214
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,20
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 11,13
ST   FGA: 19,21
ST   Penta D: 9,14
ST   Penta E: 17,18
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 26.Mu
AC   CVCL_N522
DR   ATCC; CRL-7018
DR   Wikidata; Q54895550
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7018; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 262.St
AC   CVCL_N656
DR   ATCC; CRL-7215
DR   Wikidata; Q54895551
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7215; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 265.T
AC   CVCL_N657
DR   ATCC; CRL-7216
DR   Wikidata; Q54895552
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7216; true.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 266.Pe
AC   CVCL_N473
DR   ATCC; CRL-7217
DR   Wikidata; Q54895554
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7217; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   58Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 4
//
ID   Hs 268.T
AC   CVCL_0709
DR   CLO; CLO_0003909
DR   ATCC; CRL-7218
DR   BioSample; SAMN03471533
DR   Wikidata; Q54895555
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7218; true.
ST   Source(s): ATCC=CRL-7218
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 270.T
AC   CVCL_N658
DR   ATCC; CRL-7219
DR   Wikidata; Q54895556
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7219; true.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 272.Pe
AC   CVCL_N474
DR   ATCC; CRL-7220
DR   Wikidata; Q54895557
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7220; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   Hs 273.T
AC   CVCL_N659
DR   ATCC; CRL-7221
DR   Wikidata; Q54895558
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7221; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3113; Hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 7
//
ID   Hs 274.T
AC   CVCL_0711
SY   Hs-274-T; Hs274T; HS274T; Hs 274
DR   CLO; CLO_0003911
DR   ATCC; CRL-7222
DR   BioSample; SAMN03471535
DR   BioSample; SAMN10988532
DR   cancercelllines; CVCL_0711
DR   Cell_Model_Passport; SIDM01592
DR   DepMap; ACH-000134
DR   GEO; GSM887094
DR   GEO; GSM888165
DR   IARC_TP53; 30045
DR   PharmacoDB; Hs274_T_571_2019
DR   Progenetix; CVCL_0711
DR   Wikidata; Q54895559
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a breast carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000134).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.6%; Native American=0%; East Asian, North=1.24%; East Asian, South=0.53%; South Asian=0.28%; European, North=67.67%; European, South=29.67% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7222
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 275.Sk
AC   CVCL_0712
DR   CLO; CLO_0003912
DR   ATCC; CRL-7223
DR   BioSample; SAMN03471536
DR   Wikidata; Q54895567
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7223; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7223
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 7,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N660 ! Hs 275.T
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 275.T
AC   CVCL_N660
DR   ATCC; CRL-7224
DR   Wikidata; Q54895568
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7224; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0712 ! Hs 275.Sk
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 277.T
AC   CVCL_0713
SY   HS 277T
DR   CLO; CLO_0003913
DR   ATCC; CRL-7225
DR   Wikidata; Q54895569
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7225; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   Hs 28.Fs
AC   CVCL_N523
DR   ATCC; CRL-7019
DR   Wikidata; Q54895570
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7019; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 280.T
AC   CVCL_0714
SY   HS 280T
DR   CLO; CLO_0003914
DR   ATCC; CRL-7226
DR   BioSample; SAMN03471537
DR   Wikidata; Q54895571
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7226; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7226
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 281.T
AC   CVCL_0715
SY   Hs-281-T; Hs281T; HS281T
DR   CLO; CLO_0003915
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7227
DR   BioSample; SAMN03471539
DR   BioSample; SAMN10988524
DR   cancercelllines; CVCL_0715
DR   Cell_Model_Passport; SIDM01594
DR   DepMap; ACH-000083
DR   GEO; GSM887095
DR   GEO; GSM888166
DR   IARC_TP53; 30046
DR   LiGeA; CCLE_907
DR   PharmacoDB; Hs281_T_572_2019
DR   Progenetix; CVCL_0715
DR   Wikidata; Q54895572
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a breast carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000083).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.57%; Native American=0.98%; East Asian, North=2.05%; East Asian, South=0%; South Asian=5.19%; European, North=31.57%; European, South=58.64% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7227; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7227
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Hs 284.Pe
AC   CVCL_0716
DR   CLO; CLO_0003916
DR   ATCC; CRL-7228
DR   BioSample; SAMN03471538
DR   Wikidata; Q54895573
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7228; true.
ST   Source(s): ATCC=CRL-7228
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 9,11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 285.T
AC   CVCL_N661
DR   ATCC; CRL-7229
DR   Wikidata; Q54895574
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7229; true.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 290.Ov
AC   CVCL_N662
DR   ATCC; CRL-7230
DR   Wikidata; Q54895575
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7230; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 291.T
AC   CVCL_S454
DR   ATCC; CRL-7839
DR   Wikidata; Q54895576
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7839; true.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 293.T
AC   CVCL_N663
DR   ATCC; CRL-7231
DR   Wikidata; Q54895577
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7231; true.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 294T
AC   CVCL_0331
SY   HS-294T; Hs-294T; HS-294-T; HS-294; Hs294T; HS294T; Hs294; HS294
DR   BTO; BTO_0003467
DR   CLO; CLO_0003917
DR   EFO; EFO_0006585
DR   MCCL; MCC:0000227
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-140
DR   BioGRID_ORCS_Cell_line; 178
DR   BioSample; SAMN03471454
DR   BioSample; SAMN10988350
DR   cancercelllines; CVCL_0331
DR   Cell_Model_Passport; SIDM00800
DR   CGH-DB; 9319-4
DR   ChEMBL-Cells; CHEMBL4523539
DR   ChEMBL-Targets; CHEMBL4523570
DR   Cosmic; 905232
DR   Cosmic; 933000
DR   DepMap; ACH-000014
DR   EGA; EGAS00001000610
DR   GEO; GSE52246
DR   GEO; GSM206511
DR   GEO; GSM274685
DR   GEO; GSM887096
DR   GEO; GSM888167
DR   IARC_TP53; 30047
DR   LiGeA; CCLE_572
DR   PharmacoDB; Hs294T_573_2019
DR   Progenetix; CVCL_0331
DR   PubChem_Cell_line; CVCL_0331
DR   Wikidata; Q54895578
RX   PubMed=265522;
RX   PubMed=327080;
RX   PubMed=375235;
RX   PubMed=478563;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=8755562;
RX   PubMed=11414198;
RX   PubMed=15467732;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=39175042;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,25:01; B*07:02,08:01; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15467732; DepMap=ACH-000014).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.39%; East Asian, North=0%; East Asian, South=0%; South Asian=0.34%; European, North=72.19%; European, South=27.07% (PubMed=30894373).
CC   Misspelling: HTB-140; Note=Based on the ATCC catalog number.
CC   Misspelling: HTB140; Note=Based on the ATCC catalog number.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-140; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 14,14.2
ST   D21S11: 30
ST   D2S1338: 17,24
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13,14 (ATCC=HTB-140)
ST   D8S1179: 14 (PubMed=25877200)
ST   FGA: 23,24
ST   Penta D: 13
ST   Penta E: 7,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   Hs 295.Sk
AC   CVCL_0717
DR   CLO; CLO_0003918
DR   ATCC; CRL-7232
DR   BioSample; SAMN03471540
DR   Wikidata; Q54895579
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7232; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7232
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0718 ! Hs 295.T
SX   Female
AG   83Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 295.T
AC   CVCL_0718
DR   CLO; CLO_0003919
DR   ATCC; CRL-7233
DR   Wikidata; Q54895580
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7233; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7233
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0717 ! Hs 295.Sk
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 296.Thd
AC   CVCL_N811
DR   ATCC; CRL-7234
DR   Wikidata; Q54895581
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7234; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 3.Sk
AC   CVCL_0719
DR   CLO; CLO_0003920
DR   ATCC; CRL-7006
DR   Wikidata; Q54895582
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7006; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0720 ! Hs 3.T
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 3.T
AC   CVCL_0720
DR   CLO; CLO_0003921
DR   ATCC; CRL-7005
DR   BioSample; SAMN03472637
DR   Wikidata; Q54895583
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7005; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7005
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 8,9.3
ST   TPOX: 7,8
ST   vWA: 17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0719 ! Hs 3.Sk
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 31.Th
AC   CVCL_N524
DR   ATCC; CRL-7020
DR   Wikidata; Q54895584
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7020; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5FM
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 313.Sk
AC   CVCL_S448
DR   ATCC; CRL-7840
DR   Wikidata; Q54895585
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7840; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0721 ! Hs 313.T
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 6
//
ID   Hs 313.T
AC   CVCL_0721
DR   CLO; CLO_0003922
DR   ATCC; CRL-7235
DR   BioSample; SAMN03471541
DR   Wikidata; Q54895586
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-7235
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,13
ST   D16S539: 10,14
ST   D18S51: 12,16
ST   D19S433: 13,15.2
ST   D21S11: 29,30
ST   D2S1338: 23,25
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S448 ! Hs 313.Sk
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   Hs 319.T
AC   CVCL_0722
DR   CLO; CLO_0003923
DR   ATCC; CRL-7236
DR   BioSample; SAMN03471542
DR   Wikidata; Q54895587
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7236; true.
ST   Source(s): ATCC=CRL-7236
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 322.Lu
AC   CVCL_N812
DR   ATCC; CRL-7237
DR   BioSample; SAMN03471543
DR   Wikidata; Q54895588
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7237; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7237
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 7,11
ST   TH01: 6,9.3
ST   TPOX: 9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N666 ! Hs 322.Sk
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 9
//
ID   Hs 322.Sk
AC   CVCL_N666
DR   ATCC; CRL-7238
DR   Wikidata; Q54895589
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7238; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N812 ! Hs 322.Lu
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 324.T
AC   CVCL_0723
DR   CLO; CLO_0003924
DR   ATCC; CRL-7239
DR   Wikidata; Q54895590
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7239; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C27349; Histiocytic sarcoma
DI   ORDO; Orphanet_86896; Histiocytic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   Hs 325.Ln
AC   CVCL_0724
DR   CLO; CLO_0003925
DR   ATCC; CRL-7240
DR   BioSample; SAMN03471544
DR   Wikidata; Q54895591
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7240; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-7240
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C26966; Chronic lymphadenitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   Hs 327.Fs
AC   CVCL_N667
DR   ATCC; CRL-7241
DR   Wikidata; Q54895592
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7241; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 329.T
AC   CVCL_0725
DR   CLO; CLO_0003926
DR   ATCC; CRL-7242
DR   BioSample; SAMN03471546
DR   Wikidata; Q54895593
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7242; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7242
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 34.T
AC   CVCL_S293
DR   ATCC; CRL-7825
DR   Wikidata; Q54895594
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7825; true.
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 340.Sk
AC   CVCL_N668
DR   ATCC; CRL-7243
DR   Wikidata; Q54895595
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7243; true.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 341.T
AC   CVCL_N807
DR   ATCC; CRL-7244
DR   Wikidata; Q54895596
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7244; true.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 343.T
AC   CVCL_0726
SY   Hs-343-T; Hs343T; HS343T
DR   CLO; CLO_0003927
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7245
DR   BioSample; SAMN03471547
DR   BioSample; SAMN10988552
DR   cancercelllines; CVCL_0726
DR   Cell_Model_Passport; SIDM01590
DR   DepMap; ACH-000184
DR   GEO; GSM887097
DR   GEO; GSM888168
DR   IARC_TP53; 30048
DR   LiGeA; CCLE_919
DR   PharmacoDB; Hs343_T_574_2019
DR   Progenetix; CVCL_0726
DR   Wikidata; Q54895598
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a breast carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000184).
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.49%; Native American=0%; East Asian, North=0.52%; East Asian, South=1.3%; South Asian=6.72%; European, North=33.67%; European, South=56.3% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7245
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 16,21
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 7,10
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   Penta D: 12,13
ST   Penta E: 12,13
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 344.T
AC   CVCL_0727
DR   CLO; CLO_0003928
DR   ATCC; CRL-7246
DR   BioSample; SAMN03471548
DR   Wikidata; Q54895599
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7246; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7246
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 347.T
AC   CVCL_N611
DR   ATCC; CRL-7247
DR   Wikidata; Q54895600
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7247; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 35.T
AC   CVCL_N525
SY   HS 35T
DR   ATCC; CRL-7021
DR   Wikidata; Q54895601
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7021; true.
DI   NCIt; C3739; Benign fibrous histiocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 350.T
AC   CVCL_0728
DR   CLO; CLO_0003929
DR   ATCC; CRL-7248
DR   BioSample; SAMN03471549
DR   Wikidata; Q54895602
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7248; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7248
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 352.Lu
AC   CVCL_N612
DR   ATCC; CRL-7249
DR   Wikidata; Q54895603
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7249; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N613 ! Hs 352.Sk
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 352.Sk
AC   CVCL_N613
DR   ATCC; CRL-7250
DR   GEO; GSM2887650
DR   GEO; GSM2887651
DR   Wikidata; Q54895604
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-7250; true.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N612 ! Hs 352.Lu
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   Hs 355.T
AC   CVCL_N614
DR   ATCC; CRL-7251
DR   Wikidata; Q54895605
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7251; true.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 357.T
AC   CVCL_0729
DR   CLO; CLO_0003930
DR   ATCC; CRL-7252
DR   BioSample; SAMN03471513
DR   Wikidata; Q54895606
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7252; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7252
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 11,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 36.T
AC   CVCL_N526
DR   ATCC; CRL-7022
DR   Wikidata; Q54895607
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7022; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 362.T
AC   CVCL_0730
SY   Hs362.T
DR   CLO; CLO_0003931
DR   ATCC; CRL-7253
DR   BioSample; SAMN03471514
DR   Wikidata; Q54895610
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7253
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13.2,16.2
ST   D21S11: 30,31.2
ST   D2S1338: 17,19
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 364.Ct
AC   CVCL_0731
DR   CLO; CLO_0003932
DR   ATCC; CRL-7254
DR   BioSample; SAMN03471515
DR   Wikidata; Q54895611
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7254; true.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7254
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 365.Ct
AC   CVCL_0732
DR   CLO; CLO_0003933
DR   ATCC; CRL-7255
DR   BioSample; SAMN03471516
DR   Wikidata; Q54895612
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7255; true.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7255
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 13
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 371.T
AC   CVCL_0733
DR   CLO; CLO_0003934
DR   ATCC; CRL-7256
DR   BioSample; SAMN03472825
DR   Wikidata; Q54895613
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7256
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 372.Sk
AC   CVCL_0734
DR   CLO; CLO_0003935
DR   ATCC; CRL-7257
DR   BioSample; SAMN03472826
DR   Wikidata; Q54895614
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7257; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7257
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13,14
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 11,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 377.T
AC   CVCL_N810
DR   ATCC; CRL-7258
DR   Wikidata; Q54895615
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7258; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 38.T
AC   CVCL_0735
SY   Hs38T
DR   CLO; CLO_0003936
DR   EFO; EFO_0006586
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-7826
DR   BioSample; SAMN03472520
DR   EGA; EGAS00001000610
DR   PharmacoDB; Hs38_T_575_2019
DR   Wikidata; Q54895616
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   HLA typing: A*02:05,02:05; B*35:08,58:01; C*07:01,07:01; DQA1*03:02,03:02 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=CRL-7826; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 15
ST   FGA: 25
ST   Penta D: 10
ST   Penta E: 19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C8110; Ovarian teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   Hs 382.T
AC   CVCL_N683
DR   ATCC; CRL-7259
DR   Wikidata; Q54895617
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7259; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 383.Sk
AC   CVCL_0736
DR   CLO; CLO_0003937
DR   ATCC; CRL-7842
DR   BioSample; SAMN03471105
DR   Wikidata; Q54895618
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7842; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7842
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,11
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N684 ! Hs 383.T
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 383.T
AC   CVCL_N684
DR   ATCC; CRL-7260
DR   Wikidata; Q54895619
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7260; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0736 ! Hs 383.Sk
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 385.T
AC   CVCL_N685
DR   ATCC; CRL-7261
DR   Wikidata; Q54895620
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7261; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 386.Sk
AC   CVCL_N686
DR   ATCC; CRL-7262
DR   Wikidata; Q54895621
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7262; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 387.T
AC   CVCL_0737
DR   CLO; CLO_0003938
DR   ATCC; CRL-7263
DR   BioSample; SAMN03472828
DR   Wikidata; Q54895622
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7263; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7263
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 17,19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 388.T
AC   CVCL_N615
DR   ATCC; CRL-7264
DR   Wikidata; Q54895623
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7264; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   Hs 389(A).Lu
AC   CVCL_0738
DR   CLO; CLO_0003939
DR   ATCC; CRL-7265
DR   BioSample; SAMN03472829
DR   Wikidata; Q54895624
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Donor information: Established from dizygotic twin of Hs 389(B).Lu (Cellosaurus=CVCL_0739).
CC   Discontinued: ATCC; CRL-7265; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7265
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 389(B).Lu
AC   CVCL_0739
DR   CLO; CLO_0003940
DR   ATCC; CRL-7266
DR   BioSample; SAMN03471517
DR   Wikidata; Q54895625
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Donor information: Established from dizygotic twin of Hs 389(A).Lu (Cellosaurus=CVCL_0738).
CC   Discontinued: ATCC; CRL-7266; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7266
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 39.T
AC   CVCL_0740
DR   CLO; CLO_0003941
DR   ATCC; CRL-7023
DR   BioSample; SAMN03472642
DR   Wikidata; Q54895627
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7023
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,17
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 391.We
AC   CVCL_0741
DR   CLO; CLO_0003942
DR   ATCC; CRL-7267
DR   BioSample; SAMN03471518
DR   Wikidata; Q54895628
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7267; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7267
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 392.Sk
AC   CVCL_0742
SY   392SK
DR   CLO; CLO_0003943
DR   ATCC; CRL-7268
DR   BioSample; SAMN03471520
DR   Wikidata; Q54895629
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7268; true.
CC   Derived from site: In situ; Finger, skin; UBERON=UBERON_0003533.
ST   Source(s): ATCC=CRL-7268
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 394.Lu
AC   CVCL_0743
DR   CLO; CLO_0003944
DR   ATCC; CRL-7269
DR   BioSample; SAMN03471519
DR   Wikidata; Q54895630
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7269; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7269
ST   Amelogenin: X,Y
ST   CSF1PO: 7
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0744 ! Hs 394.Sk
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 394.Sk
AC   CVCL_0744
DR   CLO; CLO_0003945
DR   ATCC; CRL-7270
DR   Wikidata; Q54895631
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7270; true.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7270
ST   Amelogenin: X,Y
ST   CSF1PO: 7
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0743 ! Hs 394.Lu
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 395.We
AC   CVCL_6403
DR   ATCC; CRL-7271
DR   BioSample; SAMN03471521
DR   Wikidata; Q54895632
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7271; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7271
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,7,9
ST   TPOX: 6,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 396.We
AC   CVCL_S452
DR   ATCC; CRL-7841
DR   Wikidata; Q54895634
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7841; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 397.Lu
AC   CVCL_0745
DR   CLO; CLO_0003946
DR   ATCC; CRL-7272
DR   BioSample; SAMN03471522
DR   Wikidata; Q54895635
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7272; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7272
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 398.T
AC   CVCL_3520
DR   ATCC; CRL-7273
DR   Wikidata; Q54895636
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7273; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   Hs 399.Li
AC   CVCL_0746
DR   CLO; CLO_0003947
DR   ATCC; CRL-7274
DR   Wikidata; Q54895637
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7274; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 4.Bm
AC   CVCL_N518
DR   ATCC; CRL-7009
DR   Wikidata; Q54895638
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7009; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N517 ! Hs 4.Li
OI   CVCL_N516 ! Hs 4.We
SX   Male
AG   <12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 4.Li
AC   CVCL_N517
DR   ATCC; CRL-7008
DR   Wikidata; Q54895639
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7008; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N518 ! Hs 4.Bm
OI   CVCL_N516 ! Hs 4.We
SX   Male
AG   <12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 4.We
AC   CVCL_N516
DR   ATCC; CRL-7007
DR   BioSample; SAMN03472638
DR   Wikidata; Q54895640
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7007; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7007
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13,14
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N518 ! Hs 4.Bm
OI   CVCL_N517 ! Hs 4.Li
SX   Male
AG   <12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 401.Lu
AC   CVCL_0747
DR   CLO; CLO_0003948
DR   ATCC; CRL-7275
DR   BioSample; SAMN03471550
DR   Wikidata; Q54895641
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7275; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7275
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 8,9
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 402.Sk
AC   CVCL_0748
DR   CLO; CLO_0003949
DR   ATCC; CRL-7276
DR   BioSample; SAMN03471551
DR   Wikidata; Q54895642
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7276; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7276
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N475 ! Hs 402.T
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 402.T
AC   CVCL_N475
DR   ATCC; CRL-7277
DR   Wikidata; Q54895643
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7277; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0748 ! Hs 402.Sk
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 404.Sk
AC   CVCL_0749
DR   CLO; CLO_0003950
DR   ATCC; CRL-7278
DR   Wikidata; Q54895644
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7278; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 405.Sk
AC   CVCL_0750
DR   CLO; CLO_0003951
DR   ATCC; CRL-7279
DR   Wikidata; Q54895645
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7279; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 407.Ov
AC   CVCL_N687
DR   ATCC; CRL-7280
DR   Wikidata; Q54895646
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7280; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 409.We
AC   CVCL_0751
DR   CLO; CLO_0003952
DR   ATCC; CRL-7281
DR   BioSample; SAMN03471554
DR   Wikidata; Q54895647
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7281; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7281
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 8,11
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 410.We
AC   CVCL_0752
DR   CLO; CLO_0003953
DR   ATCC; CRL-7282
DR   BioSample; SAMN03471555
DR   Wikidata; Q54895648
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7282; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7282
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 10,12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 411.We
AC   CVCL_N688
DR   ATCC; CRL-7283
DR   BioSample; SAMN03471556
DR   Wikidata; Q54895649
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7283; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7283
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 412.Li
AC   CVCL_N689
DR   ATCC; CRL-7284
DR   Wikidata; Q54895650
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7284; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0753 ! Hs 412.Lu
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   Hs 412.Lu
AC   CVCL_0753
DR   CLO; CLO_0003954
DR   ATCC; CRL-7285
DR   BioSample; SAMN03471557
DR   Wikidata; Q54895651
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7285; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
ST   Source(s): ATCC=CRL-7285
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N689 ! Hs 412.Li
SX   Male
AG   19FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 413.We
AC   CVCL_0754
DR   CLO; CLO_0003955
DR   ATCC; CRL-7286
DR   BioSample; SAMN03471558
DR   Wikidata; Q54895657
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7286; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7286
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 9,11
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 9,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 414.T
AC   CVCL_0755
SY   HS 414T
DR   CLO; CLO_0003956
DR   ATCC; CRL-7287
DR   GEO; GSM1676367
DR   GEO; GSM1701694
DR   Wikidata; Q54895658
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
ST   Source(s): ATCC=CRL-7287
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 14,16
ST   D21S11: 29,30
ST   D2S1338: 20,24
ST   D3S1358: 14,18
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 13
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 415.Sk
AC   CVCL_0756
DR   CLO; CLO_0003957
DR   ATCC; CRL-7288
DR   BioSample; SAMN03471559
DR   Wikidata; Q54895659
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7288; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7288
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 416.T
AC   CVCL_0757
DR   CLO; CLO_0003958
DR   ATCC; CRL-7289
DR   BioSample; SAMN03471560
DR   Wikidata; Q54895660
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7289
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D5S818: 8,11
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 6,11
ST   vWA: 14,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 417.Li
AC   CVCL_N616
DR   ATCC; CRL-7290
DR   Wikidata; Q54895661
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7290; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0758 ! Hs 417.Lu
SX   Female
AG   9FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 417.Lu
AC   CVCL_0758
SY   Hs417Lu
DR   CLO; CLO_0003959
DR   ATCC; CRL-7291
DR   cancercelllines; CVCL_0758
DR   GEO; GSM827498
DR   Progenetix; CVCL_0758
DR   Wikidata; Q54895662
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7291; true.
CC   Derived from site: In situ; Fetal lung, bronchus; UBERON=UBERON_0002185.
CC   Derived from site: In situ; Fetal lung; Note=Uncertainty of sampling site; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N616 ! Hs 417.Li
SX   Female
AG   9FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Hs 42.T
AC   CVCL_S294
DR   ATCC; CRL-7827
DR   Wikidata; Q54895663
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7827; true.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 421
AC   CVCL_N690
SY   Hs421Sk; 421SK
DR   ATCC; CRL-7292
DR   Wikidata; Q54895664
RX   PubMed=176412;
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7292; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 422.T
AC   CVCL_N617
DR   ATCC; CRL-7293
DR   Wikidata; Q54895665
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7293; true.
DI   NCIt; C3272; Neurofibroma
DI   ORDO; Orphanet_252183; Neurofibroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 425.T
AC   CVCL_N691
DR   ATCC; CRL-7294
DR   Wikidata; Q54895666
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7294; true.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 426.T
AC   CVCL_N692
DR   ATCC; CRL-7295
DR   Wikidata; Q54895667
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7295; true.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 427.Sp
AC   CVCL_N693
SY   HS 427sp
DR   ATCC; CRL-7296
DR   Wikidata; Q54895668
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7296; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 428.Li
AC   CVCL_N694
DR   ATCC; CRL-7297
DR   Wikidata; Q54895669
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7297; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 430.T
AC   CVCL_S453
DR   ATCC; CRL-7843
DR   Wikidata; Q54895670
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7843; true.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 431.T
AC   CVCL_0759
SY   Hs 431; Hs431
DR   CLO; CLO_0003960
DR   CLDB; cl1714
DR   ATCC; CRL-7298
DR   ECACC; 90011205
DR   Wikidata; Q54895671
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7298; true.
CC   Discontinued: ECACC; 90011205; true.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   Hs 432.T
AC   CVCL_2256
SY   Hs432.T
DR   CLO; CLO_0004253
DR   ATCC; CRL-7299
DR   Wikidata; Q54895672
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7299; true.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 439.T
AC   CVCL_S451
DR   ATCC; CRL-7844
DR   Wikidata; Q54895673
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7844; true.
DI   NCIt; C3404; Testicular neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 44.Fs
AC   CVCL_N619
DR   ATCC; CRL-7024
DR   Wikidata; Q54895674
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7024; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 443.T
AC   CVCL_0760
DR   CLO; CLO_0003961
DR   ATCC; CRL-7300
DR   BioSample; SAMN03471561
DR   Wikidata; Q54895675
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7300; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-7300
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C3113; Hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Hs 444(A).T
AC   CVCL_S246
DR   ATCC; CRL-7799
DR   Wikidata; Q54895676
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7799; true.
DI   NCIt; C7328; Testicular seminoma
DI   ORDO; Orphanet_842; Testicular seminomatous germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S251 ! Hs 444(B).T
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 444(B).T
AC   CVCL_S251
DR   ATCC; CRL-7800
DR   BioSample; SAMN03471156
DR   Wikidata; Q54895677
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7800; true.
ST   Source(s): ATCC=CRL-7800
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7328; Testicular seminoma
DI   ORDO; Orphanet_842; Testicular seminomatous germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S246 ! Hs 444(A).T
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 445
AC   CVCL_0761
SY   HS-445; Hs-445; HS 445T; Hs445; HS445
DR   CLO; CLO_0003962
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-146
DR   BioSample; SAMN03472720
DR   Cell_Model_Passport; SIDM00668
DR   Cosmic-CLP; 1322218
DR   DepMap; ACH-002245
DR   EGA; EGAS00001000978
DR   GDSC; 1322218
DR   GEO; GSM1669894
DR   LINCS_LDP; LCL-2006
DR   PharmacoDB; Hs445_613_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54895678
RX   PubMed=6500159;
RX   PubMed=11021758;
RX   PubMed=12592342;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=29533902).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.48%; Native American=0%; East Asian, North=1.04%; East Asian, South=0.01%; South Asian=0%; European, North=63.69%; European, South=34.78% (PubMed=30894373).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-146; Cosmic-CLP=1322218
ST   Amelogenin: X
ST   CSF1PO: 10.3,11 (ATCC=HTB-146)
ST   CSF1PO: 11 (Cosmic-CLP=1322218)
ST   D13S317: 11,13
ST   D16S539: 9 (Cosmic-CLP=1322218)
ST   D16S539: 9,11 (ATCC=HTB-146)
ST   D18S51: 13,15
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 20,24
ST   D3S1358: 16,18
ST   D5S818: 9,12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 24,26
ST   Penta D: 10,11
ST   Penta E: 12,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   Hs 446.Sk
AC   CVCL_0762
DR   CLO; CLO_0003963
DR   ATCC; CRL-7801
DR   Wikidata; Q54895679
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7801; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 45.Fs
AC   CVCL_0763
DR   CLO; CLO_0003964
DR   ATCC; CRL-7025
DR   BioSample; SAMN03472643
DR   Wikidata; Q54895680
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7025; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7025
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 454.T
AC   CVCL_0764
SY   Hs454.T
DR   CLO; CLO_0003965
DR   ATCC; CRL-7802
DR   BioSample; SAMN03471157
DR   Wikidata; Q54895681
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7802; true.
ST   Source(s): ATCC=CRL-7802
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3016; Eosinophilic granuloma
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   Hs 455.T
AC   CVCL_S252
DR   ATCC; CRL-7803
DR   Wikidata; Q54895682
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7803; true.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 456.Bt
AC   CVCL_0765
SY   Hs 456.BT
DR   CLO; CLO_0003966
DR   ATCC; CRL-7805
DR   Wikidata; Q54895683
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7805; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7805
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0766 ! Hs 456.Sk
OI   CVCL_D782 ! Hs 456.T
SX   Female
AG   80Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 456.Sk
AC   CVCL_0766
DR   CLO; CLO_0003967
DR   ATCC; CRL-7804
DR   BioSample; SAMN03471158
DR   Wikidata; Q54895684
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7804; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7804
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0765 ! Hs 456.Bt
OI   CVCL_D782 ! Hs 456.T
SX   Female
AG   80Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 456.T
AC   CVCL_D782
DR   ATCC; CRL-7806
DR   Wikidata; Q54895685
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7806; true.
DI   NCIt; C2921; Skin basal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0765 ! Hs 456.Bt
OI   CVCL_0766 ! Hs 456.Sk
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 46.Fs
AC   CVCL_0767
SY   Hs 46
DR   CLO; CLO_0003968
DR   ATCC; CRL-7026
DR   BioSample; SAMN03472644
DR   Wikidata; Q54895686
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7026; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-7026
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 466.Sk
AC   CVCL_0768
DR   CLO; CLO_0003969
DR   ATCC; CRL-7807
DR   Wikidata; Q54895687
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7807; true.
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 467.Sk
AC   CVCL_0769
DR   CLO; CLO_0003970
DR   ATCC; CRL-7808
DR   Wikidata; Q54895688
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7808; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D783 ! Hs 467.T
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 467.T
AC   CVCL_D783
SY   HS-467-T; HS467T
DR   ATCC; CRL-7809
DR   Cosmic; 897417
DR   Cosmic; 1044230
DR   Wikidata; Q54895689
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7809; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0769 ! Hs 467.Sk
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 468.Lu
AC   CVCL_0770
DR   CLO; CLO_0003971
DR   ATCC; CRL-7810
DR   Wikidata; Q54895690
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7810; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 469.Sk
AC   CVCL_0771
DR   CLO; CLO_0003972
DR   ATCC; CRL-7811
DR   Wikidata; Q54895691
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7811; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 474.T
AC   CVCL_S288
DR   ATCC; CRL-7812
DR   Wikidata; Q54895692
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7812; true.
DI   NCIt; C8712; Pineal region germinoma
DI   ORDO; Orphanet_91352; Germinoma of the central nervous system
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 479.T
AC   CVCL_0772
DR   CLO; CLO_0003973
DR   ATCC; CRL-7813
DR   Wikidata; Q54895693
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7813; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 48.Fs
AC   CVCL_0773
DR   CLO; CLO_0003974
DR   ATCC; CRL-7027
DR   BioSample; SAMN03472645
DR   Wikidata; Q54895694
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7027; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7027
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 483.Sk
AC   CVCL_0774
DR   CLO; CLO_0003975
DR   ATCC; CRL-7815
DR   Wikidata; Q54895695
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7815; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7815
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0775 ! Hs 483.T
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 483.T
AC   CVCL_0775
DR   CLO; CLO_0003976
DR   ATCC; CRL-7814
DR   BioSample; SAMN03471160
DR   Wikidata; Q54895696
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7814; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7814
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C2983; Dermatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0774 ! Hs 483.Sk
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 484.T
AC   CVCL_S289
DR   ATCC; CRL-7816
DR   Wikidata; Q54895701
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7816; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 485.T
AC   CVCL_S290
DR   ATCC; CRL-7817
DR   Wikidata; Q54895702
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7817; true.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
DI   NCIt; C3417; Tonsillar neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 49.Fs
AC   CVCL_0776
DR   CLO; CLO_0003977
DR   ATCC; CRL-7028
DR   Wikidata; Q54895703
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7028; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 491.T
AC   CVCL_0777
DR   CLO; CLO_0003978
DR   ATCC; CRL-7818
DR   Wikidata; Q54895704
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7818; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7540; Small lymphocytic lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   Hs 494
AC   CVCL_N695
DR   ATCC; CRL-7301
DR   Wikidata; Q54895705
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7301; true.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 496.Sk
AC   CVCL_G020
DR   ATCC; CRL-7302
DR   Wikidata; Q54895706
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7302; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G021 ! Hs 496.T
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 496.T
AC   CVCL_G021
SY   HS496T
DR   ATCC; CRL-7303
DR   Cosmic; 1044231
DR   Wikidata; Q54895707
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7303; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G020 ! Hs 496.Sk
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 5.T
AC   CVCL_0778
DR   CLO; CLO_0003979
DR   ATCC; CRL-7822
DR   BioSample; SAMN03471162
DR   FANTOM5_SSTAR; 10722-110A2
DR   Wikidata; Q54895708
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7822; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
ST   Source(s): ATCC=CRL-7822
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Hs 50.Bm
AC   CVCL_S088
DR   ATCC; CRL-7695
DR   Wikidata; Q54895709
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7695; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 503.Sk
AC   CVCL_N696
DR   ATCC; CRL-7304
DR   Wikidata; Q54895710
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7304; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 504.T
AC   CVCL_N697
DR   ATCC; CRL-7305
DR   Wikidata; Q54895711
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7305; true.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 505.T
AC   CVCL_0779
DR   CLO; CLO_0003980
DR   ATCC; CRL-7306
DR   BioSample; SAMN03471562
DR   Wikidata; Q54895712
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Donor information: Established from a patient suffering from a Kaposi sarcoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-7306
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 28,33.2
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 7,14
ST   TH01: 8,9
ST   TPOX: 6,8
ST   vWA: 15
DI   NCIt; C7540; Small lymphocytic lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   Hs 507.Sk
AC   CVCL_0780
DR   CLO; CLO_0003981
DR   ATCC; CRL-7307
DR   BioSample; SAMN03471563
DR   Wikidata; Q54895713
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7307; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7307
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N698 ! Hs 507.T
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 507.T
AC   CVCL_N698
DR   ATCC; CRL-7308
DR   Wikidata; Q54895714
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7308; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0780 ! Hs 507.Sk
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 51.Mu
AC   CVCL_N620
DR   ATCC; CRL-7029
DR   Wikidata; Q54895716
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7029; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3521 ! Hs 51.T
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 51.T
AC   CVCL_3521
DR   ATCC; CRL-7030
DR   BioSample; SAMN03472647
DR   Wikidata; Q54895717
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7030; true.
ST   Source(s): ATCC=CRL-7030
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D5S818: 10,12
ST   D7S820: 8,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C27005; Spindle cell sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N620 ! Hs 51.Mu
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 514.T
AC   CVCL_N699
DR   ATCC; CRL-7310
DR   Wikidata; Q54895718
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7310; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   Hs 517.Sk
AC   CVCL_0781
DR   CLO; CLO_0003982
DR   ATCC; CRL-7311
DR   BioSample; SAMN03471565
DR   Wikidata; Q54895719
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7311; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7311
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N757 ! Hs 517.T
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 517.T
AC   CVCL_N757
DR   ATCC; CRL-7312
DR   Wikidata; Q54895720
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7312; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0781 ! Hs 517.Sk
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 518.T
AC   CVCL_0782
DR   CLO; CLO_0003983
DR   ATCC; CRL-7313
DR   Wikidata; Q54895721
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7313; true.
DI   NCIt; C7540; Small lymphocytic lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Hs 52.Sk
AC   CVCL_0783
DR   CLO; CLO_0003984
DR   ATCC; CRL-7031
DR   BioSample; SAMN03472648
DR   Wikidata; Q54895722
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7031; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7031
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 8,9
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0784 ! Hs 52.Th
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   Hs 52.Th
AC   CVCL_0784
DR   CLO; CLO_0003985
DR   ATCC; CRL-7032
DR   Wikidata; Q54895723
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7032; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
ST   Source(s): ATCC=CRL-7032
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 8,9
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0783 ! Hs 52.Sk
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 523.Sk
AC   CVCL_0785
DR   CLO; CLO_0003986
DR   ATCC; CRL-7314
DR   BioSample; SAMN03471566
DR   Wikidata; Q54895724
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7314; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7314
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 53.T
AC   CVCL_0786
SY   Hs53.T; Hs53T; HS53T
DR   CLO; CLO_0003987
DR   ATCC; CRL-7033
DR   BioSample; SAMN03472649
DR   FANTOM5_SSTAR; 10729-110A9
DR   Wikidata; Q54895725
RX   PubMed=32076030;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7033; PubMed=32076030
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D18S51: 18,19
ST   D19S433: 13,14.2
ST   D21S11: 27,29
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,12
ST   FGA: 23,24
ST   Penta D: 9,11
ST   Penta E: 8,9
ST   TH01: 8,9
ST   TPOX: 7,9
ST   vWA: 15,16
DI   NCIt; C3272; Neurofibroma
DI   ORDO; Orphanet_252183; Neurofibroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   Hs 531.Sk
AC   CVCL_0787
SY   531SK
DR   CLO; CLO_0003988
DR   ATCC; CRL-7315
DR   BioSample; SAMN03471567
DR   Wikidata; Q54895726
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7315; true.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
ST   Source(s): ATCC=CRL-7315
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 7,11
ST   D7S820: 12
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 54.T
AC   CVCL_N476
DR   ATCC; CRL-7034
DR   Wikidata; Q54895727
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7034; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 540.T
AC   CVCL_0788
SY   Hs540.T
DR   CLO; CLO_0003989
DR   ATCC; CRL-7316
DR   BioSample; SAMN03471568
DR   Wikidata; Q54895728
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7316; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7316
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 544.Sk
AC   CVCL_0789
DR   CLO; CLO_0003990
DR   ATCC; CRL-7317
DR   Wikidata; Q54895729
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Misspelling: Hs 544..Sk; Note=Occasionally.
CC   Discontinued: ATCC; CRL-7317; true.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 545.Sk
AC   CVCL_0790
DR   CLO; CLO_0003991
DR   ATCC; CRL-7318
DR   BioSample; SAMN03471569
DR   Wikidata; Q54895730
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7318; true.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
ST   Source(s): ATCC=CRL-7318
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 547.Sk
AC   CVCL_N303
SY   547SK
DR   ATCC; CRL-7319
DR   Wikidata; Q54895731
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7319; true.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 548.Sk
AC   CVCL_0791
DR   CLO; CLO_0003992
DR   ATCC; CRL-7320
DR   Wikidata; Q54895732
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7320; true.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 55.Fs
AC   CVCL_0792
DR   CLO; CLO_0003993
DR   ATCC; CRL-7035
DR   BioSample; SAMN03472650
DR   Wikidata; Q54895733
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7035; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7035
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 556.Sk
AC   CVCL_0793
DR   CLO; CLO_0003994
DR   ATCC; CRL-7321
DR   Wikidata; Q54895734
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7321; true.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 559.Li
AC   CVCL_N302
DR   ATCC; CRL-7322
DR   Wikidata; Q54895735
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7322; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0794 ! Hs 559.Sk
SX   Sex unspecified
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 559.Sk
AC   CVCL_0794
DR   CLO; CLO_0003995
DR   ATCC; CRL-7323
DR   Wikidata; Q54895736
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7323; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N302 ! Hs 559.Li
SX   Sex unspecified
AG   >12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 56.Fs
AC   CVCL_0795
DR   CLO; CLO_0003996
DR   ATCC; CRL-7036
DR   Wikidata; Q54895737
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7036; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 561.Pl
AC   CVCL_N758
DR   ATCC; CRL-7324
DR   Wikidata; Q54895738
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7324; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 562.Pl
AC   CVCL_N759
DR   ATCC; CRL-7325
DR   Wikidata; Q54895739
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7325; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 564(A).T
AC   CVCL_N299
DR   ATCC; CRL-7326
DR   Wikidata; Q54895740
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7326; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N300 ! Hs 564(B).Mg
OI   CVCL_N301 ! Hs 564(C).Mg
OI   CVCL_0796 ! Hs 564(E).Mg
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 564(B).Mg
AC   CVCL_N300
DR   ATCC; CRL-7327
DR   Wikidata; Q54895741
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7327; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N299 ! Hs 564(A).T
OI   CVCL_N301 ! Hs 564(C).Mg
OI   CVCL_0796 ! Hs 564(E).Mg
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 564(C).Mg
AC   CVCL_N301
DR   ATCC; CRL-7328
DR   Wikidata; Q54895747
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7328; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N299 ! Hs 564(A).T
OI   CVCL_N300 ! Hs 564(B).Mg
OI   CVCL_0796 ! Hs 564(E).Mg
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 564(E).Mg
AC   CVCL_0796
DR   CLO; CLO_0003997
DR   ATCC; CRL-7329
DR   BioSample; SAMN03471571
DR   Wikidata; Q54895748
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7329
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12,13
ST   D16S539: 12,13
ST   D18S51: 15,19
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 17,22
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 13
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N299 ! Hs 564(A).T
OI   CVCL_N300 ! Hs 564(B).Mg
OI   CVCL_N301 ! Hs 564(C).Mg
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 565(A).Mg
AC   CVCL_0797
DR   CLO; CLO_0003998
DR   ATCC; CRL-7330
DR   BioSample; SAMN03471570
DR   Wikidata; Q54895749
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7330; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7330
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N761 ! Hs 565(B).Mg
OI   CVCL_N762 ! Hs 565(C).Mg
OI   CVCL_0798 ! Hs 565(D).Mg
OI   CVCL_N298 ! Hs 565(E)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 565(B).Mg
AC   CVCL_N761
DR   ATCC; CRL-7331
DR   Wikidata; Q54895750
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7331; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0797 ! Hs 565(A).Mg
OI   CVCL_N762 ! Hs 565(C).Mg
OI   CVCL_0798 ! Hs 565(D).Mg
OI   CVCL_N298 ! Hs 565(E)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 565(C).Mg
AC   CVCL_N762
DR   ATCC; CRL-7332
DR   Wikidata; Q54895751
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7332; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0797 ! Hs 565(A).Mg
OI   CVCL_N761 ! Hs 565(B).Mg
OI   CVCL_0798 ! Hs 565(D).Mg
OI   CVCL_N298 ! Hs 565(E)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 565(D).Mg
AC   CVCL_0798
DR   CLO; CLO_0003999
DR   ATCC; CRL-7333
DR   Wikidata; Q54895753
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7333; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7333
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0797 ! Hs 565(A).Mg
OI   CVCL_N761 ! Hs 565(B).Mg
OI   CVCL_N762 ! Hs 565(C).Mg
OI   CVCL_N298 ! Hs 565(E)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 565(E)
AC   CVCL_N298
DR   ATCC; CRL-7334
DR   Wikidata; Q54895754
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7334; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0797 ! Hs 565(A).Mg
OI   CVCL_N761 ! Hs 565(B).Mg
OI   CVCL_N762 ! Hs 565(C).Mg
OI   CVCL_0798 ! Hs 565(D).Mg
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 566(A).T
AC   CVCL_N294
SY   Hs 566(A)
DR   ATCC; CRL-7335
DR   Wikidata; Q54895755
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7335; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0799 ! Hs 566(B).T
OI   CVCL_N295 ! Hs 566(C).Mg
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 566(B).T
AC   CVCL_0799
SY   Hs566(B).T
DR   CLO; CLO_0004000
DR   ATCC; CRL-7336
DR   BioSample; SAMN03471572
DR   Wikidata; Q54895756
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7336
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 13,16
ST   D19S433: 13,15
ST   D21S11: 29,32
ST   D2S1338: 23,26
ST   D3S1358: 14,17
ST   D5S818: 9,13
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 18,26
ST   Penta D: 11,15
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N294 ! Hs 566(A).T
OI   CVCL_N295 ! Hs 566(C).Mg
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 566(C).Mg
AC   CVCL_N295
DR   ATCC; CRL-7337
DR   Wikidata; Q54895758
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7337; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N294 ! Hs 566(A).T
OI   CVCL_0799 ! Hs 566(B).T
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 567(A).T
AC   CVCL_N763
DR   ATCC; CRL-7338
DR   Wikidata; Q54895759
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7338; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N764 ! Hs 567(B).Mg
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 567(B).Mg
AC   CVCL_N764
DR   ATCC; CRL-7339
DR   Wikidata; Q54895760
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7339; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N763 ! Hs 567(A).T
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 568.We
AC   CVCL_0800
DR   CLO; CLO_0004001
DR   ATCC; CRL-7340
DR   Wikidata; Q54895761
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7340; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 57.T
AC   CVCL_0801
DR   CLO; CLO_0004002
DR   ATCC; CRL-7037
DR   BioSample; SAMN03472651
DR   Wikidata; Q54895762
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7037; true.
ST   Source(s): ATCC=CRL-7037
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 570.T
AC   CVCL_N765
DR   ATCC; CRL-7341
DR   Wikidata; Q54895763
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7341; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 571.T
AC   CVCL_0802
SY   Hs571T; HS571T
DR   CLO; CLO_0004003
DR   ATCC; CRL-7846
DR   BioSample; SAMN03471106
DR   BioSample; SAMN10988221
DR   cancercelllines; CVCL_0802
DR   Cell_Model_Passport; SIDM01707
DR   DepMap; ACH-001092
DR   IARC_TP53; 28356
DR   PharmacoDB; Hs571_T_576_2019
DR   Progenetix; CVCL_0802
DR   Wikidata; Q54895764
RX   PubMed=23839242;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Ala (c.109T>G); ClinVar=VCV000376235; Zygosity=Homozygous (DepMap=ACH-001092).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (DepMap=ACH-001092).
CC   Omics: Genomics; Whole exome sequencing.
CC   Genome ancestry: African=0%; Native American=0.08%; East Asian, North=0.95%; East Asian, South=0%; South Asian=1.65%; European, North=57.56%; European, South=39.76% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7846; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=CRL-7846
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Hs 572.Mg
AC   CVCL_N766
DR   ATCC; CRL-7342
DR   Wikidata; Q54895765
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7342; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 573.Lu
AC   CVCL_0803
SY   573Lu
DR   CLO; CLO_0004004
DR   ATCC; CRL-7344
DR   BioSample; SAMN03471574
DR   Wikidata; Q54895766
RX   PubMed=7171457;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7344; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-7344
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0804 ! Hs 573.T
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 573.T
AC   CVCL_0804
SY   HS 573T; Hs573.T; Hs573T; 573
DR   CLO; CLO_0004005
DR   ATCC; CRL-7343
DR   BioSample; SAMN03471573
DR   cancercelllines; CVCL_0804
DR   GEO; GSM827559
DR   Progenetix; CVCL_0804
DR   Wikidata; Q54895768
RX   PubMed=6500159;
RX   PubMed=7171457;
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7343; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7343
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0803 ! Hs 573.Lu
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Hs 574.Mg
AC   CVCL_S249
DR   ATCC; CRL-7847
DR   Wikidata; Q54895769
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7847; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0805 ! Hs 574.Sk
OI   CVCL_0806 ! Hs 574.T
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 574.Sk
AC   CVCL_0805
DR   CLO; CLO_0004006
DR   ATCC; CRL-7346
DR   Wikidata; Q54895770
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7346; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7346
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S249 ! Hs 574.Mg
OI   CVCL_0806 ! Hs 574.T
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 574.T
AC   CVCL_0806
SY   HS 574T
DR   CLO; CLO_0004007
DR   ATCC; CRL-7345
DR   BioSample; SAMN03471576
DR   Wikidata; Q54895771
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7345
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 9,13
ST   D18S51: 12,15
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 19,24
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S249 ! Hs 574.Mg
OI   CVCL_0805 ! Hs 574.Sk
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 578.Mg
AC   CVCL_S253
DR   ATCC; CRL-7848
DR   Wikidata; Q54895772
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7848; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0807 ! Hs 578Bst
OI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 578Bst
AC   CVCL_0807
SY   Hs578Bst; HS578BST; Hs-578Bst; Hs 578.Bst; Homo sapiens No. 578, breast cells
DR   BTO; BTO_0003886
DR   CLO; CLO_0004008
DR   EFO; EFO_0022653
DR   CLDB; cl1715
DR   ATCC; HTB-125
DR   BioSample; SAMN03471102
DR   CCRID; 3101HUMGNHu16
DR   IZSLER; BS CL 190
DR   PharmacoDB; HS578BST_617_2019
DR   Wikidata; Q54895773
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=864756;
RX   PubMed=29671673;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7427; MT-CYB; Simple; p.Ala125Thr (m.15119G>A); ClinVar=VCV000693829; Zygosity=Heteroplasmic; Note=Less <1% while homoplasmic in autologous cell line Hs 578T (PubMed=29671673).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Caution: Although it is part of a cancer cell line panel, it is a normal fibroblastic epithelial/myoepithelial cell line.
CC   Misspelling: Hs57Bst; DOI=10.1016/B978-0-12-333530-2.50009-5.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=HTB-125
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 17,26
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 8,13
ST   Penta E: 13,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S253 ! Hs 578.Mg
OI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   Hs 578T
AC   CVCL_0332
SY   HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells
DR   BTO; BTO_0003885
DR   CLO; CLO_0004009
DR   EFO; EFO_0001192
DR   MCCL; MCC:0000228
DR   CLDB; cl1716
DR   CLDB; cl1717
DR   CLDB; cl5023
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-7849
DR   ATCC; HTB-126
DR   BCRC; 60120
DR   BioGRID_ORCS_Cell_line; 654
DR   BioSample; SAMN03473213
DR   BioSample; SAMN10987893
DR   cancercelllines; CVCL_0332
DR   CCRID; 1101HUM-PUMC000670
DR   CCRID; 3101HUMTCHu127
DR   CCRID; 4201HUM-CCTCC00252
DR   CCTCC; GDC0252
DR   Cell_Model_Passport; SIDM00135
DR   ChEMBL-Cells; CHEMBL3307672
DR   ChEMBL-Targets; CHEMBL614645
DR   CLS; 305089
DR   Cosmic; 871142
DR   Cosmic; 875877
DR   Cosmic; 897418
DR   Cosmic; 904372
DR   Cosmic; 905957
DR   Cosmic; 921973
DR   Cosmic; 934524
DR   Cosmic; 974234
DR   Cosmic; 979715
DR   Cosmic; 997928
DR   Cosmic; 1010929
DR   Cosmic; 1017164
DR   Cosmic; 1018473
DR   Cosmic; 1027051
DR   Cosmic; 1044232
DR   Cosmic; 1046945
DR   Cosmic; 1047714
DR   Cosmic; 1092606
DR   Cosmic; 1136373
DR   Cosmic; 1175831
DR   Cosmic; 1176633
DR   Cosmic; 1218873
DR   Cosmic; 1235086
DR   Cosmic; 1287921
DR   Cosmic; 1289390
DR   Cosmic; 1305385
DR   Cosmic; 1312371
DR   Cosmic; 1430343
DR   Cosmic; 1473054
DR   Cosmic; 1518105
DR   Cosmic; 1603214
DR   Cosmic; 1609463
DR   Cosmic; 1998448
DR   Cosmic; 2009515
DR   Cosmic; 2164996
DR   Cosmic; 2301525
DR   Cosmic; 2560243
DR   Cosmic; 2668302
DR   Cosmic-CLP; 905957
DR   DepMap; ACH-000148
DR   DSMZ; ACC-781
DR   DSMZCellDive; ACC-781
DR   ECACC; 86082104
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905957
DR   GEO; GSM2113
DR   GEO; GSM50182
DR   GEO; GSM50246
DR   GEO; GSM217581
DR   GEO; GSM219968
DR   GEO; GSM344346
DR   GEO; GSM344396
DR   GEO; GSM421868
DR   GEO; GSM750776
DR   GEO; GSM783962
DR   GEO; GSM799319
DR   GEO; GSM799382
DR   GEO; GSM839032
DR   GEO; GSM844563
DR   GEO; GSM844564
DR   GEO; GSM844565
DR   GEO; GSM846359
DR   GEO; GSM847392
DR   GEO; GSM847488
DR   GEO; GSM887098
DR   GEO; GSM888169
DR   GEO; GSM1008903
DR   GEO; GSM1053700
DR   GEO; GSM1153388
DR   GEO; GSM1172877
DR   GEO; GSM1181262
DR   GEO; GSM1181319
DR   GEO; GSM1214564
DR   GEO; GSM1238131
DR   GEO; GSM1374549
DR   GEO; GSM1374550
DR   GEO; GSM1669895
DR   GEO; GSM1833625
DR   GEO; GSM2124656
DR   IARC_TP53; 579
DR   IBRC; C10150
DR   ICLC; HTL00007
DR   KCB; KCB 2012025YJ
DR   KCLB; 30126
DR   LiGeA; CCLE_743
DR   LINCS_HMS; 50238
DR   LINCS_LDP; LCL-1315
DR   Lonza; 1444
DR   NCI-DTP; HS 578T
DR   PharmacoDB; Hs578T_614_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005292
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0332
DR   PubChem_Cell_line; CVCL_0332
DR   SKY/M-FISH/CGH; 2663
DR   SLKBase; 3558
DR   Wikidata; Q54895774
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=864756;
RX   PubMed=1961733;
RX   PubMed=3335022;
RX   PubMed=7902062;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=10969801;
RX   PubMed=15153330;
RX   PubMed=15677628;
RX   PubMed=15748285;
RX   PubMed=16142302;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=16959974;
RX   PubMed=17088437;
RX   PubMed=17157791;
RX   PubMed=17932254;
RX   PubMed=18277095;
RX   PubMed=18386134;
RX   PubMed=18516279;
RX   PubMed=19372543;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=21778573;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29671673;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-and-growth-of-atcc-htb-126
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=3
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-305.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/hs578t-xenograft-model/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 34 hours (PubMed=18386134); ~48 hours (DSMZ=ACC-781); 53.8 hours (NCI-DTP=HS 578T); 32.35 hours (JWGray panel).
CC   HLA typing: A*03,24; B*35,40; C*03:04:01,04; DPB1*04:01,78:01; DQB1*05:01:01,06:02; DRB1*01,15:01:01 (PubMed=15748285).
CC   HLA typing: A*03:01,24:02; B*35:03,40:01; C*03:04,04:01; DQA1*03:02,03:02 (PubMed=25960936).
CC   HLA typing: A*03:01,24:02; B*35:03,40:01; C*03:04,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; PubMed=28889351).
CC   Sequence variation: Mutation; HGNC; HGNC:7427; MT-CYB; Simple; p.Ala125Thr (m.15119G>A); ClinVar=VCV000693829; Zygosity=Homoplasmic (PubMed=29671673).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (PubMed=1961733; PubMed=16541312; PubMed=17088437; PubMed=18277095; PubMed=28889351).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.53%; Native American=0%; East Asian, North=1.71%; East Asian, South=0%; South Asian=0%; European, North=63.73%; European, South=34.01% (PubMed=30894373).
CC   Misspelling: HS758T; Cosmic=904372.
CC   Misspelling: Hs-587-T; Cosmic=1010929; Cosmic=1176633.
CC   Misspelling: HTB126; Note=Based on the ATCC catalog number.
CC   Discontinued: ATCC; CRL-7849; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=HTB-126; CCRID; Cosmic-CLP=905957; DSMZ=ACC-781; ECACC=86082104; KCLB=30126; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D10S1248: 16
ST   D12S391: 19
ST   D13S317: 11
ST   D16S539: 9,12 (ATCC=HTB-126; CCRID; Cosmic-CLP=905957; ECACC=86082104; KCLB=30126; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; PubMed=28889351; Technion Genomics Center)
ST   D16S539: 12 (DSMZ=ACC-781)
ST   D18S51: 16
ST   D19S433: 14,15
ST   D1S1656: 11,16
ST   D21S11: 29,32.2 (ATCC=HTB-126; CCRID; DSMZ=ACC-781; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; Technion Genomics Center)
ST   D21S11: 32.2 (PubMed=28889351)
ST   D22S1045: 15,16
ST   D2S1338: 17,26
ST   D2S441: 14
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 8,13
ST   Penta E: 13,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S253 ! Hs 578.Mg
OI   CVCL_0807 ! Hs 578Bst
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   Hs 578T Hc5-1
AC   CVCL_E8BS
SY   Hc5-1
RX   PubMed=7949216;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Glu168Gly and p.Met234Ile).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Hs 578T Hc5-2
AC   CVCL_E8BT
SY   Hc5-2
RX   PubMed=7949216;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Glu168Gly and p.Met234Ile).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Hs 578T Hcg-11
AC   CVCL_E8BU
SY   Hcg-11
RX   PubMed=7949216;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala135Val = p53Val135).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Hs 579.Mg
AC   CVCL_0808
DR   CLO; CLO_0004010
DR   ATCC; CRL-7347
DR   ATCC; CRL-7347_FL
DR   BioSample; SAMN03471577
DR   Wikidata; Q54895775
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7347; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7347_FL
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F647 ! Hs 579.T
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 579.T
AC   CVCL_F647
DR   ATCC; CRL-7348
DR   Wikidata; Q54895776
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7348; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0808 ! Hs 579.Mg
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 58.Fs
AC   CVCL_0809
SY   Hs 58
DR   CLO; CLO_0004011
DR   ATCC; CRL-7038
DR   BioSample; SAMN03472652
DR   Wikidata; Q54895777
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7038; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7038
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 584.Mg
AC   CVCL_R690
DR   ATCC; CRL-7349
DR   Wikidata; Q54895778
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7349; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 586.Int
AC   CVCL_N477
DR   ATCC; CRL-7350
DR   Wikidata; Q54895779
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7350; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N478 ! Hs 586.T
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 586.T
AC   CVCL_N478
DR   ATCC; CRL-7351
DR   Wikidata; Q54895780
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7351; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N477 ! Hs 586.Int
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 587.Int
AC   CVCL_0810
SY   Hs-587
DR   CLO; CLO_0004012
DR   ATCC; CRL-7352
DR   BioSample; SAMN03471578
DR   Cosmic; 1609508
DR   Wikidata; Q54895781
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7352; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-7352
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,14
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 588.T
AC   CVCL_0811
DR   CLO; CLO_0004013
DR   ATCC; CRL-7850
DR   BioSample; SAMN03471107
DR   LINCS_LDP; LCL-1513
DR   Wikidata; Q54895782
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Miscellaneous: STR profile from personal communication of Chu, Vi.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-7850; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 13.2,14
ST   D21S11: 28,30
ST   D2S1338: 20,24
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 5,15
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 18
//
ID   Hs 59.Fs
AC   CVCL_N621
DR   ATCC; CRL-7039
DR   Wikidata; Q54895783
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7039; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 590.We
AC   CVCL_0812
DR   CLO; CLO_0004014
DR   ATCC; CRL-7353
DR   BioSample; SAMN03471579
DR   Wikidata; Q54895784
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Karyotypic information: Triploid (ATCC=CRL-7353).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7353
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,15
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 8,12,13
ST   D7S820: 10,11
ST   D8S1179: 12,14,15
ST   FGA: 22,24,46.2
ST   Penta D: 2.2,11
ST   Penta E: 8,11,15
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 593.Mg
AC   CVCL_R688
DR   ATCC; CRL-7354
DR   Wikidata; Q54895785
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7354; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R689 ! Hs 593.T
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 593.T
AC   CVCL_R689
DR   ATCC; CRL-7355
DR   Wikidata; Q54895786
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7355; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R688 ! Hs 593.Mg
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 597.Sk
AC   CVCL_G018
DR   ATCC; CRL-7356
DR   Wikidata; Q54895788
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7356; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G017 ! Hs 597.T
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 597.T
AC   CVCL_G017
SY   Hs-597; HS597
DR   ATCC; CRL-7357
DR   Cosmic; 706117
DR   Cosmic; 897495
DR   Wikidata; Q54895789
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7357; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G018 ! Hs 597.Sk
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 598.Af
AC   CVCL_R691
DR   ATCC; CRL-7358
DR   Wikidata; Q54895790
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7358; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 60.Fs
AC   CVCL_0813
DR   CLO; CLO_0004015
DR   ATCC; CRL-7040
DR   Wikidata; Q54895797
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7040; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 600.Sk
AC   CVCL_G019
DR   ATCC; CRL-7359
DR   Wikidata; Q54895799
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7359; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0814 ! Hs 600.T
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 600.T
AC   CVCL_0814
SY   Hs-600-T; Hs600T; HS600T
DR   CLO; CLO_0004016
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7360
DR   BioSample; SAMN03471483
DR   BioSample; SAMN10988168
DR   cancercelllines; CVCL_0814
DR   Cell_Model_Passport; SIDM01580
DR   DepMap; ACH-000240
DR   GEO; GSM827397
DR   GEO; GSM887099
DR   GEO; GSM888170
DR   IARC_TP53; 30049
DR   LiGeA; CCLE_894
DR   PharmacoDB; Hs600_T_577_2019
DR   Progenetix; CVCL_0814
DR   Wikidata; Q54895800
RX   DOI=10.1101/166199;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a melanoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000240).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.98%; East Asian, North=1.7%; East Asian, South=0%; South Asian=0%; European, North=65.3%; European, South=31.02% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7360
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D19S433: 15,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20.2,22
ST   Penta D: 9,10
ST   Penta E: 5,7
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G019 ! Hs 600.Sk
SX   Male
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 601.T
AC   CVCL_R692
DR   ATCC; CRL-7361
DR   Wikidata; Q54895801
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7361; true.
DI   NCIt; C6451; Thymic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 602
AC   CVCL_0815
SY   HS 602T
DR   CLO; CLO_0004017
DR   ATCC; HTB-142
DR   BioSample; SAMN03472716
DR   Wikidata; Q54895802
RX   PubMed=6500159;
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): ATCC=HTB-142
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 8,10
ST   D18S51: 15
ST   D19S433: 12,13
ST   D21S11: 28
ST   D2S1338: 24,27
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 13
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 604.T
AC   CVCL_0816
SY   Hs-604-T; Hs604T; HS604T
DR   CLO; CLO_0004018
DR   ATCC; CRL-7362
DR   BioSample; SAMN03471484
DR   BioSample; SAMN10987929
DR   cancercelllines; CVCL_0816
DR   Cell_Model_Passport; SIDM01706
DR   DepMap; ACH-001093
DR   GEO; GSM887100
DR   GEO; GSM888171
DR   IARC_TP53; 30050
DR   PharmacoDB; Hs604_T_578_2019
DR   Progenetix; CVCL_0816
DR   Wikidata; Q54895803
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-001093).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.15%; East Asian, North=0%; East Asian, South=4.01%; South Asian=2.02%; European, North=84.03%; European, South=9.79% (PubMed=30894373).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7362
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 16,21
ST   D19S433: 14,15.2
ST   D21S11: 28,30
ST   D2S1338: 25,26
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 11,12
ST   Penta E: 5,10
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 605.Mg
AC   CVCL_R693
DR   ATCC; CRL-7363
DR   Wikidata; Q54895804
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7363; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0817 ! Hs 605.Sk
OI   CVCL_0818 ! Hs 605.T
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 605.Sk
AC   CVCL_0817
DR   CLO; CLO_0004019
DR   ATCC; CRL-7364
DR   BioSample; SAMN03471485
DR   Wikidata; Q54895805
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7364
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 29,31.2
ST   D2S1338: 25
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 10,13
ST   Penta E: 13,18
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R693 ! Hs 605.Mg
OI   CVCL_0818 ! Hs 605.T
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 605.T
AC   CVCL_0818
SY   Hs605.T
DR   CLO; CLO_0004020
DR   ATCC; CRL-7365
DR   Wikidata; Q54895806
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7365
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 29,31.2
ST   D2S1338: 25
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 10,13
ST   Penta E: 13,18
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R693 ! Hs 605.Mg
OI   CVCL_0817 ! Hs 605.Sk
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 606.Mg
AC   CVCL_R694
DR   ATCC; CRL-7366
DR   Wikidata; Q54895807
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7366; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0820 ! Hs 606.Sk
OI   CVCL_0819 ! Hs 606.T
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 606.Sk
AC   CVCL_0820
DR   CLO; CLO_0004022
DR   ATCC; CRL-7367
DR   BioSample; SAMN03471486
DR   Wikidata; Q54895808
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7367; true.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7367
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R694 ! Hs 606.Mg
OI   CVCL_0819 ! Hs 606.T
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 606.T
AC   CVCL_0819
SY   Hs-606-T; Hs606T; HS606T; Hs 606; Hs606
DR   CLO; CLO_0004021
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7368
DR   BioSample; SAMN10988335
DR   cancercelllines; CVCL_0819
DR   Cell_Model_Passport; SIDM01591
DR   DepMap; ACH-000540
DR   GEO; GSM887101
DR   GEO; GSM888172
DR   IARC_TP53; 30051
DR   LiGeA; CCLE_617
DR   PharmacoDB; Hs606_T_579_2019
DR   Progenetix; CVCL_0819
DR   Wikidata; Q54895809
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a breast carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000540).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.63%; Native American=1.87%; East Asian, North=0%; East Asian, South=0.76%; South Asian=7.27%; European, North=28.96%; European, South=59.5% (PubMed=30894373).
ST   Source(s): ATCC=CRL-7368
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 30,33.2
ST   D2S1338: 22,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 15
ST   FGA: 19,23
ST   Penta D: 9,12
ST   Penta E: 5,22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R694 ! Hs 606.Mg
OI   CVCL_0820 ! Hs 606.Sk
SX   Female
AG   44Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Hs 607.T
AC   CVCL_N479
DR   ATCC; CRL-7369
DR   Wikidata; Q54895810
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7369; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 608.Mg
AC   CVCL_N771
DR   ATCC; CRL-7370
DR   Wikidata; Q54895811
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7370; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N772 ! Hs 608.T
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 608.T
AC   CVCL_N772
DR   ATCC; CRL-7371
DR   Wikidata; Q54895812
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7371; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N771 ! Hs 608.Mg
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 61.Fs
AC   CVCL_0821
DR   CLO; CLO_0004023
DR   ATCC; CRL-7041
DR   Wikidata; Q54895813
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7041; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 610.Sk
AC   CVCL_0822
DR   CLO; CLO_0004024
DR   ATCC; CRL-7372
DR   Wikidata; Q54895814
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7372; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 611.T
AC   CVCL_0823
SY   Hs-611-T; Hs611T; HS611T
DR   CLO; CLO_0004025
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7373
DR   BioSample; SAMN03471487
DR   BioSample; SAMN10987632
DR   cancercelllines; CVCL_0823
DR   Cell_Model_Passport; SIDM01567
DR   DepMap; ACH-000069
DR   GEO; GSM887102
DR   GEO; GSM888173
DR   IARC_TP53; 30052
DR   LiGeA; CCLE_287
DR   PharmacoDB; Hs611_T_580_2019
DR   Progenetix; CVCL_0823
DR   Wikidata; Q54895815
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.5%; East Asian, South=0.05%; South Asian=1.24%; European, North=71.76%; European, South=26.44% (PubMed=30894373).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-7373
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 12,16
ST   D21S11: 30
ST   D2S1338: 16,24
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Hs 612.Bl
AC   CVCL_N770
DR   ATCC; CRL-7374
DR   Wikidata; Q54895816
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7374; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S303 ! Hs 612.T
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 612.T
AC   CVCL_S303
DR   ATCC; CRL-7851
DR   Wikidata; Q54895817
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7851; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N770 ! Hs 612.Bl
SX   Male
AG   87Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 613.Sk
AC   CVCL_0824
DR   CLO; CLO_0004026
DR   ATCC; CRL-7375
DR   Wikidata; Q54895818
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7375; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 614.T
AC   CVCL_N480
SY   Hs614T
DR   ATCC; CRL-7376
DR   Wikidata; Q54895819
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 12-14 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7376; true.
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 615.T
AC   CVCL_N767
DR   ATCC; CRL-7377
DR   Wikidata; Q54895821
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7377; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C27349; Histiocytic sarcoma
DI   ORDO; Orphanet_86896; Histiocytic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   Hs 616.T
AC   CVCL_0825
SY   Hs-616-T; Hs616T; HS616T
DR   CLO; CLO_0004027
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7378
DR   BioSample; SAMN03471488
DR   BioSample; SAMN10988167
DR   cancercelllines; CVCL_0825
DR   Cell_Model_Passport; SIDM01566
DR   DepMap; ACH-000063
DR   GEO; GSM887103
DR   GEO; GSM888174
DR   IARC_TP53; 30053
DR   LiGeA; CCLE_138
DR   PharmacoDB; Hs616_T_581_2019
DR   Progenetix; CVCL_0825
DR   Wikidata; Q54895822
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000063).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.47%; East Asian, North=0%; East Asian, South=0.96%; South Asian=2.19%; European, North=68.82%; European, South=27.55% (PubMed=30894373).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7378
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   Hs 617.Mg
AC   CVCL_0826
DR   CLO; CLO_0004028
DR   ATCC; CRL-7379
DR   ATCC; CRL-7379_FL
DR   BioSample; SAMN03471491
DR   Wikidata; Q54895823
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7379; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7379_FL
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 618.Lu
AC   CVCL_S304
SY   618Lu
DR   ATCC; CRL-7852
DR   Wikidata; Q54895824
RX   PubMed=7171457;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7852; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0827 ! Hs 618.T
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 618.T
AC   CVCL_0827
SY   Hs-618-T; Hs618T; HS618T; 618T
DR   CLO; CLO_0004029
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7380
DR   ATCC; CRL-7380_FL
DR   BioSample; SAMN03471490
DR   BioSample; SAMN10987679
DR   cancercelllines; CVCL_0827
DR   Cell_Model_Passport; SIDM01565
DR   DepMap; ACH-000539
DR   GEO; GSM887104
DR   GEO; GSM888175
DR   IARC_TP53; 30054
DR   LiGeA; CCLE_832
DR   PharmacoDB; Hs618_T_582_2019
DR   Progenetix; CVCL_0827
DR   Wikidata; Q54895825
RX   DOI=10.1101/166199;
RX   PubMed=7171457;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a lung adenocarcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000539).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.37%; Native American=21.61%; East Asian, North=1.07%; East Asian, South=1.4%; South Asian=1.63%; European, North=38.2%; European, South=33.72% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7380; true.
CC   Discontinued: ATCC; CRL-7380_FL; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-7380_FL
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 9,10
ST   D7S820: 12,14
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S304 ! Hs 618.Lu
SX   Female
AG   60Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 619.Int
AC   CVCL_N768
DR   ATCC; CRL-7381
DR   Wikidata; Q54895826
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7381; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N769 ! Hs 619.T
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 619.T
AC   CVCL_N769
DR   ATCC; CRL-7382
DR   Wikidata; Q54895827
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7382; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N768 ! Hs 619.Int
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 62.Fs
AC   CVCL_0828
DR   CLO; CLO_0004030
DR   ATCC; CRL-7042
DR   Wikidata; Q54895829
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7042; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 621.Sk
AC   CVCL_0829
DR   CLO; CLO_0004031
DR   ATCC; CRL-7383
DR   Wikidata; Q54895830
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7383; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D784 ! Hs 621.T
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 621.T
AC   CVCL_D784
SY   Hs621T
DR   ATCC; CRL-7384
DR   Wikidata; Q54895831
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 18-20 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7384; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0829 ! Hs 621.Sk
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   Hs 622.Sk
AC   CVCL_0830
DR   CLO; CLO_0004032
DR   ATCC; CRL-7385
DR   Wikidata; Q54895832
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7385; true.
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F648 ! Hs 622.T
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 622.T
AC   CVCL_F648
DR   ATCC; CRL-7386
DR   Wikidata; Q54895833
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7386; true.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
DI   NCIt; C3329; Pituitary gland adenoma
DI   ORDO; Orphanet_99408; Pituitary adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0830 ! Hs 622.Sk
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 623.T
AC   CVCL_R695
DR   ATCC; CRL-7387
DR   Wikidata; Q54895834
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7387; true.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 625.Ln
AC   CVCL_R696
DR   ATCC; CRL-7388
DR   Wikidata; Q54895835
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7388; true.
CC   Derived from site: In situ; Mesenteric lymph node; UBERON=UBERON_0002509.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R697 ! Hs 625.T
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 625.T
AC   CVCL_R697
DR   ATCC; CRL-7389
DR   Wikidata; Q54895836
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7389; true.
CC   Derived from site: Metastatic; Ileal lymph node; UBERON=UBERON_0037522.
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R696 ! Hs 625.Ln
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 626.T
AC   CVCL_R698
DR   ATCC; CRL-7390
DR   Wikidata; Q54895837
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7390; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R699 ! Hs 626.Thd
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 626.Thd
AC   CVCL_R699
DR   ATCC; CRL-7391
DR   Wikidata; Q54895838
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7391; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R698 ! Hs 626.T
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 627.T
AC   CVCL_R700
DR   ATCC; CRL-7392
DR   Wikidata; Q54895839
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7392; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R701 ! Hs 627.Thd
SX   Female
AG   77Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 627.Thd
AC   CVCL_R701
DR   ATCC; CRL-7393
DR   Wikidata; Q54895843
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7393; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R700 ! Hs 627.T
SX   Female
AG   77Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 63.T
AC   CVCL_0831
SY   HS 63T
DR   CLO; CLO_0004033
DR   ATCC; CRL-7043
DR   BioSample; SAMN03472653
DR   Wikidata; Q54895844
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7043
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D19S433: 15.2,17.2
ST   D21S11: 31.2,32.2
ST   D2S1338: 16
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 24,26
ST   Penta D: 5,12
ST   Penta E: 13,16
ST   TH01: 6,7
ST   TPOX: 6,11
ST   vWA: 14,15
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   Hs 630.T
AC   CVCL_R702
SY   Hs-630-T; BeWo/cc
DR   ATCC; CRL-7394
DR   Cell_Model_Passport; SIDM00691
DR   Wikidata; Q54895845
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7394; true.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   Hs 631.T
AC   CVCL_N481
SY   734-B; 734 B; 734B
DR   ATCC; CRL-7853
DR   Wikidata; Q54895846
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4357757;
RX   PubMed=6500159;
RX   PubMed=6935474;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7853; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0031 ! MCF-7
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   Hs 633.T
AC   CVCL_0832
AS   CVCL_0129
SY   Hs-633-T; Hs 633T; HS 633T; HS-633T; Hs633T; MBA/8387; MB 8387; 8387; Line 8387; HS 8387
DR   CLO; CLO_0004034
DR   MCCL; MCC:0000021
DR   CLDB; cl1718
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7395
DR   cancercelllines; CVCL_0832
DR   Cell_Model_Passport; SIDM00667
DR   Cosmic; 1995445
DR   Cosmic; 2009543
DR   Cosmic-CLP; 1240149
DR   DepMap; ACH-002246
DR   ECACC; 89050201
DR   EGA; EGAS00001000978
DR   GDSC; 1240149
DR   GEO; GSM827368
DR   GEO; GSM1669896
DR   LINCS_LDP; LCL-1436
DR   PharmacoDB; Hs633T_615_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0832
DR   Wikidata; Q54895847
RX   PubMed=375235;
RX   PubMed=833871;
RX   PubMed=1385192;
RX   PubMed=2902939;
RX   PubMed=3518877;
RX   PubMed=5431618;
RX   PubMed=6500159;
RX   PubMed=6935474;
RX   PubMed=6954533;
RX   PubMed=8188761;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Microsatellite instability: Stable (MSS) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Pro (c.436G>C); ClinVar=VCV000375963; Zygosity=Heterozygous (Cosmic-CLP=1240149; DepMap=ACH-002246).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Argfs*60 (c.852delA); Zygosity=Heterozygous (Cosmic-CLP=1240149; DepMap=ACH-002246).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7395; true.
ST   Source(s): Cosmic-CLP=1240149
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15,20
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Hs 64.T
AC   CVCL_N622
DR   ATCC; CRL-7044
DR   Wikidata; Q54895848
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7044; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 653.T
AC   CVCL_S305
DR   ATCC; CRL-7854
DR   Wikidata; Q54895849
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7854; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 66.Sk/Mu
AC   CVCL_N623
DR   ATCC; CRL-7045
DR   Wikidata; Q54895850
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Donor information: Obtained from a pool of tissues from twin fetuses.
CC   Discontinued: ATCC; CRL-7045; true.
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N624 ! Hs 66.Th
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 66.Th
AC   CVCL_N624
DR   ATCC; CRL-7046
DR   Wikidata; Q54895851
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Donor information: Obtained from twin A of the twin fetuses from which Hs 66.Sk/Mu (Cellosaurus=CVCL_N623) is derived.
CC   Discontinued: ATCC; CRL-7046; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N623 ! Hs 66.Sk/Mu
SX   Male
AG   >12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 67
AC   CVCL_0833
AS   CVCL_0834
SY   Hs 67.Th; Hs67
DR   CLO; CLO_0004035
DR   CLO; CLO_0004036
DR   ATCC; CRL-7828
DR   ATCC; HTB-163
DR   BCRC; 60518
DR   BioSample; SAMN03472728
DR   Wikidata; Q54895852
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7828; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=HTB-163
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 674.Sk
AC   CVCL_0835
DR   CLO; CLO_0004037
DR   ATCC; CRL-7397
DR   BioSample; SAMN03471492
DR   Wikidata; Q54895853
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7397; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7397
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 10
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N491 ! Hs 674.T
OI   CVCL_N482 ! Hs 674.T/cc
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 674.T
AC   CVCL_N491
SY   Hs674T
DR   ATCC; CRL-7398
DR   Wikidata; Q54895854
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 12-14 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7398; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0835 ! Hs 674.Sk
OI   CVCL_N482 ! Hs 674.T/cc
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 674.T/cc
AC   CVCL_N482
DR   ATCC; CRL-7399
DR   Wikidata; Q54895855
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7399; true.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0835 ! Hs 674.Sk
OI   CVCL_N491 ! Hs 674.T
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 675.T
AC   CVCL_0836
SY   Hs-675-T; Hs675T; HS675T; Hs675; 675T
DR   CLO; CLO_0004038
DR   EFO; EFO_0006587
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7400
DR   BioSample; SAMN03471493
DR   BioSample; SAMN03473156
DR   BioSample; SAMN10988123
DR   cancercelllines; CVCL_0836
DR   Cell_Model_Passport; SIDM01564
DR   ColonAtlas; Hs%20675.T
DR   DepMap; ACH-000214
DR   EGA; EGAS00001000610
DR   GEO; GSM887105
DR   GEO; GSM888176
DR   IARC_TP53; 30055
DR   LiGeA; CCLE_230
DR   PharmacoDB; Hs675_T_583_2019
DR   Progenetix; CVCL_0836
DR   Wikidata; Q54895856
RX   DOI=10.1101/166199;
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a colorectal carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000214).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 6-7 days (PubMed=176412).
CC   HLA typing: A*29:02,30:02; B*18:01,44:03; C*05:01,16:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.02%; East Asian, North=0.97%; East Asian, South=0%; South Asian=3.25%; European, North=70.6%; European, South=25.15% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7400; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 16,16.2
ST   D21S11: 29,32.2
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 20,26
ST   Penta D: 9,10
ST   Penta E: 5,11
ST   TH01: 7,9.3
ST   TPOX: 9 (PubMed=25877200)
ST   TPOX: 9,12 (ATCC=CRL-7400)
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   Hs 677.Bl
AC   CVCL_R703
DR   ATCC; CRL-7401
DR   Wikidata; Q54895857
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7401; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R706 ! Hs 677.Eye
OI   CVCL_R707 ! Hs 677.Int
OI   CVCL_R708 ! Hs 677.K
OI   CVCL_R709 ! Hs 677.Rec
OI   CVCL_0837 ! Hs 677.Sk
OI   CVCL_0838 ! Hs 677.Tg
OI   CVCL_R710 ! Hs 677.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 677.Eye
AC   CVCL_R706
DR   ATCC; CRL-7402
DR   Wikidata; Q54895858
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7402; true.
CC   Derived from site: In situ; Fetal eye; UBERON=UBERON_0010312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R703 ! Hs 677.Bl
OI   CVCL_R707 ! Hs 677.Int
OI   CVCL_R708 ! Hs 677.K
OI   CVCL_R709 ! Hs 677.Rec
OI   CVCL_0837 ! Hs 677.Sk
OI   CVCL_0838 ! Hs 677.Tg
OI   CVCL_R710 ! Hs 677.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 677.Int
AC   CVCL_R707
SY   FHs677Int; FHs677 Int; 677Int
DR   ATCC; CRL-7403
DR   Wikidata; Q54895859
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 4-5 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7403; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R703 ! Hs 677.Bl
OI   CVCL_R706 ! Hs 677.Eye
OI   CVCL_R708 ! Hs 677.K
OI   CVCL_R709 ! Hs 677.Rec
OI   CVCL_0837 ! Hs 677.Sk
OI   CVCL_0838 ! Hs 677.Tg
OI   CVCL_R710 ! Hs 677.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 677.K
AC   CVCL_R708
DR   ATCC; CRL-7404
DR   Wikidata; Q54895860
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7404; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R703 ! Hs 677.Bl
OI   CVCL_R706 ! Hs 677.Eye
OI   CVCL_R707 ! Hs 677.Int
OI   CVCL_R709 ! Hs 677.Rec
OI   CVCL_0837 ! Hs 677.Sk
OI   CVCL_0838 ! Hs 677.Tg
OI   CVCL_R710 ! Hs 677.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 677.Rec
AC   CVCL_R709
DR   ATCC; CRL-7405
DR   BioSample; SAMN03471494
DR   Wikidata; Q54895861
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7405; true.
CC   Derived from site: In situ; Fetal rectum; UBERON=UBERON_0001052.
ST   Source(s): ATCC=CRL-7405
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13,14
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R703 ! Hs 677.Bl
OI   CVCL_R706 ! Hs 677.Eye
OI   CVCL_R707 ! Hs 677.Int
OI   CVCL_R708 ! Hs 677.K
OI   CVCL_0837 ! Hs 677.Sk
OI   CVCL_0838 ! Hs 677.Tg
OI   CVCL_R710 ! Hs 677.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 677.Sk
AC   CVCL_0837
DR   CLO; CLO_0004039
DR   ATCC; CRL-7406
DR   Wikidata; Q54895862
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7406; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7406
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13,14
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R703 ! Hs 677.Bl
OI   CVCL_R706 ! Hs 677.Eye
OI   CVCL_R707 ! Hs 677.Int
OI   CVCL_R708 ! Hs 677.K
OI   CVCL_R709 ! Hs 677.Rec
OI   CVCL_0838 ! Hs 677.Tg
OI   CVCL_R710 ! Hs 677.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 677.St
AC   CVCL_F646
DR   ATCC; CRL-7407
DR   BioSample; SAMN03152015
DR   Wikidata; Q54895863
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/hs-677st-atcc-crl-7407
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00401.
CC   Discontinued: ATCC; CRL-7407; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   Hs 677.Tg
AC   CVCL_0838
DR   CLO; CLO_0004040
DR   ATCC; CRL-7408
DR   Wikidata; Q54895864
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7408; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
ST   Source(s): ATCC=CRL-7408
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13,14
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R703 ! Hs 677.Bl
OI   CVCL_R706 ! Hs 677.Eye
OI   CVCL_R707 ! Hs 677.Int
OI   CVCL_R708 ! Hs 677.K
OI   CVCL_R709 ! Hs 677.Rec
OI   CVCL_0837 ! Hs 677.Sk
OI   CVCL_R710 ! Hs 677.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 677.Tr
AC   CVCL_R710
DR   ATCC; CRL-7409
DR   Wikidata; Q54895865
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7409; true.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R703 ! Hs 677.Bl
OI   CVCL_R706 ! Hs 677.Eye
OI   CVCL_R707 ! Hs 677.Int
OI   CVCL_R708 ! Hs 677.K
OI   CVCL_R709 ! Hs 677.Rec
OI   CVCL_0837 ! Hs 677.Sk
OI   CVCL_0838 ! Hs 677.Tg
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 679.T
AC   CVCL_R711
DR   ATCC; CRL-7410
DR   Wikidata; Q54895866
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7410; true.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 68
AC   CVCL_0839
SY   HS 68; HS-68; Hs68
DR   BTO; BTO_0002260
DR   CLO; CLO_0004041
DR   CLO; CLO_0004255
DR   EFO; EFO_0022453
DR   CLDB; cl1719
DR   ATCC; CRL-1635
DR   BCRC; 60038
DR   BioSample; SAMN01821561
DR   BioSample; SAMN01821730
DR   BioSample; SAMN03471410
DR   CCRID; 4201HUM-CCTCC00614
DR   CCTCC; GDC0403
DR   ChEMBL-Cells; CHEMBL3307408
DR   ChEMBL-Targets; CHEMBL614578
DR   ECACC; 89051701
DR   GEO; GSE39177
DR   JCRB; IFO50350
DR   PubChem_Cell_line; CVCL_0839
DR   Wikidata; Q54895867
RX   PubMed=23311377;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-306.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Senescence: Senesces after 42 PDL (ATCC=CRL-1635).
CC   Doubling time: ~1.2 days (Note=Lot 01242005), ~2 days (Note=Lot 01222018) (JCRB=IFO50350).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-1635; JCRB=IFO50350
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 12,14
ST   D21S11: 28
ST   D2S1338: 21,24
ST   D3S1358: 16,17
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 14,15
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Hs 680.Ad
AC   CVCL_R712
DR   ATCC; CRL-7411
DR   Wikidata; Q54895868
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7411; true.
CC   Derived from site: In situ; Fetal adrenal gland; UBERON=UBERON_0002369.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 680.Cor
AC   CVCL_R713
DR   ATCC; CRL-7412
DR   Wikidata; Q54895869
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7412; true.
CC   Derived from site: In situ; Fetal eye, cornea; UBERON=UBERON_0005427.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 680.Int
AC   CVCL_R714
SY   FHs680Int; 680Int
DR   ATCC; CRL-7413
DR   Wikidata; Q54895870
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 8-10 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7413; true.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 680.Ir
AC   CVCL_R715
DR   ATCC; CRL-7414
DR   Wikidata; Q54895871
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7414; true.
CC   Derived from site: In situ; Fetal eye, iris; UBERON=UBERON_0010312+UBERON_0001769.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   12-16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 680.K
AC   CVCL_R716
DR   ATCC; CRL-7415
DR   Wikidata; Q54895873
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7415; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 680.Li
AC   CVCL_R717
DR   ATCC; CRL-7416
DR   BioSample; SAMN03471495
DR   Wikidata; Q54895874
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7416; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-7416
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 9
//
ID   Hs 680.Pan
AC   CVCL_R718
DR   ATCC; CRL-7417
DR   Wikidata; Q54895875
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7417; true.
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 680.Rec
AC   CVCL_0840
DR   CLO; CLO_0004042
DR   ATCC; CRL-7418
DR   Wikidata; Q54895876
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7418; true.
CC   Derived from site: In situ; Fetal rectum; UBERON=UBERON_0001052.
ST   Source(s): ATCC=CRL-7418
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 680.Sk
AC   CVCL_0841
DR   CLO; CLO_0004043
DR   ATCC; CRL-7419
DR   Wikidata; Q54895877
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7419; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7419
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 680.St
AC   CVCL_R719
DR   ATCC; CRL-7420
DR   Wikidata; Q54895878
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7420; true.
CC   Derived from site: In situ; Fetal stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_0842 ! Hs 680.Tg
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 680.Tg
AC   CVCL_0842
DR   CLO; CLO_0004044
DR   ATCC; CRL-7421
DR   Wikidata; Q54895879
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7421; true.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
ST   Source(s): ATCC=CRL-7421
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0843 ! Hs 680.Tr
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 680.Tr
AC   CVCL_0843
DR   CLO; CLO_0004045
DR   ATCC; CRL-7422
DR   Wikidata; Q54895880
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
ST   Source(s): ATCC=CRL-7422
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 20,25
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R712 ! Hs 680.Ad
OI   CVCL_R713 ! Hs 680.Cor
OI   CVCL_R714 ! Hs 680.Int
OI   CVCL_R715 ! Hs 680.Ir
OI   CVCL_R716 ! Hs 680.K
OI   CVCL_R717 ! Hs 680.Li
OI   CVCL_R718 ! Hs 680.Pan
OI   CVCL_0840 ! Hs 680.Rec
OI   CVCL_0841 ! Hs 680.Sk
OI   CVCL_R719 ! Hs 680.St
OI   CVCL_0842 ! Hs 680.Tg
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 682.T
AC   CVCL_N483
DR   ATCC; CRL-7423
DR   Wikidata; Q54895881
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7423; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 683
AC   CVCL_0844
SY   HS 683; HS-683; Hs-683; Hs683; HS683; Hs 683.T; HS 683T; Hs683T
DR   BTO; BTO_0002139
DR   CLO; CLO_0004046
DR   EFO; EFO_0006441
DR   CLDB; cl5203
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-138
DR   BCRC; 60519
DR   BioGRID_ORCS_Cell_line; 653
DR   BioSample; SAMN03471202
DR   BioSample; SAMN10988175
DR   cancercelllines; CVCL_0844
DR   CCRID; 1101HUM-PUMC000345
DR   Cell_Model_Passport; SIDM00666
DR   ChEMBL-Cells; CHEMBL3308452
DR   ChEMBL-Targets; CHEMBL612596
DR   CLS; 300213
DR   Cosmic; 849882
DR   Cosmic; 1175812
DR   Cosmic; 1218882
DR   Cosmic; 1746954
DR   Cosmic; 1995446
DR   Cosmic; 2302319
DR   Cosmic; 2367487
DR   Cosmic; 2516019
DR   Cosmic; 2550356
DR   Cosmic-CLP; 1240150
DR   DepMap; ACH-000067
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240150
DR   GEO; GSM326235
DR   GEO; GSM887106
DR   GEO; GSM888177
DR   GEO; GSM1374551
DR   GEO; GSM1669897
DR   IARC_TP53; 28225
DR   IZSLER; BS TCL 126
DR   KCB; KCB 2012026YJ
DR   KCLB; 30138
DR   LiGeA; CCLE_822
DR   LINCS_LDP; LCL-1402
DR   PharmacoDB; Hs683_584_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0844
DR   PubChem_Cell_line; CVCL_0844
DR   Wikidata; Q54895882
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=176412;
RX   PubMed=450131;
RX   PubMed=6500159;
RX   PubMed=10416987;
RX   PubMed=11414198;
RX   PubMed=21406405;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 3-4 days (PubMed=176412); 49 hours (PubMed=25984343).
CC   HLA typing: A*32:01,32:01; B*07:02,44:02; C*05:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3942; MTOR; Simple; p.Glu1799Lys (c.5395G>A); ClinVar=VCV000217823; Zygosity=Heterozygous (DepMap=ACH-000067).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=10416987; DepMap=ACH-000067).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.33%; East Asian, North=0.16%; East Asian, South=0%; South Asian=0.7%; European, North=68.26%; European, South=30.54% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): ATCC=HTB-138; CCRID=1101HUM-PUMC000345; CLS=300213; Cosmic-CLP=1240150; KCLB=30138; PubMed=22570425; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 27,33.2
ST   D2S1338: 18,20
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 21.2,22
ST   Penta D: 13,14
ST   Penta E: 13,15
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 18,20
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   Hs 687.Sk
AC   CVCL_0845
DR   CLO; CLO_0004047
DR   ATCC; CRL-7424
DR   Wikidata; Q54895883
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7424; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 688(A).T
AC   CVCL_0846
SY   Hs688(A)T; Hs-688A-T; HS688AT
DR   CLO; CLO_0004048
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7425
DR   BioSample; SAMN03471496
DR   BioSample; SAMN10988159
DR   cancercelllines; CVCL_0846
DR   Cell_Model_Passport; SIDM01563
DR   DepMap; ACH-000306
DR   GEO; GSM887107
DR   GEO; GSM888178
DR   IARC_TP53; 30056
DR   LiGeA; CCLE_203
DR   PharmacoDB; Hs688_A_T_585_2019
DR   Progenetix; CVCL_0846
DR   Wikidata; Q54895887
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a melanoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000306).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.14%; East Asian, South=0%; South Asian=2.86%; European, North=65.65%; European, South=31.35% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7425
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D18S51: 19
ST   D19S433: 12
ST   D21S11: 28,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16,17
ST   D5S818: 8,11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 23,26
ST   Penta D: 12,14
ST   Penta E: 5,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0847 ! Hs 688(B).T
SX   Male
AG   69Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 688(B).T
AC   CVCL_0847
SY   Hs-688B-T; HS 688T
DR   CLO; CLO_0004049
DR   ATCC; CRL-7426
DR   Cell_Model_Passport; SIDM01562
DR   Wikidata; Q54895888
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): ATCC=CRL-7426
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D18S51: 19
ST   D19S433: 12
ST   D21S11: 28,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16,17
ST   D5S818: 8,11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 23,26
ST   Penta D: 12,14
ST   Penta E: 5,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0846 ! Hs 688(A).T
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   Hs 69.Fs
AC   CVCL_0848
DR   CLO; CLO_0004050
DR   ATCC; CRL-7047
DR   BioSample; SAMN03472654
DR   Wikidata; Q54895889
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7047; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7047
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 7,9
ST   D7S820: 8,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 691.Thd
AC   CVCL_N760
DR   ATCC; CRL-7427
DR   Wikidata; Q54895890
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7427; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 692(A).T
AC   CVCL_0849
DR   CLO; CLO_0004051
DR   ATCC; CRL-7428
DR   Wikidata; Q54895891
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7428; true.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C119 ! Hs 692(B).T
OI   CVCL_N840 ! Hs 692(C).Int
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 692(B).T
AC   CVCL_C119
DR   ATCC; CRL-7429
DR   Wikidata; Q54895892
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7429; true.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0849 ! Hs 692(A).T
OI   CVCL_N840 ! Hs 692(C).Int
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   Hs 692(C).Int
AC   CVCL_N840
DR   ATCC; CRL-7430
DR   Wikidata; Q54895893
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7430; true.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0849 ! Hs 692(A).T
OI   CVCL_C119 ! Hs 692(B).T
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 695.Sk
AC   CVCL_0850
DR   CLO; CLO_0004052
DR   ATCC; CRL-7855
DR   Wikidata; Q54895894
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7855; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0851 ! Hs 695T
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   Hs 695T
AC   CVCL_0851
SY   Hs 695.T; Hs-695-T; HS-695T; HS 695T; Hs695T; HS695T; Hs695
DR   CLO; CLO_0004053
DR   EFO; EFO_0006588
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-137
DR   BCRC; 60268
DR   BioGRID_ORCS_Cell_line; 652
DR   BioSample; SAMN03470910
DR   BioSample; SAMN10988229
DR   cancercelllines; CVCL_0851
DR   Cell_Model_Passport; SIDM01561
DR   ChEMBL-Cells; CHEMBL4523540
DR   ChEMBL-Targets; CHEMBL4523571
DR   CLS; 300211
DR   Cosmic; 933004
DR   DepMap; ACH-000799
DR   EGA; EGAS00001000610
DR   GEO; GSM206512
DR   GEO; GSM274686
DR   GEO; GSM887108
DR   GEO; GSM888179
DR   IARC_TP53; 30057
DR   LiGeA; CCLE_227
DR   PharmacoDB; Hs695T_586_2019
DR   Progenetix; CVCL_0851
DR   PubChem_Cell_line; CVCL_0851
DR   Wikidata; Q54895895
RX   PubMed=478563;
RX   PubMed=6500159;
RX   PubMed=6988327;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (ATCC=HTB-137).
CC   HLA typing: A*02:01,02:01; B*49:01,49:01; C*07:01,07:01; DQA1*01:03,01:03; DQB1*06:03,06:03; DRB1*03:38,13:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (ATCC=HTB-137; DepMap=ACH-000799).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.62%; East Asian, North=0.95%; East Asian, South=0.69%; South Asian=0.98%; European, North=71.17%; European, South=25.59% (PubMed=30894373).
CC   Misspelling: Hs 69ST; PubMed=25485619; PubMed=25877200.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-137; CLS=300211; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 18
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 9,12
ST   Penta E: 5,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0850 ! Hs 695.Sk
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Hs 696
AC   CVCL_0852
SY   Hs 696.T; Hs696T; 696T
DR   CLO; CLO_0004054
DR   ATCC; CRL-7432
DR   ATCC; HTB-151
DR   BioSample; SAMN03472724
DR   Wikidata; Q54895896
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 6-7 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7432; true.
CC   Derived from site: Metastatic; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=HTB-151
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,12
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 7,11
ST   vWA: 14
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1042 ! Hs 696.Sk
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   Hs 696.Sk
AC   CVCL_1042
DR   CLO; CLO_0004055
DR   ATCC; CRL-7431
DR   BioSample; SAMN03471497
DR   Wikidata; Q54895897
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7431; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7431
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 9
ST   D16S539: 10,12
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 7,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0852 ! Hs 696
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 697.Ln
AC   CVCL_0853
DR   CLO; CLO_0004056
DR   ATCC; CRL-7434
DR   Wikidata; Q54895898
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7434; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0854 ! Hs 697.Sp
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   Hs 697.Sp
AC   CVCL_0854
DR   CLO; CLO_0004057
DR   ATCC; CRL-7433
DR   BioSample; SAMN03471498
DR   Wikidata; Q54895899
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7433
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0853 ! Hs 697.Ln
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 698.T
AC   CVCL_0855
SY   Hs-698-T; Hs698T; HS698T
DR   CLO; CLO_0004058
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7435
DR   BioSample; SAMN03471499
DR   BioSample; SAMN10988478
DR   cancercelllines; CVCL_0855
DR   Cell_Model_Passport; SIDM01705
DR   ColonAtlas; Hs%20698.T
DR   DepMap; ACH-000850
DR   GEO; GSM887109
DR   GEO; GSM888180
DR   IARC_TP53; 30058
DR   LiGeA; CCLE_020
DR   PharmacoDB; Hs698_T_587_2019
DR   Progenetix; CVCL_0855
DR   Wikidata; Q54895900
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a colorectal carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000850).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: South Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=0%; East Asian, North=3.02%; East Asian, South=0%; South Asian=93.06%; European, North=0%; European, South=3.59% (PubMed=30894373).
CC   Caution: According to ATCC the ethnicity of the donor is Native American, but exome analysis finds it to be South Asian.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7435
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 15,18
ST   D19S433: 13,15.2
ST   D21S11: 32.2
ST   D2S1338: 20,21
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 19,23
ST   Penta D: 9,12
ST   Penta E: 16,17
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 699.K
AC   CVCL_S141
SY   Hs699K; 699K
DR   Wikidata; Q54895901
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Doubling time: 8-10 days (PubMed=176412).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R720 ! Hs 699.Sk
OI   CVCL_R721 ! Hs 699.T
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 699.Sk
AC   CVCL_R720
DR   ATCC; CRL-7437
DR   Wikidata; Q54895902
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7437; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S141 ! Hs 699.K
OI   CVCL_R721 ! Hs 699.T
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 699.T
AC   CVCL_R721
DR   ATCC; CRL-7438
DR   Wikidata; Q54895903
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7438; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S141 ! Hs 699.K
OI   CVCL_R720 ! Hs 699.Sk
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 70.Fs
AC   CVCL_0856
DR   CLO; CLO_0004059
DR   ATCC; CRL-7048
DR   Wikidata; Q54895904
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7048; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 700.Sk
AC   CVCL_0857
DR   CLO; CLO_0004060
DR   ATCC; CRL-7439
DR   Wikidata; Q54895905
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7439; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0858 ! Hs 700T
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   Hs 700T
AC   CVCL_0858
SY   HS-700-T; Hs-700-T; Hs-700T; HS-700T; HS 700T; HS700T; Hs700T; 700T
DR   CLO; CLO_0004061
DR   ATCC; HTB-147
DR   BioSample; SAMN03472721
DR   cancercelllines; CVCL_0858
DR   Cosmic; 730528
DR   Cosmic; 922262
DR   Cosmic; 947402
DR   Cosmic; 1218872
DR   Cosmic; 1299300
DR   Cosmic; 1366276
DR   Cosmic; 2434106
DR   GEO; GSM621856
DR   GEO; GSM784697
DR   IARC_TP53; 314
DR   IZSLER; BS TCL 229
DR   PRIDE; PXD003198
DR   Progenetix; CVCL_0858
DR   Wikidata; Q54895906
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=1630814;
RX   PubMed=6500159;
RX   PubMed=7961102;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=25167228;
RX   PubMed=27259358;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 4-5 days (PubMed=176412).
CC   Karyotypic information: Most chromosome counts are in the hypertetraploid range. A substantial (30%) population of hyperdiploid to hypotriploid cells is present (ATCC=HTB-147).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Met (c.746G>T); ClinVar=VCV000376653; Zygosity=Unspecified (PubMed=1630814; PubMed=7961102).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: The mucin producing, primary tumor was thought to have originated from the intestines or pancreas (ATCC=HTB-147).
CC   Derived from site: Metastatic; Pelvis; UBERON=UBERON_0002355.
ST   Source(s): ATCC=HTB-147; IZSLER=BS TCL 229
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10,13
ST   D18S51: 13,18
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 17,24,25
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,12,13
ST   FGA: 20,21,22
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0857 ! Hs 700.Sk
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Hs 701.T
AC   CVCL_0859
SY   HS 701T; Hs701.T
DR   CLO; CLO_0004062
DR   ATCC; CRL-7440
DR   BioSample; SAMN03471501
DR   Wikidata; Q54895907
RX   PubMed=6500159;
RX   PubMed=16955392;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7440; true.
ST   Source(s): ATCC=CRL-7440
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 702.T
AC   CVCL_S306
DR   ATCC; CRL-7856
DR   Wikidata; Q54895908
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7856; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C3412; Thymus neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R722 ! Hs 702.Thm
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 702.Thm
AC   CVCL_R722
DR   ATCC; CRL-7441
DR   Wikidata; Q54895909
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7441; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S306 ! Hs 702.T
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 703.T
AC   CVCL_N488
SY   HS 703T; Hs703T; Hs703
DR   ATCC; CRL-7442
DR   Wikidata; Q54895910
RX   PubMed=176412;
RX   PubMed=450131;
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 18-20 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7442; true.
CC   Derived from site: Metastatic; Colon; UBERON=UBERON_0001155.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 704.Sk
AC   CVCL_0860
DR   CLO; CLO_0004063
DR   ATCC; CRL-7443
DR   BioSample; SAMN03471502
DR   Wikidata; Q54895911
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7443; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7443
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0861 ! Hs 704.T
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 704.T
AC   CVCL_0861
SY   HS 704T; Hs 704(A).T
DR   CLO; CLO_0004064
DR   ATCC; CRL-7444
DR   Wikidata; Q54895912
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7444
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 24,26
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0860 ! Hs 704.Sk
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 705.T
AC   CVCL_R723
DR   ATCC; CRL-7445
DR   Wikidata; Q54895913
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7445; true.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 706.Sk
AC   CVCL_0862
DR   CLO; CLO_0004065
DR   ATCC; CRL-7446
DR   BioSample; SAMN03471503
DR   Wikidata; Q54895914
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7446; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7446
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,13
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0863 ! Hs 706.T
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 706.T
AC   CVCL_0863
SY   Hs-706-T; Hs706T; HS706T
DR   CLO; CLO_0004066
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7447
DR   BioSample; SAMN10987681
DR   cancercelllines; CVCL_0863
DR   Cell_Model_Passport; SIDM01704
DR   DepMap; ACH-000071
DR   FANTOM5_SSTAR; 10704-109H2
DR   GEO; GSM887110
DR   GEO; GSM888181
DR   GEO; GSM1676362
DR   GEO; GSM1701691
DR   IARC_TP53; 30059
DR   LiGeA; CCLE_608
DR   PharmacoDB; Hs706_T_589_2019
DR   Progenetix; CVCL_0863
DR   Wikidata; Q54895915
RX   PubMed=22460905;
RX   PubMed=26351324;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.7%; Native American=0.03%; East Asian, North=2.51%; East Asian, South=0%; South Asian=0.07%; European, North=57.98%; European, South=36.71% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7447
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,13
ST   D16S539: 13
ST   D18S51: 12,13
ST   D19S433: 13,15
ST   D21S11: 31.2,32.2
ST   D2S1338: 17,22
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0862 ! Hs 706.Sk
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Hs 707(A).T
AC   CVCL_0864
DR   CLO; CLO_0004067
DR   ATCC; CRL-7448
DR   BioSample; SAMN03471504
DR   cancercelllines; CVCL_0864
DR   GEO; GSM827262
DR   Progenetix; CVCL_0864
DR   Wikidata; Q54895917
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7448
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   D8S1179: 14,16
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 5,16
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0865 ! Hs 707(B).Ep
OI   CVCL_R757 ! Hs 707(C).Sk
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   Hs 707(B).Ep
AC   CVCL_0865
DR   CLO; CLO_0004068
DR   ATCC; CRL-7449
DR   Wikidata; Q54895918
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7449
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   D8S1179: 14,16
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 5,16
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0864 ! Hs 707(A).T
OI   CVCL_R757 ! Hs 707(C).Sk
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 707(C).Sk
AC   CVCL_R757
DR   ATCC; CRL-7450
DR   Wikidata; Q54895919
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7450; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0864 ! Hs 707(A).T
OI   CVCL_0865 ! Hs 707(B).Ep
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 708.T
AC   CVCL_R758
DR   ATCC; CRL-7451
DR   Wikidata; Q54895920
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7451; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C3411; Thymoma
DI   ORDO; Orphanet_99867; Thymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 709.Sk
AC   CVCL_1043
DR   CLO; CLO_0004069
DR   ATCC; CRL-7452
DR   BioSample; SAMN03471506
DR   Wikidata; Q54895921
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7452; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7452
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0866 ! Hs 709.T
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 709.T
AC   CVCL_0866
DR   CLO; CLO_0004070
DR   ATCC; CRL-7453
DR   Wikidata; Q54895922
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7453; true.
ST   Source(s): ATCC=CRL-7453
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3064; Granuloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1043 ! Hs 709.Sk
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 715.K
AC   CVCL_N484
SY   HS 715K; Hs715K; 715K
DR   ATCC; CRL-7454
DR   Wikidata; Q54895923
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 6-7 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7454; true.
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R829 ! Hs 715.T
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 715.T
AC   CVCL_R829
SY   Hs715T
DR   Wikidata; Q54895925
RX   PubMed=176412;
CC   Doubling time: 12-14 days (PubMed=176412).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N484 ! Hs 715.K
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 717.T
AC   CVCL_N342
DR   ATCC; CRL-7455
DR   Wikidata; Q54895926
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7455; true.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 718.T
AC   CVCL_S307
DR   ATCC; CRL-7858
DR   Wikidata; Q54895927
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7858; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C3326; Adrenal gland pheochromocytoma
DI   ORDO; Orphanet_276621; Sporadic pheochromocytoma/secreting paraganglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   Hs 72.Fs
AC   CVCL_0867
SY   Hs 72
DR   CLO; CLO_0004071
DR   ATCC; CRL-7049
DR   BioSample; SAMN03472655
DR   Wikidata; Q54895928
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7049; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7049
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 722.T
AC   CVCL_0868
SY   Hs-722; Hs722
DR   CLO; CLO_0004072
DR   ATCC; CRL-7456
DR   BioSample; SAMN03471505
DR   Cosmic; 1609546
DR   Wikidata; Q54895934
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7456; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ATCC=CRL-7456
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 723.Pl
AC   CVCL_R759
DR   ATCC; CRL-7457
DR   Wikidata; Q54895935
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7457; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 724.Pl
AC   CVCL_R760
DR   ATCC; CRL-7458
DR   Wikidata; Q54895936
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7458; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 725.Pl
AC   CVCL_R761
DR   ATCC; CRL-7459
DR   Wikidata; Q54895937
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7459; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 726.Pl
AC   CVCL_0869
DR   CLO; CLO_0004073
DR   ATCC; CRL-7460
DR   BioSample; SAMN03471507
DR   Wikidata; Q54895938
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7460
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 27,29,31
ST   D2S1338: 16,17,21
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 18.2,22,26
ST   Penta D: 8,10,13
ST   Penta E: 5,13,15
ST   TH01: 7,8
ST   TPOX: 6,10,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 728.K
AC   CVCL_R762
DR   ATCC; CRL-7461
DR   Wikidata; Q54895939
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7461; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S309 ! Hs 728.Li
OI   CVCL_0870 ! Hs 728.Sk/Mu
OI   CVCL_1044 ! Hs 728.Sp
OI   CVCL_S310 ! Hs 728.Th
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 728.Li
AC   CVCL_S309
DR   ATCC; CRL-7859
DR   Wikidata; Q54895940
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7859; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R762 ! Hs 728.K
OI   CVCL_0870 ! Hs 728.Sk/Mu
OI   CVCL_1044 ! Hs 728.Sp
OI   CVCL_S310 ! Hs 728.Th
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 728.Sk/Mu
AC   CVCL_0870
DR   CLO; CLO_0004074
DR   ATCC; CRL-7462
DR   BioSample; SAMN03471508
DR   Wikidata; Q54895941
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7462; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7462
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 7,13
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R762 ! Hs 728.K
OI   CVCL_S309 ! Hs 728.Li
OI   CVCL_1044 ! Hs 728.Sp
OI   CVCL_S310 ! Hs 728.Th
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 728.Sp
AC   CVCL_1044
DR   CLO; CLO_0004075
DR   ATCC; CRL-7463
DR   Wikidata; Q54895942
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7463; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
ST   Source(s): ATCC=CRL-7463
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 7,13
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R762 ! Hs 728.K
OI   CVCL_S309 ! Hs 728.Li
OI   CVCL_0870 ! Hs 728.Sk/Mu
OI   CVCL_S310 ! Hs 728.Th
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 728.Th
AC   CVCL_S310
DR   ATCC; CRL-7860
DR   Wikidata; Q54895943
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7860; true.
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R762 ! Hs 728.K
OI   CVCL_S309 ! Hs 728.Li
OI   CVCL_0870 ! Hs 728.Sk/Mu
OI   CVCL_1044 ! Hs 728.Sp
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 729.Sk
AC   CVCL_S311
DR   ATCC; CRL-7861
DR   Wikidata; Q54895944
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7861; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0871 ! Hs 729.T
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 729.T
AC   CVCL_0871
AS   CVCL_0872
SY   Hs 729; HS-729; Hs729; HS729; Hs-729-T; Hs 729T; Hs729T; HS729T
DR   CLO; CLO_0004076
DR   CLO; CLO_0004077
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7862
DR   ATCC; HTB-153
DR   BioGRID_ORCS_Cell_line; 651
DR   BioSample; SAMN03472726
DR   BioSample; SAMN10988177
DR   cancercelllines; CVCL_0871
DR   Cell_Model_Passport; SIDM01560
DR   CLS; 300443
DR   Cosmic; 1097755
DR   Cosmic; 1309329
DR   Cosmic; 2301589
DR   DepMap; ACH-000133
DR   GEO; GSM219750
DR   GEO; GSM887111
DR   GEO; GSM888182
DR   GEO; GSM1676363
DR   GEO; GSM1701692
DR   IARC_TP53; 28351
DR   LiGeA; CCLE_852
DR   PharmacoDB; Hs729_590_2019
DR   Progenetix; CVCL_0871
DR   Wikidata; Q54895945
RX   PubMed=8275086;
RX   PubMed=19235922;
RX   PubMed=22460905;
RX   PubMed=26351324;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Homozygous (DepMap=ACH-000133).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.21%; Native American=0%; East Asian, North=2.49%; East Asian, South=0%; South Asian=0.96%; European, North=57.58%; European, South=37.75% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7862; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
ST   Source(s): ATCC=HTB-153; CLS=300443
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11 (CLS=300443)
ST   D13S317: 11,12 (ATCC=HTB-153)
ST   D16S539: 11
ST   D18S51: 12 (CLS=300443)
ST   D18S51: 12,19 (ATCC=HTB-153)
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 17
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 19,20
ST   Penta D: 9,14
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S311 ! Hs 729.Sk
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Hs 730.Pl
AC   CVCL_0873
DR   CLO; CLO_0004078
DR   ATCC; CRL-7464
DR   Wikidata; Q54895946
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7464; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 731.Sk
AC   CVCL_0874
DR   CLO; CLO_0004079
DR   ATCC; CRL-7465
DR   Wikidata; Q54895947
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7465; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 732.K
AC   CVCL_S312
DR   ATCC; CRL-7863
DR   Wikidata; Q54895948
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7863; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S313 ! Hs 732.Li
OI   CVCL_R763 ! Hs 732.Pl
OI   CVCL_R764 ! Hs 732.Sk/Mu
OI   CVCL_R765 ! Hs 732.Sp
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 732.Li
AC   CVCL_S313
DR   ATCC; CRL-7864
DR   Wikidata; Q54895949
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7864; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S312 ! Hs 732.K
OI   CVCL_R763 ! Hs 732.Pl
OI   CVCL_R764 ! Hs 732.Sk/Mu
OI   CVCL_R765 ! Hs 732.Sp
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 732.Pl
AC   CVCL_R763
DR   ATCC; CRL-7466
DR   BioSample; SAMN03471510
DR   Wikidata; Q54895950
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7466; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7466
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S312 ! Hs 732.K
OI   CVCL_S313 ! Hs 732.Li
OI   CVCL_R764 ! Hs 732.Sk/Mu
OI   CVCL_R765 ! Hs 732.Sp
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 732.Sk/Mu
AC   CVCL_R764
DR   ATCC; CRL-7467
DR   BioSample; SAMN03471509
DR   Wikidata; Q54895951
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7467; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-7467
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S312 ! Hs 732.K
OI   CVCL_S313 ! Hs 732.Li
OI   CVCL_R763 ! Hs 732.Pl
OI   CVCL_R765 ! Hs 732.Sp
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 732.Sp
AC   CVCL_R765
DR   ATCC; CRL-7468
DR   Wikidata; Q54895952
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7468; true.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S312 ! Hs 732.K
OI   CVCL_S313 ! Hs 732.Li
OI   CVCL_R763 ! Hs 732.Pl
OI   CVCL_R764 ! Hs 732.Sk/Mu
SX   Male
AG   16FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 733.Sk
AC   CVCL_0875
DR   CLO; CLO_0004080
DR   ATCC; CRL-7469
DR   BioSample; SAMN03471512
DR   Wikidata; Q54895953
RX   PubMed=10741968;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7469
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 30,33.2
ST   D2S1338: 17,22
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 9,15
ST   FGA: 23,25
ST   Penta D: 9
ST   Penta E: 11,17
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 734.Sk
AC   CVCL_0876
DR   CLO; CLO_0004081
DR   ATCC; CRL-7470
DR   Wikidata; Q54895954
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7470; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 735.Sk
AC   CVCL_G024
DR   ATCC; CRL-7865
DR   Wikidata; Q54895955
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Caution: Established from same individual as Hs 735.T (Cellosaurus=CVCL_0877) which is said to originate from a 16 year old female.
CC   Discontinued: ATCC; CRL-7865; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0877 ! Hs 735.T
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 735.T
AC   CVCL_0877
DR   CLO; CLO_0004082
DR   ATCC; CRL-7471
DR   Wikidata; Q54895956
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Caution: Established from same individual as Hs 735.Sk (Cellosaurus=CVCL_G024) which is said to originate from a 26 year old female.
CC   Discontinued: ATCC; CRL-7471; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G024 ! Hs 735.Sk
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Hs 737.Sk
AC   CVCL_R766
DR   ATCC; CRL-7472
DR   Wikidata; Q54895958
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7472; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0878 ! Hs 737.T
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 737.T
AC   CVCL_0878
SY   Hs-737-T; Hs737T; HS737T
DR   CLO; CLO_0004083
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7473
DR   BioSample; SAMN03471220
DR   BioSample; SAMN10988166
DR   cancercelllines; CVCL_0878
DR   Cell_Model_Passport; SIDM01703
DR   DepMap; ACH-000185
DR   GEO; GSM827445
DR   GEO; GSM887112
DR   GEO; GSM888183
DR   IARC_TP53; 30060
DR   LiGeA; CCLE_038
DR   PharmacoDB; Hs737_T_591_2019
DR   Progenetix; CVCL_0878
DR   Wikidata; Q54895959
RX   DOI=10.1101/166199;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a giant cell tumor of bone cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000185).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.61%; East Asian, North=1.03%; East Asian, South=0%; South Asian=0%; European, North=67.56%; European, South=30.8% (PubMed=30894373).
ST   Source(s): ATCC=CRL-7473
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 15,16
ST   D21S11: 26.2,30
ST   D2S1338: 19,21
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,14
ST   Penta E: 12,14
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R766 ! Hs 737.Sk
SX   Female
AG   10Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 738.Bl
AC   CVCL_R767
DR   ATCC; CRL-7474
DR   Wikidata; Q54895960
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7474; true.
CC   Derived from site: In situ; Fetal urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T279 ! FHs 738Bl
OI   CVCL_3309 ! FHs 738Lu
OI   CVCL_S035 ! Hs 738.Eye
OI   CVCL_S314 ! Hs 738.K/Ad/Ts
OI   CVCL_0879 ! Hs 738.Lu
OI   CVCL_0880 ! Hs 738.St/Int
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 738.Eye
AC   CVCL_S035
DR   ATCC; CRL-7475
DR   Wikidata; Q54895961
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7475; true.
CC   Derived from site: In situ; Fetal eye; UBERON=UBERON_0010312.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T279 ! FHs 738Bl
OI   CVCL_3309 ! FHs 738Lu
OI   CVCL_R767 ! Hs 738.Bl
OI   CVCL_S314 ! Hs 738.K/Ad/Ts
OI   CVCL_0879 ! Hs 738.Lu
OI   CVCL_0880 ! Hs 738.St/Int
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 738.K/Ad/Ts
AC   CVCL_S314
DR   ATCC; CRL-7866
DR   Wikidata; Q54895963
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7866; true.
CC   Derived from site: In situ; Fetal adrenal gland; UBERON=UBERON_0002369.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T279 ! FHs 738Bl
OI   CVCL_3309 ! FHs 738Lu
OI   CVCL_R767 ! Hs 738.Bl
OI   CVCL_S035 ! Hs 738.Eye
OI   CVCL_0879 ! Hs 738.Lu
OI   CVCL_0880 ! Hs 738.St/Int
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 738.Lu
AC   CVCL_0879
DR   CLO; CLO_0004084
DR   ATCC; CRL-7868
DR   BioSample; SAMN03471108
DR   Wikidata; Q54895964
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7868; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-7868
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T279 ! FHs 738Bl
OI   CVCL_3309 ! FHs 738Lu
OI   CVCL_R767 ! Hs 738.Bl
OI   CVCL_S035 ! Hs 738.Eye
OI   CVCL_S314 ! Hs 738.K/Ad/Ts
OI   CVCL_0880 ! Hs 738.St/Int
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 738.St/Int
AC   CVCL_0880
DR   CLO; CLO_0004085
DR   ATCC; CRL-7869
DR   GEO; GSM827263
DR   Wikidata; Q54895965
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Derived from site: In situ; Fetal stomach; UBERON=UBERON_0000945.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7869
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 17,22
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9,10
ST   Penta E: 11,15
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T279 ! FHs 738Bl
OI   CVCL_3309 ! FHs 738Lu
OI   CVCL_R767 ! Hs 738.Bl
OI   CVCL_S035 ! Hs 738.Eye
OI   CVCL_S314 ! Hs 738.K/Ad/Ts
OI   CVCL_0879 ! Hs 738.Lu
SX   Male
AG   18FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   Hs 739.Sk
AC   CVCL_0881
DR   CLO; CLO_0004086
DR   ATCC; CRL-7476
DR   BioSample; SAMN03471221
DR   Wikidata; Q54895966
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Asian.
CC   Discontinued: ATCC; CRL-7476; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7476
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0882 ! Hs 739.T
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 739.T
AC   CVCL_0882
SY   Hs-739-T; Hs739T; HS739T
DR   CLO; CLO_0004087
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7477
DR   BioSample; SAMN10987649
DR   cancercelllines; CVCL_0882
DR   Cell_Model_Passport; SIDM01702
DR   DepMap; ACH-000413
DR   GEO; GSM887113
DR   GEO; GSM888184
DR   LiGeA; CCLE_082
DR   PharmacoDB; Hs739_T_592_2019
DR   Progenetix; CVCL_0882
DR   Wikidata; Q54895967
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a breast carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000413).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.34%; Native American=0.15%; East Asian, North=79.91%; East Asian, South=19.42%; South Asian=0.17%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7477
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0881 ! Hs 739.Sk
SX   Female
AG   52Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 74.Ad
AC   CVCL_N625
DR   ATCC; CRL-7050
DR   Wikidata; Q54895968
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7050; true.
CC   Derived from site: In situ; Fetal adrenal gland; UBERON=UBERON_0002369.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N626 ! Hs 74.Bm
OI   CVCL_N627 ! Hs 74.Hp
OI   CVCL_N628 ! Hs 74.Ht
OI   CVCL_S089 ! Hs 74.Int
OI   CVCL_N629 ! Hs 74.Lu
SX   Female
AG   3-4FM
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 74.Bm
AC   CVCL_N626
AS   CVCL_G292
SY   HS74; Hs74; HS-74; HS 74; HS74BM; 74BM
DR   BTO; BTO_0002749
DR   ATCC; CRL-7051
DR   Wikidata; Q54895969
RX   PubMed=1061701;
RX   PubMed=2823105;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7051; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N625 ! Hs 74.Ad
OI   CVCL_N627 ! Hs 74.Hp
OI   CVCL_N628 ! Hs 74.Ht
OI   CVCL_S089 ! Hs 74.Int
OI   CVCL_N629 ! Hs 74.Lu
SX   Female
AG   3-4FM
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   Hs 74.Hp
AC   CVCL_N627
DR   ATCC; CRL-7052
DR   Wikidata; Q54895970
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7052; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N625 ! Hs 74.Ad
OI   CVCL_N626 ! Hs 74.Bm
OI   CVCL_N628 ! Hs 74.Ht
OI   CVCL_S089 ! Hs 74.Int
OI   CVCL_N629 ! Hs 74.Lu
SX   Female
AG   3-4FM
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 74.Ht
AC   CVCL_N628
DR   ATCC; CRL-7053
DR   Wikidata; Q54895971
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7053; true.
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N625 ! Hs 74.Ad
OI   CVCL_N626 ! Hs 74.Bm
OI   CVCL_N627 ! Hs 74.Hp
OI   CVCL_S089 ! Hs 74.Int
OI   CVCL_N629 ! Hs 74.Lu
SX   Female
AG   3-4FM
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 74.Int
AC   CVCL_S089
DR   ATCC; CRL-7696
DR   Wikidata; Q54895972
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Caution: Could be identical to FHs 74 Int (Cellosaurus=CVCL_2899).
CC   Discontinued: ATCC; CRL-7696; true.
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N625 ! Hs 74.Ad
OI   CVCL_N626 ! Hs 74.Bm
OI   CVCL_N627 ! Hs 74.Hp
OI   CVCL_N628 ! Hs 74.Ht
OI   CVCL_N629 ! Hs 74.Lu
SX   Female
AG   3-4FM
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 74.Lu
AC   CVCL_N629
DR   ATCC; CRL-7054
DR   Wikidata; Q54895974
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7054; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N625 ! Hs 74.Ad
OI   CVCL_N626 ! Hs 74.Bm
OI   CVCL_N627 ! Hs 74.Hp
OI   CVCL_N628 ! Hs 74.Ht
OI   CVCL_S089 ! Hs 74.Int
SX   Female
AG   3-4FM
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 740.Sk
AC   CVCL_0883
DR   CLO; CLO_0004088
DR   ATCC; CRL-7478
DR   BioSample; SAMN03471222
DR   Wikidata; Q54895975
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7478; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7478
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0884 ! Hs 740.T
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 740.T
AC   CVCL_0884
DR   CLO; CLO_0004089
DR   ATCC; CRL-7870
DR   Wikidata; Q54895976
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7870; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): ATCC=CRL-7870
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0883 ! Hs 740.Sk
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 741.Sk
AC   CVCL_0885
DR   CLO; CLO_0004090
DR   ATCC; CRL-7479
DR   BioSample; SAMN03471223
DR   Wikidata; Q54895979
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7479; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7479
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0886 ! Hs 741.T
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 741.T
AC   CVCL_0886
DR   CLO; CLO_0004091
DR   ATCC; CRL-7480
DR   Wikidata; Q54895980
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7480; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7480
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0885 ! Hs 741.Sk
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 742.Sk
AC   CVCL_0887
DR   CLO; CLO_0004092
DR   ATCC; CRL-7481
DR   BioSample; SAMN03471224
DR   Wikidata; Q54895981
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7481; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7481
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0888 ! Hs 742.T
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 742.T
AC   CVCL_0888
SY   Hs-742-T; Hs742T; HS742T
DR   CLO; CLO_0004093
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7482
DR   BioSample; SAMN10987685
DR   cancercelllines; CVCL_0888
DR   Cell_Model_Passport; SIDM01701
DR   DepMap; ACH-000230
DR   GEO; GSM887114
DR   GEO; GSM888185
DR   IARC_TP53; 30061
DR   LiGeA; CCLE_890
DR   PharmacoDB; Hs742_T_593_2019
DR   Progenetix; CVCL_0888
DR   Wikidata; Q54895982
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a breast carcinoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000230).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.14%; East Asian, North=0%; East Asian, South=0.7%; South Asian=0%; European, North=72.94%; European, South=25.22% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7482
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 18,19
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 17
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0887 ! Hs 742.Sk
SX   Female
AG   71Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Hs 743.Sk
AC   CVCL_S036
DR   ATCC; CRL-7483
DR   Wikidata; Q54895983
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7483; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N485 ! Hs 743.T
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 743.T
AC   CVCL_N485
DR   ATCC; CRL-7484
DR   Wikidata; Q54895984
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7484; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S036 ! Hs 743.Sk
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 746.Sk
AC   CVCL_S315
DR   ATCC; CRL-7871
DR   Wikidata; Q54895985
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7871; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0333 ! Hs 746.T
OI   CVCL_ZX69 ! Hs 750.M
OI   CVCL_N486 ! Hs 750.T
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 7
//
ID   Hs 746.T
AC   CVCL_0333
SY   Hs 746T; HS 746T; Hs-746T; HS-746T; Hs746T; HS746T; Hs746-T; 746T
DR   CLO; CLO_0004094
DR   EFO; EFO_0006589
DR   MCCL; MCC:0000229
DR   AddexBio; C0023003/4957
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-135
DR   BioSample; SAMN03470907
DR   BioSample; SAMN03472714
DR   BioSample; SAMN10987647
DR   cancercelllines; CVCL_0333
DR   CCRID; 4201HUM-CCTCC00069
DR   CCTCC; GDC0069
DR   Cell_Model_Passport; SIDM00665
DR   ChEMBL-Cells; CHEMBL3307498
DR   ChEMBL-Targets; CHEMBL614579
DR   CLS; 305121
DR   Cosmic; 1187275
DR   Cosmic; 1329184
DR   Cosmic; 1460704
DR   Cosmic; 1479630
DR   Cosmic; 1482075
DR   Cosmic; 1995447
DR   Cosmic; 2069776
DR   Cosmic; 2484963
DR   Cosmic-CLP; 1240151
DR   DepMap; ACH-000616
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240151
DR   GEO; GSM267418
DR   GEO; GSM267425
DR   GEO; GSM267432
DR   GEO; GSM267439
DR   GEO; GSM552359
DR   GEO; GSM562402
DR   GEO; GSM827402
DR   GEO; GSM844566
DR   GEO; GSM887115
DR   GEO; GSM888186
DR   GEO; GSM1237674
DR   GEO; GSM1237699
DR   GEO; GSM1374552
DR   GEO; GSM1669898
DR   KCB; KCB 2013048YJ
DR   LiGeA; CCLE_544
DR   LINCS_LDP; LCL-1883
DR   PharmacoDB; Hs746T_594_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0333
DR   PubChem_Cell_line; CVCL_0333
DR   Wikidata; Q54895986
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=6500159;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/gastric-xenograft-model/hs746t-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MET genetic alteration cell panel (ATCC TCP-1036).
CC   Population: Caucasian.
CC   Characteristics: MET-amplified, contains 13-14 copies of the gene (PubMed=29435981).
CC   Doubling time: 41 hours (PubMed=29435981).
CC   HLA typing: A*25:01,25:01; B*18:01,18:01; C*12:03,12:03; DQA1*01:02,01:02; DQB1*05:01,05:01; DRB1*01:01,01:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.16%; East Asian, North=2.9%; East Asian, South=0%; South Asian=0.58%; European, North=65.13%; European, South=31.23% (PubMed=30894373).
CC   Derived from site: Metastatic; Left leg, skeletal muscle; UBERON=UBERON_0001383.
ST   Source(s): AddexBio=C0023003/4957; ATCC=HTB-135; Cosmic-CLP=1240151; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 23
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 7,9
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 15,17 (AddexBio=C0023003/4957; ATCC=HTB-135; Cosmic-CLP=1240151)
ST   vWA: 17 (PubMed=25877200)
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S315 ! Hs 746.Sk
OI   CVCL_ZX69 ! Hs 750.M
OI   CVCL_N486 ! Hs 750.T
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   Hs 748.Sk
AC   CVCL_G022
DR   ATCC; CRL-7485
DR   Wikidata; Q54895987
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7485; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0889 ! Hs 748.T
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 748.T
AC   CVCL_0889
DR   CLO; CLO_0004095
DR   ATCC; CRL-7486
DR   BioSample; SAMN03471225
DR   Wikidata; Q54895988
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7486
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 13
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,14
ST   D8S1179: 12,16
ST   FGA: 22
ST   Penta D: 11,14
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G022 ! Hs 748.Sk
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 749.Sk
AC   CVCL_0890
DR   CLO; CLO_0004096
DR   ATCC; CRL-7487
DR   Wikidata; Q54895989
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7487; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S402 ! Hs 749.T
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 749.T
AC   CVCL_S402
DR   ATCC; CRL-7872
DR   Wikidata; Q54895990
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7872; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0890 ! Hs 749.Sk
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 750.M
AC   CVCL_ZX69
SY   Hs750M
DR   Wikidata; Q102114151
RX   PubMed=6256643;
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S315 ! Hs 746.Sk
OI   CVCL_0333 ! Hs 746.T
OI   CVCL_N486 ! Hs 750.T
SX   Male
AG   74Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 5
//
ID   Hs 750.T
AC   CVCL_N486
SY   Hs750T
DR   ATCC; CRL-7873
DR   Wikidata; Q54895991
RX   PubMed=6256643;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7873; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S315 ! Hs 746.Sk
OI   CVCL_0333 ! Hs 746.T
OI   CVCL_ZX69 ! Hs 750.M
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   Hs 751.T
AC   CVCL_0891
SY   Hs751T; HS751T
DR   CLO; CLO_0004097
DR   ATCC; CRL-7488
DR   BioSample; SAMN10987975
DR   cancercelllines; CVCL_0891
DR   Cell_Model_Passport; SIDM01700
DR   DepMap; ACH-000165
DR   GEO; GSM827499
DR   GEO; GSM887116
DR   GEO; GSM888187
DR   IARC_TP53; 30062
DR   PharmacoDB; Hs751_T_595_2019
DR   Progenetix; CVCL_0891
DR   Wikidata; Q54895992
RX   DOI=10.1101/166199;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000165).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=0.12%; East Asian, North=0.59%; East Asian, South=0%; South Asian=0%; European, North=67.84%; European, South=31.12% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7488; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 754.T
AC   CVCL_S069
DR   ATCC; CRL-7874
DR   Wikidata; Q54895993
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7874; true.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 755(A).T
AC   CVCL_N346
SY   HS 755T
DR   ATCC; CRL-7877
DR   Wikidata; Q54895994
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7877; true.
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0892 ! Hs 755(B).T
OI   CVCL_N347 ! Hs 755.Mu
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 755(B).T
AC   CVCL_0892
SY   755T2
DR   CLO; CLO_0004098
DR   ATCC; CRL-7489
DR   ATCC; CRL-7489_FL
DR   BioSample; SAMN03471226
DR   Wikidata; Q54895995
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7489; true.
CC   Derived from site: Metastatic; Bone, proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): ATCC=CRL-7489_FL
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N346 ! Hs 755(A).T
OI   CVCL_N347 ! Hs 755.Mu
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   Hs 755.Mu
AC   CVCL_N347
DR   ATCC; CRL-7876
DR   Wikidata; Q54895996
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7876; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N346 ! Hs 755(A).T
OI   CVCL_0892 ! Hs 755(B).T
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 756.T
AC   CVCL_S070
DR   ATCC; CRL-7875
DR   Wikidata; Q54895997
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7875; true.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 757.T
AC   CVCL_0893
DR   CLO; CLO_0004099
DR   ATCC; CRL-7490
DR   Wikidata; Q54895998
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7490; true.
DI   NCIt; C3113; Hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 758.T
AC   CVCL_S066
DR   ATCC; CRL-7878
DR   Wikidata; Q54895999
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7878; true.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 760.T
AC   CVCL_R831
SY   Hs 760 T; Hs760.T
DR   ATCC; CRL-7491
DR   ECACC; 93071610
DR   Wikidata; Q54896000
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7491; true.
CC   Discontinued: ECACC; 93071610; true.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 8
//
ID   Hs 761.K
AC   CVCL_S067
SY   Hs761K; 761K
DR   ATCC; CRL-7879
DR   Wikidata; Q54896001
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 6-7 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7879; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R830 ! Hs 761.T
OI   CVCL_0939 ! Hs 835.T
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 761.T
AC   CVCL_R830
SY   Hs761T; 761T
DR   Wikidata; Q54896002
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Doubling time: 12-14 days (PubMed=176412).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S067 ! Hs 761.K
OI   CVCL_0939 ! Hs 835.T
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   Hs 762.Sk
AC   CVCL_0894
DR   CLO; CLO_0004100
DR   ATCC; CRL-7492
DR   Wikidata; Q54896003
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7492; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R832 ! Hs 762.T
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   Hs 762.T
AC   CVCL_R832
DR   ATCC; CRL-7493
DR   Wikidata; Q54896004
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7493; true.
DI   NCIt; C3043; Fibrosarcoma
DI   NCIt; C7073; Paget disease
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0894 ! Hs 762.Sk
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 764.Mu
AC   CVCL_0895
DR   CLO; CLO_0004101
DR   ATCC; CRL-7494
DR   BioSample; SAMN03471228
DR   Wikidata; Q54896005
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7494; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
ST   Source(s): ATCC=CRL-7494
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 766T
AC   CVCL_0334
SY   Hs 766.T; HS-766T; Hs-766T; HS 766T; HS-766-T; Hs-766-T; HS766T; Hs766T; H766T; 766T; Hs 766
DR   BTO; BTO_0003267
DR   CLO; CLO_0004102
DR   EFO; EFO_0006590
DR   MCCL; MCC:0000230
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-134
DR   BioGRID_ORCS_Cell_line; 417
DR   BioSample; SAMN03471934
DR   BioSample; SAMN03472713
DR   BioSample; SAMN10988214
DR   cancercelllines; CVCL_0334
DR   CCRID; 1101HUM-PUMC000377
DR   Cell_Model_Passport; SIDM00664
DR   CGH-DB; 166-1
DR   CGH-DB; 9276-4
DR   ChEMBL-Cells; CHEMBL3308000
DR   ChEMBL-Targets; CHEMBL612597
DR   Cosmic; 868240
DR   Cosmic; 873005
DR   Cosmic; 913311
DR   Cosmic; 922254
DR   Cosmic; 923169
DR   Cosmic; 932519
DR   Cosmic; 947401
DR   Cosmic; 948380
DR   Cosmic; 948738
DR   Cosmic; 949323
DR   Cosmic; 1006370
DR   Cosmic; 1108344
DR   Cosmic; 1122344
DR   Cosmic; 1299301
DR   Cosmic; 1320468
DR   Cosmic; 1366279
DR   Cosmic; 1518235
DR   Cosmic; 1571778
DR   Cosmic; 2434086
DR   Cosmic; 2755952
DR   Cosmic-CLP; 1298141
DR   DepMap; ACH-000178
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298141
DR   GEO; GSM206513
DR   GEO; GSM621912
DR   GEO; GSM784692
DR   GEO; GSM887117
DR   GEO; GSM888188
DR   GEO; GSM1024403
DR   GEO; GSM1374553
DR   GEO; GSM1374554
DR   GEO; GSM1374555
DR   GEO; GSM1669899
DR   IARC_TP53; 315
DR   IARC_TP53; 21071
DR   LiGeA; CCLE_905
DR   LINCS_LDP; LCL-1737
DR   PharmacoDB; Hs766T_596_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0334
DR   PubChem_Cell_line; CVCL_0334
DR   SKY/M-FISH/CGH; 1994
DR   Wikidata; Q54896006
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=1630814;
RX   PubMed=6500159;
RX   PubMed=8026879;
RX   PubMed=10027410;
RX   PubMed=10408907;
RX   PubMed=11169959;
RX   PubMed=14695172;
RX   PubMed=15126341;
RX   PubMed=15367885;
RX   PubMed=15688027;
RX   PubMed=16912165;
RX   PubMed=18380791;
RX   PubMed=19305140;
RX   PubMed=20418756;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/Hs766T.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 6-7 days (PubMed=176412); 30 hours (PubMed=25984343).
CC   HLA typing: A*03:01,26:01; B*35:01,38:01; C*04:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=10408907; PubMed=15367885; PubMed=18380791).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Homozygous (PubMed=11169959; Cosmic-CLP=1298141; DepMap=ACH-000178).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8026879; PubMed=15367885).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.11%; Native American=0.92%; East Asian, North=1.96%; East Asian, South=0%; South Asian=1.54%; European, North=62.85%; European, South=32.62% (PubMed=30894373).
CC   Caution: Indicated as originating from a 46 year old male patient in ATCC and from a 64 year old male patient in PubMed=283258 and PubMed=761205.
CC   Caution: Incorrectly reported to have no KRAS mutation in PubMed=8026879 and PubMed=15367885.
CC   Caution: TP53 mutation indicated incorrectly as being at c.542G>A in PubMed=1630814.
CC   Misspelling: Hs-776-T; Cosmic=873005; Cosmic=948380; PubMed=10408907.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-134; CCRID=1101HUM-PUMC000377; Cosmic-CLP=1298141; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,11,12 (PubMed=25877200)
ST   D16S539: 9,12 (ATCC=HTB-134; CCRID=1101HUM-PUMC000377; Cosmic-CLP=1298141)
ST   D18S51: 13
ST   D19S433: 15
ST   D21S11: 28
ST   D2S1338: 18,26
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 19,20
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Hs 767.Bl
AC   CVCL_S291
SY   HS0767; 767Bl; 767BL
DR   ATCC; CRL-7819
DR   Wikidata; Q54896007
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=3708594;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 4-5 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7819; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S037 ! Hs 767.Sk
OI   CVCL_S068 ! Hs 767.T
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 767.Sk
AC   CVCL_S037
DR   ATCC; CRL-7495
DR   Wikidata; Q54896008
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7495; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S291 ! Hs 767.Bl
OI   CVCL_S068 ! Hs 767.T
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 767.T
AC   CVCL_S068
DR   ATCC; CRL-7880
DR   Wikidata; Q54896009
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7880; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S291 ! Hs 767.Bl
OI   CVCL_S037 ! Hs 767.Sk
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 768(A).T
AC   CVCL_S038
SY   Hs768; 768T
DR   ATCC; CRL-7496
DR   Wikidata; Q54896010
RX   PubMed=1061701;
RX   PubMed=22282976;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7496; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 769.Bl
AC   CVCL_N348
DR   ATCC; CRL-7881
DR   Wikidata; Q54896011
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7881; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S039 ! Hs 769.Mu
OI   CVCL_0896 ! Hs 769.T
OI   CVCL_S040 ! Hs 769.Ut
OI   CVCL_S041 ! Hs 769.Vg
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 769.Mu
AC   CVCL_S039
DR   ATCC; CRL-7497
DR   Wikidata; Q54896012
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7497; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N348 ! Hs 769.Bl
OI   CVCL_0896 ! Hs 769.T
OI   CVCL_S040 ! Hs 769.Ut
OI   CVCL_S041 ! Hs 769.Vg
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 769.T
AC   CVCL_0896
SY   HS 769T; 769T
DR   CLO; CLO_0004103
DR   ATCC; CRL-7882
DR   BioSample; SAMN03471109
DR   FANTOM5_SSTAR; 10707-109H5
DR   Wikidata; Q54896013
RX   PubMed=283258;
RX   PubMed=761205;
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Derived from site: In situ; Urethra; UBERON=UBERON_0000057.
ST   Source(s): ATCC=CRL-7882
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C6166; Urethral urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N348 ! Hs 769.Bl
OI   CVCL_S039 ! Hs 769.Mu
OI   CVCL_S040 ! Hs 769.Ut
OI   CVCL_S041 ! Hs 769.Vg
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Hs 769.Ut
AC   CVCL_S040
DR   ATCC; CRL-7498
DR   Wikidata; Q54896014
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7498; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N348 ! Hs 769.Bl
OI   CVCL_S039 ! Hs 769.Mu
OI   CVCL_0896 ! Hs 769.T
OI   CVCL_S041 ! Hs 769.Vg
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 769.Vg
AC   CVCL_S041
DR   ATCC; CRL-7499
DR   Wikidata; Q54896015
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7499; true.
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N348 ! Hs 769.Bl
OI   CVCL_S039 ! Hs 769.Mu
OI   CVCL_0896 ! Hs 769.T
OI   CVCL_S040 ! Hs 769.Ut
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 77.Fs
AC   CVCL_0897
DR   CLO; CLO_0004104
DR   ATCC; CRL-7055
DR   Wikidata; Q54896016
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7055; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 772.Vd
AC   CVCL_S042
DR   ATCC; CRL-7500
DR   Wikidata; Q54896017
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7500; true.
CC   Derived from site: In situ; Vas deferens; UBERON=UBERON_0001000.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 773.T
AC   CVCL_S043
SY   Hs773T
DR   ATCC; CRL-7501
DR   Wikidata; Q54896018
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 8-10 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7501; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 774.Pl
AC   CVCL_0898
DR   CLO; CLO_0004105
DR   ATCC; CRL-7502
DR   Wikidata; Q54896020
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7502; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 775.Li
AC   CVCL_S044
DR   ATCC; CRL-7503
DR   Wikidata; Q54896021
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7503; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S045 ! Hs 775.T
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 775.T
AC   CVCL_S045
SY   Hs775T
DR   ATCC; CRL-7504
DR   Wikidata; Q54896022
RX   PubMed=176412;
RX   PubMed=450131;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 6-7 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7504; true.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S044 ! Hs 775.Li
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 776.Sk
AC   CVCL_S046
DR   ATCC; CRL-7505
DR   Wikidata; Q54896023
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7505; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S047 ! Hs 776.T
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 776.T
AC   CVCL_S047
DR   ATCC; CRL-7506
DR   Wikidata; Q54896024
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7506; true.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S046 ! Hs 776.Sk
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 777.T
AC   CVCL_0899
DR   CLO; CLO_0004106
DR   ATCC; CRL-7507
DR   Wikidata; Q54896025
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7507; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   Hs 778(A).T
AC   CVCL_0900
DR   CLO; CLO_0004107
DR   ATCC; CRL-7508
DR   BioSample; SAMN03471227
DR   Wikidata; Q54896026
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7508; true.
ST   Source(s): ATCC=CRL-7508
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0901 ! Hs 778(B).T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 778(B).T
AC   CVCL_0901
DR   CLO; CLO_0004108
DR   ATCC; CRL-7509
DR   Wikidata; Q54896027
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7509; true.
ST   Source(s): ATCC=CRL-7509
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0900 ! Hs 778(A).T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 78.T
AC   CVCL_N600
DR   ATCC; CRL-7056
DR   Wikidata; Q54896028
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7056; true.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 781.Sk
AC   CVCL_0902
SY   781SK
DR   CLO; CLO_0004109
DR   ATCC; CRL-7510
DR   BioSample; SAMN03471230
DR   Wikidata; Q54896029
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7510; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7510
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0903 ! Hs 781.T
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 781.T
AC   CVCL_0903
SY   Hs781T; HS781; Hs781; 781T
DR   CLO; CLO_0004110
DR   ATCC; CRL-7511
DR   cancercelllines; CVCL_0903
DR   Cosmic; 931916
DR   GEO; GSM827500
DR   Progenetix; CVCL_0903
DR   Wikidata; Q54896030
RX   PubMed=1061701;
RX   PubMed=20215515;
RX   PubMed=22282976;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7511; true.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0902 ! Hs 781.Sk
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   Hs 782.Sk
AC   CVCL_0904
DR   CLO; CLO_0004111
DR   ATCC; CRL-7513
DR   BioSample; SAMN03471232
DR   Wikidata; Q54896031
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7513; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7513
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0905 ! Hs 782.T
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 782.T
AC   CVCL_0905
DR   CLO; CLO_0004112
DR   ATCC; CRL-7512
DR   Wikidata; Q54896032
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7512; true.
ST   Source(s): ATCC=CRL-7512
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0904 ! Hs 782.Sk
SX   Female
AG   52Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 783.Sk
AC   CVCL_S048
DR   ATCC; CRL-7514
DR   Wikidata; Q54896033
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7514; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S049 ! Hs 783.T
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 783.T
AC   CVCL_S049
SY   Hs783T
DR   ATCC; CRL-7883
DR   Wikidata; Q54896034
RX   PubMed=450131;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7883; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S048 ! Hs 783.Sk
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 785.Co
AC   CVCL_S050
DR   ATCC; CRL-7515
DR   Wikidata; Q54896035
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7515; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N487 ! Hs 785.T
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 785.T
AC   CVCL_N487
SY   Hs785T; 785T
DR   ATCC; CRL-7884
DR   Wikidata; Q54896036
RX   PubMed=176412;
RX   PubMed=283258;
RX   PubMed=761205;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 8-10 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7884; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S050 ! Hs 785.Co
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 787.Mg
AC   CVCL_S064
DR   ATCC; CRL-7885
DR   Wikidata; Q54896037
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7885; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 788.Sk
AC   CVCL_0906
SY   788SK
DR   CLO; CLO_0004113
DR   ATCC; CRL-7516
DR   Wikidata; Q54896038
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7516; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S051 ! Hs 788.T
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 788.T
AC   CVCL_S051
SY   788T
DR   ATCC; CRL-7517
DR   Wikidata; Q54896039
RX   PubMed=1061701;
RX   PubMed=7171457;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7517; true.
CC   Derived from site: Metastatic; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0906 ! Hs 788.Sk
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 789.Sk
AC   CVCL_0907
DR   CLO; CLO_0004114
DR   ATCC; CRL-7518
DR   BioSample; SAMN03471231
DR   Wikidata; Q54896040
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7518
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,19
ST   D19S433: 14,16
ST   D21S11: 30,31
ST   D2S1338: 23,25
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0908 ! Hs 789.T
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 789.T
AC   CVCL_0908
SY   Hs789T
DR   CLO; CLO_0004115
DR   ATCC; CRL-7886
DR   BioSample; SAMN03471110
DR   Wikidata; Q54896041
RX   PubMed=176412;
RX   PubMed=29732388;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 12-14 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7886; true.
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-7886
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11,13
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0907 ! Hs 789.Sk
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 79.T
AC   CVCL_N601
DR   ATCC; CRL-7057
DR   Wikidata; Q54896042
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7057; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 791.Sk
AC   CVCL_0909
SY   791SK
DR   CLO; CLO_0004116
DR   ATCC; CRL-7519
DR   BioSample; SAMN03471233
DR   Wikidata; Q54896043
RX   PubMed=1061701;
RX   PubMed=6941806;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7519; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7519
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S301 ! Hs 791.T
OI   CVCL_0957 ! Hs 860.T
OI   CVCL_0966 ! Hs 870.T
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 791.T
AC   CVCL_S301
AS   CVCL_D535
SY   Hs-791-T; 791T
DR   ATCC; CRL-7798
DR   Cell_Model_Passport; SIDM01747
DR   ChEMBL-Cells; CHEMBL3307892
DR   ChEMBL-Targets; CHEMBL614254
DR   PubChem_Cell_line; CVCL_S301
DR   Wikidata; Q54896044
RX   PubMed=1061701;
RX   PubMed=6941806;
RX   PubMed=7171457;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7798; true.
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0909 ! Hs 791.Sk
OI   CVCL_0957 ! Hs 860.T
OI   CVCL_0966 ! Hs 870.T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   Hs 792(A).T
AC   CVCL_0910
SY   Hs 792(A)
DR   CLO; CLO_0004117
DR   ATCC; CRL-7520
DR   Wikidata; Q54896045
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7520; true.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0911 ! Hs 792(B).T
OI   CVCL_0912 ! Hs 792(C).M
OI   CVCL_0945 ! Hs 845.T
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 792(B).T
AC   CVCL_0911
SY   Hs 792(B)
DR   CLO; CLO_0004118
DR   ATCC; CRL-7521
DR   BioSample; SAMN03471234
DR   Wikidata; Q54896046
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7521; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7521
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 8,9.3
ST   TPOX: 9,10
ST   vWA: 16,19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0910 ! Hs 792(A).T
OI   CVCL_0912 ! Hs 792(C).M
OI   CVCL_0945 ! Hs 845.T
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 792(C).M
AC   CVCL_0912
SY   Hs 792(C)
DR   CLO; CLO_0004119
DR   ATCC; CRL-7522
DR   Wikidata; Q54896047
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7522
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D16S539: 12,13
ST   D18S51: 15,18
ST   D19S433: 13,15
ST   D21S11: 28,31.2
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 19,26
ST   Penta D: 11
ST   Penta E: 11,16
ST   TH01: 8,9.3
ST   TPOX: 9,10
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0910 ! Hs 792(A).T
OI   CVCL_0911 ! Hs 792(B).T
OI   CVCL_0945 ! Hs 845.T
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 793.Sk
AC   CVCL_0913
DR   CLO; CLO_0004120
DR   ATCC; CRL-7523
DR   BioSample; SAMN03471236
DR   Wikidata; Q54896048
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7523
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 28,34.2
ST   D2S1338: 18,23
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   Penta D: 9,13
ST   Penta E: 8,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0914 ! Hs 793.T
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 793.T
AC   CVCL_0914
DR   CLO; CLO_0004121
DR   ATCC; CRL-7524
DR   Wikidata; Q54896049
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7524; true.
CC   Derived from site: In situ; Mesenteric lymph node; UBERON=UBERON_0002509.
ST   Source(s): ATCC=CRL-7524
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3113; Hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0913 ! Hs 793.Sk
SX   Female
AG   50Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 794.K
AC   CVCL_S052
SY   Hs794K
DR   ATCC; CRL-7525
DR   Wikidata; Q54896050
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 12-14 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7525; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S053 ! Hs 794.T
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 794.T
AC   CVCL_S053
SY   HS 794T; Hs794T; HS794.T
DR   ATCC; CRL-7887
DR   Wikidata; Q54896051
RX   PubMed=176412;
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 6-7 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7887; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S052 ! Hs 794.K
SX   Male
AG   9M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 795.Pl
AC   CVCL_0915
DR   CLO; CLO_0004122
DR   ATCC; CRL-7526
DR   BioSample; SAMN03471235
DR   Wikidata; Q54896052
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7526
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 8,11
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 10,14
ST   Penta E: 7,11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 796.Pl
AC   CVCL_S055
DR   ATCC; CRL-7527
DR   Wikidata; Q54896053
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7527; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 797.Pl
AC   CVCL_S056
DR   ATCC; CRL-7528
DR   Wikidata; Q54896054
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7528; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39FW
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 798.Pl
AC   CVCL_0916
DR   CLO; CLO_0004123
DR   ATCC; CRL-7529
DR   BioSample; SAMN03471237
DR   Wikidata; Q54896055
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7529; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7529
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 799.Pl
AC   CVCL_0917
DR   CLO; CLO_0004124
DR   ATCC; CRL-7530
DR   BioSample; SAMN03471239
DR   Wikidata; Q54896056
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7530; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7530
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12,13
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,7,10
ST   TPOX: 8,11
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 80.Fs
AC   CVCL_0918
SY   Hs 80
DR   CLO; CLO_0004125
DR   ATCC; CRL-7058
DR   BioSample; SAMN03472656
DR   Wikidata; Q54896057
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7058; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC=CRL-7058
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 800.T
AC   CVCL_S057
DR   ATCC; CRL-7531
DR   Wikidata; Q54896058
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7531; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 801.Pl
AC   CVCL_0919
DR   CLO; CLO_0004126
DR   ATCC; CRL-7888
DR   BioSample; SAMN03471112
DR   Wikidata; Q54896059
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7888; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7888
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 802.T
AC   CVCL_S058
DR   ATCC; CRL-7532
DR   Wikidata; Q54896062
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7532; true.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 803.Sk
AC   CVCL_0920
SY   803SK
DR   CLO; CLO_0004127
DR   ATCC; CRL-7533
DR   Wikidata; Q54896063
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7533; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0921 ! Hs 803.T
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 803.T
AC   CVCL_0921
SY   803T
DR   CLO; CLO_0004128
DR   ATCC; CRL-7534
DR   Wikidata; Q54896064
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7534; true.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0920 ! Hs 803.Sk
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Hs 804.Sk
AC   CVCL_F284
DR   ATCC; CRL-7535
DR   BioSample; SAMN03471238
DR   Wikidata; Q54896065
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7535
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 14,16
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 10,11
ST   Penta E: 5,16
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G026 ! Hs 804.T
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 804.T
AC   CVCL_G026
DR   ATCC; CRL-7889
DR   Wikidata; Q54896066
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7889; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F284 ! Hs 804.Sk
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 805.Sk
AC   CVCL_N349
SY   805SK
DR   ATCC; CRL-7536
DR   Wikidata; Q54896067
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7536; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0922 ! Hs 805.T
OI   CVCL_0923 ! Hs 811.T
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 805.T
AC   CVCL_0922
DR   CLO; CLO_0004129
DR   ATCC; CRL-7537
DR   Wikidata; Q54896068
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7537; true.
CC   Derived from site: Metastatic; Bone, proximal humerus; UBERON=UBERON_0004411.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N349 ! Hs 805.Sk
OI   CVCL_0923 ! Hs 811.T
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 806.T
AC   CVCL_S059
SY   Hs806T
DR   ATCC; CRL-7538
DR   Wikidata; Q54896069
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 18-20 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7538; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 807.K
AC   CVCL_S060
SY   Hs807K
DR   ATCC; CRL-7539
DR   Wikidata; Q54896070
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 12-14 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7539; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S061 ! Hs 807.T
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 807.T
AC   CVCL_S061
DR   ATCC; CRL-7540
DR   Wikidata; Q54896071
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7540; true.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S060 ! Hs 807.K
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 808.Bm
AC   CVCL_S062
SY   808BM
DR   ATCC; CRL-7541
DR   Wikidata; Q54896072
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7541; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C85062; Sea-blue histiocyte syndrome
DI   ORDO; Orphanet_158029; Sea-blue histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 810.Bm
AC   CVCL_S063
DR   ATCC; CRL-7542
DR   Wikidata; Q54896073
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7542; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 811.T
AC   CVCL_0923
DR   CLO; CLO_0004130
DR   ATCC; CRL-7543
DR   Wikidata; Q54896074
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7543; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N349 ! Hs 805.Sk
OI   CVCL_0922 ! Hs 805.T
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 812.Bm
AC   CVCL_N537
SY   812BM
DR   ATCC; CRL-7544
DR   Wikidata; Q54896075
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Pacific; Polynesian.
CC   Discontinued: ATCC; CRL-7544; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 813.Sk
AC   CVCL_0924
DR   CLO; CLO_0004131
DR   ATCC; CRL-7545
DR   Wikidata; Q54896076
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7545; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 814.Sk
AC   CVCL_0925
DR   CLO; CLO_0004132
DR   ATCC; CRL-7546
DR   Wikidata; Q54896077
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7546; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0926 ! Hs 814.T
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 814.T
AC   CVCL_0926
DR   CLO; CLO_0004133
DR   ATCC; CRL-7547
DR   Wikidata; Q54896078
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7547; true.
CC   Derived from site: In situ; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0925 ! Hs 814.Sk
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Hs 815.Pl
AC   CVCL_0927
DR   CLO; CLO_0004134
DR   ATCC; CRL-7548
DR   BioSample; SAMN03471241
DR   Wikidata; Q54896079
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7548
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17-20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 817.T
AC   CVCL_S071
DR   ATCC; CRL-7549
DR   Wikidata; Q54896080
CC   Problematic cell line: Possibly misidentified: Not certain if this a human or mouse cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7549; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 818.T
AC   CVCL_N536
DR   ATCC; CRL-7890
DR   Wikidata; Q54896081
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7890; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 819.Sk
AC   CVCL_S072
DR   ATCC; CRL-7550
DR   Wikidata; Q54896082
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7550; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0928 ! Hs 819.T
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 819.T
AC   CVCL_0928
SY   Hs-819-T; Hs819.T; Hs819T; HS819T
DR   CLO; CLO_0004135
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7891
DR   BioSample; SAMN03471113
DR   BioSample; SAMN10988131
DR   cancercelllines; CVCL_0928
DR   Cell_Model_Passport; SIDM01699
DR   DepMap; ACH-000224
DR   GEO; GSM887118
DR   GEO; GSM888189
DR   GEO; GSM1676366
DR   GEO; GSM1701696
DR   IARC_TP53; 30063
DR   LiGeA; CCLE_521
DR   PharmacoDB; Hs819_T_597_2019
DR   Progenetix; CVCL_0928
DR   Wikidata; Q54896083
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a chondrosarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000224).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.16%; East Asian, South=0.22%; South Asian=1.63%; European, North=67.05%; European, South=29.93% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7891
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10,13
ST   D18S51: 12,14,18
ST   D19S433: 13,14
ST   D21S11: 28,29,32.2
ST   D2S1338: 17,19,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   FGA: 20,22,24,26
ST   Penta D: 9,12,17
ST   Penta E: 7,10,13,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S072 ! Hs 819.Sk
SX   Male
AG   60Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 820.Sk
AC   CVCL_0929
SY   820SK
DR   CLO; CLO_0004136
DR   ATCC; CRL-7551
DR   BioSample; SAMN03471243
DR   Wikidata; Q54896084
RX   PubMed=1061701;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7551; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7551
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0930 ! Hs 820.T
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 820.T
AC   CVCL_0930
DR   CLO; CLO_0004137
DR   ATCC; CRL-7552
DR   Wikidata; Q54896085
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7552; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7552
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0929 ! Hs 820.Sk
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 821.Sk
AC   CVCL_0931
DR   CLO; CLO_0004138
DR   ATCC; CRL-7553
DR   BioSample; SAMN03471242
DR   Wikidata; Q54896086
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7553; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7553
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0932 ! Hs 821.T
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 821.T
AC   CVCL_0932
SY   Hs-821-T; Hs821T; HS821T
DR   CLO; CLO_0004139
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7554
DR   BioSample; SAMN10988537
DR   cancercelllines; CVCL_0932
DR   Cell_Model_Passport; SIDM01698
DR   DepMap; ACH-000526
DR   GEO; GSM887119
DR   GEO; GSM888190
DR   IARC_TP53; 30064
DR   LiGeA; CCLE_842
DR   PharmacoDB; Hs821_T_598_2019
DR   Progenetix; CVCL_0932
DR   Wikidata; Q54896087
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a giant cell tumor of bone cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000526).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.92%; Native American=46.51%; East Asian, North=5.29%; East Asian, South=0%; South Asian=1.88%; European, North=22.78%; European, South=21.62% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7554
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D18S51: 16,18
ST   D19S433: 13,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,23
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 24,27
ST   Penta D: 12,14
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0931 ! Hs 821.Sk
SX   Female
AG   31Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 822.Sk
AC   CVCL_S073
DR   ATCC; CRL-7555
DR   Wikidata; Q54896088
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7555; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0933 ! Hs 822.T
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 822.T
AC   CVCL_0933
SY   Hs-822-T; Hs822T; HS822T
DR   CLO; CLO_0004140
DR   ATCC; CRL-7556
DR   BioSample; SAMN03471244
DR   BioSample; SAMN10988161
DR   cancercelllines; CVCL_0933
DR   Cell_Model_Passport; SIDM01697
DR   DepMap; ACH-000229
DR   GEO; GSM887120
DR   GEO; GSM888191
DR   IARC_TP53; 30065
DR   LiGeA; CCLE_706
DR   PharmacoDB; Hs822_T_599_2019
DR   Progenetix; CVCL_0933
DR   Wikidata; Q54896089
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a Ewing sarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000229).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.59%; Native American=21.59%; East Asian, North=1.66%; East Asian, South=0%; South Asian=2.06%; European, North=43.77%; European, South=30.33% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7556
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D19S433: 13,15
ST   D21S11: 32.2
ST   D2S1338: 20,23
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S073 ! Hs 822.Sk
SX   Female
AG   9Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Hs 823.T
AC   CVCL_S074
DR   ATCC; CRL-7557
DR   Wikidata; Q54896090
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7557; true.
CC   Derived from site: Metastatic; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 824.Sk
AC   CVCL_0934
DR   CLO; CLO_0004141
DR   ATCC; CRL-7558
DR   Wikidata; Q54896091
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7558; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S075 ! Hs 824.T
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 824.T
AC   CVCL_S075
DR   ATCC; CRL-7559
DR   Wikidata; Q54896092
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7559; true.
DI   NCIt; C27349; Histiocytic sarcoma
DI   ORDO; Orphanet_86896; Histiocytic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0934 ! Hs 824.Sk
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 825.T
AC   CVCL_S076
SY   HS 825T
DR   ATCC; CRL-7560
DR   Wikidata; Q54896093
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7560; true.
DI   NCIt; C3113; Hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 826.T
AC   CVCL_S077
DR   ATCC; CRL-7562
DR   Wikidata; Q54896094
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7562; true.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 827.Pl
AC   CVCL_S078
DR   ATCC; CRL-7563
DR   Wikidata; Q54896095
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7563; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 828.Sk
AC   CVCL_0935
DR   CLO; CLO_0004142
DR   ATCC; CRL-7564
DR   Wikidata; Q54896096
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7564; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S079 ! Hs 828.T
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 828.T
AC   CVCL_S079
DR   ATCC; CRL-7565
DR   Wikidata; Q54896097
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7565; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0935 ! Hs 828.Sk
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 832(C).T
AC   CVCL_0936
SY   Hs832.Tc; Hs832T
DR   CLO; CLO_0004143
DR   ATCC; CRL-7566
DR   BioSample; SAMN03472531
DR   Wikidata; Q54896098
RX   PubMed=176412;
RX   PubMed=23853725;
RX   PubMed=25877200;
RX   PubMed=32106286;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Senescence: Senesces after 28 PDL (ATCC=CRL-7566).
CC   Doubling time: 8-12 days (PubMed=176412); 72 hours (ATCC=CRL-7566).
CC   Miscellaneous: This cell line was discontinued by ATCC due to slow grow rate and difficulties to maintain the cell (PubMed=32106286).
CC   Discontinued: ATCC; CRL-7566; true.
ST   Source(s): ATCC=CRL-7566; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D21S11: 28,32.2
ST   D3S1358: 14,16
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 24,26
ST   Penta D: 12,13
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 833(C).Sk
AC   CVCL_0937
DR   CLO; CLO_0004144
DR   ATCC; CRL-7567
DR   Wikidata; Q54896099
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7567; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 834.T
AC   CVCL_0938
SY   Hs-834-T; Hs834T; HS834T
DR   CLO; CLO_0004145
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7568
DR   BioSample; SAMN03471245
DR   BioSample; SAMN10988445
DR   cancercelllines; CVCL_0938
DR   Cell_Model_Passport; SIDM01709
DR   DepMap; ACH-000275
DR   GEO; GSM827550
DR   IARC_TP53; 30066
DR   LiGeA; CCLE_656
DR   PharmacoDB; Hs834_T_600_2019
DR   Progenetix; CVCL_0938
DR   Wikidata; Q54896100
RX   DOI=10.1101/166199;
RX   PubMed=20215515;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a melanoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000275).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7568; true.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7568
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 835.T
AC   CVCL_0939
SY   Hs835T
DR   CLO; CLO_0004146
DR   ATCC; CRL-7569
DR   Wikidata; Q54896101
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Characteristics: Derived from a tumor arising from human renal carcinoma cells injected into a nude mouse (ATCC=CRL-7569).
CC   Doubling time: 3-4 days (PubMed=176412).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S067 ! Hs 761.K
OI   CVCL_R830 ! Hs 761.T
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   Hs 836.Sk
AC   CVCL_0940
DR   CLO; CLO_0004147
DR   ATCC; CRL-7570
DR   Wikidata; Q54896104
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7570; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G025 ! Hs 836.T
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 836.T
AC   CVCL_G025
DR   ATCC; CRL-7571
DR   Wikidata; Q54896105
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7571; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0940 ! Hs 836.Sk
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   Hs 839.T
AC   CVCL_0941
SY   Hs-839-T; Hs839.T; Hs839T; HS839T
DR   CLO; CLO_0004148
DR   EFO; EFO_0006591
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7572
DR   BioSample; SAMN03473235
DR   BioSample; SAMN10988128
DR   cancercelllines; CVCL_0941
DR   Cell_Model_Passport; SIDM01724
DR   DepMap; ACH-000180
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM827184
DR   GEO; GSM887121
DR   GEO; GSM888192
DR   IARC_TP53; 28283
DR   LiGeA; CCLE_266
DR   PharmacoDB; Hs839_T_601_2019
DR   Progenetix; CVCL_0941
DR   Wikidata; Q54896106
RX   DOI=10.1101/166199;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a melanoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000180).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01; DQA1*04:01,04:01; DQB1*06:04,06:04; DRB1*03:05,11:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Unspecified (DepMap=ACH-000180).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.72%; Native American=0.18%; East Asian, North=0.79%; East Asian, South=0%; South Asian=0%; European, North=67.25%; European, South=31.06% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7572; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,16
ST   FGA: 20,23
ST   Penta D: 12,13
ST   Penta E: 12,15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   Hs 840.T
AC   CVCL_0942
SY   Hs-840-T; Hs840_T; Hs840T; HS840T
DR   CLO; CLO_0004149
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7573
DR   BCRC; 60315
DR   BioSample; SAMN03471247
DR   BioSample; SAMN10988148
DR   cancercelllines; CVCL_0942
DR   Cell_Model_Passport; SIDM01725
DR   Cosmic; 1339926
DR   DepMap; ACH-000284
DR   GEO; GSM887122
DR   GEO; GSM888193
DR   GEO; GSM1374556
DR   GEO; GSM1374557
DR   IARC_TP53; 30067
DR   LiGeA; CCLE_444
DR   PharmacoDB; Hs840_T_602_2019
DR   Progenetix; CVCL_0942
DR   Wikidata; Q54896107
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a squamous cell papilloma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000284).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.34%; East Asian, North=0%; East Asian, South=1.56%; South Asian=0%; European, North=76.29%; European, South=21.8% (PubMed=30894373).
CC   Derived from site: In situ; Pharynx; UBERON=UBERON_0006562.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7573
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13,19
ST   D19S433: 13,15
ST   D21S11: 31,32
ST   D2S1338: 21,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 19,22
ST   Penta D: 9,13
ST   Penta E: 12,13
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   Hs 841.T
AC   CVCL_0943
DR   CLO; CLO_0004150
DR   ATCC; CRL-7574
DR   ATCC; CRL-7574_FL
DR   Wikidata; Q54896108
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7574; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 843.T
AC   CVCL_S080
SY   Hs843T
DR   ATCC; CRL-7575
DR   Wikidata; Q54896109
RX   PubMed=176412;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 6-7 days (PubMed=176412).
CC   Discontinued: ATCC; CRL-7575; true.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   Hs 844.Sk
AC   CVCL_0944
DR   CLO; CLO_0004151
DR   ATCC; CRL-7576
DR   Wikidata; Q54896110
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7576; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N489 ! Hs 844.T
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 844.T
AC   CVCL_N489
SY   Hs-844-T; Hs844T
DR   ATCC; CRL-7892
DR   Cosmic; 1609487
DR   Wikidata; Q54896111
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7892; true.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0944 ! Hs 844.Sk
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 845.T
AC   CVCL_0945
DR   CLO; CLO_0004152
DR   ATCC; CRL-7577
DR   Wikidata; Q54896112
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7577; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0910 ! Hs 792(A).T
OI   CVCL_0911 ! Hs 792(B).T
OI   CVCL_0912 ! Hs 792(C).M
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 846.Sk
AC   CVCL_0946
DR   CLO; CLO_0004153
DR   ATCC; CRL-7578
DR   BioSample; SAMN03471246
DR   Wikidata; Q54896113
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7578; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7578
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 8,9
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0947 ! Hs 846.T
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 846.T
AC   CVCL_0947
DR   CLO; CLO_0004154
DR   ATCC; CRL-7579
DR   Wikidata; Q54896114
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7579; true.
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0946 ! Hs 846.Sk
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   Hs 848.Mu
AC   CVCL_S081
DR   ATCC; CRL-7580
DR   Wikidata; Q54896116
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7580; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N297 ! Hs 848.Sk
OI   CVCL_S082 ! Hs 848.T
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 848.Sk
AC   CVCL_N297
DR   ATCC; CRL-7581
DR   BioSample; SAMN03471248
DR   Wikidata; Q54896117
RX   PubMed=10741968;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7581; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7581
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13,14
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 7,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S081 ! Hs 848.Mu
OI   CVCL_S082 ! Hs 848.T
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 9
//
ID   Hs 848.T
AC   CVCL_S082
DR   ATCC; CRL-7582
DR   Wikidata; Q54896118
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7582; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S081 ! Hs 848.Mu
OI   CVCL_N297 ! Hs 848.Sk
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 849.T
AC   CVCL_0948
DR   CLO; CLO_0004155
DR   ATCC; CRL-7583
DR   ATCC; CRL-7583_FL
DR   Wikidata; Q54896119
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7583; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Hs 851.T
AC   CVCL_0949
DR   CLO; CLO_0004156
DR   ATCC; CRL-7584
DR   ATCC; CRL-7584_FL
DR   Wikidata; Q54896120
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7584; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Hs 852.T
AC   CVCL_0950
SY   Hs-852-T; HS852.T; Hs852.T; Hs852T; HS852T; Hs852
DR   CLO; CLO_0004157
DR   EFO; EFO_0006592
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7585
DR   BioSample; SAMN03473222
DR   BioSample; SAMN10988521
DR   cancercelllines; CVCL_0950
DR   Cell_Model_Passport; SIDM01559
DR   DepMap; ACH-000274
DR   EGA; EGAS00001000610
DR   GEO; GSM827551
DR   GEO; GSM887123
DR   GEO; GSM888194
DR   IARC_TP53; 30068
DR   LiGeA; CCLE_836
DR   PharmacoDB; Hs852_T_603_2019
DR   Progenetix; CVCL_0950
DR   Wikidata; Q54896122
RX   PubMed=478563;
RX   PubMed=20215515;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Population: Asian.
CC   HLA typing: A*24:02,24:02; B*07:02,35:01; C*03:04,07:02; DQA1*01:01,03:02; DQB1*04:01,05:01; DRB1*01:01,04:05 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000040470; Zygosity=Heterozygous (ATCC=CRL-7585).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.89%; Native American=0%; East Asian, North=80.03%; East Asian, South=16.58%; South Asian=0.19%; European, North=0%; European, South=1.3% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-7585; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 13.3,15.3 (ATCC=CRL-7585)
ST   D18S51: 14,16 (PubMed=25877200)
ST   D19S433: 13,15.2
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 18,21
ST   Penta D: 11,13
ST   Penta E: 11,16
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   Hs 853.Bm
AC   CVCL_S083
DR   ATCC; CRL-7586
DR   Wikidata; Q54896123
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7586; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S084 ! Hs 853.Lu
OI   CVCL_S065 ! Hs 853.Sk
OI   CVCL_N021 ! Hs 853.T
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 853.Lu
AC   CVCL_S084
DR   ATCC; CRL-7587
DR   Wikidata; Q54896124
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7587; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S083 ! Hs 853.Bm
OI   CVCL_S065 ! Hs 853.Sk
OI   CVCL_N021 ! Hs 853.T
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 853.Sk
AC   CVCL_S065
DR   ATCC; CRL-7893
DR   Wikidata; Q54896125
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7893; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S083 ! Hs 853.Bm
OI   CVCL_S084 ! Hs 853.Lu
OI   CVCL_N021 ! Hs 853.T
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 853.T
AC   CVCL_N021
DR   ATCC; CRL-7588
DR   Wikidata; Q54896126
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7588; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S083 ! Hs 853.Bm
OI   CVCL_S084 ! Hs 853.Lu
OI   CVCL_S065 ! Hs 853.Sk
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 854.Sk
AC   CVCL_0951
DR   CLO; CLO_0004158
DR   ATCC; CRL-7589
DR   BioSample; SAMN03471249
DR   Wikidata; Q54896127
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7589; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7589
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N306 ! Hs 854.T
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 854.T
AC   CVCL_N306
DR   ATCC; CRL-7590
DR   Wikidata; Q54896129
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7590; true.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0951 ! Hs 854.Sk
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 855.Sk
AC   CVCL_0952
DR   CLO; CLO_0004159
DR   ATCC; CRL-7591
DR   Wikidata; Q54896130
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7591; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0953 ! Hs 855.T
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hs 855.T
AC   CVCL_0953
DR   CLO; CLO_0004160
DR   ATCC; CRL-7592
DR   BioSample; SAMN03471161
DR   Wikidata; Q54896131
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Discontinued: ATCC; CRL-7592; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7592
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 6,8
ST   vWA: 15
DI   NCIt; C34609; Fibrous dysplasia
DI   ORDO; Orphanet_249; Fibrous dysplasia of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0952 ! Hs 855.Sk
SX   Male
AG   27Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 856.T
AC   CVCL_0954
SY   HS856T
DR   CLO; CLO_0004161
DR   ATCC; CRL-7593
DR   BioSample; SAMN03471164
DR   Wikidata; Q54896132
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
ST   Source(s): ATCC=CRL-7593
ST   Amelogenin: X
ST   CSF1PO: 7,8
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 11,12.2
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 8,11
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 23,25
ST   Penta D: 9,11
ST   Penta E: 8,16
ST   TH01: 7,9
ST   TPOX: 7,10
ST   vWA: 15,18
DI   NCIt; C35765; Histiocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 859.T
AC   CVCL_0955
DR   CLO; CLO_0004162
DR   ATCC; CRL-7594
DR   Wikidata; Q54896133
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7594; true.
DI   NCIt; C3146; Skin keratoacanthoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0986 ! Hs 892.T
OI   CVCL_0994 ! Hs 898.Sk
OI   CVCL_0995 ! Hs 898.T
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 8
//
ID   Hs 86.Fs
AC   CVCL_0956
DR   CLO; CLO_0004163
DR   ATCC; CRL-7059
DR   Wikidata; Q54896134
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7059; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 860.T
AC   CVCL_0957
SY   Hs-860-T; HS860T
DR   CLO; CLO_0004164
DR   ATCC; CRL-7595
DR   Cell_Model_Passport; SIDM01748
DR   DepMap; ACH-001712
DR   Wikidata; Q54896135
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7595; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7595
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0909 ! Hs 791.Sk
OI   CVCL_S301 ! Hs 791.T
OI   CVCL_0966 ! Hs 870.T
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   Hs 861.T
AC   CVCL_0958
DR   CLO; CLO_0004165
DR   ATCC; CRL-7596
DR   Wikidata; Q54896136
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7596; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 862.T
AC   CVCL_N020
SY   Hs 862
DR   ATCC; CRL-7597
DR   Wikidata; Q54896137
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7597; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 863.T
AC   CVCL_0959
SY   Hs-863-T; Hs863T; HS863T
DR   CLO; CLO_0004166
DR   CLDB; cl5206
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7598
DR   BioSample; SAMN03471165
DR   BioSample; SAMN10988535
DR   cancercelllines; CVCL_0959
DR   Cell_Model_Passport; SIDM01726
DR   DepMap; ACH-000119
DR   FANTOM5_SSTAR; 10705-109H3
DR   GEO; GSM887124
DR   GEO; GSM888195
DR   IARC_TP53; 30069
DR   IZSLER; BS TCL 146
DR   LiGeA; CCLE_050
DR   PharmacoDB; Hs863_T_604_2019
DR   Progenetix; CVCL_0959
DR   Wikidata; Q54896138
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a Ewing sarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000119).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.35%; East Asian, North=4.46%; East Asian, South=1.13%; South Asian=0.95%; European, North=67.06%; European, South=26.04% (PubMed=30894373).
CC   Discontinued: IZSLER; BS TCL 146; probable.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7598
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 28,29
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 9,12
ST   Penta E: 7,16
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Hs 864.Sk
AC   CVCL_0960
DR   CLO; CLO_0004167
DR   ATCC; CRL-7599
DR   BioSample; SAMN03471166
DR   Wikidata; Q54896139
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7599; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7599
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0961 ! Hs 864.T
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 864.T
AC   CVCL_0961
DR   CLO; CLO_0004168
DR   ATCC; CRL-7600
DR   Wikidata; Q54896140
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7600; true.
ST   Source(s): ATCC=CRL-7600
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0960 ! Hs 864.Sk
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 865.Sk
AC   CVCL_0962
DR   CLO; CLO_0004169
DR   ATCC; CRL-7601
DR   BioSample; SAMN03471167
DR   Wikidata; Q54896141
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7601
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13,16
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 13,14
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 13,17
ST   FGA: 20,21
ST   Penta D: 11
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N599 ! Hs 869.T
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 866.T
AC   CVCL_0963
DR   CLO; CLO_0004170
DR   ATCC; CRL-7602
DR   Wikidata; Q54896142
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7602; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Hs 867.Sk
AC   CVCL_0964
DR   CLO; CLO_0004171
DR   ATCC; CRL-7603
DR   BioSample; SAMN03471168
DR   Wikidata; Q54896143
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7603; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7603
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 868.T
AC   CVCL_0965
DR   CLO; CLO_0004172
DR   ATCC; CRL-7604
DR   BioSample; SAMN03471169
DR   Wikidata; Q54896144
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7604
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 869.T
AC   CVCL_N599
DR   ATCC; CRL-7605
DR   Wikidata; Q54896146
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7605; true.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0962 ! Hs 865.Sk
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   Hs 870.T
AC   CVCL_0966
SY   Hs-870-T; Hs870T; HS870T
DR   CLO; CLO_0004173
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7606
DR   BioSample; SAMN10987680
DR   cancercelllines; CVCL_0966
DR   Cell_Model_Passport; SIDM01749
DR   DepMap; ACH-000340
DR   GEO; GSM887125
DR   GEO; GSM888196
DR   IARC_TP53; 30070
DR   LiGeA; CCLE_576
DR   PharmacoDB; Hs870_T_605_2019
DR   Progenetix; CVCL_0966
DR   Wikidata; Q54896147
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a osteosarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000340).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Pro (c.329G>C); ClinVar=VCV000233627; Zygosity=Heterozygous (DepMap=ACH-000340).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.79%; Native American=28.57%; East Asian, North=5.49%; East Asian, South=0%; South Asian=0.01%; European, North=21.38%; European, South=38.77% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7606
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 13,19
ST   D19S433: 10,16
ST   D21S11: 31.2,32.2
ST   D2S1338: 18
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 18.2,22
ST   Penta D: 10,12
ST   Penta E: 12,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0909 ! Hs 791.Sk
OI   CVCL_S301 ! Hs 791.T
OI   CVCL_0957 ! Hs 860.T
SX   Male
AG   22Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 871.Bm
AC   CVCL_N598
DR   ATCC; CRL-7607
DR   Wikidata; Q54896149
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7607; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0967 ! Hs 871.Sk
OI   CVCL_3522 ! Hs 871.T
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 871.Sk
AC   CVCL_0967
DR   CLO; CLO_0004174
DR   ATCC; CRL-7608
DR   BioSample; SAMN03471170
DR   Wikidata; Q54896150
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7608; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7608
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N598 ! Hs 871.Bm
OI   CVCL_3522 ! Hs 871.T
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 871.T
AC   CVCL_3522
DR   ATCC; CRL-7609
DR   Wikidata; Q54896151
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7609; true.
ST   Source(s): ATCC=CRL-7609
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C3294; Osteoblastoma
DI   ORDO; Orphanet_58040; Osteoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N598 ! Hs 871.Bm
OI   CVCL_0967 ! Hs 871.Sk
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 873.T
AC   CVCL_0968
DR   CLO; CLO_0004175
DR   ATCC; CRL-7610
DR   Wikidata; Q54896152
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7610; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Hs 874.T
AC   CVCL_0969
DR   CLO; CLO_0004176
DR   ATCC; CRL-7611
DR   Wikidata; Q54896153
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7611; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   Hs 875.T
AC   CVCL_0970
DR   CLO; CLO_0004177
DR   ATCC; CRL-7612
DR   BioSample; SAMN03471171
DR   Wikidata; Q54896154
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7612; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-7612
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,13
ST   D16S539: 11
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 877.T
AC   CVCL_0971
DR   CLO; CLO_0004178
DR   ATCC; CRL-7613
DR   Wikidata; Q54896155
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7613; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Hs 879(A).T
AC   CVCL_N597
DR   ATCC; CRL-7614
DR   Wikidata; Q54896156
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7614; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0972 ! Hs 879(B).T
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 879(B).T
AC   CVCL_0972
DR   CLO; CLO_0004179
DR   ATCC; CRL-7615
DR   Wikidata; Q54896157
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7615; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N597 ! Hs 879(A).T
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Hs 88.T
AC   CVCL_0973
SY   HS 88T; Hs88.T
DR   CLO; CLO_0004180
DR   ATCC; CRL-7060
DR   BioSample; SAMN03472658
DR   Wikidata; Q54896158
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7060
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D19S433: 14,16
ST   D21S11: 30,31.2
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,28
ST   Penta D: 13,15
ST   Penta E: 11,13
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 880.T
AC   CVCL_0974
DR   CLO; CLO_0004181
DR   ATCC; CRL-7616
DR   Wikidata; Q54896159
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7616; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 883.T
AC   CVCL_0975
DR   CLO; CLO_0004182
DR   CLDB; cl5207
DR   ATCC; CRL-7617
DR   BioSample; SAMN03471172
DR   IZSLER; BS TCL 142
DR   Wikidata; Q54896160
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7617; true.
CC   Discontinued: IZSLER; BS TCL 142; probable.
ST   Source(s): ATCC=CRL-7617
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 885.T
AC   CVCL_0976
DR   CLO; CLO_0004183
DR   ATCC; CRL-7618
DR   Wikidata; Q54896161
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7618; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Hs 887.Lu
AC   CVCL_N490
DR   ATCC; CRL-7619
DR   Wikidata; Q54896162
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7619; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S085 ! Hs 887.Sk
OI   CVCL_N343 ! Hs 887.T
OI   CVCL_0985 ! Hs 891.T
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 887.Sk
AC   CVCL_S085
DR   ATCC; CRL-7620
DR   Wikidata; Q54896163
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7620; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N490 ! Hs 887.Lu
OI   CVCL_N343 ! Hs 887.T
OI   CVCL_0985 ! Hs 891.T
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   Hs 887.T
AC   CVCL_N343
DR   ATCC; CRL-7621
DR   Wikidata; Q54896164
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7621; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N490 ! Hs 887.Lu
OI   CVCL_S085 ! Hs 887.Sk
OI   CVCL_0985 ! Hs 891.T
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 9
//
ID   Hs 888.Lu
AC   CVCL_0977
SY   Hs888Lu; HS888LU; HS888Lu; Hs888 Lu; Hs 888Lu
DR   BTO; BTO_0005840
DR   CLO; CLO_0004184
DR   CLO; CLO_0004187
DR   CLO; CLO_0004256
DR   CLDB; cl1726
DR   CLDB; cl1727
DR   ATCC; CCL-211
DR   ATCC; CRL-7624
DR   Cell_Model_Passport; SIDM01745
DR   ECACC; 90112709
DR   IZSLER; BS CL 50
DR   PharmacoDB; HS888LU_618_2019
DR   Wikidata; Q54896165
RX   PubMed=7065527;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-211; ATCC=CRL-7624; IZSLER=BS CL 50
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 7,11
ST   D8S1179: 14,16
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 13,19
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   Hs 888.Sk
AC   CVCL_0978
DR   CLO; CLO_0004185
DR   ATCC; CRL-7623
DR   BioSample; SAMN03471173
DR   BioSample; SAMN03471613
DR   Cell_Model_Passport; SIDM01744
DR   Wikidata; Q54896166
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7623
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 7,11
ST   D8S1179: 14,16
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 13,19
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 888.T
AC   CVCL_0979
SY   Hs-888-T; Hs888T; HS888T
DR   CLO; CLO_0004186
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7622
DR   BioSample; SAMN10988554
DR   cancercelllines; CVCL_0979
DR   Cell_Model_Passport; SIDM01746
DR   DepMap; ACH-000154
DR   GEO; GSM887126
DR   GEO; GSM888197
DR   IARC_TP53; 30071
DR   LiGeA; CCLE_713
DR   PharmacoDB; Hs888_T_606_2019
DR   Progenetix; CVCL_0979
DR   Wikidata; Q54896167
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a osteosarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000154).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.45%; Native American=0.69%; East Asian, North=0.26%; East Asian, South=1.64%; South Asian=7.7%; European, North=29.88%; European, South=57.38% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-7622
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 7,11
ST   D8S1179: 14,16
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 13,19
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   Hs 889.Sk
AC   CVCL_0981
DR   CLO; CLO_0004188
DR   ATCC; CRL-7625
DR   ATCC; CRL-7625_FL
DR   BioSample; SAMN03471175
DR   Wikidata; Q54896168
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7625; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7625_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 7,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0982 ! Hs 889.T
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 889.T
AC   CVCL_0982
DR   CLO; CLO_0004189
DR   ATCC; CRL-7626
DR   Wikidata; Q54896169
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7626; true.
ST   Source(s): ATCC=CRL-7626
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 7,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0981 ! Hs 889.Sk
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 890.Sk
AC   CVCL_0983
DR   CLO; CLO_0004190
DR   ATCC; CRL-7627
DR   ATCC; CRL-7627_FL
DR   BioSample; SAMN03471176
DR   Wikidata; Q54896170
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7627; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7627_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 7,8
ST   TPOX: 9,12
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0984 ! Hs 890.T
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 890.T
AC   CVCL_0984
DR   CLO; CLO_0004191
DR   ATCC; CRL-7628
DR   Wikidata; Q54896171
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7628
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 11,14
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 20,23
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 7,8
ST   TPOX: 9,12
ST   vWA: 17,19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0983 ! Hs 890.Sk
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 891.T
AC   CVCL_0985
SY   Hs891T; HS891T
DR   CLO; CLO_0004192
DR   ATCC; CRL-7629
DR   BioSample; SAMN03471177
DR   cancercelllines; CVCL_0985
DR   GEO; GSM827555
DR   Progenetix; CVCL_0985
DR   Wikidata; Q54896172
RX   PubMed=20215515;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-7629
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 12,13
ST   D21S11: 30,31.2
ST   D2S1338: 18,26
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   Penta D: 12,13
ST   Penta E: 10,13
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N490 ! Hs 887.Lu
OI   CVCL_S085 ! Hs 887.Sk
OI   CVCL_N343 ! Hs 887.T
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Hs 892.T
AC   CVCL_0986
SY   Hs892.T; HS892.T; HS892-T
DR   CLO; CLO_0004193
DR   ATCC; CRL-7630
DR   BioSample; SAMN03472813
DR   Wikidata; Q54896173
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7630; true.
ST   Source(s): ATCC=CRL-7630
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3146; Skin keratoacanthoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0955 ! Hs 859.T
OI   CVCL_0994 ! Hs 898.Sk
OI   CVCL_0995 ! Hs 898.T
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   Hs 894(A).T
AC   CVCL_0987
DR   CLO; CLO_0004194
DR   ATCC; CRL-7631
DR   ATCC; CRL-7631_FL
DR   Wikidata; Q54896174
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7631; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7631_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 894(B).T
AC   CVCL_0988
DR   CLO; CLO_0004195
DR   ATCC; CRL-7632
DR   Wikidata; Q54896175
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7632; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   Hs 894(C).T
AC   CVCL_0989
DR   CLO; CLO_0004196
DR   ATCC; CRL-7633
DR   Wikidata; Q54896176
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7633; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7633
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 894(D).T
AC   CVCL_0990
DR   CLO; CLO_0004197
DR   ATCC; CRL-7634
DR   Wikidata; Q54896177
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7634; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7634
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 894(E).Lu
AC   CVCL_0991
DR   CLO; CLO_0004198
DR   ATCC; CRL-7635
DR   GEO; GSM827501
DR   Wikidata; Q54896178
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7635; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7635
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Hs 895.Sk
AC   CVCL_0992
SY   Hs-895-Sk; Hs 895 Sk
DR   CLO; CLO_0004199
DR   ATCC; CRL-7636
DR   BCRJ; 0335
DR   Cell_Model_Passport; SIDM01742
DR   PRIDE; PXD007265
DR   Wikidata; Q54896179
RX   PubMed=25877200;
RX   PubMed=29275043;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 52.2 +- 0.1 hours (PubMed=29275043).
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7636; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,14
ST   D18S51: 12,15
ST   D19S433: 12,13
ST   D21S11: 30,31
ST   D2S1338: 17,19
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 19,25
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0993 ! Hs 895.T
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Hs 895.T
AC   CVCL_0993
SY   Hs-895-T; Hs 895 T; Hs895.T; Hs895T; HS895T
DR   CLO; CLO_0004200
DR   EFO; EFO_0006593
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7637
DR   BCRJ; 0336
DR   BioSample; SAMN03472962
DR   BioSample; SAMN10987618
DR   cancercelllines; CVCL_0993
DR   Cell_Model_Passport; SIDM01743
DR   DepMap; ACH-000043
DR   EGA; EGAS00001000610
DR   GEO; GSM827552
DR   GEO; GSM887127
DR   GEO; GSM888198
DR   IARC_TP53; 30072
DR   LiGeA; CCLE_078
DR   PharmacoDB; Hs895_T_607_2019
DR   PRIDE; PXD007265
DR   Progenetix; CVCL_0993
DR   Wikidata; Q54896180
RX   DOI=10.1101/166199;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29275043;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a melanoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000043).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 35.2 +- 1.45 hours (PubMed=29275043).
CC   HLA typing: A*01:01,25:01; B*07:02,08:01; C*07:02,07:02; DQA1*01:02,03:02; DQB1*02:02,02:02; DRB1*04:05,11:09 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.77%; Native American=1.02%; East Asian, North=0.49%; East Asian, South=0%; South Asian=0.06%; European, North=67.7%; European, South=29.96% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7637; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,14
ST   D18S51: 12,15
ST   D19S433: 12,13
ST   D21S11: 30,31
ST   D2S1338: 17,19
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 19,25
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0992 ! Hs 895.Sk
SX   Female
AG   48Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   Hs 897.Sk
AC   CVCL_S011
DR   ATCC; CRL-7638
DR   Wikidata; Q54896181
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7638; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S012 ! Hs 897.T
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 897.T
AC   CVCL_S012
DR   ATCC; CRL-7639
DR   Wikidata; Q54896182
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7639; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S011 ! Hs 897.Sk
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 898.Sk
AC   CVCL_0994
DR   CLO; CLO_0004201
DR   ATCC; CRL-7640
DR   Wikidata; Q54896183
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7640; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0955 ! Hs 859.T
OI   CVCL_0986 ! Hs 892.T
OI   CVCL_0995 ! Hs 898.T
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 898.T
AC   CVCL_0995
DR   CLO; CLO_0004202
DR   ATCC; CRL-7641
DR   ATCC; CRL-7641_FL
DR   Wikidata; Q54896184
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7641; true.
ST   Source(s): ATCC=CRL-7641_FL
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3146; Skin keratoacanthoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0955 ! Hs 859.T
OI   CVCL_0986 ! Hs 892.T
OI   CVCL_0994 ! Hs 898.Sk
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   Hs 899(A).T
AC   CVCL_0996
DR   CLO; CLO_0004203
DR   ATCC; CRL-7642
DR   Wikidata; Q54896185
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7642; true.
ST   Source(s): ATCC=CRL-7642
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 899(B).T
AC   CVCL_0997
DR   CLO; CLO_0004204
DR   ATCC; CRL-7643
DR   Wikidata; Q54896186
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7643; true.
ST   Source(s): ATCC=CRL-7643
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 899(C).T
AC   CVCL_0998
DR   CLO; CLO_0004205
DR   ATCC; CRL-7644
DR   ATCC; CRL-7644_FL
DR   Wikidata; Q54896187
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7644; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7644_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 899(D).T
AC   CVCL_0999
SY   Hs 899(D).Lu
DR   CLO; CLO_0004206
DR   ATCC; CRL-7645
DR   ATCC; CRL-7645_FL
DR   Wikidata; Q54896188
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7645; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7645_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0979 ! Hs 888.T
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 900.T
AC   CVCL_1000
DR   CLO; CLO_0004207
DR   ATCC; CRL-7646
DR   Wikidata; Q54896191
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7646; true.
DI   NCIt; C3297; Osteoid osteoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 902.T
AC   CVCL_S013
DR   ATCC; CRL-7647
DR   Wikidata; Q54896192
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7647; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   Hs 903.Sk
AC   CVCL_1001
SY   HS903.SK
DR   CLO; CLO_0004208
DR   ATCC; CRL-7648
DR   KCLB; 27648
DR   Wikidata; Q54896193
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7648; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): KCLB=27648
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,14
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   FGA: 20,25
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1002 ! Hs 903.T
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 903.T
AC   CVCL_1002
SY   Hs903.T
DR   CLO; CLO_0004209
DR   ATCC; CRL-7649
DR   KCLB; 27649
DR   Wikidata; Q54896194
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7649; true.
ST   Source(s): KCLB=27649
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,14
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   FGA: 20,25
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3297; Osteoid osteoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1001 ! Hs 903.Sk
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 904.Sk
AC   CVCL_1003
DR   CLO; CLO_0004210
DR   ATCC; CRL-7650
DR   BioSample; SAMN03471179
DR   Wikidata; Q54896195
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7650; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7650
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1004 ! Hs 904.T
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 904.T
AC   CVCL_1004
DR   CLO; CLO_0004211
DR   ATCC; CRL-7651
DR   Wikidata; Q54896196
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7651; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1003 ! Hs 904.Sk
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Hs 905.T
AC   CVCL_1005
SY   HS 905T
DR   CLO; CLO_0004212
DR   ATCC; CRL-7652
DR   Wikidata; Q54896197
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7652; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 906(A).M
AC   CVCL_1006
SY   Hs 906(A).T
DR   CLO; CLO_0004213
DR   ATCC; CRL-7653
DR   BioSample; SAMN03471178
DR   Wikidata; Q54896198
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7653
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 20,25
ST   D3S1358: 9,14
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,14
ST   FGA: 20,22
ST   Penta D: 13,14
ST   Penta E: 13,18
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1007 ! Hs 906(B).T
OI   CVCL_S014 ! Hs 906(C).Sk
OI   CVCL_S015 ! Hs 906(D).Mu
OI   CVCL_1031 ! Hs 934.T
OI   CVCL_1032 ! Hs 935.T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 906(B).T
AC   CVCL_1007
DR   CLO; CLO_0004214
DR   ATCC; CRL-7654
DR   Wikidata; Q54896199
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7654
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 20,25
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,14
ST   FGA: 20,22
ST   Penta D: 13,14
ST   Penta E: 13,18
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1006 ! Hs 906(A).M
OI   CVCL_S014 ! Hs 906(C).Sk
OI   CVCL_S015 ! Hs 906(D).Mu
OI   CVCL_1031 ! Hs 934.T
OI   CVCL_1032 ! Hs 935.T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 906(C).Sk
AC   CVCL_S014
DR   ATCC; CRL-7655
DR   Wikidata; Q54896200
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7655; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1006 ! Hs 906(A).M
OI   CVCL_1007 ! Hs 906(B).T
OI   CVCL_S015 ! Hs 906(D).Mu
OI   CVCL_1031 ! Hs 934.T
OI   CVCL_1032 ! Hs 935.T
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 906(D).Mu
AC   CVCL_S015
DR   ATCC; CRL-7656
DR   Wikidata; Q54896201
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7656; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1006 ! Hs 906(A).M
OI   CVCL_1007 ! Hs 906(B).T
OI   CVCL_S014 ! Hs 906(C).Sk
OI   CVCL_1031 ! Hs 934.T
OI   CVCL_1032 ! Hs 935.T
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 907.Lu
AC   CVCL_1008
DR   CLO; CLO_0004215
DR   ATCC; CRL-7657
DR   BioSample; SAMN03471180
DR   Wikidata; Q54896202
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7657; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-7657
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 908.T
AC   CVCL_1009
SY   Hs908T; Hs 908.Sk
DR   CLO; CLO_0004216
DR   ATCC; CRL-7658
DR   BioSample; SAMN03471181
DR   cancercelllines; CVCL_1009
DR   GEO; GSM827553
DR   Progenetix; CVCL_1009
DR   Wikidata; Q54896203
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7658; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7658
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   Hs 910.Sk
AC   CVCL_1010
DR   CLO; CLO_0004217
DR   ATCC; CRL-7894
DR   Wikidata; Q54896204
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7894; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N671 ! Hs 910.T
OI   CVCL_1011 ! Hs 910.Thm
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hs 910.T
AC   CVCL_N671
DR   ATCC; CRL-7659
DR   Wikidata; Q54896205
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7659; true.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1010 ! Hs 910.Sk
OI   CVCL_1011 ! Hs 910.Thm
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 910.Thm
AC   CVCL_1011
DR   CLO; CLO_0004218
DR   ATCC; CRL-7660
DR   ATCC; CRL-7660_FL
DR   Wikidata; Q54896206
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7660; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
ST   Source(s): ATCC=CRL-7660_FL
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1010 ! Hs 910.Sk
OI   CVCL_N671 ! Hs 910.T
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 912.T
AC   CVCL_1012
DR   CLO; CLO_0004219
DR   ATCC; CRL-7661
DR   Wikidata; Q54896207
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7661; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 913(A).T
AC   CVCL_N665
DR   ATCC; CRL-7663
DR   Wikidata; Q54896208
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7663; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1013 ! Hs 913(B).T
OI   CVCL_1014 ! Hs 913(C).T
OI   CVCL_1015 ! Hs 913(D).T
OI   CVCL_N664 ! Hs 913(E).T
OI   CVCL_1016 ! Hs 913(F).T
OI   CVCL_S016 ! Hs 913(G).Sk
OI   CVCL_1017 ! Hs 913T
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 6
//
ID   Hs 913(B).T
AC   CVCL_1013
DR   CLO; CLO_0004220
DR   ATCC; CRL-7664
DR   BioSample; SAMN03471182
DR   Wikidata; Q54896209
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7664; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7664
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N665 ! Hs 913(A).T
OI   CVCL_1014 ! Hs 913(C).T
OI   CVCL_1015 ! Hs 913(D).T
OI   CVCL_N664 ! Hs 913(E).T
OI   CVCL_1016 ! Hs 913(F).T
OI   CVCL_S016 ! Hs 913(G).Sk
OI   CVCL_1017 ! Hs 913T
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 913(C).T
AC   CVCL_1014
DR   CLO; CLO_0004221
DR   ATCC; CRL-7665
DR   Wikidata; Q54896210
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7665; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
ST   Source(s): ATCC=CRL-7665
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N665 ! Hs 913(A).T
OI   CVCL_1013 ! Hs 913(B).T
OI   CVCL_1015 ! Hs 913(D).T
OI   CVCL_N664 ! Hs 913(E).T
OI   CVCL_1016 ! Hs 913(F).T
OI   CVCL_S016 ! Hs 913(G).Sk
OI   CVCL_1017 ! Hs 913T
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 913(D).T
AC   CVCL_1015
DR   CLO; CLO_0004222
DR   ATCC; CRL-7666
DR   Wikidata; Q54896211
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7666; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7666
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N665 ! Hs 913(A).T
OI   CVCL_1013 ! Hs 913(B).T
OI   CVCL_1014 ! Hs 913(C).T
OI   CVCL_N664 ! Hs 913(E).T
OI   CVCL_1016 ! Hs 913(F).T
OI   CVCL_S016 ! Hs 913(G).Sk
OI   CVCL_1017 ! Hs 913T
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 913(E).T
AC   CVCL_N664
SY   HS 913TE
DR   ATCC; CRL-7667
DR   Wikidata; Q54896212
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7667; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N665 ! Hs 913(A).T
OI   CVCL_1013 ! Hs 913(B).T
OI   CVCL_1014 ! Hs 913(C).T
OI   CVCL_1015 ! Hs 913(D).T
OI   CVCL_1016 ! Hs 913(F).T
OI   CVCL_S016 ! Hs 913(G).Sk
OI   CVCL_1017 ! Hs 913T
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 913(F).T
AC   CVCL_1016
DR   CLO; CLO_0004223
DR   ATCC; CRL-7668
DR   Wikidata; Q54896213
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-7668
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 29,33.2
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 13
ST   Penta E: 7,12
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N665 ! Hs 913(A).T
OI   CVCL_1013 ! Hs 913(B).T
OI   CVCL_1014 ! Hs 913(C).T
OI   CVCL_1015 ! Hs 913(D).T
OI   CVCL_N664 ! Hs 913(E).T
OI   CVCL_S016 ! Hs 913(G).Sk
OI   CVCL_1017 ! Hs 913T
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Hs 913(G).Sk
AC   CVCL_S016
DR   ATCC; CRL-7662
DR   Wikidata; Q54896214
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7662; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N665 ! Hs 913(A).T
OI   CVCL_1013 ! Hs 913(B).T
OI   CVCL_1014 ! Hs 913(C).T
OI   CVCL_1015 ! Hs 913(D).T
OI   CVCL_N664 ! Hs 913(E).T
OI   CVCL_1016 ! Hs 913(F).T
OI   CVCL_1017 ! Hs 913T
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 6
//
ID   Hs 913T
AC   CVCL_1017
SY   HS 913T; Hs 913.T; Hs913T; HS913T
DR   CLO; CLO_0004224
DR   CLO; CLO_0004257
DR   CLDB; cl4958
DR   ATCC; HTB-152
DR   BioSample; SAMN03472725
DR   GEO; GSM1676301
DR   GEO; GSM1701636
DR   ICLC; HTL99012
DR   NCI-DTP; HS 913T
DR   Wikidata; Q54896215
RX   PubMed=2216456;
RX   PubMed=3335022;
RX   PubMed=26351324;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=HTB-152
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 29,33.2
ST   D2S1338: 17,18
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,12
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N665 ! Hs 913(A).T
OI   CVCL_1013 ! Hs 913(B).T
OI   CVCL_1014 ! Hs 913(C).T
OI   CVCL_1015 ! Hs 913(D).T
OI   CVCL_N664 ! Hs 913(E).T
OI   CVCL_1016 ! Hs 913(F).T
OI   CVCL_S016 ! Hs 913(G).Sk
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Hs 914
AC   CVCL_1018
DR   CLO; CLO_0004225
DR   ATCC; CRL-7895
DR   Wikidata; Q54896216
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7895; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <12FW
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 915
AC   CVCL_1019
DR   CLO; CLO_0004226
DR   ATCC; CRL-7896
DR   Wikidata; Q54896217
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7896; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <12FW
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 916
AC   CVCL_1020
DR   CLO; CLO_0004227
DR   ATCC; CRL-7897
DR   Wikidata; Q54896218
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7897; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <12FW
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Hs 917.T
AC   CVCL_1021
DR   CLO; CLO_0004228
DR   ATCC; CRL-7669
DR   BioSample; SAMN03471183
DR   Wikidata; Q54896219
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
ST   Source(s): ATCC=CRL-7669
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,19
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 16,18
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 918.Sk
AC   CVCL_S017
DR   ATCC; CRL-7670
DR   Wikidata; Q54896220
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7670; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 919.Sk
AC   CVCL_1022
DR   CLO; CLO_0004229
DR   ATCC; CRL-7671
DR   BioSample; SAMN03471186
DR   Wikidata; Q54896221
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7671; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7671
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1023 ! Hs 919.T
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 919.T
AC   CVCL_1023
SY   Hs919.T
DR   CLO; CLO_0004230
DR   ATCC; CRL-7672
DR   Wikidata; Q54896222
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7672; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7672
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3297; Osteoid osteoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1022 ! Hs 919.Sk
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 923.Sk
AC   CVCL_S018
DR   ATCC; CRL-7673
DR   Wikidata; Q54896223
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7673; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 924.LiT
AC   CVCL_S019
DR   ATCC; CRL-7675
DR   Wikidata; Q54896224
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Pacific; Micronesian.
CC   Discontinued: ATCC; CRL-7675; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1024 ! Hs 924.Sk
OI   CVCL_S446 ! Hs 924.T
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Hs 924.Sk
AC   CVCL_1024
DR   CLO; CLO_0004231
DR   ATCC; CRL-7674
DR   BioSample; SAMN03471187
DR   Wikidata; Q54896225
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Pacific; Micronesian.
CC   Discontinued: ATCC; CRL-7674; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7674
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S019 ! Hs 924.LiT
OI   CVCL_S446 ! Hs 924.T
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 924.T
AC   CVCL_S446
SY   HS 924.T
DR   ATCC; CRL-7918
DR   Wikidata; Q54896226
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Pacific; Micronesian.
CC   Discontinued: ATCC; CRL-7918; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1024 ! Hs 924.Sk
OI   CVCL_S019 ! Hs 924.LiT
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Hs 925.Sk
AC   CVCL_1025
DR   CLO; CLO_0004232
DR   ATCC; CRL-7676
DR   BioSample; SAMN03471188
DR   Wikidata; Q54896227
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7676
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 17,18
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   D8S1179: 9,13
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 10,14
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1026 ! Hs 925.T
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 925.T
AC   CVCL_1026
SY   HS 925T; Hs925T
DR   BTO; BTO_0002638
DR   CLO; CLO_0004233
DR   ATCC; CRL-7677
DR   BioSample; SAMN03471189
DR   FANTOM5_SSTAR; 10732-110B3
DR   Wikidata; Q54896228
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7677
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 17,18
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 14
ST   D7S820: 9,10
ST   D8S1179: 9,13
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 10,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C7073; Paget disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1025 ! Hs 925.Sk
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Hs 926.T
AC   CVCL_1027
SY   Hs-926; Hs 926
DR   CLO; CLO_0004234
DR   ATCC; CRL-7678
DR   BioSample; SAMN03471190
DR   Cosmic; 1309334
DR   Wikidata; Q54896229
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-7678
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 20,24
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 9,14
ST   Penta E: 12,15
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 927.T
AC   CVCL_S020
DR   ATCC; CRL-7679
DR   Wikidata; Q54896230
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7679; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 928.T
AC   CVCL_S021
DR   ATCC; CRL-7680
DR   Wikidata; Q54896233
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7680; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Hs 929.Sk
AC   CVCL_1028
DR   CLO; CLO_0004235
DR   ATCC; CRL-7681
DR   BioSample; SAMN03471133
DR   Wikidata; Q54896234
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7681; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S086 ! Hs 929.T
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Hs 929.T
AC   CVCL_S086
DR   ATCC; CRL-7682
DR   Wikidata; Q54896236
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7682; true.
DI   NCIt; C3016; Eosinophilic granuloma
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1028 ! Hs 929.Sk
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 7
//
ID   Hs 93.Mu
AC   CVCL_N602
DR   ATCC; CRL-7061
DR   Wikidata; Q54896237
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7061; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1029 ! Hs 93.T
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   Hs 93.T
AC   CVCL_1029
DR   CLO; CLO_0004236
DR   ATCC; CRL-7062
DR   BioSample; SAMN03472659
DR   GEO; GSM1676365
DR   GEO; GSM1701695
DR   Wikidata; Q54896238
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
ST   Source(s): ATCC=CRL-7062
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 14,16
ST   D21S11: 29,30
ST   D2S1338: 20,24
ST   D3S1358: 14,18
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 13
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N602 ! Hs 93.Mu
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 933.T
AC   CVCL_1030
SY   HS 933T
DR   CLO; CLO_0004237
DR   ATCC; CRL-7683
DR   Wikidata; Q54896239
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7683; true.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 934.T
AC   CVCL_1031
SY   Hs-934-T; Hs934T; HS934T
DR   CLO; CLO_0004238
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7684
DR   BioSample; SAMN10988525
DR   cancercelllines; CVCL_1031
DR   Cell_Model_Passport; SIDM01741
DR   DepMap; ACH-000194
DR   GEO; GSM887128
DR   GEO; GSM888199
DR   LiGeA; CCLE_171
DR   PharmacoDB; Hs934_T_608_2019
DR   Progenetix; CVCL_1031
DR   Wikidata; Q54896240
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a melanoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000194).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.08%; East Asian, North=0.36%; East Asian, South=0.85%; South Asian=0%; European, North=69.72%; European, South=28.98% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7684; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7684
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1006 ! Hs 906(A).M
OI   CVCL_1007 ! Hs 906(B).T
OI   CVCL_S014 ! Hs 906(C).Sk
OI   CVCL_S015 ! Hs 906(D).Mu
OI   CVCL_1032 ! Hs 935.T
SX   Female
AG   58Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Hs 935.T
AC   CVCL_1032
SY   Hs-935-T; HS 935.T
DR   CLO; CLO_0004239
DR   ATCC; CRL-7685
DR   Cell_Model_Passport; SIDM01740
DR   Wikidata; Q54896241
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7685; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7685
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1006 ! Hs 906(A).M
OI   CVCL_1007 ! Hs 906(B).T
OI   CVCL_S014 ! Hs 906(C).Sk
OI   CVCL_S015 ! Hs 906(D).Mu
OI   CVCL_1031 ! Hs 934.T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 936.T
AC   CVCL_1033
SY   Hs-936-T; HS 936.T; HS 936T; Hs-936.T; Hs936.T; Hs936T; HS936T
DR   CLO; CLO_0004240
DR   EFO; EFO_0006594
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7686
DR   BioSample; SAMN03471134
DR   BioSample; SAMN10987676
DR   cancercelllines; CVCL_1033
DR   Cell_Model_Passport; SIDM01750
DR   DepMap; ACH-000801
DR   EGA; EGAS00001000610
DR   GEO; GSM827554
DR   GEO; GSM887129
DR   GEO; GSM888200
DR   IARC_TP53; 30073
DR   LiGeA; CCLE_556
DR   PharmacoDB; Hs936_T_609_2019
DR   Progenetix; CVCL_1033
DR   Wikidata; Q54896242
RX   PubMed=6500159;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*07:02,37:04; C*07:02,07:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000801).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.32%; Native American=0%; East Asian, North=3.21%; East Asian, South=0%; South Asian=0.68%; European, North=60.44%; European, South=34.35% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7686; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7686
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   Hs 936.T(C1)
AC   CVCL_1034
DR   CLO; CLO_0004241
DR   ATCC; CRL-7687
DR   cancercelllines; CVCL_1034
DR   Wikidata; Q54896243
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7687
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 17,18
ST   D19S433: 14.2
ST   D21S11: 29,30
ST   D2S1338: 17,21
ST   D3S1358: 15,18
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 11,16
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 12,18
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1033 ! Hs 936.T
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   Hs 938.T
AC   CVCL_1035
SY   HS 938T
DR   CLO; CLO_0004242
DR   ATCC; CRL-7688
DR   Wikidata; Q54896244
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7688; true.
DI   NCIt; C3073; Gynecomastia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Hs 939.Sk
AC   CVCL_G023
SY   Hs939SK
DR   ATCC; CRL-7689
DR   Wikidata; Q54896245
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-7689; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1036 ! Hs 939.T
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 9
//
ID   Hs 939.T
AC   CVCL_1036
SY   Hs-939-T; HS-939-T; Hs939-T; Hs939T; HS939T
DR   CLO; CLO_0004243
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7690
DR   BioSample; SAMN03471135
DR   BioSample; SAMN10988129
DR   cancercelllines; CVCL_1036
DR   Cell_Model_Passport; SIDM00663
DR   Cosmic; 888862
DR   Cosmic; 897478
DR   Cosmic-CLP; 1298144
DR   DepMap; ACH-000814
DR   GDSC; 1298144
DR   GEO; GSM887130
DR   GEO; GSM888201
DR   GEO; GSM1669900
DR   IARC_TP53; 30074
DR   LiGeA; CCLE_873
DR   PharmacoDB; Hs939_T_610_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1036
DR   Wikidata; Q54896246
RX   PubMed=15009714;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15009714; Cosmic-CLP=1298144; DepMap=ACH-000814).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (Cosmic-CLP=1298144; DepMap=ACH-000814).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=2.9%; East Asian, South=0%; South Asian=0.5%; European, North=68.28%; European, South=27.95% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7690; true.
ST   Source(s): ATCC=CRL-7690; Cosmic-CLP=1298144
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G023 ! Hs 939.Sk
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Hs 94.Mu
AC   CVCL_N604
DR   ATCC; CRL-7063
DR   Wikidata; Q54896247
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7063; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1037 ! Hs 94.T
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Hs 94.T
AC   CVCL_1037
DR   CLO; CLO_0004244
DR   ATCC; CRL-7064
DR   BioSample; SAMN03472660
DR   Wikidata; Q54896248
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7064; true.
ST   Source(s): ATCC=CRL-7064
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N604 ! Hs 94.Mu
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Hs 940.T
AC   CVCL_1038
SY   Hs-940-T; HS-940-T; Hs940-T; Hs940.T; Hs940T; HS940T; Hs-940; HS940
DR   CLO; CLO_0004245
DR   EFO; EFO_0006595
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7691
DR   BioSample; SAMN03471136
DR   BioSample; SAMN10987631
DR   cancercelllines; CVCL_1038
DR   Cell_Model_Passport; SIDM00662
DR   Cosmic; 706093
DR   Cosmic; 888837
DR   Cosmic; 897476
DR   Cosmic-CLP; 1298145
DR   DepMap; ACH-000135
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298145
DR   GEO; GSM887131
DR   GEO; GSM888202
DR   GEO; GSM1669901
DR   IARC_TP53; 30075
DR   LiGeA; CCLE_121
DR   PharmacoDB; Hs940_T_611_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1038
DR   Wikidata; Q54896249
RX   DOI=10.1101/166199;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Problematic cell line: Misclassified. Originally thought to be a cutaneous melanoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000135).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:06,07:06; DQA1*02:01,05:02; DQB1*06:13,06:13; DRB1*03:01,03:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=10766161; PubMed=15009714; DepMap=ACH-000135).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Leu (c.646G>T); ClinVar=VCV000376670; Zygosity=Homozygous (DepMap=ACH-000135).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.79%; Native American=0.31%; East Asian, North=1.11%; East Asian, South=0%; South Asian=0%; European, North=71.04%; European, South=26.75% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7691; Cosmic-CLP=1298145
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   Hs 941.T
AC   CVCL_1039
SY   HS 941T
DR   CLO; CLO_0004246
DR   ATCC; CRL-7692
DR   BioSample; SAMN03471137
DR   Wikidata; Q54896250
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7692; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7692
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Hs 944.T
AC   CVCL_1040
SY   Hs-944-T; HS-944-T; HS 944T; Hs944T; HS944T; HS 944; Hs 944; HS944
DR   CLO; CLO_0004247
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7693
DR   BioGRID_ORCS_Cell_line; 649
DR   BioSample; SAMN10988352
DR   cancercelllines; CVCL_1040
DR   Cell_Model_Passport; SIDM00063
DR   Cosmic; 706096
DR   Cosmic; 888839
DR   DepMap; ACH-000632
DR   EGA; EGAS00001000978
DR   GEO; GSM887132
DR   GEO; GSM888203
DR   GEO; GSM1669902
DR   IARC_TP53; 30076
DR   LiGeA; CCLE_597
DR   PharmacoDB; Hs944_T_612_2019
DR   Progenetix; CVCL_1040
DR   Wikidata; Q54896251
RX   PubMed=6500159;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343).
CC   HLA typing: A*02:01,03:01; B*07:02,44:02; C*05:01,07:02; DQA1*01:02,01:02; DQB1*03:01,06:02; DRB1*12:01,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Homozygous (DepMap=ACH-000632).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Heterozygous (DepMap=ACH-000632).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=10766161; PubMed=15009714; DepMap=ACH-000632).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys163fs (c.486_487insA); Zygosity=Heterozygous (DepMap=ACH-000632).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys382Asnfs*40 (c.1146delA); ClinVar=VCV001408583; Zygosity=Homozygous (DepMap=ACH-000632).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.22%; East Asian, South=0%; South Asian=0%; European, North=66.41%; European, South=31.37% (PubMed=30894373).
CC   Misspelling: Hs-994; Cosmic=706096; Cosmic=888839.
CC   Discontinued: ATCC; CRL-7693; true.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   Hs 946.Pl
AC   CVCL_S087
DR   ATCC; CRL-7694
DR   Wikidata; Q54896252
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7694; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Hs 97.Fs
AC   CVCL_1041
DR   CLO; CLO_0004248
DR   ATCC; CRL-7065
DR   BioSample; SAMN03472661
DR   ChEMBL-Cells; CHEMBL3308441
DR   ChEMBL-Targets; CHEMBL614151
DR   PubChem_Cell_line; CVCL_1041
DR   Wikidata; Q54896253
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Native American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): ATCC=CRL-7065
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 13,17
ST   D19S433: 15,16.2
ST   D21S11: 30,31.2
ST   D2S1338: 17,22
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 22,26
ST   Penta D: 9,12
ST   Penta E: 13,19
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Hs 99.T
AC   CVCL_S295
DR   ATCC; CRL-7829
DR   Wikidata; Q54896254
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7829; true.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   hs SKOM C13
AC   CVCL_RX78
SY   hs C13
DR   Wikidata; Q54896255
RX   PubMed=19376775;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Tibetan; VBO=VBO_0012856.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   37FD
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   hs SKOM C17
AC   CVCL_RX79
SY   hs C17
DR   Wikidata; Q54896256
RX   PubMed=19376775;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Tibetan; VBO=VBO_0012856.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   37FD
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   hs-103-3
AC   CVCL_8549
SY   hs-103
DR   JCRB; JCRB1096
DR   JCRB; NIHS0378
DR   Wikidata; Q54896257
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Heat-sensitive mutant of CHL. Unable to form colonies in soft agar at 39.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0378; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   HS-131
AC   CVCL_E5PR
RX   PubMed=7507084;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08620; Human FGF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HS-16
AC   CVCL_J345
DR   Wikidata; Q54896258
RX   PubMed=8945624;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 40 hours (PubMed=8945624).
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   hs-164-2
AC   CVCL_8550
SY   hs-164
DR   JCRB; JCRB1097
DR   JCRB; NIHS0379
DR   Wikidata; Q54896259
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Heat-sensitive mutant of CHL. Unable to form colonies in soft agar at 39.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0379; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   hs-171-1
AC   CVCL_8551
SY   hs-171
DR   JCRB; JCRB1098
DR   JCRB; NIHS0380
DR   Wikidata; Q54896260
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Heat-sensitive mutant of CHL. Unable to form colonies in soft agar at 39.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0380; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   hs-172-3
AC   CVCL_8552
SY   hs-172
DR   JCRB; JCRB1099
DR   JCRB; NIHS0381
DR   Wikidata; Q54896261
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Heat-sensitive mutant of CHL. Unable to form colonies in soft agar at 39.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0381; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   HS-18
AC   CVCL_J346
DR   Wikidata; Q54896262
RX   PubMed=8945624;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 33 hours (PubMed=8945624).
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 12
//
ID   HS-21
AC   CVCL_0E36
SY   HS21
DR   Wikidata; Q54896263
RX   Patent=US7129086;
RX   PubMed=7849321;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   HS-21 (subclone 1H3)
AC   CVCL_G653
SY   HS-21; HS21
DR   CLO; CLO_0004250
DR   ATCC; HB-255
DR   Wikidata; Q54896264
RX   PubMed=2541813;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on sperm acrosomal vesicle.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 5
//
ID   HS-210
AC   CVCL_E5PS
RX   PubMed=7507084;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08620; Human FGF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   hs-211
AC   CVCL_8553
DR   JCRB; JCRB1100
DR   JCRB; NIHS0382
DR   Wikidata; Q54896265
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Heat-sensitive mutant of CHL. Unable to form colonies in soft agar at 39.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0382; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   HS-22
AC   CVCL_5527
DR   JCRB; JCRB1215
DR   Wikidata; Q54896266
CC   Discontinued: JCRB; JCRB1215; probable.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   hs-222-3
AC   CVCL_8554
SY   hs-222
DR   JCRB; JCRB1101
DR   JCRB; NIHS0383
DR   Wikidata; Q54896267
RX   PubMed=1170023;
RX   PubMed=8168155;
CC   Characteristics: Heat-sensitive mutant of CHL. Unable to form colonies in soft agar at 39.5 Celsius.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0383; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8483 ! CHL AIG
SX   Female
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   HS-23
AC   CVCL_0E35
SY   HS23
DR   ATCC; CRL-2495
DR   Wikidata; Q54896268
RX   Patent=US7129086;
RX   PubMed=7849321;
RX   PubMed=20924730;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-2495; true.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3720 ! HS-5
OI   CVCL_0E34 ! HS-27
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 18
//
ID   HS-233
AC   CVCL_E5PT
RX   PubMed=7507084;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08620; Human FGF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HS-24
AC   CVCL_Y110
SY   HS 24
DR   CGH-DB; 186-1
DR   CGH-DB; 9173-4
DR   Cosmic; 889099
DR   Wikidata; Q54896269
RX   PubMed=1316092;
RX   PubMed=2201737;
RX   PubMed=2208054;
RX   PubMed=2695238;
RX   PubMed=3327702;
RX   PubMed=3678487;
RX   PubMed=11414198;
RX   PubMed=14581340;
RX   PubMed=15746151;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   HS-27
AC   CVCL_0E34
SY   HS27
DR   TOKU-E; 1947
DR   Wikidata; Q54896270
RX   Patent=US7129086;
RX   PubMed=2987007;
RX   PubMed=7849321;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E35 ! HS-23
OI   CVCL_3720 ! HS-5
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   HS-276
AC   CVCL_E5PU
RX   PubMed=7507084;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08620; Human FGF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HS-27A
AC   CVCL_3719
SY   HS27A; HS27a
DR   CLO; CLO_0004252
DR   EFO; EFO_0005283
DR   ATCC; CRL-2496
DR   BioSample; SAMN03471594
DR   ENCODE; ENCBS009ENC
DR   Wikidata; Q54896271
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
ST   Source(s): ATCC=CRL-2496; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 15
ST   D12S391: 19,21
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 15
ST   D1S1656: 15,17.3
ST   D21S11: 29,30
ST   D22S1045: 15,16
ST   D2S1338: 22,26
ST   D2S441: 11
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13,16
ST   DYS391: 10
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 5,6
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0E34 ! HS-27
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   HS-30
AC   CVCL_J347
DR   Wikidata; Q54896272
RX   PubMed=8945624;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 39 hours (PubMed=8945624).
DI   NCIt; C3087; Hemangiopericytoma
DI   ORDO; Orphanet_2126; Solitary fibrous tumour/hemangiopericytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   HS-42
AC   CVCL_J348
DR   Wikidata; Q54896273
RX   PubMed=8945624;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 34 hours (PubMed=8945624).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9306; Soft tissue sarcoma
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   HS-5
AC   CVCL_3720
SY   HS5
DR   BTO; BTO_0004123
DR   CLO; CLO_0004254
DR   EFO; EFO_0005282
DR   ATCC; CRL-3611
DR   ATCC; CRL-11882
DR   BioSample; SAMN03471343
DR   ENCODE; ENCBS010ENC
DR   NCBI_Iran; C626
DR   PRIDE; PXD030239
DR   Wikidata; Q54896276
RX   Patent=US7129086;
RX   PubMed=7849321;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11882.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics; Quantitative.
CC   Discontinued: ATCC; CRL-11882; true.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
ST   Source(s): ATCC=CRL-3611; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 13,15
ST   D12S391: 19,21
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 15
ST   D1S1656: 15,17.3
ST   D21S11: 29,30
ST   D22S1045: 15,16
ST   D2S1338: 22,26
ST   D2S441: 11
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13,16
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 5,6
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E35 ! HS-23
OI   CVCL_0E34 ! HS-27
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   HS-57
AC   CVCL_Y111
SY   HS 57
DR   Wikidata; Q54006382
RX   CelloPub=CLPUB00569;
RX   PubMed=2695238;
RX   PubMed=3327702;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   HS-63
AC   CVCL_DF13
SY   HS 63
DR   Wikidata; Q54896277
RX   PubMed=3820188;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26436; Human ACRV1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   HS-67
AC   CVCL_E705
SY   HS67
DR   dbMHC; 48901
DR   ECACC; 94071425
DR   IHW; IHW09277
DR   IPD-IMGT/HLA; 10764
DR   Wikidata; Q54896278
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01,11:01:01:01; B*48:01:01,67:01:01; C*07:02:01:01,08:03:01; DRB1*16,08 (IPD-IMGT/HLA=10764).
CC   HLA typing: A*11:01:01:01,24:02:01:01; B*48:01:01,67:01:01; C*07:02:01:01,08:03:01; DPA1*02:02:02; DPB1*05:01:01; DQA1*01:02:02,01:03:01; DQB1*05:02:01,06:01:01; DRB1*16:02:01:02,08:03:02; DRB5*02:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   HS-7
AC   CVCL_KR85
DR   Wikidata; Q54896279
RX   PubMed=7498552;
RX   PubMed=7553220;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   HS-72
AC   CVCL_H243
DR   Wikidata; Q54896280
RX   PubMed=7498552;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_KR85 ! HS-7
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   HS-80
AC   CVCL_9708
DR   Wikidata; Q54896281
RX   PubMed=1320624;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS-ES-1
AC   CVCL_8713
SY   HS-ES-1M; HE-ES; HEES; HSES
DR   CLO; CLO_0050148
DR   BioSample; SAMN03471915
DR   FANTOM5_SSTAR; 10443-106F2
DR   GEO; GSM1632456
DR   GEO; GSM1632457
DR   GEO; GSM1632460
DR   GEO; GSM1632461
DR   RCB; RCB2364
DR   Wikidata; Q54006383
RX   PubMed=9216728;
RX   PubMed=16557275;
RX   PubMed=26365879;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=26365879).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): RCB=RCB2364
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 10
ST   D5S818: 10
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HS-ES-2M
AC   CVCL_8714
SY   HSES2M
DR   CLO; CLO_0050149
DR   BioSample; SAMN03471971
DR   GEO; GSM2409682
DR   GEO; GSM2409683
DR   GEO; GSM2409684
DR   GEO; GSM2409685
DR   GEO; GSM2409686
DR   GEO; GSM2409687
DR   GEO; GSM2787356
DR   RCB; RCB2360
DR   Wikidata; Q54006384
RX   PubMed=28945250;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=28945250).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2360
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8715 ! HS-ES-2R
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HS-ES-2M BAF47
AC   CVCL_QW56
SY   HS-ES-2M_BAF47; HSES2M_BAF47
DR   GEO; GSM2409688
DR   GEO; GSM2409689
DR   GEO; GSM2409690
DR   GEO; GSM2409691
DR   GEO; GSM2409692
DR   GEO; GSM2409693
DR   GEO; GSM2787357
DR   Wikidata; Q54896282
RX   PubMed=28945250;
CC   Population: Japanese.
CC   Characteristics: Transfection of SMARCB1 rescues the phenotype of the parent cell line which is heterozygous for its deletion.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11103; SMARCB1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8714 ! HS-ES-2M
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   HS-ES-2R
AC   CVCL_8715
DR   CLO; CLO_0050147
DR   BioSample; SAMN03471973
DR   FANTOM5_SSTAR; 10495-107B9
DR   RCB; RCB2361
DR   Wikidata; Q54896283
CC   Population: Japanese.
ST   Source(s): RCB=RCB2361
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8714 ! HS-ES-2M
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   HS-K
AC   CVCL_K100
DR   CLO; CLO_0050643
DR   BioSample; SAMN03472340
DR   RCB; RCB0159
DR   Wikidata; Q54896284
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): RCB=RCB0159
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   HS-MM
AC   CVCL_W472
DR   Wikidata; Q54896285
RX   PubMed=2095846;
RX   PubMed=8492224;
RX   PubMed=10398127;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=8492224).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   HS-Os-1
AC   CVCL_8716
SY   HSOS1
DR   CLO; CLO_0050022
DR   BioSample; SAMN03470989
DR   BioSample; SAMN03472027
DR   cancercelllines; CVCL_8716
DR   DepMap; ACH-002069
DR   FANTOM5_SSTAR; 10558-107I9
DR   RCB; RCB2229
DR   Wikidata; Q54896286
RX   PubMed=1679269;
RX   PubMed=2085479;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~58 hours (PubMed=1679269).
CC   Derived from site: Metastatic; Bone, left humerus; UBERON=UBERON_0000976.
ST   Source(s): PubMed=25877200; RCB=RCB2229
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,11.3,12 (PubMed=25877200)
ST   D13S317: 11,12 (RCB=RCB2229)
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 12
ST   D21S11: 30,31.2
ST   D2S1338: 18,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 24,25
ST   Penta D: 9,12
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8 (PubMed=25877200)
ST   TPOX: 8,11 (RCB=RCB2229)
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HS-P
AC   CVCL_5291
DR   CLO; CLO_0050624
DR   RCB; RCB1757
DR   Wikidata; Q54896287
RX   PubMed=11222016;
RX   PubMed=11437512;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60419; Rat histiocytic sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   HS-PSS
AC   CVCL_8717
SY   Hs-PSS; HSPSS
DR   CLO; CLO_0051534
DR   BioSample; SAMN03471914
DR   DepMap; ACH-002065
DR   FANTOM5_SSTAR; 10442-106F1
DR   RCB; RCB2362
DR   Wikidata; Q54896288
RX   PubMed=28556483;
RX   PubMed=33707600;
RX   PubMed=34059954;
RX   PubMed=36818284;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Karyotypic information: Average ploidy of 1.82 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34059954).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=28556483; PubMed=33707600; PubMed=36818284; RCB=RCB2362
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 14,15
ST   D19S433: 10.2,12,13 (PubMed=33707600)
ST   D19S433: 13 (PubMed=28556483; PubMed=36818284)
ST   D21S11: 28,32
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 14,15 (PubMed=28556483; PubMed=36818284)
ST   D8S1179: 14,15,19 (PubMed=33707600)
ST   FGA: 22
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HS-RMS-1
AC   CVCL_A791
DR   Wikidata; Q54896289
RX   PubMed=10853028;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=10853028).
CC   Derived from site: In situ; Left gluteal muscle; UBERON=UBERON_0002000.
DI   NCIt; C4258; Pleomorphic rhabdomyosarcoma
DI   ORDO; Orphanet_293199; Pleomorphic rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   HS-RMS-2
AC   CVCL_Y582
DR   Wikidata; Q54896290
RX   PubMed=22432055;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Derived from site: In situ; Left gluteal muscle; UBERON=UBERON_0002000.
DI   NCIt; C4258; Pleomorphic rhabdomyosarcoma
DI   ORDO; Orphanet_293199; Pleomorphic rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   HS-Sch-2
AC   CVCL_8718
SY   HS-sch-2; HSSCH2
DR   CLO; CLO_0050146
DR   BCRJ; 0376
DR   BioSample; SAMN03472028
DR   cancercelllines; CVCL_8718
DR   DepMap; ACH-002066
DR   IARC_TP53; 17934
DR   RCB; RCB2230
DR   Wikidata; Q54896291
RX   PubMed=10891546;
RX   PubMed=28556483;
RX   PubMed=32642732;
RX   PubMed=33707600;
RX   PubMed=34059954;
RX   PubMed=36818284;
CC   Problematic cell line: Misclassified. Originally thought to be a malignant peripheral nerve sheath tumor (MPNST) but shown to be from a desmplastic melanoma (PubMed=36818284). This is based on a number of criteria such as the result of a methylome-based classifier, the expression of the SOX10 and S100B markers, a WT status for PRC2 genes, the complete inactivation of NF1 and CDKN2A and negative staining for Melan-A.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~56 hours (PubMed=10891546).
CC   Karyotypic information: Average ploidy of 3.89 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous; Note=By translocation (PubMed=34059954).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Glu91Asnfs*6 (c.270_288del); Zygosity=Heterozygous; Note=Somatic (PubMed=36818284).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.3113+1G>A; ClinVar=VCV000000345; Zygosity=Heterozygous; Note=Splice donor mutation. Somatic (PubMed=36818284).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=10891546; DepMap=ACH-002066).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Peripheral nervous system, left sciatic nerve; UBERON=UBERON_0001322.
ST   Source(s): PubMed=28556483; PubMed=33707600; PubMed=36818284; RCB=RCB2230
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13 (PubMed=33707600)
ST   D18S51: 13,14 (PubMed=28556483; PubMed=36818284)
ST   D19S433: 10.2,14.2 (PubMed=33707600)
ST   D19S433: 14.2 (PubMed=28556483; PubMed=36818284)
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 8,11 (PubMed=28556483; PubMed=36818284; RCB=RCB2230)
ST   D7S820: 11 (PubMed=33707600)
ST   D8S1179: 14
ST   FGA: 23,26
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C37257; Desmoplastic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   HS-Sultan
AC   CVCL_2516
SY   Hs-Sultan; HS-SULTAN; HS-sultan; HS Sultan; HSSultan; H. S. Sultan; SULTAN; Sultan
DR   BTO; BTO_0003035
DR   CLO; CLO_0004264
DR   EFO; EFO_0002199
DR   CLDB; cl1723
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-1484
DR   BioSample; SAMN03151805
DR   cancercelllines; CVCL_2516
DR   Cosmic; 759913
DR   Cosmic; 846385
DR   ECACC; 87012701
DR   EGA; EGAS00001000610
DR   IARC_TP53; 27008
DR   IGRhCellID; HSSultan
DR   JCRB; JCRB9062
DR   LINCS_LDP; LCL-2036
DR   PharmacoDB; HSSultan_616_2019
DR   Progenetix; CVCL_2516
DR   Wikidata; Q54896292
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=4549735;
RX   PubMed=6365856;
RX   PubMed=10516762;
RX   PubMed=11021758;
RX   PubMed=12592342;
RX   PubMed=19220422;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=29892436;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jiyoye derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from a plasma cell myeloma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00214.
CC   Population: African; Nigerian.
CC   Doubling time: 24 hours (PubMed=6365856).
CC   HLA typing: A*03:01,74:01; B*53:01,58:01; C*04:01,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1484; ECACC=87012701; JCRB=JCRB9062
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 12,19
ST   D19S433: 12,15
ST   D21S11: 28,36
ST   D2S1338: 21
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   Penta D: 2.2,12
ST   Penta E: 8,12
ST   TH01: 7,9
ST   TPOX: 6,8
ST   vWA: 15,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1317 ! Jiyoye
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   HS-SY-2
AC   CVCL_8719
SY   HS-SY-II; HSSY-II; HSSYII; HSSY2; Hiroshi Sonobe-SYnovial-2
DR   BTO; BTO_0006086
DR   CLO; CLO_0050072
DR   BioSample; SAMN03472029
DR   cancercelllines; CVCL_8719
DR   Cosmic; 1217465
DR   Cosmic; 1319811
DR   Cosmic; 2307724
DR   DepMap; ACH-002085
DR   FANTOM5_SSTAR; 10441-106E9
DR   GEO; GSM482569
DR   GEO; GSM1676333
DR   GEO; GSM1701665
DR   GEO; GSM2887618
DR   GEO; GSM2887619
DR   Progenetix; CVCL_8719
DR   RCB; RCB2231
DR   Wikidata; Q54896293
RX   PubMed=1331610;
RX   PubMed=7539744;
RX   PubMed=7736791;
RX   PubMed=24726063;
RX   PubMed=26351324;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=1331610).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=1331610; PubMed=7539744).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: HS-SY-11; Note=Occasionally.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB2231
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HS-SY-3
AC   CVCL_N587
SY   Hiroshi Sonobe-SYnovial-3
DR   Wikidata; Q54896294
RX   PubMed=10399965;
CC   Population: Japanese.
CC   Doubling time: 120 hours (Note=At 18th passage) (PubMed=10399965).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1; Note=Truncated (PubMed=10399965).
CC   Derived from site: In situ; Popliteal fossa; UBERON=UBERON_0013069.
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   hS1
AC   CVCL_B6MV
SY   human Sertoli 1
DR   Wikidata; Q111733447
RX   PubMed=28152522;
CC   Population: Chinese.
CC   Doubling time: 1.3 days (Note=In 10% FBS), 1.03 days (Note=In 15% FBS) (PubMed=28152522).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   HS1
AC   CVCL_E4R1
RX   PubMed=32891180;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U857 ! Anti-theta(1)3H10
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HS1-CLS
AC   CVCL_5978
DR   CLS; 300212
DR   Wikidata; Q54896295
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): CLS=300212
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 14
ST   D18S51: 12,14
ST   D21S11: 28,32
ST   D3S1358: 17,18
ST   D5S818: 13,16
ST   D7S820: 11
ST   D8S1179: 12,13,14
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 11,13
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 17,18
DI   NCIt; C5585; Skin sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HS1_L1HS-CRISPRi_g1
AC   CVCL_E8I4
DR   GEO; GSM8667518
DR   GEO; GSM8667519
DR   GEO; GSM8667520
DR   PRIDE; PXD059661
RX   DOI=10.1101/2025.01.17.633315;
CC   Characteristics: Transduced with the FUGW U6 gL1HSg1dCas9-KRAB-T2a-GFP vector that contains dCas9 fused to a KRAB repressive domain, a LINE-1 targeting gRNA (gL1HSg1) and eGFP (DOI=10.1101/2025.01.17.633315).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ11 ! 606A1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HS1_L1HS-CRISPRi_g2
AC   CVCL_E8I5
DR   GEO; GSM8667527
DR   GEO; GSM8667528
DR   GEO; GSM8667529
DR   PRIDE; PXD059661
RX   DOI=10.1101/2025.01.17.633315;
CC   Characteristics: Transduced with the FUGW U6 gL1HSg2dCas9-KRAB-T2a-GFP vector that contains dCas9 fused to a KRAB repressive domain, a LINE-1 targeting gRNA (gL1HSg2) and eGFP (DOI=10.1101/2025.01.17.633315).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ11 ! 606A1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HS1_L1HS-CRISPRi_LacZ
AC   CVCL_E8I6
DR   GEO; GSM8667515
DR   GEO; GSM8667516
DR   GEO; GSM8667517
DR   GEO; GSM8667530
DR   GEO; GSM8667531
DR   GEO; GSM8667532
DR   PRIDE; PXD059661
RX   DOI=10.1101/2025.01.17.633315;
CC   Characteristics: Control cell line for HS1_L1HS-CRISPRi_g1 (Cellosaurus=CVCL_E8I4) and HS1_L1HS-CRISPRi_g2 (Cellosaurus=CVCL_E8I5).
CC   Characteristics: Transduced with the FUGW U6 gLacZ dCas9-KRAB-T2a-GFP vector that contains dCas9 fused to a KRAB repressive domain, a lacZ targeting gRNA and eGFP (DOI=10.1101/2025.01.17.633315).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ11 ! 606A1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HS1001
AC   CVCL_HF74
SY   KIe055-A
DR   BioSamples; SAMEA6878138
DR   GEO; GSM1293445
DR   GEO; GSM1293453
DR   hPSCreg; KIe055-A
DR   Wikidata; Q54896296
RX   PubMed=24463987;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   HS1023
AC   CVCL_ZA67
SY   KIe056-A
DR   hPSCreg; KIe056-A
DR   Wikidata; Q98126710
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS1024
AC   CVCL_ZA68
SY   KIe057-A
DR   hPSCreg; KIe057-A
DR   Wikidata; Q98126711
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS1036
AC   CVCL_ZA69
SY   KIe058-A
DR   hPSCreg; KIe058-A
DR   Wikidata; Q98126713
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS1038
AC   CVCL_ZA70
SY   KIe059-A
DR   hPSCreg; KIe059-A
DR   Wikidata; Q98126714
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS1041
AC   CVCL_ZA71
SY   KIe060-A
DR   hPSCreg; KIe060-A
DR   Wikidata; Q98126715
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS1042
AC   CVCL_ZA72
SY   KIe061-A
DR   BioSamples; SAMEA6878131
DR   hPSCreg; KIe061-A
DR   Wikidata; Q98126716
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS1052
AC   CVCL_YC34
SY   KIe035-A
DR   BioSamples; SAMEA5928373
DR   hPSCreg; KIe035-A
DR   Wikidata; Q94301437
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   HS181
AC   CVCL_C229
SY   KIe001-A
DR   GEO; GSM569193
DR   GEO; GSM569194
DR   GEO; GSM1293456
DR   GEO; GSM1293457
DR   GEO; GSM1293458
DR   GEO; GSM1293459
DR   hPSCreg; KIe001-A
DR   SKIP; SKIP001792
DR   Wikidata; Q54896297
RX   PubMed=12832363;
RX   PubMed=17572666;
RX   PubMed=18930318;
RX   PubMed=20198446;
RX   PubMed=20641038;
RX   PubMed=20736931;
RX   PubMed=21217828;
RX   PubMed=24463987;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0009.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC03-09.
CC   Doubling time: ~24-36 hours (PubMed=12832363).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 18
//
ID   HS181 EGFP-2A-SCL
AC   CVCL_A8HR
SY   HS181 pRRL-EF1a-EGFP-2A-SCL-PGK-Neo
DR   Wikidata; Q107115362
RX   PubMed=22491213;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud_Deposito_lineas_embrionaria_HS181-SCL-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_HS181-SCL.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-SCL-PGKp-Neo construct.
CC   Karyotypic information: 46,XX [15]; 46,XX,der(5)t(q35;?)+der(12)t(q11;?) [7] (BNLC).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C229 ! HS181
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   HS181 EGFP-2A-RUNX1c
AC   CVCL_A8HS
SY   HS181 pRRL-EF1a-EGFP-2A-RUNX1c-PGK-Neo
DR   Wikidata; Q107115363
RX   PubMed=28869683;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud_Deposito_linea_HS18_RUNX1c.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_HS181_RUNXc-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-RUNX1c-PGKp-Neo construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10471; RUNX1 (Note=Isoform AML-1C).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C229 ! HS181
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HS181-GFP
AC   CVCL_EG08
DR   Wikidata; Q54896298
RX   PubMed=15345126;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C229 ! HS181
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   HS2
AC   CVCL_E4R5
DR   ABCD; ABCD_AV989
RX   PubMed=32891180;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4R4 ! 4D8 [Mouse hybridoma against C.perfringens pfo]
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HS2_L1HS-CRISPRi_g1
AC   CVCL_E8I7
DR   GEO; GSM8667521
DR   GEO; GSM8667522
DR   GEO; GSM8667523
RX   DOI=10.1101/2025.01.17.633315;
CC   Population: Japanese.
CC   Characteristics: Transduced with the FUGW U6 gL1HSg1dCas9-KRAB-T2a-GFP vector that contains dCas9 fused to a KRAB repressive domain, a LINE-1 targeting gRNA (gL1HSg1) and eGFP (DOI=10.1101/2025.01.17.633315).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ30 ! 648A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HS2_L1HS-CRISPRi_LacZ
AC   CVCL_E8I8
DR   GEO; GSM8667524
DR   GEO; GSM8667525
DR   GEO; GSM8667526
RX   DOI=10.1101/2025.01.17.633315;
CC   Population: Japanese.
CC   Characteristics: Control cell line for HS2_L1HS-CRISPRi_g1 (Cellosaurus=CVCL_E8I7).
CC   Characteristics: Transduced with the FUGW U6 gLacZ dCas9-KRAB-T2a-GFP vector that contains dCas9 fused to a KRAB repressive domain, a lacZ targeting gRNA and eGFP (DOI=10.1101/2025.01.17.633315).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ30 ! 648A1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HS207
AC   CVCL_C230
SY   KIe002-A
DR   hPSCreg; KIe002-A
DR   SKIP; SKIP001793
DR   Wikidata; Q54896299
RX   PubMed=12832363;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   HS235
AC   CVCL_C231
SY   KIe003-A
DR   hPSCreg; KIe003-A
DR   SKIP; SKIP001794
DR   Wikidata; Q54896300
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0008.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HS237
AC   CVCL_C232
SY   HS237 p135; KIe004-A
DR   hPSCreg; KIe004-A
DR   IGRhCellID; HS237%20p135
DR   SKIP; SKIP001795
DR   Wikidata; Q54896301
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0007.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   Hs27
AC   CVCL_0335
AS   CVCL_0710
SY   Hs-27; Hs 27; Hs.27; HS27; Hs27F
DR   BTO; BTO_0006137
DR   CLO; CLO_0003910
DR   CLO; CLO_0004251
DR   MCCL; MCC:0000231
DR   CLDB; cl1713
DR   CLDB; cl5202
DR   AddexBio; T0020010/4997
DR   ATCC; CRL-1634
DR   BioSample; SAMN03471409
DR   ChEMBL-Cells; CHEMBL3307678
DR   ChEMBL-Targets; CHEMBL614666
DR   ECACC; 94041901
DR   GEO; GSM114601
DR   IZSLER; BS CL 136
DR   PubChem_Cell_line; CVCL_0335
DR   Wikidata; Q54896302
RX   PubMed=4472134;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): AddexBio=T0020010/4997; ATCC=CRL-1634; ECACC=94041901; IZSLER=BS CL 136
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 12.2,14
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 11,15
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 7,12
ST   TH01: 7,8
ST   TPOX: 6,8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   HS27-iPS
AC   CVCL_A9K2
SY   HS27 iPS
DR   Wikidata; Q102114153
RX   PubMed=23861493;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0335 ! Hs27
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   HS293
AC   CVCL_C197
SY   KIe005-A
DR   hPSCreg; KIe005-A
DR   IGRhCellID; HS293%20p26
DR   IGRhCellID; HS293%20p60
DR   SKIP; SKIP001796
DR   Wikidata; Q54896303
RX   PubMed=15790775;
RX   PubMed=18930318;
RX   PubMed=20198446;
RX   PubMed=20428235;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0010.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Hs294T R
AC   CVCL_E3AI
RX   PubMed=39175042;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90851; Cobimetinib (Cotellic).
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0331 ! Hs 294T
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HS3
AC   CVCL_E4R3
DR   ABCD; ABCD_AV990
RX   PubMed=32891180;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C2E9; Clostridium perfringens pfo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4R2 ! 2C5 [Mouse hybridoma against C.perfringens pfo]
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HS306
AC   CVCL_C198
SY   KIe006-A
DR   hPSCreg; KIe006-A
DR   IGRhCellID; HS306%20p35
DR   SKIP; SKIP001797
DR   Wikidata; Q54896304
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0011.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   HS346
AC   CVCL_C199
SY   KIe007-A
DR   hPSCreg; KIe007-A
DR   NIHhESC; NIHhESC-13-0201
DR   SKIP; SKIP001798
DR   Wikidata; Q54896305
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=28445466;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0201.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-20.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   HS351
AC   CVCL_C200
SY   KIe008-A
DR   hPSCreg; KIe008-A
DR   SKIP; SKIP001799
DR   Wikidata; Q54896306
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-20.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HS356
AC   CVCL_C201
SY   KIe030-A
DR   hPSCreg; KIe030-A
DR   SKIP; SKIP002077
DR   Wikidata; Q54896307
RX   PubMed=15790775;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Miscellaneous: Not distributed by the Karolinska Institutet Human Embryonic Stem Cell Bank.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS360
AC   CVCL_C202
SY   KIe009-A
DR   hPSCreg; KIe009-A
DR   SKIP; SKIP001800
DR   Wikidata; Q54896308
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS361
AC   CVCL_C203
SY   KIe010-A
DR   hPSCreg; KIe010-A
DR   SKIP; SKIP001801
DR   Wikidata; Q54896309
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS362
AC   CVCL_C204
SY   KIe011-A
DR   hPSCreg; KIe011-A
DR   SKIP; SKIP001802
DR   Wikidata; Q54896310
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS363
AC   CVCL_C205
SY   KIe012-A
DR   hPSCreg; KIe012-A
DR   SKIP; SKIP001803
DR   Wikidata; Q54896311
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS364
AC   CVCL_C206
SY   KIe013-A
DR   hPSCreg; KIe013-A
DR   SKIP; SKIP001804
DR   Wikidata; Q54896312
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS366
AC   CVCL_C207
SY   KIe014-A
DR   hPSCreg; KIe014-A
DR   SKIP; SKIP001805
DR   Wikidata; Q54896313
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS368
AC   CVCL_C208
SY   KIe015-A
DR   hPSCreg; KIe015-A
DR   SKIP; SKIP001806
DR   Wikidata; Q54896314
RX   PubMed=15790775;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS380
AC   CVCL_C209
SY   KIe016-A
DR   hPSCreg; KIe016-A
DR   SKIP; SKIP001807
DR   Wikidata; Q54896315
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS382
AC   CVCL_C210
SY   KIe017-A
DR   hPSCreg; KIe017-A
DR   SKIP; SKIP001808
DR   Wikidata; Q54896318
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS400
AC   CVCL_C211
SY   KIe018-A
DR   hPSCreg; KIe018-A
DR   SKIP; SKIP001809
DR   Wikidata; Q54896319
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS401
AC   CVCL_C212
SY   KIe019-A
DR   GEO; GSM1293450
DR   hPSCreg; KIe019-A
DR   IGRhCellID; HS401%20p53
DR   NIHhESC; NIHhESC-13-0202
DR   SKIP; SKIP001810
DR   Wikidata; Q54896320
RX   PubMed=20198446;
RX   PubMed=20428235;
RX   PubMed=21217828;
RX   PubMed=24463987;
RX   PubMed=28445466;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0202.
CC   Registration: Swiss research registry; BAG-hES-IMP-0024.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-20.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   HS402
AC   CVCL_C213
SY   KIe020-A
DR   hPSCreg; KIe020-A
DR   SKIP; SKIP001811
DR   Wikidata; Q54896321
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS415
AC   CVCL_C214
SY   KIe021-A
DR   hPSCreg; KIe021-A
DR   SKIP; SKIP001812
DR   Wikidata; Q54896322
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0048.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-20.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   HS420
AC   CVCL_C215
SY   KIe022-A
DR   hPSCreg; KIe022-A
DR   NIHhESC; NIHhESC-13-0203
DR   SKIP; SKIP001813
DR   Wikidata; Q54896323
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=28445466;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0203.
CC   Registration: Swiss research registry; BAG-hES-IMP-0046.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HS422
AC   CVCL_C216
SY   KIe029-A
DR   hPSCreg; KIe029-A
DR   SKIP; SKIP001898
DR   Wikidata; Q54896324
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0047.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS426
AC   CVCL_C217
SY   KIe023-A
DR   hPSCreg; KIe023-A
DR   SKIP; SKIP001814
DR   Wikidata; Q54896325
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0042.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS429
AC   CVCL_C218
SY   KIe024-A
DR   hPSCreg; KIe024-A
DR   SKIP; SKIP001815
DR   Wikidata; Q54896326
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0043.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS429A
AC   CVCL_C219
SY   KIe024-A-1
DR   hPSCreg; KIe024-A-1
DR   SKIP; SKIP002295
DR   Wikidata; Q54896327
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C218 ! HS429
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HS429B
AC   CVCL_C220
SY   KIe024-A-2
DR   hPSCreg; KIe024-A-2
DR   SKIP; SKIP002296
DR   Wikidata; Q54896328
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C218 ! HS429
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HS429C
AC   CVCL_C221
SY   KIe024-A-3
DR   hPSCreg; KIe024-A-3
DR   SKIP; SKIP002297
DR   Wikidata; Q54896329
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C218 ! HS429
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HS429D
AC   CVCL_C222
SY   KIe024-A-4
DR   hPSCreg; KIe024-A-4
DR   SKIP; SKIP002298
DR   Wikidata; Q54896330
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C218 ! HS429
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   HS475
AC   CVCL_C223
SY   KIe025-A
DR   hPSCreg; KIe025-A
DR   SKIP; SKIP001816
DR   Wikidata; Q54896331
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0044.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS480
AC   CVCL_C224
SY   KIe026-A
DR   hPSCreg; KIe026-A
DR   SKIP; SKIP001817
DR   Wikidata; Q54896332
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0045.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS481
AC   CVCL_C225
SY   KIe027-A
DR   hPSCreg; KIe027-A
DR   SKIP; SKIP001818
DR   Wikidata; Q54896333
RX   PubMed=17959612;
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS491
AC   CVCL_C226
SY   KIe028-A
DR   hPSCreg; KIe028-A
DR   SKIP; SKIP001897
DR   Wikidata; Q54896334
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   HS5-CD40L
AC   CVCL_E3RF
RX   PubMed=38877102;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3720 ! HS-5
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HS5-CD40L-IL4
AC   CVCL_E3RI
RX   PubMed=38877102;
CC   Population: Caucasian.
CC   Characteristics: Obtained from the parent cell line by flow sorting (personal communication of Mraz, Marek).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6014; IL4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3RJ ! HS5-CD40L(LOW)-IL4
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HS5-CD40L-IL4-IL21
AC   CVCL_E3RK
RX   PubMed=38877102;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6005; IL21.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6014; IL4.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88346; Cd8a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3RI ! HS5-CD40L-IL4
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HS5-CD40L(LOW)-IL4
AC   CVCL_E3RJ
SY   HS5-CD40LLOW-IL4
RX   PubMed=38877102;
CC   Population: Caucasian.
CC   Characteristics: Expresses low level of CD40LG (PubMed=38877102).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6014; IL4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3RG ! HS5-IL4
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HS5-IL21
AC   CVCL_E3RH
RX   PubMed=38877102;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6005; IL21.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88346; Cd8a.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3720 ! HS-5
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HS5-IL4
AC   CVCL_E3RG
RX   PubMed=38877102;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6014; IL4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3720 ! HS-5
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HS5-SV.hiPS
AC   CVCL_9U79
DR   Wikidata; Q54896335
RX   PubMed=27345776;
CC   From: Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Skin; Note=From a scar; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HS539
AC   CVCL_C227
SY   KIe031-A
DR   hPSCreg; KIe031-A
DR   SKIP; SKIP002303
DR   Wikidata; Q54896336
RX   PubMed=20198446;
RX   PubMed=21217828;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   Hs578T-delta-hTfR1
AC   CVCL_YL24
SY   Hs578TdeltahTfR1
DR   cancercelllines; CVCL_YL24
DR   Wikidata; Q94301899
RX   PubMed=25980759;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11763; TFRC (Note=3 of 3 alleles).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   Hs578T-Dox
AC   CVCL_IR02
SY   Hs578T/Doxo
DR   cancercelllines; CVCL_IR02
DR   Wikidata; Q54896337
RX   PubMed=7902062;
RX   PubMed=10571255;
RX   PubMed=15239129;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   Hs578T-Luc
AC   CVCL_J255
SY   HS578T-Luc
DR   cancercelllines; CVCL_J255
DR   JCRB; JCRB1375
DR   JCRB; NIHS0636
DR   Wikidata; Q54896338
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0636; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): JCRB=JCRB1375
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   Hs578Ts(i)8
AC   CVCL_M363
DR   cancercelllines; CVCL_M363
DR   Wikidata; Q54896339
RX   PubMed=18386134;
CC   Population: Caucasian.
CC   Characteristics: Invasive subclone of Hs 587T.
CC   Doubling time: 22 hours (PubMed=18386134).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0332 ! Hs 578T
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   HS659
AC   CVCL_ZB59
SY   KIe036-A
DR   hPSCreg; KIe036-A
DR   Wikidata; Q98126717
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS660
AC   CVCL_ZA54
SY   KIe037-A
DR   hPSCreg; KIe037-A
DR   Wikidata; Q98126718
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS685
AC   CVCL_ZA55
SY   KIe038-A
DR   hPSCreg; KIe038-A
DR   Wikidata; Q98126719
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS699
AC   CVCL_ZA56
SY   KIe039-A
DR   hPSCreg; KIe039-A
DR   Wikidata; Q98126720
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS700
AC   CVCL_ZA57
SY   KIe040-A
DR   hPSCreg; KIe040-A
DR   Wikidata; Q98126721
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS717
AC   CVCL_ZA58
SY   KIe041-A
DR   hPSCreg; KIe041-A
DR   Wikidata; Q98126722
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS719
AC   CVCL_ZA59
SY   KIe042-A
DR   hPSCreg; KIe042-A
DR   Wikidata; Q98126725
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS795
AC   CVCL_ZA60
SY   KIe043-A
DR   hPSCreg; KIe043-A
DR   Wikidata; Q98126726
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS798
AC   CVCL_ZA61
SY   KIe044-A
DR   hPSCreg; KIe044-A
DR   Wikidata; Q98126727
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS799
AC   CVCL_C228
SY   KIe045-A
DR   hPSCreg; KIe045-A
DR   NIHhESC; NIHhESC-13-0207
DR   Wikidata; Q54896341
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0207.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   HS800
AC   CVCL_ZA62
SY   KIe046-A
DR   hPSCreg; KIe046-A
DR   Wikidata; Q98126728
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS838
AC   CVCL_ZA63
SY   KIe047-A
DR   hPSCreg; KIe047-A
DR   Wikidata; Q98126729
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS839
AC   CVCL_ZA64
SY   KIe048-A
DR   hPSCreg; KIe048-A
DR   Wikidata; Q98126730
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS841
AC   CVCL_ZA65
SY   KIe049-A
DR   hPSCreg; KIe049-A
DR   Wikidata; Q98126731
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS842
AC   CVCL_ZA66
SY   KIe050-A
DR   hPSCreg; KIe050-A
DR   Wikidata; Q98126732
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS916
AC   CVCL_HF72
SY   KIe051-A
DR   BioSamples; SAMEA6878150
DR   GEO; GSM1293448
DR   hPSCreg; KIe051-A
DR   Wikidata; Q54896342
RX   PubMed=24463987;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   HS970
AC   CVCL_ZB50
SY   KIe052-A
DR   hPSCreg; KIe052-A
DR   Wikidata; Q98126733
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   HS975
AC   CVCL_9S00
SY   KIe032-A
DR   GEO; GSM1293447
DR   GEO; GSM1293454
DR   hPSCreg; KIe032-A
DR   SKIP; SKIP002563
DR   Wikidata; Q54896343
RX   PubMed=24463987;
RX   PubMed=28445466;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   HS980
AC   CVCL_2Z88
SY   KIe033-A
DR   GEO; GSM1293446
DR   GEO; GSM1293452
DR   hPSCreg; KIe033-A
DR   SKIP; SKIP002564
DR   Wikidata; Q54896344
RX   PubMed=24463987;
RX   PubMed=28445466;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   HS983a
AC   CVCL_HF71
SY   KIe053-A
DR   BioSamples; SAMEA6878144
DR   GEO; GSM1293449
DR   GEO; GSM1293455
DR   hPSCreg; KIe053-A
DR   Wikidata; Q54896345
RX   PubMed=24463987;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 10
//
ID   HS999
AC   CVCL_HF73
SY   KIe054-A
DR   BioSamples; SAMEA6878141
DR   GEO; GSM1293444
DR   hPSCreg; KIe054-A
DR   Wikidata; Q54896346
RX   PubMed=24463987;
RX   PubMed=32339905;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   HSA-S4
AC   CVCL_A9FC
SY   HSAS4; HSF
DR   CCRID; 5301HUM-KCB05037ZJ
DR   KCB; KCB 200537ZJ
DR   Wikidata; Q108820501
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): CCRID=5301HUM-KCB05037ZJ
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 21,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 6
//
ID   HSA/c
AC   CVCL_JH11
DR   Wikidata; Q54896347
RX   PubMed=16489088;
RX   PubMed=16832412;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   Hsa/TR/mock
AC   CVCL_A9A6
DR   Wikidata; Q102114154
RX   PubMed=16489088;
CC   Population: Japanese.
CC   Characteristics: Control cell line for Hsa/TR/OPN1 (Cellosaurus=CVCL_A9A7) and Hsa/TR/OPN2 (Cellosaurus=CVCL_A9A8) (PubMed=16489088).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JH11 ! HSA/c
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   Hsa/TR/OPN1
AC   CVCL_A9A7
DR   Wikidata; Q102114155
RX   PubMed=16489088;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11255; SPP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JH11 ! HSA/c
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   Hsa/TR/OPN2
AC   CVCL_A9A8
DR   Wikidata; Q102114157
RX   PubMed=16489088;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11255; SPP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JH11 ! HSA/c
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   hSABCi-NS1.1
AC   CVCL_YB44
SY   human Small Airway Basal Cells immortalized-NonSmoker 1.1
DR   GEO; GSE124265
DR   Wikidata; Q94301994
RX   PubMed=31443657;
CC   Population: African American.
CC   Characteristics: Useful for understanding the biology of small airway epithelium (SAE), the pathogenesis of SAE-related diseases and testing new pharmacologic agents (PubMed=31443657).
CC   Doubling time: 16 hours (PubMed=31443657).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HSAEC1-KT
AC   CVCL_X488
DR   ATCC; CRL-4050
DR   GEO; GSM794438
DR   Wikidata; Q54896348
RX   PubMed=24228254;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
ST   Source(s): ATCC=CRL-4050
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 7,8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 15
//
ID   HSAEC13-KT
AC   CVCL_ER03
DR   GEO; GSM794442
DR   Wikidata; Q54896349
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC15-KT
AC   CVCL_ER04
DR   GEO; GSM794444
DR   Wikidata; Q54896350
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC18-KT
AC   CVCL_ER05
DR   GEO; GSM794446
DR   Wikidata; Q54896351
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC19-KT
AC   CVCL_ER06
DR   GEO; GSM794447
DR   Wikidata; Q54896352
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC2-KT
AC   CVCL_ER07
DR   GEO; GSM794440
DR   Wikidata; Q54896353
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC22-KT
AC   CVCL_ER08
DR   GEO; GSM794448
DR   Wikidata; Q54896354
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC24-KT
AC   CVCL_ER09
DR   GEO; GSM794450
DR   Wikidata; Q54896355
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC30-KT
AC   CVCL_ER10
DR   GEO; GSM794452
DR   Wikidata; Q54896356
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC31-KT
AC   CVCL_ER11
DR   GEO; GSM794454
DR   Wikidata; Q54896357
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC35-KT
AC   CVCL_ER12
DR   GEO; GSM794456
DR   Wikidata; Q54896359
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC36-KT
AC   CVCL_ER13
DR   GEO; GSM794458
DR   Wikidata; Q54896360
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC37-KT
AC   CVCL_ER14
DR   GEO; GSM794460
DR   Wikidata; Q54896361
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC45-KT
AC   CVCL_ER15
DR   GEO; GSM794463
DR   Wikidata; Q54896362
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   HSAEC49-KT
AC   CVCL_ER16
DR   GEO; GSM794465
DR   Wikidata; Q54896363
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Airway epithelium basal cell; CL=CL_0002633.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   hsAQC2
AC   CVCL_5A36
DR   Wikidata; Q54896364
RX   Patent=US7358054;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3356.
CC   Characteristics: Produces a humanized version of mAB mAQC2 (Patent=US7358054).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   HSAt-005
AC   CVCL_JG01
DR   JCRB; JCRB1694
DR   JCRB; NIHS1008
DR   Wikidata; Q54896365
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS1008; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9505; ! Aotus trivirgatus (Three-striped night monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSB.2-A7-D2
AC   CVCL_A0DR
DR   cancercelllines; CVCL_A0DR
DR   Wikidata; Q108820502
RX   PubMed=3871456;
CC   Population: Caucasian.
CC   Characteristics: Produces high level of IL2 in response to IL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1859 ! CCRF-HSB-2
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   HSB.2-A7-D9
AC   CVCL_A0DS
DR   cancercelllines; CVCL_A0DS
DR   Wikidata; Q108820503
RX   PubMed=3871456;
CC   Population: Caucasian.
CC   Characteristics: Produces high level of IL2 in response to IL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1859 ! CCRF-HSB-2
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   HSB.2-C5-B2
AC   CVCL_A0DT
DR   cancercelllines; CVCL_A0DT
DR   Wikidata; Q108820504
RX   PubMed=3871456;
CC   Population: Caucasian.
CC   Characteristics: Produces high level of IL2 in response to IL1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1859 ! CCRF-HSB-2
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   HSB2/GS
AC   CVCL_1Y12
SY   HSB2 / GS; HSB2 HHV6A (GS); HSB2/HHV6A
DR   BEI_Resources; ARP-350
DR   cancercelllines; CVCL_1Y12
DR   Wikidata; Q54896366
RX   PubMed=1653487;
WW   Provider; HHV-6 Foundation; -; https://hhv-6foundation.org/wp-content/uploads/2016/12/hhv-6a-gs-strain-in-hsb2-cell-line.pdf
CC   Population: Caucasian.
CC   Virology: Infected with human herpesvirus 6A (HHV-6A) strain GS (PubMed=1653487).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1859 ! CCRF-HSB-2
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 17
//
ID   HsBt
AC   CVCL_X901
DR   CGH-DB; 9332-4
DR   Wikidata; Q54896367
RX   PubMed=10761702;
CC   Population: Japanese.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   HSC 172
AC   CVCL_0D85
SY   HSC-172
DR   Wikidata; Q54896368
RX   PubMed=277932;
RX   PubMed=1028170;
RX   PubMed=3558490;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   HSC 180
AC   CVCL_M101
SY   HSC-180
DR   BTO; BTO_0003514
DR   Wikidata; Q54896369
RX   PubMed=16928215;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   HSC 20
AC   CVCL_YT57
DR   Wikidata; Q94302211
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HSC 22
AC   CVCL_YT58
DR   Wikidata; Q94302216
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   HSC 230
AC   CVCL_AK39
AS   CVCL_G043
SY   HSC-230; HSC230; GM13071; GM13071A
DR   CLO; CLO_0013842
DR   BioSample; SAMN00802085
DR   Coriell; GM13071
DR   Wikidata; Q54896370
RX   PubMed=6809308;
RX   PubMed=7994019;
RX   PubMed=12065746;
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ala938Profs*21 (c.2808_2811del) (3033delAAAC) (3036delACAA); ClinVar=VCV000009322; Zygosity=Heterozygous (PubMed=12065746).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys3326Ter (c.9976A>T) (10204A>T); ClinVar=VCV000038266; Zygosity=Heterozygous (PubMed=12065746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125703; Fanconi anemia, complementation group B
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   HSC 231
AC   CVCL_G044
SY   HSC-231; HSC231
DR   Wikidata; Q54896371
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   HSC 49
AC   CVCL_A1RC
SY   HSC49
DR   Wikidata; Q105509463
RX   PubMed=3015015;
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HSC 50
AC   CVCL_A1RD
SY   HSC50
DR   Wikidata; Q105509466
RX   PubMed=3015015;
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HSC 536
AC   CVCL_G045
SY   HSC-536; HSC536; GM13020
DR   CLO; CLO_0013992
DR   BioSample; SAMN00802014
DR   Coriell; GM13020
DR   Wikidata; Q54896372
RX   PubMed=7994019;
RX   PubMed=14754601;
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Leu554Pro (c.1661T>C); ClinVar=VCV000012043; Zygosity=Unspecified (Coriell=GM13020).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   HSC 536 FANCC
AC   CVCL_E3YF
SY   FA-C+C
RX   PubMed=14754601;
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Leu554Pro (c.1661T>C); ClinVar=VCV000012043; Zygosity=Unspecified (Coriell=GM13020).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3584; FANCC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G045 ! HSC 536
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HSC 536N
AC   CVCL_AK36
SY   HSC-536N; HSC536N; HSC 536/N; HSC/536N; GM13021
DR   CLO; CLO_0013991
DR   BioSample; SAMN00802016
DR   Coriell; GM13021
DR   Wikidata; Q54896373
RX   PubMed=8822951;
RX   PubMed=11926188;
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Leu554Pro (c.1661T>C); ClinVar=VCV000012043; Zygosity=Unspecified (Coriell=GM13021).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G045 ! HSC 536
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 15
//
ID   HSC 55
AC   CVCL_A1RE
SY   HSC55
DR   Wikidata; Q105509469
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HSC 62
AC   CVCL_G046
AS   CVCL_AK38
SY   HSC-62; HSC62; GM13023
DR   CLO; CLO_0013995
DR   BioSample; SAMN00802020
DR   Coriell; GM13023
DR   Wikidata; Q54896374
RX   PubMed=6809308;
RX   PubMed=7994019;
RX   PubMed=12065746;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.8488-1G>A (IVS19-1G>A); ClinVar=VCV000038164; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=12065746).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   HSC 72
AC   CVCL_AK37
AS   CVCL_G047
SY   HSC-72; HSC72; GM13022
DR   CLO; CLO_0013997
DR   BioSample; SAMN00802018
DR   Coriell; GM13022
DR   Wikidata; Q54896375
RX   PubMed=2805228;
RX   PubMed=6809308;
RX   PubMed=7994019;
RX   PubMed=14754601;
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Unexplicit; Ex18-28del; Zygosity=Unspecified (PubMed=16166284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   HSC 72OT
AC   CVCL_AK42
SY   HSC72OT; HSC720.T; GM16749
DR   CLO; CLO_0018430
DR   Coriell; GM16749
DR   Wikidata; Q54848721
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Unexplicit; Ex18-28del; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AK37 ! HSC 72
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   HSC 89
AC   CVCL_A1RB
SY   HSC89
DR   Wikidata; Q105509473
RX   PubMed=3015015;
RX   PubMed=6809308;
RX   PubMed=7798274;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   HSC 92
AC   CVCL_G048
SY   HSC92
DR   Wikidata; Q54896376
RX   PubMed=3015015;
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   HSC 93
AC   CVCL_G049
SY   HSC-93; HSC93
DR   Wikidata; Q54896377
RX   PubMed=3015015;
RX   PubMed=6809308;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   HSC 99
AC   CVCL_G050
SY   HSC-99; HSC99
DR   Wikidata; Q54896378
RX   PubMed=2805228;
RX   PubMed=6809308;
RX   PubMed=7987813;
RX   PubMed=7994019;
RX   PubMed=8340107;
CC   Doubling time: ~30 hours (PubMed=8340107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   HSC-1
AC   CVCL_2807
SY   HSC1; HSC-I
DR   BTO; BTO_0005167
DR   BioSample; SAMN03470890
DR   cancercelllines; CVCL_2807
DR   Cell_Model_Passport; SIDM01557
DR   DepMap; ACH-001523
DR   IARC_TP53; 26921
DR   JCRB; JCRB1015
DR   JCRB; NIHS0249
DR   Wikidata; Q54896379
RX   PubMed=7284243;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Unspecified (DepMap=ACH-001523).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (DepMap=ACH-001523).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: JCRB; NIHS0249; true.
CC   Derived from site: In situ; Hand, skin; UBERON=UBERON_0001519.
ST   Source(s): DepMap=ACH-001523; JCRB=JCRB1015; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 21
ST   D19S433: 12.2,13
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 5,17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M669 ! HSC-1b
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HSC-1 [Macaca fascicularis]
AC   CVCL_JF89
DR   JCRB; JCRB1640
DR   Wikidata; Q54896380
RX   PubMed=8610465;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSC-1-Luc
AC   CVCL_JG49
DR   cancercelllines; CVCL_JG49
DR   JCRB; JCRB1577
DR   Wikidata; Q54896381
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Hand, skin; UBERON=UBERON_0001519.
ST   Source(s): JCRB=JCRB1577
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2807 ! HSC-1
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   HSC-1b
AC   CVCL_M669
SY   HSC-Ib
DR   cancercelllines; CVCL_M669
DR   Wikidata; Q54896382
RX   PubMed=7284243;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Unspecified (from autologous cell line HSC-1).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (from autologous cell line HSC-1).
CC   Derived from site: In situ; Hand, skin; UBERON=UBERON_0001519.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2807 ! HSC-1
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   HSC-2
AC   CVCL_1287
SY   HSC2
DR   BTO; BTO_0003881
DR   CLO; CLO_0051383
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1284
DR   BioSample; SAMN03471637
DR   BioSample; SAMN03472038
DR   BioSample; SAMN10987832
DR   cancercelllines; CVCL_1287
DR   Cell_Model_Passport; SIDM00590
DR   CGH-DB; 358-2
DR   ChEMBL-Cells; CHEMBL3308482
DR   ChEMBL-Targets; CHEMBL1075468
DR   Cosmic; 753562
DR   Cosmic; 930330
DR   Cosmic; 932147
DR   Cosmic; 1046027
DR   Cosmic; 1118788
DR   Cosmic; 1120697
DR   Cosmic; 1123038
DR   Cosmic; 1140780
DR   Cosmic; 1219864
DR   Cosmic; 1530743
DR   Cosmic; 1571799
DR   Cosmic; 2266783
DR   Cosmic; 2546835
DR   Cosmic-CLP; 753562
DR   DepMap; ACH-000472
DR   EGA; EGAS00001000978
DR   GDSC; 753562
DR   GEO; GSM243521
DR   GEO; GSM827233
DR   GEO; GSM850382
DR   GEO; GSM887133
DR   GEO; GSM888204
DR   GEO; GSM1669903
DR   IARC_TP53; 1101
DR   JCRB; JCRB0622
DR   LiGeA; CCLE_109
DR   LINCS_LDP; LCL-1206
DR   PharmacoDB; HSC2_619_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1287
DR   PubChem_Cell_line; CVCL_1287
DR   RCB; RCB1945
DR   TKG; TKG 0487
DR   Wikidata; Q54076889
RX   PubMed=1570156;
RX   PubMed=2228902;
RX   PubMed=2585303;
RX   PubMed=9023415;
RX   PubMed=9290701;
RX   PubMed=10069537;
RX   PubMed=11416159;
RX   PubMed=11755821;
RX   PubMed=12738951;
RX   PubMed=15800904;
RX   PubMed=17052259;
RX   PubMed=17325662;
RX   PubMed=17599052;
RX   PubMed=18097548;
RX   PubMed=18973137;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23992541;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32990596;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~38 hours (Note=Lot 012999), 27 hours (Note=Lot 07152004), 34 hours (Note=Lot 02172009), ~32 hours (Note=Lot 08082012), ~30 hours (Note=Lot 06192015), ~18 hours (Note=Lot 06192017), ~26 hours (Note=Lot 02082021) (JCRB=JCRB0622).
CC   HLA typing: A*24:02,33:02; B*44:03:01,54:01; C*01:02,14:03 (PubMed=9023415).
CC   HLA typing: A*24:02,33:03; B*08:01,54:01; C*01:02,14:03; DQA1*02:01,05:02; DQB1*06:08,06:08; DRB1*11:30,13:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=18097548).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=1570156).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0%; East Asian, North=83.8%; East Asian, South=14.71%; South Asian=1.36%; European, North=0%; European, South=0.07% (PubMed=30894373).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=753562; JCRB=JCRB0622; PubMed=11416159; RCB=RCB1945; Technion Genomics Center; TKG=TKG 0487
ST   Amelogenin: X (JCRB=JCRB0622)
ST   Amelogenin: X,Y (Cosmic-CLP=753562; PubMed=11416159; RCB=RCB1945; Technion Genomics Center; TKG=TKG 0487)
ST   CSF1PO: 12,13
ST   D10S1248: 13
ST   D12S391: 18
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 19
ST   D19S433: 14
ST   D1S1656: 15,17,18
ST   D21S11: 31.2
ST   D22S1045: 15
ST   D2S1338: 19
ST   D2S441: 10
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 10,14
ST   DYS391: 10
ST   FGA: 19,21
ST   Penta D: 9
ST   Penta E: 12,15
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   HSC-2015
AC   CVCL_JG02
DR   JCRB; NIHS0967
DR   Wikidata; Q54896383
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS0967; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HSC-3
AC   CVCL_1288
SY   HSC 3; HSC3
DR   BTO; BTO_0002025
DR   CLO; CLO_0051569
DR   EFO; EFO_0022703
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 647
DR   BioSample; SAMN01821684
DR   BioSample; SAMN03471639
DR   BioSample; SAMN10987855
DR   cancercelllines; CVCL_1288
DR   Cell_Model_Passport; SIDM00589
DR   CGH-DB; 364-2
DR   ChEMBL-Cells; CHEMBL3307947
DR   ChEMBL-Targets; CHEMBL612279
DR   CLS; 305312
DR   Cosmic; 907061
DR   Cosmic; 930331
DR   Cosmic; 932148
DR   Cosmic; 1042299
DR   Cosmic; 1046028
DR   Cosmic; 1118789
DR   Cosmic; 1120698
DR   Cosmic; 1123039
DR   Cosmic; 1140781
DR   Cosmic; 1219865
DR   Cosmic; 1530744
DR   Cosmic; 1571802
DR   Cosmic; 2266784
DR   Cosmic; 2546836
DR   Cosmic-CLP; 907061
DR   DepMap; ACH-000778
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10545-107H5
DR   GDSC; 907061
DR   GEO; GSM243522
DR   GEO; GSM301579
DR   GEO; GSM827234
DR   GEO; GSM850383
DR   GEO; GSM887134
DR   GEO; GSM888205
DR   GEO; GSM950317
DR   GEO; GSM950318
DR   GEO; GSM950319
DR   GEO; GSM950320
DR   GEO; GSM1669904
DR   IARC_TP53; 1100
DR   JCRB; JCRB0623
DR   LiGeA; CCLE_819
DR   LINCS_LDP; LCL-1217
DR   Millipore; SCC193
DR   PharmacoDB; HSC3_620_2019
DR   PRIDE; PXD029420
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1288
DR   PubChem_Cell_line; CVCL_1288
DR   RCB; RCB1975
DR   TKG; TKG 0484
DR   Ubigene; YC-C063
DR   Wikidata; Q54896384
RX   PubMed=1570156;
RX   PubMed=2228902;
RX   PubMed=2585303;
RX   PubMed=7591301;
RX   PubMed=9023415;
RX   PubMed=9290701;
RX   PubMed=9813718;
RX   PubMed=10069537;
RX   PubMed=10741724;
RX   PubMed=11416159;
RX   PubMed=11755821;
RX   PubMed=12738951;
RX   PubMed=16127291;
RX   PubMed=17052259;
RX   PubMed=17325662;
RX   PubMed=17599052;
RX   PubMed=17719389;
RX   PubMed=18097548;
RX   PubMed=18423281;
RX   PubMed=18973137;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21362583;
RX   PubMed=22460905;
RX   PubMed=24627082;
RX   PubMed=26754630;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 20.28 hours (PubMed=21362583); 20 hours (PubMed=24627082); ~60 hours (Note=Lot 121498), ~44 hours (Note=Lot 07242009), ~52 hours (Note=Lot 02022015), 42-65 hours (Note=Lot 07112016), ~37 hours (Note=Lot 06112018) (JCRB=JCRB0623).
CC   HLA typing: A*02:01,24:02; B*48:01,52:01; C*08:03,12:02 (PubMed=9023415).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (Cosmic-CLP=907061; DepMap=ACH-000778).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (PubMed=18097548).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (PubMed=1570156; PubMed=10741724; DepMap=ACH-000778).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=0%; East Asian, North=85.88%; East Asian, South=12.09%; South Asian=0%; European, North=0%; European, South=1.7% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of Sano, Daisuke.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=907061; Direct_author_submission; JCRB=JCRB0623; Millipore=SCC193; PubMed=11416159; RCB=RCB1975; Technion Genomics Center; TKG=TKG 0484
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 14,15
ST   D12S391: 18
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D1S1656: 13,16
ST   D21S11: 30,31.2
ST   D22S1045: 15
ST   D2S1338: 19,23
ST   D2S441: 11
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 13
ST   D8S1179: 12
ST   DYS391: 10
ST   FGA: 22,26
ST   Penta D: 10
ST   Penta E: 11,15
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   HSC-3 [Macaca fascicularis]
AC   CVCL_JG03
DR   JCRB; JCRB1646
DR   JCRB; NIHS0969
DR   Wikidata; Q54896385
RX   PubMed=8610465;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS0969; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HSC-3-M3
AC   CVCL_8323
DR   JCRB; JCRB1354
DR   JCRB; NIHS0589
DR   Wikidata; Q54896386
RX   PubMed=9813718;
CC   Population: Japanese.
CC   Characteristics: Has lymph node metastatizing potential. Established from a xenograft obtained by injection of the parent cell line in the tongue of BALB/c nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (from parent cell line).
CC   Discontinued: JCRB; NIHS0589; true.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): JCRB=JCRB1354
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1288 ! HSC-3
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   HSC-3/CMV-Luc
AC   CVCL_JF94
SY   HSC-3 CMV-Luc
DR   JCRB; JCRB1685
DR   JCRB; NIHS1045
DR   Wikidata; Q54896387
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1685).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1045; true.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): JCRB=JCRB1685
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1288 ! HSC-3
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   HSC-3028
AC   CVCL_JG04
DR   JCRB; JCRB1707
DR   Wikidata; Q54896388
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSC-39
AC   CVCL_A385
SY   HSC39
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 891
DR   cancercelllines; CVCL_A385
DR   Cell_Model_Passport; SIDM00045
DR   CGH-DB; 106-1
DR   CGH-DB; 9001-4
DR   Cosmic; 875904
DR   Cosmic; 876557
DR   Cosmic; 877037
DR   Cosmic; 897522
DR   Cosmic; 922691
DR   Cosmic; 926116
DR   Cosmic; 1223584
DR   Cosmic; 1460703
DR   Cosmic; 1518248
DR   Cosmic; 1571763
DR   Cosmic-CLP; 1322224
DR   DepMap; ACH-002141
DR   EGA; EGAS00001000978
DR   GDSC; 1322224
DR   GEO; GSM1669905
DR   IARC_TP53; 13724
DR   JCRB; JCRB1864
DR   PharmacoDB; HSC39_621_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54896389
RX   PubMed=1846312;
RX   PubMed=11107048;
RX   PubMed=11543663;
RX   PubMed=15723654;
RX   PubMed=26934957;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 28-30 hours (PubMed=1846312).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=11107048; Cosmic-CLP=1322224; DepMap=ACH-002141).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.43%; Native American=0%; East Asian, North=78.69%; East Asian, South=18.67%; South Asian=0.72%; European, North=1.03%; European, South=0.47% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1322224; JCRB=JCRB1864
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 13 (Cosmic-CLP=1322224)
ST   D5S818: 13,14 (JCRB=JCRB1864)
ST   D7S820: 11,12 (JCRB=JCRB1864)
ST   D7S820: 12 (Cosmic-CLP=1322224)
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A386 ! HSC-40A
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   HSC-39 PF
AC   CVCL_D5HX
SY   HSC-39 Protein Free
DR   JCRB; JCRB1956
DR   Wikidata; Q127381827
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1956
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 13,14
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A385 ! HSC-39
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HSC-4
AC   CVCL_1289
SY   HSC4
DR   BTO; BTO_0002026
DR   CLO; CLO_0051567
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 892
DR   BioSample; SAMN03471638
DR   BioSample; SAMN03472086
DR   BioSample; SAMN10987856
DR   cancercelllines; CVCL_1289
DR   Cell_Model_Passport; SIDM00588
DR   CGH-DB; 365-2
DR   ChEMBL-Cells; CHEMBL3308109
DR   ChEMBL-Targets; CHEMBL1075469
DR   Cosmic; 907062
DR   Cosmic; 930332
DR   Cosmic; 932149
DR   Cosmic; 1046029
DR   Cosmic; 1118790
DR   Cosmic; 1120699
DR   Cosmic; 1123040
DR   Cosmic; 1140782
DR   Cosmic; 1219866
DR   Cosmic; 2266785
DR   Cosmic; 2546837
DR   Cosmic-CLP; 907062
DR   DepMap; ACH-000546
DR   EGA; EGAS00001000978
DR   GDSC; 907062
DR   GEO; GSM827203
DR   GEO; GSM850384
DR   GEO; GSM887135
DR   GEO; GSM888206
DR   GEO; GSM1669906
DR   GEO; GSM7695972
DR   GEO; GSM7695973
DR   IARC_TP53; 1102
DR   JCRB; JCRB0624
DR   LiGeA; CCLE_513
DR   LINCS_LDP; LCL-1218
DR   PharmacoDB; HSC4_622_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1289
DR   PubChem_Cell_line; CVCL_1289
DR   RCB; RCB1902
DR   TKG; TKG 0489
DR   Wikidata; Q54896390
RX   PubMed=1570156;
RX   PubMed=2228902;
RX   PubMed=2585303;
RX   PubMed=7591301;
RX   PubMed=9023415;
RX   PubMed=9247707;
RX   PubMed=9290701;
RX   PubMed=10069537;
RX   PubMed=10741724;
RX   PubMed=11416159;
RX   PubMed=11755821;
RX   PubMed=12738951;
RX   PubMed=17052259;
RX   PubMed=17325662;
RX   PubMed=17599052;
RX   PubMed=18097548;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32990596;
RX   PubMed=35839778;
RX   PubMed=37949965;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~25 hours (Note=Lots 04012002 and 06292012), ~21 hours (Note=Lot 03202018) (JCRB=JCRB0624).
CC   HLA typing: A*24:02,31:01; B*07:02,51:01; C*07:02,14:02 (PubMed=9023415).
CC   HLA typing: A*24:02,31:01; B*07:02,51:01; C*07:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (DepMap=ACH-000546).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=18097548; DepMap=ACH-000546).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=1570156; PubMed=10741724).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=84.74%; East Asian, South=13.79%; South Asian=1.33%; European, North=0%; European, South=0.12% (PubMed=30894373).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=907062; JCRB=JCRB0624; PubMed=11416159; RCB=RCB1902; Technion Genomics Center; TKG=TKG 0489
ST   Amelogenin: X
ST   CSF1PO: 9 (TKG=TKG 0489)
ST   CSF1PO: 9,10 (Cosmic-CLP=907062; JCRB=JCRB0624; RCB=RCB1902; Technion Genomics Center)
ST   D10S1248: 12,13
ST   D12S391: 18,19
ST   D13S317: 8,13
ST   D16S539: 12
ST   D18S51: 15,20
ST   D19S433: 13,14
ST   D1S1656: 15,16
ST   D21S11: 29,30
ST   D22S1045: 17
ST   D2S1338: 24
ST   D2S441: 10
ST   D3S1358: 15,16
ST   D5S818: 8,11
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 17,19
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   HSC-4 [Macaca fascicularis]
AC   CVCL_EG69
DR   JCRB; JCRB1652
DR   Wikidata; Q54896391
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   HSC-40A
AC   CVCL_A386
SY   HSC40A
DR   CGH-DB; 107-1
DR   CGH-DB; 9002-4
DR   Cosmic; 876558
DR   Cosmic; 877038
DR   JCRB; JCRB1867
DR   Wikidata; Q54896392
RX   PubMed=1846312;
RX   PubMed=15723654;
CC   Population: Japanese.
CC   Doubling time: 28-30 hours (PubMed=1846312).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1867
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A385 ! HSC-39
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   HSC-41
AC   CVCL_8355
SY   HSC41; HSC-41E6
DR   BioSample; SAMN03151781
DR   BioSample; SAMN03472483
DR   CGH-DB; 108-1
DR   CGH-DB; 9003-4
DR   Cosmic; 897523
DR   Cosmic; 1571764
DR   JCRB; JCRB1035
DR   Wikidata; Q54896393
RX   PubMed=8242641;
RX   PubMed=15723654;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a HSC-42 derivative (PubMed=20143388). Originally thought to originate from a 45 year old male patient with a stomach carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00312.
CC   Population: Japanese.
CC   Doubling time: 23 hours (PubMed=8242641).
CC   Discontinued: JCRB; JCRB1035; probable.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): JCRB=JCRB1035
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0316 ! HSC-42
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   HSC-42
AC   CVCL_0316
AS   CVCL_8356
SY   HSC42; HSC-42H
DR   MCCL; MCC:0000209
DR   CGH-DB; 109-1
DR   CGH-DB; 9004-4
DR   Cosmic; 877048
DR   Cosmic; 897524
DR   JCRB; JCRB1036
DR   Wikidata; Q54896394
RX   PubMed=8242641;
RX   PubMed=15723654;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 26 hours (PubMed=8242641).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; JCRB1036; probable.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): JCRB=JCRB1036
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   HSC-43
AC   CVCL_A387
SY   HSC43
DR   CGH-DB; 110-1
DR   CGH-DB; 9005-4
DR   Cosmic; 877049
DR   Cosmic; 1518249
DR   JCRB; JCRB1878
DR   Wikidata; Q54896395
RX   PubMed=8387462;
RX   PubMed=15723654;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: ~55 hours (PubMed=8387462).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): JCRB=JCRB1878
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16,17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   HSC-44PE
AC   CVCL_A388
SY   HSC-44-PE; HSC44PE; HSC-44
DR   CGH-DB; 111-1
DR   CGH-DB; 9006-4
DR   Cosmic; 877050
DR   Cosmic; 897525
DR   Cosmic; 1518315
DR   Cosmic; 2443796
DR   JCRB; JCRB1873
DR   Wikidata; Q54896396
RX   PubMed=15245593;
RX   PubMed=15723654;
RX   PubMed=15958054;
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=15245593).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 13
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A389 ! HSC-45
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
ID   HSC-45
AC   CVCL_A389
SY   HSC45
DR   CGH-DB; 112-1
DR   CGH-DB; 9007-4
DR   Cosmic; 877051
DR   Cosmic; 1518316
DR   Cosmic; 1571765
DR   JCRB; JCRB1876
DR   Wikidata; Q54896397
RX   PubMed=8242641;
RX   PubMed=15245593;
RX   PubMed=15723654;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1876
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 13
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A388 ! HSC-44PE
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   HSC-45M2
AC   CVCL_A390
SY   HSC45-M2
DR   Cosmic; 997913
DR   Wikidata; Q54896398
RX   PubMed=8242641;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=8242641).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A389 ! HSC-45
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HSC-5 [Human OCSCC]
AC   CVCL_W943
SY   HSC5
DR   cancercelllines; CVCL_W943
DR   CGH-DB; 366-2
DR   Cosmic; 930333
DR   Cosmic; 1046032
DR   Cosmic; 1123041
DR   IARC_TP53; 1103
DR   Wikidata; Q54896402
RX   PubMed=1570156;
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (PubMed=1570156).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   HSC-5 [Human skin squamous cell carcinoma]
AC   CVCL_0314
SY   HSC5
DR   MCCL; MCC:0000207
DR   BioSample; SAMN03470884
DR   cancercelllines; CVCL_0314
DR   Cell_Model_Passport; SIDM01738
DR   DepMap; ACH-001524
DR   JCRB; JCRB1016
DR   JCRB; NIHS0250
DR   Wikidata; Q54896401
RX   PubMed=1693926;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: JCRB; NIHS0250; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): DepMap=ACH-001524; JCRB=JCRB1016; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 11,16
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 20
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   HSC-5-Luc
AC   CVCL_JG50
DR   JCRB; JCRB1586
DR   Wikidata; Q54896403
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): JCRB=JCRB1586
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0314 ! HSC-5 [Human skin squamous cell carcinoma]
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   HSC-52a
AC   CVCL_J231
DR   TKG; TKG 0200
DR   Wikidata; Q54896404
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   HSC-57
AC   CVCL_A613
SY   HSC57
DR   CGH-DB; 113-1
DR   CGH-DB; 9008-4
DR   Cosmic; 897526
DR   JCRB; JCRB1879
DR   Wikidata; Q54896405
RX   PubMed=15245593;
RX   PubMed=15723654;
RX   PubMed=24483192;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=15245593).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1879
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D5S818: 10,14
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 11
//
ID   HSC-58
AC   CVCL_A391
SY   HSC58
DR   CGH-DB; 114-1
DR   CGH-DB; 9009-4
DR   Cosmic; 897527
DR   Cosmic; 1518250
DR   Cosmic; 2443797
DR   JCRB; JCRB1881
DR   Wikidata; Q54896406
RX   PubMed=15245593;
RX   PubMed=15723654;
RX   PubMed=15958054;
RX   PubMed=22844455;
RX   PubMed=26934957;
CC   Population: Japanese.
CC   Doubling time: 23 hours (PubMed=15245593); 34 hours (PubMed=22844455).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1881
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 15
//
ID   HSC-59
AC   CVCL_A614
SY   HSC59
DR   Cosmic; 897528
DR   Cosmic; 1518251
DR   JCRB; JCRB1880
DR   Wikidata; Q54896407
RX   PubMed=15245593;
CC   Population: Japanese.
CC   Doubling time: 22 hours (PubMed=15245593).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1880
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 10
//
ID   HSC-6
AC   CVCL_A615
SY   HSC6
DR   cancercelllines; CVCL_A615
DR   CGH-DB; 367-2
DR   Cosmic; 930334
DR   Cosmic; 1046033
DR   Cosmic; 1123042
DR   Wikidata; Q54896408
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Unspecified (PubMed=18097548).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   HSC-60
AC   CVCL_A616
SY   HSC60
DR   CGH-DB; 115-1
DR   CGH-DB; 9010-4
DR   Cosmic; 897529
DR   Cosmic; 1518252
DR   JCRB; JCRB1884
DR   Wikidata; Q54896409
RX   PubMed=15245593;
RX   PubMed=15723654;
CC   Population: Japanese.
CC   Doubling time: 26 hours (PubMed=15245593).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1884
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 12
//
ID   HSC-64
AC   CVCL_A617
SY   HSC64
DR   CGH-DB; 116-1
DR   CGH-DB; 9011-4
DR   Cosmic; 897530
DR   Cosmic; 1518253
DR   JCRB; JCRB1885
DR   Wikidata; Q54896410
RX   PubMed=15245593;
RX   PubMed=15723654;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=15245593).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1885
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13,15
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 14,16
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 11
//
ID   HSC-7
AC   CVCL_A618
SY   HSC7
DR   CGH-DB; 368-2
DR   Cosmic; 930335
DR   Cosmic; 1046034
DR   Wikidata; Q54896411
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   HSC-72
AC   CVCL_J232
DR   TKG; TKG 0201
DR   Wikidata; Q54896412
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on spleen interstitial cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   HSC-8230
AC   CVCL_JG05
DR   JCRB; NIHS0972
DR   Wikidata; Q54896413
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Miscellaneous: Cell line not distributed due to difficulties to put in culture.
CC   Discontinued: JCRB; NIHS0972; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HSC-F
AC   CVCL_5485
DR   CLO; CLO_0050247
DR   JCRB; JCRB1164
DR   RCB; RCB1846
DR   Wikidata; Q54896414
RX   PubMed=10370378;
RX   PubMed=12684704;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: NHPRR; Catalog number 127.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   HSC-GRW
AC   CVCL_S965
DR   Cosmic; 977943
DR   Wikidata; Q54896415
RX   CelloPub=CLPUB00052;
RX   PubMed=12586620;
CC   Characteristics: KITLG dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:4170; GATA1; Simple; p.Pro50fs*6 (c.150_184del35); Zygosity=Unspecified (PubMed=12586620).
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   HSC-Li
AC   CVCL_A5TB
DR   Wikidata; Q107115364
RX   PubMed=25678842;
RX   PubMed=27020634;
CC   Population: Chinese.
CC   Characteristics: Produces both HGF and TGFB1 in a time-dependent manner (PubMed=25678842).
CC   Doubling time: 8 hours (PubMed=25678842).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   HSC-M1
AC   CVCL_H630
DR   Wikidata; Q54896416
RX   PubMed=11426532;
RX   PubMed=15356658;
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=11426532).
CC   Miscellaneous: Cell line has been lost (PubMed=15356658).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   HSC-PQ
AC   CVCL_A281
SY   Hepatic Stellate Cell-PQ; PQ
DR   BTO; BTO_0003524
DR   Wikidata; Q54896417
RX   PubMed=15908330;
RX   PubMed=17760834;
CC   Doubling time: ~75 hours (PubMed=15908330).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 15
//
ID   HSC-T6
AC   CVCL_0315
SY   HSCT6
DR   BTO; BTO_0003520
DR   MCCL; MCC:0000208
DR   ChEMBL-Cells; CHEMBL4651377
DR   CLS; 305199
DR   KCB; KCB 200703YJ
DR   Millipore; SCC069
DR   PubChem_Cell_line; CVCL_0315
DR   Wikidata; Q54896418
RX   PubMed=10828080;
RX   PubMed=17760834;
RX   PubMed=26300973;
RX   PubMed=35681478;
CC   Doubling time: 10 hours (PubMed=26300973).
CC   Karyotypic information: 43,XX,der(1),+4,+7,-12,+mar (PubMed=35681478).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Was originally (PubMed=10828080) reported to be established from a male rat, but was later shown (PubMed=35681478) to have a female karyotype.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   HSC3/hPDPN
AC   CVCL_YA14
SY   HSC3-hPDPN
DR   Wikidata; Q94302977
RX   PubMed=23012488;
RX   PubMed=25080943;
RX   PubMed=28387591;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1288 ! HSC-3
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   HSCj-002
AC   CVCL_JG08
DR   JCRB; JCRB1665
DR   Wikidata; Q54896419
RX   PubMed=19073238;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10384; Saimiriine herpesvirus 2 (Herpesvirus saimiri) (strain 488).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   HSCj-009
AC   CVCL_VA20
DR   Wikidata; Q54896420
RX   PubMed=19073238;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10384; Saimiriine herpesvirus 2 (Herpesvirus saimiri) (strain 488).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 6
//
ID   HSCj-101
AC   CVCL_JG09
DR   JCRB; JCRB1759
DR   JCRB; NIHS1009
DR   Wikidata; Q54896421
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10384; Saimiriine herpesvirus 2 (Herpesvirus saimiri) (strain 488).
CC   Discontinued: JCRB; NIHS1009; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   HSCj-109
AC   CVCL_JG10
DR   JCRB; JCRB1663
DR   Wikidata; Q54896422
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10384; Saimiriine herpesvirus 2 (Herpesvirus saimiri) (strain 488).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   HSCj-110
AC   CVCL_JG11
DR   JCRB; JCRB1655
DR   Wikidata; Q54896423
RX   PubMed=19073238;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10384; Saimiriine herpesvirus 2 (Herpesvirus saimiri) (strain 488).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   HSCR-iPSC 1
AC   CVCL_VL53
DR   Wikidata; Q94303056
RX   PubMed=29965875;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Glu61Argfs*163 (c.180delT); Zygosity=Heterozygous (PubMed=29965875).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL54 ! HSCR-iPSC 2
OI   CVCL_VL55 ! HSCR-iPSC 3
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   HSCR-iPSC 2
AC   CVCL_VL54
DR   Wikidata; Q94303062
RX   PubMed=29965875;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Glu61Argfs*163 (c.180delT); Zygosity=Heterozygous (PubMed=29965875).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL53 ! HSCR-iPSC 1
OI   CVCL_VL55 ! HSCR-iPSC 3
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   HSCR-iPSC 3
AC   CVCL_VL55
DR   Wikidata; Q94303068
RX   PubMed=29965875;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Glu61Argfs*163 (c.180delT); Zygosity=Heterozygous (PubMed=29965875).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34700; Hirschsprung disease
DI   ORDO; Orphanet_388; Hirschsprung disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL53 ! HSCR-iPSC 1
OI   CVCL_VL54 ! HSCR-iPSC 2
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   HSD-10
AC   CVCL_A2BP
DR   Wikidata; Q105509477
RX   DOI=10.11277/stomatology1952.37.879;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, minor salivary gland; UBERON=UBERON_0001830.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HSDM1
AC   CVCL_5U36
DR   Wikidata; Q54896424
RX   PubMed=4345106;
RX   PubMed=5063598;
CC   Breed/subspecies: Swiss albino.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 3
//
ID   HSDM1C1
AC   CVCL_3518
DR   BTO; BTO_0000461
DR   CLO; CLO_0004259
DR   CLO; CLO_0004260
DR   CLDB; cl1730
DR   CLDB; cl5204
DR   ATCC; CCL-148
DR   ECACC; 90112810
DR   IZSLER; BS TCL 105
DR   Wikidata; Q54896425
RX   PubMed=4345106;
RX   PubMed=5063598;
CC   Misspelling: HSDM11C11; CLO=CLO_0004259.
CC   Breed/subspecies: Swiss albino.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U36 ! HSDM1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   HSDM1C3
AC   CVCL_5U37
DR   Wikidata; Q54896426
RX   PubMed=4345106;
RX   PubMed=5063598;
CC   Breed/subspecies: Swiss albino.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U36 ! HSDM1
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 3
//
ID   HSE/LULS51
AC   CVCL_C1GT
DR   Wikidata; Q114311660
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=1260755; ! Hyalomma scupense (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   HSE/LULS59
AC   CVCL_C1GU
DR   Wikidata; Q114311661
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=1260755; ! Hyalomma scupense (Tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   HSF-1
AC   CVCL_D003
SY   UC01; UCSFe003-A
DR   BioSample; SAMN03471902
DR   GEO; GSM239977
DR   GEO; GSM239978
DR   GEO; GSM288327
DR   GEO; GSM288332
DR   GEO; GSM288337
DR   hPSCreg; UCSFe003-A
DR   SKIP; SKIP002001
DR   Wikidata; Q54896427
RX   PubMed=14749348;
RX   PubMed=23117585;
RX   PubMed=25877200;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/affy/2
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/2
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   HSF-1-14
AC   CVCL_D004
SY   HSF1.14; UCSFe003-A-1; UCSFe001-A
DR   GEO; GSM288379
DR   hPSCreg; UCSFe003-A-1
DR   SKIP; SKIP001946
DR   Wikidata; Q54896429
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D003 ! HSF-1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   HSF-10
AC   CVCL_JG12
DR   JCRB; JCRB1684
DR   Wikidata; Q54896430
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9515; ! Sapajus apella (Brown-capped capuchin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HSF-11
AC   CVCL_JG13
DR   JCRB; JCRB1690
DR   Wikidata; Q54896431
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9515; ! Sapajus apella (Brown-capped capuchin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HSF-412
AC   CVCL_M811
SY   AD387; AD 387
DR   Wikidata; Q54608721
RX   PubMed=3140712;
RX   PubMed=8744932;
RX   PubMed=8790940;
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   HSF-6
AC   CVCL_D005
SY   HSF6; hSF6; UC06; UC 06; UCSFe002-A
DR   GEO; GSM383882
DR   GEO; GSM384103
DR   GEO; GSM856728
DR   GEO; GSM856738
DR   GEO; GSM862727
DR   hPSCreg; UCSFe002-A
DR   SKIP; SKIP001947
DR   WiCell; uc06
DR   Wikidata; Q54896437
RX   PubMed=14749348;
RX   PubMed=17570852;
RX   PubMed=23117585;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/7
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0015.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-58.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=uc06
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,13
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   HSF-9
AC   CVCL_JG14
DR   JCRB; JCRB1711
DR   Wikidata; Q54896432
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9515; ! Sapajus apella (Brown-capped capuchin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HSF-PI 16
AC   CVCL_9V77
DR   NCBI_Iran; C192
DR   Wikidata; Q54896433
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HSF-PI 17
AC   CVCL_9V78
DR   NCBI_Iran; C193
DR   Wikidata; Q54896434
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HSF-PI 18
AC   CVCL_9V79
DR   NCBI_Iran; C194
DR   Wikidata; Q54896435
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HSF-PI 19
AC   CVCL_9V80
DR   NCBI_Iran; C195
DR   Wikidata; Q54896436
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HSF10
AC   CVCL_D006
SY   SUSMe004-A
DR   hPSCreg; SUSMe004-A
DR   SKIP; SKIP002040
DR   Wikidata; Q54896438
RX   PubMed=18513167;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   HSF12
AC   CVCL_D007
SY   SUSMe005-A
DR   hPSCreg; SUSMe005-A
DR   SKIP; SKIP002041
DR   Wikidata; Q54896439
RX   PubMed=18513167;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   HSF13
AC   CVCL_D008
SY   SUSMe006-A
DR   hPSCreg; SUSMe006-A
DR   SKIP; SKIP002042
DR   Wikidata; Q54896440
RX   PubMed=18513167;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   HSF2
AC   CVCL_A9JS
DR   CCRID; 5301HUM-KCB09007ZJ
DR   KCB; KCB 200907ZJ
DR   Wikidata; Q108820505
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   HSF7
AC   CVCL_D009
SY   SUSMe001-A
DR   hPSCreg; SUSMe001-A
DR   SKIP; SKIP002037
DR   Wikidata; Q54896441
RX   PubMed=18513167;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   HSF8
AC   CVCL_D010
SY   SUSMe002-A
DR   hPSCreg; SUSMe002-A
DR   SKIP; SKIP002038
DR   Wikidata; Q54896443
RX   PubMed=18513167;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   HSF9
AC   CVCL_D011
SY   SUSMe003-A
DR   hPSCreg; SUSMe003-A
DR   SKIP; SKIP002039
DR   Wikidata; Q54896444
RX   PubMed=18513167;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   HSG
AC   CVCL_2517
SY   Human Salivary Gland
DR   CLO; CLO_0004263
DR   BioSample; SAMN03151712
DR   BioSample; SAMN03471295
DR   Cosmic; 974319
DR   ECACC; 95031024
DR   JCRB; CHB0004
DR   Wikidata; Q54896445
RX   CelloPub=CLPUB00653;
RX   DOI=10.1007/0-306-46872-7_9;
RX   DOI=10.2330/joralbiosci1965.34.164;
RX   PubMed=2440567;
RX   PubMed=7248901;
RX   PubMed=9183635;
RX   PubMed=16391823;
RX   PubMed=17390010;
RX   PubMed=20143388;
RX   PubMed=29923277;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HSG
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388; PubMed=29923277; CelloPub=CLPUB00653). Originally thought to originate from a 54 year old male irradiated submandibular salivary gland.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00313.
CC   Population: African American.
CC   Doubling time: 29 hours (DOI=10.2330/joralbiosci1965.34.164).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE-MS.
CC   Discontinued: JCRB; CHB0004; probable.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CelloPub=CLPUB00653; JCRB=CHB0004; PubMed=29923277
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 10,11 (CelloPub=CLPUB00653; PubMed=29923277)
ST   D5S818: 11 (JCRB=CHB0004)
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HSG-AZA1
AC   CVCL_A047
SY   HSGAza1; AZA1; AZA-1
DR   BioSample; SAMN03151713
DR   IARC_TP53; 25034
DR   JCRB; CHB0003
DR   Wikidata; Q54896446
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=2440567;
RX   PubMed=16391823;
RX   PubMed=17390010;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00314.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE-MS.
CC   Discontinued: JCRB; CHB0003; probable.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=CHB0003
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2517 ! HSG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   HSG-AZA3
AC   CVCL_A048
SY   AZA3; AZA-3
DR   BioSample; SAMN03151714
DR   IARC_TP53; 25035
DR   JCRB; CHB0002
DR   Wikidata; Q54896447
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=2440567;
RX   PubMed=16391823;
RX   PubMed=17390010;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00315.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE-MS.
CC   Discontinued: JCRB; CHB0002; probable.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=CHB0002
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2517 ! HSG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   hSG-Bmi1
AC   CVCL_ZE91
DR   Wikidata; Q98126734
RX   PubMed=32249592;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: Stated to be immortalized but it is not clear from the paper if they are really immortal or have a extended life time.
CC   Derived from site: In situ; Larynx, subglottis; UBERON=UBERON_0036068.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   HSG-S6
AC   CVCL_WL39
SY   HSG-S 6
DR   Wikidata; Q94303414
RX   DOI=10.2330/joralbiosci1965.34.164;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 30.5 hours (DOI=10.2330/joralbiosci1965.34.164).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2517 ! HSG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HSG-S8
AC   CVCL_WL38
SY   HSG-S 8
DR   Wikidata; Q94303419
RX   DOI=10.2330/joralbiosci1965.34.164;
RX   PubMed=8439320;
RX   PubMed=9247707;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 49.3 hours (DOI=10.2330/joralbiosci1965.34.164); 53.6 hours (Note=In SFM101 medium) (PubMed=8439320).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2517 ! HSG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HSGc-C5
AC   CVCL_2951
DR   BioSample; SAMN03151715
DR   JCRB; JCRB1070
DR   JCRB; NIHS0331
DR   Wikidata; Q54896448
RX   PubMed=2417703;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HSG) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00316.
CC   Population: African American.
CC   Doubling time: 23 hours (JCRB=JCRB1070).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: JCRB; NIHS0331; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1070
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2517 ! HSG
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   HSGm-2014
AC   CVCL_JG06
DR   JCRB; NIHS0980
DR   Wikidata; Q54896449
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS0980; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSGm-6009
AC   CVCL_JG07
DR   JCRB; NIHS0981
DR   Wikidata; Q54896450
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Miscellaneous: Cell line not distributed due to difficulties to put in culture.
CC   Discontinued: JCRB; NIHS0981; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSJ-2099
AC   CVCL_JG15
DR   JCRB; JCRB1645
DR   Wikidata; Q54896451
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSJ-2178
AC   CVCL_JG16
DR   JCRB; JCRB1660
DR   Wikidata; Q54896452
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSJD-DIPG-007
AC   CVCL_VU70
SY   HSJD-DIPG007; DIPG007; Hospital Sant Joan de Deu-Diffuse Intrinsic Pontine Glioma-007
DR   cancercelllines; CVCL_VU70
DR   Cell_Model_Passport; SIDM01714
DR   DepMap; ACH-002348
DR   GEO; GSM4969594
DR   GEO; GSM4969595
DR   GEO; GSM4969596
DR   GEO; GSM4969597
DR   GEO; GSM4969623
DR   GEO; GSM4969655
DR   GEO; GSM4969656
DR   GEO; GSM4969658
DR   GEO; GSM4969662
DR   GEO; GSM4969663
DR   GEO; GSM4969664
DR   GEO; GSM5356018
DR   Wikidata; Q94303494
RX   PubMed=25628092;
RX   PubMed=27325687;
RX   PubMed=28947132;
RX   PubMed=31439867;
RX   PubMed=32229503;
RX   PubMed=34078608;
RX   PubMed=34732238;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Unspecified (PubMed=27325687).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=27325687; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Pro428Glnfs*3 (c.1283delC); Zygosity=Unspecified (PubMed=32229503; PubMed=34732238).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 13,14
ST   D21S11: 29,30
ST   D5S818: 13
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 13
//
ID   HSJD-DIPG-007-NTC
AC   CVCL_C1MT
SY   HSJD-DIPG-007 NTC
DR   cancercelllines; CVCL_C1MT
DR   Wikidata; Q114311662
RX   PubMed=32229503;
RX   PubMed=34732238;
CC   Characteristics: Control cell line for HSJD-DIPG-007-TP53 KO (Cellosaurus=CVCL_C1MU).
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Pro428Glnfs*3 (c.1283delC); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 13,14
ST   D21S11: 29,30
ST   D5S818: 13
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VU70 ! HSJD-DIPG-007
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HSJD-DIPG-007-TP53 KO
AC   CVCL_C1MU
SY   HSJD-DIPG-007 TP53-KO
DR   cancercelllines; CVCL_C1MU
DR   Wikidata; Q114311663
RX   PubMed=32229503;
RX   PubMed=34732238;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Pro428Glnfs*3 (c.1283delC); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 13,14
ST   D21S11: 29,30
ST   D5S818: 13
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VU70 ! HSJD-DIPG-007
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HSJD-DIPG-008
AC   CVCL_C1N2
SY   Hospital Sant Joan de Deu-Diffuse Intrinsic Pontine Glioma-008
DR   cancercelllines; CVCL_C1N2
DR   Wikidata; Q114311664
RX   PubMed=31439867;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=31439867).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg429fs; Zygosity=Unspecified (PubMed=31439867).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HSJD-DIPG-012
AC   CVCL_VU71
SY   DIPG012; Hospital Sant Joan de Deu-Diffuse Intrinsic Pontine Glioma-012
DR   cancercelllines; CVCL_VU71
DR   Wikidata; Q94303502
RX   Patent=US20200384022;
RX   PubMed=28947132;
RX   PubMed=32229503;
RX   PubMed=34732238;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (Patent=US20200384022; PubMed=32229503; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=32229503; PubMed=34732238).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D21S11: 28,30
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   HSJD-DIPG-013
AC   CVCL_C1MI
SY   Hospital Sant Joan de Deu-Diffuse Intrinsic Pontine Glioma-013
DR   cancercelllines; CVCL_C1MI
DR   Wikidata; Q114311665
RX   PubMed=32229503;
RX   PubMed=34732238;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=32229503; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=32229503; PubMed=34732238).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 29,34.2
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 13,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HSJD-DIPG-014b
AC   CVCL_C1N3
SY   Hospital Sant Joan de Deu-Diffuse Intrinsic Pontine Glioma-008
DR   cancercelllines; CVCL_C1N3
DR   Wikidata; Q114311666
RX   PubMed=31439867;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=31439867).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu484Phefs*5 (c.1451dup); ClinVar=VCV000871469; Zygosity=Unspecified (PubMed=31439867).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HSkMEC.2
AC   CVCL_A1BD
SY   Human Skin Microvascular Endothelial Cells.2
DR   Wikidata; Q102114158
RX   PubMed=15843556;
RX   PubMed=32705508;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   HSKT-C
AC   CVCL_8234
SY   HSKTC
DR   CLO; CLO_0051438
DR   BioSample; SAMN03472278
DR   cancercelllines; CVCL_8234
DR   DepMap; ACH-002038
DR   FANTOM5_SSTAR; 10687-109F3
DR   RCB; RCB0515
DR   Wikidata; Q54896453
RX   PubMed=2160890;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 60 hours (Note=At 5th passage), 57 hours (Note=At 10th passage), 52 hours (Note=At 20th passage) (PubMed=2160890).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): RCB=RCB0515
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3153; Krukenberg tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8235 ! HSKT-F
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HSKT-F
AC   CVCL_8235
SY   HSKTF
DR   Wikidata; Q54896454
RX   PubMed=2160890;
CC   Population: Japanese.
CC   Doubling time: 120 hours (Note=At 5th passage) (PubMed=2160890).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C3153; Krukenberg tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8234 ! HSKT-C
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   HSM-1
AC   CVCL_5U53
DR   Wikidata; Q54896455
RX   PubMed=1419799;
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C35815; Granulocytic sarcoma
DI   ORDO; Orphanet_86850; Myeloid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HSM-2
AC   CVCL_M512
DR   Wikidata; Q54896456
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2064960;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgM kappa.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   HSM-2.3
AC   CVCL_M513
DR   Wikidata; Q54896457
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2064960;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgM kappa.
CC   Characteristics: IL3 or IL6 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M512 ! HSM-2
SX   Male
AG   90Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   HSM-911
AC   CVCL_E5EG
SY   HSM911
RX   PubMed=7525434;
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: CSF2, IL3 and KITLG (PubMed=7525434).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HSM-911 pGD210-1
AC   CVCL_E5EH
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Conserves dependency on CSF2 and IL3 (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pGD210-2
AC   CVCL_E5EI
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Conserves dependency on CSF2 and IL3 (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pGD210-3
AC   CVCL_E5EJ
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Conserves dependency on CSF2 and IL3 (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pGD210-4
AC   CVCL_E5EK
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Conserves dependency on CSF2 and IL3 (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pGD210-5
AC   CVCL_E5EL
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Conserves dependency on CSF2 and IL3 (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pGD210-6
AC   CVCL_E5EM
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Conserves dependency on CSF2 and IL3 (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pGD210-7
AC   CVCL_E5EN
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Conserves dependency on CSF2 and IL3 (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pMPZenNeo(bcr-v-abl)-1
AC   CVCL_E5EP
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Became independant of growth factors (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=Synthetic BCR-v-ABL fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00521; Abelson murine leukemia virus v-Abl (Note=Synthetic BCR-v-Abl fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pMPZenNeo(bcr-v-abl)-2
AC   CVCL_E5EQ
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Became independant of growth factors (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=Synthetic BCR-v-ABL fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00521; Abelson murine leukemia virus v-Abl (Note=Synthetic BCR-v-Abl fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pMPZenNeo(bcr-v-abl)-3
AC   CVCL_E5ER
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Became independant of growth factors (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=Synthetic BCR-v-ABL fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00521; Abelson murine leukemia virus v-Abl (Note=Synthetic BCR-v-Abl fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pMPZenNeo(bcr-v-abl)-4
AC   CVCL_E5ES
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Became independant of growth factors (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=Synthetic BCR-v-ABL fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00521; Abelson murine leukemia virus v-Abl (Note=Synthetic BCR-v-Abl fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSM-911 pMPZenNeo(bcr-v-abl)-5
AC   CVCL_E5ET
RX   PubMed=9444946;
CC   Population: Japanese.
CC   Characteristics: Became independant of growth factors (PubMed=9444946).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1014; BCR (Note=Synthetic BCR-v-ABL fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00521; Abelson murine leukemia virus v-Abl (Note=Synthetic BCR-v-Abl fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EG ! HSM-911
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HSmC-78
AC   CVCL_M122
SY   HSmC 78; HSmC78
DR   Wikidata; Q54896458
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=548013;
RX   PubMed=6837290;
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
DI   NCIt; C5943; Submandibular gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   HSME6o-
AC   CVCL_IN67
DR   Wikidata; Q54896459
RX   PubMed=15463957;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, submucosal gland; UBERON=UBERON_8410043.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 7
//
ID   HSME82o-
AC   CVCL_IN68
DR   Wikidata; Q54896460
RX   PubMed=15463957;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, submucosal gland; UBERON=UBERON_8410043.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 7
//
ID   HSMn-3942
AC   CVCL_JG17
DR   JCRB; JCRB1656
DR   JCRB; NIHS0977
DR   Wikidata; Q54896461
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS0977; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HSMn-3943
AC   CVCL_JG18
DR   JCRB; NIHS0976
DR   Wikidata; Q54896462
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS0976; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HSMn-4613
AC   CVCL_JG19
DR   JCRB; NIHS0975
DR   Wikidata; Q54896463
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS0975; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   HsMo
AC   CVCL_E9TM
RX   DOI=10.13140/2.1.5049.4087;
CC   Virology: Susceptible to infection by West Nile virus (WNV) (DOI=10.13140/2.1.5049.4087).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HSNB
AC   CVCL_L554
DR   CLO; CLO_0051414
DR   BioSample; SAMN03472270
DR   RCB; RCB0666
DR   Wikidata; Q54896464
RX   PubMed=2486666;
CC   Population: Japanese.
CC   Doubling time: ~50 hours (PubMed=2486666).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): RCB=RCB0666
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 15
//
ID   HSNT1
AC   CVCL_K096
DR   RCB; AES0128
DR   RCB; RCB2702
DR   SKIP; SKIP001671
DR   Wikidata; Q54896465
CC   Discontinued: RCB; RCB2702; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   HSNT2
AC   CVCL_K097
DR   RCB; AES0129
DR   RCB; RCB2703
DR   SKIP; SKIP001672
DR   Wikidata; Q54896466
CC   Discontinued: RCB; RCB2703; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   HSOGT
AC   CVCL_6655
SY   Homo Sapiens Ovarian Granulosa Tumor
DR   Wikidata; Q54896467
RX   PubMed=15005243;
CC   Population: Japanese.
CC   Doubling time: 18.9 hours (PubMed=15005243).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   HSP-239
AC   CVCL_2518
DR   CLO; CLO_0050225
DR   JCRB; JCRB1165
DR   RCB; RCB1854
DR   Wikidata; Q54896468
CC   Group: Non-human primate cell line.
CC   Characteristics: While not dependent on IL2 it will grow faster with addition of the cytokine in the growth medium (JCRB=JCRB1165).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   HSP-250
AC   CVCL_2519
DR   CLO; CLO_0050224
DR   JCRB; JCRB1177
DR   RCB; RCB1855
DR   Wikidata; Q54896469
CC   Group: Non-human primate cell line.
CC   Characteristics: While not dependent on IL2 it will grow faster with addition of the cytokine in the growth medium (JCRB=JCRB1177).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   HSP00332IN
AC   CVCL_E163
DR   Wikidata; Q29583703
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9581; ! Hylobates sp. (Gibbon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   HSPH 14
AC   CVCL_ZS48
SY   HSPH14; 14
DR   Wikidata; Q98126736
RX   PubMed=2897722;
RX   PubMed=6442144;
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   HSQ-115
AC   CVCL_JG20
DR   JCRB; NIHS0990
DR   Wikidata; Q54896470
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Miscellaneous: Cell line not distributed due to difficulties to put in culture.
CC   Discontinued: JCRB; NIHS0990; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9521; ! Saimiri sciureus (Common squirrel monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HSQ-89
AC   CVCL_7674
SY   HSQ89
DR   CLO; CLO_0050085
DR   BioSample; SAMN03472238
DR   cancercelllines; CVCL_7674
DR   DepMap; ACH-002044
DR   FANTOM5_SSTAR; 10414-106B9
DR   GEO; GSM850385
DR   IARC_TP53; 28403
DR   Progenetix; CVCL_7674
DR   RCB; RCB0789
DR   Wikidata; Q54896471
RX   PubMed=10741724;
RX   PubMed=14733907;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*02:01,24:02 (PubMed=10741724).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Unspecified (PubMed=10741724; DepMap=ACH-002044).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
ST   Source(s): RCB=RCB0789
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 14,20
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   HSR-1
AC   CVCL_9Q49
DR   JCRB; JCRB1644
DR   JCRB; NIHS0973
DR   Wikidata; Q54896472
RX   PubMed=8610465;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: JCRB; NIHS0973; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   HSR-4
AC   CVCL_EG68
DR   JCRB; JCRB1641
DR   Wikidata; Q54896473
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   HSR-5
AC   CVCL_2952
DR   JCRB; JCRB1211
DR   Wikidata; Q54896474
RX   PubMed=8610465;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   HSR-GBM1A
AC   CVCL_DI57
SY   HSR-GBM1a; HSR GBM1A; GBM 0913; 0913; 020913; 20913
DR   Wikidata; Q54896475
RX   PubMed=15466194;
RX   PubMed=22380883;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   HSR-GBM1B
AC   CVCL_DI58
SY   GBM 0627; 0627; 010627; 10627
DR   cancercelllines; CVCL_DI58
DR   Cosmic; 2568871
DR   GEO; GSM481415
DR   Progenetix; CVCL_DI58
DR   Wikidata; Q54896476
RX   PubMed=15466194;
RX   PubMed=22380883;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
ID   hSS-005R
AC   CVCL_A2EV
DR   CCRID; 4201PAT-CCTCC01327
DR   Wikidata; Q105509480
RX   Patent=CN110106150B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201911.
CC   Population: Chinese.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   HSS-84
AC   CVCL_N592
DR   Wikidata; Q54896477
RX   PubMed=2851424;
CC   Population: Chinese.
CC   Doubling time: 65 hours (PubMed=2851424).
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   HST-1
AC   CVCL_E316
SY   HST-I
DR   Wikidata; Q54896478
RX   PubMed=2759736;
CC   Population: Japanese.
CC   Doubling time: 21 hours (PubMed=2759736).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   HST-1 [Saguinus midas]
AC   CVCL_JG21
DR   JCRB; JCRB1666
DR   Wikidata; Q54896479
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=30586; ! Saguinus midas (Golden-handed tamarin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HST-3
AC   CVCL_JG22
DR   JCRB; JCRB1669
DR   Wikidata; Q54896480
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=78454; ! Saguinus labiatus (Red-chested mustached tamarin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HST-4
AC   CVCL_JG23
DR   JCRB; JCRB1672
DR   Wikidata; Q54896481
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=78454; ! Saguinus labiatus (Red-chested mustached tamarin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HST-5
AC   CVCL_JG24
DR   JCRB; JCRB1673
DR   Wikidata; Q54896482
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=78454; ! Saguinus labiatus (Red-chested mustached tamarin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HST-6
AC   CVCL_JG25
DR   JCRB; JCRB1678
DR   Wikidata; Q54896484
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=78454; ! Saguinus labiatus (Red-chested mustached tamarin)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   HST2
AC   CVCL_T740
SY   HST-2
DR   Wikidata; Q54896485
RX   PubMed=8391386;
RX   PubMed=9023415;
CC   Population: Japanese.
CC   HLA typing: A*02:06,31:01; B*38:02,55:02; C*01:02,07:02 (PubMed=9023415).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HSUA
AC   CVCL_VT04
DR   Wikidata; Q94304006
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3778323;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 35 hours (PubMed=10457904).
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   HSV33
AC   CVCL_G033
DR   IPD-IMGT/HLA; 12983
DR   Wikidata; Q54896486
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,24; B*44:05,49; C*02,07; DRB1*01,16; DRB5*02 (IPD-IMGT/HLA=12983).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   HSV48
AC   CVCL_G034
DR   IPD-IMGT/HLA; 13095
DR   Wikidata; Q54896487
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01,68; B*15:24,35; C*03,04 (IPD-IMGT/HLA=13095).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   HSY
AC   CVCL_B032
DR   BioSample; SAMN03151716
DR   BioSample; SAMN03471294
DR   Cosmic; 974318
DR   GEO; GSM1132848
DR   GEO; GSM1132849
DR   GEO; GSM1132850
DR   GEO; GSM1132851
DR   GEO; GSM1132856
DR   GEO; GSM1132857
DR   GEO; GSM1132858
DR   GEO; GSM1132859
DR   GEO; GSM1132860
DR   GEO; GSM1132861
DR   JCRB; CHB0001
DR   Wikidata; Q54896488
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=2446043;
RX   PubMed=20143388;
RX   PubMed=29923277;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388; PubMed=29923277). Originally thought to originate from a 51 year old female patient with a parotid gland adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00317.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; CHB0001; probable.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=CHB0001; PubMed=29923277
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   HSY-EB
AC   CVCL_U462
DR   Wikidata; Q54896489
RX   PubMed=11997388;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-513.html
CC   Problematic cell line: Contaminated. Parent cell line (HSY) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B032 ! HSY
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   HT
AC   CVCL_1290
DR   CLO; CLO_0004265
DR   EFO; EFO_0002200
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2260
DR   BCRC; 60486
DR   BioSample; SAMN01821562
DR   BioSample; SAMN01821633
DR   BioSample; SAMN03472827
DR   BioSample; SAMN03473482
DR   BioSample; SAMN10987949
DR   cancercelllines; CVCL_1290
DR   Cell_Model_Passport; SIDM00661
DR   ChEMBL-Cells; CHEMBL3308143
DR   ChEMBL-Targets; CHEMBL2366130
DR   Cosmic; 687844
DR   Cosmic; 907063
DR   Cosmic; 1067441
DR   Cosmic; 1541915
DR   Cosmic; 1945181
DR   Cosmic; 2022501
DR   Cosmic; 2276317
DR   Cosmic-CLP; 907063
DR   DepMap; ACH-000914
DR   DSMZ; ACC-567
DR   DSMZCellDive; ACC-567
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GDSC; 907063
DR   GEO; GSM274841
DR   GEO; GSM380127
DR   GEO; GSM552431
DR   GEO; GSM562824
DR   GEO; GSM887143
DR   GEO; GSM888215
DR   GEO; GSM1035314
DR   GEO; GSM1059806
DR   GEO; GSM1151288
DR   GEO; GSM1374558
DR   GEO; GSM1669907
DR   IARC_TP53; 21377
DR   IGRhCellID; HT
DR   Kerafast; EMI025
DR   LiGeA; CCLE_740
DR   LINCS_LDP; LCL-1949
DR   PharmacoDB; HT_624_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1290
DR   PubChem_Cell_line; CVCL_1290
DR   Wikidata; Q54896490
RX   PubMed=2313723;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26787899;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30165192;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-567).
CC   HLA typing: A*24:02,24:02; B*07:02,55:01; C*03:03,07:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Heterozygous (Cosmic-CLP=907063).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (Cosmic-CLP=907063).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=0%; East Asian, North=0%; East Asian, South=0.35%; South Asian=0.95%; European, North=67.93%; European, South=30.44% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-2260; Cosmic-CLP=907063; DSMZ=ACC-567; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13,14
ST   D16S539: 11,13
ST   D18S51: 12,19
ST   D19S433: 12,16
ST   D21S11: 29,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 7.3,8,10 (DSMZ=ACC-567)
ST   D7S820: 8,10 (ATCC=CRL-2260; Cosmic-CLP=907063; PubMed=25877200)
ST   D8S1179: 10,13
ST   FGA: 21,22.2
ST   Penta D: 13
ST   Penta E: 10,20
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 17,18 (ATCC=CRL-2260; DSMZ=ACC-567; PubMed=25877200)
ST   vWA: 17,18,19 (Cosmic-CLP=907063)
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   HT [Human HeLa contaminated cell line]
AC   CVCL_WU77
SY   Human Trophoblast
DR   BCRC; 60527
DR   Wikidata; Q94304079
RX   PubMed=7952508;
RX   PubMed=11409691;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (BCRC=60527). Originally thought to originate from the placenta a 29 year old female donor.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: BCRC; 60527; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   HT [Human ovarian serous cystadenocarcinoma]
AC   CVCL_Y005
DR   CGH-DB; 324-2
DR   Wikidata; Q54896491
RX   PubMed=17671176;
CC   Population: Japanese.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 5
//
ID   HT 29/15
AC   CVCL_J689
SY   HT 29-15; HT29/15
DR   ATCC; HB-8246
DR   Wikidata; Q54896492
RX   Patent=US4579827;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8246.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   HT 29/26
AC   CVCL_J690
SY   SKI 294/HT 29/26; SKI294/HT29/26; HT 29-26; HT29/26; C26
DR   CLO; CLO_0004270
DR   ATCC; HB-8247
DR   Wikidata; Q54896493
RX   Patent=US4579827;
RX   Patent=US4935344;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8247.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   HT 29/36
AC   CVCL_J691
SY   SKI 294/HT 29/36; SKI294/HT29/36; HT 29-36; HT29/36; H 29-36
DR   CLO; CLO_0004271
DR   ATCC; HB-8248
DR   Wikidata; Q54896494
RX   Patent=US4579827;
RX   Patent=US5168043;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8248.
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   HT patient 1 line 1
AC   CVCL_WV77
SY   HT line 1
DR   Wikidata; Q94304149
RX   PubMed=20739751;
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Val166Gly (c.497T>G) (553T>G); ClinVar=VCV000558415; Zygosity=Heterozygous (from parent cell line).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM00286, the patient description and its mutation description are identical (up to the point of using the same obsolete cDNA position information).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L937 ! GM00286
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   HT patient 1 line 2
AC   CVCL_WV78
SY   HT line 2
DR   Wikidata; Q94304154
RX   PubMed=20739751;
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Val166Gly (c.497T>G) (553T>G); ClinVar=VCV000558415; Zygosity=Heterozygous (from parent cell line).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM00286, the patient description and its mutation description are identical (up tp the point of using the same obsolete cDNA position information).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L937 ! GM00286
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   HT patient 1 line 3
AC   CVCL_WV79
SY   HT line 3
DR   Wikidata; Q94304159
RX   PubMed=20739751;
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Val166Gly (c.497T>G) (553T>G); ClinVar=VCV000558415; Zygosity=Heterozygous (from parent cell line).
CC   Caution: While PubMed=20739751 does not specifically indicates that this cell line is derived from Coriell GM00286, the patient description and its mutation description are identical (up tp the point of using the same obsolete cDNA position information).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L937 ! GM00286
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   HT TRAF6 KD
AC   CVCL_ZC30
SY   TRAF6 Knock Down HT
DR   cancercelllines; CVCL_ZC30
DR   Kerafast; EMI026
DR   Wikidata; Q98126737
RX   PubMed=30165192;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:12036; TRAF6.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1290 ! HT
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   HT-1 [Hamster]
AC   CVCL_Y446
SY   Hamster Tumor-1
DR   ATCC; CRL-6283
DR   Wikidata; Q54896496
RX   PubMed=5230142;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Discontinued: ATCC; CRL-6283; true.
DI   NCIt; C134988; Hamster neoplasm
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 8
//
ID   HT-1 [Human lymphoma]
AC   CVCL_5T93
DR   Wikidata; Q54896497
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1310890;
CC   Population: Japanese.
CC   Doubling time: ~51 hours (PubMed=1310890).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7226; Adult T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HT-1080
AC   CVCL_0317
SY   Ht-1080; HT 1080; HT1080; HT 1080.T
DR   BTO; BTO_0001282
DR   CLO; CLO_0004266
DR   CLO; CLO_0004276
DR   EFO; EFO_0002059
DR   MCCL; MCC:0000210
DR   CLDB; cl1735
DR   CLDB; cl1736
DR   CLDB; cl1737
DR   CLDB; cl1738
DR   CLDB; cl1740
DR   CLDB; cl1741
DR   CLDB; cl1742
DR   CLDB; cl4913
DR   ABM; T8971
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-121
DR   ATCC; CRL-7951
DR   BCRC; 60037
DR   BCRJ; 0110
DR   BioGRID_ORCS_Cell_line; 279
DR   BioSample; SAMN01821563
DR   BioSample; SAMN01821634
DR   BioSample; SAMN01821685
DR   BioSample; SAMN01821731
DR   BioSample; SAMN03471913
DR   BioSample; SAMN10987635
DR   cancercelllines; CVCL_0317
DR   CCRID; 1101HUM-PUMC000070
DR   CCRID; 3101HUMTCHu170
DR   CCRID; 4201HUM-CCTCC00105
DR   CCTCC; GDC0105
DR   Cell_Model_Passport; SIDM00828
DR   ChEMBL-Cells; CHEMBL3308396
DR   ChEMBL-Targets; CHEMBL614580
DR   CLS; 300216
DR   Cosmic; 716177
DR   Cosmic; 716188
DR   Cosmic; 724819
DR   Cosmic; 907064
DR   Cosmic; 912000
DR   Cosmic; 1045409
DR   Cosmic; 1067221
DR   Cosmic; 1933190
DR   Cosmic; 2009505
DR   Cosmic; 2301553
DR   Cosmic; 2307731
DR   Cosmic; 2560245
DR   Cosmic; 2764533
DR   Cosmic-CLP; 907064
DR   DepMap; ACH-000054
DR   DSMZ; ACC-315
DR   DSMZCellDive; ACC-315
DR   ECACC; 85111505
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS039VHD
DR   ENCODE; ENCBS225AAA
DR   ENCODE; ENCBS512AAA
DR   ENCODE; ENCBS513AAA
DR   ENCODE; ENCBS617SGR
DR   ENCODE; ENCBS688VJF
DR   ENCODE; ENCBS798NML
DR   ENCODE; ENCBS816VMN
DR   ENCODE; ENCBS937RAY
DR   FANTOM5_SSTAR; 10758-110E2
DR   GDSC; 907064
DR   GEO; GSM185089
DR   GEO; GSM185090
DR   GEO; GSM256074
DR   GEO; GSM256075
DR   GEO; GSM256076
DR   GEO; GSM256077
DR   GEO; GSM256078
DR   GEO; GSM256079
DR   GEO; GSM256080
DR   GEO; GSM256081
DR   GEO; GSM256082
DR   GEO; GSM256083
DR   GEO; GSM256084
DR   GEO; GSM256085
DR   GEO; GSM256086
DR   GEO; GSM256087
DR   GEO; GSM256088
DR   GEO; GSM256089
DR   GEO; GSM256090
DR   GEO; GSM256091
DR   GEO; GSM256092
DR   GEO; GSM256093
DR   GEO; GSM256094
DR   GEO; GSM256095
DR   GEO; GSM256096
DR   GEO; GSM256097
DR   GEO; GSM256098
DR   GEO; GSM256099
DR   GEO; GSM256100
DR   GEO; GSM256101
DR   GEO; GSM256102
DR   GEO; GSM256103
DR   GEO; GSM256104
DR   GEO; GSM256105
DR   GEO; GSM256106
DR   GEO; GSM256107
DR   GEO; GSM256108
DR   GEO; GSM256109
DR   GEO; GSM256110
DR   GEO; GSM256111
DR   GEO; GSM256112
DR   GEO; GSM256113
DR   GEO; GSM256114
DR   GEO; GSM827307
DR   GEO; GSM887136
DR   GEO; GSM888207
DR   GEO; GSM1669908
DR   GEO; GSM1676302
DR   GEO; GSM1701637
DR   GEO; GSM3585511
DR   GEO; GSM3585512
DR   GEO; GSM3585513
DR   GEO; GSM3585514
DR   IARC_TP53; 21378
DR   IBRC; C10104
DR   ICLC; HTL98016
DR   IGRhCellID; HT1080
DR   IZSLER; BS TCL 27
DR   JCRB; IFO50354
DR   JCRB; JCRB9113
DR   KCB; KCB 2013029YJ
DR   KCLB; 10121
DR   LiGeA; CCLE_463
DR   LINCS_LDP; LCL-1435
DR   Lonza; 744
DR   NCBI_Iran; C437
DR   PharmacoDB; HT1080_625_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0317
DR   PubChem_Cell_line; CVCL_0317
DR   RCB; RCB1956
DR   TKG; TKG 0202
DR   TOKU-E; 1963
DR   Wikidata; Q5636047
RX   CelloPub=CLPUB00698;
RX   PubMed=375235;
RX   PubMed=3335022;
RX   PubMed=3413074;
RX   PubMed=3558490;
RX   PubMed=3986962;
RX   PubMed=4132053;
RX   PubMed=6304521;
RX   PubMed=6538202;
RX   PubMed=6652615;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=17254797;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=24726063;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=26368816;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-124.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HT1080
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/sarcoma-xenograft/ht1080-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=4132053); ~30 hours (DSMZ=ACC-315).
CC   HLA typing: A*31:01,68:01; B*27:05,27:05; C*02:02,02:02 (PubMed=26589293).
CC   HLA typing: A*31:01:02,68:01:01; B*27:05:02; C*02:02:02; DPB1*03:01,04:01; DQA1*03:03:01,05:01:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,04:07:01 (CLS=300216).
CC   HLA typing: A*31:01:02,68:01:01; B*27:05:02,27:05:02; C*02:02:02,02:02:02; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DRA*01:01:01,01:02:02 (DSMZCellDive=ACC-315).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (ATCC=CCL-121).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (PubMed=26368816).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; ATCC=CCL-121; Cosmic-CLP=907064; DepMap=ACH-000054).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.86%; Native American=0.35%; East Asian, North=1.36%; East Asian, South=0.29%; South Asian=0%; European, North=68.21%; European, South=28.94% (PubMed=30894373).
CC   Anecdotal: One of the 3 cell lines (HT-1080, RD and SK-N-SH) where the NRAS oncogene was first identified (PubMed=6304521).
CC   Caution: This cell line is considered by some researchers to represent a dedifferentiated chondrosarcoma due to the presence of an IDH1 mutation (PubMed=26368816).
CC   Misspelling: HT1180; Note=Occasionally.
CC   Discontinued: ATCC; CRL-7951; true.
CC   Discontinued: RCB; RCB1956; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ATCC=CCL-121; CCRID; CLS=300216; Cosmic-CLP=907064; DSMZ=ACC-315; ECACC=85111505; JCRB=IFO50354; JCRB=JCRB9113; KCLB=10121; CelloPub=CLPUB00698; PubMed=11416159; PubMed=17254797; PubMed=25877200; RCB=RCB1956; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11 (PubMed=17254797)
ST   CSF1PO: 12 (ATCC=CCL-121; CCRID; CLS=300216; Cosmic-CLP=907064; DSMZ=ACC-315; ECACC=85111505; JCRB=IFO50354; JCRB=JCRB9113; KCLB=10121; PubMed=25877200; RCB=RCB1956; Technion Genomics Center)
ST   D10S1248: 13,15
ST   D12S391: 20,22
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D19S433: 13.2,15 (CCRID; Technion Genomics Center)
ST   D19S433: 14,15 (DSMZ=ACC-315)
ST   D1S1656: 16,17.3
ST   D21S11: 28,30
ST   D22S1045: 11,16
ST   D2S1338: 25,26
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 22,25
ST   Penta D: 9,12
ST   Penta E: 5,15
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   HT-1080 JH-1/FIX
AC   CVCL_XG90
SY   JH-1 / FIX
DR   cancercelllines; CVCL_XG90
DR   Wikidata; Q94304215
RX   Patent=US7361639;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200005.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3551; F9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   HT-1080 NucLight Green
AC   CVCL_DF43
DR   cancercelllines; CVCL_DF43
DR   Wikidata; Q54896498
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4486.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 22
//
ID   HT-1080 NucLight Red
AC   CVCL_DF44
DR   cancercelllines; CVCL_DF44
DR   Wikidata; Q54896499
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4485.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 22
//
ID   HT-1080 Tet-Off
AC   CVCL_V355
SY   Tet-off HT-1080
DR   cancercelllines; CVCL_V355
DR   TOKU-E; 3749
DR   Wikidata; Q54896500
WW   Provider; Takara Bio; 630916; https://www.takarabio.com/documents/Certificate%20of%20Analysis/630916/630916-PA033658.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 23
//
ID   HT-1080-Luc2
AC   CVCL_UZ99
DR   ATCC; CCL-121-LUC2
DR   cancercelllines; CVCL_UZ99
DR   Wikidata; Q94304256
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-121-LUC2).
CC   Doubling time: ~11 hours (ATCC=CCL-121-LUC2).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ATCC=CCL-121-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 16
//
ID   HT-1080/Arabidopsis hybrid chr15
AC   CVCL_VI98
DR   Wikidata; Q94304258
RX   PubMed=27696824;
RX   PubMed=29754235;
RX   PubMed=33785802;
CC   Characteristics: Hybrid human cell containing an Arabidopsis chromosome translocated on hum chr15.
CC   Characteristics: Arabidopsis cells were transformed using two constructs, one containing EGFP under the control of the CAG promoter and the other containing Bsd under the control of the human pGK promoter. The CAG and pGK promoter have high activity only in human cells, resulting in the CC strong EGFP expression only after the plant chromosome carrying marker genes was transferred into human cells.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=3702; ! Arabidopsis thaliana (Mouse-ear cress)
HI   CVCL_0317 ! HT-1080
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   HT-1080/CMV-Luc
AC   CVCL_JG56
DR   cancercelllines; CVCL_JG56
DR   JCRB; JCRB1670
DR   Wikidata; Q54896501
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1670).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): JCRB=JCRB1670
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 17
//
ID   HT-1080/hCLDN-1
AC   CVCL_C3V7
SY   hCLDN-1/HT1080
DR   Wikidata; Q116049506
RX   PubMed=25118216;
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2032; CLDN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1080/hCLDN-2
AC   CVCL_C3V8
SY   hCLDN-2/HT1080
DR   Wikidata; Q116049507
RX   PubMed=25118216;
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2041; CLDN2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1080/hCLDN-3
AC   CVCL_C3V9
SY   hCLDN-3/HT1080
DR   Wikidata; Q116049508
RX   PubMed=25118216;
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2045; CLDN3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1080/hCLDN-4
AC   CVCL_C3VA
SY   hCLDN-4/HT1080
DR   Wikidata; Q116049509
RX   PubMed=25118216;
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2046; CLDN4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1080/hCLDN-5
AC   CVCL_C3VB
SY   hCLDN-5/HT1080
DR   Wikidata; Q116049510
RX   PubMed=25118216;
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2047; CLDN5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1080/hCLDN-6
AC   CVCL_C3VC
SY   hCLDN-6/HT1080
DR   Wikidata; Q116049511
RX   PubMed=25118216;
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2048; CLDN6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1080/hCLDN-7
AC   CVCL_C3VD
SY   hCLDN-7/HT1080
DR   Wikidata; Q116049512
RX   PubMed=25118216;
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2049; CLDN7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1080/hCLDN-9
AC   CVCL_C3VE
SY   hCLDN-9/HT1080
DR   Wikidata; Q116049513
RX   PubMed=27713828;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2051; CLDN9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HT-1197
AC   CVCL_1291
SY   HT 1197; HT1197; HT 1197.T
DR   BTO; BTO_0004124
DR   CLO; CLO_0004267
DR   CLO; CLO_0004278
DR   EFO; EFO_0002202
DR   CLDB; cl1734
DR   CLDB; cl7161
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1473
DR   ATCC; CRL-7926
DR   BCRC; 60059
DR   BioGRID_ORCS_Cell_line; 415
DR   BioSample; SAMN03471362
DR   BioSample; SAMN10988033
DR   cancercelllines; CVCL_1291
DR   Cell_Model_Passport; SIDM00676
DR   ChEMBL-Cells; CHEMBL3308506
DR   ChEMBL-Targets; CHEMBL614836
DR   Cosmic; 715772
DR   Cosmic; 760473
DR   Cosmic; 845563
DR   Cosmic; 907065
DR   Cosmic; 925822
DR   Cosmic; 928814
DR   Cosmic; 1285117
DR   Cosmic; 1285988
DR   Cosmic; 1927306
DR   Cosmic; 2037946
DR   Cosmic; 2050443
DR   Cosmic; 2057448
DR   Cosmic; 2444236
DR   Cosmic; 2685944
DR   Cosmic-CLP; 907065
DR   DepMap; ACH-000547
DR   ECACC; 87032403
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS699THW
DR   ENCODE; ENCBS772EGW
DR   GDSC; 907065
DR   GEO; GSM136229
DR   GEO; GSM142304
DR   GEO; GSM827290
DR   GEO; GSM887138
DR   GEO; GSM888209
DR   GEO; GSM1374559
DR   GEO; GSM1669910
DR   IARC_TP53; 3719
DR   IARC_TP53; 21130
DR   ICLC; HTL04006
DR   IGRhCellID; HT1197
DR   KCLB; 21473
DR   LiGeA; CCLE_192
DR   LINCS_LDP; LCL-1713
DR   PharmacoDB; HT1197_627_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1291
DR   PubChem_Cell_line; CVCL_1291
DR   SKY/M-FISH/CGH; 1463
DR   Wikidata; Q54896502
RX   PubMed=191628;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=6244232;
RX   PubMed=7787250;
RX   PubMed=8873383;
RX   PubMed=11416159;
RX   PubMed=11921286;
RX   PubMed=12068308;
RX   PubMed=15846775;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25984343;
RX   PubMed=25997541;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 61 hours (PubMed=3708594); 46 hours (PubMed=25984343).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His365Arg (c.1094A>G); Zygosity=Unspecified (PubMed=7787250).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.12%; East Asian, North=1.86%; East Asian, South=0%; South Asian=0%; European, North=66.24%; European, South=31.77% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7926; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-1473; Cosmic-CLP=907065; ECACC=87032403; KCLB=21473; PubMed=11416159; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 19
ST   D19S433: 14,16
ST   D21S11: 31,32.2
ST   D2S1338: 20,21
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 9,13
ST   FGA: 20,23
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 16,18
DI   NCIt; C7899; Recurrent bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   HT-1376
AC   CVCL_1292
SY   HT1376; HT 1376; HT 1376.T
DR   BTO; BTO_0003461
DR   CLO; CLO_0004268
DR   CLO; CLO_0004279
DR   EFO; EFO_0002203
DR   CLDB; cl1743
DR   CLDB; cl1744
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1472
DR   ATCC; CRL-7927
DR   BCRC; 60058
DR   BioGRID_ORCS_Cell_line; 414
DR   BioSample; SAMN01821564
DR   BioSample; SAMN01821635
DR   BioSample; SAMN03472820
DR   BioSample; SAMN10988225
DR   cancercelllines; CVCL_1292
DR   Cell_Model_Passport; SIDM00678
DR   ChEMBL-Cells; CHEMBL3308398
DR   ChEMBL-Cells; CHEMBL3308610
DR   ChEMBL-Targets; CHEMBL612258
DR   ChEMBL-Targets; CHEMBL614664
DR   CLS; 305100
DR   Cosmic; 715761
DR   Cosmic; 760481
DR   Cosmic; 845562
DR   Cosmic; 907066
DR   Cosmic; 925821
DR   Cosmic; 928815
DR   Cosmic; 943733
DR   Cosmic; 1046691
DR   Cosmic; 1285118
DR   Cosmic; 1285987
DR   Cosmic; 1927303
DR   Cosmic; 2050444
DR   Cosmic; 2057449
DR   Cosmic; 2444252
DR   Cosmic; 2686096
DR   Cosmic-CLP; 907066
DR   DepMap; ACH-000724
DR   DSMZ; ACC-397
DR   DSMZCellDive; ACC-397
DR   ECACC; 87032402
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS266UUE
DR   ENCODE; ENCBS956LPK
DR   GDSC; 907066
DR   GEO; GSM136230
DR   GEO; GSM142305
DR   GEO; GSM142310
DR   GEO; GSM827432
DR   GEO; GSM887139
DR   GEO; GSM888210
DR   GEO; GSM1374560
DR   GEO; GSM1574553
DR   GEO; GSM1669911
DR   IARC_TP53; 3720
DR   IGRhCellID; HT1376
DR   IZSLER; BS TCL 70
DR   KCLB; 21472
DR   LiGeA; CCLE_036
DR   LINCS_LDP; LCL-1712
DR   PharmacoDB; HT1376_628_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1292
DR   PubChem_Cell_line; CVCL_1292
DR   Wikidata; Q54896503
RX   PubMed=191628;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=6244232;
RX   PubMed=7787250;
RX   PubMed=8873383;
RX   PubMed=9850064;
RX   PubMed=11416159;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=24459064;
RX   PubMed=25997541;
RX   PubMed=26055179;
RX   PubMed=26589293;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 31 hours (PubMed=3708594); 31 hours (PubMed=26055179); ~60 hours (DSMZ=ACC-397).
CC   HLA typing: A*24:02,24:02; B*15:01,15:01; C*03:03,03:03; DQA1*01:02,03:02; DQB1*06:03,06:03; DRB1*13:27,14:121 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln702Ter (c.2104C>T); ClinVar=VCV000428683; Zygosity=Homozygous (PubMed=27270441).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro250Leu (c.749C>T); ClinVar=VCV000420136; Zygosity=Unspecified (PubMed=7787250; PubMed=9850064).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.48%; Native American=1.4%; East Asian, North=1.78%; East Asian, South=1.08%; South Asian=9.04%; European, North=26.62%; European, South=58.6% (PubMed=30894373).
CC   Misspelling: HT-137; ChEMBL-Targets=CHEMBL614664; ChEMBL-Cells=CHEMBL3308610.
CC   Misspelling: HT-1367; PubMed=29732388.
CC   Discontinued: ATCC; CRL-7927; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-1472; Cosmic-CLP=907066; DSMZ=ACC-397; ECACC=87032402; KCLB=21472; PubMed=11416159; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,14
ST   D18S51: 14,15
ST   D19S433: 16
ST   D21S11: 26,32.2 (ATCC=CRL-1472; PubMed=11416159)
ST   D21S11: 26,33.2 (DSMZ=ACC-397)
ST   D2S1338: 17,19
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 14,16
ST   FGA: 21,22
ST   Penta D: 11
ST   Penta E: 7,13
ST   TH01: 7,9.3 (KCLB=21472; PubMed=11416159)
ST   TH01: 7,10 (ATCC=CRL-1472; Cosmic-CLP=907066; DSMZ=ACC-397; ECACC=87032402; PubMed=27270441)
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   HT-1417
AC   CVCL_3523
SY   HT 1417
DR   CLO; CLO_0004269
DR   ATCC; CRL-7797
DR   BioSample; SAMN03471155
DR   Wikidata; Q54896504
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
ST   Source(s): ATCC=CRL-7797
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HT-144
AC   CVCL_0318
SY   HT 144; HT144; HT144-mel; HT144mel
DR   BTO; BTO_0001406
DR   CLO; CLO_0004280
DR   EFO; EFO_0006443
DR   MCCL; MCC:0000211
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-63
DR   BioGRID_ORCS_Cell_line; 646
DR   BioSample; SAMN03472749
DR   BioSample; SAMN10988126
DR   cancercelllines; CVCL_0318
DR   CancerTools; 161928
DR   Cell_Model_Passport; SIDM00695
DR   CGH-DB; 9314-4
DR   ChEMBL-Cells; CHEMBL3308870
DR   ChEMBL-Targets; CHEMBL2366291
DR   Cosmic; 687436
DR   Cosmic; 889003
DR   Cosmic; 905227
DR   Cosmic; 907067
DR   Cosmic; 928717
DR   Cosmic; 929192
DR   Cosmic; 932999
DR   Cosmic; 1022276
DR   Cosmic; 1028800
DR   Cosmic; 1102379
DR   Cosmic; 1155271
DR   Cosmic; 1477411
DR   Cosmic; 2159445
DR   Cosmic; 2651883
DR   Cosmic-CLP; 907067
DR   DepMap; ACH-000322
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907067
DR   GEO; GSM162902
DR   GEO; GSM219028
DR   GEO; GSM887140
DR   GEO; GSM888211
DR   GEO; GSM1669912
DR   GEO; GSM1671957
DR   GEO; GSM1671964
DR   GEO; GSM1671976
DR   GEO; GSM1671980
DR   GEO; GSM1671984
DR   GEO; GSM1671985
DR   GEO; GSM1671988
DR   GEO; GSM1671993
DR   GEO; GSM1672009
DR   GEO; GSM1672016
DR   GEO; GSM1672018
DR   GEO; GSM1672020
DR   GEO; GSM1672021
DR   GEO; GSM1672026
DR   GEO; GSM1672029
DR   GEO; GSM1672045
DR   GEO; GSM1672059
DR   GEO; GSM1672063
DR   GEO; GSM3039508
DR   IARC_TP53; 21381
DR   LiGeA; CCLE_917
DR   LINCS_LDP; LCL-1273
DR   PharmacoDB; HT144_629_2019
DR   PRIDE; PXD002192
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0318
DR   PubChem_Cell_line; CVCL_0318
DR   Wikidata; Q54896505
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   DOI=10.1007/BF00199208;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=9354451;
RX   PubMed=10338330;
RX   PubMed=10752474;
RX   PubMed=12068308;
RX   PubMed=14692828;
RX   PubMed=14871852;
RX   PubMed=15048078;
RX   PubMed=15467732;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=20164919;
RX   PubMed=21654344;
RX   PubMed=22383533;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=26405815;
RX   PubMed=26589293;
RX   PubMed=26673621;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/skin/ht144/index.html
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/ht-144-human-melanoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-544.
CC   Population: Caucasian.
CC   HLA typing: A*01,24; B*13; C*03 (ATCC=HTB-63).
CC   HLA typing: A*01:01,24:02; B*15:01,57:01; C*03:03,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15048078; PubMed=15467732; PubMed=17363583; PubMed=22383533; PubMed=26405815; Cosmic-CLP=907067; DepMap=ACH-000322).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.49%; East Asian, North=0.47%; East Asian, South=0%; South Asian=0%; European, North=73.18%; European, South=25.86% (PubMed=30894373).
CC   Misspelling: HT-114; Cosmic=929192.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ATCC=HTB-63; Cosmic-CLP=907067
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 12,16
ST   D21S11: 30,31.2
ST   D2S1338: 23,25
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 23,26
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   HT-144 Dab-R
AC   CVCL_A1VJ
SY   HT144_Dab; HT144 SKIN FV1; HT144SKINFV1
DR   cancercelllines; CVCL_A1VJ
DR   DepMap; ACH-002458
DR   Wikidata; Q105509481
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002458).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0318 ! HT-144
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   HT-144 Dab-R/Rox-R
AC   CVCL_A1VK
SY   HT144_Dab_Rox; HT144 SKIN FV2; HT144SKINFV2
DR   cancercelllines; CVCL_A1VK
DR   DepMap; ACH-002460
DR   Wikidata; Q105509484
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Selected for resistance to: ChEBI; CHEBI_132774; Roxadustat (FG4592).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002460).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0318 ! HT-144
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   HT-144 Dab-R/Tram-R
AC   CVCL_A1VL
SY   HT144_Dab_Tram; HT144 SKIN FV3; HT144SKINFV3
DR   cancercelllines; CVCL_A1VL
DR   DepMap; ACH-002459
DR   Wikidata; Q105509486
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002459).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0318 ! HT-144
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   HT-17
AC   CVCL_B408
SY   HT17
DR   Cosmic; 1187340
DR   Cosmic; 1571787
DR   Cosmic; 2629286
DR   RCB; RCB1885
DR   TKG; TKG 0203
DR   Wikidata; Q54896506
CC   Population: Japanese.
CC   Misspelling: HT7; Cosmic=2629286.
CC   Discontinued: RCB; RCB1885; true.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   HT-2
AC   CVCL_5T92
SY   HT2
DR   BTO; BTO_0004010
DR   Wikidata; Q54896507
RX   PubMed=92524;
RX   PubMed=2953804;
RX   PubMed=3100639;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HT-2
CC   Characteristics: IL2 dependent.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   HT-2 clone A5E
AC   CVCL_0319
SY   HT2-clone-A5E; HT2 Clone A5E
DR   CLO; CLO_0004281
DR   CLO; CLO_0004282
DR   MCCL; MCC:0000212
DR   CLDB; cl1745
DR   ATCC; CRL-1841
DR   ECACC; 92021401
DR   Wikidata; Q54896508
RX   PubMed=31220119;
CC   Problematic cell line: Probably misidentified/contaminated. While said to originate from a BALB/c mouse it exhibits a greater similarity with a C57BL strain. Its STR profile has three alleles or more at seven loci, high peak height imbalance and is discordant at eight STR markers. It therefore needs more characterization to determine if it is contaminated or misidentified due to the inconsistencies with the strain of origin and the increase of alleles per marker (PubMed=31220119).
CC   Characteristics: IL2 and IL4 dependent.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5T92 ! HT-2
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   HT-22 rho-0
AC   CVCL_C0DX
SY   HT-22rho-0
DR   CancerTools; 160509
DR   Kerafast; ESA111
DR   Wikidata; Q112929754
DR   Ximbio; 160509
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 7
//
ID   HT-29
AC   CVCL_0320
SY   HT 29; HT29
DR   BTO; BTO_0000182
DR   CLO; CLO_0004283
DR   EFO; EFO_0001193
DR   MCCL; MCC:0000213
DR   CLDB; cl1747
DR   CLDB; cl1748
DR   CLDB; cl1749
DR   CLDB; cl1751
DR   CLDB; cl1752
DR   CLDB; cl1753
DR   CLDB; cl1754
DR   CLDB; cl4978
DR   CLDB; cl5205
DR   ABM; T8972
DR   AddexBio; C0009004/48
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-38
DR   BCRJ; 0111
DR   BioGRID_ORCS_Cell_line; 179
DR   BioSample; SAMN01821565
DR   BioSample; SAMN03470953
DR   BioSample; SAMN05292462
DR   BioSample; SAMN10988348
DR   cancercelllines; CVCL_0320
DR   CancerTools; 161929
DR   CCLV; CCLV-RIE 0960
DR   CCRID; 1101HUM-PUMC000109
DR   CCRID; 3101HUMSCSP5032
DR   CCRID; 3101HUMTCHu103
DR   CCRID; 4201HUM-CCTCC00149
DR   CCRID; 5301HUM-KCB05008YJ
DR   CCTCC; GDC0149
DR   Cell_Model_Passport; SIDM00136
DR   ChEMBL-Cells; CHEMBL3307768
DR   ChEMBL-Targets; CHEMBL384
DR   CLS; 300215
DR   ColonAtlas; HT29
DR   Cosmic; 685867
DR   Cosmic; 711273
DR   Cosmic; 720331
DR   Cosmic; 738929
DR   Cosmic; 755308
DR   Cosmic; 875295
DR   Cosmic; 875898
DR   Cosmic; 876716
DR   Cosmic; 887217
DR   Cosmic; 889523
DR   Cosmic; 897459
DR   Cosmic; 902789
DR   Cosmic; 905939
DR   Cosmic; 913891
DR   Cosmic; 934562
DR   Cosmic; 948132
DR   Cosmic; 974246
DR   Cosmic; 983739
DR   Cosmic; 995412
DR   Cosmic; 1043817
DR   Cosmic; 1045405
DR   Cosmic; 1057765
DR   Cosmic; 1067225
DR   Cosmic; 1071887
DR   Cosmic; 1092605
DR   Cosmic; 1122326
DR   Cosmic; 1132575
DR   Cosmic; 1154652
DR   Cosmic; 1175842
DR   Cosmic; 1176613
DR   Cosmic; 1184093
DR   Cosmic; 1184326
DR   Cosmic; 1223142
DR   Cosmic; 1248331
DR   Cosmic; 1295658
DR   Cosmic; 1299294
DR   Cosmic; 1305355
DR   Cosmic; 1310947
DR   Cosmic; 1312339
DR   Cosmic; 1436019
DR   Cosmic; 1466816
DR   Cosmic; 1479609
DR   Cosmic; 1481417
DR   Cosmic; 1482521
DR   Cosmic; 1524327
DR   Cosmic; 1537489
DR   Cosmic; 1571769
DR   Cosmic; 1609503
DR   Cosmic; 1676733
DR   Cosmic; 1708406
DR   Cosmic; 1803945
DR   Cosmic; 1888955
DR   Cosmic; 1889160
DR   Cosmic; 1933016
DR   Cosmic; 1945866
DR   Cosmic; 1995448
DR   Cosmic; 1998447
DR   Cosmic; 2036654
DR   Cosmic; 2052596
DR   Cosmic; 2145575
DR   Cosmic; 2156939
DR   Cosmic; 2301545
DR   Cosmic; 2301988
DR   Cosmic; 2389572
DR   Cosmic; 2433757
DR   Cosmic; 2550354
DR   Cosmic; 2646771
DR   Cosmic; 2664047
DR   Cosmic; 2667882
DR   Cosmic; 2668251
DR   Cosmic; 2727481
DR   Cosmic; 2760077
DR   Cosmic; 2787549
DR   Cosmic; 2800591
DR   Cosmic; 2811052
DR   Cosmic-CLP; 905939
DR   DepMap; ACH-000552
DR   DSMZ; ACC-299
DR   DSMZCellDive; ACC-299
DR   ECACC; 91072201
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS604AAA
DR   ENCODE; ENCBS605AAA
DR   ENCODE; ENCBS668UDT
DR   ENCODE; ENCBS814TLB
DR   ENCODE; ENCBS836FPI
DR   ENCODE; ENCBS914HXH
DR   GDSC; 905939
DR   GEO; GSM811
DR   GEO; GSM2112
DR   GEO; GSM50190
DR   GEO; GSM50254
DR   GEO; GSM206503
DR   GEO; GSM274780
DR   GEO; GSM288491
DR   GEO; GSM288497
DR   GEO; GSM288499
DR   GEO; GSM513815
DR   GEO; GSM514295
DR   GEO; GSM736967
DR   GEO; GSM741261
DR   GEO; GSM743445
DR   GEO; GSM799333
DR   GEO; GSM799396
DR   GEO; GSM827150
DR   GEO; GSM887141
DR   GEO; GSM888212
DR   GEO; GSM1006213
DR   GEO; GSM1006214
DR   GEO; GSM1006215
DR   GEO; GSM1153403
DR   GEO; GSM1178239
DR   GEO; GSM1178240
DR   GEO; GSM1178241
DR   GEO; GSM1181252
DR   GEO; GSM1181366
DR   GEO; GSM1346844
DR   GEO; GSM1374561
DR   GEO; GSM1374562
DR   GEO; GSM1374563
DR   GEO; GSM1374564
DR   GEO; GSM1448179
DR   GEO; GSM1669913
DR   GEO; GSM2124658
DR   GEO; GSM2550003
DR   IARC_TP53; 23
DR   IBRC; C10097
DR   ICLC; HTL99026
DR   IZSLER; BS TCL 132
DR   KCB; KCB 200508YJ
DR   KCLB; 30038
DR   LiGeA; CCLE_686
DR   LINCS_LDP; LCL-1180
DR   Lonza; 430
DR   MeSH; D019073
DR   MetaboLights; MTBLS227
DR   MetaboLights; MTBLS1358
DR   NCBI_Iran; C466
DR   NCI-DTP; HT-29
DR   PharmacoDB; HT29_630_2019
DR   PRIDE; PRD000369
DR   PRIDE; PRD000414
DR   PRIDE; PXD001271
DR   PRIDE; PXD001550
DR   PRIDE; PXD003539
DR   PRIDE; PXD003623
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   PRIDE; PXD037651
DR   Progenetix; CVCL_0320
DR   PubChem_Cell_line; CVCL_0320
DR   SKY/M-FISH/CGH; 1435
DR   SKY/M-FISH/CGH; 2124
DR   SKY/M-FISH/CGH; 2836
DR   TOKU-E; 1968
DR   Ubigene; YC-C008
DR   Wikidata; Q28334700
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=72600;
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=468301;
RX   PubMed=626984;
RX   PubMed=833871;
RX   PubMed=864752;
RX   PubMed=1159834;
RX   PubMed=1389533;
RX   PubMed=1730571;
RX   PubMed=1778766;
RX   PubMed=1937958;
RX   PubMed=2041050;
RX   PubMed=2288877;
RX   PubMed=3281752;
RX   PubMed=3335022;
RX   PubMed=3349466;
RX   PubMed=3472642;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6256643;
RX   PubMed=6445228;
RX   PubMed=6500159;
RX   PubMed=6582512;
RX   PubMed=6825208;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=7651727;
RX   PubMed=7972006;
RX   PubMed=8464898;
RX   PubMed=8895552;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9294210;
RX   PubMed=9331090;
RX   PubMed=10612807;
RX   PubMed=10700174;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11526487;
RX   PubMed=11668190;
RX   PubMed=11687795;
RX   PubMed=11921276;
RX   PubMed=12068308;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=16083285;
RX   PubMed=17088437;
RX   PubMed=18258742;
RX   PubMed=19372543;
RX   PubMed=19927377;
RX   PubMed=19941903;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=20831567;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22282976;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22940288;
RX   PubMed=23272949;
RX   PubMed=23546019;
RX   PubMed=23631600;
RX   PubMed=23856246;
RX   PubMed=23932154;
RX   PubMed=23933261;
RX   PubMed=24042735;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25841592;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28179481;
RX   PubMed=28192450;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29207035;
RX   PubMed=29787047;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32172478;
RX   PubMed=32927768;
RX   PubMed=33389257;
RX   PubMed=35839778;
RX   PubMed=36648961;
RX   PubMed=38861359;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/htb-38-morphology-and-media
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/HT29.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=15
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544471
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-32.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HT-29
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/ht29-xenograft-model/
WW   Provider; BRICS; BRICS0119; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3923
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-colorectal-adenocarcinoma-cell-line-ht-29
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 809.
CC   Population: Caucasian.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 1.2 days (PubMed=6445228); 26.9 +- 3.3 hours (PubMed=3281752); 36.93 hours (PubMed=25944804); 24 hours (PubMed=25984343); 24 hours (PubMed=23546019); 21.87 +- 0.12 hours (PubMed=32927768); ~24 hours (CLS=300215); ~40-60 hours (DSMZ=ACC-299); 19.5 hours (NCI-DTP=HT-29); ~23 hours (PBCF).
CC   HLA typing: A*01/11,03; B*12,17 (PubMed=77569).
CC   HLA typing: A*01,24; B*35,44:03:01; C*04; DPB1*04:01; DQB1*02,03:02; DRB1*04:02,07:01 (PubMed=15748285).
CC   HLA typing: A*01:01,24:03; B*35:01,44:03; C*04:01,04:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,24:03:01; B*35:01:01,44:03:01; C*04:01:01; DPB1*04:01; DQA1*02:01:01,03:01:01; DQB1*02:02:01,03:02:01; DRB1*04:02:01,07:01:01 (CLS=300215).
CC   Karyotypic information: Hypertriploid karyotype.
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905939; DepMap=ACH-000552).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (PubMed=17088437; PubMed=24755471; PubMed=28179481; Cosmic-CLP=905939; DepMap=ACH-000552).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905939; DepMap=ACH-000552).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (PubMed=17088437; PubMed=20570890; PubMed=24755471; Cosmic-CLP=905939; DepMap=ACH-000552).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (PubMed=17088437; PubMed=24755471; Cosmic-CLP=905939; DepMap=ACH-000552).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=7651727; PubMed=9000147; PubMed=9331090; PubMed=15900046; PubMed=17088437; PubMed=21912889; PubMed=24755471; PubMed=28683746; Cosmic-CLP=905939; DepMap=ACH-000552).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Extracellular vesicles.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.57%; Native American=1.05%; East Asian, North=3.24%; East Asian, South=0%; South Asian=4.8%; European, North=26.11%; European, South=63.24% (PubMed=30894373).
CC   Caution: Indicated in PubMed=11921276 as originating from an adenocarcinoma of the rectosigmoid part of the intestine, but is only indicated in the oldest publication (DOI=10.1007/978-1-4757-1647-4_5) as a colon adenocarcinoma.
CC   Misspelling: HCT29; GEO=GSM206503.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009004/48; ATCC=HTB-38; CCRID; CLS=300215; Cosmic-CLP=905939; DSMZ=ACC-299; ECACC=91072201; KCLB=30038; PubMed=11416159; PubMed=19372543; PubMed=25877200; PubMed=25926053; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14,16
ST   D12S391: 18.3,21
ST   D13S317: 11 (AddexBio=C0009004/48; CLS=300215)
ST   D13S317: 11,12 (ATCC=HTB-38; CCRID; Cosmic-CLP=905939; DSMZ=ACC-299; ECACC=91072201; KCLB=30038; PubMed=19372543; PubMed=25877200; PubMed=25926053; Technion Genomics Center)
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 14
ST   D1S1656: 15,16
ST   D21S11: 29,30
ST   D22S1045: 16
ST   D2S1338: 19,23
ST   D2S441: 11
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10 (AddexBio=C0009004/48; CLS=300215; DSMZ=ACC-299; PubMed=19372543; PubMed=25877200)
ST   D8S1179: 10,16 (ATCC=HTB-38; CCRID; PubMed=11416159; Technion Genomics Center)
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   HT-29 BR100
AC   CVCL_DH88
SY   HT29 BR100; BR100
DR   cancercelllines; CVCL_DH88
DR   GEO; GSM736968
DR   Progenetix; CVCL_DH88
DR   Wikidata; Q54896509
RX   PubMed=22216088;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   HT-29 BR200
AC   CVCL_DH89
SY   HT29 BR200; BR200
DR   cancercelllines; CVCL_DH89
DR   GEO; GSM736969
DR   Progenetix; CVCL_DH89
DR   Wikidata; Q54896510
RX   PubMed=22216088;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   HT-29 BR300
AC   CVCL_DH90
SY   HT29 BR300; BR300
DR   cancercelllines; CVCL_DH90
DR   GEO; GSM736970
DR   Progenetix; CVCL_DH90
DR   Wikidata; Q54896511
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   HT-29 HD3
AC   CVCL_H252
SY   HD3
DR   cancercelllines; CVCL_H252
DR   Wikidata; Q54882115
RX   PubMed=2288877;
CC   Population: Caucasian.
CC   Characteristics: Clone of HT-29 established after treatment with hexamethylene bisacetamide (HMBA).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 23
//
ID   HT-29 HD4
AC   CVCL_H253
SY   HD4
DR   cancercelllines; CVCL_H253
DR   Wikidata; Q54882119
RX   PubMed=2288877;
CC   Population: Caucasian.
CC   Characteristics: Clone of HT-29 established after treatment with hexamethylene bisacetamide (HMBA).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   HT-29 HD6
AC   CVCL_H254
SY   HD6
DR   cancercelllines; CVCL_H254
DR   Wikidata; Q54882123
RX   PubMed=2288877;
CC   Population: Caucasian.
CC   Characteristics: Clone of HT-29 established after treatment with hexamethylene bisacetamide (HMBA).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   HT-29 HD8
AC   CVCL_H255
SY   HD8
DR   cancercelllines; CVCL_H255
DR   Wikidata; Q54882128
RX   PubMed=2288877;
CC   Population: Caucasian.
CC   Characteristics: Clone of HT-29 established after treatment with hexamethylene bisacetamide (HMBA).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   HT-29 Y1-16
AC   CVCL_C1KN
SY   Y1-16
DR   cancercelllines; CVCL_C1KN
DR   Wikidata; Q114311667
RX   CelloPub=CLPUB00715;
RX   PubMed=8886416;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HT-29 Y1-4
AC   CVCL_C1KP
SY   Y1-4
DR   cancercelllines; CVCL_C1KP
DR   Wikidata; Q114311668
RX   CelloPub=CLPUB00715;
RX   PubMed=8886416;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HT-29 Y1-7
AC   CVCL_C1KQ
SY   Y1-7
DR   cancercelllines; CVCL_C1KQ
DR   Wikidata; Q114311669
RX   CelloPub=CLPUB00715;
RX   PubMed=8886416;
RX   PubMed=10737675;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3198; Npy1r.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HT-29-D4
AC   CVCL_8118
SY   HT 29-D4; HT29-D4
DR   cancercelllines; CVCL_8118
DR   Lonza; 371
DR   Wikidata; Q54896512
RX   PubMed=2736330;
RX   PubMed=3543033;
CC   Population: Caucasian.
CC   Characteristics: Can be induced to differentiate into enterocyte-like cells by replacing glucose with galactose in the culture medium (PubMed=3543033).
CC   Doubling time: 48 hours (Note=With glucose), 60 hours (Note=With galactose) (PubMed=3543033).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   HT-29-D9
AC   CVCL_4Z22
SY   HT 29-D9; HT29-D9
DR   cancercelllines; CVCL_4Z22
DR   Wikidata; Q54896513
RX   PubMed=3543033;
CC   Population: Caucasian.
CC   Doubling time: 36 hours (PubMed=3543033).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   HT-29-G
AC   CVCL_6833
SY   HT-29 G; HT29G
DR   BTO; BTO_0001566
DR   cancercelllines; CVCL_6833
DR   Wikidata; Q54896514
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   HT-29-Luc [JCRB]
AC   CVCL_J256
DR   cancercelllines; CVCL_J256
DR   JCRB; JCRB1383
DR   JCRB; NIHS0646
DR   Wikidata; Q54896515
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0646; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): JCRB=JCRB1383
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 26
//
ID   HT-29-Luc [Ubigene]
AC   CVCL_C8XV
DR   Ubigene; YC-C008-Luc-P
DR   Wikidata; Q123032635
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HT-29-luc-D6
AC   CVCL_5J34
DR   cancercelllines; CVCL_5J34
DR   Revvity/PerkinElmer; 119264
DR   Wikidata; Q54896516
RX   PubMed=14713107;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119264; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 22
//
ID   HT-29-M6
AC   CVCL_G077
SY   HT-29 M6; HT29-M6; HT29-5M6; 5M6
DR   cancercelllines; CVCL_G077
DR   Wikidata; Q54896517
RX   PubMed=9579576;
RX   PubMed=17311291;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   HT-29-MTX
AC   CVCL_6834
SY   HT-29 MTX; HT29-MTX
DR   BTO; BTO_0001565
DR   cancercelllines; CVCL_6834
DR   Wikidata; Q54896518
RX   PubMed=12820722;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   HT-29-MTX-E12
AC   CVCL_G356
SY   HT29-MTX-E12; MTX-E12
DR   cancercelllines; CVCL_G356
DR   ECACC; 12040401
DR   Wikidata; Q54896519
RX   PubMed=11587485;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=12040401
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6834 ! HT-29-MTX
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 23
//
ID   HT-29-Red-FLuc
AC   CVCL_5J00
SY   HT29-Red-FLuc; HT29 Red-FLuc; Bioware Brite HT29 Red-FLuc; IVISbrite HT-29 Red F-luc
DR   cancercelllines; CVCL_5J00
DR   Revvity/PerkinElmer; BW124353
DR   Wikidata; Q54896520
CC   Population: Caucasian.
CC   Doubling time: 24 hours (Revvity/PerkinElmer=BW124353).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 20
//
ID   HT-29/5-FU
AC   CVCL_0I27
DR   cancercelllines; CVCL_0I27
DR   Wikidata; Q54896521
RX   PubMed=25744837;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 19
//
ID   HT-29/5-FU/S
AC   CVCL_0T66
DR   cancercelllines; CVCL_0T66
DR   Wikidata; Q54896522
RX   PubMed=9600127;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   HT-29/ADM
AC   CVCL_Y178
DR   cancercelllines; CVCL_Y178
DR   CGH-DB; 9105-4
DR   Wikidata; Q54896523
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 19
//
ID   HT-29/B6
AC   CVCL_LJ30
SY   HT29/B6
DR   cancercelllines; CVCL_LJ30
DR   Wikidata; Q54896526
RX   PubMed=1656765;
RX   PubMed=11533143;
CC   Population: Caucasian.
CC   Characteristics: Derived from a glucose-free culture of HT-29.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 16
//
ID   HT-29/Cas9-hyg
AC   CVCL_C9ER
DR   GeneCopoeia; SL523
DR   Wikidata; Q123032636
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL523).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HT-29/cDDP
AC   CVCL_Y177
SY   HT/DDP
DR   cancercelllines; CVCL_Y177
DR   CGH-DB; 9104-4
DR   Wikidata; Q54896527
RX   PubMed=9816187;
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 19
//
ID   HT-29/cl.f8
AC   CVCL_DE12
SY   HT-29 cl.F8; HT29.f8; HT29.F8
DR   cancercelllines; CVCL_DE12
DR   Wikidata; Q54896528
RX   PubMed=15780006;
CC   Population: Caucasian.
CC   Characteristics: Spontaneously polarizing cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 19
//
ID   HT-29/CPT
AC   CVCL_H269
SY   HT-29 / CPT
DR   cancercelllines; CVCL_H269
DR   CGH-DB; 9103-4
DR   Wikidata; Q54896529
RX   PubMed=2170010;
RX   PubMed=2174738;
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 23
//
ID   HT-29/ETP
AC   CVCL_Y179
DR   cancercelllines; CVCL_Y179
DR   CGH-DB; 9106-4
DR   Wikidata; Q54896530
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 19
//
ID   HT-29/SN-38
AC   CVCL_WV61
DR   cancercelllines; CVCL_WV61
DR   Wikidata; Q94304661
RX   PubMed=23546019;
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=23546019).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   HT-29(Cas9)
AC   CVCL_E7J7
WW   Provider; BRICS; ECC3019; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3953
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HT-29_6244R
AC   CVCL_C3GK
SY   HT6244-R
DR   cancercelllines; CVCL_C3GK
DR   Wikidata; Q114311670
RX   PubMed=31048689;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   HT-295.T
AC   CVCL_N341
SY   HT 295.T
DR   ATCC; CRL-7781
DR   Wikidata; Q54896531
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7781; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C2921; Skin basal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   HT-297.T
AC   CVCL_6404
SY   HT 297.T
DR   CLO; CLO_0004272
DR   ATCC; CRL-7782
DR   BioSample; SAMN03471154
DR   Wikidata; Q54896532
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7782
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 20,22
ST   D3S1358: 17,18
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   D8S1179: 9,14
ST   FGA: 24,26
ST   Penta D: 11,14
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3148; Actinic keratosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   HT-29KM
AC   CVCL_WN77
SY   HT29KM
DR   cancercelllines; CVCL_WN77
DR   Wikidata; Q94304680
RX   PubMed=1730571;
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line by passages in BALB/c nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   HT-29R
AC   CVCL_EQ49
DR   cancercelllines; CVCL_EQ49
DR   Cosmic; 1889159
DR   Wikidata; Q54896533
RX   PubMed=21705440;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132984; RO4927350.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 18
//
ID   HT-29R13
AC   CVCL_4V27
DR   cancercelllines; CVCL_4V27
DR   Wikidata; Q54896534
RX   PubMed=7903534;
RX   PubMed=8324877;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   HT-3
AC   CVCL_1293
SY   HT3
DR   CLO; CLO_0004286
DR   EFO; EFO_0002204
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-32
DR   BioSample; SAMN03472916
DR   cancercelllines; CVCL_1293
DR   CancerTools; 161930
DR   Cell_Model_Passport; SIDM00679
DR   ChEMBL-Cells; CHEMBL3308745
DR   ChEMBL-Targets; CHEMBL1075470
DR   Cosmic; 760222
DR   Cosmic; 809227
DR   Cosmic; 846183
DR   Cosmic; 907068
DR   Cosmic; 925353
DR   Cosmic; 928908
DR   Cosmic; 1131521
DR   Cosmic; 1193036
DR   Cosmic; 1201774
DR   Cosmic; 1995449
DR   Cosmic; 2301540
DR   Cosmic; 2660191
DR   Cosmic; 2816219
DR   Cosmic-CLP; 907068
DR   DepMap; ACH-001525
DR   EGA; EGAS00001000978
DR   GDSC; 907068
DR   GEO; GSM253299
DR   GEO; GSM675735
DR   GEO; GSM685442
DR   GEO; GSM1669914
DR   IARC_TP53; 325
DR   IGRhCellID; HT3
DR   LINCS_LDP; LCL-1304
DR   PharmacoDB; HT3_631_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1293
DR   PubChem_Cell_line; CVCL_1293
DR   Wikidata; Q54896535
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1648218;
RX   PubMed=2990217;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=7459858;
RX   PubMed=10392903;
RX   PubMed=15531914;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=24134916;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/ht-3-human-cervical-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 784-01.
CC   Population: Caucasian.
CC   Doubling time: 2.48 days (PubMed=29156801).
CC   HLA typing: A*03,28; B*8,05/w35; C*w02,w03 (PubMed=77569).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (PubMed=1648218).
CC   Transformant: NCBI_TaxID; 10611; Human papillomavirus type 30 (HPV30).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.04%; Native American=0%; East Asian, North=3.34%; East Asian, South=0%; South Asian=1.53%; European, North=55.35%; European, South=37.73% (PubMed=30894373).
CC   Caution: Indicated as originating from a 58 year old female patient in ATCC and from a 53 year old in Sloan Kettering tech transfer site.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-32; Cosmic-CLP=907068; DepMap=ACH-001525; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 21
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 12
ST   Penta E: 11,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   HT-55
AC   CVCL_1294
SY   HT55
DR   CLO; CLO_0004287
DR   EFO; EFO_0006444
DR   CLDB; cl1759
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 645
DR   BioSample; SAMN03470915
DR   BioSample; SAMN03473195
DR   BioSample; SAMN10988014
DR   cancercelllines; CVCL_1294
DR   Cell_Model_Passport; SIDM00541
DR   ChEMBL-Cells; CHEMBL3308746
DR   ChEMBL-Targets; CHEMBL1075471
DR   ColonAtlas; HT55
DR   Cosmic; 907287
DR   Cosmic; 948835
DR   Cosmic; 995386
DR   Cosmic; 1223143
DR   Cosmic; 1803946
DR   Cosmic; 2301989
DR   Cosmic; 2647535
DR   Cosmic; 2800579
DR   Cosmic-CLP; 907287
DR   DepMap; ACH-000926
DR   ECACC; 85061105
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907287
DR   GEO; GSM206514
DR   GEO; GSM274837
DR   GEO; GSM827369
DR   GEO; GSM887142
DR   GEO; GSM888213
DR   GEO; GSM1346845
DR   GEO; GSM1448082
DR   GEO; GSM1669915
DR   IARC_TP53; 21382
DR   IARC_TP53; 21739
DR   LiGeA; CCLE_814
DR   LINCS_LDP; LCL-1163
DR   PharmacoDB; HT55_632_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1294
DR   PubChem_Cell_line; CVCL_1294
DR   Wikidata; Q54896536
RX   PubMed=194617;
RX   PubMed=199545;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HT55
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=25984343).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1131Ter (c.3391C>T); ClinVar=VCV000236590; Zygosity=Heterozygous (PubMed=24755471; DepMap=ACH-000926).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1303Ter (c.3907C>T); ClinVar=VCV001076263; Zygosity=Heterozygous (PubMed=24755471; DepMap=ACH-000926).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1463Ser (c.4389A>T); Zygosity=Heterozygous (PubMed=24755471; DepMap=ACH-000926).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asn581Tyr (c.1741A>T); Zygosity=Heterozygous (DepMap=ACH-000926).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Lys241Ter (c.721A>T); Zygosity=Heterozygous (DepMap=ACH-000926).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Leu (c.638G>T); ClinVar=VCV000376650; Zygosity=Homozygous (PubMed=16418264; PubMed=24755471; DepMap=ACH-000926).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.79%; Native American=0%; East Asian, North=2.4%; East Asian, South=0%; South Asian=0%; European, North=61.97%; European, South=33.83% (PubMed=30894373).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): Cosmic-CLP=907287; ECACC=85061105; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 14
ST   D18S51: 13
ST   D21S11: 28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 7,8
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   HT-728.T
AC   CVCL_3524
SY   HT 728.T; HT-728-T; HT728T
DR   CLO; CLO_0004273
DR   ATCC; CRL-7783
DR   cancercelllines; CVCL_3524
DR   Cosmic; 687929
DR   GEO; GSM827463
DR   Progenetix; CVCL_3524
DR   Wikidata; Q54896537
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7783; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   HT-738.T
AC   CVCL_N465
SY   HT 738.T
DR   ATCC; CRL-7784
DR   Wikidata; Q54896538
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7784; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HT-755.Mg
AC   CVCL_S254
SY   HT 755.Mg
DR   ATCC; CRL-7785
DR   Wikidata; Q54896539
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7785; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HT-756.Lu
AC   CVCL_N461
SY   HT 756.Lu
DR   ATCC; CRL-7786
DR   Wikidata; Q54896540
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7786; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N462 ! HT-756.T
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HT-756.T
AC   CVCL_N462
SY   HT 756.T
DR   ATCC; CRL-7787
DR   Wikidata; Q54896541
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7787; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N461 ! HT-756.Lu
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   HT-758.Sk
AC   CVCL_N463
SY   HT 758.Sk
DR   ATCC; CRL-7788
DR   Wikidata; Q54896542
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7788; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   HT-762.T
AC   CVCL_3525
SY   HT 762.T
DR   CLO; CLO_0004274
DR   ATCC; CRL-7789
DR   Wikidata; Q54896543
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7789; true.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   HT-768.M
AC   CVCL_6405
SY   HT 768.M
DR   CLO; CLO_0004275
DR   ATCC; CRL-7790
DR   Wikidata; Q54896544
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7790; true.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   HT-78
AC   CVCL_9709
DR   Wikidata; Q54896545
RX   PubMed=1320624;
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9710 ! HT-M1-78
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   HT-800.T
AC   CVCL_S255
SY   HT 800.T
DR   ATCC; CRL-7791
DR   Wikidata; Q54896546
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7791; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   HT-801.T
AC   CVCL_S398
SY   HT 801.T
DR   ATCC; CRL-7792
DR   Wikidata; Q54896547
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7792; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   HT-804.Ut
AC   CVCL_S399
SY   HT 804.Ut
DR   ATCC; CRL-7793
DR   Wikidata; Q54896548
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7793; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   HT-805.Ut
AC   CVCL_S400
SY   HT 805.Ut
DR   ATCC; CRL-7794
DR   Wikidata; Q54896549
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7794; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   HT-806.Ut
AC   CVCL_S302
SY   HT 806.Ut
DR   ATCC; CRL-7795
DR   Wikidata; Q54896550
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7795; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   HT-824.Pe
AC   CVCL_N464
SY   HT 824.Pe
DR   ATCC; CRL-7796
DR   Wikidata; Q54896551
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7796; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 4
//
ID   HT-M1-78
AC   CVCL_9710
DR   Wikidata; Q54896552
RX   PubMed=1320624;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9709 ! HT-78
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   hT-MECs
AC   CVCL_A9G6
SY   human Telomerase-immortalized Mammary Epithelial Cells
DR   Wikidata; Q102114160
RX   PubMed=24889218;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Xinong Saanen; VBO=VBO_0017515.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   hT-SerC
AC   CVCL_B6MW
SY   human Telomerase-immortalized Sertoli Cells
DR   Wikidata; Q111733448
RX   PubMed=33105674;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HT-STAR
AC   CVCL_AR54
DR   cancercelllines; CVCL_AR54
DR   ECACC; 04072122
DR   Wikidata; Q54896553
RX   PubMed=12679787;
CC   Group: Retrovirus packaging cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=04072122
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   HT-STAR-A
AC   CVCL_AR55
DR   cancercelllines; CVCL_AR55
DR   ECACC; 04072123
DR   Wikidata; Q54896554
CC   Group: Retrovirus packaging cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ECACC=04072123
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR54 ! HT-STAR
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   HT02s-p
AC   CVCL_F1GX
WW   Provider; ARI-TOX MWCB; HT02s-p; https://aritox.com/mwcb/mwcb-ht02s-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=27787; ! Eretmochelys imbricata (Hawksbill sea turtle)
SX   Male
AG   Juvenile
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT10
AC   CVCL_C4ZB
DR   Wikidata; Q116049514
RX   PubMed=11394531;
RX   PubMed=11429100;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mesocricetus auratus 190 kDa airway mucin-associated protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HT100
AC   CVCL_2953
SY   HT-100; HT-100-A
DR   JCRB; JCRB0221
DR   Wikidata; Q54896555
RX   PubMed=5144528;
CC   Transformant: Cigarette tar.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C134991; Hamster lung carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   2-3D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   HT1080 cyno OX40
AC   CVCL_E8JI
SY   HT1080-cyno-OX40
DR   KYinno; KC-0290
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; A0A2K5TJH8; Macaca fascicularis TNFRSF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT1080 EGFP
AC   CVCL_C0RF
SY   HT1080_EGFP
DR   cancercelllines; CVCL_C0RF
DR   GEO; GSM3585515
DR   GEO; GSM3585516
DR   GEO; GSM3585517
DR   GEO; GSM3585518
DR   Wikidata; Q112929755
RX   PubMed=30962207;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   HT1080 EWSR1-FLI1-EGFP
AC   CVCL_C0RG
SY   HT1080_EWSR1-FLI1-EGFP
DR   cancercelllines; CVCL_C0RG
DR   GEO; GSM3585522
DR   GEO; GSM3585523
DR   GEO; GSM3585524
DR   GEO; GSM3585525
DR   Wikidata; Q112929756
RX   PubMed=30962207;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3508; EWSR1 (Note=EWSR1-FLI1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3749; FLI1 (Note=EWSR1-FLI1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   HT1080 FUS-DDIT3-EGFP
AC   CVCL_AX37
SY   HT1080_FUS-DDIT3-EGFP
DR   cancercelllines; CVCL_AX37
DR   GEO; GSM3585519
DR   GEO; GSM3585520
DR   GEO; GSM3585521
DR   Wikidata; Q54896556
RX   PubMed=16651630;
RX   PubMed=25393000;
RX   PubMed=30962207;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2726; DDIT3 (Note=FUS-DDIT3 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4010; FUS (Note=FUS-DDIT3 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 21
//
ID   HT1080 human CD137
AC   CVCL_XZ54
SY   HT1080-CD137
DR   cancercelllines; CVCL_XZ54
DR   KYinno; KC-0145
DR   Wikidata; Q94094826
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-0145).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HT1080 human CD27
AC   CVCL_XZ55
SY   HT1080-CD27
DR   cancercelllines; CVCL_XZ55
DR   KYinno; KC-0144
DR   Wikidata; Q94094830
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-0144).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11922; CD27.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: KYinno; KC-0144; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HT1080 human CD30
AC   CVCL_E8JF
SY   HT1080-CD30
DR   KYinno; KC-0143
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11923; TNFRSF8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT1080 human CD40
AC   CVCL_XZ56
SY   HT1080-CD40
DR   cancercelllines; CVCL_XZ56
DR   KYinno; KC-0142
DR   Wikidata; Q94094834
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-0142).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11919; CD40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   HT1080 human FAP
AC   CVCL_E8JG
SY   HT1080-FAP
DR   KYinno; KC-2635
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-2635).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3590; FAP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT1080 human GITR
AC   CVCL_UE32
SY   HT1080-GITR
DR   cancercelllines; CVCL_UE32
DR   KYinno; KC-0141
DR   Wikidata; Q94304925
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-0141).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11914; TNFRSF18.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: KYinno; KC-0141; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 15
//
ID   HT1080 human OX40
AC   CVCL_UE31
SY   HT1080-OX40
DR   cancercelllines; CVCL_UE31
DR   KYinno; KC-0140
DR   Wikidata; Q94304930
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-0140).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11918; TNFRSF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 15
//
ID   HT1080 mouse CD40
AC   CVCL_E8JH
SY   HT1080-mouse-CD40
DR   KYinno; KC-1663
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (KYinno=KC-1663).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88336; Cd40.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT1080-eGFP-Puro
AC   CVCL_RA09
DR   cancercelllines; CVCL_RA09
DR   Imanis; CL075
DR   Wikidata; Q54896557
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL075).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HT1080-Fluc-Neo/eGFP-Puro
AC   CVCL_RA10
DR   cancercelllines; CVCL_RA10
DR   Imanis; CL104
DR   Wikidata; Q54896558
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL104).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   HT1080-Fluc-Neo/iRFP-Puro
AC   CVCL_RA11
DR   cancercelllines; CVCL_RA11
DR   Imanis; CL106
DR   Wikidata; Q54896559
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-iRFP-P2A-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL106).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   HT1080-Fluc-Puro
AC   CVCL_RA12
DR   cancercelllines; CVCL_RA12
DR   Imanis; CL076
DR   Wikidata; Q54896560
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL076).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HT1080-HMGB1-Lucia
AC   CVCL_E8F2
DR   InvivoGen; ht80-gb1lc
CC   Population: Caucasian.
CC   Characteristics: Designed to monitor ferroptosis, a form of non-apoptotic cell death. Stably express an HMGB1::Lucia luciferase fusion protein in the cytoplasm, following ferroptosis activation, the cell membrane ruptures and HMGB1::Lucia is released in the extracellular milieu (InvivoGen=ht80-gb1lc).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4983; HMGB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HT1080-hNIS-Neo/eGFP-Puro
AC   CVCL_RA13
DR   cancercelllines; CVCL_RA13
DR   Imanis; CL103
DR   Wikidata; Q54896561
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-eGFP-PGKp-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL103).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   HT1080-hNIS-Neo/Fluc-Puro
AC   CVCL_RA14
DR   cancercelllines; CVCL_RA14
DR   Imanis; CL105
DR   Wikidata; Q54896562
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-Fluc-P2A-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL105).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   HT1080-hNIS-Neo/iRFP-Puro
AC   CVCL_RA15
DR   cancercelllines; CVCL_RA15
DR   Imanis; CL107
DR   Wikidata; Q54896563
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-hNIS-IRES-Neo and LV-iRFP-P2A-Puro vectors. LV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL107).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 18
//
ID   HT1080-hNIS-Puro
AC   CVCL_RA16
DR   cancercelllines; CVCL_RA16
DR   Imanis; CL102
DR   Wikidata; Q54896564
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-hNIS-P2A-Puro vector encoding for human SLC5A5 linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL102).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HT1080-iRFP-Puro
AC   CVCL_RA17
DR   cancercelllines; CVCL_RA17
DR   Imanis; CL077
DR   Wikidata; Q54896565
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Puro vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL077).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 16
//
ID   HT1080-luc2
AC   CVCL_L898
DR   cancercelllines; CVCL_L898
DR   Revvity/PerkinElmer; 128092
DR   Wikidata; Q54896567
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 128092; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 22
//
ID   HT1080-MFAP4 W235F-MH
AC   CVCL_ZJ81
DR   cancercelllines; CVCL_ZJ81
DR   Wikidata; Q98126738
RX   PubMed=32442478;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7035; MFAP4 (Note=With p.Trp235Phe and a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   HT1080-MFAP4 wt-MH
AC   CVCL_ZJ80
DR   cancercelllines; CVCL_ZJ80
DR   Wikidata; Q98126739
RX   PubMed=32442478;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7035; MFAP4 (Note=With a C-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   HT1080-Red-FLuc
AC   CVCL_5I99
SY   HT1080 Red-FLuc; Bioware Brite HT1080 Red-FLuc; IVISbrite HT1080 Red F-luc
DR   cancercelllines; CVCL_5I99
DR   Revvity/PerkinElmer; BW128092
DR   Wikidata; Q54896568
CC   Population: Caucasian.
CC   Doubling time: 22 hours (Revvity/PerkinElmer=BW128092).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   HT1080/Cas9 AAVS1
AC   CVCL_C9F8
SY   HT1080-Cas9 AAVS1
DR   GeneCopoeia; SL512
DR   Wikidata; Q123032637
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL512).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   HT1080/DR4
AC   CVCL_6C48
DR   cancercelllines; CVCL_6C48
DR   Wikidata; Q54896569
RX   PubMed=1673331;
RX   PubMed=1976136;
RX   PubMed=2896069;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   HT11
AC   CVCL_A8EU
DR   TKG; TKG 0769
DR   Wikidata; Q107115365
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT115
AC   CVCL_2520
SY   HT-115; HT 115
DR   BTO; BTO_0003460
DR   CLO; CLO_0004277
DR   EFO; EFO_0006442
DR   CLDB; cl1756
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 416
DR   BioSample; SAMN03472979
DR   BioSample; SAMN10987744
DR   cancercelllines; CVCL_2520
DR   Cell_Model_Passport; SIDM00534
DR   ColonAtlas; HT115
DR   Cosmic; 1609486
DR   Cosmic; 2301987
DR   Cosmic-CLP; 907289
DR   DepMap; ACH-000986
DR   ECACC; 85061104
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 907289
DR   GEO; GSM827330
DR   GEO; GSM887137
DR   GEO; GSM888208
DR   GEO; GSM1346843
DR   GEO; GSM1448111
DR   GEO; GSM1669909
DR   IARC_TP53; 21379
DR   LiGeA; CCLE_101
DR   LINCS_LDP; LCL-1162
DR   PharmacoDB; HT115_626_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2520
DR   PubChem_Cell_line; CVCL_2520
DR   Wikidata; Q54896570
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HT115
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*51:01,51:01; C*02:02,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (Cosmic-CLP=907289; DepMap=ACH-000986).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.18%; Native American=0.04%; East Asian, North=1.25%; East Asian, South=0%; South Asian=0.21%; European, North=66.59%; European, South=31.73% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=907289; ECACC=85061104; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 7,12
ST   D13S317: 13
ST   D16S539: 10
ST   D18S51: 12,15
ST   D21S11: 30,32.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 12
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   HT134A
AC   CVCL_B5TX
SY   GM27466; GM27466*A
DR   Coriell; GM27466
DR   Wikidata; Q111733449
RX   PubMed=30220252;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM27466).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=30220252
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 13,15
ST   D19S433: 14
ST   D21S11: 31.2,33.2
ST   D2S1338: 18,24
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 20,25
ST   Penta D: 13,15
ST   Penta E: 11,14
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U381 ! GM00221
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HT134E
AC   CVCL_B5U0
DR   Wikidata; Q111733450
RX   PubMed=30220252;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (from parent cell line).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=30220252
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 13,15
ST   D19S433: 14
ST   D21S11: 31.2,33.2
ST   D2S1338: 18,24
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 20,25
ST   Penta D: 13,15
ST   Penta E: 11,14
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U381 ! GM00221
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   HT1376 FOXP3
AC   CVCL_C3H1
DR   cancercelllines; CVCL_C3H1
DR   Wikidata; Q114311671
RX   PubMed=27189164;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln702Ter (c.2104C>T); ClinVar=VCV000428683; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro250Leu (c.749C>T); ClinVar=VCV000420136; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6106; FOXP3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1292 ! HT-1376
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HT1376 FOXP3Delta3
AC   CVCL_C3H2
DR   cancercelllines; CVCL_C3H2
DR   Wikidata; Q114311672
RX   PubMed=27189164;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln702Ter (c.2104C>T); ClinVar=VCV000428683; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro250Leu (c.749C>T); ClinVar=VCV000420136; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6106; FOXP3 (Note=Isoform Delta3).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1292 ! HT-1376
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   HT1376rCDDP1000
AC   CVCL_RR15
DR   cancercelllines; CVCL_RR15
DR   Wikidata; Q54896571
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 31.2 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln702Ter (c.2104C>T); ClinVar=VCV000428683; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro250Leu (c.749C>T); ClinVar=VCV000420136; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1292 ! HT-1376
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   HT1376rGEMCI20
AC   CVCL_RR16
DR   cancercelllines; CVCL_RR16
DR   Wikidata; Q54896572
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 41.8 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln702Ter (c.2104C>T); ClinVar=VCV000428683; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro250Leu (c.749C>T); ClinVar=VCV000420136; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1292 ! HT-1376
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   HT140A
AC   CVCL_C7KX
SY   GM27465; GM27465*A
DR   Coriell; GM27465
DR   Wikidata; Q117704504
RX   PubMed=29631617;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg127Ter (c.379C>T); ClinVar=VCV000207569; Zygosity=Heterozygous (PubMed=29631617).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=29631617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA46 ! GM16485
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HT140E
AC   CVCL_C7KY
DR   Wikidata; Q117704505
RX   PubMed=29631617;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg127Ter (c.379C>T); ClinVar=VCV000207569; Zygosity=Heterozygous (PubMed=29631617).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=29631617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA46 ! GM16485
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HT142C
AC   CVCL_B5TJ
SY   HT142 (C); GM28383; GM28383*B
DR   Coriell; GM28383
DR   Wikidata; Q111733451
RX   PubMed=30052969;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; c.590-7G>A (IVS5AS-7G>A); ClinVar=VCV000222996; Zygosity=Heterozygous (Coriell=GM28383).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (Coriell=GM28383).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61265; Scheie syndrome
DI   ORDO; Orphanet_93474; Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1V17 ! GM01256
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   HT144A
AC   CVCL_UD78
AS   CVCL_WM13
SY   GM27446; GM27446*B
DR   Coriell; GM27446
DR   Wikidata; Q93933233
RX   PubMed=28659158;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Ala199Cysfs*13 (c.594dupT); ClinVar=VCV000000080; Zygosity=Heterozygous (Coriell=GM27446).
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Gly266Ter (c.796G>T); ClinVar=VCV000000078; Zygosity=Heterozygous (Coriell=GM27446).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28659158
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 15,16
ST   D21S11: 30,32.2
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 14
ST   Penta E: 15,16
ST   TH01: 7,9.3
ST   TPOX: 10
ST   vWA: 19
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X456 ! GM06144
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 14
//
ID   HT144B
AC   CVCL_UD79
DR   Wikidata; Q94305121
RX   PubMed=28659158;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Ala199Cysfs*13 (c.594dupT); ClinVar=VCV000000080; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6617; LIPA; Simple; p.Gly266Ter (c.796G>T); ClinVar=VCV000000078; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28659158
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 15,16
ST   D21S11: 30,32.2
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 14
ST   Penta E: 15,16
ST   TH01: 7,9.3
ST   TPOX: 10
ST   vWA: 19
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X456 ! GM06144
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 13
//
ID   HT146B
AC   CVCL_C7KZ
DR   Wikidata; Q117704506
RX   PubMed=29631617;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000056193; Zygosity=Heterozygous (PubMed=29631617).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Tyr247His (c.739T>C); ClinVar=VCV000056214; Zygosity=Heterozygous (PubMed=29631617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA99 ! GM20389
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HT146F
AC   CVCL_C7L0
DR   Wikidata; Q117704507
RX   PubMed=29631617;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000056193; Zygosity=Heterozygous (PubMed=29631617).
CC   Sequence variation: Mutation; HGNC; HGNC:9325; PPT1; Simple; p.Tyr247His (c.739T>C); ClinVar=VCV000056214; Zygosity=Heterozygous (PubMed=29631617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85861; Neuronal ceroid lipofuscinosis type 1
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA99 ! GM20389
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HT147D
AC   CVCL_B5TK
SY   HT147 (D)
DR   Wikidata; Q111733452
RX   PubMed=30052969;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122782; Hurler-Scheie syndrome
DI   ORDO; Orphanet_93476; Hurler-Scheie syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1V22 ! GM00963
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HT148A
AC   CVCL_B5TL
SY   HT148 (A)
DR   Wikidata; Q111733453
RX   PubMed=30052969;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V529 ! GM00415
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HT148D
AC   CVCL_B5TM
SY   HT148 (D)
DR   Wikidata; Q111733454
RX   PubMed=30052969;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V529 ! GM00415
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HT149B
AC   CVCL_UD80
DR   Wikidata; Q94305139
RX   PubMed=28659158;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28659158
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D21S11: 28,29
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8B12 ! GM11851
SX   Female
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 8
//
ID   HT149E
AC   CVCL_UD81
DR   Wikidata; Q94305142
RX   PubMed=28659158;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28659158
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D21S11: 28,29
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C61271; Wolman disease
DI   ORDO; Orphanet_75233; Wolman disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8B12 ! GM11851
SX   Female
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 8
//
ID   HT151A
AC   CVCL_B5TY
DR   Wikidata; Q111733455
RX   PubMed=30220252;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp392Ter (c.1176G>A); ClinVar=VCV000003936; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
ST   Source(s): PubMed=30220252
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,14
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 19,25
ST   Penta D: 12
ST   Penta E: 11,13
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 14,15
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U384 ! GM00515
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   HT151C
AC   CVCL_B5TZ
DR   Wikidata; Q111733456
RX   PubMed=30220252;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp392Ter (c.1176G>A); ClinVar=VCV000003936; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
ST   Source(s): PubMed=30220252
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,14
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 19,25
ST   Penta D: 12
ST   Penta E: 11,13
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 14,15
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U384 ! GM00515
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   HT16
AC   CVCL_A8EV
DR   TKG; TKG 0770
DR   Wikidata; Q107115366
RX   PubMed=22499954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT168
AC   CVCL_2H38
SY   HT-168
DR   BTO; BTO_0005041
DR   cancercelllines; CVCL_2H38
DR   Wikidata; Q54896575
RX   PubMed=2203689;
RX   PubMed=11448059;
CC   Population: Caucasian.
CC   Characteristics: Low metastatic potential.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1059 ! A2058
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   HT168-M1
AC   CVCL_2H39
SY   M1
DR   BTO; BTO_0005043
DR   cancercelllines; CVCL_2H39
DR   Wikidata; Q54896576
RX   PubMed=2203689;
RX   PubMed=11448059;
CC   Population: Caucasian.
CC   Characteristics: High metastatic potential.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H38 ! HT168
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   HT17
AC   CVCL_A8EW
SY   HT17.4
DR   TKG; TKG 0771
DR   Wikidata; Q107115367
RX   PubMed=22499954;
RX   PubMed=24021278;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 4
//
ID   HT2 [Mouse hybridoma against human HERPUD1]
AC   CVCL_AS20
DR   TKG; TKG 0716
DR   Wikidata; Q54896578
RX   PubMed=17660709;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15011; Human HERPUD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   HT2 [Mouse hybridoma against human TLR4]
AC   CVCL_A8EX
DR   TKG; TKG 0767
DR   Wikidata; Q107115368
RX   PubMed=22499954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT22
AC   CVCL_0321
SY   HT-22
DR   BTO; BTO_0003037
DR   MCCL; MCC:0000214
DR   ChEMBL-Cells; CHEMBL3307590
DR   ChEMBL-Targets; CHEMBL614316
DR   CLS; 305158
DR   Lonza; 248
DR   Millipore; SCC129
DR   PRIDE; PXD001597
DR   PRIDE; PXD023294
DR   PubChem_Cell_line; CVCL_0321
DR   Ubigene; YC-A004
DR   Wikidata; Q54896579
RX   PubMed=7953717;
RX   PubMed=9292733;
RX   PubMed=19135458;
RX   PubMed=26227174;
RX   PubMed=33430126;
WW   Info; -; -; https://github.com/TNTurnerLab/HT22_genome_epigenome_functional_genomics_project
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-569.html
WW   Provider; Salk; T09031; https://web.archive.org/web/20180601190237/http://salkinnovations.testtechnologypublisher.com:80/technology/7060
CC   Characteristics: Highly sensitive to glutamate and is therefore used to study glutamate-induced toxicity in neuronal cells (Millipore=SCC129).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
ST   Source(s): Millipore=SCC129
ST   Mouse STR 1-1: 10,11
ST   Mouse STR 1-2: 13,17
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 18.3,19.3,20.3
ST   Mouse STR 5-5: 13,14,15
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 15
ST   Mouse STR 11-2: 15,17,18
ST   Mouse STR 12-1: 20
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 12,13,14
ST   Mouse STR 18-3: 17,19
ST   Mouse STR 19-2: 11,12
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U378 ! HT4 [Mouse neurons]
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 28
//
ID   HT22 Klf13 KO
AC   CVCL_C0NE
SY   HT-22 Klf13 KO
DR   Kerafast; EMU048
DR   Wikidata; Q112929757
RX   PubMed=32241200;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1354948; Klf13.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   HT22 Klf9 KO
AC   CVCL_C0NF
SY   HT-22 Klf9 KO; HT22[Klf9 CRISPR]
DR   Kerafast; EMU047
DR   Wikidata; Q112929758
RX   PubMed=28407733;
RX   PubMed=32241200;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1333856; Klf9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   HT22 Klf9/Klf13 double KO
AC   CVCL_C0NG
SY   HT-22 Klf9/Klf13 double KO; HT22 Klf9+Klf13 KO
DR   Kerafast; EMU049
DR   Wikidata; Q112929759
RX   PubMed=32241200;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1333856; Klf9.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1354948; Klf13.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0NE ! HT22 Klf13 KO
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   HT22 TR/TO-rKlf9 clone 2.1
AC   CVCL_C0UA
SY   HT22 [TR/TO-rKlf9] clone 2.1; HT-22 [TR/TO-rKlf9] clone 2.1; HT22 [TR/TO-Klf9] line 2-1; HT22[TR/TO-Klf9]
DR   Kerafast; EMU045
DR   Wikidata; Q112929760
RX   PubMed=28407733;
RX   PubMed=32241200;
CC   Characteristics: Doxycycline induced expression of Klf9. Transfected with both pCDNA4:TO-Klf9 containing CMV-tetO2-Klf9 and the zeocin resistance gene (ble) and pCDNA6:TR containing tetR and the blasticidin resistance gene Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=RGD; 70934; Klf9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 10
//
ID   HT22 TR/TO-mKlf13
AC   CVCL_C0UB
SY   HT22 [TR/TO-mKlf13]; HT-22 [TR/TO-mKlf13]
DR   Kerafast; EMU046
DR   Wikidata; Q112929761
CC   Characteristics: Doxycycline induced expression of Klf13. Transfected with both pCDNA4:TO-Klf9 containing CMV-tetO2-Klf9 and the zeocin resistance gene (ble) and pCDNA6:TR containing tetR and the blasticidin resistance gene Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1354948; Klf13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 10
//
ID   HT22-BLRP-hTRb/pSV40-BirAV5
AC   CVCL_C0U8
DR   Kerafast; EMU043
DR   Wikidata; Q112929762
CC   Characteristics: Expresses human THRB fused to a biotin ligase recognition peptide (BLRP).
CC   Characteristics: Expresses C-terminal V5-tagged birA under the control of the human EF1a promoter.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB (Note=With a N-terminal BLRP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06709; Escherichia coli birA (Note=With a C-terminal V5 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 10
//
ID   HT22-FLBIO-rKLF9/SV40-BirAV5
AC   CVCL_C0U9
SY   HT22 [BirA/FLBIO-Klf9]
DR   Kerafast; EMU044
DR   Wikidata; Q112929764
RX   PubMed=28407733;
CC   Characteristics: Expresses C-terminal V5-tagged birA under the control of the human EF1a promoter.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=RGD; 70934; Klf9 (Note=With a N-terminal FLBIO tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06709; Escherichia coli birA (Note=With a C-terminal V5 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   HT22-pSV40-BirAV5
AC   CVCL_C0U7
SY   HT22-BirAV5; HT22 [BirA]
DR   Kerafast; EMU042
DR   Wikidata; Q112929767
RX   PubMed=28407733;
CC   Characteristics: Expresses C-terminal V5-tagged birA under the control of the human EF1a promoter.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06709; Escherichia coli birA (Note=With a C-terminal V5 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   HT26
AC   CVCL_A8EY
DR   TKG; TKG 0772
DR   Wikidata; Q107115369
RX   PubMed=22499954;
RX   PubMed=24021278;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT264A
AC   CVCL_C7L1
DR   Wikidata; Q117704508
RX   PubMed=29631617;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg127Gln (c.380G>A); ClinVar=VCV000068746; Zygosity=Heterozygous (PubMed=29631617).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=29631617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA47 ! GM16486
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   HT264B
AC   CVCL_C7L2
SY   GM28380; GM28380*B
DR   Coriell; GM28380
DR   Wikidata; Q117704509
RX   PubMed=29631617;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg127Gln (c.380G>A); ClinVar=VCV000068746; Zygosity=Heterozygous (PubMed=29631617).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=29631617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA47 ! GM16486
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   hT279
AC   CVCL_XE58
DR   CCRID; 4201PAT-CCTCC00305
DR   Wikidata; Q94305217
RX   Patent=CN101775372B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200953.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96KW9; Human SPACA7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   HT29
AC   CVCL_A8EZ
DR   TKG; TKG 0773
DR   Wikidata; Q107115370
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT29 gluc C1
AC   CVCL_0322
SY   HT29glucC1
DR   CLO; CLO_0004284
DR   MCCL; MCC:0000215
DR   CLDB; cl1757
DR   cancercelllines; CVCL_0322
DR   Cosmic; 1609500
DR   ECACC; 92012401
DR   Wikidata; Q54896580
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5941 ! HT29-18-C1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   HT29 LM1
AC   CVCL_5U94
DR   cancercelllines; CVCL_5U94
DR   Wikidata; Q54896581
RX   PubMed=24823486;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 18
//
ID   HT29 LM2
AC   CVCL_5U95
DR   cancercelllines; CVCL_5U95
DR   Wikidata; Q54896582
RX   PubMed=24823486;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U94 ! HT29 LM1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 18
//
ID   HT29 LM3
AC   CVCL_5U96
DR   cancercelllines; CVCL_5U96
DR   Wikidata; Q54896583
RX   PubMed=24823486;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U95 ! HT29 LM2
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 18
//
ID   HT29-12B
AC   CVCL_C764
SY   HT29 cl.12B; HT29 clone 12B
DR   cancercelllines; CVCL_C764
DR   Wikidata; Q54896584
RX   PubMed=6744312;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   HT29-13G
AC   CVCL_C765
SY   HT29 cl.13G; HT29 clone 13G
DR   cancercelllines; CVCL_C765
DR   Wikidata; Q54896585
RX   PubMed=6744312;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   HT29-16E
AC   CVCL_C763
SY   HT29 16E; HT-29 16E; HT29-Cl.16E; HT29-cl16E; HT29 clone 16E; Cl.16E
DR   ABM; T8213
DR   cancercelllines; CVCL_C763
DR   Wikidata; Q54896586
RX   PubMed=6744312;
RX   PubMed=8801204;
RX   PubMed=25944804;
CC   Population: Caucasian.
CC   Doubling time: 43.37 hours (PubMed=25944804).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: C1.16E; Note=Occasionally.
CC   Misspelling: HT29-C1.16E; ABM=T8213; Note=In old versions, corrected in Jan 2025.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   HT29-18
AC   CVCL_5940
DR   cancercelllines; CVCL_5940
DR   Wikidata; Q54896587
RX   PubMed=3611191;
RX   PubMed=8470895;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   HT29-18-C1
AC   CVCL_5941
SY   HT29-18C1; HT29-18C(1)
DR   cancercelllines; CVCL_5941
DR   Wikidata; Q54896588
RX   PubMed=3611191;
RX   PubMed=8470895;
RX   PubMed=8932439;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5940 ! HT29-18
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   HT29-18-N2
AC   CVCL_5942
SY   HT29-18N2; HT-29-18 N2; N2
DR   cancercelllines; CVCL_5942
DR   Wikidata; Q54896589
RX   PubMed=2154122;
RX   PubMed=3360261;
RX   PubMed=3611191;
RX   PubMed=8589882;
RX   PubMed=12388101;
CC   Population: Caucasian.
CC   Characteristics: Mucus-secreting clone of parent cell line. When grown in the absence of glucose they form homogeneous epithelial monolayers of columnar cells with typical goblet cell morphology (PubMed=3360261).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5940 ! HT29-18
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   HT29-18A
AC   CVCL_C766
SY   HT29 cl.18A; HT29 clone 18A
DR   cancercelllines; CVCL_C766
DR   Wikidata; Q54896590
RX   PubMed=6744312;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5940 ! HT29-18
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 22
//
ID   HT29-19A
AC   CVCL_0323
SY   HT2919A; HT 29/19A; HT29/19A; HT29 cl.19A; HT29-cl19A; HT29 CL19A; HT29 cl 19A; HT 29 cl.19A; HT29-Cl.19A; HT-29 clone 19A; HT29 clone 19A; HT29clone19A
DR   MCCL; MCC:0000216
DR   ABM; T8212
DR   cancercelllines; CVCL_0323
DR   Wikidata; Q54896591
RX   PubMed=6744312;
RX   PubMed=12508250;
RX   PubMed=12714179;
RX   PubMed=15463957;
RX   PubMed=25944804;
CC   Population: Caucasian.
CC   Doubling time: 43.47 hours (PubMed=25944804).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: HT29-C1.19A; ABM=T8212; Note=In old versions, corrected in Jan 2025.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   HT29-27
AC   CVCL_E5Z7
SY   HT29 line 27
RX   PubMed=3281752;
CC   Population: Caucasian.
CC   Characteristics: Obtained after treatment of parent cell line in polyethylene glycol (PEG). Two types of differentiated cells are present, namely, enterocytic cells and mucus-secreting goblet cells (PubMed=3281752).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HT29-27H
AC   CVCL_E5ZB
SY   HT29-Cl.27H; HT-29-Cl.27H; HT29-27 clone H; HT29 line 27 clone H; Cl.27H
DR   ABM; T8211
RX   PubMed=3281752;
CC   Population: Caucasian.
CC   Characteristics: Obtained after treatment of parent cell line in polyethylene glycol (PEG). Two types of differentiated cells are present, namely, enterocytic cells and mucus-secreting goblet cells. This clone secretes mucus (PubMed=3281752).
CC   Doubling time: 24.8 +- 0.7 hours (PubMed=3281752).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: HT-29-C1.27H; ABM=T8211; Note=In old versions, corrected in Jan 2025.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5Z7 ! HT29-27
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HT29-27J
AC   CVCL_E5ZC
SY   HT29-Cl.27J; HT29-27 clone J; HT29 line 27 clone J; Cl.27J
RX   PubMed=3281752;
CC   Population: Caucasian.
CC   Characteristics: Obtained after treatment of parent cell line in polyethylene glycol (PEG). Two types of differentiated cells are present, namely, enterocytic cells and mucus-secreting goblet cells. This clone does not secrete mucus (PubMed=3281752).
CC   Doubling time: 30.9 +- 2.7 hours (PubMed=3281752).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5Z7 ! HT29-27
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HT29-28
AC   CVCL_E5Z8
SY   HT29 line 28
RX   PubMed=3281752;
CC   Population: Caucasian.
CC   Characteristics: Obtained after treatment of parent cell line in polyethylene glycol (PEG). Two types of differentiated cells are present, namely, enterocytic cells and mucus-secreting goblet cells (PubMed=3281752).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HT29-30
AC   CVCL_E5Z9
SY   HT29 line 30
RX   PubMed=3281752;
CC   Population: Caucasian.
CC   Characteristics: Obtained after treatment of parent cell line in polyethylene glycol (PEG). Two types of differentiated cells are present, namely, enterocytic cells and mucus-secreting goblet cells (PubMed=3281752).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HT29-31
AC   CVCL_E5ZA
SY   HT29 line 31
RX   PubMed=3281752;
CC   Population: Caucasian.
CC   Characteristics: Obtained after treatment of parent cell line in polyethylene glycol (PEG). Two types of differentiated cells are present, namely, enterocytic cells and mucus-secreting goblet cells (PubMed=3281752).
CC   Doubling time: 25.4 +- 2.5 hours (PubMed=3281752).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HT29-5F12
AC   CVCL_A8P7
DR   cancercelllines; CVCL_A8P7
DR   ECACC; 15121702
DR   Wikidata; Q102114161
RX   PubMed=15050369;
CC   Population: Caucasian.
CC   Characteristics: Mucus-secreting clone of HT-29. Consists of unpolarized cells with mucus secretions that have anti-colonic mucin immunoreactivity and mainly expresses MUC2. Resistant to 5-fluorouracil and sensitive to methotrexate.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121702
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8P6 ! HT29-5FU resistant (10 microMolar)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   HT29-5F7
AC   CVCL_A8P8
DR   cancercelllines; CVCL_A8P8
DR   ECACC; 15121701
DR   Wikidata; Q102114162
RX   PubMed=15050369;
CC   Population: Caucasian.
CC   Characteristics: Has an enterocyte-like phenotype. Resistant to both 5-fluorouracil and methotrexate.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121701
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8P6 ! HT29-5FU resistant (10 microMolar)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   HT29-5FU resistant (1 microMolar)
AC   CVCL_A3CP
SY   HT29-5FU resistant (10-6)
DR   cancercelllines; CVCL_A3CP
DR   ECACC; 15121704
DR   Wikidata; Q105509490
RX   PubMed=1937958;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 1 muM of 5-fluorouracil (PubMed=1937958).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121704
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,20.2
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 14
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   HT29-5FU resistant (10 microMolar)
AC   CVCL_A8P6
SY   HT29-5FU resistant (10-5); HT29-FU
DR   cancercelllines; CVCL_A8P6
DR   ECACC; 15121709
DR   Wikidata; Q102114166
RX   PubMed=1937958;
RX   PubMed=8308060;
RX   PubMed=15050369;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 10 muM of 5-fluorouracil (PubMed=1937958).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121709
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 14
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   HT29-5M12
AC   CVCL_A8P9
DR   cancercelllines; CVCL_A8P9
DR   ECACC; 15121707
DR   Wikidata; Q102114163
RX   PubMed=9579576;
RX   PubMed=15050369;
CC   Population: Caucasian.
CC   Characteristics: Has an enterocyte-like phenotype. Resistant to both 5-fluorouracil and methotrexate.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121707
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   HT29-5M21
AC   CVCL_A8Q0
DR   cancercelllines; CVCL_A8Q0
DR   ECACC; 15121706
DR   Wikidata; Q102114164
RX   PubMed=9579576;
RX   PubMed=15050369;
CC   Population: Caucasian.
CC   Characteristics: Mucus-secreting clone of HT-29 which forms a monolayer of polarized cells with strong anti-gastric mucin immunoreactivity and mainly expresses MUC5AC and MUC5B. Resistant to methotrexate and sensitive to 5-fluorouracil.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121706
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   HT29-Cx43
AC   CVCL_E9CB
RX   PubMed=11916247;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4274; GJA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT29-Cx43TK
AC   CVCL_E9CC
RX   PubMed=11916247;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4274; GJA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E9CA ! HT29-TK
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT29-DR3
AC   CVCL_E7H8
RX   PubMed=30688306;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11910; TNFRSF25 (Note=With a C-terminal 3xFLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HT29-luc2
AC   CVCL_5J20
DR   cancercelllines; CVCL_5J20
DR   Revvity/PerkinElmer; 124353
DR   Wikidata; Q54896592
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124353; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 21
//
ID   HT29-Lucia AhR
AC   CVCL_A8BX
DR   cancercelllines; CVCL_A8BX
DR   InvivoGen; ht2l-ahr
DR   Wikidata; Q107115371
CC   Population: Caucasian.
CC   Characteristics: Used for the study of aryl hydrocarbon receptor (AhR) genomic signaling induction (InvivoGen=ht2l-ahr).
CC   Characteristics: The Lucia luciferase reporter gene is under the control of a minimal promoter coupled with the human CYP1A1 gene entire regulatory sequence which contains 6 dioxin responsive elements (DRE) (InvivoGen=ht2l-ahr).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 12
//
ID   HT29-MTX resistant (1 microMolar)
AC   CVCL_F0KM
SY   HT29-MTX resistant (10-6M); HT29-MTX
DR   ECACC; 15121705
RX   PubMed=2205381;
RX   PubMed=8308060;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 1 muM of methotrexate (PubMed=2205381).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121705
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,20.2
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT29-MTX resistant (10 microMolar)
AC   CVCL_F0KN
SY   HT29-MTX resistant (10-5M)
DR   ECACC; 15121711
RX   PubMed=2205381;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 10 muM of methotrexate (PubMed=2205381).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121711
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,20.2
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9.3
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT29-MTX resistant (100 microMolar)
AC   CVCL_F0KP
SY   HT29-MTX resistant (10-4M)
DR   ECACC; 15121710
CC   Population: Caucasian.
CC   Characteristics: Resistant to 100 muM of methotrexate (ECACC=15121710).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=15121710
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT29-OxR
AC   CVCL_5949
DR   cancercelllines; CVCL_5949
DR   Wikidata; Q54896593
RX   PubMed=16857785;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   HT29-R
AC   CVCL_EQ23
SY   HT29R
DR   cancercelllines; CVCL_EQ23
DR   ColonAtlas; HT29R
DR   GEO; GSM288501
DR   GEO; GSM288502
DR   GEO; GSM288536
DR   Wikidata; Q54896594
RX   PubMed=17945194;
RX   PubMed=18694510;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 20
//
ID   HT29-TK
AC   CVCL_E9CA
RX   PubMed=11916247;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HT29/219
AC   CVCL_2521
AS   CVCL_6835
SY   HT-29/219; HT29219
DR   BTO; BTO_0002838
DR   CLO; CLO_0004285
DR   CLDB; cl1758
DR   cancercelllines; CVCL_2521
DR   ECACC; 85061109
DR   NCBI_Iran; C154
DR   Wikidata; Q54896595
RX   PubMed=17254797;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=85061109; PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11 (PubMed=17254797)
ST   CSF1PO: 11,12 (ECACC=85061109)
ST   D13S317: 11 (PubMed=17254797)
ST   D13S317: 11,12 (ECACC=85061109)
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 19,21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HT29/L-OHP
AC   CVCL_4V74
DR   cancercelllines; CVCL_4V74
DR   Wikidata; Q54896596
RX   PubMed=26400331;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   HT3
AC   CVCL_A8FA
DR   TKG; TKG 0768
DR   Wikidata; Q107115372
RX   PubMed=22499954;
RX   PubMed=24021278;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT4 [Mouse hybridoma against human TLR4]
AC   CVCL_A8FB
DR   Wikidata; Q107115373
RX   PubMed=22499954;
RX   PubMed=28741733;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT4 [Mouse neurons]
AC   CVCL_U378
SY   HT-4
DR   Wikidata; Q54896597
RX   PubMed=1970639;
RX   PubMed=1980069;
RX   PubMed=2033646;
CC   Characteristics: At the restrictive temperature (39 Celsius) the cells take on properties of differentiated neurons they express neuronal antigens, synthesize NGF mRNA and secrete biologically active NGF in vitro.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 17
//
ID   HT40
AC   CVCL_A8FC
DR   TKG; TKG 0774
DR   Wikidata; Q107115374
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT41
AC   CVCL_A8FD
DR   TKG; TKG 0775
DR   Wikidata; Q107115375
RX   PubMed=22499954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT43
AC   CVCL_A8FE
DR   TKG; TKG 0776
DR   Wikidata; Q107115376
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT44
AC   CVCL_A8FF
DR   TKG; TKG 0778
DR   Wikidata; Q107115377
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT45
AC   CVCL_A8FG
DR   TKG; TKG 0779
DR   Wikidata; Q107115378
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT52
AC   CVCL_A8FH
DR   Wikidata; Q107115379
RX   PubMed=22499954;
RX   PubMed=26602081;
RX   PubMed=28741733;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT53
AC   CVCL_A8FI
DR   TKG; TKG 0780
DR   Wikidata; Q107115380
RX   PubMed=22499954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT55
AC   CVCL_A8FJ
DR   TKG; TKG 0781
DR   Wikidata; Q107115381
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT58 [Human lymphoma]
AC   CVCL_QY02
SY   HT-58; HT 58
DR   Cosmic; 1086337
DR   Wikidata; Q54896598
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3224446;
RX   PubMed=8558920;
RX   PubMed=8847085;
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HT58 [Mouse hybridoma against human TLR4]
AC   CVCL_A8FK
SY   HT58.5
DR   TKG; TKG 0782
DR   Wikidata; Q107115382
RX   PubMed=22499954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 4
//
ID   HT59
AC   CVCL_A8FL
DR   TKG; TKG 0783
DR   Wikidata; Q107115384
RX   PubMed=22499954;
RX   PubMed=24021278;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT60
AC   CVCL_A8FM
DR   TKG; TKG 0784
DR   Wikidata; Q107115385
RX   PubMed=22499954;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT66
AC   CVCL_A8FN
DR   TKG; TKG 0785
DR   Wikidata; Q107115386
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT68
AC   CVCL_A8FP
DR   TKG; TKG 0786
DR   Wikidata; Q107115387
RX   PubMed=22499954;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HT707
AC   CVCL_F0Y7
RX   PubMed=40568761;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Pro68Argfs*23 (c.203delC); ClinVar=VCV001321450; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg296Ter (c.886C>T) (R247X); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT707 TH-neo
AC   CVCL_F0Y8
RX   PubMed=38529501;
RX   PubMed=40568761;
CC   Characteristics: Using CRISPR/Cas9 a neo gene was inserted into the TH locus after exon 14 following a T2A self-cleavage peptide, placing its expression under the control of the TH promoter. This allows for TH+ DA neuron enrichment through geneticin selection (PubMed=38529501).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Pro68Argfs*23 (c.203delC); ClinVar=VCV001321450; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg296Ter (c.886C>T) (R247X); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0Y7 ! HT707
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT708
AC   CVCL_F0Y9
RX   PubMed=40568761;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Pro68Argfs*23 (c.203delC); ClinVar=VCV001321450; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg296Ter (c.886C>T) (R247X); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT708 TH-neo,
AC   CVCL_F0YA
RX   PubMed=38529501;
RX   PubMed=40568761;
CC   Characteristics: Using CRISPR/Cas9 a neo gene was inserted into the TH locus after exon 14 following a T2A self-cleavage peptide, placing its expression under the control of the TH promoter. This allows for TH+ DA neuron enrichment through geneticin selection (PubMed=38529501).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Pro68Argfs*23 (c.203delC); ClinVar=VCV001321450; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg296Ter (c.886C>T) (R247X); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=40568761).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0Y9 ! HT708
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT711
AC   CVCL_F0YB
RX   PubMed=40568761;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT711 TH-neo
AC   CVCL_F0YC
RX   PubMed=38529501;
RX   PubMed=40568761;
CC   Characteristics: Using CRISPR/Cas9 a neo gene was inserted into the TH locus after exon 14 following a T2A self-cleavage peptide, placing its expression under the control of the TH promoter. This allows for TH+ DA neuron enrichment through geneticin selection (PubMed=38529501).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0YB ! HT711
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809
AC   CVCL_F1KV
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=40667145).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato
AC   CVCL_F1KW
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (PubMed=40667145).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KV ! HT809
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP
AC   CVCL_F1KX
SY   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 N370S/N370S; HT809-GBA1(N370S/N370S)
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (PubMed=40667145).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KW ! HT809-TH-tdTomato
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP + GPNMB KO
AC   CVCL_F1L5
SY   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 N370S/N370S + GPNMB KO; HT809-GBA1(N370S/N370S) + GPNMB KO
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KX ! HT809-TH-tdTomato-LysoIP-MitoIP
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 KO/KO
AC   CVCL_F1KY
SY   HT809-GBA1(KO/KO)
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KX ! HT809-TH-tdTomato-LysoIP-MitoIP
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 KO/KO + GPNMB KO
AC   CVCL_F1L2
SY   HT809-GBA1(KO/KO) + GPNMB KO
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KY ! HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 KO/KO
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 WT/WT
AC   CVCL_F1KZ
SY   HT809-GBA1(WT/WT)
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KX ! HT809-TH-tdTomato-LysoIP-MitoIP
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 WT/WT + GPNMB KO
AC   CVCL_F1L3
SY   HT809-GBA1(WT/WT) + GPNMB KO
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KZ ! HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 WT/WT
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 WT/L444P
AC   CVCL_F1L0
SY   HT809-GBA1(L444P/WT)
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1KZ ! HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 WT/WT
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 L444P/L444P
AC   CVCL_F1L1
SY   HT809-GBA1(L444P/L444P)
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1L0 ! HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 WT/L444P
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 L444P/L444P + GPNMB KO
AC   CVCL_F1L4
SY   HT809-GBA1(L444P/L444P) + GPNMB KO
RX   PubMed=40667145;
CC   Population: Jewish; Ashkenazi.
CC   Characteristics: Using CRISPR/Cas9 a P2-tdTomato constructs was inserted at the C-terminus of one allele of TH. This allows dopaminergic neurons differentiated from this cell line to express tdTomato and be readily identified (from parent cell line).
CC   Characteristics: Using TALEN a CAG driven construct containing TMEM192-mGFP-3xHA (LysoIP tag) and TOM20-mTagBFP-TwinStrep(2 copies of WSHPQFEK) (MitoIP tag) separated by a T2A self-cleavage peptide was inserted at one allele of the CLYBL locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=40667145).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:26775; TMEM192.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:20947; TOM20.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1L1 ! HT809-TH-tdTomato-LysoIP-MitoIP-GBA1 L444P/L444P
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT810
AC   CVCL_F0YD
RX   PubMed=40568761;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=40568761).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT9
AC   CVCL_UJ40
SY   HT 9
DR   Wikidata; Q94305457
RX   PubMed=1091196;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 8
//
ID   HT9-C7
AC   CVCL_UJ36
SY   HT9 C7; Ht9-C7; HT 9 clone C7; C7
DR   Wikidata; Q94305462
RX   PubMed=193040;
RX   PubMed=1091196;
RX   PubMed=4372626;
RX   PubMed=19604955;
CC   Characteristics: Secretes vasopressin and neurophysin.
CC   Doubling time: ~24 hours (PubMed=1091196).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UJ40 ! HT9
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 8
//
ID   HT932
AC   CVCL_F0YE
RX   PubMed=40568761;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=40568761).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HT93A
AC   CVCL_E331
SY   HT-93A; HT-93; HT93
DR   Cosmic; 975254
DR   Cosmic; 1281317
DR   DSMZ; ACC-735
DR   DSMZCellDive; ACC-735
DR   TKG; TKG 0703
DR   Wikidata; Q54896599
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690048;
RX   PubMed=9472803;
RX   PubMed=10706884;
RX   PubMed=25373509;
RX   PubMed=36982453;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=9472803); ~50 hours (DSMZ=ACC-735).
CC   Sequence variation: Gene fusion; HGNC; HGNC:77; ABL2 + HGNC; HGNC:3495; ETV6; Name(s)=ETV6-ABL2, ETV6-ARG (PubMed=10706884).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=9472803).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-735; TKG=TKG 0703
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 9,13
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 16,18
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 22
//
ID   HT94
AC   CVCL_C6VK
SY   HT 94
DR   Wikidata; Q117704510
RX   PubMed=199545;
CC   Population: Caucasian.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   HTAU
AC   CVCL_H238
DR   BTO; BTO_0002664
DR   Wikidata; Q54896600
RX   PubMed=15048935;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6893; MAPT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B396 ! CN1.4
SX   Sex unspecified
AG   13FD
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   HTB1
AC   CVCL_A8FQ
DR   TKG; TKG 0787
DR   Wikidata; Q107115388
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HTB2
AC   CVCL_A8FR
DR   Wikidata; Q107115390
RX   PubMed=26602081;
RX   PubMed=28741733;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O00206; Human TLR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   hTBME
AC   CVCL_B6BU
SY   human TERT-immortalized Bovine Mammary Epithelial cells
DR   Wikidata; Q111733457
RX   PubMed=28918563;
CC   Doubling time: ~54 hours (PubMed=28918563).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HTBOA
AC   CVCL_X939
SY   HTBoA
DR   CGH-DB; 378-2
DR   CGH-DB; 9353-4
DR   Wikidata; Q54896601
RX   PubMed=2448191;
RX   PubMed=3259199;
RX   PubMed=3593088;
RX   PubMed=9436037;
RX   PubMed=10457904;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Doubling time: 26 hours (PubMed=3259199); 28 hours (PubMed=3593088).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4509; Ovarian undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   HTC
AC   CVCL_3382
SY   Hepatoma Tissue Culture
DR   BTO; BTO_0000607
DR   CLO; CLO_0004288
DR   EFO; EFO_0022738
DR   CLDB; cl1761
DR   CLDB; cl1762
DR   CLDB; cl1763
DR   CLDB; cl1764
DR   BCRJ; 0112
DR   ECACC; 93120108
DR   ICLC; ATL95006
DR   Lonza; 246
DR   Wikidata; Q54896602
RX   PubMed=189932;
RX   PubMed=4381784;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HTC (BUdR)
AC   CVCL_7217
DR   CLO; CLO_0004289
DR   CLDB; cl1765
DR   ECACC; 85061110
DR   Wikidata; Q54896603
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3382 ! HTC
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   HTC-C3
AC   CVCL_1295
SY   HTC/C3; HTC C3; HTCC3
DR   BTO; BTO_0006211
DR   CLO; CLO_0037152
DR   CLO; CLO_0050946
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821636
DR   BioSample; SAMN01821686
DR   BioSample; SAMN03470940
DR   cancercelllines; CVCL_1295
DR   Cell_Model_Passport; SIDM00496
DR   CGH-DB; 58-1
DR   ChEMBL-Cells; CHEMBL3308747
DR   ChEMBL-Targets; CHEMBL1075472
DR   Cosmic; 924151
DR   Cosmic; 2009524
DR   Cosmic; 2054084
DR   Cosmic; 2613249
DR   Cosmic-CLP; 924151
DR   DepMap; ACH-001350
DR   DSMZ; ACC-580
DR   DSMZCellDive; ACC-580
DR   EGA; EGAS00001000978
DR   GDSC; 924151
DR   GEO; GSM1669916
DR   IARC_TP53; 1306
DR   JCRB; FDSC0042
DR   JCRB; JCRB0164
DR   LINCS_LDP; LCL-1689
DR   PharmacoDB; HTCC3_633_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1295
DR   RCB; RCB0452
DR   Wikidata; Q54896604
RX   PubMed=1516062;
RX   PubMed=2196988;
RX   PubMed=9177455;
RX   PubMed=16924234;
RX   PubMed=20164919;
RX   PubMed=23833040;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~100 hours (DSMZ=ACC-580); ~2 days (Note=Lot 04162002) (JCRB=JCRB0164).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244; Cosmic-CLP=924151; DepMap=ACH-001350).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Homozygous (PubMed=1516062; PubMed=30737244; Cosmic-CLP=924151; DepMap=ACH-001350).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.77%; Native American=0.3%; East Asian, North=74.17%; East Asian, South=22.11%; South Asian=0.65%; European, North=0.12%; European, South=1.88% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0042; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=924151; DSMZ=ACC-580; JCRB=JCRB0164; PubMed=25877200; PubMed=30737244; RCB=RCB0452
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 14,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 11,16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   HTC-M1
AC   CVCL_WL68
DR   Wikidata; Q94305559
RX   PubMed=189932;
CC   Virology: Infected by MMTV from GR cell line.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3382 ! HTC
SX   Male
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   HTC4
AC   CVCL_D053
SY   HTC-4; Hepatoma Tissue Culture-4
DR   BTO; BTO_0003574
DR   Wikidata; Q54896605
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3382 ! HTC
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   HTC75
AC   CVCL_WM79
DR   EFO; EFO_0022531
DR   cancercelllines; CVCL_WM79
DR   Wikidata; Q94305579
RX   PubMed=9034193;
RX   PubMed=9476899;
RX   PubMed=19864690;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): PubMed=19864690
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D19S433: 13.2,15
ST   D21S11: 28,30
ST   D2S1338: 25,26
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 15
//
ID   HTC75 T19
AC   CVCL_WM80
SY   HTC75T19; HTC75 clone T19; T19
DR   cancercelllines; CVCL_WM80
DR   Wikidata; Q94305585
RX   PubMed=9476899;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11729; TERF2 (Note=With p.Met1_Ala44del and p.Lys501_Asn542del and a N-terminal FLAG tag = TRF2deltaBdeltaM).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM79 ! HTC75
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 17
//
ID   HTC75 T4
AC   CVCL_WM81
SY   HTC75T4; HTC75 clone T4; T4
DR   cancercelllines; CVCL_WM81
DR   Wikidata; Q94305591
RX   PubMed=9476899;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11729; TERF2 (Note=With p.Met1_Ala44del and p.Lys501_Asn542del and a N-terminal FLAG tag = TRF2deltaBdeltaM).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM79 ! HTC75
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 17
//
ID   hTCEpi
AC   CVCL_AQ44
AS   CVCL_A5RG
SY   hTCE-Pi; human Telomerase-immortalized Corneal Epithelial cell line; THCE; Telomerase-immortalized Human Corneal Epithelial cells
DR   BTO; BTO_0004498
DR   Evercyte; CHT-045-0237
DR   GEO; GSM7701472
DR   GEO; GSM7701473
DR   Wikidata; Q54896606
RX   PubMed=15671271;
RX   PubMed=17543179;
RX   PubMed=21780919;
RX   PubMed=29787296;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: 24-32 hours (Evercyte=CHT-045-0237).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
ST   Source(s): PubMed=29787296
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D21S11: 32.2,33.2
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 15,17
ST   Penta D: 12,14
ST   Penta E: 12,15
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 15
//
ID   HTD-02
AC   CVCL_WB28
SY   HearT Disease-02
DR   IBRC; C10959
DR   Wikidata; Q94305612
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-03
AC   CVCL_WB29
SY   HearT Disease-03
DR   IBRC; C10960
DR   Wikidata; Q94305618
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-04
AC   CVCL_WB30
SY   HearT Disease-04
DR   IBRC; C10961
DR   Wikidata; Q94305622
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-05
AC   CVCL_WB31
SY   HearT Disease-05
DR   IBRC; C10962
DR   Wikidata; Q94305628
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-06
AC   CVCL_WB32
SY   HearT Disease-06
DR   IBRC; C10963
DR   Wikidata; Q94305634
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-07
AC   CVCL_WB33
SY   HearT Disease-07
DR   IBRC; C10964
DR   Wikidata; Q94305638
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-09
AC   CVCL_WB34
SY   HearT Disease-09
DR   IBRC; C10977
DR   Wikidata; Q94305644
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-10
AC   CVCL_WB35
SY   HearT Disease-10
DR   IBRC; C11050
DR   Wikidata; Q94305647
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-11
AC   CVCL_WB36
SY   HearT Disease-11
DR   IBRC; C11051
DR   Wikidata; Q94305652
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-12
AC   CVCL_WB37
SY   HearT Disease-12
DR   IBRC; C11052
DR   Wikidata; Q94305657
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-13
AC   CVCL_WB38
SY   HearT Disease-13
DR   IBRC; C11007
DR   Wikidata; Q94305659
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-14
AC   CVCL_WB39
SY   HearT Disease-14
DR   IBRC; C11008
DR   Wikidata; Q94305664
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-15
AC   CVCL_WB40
SY   HearT Disease-15
DR   IBRC; C11009
DR   Wikidata; Q94305669
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-16
AC   CVCL_WB41
SY   HearT Disease-16
DR   IBRC; C11010
DR   Wikidata; Q94305673
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-17
AC   CVCL_WB42
SY   HearT Disease-17
DR   IBRC; C11105
DR   Wikidata; Q94305677
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD-18
AC   CVCL_WB43
SY   HearT Disease-18
DR   IBRC; C11106
DR   Wikidata; Q94305683
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3079; Heart disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HTD114
AC   CVCL_D683
SY   HTD-114; HTD 114
DR   BTO; BTO_0004315
DR   cancercelllines; CVCL_D683
DR   Wikidata; Q54896609
RX   PubMed=6307822;
RX   PubMed=7510848;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   hTEC/SVTERT24-B
AC   CVCL_JM27
DR   Evercyte; CLHT-010-0024-B
DR   GEO; GSM7701482
DR   GEO; GSM7701483
DR   Wikidata; Q54896610
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: ~30 hours (Evercyte=CLHT-010-0024-B).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
ST   Source(s): Evercyte=CLHT-010-0024-B
ST   CSF1PO: 9,10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   hTERT A41hBAT-SVF
AC   CVCL_UI86
SY   hTERT-A41hBAT-SVF
DR   ATCC; CRL-3385
DR   Wikidata; Q94305713
RX   PubMed=26076036;
RX   PubMed=28244042;
CC   Doubling time: ~48-72 hours (ATCC=CRL-3385).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
ST   Source(s): ATCC=CRL-3385
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 8,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR30 ! hTERT A41hWAT-SVF
SX   Male
AG   56Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   hTERT A41hWAT-SVF
AC   CVCL_UR30
DR   ATCC; CRL-3386
DR   Wikidata; Q94305721
RX   PubMed=26076036;
RX   PubMed=28244042;
CC   Doubling time: ~48-72 hours (ATCC=CRL-3386).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; White adipose tissue; UBERON=UBERON_0001347.
ST   Source(s): ATCC=CRL-3386
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 8,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI86 ! hTERT A41hBAT-SVF
SX   Male
AG   56Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   hTERT EP153T
AC   CVCL_B7DV
SY   EP153T
DR   Wikidata; Q112929770
RX   PubMed=16585177;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   hTERT EP156T
AC   CVCL_RW45
SY   EP156T
DR   ATCC; CRL-3289
DR   Wikidata; Q54832385
RX   PubMed=16585177;
CC   Doubling time: ~60-68 hours (ATCC=CRL-3289).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-3289
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   hTERT hESC 1399
AC   CVCL_VS80
SY   hTERT-immortalized human Endometrial Stromal Cells 1399; 1399
DR   Wikidata; Q94305741
RX   PubMed=30770928;
CC   Doubling time: 2.08 days (PubMed=30770928).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1400
AC   CVCL_VS81
SY   hTERT-immortalized human Endometrial Stromal Cells 1400; 1400
DR   Wikidata; Q94305746
RX   PubMed=30770928;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1405
AC   CVCL_VS82
SY   hTERT-immortalized human Endometrial Stromal Cells 1405; 1405
DR   Wikidata; Q94305751
RX   PubMed=30770928;
CC   Doubling time: 1.91 days (PubMed=30770928).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1406
AC   CVCL_VS83
SY   hTERT-immortalized human Endometrial Stromal Cells 1406; 1406
DR   Wikidata; Q94305755
RX   PubMed=30770928;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1415
AC   CVCL_VS84
SY   hTERT-immortalized human Endometrial Stromal Cells 1415; 1415
DR   Wikidata; Q94305761
RX   PubMed=30770928;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1418
AC   CVCL_VS85
SY   hTERT-immortalized human Endometrial Stromal Cells 1418; 1418
DR   Wikidata; Q94305767
RX   PubMed=30770928;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1429
AC   CVCL_VS86
SY   hTERT-immortalized human Endometrial Stromal Cells 1429; 1429
DR   Wikidata; Q94305774
RX   PubMed=30770928;
CC   Doubling time: 1.31 days (PubMed=30770928).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1433
AC   CVCL_VS87
SY   hTERT-immortalized human Endometrial Stromal Cells 1433; 1433
DR   Wikidata; Q94305779
RX   PubMed=30770928;
CC   Doubling time: 2.47 days (PubMed=30770928).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1440
AC   CVCL_VS88
SY   hTERT-immortalized human Endometrial Stromal Cells 1440; 1440
DR   Wikidata; Q94305784
RX   PubMed=30770928;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1441
AC   CVCL_VS89
SY   hTERT-immortalized human Endometrial Stromal Cells 1441; 1441
DR   Wikidata; Q94305788
RX   PubMed=30770928;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1448
AC   CVCL_VS90
SY   hTERT-immortalized human Endometrial Stromal Cells 1448; 1448
DR   Wikidata; Q94305794
RX   PubMed=30770928;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1455
AC   CVCL_VS91
SY   hTERT-immortalized human Endometrial Stromal Cells 1455; 1455
DR   Wikidata; Q94305799
RX   PubMed=30770928;
CC   Doubling time: 1.13-1.15 days (PubMed=30770928).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT hESC 1458
AC   CVCL_VS92
SY   hTERT-immortalized human Endometrial Stromal Cells 1458; 1458
DR   Wikidata; Q94305802
RX   PubMed=30770928;
CC   Doubling time: 2.11 days (PubMed=30770928).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT-hNOF
AC   CVCL_C0UE
SY   hTERT-immortalized human Normal Oral Fibroblasts
DR   ABM; T0026
DR   Wikidata; Q112929773
RX   PubMed=22071981;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   hTERT Lung Fibroblast
AC   CVCL_UJ25
DR   ATCC; CRL-4058
DR   Wikidata; Q94305808
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/medium-for-htert-lung-fibroblasts
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/seeding-density-for-htert-immortalized-lung-fibroblasts
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/subculture-for-htert-lung-fibroblasts
CC   Doubling time: 22-24 hours (ATCC=CRL-4058).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CRL-4058
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 9,10
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   hTERT NF1 ipNF00.6
AC   CVCL_UI76
SY   ipNF00.6
DR   ABM; T0192
DR   Wikidata; Q94305811
RX   PubMed=27617404;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-70Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   hTERT NF1 ipNF03.3
AC   CVCL_UI77
SY   ipNF03.3
DR   ABM; T0193
DR   Wikidata; Q94305815
RX   PubMed=27617404;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys1423Lys (c.4269G>A); ClinVar=VCV000423536; Zygosity=Heterozygous; Note=Exon skipping mutation. Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: ABM wrongly indicates that this cell line originates from a female donor (ABM=T0193).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   hTERT NF1 ipNF04.4
AC   CVCL_UI78
SY   ipNF04.4
DR   ABM; T0194
DR   Wikidata; Q94305819
RX   PubMed=27617404;
RX   PubMed=29893754;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=27617404).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg2258Ter (c.6772C>T) (p.Arg2237Ter, c.6709C>T) (R2237*); ClinVar=VCV000230389; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Caution: ABM wrongly indicates that this cell line originates from a male donor (ABM=T0194).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   hTERT NF1 ipNF05.5
AC   CVCL_UI71
SY   ipNF05.5
DR   ABM; T0180
DR   ATCC; CRL-3388
DR   Wikidata; Q94305827
RX   PubMed=27617404;
RX   PubMed=29893754;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
CC   Population: Caucasian.
CC   Doubling time: ~59 hours (ATCC=CRL-3388).
CC   Karyotypic information: 46,XY,t(2;3)(q23;p26) [18]; 47,sl,+9 [2] (ATCC=CRL-3388).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=27617404).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu1153Thrfs*42 (c.3456dupA) (3456_3457insA); ClinVar=VCV000656975; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Caution: This cell line was also termed 'ipNF05.5 (single clone)', but this is a misnomer as this cell line is not clonal (personal communication of Allaway, Robert J.).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-3388; PubMed=27617404
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 15,19
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 5,10
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI72 ! hTERT NF1 ipNF05.5 (Mixed clones)
OI   CVCL_UI73 ! hTERT NF1 ipnNF09.4
SX   Male
AG   22Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 17
//
ID   hTERT NF1 ipNF05.5 (Mixed clones)
AC   CVCL_UI72
SY   hTERT NF1 ipNF05.5 mixed clones; ipNF05.5 mixed clone; ipNF05.5 (mixed clone)
DR   ATCC; CRL-3387
DR   Wikidata; Q94305831
RX   PubMed=27617404;
RX   PubMed=29893754;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
CC   Population: Caucasian.
CC   Doubling time: ~59 hours (ATCC=CRL-3387).
CC   Karyotypic information: 46,XY,t(2;3)(q23;p26) (ATCC=CRL-3387).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=27617404).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu1153Thrfs*42 (c.3456dupA) (3456_3457insA); ClinVar=VCV000656975; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-3387; PubMed=27617404
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 15,19
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 5,10
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI71 ! hTERT NF1 ipNF05.5
OI   CVCL_UI73 ! hTERT NF1 ipnNF09.4
SX   Male
AG   22Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 16
//
ID   hTERT NF1 ipNF06.2A
AC   CVCL_UI74
SY   ipNF06.2A
DR   ABM; T0191
DR   Wikidata; Q94305834
RX   PubMed=27617404;
RX   PubMed=29893754;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gly848Trp (c.2542G>T); Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-70Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   hTERT NF1 ipNF08.1.5
AC   CVCL_D3CC
SY   ipNF08.1.5
DR   ABM; T0182
DR   Wikidata; Q127381828
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-20Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   hTERT NF1 ipNF95.11b C
AC   CVCL_UI67
SY   ipNF95.11b C; ipNF95.11b "C"; ipNF95.11bC
DR   ABM; T0179
DR   ATCC; CRL-3390
DR   Wikidata; Q94305840
RX   PubMed=27617404;
RX   PubMed=29055717;
RX   PubMed=29893754;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
CC   Doubling time: ~32.7 hours (ATCC=CRL-3390).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=27617404).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Thr586Valfs*18 (c.1756_1759delACTA) (1756delACTA); ClinVar=VCV000186215; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-3390; PubMed=27617404
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13,14
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   Penta D: 8,11
ST   Penta E: 7,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI68 ! hTERT NF1 ipNF95.11b C/T
OI   CVCL_UI69 ! hTERT NF1 ipnNF95.11c
SX   Male
AG   19Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   hTERT NF1 ipNF95.11b C/T
AC   CVCL_UI68
SY   ipNF95.11b C/T; ipNF95.11bC_T
DR   Wikidata; Q94305844
RX   PubMed=27617404;
RX   PubMed=29055717;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Somatic LOH (PubMed=27617404).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Thr586Valfs*18 (c.1756_1759delACTA) (1756delACTA); ClinVar=VCV000186215; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI67 ! hTERT NF1 ipNF95.11b C
OI   CVCL_UI69 ! hTERT NF1 ipnNF95.11c
SX   Male
AG   19Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   hTERT NF1 ipNF95.6
AC   CVCL_UI70
SY   ipNF95.6
DR   ABM; T0178
DR   ATCC; CRL-3389
DR   Wikidata; Q94305850
RX   PubMed=27617404;
RX   PubMed=29055717;
RX   PubMed=29893754;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
CC   Population: Caucasian.
CC   Doubling time: ~32.7 hours (ATCC=CRL-3389).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg816Ter (c.2446C>T); ClinVar=VCV000280055; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg2258Ter (c.6772C>T) (p.Arg2237Ter, c.6709C>T) (R2237*); ClinVar=VCV000230389; Zygosity=Heterozygous; Note=Somatic (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, cranial nerve, hypoglossal nerve; UBERON=UBERON_0001650.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-3389; PubMed=27617404
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (ATCC=CRL-3389)
ST   CSF1PO: 10,11 (PubMed=27617404)
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12.1,13
ST   D21S11: 30,32.2
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 7,14
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 15
//
ID   hTERT NF1 ipnNF09.4
AC   CVCL_UI73
SY   ipnNF09.4
DR   ABM; T0195
DR   Wikidata; Q94305854
RX   PubMed=27617404;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu1153Thrfs*42 (c.3456dupA) (3456_3457insA); ClinVar=VCV000656975; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI71 ! hTERT NF1 ipNF05.5
OI   CVCL_UI72 ! hTERT NF1 ipNF05.5 (Mixed clones)
SX   Male
AG   22Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   hTERT NF1 ipnNF95.11c
AC   CVCL_UI69
SY   ipnNF95.11c; ipnNF95.11C
DR   ATCC; CRL-3391
DR   Wikidata; Q94305859
RX   PubMed=27617404;
RX   PubMed=29893754;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
CC   Doubling time: ~33.5 hours (ATCC=CRL-3391).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Thr586Valfs*18 (c.1756_1759delACTA) (1756delACTA); ClinVar=VCV000186215; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-3391; PubMed=27617404
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13,14
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   Penta D: 8,11
ST   Penta E: 7,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI67 ! hTERT NF1 ipNF95.11b C
OI   CVCL_UI68 ! hTERT NF1 ipNF95.11b C/T
SX   Male
AG   32Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   hTERT NF1 sipnNF95.12B
AC   CVCL_UI75
SY   sipnNF95.12B
DR   Wikidata; Q94305862
RX   PubMed=27617404;
RX   PubMed=29893754;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu216Pro (c.647T>C); ClinVar=VCV000068360; Zygosity=Heterozygous; Note=Germline (PubMed=27617404).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   hTERT PF179T CAF
AC   CVCL_JL59
SY   hTERT PF179 CAF; hTERT-immortalized PF179 Cancer-Associated Fibroblasts
DR   ATCC; CRL-3290
DR   Wikidata; Q54896611
RX   PubMed=18842679;
CC   Karyotypic information: Has lost chromosome Y.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-3290
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   hTERT SC ipn02.3 2lambda
AC   CVCL_UI64
SY   ipn02.3 2lambda; ipn02.3, 2lambda; ipn02.3
DR   ABM; T0181
DR   ATCC; CRL-3392
DR   Wikidata; Q94305879
RX   PubMed=27617404;
RX   PubMed=29055717;
RX   PubMed=29893754;
WW   Info; NTAP; -; https://www.n-tap.org/for-researchers/cell-model-systems
CC   Doubling time: 38.8 hours (ATCC=CRL-3392).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, sural nerve; UBERON=UBERON_0015488.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-3392; PubMed=27617404
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 30.2,32.2
ST   D2S1338: 16,17
ST   D3S1358: 17,18
ST   D5S818: 8,11
ST   D7S820: 8,12
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 17,18
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   hTERT SC ipn02.8
AC   CVCL_UI65
SY   ipn02.8
DR   ABM; T0197
DR   Wikidata; Q94305883
RX   PubMed=27617404;
RX   PubMed=29055717;
RX   PubMed=29893754;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   hTERT SC ipn97.4
AC   CVCL_UI66
SY   ipn97.4
DR   ABM; T0196
DR   Wikidata; Q94305889
RX   PubMed=27617404;
RX   PubMed=29055717;
RX   PubMed=29893754;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   hTERT SMC PM151T
AC   CVCL_LF77
SY   PM151T
DR   ABM; T0727
DR   ATCC; CRL-3291
DR   Wikidata; Q54947615
RX   PubMed=16585177;
RX   PubMed=18462435;
CC   Doubling time: ~60 hours (ATCC=CRL-3291).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
ST   Source(s): ATCC=CRL-3291
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,13
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9.3,10
ST   TPOX: 9,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Telomerase immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 12
//
ID   hTERT TIGKs
AC   CVCL_M095
SY   TIGKs; TIGK; Telomerase Immortalized Gingival Keratinocytes
DR   ATCC; CRL-3397
DR   ChEMBL-Cells; CHEMBL4483162
DR   ChEMBL-Targets; CHEMBL4483271
DR   PubChem_Cell_line; CVCL_M095
DR   Wikidata; Q54972476
RX   PubMed=23441958;
CC   Doubling time: ~1 week (ATCC=CRL-3397).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Oral cavity, gingiva, epithelium; UBERON=UBERON_0001949.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): ATCC=CRL-3397
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   hTERT-1604
AC   CVCL_C472
SY   1604hTERT; hTERT-NOR2; hTERT-GM01604; GM1604-hTERT; Tel1604
DR   Wikidata; Q54896613
RX   PubMed=10655550;
RX   PubMed=11731418;
RX   PubMed=12604777;
RX   PubMed=12714694;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7325 ! GM01604
SX   Male
AG   12FW
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   hTERT-1604-PMS134
AC   CVCL_A5IQ
DR   Wikidata; Q107115391
RX   PubMed=12714694;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9122; PMS2 (Note=With p.Arg134Ter = PMS134).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C472 ! hTERT-1604
SX   Male
AG   12FW
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   HTERT-AEC II
AC   CVCL_T048
DR   Wikidata; Q54896614
RX   PubMed=24086682;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal lung, alveolus; UBERON=UBERON_0005597+UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   90FD
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   hTERT-ATL3 Y192C
AC   CVCL_YU33
DR   Wikidata; Q94305935
RX   PubMed=30666337;
CC   Sequence variation: Mutation; HGNC; HGNC:24526; ATL3; Simple; p.Tyr192Cys (c.575A>G); ClinVar=VCV000097070; Zygosity=Heterozygous (PubMed=30666337).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Age/sex of donor from personal communication of Kaether, Christoph.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C170433; Neuropathy, hereditary sensory and autonomic, type I
DI   ORDO; Orphanet_36386; Hereditary sensory and autonomic neuropathy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Telomerase immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   hTERT-BIEC
AC   CVCL_UZ24
SY   hTERT-immortalized Bovine Intestinal Epithelial Cells
DR   Wikidata; Q94305936
RX   PubMed=30600465;
CC   Doubling time: 13.33 hours (PubMed=30600465).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_UZ22 ! BIEC-c4
SX   Male
AG   2D
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   hTERT-BLM
AC   CVCL_ZS68
DR   Wikidata; Q98126740
RX   PubMed=10655550;
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser595Ter (c.1784C>A); ClinVar=VCV000820081; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U694 ! GM03509
SX   Male
AG   7Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   hTERT-BMSC clone Y101
AC   CVCL_VG66
SY   Y101
DR   ArrayExpress; E-MTAB-3511
DR   Wikidata; Q54896615
RX   PubMed=26070611;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG67 ! hTERT-BMSC clone Y102
OI   CVCL_VG68 ! hTERT-BMSC clone Y201
OI   CVCL_VG69 ! hTERT-BMSC clone Y202
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   hTERT-BMSC clone Y102
AC   CVCL_VG67
SY   Y102
DR   ArrayExpress; E-MTAB-3511
DR   Wikidata; Q54896616
RX   PubMed=26070611;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG66 ! hTERT-BMSC clone Y101
OI   CVCL_VG68 ! hTERT-BMSC clone Y201
OI   CVCL_VG69 ! hTERT-BMSC clone Y202
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   hTERT-BMSC clone Y201
AC   CVCL_VG68
SY   Y201
DR   ArrayExpress; E-MTAB-3511
DR   Wikidata; Q54896617
RX   PubMed=26070611;
RX   PubMed=29895825;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG66 ! hTERT-BMSC clone Y101
OI   CVCL_VG67 ! hTERT-BMSC clone Y102
OI   CVCL_VG69 ! hTERT-BMSC clone Y202
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   hTERT-BMSC clone Y202
AC   CVCL_VG69
SY   Y202
DR   ArrayExpress; E-MTAB-3511
DR   Wikidata; Q54896618
RX   PubMed=26070611;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG66 ! hTERT-BMSC clone Y101
OI   CVCL_VG67 ! hTERT-BMSC clone Y102
OI   CVCL_VG68 ! hTERT-BMSC clone Y201
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   hTERT-BTY
AC   CVCL_WN78
SY   hTERT-immortalized Bovine ThYroid cells
DR   CCRID; 4201PAT-CCTCC00455
DR   Wikidata; Q94305992
RX   Patent=CN104293736B;
RX   PubMed=30254623;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014109.
CC   Virology: Susceptible to infection by foot-and-mouth disease virus (PubMed=30254623).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   1D
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   hTERT-CBECs
AC   CVCL_2H44
SY   CBE1; hTERT-immortalized Canine Bronchiolar Epithelial Cells
DR   CCRID; 4201PAT-CCTCC00554
DR   Wikidata; Q54896619
RX   Patent=CN104531607B;
RX   PubMed=26156242;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014223.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   45D
CA   Telomerase immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 14
//
ID   hTERT-CLCs
AC   CVCL_WK96
SY   hTERT-immortalized Caprine Luteal Cells
DR   Wikidata; Q94306008
RX   PubMed=22578611;
CC   Doubling time: 23.5 hours (PubMed=22578611).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, corpus luteum; UBERON=UBERON_0002512.
CC   Cell type: Luteal cell; CL=CL_0000175.
CC   Breed/subspecies: Saanen; VBO=VBO_0000827.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   2-3Y
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   hTERT-CSF
AC   CVCL_C7GX
SY   hTERT-immortalized Cow Skin Fibroblast
DR   Wikidata; Q117704511
RX   PubMed=35961484;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   hTERT-DM
AC   CVCL_UJ26
SY   hTERT-immortalized Dermal Melanocyte
DR   ATCC; CRL-4059
DR   Wikidata; Q94306010
CC   Doubling time: 46 hours (ATCC=CRL-4059).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
ST   Source(s): ATCC=CRL-4059
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   hTERT-DMECN
AC   CVCL_B7EJ
SY   hTERT Dermal Microvascular Endothelial Cell, Neonatal
DR   ATCC; CRL-4060
DR   Wikidata; Q112929777
CC   Doubling time: ~56 hours (ATCC=CRL-4060).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis, microvascular endothelium; UBERON=UBERON_0002067.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
ST   Source(s): ATCC=CRL-4060
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   hTERT-EEC-B37
AC   CVCL_X007
SY   hTERT-EEC
DR   BioSample; SAMN03151839
DR   cancercelllines; CVCL_X007
DR   Wikidata; Q54896620
RX   DOI=10.1530/jme.1.01550e;
RX   PubMed=15821114;
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a MCF-7 derivative (PubMed=22710073).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00462.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 23
//
ID   hTERT-GF
AC   CVCL_B7EK
SY   hTERT Gingival Fibroblast
DR   ATCC; CRL-4061
DR   Wikidata; Q112929778
CC   Doubling time: ~22-25 hours (ATCC=CRL-4061).
CC   Karyotypic information: 46,XX,del(16)(q10) [17]; 46,XX [1] (ATCC=CRL-4061).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
ST   Source(s): ATCC=CRL-4061
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   hTERT-GM01389
AC   CVCL_ZS66
SY   hTERT-XPE
DR   Wikidata; Q98126741
RX   PubMed=10655550;
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Asn349del (c.1045_1047del); ClinVar=VCV002137064; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Leu350Pro (c.1049T>C); ClinVar=VCV002137065; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F028 ! GM01389
SX   Female
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   hTERT-GTCs
AC   CVCL_S894
SY   hTERT-immortalized Goat Trophoblast Cells
DR   Wikidata; Q54896621
RX   PubMed=24112823;
CC   Doubling time: 26.79 hours (PubMed=24112823).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Breed/subspecies: Saanen; VBO=VBO_0000827.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   hTERT-HM
AC   CVCL_S888
SY   myo-hTERT; hTERT-immortalized Human Myometrial
DR   EFO; EFO_0005912
DR   ABM; T0198
DR   ENCODE; ENCBS560ENC
DR   Wikidata; Q54896622
RX   PubMed=12135889;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Myometr_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a premenopausal woman who underwent hysterectomy (PubMed=12135889).
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Myometrial cell; CL=CL_0002366.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 17
//
ID   hTERT-HME1
AC   CVCL_3383
SY   hTERT-HME-1; hTERTHME1; HME-1; HME1; ME16C
DR   CLO; CLO_0004291
DR   CLO; CLO_0037172
DR   EFO; EFO_0022410
DR   ATCC; CRL-4010
DR   BioSample; SAMN03471718
DR   BioSample; SAMN05292449
DR   ENCODE; ENCBS062ZDL
DR   ENCODE; ENCBS245QRF
DR   Evercyte; CHT-044-0236
DR   GEO; GSM756369
DR   GEO; GSM1008912
DR   GEO; GSM7701480
DR   GEO; GSM7701481
DR   LINCS_HMS; 50056
DR   LINCS_LDP; LCL-2083
DR   Wikidata; Q54896623
RX   PubMed=19582160;
RX   PubMed=24162158;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544520
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: 48-64 hours (Evercyte=CHT-044-0236); ~25 hours (PBCF).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-4010
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,20
ST   D19S433: 14,16.2
ST   D21S11: 28,31
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 7,12
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 12
ST   TH01: 7,8
ST   TPOX: 10,12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   hTERT-hOd-1
AC   CVCL_0E49
SY   hTERT-human Odontoblast-1
DR   Wikidata; Q54896624
RX   DOI=10.3321/j.issn:1000-2790.2003.10.005;
RX   PubMed=16430186;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Tooth bud, dental papilla; UBERON=UBERON_0001763.
CC   Cell type: Odontoblast; CL=CL_0000060.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   hTERT-HPNE
AC   CVCL_C466
SY   hTERT-Human Pancreatic Nestin-Expressing cells
DR   BTO; BTO_0006092
DR   EFO; EFO_0022415
DR   ATCC; CRL-4023
DR   BioSample; SAMN05292450
DR   Wikidata; Q54896625
RX   PubMed=12589817;
RX   PubMed=17332339;
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544518
CC   Doubling time: ~26 hours (PBCF).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): ATCC=CRL-4023
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D19S433: 12,16.2
ST   D21S11: 30
ST   D2S1338: 17,22
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   hTERT-HPNE E6/E7
AC   CVCL_C467
DR   ATCC; CRL-4036
DR   PRIDE; PXD030180
DR   Wikidata; Q54896626
RX   PubMed=17332339;
RX   PubMed=35454872;
CC   Doubling time: 17.96 hours (PubMed=35454872); ~30 hours (ATCC=CRL-4036).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): ATCC=CRL-4036
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D19S433: 12,16.2
ST   D21S11: 30
ST   D2S1338: 17,22
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C466 ! hTERT-HPNE
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   hTERT-HPNE E6/E7/K-RasG12D
AC   CVCL_C469
DR   ATCC; CRL-4038
DR   PRIDE; PXD030180
DR   Wikidata; Q54896627
RX   PubMed=17332339;
RX   PubMed=35454872;
CC   Doubling time: 19.03 hours (PubMed=35454872); ~29 hours (ATCC=CRL-4038).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Asp (c.35G>A)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): ATCC=CRL-4038
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C467 ! hTERT-HPNE E6/E7
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   hTERT-HPNE E6/E7/K-RasG12D/st
AC   CVCL_C470
DR   ATCC; CRL-4039
DR   Wikidata; Q54896628
RX   PubMed=17332339;
CC   Doubling time: ~31 hours (ATCC=CRL-4039).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Asp (c.35G>A)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): ATCC=CRL-4039
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D19S433: 12,16.2
ST   D21S11: 30
ST   D2S1338: 17,22
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C469 ! hTERT-HPNE E6/E7/K-RasG12D
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   hTERT-HPNE E6/E7/st
AC   CVCL_C468
DR   ATCC; CRL-4037
DR   Wikidata; Q54896629
RX   PubMed=17332339;
CC   Doubling time: ~29 hours (ATCC=CRL-4037).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): ATCC=CRL-4037
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D19S433: 12,16.2
ST   D21S11: 30
ST   D2S1338: 17,22
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C467 ! hTERT-HPNE E6/E7
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   hTERT-HSC
AC   CVCL_M102
SY   hTERT-immortalized Hepatic Stellate Cells
DR   BTO; BTO_0003517
DR   Wikidata; Q54896630
RX   PubMed=11896211;
RX   PubMed=17760834;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   hTERT-LSC
AC   CVCL_YM07
SY   hTERT-immortalized Lamb Sertoli Cells
DR   CCRID; 4201PAT-CCTCC01306
DR   Wikidata; Q94306159
RX   Patent=CN109837250B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018202.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   Lamb
CA   Telomerase immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   hTERT-NBSC
AC   CVCL_YM06
SY   hTERT-immortalized Newborn Bovine Sertoli Cells
DR   CCRID; 4201PAT-CCTCC01305
DR   Wikidata; Q94306163
RX   Patent=CN109735499B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018201.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   hTERT-NDM
AC   CVCL_B7EL
SY   hTERT Neonatal Dermal Melanocytes
DR   ATCC; CRL-4064
DR   Wikidata; Q112929779
CC   Population: Asian.
CC   Doubling time: ~123 hours (ATCC=CRL-4064).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
ST   Source(s): ATCC=CRL-4064
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,13
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   hTERT-PBEC
AC   CVCL_VN10
SY   hTERT-immortalized Porcine Bronchial Epithelial Cells
DR   CCRID; 4201PAT-CCTCC01043
DR   Wikidata; Q94306168
RX   Patent=CN107338225B;
RX   PubMed=30078190;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201749.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   7W
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 14
//
ID   hTERT-PLCs
AC   CVCL_JF74
SY   hTERT-immortalized Porcine Luteal Cells
DR   Wikidata; Q54896631
RX   PubMed=28407852;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, corpus luteum; UBERON=UBERON_0002512.
CC   Cell type: Luteal cell; CL=CL_0000175.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   hTERT-PNH
AC   CVCL_YL10
SY   hTERT-immortalized Porcine Neonatal Hepatocytes
DR   Wikidata; Q94306183
RX   PubMed=31845076;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the transformation method, the species of origin and the primary cell type name.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 9
//
ID   hTERT-POMEC
AC   CVCL_WN34
SY   hTERT-immortalized Porcine Oral Mucosal Epithelial Cells
DR   Wikidata; Q94306188
RX   PubMed=31165052;
CC   Virology: Susceptible to infection by porcine circovirus 2 (PCV2) (PubMed=31165052).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   hTERT-PTECs
AC   CVCL_A2EY
SY   hTERT-immortalized Porcine Tracheal Epithelial Cells
DR   Wikidata; Q105509495
RX   DOI=10.1016/S2095-3119(21)63644-4;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   7W
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   hTERT-PVEEC
AC   CVCL_C3NZ
SY   hTERT-immortalized Porcine Ventricular Endocardial Endothelial Cells
DR   Wikidata; Q116049515
RX   PubMed=17364895;
CC   Doubling time: 43 hours (Note=In 5% FBS), 53 hours (Note=In 10% FBS) (PubMed=17364895).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   hTERT-RBS
AC   CVCL_HE60
SY   hTERT-GM03913
DR   Wikidata; Q54896632
RX   PubMed=10655550;
CC   Population: Caucasian; French Canadian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4681; Roberts-SC phocomelia syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1K35 ! GM03913
SX   Male
AG   1Y8M
CA   Telomerase immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   hTERT-RPE1
AC   CVCL_4388
SY   hTERT RPE1; hTERT-RPE-1; hTERT RPE-1; hTERT-RPE; TERT-RPE1; RPE-1; RPE1; RPE1-hTERT; RPE1-hTert; RPE-hTERT
DR   BTO; BTO_0004790
DR   EFO; EFO_0022539
DR   4DN; 4DNSRHGVFSRJ
DR   ATCC; CRL-4000
DR   BioGRID_ORCS_Cell_line; 157
DR   BioSample; SAMN03472089
DR   Cell_Model_Passport; SIDM00409
DR   ChEMBL-Cells; CHEMBL3307755
DR   ChEMBL-Targets; CHEMBL615013
DR   GEO; GSM2371252
DR   GEO; GSM7701393
DR   GEO; GSM7701394
DR   PRIDE; PXD004915
DR   PubChem_Cell_line; CVCL_4388
DR   Wikidata; Q54896633
RX   PubMed=9454332;
RX   PubMed=11980883;
RX   PubMed=25177495;
RX   PubMed=25877200;
RX   PubMed=28350380;
RX   PubMed=30971826;
WW   Info; CIL; 35201; https://www.cellimagelibrary.org/images/35201
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: hTERT1-RPE1; Note=Occasionally.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
ST   Source(s): ATCC=CRL-4000; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 14,16.2
ST   D21S11: 31,32.2
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B365 ! RPE-340
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   hTERT-RPE1 FRT/TR
AC   CVCL_VP32
SY   RPE1 FRT/TR
DR   CancerTools; 153242
DR   Wikidata; Q94306221
DR   Ximbio; 153242
RX   PubMed=21926987;
CC   Characteristics: Transfected with the pcDNA5/FRT/TO construct.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 12
//
ID   hTERT-RPE1 mRuby-APC15
AC   CVCL_5F68
SY   hTERT-RPE1/APC15; hTERT-RPE1 APC15
DR   CancerTools; 151710
DR   Wikidata; Q54896634
DR   Ximbio; 151710
RX   PubMed=21926987;
CC   Characteristics: Tetracycline-inducible expression of APC15-IRES2-mRuby.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8MJ78; mRuby2 (Note=Bright red fluorescent protein derived from eqFP61).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24531; ANAPC15.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VP32 ! hTERT-RPE1 FRT/TR
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   hTERT-RPE1 PBRM1 KO 1
AC   CVCL_E3VG
SY   RPE1 PBRM1 KO1; hTERT-RPE1 knockout for PBRM1 clone 1; hTERT-RPE1 knockout for PBRM1 clone B3
DR   CancerTools; 161856
RX   PubMed=35902118;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-RPE1 PBRM1 KO 1 + PBRM1
AC   CVCL_E3W8
SY   RPE1 PBRM1 KO1 + PBRM1
DR   CancerTools; 161868
CC   Characteristics: PBRM1 is expressed upon doxycycline induction.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3VG ! hTERT-RPE1 PBRM1 KO 1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   hTERT-RPE1 PBRM1 KO 2
AC   CVCL_E3VH
SY   RPE1 PBRM1 KO2; hTERT-RPE1 knockout for PBRM1 clone 2; hTERT-RPE1 knockout for PBRM1 clone B16
DR   CancerTools; 161857
RX   PubMed=35902118;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-RPE1 PBRM1 KO 2 + PBRM1
AC   CVCL_E3W9
SY   RPE1 PBRM1 KO2 + PBRM1
DR   CancerTools; 161869
CC   Characteristics: PBRM1 is expressed upon doxycycline induction.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3VG ! hTERT-RPE1 PBRM1 KO 1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   hTERT-RPE1 PBRM1 KO 3
AC   CVCL_E3VI
SY   RPE1 PBRM1 KO3; hTERT-RPE1 knockout for PBRM1 clone 3; hTERT-RPE1 knockout for PBRM1 clone B38
DR   CancerTools; 161858
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-RPE1 SMARCA4 KO 1C9
AC   CVCL_E3WG
SY   RPE1 SMARCA4 1C9; hTERT-RPE1 knockout for SMARCA4 clone 1C9
DR   CancerTools; 161859
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-RPE1 SMARCA4 KO 1D2
AC   CVCL_E3WH
SY   RPE1 SMARCA4 1D2; hTERT-RPE1 knockout for SMARCA4 clone 1D2
DR   CancerTools; 161862
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-RPE1 SMARCA4 KO 1H1
AC   CVCL_E3WI
SY   RPE1 SMARCA4 1H1; hTERT-RPE1 knockout for SMARCA4 clone 1H1
DR   CancerTools; 161863
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-RPE1 SMARCA4 KO 2BS
AC   CVCL_E3WJ
SY   RPE1 SMARCA4 2BS; hTERT-RPE1 knockout for SMARCA4 clone 2BS
DR   CancerTools; 161861
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-RPE1 SMARCA4 KO TH12
AC   CVCL_E3WK
SY   RPE1 SMARCA4 TH12; hTERT-RPE1 knockout for SMARCA4 clone TH12
DR   CancerTools; 161860
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   hTERT-SSF
AC   CVCL_E7B0
RX   PubMed=39918276;
CC   Doubling time: 16.16 hours (Note=At 6th passage), 19.66 hours (Note=At 16th passage), 20.33 hours (Note=At 26th passage), 22.45 hours (Note=At 36th passage) (PubMed=39918276).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mongolian; VBO=VBO_0001514.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   hTERT-STCs
AC   CVCL_C1CM
SY   hTERT-immortalized Sheep Trophoblast Cells
DR   Wikidata; Q114311673
RX   PubMed=26998488;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Breed/subspecies: Mongolian; VBO=VBO_0001514.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   45-60FD
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   hTERT-VFF A10
AC   CVCL_A4GH
SY   hTERT-immortalized Vocal Fold Fibroblast clone A10
DR   Wikidata; Q105509498
RX   PubMed=19108681;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Larynx, vocal fold, lamina propria; UBERON=UBERON_0000030.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=19108681
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 10,21
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GF ! hTERT-VFF A2
OI   CVCL_A4GG ! hTERT-VFF A8
SX   Male
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   hTERT-VFF A2
AC   CVCL_A4GF
SY   hTERT-immortalized Vocal Fold Fibroblast clone A2
DR   Wikidata; Q105509502
RX   PubMed=19108681;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Larynx, vocal fold, lamina propria; UBERON=UBERON_0000030.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=19108681
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 10,21
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GG ! hTERT-VFF A8
OI   CVCL_A4GH ! hTERT-VFF A10
SX   Male
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   hTERT-VFF A8
AC   CVCL_A4GG
SY   hTERT-immortalized Vocal Fold Fibroblast clone A8
DR   Wikidata; Q105509504
RX   PubMed=19108681;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Larynx, vocal fold, lamina propria; UBERON=UBERON_0000030.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=19108681
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 10,21
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GF ! hTERT-VFF A2
OI   CVCL_A4GH ! hTERT-VFF A10
SX   Male
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   hTERT-VFF E10
AC   CVCL_A4GK
SY   hTERT-immortalized Vocal Fold Fibroblast clone E10
DR   Wikidata; Q105509507
RX   PubMed=19108681;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Larynx, vocal fold, lamina propria; UBERON=UBERON_0000030.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=19108681
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D21S11: 29,31.2
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 11,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GI ! hTERT-VFF E6
OI   CVCL_A4GJ ! hTERT-VFF E7
SX   Female
AG   59Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   hTERT-VFF E6
AC   CVCL_A4GI
SY   hTERT-immortalized Vocal Fold Fibroblast clone E6
DR   Wikidata; Q105509509
RX   PubMed=19108681;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Larynx, vocal fold, lamina propria; UBERON=UBERON_0000030.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=19108681
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D21S11: 29,31.2
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 11,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GJ ! hTERT-VFF E7
OI   CVCL_A4GK ! hTERT-VFF E10
SX   Female
AG   59Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   hTERT-VFF E7
AC   CVCL_A4GJ
SY   hTERT-immortalized Vocal Fold Fibroblast clone E7
DR   Wikidata; Q105509513
RX   PubMed=19108681;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Larynx, vocal fold, lamina propria; UBERON=UBERON_0000030.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=19108681
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D21S11: 29,31.2
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 11,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GI ! hTERT-VFF E6
OI   CVCL_A4GK ! hTERT-VFF E10
SX   Female
AG   59Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   hTERT-WRN1
AC   CVCL_ZS69
DR   Wikidata; Q98126742
RX   PubMed=10655550;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln748Ter (c.2242C>T) (2476C>T); ClinVar=VCV000835212; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X767 ! AG03141
SX   Female
AG   29Y11M
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   hTERT-WRN2
AC   CVCL_ZS70
DR   Wikidata; Q98126743
RX   PubMed=10655550;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U316 ! AG12795
SX   Male
AG   19Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   hTf/CHO-S #17
AC   CVCL_JG26
DR   JCRB; JCRB1616
DR   Wikidata; Q54896635
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   hTf/CHO-S #17/sf
AC   CVCL_JG27
SY   hTf/CHO-S #17/serum free
DR   JCRB; JCRB1629
DR   JCRB; JCRB1629.01
DR   Wikidata; Q54896636
CC   Group: Serum/protein free medium cell line.
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_JG26 ! hTf/CHO-S #17
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   hTf/CHO-S #29
AC   CVCL_JG28
DR   JCRB; JCRB1620
DR   Wikidata; Q54896637
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   hTf/CHO-S #29/sf
AC   CVCL_JF87
SY   hTf/CHO-S #29/serum free
DR   JCRB; JCRB1631
DR   JCRB; JCRB1631.01
DR   Wikidata; Q54896638
CC   Group: Serum/protein free medium cell line.
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_JG28 ! hTf/CHO-S #29
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   hTf18-10C
AC   CVCL_JG32
DR   JCRB; JCRB1603
DR   Wikidata; Q54896639
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   hTf18-10C/sf
AC   CVCL_4W45
SY   hTf18-10C/serum free
DR   JCRB; JCRB1611
DR   Wikidata; Q54896641
CC   Group: Serum/protein free medium cell line.
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JG32 ! hTf18-10C
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   hTf2-9F
AC   CVCL_4W46
DR   JCRB; JCRB1504
DR   Wikidata; Q54896642
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   hTf2-9F/sf
AC   CVCL_JF91
SY   hTf2-9F/serum free
DR   JCRB; JCRB1621
DR   Wikidata; Q54896643
CC   Group: Serum/protein free medium cell line.
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W46 ! hTf2-9F
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   hTf26-9B
AC   CVCL_4W47
DR   JCRB; JCRB1613
DR   Wikidata; Q54896644
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   hTf26-9B/sf
AC   CVCL_JF93
SY   hTf26-9B/serum free
DR   JCRB; JCRB1614
DR   Wikidata; Q54896645
CC   Group: Serum/protein free medium cell line.
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W47 ! hTf26-9B
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   hTf30-8H
AC   CVCL_4W48
DR   JCRB; JCRB1599
DR   Wikidata; Q54896646
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   hTf30-8H/sf
AC   CVCL_4W49
SY   hTf30-8H/serum free
DR   JCRB; JCRB1602
DR   Wikidata; Q54896648
CC   Group: Serum/protein free medium cell line.
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4W48 ! hTf30-8H
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   hTf9-11E
AC   CVCL_4W50
DR   JCRB; JCRB1617
DR   Wikidata; Q54896649
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02787; Human TF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   HTFU
AC   CVCL_C8V7
DR   Wikidata; Q123032638
RX   PubMed=6445228;
CC   Population: Caucasian.
CC   Doubling time: 2.8 days (PubMed=6445228).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   HTG-1
AC   CVCL_5G09
SY   HTG1
DR   Wikidata; Q54896650
RX   Patent=US11085020;
RX   PubMed=21900896;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   HTG-2
AC   CVCL_5G10
SY   HTG2
DR   Wikidata; Q54896651
RX   Patent=US11085020;
RX   PubMed=21900896;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   HTh104
AC   CVCL_A427
AS   CVCL_6477
SY   HTh 104; HTh-104; Uhth-104; U-Hth104; U-hth104
DR   cancercelllines; CVCL_A427
DR   Cosmic; 1068620
DR   Cosmic; 1239962
DR   Cosmic; 2050370
DR   Cosmic; 2054083
DR   Wikidata; Q54896653
RX   PubMed=17465858;
RX   PubMed=18713817;
RX   PubMed=21868764;
RX   PubMed=23833040;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Pro16fs (c.46delC); Zygosity=Unspecified (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro29Ala (c.85C>G); Zygosity=Unspecified (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=17465858; PubMed=18713817; PubMed=21868764; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 8,9,12 (PubMed=21868764)
ST   D16S539: 8,12 (PubMed=30737244)
ST   D18S51: 14,18 (PubMed=17465858)
ST   D18S51: 14,19 (PubMed=18713817; PubMed=30737244)
ST   D21S11: 27,31.2
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   HTh112
AC   CVCL_A428
SY   HTh 112; HTh-112; Uhth-112; U-hth112; U-Hth112
DR   Cosmic; 1068621
DR   Cosmic; 1239972
DR   Cosmic; 2050369
DR   Wikidata; Q54896654
RX   PubMed=17465858;
RX   PubMed=21868764;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=17465858; PubMed=21868764
ST   Amelogenin: X (PubMed=21868764)
ST   Amelogenin: X,Y (PubMed=17465858)
ST   CSF1PO: 12
ST   D13S317: 11 (PubMed=21868764)
ST   D13S317: 12 (PubMed=17465858)
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 31
ST   D3S1358: 15,18
ST   D5S818: 11 (PubMed=21868764)
ST   D5S818: 12 (PubMed=17465858)
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 21
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 19 (PubMed=21868764)
ST   vWA: 20 (PubMed=17465858)
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 15
//
ID   HTh7
AC   CVCL_6289
SY   Hth7; HTh 7; HTh-7; Uhth-7; U-hth7; U-Hth7
DR   BTO; BTO_0005146
DR   cancercelllines; CVCL_6289
DR   CCRID; 3101HUMSCSP547
DR   CLS; 305128
DR   Cosmic; 1068622
DR   Cosmic; 1239969
DR   Cosmic; 1280043
DR   Cosmic; 1507376
DR   Cosmic; 1533553
DR   Cosmic; 1536129
DR   Cosmic; 1889008
DR   Cosmic; 2050367
DR   Cosmic; 2054111
DR   Cosmic; 2319851
DR   Cosmic; 2791085
DR   IARC_TP53; 21623
DR   Wikidata; Q54896655
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=17465858;
RX   PubMed=18713817;
RX   PubMed=21868764;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=26680454;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln4118Ter (c.12352C>T); Zygosity=Unspecified (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: CLS; 305128; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=17465858; PubMed=18713817; PubMed=21868764; PubMed=25365311; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12 (PubMed=25365311)
ST   CSF1PO: 12,13 (PubMed=30737244)
ST   D13S317: 11,14
ST   D16S539: 9,13
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14 (PubMed=17465858; PubMed=21868764)
ST   vWA: 14,18 (PubMed=18713817; PubMed=25365311; PubMed=30737244)
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HTh74
AC   CVCL_6288
SY   Hth74; HTH74; HTh 74; HTh-74; Uhth-74; U-hth74
DR   BTO; BTO_0005147
DR   Cosmic; 889490
DR   Cosmic; 1068623
DR   Cosmic; 1084284
DR   Cosmic; 1132594
DR   Cosmic; 1152119
DR   Cosmic; 1239982
DR   Cosmic; 1280050
DR   Cosmic; 1507377
DR   Cosmic; 1533554
DR   Cosmic; 1536130
DR   Cosmic; 1889009
DR   Cosmic; 2036690
DR   Cosmic; 2050368
DR   Cosmic; 2054102
DR   Cosmic; 2319855
DR   Cosmic; 2791086
DR   IARC_TP53; 21622
DR   IARC_TP53; 25014
DR   Wikidata; Q54896656
RX   PubMed=1655394;
RX   PubMed=1726925;
RX   PubMed=14522906;
RX   PubMed=17465858;
RX   PubMed=17725429;
RX   PubMed=18713817;
RX   PubMed=19087340;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=30737244;
CC   Characteristics: Established from a tumor implanted into a nude mice (PubMed=1655394).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu732fs (c.2195_2202delTGCCCAAC); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Homozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: Hth47; Cosmic=889490.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=17465858; PubMed=18713817; PubMed=25365311; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,12 (PubMed=30737244)
ST   CSF1PO: 11,12 (PubMed=25365311)
ST   D13S317: 12,13
ST   D16S539: 9 (PubMed=25365311)
ST   D16S539: 11 (PubMed=30737244)
ST   D18S51: 14
ST   D21S11: 31,32 (PubMed=17465858; PubMed=30737244)
ST   D21S11: 32 (PubMed=18713817)
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,9 (PubMed=17465858; PubMed=18713817; PubMed=30737244)
ST   D7S820: 9 (PubMed=25365311)
ST   D8S1179: 13,15 (PubMed=17465858; PubMed=30737244)
ST   D8S1179: 13,15,16 (PubMed=18713817)
ST   FGA: 25
ST   TH01: 8 (PubMed=25365311)
ST   TH01: 8,9 (PubMed=30737244)
ST   TPOX: 8,10 (PubMed=25365311)
ST   TPOX: 11 (PubMed=30737244)
ST   vWA: 16,17 (PubMed=25365311)
ST   vWA: 17,19 (PubMed=17465858; PubMed=18713817; PubMed=30737244)
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   HTh74 clone 7
AC   CVCL_AT82
SY   HTh-74 clone7; U-Hth74-clone7
DR   Wikidata; Q54896657
RX   PubMed=21868764;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu732fs (c.2195_2202delTGCCCAAC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Homozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6288 ! HTh74
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   HTh83
AC   CVCL_0046
SY   Hth83; HTH83; HTh 83; HTh-83; hth83; U-Hth83
DR   BTO; BTO_0005148
DR   cancercelllines; CVCL_0046
DR   CCRID; 3101HUMSCSP548
DR   Cosmic; 1068624
DR   Cosmic; 1152120
DR   Cosmic; 1239973
DR   Cosmic; 2054092
DR   Wikidata; Q54896658
RX   PubMed=10918212;
RX   PubMed=16957166;
RX   PubMed=17465858;
RX   PubMed=21868764;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=30737244;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Gly456_Gly457insGly (c.1368_1369insGGA); Zygosity=Hemizygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000160364; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (PubMed=30737244).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=17465858; PubMed=21868764; PubMed=25365311; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D21S11: 28,32.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13,17
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,19 (PubMed=17465858; PubMed=25365311; PubMed=30737244)
ST   vWA: 19 (PubMed=21868764)
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   HTHCL-PI 47
AC   CVCL_9V81
DR   NCBI_Iran; C478
DR   Wikidata; Q54896659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V82 ! HHCL-PI 48
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HTk
AC   CVCL_9W65
DR   Wikidata; Q54896660
RX   PubMed=12429219;
RX   PubMed=16646156;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
DI   NCIt; C125660; Mouse trisomy 16
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-16FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   HTK
AC   CVCL_YM13
DR   CCRID; 4201PAT-CCTCC00293
DR   Wikidata; Q94306519
RX   Patent=CN101928346B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200928.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06870; Human KLK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 5
//
ID   HTK-
AC   CVCL_2522
DR   CLO; CLO_0004292
DR   CLDB; cl1766
DR   BioSample; SAMN10988064
DR   cancercelllines; CVCL_2522
DR   Cell_Model_Passport; SIDM00805
DR   DepMap; ACH-001094
DR   ECACC; 88022409
DR   GEO; GSM888214
DR   IARC_TP53; 30195
DR   PharmacoDB; HTK_634_2019
DR   Progenetix; CVCL_2522
DR   Wikidata; Q54896661
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (DepMap=ACH-001094).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (DepMap=ACH-001094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (DepMap=ACH-001094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=5.13%; South Asian=34.91%; European, North=0%; European, South=59.95% (PubMed=30894373).
CC   Caution: Could be identical to 143B (Cellosaurus=CVCL_2270).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ECACC=88022409
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HTLA145
AC   CVCL_W846
SY   HT145
DR   Wikidata; Q54896573
RX   PubMed=2253237;
RX   PubMed=3297309;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=2253237).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C834 ! HTLA161
OI   CVCL_W847 ! HTLA195
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
ID   HTLA161
AC   CVCL_C834
SY   HTLA-161; HT-161; HT161; Ht161
DR   Cosmic; 931915
DR   Cosmic; 1070845
DR   Cosmic; 2816209
DR   Wikidata; Q54896574
RX   PubMed=2233717;
RX   PubMed=2253237;
RX   PubMed=3297309;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=2233717; PubMed=2253237).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W846 ! HTLA145
OI   CVCL_W847 ! HTLA195
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   HTLA195
AC   CVCL_W847
SY   HT195
DR   Wikidata; Q54896577
RX   PubMed=2253237;
RX   PubMed=3297309;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=2253237).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W846 ! HTLA145
OI   CVCL_C834 ! HTLA161
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
ID   HTLA230
AC   CVCL_8881
SY   HTLA-230; HT230
DR   BioSample; SAMN04459501
DR   Wikidata; Q54896662
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=1568793;
RX   PubMed=8490657;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-563.html
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): BioSample=SAMN04459501
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   HTLC
AC   CVCL_R876
SY   Half-smooth Tongue-sole Liver Cell line
DR   Wikidata; Q54896663
RX   CelloPub=CLPUB00053;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   HTLC-11
AC   CVCL_B5W7
DR   Wikidata; Q111733458
RX   PubMed=11370807;
CC   Doubling time: 14-20 days (PubMed=11370807).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HTLC-15
AC   CVCL_B5W8
DR   Wikidata; Q111733459
RX   PubMed=11370807;
CC   Doubling time: 14-20 days (PubMed=11370807).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HTLC-17
AC   CVCL_B5W6
DR   Wikidata; Q111733460
RX   PubMed=11370807;
CC   Doubling time: 7-10 days (PubMed=11370807).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HTLC-19
AC   CVCL_B5W9
DR   Wikidata; Q111733461
RX   PubMed=11370807;
CC   Doubling time: 14-20 days (PubMed=11370807).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HTLC-7
AC   CVCL_B5WA
DR   Wikidata; Q111733462
RX   PubMed=11370807;
CC   Doubling time: 14-20 days (PubMed=11370807).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HTLS
AC   CVCL_W385
DR   Wikidata; Q54896664
RX   PubMed=16130899;
CC   Population: Japanese.
CC   Doubling time: 98 hours (Note=At 5th passage), 89 hours (Note=At 10th passage), 82 hours (Note=At 30th passage) (PubMed=16130899).
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   HTM-2
AC   CVCL_5G31
SY   HTM2; Human Trabecular Meshwork-2
DR   Wikidata; Q54896665
RX   PubMed=1607235;
RX   PubMed=8156826;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
DI   NCIt; C26782; Glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   HTM-4
AC   CVCL_5G32
SY   HTM4; Human Trabecular Meshwork-4
DR   Wikidata; Q54896666
RX   PubMed=1607235;
RX   PubMed=8156826;
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   HTMM
AC   CVCL_8720
DR   CLO; CLO_0050076
DR   BioSample; SAMN03472221
DR   RCB; RCB0700
DR   Wikidata; Q54896667
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB0700
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 10
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HTMMT
AC   CVCL_8721
DR   CLO; CLO_0050882
DR   BioSample; SAMN03472266
DR   cancercelllines; CVCL_8721
DR   DepMap; ACH-002046
DR   FANTOM5_SSTAR; 10689-109F5
DR   RCB; RCB0660
DR   Wikidata; Q54896669
RX   PubMed=9573483;
RX   PubMed=15859158;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 72 hours (Note=At 20th passage), 70 hours (Note=At 40th passage), 60 hours (Note=At 50th passage) (PubMed=15859158).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gly (c.388C>G); ClinVar=VCV000375958; Zygosity=Unspecified (DepMap=ACH-002046).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ter404Leuext*8 (c.1211G>T); Zygosity=Unspecified (DepMap=ACH-002046).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (DepMap=ACH-002046).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): RCB=RCB0660
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HTOA
AC   CVCL_5457
DR   CLO; CLO_0051442
DR   BioSample; SAMN03472217
DR   CGH-DB; 342-2
DR   CGH-DB; 9351-4
DR   Cosmic; 931366
DR   FANTOM5_SSTAR; 10693-109F9
DR   RCB; RCB0692
DR   Wikidata; Q54896670
RX   PubMed=2429643;
RX   PubMed=2435620;
RX   PubMed=2448191;
RX   PubMed=3593088;
RX   PubMed=9436037;
RX   PubMed=9573483;
RX   PubMed=10457904;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Doubling time: 74.5 hours (Note=At 5th passage), 68.2 hours (Note=At 25th passage), 72 hours (Note=At 50th passage) (PubMed=2435620); 70 hours (PubMed=3593088).
CC   Discontinued: RCB; RCB0692; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): RCB=RCB0692
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   hTobC(Y5432)
AC   CVCL_A6YL
SY   Y5432
DR   RCB; RCB4253
DR   Wikidata; Q107115392
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P50616; Human TOB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   hTobC(Y5443)
AC   CVCL_A6YM
SY   Y5443
DR   RCB; RCB4254
DR   Wikidata; Q107115393
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P50616; Human TOB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   hTobC(Y5444)
AC   CVCL_A6YN
SY   Y5444
DR   RCB; RCB4255
DR   Wikidata; Q107115394
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P50616; Human TOB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   hTobC(Y5452)
AC   CVCL_A6YP
SY   Y5452
DR   RCB; RCB4256
DR   Wikidata; Q107115395
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P50616; Human TOB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   HTOG
AC   CVCL_6656
DR   Wikidata; Q54896671
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=6323807;
RX   PubMed=9436037;
RX   PubMed=10457904;
RX   PubMed=15541573;
CC   Population: Japanese.
CC   Characteristics: Established from the granulosa cells of a granulosa-theca cell tumor.
CC   Doubling time: 46.2 hours (Note=At 5th passage), 28.4 hours (Note=At 20th passage), 23.8 hours (Note=At 40th passage) (PubMed=6323807); 25 hours (PubMed=10457904).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6657 ! HTOT
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   HTori-3
AC   CVCL_4W02
SY   HTori:3; HTori 3; HTori3
DR   Wikidata; Q54896672
RX   PubMed=2557880;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3F9 ! HTori-5
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   HTori-5
AC   CVCL_E3F9
RX   PubMed=2557880;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W02 ! HTori-3
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HTOT
AC   CVCL_6657
DR   Wikidata; Q54896673
RX   PubMed=6323807;
CC   Population: Japanese.
CC   Characteristics: Established from the theca cells of a granulosa-theca cell tumor.
CC   Doubling time: 78 hours (PubMed=6323807).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Theca cell; CL=CL_0000503.
DI   NCIt; C6929; Malignant ovarian thecoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6656 ! HTOG
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   HTOXAR3
AC   CVCL_8476
SY   HTOXAR-3
DR   BTO; BTO_0005026
DR   cancercelllines; CVCL_8476
DR   Wikidata; Q54896674
RX   PubMed=16773204;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   htr-20
AC   CVCL_U031
DR   ECACC; 10080903
DR   Wikidata; Q54896675
RX   PubMed=2158104;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P19438; Human TNFRSF1A/CD120a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   HTR-8
AC   CVCL_D728
SY   HTR8
DR   BTO; BTO_0006212
DR   Wikidata; Q54896676
RX   PubMed=7684692;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6-12FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   HTR-8/SVneo
AC   CVCL_7162
SY   HTR-8/SV neo; HTR-8/SV-neo; HTR8/SVneo; HTR8svn
DR   BTO; BTO_0004125
DR   EFO; EFO_0005709
DR   ATCC; CRL-3271
DR   CLS; 305221
DR   ENCODE; ENCBS331AAA
DR   GEO; GSM816644
DR   TOKU-E; 4099
DR   Ubigene; YC-C050
DR   Wikidata; Q54896677
RX   PubMed=7684692;
RX   PubMed=23325432;
RX   PubMed=28161053;
RX   PubMed=33096371;
RX   PubMed=33810901;
WW   Info; -; -; https://articles.sonidel.com/electroporation/nepa21-electroporator/cell-lines-htr-8-svneo-human-trophoblast-cells/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/HTR8svn_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Characteristics: Useful to study trophoblast and placental biology (ATCC=CRL-3271).
CC   Characteristics: Contains both epithelial and mesenchymal-like cell populations (PubMed=28161053).
CC   Karyotypic information: Near triploid karyotype (PubMed=33096371).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
ST   Source(s): ATCC=CRL-3271; PubMed=33810901
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 16
ST   D12S391: 19
ST   D13S317: 9,12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 14,15
ST   D1S1656: 16,17.3
ST   D21S11: 29,30
ST   D22S1045: 15
ST   D2S1338: 23,24
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 7,13
ST   SE33: 25.2,27.2
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 13,18 (ATCC=CRL-3271)
ST   vWA: 18 (PubMed=33810901)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D728 ! HTR-8
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   htr-9c
AC   CVCL_U032
DR   ECACC; 10080902
DR   Wikidata; Q54896678
RX   PubMed=2158104;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19438; Human TNFRSF1A/CD120a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   HTR.B7-1
AC   CVCL_C0DG
SY   P1.HTR.B7-1
DR   Wikidata; Q112929780
RX   PubMed=8609411;
RX   PubMed=9310829;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4265 ! P1.HTR
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   HTR.B7-1/C
AC   CVCL_C0DH
DR   Wikidata; Q112929781
RX   PubMed=8609411;
RX   PubMed=9310829;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DG ! HTR.B7-1
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HTR.B7-1/B7-2
AC   CVCL_C0DI
DR   Wikidata; Q112929782
RX   PubMed=8609411;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101773; Cd86.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DG ! HTR.B7-1
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HTR.B7-1/IL-12
AC   CVCL_C0DJ
DR   Wikidata; Q112929783
RX   PubMed=9310829;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96539; Il12a.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96540; Il12b.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DG ! HTR.B7-1
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HTR.B7-2
AC   CVCL_C0DK
DR   Wikidata; Q112929784
RX   PubMed=8609411;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101773; Cd86.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4265 ! P1.HTR
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   HTR.C
AC   CVCL_C0DL
DR   Wikidata; Q112929785
RX   PubMed=8609411;
RX   PubMed=9310829;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4265 ! P1.HTR
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   HTR.C/B7-2
AC   CVCL_C0DM
DR   Wikidata; Q112929787
RX   PubMed=8609411;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101773; Cd86.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DL ! HTR.C
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HTR.C/C
AC   CVCL_C0DN
DR   Wikidata; Q112929788
RX   PubMed=8609411;
RX   PubMed=9310829;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DL ! HTR.C
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HTR.C/IL-12
AC   CVCL_C0DP
DR   Wikidata; Q112929789
RX   PubMed=9310829;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96539; Il12a.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96540; Il12b.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DL ! HTR.C
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   HTR8/SVneo/EGFP
AC   CVCL_F0D6
RX   PubMed=21787741;
RX   PubMed=24424471;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Omics: Glycomics; N-glycan profiling; Lectin array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HTR8/SVneo/HRASV12
AC   CVCL_F0D7
RX   PubMed=21787741;
CC   Characteristics: Transduced with a pMX-HRASV12-IRES-EGFP construct (PubMed=21787741).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HTRL
AC   CVCL_C8AG
DR   Wikidata; Q123032639
RX   PubMed=30291474;
CC   Transformant: NCBI_TaxID; 2341050; Macaca arctoides gammaherpesvirus 1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   HTS-1
AC   CVCL_WK97
DR   Wikidata; Q94306722
RX   PubMed=12361681;
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
CC   Breed/subspecies: Shiba; VBO=VBO_0017514.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   hTSC29
AC   CVCL_XE57
DR   CCRID; 4201PAT-CCTCC00304
DR   Wikidata; Q94306726
RX   Patent=CN101775371B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200952.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5T0L3; Human SPATA46.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   hTSH mAb 1
AC   CVCL_F0I4
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 10
AC   CVCL_F0ID
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human TSH complex (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 11
AC   CVCL_F0IE
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 12
AC   CVCL_F0IF
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 13
AC   CVCL_F0IG
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 14
AC   CVCL_F0IH
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 15
AC   CVCL_F0II
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 16
AC   CVCL_F0IJ
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 17
AC   CVCL_F0IK
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 18
AC   CVCL_F0IL
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 19
AC   CVCL_F0IM
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 2
AC   CVCL_F0I5
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 20
AC   CVCL_F0IN
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 21
AC   CVCL_F0IP
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 22
AC   CVCL_F0IQ
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 23
AC   CVCL_F0IR
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 24
AC   CVCL_F0IS
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 25
AC   CVCL_F0IT
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 26
AC   CVCL_F0IU
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 27
AC   CVCL_F0IV
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 28
AC   CVCL_F0IW
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 3
AC   CVCL_F0I6
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 4
AC   CVCL_F0I7
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 5
AC   CVCL_F0I8
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human TSH complex (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 6
AC   CVCL_F0I9
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human TSH complex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 7
AC   CVCL_F0IA
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human TSH complex (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 8
AC   CVCL_F0IB
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human TSH complex (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   hTSH mAb 9
AC   CVCL_F0IC
RX   PubMed=2441979;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human TSH complex (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HTST
AC   CVCL_8722
DR   CLO; CLO_0050139
DR   BioSample; SAMN03472191
DR   FANTOM5_SSTAR; 10695-109G2
DR   RCB; RCB0967
DR   Wikidata; Q54896679
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, coccyx; UBERON=UBERON_0001350.
ST   Source(s): RCB=RCB0967
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 7,12
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C99055; Sacrococcygeal teratoma
DI   ORDO; Orphanet_494421; Sacrococcygeal teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   HtTA-1
AC   CVCL_2523
SY   HtTA1
DR   CLO; CLO_0004293
DR   CLDB; cl1767
DR   ECACC; 95091410
DR   Wikidata; Q54896680
RX   PubMed=1319065;
CC   Population: African American.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   HTUD1
AC   CVCL_L695
DR   RCB; RCB0713
DR   Wikidata; Q54896681
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=324344; ! Hynobius tokyoensis (Tokyo salamander)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   HTUS
AC   CVCL_VS98
DR   Wikidata; Q94306762
RX   PubMed=2429643;
CC   Population: Japanese.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   HTZ-146
AC   CVCL_C3Q4
DR   Wikidata; Q116049516
RX   PubMed=8232809;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HTZ-17
AC   CVCL_C3Q5
DR   Wikidata; Q116049517
RX   PubMed=1292782;
RX   PubMed=2208165;
RX   PubMed=8232809;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   HTZ-19 dM
AC   CVCL_IS45
SY   HTZ 19-dM; HTZ-19; HTZ 19
DR   Wikidata; Q54896682
RX   PubMed=1292782;
RX   PubMed=2208165;
RX   PubMed=2766302;
RX   PubMed=8232809;
CC   Doubling time: 88.3 hours (PubMed=2208165).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   HTZ17XP
AC   CVCL_3721
SY   HTZ17BE
DR   CLO; CLO_0004294
DR   ATCC; CRL-1361
DR   Wikidata; Q54896683
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M998 ! GM02473
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hu 126
AC   CVCL_U699
DR   ATCC; CRL-1246
DR   Wikidata; Q54896684
CC   Discontinued: ATCC; CRL-1246; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   HU 214
AC   CVCL_W443
SY   Hu 214; HU-214
DR   Wikidata; Q54896685
RX   PubMed=3368969;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   HU-01
AC   CVCL_HE65
DR   Wikidata; Q54896686
RX   Patent=US5128259;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10249.
CC   Characteristics: CSF2 dependent (Patent=US5128259).
DI   NCIt; C3170; Acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Hu-04
AC   CVCL_WG22
DR   IBRC; C10450
DR   Wikidata; Q94306819
CC   Population: Iranian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C61259; Mucopolysaccharidosis
DI   ORDO; Orphanet_79213; Mucopolysaccharidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WB00 ! MPS-1
SX   Female
AG   1Y8M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HU-3
AC   CVCL_A619
DR   Cosmic; 787436
DR   Cosmic; 975255
DR   Cosmic; 1012070
DR   Cosmic; 1281318
DR   Cosmic; 2306210
DR   Wikidata; Q54896687
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096695;
RX   PubMed=9406997;
RX   PubMed=16408098;
CC   Characteristics: CSF2 dependent (PubMed=9406997).
CC   Doubling time: 60 +- 11 hours (PubMed=9096695).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   HU-3 clone D3
AC   CVCL_E9WZ
SY   D3
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone D7
AC   CVCL_E9X0
SY   D7
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone E11
AC   CVCL_E9X1
SY   E11
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone E6
AC   CVCL_E9X2
SY   E6
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone F5
AC   CVCL_E9X3
SY   F5
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone G3
AC   CVCL_E9X4
SY   G3
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone G5
AC   CVCL_E9X5
SY   G5
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone H7
AC   CVCL_E9X6
SY   H7
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3 clone H9
AC   CVCL_E9X7
SY   H9
RX   PubMed=9406997;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HU-3/TPO
AC   CVCL_RM04
DR   Wikidata; Q54896688
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096695;
CC   Characteristics: TPO dependent.
CC   Doubling time: 65 +- 15 hours (PubMed=9096695).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A619 ! HU-3
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   HU-E
AC   CVCL_0C14
DR   Wikidata; Q54896689
RX   PubMed=7736387;
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   HU/Ch-22
AC   CVCL_C5H1
DR   Wikidata; Q116049518
RX   PubMed=2045661;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgG+IgM.
CC   Monoclonal antibody target: UniProtKB; Q10583; Megathura crenulata hemocyanin 1 (KLH1).
CC   Monoclonal antibody target: UniProtKB; Q10584; Megathura crenulata hemocyanin 2 (KLH2).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H0 ! R27H4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HU/Ch-22-2
AC   CVCL_C5H2
DR   Wikidata; Q116049519
RX   PubMed=2045661;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgG+IgM.
CC   Monoclonal antibody target: UniProtKB; Q10583; Megathura crenulata hemocyanin 1 (KLH1).
CC   Monoclonal antibody target: UniProtKB; Q10584; Megathura crenulata hemocyanin 2 (KLH2).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H1 ! HU/Ch-22
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HU/Ch-22-6
AC   CVCL_C5H3
DR   Wikidata; Q116049520
RX   PubMed=2045661;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgG+IgM.
CC   Monoclonal antibody target: UniProtKB; Q10583; Megathura crenulata hemocyanin 1 (KLH1).
CC   Monoclonal antibody target: UniProtKB; Q10584; Megathura crenulata hemocyanin 2 (KLH2).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H1 ! HU/Ch-22
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Hu02
AC   CVCL_WG43
DR   IBRC; C10309
DR   Wikidata; Q94306857
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   Hu02-KP
AC   CVCL_WG44
DR   IBRC; C10721
DR   Wikidata; Q94306861
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WG43 ! Hu02
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   Hu02-OhT
AC   CVCL_WG45
DR   IBRC; C10720
DR   Wikidata; Q94306865
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WG43 ! Hu02
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   Hu02-OhT/KP
AC   CVCL_WG46
DR   IBRC; C10722
DR   Wikidata; Q94306870
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WG43 ! Hu02
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   Hu104
AC   CVCL_A3BG
SY   HU104; Hu 104
DR   Wikidata; Q105509516
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2908920;
RX   PubMed=22358439;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Hu112
AC   CVCL_A3BH
SY   HU112; Hu 112
DR   Wikidata; Q105509519
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2908920;
RX   PubMed=22358439;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Hu1125
AC   CVCL_8449
SY   Hu 1125; HU 1125
DR   Wikidata; Q54896690
RX   PubMed=7262169;
RX   PubMed=7905254;
CC   HLA typing: A*11; B*27 (PubMed=7905254).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hu1694
AC   CVCL_8450
SY   Hu 1694
DR   Wikidata; Q54896691
RX   PubMed=7905254;
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   Hu1703He
AC   CVCL_8236
SY   Hu 1703He; HU 1703He; HU 1703 He; Hu 1703 He
DR   Wikidata; Q54896692
RX   PubMed=3800330;
RX   PubMed=8105864;
RX   PubMed=8900435;
RX   PubMed=11848473;
CC   Doubling time: 38 hours (PubMed=11848473).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Hu1703He/lacZ
AC   CVCL_C0RM
DR   Wikidata; Q112929791
RX   PubMed=11848473;
RX   PubMed=16158950;
CC   Doubling time: 25 hours (PubMed=11848473).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=16158950).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8236 ! Hu1703He
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   Hu1734
AC   CVCL_8451
SY   Hu 1734; HU 1734
DR   BioSample; SAMN03151654
DR   cancercelllines; CVCL_8451
DR   Wikidata; Q54896693
RX   PubMed=7905254;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HCV-29 derivative (PubMed=7905254; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00128.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Val (c.1406G>T); ClinVar=VCV000044803; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Gln55Ter (c.163C>T); ClinVar=VCV000048808; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8228 ! HCV-29
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Hu1752
AC   CVCL_8452
SY   Hu 1752; HU 1752
DR   Wikidata; Q54896696
RX   PubMed=7905254;
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hu1922
AC   CVCL_8237
SY   Hu 1922; HU 1922
DR   Wikidata; Q54896697
RX   PubMed=3800330;
RX   PubMed=8105864;
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Hu195
AC   CVCL_A3BI
SY   HU195; Hu 195
DR   Wikidata; Q105509523
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2908920;
RX   PubMed=22358439;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Hu197
AC   CVCL_A3BJ
SY   HU197; Hu 197
DR   Wikidata; Q105509527
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2908920;
RX   PubMed=22358439;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   HU3R15
AC   CVCL_C5GM
DR   Wikidata; Q116049521
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 22.32 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R22
AC   CVCL_C5GN
DR   Wikidata; Q116049522
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 18.01 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R23
AC   CVCL_C5GP
DR   Wikidata; Q116049523
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 28.01 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R24
AC   CVCL_C5GQ
DR   Wikidata; Q116049524
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 21.78 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R25
AC   CVCL_C5GR
DR   Wikidata; Q116049525
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 18.41 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R26
AC   CVCL_C5GS
DR   Wikidata; Q116049527
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 21.06 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R27
AC   CVCL_C5GT
DR   Wikidata; Q116049528
RX   PubMed=2045661;
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 18.04 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R27N
AC   CVCL_C5GW
DR   Wikidata; Q116049531
RX   PubMed=2045661;
CC   Group: Bird cell line.
CC   Characteristics: Fusion between HU3R27 and spleen cells from a chicken immunized with Newcastle disease virus (NDV) (PubMed=2045661).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GT ! HU3R27
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   HU3R28
AC   CVCL_C5GU
DR   Wikidata; Q116049533
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 18.67 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   HU3R29
AC   CVCL_C5GV
DR   Wikidata; Q116049534
RX   PubMed=2793228;
CC   Group: Bird cell line.
CC   Doubling time: 19.35 hours (PubMed=2793228).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GL ! RECC-HU3
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   Hu44
AC   CVCL_DD90
DR   Wikidata; Q54896698
RX   Patent=US4695538;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8576.
CC   Monoclonal antibody isotype: IgA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8119 ! HMy.2 B
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   Hu456
AC   CVCL_8238
SY   Hu 456; HU 456; HU456
DR   BioSample; SAMN03151943
DR   cancercelllines; CVCL_8238
DR   Cosmic; 925829
DR   Cosmic; 2037947
DR   GEO; GSM136253
DR   GEO; GSM1574544
DR   Wikidata; Q54896699
RX   PubMed=3708594;
RX   PubMed=6546195;
RX   PubMed=6823318;
RX   PubMed=6826254;
RX   PubMed=7262169;
RX   PubMed=8105864;
RX   PubMed=8900435;
RX   PubMed=11416159;
RX   PubMed=20143388;
RX   PubMed=24018021;
RX   PubMed=25997541;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00129.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 21 hours (PubMed=3708594).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16,18
ST   D21S11: 29
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 6
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   Hu5
AC   CVCL_B0BH
DR   Wikidata; Q108820507
RX   PubMed=12050145;
RX   PubMed=16919240;
CC   Caution: Indicated as originating from a 44 year old female donor PubMed=12050145 and from a 42 year old in PubMed=16919240.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   Hu5/E18
AC   CVCL_U895
SY   E18
DR   BioSample; SAMN03471917
DR   FANTOM5_SSTAR; 10568-108B1
DR   RCB; RCB2366
DR   Wikidata; Q54896700
RX   PubMed=16919240;
CC   Doubling time: 34.7 +- 4.1 hours (PubMed=16919240).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: RCB; RCB2366; probable.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
ST   Source(s): RCB=RCB2366
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0BH ! Hu5
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   Hu549
AC   CVCL_8239
SY   Hu 549; HU 549
DR   BioSample; SAMN03151944
DR   cancercelllines; CVCL_8239
DR   Wikidata; Q54896701
RX   PubMed=7262169;
RX   PubMed=8105864;
RX   PubMed=8900435;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00130.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Hu564
AC   CVCL_8453
SY   Hu 564
DR   Wikidata; Q54896702
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Hu609
AC   CVCL_8240
SY   HU609; Hu 609; HU 609
DR   BioSample; SAMN03151802
DR   cancercelllines; CVCL_8240
DR   Lonza; 245
DR   Wikidata; Q54896703
RX   PubMed=3708594;
RX   PubMed=3800330;
RX   PubMed=6546195;
RX   PubMed=7262169;
RX   PubMed=7905254;
RX   PubMed=8105864;
RX   PubMed=11416159;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a J82 derivative (PubMed=7905254; PubMed=20143388). Originally thought to originate from the histologically normal ureter of a female patient with clear cell renal carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00131.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser770Pro (c.2308T>C); ClinVar=VCV000140988; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro124Leu (c.371C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs*1 (c.635_1212del578); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2107-2A>G; ClinVar=VCV000013077; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys320Asn (c.960G>C); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 10,12
ST   D21S11: 30,31
ST   D8S1179: 8,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0359 ! J82
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   Hu609T
AC   CVCL_8241
SY   Hu 609T; HU 609 T
DR   cancercelllines; CVCL_8241
DR   Wikidata; Q54896704
RX   PubMed=6546195;
RX   PubMed=7262169;
RX   PubMed=8105864;
RX   PubMed=8900435;
CC   Problematic cell line: Contaminated. Parent cell line (Hu609) has been shown to be a J82 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser770Pro (c.2308T>C); ClinVar=VCV000140988; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro124Leu (c.371C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs*1 (c.635_1212del578); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2107-2A>G; ClinVar=VCV000013077; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys320Asn (c.960G>C); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8240 ! Hu609
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   Hu609Tmv
AC   CVCL_8242
DR   BioSample; SAMN03151945
DR   cancercelllines; CVCL_8242
DR   Wikidata; Q54896705
RX   PubMed=8105864;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=8105864; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00132.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Hu70
AC   CVCL_A3BF
SY   HU70; Hu 70
DR   Wikidata; Q105509530
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2908920;
RX   PubMed=22358439;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Hu961a
AC   CVCL_8243
SY   Hu 961a; Hu 961T; Hu961t; HU961T
DR   BioSample; SAMN03151946
DR   cancercelllines; CVCL_8243
DR   Cosmic; 925830
DR   Wikidata; Q54896706
RX   PubMed=3708594;
RX   PubMed=6823318;
RX   PubMed=8105864;
RX   PubMed=11416159;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=8105864; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00133.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 21 hours (PubMed=3708594).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16,18
ST   D21S11: 29
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 6
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Hu961b
AC   CVCL_8244
SY   Hu 961b; HU 961b
DR   Wikidata; Q54896707
RX   PubMed=3800330;
RX   PubMed=7905254;
CC   HLA typing: A*02; B*18 (PubMed=7905254).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   HUAEC:SSAO clone 8
AC   CVCL_F1YD
RX   PubMed=23546801;
CC   Characteristics: Transfected with a pcDNA.3.1/myc-His:SSAO construct (PubMed=23546801).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:550; AOC3 (Note=With a N-terminal mycHis6 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Umbilical artery, endothelium; UBERON=UBERON_0007778.
CC   Cell type: Endothelial cell of umbilical artery; CL=CL_2000052.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HUB-41
AC   CVCL_M875
SY   HUB 41; HUB41
DR   Wikidata; Q54896708
RX   PubMed=2607719;
RX   PubMed=7474403;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Pro419His (c.1256C>A); Zygosity=Unspecified (PubMed=7474403).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   HubCCA-1
AC   CVCL_C1L8
DR   Wikidata; Q114311674
RX   PubMed=12587840;
RX   PubMed=16475706;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   HUBi001-A
AC   CVCL_LE85
SY   HUB001Ai
DR   BioSamples; SAMEA2629457
DR   EBiSC; HUBi001-A
DR   ECACC; 66540042
DR   hPSCreg; HUBi001-A
DR   Wikidata; Q54896709
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: ECACC; 66540042; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   HUBi001-A-1
AC   CVCL_WP91
DR   BioSamples; SAMEA3473825
DR   EBiSC; HUBi001-A-1
DR   ECACC; 66540496
DR   hPSCreg; HUBi001-A-1
DR   Wikidata; Q94307085
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi001-A-1; true.
CC   Discontinued: ECACC; 66540496; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LE85 ! HUBi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 7
//
ID   HUBi001-A-2
AC   CVCL_WP92
DR   BioSamples; SAMEA3473910
DR   EBiSC; HUBi001-A-2
DR   ECACC; 66540497
DR   hPSCreg; HUBi001-A-2
DR   Wikidata; Q94307092
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi001-A-2; true.
CC   Discontinued: ECACC; 66540497; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LE85 ! HUBi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 7
//
ID   HUBi002-A
AC   CVCL_VD65
DR   BioSamples; SAMEA2785992
DR   EBiSC; HUBi002-A
DR   ECACC; 66540124
DR   hPSCreg; HUBi002-A
DR   Wikidata; Q54896710
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi002-A; true.
CC   Discontinued: ECACC; 66540124; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   HUBi003-A
AC   CVCL_VD66
DR   BioSamples; SAMEA2825592
DR   EBiSC; HUBi003-A
DR   ECACC; 66540053
DR   hPSCreg; HUBi003-A
DR   Wikidata; Q54896711
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi003-A; true.
CC   Discontinued: ECACC; 66540053; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   HUBi004-A
AC   CVCL_VD67
DR   BioSamples; SAMEA2825636
DR   EBiSC; HUBi004-A
DR   ECACC; 66540054
DR   hPSCreg; HUBi004-A
DR   Wikidata; Q54896712
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi004-A; true.
CC   Discontinued: ECACC; 66540054; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   HUBi005-A
AC   CVCL_VD68
DR   BioSamples; SAMEA2825691
DR   EBiSC; HUBi005-A
DR   ECACC; 66540055
DR   hPSCreg; HUBi005-A
DR   Wikidata; Q54896713
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi005-A; true.
CC   Discontinued: ECACC; 66540055; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   HUBi006-A
AC   CVCL_VD69
DR   BioSamples; SAMEA2825733
DR   hPSCreg; HUBi006-A
DR   Wikidata; Q54896714
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   HUBi007-A
AC   CVCL_VD70
DR   BioSamples; SAMEA2786052
DR   EBiSC; HUBi007-A
DR   ECACC; 66540026
DR   hPSCreg; HUBi007-A
DR   Wikidata; Q54896715
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi007-A; true.
CC   Discontinued: ECACC; 66540026; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   HUBi008-A
AC   CVCL_VD71
DR   BioSamples; SAMEA2786077
DR   EBiSC; HUBi008-A
DR   ECACC; 66540047
DR   hPSCreg; HUBi008-A
DR   Wikidata; Q54896716
CC   From: The Hubrecht Institute; Utrecht; Netherlands.
CC   Discontinued: EBiSC; HUBi008-A; true.
CC   Discontinued: ECACC; 66540047; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   HUBT-n
AC   CVCL_S812
SY   HUBTn
DR   Wikidata; Q54896717
RX   PubMed=16130901;
CC   Population: Japanese.
CC   Characteristics: Established from a nude mice xenograft.
CC   Doubling time: 32 hours (Note=At 20th passage), 30 hours (Note=At 50th passage) (PubMed=16130901).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   HUBUi001-A
AC   CVCL_A2EJ
DR   hPSCreg; HUBUi001-A
DR   Wikidata; Q105509533
RX   PubMed=32942234;
CC   From: Hubei University; Hubei; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Gly35Val (c.104G>T); Zygosity=Heterozygous (PubMed=32942234).
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Arg1873Cys (c.5617C>T); ClinVar=VCV000222581; Zygosity=Heterozygous (PubMed=32942234).
CC   Caution: Indicated to be of female origin in PubMed=32942234, but karyotype from the same paper shows X,Y.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HUBUi002-A
AC   CVCL_A2EK
DR   hPSCreg; HUBUi002-A
DR   Wikidata; Q105509535
RX   PubMed=32942234;
CC   From: Hubei University; Hubei; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Gly35Val (c.104G>T); Zygosity=Heterozygous (PubMed=32942234).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HUBUi003-A
AC   CVCL_A2EL
DR   hPSCreg; HUBUi003-A
DR   Wikidata; Q105509538
RX   PubMed=32942234;
CC   From: Hubei University; Hubei; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Arg1873Cys (c.5617C>T); ClinVar=VCV000222581; Zygosity=Heterozygous (PubMed=32942234).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   HUC-5
AC   CVCL_B5ZH
SY   Human Umbilical Cord-5
DR   Wikidata; Q111733463
RX   PubMed=20973836;
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HUC-F
AC   CVCL_4684
SY   Human Umbilical Cord-Fibroblast
DR   CLO; CLO_0050430
DR   BioSample; SAMN03472336
DR   RCB; RCB0153
DR   Wikidata; Q54896718
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 32 PDL (PubMed=17395773).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB0153
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 11,13
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HUC-F2
AC   CVCL_4682
SY   Human Umbilical Cord-Fibroblast 2
DR   CLO; CLO_0050429
DR   BioSample; SAMN03472309
DR   RCB; RCB0436
DR   Wikidata; Q54896719
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 36 PDL (PubMed=17395773).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB0436
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HUC-Fm
AC   CVCL_2524
SY   Human Umbilical Cord-Fibroblast male
DR   CLO; CLO_0004295
DR   CLO; CLO_0050431
DR   CLDB; cl1768
DR   BioSample; SAMN03472344
DR   ECACC; 87100801
DR   RCB; RCB0197
DR   Wikidata; Q54896720
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 34 PDL (PubMed=17395773).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ECACC=87100801; RCB=RCB0197
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 11,14
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HUC-Fm2
AC   CVCL_4683
SY   Human Umbilical Cord-Fibroblast male 2
DR   CLO; CLO_0050432
DR   BioSample; SAMN03472310
DR   RCB; RCB0437
DR   Wikidata; Q54896721
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 16 PDL (PubMed=17395773).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB0437
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HUC2-13
AC   CVCL_C5HE
DR   Wikidata; Q116049535
RX   PubMed=10219590;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgY.
CC   Monoclonal antibody target: UniProtKB; P04156; Human PRNP (Note=Recognizs AA 25-29).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HUCB-NSC
AC   CVCL_EG09
SY   HUCB-NSCs; Human Umbilical Cord Blood-Neural Stem Cells
DR   Wikidata; Q54896722
RX   PubMed=16846376;
RX   PubMed=16909032;
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Somatic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   HuCC-A1
AC   CVCL_M255
SY   HuCCA-1; HuCCA1
DR   ChEMBL-Cells; CHEMBL4513113
DR   ChEMBL-Targets; CHEMBL4513129
DR   JCRB; JCRB1657
DR   PubChem_Cell_line; CVCL_M255
DR   Wikidata; Q54896723
RX   CelloPub=CLPUB00275;
RX   PubMed=1666951;
RX   PubMed=9031402;
RX   PubMed=12587840;
RX   PubMed=15048994;
RX   PubMed=16475706;
RX   PubMed=20069059;
RX   PubMed=31077409;
RX   PubMed=35640676;
WW   Info; -; -; https://www2.cri.or.th/lab/biochemistry/res_act
CC   Population: Southeast Asian; Thai.
CC   Doubling time: ~55 hours (PubMed=1666951).
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB=JCRB1657
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   HuCC-A1Nu
AC   CVCL_HF36
SY   HuCCA-1Nu
DR   Wikidata; Q54896724
RX   PubMed=9031402;
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M255 ! HuCC-A1
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   HuCC-T1
AC   CVCL_0324
SY   HuCCT-1; HUCCT-1; HUCC-T1; HUCCT1; HuCCT1; HuccT1
DR   BTO; BTO_0003911
DR   CLO; CLO_0050009
DR   MCCL; MCC:0000217
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821687
DR   BioSample; SAMN03470954
DR   BioSample; SAMN03471627
DR   BioSample; SAMN10987837
DR   cancercelllines; CVCL_0324
DR   CCRID; 5301HUM-KCB21005YJ
DR   Cell_Model_Passport; SIDM00587
DR   ChEMBL-Cells; CHEMBL3307409
DR   ChEMBL-Targets; CHEMBL614581
DR   CLS; 300469
DR   Cosmic; 907069
DR   Cosmic; 1122350
DR   Cosmic; 1571782
DR   Cosmic; 2009540
DR   Cosmic; 2629288
DR   Cosmic; 2674063
DR   Cosmic-CLP; 907069
DR   DepMap; ACH-000976
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10432-106D9
DR   GDSC; 907069
DR   GEO; GSM827224
DR   GEO; GSM887144
DR   GEO; GSM888216
DR   GEO; GSM1669917
DR   IARC_TP53; 21387
DR   JCRB; JCRB0425
DR   KCB; KCB 202105YJ
DR   LiGeA; CCLE_833
DR   LINCS_LDP; LCL-1788
DR   PharmacoDB; HuCCT1_635_2019
DR   PRIDE; PXD030304
DR   PRIDE; PXD033685
DR   Progenetix; CVCL_0324
DR   PubChem_Cell_line; CVCL_0324
DR   RCB; RCB1960
DR   TKG; TKG 0389
DR   Wikidata; Q54896725
RX   CelloPub=CLPUB00275;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=2544546;
RX   PubMed=9290701;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21451941;
RX   PubMed=21687941;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26956050;
RX   PubMed=27231123;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31077409;
RX   PubMed=31395879;
RX   PubMed=32899426;
RX   PubMed=35640676;
RX   PubMed=35839778;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~55 hours (Note=At 10th passage in RPMI + 10% FBS), ~74 hours (Note=At 25th passage in RPMI + 0.2% LA) (PubMed=2544546).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=907069; DepMap=ACH-000976).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4071_4072insGATT); Zygosity=Heterozygous (Cosmic-CLP=907069; DepMap=ACH-000976).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (Cosmic-CLP=907069; DepMap=ACH-000976).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=7.42%; Native American=0%; East Asian, North=82%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=10.57% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CLS=300469; Cosmic-CLP=907069; JCRB=JCRB0425; PubMed=25877200; RCB=RCB1960; TKG=TKG 0389
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,20
ST   D13S317: 11,13
ST   D16S539: 9,11,12 (PubMed=25877200)
ST   D16S539: 11,12 (CLS=300469; Cosmic-CLP=907069; JCRB=JCRB0425; RCB=RCB1960; TKG=TKG 0389)
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D6S1043: 13
ST   D7S820: 10,11
ST   D8S1179: 10
ST   FGA: 20,23
ST   Penta D: 10
ST   Penta E: 15,18
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   HuCC-T1-G10
AC   CVCL_QZ44
SY   HuCCT1-G10
DR   cancercelllines; CVCL_QZ44
DR   Wikidata; Q54896726
RX   PubMed=21451941;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4071_4072insGATT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0324 ! HuCC-T1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   HuCC-T1-G100
AC   CVCL_QZ45
SY   HuCCT1-G100
DR   cancercelllines; CVCL_QZ45
DR   Wikidata; Q54896727
RX   PubMed=21451941;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4071_4072insGATT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0324 ! HuCC-T1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   HUCL-1
AC   CVCL_0J48
DR   Wikidata; Q54896728
RX   PubMed=6170720;
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3622 ! WEHI-3
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   HuCL-22
AC   CVCL_UZ26
DR   Wikidata; Q94307299
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 24 PDL (PubMed=12077343).
CC   Derived from site: In situ; Eye, cornea, limbus; UBERON=UBERON_0006761.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   HUDEP-1
AC   CVCL_VI05
SY   Human Umbilical cord blood-Derived Erythroid Progenitor-1
DR   RCB; RCB4556
DR   Wikidata; Q54896729
RX   Patent=US8975072;
RX   PubMed=23533656;
CC   Population: Japanese.
CC   Characteristics: After in vitro induction of differentiation, will produce enucleated red blood cells.
CC   Characteristics: Expression of the HPV16 E6 and E7 genes is induced by tetracycline (PubMed=23533656).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 11
//
ID   HUDEP-2
AC   CVCL_VI06
SY   HUDEP2; Human Umbilical cord blood-Derived Erythroid Progenitor-2
DR   EFO; EFO_0022838
DR   BioGRID_ORCS_Cell_line; 1800
DR   PRIDE; PXD030182
DR   RCB; RCB4557
DR   Wikidata; Q54896730
RX   Patent=US8975072;
RX   PubMed=23533656;
RX   PubMed=31164570;
RX   PubMed=31753923;
RX   PubMed=35269949;
CC   Population: Japanese.
CC   Characteristics: After in vitro induction of differentiation, will produce enucleated red blood cells.
CC   Characteristics: Expression of the HPV16 E6 and E7 genes is induced by tetracycline (PubMed=23533656).
CC   Doubling time: 22.7 +- 5.0 hours (PubMed=31753923).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Please contact directly Dr. Nakamura Y. for the use of this cell line (yukionak@brc.riken.jp).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 16
//
ID   HUDEP-3
AC   CVCL_VI07
SY   Human Umbilical cord blood-Derived Erythroid Progenitor-3
DR   RCB; RCB4562
DR   Wikidata; Q54896731
RX   Patent=US8975072;
RX   PubMed=23533656;
CC   Population: Japanese.
CC   Characteristics: After in vitro induction of differentiation, will produce enucleated red blood cells.
CC   Characteristics: Expression of the HPV16 E6 and E7 genes is induced by tetracycline (PubMed=23533656).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 11
//
ID   HUDEP2 HBB-KO
AC   CVCL_C0QM
DR   PRIDE; PXD030182
DR   Wikidata; Q112929794
RX   PubMed=35269949;
CC   Population: Japanese.
CC   Characteristics: Expression of the HPV16 E6 and E7 genes is induced by tetracycline (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4827; HBB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VI06 ! HUDEP-2
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   HuE 13
AC   CVCL_JM10
DR   Wikidata; Q54896732
RX   PubMed=186619;
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   HUEhT-1
AC   CVCL_4W51
SY   HUE101-1-hTERT clone hT-1; hT-1
DR   JCRB; JCRB1458
DR   Wikidata; Q54896733
RX   PubMed=17207773;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): JCRB=JCRB1458
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W52 ! HUEhT-2
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HUEhT-2
AC   CVCL_4W52
SY   HUE101-1-hTERT clone hT-2; hT-2
DR   JCRB; JCRB1459
DR   Wikidata; Q54896735
RX   PubMed=17207773;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): JCRB=JCRB1459
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W51 ! HUEhT-1
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   HUES 1
AC   CVCL_B139
SY   HUES-1; HUES1; HuES1; Hues1; HuES01; HVRDe001-A
DR   EFO; EFO_0005355
DR   ENCODE; ENCBS771TSF
DR   ENCODE; ENCBS790PAZ
DR   ENCODE; ENCBS836MPJ
DR   GEO; GSM637758
DR   GEO; GSM1422443
DR   GEO; GSM1422444
DR   hPSCreg; HVRDe001-A
DR   NIHhESC; NIHhESC-10-0014
DR   SKIP; SKIP001019
DR   SKIP; SKIP001905
DR   Wikidata; Q54896736
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=18772870;
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=21714037;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0014.
CC   Registration: Swiss research registry; BAG-hES-IMP-0035.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-033, Steering comm. appl. SCSC04-25(1).
CC   Doubling time: 24 hours (PubMed=14999088).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 8,12
ST   D18S51: 13
ST   D21S11: 28,30
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,12
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   HUES 10
AC   CVCL_B140
SY   HUES-10; HUES10; HuES10; HVRDe010-A
DR   hPSCreg; HVRDe010-A
DR   NIHhESC; NIHhESC-10-0023
DR   SKIP; SKIP001493
DR   SKIP; SKIP001914
DR   Wikidata; Q54896739
RX   PubMed=14999088;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0023.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-010, Steering comm. appl. SCSC04-25(10).
CC   Doubling time: 72 hours (PubMed=14999088).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,13
ST   D19S433: 15,16.2
ST   D21S11: 29,30
ST   D2S1338: 29,30
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 12,13
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
ID   HUES 11
AC   CVCL_B141
SY   HUES-11; HUES11; HuES11; HVRDe011-A
DR   hPSCreg; HVRDe011-A
DR   NIHhESC; NIHhESC-10-0024
DR   SKIP; SKIP001494
DR   SKIP; SKIP001915
DR   Wikidata; Q54896740
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0024.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-011, Steering comm. appl. SCSC04-25(11).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 16,17
ST   D21S11: 27,28
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   Penta D: 13,14
ST   Penta E: 5,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
ID   HUES 12
AC   CVCL_B142
SY   HUES-12; HUES12; HuES12; Hues12; HVRDe012-A
DR   hPSCreg; HVRDe012-A
DR   NIHhESC; NIHhESC-10-0025
DR   SKIP; SKIP001495
DR   SKIP; SKIP001916
DR   Wikidata; Q54896741
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0025.
CC   Registration: Swiss research registry; BAG-hES-IMP-0040.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-012, Steering comm. appl. SCSC04-25(12).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D21S11: 27,28
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 13,16
ST   Penta E: 7,16
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
ID   HUES 13
AC   CVCL_B143
SY   HUES-13; HUES13; HuES13; Hues13; HVRDe013-A
DR   EFO; EFO_0007078
DR   ENCODE; ENCBS429TAI
DR   GEO; GSM637763
DR   GEO; GSM670087
DR   hPSCreg; HVRDe013-A
DR   NIHhESC; NIHhESC-10-0026
DR   SKIP; SKIP001496
DR   SKIP; SKIP001917
DR   Wikidata; Q54896742
RX   PubMed=14999088;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=19200798;
RX   PubMed=21295703;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0026.
CC   Registration: Swiss research registry; BAG-hES-IMP-0041.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-013, Steering comm. appl. SCSC04-25(13).
CC   Doubling time: 24 hours (PubMed=14999088).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   HUES 14
AC   CVCL_B144
SY   HUES-14; HUES14; HuES14; Hues14; HVRDe014-A
DR   hPSCreg; HVRDe014-A
DR   NIHhESC; NIHhESC-10-0027
DR   SKIP; SKIP001497
DR   SKIP; SKIP001918
DR   Wikidata; Q54896743
RX   PubMed=14999088;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0027.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-014, Steering comm. appl. SCSC04-25(14).
CC   Doubling time: 48 hours (PubMed=14999088).
CC   Donor information: Embryo is sibling to that giving rise to HUES 15 (Cellosaurus=CVCL_B145).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,19
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 7,10
ST   D8S1179: 10,11
ST   FGA: 20
ST   Penta D: 10,13
ST   Penta E: 9,18
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 20
//
ID   HUES 15
AC   CVCL_B145
SY   HUES-15; HUES15; HuES15; HVRDe015-A
DR   hPSCreg; HVRDe015-A
DR   NIHhESC; NIHhESC-10-0028
DR   SKIP; SKIP001498
DR   SKIP; SKIP001919
DR   Wikidata; Q54896744
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=18772870;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0028.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-015, Steering comm. appl. SCSC04-25(15).
CC   Doubling time: 48 hours (PubMed=14999088).
CC   Donor information: Embryo is sibling to that giving rise to HUES 14 (Cellosaurus=CVCL_B144).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 13,15
ST   D21S11: 28,30
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 20,21
ST   Penta D: 10,12
ST   Penta E: 16,18
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 21
//
ID   HUES 16
AC   CVCL_B146
SY   HUES-16; HUES16; HuES16; Hues16; HVRDe016-A
DR   hPSCreg; HVRDe016-A
DR   NIHhESC; NIHhESC-10-0029
DR   SKIP; SKIP001499
DR   SKIP; SKIP001920
DR   Wikidata; Q54896746
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0029.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-016, Steering comm. appl. SCSC04-25(16).
CC   Doubling time: 48 hours (PubMed=14999088).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D21S11: 30.2,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 19
//
ID   HUES 17
AC   CVCL_B147
SY   HUES-17; HUES17; HuES17; HVRDe017-A
DR   hPSCreg; HVRDe017-A
DR   NIHhESC; NIHhESC-10-0030
DR   SKIP; SKIP001500
DR   SKIP; SKIP001921
DR   Wikidata; Q54896747
RX   PubMed=14999088;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=19200798;
RX   PubMed=20831567;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0030.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-017, Steering comm. appl. SCSC04-25(17).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D21S11: 29,30.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21,22
ST   Penta D: 11,13
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   HUES 17-H2B-RFP
AC   CVCL_A5NL
SY   HUES-17-H2B-RFP
DR   Wikidata; Q107115396
CC   Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Miscellaneous: Cell line information from personal communication of Price, Christopher John.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B147 ! HUES 17
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   HUES 17v12,17
AC   CVCL_A5KC
SY   HUES-17v12,17
DR   Wikidata; Q107115397
CC   Characteristics: Aneuploid HUES 17 subline with gain of chromosomes 12 and 17.
CC   Karyotypic information: 48,XY,+12,+17 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Price, Christopher John.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B147 ! HUES 17
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   HUES 18
AC   CVCL_B148
SY   HUES18; HuES18
DR   NIHhESC; NIHhESC-10-0031
DR   SKIP; SKIP001501
DR   Wikidata; Q54896748
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0031.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,21
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 23,26
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   HUES 19
AC   CVCL_B149
SY   HUES19; HuES19
DR   NIHhESC; NIHhESC-10-0032
DR   SKIP; SKIP001502
DR   Wikidata; Q54896749
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0032.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 14,19
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 10,11
ST   Penta E: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   HUES 2
AC   CVCL_B150
SY   HUES-2; HUES2; HuES2; HuES02; HVRDe002-A
DR   GEO; GSM608010
DR   hPSCreg; HVRDe002-A
DR   NIHhESC; NIHhESC-10-0015
DR   SKIP; SKIP001480
DR   SKIP; SKIP001906
DR   Wikidata; Q54896750
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=19200798;
RX   PubMed=21637780;
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0015.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-006, Steering comm. appl. SCSC04-25(2).
CC   Doubling time: 24 hours (PubMed=14999088).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798; PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D21S11: 31,32
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   D8S1179: 8,12
ST   FGA: 18,23
ST   Penta D: 11,13
ST   Penta E: 7,15
ST   TH01: 5,6
ST   TPOX: 9,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   HUES 20
AC   CVCL_B151
SY   HUES20; HuES20
DR   NIHhESC; NIHhESC-10-0033
DR   SKIP; SKIP001503
DR   Wikidata; Q54896751
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0033.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   HUES 21
AC   CVCL_B152
SY   HUES21; HuES21
DR   NIHhESC; NIHhESC-10-0034
DR   SKIP; SKIP001504
DR   Wikidata; Q54896752
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0034.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 8,12
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   HUES 22
AC   CVCL_B153
SY   HUES22; HuES22
DR   NIHhESC; NIHhESC-10-0035
DR   SKIP; SKIP001505
DR   Wikidata; Q54896753
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0035.
CC   Donor information: Embryo is sibling to that giving rise to HUES 23 (Cellosaurus=CVCL_B154).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 30,30.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 21,24
ST   Penta D: 13,14
ST   Penta E: 5,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   HUES 23
AC   CVCL_B154
SY   HUES23; HuES23
DR   NIHhESC; NIHhESC-10-0036
DR   SKIP; SKIP001506
DR   Wikidata; Q54896754
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0036.
CC   Donor information: Embryo is sibling to that giving rise to HUES 22 (Cellosaurus=CVCL_B153).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D21S11: 30,30.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 6
ST   TPOX: 11,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   HUES 24
AC   CVCL_B155
SY   HUES24; HuES24
DR   NIHhESC; NIHhESC-10-0037
DR   SKIP; SKIP001507
DR   Wikidata; Q54896755
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0037.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 11,17
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   HUES 25
AC   CVCL_B156
SY   HUES25; HuES25
DR   SKIP; SKIP001508
DR   Wikidata; Q54896756
RX   PubMed=19200798;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   HUES 26
AC   CVCL_B157
SY   HUES26; HuES26
DR   NIHhESC; NIHhESC-10-0038
DR   SKIP; SKIP001509
DR   Wikidata; Q54896757
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0038.
CC   Donor information: Embryo is sibling to that giving rise to HUES 27 (Cellosaurus=CVCL_B158).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 13,20
ST   D21S11: 28,31.2
ST   D3S1358: 13,18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 25,26
ST   Penta D: 9,14
ST   Penta E: 12,13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   HUES 27
AC   CVCL_B158
SY   HUES27; HuES27
DR   NIHhESC; NIHhESC-10-0039
DR   SKIP; SKIP001510
DR   Wikidata; Q54896758
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0039.
CC   Donor information: Embryo is sibling to that giving rise to HUES 26 (Cellosaurus=CVCL_B157).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 14,20
ST   D21S11: 28
ST   D3S1358: 13,18
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 21,23
ST   Penta D: 9,14
ST   Penta E: 12,17
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   HUES 28
AC   CVCL_B159
SY   HUES28; HuES28
DR   EFO; EFO_0007079
DR   ENCODE; ENCBS356KHC
DR   GEO; GSM637764
DR   NIHhESC; NIHhESC-10-0040
DR   SKIP; SKIP001511
DR   Wikidata; Q54896759
RX   PubMed=19200798;
RX   PubMed=21295703;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0040.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 12
ST   D18S51: 12,14
ST   D21S11: 28,30
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   HUES 29
AC   CVCL_B160
SY   HUES29; HuES29
DR   SKIP; SKIP001512
DR   Wikidata; Q54896760
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D21S11: 31.2
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 12
ST   Penta E: 16,18
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 3
AC   CVCL_B161
SY   HUES-3; HuES-3; HUES3; HuES3; Hues3; HuES03; HVRDe003-A
DR   CLO; CLO_0037316
DR   EFO; EFO_0007080
DR   ENCODE; ENCBS087WPL
DR   ENCODE; ENCBS433HCT
DR   GEO; GSM608011
DR   GEO; GSM608029
DR   GEO; GSM621767
DR   GEO; GSM637759
DR   GEO; GSM670075
DR   hPSCreg; HVRDe003-A
DR   NIHhESC; NIHhESC-10-0016
DR   SKIP; SKIP001481
DR   SKIP; SKIP001907
DR   Wikidata; Q54896761
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=18713948;
RX   PubMed=19200798;
RX   PubMed=20973834;
RX   PubMed=21295703;
RX   PubMed=21637780;
RX   PubMed=22514597;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0016.
CC   Registration: Swiss research registry; BAG-hES-IMP-0036.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-034, Steering comm. appl. SCSC04-25(3).
CC   Doubling time: 60 hours (PubMed=14999088).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798; PubMed=20973834; PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D16S539: 12,14
ST   D18S51: 13,17
ST   D21S11: 28,29
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   HUES 3 Hb9::GFP
AC   CVCL_X724
SY   HUES 3 HB9::GFP; HuES 3 Hb9::GFP; HuES-3 Hb9::GFP; HUES3 Hb9::GFP
DR   Wikidata; Q54896762
RX   PubMed=19041780;
CC   From: Harvard University; Boston; USA.
CC   Characteristics: Transfected with GFP under the control of a murine Hb9 promoter (PubMed=19041780).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B161 ! HUES 3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 9
//
ID   HUES 30
AC   CVCL_B162
SY   HUES30; HuES30
DR   SKIP; SKIP001513
DR   Wikidata; Q54896763
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13
ST   D21S11: 30,31.2
ST   D3S1358: 14,19
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 22,25
ST   Penta D: 12,14
ST   Penta E: 11,21
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   HUES 31
AC   CVCL_B163
SY   HUES31; HuES31
DR   SKIP; SKIP001550
DR   Wikidata; Q54896764
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 9,13
ST   Penta E: 13,20
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 32
AC   CVCL_B164
SY   HUES32; HuES32
DR   SKIP; SKIP001514
DR   Wikidata; Q54896765
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,18
ST   D19S433: 14,16
ST   D21S11: 29,31
ST   D2S1338: 16,17
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 33
AC   CVCL_B165
SY   HUES33; HuES33
DR   SKIP; SKIP001515
DR   Wikidata; Q54896766
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,20
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 11
ST   FGA: 23,25
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 34
AC   CVCL_B166
SY   HUES34; HuES34
DR   SKIP; SKIP001516
DR   Wikidata; Q54896767
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 11.2,14,17
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,18
ST   D3S1358: 15,16,20
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 8
ST   FGA: 21,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 35
AC   CVCL_B167
SY   HUES35; HuES35
DR   SKIP; SKIP001517
DR   Wikidata; Q54896768
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D18S51: 15,18
ST   D19S433: 14,14.2
ST   D21S11: 28,32.2
ST   D2S1338: 17
ST   D3S1358: 15,20
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 36
AC   CVCL_B168
SY   HUES36; HuES36
DR   SKIP; SKIP001518
DR   Wikidata; Q54896769
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Donor information: Embryo is sibling to those giving rise to HUES 37 (Cellosaurus=CVCL_B169), HUES 38 (Cellosaurus=CVCL_B170) and HUES 39 (Cellosaurus=CVCL_B171).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 27,31.2
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HUES 37
AC   CVCL_B169
SY   HUES37; HuES37
DR   SKIP; SKIP001519
DR   Wikidata; Q54896771
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Donor information: Embryo is sibling to those giving rise to HUES 36 (Cellosaurus=CVCL_B168), HUES 38 (Cellosaurus=CVCL_B170) and HUES 39 (Cellosaurus=CVCL_B171).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 15,17
ST   D21S11: 31.2,32.2
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HUES 38
AC   CVCL_B170
SY   HUES38; HuES38
DR   SKIP; SKIP001520
DR   Wikidata; Q54896772
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Donor information: Embryo is sibling to those giving rise to HUES 36 (Cellosaurus=CVCL_B168), HUES 37 (Cellosaurus=CVCL_B169) and HUES 39 (Cellosaurus=CVCL_B171).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 17,19
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HUES 39
AC   CVCL_B171
SY   HUES39; HuES39
DR   SKIP; SKIP001521
DR   Wikidata; Q54896773
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Donor information: Embryo is sibling to those giving rise to HUES 36 (Cellosaurus=CVCL_B168), HUES 37 (Cellosaurus=CVCL_B169) and HUES 38 (Cellosaurus=CVCL_B170).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 15,17
ST   D21S11: 31.2,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 21,22
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HUES 4
AC   CVCL_B172
SY   HUES-4; HUES4; HuES4; HuES04; HVRDe004-A
DR   hPSCreg; HVRDe004-A
DR   NIHhESC; NIHhESC-10-0017
DR   SKIP; SKIP001482
DR   SKIP; SKIP001908
DR   Wikidata; Q54896774
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0017.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-007, Steering comm. appl. SCSC04-25(4).
CC   Doubling time: 48 hours (PubMed=14999088).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 12,19
ST   D21S11: 30,31
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 16
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   HUES 40
AC   CVCL_B173
SY   HUES40; HuES40
DR   SKIP; SKIP001522
DR   Wikidata; Q54896775
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 27,31
ST   D2S1338: 24
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 22
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 41
AC   CVCL_B174
SY   HUES41; HuES41
DR   SKIP; SKIP001523
DR   Wikidata; Q54896776
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 12,14
ST   D18S51: 16,17
ST   D19S433: 13,16
ST   D21S11: 33.2
ST   D2S1338: 21,25
ST   D3S1358: 15,17
ST   D5S818: 13,14
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 19,20
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 42
AC   CVCL_B175
SY   HUES42; HuES42
DR   NIHhESC; NIHhESC-12-0157
DR   SKIP; SKIP001524
DR   Wikidata; Q54896777
RX   PubMed=19200798;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0157.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 17,20
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 17,24
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   FGA: 20,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   HUES 43
AC   CVCL_B176
SY   HUES43; HuES43
DR   SKIP; SKIP001525
DR   Wikidata; Q54896778
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   HUES 44
AC   CVCL_B177
SY   HUES44; HuES44
DR   EFO; EFO_0007081
DR   ENCODE; ENCBS440AUU
DR   GEO; GSM637765
DR   GEO; GSM670089
DR   NIHhESC; NIHhESC-12-0158
DR   SKIP; SKIP001526
DR   Wikidata; Q54896779
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0158.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 15,16
ST   D19S433: 14,15.2
ST   D21S11: 27,30
ST   D2S1338: 19,21
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   HUES 45
AC   CVCL_B178
SY   HUES45; HuES45
DR   EFO; EFO_0007082
DR   ENCODE; ENCBS142AAM
DR   ENCODE; ENCBS384VFC
DR   GEO; GSM637766
DR   GEO; GSM670084
DR   GEO; GSM670091
DR   NIHhESC; NIHhESC-10-0076
DR   SKIP; SKIP001527
DR   Wikidata; Q54896780
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0076.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 12,15.2
ST   D21S11: 30,32.2
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   FGA: 20,24
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   HUES 46
AC   CVCL_B179
SY   HUES46; HuES46
DR   SKIP; SKIP001528
DR   Wikidata; Q54896783
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 15,16
ST   D21S11: 31.2,32.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 21,26
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 47
AC   CVCL_B180
SY   HUES47; HuES47
DR   Wikidata; Q54896784
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 7,12
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 15,18
ST   D19S433: 12,17.2
ST   D21S11: 27,29
ST   D2S1338: 23,26
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 21.2,22
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   HUES 48
AC   CVCL_B181
SY   HUES48; HuES48
DR   EFO; EFO_0007083
DR   BioSample; SAMN00849560
DR   BioSample; SAMN03732527
DR   BioSample; SAMN04096428
DR   ENCODE; ENCBS099BXQ
DR   ENCODE; ENCBS203SNR
DR   ENCODE; ENCBS395IFY
DR   ENCODE; ENCBS585ALE
DR   GEO; GSM621598
DR   GEO; GSM637767
DR   GEO; GSM669936
DR   GEO; GSM669942
DR   GEO; GSM669954
DR   GEO; GSM670013
DR   GEO; GSM670039
DR   GEO; GSM772755
DR   GEO; GSM772766
DR   GEO; GSM772780
DR   GEO; GSM772793
DR   GEO; GSM772794
DR   GEO; GSM772796
DR   GEO; GSM772797
DR   GEO; GSM772798
DR   GEO; GSM772799
DR   GEO; GSM909322
DR   GEO; GSM997250
DR   NIHhESC; NIHhESC-10-0053
DR   SKIP; SKIP001529
DR   Wikidata; Q54896785
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0053.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 14,15
ST   D21S11: 30.2,31.2
ST   D2S1338: 20,21
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   HUES 49
AC   CVCL_B182
SY   HUES49; HuES49
DR   EFO; EFO_0007084
DR   ENCODE; ENCBS684BJP
DR   GEO; GSM621603
DR   GEO; GSM637768
DR   GEO; GSM909323
DR   NIHhESC; NIHhESC-10-0054
DR   SKIP; SKIP001530
DR   Wikidata; Q54896786
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0054.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 11.2,14,16
ST   D19S433: 14
ST   D21S11: 32.2,33.2
ST   D2S1338: 17
ST   D3S1358: 16,18,20
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   HUES 5
AC   CVCL_B183
SY   HUES-5; HUES5; HuES5; Hues5; HuES05; HVRDe005-A
DR   hPSCreg; HVRDe005-A
DR   NIHhESC; NIHhESC-10-0018
DR   SKIP; SKIP001483
DR   SKIP; SKIP001909
DR   Wikidata; Q54896787
RX   PubMed=14999088;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=18772870;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0018.
CC   Registration: Swiss research registry; BAG-hES-IMP-0037.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-008, Steering comm. appl. SCSC04-25(5).
CC   Doubling time: 72 hours (PubMed=14999088).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 10,12
ST   Penta E: 10,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   HUES 50
AC   CVCL_B184
SY   HUES50; HuES50
DR   SKIP; SKIP001531
DR   Wikidata; Q54896788
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Donor information: Embryo is sibling to that giving rise to HUES 51 (Cellosaurus=CVCL_B185).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12,14
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 16,19
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   HUES 51
AC   CVCL_B185
SY   HUES51; HuES51
DR   SKIP; SKIP001532
DR   Wikidata; Q54896789
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Donor information: Embryo is sibling to that giving rise to HUES 50 (Cellosaurus=CVCL_B184).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 15,16,23
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D3S1358: 16,19
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 23
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   HUES 52
AC   CVCL_B186
SY   HUES52; HuES52
DR   SKIP; SKIP001533
DR   Wikidata; Q54896790
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   HUES 53
AC   CVCL_B187
SY   HUES53; HuES53
DR   EFO; EFO_0007085
DR   ENCODE; ENCBS629MNT
DR   GEO; GSM621601
DR   GEO; GSM637769
DR   GEO; GSM909324
DR   NIHhESC; NIHhESC-10-0055
DR   SKIP; SKIP001534
DR   Wikidata; Q54896791
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0055.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,20
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   HUES 54
AC   CVCL_B188
SY   HUES54; HuES54
DR   SKIP; SKIP001535
DR   Wikidata; Q54896792
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 9,10
ST   D16S539: 9,10,13
ST   D19S433: 13,14
ST   D21S11: 29,32
ST   D2S1338: 21,22
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 55
AC   CVCL_B189
SY   HUES55; HuES55
DR   SKIP; SKIP001536
DR   Wikidata; Q54896793
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D19S433: 13,13.2
ST   D21S11: 32.2
ST   D2S1338: 18,22
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 22,24
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 56
AC   CVCL_B190
SY   HUES56; HuES56
DR   SKIP; SKIP001537
DR   Wikidata; Q54896794
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 9,10
ST   D16S539: 9
ST   D18S51: 14,16
ST   D19S433: 13,13.2
ST   D21S11: 32,32.2
ST   D2S1338: 18,22
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 57
AC   CVCL_B191
SY   HUES57; HuES57
DR   SKIP; SKIP001538
DR   Wikidata; Q54896795
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 11,14
ST   D16S539: 9,10,13
ST   D18S51: 15,16
ST   D19S433: 13.2,14
ST   D21S11: 29,32.2
ST   D2S1338: 18,21,22
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 58
AC   CVCL_B192
SY   HUES58; HuES58
DR   SKIP; SKIP001539
DR   Wikidata; Q54896796
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,13
ST   D18S51: 14,19
ST   D19S433: 13,14
ST   D21S11: 32.2
ST   D2S1338: 18,22
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 59
AC   CVCL_B193
SY   HUES59; HuES59
DR   SKIP; SKIP001540
DR   Wikidata; Q54896797
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D18S51: 14,19
ST   D19S433: 13.2,14
ST   D21S11: 29,32
ST   D2S1338: 18,22
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   TH01: 6.3,7
ST   TPOX: 9,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 6
AC   CVCL_B194
SY   HUES-6; HUES6; HuES6; Hues6; HuES06; HVRDe006-A
DR   EFO; EFO_0007086
DR   BioSamples; SAMEA7771168
DR   ENCODE; ENCBS153ORV
DR   ENCODE; ENCBS271TBU
DR   ENCODE; ENCBS530IZG
DR   ENCODE; ENCBS912XKA
DR   GEO; GSM525424
DR   GEO; GSM525425
DR   GEO; GSM525426
DR   GEO; GSM608012
DR   GEO; GSM621700
DR   GEO; GSM637760
DR   GEO; GSM669885
DR   GEO; GSM669886
DR   GEO; GSM669887
DR   GEO; GSM669888
DR   GEO; GSM669889
DR   GEO; GSM669890
DR   GEO; GSM669891
DR   GEO; GSM669892
DR   GEO; GSM669893
DR   GEO; GSM669894
DR   GEO; GSM669895
DR   GEO; GSM669897
DR   GEO; GSM669898
DR   GEO; GSM670080
DR   GEO; GSM1112774
DR   GEO; GSM1112776
DR   GEO; GSM1153528
DR   hPSCreg; HVRDe006-A
DR   NIHhESC; NIHhESC-10-0019
DR   SKIP; SKIP001484
DR   SKIP; SKIP001910
DR   Wikidata; Q54896798
RX   PubMed=14999088;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=21637780;
RX   PubMed=28677534;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0019.
CC   Registration: Swiss research registry; BAG-hES-IMP-0038.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-009, Steering comm. appl. SCSC04-25(6).
CC   Doubling time: 24 hours (PubMed=14999088).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798; PubMed=21637780; PubMed=28677534
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 24,25
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 12,14
ST   D19S433: 13,15
ST   D1S1656: 15,18.3
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   HUES 60
AC   CVCL_B195
SY   HUES60; HuES60
DR   SKIP; SKIP001541
DR   Wikidata; Q54896799
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 11,14
ST   D16S539: 10,13
ST   D19S433: 13,14
ST   D21S11: 29,32
ST   D2S1338: 18,22
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 21,23
ST   TH01: 6.3,7
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 61
AC   CVCL_B196
SY   HUES61; HuES61
DR   SKIP; SKIP001542
DR   Wikidata; Q54896800
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 10,11
ST   D16S539: 8,14
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 16,17,20
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   HUES 62
AC   CVCL_B197
SY   HUES62; HuES62
DR   EFO; EFO_0007087
DR   BioGRID_ORCS_Cell_line; 45
DR   ENCODE; ENCBS107ECP
DR   GEO; GSM621595
DR   GEO; GSM637770
DR   NIHhESC; NIHhESC-10-0065
DR   SKIP; SKIP001543
DR   Wikidata; Q54896801
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0065.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to those giving rise to HUES 63 (Cellosaurus=CVCL_B198) and HUES 64 (Cellosaurus=CVCL_B199).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 20,22
ST   D3S1358: 15,20
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   HUES 63
AC   CVCL_B198
SY   HUES63; HuES63
DR   EFO; EFO_0007088
DR   ENCODE; ENCBS301DIL
DR   GEO; GSM621591
DR   GEO; GSM637771
DR   NIHhESC; NIHhESC-10-0066
DR   SKIP; SKIP001544
DR   Wikidata; Q54896802
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0066.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to those giving rise to HUES 62 (Cellosaurus=CVCL_B197) and HUES 64 (Cellosaurus=CVCL_B199).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D16S539: 12,13
ST   D19S433: 13
ST   D21S11: 31,31.2
ST   D2S1338: 18,20
ST   D3S1358: 15,16,20
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   HUES 64
AC   CVCL_B199
SY   HUES64; HuES64
DR   EFO; EFO_0007089
DR   ENCODE; ENCBS015UPH
DR   ENCODE; ENCBS078ITI
DR   ENCODE; ENCBS179VGA
DR   ENCODE; ENCBS183DGX
DR   ENCODE; ENCBS389KQW
DR   ENCODE; ENCBS479IFR
DR   ENCODE; ENCBS553VXQ
DR   ENCODE; ENCBS614QHK
DR   ENCODE; ENCBS666HUG
DR   ENCODE; ENCBS766XXZ
DR   ENCODE; ENCBS918DAB
DR   GEO; GSM621594
DR   GEO; GSM637772
DR   GEO; GSM669928
DR   GEO; GSM669932
DR   GEO; GSM669963
DR   GEO; GSM669966
DR   GEO; GSM669967
DR   GEO; GSM669974
DR   GEO; GSM772749
DR   GEO; GSM772750
DR   GEO; GSM772751
DR   GEO; GSM772752
DR   GEO; GSM772754
DR   GEO; GSM772756
DR   GEO; GSM772800
DR   GEO; GSM772807
DR   GEO; GSM772856
DR   GEO; GSM772912
DR   GEO; GSM772913
DR   GEO; GSM772971
DR   GEO; GSM772977
DR   GEO; GSM772978
DR   GEO; GSM772979
DR   GEO; GSM772980
DR   GEO; GSM773002
DR   GEO; GSM773003
DR   GEO; GSM997249
DR   GEO; GSM1112775
DR   GEO; GSM1112834
DR   GEO; GSM1112837
DR   GEO; GSM1112840
DR   GEO; GSM1112841
DR   GEO; GSM1227087
DR   NIHhESC; NIHhESC-10-0067
DR   SKIP; SKIP001551
DR   Wikidata; Q54896803
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0067.
CC   Registration: Swiss research registry; BAG-hES-IMP-0054.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to those giving rise to HUES 62 (Cellosaurus=CVCL_B197) and HUES 63 (Cellosaurus=CVCL_B198).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D16S539: 11,13
ST   D19S433: 13,14
ST   D21S11: 31,31.2
ST   D2S1338: 18,20
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   HUES 65
AC   CVCL_B200
SY   HUES65; HuES65
DR   EFO; EFO_0007091
DR   ENCODE; ENCBS155QMO
DR   GEO; GSM621599
DR   GEO; GSM637773
DR   NIHhESC; NIHhESC-10-0056
DR   SKIP; SKIP001552
DR   Wikidata; Q54896804
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0056.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 12,13
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 16,18,20
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 13,14,15
ST   FGA: 21,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   HUES 66
AC   CVCL_B201
SY   HUES66; HuES66
DR   EFO; EFO_0007092
DR   ENCODE; ENCBS032OHT
DR   GEO; GSM621592
DR   GEO; GSM637774
DR   GEO; GSM670049
DR   NIHhESC; NIHhESC-10-0057
DR   SKIP; SKIP001553
DR   Wikidata; Q54896806
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0057.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 31.2,32.2
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 21,23
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   HUES 67
AC   CVCL_B202
SY   HUES67; HuES67
DR   Wikidata; Q54896808
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   HUES 68
AC   CVCL_B203
SY   HUES68; HuES68
DR   NIHhESC; NIHhESC-12-0176
DR   SKIP; SKIP001545
DR   Wikidata; Q54896809
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0176.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   HUES 69
AC   CVCL_B204
SY   HUES69; HuES69
DR   NIHhESC; NIHhESC-12-0178
DR   SKIP; SKIP001546
DR   Wikidata; Q54896810
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0178.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   HUES 7
AC   CVCL_B205
SY   HUES-7; HUES7; HuES7; HuES07; HVRDe007-A
DR   hPSCreg; HVRDe007-A
DR   NIHhESC; NIHhESC-10-0020
DR   SKIP; SKIP001485
DR   SKIP; SKIP001911
DR   TOKU-E; 4083
DR   Wikidata; Q54896812
RX   PubMed=14999088;
RX   PubMed=16919167;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=18772870;
RX   PubMed=19200798;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0020.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-035, Steering comm. appl. SCSC04-25(7).
CC   Doubling time: 48 hours (PubMed=14999088).
CC   HLA typing: A*02:03; B*35,51; C*04,14; DQB1*03,06; DRB1*04,15; DRB5*01 (PubMed=16919167).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; PubMed=19200798
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 27,32.2
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 25
ST   Penta D: 9,11
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   HUES 70
AC   CVCL_B206
SY   HUES70; HuES70
DR   NIHhESC; NIHhESC-12-0177
DR   SKIP; SKIP001547
DR   Wikidata; Q54896813
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0177.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   HUES 71
AC   CVCL_W717
SY   HUES71; HuES71
DR   NIHhESC; NIHhESC-14-0281
DR   Wikidata; Q54896814
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0281.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   HUES 72
AC   CVCL_W718
SY   HUES72; HuES72
DR   NIHhESC; NIHhESC-14-0282
DR   Wikidata; Q54896815
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0282.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HUES 73
AC   CVCL_W719
SY   HUES73; HuES73
DR   NIHhESC; NIHhESC-14-0283
DR   Wikidata; Q54896816
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0283.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HUES 74
AC   CVCL_Y572
SY   HUES74; HuES74
DR   NIHhESC; NIHhESC-15-0304
DR   Wikidata; Q54896817
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0304.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   HUES 75
AC   CVCL_W720
SY   HUES75; HuES75
DR   NIHhESC; NIHhESC-14-0280
DR   Wikidata; Q54896819
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0280.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HUES 8
AC   CVCL_B207
SY   HUES-8; HUES8; HuES8; HuES08; HVRDe008-A
DR   EFO; EFO_0007093
DR   ENCODE; ENCBS458EUG
DR   ENCODE; ENCBS989VLH
DR   GEO; GSM608013
DR   GEO; GSM608030
DR   GEO; GSM621709
DR   GEO; GSM637761
DR   hPSCreg; HVRDe008-A
DR   NIHhESC; NIHhESC-10-0021
DR   SKIP; SKIP001912
DR   Wikidata; Q54896820
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=21637780;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0021.
CC   Registration: Swiss research registry; BAG-hES-IMP-0056.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-018, Steering comm. appl. SCSC04-25(8).
CC   Doubling time: 48 hours (PubMed=14999088).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798; PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D21S11: 28,29
ST   D3S1358: 15,19
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 20,25
ST   Penta D: 10,11
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   HUES 9
AC   CVCL_0057
SY   HUES-9; HUES9; HuES9; Hues9; HuES09; HVRDe009-A
DR   EFO; EFO_0007094
DR   ENCODE; ENCBS579EEW
DR   GEO; GSM608014
DR   GEO; GSM608031
DR   GEO; GSM621718
DR   GEO; GSM637762
DR   hPSCreg; HVRDe009-A
DR   NIHhESC; NIHhESC-10-0022
DR   SKIP; SKIP001492
DR   SKIP; SKIP001913
DR   Wikidata; Q54896821
RX   PubMed=14999088;
RX   PubMed=17572666;
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=21406692;
RX   PubMed=21637780;
RX   PubMed=29861859;
RX   PubMed=33360445;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0022.
CC   Registration: Swiss research registry; BAG-hES-IMP-0039.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-037, Steering comm. appl. SCSC04-25(9).
CC   Doubling time: 24 hours (PubMed=14999088).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798; PubMed=21637780; PubMed=33360445
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,11.3 (PubMed=33360445)
ST   D13S317: 11,12 (PubMed=19200798; PubMed=21637780)
ST   D16S539: 12,13
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 9,12
ST   FGA: 19,21
ST   Penta D: 9,13
ST   Penta E: 10,12
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   HUES PGD 1
AC   CVCL_B208
DR   NIHhESC; NIHhESC-12-0148
DR   Wikidata; Q54896822
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0148.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   HUES PGD 10
AC   CVCL_B209
DR   NIHhESC; NIHhESC-12-0179
DR   Wikidata; Q54896823
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0179.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   HUES PGD 11
AC   CVCL_B210
DR   NIHhESC; NIHhESC-11-0094
DR   Wikidata; Q54896824
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0094.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   HUES PGD 12
AC   CVCL_B211
DR   NIHhESC; NIHhESC-11-0095
DR   Wikidata; Q54896825
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0095.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   HUES PGD 13
AC   CVCL_B212
DR   NIHhESC; NIHhESC-11-0090
DR   Wikidata; Q54896826
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0090.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   HUES PGD 14
AC   CVCL_B213
DR   NIHhESC; NIHhESC-11-0136
DR   Wikidata; Q54896829
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0136.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   HUES PGD 15
AC   CVCL_B214
DR   NIHhESC; NIHhESC-12-0149
DR   Wikidata; Q54896830
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0149.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   HUES PGD 16
AC   CVCL_B215
DR   NIHhESC; NIHhESC-12-0150
DR   Wikidata; Q54896831
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0150.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   HUES PGD 17
AC   CVCL_DF04
DR   NIHhESC; NIHhESC-17-0379
DR   Wikidata; Q54896832
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0379.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C133724; Brown-Vialetto-van Laere syndrome 1
DI   ORDO; Orphanet_572550; RFVT3-related riboflavin transporter deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   HUES PGD 2
AC   CVCL_E084
DR   NIHhESC; NIHhESC-12-0195
DR   Wikidata; Q54896833
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0195.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   HUES PGD 3
AC   CVCL_B216
DR   NIHhESC; NIHhESC-11-0091
DR   Wikidata; Q54896834
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0091.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   HUES6 SOX11 ES.HET1
AC   CVCL_E6IC
SY   ES.HET1
RX   PubMed=31035284;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11191; SOX11 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HUES6 SOX11 ES.HET2
AC   CVCL_E6ID
SY   ES.HET2
RX   PubMed=31035284;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11191; SOX11 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   HUES8 iCas9
AC   CVCL_VR10
DR   Wikidata; Q94308392
RX   PubMed=24931489;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Cell line with robust Dox-inducible expression of Cas9. Can be used for rapid and highly efficient generation of biallelic knockout hPSCs for loss-of-function studies.
CC   Characteristics: Using TALEN two constructs SA-2A-PuroR-Cas9-TRE and SA-2A-Neo-M2rtTA were introduced in the AAVS1 safe harbor locus, one in each allele.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 14
ST   D12S391: 16,18
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D19S433: 13,15
ST   D1S1656: 15
ST   D21S11: 28,29
ST   D22S1045: 14,15,16
ST   D2S1338: 17
ST   D2S441: 11,15
ST   D3S1358: 15,19
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   DYS391: 10
ST   FGA: 20,25
ST   Penta D: 10,11
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B207 ! HUES 8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   HUF1
AC   CVCL_ZX95
SY   HUman Fibroblast 1
DR   Wikidata; Q102114167
RX   PubMed=19774082;
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   HUF2
AC   CVCL_ZX96
SY   HUman Fibroblast 2
DR   Wikidata; Q102114168
RX   PubMed=19774082;
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   HUF3
AC   CVCL_ZX97
SY   HUman Fibroblast 3
DR   Wikidata; Q102114169
RX   PubMed=19774082;
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   HUF4
AC   CVCL_ZX98
SY   HUman Fibroblast 4
DR   Wikidata; Q102114170
RX   PubMed=19774082;
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=19774082).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   HUF5
AC   CVCL_ZX99
SY   HUman Fibroblast 5
DR   Wikidata; Q102114171
RX   PubMed=19774082;
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   HUF6
AC   CVCL_ZY00
SY   HUman Fibroblast 6
DR   Wikidata; Q102114172
RX   PubMed=19774082;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (PubMed=19774082).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   HUF7
AC   CVCL_ZY01
SY   HUman Fibroblast 7
DR   Wikidata; Q102114173
RX   PubMed=19774082;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=19774082).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   HUF8
AC   CVCL_ZY02
SY   HUman Fibroblast 8
DR   Wikidata; Q102114174
RX   PubMed=19774082;
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   HUF9
AC   CVCL_ZY03
SY   HUman Fibroblast 9
DR   Wikidata; Q102114175
RX   PubMed=19774082;
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C80099; Premature menopause
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   huFasM3
AC   CVCL_C506
SY   M3
DR   CLO; CLO_0004296
DR   Wikidata; Q54896835
RX   Patent=US5620889;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11726.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 7
//
ID   huFasM38
AC   CVCL_2525
SY   M38
DR   CLO; CLO_0004297
DR   Wikidata; Q54896836
RX   Patent=US5620889;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11465.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 8
//
ID   HuG-1
AC   CVCL_4845
SY   HuG
DR   Cell_Model_Passport; SIDM01736
DR   Wikidata; Q54896837
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=2334935;
CC   Population: Japanese.
CC   Doubling time: ~38 hours (PubMed=2334935).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   HUG-11
AC   CVCL_VR04
DR   cancercelllines; CVCL_VR04
DR   IARC_TP53; 6270
DR   Wikidata; Q94308440
RX   PubMed=8707423;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=8707423).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   HUG-15
AC   CVCL_VR05
DR   cancercelllines; CVCL_VR05
DR   IARC_TP53; 6272
DR   Wikidata; Q94308444
RX   PubMed=8707423;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Gly (c.518T>G); ClinVar=VCV000376016; Zygosity=Homozygous (PubMed=8707423).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   HUG-2
AC   CVCL_VR02
DR   IARC_TP53; 23573
DR   Wikidata; Q94308450
RX   PubMed=8707423;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8707423).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   HUG-27
AC   CVCL_VR06
DR   IARC_TP53; 6264
DR   Wikidata; Q94308455
RX   PubMed=8707423;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His115Tyr (c.343C>T); Zygosity=Heterozygous (PubMed=8707423).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   HUG-31
AC   CVCL_VR07
SY   HUG31
DR   IARC_TP53; 6265
DR   Wikidata; Q94308460
RX   PubMed=8707423;
RX   PubMed=9614553;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Gly (c.482C>G); Zygosity=Heterozygous (PubMed=8707423).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   HUG-9
AC   CVCL_VR03
DR   cancercelllines; CVCL_VR03
DR   IARC_TP53; 6268
DR   Wikidata; Q94308466
RX   PubMed=8707423;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.159G>A); ClinVar=VCV000420659; Zygosity=Heterozygous (PubMed=8707423).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   HuG1-N
AC   CVCL_4846
SY   HuG-1N; HUG1N
DR   CLO; CLO_0050788
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472167
DR   BioSample; SAMN10987865
DR   cancercelllines; CVCL_4846
DR   Cell_Model_Passport; SIDM01753
DR   Cosmic; 1187276
DR   DepMap; ACH-000239
DR   GEO; GSM887145
DR   GEO; GSM888217
DR   IARC_TP53; 21632
DR   LiGeA; CCLE_573
DR   PharmacoDB; HuG1N_636_2019
DR   Progenetix; CVCL_4846
DR   RCB; RCB1179
DR   Wikidata; Q54896838
RX   PubMed=15901131;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 33 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Pro (c.578A>C); ClinVar=VCV000376612; Zygosity=Unspecified (PubMed=15901131).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.71%; Native American=0.2%; East Asian, North=75.56%; East Asian, South=21.1%; South Asian=0%; European, North=0%; European, South=1.43% (PubMed=30894373).
CC   Misspelling: HuG-N; Cosmic=1187276.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB1179
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4845 ! HuG-1
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HuG1-PI
AC   CVCL_4847
DR   CLO; CLO_0050787
DR   Cell_Model_Passport; SIDM01751
DR   Cosmic; 1187277
DR   RCB; RCB1178
DR   Wikidata; Q54896839
CC   Population: Japanese.
CC   Misspelling: HuG1-P; Cosmic=1187277.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB1178
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4845 ! HuG-1
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   HuGC-OOHIRA
AC   CVCL_5292
DR   Wikidata; Q54896840
RX   PubMed=7541602;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HuGC-OOHIRA
CC   Population: Japanese.
CC   Doubling time: 25-30 hours (PubMed=7541602).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   Hughes
AC   CVCL_L357
DR   BTO; BTO_0005356
DR   Wikidata; Q54896842
RX   PubMed=21552385;
RX   PubMed=22916246;
CC   Doubling time: 17.9 hours (PubMed=22916246).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   HuGu
AC   CVCL_WA85
SY   Human Gum
DR   IBRC; C10459
DR   Wikidata; Q94308532
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   HuH-1
AC   CVCL_2956
SY   huH-1; HUH-1; huH 1; HuH1; HUh1; HUH1; huH1
DR   BTO; BTO_0005773
DR   CLO; CLO_0009988
DR   EFO; EFO_0006445
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 644
DR   BioSample; SAMN03473212
DR   BioSample; SAMN10988262
DR   cancercelllines; CVCL_2956
DR   Cell_Model_Passport; SIDM00586
DR   CGH-DB; 452-3
DR   Cosmic; 1187328
DR   Cosmic; 2023878
DR   Cosmic-CLP; 1298146
DR   DepMap; ACH-000475
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298146
DR   GEO; GSM827219
DR   GEO; GSM887146
DR   GEO; GSM888218
DR   GEO; GSM936761
DR   GEO; GSM1374565
DR   GEO; GSM1669918
DR   GEO; GSM2551568
DR   IARC_TP53; 30077
DR   JCRB; JCRB0199
DR   LiGeA; CCLE_117
DR   LIMORE; HuH1
DR   LINCS_LDP; LCL-1940
DR   Lonza; 1679
DR   PharmacoDB; huH1_637_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2956
DR   Wikidata; Q54896843
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6268479;
RX   PubMed=6310497;
RX   PubMed=8389256;
RX   PubMed=8835345;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29892436;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=32899426;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/Huh1
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Virology: Contains multiple copies of integrated hepatitis B virus (HBV) genomes.
CC   Doubling time: 28.23 hours (PubMed=31378681); ~36 hours (Note=Lot 02172003), ~31 hours (Note=Lot 07192012), ~39 hours (Note=Lot 08102017), ~35 hours (Note=Lot 04022021) (JCRB=JCRB0199).
CC   HLA typing: A*02:06,11:01; B*08:20,35:08; C*01:03,07:02; DRB1*04:05,13:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Asn302Profs*111 (c.904_907delAACC); Zygosity=Homozygous (PubMed=31395879; DepMap=ACH-000475).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (PubMed=31395879; Cosmic-CLP=1298146; DepMap=ACH-000475).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.02%; Native American=0.87%; East Asian, North=80.09%; East Asian, South=18.1%; South Asian=0%; European, North=0%; European, South=0.92% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Cosmic-CLP=1298146; JCRB=JCRB0199; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9
ST   D18S51: 16
ST   D21S11: 33.2
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 16,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   HuH-2
AC   CVCL_W463
SY   huH-2; huH 2
DR   Wikidata; Q54896844
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6310497;
RX   PubMed=8389256;
RX   PubMed=8835345;
CC   Population: Japanese.
CC   Virology: Contains multiple copies of integrated hepatitis B virus (HBV) genomes.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   HuH-28
AC   CVCL_2955
SY   HUH-28; HuH28; HUH28
DR   CLO; CLO_0050855
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03470952
DR   BioSample; SAMN03472037
DR   BioSample; SAMN10987843
DR   cancercelllines; CVCL_2955
DR   Cell_Model_Passport; SIDM01735
DR   ChEMBL-Cells; CHEMBL3308110
DR   Cosmic; 924163
DR   Cosmic; 1373551
DR   Cosmic; 2674045
DR   DepMap; ACH-000808
DR   FANTOM5_SSTAR; 10536-107G5
DR   GEO; GSM887147
DR   GEO; GSM888219
DR   IARC_TP53; 28291
DR   JCRB; JCRB0426
DR   PharmacoDB; HuH28_638_2019
DR   Progenetix; CVCL_2955
DR   RCB; RCB1943
DR   TKG; TKG 0438
DR   Wikidata; Q54896845
RX   CelloPub=CLPUB00275;
RX   PubMed=2852388;
RX   PubMed=2856443;
RX   PubMed=9290701;
RX   PubMed=20164919;
RX   PubMed=21451941;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26956050;
RX   PubMed=27231123;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31077409;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~80 hours (PubMed=2852388); ~1 week (Note=Lot 09082006), ~88 hours (Note=Lot 01062011), 55-128 hours (Note=Lot 07222016), 5 days (Note=Lot 10022018) (JCRB=JCRB0426).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (DepMap=ACH-000808).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (DepMap=ACH-000808).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.05%; Native American=0%; East Asian, North=84.08%; East Asian, South=11.01%; South Asian=0%; European, North=0%; European, South=1.86% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB0426; PubMed=25877200; RCB=RCB1943; TKG=TKG 0438
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D21S11: 30,33.2
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 10 (RCB=RCB1943)
ST   D7S820: 10,11 (JCRB=JCRB0426; PubMed=25877200; TKG=TKG 0438)
ST   D8S1179: 11
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 13,22
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   HuH-4
AC   CVCL_B373
SY   huH-4; HUH-4; huH 4; HuH4
DR   Cosmic; 934551
DR   Cosmic; 2668281
DR   IARC_TP53; 2010
DR   Wikidata; Q54896846
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6268479;
RX   PubMed=7972006;
RX   PubMed=8389256;
RX   PubMed=8835345;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu265_Phe270del (c.790_807del18); Zygosity=Unspecified (PubMed=8389256).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   Huh-5-2
AC   CVCL_X943
SY   Huh 5-2; 5-2
DR   cancercelllines; CVCL_X943
DR   ChEMBL-Cells; CHEMBL3308089
DR   ChEMBL-Targets; CHEMBL613881
DR   PubChem_Cell_line; CVCL_X943
DR   Wikidata; Q54896847
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   HuH-6
AC   CVCL_4381
SY   HUH-6; HuH 6; HuH6; HUH6; Huh6
DR   BTO; BTO_0001670
DR   CLO; CLO_0050851
DR   ABM; T9914
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 643
DR   BioSample; SAMN10987713
DR   cancercelllines; CVCL_4381
DR   CCRID; 1101HUM-PUMC000477
DR   CCRID; 3101HUMTCHu181
DR   Cell_Model_Passport; SIDM00062
DR   CLS; 305092
DR   Cosmic; 869168
DR   Cosmic; 869279
DR   Cosmic; 873714
DR   Cosmic; 1187329
DR   Cosmic; 1237546
DR   Cosmic; 1518228
DR   Cosmic; 1622750
DR   Cosmic; 2162537
DR   Cosmic; 2369478
DR   Cosmic; 2771602
DR   DepMap; ACH-000671
DR   FANTOM5_SSTAR; 10633-108I3
DR   GEO; GSM887148
DR   GEO; GSM888220
DR   GEO; GSM936762
DR   IARC_TP53; 28317
DR   LiGeA; CCLE_149
DR   Progenetix; CVCL_4381
DR   RCB; RCB1367
DR   Wikidata; Q54896848
RX   DOI=10.11418/jtca1981.12.3_221;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=57894;
RX   PubMed=8389256;
RX   PubMed=9359923;
RX   PubMed=9671767;
RX   PubMed=15767549;
RX   PubMed=20937217;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32899426;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/Huh6
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (PubMed=9671767; DepMap=ACH-000671).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Asp (c.476C>A); ClinVar=VCV001026335; Zygosity=Heterozygous (DepMap=ACH-000671).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (DepMap=ACH-000671).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.79%; Native American=0.3%; East Asian, North=80.92%; East Asian, South=17.99%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID; RCB=RCB1367
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 13,21
ST   D19S433: 12,12.2
ST   D21S11: 29,30
ST   D2S1338: 18
ST   D3S1358: 14,17
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,24
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   HuH-6 Clone 5
AC   CVCL_1296
SY   HuH-6 clone-5; Huh-6 clone 5; HUH-6 Clone 5; HUH-6-clone 5; HUH-6-clone5; HUH6CLONE5; HuH-6 cl-5; HuH-6-cl5; HUH6-Cl-5; HuH-6 cl5; HuH6-Cl5; HUH6 Cl5; HUH6 CL5; Huh6cl5; HuH6-C15; Huh6-c15; HUH6 C15; Huh6c15; JTC38; JTC-38; Japanese Tissue Culture-38
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03471623
DR   cancercelllines; CVCL_1296
DR   Cell_Model_Passport; SIDM01257
DR   ChEMBL-Cells; CHEMBL3308701
DR   Cosmic; 907070
DR   Cosmic-CLP; 907070
DR   DepMap; ACH-002395
DR   GDSC; 907070
DR   GEO; GSM2551569
DR   IARC_TP53; 21384
DR   JCRB; JCRB0401
DR   LIMORE; HuH6
DR   PharmacoDB; HUH6clone5_639_2019
DR   Wikidata; Q54896849
RX   PubMed=57894;
RX   PubMed=6161524;
RX   PubMed=6290537;
RX   PubMed=6301464;
RX   PubMed=8835345;
RX   PubMed=9290701;
RX   PubMed=20164919;
RX   PubMed=30894373;
RX   PubMed=31378681;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Japanese.
CC   Doubling time: 25.57 hours (PubMed=31378681); 35 hours (Note=Lot 05262008), 38-55 hours (Note=Lot 12142012), ~37 hours (Note=Lot 07222016) (JCRB=JCRB0401).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (PubMed=31378681; Cosmic-CLP=907070; DepMap=ACH-002395).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Asp (c.476C>A); ClinVar=VCV001026335; Zygosity=Heterozygous (Cosmic-CLP=907070; DepMap=ACH-002395).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (Cosmic-CLP=907070; DepMap=ACH-002395).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.77%; Native American=1.36%; East Asian, North=76.85%; East Asian, South=16.52%; South Asian=0%; European, North=0%; European, South=3.49% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Cosmic-CLP=907070; JCRB=JCRB0401; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4381 ! HuH-6
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   HuH-6-Luc
AC   CVCL_JF84
DR   cancercelllines; CVCL_JF84
DR   JCRB; JCRB1633
DR   Wikidata; Q54896852
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Asp (c.476C>A); ClinVar=VCV001026335; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1633
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4381 ! HuH-6
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 15
//
ID   Huh-7
AC   CVCL_0336
SY   HuH-7; HUH-7; HuH7; Huh7; HUH7; HUH7.0; JTC-39; Japanese Tissue Culture-39
DR   BTO; BTO_0001950
DR   CLO; CLO_0009989
DR   CLO; CLO_0050850
DR   CLO; CLO_0050853
DR   EFO; EFO_0005384
DR   MCCL; MCC:0000232
DR   ABM; T8973
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7847
DR   BioGRID_ORCS_Cell_line; 641
DR   BioSample; SAMN03471912
DR   BioSample; SAMN03472130
DR   BioSample; SAMN10987834
DR   cancercelllines; CVCL_0336
DR   CCLV; CCLV-RIE 1079
DR   CCRID; 1101HUM-PUMC000679
DR   CCRID; 3101HUMSCSP526
DR   CCRID; 3101HUMTCHu182
DR   CCRID; 5301HUM-KCB09070YJ
DR   CCTCC; GDC0134
DR   Cell_Model_Passport; SIDM00585
DR   CGH-DB; 453-3
DR   CGH-DB; 9072-4
DR   ChEMBL-Cells; CHEMBL3307515
DR   ChEMBL-Targets; CHEMBL614039
DR   CLS; 300156
DR   Cosmic; 871515
DR   Cosmic; 873395
DR   Cosmic; 907071
DR   Cosmic; 945154
DR   Cosmic; 948063
DR   Cosmic; 979730
DR   Cosmic; 1187330
DR   Cosmic; 1351512
DR   Cosmic; 1518226
DR   Cosmic; 1622751
DR   Cosmic; 1995450
DR   Cosmic; 2023863
DR   Cosmic; 2162528
DR   Cosmic; 2321028
DR   Cosmic; 2668283
DR   Cosmic; 2674232
DR   Cosmic; 2771603
DR   Cosmic; 2773182
DR   Cosmic-CLP; 907071
DR   DepMap; ACH-000480
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS226AAA
DR   FCS-free; 213-2-437-1-3-3
DR   FCS-free; 213-2-540-1-3-3
DR   GDSC; 907071
DR   GEO; GSM207048
DR   GEO; GSM388882
DR   GEO; GSM388883
DR   GEO; GSM388884
DR   GEO; GSM481447
DR   GEO; GSM501781
DR   GEO; GSM565880
DR   GEO; GSM816641
DR   GEO; GSM827171
DR   GEO; GSM887149
DR   GEO; GSM888221
DR   GEO; GSM936763
DR   GEO; GSM1178257
DR   GEO; GSM1178258
DR   GEO; GSM1374566
DR   GEO; GSM1669919
DR   GEO; GSM2551570
DR   IARC_TP53; 2011
DR   JCRB; JCRB0403
DR   KCB; KCB 200970YJ
DR   KCLB; 60104
DR   LiGeA; CCLE_245
DR   LIMORE; HuH7
DR   LINCS_LDP; LCL-1926
DR   Lonza; 244
DR   PharmacoDB; HuH7_640_2019
DR   PRIDE; PXD001339
DR   PRIDE; PXD005955
DR   PRIDE; PXD008190
DR   PRIDE; PXD023760
DR   PRIDE; PXD028149
DR   PRIDE; PXD028169
DR   PRIDE; PXD028693
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0336
DR   PubChem_Cell_line; CVCL_0336
DR   RCB; RCB1366
DR   RCB; RCB1942
DR   TKG; TKG 0206
DR   TOKU-E; 3614
DR   Ubigene; YC-D001
DR   Wikidata; Q27555640
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   DOI=10.11418/jtca1981.12.3_221;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=6203805;
RX   PubMed=8224613;
RX   PubMed=8389256;
RX   PubMed=8835345;
RX   PubMed=9290701;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=11152498;
RX   PubMed=12029633;
RX   PubMed=15708988;
RX   PubMed=15767549;
RX   PubMed=16935386;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23285155;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=24973239;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27329724;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29610054;
RX   PubMed=29774518;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31395879;
RX   PubMed=31903165;
RX   PubMed=31978347;
RX   PubMed=32899426;
RX   PubMed=33193621;
RX   PubMed=34320349;
RX   PubMed=34800366;
RX   PubMed=35839778;
WW   Info; -; -; https://huh7.com/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Huh-7_Crawford_protocol.pdf
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/Huh7
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-309.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Huh7
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/huh7-xenograft-model/
WW   Provider; BRICS; BRICS0114; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3919
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 40.2 hours (Note=In L-RPMI medium), 46.4 hours (Note=In IS-RPMI medium), 56.3 hours (Note=In S-RPMI medium), 60.9 hours (Note=In IS-MEM medium) (PubMed=6203805); 22 +- 1 hours (PubMed=11152498); 32.2 hours (PubMed=31378681); ~48 hours (CLS=300156).
CC   HLA typing: A*11:01,11:01; B*08:03,35:09; C*01:02,01:02 (PubMed=26589293).
CC   HLA typing: A*11:01:01; B*54:01:01; C*01:02:01; DPB1*02:01:02; DQA1*01:03:01; DQB1*06:01:01; DRB1*08:03:02 (CLS=300156).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (PubMed=29774518).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (PubMed=33193621).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=8389256; PubMed=29774518; PubMed=31395879).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Mitochondrion.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.56%; Native American=0%; East Asian, North=79.68%; East Asian, South=13.08%; South Asian=0%; European, North=0%; European, South=5.69% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID; CLS=300156; Cosmic-CLP=907071; JCRB=JCRB0403; KCLB=60104; PubMed=25877200; PubMed=29774518; PubMed=31378681; RCB=RCB1366; Technion Genomics Center; TKG=TKG 0206
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 16
ST   D12S391: 20 (CLS=300156; Technion Genomics Center)
ST   D12S391: 20,21 (CCRID)
ST   D13S317: 10 (CLS=300156; RCB=RCB1366; Technion Genomics Center)
ST   D13S317: 10,11 (CCRID; Cosmic-CLP=907071; JCRB=JCRB0403; KCLB=60104; PubMed=25877200; PubMed=29774518; PubMed=31378681; TKG=TKG 0206)
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 13,14
ST   D1S1656: 16
ST   D21S11: 30
ST   D22S1045: 17,20
ST   D2S1338: 19
ST   D2S441: 12,14
ST   D3S1358: 15
ST   D5S818: 12
ST   D6S1043: 13,15
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18 (CCRID; Cosmic-CLP=907071; JCRB=JCRB0403; KCLB=60104; PubMed=25877200; PubMed=29774518; PubMed=31378681; RCB=RCB1366; TKG=TKG 0206)
ST   vWA: 18 (CLS=300156; Technion Genomics Center)
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   Huh-7 clone 5-15
AC   CVCL_C8QS
DR   Wikidata; Q123032640
RX   PubMed=10390360;
RX   PubMed=11152498;
CC   Population: Japanese.
CC   Virology: Harbors a self-replicating bicistronic hepatitis C virus (HCV) genotype 1b subgenomic replicon (PubMed=10390360; PubMed=11152498).
CC   Doubling time: 25.5 +- 2.5 hours (PubMed=11152498).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Huh-7 clone 8-1
AC   CVCL_C8QU
DR   Wikidata; Q123032643
RX   PubMed=10390360;
RX   PubMed=11152498;
CC   Population: Japanese.
CC   Characteristics: Control cell line for Huh-7 clone 5-15 (Cellosaurus=CVCL_C8QS) and Huh-7 clone 9-13 (Cellosaurus=CVCL_C8QT).
CC   Doubling time: 22.0 +- 1.5 hours (PubMed=11152498).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Huh-7 clone 9-13
AC   CVCL_C8QT
DR   Wikidata; Q123032644
RX   PubMed=10390360;
RX   PubMed=11152498;
RX   PubMed=12692249;
CC   Population: Japanese.
CC   Virology: Harbors a self-replicating bicistronic hepatitis C virus (HCV) genotype 1b subgenomic replicon (PubMed=10390360; PubMed=11152498).
CC   Doubling time: 21.5 +- 1.0 hours (PubMed=11152498).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HUH-7 SR
AC   CVCL_C8ZK
DR   BioGRID_ORCS_Cell_line; 1535
DR   Wikidata; Q123032645
RX   PubMed=31903165;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   HuH-7-EGFP
AC   CVCL_C8W2
DR   Ubigene; YC-D001-EGFP-P
DR   Wikidata; Q123032646
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   HuH-7-END
AC   CVCL_ZW90
SY   HuH7-HDV-Env-NTCP clone B1
DR   cancercelllines; CVCL_ZW90
DR   Wikidata; Q102114176
RX   PubMed=31292511;
CC   Population: Japanese.
CC   Characteristics: Transfected with pJC126, a plasmid harboring a 1.1-fold cDNA copy of the HDV antigenome.
CC   Virology: Persistently replicates and secretes hepatitis delta virus (HDV).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10905; SLC10A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw (isolate France/Tiollais/1979) envelope protein (HBsAg).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   Huh-7-Luc [JCRB]
AC   CVCL_JG51
SY   HuH-7-Luc
DR   cancercelllines; CVCL_JG51
DR   JCRB; JCRB1600
DR   Wikidata; Q54896853
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1600
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 17
//
ID   HuH-7-Luc [Ubigene]
AC   CVCL_C8W3
DR   Ubigene; YC-D001-Luc-P
DR   Wikidata; Q123032647
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Huh-7-Lunet
AC   CVCL_U459
SY   Huh-7 Lunet; Huh-7/Lunet; Huh7-Lunet; Huh7Lunet; Huh7L; Huh-7-Luc-Neo-ET
DR   BTO; BTO_0005725
DR   EFO; EFO_0022663
DR   cancercelllines; CVCL_U459
DR   Wikidata; Q54896854
RX   PubMed=15596831;
RX   PubMed=17079281;
RX   PubMed=17552027;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   Huh-7-Lunet/Con1
AC   CVCL_CW91
SY   Huh7 Lunet/Con1; Lunet-Con1
DR   BTO; BTO_0005726
DR   cancercelllines; CVCL_CW91
DR   Wikidata; Q54896855
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U459 ! Huh-7-Lunet
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 16
//
ID   Huh-7.5
AC   CVCL_7927
SY   Huh 7.5; Huh7.5
DR   BTO; BTO_0004126
DR   EFO; EFO_0005704
DR   BioGRID_ORCS_Cell_line; 1220
DR   cancercelllines; CVCL_7927
DR   ENCODE; ENCBS227AAA
DR   GEO; GSM816671
DR   GEO; GSM2247740
DR   GEO; GSM2247741
DR   GEO; GSM2247742
DR   Lonza; 1432
DR   PRIDE; PXD006386
DR   Wikidata; Q54896856
RX   PubMed=12438626;
RX   PubMed=15708988;
RX   PubMed=17079281;
RX   PubMed=17552027;
RX   PubMed=25768906;
RX   PubMed=27929099;
RX   PubMed=29468137;
RX   PubMed=30504788;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Huh-7.5_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Japanese.
CC   Virology: Highly permissive for hepatitis C virus (HCV) replication.
CC   Virology: Highly susceptible to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Homozygous (PubMed=15708988).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   Huh-7.5 STAT1 KO #1
AC   CVCL_C2UW
DR   cancercelllines; CVCL_C2UW
DR   GEO; GSM2247743
DR   GEO; GSM2247744
DR   GEO; GSM2247745
DR   Wikidata; Q114311675
RX   PubMed=27929099;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7927 ! Huh-7.5
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Huh-7.5 STAT1 KO #2
AC   CVCL_C2UX
DR   cancercelllines; CVCL_C2UX
DR   Wikidata; Q114311676
RX   PubMed=27929099;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7927 ! Huh-7.5
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Huh-7.5 STAT2 KO #1
AC   CVCL_C2UY
DR   cancercelllines; CVCL_C2UY
DR   Wikidata; Q114311677
RX   PubMed=27929099;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7927 ! Huh-7.5
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Huh-7.5 STAT2 KO #2
AC   CVCL_C2UZ
DR   cancercelllines; CVCL_C2UZ
DR   Wikidata; Q114311678
RX   PubMed=27929099;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7927 ! Huh-7.5
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   Huh-7.5 Tet-On
AC   CVCL_A0TI
SY   Huh-7.5 TetON
DR   cancercelllines; CVCL_A0TI
DR   Millipore; SCC265
DR   Wikidata; Q108820508
RX   PubMed=25768906;
CC   Population: Japanese.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Millipore=SCC265
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7927 ! Huh-7.5
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   Huh-7.5.1
AC   CVCL_E049
SY   Huh 7.5.1; Huh7.5.1
DR   BTO; BTO_0005463
DR   BioGRID_ORCS_Cell_line; 735
DR   cancercelllines; CVCL_E049
DR   CCTCC; GDC0137
DR   ChEMBL-Cells; CHEMBL4483152
DR   ChEMBL-Targets; CHEMBL4483247
DR   PubChem_Cell_line; CVCL_E049
DR   Wikidata; Q54896857
RX   PubMed=15939869;
RX   PubMed=23285155;
RX   PubMed=25420655;
CC   Population: Japanese.
CC   Virology: Compared to the parent Huh-7 cell line, permits improved hepatitis C virus (HCV) production when infected with strain JFH-1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7927 ! Huh-7.5
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   Huh7.5.1-5
AC   CVCL_YU21
DR   cancercelllines; CVCL_YU21
DR   Wikidata; Q94308754
RX   PubMed=25420655;
CC   Population: Japanese.
CC   Virology: CD81-defective clone not susceptible to infection by hepatitis C virus (HCV).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E049 ! Huh-7.5.1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 12
//
ID   Huh-7.5.1-ACE2
AC   CVCL_C9AS
DR   BioGRID_ORCS_Cell_line; 1716
DR   Wikidata; Q123032648
RX   PubMed=35879413;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E049 ! Huh-7.5.1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   Huh7.5.1-8
AC   CVCL_YU20
DR   cancercelllines; CVCL_YU20
DR   Wikidata; Q94308759
RX   PubMed=25420655;
RX   PubMed=33193621;
CC   Population: Japanese.
CC   Virology: Highly susceptible to infection by hepatitis C virus (HCV).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (PubMed=33193621).
CC   Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Heterozygous (PubMed=33193621).
CC   Sequence variation: Mutation; HGNC; HGNC:11255; SPP1; Simple; p.Lys241Thr (c.722A>C); Zygosity=Heterozygous; Note=Newly acquired mutation (PubMed=33193621).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E049 ! Huh-7.5.1
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 12
//
ID   Huh-7/F24
AC   CVCL_WJ09
DR   cancercelllines; CVCL_WJ09
DR   CCRID; 4201PAT-CCTCC00574
DR   Wikidata; Q94308765
CC   Group: Patented cell line.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 12
//
ID   Huh-7/M8
AC   CVCL_XE85
DR   cancercelllines; CVCL_XE85
DR   CCRID; 4201PAT-CCTCC00575
DR   Wikidata; Q94308768
RX   Patent=CN105861442B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014247.
CC   Population: Japanese.
CC   Characteristics: Highly metastatic.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): Patent=CN105861442B
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 20,21
ST   D13S317: 10,11
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19
ST   D2S441: 12,14
ST   D3S1358: 15
ST   D5S818: 12
ST   D6S1043: 13,15
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   Huh-7D12
AC   CVCL_2957
SY   HuH-7D12
DR   cancercelllines; CVCL_2957
DR   ECACC; 01042712
DR   Wikidata; Q54896858
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ECACC=01042712
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   HuH-7T1
AC   CVCL_LG22
DR   cancercelllines; CVCL_LG22
DR   Wikidata; Q54896859
RX   PubMed=23285155;
CC   Population: Japanese.
CC   Virology: Compared to the parent Huh-7 cell line, permits improved hepatitis C virus (HCV) production when infected with strain JFH-1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 15
//
ID   HUH6-eGFP
AC   CVCL_M176
DR   cancercelllines; CVCL_M176
DR   Wikidata; Q54896860
RX   PubMed=15852273;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Asp (c.476C>A); ClinVar=VCV001026335; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4381 ! HuH-6
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   Huh7.93
AC   CVCL_A5AV
SY   Huh7.TA61.93
DR   cancercelllines; CVCL_A5AV
DR   Wikidata; Q107115398
RX   PubMed=16935386;
CC   Population: Japanese.
CC   Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16. Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Huh7 IFITM2-/-
AC   CVCL_UZ56
DR   cancercelllines; CVCL_UZ56
DR   Wikidata; Q94308822
RX   PubMed=30723923;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   HuH7-2C8
AC   CVCL_C8HQ
DR   Wikidata; Q123032649
RX   PubMed=36511319;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HuH7-2C8D
AC   CVCL_C8HR
DR   Wikidata; Q123032650
RX   PubMed=36511319;
CC   Population: Japanese.
CC   Virology: Produces hepatitis D virus (HDV) infectious particles (PubMed=36511319).
CC   Virology: Transfected with pSVLD3-neo, a plasmid harboring 3 copies of the HDV genome (PubMed=36511319).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03138; Hepatitis B virus genotype D subtype ayw envelope protein (HBsAg).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8HQ ! HuH7-2C8
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   HuH7-FLVCR2-KO-c1
AC   CVCL_D4RG
SY   CE05NW-3
DR   Wikidata; Q127381829
WW   Info; RESOLUTE; CE05NW-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20105; FLVCR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-FLVCR2-KO-c5
AC   CVCL_D4RH
SY   CE05NV-Y
DR   Wikidata; Q127381830
WW   Info; RESOLUTE; CE05NV-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20105; FLVCR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HUH7-ins
AC   CVCL_HA62
SY   Huh7ins
DR   cancercelllines; CVCL_HA62
DR   Wikidata; Q54896861
RX   Patent=US10738285;
RX   PubMed=12621453;
RX   PubMed=21084851;
CC   Population: Japanese.
CC   Characteristics: Secretes insulin in a regulated manner in response to glucose, calcium and theophylline.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 20
//
ID   HuH7-MPC2-KO-c10
AC   CVCL_D4RI
SY   CE077K-W
DR   Wikidata; Q127381831
WW   Info; RESOLUTE; CE077K-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24515; MPC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-MPC2-KO-c12
AC   CVCL_D4RJ
SY   CE077M-E
DR   Wikidata; Q127381832
WW   Info; RESOLUTE; CE077M-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24515; MPC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-NPC1L1-KO-c6
AC   CVCL_D4RK
SY   CE0538-3
DR   Wikidata; Q127381833
WW   Info; RESOLUTE; CE0538-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7898; NPC1L1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HUH7-R
AC   CVCL_B7TI
DR   cancercelllines; CVCL_B7TI
DR   Wikidata; Q112929797
RX   DOI=10.5282/edoc.26548;
RX   PubMed=32652772;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   HUH7-R-LUC
AC   CVCL_B7TJ
DR   cancercelllines; CVCL_B7TJ
DR   Wikidata; Q112929800
RX   DOI=10.5282/edoc.26548;
RX   PubMed=32652772;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7TI ! HUH7-R
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   HuH7-SFXN5-KO-c12
AC   CVCL_D4RL
SY   CE077R-Q
DR   Wikidata; Q127381834
WW   Info; RESOLUTE; CE077R-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16073; SFXN5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SFXN5-KO-c14
AC   CVCL_D4RM
SY   CE077S-U
DR   Wikidata; Q127381835
WW   Info; RESOLUTE; CE077S-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16073; SFXN5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC12A5-KO-c3
AC   CVCL_D4RN
SY   CE05P1-S
DR   Wikidata; Q127381836
WW   Info; RESOLUTE; CE05P1-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13818; SLC12A5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC12A5-KO-c4
AC   CVCL_D4RP
SY   CE05P2-9
DR   Wikidata; Q127381837
WW   Info; RESOLUTE; CE05P2-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13818; SLC12A5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC13A5-KO-c4
AC   CVCL_D4RQ
SY   CE05P8-R
DR   Wikidata; Q127381838
WW   Info; RESOLUTE; CE05P8-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23089; SLC13A5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC13A5-KO-c5
AC   CVCL_D4RR
SY   CE05P7-P
DR   Wikidata; Q127381839
WW   Info; RESOLUTE; CE05P7-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23089; SLC13A5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC15A1-KO-c2
AC   CVCL_D4RS
SY   CE07AX-W
DR   Wikidata; Q127381840
WW   Info; RESOLUTE; CE07AX-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10920; SLC15A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC15A1-KO-c6
AC   CVCL_D4RT
SY   CE07B0-B
DR   Wikidata; Q127381841
WW   Info; RESOLUTE; CE07B0-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10920; SLC15A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC16A12-KO-c1
AC   CVCL_D4RU
SY   CE07B2-Q
DR   Wikidata; Q127381842
WW   Info; RESOLUTE; CE07B2-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23094; SLC16A12.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC16A12-KO-c9
AC   CVCL_D4RV
SY   CE07B5-6
DR   Wikidata; Q127381843
WW   Info; RESOLUTE; CE07B5-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23094; SLC16A12.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A1-KO-c1
AC   CVCL_D4RW
SY   CE054B-3
DR   Wikidata; Q127381844
WW   Info; RESOLUTE; CE054B-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10929; SLC17A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A1-KO-c3
AC   CVCL_D4RX
SY   CE054C-M
DR   Wikidata; Q127381845
WW   Info; RESOLUTE; CE054C-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10929; SLC17A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A2-KO-c2
AC   CVCL_D4RY
SY   CE0535-X
DR   Wikidata; Q127381846
WW   Info; RESOLUTE; CE0535-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10930; SLC17A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A2-KO-c3
AC   CVCL_D4RZ
SY   CE0536-G
DR   Wikidata; Q127381847
WW   Info; RESOLUTE; CE0536-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10930; SLC17A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A8-KO-c1
AC   CVCL_D4S0
SY   CE054F-F
DR   Wikidata; Q127381848
WW   Info; RESOLUTE; CE054F-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20151; SLC17A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A8-KO-c4
AC   CVCL_D4S1
SY   CE054G-S
DR   Wikidata; Q127381849
WW   Info; RESOLUTE; CE054G-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20151; SLC17A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A9-KO-c11
AC   CVCL_D4S2
SY   CE077W-2
DR   Wikidata; Q127381850
WW   Info; RESOLUTE; CE077W-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16192; SLC17A9.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC17A9-KO-c16
AC   CVCL_D4S3
SY   CE077Z-K
DR   Wikidata; Q127381851
WW   Info; RESOLUTE; CE077Z-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16192; SLC17A9.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC19A3-KO-c2
AC   CVCL_D4S4
SY   CE05PN-6
DR   Wikidata; Q127381852
WW   Info; RESOLUTE; CE05PN-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16266; SLC19A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC19A3-KO-c6
AC   CVCL_D4S5
SY   CE05PR-4
DR   Wikidata; Q127381853
WW   Info; RESOLUTE; CE05PR-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16266; SLC19A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A10-KO-c10
AC   CVCL_D4S6
SY   CE07B6-2
DR   Wikidata; Q127381854
WW   Info; RESOLUTE; CE07B6-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18057; SLC22A10.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A10-KO-c15
AC   CVCL_D4S7
SY   CE07B7-4
DR   Wikidata; Q127381855
WW   Info; RESOLUTE; CE07B7-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18057; SLC22A10.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A15-KO-c7
AC   CVCL_D4S8
SY   CE054K-V
DR   Wikidata; Q127381856
WW   Info; RESOLUTE; CE054K-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20301; SLC22A15.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A15-KO-c8
AC   CVCL_D4S9
SY   CE054M-N
DR   Wikidata; Q127381857
WW   Info; RESOLUTE; CE054M-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20301; SLC22A15.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A3-KO-c14
AC   CVCL_D4SA
SY   CE0781-A
DR   Wikidata; Q127381858
WW   Info; RESOLUTE; CE0781-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10967; SLC22A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A3-KO-c4
AC   CVCL_D4SB
SY   CE0782-X
DR   Wikidata; Q127381859
WW   Info; RESOLUTE; CE0782-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10967; SLC22A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A7-KO-c2
AC   CVCL_D4SC
SY   CE061N-8
DR   Wikidata; Q127381860
WW   Info; RESOLUTE; CE061N-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10971; SLC22A7.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A7-KO-c6
AC   CVCL_D4SD
SY   CE061R-X
DR   Wikidata; Q127381861
WW   Info; RESOLUTE; CE061R-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10971; SLC22A7.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A9-KO-c4
AC   CVCL_D4SE
SY   CE05R0-3
DR   Wikidata; Q127381862
WW   Info; RESOLUTE; CE05R0-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16261; SLC22A9.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC22A9-KO-c5
AC   CVCL_D4SF
SY   CE05PZ-Y
DR   Wikidata; Q127381863
WW   Info; RESOLUTE; CE05PZ-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16261; SLC22A9.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC23A1-KO-c2
AC   CVCL_D4SG
SY   CE05R1-M
DR   Wikidata; Q127381864
WW   Info; RESOLUTE; CE05R1-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10974; SLC23A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC23A1-KO-c3
AC   CVCL_D4SH
SY   CE05R2-T
DR   Wikidata; Q127381865
WW   Info; RESOLUTE; CE05R2-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10974; SLC23A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A18-KO-c10
AC   CVCL_D4SI
SY   CE07BA-A
DR   Wikidata; Q127381867
WW   Info; RESOLUTE; CE07BA-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10988; SLC25A18.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A18-KO-c3
AC   CVCL_D4SJ
SY   CE07BB-X
DR   Wikidata; Q127381868
WW   Info; RESOLUTE; CE07BB-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10988; SLC25A18.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A18-KO-c9
AC   CVCL_D4SK
SY   CE04M1-M
DR   Wikidata; Q127381870
WW   Info; RESOLUTE; CE04M1-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10988; SLC25A18.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A20-KO-c1
AC   CVCL_D4SL
SY   CE06H4-X
DR   Wikidata; Q127381871
WW   Info; RESOLUTE; CE06H4-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1421; SLC25A20.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A20-KO-c6
AC   CVCL_D4SM
SY   CE06H5-G
DR   Wikidata; Q127381872
WW   Info; RESOLUTE; CE06H5-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1421; SLC25A20.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A42-KO-c1
AC   CVCL_D4SN
SY   CE05RA-P
DR   Wikidata; Q127381874
WW   Info; RESOLUTE; CE05RA-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28380; SLC25A42.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A42-KO-c2
AC   CVCL_D4SP
SY   CE05RB-R
DR   Wikidata; Q127381875
WW   Info; RESOLUTE; CE05RB-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28380; SLC25A42.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A45-KO-c3
AC   CVCL_D4SQ
SY   CE017K-2
DR   Wikidata; Q127381876
WW   Info; RESOLUTE; CE017K-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27442; SLC25A45.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC25A45-KO-c6
AC   CVCL_D4SR
SY   CE04ZV-X
DR   Wikidata; Q127381877
WW   Info; RESOLUTE; CE04ZV-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27442; SLC25A45.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC26A1-KO-c1
AC   CVCL_D4SS
SY   CE054P-Z
DR   Wikidata; Q127381878
WW   Info; RESOLUTE; CE054P-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10993; SLC26A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC26A1-KO-c2
AC   CVCL_D4ST
SY   CE054R-P
DR   Wikidata; Q127381879
WW   Info; RESOLUTE; CE054R-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10993; SLC26A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC26A3-KO-c3
AC   CVCL_D4SU
SY   CE05EF-N
DR   Wikidata; Q127381880
WW   Info; RESOLUTE; CE05EF-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3018; SLC26A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC26A3-KO-c6
AC   CVCL_D4SV
SY   CE05EG-H
DR   Wikidata; Q127381881
WW   Info; RESOLUTE; CE05EG-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3018; SLC26A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC29A3-KO-c12
AC   CVCL_D4SW
SY   CE06HP-5
DR   Wikidata; Q127381882
WW   Info; RESOLUTE; CE06HP-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23096; SLC29A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC29A3-KO-c13
AC   CVCL_D4SX
SY   CE06HR-1
DR   Wikidata; Q127381883
WW   Info; RESOLUTE; CE06HR-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23096; SLC29A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A14-KO-c2
AC   CVCL_D4SY
SY   CE06X6-3
DR   Wikidata; Q127381884
WW   Info; RESOLUTE; CE06X6-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18301; SLC2A14.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A14-KO-c4
AC   CVCL_D4SZ
SY   CE06X7-M
DR   Wikidata; Q127381885
WW   Info; RESOLUTE; CE06X7-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18301; SLC2A14.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A2-KO-c5
AC   CVCL_D4T0
SY   CE05NG-0
DR   Wikidata; Q127381886
WW   Info; RESOLUTE; CE05NG-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11006; SLC2A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A2-KO-c7
AC   CVCL_D4T1
SY   CE05NH-6
DR   Wikidata; Q127381887
WW   Info; RESOLUTE; CE05NH-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11006; SLC2A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A4-KO-c1
AC   CVCL_D4T2
SY   CE05NM-4
DR   Wikidata; Q127381888
WW   Info; RESOLUTE; CE05NM-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11009; SLC2A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A4-KO-c2
AC   CVCL_D4T3
SY   CE05NN-K
DR   Wikidata; Q127381889
WW   Info; RESOLUTE; CE05NN-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11009; SLC2A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A8-KO-c5
AC   CVCL_D4T4
SY   CE06T6-Z
DR   Wikidata; Q127381890
WW   Info; RESOLUTE; CE06T6-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13812; SLC2A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC2A8-KO-c6
AC   CVCL_D4T5
SY   CE06T7-P
DR   Wikidata; Q127381891
WW   Info; RESOLUTE; CE06T7-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13812; SLC2A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC30A10-KO-c18
AC   CVCL_D4T6
SY   CE066W-B
DR   Wikidata; Q127381892
WW   Info; RESOLUTE; CE066W-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25355; SLC30A10.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC30A10-KO-c5
AC   CVCL_D4T7
SY   CE05RM-7
DR   Wikidata; Q127381893
WW   Info; RESOLUTE; CE05RM-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25355; SLC30A10.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC35D1-KO-c2
AC   CVCL_D4T8
SY   CE0783-G
DR   Wikidata; Q127381894
WW   Info; RESOLUTE; CE0783-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20800; SLC35D1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC35D1-KO-c9
AC   CVCL_D4T9
SY   CE0786-M
DR   Wikidata; Q127381895
WW   Info; RESOLUTE; CE0786-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20800; SLC35D1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC35D2-KO-c3
AC   CVCL_D4TA
SY   CE06T1-S
DR   Wikidata; Q127381896
WW   Info; RESOLUTE; CE06T1-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20799; SLC35D2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC35D2-KO-c4
AC   CVCL_D4TB
SY   CE06T2-9
DR   Wikidata; Q127381897
WW   Info; RESOLUTE; CE06T2-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20799; SLC35D2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC37A4-KO-c5
AC   CVCL_D4TC
SY   CE00C7-U
DR   Wikidata; Q127381898
WW   Info; RESOLUTE; CE00C7-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4061; SLC37A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC37A4-KO-c6
AC   CVCL_D4TD
SY   CE00C8-0
DR   Wikidata; Q127381899
WW   Info; RESOLUTE; CE00C8-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4061; SLC37A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A11-KO-c4
AC   CVCL_D4TE
SY   CE07BE-Y
DR   Wikidata; Q127381900
WW   Info; RESOLUTE; CE07BE-Y; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26836; SLC38A11.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A3-KO-c2
AC   CVCL_D4TF
SY   CE05RT-2
DR   Wikidata; Q127381901
WW   Info; RESOLUTE; CE05RT-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18044; SLC38A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A3-KO-c3
AC   CVCL_D4TG
SY   CE05RV-4
DR   Wikidata; Q127381902
WW   Info; RESOLUTE; CE05RV-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18044; SLC38A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A4-KO-c1
AC   CVCL_D4TH
SY   CE05RW-K
DR   Wikidata; Q127381903
WW   Info; RESOLUTE; CE05RW-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14679; SLC38A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A4-KO-c2
AC   CVCL_D4TI
SY   CE05RX-8
DR   Wikidata; Q127381904
WW   Info; RESOLUTE; CE05RX-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14679; SLC38A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A6-KO-c1
AC   CVCL_D4TJ
SY   CE07BF-3
DR   Wikidata; Q127381905
WW   Info; RESOLUTE; CE07BF-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19863; SLC38A6.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A6-KO-c12
AC   CVCL_D4TK
SY   CE06SS-X
DR   Wikidata; Q127381906
WW   Info; RESOLUTE; CE06SS-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19863; SLC38A6.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC38A6-KO-c14
AC   CVCL_D4TL
SY   CE07BG-M
DR   Wikidata; Q127381907
WW   Info; RESOLUTE; CE07BG-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19863; SLC38A6.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC3A1-KO-c1
AC   CVCL_D4TM
SY   CE05S3-3
DR   Wikidata; Q127381908
WW   Info; RESOLUTE; CE05S3-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11025; SLC3A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC3A1-KO-c2
AC   CVCL_D4TN
SY   CE05S4-M
DR   Wikidata; Q127381909
WW   Info; RESOLUTE; CE05S4-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11025; SLC3A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC40A1-KO-c3
AC   CVCL_D4TP
SY   CE06SW-3
DR   Wikidata; Q127381910
WW   Info; RESOLUTE; CE06SW-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10909; SLC40A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC40A1-KO-c5
AC   CVCL_D4TQ
SY   CE06SX-M
DR   Wikidata; Q127381911
WW   Info; RESOLUTE; CE06SX-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10909; SLC40A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC43A1-KO-c1
AC   CVCL_D4TR
SY   CE07BK-F
DR   Wikidata; Q127381912
WW   Info; RESOLUTE; CE07BK-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9225; SLC43A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC43A1-KO-c12
AC   CVCL_D4TS
SY   CE07BN-9
DR   Wikidata; Q127381913
WW   Info; RESOLUTE; CE07BN-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9225; SLC43A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC44A5-KO-c3
AC   CVCL_D4TT
SY   CE06SA-E
DR   Wikidata; Q127381914
WW   Info; RESOLUTE; CE06SA-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28524; SLC44A5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC44A5-KO-c5
AC   CVCL_D4TU
SY   CE06SB-B
DR   Wikidata; Q127381915
WW   Info; RESOLUTE; CE06SB-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28524; SLC44A5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC47A1-KO-c4
AC   CVCL_D4TV
SY   CE0788-F
DR   Wikidata; Q127381916
WW   Info; RESOLUTE; CE0788-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25588; SLC47A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC47A1-KO-c7
AC   CVCL_D4TW
SY   CE0789-S
DR   Wikidata; Q127381917
WW   Info; RESOLUTE; CE0789-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25588; SLC47A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC4A4-KO-c2
AC   CVCL_D4TX
SY   CE078A-9
DR   Wikidata; Q127381918
WW   Info; RESOLUTE; CE078A-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11030; SLC4A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC4A4-KO-c4
AC   CVCL_D4TY
SY   CE078C-N
DR   Wikidata; Q127381919
WW   Info; RESOLUTE; CE078C-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11030; SLC4A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC51A-KO-c1
AC   CVCL_D4TZ
SY   CE07BR-N
DR   Wikidata; Q127381920
WW   Info; RESOLUTE; CE07BR-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29955; SLC51A.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC51A-KO-c2
AC   CVCL_D4U0
SY   CE07BS-H
DR   Wikidata; Q127381921
WW   Info; RESOLUTE; CE07BS-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29955; SLC51A.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC51B-KO-c10
AC   CVCL_D4U1
SY   CE06S9-W
DR   Wikidata; Q127381922
WW   Info; RESOLUTE; CE06S9-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29956; SLC51B.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC51B-KO-c2
AC   CVCL_D4U2
SY   CE06S8-1
DR   Wikidata; Q127381923
WW   Info; RESOLUTE; CE06S8-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29956; SLC51B.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC5A12-KO-c1
AC   CVCL_D4U3
SY   CE05SE-P
DR   Wikidata; Q127381924
WW   Info; RESOLUTE; CE05SE-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28750; SLC5A12.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC5A12-KO-c2
AC   CVCL_D4U4
SY   CE05SF-R
DR   Wikidata; Q127381925
WW   Info; RESOLUTE; CE05SF-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28750; SLC5A12.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC5A8-KO-c2
AC   CVCL_D4U5
SY   CE05SG-C
DR   Wikidata; Q127381926
WW   Info; RESOLUTE; CE05SG-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19119; SLC5A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC5A8-KO-c3
AC   CVCL_D4U6
SY   CE05SH-5
DR   Wikidata; Q127381927
WW   Info; RESOLUTE; CE05SH-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19119; SLC5A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC5A9-KO-c13
AC   CVCL_D4U7
SY   CE06SR-A
DR   Wikidata; Q127381928
WW   Info; RESOLUTE; CE06SR-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22146; SLC5A9.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC5A9-KO-c7
AC   CVCL_D4U8
SY   CE06SP-8
DR   Wikidata; Q127381929
WW   Info; RESOLUTE; CE06SP-8; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22146; SLC5A9.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A11-KO-c2
AC   CVCL_D4U9
SY   CE05SK-1
DR   Wikidata; Q127381930
WW   Info; RESOLUTE; CE05SK-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11044; SLC6A11.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A11-KO-c5
AC   CVCL_D4UA
SY   CE05SM-W
DR   Wikidata; Q127381931
WW   Info; RESOLUTE; CE05SM-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11044; SLC6A11.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A12-KO-c3
AC   CVCL_D4UB
SY   CE06S0-V
DR   Wikidata; Q127381932
WW   Info; RESOLUTE; CE06S0-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11045; SLC6A12.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A12-KO-c8
AC   CVCL_D4UC
SY   CE06S1-N
DR   Wikidata; Q127381933
WW   Info; RESOLUTE; CE06S1-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11045; SLC6A12.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A19-KO-c10
AC   CVCL_D4UD
SY   CE078F-Z
DR   Wikidata; Q127381934
WW   Info; RESOLUTE; CE078F-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27960; SLC6A19.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A19-KO-c7
AC   CVCL_D4UE
SY   CE078H-R
DR   Wikidata; Q127381935
WW   Info; RESOLUTE; CE078H-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27960; SLC6A19.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A4-KO-c2
AC   CVCL_D4UF
SY   CE05SS-Q
DR   Wikidata; Q127381936
WW   Info; RESOLUTE; CE05SS-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11050; SLC6A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC6A4-KO-c3
AC   CVCL_D4UG
SY   CE05ST-U
DR   Wikidata; Q127381937
WW   Info; RESOLUTE; CE05ST-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11050; SLC6A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC7A10-KO-c6
AC   CVCL_D4UH
SY   CE06S4-P
DR   Wikidata; Q127381938
WW   Info; RESOLUTE; CE06S4-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11058; SLC7A10.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC7A10-KO-c7
AC   CVCL_D4UI
SY   CE06S5-R
DR   Wikidata; Q127381939
WW   Info; RESOLUTE; CE06S5-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11058; SLC7A10.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC7A2-KO-c4
AC   CVCL_D4UJ
SY   CE06T8-R
DR   Wikidata; Q127381940
WW   Info; RESOLUTE; CE06T8-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11060; SLC7A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC7A2-KO-c5
AC   CVCL_D4UK
SY   CE06T9-C
DR   Wikidata; Q127381941
WW   Info; RESOLUTE; CE06T9-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11060; SLC7A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC7A7-KO-c6
AC   CVCL_D4UL
SY   CE06T4-N
DR   Wikidata; Q127381942
WW   Info; RESOLUTE; CE06T4-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11065; SLC7A7.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLC7A7-KO-c9
AC   CVCL_D4UM
SY   CE06TA-5
DR   Wikidata; Q127381944
WW   Info; RESOLUTE; CE06TA-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11065; SLC7A7.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO1A2-KO-c4
AC   CVCL_D4UN
SY   CE053N-R
DR   Wikidata; Q127381945
WW   Info; RESOLUTE; CE053N-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10956; SLCO1A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO1A2-KO-c5
AC   CVCL_D4UP
SY   CE053M-P
DR   Wikidata; Q127381946
WW   Info; RESOLUTE; CE053M-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10956; SLCO1A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO2A1-KO-c2
AC   CVCL_D4UQ
SY   CE05B8-N
DR   Wikidata; Q127381947
WW   Info; RESOLUTE; CE05B8-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10955; SLCO2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO2A1-KO-c3
AC   CVCL_D4UR
SY   CE05B9-H
DR   Wikidata; Q127381948
WW   Info; RESOLUTE; CE05B9-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10955; SLCO2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO2B1-KO-c2
AC   CVCL_D4US
SY   CE05T3-X
DR   Wikidata; Q127381949
WW   Info; RESOLUTE; CE05T3-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10962; SLCO2B1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO2B1-KO-c3
AC   CVCL_D4UT
SY   CE05T4-G
DR   Wikidata; Q127381950
WW   Info; RESOLUTE; CE05T4-G; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10962; SLCO2B1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO4C1-KO-c1
AC   CVCL_D4UU
SY   CE078M-5
DR   Wikidata; Q127381951
WW   Info; RESOLUTE; CE078M-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23612; SLCO4C1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SLCO4C1-KO-c7
AC   CVCL_D4UV
SY   CE078R-E
DR   Wikidata; Q127381952
WW   Info; RESOLUTE; CE078R-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23612; SLCO4C1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SVOPL-KO-c2
AC   CVCL_D4UW
SY   CE053S-1
DR   Wikidata; Q127381953
WW   Info; RESOLUTE; CE053S-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27034; SVOPL.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-SVOPL-KO-c3
AC   CVCL_D4UX
SY   CE053T-W
DR   Wikidata; Q127381954
WW   Info; RESOLUTE; CE053T-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27034; SVOPL.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-UCP1-KO-c11
AC   CVCL_D4UY
SY   CE04M4-S
DR   Wikidata; Q127381955
WW   Info; RESOLUTE; CE04M4-S; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12517; UCP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-UCP1-KO-c9
AC   CVCL_D4UZ
SY   CE04M5-9
DR   Wikidata; Q127381956
WW   Info; RESOLUTE; CE04M5-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12517; UCP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-UNC93A-KO-c11
AC   CVCL_D4V0
SY   CE078S-B
DR   Wikidata; Q127381957
WW   Info; RESOLUTE; CE078S-B; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12570; UNC93A.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   HuH7-UNC93A-KO-c3
AC   CVCL_D4V1
SY   CE078T-7
DR   Wikidata; Q127381959
WW   Info; RESOLUTE; CE078T-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12570; UNC93A.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   Huh7S1
AC   CVCL_4W53
DR   cancercelllines; CVCL_4W53
DR   Wikidata; Q54896862
RX   PubMed=23111106;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   HUi001-A
AC   CVCL_ZZ65
SY   iPSC AG09908R
DR   SKIP; SKIP005857
DR   Wikidata; Q102114178
RX   PubMed=32623353;
CC   From: Hanyang Biomedical Research Institute, Hanyang University; Seoul; South Korea.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=32623353).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T872 ! AG09908
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   HUi002-A
AC   CVCL_A4XA
SY   iPSC AG20442R3
DR   Wikidata; Q107115399
RX   PubMed=33418202;
CC   From: Hanyang Biomedical Research Institute, Hanyang University; Seoul; South Korea.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   HUIEC
AC   CVCL_6C15
SY   HUman Intestinal Epithelial Cell line
DR   Wikidata; Q54896863
RX   PubMed=25821058;
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   HUJIi001-A
AC   CVCL_C1TE
SY   iWSM-F1
DR   BioSamples; SAMEA6907397
DR   hPSCreg; HUJIi001-A
DR   Wikidata; Q114311679
CC   From: Hebrew University; Jerusalem; Israel.
CC   Population: Jewish; Yemenite.
CC   Sequence variation: Mutation; HGNC; HGNC:12799; WWOX; Simple; c.517-2A>G; ClinVar=VCV003774965; Zygosity=Heterozygous; Note=Splice acceptor mutation (hPSCreg=HUJIi001-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   HUJIi002-A
AC   CVCL_C1TF
SY   iWSM-M2
DR   BioSamples; SAMEA6914465
DR   hPSCreg; HUJIi002-A
DR   Wikidata; Q114311680
CC   From: Hebrew University; Jerusalem; Israel.
CC   Population: Jewish; Yemenite.
CC   Sequence variation: Mutation; HGNC; HGNC:12799; WWOX; Simple; c.517-2A>G; ClinVar=VCV003774965; Zygosity=Heterozygous; Note=Splice acceptor mutation (hPSCreg=HUJIi002-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   HUJIi003-A
AC   CVCL_C1TG
SY   iWSM-S5
DR   BioSamples; SAMEA6914467
DR   hPSCreg; HUJIi003-A
DR   Wikidata; Q114311681
CC   From: Hebrew University; Jerusalem; Israel.
CC   Population: Jewish; Yemenite.
CC   Sequence variation: Mutation; HGNC; HGNC:12799; WWOX; Simple; c.517-2A>G; ClinVar=VCV003774965; Zygosity=Homozygous; Note=Splice acceptor mutation (hPSCreg=HUJIi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C189273; Developmental and epileptic encephalopathy 28
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   HUJIi004-A
AC   CVCL_E4CY
SY   ITM-iPS10; ITM-iPS, clone 10
DR   BioSamples; SAMEA115345294
DR   hPSCreg; HUJIi004-A
RX   PubMed=39951836;
CC   From: Hebrew University; Jerusalem; Israel.
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Glu642Valfs*4 (c.1923_1924delAG); Zygosity=Heterozygous (PubMed=39951836).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176897; Neurodevelopmental disorder with spastic diplegia and visual defects
DI   ORDO; Orphanet_404473; Severe intellectual disability-progressive spastic diplegia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4CZ ! HUJIi004-B
SX   Male
AG   11-12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   HUJIi004-B
AC   CVCL_E4CZ
SY   ITM-iPS11; ITM-iPS, clone 11
DR   BioSamples; SAMEA115495196
DR   hPSCreg; HUJIi004-B
RX   PubMed=39951836;
CC   From: Hebrew University; Jerusalem; Israel.
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Glu642Valfs*4 (c.1923_1924delAG); Zygosity=Heterozygous (PubMed=39951836).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176897; Neurodevelopmental disorder with spastic diplegia and visual defects
DI   ORDO; Orphanet_404473; Severe intellectual disability-progressive spastic diplegia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4CY ! HUJIi004-A
SX   Male
AG   11-12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   HUJIi005-A
AC   CVCL_E4D0
SY   ID-iPS7; ID-iPS, clone 7
DR   BioSamples; SAMEA115345296
DR   hPSCreg; HUJIi005-A
RX   PubMed=39951836;
CC   From: Hebrew University; Jerusalem; Israel.
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala689Alafs*45 (c.2067delT); Zygosity=Heterozygous (PubMed=39951836).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176897; Neurodevelopmental disorder with spastic diplegia and visual defects
DI   ORDO; Orphanet_404473; Severe intellectual disability-progressive spastic diplegia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4D1 ! HUJIi005-B
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   HUJIi005-B
AC   CVCL_E4D1
SY   ID-iPS10; ID-iPS, clone 10
DR   BioSamples; SAMEA115495200
DR   hPSCreg; HUJIi005-B
RX   PubMed=39951836;
CC   From: Hebrew University; Jerusalem; Israel.
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala689Alafs*45 (c.2067delT); Zygosity=Heterozygous (PubMed=39951836).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176897; Neurodevelopmental disorder with spastic diplegia and visual defects
DI   ORDO; Orphanet_404473; Severe intellectual disability-progressive spastic diplegia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4D0 ! HUJIi005-A
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   HuK-1
AC   CVCL_WH75
SY   Human Kidney-1
DR   Wikidata; Q94308861
RX   PubMed=7206264;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4FM
CA   Undefined cell line type
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   HuK-1.P3
AC   CVCL_WH76
SY   HuK-1 P3
DR   Wikidata; Q94308865
RX   PubMed=2993257;
RX   PubMed=3877731;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WH75 ! HuK-1
SX   Male
AG   4FM
CA   Undefined cell line type
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   Huker
AC   CVCL_9T09
SY   Human keratinocytes
DR   IZSLER; BS CL 186
DR   Wikidata; Q54896864
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (STR profile). Was originally thought to originate from keratinocytes.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00636.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): IZSLER=BS CL 186
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,14
ST   D16S539: 9,10
ST   D21S11: 27,28
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   HuKo39
AC   CVCL_8283
DR   BioSample; SAMN03151717
DR   Wikidata; Q54896865
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00066.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   HuL-1
AC   CVCL_8357
SY   HUL-1; Human Liver-1
DR   BioSample; SAMN03151718
DR   BioSample; SAMN03472367
DR   JCRB; NIHS0231
DR   RCB; RCB0077
DR   RCB; RCB1457
DR   Wikidata; Q54896866
RX   CelloPub=CLPUB00527;
RX   PubMed=2836073;
RX   PubMed=3986962;
RX   PubMed=7206264;
RX   PubMed=15767549;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a 4 month old male fetal liver.
CC   Part of: JFCR45 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00318.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0231; true.
CC   Discontinued: RCB; RCB0077; true.
CC   Discontinued: RCB; RCB1457; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=NIHS0231; RCB=RCB0077
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   HuL-1-317
AC   CVCL_WH71
DR   Wikidata; Q94308904
RX   PubMed=2535785;
RX   PubMed=2836073;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Grand-parent cell line (HuL-1) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: ~72 hours (PubMed=2836073).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WH70 ! HuL-1.P3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HuL-1.P3
AC   CVCL_WH70
SY   HuL-1-P3
DR   Wikidata; Q94308909
RX   PubMed=2836073;
RX   PubMed=3242846;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Parent cell line (HuL-1) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8357 ! HuL-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HUL-42
AC   CVCL_YA04
SY   HUL42
DR   KCB; KCB 200545YJ
DR   Wikidata; Q94308913
RX   PubMed=25433501;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   HuLa-PC
AC   CVCL_UC74
AS   CVCL_ZE90
SY   Pt65 HPV
DR   ATCC; CRL-3342
DR   Wikidata; Q94308919
RX   PubMed=25272366;
CC   Population: Caucasian.
CC   Doubling time: 60-70 hours (ATCC=CRL-3342).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Larynx, glottis, posterior commissure; UBERON=UBERON_8480036.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-3342
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41D
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   HuLEC-1
AC   CVCL_0A09
SY   CDC.EU./HuLEC-1; Human Lung microvascular Endothelial Cell line-1
DR   Wikidata; Q54896867
RX   CelloPub=CLPUB00216;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   HuLEC-2
AC   CVCL_0A10
SY   CDC.EU./HuLEC-2; Human Lung microvascular Endothelial Cell line-2
DR   Wikidata; Q54896869
RX   CelloPub=CLPUB00216;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HuLEC-5a
AC   CVCL_0A11
SY   HULEC-5a; HULEC-5A; Human Lung Microvascular Endothelial Cell line-5a
DR   ATCC; CRL-3244
DR   Wikidata; Q54896870
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/HuLEC-5a
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVT).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
ST   Source(s): ATCC=CRL-3244
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13,14
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   Huma 25
AC   CVCL_Y906
SY   Human mammary clone 25
DR   Wikidata; Q54896871
RX   PubMed=1708370;
RX   PubMed=2478401;
CC   Doubling time: 53 hours (Note=In routine medium), 68 hours (Note=In growth medium) (PubMed=2478401).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y908 ! SVE3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   Huma 50
AC   CVCL_E3C3
SY   Human mammary clone 50
RX   PubMed=1708370;
RX   PubMed=2478401;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y905 ! Huma 7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Huma 6
AC   CVCL_E3C1
SY   Human mammary clone 6
RX   PubMed=1708370;
RX   PubMed=2478401;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y908 ! SVE3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Huma 62
AC   CVCL_Y907
SY   Human mammary clone 62
DR   Wikidata; Q54896872
RX   PubMed=1708370;
RX   PubMed=2478401;
CC   Doubling time: 68 hours (Note=In routine medium), 17 hours (Note=In growth medium) (PubMed=2478401).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y905 ! Huma 7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   Huma 7
AC   CVCL_Y905
SY   Huma-7; Huma7; Human mammary clone 7
DR   BTO; BTO_0004127
DR   Wikidata; Q54896876
RX   PubMed=1708370;
RX   PubMed=1911442;
RX   PubMed=2478401;
CC   Doubling time: 17 hours (Note=In routine medium), 19 hours (Note=In growth medium) (PubMed=2478401).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y908 ! SVE3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   Huma 8
AC   CVCL_E3C2
SY   Human mammary clone 8
RX   PubMed=1708370;
RX   PubMed=2478401;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y908 ! SVE3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HUMEMS
AC   CVCL_S872
DR   Wikidata; Q54896877
RX   PubMed=17547718;
RX   PubMed=20712710;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=17547718).
CC   Misspelling: HUMENS; PubMed=20712710.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   HuMI
AC   CVCL_9U06
SY   Hu-MI
DR   Wikidata; Q54896878
RX   PubMed=1703035;
RX   PubMed=8217602;
RX   PubMed=9766434;
RX   PubMed=11414198;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HuMI-T
AC   CVCL_9U07
DR   Wikidata; Q54896879
RX   PubMed=8217602;
RX   PubMed=9766434;
RX   PubMed=11414198;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U06 ! HuMI
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HuMI-TTu1
AC   CVCL_9U08
SY   TTu1
DR   Wikidata; Q54896880
RX   PubMed=8217602;
RX   PubMed=11414198;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U07 ! HuMI-T
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HuMI-TTu2
AC   CVCL_9U09
SY   TTu2
DR   Wikidata; Q54896881
RX   PubMed=9766434;
RX   PubMed=11414198;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U07 ! HuMI-T
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   HUN1
AC   CVCL_YE06
SY   HUN
DR   Wikidata; Q94309045
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
RX   PubMed=7316467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3167; Acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   HUNC-E
AC   CVCL_G211
DR   Wikidata; Q54896882
RX   PubMed=9600341;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   HUNC-S
AC   CVCL_G212
DR   Wikidata; Q54896883
RX   PubMed=9600341;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   HuNET
AC   CVCL_W948
DR   Wikidata; Q54896884
RX   PubMed=11138979;
RX   PubMed=22538498;
CC   Doubling time: Several weeks (PubMed=11138979).
DI   NCIt; C26749; VIP-producing neuroendocrine tumor
DI   ORDO; Orphanet_97282; VIPoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   HUNN1
AC   CVCL_C5HK
DR   Wikidata; Q116049536
RX   PubMed=15297752;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgY.
CC   Monoclonal antibody target: UniProtKB; P04925; Mouse Prnp (Note=Also reacts with bovine and sheep).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   HUNN2
AC   CVCL_C5HL
DR   Wikidata; Q116049537
RX   PubMed=15297752;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: IgY.
CC   Monoclonal antibody target: UniProtKB; P04925; Mouse Prnp (Note=Also reacts with bovine and sheep).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 3
//
ID   HuNS1
AC   CVCL_2526
SY   HUNS1
DR   CLO; CLO_0004298
DR   EFO; EFO_0002207
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-8644
DR   BioSample; SAMN03471205
DR   BioSample; SAMN10987603
DR   cancercelllines; CVCL_2526
DR   Cell_Model_Passport; SIDM01556
DR   Cosmic; 683664
DR   DepMap; ACH-000829
DR   GEO; GSM887150
DR   GEO; GSM888222
DR   IARC_TP53; 21388
DR   IGRhCellID; HuNS1
DR   LiGeA; CCLE_868
DR   PharmacoDB; HuNS1_641_2019
DR   Progenetix; CVCL_2526
DR   Wikidata; Q54896885
RX   Patent=US4720459;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Grand-parent cell line (GM01500) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8644.
CC   Population: Caucasian.
CC   Characteristics: Secretes IgG2 kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.22%; East Asian, North=0%; East Asian, South=1.71%; South Asian=5.64%; European, North=56.19%; European, South=35.24% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-8644
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,18
ST   D19S433: 15,15.2
ST   D21S11: 30,33.2
ST   D2S1338: 20,21,22
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 16,17
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H615 ! GM1500-6TG-A11
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   HuO-3N1
AC   CVCL_1297
SY   HuO3N1; HUO3N1
DR   BTO; BTO_0002431
DR   CLO; CLO_0050099
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471625
DR   cancercelllines; CVCL_1297
DR   Cell_Model_Passport; SIDM00584
DR   ChEMBL-Cells; CHEMBL3308818
DR   ChEMBL-Targets; CHEMBL1075475
DR   Cosmic; 909977
DR   Cosmic-CLP; 909977
DR   DepMap; ACH-002142
DR   EGA; EGAS00001000978
DR   GDSC; 909977
DR   GEO; GSM320824
DR   GEO; GSM1669920
DR   IARC_TP53; 21389
DR   JCRB; JCRB0413
DR   LINCS_LDP; LCL-1422
DR   PharmacoDB; HuO3N1_642_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1297
DR   RCB; RCB2104
DR   TKG; TKG 0452
DR   Wikidata; Q54896886
RX   PubMed=3862491;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala76fs*73 (c.225_226insT); Zygosity=Heterozygous (Cosmic-CLP=909977; DepMap=ACH-002142).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.58%; Native American=0%; East Asian, North=72.02%; East Asian, South=23.28%; South Asian=1.73%; European, North=1.15%; European, South=0.24% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): Cosmic-CLP=909977; JCRB=JCRB0413; RCB=RCB2104; TKG=TKG 0452
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   HuO9
AC   CVCL_1298
SY   Huo9; HUO9; Hu09
DR   CLO; CLO_0009875
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471626
DR   cancercelllines; CVCL_1298
DR   Cell_Model_Passport; SIDM00599
DR   ChEMBL-Cells; CHEMBL3308748
DR   ChEMBL-Targets; CHEMBL1075476
DR   Cosmic; 907072
DR   Cosmic; 931040
DR   Cosmic-CLP; 907072
DR   DepMap; ACH-001526
DR   EGA; EGAS00001000978
DR   GDSC; 907072
DR   GEO; GSM320823
DR   GEO; GSM1669921
DR   GEO; GSM1676303
DR   GEO; GSM1701638
DR   GEO; GSM1914988
DR   GEO; GSM1914989
DR   GEO; GSM1914990
DR   GEO; GSM1914991
DR   IARC_TP53; 21390
DR   JCRB; JCRB0427
DR   LINCS_LDP; LCL-1423
DR   PharmacoDB; HuO9_643_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1298
DR   Wikidata; Q54896887
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=2170070;
RX   PubMed=2691514;
RX   PubMed=9359923;
RX   PubMed=12405284;
RX   PubMed=14669798;
RX   PubMed=15289353;
RX   PubMed=20164919;
RX   PubMed=26320182;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=29334376;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in athymic nude mice after five passages.
CC   Doubling time: 57 hours (PubMed=2170070); 43.3 hours (PubMed=14669798).
CC   HLA typing: A*24:01,33:03; B*44:03:01,51:01; C*14:02,14:03 (PubMed=15289353).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9359923).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.89%; Native American=0%; East Asian, North=77.77%; East Asian, South=13.74%; South Asian=0%; European, North=1.78%; European, South=3.83% (PubMed=30894373).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): Cosmic-CLP=907072; DepMap=ACH-001526; JCRB=JCRB0427
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 11,13
ST   Penta E: 17,21
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2958 ! HuO9N2
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   HuO9-H3
AC   CVCL_WL11
SY   Hu09-H3; H3
DR   Wikidata; Q94309126
RX   PubMed=14669798;
RX   PubMed=26320182;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic.
CC   Doubling time: 49.3 hours (PubMed=14669798).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   HuO9-L12
AC   CVCL_WL12
SY   L12
DR   Wikidata; Q94309130
RX   PubMed=14669798;
CC   Population: Japanese.
CC   Characteristics: Low metastatic phenotype.
CC   Doubling time: 44.9 hours (PubMed=14669798).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   HuO9-L13
AC   CVCL_WL13
SY   L13
DR   Wikidata; Q94309133
RX   PubMed=14669798;
CC   Population: Japanese.
CC   Characteristics: Low metastatic phenotype.
CC   Doubling time: 48.6 hours (PubMed=14669798).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   HuO9-L6
AC   CVCL_WL14
SY   L6
DR   Wikidata; Q94309139
RX   PubMed=14669798;
CC   Population: Japanese.
CC   Characteristics: Low metastatic phenotype.
CC   Doubling time: 48.6 hours (PubMed=14669798).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   HuO9-M112
AC   CVCL_R725
SY   Hu09-M112; M112
DR   GEO; GSM1914996
DR   GEO; GSM1914997
DR   GEO; GSM1914998
DR   GEO; GSM1914999
DR   Wikidata; Q54896888
RX   PubMed=12405284;
RX   PubMed=14669798;
RX   PubMed=26320182;
RX   PubMed=29334376;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic.
CC   Doubling time: 42.4 hours (PubMed=14669798).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   HuO9-M132
AC   CVCL_R726
SY   Hu09-M132; M132
DR   Wikidata; Q54896889
RX   PubMed=12405284;
RX   PubMed=14669798;
RX   PubMed=26320182;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic.
CC   Doubling time: 44.9 hours (PubMed=14669798).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   HuO9/CMV-Luc
AC   CVCL_JG37
SY   HuO9 CMV-Luc
DR   JCRB; JCRB1692
DR   JCRB; NIHS1047
DR   Wikidata; Q54896890
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1692).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1047; true.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): JCRB=JCRB1692
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   HuO9N2
AC   CVCL_2958
SY   HUO9N2; HuO 9N2; O9N2
DR   CLO; CLO_0009876
DR   CLO; CLO_0050809
DR   BioSample; SAMN03470948
DR   GEO; GSM320821
DR   JCRB; JCRB0428
DR   LINCS_LDP; LCL-1424
DR   RCB; RCB2532
DR   TKG; TKG 0451
DR   Wikidata; Q54896891
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=2691514;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in athymic nude mice after two passages.
CC   Doubling time: ~5 days (Note=Lot 031297) (JCRB=JCRB0428).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): JCRB=JCRB0428; PubMed=25877200; RCB=RCB2532; TKG=TKG 0451
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 11,13
ST   Penta E: 17,21
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
ID   HUOA
AC   CVCL_X935
DR   CGH-DB; 341-2
DR   CGH-DB; 9349-4
DR   Cosmic; 877484
DR   Cosmic; 1152564
DR   Wikidata; Q54896892
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3593088;
RX   PubMed=3598277;
RX   PubMed=9573483;
RX   PubMed=10457904;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Doubling time: 78 hours (Note=At 40th passage), 77 hours (Note=At 100th passage) (PubMed=3598277); 80 hours (PubMed=3593088).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 10
//
ID   HUOCA-II
AC   CVCL_A620
SY   HVOCA-II
DR   Cosmic; 877482
DR   Cosmic; 1152562
DR   Wikidata; Q54896893
RX   PubMed=2435943;
RX   PubMed=2448191;
RX   PubMed=3593088;
RX   PubMed=9573483;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 24 hours (Note=At 45th passage) (PubMed=2435943; PubMed=3593088).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   HuOS
AC   CVCL_A6RQ
DR   Wikidata; Q107115400
RX   PubMed=433590;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=433590).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   HUOT
AC   CVCL_VS95
DR   Wikidata; Q94309225
RX   PubMed=2411992;
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=9436037;
RX   PubMed=9573483;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 72-98 hours (PubMed=2411992); 80 hours (PubMed=10457904).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C39995; Malignant ovarian teratoma
DI   ORDO; Orphanet_398987; Malignant teratoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   HuP-T3
AC   CVCL_1299
SY   HUP-T3; Hu-P-T3; HuPT3; HupT3; HUPT3
DR   BTO; BTO_0006547
DR   CLO; CLO_0004299
DR   CLO; CLO_0004300
DR   EFO; EFO_0006596
DR   CLDB; cl1769
DR   CLDB; cl1770
DR   CLDB; cl1771
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 640
DR   BioSample; SAMN03472116
DR   BioSample; SAMN10987811
DR   cancercelllines; CVCL_1299
DR   Cell_Model_Passport; SIDM00533
DR   ChEMBL-Cells; CHEMBL3308399
DR   ChEMBL-Targets; CHEMBL1075477
DR   Cosmic; 907285
DR   Cosmic; 1995451
DR   Cosmic; 2434096
DR   Cosmic-CLP; 907285
DR   DepMap; ACH-000118
DR   DSMZ; ACC-259
DR   DSMZCellDive; ACC-259
DR   ECACC; 93121055
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907285
DR   GEO; GSM206515
DR   GEO; GSM827205
DR   GEO; GSM887151
DR   GEO; GSM888223
DR   GEO; GSM1374567
DR   GEO; GSM1669922
DR   IARC_TP53; 21391
DR   ICLC; HTL96006
DR   LiGeA; CCLE_385
DR   LINCS_LDP; LCL-1790
DR   PharmacoDB; HuPT3_644_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1299
DR   PubChem_Cell_line; CVCL_1299
DR   Wikidata; Q54896894
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=8454916;
RX   PubMed=11668190;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-259).
CC   HLA typing: A*02:07,24:02; B*40:06,40:06; C*01:02,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (Cosmic-CLP=907285; DepMap=ACH-000118).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4071_4072insGATT); Zygosity=Heterozygous (Cosmic-CLP=907285; DepMap=ACH-000118).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (Cosmic-CLP=907285; DepMap=ACH-000118).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.94%; Native American=0%; East Asian, North=78.19%; East Asian, South=19.92%; South Asian=0%; European, North=0%; European, South=0.95% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=907285; DSMZ=ACC-259; ECACC=93121055; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D18S51: 16,17
ST   D19S433: 13,16
ST   D21S11: 28,30
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 10,14
ST   D7S820: 12
ST   D8S1179: 15
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 16,17
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   HuP-T4
AC   CVCL_1300
SY   HUP-T4; Hu-P-T4; HuPT4; HUPT4
DR   CLO; CLO_0004301
DR   CLO; CLO_0004302
DR   EFO; EFO_0002208
DR   CLDB; cl1772
DR   CLDB; cl1773
DR   CLDB; cl1774
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 895
DR   BioSample; SAMN03472974
DR   BioSample; SAMN03473381
DR   BioSample; SAMN10988380
DR   cancercelllines; CVCL_1300
DR   Cell_Model_Passport; SIDM00531
DR   ChEMBL-Cells; CHEMBL3308815
DR   ChEMBL-Targets; CHEMBL1075478
DR   Cosmic; 907286
DR   Cosmic; 2434089
DR   Cosmic-CLP; 907286
DR   DepMap; ACH-000213
DR   DSMZ; ACC-223
DR   DSMZCellDive; ACC-223
DR   ECACC; 93121056
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907286
DR   GEO; GSM827185
DR   GEO; GSM887152
DR   GEO; GSM888224
DR   GEO; GSM1374568
DR   GEO; GSM1669923
DR   IARC_TP53; 21392
DR   ICLC; HTL95006
DR   IGRhCellID; HuPT4
DR   LiGeA; CCLE_379
DR   LINCS_LDP; LCL-1791
DR   PharmacoDB; HuPT4_645_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1300
DR   PubChem_Cell_line; CVCL_1300
DR   Wikidata; Q54896895
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=8454916;
RX   PubMed=11668190;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~38 hours (DSMZ=ACC-223).
CC   HLA typing: A*02:06,02:06; B*15:01,51:01; C*07:02,15:02; DRB1*04:08,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (Cosmic-CLP=907286; DepMap=ACH-000213).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Thr (c.764T>C); ClinVar=VCV000376623; Zygosity=Homozygous (Cosmic-CLP=907286; DepMap=ACH-000213).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.39%; East Asian, North=74.65%; East Asian, South=24.82%; South Asian=0%; European, North=0%; European, South=0.13% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=907286; DSMZ=ACC-223; ECACC=93121056; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8 (DSMZ=ACC-223)
ST   D13S317: 8,9 (Cosmic-CLP=907286; ECACC=93121056; PubMed=25877200)
ST   D16S539: 10,11
ST   D18S51: 18
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 11,16
ST   FGA: 23,24,25
ST   Penta D: 9
ST   Penta E: 18,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   HUPEC 001 G0/G0
AC   CVCL_B0C8
DR   ATCC; CRL-3462
DR   Wikidata; Q108820509
RX   PubMed=19955187;
CC   Population: Asian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte-like epithelial cell; CL=CL_0000653.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   HUPEC 002 FSGS G0/G0
AC   CVCL_B0D0
DR   ATCC; CRL-3463
DR   Wikidata; Q108820510
RX   PubMed=19955187;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte-like epithelial cell; CL=CL_0000653.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   HUPEC 003 FSGS G0/G0
AC   CVCL_B0C9
DR   ATCC; CRL-3466
DR   Wikidata; Q108820511
RX   PubMed=19955187;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte-like epithelial cell; CL=CL_0000653.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   HUPEC 004 FSGS G1/G2
AC   CVCL_B6A5
DR   ATCC; CRL-3464
DR   Wikidata; Q111733464
RX   PubMed=19955187;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte-like epithelial cell; CL=CL_0000653.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   HUPEC 005 FSGS G1/G2
AC   CVCL_B0CA
DR   ATCC; CRL-3465
DR   Wikidata; Q108820512
RX   PubMed=19955187;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte-like epithelial cell; CL=CL_0000653.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   hURO18H7
AC   CVCL_E7CN
SY   Huro18H7
RX   CelloPub=CLPUB00789;
CC   From: Le, Phong T.; Loyola University Chicago; Chicago; USA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a perimenopausal female patient undergoing urogynecological surgery for stress urinary incontinence (CelloPub=CLPUB00789).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   hURO18H7 IQAD biosensor
AC   CVCL_E7CP
SY   hURO18H7 caspase-1 biosensor
RX   CelloPub=CLPUB00789;
CC   Characteristics: Can be used as a biosensor to measure caspase-1 induced cellular inflammatory responses to when infected bacterial urinary pathogens (CelloPub=CLPUB007899).
CC   Characteristics: Transduced with a firefly luciferase reporter circularly permuted in which the N- and C-terminal domains are physically separated by a flexible hinge region containing a caspase-1 cleaving site (IQADSGPIG) (CelloPub=CLPUB00789).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=Circ. permuted with an IQAD caspase-1 site).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a perimenopausal female patient undergoing urogynecological surgery for stress urinary incontinence (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7CN ! hURO18H7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   hURO23A
AC   CVCL_E7D1
RX   CelloPub=CLPUB00789;
CC   From: Le, Phong T.; Loyola University Chicago; Chicago; USA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a perimenopausal female patient undergoing urogynecological surgery for stress urinary incontinence (CelloPub=CLPUB00789).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HURP-159
AC   CVCL_Y094
DR   BCRC; 60525
DR   Wikidata; Q54896896
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15398; Human DLGAP5.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   HURP-196
AC   CVCL_Y095
DR   BCRC; 60526
DR   Wikidata; Q54896897
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15398; Human DLGAP5.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   HuS-1
AC   CVCL_B0U5
SY   Hu S-1
DR   Wikidata; Q108820513
RX   Patent=US4752583;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8660.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P68871; Human HBB (Note=Recognizes Hb S, p.Glu7Val).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HUS-2
AC   CVCL_S874
SY   HUS 2; HUS2
DR   Wikidata; Q54896898
RX   CelloPub=CLPUB00156;
RX   CelloPub=CLPUB00569;
RX   PubMed=76683;
RX   PubMed=4425030;
RX   PubMed=23882450;
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   HuS-2
AC   CVCL_B0U6
SY   Hu S-2
DR   Wikidata; Q108820514
RX   Patent=US4752583;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8661.
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: UniProtKB; P68871; Human HBB (Note=Recognizes Hb S, p.Glu7Val).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HuS-L12/10
AC   CVCL_JG29
DR   JCRB; JCRB1612
DR   Wikidata; Q54896899
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1612
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 8
//
ID   Hushu-Dsfin
AC   CVCL_E4CC
RX   DOI=10.1080/00087114.1997.10797388;
CC   Group: Fish cell line.
CC   Doubling time: 24-48 hours (DOI=10.1080/00087114.1997.10797388).
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=61971; ! Huso huso (Beluga)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   HuSI-L23
AC   CVCL_4W54
DR   JCRB; JCRB1623
DR   Wikidata; Q54896900
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1623
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 11
//
ID   HuSI-L23-14-5
AC   CVCL_EG62
DR   JCRB; JCRB1625
DR   Wikidata; Q54896901
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1625
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4W54 ! HuSI-L23
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 9
//
ID   HuSI-L23-9-10
AC   CVCL_4W55
DR   JCRB; JCRB1624
DR   Wikidata; Q54896902
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1624
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4W54 ! HuSI-L23
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 11
//
ID   huSP
AC   CVCL_F0A3
RX   PubMed=2982143;
CC   Population: Japanese.
CC   Virology: Contains multiple copies of integrated hepatitis B virus (HBV) genomes. Compared to parent cell line, has a higher production of hepatitis B surface antigen. Produces no HBV core or E antigens (PubMed=2982143).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Asn302Profs*111 (c.904_907delAACC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2956 ! HuH-1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HUSP-3L
AC   CVCL_B7RG
DR   Wikidata; Q112929802
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   HUSTe001-A
AC   CVCL_C117
SY   hES-8; HES-8
DR   hPSCreg; HUSTe001-A
DR   SKIP; SKIP002290
DR   Wikidata; Q54896903
CC   From: Huazhong University of Science and Technology Tongji Medicine College; Wuhan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HUSTe002-A
AC   CVCL_C064
SY   hES-18; HES-18
DR   hPSCreg; HUSTe002-A
DR   SKIP; SKIP002291
DR   Wikidata; Q54896904
CC   From: Huazhong University of Science and Technology Tongji Medicine College; Wuhan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   HUSTi001-A
AC   CVCL_RV22
SY   1122 iPSC; 1122iPSC
DR   hPSCreg; HUSTi001-A
DR   Wikidata; Q54896905
RX   PubMed=29414604;
CC   From: Huazhong University of Science and Technology Tongji Medicine College; Wuhan; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29414604
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D10S1248: 13,14
ST   D12S391: 17,24
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14,20
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 18,19
ST   D2S441: 10,12
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D6S1043: 18
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 20,23
ST   Penta D: 9
ST   Penta E: 15,22
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3836; Infertility
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   HUSTi002-A
AC   CVCL_YR04
DR   hPSCreg; HUSTi002-A
DR   SKIP; SKIP005639
DR   Wikidata; Q94309394
RX   PubMed=32006804;
CC   From: Huazhong University of Science and Technology Tongji Medicine College; Wuhan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:17644; PIWIL2; Simple; p.His244Argfs (c.731_732delAT); Zygosity=Homozygous (PubMed=32006804).
CC   Derived from site: In situ; Scrotum, skin; UBERON=UBERON_0015479.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32006804
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10
ST   D21S11: 30,32.2
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C168988; Sertoli cell-only syndrome
DI   ORDO; Orphanet_399786; Male infertility with spermatogenesis disorder due to single gene mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   HUSTTJi001-A
AC   CVCL_B3TA
DR   BioSamples; SAMEA9537268
DR   hPSCreg; HUSTTJi001-A
DR   Wikidata; Q110432900
RX   PubMed=34749017;
CC   From: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Wuhan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14539; RNF213; Simple; p.Arg4810Lys (c.14429G>A); ClinVar=VCV000039700; Zygosity=Heterozygous (PubMed=34749017).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183312; Moyamoya disease 2
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   Hut
AC   CVCL_M861
DR   BioSample; SAMN03151719
DR   Wikidata; Q54896906
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00067.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   HuT 102
AC   CVCL_3526
SY   HUT 102; Hut 102; HuT-102; Hut-102; HUT-102; HuT102; Hut102; HUT102; NCI-H102
DR   CLO; CLO_0004303
DR   EFO; EFO_0022624
DR   CLDB; cl1776
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; TIB-162
DR   BioSample; SAMN03471941
DR   BioSample; SAMN10987657
DR   cancercelllines; CVCL_3526
DR   CCRID; 1101HUM-PUMC000468
DR   CCRID; 1102HUM-NIFDC00031
DR   CCTCC; GDC0051
DR   Cell_Model_Passport; SIDM01734
DR   Cosmic; 850197
DR   Cosmic; 933552
DR   Cosmic; 2361371
DR   DepMap; ACH-000612
DR   FANTOM5_SSTAR; 10744-110C6
DR   GEO; GSE168554
DR   GEO; GSM887153
DR   GEO; GSM888225
DR   IARC_TP53; 27004
DR   IPD-IMGT/HLA; 10777
DR   KCLB; 90102
DR   LiGeA; CCLE_120
DR   Lonza; 99
DR   PharmacoDB; HuT102_646_2019
DR   Progenetix; CVCL_3526
DR   RCB; RCB1979
DR   TKG; TKG 0382
DR   Wikidata; Q54896907
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3001699;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6244013;
RX   PubMed=6261256;
RX   PubMed=6272125;
RX   PubMed=6327813;
RX   PubMed=6954533;
RX   PubMed=6975346;
RX   PubMed=7662981;
RX   PubMed=8127147;
RX   PubMed=8547074;
RX   PubMed=8641406;
RX   PubMed=8806089;
RX   PubMed=8806090;
RX   PubMed=8806092;
RX   PubMed=8957066;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=12920029;
RX   PubMed=15638862;
RX   PubMed=17170727;
RX   PubMed=19220422;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26696625;
RX   PubMed=28357668;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=34794206;
WW   Info; -; -; https://www.bmj.com/rapid-response/2011/10/30/cell-lines-hut102-and-hut78
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/hut-102-atcc-tib-162-cell-growth
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: African American.
CC   Doubling time: 38 hours (PubMed=6244013).
CC   HLA typing: A*66:02 (IPD-IMGT/HLA=10777).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=84.86%; Native American=0.23%; East Asian, North=1.93%; East Asian, South=0%; South Asian=0%; European, North=6.73%; European, South=6.25% (PubMed=30894373).
CC   Anecdotal: This is the cell line that was used by Gallo's lab to isolate HTLV-1 (PubMed=26696625).
CC   Caution: Indicated as originating from a 28 year old at sampling in PubMed=6261256, 26 year old in PubMed=6244013 and 29 year old in PubMed=8806092.
CC   Discontinued: ATCC; TIB-162; true.
CC   Discontinued: KCLB; 90102; probable.
CC   Discontinued: RCB; RCB1979; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=TIB-162; CCRID; PubMed=28357668
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D12S391: 16,19
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 20
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 19,23
ST   D3S1358: 15,16
ST   D5S818: 8,13
ST   D6S1043: 11,18
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 8,10
ST   Penta E: 7,8
ST   TH01: 7,8
ST   TPOX: 6
ST   vWA: 16,19
DI   NCIt; C3246; Mycosis fungoides
DI   ORDO; Orphanet_2584; Classic mycosis fungoides
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7GH ! CTCL-3
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   HuT 102B
AC   CVCL_8329
SY   HUT 102B; HUT 102b; HUT-102B; HUT102B
DR   Wikidata; Q54896908
RX   PubMed=11021758;
RX   PubMed=11737246;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3246; Mycosis fungoides
DI   ORDO; Orphanet_2584; Classic mycosis fungoides
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3526 ! HuT 102
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   HuT 78
AC   CVCL_0337
SY   Hut 78; HUT 78; HuT-78; HUT-78; HuT78; Hut78; HUT78; NCI-H78
DR   BTO; BTO_0001945
DR   CLO; CLO_0004304
DR   CLO; CLO_0051010
DR   EFO; EFO_0002209
DR   MCCL; MCC:0000233
DR   CLDB; cl1778
DR   CLDB; cl1779
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRM-TIB-161
DR   ATCC; TIB-161
DR   BCRC; 60522
DR   BCRJ; 0370
DR   BEI_Resources; ARP-89
DR   BioSample; SAMN01821566
DR   BioSample; SAMN03471940
DR   BioSample; SAMN03473203
DR   BioSample; SAMN10987600
DR   cancercelllines; CVCL_0337
DR   CCRID; 1101HUM-PUMC000190
DR   CCRID; 3101HUMTCHu206
DR   CCTCC; GDC0307
DR   Cell_Model_Passport; SIDM00851
DR   CGH-DB; 9026-4
DR   ChEMBL-Cells; CHEMBL3307500
DR   ChEMBL-Targets; CHEMBL613978
DR   CLS; 300338
DR   Cosmic; 724829
DR   Cosmic; 1551450
DR   Cosmic; 2153070
DR   Cosmic; 2402468
DR   Cosmic; 2765583
DR   DepMap; ACH-000509
DR   ECACC; 88041901
DR   GEO; GSM887154
DR   GEO; GSM888226
DR   GEO; GSM1374569
DR   IARC_TP53; 185
DR   IGRhCellID; HuT78
DR   KCLB; 90078
DR   LiGeA; CCLE_696
DR   LINCS_LDP; LCL-2005
DR   Lonza; 813
DR   NCBI_Iran; C185
DR   PharmacoDB; HuT78_647_2019
DR   Progenetix; CVCL_0337
DR   PubChem_Cell_line; CVCL_0337
DR   RCB; RCB1934
DR   TKG; TKG 0375
DR   TOKU-E; 1977
DR   Wikidata; Q54896909
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2144611;
RX   PubMed=2193399;
RX   PubMed=2567177;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3495441;
RX   PubMed=3874327;
RX   PubMed=6151082;
RX   PubMed=6244013;
RX   PubMed=6954533;
RX   PubMed=6975346;
RX   PubMed=7707540;
RX   PubMed=8127147;
RX   PubMed=8806089;
RX   PubMed=8806090;
RX   PubMed=8806092;
RX   PubMed=9738977;
RX   PubMed=10570904;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25877200;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-70.html
WW   Provider; NIBSC; 0002; http://www.nibsc.org/Default.aspx?pageid=597&id=0002&theme=default
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=6244013); ~65 hours (ATCC=TIB-161); 26 hours (BEI_Resources=ARP-89).
CC   HLA typing: DRB1*04:01 (PubMed=7707540).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-000509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (PubMed=2144611; DepMap=ACH-000509).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=0.76%; East Asian, North=2.56%; East Asian, South=0%; South Asian=0.32%; European, North=68.01%; European, South=28.04% (PubMed=30894373).
CC   Anecdotal: For a number of years it was not known that H9 used by Gallo's lab to isolate HIV-1 (HTLV-III) was in fact a clone of Hut 78 from Minna's lab (PubMed=2567177). This created a controversy between the labs of Minna and Gallo (PubMed=2193399).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=TIB-161; CCRID; CLS=300338; PubMed=11416159; PubMed=25877200; RCB=RCB1934; TKG=TKG 0375
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 18
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8 (PubMed=25877200)
ST   D7S820: 8,11 (ATCC=TIB-161; CCRID; CLS=300338; RCB=RCB1934; TKG=TKG 0375)
ST   D8S1179: 12,14
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 13,15
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   HuT 78/HIV-1 FRE-3 clone B4A
AC   CVCL_D3XT
DR   Wikidata; Q127381960
RX   PubMed=2231688;
CC   Population: Caucasian.
CC   Virology: Infected with HIV-1 isolate FRE-3 (Frederick isolate #3) (PubMed=2231688).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HuT 78/HIV-1 FRE-3 clone C9A
AC   CVCL_D3XU
DR   Wikidata; Q127381961
RX   PubMed=2231688;
CC   Population: Caucasian.
CC   Virology: Infected with HIV-1 isolate FRE-3 (Frederick isolate #3) (PubMed=2231688).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HuT 78/HIV-1 FRE-3 clone D5A
AC   CVCL_D3XV
DR   Wikidata; Q127381962
RX   PubMed=2231688;
CC   Population: Caucasian.
CC   Virology: Infected with HIV-1 isolate FRE-3 (Frederick isolate #3) (PubMed=2231688).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HuT 78/HIV-1 FRE-3 clone E2D
AC   CVCL_D3XW
DR   Wikidata; Q127381963
RX   PubMed=2231688;
CC   Population: Caucasian.
CC   Virology: Infected with HIV-1 isolate FRE-3 (Frederick isolate #3). Does not produce any muture gag proteins (PubMed=2231688).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HUT 78/HIV-1SF2
AC   CVCL_X617
SY   HUT 78/HIV-1SF2 (ARV-2); HuT78/HIV-1SF2; HUT78/HIV1SF2
DR   BEI_Resources; ARP-279
DR   cancercelllines; CVCL_X617
DR   Wikidata; Q54896910
CC   Population: Caucasian.
CC   Virology: Infected with HIV-1 isolate SF2 (BEI_Resources=ARP-279).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   HUT 78/HIV-2D194
AC   CVCL_X682
SY   HUT 78 HIV-2 D194-Infected
DR   BEI_Resources; ARP-1119
DR   cancercelllines; CVCL_X682
DR   Wikidata; Q54896911
RX   PubMed=2467304;
CC   Population: Caucasian.
CC   Virology: Infected with HIV-2 isolate D194 (BEI_Resources=ARP-1119).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   HUT 78/HIV-2D205
AC   CVCL_X683
SY   HUT 78 HIV-2 D205-Infected
DR   cancercelllines; CVCL_X683
DR   Wikidata; Q54896912
RX   PubMed=2467304;
CC   Population: Caucasian.
CC   Virology: Infected with HIV-2 isolate D205.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   HUT 78/SIV-BK28
AC   CVCL_X611
SY   HUT 78 SIV BK28-Infected
DR   BEI_Resources; ARP-173
DR   cancercelllines; CVCL_X611
DR   Wikidata; Q54896913
CC   Population: Caucasian.
CC   Virology: Infected with simian immunodeficiency virus isolate BK28 (BEI_Resources=ARP-173).
CC   Doubling time: 3 days (BEI_Resources=ARP-173).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   HUT 78/SIV-BK44
AC   CVCL_X616
SY   HUT 78/SIV BK44; HUT 78 SIV BK44-Infected
DR   BEI_Resources; ARP-312
DR   cancercelllines; CVCL_X616
DR   Wikidata; Q54896914
CC   Population: Caucasian.
CC   Virology: Infected with simian immunodeficiency virus isolate BK44 (BEI_Resources=ARP-312).
CC   Doubling time: 3 days (BEI_Resources=ARP-312).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   HuT 78/SIV/Mne clone E11S
AC   CVCL_D3XX
DR   Wikidata; Q127381964
RX   PubMed=2231688;
RX   PubMed=7707540;
CC   Population: Caucasian.
CC   Virology: Infected with simian immunodeficiency virus isolate Mne (SIV/Mne). Produces virus with large amounts of envelope glycoprotein gp 120 associated with sucrose gradient purified virus. (PubMed=2231688).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   HUT 78/SIVmac251
AC   CVCL_X609
SY   HUT-78-SIVmac251
DR   BEI_Resources; ARP-160
DR   cancercelllines; CVCL_X609
DR   Wikidata; Q54896915
RX   PubMed=3159089;
CC   Population: Caucasian.
CC   Virology: Infected with simian immunodeficiency virus isolate SIVmac251 (BEI_Resources=ARP-160).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   HuT-11
AC   CVCL_G137
DR   Wikidata; Q54896918
RX   PubMed=418410;
RX   PubMed=2902939;
CC   Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939).
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0832 ! Hs 633.T
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   HuT-12
AC   CVCL_G138
DR   Wikidata; Q54896919
RX   PubMed=418410;
RX   PubMed=2902939;
CC   Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939). Originally thought to originate from the chemical transformation of KD (Cellosaurus=CVCL_2970) fibroblast cells.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0832 ! Hs 633.T
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   HuT-13
AC   CVCL_G139
DR   Wikidata; Q54896920
RX   PubMed=418410;
RX   PubMed=2902939;
CC   Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939). Originally thought to originate from the chemical transformation of KD (Cellosaurus=CVCL_2970) fibroblast cells.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0832 ! Hs 633.T
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   HuT-14
AC   CVCL_G140
SY   HUT 14
DR   Wikidata; Q54896921
RX   PubMed=418410;
RX   PubMed=2902939;
CC   Problematic cell line: Contaminated. Shown to be a Hs 633.T derivative (PubMed=2902939). Originally thought to originate from the chemical transformation of KD (Cellosaurus=CVCL_2970) fibroblast cells.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0832 ! Hs 633.T
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   HuT11
AC   CVCL_G136
SY   HUT-11
DR   Wikidata; Q54896922
RX   PubMed=209894;
RX   PubMed=29533902;
CC   Doubling time: 12.3 +- 0.6 hours (PubMed=209894).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   HuT11-1
AC   CVCL_VL79
DR   Wikidata; Q94309596
RX   PubMed=209894;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G136 ! HuT11
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   HuT11-2
AC   CVCL_VL80
DR   Wikidata; Q94309600
RX   PubMed=209894;
CC   Doubling time: 12.1 +- 1.7 hours (PubMed=209894).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G136 ! HuT11
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   HuT11-5
AC   CVCL_VL81
DR   Wikidata; Q94309603
RX   PubMed=209894;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G136 ! HuT11
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   HuT11-6
AC   CVCL_VL82
DR   Wikidata; Q94309608
RX   PubMed=209894;
CC   Doubling time: 13.6 +- 0.8 hours (PubMed=209894).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G136 ! HuT11
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 6
//
ID   HUT15
AC   CVCL_Y030
SY   HUT-15
DR   CGH-DB; 187-1
DR   CGH-DB; 9176-4
DR   Wikidata; Q54896923
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=23381221;
RX   PubMed=25120651;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 7
//
ID   HUT29
AC   CVCL_Y031
SY   HUT-29
DR   CGH-DB; 204-1
DR   CGH-DB; 9170-4
DR   Wikidata; Q54896924
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=23381221;
RX   PubMed=25120651;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hut292DM
AC   CVCL_B409
SY   HUT292DM; Hut292-Dm
DR   Cosmic; 929965
DR   Cosmic; 932918
DR   Wikidata; Q54896925
RX   PubMed=1458487;
RX   PubMed=1855224;
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Pro496Thrfs*8 (c.1484_1485insA); Zygosity=Heterozygous (from parent cell line).
CC   Caution: It is not clear if Hut292DM is derived from NCI-H292 or is identical to that cell line.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0455 ! NCI-H292
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   HUT70
AC   CVCL_Y129
DR   Wikidata; Q54896926
RX   PubMed=23381221;
RX   PubMed=25120651;
CC   Population: Japanese.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 7
//
ID   HuT78B1
AC   CVCL_0325
SY   HUT78B1; HUT78-B1
DR   MCCL; MCC:0000218
DR   cancercelllines; CVCL_0325
DR   Cosmic; 2765584
DR   Wikidata; Q54896927
RX   PubMed=8598453;
RX   PubMed=15161037;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   Hutt45
AC   CVCL_HA55
SY   H3; H3.iPSC; Hutt45_iPSC
DR   GEO; GSM1495405
DR   GEO; GSM1502707
DR   Wikidata; Q54896928
RX   PubMed=26102527;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   Hutt60
AC   CVCL_HA56
SY   H4; H4.iPSC; Hutt60_iPSC
DR   GEO; GSM1495406
DR   GEO; GSM1502708
DR   Wikidata; Q54896929
RX   PubMed=26102527;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   HuTu 80
AC   CVCL_1301
SY   HUTU 80; Hutu 80; HuTu-80; HUTU-80; Hutu-80; HUTU80; HuTu80; Hutu80
DR   BTO; BTO_0005967
DR   CLO; CLO_0004305
DR   CLO; CLO_0009964
DR   EFO; EFO_0022687
DR   CLDB; cl1780
DR   CLDB; cl5208
DR   AddexBio; C0010001/49
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7928
DR   ATCC; HTB-40
DR   BioSample; SAMN03471124
DR   BioSample; SAMN10988182
DR   cancercelllines; CVCL_1301
DR   CCRID; 1101HUM-PUMC000141
DR   Cell_Model_Passport; SIDM00694
DR   ChEMBL-Cells; CHEMBL3307410
DR   ChEMBL-Targets; CHEMBL614582
DR   CLS; 300218
DR   Cosmic; 687549
DR   Cosmic; 907073
DR   Cosmic; 1071891
DR   Cosmic; 1176592
DR   Cosmic; 1223144
DR   Cosmic; 2301549
DR   Cosmic-CLP; 907073
DR   DepMap; ACH-000538
DR   EGA; EGAS00001000978
DR   GDSC; 907073
DR   GEO; GSM887155
DR   GEO; GSM888227
DR   GEO; GSM1448180
DR   GEO; GSM1669924
DR   IARC_TP53; 21385
DR   IZSLER; BS TCL 95
DR   KCB; KCB 200721YJ
DR   KCLB; 30040
DR   LiGeA; CCLE_186
DR   LINCS_HMS; 50016
DR   LINCS_LDP; LCL-1150
DR   PharmacoDB; HUTU80_648_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1301
DR   PubChem_Cell_line; CVCL_1301
DR   Wikidata; Q54896930
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6256643;
RX   PubMed=6500159;
RX   PubMed=6825208;
RX   PubMed=20164919;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-467.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 26.90 hours (PubMed=25944804); 26 hours (PubMed=25984343); 26-30 hours (CLS=300218).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Phe (c.110C>T); ClinVar=VCV000017586; Zygosity=Heterozygous (ATCC=HTB-40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=77.36%; Native American=0%; East Asian, North=2.96%; East Asian, South=0%; South Asian=0%; European, North=8.45%; European, South=11.22% (PubMed=30894373).
CC   Caution: According to ATCC the ethnicity of the donor is White, but exome analysis finds it to be mostly of African lineage.
CC   Discontinued: ATCC; CRL-7928; true.
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
ST   Source(s): AddexBio=C0010001/49; ATCC=HTB-40; CCRID=1101HUM-PUMC000141; CLS=300218; Cosmic-CLP=907073; KCLB=30040; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 14,17
ST   D19S433: 13,15.2
ST   D21S11: 31,32.2
ST   D2S1338: 17,21
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 15
ST   FGA: 21,23
ST   Penta D: 2.2
ST   Penta E: 12,18
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C7889; Duodenal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   HUUCLEC
AC   CVCL_J314
SY   HUman Uterine Cervix Lympho-Epithelioma-like Carcinoma
DR   Wikidata; Q54896931
RX   PubMed=12227504;
RX   PubMed=35692560;
CC   Population: Japanese.
CC   Doubling time: ~82 hours (Note=Indicated as 72 hours in abstract) (PubMed=12227504).
CC   Transformant: NCBI_TaxID; 10596; Human papillomavirus type 56 (HPV56).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 12
//
ID   HUVE-12
AC   CVCL_3722
SY   Human Umbilical Vein Endothelial-12; WC00103
DR   BTO; BTO_0004444
DR   CLO; CLO_0004306
DR   ATCC; CRL-2480
DR   BioSample; SAMN03471591
DR   Coriell; WC00103
DR   Wikidata; Q54896932
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2480; true.
CC   Discontinued: Coriell; WC00103; probable.
CC   Derived from site: In situ; Fetal umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): ATCC=CRL-2480
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   HUVE-12M
AC   CVCL_A2DA
SY   Human Umbilical Vein Endothelial-12M
DR   Wikidata; Q105509541
RX   PubMed=3156882;
CC   Derived from site: In situ; Fetal umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3722 ! HUVE-12
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   HUVE-31
AC   CVCL_0E10
SY   Human Umbilical Vein Endothelial-31
DR   Wikidata; Q54896933
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Fetal umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HUVE-34
AC   CVCL_0E11
SY   Human Umbilical Vein Endothelial-34
DR   Wikidata; Q54896934
RX   PubMed=3654763;
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Derived from site: In situ; Fetal umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   HUVEC-94
AC   CVCL_A4BB
SY   Human Umbilical Vein Endothelial Cell line-94
DR   Wikidata; Q105509544
RX   PubMed=10428507;
RX   PubMed=10886302;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   HUVEC-95
AC   CVCL_A4BC
SY   Human Umbilical Vein Endothelial Cell line-95
DR   Wikidata; Q105509547
RX   PubMed=10428507;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   HUVEC-96
AC   CVCL_A4BD
SY   Human Umbilical Vein Endothelial Cell line-96
DR   Wikidata; Q105509550
RX   PubMed=10428507;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   HUVEC-C
AC   CVCL_2959
SY   HUV-EC-C; HUVEC
DR   BTO; BTO_0001949
DR   CLO; CLO_0004307
DR   ATCC; CRL-1730
DR   BioSample; SAMN01821567
DR   BioSample; SAMN01821732
DR   BioSample; SAMN03471415
DR   CCRID; 4201HUM-CCTCC00635
DR   CCTCC; GDC0166
DR   IZSLER; BS CL 145
DR   JCRB; IFO50271
DR   KCB; KCB 200648YJ
DR   KCB; KCB 2012087YJ
DR   Lonza; 1085
DR   NCBI_Iran; C554
DR   Wikidata; Q54896935
RX   PubMed=6333682;
RX   PubMed=28755030;
RX   PubMed=29892436;
CC   Senescence: Life expectancy of 50 to 60 population doublings (ATCC=CRL-1730). 54 PDL (PubMed=28755030).
CC   Virology: Contains a chromosomally integrated copy of human herpesvirus 6B (CI-HHV-6B) at the distal end of chromosome 9 (PubMed=28755030).
CC   Doubling time: ~23.5 hours (Note=Between passages 18 and 30), ~67 hours (Note=Between passages 24 and 27), ~84 hours (Note=Between passages 27 and 30), ~100 hours (Note=Between passages 32 and 34) (PubMed=28755030).
CC   Discontinued: IZSLER; BS CL 145; probable.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): ATCC=CRL-1730; JCRB=IFO50271; PubMed=28755030
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 12,13
ST   D21S11: 28,31
ST   D2S1338: 18,22
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 21,23
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   HUVEC-CS
AC   CVCL_0F27
DR   ATCC; CRL-2873
DR   Wikidata; Q54896936
RX   PubMed=15350190;
CC   Discontinued: ATCC; CRL-2873; true.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): ATCC=CRL-2873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2959 ! HUVEC-C
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   HUVEC/TERT2
AC   CVCL_9Q53
SY   HUVEC TERT2; HUVEC/TERT 2
DR   ATCC; CRL-4053
DR   Evercyte; CHT-006-0008
DR   GEO; GSM7701469
DR   GEO; GSM7701470
DR   Wikidata; Q54896937
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Doubling time: ~2.5 days (ATCC=CRL-4053); 28 hours (Evercyte=CHT-006-0008).
CC   Karyotypic information: 46,XX,add(14) (ATCC=CRL-4053).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): ATCC=CRL-4053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D5S818: 15,16
ST   D7S820: 9,11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 20
//
ID   HUVEC/TERT66
AC   CVCL_B5SV
DR   Evercyte; CHT-006-0066
DR   Wikidata; Q111733465
CC   Doubling time: ~72 hours (Evercyte=CHT-006-0066).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile and sex of donor from personal communication of Evercyte.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): Evercyte=CHT-006-0066
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7,10
ST   TPOX: 10,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   HUVECs-hTERT
AC   CVCL_B6YK
DR   Wikidata; Q111733466
RX   PubMed=34906292;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   HUVS-112D
AC   CVCL_3723
SY   Human Umbilical Vein Smooth muscle-112D; WC00104
DR   CLO; CLO_0004308
DR   ATCC; CRL-2481
DR   BioSample; SAMN03471592
DR   Coriell; WC00104
DR   Wikidata; Q54896938
CC   Part of: Wistar Institute Special Collection vascular cell lines.
CC   Discontinued: ATCC; CRL-2481; true.
CC   Discontinued: Coriell; WC00104; probable.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Umbilical vein smooth muscle cell; CL=CL_0002588.
ST   Source(s): ATCC=CRL-2481
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 6,10
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   HuWa-TERT
AC   CVCL_UJ99
SY   HuWaTERT1; HuWaTERT
DR   Wikidata; Q94309834
RX   DOI=10.25904/1912/492;
RX   PubMed=30627956;
RX   PubMed=35540658;
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Doubling time: 25 hours (PubMed=30627956).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9773; ! Megaptera novaeangliae (Humpback whale)
HI   CVCL_4U66 ! HuWa1
SX   Male
AG   1-2Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   HuWa1
AC   CVCL_4U66
SY   Humpback Whale 1; HuWa; HuWa(wild-type)
DR   Wikidata; Q54896939
RX   DOI=10.25904/1912/492;
RX   PubMed=26363275;
RX   PubMed=30627956;
WW   Info; -; -; http://app.griffith.edu.au/sciencesimpact/whale-of-a-lab/
WW   Info; Eawag; -; https://www.eawag.ch/en/department/utox/projects/humpback-whale-cell-lines/
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Characteristics: Developed to test the toxicity of persistent organic pollutants (POPs) on marine mammals.
CC   Doubling time: ~41 hours (PubMed=26363275).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9773; ! Megaptera novaeangliae (Humpback whale)
SX   Male
AG   1-2Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   HuWa2
AC   CVCL_4U67
SY   Humpback Whale 2
DR   Wikidata; Q54896940
RX   DOI=10.25904/1912/492;
RX   PubMed=26363275;
WW   Info; -; -; http://app.griffith.edu.au/sciencesimpact/whale-of-a-lab/
WW   Info; Eawag; -; https://www.eawag.ch/en/department/utox/projects/humpback-whale-cell-lines/
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Characteristics: Developed to test the toxicity of persistent organic pollutants (POPs) on marine mammals.
CC   Doubling time: ~42 hours (Direct_author_submission).
CC   Miscellaneous: Doubling time from personal communication of Burkard, Michael.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9773; ! Megaptera novaeangliae (Humpback whale)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   HuWaTERT2
AC   CVCL_UK00
DR   Wikidata; Q94309859
RX   DOI=10.25904/1912/492;
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Doubling time: 30 hours (DOI=10.25904/1912/492).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9773; ! Megaptera novaeangliae (Humpback whale)
HI   CVCL_4U66 ! HuWa1
SX   Male
AG   1-2Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   HuZP3-CHOLec3.2.8.1
AC   CVCL_K172
DR   ATCC; CRL-2866
DR   Wikidata; Q54896941
RX   PubMed=15379548;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13189; ZP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_K173 ! Lec3.2.8.1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   hV-Bmi1
AC   CVCL_ZE92
DR   Wikidata; Q98126744
RX   PubMed=32249592;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: Stated to be immortalized but it is not clear from the paper if they are really immortal or have a extended life time.
CC   Derived from site: In situ; Larynx, ventricle; UBERON=UBERON_0035453.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   HV64
AC   CVCL_C4N0
SY   HV64-08; Human Vitrous body 64
DR   Wikidata; Q116049538
RX   PubMed=19878119;
CC   Population: Japanese.
CC   Senescence: Not immortalized (PubMed=19878119).
CC   Doubling time: 58 +- 2 hours (PubMed=19878119).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient who underwent evisceration surgery for the treatment of neovascular glaucoma.
CC   Derived from site: In situ; Eye, vitreous body; UBERON=UBERON_0001798.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HV65
AC   CVCL_C4N1
SY   HV65-08; Human Vitrous body 65
DR   Wikidata; Q116049539
RX   PubMed=19878119;
CC   Population: Japanese.
CC   Senescence: Not immortalized (PubMed=19878119).
CC   Doubling time: 76 +- 5 hours (PubMed=19878119).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient who underwent enucleation surgery for the treatment of choroidal tumour.
CC   Derived from site: In situ; Eye, vitreous body; UBERON=UBERON_0001798.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   HVEC
AC   CVCL_VP88
SY   Human Vaginal Epithelial Cell line; V428
DR   CancerTools; 153753
DR   Wikidata; Q94309874
DR   Ximbio; 153753
RX   PubMed=15784559;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   hVEGF-luc/PC3M
AC   CVCL_5J43
DR   cancercelllines; CVCL_5J43
DR   Revvity/PerkinElmer; 119273
DR   Wikidata; Q54896942
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119273; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   HVEM 11.8
AC   CVCL_B7FB
SY   HVEM-11.8
DR   Wikidata; Q112929804
RX   Patent=US10005839;
RX   PubMed=23692853;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q92956; Human TNFRSF14/CD270.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   HVEM 18.10
AC   CVCL_B7FA
DR   Wikidata; Q112929806
RX   Patent=US10005839;
RX   PubMed=23692853;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4752.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q92956; Human TNFRSF14/CD270.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   HVEM8.5
AC   CVCL_B7F4
SY   HVEM 8.5
DR   Wikidata; Q112929807
RX   Patent=US9896507;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92956; Human TNFRSF14/CD270.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   HVO-156
AC   CVCL_WJ14
SY   HVO 156; HVO156
DR   Wikidata; Q94309890
RX   Patent=US6821777;
RX   PubMed=12368331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2440.
CC   Virology: Susceptible to infection by ovine adebonviruses.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   HVP
AC   CVCL_C3HT
DR   Wikidata; Q114311682
RX   PubMed=1711532;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pX8 ori-).
CC   Donor information: Established from a fetus heterozygous carrier of an unknown paternal CFTR mutation.
CC   Derived from site: In situ; Fetal vas deferens, epithelium; UBERON=UBERON_0004806.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3HW ! HEP
SX   Male
AG   19FW
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   HVR-1
AC   CVCL_V166
SY   HVR1; CABFPSe001-A
DR   BioSamples; SAMEA5093254
DR   hPSCreg; CABFPSe001-A
DR   Wikidata; Q54896943
RX   PubMed=27346196;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas%2520-%2520Solicitud_Deposito_HVR-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo%2520%2520HVR-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HVR-2
AC   CVCL_V167
SY   HVR2; CABFPSe002-A
DR   hPSCreg; CABFPSe002-A
DR   Wikidata; Q54896944
RX   PubMed=27346196;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Linea_HVR-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_HVR-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HVR-3
AC   CVCL_V168
SY   HVR3; CABFPSe003-A
DR   hPSCreg; CABFPSe003-A
DR   Wikidata; Q54896945
RX   PubMed=27346196;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud_Deposito_HVR-3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo_Deposito_HVR-3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   HVRDe006-A-1
AC   CVCL_YN14
SY   84e5 S1; UKERe007-A-1
DR   BioSamples; SAMEA6613186
DR   hPSCreg; HVRDe006-A-1
DR   Wikidata; Q94309930
RX   PubMed=32682288;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple_edited; p.Gly647Metfs*4 (c.1939_1951del) (p.Gly660Metfs*4, c.1978_1990del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32682288).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   HVRDe006-A-4
AC   CVCL_YN72
SY   84e5 S10; UKERe007-A-4
DR   BioSamples; SAMEA6621868
DR   hPSCreg; HVRDe006-A-4
DR   Wikidata; Q94309935
RX   PubMed=32682288;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple_edited; p.Gly647Ter (c.1939_1946del) (p.Gly660Ter, c.1978_1985del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32682288).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   HVRDe006-A-6
AC   CVCL_YN73
SY   922e6 S16; UKERe007-A-6
DR   BioSamples; SAMEA6621869
DR   hPSCreg; HVRDe006-A-6
DR   Wikidata; Q94309941
RX   PubMed=32682288;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple_edited; p.Gly691Glufs*6 (c.2072del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32682288).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   HVRDe006-A-7
AC   CVCL_A9YS
SY   84e5 S3; UKERe006-B; UKERe007-A-7
DR   BioSamples; SAMEA6655203
DR   hPSCreg; HVRDe006-A-7
DR   Wikidata; Q102115058
RX   PubMed=32682288;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 5
//
ID   HVRDe008-A-1
AC   CVCL_A8ZA
SY   GAPluc; MLBe009-A-1
DR   BioSamples; SAMEA8633544
DR   hPSCreg; HVRDe008-A-1
DR   Wikidata; Q108820515
RX   PubMed=34088000;
CC   Characteristics: Using CRISPR/Cas9 a P2A-Luc2-IRES-PuroR-pA construct was integrated at the 3'end of one allele of GAPDH (PubMed=34088000).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B207 ! HUES 8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   HVRDe008-A-2
AC   CVCL_B5S4
SY   GAPDH-Cas9-Puro clone #28; GC9P clone #28
DR   BioSamples; SAMEA10271031
DR   hPSCreg; HVRDe008-A-2
DR   Wikidata; Q111733467
RX   PubMed=34741877;
CC   Characteristics: Using CRISPR/Cas9 a P2A-eSpCas9-IRES-PuroR-pA construct was introduced at the C-terminus of one allele of GAPDH (PubMed=34741877).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B207 ! HUES 8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   HVRDe009-A-1
AC   CVCL_A4DR
SY   HuES9DGCR8+/-; RCNSe010-A-1
DR   hPSCreg; HVRDe009-A-1
DR   Wikidata; Q105509552
RX   PubMed=33360445;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2847; DGCR8 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=33360445
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0057 ! HUES 9
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   HVRDe009-A-2
AC   CVCL_A8QB
SY   HUES9 CTNNB1 3X FLAG; Hues9 3X Flag CTNNB1; ASUe010-A-2
DR   BioSamples; SAMEA9005187
DR   hPSCreg; HVRDe009-A-2
DR   Wikidata; Q108820516
RX   PubMed=34736039;
CC   From: Arizona State University; Tempe; USA.
CC   Characteristics: Using CRISPR/Cas9 a 3xFLAG tag was introduced at the C-terminal region of CTNNB1 (PubMed=34736039).
CC   Karyotypic information: 46,XX,inv(9)(p12;q13) (hPSCreg=HVRDe009-A-2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0057 ! HUES 9
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 7
//
ID   HVRDi001-A
AC   CVCL_JV23
SY   hFAD-1 clone a; fAD1; faD-1; TYP1-fADa
DR   hPSCreg; HVRDi001-A
DR   SKIP; SKIP001346
DR   WiCell; hvrdi001-a
DR   Wikidata; Q54896946
RX   PubMed=24524897;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=24524897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JV24 ! HVRDi001-A-1
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   HVRDi001-A-1
AC   CVCL_JV24
SY   hFAD-1 clone b; fAD1; fAD-1A; TYP1fADb
DR   hPSCreg; HVRDi001-A-1
DR   SKIP; SKIP001347
DR   WiCell; hvrdi001-a-1
DR   Wikidata; Q54896947
RX   PubMed=24524897;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=24524897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JV23 ! HVRDi001-A
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   HVRDi002-A
AC   CVCL_JV25
SY   hFAD-2 clone a; fAD2; fAD-2A; TYP2-fADa
DR   hPSCreg; HVRDi002-A
DR   SKIP; SKIP001348
DR   WiCell; hvrdi002-a
DR   Wikidata; Q54896948
RX   PubMed=24524897;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=24524897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JV26 ! HVRDi002-A-1
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   HVRDi002-A-1
AC   CVCL_JV26
SY   hFAD-2 clone b; fAD2; fAD-2B; TYP2-fADb
DR   hPSCreg; HVRDi002-A-1
DR   SKIP; SKIP001349
DR   WiCell; hvrdi002-a-1
DR   Wikidata; Q54896949
RX   PubMed=24524897;
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=24524897).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JV25 ! HVRDi002-A
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   HVRDi007-A
AC   CVCL_UK18
SY   DiPS 1016 SevA; DiPS-1016SevA; DiPS 1016SevA; 1016SeVA; 1016; ND-2; hiPSC-2
DR   BioSamples; SAMEA8325234
DR   hPSCreg; HVRDi007-A
DR   Wikidata; Q94309994
RX   PubMed=25303535;
RX   PubMed=27163171;
RX   PubMed=30661993;
CC   From: Harvard University; Boston; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 7
//
ID   HVRDi014-A
AC   CVCL_WS85
SY   TDP43-47d; TDP-43G298S
DR   BioSamples; SAMEA5574038
DR   hPSCreg; HVRDi014-A
DR   Wikidata; Q94310000
RX   PubMed=24507191;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly298Ser (c.892G>A); ClinVar=VCV000005232; Zygosity=Heterozygous (PubMed=24507191).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   HVRDi015-A
AC   CVCL_WS08
SY   SMA 3-9C Sev
DR   BioSamples; SAMEA8325235
DR   hPSCreg; HVRDi015-A
DR   Wikidata; Q94310003
RX   PubMed=28178525;
CC   From: Harvard University; Boston; USA.
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 5
//
ID   HVRDi016-A
AC   CVCL_WS09
SY   PNN 1-38 (SMA); PNN1-38
DR   BioSamples; SAMEA12598003
DR   hPSCreg; HVRDi016-A
DR   Wikidata; Q94310009
RX   PubMed=28178525;
CC   From: Harvard University; Boston; USA.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 5
//
ID   HVRDi017-A
AC   CVCL_WS10
SY   SMA 1-51 (type II)
DR   BioSamples; SAMEA5746312
DR   hPSCreg; HVRDi017-A
DR   Wikidata; Q94310013
RX   PubMed=28178525;
CC   From: Harvard University; Boston; USA.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   HVS-SILVA 40
AC   CVCL_3824
SY   HVS.SILVA 40
DR   CLO; CLO_0004309
DR   CLDB; cl1785
DR   ATCC; CRL-1773
DR   ECACC; 90020105
DR   Wikidata; Q54896951
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Discontinued: ATCC; CRL-1773; true.
CC   Discontinued: ECACC; 90020105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   HVTs-SM1
AC   CVCL_D051
SY   SM1
DR   EFO; EFO_0022696
DR   Wikidata; Q54954896
RX   PubMed=10764661;
CC   Doubling time: 49 +- 9 hours (PubMed=10764661).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Saphenous vein, smooth muscle; UBERON=UBERON_8480068.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   HWB-MoOvGr-SV40im
AC   CVCL_F0QC
SY   Hefei Wanwu Biotechnology-Mouse Ovarian Granulosa-SV40 immortalized
WW   Provider; Hefei Wanwu Biotechnology; Delf-16320; http://www.hfwanwu.com/proc/9360
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-10W
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HWL
AC   CVCL_A1FR
DR   Cosmic; 2808227
DR   Wikidata; Q102114179
RX   PubMed=8220424;
RX   PubMed=8402660;
CC   Doubling time: 23 hours (PubMed=8402660).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 4
//
ID   HWTUA
AC   CVCL_VT05
DR   Wikidata; Q94310026
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3778323;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 29 hours (PubMed=10457904).
CC   Misspelling: HTWUA; PubMed=9436037; Note=In table 1.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   HWUA-1
AC   CVCL_X945
SY   HWUA
DR   Wikidata; Q54896952
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=7194144;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 41 hours (Note=At 10th passage), 33 hours (Note=At 30th passage), 31 hours (Note=At 50th passage) (PubMed=7194144).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X946 ! HWUA-2
OI   CVCL_X947 ! HWUS-1
OI   CVCL_X948 ! HWUS-2
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   HWUA-2
AC   CVCL_X946
DR   Wikidata; Q54896953
RX   PubMed=7194144;
CC   Population: Japanese.
CC   Doubling time: 40 hours (Note=At 10th passage), 32 hours (Note=At 30th passage), 31 hours (Note=At 50th passage) (PubMed=7194144).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X945 ! HWUA-1
OI   CVCL_X947 ! HWUS-1
OI   CVCL_X948 ! HWUS-2
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   HWUS-1
AC   CVCL_X947
SY   HWUS
DR   Wikidata; Q54896954
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=7194144;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 46 hours (Note=At 10th passage), 34 hours (Note=At 30th passage), 31 hours (Note=At 50th passage) (PubMed=7194144).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X945 ! HWUA-1
OI   CVCL_X946 ! HWUA-2
OI   CVCL_X948 ! HWUS-2
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   HWUS-1a
AC   CVCL_X949
DR   Wikidata; Q54896955
RX   PubMed=7194144;
CC   Population: Japanese.
CC   Doubling time: 30 hours (Note=At 5th passage), 26 hours (Note=At 30th passage), 24 hours (Note=At 50th passage) (PubMed=7194144).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X947 ! HWUS-1
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   HWUS-2
AC   CVCL_X948
DR   Wikidata; Q54896956
RX   PubMed=7194144;
CC   Population: Japanese.
CC   Doubling time: 38 hours (Note=At 10th passage), 31 hours (Note=At 30th passage), 29 hours (Note=At 50th passage) (PubMed=7194144).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X945 ! HWUA-1
OI   CVCL_X946 ! HWUA-2
OI   CVCL_X947 ! HWUS-1
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   HX
AC   CVCL_3318
SY   HT1080 xeno
DR   CLO; CLO_0004310
DR   ATCC; CRL-12011
DR   cancercelllines; CVCL_3318
DR   Cell_Model_Passport; SIDM01213
DR   Wikidata; Q54896957
RX   Patent=US5591624;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12011.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-12011; true.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): ATCC=CRL-12011
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   HX/62
AC   CVCL_4995
SY   HX-62; HX 62; HX62; Hx62
DR   cancercelllines; CVCL_4995
DR   ChEMBL-Cells; CHEMBL3308618
DR   ChEMBL-Targets; CHEMBL614686
DR   Cosmic; 1609539
DR   GEO; GSM313712
DR   Progenetix; CVCL_4995
DR   PubChem_Cell_line; CVCL_4995
DR   Wikidata; Q54896958
RX   PubMed=1423261;
RX   PubMed=1892748;
RX   PubMed=2653399;
RX   PubMed=15677628;
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft established in female nude mice (PubMed=2653399).
CC   Doubling time: 32 hours (PubMed=2653399).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 18
//
ID   HX011-1D9
AC   CVCL_A3FD
SY   1D9
DR   CCRID; 4201PAT-CCTCC01304
DR   Wikidata; Q105509555
RX   Patent=WO2020132857A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018198.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P43489; Human TNFRSF4/CD134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   HX011-9C12
AC   CVCL_A3FE
SY   9C12
DR   CCRID; 4201PAT-CCTCC01303
DR   Wikidata; Q105509558
RX   Patent=WO2020132857A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018197.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P43489; Human TNFRSF4/CD134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   HX1
AC   CVCL_Y020
DR   Wikidata; Q54896962
RX   PubMed=19833967;
RX   PubMed=23828270;
CC   Group: Fish cell line.
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   Hx104
AC   CVCL_Y040
DR   Cosmic; 687487
DR   Wikidata; Q54896963
RX   PubMed=12068308;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx109
AC   CVCL_Y041
DR   Cosmic; 688096
DR   Wikidata; Q54896964
RX   PubMed=12068308;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx110a
AC   CVCL_Y042
DR   Cosmic; 688039
DR   Wikidata; Q54896965
RX   PubMed=12068308;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx110b
AC   CVCL_Y043
DR   Cosmic; 688040
DR   Wikidata; Q54896966
RX   PubMed=12068308;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx113
AC   CVCL_Y044
DR   Cosmic; 687488
DR   Wikidata; Q54896967
RX   PubMed=12068308;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx117
AC   CVCL_Y045
DR   Cosmic; 688045
DR   Wikidata; Q54896968
RX   PubMed=12068308;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HX118
AC   CVCL_H762
SY   HX-118; Hx118
DR   Cosmic; 688046
DR   Wikidata; Q54896969
RX   PubMed=12068308;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/skin/hx118/index.html
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   Hx122
AC   CVCL_Y046
DR   Cosmic; 688097
DR   Wikidata; Q54896970
RX   PubMed=12068308;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx124
AC   CVCL_Y047
DR   Cosmic; 687986
DR   Wikidata; Q54896971
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hx126
AC   CVCL_Y048
DR   Cosmic; 688047
DR   Wikidata; Q54896972
RX   PubMed=12068308;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx128
AC   CVCL_Y049
DR   Cosmic; 688042
DR   Wikidata; Q54896973
RX   PubMed=12068308;
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   Hx129
AC   CVCL_Y050
DR   cancercelllines; CVCL_Y050
DR   Cosmic; 724823
DR   Wikidata; Q54896974
RX   PubMed=12068308;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=12068308).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 8
//
ID   Hx132
AC   CVCL_Y051
DR   cancercelllines; CVCL_Y051
DR   Cosmic; 724880
DR   Wikidata; Q54896975
RX   PubMed=12068308;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=12068308).
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 8
//
ID   HX138
AC   CVCL_H760
SY   HX-138
DR   Wikidata; Q54896976
RX   PubMed=2245172;
RX   PubMed=4001442;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/neuroblastoma/hx138/index.html
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   Hx138A
AC   CVCL_Y052
DR   Cosmic; 688066
DR   Wikidata; Q54896977
RX   PubMed=12068308;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H760 ! HX138
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   HX142
AC   CVCL_H761
SY   HX-142
DR   Wikidata; Q54896978
RX   PubMed=2245172;
RX   PubMed=2903891;
RX   PubMed=4001442;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/neuroblastoma/hx142/index.html
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   Hx147
AC   CVCL_Y053
SY   Hx-147
DR   cancercelllines; CVCL_Y053
DR   Cosmic; 724861
DR   GEO; GSM1374570
DR   Wikidata; Q54896979
RX   PubMed=12068308;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Unspecified (PubMed=12068308).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 10
//
ID   HX151c
AC   CVCL_L441
SY   HX151; HX/151; HX/151c
DR   IARC_TP53; 21692
DR   Wikidata; Q54896980
RX   PubMed=2441858;
RX   PubMed=2475347;
RX   PubMed=7751322;
RX   PubMed=8347478;
RX   PubMed=9887230;
RX   PubMed=35692560;
CC   Doubling time: 42 hours (Note=At 70th passage) (PubMed=2441858).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   HX155c
AC   CVCL_L442
SY   HX155; Hx155; HX/155; HX/155c
DR   Cosmic; 687511
DR   Wikidata; Q54896981
RX   PubMed=2441858;
RX   PubMed=2475347;
RX   PubMed=2813837;
RX   PubMed=8347478;
RX   PubMed=35692560;
CC   Doubling time: 48 hours (Note=At 50th passage) (PubMed=2441858).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   HX155cisR
AC   CVCL_M691
SY   HX/155cisR
DR   Wikidata; Q54896982
RX   PubMed=8347478;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L442 ! HX155c
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   HX156c
AC   CVCL_L443
SY   HX156; HX/156; HX/156c; HX-156c
DR   IARC_TP53; 21693
DR   Wikidata; Q54896983
RX   PubMed=2441858;
RX   PubMed=2475347;
RX   PubMed=2813837;
RX   PubMed=7751322;
RX   PubMed=8347478;
RX   PubMed=9887230;
RX   PubMed=35692560;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/cervix/hx156/index.html
CC   Doubling time: 30 hours (Note=At 75th passage) (PubMed=2441858).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   Hx159
AC   CVCL_Y054
DR   Cosmic; 687512
DR   Wikidata; Q54896984
RX   PubMed=12068308;
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HX160c
AC   CVCL_L444
SY   HX160; HX/160; HX-160c
DR   Wikidata; Q54896985
RX   PubMed=2441858;
RX   PubMed=2813837;
RX   PubMed=8347478;
RX   PubMed=35692560;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/cervix/hx160c/index.html
CC   Doubling time: 68 hours (Note=At 50th passage) (PubMed=2441858).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Hx163
AC   CVCL_Y055
DR   Cosmic; 687949
DR   Wikidata; Q54896986
RX   PubMed=12068308;
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   HX165c
AC   CVCL_N849
SY   HX 165c
DR   Wikidata; Q54896988
RX   PubMed=3179184;
CC   Doubling time: 38 hours (PubMed=3179184).
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   Hx169
AC   CVCL_Y056
DR   Cosmic; 687950
DR   Wikidata; Q54896989
RX   PubMed=12068308;
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   HX170c
AC   CVCL_N850
SY   Hx170c
DR   Cosmic; 687951
DR   Wikidata; Q54896990
RX   CelloPub=CLPUB00569;
RX   PubMed=2930681;
RX   PubMed=12068308;
RX   PubMed=23882450;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   HX171c
AC   CVCL_M690
SY   HX171; HX/171; HX/171c
DR   Wikidata; Q54896991
RX   PubMed=2475347;
RX   PubMed=8347478;
CC   Doubling time: 36 hours (PubMed=2475347).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 8
//
ID   HX2
AC   CVCL_Y021
DR   Wikidata; Q54896992
RX   PubMed=19833967;
CC   Group: Fish cell line.
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   Hx29
AC   CVCL_Y057
DR   Cosmic; 687987
DR   Wikidata; Q54896993
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   HX3
AC   CVCL_Y022
DR   Wikidata; Q54896995
RX   PubMed=19833967;
CC   Group: Fish cell line.
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   Hx34
AC   CVCL_H763
SY   HX34
DR   Cosmic; 688049
DR   Wikidata; Q54896996
RX   PubMed=2903891;
RX   PubMed=12068308;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   Hx39
AC   CVCL_Y058
DR   Cosmic; 688041
DR   Wikidata; Q54896997
RX   PubMed=12068308;
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   Hx53
AC   CVCL_Y059
DR   Cosmic; 687967
DR   Wikidata; Q54896998
RX   PubMed=12068308;
DI   NCIt; C7328; Testicular seminoma
DI   ORDO; Orphanet_842; Testicular seminomatous germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   Hx55
AC   CVCL_Y060
DR   Cosmic; 687522
DR   Wikidata; Q54896999
RX   PubMed=12068308;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx60
AC   CVCL_Y061
DR   Cosmic; 688099
DR   Wikidata; Q54897000
RX   PubMed=12068308;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx62-26
AC   CVCL_Y036
SY   Hx62/26; HX62-26
DR   cancercelllines; CVCL_Y036
DR   Cosmic; 724836
DR   Cosmic; 1609536
DR   Wikidata; Q54897001
RX   PubMed=12068308;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Glu (c.1391G>A); ClinVar=VCV000013964; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=12068308).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4995 ! HX/62
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   Hx71
AC   CVCL_Y062
DR   Cosmic; 687988
DR   Wikidata; Q54897002
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hx72
AC   CVCL_Y063
DR   Cosmic; 687989
DR   Wikidata; Q54897003
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hx74
AC   CVCL_Y064
DR   Cosmic; 687990
DR   Wikidata; Q54897006
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hx78
AC   CVCL_Y065
DR   Cosmic; 687991
DR   Wikidata; Q54897007
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hx81
AC   CVCL_Y066
DR   Cosmic; 687992
DR   Wikidata; Q54897008
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hx83
AC   CVCL_Y067
DR   Cosmic; 687785
DR   Wikidata; Q54897009
RX   PubMed=12068308;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   Hx87
AC   CVCL_Y068
DR   Cosmic; 687597
DR   Wikidata; Q54897010
RX   PubMed=12068308;
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx88
AC   CVCL_Y069
DR   Cosmic; 687993
DR   Wikidata; Q54897011
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   Hx90
AC   CVCL_Y070
DR   Cosmic; 687598
DR   Wikidata; Q54897012
RX   PubMed=12068308;
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx93
AC   CVCL_Y071
DR   Cosmic; 687599
DR   Wikidata; Q54897013
RX   PubMed=12068308;
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   Hx94
AC   CVCL_Y072
DR   cancercelllines; CVCL_Y072
DR   Cosmic; 724862
DR   Wikidata; Q54897014
RX   PubMed=12068308;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Unspecified (PubMed=12068308).
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 8
//
ID   Hx96
AC   CVCL_Y073
DR   Cosmic; 687994
DR   Wikidata; Q54897015
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   HxAC4
AC   CVCL_Y074
DR   Cosmic; 687523
DR   Wikidata; Q54897016
RX   PubMed=12068308;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HxEC4
AC   CVCL_Y075
DR   Cosmic; 687524
DR   Wikidata; Q54897017
RX   PubMed=12068308;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HXEX-ALL1
AC   CVCL_WL67
DR   Wikidata; Q94310799
RX   Patent=WO2019144636A1;
RX   PubMed=31168295;
RX   PubMed=31221196;
RX   PubMed=33740980;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017232.
CC   Population: Chinese.
CC   Doubling time: 26-32 hours (PubMed=31168295).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=31168295; Patent=WO2019144636A1
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D10S1248: 13,14
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 13,23
ST   D19S433: 14,15
ST   D21S11: 29,33
ST   D2S1338: 18,24
ST   D2S441: 11,11.3
ST   D3S1358: 15
ST   D5S818: 7,10
ST   D6S1043: 12,19
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 24,26
ST   Penta D: 9,11
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   HXEX-ALL1/HDR
AC   CVCL_B7A7
DR   Wikidata; Q111733469
RX   PubMed=31221196;
CC   Population: Chinese.
CC   Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WL67 ! HXEX-ALL1
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   HxGC3
AC   CVCL_Y076
DR   Cosmic; 687525
DR   Wikidata; Q54897018
RX   PubMed=1378304;
RX   PubMed=12068308;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 6
//
ID   HxGo
AC   CVCL_Y077
DR   Cosmic; 688035
DR   Wikidata; Q54897019
RX   PubMed=12068308;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   HxHC1
AC   CVCL_Y078
DR   Cosmic; 687526
DR   Wikidata; Q54897020
RX   PubMed=12068308;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HxLe
AC   CVCL_X163
DR   Cosmic; 688050
DR   Wikidata; Q54897021
RX   PubMed=12068308;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   HxLL
AC   CVCL_X164
DR   cancercelllines; CVCL_X164
DR   Cosmic; 687437
DR   Wikidata; Q54897022
RX   PubMed=12068308;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=12068308).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   HxLo
AC   CVCL_Y079
DR   Cosmic; 687489
DR   Wikidata; Q54897023
RX   PubMed=12068308;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HxMm
AC   CVCL_X165
DR   Cosmic; 688051
DR   Wikidata; Q54897024
RX   PubMed=12068308;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 6
//
ID   HxMu
AC   CVCL_Y080
DR   Cosmic; 687513
DR   Wikidata; Q54897026
RX   PubMed=12068308;
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HXO-Rb44
AC   CVCL_D542
SY   HXO-RB44
DR   ChEMBL-Cells; CHEMBL3307832
DR   ChEMBL-Targets; CHEMBL613981
DR   PubChem_Cell_line; CVCL_D542
DR   Wikidata; Q54897027
RX   PubMed=8575599;
RX   PubMed=22553703;
CC   Population: Chinese.
CC   Doubling time: 44 hours (PubMed=8575599).
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   HxURC
AC   CVCL_Y081
DR   Cosmic; 687527
DR   Wikidata; Q54897028
RX   PubMed=12068308;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   HxWe
AC   CVCL_Y082
DR   Cosmic; 687968
DR   Wikidata; Q54897029
RX   PubMed=12068308;
DI   NCIt; C7328; Testicular seminoma
DI   ORDO; Orphanet_842; Testicular seminomatous germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   HXWMF-1
AC   CVCL_A8QE
DR   Wikidata; Q108820517
RX   PubMed=33740980;
CC   Characteristics: Produced by subcutaneous injection of HXEX-ALL1 cells of BALB/c (nu/nu) nude mice (PubMed=33740980).
CC   Doubling time: 12-17 hours (PubMed=33740980).
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=33740980
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 17.3,19.3
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 15.3,16.3
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 18-3: 19,20
ST   Mouse STR X-1: 24.3,25.3
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   HY0003
AC   CVCL_8X67
DR   ECACC; 97102205
DR   Wikidata; Q54897030
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(3;4)(q25.2;q31.2); de novo (ECACC=97102205).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   HY0007
AC   CVCL_8X68
DR   ECACC; 98090202
DR   Wikidata; Q54897031
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(12)(q21.33;q24.1) (ECACC=98090202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98090202; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   HY3-11.27
AC   CVCL_J126
DR   CLO; CLO_0004311
DR   ATCC; HB-8116
DR   Wikidata; Q54897032
RX   Patent=US4511661;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8116.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human H-Y antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   HY595
AC   CVCL_Y286
DR   IPD-IMGT/HLA; 10784
DR   Wikidata; Q54897033
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*02:01,05:01; DQA1*01:03; DQB1*03:03; DRB1*09:01 (IPD-IMGT/HLA=10784).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 11
//
ID   HYB-195
AC   CVCL_B0FE
DR   Wikidata; Q108820518
RX   PubMed=2566379;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HYB-241
AC   CVCL_B0FF
DR   Wikidata; Q108820519
RX   PubMed=2566379;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   HYB-612
AC   CVCL_B0FG
DR   Wikidata; Q108820520
RX   PubMed=2566379;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Hybrid 15B
AC   CVCL_VU59
SY   15B
DR   Wikidata; Q94310958
RX   PubMed=2108149;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
HI   CVCL_VT74 ! Sp2/HL-BU
CA   Hybrid cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 4
//
ID   Hybrid 26A7
AC   CVCL_VU60
SY   26A7
DR   Wikidata; Q94310964
RX   PubMed=2108149;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
HI   CVCL_VT74 ! Sp2/HL-BU
CA   Hybrid cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 4
//
ID   Hybrid 27-1
AC   CVCL_VU61
SY   27-1
DR   Wikidata; Q94310968
RX   PubMed=2108149;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
HI   CVCL_VT74 ! Sp2/HL-BU
CA   Hybrid cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 4
//
ID   Hybridoma 231
AC   CVCL_L524
SY   231
DR   CLO; CLO_0004312
DR   ATCC; HB-9401
DR   Wikidata; Q54897034
RX   Patent=US5169775;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9401.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   Hybridoma 234
AC   CVCL_L525
SY   Hybridoma 234 s.1; 234(1); 234
DR   CLO; CLO_0004313
DR   ATCC; HB-9402
DR   Wikidata; Q54897035
RX   Patent=US5169775;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9402.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dog antigen on monocytes and lymphocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 9
//
ID   Hybridoma 234 s.2a
AC   CVCL_L526
SY   234(2a)
DR   CLO; CLO_0004314
DR   ATCC; HB-9403
DR   Wikidata; Q54897036
RX   Patent=US5169775;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9403.
CC   Characteristics: Isotype switched derivative of Hybridoma 234.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Dog antigen on monocytes and lymphocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L525 ! Hybridoma 234
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 9
//
ID   Hybridoma 84
AC   CVCL_WS43
SY   84
DR   FCS-free; 235-26-481-1-16-3
DR   Wikidata; Q94311006
RX   PubMed=18356574;
RX   PubMed=18992891;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O00592; Human PODXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Hybridoma cell line 23
AC   CVCL_N459
SY   Hybridoma 23
DR   Wikidata; Q54897037
RX   Patent=US4707438;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8630.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   HyGPD-YK-1-1
AC   CVCL_L551
SY   HyGPD.YK-1-1
DR   CLO; CLO_0050287
DR   ECACC; 92120704
DR   RCB; RCB0711
DR   Wikidata; Q54897038
CC   Group: Serum/protein free medium cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P46406; Rabbit GAPDH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   HyHEL-10
AC   CVCL_C4SJ
DR   ABCD; ABCD_AE891
DR   Wikidata; Q116049540
RX   PubMed=6418816;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HyHEL-11
AC   CVCL_C4SK
DR   Wikidata; Q116049541
RX   PubMed=6172484;
RX   PubMed=6418816;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HyHEL-12
AC   CVCL_C4SL
DR   Wikidata; Q116049543
RX   PubMed=6172484;
RX   PubMed=6418816;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HyHEL-5
AC   CVCL_C4SF
DR   ABCD; ABCD_AE890
DR   Wikidata; Q116049544
RX   PubMed=6172484;
RX   PubMed=6418816;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HyHEL-7
AC   CVCL_C4SG
DR   Wikidata; Q116049545
RX   PubMed=6418816;
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HyHEL-8
AC   CVCL_C4SH
DR   ABCD; ABCD_AE892
DR   Wikidata; Q116049546
RX   PubMed=6172484;
RX   PubMed=6418816;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HyHEL-9
AC   CVCL_C4SI
DR   Wikidata; Q116049547
RX   PubMed=6172484;
RX   PubMed=6418816;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00698; Chicken LYZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   HYKO6
AC   CVCL_F752
DR   ABM; T3031
DR   Wikidata; Q54897039
RX   PubMed=15696577;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1340806; Parp1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   HYKSSPC
AC   CVCL_W382
DR   Wikidata; Q54897040
RX   PubMed=17257376;
CC   Population: Japanese.
CC   Doubling time: 51.4 hours (PubMed=17257376).
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   HYL
AC   CVCL_WZ53
DR   CCRID; 5301HUM-KCB94022ZJ
DR   KCB; KCB 94022ZJ
DR   Wikidata; Q94311058
CC   Population: Chinese/Asian ethnic group; Yi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
//
ID   HyLDH-YK-1
AC   CVCL_L552
SY   HyLDH.YK-1; HyLDH/YK-1
DR   CLO; CLO_0050303
DR   RCB; RCB0709
DR   Wikidata; Q54897041
CC   Group: Serum/protein free medium cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13491; Rabbit LDHA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   HyLDH-YK-2
AC   CVCL_L553
SY   HyLDH.YK-2
DR   CLO; CLO_0050285
DR   RCB; RCB0710
DR   Wikidata; Q54897042
CC   Group: Serum/protein free medium cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13491; Rabbit LDHA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   HYMEQ-1
AC   CVCL_5293
DR   Wikidata; Q54897043
RX   PubMed=12662435;
CC   Doubling time: ~3 days (PubMed=12662435).
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   HYMEQ-5
AC   CVCL_5294
DR   Wikidata; Q54897044
RX   PubMed=12662435;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=HYMEQ-5
CC   Doubling time: ~3 days (PubMed=12662435).
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   HYMEQ-8
AC   CVCL_5295
DR   Wikidata; Q54897045
RX   PubMed=12662435;
CC   Doubling time: ~3 days (PubMed=12662435).
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12FD
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   HYNI-1
AC   CVCL_E8U6
RX   PubMed=2273757;
RX   PubMed=3267026;
CC   Characteristics: Fusion of Raji 6-TGR-neoR cell line with pokeweed mitogen-stimulated B cells (PWM-B cells) (PubMed=2273757).
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8U5 ! Raji 6-TGR-neoR
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HYNI-2
AC   CVCL_E8U7
RX   PubMed=2273757;
RX   PubMed=3267026;
CC   Characteristics: Fusion of Raji 6-TGR-neoR cell line with pokeweed mitogen-stimulated B cells (PWM-B cells) (PubMed=2273757).
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8U5 ! Raji 6-TGR-neoR
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   HYOA
AC   CVCL_VT06
DR   Wikidata; Q94311123
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3593088;
RX   PubMed=9436037;
RX   PubMed=10457904;
CC   Population: Japanese.
CC   Doubling time: 31 hours (PubMed=3593088).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   HYON
AC   CVCL_IN53
DR   Wikidata; Q54897046
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6230491;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=6230491).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   HypLu/2
AC   CVCL_RX56
SY   HypLu-2
DR   Wikidata; Q54897048
RX   CelloPub=CLPUB00422;
RX   PubMed=25100832;
RX   PubMed=25741010;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=448084; ! Hypsignathus monstrosus (Hammer-headed fruit bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   HypLu/45
AC   CVCL_RX48
SY   HypLu-45
DR   Wikidata; Q54897049
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=448084; ! Hypsignathus monstrosus (Hammer-headed fruit bat)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HypLu/45.1
AC   CVCL_RX16
DR   Wikidata; Q54897051
RX   PubMed=21987760;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=448084; ! Hypsignathus monstrosus (Hammer-headed fruit bat)
HI   CVCL_RX48 ! HypLu/45
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HypNi/1
AC   CVCL_RX47
SY   HypNi-1
DR   Wikidata; Q54897052
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=448084; ! Hypsignathus monstrosus (Hammer-headed fruit bat)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HypNi/1.1
AC   CVCL_RX17
DR   Wikidata; Q54897053
RX   PubMed=21987760;
RX   PubMed=24023659;
RX   PubMed=25100832;
RX   PubMed=25741010;
RX   PubMed=26698106;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=448084; ! Hypsignathus monstrosus (Hammer-headed fruit bat)
HI   CVCL_RX47 ! HypNi/1
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HypNi/21
AC   CVCL_RX57
SY   HypNi-21
DR   Wikidata; Q54897054
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=448084; ! Hypsignathus monstrosus (Hammer-headed fruit bat)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   HyCyte 143B KO-hIBSP
AC   CVCL_F1LH
SY   hIBSP knockout 143B
DR   Hysigen; CGKO-M3273
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3273).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5341; IBSP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2270 ! 143B
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 22Rv1 KO-hFOXA1
AC   CVCL_D6A1
SY   hFOXA1 knockout 22Rv1
DR   Hysigen; CGKO-M2386
DR   Wikidata; Q127381965
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2386).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte 22Rv1 KO-hPTEN
AC   CVCL_D6A2
SY   hPTEN knockout 22RV1
DR   Hysigen; CGKO-M2454
DR   Wikidata; Q127381966
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2454).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte 22Rv1-Luc
AC   CVCL_E3GG
SY   Luciferase Reporter 22Rv1 Cell Line
DR   Hysigen; TCH-C100L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C100L).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte 3T3-L1 KO-mAckr3
AC   CVCL_D6A9
SY   mAckr3 knockout 3T3-L1
DR   Hysigen; CGKO-M2514
DR   Wikidata; Q127381973
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2514).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109562; Ackr3.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte 3T3-L1 KO-mFasn
AC   CVCL_E1IK
SY   mFasn knockout 3T3-L1
DR   Hysigen; CGKO-M2261
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2261).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95485; Fasn.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte 3T3-L1 KO-mSfrp5
AC   CVCL_F1LI
SY   mSfrp5 knockout 3T3-L1
DR   Hysigen; CGKO-M2978
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2978).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1860298; Sfrp5.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0123 ! 3T3-L1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 4T1 KO-mBtn1a1
AC   CVCL_E1IL
SY   mBtn1a1 knockout 4T1
DR   Hysigen; CGKO-M2337
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2337).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103118; Btn1a1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte 4T1 KO-mCd200
AC   CVCL_F1LJ
SY   mCd200 knockout 4T1
DR   Hysigen; CGKO-M3104
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3104).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1196990; Cd200.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 4T1 KO-mEhd4
AC   CVCL_D6AA
SY   mEhd4 knockout 4T1
DR   Hysigen; CGKO-M2383
DR   Wikidata; Q127381974
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2383).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919619; Ehd4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte 4T1 KO-mEnpp1
AC   CVCL_E1IM
SY   mEnpp1 knockout 4T1
DR   Hysigen; CGKO-M2716
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2716).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97370; Enpp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte 4T1 KO-mInhba
AC   CVCL_D6AB
SY   mInhba knockout 4T1
DR   Hysigen; CGKO-M2511
DR   Wikidata; Q127381975
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2511).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96570; Inhba.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte 4T1 KO-mLdha
AC   CVCL_F1LK
SY   mLdha knockout 4T1
DR   Hysigen; CGKO-M2899
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2899).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96759; Ldha.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 4T1 KO-mStk11
AC   CVCL_F1LL
SY   mStk11 knockout 4T1
DR   Hysigen; CGKO-M3137
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3137).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341870; Stk11.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 4T1 KO-mTmem176b
AC   CVCL_E1IN
SY   mTmem176b knockout 4T1
DR   Hysigen; CGKO-M2282
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2282).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916348; Tmem176b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte 4T1 KO-mUsp22
AC   CVCL_D6AC
SY   mUsp22 knockout 4T1
DR   Hysigen; CGKO-M2346
DR   Wikidata; Q127381976
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2346).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2144157; Usp22.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte 4T1 KO-mZdhhc20
AC   CVCL_D6AD
SY   mZdhhc20 knockout 4T1
DR   Hysigen; CGKO-M2384
DR   Wikidata; Q127381977
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2384).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1923215; Zdhhc20.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte 4T1-Luc
AC   CVCL_E3GH
SY   Luciferase Reporter 4T1 Cell Line
DR   Hysigen; TCM-C705L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C705L).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte 4T1.2-Luc
AC   CVCL_E3GI
SY   Luciferase Reporter 4T1.2 Cell Line
DR   Hysigen; TCM-C810L
CC   Doubling time: 36-48 hours (Hysigen=TCM-C810L).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR32 ! 4T1.2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte 5637 KO-hCKAP4
AC   CVCL_F1LM
SY   hCKAP4 knockout 5637
DR   Hysigen; CGKO-M3261
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3261).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16991; CKAP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 5637 KO-hFGFR3
AC   CVCL_F1LN
SY   hFGFR3 knockout 5637
DR   Hysigen; CGKO-M3061
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3061).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3690; FGFR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 786-O KO-hBAP1
AC   CVCL_F1LP
SY   hBAP1 knockout 786-O
DR   Hysigen; CGKO-M3198
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3198).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:950; BAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte 786-O KO-hCBX7
AC   CVCL_E1IP
SY   hCBX7 knockout 786-O
DR   Hysigen; CGKO-M2369
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2369).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1557; CBX7.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-172 KO-hTP53
AC   CVCL_D6AE
SY   hTP53 knockout A-172
DR   Hysigen; CGKO-M2377
DR   Wikidata; Q127381978
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2377).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0131 ! A-172
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-172-Luc
AC   CVCL_E3GJ
SY   Luciferase Reporter A-172 Cell Line
DR   Hysigen; TCH-C111L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C111L).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1539; CBFB; Name(s)=ABL1-CBFB (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0131 ! A-172
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte A-375 KO-hSETD2
AC   CVCL_D6AF
SY   hSETD2 knockout A-375
DR   Hysigen; CGKO-M2412
DR   Wikidata; Q127381979
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2412).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-375 KO-hSYVN1
AC   CVCL_F1LQ
SY   hSYVN1 knockout A-375
DR   Hysigen; CGKO-M3235
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3235).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20738; SYVN1.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-375-Luc
AC   CVCL_E3GK
SY   Luciferase Reporter A-375 Cell Line
DR   Hysigen; TCH-C114L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C114L).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte A-431-Luc
AC   CVCL_E3GL
SY   Luciferase Reporter A-431-Luc Cell Line
DR   Hysigen; TCH-C115L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C115L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte A-498 KO-hCBX7
AC   CVCL_E1IQ
SY   hCBX7 knockout A-498
DR   Hysigen; CGKO-M2370
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2370).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1557; CBX7.
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Asp1067Val (c.3200A>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly144Serfs*14 (c.426_429delTGAC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1056 ! A-498
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hACSL4
AC   CVCL_F1LR
SY   hACSL4 knockout A-549
DR   Hysigen; CGKO-M3152
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3152).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hASPH
AC   CVCL_F1LS
SY   hASPH knockout A-549
DR   Hysigen; CGKO-M3050
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3050).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:757; ASPH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hBAD
AC   CVCL_F1LT
SY   hBAD knockout A-549
DR   Hysigen; CGKO-M2873
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2873).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hBAX
AC   CVCL_E1IR
SY   hBAX knockout A-549
DR   Hysigen; CGKO-M2665
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2665).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hBZW1
AC   CVCL_F1LU
SY   hBZW1 knockout A-549
DR   Hysigen; CGKO-M2854
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2854).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18380; BZW1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hC11orf86
AC   CVCL_E1IS
SY   hC11orf86 knockout A-549
DR   Hysigen; CGKO-M2226
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2226).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34442; C11orf86.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hCADM1
AC   CVCL_F1LV
SY   hCADM1 knockout A-549
DR   Hysigen; CGKO-M2958
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2958).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5951; CADM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hCASP3
AC   CVCL_D6AG
SY   hCASP3 knockout A-549
DR   Hysigen; CGKO-M2487
DR   Wikidata; Q127381980
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2487).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hCASP6
AC   CVCL_D6AH
SY   hCASP6 knockout A-549
DR   Hysigen; CGKO-M2506
DR   Wikidata; Q127381982
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2506).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1507; CASP6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hCASP7
AC   CVCL_D6AI
SY   hCASP7 knockout A-549
DR   Hysigen; CGKO-M2507
DR   Wikidata; Q127381983
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2507).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1508; CASP7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hCASP8
AC   CVCL_D6AJ
SY   hCASP8 knockout A-549
DR   Hysigen; CGKO-M2488
DR   Wikidata; Q127381984
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2488).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hCAV1
AC   CVCL_E1IT
SY   hCAV1 knockout A-549
DR   Hysigen; CGKO-M2262
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2262).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hCUL5
AC   CVCL_F1LW
SY   hCUL5 knockout A-549
DR   Hysigen; CGKO-M2868
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2868).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2556; CUL5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hDGCR8
AC   CVCL_F1LX
SY   hDGCR8 knockout A-549
DR   Hysigen; CGKO-M3032
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3032).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2847; DGCR8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hDHX58
AC   CVCL_F1LY
SY   hDHX58 knockout A-549
DR   Hysigen; CGKO-M3052
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3052).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29517; DHX58.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hEGFR
AC   CVCL_F1LZ
SY   hEGFR knockout A-549
DR   Hysigen; CGKO-M2768
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2768).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hEIF2AK2
AC   CVCL_E1IU
SY   hEIF2AK2 knockout A-549
DR   Hysigen; CGKO-M2651
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2651).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hFAM83A
AC   CVCL_F1M0
SY   hFAM83A knockout A-549
DR   Hysigen; CGKO-M2908
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2908).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28210; FAM83A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hFXR1
AC   CVCL_F1M1
SY   hFXR1 knockout A-549
DR   Hysigen; CGKO-M2706
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2706).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4023; FXR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hGSDME
AC   CVCL_D6AK
SY   hGSDME knockout A-549
DR   Hysigen; CGKO-M2486
DR   Wikidata; Q127381985
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2486).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2810; GSDME.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hIFIH1
AC   CVCL_F1M2
SY   hIFIH1 knockout A-549
DR   Hysigen; CGKO-M3053
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3053).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hIFT88
AC   CVCL_F1M3
SY   hIFT88 knockout A-549
DR   Hysigen; CGKO-M2994
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2994).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20606; IFT88.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hKEAP1
AC   CVCL_F1M4
SY   hKEAP1 knockout A-549
DR   Hysigen; CGKO-M2896
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2896).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hKIF18B
AC   CVCL_F1M5
SY   hKIF18B knockout A-549
DR   Hysigen; CGKO-M3209
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3209).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27102; KIF18B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hMAVS
AC   CVCL_F1M6
SY   hMAVS knockout A-549
DR   Hysigen; CGKO-M3049
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3049).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hMPI
AC   CVCL_E1IV
SY   hMPI knockout A-549
DR   Hysigen; CGKO-M2645
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2645).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7216; MPI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hMUC1
AC   CVCL_D6AL
SY   hMUC1 knockout A-549
DR   Hysigen; CGKO-M2526
DR   Wikidata; Q127381986
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2526).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hMUC16
AC   CVCL_D6AM
SY   hMUC16 knockout A-549
DR   Hysigen; CGKO-M2528
DR   Wikidata; Q127381987
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2528).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15582; MUC16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hMUC4
AC   CVCL_D6AN
SY   hMUC4 knockout A-549
DR   Hysigen; CGKO-M2527
DR   Wikidata; Q127381988
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2527).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7514; MUC4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hMUC5AC
AC   CVCL_D6AP
SY   hMUC5AC knockout A-549
DR   Hysigen; CGKO-M2524
DR   Wikidata; Q127381989
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2524).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7515; MUC5AC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hMUC5B
AC   CVCL_D6AQ
SY   hMUC5B knockout A-549
DR   Hysigen; CGKO-M2525
DR   Wikidata; Q127381990
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2525).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7516; MUC5B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hNETO2
AC   CVCL_F1M7
SY   hNETO2 knockout A-549
DR   Hysigen; CGKO-M2901
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2901).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14644; NETO2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hNUMB
AC   CVCL_F1M8
SY   hNUMB knockout A-549
DR   Hysigen; CGKO-M3092
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3092).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hP4HB
AC   CVCL_F1M9
SY   hP4HB knockout A-549
DR   Hysigen; CGKO-M3115
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3115).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8548; P4HB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hPARP1
AC   CVCL_E1IW
SY   hPARP1 knockout A-549
DR   Hysigen; CGKO-M0004
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0004).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hPARP1 2
AC   CVCL_F1MA
SY   hPARP1 knockout 2 A-549
DR   Hysigen; CGKO-M2566
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2566).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hPARP2
AC   CVCL_E1IX
SY   hPARP2 knockout A-549
DR   Hysigen; CGKO-M0005
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0005).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hPFKFB4
AC   CVCL_D6AR
SY   hPFKFB4 knockout A-549
DR   Hysigen; CGKO-M2555
DR   Wikidata; Q127381991
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2555).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8875; PFKFB4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hPNPT1
AC   CVCL_F1MB
SY   hPNPT1 knockout A-549
DR   Hysigen; CGKO-M3116
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3116).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23166; PNPT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hPRKDC
AC   CVCL_F1MC
SY   hPRKDC knockout A-549
DR   Hysigen; CGKO-M2565
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2565).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9413; PRKDC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hRB1
AC   CVCL_D6AS
SY   hRB1 knockout A-549
DR   Hysigen; CGKO-M2219
DR   Wikidata; Q127381992
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2219).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hRIGI
AC   CVCL_F1MD
SY   hRIGI knockout A-549
DR   Hysigen; CGKO-M3051
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3051).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hRNASEL
AC   CVCL_F1ME
SY   hRNASEL knockout A-549
DR   Hysigen; CGKO-M3143
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3143).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10050; RNASEL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hSIRT1
AC   CVCL_E1IY
SY   hSIRT1 knockout A-549
DR   Hysigen; CGKO-M2598
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2598).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hSPP1
AC   CVCL_E1IZ
SY   hSPP1 knockout A-549
DR   Hysigen; CGKO-M2579
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2579).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hTERT
AC   CVCL_D6AT
SY   hTERT knockout A-549
DR   Hysigen; CGKO-M2551
DR   Wikidata; Q127381993
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2551).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte A-549 KO-hTMPRSS2
AC   CVCL_F1MF
SY   hTMPRSS2 knockout A-549
DR   Hysigen; CGKO-M2924
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2924).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11876; TMPRSS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hUBE3A
AC   CVCL_E1J0
SY   hUBE3A knockout A-549
DR   Hysigen; CGKO-M0006
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0006).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12496; UBE3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hUPP1
AC   CVCL_F1MG
SY   hUPP1 knockout A-549
DR   Hysigen; CGKO-M3165
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3165).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12576; UPP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549 KO-hUSP7
AC   CVCL_E1J1
SY   hUSP7 knockout A-549
DR   Hysigen; CGKO-M2159
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2159).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12630; USP7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte A-549 KO-hZDHHC20
AC   CVCL_F1MH
SY   hZDHHC20 knockout A-549
DR   Hysigen; CGKO-M3089
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3089).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20749; ZDHHC20.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A-549-Luc
AC   CVCL_E3GM
SY   Luciferase Reporter A-549 Cell Line
DR   Hysigen; TCH-C116L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C116L).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte A20 KO-mCalr
AC   CVCL_F1MI
SY   mCalr knockout A20
DR   Hysigen; CGKO-M3028
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3028).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88252; Calr.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A20 KO-mCd274
AC   CVCL_E1J2
SY   mCd274 knockout A20
DR   Hysigen; CGKO-M2325
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2325).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte A20 KO-mItgb1
AC   CVCL_F1MJ
SY   mItgb1 knockout A20
DR   Hysigen; CGKO-M3147
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3147).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96610; Itgb1.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte A20-Luc
AC   CVCL_E3GN
SY   Luciferase Reporter A20 Cell Line
DR   Hysigen; TCM-C804L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C804L).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1940 ! A20
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte AC16 hRYR2_p.D179E_c.537T>G
AC   CVCL_E2Q0
SY   hRYR2_p.D179E_c.537T>G AC16
DR   Hysigen; CGMU-M2170
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2170).
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple_edited; p.Asp179Glu (c.537T>A); ClinVar=VCV001067138; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2170).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U18 ! AC16 [Human hybrid cardiomyocyte]
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte AC16 KO-hCGAS
AC   CVCL_E1J3
SY   hCGAS knockout AC16
DR   Hysigen; CGKO-M2599
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2599).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21367; CGAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U18 ! AC16 [Human hybrid cardiomyocyte]
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte AC16 KO-hEPAS1
AC   CVCL_F1MK
SY   hEPAS1 knockout AC16
DR   Hysigen; CGKO-M3162
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3162).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3374; EPAS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U18 ! AC16 [Human hybrid cardiomyocyte]
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte AC16 KO-hFGD5-AS1
AC   CVCL_F1ML
SY   hFGD5-AS1 knockout AC16
DR   Hysigen; CGKO-M2850
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2850).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19117; FGD5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U18 ! AC16 [Human hybrid cardiomyocyte]
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte ACHN KO-hTNFSF9
AC   CVCL_E1J4
SY   hTNFSF9 knockout ACHN
DR   Hysigen; CGKO-M2294
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2294).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11939; TNFSF9.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1067 ! ACHN
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte ACHN-Luc
AC   CVCL_E3GP
SY   Luciferase Reporter ACHN Cell Line
DR   Hysigen; TCH-C122L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C122L).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1067 ! ACHN
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte AGS-Luc
AC   CVCL_E3GQ
SY   Luciferase Reporter AGS Cell Line
DR   Hysigen; TCH-C124L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C124L).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte AML12 KO-mIgf2
AC   CVCL_D6AU
SY   mIgf2 knockout AML12
DR   Hysigen; CGKO-M2349
DR   Wikidata; Q127381994
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2349).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96434; Igf2.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte AML12 KO-mKat7
AC   CVCL_F1MM
SY   mKat7 knockout AML12
DR   Hysigen; CGKO-M2787
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2787).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2182799; Kat7.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte AML12 KO-mNsun6
AC   CVCL_E1J5
SY   mNsun6 knockout AML12
DR   Hysigen; CGKO-M2301
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2301).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1921705; Nsun6.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte AML12 KO-mRtn4
AC   CVCL_F1MN
SY   mRtn4 knockout AML12
DR   Hysigen; CGKO-M2718
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2718).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1915835; Rtn4.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte AML12 KO-mSelenoo
AC   CVCL_F1MP
SY   mSelenoo knockout AML12
DR   Hysigen; CGKO-M2928
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2928).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919007; Selenoo.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte AML12 KO-mTrim14
AC   CVCL_F1MQ
SY   mTrim14 knockout AML12
DR   Hysigen; CGKO-M2752
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2752).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1921985; Trim14.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte AML12-Luc
AC   CVCL_E3GR
SY   Luciferase Reporter AML12 Cell Line
DR   Hysigen; TCM-C709L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C709L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte ARPE-19 KO-hCYP4V2
AC   CVCL_E1J6
SY   hCYP4V2 knockout ARPE-19
DR   Hysigen; CGKO-M2249
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2249).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23198; CYP4V2.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte ARPE-19 KO-hDDIT4
AC   CVCL_E1J7
SY   hDDIT4 knockout ARPE-19
DR   Hysigen; CGKO-M2585
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2585).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24944; DDIT4.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte AsPC-1 KO-hCDH17
AC   CVCL_F1MR
SY   hCDH17 knockout AsPC-1
DR   Hysigen; CGKO-M2890
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2890).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1756; CDH17.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte AsPC-1 KO-hLINC00511
AC   CVCL_E1J8
SY   hLINC00511 knockout AsPC-1
DR   Hysigen; CGKO-M2574
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2574).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43564; LINC00511.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte AsPC-1-Luc
AC   CVCL_E3GS
SY   Luciferase Reporter AsPC-1 Cell Line
DR   Hysigen; TCH-C128L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C128L).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte B-CPAP KO-hSLC5A5
AC   CVCL_F1MW
SY   hSLC5A5 knockout B-CPAP
DR   Hysigen; CGKO-M3044
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3044).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11040; SLC5A5.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Tyr (c.775G>T); ClinVar=VCV000634680; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0153 ! B-CPAP
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte B16 KO-mNlrc5
AC   CVCL_F1MS
SY   mNlrc5 knockout B16
DR   Hysigen; CGKO-M3233
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3233).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3612191; Nlrc5.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte B16 KO-mTnfaip8
AC   CVCL_D6AV
SY   mTnfaip8 knockout B16
DR   Hysigen; CGKO-M2537
DR   Wikidata; Q127381995
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2537).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2147191; Tnfaip8.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte B16-F10 KO-mBtnl2
AC   CVCL_D6AW
SY   mBtnl2 knockout B16-F10
DR   Hysigen; CGKO-M2469
DR   Wikidata; Q127381996
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2469).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1859549; Btnl2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte B16-F10 KO-mCd274
AC   CVCL_F1MT
SY   mCd274 knockout B16-F10
DR   Hysigen; CGKO-M3222
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3222).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte B16-F10 KO-mFgl2
AC   CVCL_D6AX
SY   mFgl2 knockout B16-F10
DR   Hysigen; CGKO-M2361
DR   Wikidata; Q127381997
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2361).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103266; Fgl2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte B16-F10 KO-mPkm
AC   CVCL_E1J9
SY   mPkm knockout B16-F10
DR   Hysigen; CGKO-M2594
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2594).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97591; Pkm.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte B16-F10 KO-mPrmt3
AC   CVCL_F1MU
SY   mPrmt3 knockout B16-F10
DR   Hysigen; CGKO-M2953
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2953).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919224; Prmt3.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte B16-F10 KO-mRipk1
AC   CVCL_E1JA
SY   mRipk1 knockout B16-F10
DR   Hysigen; CGKO-M2686
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2686).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108212; Ripk1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte B16-F10 KO-mTmem176b
AC   CVCL_E1JB
SY   mTmem176b knockout B16-F10
DR   Hysigen; CGKO-M2280
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2280).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916348; Tmem176b.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte B16-F10 KO-mUbd
AC   CVCL_F1MV
SY   mUbd knockout B16-F10
DR   Hysigen; CGKO-M2838
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2838).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1344410; Ubd.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte B16-F10-Luc
AC   CVCL_E3GU
SY   Luciferase Reporter B16-F10 Cell Line
DR   Hysigen; TCM-C713L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C713L).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte B16-F10-Luc-GFP
AC   CVCL_E3GV
SY   Luciferase/GFP Dual-Reporter B16-F10 Cell Line
DR   Hysigen; TCM-C713LG
CC   Doubling time: 24-48 hours (Hysigen=TCM-C713LG).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte B16-Luc
AC   CVCL_E3GT
SY   Luciferase Reporter B16 Cell Line
DR   Hysigen; TCM-C712L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C712L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte BEAS-2B KO-hCYP2A6
AC   CVCL_F1MX
SY   hCYP2A6 knockout BEAS-2B
DR   Hysigen; CGKO-M3129
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3129).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2610; CYP2A6.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BEAS-2B KO-hEPAS1
AC   CVCL_F1MY
SY   hEPAS1 knockout BEAS-2B
DR   Hysigen; CGKO-M3016
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3016).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3374; EPAS1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BEAS-2B KO-hFTO
AC   CVCL_F1MZ
SY   hFTO knockout BEAS-2B
DR   Hysigen; CGKO-M3141
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3141).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BEAS-2B KO-hHIF1A
AC   CVCL_F1N0
SY   hHIF1A knockout BEAS-2B
DR   Hysigen; CGKO-M3015
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3015).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte bEnd.3 KO-mCdh5
AC   CVCL_E1JC
SY   mCdh5 knockout bEnd.3
DR   Hysigen; CGKO-M2720
CC   Doubling time: 24-32 hours (Hysigen=CGKO-M2720).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:105057; Cdh5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0170 ! bEnd.3
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   HyCyte bEnd.3 KO-mSpp1
AC   CVCL_F1N1
SY   mSpp1 knockout bEnd.3
DR   Hysigen; CGKO-M3090
CC   Doubling time: 26-30 hours (Hysigen=CGKO-M3090).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98389; Spp1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0170 ! bEnd.3
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Bewo KO-hABCC1
AC   CVCL_E1JD
SY   hABCC1 knockout Bewo
DR   Hysigen; CGKO-M0009
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0009).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Bewo KO-hABCG2
AC   CVCL_E1JE
SY   hABCG2 knockout Bewo
DR   Hysigen; CGKO-M0010
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0010).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:74; ABCG2.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte BT-549 KO-hARTN
AC   CVCL_F1N2
SY   hARTN knockout BT-549
DR   Hysigen; CGKO-M3185
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3185).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:727; ARTN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BT-549 KO-hBAD
AC   CVCL_F1N3
SY   hBAD knockout BT-549
DR   Hysigen; CGKO-M3283
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3283).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BT-549 KO-hCD70
AC   CVCL_F1N4
SY   hCD70 knockout BT-549
DR   Hysigen; CGKO-M2819
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2819).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11937; CD70.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BT-549 KO-hEOMES
AC   CVCL_F1N5
SY   hEOMES knockout BT-549
DR   Hysigen; CGKO-M2778
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2778).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3372; EOMES.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val275fs*1 (c.821delG) (p.W274fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_607del343; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1092 ! BT-549
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mAgo2
AC   CVCL_E1JF
SY   mAgo2 knockout BV-2
DR   Hysigen; CGKO-M2328
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2328).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2446632; Ago2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte BV-2 KO-mCadm1
AC   CVCL_E1JG
SY   mCadm1 knockout BV-2
DR   Hysigen; CGKO-M2329
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2329).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1889272; Cadm1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte BV-2 KO-mCd83
AC   CVCL_E1JH
SY   mCd83 knockout BV-2
DR   Hysigen; CGKO-M2577
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2577).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1328316; Cd83.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte BV-2 KO-mDhrs3
AC   CVCL_F1N6
SY   mDhrs3 knockout BV-2
DR   Hysigen; CGKO-M2949
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2949).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1315215; Dhrs3.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mIkzf1
AC   CVCL_F1N7
SY   mIkzf1 knockout BV-2
DR   Hysigen; CGKO-M2767
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2767).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1342540; Ikzf1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mLy96
AC   CVCL_F1N8
SY   mLy96 knockout BV-2
DR   Hysigen; CGKO-M3001
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3001).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341909; Ly96.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mMapt
AC   CVCL_F1N9
SY   mMapt knockout BV-2
DR   Hysigen; CGKO-M3229
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3229).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97180; Mapt.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mMir124a-3
AC   CVCL_F1NA
SY   mMir124a-3 knockout BV-2
DR   Hysigen; CGKO-M2917
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2917).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3618704; Mir124a-3.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mNpc1
AC   CVCL_E1JI
SY   mNpc1 knockout BV-2
DR   Hysigen; CGKO-M2241
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2241).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1097712; Npc1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte BV-2 KO-mRgs1
AC   CVCL_F1NB
SY   mRgs1 knockout BV-2
DR   Hysigen; CGKO-M2806
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2806).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1354694; Rgs1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mSlc2a5
AC   CVCL_F1NC
SY   mSlc2a5 knockout BV-2
DR   Hysigen; CGKO-M2837
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2837).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1928369; Slc2a5.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mSqstm1
AC   CVCL_F1ND
SY   mSqstm1 knockout BV-2
DR   Hysigen; CGKO-M2756
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2756).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107931; Sqstm1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mStat3
AC   CVCL_F1NE
SY   mStat3 knockout BV-2
DR   Hysigen; CGKO-M3045
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3045).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103038; Stat3.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2 KO-mTrem2
AC   CVCL_E1JJ
SY   mTrem2 knockout BV-2
DR   Hysigen; CGKO-M2242
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2242).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1913150; Trem2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte BV-2 KO-mTxnip
AC   CVCL_F1NF
SY   mTxnip knockout BV-2
DR   Hysigen; CGKO-M3228
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3228).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1889549; Txnip.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BV-2-Luc
AC   CVCL_E3GW
SY   Luciferase Reporter BV-2 Cell Line
DR   Hysigen; TCM-C718L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C718L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte BxPC-3 hKRAS_p.G12D_c.35G>A
AC   CVCL_E2Q1
SY   hKRAS_p.G12D_c.35G>A BxPC-3
DR   Hysigen; CGMU-M2185
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2185).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2185).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte BxPC-3 KO-hDTNBP1
AC   CVCL_F1NG
SY   hDTNBP1 knockout BxPC-3
DR   Hysigen; CGKO-M2747
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2747).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17328; DTNBP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2185).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte BxPC-3 KO-hITGB6
AC   CVCL_D6AY
SY   hITGB6 knockout BxPC-3
DR   Hysigen; CGKO-M2458
DR   Wikidata; Q127381998
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2458).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6161; ITGB6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte BxPC-3-Luc
AC   CVCL_E3GX
SY   Luciferase Reporter BxPC-3 Cell Line
DR   Hysigen; TCH-C142L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C142L).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2185).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte C1498 KO-mCd7
AC   CVCL_E1JK
SY   mCd7 knockout C1498
DR   Hysigen; CGKO-M2675
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2675).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88344; Cd7.
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3494 ! C1498
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte C1498 KO-mSdc1
AC   CVCL_D6AZ
SY   mSdc1 knockout C1498
DR   Hysigen; CGKO-M2220
DR   Wikidata; Q127381999
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2220).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1349162; Sdc1.
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3494 ! C1498
SX   Female
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte C1498-Fluc-Puro KO-mTrem2
AC   CVCL_E1JL
SY   mTrem2 knockout C1498-Fluc-Puro
DR   Hysigen; CGKO-M2184
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2184).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1913150; Trem2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_QZ98 ! C1498-Fluc-Puro
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte C1498-Luc
AC   CVCL_E3GY
SY   Luciferase Reporter C1498 Cell Line
DR   Hysigen; TCM-C785L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C785L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Lymphoblast; CL=CL_0017005.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3494 ! C1498
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte C2C12 KO-mLrrc20
AC   CVCL_F1NH
SY   mLrrc20 knockout C2C12
DR   Hysigen; CGKO-M3075
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3075).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2387182; Lrrc20.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte C2C12 KO-mNqo1
AC   CVCL_E1JM
SY   mNqo1 knockout C2C12
DR   Hysigen; CGKO-M2338
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2338).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103187; Nqo1.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte C2C12 KO-mNqo2
AC   CVCL_E1JN
SY   mNqo2 knockout C2C12
DR   Hysigen; CGKO-M2339
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2339).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104513; Nqo2.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte C2C12 KO-mSidt2
AC   CVCL_F1NI
SY   mSidt2 knockout C2C12
DR   Hysigen; CGKO-M3145
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3145).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2446134; Sidt2.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte C3H/10T1/2 clone 8 KO-mRmrp
AC   CVCL_F1NJ
SY   mRmrp knockout C3H/10T1/2 clone 8
DR   Hysigen; CGKO-M3171
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3171).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97937; Rmrp.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte C6-Luc
AC   CVCL_E3GZ
SY   Luciferase Reporter C6 Cell Line
DR   Hysigen; TCR-C605L
CC   Doubling time: 24-48 hours (Hysigen=TCR-C605L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0194 ! C6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte Caco-2 KO-hAPOA1
AC   CVCL_D6B0
SY   hAPOA1 knockout Caco-2
DR   Hysigen; CGKO-M2347
DR   Wikidata; Q127382000
CC   Population: Caucasian.
CC   Doubling time: 60-80 hours (Hysigen=CGKO-M2347).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:600; APOA1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Caco-2-Luc
AC   CVCL_E3H0
SY   Luciferase Reporter Caco-2 Cell Line
DR   Hysigen; TCH-C146L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C146L).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte CBRH-7919 KO-rInsrr
AC   CVCL_F1NK
SY   rInsrr knockout CBRH-7919
DR   Hysigen; CGKO-M2948
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2948).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 67399; Insrr.
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7176 ! CBRH-7919
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte CCRF-CEM-Luc
AC   CVCL_E3H1
SY   Luciferase Reporter CCRF-CEM Cell Line
DR   Hysigen; TCH-C155L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C155L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte CHO KO-Slc2a4
AC   CVCL_F1NL
SY   Slc2a4 knockout CHO
DR   Hysigen; CGKO-M3133
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3133).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A8C2M7K8; Slc2a4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte COLO 205-Luc
AC   CVCL_E3H2
SY   Luciferase Reporter COLO 205 Cell Line
DR   Hysigen; TCH-C161L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C161L).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0218 ! COLO 205
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte COS-7 KO-veMIEF2
AC   CVCL_F1NM
SY   veMIEF2 knockout COS-7
DR   Hysigen; CGKO-M3109
CC   Group: Non-human primate cell line.
CC   Doubling time: 35-48 hours (Hysigen=CGKO-M3109).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9R714; MIEF2 (Note=Not from Chlorocebus aethiops but from Chlorocebus sabaeus, the closest currently available sequenced species).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte CT26 KO-mAtm
AC   CVCL_F1NN
SY   mAtm knockout CT26
DR   Hysigen; CGKO-M2560
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2560).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107202; Atm.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte CT26 KO-mCd274
AC   CVCL_E1JP
SY   mCd274 knockout CT26
DR   Hysigen; CGKO-M2300
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2300).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte CT26 KO-mParp1
AC   CVCL_F1NP
SY   mParp1 knockout CT26
DR   Hysigen; CGKO-M2559
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2559).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1340806; Parp1.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte CT26 KO-mPrkdc
AC   CVCL_F1NQ
SY   mPrkdc knockout CT26
DR   Hysigen; CGKO-M2558
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2558).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104779; Prkdc.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte CT26 KO-mSenp1
AC   CVCL_D6B1
SY   mSenp1 knockout CT26
DR   Hysigen; CGKO-M2450
DR   Wikidata; Q127382001
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2450).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2445054; Senp1.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte CT26 KO-mTmem176b
AC   CVCL_E1JQ
SY   mTmem176B knockout CT26
DR   Hysigen; CGKO-M2281
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2281).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916348; Tmem176b.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte CT26-Luc
AC   CVCL_E3H3
SY   Luciferase Reporter CT26 Cell Line
DR   Hysigen; TCM-C723L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C723L).
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Daudi KO-hCD72
AC   CVCL_E1JS
SY   hCD72 knockout Daudi
DR   Hysigen; CGKO-M2701
CC   Population: African; Kenyan.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2701).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1696; CD72.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Daudi KO-hCMTM6
AC   CVCL_D6B2
SY   hCMTM6 knockout Daudi
DR   Hysigen; CGKO-M2520
DR   Wikidata; Q127382002
CC   Population: African; Kenyan.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2520).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte DF1 KO-ggaSERBP1
AC   CVCL_D6B3
SY   ggaSERBP1 knockout DF1
DR   Hysigen; CGKO-M2510
DR   Wikidata; Q127382003
CC   Group: Bird cell line.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2510).
CC   Knockout cell: Method=CRISPR/Cas9; CGNC; 8530; SERBP1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte DLD-1 KO-hBRCA2
AC   CVCL_D6B4
SY   hBRCA2 knockout DLD-1
DR   Hysigen; CGKO-M2436
DR   Wikidata; Q127382004
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2436).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte DLD-1 KO-hPDX1
AC   CVCL_D6B5
SY   hPDX1 knockout DLD-1
DR   Hysigen; CGKO-M2462
DR   Wikidata; Q127382005
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2462).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6107; PDX1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte DLD-1-Luc
AC   CVCL_E3H4
SY   Luciferase Reporter DLD-1 Cell Line
DR   Hysigen; TCH-C169L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C169L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte DU145 KO-hLncRNA
AC   CVCL_E1JR
SY   hLncRNA knockout DU145
DR   Hysigen; CGKO-M2632
CC   Population: Caucasian.
CC   Characteristics: This cell line is a knock-out for a transcript (Ensembl ENST00000510619) from a non-coding RNA gene (Ensembl ENSG00000251194) not yet in HGNC.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2632).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte DU145-Luc
AC   CVCL_E3H5
SY   Luciferase Reporter DU145 Cell Line
DR   Hysigen; TCH-C170L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C170L).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte EL4 KO-mErlin1
AC   CVCL_E1JT
SY   mErlin1 knockout EL4
DR   Hysigen; CGKO-M2368
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2368).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2387613; Erlin1.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte EL4 KO-mTmem176b
AC   CVCL_E1JU
SY   mTmem176b knockout EL4
DR   Hysigen; CGKO-M2284
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2284).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916348; Tmem176b.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte EL4-Luc
AC   CVCL_E3H6
SY   Luciferase Reporter EL4 Cell Line
DR   Hysigen; TCM-C727L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C727L).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0255 ! EL4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte G422-Luc-GFP
AC   CVCL_E3KS
SY   Luciferase/GFP Dual-Reporter G422 Cell Line
DR   Hysigen; TCM-C792LG
CC   Doubling time: 24-48 hours (Hysigen=TCH-C792LG).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Kunming.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3KP ! G422
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte GC-1spg KO-mTdrp
AC   CVCL_F1NR
SY   mTdrp knockout GC-1spg
DR   Hysigen; CGKO-M2983
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2983).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919398; Tdrp.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatocyte; CL=CL_0000017.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8872 ! GC-1spg
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte GC-2spd(ts) KO-mTdrp
AC   CVCL_F1NS
SY   mTdrp knockout GC-2spd(ts)
DR   Hysigen; CGKO-M2984
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2984).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919398; Tdrp.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala132Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatocyte; CL=CL_0000017.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6633 ! GC-2spd(ts)
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte GES-1 KO-hCD14
AC   CVCL_E1JV
SY   hCD14 knockout GES-1
DR   Hysigen; CGKO-M2729
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2729).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1628; CD14.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ22 ! GES-1
SX   Sex unspecified
AG   9FM
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte GES-1 KO-hCTSB
AC   CVCL_F1NT
SY   hCTSB knockout GES-1
DR   Hysigen; CGKO-M3031
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3031).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ22 ! GES-1
SX   Sex unspecified
AG   9FM
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte GES-1 KO-hDDX17
AC   CVCL_F1NU
SY   hDDX17 knockout GES-1
DR   Hysigen; CGKO-M3065
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3065).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2740; DDX17.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ22 ! GES-1
SX   Sex unspecified
AG   9FM
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte GES-1 KO-hGBP5
AC   CVCL_F1NV
SY   hGBP5 knockout GES-1
DR   Hysigen; CGKO-M3054
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3054).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19895; GBP5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ22 ! GES-1
SX   Sex unspecified
AG   9FM
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte GES-1 KO-hGSDMD
AC   CVCL_D6B6
SY   hGSDMD knockout GES-1
DR   Hysigen; CGKO-M2411
DR   Wikidata; Q127382006
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2411).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25697; GSDMD.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ22 ! GES-1
SX   Sex unspecified
AG   9FM
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte H22-Luc
AC   CVCL_E3H7
SY   Luciferase Reporter H22 Cell Line
DR   Hysigen; TCM-C788L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C788L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H613 ! H22
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte H4 KO-hGSPT2
AC   CVCL_F1NW
SY   hGSPT2 knockout H4
DR   Hysigen; CGKO-M2939
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2939).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4622; GSPT2.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1239 ! H4
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte H4 KO-hNGLY1
AC   CVCL_F1NX
SY   hNGLY1 knockout H4
DR   Hysigen; CGKO-M2573
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2573).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1239 ! H4
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte H4 KO-hPER2
AC   CVCL_F1NY
SY   hPER2 knockout H4
DR   Hysigen; CGKO-M3046
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M3046).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8846; PER2.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1239 ! H4
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte H4-II KO-rInsrr
AC   CVCL_E1JW
SY   rInsrr knockout H4-II
DR   Hysigen; CGKO-M2625
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2625).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 67399; Insrr.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4623 ! H4-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte H9c2(2-1) KO-rCpt1a
AC   CVCL_E1JX
SY   rCpt1a knockout H9c2(2-1)
DR   Hysigen; CGKO-M2170
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2170).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 2396; Cpt1a.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HyCyte H9c2(2-1) KO-rLOC102549962
AC   CVCL_F1NZ
SY   rLOC102549962 knockout H9c2(2-1)
DR   Hysigen; CGKO-M2932
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2932).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 7627339; LOC102549962.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte H9c2(2-1) KO-rMapk1
AC   CVCL_E1JY
SY   rMapk1 knockout H9c2(2-1)
DR   Hysigen; CGKO-M2169
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2169).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 70500; Mapk1.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HyCyte HaCaT KO-hPI3
AC   CVCL_E1JZ
SY   hPI3 knockout HaCaT
DR   Hysigen; CGKO-M2682
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2682).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8947; PI3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HaCaT-Luc
AC   CVCL_E3H8
SY   Luciferase Reporter HaCaT Cell Line
DR   Hysigen; TCH-C388L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C388L).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HCCLM3 KO-hGIHCG
AC   CVCL_F1P0
SY   hGIHCG knockout HCCLM3
DR   Hysigen; CGKO-M3079
CC   Population: Chinese.
CC   Doubling time: 35-48 hours (Hysigen=CGKO-M3079).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:52649; GIHCG.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6832 ! HCCLM3
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCCLM3 KO-hHSPA4
AC   CVCL_D6B7
SY   hHSPA4 knockout HCCLM3
DR   Hysigen; CGKO-M2406
DR   Wikidata; Q127382007
CC   Population: Chinese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2406).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5237; HSPA4.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6832 ! HCCLM3
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 4
//
ID   HyCyte HCCLM3 KO-hUSP22
AC   CVCL_D6B8
SY   hUSP22 knockout HCCLM3
DR   Hysigen; CGKO-M2426
DR   Wikidata; Q127382008
CC   Population: Chinese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2426).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6832 ! HCCLM3
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 4
//
ID   HyCyte HCC1806-Luc
AC   CVCL_E3H9
SY   Luciferase Reporter HCC1806 Cell Line
DR   Hysigen; TCH-C444L
CC   Population: African American.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C444L).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HCC827-Luc
AC   CVCL_E3HA
SY   Luciferase Reporter HCC827 Cell Line
DR   Hysigen; TCH-C182L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C182L).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2063 ! HCC827
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte hCMEC/D3 hRNF213_p.R4810K_c.12429G>A
AC   CVCL_E2Q2
SY   hRNF213_p.R4810K_c.14429G>A hCMEC/D3
DR   Hysigen; CGMU-M2169
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2169).
CC   Sequence variation: Mutation; HGNC; HGNC:14539; RNF213; Simple_edited; p.Arg4810Lys (c.14429G>A); ClinVar=VCV000039700; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2169).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, temporal lobe, blood microvessel; UBERON=UBERON_0001871+UBERON_8410081.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C183312; Moyamoya disease 2
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U985 ! hCMEC/D3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte hCMEC/D3 KO-hRNF213
AC   CVCL_E1K0
SY   hRNF213 knockout hCMEC/D3
DR   Hysigen; CGKO-M2541
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2541).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14539; RNF213.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, temporal lobe, blood microvessel; UBERON=UBERON_0001871+UBERON_8410081.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U985 ! hCMEC/D3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HCT 116 KO-hANK3
AC   CVCL_D6B9
SY   hANK3 knockout HCT 116
DR   Hysigen; CGKO-M2371
DR   Wikidata; Q127382009
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2371).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:494; ANK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte HCT 116 KO-hARRDC4
AC   CVCL_F1P1
SY   hARRDC4 knockout HCT 116
DR   Hysigen; CGKO-M3179
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3179).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28087; ARRDC4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCT 116 KO-hCCAT2
AC   CVCL_D6BA
SY   hCCAT2 knockout HCT 116
DR   Hysigen; CGKO-M2373
DR   Wikidata; Q127382010
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2373).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:47044; CCAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte HCT 116 KO-hCEMIP
AC   CVCL_E1K1
SY   hCEMIP knockout HCT 116
DR   Hysigen; CGKO-M2691
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2691).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29213; CEMIP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HCT 116 KO-hHPD
AC   CVCL_F1P2
SY   hHPD knockout HCT 116
DR   Hysigen; CGKO-M2926
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2926).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5147; HPD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCT 116 KO-hKLF7
AC   CVCL_F1P3
SY   hKLF7 knockout HCT 116
DR   Hysigen; CGKO-M3005
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3005).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6350; KLF7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCT 116 KO-hMMP1
AC   CVCL_F1P4
SY   hMMP1 knockout HCT 116
DR   Hysigen; CGKO-M3178
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3178).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7155; MMP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCT 116 KO-hMVB12A
AC   CVCL_F1P5
SY   hMVB12A knockout HCT 116
DR   Hysigen; CGKO-M2987
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2987).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25153; MVB12A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCT 116 KO-hPLD2
AC   CVCL_F1P6
SY   hPLD2 knockout HCT 116
DR   Hysigen; CGKO-M2860
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2860).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9068; PLD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCT 116 KO-hPTK7
AC   CVCL_D6BB
SY   hPTK7 knockout HCT 116
DR   Hysigen; CGKO-M2228
DR   Wikidata; Q127382011
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2228).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9618; PTK7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte HCT 116 KO-hRPTOR
AC   CVCL_E1K2
SY   hRPTOR knockout HCT 116
DR   Hysigen; CGKO-M2641
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2641).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30287; RPTOR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HCT 116 KO-hS1PR3
AC   CVCL_E1K3
SY   hS1PR knockout HCT 116
DR   Hysigen; CGKO-M2660
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2660).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3167; S1PR3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HCT 116 KO-hSOAT1
AC   CVCL_E1K4
SY   hSOAT1 knockout HCT 116
DR   Hysigen; CGKO-M2709
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2709).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11177; SOAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HCT 116-Luc
AC   CVCL_E3HB
SY   Luciferase Reporter HCT 116 Cell Line
DR   Hysigen; TCH-C185L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C185L).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HCT 15 KO-hARG1
AC   CVCL_F1P7
SY   hARG1 knockout HCT 15
DR   Hysigen; CGKO-M2780
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2780).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:663; ARG1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0292 ! HCT 15
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HCT 15 KO-hBRCA2
AC   CVCL_E1K5
SY   hBRCA2 knockout HCT 15
DR   Hysigen; CGKO-M2178
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2178).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0292 ! HCT 15
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HCT 15-Luc
AC   CVCL_E3HC
SY   Luciferase Reporter HCT 15 Cell Line
DR   Hysigen; TCH-C186L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C186L).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0292 ! HCT 15
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HEK293 hVPS35-eGFP
AC   CVCL_E2SW
SY   hVPS35 insert eGFP in C-terminal HEK293
DR   Hysigen; CGKI-M2128
CC   Characteristics: Using CRISPR/Cas9 VPS35 has been endogenously tagged at the C-terminus with EGFP (Hysigen=CGKI-M2128).
CC   Doubling time: 24-48 hours (Hysigen=CGKI-M2128).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HEK293 KO-hCAMP
AC   CVCL_F1P8
SY   hCAMP knockout HEK293
DR   Hysigen; CGKO-M2861
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2861).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1472; CAMP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293 KO-hFAM83A
AC   CVCL_F1P9
SY   hFAM83A knockout HEK293
DR   Hysigen; CGKO-M2907
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2907).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28210; FAM83A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293 KO-hKIAA0319L
AC   CVCL_E1K6
SY   hKIAA0319L knockout HEK293
DR   Hysigen; CGKO-M2628
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2628).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30071; KIAA0319L.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293 KO-hMRC1
AC   CVCL_F1PA
SY   hMRC1 knockout HEK293
DR   Hysigen; CGKO-M3029
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3029).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7228; MRC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293 KO-hMTNR1A
AC   CVCL_F1PB
SY   hMTNR1A knockout HEK293
DR   Hysigen; CGKO-M3202
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3202).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7463; MTNR1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293 KO-hOPA1
AC   CVCL_D6BC
SY   hOPA1 knockout HEK293
DR   Hysigen; CGKO-M2390
DR   Wikidata; Q127382012
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2390).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8140; OPA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293 KO-hPVR
AC   CVCL_E1K7
SY   hPVR knockout HEK293
DR   Hysigen; CGKO-M2624
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2624).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293 KO-hTPP1
AC   CVCL_F1PC
SY   hTPP1 knockout HEK293
DR   Hysigen; CGKO-M3192
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3192).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293 KO-hUSP11
AC   CVCL_D6BD
SY   hUSP11 knockout HEK293
DR   Hysigen; CGKO-M2459
DR   Wikidata; Q127382013
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2459).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12609; USP11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293 KO-hUSP16
AC   CVCL_D6BE
SY   hUSP16 knockout HEK293
DR   Hysigen; CGKO-M2414
DR   Wikidata; Q127382014
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2414).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293 KO-hUSP25
AC   CVCL_D6BF
SY   hUSP25 knockout HEK293
DR   Hysigen; CGKO-M2467
DR   Wikidata; Q127382015
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2467).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12624; USP25.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293 KO-hUSP9X
AC   CVCL_D6BG
SY   hUSP9X knockout HEK293
DR   Hysigen; CGKO-M2466
DR   Wikidata; Q127382016
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2466).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12632; USP9X.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293-Luc
AC   CVCL_E3HD
SY   Luciferase Reporter HEK-293 Cell Line
DR   Hysigen; TCH-C190L
CC   Doubling time: 24-48 hours (Hysigen=TCH-C190L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293-FT KO-hFURIN
AC   CVCL_F1PD
SY   hFURIN knockout HEK293-FT
DR   Hysigen; CGKO-M2827
CC   Doubling time: 20-30 hours (Hysigen=CGKO-M2827).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8568; FURIN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6911 ! HEK293-FT
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T hXRCC4_p.D103H_c.307G>C
AC   CVCL_E2Q3
SY   hXRCC4_p.D103H_c.307G>C HEK293T
DR   Hysigen; CGMU-M2204
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2204).
CC   Sequence variation: Mutation; HGNC; HGNC:12831; XRCC4; Simple_edited; p.Asp103His (c.307G>C); dbSNP=rs144653114; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2204).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hAP2M1
AC   CVCL_E1K8
SY   hAP2M1 knockout HEK293T
DR   Hysigen; CGKO-M2657
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2657).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:564; AP2M1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hATP7A
AC   CVCL_F1PE
SY   hATP7A knockout HEK293T
DR   Hysigen; CGKO-M3286
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3286).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:869; ATP7A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hB2M
AC   CVCL_E1K9
SY   hB2M knockout HEK293T
DR   Hysigen; CGKO-M2213
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2213).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hEDF1
AC   CVCL_F1PF
SY   hEDF1 knockout HEK293T
DR   Hysigen; CGKO-M2956
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2956).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3164; EDF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hERAP1
AC   CVCL_E1KA
SY   hERAP1 knockout HEK293T
DR   Hysigen; CGKO-M2183
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2183).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hFKBP1A
AC   CVCL_F1PG
SY   hFKBP1A knockout HEK293T
DR   Hysigen; CGKO-M3180
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3180).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hFOLR1
AC   CVCL_F1PH
SY   hFOLR1 knockout HEK293T
DR   Hysigen; CGKO-M3211
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3211).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hFZD7
AC   CVCL_E1KB
SY   hFZD7 knockout HEK293T
DR   Hysigen; CGKO-M2250
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2250).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hGGN
AC   CVCL_E1KC
SY   hGGN knockout HEK293T
DR   Hysigen; CGKO-M2254
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2254).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18869; GGN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hLDLR
AC   CVCL_E1KD
SY   hLDLR knockout HEK293T
DR   Hysigen; CGKO-M2694
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2694).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hMIR190B
AC   CVCL_F1PI
SY   hMIR190B knockout HEK293T
DR   Hysigen; CGKO-M3150
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3150).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33656; MIR190B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hNGLY1
AC   CVCL_E1KE
SY   hNGLY1 knockout HEK293T
DR   Hysigen; CGKO-M2258
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2258).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hNOD2
AC   CVCL_F1PJ
SY   hNOD2 knockout HEK293T
DR   Hysigen; CGKO-M2750
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2750).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5331; NOD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hNPHP3
AC   CVCL_D6A3
SY   hNPHP3 knockout HEK293T
DR   Hysigen; CGKO-M2516
DR   Wikidata; Q127381967
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2516).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7907; NPHP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293T KO-hNQO1
AC   CVCL_E1KF
SY   hNQO1 knockout HEK293T
DR   Hysigen; CGKO-M2341
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2341).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2874; NQO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hNQO2
AC   CVCL_E1KG
SY   hNQO2 knockout HEK293T
DR   Hysigen; CGKO-M2342
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2342).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7856; NQO2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hNTAN1
AC   CVCL_E1KH
SY   hNTAN1 knockout HEK293T
DR   Hysigen; CGKO-M2260
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2260).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29909; NTAN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hNTAQ1
AC   CVCL_E1KI
SY   hNTAQ1 knockout HEK293T
DR   Hysigen; CGKO-M2259
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2259).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25490; NTAQ1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hNUP107
AC   CVCL_F1PK
SY   hNUP107 knockout HEK293T
DR   Hysigen; CGKO-M3148
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3148).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29914; NUP107.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hPLD3
AC   CVCL_F1PL
SY   hPLD3 knockout HEK293T
DR   Hysigen; CGKO-M2841
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2841).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hSHOC2
AC   CVCL_F1PM
SY   hSHOC2 knockout HEK293T
DR   Hysigen; CGKO-M2793
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2793).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15454; SHOC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hSMPD1
AC   CVCL_D6A4
SY   hSMPD1 knockout HEK293T
DR   Hysigen; CGKO-M2407
DR   Wikidata; Q127381968
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2407).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293T KO-hTIMD4
AC   CVCL_E1KJ
SY   hTIMD4 knockout HEK293T
DR   Hysigen; CGKO-M2695
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2695).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25132; TIMD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HEK293T KO-hTRPA1
AC   CVCL_D6A5
SY   hTRPA1 knockout HEK293T
DR   Hysigen; CGKO-M2440
DR   Wikidata; Q127381969
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2440).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:497; TRPA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293T KO-hTRPV1
AC   CVCL_D6A6
SY   hTRPV1 knockout HEK293T
DR   Hysigen; CGKO-M2442
DR   Wikidata; Q127381970
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2442).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12716; TRPV1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293T KO-hTRPV4
AC   CVCL_D6A7
SY   hTRPV4 knockout HEK293T
DR   Hysigen; CGKO-M2441
DR   Wikidata; Q127381971
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2441).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18083; TRPV4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293T KO-hVWA7
AC   CVCL_F1PN
SY   hVWA7 knockout HEK293T
DR   Hysigen; CGKO-M2057
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2057).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13939; VWA7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HEK293T KO-hYWHAZ
AC   CVCL_D6A8
SY   hYWHAZ knockout HEK293T
DR   Hysigen; CGKO-M2395
DR   Wikidata; Q127381972
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2395).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12855; YWHAZ.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HEK293T KO-hZNF598
AC   CVCL_F1PP
SY   hZNF598 knockout HEK293T
DR   Hysigen; CGKO-M2955
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2955).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28079; ZNF598.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hARID1A
AC   CVCL_E1KK
SY   hARID1A knockout HeLa
DR   Hysigen; CGKO-M2307
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2307).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hATRX
AC   CVCL_E1KL
SY   hATRX knockout HeLa
DR   Hysigen; CGKO-M2308
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2308).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hBAHD1
AC   CVCL_D6BH
SY   hBAHD1 knockout HeLa
DR   Hysigen; CGKO-M2522
DR   Wikidata; Q127382017
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2522).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29153; BAHD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HyCyte HeLa KO-hBPNT1
AC   CVCL_E1KM
SY   hBPNT1 knockout HeLa
DR   Hysigen; CGKO-M2679
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2679).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1096; BPNT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hCEMIP
AC   CVCL_E1KN
SY   hCEMIP knockout HeLa
DR   Hysigen; CGKO-M2680
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2680).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29213; CEMIP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hCPEB1
AC   CVCL_F1PQ
SY   hCPEB1 knockout HeLa
DR   Hysigen; CGKO-M3144
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M3144).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21744; CPEB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hDNM1L
AC   CVCL_E1KP
SY   hDNM1L knockout HeLa
DR   Hysigen; CGKO-M2693
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2693).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2973; DNM1L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hECM1
AC   CVCL_E1KQ
SY   hECM1 knockout HeLa
DR   Hysigen; CGKO-M2296
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2296).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3153; ECM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hFAF2
AC   CVCL_F1PR
SY   hFAF2 knockout HeLa
DR   Hysigen; CGKO-M3243
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M3243).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24666; FAF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hFANCD2
AC   CVCL_D6BI
SY   hFANCD2 knockout HeLa
DR   Hysigen; CGKO-M2423
DR   Wikidata; Q127382018
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2423).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HyCyte HeLa KO-hFBXW7
AC   CVCL_E1KR
SY   hFBXW7 knockout HeLa
DR   Hysigen; CGKO-M2306
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2306).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hHGS
AC   CVCL_F1PS
SY   hHGS knockout HeLa
DR   Hysigen; CGKO-M3201
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M3201).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4897; HGS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hIFNGR1
AC   CVCL_F1PT
SY   hIFNGR1 knockout HeLa
DR   Hysigen; CGKO-M3212
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M3212).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hIMPDH2
AC   CVCL_F1PU
SY   hIMPDH2 knockout HeLa
DR   Hysigen; CGKO-M2707
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M2707).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6053; IMPDH2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hLTA
AC   CVCL_F1PV
SY   hLTA knockout HeLa
DR   Hysigen; CGKO-M3213
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M3213).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6709; LTA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hMCU
AC   CVCL_E1KS
SY   hMCU knockout HeLa
DR   Hysigen; CGKO-M2692
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2692).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23526; MCU.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hMIEF2
AC   CVCL_F1PW
SY   hMIEF2 knockout HeLa
DR   Hysigen; CGKO-M3108
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M3108).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17920; MIEF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hMSANTD3
AC   CVCL_E1KT
SY   hMSANTD3 knockout HeLa
DR   Hysigen; CGKO-M2304
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2304).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23370; MSANTD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hNEU1
AC   CVCL_E1KU
SY   hNEU1 knockout HeLa
DR   Hysigen; CGKO-M2734
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2734).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hNEU3
AC   CVCL_E1KV
SY   hNEU3 knockout HeLa
DR   Hysigen; CGKO-M2735
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2735).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7760; NEU3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hPDE3A
AC   CVCL_D6BJ
SY   hPDE3A knockout HeLa
DR   Hysigen; CGKO-M2387
DR   Wikidata; Q127382019
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2387).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8778; PDE3A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HyCyte HeLa KO-hPLD3
AC   CVCL_F1PX
SY   hPLD3 knockout HeLa
DR   Hysigen; CGKO-M2840
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M2840).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hRB1CC1
AC   CVCL_E1KW
SY   hRB1CC1 knockout HeLa
DR   Hysigen; CGKO-M2681
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2681).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15574; RB1CC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hSLFN12
AC   CVCL_D6BK
SY   hSLFN12 knockout HeLa
DR   Hysigen; CGKO-M2388
DR   Wikidata; Q127382020
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2388).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25500; SLFN12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HyCyte HeLa KO-hSPOP
AC   CVCL_E1KX
SY   hSPOP knockout HeLa
DR   Hysigen; CGKO-M2309
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2309).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11254; SPOP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hTREX1
AC   CVCL_F1PY
SY   hTREX1 knockout HeLa
DR   Hysigen; CGKO-M2805
CC   Population: African American.
CC   Doubling time: 30-48 hours (Hysigen=CGKO-M2805).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HeLa KO-hYY1
AC   CVCL_E1KY
SY   hYY1 knockout HeLa
DR   Hysigen; CGKO-M2375
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2375).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12856; YY1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   HyCyte HeLa KO-hZKSCAN3
AC   CVCL_D5Y9
SY   hZKSCAN3 knockout HeLa
DR   Hysigen; CGKO-M2345
DR   Wikidata; Q127382022
CC   Population: African American.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2345).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13853; ZKSCAN3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   HyCyte HeLa-Luc
AC   CVCL_E3HE
SY   Luciferase Reporter HeLa Cell Line
DR   Hysigen; TCH-C193L
CC   Population: African American.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C193L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte Hep 3B2.1-7 KO-hMFSD2A
AC   CVCL_F1PZ
SY   hMFSD2A knockout Hep 3B2.1-7
DR   Hysigen; CGKO-M3191
CC   Population: African American.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3191).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25897; MFSD2A.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep 3B2.1-7-Luc
AC   CVCL_E3HF
SY   Luciferase Reporter Hep 3B2.1-7 Cell Line
DR   Hysigen; TCH-C195L
CC   Population: African American.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C195L).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Hep-G2 KO-hADAR
AC   CVCL_E1KZ
SY   hADAR knockout Hep-G2
DR   Hysigen; CGKO-M2721
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2721).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hALB
AC   CVCL_E1L0
SY   hALB knockout Hep-G2
DR   Hysigen; CGKO-M2210
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2210).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:399; ALB.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hALDH2
AC   CVCL_E1L1
SY   hALDH2 knockout Hep-G2
DR   Hysigen; CGKO-M2606
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2606).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:404; ALDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hALDOB
AC   CVCL_E1L2
SY   hALDOB knockout Hep-G2
DR   Hysigen; CGKO-M2236
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2236).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:417; ALDOB.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hAPOA4
AC   CVCL_D6BM
SY   hAPOA4 knockout Hep-G2
DR   Hysigen; CGKO-M2422
DR   Wikidata; Q127382024
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2422).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:602; APOA4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Hep-G2 KO-hCAMKK2
AC   CVCL_F1Q4
SY   hCAMKK2 knockout Hep-G2
DR   Hysigen; CGKO-M3042
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M3042).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1470; CAMKK2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hDEGS1
AC   CVCL_F1Q5
SY   hDEGS1 knockout Hep-G2
DR   Hysigen; CGKO-M3146
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M3146).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13709; DEGS1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hFDFT1
AC   CVCL_F1Q6
SY   hFDFT1 knockout Hep-G2
DR   Hysigen; CGKO-M2944
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2944).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3629; FDFT1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hGLI4
AC   CVCL_E1L3
SY   hGLI4 knockout Hep-G2
DR   Hysigen; CGKO-M2713
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2713).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4320; GLI4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hGPX8
AC   CVCL_F1Q7
SY   hGPX8 knockout Hep-G2
DR   Hysigen; CGKO-M3007
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M3007).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33100; GPX8.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hIFNAR2
AC   CVCL_F1Q8
SY   hIFNAR2 knockout Hep-G2
DR   Hysigen; CGKO-M2885
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2885).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5433; IFNAR2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hIGF2BP3
AC   CVCL_F1Q9
SY   hIGF2BP3 knockout Hep-G2
DR   Hysigen; CGKO-M2914
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2914).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hINSR
AC   CVCL_F1QA
SY   hINSR knockout Hep-G2
DR   Hysigen; CGKO-M3043
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M3043).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6091; INSR.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hNR1H3
AC   CVCL_E1L4
SY   hNR1H3 knockout Hep-G2
DR   Hysigen; CGKO-M2231
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2231).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hNUP188
AC   CVCL_F1QB
SY   hNUP188 knockout Hep-G2
DR   Hysigen; CGKO-M2929
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2929).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17859; NUP188.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hPAH
AC   CVCL_E1L5
SY   hPAH knockout Hep-G2
DR   Hysigen; CGKO-M2202
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2202).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8582; PAH.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hPCSK9
AC   CVCL_F1QC
SY   hPCSK9 knockout Hep-G2
DR   Hysigen; CGKO-M3250
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M3250).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20001; PCSK9.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hPRKAG1
AC   CVCL_E1L6
SY   hPRKAG1 knockout Hep-G2
DR   Hysigen; CGKO-M2684
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2684).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hRBP4
AC   CVCL_D6BN
SY   hRBP4 knockout Hep-G2
DR   Hysigen; CGKO-M2405
DR   Wikidata; Q127382025
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2405).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9922; RBP4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Hep-G2 KO-hSMYD5
AC   CVCL_F1QD
SY   hSMYD5 knockout Hep-G2
DR   Hysigen; CGKO-M2920
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2920).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16258; SMYD5.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hTHRAP3
AC   CVCL_E1L7
SY   hTHRAP3 knockout Hep-G2
DR   Hysigen; CGKO-M2288
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2288).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22964; THRAP3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Hep-G2 KO-hTP53
AC   CVCL_F1QE
SY   hTP53 knockout Hep-G2
DR   Hysigen; CGKO-M2916
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2916).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hep-G2 KO-hUSP21
AC   CVCL_D6BP
SY   hUSP21 knockout Hep-G2
DR   Hysigen; CGKO-M2415
DR   Wikidata; Q127382026
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2415).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12620; USP21.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Hep-G2-Luc
AC   CVCL_E3HG
SY   Luciferase Reporter Hep-G2 Cell Line
DR   Hysigen; TCH-C196L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C196L).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Hepa 1-6 KO-mEno1
AC   CVCL_E1L8
SY   mEno1 knockout Hepa 1-6
DR   Hysigen; CGKO-M2704
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2704).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95393; Eno1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte Hepa 1-6 KO-mGstp3
AC   CVCL_F1Q0
SY   mGstp3 knockout Hepa 1-6
DR   Hysigen; CGKO-M2942
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2942).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2385078; Gstp3.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hepa 1-6 KO-mLgals4
AC   CVCL_F1Q1
SY   mLgals4 knockout Hepa 1-6
DR   Hysigen; CGKO-M3156
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3156).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107536; Lgals4.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hepa 1-6 KO-mPrrc2c
AC   CVCL_F1Q2
SY   mPrrc2c knockout Hepa 1-6
DR   Hysigen; CGKO-M2976
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2976).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1913754; Prrc2c.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hepa 1-6 KO-mSlc39a1
AC   CVCL_D6BL
SY   mSlc39a1 knockout Hepa 1-6
DR   Hysigen; CGKO-M2475
DR   Wikidata; Q127382023
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2475).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353474; Slc39a1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte Hepa 1-6 KO-mSmyd5
AC   CVCL_F1Q3
SY   mSmyd5 knockout Hepa 1-6
DR   Hysigen; CGKO-M2919
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2919).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108048; Smyd5.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hepa 1-6 KO-mTrp53
AC   CVCL_E1L9
SY   mTrp53 knockout Hepa 1-6
DR   Hysigen; CGKO-M2687
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2687).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte Hepa 1-6-Luc
AC   CVCL_E3HH
SY   Luciferase Reporter Hepa 1-6-Luc Cell Line
DR   Hysigen; TCM-C734L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C734L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HGC-27 hKDM6A_p.A694T_c.2080G>A
AC   CVCL_E2Q4
SY   hKDM6A_p.A694T_c.2080G>A HGC-27
DR   Hysigen; CGMU-M2173
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2173).
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple_edited; p.Ala746Thr (c.2080G>A); ClinVar=VCV002714479; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2173).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HGC-27 KO-hHKDC1
AC   CVCL_F1QF
SY   hHKDC1 knockout HGC-27
DR   Hysigen; CGKO-M3002
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3002).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23302; HKDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple_edited; p.Ala746Thr (c.2080G>A); ClinVar=VCV002714479; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2173).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HGC-27 KO-hLIN28B
AC   CVCL_F1QG
SY   hLIN28B knockout HGC-27
DR   Hysigen; CGKO-M2762
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2762).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple_edited; p.Ala746Thr (c.2080G>A); ClinVar=VCV002714479; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2173).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HGC-27 KO-hPIN1
AC   CVCL_F1QH
SY   hPIN1 knockout HGC-27
DR   Hysigen; CGKO-M2912
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2912).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8988; PIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple_edited; p.Ala746Thr (c.2080G>A); ClinVar=VCV002714479; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2173).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HGC-27 KO-hZC3H13
AC   CVCL_F1QI
SY   hZC3H13 knockout HGC-27
DR   Hysigen; CGKO-M3135
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3135).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20368; ZC3H13.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple_edited; p.Ala746Thr (c.2080G>A); ClinVar=VCV002714479; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2173).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HGC-27-Luc
AC   CVCL_E3HI
SY   Luciferase Reporter HGC-27 Cell Line
DR   Hysigen; TCH-C202L
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C202L).
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple_edited; p.Ala746Thr (c.2080G>A); ClinVar=VCV002714479; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2173).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HK-2 KO-hFOXO3
AC   CVCL_F1QJ
SY   hFOXO3 knockout HK-2
DR   Hysigen; CGKO-M2858
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2858).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HK-2 KO-hIRF8
AC   CVCL_F1QK
SY   hIRF8 knockout HK-2
DR   Hysigen; CGKO-M3023
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3023).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HK-2 KO-hKDM5A
AC   CVCL_E1LA
SY   hKDM5A knockout HK-2
DR   Hysigen; CGKO-M2654
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2654).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HK-2 KO-hNPHP3
AC   CVCL_D6BQ
SY   hNPHP3 knockout HK-2
DR   Hysigen; CGKO-M2504
DR   Wikidata; Q127382027
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2504).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7907; NPHP3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte HK-2 KO-hSLC22A5
AC   CVCL_F1QL
SY   hSLC22A5 knockout HK-2
DR   Hysigen; CGKO-M2973
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2973).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10969; SLC22A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HL-60 KO-hARHGDIB
AC   CVCL_F1QM
SY   hARHGDIB knockout HL-60
DR   Hysigen; CGKO-M2970
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2970).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:679; ARHGDIB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HL-60 KO-hIRAK4
AC   CVCL_E1LB
SY   hIRAK4 knockout HL-60
DR   Hysigen; CGKO-M2295
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2295).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte HL-60-Luc-GFP
AC   CVCL_E3HJ
SY   Luciferase/GFP Dual-Reporter HL-60 Cell Line
DR   Hysigen; TCH-C204LG
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=TCH-C204LG).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HMy2.C1R KO-hCD81
AC   CVCL_F1QN
SY   hCD81 knockout HMy2.C1R
DR   Hysigen; CGKO-M3021
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3021).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Hs 683 KO-hREEP4
AC   CVCL_F1QP
SY   hREEP4 knockout Hs 683
DR   Hysigen; CGKO-M2851
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2851).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26176; REEP4.
CC   Sequence variation: Mutation; HGNC; HGNC:3942; MTOR; Simple; p.Glu1799Lys (c.5395G>A); ClinVar=VCV000217823; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0844 ! Hs 683
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HT-1080 KO-hSMARCA4
AC   CVCL_D6BS
SY   hSMARCA4 knockout HT-1080
DR   Hysigen; CGKO-M2389
DR   Wikidata; Q127382029
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2389).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte HT-29 KO-hCCAT2
AC   CVCL_D6BR
SY   hCCAT2 knockout HT-29
DR   Hysigen; CGKO-M2372
DR   Wikidata; Q127382028
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2372).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:47044; CCAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte HT-29 KO-hDCAF4
AC   CVCL_E1LC
SY   hDCAF4 knockout HT-29
DR   Hysigen; CGKO-M2293
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2293).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20229; DCAF4.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HT-29 KO-hGATC
AC   CVCL_F1QR
SY   hGATC knockout HT-29
DR   Hysigen; CGKO-M2963
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2963).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25068; GATC.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HT-29 KO-hGDF15
AC   CVCL_F1QS
SY   hGDF15 knockout HT-29
DR   Hysigen; CGKO-M3253
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3253).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30142; GDF15.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HT-29 KO-hPCGF1
AC   CVCL_F1QT
SY   hPCGF1 knockout HT-29
DR   Hysigen; CGKO-M2789
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2789).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17615; PCGF1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HT-29 KO-hTIMM17B
AC   CVCL_E1LD
SY   hTIMM17B knockout HT-29
DR   Hysigen; CGKO-M2626
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2626).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17310; TIMM17B.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte HT-29-Luc
AC   CVCL_E3HK
SY   Luciferase Reporter HT-29 Cell Line
DR   Hysigen; TCH-C213L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C213L).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HT22 KO-mCpt1c
AC   CVCL_F1QQ
SY   mCpt1c knockout HT22
DR   Hysigen; CGKO-M3158
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3158).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2446526; Cpt1c.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte HT22 KO-mNlrp3
AC   CVCL_D6BT
SY   mNlrp3 knockout HT22
DR   Hysigen; CGKO-M2529
DR   Wikidata; Q127382030
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2529).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2653833; Nlrp3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte HT22 mSirt2_p.S368D_c.1102T>G_c.1103C>A
AC   CVCL_E2Q5
SY   mSirt2_p.S368D_c.1102T>G_c.1103C>A HT22
DR   Hysigen; CGMU-M2197
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2197).
CC   Sequence variation: Mutation; MGI; MGI:1927664; Sirt2; Simple_edited; p.Ser368Asp (c.1102_1103TC>GA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2197).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   HyCyte HTR-8/SVneo KO-hCGAS
AC   CVCL_E1LE
SY   hCGAS knockout HTR-8/SVneo
DR   Hysigen; CGKO-M2230
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2230).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21367; CGAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte Huh-7 KO-hGIHCG
AC   CVCL_F1QU
SY   hGIHCG knockout Huh-7
DR   Hysigen; CGKO-M3078
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3078).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:52649; GIHCG.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Huh-7 KO-hHSD17B13
AC   CVCL_F1QV
SY   hHSD17B13 knockout Huh-7
DR   Hysigen; CGKO-M2530
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2530).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18685; HSD17B13.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Huh-7 KO-hPRRC2C
AC   CVCL_F1QW
SY   hPRRC2C knockout Huh-7
DR   Hysigen; CGKO-M2975
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2975).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24903; PRRC2C.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Huh-7 KO-hSLC39A1
AC   CVCL_D6BU
SY   hSLC39A1 knockout Huh-7
DR   Hysigen; CGKO-M2476
DR   Wikidata; Q127382031
CC   Population: Japanese.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2476).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12876; SLC39A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Huh-7 KO-hSMARCA4
AC   CVCL_F1QX
SY   hSMARCA4 knockout Huh-7
DR   Hysigen; CGKO-M2937
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2937).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Huh-7 KO-hTIMM17B
AC   CVCL_E1LF
SY   hTIMM17B knockout Huh-7
DR   Hysigen; CGKO-M2627
CC   Population: Japanese.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2627).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17310; TIMM17B.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Huh-7 KO-hUSP20
AC   CVCL_F1QY
SY   hUSP20 knockout Huh-7
DR   Hysigen; CGKO-M2703
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2703).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12619; USP20.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Huh-7-Luc
AC   CVCL_E3HL
SY   Luciferase Reporter Huh-7-Luc Cell Line
DR   Hysigen; TCH-C217L
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C217L).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte HUVEC
AC   CVCL_E5ZU
DR   Hysigen; TCH-C406
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
ST   Source(s): Hysigen=TCH-C406
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13
ST   D12S391: 17,18
ST   D13S317: 10,13
ST   D16S539: 9
ST   D18S51: 13,15
ST   D19S433: 12,16.2
ST   D1S1656: 13,15
ST   D21S11: 29,30
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D6S1043: 11,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   HyCyte INS-1 KO-rAbcc8
AC   CVCL_F1QZ
SY   rAbcc8 knockout INS-1
DR   Hysigen; CGKO-M2492
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2492).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 3786; Abcc8.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte INS-1 KO-rHnf1a
AC   CVCL_E1LG
SY   rHnf1a knockout INS-1
DR   Hysigen; CGKO-M2493
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2493).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 3828; Hnf1a.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HyCyte INS-1 KO-rHnf4a
AC   CVCL_E1LH
SY   rHnf4a knockout INS-1
DR   Hysigen; CGKO-M2497
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2497).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 2810; Hnf4a.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HyCyte INS-1 KO-rIer3ip1
AC   CVCL_E1LI
SY   rIer3ip1 knockout INS-1
DR   Hysigen; CGKO-M2499
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2499).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 155663513; Ier3ip1.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HyCyte INS-1 KO-rKcnj11
AC   CVCL_F1R0
SY   rKcnj11 knockout INS-1
DR   Hysigen; CGKO-M2491
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2491).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 69247; Kcnj11.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte INS-1 KO-rPax4
AC   CVCL_F1R1
SY   rPax4 knockout INS-1
DR   Hysigen; CGKO-M2496
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2496).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 620433; Pax4.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte INS-1 KO-rSsr1
AC   CVCL_E1LJ
SY   rSsr1 knockout INS-1
DR   Hysigen; CGKO-M2498
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2498).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1310961; Ssr1.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   HyCyte INS-1 KO-rSting1
AC   CVCL_F1R2
SY   rSting1 knockout INS-1
DR   Hysigen; CGKO-M2500
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2500).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1562552; Sting1.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Ishikawa KO-hCTNNBIP1
AC   CVCL_F1R3
SY   hCTNNBIP1 knockout Ishikawa
DR   Hysigen; CGKO-M3000
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3000).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16913; CTNNBIP1.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte J558-Luc
AC   CVCL_E3HM
SY   Luciferase Reporter J558 Cell Line
DR   Hysigen; TCM-C799L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C799L).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3529 ! J558
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte J774A1 KO-mSetdb2
AC   CVCL_E1LK
SY   mSetdb2 knockout J774A1
DR   Hysigen; CGKO-M2297
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2297).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2685139; Setdb2.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0358 ! J774A1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte JEG-3 KO-hB2M
AC   CVCL_E1LL
SY   hB2M knockout JEG-3
DR   Hysigen; CGKO-M2320
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2320).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte JEG-3 KO-hLUM
AC   CVCL_D6BV
SY   hLUM knockout JEG-3
DR   Hysigen; CGKO-M2444
DR   Wikidata; Q127382032
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2444).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6724; LUM.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte JEG-3 KO-hMAPKAPK2
AC   CVCL_F1R4
SY   hMAPKAPK2 knockout JEG-3
DR   Hysigen; CGKO-M2799
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2799).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6887; MAPKAPK2.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Jeko-1-Luc-GFP
AC   CVCL_E3HN
SY   Luciferase/GFP Dual-Reporter Jeko-1 Cell Line
DR   Hysigen; TCH-C224LG
CC   Population: Korean.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C224LG).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro58Glnfs*65 (c.173delC); ClinVar=VCV001394451; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1865 ! JeKo-1
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Jurkat KO-hATM
AC   CVCL_E1LM
SY   hATM knockout Jurkat
DR   Hysigen; CGKO-M2203
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2203).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Jurkat KO-hBCL10
AC   CVCL_F1R5
SY   hBCL10 knockout Jurkat
DR   Hysigen; CGKO-M3010
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3010).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Jurkat-Luc
AC   CVCL_E3HP
SY   Luciferase Reporter Jurkat Cell Line
DR   Hysigen; TCH-C225L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C225L).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte K-562 KO-hERAP1
AC   CVCL_E1LN
SY   hERAP1 knockout K-562
DR   Hysigen; CGKO-M2197
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2197).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte K-562-Luc
AC   CVCL_E3HQ
SY   Luciferase Reporter K-562 Cell Line
DR   Hysigen; TCH-C226L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C226L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte KGN KO-hYTHDC2
AC   CVCL_F1R6
SY   hYTHDC2 knockout KGN
DR   Hysigen; CGKO-M2758
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2758).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24721; YTHDC2.
CC   Sequence variation: Mutation; HGNC; HGNC:1092; FOXL2; Simple; p.Cys134Trp (c.402C>G); ClinVar=VCV000376348; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0375 ! KGN
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte KYSE-150 KO-hDYRK2
AC   CVCL_E1LP
SY   hDYRK2 knockout KYSE-150
DR   Hysigen; CGKO-M2614
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2614).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3093; DYRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte KYSE-150 KO-hNSUN2
AC   CVCL_F1R7
SY   hNSUN2 knockout KYSE-150
DR   Hysigen; CGKO-M3114
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3114).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25994; NSUN2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte KYSE-150 KO-hZNF750
AC   CVCL_E1LQ
SY   hZNF750 knockout KYSE-150
DR   Hysigen; CGKO-M2730
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2730).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25843; ZNF750.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte KYSE-150-Luc
AC   CVCL_E3HR
SY   Luciferase Reporter KYSE-150 Cell Line
DR   Hysigen; TCH-C236L
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C236L).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte LL/2 (LLC1) KO-mArg2
AC   CVCL_F1R8
SY   mArg2 knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M3039
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3039).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1330806; Arg2.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LL/2 (LLC1) KO-mIrf7
AC   CVCL_E1LR
SY   mIrf7 knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M2317
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2317).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1859212; Irf7.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte LL/2 (LLC1) KO-mItgal
AC   CVCL_F1R9
SY   mItgal knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M2985
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2985).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96606; Itgal.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LL/2 (LLC1) KO-mKeap1
AC   CVCL_D6BW
SY   mKeap1 knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M2264
DR   Wikidata; Q127382033
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2264).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1858732; Keap1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte LL/2 (LLC1) KO-mMdm4
AC   CVCL_D6BX
SY   mMdm4 knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M2429
DR   Wikidata; Q127382034
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2429).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107934; Mdm4.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte LL/2 (LLC1) KO-mMif
AC   CVCL_D6BY
SY   mMif knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M2456
DR   Wikidata; Q127382035
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2456).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96982; Mif.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte LL/2 (LLC1) KO-mMlkl
AC   CVCL_F1RA
SY   mMlkl knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M3237
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3237).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1921818; Mlkl.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LL/2 (LLC1) KO-mPrmt3
AC   CVCL_F1RB
SY   mPrmt3 knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M2954
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2954).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919224; Prmt3.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LL/2 (LLC1) KO-mSting1
AC   CVCL_E1LS
SY   mSting1 knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M2578
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2578).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919762; Sting1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte LL/2 (LLC1) KO-mZdhhc6
AC   CVCL_F1RC
SY   mZdhhc6 knockout LL/2 (LLC1)
DR   Hysigen; CGKO-M3117
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3117).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1914230; Zdhhc6.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LL/2 (LLC1)-Luc
AC   CVCL_E3HS
SY   Luciferase Reporter LL/2 (LLC1) Cell Line
DR   Hysigen; TCM-C742L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C742L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte LM8 KO-mFgl2
AC   CVCL_D6BZ
SY   mFgl2 knockout LM8
DR   Hysigen; CGKO-M2362
DR   Wikidata; Q127382036
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2362).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103266; Fgl2.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6669 ! DLM8
SX   Female
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte LN-229 KO-hAP1S1
AC   CVCL_F1RD
SY   hAP1S1 knockout LN-229
DR   Hysigen; CGKO-M2950
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2950).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:559; AP1S1.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LN-229 KO-hSMARCAL1
AC   CVCL_F1RE
SY   hSMARCAL1 knockout LN-229
DR   Hysigen; CGKO-M3177
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3177).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LNCaP KO-hFOXA1
AC   CVCL_E1LT
SY   hFOXA1 knockout LNCaP
DR   Hysigen; CGKO-M0012
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M0012).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte LNCaP-Luc
AC   CVCL_E3HT
SY   Luciferase Reporter LNCaP Cell Line
DR   Hysigen; TCH-C238L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C238L).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte LoVo-Luc
AC   CVCL_E3HU
SY   Luciferase Reporter LoVo Cell Line
DR   Hysigen; TCH-C239L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C239L).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte LX-2 KO-hNGLY1
AC   CVCL_E1LU
SY   hNGLY1 knockout LX-2
DR   Hysigen; CGKO-M2705
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2705).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5792 ! LX-2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte LX-2 KO-hTPP1
AC   CVCL_F1RF
SY   hTPP1 knockout LX-2
DR   Hysigen; CGKO-M3203
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3203).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5792 ! LX-2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte LX-2-Luc
AC   CVCL_E3HV
SY   Luciferase Reporter LX-2 Cell Line
DR   Hysigen; TCH-C391L
CC   Doubling time: 24-48 hours (Hysigen=TCH-C391L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5792 ! LX-2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MAC-T KO-cwHMOX1
AC   CVCL_E1LV
SY   cwHMOX1 knockout MAC-T
DR   Hysigen; CGKO-M2431
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2431).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:29885; HMOX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte MAC-T KO-cwNFE2L2
AC   CVCL_E1LW
SY   cwNFE2L2 knockout MAC-T
DR   Hysigen; CGKO-M2430
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2430).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:32036; NFE2L2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte MAC-T KO-cwNUP62
AC   CVCL_D6C0
SY   cwNUP62 knockout MAC-T
DR   Hysigen; CGKO-M2432
DR   Wikidata; Q127382037
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2432).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:106850; NUP62.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   HyCyte MAC-T KO-cwSIRT5
AC   CVCL_E1LX
SY   cwSIRT5 knockout MAC-T
DR   Hysigen; CGKO-M2323
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2323).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:34634; SIRT5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte MB49 KO-mSmim1
AC   CVCL_F1RG
SY   mSmim1 knockout MB49
DR   Hysigen; CGKO-M3077
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M3077).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916109; Smim1.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7076 ! MB49
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MB49-Luc
AC   CVCL_E3HW
SY   Luciferase Reporter MB49 Cell Line
DR   Hysigen; TCM-C794L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C794L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7076 ! MB49
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MBT-2-Luc
AC   CVCL_E3KQ
SY   Luciferase Reporter MBT-2 Cell Line
DR   Hysigen; TCM-C802L
CC   Doubling time: 24-48 hours (Hysigen=TCH-C802L).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4660 ! MBT-2
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MC-38 KO-mCasp8
AC   CVCL_E1LY
SY   mCasp8 knockout MC-38
DR   Hysigen; CGKO-M2685
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2685).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1261423; Casp8.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   HyCyte MC-38 KO-mCd274
AC   CVCL_E1LZ
SY   mCd274 knockout MC-38
DR   Hysigen; CGKO-M2315
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2315).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   HyCyte MC-38 KO-mCxcl9
AC   CVCL_D6C1
SY   mCxcl9 knockout MC-38
DR   Hysigen; CGKO-M2546
DR   Wikidata; Q127382038
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2546).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1352449; Cxcl9.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte MC-38 KO-mFmr1
AC   CVCL_E1M0
SY   mFmr1 knockout MC-38
DR   Hysigen; CGKO-M2607
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2607).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95564; Fmr1.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   HyCyte MC-38 KO-mMdm4
AC   CVCL_D6C2
SY   mMdm4 knockout MC-38
DR   Hysigen; CGKO-M2428
DR   Wikidata; Q127382039
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2428).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107934; Mdm4.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte MC-38 KO-mPrmt3
AC   CVCL_E1M1
SY   mPrmt3 knockout MC-38
DR   Hysigen; CGKO-M2715
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2715).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919224; Prmt3.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   HyCyte MC-38 KO-mStk11
AC   CVCL_D6C3
SY   mStk11 knockout MC-38
DR   Hysigen; CGKO-M2419
DR   Wikidata; Q127382040
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2419).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341870; Stk11.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte MC-38 KO-mTgm2
AC   CVCL_F1RH
SY   mTgm2 knockout MC-38
DR   Hysigen; CGKO-M3264
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3264).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98731; Tgm2.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MC-38-Luc
AC   CVCL_E3HX
SY   Luciferase Reporter MC-38 Cell Line
DR   Hysigen; TCM-C790L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C790L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte MCF-7 KO-hDUSP8
AC   CVCL_F1RI
SY   hDUSP8 knockout MCF-7
DR   Hysigen; CGKO-M2909
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2909).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3074; DUSP8.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MCF-7 KO-hINSR
AC   CVCL_D6C4
SY   hINSR knockout MCF-7
DR   Hysigen; CGKO-M2533
DR   Wikidata; Q127382041
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2533).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6091; INSR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte MCF-7 KO-hPIP4K2B
AC   CVCL_E1M2
SY   hPIP4K2B knockout MCF-7
DR   Hysigen; CGKO-M2234
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2234).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8998; PIP4K2B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte MCF-7 KO-hPTK2
AC   CVCL_F1RJ
SY   hPTK2 knockout MCF-7
DR   Hysigen; CGKO-M2753
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2753).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MCF-7 KO-hZNF570
AC   CVCL_F1RK
SY   hZNF570 knockout MCF-7
DR   Hysigen; CGKO-M2853
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2853).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26416; ZNF570.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hACE
AC   CVCL_F1RL
SY   hACE knockout MDA-MB-231
DR   Hysigen; CGKO-M3119
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3119).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2707; ACE.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hARTN
AC   CVCL_F1RM
SY   hARTN knockout MDA-MB-231
DR   Hysigen; CGKO-M3048
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3048).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:727; ARTN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hBAD
AC   CVCL_F1RN
SY   hBAD knockout MDA-MB-231
DR   Hysigen; CGKO-M3047
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3047).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hCT83
AC   CVCL_E1M3
SY   hCT83 knockout MDA-MB-231
DR   Hysigen; CGKO-M2235
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2235).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33494; CT83.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte MDA-MB-231 KO-hHACD2
AC   CVCL_D6C5
SY   hHACD2 knockout MDA-MB-231
DR   Hysigen; CGKO-M2534
DR   Wikidata; Q127382042
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2534).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9640; HACD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte MDA-MB-231 KO-hHNRNPA2B1
AC   CVCL_D6C6
SY   hHNRNPA2B1 knockout MDA-MB-231
DR   Hysigen; CGKO-M2470
DR   Wikidata; Q127382043
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2470).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5033; HNRNPA2B1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte MDA-MB-231 KO-hMIR301A
AC   CVCL_F1RP
SY   hMIR301A knockout MDA-MB-231
DR   Hysigen; CGKO-M2843
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2843).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31622; MIR301A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hMUC1
AC   CVCL_E1M4
SY   hMUC1 knockout MDA-MB-231
DR   Hysigen; CGKO-M2671
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2671).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte MDA-MB-231 KO-hRASAL2
AC   CVCL_E1M5
SY   hRASAL2 knockout MDA-MB-231
DR   Hysigen; CGKO-M2723
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2723).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9874; RASAL2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte MDA-MB-231 KO-hSOST
AC   CVCL_F1RQ
SY   hSOST knockout MDA-MB-231
DR   Hysigen; CGKO-M2808
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2808).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13771; SOST.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hSTK11
AC   CVCL_F1RR
SY   hSTK11 knockout MDA-MB-231
DR   Hysigen; CGKO-M3138
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3138).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hSTK39
AC   CVCL_D6C7
SY   hSTK39 knockout MDA-MB-231
DR   Hysigen; CGKO-M2485
DR   Wikidata; Q127382044
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2485).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17717; STK39.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte MDA-MB-231 KO-hTACSTD2
AC   CVCL_F1RS
SY   hTACSTD2 knockout MDA-MB-231
DR   Hysigen; CGKO-M3173
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3173).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-231 KO-hUSP22
AC   CVCL_E1M6
SY   hUSP22 knockout MDA-MB-231
DR   Hysigen; CGKO-M2287
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2287).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte MDA-MB-436 KO-hARTN
AC   CVCL_F1RT
SY   hARTN knockout MDA-MB-436
DR   Hysigen; CGKO-M3186
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M3186).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:727; ARTN.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.5277+1G>A; ClinVar=VCV000037654; Zygosity=Hemizygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly203fs*9 (c.607_608ins227); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204fs*7 (c.610_612delinsGCGTGTGG); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0623 ! MDA-MB-436
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MDA-MB-468-Luc
AC   CVCL_E3HY
SY   Luciferase Reporter MDA-MB-468 Cell Line
DR   Hysigen; TCH-C468L
CC   Population: African American.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C468L).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MEG-01 hJAK2_p.V617F_c.1849G>T
AC   CVCL_E2Q6
SY   hJAK2_p.V617F_c.1849G>T MEG-01
DR   Hysigen; CGMU-M2166
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2166).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Gly646Trpfs*12 (c.1934dupG); ClinVar=VCV000426927; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple_edited; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2166).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His233del (c.697_699delCAC); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0425 ! MEG-01
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte MH-S KO-mSirt2
AC   CVCL_F1RU
SY   mSirt2 knockout MH-S
DR   Hysigen; CGKO-M2889
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2889).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1927664; Sirt2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: BALB/cJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3855 ! MH-S
SX   Male
AG   7W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MH-S-Luc
AC   CVCL_E3HZ
SY   Luciferase Reporter MH-S Cell Line
DR   Hysigen; TCM-C795L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C795L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: BALB/cJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3855 ! MH-S
SX   Male
AG   7W
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MHCC97-H-Luc
AC   CVCL_E3I0
SY   Luciferase Reporter MHCC97-H Cell Line
DR   Hysigen; TCH-C258L
CC   Population: Chinese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C258L).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MIA PaCa-2 KO-hSNAP23
AC   CVCL_F1RV
SY   hSNAP23 knockout MIA PaCa-2
DR   Hysigen; CGKO-M3167
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3167).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11131; SNAP23.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MIN6 KO-mSec61a2
AC   CVCL_F1RW
SY   mSec61a2 knockout MIN6
DR   Hysigen; CGKO-M2828
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2828).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1931071; Sec61a2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0431 ! MIN6
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MIN6 KO-mSlc30a8
AC   CVCL_F1RX
SY   mSlc30a8 knockout MIN6
DR   Hysigen; CGKO-M3024
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3024).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2442682; Slc30a8.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0431 ! MIN6
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MKN45 KO-hEDAR
AC   CVCL_F1RY
SY   hEDAR knockout MKN45
DR   Hysigen; CGKO-M2871
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2871).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2895; EDAR.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MKN45 KO-hSORCS2
AC   CVCL_E1M7
SY   hSORCS2 knockout MKN45
DR   Hysigen; CGKO-M2616
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2616).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16698; SORCS2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte MKN45-Luc
AC   CVCL_E3I1
SY   Luciferase Reporter MKN45 Cell Line
DR   Hysigen; TCH-C397L
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C397L).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MLE-12 KO-mFmr1
AC   CVCL_F1RZ
SY   mFmr1 knockout MLE-12
DR   Hysigen; CGKO-M3080
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3080).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95564; Fmr1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: FVB/N-Tg(SFTPC-TAg)5.1Jaw transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3751 ! MLE-12
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MLE-12 KO-mMfsd2a
AC   CVCL_F1S0
SY   mMfsd2a knockout MLE-12
DR   Hysigen; CGKO-M3181
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3181).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1923824; Mfsd2a.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: FVB/N-Tg(SFTPC-TAg)5.1Jaw transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3751 ! MLE-12
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MLE-12 KO-mSnx10
AC   CVCL_F1S1
SY   mSnx10 knockout MLE-12
DR   Hysigen; CGKO-M3169
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3169).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919232; Snx10.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: FVB/N-Tg(SFTPC-TAg)5.1Jaw transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3751 ! MLE-12
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MLE-12 KO-mZbp1
AC   CVCL_F1S2
SY   mZbp1 knockout MLE-12
DR   Hysigen; CGKO-M3208
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3208).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1927449; Zbp1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: FVB/N-Tg(SFTPC-TAg)5.1Jaw transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3751 ! MLE-12
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MM.1S-Luc-GFP
AC   CVCL_E3I2
SY   Luciferase/GFP Dual-Reporter MM.1S Cell Line
DR   Hysigen; TCH-C260LG
CC   Population: African American.
CC   Characteristics: Produces IgA lambda (from parent cell line).
CC   Doubling time: 24-48 hours (Hysigen=TCH-C260LG).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8792 ! MM1.S
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte MOLM-13 KO-hADGRE2
AC   CVCL_F1S3
SY   hADGRE2 knockout MOLM-13
DR   Hysigen; CGKO-M3285
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3285).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3337; ADGRE2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MOLM-13 KO-hPTEN
AC   CVCL_F1S4
SY   hPTEN knockout MOLM-13
DR   Hysigen; CGKO-M3030
CC   Population: Japanese.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3030).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte MV4-11 KO-hCEBPA-DT
AC   CVCL_F1S5
SY   hCEBPA-DT knockout MV4-11
DR   Hysigen; CGKO-M3003
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3003).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25710; CEBPA-DT.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0064 ! MV4-11
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-H1299 hHFE_p.C282Y_c.845G>A
AC   CVCL_E2Q7
SY   hHFE_p.C282Y_c.845G>A NCI-H1299
DR   Hysigen; CGMU-M2157
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2157).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple_edited; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2157).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte NCI-H1299 KO-hG6PD
AC   CVCL_E1M8
SY   hG6PD knockout NCI-H1299
DR   Hysigen; CGKO-M2719
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2719).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4057; G6PD.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte NCI-H1299 KO-hUBE3A
AC   CVCL_E1M9
SY   hUBE3A knockout NCI-H1299
DR   Hysigen; CGKO-M0007
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0007).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12496; UBE3A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte NCI-H157-Luc
AC   CVCL_E3I3
SY   Luciferase Reporter NCI-H157 Cell Line
DR   Hysigen; TCH-C431L
CC   Problematic cell line: Contaminated. Parent cell line (NCI-H157) has been shown to be identical to NCI-H1264.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C431L).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Phefs*8 (c.102_103insT) (c.103_104insT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0463 ! NCI-H157
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte NCI-H1703 KO-hGALNT14
AC   CVCL_F1S6
SY   hGALNT14 knockout NCI-H1703
DR   Hysigen; CGKO-M2991
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2991).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22946; GALNT14.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Val (c.251A>T); ClinVar=VCV002136746; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>T (IVS8+1G>T); ClinVar=VCV000495326; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1490 ! NCI-H1703
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-H1975 KO-hARTN
AC   CVCL_F1S7
SY   hARTN knockout NCI-H1975
DR   Hysigen; CGKO-M2872
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2872).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:727; ARTN.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-H1975 KO-hKIF18B
AC   CVCL_F1S8
SY   hKIF18B knockout NCI-H1975
DR   Hysigen; CGKO-M3210
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3210).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27102; KIF18B.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-H1975 KO-hTP53
AC   CVCL_F1S9
SY   hTP53 knockout NCI-H1975
DR   Hysigen; CGKO-M3068
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3068).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-H1975-Luc
AC   CVCL_E3I4
SY   Luciferase Reporter NCI-H1975 Cell Line
DR   Hysigen; TCH-C276L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C276L).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte NCI-H1975-Luc-GFP
AC   CVCL_E3I5
SY   Luciferase/GFP Dual-Reporter NCI-H1975 Cell Line
DR   Hysigen; TCH-C276LG
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C276LG).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte NCI-H2228-Luc
AC   CVCL_E3I6
SY   Luciferase Reporter NCI-H2228 Cell Line
DR   Hysigen; TCH-C278L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C278L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:9655; PTPN3; Name(s)=ALK-PTPN3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1543 ! NCI-H2228
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte NCI-H295R KO-hNPC1
AC   CVCL_F1SA
SY   hNPC1 knockout NCI-H295R
DR   Hysigen; CGKO-M2615
CC   Population: Caribbean; Bahamas.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2615).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0458 ! NCI-H295R
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-H23-Luc
AC   CVCL_E3I7
SY   Luciferase Reporter NCI-H23 Cell Line
DR   Hysigen; TCH-C280L
CC   Population: African American.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C280L).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1919Pro (c.5756A>C); ClinVar=VCV000580726; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Trp332Ter (c.996G>A); ClinVar=VCV000376339; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>C); ClinVar=VCV001758655; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1547 ! NCI-H23
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte NCI-H446 hHFE_p.C282Y_c.845G>A
AC   CVCL_E2Q8
SY   hHFE_p.C282Y_c.845G>A NCI-H446
DR   Hysigen; CGMU-M2154
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2154).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6728; LY6H + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-LY6H (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4886; HFE; Simple_edited; p.Cys282Tyr (c.845G>A); ClinVar=VCV000000009; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2154).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1562 ! NCI-H446
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte NCI-H460 KO-hIMPDH2
AC   CVCL_F1SB
SY   hIMPDH2 knockout NCI-H460
DR   Hysigen; CGKO-M2763
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2763).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6053; IMPDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-H460-Luc
AC   CVCL_E3I8
SY   Luciferase Reporter NCI-H460 Cell Line
DR   Hysigen; TCH-C286L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C286L).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte NCI-H520 KO-hPTPRZ1
AC   CVCL_E1MA
SY   hPTPRZ1 knockout NCI-H520
DR   Hysigen; CGKO-M2278
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2278).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9685; PTPRZ1.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro383Ala (c.1147C>G); ClinVar=VCV001001330; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly45Valfs*8 (c.134delG); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1566 ! NCI-H520
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte NCI-N87 KO-hDKK1
AC   CVCL_F1SC
SY   hDKK1 knockout NCI-N87
DR   Hysigen; CGKO-M2814
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2814).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2891; DKK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NCI-N87 KO-hSOX9
AC   CVCL_F1SD
SY   hSOX9 knockout NCI-N87
DR   Hysigen; CGKO-M2759
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2759).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11204; SOX9.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Neuro-2a KO-mSv2c
AC   CVCL_F1SE
SY   mSv2c knockout Neuro-2a
DR   Hysigen; CGKO-M2834
CC   Doubling time: 60-72 hours (Hysigen=CGKO-M2834).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1922459; Sv2c.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NIH 3T3 KO-mBst2
AC   CVCL_F1SF
SY   mBst2 knockout NIH 3T3
DR   Hysigen; CGKO-M3121
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3121).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916800; Bst2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NIH 3T3 KO-mCiita
AC   CVCL_F1SG
SY   mCiita knockout NIH 3T3
DR   Hysigen; CGKO-M2911
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2911).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108445; Ciita.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NIH 3T3 KO-mCul3
AC   CVCL_D6C8
SY   mCul3 knockout NIH 3T3
DR   Hysigen; CGKO-M2427
DR   Wikidata; Q127382045
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2427).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1347360; Cul3.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte NIH 3T3 KO-mImpdh2
AC   CVCL_E1MB
SY   mImpdh2 knockout NIH 3T3
DR   Hysigen; CGKO-M2569
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2569).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109367; Impdh2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte NIH 3T3 KO-mLgals9
AC   CVCL_F1SH
SY   mLgals9 knockout NIH 3T3
DR   Hysigen; CGKO-M3124
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3124).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109496; Lgals9.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NIH 3T3 KO-mNsun6
AC   CVCL_E1MC
SY   mNsun6 knockout NIH 3T3
DR   Hysigen; CGKO-M2316
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2316).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1921705; Nsun6.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte NIH 3T3 KO-mPtbp1
AC   CVCL_F1SI
SY   mPtbp1 knockout NIH 3T3
DR   Hysigen; CGKO-M3123
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3123).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97791; Ptbp1.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NIH 3T3 KO-mRai14
AC   CVCL_F1SJ
SY   mRai14 knockout NIH 3T3
DR   Hysigen; CGKO-M3122
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3122).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1922896; Rai14.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NIH 3T3 KO-mYbx3
AC   CVCL_F1SK
SY   mYbx3 knockout NIH 3T3
DR   Hysigen; CGKO-M3125
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3125).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2137670; Ybx3.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NK-92 KO-hHMGB2
AC   CVCL_F1SL
SY   hHMGB2 knockout NK-92
DR   Hysigen; CGKO-M2638
CC   Population: Caucasian.
CC   Doubling time: 35-40 hours (Hysigen=CGKO-M2638).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5000; HMGB2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NK-92 KO-hZYX
AC   CVCL_F1SM
SY   hZYX knockout NK-92
DR   Hysigen; CGKO-M2538
CC   Population: Caucasian.
CC   Doubling time: 35-40 hours (Hysigen=CGKO-M2538).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13200; ZYX.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NRK-52E KO-rMapk8
AC   CVCL_F1SN
SY   rMapk8 knockout NRK-52E
DR   Hysigen; CGKO-M3226
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3226).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 621506; Mapk8.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0468 ! NRK-52E
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte NRK-52E KO-rMapk9
AC   CVCL_F1SP
SY   rMapk9 knockout NRK-52E
DR   Hysigen; CGKO-M3227
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3227).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 628847; Mapk9.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0468 ! NRK-52E
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte OCI-AML3 KO-hFGL2
AC   CVCL_D6C9
SY   hFGL2 knockout OCI-AML3
DR   Hysigen; CGKO-M2505
DR   Wikidata; Q127382046
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2505).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3696; FGL2.
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882Cys (c.2644C>T); ClinVar=VCV000375882; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1844 ! OCI-AML-3
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   HyCyte OVCAR-3-Luc-GFP
AC   CVCL_E3I9
SY   Luciferase/GFP Dual-Reporter OVCAR-3 Cell Line
DR   Hysigen; TCH-C291LG
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C291LG).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte PANC-1 KO-hCHST15
AC   CVCL_F1SQ
SY   hCHST15 knockout PANC-1
DR   Hysigen; CGKO-M2930
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2930).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18137; CHST15.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte PANC-1 KO-hDTNBP1
AC   CVCL_E1MD
SY   hDTNBP1 knockout PANC-1
DR   Hysigen; CGKO-M2746
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2746).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17328; DTNBP1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte PANC-1 KO-hFBXW7
AC   CVCL_D6CA
SY   hFBXW7 knockout PANC-1
DR   Hysigen; CGKO-M2348
DR   Wikidata; Q127382047
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2348).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte PANC-1 KO-hFN1
AC   CVCL_E1ME
SY   hFN1 knockout PANC-1
DR   Hysigen; CGKO-M2722
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2722).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte PANC-1 KO-hFOSL1
AC   CVCL_F1SR
SY   hFOSL1 knockout PANC-1
DR   Hysigen; CGKO-M2957
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2957).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte PANC-1 KO-hKDM5B
AC   CVCL_F1SS
SY   hKDM5B knockout PANC-1
DR   Hysigen; CGKO-M2852
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2852).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte PANC-1-Luc
AC   CVCL_E3IA
SY   Luciferase Reporter PANC-1 Cell Line
DR   Hysigen; TCH-C296L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C296L).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Panc02-Luc
AC   CVCL_E3IB
SY   Luciferase Reporter Panc02 Cell Line
DR   Hysigen; TCM-C811L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C811L).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Panc02-Luc-GFP
AC   CVCL_E3IC
SY   Luciferase/GFP Dual-Reporter Panc02 Cell Line
DR   Hysigen; TCM-C811LG
CC   Doubling time: 24-48 hours (Hysigen=TCM-C811LG).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte PC-3 KO-hTRAF4
AC   CVCL_E1MF
SY   hTRAF4 knockout PC-3
DR   Hysigen; CGKO-M2618
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2618).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12034; TRAF4.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte PC-3-Luc
AC   CVCL_E3ID
SY   Luciferase Reporter PC-3 Cell Line
DR   Hysigen; TCH-C297L
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=TCH-C297L).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte PC-9-Luc
AC   CVCL_E3IE
SY   Luciferase Reporter PC-9 Cell Line
DR   Hysigen; TCH-C380L
CC   Population: Chinese; Han and Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C380L).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte PC-9-Luc-GFP
AC   CVCL_E3IF
SY   Luciferase/GFP Dual-Reporter PC-9 Cell Line
DR   Hysigen; TCH-C380LG
CC   Population: Chinese; Han and Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C380LG).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte PC12 KO-rYthdc2
AC   CVCL_F1ST
SY   rYthdc2 knockout PC12
DR   Hysigen; CGKO-M3100
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3100).
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1563192; Ythdc2.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Py8119-Luc
AC   CVCL_E3IG
SY   Luciferase Reporter Py8119 Cell Line
DR   Hysigen; TCM-C764L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C764L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6 MMTV-PyMT transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AQ09 ! Py8119
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Raji KO-hCD19
AC   CVCL_D6CB
SY   hCD19 knockout Raji
DR   Hysigen; CGKO-M2489
DR   Wikidata; Q127382048
CC   Population: African; Nigerian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2489).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Raji KO-hCD79B
AC   CVCL_F1SU
SY   hCD79B knockout Raji
DR   Hysigen; CGKO-M3197
CC   Population: African; Nigerian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3197).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1699; CD79B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Raji KO-hCMTM6
AC   CVCL_D6CC
SY   hCMTM6 knockout Raji
DR   Hysigen; CGKO-M2521
DR   Wikidata; Q127382049
CC   Population: African; Nigerian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2521).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Raji KO-hJAK2
AC   CVCL_D6CD
SY   hJAK2 knockout Raji
DR   Hysigen; CGKO-M2404
DR   Wikidata; Q127382050
CC   Population: African; Nigerian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2404).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte Raji-Luc
AC   CVCL_E3IH
SY   Luciferase Reporter Raji Cell Line
DR   Hysigen; TCH-C304L
CC   Population: African; Nigerian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C304L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte Ramos KO-hCD22
AC   CVCL_F1SV
SY   hCD22 knockout Ramos
DR   Hysigen; CGKO-M2974
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2974).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1643; CD22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Ramos KO-hIRF1
AC   CVCL_E1MG
SY   hIRF1 knockout Ramos
DR   Hysigen; CGKO-M2209
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2209).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Ramos KO-hSEPTIN6
AC   CVCL_F1SW
SY   hSEPTIN6 knockout Ramos
DR   Hysigen; CGKO-M2783
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2783).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15848; SEPTIN6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Ramos KO-hSH3KBP1
AC   CVCL_E1MH
SY   hSH3KBP1 knockout Ramos
DR   Hysigen; CGKO-M0001
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0001).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13867; SH3KBP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte Ramos KO-hWAS
AC   CVCL_E1MI
SY   hWAS knockout Ramos
DR   Hysigen; CGKO-M0003
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0003).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12731; WAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte RAW 264.7 KO-mAcod1
AC   CVCL_F1SX
SY   mAcod1 knockout RAW 264.7
DR   Hysigen; CGKO-M2796
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2796).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103206; Acod1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mBcl2
AC   CVCL_E1MJ
SY   mBcl2 knockout RAW 264.7
DR   Hysigen; CGKO-M0008
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M0008).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88138; Bcl2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RAW 264.7 KO-mCd274
AC   CVCL_D6CE
SY   mCd274 knockout RAW 264.7
DR   Hysigen; CGKO-M2439
DR   Wikidata; Q127382051
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2439).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte RAW 264.7 KO-mClec4e
AC   CVCL_E1MK
SY   mClec4e knockout RAW 264.7
DR   Hysigen; CGKO-M2593
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2593).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1861232; Clec4e.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RAW 264.7 KO-mClec7a
AC   CVCL_F1SY
SY   mClec7a knockout RAW 264.7
DR   Hysigen; CGKO-M2575
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2575).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1861431; Clec7a.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mCmpk2
AC   CVCL_F1SZ
SY   mCmpk2 knockout RAW 264.7
DR   Hysigen; CGKO-M3216
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3216).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99830; Cmpk2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mEp300
AC   CVCL_F1T0
SY   mEp300 knockout RAW 264.7
DR   Hysigen; CGKO-M2581
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2581).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1276116; Ep300.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mErlin1
AC   CVCL_D6CF
SY   mErlin1 knockout RAW 264.7
DR   Hysigen; CGKO-M2366
DR   Wikidata; Q127382052
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2366).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2387613; Erlin1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte RAW 264.7 KO-mFfar2
AC   CVCL_F1T1
SY   mFfar2 knockout RAW 264.7
DR   Hysigen; CGKO-M2993
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2993).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2441731; Ffar2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mHp
AC   CVCL_F1T2
SY   mHp knockout RAW 264.7
DR   Hysigen; CGKO-M3160
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3160).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96211; Hp.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mIl15ra
AC   CVCL_F1T3
SY   mIl15ra knockout RAW 264.7
DR   Hysigen; CGKO-M3093
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3093).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104644; Il15ra.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mIl1rap
AC   CVCL_F1T4
SY   mIl1rap knockout RAW 264.7
DR   Hysigen; CGKO-M2742
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2742).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104975; Il1rap.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mLy96
AC   CVCL_E1ML
SY   mLy96 knockout RAW 264.7
DR   Hysigen; CGKO-M2676
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2676).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341909; Ly96.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RAW 264.7 KO-mMcfd2
AC   CVCL_E1MM
SY   mMcfd2 knockout RAW 264.7
DR   Hysigen; CGKO-M2224
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2224).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2183439; Mcfd2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RAW 264.7 KO-mMettl1
AC   CVCL_D6CG
SY   mMettl1 knockout RAW 264.7
DR   Hysigen; CGKO-M2481
DR   Wikidata; Q127382053
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2481).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1339986; Mettl1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte RAW 264.7 KO-mMir146
AC   CVCL_E1MN
SY   mMir146 knockout RAW 264.7
DR   Hysigen; CGKO-M2302
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2302).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2676831; Mir146.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RAW 264.7 KO-mPcyt2
AC   CVCL_F1T5
SY   mPcyt2 knockout RAW 264.7
DR   Hysigen; CGKO-M2797
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2797).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1915921; Pcyt2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mPglyrp1
AC   CVCL_F1T6
SY   mPglyrp1 knockout RAW 264.7
DR   Hysigen; CGKO-M3168
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3168).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1345092; Pglyrp1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mPrdm2
AC   CVCL_D6CH
SY   mPrdm2 knockout RAW 264.7
DR   Hysigen; CGKO-M2365
DR   Wikidata; Q127382054
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2365).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107628; Prdm2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte RAW 264.7 KO-mPrmt6
AC   CVCL_F1T7
SY   mPrmt6 knockout RAW 264.7
DR   Hysigen; CGKO-M3026
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3026).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2139971; Prmt6.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mSamhd1
AC   CVCL_D6CI
SY   mSamhd1 knockout RAW 264.7
DR   Hysigen; CGKO-M2367
DR   Wikidata; Q127382055
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2367).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1927468; Samhd1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   HyCyte RAW 264.7 KO-mSetdb2
AC   CVCL_E1MP
SY   mSetdb2 knockout RAW 264.7
DR   Hysigen; CGKO-M2298
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2298).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2685139; Setdb2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RAW 264.7 KO-mSgpl1
AC   CVCL_F1T8
SY   mSgpl1 knockout RAW 264.7
DR   Hysigen; CGKO-M3196
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3196).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1261415; Sgpl1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mSlc9a9
AC   CVCL_F1T9
SY   mSlc9a9 knockout RAW 264.7
DR   Hysigen; CGKO-M3127
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3127).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2679732; Slc9a9.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mSphk1
AC   CVCL_F1TA
SY   mSphk1 knockout RAW 264.7
DR   Hysigen; CGKO-M3194
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3194).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1316649; Sphk1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mSphk2
AC   CVCL_F1TB
SY   mSphk2 knockout RAW 264.7
DR   Hysigen; CGKO-M3195
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3195).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1861380; Sphk2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mSsty2
AC   CVCL_E1MQ
SY   mSsty2 knockout RAW 264.7
DR   Hysigen; CGKO-M2669
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2669).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1917259; Ssty2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RAW 264.7 KO-mTrem2
AC   CVCL_F1TC
SY   mTrem2 knockout RAW 264.7
DR   Hysigen; CGKO-M2918
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2918).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1913150; Trem2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7 KO-mVcpip1
AC   CVCL_F1TD
SY   mVcpip1 knockout RAW 264.7
DR   Hysigen; CGKO-M2755
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2755).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1917925; Vcpip1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RAW 264.7-Luc
AC   CVCL_E3II
SY   Luciferase Reporter RAW 264.7 Cell Line
DR   Hysigen; TCM-C766L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C766L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte RenCa-Luc
AC   CVCL_E3IJ
SY   Luciferase Reporter RenCa Cell Line
DR   Hysigen; TCM-C784L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C784L).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2174 ! RenCa
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte RenCa-Luc KO-mPbrm1
AC   CVCL_F1TE
SY   mPbrm1 knockout RenCa-Luc
DR   Hysigen; CGKO-M2887
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2887).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1923998; Pbrm1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3IJ ! HyCyte RenCa-Luc
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RKO-Luc
AC   CVCL_E3IK
SY   Luciferase Reporter RKO Cell Line
DR   Hysigen; TCH-C308L
CC   Doubling time: 24-48 hours (Hysigen=TCH-C308L).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte RM-1 KO-mTmem176b
AC   CVCL_E1MR
SY   mTMEM176B knockout RM-1
DR   Hysigen; CGKO-M2283
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2283).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916348; Tmem176b.
CC   Transformant: Recombinant retrovirus Zipras/myc9 (v-Ha-Ras and v-Myc).
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B459 ! RM-1 [Mouse prostate carcinoma]
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte RM-1 KO-mTrp53
AC   CVCL_F1TF
SY   mTrp53 knockout RM-1
DR   Hysigen; CGKO-M3151
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3151).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53.
CC   Transformant: Recombinant retrovirus Zipras/myc9 (v-Ha-Ras and v-Myc).
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B459 ! RM-1 [Mouse prostate carcinoma]
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte RPMI-8226-Luc
AC   CVCL_E3IL
SY   Luciferase Reporter RPMI-8226 Cell Line
DR   Hysigen; TCH-C312L
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Doubling time: 24-48 hours (Hysigen=TCH-C312L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte S180-Luc
AC   CVCL_E3KR
SY   Luciferase Reporter S180 Cell Line
DR   Hysigen; TCM-C789L
CC   Doubling time: 24-48 hours (Hysigen=TCM-C789L).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte SCC7 KO-mCcl20
AC   CVCL_E1MS
SY   mCcl20 knockout SCC7
DR   Hysigen; CGKO-M2668
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2668).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1329031; Ccl20.
CC   Derived from site: In situ; Abdominal wall; UBERON=UBERON_0003697.
CC   Breed/subspecies: C3H.
DI   NCIt; C21609; Mouse squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V412 ! SCC7
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte SH-SY5Y KO-hCNR1
AC   CVCL_F1TG
SY   hCNR1 knockout SH-SY5Y
DR   Hysigen; CGKO-M3193
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3193).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2159; CNR1.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SH-SY5Y KO-hEMP3
AC   CVCL_D6CJ
SY   hEMP3 knockout SH-SY5Y
DR   Hysigen; CGKO-M2477
DR   Wikidata; Q127382056
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2477).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3335; EMP3.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte SH-SY5Y KO-hPIEZO2
AC   CVCL_F1TH
SY   hPIEZO2 knockout SH-SY5Y
DR   Hysigen; CGKO-M3131
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3131).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26270; PIEZO2.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SH-SY5Y KO-hPLA2G6
AC   CVCL_F1TI
SY   hPLA2G6 knockout SH-SY5Y
DR   Hysigen; CGKO-M3070
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3070).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9039; PLA2G6.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SH-SY5Y KO-hPLD3
AC   CVCL_F1TJ
SY   hPLD3 knockout SH-SY5Y
DR   Hysigen; CGKO-M3017
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3017).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SH-SY5Y KO-hSPART
AC   CVCL_F1TK
SY   hSPART knockout SH-SY5Y
DR   Hysigen; CGKO-M3069
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3069).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18514; SPART.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SH-SY5Y KO-hSV2A
AC   CVCL_F1TL
SY   hSV2A knockout SH-SY5Y
DR   Hysigen; CGKO-M2835
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2835).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20566; SV2A.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SH-SY5Y KO-hSV2A hSV2C
AC   CVCL_F1TM
SY   hSV2A hSV2C knockout SH-SY5Y
DR   Hysigen; CGKO-M2836
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M2836).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20566; SV2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30670; SV2C.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1TL ! HyCyte SH-SY5Y KO-hSV2A
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SH-SY5Y KO-hUSP11
AC   CVCL_D6CK
SY   hUSP11 knockout SH-SY5Y
DR   Hysigen; CGKO-M2460
DR   Wikidata; Q127382057
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2460).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12609; USP11.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte SH-SY5Y KO-hUSP16
AC   CVCL_D6CL
SY   hUSP16 knockout SH-SY5Y
DR   Hysigen; CGKO-M2461
DR   Wikidata; Q127382058
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2461).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte SiHa KO-hFANCD2
AC   CVCL_D6CM
SY   hFANCD2 knockout SiHa
DR   Hysigen; CGKO-M2482
DR   Wikidata; Q127382059
CC   Population: Japanese.
CC   Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (from parent cell line).
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2482).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0032 ! SiHa
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte SK-HEP-1 KO-hHSP90AA1
AC   CVCL_E1MT
SY   hHSP90AA1 knockout SK-HEP-1
DR   Hysigen; CGKO-M2661
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2661).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte SK-HEP-1 KO-hMGST1
AC   CVCL_E1MU
SY   hMGST1 knockout SK-HEP-1
DR   Hysigen; CGKO-M2743
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2743).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7061; MGST1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte SK-HEP-1 KO-hPFDN2
AC   CVCL_E1MV
SY   hPFDN2 knockout SK-HEP-1
DR   Hysigen; CGKO-M2610
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2610).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8867; PFDN2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte SK-MEL-1-Luc
AC   CVCL_E3IM
SY   Luciferase Reporter SK-MEL-1 Cell Line
DR   Hysigen; TCH-C461L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C461L).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Cys (c.98C>G); ClinVar=VCV000376231; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0068 ! SK-MEL-1
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte SK-OV-3-Luc
AC   CVCL_E3IN
SY   Luciferase Reporter SK-OV-3 Cell Line
DR   Hysigen; TCH-C335L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C335L).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte SNU-1 KO-hMNX1
AC   CVCL_F1TN
SY   hMNX1 knockout SNU-1
DR   Hysigen; CGKO-M2925
CC   Population: Korean.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2925).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4979; MNX1.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu1154fs*12 (c.3457_3458insT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Lys860Asnfs*16 (c.2580delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0099 ! SNU-1
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SNU-1 KO-hSOX9
AC   CVCL_F1TP
SY   hSOX9 knockout SNU-1
DR   Hysigen; CGKO-M3101
CC   Population: Korean.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M3101).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11204; SOX9.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu1154fs*12 (c.3457_3458insT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Lys860Asnfs*16 (c.2580delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0099 ! SNU-1
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SNU-5 KO-hSOX9
AC   CVCL_F1TQ
SY   hSOX9 knockout SNU-5
DR   Hysigen; CGKO-M3102
CC   Population: Korean.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3102).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11204; SOX9.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262_Ser269delGlyAsnLeuLeuGlyArgAsnSer (c.784_807del24); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0078 ! SNU-5
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SW1353-Luc
AC   CVCL_E3IP
SY   Luciferase Reporter SW1353 Cell Line
DR   Hysigen; TCH-C342L
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=TCH-C342L).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple; p.Arg172Ser (c.516G>C); ClinVar=VCV000375985; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val203Leu (c.607G>C); ClinVar=VCV000482235; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, right humerus; UBERON=UBERON_0000976.
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0543 ! SW1353
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte SW1990 KO-hLINC00511
AC   CVCL_E1MW
SY   hLINC00511 knockout SW1990
DR   Hysigen; CGKO-M2568
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2568).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43564; LINC00511.
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   HyCyte SW480 KO-hPROM1
AC   CVCL_F1TR
SY   hPROM1 knockout SW480
DR   Hysigen; CGKO-M3038
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3038).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9454; PROM1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SW480 KO-hSERPINB2
AC   CVCL_F1TS
SY   hSERPINB2 knockout SW480
DR   Hysigen; CGKO-M3063
CC   Population: Caucasian.
CC   Doubling time: 48-60 hours (Hysigen=CGKO-M3063).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8584; SERPINB2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte SW620 KO-hHKDC1
AC   CVCL_F1TT
SY   hHKDC1 knockout SW620
DR   Hysigen; CGKO-M3064
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3064).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23302; HKDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte T24 hADAR_p.E912A_c.2735A>C
AC   CVCL_E2Q9
SY   hADAR_p.E912A_c.2735A>C T24
DR   Hysigen; CGMU-M2163
CC   Population: Caucasian; Swedish.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2163).
CC   Sequence variation: Mutation; HGNC; HGNC:225; ADAR; Simple_edited; p.Glu912Ala (c.2735A>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2163).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte T24-Luc
AC   CVCL_E3IQ
SY   Luciferase Reporter T24 Cell Line
DR   Hysigen; TCH-C352L
CC   Population: Caucasian; Swedish.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C352L).
CC   Sequence variation: Mutation; HGNC; HGNC:225; ADAR; Simple_edited; p.Glu912Ala (c.2735A>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2163).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte TCCSUP-Luc
AC   CVCL_E3IR
SY   Luciferase Reporter TCCSUP Cell Line
DR   Hysigen; TCH-C356L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C356L).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1738 ! TCCSUP
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte TE-1 KO-hCHST1
AC   CVCL_E1MX
SY   hCHST1 knockout TE-1
DR   Hysigen; CGKO-M2576
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2576).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1969; CHST1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1759 ! TE-1
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 hADAP1_p.P14R_c.41C>G
AC   CVCL_E2QA
SY   hADAP1_p.P14R_c.41C>G THP-1
DR   Hysigen; CGMU-M2179
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2179).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16486; ADAP1; Simple_edited; p.Pro14Arg (c.41C>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2179).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 hKDM6A_p.A694T_c.2080G>A
AC   CVCL_E2QB
SY   hKDM6A_p.A694T_c.2080G>A THP-1
DR   Hysigen; CGMU-M2174
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2174).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple_edited; p.Ala746Thr (c.2080G>A); ClinVar=VCV002714479; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2174).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hACSL4
AC   CVCL_F1TU
SY   hACSL4 knockout THP-1
DR   Hysigen; CGKO-M2820
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2820).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hCASP1
AC   CVCL_D6CN
SY   hCASP1 knockout THP-1
DR   Hysigen; CGKO-M2360
DR   Wikidata; Q127382060
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2360).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1499; CASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte THP-1 KO-hCD22
AC   CVCL_F1TV
SY   hCD22 knockout THP-1
DR   Hysigen; CGKO-M3008
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3008).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1643; CD22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hCD274
AC   CVCL_D6CP
SY   hCD274 knockout THP-1
DR   Hysigen; CGKO-M2438
DR   Wikidata; Q127382061
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2438).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte THP-1 KO-hCD33
AC   CVCL_F1TW
SY   hCD33 knockout THP-1
DR   Hysigen; CGKO-M2904
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2904).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1659; CD33.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hCD44
AC   CVCL_D6CQ
SY   hCD44 knockout THP-1
DR   Hysigen; CGKO-M2393
DR   Wikidata; Q127382062
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2393).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte THP-1 KO-hCEBPB
AC   CVCL_F1TX
SY   hCEBPB knockout THP-1
DR   Hysigen; CGKO-M3188
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3188).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1834; CEBPB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hCGAS
AC   CVCL_F1TY
SY   hCGAS knockout THP-1
DR   Hysigen; CGKO-M2848
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2848).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21367; CGAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hDAPP1
AC   CVCL_F1TZ
SY   hDAPP1 knockout THP-1
DR   Hysigen; CGKO-M2842
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2842).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16500; DAPP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hELF4
AC   CVCL_E1MY
SY   hELF4 knockout THP-1
DR   Hysigen; CGKO-M2321
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2321).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3319; ELF4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hFPR2
AC   CVCL_F1U0
SY   hFPR2 knockout THP-1
DR   Hysigen; CGKO-M2997
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2997).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3827; FPR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hGPR39
AC   CVCL_F1U1
SY   hGPR39 knockout THP-1
DR   Hysigen; CGKO-M3009
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3009).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4496; GPR39.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hGSDMD
AC   CVCL_E1MZ
SY   hGSDMD knockout THP-1
DR   Hysigen; CGKO-M2245
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2245).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25697; GSDMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hGSDME
AC   CVCL_F1U2
SY   hGSDME knockout THP-1
DR   Hysigen; CGKO-M3242
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3242).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2810; GSDME.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hHNRNPA2B1
AC   CVCL_E1N0
SY   hHNRNPA2B1 knockout THP-1
DR   Hysigen; CGKO-M2313
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2313).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5033; HNRNPA2B1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hIFI27
AC   CVCL_F1U3
SY   hIFI27 knockout THP-1
DR   Hysigen; CGKO-M2855
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2855).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5397; IFI27.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hIL6R
AC   CVCL_F1U4
SY   hIL6R knockout THP-1
DR   Hysigen; CGKO-M3225
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3225).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hIRAK4
AC   CVCL_E1N1
SY   hIRAK4 knockout THP-1
DR   Hysigen; CGKO-M2286
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2286).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hITGAM
AC   CVCL_F1U5
SY   hITGAM knockout THP-1
DR   Hysigen; CGKO-M3166
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3166).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hLAMTOR2
AC   CVCL_E1N2
SY   hLAMTOR2 knockout THP-1
DR   Hysigen; CGKO-M2724
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2724).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29796; LAMTOR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hLINC01355
AC   CVCL_F1U6
SY   hLINC01355 knockout THP-1
DR   Hysigen; CGKO-M2880
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2880).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:50584; LINC01355.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hMCFD2
AC   CVCL_E1N3
SY   hMCFD2 knockout THP-1
DR   Hysigen; CGKO-M2227
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2227).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18451; MCFD2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hMLKL
AC   CVCL_F1U7
SY   hMLKL knockout THP-1
DR   Hysigen; CGKO-M3241
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3241).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26617; MLKL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hNCF1
AC   CVCL_E1N4
SY   hNCF1 knockout THP-1
DR   Hysigen; CGKO-M2666
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2666).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7660; NCF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hNR1H3
AC   CVCL_F1U8
SY   hNR1H3 knockout THP-1
DR   Hysigen; CGKO-M2977
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2977).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hNSUN3
AC   CVCL_F1U9
SY   hNSUN3 knockout THP-1
DR   Hysigen; CGKO-M2966
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2966).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26208; NSUN3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hOASL
AC   CVCL_F1UA
SY   hOASL knockout THP-1
DR   Hysigen; CGKO-M2878
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2878).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8090; OASL.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hOSM
AC   CVCL_E1N5
SY   hOSM knockout THP-1
DR   Hysigen; CGKO-M2710
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2710).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8506; OSM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hPGAM5
AC   CVCL_F1UB
SY   hPGAM5 knockout THP-1
DR   Hysigen; CGKO-M3006
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3006).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28763; PGAM5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hPLD3
AC   CVCL_F1UC
SY   hPLD3 knockout THP-1
DR   Hysigen; CGKO-M2995
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2995).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hPYCARD
AC   CVCL_F1UD
SY   hPYCARD knockout THP-1
DR   Hysigen; CGKO-M3247
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3247).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16608; PYCARD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hSERPINB3
AC   CVCL_F1UE
SY   hSERPINB3 knockout THP-1
DR   Hysigen; CGKO-M3013
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3013).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10569; SERPINB3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hSETDB2
AC   CVCL_E1N6
SY   hSETDB2 knockout THP-1
DR   Hysigen; CGKO-M2299
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2299).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20263; SETDB2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hSMAD3
AC   CVCL_E1N7
SY   hSMAD3 knockout THP-1
DR   Hysigen; CGKO-M2725
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2725).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte THP-1 KO-hTARM1
AC   CVCL_F1UF
SY   hTARM1 knockout THP-1
DR   Hysigen; CGKO-M2800
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2800).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37250; TARM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hTBK1
AC   CVCL_F1UG
SY   hTBK1 knockout THP-1
DR   Hysigen; CGKO-M3244
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3244).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hTGFBR1
AC   CVCL_F1UH
SY   hTGFBR1 knockout THP-1
DR   Hysigen; CGKO-M3224
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3224).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hTHRAP3
AC   CVCL_D6CR
SY   hTHRAP3 knockout THP-1
DR   Hysigen; CGKO-M2400
DR   Wikidata; Q127382063
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2400).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22964; THRAP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte THP-1 KO-hTLR4
AC   CVCL_F1UI
SY   hTLR4 knockout THP-1
DR   Hysigen; CGKO-M2996
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2996).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1 KO-hTNF
AC   CVCL_D6CS
SY   hTNF knockout THP-1
DR   Hysigen; CGKO-M2358
DR   Wikidata; Q127382064
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2358).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11892; TNF.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte THP-1 KO-hUSP10
AC   CVCL_D6CT
SY   hUSP10 knockout THP-1
DR   Hysigen; CGKO-M2434
DR   Wikidata; Q127382065
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2434).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12608; USP10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte THP-1 KO-hVCPIP1
AC   CVCL_F1UJ
SY   hVCPIP1 knockout THP-1
DR   Hysigen; CGKO-M2754
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2754).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30897; VCPIP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte THP-1-Luc
AC   CVCL_E3IS
SY   Luciferase Reporter THP-1 Cell Line
DR   Hysigen; TCH-C361L
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C361L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16486; ADAP1; Simple_edited; p.Pro14Arg (c.41C>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Hysigen=CGMU-M2179).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte TM4 KO-mGja1
AC   CVCL_F1UK
SY   mGja1 knockout TM4
DR   Hysigen; CGKO-M3234
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M3234).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95713; Gja1.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4327 ! TM4
SX   Male
AG   11-13D
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte TPC-1-Luc
AC   CVCL_E3IT
SY   Luciferase Reporter TPC-1 Cell Line
DR   Hysigen; TCH-C381L
CC   Population: Japanese.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C381L).
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6298 ! TPC-1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte U-118MG KO-hBSG
AC   CVCL_D6CY
SY   hBSG knockout U-118MG
DR   Hysigen; CGKO-M2480
DR   Wikidata; Q127382071
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=CGKO-M2480).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0633 ! U-118MG
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 4
//
ID   HyCyte U-118MG KO-hNTN4
AC   CVCL_F1UL
SY   hNTN4 knockout U-118MG
DR   Hysigen; CGKO-M3238
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M3238).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13658; NTN4.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0633 ! U-118MG
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-251MG KO-hELDR
AC   CVCL_F1UN
SY   hELDR knockout U-251MG
DR   Hysigen; CGKO-M2801
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2801).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:49511; ELDR.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-251MG KO-hFADS1
AC   CVCL_F1UP
SY   hFADS1 knockout U-251MG
DR   Hysigen; CGKO-M3154
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3154).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3574; FADS1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-251MG KO-hNR3C1
AC   CVCL_F1UQ
SY   hNR3C1 knockout U-251MG
DR   Hysigen; CGKO-M3236
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3236).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-251MG KO-hOXSR1
AC   CVCL_E1N9
SY   hOXSR1 knockout U-251MG
DR   Hysigen; CGKO-M2266
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2266).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8508; OXSR1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte U-251MG KO-hRERE
AC   CVCL_F1UR
SY   hRERE knockout U-251MG
DR   Hysigen; CGKO-M3128
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3128).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9965; RERE.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-251MG KO-hSCAMP2
AC   CVCL_F1US
SY   hSCAMP2 knockout U-251MG
DR   Hysigen; CGKO-M2765
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M2765).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10564; SCAMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-251MG KO-hSLC52A2
AC   CVCL_F1UT
SY   hSLC52A2 knockout U-251MG
DR   Hysigen; CGKO-M3239
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3239).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30224; SLC52A2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-251MG KO-hSTK39
AC   CVCL_E1NA
SY   hSTK39 knockout U-251MG
DR   Hysigen; CGKO-M2265
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2265).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17717; STK39.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   HyCyte U-87MG KO-hAPOD
AC   CVCL_F1UU
SY   hAPOD knockout U-87MG
DR   Hysigen; CGKO-M2784
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2784).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:612; APOD.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-87MG KO-hCD274
AC   CVCL_F1UV
SY   hCD274 knockout U-87MG
DR   Hysigen; CGKO-M2959
CC   Population: Caucasian.
CC   Doubling time: 72-96 hours (Hysigen=CGKO-M2959).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-87MG KO-hFGL2
AC   CVCL_D6CV
SY   hFGL2 knockout U-87MG
DR   Hysigen; CGKO-M2437
DR   Wikidata; Q127382067
CC   Population: Caucasian.
CC   Doubling time: 36-72 hours (Hysigen=CGKO-M2437).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3696; FGL2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte U-87MG KO-hNUPR1
AC   CVCL_D6CW
SY   hNUPR1 knockout U-87MG
DR   Hysigen; CGKO-M2478
DR   Wikidata; Q127382068
CC   Population: Caucasian.
CC   Doubling time: 36-72 hours (Hysigen=CGKO-M2478).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29990; NUPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte U-87MG KO-hTP53
AC   CVCL_D6CX
SY   hTP53 knockout U-87MG
DR   Hysigen; CGKO-M2376
DR   Wikidata; Q127382070
CC   Population: Caucasian.
CC   Doubling time: 36-72 hours (Hysigen=CGKO-M2376).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   HyCyte U-87MG-Luc
AC   CVCL_E3IU
SY   Luciferase Reporter U-87MG Cell Line
DR   Hysigen; TCH-C367L
CC   Population: Caucasian.
CC   Doubling time: 24-48 hours (Hysigen=TCH-C367L).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   HyCyte U-937 KO-hCRBN
AC   CVCL_F1UW
SY   hCRBN knockout U-937
DR   Hysigen; CGKO-M3105
CC   Population: Caucasian.
CC   Doubling time: 95-100 hours (Hysigen=CGKO-M3105).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-937 KO-hIL1RAP
AC   CVCL_F1UX
SY   hIL1RAP knockout U-937
DR   Hysigen; CGKO-M2741
CC   Population: Caucasian.
CC   Doubling time: 95-100 hours (Hysigen=CGKO-M2741).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5995; IL1RAP.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U-937 KO-hPTPRA
AC   CVCL_E1N8
SY   hPTPRA knockout U-937
DR   Hysigen; CGKO-M2708
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2708).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9664; PTPRA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   HyCyte U14 KO-mGdf15
AC   CVCL_F1UM
SY   mGdf15 knockout U14
DR   Hysigen; CGKO-M2749
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2749).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1346047; Gdf15.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Kunming.
DI   NCIt; C24068; Mouse cervical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9U56 ! U14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U2OS KO-hIQGAP3
AC   CVCL_F1UY
SY   hIQGAP3 knockout U2OS
DR   Hysigen; CGKO-M2795
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (Hysigen=CGKO-M2795).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20669; IQGAP3.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte U2OS KO-hNFIC
AC   CVCL_D6CU
SY   hNFIC knockout U2OS
DR   Hysigen; CGKO-M2548
DR   Wikidata; Q127382066
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2548).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7786; NFIC.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 4
//
ID   HyCyte Vero KO-veCCN2
AC   CVCL_F1UZ
SY   veCCN2 knockout Vero
DR   Hysigen; CGKO-M3159
CC   Group: Non-human primate cell line.
CC   Doubling time: 24-36 hours (Hysigen=CGKO-M3159).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RVT3; CCN2.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HyCyte Vero KO-veMED23
AC   CVCL_E1NB
SY   veMED23 knockout Vero
DR   Hysigen; CGKO-M2738
CC   Group: Non-human primate cell line.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2738).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RVR8; MED23.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte Vero KO-veSLC3A2
AC   CVCL_E1NC
SY   veSLC3A2 knockout Vero
DR   Hysigen; CGKO-M2673
CC   Group: Non-human primate cell line.
CC   Doubling time: 48-72 hours (Hysigen=CGKO-M2673).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9R354; SLC3A2.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   HyCyte WPMY-1 KO-hHIF1A
AC   CVCL_F1V0
SY   hHIF1A knockout WPMY-1
DR   Hysigen; CGKO-M2934
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (Hysigen=CGKO-M2934).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3814 ! WPMY-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   HYT-1
AC   CVCL_4639
DR   CLO; CLO_0051543
DR   BioSample; SAMD00005964
DR   BioSample; SAMN03472127
DR   FANTOM5_SSTAR; 10828-111C9
DR   RCB; RCB1297
DR   Wikidata; Q54897055
CC   Population: Japanese.
CC   Characteristics: Able to differentiate to megakaryocyte-like cells (RCB=RCB1297).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): RCB=RCB1297
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   HYVC
AC   CVCL_S743
DR   Wikidata; Q54897056
RX   CelloPub=CLPUB00526;
RX   PubMed=12889856;
CC   Population: Japanese.
CC   Doubling time: 41-43 hours (PubMed=12889856).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   HZ-293TS
AC   CVCL_1H36
DR   Wikidata; Q54897057
RX   Patent=US8236527;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10165.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   hZK-1
AC   CVCL_IY40
DR   Wikidata; Q54897058
RX   PubMed=28260147;
CC   Population: Japanese.
CC   Doubling time: ~36 hours (Note=At 10th passage), ~33 hours (Note=At 20th passage), ~29 hours (Note=At 30th passage) (PubMed=28260147).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   I 2.1
AC   CVCL_3724
SY   I-2-1; I2.1; I2-1
DR   CLO; CLO_0004316
DR   ATCC; CRL-2572
DR   BioSample; SAMN03471680
DR   cancercelllines; CVCL_3724
DR   CCRID; 1101HUM-PUMC000241
DR   Cell_Model_Passport; SIDM01223
DR   LINCS_LDP; LCL-1027
DR   Wikidata; Q54897059
RX   PubMed=10616904;
CC   Population: Caucasian.
CC   Characteristics: Lacks expression of FADD (PubMed=10616904).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2572; CCRID=1101HUM-PUMC000241
ST   Amelogenin: X (CCRID=1101HUM-PUMC000241)
ST   Amelogenin: X,Y (ATCC=CRL-2572)
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 13,21
ST   D19S433: 13,15.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 19,22
ST   Penta D: 11
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1061 ! Jurkat clone A3
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 27
//
ID   I 3
AC   CVCL_C376
SY   I3; Israel number 3; TE03; TE-03; ES-I3; hES I3; HESI3; TECHe001-A
DR   BTO; BTO_0006059
DR   EFO; EFO_0007076
DR   BioSample; SAMN03471893
DR   ENCODE; ENCBS057COO
DR   ENCODE; ENCBS058LJQ
DR   ENCODE; ENCBS065EQG
DR   ENCODE; ENCBS224XQX
DR   ENCODE; ENCBS268NCC
DR   ENCODE; ENCBS312JDV
DR   ENCODE; ENCBS401QZO
DR   ENCODE; ENCBS412HHB
DR   ENCODE; ENCBS421TWG
DR   ENCODE; ENCBS433JWB
DR   ENCODE; ENCBS524MEF
DR   ENCODE; ENCBS533SYQ
DR   ENCODE; ENCBS593HOC
DR   ENCODE; ENCBS599JGY
DR   ENCODE; ENCBS682JTI
DR   ENCODE; ENCBS811OSD
DR   GEO; GSM537624
DR   GEO; GSM537625
DR   GEO; GSM537626
DR   GEO; GSM537627
DR   GEO; GSM537647
DR   GEO; GSM537648
DR   GEO; GSM537664
DR   GEO; GSM537665
DR   GEO; GSM537668
DR   GEO; GSM537669
DR   GEO; GSM537670
DR   GEO; GSM537672
DR   GEO; GSM621345
DR   GEO; GSM621348
DR   GEO; GSM621386
DR   GEO; GSM772789
DR   GEO; GSM856736
DR   GEO; GSM981282
DR   GEO; GSM981293
DR   GEO; GSM1342462
DR   GEO; GSM1342464
DR   hPSCreg; TECHe001-A
DR   IGRhCellID; I3%20p41
DR   NIHhESC; NIHhESC-13-0204
DR   SKIP; SKIP001859
DR   WiCell; te03
DR   Wikidata; Q54897060
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=23117585;
RX   PubMed=28445466;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/affy/8
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/8
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0204.
CC   Registration: Swiss research registry; BAG-hES-IMP-0005.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=te03
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   I 3.2
AC   CVCL_C377
SY   I3.2; TE32; TECHe001-A-1
DR   hPSCreg; TECHe001-A-1
DR   IGRhCellID; I3.2%20p55
DR   SKIP; SKIP001951
DR   Wikidata; Q54897061
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C376 ! I 3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   I 3.3
AC   CVCL_C378
SY   I3.3; TE33; TECHe001-A-2
DR   hPSCreg; TECHe001-A-2
DR   SKIP; SKIP002004
DR   Wikidata; Q54897062
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C376 ! I 3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   I 4
AC   CVCL_C379
SY   I4; Israel number 4; TE04; TE-04; TECHe002-A
DR   GEO; GSM856735
DR   GEO; GSM862726
DR   hPSCreg; TECHe002-A
DR   NIHhESC; NIHhESC-13-0205
DR   SKIP; SKIP001860
DR   WiCell; te04
DR   Wikidata; Q54897063
RX   PubMed=16919167;
RX   PubMed=23117585;
RX   PubMed=28445466;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/42
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0205.
CC   HLA typing: A*03:24; B*35:02,38; C*04,12; DQB1*01,06; DRB1*13,13; DRB3*01 (PubMed=16919167).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=te04
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14 (PubMed=16919167)
ST   D13S317: 12,14,15 (WiCell=te04)
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   I 6
AC   CVCL_C380
SY   I6; Israel number 6; TE06; TE-06; I6 p50; TECHe003-A
DR   BioSample; SAMN03471894
DR   GEO; GSM856737
DR   hPSCreg; TECHe003-A
DR   IGRhCellID; I6%20p50
DR   NIHhESC; NIHhESC-13-0206
DR   SKIP; SKIP001861
DR   WiCell; te06
DR   Wikidata; Q54897064
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=23117585;
RX   PubMed=30679931;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/9
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0206.
CC   Registration: Swiss research registry; BAG-hES-IMP-0004.
CC   HLA typing: A*01:26; B*38,44; C*04,12; DQB1*02,03; DRB1*04,07 (PubMed=16919167).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: In STR D13S317 allele 12 which is present at passage 44 is missing at passage 47 (PubMed=16919167).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=te06
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11 (PubMed=16919167)
ST   CSF1PO: 11 (WiCell=te06)
ST   D13S317: 8,11,12
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   I 6.2
AC   CVCL_C381
SY   I6.2; TE62; TECHe003-A-1
DR   hPSCreg; TECHe003-A-1
DR   SKIP; SKIP002005
DR   Wikidata; Q54897065
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C380 ! I 6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   I 9.2
AC   CVCL_3725
SY   I9.2; I9-2; I-9-2
DR   BTO; BTO_0003683
DR   CLO; CLO_0004317
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2571
DR   BioSample; SAMN03471679
DR   cancercelllines; CVCL_3725
DR   Cell_Model_Passport; SIDM01224
DR   GEO; GSM1669925
DR   LINCS_LDP; LCL-1028
DR   PharmacoDB; I92_649_2019
DR   Wikidata; Q54897066
RX   PubMed=10616904;
CC   Population: Caucasian.
CC   Characteristics: Functionally defective for caspase-8 (PubMed=10616904).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2571
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 13,21
ST   D19S433: 14,14.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,9.2
ST   D8S1179: 12,14
ST   FGA: 19,21
ST   Penta D: 11
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1061 ! Jurkat clone A3
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   I(TL.m9)
AC   CVCL_L527
SY   I (TL.m9)
DR   CLO; CLO_0004318
DR   ATCC; HB-131
DR   Wikidata; Q54897076
RX   PubMed=7106865;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   I-10
AC   CVCL_3527
SY   I 10; I10
DR   CLO; CLO_0004315
DR   CLO; CLO_0004320
DR   CLDB; cl1786
DR   CLDB; cl1787
DR   ATCC; CCL-83
DR   ChEMBL-Cells; CHEMBL4632326
DR   ChEMBL-Targets; CHEMBL4632333
DR   ECACC; 89031605
DR   IZSLER; BS TCL 28
DR   JCRB; JCRB9097
DR   PubChem_Cell_line; CVCL_3527
DR   Wikidata; Q54897067
RX   DOI=10.1007/BF02618370;
RX   DOI=10.21926/obm.genet.2202159;
RX   PubMed=4288399;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/cJ.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   I-10/DDPh
AC   CVCL_HF54
DR   Wikidata; Q54897068
RX   PubMed=26714911;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/cJ.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3527 ! I-10
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   I-10/DDPi
AC   CVCL_HF53
DR   Wikidata; Q54897069
RX   PubMed=26714911;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/cJ.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3527 ! I-10
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
ID   I-11.15
AC   CVCL_6406
DR   CLO; CLO_0004322
DR   ATCC; CRL-2470
DR   Wikidata; Q54897070
RX   PubMed=1707081;
CC   Characteristics: CSF1 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   I-13.35
AC   CVCL_6407
DR   CLO; CLO_0004323
DR   ATCC; CRL-2471
DR   Wikidata; Q54897071
RX   PubMed=1707081;
CC   Characteristics: CSF1 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   I-2
AC   CVCL_JL38
SY   I2
DR   Wikidata; Q54897072
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   I-45
AC   CVCL_M200
SY   1-45
DR   Wikidata; Q54897073
RX   PubMed=8010779;
RX   PubMed=8174104;
RX   PubMed=12063468;
RX   PubMed=20482802;
CC   From: Testa, Joseph R.; Fox Chase Cancer Center; Philadelphia; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12063468; PubMed=20482802).
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   I-45-BTZ-R
AC   CVCL_M201
DR   Wikidata; Q54897074
RX   PubMed=20482802;
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M200 ! I-45
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   I-542
AC   CVCL_UW11
SY   Heska Hybridoma I-542; H425
DR   Wikidata; Q94311419
RX   Patent=US7482128;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9498.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P49064; Cat ALB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 5
//
ID   I/1Ki
AC   CVCL_B6ZK
DR   Wikidata; Q111733470
RX   PubMed=23926354;
RX   PubMed=32184255;
RX   PubMed=32252443;
RX   PubMed=35062311;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 6
//
ID   I/1Ki-1.2xDelta
AC   CVCL_B6ZX
DR   Wikidata; Q111733471
RX   PubMed=35062311;
CC   Group: Reptilian cell line.
CC   Virology: Persistently infected by a '1.2 genome' Swiss snake colony virus 1 (SwSCV-1). This is a construct bearing two copies of the genomic and antigenomic ribozymes (PubMed=35062311).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
HI   CVCL_B6ZK ! I/1Ki
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 6
//
ID   I/1Ki-Delta
AC   CVCL_B6ZS
DR   Wikidata; Q111733472
RX   PubMed=32184255;
RX   PubMed=35062311;
CC   Group: Reptilian cell line.
CC   Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
HI   CVCL_B6ZK ! I/1Ki
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 6
//
ID   I/24.D6
AC   CVCL_9181
SY   I/24
DR   CLO; CLO_0004319
DR   ATCC; HB-251
DR   Wikidata; Q54897075
RX   PubMed=1370168;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   I1-12C
AC   CVCL_9S80
DR   Wikidata; Q54897077
RX   PubMed=26246272;
CC   From: Edith Nourse Rogers Memorial Veterans Hospital; Bedford; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   I1-Hybridoma
AC   CVCL_G654
DR   CLO; CLO_0004325
DR   ATCC; CRL-2700
DR   Wikidata; Q54897078
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   I101C9-R1A5
AC   CVCL_A2IG
SY   B11
DR   Wikidata; Q105509562
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1+IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   I101D4-R1D8
AC   CVCL_A2IH
SY   B16
DR   Wikidata; Q105509567
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1+IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   I101F5-R1G2
AC   CVCL_A2IK
SY   B18
DR   Wikidata; Q105509570
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   I101F8-R1G5
AC   CVCL_A2II
SY   B20
DR   Wikidata; Q105509572
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1+IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   I101H12-R1GB
AC   CVCL_A2IJ
SY   B17
DR   Wikidata; Q105509575
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02647; Human APOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   i10984
AC   CVCL_IJ10
DR   Wikidata; Q54897079
RX   PubMed=27789402;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M53 ! AG10984
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   I11
AC   CVCL_2H89
SY   I11/GrsrJ; C57BL/6J-Chr 1A/J/NaJ I11/GrsrJ
DR   Wikidata; Q54897080
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004379P8productspec.pdf
CC   Misspelling: I11/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 1A/J/NaJ I11/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 1A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   i11001
AC   CVCL_IJ11
DR   Wikidata; Q54897081
RX   PubMed=27789405;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M57 ! AG11001
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   I2-12F
AC   CVCL_DQ92
DR   Wikidata; Q54897082
RX   PubMed=27345971;
CC   From: Edith Nourse Rogers Memorial Veterans Hospital; Bedford; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   I21
AC   CVCL_2H90
SY   I21/GrsrJ; C57BL/6J-Chr 2A/J/NaJ I21/GrsrJ
DR   Wikidata; Q54897083
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004380P7productspec.pdf
CC   Misspelling: I21/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 2A/J/NaJ I21/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 2A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   I27
AC   CVCL_2H91
SY   I27/GrsrJ; C57BL/6J-Chr 3A/J/NaJ I27/GrsrJ
DR   Wikidata; Q54897084
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004381P8productspec.pdf
CC   Misspelling: I27/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 3A/J/NaJ I27/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 3A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   i28cNF
AC   CVCL_B9VA
DR   Wikidata; Q112929808
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D21S11: 30,31
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B9V9 ! 28cNF
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   I3-iPSC
AC   CVCL_DD60
SY   I03-iPSC
DR   Wikidata; Q54897085
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Asn52Metfs*29 (c.155delA) (255delA); ClinVar=VCV000536457; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3-4del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y811 ! ND29543
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   I3.4.2
AC   CVCL_B0GV
SY   T42402I3.4.2
DR   Wikidata; Q108820521
RX   Patent=US7252992;
RX   PubMed=16524757;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5201.
CC   Population: Caucasian.
CC   Characteristics: High expression of MCHR1. Responds to melanin-concentrating hormone (MCH) in Calcium-mobilization assays (PubMed=16524757).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4383; GNA15.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   I3/2
AC   CVCL_DC75
DR   Wikidata; Q54897086
RX   PubMed=78961;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   I3L6
AC   CVCL_E8E7
RX   PubMed=2785856;
CC   Characteristics: Expression of Il4 is constitutive and under the control of a promoter/enhancer from an IgH (PubMed=2785856).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96556; Il4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   I5061F
AC   CVCL_A8YN
DR   GEO; GSM4617903
DR   Wikidata; Q108820522
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   I5061F B-3-15 iPSC
AC   CVCL_A8YP
SY   I5061F_B3_15_iPS
DR   GEO; GSM4617900
DR   Wikidata; Q108820523
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8YN ! I5061F
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   I5061F B-3-3 iPSC
AC   CVCL_A8YQ
SY   I5061F_B3_3_iPS
DR   GEO; GSM4617901
DR   Wikidata; Q108820524
RX   PubMed=33798453;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8YN ! I5061F
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   I51T
AC   CVCL_5530
DR   JCRB; JCRB1225
DR   Wikidata; Q54897087
RX   PubMed=11504597;
RX   PubMed=27844419;
CC   Problematic cell line: Contaminated/misidentified. Not from strain C57BL/6 as originally assigned but from a C57BL/6 x CBA cross (PubMed=27844419).
CC   Knockout cell: Method=KO mouse; MGI; MGI:88151; Glb1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4298; GLB1 (Note=With p.Ile51Thr).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E938 ! SV
AG   4D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   I78
AC   CVCL_2H92
SY   I78/GrsrJ; C57BL/6J-Chr 6A/J/NaJ I78/GrsrJ
DR   Wikidata; Q54897088
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004384productspec.pdf
CC   Misspelling: I78/GrsJ; Note=In JAX product sheet.
CC   Misspelling: C57BL/6J-Chr 6A/J/NaJ I78/GrsJ; Note=In JAX product sheet.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Chr 6A/J/NaJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   I83-E95
AC   CVCL_Y437
SY   183-E95; I83E95
DR   DSMZ; ACC-763
DR   DSMZCellDive; ACC-763
DR   NCBI_Iran; C492
DR   Wikidata; Q54897090
RX   PubMed=8127151;
RX   PubMed=23297799;
CC   Doubling time: ~30-60 hours (DSMZ=ACC-763).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-763
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 16,17
ST   D19S433: 13,16
ST   D21S11: 31,31.2
ST   D2S1338: 17,23
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9.3,11
ST   D8S1179: 15,16
ST   FGA: 21,22
ST   Penta D: 12,14
ST   Penta E: 15,21
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y546 ! I83-LCL
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 12
//
ID   I83-LCL
AC   CVCL_Y546
DR   DSMZ; ACC-764
DR   DSMZCellDive; ACC-764
DR   Wikidata; Q54897091
RX   PubMed=8127151;
RX   PubMed=23297799;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-764).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 16,17
ST   D19S433: 13,16
ST   D21S11: 31
ST   D2S1338: 17,23
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 15,16
ST   FGA: 21,22
ST   Penta D: 12,14
ST   Penta E: 15,21
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y437 ! I83-E95
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 11
//
ID   IA-1g1
AC   CVCL_A9X8
DR   BCRC; 60583
DR   Wikidata; Q102114181
RX   PubMed=12464391;
CC   Characteristics: Type-1 astrocyte.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   Ia-270
AC   CVCL_0T74
DR   Wikidata; Q54897092
RX   PubMed=3978245;
CC   Doubling time: 76 hours (PubMed=3978245).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   IA-5
AC   CVCL_6658
DR   CLO; CLO_0050074
DR   BioSample; SAMN03472288
DR   RCB; RCB0548
DR   Wikidata; Q54897093
RX   PubMed=22576795;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): RCB=RCB0548
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1302 ! IA-LM
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   IA-LM
AC   CVCL_1302
SY   IALM
DR   CLO; CLO_0050075
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472289
DR   BioSample; SAMN10987936
DR   cancercelllines; CVCL_1302
DR   Cell_Model_Passport; SIDM00306
DR   ChEMBL-Cells; CHEMBL3308833
DR   ChEMBL-Targets; CHEMBL2366366
DR   Cosmic; 910779
DR   Cosmic; 1995452
DR   Cosmic-CLP; 910779
DR   DepMap; ACH-000672
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10509-107D5
DR   GDSC; 910779
DR   GEO; GSM887156
DR   GEO; GSM888228
DR   GEO; GSM1669926
DR   IARC_TP53; 21393
DR   LiGeA; CCLE_729
DR   LINCS_HMS; 50017
DR   LINCS_LDP; LCL-1778
DR   PharmacoDB; IALM_650_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1302
DR   PubChem_Cell_line; CVCL_1302
DR   RCB; RCB0554
DR   Wikidata; Q54897094
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (Cosmic-CLP=910779; DepMap=ACH-000672).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (Cosmic-CLP=910779; DepMap=ACH-000672).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.16%; Native American=0.29%; East Asian, North=82.4%; East Asian, South=13.99%; South Asian=1.48%; European, North=0%; European, South=1.68% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=910779; RCB=RCB0554
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6658 ! IA-5
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   IA-XsSBR
AC   CVCL_3528
SY   IA-Xs SBR
DR   CLO; CLO_0004327
DR   CLO; CLO_0004328
DR   CLDB; cl1793
DR   ATCC; CRL-1677
DR   ChEMBL-Cells; CHEMBL3308400
DR   ChEMBL-Targets; CHEMBL614007
DR   ECACC; 88090801
DR   PubChem_Cell_line; CVCL_3528
DR   Wikidata; Q54897095
RX   PubMed=904002;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   IA1-7
AC   CVCL_6G75
DR   Wikidata; Q54897096
RX   PubMed=1714402;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2438; CSF3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   IAC
AC   CVCL_X373
SY   Immortalized Astrocyte Cells
DR   Wikidata; Q54897097
RX   DOI=10.3760/j.issn:0254-1416.2004.11.010;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   IAC/hPPE
AC   CVCL_0U76
DR   Wikidata; Q54897098
RX   PubMed=18045517;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8831; PENK.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_X373 ! IAC
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   iADE-DM1
AC   CVCL_E9XM
RX   PubMed=38832025;
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=38832025).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a patient suffering from adult DM1 subtype.
CC   Derived from site: In situ; Muscle, left biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
ST   Source(s): PubMed=38832025
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 21,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IAFEs-1
AC   CVCL_Z261
SY   IAFES-1; IAF-ES-1; IAF Es 1
DR   NISES; SK0027
DR   Wikidata; Q54897307
RX   DOI=10.1007/BF02372282;
CC   Group: Insect cell line.
CC   Misspelling: IEAFEs-1; Note=In Cellosaurus releases 12 to 34.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=690670; ! Euxoa scandens (White cutworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   IAHF
AC   CVCL_C8CP
SY   IntrAlobular Human Fibroblast
DR   CancerTools; 153783
DR   Wikidata; Q123032651
DR   Ximbio; 153783
RX   PubMed=27809866;
CC   Characteristics: CD105high/CD26low lobular fibroblasts that can differentiate into adipogenic and osteogenic lineages (Ximbio=153783).
CC   Derived from site: In situ; Breast, terminal lactiferous duct; UBERON=UBERON_0015133.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8CQ ! IEHF
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   IAIi001-A
AC   CVCL_VM12
SY   IAIi001RSTS2-65-A
DR   BioSamples; SAMEA4760691
DR   hPSCreg; IAIi001-A
DR   Wikidata; Q94311605
RX   PubMed=29883886;
RX   PubMed=29944992;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Lys1277Ter (c.3829A>T); Zygosity=Heterozygous (PubMed=29883886; PubMed=29944992).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153291; Rubinstein-Taybi syndrome type 2
DI   ORDO; Orphanet_353284; Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   IAIi002-A
AC   CVCL_VM13
SY   IAIi002; IAIi002RSTS1-34-A
DR   BioSamples; SAMEA4861901
DR   hPSCreg; IAIi002-A
DR   Wikidata; Q94311609
RX   PubMed=29883886;
RX   PubMed=31491690;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Gly1479Ter (c.4435G>T); Zygosity=Heterozygous (PubMed=29883886).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   IAIi003-A
AC   CVCL_VM14
SY   IAIi003; IAIi003RSTS1-46-A
DR   BioSamples; SAMEA4862112
DR   hPSCreg; IAIi003-A
DR   Wikidata; Q94311612
RX   PubMed=29883886;
RX   PubMed=31491690;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Asp1543Tyr (c.4627G>T); Zygosity=Heterozygous (PubMed=29883886; PubMed=31491690).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   IAIi004-A
AC   CVCL_VM15
SY   IAIi004; IAIi004RSTS1-149-A
DR   BioSamples; SAMEA4862234
DR   hPSCreg; IAIi004-A
DR   Wikidata; Q94311616
RX   PubMed=29883886;
RX   PubMed=31491690;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Trp1158Ter (c.3474G>A); Zygosity=Heterozygous (PubMed=29883886; PubMed=31491690).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153290; Rubinstein-Taybi syndrome type 1
DI   ORDO; Orphanet_353277; Rubinstein-Taybi syndrome due to CREBBP mutations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   IAIi005-A
AC   CVCL_C3RN
SY   AC52
DR   BioSamples; SAMEA111351711
DR   hPSCreg; IAIi005-A
DR   Wikidata; Q116049548
RX   PubMed=36528014;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=36528014).
CC   Donor information: At sampling donor was asymptomatic for amyotrophic lateral sclerosis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   IAIi006-A
AC   CVCL_C3RP
SY   BC6
DR   BioSamples; SAMEA111353514
DR   hPSCreg; IAIi006-A
DR   Wikidata; Q116049549
RX   PubMed=36528014;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=36528014).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   IAIi007-A
AC   CVCL_C3RQ
SY   CC5
DR   BioSamples; SAMEA111353515
DR   hPSCreg; IAIi007-A
DR   Wikidata; Q116049550
RX   PubMed=36528014;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=36528014).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   IAIi008-A
AC   CVCL_C3RR
SY   DC2
DR   BioSamples; SAMEA111360385
DR   hPSCreg; IAIi008-A
DR   Wikidata; Q116049551
RX   PubMed=36528014;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=36528014).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   IAIi009-A
AC   CVCL_C3RS
SY   EC1
DR   BioSamples; SAMEA111360448
DR   hPSCreg; IAIi009-A
DR   Wikidata; Q116049552
RX   PubMed=36528014;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   IAIi010-A
AC   CVCL_C6Q0
SY   Kif5A 1847 C3; KIF5A_C3
DR   BioSamples; SAMEA111554064
DR   hPSCreg; IAIi010-A
DR   Wikidata; Q117704512
RX   PubMed=36565680;
CC   From: Istituto Auxologico Italiano (IAI)-IRCCS; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple; p.Arg17Gln (c.50G>A); Zygosity=Heterozygous (PubMed=36565680).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   IAL-PID2
AC   CVCL_Z393
SY   IAL-PID-2; PID2; Insect Attractants Laboratory-Plodia Interpunctella Discs 2
DR   ICLDB; ial-pid2
DR   Wikidata; Q54897099
RX   DOI=10.1016/0022-1910(83)90026-4;
RX   DOI=10.2307/3576171;
RX   PubMed=1561320;
RX   PubMed=10475266;
RX   PubMed=16593348;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=58824; ! Plodia interpunctella (Indianmeal moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IAL-SFD1
AC   CVCL_Z392
SY   SFD1; Insect Attractants Laboratory-Spodoptera Frugiperda Discs 1
DR   ICLDB; ial-sfd1
DR   Wikidata; Q54897100
RX   DOI=10.1016/0022-1910(83)90026-4;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IAL-TND1
AC   CVCL_Z391
SY   TND1; Insect Attractants Laboratory-Trichoplusia Ni Discs 1
DR   ICLDB; ial-tnd1
DR   Wikidata; Q54897101
RX   PubMed=12623313;
RX   PubMed=15926859;
RX   PubMed=16593180;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/SP2UserFiles/person/3489/TND1.pdf
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   iAN1
AC   CVCL_EQ30
SY   iPSC_AN1; Normal iPSC from AN1
DR   GEO; GSM1184274
DR   GEO; GSM1184275
DR   Wikidata; Q54897102
RX   PubMed=24749076;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   iAN2
AC   CVCL_EQ31
SY   iPSC_AN2; Normal iPSC from AN2
DR   GEO; GSM1184276
DR   GEO; GSM1184277
DR   Wikidata; Q54897103
RX   PubMed=24749076;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   iAN3
AC   CVCL_EQ32
SY   iPSC_AN3; Normal iPSC from AN3
DR   GEO; GSM1184278
DR   GEO; GSM1184279
DR   Wikidata; Q54897104
RX   PubMed=24749076;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   iAND-4
AC   CVCL_K225
SY   iAND4; iPS-AND4; iPS-AND-4; AND-4; CONCE-1; conce-1; iPSCs-conce1
DR   Wikidata; Q54897105
RX   PubMed=20641038;
RX   PubMed=21989055;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_Deposito_AND-4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_AND-4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   Population: Caucasian.
CC   HLA typing: A*23:01,30:02; B*53:01,58:01; C*04:01,07:01; DQB1*05:02,06:02; DRB1*15:03,16:03 (BNLC).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   IAR 2
AC   CVCL_J447
SY   IAR-2; IAR2
DR   Wikidata; Q54897106
RX   PubMed=1176206;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   IAR 2-19
AC   CVCL_D608
SY   IAR-2-19; IAR2-19
DR   Wikidata; Q54897107
RX   PubMed=1176206;
RX   PubMed=6288280;
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Misspelling: IAR-19; PubMed=6288280; Note=In abstract.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_J447 ! IAR 2
SX   Sex unspecified
AG   10D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   IAR 2-28
AC   CVCL_D611
SY   IAR-2-28; IAR2-28
DR   Wikidata; Q54897108
RX   PubMed=1176206;
RX   PubMed=6288280;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Misspelling: IAR-28; PubMed=6288280; Note=In abstract.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_J447 ! IAR 2
SX   Sex unspecified
AG   10D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   IAR 20
AC   CVCL_5296
SY   IAR-20; IAR20
DR   CCRID; 1101RAT-PUMC000142
DR   JCRB; JCRB0610
DR   Wikidata; Q54897109
RX   PubMed=3013663;
RX   PubMed=3402047;
RX   PubMed=6288280;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   IAR 27
AC   CVCL_HF37
SY   IAR-27; IAR27
DR   Wikidata; Q54897110
RX   PubMed=3013663;
RX   PubMed=6288280;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10W
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   IAR 27E
AC   CVCL_D609
SY   IAR 27 E; IAR27E
DR   Wikidata; Q54897111
RX   PubMed=3013663;
RX   PubMed=3402047;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HF37 ! IAR 27
SX   Sex unspecified
AG   10W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   IAR 27F
AC   CVCL_D610
SY   IAR 27 F; IAR27F
DR   Wikidata; Q54897112
RX   PubMed=3013663;
RX   PubMed=3402047;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HF37 ! IAR 27
SX   Sex unspecified
AG   10W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   IAR 6
AC   CVCL_D612
SY   IAR-6; IAR6
DR   Wikidata; Q54897113
RX   PubMed=1176206;
RX   PubMed=7042722;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8W
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   IAR 6-1
AC   CVCL_D613
SY   IAR-6-1; IAR6-1; IAR 6.1
DR   Wikidata; Q54897115
RX   PubMed=1176206;
RX   PubMed=3013663;
RX   PubMed=3402047;
RX   PubMed=6288280;
RX   PubMed=7042722;
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D612 ! IAR 6
SX   Sex unspecified
AG   8W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   IAR 6-7
AC   CVCL_D614
SY   IAR-6-7; IAR6-7
DR   Wikidata; Q54897116
RX   PubMed=1176206;
RX   PubMed=7042722;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BDVI; RS=RS_0000095.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D612 ! IAR 6
SX   Sex unspecified
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   IARC-067
AC   CVCL_IY22
SY   IARC-67; IARC/067; IARC 67; IARC67
DR   Wikidata; Q54897148
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-070
AC   CVCL_VQ50
SY   IARC-70; IARC 070; IARC/070; IARC/70; IARC070
DR   Wikidata; Q94311848
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Turkish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M558 ! BL-14
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 8
//
ID   IARC-079
AC   CVCL_IY23
SY   IARC-79; IARC/079; IARC 79; IARC79
DR   Wikidata; Q54897149
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-089
AC   CVCL_IY24
SY   IARC-89; IARC/089; IARC 89; IARC89
DR   Wikidata; Q54897150
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-090
AC   CVCL_IY25
SY   IARC-90; IARC/090; IARC 90; IARC90
DR   Wikidata; Q54897151
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-099
AC   CVCL_VQ19
SY   IARC-99; IARC 099; IARC/099; IARC099
DR   Wikidata; Q94311894
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C139 ! BL-18
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-100
AC   CVCL_IW33
SY   IARC 100; IARC/100; IARC100
DR   Wikidata; Q54897117
RX   PubMed=3934070;
RX   PubMed=6327071;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Africans south of the Sahara.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C137 ! BL-16
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 8
//
ID   IARC-104
AC   CVCL_IY18
SY   IARC 104; IARC/104; IARC104
DR   Wikidata; Q54897118
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-105
AC   CVCL_IY19
SY   IARC 105; IARC/105; IARC105
DR   Wikidata; Q54897119
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-113
AC   CVCL_VQ18
SY   IARC 113; IARC/113; IARC113
DR   Wikidata; Q94311932
RX   PubMed=3934070;
RX   PubMed=6286514;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C131 ! BL-10
OI   CVCL_C143 ! BL-31
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 6
//
ID   IARC-139
AC   CVCL_IV21
SY   IARC 139; IARC/139; IARC139; Iarc139
DR   DSMZ; ACC-924
DR   Wikidata; Q54897120
RX   PubMed=1356511;
RX   PubMed=3037521;
RX   PubMed=3934070;
RX   PubMed=6286514;
RX   PubMed=9473234;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (DSMZ=ACC-924).
CC   HLA typing: A*01,11; B*08,16 (PubMed=3037521).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-924
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 19,24
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 23,25
ST   Penta D: 8,9
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M567 ! BL-28
OI   CVCL_C142 ! BL-30
OI   CVCL_C144 ! BL-32
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   IARC-151
AC   CVCL_IV09
SY   IARC 151; IARC/151; IARC151; IARC-151C; IARC/0151C
DR   Wikidata; Q54897121
RX   PubMed=10997876;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M643 ! BL-47
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   IARC-153
AC   CVCL_IY20
SY   IARC 153; IARC/153; IARC153
DR   Wikidata; Q54897122
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-167
AC   CVCL_VQ21
SY   IARC 167; IARC/167; IARC167
DR   Wikidata; Q94311972
RX   PubMed=1356511;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C141 ! BL-29
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-171
AC   CVCL_IV22
SY   IARC 171; IARC/171; IARC171; Iarc171
DR   DSMZCellDive; IARC-171
DR   Wikidata; Q54897123
RX   PubMed=2645221;
RX   PubMed=3037521;
RX   PubMed=3934070;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=22720208;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   HLA typing: A*11,32; B*35,49 (PubMed=3037521).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   IARC-174
AC   CVCL_IV23
SY   IARC 174; IARC/174; IARC174; Iarc174
DR   DSMZ; ACC-925
DR   Wikidata; Q54897124
RX   PubMed=1356511;
RX   PubMed=3934070;
RX   PubMed=9473234;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Doubling time: ~2-3 days (DSMZ=ACC-925).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-925
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 29.2,33.2
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 3,11
ST   Penta E: 13,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C146 ! BL-36
OI   CVCL_M641 ! BL-42
OI   CVCL_M565 ! BL-43
OI   CVCL_M566 ! BL-44
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   IARC-176A
AC   CVCL_IV05
SY   IARC 176A; IARC/176A; IARC/176 A; IARC176A
DR   DSMZ; ACC-926
DR   Wikidata; Q54897125
RX   PubMed=2052620;
RX   PubMed=3035497;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Doubling time: ~25-30 hours (DSMZ=ACC-926).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-926
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 9,18
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 19,24
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 9,12
ST   Penta E: 7,15
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C147 ! BL-37
OI   CVCL_VQ32 ! BL-39
OI   CVCL_A2XI ! IARC-176B
OI   CVCL_VQ22 ! IARC-303A
OI   CVCL_A2XH ! IARC-303B
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   IARC-176B
AC   CVCL_A2XI
SY   IARC 176B; IARC/176B; IARC/176 B; IARC176B
DR   Wikidata; Q105509577
RX   PubMed=3934070;
RX   PubMed=6087353;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C147 ! BL-37
OI   CVCL_VQ32 ! BL-39
OI   CVCL_IV05 ! IARC-176A
OI   CVCL_VQ22 ! IARC-303A
OI   CVCL_A2XH ! IARC-303B
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 5
//
ID   IARC-186
AC   CVCL_IX45
SY   IARC 186; IARC/186; IARC186
DR   Wikidata; Q54897126
RX   PubMed=1326305;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   IARC-205A
AC   CVCL_VQ31
SY   IARC 205A; IARC/205 A; IARC205A
DR   Wikidata; Q94312017
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ30 ! BL-55
OI   CVCL_C152 ! BL-57
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-207
AC   CVCL_VQ25
SY   IARC 207; IARC/207; IARC207
DR   Wikidata; Q94312021
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M559 ! BL-46
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-208
AC   CVCL_VQ26
SY   IARC 208; IARC/208; IARC208; IARC/208 A; IARC-208B; IARC/0208B
DR   Wikidata; Q94312027
RX   PubMed=3934070;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C150 ! BL-49
OI   CVCL_IV15 ! BL-50
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-210
AC   CVCL_IY21
SY   IARC 210; IARC/210; IARC210
DR   Wikidata; Q54897127
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-211
AC   CVCL_VM48
SY   IARC 211; IARC/211; IARC211
DR   Wikidata; Q94312045
RX   PubMed=2825176;
RX   PubMed=3934070;
RX   PubMed=12437638;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C149 ! BL-40
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-247
AC   CVCL_IV19
SY   IARC 247; IARC/247; IARC247
DR   Wikidata; Q54897128
RX   PubMed=3934070;
RX   PubMed=6087353;
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M645 ! BL-54
OI   CVCL_M568 ! BL-59
OI   CVCL_VQ48 ! IARC-293
OI   CVCL_VQ49 ! IARC-470
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   IARC-261
AC   CVCL_IV17
SY   IARC 261; IARC/261; IARC261
DR   Wikidata; Q54897129
RX   PubMed=3035497;
RX   PubMed=3934070;
RX   PubMed=6087353;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7034 ! BL-60
OI   CVCL_IV06 ! IARC-277
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   IARC-262
AC   CVCL_IY49
SY   IARC 262; IARC/262; IARC262
DR   Wikidata; Q54897130
RX   PubMed=6090749;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   IARC-277
AC   CVCL_IV06
SY   IARC 277; IARC/277; IARC277
DR   Wikidata; Q54897133
RX   PubMed=1356511;
RX   PubMed=2052620;
RX   PubMed=3035497;
RX   PubMed=3934070;
RX   PubMed=6087353;
RX   PubMed=6090749;
RX   PubMed=10997876;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7034 ! BL-60
OI   CVCL_IV17 ! IARC-261
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 9
//
ID   IARC-290A
AC   CVCL_C9BR
SY   IARC 290A; IARC/290 A; IARC290A
DR   DSMZ; ACC-929
DR   Wikidata; Q123032652
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-929
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 8,13
ST   D18S51: 12,15
ST   D19S433: 13,17
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 13,16
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C158 ! BL-74
OI   CVCL_IV08 ! IARC-290B
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   IARC-290B
AC   CVCL_IV08
SY   IARC 290B; IARC/290 B; IARC290B
DR   Wikidata; Q54897134
RX   PubMed=1356511;
RX   PubMed=3934070;
RX   PubMed=10997876;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C158 ! BL-74
OI   CVCL_C9BR ! IARC-290A
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 8
//
ID   IARC-293
AC   CVCL_VQ48
SY   IARC 293; IARC/293; IARC293
DR   Wikidata; Q94312124
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M645 ! BL-54
OI   CVCL_M568 ! BL-59
OI   CVCL_IV19 ! IARC-247
OI   CVCL_VQ49 ! IARC-470
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   IARC-303A
AC   CVCL_VQ22
SY   IARC 303A; IARC/303A; IARC/303 A; IARC303A
DR   Wikidata; Q94312129
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C147 ! BL-37
OI   CVCL_VQ32 ! BL-39
OI   CVCL_IV05 ! IARC-176A
OI   CVCL_A2XI ! IARC-176B
OI   CVCL_A2XH ! IARC-303B
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   IARC-303B
AC   CVCL_A2XH
SY   IARC 303B; IARC/303B; IARC/303 B; IARC303B
DR   Wikidata; Q105509580
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C147 ! BL-37
OI   CVCL_VQ32 ! BL-39
OI   CVCL_IV05 ! IARC-176A
OI   CVCL_A2XI ! IARC-176B
OI   CVCL_VQ22 ! IARC-303A
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   IARC-304
AC   CVCL_IV28
SY   IARC 304; IARC/304; IARC304
DR   DSMZ; ACC-897
DR   DSMZCellDive; ACC-897
DR   Wikidata; Q54897135
RX   PubMed=1356511;
RX   PubMed=3004968;
RX   PubMed=3035497;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian; French.
CC   Doubling time: ~60 hours (DSMZ=ACC-897).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-897
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,21
ST   D19S433: 12,15
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,15
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1966 ! BL-2
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 10
//
ID   IARC-305
AC   CVCL_VQ46
SY   IARC 305; IARC/305; IARC305
DR   DSMZ; ACC-928
DR   Wikidata; Q94312146
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   Doubling time: ~2-4 days (DSMZ=ACC-928).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-928
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 29,32.2
ST   D2S1338: 16,17
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23,26
ST   Penta D: 13,14
ST   Penta E: 7,17
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C163 ! BL-65
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 8
//
ID   IARC-306
AC   CVCL_IU91
SY   IARC 306; IARC/306; IARC306
DR   Wikidata; Q54897136
RX   PubMed=1395095;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   IARC-307
AC   CVCL_IV24
SY   IARC 307; IARC/307; IARC307; Iarc307
DR   Wikidata; Q54897137
RX   PubMed=3037521;
RX   PubMed=3934070;
RX   PubMed=9473234;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   HLA typing: A*11,28; B*27,45 (PubMed=3037521).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C157 ! BL-72
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   IARC-308
AC   CVCL_VQ47
SY   IARC 308; IARC/308; IARC308
DR   Wikidata; Q94312180
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ35 ! BL-66
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   IARC-309
AC   CVCL_IV27
SY   IARC 309; IARC/309; IARC309
DR   Wikidata; Q54897138
RX   PubMed=1620543;
RX   PubMed=3004968;
RX   PubMed=3934070;
RX   PubMed=8108117;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C156 ! BL-67
OI   CVCL_A1DZ ! BL-78
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 9
//
ID   IARC-317
AC   CVCL_IU92
SY   IARC 317; IARC/317; IARC317
DR   Wikidata; Q54897139
RX   PubMed=1395095;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   IARC-318
AC   CVCL_IU84
SY   IARC 318; IARC/318; IARC.318; IARC318
DR   Cosmic; 2491067
DR   Wikidata; Q54897140
RX   PubMed=1395095;
RX   PubMed=8381152;
RX   PubMed=9067587;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   IARC-370
AC   CVCL_ZJ30
SY   IARC/0370
DR   Wikidata; Q98126745
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ24 ! BL-81
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-373
AC   CVCL_VQ20
SY   IARC 373; IARC/373; IARC373
DR   Wikidata; Q94312227
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C140 ! BL-22
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   IARC-385
AC   CVCL_IV11
SY   IARC 385; IARC/385; IARC385
DR   Wikidata; Q54897141
RX   PubMed=10997876;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C165 ! BL-79
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   IARC-431
AC   CVCL_VQ23
SY   IARC 431; IARC/431; IARC431
DR   Wikidata; Q94312244
RX   PubMed=1356511;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C148 ! BL-38
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-435B
AC   CVCL_ZJ32
SY   IARC/0435B
DR   Wikidata; Q98126746
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ25 ! BL-86
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-443B
AC   CVCL_ZJ31
SY   IARC/0443B
DR   Wikidata; Q98126748
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IU52 ! BL-84
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 4
//
ID   IARC-464
AC   CVCL_VQ24
SY   IARC 464; IARC/464; IARC464
DR   Wikidata; Q94312250
RX   PubMed=1356511;
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M642 ! BL-45
OI   CVCL_C151 ! BL-53
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   IARC-470
AC   CVCL_VQ49
SY   IARC 470; IARC/470; IARC470
DR   Wikidata; Q94312255
RX   PubMed=3934070;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M645 ! BL-54
OI   CVCL_M568 ! BL-59
OI   CVCL_IV19 ! IARC-247
OI   CVCL_VQ48 ! IARC-293
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   IARC-48
AC   CVCL_E8TY
SY   IARC 48
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-49
AC   CVCL_E8TZ
SY   IARC 49
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-503
AC   CVCL_ZJ33
SY   IARC/0503
DR   Wikidata; Q98126749
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI24 ! BL-92
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-518
AC   CVCL_IU90
SY   IARC 518; IARC/518; IARC.518; IARC518
DR   Wikidata; Q54897142
RX   PubMed=1395095;
RX   PubMed=8381152;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   IARC-549
AC   CVCL_IV10
SY   IARC 549; IARC/549; IARC549
DR   DSMZ; ACC-927
DR   Wikidata; Q54897144
RX   PubMed=10997876;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Africans north of the Sahara.
CC   Doubling time: ~2-3 days (DSMZ=ACC-927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): DSMZ=ACC-927
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 12,15
ST   D21S11: 29,32.2
ST   D2S1338: 18,24
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 20,24
ST   Penta D: 10,14
ST   Penta E: 10,11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M556 ! BL-61
OI   CVCL_C155 ! BL-64
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 8
//
ID   IARC-57
AC   CVCL_E8U0
SY   IARC 57
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-582
AC   CVCL_IU93
SY   IARC 582; IARC/582; IARC582
DR   Wikidata; Q54897145
RX   PubMed=1395095;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   IARC-591
AC   CVCL_A1FK
SY   IARC591
DR   Wikidata; Q102114182
RX   PubMed=8108117;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-594
AC   CVCL_ZJ27
SY   IARC/0594
DR   Wikidata; Q98126750
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ22 ! BL-103
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-602
AC   CVCL_ZU64
SY   IARC 602; IARC/602; IARC602
DR   Wikidata; Q98126751
RX   PubMed=1356511;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV12 ! BL-108
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-629
AC   CVCL_IV18
SY   IARC 629; IARC/629; IARC629
DR   Wikidata; Q54897146
RX   PubMed=3035497;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IU51 ! BL-104
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 5
//
ID   IARC-632
AC   CVCL_IV07
SY   IARC 632; IARC/632; IARC632
DR   Wikidata; Q54897147
RX   PubMed=1356511;
RX   PubMed=2052620;
RX   PubMed=10997876;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C132 ! BL-113
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   IARC-661
AC   CVCL_ZJ28
SY   IARC661; IARC/0661
DR   Wikidata; Q98126752
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C133 ! BL-116
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-69
AC   CVCL_E8TX
SY   IARC 69
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-693
AC   CVCL_ZJ26
SY   IARC/0693
DR   Wikidata; Q98126753
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ23 ! BL-123
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-70
AC   CVCL_E8U1
SY   IARC 70
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-74
AC   CVCL_E8U2
SY   IARC 74
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-78
AC   CVCL_E8U3
SY   IARC 78
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-80
AC   CVCL_E8U4
SY   IARC 80
RX   PubMed=6286514;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IARC-822
AC   CVCL_ZU65
SY   IARC 822; IARC822; IARC/0837
DR   Wikidata; Q98126754
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV13 ! BL-135
OI   CVCL_ZJ29 ! IARC-837
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IARC-837
AC   CVCL_ZJ29
SY   IARC 837; IARC837; IARC/0837
DR   Wikidata; Q98126755
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV13 ! BL-135
OI   CVCL_ZU65 ! IARC-822
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   IB C1 (clon A201)
AC   CVCL_9S13
SY   IBC1; BP143 clon A201; BP143 A201
DR   Wikidata; Q54897152
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520de%2520deposito%2520IB%2520C1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520IB%2520C1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   IB PD-G1
AC   CVCL_9S14
SY   FH10-54 B21
DR   Wikidata; Q54897153
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Ib_pd_g1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_IB_PD_G1_PHD_54.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   IB PD-G2
AC   CVCL_9S15
SY   FH09-32 A4001
DR   Wikidata; Q54897154
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Ib_pd_g2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_IB_PD_G2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   IB PD-I1
AC   CVCL_9S16
SY   IB-PDI1; FH10-70 B41
DR   Wikidata; Q54897155
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/IB_pdi1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_IBpdi1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   IB PD-P1
AC   CVCL_UM93
SY   PDP1 B51
DR   Wikidata; Q94312388
RX   PubMed=27975167;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/IB_PD-P1_PDP1_deposito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_IB_PDP1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; c.1252_1488del; Zygosity=Heterozygous (PubMed=27975167).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; c.1488+1G>A; ClinVar=VCV000961640; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=27975167).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 14
//
ID   IB PD-P2
AC   CVCL_UM94
SY   PDP2 B61
DR   Wikidata; Q94312392
RX   PubMed=27975167;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/IB_PD-P2_PDP2_deposito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos-IB_PD-P2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; c.1488+1G>A; ClinVar=VCV000961640; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=27975167).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   IB PD-P3
AC   CVCL_UM95
SY   PDP3 B3001
DR   Wikidata; Q94312397
RX   PubMed=27975167;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/IB_PD-P3_PDP3_deposito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO_IB_PD-P3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; c.1252_1488del; Zygosity=Heterozygous (PubMed=27975167).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; c.1488+1G>A; ClinVar=VCV000961640; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=27975167).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 14
//
ID   IB PD-R1
AC   CVCL_UM96
SY   FH09-78 C4
DR   Wikidata; Q94312400
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/IB_PD-R1_FH09-78_C4_Deposito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-IB_PD-R1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   IB SvC1
AC   CVCL_9S17
SY   IB SVC1; FH11-03
DR   Wikidata; Q54897156
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud-de-deposito-IB-SvC1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos-IB-SvC1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Inbiomed; Gipuzkoa; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   IB-4
AC   CVCL_UE01
SY   IB4
DR   Wikidata; Q94312417
RX   PubMed=1645805;
RX   PubMed=6112750;
RX   PubMed=6253674;
RX   PubMed=15681063;
CC   Virology: Contains 4 to 5 copies of the EBV genome. These are chromosomally integrated and do not exist in an episomal form (PubMed=1645805; PubMed=15681063).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1M
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   IB-9
AC   CVCL_0J49
SY   IB9; T10 clone IB9; 1B9
DR   Wikidata; Q54897157
RX   PubMed=2529426;
RX   PubMed=7432518;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 6
//
ID   IB-RS-10
AC   CVCL_UG44
SY   Instituto Biologico-Rim Suino-10
DR   Wikidata; Q94312434
RX   PubMed=754670;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Landrace x Yorkshire x Edelschwein; VBO=VBO_0001161+VBO_0001212+VBO_0012372.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 6
//
ID   IB-RS-10-I
AC   CVCL_UF36
SY   Instituto Biologico-Rim Suino-10-I
DR   Wikidata; Q94312438
RX   PubMed=224843;
RX   PubMed=754670;
RX   PubMed=754676;
CC   Virology: Susceptible to infection by foot-and-mouth disease virus. Less susceptible than IB-RS-10-II.
CC   Karyotypic information: Diploid karyotype.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Landrace x Yorkshire x Edelschwein; VBO=VBO_0001161+VBO_0001212+VBO_0012372.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_UG44 ! IB-RS-10
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 9
//
ID   IB-RS-10-II
AC   CVCL_UF37
SY   Instituto Biologico-Rim Suino-10-II
DR   Wikidata; Q94312442
RX   PubMed=224843;
RX   PubMed=754670;
RX   PubMed=754676;
CC   Virology: Susceptible to infection by foot-and-mouth disease virus. More susceptible than IB-RS-10-I.
CC   Karyotypic information: Tetraploid karyotype.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Landrace x Yorkshire x Edelschwein; VBO=VBO_0001161+VBO_0001212+VBO_0012372.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_UG44 ! IB-RS-10
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 9
//
ID   IB-RS-11
AC   CVCL_UF34
SY   Instituto Biologico-Rim Suino-11
DR   Wikidata; Q94312447
RX   CelloPub=CLPUB00421;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   39D
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 6
//
ID   IB-RS-11 S6
AC   CVCL_RX33
SY   S6; Instituto Biologico-Rim Suino-11 strain 6
DR   Wikidata; Q54897158
RX   CelloPub=CLPUB00421;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_UF34 ! IB-RS-11
SX   Female
AG   39D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   IB-RS-2
AC   CVCL_4528
SY   IB-RS2; IBRS-2; IBRS2; Instituto Biologico-Rim Suino-2
DR   CLO; CLO_0004332
DR   CLDB; cl1794
DR   CLDB; cl1795
DR   CCLV; CCLV-RIE 0103
DR   CCRID; 1101SWI-PUMC000402
DR   CCRID; 4201SWI-CCTCC00022
DR   CCTCC; GDC0022
DR   CLS; 305212
DR   ECACC; 84100503
DR   IZSLER; BS CL 51
DR   RCB; RCB0532
DR   TOKU-E; 4142
DR   Wikidata; Q54897159
RX   CelloPub=CLPUB00054;
RX   CelloPub=CLPUB00449;
CC   Discontinued: ECACC; 84100503; true.
CC   Discontinued: RCB; RCB0532; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 18
//
ID   IB-RS-2 clone 13
AC   CVCL_UF35
SY   IB-RS-2 C-13; IB-RS2 (clone 13); C-13; C13
DR   Wikidata; Q94312472
RX   CelloPub=CLPUB00449;
RX   PubMed=4806508;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_4528 ! IB-RS-2
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   IB-RS-2 clone 17
AC   CVCL_U235
SY   IB-RS-2 C-17; IB-RS-2 C17
DR   BCRJ; 0340
DR   Wikidata; Q54897160
RX   PubMed=2840431;
CC   Virology: Infected by classical swine fever virus (CSFV).
CC   Virology: Susceptible to infection by foot-and-mouth disease virus.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_4528 ! IB-RS-2
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   IB-RS-2 clone 60
AC   CVCL_IP69
SY   C-60; C60
DR   Wikidata; Q54897161
RX   CelloPub=CLPUB00449;
RX   PubMed=4329431;
CC   Virology: Susceptible to infection by foot-and-mouth disease virus.
CC   Doubling time: ~48 hours (PubMed=4329431).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_4528 ! IB-RS-2
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   IB-RS-2 D10
AC   CVCL_4529
SY   IB-RS-2 clone D10; IBRS-2 clone D-10; IBRS-2 D10
DR   CLO; CLO_0004333
DR   CLDB; cl1796
DR   ATCC; CRL-1835
DR   IZSLER; BS CL 97
DR   Wikidata; Q54897162
RX   PubMed=2840431;
RX   PubMed=7989247;
RX   PubMed=34737324;
CC   Virology: Infected by classical swine fever virus (CSFV) (PubMed=7989247; PubMed=34737324). These results contradict the original report that stated the cell line was not infected (PubMed=2840431).
CC   Discontinued: ATCC; CRL-1835; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_U235 ! IB-RS-2 clone 17
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   IB3-1
AC   CVCL_0338
SY   IB3
DR   BTO; BTO_0004445
DR   CLO; CLO_0004329
DR   EFO; EFO_0001194
DR   MCCL; MCC:0000234
DR   ATCC; CRL-2777
DR   ATCC; JHU-52
DR   BCRJ; 0114
DR   ChEMBL-Cells; CHEMBL4295410
DR   ChEMBL-Targets; CHEMBL4296439
DR   PubChem_Cell_line; CVCL_0338
DR   Wikidata; Q54897163
RX   PubMed=1380129;
RX   PubMed=1849726;
RX   PubMed=7679117;
RX   PubMed=15463957;
RX   PubMed=16512671;
RX   PubMed=18441018;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-527.html
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=15463957).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (PubMed=15463957).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Proteomics; 2DE-MS.
CC   Discontinued: ATCC; CRL-2777; true.
CC   Discontinued: ATCC; JHU-52; true.
ST   Source(s): ATCC=CRL-2777
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12,13
ST   D16S539: 9,11
ST   D5S818: 11,12,13
ST   D7S820: 11,12
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   IB3-1/C38
AC   CVCL_4462
SY   C38
DR   BTO; BTO_0004447
DR   CLO; CLO_0002118
DR   ATCC; CRL-2779
DR   ATCC; JHU-54
DR   BioSample; SAMN03471787
DR   Wikidata; Q54897164
RX   PubMed=1380129;
RX   PubMed=7679117;
RX   PubMed=18441018;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1884; CFTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-2779; true.
CC   Discontinued: ATCC; JHU-54; true.
ST   Source(s): ATCC=CRL-2779
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12,13
ST   D16S539: 9,11
ST   D5S818: 11,12,13
ST   D7S820: 11,12
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0338 ! IB3-1
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   IB3-1/S9
AC   CVCL_4461
SY   S9
DR   BTO; BTO_0004446
DR   CLO; CLO_0008935
DR   ATCC; CRL-2778
DR   ATCC; JHU-53
DR   BioSample; SAMN03471786
DR   ChEMBL-Cells; CHEMBL3307435
DR   ChEMBL-Targets; CHEMBL614892
DR   MetaboLights; MTBLS102
DR   PubChem_Cell_line; CVCL_4461
DR   Wikidata; Q54897165
RX   PubMed=1380129;
RX   PubMed=15463957;
CC   Characteristics: Stably transduced to achieve low-level expression of full-length wild-type CFTR.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1884; CFTR.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Metabolomics.
CC   Discontinued: ATCC; CRL-2778; true.
CC   Discontinued: ATCC; JHU-53; true.
ST   Source(s): ATCC=CRL-2778
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12,13
ST   D16S539: 9,11
ST   D5S818: 11,12,13
ST   D7S820: 11,12
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0338 ! IB3-1
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   IB4
AC   CVCL_0339
DR   CLO; CLO_0004330
DR   MCCL; MCC:0000235
DR   ATCC; HB-10164
DR   Wikidata; Q54897166
RX   Patent=US5147637;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10164.
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
CC   Discontinued: ATCC; HB-10164; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   IB7
AC   CVCL_C5AX
DR   Wikidata; Q116049553
RX   PubMed=23244329;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I7AFU8; Bluetongue virus 16 VP7 (Note=Also reacts with most other BPV serotypes except BTV7, BTV15 and BTV19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   IBBISTi001-A
AC   CVCL_A5FE
SY   2042 clone 9; 2042 cl9
DR   hPSCreg; IBBISTi001-A
DR   Wikidata; Q107115401
RX   PubMed=33631522;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FF ! IBBISTi001-B
OI   CVCL_A5FG ! IBBISTi001-C
OI   CVCL_A5FH ! IBBISTi001-D
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   IBBISTi001-B
AC   CVCL_A5FF
SY   2042 clone 1; 2042 cl1
DR   hPSCreg; IBBISTi001-B
DR   Wikidata; Q107115402
RX   PubMed=33631522;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FE ! IBBISTi001-A
OI   CVCL_A5FG ! IBBISTi001-C
OI   CVCL_A5FH ! IBBISTi001-D
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   IBBISTi001-C
AC   CVCL_A5FG
SY   2042 clone 4; 2042 cl4
DR   hPSCreg; IBBISTi001-C
DR   Wikidata; Q107115403
RX   PubMed=33631522;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FE ! IBBISTi001-A
OI   CVCL_A5FF ! IBBISTi001-B
OI   CVCL_A5FH ! IBBISTi001-D
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   IBBISTi001-D
AC   CVCL_A5FH
SY   2042 clone 5; 2042 cl5
DR   hPSCreg; IBBISTi001-D
DR   Wikidata; Q107115404
RX   PubMed=33631522;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FE ! IBBISTi001-A
OI   CVCL_A5FF ! IBBISTi001-B
OI   CVCL_A5FG ! IBBISTi001-C
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   IBBISTi002-A
AC   CVCL_A5FI
SY   2040 clone 6; 2040 cl6
DR   hPSCreg; IBBISTi002-A
DR   Wikidata; Q107115405
RX   PubMed=33631522;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FJ ! IBBISTi002-B
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   IBBISTi002-B
AC   CVCL_A5FJ
SY   2040 clone 8; 2040 cl8
DR   hPSCreg; IBBISTi002-B
DR   Wikidata; Q107115406
RX   PubMed=33631522;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FI ! IBBISTi002-A
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   IBBISTi003-A
AC   CVCL_A5FK
SY   2041 clone 13
DR   hPSCreg; IBBISTi003-A
DR   Wikidata; Q107115408
RX   PubMed=34087993;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FL ! IBBISTi003-B
OI   CVCL_A5FM ! IBBISTi003-C
OI   CVCL_A5FN ! IBBISTi003-D
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   IBBISTi003-B
AC   CVCL_A5FL
SY   2041 clone 2
DR   hPSCreg; IBBISTi003-B
DR   Wikidata; Q107115409
RX   PubMed=34087993;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FK ! IBBISTi003-A
OI   CVCL_A5FM ! IBBISTi003-C
OI   CVCL_A5FN ! IBBISTi003-D
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   IBBISTi003-C
AC   CVCL_A5FM
SY   2041 clone 8
DR   hPSCreg; IBBISTi003-C
DR   Wikidata; Q107115410
RX   PubMed=34087993;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FK ! IBBISTi003-A
OI   CVCL_A5FL ! IBBISTi003-B
OI   CVCL_A5FN ! IBBISTi003-D
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   IBBISTi003-D
AC   CVCL_A5FN
SY   2041 clone 19
DR   hPSCreg; IBBISTi003-D
DR   Wikidata; Q107115411
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (from autologous cell lines IBBISTi003-A; IBBISTi003-B; IBBISTi003-C).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FK ! IBBISTi003-A
OI   CVCL_A5FL ! IBBISTi003-B
OI   CVCL_A5FM ! IBBISTi003-C
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   IBBISTi004-A
AC   CVCL_B7GS
SY   iPSC AS-GB clone 12; AS-GB clone 12
DR   BioSamples; SAMEA13010029
DR   hPSCreg; IBBISTi004-A
DR   Wikidata; Q112929809
RX   PubMed=35339881;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7GT ! IBBISTi004-B
OI   CVCL_B7GU ! IBBISTi004-C
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   IBBISTi004-B
AC   CVCL_B7GT
SY   iPSC AS-GB clone 20; AS-GB clone 20
DR   BioSamples; SAMEA13019138
DR   hPSCreg; IBBISTi004-B
DR   Wikidata; Q112929810
RX   PubMed=35339881;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7GS ! IBBISTi004-A
OI   CVCL_B7GU ! IBBISTi004-C
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   IBBISTi004-C
AC   CVCL_B7GU
SY   iPSC AS-GB clone 22; AS-GB clone 22
DR   BioSamples; SAMEA13024226
DR   hPSCreg; IBBISTi004-C
DR   Wikidata; Q112929811
RX   PubMed=35339881;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7GS ! IBBISTi004-A
OI   CVCL_B7GT ! IBBISTi004-B
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   IBBISTi005-A
AC   CVCL_D1G1
SY   F81 (940) clone 5; 5F81
DR   BioSamples; SAMEA114426148
DR   hPSCreg; IBBISTi005-A
DR   Wikidata; Q127382072
RX   PubMed=38104429;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg495Gln (c.1484G>A); ClinVar=VCV000164113; Zygosity=Heterozygous (PubMed=38104429).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1G2 ! IBBISTi005-B
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   IBBISTi005-B
AC   CVCL_D1G2
SY   F81 (940) clone 8; 8F81
DR   BioSamples; SAMEA114560167
DR   hPSCreg; IBBISTi005-B
DR   Wikidata; Q127382073
RX   PubMed=38104429;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg495Gln (c.1484G>A); ClinVar=VCV000164113; Zygosity=Heterozygous (PubMed=38104429).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1G1 ! IBBISTi005-A
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   IBBISTi006-A
AC   CVCL_D1G3
SY   F93 clone 5; 5F93
DR   BioSamples; SAMEA114560785
DR   hPSCreg; IBBISTi006-A
DR   Wikidata; Q127382074
RX   PubMed=38104429;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg495Gln (c.1484G>A); ClinVar=VCV000164113; Zygosity=Heterozygous (PubMed=38104429).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1G4 ! IBBISTi006-B
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   IBBISTi006-B
AC   CVCL_D1G4
SY   F93 clone 6; 6F93
DR   BioSamples; SAMEA114561129
DR   hPSCreg; IBBISTi006-B
DR   Wikidata; Q127382076
RX   PubMed=38104429;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg495Gln (c.1484G>A); ClinVar=VCV000164113; Zygosity=Heterozygous (PubMed=38104429).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D1G3 ! IBBISTi006-A
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   IBBISTi007-A
AC   CVCL_D6LY
SY   F26 clone 6; 6F26
DR   BioSamples; SAMEA115158738
DR   hPSCreg; IBBISTi007-A
DR   Wikidata; Q127382077
RX   PubMed=38417376;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Trp577Ter (c.1731G>A); ClinVar=VCV000180943; Zygosity=Heterozygous (PubMed=38417376).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6LZ ! IBBISTi007-B
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   IBBISTi007-B
AC   CVCL_D6LZ
SY   F26 clone 2; 2F26
DR   BioSamples; SAMEA115160098
DR   hPSCreg; IBBISTi007-B
DR   Wikidata; Q127382078
RX   PubMed=38417376;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Trp577Ter (c.1731G>A); ClinVar=VCV000180943; Zygosity=Heterozygous (PubMed=38417376).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6LY ! IBBISTi007-A
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   IBBISTi008-A
AC   CVCL_D6M0
SY   F82 clone 8; 8F82; 128_8
DR   BioSamples; SAMEA115165681
DR   hPSCreg; IBBISTi008-A
DR   Wikidata; Q127382079
RX   PubMed=38417376;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Trp890Ter (c.2670G>A); ClinVar=VCV000042650; Zygosity=Heterozygous (PubMed=38417376).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M1 ! IBBISTi008-B
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   IBBISTi008-B
AC   CVCL_D6M1
SY   F82 clone 3; 3F82; 128_3
DR   BioSamples; SAMEA115165747
DR   hPSCreg; IBBISTi008-B
DR   Wikidata; Q127382080
RX   PubMed=38417376;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Trp890Ter (c.2670G>A); ClinVar=VCV000042650; Zygosity=Heterozygous (PubMed=38417376).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M0 ! IBBISTi008-A
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   IBBISTi009-A
AC   CVCL_D6M2
SY   1F97
DR   BioSamples; SAMEA115337447
DR   hPSCreg; IBBISTi009-A
DR   Wikidata; Q127382082
RX   PubMed=38762696;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000042792; Zygosity=Heterozygous (PubMed=38762696).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38762696
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 14,18
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 16,17
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M3 ! IBBISTi009-B
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   IBBISTi009-B
AC   CVCL_D6M3
SY   5F97
DR   BioSamples; SAMEA115343967
DR   hPSCreg; IBBISTi009-B
DR   Wikidata; Q127382083
RX   PubMed=38762696;
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000042792; Zygosity=Heterozygous (PubMed=38762696).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38762696
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 14,18
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 16,17
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M2 ! IBBISTi009-A
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   IBBISTi010-A
AC   CVCL_E4D2
SY   4_H17
DR   BioSamples; SAMEA115861649
DR   hPSCreg; IBBISTi010-A
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.1224-52G>A; ClinVar=VCV000188544; Zygosity=Heterozygous (hPSCreg; IBBISTi010-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   IBBISTi011-A
AC   CVCL_E4D3
SY   3_H24
DR   BioSamples; SAMEA115875393
DR   hPSCreg; IBBISTi011-A
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.1898-23A>G; dbSNP=rs1158983908; Zygosity=Heterozygous (hPSCreg; IBBISTi011-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   IBBISTi012-A
AC   CVCL_E4D4
SY   6_H35
DR   BioSamples; SAMEA115875593
DR   hPSCreg; IBBISTi012-A
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.1898-23A>G; dbSNP=rs1158983908; Zygosity=Heterozygous (hPSCreg; IBBISTi012-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   IBBISTi013-A
AC   CVCL_E4D5
SY   4_H22
DR   BioSamples; SAMEA115877053
DR   hPSCreg; IBBISTi013-A
CC   From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.1224-52G>A; ClinVar=VCV000188544; Zygosity=Heterozygous (hPSCreg; IBBISTi013-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   iBC
AC   CVCL_EQ33
SY   iPSC_BC; Normal iPSC from BC
DR   GEO; GSM1184280
DR   GEO; GSM1184281
DR   Wikidata; Q54897167
RX   PubMed=24749076;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   IBCHi001-A
AC   CVCL_XC40
SY   iDRPLA_8
DR   hPSCreg; IBCHi001-A
DR   Wikidata; Q94312588
RX   PubMed=31374462;
CC   From: Institute of Bioorganic Chemistry Polish Academy of Sciences; Poznan; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3033; ATN1; Repeat_expansion; CAG[68] (g.17267CAG[(54-68)]); ClinVar=VCV000590267; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[16] (PubMed=31374462).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122653; Dentatorubral-pallidoluysian atrophy
DI   ORDO; Orphanet_101; Dentatorubral pallidoluysian atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T902 ! GM13716
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   IBCHi002-A
AC   CVCL_XC41
SY   iPSC_SCA3; iSCA3-34
DR   hPSCreg; IBCHi002-A
DR   Wikidata; Q94312592
RX   PubMed=32361312;
CC   From: Institute of Bioorganic Chemistry Polish Academy of Sciences; Poznan; Poland.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[71]; Zygosity=Heterozygous; Note=The other allele has 23 repeats (PubMed=32361312).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7452 ! GM06153
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   IBE
AC   CVCL_M956
DR   Wikidata; Q54897168
RX   PubMed=8838868;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   2W
CA   Conditionally immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   IBEC line A
AC   CVCL_B7GB
SY   Immortalized Biliary Epithelial Cells line A
DR   Wikidata; Q112929812
RX   PubMed=10421641;
CC   Doubling time: ~24-48 hours (PubMed=10421641).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: BALB/c/aNn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   IBEC line B
AC   CVCL_B7GC
SY   Immortalized Biliary Epithelial Cells line B
DR   Wikidata; Q112929813
RX   PubMed=10421641;
CC   Doubling time: ~168-192 hours (PubMed=10421641).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: BALB/c/aNn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   IBEC line C
AC   CVCL_B7GD
SY   Immortalized Biliary Epithelial Cells line C
DR   Wikidata; Q112929814
RX   PubMed=10421641;
CC   Doubling time: ~72-96 hours (PubMed=10421641).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: BALB/c/aNn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   IBEC line D
AC   CVCL_B7GE
SY   Immortalized Biliary Epithelial Cells line D
DR   Wikidata; Q112929815
RX   PubMed=10421641;
CC   Doubling time: ~24-48 hours (PubMed=10421641).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: BALB/c/aNn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   IBEP-1
AC   CVCL_G209
SY   IBEP1
DR   cancercelllines; CVCL_G209
DR   GEO; GSM217582
DR   GEO; GSM219876
DR   Progenetix; CVCL_G209
DR   Wikidata; Q54897169
RX   PubMed=9610725;
RX   PubMed=16142302;
CC   Doubling time: 68 hours (PubMed=9610725).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   IBEP-2
AC   CVCL_0340
SY   IBEP2
DR   MCCL; MCC:0000236
DR   Wikidata; Q54897170
RX   PubMed=9610725;
RX   PubMed=15218360;
RX   PubMed=16142302;
CC   Doubling time: 29 hours (PubMed=9610725).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   IBEP-3
AC   CVCL_G210
SY   IBEP3
DR   Wikidata; Q54897171
RX   PubMed=9610725;
RX   PubMed=16142302;
CC   Doubling time: 39 hours (PubMed=9610725).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   IBF9
AC   CVCL_C1GB
DR   Wikidata; Q114311683
RX   PubMed=1539903;
RX   PubMed=8989495;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dog melanoma antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   IBH-4
AC   CVCL_M356
DR   Wikidata; Q54897172
RX   PubMed=15095293;
RX   PubMed=19194992;
CC   Population: Caucasian.
CC   Characteristics: ER-alpha, ER-beta and PR-positive (PubMed=15095293).
CC   Doubling time: 43.47 hours (PubMed=15095293).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   IBH-6
AC   CVCL_M357
DR   Wikidata; Q54897173
RX   PubMed=15095293;
RX   PubMed=19194992;
CC   Population: Caucasian.
CC   Characteristics: ER-alpha, ER-beta and PR-positive (PubMed=15095293).
CC   Doubling time: 39.12 hours (PubMed=15095293).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   IBH-7
AC   CVCL_M358
DR   Wikidata; Q54897176
RX   PubMed=15095293;
RX   PubMed=19194992;
CC   Population: Caucasian.
CC   Characteristics: ER-alpha, ER-beta and PR-positive (PubMed=15095293).
CC   Doubling time: 49.63 hours (PubMed=15095293).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   IBHK-4
AC   CVCL_W219
SY   INCELL BHK21-C13 clone 4
DR   Wikidata; Q54897177
WW   Provider; INCELL; -; https://www.incell.com/wp-content/files/IBHK-4_Cell_Line_Product_Information_Sheet_INCELL_2016.pdf
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   IBKMOLi001-A
AC   CVCL_C0CY
SY   hIPSC-1-MNX1-2xTY1-T2A-mScarlet; hiPSC-1-MNX1-2xTY1-mScarlet
DR   hPSCreg; IBKMOLi001-A
DR   Wikidata; Q112929816
RX   PubMed=34509159;
CC   From: Institute for Molecular Biology, University of Innsbruck; Innsbruck; Austria.
CC   Characteristics: Using CRISPR/Cas9 MNX1 was C-terminally tagged on one allele with 2 x TY1 epitope tags together with a T2A-mScarlet (PubMed=34509159).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; FVS3D; mScarlet (Note=Red fluorescent protein).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9M5 ! 1013-4FA
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   IBKMOLi002-A
AC   CVCL_C0HB
SY   CACNA1D L271H iPSC
DR   BioSamples; SAMEA9468091
DR   hPSCreg; IBKMOLi002-A
DR   Wikidata; Q112929819
RX   PubMed=35453044;
CC   From: Institute for Molecular Biology, University of Innsbruck; Innsbruck; Austria.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1391; CACNA1D; Simple; p.Leu271His (c.812T>A); Zygosity=Heterozygous; Note=De novo mutation (PubMed=35453044).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188151; Primary aldosteronism, seizures, and neurologic abnormalities
DI   ORDO; Orphanet_369929; Primary hyperaldosteronism-seizures-neurological abnormalities syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   IBKMOLi003-A
AC   CVCL_D1G5
SY   vEDS COL3A1 Q105* iPSC
DR   BioSamples; SAMEA114409263
DR   hPSCreg; IBKMOLi003-A
DR   Wikidata; Q127382084
RX   PubMed=38301384;
CC   From: Institute for Molecular Biology, University of Innsbruck; Innsbruck; Austria.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gln105Ter; Zygosity=Heterozygous (PubMed=38301384).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   IBKMOLi004-A
AC   CVCL_D6MF
SY   sCeAD iPSC
DR   BioSamples; SAMEA114644412
DR   hPSCreg; IBKMOLi004-A
DR   Wikidata; Q127382085
CC   From: Institute for Molecular Biology, University of Innsbruck; Innsbruck; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IBKMOLi005-A
AC   CVCL_D6MG
SY   CTRL iPSC
DR   BioSamples; SAMEA114648003
DR   hPSCreg; IBKMOLi005-A
DR   Wikidata; Q127382086
CC   From: Institute for Molecular Biology, University of Innsbruck; Innsbruck; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IBL-1
AC   CVCL_9638
SY   IBL1
DR   Wikidata; Q54897178
RX   PubMed=18230756;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C8285; AIDS-related immunoblastic lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   IBL-4
AC   CVCL_9639
SY   IBL4
DR   EFO; EFO_0002060
DR   BioSamples; SAMEA365964
DR   BioSamples; SAMEA365976
DR   GEO; GSM38804
DR   GEO; GSM38805
DR   Wikidata; Q54897179
RX   DOI=10.1186/1742-4690-3-S1-P24;
RX   PubMed=10554028;
RX   PubMed=15613351;
RX   PubMed=18230756;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8285; AIDS-related immunoblastic lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   IBL-Sf-21AE-Cl 1
AC   CVCL_C2TG
SY   IBL-21AE2-1A1 (CL1)
DR   ICLDB; ibl-21ae2-1a1-cl1
DR   Wikidata; Q114311684
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 10
AC   CVCL_C2TJ
SY   IBL-21AE2-4A1 (CL10)
DR   ICLDB; ibl-21ae2-4a1-cl10
DR   Wikidata; Q114311685
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 13
AC   CVCL_C2TK
SY   IBL-21AE2-4A2b (CL13)
DR   ICLDB; ibl-21ae2-4a2b-cl13
DR   Wikidata; Q114311686
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 14
AC   CVCL_C2TM
SY   IBL-21AE2-CL1 (CL14)
DR   ICLDB; ibl-21ae2-cl1-cl14
DR   Wikidata; Q114311687
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 15
AC   CVCL_C2TN
SY   IBL-21AE2-SC1 (CL15)
DR   ICLDB; ibl-21ae2-sc1-cl15
DR   Wikidata; Q114311688
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 18
AC   CVCL_C2TL
SY   IBL-21AE2-5C2 (CL18)
DR   ICLDB; ibl-21ae2-5c2-cl18
DR   Wikidata; Q114311689
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 2
AC   CVCL_C2TH
SY   IBL-21AE2-1A3 (CL2)
DR   ICLDB; ibl-21ae2-1a3-cl2
DR   Wikidata; Q114311690
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 3
AC   CVCL_Z451
SY   IBL-21AE2-4A2 (CL3)
DR   ICLDB; ibl-21ae2-4a2-cl3
DR   Wikidata; Q54898030
RX   Patent=US6379958;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2207.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IBL-Sf-21AE-Cl 5
AC   CVCL_Z452
SY   IBL-21AE2-3D1b (CL5)
DR   ICLDB; ibl-21ae2-3d1b-cl5
DR   Wikidata; Q54898031
RX   Patent=US6379958;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2206.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IBL-Sf-21AE-Cl 7
AC   CVCL_C2TI
SY   IBL-21AE2-5D2 (CL7)
DR   ICLDB; ibl-21ae2-5d2-cl7
DR   Wikidata; Q114311691
CC   Group: Insect cell line.
CC   From: Vaughn, James Lloyd; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IBL-Sf-21AE-Cl 9
AC   CVCL_Z453
SY   IBL-21AE2-6A1 (CL9)
DR   ICLDB; ibl-21ae2-6a1-cl9
DR   Wikidata; Q54898033
RX   Patent=US6379958;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2205.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IBL-SLO-1A
AC   CVCL_Z346
SY   IBL-SLO1A; IBL-SL1A; SL1A
DR   ICLDB; ibl-slo-1a
DR   Wikidata; Q54897180
RX   PubMed=9028921;
CC   Group: Insect cell line.
CC   Doubling time: 21.9 hours (PubMed=9028921).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   IBL-SLO-7A
AC   CVCL_Z345
SY   SL7A
DR   ICLDB; ibl-slo-7a
DR   Wikidata; Q54897181
RX   DOI=10.6660/TESFE.1995030;
CC   Group: Insect cell line.
CC   Doubling time: 21.4 hours (DOI=10.6660/TESFE.1995030).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IBL-SLO-7B
AC   CVCL_A6IT
SY   IBL-SLO7B; SL7B
DR   ICLDB; ibl-slo-7b
DR   Wikidata; Q107115412
RX   DOI=10.1303/aez.32.179;
RX   DOI=10.6660/TESFE.1996018;
RX   DOI=10.6660/TESFE.1999004;
CC   Group: Insect cell line.
CC   Doubling time: 20.8 hours (Note=At 28 Celsius) (DOI=10.1303/aez.32.179); 28.45 hours (DOI=10.6660/TESFE.1999004).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   iBM5
AC   CVCL_B942
DR   Wikidata; Q54897183
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   iBM9
AC   CVCL_B943
DR   Wikidata; Q54897184
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   iBMK Atg5+/+ 6.1
AC   CVCL_D3I5
SY   Atg5+/+ 6.1; immortalized Baby Mouse Kidney epithelial cell line Atg5+/+ 6.1
DR   Wikidata; Q127382087
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
OI   CVCL_D3I7 ! iBMK Atg5+/+ 6.3
OI   CVCL_D3I8 ! iBMK Atg5+/+ 6.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/+ 6.1/pcDNA3 Cl.1-2
AC   CVCL_D3IH
SY   6.1/pcDNA3 Cl.1-2
DR   Wikidata; Q127382088
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I5 ! iBMK Atg5+/+ 6.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/+ 6.1B2
AC   CVCL_D3II
SY   6.1B2
DR   Wikidata; Q127382089
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I5 ! iBMK Atg5+/+ 6.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/+ 6.1B3
AC   CVCL_D3IJ
SY   6.1B3
DR   Wikidata; Q127382090
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I5 ! iBMK Atg5+/+ 6.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/+ 6.1B5
AC   CVCL_D3IK
SY   6.1B5
DR   Wikidata; Q127382091
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I5 ! iBMK Atg5+/+ 6.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/+ 6.2
AC   CVCL_D3I6
SY   Atg5+/+ 6.2; immortalized Baby Mouse Kidney epithelial cell line Atg5+/+ 6.2
DR   Wikidata; Q127382093
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3I5 ! iBMK Atg5+/+ 6.1
OI   CVCL_D3I7 ! iBMK Atg5+/+ 6.3
OI   CVCL_D3I8 ! iBMK Atg5+/+ 6.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/+ 6.2/pcDNA3 Cl.1-4
AC   CVCL_D3IL
SY   6.2/pcDNA3 Cl.1-4
DR   Wikidata; Q127382095
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/+ 6.2B1
AC   CVCL_D3IM
SY   6.2B1
DR   Wikidata; Q127382096
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/+ 6.2B10
AC   CVCL_D3IQ
SY   6.2B10
DR   Wikidata; Q127382097
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/+ 6.2B5
AC   CVCL_D3IN
SY   6.2B5
DR   Wikidata; Q127382098
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/+ 6.2B8
AC   CVCL_D3IP
SY   6.2B8
DR   Wikidata; Q127382099
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/+ 6.3
AC   CVCL_D3I7
SY   Atg5+/+ 6.3; immortalized Baby Mouse Kidney epithelial cell line Atg5+/+ 6.3
DR   Wikidata; Q127382100
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3I5 ! iBMK Atg5+/+ 6.1
OI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
OI   CVCL_D3I8 ! iBMK Atg5+/+ 6.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/+ 6.4
AC   CVCL_D3I8
SY   Atg5+/+ 6.4; immortalized Baby Mouse Kidney epithelial cell line Atg5+/+ 6.4
DR   Wikidata; Q127382101
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3I5 ! iBMK Atg5+/+ 6.1
OI   CVCL_D3I6 ! iBMK Atg5+/+ 6.2
OI   CVCL_D3I7 ! iBMK Atg5+/+ 6.3
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/- 5.1
AC   CVCL_D3I9
SY   Atg5+/- 5.1; immortalized Baby Mouse Kidney epithelial cell line Atg5+/- 5.1
DR   Wikidata; Q127382102
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3IA ! iBMK Atg5+/- 5.2
OI   CVCL_D3IB ! iBMK Atg5+/- 5.3
OI   CVCL_D3IC ! iBMK Atg5+/- 5.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/- 5.1/pcDNA3 Cl.1-2
AC   CVCL_D3IR
SY   5.1/pcDNA3 Cl.1-2
DR   Wikidata; Q127382103
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I9 ! iBMK Atg5+/- 5.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/- 5.1B2
AC   CVCL_D3IS
SY   5.1B2
DR   Wikidata; Q127382104
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3I9 ! iBMK Atg5+/- 5.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5+/- 5.2
AC   CVCL_D3IA
SY   Atg5+/- 5.2; immortalized Baby Mouse Kidney epithelial cell line Atg5+/- 5.2
DR   Wikidata; Q127382105
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3I9 ! iBMK Atg5+/- 5.1
OI   CVCL_D3IB ! iBMK Atg5+/- 5.3
OI   CVCL_D3IC ! iBMK Atg5+/- 5.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/- 5.3
AC   CVCL_D3IB
SY   Atg5+/- 5.3; immortalized Baby Mouse Kidney epithelial cell line Atg5+/- 5.3
DR   Wikidata; Q127382107
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3I9 ! iBMK Atg5+/- 5.1
OI   CVCL_D3IA ! iBMK Atg5+/- 5.2
OI   CVCL_D3IC ! iBMK Atg5+/- 5.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5+/- 5.4
AC   CVCL_D3IC
SY   Atg5+/- 5.4; immortalized Baby Mouse Kidney epithelial cell line Atg5+/- 5.4
DR   Wikidata; Q127382108
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3I9 ! iBMK Atg5+/- 5.1
OI   CVCL_D3IA ! iBMK Atg5+/- 5.2
OI   CVCL_D3IB ! iBMK Atg5+/- 5.3
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5-/- 7.1
AC   CVCL_D3ID
SY   Atg5-/- 7.1; immortalized Baby Mouse Kidney epithelial cell line Atg5-/- 7.1
DR   Wikidata; Q127382109
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3IE ! iBMK Atg5-/- 7.2
OI   CVCL_D3IF ! iBMK Atg5-/- 7.3
OI   CVCL_D3IG ! iBMK Atg5-/- 7.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5-/- 7.1/pcDNA3 Cl.1-2
AC   CVCL_D3IT
SY   7.1/pcDNA3 Cl.1-2
DR   Wikidata; Q127382110
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3ID ! iBMK Atg5-/- 7.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5-/- 7.1B1
AC   CVCL_D3IU
SY   7.1B1
DR   Wikidata; Q127382111
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3ID ! iBMK Atg5-/- 7.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.1B2
AC   CVCL_D3IV
SY   7.1B2
DR   Wikidata; Q127382112
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3ID ! iBMK Atg5-/- 7.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.1B4
AC   CVCL_D3IW
SY   7.1B4
DR   Wikidata; Q127382113
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3ID ! iBMK Atg5-/- 7.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.1B5
AC   CVCL_D3IX
SY   7.1B5
DR   Wikidata; Q127382114
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3ID ! iBMK Atg5-/- 7.1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.2
AC   CVCL_D3IE
SY   Atg5-/- 7.2; immortalized Baby Mouse Kidney epithelial cell line Atg5-/- 7.2
DR   Wikidata; Q127382115
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3ID ! iBMK Atg5-/- 7.1
OI   CVCL_D3IF ! iBMK Atg5-/- 7.3
OI   CVCL_D3IG ! iBMK Atg5-/- 7.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5-/- 7.2/pcDNA3 Cl.1-4
AC   CVCL_D3IY
SY   7.2/pcDNA3 Cl.1-4
DR   Wikidata; Q127382116
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3IE ! iBMK Atg5-/- 7.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5-/- 7.2B2
AC   CVCL_D3IZ
SY   7.2B2
DR   Wikidata; Q127382117
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3IE ! iBMK Atg5-/- 7.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.2B3
AC   CVCL_D3J0
SY   7.2B3
DR   Wikidata; Q127382118
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3IE ! iBMK Atg5-/- 7.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.2B6
AC   CVCL_D3J1
SY   7.2B6
DR   Wikidata; Q127382119
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3IE ! iBMK Atg5-/- 7.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.2B9
AC   CVCL_D3J2
SY   7.2B9
DR   Wikidata; Q127382120
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3IE ! iBMK Atg5-/- 7.2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK Atg5-/- 7.3
AC   CVCL_D3IF
SY   Atg5-/- 7.3; immortalized Baby Mouse Kidney epithelial cell line Atg5-/- 7.3
DR   Wikidata; Q127382121
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3ID ! iBMK Atg5-/- 7.1
OI   CVCL_D3IE ! iBMK Atg5-/- 7.2
OI   CVCL_D3IG ! iBMK Atg5-/- 7.4
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Atg5-/- 7.4
AC   CVCL_D3IG
SY   Atg5-/- 7.4; immortalized Baby Mouse Kidney epithelial cell line Atg5-/- 7.4
DR   Wikidata; Q127382123
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3ID ! iBMK Atg5-/- 7.1
OI   CVCL_D3IE ! iBMK Atg5-/- 7.2
OI   CVCL_D3IF ! iBMK Atg5-/- 7.3
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/+ A
AC   CVCL_D3KT
SY   BIM+/+ A; immortalized Baby Mouse Kidney epithelial cell line BIM+/+ A
DR   Wikidata; Q127382125
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/+ A.Hras-B
AC   CVCL_D3KU
SY   BIM+/+ A.Hras-B
DR   Wikidata; Q127382127
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KT ! iBMK BIM+/+ A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM+/+ A.Hras-C
AC   CVCL_D3KV
SY   BIM+/+ A.Hras-C
DR   Wikidata; Q127382128
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KT ! iBMK BIM+/+ A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM+/+ A.Hras-D
AC   CVCL_D3KW
SY   BIM+/+ A.Hras-D
DR   Wikidata; Q127382129
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KT ! iBMK BIM+/+ A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM+/+ B1
AC   CVCL_D3KX
SY   BIM+/+ B1; immortalized Baby Mouse Kidney epithelial cell line BIM+/+ B1
DR   Wikidata; Q127382130
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KY ! iBMK BIM+/+ B2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/+ B2
AC   CVCL_D3KY
SY   BIM+/+ B2; immortalized Baby Mouse Kidney epithelial cell line BIM+/+ B2
DR   Wikidata; Q127382131
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KX ! iBMK BIM+/+ B1
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/+ C1
AC   CVCL_D3KZ
SY   BIM+/+ C1; immortalized Baby Mouse Kidney epithelial cell line BIM+/+ C1
DR   Wikidata; Q127382133
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3L0 ! iBMK BIM+/+ C2
OI   CVCL_D3L1 ! iBMK BIM+/+ C3
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/+ C2
AC   CVCL_D3L0
SY   BIM+/+ C2; immortalized Baby Mouse Kidney epithelial cell line BIM+/+ C2
DR   Wikidata; Q127382134
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KZ ! iBMK BIM+/+ C1
OI   CVCL_D3L1 ! iBMK BIM+/+ C3
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/+ C3
AC   CVCL_D3L1
SY   BIM+/+ C3; immortalized Baby Mouse Kidney epithelial cell line BIM+/+ C3
DR   Wikidata; Q127382135
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KZ ! iBMK BIM+/+ C1
OI   CVCL_D3L0 ! iBMK BIM+/+ C2
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/- A
AC   CVCL_D3KH
SY   BIM+/- A; immortalized Baby Mouse Kidney epithelial cell line BIM+/- A
DR   Wikidata; Q127382136
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/- B
AC   CVCL_D3KI
SY   BIM+/- B; immortalized Baby Mouse Kidney epithelial cell line BIM+/- B
DR   Wikidata; Q127382137
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM+/- C
AC   CVCL_D3KJ
SY   BIM+/- C; immortalized Baby Mouse Kidney epithelial cell line BIM+/- C
DR   Wikidata; Q127382139
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM-/- A
AC   CVCL_D3KE
SY   BIM-/- A; immortalized Baby Mouse Kidney epithelial cell line BIM-/- A
DR   Wikidata; Q127382140
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM-/- A.3.1-C1
AC   CVCL_D3KK
SY   BIM-/- A.3.1-C1
DR   Wikidata; Q127382141
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM-/- A.3.1-C2
AC   CVCL_D3KL
SY   BIM-/- A.3.1-C2
DR   Wikidata; Q127382142
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM-/- A.Hras-A
AC   CVCL_D3KM
SY   BIM-/- A.Hras-A
DR   Wikidata; Q127382143
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM-/- A.Hras-B
AC   CVCL_D3KN
SY   BIM-/- A.Hras-B
DR   Wikidata; Q127382144
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM-/- A.Hras-C
AC   CVCL_D3KP
SY   BIM-/- A.Hras-C
DR   Wikidata; Q127382145
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM-/- A.Raf-A
AC   CVCL_D3KQ
SY   BIM-/- A.Raf-A
DR   Wikidata; Q127382146
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM-/- A.Raf-B
AC   CVCL_D3KR
SY   BIM-/- A.Raf-B
DR   Wikidata; Q127382147
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM-/- A.Raf-C
AC   CVCL_D3KS
SY   BIM-/- A.Raf-C
DR   Wikidata; Q127382148
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3KE ! iBMK BIM-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BIM-/- B
AC   CVCL_D3KF
SY   BIM-/- B; immortalized Baby Mouse Kidney epithelial cell line BIM-/- B
DR   Wikidata; Q127382149
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BIM-/- C
AC   CVCL_D3KG
SY   BIM-/- C; immortalized Baby Mouse Kidney epithelial cell line BIM-/- C
DR   Wikidata; Q127382150
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1197519; Bcl2l11.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BLN-34-3
AC   CVCL_D3HP
SY   BLN-34-3; BLN34-3; BCLN34-3; immortalized Baby Mouse Kidney epithelial cell line BLN-34-3
DR   Wikidata; Q127382151
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HQ ! iBMK BLN-4-1
OI   CVCL_D3HV ! iBMK BLNB-1
OI   CVCL_D3HW ! iBMK BLNB-4
OI   CVCL_D3HX ! iBMK BLNB-12
OI   CVCL_D3HY ! iBMK BLNB-13
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BLN-4-1
AC   CVCL_D3HQ
SY   BLN-4-1; BLN4-1; BCLN4-1; immortalized Baby Mouse Kidney epithelial cell line BLN-4-1
DR   Wikidata; Q127382152
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HP ! iBMK BLN-34-3
OI   CVCL_D3HV ! iBMK BLNB-1
OI   CVCL_D3HW ! iBMK BLNB-4
OI   CVCL_D3HX ! iBMK BLNB-12
OI   CVCL_D3HY ! iBMK BLNB-13
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BLN-A3
AC   CVCL_D3HR
SY   BLN-A3; immortalized Baby Mouse Kidney epithelial cell line BLN-A3
DR   Wikidata; Q127382153
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HS ! iBMK BLN-B2
OI   CVCL_D3HT ! iBMK BLN-C3
OI   CVCL_D3HU ! iBMK BLN-D1
OI   CVCL_D3HZ ! iBMK BLNB-A4
OI   CVCL_D3I0 ! iBMK BLNB-B1
OI   CVCL_D3I1 ! iBMK BLNB-C2
OI   CVCL_D3I2 ! iBMK BLNB-D1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BLN-B2
AC   CVCL_D3HS
SY   BLN-B2; immortalized Baby Mouse Kidney epithelial cell line BLN-B2
DR   Wikidata; Q127382154
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HR ! iBMK BLN-A3
OI   CVCL_D3HT ! iBMK BLN-C3
OI   CVCL_D3HU ! iBMK BLN-D1
OI   CVCL_D3HZ ! iBMK BLNB-A4
OI   CVCL_D3I0 ! iBMK BLNB-B1
OI   CVCL_D3I1 ! iBMK BLNB-C2
OI   CVCL_D3I2 ! iBMK BLNB-D1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BLN-C3
AC   CVCL_D3HT
SY   BLN-C3; immortalized Baby Mouse Kidney epithelial cell line BLN-C3
DR   Wikidata; Q127382155
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HR ! iBMK BLN-A3
OI   CVCL_D3HS ! iBMK BLN-B2
OI   CVCL_D3HU ! iBMK BLN-D1
OI   CVCL_D3HZ ! iBMK BLNB-A4
OI   CVCL_D3I0 ! iBMK BLNB-B1
OI   CVCL_D3I1 ! iBMK BLNB-C2
OI   CVCL_D3I2 ! iBMK BLNB-D1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BLN-D1
AC   CVCL_D3HU
SY   BLN-D1; immortalized Baby Mouse Kidney epithelial cell line BLN-D1
DR   Wikidata; Q127382156
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HR ! iBMK BLN-A3
OI   CVCL_D3HS ! iBMK BLN-B2
OI   CVCL_D3HT ! iBMK BLN-C3
OI   CVCL_D3HZ ! iBMK BLNB-A4
OI   CVCL_D3I0 ! iBMK BLNB-B1
OI   CVCL_D3I1 ! iBMK BLNB-C2
OI   CVCL_D3I2 ! iBMK BLNB-D1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK BLNB-1
AC   CVCL_D3HV
SY   BLNB-1; BLN-B1; immortalized Baby Mouse Kidney epithelial cell line BLNB-1
DR   Wikidata; Q127382157
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HP ! iBMK BLN-34-3
OI   CVCL_D3HQ ! iBMK BLN-4-1
OI   CVCL_D3HW ! iBMK BLNB-4
OI   CVCL_D3HX ! iBMK BLNB-12
OI   CVCL_D3HY ! iBMK BLNB-13
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-12
AC   CVCL_D3HX
SY   BLNB-12; BLN-B12; immortalized Baby Mouse Kidney epithelial cell line BLNB-12
DR   Wikidata; Q127382158
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HP ! iBMK BLN-34-3
OI   CVCL_D3HQ ! iBMK BLN-4-1
OI   CVCL_D3HV ! iBMK BLNB-1
OI   CVCL_D3HW ! iBMK BLNB-4
OI   CVCL_D3HY ! iBMK BLNB-13
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-13
AC   CVCL_D3HY
SY   BLNB-13; BLN-B13; immortalized Baby Mouse Kidney epithelial cell line BLNB-13
DR   Wikidata; Q127382159
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HP ! iBMK BLN-34-3
OI   CVCL_D3HQ ! iBMK BLN-4-1
OI   CVCL_D3HV ! iBMK BLNB-1
OI   CVCL_D3HW ! iBMK BLNB-4
OI   CVCL_D3HX ! iBMK BLNB-12
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-13-EGFP-LC3
AC   CVCL_D3I4
SY   BLNB-13-EGFP-LC3; BLNB-13 LC3
DR   Wikidata; Q127382160
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3HY ! iBMK BLNB-13
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-4
AC   CVCL_D3HW
SY   BLNB-4; BLN-B4; immortalized Baby Mouse Kidney epithelial cell line BLNB-4
DR   Wikidata; Q127382161
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HP ! iBMK BLN-34-3
OI   CVCL_D3HQ ! iBMK BLN-4-1
OI   CVCL_D3HV ! iBMK BLNB-1
OI   CVCL_D3HX ! iBMK BLNB-12
OI   CVCL_D3HY ! iBMK BLNB-13
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-A4
AC   CVCL_D3HZ
SY   BLNB-A4; immortalized Baby Mouse Kidney epithelial cell line BLNB-A4
DR   Wikidata; Q127382162
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HR ! iBMK BLN-A3
OI   CVCL_D3HS ! iBMK BLN-B2
OI   CVCL_D3HT ! iBMK BLN-C3
OI   CVCL_D3HU ! iBMK BLN-D1
OI   CVCL_D3I0 ! iBMK BLNB-B1
OI   CVCL_D3I1 ! iBMK BLNB-C2
OI   CVCL_D3I2 ! iBMK BLNB-D1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-B1
AC   CVCL_D3I0
SY   BLNB-B1; immortalized Baby Mouse Kidney epithelial cell line BLNB-B1
DR   Wikidata; Q127382164
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HR ! iBMK BLN-A3
OI   CVCL_D3HS ! iBMK BLN-B2
OI   CVCL_D3HT ! iBMK BLN-C3
OI   CVCL_D3HU ! iBMK BLN-D1
OI   CVCL_D3HZ ! iBMK BLNB-A4
OI   CVCL_D3I1 ! iBMK BLNB-C2
OI   CVCL_D3I2 ! iBMK BLNB-D1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-C2
AC   CVCL_D3I1
SY   BLNB-C2; immortalized Baby Mouse Kidney epithelial cell line BLNB-C2
DR   Wikidata; Q127382165
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HR ! iBMK BLN-A3
OI   CVCL_D3HS ! iBMK BLN-B2
OI   CVCL_D3HT ! iBMK BLN-C3
OI   CVCL_D3HU ! iBMK BLN-D1
OI   CVCL_D3HZ ! iBMK BLNB-A4
OI   CVCL_D3I0 ! iBMK BLNB-B1
OI   CVCL_D3I2 ! iBMK BLNB-D1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK BLNB-D1
AC   CVCL_D3I2
SY   BLNB-D1; immortalized Baby Mouse Kidney epithelial cell line BLNB-D1
DR   Wikidata; Q127382167
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3HR ! iBMK BLN-A3
OI   CVCL_D3HS ! iBMK BLN-B2
OI   CVCL_D3HT ! iBMK BLN-C3
OI   CVCL_D3HU ! iBMK BLN-D1
OI   CVCL_D3HZ ! iBMK BLNB-A4
OI   CVCL_D3I0 ! iBMK BLNB-B1
OI   CVCL_D3I1 ! iBMK BLNB-C2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D1
AC   CVCL_D3FT
SY   D1; D1-3; immortalized Baby Mouse Kidney epithelial cell line D1
DR   Wikidata; Q127382168
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D2
AC   CVCL_D3FU
SY   D2; immortalized Baby Mouse Kidney epithelial cell line D2
DR   Wikidata; Q127382169
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3
AC   CVCL_D3FV
SY   D3; immortalized Baby Mouse Kidney epithelial cell line D3
DR   Wikidata; Q127382170
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.19K-4
AC   CVCL_D3JL
SY   D3.19K-4
DR   Wikidata; Q127382172
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03246; Human adenovirus C serotype 5 E1B 19 kDa protein (Note=With a C-terminal V5-His tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.19K-7
AC   CVCL_D3JM
SY   D3.19K-7
DR   Wikidata; Q127382173
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03246; Human adenovirus C serotype 5 E1B 19 kDa protein (Note=With a C-terminal V5-His tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.19K-8
AC   CVCL_D3JN
SY   D3.19K-8
DR   Wikidata; Q127382174
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03246; Human adenovirus C serotype 5 E1B 19 kDa protein (Note=With a C-terminal V5-His tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.Akt-D5
AC   CVCL_D3GB
SY   D3.Akt-D5; D3 AKT-D5
DR   Wikidata; Q127382175
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Akt-F7
AC   CVCL_D3GC
SY   D3.Akt-F7; D3 AKT-F7
DR   Wikidata; Q127382176
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Akt-G1
AC   CVCL_D3GD
SY   D3.Akt-G1; D3 AKT-G1
DR   Wikidata; Q127382178
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.B4
AC   CVCL_D3G9
SY   D3.B4; D3 PCDNA3 B4
DR   Wikidata; Q127382179
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.Bcl2-3
AC   CVCL_D3GF
SY   D3.Bcl2-3
DR   Wikidata; Q127382180
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Bcl2-4
AC   CVCL_D3GG
SY   D3.Bcl2-4
DR   Wikidata; Q127382181
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Bcl2-4RED-14
AC   CVCL_D3J9
SY   D3.Bcl2-4RED-14
DR   Wikidata; Q127382182
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GG ! iBMK D3.Bcl2-4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Bcl2-4RED-5
AC   CVCL_D3J7
SY   D3.Bcl2-4RED-5
DR   Wikidata; Q127382186
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GG ! iBMK D3.Bcl2-4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Bcl2-4RED-9
AC   CVCL_D3J8
SY   D3.Bcl2-4RED-9
DR   Wikidata; Q127382187
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GG ! iBMK D3.Bcl2-4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Bcl2-6
AC   CVCL_D3GH
SY   D3.Bcl2-6
DR   Wikidata; Q127382188
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.C4
AC   CVCL_D3GA
SY   D3.C4; D3 PCDNA3 C4
DR   Wikidata; Q127382189
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3 EGFP-LC3
AC   CVCL_D3GE
SY   D3 EGFP-LC3
DR   Wikidata; Q127382192
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.Hras-1
AC   CVCL_D3GI
SY   D3.Hras-1; D3 Hras-1
DR   Wikidata; Q127382193
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Hras-1RED-10
AC   CVCL_D3JC
SY   D3.Hras-RED-10
DR   Wikidata; Q127382194
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GI ! iBMK D3.Hras-1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Hras-1RED-2
AC   CVCL_D3JA
SY   D3.Hras-1RED-2
DR   Wikidata; Q127382196
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GI ! iBMK D3.Hras-1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Hras-1RED-7
AC   CVCL_D3JB
SY   D3.Hras-1RED-7
DR   Wikidata; Q127382197
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GI ! iBMK D3.Hras-1
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Hras-3
AC   CVCL_D3GJ
SY   D3.Hras-3; D3 Hras-3
DR   Wikidata; Q127382198
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Hras-6
AC   CVCL_D3GK
SY   D3.Hras-6; D3 Hras-6
DR   Wikidata; Q127382199
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Raf-1
AC   CVCL_D3GL
SY   D3.Raf-1; D3.Raf-CAAX-1
DR   Wikidata; Q127382201
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Raf-2
AC   CVCL_D3GM
SY   D3.Raf-2; D3.Raf-CAAX-2
DR   Wikidata; Q127382203
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.Raf-3
AC   CVCL_D3GN
SY   D3.Raf-3; D3.Raf-CAAX-3
DR   Wikidata; Q127382205
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK D3.zeo-1
AC   CVCL_D3GP
SY   D3.zeo-1; D3 Zeo-1
DR   Wikidata; Q127382207
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.zeo-2
AC   CVCL_D3GQ
SY   D3.zeo-2; D3 Zeo-2
DR   Wikidata; Q127382210
RX   PubMed=15314031;
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.zeo-2RED 1
AC   CVCL_D3J3
SY   D3.zeo-2RED 1
DR   Wikidata; Q127382212
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GQ ! iBMK D3.zeo-2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.zeo-2RED 10
AC   CVCL_D3J6
SY   D3.zeo-2RED 10
DR   Wikidata; Q127382215
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GQ ! iBMK D3.zeo-2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.zeo-2RED 2
AC   CVCL_D3J4
SY   D3.zeo-2RED 2
DR   Wikidata; Q127382216
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GQ ! iBMK D3.zeo-2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.zeo-2RED 4
AC   CVCL_D3J5
SY   D3.zeo-2RED 4
DR   Wikidata; Q127382219
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GQ ! iBMK D3.zeo-2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK D3.zeo-3
AC   CVCL_D3GR
SY   D3.zeo-3; D3 Zeo-3
DR   Wikidata; Q127382221
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3FV ! iBMK D3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK K1
AC   CVCL_D3FW
SY   K1; K1-3; immortalized Baby Mouse Kidney epithelial cell line K1
DR   Wikidata; Q127382222
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK K2
AC   CVCL_D3FX
SY   K2; immortalized Baby Mouse Kidney epithelial cell line K2
DR   Wikidata; Q127382223
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK K3
AC   CVCL_D3FY
SY   K3; immortalized Baby Mouse Kidney epithelial cell line K3
DR   Wikidata; Q127382226
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK p53-/- 1
AC   CVCL_D3FZ
SY   p53-/- 1; immortalized Baby Mouse Kidney epithelial cell line p53-/- 1
DR   Wikidata; Q127382227
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK p53-/- 2
AC   CVCL_D3G0
SY   p53-/- 2; immortalized Baby Mouse Kidney epithelial cell line p53-/- 2
DR   Wikidata; Q127382228
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Puma+/+ A
AC   CVCL_D3KA
SY   Puma+/+ A; PUMA+/+ A; immortalized Baby Mouse Kidney epithelial cell line Puma+/+ A
DR   Wikidata; Q127382229
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KB ! iBMK Puma+/+ B
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Puma+/+ B
AC   CVCL_D3KB
SY   Puma+/+ B; PUMA+/+ B; immortalized Baby Mouse Kidney epithelial cell line Puma+/+ B
DR   Wikidata; Q127382230
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KA ! iBMK Puma+/+ A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Puma-/- A
AC   CVCL_D3KC
SY   Puma-/- A; PUMA-/- A; immortalized Baby Mouse Kidney epithelial cell line Puma-/- A
DR   Wikidata; Q127382232
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2181667; Bbc3.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KD ! iBMK Puma-/- B
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK Puma-/- B
AC   CVCL_D3KD
SY   Puma-/- B; PUMA-/- B; immortalized Baby Mouse Kidney epithelial cell line Puma-/- B
DR   Wikidata; Q127382235
RX   PubMed=15766661;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2181667; Bbc3.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D3KC ! iBMK Puma-/- A
SX   Sex unspecified
AG   <2D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W1
AC   CVCL_D3G1
SY   W1; W1-3; immortalized Baby Mouse Kidney epithelial cell line W1
DR   Wikidata; Q127382237
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2
AC   CVCL_D3G2
SY   W2; immortalized Baby Mouse Kidney epithelial cell line W2
DR   ABM; T0082
DR   Wikidata; Q127382239
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.3.1-2
AC   CVCL_D3GS
SY   W2.3.1-2; W2.3.1.2; W2 3.1.2
DR   Wikidata; Q127382240
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.3.1-5
AC   CVCL_D3GT
SY   W2.3.1-5; W2.3.1.5; W2 3.1.5
DR   Wikidata; Q127382241
RX   PubMed=15314031;
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.3.1-5RED-11
AC   CVCL_D3JF
SY   W2.3.1-5RED-11
DR   Wikidata; Q127382243
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GT ! iBMK W2.3.1-5
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.3.1-5RED-4
AC   CVCL_D3JD
SY   W2.3.1-5RED-4
DR   Wikidata; Q127382244
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GT ! iBMK W2.3.1-5
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.3.1-5RED-6
AC   CVCL_D3JE
SY   W2.3.1-5RED-6
DR   Wikidata; Q127382245
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3GT ! iBMK W2.3.1-5
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.3.1-6
AC   CVCL_D3GU
SY   W2.3.1-6; W2.3.1.6; W2 3.1.6
DR   Wikidata; Q127382246
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.A1
AC   CVCL_D3GV
SY   W2.A1; W2 PCDNA3 A1
DR   Wikidata; Q127382248
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.Akt-C1
AC   CVCL_D3GY
SY   W2.Akt-C1; W2.AKT-C1; W2 AKT C1
DR   Wikidata; Q127382250
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Akt-D1
AC   CVCL_D3GZ
SY   W2.Akt-D1; W2.AKT-D1; W2 AKT D1
DR   Wikidata; Q127382253
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Akt-E4
AC   CVCL_D3H0
SY   W2.Akt-E4; W2.AKT-E4; W2 AKT E4
DR   Wikidata; Q127382254
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.B1
AC   CVCL_D3GW
SY   W2.B1; W2 PCDNA3 B1
DR   Wikidata; Q127382255
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.Bcl2-14
AC   CVCL_D3H2
SY   W2.Bcl2-14
DR   Wikidata; Q127382256
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Bcl2-15
AC   CVCL_D3H3
SY   W2.Bcl2-15
DR   Wikidata; Q127382257
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Bcl2-3
AC   CVCL_D3H1
SY   W2.Bcl2-3
DR   Wikidata; Q127382258
RX   PubMed=15314031;
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Bcl2-3RED
AC   CVCL_D3JG
SY   W2.Bcl2-3RED
DR   Wikidata; Q127382259
RX   PubMed=15314031;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3H1 ! iBMK W2.Bcl2-3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.D2
AC   CVCL_D3GX
SY   W2.D2; W2 PCDNA3 D2
DR   Wikidata; Q127382260
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W2.Hras-2
AC   CVCL_D3H4
SY   W2.Hras-2: W2-Hras.2
DR   Wikidata; Q127382261
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Hras-3
AC   CVCL_D3H5
SY   W2.Hras-3: W2-Hras.3
DR   Wikidata; Q127382262
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Hras-3RED-3
AC   CVCL_D3JH
SY   W2.Hras-3RED-3
DR   Wikidata; Q127382263
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3H5 ! iBMK W2.Hras-3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Hras-3RED-6
AC   CVCL_D3JI
SY   W2.Hras-3RED-6
DR   Wikidata; Q127382264
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3H5 ! iBMK W2.Hras-3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Hras-3RED-8
AC   CVCL_D3JJ
SY   W2.Hras-3RED-8
DR   Wikidata; Q127382267
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3H5 ! iBMK W2.Hras-3
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Hras-7
AC   CVCL_D3H6
SY   W2.Hras-7: W2-Hras.7
DR   Wikidata; Q127382268
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Raf-13
AC   CVCL_D3H7
SY   W2.Raf-13
DR   Wikidata; Q127382269
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Raf-15
AC   CVCL_D3H8
SY   W2.Raf-15
DR   Wikidata; Q127382270
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2.Raf-16
AC   CVCL_D3H9
SY   W2.Raf-16
DR   Wikidata; Q127382272
RX   PubMed=15766661;
RX   PubMed=16843265;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9829; RAF1 (Note=With at the C-terminus the addition of the C-terminal 18 AA of KRAS isoform 2B/K-Ras4B = Raf-CAAX).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK W2RED
AC   CVCL_D3JK
SY   W2RED
DR   Wikidata; Q127382274
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G2 ! iBMK W2
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W3
AC   CVCL_D3G3
SY   W3; immortalized Baby Mouse Kidney epithelial cell line W3
DR   Wikidata; Q127382275
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W4
AC   CVCL_D3G4
SY   W4; immortalized Baby Mouse Kidney epithelial cell line W4
DR   Wikidata; Q127382276
RX   PubMed=12242152;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W4-1
AC   CVCL_D3HA
SY   W4-1
DR   Wikidata; Q127382277
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W4-2
AC   CVCL_D3HB
SY   W4-2
DR   Wikidata; Q127382278
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W4-A1
AC   CVCL_D3HC
SY   W4-A1
DR   Wikidata; Q127382279
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W4-B1
AC   CVCL_D3HD
SY   W4-B1
DR   Wikidata; Q127382280
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W4-C1
AC   CVCL_D3HE
SY   W4-C1
DR   Wikidata; Q127382281
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W4-E1
AC   CVCL_D3HF
SY   W4-E1
DR   Wikidata; Q127382282
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK W5
AC   CVCL_D3G5
SY   W5; immortalized Baby Mouse Kidney epithelial cell line W5
DR   Wikidata; Q127382284
RX   PubMed=12242152;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK WB-3
AC   CVCL_D3HG
SY   WB-3
DR   Wikidata; Q127382285
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK WB-5
AC   CVCL_D3HH
SY   WB-5
DR   Wikidata; Q127382286
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK WB-10
AC   CVCL_D3HI
SY   WB-10
DR   Wikidata; Q127382287
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK WB-13
AC   CVCL_D3HJ
SY   WB-13
DR   Wikidata; Q127382290
RX   PubMed=16843265;
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK WB-13-EGFP-LC3
AC   CVCL_D3I3
SY   WB-13-EGFP-LC3; WB-13 LC3
DR   Wikidata; Q127382292
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3HJ ! iBMK WB-13
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK WB-A2
AC   CVCL_D3HK
SY   WB-A2
DR   Wikidata; Q127382294
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK WB-B1
AC   CVCL_D3HL
SY   WB-B1
DR   Wikidata; Q127382295
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK WB-D1
AC   CVCL_D3HM
SY   WB-D1
DR   Wikidata; Q127382297
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK WB-D3
AC   CVCL_D3HN
SY   WB-D3
DR   Wikidata; Q127382299
RX   PubMed=17510285;
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3G4 ! iBMK W4
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iBMK X1
AC   CVCL_D3G6
SY   X1; X1-3; immortalized Baby Mouse Kidney epithelial cell line X1
DR   Wikidata; Q127382300
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK X2
AC   CVCL_D3G7
SY   X2; immortalized Baby Mouse Kidney epithelial cell line X2
DR   Wikidata; Q127382301
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1 (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iBMK X3
AC   CVCL_D3G8
SY   X3; immortalized Baby Mouse Kidney epithelial cell line X3
DR   Wikidata; Q127382302
RX   PubMed=11836241;
RX   PubMed=12242152;
RX   PubMed=18603117;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1 (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   IBMS-iPSC-001-02
AC   CVCL_GT27
SY   IBMS-iPSC-01-02
DR   BCRC; SC81036
DR   BCRC; SC81103
DR   SKIP; SKIP005624
DR   SKIP; SKIP005707
DR   Wikidata; Q54897185
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   IBMS-iPSC-002-07
AC   CVCL_GT28
SY   IBMS-iPSC-02-07; IBMS-iPS-02-07
DR   BCRC; SC81031
DR   BCRC; SC81104
DR   SKIP; SKIP005619
DR   SKIP; SKIP005708
DR   Wikidata; Q54897186
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   IBMS-iPSC-003-06
AC   CVCL_LG32
SY   IBMS-iPSC-03-06
DR   BCRC; SC81039
DR   BCRC; SC81105
DR   SKIP; SKIP005626
DR   SKIP; SKIP005709
DR   Wikidata; Q54897187
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   IBMS-iPSC-004-02
AC   CVCL_LG33
SY   IBMS-iPSC-04-02
DR   BCRC; SC81040
DR   BCRC; SC81106
DR   SKIP; SKIP005627
DR   SKIP; SKIP005710
DR   Wikidata; Q54897188
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   IBMS-iPSC-005-11
AC   CVCL_B9UN
DR   BCRC; SC81138
DR   Wikidata; Q112929821
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-006-02
AC   CVCL_B9UP
DR   BCRC; SC81139
DR   Wikidata; Q112929824
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-009-05
AC   CVCL_B9UQ
DR   BCRC; SC81140
DR   Wikidata; Q112929827
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-011-05
AC   CVCL_B9UR
DR   BCRC; SC81141
DR   Wikidata; Q112929829
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-012-12
AC   CVCL_LJ95
SY   IBMSi001-A
DR   BCRC; SC81042
DR   BCRC; SC81043
DR   BioSamples; SAMEA104387150
DR   hPSCreg; IBMSi001-A
DR   SKIP; SKIP005629
DR   SKIP; SKIP005630
DR   Wikidata; Q54897189
RX   PubMed=29034881;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Ala1458Profs*64 (c.4369_4370delTC) (p.Ser1457fs); Zygosity=Heterozygous (PubMed=29034881).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034881
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 22,23
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,20
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-013-06
AC   CVCL_QY05
SY   IBMSi002-A
DR   BioSamples; SAMEA104387750
DR   hPSCreg; IBMSi002-A
DR   SKIP; SKIP005871
DR   Wikidata; Q54897190
RX   PubMed=29121521;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Gln533Ter (c.1597C>T); Zygosity=Heterozygous (PubMed=29121521).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29121521
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D19S433: 14,14.2
ST   D21S11: 29,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RP79 ! IBMS-iPSC-013-07
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-013-07
AC   CVCL_RP79
DR   BCRC; SC81044
DR   BCRC; SC81045
DR   SKIP; SKIP005631
DR   SKIP; SKIP005632
DR   Wikidata; Q54897191
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Gln533Ter (c.1597C>T); Zygosity=Heterozygous (from autologous cell line IBMS-iPSC-013-06).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY05 ! IBMS-iPSC-013-06
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   IBMS-iPSC-014-05
AC   CVCL_QY07
SY   IBMSi003-A
DR   BCRC; SC81046
DR   BCRC; SC81047
DR   BioSamples; SAMEA104387752
DR   hPSCreg; IBMSi003-A
DR   SKIP; SKIP005633
DR   SKIP; SKIP005634
DR   Wikidata; Q54897192
RX   PubMed=29055226;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple; p.Arg803Ter (c.2407C>T); ClinVar=VCV000618321; Zygosity=Heterozygous (PubMed=29055226).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29055226
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 19,24
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-014-C
AC   CVCL_ZE87
SY   IBMSi003-A-1
DR   hPSCreg; IBMSi003-A-1
DR   SKIP; SKIP005790
DR   Wikidata; Q98126756
RX   PubMed=32361310;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple_corrected; p.Arg803Ter (c.2407C>T); ClinVar=VCV000618321; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32361310).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QY07 ! IBMS-iPSC-014-05
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   IBMS-iPSC-015-06
AC   CVCL_YC02
SY   IBMSi013-A
DR   BCRC; SC81122
DR   hPSCreg; IBMSi013-A
DR   Wikidata; Q94312922
RX   PubMed=34119955;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   IBMS-iPSC-016-06
AC   CVCL_YC03
SY   IBMSi014-A
DR   BCRC; SC81123
DR   hPSCreg; IBMSi014-A
DR   Wikidata; Q94312924
RX   PubMed=34119955;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   IBMS-iPSC-017-02
AC   CVCL_YC04
SY   IBMSi015-A
DR   BCRC; SC81124
DR   hPSCreg; IBMSi015-A
DR   Wikidata; Q94312929
RX   PubMed=34119955;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   IBMS-iPSC-018-09
AC   CVCL_QY27
SY   IBMSi007-A
DR   BCRC; SC81095
DR   hPSCreg; IBMSi007-A
DR   SKIP; SKIP005726
DR   Wikidata; Q54897193
RX   PubMed=29414410;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2385Arg (c.7153G>A); ClinVar=VCV000001943; Zygosity=Heterozygous (PubMed=29414410).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29414410
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 14
ST   D19S433: 14.2,15.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 19,23.2
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   IBMS-iPSC-019-11
AC   CVCL_QY06
SY   IBMSi006-A
DR   BCRC; SC81048
DR   BCRC; SC81049
DR   hPSCreg; IBMSi006-A
DR   SKIP; SKIP005635
DR   SKIP; SKIP005636
DR   Wikidata; Q54897194
RX   PubMed=29127874;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile2012Thr (c.6035T>C); ClinVar=VCV000039218; Zygosity=Heterozygous (PubMed=29127874).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29127874
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,13
ST   D18S51: 16,17
ST   D19S433: 13,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 19,24
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 16
ST   FGA: 23
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   IBMS-iPSC-020-01
AC   CVCL_QY28
SY   IBMSi008-A
DR   BCRC; SC81050
DR   BCRC; SC81051
DR   hPSCreg; IBMSi008-A
DR   SKIP; SKIP005637
DR   SKIP; SKIP005638
DR   Wikidata; Q54897195
RX   PubMed=29414410;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2385Arg (c.7153G>A); ClinVar=VCV000001943; Zygosity=Heterozygous (PubMed=29414410).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29414410
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 13,15
ST   D21S11: 31.2
ST   D2S1338: 19,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-021-04
AC   CVCL_YC05
SY   IBMSi016-A
DR   BCRC; SC81125
DR   hPSCreg; IBMSi016-A
DR   Wikidata; Q94312972
RX   PubMed=34118567;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Unspecified; Note=Allele ALDH2*2 (PubMed=34118567).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   IBMS-iPSC-022-01
AC   CVCL_YC06
SY   IBMSi017-A
DR   BCRC; SC81126
DR   hPSCreg; IBMSi017-A
DR   Wikidata; Q94312977
RX   PubMed=34118567;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Unspecified; Note=Allele ALDH2*2 (PubMed=34118567).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   IBMS-iPSC-023-03
AC   CVCL_YC07
SY   IBMSi018-A
DR   BCRC; SC81127
DR   hPSCreg; IBMSi018-A
DR   Wikidata; Q94312979
RX   PubMed=34118567;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Unspecified; Note=Allele ALDH2*2 (PubMed=34118567).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   IBMS-iPSC-024-03
AC   CVCL_VL28
DR   BCRC; SC81087
DR   SKIP; SKIP005683
DR   Wikidata; Q94312983
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Glu398Aspfs*6 (c.1194delA); Zygosity=Hemizygous (BCRC=SC81087).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-025-03
AC   CVCL_QY29
DR   BCRC; SC81052
DR   BCRC; SC81053
DR   SKIP; SKIP005648
DR   SKIP; SKIP005649
DR   Wikidata; Q54897196
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; c.640-801G>A (c.639+919G>A) (IVS4+919G>A); ClinVar=VCV000010768; Zygosity=Hemizygous (BCRC=SC81052).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-026-02
AC   CVCL_VL29
DR   BCRC; SC81088
DR   SKIP; SKIP005684
DR   Wikidata; Q94312995
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; c.640-801G>A (c.639+919G>A) (IVS4+919G>A); ClinVar=VCV000010768; Zygosity=Hemizygous (BCRC=SC81088).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-027-01
AC   CVCL_RP80
DR   BCRC; SC81077
DR   SKIP; SKIP005673
DR   Wikidata; Q54897197
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2719; DDC; Simple; c.714+4A>T (IVS6+4A>T) (IVS6DS,A-T,+4); ClinVar=VCV000864024; Zygosity=Homozygous (BCRC=SC81077).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142085; Aromatic L-amino-acid decarboxylase deficiency
DI   ORDO; Orphanet_35708; Aromatic L-amino acid decarboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-028-01
AC   CVCL_UD69
DR   BCRC; SC81096
DR   SKIP; SKIP005701
DR   Wikidata; Q94313001
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2719; DDC; Simple; c.714+4A>T (IVS6+4A>T) (IVS6DS,A-T,+4); ClinVar=VCV000864024; Zygosity=Heterozygous (BCRC=SC81096).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142085; Aromatic L-amino-acid decarboxylase deficiency
DI   ORDO; Orphanet_35708; Aromatic L-amino acid decarboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-029-01
AC   CVCL_QY30
DR   BCRC; SC81054
DR   BCRC; SC81055
DR   SKIP; SKIP005650
DR   SKIP; SKIP005651
DR   Wikidata; Q54897198
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2719; DDC; Simple; c.714+4A>T (IVS6+4A>T) (IVS6DS,A-T,+4); ClinVar=VCV000864024; Zygosity=Homozygous (BCRC=SC81054).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142085; Aromatic L-amino-acid decarboxylase deficiency
DI   ORDO; Orphanet_35708; Aromatic L-amino acid decarboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-030-06
AC   CVCL_QY31
SY   IBMSi004-A
DR   BCRC; SC81056
DR   BCRC; SC81057
DR   hPSCreg; IBMSi004-A
DR   SKIP; SKIP005652
DR   SKIP; SKIP005653
DR   Wikidata; Q54897199
RX   PubMed=29174977;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7470; MT-RNR1; Simple; m.1555A>G; ClinVar=VCV000009628; Zygosity=Unspecified (PubMed=29174977).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29174977
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 15,22
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 24,26
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C148321; Mitochondrially inherited nonsyndromic sensorineural deafness
DI   ORDO; Orphanet_90641; Mitochondrial non-syndromic sensorineural deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-031-05
AC   CVCL_QY32
SY   IBMSi005-A
DR   BCRC; SC81058
DR   BCRC; SC81059
DR   hPSCreg; IBMSi005-A
DR   SKIP; SKIP003051
DR   SKIP; SKIP005654
DR   SKIP; SKIP005655
DR   Wikidata; Q54897200
RX   PubMed=29288969;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7489; MT-TK; Simple; m.8344A>G; ClinVar=VCV000009579; Zygosity=Unspecified (PubMed=29288969).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29288969
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   FGA: 21,22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C84889; Myoclonic epilepsy associated with ragged-red fibers
DI   ORDO; Orphanet_551; MERRF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   IBMS-iPSC-033-02
AC   CVCL_QY33
SY   IBMSi009-A
DR   BCRC; SC81060
DR   BCRC; SC81061
DR   hPSCreg; IBMSi009-A
DR   SKIP; SKIP003162
DR   SKIP; SKIP005656
DR   SKIP; SKIP005657
DR   Wikidata; Q54897201
RX   PubMed=29414417;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Ser182Gly (c.544A>G); ClinVar=VCV000430337; Zygosity=Unspecified (PubMed=29414417).
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Leu223Glufs*76 (c.667_679delCTGGAGCGGGACG); Zygosity=Unspecified (PubMed=29414417).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29414417
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 16,21
ST   D19S433: 13,16.2
ST   D21S11: 29,31.2
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 22
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-036-01
AC   CVCL_UD67
SY   IBMSi010-A
DR   hPSCreg; IBMSi010-A
DR   Wikidata; Q94313042
RX   PubMed=30316039;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Val37Ile (c.109G>A); ClinVar=VCV000017023; Zygosity=Heterozygous (PubMed=30316039).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   IBMS-iPSC-042-01
AC   CVCL_UK19
SY   IBMSi011-A
DR   BCRC; SC81107
DR   BioSamples; SAMEA5728487
DR   hPSCreg; IBMSi011-A
DR   SKIP; SKIP005540
DR   SKIP; SKIP005711
DR   Wikidata; Q94313048
RX   PubMed=31029016;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile1371Val (c.4111A>G); ClinVar=VCV000039176; Zygosity=Heterozygous (PubMed=31029016).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31029016
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 31.2,32
ST   D2S1338: 22,24
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 23
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   IBMS-iPSC-043-05
AC   CVCL_UK20
SY   IBMSi012-A
DR   BCRC; SC81108
DR   hPSCreg; IBMSi012-A
DR   SKIP; SKIP005712
DR   Wikidata; Q94313052
RX   PubMed=30978640;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Asp331Tyr (c.991G>T); ClinVar=VCV000030371; Zygosity=Homozygous (PubMed=30978640).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201519; Parkinson disease 14, autosomal recessive
DI   ORDO; Orphanet_199351; Adult-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   IBMS-iPSC-044-05
AC   CVCL_XD51
DR   BCRC; SC81109
DR   SKIP; SKIP005713
DR   Wikidata; Q94313055
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C71060; Short QT syndrome
DI   ORDO; Orphanet_51083; Familial short QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   IBMS-iPSC-045-02
AC   CVCL_XD52
DR   BCRC; SC81110
DR   SKIP; SKIP005714
DR   Wikidata; Q94313060
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Arg2639Gln (c.7916G>A); ClinVar=VCV000163287; Zygosity=Unspecified (BCRC=SC81110).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C71060; Short QT syndrome
DI   ORDO; Orphanet_51083; Familial short QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-046-06
AC   CVCL_XD53
DR   BCRC; SC81111
DR   SKIP; SKIP005715
DR   Wikidata; Q94313066
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:6239; KCND3; Simple; p.Phe227del (c.677_679TCT[1]) (c.679_681delTTC); ClinVar=VCV000066061; Zygosity=Unspecified (BCRC=SC81111).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163756; Spinocerebellar ataxia type 19/22
DI   ORDO; Orphanet_98772; Spinocerebellar ataxia type 19/22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-047-03
AC   CVCL_XD54
DR   BCRC; SC81112
DR   SKIP; SKIP005716
DR   Wikidata; Q94313072
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:6239; KCND3; Simple; p.Phe227del (c.677_679TCT[1]) (c.679_681delTTC); ClinVar=VCV000066061; Zygosity=Unspecified (BCRC=SC81112).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163756; Spinocerebellar ataxia type 19/22
DI   ORDO; Orphanet_98772; Spinocerebellar ataxia type 19/22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   IBMS-iPSC-048-05
AC   CVCL_YC08
SY   IBMSi019-A
DR   hPSCreg; IBMSi019-A
DR   SKIP; SKIP005734
DR   Wikidata; Q94313075
RX   PubMed=32151952;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=32151952).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   IBMS-iPSC-050-04
AC   CVCL_A9WA
DR   BCRC; SC81128
DR   Wikidata; Q102114184
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WB ! IBMS-iPSC-050-05
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-050-05
AC   CVCL_A9WB
DR   BCRC; SC81129
DR   Wikidata; Q102114185
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WA ! IBMS-iPSC-050-04
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-051-02
AC   CVCL_A9WC
DR   BCRC; SC81130
DR   Wikidata; Q102114186
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WD ! IBMS-iPSC-051-05
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-051-05
AC   CVCL_A9WD
DR   BCRC; SC81131
DR   Wikidata; Q102114188
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WC ! IBMS-iPSC-051-02
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-052-01
AC   CVCL_A9WE
DR   BCRC; SC81132
DR   Wikidata; Q102114190
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-053-02
AC   CVCL_A9WF
DR   BCRC; SC81133
DR   Wikidata; Q102114191
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WG ! IBMS-iPSC-053-05
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-053-05
AC   CVCL_A9WG
DR   BCRC; SC81134
DR   Wikidata; Q102114192
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9WF ! IBMS-iPSC-053-02
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IBMS-iPSC-057-05
AC   CVCL_A1MA
SY   IBMSi022-A
DR   BioSamples; SAMEA7438821
DR   hPSCreg; IBMSi022-A
DR   SKIP; SKIP005875
DR   Wikidata; Q102114193
RX   PubMed=33070102;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:12585; UQCRC1; Simple; p.Tyr314Ser (c.941A>C); ClinVar=VCV001064663; Zygosity=Heterozygous (PubMed=33070102).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201521; Parkinsonism with polyneuropathy
DI   ORDO; Orphanet_611237; Parkinsonism with polyneuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   IBMS-iPSC-060-04
AC   CVCL_A1MB
SY   IBMSi024-A
DR   BioSamples; SAMEA7440417
DR   hPSCreg; IBMSi024-A
DR   Wikidata; Q102114194
RX   PubMed=33068888;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:25443; C19orf12; Simple; p.Pro92Thrfs*9 (c.273_274insA); Zygosity=Heterozygous (PubMed=33068888).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175707; Neurodegeneration with brain iron accumulation 4
DI   ORDO; Orphanet_289560; Mitochondrial membrane protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   IBMS-iPSC-063-06
AC   CVCL_A1MC
SY   IBMSi021-A
DR   BCRC; SC81137
DR   BioSamples; SAMEA7332552
DR   hPSCreg; IBMSi021-A
DR   Wikidata; Q102114195
RX   PubMed=34364070;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:967; BBS2; Simple; c.534+1G>T; ClinVar=VCV000553927; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=34364070).
CC   Misspelling: IBMS-iPSC-063-05; Note=In Cellosaurus releases 36 and 37.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   IBMS-iPSC-068-02
AC   CVCL_A5GY
DR   BCRC; SC81135
DR   Wikidata; Q107115413
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   IBMS-iPSC-069-05
AC   CVCL_B7V3
DR   BCRC; SC81136
DR   Wikidata; Q112929831
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   IBMS-iPSC-070-02
AC   CVCL_A4YW
SY   IBMSi025-A
DR   BioSamples; SAMEA7873754
DR   hPSCreg; IBMSi025-A
DR   Wikidata; Q107115414
RX   PubMed=33517123;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple; p.Leu111Gln (c.332T>A); ClinVar=VCV000193506; Zygosity=Heterozygous (PubMed=33517123).
CC   Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple; c.1413-9_-14dupTTCCCC; Zygosity=Heterozygous (PubMed=33517123).
CC   Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple; p.Asn500Ile (c.1499A>T); dbSNP=rs759332123; Zygosity=Heterozygous (PubMed=33517123).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8967; Brain iron accumulation type I syndrome
DI   ORDO; Orphanet_216873; Atypical pantothenate kinase-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   IBMS-iPSC-073-01
AC   CVCL_C7TR
SY   IBMSi027-A
DR   BioSamples; SAMEA112445290
DR   hPSCreg; IBMSi027-A
DR   Wikidata; Q117704513
RX   PubMed=36933359;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Ala684Val (c.2051C>T); ClinVar=VCV000030556; Zygosity=Heterozygous (PubMed=36933359).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   IBMS-iPSC-074-01
AC   CVCL_C0HC
SY   IBMSi026-A
DR   hPSCreg; IBMSi026-A
DR   Wikidata; Q112929832
RX   PubMed=36075118;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Cys490Arg (c.1468T>C); Zygosity=Heterozygous (PubMed=36075118).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169000; Optic atrophy 1
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   IBMS-iPSC-075-01
AC   CVCL_B9US
DR   BCRC; SC81142
DR   Wikidata; Q112929833
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   IBMS-iPSC-077-01
AC   CVCL_C1XX
SY   NTUHi002-A
DR   BioSamples; SAMEA110190487
DR   hPSCreg; NTUHi002-A
DR   Wikidata; Q114311692
RX   PubMed=35868289;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:2295; CP; Simple; c.607+1delG; ClinVar=VCV000426814; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=35868289).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C189281; Aceruloplasminemia
DI   ORDO; Orphanet_48818; Aceruloplasminemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IBMS-iPSC-082-01
AC   CVCL_D3FE
DR   BCRC; SC81144
DR   Wikidata; Q127382304
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8967; Brain iron accumulation type I syndrome
DI   ORDO; Orphanet_216873; Atypical pantothenate kinase-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   IBMS-iPSC-084-01
AC   CVCL_D3FF
DR   BCRC; SC81145
DR   Wikidata; Q127382305
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8967; Brain iron accumulation type I syndrome
DI   ORDO; Orphanet_216873; Atypical pantothenate kinase-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   IBMS-iPSC-089
AC   CVCL_D6NY
SY   NTUHi004-A
DR   BioSamples; SAMEA114482263
DR   hPSCreg; NTUHi004-A
RX   PubMed=38458030;
CC   From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:15899; NDUFAF5; Simple; p.Met279Arg (c.836T>G); ClinVar=VCV000225036; Zygosity=Homozygous (PubMed=38458030).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   IBPi001-A
AC   CVCL_VL44
SY   HPrF iPSCs 20A
DR   BioSamples; SAMEA4867770
DR   hPSCreg; IBPi001-A
DR   Wikidata; Q94313079
RX   PubMed=30776675;
CC   From: Institute of Biophysics of the Czech Academy of Sciences; Brno; Czech Republic.
CC   Derived from site: In situ; Fetal prostate; UBERON=UBERON_0003820.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18-24FW
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   IBPi002-A
AC   CVCL_VL45
SY   P71 iPSCs 1
DR   BioSamples; SAMEA4867771
DR   hPSCreg; IBPi002-A
DR   Wikidata; Q94313086
RX   PubMed=30481741;
CC   From: Institute of Biophysics of the Czech Academy of Sciences; Brno; Czech Republic.
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   iBSC1
AC   CVCL_E7ZK
SY   iBSC; immortalized Bovine Satellite Cells 1
DR   Kerafast; ETU009
RX   PubMed=37146268;
CC   Characteristics: Created by sleeping Beauty transposon-mediated integration of a PuroR-TERT-T2A-CDK4 construct (PubMed=37146268).
CC   Doubling time: 17.4 hours (Note=At early passages), 15.1 hours (Note=At late passages) (PubMed=37146268).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=VGNC; VGNC:111241; Bovine CDK4.
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=VGNC; VGNC:35751; Bovine TERT.
CC   Derived from site: In situ; Muscle, semitendinosus; UBERON=UBERON_0001375.
CC   Cell type: Muscle satellite cell; CL=CL_0000594.
CC   Breed/subspecies: Simmental; VBO=VBO_0000380.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   5W
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IBT-EP 1
AC   CVCL_WK70
SY   Institut fur Biologie II, universitat Tubingen-Ephedrus Plagiator 1
DR   Wikidata; Q94313091
RX   CelloPub=CLPUB00493;
CC   Group: Insect cell line.
OX   NCBI_TaxID=55914; ! Ephedrus plagiator (Aphid parasite)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IBT-EP 2
AC   CVCL_WK36
SY   Institut fur Biologie II, universitat Tubingen-Ephedrus Plagiator 2; BT-EP
DR   Wikidata; Q94313095
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00493;
CC   Group: Insect cell line.
OX   NCBI_TaxID=55914; ! Ephedrus plagiator (Aphid parasite)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IBTCMi001-A
AC   CVCL_A8LN
SY   NDC1; NDC-1
DR   BioSamples; SAMEA8325242
DR   hPSCreg; IBTCMi001-A
DR   Wikidata; Q108820525
RX   DOI=10.1016/j.nantod.2023.102051;
CC   From: Institute of Basic Theory for Chinese Medicine; Beijing; China.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   IBTCMi002-A
AC   CVCL_C1PZ
SY   NDC2
DR   BioSamples; SAMEA14096002
DR   hPSCreg; IBTCMi002-A
DR   Wikidata; Q114311693
RX   DOI=10.1016/j.nantod.2023.102051;
RX   PubMed=37421767;
CC   From: Institute of Basic Theory for Chinese Medicine; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (DOI=10.1016/j.nantod.2023.102051).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IBTCMi003-A
AC   CVCL_C1Q0
SY   AD1
DR   BioSamples; SAMEA14096092
DR   hPSCreg; IBTCMi003-A
DR   Wikidata; Q114311694
CC   From: Institute of Basic Theory for Chinese Medicine; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (hPSCreg=IBTCMi003-A).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IBTCMi004-A
AC   CVCL_C1Q1
SY   AD2
DR   BioSamples; SAMEA14096094
DR   hPSCreg; IBTCMi004-A
DR   Wikidata; Q114311695
RX   DOI=10.1016/j.nantod.2023.102051;
CC   From: Institute of Basic Theory for Chinese Medicine; Beijing; China.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IBTCMi005-A
AC   CVCL_C1Q2
SY   AD3
DR   BioSamples; SAMEA14096097
DR   hPSCreg; IBTCMi005-A
DR   Wikidata; Q114311696
RX   DOI=10.1016/j.nantod.2023.102051;
CC   From: Institute of Basic Theory for Chinese Medicine; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (DOI=10.1016/j.nantod.2023.102051).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IBTCMi006-A
AC   CVCL_E4D6
SY   ACNE1
DR   BioSamples; SAMEA115474369
DR   hPSCreg; IBTCMi006-A
CC   From: Institute of Basic Theory for Chinese Medicine; Beijing; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27195; Acne
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IBTCMi007-A
AC   CVCL_E4D7
SY   ACNE2
DR   BioSamples; SAMEA115474371
DR   hPSCreg; IBTCMi007-A
CC   From: Institute of Basic Theory for Chinese Medicine; Beijing; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27195; Acne
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IBW4
AC   CVCL_F525
SY   IBw4; GM03104; GM3104A; GM03104B
DR   CLO; CLO_0013566
DR   Coriell; GM03104
DR   Wikidata; Q54897202
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   IBW9
AC   CVCL_E706
SY   IBW 9; IBw9; GM08065; GM08065A
DR   CLO; CLO_0010028
DR   Coriell; GM08065
DR   dbMHC; 48902
DR   ECACC; 85052104
DR   IHW; IHW09049
DR   IPD-IMGT/HLA; 11634
DR   Wikidata; Q54897203
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   HLA typing: A*33:01:01:01; B*14:02:01:01; C*08:02:01:01; DPA1*02; DPB1*01:01:02; DQA1*02:01; DQB1*02:02:01; DRB1*07:01:01 (IPD-IMGT/HLA=11634).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Discontinued: Coriell; GM08065; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   iC(3)-1
AC   CVCL_M689
SY   iC3-1; Induced ChorioCarcinoma Cell-1
DR   Wikidata; Q54897211
RX   PubMed=21787741;
RX   PubMed=23199791;
RX   PubMed=24424471;
CC   Characteristics: Transduced with a pMX-HRASV12-IRES-EGFP construct (PubMed=21787741).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Omics: Glycomics; N-glycan profiling; Lectin array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0D7 ! HTR8/SVneo/HRASV12
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   IC-01
AC   CVCL_L845
SY   O1
DR   ECACC; 93042001
DR   Wikidata; Q54897204
RX   PubMed=6786942;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   IC-04
AC   CVCL_Z932
SY   O4
DR   ECACC; 93042002
DR   Wikidata; Q54897205
RX   PubMed=6786942;
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: ECACC; 93042002; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 5
//
ID   IC-07
AC   CVCL_L846
DR   ECACC; 93062301
DR   Wikidata; Q54897206
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IC-08
AC   CVCL_L847
DR   ECACC; 93062302
DR   Wikidata; Q54897207
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IC-09
AC   CVCL_L848
DR   ECACC; 93062303
DR   Wikidata; Q54897208
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IC-2
AC   CVCL_0341
SY   IC2
DR   CLO; CLO_0050771
DR   MCCL; MCC:0000237
DR   RCB; RCB0102
DR   Wikidata; Q54897209
RX   PubMed=2580015;
RX   PubMed=3079807;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=IC-2
CC   Characteristics: CSF2 and IL3 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   IC-21
AC   CVCL_3726
SY   IC21; TM; Transformed macrophage
DR   BTO; BTO_0000806
DR   CLO; CLO_0004334
DR   CLDB; cl1797
DR   ATCC; TIB-186
DR   Wikidata; Q54897210
RX   PubMed=1167563;
RX   PubMed=1254971;
RX   PubMed=4357034;
WW   Info; -; -; https://web.archive.org/web/20060917025603/http://genepath.med.harvard.edu/bdlab/labprotocols/ic21.html
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-tib-186
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   IC1.11B4.6
AC   CVCL_D1FK
DR   Wikidata; Q127382307
RX   Patent=US5041381;
RX   Patent=US5863537;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9550.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   IC441
AC   CVCL_EP78
DR   Wikidata; Q54897212
RX   PubMed=14647443;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Leu1404Arg (c.4211T>G); ClinVar=VCV000491071; Zygosity=Unspecified (PubMed=14647443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   IC5-2A6
AC   CVCL_C5LJ
DR   Wikidata; Q116049554
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   IC5-3A4
AC   CVCL_C5LK
DR   ABCD; ABCD_AE207
DR   Wikidata; Q116049555
RX   PubMed=1908881;
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   IC5-4D1
AC   CVCL_C5LL
SY   HIC5-4D1
DR   ABCD; ABCD_AE262
DR   Wikidata; Q116049556
RX   PubMed=2427335;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   IC5-4F8
AC   CVCL_C5LM
DR   Wikidata; Q116049557
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   IC52
AC   CVCL_EP79
DR   Wikidata; Q54897213
RX   PubMed=14647443;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys56Arg (c.167A>G); ClinVar=VCV000054324; Zygosity=Unspecified (PubMed=14647443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   IC692
AC   CVCL_EP80
DR   Wikidata; Q54897215
RX   PubMed=14647443;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Asp1692His (c.5074G>C); ClinVar=VCV000037633; Zygosity=Unspecified (PubMed=14647443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   IC954
AC   CVCL_EP81
DR   Wikidata; Q54897216
RX   PubMed=14647443;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu575Lys (c.1723G>A); ClinVar=VCV000054334; Zygosity=Unspecified (PubMed=14647443).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ICANi001-A
AC   CVCL_A5RE
SY   ICANi001-P; CDGEN1.16
DR   BioSamples; SAMEA10202562
DR   hPSCreg; ICANi001-A
DR   Wikidata; Q107115415
RX   PubMed=33610018;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple_edited; p.Arg403Leu (c.1208G>T); ClinVar=VCV000014101; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33610018).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   ICANi001-A-1
AC   CVCL_A5RF
SY   ICANi001-P-40; CDGEN1.16.40.5
DR   BioSamples; SAMEA10203005
DR   hPSCreg; ICANi001-A-1
DR   Wikidata; Q107115416
RX   PubMed=33610018;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple_corrected; p.Arg403Leu (c.1208G>T); ClinVar=VCV000014101; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33610018).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5RE ! ICANi001-A
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   ICANi002-A
AC   CVCL_B5EX
SY   ICAN-403.3; ICAN403.3
DR   BioSamples; SAMEA10203006
DR   hPSCreg; ICANi002-A
DR   Wikidata; Q110432901
RX   PubMed=34883448;
RX   PubMed=35093717;
RX   PubMed=38382214;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38382214
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 17,18
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   Penta D: 9,11
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
ID   ICANi002-A-1
AC   CVCL_B5EY
SY   ICAN-FLNC42.1
DR   BioSamples; SAMEA10203007
DR   hPSCreg; ICANi002-A-1
DR   Wikidata; Q110432902
RX   PubMed=34883448;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Unexplicit_edited; Ex42del; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34883448).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EX ! ICANi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ICANi002-A-2
AC   CVCL_B5EZ
SY   SCN5A-clone 5
DR   BioSamples; SAMEA11293803
DR   hPSCreg; ICANi002-A-2
DR   Wikidata; Q110432903
RX   PubMed=35093717;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10593; SCN5A (Note=1 of 2 alleles).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EX ! ICANi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   ICANi002-A-3
AC   CVCL_D6M9
SY   V468M-C34; ICAN-BAG3-V468MC34
DR   BioSamples; SAMEA114328982
DR   hPSCreg; ICANi002-A-3
DR   Wikidata; Q127382308
RX   PubMed=38183888;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple_edited; p.Val468Met (c.1402G>A); ClinVar=VCV001771846; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38183888).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192082; Dilated cardiomyopathy-1HH
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EX ! ICANi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ICANi002-A-4
AC   CVCL_D6MA
SY   M468M-C19; ICAN_BAG3_M468MC19
DR   BioSamples; SAMEA114332063
DR   hPSCreg; ICANi002-A-4
DR   Wikidata; Q127382309
RX   PubMed=38183888;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple_edited; p.Val468Met (c.1402G>A); ClinVar=VCV001771846; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38183888).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192082; Dilated cardiomyopathy-1HH
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EX ! ICANi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ICANi002-A-5
AC   CVCL_D6MB
SY   PKP2-H695VfsX5; ICAN-PKP2-H695-W11
DR   BioSamples; SAMEA114772233
DR   hPSCreg; ICANi002-A-5
DR   Wikidata; Q127382311
RX   PubMed=38382214;
CC   From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple_edited; p.His695Valfs*5 (c.2083_2089delCATGTTG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38382214).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38382214
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 17,18
ST   D21S11: 29,30
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   Penta D: 9,11
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5EX ! ICANi002-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ICB-104
AC   CVCL_W328
SY   ICB 104; ICB104
DR   Wikidata; Q54897217
RX   PubMed=11004677;
RX   PubMed=11423975;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 3 fusion (Ex10/Ex6) (PubMed=11423975).
CC   Derived from site: In situ; Knee; UBERON=UBERON_0001465.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   ICB-112
AC   CVCL_1H29
SY   ICB 112
DR   Wikidata; Q54897220
RX   PubMed=7798952;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   iCB5
AC   CVCL_C958
DR   Wikidata; Q54897221
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   ICBD-1
AC   CVCL_L093
DR   Wikidata; Q54897222
RX   CelloPub=CLPUB00275;
RX   PubMed=9468580;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: ~31.5 hours (Note=At 30th passage) (PubMed=9468580).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   ICC-1
AC   CVCL_C6N3
DR   Wikidata; Q116049558
RX   PubMed=29913454;
RX   PubMed=35640676;
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 3
//
ID   ICC-2
AC   CVCL_C6N4
DR   Wikidata; Q116049559
RX   PubMed=29913454;
RX   PubMed=35640676;
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 3
//
ID   ICC-X1
AC   CVCL_C2UP
DR   CCRID; 4201PAT-CCTCC02049
DR   Wikidata; Q123032653
RX   Patent=CN114606194B;
RX   PubMed=36578029;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202258.
CC   Population: Chinese.
CC   Doubling time: ~48 hours (Patent=CN114606194B; PubMed=36578029).
CC   Karyotypic information: Hypotriploid (PubMed=36578029).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): Patent=CN114606194B; PubMed=36578029
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 22,24
ST   D2S441: 12
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D6S1043: 10,12
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 5,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   ICC-X3
AC   CVCL_C8PY
DR   CCRID; 4201PAT-CCTCC02051
DR   Wikidata; Q123032654
RX   Patent=CN114717191B;
RX   PubMed=36662372;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202260.
CC   Population: Chinese.
CC   Doubling time: ~36 hours (Patent=CN114717191B; PubMed=36662372).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Heterozygous (PubMed=36662372).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): Patent=CN114717191B; PubMed=36662372
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 21
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 11,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 15,21
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,20
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ICC1
AC   CVCL_VV26
DR   Wikidata; Q94313309
RX   PubMed=27231123;
RX   PubMed=35640676;
CC   Doubling time: 5 days (Direct_author_submission).
CC   Miscellaneous: Doubling time and age/sex of donor from personal communication of Bardeesy, Nabeel M.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   ICC10
AC   CVCL_A1VB
DR   cancercelllines; CVCL_A1VB
DR   DepMap; ACH-001834
DR   Wikidata; Q105509582
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:8923; PHGDH; Name(s)=FGFR2-PHGDH (DepMap=ACH-001834; PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln219Ter (c.655C>T); ClinVar=VCV002630888; Zygosity=Unspecified (DepMap=ACH-001834; PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Cysfs*9 (c.102delC); ClinVar=VCV001072141; Zygosity=Unspecified (DepMap=ACH-001834; PubMed=39026794).
ST   Source(s): DepMap=ACH-001834
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 31.2
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 8,13
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1UZ ! ICC10-6
OI   CVCL_A1VA ! ICC10-8
OI   CVCL_E4KQ ! ICC11
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   ICC10-6
AC   CVCL_A1UZ
SY   ICC106
DR   cancercelllines; CVCL_A1UZ
DR   Cell_Model_Passport; SIDM01975
DR   DepMap; ACH-001835
DR   Wikidata; Q105509585
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:8923; PHGDH; Name(s)=FGFR2-PHGDH (DepMap=ACH-001835; PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln219Ter (c.655C>T); ClinVar=VCV002630888; Zygosity=Unspecified (DepMap=ACH-001835; PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Cysfs*9 (c.102delC); ClinVar=VCV001072141; Zygosity=Unspecified (DepMap=ACH-001835; PubMed=39026794).
ST   Source(s): DepMap=ACH-001835
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 31,31.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,13
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 8,9
ST   Penta E: 8,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1VB ! ICC10
OI   CVCL_A1VA ! ICC10-8
OI   CVCL_E4KQ ! ICC11
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   ICC10-8
AC   CVCL_A1VA
SY   ICC108
DR   cancercelllines; CVCL_A1VA
DR   Cell_Model_Passport; SIDM01976
DR   DepMap; ACH-001836
DR   Wikidata; Q105509588
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:8923; PHGDH; Name(s)=FGFR2-PHGDH (DepMap=ACH-001836; PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln219Ter (c.655C>T); ClinVar=VCV002630888; Zygosity=Unspecified (DepMap=ACH-001836; PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Cysfs*9 (c.102delC); ClinVar=VCV001072141; Zygosity=Unspecified (DepMap=ACH-001836; PubMed=39026794).
ST   Source(s): DepMap=ACH-001836
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 31,31.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,13
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 8,9
ST   Penta E: 8,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1VB ! ICC10
OI   CVCL_A1UZ ! ICC10-6
OI   CVCL_E4KQ ! ICC11
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   ICC11
AC   CVCL_E4KQ
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:8923; PHGDH; Name(s)=FGFR2-PHGDH (PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln219Ter (c.655C>T); ClinVar=VCV002630888; Zygosity=Unspecified (PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Cysfs*9 (c.102delC); ClinVar=VCV001072141; Zygosity=Unspecified (PubMed=39026794).
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1VB ! ICC10
OI   CVCL_A1UZ ! ICC10-6
OI   CVCL_A1VA ! ICC10-8
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ICC12
AC   CVCL_A1VC
DR   cancercelllines; CVCL_A1VC
DR   Cell_Model_Passport; SIDM01981
DR   DepMap; ACH-001838
DR   Wikidata; Q105509591
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001838).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leu (c.569C>T); ClinVar=VCV000418517; Zygosity=Unspecified (DepMap=ACH-001838).
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): DepMap=ACH-001838
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 9
ST   D18S51: 12,18,19
ST   D21S11: 31.2
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 12,14
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   ICC13-7
AC   CVCL_A1VD
SY   ICC137
DR   cancercelllines; CVCL_A1VD
DR   DepMap; ACH-001839
DR   Wikidata; Q105509595
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:17142; OPTN; Name(s)=FGFR2-OPTN; Note=In frame. FGFR2 exon 17 fused to OPTN exon 9 (PubMed=31109923).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001839
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 32.2
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 5,7
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   ICC14
AC   CVCL_E4KI
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC16
AC   CVCL_E4KJ
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC17
AC   CVCL_E4KK
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC18
AC   CVCL_E4KL
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Unspecified (PubMed=39026794).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC19
AC   CVCL_E4KR
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC2
AC   CVCL_VV27
DR   cancercelllines; CVCL_VV27
DR   Cell_Model_Passport; SIDM01804
DR   DepMap; ACH-001842
DR   Wikidata; Q94313313
RX   PubMed=27231123;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 3 days (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Doubling time and age/sex of donor from personal communication of Bardeesy, Nabeel M.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001842
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 21
ST   D21S11: 31,31.2
ST   D3S1358: 14
ST   D5S818: 12,14
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 10,13
ST   Penta E: 14
ST   TH01: 8,9
ST   TPOX: 9,12
ST   vWA: 14
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 14
//
ID   ICC20
AC   CVCL_E4KS
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=39026794).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC21
AC   CVCL_E4KT
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:1555; CBX5; Name(s)=FGFR2-CBX5 (PubMed=39026794).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC24
AC   CVCL_E4KU
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:17327; WAC; Name(s)=FGFR2-WAC (PubMed=39026794).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC25
AC   CVCL_E4KV
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:344; AHCYL1 + HGNC; HGNC:3689; FGFR2; Name(s)=FGFR2-AHCYL1 (PubMed=39026794).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=39026794).
CC   Derived from site: Metastatic; Bone, scapula; UBERON=UBERON_0006849.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC26
AC   CVCL_E4KW
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC28
AC   CVCL_E4KX
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: North African.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC4
AC   CVCL_A1VI
DR   cancercelllines; CVCL_A1VI
DR   DepMap; ACH-001844
DR   Wikidata; Q105509603
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu137Gln (c.410T>A); Zygosity=Unspecified (DepMap=ACH-001844).
CC   Derived from site: Metastatic; Bone, spine; UBERON=UBERON_0001130.
ST   Source(s): DepMap=ACH-001844
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 27,31.2
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 10,11
ST   Penta E: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   ICC5
AC   CVCL_VV28
DR   cancercelllines; CVCL_VV28
DR   Cell_Model_Passport; SIDM01803
DR   DepMap; ACH-001845
DR   Wikidata; Q94313317
RX   PubMed=27231123;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 5 days (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Val (c.394_395CG>GT); Zygosity=Unspecified (PubMed=27231123; DepMap=ACH-001845).
CC   Miscellaneous: Doubling time and age/sex of donor from personal communication of Bardeesy, Nabeel M.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001845
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 13
ST   D18S51: 15,17
ST   D21S11: 28,32.2
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 23,25
ST   Penta D: 10,11
ST   Penta E: 9,11
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 21
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   ICC6
AC   CVCL_A1VF
DR   cancercelllines; CVCL_A1VF
DR   DepMap; ACH-001846
DR   Wikidata; Q105509606
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Thr (c.395A>C); ClinVar=VCV000376627; Zygosity=Unspecified (DepMap=ACH-001846).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Unspecified (DepMap=ACH-001846).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001846
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 15
ST   Penta E: 12,19
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,20
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   ICC7
AC   CVCL_E4KY
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Caucasian.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ICC8
AC   CVCL_A1VG
DR   cancercelllines; CVCL_A1VG
DR   Cell_Model_Passport; SIDM01978
DR   DepMap; ACH-001848
DR   Wikidata; Q105509609
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001848).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001848
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12,14
ST   D18S51: 15
ST   D21S11: 28,30
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 7,16
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   ICC9
AC   CVCL_A1VH
DR   cancercelllines; CVCL_A1VH
DR   Cell_Model_Passport; SIDM01980
DR   DepMap; ACH-001849
DR   Wikidata; Q105509612
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (DepMap=ACH-001849).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001849
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,13
ST   D16S539: 12,13
ST   D18S51: 18
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 11
ST   FGA: 19,24
ST   Penta D: 13
ST   Penta E: 15
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   ICCSICi001-A
AC   CVCL_UN07
SY   IC-PD1-F-iPS-4F-1
DR   BioSamples; SAMEA6542865
DR   hPSCreg; ICCSICi001-A
DR   Wikidata; Q94313321
RX   PubMed=31203165;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS_IC-PD1-F-iPS-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos-IC-PD1-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=31203165).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   ICCSICi002-A
AC   CVCL_UN08
SY   IC-PD2-F-iPS-4F-1
DR   hPSCreg; ICCSICi002-A
DR   Wikidata; Q94313327
RX   PubMed=31203165;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS_IC-PD2-F-iPS-4F-1-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos-IC-PD2-F-iPS-4F-1-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=31203165).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D21S11: 29,30
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   ICCSICi003-A
AC   CVCL_UN09
SY   IC-PD3-F-iPS-4F-1
DR   hPSCreg; ICCSICi003-A
DR   Wikidata; Q94313331
RX   PubMed=31203165;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS_IC-PD3-F-iPS-4F-1-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos-IC-PD3-F-iPS-4F-1-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31203165).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D21S11: 29,31.2
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 14
//
ID   ICCSICi004-A
AC   CVCL_UN10
SY   IC-PD4-F-iPS-4F-1
DR   hPSCreg; ICCSICi004-A
DR   Wikidata; Q94313335
RX   PubMed=31203165;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS_IC-PD4-F-iPS-4F-1-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos-IC-PD4-F-iPS-4F-1-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31203165).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D21S11: 29,33.2
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 14
//
ID   ICCSICi005-A
AC   CVCL_WP95
SY   IC-PD5-F-iPS-4F-1
DR   hPSCreg; ICCSICi005-A
DR   Wikidata; Q94313339
RX   PubMed=31539859;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS_IC-PD5-F-iPS-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520IC-PD5-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31539859).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D21S11: 28,32.2
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 15,19
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 13
//
ID   ICCSICi006-A
AC   CVCL_UN03
SY   IC-AD6-F-iPS-4F-1
DR   hPSCreg; ICCSICi006-A
DR   Wikidata; Q94313345
RX   PubMed=31627126;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+de+Dep%C3%B3sito+IC-AD6-F-iPS-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo%2520IC-AD6-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Gly206Asp (c.617G>A); ClinVar=VCV000807473; Zygosity=Heterozygous (PubMed=31627126).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D21S11: 30,31.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   ICCSICi007-A
AC   CVCL_UN02
SY   IC-AD2-F-iPS-4F-1
DR   hPSCreg; ICCSICi007-A
DR   Wikidata; Q94313350
RX   PubMed=31698192;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+de+Depo%CC%81sito+L%C3%ADnea+IC-AD2-F-iPS-4F-1-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520IC-AD2-F-iPS-4F-1-v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=31698192).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D21S11: 27,30
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   ICCSICi008-A
AC   CVCL_VR76
SY   IC-AD1-F-iPS-4F-1; IC8-APOE 4/4
DR   hPSCreg; ICCSICi008-A
DR   Wikidata; Q94313355
RX   PubMed=31401456;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+de+Depo%CC%81sito+IC-AD1-F-iPS-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520IC-AD1-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=31401456).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   ICCSICi009-A
AC   CVCL_WP97
SY   IC-AD3-F-iPS-4F-1; IC9-APOE 3/3
DR   hPSCreg; ICCSICi009-A
DR   Wikidata; Q94313358
RX   PubMed=31401456;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+de+Dep%C3%B3sito+IC-AD3-F-iPS-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo%2520IC-AD3-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D21S11: 30,31
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 17,19
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   ICCSICi010-A
AC   CVCL_WP96
SY   IC-AD4-F-iPS-4F-1; IC10-APOE 3/3
DR   hPSCreg; ICCSICi010-A
DR   Wikidata; Q94313362
RX   PubMed=31401456;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+de+Dep%C3%B3sito+IC-AD4-F-iPS-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520IC-AD4-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 30,33.2
ST   D5S818: 11,13
ST   D7S820: 9
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   ICCSICi011-A
AC   CVCL_VR77
SY   IC-AD5-F-iPS-4F-1; IC11-APOE 3/3
DR   hPSCreg; ICCSICi011-A
DR   Wikidata; Q94313364
RX   PubMed=31401456;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+de+Depo%CC%81sito+IC-AD5-F-iPS-4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520IC-AD5-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   ICCSICi012-A
AC   CVCL_UN04
SY   IC-Ctrl1-F-iPS-4F-1
DR   hPSCreg; ICCSICi012-A
DR   Wikidata; Q94313368
RX   PubMed=31794941;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+de+Dep%C3%B3sito+L%C3%ADnea+IC-Ctrl1-F-iPS-4F-1-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos%2520IC-Ctrl1-F-iPS-4F-1-v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D21S11: 30,33.2
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   ICCSICi013-A
AC   CVCL_UN05
SY   IC-Ctrl2-F-iPS-4F-1
DR   hPSCreg; ICCSICi013-A
DR   Wikidata; Q94313372
RX   PubMed=31794941;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento-Deposito_lineas_iPS_IC-Ctrl2-F-iPS-4F-1-v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo-IC-Ctrl2-F-iPS-4F-1-v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   ICCSICi014-A
AC   CVCL_UN06
SY   IC-Ctrl3-F-iPS-4F-1; Ctrl3-F-iPS-4F-1
DR   hPSCreg; ICCSICi014-A
DR   Wikidata; Q94313375
RX   PubMed=31794941;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS_Ctrl3-F-iPS-4F-1_%282%29.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_IC-Ctrl3-F-iPS-4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto Cajal; Madrid; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D21S11: 28,30.2
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   ICF
AC   CVCL_M423
SY   Indian Catfish Fin
DR   NRFC; NRFC022
DR   Wikidata; Q54897223
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=21401643;
WW   Provider; AAHL; -; https://aahl.res.in/catfish-clarius-batrachus-fin-icf-cell-line/
WW   Provider; NRFC; NRFC022; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC022.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   iCFB46
AC   CVCL_C1Y3
SY   iCFB subclone 46
DR   GEO; GSM702137
DR   GEO; GSM702138
DR   Wikidata; Q114311697
RX   PubMed=25889179;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y4 ! iCFB50
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   iCFB50
AC   CVCL_C1Y4
SY   iCFB subclone 50
DR   GEO; GSM702139
DR   GEO; GSM702140
DR   Wikidata; Q114311698
RX   PubMed=25889179;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y3 ! iCFB46
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   ICG
AC   CVCL_1G91
SY   Indian Catla Gill
DR   NRFC; NRFC021
DR   Wikidata; Q54897224
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=23237299;
RX   PubMed=25052522;
WW   Provider; AAHL; -; https://aahl.res.in/catla-catla-catla-heart-sich-brain-cb-gill-icg-and-eye-sice-cell-lines/
WW   Provider; NRFC; NRFC021; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC021.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   ICGi002-A
AC   CVCL_YK90
SY   DMD1_1
DR   BioSamples; SAMEA6098718
DR   hPSCreg; ICGi002-A
DR   SKIP; SKIP005821
DR   Wikidata; Q94313397
RX   PubMed=32777771;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.2950-1G>C; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=32777771).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YK91 ! ICGi002-B
OI   CVCL_YK92 ! ICGi002-C
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi002-B
AC   CVCL_YK91
SY   DMD1_4
DR   BioSamples; SAMEA6351049
DR   hPSCreg; ICGi002-B
DR   SKIP; SKIP005818
DR   Wikidata; Q94313401
RX   PubMed=32777771;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.2950-1G>C; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=32777771).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YK90 ! ICGi002-A
OI   CVCL_YK92 ! ICGi002-C
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi002-C
AC   CVCL_YK92
SY   DMD1_11
DR   BioSamples; SAMEA6357839
DR   hPSCreg; ICGi002-C
DR   SKIP; SKIP005819
DR   Wikidata; Q94313404
RX   PubMed=32777771;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.2950-1G>C; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=32777771).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YK90 ! ICGi002-A
OI   CVCL_YK91 ! ICGi002-B
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi003-A
AC   CVCL_ZA26
SY   f3SMA3
DR   BioSamples; SAMEA6877529
DR   hPSCreg; ICGi003-A
DR   Wikidata; Q98126757
RX   PubMed=32795928;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=32795928).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=32795928).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ICGi005-A
AC   CVCL_UF65
SY   iSMA40
DR   BioSamples; SAMEA5100024
DR   hPSCreg; ICGi005-A
DR   Wikidata; Q94313406
RX   DOI=10.23868/gc120584;
RX   PubMed=30660867;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=30660867).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UF66 ! ICGi005-B
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   ICGi005-B
AC   CVCL_UF66
SY   iSMA37
DR   BioSamples; SAMEA5131663
DR   hPSCreg; ICGi005-B
DR   Wikidata; Q94313409
RX   DOI=10.23868/gc120584;
RX   PubMed=30660867;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=30660867).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UF65 ! ICGi005-A
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 12
//
ID   ICGi006-A
AC   CVCL_UF67
SY   m3SMA13
DR   BioSamples; SAMEA5131664
DR   hPSCreg; ICGi006-A
DR   Wikidata; Q94313412
RX   PubMed=30660867;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=30660867).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=30660867).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UF68 ! ICGi006-B
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   ICGi006-B
AC   CVCL_UF68
SY   m3SMA20
DR   BioSamples; SAMEA5131666
DR   hPSCreg; ICGi006-B
DR   Wikidata; Q94313415
RX   PubMed=30660867;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=30660867).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=30660867).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UF67 ! ICGi006-A
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   ICGi007-A
AC   CVCL_UJ80
SY   47Q-3Lf
DR   BioSamples; SAMEA5275258
DR   hPSCreg; ICGi007-A
DR   SKIP; SKIP005533
DR   Wikidata; Q94313418
RX   PubMed=30658253;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[47] (c.52CAG(47)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30658253).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk (personal communication of Grigor'eva, Elena V. to hPSCreg).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   ICGi008-A
AC   CVCL_UJ81
SY   m55Alz-9L
DR   BioSamples; SAMEA5341576
DR   hPSCreg; ICGi008-A
DR   Wikidata; Q94313420
RX   PubMed=30851551;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=30851551).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UJ82 ! ICGi008-B
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   ICGi008-B
AC   CVCL_UJ82
SY   m55Alz-15L
DR   BioSamples; SAMEA5359103
DR   hPSCreg; ICGi008-B
DR   Wikidata; Q94313423
RX   PubMed=30851551;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=30851551).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UJ81 ! ICGi008-A
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   ICGi009-A
AC   CVCL_WP98
SY   iTAF3-17; iTAF3del17
DR   BioSamples; SAMEA5780089
DR   hPSCreg; ICGi009-A
DR   SKIP; SKIP005567
DR   Wikidata; Q94313427
RX   PubMed=31678775;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2176; CNTN6; Unexplicit; Microdeletion; Zygosity=Unspecified; Note=De novo mutation (PubMed=31678775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU28 ! ICGi009-B
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi009-B
AC   CVCL_WU28
AS   CVCL_WP99
SY   iTAF3-37; iTAF3del37; ICGi010-A
DR   BioSamples; SAMEA5843918
DR   BioSamples; SAMEA5859257
DR   hPSCreg; ICGi009-B
DR   SKIP; SKIP005568
DR   Wikidata; Q94313432
RX   PubMed=31678775;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2176; CNTN6; Unexplicit; Microdeletion; Zygosity=Unspecified; Note=De novo mutation (PubMed=31678775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WP98 ! ICGi009-A
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   ICGi013-A
AC   CVCL_WU29
SY   iTAF13-26; iTAF13del26
DR   BioSamples; SAMEA5859254
DR   hPSCreg; ICGi013-A
DR   SKIP; SKIP005570
DR   Wikidata; Q94313435
RX   PubMed=31678775;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2176; CNTN6; Unexplicit; Microdeletion; Zygosity=Unspecified; Note=De novo mutation (PubMed=31678775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU30 ! ICGi013-B
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi013-B
AC   CVCL_WU30
SY   iTAF13-27; iTAF13del27
DR   BioSamples; SAMEA5859256
DR   hPSCreg; ICGi013-B
DR   SKIP; SKIP005569
DR   Wikidata; Q94313439
RX   PubMed=31678775;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2176; CNTN6; Unexplicit; Microdeletion; Zygosity=Unspecified; Note=De novo mutation (PubMed=31678775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU29 ! ICGi013-A
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi014-A
AC   CVCL_XI91
SY   2M_iALS
DR   BioSamples; SAMEA6032304
DR   hPSCreg; ICGi014-A
DR   Wikidata; Q94313442
RX   PubMed=31830646;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Homozygous (PubMed=31830646).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   ICGi015-A
AC   CVCL_XY44
SY   m6.6
DR   BioSamples; SAMEA6098039
DR   hPSCreg; ICGi015-A
DR   SKIP; SKIP005585
DR   Wikidata; Q94313448
RX   PubMed=31733442;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple; p.Pro1172Pro (c.3516G>A) (p.Ala1072Thr, c.3214G>A); ClinVar=VCV000128475; Zygosity=Heterozygous (PubMed=31733442).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ala419Val (c.1256C>T); ClinVar=VCV000039131; Zygosity=Heterozygous (PubMed=31733442).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Met318Leu (c.952A>T); ClinVar=VCV000447942; Zygosity=Heterozygous (PubMed=31733442).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XY45 ! ICGi015-B
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   ICGi015-B
AC   CVCL_XY45
SY   m6.7
DR   BioSamples; SAMEA6098717
DR   hPSCreg; ICGi015-B
DR   SKIP; SKIP005584
DR   Wikidata; Q94313451
RX   PubMed=31733442;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple; p.Pro1172Pro (c.3516G>A) (p.Ala1072Thr, c.3214G>A); ClinVar=VCV000128475; Zygosity=Heterozygous (PubMed=31733442).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ala419Val (c.1256C>T); ClinVar=VCV000039131; Zygosity=Heterozygous (PubMed=31733442).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Met318Leu (c.952A>T); ClinVar=VCV000447942; Zygosity=Heterozygous (PubMed=31733442).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XY44 ! ICGi015-A
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   ICGi016-A
AC   CVCL_UF64
SY   iTAF9-11; iTaf9-11; ICAGi001-A
DR   BioSamples; SAMEA5230331
DR   hPSCreg; ICGi016-A
DR   Wikidata; Q94313458
RX   PubMed=30616144;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156309; Intellectual developmental disorder, autosomal dominant 39
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 9
//
ID   ICGi017-A
AC   CVCL_WP94
SY   TAF14dup10; ICAGi002-A
DR   BioSamples; SAMEA5763661
DR   hPSCreg; ICGi017-A
DR   SKIP; SKIP005564
DR   Wikidata; Q94313461
RX   PubMed=31518906;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 9
//
ID   ICGi018-A
AC   CVCL_YK93
SY   iHD38Q-3
DR   BioSamples; SAMEA6438237
DR   hPSCreg; ICGi018-A
DR   SKIP; SKIP005696
DR   Wikidata; Q94313465
RX   PubMed=32179492;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[38] (c.52CAG(38)) (c.52CAG[(36_39)]); ClinVar=VCV000031916; Zygosity=Heterozygous (PubMed=32179492).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YK94 ! ICGi018-B
OI   CVCL_YK95 ! ICGi018-C
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   ICGi018-B
AC   CVCL_YK94
SY   iHD38Q-2
DR   BioSamples; SAMEA6438550
DR   hPSCreg; ICGi018-B
DR   Wikidata; Q94313469
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[38] (c.52CAG(38)) (c.52CAG[(36_39)]); ClinVar=VCV000031916; Zygosity=Heterozygous (from autologous cell line ICGi018-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YK93 ! ICGi018-A
OI   CVCL_YK95 ! ICGi018-C
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi018-C
AC   CVCL_YK95
SY   iHD38Q-1
DR   BioSamples; SAMEA6529299
DR   hPSCreg; ICGi018-C
DR   Wikidata; Q94313472
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[38] (c.52CAG(38)) (c.52CAG[(36_39)]); ClinVar=VCV000031916; Zygosity=Heterozygous (from autologous cell line ICGi018-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YK93 ! ICGi018-A
OI   CVCL_YK94 ! ICGi018-B
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   ICGi019-A
AC   CVCL_ZA52
SY   HCM1f6
DR   BioSamples; SAMEA6878102
DR   hPSCreg; ICGi019-A
DR   SKIP; SKIP005766
DR   Wikidata; Q98126758
RX   PubMed=32422568;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Met659Ile (c.1977G>A); ClinVar=VCV001054170; Zygosity=Heterozygous (PubMed=32422568).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA53 ! ICGi019-B
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   ICGi019-B
AC   CVCL_ZA53
SY   HCM1f33
DR   BioSamples; SAMEA6878103
DR   hPSCreg; ICGi019-B
DR   SKIP; SKIP005767
DR   Wikidata; Q98126760
RX   PubMed=32422568;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Met659Ile (c.1977G>A); ClinVar=VCV001054170; Zygosity=Heterozygous (PubMed=32422568).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA52 ! ICGi019-A
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   ICGi020-A
AC   CVCL_ZE00
SY   ATP7bIL23f
DR   BioSamples; SAMEA6938907
DR   hPSCreg; ICGi020-A
DR   Wikidata; Q98126761
RX   PubMed=32738633;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (PubMed=32738633).
CC   Miscellaneous: While Wilson disease is autosomal recessive no other ATP7B mutation was found in the donor of this cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE01 ! ICGi020-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   ICGi020-B
AC   CVCL_ZE01
SY   ATP7bIL24f
DR   BioSamples; SAMEA6983567
DR   hPSCreg; ICGi020-B
DR   Wikidata; Q98126762
RX   PubMed=32738633;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (PubMed=32738633).
CC   Miscellaneous: While Wilson disease is autosomal recessive no other ATP7B mutation was found in the donor of this cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE00 ! ICGi020-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   ICGi021-A
AC   CVCL_ZD99
SY   K6-4f
DR   BioSamples; SAMEA6983568
DR   hPSCreg; ICGi021-A
DR   SKIP; SKIP005826
DR   Wikidata; Q98126763
RX   PubMed=32805537;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   ICGi022-A
AC   CVCL_ZE02
SY   K7-4Lf; K7-4L-f
DR   BioSamples; SAMEA7001541
DR   hPSCreg; ICGi022-A
DR   SKIP; SKIP005827
DR   Wikidata; Q98126764
RX   PubMed=32805537;
RX   PubMed=40149527;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   ICGi022-A-1
AC   CVCL_D0VR
SY   SOD1-G128R_K7-4Lf; SOD1-G128R_K7-4L-f; SOD1-G128R
DR   BioSamples; SAMEA9333558
DR   hPSCreg; ICGi022-A-1
DR   Wikidata; Q123032655
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Gly128Arg (c382G>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=ICGi022-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE02 ! ICGi022-A
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ICGi022-A-10
AC   CVCL_E9BC
SY   K7-4Lf MT16
DR   BioSamples; SAMEA117402932
DR   hPSCreg; ICGi022-A-10
RX   PubMed=40149527;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Characteristics: Upon doxycycline induction expresses a MitoTimer biosensor. MitoTimer is a DsRed-Timer protein fused to the transit peptide of COX18 so as to target it to the mitochondrial matrix (PubMed=40149527; DOI=10.3390/biomedicines13030550; PMCID=PMC11940372).
CC   Characteristics: Using CRISPR/Cas9 a Neo-M2rtTA construct and a Puro-TRE-mCMV-MitoTimer were introduced at the AAVS1 safe harbor locus (PubMed=40149527).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 55DQE; DsRed-Timer.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE02 ! ICGi022-A
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICGi022-A-2
AC   CVCL_D0VS
SY   SOD1-D91A_K7-4Lf; SOD1-D91A
DR   BioSamples; SAMEA9370373
DR   hPSCreg; ICGi022-A-2
DR   Wikidata; Q123032656
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=ICGi022-A-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE02 ! ICGi022-A
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ICGi022-A-3
AC   CVCL_D0VN
SY   K7-MYBPC3-N515del-1
DR   BioSamples; SAMEA110674461
DR   hPSCreg; ICGi022-A-3
DR   Wikidata; Q123032657
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_edited; p.Asn515del (c.1543_1545delAAC); ClinVar=VCV000181070; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=ICGi022-A-3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE02 ! ICGi022-A
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ICGi022-A-4
AC   CVCL_D0VP
SY   K7-MYBPC3-N515del-2
DR   BioSamples; SAMEA110675906
DR   hPSCreg; ICGi022-A-4
DR   Wikidata; Q123032658
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_edited; p.Asn515del (c.1543_1545delAAC); ClinVar=VCV000181070; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=ICGi022-A-4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE02 ! ICGi022-A
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ICGi022-A-5
AC   CVCL_D0VQ
SY   K7-MYBPC3-N515del-3
DR   BioSamples; SAMEA110676106
DR   hPSCreg; ICGi022-A-5
DR   Wikidata; Q123032659
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_edited; p.Asn515del (c.1543_1545delAAC); ClinVar=VCV000181070; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=ICGi022-A-5).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE02 ! ICGi022-A
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ICGi022-A-9
AC   CVCL_E9BB
SY   K7-4Lf MT21
DR   BioSamples; SAMEA117402930
DR   hPSCreg; ICGi022-A-9
RX   PubMed=40149527;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian; Siberian.
CC   Characteristics: Upon doxycycline induction expresses a MitoTimer biosensor. MitoTimer is a DsRed-Timer protein fused to the transit peptide of COX18 so as to target it to the mitochondrial matrix (PubMed=40149527; DOI=10.3390/biomedicines13030550; PMCID=PMC11940372).
CC   Characteristics: Using CRISPR/Cas9 a Neo-M2rtTA construct and a Puro-TRE-mCMV-MitoTimer were introduced at the AAVS1 safe harbor locus (PubMed=40149527).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 55DQE; DsRed-Timer.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE02 ! ICGi022-A
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICGi023-A
AC   CVCL_ZX49
SY   PD45-K6; PD45-6-1Lm; PD45-K6-1Lm
DR   BioSamples; SAMEA7041281
DR   hPSCreg; ICGi023-A
DR   Wikidata; Q102114196
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX50 ! ICGi023-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   ICGi023-B
AC   CVCL_ZX50
SY   PD45-9-1Lm
DR   BioSamples; SAMEA10059239
DR   hPSCreg; ICGi023-B
DR   Wikidata; Q102114197
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX49 ! ICGi023-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   ICGi024-A
AC   CVCL_ZX51
SY   iPSC-r(18)-3; iTAF12-19
DR   BioSamples; SAMEA7178105
DR   hPSCreg; ICGi024-A
DR   Wikidata; Q102114198
RX   PubMed=33212351;
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(18) [50]; 45,XY,-18 [6]; 47,XY,r(18),r(18) [1] (PubMed=33212351).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175706; Ring chromosome 18 syndrome
DI   ORDO; Orphanet_1442; Ring chromosome 18 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7MS ! TAF12
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   ICGi024-B
AC   CVCL_A7MQ
SY   iPSC-r(18)-1; iTAF12-3
DR   Wikidata; Q107115417
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We assigned the ICGi024-B name for consistency with the ICGi024-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175706; Ring chromosome 18 syndrome
DI   ORDO; Orphanet_1442; Ring chromosome 18 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7MS ! TAF12
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ICGi024-C
AC   CVCL_A7MR
SY   iPSC-r(18)-2; iTAF12-6
DR   Wikidata; Q107115418
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We assigned the ICGi024-C name for consistency with the ICGi024-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175706; Ring chromosome 18 syndrome
DI   ORDO; Orphanet_1442; Ring chromosome 18 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7MS ! TAF12
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ICGi025-A
AC   CVCL_ZX52
SY   iPSC-r(8)-2; iTAF11-4
DR   BioSamples; SAMEA7180213
DR   hPSCreg; ICGi025-A
DR   Wikidata; Q102114199
RX   PubMed=33070101;
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(8)(p23;q24.3) [88]; 45,XY,-8 [11] (PubMed=33070101).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175705; Ring chromosome 8 syndrome
DI   ORDO; Orphanet_1450; Ring chromosome 8 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ML ! TAF11
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   ICGi025-B
AC   CVCL_A7MG
SY   iPSC-r(8)-1; iTAF11-1
DR   Wikidata; Q107115420
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We assigned the ICGi025-B name for consistency with the ICGi025-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175705; Ring chromosome 8 syndrome
DI   ORDO; Orphanet_1450; Ring chromosome 8 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ML ! TAF11
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ICGi025-C
AC   CVCL_A7MH
SY   iPSC-r(8)-3; iTAF11-5
DR   Wikidata; Q107115421
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We assigned the ICGi025-C name for consistency with the ICGi025-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175705; Ring chromosome 8 syndrome
DI   ORDO; Orphanet_1450; Ring chromosome 8 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ML ! TAF11
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ICGi025-D
AC   CVCL_A7MI
SY   iPSC-r(8)-4; iTAF11-9
DR   Wikidata; Q107115422
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We assigned the ICGi025-D name for consistency with the ICGi025-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175705; Ring chromosome 8 syndrome
DI   ORDO; Orphanet_1450; Ring chromosome 8 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ML ! TAF11
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ICGi025-E
AC   CVCL_A7MJ
SY   iPSC-r(8)-5; iTAF11-11
DR   Wikidata; Q107115423
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We assigned the ICGi025-E name for consistency with the ICGi025-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175705; Ring chromosome 8 syndrome
DI   ORDO; Orphanet_1450; Ring chromosome 8 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ML ! TAF11
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ICGi025-F
AC   CVCL_A7MK
SY   iPSC-r(8)-6; iTAF11-12
DR   Wikidata; Q107115424
RX   PubMed=33619287;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We assigned the ICGi025-F name for consistency with the ICGi025-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175705; Ring chromosome 8 syndrome
DI   ORDO; Orphanet_1450; Ring chromosome 8 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7ML ! TAF11
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   ICGi026-A
AC   CVCL_A1MJ
DR   BioSamples; SAMEA7484326
DR   hPSCreg; ICGi026-A
DR   Wikidata; Q102114200
RX   PubMed=33189043;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[27]; ClinVar=VCV000009972; Zygosity=Mosaic (PubMed=33189043).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[60]; ClinVar=VCV000009972; Zygosity=Mosaic (PubMed=33189043).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[110]; ClinVar=VCV000009972; Zygosity=Mosaic (PubMed=33189043).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[410]; ClinVar=VCV000009972; Zygosity=Mosaic (PubMed=33189043).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   ICGi028-A
AC   CVCL_A5VU
SY   HCM4fm5.2
DR   BioSamples; SAMEA8307099
DR   hPSCreg; ICGi028-A
DR   Wikidata; Q107115425
RX   PubMed=33887580;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4801; HADHA; Simple; p.Glu510Gln (c.1528G>C); ClinVar=VCV000100085; Zygosity=Heterozygous (PubMed=33887580).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi029-A
AC   CVCL_A5VV
SY   HCM14fm6.2
DR   BioSamples; SAMEA8307096
DR   hPSCreg; ICGi029-A
DR   Wikidata; Q107115426
RX   PubMed=33892289;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Asn515del (c.1543_1545delAAC); ClinVar=VCV000181070; Zygosity=Heterozygous (PubMed=33892289).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi030-A
AC   CVCL_A0VT
SY   HF2
DR   BioSamples; SAMEA9273287
DR   hPSCreg; ICGi030-A
DR   Wikidata; Q108820526
RX   PubMed=34736038;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Lys1013Glnfs*15 (c.3036dupC); ClinVar=VCV000495410; Zygosity=Heterozygous (PubMed=34736038).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (PubMed=34736038).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   ICGi031-A
AC   CVCL_B3RQ
DR   BioSamples; SAMEA10772543
DR   hPSCreg; ICGi031-A
DR   Wikidata; Q110432904
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y800 ! GM06077
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi032-A
AC   CVCL_B3RR
DR   BioSamples; SAMEA9652840
DR   hPSCreg; ICGi032-A
DR   Wikidata; Q110432905
RX   PubMed=34864218;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3RU ! CPG18
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ICGi033-A
AC   CVCL_B3RX
SY   77Q-17
DR   BioSamples; SAMEA10329920
DR   hPSCreg; ICGi033-A
DR   Wikidata; Q110432906
RX   PubMed=35872525;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[77] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=35872525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0PM ! ICGi033-B
OI   CVCL_C0PN ! ICGi033-C
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   ICGi033-B
AC   CVCL_C0PM
SY   77Q-9
DR   BioSamples; SAMEA20004557
DR   hPSCreg; ICGi033-B
DR   Wikidata; Q112929834
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[77] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line ICGi033-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3RX ! ICGi033-A
OI   CVCL_C0PN ! ICGi033-C
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   ICGi033-C
AC   CVCL_C0PN
SY   77Q-20
DR   BioSamples; SAMEA20004558
DR   hPSCreg; ICGi033-C
DR   Wikidata; Q112929835
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[77] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell line ICGi033-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3RX ! ICGi033-A
OI   CVCL_C0PM ! ICGi033-B
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   ICGi034-A
AC   CVCL_B3RY
SY   PD30-4-7
DR   BioSamples; SAMEA10450936
DR   hPSCreg; ICGi034-A
DR   Wikidata; Q110432907
RX   PubMed=35007918;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=35007918).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5EL ! ICGi034-B
OI   CVCL_B5EM ! ICGi034-C
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ICGi034-B
AC   CVCL_B5EL
SY   PD30-5-16
DR   BioSamples; SAMEA11421031
DR   hPSCreg; ICGi034-B
DR   Wikidata; Q110432908
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line ICGi034-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3RY ! ICGi034-A
OI   CVCL_B5EM ! ICGi034-C
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   ICGi034-C
AC   CVCL_B5EM
SY   PD30-5-27
DR   BioSamples; SAMEA11421036
DR   hPSCreg; ICGi034-C
DR   Wikidata; Q110432909
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line ICGi034-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3RY ! ICGi034-A
OI   CVCL_B5EL ! ICGi034-B
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   ICGi035-A
AC   CVCL_B3UB
SY   iCS-MAF1-1
DR   BioSamples; SAMEA10768636
DR   hPSCreg; ICGi035-A
DR   Wikidata; Q110432911
RX   PubMed=35026660;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:2183; VPS13B; Simple; c.3870+1G>T; ClinVar=VCV000559917; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35026660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3UC ! ICGi035-B
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi035-B
AC   CVCL_B3UC
SY   iCS-MAF1-11
DR   BioSamples; SAMEA10839086
DR   hPSCreg; ICGi035-B
DR   Wikidata; Q110432912
RX   PubMed=35026660;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:2183; VPS13B; Simple; c.3870+1G>T; ClinVar=VCV000559917; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35026660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3UB ! ICGi035-A
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi036-A
AC   CVCL_B5EJ
SY   FH 1.3.1S
DR   BioSamples; SAMEA10985996
DR   hPSCreg; ICGi036-A
DR   Wikidata; Q110432913
RX   PubMed=34999421;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Ser177Leu (c.530C>T); ClinVar=VCV000003686; Zygosity=Heterozygous (PubMed=34999421).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys352Arg (c.1054T>C); ClinVar=VCV000251618; Zygosity=Heterozygous (PubMed=34999421).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi037-A
AC   CVCL_B5EK
SY   FH 3.2.8T
DR   BioSamples; SAMEA11421028
DR   hPSCreg; ICGi037-A
DR   Wikidata; Q110432914
RX   PubMed=35152179;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Trp443Arg (c.1327T>C); ClinVar=VCV000998052; Zygosity=Heterozygous (PubMed=35152179).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Glu714_Ile796del (c.2141-966_2390-330del); Zygosity=Heterozygous (hPSCreg=ICGi037-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi038-A
AC   CVCL_B5EN
SY   FH 5.1.2Sh
DR   BioSamples; SAMEA11421032
DR   hPSCreg; ICGi038-A
DR   Wikidata; Q110432915
RX   PubMed=35152178;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.940+3_940+6delGAGT; ClinVar=VCV000869390; Zygosity=Heterozygous (PubMed=35152178).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Arg416Trp (c.1246C>T); ClinVar=VCV000183110; Zygosity=Heterozygous (PubMed=35152178).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ICGi039-A
AC   CVCL_B6RM
SY   PD31-6
DR   BioSamples; SAMEA12340567
DR   hPSCreg; ICGi039-A
DR   Wikidata; Q111733473
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6RN ! ICGi039-B
OI   CVCL_B6RP ! ICGi039-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ICGi039-B
AC   CVCL_B6RN
SY   PD31-7
DR   BioSamples; SAMEA12927542
DR   hPSCreg; ICGi039-B
DR   Wikidata; Q111733474
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6RM ! ICGi039-A
OI   CVCL_B6RP ! ICGi039-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ICGi039-C
AC   CVCL_B6RP
SY   PD31-15
DR   BioSamples; SAMEA12927543
DR   hPSCreg; ICGi039-C
DR   Wikidata; Q111733475
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6RM ! ICGi039-A
OI   CVCL_B6RN ! ICGi039-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ICGi040-A
AC   CVCL_B6RQ
SY   iTAF16-3
DR   BioSamples; SAMEA12616040
DR   hPSCreg; ICGi040-A
DR   Wikidata; Q111733476
RX   PubMed=35303600;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+mar [26]; 46,XY [4] (PubMed=35303600).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3360; Supernumerary circular chromosome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ICGi041-A
AC   CVCL_C0H2
SY   PD12-4
DR   BioSamples; SAMEA14491688
DR   hPSCreg; ICGi041-A
DR   Wikidata; Q112929836
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   ICGi042-A
AC   CVCL_C1TN
SY   PD12-4Lm
DR   BioSamples; SAMEA110644571
DR   hPSCreg; ICGi042-A
DR   Wikidata; Q114311699
RX   DOI=10.1134/S106236042301006X;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Glu334Lys (c.1000G>A); ClinVar=VCV000039128; Zygosity=Heterozygous (DOI=10.1134/S106236042301006X).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile723Val (c.2167A>G); ClinVar=VCV000039146; Zygosity=Heterozygous (DOI=10.1134/S106236042301006X).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Asn521Thr (c.1562A>C); ClinVar=VCV000295006; Zygosity=Heterozygous (DOI=10.1134/S106236042301006X).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TP ! ICGi042-B
OI   CVCL_C1TQ ! ICGi042-C
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   ICGi042-B
AC   CVCL_C1TP
SY   PD12-5Lm
DR   BioSamples; SAMEA110644573
DR   hPSCreg; ICGi042-B
DR   Wikidata; Q114311700
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Glu334Lys (c.1000G>A); ClinVar=VCV000039128; Zygosity=Heterozygous (hPSCreg=ICGi042-B).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile723Val (c.2167A>G); ClinVar=VCV000039146; Zygosity=Heterozygous (hPSCreg=ICGi042-B).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Asn521Thr (c.1562A>C); ClinVar=VCV000295006; Zygosity=Heterozygous (hPSCreg=ICGi042-B).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TN ! ICGi042-A
OI   CVCL_C1TQ ! ICGi042-C
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   ICGi042-C
AC   CVCL_C1TQ
SY   PD12-6Lm
DR   BioSamples; SAMEA110644574
DR   hPSCreg; ICGi042-C
DR   Wikidata; Q114311702
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Glu334Lys (c.1000G>A); ClinVar=VCV000039128; Zygosity=Heterozygous (hPSCreg=ICGi042-C).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile723Val (c.2167A>G); ClinVar=VCV000039146; Zygosity=Heterozygous (hPSCreg=ICGi042-C).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Asn521Thr (c.1562A>C); ClinVar=VCV000295006; Zygosity=Heterozygous (hPSCreg=ICGi042-C).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TN ! ICGi042-A
OI   CVCL_C1TP ! ICGi042-B
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   ICGi043-A
AC   CVCL_C3RW
SY   LR-21
DR   BioSamples; SAMEA111344463
DR   hPSCreg; ICGi043-A
DR   Wikidata; Q117704514
RX   DOI=10.1134/S1062360423010058;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (DOI=10.1134/S1062360423010058).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3RX ! ICGi043-B
OI   CVCL_C3RY ! ICGi043-C
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   ICGi043-B
AC   CVCL_C3RX
SY   LR-2
DR   BioSamples; SAMEA111344464
DR   hPSCreg; ICGi043-B
DR   Wikidata; Q117704515
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (hPSCreg=ICGi043-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3RW ! ICGi043-A
OI   CVCL_C3RY ! ICGi043-C
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   ICGi043-C
AC   CVCL_C3RY
SY   LR-15
DR   BioSamples; SAMEA111344465
DR   hPSCreg; ICGi043-C
DR   Wikidata; Q117704516
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (hPSCreg=ICGi043-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3RW ! ICGi043-A
OI   CVCL_C3RX ! ICGi043-B
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   ICGi044-A
AC   CVCL_C6NX
SY   PD40-7
DR   BioSamples; SAMEA111531212
DR   hPSCreg; ICGi044-A
DR   Wikidata; Q117704517
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4336; GLUD2; Simple; p.Ser498Ala (c.1492T>G); ClinVar=VCV000029936; Zygosity=Hemizygous (hPSCreg=ICGi044-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6NY ! ICGi044-B
OI   CVCL_C6NZ ! ICGi044-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ICGi044-B
AC   CVCL_C6NY
SY   PD40-8
DR   BioSamples; SAMEA111531211
DR   hPSCreg; ICGi044-B
DR   Wikidata; Q117704518
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4336; GLUD2; Simple; p.Ser498Ala (c.1492T>G); ClinVar=VCV000029936; Zygosity=Hemizygous (hPSCreg=ICGi044-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6NX ! ICGi044-A
OI   CVCL_C6NZ ! ICGi044-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ICGi044-C
AC   CVCL_C6NZ
SY   PD40-13
DR   BioSamples; SAMEA111531210
DR   hPSCreg; ICGi044-C
DR   Wikidata; Q117704519
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4336; GLUD2; Simple; p.Ser498Ala (c.1492T>G); ClinVar=VCV000029936; Zygosity=Hemizygous (hPSCreg=ICGi044-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6NX ! ICGi044-A
OI   CVCL_C6NY ! ICGi044-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   ICGi046-A
AC   CVCL_E2V2
SY   V2-1
DR   BioSamples; SAMEA114563820
DR   hPSCreg; ICGi046-A
RX   DOI=10.1134/S1062360423070032;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser259Thr (c.775T>A); ClinVar=VCV000040601; Zygosity=Heterozygous (DOI=10.1134/S1062360423070032).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   ICGi047-A
AC   CVCL_E9B6
SY   HC10-31
DR   BioSamples; SAMEA115043949
DR   hPSCreg; ICGi047-A
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICGi052-A
AC   CVCL_E9B7
SY   PD57-6
DR   BioSamples; SAMEA115761167
DR   hPSCreg; ICGi052-A
RX   PubMed=39722675;
RX   PubMed=40149527;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (PubMed=39722675).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9B8 ! ICGi052-B
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICGi052-B
AC   CVCL_E9B8
SY   PD57-7
DR   BioSamples; SAMEA115767763
DR   hPSCreg; ICGi052-B
RX   PubMed=39722675;
RX   PubMed=40149527;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (PubMed=39722675).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9B7 ! ICGi052-A
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICGi052-B-1
AC   CVCL_E9B9
SY   PD57-7 MT8
DR   BioSamples; SAMEA117400231
DR   hPSCreg; ICGi052-B-1
RX   PubMed=40149527;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Characteristics: Upon doxycycline induction expresses a MitoTimer biosensor. MitoTimer is a DsRed-Timer protein fused to the transit peptide of COX18 so as to target it to the mitochondrial matrix (PubMed=40149527; DOI=10.3390/biomedicines13030550; PMCID=PMC11940372).
CC   Characteristics: Using CRISPR/Cas9 a Neo-M2rtTA construct and a Puro-TRE-mCMV-MitoTimer were introduced at the AAVS1 safe harbor locus (PubMed=40149527).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (PubMed=40149527).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 55DQE; DsRed-Timer.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E9B8 ! ICGi052-B
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICGi052-B-2
AC   CVCL_E9BA
SY   PD57-7 MT6
DR   BioSamples; SAMEA117402859
DR   hPSCreg; ICGi052-B-2
RX   PubMed=40149527;
CC   From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia.
CC   Population: Caucasian.
CC   Characteristics: Upon doxycycline induction expresses a MitoTimer biosensor. MitoTimer is a DsRed-Timer protein fused to the transit peptide of COX18 so as to target it to the mitochondrial matrix (PubMed=40149527; DOI=10.3390/biomedicines13030550; PMCID=PMC11940372).
CC   Characteristics: Using CRISPR/Cas9 a Neo-M2rtTA construct and a Puro-TRE-mCMV-MitoTimer were introduced at the AAVS1 safe harbor locus (PubMed=40149527).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (PubMed=40149527).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 55DQE; DsRed-Timer.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E9B8 ! ICGi052-B
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICH-ERMS-1
AC   CVCL_EG67
SY   Ibaraki Children's Hospital-Embryonal RhabdoMyoSarcoma-1
DR   cancercelllines; CVCL_EG67
DR   GEO; GSM1528055
DR   JCRB; JCRB1648
DR   Wikidata; Q54897225
RX   PubMed=23578105;
RX   PubMed=33021000;
CC   Population: Japanese.
CC   Doubling time: ~31 hours (PubMed=33021000).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Glu69Lys (c.205G>A); ClinVar=VCV000224414; Zygosity=Heterozygous (PubMed=33021000).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=33021000).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
ST   Source(s): JCRB=JCRB1648
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   Ich1
AC   CVCL_JM20
DR   JCRB; KURB1968
DR   Wikidata; Q54897226
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_79354; Ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   Ich1M
AC   CVCL_JM21
DR   JCRB; KURB1969
DR   Wikidata; Q54897227
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   Ich2
AC   CVCL_JM22
DR   JCRB; KURB1970
DR   Wikidata; Q54897228
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62569; Epidermolytic ichthyosis
DI   ORDO; Orphanet_312; Autosomal dominant epidermolytic ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iChEC-1
AC   CVCL_B4IK
SY   immortalized Choroidal Endothelial Cell-1
DR   Wikidata; Q110432916
RX   PubMed=30571950;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Val62Ile (c.184G>A); ClinVar=VCV000016550; Zygosity=Homozygous (PubMed=30571950).
CC   Sequence variation: Mutation; HGNC; HGNC:13941; SLC44A4; Simple; p.Asp123Val (c.368A>T); ClinVar=VCV001266965; Zygosity=Homozygous (PubMed=30571950).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   ICI 101
AC   CVCL_WG90
SY   ICI-101; Institut du Cancer et d'Immunogenetique 101
DR   Wikidata; Q94313504
RX   PubMed=4576460;
RX   PubMed=4890347;
RX   PubMed=5252515;
RX   PubMed=5800808;
CC   Doubling time: ~85 hours (PubMed=5252515).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   ICI 104A
AC   CVCL_WG91
SY   ICI 104 A; Institut du Cancer et d'Immunogenetique 104A
DR   Wikidata; Q94313507
RX   PubMed=4576460;
RX   PubMed=4890347;
RX   PubMed=5800808;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WG92 ! ICI 104B
OI   CVCL_WG93 ! ICI 104C
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   ICI 104B
AC   CVCL_WG92
SY   Institut du Cancer et d'Immunogenetique 104B
DR   Wikidata; Q94313509
RX   PubMed=4890347;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WG91 ! ICI 104A
OI   CVCL_WG93 ! ICI 104C
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   ICI 104C
AC   CVCL_WG93
SY   Institut du Cancer et d'Immunogenetique 104C
DR   Wikidata; Q94313514
RX   PubMed=4890347;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WG91 ! ICI 104A
OI   CVCL_WG92 ! ICI 104B
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   ICI 106
AC   CVCL_WG98
SY   Institut du Cancer et d'Immunogenetique 106
DR   Wikidata; Q94313517
RX   PubMed=4576460;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   ICI 107
AC   CVCL_WG99
SY   Institut du Cancer et d'Immunogenetique 107
DR   Wikidata; Q94313521
RX   PubMed=4576460;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   ICI 202
AC   CVCL_WG94
SY   Institut du Cancer et d'Immunogenetique 202
DR   Wikidata; Q94313523
RX   PubMed=4890347;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ICIG-7
AC   CVCL_A9E2
SY   ICIG7; Institut de Cancerologie et d'ImmunoGenetique-7
DR   Wikidata; Q102114201
RX   PubMed=1309725;
RX   PubMed=3374507;
RX   PubMed=6538202;
RX   PubMed=7140842;
RX   PubMed=9796908;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5FM
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   ICIG-7-SV40
AC   CVCL_A9E3
DR   Wikidata; Q102114202
RX   PubMed=6538202;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9E2 ! ICIG-7
SX   Male
AG   5FM
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   ICIG-8
AC   CVCL_A9E4
SY   ICIG 8; Institut de Cancerologie et d'ImmunoGenetique-8
DR   Wikidata; Q102114204
RX   PubMed=3374507;
RX   PubMed=6538202;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9E5 ! ICIG-9
SX   Sex unspecified
AG   4FM
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   ICIG-9
AC   CVCL_A9E5
SY   ICIG IX; Institut de Cancerologie et d'ImmunoGenetique-9
DR   Wikidata; Q102114205
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6538202;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9E4 ! ICIG-8
SX   Sex unspecified
AG   4FM
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iCK10
AC   CVCL_Y698
SY   A000049#10; A000049# 10; HPS0085
DR   RCB; HPS0085
DR   SKIP; SKIP000030
DR   Wikidata; Q54897229
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4726 ! NCU-F10
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   iCK2
AC   CVCL_T827
SY   A000049#2; A000049# 2; HPS0083
DR   RCB; HPS0083
DR   SKIP; SKIP000028
DR   SKIP; SKIP000267
DR   Wikidata; Q54897230
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4726 ! NCU-F10
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   iCK8
AC   CVCL_Y697
SY   A000049#8; A000049# 8; HPS0084
DR   SKIP; SKIP000029
DR   Wikidata; Q54897232
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4726 ! NCU-F10
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ICLU-B
AC   CVCL_E8UA
RX   PubMed=10405829;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICLU-E
AC   CVCL_E8UB
RX   PubMed=10405829;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:19124; FIP1L1 + HGNC; HGNC:8803; PDGFRA; Name(s)=FIP1L1-PDGFRA (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4563; Chronic eosinophilic leukemia, not otherwise specified
DI   ORDO; Orphanet_168940; Chronic eosinophilic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0258 ! EoL-1
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICLU-T
AC   CVCL_E8UC
RX   PubMed=10405829;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:8064; NUP214; Name(s)=NUP214-ABL1; Note=NUP214 exon 34 fused to ABL1 exon 2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1913 ! Peer
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ICNDXHi001-A
AC   CVCL_B5QS
DR   BioSamples; SAMEA10146948
DR   hPSCreg; ICNDXHi001-A
DR   Wikidata; Q111733477
RX   PubMed=34995843;
CC   From: Innovation Center for Neurological Disorders, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Leu658Val (c.1972C>G) (p.Leu266Val, c.796C>G or p.Leu583Val, c.1747C>G); ClinVar=VCV000014266; Zygosity=Heterozygous (PubMed=34995843).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   icNF00.10a
AC   CVCL_B9V0
DR   Wikidata; Q112929838
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D21S11: 28,31.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B9UZ ! cNF00.10a
SX   Male
AG   12Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   icNF04.9a
AC   CVCL_B9VC
DR   Wikidata; Q112929839
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D21S11: 30,34.2
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B9VB ! cNF04.9a
SX   Female
AG   24Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   icNF09.5
AC   CVCL_D3C7
DR   ABM; T0189
DR   Wikidata; Q127382312
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-60Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   icNF18.1a
AC   CVCL_D3C8
DR   ABM; T0190
DR   Wikidata; Q127382313
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-60Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   icNF93.1a
AC   CVCL_D3C9
DR   ABM; T0183
DR   Wikidata; Q127382314
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-40Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   icNF97.2a
AC   CVCL_B9V3
DR   Wikidata; Q112929840
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D21S11: 28,32.2
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 14
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B9V1 ! cNF97.2a
SX   Female
AG   62Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   icNF97.2b
AC   CVCL_B9V4
DR   ABM; T0184
DR   Wikidata; Q112929842
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Caution: ABM wrongly indicates that this cell line originates from a 70-80 year old donor (ABM=T0184).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D21S11: 28,32.2
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 14
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B9V2 ! cNF97.2b
SX   Female
AG   62Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   icNF97.5
AC   CVCL_D3CA
DR   ABM; T0185
DR   Wikidata; Q127382315
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   0-2Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   icNF98.4c
AC   CVCL_B9V7
DR   ABM; T0186
DR   Wikidata; Q112929843
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 11,14
ST   D16S539: 9,12
ST   D21S11: 29,32.2
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B9V5 ! cNF98.4c
SX   Male
AG   66Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   icNF98.4d
AC   CVCL_B9V8
DR   ABM; T0187
DR   Wikidata; Q112929844
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Miscellaneous: Cell line information from personal communication of Allaway, Robert J.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 11,14
ST   D16S539: 9,12
ST   D21S11: 29,32.2
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B9V6 ! cNF98.4d
SX   Male
AG   66Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   icNF99.1
AC   CVCL_D3CB
DR   ABM; T0188
DR   Wikidata; Q127382316
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C128451; Cutaneous neurofibroma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-40Y
CA   Telomerase immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   ICO
AC   CVCL_UC80
SY   Immature Carp Ovary
DR   Wikidata; Q94313559
RX   CelloPub=CLPUB00445;
RX   CelloPub=CLPUB00446;
RX   Patent=RU2353650;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 66.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   ICO-401
AC   CVCL_D6NH
RX   DOI=10.17650/1726-9784-2015-14-3-37-40;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O43490; Human PROM1/CD133.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ICP1
AC   CVCL_C3NL
SY   Immortalized Chicken Preadipocyte 1
DR   Wikidata; Q116049560
RX   PubMed=28486516;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transduction; Gene=CGNC; 9953; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: Arbor Acres; VBO=VBO_0000472.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   10D
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   ICP2
AC   CVCL_C3NM
SY   Immortalized Chicken Preadipocyte 2
DR   Wikidata; Q116049561
RX   PubMed=28486516;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transduction; Gene=CGNC; 49151; TERC.
CC   Genetic integration: Method=Transduction; Gene=CGNC; 9953; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: Arbor Acres; VBO=VBO_0000472.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   10D
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   ICR B20
AC   CVCL_5G40
SY   B20
DR   Wikidata; Q54897233
RX   DOI=10.2172/4607053;
RX   DOI=10.2172/4623769;
RX   PubMed=1261610;
RX   PubMed=4543150;
CC   Group: Amphibian cell line.
CC   Group: Haploid karyotype cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_189531; Benzo(b)(1,5)naphthyridine,7-chloro-10-(3-(N-(2-chloroethyl)-N-ethyl)aminopropylamino)-2-methoxy-,dihydrochloride (ICR 340).
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_4345 ! ICR-2A
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   ICR B9
AC   CVCL_B0V7
SY   B9
DR   Wikidata; Q108820527
RX   DOI=10.2172/4607053;
RX   PubMed=1261610;
RX   PubMed=4543150;
CC   Group: Amphibian cell line.
CC   Karyotypic information: Diploid.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_4345 ! ICR-2A
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   ICR MEF
AC   CVCL_6409
DR   CLO; CLO_0004337
DR   ATCC; SCRC-1046
DR   CCRID; 3101MOUSCSP107
DR   Wikidata; Q54897234
CC   Discontinued: ATCC; SCRC-1046; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   13FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   ICR-134
AC   CVCL_6408
SY   ICR 134; ICR134; RPH 67.134c2; RPH67.134c2
DR   CLO; CLO_0004336
DR   ATCC; CCL-128
DR   Wikidata; Q54897235
RX   DOI=10.1007/978-3-642-85791-1_7;
RX   PubMed=5263768;
RX   PubMed=23891577;
CC   Group: Amphibian cell line.
CC   Doubling time: ~50 hours (DOI=10.1007/978-3-642-85791-1_7).
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   ICR-2A
AC   CVCL_4345
SY   ICR 2A; ICR2A; RPH 68.2A; RPH68.2A
DR   CLO; CLO_0004338
DR   CLDB; cl1800
DR   ATCC; CCL-145
DR   ECACC; 89072615
DR   IZSLER; BS CL 191
DR   Wikidata; Q54897236
RX   DOI=10.2172/4607053;
RX   DOI=10.2172/4623769;
RX   PubMed=301813;
RX   PubMed=307556;
RX   PubMed=307557;
RX   PubMed=2569015;
RX   PubMed=2910704;
RX   PubMed=3500873;
RX   PubMed=4543150;
RX   PubMed=5263768;
CC   Group: Amphibian cell line.
CC   Group: Haploid karyotype cell line.
CC   Doubling time: ~40 hours (PubMed=5263768); 48 hours (PubMed=3500873).
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   ICR-2A1
AC   CVCL_B0V5
SY   ICR 2A1
DR   Wikidata; Q108820528
RX   DOI=10.2172/4607053;
RX   PubMed=1261610;
CC   Group: Amphibian cell line.
CC   Group: Haploid karyotype cell line.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_4345 ! ICR-2A
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   ICR-2A2
AC   CVCL_B0V6
SY   ICR 2A2
DR   Wikidata; Q108820529
RX   DOI=10.2172/4607053;
RX   PubMed=1261610;
CC   Group: Amphibian cell line.
CC   Karyotypic information: Diploid.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_4345 ! ICR-2A
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   ICR-SS-1
AC   CVCL_C6LR
DR   Wikidata; Q116049562
RX   PubMed=35954262;
CC   Characteristics: Established from the J000104314 xenograft maintained in NOD Scid gamma mice.
CC   Doubling time: 93 hours (PubMed=35954262).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=35954262).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): PubMed=35954262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 7,8
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   ICRft-2
AC   CVCL_F047
DR   RCB; AES0049
DR   RCB; RCB2198
DR   SKIP; SKIP001659
DR   Wikidata; Q54897237
CC   Discontinued: RCB; RCB2198; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   ICRmt-1
AC   CVCL_4E29
DR   RCB; RCB2196
DR   Wikidata; Q54897238
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Caution: Not from strain ICR as originally assigned (DOI=10.4051/ibc.2010.2.4.0014).
CC   Discontinued: RCB; RCB2196; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   iCS-01
AC   CVCL_D5HJ
SY   iCS01; induced ChondroSarcoma-01
DR   GEO; GSM737450
DR   JCRB; JCRB1553
DR   Wikidata; Q127382317
RX   PubMed=22833560;
CC   Characteristics: Decidual cells were converted into chondrocytes using BCL6, MITF, MYC, SMARCD3 and T. The cell underwent malignant transformation into chondrosarcoma (PubMed=22833560).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): JCRB=JCRB1553; PubMed=22833560
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 22,26
ST   Penta D: 10,12
ST   Penta E: 14,21
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5HK ! iCS-02
OI   CVCL_D5HL ! iCS-03
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   iCS-02
AC   CVCL_D5HK
SY   iCS02; induced ChondroSarcoma-02
DR   GEO; GSM737451
DR   JCRB; JCRB1589
DR   Wikidata; Q127382318
RX   PubMed=22833560;
CC   Characteristics: Decidual cells were converted into chondrocytes using BCL6, MITF, MYC, SMARCD3 and T. The cell underwent malignant transformation into chondrosarcoma (PubMed=22833560).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): JCRB=JCRB1589; PubMed=22833560
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11 (PubMed=22833560)
ST   D13S317: 11,12 (JCRB=JCRB1589)
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 22,26
ST   Penta D: 10,12
ST   Penta E: 14,21
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5HJ ! iCS-01
OI   CVCL_D5HL ! iCS-03
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   iCS-03
AC   CVCL_D5HL
SY   iCS03; induced ChondroSarcoma-03
DR   GEO; GSM737452
DR   JCRB; JCRB1593
DR   Wikidata; Q127382319
RX   PubMed=22833560;
CC   Characteristics: Decidual cells were converted into chondrocytes using BCL6, MITF, MYC, SMARCD3 and T. The cell underwent malignant transformation into chondrosarcoma (PubMed=22833560).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): JCRB=JCRB1593; PubMed=22833560
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11 (PubMed=22833560)
ST   D13S317: 11,12 (JCRB=JCRB1593)
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 22,26
ST   Penta D: 10,12
ST   Penta E: 14,21
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5HJ ! iCS-01
OI   CVCL_D5HK ! iCS-02
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   iCS-05
AC   CVCL_D5HM
SY   iCS05; induced ChondroSarcoma-05
DR   GEO; GSM737454
DR   Wikidata; Q127382320
RX   PubMed=22833560;
CC   Characteristics: Chorion cells were converted into chondrocytes using BCL6, MITF, MYC, SMARCD3 and T. The cell underwent malignant transformation into chondrosarcoma (PubMed=22833560).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): PubMed=22833560
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,19
ST   D21S11: 30,31.2
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 19,22
ST   Penta D: 12
ST   Penta E: 15,21
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   ICSSUi001-A
AC   CVCL_B5IL
SY   FBN1-C2633G-iPSC
DR   BioSamples; SAMEA8286668
DR   hPSCreg; ICSSUi001-A
DR   Wikidata; Q110432917
RX   PubMed=35231796;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2633Gly (c.7897T>G); ClinVar=VCV000984411; Zygosity=Heterozygous (PubMed=35231796).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   ICSSUi002-A
AC   CVCL_B5IM
DR   BioSamples; SAMEA13061469
DR   hPSCreg; ICSSUi002-A
DR   Wikidata; Q110432918
RX   PubMed=35305471;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Homozygous (PubMed=35305471).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50461; Aortic dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   ICSSUi003-A
AC   CVCL_B5IN
DR   hPSCreg; ICSSUi003-A
DR   Wikidata; Q110432919
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   ICSSUi004-A
AC   CVCL_D6NU
SY   hiPSC-CRYAB-c.326A>G; hiPSC-CRYABD109G
DR   BioSamples; SAMEA115064445
DR   hPSCreg; ICSSUi004-A
RX   PubMed=38428347;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2389; CRYAB; Simple; p.Asp109Gly (c.326A>G); ClinVar=VCV000265829; Zygosity=Heterozygous (PubMed=38428347).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62798; Restrictive cardiomyopathy
DI   ORDO; Orphanet_217632; Restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   ICSSUi005-A
AC   CVCL_D6NV
SY   iPSCm.3243A>G
DR   BioSamples; SAMEA115117015
DR   hPSCreg; ICSSUi005-A
RX   PubMed=38489977;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=In 80% of cells (PubMed=38489977).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C130996; Maternal diabetes and deafness syndrome
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   ICSSUi006-A
AC   CVCL_D6NW
SY   hiPSCs-TNNT2c.A553G; hiPSCs-cTnTp.K185E
DR   BioSamples; SAMEA115432439
DR   hPSCreg; ICSSUi006-A
RX   PubMed=38861774;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Lys185Glu (c.553A>G); ClinVar=VCV002682717; Zygosity=Heterozygous (PubMed=38861774).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142892; Familial hypertrophic cardiomyopathy type 2
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   ICT-01
AC   CVCL_WA86
SY   IChThyosis-01
DR   IBRC; C11109
DR   Wikidata; Q94313602
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84776; Ichthyosis
DI   ORDO; Orphanet_79354; Ichthyosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ICT1
AC   CVCL_C3SV
DR   Wikidata; Q116049563
RX   PubMed=2983000;
RX   PubMed=3004943;
CC   Transformant: NCBI_TaxID; 10315; Human herpesvirus 2 (HHV-2) (strain HG52).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   ID 11599 iPSC
AC   CVCL_A4MJ
SY   Control1
DR   SKIP; SKIP003171
DR   Wikidata; Q105509614
RX   PubMed=29513666;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   ID 16421 iPSC
AC   CVCL_A4MK
SY   Control3
DR   Wikidata; Q105509618
RX   PubMed=29513666;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   ID 16423 iPSC
AC   CVCL_A4ML
SY   Control4
DR   SKIP; SKIP003173
DR   Wikidata; Q105509621
RX   PubMed=29513666;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   ID 16424 iPSC
AC   CVCL_A4MM
SY   Control2
DR   SKIP; SKIP003172
DR   Wikidata; Q105509625
RX   PubMed=29513666;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   ID-1
AC   CVCL_D3UG
DR   Wikidata; Q127382321
RX   PubMed=9890710;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04912; Human MST1R/CD136.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ID-2
AC   CVCL_D3UH
DR   Wikidata; Q127382322
RX   PubMed=9890710;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q04912; Human MST1R/CD136.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ID00001
AC   CVCL_2Z01
DR   CLO; CLO_0029274
DR   Coriell; ID00001
DR   Wikidata; Q54897239
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple; p.Tyr361Cys (c.1082A>G); ClinVar=VCV000011346; Zygosity=Hemizygous (Coriell=ID00001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00002
AC   CVCL_2Z02
DR   CLO; CLO_0029275
DR   Coriell; ID00002
DR   Wikidata; Q54897240
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:11935; CD40LG; Simple; p.Leu155Pro (c.464T>C); ClinVar=VCV000011160; Zygosity=Hemizygous (Coriell=ID00002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84783; Immunodeficiency with hyper-IgM
DI   ORDO; Orphanet_101088; X-linked hyper-IgM syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00003
AC   CVCL_2Z03
DR   CLO; CLO_0029273
DR   Coriell; ID00003
DR   Wikidata; Q54897241
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:12731; WAS; Simple; p.Glu133Lys (c.397G>A); ClinVar=VCV000870492; Zygosity=Unspecified (Coriell=ID00003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00004
AC   CVCL_2Z04
DR   CLO; CLO_0029219
DR   Coriell; ID00004
DR   Wikidata; Q54897242
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:12731; WAS; Simple; p.Glu133Lys (c.397G>A); ClinVar=VCV000870492; Zygosity=Unspecified (Coriell=ID00004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00006
AC   CVCL_2Z05
DR   CLO; CLO_0029221
DR   Coriell; ID00006
DR   Wikidata; Q54897243
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00011
AC   CVCL_2Z06
DR   CLO; CLO_0029223
DR   Coriell; ID00011
DR   Wikidata; Q54897244
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00013
AC   CVCL_2Z07
DR   CLO; CLO_0029224
DR   Coriell; ID00013
DR   Wikidata; Q54897245
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00014
AC   CVCL_2Z08
DR   CLO; CLO_0029227
DR   Coriell; ID00014
DR   Wikidata; Q54897246
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   ID00015
AC   CVCL_2Z09
DR   CLO; CLO_0029229
DR   Coriell; ID00015
DR   Wikidata; Q54897248
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00016
AC   CVCL_2Z10
DR   CLO; CLO_0029230
DR   Coriell; ID00016
DR   Wikidata; Q54897249
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   ID00017
AC   CVCL_6G82
DR   CLO; CLO_0029232
DR   Coriell; ID00017
DR   Wikidata; Q54897250
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg156His (c.467G>A); ClinVar=VCV000001984; Zygosity=Heterozygous (Coriell=ID00017).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Gly216Arg (c.646G>A); ClinVar=VCV000001968; Zygosity=Heterozygous (Coriell=ID00017).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   ID00018
AC   CVCL_4T32
DR   CLO; CLO_0029234
DR   Coriell; ID00018
DR   Wikidata; Q54897251
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00021
AC   CVCL_2Z11
DR   CLO; CLO_0029233
DR   Coriell; ID00021
DR   Wikidata; Q54897252
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00022
AC   CVCL_2Z12
DR   CLO; CLO_0029188
DR   Coriell; ID00022
DR   Wikidata; Q54897253
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00024
AC   CVCL_2Z13
DR   CLO; CLO_0029196
DR   Coriell; ID00024
DR   Wikidata; Q54897254
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00025
AC   CVCL_2Z14
DR   CLO; CLO_0029199
DR   Coriell; ID00025
DR   Wikidata; Q54897255
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00026
AC   CVCL_2Z15
DR   CLO; CLO_0029191
DR   Coriell; ID00026
DR   Wikidata; Q54897256
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00028
AC   CVCL_2Z16
DR   CLO; CLO_0029193
DR   Coriell; ID00028
DR   Wikidata; Q54897257
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00029
AC   CVCL_2Z17
DR   CLO; CLO_0029207
DR   Coriell; ID00029
DR   Wikidata; Q54897258
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00030
AC   CVCL_8B16
DR   CLO; CLO_0029210
DR   Coriell; ID00030
DR   Wikidata; Q54897259
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85073; Selective antibody deficiency with normal immunoglobulins
DI   ORDO; Orphanet_169443; Specific antibody deficiency with normal immunoglobulin concentrations and normal numbers of B cells
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   ID00031
AC   CVCL_2Z18
DR   CLO; CLO_0029201
DR   Coriell; ID00031
DR   Wikidata; Q54897260
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00032
AC   CVCL_2Z19
DR   CLO; CLO_0029204
DR   Coriell; ID00032
DR   Wikidata; Q54897261
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00034
AC   CVCL_2Z20
DR   CLO; CLO_0029213
DR   Coriell; ID00034
DR   Wikidata; Q54897266
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00035
AC   CVCL_2Z21
DR   CLO; CLO_0029164
DR   Coriell; ID00035
DR   Wikidata; Q54897267
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple; c.361C>A; Zygosity=Hemizygous (Coriell=ID00035).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   ID00036
AC   CVCL_4T33
DR   CLO; CLO_0029165
DR   Coriell; ID00036
DR   Wikidata; Q54897268
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00037
AC   CVCL_4T34
DR   CLO; CLO_0029175
DR   Coriell; ID00037
DR   Wikidata; Q54897269
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00038
AC   CVCL_4T35
DR   CLO; CLO_0029178
DR   Coriell; ID00038
DR   Wikidata; Q54897270
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00044
AC   CVCL_2Z22
DR   Coriell; ID00044
DR   Wikidata; Q54897271
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00045
AC   CVCL_2Z23
DR   CLO; CLO_0029180
DR   Coriell; ID00045
DR   Wikidata; Q54897272
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00050
AC   CVCL_2Z24
DR   CLO; CLO_0029182
DR   Coriell; ID00050
DR   Wikidata; Q54897273
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:10820; SH2D1A; Simple; p.Arg55Ter (c.163C>T); ClinVar=VCV000010898; Zygosity=Hemizygous (Coriell=ID00050).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C170434; X-linked lymphoproliferative syndrome 1
DI   ORDO; Orphanet_538931; X-linked lymphoproliferative disease due to SH2D1A deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   ID00051
AC   CVCL_2Z25
DR   CLO; CLO_0029167
DR   Coriell; ID00051
DR   Wikidata; Q54897274
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:10820; SH2D1A; Simple; c.577G>A; Zygosity=Hemizygous (Coriell=ID00051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C170434; X-linked lymphoproliferative syndrome 1
DI   ORDO; Orphanet_538931; X-linked lymphoproliferative disease due to SH2D1A deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   ID00052
AC   CVCL_2Z26
DR   CLO; CLO_0029169
DR   Coriell; ID00052
DR   Wikidata; Q54897275
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4682; X-linked severe combined immunodeficiency
DI   ORDO; Orphanet_276; T-B+ severe combined immunodeficiency due to gamma chain deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00057
AC   CVCL_4T36
DR   CLO; CLO_0029171
DR   Coriell; ID00057
DR   Wikidata; Q54897276
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00058
AC   CVCL_4T37
DR   CLO; CLO_0029174
DR   Coriell; ID00058
DR   Wikidata; Q54897278
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ID00059
AC   CVCL_8B17
DR   CLO; CLO_0030017
DR   Coriell; ID00059
DR   Wikidata; Q54897279
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85073; Selective antibody deficiency with normal immunoglobulins
DI   ORDO; Orphanet_169443; Specific antibody deficiency with normal immunoglobulin concentrations and normal numbers of B cells
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   ID00060
AC   CVCL_8B14
DR   CLO; CLO_0030018
DR   Coriell; ID00060
DR   Wikidata; Q54897280
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   ID00061
AC   CVCL_8B15
DR   CLO; CLO_0030019
DR   Coriell; ID00061
DR   Wikidata; Q54897282
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   ID00063
AC   CVCL_2Z27
DR   Coriell; ID00063
DR   Wikidata; Q54897283
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:11935; CD40LG; Simple; p.Ala187Leufs*4 (c.559delG) (580delG); ClinVar=VCV000521393; Zygosity=Hemizygous (Coriell=ID00063).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84783; Immunodeficiency with hyper-IgM
DI   ORDO; Orphanet_101088; X-linked hyper-IgM syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   ID00064
AC   CVCL_2Z28
DR   Coriell; ID00064
DR   Wikidata; Q54897284
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:11935; CD40LG; Simple; p.Ala187Leufs*4 (c.559delG) (580delG); ClinVar=VCV000521393; Zygosity=Hemizygous (Coriell=ID00064).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84783; Immunodeficiency with hyper-IgM
DI   ORDO; Orphanet_101088; X-linked hyper-IgM syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   ID00078
AC   CVCL_2Z29
DR   Coriell; ID00078
DR   Wikidata; Q54897285
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:9831; RAG1; Simple; p.Arg332Ter (c.994C>T); ClinVar=VCV000649706; Zygosity=Heterozygous (Coriell=ID00078).
CC   Sequence variation: Mutation; HGNC; HGNC:9831; RAG1; Simple; p.Arg561His (c.1682G>A); ClinVar=VCV000013143; Zygosity=Heterozygous (Coriell=ID00078).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61240; Omenn syndrome
DI   ORDO; Orphanet_39041; Omenn syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   ID00079
AC   CVCL_2Z30
DR   Coriell; ID00079
DR   Wikidata; Q54897286
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:10031; RMRP; Simple; n.71A>G (70A>G); ClinVar=VCV000014208; Zygosity=Homozygous (Coriell=ID00079).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00081
AC   CVCL_2Z31
DR   Coriell; ID00081
DR   Wikidata; Q54897287
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:10031; RMRP; Simple; n.71A>G (70A>G); ClinVar=VCV000014208; Zygosity=Homozygous (Coriell=ID00081).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00082
AC   CVCL_2Z32
DR   Coriell; ID00082
DR   Wikidata; Q54897288
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:10031; RMRP; Simple; n.71A>G (70A>G); ClinVar=VCV000014208; Zygosity=Homozygous (Coriell=ID00082).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00083
AC   CVCL_2Z33
DR   Coriell; ID00083
DR   Wikidata; Q54897289
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:10031; RMRP; Simple; n.71A>G (70A>G); ClinVar=VCV000014208; Zygosity=Homozygous (Coriell=ID00083).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 13
//
ID   ID00084
AC   CVCL_2Z34
DR   Coriell; ID00084
DR   Wikidata; Q54897290
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:10031; RMRP; Simple; n.-24_-4dupACTACTCTGTGAAGCTGAGGA (n.-24_-4dup21) (g.-25_-5dup); ClinVar=VCV000632969; Zygosity=Heterozygous (Coriell=ID00084).
CC   Sequence variation: Mutation; HGNC; HGNC:10031; RMRP; Simple; n.147G>A (146G>A); ClinVar=VCV000379208; Zygosity=Heterozygous (Coriell=ID00084).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61245; Cartilage hair hypoplasia
DI   ORDO; Orphanet_175; Cartilage-hair hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   ID00085
AC   CVCL_2Z35
DR   Coriell; ID00085
DR   Wikidata; Q54897291
CC   Part of: US Immunodeficiency Network (USIDNET) cell repository.
CC   Sequence variation: Mutation; HGNC; HGNC:6010; IL2RG; Simple; p.Val187Gly (c.574T>G); Zygosity=Hemizygous (Coriell=ID00085).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4682; X-linked severe combined immunodeficiency
DI   ORDO; Orphanet_276; T-B+ severe combined immunodeficiency due to gamma chain deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   ID1-V-LUC hES
AC   CVCL_B0JB
SY   CGMCC11091
DR   Wikidata; Q108820530
RX   Patent=US20180172669;
RX   PubMed=29449428;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.11091.
CC   Characteristics: Stem cell model for screening drugs for pulmonary hypertension and to find a novel lead compound for the treatment of pulmonary hypertension using BMP signaling.
CC   Characteristics: Transduced with a Id1-Venus-Luc-MC1-DTA construct in which expression of the genes for Venus and luciferase are under the control of a full-length human ID1 promoter.
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   ID3-B9
AC   CVCL_C5WK
DR   Wikidata; Q116049565
RX   PubMed=36229227;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9UJQ4; Human SALL4 (Note=Isoform SALL4A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   ID228-Muscle-GG
AC   CVCL_F1G8
RX   Patent=WO2021165421A1;
CC   Group: Cetacean cell line.
CC   Group: Patented cell line.
CC   Part of: Sea Sentinels System (SSS) kit.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 19001.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=83653; ! Grampus griseus (Risso's dolphin)
OI   CVCL_F1G9 ! ID228-Skin-GG
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ID228-Skin-GG
AC   CVCL_F1G9
RX   Patent=WO2021165421A1;
CC   Group: Cetacean cell line.
CC   Group: Patented cell line.
CC   Part of: Sea Sentinels System (SSS) kit.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 19002.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=83653; ! Grampus griseus (Risso's dolphin)
OI   CVCL_F1G8 ! ID228-Muscle-GG
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ID429-Muscle-ZC
AC   CVCL_F1G7
RX   Patent=WO2021165421A1;
RX   PubMed=39608061;
CC   Group: Cetacean cell line.
CC   Group: Patented cell line.
CC   Part of: Sea Sentinels System (SSS) kit.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 19005.
CC   Doubling time: ~54 hours (PubMed=39608061).
CC   Karyotypic information: 42,XY; with ~5% tetraploid cells (PubMed=39608061).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Animal died after being stranded on a Tuscany coastline beach (PubMed=39608061).
CC   Derived from site: In situ; Skeletal muscle, longissimus; UBERON=UBERON_0000392.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9760; ! Ziphius cavirostris (Cuvier's beaked whale)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ID457-Muscle-TT
AC   CVCL_F1GA
RX   Patent=WO2021165421A1;
CC   Group: Cetacean cell line.
CC   Group: Patented cell line.
CC   Part of: Sea Sentinels System (SSS) kit.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 19003.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Animal died after being stranded on a Veneto coastline beach.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
OI   CVCL_F1GB ! ID457-Skin-TT
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ID457-Skin-TT
AC   CVCL_F1GB
RX   Patent=WO2021165421A1;
RX   PubMed=38861523;
CC   Group: Cetacean cell line.
CC   Group: Patented cell line.
CC   Part of: Sea Sentinels System (SSS) kit.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 19004.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Animal died after being stranded on a Veneto coastline beach (PubMed=38861523).
CC   Derived from site: In situ; Dorsal, skin; UBERON=UBERON_3010006.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
OI   CVCL_F1GA ! ID457-Muscle-TT
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   id5P
AC   CVCL_A6ZK
DR   RCB; RCB4667
DR   Wikidata; Q107115427
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6ZH ! rRCCd5
SX   Male
AG   25W
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   id5krm3
AC   CVCL_A6ZL
SY   id5krm#3
DR   RCB; RCB4669
DR   Wikidata; Q107115428
CC   Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4669).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6ZJ ! d5krm3
SX   Male
AG   25W
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   id5krm7
AC   CVCL_A6ZM
SY   id5krm#7
DR   RCB; RCB4668
DR   Wikidata; Q107115429
CC   Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4668).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6ZI ! d5krm7
SX   Male
AG   25W
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   ID8
AC   CVCL_IU14
SY   ID8/MOSEC
DR   CLS; 305305
DR   Millipore; SCC145
DR   PRIDE; PXD013062
DR   Ubigene; YC-C103
DR   Wikidata; Q54897292
RX   PubMed=10753190;
RX   PubMed=16886597;
RX   PubMed=18036641;
RX   PubMed=27235858;
CC   Characteristics: Physiologically and biologically closely resembles human epithelial ovarian cancer.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC145; Ubigene=YC-C103
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 18
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   ID8 Brca1 KO
AC   CVCL_F1K9
SY   ID8-Brca1-/-
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104537; Brca1.
CC   Miscellaneous: Cell line information from personal communication of Liu, Hai-Ou; Obstetrics and Gynecology Hospital; Fudan University.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ID8 Brca1/Trp53 DKO
AC   CVCL_F1JN
SY   ID8-Trp53-/-Brca1-/-
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104537; Brca1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53.
CC   Miscellaneous: Cell line information from personal communication of Liu, Hai-Ou; Obstetrics and Gynecology Hospital; Fudan University.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1KA ! ID8 Trp53 KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ID8 fat-1
AC   CVCL_E6ZE
DR   ABM; T6265
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6265).
CC   Doubling time: 30-40 hours (ABM=T6265).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ID8 Trp53 KO
AC   CVCL_F1KA
SY   ID8-Trp53-/-
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53.
CC   Miscellaneous: Cell line information from personal communication of Liu, Hai-Ou; Obstetrics and Gynecology Hospital; Fudan University.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ID8-B7H6
AC   CVCL_VA22
SY   ID8/B7H6
DR   Wikidata; Q54897293
RX   PubMed=25830550;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:42400; NCR3LG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   ID8-Fluc
AC   CVCL_IU15
SY   ID8-fluc
DR   Wikidata; Q54897294
RX   PubMed=26676113;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   ID8-Luc
AC   CVCL_C8UV
DR   Ubigene; YC-C103-Luc-P
DR   Wikidata; Q123032660
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   ID8-Luc2
AC   CVCL_IU16
SY   ID8luc2
DR   Wikidata; Q54897295
RX   PubMed=25992288;
RX   PubMed=26676113;
RX   PubMed=27235858;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   IDD-02
AC   CVCL_WA87
SY   Immune Deficiency Disease-02
DR   IBRC; C10746
DR   Wikidata; Q94314002
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   IDD-03
AC   CVCL_WA88
SY   Immune Deficiency Disease-03
DR   IBRC; C10980
DR   Wikidata; Q94314004
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3507; Immune system disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   IDE1
AC   CVCL_Z164
DR   Wikidata; Q54897296
RX   Patent=US5869335;
RX   PubMed=8064520;
CC   Group: Tick cell line.
OX   NCBI_TaxID=6945; ! Ixodes scapularis (Black-legged tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   IDE12
AC   CVCL_Z165
DR   Wikidata; Q28658510
RX   Patent=US5869335;
RX   PubMed=8057317;
RX   PubMed=8064520;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=25894426;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_0941d3180e
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=6945; ! Ixodes scapularis (Black-legged tick)
SX   Mixed sex
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IDE2
AC   CVCL_Z166
DR   Wikidata; Q54897297
RX   Patent=US5869335;
RX   PubMed=8064520;
RX   PubMed=9364140;
RX   PubMed=11257184;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_0941d3180e
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=6945; ! Ixodes scapularis (Black-legged tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IDE8
AC   CVCL_Z167
DR   Wikidata; Q54897298
RX   Patent=US5869335;
RX   PubMed=8057317;
RX   PubMed=8064520;
RX   PubMed=8812616;
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=20388200;
RX   PubMed=22743047;
RX   PubMed=29017825;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_0941d3180e
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11973.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=6945; ! Ixodes scapularis (Black-legged tick)
SX   Mixed sex
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   IDF
AC   CVCL_E707
SY   GM03105; GM 3105; GM03105A; GM3105A
DR   CLO; CLO_0013565
DR   Coriell; GM03105
DR   dbMHC; 48903
DR   ECACC; 94022530
DR   IHW; IHW09211
DR   IPD-IMGT/HLA; 10795
DR   Wikidata; Q54897299
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Jewish; Ashkenazi.
CC   HLA typing: A*69:01,66:01:01; B*18:01:01:02,38:01:01; C*12:03:01:01; DPA1*01:03:01:05,01:03:01:02; DPB1*04:01:01:01,04:02:01:01; DQA1*05:05::01:01; DQB1*03:01:01:03; DRB1*11:01:01,11:04:01; DRB3*02:02:01:02 (IPD-IMGT/HLA=10795).
CC   HLA typing: A*66:01:01,69:01; B*38:01:01,18:01:01:02; C*12:03:01:01; DPA1*01:03:01:02,01:03:01:05; DPB1*04:01:01:01(126:01),04:02:01:01(105:01); DQA1*05:05:01; DQB1*03:01:01:03; DRB1*11:01:01:01,11:04:01; DRB3*02:02:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 20
//
ID   iDFF24
AC   CVCL_VR61
SY   iDFF24.10; iPSC from Diabetic Foot Fibroblasts 24; RCSIi005-A
DR   BioSamples; SAMEA5126966
DR   hPSCreg; RCSIi005-A
DR   SKIP; SKIP003230
DR   Wikidata; Q94314056
RX   PubMed=27328415;
CC   From: Royal College of Surgeons in Ireland; Dublin; Ireland.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   iDFF9
AC   CVCL_VR62
SY   iDFF9.5; iPSC from Diabetic Foot Fibroblasts 9
DR   SKIP; SKIP003229
DR   Wikidata; Q94314059
RX   PubMed=27328415;
CC   From: Royal College of Surgeons in Ireland; Dublin; Ireland.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   iDFU25
AC   CVCL_VR64
SY   iDFU25.5; iPSC from Diabetic Foot Ulcer 25
DR   SKIP; SKIP003228
DR   Wikidata; Q94314063
RX   PubMed=27328415;
CC   From: Royal College of Surgeons in Ireland; Dublin; Ireland.
CC   Derived from site: In situ; Skin; Note=From an ulcer; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   iDFU8
AC   CVCL_VR63
SY   iDFU8.2; iPSC from Diabetic Foot Ulcer 8; RCSIi002-A
DR   BioSamples; SAMEA5120744
DR   hPSCreg; RCSIi002-A
DR   SKIP; SKIP003227
DR   Wikidata; Q94314065
RX   PubMed=27328415;
CC   From: Royal College of Surgeons in Ireland; Dublin; Ireland.
CC   Derived from site: In situ; Skin; Note=From an ulcer; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   IDG-CM6
AC   CVCL_XC35
SY   Immortomouse/Dmp1-GFP-CM6
DR   Kerafast; EKC005
DR   Kerafast; EKC006
DR   Wikidata; Q94314263
RX   PubMed=26274352;
CC   Characteristics: Expresses GFP Topaz under the control of the Dmp1 promoter.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; SY6TH; Topaz (Note=Green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Misspelling: IDG-M6; Note=In Cellosaurus releases 32 to 34.
CC   Derived from site: In situ; Tooth root; UBERON=UBERON_0003677.
CC   Cell type: Cementocyte; CL=CL_0000141.
CC   Breed/subspecies: C57BL/6-Tg(Dmp1-Topaz)1Ikal/J x (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   3M
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   IDG-HEK293T-CACNA2D4-V5-OE
AC   CVCL_YA24
DR   Wikidata; Q94314070
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacna2d4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNA2D4 with a C-terminal V5 tag. Very low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20202; CACNA2D4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNB1-V5-OE
AC   CVCL_YA25
DR   Wikidata; Q94314072
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacnb1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNB1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1401; CACNB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNB2-V5-OE
AC   CVCL_YA26
DR   Wikidata; Q94314076
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacnb2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNB2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1402; CACNB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNB4-V5-OE
AC   CVCL_YA27
DR   Wikidata; Q94314081
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacnb4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNB4 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1404; CACNB4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNG1-V5-OE
AC   CVCL_YA28
DR   Wikidata; Q94314085
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacng1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNG1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1405; CACNG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNG3-V5-OE
AC   CVCL_YA29
DR   Wikidata; Q94314088
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacng3-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNG3 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1407; CACNG3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNG5-V5-OE
AC   CVCL_YA30
DR   Wikidata; Q94314092
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacng5-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNG5 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1409; CACNG5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNG7-V5-OE
AC   CVCL_YA31
DR   Wikidata; Q94314095
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacng7-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNG7 with a C-terminal V5 tag. Very low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13626; CACNG7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CACNG8-V5-OE
AC   CVCL_YA32
DR   Wikidata; Q94314098
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cacng8-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CACNG8 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13628; CACNG8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CALHM4-V5-OE
AC   CVCL_YA44
DR   Wikidata; Q94314101
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-calhm4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CALHM4 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21094; CALHM4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CATSPER2-V5-OE
AC   CVCL_YA33
DR   Wikidata; Q94314104
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-catsper2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CATSPER2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18810; CATSPER2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CHRNA10-V5-OE
AC   CVCL_YA34
DR   Wikidata; Q94314108
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-chrna10-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CHRNA10 with a C-terminal V5 tag. Very low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13800; CHRNA10.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CHRNA2-V5-OE
AC   CVCL_YA35
DR   Wikidata; Q94314111
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-chrna2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CHRNA2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1956; CHRNA2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CHRNB1-V5-OE
AC   CVCL_YA36
DR   Wikidata; Q94314114
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-chrnb1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CHRNB1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1961; CHRNB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CHRND-V5-OE
AC   CVCL_YA37
DR   Wikidata; Q94314119
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-chrnd-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CHRND with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1965; CHRND.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CLCA4-V5-OE
AC   CVCL_YA38
DR   Wikidata; Q94314121
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-clca4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CLCA4 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2018; CLCA4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CLCN6-V5-OE
AC   CVCL_YA39
DR   Wikidata; Q94314125
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-clcn6-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CLCN6 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2024; CLCN6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CLCNKA-V5-OE
AC   CVCL_YA40
DR   Wikidata; Q94314129
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-clcnka-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CLCNKA with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2026; CLCNKA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CLIC2-V5-OE
AC   CVCL_YA41
DR   Wikidata; Q94314134
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-clic2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CLIC2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2063; CLIC2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CLIC5-V5-OE
AC   CVCL_YA42
DR   Wikidata; Q94314136
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-clic5-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CLIC5 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13517; CLIC5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-CNGA4-V5-OE
AC   CVCL_YA43
DR   Wikidata; Q94314139
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-cnga4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses CNGA4 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2152; CNGA4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-FXYD3-V5-OE
AC   CVCL_YA45
DR   Wikidata; Q94314141
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-fxyd3-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses FXYD3 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4027; FXYD3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-FXYD7-V5-OE
AC   CVCL_YA46
DR   Wikidata; Q94314145
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-fxyd7-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses FXYD7 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4034; FXYD7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-GABRA5-V5-OE
AC   CVCL_YA47
DR   Wikidata; Q94314150
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-gabra5-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses GABRA5 with a C-terminal V5 tag. The V5 tag is not detectable (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4079; GABRA5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-GABRG1-V5-OE
AC   CVCL_YA48
DR   Wikidata; Q94314152
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-gabrg1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses GABRG1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4086; GABRG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-GABRP-V5-OE
AC   CVCL_YA49
DR   Wikidata; Q94314155
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-gabrp-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses GABRP with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4089; GABRP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-GABRR1-V5-OE
AC   CVCL_YA50
DR   Wikidata; Q94314159
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-gabrr1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses GABRR1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4090; GABRR1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-GLRA3-V5-OE
AC   CVCL_YA51
DR   Wikidata; Q94314162
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-glra3-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses GLRA3 with a C-terminal V5 tag. The V5 tag is expressed in few cells (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4328; GLRA3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-GRID1-isoform-1-V5-OE
AC   CVCL_YA52
DR   Wikidata; Q94314165
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-grid1-isoform-1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses GRID1 isoform 1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4575; GRID1 (Note=Isoform 1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-GRID1-isoform-2-V5-OE
AC   CVCL_YA53
DR   Wikidata; Q94314170
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-grid1-isoform-2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses GRID1 isoform 2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4575; GRID1 (Note=Isoform 2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-HTR3C-V5-OE
AC   CVCL_YA54
DR   Wikidata; Q94314173
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-htr3c-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses HTR3C with a C-terminal V5 tag. Very low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24003; HTR3C.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-HTR3D-V5-OE
AC   CVCL_YA55
DR   Wikidata; Q94314175
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-htr3d-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses HTR3D with a C-terminal V5 tag. Low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24004; HTR3D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-HTR3E-V5-OE
AC   CVCL_YA56
DR   Wikidata; Q94314179
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-htr3e-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses HTR3E with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24005; HTR3E.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNA6-V5-OE
AC   CVCL_YA57
DR   Wikidata; Q94314180
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcna6-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNA6 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6225; KCNA6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNA7-V5-OE
AC   CVCL_YA58
DR   Wikidata; Q94314183
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcna7-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNA7 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6226; KCNA7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNAB2-V5-OE
AC   CVCL_YA59
DR   Wikidata; Q94314185
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnab2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNAB2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6229; KCNAB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNAB3-V5-OE
AC   CVCL_YA60
DR   Wikidata; Q94314187
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnab3-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNAB3 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6230; KCNAB3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNG4-V5-OE
AC   CVCL_YA61
DR   Wikidata; Q94314190
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcng4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNG4 with a C-terminal V5 tag. Very low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19697; KCNG4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNIP1-V5-OE
AC   CVCL_YA62
DR   Wikidata; Q94314191
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnip1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNIP1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15521; KCNIP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNIP4-V5-OE
AC   CVCL_YA63
DR   Wikidata; Q94314194
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnip4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNIP4 with a C-terminal V5 tag. Low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30083; KCNIP4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNJ14-V5-OE
AC   CVCL_YA64
DR   Wikidata; Q94314198
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnj14-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNJ14 with a C-terminal V5 tag. The V5 tag is not detectable (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6260; KCNJ14.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNJ15-V5-OE
AC   CVCL_YA65
DR   Wikidata; Q94314200
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnj15-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNJ15 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6261; KCNJ15.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNK12-V5-OE
AC   CVCL_YA66
DR   Wikidata; Q94314202
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnk12-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNK12 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6274; KCNK12.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNK4-V5-OE
AC   CVCL_YA67
DR   Wikidata; Q94314203
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnk4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNK4 with a C-terminal V5 tag. Low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6279; KCNK4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNK7-V5-OE
AC   CVCL_YA68
DR   Wikidata; Q94314207
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcnk7-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNK7 with a C-terminal V5 tag. Low expression of V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6282; KCNK7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNS1-V5-OE
AC   CVCL_YA69
DR   Wikidata; Q94314210
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcns1-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNS1 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6300; KCNS1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNS2-V5-OE
AC   CVCL_YA70
DR   Wikidata; Q94314214
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcns2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNS2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6301; KCNS2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-KCNS3-V5-OE
AC   CVCL_YA71
DR   Wikidata; Q94314215
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-kcns3-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses KCNS3 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6302; KCNS3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-LRRC55-V5-OE
AC   CVCL_YA73
DR   Wikidata; Q94314218
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-lrrc55-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses LRRC55 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:32324; LRRC55.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-PANX2-V5-OE
AC   CVCL_YA74
DR   Wikidata; Q94314220
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-panx2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses PANX2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8600; PANX2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-PKD1L2-V5-OE
AC   CVCL_YA75
DR   Wikidata; Q94314223
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-pkd1l2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses PKD1L2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:21715; PKD1L2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-PKD2L2-V5-OE
AC   CVCL_YA76
DR   Wikidata; Q94314224
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-pkd2l2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses PKD2L2 with a C-terminal V5 tag. The V5 tag is not detectable (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9012; PKD2L2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-PLLP-V5-OE
AC   CVCL_YA77
DR   Wikidata; Q94314227
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-pllp-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses PLLP with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:18553; PLLP.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-SCN2B-V5-OE
AC   CVCL_YA78
DR   Wikidata; Q94314230
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-scn2b-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses SCN2B with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10589; SCN2B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-SCNN1B-V5-OE
AC   CVCL_YA79
DR   Wikidata; Q94314234
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-scnn1b-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses SCNN1B with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10600; SCNN1B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-SCNN1D-V5-OE
AC   CVCL_YA80
DR   Wikidata; Q94314237
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-scnn1d-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses SCNN1D with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10601; SCNN1D.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-TMC4-V5-OE
AC   CVCL_YA81
DR   Wikidata; Q94314241
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-tmc4-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses TMC4 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:22998; TMC4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-TMEM63A-V5-OE
AC   CVCL_YA82
DR   Wikidata; Q94314245
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-tmem63a-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses TMEM63A with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29118; TMEM63A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-TMEM63B-V5-OE
AC   CVCL_YA83
DR   Wikidata; Q94314249
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-tmem63b-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses TMEM63B with a C-terminal V5 tag. The V5 tag is expressed in very few cells (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17735; TMEM63B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-TMEM63C-V5-OE
AC   CVCL_YA84
DR   Wikidata; Q94314253
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-tmem63c-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses TMEM63C with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:23787; TMEM63C.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-HEK293T-TTYH2-V5-OE
AC   CVCL_YA85
DR   Wikidata; Q94314257
WW   Provider; IDG; -; https://darkmatter.ucsf.edu/cells/idg-hek293t-ttyh2-v5-oe
CC   Part of: Illuminating the Druggable Genome consortium cell line panel.
CC   From: UCSF Cell Core; San Fransisco; USA.
CC   Characteristics: Expresses TTYH2 with a C-terminal V5 tag (IDG).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13877; TTYH2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   IDG-SW3
AC   CVCL_0P23
SY   Immortomouse/Dmp1-GFP-SW3
DR   ABM; T0231
DR   Kerafast; EKC001
DR   Kerafast; EKC004
DR   Wikidata; Q54897300
RX   PubMed=21735478;
RX   PubMed=26274352;
CC   Characteristics: Expresses GFP Topaz under the control of the Dmp1 promoter.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; SY6TH; Topaz (Note=Green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6-Tg(Dmp1-Topaz)1Ikal/J x (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Conditionally immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   IDG26.10-3
AC   CVCL_A2WP
SY   IDG3.2-R26.10-3; IDG3.2 Rosa 26.10
DR   TOKU-E; 4135
DR   Wikidata; Q105509628
RX   PubMed=17586814;
CC   Characteristics: Contains a recombinase-mediated cassette exchange (RMCE) acceptor vector pRosa26.10 (PubMed=17586814).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2WN ! IDG3.2
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 7
//
ID   IDG3.2
AC   CVCL_A2WN
SY   IDG 3.2
DR   Wikidata; Q105509631
RX   PubMed=17586814;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   IDH4
AC   CVCL_3874
SY   IMR90-D305.2H4
DR   BTO; BTO_0001896
DR   Wikidata; Q54897301
RX   PubMed=1330670;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   IDIBGIi001-A
AC   CVCL_B5TB
SY   GPG1-C23
DR   BioSamples; SAMEA12290546
DR   hPSCreg; IDIBGIi001-A
DR   Wikidata; Q111733478
RX   PubMed=35231795;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+GPG21-C23+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+GPG21-C23_Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D21S11: 27,31
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7HH ! Ctrl. BS PBiPS37-Sv4F-1
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   IDIBGIi002-A
AC   CVCL_B5TC
SY   RB20234; Rb20234-C17
DR   BioSamples; SAMEA12361512
DR   hPSCreg; IDIBGIi002-A
DR   Wikidata; Q111733479
RX   PubMed=35772296;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_Rb20234-C17.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Lineas_Rb20234-C17.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val1525Met (c.4573G>A) (p.Val1524Met, c.4570G>A); ClinVar=VCV000067910; Zygosity=Heterozygous (PubMed=35772296).
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 13
ST   D21S11: 27,32.2
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   IDIBGIi003-A
AC   CVCL_B5TD
SY   RB20235; RB20235-C5; Rb20235-C5
DR   BioSamples; SAMEA12362202
DR   hPSCreg; IDIBGIi003-A
DR   Wikidata; Q111733480
RX   PubMed=35772296;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_Rb20235-C5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_Rb20235-C5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val1525Met (c.4573G>A) (p.Val1524Met, c.4570G>A); ClinVar=VCV000067910; Zygosity=Heterozygous (PubMed=35772296).
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 13
ST   D21S11: 27,32.2
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   IDIBGIi004-A
AC   CVCL_B5TE
SY   RB20236; RB20236-C21; Rb20236-C21
DR   BioSamples; SAMEA12362304
DR   hPSCreg; IDIBGIi004-A
DR   Wikidata; Q111733481
RX   PubMed=35772296;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_Rb20236-C21.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_Rb20236-C21.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val1525Met (c.4573G>A) (p.Val1524Met, c.4570G>A); ClinVar=VCV000067910; Zygosity=Heterozygous (PubMed=35772296).
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D21S11: 30,32.2
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   IDIBGIi005-A
AC   CVCL_B5WW
SY   RB20237
DR   BioSamples; SAMEA12362312
DR   hPSCreg; IDIBGIi005-A
DR   Wikidata; Q111733482
RX   PubMed=35772296;
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   IDIBGIi006-A
AC   CVCL_C0FJ
SY   CPVT FiPS 51 EP6F-1; RB20651
DR   hPSCreg; IDIBGIi006-A
DR   Wikidata; Q112929847
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   IDIBGIi007-A
AC   CVCL_C0FK
SY   CPVT FiPS 52 EP6F-8; RB20652
DR   hPSCreg; IDIBGIi007-A
DR   Wikidata; Q112929850
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   IDIBGIi008-A
AC   CVCL_C0FL
SY   CPVT FiPS 53 EP6F-4; RB20653
DR   hPSCreg; IDIBGIi008-A
DR   Wikidata; Q112929853
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   IDIBGIi009-A
AC   CVCL_C0FM
SY   CPVT FiPS 54 EP6F-6; RB20654
DR   hPSCreg; IDIBGIi009-A
DR   Wikidata; Q112929855
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   IDIBGIi010-A
AC   CVCL_C0FN
SY   CPVT FiPS 55 EP6F-8; RB20655
DR   hPSCreg; IDIBGIi010-A
DR   Wikidata; Q112929858
CC   From: Institut d'Investigacio Biomedica de Girona Dr. Josep Trueta; Salt; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   IDISi001-A
AC   CVCL_RV23
DR   BioSamples; SAMEA4675695
DR   hPSCreg; IDISi001-A
DR   Wikidata; Q54897302
RX   PubMed=29414412;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_IDISi001-A-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_IDISi001-A-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Health Research Institute of Santiago de Compostela; Santiago de Compostela; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg1242Cys (c.3724C>T); Zygosity=Heterozygous (PubMed=29414412).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29414412
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D21S11: 30,33
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   IDMi001-A
AC   CVCL_D0FD
SY   K40
DR   BioSamples; SAMEA113400484
DR   hPSCreg; IDMi001-A
DR   Wikidata; Q123032661
CC   From: Institute for Diabetes Research and Metabolic Diseases, Helmholtz Zentrum Munchen; Munchen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; c.450+33966C>T; ClinVar=VCV000007413; Zygosity=Homozygous (hPSCreg=IDMi001-A).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IDMi001-A-1
AC   CVCL_D0FE
SY   K40 V010 39
DR   BioSamples; SAMEA113432582
DR   hPSCreg; IDMi001-A-1
DR   Wikidata; Q123032662
CC   From: Institute for Diabetes Research and Metabolic Diseases, Helmholtz Zentrum Munchen; Munchen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11641; TCF7L2; Simple; c.450+33966C>T; ClinVar=VCV000007413; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0FD ! IDMi001-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   iDP6
AC   CVCL_WK43
SY   immortalized Dermal Papilla 6
DR   ABM; T0720
DR   Wikidata; Q94314294
RX   PubMed=29383288;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   iDPC3
AC   CVCL_C1Y5
SY   iDPC subclone 3
DR   GEO; GSM702127
DR   GEO; GSM702128
DR   Wikidata; Q114311703
RX   PubMed=25889179;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y6 ! iDPC4
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   iDPC4
AC   CVCL_C1Y6
DR   Wikidata; Q114311704
RX   PubMed=25889179;
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y5 ! iDPC3
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   IDVi001-A
AC   CVCL_QX82
SY   NR2E3-86-iPS; iPS-NR2E3-86
DR   BioSamples; SAMEA994012
DR   hPSCreg; IDVi001-A
DR   Wikidata; Q54897303
RX   PubMed=29034877;
CC   From: Institut de la Vision; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:7974; NR2E3; Simple; p.Gly56Arg (c.166G>A); ClinVar=VCV000005533; Zygosity=Heterozygous (PubMed=29034877).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   IDVi002-A
AC   CVCL_QY74
SY   PRPF31-4138-iPS; iPS-PRPF31-4138
DR   BioSamples; SAMEA994013
DR   hPSCreg; IDVi002-A
DR   Wikidata; Q54897304
RX   PubMed=29040912;
CC   From: Institut de la Vision; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Cys247Ter (c.709_734dup); Zygosity=Heterozygous (PubMed=29040912).
CC   Misspelling: IDVi0002-A; Note=In Cellosaurus release 25.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   IDVi003-A
AC   CVCL_XJ40
SY   ITM2B-5286-3
DR   BioSamples; SAMEA5945660
DR   hPSCreg; IDVi003-A
DR   Wikidata; Q94314311
RX   PubMed=31731182;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6174; ITM2B; Simple; p.Glu261Ala (c.782A>C); ClinVar=VCV000157606; Zygosity=Heterozygous (PubMed=31731182).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168587; Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
DI   ORDO; Orphanet_397758; Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ41 ! IDVi003-B
OI   CVCL_XJ42 ! IDVi003-C
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   IDVi003-A-4
AC   CVCL_C9J4
SY   IDVi003-A_CR13; ITM2B-5286-3_CR13
DR   hPSCreg; IDVi003-A-4
DR   Wikidata; Q123032663
RX   PubMed=37473460;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6174; ITM2B; Simple_corrected; p.Glu261Ala (c.782A>C); ClinVar=VCV000157606; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37473460).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168587; Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
DI   ORDO; Orphanet_397758; Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XJ40 ! IDVi003-A
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IDVi003-A-5
AC   CVCL_C9J5
SY   IDVi003-A_CR21; ITM2B-5286-3_CR21
DR   hPSCreg; IDVi003-A-5
DR   Wikidata; Q123032664
RX   PubMed=37473460;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6174; ITM2B; Simple_corrected; p.Glu261Ala (c.782A>C); ClinVar=VCV000157606; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37473460).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168587; Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
DI   ORDO; Orphanet_397758; Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XJ40 ! IDVi003-A
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IDVi003-A-6
AC   CVCL_C9J6
SY   IDVi003-A_CR24; ITM2B-5286-3_CR24
DR   hPSCreg; IDVi003-A-6
DR   Wikidata; Q123032665
RX   PubMed=37473460;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6174; ITM2B; Simple_corrected; p.Glu261Ala (c.782A>C); ClinVar=VCV000157606; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37473460).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168587; Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
DI   ORDO; Orphanet_397758; Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XJ40 ! IDVi003-A
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IDVi003-B
AC   CVCL_XJ41
SY   ITM2B-5286-12
DR   hPSCreg; IDVi003-B
DR   Wikidata; Q94314313
RX   PubMed=31731182;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6174; ITM2B; Simple; p.Glu261Ala (c.782A>C); ClinVar=VCV000157606; Zygosity=Heterozygous (PubMed=31731182).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168587; Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
DI   ORDO; Orphanet_397758; Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ40 ! IDVi003-A
OI   CVCL_XJ42 ! IDVi003-C
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   IDVi003-C
AC   CVCL_XJ42
SY   ITM2B-5286-19
DR   hPSCreg; IDVi003-C
DR   Wikidata; Q94314317
RX   PubMed=31731182;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6174; ITM2B; Simple; p.Glu261Ala (c.782A>C); ClinVar=VCV000157606; Zygosity=Heterozygous (PubMed=31731182).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168587; Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities
DI   ORDO; Orphanet_397758; Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ40 ! IDVi003-A
OI   CVCL_XJ41 ! IDVi003-B
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   IDVi004-A
AC   CVCL_XJ43
SY   ITM2B-5269-1
DR   hPSCreg; IDVi004-A
DR   Wikidata; Q94314320
RX   PubMed=31731182;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ44 ! IDVi004-B
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 7
//
ID   IDVi004-B
AC   CVCL_XJ44
SY   ITM2B-5269-2
DR   hPSCreg; IDVi004-B
DR   Wikidata; Q94314323
RX   PubMed=31731182;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ43 ! IDVi004-A
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 7
//
ID   IDVi005-A
AC   CVCL_XD14
SY   hiPSC_5f; iPSC-line-5f; hiPSC line-5f
DR   BioSamples; SAMEA6032587
DR   hPSCreg; IDVi005-A
DR   Wikidata; Q94314327
RX   PubMed=31396286;
CC   From: Institut de la Vision; Paris; France.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   IE-10
AC   CVCL_9182
DR   CLO; CLO_0004339
DR   ATCC; CRL-2462
DR   Wikidata; Q54897305
RX   PubMed=3996750;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10761; Mouse Zp3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   IE-3
AC   CVCL_9183
DR   CLO; CLO_0004340
DR   ABCD; ABCD_AF378
DR   ATCC; CRL-2463
DR   Wikidata; Q54897306
RX   PubMed=6699085;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20239; Mouse Zp2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   IEB
AC   CVCL_W362
SY   Indian Etroplus Brain
DR   NRFC; NRFC043
DR   Wikidata; Q54897311
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=22268432;
WW   Provider; AAHL; -; https://aahl.res.in/pearl-spot-fish-etroplus-suratensis-eye-iee-gill-ieg-kidney-iek-and-brain-ieb-cell-lines/
WW   Provider; NRFC; NRFC043; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC043.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=238232; ! Etroplus suratensis (Green chromide)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   IEC-14
AC   CVCL_T758
SY   IEC 14; IEC14; Intestinal Epithelioid Cell line No. 14
DR   Wikidata; Q54897312
RX   PubMed=88453;
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   18-24D
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   IEC-17
AC   CVCL_T759
SY   IEC 17; IEC17; Intestinal Epithelioid Cell line No. 17
DR   TOKU-E; 4045
DR   Wikidata; Q54897313
RX   PubMed=3757038;
RX   PubMed=6273638;
CC   Doubling time: 22.4 hours (PubMed=6273638).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18-24D
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   IEC-18
AC   CVCL_0342
SY   IEC 18; IEC18; Intestinal Epithelioid Cell line No. 18
DR   BTO; BTO_0004604
DR   CLO; CLO_0004341
DR   MCCL; MCC:0000238
DR   CLDB; cl1801
DR   ATCC; CRL-1589
DR   BCRC; 60230
DR   BCRJ; 0116
DR   CLS; 305302
DR   ECACC; 88011801
DR   IZSLER; BS CL 224
DR   KCLB; 21589
DR   NCBI_Iran; C528
DR   Wikidata; Q54897314
RX   PubMed=6273638;
RX   PubMed=22358603;
CC   Senescence: Capable of at least 20 PDL.
CC   Doubling time: 16.6 hours (PubMed=6273638).
CC   Discontinued: IZSLER; BS CL 224; probable.
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18-24D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   IEC-6
AC   CVCL_0343
SY   IEC 6; IEC6; Intestinal Epithelioid Cell line No. 6
DR   BTO; BTO_0001497
DR   CLO; CLO_0004342
DR   CLO; CLO_0050826
DR   MCCL; MCC:0000239
DR   CLDB; cl1802
DR   CLDB; cl1803
DR   CLDB; cl5209
DR   AddexBio; P0021001/81
DR   ATCC; CRL-1592
DR   BCRC; 60301
DR   BCRJ; 0117
DR   CCRID; 1101RAT-PUMC000110
DR   ChEMBL-Cells; CHEMBL4295425
DR   ChEMBL-Targets; CHEMBL4296440
DR   CLS; 302149
DR   DSMZ; ACC-111
DR   DSMZCellDive; ACC-111
DR   ECACC; 88071401
DR   IZSLER; BS CL 117
DR   KCB; KCB 200720YJ
DR   KCLB; 21592
DR   Lonza; 980
DR   PubChem_Cell_line; CVCL_0343
DR   RCB; RCB0993
DR   Wikidata; Q54897315
RX   PubMed=88453;
RX   PubMed=7681632;
RX   PubMed=8552090;
RX   PubMed=11925460;
RX   PubMed=15463957;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-606.html
CC   Senescence: Capable of at least 10 PDL.
CC   Doubling time: ~20 hours (PubMed=88453); ~50 hours (DSMZ=ACC-111).
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   18-24D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   IEC-CF7
AC   CVCL_6973
DR   BTO; BTO_0002579
DR   Wikidata; Q54897316
RX   PubMed=7681632;
RX   PubMed=15463957;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1884; CFTR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0343 ! IEC-6
SX   Male
AG   18-24D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   iEc-ESC
AC   CVCL_A9J8
SY   immortalized Endometrial cyst-Endometriotic Stromal Cell line
DR   Wikidata; Q102114206
RX   PubMed=32542539;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C4069; Ovarian endometriotic cyst
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   IEC-Mx2Luc-10
AC   CVCL_E6EK
RX   PubMed=23940817;
CC   Characteristics: Developed from a transgenic mouse that expresses luciferase driven by the promoter of the interferon-stimulated gene Mx2. Tool for the detection of type I and type III IFN responses that recapitulate the in vivo situation and to study the molecular mechanisms of innate immunity of the small intestinal epithelium (PubMed=23940817).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Mx2-Luc transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   19-20FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IEC6-Cdx2L1
AC   CVCL_A5RH
DR   Wikidata; Q107115430
RX   PubMed=8552090;
CC   Characteristics: Cdx2 can conditionally be expressed by addition of IPTG in the culture media. This cell line was engineered with the LacSwitch system in this case composed of two plasmids, pOPRSVI-Cdx2 that contains a RSV LTR promoter, 2 lacO sites (lactose repressor), cdX2 and a neo gene and p3'SS that contains the LacI and hph genes. Thus when IPTG is added to the culture media, repression mediated by lacI is removed and Cdx2 is expressed (PubMed=8552090).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88361; Cdx2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0343 ! IEC-6
SX   Male
AG   18-24D
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   IEC6-Cdx2L2
AC   CVCL_A5RI
DR   Wikidata; Q107115431
RX   PubMed=8552090;
CC   Characteristics: Cdx2 can conditionally be expressed by addition of IPTG in the culture media. This cell line was engineered with the LacSwitch system in this case composed of two plasmids, pOPRSVI-Cdx2 that contains a RSV LTR promoter, 2 lacO sites (lactose repressor), cdX2 and a neo gene and p3'SS that contains the LacI and hph genes. Thus when IPTG is added to the culture media, repression mediated by lacI is removed and Cdx2 is expressed (PubMed=8552090).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88361; Cdx2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03023; Escherichia coli lacI.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0343 ! IEC-6
SX   Male
AG   18-24D
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   IEC6-Cdx2MT15
AC   CVCL_A5RJ
DR   Wikidata; Q107115433
RX   PubMed=8552090;
CC   Characteristics: The transfected Cdx2 gene is under the csheep MT1 gene (PubMed=8552090).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88361; Cdx2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0343 ! IEC-6
SX   Male
AG   18-24D
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   IEE
AC   CVCL_W361
SY   Indian Etroplus Eye
DR   NRFC; NRFC040
DR   Wikidata; Q54897317
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=22268432;
WW   Provider; AAHL; -; https://aahl.res.in/pearl-spot-fish-etroplus-suratensis-eye-iee-gill-ieg-kidney-iek-and-brain-ieb-cell-lines/
WW   Provider; NRFC; NRFC040; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC040.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=238232; ! Etroplus suratensis (Green chromide)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   iEECs
AC   CVCL_C0WP
SY   immortal Endometrial Epithelial Cells
DR   Wikidata; Q114311705
RX   PubMed=35278881;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   IEG
AC   CVCL_W364
SY   Indian Etroplus Gill
DR   NRFC; NRFC042
DR   Wikidata; Q54897318
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=22268432;
RX   PubMed=25052522;
WW   Provider; AAHL; -; https://aahl.res.in/pearl-spot-fish-etroplus-suratensis-eye-iee-gill-ieg-kidney-iek-and-brain-ieb-cell-lines/
WW   Provider; NRFC; NRFC042; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC042.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=238232; ! Etroplus suratensis (Green chromide)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   iehESCs
AC   CVCL_F0JZ
SY   Immortalized human Endometrial Stromal Cells
WW   Provider; Immocell; IM-H442; http://www.immocell.com/?ryxbx/1318.html
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Misspelling: iheESCs; Note=In some Immocell documents and web pages.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
ST   Source(s): Immocell=IM-H442
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18,20,23
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D18S51: 12,15
ST   D19S433: 13,15.2
ST   D1S1656: 13,14,15
ST   D21S11: 29,31
ST   D2S1338: 20,25
ST   D2S441: 12
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D6S1043: 11,19
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IEHF
AC   CVCL_C8CQ
SY   IntErlobular Human Fibroblast
DR   CancerTools; 153784
DR   Wikidata; Q123032666
DR   Ximbio; 153784
RX   PubMed=27809866;
CC   Characteristics: CD105low/CD26high fibroblasts (Ximbio=153784).
CC   Derived from site: In situ; Breast, terminal lactiferous duct; UBERON=UBERON_0015133.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8CP ! IAHF
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   IEK
AC   CVCL_W363
SY   Indian Etroplus Kidney
DR   NRFC; NRFC041
DR   Wikidata; Q54897319
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=22268432;
WW   Provider; AAHL; -; https://aahl.res.in/pearl-spot-fish-etroplus-suratensis-eye-iee-gill-ieg-kidney-iek-and-brain-ieb-cell-lines/
WW   Provider; NRFC; NRFC041; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC041.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=238232; ! Etroplus suratensis (Green chromide)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   iEM
AC   CVCL_B6XW
DR   Wikidata; Q111733484
RX   PubMed=34997030;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, sweat gland; UBERON=UBERON_0001820.
CC   Cell type: Myoepithelial cell of sweat gland; CL=CL_1000417.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   iETF-Mecp2-R255X
AC   CVCL_E6BP
DR   ABM; T0870
RX   PubMed=32469049;
CC   Sequence variation: Mutation; MGI; MGI:99918; Mecp2; Simple_edited; p.Arg255Ter; Zygosity=Hemizygous; Note=By CRISPR/Cas9. In the mouse line (PubMed=32469049).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iETF-Mecp2-R294X
AC   CVCL_E6BQ
DR   ABM; T0871
RX   PubMed=32469049;
CC   Sequence variation: Mutation; MGI; MGI:99918; Mecp2; Simple_edited; p.Arg294Ter; Zygosity=Hemizygous; Note=By CRISPR/Cas9. In the mouse line (PubMed=32469049).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iETF-Mecp2-WT
AC   CVCL_E6BR
DR   ABM; T0869
RX   PubMed=32469049;
CC   Characteristics: Control cell line for iETF-Mecp2-R255X (CVCL_E6BP) and iETF-Mecp2-R294X (CVCL_E6BQ) (PubMed=32469049).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IF6
AC   CVCL_6999
SY   IF-6; 1F6
DR   BTO; BTO_0002802
DR   Cosmic; 1181746
DR   Wikidata; Q54366474
RX   PubMed=1918136;
RX   PubMed=2060184;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   IFAR-632/2
AC   CVCL_UI91
SY   IFAR 632/2; FA32
DR   Wikidata; Q93549304
RX   PubMed=15004464;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.631+1G>A (IVS7+1G>A); ClinVar=VCV000009348; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=15004464).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1894Ter (c.5682C>G) (5910C>G); ClinVar=VCV000037989; Zygosity=Heterozygous (PubMed=15004464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   IFAR-772/1
AC   CVCL_UI89
SY   IFAR 772/1; FA19
DR   Wikidata; Q93549189
RX   PubMed=15004464;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Val220Ilefs*4 (c.658_659delGT) (886delGT); ClinVar=VCV000009342; Zygosity=Heterozygous (PubMed=15004464).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Leu2740Ter (c.8219T>A) (8447T>A); ClinVar=VCV000009343; Zygosity=Heterozygous (PubMed=15004464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   IFAR-847
AC   CVCL_A2WT
DR   Wikidata; Q105509634
RX   PubMed=17200671;
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Arg753Ter (c.2257C>T); ClinVar=VCV002418913; ClinVar=VCV000142403; Zygosity=Heterozygous (PubMed=17200671).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Tyr1183Ter (c.3549C>A); ClinVar=VCV000128144; Zygosity=Heterozygous (PubMed=17200671).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176894; Fanconi anemia, complementation group N
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   IFAR-849
AC   CVCL_A2WU
DR   Wikidata; Q105509637
RX   PubMed=17200671;
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Asn1039Ilefs*2 (c.3116delA); ClinVar=VCV000126715; Zygosity=Heterozygous (PubMed=17200671).
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Tyr1183Ter (c.3549C>G); ClinVar=VCV000001245; Zygosity=Heterozygous (PubMed=17200671).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176894; Fanconi anemia, complementation group N
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   IFAR-900/1
AC   CVCL_UI90
SY   IFAR 900/1; FA30
DR   Wikidata; Q93549277
RX   PubMed=15004464;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn372His (c.1114A>C) (1342C>A); ClinVar=VCV000009329; Zygosity=Heterozygous (PubMed=15004464).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn863Lysfs*18 (c.2588dupA) (2816insA); ClinVar=VCV000037793; Zygosity=Heterozygous (PubMed=15004464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   IFGCP-F1BA10
AC   CVCL_G125
DR   CLO; CLO_0004343
DR   ATCC; HB-8291
DR   BCRC; 60431
DR   Wikidata; Q54897320
RX   Patent=US4599306;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8291.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   IFN-alpha/beta Rec KO (129)
AC   CVCL_C0L4
SY   IFN-alpha/beta Rec KO (129) Macrophage Cell Line
DR   Kerafast; ENH173-FP
DR   Wikidata; Q112929859
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:107658; Ifnar1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   IFN-gamma KO (C57)
AC   CVCL_C0L5
SY   IFN-gamma KO (C57) Macrophage Cell Line
DR   Kerafast; ENH172-FP
DR   Wikidata; Q112929860
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:107656; Ifng.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   IFN-gamma Rec KO (129)
AC   CVCL_C0L6
SY   IFN-gamma Rec KO (129) Macrophage Cell Line
DR   Kerafast; ENH174-FP
DR   Wikidata; Q112929861
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:107655; Ifngr1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:107654; Ifngr2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   IFRS1
AC   CVCL_E5UZ
SY   Immortalized Fischer Rat Schwann cells 1
DR   ABM; T0294
RX   PubMed=21394758;
RX   PubMed=28707715;
WW   Provider; Cosmo Bio; PMC-SWN-IFRS1C; https://www.cosmobiousa.com/products/schwann-cell-line-ifrs1-rat
CC   Characteristics: Has the ability to myelinate neurites in co-culture with rat DRG neurons (PubMed=21394758).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IFRS1L11
AC   CVCL_E5V0
RX   PubMed=21394758;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E5UZ ! IFRS1
SX   Sex unspecified
AG   4-6W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   iFTSEC283
AC   CVCL_C3M9
SY   iFTE283
DR   GEO; GSM2889275
DR   GEO; GSM2889276
DR   GEO; GSM2889277
DR   GEO; GSM2889278
DR   GEO; GSM2889279
DR   GEO; GSM2889280
DR   Wikidata; Q116049566
RX   PubMed=29844388;
RX   PubMed=30487138;
RX   PubMed=34253763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Monteiro, Alvaro N.A.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D21S11: 30,33.2
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 9,13
ST   FGA: 19,23
ST   Penta D: 10,13
ST   Penta E: 7,15
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3H7 ! FTE283
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   iFTSEC283 p53R175H
AC   CVCL_C3MA
SY   iFTSEC283p53R175H
DR   Wikidata; Q116049567
RX   PubMed=34253763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg175His).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Cell type: Fallopian tube secretory epithelial cell; CL=CL_4030006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3M9 ! iFTSEC283
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   Ig(1a)8.3
AC   CVCL_L528
SY   20-8.3
DR   CLO; CLO_0004344
DR   ATCC; TIB-148
DR   Wikidata; Q54897321
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   Ig(4a)10.9
AC   CVCL_L529
SY   20-9.10
DR   CLO; CLO_0004345
DR   ATCC; HB-146
DR   Wikidata; Q54897322
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   Ig(5a)7.2
AC   CVCL_L530
SY   10-4-22
DR   CLO; CLO_0004346
DR   ATCC; TIB-97
DR   ATCC; TIB-149
DR   Wikidata; Q54897323
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Discontinued: ATCC; TIB-97; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   Ig(5b)6.3
AC   CVCL_L531
SY   11-6.3.1
DR   CLO; CLO_0004347
DR   ATCC; TIB-96
DR   Wikidata; Q54897324
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   Ig1.Sk/mu
AC   CVCL_S179
DR   ATCC; CRL-6259
DR   Wikidata; Q54897325
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6259; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9725; ! Inia geoffrensis (Amazon river dolphin)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   IG10
AC   CVCL_C7EZ
DR   Wikidata; Q117704520
RX   PubMed=6548727;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03972; Bovine AMH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Ig2.M
AC   CVCL_S180
DR   ATCC; CRL-6260
DR   Wikidata; Q54897326
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6260; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9725; ! Inia geoffrensis (Amazon river dolphin)
OI   CVCL_S181 ! Ig2.Sk
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Ig2.Sk
AC   CVCL_S181
DR   ATCC; CRL-6261
DR   Wikidata; Q54897327
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6261; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9725; ! Inia geoffrensis (Amazon river dolphin)
OI   CVCL_S180 ! Ig2.M
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Igaki
AC   CVCL_VG00
DR   Wikidata; Q54897328
RX   PubMed=12738951;
CC   Population: Japanese.
CC   Virology: HPV16 in only detected in early passages.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 11
//
ID   IG8
AC   CVCL_C7F0
DR   Wikidata; Q117704521
RX   PubMed=6548727;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03972; Bovine AMH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IgE-14-205
AC   CVCL_DC76
DR   Wikidata; Q54897329
RX   Patent=EP0008092B1;
RX   PubMed=703844;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8009.
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   IGEL a2
AC   CVCL_K044
SY   15.3
DR   CLO; CLO_0004384
DR   ATCC; TIB-142
DR   Wikidata; Q54897330
RX   PubMed=6790293;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgE Iga haplotype.
CC   Monoclonal antibody target: ChEBI; CHEBI_53067; 2,4,6-trinitrophenyl group (TNP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   IGEL b4
AC   CVCL_K045
DR   CLO; CLO_0004385
DR   ATCC; TIB-141
DR   BCRC; 60451
DR   Wikidata; Q54897331
RX   PubMed=6790293;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgE Igb haplotype.
CC   Monoclonal antibody target: ChEBI; CHEBI_53067; 2,4,6-trinitrophenyl group (TNP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   IGF031/85
AC   CVCL_U950
DR   CLO; CLO_0005024
DR   CLDB; cl2029
DR   Wikidata; Q54897332
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84546; Alkaptonuria
DI   ORDO; Orphanet_56; Alkaptonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   IgG-11H4
AC   CVCL_L597
DR   CLO; CLO_0006466
DR   ATCC; CRL-1936
DR   Wikidata; Q54897333
RX   PubMed=2762297;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q07954; Human LRP1/CD91.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 6
//
ID   IgG-11H9
AC   CVCL_G655
DR   CLO; CLO_0006467
DR   ATCC; CRL-2213
DR   Wikidata; Q54897334
RX   PubMed=1730758;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16258; Rabbit OSBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   IgG-13D3
AC   CVCL_0F32
SY   13D3
DR   ATCC; CRL-2932
DR   Wikidata; Q54897335
RX   PubMed=17080197;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NBP7; Human PCSK9.
CC   Discontinued: ATCC; CRL-2932; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   IgG-15A6
AC   CVCL_0F33
SY   15A6
DR   ATCC; CRL-2933
DR   Wikidata; Q54897336
RX   PubMed=17080197;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NBP7; Human PCSK9.
CC   Discontinued: ATCC; CRL-2933; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   IgG-1B3
AC   CVCL_G656
SY   anti LRP 85
DR   CLO; CLO_0006468
DR   ATCC; CRL-1937
DR   Wikidata; Q54897337
RX   PubMed=2250029;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; G1T4Z1; Rabbit LRP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-1B7
AC   CVCL_G666
SY   IgG-IB7
DR   CLO; CLO_0006480
DR   ATCC; CRL-2418
DR   Wikidata; Q54897338
RX   PubMed=8419339;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04631; Rat Fnta.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-1C6
AC   CVCL_G657
DR   CLO; CLO_0006469
DR   ATCC; CRL-2224
DR   Wikidata; Q54897339
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q12772; Human SREBF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-1D2
AC   CVCL_G658
DR   CLO; CLO_0006470
DR   ATCC; CRL-2545
DR   Wikidata; Q54897340
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q12772; Human SREBF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-2A4
AC   CVCL_G659
DR   CLO; CLO_0006471
DR   ATCC; CRL-2121
DR   Wikidata; Q54897341
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P36956; Human SREBF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-2F1
AC   CVCL_G660
DR   CLO; CLO_0006472
DR   ATCC; CRL-2419
DR   Wikidata; Q54897342
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P24386; Human CHM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   IgG-3B2
AC   CVCL_G661
DR   CLO; CLO_0006473
DR   ATCC; CRL-2693
DR   Wikidata; Q54897343
RX   PubMed=11832248;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9VW37; Drosophila melanogaster SREBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-4A4
AC   CVCL_G662
DR   CLO; CLO_0006474
DR   ATCC; CRL-1898
DR   BCRC; 60033
DR   Wikidata; Q54897344
RX   PubMed=3320043;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01130; Human LDLR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   IgG-5D7
AC   CVCL_G663
SY   anti LRP 515
DR   CLO; CLO_0006475
DR   ATCC; CRL-1938
DR   Wikidata; Q54897345
RX   PubMed=2250029;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; G1T4Z1; Rabbit LRP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-6A6
AC   CVCL_G664
DR   CLO; CLO_0006476
DR   ATCC; CRL-2197
DR   ECACC; 97040309
DR   Wikidata; Q54897346
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P98166; Rat Vldlr (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   IgG-7D4
AC   CVCL_G665
DR   CLO; CLO_0006477
DR   ATCC; CRL-2198
DR   Wikidata; Q54897347
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q60429; Cricetulus griseus Srebf2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-9D5
AC   CVCL_L598
DR   CLO; CLO_0006478
DR   ATCC; CRL-2347
DR   Wikidata; Q54897349
RX   PubMed=9242699;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P97260; Cricetulus griseus Scap.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   IgG-9D9
AC   CVCL_E976
SY   9D9
DR   CLO; CLO_0001539
DR   ATCC; CRL-1703
DR   Wikidata; Q54897350
RX   PubMed=6088578;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01131; Bovine LDLR (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   IgG-B16
AC   CVCL_G126
DR   CLO; CLO_0006479
DR   ATCC; CRL-1899
DR   ECACC; 94080428
DR   Wikidata; Q54897351
RX   PubMed=2722817;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A0A3Q0CFT2; Mesocricetus auratus OSBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   IgG-C7
AC   CVCL_1971
SY   C7
DR   CLO; CLO_0002147
DR   ATCC; CRL-1691
DR   ECACC; 88090802
DR   Wikidata; Q54897353
RX   PubMed=3320043;
RX   PubMed=6271765;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01131; Bovine LDLR (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   IGGi001-A
AC   CVCL_C7FT
DR   BioSamples; SAMEA113595389
DR   hPSCreg; IGGi001-A
DR   Wikidata; Q117704522
RX   PubMed=36580887;
CC   From: IRCCS Istituto Giannina Gaslini; Genova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:14234; NSD1; Zygosity=Unspecified; Note=5q35.2q35.3 microdeletion (PubMed=36580887).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7FU ! IGGi001-B
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   IGGi001-B
AC   CVCL_C7FU
DR   BioSamples; SAMEA113595160
DR   hPSCreg; IGGi001-B
DR   Wikidata; Q117704523
RX   PubMed=36580887;
CC   From: IRCCS Istituto Giannina Gaslini; Genova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:14234; NSD1; Zygosity=Unspecified; Note=5q35.2q35.3 microdeletion (PubMed=36580887).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7FT ! IGGi001-A
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   IGGi002-A
AC   CVCL_D0FF
SY   IGGi002A; hNEC-iPSC-G542X-7
DR   BioSamples; SAMEA113585496
DR   hPSCreg; IGGi002-A
DR   Wikidata; Q123032667
RX   PubMed=37865062;
CC   From: IRCCS Istituto Giannina Gaslini; Genova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gly542Ter (c.1624G>T); ClinVar=VCV000007115; Zygosity=Homozygous (PubMed=37865062).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IGGi003-A
AC   CVCL_D6MP
DR   BioSamples; SAMEA114498470
DR   hPSCreg; IGGi003-A
DR   Wikidata; Q127382323
RX   PubMed=38301425;
CC   From: IRCCS Istituto Giannina Gaslini; Genova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14234; NSD1; Simple; p.Thr545Argfs*10 (c.1633delA); Zygosity=Heterozygous; Note=De novo mutation (PubMed=38301425).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IGGi004-A
AC   CVCL_D6MQ
SY   ZEB2 case 1
DR   BioSamples; SAMEA114786339
DR   hPSCreg; IGGi004-A
DR   Wikidata; Q127382324
RX   PubMed=38350246;
CC   From: IRCCS Istituto Giannina Gaslini; Genova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14881; ZEB2; Simple; p.Leu894Phefs*36 (c.2682delA); ClinVar=VCV002687500; Zygosity=Heterozygous (PubMed=38350246).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74999; Mowat-Wilson syndrome
DI   ORDO; Orphanet_261552; Mowat-Wilson syndrome due to a ZEB2 point mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IGGi005-A
AC   CVCL_D6MR
SY   ZEB2 case 2
DR   BioSamples; SAMEA114786370
DR   hPSCreg; IGGi005-A
DR   Wikidata; Q127382325
RX   PubMed=38350246;
CC   From: IRCCS Istituto Giannina Gaslini; Genova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14881; ZEB2; Simple; p.Arg218Argfs*21 (c.653_654insACCG); Zygosity=Heterozygous (PubMed=38350246).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C74999; Mowat-Wilson syndrome
DI   ORDO; Orphanet_261552; Mowat-Wilson syndrome due to a ZEB2 point mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IGGi006-A
AC   CVCL_E8AZ
DR   BioSamples; SAMEA115597188
DR   hPSCreg; IGGi006-A
RX   PubMed=40112765;
CC   From: IRCCS Istituto Giannina Gaslini; Genova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6743; CAPRIN1; Simple; p.Gln582Ter (c.1744C>T); ClinVar=VCV003069142; Zygosity=Heterozygous (PubMed=40112765).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215155; Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder
DI   ORDO; Orphanet_528084; Non-specific syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IgH-2
AC   CVCL_4346
SY   IGH-2; IgH2; Iguana Heart-2
DR   CLO; CLO_0006481
DR   CLDB; cl2608
DR   ATCC; CCL-108
DR   ECACC; 90030804
DR   IZSLER; BS CL 185
DR   Wikidata; Q54897355
RX   DOI=10.1007/BF02618370;
RX   PubMed=4314147;
RX   PubMed=4344303;
RX   PubMed=4350126;
RX   PubMed=15621521;
RX   PubMed=23891577;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8517; ! Iguana iguana (Common iguana)
SX   Male
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   IGIBi001-A
AC   CVCL_WR00
SY   SCP28
DR   BioSamples; SAMEA5780087
DR   hPSCreg; IGIBi001-A
DR   SKIP; SKIP005534
DR   Wikidata; Q94314634
RX   PubMed=31255831;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=31255831).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   IGIBi002-A [2018]
AC   CVCL_VN63
SY   SCA12_001
DR   BioSamples; SAMEA7683938
DR   Wikidata; Q94314638
RX   PubMed=30130680;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion; CAG[59]; ClinVar=VCV000005614; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[14] (PubMed=30130680).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Two different cell lines were established by CSIR-IGIB with the same IGIBi002-A designation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154316; Spinocerebellar ataxia type 12
DI   ORDO; Orphanet_98762; Spinocerebellar ataxia type 12
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   IGIBi002-A [2021]
AC   CVCL_A4WZ
SY   BTP8
DR   hPSCreg; IGIBi002-A
DR   Wikidata; Q107115435
RX   PubMed=33338925;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.92+5G>C (IVS1,G>C,+5) (IVS1-5G>C); ClinVar=VCV000015447; Zygosity=Homozygous (PubMed=33338925).
CC   Caution: Two different cell lines were established by CSIR-IGIB with the same IGIBi002-A designation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   IGIBi003-A
AC   CVCL_VN64
SY   SCA12_002
DR   hPSCreg; IGIBi003-A
DR   Wikidata; Q94314642
RX   PubMed=30130680;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion; CAG[67]; ClinVar=VCV000005614; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[10] (PubMed=30130680).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154316; Spinocerebellar ataxia type 12
DI   ORDO; Orphanet_98762; Spinocerebellar ataxia type 12
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   IGIBi004-A
AC   CVCL_VN65
SY   SCA12_003
DR   hPSCreg; IGIBi004-A
DR   Wikidata; Q94314644
RX   PubMed=30130680;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion; CAG[65]; ClinVar=VCV000005614; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[17] (PubMed=30130680).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154316; Spinocerebellar ataxia type 12
DI   ORDO; Orphanet_98762; Spinocerebellar ataxia type 12
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   IGIBi005-A
AC   CVCL_C2VZ
SY   KIF5A-GOC-02; KIF5A_GOC02; GOC02_KIF5a
DR   hPSCreg; IGIBi005-A
DR   Wikidata; Q114311706
RX   PubMed=36055117;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple; c.3020+3A>T; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=36055117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C189922; Amyotrophic lateral sclerosis 25
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   IGIBi006-A
AC   CVCL_C3RT
SY   DMD46-48
DR   hPSCreg; IGIBi006-A
DR   Wikidata; Q116049568
RX   PubMed=36191544;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex46-48del; Zygosity=Hemizygous (PubMed=36191544).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   IGIBi007-A
AC   CVCL_A7JB
SY   GOC-01
DR   hPSCreg; IGIBi007-A
DR   Wikidata; Q107115436
RX   PubMed=33887582;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9416; PRKG2; Simple; p.Asn164Lysfs*2 (c.491dup); ClinVar=VCV001326258; Zygosity=Homozygous (PubMed=33887582).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179298; Acromesomelic dysplasia, PRKG2 type
DI   ORDO; Orphanet_93437; Acromesomelic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   IGIBi008-A
AC   CVCL_C3RU
SY   DMD49-50
DR   hPSCreg; IGIBi008-A
DR   Wikidata; Q116049569
RX   PubMed=36191544;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (PubMed=36191544).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   IGIBi009-A
AC   CVCL_C3RV
SY   DBT-MLC2
DR   hPSCreg; IGIBi009-A
DR   Wikidata; Q116049570
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   IGIBi010-A
AC   CVCL_D5AF
SY   GOC-15
DR   hPSCreg; IGIBi010-A
DR   Wikidata; Q127382326
RX   PubMed=39126919;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11280; SQSTM1; Simple; p.Leu251Serfs*4 (c.749_750insC); Zygosity=Homozygous (PubMed=39126919).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C210892; Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IGIBi011-A
AC   CVCL_D5AE
SY   SCA12_004 (CAG-09/58); GOC-13
DR   BioSamples; SAMEA115077150
DR   hPSCreg; IGIBi011-A
DR   Wikidata; Q127382327
RX   PubMed=38340452;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion; CAG[58]; ClinVar=VCV000005614; Zygosity=Heterozygous; Note=The non-expanded allele has CAG[9] (PubMed=38340452).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154316; Spinocerebellar ataxia type 12
DI   ORDO; Orphanet_98762; Spinocerebellar ataxia type 12
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   IGIBi012-A
AC   CVCL_D5A2
SY   FA-hiPSC_001
DR   BioSamples; SAMEA115068259
DR   hPSCreg; IGIBi012-A
DR   Wikidata; Q127382328
RX   PubMed=38367363;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[704]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38367363).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1204]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38367363).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   IGIBi013-A
AC   CVCL_D5A3
SY   FA-hiPSC_002
DR   BioSamples; SAMEA115071470
DR   hPSCreg; IGIBi013-A
DR   Wikidata; Q127382329
RX   PubMed=38367363;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[870]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38367363).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1370]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38367363).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   IGIBi014-A
AC   CVCL_D4ZX
SY   FA_hiPSC_003
DR   hPSCreg; IGIBi014-A
DR   Wikidata; Q127382330
RX   PubMed=38141359;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[537]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38141359).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1154]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38141359).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   IGIBi015-A
AC   CVCL_D4ZY
SY   FA_hiPSC_004
DR   hPSCreg; IGIBi015-A
DR   Wikidata; Q127382331
RX   PubMed=38141359;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[670]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38141359).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1037]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38141359).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   IGIBi016-A
AC   CVCL_D5A4
SY   FA-hiPSC_005
DR   BioSamples; SAMEA115296842
DR   hPSCreg; IGIBi016-A
DR   Wikidata; Q127382332
RX   PubMed=38484450;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[537]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38484450).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1170]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=38484450).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IGIBi017-A
AC   CVCL_D5A5
SY   CT_hiPSC_001
DR   BioSamples; SAMEA115296868
DR   hPSCreg; IGIBi017-A
DR   Wikidata; Q127382333
RX   PubMed=38484450;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi018-A
AC   CVCL_D5A6
SY   iPSC-RSTS3A; RSTS3A
DR   BioSamples; SAMEA115383872
DR   hPSCreg; IGIBi018-A
DR   Wikidata; Q127382335
RX   PubMed=38820863;
RX   PubMed=39179505;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; c.6082delC; Zygosity=Unspecified (PubMed=38820863; PubMed=39179505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75466; Rubinstein-Taybi syndrome
DI   ORDO; Orphanet_783; Rubinstein-Taybi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IGIBi019-A
AC   CVCL_D5A7
SY   iPSC V2b
DR   BioSamples; SAMEA115672694
DR   hPSCreg; IGIBi019-A
DR   Wikidata; Q127382336
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi020-A
AC   CVCL_D5A8
SY   iPSC V1b
DR   BioSamples; SAMEA115673904
DR   hPSCreg; IGIBi020-A
DR   Wikidata; Q127382337
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi021-A
AC   CVCL_D5A9
SY   iPSC V3b
DR   BioSamples; SAMEA115673906
DR   hPSCreg; IGIBi021-A
DR   Wikidata; Q127382339
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi022-A
AC   CVCL_D5AA
SY   iPSC V2c
DR   BioSamples; SAMEA115673908
DR   hPSCreg; IGIBi022-A
DR   Wikidata; Q127382340
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi023-A
AC   CVCL_D5AB
SY   iPSC V1c
DR   BioSamples; SAMEA115673912
DR   hPSCreg; IGIBi023-A
DR   Wikidata; Q127382341
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi024-A
AC   CVCL_D5AC
SY   iPSC V3c
DR   BioSamples; SAMEA115673914
DR   hPSCreg; IGIBi024-A
DR   Wikidata; Q127382343
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi025-A
AC   CVCL_D5AD
SY   iPSC V3a
DR   BioSamples; SAMEA115674431
DR   hPSCreg; IGIBi025-A
DR   Wikidata; Q127382344
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IGIBi026-A
AC   CVCL_D6RG
SY   BKWD01C; BKWD01
DR   hPSCreg; IGIBi026-A
RX   PubMed=39326255;
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Cys271Ter (c.813C>A); ClinVar=VCV000188930; Zygosity=Heterozygous (PubMed=39326255).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Arg723Glufs*31 (c.2165dupT); ClinVar=VCV000210483; Zygosity=Heterozygous (PubMed=39326255).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   IGIBi027-A
AC   CVCL_E3CG
DR   hPSCreg; IGIBi027-A
CC   From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   IGK
AC   CVCL_1G92
SY   Indian Grouper Kidney
DR   NRFC; NRFC017
DR   Wikidata; Q54897356
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC017; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC017.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   IgK-17
AC   CVCL_UA28
SY   IgK17; Iguana Kidney-17
DR   Wikidata; Q94314656
RX   PubMed=4344303;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8517; ! Iguana iguana (Common iguana)
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   IgM-1
AC   CVCL_B6ZH
DR   CCRID; 4201PAT-CCTCC01171
DR   Wikidata; Q111733485
RX   Patent=CN108588031B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201843.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   IgM-8
AC   CVCL_A0DZ
DR   CCRID; 4201PAT-CCTCC01178
DR   Wikidata; Q108820531
RX   Patent=CN108517316B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201850.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   iGM440
AC   CVCL_EQ34
SY   iPSC_GM03440; Normal iPSC from GM03440
DR   GEO; GSM1184282
DR   GEO; GSM1184283
DR   Wikidata; Q54897357
RX   PubMed=24749076;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7388 ! GM03440
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   iGPM-DM1
AC   CVCL_E9XN
RX   PubMed=38832025;
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[280] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=38832025).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a patient suffering from late onset DM1 subtype.
CC   Derived from site: In situ; Muscle, left biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
ST   Source(s): PubMed=38832025
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 12,13
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25,26
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IGR-1
AC   CVCL_1303
SY   IGR 1; IGR1; Institut Gustave Roussy-1
DR   CLO; CLO_0006669
DR   CLDB; cl2624
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 639
DR   BioSample; SAMN03472901
DR   BioSample; SAMN10987998
DR   cancercelllines; CVCL_1303
DR   Cell_Model_Passport; SIDM01060
DR   ChEMBL-Cells; CHEMBL3308749
DR   ChEMBL-Targets; CHEMBL1075479
DR   CLS; 300219
DR   CLS; 300219-SF
DR   Cosmic; 907169
DR   Cosmic; 2230115
DR   Cosmic-CLP; 907169
DR   DepMap; ACH-000882
DR   DSMZ; ACC-236
DR   DSMZCellDive; ACC-236
DR   EGA; EGAS00001000978
DR   GDSC; 907169
DR   GEO; GSM887157
DR   GEO; GSM888229
DR   GEO; GSM1669927
DR   IARC_TP53; 21394
DR   LiGeA; CCLE_169
DR   LINCS_LDP; LCL-1247
DR   PharmacoDB; IGR1_651_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1303
DR   PubChem_Cell_line; CVCL_1303
DR   Wikidata; Q54897358
RX   PubMed=405430;
RX   PubMed=954556;
RX   PubMed=1822769;
RX   PubMed=4153924;
RX   PubMed=6929009;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25056119;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~75-100 hours (DSMZ=ACC-236).
CC   HLA typing: A*02:01:01,03:01:01; B*11:01:01,44:02:01; C*04:01:01,05:01:01; DPB1*04:01:01G,04:02:01G; DQA1*01:01:01,03:03:01; DQB1*03:01:01,05:01:01; DRB1*01:01:01,04:01:01 (CLS=300219).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=25056119; Cosmic-CLP=907169; DepMap=ACH-000882).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro29Ser (c.85C>T); ClinVar=VCV000376362; Zygosity=Heterozygous (PubMed=25056119; Cosmic-CLP=907169; DepMap=ACH-000882).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.53%; Native American=0%; East Asian, North=2.53%; East Asian, South=0%; South Asian=0.58%; European, North=60.87%; European, South=35.49% (PubMed=30894373).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): CLS=300219; Cosmic-CLP=907169; DSMZ=ACC-236; PubMed=25056119; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 11 (PubMed=25056119)
ST   D16S539: 11,13 (CLS=300219; Cosmic-CLP=907169; DSMZ=ACC-236; PubMed=25877200)
ST   D18S51: 14,16 (DSMZ=ACC-236; PubMed=25877200)
ST   D18S51: 16 (CLS=300219)
ST   D19S433: 15,16
ST   D21S11: 32.2
ST   D2S1338: 20,22
ST   D3S1358: 14,17
ST   D5S818: 10,11 (CLS=300219; Cosmic-CLP=907169; DSMZ=ACC-236; PubMed=25877200)
ST   D5S818: 10,14 (PubMed=25056119)
ST   D7S820: 10,11
ST   D8S1179: 10 (CLS=300219)
ST   D8S1179: 10,14 (DSMZ=ACC-236; PubMed=25056119; PubMed=25877200)
ST   FGA: 23,24
ST   Penta D: 10
ST   Penta E: 7,11
ST   TH01: 7,9.3 (CLS=300219)
ST   TH01: 9.3 (Cosmic-CLP=907169; DSMZ=ACC-236; PubMed=25056119; PubMed=25877200)
ST   TPOX: 8
ST   vWA: 17,18 (CLS=300219; Cosmic-CLP=907169; DSMZ=ACC-236; PubMed=25877200)
ST   vWA: 18 (PubMed=25056119)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   IGR-10
AC   CVCL_B5LI
SY   IGR 10; Institut Gustave Roussy-10
DR   cancercelllines; CVCL_B5LI
DR   Wikidata; Q111733486
RX   PubMed=4153924;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro29Ser (c.85C>T); ClinVar=VCV000376362; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1303 ! IGR-1
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   IGR-1rCDDP2000
AC   CVCL_RS51
DR   cancercelllines; CVCL_RS51
DR   Wikidata; Q54897359
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro29Ser (c.85C>T); ClinVar=VCV000376362; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1303 ! IGR-1
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   IGR-1rDACARB40
AC   CVCL_RS52
DR   cancercelllines; CVCL_RS52
DR   Wikidata; Q54897360
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro29Ser (c.85C>T); ClinVar=VCV000376362; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1303 ! IGR-1
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   IGR-2
AC   CVCL_Y557
SY   IGR 2; Institut Gustave Roussy-2
DR   Wikidata; Q54897361
RX   PubMed=405430;
RX   PubMed=954556;
RX   PubMed=4153924;
RX   PubMed=6929009;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   IGR-20
AC   CVCL_Y559
SY   IGR 20; Institut Gustave Roussy-20
DR   Wikidata; Q54897362
RX   PubMed=954556;
RX   PubMed=6929009;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y560 ! IGR-22
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   IGR-22
AC   CVCL_Y560
SY   IGR 22; Institut Gustave Roussy-22
DR   Wikidata; Q54897363
RX   PubMed=405430;
RX   PubMed=954556;
RX   PubMed=6929009;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y559 ! IGR-20
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   IGR-3
AC   CVCL_Y558
AS   CVCL_GR43
SY   IGR 3; IGR3; IgR3; Institut Gustave Roussy-3
DR   BTO; BTO_0005709
DR   cancercelllines; CVCL_Y558
DR   Wikidata; Q54897364
RX   PubMed=405430;
RX   PubMed=954556;
RX   PubMed=1171141;
RX   PubMed=2337917;
RX   PubMed=4153924;
RX   PubMed=6539703;
RX   PubMed=6929009;
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9725211;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:3432; ERBB4; Simple; p.Glu452Lys (c.1354G>A); ClinVar=VCV000091898; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR46 ! IGR-4
OI   CVCL_B5LJ ! IGR-5
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   IGR-31
AC   CVCL_GR50
SY   IGR 31; Institut Gustave Roussy-31
DR   Wikidata; Q54897365
RX   PubMed=405430;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   IGR-36
AC   CVCL_Y561
SY   IGR 36; Institut Gustave Roussy-36
DR   Wikidata; Q54897366
RX   PubMed=954556;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y560 ! IGR-22
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   IGR-37
AC   CVCL_2075
SY   IgR-37; IGR 37; IGR37; MM1; Institut Gustave Roussy-37
DR   BTO; BTO_0005747
DR   CLO; CLO_0006670
DR   EFO; EFO_0006597
DR   CLDB; cl2625
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472906
DR   BioSample; SAMN10988387
DR   cancercelllines; CVCL_2075
DR   Cell_Model_Passport; SIDM01066
DR   ChEMBL-Cells; CHEMBL3308435
DR   ChEMBL-Targets; CHEMBL613985
DR   Cosmic; 888064
DR   Cosmic; 1995453
DR   Cosmic-CLP; 1240153
DR   DepMap; ACH-000650
DR   DSMZ; ACC-237
DR   DSMZCellDive; ACC-237
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240153
DR   GEO; GSM557941
DR   GEO; GSM887158
DR   GEO; GSM888230
DR   GEO; GSM1669928
DR   IARC_TP53; 28327
DR   LiGeA; CCLE_202
DR   LINCS_LDP; LCL-1248
DR   PharmacoDB; IGR37_652_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2075
DR   PubChem_Cell_line; CVCL_2075
DR   Wikidata; Q54897367
RX   PubMed=405430;
RX   PubMed=2337917;
RX   PubMed=2344628;
RX   PubMed=6539703;
RX   PubMed=6929009;
RX   PubMed=10709110;
RX   PubMed=11668190;
RX   PubMed=21584902;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~48-72 hours (DSMZ=ACC-237).
CC   HLA typing: A*01:01,01:01; B*39:01,39:01; C*12:03,12:03; DRB1*16:05,16:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=1240153; DepMap=ACH-000650).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Tyrfs*10 (c.686_687delGT); ClinVar=VCV000863486; Zygosity=Heterozygous (Cosmic-CLP=1240153; DepMap=ACH-000650).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.28%; Native American=0.29%; East Asian, North=1.79%; East Asian, South=0%; South Asian=0%; European, North=61.87%; European, South=34.77% (PubMed=30894373).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Cosmic-CLP=1240153; DSMZ=ACC-237; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,24
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,21
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2076 ! IGR-39
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   IGR-39
AC   CVCL_2076
SY   IGR 39; IGR39; PM1; Institut Gustave Roussy-39
DR   CLO; CLO_0006671
DR   CLDB; cl2626
DR   BioGRID_ORCS_Cell_line; 638
DR   BioSample; SAMN10988096
DR   cancercelllines; CVCL_2076
DR   Cell_Model_Passport; SIDM01065
DR   Cosmic; 886828
DR   Cosmic; 2163786
DR   DepMap; ACH-000550
DR   DSMZ; ACC-239
DR   DSMZCellDive; ACC-239
DR   ESTDAB; ESTDAB-037
DR   GEO; GSM557940
DR   GEO; GSM557942
DR   GEO; GSM887159
DR   GEO; GSM888231
DR   GEO; GSM1669929
DR   IARC_TP53; 30078
DR   LINCS_LDP; LCL-1249
DR   PharmacoDB; IGR39_653_2019
DR   Progenetix; CVCL_2076
DR   Wikidata; Q54897368
RX   PubMed=405430;
RX   PubMed=2337917;
RX   PubMed=2344628;
RX   PubMed=6539703;
RX   PubMed=6929009;
RX   PubMed=11668190;
RX   PubMed=15592718;
RX   PubMed=21584902;
RX   PubMed=22460905;
RX   PubMed=23851445;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 34 hours (PubMed=25984343); ~30 hours (DSMZ=ACC-239).
CC   HLA typing: B*39:01:01,39:01:01; C*07:02,07:02; DPB1*31:01,09:01; DQB1*06:02; DRB1*16:02 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23851445; DepMap=ACH-000550).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Tyrfs*10 (c.686_687delGT); ClinVar=VCV000863486; Zygosity=Unspecified (DepMap=ACH-000550).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.8%; Native American=1.18%; East Asian, North=2.76%; East Asian, South=0%; South Asian=0%; European, North=58.99%; European, South=35.28% (PubMed=30894373).
CC   Discontinued: ESTDAB; ESTDAB-037; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): DSMZ=ACC-239
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,24
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,21
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2075 ! IGR-37
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   IGR-39D
AC   CVCL_B491
SY   IGR 39D; IGR39D
DR   cancercelllines; CVCL_B491
DR   Cosmic; 1418459
DR   IARC_TP53; 10955
DR   Wikidata; Q54897369
RX   PubMed=3402430;
RX   PubMed=10070891;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Tyrfs*10 (c.686_687delGT); ClinVar=VCV000863486; Zygosity=Unspecified (PubMed=10070891).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2076 ! IGR-39
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   IGR-39rPLX4032_20muM
AC   CVCL_RR33
SY   IGR-39rPLX4032(20muM)
DR   cancercelllines; CVCL_RR33
DR   Wikidata; Q54897370
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Tyrfs*10 (c.686_687delGT); ClinVar=VCV000863486; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2076 ! IGR-39
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   IGR-39rPLX4720_20muM
AC   CVCL_RR34
SY   IGR-39rPLX4720(20muM)
DR   cancercelllines; CVCL_RR34
DR   Wikidata; Q54897371
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90295; PLX-4720 (PLX4720).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Tyrfs*10 (c.686_687delGT); ClinVar=VCV000863486; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2076 ! IGR-39
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   IGR-39rVCR10
AC   CVCL_RR35
DR   cancercelllines; CVCL_RR35
DR   Wikidata; Q54897373
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Tyrfs*10 (c.686_687delGT); ClinVar=VCV000863486; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2076 ! IGR-39
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   IGR-4
AC   CVCL_GR46
SY   IGR 4; IGR4; Institut Gustave Roussy-4
DR   Wikidata; Q54897374
RX   PubMed=405430;
RX   PubMed=2337917;
RX   PubMed=6539703;
RX   PubMed=6929009;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y558 ! IGR-3
OI   CVCL_B5LJ ! IGR-5
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   IGR-5
AC   CVCL_B5LJ
SY   IGR 5; IGR5; Institut Gustave Roussy-5
DR   Wikidata; Q111733487
RX   PubMed=4153924;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y558 ! IGR-3
OI   CVCL_GR46 ! IGR-4
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   IGR-BLA
AC   CVCL_A2AZ
SY   Institut Gustave Roussy-BLA
DR   Wikidata; Q105509640
RX   PubMed=9639386;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   IGR-CaP1
AC   CVCL_A018
SY   Institut Gustave Roussy-Carcinoma Pancreas 1
DR   cancercelllines; CVCL_A018
DR   IARC_TP53; 28239
DR   Wikidata; Q54897375
RX   Patent=US8674172;
RX   PubMed=20974126;
RX   PubMed=24525428;
RX   PubMed=27198502;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4126.
CC   Doubling time: 43 hours (PubMed=20974126).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (PubMed=20974126).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): Patent=US8674172; PubMed=20974126
ST   Amelogenin: X
ST   CSF1PO: 11,14,16
ST   D13S317: 8,10
ST   D16S539: 11,12,13
ST   D18S51: 14,15,16
ST   D19S433: 13,14
ST   D21S11: 26,30.2
ST   D2S1338: 17,24,25
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 9.1,10.1,11.2
ST   D8S1179: 13,14,15,16,17
ST   FGA: 20,21,25,26
ST   TH01: 7,8,9.3
ST   TPOX: 8,10,11
ST   vWA: 16,20,21
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   IGR-CaP1-R-caba
AC   CVCL_WM75
DR   cancercelllines; CVCL_WM75
DR   Wikidata; Q94314872
RX   PubMed=27198502;
CC   Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A018 ! IGR-CaP1
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   IGR-CaP1-R100
AC   CVCL_IR45
DR   cancercelllines; CVCL_IR45
DR   Wikidata; Q54897377
RX   Patent=US8674172;
RX   PubMed=24525428;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4127.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): Patent=US8674172
ST   Amelogenin: X
ST   CSF1PO: 11,12,14,15,16
ST   D13S317: 8,10
ST   D16S539: 10,11,12,13
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 26,30.2
ST   D2S1338: 17,24,25
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 9.1,10.1,11.2
ST   D8S1179: 13,14,16,17
ST   FGA: 19,20,21,25
ST   TH01: 6,7,8,9.3
ST   TPOX: 8,10,11
ST   vWA: 16,20,21
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A018 ! IGR-CaP1
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   IGR-HEU
AC   CVCL_A2BA
SY   IGR-Heu; Institut Gustave Roussy-HEU
DR   cancercelllines; CVCL_A2BA
DR   IARC_TP53; 21659
DR   Wikidata; Q105509642
RX   PubMed=9639386;
RX   PubMed=15634909;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Unspecified (PubMed=15634909).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   IGR-N-331
AC   CVCL_A2BG
SY   Institut Gustave Roussy-Neuroblastoma-331
DR   Wikidata; Q105509646
RX   PubMed=10686938;
RX   PubMed=11464856;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   IGR-N-337
AC   CVCL_A2BH
SY   Institut Gustave Roussy-Neuroblastoma-337
DR   Wikidata; Q105509649
RX   PubMed=10686938;
RX   PubMed=11464856;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   IGR-N-835
AC   CVCL_8882
SY   IGR-N835; IGRN-835; IGRN835; Institut Gustave Roussy-Neuroblastoma-835
DR   Wikidata; Q54897378
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2777412;
CC   Doubling time: 65 hours (PubMed=2777412).
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   IGR-N-91
AC   CVCL_8883
SY   IGR-N91; IGRN91; Institut Gustave Roussy-Neuroblastoma-91
DR   IARC_TP53; 24361
DR   Wikidata; Q54897379
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8101511;
RX   PubMed=10686938;
RX   PubMed=11464856;
RX   PubMed=14676279;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex7-9dup; Zygosity=Unspecified (PubMed=14676279).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   IGR-PUB
AC   CVCL_A2BB
SY   Institut Gustave Roussy-PUB
DR   Wikidata; Q105509652
RX   PubMed=9639386;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   IGR/Cut40
AC   CVCL_A9AP
DR   cancercelllines; CVCL_A9AP
DR   IARC_TP53; 3786
DR   Wikidata; Q108820532
RX   PubMed=9581783;
RX   PubMed=21556589;
CC   Doubling time: ~28 hours (PubMed=21556589).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=21556589).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   iGRA1
AC   CVCL_C1Y7
SY   IGRA1; iGra subclone 1
DR   GEO; GSM702131
DR   GEO; GSM702132
DR   Wikidata; Q114311707
RX   PubMed=25889179;
CC   Population: Asian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y8 ! iGRA2
OI   CVCL_C1Y9 ! iGRA3
OI   CVCL_C1YA ! iGRA4
OI   CVCL_C1YC ! iGRA7
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iGRA2
AC   CVCL_C1Y8
SY   IGRA2; iGra subclone 2
DR   GEO; GSM702133
DR   GEO; GSM702134
DR   Wikidata; Q114311708
RX   PubMed=25889179;
CC   Population: Asian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y7 ! iGRA1
OI   CVCL_C1Y9 ! iGRA3
OI   CVCL_C1YA ! iGRA4
OI   CVCL_C1YC ! iGRA7
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iGRA3
AC   CVCL_C1Y9
SY   IGRA3
DR   Wikidata; Q114311709
RX   PubMed=25889179;
CC   Population: Asian.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): PubMed=25889179
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8,11
ST   D16S539: 8,10
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 19,23
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y7 ! iGRA1
OI   CVCL_C1Y8 ! iGRA2
OI   CVCL_C1YA ! iGRA4
OI   CVCL_C1YC ! iGRA7
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   iGRA4
AC   CVCL_C1YA
SY   IGRA4
DR   Wikidata; Q114311711
RX   PubMed=25889179;
CC   Population: Asian.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): PubMed=25889179
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8,11
ST   D16S539: 8,10
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 19,23
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y7 ! iGRA1
OI   CVCL_C1Y8 ! iGRA2
OI   CVCL_C1Y9 ! iGRA3
OI   CVCL_C1YC ! iGRA7
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   iGRA6
AC   CVCL_C1YB
SY   IGRA6
DR   Wikidata; Q114311713
RX   PubMed=25889179;
CC   Population: Asian.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): PubMed=25889179
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D19S433: 13,14.2
ST   D21S11: 29
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 18,21
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   iGRA7
AC   CVCL_C1YC
SY   IGRA7
DR   Wikidata; Q114311714
RX   PubMed=25889179;
CC   Population: Asian.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): PubMed=25889179
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8,11
ST   D16S539: 8,10
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 19,23
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Y7 ! iGRA1
OI   CVCL_C1Y8 ! iGRA2
OI   CVCL_C1Y9 ! iGRA3
OI   CVCL_C1YA ! iGRA4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   IGRMel1
AC   CVCL_B4KT
SY   Institut Gustave Roussy Melanoma 1
DR   cancercelllines; CVCL_B4KT
DR   Wikidata; Q110432920
RX   PubMed=27533468;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=27533468).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   IGROV(CDDP)
AC   CVCL_C1M7
SY   IGROVCDDP
DR   cancercelllines; CVCL_C1M7
DR   Wikidata; Q114311715
RX   PubMed=9443634;
RX   PubMed=9488600;
RX   PubMed=22792399;
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=9488600).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IGROV(T100r)
AC   CVCL_4V48
DR   cancercelllines; CVCL_4V48
DR   Wikidata; Q54897390
RX   PubMed=9635842;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   IGROV-1
AC   CVCL_1304
SY   Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P
DR   BTO; BTO_0002575
DR   CLO; CLO_0006672
DR   EFO; EFO_0005385
DR   CLDB; cl2627
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 897
DR   BioSample; SAMN03470926
DR   BioSample; SAMN10988218
DR   cancercelllines; CVCL_1304
DR   Cell_Model_Passport; SIDM00151
DR   ChEMBL-Cells; CHEMBL3307502
DR   ChEMBL-Targets; CHEMBL613984
DR   Cosmic; 688100
DR   Cosmic; 875857
DR   Cosmic; 897430
DR   Cosmic; 905968
DR   Cosmic; 920360
DR   Cosmic; 947357
DR   Cosmic; 1044236
DR   Cosmic; 1092607
DR   Cosmic; 1093557
DR   Cosmic; 1102823
DR   Cosmic; 1175880
DR   Cosmic; 1305334
DR   Cosmic; 1312353
DR   Cosmic; 1707557
DR   Cosmic; 1709252
DR   Cosmic; 1998449
DR   Cosmic; 2464669
DR   Cosmic-CLP; 905968
DR   DepMap; ACH-000966
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905968
DR   GEO; GSE23440
DR   GEO; GSE25191
DR   GEO; GSM2127
DR   GEO; GSM50218
DR   GEO; GSM50281
DR   GEO; GSM313715
DR   GEO; GSM711720
DR   GEO; GSM743472
DR   GEO; GSM743496
DR   GEO; GSM750827
DR   GEO; GSM799361
DR   GEO; GSM799424
DR   GEO; GSM844567
DR   GEO; GSM844568
DR   GEO; GSM844569
DR   GEO; GSM844570
DR   GEO; GSM846360
DR   GEO; GSM851919
DR   GEO; GSM887160
DR   GEO; GSM888232
DR   GEO; GSM1153432
DR   GEO; GSM1181284
DR   GEO; GSM1181285
DR   GEO; GSM1291142
DR   GEO; GSM1374571
DR   GEO; GSM1669930
DR   GEO; GSM2124667
DR   IARC_TP53; 21072
DR   IARC_TP53; 21125
DR   IARC_TP53; 30209
DR   LiGeA; CCLE_165
DR   Lonza; 175
DR   Millipore; SCC203
DR   NCI-DTP; IGR-OV1
DR   PharmacoDB; IGROV1_654_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD003668
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1304
DR   PubChem_Cell_line; CVCL_1304
DR   SKY/M-FISH/CGH; 2739
DR   Wikidata; Q54897382
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=8564971;
RX   PubMed=9331090;
RX   PubMed=9443634;
RX   PubMed=9488600;
RX   PubMed=9636834;
RX   PubMed=10700174;
RX   PubMed=10817511;
RX   PubMed=12960427;
RX   PubMed=15748285;
RX   PubMed=16319398;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22328975;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=23856246;
RX   PubMed=23913215;
RX   PubMed=23933261;
RX   PubMed=24023729;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32612269;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=26
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343); ~23 hours (PubMed=10817511); 28 +- 1 hours (PubMed=9636834); 28 hours (PubMed=9488600); 31 hours (NCI-DTP=IGR-OV1); 19.53 hours (JWGray panel).
CC   HLA typing: A*24:02:01,33:01; B*49:01; C*07; DPB1*05:01; DQB1*03; DRB1*11,11 (PubMed=15748285).
CC   HLA typing: A*24:02,33:03; B*45:01,49:01; C*07:01,07:01; DQA1*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (PubMed=17088437; PubMed=25230021; Cosmic-CLP=905968).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (PubMed=17088437; PubMed=25230021; Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (PubMed=17088437; PubMed=24023729; PubMed=25230021; Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (PubMed=17088437; PubMed=24023729; PubMed=25230021; Cosmic-CLP=905968; DepMap=ACH-000966).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.69%; Native American=0%; East Asian, North=0%; East Asian, South=1.43%; South Asian=4.55%; European, North=46.04%; European, South=47.29% (PubMed=30894373).
CC   Misspelling: IGROV-4; PubMed=12960427.
CC   Misspelling: IGR-OV1-RU; Cosmic=1175880.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=905968; Millipore=SCC203; PubMed=19372543; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11,12,13,14,15,16 (Millipore=SCC203)
ST   CSF1PO: 11,13 (PubMed=19372543; PubMed=30485824)
ST   CSF1PO: 11,13,14,15 (Cosmic-CLP=905968)
ST   CSF1PO: 11,13,15 (PubMed=25877200)
ST   CSF1PO: 11,16 (PubMed=25230021)
ST   D13S317: 8,10
ST   D16S539: 10,11,12,13 (Millipore=SCC203)
ST   D16S539: 11,12 (Cosmic-CLP=905968; PubMed=19372543; PubMed=25877200)
ST   D16S539: 11,13 (PubMed=30485824)
ST   D16S539: 12 (PubMed=25230021)
ST   D18S51: 14,15,16 (Millipore=SCC203)
ST   D18S51: 14,16,17 (PubMed=25230021)
ST   D18S51: 15,16 (PubMed=25877200)
ST   D19S433: 13,14
ST   D21S11: 26,29.2,30.2 (PubMed=25230021)
ST   D21S11: 26,30.2 (PubMed=25877200; PubMed=30485824)
ST   D21S11: 26,30.2,31.2 (Millipore=SCC203)
ST   D2S1338: 17,25
ST   D3S1358: 13,14,15 (Millipore=SCC203; PubMed=25230021; PubMed=25877200)
ST   D3S1358: 13,15 (PubMed=19372543)
ST   D5S818: 11,12,13 (Millipore=SCC203)
ST   D5S818: 12 (PubMed=25877200; PubMed=30485824)
ST   D5S818: 12,13 (Cosmic-CLP=905968; PubMed=19372543; PubMed=25230021)
ST   D7S820: 9.1,10.1,11.1 (PubMed=25230021)
ST   D7S820: 9.3,10.1 (PubMed=30485824)
ST   D7S820: 10 (PubMed=25877200)
ST   D7S820: 10,10.1,10.3,11.1 (Millipore=SCC203)
ST   D7S820: 11 (Cosmic-CLP=905968)
ST   D8S1179: 13,14,15,16,17 (Millipore=SCC203)
ST   D8S1179: 14,16 (PubMed=25230021; PubMed=25877200)
ST   FGA: 20,21,26 (PubMed=25230021)
ST   FGA: 21,25,26 (Millipore=SCC203)
ST   FGA: 21,26 (PubMed=25877200)
ST   Penta D: 8,10
ST   Penta E: 13,17
ST   TH01: 7,9.3
ST   TPOX: 8,11 (Millipore=SCC203; PubMed=19372543; PubMed=25230021; PubMed=25877200; PubMed=30485824)
ST   TPOX: 8,11,12 (Cosmic-CLP=905968)
ST   vWA: 16,17,20,21,22 (Millipore=SCC203)
ST   vWA: 16,17,20,22 (PubMed=25230021)
ST   vWA: 17,21 (Cosmic-CLP=905968; PubMed=19372543; PubMed=30485824)
ST   vWA: 17,21,22 (PubMed=25877200)
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   IGROV-1/25 ET
AC   CVCL_8723
SY   Igrov-1/25 ET
DR   cancercelllines; CVCL_8723
DR   Wikidata; Q54897383
RX   PubMed=10817511;
CC   Population: Caucasian.
CC   Doubling time: ~23 hours (PubMed=10817511).
CC   Selected for resistance to: ChEBI; CHEBI_84050; Trabectedin (Ecteinascidin-743; ET-743).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   IGROV-1/APL
AC   CVCL_4Y61
DR   cancercelllines; CVCL_4Y61
DR   Wikidata; Q54897384
RX   PubMed=16258264;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90205; Plitidepsin (Dehydrodidemnin B; Aplidin).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   IGROV-1/CP
AC   CVCL_IQ21
SY   IGROV-1-CP; IGROV1CP
DR   cancercelllines; CVCL_IQ21
DR   PRIDE; PXD003668
DR   Wikidata; Q54897385
RX   PubMed=16319398;
RX   PubMed=23913215;
RX   PubMed=27561551;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 19
//
ID   IGROV-1/MX3
AC   CVCL_EQ59
SY   IGROV1/MX3; Igrov1 MX3; MX3
DR   cancercelllines; CVCL_EQ59
DR   Wikidata; Q54897386
RX   PubMed=10493507;
RX   PubMed=10825126;
RX   PubMed=11309308;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   IGROV-1/Pt0.5
AC   CVCL_EQ61
SY   IGROV-1/Pt 0.5; IGROV1/Pt0.5
DR   cancercelllines; CVCL_EQ61
DR   IARC_TP53; 5443
DR   Wikidata; Q54897387
RX   PubMed=8564971;
RX   PubMed=9636834;
CC   Population: Caucasian.
CC   Doubling time: 36 +- 2.2 hours (PubMed=9636834).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe270Leu (c.808T>C); ClinVar=VCV000634778; Zygosity=Heterozygous (PubMed=8564971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=8564971).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   IGROV-1/Pt1
AC   CVCL_EQ62
SY   IGROV-1/Pt 1; IGROV1/Pt1
DR   cancercelllines; CVCL_EQ62
DR   IARC_TP53; 5445
DR   Wikidata; Q54897388
RX   PubMed=8564971;
RX   PubMed=9636834;
CC   Population: Caucasian.
CC   Doubling time: 33 +- 2 hours (PubMed=9636834).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe270Leu (c.808T>C); ClinVar=VCV000634778; Zygosity=Heterozygous (PubMed=8564971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=8564971).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   IGROV-1/T8
AC   CVCL_EQ60
SY   IGROV1/T8; Igrov1 T8; T8
DR   cancercelllines; CVCL_EQ60
DR   GEO; GSM851943
DR   Wikidata; Q54897389
RX   PubMed=10493507;
RX   PubMed=10825126;
RX   PubMed=11309308;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   IGRT-27
AC   CVCL_GR51
SY   IGRT 27
DR   Wikidata; Q54897391
RX   PubMed=405430;
RX   PubMed=6929009;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   iGS1b8-2
AC   CVCL_T945
AS   CVCL_T889
SY   A000001S8-2; HPS0064
DR   RCB; HPS0064
DR   SKIP; SKIP000017
DR   SKIP; SKIP000268
DR   Wikidata; Q54897392
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T888 ! iGS1b8-6
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   iGS1b8-6
AC   CVCL_T888
SY   A000001S3-6; HPS0065
DR   SKIP; SKIP000018
DR   Wikidata; Q54897394
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122661; Glycogen storage disease type Ib
DI   ORDO; Orphanet_79259; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T945 ! iGS1b8-2
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   IGSK-1
AC   CVCL_S832
DR   Wikidata; Q54897395
RX   PubMed=17506773;
CC   Population: Japanese.
CC   Doubling time: ~34 hours (PubMed=17506773).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   IGSK-2
AC   CVCL_W378
DR   Wikidata; Q54897396
RX   PubMed=17547719;
CC   Population: Japanese.
CC   Doubling time: ~83 hours (PubMed=17547719).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5248; Gastric mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   IGSK-3
AC   CVCL_W377
DR   Wikidata; Q54897397
RX   PubMed=18667025;
CC   Population: Japanese.
CC   Doubling time: ~43 hours (PubMed=18667025).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   IgSV195
AC   CVCL_AP98
DR   Wikidata; Q54897400
RX   PubMed=2502459;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: (C57BL/6 x SJL) F2 transgenic.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   IGTP KO
AC   CVCL_C0L7
SY   IGTP KO Macrophage Cell Line
DR   Kerafast; ENH175-FP
DR   Wikidata; Q112929862
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:107729; Igtp.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   IH-1
AC   CVCL_WZ44
DR   Wikidata; Q94315045
RX   PubMed=11154231;
RX   PubMed=22806891;
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   iHAEC
AC   CVCL_C0EQ
SY   HAEC; immortalized Human Aortic Endothelial Cell
DR   EFO; EFO_0022506
DR   CancerTools; 153751
DR   Wikidata; Q112929863
DR   Ximbio; 153751
RX   PubMed=29229737;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   IHBV6.7
AC   CVCL_SA12
SY   IHBV 6.7
DR   Wikidata; Q54897401
RX   Patent=US20010007153;
RX   PubMed=10613743;
CC   Group: Patented cell line.
CC   Virology: Transfected with a circular hepatitis B virus (HBV) genome. Produces HBsAg.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_SA11 ! MIHA
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   IHCE
AC   CVCL_6E29
SY   Immortalized Human Corneal Endothelial cells
DR   ABM; T0577
DR   Wikidata; Q54897402
RX   PubMed=23811495;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E30 ! IHCF
OI   CVCL_6E31 ! IHCK
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   iHCE-NY1
AC   CVCL_BW58
SY   immortalized Human Corneal Epithelial cell-NY1
DR   Wikidata; Q54897403
RX   DOI=10.1089/aivt.2020.0003;
RX   PubMed=27130679;
CC   Biotechnology: Can be used to produce a reconstructed human corneal epithelium (RhCE) so as to test the eye irritation potential of chemicals (DOI=10.1089/aivt.2020.0003).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   IHCF
AC   CVCL_6E30
SY   Immortalized Human Corneal Fibroblasts
DR   EFO; EFO_0022633
DR   ABM; T0578
DR   Wikidata; Q54897404
RX   PubMed=23811495;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E29 ! IHCE
OI   CVCL_6E31 ! IHCK
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   IHCK
AC   CVCL_6E31
SY   Immortalized Human Corneal Keratinocytes
DR   ABM; T0579
DR   Wikidata; Q54897405
RX   PubMed=23811495;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6E29 ! IHCE
OI   CVCL_6E30 ! IHCF
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 11
//
ID   ihFib3.2
AC   CVCL_9S77
DR   Wikidata; Q54897408
RX   PubMed=26413783;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   iHFK-shNeg
AC   CVCL_ZW73
DR   Wikidata; Q102114207
RX   PubMed=31319135;
CC   Characteristics: Control cell line for the iHFK-shNrf2 cell lines.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW74 ! iHFK-shNrf2#1
OI   CVCL_ZW75 ! iHFK-shNrf2#2
OI   CVCL_ZW76 ! iHFK-shNrf2#3
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   iHFK-shNrf2#1
AC   CVCL_ZW74
DR   Wikidata; Q102114208
RX   PubMed=31319135;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7782; NFE2L2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW73 ! iHFK-shNeg
OI   CVCL_ZW75 ! iHFK-shNrf2#2
OI   CVCL_ZW76 ! iHFK-shNrf2#3
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   iHFK-shNrf2#2
AC   CVCL_ZW75
DR   Wikidata; Q102114209
RX   PubMed=31319135;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7782; NFE2L2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW73 ! iHFK-shNeg
OI   CVCL_ZW74 ! iHFK-shNrf2#1
OI   CVCL_ZW76 ! iHFK-shNrf2#3
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   iHFK-shNrf2#3
AC   CVCL_ZW76
DR   Wikidata; Q102114211
RX   PubMed=31319135;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7782; NFE2L2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZW73 ! iHFK-shNeg
OI   CVCL_ZW74 ! iHFK-shNrf2#1
OI   CVCL_ZW75 ! iHFK-shNrf2#2
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   IHGGK
AC   CVCL_F928
DR   RCB; RCB2091
DR   TKG; TKG 0623
DR   Wikidata; Q54897409
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Discontinued: RCB; RCB2091; true.
ST   Source(s): TKG=TKG 0623
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 17,20
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   IHGK
AC   CVCL_6E42
SY   Immortalized Human Gingival Keratinocytes
DR   Wikidata; Q54897410
RX   PubMed=8824527;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   iHGPINc
AC   CVCL_C4N2
SY   immortalized High-grade prostatic intraepithelial neoplasia cell line
DR   Wikidata; Q116049571
RX   PubMed=10339677;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=pSHVPV-18m).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C5541; High grade prostatic intraepithelial neoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   IHH-A5
AC   CVCL_8278
SY   IHH; Immortalized Human Hepatocyte-A5
DR   BTO; BTO_0006147
DR   Lonza; 8
DR   Wikidata; Q54897411
RX   PubMed=9298258;
RX   PubMed=22594799;
RX   PubMed=28013369;
CC   Sequence variation: Mutation; HGNC; HGNC:8860; PEX7; Unexplicit; Ex1 del; Zygosity=Homozygous (PubMed=28013369).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   IHH-4
AC   CVCL_2960
SY   IHH4
DR   CLO; CLO_0037153
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03481111
DR   cancercelllines; CVCL_2960
DR   Cell_Model_Passport; SIDM00600
DR   Cosmic; 1995454
DR   Cosmic; 2054088
DR   Cosmic-CLP; 1240154
DR   DepMap; ACH-001528
DR   EGA; EGAS00001000978
DR   GDSC; 1240154
DR   GEO; GSM827172
DR   GEO; GSM1669931
DR   JCRB; JCRB1079
DR   JCRB; NIHS0270
DR   JCRB; NIHS0270.1
DR   JCRB; NIHS0271.1
DR   LINCS_LDP; LCL-1693
DR   PharmacoDB; IHH4_655_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2960
DR   Wikidata; Q54897412
RX   PubMed=11686581;
RX   PubMed=20215515;
RX   PubMed=23833040;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 42 hours (PubMed=11686581).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:391; AKT1; Simple; p.Glu17Lys (c.49G>A); ClinVar=VCV000013983; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244; Cosmic-CLP=1240154; DepMap=ACH-001528).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244; Cosmic-CLP=1240154; DepMap=ACH-001528).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Trp592Ter (c.1776G>A); Zygosity=Heterozygous (PubMed=30737244; Cosmic-CLP=1240154; DepMap=ACH-001528).
CC   Sequence variation: Mutation; HGNC; HGNC:14281; CRLF2; Simple; p.Trp255Ter (c.765G>A); Zygosity=Heterozygous (PubMed=30737244; Cosmic-CLP=1240154; DepMap=ACH-001528).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Arg1312Ter (c.3934C>T); ClinVar=VCV000545969; Zygosity=Heterozygous (PubMed=30737244; Cosmic-CLP=1240154; DepMap=ACH-001528).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Asp11Glu (c.33C>G); Zygosity=Heterozygous (PubMed=30737244; Cosmic-CLP=1240154; DepMap=ACH-001528).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.71%; Native American=0%; East Asian, North=73.08%; East Asian, South=21.44%; South Asian=0%; European, North=0.89%; European, South=2.88% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0270; true.
CC   Discontinued: JCRB; NIHS0270.1; true.
CC   Discontinued: JCRB; NIHS0271.1; true.
CC   Derived from site: Metastatic; Left cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=1240154; DepMap=ACH-001528; JCRB=JCRB1079; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   D8S1179: 11,15
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   IHKE-1
AC   CVCL_0344
SY   IHKE1; Immortalized Human Kidney Epithelial-1
DR   EFO; EFO_0022651
DR   MCCL; MCC:0000240
DR   Wikidata; Q54897413
RX   PubMed=2924322;
CC   Transformant: ChEBI; CHEBI_49786; Nickel(2+).
CC   Derived from site: In situ; Fetal kidney, cortex; UBERON=UBERON_0001225.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   13-28FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   IHL,AD031
AC   CVCL_E708
SY   IHL, AD031
DR   dbMHC; 48904
DR   ECACC; 94082216
DR   IHW; IHW09117
DR   IPD-IMGT/HLA; 11662
DR   Wikidata; Q54897414
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*02,31; B*27:05,40; C*02:02; DPB1*04:02,05:01; DQA1*03,01:03; DQB1*03:02,06:01; DRB1*04:01,08:03:02; DRB4*01:01 (IPD-IMGT/HLA=11662).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   IHL,AD036
AC   CVCL_E709
SY   IHL, AD036; TER235; TER-225; Ter 235; TER279; TER-279; Ter 279; TER421; TER-421; Ter 421; Extract 89; Extract 188
DR   dbMHC; 48905
DR   ECACC; 94082223
DR   IHW; IHW09124
DR   IPD-IMGT/HLA; 10797
DR   Wikidata; Q54897415
RX   PubMed=8307784;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/341cx.pdf
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*02:01:01:01,34:01:01; B*40:02:01,56:02; C*01:02:01,15:02:01:01; DPB1*02:01:02,02:01:02; DQA1*01:03,01:04:01:02; DQB1*05:03:01,06:01:01; DRB1*08:03:02,14:14; DRB3*02:02 (IPD-IMGT/HLA=10797).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   IHLPC
AC   CVCL_A4TG
SY   Immortalized Human Lung Pericyte Cell line
DR   Wikidata; Q107115437
RX   PubMed=33446892;
CC   Characteristics: Retains pericyte-specific characteristics, including normal pericyte morphology and expression of the commonly used pericyte markers, PDGFRB and NG2 (PubMed=33446892).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Pericyte; CL=CL_0000669.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   IHM-2
AC   CVCL_C3LX
SY   Immortalized Human Myoblast-2; clone no. 2; clone #2
DR   Wikidata; Q116049572
RX   Patent=US20220265727;
RX   PubMed=36092361;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Culture Collection of Switzerland (CCOS); CCOS-1902.
CC   Doubling time: 34 hours (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Miscellaneous: Cell line name and doubling time from personal communication of Lathuiliere, Aurelien.
CC   Derived from site: In situ; Muscle, semitendinosus; UBERON=UBERON_0001375.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   ihNP
AC   CVCL_T065
SY   immortalized human Nucleus Pulposus
DR   Wikidata; Q54897416
RX   PubMed=23675702;
CC   Doubling time: 53.16 +- 2.63 hours (Note=At 25th passage) (PubMed=23675702).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   IhNSCs
AC   CVCL_B6QT
SY   Immortalited human Neural Stem Cells
DR   Wikidata; Q111733488
RX   PubMed=17556596;
CC   Population: Caucasian.
CC   Doubling time: 2-3 days (PubMed=17556596).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, diencephalon; UBERON=UBERON_0006222.
CC   Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-11FW
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   IHOK
AC   CVCL_C191
SY   Immortalized Human Oral Keratinocytes
DR   Wikidata; Q54897417
RX   PubMed=16011614;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   IHOSE-0160-SV40
AC   CVCL_ZL30
SY   IHOSE0160_SV40T; 0160-SV40; Immortalized Human Ovarian Surface Epithelial-0160-SV40
DR   Wikidata; Q98126765
RX   PubMed=30296284;
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 42.92 +- 1.17 hours (PubMed=30296284).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=30296284
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 13,14
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   IHOSE-1431-E6/E7
AC   CVCL_ZL31
SY   IHOSE1431_E6E7; 1431-E6/E7; Immortalized Human Ovarian Surface Epithelial-1431-E6/E7
DR   ABM; T2050
DR   Wikidata; Q98126766
RX   PubMed=30296284;
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 90.20 +- 11.52 hours (PubMed=30296284).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=30296284
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 14,17
ST   FGA: 24,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL32 ! IHOSE-1431-SV40
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   IHOSE-1431-SV40
AC   CVCL_ZL32
SY   IHOSE1431_SV40T; 1431-SV40; Immortalized Human Ovarian Surface Epithelial-1431-SV40
DR   Wikidata; Q98126767
RX   PubMed=30296284;
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 35.81 +- 1.55 hours (PubMed=30296284).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=30296284
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 14,17
ST   FGA: 24,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL31 ! IHOSE-1431-E6/E7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   IHOSE-4138-SV40
AC   CVCL_ZL33
SY   IHOSE4138_SV40T; 4138-SV40; Immortalized Human Ovarian Surface Epithelial-4138-SV40
DR   Wikidata; Q98126768
RX   PubMed=30296284;
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 52.11 +- 2.47 hours (PubMed=30296284).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=30296284
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 10,16
ST   FGA: 26
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   IHOSE-8695-SV40
AC   CVCL_ZL34
SY   8695-SV40; Immortalized Human Ovarian Surface Epithelial-8695-SV40
DR   Wikidata; Q98126770
RX   PubMed=30296284;
CC   Population: Korean.
CC   Doubling time: 33.67 +- 2.21 hours (PubMed=30296284).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=30296284
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 13,14.2
ST   D21S11: 29,33.2
ST   D2S1338: 18,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 10,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   IHOSE05A_SV40T
AC   CVCL_E7GT
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 72.85 hours (PubMed=40034272).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=40034272
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 22,24
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 18,21
ST   Penta D: 10,11
ST   Penta E: 15,16
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IHOSE79A_E6E7
AC   CVCL_E7GU
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 39.41 hours (PubMed=40034272).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=40034272
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13,22
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19,23
ST   D3S1358: 14,16
ST   D5S818: 9,10
ST   D7S820: 12,13
ST   D8S1179: 12,15
ST   FGA: 20,22
ST   Penta D: 12,13
ST   Penta E: 5,23
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IHOSE81A_E6E7
AC   CVCL_E7GV
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 82.59 hours (PubMed=40034272).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=40034272
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 14,15.2
ST   D21S11: 28.2,31
ST   D2S1338: 17,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 11,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IHOSE85A_SV40T
AC   CVCL_E7GW
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 34.71 hours (PubMed=40034272).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=40034272
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 14,17
ST   D19S433: 13,15
ST   D21S11: 30,32.2
ST   D2S1338: 18,22
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 8,19
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IHOSE94A_E6E7
AC   CVCL_E7GX
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 248.70 hours (PubMed=40034272).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=40034272
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 17,20
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 15,18
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7GY ! IHOSE94A_SV40T
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IHOSE94A_SV40T
AC   CVCL_E7GY
RX   PubMed=40034272;
CC   Population: Korean.
CC   Doubling time: 52.05 hours (PubMed=40034272).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=40034272
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 17,20
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 15,18
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7GX ! IHOSE94A_E6E7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IHSTMi001-A
AC   CVCL_VP87
SY   HuAiPSC-A1
DR   hPSCreg; IHSTMi001-A
DR   Wikidata; Q94315173
RX   PubMed=30138849;
CC   From: Institute of Health Service and Transfusion Medicine; Beijing; China.
CC   Derived from site: In situ; Umbilical artery, endothelium; UBERON=UBERON_0007778.
CC   Cell type: Endothelial cell of umbilical artery; CL=CL_2000052.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 8
//
ID   iHUF3
AC   CVCL_B5QV
DR   GEO; GSM1084810
DR   GEO; GSM1084923
DR   Wikidata; Q111733489
RX   PubMed=27688775;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX97 ! HUF3
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ihVF
AC   CVCL_E4JV
SY   immortalized human Vaginal Fibroblast
RX   Patent=CN118879637A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.46028.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): Patent=CN118879637A
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,15
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 18,25
ST   D19S433: 13
ST   D1S1656: 13,16
ST   D21S11: 30,31
ST   D2S1338: 22,24
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D6S1043: 10,12
ST   D7S820: 9,11
ST   D8S1179: 14,16
ST   FGA: 18,23
ST   Penta D: 12
ST   Penta E: 14,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ihVFE-E67T4
AC   CVCL_A4EX
SY   immortalized hVFE-E67T4; immortalized human Vocal Fold Epithelial cell line-E67T4; E67T4
DR   Wikidata; Q105509656
RX   PubMed=33428261;
CC   Karyotypic information: Shows trisomy 7, trisomy 20, loss of one copy of chromosome 11, and gain of two marker chromosomes of unknown origin (PubMed=33428261).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile and cell line name from personal communication of Thibeault, Susan L.
CC   Derived from site: In situ; Larynx, vocal fold; UBERON=UBERON_0003706.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,15
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 9,15
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 5,13
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   II b
AC   CVCL_4347
SY   B11
DR   ECACC; 86072805
DR   Wikidata; Q54897418
RX   PubMed=3763403;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0439 ! MNNG/HOS Cl #5
HI   CVCL_0594 ! NIH 3T3
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   II-14
AC   CVCL_C7RY
SY   II14; 14
DR   Wikidata; Q117704524
RX   PubMed=1309438;
RX   PubMed=2827488;
RX   PubMed=7627973;
RX   PubMed=8205524;
CC   Doubling time: 24.8 hours (PubMed=2827488).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   II-2B1
AC   CVCL_B3SM
SY   2B1
DR   Wikidata; Q110432921
RX   PubMed=15609618;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   II-45
AC   CVCL_C7RZ
SY   II45; 45
DR   Wikidata; Q117704525
RX   PubMed=1309438;
RX   PubMed=2827488;
RX   PubMed=7627973;
RX   PubMed=8205524;
CC   Doubling time: 18.5 hours (PubMed=2827488).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Misspelling: II-15; PubMed=1309438; Note=In material and methods.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   II-5B2
AC   CVCL_B3SN
SY   5B2
DR   Wikidata; Q110432923
RX   PubMed=15609618;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   II-II6B3
AC   CVCL_B3SP
SY   II6B3; 6B3
DR   DSHB; II-II6B3
DR   Wikidata; Q110432925
RX   PubMed=7356475;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4090 ! 45.6.TG1.7
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 4
//
ID   II-WA-Ramos
AC   CVCL_B6UL
SY   II WA-Ramos; II-WA-Ra #1
DR   Wikidata; Q111733490
RX   PubMed=62724;
RX   PubMed=181343;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   IIB-BR-G
AC   CVCL_B410
SY   Instituto de Investigaciones Bioquimicas-BReast cancer-G
DR   Cosmic; 1507366
DR   Wikidata; Q54897420
RX   PubMed=1661624;
RX   PubMed=9620446;
RX   PubMed=21308409;
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (PubMed=1661624).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   IIB-BR-G-MT
AC   CVCL_T742
SY   Instituto de Investigaciones Bioquimicas-BReast cancer-G MeTastatic
DR   Cosmic; 1507367
DR   Wikidata; Q54897421
RX   PubMed=9620446;
RX   PubMed=21308409;
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B410 ! IIB-BR-G
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   IIB-MEL-IAN
AC   CVCL_JA50
SY   Instituto de Investigaciones Bioquimicas-MELanoma-IAN
DR   Wikidata; Q54897422
RX   PubMed=7567787;
RX   PubMed=12459642;
CC   Population: Caucasian.
CC   Doubling time: 61 hours (Note=At 19th passage) (PubMed=7567787).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   IIB-MEL-J
AC   CVCL_JA51
SY   IIBMel J; IIBMelJ; Instituto de Investigaciones Bioquimicas-MELanoma-J
DR   Wikidata; Q54897424
RX   PubMed=2328778;
RX   PubMed=2602342;
RX   PubMed=7567789;
RX   PubMed=11719430;
WW   Provider; ABAC; -; https://bancodecelulasabac.wordpress.com/wp-content/uploads/2024/08/lineas_celulares.pdf
CC   Population: Caucasian.
CC   Doubling time: 70-80 hours (PubMed=2602342).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   IIB-MEL-LES
AC   CVCL_JA52
SY   Instituto de Investigaciones Bioquimicas-MELanoma-LES
DR   Wikidata; Q54897425
RX   PubMed=7567787;
RX   PubMed=12459642;
CC   Population: Caucasian.
CC   Doubling time: 74-76 hours (Note=At 10th passage), 72-74 hours (Note=At 26th passage) (PubMed=7567787).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   IIBBL-ObE1
AC   CVCL_C2QK
DR   ICLDB; iibbl-obe1
DR   Wikidata; Q114311716
RX   CelloPub=CLPUB00721;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=104452; ! Operophtera brumata (Winter moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   IIC5
AC   CVCL_A0PQ
DR   Wikidata; Q108820533
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Brilliant brown; forms filopodia; movable.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   IIC9
AC   CVCL_4707
SY   IIC9 (CH0)
DR   BTO; BTO_0001894
DR   ECACC; 00030814
DR   Wikidata; Q54897426
RX   PubMed=7088192;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_J502 ! CHEF/18
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   III A4.1
AC   CVCL_C7IW
DR   Wikidata; Q117704526
RX   Patent=GB2103654A;
RX   PubMed=7057905;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_17026; Progesterone.
CC   Monoclonal antibody target: ChEBI; CHEBI_16076; 11alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7IU ! AA1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   III-2
AC   CVCL_C7S0
SY   III2; 2
DR   Wikidata; Q117704527
RX   PubMed=2827488;
RX   PubMed=7627973;
RX   PubMed=8205524;
CC   Doubling time: 26.4 hours (PubMed=2827488).
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   IIIB6
AC   CVCL_A0PW
DR   Wikidata; Q108820534
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Bright, vacuoles; immovable, forms gastrula-like sphere.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line has been lost.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   IIIC-BCHM
AC   CVCL_4409
DR   Wikidata; Q54897427
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Heterozygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0160 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT89 ! IIICF
SX   Female
AG   30-40Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   IIIC/H2
AC   CVCL_4410
DR   Wikidata; Q54897428
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Heterozygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0159 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT89 ! IIICF
SX   Female
AG   30-40Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   IIICF
AC   CVCL_ZT89
SY   III-CF
DR   Wikidata; Q98126771
RX   PubMed=1467311;
RX   PubMed=7651392;
RX   PubMed=19935656;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Heterozygous; Note=Impairs TP53 splicing dramatically (PubMed=1467311).
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-40Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   IIICF-E6E7/C4
AC   CVCL_4411
DR   Wikidata; Q54897429
RX   PubMed=22829774;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0049 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4415 ! IIICF/c
SX   Female
AG   30-40Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   IIICF-T/A6
AC   CVCL_4412
SY   LTAG-transformed IIICF clone A6
DR   Wikidata; Q54897430
RX   PubMed=8108114;
RX   PubMed=9175740;
RX   PubMed=22829774;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0055 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4415 ! IIICF/c
SX   Female
AG   30-40Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   IIICF-T/B1
AC   CVCL_6F12
SY   LTAG-transformed IIICF clone B1
DR   Wikidata; Q54897431
RX   PubMed=8108114;
RX   PubMed=9175740;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4415 ! IIICF/c
SX   Female
AG   30-40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   IIICF-T/B3
AC   CVCL_4413
SY   LTAG-transformed IIICF clone B3
DR   Wikidata; Q54897432
RX   PubMed=8108114;
RX   PubMed=19468068;
RX   PubMed=22829774;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0056 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4415 ! IIICF/c
SX   Female
AG   30-40Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   IIICF-T/C3
AC   CVCL_6F13
SY   LTAG-transformed IIICF clone C3
DR   Wikidata; Q54897433
RX   PubMed=8108114;
RX   PubMed=9175740;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4415 ! IIICF/c
SX   Female
AG   30-40Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   IIICF/a2
AC   CVCL_4414
SY   III-CF culture A2
DR   Wikidata; Q54897434
RX   PubMed=22829774;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0048 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT89 ! IIICF
SX   Female
AG   30-40Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   IIICF/c
AC   CVCL_4415
SY   III-CF/c; III-CF culture C
DR   Wikidata; Q54897435
RX   CelloPub=CLPUB00712;
RX   PubMed=7651392;
RX   PubMed=9175740;
RX   PubMed=19468068;
RX   PubMed=19935656;
RX   PubMed=22829774;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0039 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT89 ! IIICF
SX   Female
AG   30-40Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   IIICF/c/rasT21
AC   CVCL_4416
DR   Wikidata; Q54897436
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Hemizygous; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0040 but was never intended to be distributed.
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4415 ! IIICF/c
SX   Female
AG   30-40Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   IIID5
AC   CVCL_A0PV
DR   Wikidata; Q108820535
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Bright, vacuoles; immovable, forms blastula-like sphere.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   IIMCBi001-A
AC   CVCL_A7GQ
SY   ELE10
DR   hPSCreg; IIMCBi001-A
DR   Wikidata; Q107115438
RX   PubMed=33588215;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33588215
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   IIMCBi002-A
AC   CVCL_A7GR
SY   ELE30
DR   hPSCreg; IIMCBi002-A
DR   Wikidata; Q107115439
RX   PubMed=33588215;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33588215
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,15
ST   D16S539: 11
ST   D21S11: 30,32.2
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   IIMCBi003-A
AC   CVCL_C1Q3
SY   K-Pic1
DR   BioSamples; SAMEA111374570
DR   hPSCreg; IIMCBi003-A
DR   Wikidata; Q114311718
RX   PubMed=36228511;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9E9 ! IIMCBi003-B
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   IIMCBi003-B
AC   CVCL_C9E9
SY   K-Pic2
DR   BioSamples; SAMEA114240761
DR   hPSCreg; IIMCBi003-B
DR   Wikidata; Q123032668
RX   PubMed=37651831;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Q3 ! IIMCBi003-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IIMCBi004-A
AC   CVCL_C1Q4
SY   PM-H1
DR   BioSamples; SAMEA111377295
DR   hPSCreg; IIMCBi004-A
DR   Wikidata; Q114311719
RX   PubMed=36228511;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=36228511).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IIMCBi005-A
AC   CVCL_C1Q5
SY   EM-K3
DR   BioSamples; SAMEA111377735
DR   hPSCreg; IIMCBi005-A
DR   Wikidata; Q114311720
RX   PubMed=36228511;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[53] (c.52CAG(53)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=36228511).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IIMCBi006-A
AC   CVCL_C1Q6
SY   M-T1
DR   BioSamples; SAMEA111377770
DR   hPSCreg; IIMCBi006-A
DR   Wikidata; Q114311721
RX   PubMed=36228511;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[47] (c.52CAG(47)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=36228511).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9D5 ! IIMCBi006-B
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IIMCBi006-B
AC   CVCL_C9D5
SY   M-T2
DR   BioSamples; SAMEA114240762
DR   hPSCreg; IIMCBi006-B
DR   Wikidata; Q123032669
RX   PubMed=37651831;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[47] (c.52CAG(47)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=37651831).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Q6 ! IIMCBi006-A
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IIMCBi007-A
AC   CVCL_C9EA
SY   jK-N1
DR   BioSamples; SAMEA113940120
DR   hPSCreg; IIMCBi007-A
DR   Wikidata; Q123032670
RX   PubMed=37651831;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IIMCBi008-A
AC   CVCL_C9EB
SY   jHD-V1
DR   BioSamples; SAMEA113940121
DR   hPSCreg; IIMCBi008-A
DR   Wikidata; Q123032671
RX   PubMed=37651831;
CC   From: International Institute of Molecular and Cell Biology; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[54] (c.52CAG(54)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=37651831).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IISH1i-BM1
AC   CVCL_U166
SY   BM1 iPSC; IISH1i-BM1-PCBC; PCBC02hsi2012090602; SC13-043
DR   SKIP; SKIP003256
DR   WiCell; iish1i-bm1
DR   WiCell; iish1i-bm1-pcbc
DR   Wikidata; Q54897437
RX   PubMed=21296996;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   IISH2i-BM9
AC   CVCL_U167
SY   BM9 iPSC; IISH2i-BM9-PCBC; PCBC02hsi2012090601; SC13-044
DR   SKIP; SKIP003254
DR   WiCell; iish2i-bm9
DR   WiCell; iish2i-bm9-pcbc
DR   Wikidata; Q54897438
RX   PubMed=21296996;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   IISH3i-CB6
AC   CVCL_U168
SY   CB iPSC6; IISH3i-CB6-PCBC; PCBC02hsi2012090603; SC13-045
DR   SKIP; SKIP003255
DR   WiCell; iish3i-cb6
DR   WiCell; iish3i-cb6-pcbc
DR   Wikidata; Q54897439
RX   PubMed=21296996;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   IISH6i-CML17
AC   CVCL_U169
SY   CMLiPS17; CML 17
DR   SKIP; SKIP003253
DR   WiCell; iish6i-cml17
DR   Wikidata; Q54897441
RX   PubMed=21296996;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   IISHDOi001-A
AC   CVCL_QX71
SY   MA5622-FiPS4F1; MA1
DR   hPSCreg; IISHDOi001-A
DR   Wikidata; Q54897442
RX   PubMed=28925366;
RX   PubMed=36430443;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/06d6d14c-13fa-c9bb-2ff3-e3111d0f31e2
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9726; PYGM; Simple; p.Arg50Ter (c.148C>T); ClinVar=VCV000002298; Zygosity=Homozygous (PubMed=28925366).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7T5 ! IISHDOi001-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 15
//
ID   IISHDOi001-A-1
AC   CVCL_C7T7
SY   MA1-B9
DR   Wikidata; Q117704528
RX   PubMed=36430443;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9726; PYGM; Simple_edited; p.Pro49Pro (c.147A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9. Introduces a XhoI restriction site (PubMed=36430443).
CC   Sequence variation: Mutation; HGNC; HGNC:9726; PYGM; Simple_corrected; p.Arg50Ter (c.148C>T); ClinVar=VCV000002298; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36430443).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX71 ! IISHDOi001-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   IISHDOi001-B
AC   CVCL_C7T5
SY   MA4
DR   Wikidata; Q117704529
RX   PubMed=36430443;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9726; PYGM; Simple; p.Arg50Ter (c.148C>T); ClinVar=VCV000002298; Zygosity=Homozygous (PubMed=36430443).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX71 ! IISHDOi001-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   IISHDOi002-A
AC   CVCL_RI38
SY   FCE-FiPS4F-7
DR   hPSCreg; IISHDOi002-A
DR   Wikidata; Q54897443
RX   PubMed=29471262;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Solicitud++de+dep%C3%B3sito+FCE-FiPS+4F-7-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7T6 ! IISHDOi002-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IISHDOi002-B
AC   CVCL_C7T6
SY   C10
DR   Wikidata; Q117704530
RX   PubMed=36430443;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI38 ! IISHDOi002-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IISHDOi003-A
AC   CVCL_QX87
SY   OAS545-FiPS4F1
DR   hPSCreg; IISHDOi003-A
DR   Wikidata; Q54897447
RX   PubMed=29034899;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/d175ca0b-4d4b-2052-c8f8-f19ff7d90898
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Ser545Arg (c.1635C>A); ClinVar=VCV000095712; Zygosity=Heterozygous (PubMed=29034899).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169000; Optic atrophy 1
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 14
//
ID   IISHDOi004-A
AC   CVCL_VN42
SY   RPAB16-FiPS4F3
DR   hPSCreg; IISHDOi004-A
DR   Wikidata; Q94315429
RX   PubMed=30096711;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento+Dep%C3%B3sito+-+RPAB16-FiPS4F3-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys759Phe (c.2276G>T); ClinVar=VCV000002356; Zygosity=Homozygous (PubMed=30096711).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   IISHDOi005-A
AC   CVCL_WK27
SY   CmC57-FiPS4F1
DR   Wikidata; Q94315433
RX   PubMed=30897488;
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   IISHDOi006-A
AC   CVCL_XI73
SY   DOA2259-FiPS4F-8
DR   hPSCreg; IISHDOi006-A
DR   Wikidata; Q94315438
RX   PubMed=31509793;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud%2520de%2520deposito-DOA2259-FiPS4F-8-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:118; ACO2; Simple; p.Glu667Lys (c.1999G>A); ClinVar=VCV001444087; Zygosity=Heterozygous (PubMed=31509793).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84577; Autosomal dominant optic atrophy
DI   ORDO; Orphanet_98672; Autosomal dominant optic atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   IISHDOi007-A
AC   CVCL_A4DB
SY   McA2.7; MAMcA2-BiPS4F7
DR   hPSCreg; IISHDOi007-A
DR   Wikidata; Q105509658
RX   PubMed=33370875;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+MAMcA2-BiPS4F7+o+McA2.7+Solicitud+de+dep%C3%B3sito.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigacion Sanitaria Hospital 12 de Octubre; Madrid; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9726; PYGM; Simple; p.Trp798Arg (c.2392T>C); ClinVar=VCV000002312; Zygosity=Homozygous (PubMed=33370875).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84738; Glycogen storage disease type V
DI   ORDO; Orphanet_368; Glycogen storage disease due to muscle glycogen phosphorylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   IITGi001-A
AC   CVCL_C9LS
SY   NC7-CSCR-IITG
DR   hPSCreg; IITGi001-A
DR   Wikidata; Q123032672
RX   PubMed=37392703;
CC   From: Indian Institute of Technology Guwahati; Guwahati; India.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IITi001-A
AC   CVCL_VD72
SY   29.2
DR   hPSCreg; IITi001-A
DR   Wikidata; Q54897448
RX   PubMed=29653394;
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (PubMed=29653394).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29653394
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 13,15
ST   D12S391: 17,20
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 12,13
ST   D1S1656: 15,16.3
ST   D21S11: 30,31
ST   D22S1045: 15,17
ST   D2S1338: 22,23
ST   D2S441: 14
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   DYS391: 9
ST   FGA: 18,22
ST   Penta D: 11,13
ST   Penta E: 7,18
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   iJCC-DM1
AC   CVCL_E9XP
RX   PubMed=38832025;
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[654] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=38832025).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a patient suffering from juvenile DM1 subtype.
CC   Derived from site: In situ; Muscle, left biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Myoblast; CL=CL_0000056.
ST   Source(s): PubMed=38832025
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 31,32.2
ST   D2S1338: 17,19
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IK-15
AC   CVCL_N278
SY   NBnu834-2
DR   ATCC; CRL-7930
DR   Wikidata; Q54897449
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7930; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   IK-6
AC   CVCL_N296
SY   NBNu804-1Tu
DR   ATCC; CRL-7929
DR   Wikidata; Q54897450
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-7929; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2529 ! Ishikawa
CA   Hybrid cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   IK-90
AC   CVCL_9996
DR   cancercelllines; CVCL_9996
DR   Cosmic; 735334
DR   IARC_TP53; 2379
DR   Wikidata; Q54897451
RX   PubMed=3815380;
RX   PubMed=8105795;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex10del; Zygosity=Heterozygous (PubMed=8105795).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (PubMed=8105795).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   IKARS1
AC   CVCL_D3FL
SY   Immortalized Knocked out AR Schwann cells 1
DR   ABM; T0798
DR   Wikidata; Q127382345
RX   PubMed=29238976;
RX   PubMed=33494154;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1353494; Akr1b1.
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: C57BL/6N B6.Cg-Akr1b1tm1.1Kga.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   IKK-i-DEF
AC   CVCL_4W56
DR   JCRB; JCRB1534
DR   Wikidata; Q54897452
CC   Knockout cell: Method=KO mouse; MGI; MGI:1929612; Ikbke.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   iKLF1.1
AC   CVCL_B6RA
DR   Wikidata; Q111733491
RX   PubMed=28026072;
CC   Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation.
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL47 ! SFCi55
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   iKLF1.12
AC   CVCL_B6RE
DR   Wikidata; Q111733492
RX   PubMed=30787325;
CC   Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation.
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL47 ! SFCi55
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   iKLF1.2
AC   CVCL_B6RB
DR   Wikidata; Q111733493
RX   PubMed=28026072;
RX   PubMed=30787325;
CC   Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation.
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL47 ! SFCi55
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   iKLF1.6
AC   CVCL_B6RC
DR   Wikidata; Q111733494
RX   PubMed=30787325;
CC   Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation.
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL47 ! SFCi55
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   iKLF1.7
AC   CVCL_B6RD
DR   Wikidata; Q111733496
RX   PubMed=30787325;
CC   Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation.
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL47 ! SFCi55
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   iKUF01
AC   CVCL_C3NN
DR   ABM; T0390
DR   Wikidata; Q116049573
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:13:01,11:04,12:03; SLA-2:04:02; SLA-3:04:01; SLA-DQA:02:04,05:01; SLA-DQB1:03:03,05:02; SLA-DRB1:04:03,07:01.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: PWG Micropig; VBO=VBO_0017517.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   iKUF02
AC   CVCL_C3NP
DR   ABM; T0391
DR   Wikidata; Q116049574
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:16:01,08:10; SLA-2:12:01,10:09; SLA-3:06:01; SLA-DQA:01:01; SLA-DQB1:01:01,06:01; SLA-DRB1:01:01,10:01.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   iKUF03
AC   CVCL_C3NQ
DR   ABM; T0392
DR   Wikidata; Q116049575
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:02:01,04:01,07:01; SLA-2:02:01,04:01; SLA-3:04:01,03:03; SLA-DQA:02:01; SLA-DQB1:02:01,04:01:01; SLA-DRB1:02:01.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: NIH miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   iKUF04
AC   CVCL_C3NR
DR   ABM; T0393
DR   Wikidata; Q116049576
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:04:01; SLA-2:04:01; SLA-3:04:01; SLA-DQA:02:01; SLA-DQB1:04:01:01; SLA-DRB1:02:01.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: NIH miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   iKUF05
AC   CVCL_C3NS
DR   Wikidata; Q116049577
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:11:02,15:02; SLA-2:16:01,15:01; SLA-3:03:03,07:01:02; SLA-DQA:02:01,02:04; SLA-DQB1:02:01,03:03; SLA-DRB1:02:01,04:03.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   iKUF06
AC   CVCL_C3NT
DR   Wikidata; Q116049578
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:11:02,15:01,09:01; SLA-2:15:01,05:03; SLA-3:03:03,07:01:02; SLA-DQA:01:01,02:01; SLA-DQB1:02:01,06:01; SLA-DRB1:02:01,10:01.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   iKUF07
AC   CVCL_C3NU
DR   ABM; T0394
DR   Wikidata; Q116049579
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:07:02,14:01; SLA-2:02:02,10:04; SLA-3:03:03,05:01; SLA-DQA:01:06; SLA-DQB1:07:01; SLA-DRB1:06:02.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   iKUF08
AC   CVCL_C3NV
DR   Wikidata; Q116049580
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:04:01,21:01,11:03; SLA-2:04:02:01,16:03; SLA-3:04:01,03:06; SLA-DQA:01:06,02:01; SLA-DQB1:02:01,07:01; SLA-DRB1:02:01,06:02.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   iKUF09
AC   CVCL_C3NW
DR   ABM; T0395
DR   Wikidata; Q116049581
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:15:01,09:01; SLA-2:04:01,05:03; SLA-3:06:02,04:01; SLA-DQA:01:01,02:01; SLA-DQB1:04:01:01,06:01; SLA-DRB1:02:01,10:01.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   iKUF10
AC   CVCL_C3NX
DR   Wikidata; Q116049582
RX   PubMed=35198008;
CC   Characteristics: SLA gene typing is SLA-1:02:01,07:01; SLA-2:03:01,21:01; SLA-3:03:01; SLA-DQA:01:02; SLA-DQB1:03:01; SLA-DRB1:03:01.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Seoul National University miniature pig; VBO=VBO_0017518.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   9W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   IL-A105
AC   CVCL_L564
DR   ECACC; 91072535
DR   Wikidata; Q54897453
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine CD8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   IL-A11
AC   CVCL_G127
DR   CLO; CLO_0006694
DR   ATCC; CRL-1879
DR   ECACC; 91072511
DR   Wikidata; Q54897454
RX   PubMed=2423591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; I0J0K0; Bovine CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   IL-A111
AC   CVCL_D3UC
DR   Wikidata; Q127382346
RX   PubMed=1634253;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12342; Bovine IL2RA/CD25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   IL-A12
AC   CVCL_L579
DR   Wikidata; Q54897455
RX   PubMed=2423591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; I0J0K0; Bovine CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   IL-A16
AC   CVCL_L565
DR   ECACC; 91072514
DR   Wikidata; Q54897456
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A1L5SMW6; Bovine ITGAX/CD11c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   IL-A17
AC   CVCL_WM94
DR   Wikidata; Q94315547
RX   PubMed=2426182;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine CD8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   IL-A19
AC   CVCL_L566
DR   ECACC; 91072515
DR   Wikidata; Q54897457
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine MHC class I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL-A2
AC   CVCL_L567
DR   ECACC; 91072510
DR   Wikidata; Q54897458
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL-A21
AC   CVCL_L568
DR   ECACC; 91072516
DR   Wikidata; Q54897459
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine MHC class II.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL-A24
AC   CVCL_L569
DR   ECACC; 91072517
DR   Wikidata; Q54897460
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine antigen on myeloid cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 6
//
ID   IL-A26
AC   CVCL_WM91
DR   Wikidata; Q94315600
RX   PubMed=2965099;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   IL-A27
AC   CVCL_WM92
DR   Wikidata; Q94315605
RX   PubMed=2965099;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   IL-A28
AC   CVCL_WM93
DR   Wikidata; Q94315608
RX   PubMed=2965099;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   IL-A29
AC   CVCL_G128
SY   ILA29
DR   CLO; CLO_0006695
DR   ATCC; CRL-1874
DR   ECACC; 91072519
DR   Wikidata; Q54897461
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30205; Bovine WC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   IL-A30
AC   CVCL_G129
DR   CLO; CLO_0006696
DR   ATCC; CRL-1894
DR   ECACC; 91072520
DR   Wikidata; Q54897462
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine IgM (monomorphic determinant).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   IL-A42
AC   CVCL_G130
DR   CLO; CLO_0006697
DR   ATCC; CRL-1870
DR   ECACC; 91072521
DR   Wikidata; Q54897463
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q148M9; Bovine CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   IL-A43
AC   CVCL_L570
DR   ECACC; 91072522
DR   Wikidata; Q54897464
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q148M9; Bovine CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   IL-A46
AC   CVCL_L571
DR   ECACC; 91072523
DR   Wikidata; Q54897465
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Bovine antigen on myeloid cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 6
//
ID   IL-A50
AC   CVCL_L572
DR   ECACC; 91072524
DR   Wikidata; Q54897466
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine IgM (polymorphic determinant).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL-A51
AC   CVCL_G131
DR   CLO; CLO_0006698
DR   ATCC; CRL-1871
DR   Wikidata; Q54897467
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine CD8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   IL-A54
AC   CVCL_CY51
DR   Wikidata; Q54897468
RX   PubMed=2021068;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine WC5 antigen (BoWC5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   IL-A55
AC   CVCL_CY52
DR   Wikidata; Q54897469
RX   PubMed=2021068;
RX   PubMed=8310643;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine WC5 antigen (BoWC5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   IL-A57
AC   CVCL_L573
DR   ECACC; 91072526
DR   Wikidata; Q54897470
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; F1MU15; Bovine CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   IL-A58
AC   CVCL_L574
DR   ECACC; 91072527
DR   Wikidata; Q54897471
RX   PubMed=8310643;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine Ig light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL-A59
AC   CVCL_L575
DR   ECACC; 91072528
DR   Wikidata; Q54897472
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine Ig light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL-A60
AC   CVCL_L576
DR   ECACC; 91072529
DR   Wikidata; Q54897473
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Bovine IgG1.
CC   Discontinued: ECACC; 91072529; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 6
//
ID   IL-A71
AC   CVCL_L577
DR   ECACC; 91072532
DR   Wikidata; Q54897474
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine IgA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL-A88
AC   CVCL_L578
DR   ECACC; 91072534
DR   Wikidata; Q54897475
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Bovine MHC class I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   IL.X24
AC   CVCL_D3U9
DR   Wikidata; Q127382347
RX   PubMed=1634253;
CC   Genetic integration: Method=Transfection; Gene=CGNC; 5434; TK1.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:56188; Bovine IL2RA.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3392 ! LTK-
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   iLB-C-50-s9
AC   CVCL_A9PN
DR   Wikidata; Q102114212
RX   PubMed=25392050;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   iLB-C89bf
AC   CVCL_C1XF
DR   Wikidata; Q114311722
RX   PubMed=35392923;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   ILB1-H21
AC   CVCL_J752
SY   ILB1-H21B2B
DR   CLO; CLO_0006699
DR   ATCC; HB-10220
DR   Wikidata; Q54897476
RX   Patent=US4935343;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10220.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
CC   Discontinued: ATCC; HB-10220; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   ILB1-H34
AC   CVCL_J753
SY   ILB1-H34A3
DR   CLO; CLO_0006700
DR   ATCC; HB-10221
DR   Wikidata; Q54897477
RX   Patent=US4935343;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10221.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
CC   Discontinued: ATCC; HB-10221; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   ILB1-H6
AC   CVCL_J754
SY   ILB1-H6A1B
DR   CLO; CLO_0006701
DR   ATCC; HB-10219
DR   Wikidata; Q54897478
RX   Patent=US4935343;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10219.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
CC   Discontinued: ATCC; HB-10219; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   ILB1-H67
AC   CVCL_J755
DR   CLO; CLO_0006702
DR   ATCC; HB-10222
DR   Wikidata; Q54897479
RX   Patent=US4935343;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10222.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01584; Human IL1B.
CC   Discontinued: ATCC; HB-10222; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   ILCLs14
AC   CVCL_C1EQ
SY   ILCL s14
DR   Wikidata; Q114311723
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/ILCLs14_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EW ! Ff-CLs23
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   ILCLs21
AC   CVCL_C1ER
SY   ILCL s21
DR   Wikidata; Q114311724
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/ILCLs21_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EQ ! ILCLs14
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EW ! Ff-CLs23
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   ILCLs23
AC   CVCL_C1ES
SY   ILCL s23
DR   Wikidata; Q114311725
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/ILCLs23_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EQ ! ILCLs14
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ET ! ILCLs31
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EW ! Ff-CLs23
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   ILCLs31
AC   CVCL_C1ET
SY   ILCL s31
DR   Wikidata; Q114311726
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/ILCLs31_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EQ ! ILCLs14
OI   CVCL_C1ER ! ILCLs21
OI   CVCL_C1ES ! ILCLs23
OI   CVCL_C1EU ! Ff-CLs14
OI   CVCL_C1EV ! Ff-CLs21
OI   CVCL_C1EW ! Ff-CLs23
OI   CVCL_C1EX ! Ff-CLs31
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iLite IL-2 Assay Ready Cells
AC   CVCL_WK49
DR   Wikidata; Q94315785
WW   Provider; Svar Life Science; BM4002; https://www.svarlifescience.com/products/bm4002
CC   Group: Bird cell line.
CC   Characteristics: Genetically engineered and optimized to be responsive to IL2, resulting in a proportional expression of firefly luciferase. Normalization of cell counts and serum matrix effects are obtained by a second reporter gene, a Renilla reniformis renilla-type luciferase reporter gene construct, under control of a constitutive promoter (Svar Life Science=BM4002).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   iLite IL-23 Assay Ready Cells
AC   CVCL_E7RR
SY   DT4023L
RX   CelloPub=CLPUB00797;
RX   PubMed=32484379;
WW   Provider; Svar Life Science; BM4023; https://www.svarlifescience.com/products/bm4023
CC   Group: Bird cell line.
CC   Characteristics: Genetically engineered and optimized to be responsive to IL23, resulting in the specific expression of firefly luciferase. Normalization of cell counts and serum matrix effects are obtained by a second reporter gene, a Renilla reniformis renilla-type luciferase reporter gene construct, under control of a constitutive promoter (Svar Life Science=BM4023).
CC   Characteristics: Transfected with the IL23R and IL12RB1 receptor chains both under the control of a CMV reporter, firefly luciferase under the control of STAT5 responsive element and renilla luciferase under the control of a CMV promoter (CelloPub=CLPUB00797).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5971; IL12RB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19100; IL23R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iLite IL-6 Assay Ready Cells
AC   CVCL_E7RT
WW   Provider; Svar Life Science; BM4061; https://www.svarlifescience.com/products/bm4061
CC   Characteristics: Genetically engineered and optimized to be responsive to human IL6, resulting in a proportional expression of firefly Luciferase. Normalization of cell counts, and serum matrix effects is obtained by a second reporter gene, a Renilla Luciferase reporter gene construct, under the control of a constitutive promoter (Svar Life Science=BM4061).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iLite Insulin Assay Ready Cells
AC   CVCL_E7RS
WW   Provider; Svar Life Science; BM3060; https://www.svarlifescience.com/products/bm3060
CC   Group: Bird cell line.
CC   Characteristics: Genetically engineered and optimized to be responsive to insulin, resulting in the specific expression of firefly luciferase. Normalization of cell counts and serum matrix effects are obtained by a second reporter gene, a Renilla reniformis renilla-type luciferase reporter gene construct, under control of a constitutive promoter (Svar Life Science=BM3060).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iLite TNF-alpha Assay Ready Cells
AC   CVCL_E7RU
SY   KJL-Luc
RX   PubMed=21910993;
WW   Provider; Svar Life Science; BM3044; https://www.svarlifescience.com/products/bm3044
CC   Population: Caucasian.
CC   Characteristics: Genetically engineered and optimized to respond to TNF-alpha resulting in the specific expression of firefly luciferase. Normalization of cell counts and serum matrix effects is obtained by a second reporter gene, a Renilla luciferase reporter gene construct, under control of a constitutive promoter (Svar Life Science=BM3044).
CC   Characteristics: The luciferase reporter gene is under the control of 5 tandem copies of the NF-kappaB response element and the Renilla luciferase is under the control of a constitutive minimal TK promoter (PubMed=21910993).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7RV ! KK-Luc
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iLite Type I IFN Assay Ready Cells
AC   CVCL_E7RW
RX   Patent=US8759091;
WW   Provider; Svar Life Science; BM3049; https://www.svarlifescience.com/products/bm3049
CC   Population: Caucasian.
CC   Characteristics: Engineered to express firefly Luciferase under the control of an IFN alpha/beta responsive promoter. When IFN alpha or IFN beta binds to the IFN a/b receptor on the cell surface, the IFN a/b regulated firefly luciferase reporter gene construct is activated, resulting in a luminescent signal (Svar Life Science=BM3049).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iLite VEGF Assay Ready Cells
AC   CVCL_WK50
DR   Wikidata; Q94315790
WW   Provider; Svar Life Science; BM4021; https://www.svarlifescience.com/products/bm4021
CC   Characteristics: Genetically engineered and optimized to respond to VEGF with specific, proportional expression of firefly luciferase (Svar Life Science=BM4021).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   ILKM10
AC   CVCL_M544
SY   ILKM-10
DR   CGH-DB; 10-1
DR   CGH-DB; 9152-4
DR   Wikidata; Q54897480
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   ILKM12
AC   CVCL_M499
SY   ILKM-12
DR   CGH-DB; 11-1
DR   CGH-DB; 9153-4
DR   Wikidata; Q54897481
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   ILKM13
AC   CVCL_M500
SY   ILKM-13
DR   CGH-DB; 12-1
DR   CGH-DB; 9154-4
DR   Wikidata; Q54897482
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   ILKM2
AC   CVCL_A621
SY   ILKM-2
DR   CGH-DB; 9149-4
DR   Wikidata; Q54897484
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2783335;
RX   PubMed=10936422;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=15215163;
RX   PubMed=17229644;
RX   PubMed=20079716;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 120 hours (PubMed=2783335).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   ILKM2 Lyn
AC   CVCL_E2UG
RX   PubMed=20079716;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa (from parent cell line).
CC   Characteristics: IL6 dependent (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6735; LYN (Note=Isoform B/Lynp53 with a C-terminal His6 tag).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A621 ! ILKM2
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   ILKM3
AC   CVCL_A622
SY   ILKM-3
DR   CGH-DB; 9150-4
DR   Cosmic; 688961
DR   Wikidata; Q54897485
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2783335;
RX   PubMed=10936422;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=15215163;
RX   PubMed=17229644;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 96 hours (PubMed=2783335).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   ILKM8
AC   CVCL_M497
SY   ILKM-8
DR   CGH-DB; 9151-4
DR   Wikidata; Q54897486
RX   PubMed=10557056;
RX   PubMed=11429052;
RX   PubMed=15215163;
RX   PubMed=17229644;
RX   PubMed=20079716;
CC   Population: Japanese.
CC   Characteristics: IL6 dependent.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   ILKM8 Lyn
AC   CVCL_E2UH
RX   PubMed=20079716;
CC   Population: Japanese.
CC   Characteristics: IL6 dependent (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6735; LYN (Note=Isoform B/Lynp53 with a C-terminal His6 tag).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M497 ! ILKM8
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   ILT-As
AC   CVCL_F909
DR   Wikidata; Q54897487
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G008 ! TCL-As
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   ILT-Mat
AC   CVCL_A782
DR   CLO; CLO_0050973
DR   BioSample; SAMN03472321
DR   RCB; RCB0475
DR   RCB; RCB1880
DR   TKG; TKG 0286
DR   Wikidata; Q54897494
RX   PubMed=6088403;
RX   PubMed=7662981;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: RCB; RCB1880; true.
ST   Source(s): RCB=RCB0475
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G015 ! TL-Mat
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
ID   ILT-Mor
AC   CVCL_F910
DR   Wikidata; Q54897495
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG48 ! LCL-Mor8
OI   CVCL_G011 ! TCL-Mor
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   ILT-My
AC   CVCL_F911
DR   Wikidata; Q54897496
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   ILT-Om
AC   CVCL_F912
DR   Wikidata; Q54897497
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G007 ! PBL-Om
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   ILT-Su
AC   CVCL_F913
DR   Wikidata; Q54897498
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   ILT-Ter
AC   CVCL_F914
DR   Wikidata; Q54897499
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UH25 ! LCL-Ter50
OI   CVCL_G012 ! TCL-Ter
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   ILT-Yan
AC   CVCL_F915
DR   Wikidata; Q54897501
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   IM
AC   CVCL_W444
DR   Wikidata; Q54897502
RX   PubMed=9183668;
CC   Population: Japanese.
CC   Doubling time: 28.8 hours (PubMed=9183668).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Im RMC
AC   CVCL_B7D5
SY   Immortalized Rabbit Melanocyte Cell line
DR   Wikidata; Q123032673
RX   PubMed=31575080;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   IM-1178
AC   CVCL_E4AV
SY   IM1178; IM 1178
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IM-2
AC   CVCL_S548
DR   Wikidata; Q54897503
RX   PubMed=2466037;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   IM-9
AC   CVCL_1305
SY   IM 9; IM9; GM04680
DR   BTO; BTO_0002897
DR   CLO; CLO_0006703
DR   CLO; CLO_0006705
DR   CLO; CLO_0019036
DR   CLDB; cl2635
DR   CLDB; cl2636
DR   CLDB; cl2637
DR   CLDB; cl4962
DR   CLDB; cl5210
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-159
DR   BCRC; 60115
DR   BioGRID_ORCS_Cell_line; 899
DR   BioSample; SAMN03471460
DR   BioSample; SAMN03472807
DR   CCRID; 1102HUM-NIFDC00064
DR   Cell_Model_Passport; SIDM00632
DR   ChEMBL-Cells; CHEMBL3307412
DR   ChEMBL-Targets; CHEMBL614584
DR   CLS; 302151
DR   Coriell; GM04680
DR   Cosmic; 753563
DR   Cosmic; 888021
DR   Cosmic; 919137
DR   Cosmic-CLP; 753563
DR   DepMap; ACH-002247
DR   DSMZ; ACC-117
DR   DSMZCellDive; ACC-117
DR   ECACC; 86051302
DR   EGA; EGAS00001000978
DR   GDSC; 753563
DR   GEO; GSM1374572
DR   GEO; GSM1669932
DR   IARC_TP53; 21395
DR   ICLC; HTL99009
DR   IZSLER; BS TCL 98
DR   JCRB; IFO50025
DR   JCRB; JCRB0024
DR   KCLB; 10159
DR   LINCS_LDP; LCL-1958
DR   Lonza; 9
DR   PharmacoDB; IM9_656_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1305
DR   Wikidata; Q54897504
RX   CelloPub=CLPUB00447;
RX   PubMed=1366653;
RX   PubMed=2836165;
RX   PubMed=7579375;
RX   PubMed=8139288;
RX   PubMed=9290701;
RX   PubMed=9510473;
RX   PubMed=10516762;
RX   PubMed=10936422;
RX   PubMed=20164919;
RX   PubMed=20454443;
RX   PubMed=27397505;
RX   PubMed=29892436;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~45 hours (DSMZ=ACC-117); ~1 day (Note=Lot 09172008), ~23 hours (Note=Lot 03302009) (JCRB=JCRB0024).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=753563; DepMap=ACH-002247).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.41%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=68.16%; European, South=31.43% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CCL-159; CCRID=1102HUM-NIFDC00064; Cosmic-CLP=753563; DSMZ=ACC-117; JCRB=JCRB0024; KCLB=10159
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D21S11: 30,30.2
ST   D2S1338: 24,26
ST   D3S1358: 14,18
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   IM-9-P
AC   CVCL_B6CV
DR   Wikidata; Q111733497
RX   PubMed=1366653;
RX   PubMed=1697858;
RX   PubMed=2836165;
CC   Problematic cell line: Misclassified. Parent cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Produces prolactin. But after approximately 7 months in culture the capacity to synthesize prolactin is greatly reduced (PubMed=1366653; PubMed=2836165).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1305 ! IM-9
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   IM-9-P3
AC   CVCL_B6CW
DR   Wikidata; Q111733498
RX   PubMed=1324146;
RX   PubMed=1366653;
RX   PubMed=1697858;
RX   PubMed=2836165;
CC   Problematic cell line: Misclassified. Grand-parent cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Produces prolactin.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6CV ! IM-9-P
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   IM-9-P31
AC   CVCL_B6CZ
DR   Wikidata; Q111733499
RX   PubMed=1324146;
CC   Problematic cell line: Misclassified. Ancestral cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Produces low quantity of prolactin.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6CW ! IM-9-P3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   IM-9-P32
AC   CVCL_B6D0
DR   Wikidata; Q111733500
RX   PubMed=1324146;
CC   Problematic cell line: Misclassified. Ancestral cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Produces medium quantity of prolactin.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6CW ! IM-9-P3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   IM-9-P33
AC   CVCL_B6CY
DR   Wikidata; Q111733501
RX   PubMed=1324146;
RX   PubMed=1366653;
CC   Problematic cell line: Misclassified. Ancestral cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Produces high quantity of prolactin.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6CW ! IM-9-P3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   IM-9-P6
AC   CVCL_B6CX
DR   Wikidata; Q111733502
RX   PubMed=1324146;
RX   PubMed=1366653;
RX   PubMed=2836165;
CC   Problematic cell line: Misclassified. Grand-parent cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, has lost the ability to produces prolactin.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6CV ! IM-9-P
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   IM-B182
AC   CVCL_E4AW
SY   IM-B 182
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IM-E182
AC   CVCL_E4AX
SY   IM-E 182
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IM-Ep-1
AC   CVCL_S574
SY   Ep-1
DR   Wikidata; Q54897505
RX   PubMed=1473147;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S548 ! IM-2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   IM-FEN
AC   CVCL_E7VE
SY   Immortalized Mouse-Fetal Enteric Neuronal
DR   ABM; T0297
RX   PubMed=18471518;
WW   Provider; Emory OTT; 06105; https://emoryott.technologypublisher.com/techcase/06105
CC   Doubling time: 25-35 hours (ABM=T0297).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Enteric neuron; CL=CL_0007011.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
ST   Source(s): ABM=T0297
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 13,18
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 17.3,18
ST   Mouse STR 6-7: 15,17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15.3,16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16.1,17.1
ST   Mouse STR 15-3: 20.3,26.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Conditionally immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IM-FW11
AC   CVCL_C7GF
DR   Wikidata; Q117704531
RX   PubMed=28269763;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IM-HA
AC   CVCL_B5WG
SY   IMmortalized-Human Astrocytes
DR   Innoprot; P10251-IM
DR   Wikidata; Q111733503
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   IM-HAEC
AC   CVCL_B5WL
SY   IMmortalized-Human Aortic Endothelial Cells
DR   Innoprot; P10457-IM
DR   Wikidata; Q111733504
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   IM-HBlSMC
AC   CVCL_B5WI
SY   IMmortalized-Human Bladder Smooth Muscle Cells
DR   Innoprot; P10951-IM
DR   Wikidata; Q111733505
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Indicated as P10951-IM in the online catalog but as P10561-IM in the technical sheet.
CC   Derived from site: In situ; Urinary bladder, smooth muscle; UBERON=UBERON_0004228.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   IM-HBMEC
AC   CVCL_YJ35
SY   IMmortalized Human Brain Microvascular Endothelial Cells; HBMEC-IM; Human Brain Microvascular Endothelial Cells-IMmortalized
DR   Innoprot; P10361-IM
DR   Wikidata; Q93980851
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   IM-HBMEC-tGFP
AC   CVCL_YJ36
SY   IMmortalized Human Brain Microvascular Endothelial Cells-tGFP; HBMEC-IM-tGFP; Human Brain Microvascular Endothelial Cells-IMmortalized-turboGFP
DR   Innoprot; P10361-IM-tGFP
DR   Wikidata; Q93980856
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YJ35 ! IM-HBMEC
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   IM-HCF
AC   CVCL_YJ37
SY   IMmortalized-Human Cardiac Fibroblasts; HCF-IM; Human Cardiac Fibroblast-IMmortalized
DR   Innoprot; P10453-IM
DR   Wikidata; Q93984493
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   IM-HCEC
AC   CVCL_B5WF
SY   IMmortalized-Human Corneal Endothelial Cells
DR   Innoprot; P10863-IM
DR   Wikidata; Q111733507
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   IM-HCEpiC
AC   CVCL_B5WK
SY   IMmortalized-Human Corneal Epithelial Cells
DR   Innoprot; P10871-IM
DR   Wikidata; Q111733508
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   IM-HConEpiC
AC   CVCL_YJ38
SY   IMmortalized-Human Conjunctival Epithelial Cells; HConEpiC-IM; Human Conjunctival Epithelial Cells-IMmortalized
DR   Innoprot; P10870-IM
DR   Wikidata; Q93984584
RX   PubMed=35985531;
CC   Doubling time: 40.33 +- 5.67 hours (Note=In collagen-coated flasks), 41.88 +- 4.97 hours (Note=In collagen uncoated flasks) (PubMed=35985531).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   IM-HDMEC
AC   CVCL_YJ39
SY   IMmortalized-Human Dermal Microvascular Endothelial Cells; HDMEC-IM; Human Dermal Microvascular Endothelial Cells-IMmortalized
DR   Innoprot; P10861-IM
DR   Wikidata; Q94090767
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   IM-HDMEC-tGFP
AC   CVCL_YJ40
SY   IMmortalized-Human Dermal Microvascular Endothelial Cells-tGFP; HDMEC-IM-tGFP; Human Dermal Microvascular Endothelial Cells-IMmortalized-turboGFP
DR   Innoprot; P10861-IM-tGFP
DR   Wikidata; Q94090770
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YJ39 ! IM-HDMEC
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   IM-HHSEC
AC   CVCL_YJ41
SY   IMmortalized-Human Hepatic Sinusoidal Endothelial Cells; HHSEC-IM; Human Hepatic Sinusoidal Endothelial Cells-IMmortalized
DR   Innoprot; P10652-IM
DR   Wikidata; Q94207140
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   IM-HK
AC   CVCL_B5WH
SY   IMmortalized-Human Keratocytes
DR   Innoprot; P10872-IM
DR   Wikidata; Q111733509
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Keratocyte; CL=CL_0002363.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   IM-HM
AC   CVCL_YJ42
SY   IMmortalized-Human Microglia; HM-IM; Human Microglia-IMmortalized
DR   Innoprot; P10354-IM
DR   Wikidata; Q94212706
RX   PubMed=35628555;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   IM-HM-tFP602
AC   CVCL_YJ43
SY   IMmortalized-Human Microglia-tFP602; HM-IM-FP602; Human Microglia-IMmortalized-FP602
DR   Innoprot; P10354-IM-tFP602
DR   Wikidata; Q94212712
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YJ42 ! IM-HM
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   IM-HM-tGFP
AC   CVCL_YJ44
SY   IMmortalized-Human Microglia-tGFP; HM-IM-tGFP; Human Microglia-IMmortalized-turboGFP
DR   Innoprot; P10354-IM-tGFP
DR   Wikidata; Q94212717
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YJ42 ! IM-HM
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   IM-HREC
AC   CVCL_B5WJ
SY   IMmortalized-Human Retinal Endothelial Cells
DR   Innoprot; P10880-IM
DR   Wikidata; Q111733510
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Retinal endothelial cell; CL=CL_0002585.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   IM-MFS-1
AC   CVCL_UF41
DR   Wikidata; Q94315908
RX   PubMed=30366467;
CC   Doubling time: 72 hours (PubMed=30366467).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 5
//
ID   IM-PEN
AC   CVCL_E7VF
SY   Immortalized Mouse-Postnatal Enteric Neuronal
RX   PubMed=18471518;
WW   Provider; Emory OTT; 06105; https://emoryott.technologypublisher.com/techcase/06105
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Enteric neuron; CL=CL_0007011.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2D
CA   Conditionally immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IM22
AC   CVCL_D4Y8
SY   I.M.-22
DR   Wikidata; Q127382349
RX   PubMed=62390;
RX   PubMed=168255;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IM23-16
AC   CVCL_RM51
DR   GEO; GSM627787
DR   Wikidata; Q54897506
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   IM23-9
AC   CVCL_RM52
DR   GEO; GSM627791
DR   Wikidata; Q54897507
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   IM25-2
AC   CVCL_RM53
DR   GEO; GSM627792
DR   Wikidata; Q54897508
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   IM34
AC   CVCL_D4Y9
DR   Wikidata; Q127382350
RX   PubMed=168255;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   IM7
AC   CVCL_C4ZY
DR   Wikidata; Q116049584
RX   PubMed=1714441;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02595; Mizuhopecten yessoensis calmodulin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   IM7.8.1
AC   CVCL_9184
SY   IM 7.8.1
DR   CLO; CLO_0006704
DR   ATCC; TIB-235
DR   Wikidata; Q54897509
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   IM95
AC   CVCL_2961
SY   Im95; IM-95
DR   BTO; BTO_0005908
DR   CLO; CLO_0037140
DR   EFO; EFO_0006446
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 900
DR   BioSample; SAMN03470904
DR   BioSample; SAMN10988365
DR   cancercelllines; CVCL_2961
DR   Cell_Model_Passport; SIDM00602
DR   ChEMBL-Cells; CHEMBL4295463
DR   ChEMBL-Targets; CHEMBL4296441
DR   Cosmic; 1187278
DR   Cosmic; 1482079
DR   Cosmic; 1995455
DR   Cosmic; 2443798
DR   Cosmic-CLP; 1240155
DR   DepMap; ACH-000919
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1240155
DR   GEO; GSM552360
DR   GEO; GSM562403
DR   GEO; GSM827403
DR   GEO; GSM844571
DR   GEO; GSM887161
DR   GEO; GSM888233
DR   GEO; GSM1237675
DR   GEO; GSM1237700
DR   GEO; GSM1374573
DR   GEO; GSM1669933
DR   IARC_TP53; 30079
DR   JCRB; JCRB1075.0
DR   JCRB; NIHS0333
DR   LiGeA; CCLE_708
DR   LINCS_LDP; LCL-1884
DR   PharmacoDB; IM95_657_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2961
DR   PubChem_Cell_line; CVCL_2961
DR   Wikidata; Q54897510
RX   PubMed=14609362;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=14609362); ~1.2 days (Note=Lot 11162005), ~46 hours (Note=Lot 10132009), ~35 hours (Note=Lot 09302016) (JCRB=JCRB1075.0).
CC   HLA typing: A*26:03,26:03; B*15:50,55:24; C*12:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=31068700; Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=71.45%; East Asian, South=28.36%; South Asian=0.19%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0333; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): Cosmic-CLP=1240155; JCRB=JCRB1075.0; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D18S51: 14,23,24
ST   D19S433: 12,13
ST   D21S11: 31,32.2
ST   D2S1338: 18
ST   D3S1358: 14
ST   D5S818: 9,11
ST   D7S820: 9.3 (Cosmic-CLP=1240155; PubMed=25877200)
ST   D7S820: 9.3,10.3 (JCRB=JCRB1075.0)
ST   D8S1179: 12,13
ST   FGA: 19,21
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 6,10
ST   TPOX: 8,10
ST   vWA: 17,18,19 (JCRB=JCRB1075.0; PubMed=25877200)
ST   vWA: 17,19 (Cosmic-CLP=1240155)
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   IM95/CMV-Luc
AC   CVCL_4Y04
DR   JCRB; JCRB1485
DR   JCRB; NIHS0712
DR   Wikidata; Q54897511
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1485).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0712; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): JCRB=JCRB1485
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D5S818: 9,11
ST   D7S820: 9.3
ST   D8S1179: 12,13
ST   TH01: 6,10
ST   TPOX: 8,10
ST   vWA: 17,18,19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2961 ! IM95
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   IM95m
AC   CVCL_2962
SY   IM95M; IM95 m; IM-95m
DR   CLO; CLO_0037141
DR   EFO; EFO_0006598
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473261
DR   Cosmic; 2484953
DR   Cosmic; 2807628
DR   EGA; EGAS00001000610
DR   FANTOM5_SSTAR; 10796-110I4
DR   GEO; GSM844572
DR   GEO; GSM1374574
DR   JCRB; JCRB1075.1
DR   JCRB; NIHS0334
DR   LINCS_LDP; LCL-1534
DR   PharmacoDB; IM95m_658_2019
DR   Wikidata; Q54897512
RX   PubMed=14609362;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29435981;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Compared to the parent cell line, it produces higher level of HGF, IL8 and VEGFA.
CC   Doubling time: 29 hours (PubMed=29435981).
CC   HLA typing: A*26:03,26:03; B*15:40,67:02; C*12:02,12:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0334; true.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): JCRB=JCRB1075.1; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D18S51: 13,23
ST   D21S11: 31,32.2
ST   D3S1358: 14
ST   D5S818: 9,11
ST   D7S820: 9.3
ST   D8S1179: 12,13
ST   FGA: 19,21
ST   Penta D: 10,11
ST   Penta E: 12
ST   TH01: 6,10
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2961 ! IM95
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   IMa
AC   CVCL_M688
SY   IMA
DR   Cosmic; 1820649
DR   Wikidata; Q54897513
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=2878840;
RX   PubMed=6682628;
RX   PubMed=6683709;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=6683709).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C39991; Non-gestational ovarian choriocarcinoma
DI   ORDO; Orphanet_289356; Primary non-gestational choriocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   IMA
AC   CVCL_E1HV
SY   TB096; TB096-2; TB09-0096-2; IDH1-Mutated Astrocytoma
DR   Millipore; SCC431
RX   PubMed=23204232;
CC   Doubling time: ~72 hours (PubMed=23204232).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg781Ter (c.2341C>T); Zygosity=Unspecified (PubMed=23204232).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=23204232).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (PubMed=23204232).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Millipore=SCC431
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,14
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,13
ST   D8S1179: 12,14
ST   FGA: 22,22.2
ST   Penta D: 14,15
ST   Penta E: 11,14
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   IMA 2.1
AC   CVCL_X370
SY   IMA2.1
DR   ABM; T0289
DR   Wikidata; Q54897514
RX   PubMed=22847254;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Miscellaneous: Sex of donor and STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: BALB/c.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,13
ST   Mouse STR 7-1: 26,28
ST   Mouse STR 8-1: 14
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 21.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1-2D
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 11
//
ID   IMA-KO-1
AC   CVCL_E1HW
RX   PubMed=23204232;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5382; IDH1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg781Ter (c.2341C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E1HV ! IMA
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   IMA-KO-1-EV
AC   CVCL_E1HY
RX   PubMed=23204232;
CC   Characteristics: Control cell line for IMA-KO-1-IDH1 (Cellosaurus=CVCL_E1HZ) and IMA-KO-1-IDH1-R132H (Cellosaurus=CVCL_E1I0) (PubMed=23204232).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5382; IDH1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg781Ter (c.2341C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E1HW ! IMA-KO-1
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   IMA-KO-1-IDH1
AC   CVCL_E1HZ
RX   PubMed=23204232;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5382; IDH1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg781Ter (c.2341C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5382; IDH1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E1HW ! IMA-KO-1
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   IMA-KO-1-IDH1-R132H
AC   CVCL_E1I0
RX   PubMed=23204232;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5382; IDH1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg781Ter (c.2341C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132His).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E1HW ! IMA-KO-1
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   IMA-KO-2
AC   CVCL_E1HX
RX   PubMed=23204232;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:5382; IDH1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg781Ter (c.2341C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E1HV ! IMA
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   IMab-1
AC   CVCL_D3DP
DR   Wikidata; Q127382351
RX   PubMed=19818334;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132His).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   IMAGINi002-A
AC   CVCL_D0FG
SY   IMAGINE002; EBDR-K142R-iPSCs
DR   BioSamples; SAMEA112903620
DR   hPSCreg; IMAGINi002-A
DR   Wikidata; Q123032674
RX   PubMed=37148821;
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Lys142Arg (c.425A>G); ClinVar=VCV000029636; Zygosity=Homozygous (PubMed=37148821).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IMAGINi003-A
AC   CVCL_D0FH
SY   IMAGINE003; EBDR-Q2170*-iPSCs
DR   BioSamples; SAMEA112904731
DR   hPSCreg; IMAGINi003-A
DR   Wikidata; Q123032675
RX   PubMed=37148821;
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gln2170Ter (c.6508C>T); ClinVar=VCV001069041; Zygosity=Homozygous (PubMed=37148821).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   IMAGINi004-A
AC   CVCL_A9T0
SY   IMAGINE004c17
DR   BioSamples; SAMEA7248745
DR   hPSCreg; IMAGINi004-A
DR   Wikidata; Q102114213
RX   PubMed=32866896;
CC   From: Imagine Institute; Paris; France.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IMAGINi005-A
AC   CVCL_A9T1
SY   IMAGINE005c4
DR   BioSamples; SAMEA7248741
DR   hPSCreg; IMAGINi005-A
DR   Wikidata; Q102114214
RX   PubMed=32866896;
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IMAGINi006-A
AC   CVCL_D0QR
SY   IMAGINE006
DR   hPSCreg; IMAGINi006-A
DR   Wikidata; Q123032676
CC   From: Imagine Institute; Paris; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IMAGINi007-A
AC   CVCL_ZZ83
SY   IMAGINE007
DR   hPSCreg; IMAGINi007-A
DR   Wikidata; Q102114215
RX   PubMed=32585588;
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:13394; NPHS2; Simple; p.Arg138Gln (c.413G>A); ClinVar=VCV000005360; Zygosity=Homozygous (PubMed=32585588).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123095; Nephrotic syndrome - NPHS2 associated
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   IMAGINi011-A
AC   CVCL_A1WE
SY   IMAGINE011c19
DR   BioSamples; SAMEA7655476
DR   hPSCreg; IMAGINi011-A
DR   Wikidata; Q105509661
RX   PubMed=33340797;
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27962; STING1; Simple; p.Val155Met (c.463G>A); ClinVar=VCV000143862; Zygosity=Heterozygous (PubMed=33340797).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177547; STING-associated vasculopathy, infantile-onset
DI   ORDO; Orphanet_425120; STING-associated vasculopathy with onset in infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   IMAGINi012-A
AC   CVCL_D0QQ
SY   IMAGINE012
DR   hPSCreg; IMAGINi012-A
DR   Wikidata; Q123032677
CC   From: Imagine Institute; Paris; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IMAGINi013-A
AC   CVCL_A9SZ
SY   IMAGINE013; IMAGINE013c19
DR   BioSamples; SAMEA7249009
DR   hPSCreg; IMAGINi013-A
DR   Wikidata; Q102114216
RX   PubMed=35334405;
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   IMAGINi020-A
AC   CVCL_C1Q7
SY   IMAGINE020; IMAGINE020c24
DR   BioSamples; SAMEA110424191
DR   hPSCreg; IMAGINi020-A
DR   Wikidata; Q114311727
RX   PubMed=35575086;
RX   PubMed=36868038;
CC   From: Imagine Institute; Paris; France.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:30594; UNC45A; Simple; p.Leu237Pro (c.710T>C); ClinVar=VCV000978046; Zygosity=Homozygous (PubMed=36868038).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201597; Osteootohepatoenteric syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   IMAGINi021-A
AC   CVCL_A9T2
SY   IMAGINE021
DR   BioSamples; SAMEA7258627
DR   hPSCreg; IMAGINi021-A
DR   Wikidata; Q102114218
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IMAGINi022-A
AC   CVCL_A9SY
SY   IMAGINE022
DR   BioSamples; SAMEA7248743
DR   hPSCreg; IMAGINi022-A
DR   Wikidata; Q102114219
RX   PubMed=32795927;
CC   From: Imagine Institute; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11190; SOX10; Simple; p.Pro175Ala (c.523C>G); Zygosity=Heterozygous (PubMed=32795927).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   IMAGINi050-A
AC   CVCL_F0RD
SY   IMAGINE050
DR   BioSamples; SAMEA117684376
DR   hPSCreg; IMAGINi050-A
RX   PubMed=40819571;
CC   From: Imagine Institute; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Met1Leu (c.1A>T); ClinVar=VCV000496858; Zygosity=Heterozygous (PubMed=40819571).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (PubMed=40819571).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-53Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   IMAGINi051-A
AC   CVCL_F0RE
SY   IMAGINE051
DR   BioSamples; SAMEA117851156
DR   hPSCreg; IMAGINi051-A
RX   PubMed=40819571;
CC   From: Imagine Institute; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (PubMed=40819571).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Phe305del (c.912CTT[1]) (c.915_917delTTC); ClinVar=VCV000188812; Zygosity=Heterozygous (PubMed=40819571).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-53Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   IMAGINi052-A
AC   CVCL_F0RF
SY   IMAGINE052
DR   BioSamples; SAMEA117851162
DR   hPSCreg; IMAGINi052-A
RX   PubMed=40819571;
CC   From: Imagine Institute; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg178His (c.533G>A); ClinVar=VCV000003896; Zygosity=Heterozygous (PubMed=40819571).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Gly269Ser (c.805G>A); ClinVar=VCV000003898; Zygosity=Heterozygous (PubMed=40819571).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-53Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   imAPAD
AC   CVCL_VT91
SY   immortalized Abdominal PreADipocyte cell line
DR   Wikidata; Q94315996
RX   PubMed=28452592;
CC   Doubling time: 1.0 +- 0.03 days (PubMed=28452592).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; White adipose tissue; UBERON=UBERON_0001347.
CC   Cell type: Preadipocyte; CL=CL_0002334.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT92 ! imGPAD
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   iMAT
AC   CVCL_E8I3
SY   imortalized Mouse Achilles Tendon
DR   ABM; T0035
RX   PubMed=26959762;
CC   Doubling time: 34-40 hours (ABM=T0035).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMPH86).
CC   Derived from site: In situ; Achilles tendon; UBERON=UBERON_0003701.
CC   Cell type: Tenocyte; CL=CL_0000388.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4W
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ImB1ON
AC   CVCL_E6BB
DR   ABM; T0845
RX   PubMed=30006274;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Central nervous system, optic nerve; UBERON=UBERON_0000941.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-5D
CA   Conditionally immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IMBAi001-A
AC   CVCL_C1Q8
SY   SCCF-176J clone#1; 176/1; HD.1 ARID1B+/+ clone 3a (XX)
DR   BioSamples; SAMEA110247342
DR   hPSCreg; IMBAi001-A
DR   Wikidata; Q114311728
RX   PubMed=34019794;
RX   PubMed=38718796;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/hd-1-arid1b-clone-3a-xx.html
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-176j-clone-1.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FI ! IMBAi001-B
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   IMBAi001-A-1
AC   CVCL_E4GR
SY   HD.1 ARID1B+/- clone 3b (XX)
DR   BioSamples; SAMEA115958748
DR   hPSCreg; IMBAi001-A-1
RX   PubMed=38718796;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/hd-1-arid1b-clone-3b-xx.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1Q8 ! IMBAi001-A
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi001-B
AC   CVCL_D0FI
SY   SCCF-176J clone#2
DR   BioSamples; SAMEA112322845
DR   hPSCreg; IMBAi001-B
DR   Wikidata; Q123032678
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-176j-clone-2.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Q8 ! IMBAi001-A
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi002-A
AC   CVCL_C1Q9
SY   SCCF-177J clone#8; 177/8
DR   BioSamples; SAMEA110271770
DR   EGA; EGAS00001006262
DR   hPSCreg; IMBAi002-A
DR   Wikidata; Q114311729
RX   PubMed=34019794;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-177j-clone-8.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FJ ! IMBAi002-B
OI   CVCL_D0FK ! IMBAi002-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   IMBAi002-B
AC   CVCL_D0FJ
SY   SCCF-177J clone#4
DR   BioSamples; SAMEA112328779
DR   EGA; EGAS00001006262
DR   hPSCreg; IMBAi002-B
DR   Wikidata; Q123032679
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-177j-clone-4.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Q9 ! IMBAi002-A
OI   CVCL_D0FK ! IMBAi002-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi002-C
AC   CVCL_D0FK
SY   SCCF-177J clone#6
DR   BioSamples; SAMEA112328788
DR   EGA; EGAS00001006262
DR   hPSCreg; IMBAi002-C
DR   Wikidata; Q123032680
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-177j-clone-6.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1Q9 ! IMBAi002-A
OI   CVCL_D0FJ ! IMBAi002-B
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi003-A
AC   CVCL_C1QA
SY   SCCF-178J clone#5; 178/5
DR   BioSamples; SAMEA112224778
DR   EGA; EGAS00001006262
DR   hPSCreg; IMBAi003-A
DR   Wikidata; Q114311730
RX   PubMed=34019794;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-178j-clone-5.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FL ! IMBAi003-B
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   IMBAi003-B
AC   CVCL_D0FL
SY   SCCF-178J clone#6
DR   BioSamples; SAMEA112328778
DR   EGA; EGAS00001006262
DR   hPSCreg; IMBAi003-B
DR   Wikidata; Q123032681
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-178j-clone-6.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1QA ! IMBAi003-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi004-A
AC   CVCL_D0FM
SY   SCCF-733J clone#1
DR   BioSamples; SAMEA112640270
DR   hPSCreg; IMBAi004-A
DR   Wikidata; Q123032682
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-733j-clone-1.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FN ! IMBAi004-B
OI   CVCL_D0FP ! IMBAi004-C
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi004-B
AC   CVCL_D0FN
SY   SCCF-733J clone#4
DR   BioSamples; SAMEA112641023
DR   hPSCreg; IMBAi004-B
DR   Wikidata; Q123032683
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-733j-clone-4.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FM ! IMBAi004-A
OI   CVCL_D0FP ! IMBAi004-C
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi004-C
AC   CVCL_D0FP
SY   SCCF-733J clone#17
DR   BioSamples; SAMEA112647709
DR   hPSCreg; IMBAi004-C
DR   Wikidata; Q123032684
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-733j-clone-17.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FM ! IMBAi004-A
OI   CVCL_D0FN ! IMBAi004-B
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi005-A
AC   CVCL_D0FQ
SY   SCCF-734J clone#2
DR   BioSamples; SAMEA112647737
DR   hPSCreg; IMBAi005-A
DR   Wikidata; Q123032685
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-734j-clone-2.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FR ! IMBAi005-B
OI   CVCL_D0FS ! IMBAi005-C
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi005-B
AC   CVCL_D0FR
SY   SCCF-734J clone#3
DR   BioSamples; SAMEA112649013
DR   hPSCreg; IMBAi005-B
DR   Wikidata; Q123032687
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-734j-clone-3.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FQ ! IMBAi005-A
OI   CVCL_D0FS ! IMBAi005-C
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi005-C
AC   CVCL_D0FS
SY   SCCF-734J clone#10
DR   BioSamples; SAMEA112650127
DR   hPSCreg; IMBAi005-C
DR   Wikidata; Q123032688
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-734j-clone-10.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FQ ! IMBAi005-A
OI   CVCL_D0FR ! IMBAi005-B
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi006-A
AC   CVCL_D0FT
SY   SCCF-735J clone#4
DR   BioSamples; SAMEA112650204
DR   hPSCreg; IMBAi006-A
DR   Wikidata; Q123032689
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-735j-clone-4.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FU ! IMBAi006-B
OI   CVCL_D0FV ! IMBAi006-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi006-B
AC   CVCL_D0FU
SY   SCCF-735J clone#17
DR   BioSamples; SAMEA112650216
DR   hPSCreg; IMBAi006-B
DR   Wikidata; Q123032690
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-735j-clone-17.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FT ! IMBAi006-A
OI   CVCL_D0FV ! IMBAi006-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi006-C
AC   CVCL_D0FV
SY   SCCF-735J clone#20
DR   BioSamples; SAMEA112651944
DR   hPSCreg; IMBAi006-C
DR   Wikidata; Q123032691
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-735j-clone-20.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FT ! IMBAi006-A
OI   CVCL_D0FU ! IMBAi006-B
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi007-A
AC   CVCL_D0FW
SY   SCCF-180J clone#5
DR   BioSamples; SAMEA112654285
DR   hPSCreg; IMBAi007-A
DR   Wikidata; Q123032692
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-180j-clone-5.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FX ! IMBAi007-B
OI   CVCL_D0FY ! IMBAi007-C
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi007-B
AC   CVCL_D0FX
SY   SCCF-180J clone#11
DR   BioSamples; SAMEA112655537
DR   hPSCreg; IMBAi007-B
DR   Wikidata; Q123032693
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-180j-clone-11.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FW ! IMBAi007-A
OI   CVCL_D0FY ! IMBAi007-C
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi007-C
AC   CVCL_D0FY
SY   SCCF-180J clone#21
DR   BioSamples; SAMEA112655598
DR   hPSCreg; IMBAi007-C
DR   Wikidata; Q123032694
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-180j-clone-21.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FW ! IMBAi007-A
OI   CVCL_D0FX ! IMBAi007-B
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi008-A
AC   CVCL_D0FZ
SY   SCCF-181J clone#16
DR   BioSamples; SAMEA112655599
DR   hPSCreg; IMBAi008-A
DR   Wikidata; Q123032695
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-181j-clone-16.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0G0 ! IMBAi008-B
OI   CVCL_D0G1 ! IMBAi008-C
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi008-B
AC   CVCL_D0G0
SY   SCCF-181J clone#20
DR   BioSamples; SAMEA112655739
DR   hPSCreg; IMBAi008-B
DR   Wikidata; Q123032696
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-181j-clone-20.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FZ ! IMBAi008-A
OI   CVCL_D0G1 ! IMBAi008-C
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi008-C
AC   CVCL_D0G1
SY   SCCF-181J clone#24
DR   BioSamples; SAMEA112655830
DR   hPSCreg; IMBAi008-C
DR   Wikidata; Q123032697
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-181j-clone-24.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0FZ ! IMBAi008-A
OI   CVCL_D0G0 ! IMBAi008-B
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   IMBAi009-A
AC   CVCL_E4GC
SY   SCCF-179J clone#13
DR   BioSamples; SAMEA115033350
DR   hPSCreg; IMBAi009-A
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-179j-clone-13.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GD ! IMBAi009-B
OI   CVCL_E4GE ! IMBAi009-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi009-B
AC   CVCL_E4GD
SY   SCCF-179J clone#15
DR   BioSamples; SAMEA115053015
DR   hPSCreg; IMBAi009-B
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-179j-clone-15.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GC ! IMBAi009-A
OI   CVCL_E4GE ! IMBAi009-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi009-C
AC   CVCL_E4GE
SY   SCCF-179J clone#18
DR   BioSamples; SAMEA115053016
DR   hPSCreg; IMBAi009-C
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-179j-clone-18.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GC ! IMBAi009-A
OI   CVCL_E4GD ! IMBAi009-B
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi010-A
AC   CVCL_E4GF
SY   SCCF-2298J clone#1
DR   BioSamples; SAMEA115170820
DR   hPSCreg; IMBAi010-A
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-2298j-clone-1.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GG ! IMBAi010-B
OI   CVCL_E4GH ! IMBAi010-C
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi010-B
AC   CVCL_E4GG
SY   SCCF-2298J clone#2
DR   BioSamples; SAMEA115373874
DR   hPSCreg; IMBAi010-B
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-2298j-clone-2.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GF ! IMBAi010-A
OI   CVCL_E4GH ! IMBAi010-C
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi010-C
AC   CVCL_E4GH
SY   SCCF-2298J clone#5
DR   BioSamples; SAMEA115957960
DR   hPSCreg; IMBAi010-C
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-2298j-clone-5.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GF ! IMBAi010-A
OI   CVCL_E4GG ! IMBAi010-B
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi011-A
AC   CVCL_E4GI
SY   SCCF-736J clone#1
DR   BioSamples; SAMEA115962705
DR   hPSCreg; IMBAi011-A
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-736j-clone-1.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GJ ! IMBAi011-B
OI   CVCL_E4GK ! IMBAi011-C
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi011-B
AC   CVCL_E4GJ
SY   SCCF-736J clone#6
DR   BioSamples; SAMEA115962704
DR   hPSCreg; IMBAi011-B
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-736j-clone-6.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GI ! IMBAi011-A
OI   CVCL_E4GK ! IMBAi011-C
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi011-C
AC   CVCL_E4GK
SY   SCCF-736J clone#8
DR   BioSamples; SAMEA115962703
DR   hPSCreg; IMBAi011-C
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/sccf-736j-clone-8.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GI ! IMBAi011-A
OI   CVCL_E4GJ ! IMBAi011-B
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi012-A
AC   CVCL_E4GL
SY   DBA 13j #1; DBA parent_healthy control 13j #1
DR   BioSamples; SAMEA115324306
DR   hPSCreg; IMBAi012-A
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/dba-parent-healthy-contol-13j-1.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi013-A
AC   CVCL_E4GM
SY   DBA 14J #2; DBA carrier 14J#2
DR   BioSamples; SAMEA115325127
DR   hPSCreg; IMBAi013-A
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/dba-patient-13j-1.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi014-A
AC   CVCL_E4GN
SY   DBA 15J #3; DBA patient line 15J#3
DR   BioSamples; SAMEA115331272
DR   hPSCreg; IMBAi014-A
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/dba-patient-15j-3.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi015-A
AC   CVCL_E4GP
SY   DBA 16J #1; DBA patient line 16J #1
DR   BioSamples; SAMEA115331298
DR   hPSCreg; IMBAi015-A
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/dba-patient-line-16j-1.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi016-A
AC   CVCL_E4GQ
SY   Pat.1 ARID1B+/- clone 1a (XY); B001-ARID1B#10
DR   BioSamples; SAMEA115296869
DR   hPSCreg; IMBAi016-A
RX   PubMed=38718796;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/pat-1-arid1b-clone-1a-xy.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Unexplicit; Ex8-20 del; Zygosity=Heterozygous (PubMed=38718796).
CC   Donor information: Established from a patient with a 6q25 microdeletion syndrome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi017-A
AC   CVCL_E4GW
SY   Pat.2 ARID1B+/- clone 2a (XX); B002-ARID1B#8
DR   BioSamples; SAMEA115296938
DR   hPSCreg; IMBAi017-A
RX   PubMed=38718796;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/pat-2-arid1b-clone-2a-xx.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Ser806Ilefs*27 (c.2411dupG) (p.Ser819Ilefs*27, c.2450dupG); ClinVar=VCV000419490; Zygosity=Heterozygous (PubMed=38718796).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi017-A-1
AC   CVCL_E4GX
SY   Pat.2 ARID1B+/+ clone 2c (XX)
DR   BioSamples; SAMEA115960551
DR   hPSCreg; IMBAi017-A-1
RX   PubMed=38718796;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/pat-2-arid1b-clone-2c-xx.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple_corrected; p.Ser806Ilefs*27 (c.2411dupG) (p.Ser819Ilefs*27, c.2450dupG); ClinVar=VCV000419490; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38718796).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4GW ! IMBAi017-A
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi017-A-2
AC   CVCL_E4GY
SY   Pat.2 ARID1B+/+ clone 2d (XX)
DR   BioSamples; SAMEA115960552
DR   hPSCreg; IMBAi017-A-2
RX   PubMed=38718796;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/pat-2-arid1b-clone-2d-xx.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple_corrected; p.Ser806Ilefs*27 (c.2411dupG) (p.Ser819Ilefs*27, c.2450dupG); ClinVar=VCV000419490; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38718796).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4GW ! IMBAi017-A
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi017-A-3
AC   CVCL_E4GZ
SY   Pat.2 ARID1B+/- clone 2b (XX)
DR   BioSamples; SAMEA117399235
DR   hPSCreg; IMBAi017-A-3
RX   PubMed=38718796;
WW   Provider; IMBA; -; https://shop.vbc.ac.at/ipsc_biobank/pat-2-arid1b-clone-2b-xx.html
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Characteristics: Control cell line. Went through a CRISPR/Cas9 genome editing procedure but did not get edited (PubMed=38718796).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Ser806Ilefs*27 (c.2411dupG) (p.Ser819Ilefs*27, c.2450dupG); ClinVar=VCV000419490; Zygosity=Heterozygous (PubMed=38718796).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4GW ! IMBAi017-A
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IMBAi018-A
AC   CVCL_E4GS
SY   622_DS04 #1
DR   BioSamples; SAMEA115296940
DR   hPSCreg; IMBAi018-A
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IMBAi019-A
AC   CVCL_E4GT
SY   623_DS22 #10
DR   BioSamples; SAMEA115297211
DR   hPSCreg; IMBAi019-A
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IMBAi020-A
AC   CVCL_E4GU
SY   624_DS40 #8
DR   BioSamples; SAMEA115297277
DR   hPSCreg; IMBAi020-A
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GV ! IMBAi020-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IMBAi020-B
AC   CVCL_E4GV
SY   624_DS40 #3
DR   BioSamples; SAMEA115962170
DR   hPSCreg; IMBAi020-B
CC   From: Institute of Molecular Biotechnology; Vienna; Austria.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4GU ! IMBAi020-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IMBB
AC   CVCL_B4GN
DR   Wikidata; Q110432926
RX   Patent=US8389276;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9386.
CC   Doubling time: ~24 hours (Patent=US8389276).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 5
//
ID   IMBPASi001-A
AC   CVCL_YT29
SY   iPSC-WFS1-#1
DR   BioSamples; SAMEA6877873
DR   hPSCreg; IMBPASi001-A
DR   Wikidata; Q94316000
RX   PubMed=32521500;
CC   From: Institute of Medical Biology of Polish Academy of Sciences; Lodz; Poland.
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Arg611His (c.1832G>A); ClinVar=VCV000045442; Zygosity=Heterozygous (PubMed=32521500).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp648Ter (c.1944G>A); ClinVar=VCV000004511; Zygosity=Heterozygous (PubMed=32521500).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Gly695Val (c.2084G>T); ClinVar=VCV000004510; Zygosity=Heterozygous (PubMed=32521500).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D23 ! GM01610
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   IMC-1
AC   CVCL_EQ57
DR   Cosmic; 2785202
DR   GEO; GSM471998
DR   Wikidata; Q54897515
RX   PubMed=14687616;
RX   PubMed=14687623;
RX   PubMed=21052088;
CC   Characteristics: IL2 dependent.
CC   Doubling time: 24-36 hours (PubMed=14687616).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   IMC-118
AC   CVCL_B6ZB
DR   Wikidata; Q111733511
RX   Patent=CN113980904B;
RX   PubMed=35429113;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021285.
CC   Characteristics: Luminal type B inflammatory and ERBB2+ (Patent=CN113980904B; PubMed=35429113).
CC   Doubling time: 50.31 hours (Patent=CN113980904B; PubMed=35429113).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   IMC-2
AC   CVCL_8245
SY   IMC2
DR   BioSample; SAMN03151720
DR   RCB; RCB0726
DR   Wikidata; Q54897516
RX   PubMed=1610070;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a male patient (from which IMC-3 and IMC-4 were also supposed to be derived) with maxillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00134.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0726; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   IMC-3
AC   CVCL_8246
DR   BioSample; SAMN03151721
DR   RCB; RCB0727
DR   Wikidata; Q54897517
RX   PubMed=1610070;
RX   PubMed=11416159;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a male patient (from which IMC-2 and IMC-4 were also supposed to be derived) with maxillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00215.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0727; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16
ST   D21S11: 27,28
ST   D8S1179: 12
ST   FGA: 18,21
ST   TH01: 7
ST   vWA: 16,19
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   IMC-4
AC   CVCL_8247
DR   BioSample; SAMN03151722
DR   RCB; RCB0728
DR   Wikidata; Q54897518
RX   PubMed=1610070;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a male patient (from which IMC-2 and IMC-3 were also supposed to be derived) with maxillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00319.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0728; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   IMC-Hz-1
AC   CVCL_AV27
SY   IMC-HZ-1
DR   ICLDB; imc-hz-1
DR   Wikidata; Q54897519
RX   CelloPub=CLPUB00492;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=5463775;
CC   Group: Insect cell line.
CC   Doubling time: 33 hours (DOI=10.1016/B978-0-12-709902-6.50017-0).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 8
//
ID   iMC23
AC   CVCL_E5UW
DR   ABM; T0318
RX   PubMed=22592154;
CC   Characteristics: Progenitor-like melanocytes (PubMed=22592154).
CC   Characteristics: Transduced with a SSR#41 vector (LTR-FRT-HygR-HSV1-TK-IRES-SV40LT-FRT-Neo-LTR) that allows removal of the SV40 TAg by using FLP (PubMed=22592154).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMC37
AC   CVCL_E5UX
DR   ABM; T0320
RX   PubMed=22592154;
CC   Characteristics: Intermediately differentiated melanoblasts (PubMed=22592154).
CC   Characteristics: Transduced with a SSR#41 vector (LTR-FRT-HygR-HSV1-TK-IRES-SV40LT-FRT-Neo-LTR) that allows removal of the SV40 TAg by using FLP (PubMed=22592154).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMC65
AC   CVCL_E5UY
DR   ABM; T0319
RX   PubMed=22592154;
CC   Characteristics: Late stage melanocytes (PubMed=22592154).
CC   Characteristics: Transduced with a SSR#41 vector (LTR-FRT-HygR-HSV1-TK-IRES-SV40LT-FRT-Neo-LTR) that allows removal of the SV40 TAg by using FLP (PubMed=22592154).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IMC9
AC   CVCL_C8ZG
DR   BioGRID_ORCS_Cell_line; 819
DR   Wikidata; Q123032698
RX   PubMed=30797773;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: Myc.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C57BL/6 Trp53-/- transgenic.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   12-15FD
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   IMCC3
AC   CVCL_E238
DR   AddexBio; T0017001/446
DR   GEO; GSM851920
DR   Wikidata; Q54897520
RX   PubMed=19926575;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   IMCC5
AC   CVCL_E239
DR   GEO; GSM851921
DR   Wikidata; Q54897521
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   IMCE 12
AC   CVCL_C3HZ
SY   IMCE#12; IMmortalized Canine Epididymal 12
DR   Wikidata; Q114311731
RX   Patent=DE10129863A1;
RX   PubMed=11574662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2501.
CC   Doubling time: 28-30 hours (Note=At 33 Celsius), 16-18 hours (Note=At 37 Celsius) (PubMed=11574662).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   IMCE 20
AC   CVCL_C3I0
SY   IMCE#20; IMmortalized Canine Epididymal 20
DR   Wikidata; Q114311732
RX   Patent=DE10129863A1;
RX   PubMed=11574662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2502.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   IMCE 28
AC   CVCL_C3I1
SY   IMCE#28; IMmortalized Canine Epididymal 28
DR   Wikidata; Q114311733
RX   Patent=DE10129863A1;
RX   PubMed=11574662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2503.
CC   Doubling time: 18-20 hours (Note=At 33 Celsius), 8-10 hours (Note=At 37 Celsius) (PubMed=11574662).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   IMCE 29
AC   CVCL_C3I2
SY   IMCE#29; IMmortalized Canine Epididymal 29
DR   Wikidata; Q114311734
RX   Patent=DE10129863A1;
RX   PubMed=11574662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2504.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   IMCE 3
AC   CVCL_C3HX
SY   IMCE#3; IMmortalized Canine Epididymal 3
DR   Wikidata; Q114311735
RX   Patent=DE10129863A1;
RX   PubMed=11574662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2499.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   IMCE 7
AC   CVCL_C3HY
SY   IMCE#7; IMmortalized Canine Epididymal 7
DR   Wikidata; Q114311736
RX   Patent=DE10129863A1;
RX   PubMed=11574662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2500.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis, epididymis; UBERON=UBERON_0001301.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   IMDF
AC   CVCL_U509
SY   IMmortalized Dermal Fibroblasts
DR   Wikidata; Q54897522
RX   PubMed=12089160;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-484.html
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   IMEC
AC   CVCL_U969
SY   Immortalized Mammary Epithelial Cells
DR   BTO; BTO_0004896
DR   Wikidata; Q54897523
RX   PubMed=11782364;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   IMEDEAi001-A
AC   CVCL_VD73
SY   CFBhiPS3.5
DR   hPSCreg; IMEDEAi001-A
DR   Wikidata; Q54897524
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD74 ! IMEDEAi001-B
OI   CVCL_VD75 ! IMEDEAi001-C
OI   CVCL_VD76 ! IMEDEAi001-D
OI   CVCL_VD77 ! IMEDEAi001-E
OI   CVCL_VD78 ! IMEDEAi001-F
OI   CVCL_VD79 ! IMEDEAi001-G
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   IMEDEAi001-B
AC   CVCL_VD74
SY   CFBhiPS3.9
DR   hPSCreg; IMEDEAi001-B
DR   Wikidata; Q54897525
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD73 ! IMEDEAi001-A
OI   CVCL_VD75 ! IMEDEAi001-C
OI   CVCL_VD76 ! IMEDEAi001-D
OI   CVCL_VD77 ! IMEDEAi001-E
OI   CVCL_VD78 ! IMEDEAi001-F
OI   CVCL_VD79 ! IMEDEAi001-G
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi001-C
AC   CVCL_VD75
SY   CFBhiPS3.11
DR   hPSCreg; IMEDEAi001-C
DR   Wikidata; Q54897526
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD73 ! IMEDEAi001-A
OI   CVCL_VD74 ! IMEDEAi001-B
OI   CVCL_VD76 ! IMEDEAi001-D
OI   CVCL_VD77 ! IMEDEAi001-E
OI   CVCL_VD78 ! IMEDEAi001-F
OI   CVCL_VD79 ! IMEDEAi001-G
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi001-D
AC   CVCL_VD76
SY   CFBhiPS3.12
DR   hPSCreg; IMEDEAi001-D
DR   Wikidata; Q54897527
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD73 ! IMEDEAi001-A
OI   CVCL_VD74 ! IMEDEAi001-B
OI   CVCL_VD75 ! IMEDEAi001-C
OI   CVCL_VD77 ! IMEDEAi001-E
OI   CVCL_VD78 ! IMEDEAi001-F
OI   CVCL_VD79 ! IMEDEAi001-G
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi001-E
AC   CVCL_VD77
SY   CFBhiPS3.17
DR   hPSCreg; IMEDEAi001-E
DR   Wikidata; Q54897529
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD73 ! IMEDEAi001-A
OI   CVCL_VD74 ! IMEDEAi001-B
OI   CVCL_VD75 ! IMEDEAi001-C
OI   CVCL_VD76 ! IMEDEAi001-D
OI   CVCL_VD78 ! IMEDEAi001-F
OI   CVCL_VD79 ! IMEDEAi001-G
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi001-F
AC   CVCL_VD78
SY   CFBhiPS3.18
DR   hPSCreg; IMEDEAi001-F
DR   SKIP; SKIP003189
DR   Wikidata; Q54897530
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD73 ! IMEDEAi001-A
OI   CVCL_VD74 ! IMEDEAi001-B
OI   CVCL_VD75 ! IMEDEAi001-C
OI   CVCL_VD76 ! IMEDEAi001-D
OI   CVCL_VD77 ! IMEDEAi001-E
OI   CVCL_VD79 ! IMEDEAi001-G
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   IMEDEAi001-F-1
AC   CVCL_B5LL
DR   hPSCreg; IMEDEAi001-F-1
DR   Wikidata; Q111733512
RX   PubMed=32373648;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous; Note=By TALEN (PubMed=32373648).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VD78 ! IMEDEAi001-F
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   IMEDEAi001-G
AC   CVCL_VD79
SY   CFBhiPS3.23
DR   hPSCreg; IMEDEAi001-G
DR   Wikidata; Q54897531
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD73 ! IMEDEAi001-A
OI   CVCL_VD74 ! IMEDEAi001-B
OI   CVCL_VD75 ! IMEDEAi001-C
OI   CVCL_VD76 ! IMEDEAi001-D
OI   CVCL_VD77 ! IMEDEAi001-E
OI   CVCL_VD78 ! IMEDEAi001-F
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi002-A
AC   CVCL_VD80
SY   CFBhiPS4.4
DR   hPSCreg; IMEDEAi002-A
DR   SKIP; SKIP003190
DR   Wikidata; Q54897532
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD81 ! IMEDEAi002-B
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   IMEDEAi002-B
AC   CVCL_VD81
SY   CFBhiPS4.9
DR   hPSCreg; IMEDEAi002-B
DR   Wikidata; Q54897533
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=29554588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VD80 ! IMEDEAi002-A
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi003-A
AC   CVCL_VD82
SY   WTBhiPS4
DR   hPSCreg; IMEDEAi003-A
DR   Wikidata; Q54897534
RX   PubMed=29554588;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   IMEDEAi004-A
AC   CVCL_UD89
SY   iPS GM00879CL1
DR   hPSCreg; IMEDEAi004-A
DR   Wikidata; Q94316116
RX   PubMed=30269021;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Arg245His (c.734G>A); ClinVar=VCV000005107; Zygosity=Heterozygous (PubMed=30269021).
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Glu447Lys (c.1339G>A); ClinVar=VCV000005114; Zygosity=Heterozygous (PubMed=30269021).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0L95 ! GM00879
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi004-B
AC   CVCL_UD90
SY   iPS GM00879CL9
DR   hPSCreg; IMEDEAi004-B
DR   Wikidata; Q94316119
RX   PubMed=30269021;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Arg245His (c.734G>A); ClinVar=VCV000005107; Zygosity=Heterozygous (PubMed=30269021).
CC   Sequence variation: Mutation; HGNC; HGNC:10818; SGSH; Simple; p.Glu447Lys (c.1339G>A); ClinVar=VCV000005114; Zygosity=Heterozygous (PubMed=30269021).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84897; Mucopolysaccharidosis type IIIA
DI   ORDO; Orphanet_79269; Sanfilippo syndrome type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0L95 ! GM00879
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi005-A
AC   CVCL_UJ73
SY   iPS GM02931 CL2
DR   hPSCreg; IMEDEAi005-A
DR   Wikidata; Q94316122
RX   PubMed=30408744;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Pro358Leu (c.1073C>T); ClinVar=VCV000631771; Zygosity=Homozygous (PubMed=30408744).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0M05 ! GM02931
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   IMEDEAi005-B
AC   CVCL_UJ74
SY   iPS GM02931 CL3
DR   hPSCreg; IMEDEAi005-B
DR   Wikidata; Q94316124
RX   PubMed=30408744;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Pro358Leu (c.1073C>T); ClinVar=VCV000631771; Zygosity=Homozygous (PubMed=30408744).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0M05 ! GM02931
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   IMEDEAi006-A
AC   CVCL_WK45
SY   iPS 322AD CL7
DR   hPSCreg; IMEDEAi006-A
DR   Wikidata; Q94316126
RX   PubMed=31026686;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Glu280Ala (c.839A>C); ClinVar=VCV000018131; Zygosity=Heterozygous (PubMed=31026686).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   IMEDEAi007-A
AC   CVCL_A9YH
SY   IMEDEA-PBMCs CL1.12
DR   hPSCreg; IMEDEAi007-A
DR   Wikidata; Q102114221
RX   PubMed=32707489;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   IMEDEAi008-A
AC   CVCL_A9YI
SY   hiPS SCD 10.44 CL2
DR   hPSCreg; IMEDEAi008-A
DR   Wikidata; Q102114222
RX   PubMed=32702648;
CC   From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1606; CCR5; Simple; p.Ser185Ilefs*32 (c.554_585del32) (CCR5del32); ClinVar=VCV000008184; Zygosity=Homozygous (PubMed=32702648).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   iMELA1
AC   CVCL_Y912
SY   A000024#1; A000024# 1; HPS0069
DR   SKIP; SKIP000022
DR   Wikidata; Q54897535
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T946 ! iMELA2
OI   CVCL_Y913 ! iMELA3
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   iMELA2
AC   CVCL_T946
SY   A000024#2; A000024# 2; HPS0070
DR   RCB; HPS0070
DR   SKIP; SKIP000023
DR   SKIP; SKIP000269
DR   Wikidata; Q54897538
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y912 ! iMELA1
OI   CVCL_Y913 ! iMELA3
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   iMELA3
AC   CVCL_Y913
SY   A000024#3; A000024# 3; HPS0071
DR   RCB; HPS0071
DR   SKIP; SKIP000024
DR   Wikidata; Q54897540
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y912 ! iMELA1
OI   CVCL_T946 ! iMELA2
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   iMEPM
AC   CVCL_JX90
SY   immortalized Mouse Embryonic Palatal Mesenchyme cell line
DR   Wikidata; Q54897541
RX   PubMed=28582446;
CC   Characteristics: Maintains the morphology, migration ability, transcript expression and responsiveness to exogenous growth factors of primary MEPM cells.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Derived from site: In situ; Embryonic oral cavity, palate; UBERON=UBERON_0001716.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   iMERRF-C7
AC   CVCL_A4GB
DR   Wikidata; Q105509665
RX   PubMed=27934592;
CC   From: Obstetrics and Gynecology Hospital, Nanjing Medical University; Nanjing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7489; MT-TK; Simple; m.8344A>G; ClinVar=VCV000009579; Zygosity=Heteroplasmic (PubMed=27934592).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84889; Myoclonic epilepsy associated with ragged-red fibers
DI   ORDO; Orphanet_551; MERRF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   iMESO-NF3
AC   CVCL_4Z44
DR   Wikidata; Q54897542
RX   PubMed=25877069;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97307; Nf2 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 8
//
ID   iMESO-NF5
AC   CVCL_4Z45
DR   Wikidata; Q54897543
RX   PubMed=25877069;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97307; Nf2 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 8
//
ID   iMESO-NF6
AC   CVCL_4Z46
DR   Wikidata; Q54897544
RX   PubMed=25877069;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97307; Nf2 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 8
//
ID   iMESO-WT1
AC   CVCL_4Z47
DR   Wikidata; Q54897545
RX   PubMed=25877069;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   iMESO-WT2
AC   CVCL_4Z48
DR   Wikidata; Q54897546
RX   PubMed=25877069;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   iMESO-WT3
AC   CVCL_4Z49
DR   Wikidata; Q54897547
RX   PubMed=25877069;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   IMFE1
AC   CVCL_VN61
SY   IMmortalized Fabry Endothelial cell line-1
DR   Wikidata; Q94316176
RX   PubMed=17644384;
CC   Doubling time: 33.6 hours (PubMed=17644384).
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000195028; Zygosity=Unspecified (PubMed=17644384).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   IMG
AC   CVCL_HC49
SY   Immortalized MicroGlial cell line
DR   Kerafast; EF4001
DR   Millipore; SCC134
DR   Wikidata; Q54897548
RX   PubMed=26819091;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC134
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14.2
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   iMG-1
AC   CVCL_E6BT
DR   ABM; T0442
RX   PubMed=37195378;
CC   Characteristics: Expresses macrophase/microglia=specific proteins (PubMed=37195378).
CC   Doubling time: ~100 hours (PubMed=37195378).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: FVB x C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMG-990 XP3Br2
AC   CVCL_IM57
DR   CLO; CLO_0006938
DR   CLDB; cl2870
DR   Wikidata; Q54897561
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Caution: Could be identical to XP3BR (Cellosaurus=CVCL_M286).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   IMGE-5
AC   CVCL_RK72
SY   Immortalized Mouse Gastric Epithelial cell line-5
DR   Wikidata; Q54897562
RX   PubMed=11292600;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6M
CA   Conditionally immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   ImGIST
AC   CVCL_D1GJ
SY   Immortalized GastroIntestinal Stromal Tumor cells
DR   Wikidata; Q127382353
RX   PubMed=37686448;
CC   Population: Chinese.
CC   Doubling time: 37.8 hours (PubMed=37686448).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val560del (c.1676TTG[1]); ClinVar=VCV000375913; Zygosity=Unspecified (PubMed=37686448).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
ST   Source(s): PubMed=37686448
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 19,20
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 16,17.2
ST   D1S1656: 11,16
ST   D21S11: 29,30
ST   D2S1338: 22,24
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D6S1043: 12
ST   D7S820: 8,13
ST   D8S1179: 10,11
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 12,20
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   ImGNC
AC   CVCL_C0WR
SY   Immortalized Giant Nevi Cells
DR   Wikidata; Q114311737
RX   PubMed=35218152;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=35218152).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
DI   NCIt; C4234; Giant congenital nevus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   imGPAD
AC   CVCL_VT92
SY   immortalized Gluteal PreADipocyte cell line
DR   Wikidata; Q94316250
RX   PubMed=28452592;
CC   Doubling time: 1.1 +- 0.05 days (PubMed=28452592).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; White adipose tissue; UBERON=UBERON_0001347.
CC   Cell type: Preadipocyte; CL=CL_0002334.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT91 ! imAPAD
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 13
//
ID   IMGTi001-A
AC   CVCL_VQ13
SY   iPSC-r(22)-1; iTAF5-29
DR   BioSamples; SAMEA4862236
DR   hPSCreg; IMGTi001-A
DR   Wikidata; Q94316254
RX   DOI=10.1134/S1022795419100090;
RX   PubMed=30144655;
RX   PubMed=33619287;
CC   From: Research Institute of Medical Genetics; Tomsk; Russia.
CC   Population: Caucasian.
CC   Karyotypic information: r(22),del22q13.32-q13.33,dup22q13.32,del3q13.31 (PubMed=30144655).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   NCIt; C179702; Ring chromosome 22 syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
DI   ORDO; Orphanet_1446; Ring chromosome 22 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q1 ! TAF5
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 10
//
ID   IMGTi001-B
AC   CVCL_VQ14
SY   iPSC-r(22)-2; iTAF5-32
DR   BioSamples; SAMEA4862238
DR   hPSCreg; IMGTi001-B
DR   Wikidata; Q94316259
RX   DOI=10.1134/S1022795419100090;
RX   PubMed=30144655;
RX   PubMed=33619287;
CC   From: Research Institute of Medical Genetics; Tomsk; Russia.
CC   Population: Caucasian.
CC   Karyotypic information: r(22),del22q13.32-q13.33,dup22q13.32,del3q13.31 (PubMed=30144655).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   NCIt; C179702; Ring chromosome 22 syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
DI   ORDO; Orphanet_1446; Ring chromosome 22 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q1 ! TAF5
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 10
//
ID   IMGTi003-A
AC   CVCL_UJ69
SY   iPSC-r(13)-1; iTAF6-6
DR   BioSamples; SAMEA5044543
DR   hPSCreg; IMGTi003-A
DR   Wikidata; Q94316262
RX   DOI=10.1134/S1022795419100090;
RX   PubMed=30500678;
RX   PubMed=33619287;
CC   From: Research Institute of Medical Genetics; Tomsk; Russia.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(13) [19]; 45,XY,-13 [2]; 46,XY,-13,+mar [1] (PubMed=30500678).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q2 ! TAF6
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   IMGTi003-B
AC   CVCL_A7MM
SY   iPSC-r(13)-2; iTAF6-23
DR   Wikidata; Q107115441
RX   PubMed=33619287;
CC   From: Research Institute of Medical Genetics; Tomsk; Russia.
CC   Population: Caucasian.
CC   Caution: We assigned the IMGTi003-B name for consistency with the IMGTi003-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q2 ! TAF6
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   IMGTi003-C
AC   CVCL_A7MN
SY   iPSC-r(13)-3; iTAF6-25
DR   Wikidata; Q107115442
RX   PubMed=33619287;
CC   From: Research Institute of Medical Genetics; Tomsk; Russia.
CC   Population: Caucasian.
CC   Caution: We assigned the IMGTi003-C name for consistency with the IMGTi003-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q2 ! TAF6
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   IMGTi003-D
AC   CVCL_A7MP
SY   iPSC-r(13)-4; iTAF6-36
DR   Wikidata; Q107115443
RX   PubMed=33619287;
CC   From: Research Institute of Medical Genetics; Tomsk; Russia.
CC   Population: Caucasian.
CC   Caution: We assigned the IMGTi003-D name for consistency with the IMGTi003-A cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q2 ! TAF6
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   imHC
AC   CVCL_UR52
SY   BMI/hTERT-MSC; immortalized Hepatocyte-like Cell line
DR   Wikidata; Q94316264
RX   PubMed=21961524;
RX   PubMed=29370800;
RX   PubMed=31381603;
CC   Group: Malaria research cell line.
CC   Characteristics: Supports Plasmodium vivax liver-stage development (PubMed=29370800).
CC   Doubling time: 45 hours (PubMed=29370800).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell derived hepatocyte.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 10
//
ID   imHC-FVII
AC   CVCL_XY59
SY   FVII-imHC
DR   Wikidata; Q94316268
RX   PubMed=31381603;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3544; F7.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell derived hepatocyte.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UR52 ! imHC
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   imHCE_GDLD
AC   CVCL_T054
SY   immortalized Human Conjunctival Epithelial cells from Gelatinous Drop-Like Corneal Dystrophy patient
DR   Wikidata; Q54897563
RX   PubMed=23818740;
RX   PubMed=23868985;
CC   Sequence variation: Mutation; HGNC; HGNC:11530; TACSTD2; Simple; p.Gln118Ter (c.352C>T); ClinVar=VCV000016182; Zygosity=Homozygous (PubMed=23818740; PubMed=23868985).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
DI   NCIt; C142805; Gelatinous drop-like corneal dystrophy
DI   ORDO; Orphanet_98957; Gelatinous drop-like corneal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   IMHe001-A
AC   CVCL_C800
SY   NS-3
DR   hPSCreg; IMHe001-A
DR   SKIP; SKIP001965
DR   Wikidata; Q54897564
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe002-A
AC   CVCL_C801
SY   NS-4
DR   hPSCreg; IMHe002-A
DR   SKIP; SKIP001966
DR   Wikidata; Q54897565
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe003-A
AC   CVCL_C802
SY   NS-5
DR   hPSCreg; IMHe003-A
DR   SKIP; SKIP001967
DR   Wikidata; Q54897567
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe004-A
AC   CVCL_C803
SY   NS-6
DR   hPSCreg; IMHe004-A
DR   SKIP; SKIP001968
DR   Wikidata; Q54897568
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe005-A
AC   CVCL_C804
SY   NS-7
DR   hPSCreg; IMHe005-A
DR   SKIP; SKIP001969
DR   Wikidata; Q54897569
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe006-A
AC   CVCL_C805
SY   NS-8
DR   hPSCreg; IMHe006-A
DR   SKIP; SKIP001970
DR   Wikidata; Q54897570
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   IMHe007-A
AC   CVCL_B867
SY   MINE
DR   hPSCreg; IMHe007-A
DR   SKIP; SKIP001971
DR   Wikidata; Q54897571
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe008-A
AC   CVCL_B022
SY   OZ
DR   hPSCreg; IMHe008-A
DR   SKIP; SKIP001972
DR   Wikidata; Q54897572
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   IMHe009-A
AC   CVCL_B023
SY   OZ-1
DR   hPSCreg; IMHe009-A
DR   SKIP; SKIP001973
DR   Wikidata; Q54897573
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe010-A
AC   CVCL_B024
SY   OZ-2
DR   hPSCreg; IMHe010-A
DR   SKIP; SKIP001974
DR   Wikidata; Q54897574
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe011-A
AC   CVCL_B030
SY   OZ-8
DR   hPSCreg; IMHe011-A
DR   SKIP; SKIP001975
DR   Wikidata; Q54897575
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   IMHe012-A
AC   CVCL_C806
SY   NS-9
DR   hPSCreg; IMHe012-A
DR   SKIP; SKIP002310
DR   Wikidata; Q54897576
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe013-A
AC   CVCL_C799
SY   NS-10
DR   hPSCreg; IMHe013-A
DR   SKIP; SKIP002311
DR   Wikidata; Q54897577
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe014-A
AC   CVCL_B025
SY   OZ-3
DR   hPSCreg; IMHe014-A
DR   SKIP; SKIP002312
DR   Wikidata; Q54897578
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe015-A
AC   CVCL_B026
SY   OZ-4
DR   hPSCreg; IMHe015-A
DR   SKIP; SKIP002313
DR   Wikidata; Q54897579
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   IMHe016-A
AC   CVCL_B027
SY   OZ-5
DR   hPSCreg; IMHe016-A
DR   SKIP; SKIP002314
DR   Wikidata; Q54897580
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe017-A
AC   CVCL_B028
SY   OZ-6
DR   hPSCreg; IMHe017-A
DR   SKIP; SKIP002315
DR   Wikidata; Q54897581
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   IMHe018-A
AC   CVCL_B029
SY   OZ-7
DR   hPSCreg; IMHe018-A
DR   SKIP; SKIP002316
DR   Wikidata; Q54897587
RX   DOI=10.5772/25010;
RX   PubMed=20349214;
CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   IMhu
AC   CVCL_YN91
SY   Immortalized Human Microglia - SV40
DR   ABM; T0251
DR   Wikidata; Q94316404
RX   PubMed=31096716;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   ImHumAdrenal
AC   CVCL_E6M0
DR   ABM; T0621
RX   PubMed=24063979;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from a donor that underwenttumor nephrectomy for renal carcinoma (PubMed=24063979).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IMIM-PC1
AC   CVCL_4061
SY   IMIM-PC-1; IMIMPC1; IM1; Instituto Municipal de Investigacion Medica-Pancreas Cancer 1
DR   cancercelllines; CVCL_4061
DR   Cosmic; 948736
DR   Wikidata; Q54897588
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=7723277;
RX   PubMed=8026879;
RX   PubMed=9665481;
RX   PubMed=11169957;
RX   PubMed=22585861;
CC   Doubling time: 50.4 hours (PubMed=7723277).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Unspecified (PubMed=8026879).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=22585861
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   IMIM-PC2
AC   CVCL_0345
SY   IMIM-PC-2; IMIM PC-2; IMIMPC2; IM2; Instituto Municipal de Investigacion Medica-Pancreas Cancer 2
DR   MCCL; MCC:0000241
DR   cancercelllines; CVCL_0345
DR   Cosmic; 710859
DR   Cosmic; 948728
DR   IARC_TP53; 16741
DR   Wikidata; Q54897589
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=7723277;
RX   PubMed=8026879;
RX   PubMed=8795137;
RX   PubMed=9665481;
RX   PubMed=11169957;
RX   PubMed=11787853;
RX   PubMed=22585861;
CC   Doubling time: 33.6 hours (PubMed=7723277).
CC   HLA typing: A*25; B*18 (PubMed=8795137).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8026879; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=8026879; PubMed=11787853).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: IMM-PC2; Note=Occasionally.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=22585861
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   ImKC
AC   CVCL_HF55
SY   Immortalized Kupffer Cells
DR   ABM; T0062
DR   Millipore; SCC119
DR   Wikidata; Q54897590
RX   PubMed=25138015;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RAW 264.7 derivative (Millipore; ICLAC). This is based on the STR profile. Originally thought to be a SV40 immortalized liver kupffer cell from a (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00620.
CC   Doubling time: ~24 hours (PubMed=25138015); 19-29 hours (ABM=T0062).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Discontinued: ABM; T0062; true.
CC   Discontinued: Millipore; SCC119; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
ST   Source(s): Millipore=SCC119
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 22.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 14,16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 24
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   IMM002.69.47.4
AC   CVCL_L543
DR   CLO; CLO_0006946
DR   ATCC; CRL-13007
DR   Wikidata; Q54897591
RX   Patent=US6376654;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-450.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   IMM010.109.12
AC   CVCL_L795
SY   MoAb 109.12
DR   Wikidata; Q54897592
RX   Patent=US7687607;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2357.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human 200 kDa glycoprotein surface antigen of small cell lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   IMM010.21.7
AC   CVCL_KR65
SY   MoAb 21.7
DR   Wikidata; Q54897593
RX   Patent=US7687607;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   IMM010.26.1
AC   CVCL_L796
SY   MoAb 26.1
DR   Wikidata; Q54897594
RX   Patent=US7687607;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2359.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   IMM010.37.14
AC   CVCL_L797
SY   MoAb 37.14
DR   Wikidata; Q54897595
RX   Patent=US7687607;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2358.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human 200 kDa glycoprotein surface antigen of small cell lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   IMM010.51.2
AC   CVCL_L798
SY   MoAb 51.2
DR   Wikidata; Q54897596
RX   Patent=US7687607;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2360.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human 200 kDa glycoprotein surface antigen of small cell lung cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   ImM10
AC   CVCL_J384
SY   Immortmouse Muller P10
DR   Wikidata; Q54897597
RX   CelloPub=CLPUB00658;
RX   PubMed=20505190;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10D
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   iMMEC beclin1+/- BLN2
AC   CVCL_E6CJ
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- BLN2
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN2-LC3
AC   CVCL_E6CQ
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- EGFP-LC3 BLN2-LC3
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6CJ ! iMMEC beclin1+/- BLN2
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN2.B2
AC   CVCL_E6CL
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- H-Bcl-2 BLN2.B2
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6CJ ! iMMEC beclin1+/- BLN2
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN2.B4
AC   CVCL_E6CM
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- H-Bcl-2 BLN2.B4
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6CJ ! iMMEC beclin1+/- BLN2
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN2.B4-LC3.5
AC   CVCL_E6CR
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- H-Bcl-2+EGFP-LC3 BLN2.B4-LC3.5
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6CM ! iMMEC beclin1+/- BLN2.B4
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN2.B5
AC   CVCL_E6CN
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- H-Bcl-2 BLN2.B5
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6CJ ! iMMEC beclin1+/- BLN2
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN2.B8
AC   CVCL_E6CP
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- H-Bcl-2 BLN2.B8
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6CJ ! iMMEC beclin1+/- BLN2
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN2.V
AC   CVCL_E6EP
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- pcDNA3.1 vector BLN2.V
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6CJ ! iMMEC beclin1+/- BLN2
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC beclin1+/- BLN4
AC   CVCL_E6CK
SY   immortalized Mouse Mammary Epithelial Cell line beclin1+/- BLN4
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1891828; Becn1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3
AC   CVCL_E6BV
SY   immortalized Mouse Mammary Epithelial Cell line WT3
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3-LC3
AC   CVCL_E6CB
SY   immortalized Mouse Mammary Epithelial Cell line EGFP-LC3 WT3-LC3
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BV ! iMMEC WT3
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3.B1
AC   CVCL_E6C5
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2 WT3.B1
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BV ! iMMEC WT3
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3.B2
AC   CVCL_E6C6
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2 WT3.B2
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BV ! iMMEC WT3
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3.B3
AC   CVCL_E6C7
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2 WT3.B3
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BV ! iMMEC WT3
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3.B3-LC3
AC   CVCL_E6CD
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2+EGFP-LC3 WT3.B3-LC3
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6C7 ! iMMEC WT3.B3
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3.B8
AC   CVCL_E6C8
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2 WT3.B8
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BV ! iMMEC WT3
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT3.V
AC   CVCL_E6C2
SY   immortalized Mouse Mammary Epithelial Cell line pcDNA3.1 vector WT3.V
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BV ! iMMEC WT3
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WT5
AC   CVCL_E6BW
SY   immortalized Mouse Mammary Epithelial Cell line WT5
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA
AC   CVCL_E6BX
SY   immortalized Mouse Mammary Epithelial Cell line WTA
DR   ABM; T0451
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Doubling time: 40-50 hours (ABM=T0451).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA-LC3
AC   CVCL_E6CC
SY   immortalized Mouse Mammary Epithelial Cell line EGFP-LC3 WTA-LC3
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.A5
AC   CVCL_E6C9
SY   immortalized Mouse Mammary Epithelial Cell line myr-Akt WTA.A5
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.A7
AC   CVCL_E6CA
SY   immortalized Mouse Mammary Epithelial Cell line myr-Akt WTA.A7
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1 (Note=Myristoylated = myr-AKT).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.B1
AC   CVCL_E6C3
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2 WTA.B1
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.B4
AC   CVCL_E6C4
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2 WTA.B4
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.B4-LC3
AC   CVCL_E6CE
SY   immortalized Mouse Mammary Epithelial Cell line H-Bcl-2+EGFP-LC3 WTA.B4-LC3
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=RGD; 735183; Map1lc3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6C4 ! iMMEC WTA.B4
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.H2
AC   CVCL_E6CH
SY   immortalized Mouse Mammary Epithelial Cell line H-HER2/neu WTA.H2
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.H3
AC   CVCL_E6CI
SY   immortalized Mouse Mammary Epithelial Cell line H-HER2/neu WTA.H3
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.R3
AC   CVCL_E6CF
SY   immortalized Mouse Mammary Epithelial Cell line H-RasV12 WTA.R3
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.R5
AC   CVCL_E6CG
SY   immortalized Mouse Mammary Epithelial Cell line H-RasV12 WTA.R5
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTA.V
AC   CVCL_E6C1
SY   WTA.V1; immortalized Mouse Mammary Epithelial Cell line pcDNA3.1 vector WTA.V
RX   PubMed=17606641;
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E6BX ! iMMEC WTA
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTB
AC   CVCL_E6BY
SY   immortalized Mouse Mammary Epithelial Cell line WTB
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTC
AC   CVCL_E6BZ
SY   immortalized Mouse Mammary Epithelial Cell line WTC
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMMEC WTD
AC   CVCL_E6C0
SY   immortalized Mouse Mammary Epithelial Cell line WTD
RX   PubMed=18603116;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   immFEB1
AC   CVCL_A8UU
DR   Wikidata; Q108820536
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33916959
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D10S1248: 13,14
ST   D12S391: 16,18
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D1S1656: 15,15.3
ST   D21S11: 30,31
ST   D22S1045: 11,15
ST   D2S441: 10,14
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   SE33: 20,25.2
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UV ! immKEB1
SX   Male
AG   8Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immFEB2
AC   CVCL_A8UW
DR   Wikidata; Q108820537
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33916959
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 15
ST   D12S391: 18,22
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D1S1656: 16,18.3
ST   D21S11: 29
ST   D22S1045: 11,15
ST   D2S441: 14,15
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   SE33: 14,19
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UX ! immKEB2
SX   Male
AG   16Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immFEB3
AC   CVCL_A8UY
DR   Wikidata; Q108820538
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immFEB4
AC   CVCL_A8UZ
DR   Wikidata; Q108820539
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33916959
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D10S1248: 14,15
ST   D12S391: 17.3,18
ST   D13S317: 8,13
ST   D16S539: 12,13
ST   D18S51: 14,19
ST   D1S1656: 12
ST   D21S11: 30,33
ST   D22S1045: 15,16
ST   D2S441: 10,14
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 11,12
ST   FGA: 21.2,26
ST   SE33: 24.2,28.2
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immFHC1
AC   CVCL_A8VA
DR   Wikidata; Q108820540
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immFHC2
AC   CVCL_A8VB
DR   Wikidata; Q108820541
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immKEB1
AC   CVCL_A8UV
DR   Wikidata; Q108820542
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=33916959
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D10S1248: 13,14
ST   D12S391: 16,18
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D1S1656: 15,15.3
ST   D21S11: 30,31
ST   D22S1045: 11,15
ST   D2S441: 10,14
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   SE33: 20,25.2
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UU ! immFEB1
SX   Male
AG   8Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immKEB2
AC   CVCL_A8UX
DR   Wikidata; Q108820543
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=33916959
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 15
ST   D12S391: 18,22
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D1S1656: 16,18.3
ST   D21S11: 29
ST   D22S1045: 11,15
ST   D2S441: 14,15
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   SE33: 14,19
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UW ! immFEB2
SX   Male
AG   16Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   immKHC8
AC   CVCL_A8VG
DR   Wikidata; Q108820544
RX   PubMed=33916959;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=33916959
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,14
ST   D12S391: 17,23
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D1S1656: 15.3,17.3
ST   D21S11: 29
ST   D22S1045: 16
ST   D2S441: 10,11
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 21,22
ST   SE33: 25.2,29.2
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   Immortalized primary brown preadipocytes Irs1 KO
AC   CVCL_E3FP
RX   PubMed=11113206;
RX   PubMed=11948624;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99454; Irs1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: Irs1-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Immortalized primary brown preadipocytes Irs2 KO
AC   CVCL_E3FQ
RX   PubMed=10829031;
RX   PubMed=11948624;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109334; Irs2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: Irs2-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Immortalized primary brown preadipocytes Snrk KO
AC   CVCL_D4Z9
DR   ATCC; CRL-3478
DR   Wikidata; Q127382354
RX   PubMed=31420304;
CC   Knockout cell: Method=KO mouse; MGI; MGI:108104; Snrk.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: SNRK-/-,U-Cre.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   IMO-1G1
AC   CVCL_D792
SY   IMO1G1; ImmortoMouse Otocyst-1G1
DR   Wikidata; Q54897598
RX   PubMed=12382283;
RX   PubMed=15517566;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMO-2B1
AC   CVCL_D793
SY   IMO2B1; ImmortoMouse Otocyst-2B1
DR   Wikidata; Q54897599
RX   PubMed=12382283;
RX   PubMed=15517566;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMO-2D2
AC   CVCL_D794
SY   IMO2D2; ImmortoMouse Otocyst-2D2
DR   Wikidata; Q54897600
RX   PubMed=12382283;
RX   PubMed=15517566;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMO-2D3
AC   CVCL_D795
SY   IMO2D3; ImmortoMouse Otocyst-2D3
DR   Wikidata; Q54897601
RX   PubMed=12382283;
RX   PubMed=15517566;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMO-3A1
AC   CVCL_D796
SY   IMO3A1; ImmortoMouse Otocyst-3A1
DR   Wikidata; Q54897602
RX   PubMed=12382283;
RX   PubMed=15517566;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMO-3C3
AC   CVCL_D797
SY   IMO3C3; ImmortoMouse Otocyst-3C3
DR   Wikidata; Q54897603
RX   PubMed=12382283;
RX   PubMed=15517566;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMO-3C6
AC   CVCL_D809
SY   IMO3C6; ImmortoMouse Otocyst-3C6
DR   Wikidata; Q54897604
RX   PubMed=10654599;
RX   PubMed=12382283;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMO-3D1
AC   CVCL_D798
SY   IMO3D1; ImmortoMouse Otocyst-3D1
DR   Wikidata; Q54897605
RX   PubMed=12382283;
RX   PubMed=15517566;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   IMOi001-A
AC   CVCL_E7TX
SY   STGD PBiPS1-SV4F-1
DR   BioSamples; SAMEA117685024
DR   hPSCreg; IMOi001-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg212Cys (c.634C>T); ClinVar=VCV000007898; Zygosity=Heterozygous (hPSCreg=IMOi001-A).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg1129Leu (c.3386G>T); ClinVar=VCV000099224; Zygosity=Heterozygous (hPSCreg=IMOi001-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi002-A
AC   CVCL_E7TY
SY   STGD PBiPS2-SV4F-1
DR   BioSamples; SAMEA117685026
DR   hPSCreg; IMOi002-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi003-A
AC   CVCL_E7TZ
SY   STGD PBiPS3-SV4F-10
DR   BioSamples; SAMEA117685028
DR   hPSCreg; IMOi003-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi004-A
AC   CVCL_E7U0
SY   STGD PBiPS4-SV4F-1
DR   BioSamples; SAMEA117685029
DR   hPSCreg; IMOi004-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi005-A
AC   CVCL_E7U1
SY   STGD PBiPS5-SV4F-2
DR   BioSamples; SAMEA117685030
DR   hPSCreg; IMOi005-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi006-A
AC   CVCL_E7U2
SY   STGD PBiPS6-SV4F-2
DR   BioSamples; SAMEA117685031
DR   hPSCreg; IMOi006-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi007-A
AC   CVCL_E7U3
SY   STGD PBiPS7-SV4F-1
DR   BioSamples; SAMEA117685032
DR   hPSCreg; IMOi007-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi008-A
AC   CVCL_E7U4
SY   STGD PBiPS8-SV4F-11
DR   BioSamples; SAMEA117685023
DR   hPSCreg; IMOi008-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi009-A
AC   CVCL_E7U5
SY   STGD PBiPS9-SV4F-3
DR   hPSCreg; IMOi009-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi010-A
AC   CVCL_E7U6
SY   STGD PBiPS10-SV4F-3
DR   BioSamples; SAMEA117685034
DR   hPSCreg; IMOi010-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi011-A
AC   CVCL_E7U7
SY   STGD PBiPS11-SV4F-2
DR   BioSamples; SAMEA117685448
DR   hPSCreg; IMOi011-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi012-A
AC   CVCL_E7U8
SY   STGD PBiPS12-SV4F-6
DR   BioSamples; SAMEA117689159
DR   hPSCreg; IMOi012-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi013-A
AC   CVCL_E7U9
SY   STGD PBiPS13-SV4F-1
DR   BioSamples; SAMEA117689420
DR   hPSCreg; IMOi013-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi014-A
AC   CVCL_E7UA
SY   STGD PBiPS14-SV4F-1
DR   BioSamples; SAMEA117689441
DR   hPSCreg; IMOi014-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi015-A
AC   CVCL_E7UB
SY   STGD PBiPS15-SV4F-4
DR   BioSamples; SAMEA117689443
DR   hPSCreg; IMOi015-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi016-A
AC   CVCL_E7UC
SY   STGD PBiPS16-SV4F-1.1
DR   BioSamples; SAMEA117689446
DR   hPSCreg; IMOi016-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi017-A
AC   CVCL_E7UD
SY   STGD PBiPS17-SV4F-10
DR   BioSamples; SAMEA117689450
DR   hPSCreg; IMOi017-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi018-A
AC   CVCL_E7UE
SY   STGD PBiPS18-SV4F-10
DR   hPSCreg; IMOi018-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IMOi019-A
AC   CVCL_E7UF
SY   STGD PBiPS19-SV4F-1
DR   BioSamples; SAMEA117711130
DR   hPSCreg; IMOi019-A
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Microcirurgia Ocular, Grupo Miranza; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   iMOSEC-1
AC   CVCL_D3JX
SY   immortal Mouse Ovarian Surface Epithelial Cell line-1
DR   ABM; T0608
DR   Wikidata; Q127382355
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMOSEC-1/BCL-2
AC   CVCL_D3K7
DR   Wikidata; Q127382356
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3JX ! iMOSEC-1
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iMOSEC-1/H-ras
AC   CVCL_D3K5
DR   Wikidata; Q127382357
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3JX ! iMOSEC-1
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iMOSEC-2
AC   CVCL_D3JY
SY   immortal Mouse Ovarian Surface Epithelial Cell line-2
DR   Wikidata; Q127382359
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMOSEC-3
AC   CVCL_D3JZ
SY   immortal Mouse Ovarian Surface Epithelial Cell line-3
DR   Wikidata; Q127382360
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMOSEC-3/BCL-2
AC   CVCL_D3K8
DR   Wikidata; Q127382361
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3JZ ! iMOSEC-3
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iMOSEC-4
AC   CVCL_D3K0
SY   immortal Mouse Ovarian Surface Epithelial Cell line-4
DR   Wikidata; Q127382362
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMOSEC-5
AC   CVCL_D3K1
SY   immortal Mouse Ovarian Surface Epithelial Cell line-5
DR   Wikidata; Q127382363
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMOSEC-6
AC   CVCL_D3K2
SY   immortal Mouse Ovarian Surface Epithelial Cell line-6
DR   Wikidata; Q127382364
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMOSEC-6/BCL-2
AC   CVCL_D3K9
DR   Wikidata; Q127382366
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3K2 ! iMOSEC-6
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iMOSEC-6/H-ras
AC   CVCL_D3K6
DR   Wikidata; Q127382367
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3K2 ! iMOSEC-6
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   iMOSEC-7
AC   CVCL_D3K3
SY   immortal Mouse Ovarian Surface Epithelial Cell line-7
DR   Wikidata; Q127382368
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMOSEC-8
AC   CVCL_D3K4
SY   immortal Mouse Ovarian Surface Epithelial Cell line-8
DR   Wikidata; Q127382369
RX   PubMed=18603117;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPD183.C1
AC   CVCL_D178
SY   iPS MPD183 clone 1; iPS MPD 183 clone 1
DR   SKIP; SKIP000522
DR   Wikidata; Q54897606
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D185 ! iMPD183.C10
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C10
AC   CVCL_D185
SY   iPS MPD183 clone 10; iPS MPD 183 clone 10
DR   SKIP; SKIP000528
DR   Wikidata; Q54897607
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C11
AC   CVCL_D186
SY   iPS MPD183 clone 11; iPS MPD 183 clone 11
DR   SKIP; SKIP000529
DR   Wikidata; Q54897608
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D185 ! iMPD183.C10
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C2
AC   CVCL_D179
SY   iPS MPD183 clone 2; iPS MPD 183 clone 2
DR   SKIP; SKIP000523
DR   Wikidata; Q54897609
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D185 ! iMPD183.C10
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C3
AC   CVCL_D180
SY   iPS MPD183 clone 3; iPS MPD 183 clone 3
DR   SKIP; SKIP000524
DR   Wikidata; Q54897610
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D185 ! iMPD183.C10
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C5
AC   CVCL_D181
SY   iPS MPD183 clone 5; iPS MPD 183 clone 5
DR   SKIP; SKIP000525
DR   Wikidata; Q54897611
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D185 ! iMPD183.C10
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C6
AC   CVCL_D182
SY   iPS MPD183 clone 6
DR   Wikidata; Q54897612
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D185 ! iMPD183.C10
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C7
AC   CVCL_D183
SY   iPS MPD183 clone 7; iPS MPD 183 clone 7
DR   SKIP; SKIP000526
DR   Wikidata; Q54897613
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D184 ! iMPD183.C8
OI   CVCL_D185 ! iMPD183.C10
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD183.C8
AC   CVCL_D184
SY   iPS MPD183 clone 8; iPS MPD 183 clone 8
DR   SKIP; SKIP000527
DR   Wikidata; Q54897614
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D178 ! iMPD183.C1
OI   CVCL_D179 ! iMPD183.C2
OI   CVCL_D180 ! iMPD183.C3
OI   CVCL_D181 ! iMPD183.C5
OI   CVCL_D182 ! iMPD183.C6
OI   CVCL_D183 ! iMPD183.C7
OI   CVCL_D185 ! iMPD183.C10
OI   CVCL_D186 ! iMPD183.C11
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD562.C2
AC   CVCL_D187
SY   iPS MPD562 clone 2; iPS MPD 562 clone 2
DR   SKIP; SKIP000530
DR   Wikidata; Q54897615
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D188 ! iMPD562.C3
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPD562.C3
AC   CVCL_D188
SY   iMPD562.C.3; iPS MPD562 clone 3; iPS MPD 562 clone 3
DR   SKIP; SKIP000531
DR   Wikidata; Q54897616
RX   PubMed=19797525;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=19797525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4345; Myeloproliferative neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D187 ! iMPD562.C2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   iMPEC-1
AC   CVCL_D3JP
SY   immortal Mouse Prostate Epithelial Cell line-1
DR   Wikidata; Q127382370
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPEC-2
AC   CVCL_D3JQ
SY   immortal Mouse Prostate Epithelial Cell line-2
DR   Wikidata; Q127382371
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPEC-3
AC   CVCL_D3JR
SY   immortal Mouse Prostate Epithelial Cell line-3
DR   Wikidata; Q127382373
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPEC-4
AC   CVCL_D3JS
SY   immortal Mouse Prostate Epithelial Cell line-4
DR   Wikidata; Q127382374
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPEC-5
AC   CVCL_D3JT
SY   immortal Mouse Prostate Epithelial Cell line-5
DR   Wikidata; Q127382375
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPEC-6
AC   CVCL_D3JU
SY   immortal Mouse Prostate Epithelial Cell line-6
DR   Wikidata; Q127382376
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPEC-7
AC   CVCL_D3JV
SY   iMPEC, clone7; immortal Mouse Prostate Epithelial Cell line-7
DR   ABM; T0607
DR   Wikidata; Q127382377
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPEC-8
AC   CVCL_D3JW
SY   immortal Mouse Prostate Epithelial Cell line-8
DR   Wikidata; Q127382378
RX   PubMed=18603117;
RX   PubMed=19737977;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   iMPMECs
AC   CVCL_D3FM
SY   immortalized Mouse Pulmonary Microvascular Endothelial Cells
DR   Wikidata; Q127382379
RX   PubMed=34956190;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Lung microvascular endothelial cell; CL=CL_2000016.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   imPSCc1
AC   CVCL_A5TH
SY   i-mPSC C1; immortalized mouse Pancreatic Stellate Cells cloned expansion 1
DR   Wikidata; Q107115444
RX   PubMed=20847583;
CC   Doubling time: 45 hours (PubMed=20847583).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A5TI ! imPSCc2
OI   CVCL_A5TJ ! imPSCc3
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   imPSCc2
AC   CVCL_A5TI
SY   i-mPSC C2; immortalized mouse Pancreatic Stellate Cells cloned expansion 2
DR   Wikidata; Q107115445
RX   PubMed=20847583;
CC   Doubling time: 45 hours (PubMed=20847583).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A5TH ! imPSCc1
OI   CVCL_A5TJ ! imPSCc3
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   imPSCc3
AC   CVCL_A5TJ
SY   i-mPSC C3; immortalized mouse Pancreatic Stellate Cells cloned expansion 3
DR   Wikidata; Q107115446
RX   PubMed=20847583;
CC   Doubling time: 51 hours (PubMed=20847583).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A5TH ! imPSCc1
OI   CVCL_A5TI ! imPSCc2
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   IMR-31
AC   CVCL_2527
SY   IMR 31; IMR31; IMR 31 Bu; Bu (IMR-31); BU; Bu; Institute for Medical Research-31
DR   CLO; CLO_0002049
DR   CLO; CLO_0006947
DR   CLDB; cl503
DR   CLDB; cl504
DR   CLDB; cl5211
DR   ATCC; CCL-40
DR   ECACC; 89051704
DR   IZSLER; BS CL 52
DR   Wikidata; Q54897617
RX   DOI=10.1007/BF02618370;
RX   PubMed=7065527;
RX   PubMed=7989438;
CC   Senescence: Senesces at ~40 PDL (ATCC=CCL-40).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Discontinued: ATCC; CCL-40; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9901; ! Bison bison (American bison)
SX   Female
AG   Yearling
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   IMR-32
AC   CVCL_0346
SY   IMR 32; IMR32; Institute for Medical Research-32; GM03320; GM3320C; GM03320D; AG03320; AG3320
DR   BTO; BTO_0000934
DR   CLO; CLO_0006948
DR   CLO; CLO_0016777
DR   EFO; EFO_0001195
DR   MCCL; MCC:0000242
DR   CLDB; cl2878
DR   CLDB; cl2879
DR   CLDB; cl2880
DR   CLDB; cl2881
DR   CLDB; cl2882
DR   CLDB; cl2883
DR   CLDB; cl2885
DR   CLDB; cl2886
DR   CLDB; cl2887
DR   CLDB; cl2888
DR   ABM; T8975
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-127
DR   BCRC; 60014
DR   BCRJ; 0377
DR   BioGRID_ORCS_Cell_line; 637
DR   BioSample; SAMN00808348
DR   BioSample; SAMN03472412
DR   BioSample; SAMN03473082
DR   BioSample; SAMN10988103
DR   cancercelllines; CVCL_0346
DR   CCRID; 1101HUM-PUMC000282
DR   CCRID; 3101HUMTCHu145
DR   CCRID; 4201HUM-CCTCC00107
DR   CCTCC; GDC0107
DR   Cell_Model_Passport; SIDM00226
DR   CGH-DB; 78-1
DR   CGH-DB; 9095-4
DR   ChEMBL-Cells; CHEMBL3307656
DR   ChEMBL-Targets; CHEMBL614585
DR   CLS; 300148
DR   Coriell; AG03320
DR   Coriell; GM03320
DR   Cosmic; 688067
DR   Cosmic; 759892
DR   Cosmic; 801746
DR   Cosmic; 920239
DR   Cosmic; 922658
DR   Cosmic; 947702
DR   Cosmic; 1019944
DR   Cosmic; 1037352
DR   Cosmic; 1099149
DR   Cosmic; 1109111
DR   Cosmic; 1237544
DR   Cosmic; 1518066
DR   Cosmic; 1526626
DR   Cosmic; 2058113
DR   Cosmic; 2131590
DR   Cosmic; 2301580
DR   Cosmic; 2393630
DR   Cosmic; 2485944
DR   DepMap; ACH-000310
DR   DSMZ; ACC-165
DR   DSMZCellDive; ACC-165
DR   ECACC; 86041809
DR   EGA; EGAS00001000610
DR   GEO; GSM453632
DR   GEO; GSM563362
DR   GEO; GSM692859
DR   GEO; GSM887162
DR   GEO; GSM888234
DR   GEO; GSM1366406
DR   GEO; GSM1669934
DR   GEO; GSM2371237
DR   GEO; GSM2394364
DR   IARC_TP53; 23585
DR   ICLC; HTL96021
DR   IZSLER; BS TCL 29
DR   JCRB; IFO50283
DR   JCRB; JCRB9050
DR   KCB; KCB 2011100YJ
DR   KCLB; 10127
DR   LiGeA; CCLE_016
DR   LINCS_LDP; LCL-1965
DR   Lonza; 971
DR   PharmacoDB; IMR32_659_2019
DR   PRIDE; PXD000589
DR   Progenetix; CVCL_0346
DR   PubChem_Cell_line; CVCL_0346
DR   RCB; RCB1895
DR   TKG; TKG 0207
DR   Wikidata; Q54897618
RX   CelloPub=CLPUB00387;
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=62055;
RX   PubMed=71759;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=856461;
RX   PubMed=922665;
RX   PubMed=2535691;
RX   PubMed=3518877;
RX   PubMed=3698005;
RX   PubMed=5459762;
RX   PubMed=6401685;
RX   PubMed=6888561;
RX   PubMed=6935474;
RX   PubMed=7037175;
RX   PubMed=7139592;
RX   PubMed=7253718;
RX   PubMed=7459858;
RX   PubMed=7838528;
RX   PubMed=8221663;
RX   PubMed=8490657;
RX   PubMed=8665486;
RX   PubMed=9201287;
RX   PubMed=9283597;
RX   PubMed=9516836;
RX   PubMed=11550280;
RX   PubMed=11668190;
RX   PubMed=12210830;
RX   PubMed=12702577;
RX   PubMed=15390183;
RX   PubMed=15892104;
RX   PubMed=16524757;
RX   PubMed=16822308;
RX   PubMed=17974978;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=22460905;
RX   PubMed=24466371;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=26589293;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31581737;
RX   PubMed=33460449;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-508.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Neuroblastic type (N-type).
CC   Doubling time: 26 +- 5 hours (PubMed=856461); 48 hours (PubMed=5459762); ~20 hours (ATCC=CCL-127); ~40-50 hours (DSMZ=ACC-165).
CC   HLA typing: A*24:02,24:02; B*07:05,07:05; C*05:01,12:03 (PubMed=26589293).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.56%; East Asian, North=1.01%; East Asian, South=0%; South Asian=3.99%; European, North=73.7%; European, South=20.72% (PubMed=30894373).
CC   Misspelling: IMR-92; Note=Occasionally.
CC   Misspelling: IRM-32; Note=Occasionally.
CC   Discontinued: Coriell; AG03320; probable.
CC   Discontinued: RCB; RCB1895; true.
CC   Discontinued: TKG; TKG 0207; true.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): ATCC=CCL-127; CCRID; CLS=300148; COG; DSMZ=ACC-165; IZSLER=BS TCL 29; JCRB=IFO50283; JCRB=JCRB9050; KCLB=10127; PubMed=25877200; PubMed=31581737; PubMed=33460449; RCB=RCB1895; TKG=TKG 0207
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8 (ATCC=CCL-127; CCRID; COG; DSMZ=ACC-165; IZSLER=BS TCL 29; JCRB=IFO50283; JCRB=JCRB9050; PubMed=25877200; PubMed=31581737; PubMed=33460449; RCB=RCB1895; TKG=TKG 0207)
ST   D16S539: 8,10 (CLS=300148)
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3 (ATCC=CCL-127; CCRID; CLS=300148; COG; DSMZ=ACC-165; IZSLER=BS TCL 29; JCRB=IFO50283; KCLB=10127; PubMed=25877200; PubMed=31581737; PubMed=33460449; RCB=RCB1895; TKG=TKG 0207)
ST   TH01: 7,10 (JCRB=JCRB9050)
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   IMR-32 SimpleCell O-GalNAc
AC   CVCL_S028
SY   IMR32 SimpleCell; IMR32 SC
DR   Wikidata; Q54897620
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   IMR-32/CMV-Luc
AC   CVCL_A9J0
SY   IMR-32 CMV-Luc
DR   JCRB; JCRB1842
DR   JCRB; NIHS1296
DR   Wikidata; Q102114223
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1482).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1296; true.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): JCRB=JCRB1842
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   IMR-32_pCMV-DPP3
AC   CVCL_ER17
DR   GEO; GSM148455
DR   GEO; GSM148456
DR   Wikidata; Q54897622
RX   PubMed=17360324;
CC   Population: Caucasian.
CC   Characteristics: Expression of the luciferase gene is under the control of an antioxidant response element (ARE) (PubMed=17360324).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3008; DPP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   IMR-32_pCMV-SQSTM1
AC   CVCL_ER18
DR   GEO; GSM148457
DR   GEO; GSM148458
DR   Wikidata; Q54897623
RX   PubMed=17360324;
CC   Population: Caucasian.
CC   Characteristics: Expression of the luciferase gene is under the control of an antioxidant response element (ARE) (PubMed=17360324).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11280; SQSTM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   IMR-32rBORTE10
AC   CVCL_RS60
DR   Wikidata; Q54897624
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rCARBO1000
AC   CVCL_ZX18
DR   Wikidata; Q102114224
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   IMR-32rCARBO4000
AC   CVCL_RR66
DR   Wikidata; Q54897625
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rCARBO5000
AC   CVCL_RS61
DR   Wikidata; Q54897626
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rCDDP1000
AC   CVCL_RR67
DR   Wikidata; Q54897627
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rCDDP500
AC   CVCL_RS27
SY   IMR32rCDDP500
DR   Wikidata; Q54897628
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rDOX20
AC   CVCL_RR68
DR   Wikidata; Q54897632
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rETO100
AC   CVCL_RR69
DR   Wikidata; Q54897633
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rGEMCI20
AC   CVCL_RS53
DR   Wikidata; Q54897634
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rGEMCI25
AC   CVCL_RR70
DR   Wikidata; Q54897635
RX   PubMed=24466371;
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   IMR-32rMEL2000
AC   CVCL_RS54
DR   Wikidata; Q54897636
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rMEL500
AC   CVCL_RR71
DR   Wikidata; Q54897637
RX   PubMed=24466371;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rOXALI4000
AC   CVCL_RR72
DR   Wikidata; Q54897638
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rOXALI800
AC   CVCL_RS55
DR   Wikidata; Q54897639
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rTOPO20
AC   CVCL_RS56
DR   Wikidata; Q54897641
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rTOPO7.5
AC   CVCL_RR73
DR   Wikidata; Q54897642
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rTOPO8
AC   CVCL_RS57
DR   Wikidata; Q54897643
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rVCR10
AC   CVCL_RR36
DR   Wikidata; Q54897644
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rVINOR20
AC   CVCL_RS58
DR   Wikidata; Q54897645
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-32rVINOR5
AC   CVCL_RR75
DR   Wikidata; Q54897646
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-33
AC   CVCL_2528
SY   IMR 33; IMR33; Institute for Medical Research-33
DR   CLO; CLO_0006949
DR   ATCC; CCL-146
DR   ECACC; 96020931
DR   Wikidata; Q54897647
RX   PubMed=5554453;
CC   Doubling time: 36-38.5 hours (PubMed=5554453).
DI   NCIt; C134561; Gerbil fibroma
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   IMR-5
AC   CVCL_1306
SY   IMR 5; IMR5; IMR-05; Institute for Medical Research-5
DR   BTO; BTO_0005846
DR   CLO; CLO_0006950
DR   EFO; EFO_0022692
DR   CLDB; cl5097
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1306
DR   Cell_Model_Passport; SIDM01206
DR   ChEMBL-Cells; CHEMBL3308201
DR   ChEMBL-Targets; CHEMBL2366209
DR   Cosmic; 907170
DR   Cosmic; 1019939
DR   Cosmic; 1109364
DR   Cosmic; 1161989
DR   Cosmic; 1167417
DR   Cosmic; 1890113
DR   Cosmic-CLP; 907170
DR   DepMap; ACH-002248
DR   EGA; EGAS00001000978
DR   GDSC; 907170
DR   GEO; GSM1669935
DR   GEO; GSM2371236
DR   GEO; GSM2394389
DR   IARC_TP53; 21396
DR   ICLC; HTL00009
DR   LINCS_LDP; LCL-1984
DR   PharmacoDB; IMR5_660_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1306
DR   Wikidata; Q54897648
RX   PubMed=6160155;
RX   PubMed=12536080;
RX   PubMed=15150091;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=20164919;
RX   PubMed=23202128;
RX   PubMed=24466371;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=31581737;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.86%; East Asian, North=0%; East Asian, South=0.06%; South Asian=4.46%; European, North=75.37%; European, South=19.24% (PubMed=30894373).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): Cosmic-CLP=907170; PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   IMR-5/75
AC   CVCL_M473
SY   IMR-5-75; IMR5/75; IMR5-75
DR   ChEMBL-Cells; CHEMBL4523519
DR   ChEMBL-Targets; CHEMBL4523550
DR   Cosmic; 2393631
DR   PubChem_Cell_line; CVCL_M473
DR   Wikidata; Q54897649
RX   PubMed=16216448;
RX   PubMed=39255063;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Miscellaneous: STR profile from personal communication of Henssen, Anton George & Roefzaad, Claudia.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   IMR-5/M-1
AC   CVCL_M472
SY   M-1
DR   Wikidata; Q54897650
RX   PubMed=3898405;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   IMR-5rCARBO5000
AC   CVCL_RT17
DR   Wikidata; Q54897651
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rCDDP1000
AC   CVCL_RR56
DR   Wikidata; Q54897652
RX   PubMed=24466371;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rDACARB20
AC   CVCL_RS59
DR   Wikidata; Q54897654
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   IMR-5rDACARB40
AC   CVCL_ZX19
DR   Wikidata; Q102114226
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   IMR-5rDOCE20
AC   CVCL_RR57
DR   Wikidata; Q54897655
RX   PubMed=24466371;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,32
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rDOX20
AC   CVCL_RR58
DR   Wikidata; Q54897656
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rETO100
AC   CVCL_RR59
DR   Wikidata; Q54897657
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rGEMCI20
AC   CVCL_RR60
DR   Wikidata; Q54897658
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rIRINO1000
AC   CVCL_RS63
DR   Wikidata; Q54897659
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rMEL1000
AC   CVCL_RS62
DR   Wikidata; Q54897660
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rMEL3000
AC   CVCL_RR61
DR   Wikidata; Q54897661
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rOXALI4000
AC   CVCL_RR62
DR   Wikidata; Q54897662
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rPCL20
AC   CVCL_RR63
DR   Wikidata; Q54897663
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rTOPO20
AC   CVCL_RR64
DR   Wikidata; Q54897664
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rVCR10
AC   CVCL_RR37
DR   Wikidata; Q54897665
RX   PubMed=24466371;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rVINB20
AC   CVCL_RS64
DR   Wikidata; Q54897666
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 8
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 23,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 11,12
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-5rVINOR20
AC   CVCL_RR65
DR   Wikidata; Q54897667
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1306 ! IMR-5
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   IMR-6
AC   CVCL_5421
SY   IMR 6; IMR6
DR   BTO; BTO_0003535
DR   Cosmic; 922657
DR   Wikidata; Q54897668
RX   PubMed=424740;
RX   PubMed=8665486;
RX   PubMed=9815755;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   IMR-90
AC   CVCL_0347
SY   IMR 90; IMR90; Institute for Medical Research-90; I90
DR   BTO; BTO_0001229
DR   CLO; CLO_0006951
DR   CLO; CLO_0029276
DR   CLO; CLO_0029279
DR   CLO; CLO_0029284
DR   CLO; CLO_0029291
DR   CLO; CLO_0029294
DR   CLO; CLO_0029328
DR   CLO; CLO_0029330
DR   CLO; CLO_0029331
DR   CLO; CLO_0029332
DR   CLO; CLO_0029336
DR   EFO; EFO_0001196
DR   MCCL; MCC:0000243
DR   CLDB; cl2889
DR   CLDB; cl2890
DR   4DN; 4DNSRI51KRED
DR   4DN; 4DNSRXXGU3CH
DR   AddexBio; P0016019/4978
DR   ATCC; CCL-186
DR   ATCC; CRL-7931
DR   BCRC; 60204
DR   BCRJ; 0118
DR   BioSample; SAMN03471461
DR   BioSample; SAMN03472414
DR   cancercelllines; CVCL_0347
DR   CCRID; 3101HUMSCSP5013
DR   CCRID; 5301HUM-KCB17066YJ
DR   ChEMBL-Cells; CHEMBL3307985
DR   ChEMBL-Targets; CHEMBL612577
DR   CLS; 305216
DR   Coriell; I90-10
DR   Coriell; I90-15
DR   Coriell; I90-19
DR   Coriell; I90-24
DR   Coriell; I90-26
DR   Coriell; I90-33
DR   Coriell; I90-40
DR   Coriell; I90-52
DR   Coriell; I90-53
DR   Coriell; I90-78
DR   Coriell; I90-79
DR   Coriell; I90-83
DR   ECACC; 85020204
DR   ENCODE; ENCBS007TVF
DR   ENCODE; ENCBS048GPK
DR   ENCODE; ENCBS048TNH
DR   ENCODE; ENCBS073JZM
DR   ENCODE; ENCBS192DLO
DR   ENCODE; ENCBS275EWD
DR   ENCODE; ENCBS357USI
DR   ENCODE; ENCBS361XFK
DR   ENCODE; ENCBS364NFD
DR   ENCODE; ENCBS368ENC
DR   ENCODE; ENCBS369ENC
DR   ENCODE; ENCBS370ENC
DR   ENCODE; ENCBS371ENC
DR   ENCODE; ENCBS371NWL
DR   ENCODE; ENCBS372ENC
DR   ENCODE; ENCBS373ENC
DR   ENCODE; ENCBS379ENC
DR   ENCODE; ENCBS410ENC
DR   ENCODE; ENCBS411ENC
DR   ENCODE; ENCBS412ENC
DR   ENCODE; ENCBS412SDE
DR   ENCODE; ENCBS413ENC
DR   ENCODE; ENCBS414ENC
DR   ENCODE; ENCBS415ENC
DR   ENCODE; ENCBS416ENC
DR   ENCODE; ENCBS460CLV
DR   ENCODE; ENCBS470SXX
DR   ENCODE; ENCBS472JFT
DR   ENCODE; ENCBS486FIC
DR   ENCODE; ENCBS532ZGJ
DR   ENCODE; ENCBS562LLK
DR   ENCODE; ENCBS598YLQ
DR   ENCODE; ENCBS648SCY
DR   ENCODE; ENCBS683AVF
DR   ENCODE; ENCBS754TWW
DR   ENCODE; ENCBS780OTZ
DR   ENCODE; ENCBS981IKS
DR   ENCODE; ENCBS981UBX
DR   ENCODE; ENCBS982GUC
DR   ENCODE; ENCBS992YMT
DR   GEO; GSM432687
DR   GEO; GSM432688
DR   GEO; GSM432689
DR   GEO; GSM432690
DR   GEO; GSM432691
DR   GEO; GSM432692
DR   GEO; GSM438363
DR   GEO; GSM438364
DR   GEO; GSM468792
DR   GEO; GSM468801
DR   GEO; GSM469965
DR   GEO; GSM469966
DR   GEO; GSM469967
DR   GEO; GSM469968
DR   GEO; GSM469970
DR   GEO; GSM469973
DR   GEO; GSM469974
DR   GEO; GSM469975
DR   GEO; GSM521866
DR   GEO; GSM521868
DR   GEO; GSM521869
DR   GEO; GSM521870
DR   GEO; GSM521871
DR   GEO; GSM521873
DR   GEO; GSM521874
DR   GEO; GSM521875
DR   GEO; GSM521877
DR   GEO; GSM521878
DR   GEO; GSM521879
DR   GEO; GSM521880
DR   GEO; GSM521881
DR   GEO; GSM521883
DR   GEO; GSM521884
DR   GEO; GSM521885
DR   GEO; GSM521886
DR   GEO; GSM521887
DR   GEO; GSM521889
DR   GEO; GSM521890
DR   GEO; GSM521892
DR   GEO; GSM521893
DR   GEO; GSM521894
DR   GEO; GSM521895
DR   GEO; GSM521897
DR   GEO; GSM521898
DR   GEO; GSM521899
DR   GEO; GSM521900
DR   GEO; GSM521901
DR   GEO; GSM521902
DR   GEO; GSM521903
DR   GEO; GSM521904
DR   GEO; GSM521906
DR   GEO; GSM521907
DR   GEO; GSM521908
DR   GEO; GSM521909
DR   GEO; GSM521911
DR   GEO; GSM521912
DR   GEO; GSM521913
DR   GEO; GSM521914
DR   GEO; GSM521915
DR   GEO; GSM521917
DR   GEO; GSM521918
DR   GEO; GSM521919
DR   GEO; GSM521921
DR   GEO; GSM521922
DR   GEO; GSM521923
DR   GEO; GSM521924
DR   GEO; GSM521925
DR   GEO; GSM521926
DR   GEO; GSM521927
DR   GEO; GSM521928
DR   GEO; GSM521929
DR   GEO; GSM521930
DR   GEO; GSM521931
DR   GEO; GSM521932
DR   GEO; GSM521933
DR   GEO; GSM530665
DR   GEO; GSM530666
DR   GEO; GSM541279
DR   GEO; GSM541280
DR   GEO; GSM604470
DR   GEO; GSM604471
DR   GEO; GSM723024
DR   GEO; GSM752986
DR   GEO; GSM752987
DR   GEO; GSM818007
DR   GEO; GSM818008
DR   GEO; GSM818012
DR   GEO; GSM818013
DR   GEO; GSM818017
DR   GEO; GSM827198
DR   GEO; GSM832837
DR   GEO; GSM832838
DR   GEO; GSM862724
DR   GEO; GSM892307
DR   GEO; GSM909321
DR   GEO; GSM909338
DR   GEO; GSM909339
DR   GEO; GSM923447
DR   GEO; GSM927235
DR   GEO; GSM935403
DR   GEO; GSM935404
DR   GEO; GSM935513
DR   GEO; GSM935519
DR   GEO; GSM935624
DR   GEO; GSM942307
DR   GEO; GSM942928
DR   GEO; GSM959044
DR   GEO; GSM1003612
DR   GEO; GSM1003613
DR   GEO; GSM1003614
DR   GEO; GSM1003615
DR   GEO; GSM1003623
DR   GEO; GSM1008586
DR   GEO; GSM1055800
DR   GEO; GSM1055801
DR   GEO; GSM1068140
DR   GEO; GSM1068141
DR   GEO; GSM1154021
DR   GEO; GSM1154022
DR   GEO; GSM1154023
DR   GEO; GSM1154024
DR   GEO; GSM1186664
DR   GEO; GSM1204464
DR   GEO; GSM1296454
DR   GEO; GSM1463270
DR   GEO; GSM2988906
DR   IPD-IMGT/HLA; 11782
DR   IZSLER; BS CL 107
DR   JCRB; JCRB0516
DR   JCRB; JCRB9054
DR   KCB; KCB 2017066YJ
DR   KCLB; 10186
DR   Lonza; 745
DR   PRIDE; PXD000134
DR   Progenetix; CVCL_0347
DR   PubChem_Cell_line; CVCL_0347
DR   Wikidata; Q54897669
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00499;
RX   CelloPub=CLPUB00597;
RX   PubMed=211143;
RX   PubMed=535915;
RX   PubMed=738322;
RX   PubMed=841339;
RX   PubMed=1574572;
RX   PubMed=1756776;
RX   PubMed=3016668;
RX   PubMed=3335022;
RX   PubMed=6256643;
RX   PubMed=6525431;
RX   PubMed=6538202;
RX   PubMed=6887978;
RX   PubMed=7065527;
RX   PubMed=7253718;
RX   PubMed=11416159;
RX   PubMed=20215515;
RX   PubMed=22108792;
RX   PubMed=23325432;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/IMR90_Stam_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-246.html
CC   Part of: ENCODE project common cell types; tier 2.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Senescence: Capable of attaining 58 population doublings before the onset of senescence (ATCC=CCL-186).
CC   Omics: Genomics; ChIP-seq; H2A.Z.
CC   Omics: Genomics; ChIP-seq; H2AK5ac.
CC   Omics: Genomics; ChIP-seq; H2AK9ac.
CC   Omics: Genomics; ChIP-seq; H2BK120ac.
CC   Omics: Genomics; ChIP-seq; H2BK12ac.
CC   Omics: Genomics; ChIP-seq; H2BK15ac.
CC   Omics: Genomics; ChIP-seq; H2BK20ac.
CC   Omics: Genomics; ChIP-seq; H2BK5ac.
CC   Omics: Genomics; ChIP-seq; H3K14ac.
CC   Omics: Genomics; ChIP-seq; H3K18ac.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K56ac.
CC   Omics: Genomics; ChIP-seq; H3K79me1.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me1.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; ChIP-seq; H4K5ac.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; ChIP-seq; H4K91ac.
CC   Omics: Genomics; DNA methylation analysis; Bisulfite sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: IRM-90; Note=Occasionally.
CC   Discontinued: ATCC; CRL-7931; true.
CC   Discontinued: CLS; 305216; true.
CC   Discontinued: Coriell; I90-52; probable.
CC   Discontinued: Coriell; I90-78; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-186; IZSLER=BS CL 107; JCRB=JCRB9054; KCLB=10186; PubMed=11416159; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D10S1248: 13,14
ST   D12S391: 18,21
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 17
ST   D19S433: 10,13
ST   D1S1656: 11,15
ST   D21S11: 30.2,31
ST   D22S1045: 12,16
ST   D2S1338: 19,25
ST   D2S441: 11
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 25,26
ST   Penta D: 5,12
ST   Penta E: 5
ST   TH01: 8,9.3 (ATCC=CCL-186; IZSLER=BS CL 107; KCLB=10186; PubMed=11416159; Technion Genomics Center)
ST   TH01: 8,10 (JCRB=JCRB9054)
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 43
//
ID   IMR-90-40
AC   CVCL_2963
DR   JCRB; JCRB0519
DR   Wikidata; Q54897670
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   IMR-90-50
AC   CVCL_2964
DR   JCRB; JCRB0520
DR   Wikidata; Q54897671
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   IMR-90-SV
AC   CVCL_6269
SY   IMR90-SV
DR   CLO; CLO_0050033
DR   BioSample; SAMN03472209
DR   RCB; RCB1024
DR   Wikidata; Q54897672
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB1024
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   IMR-90/GFPdeltaRaf-1[YY]:ER
AC   CVCL_HA48
DR   Wikidata; Q54897673
RX   PubMed=9765202;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct that is composed of EGFP at the N-terminus, the catalytic domain of RAF1 (with p.Tyr340Asp and p.Tyr341Asp) in the middle and the hormone-binding domain of ESR1 at the C-terminus. Protein kinase activity is activated by estrogen or analogs such as 4-hydroxy-tamoxifen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Hormone-binding domain).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9829; RAF1 (Note=Catalytic domain with p.Tyr340Asp and p.Tyr341Asp).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   IMR-91
AC   CVCL_5420
SY   IMR 91; IMR91; IMR-91L; IMR-91 Lung; Institute for Medical Research-91 Lung; I91L
DR   CLO; CLO_0029259
DR   CLO; CLO_0029261
DR   CLO; CLO_0029282
DR   CLO; CLO_0029303
DR   CLO; CLO_0029304
DR   CLO; CLO_0029305
DR   CLO; CLO_0029306
DR   Coriell; I91L-07
DR   Coriell; I91L-12
DR   Coriell; I91L-13
DR   Coriell; I91L-15
DR   Coriell; I91L-16
DR   Coriell; I91L-17
DR   Coriell; I91L-18
DR   Wikidata; Q54897678
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=738322;
RX   PubMed=6629383;
RX   PubMed=7253718;
RX   PubMed=11416159;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 15,16
ST   D21S11: 27,31.2
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 9
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CX66 ! IMR-91S
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   IMR-91S
AC   CVCL_CX66
SY   IMR-91 Skin; Institute for Medical Research-91 Skin; I91S
DR   CLO; CLO_0029246
DR   CLO; CLO_0029248
DR   CLO; CLO_0029250
DR   CLO; CLO_0029252
DR   CLO; CLO_0029256
DR   Coriell; I91S-04
DR   Coriell; I91S-05
DR   Coriell; I91S-06
DR   Coriell; I91S-07
DR   Coriell; I91S-08
DR   Wikidata; Q54897679
RX   CelloPub=CLPUB00597;
RX   PubMed=738322;
RX   PubMed=6629383;
CC   Discontinued: Coriell; I91S-06; probable.
CC   Discontinued: Coriell; I91S-07; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5420 ! IMR-91
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   IMR/KAT100
AC   CVCL_A8UT
DR   cancercelllines; CVCL_A8UT
DR   IARC_TP53; 26505
DR   Wikidata; Q108820545
RX   PubMed=17974978;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2761; Dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate (Antimony potassium tartrate; KAT).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (PubMed=17974978).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   IMR32.CMV.neo
AC   CVCL_A8SG
SY   IMR32pIRES.CMV.neo
DR   Wikidata; Q108820546
RX   PubMed=10933967;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for IMR32.ODC.CE (Cellosaurus=CVCL_A8SH) (PubMed=10933967).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   IMR32.ODC.CE
AC   CVCL_A8SH
SY   IMR32pIRES.ODC.CE
DR   Wikidata; Q108820547
RX   PubMed=10933967;
CC   Population: Caucasian.
CC   Characteristics: Expresses the carboxylesterase (CE) gene under the control of an ornithine decarboxylase (ODC) promoter (PubMed=10933967).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12337; Rabbit liver carboxylesterase 1.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0346 ! IMR-32
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   IMR90-830
AC   CVCL_ZX70
DR   Wikidata; Q102114227
RX   PubMed=2463881;
RX   PubMed=6256643;
RX   PubMed=6825208;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   IMR90-890
AC   CVCL_ZX71
DR   Wikidata; Q102114228
RX   PubMed=6256643;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   IMR90-E6-E7
AC   CVCL_F0KF
RX   PubMed=24413054;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IMR90-hTERT
AC   CVCL_F0KG
RX   PubMed=24413054;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IMR90-hTERT-E6-E7
AC   CVCL_F0KH
RX   PubMed=24413054;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IMS-BC1
AC   CVCL_A7NE
DR   Wikidata; Q107115447
RX   PubMed=9650450;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=9650450).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9650450; PubMed=10071072).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   IMS-BC2
AC   CVCL_A7NF
DR   Wikidata; Q107115448
RX   PubMed=9650450;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=9650450).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9650450; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   IMS-M1
AC   CVCL_A623
SY   IMS/M1; IMS/MI; IMS-MI
DR   Cosmic; 787437
DR   Cosmic; 975256
DR   Cosmic; 996321
DR   Cosmic; 1037672
DR   Cosmic; 1281319
DR   Cosmic; 2089654
DR   Cosmic; 2378128
DR   Wikidata; Q54897680
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8180386;
RX   PubMed=8414510;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Doubling time: 36-48 hours (DOI=10.1016/B978-0-12-221970-2.50457-5).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=14671638).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   IMS-M2
AC   CVCL_RL93
SY   IMSM2
DR   cancercelllines; CVCL_RL93
DR   Wikidata; Q54897681
RX   PubMed=19854508;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:8033; NTRK3; Name(s)=ETV6-NTRK3, TEL-TRKC; Note=In frame (PubMed=19854508).
CC   Sequence variation: Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (PubMed=19854508).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   IMS32
AC   CVCL_QW88
SY   Immortalized Mouse Schwann cells clone 32
DR   ABM; T0295
DR   Wikidata; Q54897682
RX   PubMed=7650763;
RX   PubMed=33494154;
WW   Provider; Cosmo Bio; PMC-SWN-IMS32C; https://www.cosmobiousa.com/products/schwann-cell-line-ims32-mouse
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6W
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   iMSC#10
AC   CVCL_E5VM
SY   imortalized Mesenchymal Stromal Cell line 10
DR   ABM; T0380
RX   CelloPub=CLPUB00782;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMSC#12
AC   CVCL_E5VN
SY   imortalized Mesenchymal Stromal Cell line 12
DR   ABM; T0381
RX   CelloPub=CLPUB00782;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient that had a hip fracture (CelloPub=CLPUB00782).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMSC#13
AC   CVCL_E5VP
SY   imortalized Mesenchymal Stromal Cell line 13
DR   ABM; T0382
RX   CelloPub=CLPUB00782;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient that had a hip fracture (CelloPub=CLPUB00782).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMSC#3
AC   CVCL_B5PE
SY   iMSC3
DR   ABM; T0529
DR   GEO; GSE47647
DR   GEO; GSM1154010
DR   GEO; GSM1154013
DR   GEO; GSM1154016
DR   Wikidata; Q111733513
RX   PubMed=24857590;
WW   Provider; I2B; P-68; http://inven2biologics.com/shop/cell-lines/human/imsc3-human-sarcomas
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): PubMed=24857590
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,14
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D21S11: 18,19,30
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 20.2,22.2
ST   Penta D: 8,11
ST   Penta E: 12,14
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 13,14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   iMSC#6
AC   CVCL_E5VJ
SY   imortalized Mesenchymal Stromal Cell line 6
DR   ABM; T0377
RX   CelloPub=CLPUB00782;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMSC#8
AC   CVCL_E5VK
SY   imortalized Mesenchymal Stromal Cell line 8
DR   ABM; T0378
RX   CelloPub=CLPUB00782;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMSC#9
AC   CVCL_E5VL
SY   imortalized Mesenchymal Stromal Cell line 9
DR   ABM; T0379
RX   CelloPub=CLPUB00782;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient that had a hip fracture (CelloPub=CLPUB00782).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stromal cell; CL=CL_2000061.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   iMSMD-cohet.17
AC   CVCL_A4UK
DR   Wikidata; Q107115452
RX   PubMed=29249666;
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666).
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176806; Interferon gamma receptor 1 deficiency
DI   ORDO; Orphanet_99898; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UI ! iMSMD-cohet.5
OI   CVCL_A4UJ ! iMSMD-cohet.7
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   iMSMD-cohet.5
AC   CVCL_A4UI
DR   Wikidata; Q107115450
RX   PubMed=29249666;
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666).
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176806; Interferon gamma receptor 1 deficiency
DI   ORDO; Orphanet_99898; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UJ ! iMSMD-cohet.7
OI   CVCL_A4UK ! iMSMD-cohet.17
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   iMSMD-cohet.7
AC   CVCL_A4UJ
DR   SKIP; SKIP005503
DR   Wikidata; Q107115451
RX   PubMed=29249666;
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666).
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176806; Interferon gamma receptor 1 deficiency
DI   ORDO; Orphanet_99898; Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UI ! iMSMD-cohet.5
OI   CVCL_A4UK ! iMSMD-cohet.17
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   iMSMD-het.4
AC   CVCL_A4UL
DR   SKIP; SKIP005504
DR   Wikidata; Q107115454
RX   PubMed=29249666;
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666).
CC   Donor information: While obtained from a patient suffering from Mendelian susceptibility to mycobacterial diseases, this iPSC originates from the sister of this patient who was the donor for a hematopoietic stem cell transplantation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UM ! iMSMD-het.9
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   iMSMD-het.9
AC   CVCL_A4UM
DR   Wikidata; Q107115455
RX   PubMed=29249666;
CC   Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666).
CC   Donor information: While obtained from a patient suffering from Mendelian susceptibility to mycobacterial diseases, this iPSC originates from the sister of this patient who was the donor for a hematopoietic stem cell transplantation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UL ! iMSMD-het.4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   ImST
AC   CVCL_HE73
SY   Stom-WT
DR   ABM; T0569
DR   Wikidata; Q54897683
RX   PubMed=12878595;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   IMSUTi001-A
AC   CVCL_WW34
SY   TkSSD1#AA
DR   hPSCreg; IMSUTi001-A
DR   Wikidata; Q94317346
RX   PubMed=31255830;
CC   From: Institute of Medical Science, University of Tokyo; Tokyo; Japan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Simple; p.Arg551His (c.1652G>A); ClinVar=VCV000566474; Zygosity=Heterozygous (PubMed=31255830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW35 ! IMSUTi001-B
OI   CVCL_WW36 ! IMSUTi001-C
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   IMSUTi001-B
AC   CVCL_WW35
SY   TkSSD1#AB
DR   hPSCreg; IMSUTi001-B
DR   Wikidata; Q94317351
RX   PubMed=31255830;
CC   From: Institute of Medical Science, University of Tokyo; Tokyo; Japan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Simple; p.Arg551His (c.1652G>A); ClinVar=VCV000566474; Zygosity=Heterozygous (PubMed=31255830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW34 ! IMSUTi001-A
OI   CVCL_WW36 ! IMSUTi001-C
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   IMSUTi001-C
AC   CVCL_WW36
SY   TkSSD1#AM
DR   hPSCreg; IMSUTi001-C
DR   Wikidata; Q94317354
RX   PubMed=31255830;
CC   From: Institute of Medical Science, University of Tokyo; Tokyo; Japan.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11444; STXBP1; Simple; p.Arg551His (c.1652G>A); ClinVar=VCV000566474; Zygosity=Heterozygous (PubMed=31255830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162472; Developmental and epileptic encephalopathy 4
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW34 ! IMSUTi001-A
OI   CVCL_WW35 ! IMSUTi001-B
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   IMSUTi002-A
AC   CVCL_XI76
SY   7F3955-pMXs#1
DR   hPSCreg; IMSUTi002-A
DR   Wikidata; Q94317358
RX   PubMed=31476588;
CC   From: Institute of Medical Science, University of Tokyo; Tokyo; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   IMSUTi002-A-1
AC   CVCL_XI77
SY   7F3955-ETV6-RUNX1; CRIEPIi003-A-1
DR   hPSCreg; IMSUTi002-A-1
DR   SKIP; SKIP005549
DR   Wikidata; Q94317362
RX   PubMed=31476588;
CC   From: Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI); Chiba; Japan.
CC   Population: Japanese.
CC   Characteristics: Transfected with a Tet-on system so as to induce the expression of a mCherry and the ETV6-RUNX fusion protein with the addition of doxycycline to the culture medium (PubMed=31476588).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3495; ETV6 (Note=ETV6-RUNX1 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10471; RUNX1 (Note=ETV6-RUNX1 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XI76 ! IMSUTi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   IMSUTi002-A-2
AC   CVCL_C9HE
SY   7F3955-KMT2A-AFF1; CRIEPIi003-A-2
DR   hPSCreg; IMSUTi002-A-2
DR   Wikidata; Q123032699
RX   PubMed=37639801;
CC   From: Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI); Chiba; Japan.
CC   Population: Japanese.
CC   Characteristics: Transfected with a Tet-on system so as to induce the expression of EGFP and the KMT2A-AFF1 fusion protein with the addition of doxycycline to the culture medium (PubMed=37639801).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7135; AFF1 (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2-AFF1/MLL-AF4 fusion).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XI76 ! IMSUTi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   imSVF
AC   CVCL_ZD83
SY   Immortalized Mouse Inguinal Adipose Stromal Vascular Fraction Preadipocyte cell line
DR   CancerTools; 154033
DR   Kerafast; EVC005
DR   Wikidata; Q98126772
DR   Ximbio; 154033
RX   PubMed=29750960;
CC   Characteristics: Model cell line for adipocyte biology. Can be used to study adipogenesis marker expression and trans-differentiation potential. Can develop both white and brown-like adipocyte (brite or beige cell) phenotypes (Kerafast=EVC005).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Kerafast; EVC005; true.
CC   Derived from site: In situ; Inguinal fat pad, adipose tissue; UBERON=UBERON_0010410+UBERON_0001013.
CC   Cell type: Preadipocyte; CL=CL_0002334.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   IMT 9
AC   CVCL_4348
SY   IMT9
DR   ECACC; 95060901
DR   Wikidata; Q54897684
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Discontinued: ECACC; 95060901; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_4349 ! SCR5
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   IMT-1
AC   CVCL_L785
DR   Wikidata; Q54897685
RX   PubMed=22273270;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   IMT-KO2
AC   CVCL_A8HU
SY   KO2
DR   Wikidata; Q107115456
RX   PubMed=33659749;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A8HV ! IMT-KO4
OI   CVCL_A8HW ! IMT-KO9
SX   Male
AG   1-2D
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   IMT-KO4
AC   CVCL_A8HV
SY   KO4
DR   Wikidata; Q107115457
RX   PubMed=33659749;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A8HU ! IMT-KO2
OI   CVCL_A8HW ! IMT-KO9
SX   Male
AG   1-2D
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   IMT-KO9
AC   CVCL_A8HW
SY   KO9
DR   Wikidata; Q107115458
RX   PubMed=33659749;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A8HU ! IMT-KO2
OI   CVCL_A8HV ! IMT-KO4
SX   Male
AG   1-2D
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   imWilms1
AC   CVCL_A5SN
SY   IM-WT-1
DR   CLS; 300412
DR   Wikidata; Q107115459
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=33379206).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=33379206
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 15,18
ST   D21S11: 30,31
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 9,14
ST   D8S1179: 12,14
ST   FGA: 22,25
ST   Penta D: 13
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5SC ! Wilms1-2l
SX   Female
AG   2Y
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   imWilms10
AC   CVCL_DF34
SY   ImWilms10 T; ImWilms10T; IM-WT-10
DR   CLS; 300419
DR   Cosmic; 2569182
DR   GEO; GSM1831637
DR   GEO; GSM1831638
DR   Wikidata; Q54897686
RX   PubMed=27213811;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Homozygous; Note=Nested within a heterozygous 11p13 deletion (PubMed=27213811).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=27213811).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300419; PubMed=33379206
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 22,24
ST   Penta D: 10,13
ST   Penta E: 7,10
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5SL ! Wilms10T
SX   Female
AG   2Y
CA   Conditionally immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 18
//
ID   imWilms3
AC   CVCL_A5SP
DR   Wikidata; Q107115460
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Val432Serfs*87 (c.1293_1294insA); Zygosity=Homozygous; Note=Somatic (PubMed=33379206).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5SF ! Wilms3
SX   Male
AG   11-12M
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   imWilms6
AC   CVCL_A5SQ
SY   IM-WT-6
DR   Wikidata; Q107115461
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 8,9
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 11
ST   Penta E: 8,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5SI ! Wilms6
SX   Male
AG   1Y3M
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   iMycEmu-1
AC   CVCL_0348
SY   iMycEmu1
DR   MCCL; MCC:0000498
DR   Wikidata; Q54897687
RX   PubMed=16277667;
RX   PubMed=16759389;
CC   Breed/subspecies: iMycEmu transgenic.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   iMycEmu-2
AC   CVCL_0349
SY   iMycEmu2
DR   MCCL; MCC:0000499
DR   Wikidata; Q54897688
RX   PubMed=16759389;
CC   Breed/subspecies: iMycEmu transgenic.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   iMZ-11
AC   CVCL_VL48
DR   Wikidata; Q94317439
RX   PubMed=19672243;
RX   PubMed=21982236;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Pcdh21/Cre-Z/EG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   iMZ-15
AC   CVCL_VL49
DR   Wikidata; Q94317445
RX   PubMed=19672243;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Pcdh21/Cre-Z/EG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   iMZ-21
AC   CVCL_VL47
DR   Wikidata; Q94317451
RX   PubMed=19672243;
RX   PubMed=21982236;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Pcdh21/Cre-Z/EG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VL46 ! iMZ-9
SX   Male
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 6
//
ID   iMZ-9
AC   CVCL_VL46
DR   Wikidata; Q94317456
RX   PubMed=19672243;
RX   PubMed=21982236;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Pcdh21/Cre-Z/EG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VL47 ! iMZ-21
SX   Male
AG   13-14FD
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 6
//
ID   IN-1
AC   CVCL_W473
DR   Wikidata; Q54897689
RX   PubMed=1964585;
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (PubMed=1964585).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   In-1024
AC   CVCL_RZ64
DR   JCRB; JCRB1737
DR   Wikidata; Q54897690
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   In-111-R1
AC   CVCL_GR54
SY   In-111 R1
DR   Wikidata; Q54897691
RX   PubMed=221713;
RX   PubMed=2869020;
CC   Doubling time: 26.4 hours (PubMed=2869020).
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_F644 ! ITC-1
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 02-05-24; Version: 8
//
ID   IN-IC
AC   CVCL_VQ62
DR   RCB; RCB4472
DR   Wikidata; Q94317500
RX   PubMed=21415155;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, distal tubule; UBERON=UBERON_0004135.
CC   Cell type: Renal intercalated cell; CL=CL_0005010.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-12W
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   In-R1-G1
AC   CVCL_D4YA
DR   Wikidata; Q127382380
RX   PubMed=2869020;
CC   Characteristics: Produces glucagon (PubMed=2869020).
CC   Doubling time: 28.8 hours (PubMed=2869020).
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GR54 ! In-111-R1
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   In-R1-G10
AC   CVCL_D4YB
DR   Wikidata; Q127382381
RX   PubMed=2869020;
CC   Characteristics: Produces glucagon (PubMed=2869020).
CC   Doubling time: 16.8 hours (PubMed=2869020).
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GR54 ! In-111-R1
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   In-R1-G3
AC   CVCL_D4YC
DR   Wikidata; Q127382382
RX   PubMed=2869020;
CC   Characteristics: Produces glucagon (PubMed=2869020).
CC   Doubling time: 28.8 hours (PubMed=2869020).
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GR54 ! In-111-R1
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   In-R1-G7
AC   CVCL_D4YD
DR   Wikidata; Q127382384
RX   PubMed=2869020;
CC   Characteristics: Produces glucagon (PubMed=2869020).
CC   Doubling time: 28.8 hours (PubMed=2869020).
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GR54 ! In-111-R1
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   In-R1-G9
AC   CVCL_0353
SY   InR1-G9; InRIG9; INR1G9; InR1G9
DR   BTO; BTO_0002740
DR   MCCL; MCC:0000247
DR   TOKU-E; 3993
DR   Wikidata; Q54897692
RX   PubMed=2834160;
RX   PubMed=2869020;
RX   PubMed=3013554;
RX   PubMed=3406432;
CC   Characteristics: Produces glucagon (PubMed=2869020).
CC   Doubling time: 25.0 hours (PubMed=2869020).
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GR54 ! In-111-R1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   IN157
AC   CVCL_0350
SY   IN-157; IN/157; IN 157
DR   MCCL; MCC:0000244
DR   cancercelllines; CVCL_0350
DR   Wikidata; Q54897693
RX   PubMed=1620276;
RX   PubMed=2437255;
CC   Problematic cell line: Contaminated. Shown to be a RD derivative (PubMed=1620276). Originally thought to originate from an oligodendroglioma.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (PubMed=1620276).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   in203-3Y1-19
AC   CVCL_K111
DR   RCB; RCB0336
DR   Wikidata; Q54897694
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=in203S).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   in203-3Y1-23
AC   CVCL_K112
DR   RCB; RCB0337
DR   Wikidata; Q54897695
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=in203S).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   in203-3Y1-7
AC   CVCL_K113
DR   RCB; RCB0335
DR   Wikidata; Q54897696
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=in203S).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   IN2045
AC   CVCL_D1HH
SY   IN-2045
DR   BTO; BTO_0006546
DR   Wikidata; Q127382385
RX   PubMed=27564115;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   IN24
AC   CVCL_F501
DR   Wikidata; Q54897697
RX   PubMed=3210476;
CC   Group: Bird cell line.
DI   NCIt; C134945; Chicken monocytic leukemia
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   IN699
AC   CVCL_AU96
DR   Wikidata; Q54897698
RX   PubMed=22741033;
RX   PubMed=23340741;
RX   PubMed=24335698;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=24335698
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 10,11
ST   D16S539: 10,13
ST   D21S11: 28
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   IN859
AC   CVCL_D1HG
SY   IN-859
DR   BTO; BTO_0006544
DR   Wikidata; Q127382386
RX   PubMed=27564115;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   INA-6
AC   CVCL_5209
SY   INA6
DR   BTO; BTO_0004745
DR   EFO; EFO_0005386
DR   BioSample; SAMN10989605
DR   cancercelllines; CVCL_5209
DR   Cell_Model_Passport; SIDM01555
DR   Cosmic; 1424216
DR   Cosmic; 1483075
DR   Cosmic; 2081383
DR   DepMap; ACH-000512
DR   DSMZ; ACC-862
DR   DSMZCellDive; ACC-862
DR   Wikidata; Q54897699
RX   CelloPub=CLPUB00060;
RX   CelloPub=CLPUB00604;
RX   PubMed=10936422;
RX   PubMed=11920233;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=19621390;
RX   PubMed=22806891;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=INA-6
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Produces Ig kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: ~30-50 hours (DSMZ=ACC-862).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (DepMap=ACH-000512).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Met (c.395A>T); ClinVar=VCV000376629; Zygosity=Heterozygous (DepMap=ACH-000512).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Heterozygous (DepMap=ACH-000512).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0.46%; Native American=0.15%; East Asian, North=2.2%; East Asian, South=0%; South Asian=0%; European, North=63.38%; European, South=33.82% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-862
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   INA-6.Tu1
AC   CVCL_0C40
SY   Tu1
DR   cancercelllines; CVCL_0C40
DR   Wikidata; Q54897701
RX   PubMed=19621390;
CC   Population: Caucasian.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Characteristics: Derived from a tumor that grew in a SCID mouse.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Met (c.395A>T); ClinVar=VCV000376629; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5209 ! INA-6
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 17
//
ID   INBL
AC   CVCL_5140
DR   BTO; BTO_0003112
DR   SKY/M-FISH/CGH; 2650
DR   Wikidata; Q54897703
RX   CelloPub=CLPUB00743;
RX   PubMed=10369123;
RX   PubMed=12659655;
RX   PubMed=35692560;
CC   Population: Mexican.
CC   HLA typing: A*11,33; B*39,48; C*03,04 (PubMed=10369123).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell of uterus; CL=CL_0002149.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   INC
AC   CVCL_QX03
DR   Wikidata; Q54897704
RX   PubMed=8847894;
RX   PubMed=9680106;
CC   Population: Japanese.
CC   Doubling time: 44.4 hours (PubMed=8847894).
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   INC-2
AC   CVCL_3902
SY   INC2
DR   BTO; BTO_0004264
DR   Wikidata; Q54897705
RX   PubMed=9227903;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   INCABRi001-A
AC   CVCL_LK61
SY   PMF6.1; INCABRi001-A1
DR   hPSCreg; INCABRi001-A
DR   Wikidata; Q54897706
RX   PubMed=29034885;
CC   From: Instituto Nacional de Cancer (INCA); Rio de Janeiro; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Arg693Ter (c.2077C>T); ClinVar=VCV000620281; Zygosity=Unspecified (PubMed=29034885).
CC   Sequence variation: Mutation; HGNC; HGNC:1455; CALR; Simple; p.Leu367Thrfs*46 (c.1092_1143del52); ClinVar=VCV000097006; Zygosity=Unspecified (PubMed=29034885).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   INCABRi002-A
AC   CVCL_VD83
SY   PMF3.17
DR   hPSCreg; INCABRi002-A
DR   Wikidata; Q54897707
RX   PubMed=30343103;
CC   From: Instituto Nacional de Cancer (INCA); Rio de Janeiro; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:1455; CALR; Simple; p.Lys385Asnfs*47 (c.1154_1155insTTGTC) (CALRins5); ClinVar=VCV001028735; Zygosity=Heterozygous (PubMed=30343103).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.437G>A); ClinVar=VCV000634785; Zygosity=Homozygous (PubMed=30343103).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   InCELL Hunter A549 EP300 Bromodomain
AC   CVCL_KV97
DR   cancercelllines; CVCL_KV97
DR   DiscoverX; 96-0073C15
DR   Wikidata; Q54897708
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3373; EP300 (Note=With p.Met1_Pro1039del and p.Tyr1162_His2414del).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   InCELL Hunter A549 G9a Methyltransferase
AC   CVCL_KV98
DR   cancercelllines; CVCL_KV98
DR   DiscoverX; 96-0003C15
DR   Wikidata; Q54897709
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14129; EHMT2 (Note=With p.Met1_Arg917del and p.Pro1194_Thr1210del).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   InCELL Hunter A549 GLP Methyltransferase
AC   CVCL_KV99
DR   cancercelllines; CVCL_KV99
DR   DiscoverX; 96-0045C15
DR   Wikidata; Q54897710
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24650; EHMT1 (Note=With p.Met1_Val1006del and p.Glu1283_Leu1298del).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   InCELL Hunter A549 PRMT3 Methyltransferase
AC   CVCL_KW00
DR   cancercelllines; CVCL_KW00
DR   DiscoverX; 96-0072C15
DR   Wikidata; Q54897711
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30163; PRMT3 (Note=With p.Met1_Ala210del).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   InCELL Hunter HEK 293 BAZ2A Bromodomain
AC   CVCL_KW01
DR   DiscoverX; 96-0074C1
DR   Wikidata; Q54897712
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:962; BAZ2A (Note=With p.Met1_Ser1791del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter HEK 293 BRD2(1) Bromodomain
AC   CVCL_KW02
DR   DiscoverX; 96-0004C1
DR   Wikidata; Q54897714
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1103; BRD2 (Note=With p.Met1_Gly73del and p.Val189_Gly801del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter HEK 293 BRD2(1,2) Bromodomain
AC   CVCL_KW03
DR   DiscoverX; 96-0049C1
DR   Wikidata; Q54897715
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1103; BRD2 (Note=With p.Met1_Gly73del and p.Glu456_Gly801del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter HEK 293 BRD3(1) Bromodomain
AC   CVCL_KW04
DR   DiscoverX; 96-0036C1
DR   Wikidata; Q54897716
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1104; BRD3 (Note=With p.Glu144_Glu726del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter HEK 293 BRD3(1,2) Bromodomain
AC   CVCL_KW05
DR   DiscoverX; 96-0038C1
DR   Wikidata; Q54897717
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1104; BRD3 (Note=With p.Leu404_Glu726del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter HEK 293 BRD4(1) Bromodomain
AC   CVCL_KW06
DR   DiscoverX; 96-0005C1
DR   Wikidata; Q54897718
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13575; BRD4 (Note=With p.Met1_Thr43del and p.Glu167_Phe1362del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter HEK 293 BRDT(1) Bromodomain
AC   CVCL_KW07
DR   DiscoverX; 96-0006C1
DR   Wikidata; Q54897719
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1105; BRDT (Note=With p.Met1_Arg27del and p.Ser131_Asp947del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   InCELL Hunter HEK 293 BRDT(1,2) Bromodomain
AC   CVCL_KW08
DR   DiscoverX; 96-0046C1
DR   Wikidata; Q54897720
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1105; BRDT (Note=With p.Met1_Arg27del and p.Pro377_Asp947).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   InCELL Hunter HEK 293 SMARCA4 Bromodomain
AC   CVCL_KW09
DR   DiscoverX; 96-0060C1
DR   Wikidata; Q54897724
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11100; SMARCA4 (Note=With p.Met1_Pro1455del and p.Glu1567_Asp1647del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter HEK 293 TAF1L(2) Bromodomain
AC   CVCL_KW10
DR   DiscoverX; 96-0058C1
DR   Wikidata; Q54897725
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18056; TAF1L (Note=With p.Met1_Asp1522del and p.Pro1655_Lys1826del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   InCELL Hunter U2OS BCL2-BAX Protein Binding
AC   CVCL_KW11
SY   InCELL Hunter U2OS Bcl2-Bax
DR   DiscoverX; 96-0010C3
DR   Wikidata; Q54897726
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:959; BAX (Note=With p.Met1_Pro51del and p.Asn73_Gly192del).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   InCELL Hunter U2OS BCL2-BIM Protein Binding
AC   CVCL_KW12
SY   InCELL Hunter U2OS Bcl2-Bim
DR   DiscoverX; 96-0008C3
DR   Wikidata; Q54897727
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:994; BCL2L11 (Note=With p.Met1_Asp141del and p.Tyr162_His198del).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   InCELL Hunter U2OS BCL2L1-BAX Protein Binding
AC   CVCL_KW13
SY   InCELL Hunter U2OS Bcl2L1-Bax
DR   DiscoverX; 96-0009C3
DR   Wikidata; Q54897728
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:959; BAX (Note=With p.Met1_Pro51del and p.Asn73_Gly192del).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   InCELL Hunter U2OS BCL2L1-BIM Protein Binding
AC   CVCL_KW14
SY   InCELL Hunter U2OS Bcl2L1-Bim
DR   DiscoverX; 96-0037C3
DR   Wikidata; Q54897729
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:994; BCL2L11 (Note=With p.Met1_Cys121del and p.Val182_His198del).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   InCELL Hunter U2OS MCL1-BIM Protein Binding
AC   CVCL_KW15
DR   DiscoverX; 96-0075C3
DR   Wikidata; Q54897730
CC   Population: Caucasian.
CC   Characteristics: InCELL Hunter cell lines express a transfected target protein fragment tagged with a beta-galactosidase fragment (enhanced ProLabel=ePL). The technology measures compound binding to an intracellular target by detecting changes in protein stability. The amount of fusion is quantified through the addition of substrate and a second enzyme fragment (Enzyme acceptor=EA).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:994; BCL2L11 (Note=With p.Met1_Asp141del and p.Tyr162_His198del).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6943; MCL1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   Ind
AC   CVCL_B7M0
DR   Wikidata; Q112929864
RX   PubMed=10501838;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   IND.64
AC   CVCL_C7XQ
DR   Wikidata; Q123032700
RX   PubMed=1279888;
RX   PubMed=1460536;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   INDBi001-A
AC   CVCL_E9XI
SY   INDB5.2.14
DR   BioSamples; SAMEA117493622
DR   hPSCreg; INDBi001-A
RX   PubMed=40220503;
CC   From: Institute for Neuroanatomy and Developmental Biology, University of Tuebingen; Tuebingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IndFSPT1
AC   CVCL_YZ70
DR   Wikidata; Q98126773
RX   DOI=10.14943/doctoral.k12177;
RX   PubMed=24131711;
RX   PubMed=26605499;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=143291; ! Pteropus giganteus (Indian flying fox)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   INEM-1
AC   CVCL_R976
SY   INconnu EMbryonic-1
DR   Wikidata; Q54897731
RX   DOI=10.1577/1548-8667(1990)002<0061:COACLD>2.3.CO;2;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 20 Celsius (DOI=10.1577/1548-8667(1990)002<0061:COACLD>2.3.CO;2).
CC   Virology: Susceptible to infection by infectious pancreatic necrosis virus (IPNV) and infectious haematopoetic necrosis virus (IHNV) (DOI=10.1577/1548-8667(1990)002<0061:COACLD>2.3.CO;2).
CC   Doubling time: 1.5 days (DOI=10.1577/1548-8667(1990)002<0061:COACLD>2.3.CO;2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=59296; ! Stenodus leucichthys (Beloribitsa)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   INER-37
AC   CVCL_5621
SY   Instituto Nacional de Enfermedades Respiratorias-37
DR   BTO; BTO_0002558
DR   GEO; GSM1526648
DR   GEO; GSM1526649
DR   Wikidata; Q54897732
RX   PubMed=16271071;
RX   PubMed=26221079;
CC   Doubling time: 30 hours (PubMed=16271071); 79 hours (PubMed=26221079).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   INER-51
AC   CVCL_5531
SY   Instituto Nacional de Enfermedades Respiratorias-51
DR   BTO; BTO_0002559
DR   Wikidata; Q54897733
RX   PubMed=16001980;
RX   PubMed=16271071;
RX   PubMed=26221079;
CC   Doubling time: 51 hours (PubMed=26221079).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   INER-51/PSC-1
AC   CVCL_5622
SY   INER-51 PSC-1 clone; PSC-1
DR   BTO; BTO_0002567
DR   Wikidata; Q54897735
RX   PubMed=16001980;
RX   PubMed=16271071;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5531 ! INER-51
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   INER-51/VP-1
AC   CVCL_5623
SY   INER-51 VP-1 clone; VP-1
DR   Wikidata; Q54897737
RX   PubMed=16271071;
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5531 ! INER-51
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   INEUi001-A
AC   CVCL_C9LF
SY   FBDC9 1.3
DR   BioSamples; SAMEA112354813
DR   hPSCreg; INEUi001-A
DR   Wikidata; Q123032701
RX   PubMed=36963214;
CC   From: Instituto de Neurociencias; Buenos Aires; Argentina.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Unexplicit; Deletion in GGGGCC repeat; Zygosity=Heterozygous (PubMed=36963214).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   INEUi002-A
AC   CVCL_DQ93
SY   iPSC-FH2.1; iPSC-FN2.1
DR   hPSCreg; INEUi002-A
DR   Wikidata; Q54898223
RX   PubMed=27345989;
CC   From: Instituto de Neurociencias; Buenos Aires; Argentina.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
ID   INEUi002-A-1
AC   CVCL_C9LG
SY   PKP2 S140F
DR   hPSCreg; INEUi002-A-1
DR   Wikidata; Q123032702
RX   PubMed=37393721;
CC   From: Instituto de Neurociencias; Buenos Aires; Argentina.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple_edited; p.Ser140Phe (c.419C>T); ClinVar=VCV000045077; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37393721).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ93 ! INEUi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   INEUi002-A-2
AC   CVCL_C9LH
SY   PKP2 KO
DR   hPSCreg; INEUi002-A-2
DR   Wikidata; Q123032703
RX   PubMed=37393721;
CC   From: Instituto de Neurociencias; Buenos Aires; Argentina.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9024; PKP2.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DQ93 ! INEUi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   INEUi003-A
AC   CVCL_C9LI
SY   FHL1-T
DR   BioSamples; SAMEA115040734
DR   hPSCreg; INEUi003-A
DR   Wikidata; Q123032704
RX   PubMed=38244535;
CC   From: Instituto de Neurociencias; Buenos Aires; Argentina.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:3702; FHL1; Simple; p.Cys126Tyr (c.377G>A); Zygosity=Hemizygous (PubMed=38244535).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206103; X-Linked dominant scapuloperoneal myopathy
DI   ORDO; Orphanet_431272; X-linked scapuloperoneal muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   INEUi004-A
AC   CVCL_C9LJ
SY   FHL1-V
DR   BioSamples; SAMEA115040735
DR   hPSCreg; INEUi004-A
DR   Wikidata; Q123032705
RX   PubMed=38244535;
CC   From: Instituto de Neurociencias; Buenos Aires; Argentina.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:3702; FHL1; Simple; p.Cys126Tyr (c.377G>A); Zygosity=Heterozygous (PubMed=38244535).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206103; X-Linked dominant scapuloperoneal myopathy
DI   ORDO; Orphanet_431272; X-linked scapuloperoneal muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   INF-3A
AC   CVCL_S482
DR   Wikidata; Q54897738
RX   PubMed=2778838;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   iNFF12
AC   CVCL_VR59
SY   iNFF12.5; iPSC from Nondiabetic Foot Fibroblasts 12; RCSIi003-A
DR   BioSamples; SAMEA5126962
DR   hPSCreg; RCSIi003-A
DR   SKIP; SKIP003226
DR   Wikidata; Q94317963
RX   PubMed=27328415;
CC   From: Royal College of Surgeons in Ireland; Dublin; Ireland.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   iNFF14
AC   CVCL_VR60
SY   iNFF14.6; iPSC from Nondiabetic Foot Fibroblasts 14; RCSIi004-A
DR   BioSamples; SAMEA5126964
DR   hPSCreg; RCSIi004-A
DR   SKIP; SKIP003225
DR   Wikidata; Q94317967
RX   PubMed=27328415;
CC   From: Royal College of Surgeons in Ireland; Dublin; Ireland.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   Ingles
AC   CVCL_L358
DR   BTO; BTO_0005357
DR   Wikidata; Q54897739
RX   PubMed=21552385;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   IngWAT
AC   CVCL_ZL61
DR   Millipore; SCC211
DR   Wikidata; Q98126774
RX   PubMed=29692364;
CC   Characteristics: Versatile model for a broad spectrum of studies of beige adipocyte induction, maintenance and physiology (Millipore=SCC211).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; White adipose tissue; UBERON=UBERON_0001347.
ST   Source(s): Millipore=SCC211
ST   Mouse STR 1-1: 10,16,17
ST   Mouse STR 1-2: 13,19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14,18
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 12,15
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 15.3
ST   Mouse STR 11-2: 14,16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 20.3,22.3
ST   Mouse STR 17-2: 12,16
ST   Mouse STR 18-3: 16,18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   InLa
AC   CVCL_E6XH
RX   PubMed=12836015;
CC   HLA typing: A*02,11; B*15,35; DQB1*03:02,05:01:01; DRB1*01:01,04:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   INMi001-A
AC   CVCL_UJ75
SY   USH2A-RP-iPSC
DR   hPSCreg; INMi001-A
DR   Wikidata; Q94317981
RX   PubMed=30453153;
RX   PubMed=31909088;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys759Phe (c.2276G>T); ClinVar=VCV000002356; Zygosity=Heterozygous (PubMed=30453153).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Glu767Serfs*21 (c.2299delG); ClinVar=VCV000002351; Zygosity=Heterozygous (PubMed=30453153).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   INMi001-A-1
AC   CVCL_YR32
SY   USH2A-RP-iPSC clone MS3F7
DR   Wikidata; Q94317986
RX   PubMed=31909088;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple_corrected; p.Cys759Phe (c.2276G>T); ClinVar=VCV000002356; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31909088).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Glu767Serfs*21 (c.2299delG); ClinVar=VCV000002351; Zygosity=Heterozygous (PubMed=31909088).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UJ75 ! INMi001-A
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   INMi002-A
AC   CVCL_UJ76
SY   USH2A-USH-iPSC
DR   hPSCreg; INMi002-A
DR   Wikidata; Q94317989
RX   PubMed=30468996;
RX   PubMed=31909088;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Glu767Serfs*21 (c.2299delG); ClinVar=VCV000002351; Zygosity=Homozygous (PubMed=30468996).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   INMi002-A-1
AC   CVCL_YR33
SY   USH2A-USH-iPSC clone B3B1
DR   Wikidata; Q94317993
RX   PubMed=31909088;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple_corrected; p.Glu767Serfs*21 (c.2299delG); ClinVar=VCV000002351; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31909088).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UJ76 ! INMi002-A
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   INMi003-A
AC   CVCL_WR01
SY   CRX-CRD-iPSC
DR   hPSCreg; INMi003-A
DR   Wikidata; Q94317998
RX   PubMed=31203166;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2383; CRX; Simple; p.Arg41Trp (c.121C>T); ClinVar=VCV000007418; Zygosity=Heterozygous (PubMed=31203166).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162399; Cone-rod dystrophy 2
DI   ORDO; Orphanet_1872; Cone rod dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   INMi004-A
AC   CVCL_WR02
SY   CRX-LCA-iPSC
DR   hPSCreg; INMi004-A
DR   Wikidata; Q94318004
RX   PubMed=31247521;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2383; CRX; Simple; p.Pro232Argfs*139 (c.695delC); ClinVar=VCV000191298; Zygosity=Heterozygous (PubMed=31247521).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   INMi005-A
AC   CVCL_B7MC
SY   USH2A-RP-2-iPSC
DR   hPSCreg; INMi005-A
DR   Wikidata; Q112929865
RX   PubMed=35248879;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys759Phe (c.2276G>T); ClinVar=VCV000002356; Zygosity=Heterozygous (PubMed=35248879).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Leu2451Pro (c.7352T>C); Zygosity=Heterozygous (PubMed=35248879).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   INNDSUi001-A
AC   CVCL_C0JC
SY   186-Nml-F-24
DR   BioSamples; SAMEA13076458
DR   hPSCreg; INNDSUi001-A
DR   Wikidata; Q112929866
RX   PubMed=35636248;
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   INNDSUi002-A
AC   CVCL_D0G3
SY   21-013
DR   BioSamples; SAMEA13061467
DR   hPSCreg; INNDSUi002-A
DR   Wikidata; Q123032706
RX   PubMed=37019029;
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3483; ETFDH; Simple; p.Ala84Val (c.251C>T); ClinVar=VCV001451322; Zygosity=Heterozygous (PubMed=37019029).
CC   Sequence variation: Mutation; HGNC; HGNC:3483; ETFDH; Simple; p.Asp130Val (c.389A>T); ClinVar=VCV000656755; Zygosity=Heterozygous (PubMed=37019029).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84907; Multiple acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26791; Multiple acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   INNDSUi003-A
AC   CVCL_C0JB
DR   BioSamples; SAMEA13935789
DR   hPSCreg; INNDSUi003-A
DR   Wikidata; Q112929867
RX   PubMed=35526387;
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.1483-2A>G; ClinVar=VCV001322654; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=35526387).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   INNDSUi004-A
AC   CVCL_D6PQ
SY   20-235--F
DR   BioSamples; SAMEA114804862
DR   hPSCreg; INNDSUi004-A
RX   PubMed=38733812;
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12011; TPM2; Simple; p.Glu139del (c.412GAG[1]) (c.415-417delGAG); ClinVar=VCV000012465; Zygosity=Heterozygous (PubMed=38733812).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164225; Nemaline myopathy 4
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   INNDSUi005-A
AC   CVCL_D6PP
DR   BioSamples; SAMEA114785646
DR   hPSCreg; INNDSUi005-A
RX   PubMed=38484449;
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   INNDSUi006-A
AC   CVCL_E4K3
DR   BioSamples; SAMEA116072687
DR   hPSCreg; INNDSUi006-A
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   INNDSUi007-A
AC   CVCL_E4K4
SY   ZHH-KD
DR   BioSamples; SAMEA116075873
DR   hPSCreg; INNDSUi007-A
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   INNDSUi008-A
AC   CVCL_E4K5
SY   JKL-SCA
DR   BioSamples; SAMEA116075877
DR   hPSCreg; INNDSUi008-A
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   INNDSUi009-A
AC   CVCL_E4K6
DR   BioSamples; SAMEA116075879
DR   hPSCreg; INNDSUi009-A
CC   From: Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   INOF2
AC   CVCL_0T67
SY   INOF; Immortalized Normal Ovarian Fibroblast 2
DR   Wikidata; Q54897740
RX   PubMed=20360942;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   iNOS KO (C57)
AC   CVCL_C0L8
SY   iNOS KO (C57) Macrophage Cell Line
DR   Kerafast; ENH176-FP
DR   Wikidata; Q112929868
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97361; Nos2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   INPERe001-A
AC   CVCL_UL74
SY   Amicqui-1
DR   ArrayExpress; E-MTAB-10347
DR   BioSamples; SAMEA114245580
DR   hPSCreg; INPERe001-A
DR   Wikidata; Q94318017
RX   PubMed=26246271;
RX   PubMed=35815953;
CC   From: Instituto Nacional de Perinatologia; Mexico City; Mexico.
CC   Population: Mexican.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Avila-Gonzalez, Daniela.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 14
ST   D12S391: 17,18
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D19S433: 13,14.2
ST   D1S1656: 16,17.3
ST   D21S11: 28,32.2
ST   D22S1045: 14,15
ST   D2S1338: 20,23
ST   D2S441: 11,14
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D6S1043: 12,14
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 16,21
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   INPERe002-A
AC   CVCL_UL75
SY   Amicqui-2
DR   hPSCreg; INPERe002-A
DR   Wikidata; Q94318021
RX   PubMed=30611019;
CC   From: Instituto Nacional de Perinatologia; Mexico City; Mexico.
CC   Population: Mexican.
CC   Miscellaneous: STR profile from personal communication of Avila-Gonzalez, Daniela.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,14
ST   D12S391: 19,23
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 17,19
ST   D19S433: 13,13.2
ST   D1S1656: 13,16
ST   D21S11: 30
ST   D22S1045: 15,16
ST   D2S1338: 19,23
ST   D2S441: 10,11.3
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D6S1043: 11,21.3
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 23,27
ST   Penta D: 9,11
ST   Penta E: 11,14
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 6
//
ID   INPERe003-A
AC   CVCL_UL76
DR   hPSCreg; INPERe003-A
DR   Wikidata; Q94318025
CC   From: Instituto Nacional de Perinatologia; Mexico City; Mexico.
CC   Discontinued: hPSCreg; INPERe003-A; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 6
//
ID   INS-1
AC   CVCL_0352
SY   INS1
DR   BTO; BTO_0002135
DR   EFO; EFO_0002529
DR   MCCL; MCC:0000246
DR   AddexBio; C0018007/371
DR   CCRID; 1101RAT-PUMC000378
DR   ChEMBL-Cells; CHEMBL3308040
DR   ChEMBL-Targets; CHEMBL613545
DR   CLS; 300471
DR   KCB; KCB 2010005YJ
DR   Lonza; 301
DR   PRIDE; PXD013232
DR   PubChem_Cell_line; CVCL_0352
DR   TOKU-E; 3996
DR   Wikidata; Q54897741
RX   PubMed=1370150;
RX   PubMed=8697299;
RX   PubMed=22538498;
RX   PubMed=36180704;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-31.html
CC   Characteristics: Established from the transplantable insulinoma RIN.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_J993 ! INS-2
OI   CVCL_3584 ! RIN-m
OI   CVCL_D163 ! RIN-r
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Ins-1
AC   CVCL_VK12
DR   Wikidata; Q94318039
RX   DOI=10.1007/978-1-4757-1647-4_5;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C27720; Pancreatic neuroendocrine tumor
DI   ORDO; Orphanet_97253; Neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   INS-1 832/1
AC   CVCL_EG57
SY   INS-1 (832/1); 832/1
DR   BCGO; BCGO_0000113
DR   Wikidata; Q54897742
RX   PubMed=10868964;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   INS-1 832/13
AC   CVCL_7226
SY   INS1 832/13; INS-1 (832/13); INS 832/13; 832/13; 832/13 INS-1
DR   BCGO; BCGO_0000115
DR   BTO; BTO_0003318
DR   AddexBio; C0018024/5026
DR   ChEMBL-Cells; CHEMBL4483142
DR   ChEMBL-Targets; CHEMBL4483248
DR   Lonza; 11
DR   MetaboLights; MTBLS951
DR   Millipore; SCC207
DR   PubChem_Cell_line; CVCL_7226
DR   TOKU-E; 4125
DR   Wikidata; Q54897743
RX   PubMed=10868964;
RX   PubMed=18755687;
RX   PubMed=23555872;
RX   PubMed=25803449;
RX   PubMed=36180704;
CC   Characteristics: Shows robust glucose-stimulated insulin secretion (GSIS) (Millipore=SCC207).
CC   Doubling time: 44 hours (PubMed=25803449).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Misspelling: INS-1 823/13; Note=Occasionally.
CC   Misspelling: 823/13; Note=Occasionally.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   INS-1 832/2
AC   CVCL_EG56
SY   INS-1 (832/2); 832/2
DR   BCGO; BCGO_0000116
DR   Wikidata; Q54897744
RX   PubMed=10868964;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   INS-1 832/3
AC   CVCL_ZL55
SY   INS-1 (832/3); 832/3
DR   Millipore; SCC208
DR   Wikidata; Q98126775
RX   PubMed=10868964;
RX   PubMed=18755687;
CC   Characteristics: Shows robust glucose-stimulated insulin secretion (GSIS) (Millipore=SCC208).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   INS-1 833/117
AC   CVCL_2G79
SY   INS-1 (833/117); 833/117
DR   BCGO; BCGO_0000117
DR   Wikidata; Q54897745
RX   PubMed=10871193;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   INS-1 833/15
AC   CVCL_2G78
SY   INS-1 (833/15); 833/15
DR   BCGO; BCGO_0000118
DR   Wikidata; Q54897746
RX   PubMed=10871193;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   INS-1 834/40
AC   CVCL_2G77
SY   834/40
DR   BCGO; BCGO_0000119
DR   Wikidata; Q54897747
RX   PubMed=10871193;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   INS-1E
AC   CVCL_0351
SY   INS1-E; INS1E
DR   BCGO; BCGO_0000120
DR   BTO; BTO_0003317
DR   MCCL; MCC:0000245
DR   AddexBio; C0018009/4675
DR   ChEMBL-Cells; CHEMBL4651375
DR   Lonza; 1137
DR   PRIDE; PXD006544
DR   PRIDE; PXD008988
DR   PRIDE; PXD011329
DR   PubChem_Cell_line; CVCL_0351
DR   Wikidata; Q54897749
RX   PubMed=14592952;
RX   PubMed=22569486;
RX   PubMed=30310992;
WW   Provider; Unitec; 739-A617; https://web.archive.org/web/20230331090632/https://www.unige.ch/unitec/files/9915/8470/0115/TechOffer739_INS-1E_cell_line.pdf
CC   Characteristics: Used in numerous studies investigating the mechanisms of glucose stimulated insulin secretion. Is glucose responsive in a physiological range with substantial insulin content levels and a robust metabolism-secretion coupling (PubMed=30310992).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Omics: Proteomics; Subcellular; Insulin secretory granules.
CC   Caution: This cell line is owned by the University of Geneva, Switzerland, who is the sole authorized distributor for both commercial and non-commercial research use.
CC   Discontinued: AddexBio; C0018009/4675; true.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   INS-2
AC   CVCL_J993
SY   INS2
DR   Wikidata; Q54897750
RX   PubMed=1370150;
CC   Characteristics: Established from the transplantable insulinoma RIN.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0352 ! INS-1
OI   CVCL_3584 ! RIN-m
OI   CVCL_D163 ! RIN-r
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   INS-r3
AC   CVCL_W945
SY   INSr3
DR   Wikidata; Q54897751
RX   PubMed=9113996;
RX   PubMed=18708196;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0352 ! INS-1
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   INS-r3-GK27
AC   CVCL_W946
DR   Wikidata; Q54897752
RX   PubMed=9113996;
RX   PubMed=9325299;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2670; Gck.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_W945 ! INS-r3
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   INSAi001-A
AC   CVCL_YC29
SY   GD3-1
DR   BioSamples; SAMEA6358480
DR   hPSCreg; INSAi001-A
DR   Wikidata; Q94318164
RX   PubMed=31678773;
CC   From: Instituto Nacional de Saude Ricardo Jorge; Porto; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Phe252Ile (c.754T>A) (F213I); ClinVar=VCV000004301; Zygosity=Heterozygous (PubMed=31678773).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31678773).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   INSAi002-A
AC   CVCL_YC30
SY   FD-1
DR   BioSamples; SAMEA6724117
DR   hPSCreg; INSAi002-A
DR   Wikidata; Q94318170
RX   PubMed=32388441;
CC   From: Instituto Nacional de Saude Ricardo Jorge; Porto; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Trp287Ter (c.861G>A); ClinVar=VCV000010736; Zygosity=Hemizygous (PubMed=32388441).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   INSAi003-A
AC   CVCL_E9B5
DR   BioSamples; SAMEA115474367
DR   hPSCreg; INSAi003-A
RX   PubMed=40332602;
CC   From: Instituto Nacional de Saude Ricardo Jorge; Porto; Portugal.
CC   Sequence variation: Mutation; HGNC; HGNC:29670; GNPTAB; Simple; p.Leu1168Glnfs*5 (c.3501_3502TC[1]) (c.3503_3504delTC) (3665_3666delTC); ClinVar=VCV000002771; Zygosity=Homozygous (PubMed=40332602).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=40332602
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 12,13
ST   D21S11: 28,30
ST   D2S1338: 22,25
ST   D3S1358: 16,18
ST   D5S818: 9,12
ST   D7S820: 10,13
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   INSRMi001-A
AC   CVCL_WR45
DR   hPSCreg; INSRMi001-A
DR   Wikidata; Q94318173
CC   From: INSERM; Paris; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   INSRMi002-A
AC   CVCL_WN90
SY   PC117_c2
DR   BioSamples; SAMEA5794618
DR   hPSCreg; INSRMi002-A
DR   Wikidata; Q94318176
CC   From: INSERM; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18423; DEPDC5; Simple; p.Glu1420Argfs*153 (c.4260delG); Zygosity=Heterozygous (hPSCreg=INSRMi002-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C161005; Familial focal epilepsy with variable foci 1
DI   ORDO; Orphanet_98820; Familial focal epilepsy with variable foci
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   INSRMi003-A
AC   CVCL_WR03
SY   PC128_c5
DR   BioSamples; SAMEA5829802
DR   hPSCreg; INSRMi003-A
DR   Wikidata; Q94318181
CC   From: INSERM; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   INSRMi004-A
AC   CVCL_WR04
SY   PC118_c7
DR   BioSamples; SAMEA5827958
DR   hPSCreg; INSRMi004-A
DR   Wikidata; Q94318186
CC   From: INSERM; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Arg865Ter (c.2593C>T); ClinVar=VCV000189844; Zygosity=Heterozygous (hPSCreg=INSRMi004-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   INSRMi005-A
AC   CVCL_WR05
SY   PC119_c7
DR   BioSamples; SAMEA5829796
DR   hPSCreg; INSRMi005-A
DR   Wikidata; Q94318189
CC   From: INSERM; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   INSRMi006-A
AC   CVCL_WR06
SY   PC131_c8
DR   BioSamples; SAMEA5829798
DR   hPSCreg; INSRMi006-A
DR   Wikidata; Q94318194
CC   From: INSERM; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18423; DEPDC5; Simple; p.Glu1385Ter (c.4151_4152insC); Zygosity=Heterozygous (hPSCreg=INSRMi006-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C161005; Familial focal epilepsy with variable foci 1
DI   ORDO; Orphanet_98820; Familial focal epilepsy with variable foci
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   INSRMi007-A
AC   CVCL_WR07
SY   PC132-c4; pc132-c4
DR   BioSamples; SAMEA5829801
DR   hPSCreg; INSRMi007-A
DR   Wikidata; Q94318197
CC   From: INSERM; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   INSRMi008-A
AC   CVCL_A2XV
SY   DMD_YoTaz_PhyMedExp
DR   hPSCreg; INSRMi008-A
DR   Wikidata; Q105509668
RX   PubMed=33246213;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex1del; Zygosity=Hemizygous (PubMed=33246213).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   INSRMi009-A
AC   CVCL_A2XW
SY   DMD_RaPer_PhyMedExp
DR   hPSCreg; INSRMi009-A
DR   Wikidata; Q105509671
RX   PubMed=33246213;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex52del; Zygosity=Hemizygous (PubMed=33246213).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   INSRMi010-A
AC   CVCL_A2XX
SY   DMD_OuMen_PhyMedExp
DR   hPSCreg; INSRMi010-A
DR   Wikidata; Q105509674
RX   PubMed=33246213;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex55del; Zygosity=Hemizygous (PubMed=33246213).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   INSRMi011-A
AC   CVCL_A8LS
SY   CPVT_P16_PhyMedExp
DR   hPSCreg; INSRMi011-A
DR   Wikidata; Q108820548
RX   PubMed=35245853;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Arg169Pro (c.506G>C); Zygosity=Heterozygous (PubMed=35245853).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   INSRMi012-A
AC   CVCL_C9DY
SY   PC173c1
DR   hPSCreg; INSRMi012-A
DR   Wikidata; Q123032707
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Asp214_Glu245del (c.735+3A>G); ClinVar=VCV000066419; Zygosity=Heterozygous (from autologous cell line INSRMi012-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9DZ ! INSRMi012-B
OI   CVCL_C9E0 ! INSRMi012-C
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   INSRMi012-B
AC   CVCL_C9DZ
SY   PC173c6
DR   hPSCreg; INSRMi012-B
DR   Wikidata; Q123032708
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Asp214_Glu245del (c.735+3A>G); ClinVar=VCV000066419; Zygosity=Heterozygous (from autologous cell line INSRMi012-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9DY ! INSRMi012-A
OI   CVCL_C9E0 ! INSRMi012-C
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   INSRMi012-C
AC   CVCL_C9E0
SY   PC173c11; PC173T19
DR   BioSamples; SAMEA115046009
DR   hPSCreg; INSRMi012-C
DR   Wikidata; Q123032709
RX   PubMed=38354647;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Asp214_Glu245del (c.735+3A>G); ClinVar=VCV000066419; Zygosity=Heterozygous (PubMed=38354647).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9DY ! INSRMi012-A
OI   CVCL_C9DZ ! INSRMi012-B
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   INSRMi013-A
AC   CVCL_C9E1
SY   PC179c1
DR   BioSamples; SAMEA115045403
DR   hPSCreg; INSRMi013-A
DR   Wikidata; Q123032710
RX   PubMed=38354647;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Ser46Tyr (c.137C>A); ClinVar=VCV000066405; Zygosity=Heterozygous (PubMed=38354647).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9E2 ! INSRMi013-B
OI   CVCL_C9E3 ! INSRMi013-C
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   INSRMi013-B
AC   CVCL_C9E2
SY   PC179c3
DR   hPSCreg; INSRMi013-B
DR   Wikidata; Q123032711
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Ser46Tyr (c.137C>A); ClinVar=VCV000066405; Zygosity=Heterozygous (from autologous cell line INSRMi013-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9E1 ! INSRMi013-A
OI   CVCL_C9E3 ! INSRMi013-C
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   INSRMi013-C
AC   CVCL_C9E3
SY   PC179c5
DR   hPSCreg; INSRMi013-C
DR   Wikidata; Q123032712
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Ser46Tyr (c.137C>A); ClinVar=VCV000066405; Zygosity=Heterozygous (from autologous cell line INSRMi013-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9E1 ! INSRMi013-A
OI   CVCL_C9E2 ! INSRMi013-B
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   INSRMi014-A
AC   CVCL_C9DT
SY   C1-P017
DR   BioSamples; SAMEA114277528
DR   hPSCreg; INSRMi014-A
DR   Wikidata; Q123032713
RX   PubMed=37660555;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Leu127Phe (c.379C>T); ClinVar=VCV000200278; Zygosity=Homozygous (PubMed=37660555).
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Arg892Cys (c.2674C>T); ClinVar=VCV000191470; Zygosity=Homozygous (PubMed=37660555).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37660555
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 12,14
ST   D21S11: 30.2,31.2
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 14,15
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 11,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   INSRMi015-A
AC   CVCL_C9DU
SY   C1-P018
DR   BioSamples; SAMEA114268634
DR   hPSCreg; INSRMi015-A
DR   Wikidata; Q123032714
RX   PubMed=37660555;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Leu127Phe (c.379C>T); ClinVar=VCV000200278; Zygosity=Heterozygous (PubMed=37660555).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37660555
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 12,15
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 15,16
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 5,12
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   INSRMi019-A
AC   CVCL_D6P3
SY   PC129K8
DR   BioSamples; SAMEA115056948
DR   hPSCreg; INSRMi019-A
RX   PubMed=38354647;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Pro419His; Zygosity=Heterozygous (PubMed=38354647).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   INSRMi020-A
AC   CVCL_D6P4
SY   PC130K2c
DR   BioSamples; SAMEA115046805
DR   hPSCreg; INSRMi020-A
RX   PubMed=38354647;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Glu439Lys (c.1315G>A); ClinVar=VCV000265838; Zygosity=Heterozygous (PubMed=38354647).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   INSRMi021-A
AC   CVCL_D6P5
SY   PC177 3c14
DR   BioSamples; SAMEA115046807
DR   hPSCreg; INSRMi021-A
RX   PubMed=38354647;
CC   From: INSERM; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Glu245Asp (c.735G>C); ClinVar=VCV000066420; Zygosity=Heterozygous (PubMed=38354647).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   INSTEMi001-A
AC   CVCL_D0QK
SY   iN-22-01-A6
DR   hPSCreg; INSTEMi001-A
DR   Wikidata; Q123032715
RX   PubMed=37236122;
CC   From: Institute for Stem Cell Biology and Regenerative Medicine; Bangalore; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   Int-3LL
AC   CVCL_8358
SY   Intravasating-3LL
DR   JCRB; JCRB1351
DR   Wikidata; Q54897753
RX   PubMed=10408901;
CC   Characteristics: Possesses enhanced intravasating ability compared to the parent cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   INT-MEL-1
AC   CVCL_C682
SY   Me5810; Me5810/P
DR   Cosmic; 720626
DR   Wikidata; Q54897754
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=8459226;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C687 ! LCL5810
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   INT-MEL-10
AC   CVCL_HE45
SY   Me18588; Me1858/8
DR   Wikidata; Q54897755
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
ID   INT-MEL-11
AC   CVCL_HE36
SY   Me13294; Me1329/4
DR   Wikidata; Q54897756
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   INT-MEL-12
AC   CVCL_A648
SY   Me10538; ME10538; ME 10538; Me 10538; Me1053/8; 10538
DR   cancercelllines; CVCL_A648
DR   Cosmic; 889006
DR   Cosmic; 928710
DR   Cosmic; 1211153
DR   GEO; GSM1403082
DR   GEO; GSM1403083
DR   GEO; GSM1403084
DR   Wikidata; Q54897757
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=2469723;
RX   PubMed=2776368;
RX   PubMed=7520026;
RX   PubMed=8459226;
RX   PubMed=8980186;
RX   PubMed=9354451;
RX   PubMed=9725211;
RX   PubMed=9973437;
RX   PubMed=15048078;
RX   PubMed=22383533;
RX   PubMed=25576923;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15048078; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Gly414Val (c.1241G>T); Zygosity=Heterozygous (PubMed=22383533).
CC   Misspelling: ME10358; Note=Occasionally.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C690 ! LCL10538
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   INT-MEL-13
AC   CVCL_C683
SY   Me8959
DR   Wikidata; Q54897758
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=8459226;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   INT-MEL-14
AC   CVCL_QY42
DR   Wikidata; Q54897759
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-15/2
AC   CVCL_C672
SY   Me1402; ME1402; ME 1402; Me 1402; Me1402/R; Me1402r; Me1402/P
DR   cancercelllines; CVCL_C672
DR   Cosmic; 720625
DR   Cosmic; 889007
DR   Cosmic; 928698
DR   Wikidata; Q54897760
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=2469723;
RX   PubMed=2776368;
RX   PubMed=7520026;
RX   PubMed=8459226;
RX   PubMed=8980186;
RX   PubMed=9354451;
RX   PubMed=9973437;
RX   PubMed=15048078;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15048078; PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   INT-MEL-16/1
AC   CVCL_F250
SY   Me9923/P; Me9923p; Me9923; Me 9923; 9923
DR   CLO; CLO_0001015
DR   CLDB; cl141
DR   Cosmic; 720622
DR   Cosmic; 2759875
DR   Wikidata; Q54897761
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9637706;
CC   HLA typing: A*02; B*41,50; C*w02,06 (PubMed=9637706).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Asp79fs*6 (c.235_248del14); Zygosity=Homozygous (PubMed=9637706).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr86Ter (c.258C>G); Zygosity=Homozygous (PubMed=9637706).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HE37 ! INT-MEL-16/2
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   INT-MEL-16/2
AC   CVCL_HE37
SY   Me9923/M; Me9923
DR   Cosmic; 2759874
DR   Wikidata; Q54897762
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=9637706;
CC   HLA typing: A*02; B*41,50; C*w02,06 (PubMed=9637706).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Asp79fs*6 (c.235_248del14); Zygosity=Homozygous (PubMed=9637706).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr86Ter (c.258C>G); Zygosity=Homozygous (PubMed=9637706).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F250 ! INT-MEL-16/1
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   INT-MEL-17
AC   CVCL_C680
SY   Me4405; ME4405; ME-4405; ME 4405
DR   BTO; BTO_0005716
DR   cancercelllines; CVCL_C680
DR   Cosmic; 889008
DR   Cosmic; 929202
DR   GEO; GSM1403049
DR   GEO; GSM1403050
DR   GEO; GSM1403051
DR   GEO; GSM1403052
DR   GEO; GSM1403053
DR   GEO; GSM1403054
DR   Wikidata; Q54897764
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=7520026;
RX   PubMed=8459226;
RX   PubMed=8980186;
RX   PubMed=9725211;
RX   PubMed=10338330;
RX   PubMed=15048078;
RX   PubMed=22383533;
RX   PubMed=22553342;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=15048078; PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C688 ! LCL4405
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   INT-MEL-18
AC   CVCL_QY43
DR   Wikidata; Q54897765
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-19
AC   CVCL_C673
SY   Me14932; Me1493/2
DR   Wikidata; Q54897766
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=8459226;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   INT-MEL-20
AC   CVCL_C668
SY   Me1007; ME1007; ME-1007; ME 1007; Mel-007; Mel007
DR   BTO; BTO_0005711
DR   EFO; EFO_0022590
DR   Cosmic; 889005
DR   Wikidata; Q54897767
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=2469723;
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9725211;
RX   PubMed=15048078;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=22383533).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   INT-MEL-22
AC   CVCL_QY44
DR   Wikidata; Q54897772
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-23
AC   CVCL_C670
SY   Me13443; 13443-Mel; MI13443-MEL; Mi13443-MEL; Mi13443
DR   Cosmic; 1295338
DR   Wikidata; Q54897773
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=8459226;
RX   PubMed=11121133;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   32Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   INT-MEL-25
AC   CVCL_QY45
DR   Wikidata; Q54897774
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-26
AC   CVCL_QY46
DR   Wikidata; Q54897775
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-27
AC   CVCL_QY47
DR   Wikidata; Q54897776
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-28
AC   CVCL_QY48
DR   Wikidata; Q54897778
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-31
AC   CVCL_QY49
DR   Wikidata; Q54897779
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-32
AC   CVCL_QY50
DR   Wikidata; Q54897780
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-33
AC   CVCL_QY61
DR   Wikidata; Q54897781
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-38/1
AC   CVCL_QY62
DR   Wikidata; Q54897782
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY63 ! INT-MEL-38/2
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-38/2
AC   CVCL_QY63
DR   Wikidata; Q54897783
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY62 ! INT-MEL-38/1
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-39
AC   CVCL_C674
SY   Me16938; Me1693/8
DR   Wikidata; Q54897784
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=8459226;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   INT-MEL-4
AC   CVCL_HE33
SY   Me9874; ME9874
DR   Wikidata; Q54897785
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   INT-MEL-40
AC   CVCL_QY51
DR   Wikidata; Q54897786
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-41
AC   CVCL_QY72
DR   Wikidata; Q54897787
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-42
AC   CVCL_QY52
DR   Wikidata; Q54897788
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-43
AC   CVCL_HE40
SY   Me1509
DR   Wikidata; Q54897789
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   INT-MEL-44
AC   CVCL_QY53
DR   Wikidata; Q54897790
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-45
AC   CVCL_QY73
DR   Wikidata; Q54897791
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-46
AC   CVCL_QY64
DR   Wikidata; Q54897792
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57-58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   INT-MEL-47/1
AC   CVCL_QY65
DR   Wikidata; Q54897793
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY66 ! INT-MEL-47/2
OI   CVCL_QY67 ! INT-MEL-47/3
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-47/2
AC   CVCL_QY66
DR   Wikidata; Q54897794
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY65 ! INT-MEL-47/1
OI   CVCL_QY67 ! INT-MEL-47/3
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   INT-MEL-47/3
AC   CVCL_QY67
DR   Wikidata; Q54897795
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY65 ! INT-MEL-47/1
OI   CVCL_QY66 ! INT-MEL-47/2
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   INT-MEL-48/1
AC   CVCL_QY68
DR   Wikidata; Q54897796
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY69 ! INT-MEL-48/2
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-48/2
AC   CVCL_QY69
DR   Wikidata; Q54897797
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY68 ! INT-MEL-48/1
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   INT-MEL-49
AC   CVCL_QY54
DR   Wikidata; Q54897798
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-50
AC   CVCL_HE43
SY   Me10221; Me 10221
DR   Wikidata; Q54897799
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
ID   INT-MEL-51
AC   CVCL_QY55
DR   Wikidata; Q54897800
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-52
AC   CVCL_C679
SY   Me4024
DR   Wikidata; Q54897801
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=8459226;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   INT-MEL-53
AC   CVCL_QY56
DR   Wikidata; Q54897802
RX   DOI=10.1007/0-306-46872-7_16;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   INT-MEL-54
AC   CVCL_QY57
DR   Wikidata; Q54897803
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-55
AC   CVCL_QY58
DR   Wikidata; Q54897804
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-56
AC   CVCL_QY59
DR   Wikidata; Q54897805
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-57
AC   CVCL_QY60
DR   Wikidata; Q54897806
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-58
AC   CVCL_F249
SY   Me9229; Me 9229; 9229; Melanoma 9229
DR   CLO; CLO_0001014
DR   CLDB; cl139
DR   Wikidata; Q54897808
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=2469723;
RX   PubMed=3121738;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   INT-MEL-59/1
AC   CVCL_C685
SY   Me9742; ME9742
DR   Wikidata; Q54897809
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=8459226;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C686 ! LCL9742
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   INT-MEL-6
AC   CVCL_QY70
DR   Wikidata; Q54897810
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-7
AC   CVCL_QY71
DR   Wikidata; Q54897811
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   INT-MEL-8
AC   CVCL_HE42
SY   Me3046
DR   Wikidata; Q54897812
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   INT-MEL-9
AC   CVCL_HE35
SY   Me4840
DR   Wikidata; Q54897813
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   INT.Ov1
AC   CVCL_DF86
DR   Wikidata; Q54897817
RX   PubMed=9334822;
CC   HLA typing: A*23,32; B*35,49 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   INT.Ov2
AC   CVCL_DF87
SY   INTOV2
DR   cancercelllines; CVCL_DF87
DR   GEO; GSM313674
DR   Progenetix; CVCL_DF87
DR   Wikidata; Q54897818
RX   PubMed=9334822;
CC   HLA typing: A*01,02; B*35,49; C*04,06 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
ID   INT.Ov3
AC   CVCL_DF88
DR   Wikidata; Q54897819
RX   PubMed=9334822;
CC   HLA typing: A*25,29; B*39,44 (PubMed=9334822).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   INT.Ov4
AC   CVCL_DF89
DR   Wikidata; Q54897820
RX   PubMed=9334822;
CC   HLA typing: A*03; B*16,40 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   INT.Ov5
AC   CVCL_DF90
DR   Wikidata; Q54897821
RX   PubMed=9334822;
CC   HLA typing: A*24,25; B*18; C*05 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   INT.Ov6
AC   CVCL_DF91
DR   Wikidata; Q54897822
RX   PubMed=9334822;
CC   HLA typing: A*01,03; B*18,57 (PubMed=9334822).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   INT.Ov7
AC   CVCL_DF92
DR   Wikidata; Q54897823
RX   PubMed=9334822;
CC   HLA typing: A*01,26; B*27,37; C*01,06 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   INT.Ov8
AC   CVCL_DF93
DR   Wikidata; Q54897824
RX   PubMed=9334822;
CC   HLA typing: A*11,26; B*27,38; C*04 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   INT.Ov9
AC   CVCL_DF94
DR   Wikidata; Q54897825
RX   PubMed=9334822;
CC   HLA typing: A*01,02; B*37,53; C*04,06 (PubMed=9334822).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   Intestine 407
AC   CVCL_1907
SY   intestine 407; Intestine-407; intestine-407; INT 407; Int 407; INT-407; Int-407; Int407; INT407; INT 407(HeLa derivative); HI407; Henle-407; 407; HEI
DR   BTO; BTO_0000633
DR   CLO; CLO_0006953
DR   CLO; CLO_0006954
DR   CLO; CLO_0006955
DR   CLDB; cl2895
DR   CLDB; cl2896
DR   CLDB; cl2897
DR   CLDB; cl2898
DR   ATCC; CCL-6
DR   BCRC; 60022
DR   BioSample; SAMN03151723
DR   ECACC; 85051004
DR   IZSLER; BS CL 53
DR   RCB; RCB0553
DR   Wikidata; Q54897826
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=11416159;
RX   PubMed=13431913;
RX   PubMed=13475808;
RX   PubMed=14185313;
RX   PubMed=20143388;
RX   PubMed=23925245;
RX   PubMed=34697958;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from embryonic intestinal cells (jejunum/ileum).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00008.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Discontinued: BCRC; 60022; true.
CC   Discontinued: RCB; RCB0553; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-6; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   INV-3
AC   CVCL_0C65
SY   inv-3
DR   cancercelllines; CVCL_0C65
DR   Cosmic; 1037662
DR   Cosmic; 2089661
DR   Wikidata; Q54897827
RX   PubMed=16518851;
RX   PubMed=23955599;
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Asp61Val (c.182A>T); ClinVar=VCV000040496; Zygosity=Unspecified (PubMed=16518851).
DI   NCIt; C82426; Acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2) GATA2, MECOM
DI   ORDO; Orphanet_402020; Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
ID   iNV1
AC   CVCL_JK57
DR   Wikidata; Q54897828
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV10
AC   CVCL_JK66
DR   Wikidata; Q54897829
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV11
AC   CVCL_JK67
DR   BioSample; SAMN04123250
DR   Wikidata; Q54897830
RX   PubMed=26694224;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   iNV12
AC   CVCL_JK68
DR   Wikidata; Q54897831
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV13
AC   CVCL_JK69
DR   Wikidata; Q54897832
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV14
AC   CVCL_JK70
DR   Wikidata; Q54897833
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV15
AC   CVCL_JK71
DR   Wikidata; Q54897834
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV16
AC   CVCL_JK72
DR   Wikidata; Q54897835
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV17
AC   CVCL_JK73
DR   Wikidata; Q54897836
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV18
AC   CVCL_JK74
DR   Wikidata; Q54897837
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV19
AC   CVCL_JK75
DR   Wikidata; Q54897838
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV2
AC   CVCL_JK58
DR   Wikidata; Q54897839
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV20
AC   CVCL_JK76
DR   Wikidata; Q54897840
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV21
AC   CVCL_JK77
DR   Wikidata; Q54897841
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV22
AC   CVCL_JK78
DR   Wikidata; Q54897842
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV3
AC   CVCL_JK59
DR   Wikidata; Q54897843
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV4
AC   CVCL_JK60
DR   Wikidata; Q54897844
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV5
AC   CVCL_JK61
DR   Wikidata; Q54897845
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV6
AC   CVCL_JK62
DR   Wikidata; Q54897846
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV7
AC   CVCL_JK63
DR   BioSample; SAMN04123247
DR   Wikidata; Q54897847
RX   PubMed=26694224;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   iNV8
AC   CVCL_JK64
DR   Wikidata; Q54897848
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK65 ! iNV9
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   iNV9
AC   CVCL_JK65
DR   Wikidata; Q54897849
RX   PubMed=26694224;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
OI   CVCL_JK57 ! iNV1
OI   CVCL_JK58 ! iNV2
OI   CVCL_JK59 ! iNV3
OI   CVCL_JK60 ! iNV4
OI   CVCL_JK61 ! iNV5
OI   CVCL_JK62 ! iNV6
OI   CVCL_JK63 ! iNV7
OI   CVCL_JK64 ! iNV8
OI   CVCL_JK66 ! iNV10
OI   CVCL_JK67 ! iNV11
OI   CVCL_JK68 ! iNV12
OI   CVCL_JK69 ! iNV13
OI   CVCL_JK70 ! iNV14
OI   CVCL_JK71 ! iNV15
OI   CVCL_JK72 ! iNV16
OI   CVCL_JK73 ! iNV17
OI   CVCL_JK74 ! iNV18
OI   CVCL_JK75 ! iNV19
OI   CVCL_JK76 ! iNV20
OI   CVCL_JK77 ! iNV21
OI   CVCL_JK78 ! iNV22
SX   Male
AG   29FD
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   IOBA-NHC
AC   CVCL_9Y68
SY   Instituto de OftalmoBiologia Aplicada-Normal Human Conjunctiva
DR   MetaboLights; MTBLS214
DR   Wikidata; Q54897850
RX   PubMed=14507870;
RX   PubMed=19630270;
RX   PubMed=26260330;
WW   Provider; IOBA; -; https://www.dicyt.com/noticias/el-ioba-comparte-de-manera-gratuita-su-linea-celular-ioba-nhc-con-grupos-de-investigacion-internacionales
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
CC   Cell type: Epithelial cell of conjunctiva; CL=CL_1000432.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   IOBi001-A
AC   CVCL_C1TR
SY   F49B7; 01F49i-N-B7
DR   BioSamples; SAMEA12120859
DR   hPSCreg; IOBi001-A
DR   Wikidata; Q114311738
RX   PubMed=32946783;
CC   From: Institute of Molecular and Clinical Ophthalmology Basel; Basel; Switzerland.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   IOCVi001-A
AC   CVCL_D6ME
SY   iPSC-UNAM/IOCV-MFRP
DR   BioSamples; SAMEA114771343
DR   hPSCreg; IOCVi001-A
DR   Wikidata; Q127382387
RX   PubMed=38217995;
CC   From: Institute of Ophthalmology Conde de Valenciana; Mexico City; Mexico.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18121; MFRP; Simple; p.Asn167Glnfs*34 (c.498dupC) (c.498_499insC); ClinVar=VCV000004478; Zygosity=Homozygous (PubMed=38217995).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206113; Nanophthalmos 2
DI   ORDO; Orphanet_35612; Nanophthalmos
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IOCVi002-A
AC   CVCL_F0SZ
SY   IOCV-FOXE3
DR   BioSamples; SAMEA115935038
DR   hPSCreg; IOCVi002-A
RX   PubMed=40850233;
CC   From: Institute of Ophthalmology Conde de Valenciana; Mexico City; Mexico.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:3808; FOXE3; Simple; p.Tyr98His (c.292T>C); Zygosity=Homozygous (PubMed=40850233).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C222344; Anterior segment dysgenesis 2
DI   ORDO; Orphanet_83461; Congenital primary aphakia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   iOdE
AC   CVCL_JE68
SY   immortalized Odontogenic Epithelial cells
DR   GEO; GSM1942372
DR   Wikidata; Q54897851
RX   PubMed=27479086;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Epithelial cell of Malassez; CL=CL_0002166.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   iOECHHN
AC   CVCL_0P76
SY   immortalized Oral Epithelial Cells from HIV+ HAART Naive subject
DR   Kerafast; ECW001-FP
DR   Wikidata; Q54897852
CC   From: Weinberg, Aaron & Ghosh, Santosh K.; Case Western Reserve University; Cleveland; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   47Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   IOMM-Lee
AC   CVCL_5779
SY   IOMM-LEE; Iomm-Lee; IOMM Lee; IOMMLEE; IntraOsseous Malignant Meningioma-Lee
DR   BTO; BTO_0004464
DR   ATCC; CRL-3370
DR   BioSample; SAMN10988414
DR   cancercelllines; CVCL_5779
DR   Cell_Model_Passport; SIDM01733
DR   Cosmic; 2516047
DR   DepMap; ACH-000629
DR   PharmacoDB; IOMMLee_661_2019
DR   Wikidata; Q54897853
RX   PubMed=2234331;
RX   PubMed=16554968;
RX   PubMed=18261772;
RX   PubMed=25984343;
RX   PubMed=28552950;
RX   PubMed=31068700;
RX   PubMed=34850056;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Chinese.
CC   Doubling time: ~62 hours (PubMed=2234331); 18 hours (PubMed=25984343); 0.8 day (PubMed=34850056); ~22 hours (ATCC=CRL-3370).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-000629).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28552950).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3370
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4656; Intracranial meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   IOMM-Lee-LucNeo
AC   CVCL_HA67
DR   cancercelllines; CVCL_HA67
DR   Wikidata; Q54897855
RX   PubMed=18240927;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4656; Intracranial meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5779 ! IOMM-Lee
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   ior EGF/r3
AC   CVCL_C4ZA
SY   ior egf/r3; R3
DR   Wikidata; Q116049586
RX   PubMed=1400622;
RX   PubMed=11429099;
CC   Biotechnology: Widely used in the radioimmunodiagnosis of tumors of epithelial origin. Labeled with 99mTc, its main application in Nuclear Medicine is the follow up, detection and evaluation of tumor recurrences.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   IOR-C1
AC   CVCL_C7WD
SY   ior-C1
DR   Wikidata; Q123032717
RX   CelloPub=CLPUB00735;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   IOR-C2
AC   CVCL_C6UU
SY   ior-C2; ior c2
DR   Wikidata; Q117704532
RX   CelloPub=CLPUB00735;
RX   PubMed=1376720;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human colorectal glycoprotein IOR-C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IOR-C3
AC   CVCL_C7WE
SY   ior-C3
DR   Wikidata; Q123032718
RX   CelloPub=CLPUB00735;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   IOR-C5
AC   CVCL_C6UV
SY   ior c5; ior C5
DR   Wikidata; Q117704533
RX   CelloPub=CLPUB00730;
RX   Patent=US6891023;
RX   Patent=WO1997033916A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 97061101.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human colorectal glycoprotein IOR-C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IOR-CEA1
AC   CVCL_HA36
SY   IOR CEA1; IOR-ANTI CEA
DR   BCRJ; 0119
DR   Wikidata; Q54897856
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
CC   Discontinued: BCRJ; 0119; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   IOR/BER
AC   CVCL_H723
DR   Wikidata; Q54897857
RX   PubMed=11891184;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=11891184).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   IOR/BRZ
AC   CVCL_H724
SY   IOR-BRZ
DR   Wikidata; Q54897861
RX   PubMed=11891184;
RX   PubMed=18160777;
RX   PubMed=20197622;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=11891184).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   IOR/CAR
AC   CVCL_H725
DR   PRIDE; PXD012680
DR   Wikidata; Q54897862
RX   PubMed=11891184;
RX   PubMed=18160777;
RX   PubMed=30962207;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=18160777).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=11891184).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   IOR/CLB
AC   CVCL_H726
SY   IOR-CLB
DR   Wikidata; Q54897863
RX   PubMed=11891184;
RX   PubMed=18160777;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=11891184).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   IOR/EW4
AC   CVCL_A624
SY   IOR-EW4
DR   Cosmic; 1082510
DR   Wikidata; Q54897865
RX   PubMed=8617485;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C35871; Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   IOR/MOS
AC   CVCL_9986
SY   IOR-MOS; MOS
DR   Cosmic; 1082495
DR   Cosmic; 1529896
DR   GEO; GSM879214
DR   IARC_TP53; 27021
DR   Wikidata; Q54897866
RX   PubMed=8617485;
RX   PubMed=9935160;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: ~72 hours (PubMed=21519327).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.249_572del322; Zygosity=Unspecified (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 10
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 31.2,32
ST   D2S1338: 18,23
ST   D3S1358: 18
ST   D5S818: 11
ST   D8S1179: 9,10
ST   FGA: 21,22
ST   SE33: 17,21.2
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   IOR/NGR
AC   CVCL_H727
SY   IOR-NGR
DR   Wikidata; Q54897867
RX   PubMed=11891184;
RX   PubMed=18160777;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=11891184).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   IOR/OS10
AC   CVCL_9989
SY   IOR-OS10; OS-10; OS10
DR   cancercelllines; CVCL_9989
DR   Cosmic; 1082498
DR   Cosmic; 1529913
DR   GEO; GSM879210
DR   IARC_TP53; 27022
DR   Progenetix; CVCL_9989
DR   Wikidata; Q54897868
RX   PubMed=8617485;
RX   PubMed=9935160;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: ~72 hours (PubMed=21519327).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 26
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D8S1179: 11
ST   FGA: 21.2,23
ST   SE33: 16,23.2
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   IOR/OS14
AC   CVCL_9990
SY   IOR-OS14; OS-14; OS14
DR   cancercelllines; CVCL_9990
DR   Cosmic; 1082499
DR   GEO; GSM879211
DR   IARC_TP53; 27025
DR   Progenetix; CVCL_9990
DR   Wikidata; Q54897869
RX   PubMed=8617485;
RX   PubMed=9935160;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: ~48 hours (PubMed=21519327).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 32.2
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 12
ST   D8S1179: 9,10
ST   FGA: 24
ST   SE33: 14
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C4023; Small cell osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   IOR/OS15
AC   CVCL_9991
SY   IOR-OS15; OS-15; OS15
DR   cancercelllines; CVCL_9991
DR   Cosmic; 1082500
DR   Cosmic; 1529907
DR   GEO; GSM879212
DR   IARC_TP53; 27026
DR   Progenetix; CVCL_9991
DR   Wikidata; Q54897871
RX   PubMed=8617485;
RX   PubMed=9935160;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: ~48 hours (PubMed=21519327).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 9,13
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 16
ST   D3S1358: 14
ST   D5S818: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   SE33: 26.2
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   IOR/OS17
AC   CVCL_9992
SY   OS-17
DR   Cosmic; 1082501
DR   Wikidata; Q54897872
RX   PubMed=8617485;
RX   PubMed=9935160;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   IOR/OS18
AC   CVCL_9993
SY   IOR-OS18; OS-18; OS18
DR   cancercelllines; CVCL_9993
DR   Cosmic; 1082502
DR   Cosmic; 1529899
DR   GEO; GSM879213
DR   IARC_TP53; 27027
DR   Progenetix; CVCL_9993
DR   Wikidata; Q54897874
RX   PubMed=8617485;
RX   PubMed=9935160;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: ~60 hours (PubMed=21519327).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex3-4del; Zygosity=Unspecified (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X,Y
ST   D16S539: 11,12
ST   D18S51: 15,20
ST   D19S433: 15.2,16.2
ST   D21S11: 29,31.2
ST   D2S1338: 23,25
ST   D3S1358: 17
ST   D5S818: 9,13
ST   D8S1179: 10,11
ST   FGA: 20,24
ST   SE33: 16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   IOR/OS19
AC   CVCL_9994
SY   OS-19
DR   Cosmic; 1082503
DR   Wikidata; Q54897875
RX   PubMed=8617485;
RX   PubMed=9935160;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   IOR/OS7
AC   CVCL_9987
SY   OS-7
DR   Cosmic; 1082496
DR   Wikidata; Q54897876
RX   PubMed=8617485;
RX   PubMed=9935160;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   IOR/OS9
AC   CVCL_9988
SY   IOR-OS9; OS-9; OS9
DR   cancercelllines; CVCL_9988
DR   Cosmic; 1082497
DR   Cosmic; 1529911
DR   GEO; GSM879209
DR   IARC_TP53; 27028
DR   Progenetix; CVCL_9988
DR   Wikidata; Q54897877
RX   PubMed=8617485;
RX   PubMed=9935160;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: ~72 hours (PubMed=21519327).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X,Y
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 12,18
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D8S1179: 13
ST   FGA: 24
ST   SE33: 24.2
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   IOR/RCH
AC   CVCL_H728
SY   IOR-RCH
DR   Wikidata; Q54897878
RX   PubMed=11891184;
RX   PubMed=18160777;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=11891184).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   IOR/SARG
AC   CVCL_9995
SY   IOR-SARG; SARG
DR   cancercelllines; CVCL_9995
DR   Cosmic; 1082494
DR   Cosmic; 1529897
DR   GEO; GSM879215
DR   IARC_TP53; 27029
DR   Progenetix; CVCL_9995
DR   Wikidata; Q54897879
RX   PubMed=1622859;
RX   PubMed=8617485;
RX   PubMed=9935160;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: 58 +- 4 hours (PubMed=1622859); ~72 hours (PubMed=21519327).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Hemizygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Ter (c.615T>A); ClinVar=VCV000185498; Zygosity=Unspecified (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X,Y
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 29,30.2
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D8S1179: 13
ST   FGA: 21
ST   SE33: 23.2
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   IOSE-10
AC   CVCL_5532
SY   IOSE10
DR   Wikidata; Q54897880
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   IOSE-120
AC   CVCL_E240
SY   IOSE 120; IOSE120; NFHIOSE-120
DR   Wikidata; Q54897881
RX   PubMed=10329039;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 45.9 hours (PubMed=10329039).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   IOSE-121
AC   CVCL_E228
SY   IOSE 121; IOSE121; NFHIOSE-121; IOSE-Low
DR   Wikidata; Q54897882
RX   PubMed=10329039;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 35.3 hours (PubMed=10329039).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   IOSE-144
AC   CVCL_5533
SY   IOSE144; IOSE 144; NFHIOSE-144
DR   Wikidata; Q54897884
RX   DOI=10.5282/edoc.3898;
RX   PubMed=10329039;
RX   PubMed=15706405;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 28 hours (PubMed=10329039).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   IOSE-144RZ
AC   CVCL_5534
SY   IOSE 144RZ; I-144RZ
DR   Wikidata; Q54897885
RX   PubMed=17266044;
CC   Characteristics: Transfected with HA-tagged ZNF217.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13009; ZNF217.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5533 ! IOSE-144
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   IOSE-29
AC   CVCL_5535
SY   IOSE 29; IOSE29; NFHIOSE-29; IOSE-Mar; IOSE-MAR
DR   BTO; BTO_0004132
DR   IARC_TP53; 28486
DR   Wikidata; Q54897886
RX   PubMed=1326894;
RX   PubMed=7967506;
RX   PubMed=10329039;
RX   PubMed=10339573;
RX   PubMed=19926575;
RX   PubMed=20204287;
RX   PubMed=23415752;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 33.7 hours (PubMed=10329039).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   IOSE-29EC
AC   CVCL_5536
SY   IOSE29EC
DR   GEO; GSM383929
DR   Wikidata; Q54897887
RX   PubMed=10339573;
RX   PubMed=10652437;
RX   PubMed=11103784;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88354; Cdh1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5535 ! IOSE-29
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   IOSE-29EC/T4
AC   CVCL_5537
DR   Wikidata; Q54897888
RX   PubMed=10652437;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88354; Cdh1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5536 ! IOSE-29EC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   IOSE-29EC/T5
AC   CVCL_5538
DR   Wikidata; Q54897889
RX   PubMed=10652437;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88354; Cdh1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5536 ! IOSE-29EC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   IOSE-2Ap2
AC   CVCL_5539
DR   BTO; BTO_0004134
DR   Wikidata; Q54897890
RX   PubMed=16585202;
CC   From: Katabuchi, Hidetaka; Kumamoto University School of Medicine; Kumamoto; Japan.
CC   Transformant: Unknown.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   IOSE-364
AC   CVCL_5540
SY   IOSE 364; IOSE364; IOSE-364(-); IOSE-364-
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00061
DR   GDSC; 1479991
DR   GEO; GSM1669936
DR   PharmacoDB; IOSE364_662_2019
DR   Wikidata; Q54897891
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   IOSE-385
AC   CVCL_E229
SY   IOSE 385; IOSE385
DR   Wikidata; Q54897892
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   IOSE-386
AC   CVCL_E230
SY   IOSE 386; IOSE386
DR   Wikidata; Q54897893
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   IOSE-397
AC   CVCL_5541
SY   IOSE 397; IOSE397
DR   BTO; BTO_0004131
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00060
DR   GDSC; 1479992
DR   GEO; GSM1669937
DR   PharmacoDB; IOSE397_663_2019
DR   PRIDE; PXD003668
DR   Wikidata; Q54897894
RX   PubMed=22685544;
RX   PubMed=27561551;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: IOSE379; Note=In text of PubMed 20332224.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   IOSE-398
AC   CVCL_5542
SY   IOSE 398; IOSE398
DR   BTO; BTO_0004135
DR   GEO; GSM352347
DR   GEO; GSM352348
DR   GEO; GSM352349
DR   GEO; GSM352350
DR   GEO; GSM352351
DR   GEO; GSM352352
DR   GEO; GSM352353
DR   GEO; GSM352354
DR   GEO; GSM352355
DR   GEO; GSM352356
DR   GEO; GSM352357
DR   GEO; GSM352358
DR   GEO; GSM352359
DR   GEO; GSM352360
DR   GEO; GSM352361
DR   GEO; GSM352362
DR   GEO; GSM352363
DR   GEO; GSM352364
DR   GEO; GSM352365
DR   GEO; GSM352366
DR   GEO; GSM352367
DR   GEO; GSM352368
DR   GEO; GSM352369
DR   GEO; GSM352370
DR   TOKU-E; 4059
DR   Wikidata; Q54897895
RX   PubMed=15531506;
RX   PubMed=20155583;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   IOSE-4p2
AC   CVCL_5543
DR   BTO; BTO_0004133
DR   Wikidata; Q54897896
RX   PubMed=16585202;
CC   From: Katabuchi, Hidetaka; Kumamoto University School of Medicine; Kumamoto; Japan.
CC   Transformant: Unknown.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   IOSE-523
AC   CVCL_E234
SY   IOSE 523; IOSE523; IOSE-523(-); IOSE-523-
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00059
DR   GDSC; 1479993
DR   GEO; GSM1669938
DR   PharmacoDB; IOSE523_664_2019
DR   Wikidata; Q54897897
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   IOSE-53
AC   CVCL_E270
SY   IOSE 53; IOSE53; IOSE-Heff; IOSE-HEFF
DR   Wikidata; Q54897898
RX   PubMed=1326894;
RX   PubMed=7967506;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   IOSE-592F
AC   CVCL_5544
SY   IOSE 592F; IOSE592F
DR   Wikidata; Q54897899
RX   PubMed=22685544;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Val1234Glnfs*8 (c.3695_3699GTAAA[1]) (c.3700_3704delGTAAA) (3819del5) (3819_3823delGTAAA); ClinVar=VCV000037542; Zygosity=Unspecified (PubMed=22685544).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   IOSE-7
AC   CVCL_5545
SY   IOSE7
DR   Wikidata; Q54897900
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   IOSE-75-16SV40
AC   CVCL_EQ74
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00039
DR   GDSC; 1479994
DR   GEO; GSM1669939
DR   PharmacoDB; IOSE7516SV40_665_2019
DR   Wikidata; Q54897901
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   IOSE-7576
AC   CVCL_E227
SY   IOSE 7576; IOSE7576
DR   PRIDE; PXD003668
DR   Wikidata; Q54897902
RX   PubMed=22685544;
RX   PubMed=27561551;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   IOSE-80
AC   CVCL_5546
SY   IOSE 80; IOSE80; NFHIOSE-80; IOSE80UBC; IOSE-Van; IOSE-VAN
DR   Lonza; 13
DR   Wikidata; Q54897904
RX   DOI=10.5282/edoc.3898;
RX   PubMed=1326894;
RX   PubMed=7967506;
RX   PubMed=10329039;
RX   PubMed=15706405;
RX   PubMed=15947112;
RX   PubMed=19926575;
RX   PubMed=23415752;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 26.2 hours (PubMed=10329039).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   IOSE-80PC
AC   CVCL_5547
SY   IOSE-80pc; IOSE 80pc; IOSE80pc; IOSE-80 post-crisis
DR   TOKU-E; 4058
DR   Wikidata; Q54897905
RX   PubMed=15947112;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5546 ! IOSE-80
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   IOSE-80RZ
AC   CVCL_5548
SY   I-80RZ
DR   Wikidata; Q54897911
RX   PubMed=17266044;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13009; ZNF217.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5546 ! IOSE-80
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   iOSE-C10
AC   CVCL_C3HA
DR   Wikidata; Q114311739
RX   PubMed=17877616;
CC   Doubling time: ~56 hours (PubMed=17877616).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3H9 ! NOSE21R
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   iOSE-C21
AC   CVCL_C3HB
DR   Wikidata; Q114311740
RX   PubMed=17877616;
CC   Doubling time: ~56 hours (PubMed=17877616).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3H9 ! NOSE21R
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   iOSE-C9
AC   CVCL_C3HC
DR   Wikidata; Q114311741
RX   PubMed=17877616;
CC   Doubling time: ~56 hours (PubMed=17877616).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3H9 ! NOSE21R
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   IOSE11
AC   CVCL_0T68
SY   iOSE11; IOE11; Immortalized Ovarian Surface Epithelial cells 11
DR   GEO; GSM1663032
DR   GEO; GSM1663033
DR   GEO; GSM1663034
DR   GEO; GSM1663035
DR   GEO; GSM1663036
DR   GEO; GSM1663037
DR   GEO; GSM1663038
DR   GEO; GSM1663039
DR   GEO; GSM2889281
DR   GEO; GSM2889282
DR   GEO; GSM2889283
DR   GEO; GSM2889284
DR   GEO; GSM2889285
DR   GEO; GSM2889286
DR   Wikidata; Q54897912
RX   PubMed=20360942;
RX   PubMed=21859834;
RX   PubMed=25204737;
RX   PubMed=25804953;
RX   PubMed=29844388;
RX   PubMed=30487138;
RX   PubMed=34253763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Monteiro, Alvaro N.A.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 13,14
ST   D21S11: 29
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 11,15
ST   FGA: 20,22
ST   Penta D: 8,16
ST   Penta E: 14,18
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   IOSE11 p53R175H
AC   CVCL_C3MB
SY   IOSE11p53R175H
DR   Wikidata; Q116049587
RX   PubMed=34253763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg175His).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0T68 ! IOSE11
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   IOSE11CMYC
AC   CVCL_YZ54
SY   IOSE11+CMYC; IOE11CMYC
DR   Wikidata; Q98126776
RX   PubMed=20360942;
RX   PubMed=21859834;
RX   PubMed=25204737;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0T68 ! IOSE11
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   IOSE11CMYC.BRAF
AC   CVCL_YZ57
SY   IOE11CMYC.BRAF
DR   Wikidata; Q98126777
RX   PubMed=21859834;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1097; BRAF (Note=With p.Val600Glu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ54 ! IOSE11CMYC
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   IOSE11CMYC.KRAS
AC   CVCL_YZ58
SY   IOSE11+CMYC+KRAS; IOE11CMYC.KRAS
DR   Wikidata; Q98126778
RX   PubMed=21859834;
RX   PubMed=25204737;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ54 ! IOSE11CMYC
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   IOSE19
AC   CVCL_0T69
SY   IOE19; Immortalized Ovarian Surface Epithelial cells 19
DR   Wikidata; Q54897913
RX   PubMed=20360942;
RX   PubMed=21859834;
RX   PubMed=25204737;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   IOSE19CMYC
AC   CVCL_YZ55
SY   IOSE19+CMYC; IOE19CMYC
DR   Wikidata; Q98126781
RX   PubMed=20360942;
RX   PubMed=21859834;
RX   PubMed=25204737;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0T69 ! IOSE19
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   IOSE19CMYC.BRAF
AC   CVCL_YZ59
SY   IOE19CMYC.BRAF
DR   Wikidata; Q98126782
RX   PubMed=21859834;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1097; BRAF (Note=With p.Val600Glu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ55 ! IOSE19CMYC
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   IOSE19CMYC.KRAS
AC   CVCL_YZ60
SY   IOSE19+CMYC+KRAS; IOE19CMYC.KRAS
DR   Wikidata; Q98126783
RX   PubMed=21859834;
RX   PubMed=25204737;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ55 ! IOSE19CMYC
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   IOSE4
AC   CVCL_0T70
SY   iOSE4; IOE4; Immortalized Ovarian Surface Epithelial cells 4
DR   GEO; GSM1663040
DR   GEO; GSM1663041
DR   GEO; GSM1663042
DR   GEO; GSM1663043
DR   GEO; GSM1663044
DR   GEO; GSM1663045
DR   GEO; GSM1663046
DR   GEO; GSM1663047
DR   GEO; GSM1663048
DR   GEO; GSM1663049
DR   GEO; GSM1663050
DR   Wikidata; Q54897914
RX   PubMed=20360942;
RX   PubMed=25804953;
RX   PubMed=30487138;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   IOSE4CMYC
AC   CVCL_YZ56
SY   iOSE4CMYC; IOE4CMYC
DR   Wikidata; Q98126784
RX   PubMed=20360942;
RX   PubMed=30487138;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0T70 ! IOSE4
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   iOTC2
AC   CVCL_Y695
SY   A000054#2; A000054# 2; HPS0086
DR   SKIP; SKIP000034
DR   Wikidata; Q54897915
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L557 ! OTCD1TKB
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   iOTC4
AC   CVCL_T828
SY   A000054#4; A000054# 4; HPS0087
DR   RCB; HPS0087
DR   SKIP; SKIP000035
DR   SKIP; SKIP000270
DR   Wikidata; Q54897916
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L557 ! OTCD1TKB
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   iOTC6
AC   CVCL_Y696
SY   A000054#6; A000054# 6; HPS0088
DR   SKIP; SKIP000036
DR   Wikidata; Q54897917
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L557 ! OTCD1TKB
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   iOvCa241
AC   CVCL_VQ44
DR   cancercelllines; CVCL_VQ44
DR   Wikidata; Q94319943
RX   DOI=10.14288/1.0319145;
RX   PubMed=27822414;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=27822414).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 12,14
ST   D21S11: 32.2
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   iOvCa250
AC   CVCL_VQ45
DR   cancercelllines; CVCL_VQ45
DR   Wikidata; Q94319947
RX   DOI=10.14288/1.0319145;
RX   PubMed=27822414;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Homozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Met541Leu (c.1621A>C); ClinVar=VCV000041599; Zygosity=Heterozygous (PubMed=27822414).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 9,12
ST   D21S11: 29,31.2
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 16
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   IOWA-1T
AC   CVCL_6G16
DR   ATCC; CRL-3292
DR   IZSLER; BS TCL 248
DR   Wikidata; Q54897918
RX   PubMed=25326397;
CC   Population: Caucasian.
CC   Characteristics: Derived from IOWA-1 (a xenograft) after a single passage in nude mice.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-3292
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 9
//
ID   IOZCAS-Ha-1
AC   CVCL_Z303
SY   IOZCAS-Ha-I
DR   ICLDB; iozcas-ha-1
DR   Wikidata; Q54897919
RX   CelloPub=CLPUB00225;
RX   Patent=CN101070533B;
RX   PubMed=17316061;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.1690.
CC   Doubling time: 65.2 hours (CelloPub=CLPUB00225; Patent=CN101070533B).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Sixth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   IOZCAS-Ha-8
AC   CVCL_B3NE
DR   Wikidata; Q110432927
RX   Patent=CN112695010B;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.17690.
CC   Doubling time: 34.1 hours (Patent=CN112695010B).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   IOZCAS-Myse-1
AC   CVCL_B3ND
SY   Myse-1
DR   Wikidata; Q110432928
RX   Patent=CN112760277B;
RX   PubMed=34599689;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.17282.
CC   Doubling time: ~34 hours (PubMed=34599689).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   IOZCAS-Osfu-1
AC   CVCL_Z302
DR   Wikidata; Q54897920
RX   PubMed=24163160;
CC   Group: Insect cell line.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=93504; ! Ostrinia furnacalis (Asian corn borer)
SX   Female
AG   Pupal stage
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   IOZCAS-Sf-1
AC   CVCL_D3FD
DR   Wikidata; Q127382388
RX   Patent=WO2023131173A1;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.21014.
CC   Doubling time: 46.47 hours (Note=At 20th passage) (Patent=WO2023131173A1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   IOZCAS-Spex-12
AC   CVCL_9U10
SY   IOZCAS-Spex 12; OZCAS-Spex12
DR   ICLDB; iozcas-spex-12
DR   Wikidata; Q54897921
RX   Patent=CN103060258B;
RX   PubMed=22549336;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.4804.
CC   Doubling time: 71.06 hours (Patent=CN103060258B; PubMed=22549336).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Female
AG   Pupal stage
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   IOZCAS-Spex-II
AC   CVCL_0A49
DR   ICLDB; iozcas-spex-ii
DR   Wikidata; Q54897922
RX   CelloPub=CLPUB00225;
RX   CelloPub=CLPUB00304;
RX   PubMed=16376374;
RX   PubMed=19252957;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Spodoptera exigua multiple nuclear polyhedrosis virus (SeMNPV) (PubMed=16376374).
CC   Doubling time: 108.8 hours (CelloPub=CLPUB00225).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 12
//
ID   IOZCAS-Spex-II-A
AC   CVCL_0A50
SY   IOZCAS-Spex II-A; IOZCAS-Spex-IIA
DR   ICLDB; iozcas-spex-ii-0
DR   Wikidata; Q54897923
RX   PubMed=19252957;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Spodoptera exigua multiple nuclear polyhedrosis virus (SeMNPV) (PubMed=19252957).
CC   Doubling time: 28 hours (PubMed=19252957).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
HI   CVCL_0A49 ! IOZCAS-Spex-II
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 11
//
ID   IOZCAS-Spex-III
AC   CVCL_0A51
DR   ICLDB; iozcas-spex-iii
DR   Wikidata; Q54897924
RX   CelloPub=CLPUB00225;
RX   CelloPub=CLPUB00304;
RX   PubMed=16376374;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Spodoptera exigua multiple nuclear polyhedrosis virus (SeMNPV) (PubMed=16376374).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 11
//
ID   IOZCAS-Spex-IV
AC   CVCL_0A52
DR   ICLDB; iozcas-spex-iv
DR   Wikidata; Q54897925
RX   CelloPub=CLPUB00225;
RX   CelloPub=CLPUB00304;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IOZCAS-Spex-IX
AC   CVCL_B3NF
SY   IOZCAS-Spex IX
DR   Wikidata; Q110432929
RX   Patent=CN102807969B;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.4506.
CC   Doubling time: 70.09 hours (Patent=CN102807969B).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Female
AG   Pupal stage
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   IOZCAS-Spex-V
AC   CVCL_0A53
DR   ICLDB; iozcas-spex-v
DR   Wikidata; Q54897926
RX   CelloPub=CLPUB00225;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   IOZCAS-Spex-VI
AC   CVCL_0A54
DR   Wikidata; Q54897927
RX   CelloPub=CLPUB00225;
RX   CelloPub=CLPUB00304;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IOZCAS-Spex-VII
AC   CVCL_0A55
DR   ICLDB; iozcas-spex-vii
DR   Wikidata; Q54897928
RX   CelloPub=CLPUB00225;
RX   CelloPub=CLPUB00304;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IOZCAS-Spex-X
AC   CVCL_AV28
SY   IOZCAS-Spex X
DR   ICLDB; iozcas-spex-x
DR   Wikidata; Q54897929
RX   Patent=CN102807968B;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.4505.
CC   Doubling time: 56.98 hours (Patent=CN102807968B).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   IOZCAS-Spex-XI
AC   CVCL_AV29
SY   IOZCAS-Spex XI; OZCAS-Spex11
DR   ICLDB; iozcas-spex-xi
DR   Wikidata; Q54897930
RX   DOI=10.1111/j.1439-0418.2011.01689.x;
RX   Patent=CN103060258B;
CC   Group: Insect cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.4807.
CC   Doubling time: 81.7 hours (DOI=10.1111/j.1439-0418.2011.01689.x).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   IOZe001-A
AC   CVCL_VE05
SY   Q-CTS-hESC-1
DR   BioSamples; SAMEA112130219
DR   hPSCreg; IOZe001-A
DR   Wikidata; Q54897931
RX   PubMed=28506532;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Institute of Zoology, Chinese Academy of Sciences; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 6
//
ID   IOZe002-A
AC   CVCL_VE06
SY   Q-CTS-hESC-2
DR   BioSamples; SAMEA112130221
DR   hPSCreg; IOZe002-A
DR   Wikidata; Q54897932
RX   PubMed=28506532;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Institute of Zoology, Chinese Academy of Sciences; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=28506532
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D21S11: 30.2,32.2
ST   D3S1358: 16,18
ST   D5S818: 9,10
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 13,15
ST   Penta E: 10,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 6
//
ID   IP
AC   CVCL_F561
SY   23411; Extract 273
DR   IPD-IMGT/HLA; 11850
DR   Wikidata; Q54897934
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01:01,03:01:01; B*14:02,44:14; C*05:01,08:02; DPA1*01:CG,02:01; DPB1*04:AGGH,14:01; DQA1*01,03; DQB1*03:JV,06:09; DRB1*04:01,13:CZJ; DRB3*03:01; DRB4*01:NY (IPD-IMGT/HLA=11850).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   IP-1B
AC   CVCL_6485
DR   CLO; CLO_0006956
DR   ATCC; CRL-2162
DR   Wikidata; Q54897935
RX   PubMed=8496612;
CC   Characteristics: Derived from a SVEC4-10EHR1 induced ascite tumor (PubMed=8496612).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4395 ! SVEC4-10EHR1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   IP-B12
AC   CVCL_A6RU
DR   RCB; RCB2321
DR   Wikidata; Q107115463
RX   PubMed=12853701;
RX   PubMed=15144804;
CC   Characteristics: Secretes PTHrP.
CC   Doubling time: 17.9 hours (PubMed=12853701).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C64112; Carcinoma of the rat lung
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6RT ! IP-P
SX   Male
AG   2Y1M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   iP-MSC D2 cA
AC   CVCL_A9PD
SY   D2-cA; iP-MSC donor 2 clone A
DR   Wikidata; Q102114230
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9PE ! iP-MSC D2 cB
OI   CVCL_A9PF ! iP-MSC D2 cC
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iP-MSC D2 cB
AC   CVCL_A9PE
SY   D2-cB; iP-MSC donor 2 clone B
DR   Wikidata; Q102114231
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9PD ! iP-MSC D2 cA
OI   CVCL_A9PF ! iP-MSC D2 cC
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iP-MSC D2 cC
AC   CVCL_A9PF
SY   D2-cC; iP-MSC donor 2 clone C
DR   Wikidata; Q102114233
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9PD ! iP-MSC D2 cA
OI   CVCL_A9PE ! iP-MSC D2 cB
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iP-MSC D4 cA
AC   CVCL_A9PJ
SY   D4-cA; iP-MSC donor 4 clone A
DR   Wikidata; Q102114234
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S59 ! UKKi006-A
OI   CVCL_A9PK ! iP-MSC D4 cC
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iP-MSC D4 cC
AC   CVCL_A9PK
SY   D4-cC; iP-MSC donor 4 clone C
DR   Wikidata; Q102114235
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S59 ! UKKi006-A
OI   CVCL_A9PJ ! iP-MSC D4 cA
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iP-MSC D5 cA
AC   CVCL_A9PG
SY   D5-cA; iP-MSC donor 5 clone A
DR   Wikidata; Q102114236
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9PH ! iP-MSC D5 cB
OI   CVCL_A9PI ! iP-MSC D5 cC
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iP-MSC D5 cB
AC   CVCL_A9PH
SY   D5-cB; iP-MSC donor 5 clone B
DR   Wikidata; Q102114237
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9PG ! iP-MSC D5 cA
OI   CVCL_A9PI ! iP-MSC D5 cC
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   iP-MSC D5 cC
AC   CVCL_A9PI
SY   D5-cC; iP-MSC donor 5 clone C
DR   Wikidata; Q102114238
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9PG ! iP-MSC D5 cA
OI   CVCL_A9PH ! iP-MSC D5 cB
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   IP-P
AC   CVCL_A6RT
DR   Wikidata; Q107115464
RX   PubMed=12853701;
CC   Characteristics: Established from the transplantable tumor IP.
CC   Doubling time: 17.5 hours (PubMed=12853701).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C64112; Carcinoma of the rat lung
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2Y1M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   IP15
AC   CVCL_Y655
DR   Wikidata; Q54897936
RX   PubMed=12164867;
RX   PubMed=17180447;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, cortex; UBERON=UBERON_0001225.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   IP1PV
AC   CVCL_RU31
SY   Incontinentia Pigmenti 1 PaVia
DR   CLO; CLO_0006957
DR   CLDB; cl2899
DR   Wikidata; Q54897937
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   IP2-E4
AC   CVCL_6486
DR   CLO; CLO_0006958
DR   ATCC; CRL-2171
DR   Wikidata; Q54897938
RX   PubMed=8496612;
CC   Characteristics: Derived from a SVEC4-10EHR1 induced ascite tumor (PubMed=8496612).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4395 ! SVEC4-10EHR1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   iP2/14
AC   CVCL_JL77
DR   Wikidata; Q54897939
RX   PubMed=28395807;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   IP28
AC   CVCL_E2VK
RX   PubMed=7590790;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   IP2PV
AC   CVCL_RU32
SY   Incontinentia Pigmenti 2 PaVia
DR   CLO; CLO_0006959
DR   CLDB; cl2900
DR   Wikidata; Q54897940
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   IP4
AC   CVCL_B7IN
DR   Wikidata; Q112929869
RX   PubMed=34429452;
CC   Doubling time: 55 hours (PubMed=34429452).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro772_His773insProTyrAsnPro (P772_H773insPYNP); Zygosity=Heterozygous (PubMed=34429452).
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D16S539: 12,14
ST   D18S51: 19,21
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D6S1043: 13
ST   D8S1179: 10,15
ST   vWA: 14,17
DI   NCIt; C6871; Sinonasal inverted papilloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   IP4/K4DT
AC   CVCL_B7IP
DR   Wikidata; Q112929870
RX   PubMed=34429452;
CC   Doubling time: 51 hours (PubMed=34429452).
CC   Karyotypic information: 46,XY [24/50]; 46,XY,add(8)(q24) [26/50] (PubMed=34429452).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro772_His773insProTyrAsnPro (P772_H773insPYNP); Zygosity=Heterozygous (PubMed=34429452).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D16S539: 12,14
ST   D18S51: 19,21
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D6S1043: 13
ST   D8S1179: 10,15
ST   vWA: 14,17
DI   NCIt; C6871; Sinonasal inverted papilloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7IN ! IP4
SX   Male
AG   68Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   iPAI-005-B
AC   CVCL_JL79
DR   Wikidata; Q54897941
RX   PubMed=28395799;
CC   From: Department of Medicine and Cardiovascular Center, Medical College of Wisconsin; Milwaukee; USA.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   iPAI-015-2-F
AC   CVCL_JL78
DR   Wikidata; Q54897942
RX   PubMed=28395801;
CC   From: Department of Medicine and Cardiovascular Center, Medical College of Wisconsin; Milwaukee; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8583; SERPINE1; Simple; c.4977insTA (2-BP INS,4977TA); ClinVar=VCV000013571; Zygosity=Heterozygous (PubMed=28395801).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C133884; Plasminogen activator inhibitor-1 deficiency
DI   ORDO; Orphanet_465; Congenital plasminogen activator inhibitor type 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   iPAI-026-C-K
AC   CVCL_A4GV
DR   Wikidata; Q105509679
RX   PubMed=27934602;
CC   From: Department of Medicine and Cardiovascular Center, Medical College of Wisconsin; Milwaukee; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8583; SERPINE1; Simple; c.4977insTA (2-BP INS,4977TA); ClinVar=VCV000013571; Zygosity=Homozygous (PubMed=27934602).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C133884; Plasminogen activator inhibitor-1 deficiency
DI   ORDO; Orphanet_465; Congenital plasminogen activator inhibitor type 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   IPAM 3C10
AC   CVCL_C5BA
DR   Wikidata; Q116049588
RX   PubMed=12088830;
RX   PubMed=34737324;
CC   Virology: Persistently infected with porcine circovirus 1 (PCV1) (PubMed=34737324).
CC   Doubling time: 68 hours (PubMed=12088830).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_C5BB ! IPAM 3C8
OI   CVCL_0F12 ! IPAM 3D4
OI   CVCL_C5BC ! IPAM 3E8
OI   CVCL_C5BD ! IPAM 3F6
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   IPAM 3C8
AC   CVCL_C5BB
DR   Wikidata; Q116049589
RX   PubMed=12088830;
RX   PubMed=34737324;
CC   Virology: Persistently infected with porcine circovirus 1 (PCV1) (PubMed=34737324).
CC   Doubling time: 88 hours (PubMed=12088830).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_C5BA ! IPAM 3C10
OI   CVCL_0F12 ! IPAM 3D4
OI   CVCL_C5BC ! IPAM 3E8
OI   CVCL_C5BD ! IPAM 3F6
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   IPAM 3D4
AC   CVCL_0F12
DR   Wikidata; Q54585409
RX   PubMed=12088830;
CC   Doubling time: 25.5 hours (PubMed=12088830).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_C5BA ! IPAM 3C10
OI   CVCL_C5BB ! IPAM 3C8
OI   CVCL_C5BC ! IPAM 3E8
OI   CVCL_C5BD ! IPAM 3F6
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   IPAM 3D4/2
AC   CVCL_0F13
SY   3D4/2
DR   AddexBio; T0016001/4918
DR   ATCC; CRL-2845
DR   Wikidata; Q54585411
RX   PubMed=12088830;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0F12 ! IPAM 3D4
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   IPAM 3D4/21
AC   CVCL_0F14
SY   3D4/21; IPAM-WT
DR   BTO; BTO_0006201
DR   ATCC; CRL-2843
DR   Ubigene; YC-C041
DR   Wikidata; Q54585413
RX   PubMed=12088830;
RX   PubMed=28871180;
RX   PubMed=30241566;
CC   Characteristics: SLA gene typing is SLA-1:04:01:01; SLA-2:04:02:01; SLA-DQA:02:03; SLA-DQB1:02:01 and SLA-DRB1:05:01 (PubMed=30241566).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0F12 ! IPAM 3D4
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 18
//
ID   IPAM 3D4/21/CD163
AC   CVCL_ZE11
SY   3D4/21/CD163
DR   Wikidata; Q98125390
RX   PubMed=31493424;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus type 2 (PRRSV-2) (PubMed=31493424).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0F14 ! IPAM 3D4/21
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 13
//
ID   IPAM 3D4/31
AC   CVCL_0F15
SY   3D4/31
DR   ATCC; CRL-2844
DR   GEO; GSM1967249
DR   GEO; GSM1967250
DR   GEO; GSM1967251
DR   GEO; GSM1967252
DR   GEO; GSM1967253
DR   GEO; GSM1967254
DR   GEO; GSM1967255
DR   GEO; GSM1967256
DR   GEO; GSM1967257
DR   GEO; GSM1967258
DR   GEO; GSM1967259
DR   GEO; GSM1967260
DR   GEO; GSM1967261
DR   GEO; GSM1967262
DR   GEO; GSM1967263
DR   Wikidata; Q54585414
RX   PubMed=12088830;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0F12 ! IPAM 3D4
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   IPAM 3E8
AC   CVCL_C5BC
DR   Wikidata; Q116049590
RX   PubMed=12088830;
RX   PubMed=34737324;
CC   Virology: Persistently infected with porcine circovirus 1 (PCV1) (PubMed=34737324).
CC   Doubling time: 70 hours (PubMed=12088830).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_C5BA ! IPAM 3C10
OI   CVCL_C5BB ! IPAM 3C8
OI   CVCL_0F12 ! IPAM 3D4
OI   CVCL_C5BD ! IPAM 3F6
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   IPAM 3F6
AC   CVCL_C5BD
DR   Wikidata; Q116049591
RX   PubMed=34737324;
CC   Virology: Persistently infected with porcine circovirus 1 (PCV1) (PubMed=34737324).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_C5BA ! IPAM 3C10
OI   CVCL_C5BB ! IPAM 3C8
OI   CVCL_0F12 ! IPAM 3D4
OI   CVCL_C5BC ! IPAM 3E8
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   iPAM303
AC   CVCL_DX85
SY   immortalized Porcine Alveolar Macrophage 303
DR   ABM; T0754
DR   Wikidata; Q127382389
RX   PubMed=30241566;
CC   Characteristics: SLA gene typing is SLA-1:08:01,08:10; SLA-2:05:02,12:01; SLA-DQA:01:06,02:01; SLA-DQB1:02:02,07:01 and SLA-DRB1:04:02,06:02 (PubMed=30241566).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   10W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   iPAM61
AC   CVCL_DX86
SY   immortalized Porcine Alveolar Macrophage 61
DR   ABM; T0755
DR   Wikidata; Q127382390
RX   PubMed=30241566;
CC   Characteristics: SLA gene typing is SLA-1:04:02; SLA-2:08:01; SLA-DQA:02:01,03:03; SLA-DQB1:02:01,09:01 and SLA-DRB1:02:01,13:01 (PubMed=30241566).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Yorkshire; VBO=VBO_0001212.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   10W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   IPAT-1
AC   CVCL_0G01
DR   CGH-DB; 9032-4
DR   Wikidata; Q54897943
RX   PubMed=9738977;
RX   PubMed=10570904;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   IPC-164
AC   CVCL_B5LK
SY   IPC 164
DR   Wikidata; Q111733514
RX   PubMed=2337917;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5LH ! IPC-167
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   IPC-167
AC   CVCL_B5LH
SY   IPC 167
DR   Wikidata; Q111733515
RX   PubMed=2337917;
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5LK ! IPC-164
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   IPC-209
AC   CVCL_M213
SY   IPC 209
DR   Wikidata; Q54897944
RX   PubMed=8325707;
CC   Doubling time: 168 hours (PubMed=8325707).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   IPC-211
AC   CVCL_M215
SY   IPC 211
DR   Wikidata; Q54897945
RX   PubMed=8325707;
CC   Doubling time: 86 hours (PubMed=8325707).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   IPC-227E
AC   CVCL_M216
SY   IPC 227e
DR   Wikidata; Q54897946
RX   PubMed=8325707;
CC   Doubling time: 336 hours (PubMed=8325707).
CC   Misspelling: IPC-217E; Note=In Cellosaurus releases 6 to 25.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M217 ! IPC-227F
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   IPC-227F
AC   CVCL_M217
SY   IPC 227F
DR   Wikidata; Q54897947
RX   PubMed=8325707;
CC   Doubling time: 72 hours (PubMed=8325707).
CC   Misspelling: IPC-217F; Note=In Cellosaurus releases 6 to 25.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M216 ! IPC-227E
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   IPC-281
AC   CVCL_M218
SY   IPC 281
DR   Wikidata; Q54897948
RX   PubMed=8325707;
CC   Doubling time: 432 hours (PubMed=8325707).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   IPC-285
AC   CVCL_M214
SY   IPC 285
DR   Wikidata; Q54897949
RX   PubMed=8325707;
CC   Doubling time: 92 hours (PubMed=8325707).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   IPC-292
AC   CVCL_M219
SY   IPC 292
DR   Wikidata; Q54897950
RX   PubMed=8325707;
CC   Doubling time: 133 hours (PubMed=8325707).
DI   NCIt; C4550; Conjunctival melanoma
DI   ORDO; Orphanet_617910; Conjunctival malignant melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 7
//
ID   IPC-298
AC   CVCL_1307
SY   IPC 298; IPC298
DR   BTO; BTO_0005774
DR   CLO; CLO_0006961
DR   EFO; EFO_0006447
DR   CLDB; cl2901
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 413
DR   BioSample; SAMN03471908
DR   BioSample; SAMN10988211
DR   cancercelllines; CVCL_1307
DR   Cell_Model_Passport; SIDM01059
DR   ChEMBL-Cells; CHEMBL3308797
DR   ChEMBL-Targets; CHEMBL1075480
DR   Cosmic; 907171
DR   Cosmic; 928731
DR   Cosmic-CLP; 907171
DR   DepMap; ACH-000915
DR   DSMZ; ACC-251
DR   DSMZCellDive; ACC-251
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907171
DR   GEO; GSM887163
DR   GEO; GSM888235
DR   GEO; GSM1669940
DR   IARC_TP53; 21397
DR   LiGeA; CCLE_533
DR   LINCS_LDP; LCL-1250
DR   PharmacoDB; IPC298_666_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1307
DR   PubChem_Cell_line; CVCL_1307
DR   Wikidata; Q54897951
RX   PubMed=8325707;
RX   PubMed=9354451;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22383533;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 34 hours (PubMed=8325707); ~30 hours (DSMZ=ACC-251).
CC   HLA typing: A*03:01,24:02; B*07:02,35:02; C*04:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg99Pro (c.296G>C); ClinVar=VCV000491572; Zygosity=Homozygous (PubMed=9354451; Cosmic-CLP=907171; DepMap=ACH-000915).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=22383533; Cosmic-CLP=907171; DepMap=ACH-000915).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=907171; DepMap=ACH-000915).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.17%; Native American=0.2%; East Asian, North=1.84%; East Asian, South=0%; South Asian=0.84%; European, North=52.05%; European, South=44.9% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=907171; DSMZ=ACC-251; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,14
ST   D18S51: 13 (PubMed=25877200)
ST   D18S51: 13,17 (DSMZ=ACC-251)
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   Penta D: 11,14
ST   Penta E: 5,10
ST   TH01: 6,9
ST   TPOX: 10,12
ST   vWA: 18,22
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   IPC-366
AC   CVCL_0Q77
DR   ABM; T8202
DR   Wikidata; Q54897958
RX   PubMed=25807360;
RX   PubMed=26495931;
RX   PubMed=27146723;
CC   Characteristics: Triple negative (ER-, PR-, ERBB2-) inflammatory mammary carcinoma cell line.
CC   Doubling time: ~24 hours (PubMed=25807360).
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   IPC-48
AC   CVCL_WG89
SY   IPC 48; Mel-IPC-48
DR   Wikidata; Q94320442
RX   CelloPub=CLPUB00487;
RX   DOI=10.1007/BF00199208;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 4
//
ID   IPC-501
AC   CVCL_GR48
SY   IPC 501
DR   Wikidata; Q54897959
RX   PubMed=405430;
RX   PubMed=6929009;
CC   Characteristics: Pigmented.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR49 ! IPC-502
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   IPC-502
AC   CVCL_GR49
SY   IPC 502
DR   Wikidata; Q54897961
RX   PubMed=405430;
RX   PubMed=6929009;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GR48 ! IPC-501
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   IPC-clone 13
AC   CVCL_2H29
SY   Immortalized Pituitary Cells-clone 13
DR   Wikidata; Q54897962
RX   PubMed=26086106;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   IPC-clone 2
AC   CVCL_2H30
SY   Immortalized Pituitary Cells-clone 2
DR   Wikidata; Q54897963
RX   PubMed=26086106;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   IPCASi001-A
AC   CVCL_C6TT
DR   BioSamples; SAMEA111493207
DR   hPSCreg; IPCASi001-A
DR   Wikidata; Q117704534
RX   PubMed=36502620;
CC   From: Institute of Psychology, Chinese Academy of Sciences; Beijing; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   iPCP
AC   CVCL_A1YI
SY   immortal Papillary CranioPharyngioma cell line
DR   Wikidata; Q105509682
RX   PubMed=33044631;
CC   Population: Chinese.
CC   Doubling time: 23.5 hours (PubMed=33044631).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=33044631).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4725; Papillary craniopharyngioma
DI   ORDO; Orphanet_54595; Craniopharyngioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   iPD-C1
AC   CVCL_A4MQ
DR   SKIP; SKIP003176
DR   Wikidata; Q105509684
RX   PubMed=29513666;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; chr12:g.40197315A>G; dbSNP=rs1491923; Zygosity=Unspecified (PubMed=29513666).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   iPD-C2
AC   CVCL_A4MR
DR   SKIP; SKIP003177
DR   Wikidata; Q105509687
RX   PubMed=29513666;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; chr12:g.40197315A>G; dbSNP=rs1491923; Zygosity=Unspecified (PubMed=29513666).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   iPD-T1
AC   CVCL_A4MN
DR   SKIP; SKIP003174
DR   Wikidata; Q105509690
RX   PubMed=29513666;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; chr12:g.40197315A; dbSNP=rs1491923; Zygosity=Unspecified (PubMed=29513666).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   iPD-T2
AC   CVCL_A4MP
DR   SKIP; SKIP003175
DR   Wikidata; Q105509693
RX   PubMed=29513666;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; chr12:g.40197315A; dbSNP=rs1491923; Zygosity=Unspecified (PubMed=29513666).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   IPDDC-A2
AC   CVCL_7169
SY   IPDDCA2
DR   BioSample; SAMN03152016
DR   ECACC; 99050529
DR   Wikidata; Q54897964
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00320.
CC   Discontinued: ECACC; 99050529; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   IPEC
AC   CVCL_6C42
DR   Wikidata; Q54897966
RX   PubMed=22193509;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of pig origin but found to be a bovine cell line (PubMed=22193509).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 8
//
ID   IPEC-1
AC   CVCL_2245
SY   IPEC1; Intestinal Porcine Epithelial Cell line-1
DR   BTO; BTO_0006403
DR   DSMZ; ACC-705
DR   DSMZCellDive; ACC-705
DR   GEO; GSM1646395
DR   GEO; GSM1646396
DR   GEO; GSM1646397
DR   Wikidata; Q54897968
RX   DOI=10.1016/S0016-5085(89)80002-2;
RX   PubMed=8770040;
RX   PubMed=22193509;
RX   PubMed=26147118;
CC   Doubling time: ~30 hours (DSMZ=ACC-705).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   IPEC-J2
AC   CVCL_2246
SY   IPECJ2; Intestinal Porcine Epithelial Cell line-J2
DR   BTO; BTO_0006402
DR   DSMZ; ACC-701
DR   DSMZCellDive; ACC-701
DR   GEO; GSM1646398
DR   GEO; GSM1646399
DR   GEO; GSM1646400
DR   IZSLER; BS CL 205
DR   Ubigene; YC-C072
DR   Wikidata; Q54897969
RX   DOI=10.1016/S0016-5085(89)80002-2;
RX   DOI=10.1155/2013/980651;
RX   PubMed=16215741;
RX   PubMed=21626283;
RX   PubMed=22074860;
RX   PubMed=22193509;
RX   PubMed=24260272;
RX   PubMed=25407967;
RX   PubMed=26147118;
RX   PubMed=26651362;
RX   PubMed=26975772;
RX   PubMed=29787056;
RX   PubMed=32708885;
CC   Characteristics: Undergoes a process of spontaneous differentiation that leads to the formation of a polarized monolayer with low or high transepithelial electrical resistance (TEER), depending on the type of serum added to the culture medium, within 1-2 weeks (PubMed=29787056).
CC   Virology: Susceptible to infection by porcine circovirus 2 (PCV2) (PubMed=25407967).
CC   Doubling time: ~40-60 hours (DSMZ=ACC-701).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   IPEC-J2 MDR1
AC   CVCL_6C41
SY   iP-gp
DR   Wikidata; Q54897970
RX   PubMed=26651362;
RX   PubMed=29146563;
CC   Characteristics: Can be used to screen drug compounds for interactions with human efflux pump P-glycoprotein (P-gp) (PubMed=26651362).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   IPEC-J2 rMDR1a
AC   CVCL_A9M7
DR   Wikidata; Q102114239
RX   PubMed=32708885;
CC   Characteristics: Can be used to screen drug compounds for interactions with rat efflux pump P-glycoprotein (P-gp).
CC   Genetic integration: Method=Transfection; Gene=RGD; 619951; Abcb1a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   IPEC-J2-3
AC   CVCL_6C22
DR   Wikidata; Q54897971
RX   PubMed=20444515;
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   IPEC-J2-9
AC   CVCL_6C23
DR   Wikidata; Q54897972
RX   PubMed=20444515;
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   IPEC-J2-EGFP
AC   CVCL_C8W6
DR   Ubigene; YC-C072-EGFP-P
DR   Wikidata; Q123032719
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   IPFLS
AC   CVCL_C7KU
SY   Immortalized Primate Fetal Liver Stem cells
DR   Wikidata; Q117704535
RX   PubMed=11904425;
CC   Group: Non-human primate cell line.
CC   Doubling time: ~6 days (PubMed=11904425).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stem cell; CL=CL_0002195.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   89FD
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   IPH-926
AC   CVCL_A625
SY   IPH926
DR   cancercelllines; CVCL_A625
DR   Cosmic; 1179081
DR   DSMZ; ACC-827
DR   DSMZCellDive; ACC-827
DR   GEO; GSE28089
DR   Wikidata; Q54897973
RX   PubMed=19191266;
RX   PubMed=22118813;
RX   PubMed=22945757;
RX   PubMed=24344720;
RX   PubMed=25757734;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: Expresses high level of ABCB1 mRNA (PubMed=22118813).
CC   Doubling time: ~2 weeks (PubMed=19191266); 200 hours (Note=In the first 1-2 weeks), 80-120 hours (Note=After 2 weeks) (DSMZ=ACC-827).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Heterozygous (PubMed=19191266).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Val82fs*13 (c.240_241insGGTG); Zygosity=Heterozygous (PubMed=19191266).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (PubMed=22945757).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-827; PubMed=22118813
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,22
ST   D19S433: 16
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6 (DSMZ=ACC-827)
ST   TH01: 7 (PubMed=22118813)
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   iPHIS1
AC   CVCL_F1C0
RX   PubMed=34788122;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9718; ! Pusa hispida (Ringed seal)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   IPI-1
AC   CVCL_3825
SY   Immortal Pig Intestinal-1
DR   CLO; CLO_0006962
DR   CLDB; cl2902
DR   ECACC; 93100621
DR   Wikidata; Q54897974
RX   PubMed=8269973;
CC   Doubling time: 30 hours (PubMed=8269973).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_E3ET ! IPI-2
SX   Male
AG   3-4Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   IPI-2
AC   CVCL_E3ET
SY   Immortal Pig Intestinal-2
RX   PubMed=8269973;
CC   Doubling time: 24 hours (PubMed=8269973).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_3825 ! IPI-1
SX   Male
AG   3-4Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   IPI-2I
AC   CVCL_3826
SY   Immortal Pig Intestinal-2I
DR   CLO; CLO_0006963
DR   CLDB; cl2903
DR   ECACC; 93100622
DR   Wikidata; Q54897975
RX   PubMed=8269973;
CC   Doubling time: 24 hours (PubMed=8269973).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_E3ET ! IPI-2
SX   Male
AG   3-4Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   IPi001-A
AC   CVCL_C1QC
SY   AFC-iPSC-Healthy-001; iPSC-healthy-AFC-001
DR   BioSamples; SAMEA10401758
DR   hPSCreg; IPi001-A
DR   Wikidata; Q114311742
RX   PubMed=38387169;
CC   From: Institut Pasteur; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0G4 ! IPi001-B
OI   CVCL_D0G5 ! IPi001-C
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   IPi001-B
AC   CVCL_D0G4
SY   AFC-iPSC-Healthy-002; iPSC-healthy-AFC-002
DR   BioSamples; SAMEA114060446
DR   hPSCreg; IPi001-B
DR   Wikidata; Q123032720
RX   PubMed=38387169;
CC   From: Institut Pasteur; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1QC ! IPi001-A
OI   CVCL_D0G5 ! IPi001-C
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   IPi001-C
AC   CVCL_D0G5
SY   AFC-iPSC-Healthy-003; iPSC-healthy-AFC-003
DR   BioSamples; SAMEA114061286
DR   hPSCreg; IPi001-C
DR   Wikidata; Q123032721
RX   PubMed=38387169;
CC   From: Institut Pasteur; Paris; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1QC ! IPi001-A
OI   CVCL_D0G4 ! IPi001-B
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   IPi002-A
AC   CVCL_D6P8
SY   iPSC-MARCH-AFC-001
DR   BioSamples; SAMEA115370015
DR   hPSCreg; IPi002-A
RX   PubMed=39447316;
CC   From: Institut Pasteur; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:1161; CEP55; Simple; p.Ser425Ter (c.1274C>A); ClinVar=VCV000437874; Zygosity=Homozygous (PubMed=39447316).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C206523; Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly
DI   ORDO; Orphanet_500135; Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6P9 ! IPi002-B
OI   CVCL_D6PA ! IPi002-C
SX   Male
AG   15FW
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   IPi002-B
AC   CVCL_D6P9
SY   iPSC-MARCH-AFC-002
DR   BioSamples; SAMEA115370022
DR   hPSCreg; IPi002-B
RX   PubMed=39447316;
CC   From: Institut Pasteur; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:1161; CEP55; Simple; p.Ser425Ter (c.1274C>A); ClinVar=VCV000437874; Zygosity=Homozygous (PubMed=39447316).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C206523; Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly
DI   ORDO; Orphanet_500135; Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6P8 ! IPi002-A
OI   CVCL_D6PA ! IPi002-C
SX   Male
AG   15FW
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   IPi002-C
AC   CVCL_D6PA
SY   iPSC-MARCH-AFC-003
DR   BioSamples; SAMEA115370299
DR   hPSCreg; IPi002-C
RX   PubMed=39447316;
CC   From: Institut Pasteur; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:1161; CEP55; Simple; p.Ser425Ter (c.1274C>A); ClinVar=VCV000437874; Zygosity=Homozygous (PubMed=39447316).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C206523; Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly
DI   ORDO; Orphanet_500135; Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6P8 ! IPi002-A
OI   CVCL_D6P9 ! IPi002-B
SX   Male
AG   15FW
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   IPKM
AC   CVCL_E7C1
SY   Immortalized Porcine Kidney-derived Macrophage
RX   PubMed=28871285;
RX   PubMed=33637799;
RX   PubMed=40003039;
WW   Info; NARO; -; https://www.naro.go.jp/english/topics/laboratory/niah/138816.html
CC   From: Institute of Agrobiological Sciences, National Agriculture and Food Research; Tsukuba; Japan.
CC   Virology: Highly susceptible to infection by African swine fever virus (ASFV). Supports the propagation of both virulent and cell-adapted isolates of ASFV (PubMed=33637799).
CC   Doubling time: ~4 days (PubMed=28871285).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:93883; Pig TERT.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   6D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IPLB-AiE1611S
AC   CVCL_Z441
SY   AiE1611S
DR   ICLDB; iplb-aie1611s
DR   Wikidata; Q54897976
RX   PubMed=18395741;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=56364; ! Agrotis ipsilon (Black cutworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-AiE1611T
AC   CVCL_Z442
SY   AiE1611T
DR   ICLDB; iplb-aie1611t
DR   Wikidata; Q54897977
RX   PubMed=18395741;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=56364; ! Agrotis ipsilon (Black cutworm moth)
HI   CVCL_Z441 ! IPLB-AiE1611S
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-AiEd6T
AC   CVCL_Z443
SY   AiEd6T
DR   ICLDB; iplb-aied6t
DR   Wikidata; Q54897978
RX   PubMed=18395741;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=56364; ! Agrotis ipsilon (Black cutworm moth)
HI   CVCL_Z442 ! IPLB-AiE1611T
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-CPB2
AC   CVCL_Z435
DR   ICLDB; iplb-cpb2
DR   Wikidata; Q54897979
RX   PubMed=7735572;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IPLB-DnEa3
AC   CVCL_Z444
SY   IPLB DnEa3; IPLB-DnEA3
DR   ICLDB; iplb-dnea3
DR   Wikidata; Q54897980
RX   DOI=10.3954/1523-5475-25.2.81;
RX   PubMed=18395741;
CC   Group: Insect cell line.
CC   Misspelling: IPLB-DmEA3; PubMed=18395741.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1140737; ! Diaphania nitidalis (Pickleworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   IPLB-DnEa4
AC   CVCL_AV83
DR   ICLDB; iplb-dnea4
DR   Wikidata; Q54897982
RX   DOI=10.3954/1523-5475-25.2.81;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1140737; ! Diaphania nitidalis (Pickleworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   IPLB-DnEs1
AC   CVCL_Z445
SY   IPLB DnEs1; IPLB-DnES1
DR   ICLDB; iplb-dnes1
DR   Wikidata; Q54897983
RX   DOI=10.3954/1523-5475-25.2.81;
RX   PubMed=18395741;
CC   Group: Insect cell line.
CC   Misspelling: IPLB-DmES1; PubMed=18395741.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1140737; ! Diaphania nitidalis (Pickleworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   IPLB-DnEs2
AC   CVCL_AV84
DR   ICLDB; iplb-dnes2
DR   Wikidata; Q54897984
RX   DOI=10.3954/1523-5475-25.2.81;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1140737; ! Diaphania nitidalis (Pickleworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   IPLB-DnEt4
AC   CVCL_C2RB
DR   ICLDB; iplb-dnet4
DR   Wikidata; Q114311743
CC   Group: Insect cell line.
CC   From: Lynn, Dwight E.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1140737; ! Diaphania nitidalis (Pickleworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IPLB-DU102 clone A4
AC   CVCL_C2SQ
DR   ICLDB; iplb-du102-clone-a4
DR   Wikidata; Q114311744
CC   Group: Insect cell line.
CC   From: Lynn, Dwight E.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50387; ! Diabrotica undecimpunctata (Spotted cucumber beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IPLB-DU182A
AC   CVCL_Z376
SY   DU182A
DR   ICLDB; iplb-du182a
DR   Wikidata; Q54897985
RX   DOI=10.1007/BF02619580;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/ARSUserFiles/3489/DU182A-ExC.pdf
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50387; ! Diabrotica undecimpunctata (Spotted cucumber beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IPLB-DU182E
AC   CVCL_Z377
DR   ICLDB; iplb-du182e
DR   Wikidata; Q54897986
RX   DOI=10.1007/BF02619580;
RX   PubMed=10475266;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50387; ! Diabrotica undecimpunctata (Spotted cucumber beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-Ek-x4S
AC   CVCL_Z098
SY   IPLB-Ekx4S; Ek-x4S; IPLB-Ephestia kuehniella-x4 Suspension; IPLB-Ek-x4V; IPLB-Ekx4-V; IPLB-Ekx4V; Ek-x4V; IPLB-Ephestia kuehniella-x4 Vesicle
DR   ICLDB; iplb-ekx4-s
DR   Wikidata; Q54897988
RX   PubMed=15861225;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/SP2UserFiles/person/3489/Ekx4S.pdf
CC   Group: Insect cell line.
CC   Caution: This cell line was originally called IPLB-Ek-x4V because it grew as vesicles (thus the "V") but subsequently changed their morphology to grow as small aggregates or chains of cells growing in suspension (thus the "S").
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=40079; ! Ephestia kuehniella (Mediterranean flour moth)
OI   CVCL_Z097 ! IPLB-Ek-x4T
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IPLB-Ek-x4T
AC   CVCL_Z097
SY   IPLB-Ekx4-T; IPLB-Ekx4T; Ek-x4T; IPLB-Ephestia kuehniella-x4 Trypsin
DR   ICLDB; iplb-ekx4-t
DR   Wikidata; Q54897987
RX   PubMed=15861225;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/sp2userfiles/person/3489/ekx4t.pdf
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=40079; ! Ephestia kuehniella (Mediterranean flour moth)
OI   CVCL_Z098 ! IPLB-Ek-x4S
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IPLB-HvE1a
AC   CVCL_Z110
SY   IPLB-HvE1A; IPLB HvE1A; HvE1a
DR   ICLDB; iplb-hve1a
DR   Wikidata; Q54897989
RX   PubMed=9784351;
RX   PubMed=12623313;
RX   PubMed=15926859;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
OI   CVCL_Z112 ! IPLB-HvE1s
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HvE1a-lt
AC   CVCL_Z111
DR   ICLDB; iplb-hve1a-lt
DR   Wikidata; Q54897990
RX   PubMed=9784351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
HI   CVCL_Z110 ! IPLB-HvE1a
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HvE1s
AC   CVCL_Z112
SY   HvE1s
DR   ICLDB; iplb-hve1s
DR   Wikidata; Q54897991
RX   PubMed=9784351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
OI   CVCL_Z110 ! IPLB-HvE1a
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HvE6a
AC   CVCL_Z113
SY   IPLB-HvE6A; IPLB HvE6A; HvE6a
DR   ICLDB; iplb-hve6a
DR   Wikidata; Q54897992
RX   PubMed=9784351;
RX   PubMed=12623313;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/SP2UserFiles/person/3489/HvE6a.pdf
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
OI   CVCL_Z574 ! IPLB-HvE6s
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IPLB-HvE6a-lt
AC   CVCL_Z114
DR   ICLDB; iplb-hve6a-lt
DR   Wikidata; Q54897993
RX   PubMed=9784351;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
HI   CVCL_Z113 ! IPLB-HvE6a
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HvE6s
AC   CVCL_Z574
DR   ICLDB; iplb-hve6s
DR   Wikidata; Q54897994
RX   PubMed=9784351;
RX   PubMed=12623313;
RX   PubMed=15926859;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
OI   CVCL_Z113 ! IPLB-HvE6a
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HvT1
AC   CVCL_Z101
SY   HvT1
DR   ICLDB; iplb-hvt1
DR   Wikidata; Q54897995
RX   CelloPub=CLPUB00162;
RX   PubMed=1367489;
RX   PubMed=10475266;
RX   PubMed=12623313;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/SP2UserFiles/person/3489/hvt1.pdf
CC   Group: Insect cell line.
CC   Derived from site: In situ; Testicular sheath; UBERON=UBERON_8480041.
OX   NCBI_TaxID=7102; ! Heliothis virescens (Tobacco budworm moth)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IPLB-HZ-1074
AC   CVCL_AV49
DR   ICLDB; iplb-hz-1074
DR   Wikidata; Q54897996
RX   DOI=10.1007/BF02796325;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   IPLB-HZ-1075
AC   CVCL_Z209
SY   IPLB-Hz-1075; IPLB-HZ 1075; IPLB-HZ1075; IPLB-1075; Hz 1075
DR   ICLDB; iplb-hz-1075
DR   Wikidata; Q54897997
RX   DOI=10.1007/BF02620965;
RX   DOI=10.1007/BF02796325;
RX   DOI=10.1016/0022-2011(84)90091-0;
RX   DOI=10.1111/j.1550-7408.1983.tb05338.x;
RX   DOI=10.2307/3576171;
RX   PubMed=16593348;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IPLB-HZ-1075/UND-B
AC   CVCL_Z210
SY   UND-B
DR   ICLDB; iplb-hz-1075und-b
DR   Wikidata; Q54897998
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-C
AC   CVCL_Z211
SY   UND-C
DR   ICLDB; iplb-hz-1075und-c
DR   Wikidata; Q54897999
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-F
AC   CVCL_Z212
SY   UND-F
DR   ICLDB; iplb-hz-1075und-f
DR   Wikidata; Q54898000
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-G
AC   CVCL_Z213
SY   UND-G
DR   ICLDB; iplb-hz-1075und-g
DR   Wikidata; Q54898001
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-H
AC   CVCL_Z214
SY   UND-H
DR   ICLDB; iplb-hz-1075und-h
DR   Wikidata; Q54898005
RX   DOI=10.1007/BF02620965;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-I
AC   CVCL_Z215
SY   UND-I
DR   ICLDB; iplb-hz-1075und-i
DR   Wikidata; Q54898006
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-K
AC   CVCL_Z216
SY   IPLB-HZ1075/UND-K; Hz 1075/UND-K; UND-K
DR   ICLDB; iplb-hz-1075und-k
DR   Wikidata; Q54898007
RX   DOI=10.1007/BF02620965;
RX   DOI=10.1007/BF02626179;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-L
AC   CVCL_Z217
SY   UND-L
DR   ICLDB; iplb-hz-1075und-l
DR   Wikidata; Q54898008
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-O
AC   CVCL_Z218
SY   UND-O
DR   ICLDB; iplb-hz-1075und-o
DR   Wikidata; Q54898009
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-R
AC   CVCL_Z219
SY   UND-R
DR   ICLDB; iplb-hz-1075und-r
DR   Wikidata; Q54898010
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-U
AC   CVCL_Z220
SY   UND-U
DR   ICLDB; iplb-hz-1075und-u
DR   Wikidata; Q54898011
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1075/UND-V
AC   CVCL_Z221
SY   UND-V
DR   ICLDB; iplb-hz-1075und-v
DR   Wikidata; Q54898012
RX   DOI=10.1007/BF02620965;
RX   PubMed=2685005;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z209 ! IPLB-HZ-1075
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-HZ-1079
AC   CVCL_AV50
DR   ICLDB; iplb-hz-1079
DR   Wikidata; Q54898013
RX   DOI=10.1007/BF02796325;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   IPLB-HZ-110
AC   CVCL_AV51
DR   ICLDB; iplb-hz-110
DR   Wikidata; Q54898014
RX   DOI=10.1007/BF02796325;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   IPLB-HZ-124Q
AC   CVCL_AV52
DR   ICLDB; iplb-hz-124q
DR   Wikidata; Q54898015
RX   DOI=10.1007/BF02796325;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   IPLB-LD-64
AC   CVCL_Z378
SY   IPLB-Ld-64
DR   Wikidata; Q54898016
RX   CelloPub=CLPUB00496;
RX   PubMed=79542;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   IPLB-LD-65
AC   CVCL_Z379
SY   IPLB-LD 65
DR   ICLDB; iplb-ld-65
DR   Wikidata; Q54898017
RX   CelloPub=CLPUB00496;
RX   PubMed=79542;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-LD-652
AC   CVCL_Z380
SY   IPLB-Ld-652
DR   ICLDB; iplb-ld-652
DR   Wikidata; Q54898018
RX   PubMed=79542;
RX   PubMed=16346059;
RX   PubMed=24986084;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z379 ! IPLB-LD-65
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-LD-652Y
AC   CVCL_Z381
SY   IPLB-Ld-652Y; IPLB-LD652Y; IPLB-Ld652Y; IPLBLd652Y; LD-652Y; Ld652Y; 652Y
DR   ICLDB; iplb-ld-652y
DR   Wikidata; Q54898019
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   PubMed=79542;
RX   PubMed=8780687;
RX   PubMed=11549938;
RX   PubMed=24986084;
CC   Group: Insect cell line.
CC   Caution: IPLB-LD-652Y is not explicitely mentioned in PubMed=79542, but almost all authors cite this publication as the source. PubMed=24986084 discuss the possibility that this is a typo for IPLB-LD-65Y, but this is not certain.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z379 ! IPLB-LD-65
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IPLB-LD-65Y
AC   CVCL_Z382
SY   IPL-LD-65Y; IPL-LD 65Y
DR   CLO; CLO_0006965
DR   CLDB; cl2904
DR   DSMZ; ACC-181
DR   DSMZCellDive; ACC-181
DR   ICLDB; iplb-ld-65y
DR   Wikidata; Q54898020
RX   PubMed=79542;
RX   PubMed=33389257;
CC   Group: Insect cell line.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z379 ! IPLB-LD-65
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   IPLB-LD-65Z
AC   CVCL_Z383
SY   IPLB-Ld-65Z; IPLB-Ld-65z
DR   CLO; CLO_0006964
DR   CLDB; cl2905
DR   ICLDB; iplb-ld-65z
DR   Wikidata; Q54898021
RX   PubMed=79542;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z379 ! IPLB-LD-65
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   IPLB-LD-66
AC   CVCL_Z384
SY   IPLB-Ld-66
DR   ICLDB; iplb-ld-66
DR   Wikidata; Q54898022
RX   CelloPub=CLPUB00496;
RX   PubMed=79542;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-LD-67
AC   CVCL_Z385
SY   IPLB-Ld-67
DR   ICLDB; iplb-ld-67
DR   Wikidata; Q54898023
RX   CelloPub=CLPUB00496;
RX   PubMed=79542;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-LdEG
AC   CVCL_Z405
SY   LdEG
DR   ICLDB; iplb-ldeg
DR   Wikidata; Q54898024
RX   CelloPub=CLPUB00162;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IPLB-LdEI
AC   CVCL_Z406
SY   LdEI
DR   ICLDB; iplb-ldei
DR   Wikidata; Q54898025
RX   CelloPub=CLPUB00162;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IPLB-LdEIt
AC   CVCL_Z407
SY   LdEIt
DR   ICLDB; iplb-ldeit
DR   Wikidata; Q54898026
RX   CelloPub=CLPUB00162;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z406 ! IPLB-LdEI
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   IPLB-LdEIta
AC   CVCL_Z099
SY   LdEIta
DR   ICLDB; iplb-ldeita
DR   Wikidata; Q54898027
RX   PubMed=1367489;
RX   PubMed=8780687;
RX   PubMed=10475266;
RX   PubMed=10475270;
RX   PubMed=11549938;
RX   PubMed=12623313;
RX   PubMed=15926859;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/SP2UserFiles/person/3489/LDEITA.pdf
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z407 ! IPLB-LdEIt
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   IPLB-LdEIta/Gi
AC   CVCL_C2TY
SY   LdEITA/Gi
DR   ICLDB; ldeitagi
DR   Wikidata; Q114311745
RX   PubMed=8780687;
RX   PubMed=10475266;
CC   Group: Insect cell line.
CC   Virology: Infected with Glyptapanteles indiensis polydnavirus (GiPDV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z099 ! IPLB-LdEIta
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   IPLB-LdEp
AC   CVCL_Z102
SY   IPLB-LdEP; LdEp
DR   ICLDB; iplb-ldep
DR   Wikidata; Q54898028
RX   CelloPub=CLPUB00162;
RX   PubMed=8780687;
RX   PubMed=10475266;
RX   PubMed=11549938;
RX   PubMed=12623313;
RX   PubMed=15926859;
RX   PubMed=24986084;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   IPLB-LdEp/Gi
AC   CVCL_C2TZ
SY   LdEp/Gi
DR   Wikidata; Q114311746
RX   PubMed=8780687;
RX   PubMed=10475266;
CC   Group: Insect cell line.
CC   Virology: Infected with Glyptapanteles indiensis polydnavirus (GiPDV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z102 ! IPLB-LdEp
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   IPLB-LdFB
AC   CVCL_Z100
SY   IPLB-Ld-FB; LdFB
DR   ICLDB; iplb-ldfb
DR   Wikidata; Q54898029
RX   CelloPub=CLPUB00162;
RX   PubMed=10475266;
RX   PubMed=10585188;
RX   PubMed=18220824;
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/sp2userfiles/person/3489/ldfb.pdf
CC   Group: Insect cell line.
CC   Characteristics: Apoptosis can be easily induced through oxidative stress using the reducing sugar dRib or the NO donor sodium SNP (PubMed=18220824).
CC   Doubling time: 38 +- 1 hours (Note=In static culture), 42 +- 4 hours (Note=In suspension culture) (PubMed=10585188).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   IPLB-LdFB clone 1
AC   CVCL_C2UT
SY   IPLB-LdFBc1
DR   ICLDB; iplb-ldfb-clone-1
DR   Wikidata; Q114311747
CC   Group: Insect cell line.
CC   From: Lynn, Dwight E.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z100 ! IPLB-LdFB
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IPLB-LdFB clone 4
AC   CVCL_C2UU
SY   IPLB-LdFBc4
DR   ICLDB; iplb-ldfb-clone-4
DR   Wikidata; Q114311748
CC   Group: Insect cell line.
CC   From: Lynn, Dwight E.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
HI   CVCL_Z100 ! IPLB-LdFB
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IPLB-OlE505A
AC   CVCL_9U11
SY   IPLB-OLE-505A
DR   ICLDB; iplb-ole505a
DR   Wikidata; Q54898034
RX   PubMed=9282305;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=95259; ! Orgyia leucostigma (White-marked tussock moth)
OI   CVCL_9U12 ! IPLB-OlE505s
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   IPLB-OlE505s
AC   CVCL_9U12
DR   ICLDB; iplb-ole505s
DR   Wikidata; Q54898035
RX   PubMed=9282305;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=95259; ! Orgyia leucostigma (White-marked tussock moth)
OI   CVCL_9U11 ! IPLB-OlE505A
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   IPLB-OlE7
AC   CVCL_9U13
SY   IPLB-OlE-7; IPLB-OLE-7
DR   ICLDB; iplb-ole7
DR   Wikidata; Q54898036
RX   PubMed=9282305;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=95259; ! Orgyia leucostigma (White-marked tussock moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   IPLB-PiE
AC   CVCL_AV30
DR   ICLDB; iplb-pie
DR   Wikidata; Q54898037
RX   PubMed=26820856;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=58824; ! Plodia interpunctella (Indianmeal moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   IPLB-PxE1
AC   CVCL_Z575
DR   ICLDB; iplb-pxe1
DR   Wikidata; Q54898038
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-PxE2
AC   CVCL_Z576
DR   ICLDB; iplb-pxe2
DR   Wikidata; Q54898039
RX   PubMed=12623313;
RX   PubMed=15926859;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-SF-1254
AC   CVCL_Z439
SY   IPLB-Sf-1254; IPLB-SF 1254; IPLB-SF1254; Sf-1254
DR   ICLDB; iplb-sf-1254
DR   Wikidata; Q54898040
RX   DOI=10.2307/3576171;
RX   PubMed=68913;
RX   PubMed=1367489;
RX   PubMed=16593348;
CC   Group: Insect cell line.
CC   Doubling time: 36 hours (PubMed=68913).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   IPLB-Tcon1
AC   CVCL_Z504
SY   IPLB-Tcon-1; IPLB-Tcon 1
DR   ICLDB; iplb-tcon1
DR   Wikidata; Q29581353
RX   PubMed=1799679;
RX   PubMed=10475266;
CC   Group: Insect cell line.
CC   Doubling time: 29 hours (PubMed=1799679).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=238528; ! Trichogramma confusum (Parasitic wasp)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-Tex2
AC   CVCL_Z503
DR   ICLDB; iplb-tex2
DR   Wikidata; Q54898041
RX   PubMed=1799679;
RX   PubMed=10475266;
CC   Group: Insect cell line.
CC   Doubling time: 50 hours (PubMed=1799679).
CC   Misspelling: IPBL-Tex2; Note=Occasionally.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=185872; ! Trichogramma exiguum (Parasitic wasp)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   IPLB-TN-R2
AC   CVCL_Z096
SY   IPLB-TNR2; IPLB-Tn-RR; IPLB-TN-R; IPLB-TNR; TN-R2
DR   ICLDB; iplb-tn-r2
DR   Wikidata; Q54898042
RX   DOI=10.1007/BF02619626;
RX   PubMed=1367489;
RX   PubMed=1389161;
RX   PubMed=10475266;
RX   PubMed=12623313;
RX   PubMed=15926859;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPLB-TpE1
AC   CVCL_WK38
DR   ICLDB; iplb-tpe1
DR   Wikidata; Q94321372
RX   DOI=10.1007/BF02623443;
CC   Group: Insect cell line.
CC   Doubling time: 72 hours (Note=At 40th passage) (DOI=10.1007/BF02623443).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7493; ! Trichogramma pretiosum (Parasitoid wasp)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   iPM1
AC   CVCL_Y700
SY   A000011#1; A000011# 1; HPS0066
DR   SKIP; SKIP000019
DR   Wikidata; Q54898043
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y701 ! iPM2
OI   CVCL_Y702 ! iPM9
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   iPM2
AC   CVCL_Y701
SY   A000011#2; A000011# 2; HPS0067
DR   SKIP; SKIP000020
DR   Wikidata; Q54898044
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y700 ! iPM1
OI   CVCL_Y702 ! iPM9
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   iPM9
AC   CVCL_Y702
SY   A000011#9; A000011# 9; HPS0068
DR   SKIP; SKIP000021
DR   Wikidata; Q54898045
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y700 ! iPM1
OI   CVCL_Y701 ! iPM2
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   IPNN-8
AC   CVCL_5G67
DR   Wikidata; Q54898048
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7518347;
RX   PubMed=7591247;
RX   PubMed=9428346;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 24 hours (PubMed=9428346).
CC   Derived from site: In situ; Brain, fourth ventricle; UBERON=UBERON_0002422.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   IPNT-H
AC   CVCL_5G65
DR   Wikidata; Q54898049
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7518347;
RX   PubMed=7591247;
RX   PubMed=8054266;
RX   PubMed=9428346;
RX   PubMed=21556643;
CC   Doubling time: 27 hours (PubMed=9428346).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
DI   NCIt; C4047; Pilocytic astrocytoma
DI   ORDO; Orphanet_251612; Pilocytic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   IPO43
AC   CVCL_C0Z8
SY   IPOLFG Serous Ovarian Carcinoma 43
DR   cancercelllines; CVCL_C0Z8
DR   Wikidata; Q114311749
RX   PubMed=35501869;
CC   Population: Caucasian.
CC   Doubling time: 37.3 hours (PubMed=35501869).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=35501869).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Phe (c.514G>T); ClinVar=VCV000428909; Zygosity=Heterozygous (PubMed=35501869).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=35501869
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   Penta D: 12,13
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   IPPS-11
AC   CVCL_5G68
DR   Wikidata; Q54898050
RX   PubMed=7518347;
RX   PubMed=7591247;
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   IPRB
AC   CVCL_1R53
DR   BioSample; SAMN03152017
DR   Wikidata; Q54898051
RX   PubMed=20951163;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00385.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   IPRI-CF-1
AC   CVCL_Z473
SY   IPRI-Cf-1; CF-1; FPMI-CF-1
DR   ICLDB; ipri-cf-1
DR   Wikidata; Q54898052
RX   CelloPub=CLPUB00491;
RX   DOI=10.1007/BF01947579;
RX   DOI=10.1016/0022-1910(94)00139-8;
RX   DOI=10.1139/z85-337;
RX   PubMed=1367489;
RX   PubMed=7615077;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   IPRI-CF-10
AC   CVCL_Z474
DR   ICLDB; ipri-cf-10
DR   Wikidata; Q54898053
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   IPRI-CF-12
AC   CVCL_Z475
DR   ICLDB; ipri-cf-12
DR   Wikidata; Q54898054
RX   CelloPub=CLPUB00491;
RX   CelloPub=CLPUB00492;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   IPRI-CF-124
AC   CVCL_Z480
SY   IPRI-Cf-124; IPRI-Cf124; Cf124
DR   ICLDB; ipri-cf-124
DR   Wikidata; Q54898055
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z76-180;
RX   DOI=10.1139/z85-337;
RX   PubMed=903169;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Doubling time: 31 hours (PubMed=903169).
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   IPRI-CF-124-2
AC   CVCL_WK35
DR   Wikidata; Q94321471
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
HI   CVCL_Z480 ! IPRI-CF-124
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IPRI-CF-124T
AC   CVCL_Z481
SY   Cf-124T; CF-124T
DR   ICLDB; ipri-cf-124t-attached-cell-line-derived-cf-124
DR   Wikidata; Q54898056
RX   PubMed=903169;
RX   PubMed=7615077;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Characteristics: Has increased attachment adherence compared to the parent cell line.
CC   Doubling time: 25 hours (PubMed=903169).
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
HI   CVCL_Z480 ! IPRI-CF-124
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   IPRI-CF-16
AC   CVCL_Z476
DR   ICLDB; ipri-cf-16
DR   Wikidata; Q54898057
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   IPRI-CF-16T
AC   CVCL_WV94
DR   ICLDB; ipri-cf-16t
DR   Wikidata; Q94321489
RX   PubMed=7615077;
RX   PubMed=11680386;
CC   Group: Insect cell line.
CC   Characteristics: Has increased attachment adherence compared to the parent cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
HI   CVCL_Z476 ! IPRI-CF-16
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   IPRI-CF-2C1
AC   CVCL_C2UK
SY   IPRI-CF-124T (2C-1); CF-2C1
DR   ICLDB; ipri-cf-2c1-clone-cf-124t
DR   Wikidata; Q114311750
RX   DOI=10.1080/09583150050044574;
CC   Group: Insect cell line.
CC   Doubling time: 26.7 hours (Note=In Ex-Cell 405 medium), 43 hours (Note=In GM-FBS10 medium) (DOI=10.1080/09583150050044574).
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
HI   CVCL_Z481 ! IPRI-CF-124T
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   IPRI-CF-300
AC   CVCL_C2T4
DR   ICLDB; ipri-cf-300
DR   Wikidata; Q114311751
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   IPRI-CF-5
AC   CVCL_Z477
DR   ICLDB; ipri-cf-5
DR   Wikidata; Q54898058
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Male
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   IPRI-CF-6
AC   CVCL_Z478
DR   ICLDB; ipri-cf-6
DR   Wikidata; Q54898059
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Male
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   IPRI-CF-8
AC   CVCL_Z479
DR   ICLDB; ipri-cf-8
DR   Wikidata; Q54898060
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   PubMed=11680386;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   IPRI-MD-108
AC   CVCL_Z482
SY   IPRI-Md-108; IPRI-108; IPRI 108; FPMI-MD-108; Md108
DR   ICLDB; fpmi-md-108
DR   Wikidata; Q54898061
RX   CelloPub=CLPUB00188;
RX   DOI=10.1139/z76-180;
RX   PubMed=16346059;
RX   PubMed=21907208;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=40071; ! Malacosoma disstria (Forest tent caterpillar)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   IPRI-MD-109
AC   CVCL_Z483
SY   FPMI-MD-109-1; Md109
DR   ICLDB; fpmi-md-109-1
DR   Wikidata; Q54898062
RX   DOI=10.1139/z76-180;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=40071; ! Malacosoma disstria (Forest tent caterpillar)
SX   Female
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   IPRI-MD-63
AC   CVCL_Z484
SY   FPMI-MD-63; Md63
DR   ICLDB; fpmi-md-63
DR   Wikidata; Q54898063
RX   DOI=10.1139/z76-180;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=40071; ! Malacosoma disstria (Forest tent caterpillar)
SX   Female
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   IPRI-MD-66
AC   CVCL_Z437
SY   IPRI-Md-66; FPMI-MD-66; MD-66; Md66
DR   BTO; BTO_0004106
DR   ICLDB; fpmi-md-66
DR   Wikidata; Q54898064
RX   CelloPub=CLPUB00491;
RX   DOI=10.1016/0022-1910(94)00139-8;
RX   DOI=10.1139/z71-202;
RX   DOI=10.1139/z76-180;
RX   DOI=10.1139/z85-337;
RX   PubMed=7615077;
RX   PubMed=21907208;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=40071; ! Malacosoma disstria (Forest tent caterpillar)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   IPRI-OL-11
AC   CVCL_Z489
DR   BioSample; SAMN06481112
DR   Wikidata; Q54898065
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Problematic cell line: Contaminated. Shown to probably be a IPRI-CF-124 derivative. Originate from Choristoneura fumiferana and not from Orgyia leucostigma (CelloPub=CLPUB00491; DOI=10.1139/z85-337).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00512.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
HI   CVCL_Z480 ! IPRI-CF-124
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   IPRI-OL-12
AC   CVCL_Z485
SY   FPMI-OL-12
DR   Wikidata; Q54898066
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
RX   DOI=10.1385/0-89603-272-8:397;
CC   Group: Insect cell line.
OX   NCBI_TaxID=95259; ! Orgyia leucostigma (White-marked tussock moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   IPRI-OL-13
AC   CVCL_Z486
DR   Wikidata; Q54898067
RX   CelloPub=CLPUB00491;
RX   CelloPub=CLPUB00492;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
OX   NCBI_TaxID=95259; ! Orgyia leucostigma (White-marked tussock moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   IPRI-OL-4
AC   CVCL_Z487
DR   Wikidata; Q54898068
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
OX   NCBI_TaxID=95259; ! Orgyia leucostigma (White-marked tussock moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   IPRI-OL-7
AC   CVCL_Z490
DR   BioSample; SAMN06481113
DR   Wikidata; Q54898069
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Problematic cell line: Contaminated. Shown to probably be a IPRI-CF-124 derivative. Originate from Choristoneura fumiferana and not from Orgyia leucostigma (CelloPub=CLPUB00491; DOI=10.1139/z85-337).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00511.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
HI   CVCL_Z480 ! IPRI-CF-124
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   IPRI-OL-9
AC   CVCL_Z488
DR   Wikidata; Q54898070
RX   CelloPub=CLPUB00491;
RX   DOI=10.1139/z85-337;
CC   Group: Insect cell line.
OX   NCBI_TaxID=95259; ! Orgyia leucostigma (White-marked tussock moth)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   IPRM-5
AC   CVCL_5G66
DR   Wikidata; Q54898071
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7518347;
RX   PubMed=7591247;
RX   PubMed=8054266;
RX   PubMed=21556643;
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   iPS ADPKD 1
AC   CVCL_V449
DR   Wikidata; Q54898072
RX   PubMed=24009235;
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Cys39Tyr (c.116G>A); ClinVar=VCV001310359; Zygosity=Unspecified (PubMed=24009235).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   iPS ADPKD 2
AC   CVCL_V450
DR   Wikidata; Q54898073
RX   PubMed=24009235;
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Arg2051Pro (c.6152G>C); Zygosity=Unspecified (PubMed=24009235).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   iPS ADPKD 3
AC   CVCL_V451
DR   Wikidata; Q54898074
RX   PubMed=24009235;
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Glu1929Ter (c.5785G>T); Zygosity=Unspecified (PubMed=24009235).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   iPS ARPKD 4
AC   CVCL_V452
DR   Wikidata; Q54898075
RX   PubMed=24009235;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V446 ! GM10287
SX   Male
AG   36FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   iPS ARPKD 5
AC   CVCL_V453
DR   Wikidata; Q54898076
RX   PubMed=24009235;
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Thr36Met (c.107C>T); ClinVar=VCV000004108; Zygosity=Unspecified (PubMed=24009235).
CC   Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Trp2736Gly (c.8206T>G); ClinVar=VCV000496527; Zygosity=Unspecified (PubMed=24009235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84579; Autosomal recessive polycystic kidney disease
DI   ORDO; Orphanet_731; Autosomal recessive polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V447 ! GM12607
SX   Female
AG   6D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   iPS CWRU1
AC   CVCL_W123
SY   iPS_CWRU1; CWRU1
DR   EFO; EFO_0009501
DR   ENCODE; ENCBS334AAA
DR   GEO; GSM1008570
DR   Wikidata; Q54898077
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   iPS FRDA68 Pi1
AC   CVCL_ZC10
SY   Pi1
DR   Wikidata; Q98126785
RX   PubMed=25758173;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[570]; ClinVar=VCV000561195; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1200]; ClinVar=VCV000561195; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC08 ! FRDA68
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   iPS FRDA68 Pi2
AC   CVCL_ZC11
SY   Pi2
DR   Wikidata; Q98126786
RX   PubMed=25758173;
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[570]; ClinVar=VCV000561195; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1200]; ClinVar=VCV000561195; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC08 ! FRDA68
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   iPS MS1
AC   CVCL_YP26
SY   MS1
DR   Wikidata; Q94321660
RX   PubMed=18511599;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=18511599).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L749 ! GM02340
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   iPS MS2
AC   CVCL_YP27
SY   MS2
DR   Wikidata; Q94321665
RX   PubMed=18511599;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=18511599).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L749 ! GM02340
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   iPS MS3
AC   CVCL_YP28
SY   MS3
DR   Wikidata; Q94321668
RX   PubMed=18511599;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=18511599).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L749 ! GM02340
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   iPS NIHi1
AC   CVCL_AS22
SY   NIH-i1; i1
DR   GEO; GSM856734
DR   Wikidata; Q54898078
RX   PubMed=23117585;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   iPS NIHi11
AC   CVCL_W121
SY   iPS-NIHi11; iPS_NIHi11; NIH-i11
DR   EFO; EFO_0007952
DR   ENCODE; ENCBS556ENC
DR   GEO; GSM1008569
DR   Wikidata; Q54898079
RX   PubMed=23117585;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/FibroP_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N797 ! AG20443
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS NIHi12
AC   CVCL_AS26
SY   NIH-i12; i12
DR   GEO; GSM856741
DR   Wikidata; Q54898080
RX   PubMed=23117585;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N796 ! AG08396
SX   Female
AG   85Y9M
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   iPS NIHi13
AC   CVCL_AS27
SY   NIH-i13
DR   Wikidata; Q54898082
RX   PubMed=23117585;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N796 ! AG08396
SX   Female
AG   85Y9M
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   iPS NIHi2
AC   CVCL_AS23
SY   NIH-i2
DR   Wikidata; Q54898083
RX   PubMed=23117585;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N797 ! AG20443
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   iPS NIHi4
AC   CVCL_AS24
SY   NIH-i4; i4
DR   GEO; GSM856740
DR   Wikidata; Q54898084
RX   PubMed=23117585;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N797 ! AG20443
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   iPS NIHi5
AC   CVCL_AS25
SY   NIH-i5; i5
DR   GEO; GSM856739
DR   Wikidata; Q54898085
RX   PubMed=23117585;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N797 ! AG20443
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   iPS NIHi7
AC   CVCL_W122
SY   iPS-NIHi7; iPS_NIHi7; NIH-i7; i7
DR   EFO; EFO_0007953
DR   ENCODE; ENCBS041ENC
DR   ENCODE; ENCBS557ENC
DR   GEO; GSM856742
DR   GEO; GSM1008600
DR   Wikidata; Q54898086
RX   PubMed=23117585;
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N795 ! AG08395
SX   Female
AG   85Y9M
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   iPS ZK1
AC   CVCL_YP29
SY   ZS1
DR   Wikidata; Q94321774
RX   PubMed=18511599;
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2339 ! CCD-1087Sk
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   IPS(Foreskin)-1
AC   CVCL_C430
SY   IPS(FORESKIN)-1; iPS-foreskin-1; iPS Foreskin 1; WISCi003-A
DR   BioSamples; SAMEA7784668
DR   GEO; GSM658965
DR   hPSCreg; WISCi003-A
DR   SKIP; SKIP002366
DR   SKIP; SKIP003278
DR   WiCell; ips-foreskin-1
DR   Wikidata; Q54898184
RX   PubMed=18029452;
RX   PubMed=21654665;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   IPS(Foreskin)-2
AC   CVCL_C431
SY   IPS(FORESKIN)-2; iPS-foreskin-2; iPS Foreskin 2
DR   GEO; GSM658966
DR   SKIP; SKIP003274
DR   WiCell; ips-foreskin-2
DR   Wikidata; Q54898185
RX   PubMed=18029452;
RX   PubMed=21654665;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   IPS(Foreskin)-3
AC   CVCL_C432
SY   IPS(FORESKIN)-3; iPS-foreskin-3; iPS Foreskin 3
DR   GEO; GSM658952
DR   SKIP; SKIP003276
DR   WiCell; ips-foreskin-3
DR   Wikidata; Q54898186
RX   PubMed=18029452;
RX   PubMed=21654665;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   IPS(Foreskin)-4
AC   CVCL_C433
SY   IPS(FORESKIN)-4; iPS-foreskin-4; iPS Foreskin 4
DR   GEO; GSM658968
DR   SKIP; SKIP003279
DR   WiCell; ips-foreskin-4
DR   Wikidata; Q54898187
RX   PubMed=18029452;
RX   PubMed=21654665;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   IPS(IMR90)-1
AC   CVCL_C434
SY   iPS(IMR90)-1; iPS(IMR90) clone (#1); iPS-IMR90-1; IMR90-1; IMR1; WISCi004-A
DR   BioSamples; SAMEA5840270
DR   GEO; GSM658973
DR   GEO; GSM861006
DR   GEO; GSM1084841
DR   GEO; GSM1084933
DR   hPSCreg; WISCi004-A
DR   SKIP; SKIP002367
DR   SKIP; SKIP004450
DR   WiCell; ips-imr90-1
DR   Wikidata; Q54898188
RX   PubMed=18029452;
RX   PubMed=21654665;
RX   PubMed=22905176;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): WiCell=ips-imr90-1
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   IPS(IMR90)-2
AC   CVCL_C435
SY   iPS(IMR90)-2; iPS(IMR90) clone (#2); iPS-IMR90-2
DR   GEO; GSM658945
DR   SKIP; SKIP004448
DR   WiCell; ips-imr90-2
DR   Wikidata; Q54898189
RX   PubMed=18029452;
RX   PubMed=21654665;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   IPS(IMR90)-3
AC   CVCL_C436
SY   iPS(IMR90)-3; iPS(IMR90) clone (#3); iPS-IMR90-3
DR   GEO; GSM658947
DR   SKIP; SKIP004451
DR   WiCell; ips-imr90-3
DR   Wikidata; Q54898190
RX   PubMed=18029452;
RX   PubMed=21654665;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   IPS(IMR90)-4
AC   CVCL_C437
SY   iPS(IMR90)-4; iPS(IMR90) clone (#4); iPS(IMR90)-4-DL-01; iPS-IMR90-4; IMR90-4; IMR4; WISCi004-B
DR   BioSamples; SAMEA5840405
DR   GEO; GSM658950
DR   GEO; GSM861007
DR   GEO; GSM1084842
DR   GEO; GSM1084934
DR   GEO; GSM3192176
DR   GEO; GSM3192177
DR   hPSCreg; WISCi004-B
DR   SKIP; SKIP002368
DR   SKIP; SKIP004449
DR   WiCell; ips-imr90-4
DR   Wikidata; Q54898191
RX   PubMed=18029452;
RX   PubMed=21654665;
RX   PubMed=22905176;
RX   PubMed=30044992;
RX   PubMed=32946783;
RX   PubMed=36261438;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   IPS(IMR90)-4-CHMP1A KO
AC   CVCL_C3HI
SY   CHMP1A null iPSC; iPSC_CHMP1A_null
DR   GEO; GSM3192178
DR   GEO; GSM3192179
DR   Wikidata; Q114311752
RX   PubMed=30044992;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8740; CHMP1A.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C437 ! IPS(IMR90)-4
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   IPS-1
AC   CVCL_B531
SY   iPS1; Hips1
DR   GEO; GSM249028
DR   Wikidata; Q54898087
RX   PubMed=18287077;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18287077
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 18,26
ST   Penta D: 11
ST   Penta E: 13
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B533 ! IPS-2
OI   CVCL_B536 ! IPS-5
OI   CVCL_B537 ! IPS-7
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   iPS-14
AC   CVCL_D0JB
DR   Wikidata; Q123032723
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IPS-18
AC   CVCL_B532
SY   iPS18
DR   Wikidata; Q54898088
RX   PubMed=18287077;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   IPS-2
AC   CVCL_B533
SY   iPS2; Hips2
DR   GEO; GSM249096
DR   Wikidata; Q54898091
RX   PubMed=18287077;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18287077
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 18,26
ST   Penta D: 11
ST   Penta E: 13
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B531 ! IPS-1
OI   CVCL_B536 ! IPS-5
OI   CVCL_B537 ! IPS-7
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   IPS-24
AC   CVCL_B534
SY   iPS24; Hips24
DR   GEO; GSM249150
DR   Wikidata; Q54898093
RX   PubMed=18287077;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   iPS-27
AC   CVCL_D0JC
SY   C27; MSKi002-A
DR   BioSamples; SAMEA114243953
DR   hPSCreg; MSKi002-A
DR   Wikidata; Q123032724
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IPS-29
AC   CVCL_B535
SY   iPS29; Hips29
DR   GEO; GSM249152
DR   Wikidata; Q54898094
RX   PubMed=18287077;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   iPS-49
AC   CVCL_D0JD
DR   Wikidata; Q123032725
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IPS-5
AC   CVCL_B536
SY   iPS5; Hips5
DR   GEO; GSM249095
DR   Wikidata; Q54898095
RX   PubMed=18287077;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18287077
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 18,26
ST   Penta D: 11
ST   Penta E: 13
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B531 ! IPS-1
OI   CVCL_B533 ! IPS-2
OI   CVCL_B537 ! IPS-7
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   iPS-50
AC   CVCL_D0JE
DR   Wikidata; Q123032726
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   iPS-51
AC   CVCL_D0JF
DR   Wikidata; Q123032727
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   iPS-59
AC   CVCL_D0JG
DR   Wikidata; Q123032728
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   iPS-60
AC   CVCL_D0JH
DR   Wikidata; Q123032729
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   iPS-62
AC   CVCL_D0JI
DR   Wikidata; Q123032730
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IPS-7
AC   CVCL_B537
SY   iPS7; Hips7
DR   GEO; GSM249137
DR   Wikidata; Q54898096
RX   PubMed=18287077;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=18287077
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 18,26
ST   Penta D: 11
ST   Penta E: 13
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B531 ! IPS-1
OI   CVCL_B533 ! IPS-2
OI   CVCL_B536 ! IPS-5
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   iPS-71
AC   CVCL_D0JJ
DR   Wikidata; Q123032731
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   iPS-72
AC   CVCL_D0JK
DR   Wikidata; Q123032732
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   iPS-76
AC   CVCL_D0JL
DR   Wikidata; Q123032734
RX   PubMed=19549847;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   iPS-CTX-R395S
AC   CVCL_A4VG
DR   Wikidata; Q107115465
RX   PubMed=27879219;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2605; CYP27A1; Simple; p.Arg395Ser (c.1183C>A); ClinVar=VCV000004261; Zygosity=Homozygous (PubMed=27879219).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84628; Cerebrotendinous xanthomatosis
DI   ORDO; Orphanet_909; Cerebrotendinous xanthomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   iPS-DF19-9
AC   CVCL_4T92
SY   DF19-9
DR   Wikidata; Q54898097
RX   PubMed=19325077;
RX   PubMed=21296996;
CC   From: University of Wisconsin; Madison; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   iPS-DF19-9 MYF5-2A-GFP clone 5
AC   CVCL_ZW86
DR   Wikidata; Q102114240
RX   PubMed=26729410;
CC   Characteristics: Using CRISPR/Cas9 MYF5 has been endogenously tagged in both alleles at the C-terminus with a 2A-GFP reporter.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T92 ! iPS-DF19-9
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   iPS-DF19-9-11T.H
AC   CVCL_K054
SY   iPS DF19-9-11T.H; iPS-DF19-9-11T; DF19-9-11T; iPS DF 19.11; DF19.11; WAi001-A
DR   EFO; EFO_0007096
DR   BioSamples; SAMEA104492560
DR   ENCODE; ENCBS068ICJ
DR   ENCODE; ENCBS085RNG
DR   ENCODE; ENCBS087RTK
DR   ENCODE; ENCBS368AVD
DR   ENCODE; ENCBS698JQZ
DR   ENCODE; ENCBS972ZOZ
DR   hPSCreg; WAi001-A
DR   SKIP; SKIP005448
DR   WiCell; ips-df19-9-11t-h
DR   Wikidata; Q54898098
RX   PubMed=19325077;
RX   PubMed=21296996;
RX   PubMed=21983960;
CC   From: University of Wisconsin; Madison; USA.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T92 ! iPS-DF19-9
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 23
//
ID   iPS-DF19-9-7T
AC   CVCL_K055
SY   iPS DF19-9-7T; iPS DF19-9-7T-PCBC; DF19-9-7T; DF-19-9-7T; iPS DF 19.7; DF19.7; WAi001-B; PCBC02hsi2011100701; SC11-016
DR   EFO; EFO_0007095
DR   BioSamples; SAMEA6260528
DR   ENCODE; ENCBS858DVB
DR   hPSCreg; WAi001-B
DR   SKIP; SKIP005451
DR   WiCell; ips-df19-9-7t
DR   WiCell; ips-df19-9-7t-pcbc
DR   Wikidata; Q54898099
RX   PubMed=19325077;
RX   PubMed=21296996;
RX   PubMed=21983960;
RX   PubMed=26670276;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T92 ! iPS-DF19-9
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 24
//
ID   iPS-DF4-3-7T.A
AC   CVCL_K056
SY   iPS DF4-3-7T.A; DF4-3-7T; iPS DF 4.7; DF4.7; PCBC02hsi2011100703; SC11-017
DR   EFO; EFO_0007097
DR   ENCODE; ENCBS624PSN
DR   SKIP; SKIP005449
DR   WiCell; ips-df4-3-7t-a
DR   Wikidata; Q54898100
RX   PubMed=21296996;
RX   PubMed=21983960;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 22
//
ID   iPS-DF6-9
AC   CVCL_4T90
SY   iPS DF 6.9; DF6-9
DR   EFO; EFO_0007098
DR   ENCODE; ENCBS011GNQ
DR   ENCODE; ENCBS111INZ
DR   ENCODE; ENCBS586ZNR
DR   ENCODE; ENCBS757ZRB
DR   Wikidata; Q54898101
RX   PubMed=19325077;
RX   PubMed=21296996;
CC   From: University of Wisconsin; Madison; USA.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   iPS-DF6-9-12T
AC   CVCL_4T91
DR   Wikidata; Q54898102
RX   PubMed=19325077;
CC   From: University of Wisconsin; Madison; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T90 ! iPS-DF6-9
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   iPS-DF6-9-9T.B
AC   CVCL_K057
SY   iPS DF6-9-9T.B; iPS DF6-9-9T.B-PCBC; DF6-9-9T.B; iPS-DF6-9-9T; DF6-9-9T; DF6.9; WAi001-C; PCBC02hsi2011100702; SC11-018
DR   hPSCreg; WAi001-C
DR   SKIP; SKIP005450
DR   WiCell; ips-df6-9-9t-b
DR   WiCell; ips-df6-9-9t-b-pcbc
DR   Wikidata; Q54898103
RX   PubMed=19325077;
RX   PubMed=21296996;
RX   PubMed=21983960;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T90 ! iPS-DF6-9
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 24
//
ID   iPS-DP31 3f-1
AC   CVCL_DP82
DR   Wikidata; Q54898104
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP75 ! DP031
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP31 3f-2
AC   CVCL_DP83
DR   Wikidata; Q54898105
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=20554890
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   Penta D: 12,14
ST   Penta E: 16,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP75 ! DP031
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP31 3f-3
AC   CVCL_DP84
DR   Wikidata; Q54898106
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP75 ! DP031
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP31 4f-1
AC   CVCL_DQ77
SY   DP31-4f1
DR   GEO; GSM1040268
DR   GEO; GSM1040338
DR   Wikidata; Q54898107
RX   PubMed=20554890;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Although not directly described in PubMed=20554890, was established at the same time as the other DP31 iPSCs described in that paper (personal communication of Koyanagi-Aoi, Michiyo).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP75 ! DP031
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   iPS-DP31 4f-3
AC   CVCL_DP85
DR   Wikidata; Q54898108
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=20554890
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   Penta D: 12,14
ST   Penta E: 16,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP75 ! DP031
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP31 4f-5
AC   CVCL_DP86
DR   Wikidata; Q54898109
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP75 ! DP031
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP31 4f-6
AC   CVCL_DP87
DR   Wikidata; Q54898110
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP75 ! DP031
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP75 3f-1
AC   CVCL_DP77
DR   Wikidata; Q54898111
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP76 ! DP075
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP75 3f-2
AC   CVCL_DP78
DR   Wikidata; Q54898112
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=20554890
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,11
ST   D16S539: 8,11
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 8,11
ST   Penta E: 12,16
ST   TH01: 5,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP76 ! DP075
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP75 4f-1
AC   CVCL_DP79
DR   Wikidata; Q54898113
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=20554890
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,11
ST   D16S539: 8,11
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 8,11
ST   Penta E: 12,16
ST   TH01: 5,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP76 ! DP075
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP75 4f-2
AC   CVCL_DP80
DR   Wikidata; Q54898114
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP76 ! DP075
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-DP75 4f-3
AC   CVCL_DP81
DR   Wikidata; Q54898115
RX   PubMed=20554890;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP76 ! DP075
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   iPS-Hep-FB/Ng/gfp-103C-1
AC   CVCL_T784
DR   RCB; APS0007
DR   SKIP; SKIP005469
DR   Wikidata; Q54898116
RX   PubMed=18276851;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   21W
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   iPS-HHT
AC   CVCL_Y541
SY   HHT
DR   SKIP; SKIP000532
DR   Wikidata; Q54898117
RX   PubMed=20111645;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   iPS-JR036-1
AC   CVCL_A8Y6
SY   JR036 LRRK2 G2019S iPSc clone 1
DR   GEO; GSM2055812
DR   GEO; GSM2055816
DR   Wikidata; Q102114241
RX   PubMed=28096185;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=28096185).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y5 ! JR036
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   iPS-L1
AC   CVCL_B969
DR   RCB; APS0008
DR   SKIP; SKIP001755
DR   Wikidata; Q54898118
RX   PubMed=20670936;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Dutch Belted; VBO=VBO_0017527.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_B970 ! iPS-L2
OI   CVCL_B967 ! iPS-S1
OI   CVCL_B968 ! iPS-S2
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   iPS-L2
AC   CVCL_B970
DR   RCB; APS0009
DR   SKIP; SKIP001756
DR   Wikidata; Q54898119
RX   PubMed=20670936;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Dutch Belted; VBO=VBO_0017527.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_B969 ! iPS-L1
OI   CVCL_B967 ! iPS-S1
OI   CVCL_B968 ! iPS-S2
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   iPS-MEF-Fb/Ng-440A-3
AC   CVCL_T785
SY   iPS-MEF-FB/NG-440A-3
DR   RCB; APS0003
DR   SKIP; SKIP005465
DR   Wikidata; Q54898120
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   iPS-MEF-Ng-178B-5
AC   CVCL_T786
DR   RCB; APS0002
DR   SKIP; SKIP001697
DR   Wikidata; Q54898122
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   iPS-MEF-Ng-20D-17
AC   CVCL_T787
SY   20D17; Nanog iPS 20D17
DR   GEO; GSM1330515
DR   RCB; APS0001
DR   RCB; RCB2698
DR   SKIP; SKIP001676
DR   Wikidata; Q54898123
RX   PubMed=17554338;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: RCB; RCB2698; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   iPS-MEF-Ng-492B-4
AC   CVCL_T788
DR   RCB; APS0004
DR   SKIP; SKIP005466
DR   Wikidata; Q54898124
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   iPS-MEF3-1
AC   CVCL_C6W4
DR   Wikidata; Q117704536
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-MEF3-2
AC   CVCL_C6W5
DR   Wikidata; Q117704537
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-MEF3-3
AC   CVCL_C6W6
DR   Wikidata; Q117704538
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-MEF3-4
AC   CVCL_C6W7
DR   Wikidata; Q117704539
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-MEF3-5
AC   CVCL_C6W8
DR   Wikidata; Q117704540
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-MEF3-6
AC   CVCL_C6W9
DR   Wikidata; Q117704541
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-MEF4-2
AC   CVCL_C6WA
DR   Wikidata; Q117704542
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-MEF4-7
AC   CVCL_C6WB
DR   Wikidata; Q117704543
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-MEF4-10
AC   CVCL_C6WC
DR   Wikidata; Q117704544
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-MSC-H9
AC   CVCL_GR22
DR   Wikidata; Q54898125
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   iPS-MSC-SA01
AC   CVCL_GR21
DR   Wikidata; Q54898126
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   IPS-OGC-C1
AC   CVCL_C1Y2
DR   Wikidata; Q114311753
RX   PubMed=35876985;
CC   Population: Chinese; Han.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iPS-OPA1-BEHR
AC   CVCL_A4NS
DR   SKIP; SKIP003038
DR   Wikidata; Q105509696
RX   PubMed=27879217;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; c.557-668G>A (c.610+364G>A); ClinVar=VCV000496968; Zygosity=Heterozygous (PubMed=27879217).
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Ile382Met (c.1146A>G); ClinVar=VCV000050866; Zygosity=Heterozygous (PubMed=27879217).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177251; Behr syndrome
DI   ORDO; Orphanet_98671; Hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   IPS-S
AC   CVCL_C876
DR   Wikidata; Q54898127
RX   PubMed=18414447;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   iPS-S1
AC   CVCL_B967
DR   RCB; APS0010
DR   SKIP; SKIP001757
DR   Wikidata; Q54898128
RX   PubMed=20670936;
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: Dutch Belted; VBO=VBO_0017527.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_B969 ! iPS-L1
OI   CVCL_B970 ! iPS-L2
OI   CVCL_B968 ! iPS-S2
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   iPS-S2
AC   CVCL_B968
DR   RCB; APS0011
DR   SKIP; SKIP001758
DR   Wikidata; Q54898129
RX   PubMed=20670936;
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: Dutch Belted; VBO=VBO_0017527.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_B969 ! iPS-L1
OI   CVCL_B970 ! iPS-L2
OI   CVCL_B967 ! iPS-S1
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   iPS-SCU-CD34+ #1
AC   CVCL_V199
SY   CB-CD34+ iPSC1
DR   Wikidata; Q54898130
RX   PubMed=20641038;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Linea_iPS%2520SCU%2520CD34-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_iPS%2520CSU%2520CD34%2520-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   HLA typing: A*02:01,24:02; B*51:01,51:01; C*14:02,16:02; DQB1*06:02,06:03; DRB1*13:01,15:01 (BNLC).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V200 ! iPS-SCU-CD34+ #2
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   iPS-SCU-CD34+ #2
AC   CVCL_V200
SY   CB-CD34+ iPSC2
DR   Wikidata; Q54898131
RX   PubMed=20641038;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_Deposito_iPS_SCU_CD34_2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_iPS_SCU_CD34_2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   HLA typing: A*02:01,24:02; B*51:01,51:01; C*14:02,16:02; DQB1*06:02,06:03; DRB1*13:01,15:01 (BNLC).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V199 ! iPS-SCU-CD34+ #1
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   iPS-SMA-3.5
AC   CVCL_C877
SY   iPS SMA 3.5; IPS-SMA-3.5; iPS-SMA3.5; iPS-SMA clone 3.5
DR   GEO; GSM347916
DR   Wikidata; Q54898132
RX   PubMed=19098894;
CC   Problematic cell line: Misclassified. Parent cell line originally thought to be a SMA type 1 (SMA1) cell line but shown to be from a SMA type 2 (SMA2).
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (PubMed=19098894).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F172 ! GM03813
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   iPS-SMA-3.6
AC   CVCL_C878
AS   CVCL_BV18; CVCL_F171; CVCL_Y792
SY   iPS SMA 3.6; IPS-SMA-3.6; iPS-SMA3.6; iPS-SMA clone 3.6; UW13iSMA-i.6; 13iSMA; GM23240
DR   Coriell; GM23240
DR   GEO; GSM347917
DR   SKIP; SKIP000185
DR   SKIP; SKIP004350
DR   Wikidata; Q54898135
RX   PubMed=19098894;
RX   PubMed=23665875;
CC   Problematic cell line: Misclassified. Parent cell line originally thought to be a SMA type 1 (SMA1) cell line but shown to be from a SMA type 2 (SMA2).
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (PubMed=19098894).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F172 ! GM03813
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   iPS-SPG4-splice
AC   CVCL_IJ21
DR   Wikidata; Q54898136
RX   PubMed=27789400;
CC   From: German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11233; SPAST; Simple; c.1687+2T>A; ClinVar=VCV003720314; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=27789400).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129981; Spastic paraplegia 4
DI   ORDO; Orphanet_100985; Autosomal dominant spastic paraplegia type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 13
//
ID   iPS-SPG5-R486C
AC   CVCL_A4NR
DR   Wikidata; Q105509699
RX   PubMed=27879216;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2652; CYP7B1; Simple; p.Arg486Cys (c.1456C>T); ClinVar=VCV000006107; Zygosity=Homozygous (PubMed=27879216).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177250; Spastic paraplegia 5A
DI   ORDO; Orphanet_100986; Autosomal recessive spastic paraplegia type 5A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   iPS-SPG5-Y275X
AC   CVCL_A4MS
DR   SKIP; SKIP003039
DR   Wikidata; Q105509701
RX   PubMed=27879220;
CC   From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2652; CYP7B1; Simple; p.Tyr275Ter (c.825T>A); ClinVar=VCV000006105; Zygosity=Homozygous (PubMed=27879220).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177250; Spastic paraplegia 5A
DI   ORDO; Orphanet_100986; Autosomal recessive spastic paraplegia type 5A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   iPS-Stm-FB/gfp-99-1
AC   CVCL_T789
SY   iPS-Stm-99-1; Stm99-1
DR   RCB; APS0005
DR   SKIP; SKIP005467
DR   Wikidata; Q54898137
RX   PubMed=18276851;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   iPS-Stm-FB/gfp-99-3
AC   CVCL_T790
SY   iPS-Stm-99-3; Stm99-3
DR   RCB; APS0006
DR   SKIP; SKIP005468
DR   Wikidata; Q54898138
RX   PubMed=18276851;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   iPS-TIG103-4f4
AC   CVCL_C710
SY   iPS-TIG103-4F4; TIG103-4f4; TIG103-4F4
DR   GEO; GSM1040253
DR   GEO; GSM1040323
DR   Wikidata; Q54898139
RX   PubMed=24259714;
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3188 ! TIG-103
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   iPS-TIG107-3f1
AC   CVCL_T840
SY   iPS-TIG107-3F1; TIG107-3f1; TIG107 3F1
DR   GEO; GSM1040255
DR   GEO; GSM1040325
DR   JCRB; JCRB1637
DR   JCRB; NIHS0612
DR   SKIP; SKIP000003
DR   Wikidata; Q54898140
RX   PubMed=24259714;
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0612; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1637
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3192 ! TIG-107
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   iPS-TIG107-4f1
AC   CVCL_C709
SY   iPS-TIG107-4F1; iPS-TIG107-Slc-4F1; TIG107-4f1; TIG107 4F1; TIG1074F1
DR   GEO; GSM1040254
DR   GEO; GSM1040324
DR   GEO; GSM1489221
DR   GEO; GSM1489253
DR   GEO; GSM1489429
DR   JCRB; JCRB1628
DR   JCRB; NIHS0613
DR   SKIP; SKIP000004
DR   Wikidata; Q54898142
RX   PubMed=24259714;
RX   PubMed=27418197;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0613; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1628
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3192 ! TIG-107
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   iPS-TIG108-4f3
AC   CVCL_DP61
SY   TIG108-4f3
DR   GEO; GSM1040256
DR   GEO; GSM1040326
DR   Wikidata; Q54898143
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3193 ! TIG-108
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   iPS-TIG109-4f1
AC   CVCL_DP62
SY   TIG109-4f1
DR   GEO; GSM1040257
DR   GEO; GSM1040327
DR   Wikidata; Q54898145
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3194 ! TIG-109
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   iPS-TIG114-4f1
AC   CVCL_C711
SY   iPS-TIG114-4F1; TIG114-4F1; TIG114-4f1; TIG114 4F1
DR   GEO; GSM1040258
DR   GEO; GSM1040328
DR   JCRB; JCRB1437
DR   SKIP; SKIP000007
DR   SKIP; SKIP001135
DR   Wikidata; Q54898146
RX   PubMed=24259714;
RX   PubMed=25390333;
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1437
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3199 ! TIG-114
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   iPS-TIG118-4f1
AC   CVCL_DP63
SY   TIG118-4f1; TIG118 4F1
DR   GEO; GSM1040259
DR   GEO; GSM1040329
DR   SKIP; SKIP001453
DR   Wikidata; Q54898147
RX   PubMed=24259714;
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3200 ! TIG-118
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   iPS-TIG119-4f1
AC   CVCL_RL41
SY   TIG119 4F1
DR   SKIP; SKIP001454
DR   Wikidata; Q54898148
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3201 ! TIG-119
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS-TIG120-3f7
AC   CVCL_C712
SY   iPS-TIG120-3F7; TIG120-3F7; TIG120 3F7
DR   JCRB; JCRB1341
DR   JCRB; NIHS0615
DR   SKIP; SKIP000005
DR   Wikidata; Q54898149
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0615; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1341
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3202 ! TIG-120
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 13
//
ID   iPS-TIG120-4f1
AC   CVCL_C713
SY   iPS-TIG120-4F1; TIG120-4F1; iPS-TIG120-Slc-4F1; vWT-TIG120-4f1; TIG120-4f1; TIG120 4F1; TIG1204F1
DR   GEO; GSM1040260
DR   GEO; GSM1040330
DR   GEO; GSM1489222
DR   GEO; GSM1489254
DR   GEO; GSM1489430
DR   GEO; GSM1942574
DR   JCRB; JCRB1363
DR   JCRB; NIHS0616
DR   SKIP; SKIP000006
DR   SKIP; SKIP000535
DR   Wikidata; Q54898150
RX   PubMed=24259714;
RX   PubMed=27418197;
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0616; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1363
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3202 ! TIG-120
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   iPS-TIG121-4f4
AC   CVCL_DP64
SY   TIG121-4f4; TIG121 4F4
DR   GEO; GSM1040261
DR   GEO; GSM1040331
DR   SKIP; SKIP001455
DR   Wikidata; Q54898151
RX   PubMed=24259714;
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3203 ! TIG-121
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   iPS-TIG975-e2
AC   CVCL_RL43
SY   TIG975E2
DR   SKIP; SKIP001457
DR   Wikidata; Q54898152
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL42 ! iPS-TIG975-e4
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS-TIG975-e4
AC   CVCL_RL42
SY   TIG975E4
DR   SKIP; SKIP001456
DR   Wikidata; Q54898153
RX   PubMed=27418197;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL43 ! iPS-TIG975-e2
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS-TTF4-1
AC   CVCL_C6WD
DR   Wikidata; Q117704545
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129 Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-TTF4-3
AC   CVCL_C6WE
DR   Wikidata; Q117704546
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129 Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   iPS-TTFgfp4-1
AC   CVCL_C6WF
DR   Wikidata; Q117704547
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-TTFgfp4-2
AC   CVCL_C6WG
DR   Wikidata; Q117704548
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-TTFgfp4-3
AC   CVCL_C6WH
DR   Wikidata; Q117704549
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-TTFgfp4-4
AC   CVCL_C6WI
DR   Wikidata; Q117704550
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-TTFgfp4-5
AC   CVCL_C6WJ
DR   Wikidata; Q117704551
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-TTFgfp4-7
AC   CVCL_C6WK
DR   Wikidata; Q117704552
RX   PubMed=16904174;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: The transgenic mice used have a beta-geo cassette (a fusion of the beta-galactosidase and neo genes) inserted in the Fbx15 gene by homologous recombination.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6-129-ICR Fbx15bgeo/bgeo transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   iPS-WT 4.2
AC   CVCL_C879
AS   CVCL_F175
SY   IPS-WT; iPS-WT4.2; iPS-WT clone 4.2; UW14iCTR-i.2; 14iCTR; GM23241; iPS SMA 4.2
DR   Coriell; GM23241
DR   GEO; GSM347918
DR   SKIP; SKIP000186
DR   Wikidata; Q54898154
RX   PubMed=19098894;
RX   PubMed=23665875;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Discontinued: Coriell; GM23241; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   iPS.C2a
AC   CVCL_D081
DR   Wikidata; Q54898155
RX   PubMed=19998274;
CC   From: Medical College of Wisconsin; Milwaukee; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   iPS.C3a
AC   CVCL_D090
DR   Wikidata; Q54898156
RX   PubMed=19998274;
CC   From: Medical College of Wisconsin; Milwaukee; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   iPS.C6a
AC   CVCL_D091
DR   Wikidata; Q54898158
RX   PubMed=19998274;
CC   From: Medical College of Wisconsin; Milwaukee; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   iPS.II.1.1
AC   CVCL_W241
DR   Wikidata; Q54898159
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W242 ! iPS.II.1.2
OI   CVCL_W243 ! iPS.II.1.3
OI   CVCL_W244 ! iPS.II.1.4
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.II.1.2
AC   CVCL_W242
DR   Wikidata; Q54898160
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W241 ! iPS.II.1.1
OI   CVCL_W243 ! iPS.II.1.3
OI   CVCL_W244 ! iPS.II.1.4
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.II.1.3
AC   CVCL_W243
DR   Wikidata; Q54898161
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W241 ! iPS.II.1.1
OI   CVCL_W242 ! iPS.II.1.2
OI   CVCL_W244 ! iPS.II.1.4
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.II.1.4
AC   CVCL_W244
DR   Wikidata; Q54898162
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W241 ! iPS.II.1.1
OI   CVCL_W242 ! iPS.II.1.2
OI   CVCL_W243 ! iPS.II.1.3
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.II.6.1
AC   CVCL_W245
DR   Wikidata; Q54898163
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W246 ! iPS.II.6.2
OI   CVCL_W247 ! iPS.II.6.3
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.II.6.2
AC   CVCL_W246
DR   Wikidata; Q54898164
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W245 ! iPS.II.6.1
OI   CVCL_W247 ! iPS.II.6.3
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.II.6.3
AC   CVCL_W247
DR   Wikidata; Q54898165
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W245 ! iPS.II.6.1
OI   CVCL_W246 ! iPS.II.6.2
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.III.1.1
AC   CVCL_W248
DR   Wikidata; Q54898166
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W249 ! iPS.III.1.2
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.III.1.2
AC   CVCL_W249
DR   Wikidata; Q54898167
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W248 ! iPS.III.1.1
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.III.3.1
AC   CVCL_W250
DR   Wikidata; Q54898168
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W251 ! iPS.III.3.2
OI   CVCL_W252 ! iPS.III.3.3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.III.3.2
AC   CVCL_W251
DR   Wikidata; Q54898169
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W250 ! iPS.III.3.1
OI   CVCL_W252 ! iPS.III.3.3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.III.3.3
AC   CVCL_W252
DR   Wikidata; Q54898170
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W250 ! iPS.III.3.1
OI   CVCL_W251 ! iPS.III.3.2
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.III.4.1
AC   CVCL_W253
DR   Wikidata; Q54898171
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W254 ! iPS.III.4.2
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.III.4.2
AC   CVCL_W254
DR   Wikidata; Q54898172
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W253 ! iPS.III.4.1
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.III.7.1
AC   CVCL_W255
DR   Wikidata; Q54898173
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W256 ! iPS.III.7.2
OI   CVCL_W257 ! iPS.III.7.3
OI   CVCL_W258 ! iPS.III.7.4
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.III.7.2
AC   CVCL_W256
DR   Wikidata; Q54898174
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W255 ! iPS.III.7.1
OI   CVCL_W257 ! iPS.III.7.3
OI   CVCL_W258 ! iPS.III.7.4
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.III.7.3
AC   CVCL_W257
DR   Wikidata; Q54898175
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W255 ! iPS.III.7.1
OI   CVCL_W256 ! iPS.III.7.2
OI   CVCL_W258 ! iPS.III.7.4
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.III.7.4
AC   CVCL_W258
DR   Wikidata; Q54898176
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W255 ! iPS.III.7.1
OI   CVCL_W256 ! iPS.III.7.2
OI   CVCL_W257 ! iPS.III.7.3
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.IV.1.1
AC   CVCL_W259
DR   Wikidata; Q54898177
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W260 ! iPS.IV.1.2
OI   CVCL_W261 ! iPS.IV.1.3
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.IV.1.2
AC   CVCL_W260
DR   Wikidata; Q54898179
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W259 ! iPS.IV.1.1
OI   CVCL_W261 ! iPS.IV.1.3
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.IV.1.3
AC   CVCL_W261
DR   Wikidata; Q54898180
RX   PubMed=24319668;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W259 ! iPS.IV.1.1
OI   CVCL_W260 ! iPS.IV.1.2
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   iPS.IV.3.1
AC   CVCL_W262
DR   Wikidata; Q54898181
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W263 ! iPS.IV.3.2
OI   CVCL_W264 ! iPS.IV.3.3
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.IV.3.2
AC   CVCL_W263
DR   Wikidata; Q54898182
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W262 ! iPS.IV.3.1
OI   CVCL_W264 ! iPS.IV.3.3
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   iPS.IV.3.3
AC   CVCL_W264
DR   Wikidata; Q54898183
RX   PubMed=24319668;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Heterozygous (PubMed=24319668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W262 ! iPS.IV.3.1
OI   CVCL_W263 ! iPS.IV.3.2
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   ips#137
AC   CVCL_A5IM
SY   iPS clone 137
DR   Wikidata; Q107115466
RX   PubMed=19850773;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Isl1:Cre/Rosa26-LacZ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   ips#202
AC   CVCL_A5IK
SY   iPS clone 202
DR   Wikidata; Q107115467
RX   PubMed=19850773;
RX   PubMed=20026276;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   ips#231
AC   CVCL_A5IL
SY   iPS clone 231
DR   Wikidata; Q107115468
RX   PubMed=19850773;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   iPS01
AC   CVCL_E7BG
WW   Provider; ALSTEM; iPS01; https://www.alstembio.com/web/product_details.php?id=iPS01
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   iPS11
AC   CVCL_E7BE
WW   Provider; ALSTEM; iPS11; https://www.alstembio.com/web/product_details.php?id=iPS11
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   iPS11-10
AC   CVCL_C7XG
DR   Wikidata; Q123032736
WW   Provider; Cell Applications; iPS11-10; https://www.cellapplications.com/human-induced-pluripotent-stem-cells-hipsc
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   iPS12-10
AC   CVCL_C7XH
SY   IUFi004-A
DR   BioSamples; SAMEA114569716
DR   hPSCreg; IUFi004-A
DR   Wikidata; Q123032737
RX   PubMed=38217996;
WW   Provider; Cell Applications; iPS12-10; https://www.cellapplications.com/human-induced-pluripotent-stem-cells-hipsc
CC   From: Cell Applications, Inc.; San Diego; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38217996
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 21,22
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 14,15
ST   D19S433: 15
ST   D1S1656: 13,17.3
ST   D21S11: 28,29
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D6S1043: 12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 2.2,13
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   iPS15
AC   CVCL_E7BF
WW   Provider; ALSTEM; iPS15; https://www.alstembio.com/web/product_details.php?id=iPS15
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   iPS30
AC   CVCL_RG62
DR   SKIP; SKIP000684
DR   Wikidata; Q54898194
RX   PubMed=25050861;
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Cell type: Cardiac muscle myoblast; CL=CL_0000513.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS46
AC   CVCL_RG63
DR   SKIP; SKIP000685
DR   Wikidata; Q54898195
RX   PubMed=25050861;
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Cell type: Cardiac muscle myoblast; CL=CL_0000513.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS59
AC   CVCL_RG64
DR   SKIP; SKIP000686
DR   Wikidata; Q54898196
RX   PubMed=25050861;
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Cell type: Cardiac muscle myoblast; CL=CL_0000513.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS65
AC   CVCL_RG65
DR   SKIP; SKIP000689
DR   Wikidata; Q54898197
RX   PubMed=25050861;
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Cell type: Cardiac muscle myoblast; CL=CL_0000513.
DI   NCIt; C98585; Total anomalous pulmonary venous return
DI   ORDO; Orphanet_99125; Congenital total pulmonary venous return anomaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS68
AC   CVCL_RG66
DR   SKIP; SKIP000688
DR   Wikidata; Q54898198
RX   PubMed=25050861;
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Cell type: Cardiac muscle myoblast; CL=CL_0000513.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS72
AC   CVCL_RG67
DR   SKIP; SKIP000687
DR   Wikidata; Q54898199
RX   PubMed=25050861;
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Cell type: Cardiac muscle myoblast; CL=CL_0000513.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   iPS87
AC   CVCL_YZ64
DR   Wikidata; Q98126787
RX   PubMed=32256979;
CC   Characteristics: Highly tumorigenic. Established from prostate cancer stem cells.
CC   Doubling time: ~42 hours (PubMed=32256979).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   IPSB-18
AC   CVCL_5G64
DR   Wikidata; Q54898200
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1982895;
RX   PubMed=7518347;
RX   PubMed=7591247;
RX   PubMed=8054266;
RX   PubMed=21556643;
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   iPSC #2_1
AC   CVCL_UC06
DR   Wikidata; Q94323128
RX   PubMed=30264886;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_UC07 ! iPSC #2_2
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   iPSC #2_2
AC   CVCL_UC07
DR   Wikidata; Q94323134
RX   PubMed=30264886;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_UC06 ! iPSC #2_1
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   iPSC #3_1.1
AC   CVCL_UC08
DR   Wikidata; Q94323139
RX   PubMed=30264886;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_UC09 ! iPSC #3_1.2
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   iPSC #3_1.2
AC   CVCL_UC09
DR   Wikidata; Q94323141
RX   PubMed=30264886;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_UC08 ! iPSC #3_1.1
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   iPSC #5_1
AC   CVCL_UC10
DR   Wikidata; Q94323147
RX   PubMed=30264886;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_UC11 ! iPSC #5_2
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   iPSC #5_2
AC   CVCL_UC11
DR   Wikidata; Q94323151
RX   PubMed=30264886;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_UC10 ! iPSC #5_1
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   iPSC #7_1
AC   CVCL_UC12
DR   Wikidata; Q94323155
RX   PubMed=30264886;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   iPSC 08-26
AC   CVCL_9S72
SY   iPS0826#6
DR   Wikidata; Q54898192
RX   PubMed=33862537;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_iPS0826_6.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1480; CAPN3; Zygosity=Heterozygous (PubMed=33862537).
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Ter822Leuext62 (c.2465G>T); ClinVar=VCV000571060; Zygosity=Heterozygous (PubMed=33862537).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33862537
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13
ST   D21S11: 25.2,30
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   iPSC 08-46
AC   CVCL_A7HI
DR   Wikidata; Q107115469
RX   PubMed=33862537;
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Arg490Trp (c.1468C>T); ClinVar=VCV000166790; Zygosity=Heterozygous (PubMed=33862537).
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Arg788Serfs*14 (c.2362_2363delAGinsTCATCT); ClinVar=VCV000017618; Zygosity=Heterozygous (PubMed=33862537).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33862537
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   iPSC 09-24
AC   CVCL_9S73
SY   iPS0924#6
DR   Wikidata; Q54898193
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_iPS0924_6-m.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; c.1782+1072G>C; ClinVar=VCV000946832; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Arg788Serfs*14 (c.2362_2363delAGinsTCATCT); ClinVar=VCV000017618; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   iPSC 09-25
AC   CVCL_A7HJ
DR   Wikidata; Q107115470
RX   PubMed=33862537;
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Lys254Glu (c.760A>G); Zygosity=Heterozygous (PubMed=33862537).
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Pro637Hisfs*25 (c.1910delC); Zygosity=Heterozygous (PubMed=33862537).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33862537
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D21S11: 28,31.2
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 5,8
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   iPSC 09-88
AC   CVCL_A7HL
DR   Wikidata; Q107115471
RX   PubMed=33862537;
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33862537
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 32.2,33.2
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   iPSC 09-89
AC   CVCL_UM91
SY   iPS0989#2f
DR   Wikidata; Q94323026
RX   PubMed=33862537;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_iPS0989_2f-m.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Arg788Serfs*14 (c.2362_2363delAGinsTCATCT); ClinVar=VCV000017618; Zygosity=Homozygous (PubMed=33862537).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33862537
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C142079; Limb-girdle muscular dystrophy type 2A
DI   ORDO; Orphanet_267; Autosomal recessive limb-girdle muscular dystrophy type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   iPSC 11-03
AC   CVCL_A7HM
DR   Wikidata; Q107115472
RX   PubMed=33862537;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=33862537
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D21S11: 29,31.2
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   iPSC 285.1
AC   CVCL_C1UA
SY   iPSC285_1
DR   Wikidata; Q114311756
RX   PubMed=35905739;
CC   From: Cincinnati Children's Hospital Medical Center; Cincinnati; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35905739
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 11,16
ST   D21S11: 30,31.2
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 20,24
ST   Penta D: 9,12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   iPSC 72.3-NEUROG3
AC   CVCL_A1BX
SY   iPSC72.3-NEUROG3
DR   Wikidata; Q102114243
RX   PubMed=28648364;
CC   Characteristics: Dox-induced expression (using rtTA) of NEUROG3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13806; NEUROG3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1BW ! CCHMCi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   iPSC 75.1
AC   CVCL_C1UB
SY   iPSC75_1
DR   Wikidata; Q114311757
RX   PubMed=35905739;
CC   From: Cincinnati Children's Hospital Medical Center; Cincinnati; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=35905739
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D16S539: 10,11
ST   D18S51: 17,21
ST   D21S11: 28,30
ST   D3S1358: 18
ST   D5S818: 10,12
ST   D7S820: 8,14
ST   D8S1179: 13,16
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 13,14
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   iPSC A1
AC   CVCL_RG52
SY   A1
DR   SKIP; SKIP000662
DR   Wikidata; Q54898201
RX   PubMed=18786421;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V426 ! GM01660
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC A11
AC   CVCL_RG53
SY   A11
DR   Wikidata; Q54898202
RX   PubMed=18786421;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V426 ! GM01660
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC A2
AC   CVCL_RG54
SY   A2
DR   Wikidata; Q54898203
RX   PubMed=18786421;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V426 ! GM01660
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC A6
AC   CVCL_RG55
SY   A6
DR   SKIP; SKIP000663
DR   Wikidata; Q54898204
RX   PubMed=18786421;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V426 ! GM01660
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC A9
AC   CVCL_RG56
SY   A9
DR   Wikidata; Q54898205
RX   PubMed=18786421;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V426 ! GM01660
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC C1
AC   CVCL_RG57
SY   C1
DR   Wikidata; Q54898206
RX   PubMed=18786421;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V426 ! GM01660
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC carrier 1 line 5
AC   CVCL_Y957
SY   Carrier1 #5
DR   SKIP; SKIP000324
DR   Wikidata; Q54898207
RX   PubMed=23836290;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=23836290).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y958 ! iPSC carrier 1 line 6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   iPSC carrier 1 line 6
AC   CVCL_Y958
SY   Carrier1 #6
DR   SKIP; SKIP000325
DR   Wikidata; Q54898208
RX   PubMed=23836290;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=23836290).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y957 ! iPSC carrier 1 line 5
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   iPSC carrier 2 line 1
AC   CVCL_Y959
SY   Carrier2 #1
DR   SKIP; SKIP000326
DR   Wikidata; Q54898209
RX   PubMed=23836290;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=23836290).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y960 ! iPSC carrier 2 line 11
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   iPSC carrier 2 line 11
AC   CVCL_Y960
SY   Carrier2 #11
DR   SKIP; SKIP000327
DR   Wikidata; Q54898210
RX   PubMed=23836290;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=23836290).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y959 ! iPSC carrier 2 line 1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 10
//
ID   iPSC D1
AC   CVCL_RG58
SY   D1
DR   Wikidata; Q54898211
RX   PubMed=18786421;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC D4
AC   CVCL_RG59
SY   D4
DR   Wikidata; Q54898212
RX   PubMed=18786421;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   iPSC DKC1 A353V #1
AC   CVCL_UG49
SY   A353V #1; A353V1
DR   GEO; GSM1633294
DR   Wikidata; Q94323331
RX   PubMed=25992652;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Ala353Val (c.1058C>T); ClinVar=VCV000011587; Zygosity=Hemizygous (PubMed=25992652).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: iPSC DKC1 A335V #1; Note=In Cellosaurus releases 28 to 35.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG50 ! iPSC DKC1 A353V #2
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   iPSC DKC1 A353V #2
AC   CVCL_UG50
SY   A353V #2; A353V2
DR   GEO; GSM1633295
DR   Wikidata; Q94323336
RX   PubMed=25992652;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Ala353Val (c.1058C>T); ClinVar=VCV000011587; Zygosity=Hemizygous (PubMed=25992652).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: iPSC DKC1 A335V #2; Note=In Cellosaurus releases 28 to 35.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG49 ! iPSC DKC1 A353V #1
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   iPSC DKC1 Del37 #1
AC   CVCL_UG51
SY   Del37 #1; Del371
DR   GEO; GSM1633296
DR   Wikidata; Q94323338
RX   PubMed=25992652;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Hemizygous (PubMed=25992652).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7336 ! GM01774
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   iPSC DKC1 Del37 #2
AC   CVCL_UG52
SY   Del37 #2; Del372
DR   GEO; GSM1633297
DR   Wikidata; Q94323341
RX   PubMed=25992652;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Hemizygous (PubMed=25992652).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7336 ! GM01774
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   iPSC DKC1 Q31E
AC   CVCL_UG53
SY   Q31E
DR   GEO; GSM1633298
DR   Wikidata; Q94323344
RX   PubMed=25992652;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Gln31Glu (c.91C>G); ClinVar=VCV000038954; Zygosity=Hemizygous (PubMed=25992652).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   iPSC Dup15q
AC   CVCL_F0TX
RX   PubMed=39059105;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5R29 ! GM20562
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   iPSC Dup15q_iso
AC   CVCL_F0TY
SY   clone 3-41
RX   PubMed=39059105;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 the extra isodicentric chromosone 15 was removed in a four step process (PubMed=39059105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0TX ! iPSC Dup15q
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   iPSC R87C C8
AC   CVCL_C6NH
SY   Clone SP1C8
DR   Wikidata; Q123032738
RX   PubMed=37646972;
CC   From: Stem Cell Basic Biology Laboratory, Instituto Carlos Chagas, Fiocruz; Curitiba; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:13760; CYFIP2; Simple; p.Arg87Cys (c.259C>T); ClinVar=VCV000430807; Zygosity=Heterozygous (PubMed=37646972).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C201518; Developmental and epileptic encephalopathy 65
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   iPSC SZT2 I.I +/Mut1
AC   CVCL_D6L4
DR   Wikidata; Q127382391
RX   PubMed=36361881;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29040; SZT2; Simple; p.Arg2242Trp (c.6724C>T) (p.Arg2185Trp, c.6553C>T); ClinVar=VCV000429775; Zygosity=Heterozygous (PubMed=36361881).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   iPSC SZT2 I.II +/Mut2
AC   CVCL_D6L5
DR   Wikidata; Q127382392
RX   PubMed=36361881;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29040; SZT2; Simple; p.Gln166His (c.498G>T); ClinVar=VCV000559530; Zygosity=Heterozygous (PubMed=36361881).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   iPSC STZ2 II.4 Mut1/Mut2
AC   CVCL_D6L3
DR   Wikidata; Q127382393
RX   PubMed=36361881;
CC   From: EURAC Research Institute for Biomedicine; Bolzano; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29040; SZT2; Simple; p.Gln166His (c.498G>T); ClinVar=VCV000559530; Zygosity=Heterozygous (PubMed=36361881).
CC   Sequence variation: Mutation; HGNC; HGNC:29040; SZT2; Simple; p.Arg2242Trp (c.6724C>T) (p.Arg2185Trp, c.6553C>T); ClinVar=VCV000429775; Zygosity=Heterozygous (PubMed=36361881).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206098; Developmental and epileptic encephalopathy 18
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   iPSC-1s
AC   CVCL_D082
SY   mc-iPSC-1s
DR   GEO; GSM499757
DR   Wikidata; Q54898213
RX   PubMed=20139967;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   iPSC-2s
AC   CVCL_D083
SY   mc-iPSC-1s
DR   GEO; GSM499758
DR   Wikidata; Q54898214
RX   PubMed=20139967;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   iPSC-3s
AC   CVCL_D084
DR   Wikidata; Q54898215
RX   PubMed=20139967;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   iPSC-CB1RB9
AC   CVCL_A8NJ
SY   RB9-CB1
DR   Wikidata; Q108820549
RX   PubMed=25680478;
RX   PubMed=28380349;
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   iPSC-CB1RB9-WAS-GFP
AC   CVCL_A8NK
DR   Wikidata; Q108820550
RX   PubMed=28380349;
CC   Characteristics: Transduced with a lentiviral vector expressing GFP under the control of the WAS gene promoter (PubMed=28380349).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8NJ ! iPSC-CB1RB9
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   iPSC-CGD1.1
AC   CVCL_V181
DR   Wikidata; Q54898216
RX   PubMed=22311747;
CC   Sequence variation: Mutation; HGNC; HGNC:7660; NCF1; Simple; p.Tyr26Hisfs*26 (c.73_74GT[1]) (c.75_76delGT); ClinVar=VCV000002249; Zygosity=Homozygous (PubMed=22311747).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C154314; Autosomal recessive cytochrome b-positive chronic granulomatous disease type I
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V182 ! iPSC-CGD1.2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   iPSC-CGD1.2
AC   CVCL_V182
DR   Wikidata; Q54898217
RX   PubMed=22311747;
CC   Sequence variation: Mutation; HGNC; HGNC:7660; NCF1; Simple; p.Tyr26Hisfs*26 (c.73_74GT[1]) (c.75_76delGT); ClinVar=VCV000002249; Zygosity=Homozygous (PubMed=22311747).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22311747
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 30,31.2
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,16
ST   FGA: 18,19
ST   Penta D: 9,14
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C154314; Autosomal recessive cytochrome b-positive chronic granulomatous disease type I
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V181 ! iPSC-CGD1.1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   iPSC-CGD2
AC   CVCL_V183
DR   Wikidata; Q54898218
RX   PubMed=22311747;
CC   Sequence variation: Mutation; HGNC; HGNC:2578; CYBB; Simple; c.46-11T>G (IVS1-11T>G); Zygosity=Hemizygous (PubMed=22311747).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22311747
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 16,19
ST   D21S11: 30,31
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 11,15
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C154315; X-linked chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   iPSC-CGD3
AC   CVCL_V184
DR   Wikidata; Q54898222
RX   PubMed=22311747;
CC   Sequence variation: Mutation; HGNC; HGNC:2578; CYBB; Unexplicit; Ex1-3del; Zygosity=Hemizygous (PubMed=22311747).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22311747
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 10,16
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 13
ST   Penta E: 11,14
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C154315; X-linked chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   iPSc-GD-A8
AC   CVCL_IN10
SY   GD iPSC A8; Gaucher iPSC-A8; A8
DR   GEO; GSM1012130
DR   Wikidata; Q54898224
RX   PubMed=23118351;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Gly241Arg (c.721G>A) (G202R); ClinVar=VCV000093459; Zygosity=Heterozygous (PubMed=23118351).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=23118351).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN11 ! iPSc-GD-C21
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 17
//
ID   iPSc-GD-C21
AC   CVCL_IN11
SY   GD iPSC C21; Gaucher iPSC-C21; C21; 21C
DR   GEO; GSM1012128
DR   Wikidata; Q54898225
RX   PubMed=23118351;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Gly241Arg (c.721G>A) (G202R); ClinVar=VCV000093459; Zygosity=Heterozygous (PubMed=23118351).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=23118351).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN10 ! iPSc-GD-A8
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 17
//
ID   iPSC-HDF
AC   CVCL_V185
DR   Wikidata; Q54898226
RX   PubMed=22311747;
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=22311747
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,27
ST   Penta D: 10
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   iPSC-HDFs-clone 30
AC   CVCL_UM98
DR   Wikidata; Q94323467
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito-iPSC-HDFs-clone-30.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXO-iPSC-HDFs-clone-30.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15,21
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 19,25
ST   D3S1358: 14,15
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 22,24
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   iPSC-hDPSC
AC   CVCL_B7DW
DR   CLS; 300622
DR   Wikidata; Q112929873
CC   Population: Caucasian.
CC   Derived from site: In situ; Tooth, molar, dental pulp; UBERON=UBERON_0015838.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18-30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   iPSC-MHF2 c1
AC   CVCL_D089
DR   Wikidata; Q54898227
RX   PubMed=20098701;
CC   From: University of Washington; Seattle; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7421 ! GM05387
SX   Male
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   iPSC-TTNCys3892Ser het
AC   CVCL_E6ZR
RX   PubMed=37253077;
CC   From: Centro Nacional de Investigaciones Cardiovasculares (CNIC); Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Cys3892Ser (c.11674T>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37253077).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6ZP ! HDF-iPS-SV10
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   iPSC-TTNCys3892Ser hom
AC   CVCL_E6ZS
RX   PubMed=37253077;
CC   From: Centro Nacional de Investigaciones Cardiovasculares (CNIC); Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple_edited; p.Cys3892Ser (c.11674T>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37253077).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6ZP ! HDF-iPS-SV10
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   iPSC(OCT4) 1
AC   CVCL_A4VL
SY   iPSCOCT4 1; Fibroblast 1 iPSC(OCT4); Fib 1 iPSCOCT4
DR   Wikidata; Q107115473
RX   PubMed=26141785;
CC   From: McMaster Stem Cell and Cancer Research Institute, Michael G. DeGroote School of Medicine, McMaster University; Hamilton; Canada.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=26141785
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 17,21
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 19,26
ST   D3S1358: 15,17
ST   D5S818: 8,11
ST   D7S820: 8,9
ST   D8S1179: 14,17
ST   FGA: 19,23
ST   TH01: 6,7
ST   TPOX: 6,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   iPSC(OCT4) 2
AC   CVCL_A4VM
SY   iPSCOCT4 2; Fibroblast 2 iPSC(OCT4); Fib 2 iPSCOCT4
DR   Wikidata; Q107115474
RX   PubMed=26141785;
CC   From: McMaster Stem Cell and Cancer Research Institute, Michael G. DeGroote School of Medicine, McMaster University; Hamilton; Canada.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=26141785
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 14.2,15
ST   D21S11: 28,33.2
ST   D2S1338: 20,22
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 7,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   iPSC(OCT4) 3
AC   CVCL_A4VN
SY   iPSCOCT4 3; Fibroblast 3 iPSC(OCT4); Fib 3 iPSCOCT4
DR   Wikidata; Q107115475
RX   PubMed=26141785;
CC   From: McMaster Stem Cell and Cancer Research Institute, Michael G. DeGroote School of Medicine, McMaster University; Hamilton; Canada.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=26141785
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 16,18
ST   D19S433: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 15,16
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   iPSC1
AC   CVCL_D086
DR   Wikidata; Q54898228
RX   PubMed=19763270;
CC   From: University of California, San Diego; San Diego; USA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
ST   Source(s): PubMed=19763270
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D18S51: 10,17
ST   D21S11: 28,32
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,16
ST   FGA: 20,25
ST   Penta D: 9,13
ST   Penta E: 7,21
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E921 ! ReNcell VM
SX   Male
AG   10FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 14
//
ID   iPSC2
AC   CVCL_D087
DR   Wikidata; Q54898229
RX   PubMed=19763270;
CC   From: University of California, San Diego; San Diego; USA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E921 ! ReNcell VM
SX   Male
AG   10FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 14
//
ID   iPSC3
AC   CVCL_D088
DR   Wikidata; Q54898230
RX   PubMed=19763270;
CC   From: University of California, San Diego; San Diego; USA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E921 ! ReNcell VM
SX   Male
AG   10FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 13
//
ID   iPSC567-24 MUT
AC   CVCL_C3GP
SY   567.24 MUT; iPSC Patient567 RTT
DR   GEO; GSM2866259
DR   GEO; GSM2866261
DR   Wikidata; Q114311758
RX   PubMed=29742391;
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Ter487Trp (c.1461A>G) (p.Ter499Trp, c.1497A>G); ClinVar=VCV000143490; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F46 ! GM17567
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iPSC567-25 WT
AC   CVCL_C3GQ
SY   567.25 WT; iPSC Patient567 Normal WT
DR   GEO; GSM2866256
DR   Wikidata; Q114311759
RX   PubMed=29742391;
CC   Characteristics: Due to X chromosome inactivation does not express the mutated allele.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Ter487Trp (c.1461A>G) (p.Ter499Trp, c.1497A>G); ClinVar=VCV000143490; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F46 ! GM17567
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iPSC72_3-AAVS1-CAG-GFP
AC   CVCL_C7HE
SY   72.3-GFP; iPSC72.3-GFP; iPSC72_3-AAVS1-GFP
DR   Wikidata; Q117704553
RX   PubMed=34856121;
CC   Characteristics: Using CRISPR/Cas9 GFP under the control of a CAG promoter has been inserted at the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Misspelling: 77.3 GFP; PubMed=34856121.
CC   Misspelling: iPSC77.3 GFP; PubMed=34856121.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1BW ! CCHMCi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 5
//
ID   iPSC982-15 MUT
AC   CVCL_C3GR
SY   982.15 MUT; iPSC Patient982 RTT
DR   GEO; GSM2866262
DR   GEO; GSM2866263
DR   Wikidata; Q114311760
RX   PubMed=29742391;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V341 ! GM07982
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iPSC982-16 WT
AC   CVCL_C3GS
SY   982.16 WT; iPSC Patient982 Normal WT
DR   GEO; GSM2866257
DR   GEO; GSM2866258
DR   Wikidata; Q114311761
RX   PubMed=29742391;
CC   Population: Caucasian; Austrian.
CC   Characteristics: Due to X chromosome inactivation does not express the mutated allele.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V341 ! GM07982
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   iPSC982-17 MUT
AC   CVCL_C3GT
SY   982.17 MUT
DR   Wikidata; Q114311762
RX   PubMed=29742391;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V341 ! GM07982
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   iPSC982-18 WT
AC   CVCL_C3GU
SY   982.18 WT
DR   Wikidata; Q114311763
RX   PubMed=29742391;
CC   Population: Caucasian; Austrian.
CC   Characteristics: Due to X chromosome inactivation does not express the mutated allele.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V341 ! GM07982
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   iPSCWT2
AC   CVCL_RM90
DR   Wikidata; Q54898231
RX   PubMed=21494607;
CC   Population: Caucasian.
CC   Miscellaneous: Identification of parent cell line from personal communication of Zambidis, Elias Thomas.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L750 ! AG07714
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   iPSCWT4
AC   CVCL_RM91
DR   Wikidata; Q54898232
RX   PubMed=21494607;
CC   Population: Caucasian.
CC   Miscellaneous: Identification of parent cell line from personal communication of Zambidis, Elias Thomas.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L750 ! AG07714
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   IPSCZHi001-A
AC   CVCL_D0G6
SY   GM769_S6
DR   BioSamples; SAMEA113594962
DR   hPSCreg; IPSCZHi001-A
DR   Wikidata; Q123032739
CC   From: iPSCore Zurich, University of Zurich; Zurich; Switzerland.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C202072; Periventricular nodular heterotopia
DI   ORDO; Orphanet_98892; Periventricular nodular heterotopia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IPTi001-A
AC   CVCL_WR08
SY   15M0008; iPSC-15M0008
DR   BioSamples; SAMEA5574047
DR   hPSCreg; IPTi001-A
DR   SKIP; SKIP005577
DR   Wikidata; Q94323556
RX   PubMed=31689594;
RX   PubMed=33799279;
CC   From: Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   IPTi002-A
AC   CVCL_YM68
SY   15F0009
DR   BioSamples; SAMEA6456095
DR   hPSCreg; IPTi002-A
DR   Wikidata; Q94323559
RX   PubMed=33799279;
CC   From: Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=33799279).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   IPTi003-A
AC   CVCL_YM69
SY   15M0010
DR   BioSamples; SAMEA6456100
DR   hPSCreg; IPTi003-A
DR   Wikidata; Q94323565
CC   From: Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   IPTi004-A
AC   CVCL_YM70
SY   15M0011
DR   BioSamples; SAMEA6456102
DR   hPSCreg; IPTi004-A
DR   Wikidata; Q94323570
CC   From: Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   IPTi005-A
AC   CVCL_YM71
SY   16M0064
DR   BioSamples; SAMEA6456106
DR   hPSCreg; IPTi005-A
DR   SKIP; SKIP005807
DR   Wikidata; Q94323573
RX   PubMed=32402716;
CC   From: Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   IPTi006-A
AC   CVCL_YM72
SY   16M0065
DR   BioSamples; SAMEA6456108
DR   hPSCreg; IPTi006-A
DR   Wikidata; Q94323580
CC   From: Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   IPTi007-A
AC   CVCL_YM73
SY   16F0066
DR   BioSamples; SAMEA6456104
DR   hPSCreg; IPTi007-A
DR   SKIP; SKIP005808
DR   Wikidata; Q94323584
RX   PubMed=32402716;
CC   From: Institute of Pharmacology and Toxicology; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   IPTP/98
AC   CVCL_7168
SY   IPTP-98
DR   BioSample; SAMN03152018
DR   ECACC; 99050528
DR   Wikidata; Q54898236
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00321.
CC   Discontinued: ECACC; 99050528; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   IPTR-6
AC   CVCL_5G69
DR   Wikidata; Q54898237
RX   PubMed=7518347;
RX   PubMed=7591247;
DI   NCIt; C3788; Ganglioglioma
DI   ORDO; Orphanet_251949; Ganglioglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   iPWS1
AC   CVCL_T948
SY   A000041#1; A000041# 1; HPS0080
DR   SKIP; SKIP000025
DR   Wikidata; Q54898233
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L556 ! PWS-Yamaguchi
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   iPWS3
AC   CVCL_T949
SY   A000041#3; A000041# 3; HPS0081
DR   SKIP; SKIP000026
DR   Wikidata; Q54898234
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L556 ! PWS-Yamaguchi
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   iPWS5
AC   CVCL_T947
SY   A000041#5; A000041# 5; HPS0082
DR   RCB; HPS0082
DR   SKIP; SKIP000027
DR   SKIP; SKIP000283
DR   Wikidata; Q54898235
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L556 ! PWS-Yamaguchi
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   IR
AC   CVCL_ZD54
DR   Wikidata; Q98126788
RX   PubMed=8105609;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   IR-M1
AC   CVCL_WI71
DR   SKIP; SKIP000912
DR   Wikidata; Q94323659
RX   PubMed=25059784;
RX   PubMed=26831110;
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Arg924Ter (c.2770C>T) (R897*); ClinVar=VCV000014686; Zygosity=Heterozygous (PubMed=25059784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W99 ! GM05241
SX   Female
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   IR-M2
AC   CVCL_WI72
DR   SKIP; SKIP000913
DR   Wikidata; Q94323662
RX   PubMed=25059784;
RX   PubMed=26831110;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Ala2Gly (c.5C>G); ClinVar=VCV000193063; Zygosity=Homozygous (PubMed=25059784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9X16 ! GM10277
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   IR-M3
AC   CVCL_WI73
DR   SKIP; SKIP000914
DR   Wikidata; Q94323669
RX   PubMed=25059784;
RX   PubMed=26831110;
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Leu260Pro (c.779T>C) (L233P); ClinVar=VCV000014689; Zygosity=Homozygous (PubMed=25059784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9Y52 ! GM20034
SX   Male
AG   0-3M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   IR-M4
AC   CVCL_WI74
DR   SKIP; SKIP000915
DR   Wikidata; Q94323674
RX   PubMed=26831110;
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:6091; INSR; Simple; p.Glu151Ter (c.451G>T) (E124X); Zygosity=Homozygous (PubMed=26831110).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84676; Donohue syndrome
DI   ORDO; Orphanet_508; Leprechaunism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9Y54 ! GM20327
SX   Female
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   IR983F
AC   CVCL_7675
SY   IR 983F; IR 983 F; 983
DR   CCRID; 1101RAT-PUMC000221
DR   Wikidata; Q54898238
RX   CelloPub=CLPUB00609;
RX   DOI=10.1016/B978-0-08-027988-6.50144-0;
RX   PubMed=6678801;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Misspelling: IRF938F; Note=Occasionally.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: LOU/C; RS=RS_0000563.
DI   NCIt; C125416; Rat multiple myeloma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   72W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   IRAN1010 fibroblast
AC   CVCL_A9F4
DR   Wikidata; Q102114245
RX   PubMed=12927431;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Ala57Pro (c.169G>C); ClinVar=VCV000014506; Zygosity=Heterozygous (PubMed=12927431).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174217; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
DI   ORDO; Orphanet_2229; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9F5 ! IRAN1010 LCL
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   IRAN1010 LCL
AC   CVCL_A9F5
DR   Wikidata; Q102114246
RX   PubMed=12927431;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Ala57Pro (c.169G>C); ClinVar=VCV000014506; Zygosity=Heterozygous (PubMed=12927431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174217; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
DI   ORDO; Orphanet_2229; Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9F4 ! IRAN1010 fibroblast
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   IRB-1
AC   CVCL_IU71
SY   Iranian RetinoBlastoma-1
DR   Wikidata; Q54898239
RX   DOI=10.7287/peerj.preprints.2780v1;
CC   Population: Iranian.
CC   Doubling time: 36 +- 4.6 hours (DOI=10.7287/peerj.preprints.2780v1).
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   iRBMSCs
AC   CVCL_E7CC
SY   immortalized Rabbit Bone Marrow Mesenchymal Stem Cells
RX   PubMed=39592420;
CC   Characteristics: Transduced with a SSR#41 vector (LTR-FRT-HygR-HSV1-TK-IRES-SV40LT-FRT-Neo-LTR) that allows removal of the SV40 TAg by using FLP (PubMed=39592420).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IRC-1
AC   CVCL_AR97
DR   JCRB; NIHS0315
DR   Wikidata; Q54898240
CC   Discontinued: JCRB; NIHS0315; true.
ST   Source(s): JCRB=NIHS0315
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 5
//
ID   IRC-2
AC   CVCL_8359
DR   BioSample; SAMN03472498
DR   JCRB; JCRB1068
DR   JCRB; NIHS0322
DR   Wikidata; Q54898241
CC   Population: Japanese.
CC   Discontinued: JCRB; JCRB1068; true.
CC   Discontinued: JCRB; NIHS0322; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
ST   Source(s): JCRB=JCRB1068
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 9,10
ST   D5S818: 7,10
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   IRC10-30 Myc-1
AC   CVCL_E5TS
SY   Immortalized Rat Clone 10/30 Myc-1
DR   ABM; T0216
RX   PubMed=1887824;
CC   Characteristics: Osteogenic. Besides bone, also can form cartilage and fibrous tissue (PubMed=1887824).
CC   Doubling time: ~2 days (PubMed=1887824).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P12523; Avian retrovirus OK10 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Recombinant Murine myc-containing virus (MMCV OK-10 v-myc).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E5TT ! IRC10-30 Myc-3
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IRC10-30 Myc-3
AC   CVCL_E5TT
SY   Immortalized Rat Clone 10/30 Myc-3
DR   ABM; T0217
RX   PubMed=1887824;
CC   Characteristics: Osteogenic. Besides bone, also can form cartilage and fibrous tissue (PubMed=1887824).
CC   Doubling time: ~2 days (PubMed=1887824).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P12523; Avian retrovirus OK10 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Recombinant Murine myc-containing virus (MMCV OK-10 v-myc).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E5TS ! IRC10-30 Myc-1
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IRCC-Neuromed-CG
AC   CVCL_B1D2
SY   CG
DR   Wikidata; Q110432930
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, temporo-insular lobe.
DI   NCIt; C129274; Diffuse astrocytoma, IDH-wildtype
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRCC-Neuromed-CL
AC   CVCL_B1CV
SY   CL
DR   Wikidata; Q110432931
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRCC-Neuromed-COGI
AC   CVCL_B1CU
SY   COGI
DR   Wikidata; Q110432932
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRCC-Neuromed-DA
AC   CVCL_B1D3
SY   DA
DR   Wikidata; Q110432933
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, central sulcus; UBERON=UBERON_0002916.
DI   NCIt; C129274; Diffuse astrocytoma, IDH-wildtype
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRCC-Neuromed-DNA
AC   CVCL_B1CX
SY   DNA
DR   Wikidata; Q110432934
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRCC-Neuromed-FL
AC   CVCL_B1D4
SY   FL
DR   cancercelllines; CVCL_B1D4
DR   Wikidata; Q110432935
RX   PubMed=33398536;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33398536).
CC   Derived from site: In situ; Brain, cerebral cortex, insular lobe; UBERON=UBERON_0002022.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   IRCC-Neuromed-IP
AC   CVCL_B1D0
SY   IP
DR   Wikidata; Q110432936
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRCC-Neuromed-MI
AC   CVCL_B1D5
SY   MI
DR   cancercelllines; CVCL_B1D5
DR   Wikidata; Q110432937
RX   PubMed=33398536;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33398536).
CC   Derived from site: In situ; Brain, temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C129271; Astrocytoma, IDH-mutant, grade 2
DI   ORDO; Orphanet_251595; Diffuse astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   IRCC-Neuromed-NULU
AC   CVCL_B1D1
SY   NULU
DR   Wikidata; Q110432938
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   IRCC-Neuromed-PAP
AC   CVCL_B1CW
SY   PAP
DR   cancercelllines; CVCL_B1CW
DR   Wikidata; Q110432939
RX   PubMed=33398536;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33398536).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   IRCC-Neuromed-VEM
AC   CVCL_B1CZ
SY   VEM
DR   Wikidata; Q110432940
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRCC-Neuromed-ZAR
AC   CVCL_B1CY
SY   ZAR
DR   Wikidata; Q110432941
RX   PubMed=33398536;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   IRE/CTVM18
AC   CVCL_Z156
DR   Wikidata; Q54898242
RX   PubMed=15053931;
RX   PubMed=17662657;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line not distributed due to Mycoplasma contamination (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=34613; ! Ixodes ricinus (Common tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   IRE/CTVM19
AC   CVCL_Z157
DR   Wikidata; Q54898243
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
RX   PubMed=32278686;
RX   PubMed=32778731;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34613; ! Ixodes ricinus (Common tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   IRE/CTVM20
AC   CVCL_Z158
DR   Wikidata; Q54898244
RX   PubMed=17662657;
RX   PubMed=20388200;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=23146170;
RX   PubMed=29886187;
RX   PubMed=32158404;
RX   PubMed=32778731;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34613; ! Ixodes ricinus (Common tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   IRE/LUAP46
AC   CVCL_C1GV
DR   Wikidata; Q114311764
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34613; ! Ixodes ricinus (Common tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   IRE/LULS55
AC   CVCL_C1GW
DR   Wikidata; Q114311765
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34613; ! Ixodes ricinus (Common tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   IRE11
AC   CVCL_Z200
DR   Wikidata; Q54898245
RX   PubMed=12200314;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_0941d3180e
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=34613; ! Ixodes ricinus (Common tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   IREs-4
AC   CVCL_W994
SY   IFN resistant Eskol-4
DR   Wikidata; Q54898246
RX   PubMed=7694002;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B398 ! ESKOL
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   IRFMNi001-A
AC   CVCL_IT61
SY   iPS clone IV
DR   BioSamples; SAMEA7614418
DR   hPSCreg; IRFMNi001-A
DR   SKIP; SKIP002895
DR   Wikidata; Q54898247
RX   PubMed=25744951;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WF ! IRFMNi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 10
//
ID   IRFMNi001-B
AC   CVCL_A1WF
SY   iPS clone XI
DR   BioSamples; SAMEA7431388
DR   hPSCreg; IRFMNi001-B
DR   Wikidata; Q105509705
RX   PubMed=34688128;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT61 ! IRFMNi001-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   IRFMNi001-B-1
AC   CVCL_B5S3
SY   Clone XI CIITAKO; CIITA-/-
DR   BioSamples; SAMEA9266665
DR   hPSCreg; IRFMNi001-B-1
DR   Wikidata; Q111733516
RX   PubMed=34688128;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1WF ! IRFMNi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   IRFMNi001-B-2
AC   CVCL_C1TS
SY   Clone M CIITAKO-B2MKO
DR   BioSamples; SAMEA110465773
DR   hPSCreg; IRFMNi001-B-2
DR   Wikidata; Q114311766
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5S3 ! IRFMNi001-B-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   IRFMNi002-A
AC   CVCL_VL43
SY   PRM#14
DR   BioSamples; SAMEA4891335
DR   hPSCreg; IRFMNi002-A
DR   Wikidata; Q94323813
RX   PubMed=30399566;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:8616; PAX2; Simple; p.Gly189Arg (c.565G>A); ClinVar=VCV000155928; Zygosity=Heterozygous (PubMed=30399566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202604; Focal segmental glomerulosclerosis 7
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UJ77 ! IRFMNi002-B
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   IRFMNi002-B
AC   CVCL_UJ77
SY   PRM#18
DR   BioSamples; SAMEA4975314
DR   hPSCreg; IRFMNi002-B
DR   Wikidata; Q94323817
RX   PubMed=30399566;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:8616; PAX2; Simple; p.Gly189Arg (c.565G>A); ClinVar=VCV000155928; Zygosity=Heterozygous (PubMed=30399566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202604; Focal segmental glomerulosclerosis 7
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL43 ! IRFMNi002-A
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   IRFMNi003-A
AC   CVCL_WU24
DR   BioSamples; SAMEA5843912
DR   hPSCreg; IRFMNi003-A
DR   Wikidata; Q94323821
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   IRFMNi003-A-1
AC   CVCL_WZ54
SY   KO PKD2#17
DR   BioSamples; SAMEA5781291
DR   hPSCreg; IRFMNi003-A-1
DR   Wikidata; Q94323825
RX   PubMed=31830647;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple_edited; p.Arg89Profs*25 (c.266_275delGCGATAACCC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31830647).
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple_edited; p.Gly93Alafs*24 (c.276delC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31830647).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU24 ! IRFMNi003-A
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   IRFMNi003-A-2
AC   CVCL_WZ55
SY   KO PKD2#36
DR   BioSamples; SAMEA5781292
DR   hPSCreg; IRFMNi003-A-2
DR   Wikidata; Q94323830
RX   PubMed=31830647;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple_edited; p.Gln85Leufs*119 (c.254_279delAGGCGTGGAGCCGCGATAACCCCGGC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31830647).
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple_edited; p.Gly93Alafs*24 (c.276delC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31830647).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU24 ! IRFMNi003-A
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   IRFMNi003-A-3
AC   CVCL_A9YN
SY   KO PKD1#16
DR   BioSamples; SAMEA6447332
DR   hPSCreg; IRFMNi003-A-3
DR   Wikidata; Q102114247
RX   PubMed=32592954;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple_edited; p.Pro3582Glyfs*44 (c.10744_10745delCC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32592954).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU24 ! IRFMNi003-A
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   IRFMNi003-A-4
AC   CVCL_A9YP
SY   KO PKD1#5
DR   BioSamples; SAMEA6453887
DR   hPSCreg; IRFMNi003-A-4
DR   Wikidata; Q102114248
RX   PubMed=32592954;
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple_edited; p.Pro3582Glyfs*44 (c.10744_10745delCC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32592954).
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple_edited; p.Pro3582Glyfs*3 (c.10745delC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32592954).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU24 ! IRFMNi003-A
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   IRFMNi004-A
AC   CVCL_D0G7
DR   hPSCreg; IRFMNi004-A
DR   Wikidata; Q123032740
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IRFMNi005-A
AC   CVCL_D0G8
SY   MNCdLS1
DR   BioSamples; SAMEA114402112
DR   hPSCreg; IRFMNi005-A
DR   Wikidata; Q123032741
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IRFMNi006-A
AC   CVCL_D0G9
SY   MNMo1
DR   BioSamples; SAMEA114402459
DR   hPSCreg; IRFMNi006-A
DR   Wikidata; Q123032742
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IRFMNi007-A
AC   CVCL_D0GA
SY   MNFa1
DR   BioSamples; SAMEA114402616
DR   hPSCreg; IRFMNi007-A
DR   Wikidata; Q123032743
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IRFMNi008-A
AC   CVCL_D0GB
DR   hPSCreg; IRFMNi008-A
DR   Wikidata; Q123032744
CC   From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IRI-SAb1
AC   CVCL_F0HI
RX   PubMed=12470663;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IRI-SAb2
AC   CVCL_F0HJ
DR   ABCD; ABCD_AH952
RX   PubMed=15319453;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IRI-SAb3
AC   CVCL_F0HK
DR   ABCD; ABCD_AH951
RX   PubMed=15319453;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IRKHBK
AC   CVCL_9V28
SY   Iran Razi Khedmati Bovine Kidney; Razi Bovine Kidney; RBK
DR   NCBI_Iran; C541
DR   Wikidata; Q54898248
RX   CelloPub=CLPUB00759;
RX   DOI=10.32592/ari.2023.78.5.1528;
RX   DOI=10.7508/ari.2015.03.004;
CC   Virology: Susceptible to infection by bovine herpesvirus-1 (BoHV-1), bovine parainfluenza virus 3 (BPIV-3), bovine viral diarrhea virus (BVDV) and peste des petits ruminants virus (PPRV) (CelloPub=CLPUB00759; DOI=10.7508/ari.2015.03.004).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   IRM2
AC   CVCL_AW96
SY   IRM-2
DR   cancercelllines; CVCL_AW96
DR   Cosmic; 2297000
DR   GEO; GSM119540
DR   GEO; GSM629488
DR   GEO; GSM629489
DR   Progenetix; CVCL_AW96
DR   Wikidata; Q54898249
RX   PubMed=16960149;
RX   PubMed=21746927;
RX   PubMed=26194763;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   IRMBi001-A
AC   CVCL_VD86
SY   AD-PS1 hiPSC
DR   BioSamples; SAMEA104618388
DR   hPSCreg; IRMBi001-A
DR   Wikidata; Q54898250
RX   PubMed=30677723;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Gly217Asp (c.650G>A); ClinVar=VCV000098057; Zygosity=Heterozygous (PubMed=30677723).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   IRMBi002-A
AC   CVCL_VD87
SY   AD-APP hiPSC
DR   BioSamples; SAMEA4984140
DR   hPSCreg; IRMBi002-A
DR   Wikidata; Q54898251
RX   PubMed=31004935;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Asp694Asn (c.2080G>A); ClinVar=VCV000018101; Zygosity=Heterozygous (PubMed=31004935).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   IRMBi003-A
AC   CVCL_D0GC
SY   CT1
DR   BioSamples; SAMEA113946838
DR   hPSCreg; IRMBi003-A
DR   Wikidata; Q123032745
RX   PubMed=37979430;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0GD ! IRMBi003-B
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   IRMBi003-B
AC   CVCL_D0GD
SY   CT4
DR   BioSamples; SAMEA114595106
DR   hPSCreg; IRMBi003-B
DR   Wikidata; Q123032746
RX   PubMed=37979430;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0GC ! IRMBi003-A
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   IRMBi004-A
AC   CVCL_D0GE
SY   CT4
DR   BioSamples; SAMEA113947201
DR   hPSCreg; IRMBi004-A
DR   Wikidata; Q123032747
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IRMBi005-A
AC   CVCL_D0GF
SY   SAD-hiPSC; SAD
DR   BioSamples; SAMEA114238662
DR   hPSCreg; IRMBi005-A
DR   Wikidata; Q123032748
RX   PubMed=37783001;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IRMC
AC   CVCL_W170
SY   Immortalized Rat Mesangial Cells
DR   Wikidata; Q54898252
RX   PubMed=9112121;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   IRNE
AC   CVCL_C263
SY   IRNE-MEL; BB74-MEL
DR   cancercelllines; CVCL_C263
DR   Cosmic; 972261
DR   Cosmic; 2163787
DR   Cosmic; 2759412
DR   ESTDAB; ESTDAB-038
DR   Wikidata; Q54898254
RX   PubMed=9894850;
RX   PubMed=15592718;
RX   PubMed=19340423;
RX   PubMed=23472218;
RX   PubMed=23493799;
RX   PubMed=23851445;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*01:01,29:02; B*35:01,44:03:01; C*04:01:01; DPB1*04:02,02:01:02; DQB1*06:03,02:01; DRB1*11:03:01,07:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Discontinued: ESTDAB; ESTDAB-038; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   irPSCc1
AC   CVCL_A5TK
SY   immortalized rat Pancreatic Stellate Cells cloned expansion 1
DR   Wikidata; Q107115476
RX   PubMed=20847583;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A5TL ! irPSCc2
OI   CVCL_A5TM ! irPSCc3
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   irPSCc2
AC   CVCL_A5TL
SY   immortalized rat Pancreatic Stellate Cells cloned expansion 2
DR   Wikidata; Q107115477
RX   PubMed=20847583;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A5TK ! irPSCc1
OI   CVCL_A5TM ! irPSCc3
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   irPSCc3
AC   CVCL_A5TM
SY   immortalized rat Pancreatic Stellate Cells cloned expansion 3
DR   Wikidata; Q107115479
RX   PubMed=20847583;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A5TK ! irPSCc1
OI   CVCL_A5TL ! irPSCc2
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   IRR-3T3
AC   CVCL_RB15
SY   Irradiated 3T3-Swiss albino
DR   ATCC; 48-X
DR   Wikidata; Q54898255
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 10000 rads.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: ATCC; 48-X; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   IRR-MRC-5
AC   CVCL_RB14
SY   Irradiated MRC-5
DR   ATCC; 55-X
DR   Wikidata; Q54898256
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 10000 rads.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: ATCC; 55-X; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   IRR-STO
AC   CVCL_RB16
SY   Irradiated STO
DR   ATCC; 56-X
DR   Wikidata; Q54898257
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: ATCC; 56-X; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3420 ! STO
SX   Mixed sex
AG   Embryo
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   IRR-STO-SNL2
AC   CVCL_VT48
SY   IRR-STO SNL2
DR   ATCC; CRL-2225.1
DR   Wikidata; Q94323940
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 10000 rads.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: ATCC; CRL-2225.1; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N792 ! STO-SNL2
SX   Mixed sex
AG   Embryo
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   irs1
AC   CVCL_1N51
SY   irs 1; irs-1
DR   Wikidata; Q54898258
RX   PubMed=2158612;
RX   PubMed=3106801;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2796 ! V79-4
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   irs2
AC   CVCL_1N52
SY   irs 2
DR   Wikidata; Q54898259
RX   PubMed=2158612;
RX   PubMed=3106801;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2796 ! V79-4
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   irs3
AC   CVCL_1N53
SY   irs 3
DR   Wikidata; Q54898260
RX   PubMed=3106801;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2796 ! V79-4
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   IRSC-10M
AC   CVCL_RW24
DR   Wikidata; Q54898261
RX   PubMed=7847823;
CC   Characteristics: Established from a tumor implanted into a nude mice.
CC   Doubling time: 192 hours (Note=In RPMI 1640 + 10% FCS), 144 hours (Note=In 50% self conditioned medium + 50% RPMI 1640/10% FCS) (PubMed=7847823).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   IRSC-2M
AC   CVCL_RW22
DR   Wikidata; Q54898262
RX   PubMed=7847823;
CC   Characteristics: Established from a tumor implanted into a nude mice.
CC   Doubling time: 120 hours (Note=In RPMI 1640 + 10% FCS), 72 hours (Note=In 50% self conditioned medium + 50% RPMI 1640/10% FCS) (PubMed=7847823).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   IRSC-61M
AC   CVCL_RW25
DR   Wikidata; Q54898269
RX   PubMed=7847823;
CC   Characteristics: Established from a tumor implanted into a nude mice.
CC   Doubling time: 144 hours (Note=In RPMI 1640 + 10% FCS), 72 hours (Note=In 50% self conditioned medium + 50% RPMI 1640/10% FCS) (PubMed=7847823).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   IRSC-6M
AC   CVCL_RW23
DR   Wikidata; Q54898268
RX   PubMed=7847823;
CC   Characteristics: Established from a tumor implanted into a nude mice.
CC   Doubling time: 164 hours (Note=In RPMI 1640 + 10% FCS), 93 hours (Note=In 50% self conditioned medium + 50% RPMI 1640/10% FCS) (PubMed=7847823).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   IRSC-74M
AC   CVCL_RW26
DR   Wikidata; Q54898270
RX   PubMed=7847823;
CC   Characteristics: Established from a tumor implanted into a nude mice.
CC   Doubling time: 120 hours (Note=In RPMI 1640 + 10% FCS), 67 hours (Note=In 50% self conditioned medium + 50% RPMI 1640/10% FCS) (PubMed=7847823).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   IRTA17
AC   CVCL_A7NL
DR   Wikidata; Q107115480
RX   PubMed=7794765;
CC   Population: Japanese.
CC   Doubling time: ~79 hours (PubMed=7794765).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=7794765).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7NM ! IRTA21
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   IRTA21
AC   CVCL_A7NM
DR   Wikidata; Q107115482
RX   PubMed=7794765;
CC   Population: Japanese.
CC   Doubling time: ~99 hours (PubMed=7794765).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=7794765).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7NL ! IRTA17
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   IS2258
AC   CVCL_8X69
DR   ECACC; 05060325
DR   Wikidata; Q54898271
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(7:9) (ECACC=05060325).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 05060325; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   IS2259
AC   CVCL_8X70
DR   ECACC; 05060326
DR   Wikidata; Q54898272
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 05060326; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   IS2260
AC   CVCL_8X71
DR   ECACC; 05060327
DR   Wikidata; Q54898273
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,der(9)t(7:9) (ECACC=05060327).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 05060327; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   iSCA2 E209-6
AC   CVCL_XI53
DR   Wikidata; Q94324094
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[44] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=30718627).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI54 ! iSCA2 E209-9
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   iSCA2 E209-9
AC   CVCL_XI54
DR   Wikidata; Q94324097
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[44] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=30718627).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI53 ! iSCA2 E209-6
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   iSCA2-17
AC   CVCL_XI51
DR   Wikidata; Q94324102
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[35] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=30718627).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI52 ! iSCA2-28
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   iSCA2-28
AC   CVCL_XI52
DR   Wikidata; Q94324108
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[35] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=30718627).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI51 ! iSCA2-17
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   iSCA3 E149-10
AC   CVCL_XI57
DR   Wikidata; Q94324112
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[73]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=30718627).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI58 ! iSCA3 E149-12
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   iSCA3 E149-12
AC   CVCL_XI58
DR   Wikidata; Q94324116
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[73]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=30718627).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI57 ! iSCA3 E149-10
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   iSCA3-1
AC   CVCL_XI55
DR   Wikidata; Q94324122
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[70]; Zygosity=Heterozygous; Note=The other allele has 37 repeats (PubMed=30718627).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI56 ! iSCA3-36
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   iSCA3-36
AC   CVCL_XI56
DR   Wikidata; Q94324124
RX   PubMed=30718627;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[70]; Zygosity=Heterozygous; Note=The other allele has 37 repeats (PubMed=30718627).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI55 ! iSCA3-1
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   iSCN5A
AC   CVCL_A4LH
DR   Wikidata; Q105509709
RX   PubMed=22647976;
RX   PubMed=27485484;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Glu1795_Ile1796insAsp (c.5382_5384dupTGA) (1795insD); ClinVar=VCV000009382; Zygosity=Unspecified (PubMed=22647976).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_130; Brugada syndrome
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ISCRMi001-A
AC   CVCL_C6Q1
SY   hiPSC DSP hetL463Serfs*22; DSP Leu462fs; 3-0062
DR   BioSamples; SAMEA111405406
DR   hPSCreg; ISCRMi001-A
DR   Wikidata; Q117704554
RX   PubMed=36481506;
CC   From: University of Washington Institute for Stem Cell and Regenerative Medicine; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Leu463Serfs*22 (c.1386delT); ClinVar=VCV000922148; Zygosity=Heterozygous (PubMed=36481506).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   ISE18
AC   CVCL_Z168
DR   Wikidata; Q54898274
RX   Patent=US5869335;
RX   PubMed=8057317;
RX   PubMed=8064520;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
RX   PubMed=32778731;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_0941d3180e
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6945; ! Ixodes scapularis (Black-legged tick)
SX   Mixed sex
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   ISE5
AC   CVCL_Z169
DR   Wikidata; Q54898275
RX   Patent=US5869335;
RX   PubMed=8064520;
RX   PubMed=8812616;
RX   PubMed=17662657;
CC   Group: Tick cell line.
CC   Misspelling: ISE25; PubMed=8812616.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6945; ! Ixodes scapularis (Black-legged tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   ISE6
AC   CVCL_Z170
DR   ATCC; CRL-3576
DR   BEI_Resources; NR-12234
DR   PRIDE; PXD002181
DR   Wikidata; Q54898276
RX   Patent=US5869335;
RX   PubMed=8812616;
RX   PubMed=16922866;
RX   PubMed=17662657;
RX   PubMed=19242658;
RX   PubMed=22743047;
RX   PubMed=25894426;
RX   PubMed=26424601;
RX   PubMed=29886187;
RX   PubMed=32158404;
RX   PubMed=33389257;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_0941d3180e
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_20cfb4a364
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11974.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6945; ! Ixodes scapularis (Black-legged tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   iSEC
AC   CVCL_B5WE
SY   immortalized Sinusoidal Endothelial Cells
DR   Wikidata; Q111733517
RX   PubMed=1711469;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   20FW
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   ISFi001-A
AC   CVCL_YT30
SY   HMGU1; HMGU#1
DR   BioSamples; SAMEA6673882
DR   hPSCreg; ISFi001-A
DR   Wikidata; Q94324174
RX   PubMed=29593499;
RX   PubMed=30858616;
CC   From: Institute for Stem Cell Research, Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 7
//
ID   ISFi002-A
AC   CVCL_A8SS
SY   HMGU12; HMGU#12
DR   BioSamples; SAMEA9071020
DR   hPSCreg; ISFi002-A
DR   Wikidata; Q108820551
CC   From: Institute for Stem Cell Research, Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   ISFi003-A
AC   CVCL_C1G2
SY   D2
DR   BioSamples; SAMEA13882711
DR   hPSCreg; ISFi003-A
DR   Wikidata; Q114311767
RX   PubMed=30858616;
CC   From: Institute for Stem Cell Research, Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:13681; DCHS1; Simple; p.Thr848Asnfs*30 (c.2543delC); ClinVar=VCV000088998; Zygosity=Homozygous (PubMed=30858616).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188993; Van Maldergem syndrome 1
DI   ORDO; Orphanet_314679; Cerebrofacioarticular syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   ISFi004-A
AC   CVCL_C1G3
SY   F1
DR   BioSamples; SAMEA13883019
DR   hPSCreg; ISFi004-A
DR   Wikidata; Q114311768
RX   PubMed=30858616;
CC   From: Institute for Stem Cell Research, Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:23109; FAT4; Simple; p.Cys4161Phe (c.12482G>T) (p.Cys4159Phe, c.12476G>T); ClinVar=VCV000089004; Zygosity=Heterozygous (PubMed=30858616).
CC   Sequence variation: Mutation; HGNC; HGNC:23109; FAT4; Simple; p.Cys4400Tyr (c.13199G>A) (p.Cys4398Tyr, c.13193G>A); ClinVar=VCV000089005; Zygosity=Heterozygous (PubMed=30858616).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188994; Van Maldergem syndrome 2
DI   ORDO; Orphanet_314679; Cerebrofacioarticular syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   iSGEC-nSS1
AC   CVCL_A2JK
SY   immortalized Salivary Gland Epithelial Cells-non-Sjogren's Syndrome 1
DR   Wikidata; Q105509713
RX   PubMed=33255850;
CC   Population: Caucasian.
CC   Characteristics: Has a heterologous mesenchymal phenotype. Exhibits high expression of both VIM and CST3, and the low expression of KRT19 (PubMed=33255850).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, labial gland; UBERON=UBERON_8480065.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   iSGEC-nSS2
AC   CVCL_A2JL
SY   immortalized Salivary Gland Epithelial Cells-non-Sjogren's Syndrome 2
DR   Wikidata; Q105509716
RX   PubMed=33255850;
CC   Population: Caucasian.
CC   Characteristics: Has an undifferentiated ductal cell phenotype. Has a high mRNA expression of KRT5 and relatively spotty distribution of KRT19 protein (PubMed=33255850).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, labial gland; UBERON=UBERON_8480065.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   iSGEC-pSS1
AC   CVCL_A2JM
SY   immortalized Salivary Gland Epithelial Cells-primary Sjogren's Syndrome 1
DR   Wikidata; Q105509719
RX   PubMed=33255850;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, labial gland; UBERON=UBERON_8480065.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C26883; Sjogren syndrome
DI   ORDO; Orphanet_289390; Primary Sjogren syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   ISH/DDP
AC   CVCL_IR24
DR   cancercelllines; CVCL_IR24
DR   Wikidata; Q54898277
RX   PubMed=22041447;
CC   Population: Japanese.
CC   Doubling time: 40.1 hours (PubMed=22041447).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   ISH3
AC   CVCL_E710
DR   dbMHC; 48907
DR   IHW; IHW09369
DR   IPD-IMGT/HLA; 25980
DR   Wikidata; Q54898278
RX   PubMed=28360230;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24:02:01:01; B*15:26N; C*04:01:01:01; DPA1*02:02:02; DPB1*02:01:02; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:06:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=25980).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   ISH4
AC   CVCL_E711
AS   CVCL_F551
SY   ENDO; Extract 281; Extract 488
DR   dbMHC; 48908
DR   IHW; IHW09371
DR   IPD-IMGT/HLA; 10565
DR   Wikidata; Q54898279
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/350cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:18,11:01; B*15:01,46:01; C*01:02,04:01:01; DPB1*02:02,05:01; DQB1*03:02:01,06:01:01; DRB1*04:06,08:03:02; DRB4*01:03:01:01 (IPD-IMGT/HLA=10565).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   ISH5
AC   CVCL_E712
DR   dbMHC; 48909
DR   IHW; IHW09372
DR   IPD-IMGT/HLA; 25983
DR   Wikidata; Q54898280
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*24:02:01:01; B*48:01,54:01; C*01:02,08:03; DPB1*05:01; DQB1*03:03:02,05:03:01; DRB1*09:01:02,14:05:01; DRB3*02:02:01; DRB4*01:03:02 (IPD-IMGT/HLA=25983).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Ishikawa
AC   CVCL_2529
SY   ISHIKAWA; ISHI
DR   BTO; BTO_0003041
DR   CLO; CLO_0037163
DR   EFO; EFO_0005718
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0364
DR   BioSample; SAMN03471030
DR   cancercelllines; CVCL_2529
DR   CCRID; 1101HUM-PUMC000686
DR   Cell_Model_Passport; SIDM00038
DR   ChEMBL-Cells; CHEMBL3307675
DR   ChEMBL-Targets; CHEMBL614649
DR   CLS; 305262
DR   Cosmic; 713475
DR   Cosmic; 713499
DR   Cosmic; 809129
DR   Cosmic; 846174
DR   Cosmic; 1070811
DR   Cosmic; 1152553
DR   Cosmic; 1176597
DR   Cosmic; 1177618
DR   Cosmic; 1241344
DR   Cosmic; 1622902
DR   Cosmic; 1696753
DR   Cosmic; 2030475
DR   Cosmic; 2464666
DR   Cosmic; 2646616
DR   Cosmic; 2702440
DR   ECACC; 99040201
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS228AAA
DR   ENCODE; ENCBS229AAA
DR   ENCODE; ENCBS230AAA
DR   GEO; GSM374972
DR   GEO; GSM375431
DR   GEO; GSM827370
DR   GEO; GSM1008593
DR   GEO; GSM1008594
DR   GEO; GSM1669941
DR   GEO; GSM3161714
DR   GEO; GSM3161715
DR   GEO; GSM6421758
DR   GEO; GSM6421759
DR   GEO; GSM6421760
DR   GEO; GSM6421769
DR   GEO; GSM6421770
DR   GEO; GSM6421771
DR   GEO; GSM6421772
DR   GEO; GSM6421773
DR   GEO; GSM6421774
DR   GEO; GSM6421775
DR   GEO; GSM6421776
DR   GEO; GSM6727286
DR   GEO; GSM6727287
DR   IARC_TP53; 1112
DR   LINCS_HMS; 50018
DR   LINCS_LDP; LCL-1497
DR   PharmacoDB; Ishikawa_667_2019
DR   Progenetix; CVCL_2529
DR   PubChem_Cell_line; CVCL_2529
DR   TOKU-E; 3966
DR   Ubigene; YC-D023
DR   Wikidata; Q54898281
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=4031568;
RX   PubMed=10381137;
RX   PubMed=12703541;
RX   PubMed=15053063;
RX   PubMed=15901131;
RX   PubMed=20215515;
RX   PubMed=20218740;
RX   PubMed=20944090;
RX   PubMed=22710073;
RX   PubMed=23255909;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=36396974;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Ishikawa_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Japanese.
CC   Doubling time: 36 hours (Note=At 9th passage), 29 hours (Note=At 40th passage), 27 hours (Note=At 50th passage) (DOI=10.1007/978-4-431-53981-0_2); 35.14 +- 2.68 hours (PubMed=23255909).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from child cell line Ishikawa (Heraklio) 02 ER-).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from child cell line Ishikawa (Heraklio) 02 ER-).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from child cell line Ishikawa (Heraklio) 02 ER-).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from child cell line Ishikawa (Heraklio) 02 ER-).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ser302fs*4 (c.906delC); Zygosity=Heterozygous (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from child cell line Ishikawa (Heraklio) 02 ER-).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (PubMed=15901131).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: Ischikawaa; Note=Occasionally.
CC   Discontinued: CLS; 305262; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ECACC=99040201; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 13,19
ST   D19S433: 12.2,14
ST   D21S11: 28
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 12,16
ST   FGA: 21
ST   Penta D: 10,11
ST   Penta E: 11,19
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   Ishikawa (Heraklio) 02 ER-
AC   CVCL_6543
SY   Ishikawa(Heraklio)02ER-; ISHIKAWAHERAKLIO02ER; ER-02 ISH
DR   CLO; CLO_0006967
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988025
DR   cancercelllines; CVCL_6543
DR   Cell_Model_Passport; SIDM00037
DR   DepMap; ACH-000961
DR   ECACC; 98032302
DR   EGA; EGAS00001000978
DR   GDSC; 1240156
DR   GEO; GSM827371
DR   GEO; GSM887164
DR   GEO; GSM888236
DR   IARC_TP53; 28398
DR   LiGeA; CCLE_241
DR   LINCS_HMS; 50019
DR   LINCS_LDP; LCL-1498
DR   PharmacoDB; Ishikawa_Heraklio_02ER_668_2019
DR   Progenetix; CVCL_6543
DR   Wikidata; Q54898302
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (DepMap=ACH-000961).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (DepMap=ACH-000961).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (DepMap=ACH-000961).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (DepMap=ACH-000961).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (DepMap=ACH-000961).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (DepMap=ACH-000961).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (DepMap=ACH-000961).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=80.66%; East Asian, South=19.33%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: ECACC; 98032302; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): DepMap=ACH-000961
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12,13
ST   D16S539: 9
ST   D18S51: 13,14,18,19,20
ST   D21S11: 28
ST   D3S1358: 15,16,17
ST   D5S818: 10,11,12
ST   D7S820: 9,10
ST   D8S1179: 12,16
ST   FGA: 20,21
ST   Penta D: 10,11
ST   Penta E: 11,12,18,19,20
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,16,17,18
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   Ishikawa (London) 02 ER+
AC   CVCL_8783
DR   CLO; CLO_0006968
DR   cancercelllines; CVCL_8783
DR   ECACC; 98032301
DR   Wikidata; Q54898303
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 98032301; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   Ishikawa 1-A-12
AC   CVCL_W420
DR   cancercelllines; CVCL_W420
DR   Wikidata; Q54898283
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 40.8 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 1-A-9
AC   CVCL_W421
DR   cancercelllines; CVCL_W421
DR   Wikidata; Q54898284
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 34.3 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 1-C-10
AC   CVCL_W422
DR   cancercelllines; CVCL_W422
DR   Wikidata; Q54898285
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 31.2 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 1-D-9
AC   CVCL_W423
DR   cancercelllines; CVCL_W423
DR   Wikidata; Q54898286
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 35.0 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 1-E-8
AC   CVCL_W424
DR   cancercelllines; CVCL_W424
DR   Wikidata; Q54898287
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 38.9 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 1-F-6
AC   CVCL_W425
DR   cancercelllines; CVCL_W425
DR   Wikidata; Q54898288
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 37.9 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 1-H-6
AC   CVCL_W426
DR   cancercelllines; CVCL_W426
DR   Wikidata; Q54898289
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 40.1 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 2-B-12
AC   CVCL_W427
DR   cancercelllines; CVCL_W427
DR   Wikidata; Q54898290
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 36.5 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 2-C-3
AC   CVCL_W428
DR   cancercelllines; CVCL_W428
DR   Wikidata; Q54898291
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 26.4 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 2-C-7
AC   CVCL_W429
DR   cancercelllines; CVCL_W429
DR   Wikidata; Q54898292
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 38.4 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   Ishikawa 2-E-7
AC   CVCL_W430
DR   cancercelllines; CVCL_W430
DR   Wikidata; Q54898293
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 38.4 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 2-F-4
AC   CVCL_W431
DR   cancercelllines; CVCL_W431
DR   Wikidata; Q54898294
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 31.8 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 3-D-7
AC   CVCL_W432
DR   cancercelllines; CVCL_W432
DR   Wikidata; Q54898295
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 25.2 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 3-D-9
AC   CVCL_W433
DR   cancercelllines; CVCL_W433
DR   Wikidata; Q54898296
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 40.8 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 3-H-12
AC   CVCL_D199
SY   Ishikawa-3H-12; Ishikawa-3H12; Ishikawa 3H12; Ishikawa 3 H 12; Ishikawa3-H-12; Ishikawa clone 3-H-12; Ishikawa-H-12
DR   BTO; BTO_0006568
DR   CLO; CLO_0037230
DR   cancercelllines; CVCL_D199
DR   Cosmic; 871553
DR   Cosmic; 889119
DR   Cosmic; 1007163
DR   Cosmic; 1066223
DR   Cosmic; 1223489
DR   JCRB; JCRB1505
DR   Wikidata; Q54898297
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
RX   PubMed=22710073;
CC   Population: Japanese.
CC   Doubling time: 24.0 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1505
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12,13
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   Ishikawa 3-H-12 PRA-14
AC   CVCL_C3G7
SY   PRA-14
DR   cancercelllines; CVCL_C3G7
DR   Wikidata; Q114311769
RX   PubMed=12517594;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8910; PGR (Note=Isoform A).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D199 ! Ishikawa 3-H-12
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   Ishikawa 3-H-12 PRB-59
AC   CVCL_C3G8
SY   PRB-59; PRB-Ishikawa
DR   cancercelllines; CVCL_C3G8
DR   GEO; GSE72708
DR   Wikidata; Q114311770
RX   PubMed=12517594;
RX   PubMed=26996671;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8910; PGR (Note=Isoform B).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D199 ! Ishikawa 3-H-12
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   Ishikawa 3-H-12-Luc
AC   CVCL_JG52
DR   cancercelllines; CVCL_JG52
DR   JCRB; JCRB1579
DR   Wikidata; Q54898298
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1579
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D13S317: 9,12,13
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D199 ! Ishikawa 3-H-12
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   Ishikawa 3-H-3
AC   CVCL_W434
DR   cancercelllines; CVCL_W434
DR   Wikidata; Q54898299
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 44.4 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Ishikawa 3-H-4
AC   CVCL_W435
DR   cancercelllines; CVCL_W435
DR   Wikidata; Q54898300
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
RX   PubMed=22710073;
CC   Population: Japanese.
CC   Doubling time: 31.6 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 13,21,22
ST   D19S433: 12.2,14
ST   D21S11: 28
ST   D2S1338: 19,20
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 12,16
ST   FGA: 21,22
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   Ishikawa 3-H-7
AC   CVCL_W436
DR   cancercelllines; CVCL_W436
DR   Wikidata; Q54898301
RX   DOI=10.1007/978-4-431-53981-0_2;
RX   PubMed=9183638;
CC   Population: Japanese.
CC   Doubling time: 26.4 hours (PubMed=9183638).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   ISHIKAWA-Luc
AC   CVCL_C9CC
DR   Ubigene; YC-D023-Luc-P
DR   Wikidata; Q123032749
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Ishikawa-RP
AC   CVCL_IJ14
SY   Ishikawa-Resistant to Progestin
DR   cancercelllines; CVCL_IJ14
DR   Wikidata; Q54898304
RX   PubMed=23255909;
CC   Population: Japanese.
CC   Doubling time: 34.18 +- 3.15 hours (PubMed=23255909).
CC   Selected for resistance to: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Leu570Pro (c.1709T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Pro102Ser (c.304C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asn751fs (c.2252delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C40145; Type I endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2529 ! Ishikawa
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   ISI-1
AC   CVCL_A626
DR   Cosmic; 1238081
DR   IARC_TP53; 26983
DR   Wikidata; Q54898305
RX   CelloPub=CLPUB00135;
RX   PubMed=19608668;
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   iSLK
AC   CVCL_B6YU
DR   Wikidata; Q111733518
RX   PubMed=21419799;
RX   PubMed=22987579;
CC   Problematic cell line: Contaminated. Shown to be a Caki-1 derivative (PubMed=22987579). The parent cell line was originally thought to originate from a 28 year old male patient with HIV-1 negative Kaposi sarcoma.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=22987579
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9569 ! SLK
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 10
//
ID   iSLK.219
AC   CVCL_B6YV
SY   iSLK.219 clone #10
DR   Wikidata; Q111733519
RX   PubMed=21419799;
RX   PubMed=22987579;
CC   Problematic cell line: Contaminated. Shown to be a Caki-1 derivative (PubMed=22987579). The grand-parent cell line was originally thought to originate from a 28 year old male patient with HIV-1 negative Kaposi sarcoma.
CC   Population: Caucasian.
CC   Characteristics: rKSHV.219 includes a RFP-GFP-PuroR construct that contains RFP under the control of the lytic PAN RNA promoter, GFP under the control of human EF1a promoter and PuroR expressed by the RSV promoter.
CC   Characteristics: Transduced with pRetroX-Tet-On that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and with RetroX-Tight-Hyg-RTA.
CC   Virology: Maintains latent rKSHV.219 as indicated by expression of constitutively expressed (eGFP) but not a lytic phase (RFP) reporter gene. When exposed to either sodium butyrate or doxycycline, the cells are activated to lytic replication and express RFP and KSHV lytic genes and release large quantities of infectious virus (PubMed=21419799).
CC   Virology: Infected with a recombinant human herpesvirus 8 (HHV-8/KSHV) rKSHV.219.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=22987579
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6YU ! iSLK
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 10
//
ID   ISMMSi001-A
AC   CVCL_QX74
SY   MFS44-E
DR   BioSamples; SAMEA104275576
DR   hPSCreg; ISMMSi001-A
DR   Wikidata; Q54898306
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1326Arg (c.3976T>C); ClinVar=VCV002137695; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HK20 ! GM21944
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   ISMMSi001-B
AC   CVCL_QX75
SY   MFS44-16
DR   BioSamples; SAMEA104275577
DR   hPSCreg; ISMMSi001-B
DR   Wikidata; Q54898307
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1326Arg (c.3976T>C); ClinVar=VCV002137695; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HK20 ! GM21944
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   ISMMSi002-A
AC   CVCL_QX45
SY   MFS60-12
DR   BioSamples; SAMEA104275578
DR   hPSCreg; ISMMSi002-A
DR   Wikidata; Q54898308
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1361Tyr (c.4082G>A); ClinVar=VCV000519726; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HK33 ! GM21960
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   ISMMSi002-B
AC   CVCL_QX46
SY   MFS60-3-1; 60#3-1
DR   BioSamples; SAMEA104276575
DR   hPSCreg; ISMMSi002-B
DR   Wikidata; Q54898317
RX   PubMed=28925368;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1361Tyr (c.4082G>A); ClinVar=VCV000519726; Zygosity=Heterozygous (PubMed=28925368).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HK33 ! GM21960
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   ISMMSi003-A
AC   CVCL_RH84
SY   hiPSTZ16; ZCL1046
DR   hPSCreg; ISMMSi003-A
DR   Wikidata; Q54898318
RX   PubMed=29227831;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=29227831
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   ISMMSi004-A
AC   CVCL_B5H9
SY   MSN01-02S; MSN01_02S
DR   BioSamples; SAMEA9142986
DR   GEO; GSM4729925
DR   GEO; GSM4729926
DR   hPSCreg; ISMMSi004-A
DR   LINCS_LDP; LSC-1044
DR   Wikidata; Q110432942
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1044
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 7,13
ST   D8S1179: 10,13
ST   FGA: 22.2,24
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JJ91 ! ISMMSi004-B
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi004-B
AC   CVCL_JJ91
SY   MSN01-03R; MSN01-3R; MSN01-3
DR   CLO; CLO_0037510
DR   LINCS_LDP; LSC-1013
DR   Wikidata; Q54906864
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1013
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 7,13
ST   D8S1179: 10,13
ST   FGA: 22.2,24
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5H9 ! ISMMSi004-A
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   ISMMSi005-A
AC   CVCL_B5HA
SY   MSN02-01S; MSN02_01S
DR   BioSamples; SAMEA9142987
DR   GEO; GSM4729927
DR   GEO; GSM4729928
DR   hPSCreg; ISMMSi005-A
DR   LINCS_LDP; LSC-1060
DR   Wikidata; Q110432943
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1060
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 12,16
ST   D21S11: 31,32.2
ST   D3S1358: 16,19
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 23,25
ST   Penta D: 8,10
ST   Penta E: 12,18
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JJ92 ! ISMMSi005-B
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi005-B
AC   CVCL_JJ92
SY   MSN02-04R; MSN02-4R; MSN02-4
DR   CLO; CLO_0037514
DR   LINCS_LDP; LSC-1017
DR   Wikidata; Q54906865
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1017
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 12,16
ST   D21S11: 31,32.2
ST   D3S1358: 16,19
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 23,25
ST   Penta D: 8,10
ST   Penta E: 12,18
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HA ! ISMMSi005-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   ISMMSi006-A
AC   CVCL_B5HB
SY   MSN03-05S; MSN03_05S
DR   BioSamples; SAMEA9142988
DR   GEO; GSM4729929
DR   GEO; GSM4729930
DR   hPSCreg; ISMMSi006-A
DR   LINCS_LDP; LSC-1047
DR   Wikidata; Q110432944
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1047
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 13
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JJ93 ! ISMMSi006-B
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi006-B
AC   CVCL_JJ93
SY   MSN03-07R; MSN03-7R; MSN03-7
DR   CLO; CLO_0037511
DR   LINCS_LDP; LSC-1014
DR   Wikidata; Q54906874
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HB ! ISMMSi006-A
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi007-A
AC   CVCL_B5HC
SY   MSN04-05S; MSN04_05S
DR   BioSamples; SAMEA9142989
DR   GEO; GSM4729931
DR   GEO; GSM4729932
DR   hPSCreg; ISMMSi007-A
DR   LINCS_LDP; LSC-1048
DR   Wikidata; Q110432945
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1048
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D21S11: 28
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 10,11
ST   Penta E: 11,14
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi008-A
AC   CVCL_JJ94
AS   CVCL_B5HD
SY   MSN05-01R; MSN05_01R; MSN05-1R; MSN05-1
DR   CLO; CLO_0037512
DR   BioSamples; SAMEA9142990
DR   GEO; GSM4729933
DR   GEO; GSM4729934
DR   hPSCreg; ISMMSi008-A
DR   LINCS_LDP; LSC-1015
DR   Wikidata; Q54906875
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1015
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D21S11: 32.2
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 8
ST   D8S1179: 16
ST   FGA: 21,24
ST   Penta D: 11,13
ST   Penta E: 12,16
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   ISMMSi009-A
AC   CVCL_JJ95
AS   CVCL_B5HE
SY   MSN06-07R; MSN06_07R; MSN06-7R; MSN06-7
DR   CLO; CLO_0037513
DR   BioSamples; SAMEA9142991
DR   GEO; GSM4729935
DR   GEO; GSM4729936
DR   hPSCreg; ISMMSi009-A
DR   LINCS_LDP; LSC-1016
DR   Wikidata; Q54906876
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1016
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 8,13
ST   D18S51: 13,18
ST   D21S11: 29,32.2
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 7,8
ST   D8S1179: 13,14
ST   FGA: 24,29
ST   Penta D: 13
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   ISMMSi010-A
AC   CVCL_B5HF
SY   MSN07-07S; MSN07_07S
DR   BioSamples; SAMEA9142992
DR   GEO; GSM4729937
DR   GEO; GSM4729938
DR   hPSCreg; ISMMSi010-A
DR   LINCS_LDP; LSC-1049
DR   Wikidata; Q110432948
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1049
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 12
ST   D21S11: 28,31
ST   D3S1358: 14,19
ST   D5S818: 13
ST   D7S820: 10,13
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi011-A
AC   CVCL_B5HG
SY   MSN08-06S; MSN08_06S
DR   BioSamples; SAMEA9142984
DR   GEO; GSM4729939
DR   GEO; GSM4729940
DR   hPSCreg; ISMMSi011-A
DR   LINCS_LDP; LSC-1050
DR   Wikidata; Q110432949
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1050
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 19,21
ST   Penta D: 11
ST   Penta E: 11,17
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JJ96 ! ISMMSi011-B
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi011-B
AC   CVCL_JJ96
SY   MSN08-13R; MSN08-13
DR   CLO; CLO_0037515
DR   LINCS_LDP; LSC-1018
DR   Wikidata; Q54906878
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1018
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 19,21
ST   Penta D: 11
ST   Penta E: 11,17
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HG ! ISMMSi011-A
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   ISMMSi012-A
AC   CVCL_B5HH
SY   MSN09-02S; MSN09_02S
DR   BioSamples; SAMEA9142985
DR   GEO; GSM4729941
DR   GEO; GSM4729942
DR   hPSCreg; ISMMSi012-A
DR   LINCS_LDP; LSC-1051
DR   Wikidata; Q110432950
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1051
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 30,31.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   Penta D: 13
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JJ97 ! ISMMSi012-B
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi012-B
AC   CVCL_JJ97
SY   MSN09-04R; MSN09-4R; MSN09-4
DR   CLO; CLO_0037516
DR   LINCS_LDP; LSC-1019
DR   Wikidata; Q54906879
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1019
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 30,31.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   Penta D: 13
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HH ! ISMMSi012-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   ISMMSi013-A
AC   CVCL_B5HI
SY   MSN10-07S; MSN10_07S
DR   BioSamples; SAMEA9142993
DR   GEO; GSM4729943
DR   GEO; GSM4729944
DR   hPSCreg; ISMMSi013-A
DR   LINCS_LDP; LSC-1052
DR   Wikidata; Q110432951
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1052
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D21S11: 28,30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JJ98 ! ISMMSi013-B
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi013-B
AC   CVCL_JJ98
SY   MSN10-01R; MSN10-1R; MSN10-1
DR   CLO; CLO_0037517
DR   LINCS_LDP; LSC-1020
DR   Wikidata; Q54906880
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1020
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D21S11: 28,30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HI ! ISMMSi013-A
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   ISMMSi014-A
AC   CVCL_B5HJ
SY   MSN11-05S; MSN11_05S
DR   BioSamples; SAMEA9142994
DR   GEO; GSM4729945
DR   GEO; GSM4729946
DR   hPSCreg; ISMMSi014-A
DR   LINCS_LDP; LSC-1053
DR   Wikidata; Q110432952
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 11,16
ST   FGA: 22,28
ST   Penta D: 11,12
ST   Penta E: 10,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi015-A
AC   CVCL_B5HK
SY   MSN12-04S; MSN12_04S
DR   BioSamples; SAMEA9142995
DR   GEO; GSM4729947
DR   GEO; GSM4729948
DR   hPSCreg; ISMMSi015-A
DR   LINCS_LDP; LSC-1054
DR   Wikidata; Q110432953
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Jewish; Ashkenazi.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1054
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 13,14
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 21,25
ST   Penta D: 10,12
ST   Penta E: 12,16
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi016-A
AC   CVCL_B5HL
SY   MSN13-03S; MSN13_03S
DR   BioSamples; SAMEA9142996
DR   GEO; GSM4729949
DR   GEO; GSM4729950
DR   hPSCreg; ISMMSi016-A
DR   LINCS_LDP; LSC-1055
DR   Wikidata; Q110432954
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1055
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 12,15
ST   D21S11: 27
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 10,15
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi017-A
AC   CVCL_B5HM
SY   MSN14-01S; MSN14_01S
DR   BioSamples; SAMEA9142997
DR   GEO; GSM4729951
DR   GEO; GSM4729952
DR   hPSCreg; ISMMSi017-A
DR   LINCS_LDP; LSC-1057
DR   Wikidata; Q110432955
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1057
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 17,19
ST   D21S11: 27
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 5
ST   TH01: 6,8
ST   TPOX: 10,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HN ! ISMMSi017-B
OI   CVCL_B5HP ! ISMMSi017-C
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi017-B
AC   CVCL_B5HN
SY   MSN14-05S; MSN14_05S
DR   BioSamples; SAMEA9143001
DR   hPSCreg; ISMMSi017-B
DR   LINCS_LDP; LSC-1058
DR   Wikidata; Q110432956
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: African American.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1058
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 17,19
ST   D21S11: 27
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 5
ST   TH01: 6,8
ST   TPOX: 10,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HM ! ISMMSi017-A
OI   CVCL_B5HP ! ISMMSi017-C
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
ID   ISMMSi017-C
AC   CVCL_B5HP
SY   MSN14-06S; MSN14_06S
DR   BioSamples; SAMEA9143002
DR   hPSCreg; ISMMSi017-C
DR   LINCS_LDP; LSC-1059
DR   Wikidata; Q110432957
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: African American.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1059
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 17,19
ST   D21S11: 27
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 5
ST   TH01: 6,8
ST   TPOX: 10,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5HM ! ISMMSi017-A
OI   CVCL_B5HN ! ISMMSi017-B
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi018-A
AC   CVCL_B5HQ
SY   MSN15-31S; MSN15_31S
DR   BioSamples; SAMEA9142999
DR   GEO; GSM4729953
DR   GEO; GSM4729954
DR   hPSCreg; ISMMSi018-A
DR   LINCS_LDP; LSC-1082
DR   Wikidata; Q110432958
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1082
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D21S11: 28
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   Penta D: 12,14
ST   Penta E: 7,8
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi019-A
AC   CVCL_B5HR
SY   MSN16-04S; MSN16_04S
DR   BioSamples; SAMEA9143003
DR   GEO; GSM4729955
DR   GEO; GSM4729956
DR   hPSCreg; ISMMSi019-A
DR   LINCS_LDP; LSC-1061
DR   Wikidata; Q110432959
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1061
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 29,30
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 10,13
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 7,18
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi020-A
AC   CVCL_B5HS
SY   MSN17-07S; MSN17_07S
DR   BioSamples; SAMEA9143004
DR   GEO; GSM4729957
DR   GEO; GSM4729958
DR   hPSCreg; ISMMSi020-A
DR   LINCS_LDP; LSC-1062
DR   Wikidata; Q110432960
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1062
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 14
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 10,14
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi021-A
AC   CVCL_B5HT
SY   MSN18-03S; MSN18_03S
DR   BioSamples; SAMEA9143005
DR   GEO; GSM4729959
DR   GEO; GSM4729960
DR   hPSCreg; ISMMSi021-A
DR   LINCS_LDP; LSC-1063
DR   Wikidata; Q110432961
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1063
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,13
ST   D16S539: 11
ST   D18S51: 13,20
ST   D21S11: 28,31
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,16
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 13,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi022-A
AC   CVCL_B5HU
SY   MSN19-07S; MSN19_07S
DR   BioSamples; SAMEA9143007
DR   GEO; GSM4729961
DR   GEO; GSM4729962
DR   hPSCreg; ISMMSi022-A
DR   LINCS_LDP; LSC-1064
DR   Wikidata; Q110432962
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1064
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 28,31
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 18,21
ST   Penta D: 8,10
ST   Penta E: 10,14
ST   TH01: 7,9.3
ST   TPOX: 6,8
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi023-A
AC   CVCL_B5HV
SY   MSN20-06S; MSN20_06S
DR   BioSamples; SAMEA9143009
DR   GEO; GSM4729963
DR   GEO; GSM4729964
DR   hPSCreg; ISMMSi023-A
DR   LINCS_LDP; LSC-1065
DR   Wikidata; Q110432964
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1065
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 9,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi024-A
AC   CVCL_B5HW
SY   MSN21-08S; MSN21_08S
DR   BioSamples; SAMEA9143010
DR   GEO; GSM4729965
DR   GEO; GSM4729966
DR   hPSCreg; ISMMSi024-A
DR   LINCS_LDP; LSC-1079
DR   Wikidata; Q110432965
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1079
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D21S11: 27,30
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi025-A
AC   CVCL_B5HX
SY   MSN22-04S; MSN22_04S
DR   BioSamples; SAMEA9143011
DR   GEO; GSM4729967
DR   GEO; GSM4729968
DR   hPSCreg; ISMMSi025-A
DR   LINCS_LDP; LSC-1066
DR   Wikidata; Q110432966
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Jewish; Ashkenazi.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1066
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D18S51: 15
ST   D21S11: 30,32.2
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 12,15
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi026-A
AC   CVCL_B5HY
SY   MSN23-01S; MSN23_01S
DR   BioSamples; SAMEA9143034
DR   GEO; GSM4729969
DR   GEO; GSM4729970
DR   hPSCreg; ISMMSi026-A
DR   LINCS_LDP; LSC-1080
DR   Wikidata; Q110432967
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1080
ST   Amelogenin: X
ST   CSF1PO: 7,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,18
ST   D21S11: 28,33.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 12,14
ST   FGA: 22,25
ST   Penta D: 12,14
ST   Penta E: 12,16
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi027-A
AC   CVCL_B5HZ
SY   MSN24-06S; MSN24_06S
DR   BioSamples; SAMEA9143035
DR   GEO; GSM4729971
DR   GEO; GSM4729972
DR   hPSCreg; ISMMSi027-A
DR   LINCS_LDP; LSC-1067
DR   Wikidata; Q110432968
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Karyotypic information: 46,XY,t(1;17)(p34;q23) (PubMed=34739849).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1067
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 29,32.2
ST   D3S1358: 17,18
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   D8S1179: 11,14
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 8,15
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi028-A
AC   CVCL_B5I0
SY   MSN25-01S; MSN25_01S
DR   BioSamples; SAMEA9143036
DR   hPSCreg; ISMMSi028-A
DR   LINCS_LDP; LSC-1085
DR   Wikidata; Q110432969
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5I1 ! ISMMSi028-B
OI   CVCL_B5I2 ! ISMMSi028-C
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   ISMMSi028-B
AC   CVCL_B5I1
SY   MSN25-04S; MSN25_04S
DR   BioSamples; SAMEA9149100
DR   hPSCreg; ISMMSi028-B
DR   LINCS_LDP; LSC-1068
DR   Wikidata; Q110432970
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1068
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,18
ST   D21S11: 30,32
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,14
ST   Penta E: 12,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5I0 ! ISMMSi028-A
OI   CVCL_B5I2 ! ISMMSi028-C
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 6
//
ID   ISMMSi028-C
AC   CVCL_B5I2
SY   MSN25-09S; MSN25_09S
DR   BioSamples; SAMEA9149120
DR   GEO; GSM4729973
DR   GEO; GSM4729974
DR   hPSCreg; ISMMSi028-C
DR   LINCS_LDP; LSC-1069
DR   Wikidata; Q110432971
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1069
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,18
ST   D21S11: 30,32
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,14
ST   Penta E: 12,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5I0 ! ISMMSi028-A
OI   CVCL_B5I1 ! ISMMSi028-B
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi029-A
AC   CVCL_B5I3
SY   MSN26-01S; MSN26_01S
DR   BioSamples; SAMEA9149121
DR   GEO; GSM4729975
DR   GEO; GSM4729976
DR   hPSCreg; ISMMSi029-A
DR   LINCS_LDP; LSC-1071
DR   Wikidata; Q110432972
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1071
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 27,30
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 11,12
ST   FGA: 18,20
ST   Penta D: 10,11
ST   Penta E: 11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi030-A
AC   CVCL_B5I4
SY   MSN27-03S
DR   BioSamples; SAMEA9149122
DR   GEO; GSM4729977
DR   GEO; GSM4729978
DR   hPSCreg; ISMMSi030-A
DR   LINCS_LDP; LSC-1034
DR   Wikidata; Q110432973
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1034
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D21S11: 29,30.2
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 15
ST   FGA: 19,21
ST   Penta D: 12,13
ST   Penta E: 14,15
ST   TH01: 9.3,10
ST   TPOX: 8,12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi031-A
AC   CVCL_B5I5
SY   MSN28-05S; MSN28_05S
DR   BioSamples; SAMEA9149123
DR   GEO; GSM4729979
DR   GEO; GSM4729980
DR   hPSCreg; ISMMSi031-A
DR   LINCS_LDP; LSC-1035
DR   Wikidata; Q110432974
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1035
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 12,20
ST   D21S11: 31.2,32.2
ST   D3S1358: 14,17
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 12,15
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi032-A
AC   CVCL_B5I6
SY   MSN29-03S; MSN29_03S
DR   BioSamples; SAMEA9149124
DR   GEO; GSM4729981
DR   GEO; GSM4729982
DR   hPSCreg; ISMMSi032-A
DR   LINCS_LDP; LSC-1036
DR   Wikidata; Q110432976
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: African American.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1036
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 8,13
ST   D18S51: 12,13
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 8,12
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 21,28
ST   Penta D: 8,9
ST   Penta E: 11,20
ST   TH01: 6,8
ST   TPOX: 9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi033-A
AC   CVCL_B5I7
SY   MSN30-01S; MSN30_01S
DR   BioSamples; SAMEA9149125
DR   GEO; GSM4729983
DR   GEO; GSM4729984
DR   hPSCreg; ISMMSi033-A
DR   LINCS_LDP; LSC-1037
DR   Wikidata; Q110432977
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1037
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 29,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 12,17
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi034-A
AC   CVCL_B5I8
SY   MSN31-01S; MSN31_01S
DR   BioSamples; SAMEA9149126
DR   GEO; GSM4729985
DR   GEO; GSM4729986
DR   hPSCreg; ISMMSi034-A
DR   LINCS_LDP; LSC-1041
DR   Wikidata; Q110432978
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1041
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,19
ST   D21S11: 29,31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 23,24
ST   Penta D: 9,11
ST   Penta E: 4,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi035-A
AC   CVCL_B5I9
SY   MSN32-04S; MSN32_04S
DR   BioSamples; SAMEA9149127
DR   GEO; GSM4729987
DR   GEO; GSM4729988
DR   hPSCreg; ISMMSi035-A
DR   LINCS_LDP; LSC-1042
DR   Wikidata; Q110432979
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1042
ST   Amelogenin: X
ST   D13S317: 11,13
ST   D16S539: 12
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi036-A
AC   CVCL_B5IA
SY   MSN33-04S; MSN33_04S
DR   BioSamples; SAMEA9149128
DR   GEO; GSM4729989
DR   GEO; GSM4729990
DR   hPSCreg; ISMMSi036-A
DR   LINCS_LDP; LSC-1043
DR   Wikidata; Q110432980
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1043
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 14,20
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 16,17
ST   FGA: 21,25
ST   Penta D: 9,13
ST   Penta E: 16,19
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi037-A
AC   CVCL_B5IB
SY   MSN34-05S; MSN34_05S
DR   BioSamples; SAMEA9149129
DR   GEO; GSM4729991
DR   GEO; GSM4729992
DR   hPSCreg; ISMMSi037-A
DR   LINCS_LDP; LSC-1072
DR   Wikidata; Q110432981
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1072
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,14
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,12
ST   FGA: 21,22
ST   Penta D: 12
ST   Penta E: 7,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi038-A
AC   CVCL_B5IC
SY   MSN35-05S; MSN35_05S
DR   BioSamples; SAMEA9149130
DR   GEO; GSM4729993
DR   GEO; GSM4729994
DR   hPSCreg; ISMMSi038-A
DR   LINCS_LDP; LSC-1073
DR   Wikidata; Q110432982
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1073
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9,13
ST   D8S1179: 12,13
ST   FGA: 20,25
ST   Penta D: 10,12
ST   Penta E: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi039-A
AC   CVCL_B5ID
SY   MSN36-06S; MSN36_06S
DR   BioSamples; SAMEA9149111
DR   GEO; GSM4729995
DR   GEO; GSM4729996
DR   hPSCreg; ISMMSi039-A
DR   LINCS_LDP; LSC-1074
DR   Wikidata; Q110432983
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1074
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 14,19
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11,15
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 11,14
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi040-A
AC   CVCL_B5IE
SY   MSN37-01S; MSN37_01S
DR   BioSamples; SAMEA9149113
DR   GEO; GSM4729997
DR   GEO; GSM4729998
DR   hPSCreg; ISMMSi040-A
DR   LINCS_LDP; LSC-1075
DR   Wikidata; Q110432984
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1075
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D18S51: 13,23
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 11,15
ST   FGA: 22
ST   Penta D: 8,9
ST   Penta E: 5,21
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi041-A
AC   CVCL_B5IF
SY   MSN38-04S; MSN38_04S
DR   BioSamples; SAMEA9149115
DR   GEO; GSM4729999
DR   GEO; GSM4730000
DR   hPSCreg; ISMMSi041-A
DR   LINCS_LDP; LSC-1076
DR   Wikidata; Q110432985
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Asian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1076
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 31,33.2
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 7,8
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi042-A
AC   CVCL_B5IG
SY   MSN39-04S; MSN39_04S
DR   BioSamples; SAMEA9149117
DR   GEO; GSM4730001
DR   GEO; GSM4730002
DR   hPSCreg; ISMMSi042-A
DR   LINCS_LDP; LSC-1077
DR   Wikidata; Q110432987
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Jewish; Ashkenazi.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1077
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 14,17
ST   D21S11: 28,32.2
ST   D3S1358: 14,16
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 10,16
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 14,17
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi043-A
AC   CVCL_B5IH
SY   MSN40-05S; MSN40_05S
DR   BioSamples; SAMEA9149119
DR   GEO; GSM4730003
DR   GEO; GSM4730004
DR   hPSCreg; ISMMSi043-A
DR   LINCS_LDP; LSC-1078
DR   Wikidata; Q110432988
RX   PubMed=34739849;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: African American.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): LINCS_LDP=LSC-1078
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15,17
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 2.2,9
ST   Penta E: 12,15
ST   TH01: 5,8
ST   TPOX: 6,8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   ISMMSi044-A
AC   CVCL_C0FZ
SY   PLN-R14del-1BC1; PLNR14del-1BC1
DR   BioSamples; SAMEA10977552
DR   hPSCreg; ISMMSi044-A
DR   Wikidata; Q112929877
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35247838).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ISMMSi045-A
AC   CVCL_C0G0
SY   PLN-R14del-2BC4; PLNR14del-2BC4
DR   BioSamples; SAMEA11979100
DR   hPSCreg; ISMMSi045-A
DR   Wikidata; Q112929881
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35247838).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ISMMSi046-A
AC   CVCL_C0G1
SY   PLN-R14del-3BC7
DR   BioSamples; SAMEA11979118
DR   hPSCreg; ISMMSi046-A
DR   Wikidata; Q112929883
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35247838).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ISMMSi047-A
AC   CVCL_C0G2
SY   PLN-R14del-4AC4
DR   BioSamples; SAMEA11979161
DR   hPSCreg; ISMMSi047-A
DR   Wikidata; Q112929884
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35247838).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ISMMSi048-A
AC   CVCL_C0G3
SY   PLN-R14del-5BC4
DR   BioSamples; SAMEA11979880
DR   hPSCreg; ISMMSi048-A
DR   Wikidata; Q112929885
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35247838).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ISMMSi049-A
AC   CVCL_C0G4
SY   PLN-1CC1
DR   BioSamples; SAMEA11979924
DR   hPSCreg; ISMMSi049-A
DR   Wikidata; Q112929886
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   ISMMSi050-A
AC   CVCL_C0G5
SY   PLN-4CC4
DR   BioSamples; SAMEA11979953
DR   hPSCreg; ISMMSi050-A
DR   Wikidata; Q112929887
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   ISMMSi051-A
AC   CVCL_C0G6
SY   PLN-5AC2
DR   BioSamples; SAMEA11980101
DR   hPSCreg; ISMMSi051-A
DR   Wikidata; Q112929888
RX   PubMed=35247838;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   ISMMSi052-A
AC   CVCL_D0GG
SY   PLN-3CC5
DR   BioSamples; SAMEA113603006
DR   hPSCreg; ISMMSi052-A
DR   Wikidata; Q123032750
RX   PubMed=37748331;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ISMMSi053-A
AC   CVCL_D0GH
SY   aPLN-R14del-2AC4
DR   BioSamples; SAMEA113606544
DR   hPSCreg; ISMMSi053-A
DR   Wikidata; Q123032751
RX   PubMed=37748331;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=37748331).
CC   Donor information: At sampling donor was asymptomatic for cardiomyopathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ISMMSi054-A
AC   CVCL_D0GI
SY   aPLN-R14del-3AC3
DR   BioSamples; SAMEA113606545
DR   hPSCreg; ISMMSi054-A
DR   Wikidata; Q123032752
RX   PubMed=37748331;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=37748331).
CC   Donor information: At sampling donor was asymptomatic for cardiomyopathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ISMMSi056-A
AC   CVCL_D0GJ
SY   aPLN-R14del-4BC3
DR   BioSamples; SAMEA113606546
DR   hPSCreg; ISMMSi056-A
DR   Wikidata; Q123032753
RX   PubMed=37748331;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=37748331).
CC   Donor information: At sampling donor was asymptomatic for cardiomyopathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ISMMSi057-A
AC   CVCL_D0GK
SY   aPLN-R14del-5CC6
DR   BioSamples; SAMEA113606547
DR   hPSCreg; ISMMSi057-A
DR   Wikidata; Q123032754
RX   PubMed=37748331;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=37748331).
CC   Donor information: At sampling donor was asymptomatic for cardiomyopathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ISMMSi058-A
AC   CVCL_D0GL
SY   aPLN-R14del-1AC2
DR   BioSamples; SAMEA113606548
DR   hPSCreg; ISMMSi058-A
DR   Wikidata; Q123032755
RX   PubMed=37748331;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=37748331).
CC   Donor information: At sampling donor was asymptomatic for cardiomyopathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ISO-HAS
AC   CVCL_C516
SY   ISO HAS
DR   IARC_TP53; 12979
DR   JCRB; IFO50514
DR   RCB; RCB3674
DR   TKG; TKG 0593
DR   Wikidata; Q54898319
RX   PubMed=10188735;
RX   PubMed=12453433;
CC   Population: Japanese.
CC   Doubling time: 64 hours (PubMed=10188735).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser240Arg (c.720T>A); ClinVar=VCV001504304; Zygosity=Unspecified (PubMed=10188735).
CC   Discontinued: JCRB; IFO50514; true.
CC   Discontinued: RCB; RCB3674; true.
CC   Derived from site: Metastatic; Ear, skin; UBERON=UBERON_0001459.
ST   Source(s): TKG=TKG 0593
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   ISO-HAS-1
AC   CVCL_C518
SY   ISO-HAS.1; Iso-has 1
DR   CCLV; CCLV-RIE 1032
DR   Wikidata; Q54898320
RX   PubMed=12453433;
RX   PubMed=24973239;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser240Arg (c.720T>A); ClinVar=VCV001504304; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ear, skin; UBERON=UBERON_0001459.
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C516 ! ISO-HAS
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   ISO-HAS-B
AC   CVCL_AS11
DR   TKG; TKG 0715
DR   Wikidata; Q54898321
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser240Arg (c.720T>A); ClinVar=VCV001504304; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ear, skin; UBERON=UBERON_0001459.
ST   Source(s): TKG=TKG 0715
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C516 ! ISO-HAS
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   ISOS-1
AC   CVCL_C517
SY   ISOS 1
DR   JCRB; IFO50515
DR   RCB; RCB3670
DR   TKG; TKG 0590
DR   Wikidata; Q54898322
RX   PubMed=9459120;
CC   Characteristics: While this is a mouse cell line, it was established from a tumor formed by transplantation of a human angiosarcoma (PubMed=9459120).
CC   Discontinued: JCRB; IFO50515; true.
CC   Discontinued: RCB; RCB3670; true.
CC   Breed/subspecies: C.B.-17/Icr-SCID Jcl.
DI   NCIt; C24016; Mouse angiosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   20-22W
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   iSPG3A-6
AC   CVCL_RM26
DR   SKIP; SKIP001352
DR   Wikidata; Q54898323
RX   PubMed=24908668;
CC   Sequence variation: Mutation; HGNC; HGNC:11231; ATL1; Simple; p.Pro342Ser (c.1024C>T); Zygosity=Heterozygous (PubMed=24908668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142893; Spastic paraplegia 3A
DI   ORDO; Orphanet_100984; Autosomal dominant spastic paraplegia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM27 ! iSPG3A-8
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   iSPG3A-8
AC   CVCL_RM27
DR   SKIP; SKIP001353
DR   Wikidata; Q54898324
RX   PubMed=24908668;
CC   Sequence variation: Mutation; HGNC; HGNC:11231; ATL1; Simple; p.Pro342Ser (c.1024C>T); Zygosity=Heterozygous (PubMed=24908668).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142893; Spastic paraplegia 3A
DI   ORDO; Orphanet_100984; Autosomal dominant spastic paraplegia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM26 ! iSPG3A-6
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   Isreco-1
AC   CVCL_A627
SY   ISRECO-1; Isreco 1; Isreco1; ISRECO1; IS-1; IS1
DR   cancercelllines; CVCL_A627
DR   ColonAtlas; Isreco1
DR   Cosmic; 711262
DR   Cosmic; 887229
DR   Cosmic; 902793
DR   Cosmic; 1479579
DR   GEO; GSM2550004
DR   IARC_TP53; 6480
DR   Wikidata; Q54898325
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9205061;
RX   PubMed=10766420;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=20570890;
RX   PubMed=24042735;
RX   PubMed=25944804;
RX   PubMed=28683746;
CC   Doubling time: 20.96 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20570890; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): PubMed=24042735
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 10,20
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 20
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 21,22
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A628 ! Isreco-2
OI   CVCL_A629 ! Isreco-3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 25
//
ID   Isreco-2
AC   CVCL_A628
SY   ISRECO-2; Isreco 2; Isreco2; ISRECO2; IS-2; IS2
DR   cancercelllines; CVCL_A628
DR   ColonAtlas; Isreco2
DR   Cosmic; 711263
DR   Cosmic; 887237
DR   Cosmic; 1479580
DR   IARC_TP53; 6481
DR   Wikidata; Q54898326
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9205061;
RX   PubMed=10766420;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=20570890;
RX   PubMed=24042735;
RX   PubMed=25944804;
CC   Doubling time: 52.52 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (PubMed=9000147).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A627 ! Isreco-1
OI   CVCL_A629 ! Isreco-3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   Isreco-3
AC   CVCL_A629
SY   ISRECO-3; Isreco 3; Isreco3; ISRECO3; IS-3; IS3
DR   cancercelllines; CVCL_A629
DR   ColonAtlas; Isreco3
DR   Cosmic; 711264
DR   Cosmic; 887239
DR   Cosmic; 1479581
DR   GEO; GSM2550005
DR   Wikidata; Q54898327
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9205061;
RX   PubMed=10766420;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=20570890;
RX   PubMed=24042735;
RX   PubMed=25944804;
RX   PubMed=28683746;
CC   Doubling time: 69.38 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20570890; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): PubMed=24042735
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 10
ST   D19S433: 13
ST   D21S11: 31.2,32.1
ST   D2S1338: 20
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 21,22
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A627 ! Isreco-1
OI   CVCL_A628 ! Isreco-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 25
//
ID   Issac IV
AC   CVCL_IU27
SY   Issac; NK15; NK15d
DR   Wikidata; Q54898328
RX   PubMed=4174339;
RX   PubMed=4178827;
RX   PubMed=4878906;
RX   PubMed=5021706;
RX   PubMed=5786183;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 10
//
ID   ISt-1
AC   CVCL_F645
SY   Ist-1; Ist1
DR   cancercelllines; CVCL_F645
DR   GEO; GSM552361
DR   GEO; GSM562416
DR   Progenetix; CVCL_F645
DR   Wikidata; Q54898329
RX   PubMed=1716623;
RX   PubMed=11314020;
RX   PubMed=15767549;
CC   Group: Serum/protein free medium cell line.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: Produces high level of AFP.
CC   Doubling time: 31 hours (PubMed=1716623).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   IST-1 [Human contaminated placenta]
AC   CVCL_F642
DR   ATCC; CRL-2734
DR   BioSample; SAMN03151922
DR   BioSample; SAMN03471780
DR   cancercelllines; CVCL_F642
DR   Wikidata; Q54898330
RX   PubMed=9701564;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ist-1-atcc-crl-2734
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-OV-3 derivative. Originally thought to originate from an HPV16 immortalized first trimester placenta.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00402.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2734; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-2734
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 8,11,12
ST   D16S539: 10,12,13
ST   D5S818: 11,12
ST   D7S820: 9,10,13,14
ST   TH01: 7,8,9,9.3
ST   TPOX: 6,8,9,11
ST   vWA: 16,17,18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 31
//
ID   IST-1 [Mouse hybridoma against human FN]
AC   CVCL_B6SG
DR   Wikidata; Q111733520
RX   PubMed=2438158;
RX   PubMed=3988746;
RX   PubMed=6156131;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   IST-2
AC   CVCL_B6SH
SY   IST2
DR   Wikidata; Q111733521
RX   PubMed=2438158;
RX   PubMed=6156131;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   IST-3
AC   CVCL_B6SI
DR   Wikidata; Q111733522
RX   PubMed=6156131;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   IST-4
AC   CVCL_B6SJ
SY   IST4
DR   Wikidata; Q111733523
RX   PubMed=3988746;
RX   PubMed=6156131;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1 (Note=Recognizes the 5th FNIII domain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   IST-9
AC   CVCL_B6SK
DR   Wikidata; Q111733524
RX   PubMed=2438158;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1 (Note=Recognizes the ED-A domain. Also reacts with dog, mouse, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   IST-EBV-TW1.1
AC   CVCL_3903
DR   CLDB; cl7144
DR   ICLC; EBV03001
DR   Wikidata; Q54898331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW1.2 (Cellosaurus=CVCL_3904).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   IST-EBV-TW1.2
AC   CVCL_3904
DR   CLDB; cl7145
DR   ICLC; EBV03002
DR   Wikidata; Q54898332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW1.1 (Cellosaurus=CVCL_3903).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   IST-EBV-TW2.1
AC   CVCL_3905
DR   CLDB; cl7146
DR   ICLC; EBV03003
DR   Wikidata; Q54898333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of IST-EBV-TW2.2 (Cellosaurus=CVCL_3906).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   IST-EBV-TW2.2
AC   CVCL_3906
DR   CLDB; cl7147
DR   ICLC; EBV03004
DR   Wikidata; Q54898334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of IST-EBV-TW2.1 (Cellosaurus=CVCL_3905).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   IST-EBV-TW3.1
AC   CVCL_3907
DR   CLDB; cl7148
DR   ICLC; EBV03005
DR   Wikidata; Q54898335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW3.2 (Cellosaurus=CVCL_3908).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   IST-EBV-TW3.2
AC   CVCL_3908
DR   CLDB; cl7149
DR   ICLC; EBV03006
DR   Wikidata; Q54898336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW3.1 (Cellosaurus=CVCL_3907).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   IST-EBV-TW4A
AC   CVCL_3909
SY   IST-EBV-TW4.A
DR   CLDB; cl7150
DR   ICLC; EBV03007
DR   Wikidata; Q54898337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of IST-EBV-TW4B (Cellosaurus=CVCL_3909).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   IST-EBV-TW4B
AC   CVCL_3910
SY   IST-EBV-TW4.B
DR   CLDB; cl7151
DR   ICLC; EBV03008
DR   Wikidata; Q54898338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of IST-EBV-TW4A (Cellosaurus=CVCL_3908).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   IST-EBV-TW5A
AC   CVCL_3911
SY   IST-EBV-TW5.A
DR   CLDB; cl7152
DR   ICLC; EBV03009
DR   Wikidata; Q54898339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW5B (Cellosaurus=CVCL_3912).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   IST-EBV-TW5B
AC   CVCL_3912
SY   IST-EBV-TW5.B
DR   CLDB; cl7153
DR   ICLC; EBV03010
DR   Wikidata; Q54898340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW5A (Cellosaurus=CVCL_3911).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   IST-EBV-TW6A
AC   CVCL_3913
SY   IST-EBV-TW6.A
DR   CLDB; cl7157
DR   ICLC; EBV04001
DR   Wikidata; Q54898341
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW6B (Cellosaurus=CVCL_3914).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   IST-EBV-TW6B
AC   CVCL_3914
SY   IST-EBV-TW6.B
DR   CLDB; cl7158
DR   ICLC; EBV04002
DR   Wikidata; Q54898342
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from dizygotic twin of IST-EBV-TW6A (Cellosaurus=CVCL_3913).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   IST-MEL1
AC   CVCL_1308
SY   ISTMEL1; Istituto Scientifico Tumori-MELanoma 1
DR   CLO; CLO_0006969
DR   CLDB; cl5539
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 901
DR   cancercelllines; CVCL_1308
DR   Cell_Model_Passport; SIDM00225
DR   ChEMBL-Cells; CHEMBL3308290
DR   ChEMBL-Targets; CHEMBL2366094
DR   Cosmic; 907172
DR   Cosmic-CLP; 907172
DR   DepMap; ACH-002143
DR   EGA; EGAS00001000978
DR   GDSC; 907172
DR   GEO; GSM1669942
DR   IARC_TP53; 21398
DR   ICLC; HTL01006
DR   LINCS_HMS; 50020
DR   LINCS_LDP; LCL-1234
DR   PharmacoDB; ISTMEL1_669_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1308
DR   Wikidata; Q54898343
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=907172; DepMap=ACH-002143).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn247Lys (c.741C>A); Zygosity=Homozygous (Cosmic-CLP=907172; DepMap=ACH-002143).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (Cosmic-CLP=907172; DepMap=ACH-002143).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.49%; Native American=1.88%; East Asian, North=0%; East Asian, South=1.65%; South Asian=5.96%; European, North=29.45%; European, South=59.56% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Cosmic-CLP=907172; ICLC=HTL01006
ST   Amelogenin: X (Cosmic-CLP=907172)
ST   Amelogenin: X,Y (ICLC=HTL01006)
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D21S11: 33.2,34.2
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   IST-MEL2
AC   CVCL_1309
SY   Istituto Scientifico Tumori-MELanoma 2
DR   CLO; CLO_0006970
DR   CLDB; cl7047
DR   ICLC; HTL01012
DR   Wikidata; Q54898344
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ICLC=HTL01012
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   IST-MEL3
AC   CVCL_1310
SY   Istituto Scientifico Tumori-MELanoma 3
DR   CLO; CLO_0006971
DR   CLDB; cl7045
DR   ICLC; HTL01011
DR   Wikidata; Q54898345
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ICLC=HTL01011
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   IST-MELA 16
AC   CVCL_F328
DR   CLDB; cl7220
DR   ICLC; HTL11007
DR   Wikidata; Q54898346
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ICLC=HTL11007
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 10,13,14
ST   D21S11: 29,30
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   IST-Mes1
AC   CVCL_1311
SY   IST-MES1; IST-MES-1; ISTMES1; Istituto Scientifico Tumori-Mesothelioma 1
DR   CLO; CLO_0006972
DR   CLDB; cl5540
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10987671
DR   cancercelllines; CVCL_1311
DR   Cell_Model_Passport; SIDM00224
DR   ChEMBL-Cells; CHEMBL3308291
DR   ChEMBL-Targets; CHEMBL2366194
DR   Cosmic; 907173
DR   Cosmic; 1995456
DR   Cosmic-CLP; 907173
DR   DepMap; ACH-000569
DR   EGA; EGAS00001000978
DR   GDSC; 907173
DR   GEO; GSM887165
DR   GEO; GSM888237
DR   GEO; GSM1669943
DR   IARC_TP53; 21399
DR   ICLC; HTL01005
DR   LiGeA; CCLE_714
DR   LINCS_LDP; LCL-1228
DR   PharmacoDB; ISTMES1_670_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1311
DR   PubChem_Cell_line; CVCL_1311
DR   Wikidata; Q54898347
RX   PubMed=10232421;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.78%; Native American=0%; East Asian, North=4.12%; East Asian, South=0%; South Asian=1.03%; European, North=38.45%; European, South=53.62% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=907173; ICLC=HTL01005
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   IST-Mes2
AC   CVCL_1312
SY   IST-MES2; IST-MES-2; ISTMES2; IstMes2; Istituto Scientifico Tumori-Mesothelioma 2
DR   CLO; CLO_0006973
DR   CLDB; cl5544
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988152
DR   cancercelllines; CVCL_1312
DR   Cell_Model_Passport; SIDM01554
DR   DepMap; ACH-000331
DR   GEO; GSM887166
DR   GEO; GSM888238
DR   GEO; GSM1029450
DR   GEO; GSM1029451
DR   GEO; GSM1029452
DR   GEO; GSM1029453
DR   GEO; GSM1029454
DR   GEO; GSM1029455
DR   GEO; GSM1029456
DR   GEO; GSM1029457
DR   GEO; GSM1029458
DR   GEO; GSM1029459
DR   IARC_TP53; 28300
DR   ICLC; HTL01007
DR   LiGeA; CCLE_183
DR   PharmacoDB; ISTMES2_671_2019
DR   Progenetix; CVCL_1312
DR   Wikidata; Q54898348
RX   PubMed=10232421;
RX   PubMed=16704740;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,26:01; B*38:01,39:01; C*12:03,12:03; DQA1*03:02,05:01; DQB1*02:02,02:02; DRB1*03:03,10:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (DepMap=ACH-000331).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.1%; East Asian, North=2.01%; East Asian, South=0%; South Asian=2.87%; European, North=43.48%; European, South=51.54% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ICLC=HTL01007
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11
ST   D21S11: 28,29
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   IST-Mes3
AC   CVCL_C312
SY   IST-MES3; Istituto Scientifico Tumori-Mesothelioma 3
DR   Wikidata; Q54898349
RX   PubMed=10232421;
RX   PubMed=16704740;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   IST-SL1
AC   CVCL_1313
SY   IST SL1; ISTSL1; Istituto Scientifico Tumori-Small cell Lung 1
DR   CLO; CLO_0006974
DR   CLDB; cl2908
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1313
DR   Cell_Model_Passport; SIDM00223
DR   ChEMBL-Cells; CHEMBL3308263
DR   ChEMBL-Targets; CHEMBL2366104
DR   Cosmic; 753564
DR   Cosmic; 1995457
DR   Cosmic-CLP; 753564
DR   DepMap; ACH-002144
DR   EGA; EGAS00001000978
DR   GDSC; 753564
DR   GEO; GSM1669944
DR   IARC_TP53; 27558
DR   ICLC; HTL97012
DR   LINCS_LDP; LCL-1868
DR   PharmacoDB; ISTSL1_672_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1313
DR   Wikidata; Q54898350
RX   PubMed=8795583;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2520+1G>A; ClinVar=VCV000126805; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=753564; DepMap=ACH-002144).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=0.16%; East Asian, South=1.69%; South Asian=0%; European, North=34.83%; European, South=63.08% (PubMed=30894373).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
ST   Source(s): Cosmic-CLP=753564; ICLC=HTL97012
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10
ST   D21S11: 29,30
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   IST-SL2
AC   CVCL_1314
SY   IST SL2; ISTSL2; Istituto Scientifico Tumori-Small cell Lung 2
DR   CLO; CLO_0006975
DR   CLDB; cl2909
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1314
DR   Cell_Model_Passport; SIDM00230
DR   ChEMBL-Cells; CHEMBL3308871
DR   ChEMBL-Targets; CHEMBL2366101
DR   Cosmic; 753565
DR   Cosmic; 1995458
DR   Cosmic-CLP; 753565
DR   DepMap; ACH-002145
DR   EGA; EGAS00001000978
DR   GDSC; 753565
DR   GEO; GSM1669945
DR   IARC_TP53; 21400
DR   ICLC; HTL97010
DR   LINCS_LDP; LCL-1869
DR   PharmacoDB; ISTSL2_673_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1314
DR   Wikidata; Q54898351
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr424Ilefs*4 (c.1268dup) (p.Gly423Aspfs*34) (c.1266_1267insG); Zygosity=Heterozygous (Cosmic-CLP=753565; DepMap=ACH-002145).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Homozygous (Cosmic-CLP=753565; DepMap=ACH-002145).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.3%; Native American=0.72%; East Asian, North=0%; East Asian, South=0.93%; South Asian=4.5%; European, North=46.2%; European, South=47.35% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=753565; ICLC=HTL97010
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 10
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   IST0269
AC   CVCL_E4Z0
SY   IST-00269
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST0271
AC   CVCL_E4Z1
SY   IST-00271
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST0471
AC   CVCL_E4Z2
SY   IST-00471
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST0475
AC   CVCL_E4Z3
SY   IST-00475
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST0983
AC   CVCL_E4Z4
SY   IST-00983
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST1163
AC   CVCL_E4Z5
SY   IST-01163
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST1610
AC   CVCL_E4Z6
SY   IST-01610
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST1877
AC   CVCL_E4Z7
SY   IST-01877
DR   GEO; GSM7036158
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IST1894
AC   CVCL_E4Z8
SY   IST-01894
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST1899
AC   CVCL_E4Z9
SY   IST-01899
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST2085
AC   CVCL_E4ZA
SY   IST-02085
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST2104
AC   CVCL_E4ZB
SY   IST-02104
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST2105
AC   CVCL_E4ZC
SY   IST-02105
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST2168
AC   CVCL_E4ZD
SY   IST-02168
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IST2316
AC   CVCL_E4ZE
SY   IST-02316
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST2607
AC   CVCL_E4ZF
SY   IST-02607
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IST2860
AC   CVCL_E4ZG
SY   IST-02860
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST2894
AC   CVCL_E4ZH
SY   IST-02894
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST3323
AC   CVCL_E4ZI
SY   IST-03323
DR   GEO; GSM7036159
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   IST3334
AC   CVCL_E4ZJ
SY   IST-03334
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST4151
AC   CVCL_E4ZK
SY   IST-04151
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST7887
AC   CVCL_E4ZL
SY   IST-07887
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST8095
AC   CVCL_E4ZM
SY   IST-08095
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST3773
AC   CVCL_E4ZN
SY   IST-13773
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   IST3774
AC   CVCL_E4ZP
SY   IST-13774
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   ISTEMi001-A
AC   CVCL_C6Q2
DR   BioSamples; SAMEA111452363
DR   hPSCreg; ISTEMi001-A
DR   Wikidata; Q117704555
RX   PubMed=37769385;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J995 ! GM00303
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   ISTEMi002-A
AC   CVCL_C6Q3
DR   BioSamples; SAMEA112700911
DR   hPSCreg; ISTEMi002-A
DR   Wikidata; Q117704556
RX   PubMed=37769385;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Population: Arab.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1F14 ! GM03390
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 4
//
ID   ISTEMi003-A
AC   CVCL_C6Q4
DR   BioSamples; SAMEA112772305
DR   hPSCreg; ISTEMi003-A
DR   Wikidata; Q117704557
RX   PubMed=37769385;
CC   From: Institut from Stem cell Therapy and Exploration of Monogenic diseases; Corbeil-Essonnes; France.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84736; Glycogen storage disease type III
DI   ORDO; Orphanet_366; Glycogen storage disease due to glycogen debranching enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1F10 ! GM02523
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 4
//
ID   iSyn
AC   CVCL_E5VF
SY   iSin; immortalized Synoviocyte
DR   ABM; T0383
RX   CelloPub=CLPUB00782;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient that underwent leg amputation (CelloPub=CLPUB00782).
CC   Derived from site: In situ; Synovial joint; UBERON=UBERON_0002217.
CC   Cell type: Fibroblast-like synoviocyte; CL=CL_0002301.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IT 1
AC   CVCL_C7RB
SY   IT-1; IMMTUB 1; F23-49; F 23-49
DR   Wikidata; Q117704558
RX   PubMed=3943911;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P9WMK1; Mycobacterium tuberculosis hspX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IT 15
AC   CVCL_C6V5
SY   IT-15; IMMTUB 15; TB72; WTB 72-A6; NRC-2410
DR   ABCD; ABCD_AW683
DR   Wikidata; Q117704559
RX   PubMed=3943911;
RX   PubMed=6166820;
RX   PubMed=34415957;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P9WGU1; Mycobacterium tuberculosis pstS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IT 20
AC   CVCL_C7RA
SY   IT-20; IMMTUB 20; TB68; WTB 68-A2
DR   Wikidata; Q117704560
RX   PubMed=3943911;
RX   PubMed=6166820;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P9WMK1; Mycobacterium tuberculosis hspX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IT 3
AC   CVCL_C6V6
SY   IT-3; IMMTUB 3; SA-12; SA 12; NRC-2894
DR   ABCD; ABCD_AW682
DR   Wikidata; Q117704561
RX   PubMed=3943911;
RX   PubMed=34415957;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P9WPE5; Mycobacterium tuberculosis groES.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IT 4
AC   CVCL_C7RC
SY   IT-4; IMMTUB 4; F24-2; F 24-2
DR   Wikidata; Q117704562
RX   PubMed=3943911;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P9WMK1; Mycobacterium tuberculosis hspX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   IT-25
AC   CVCL_W522
DR   Wikidata; Q54898352
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=2979201;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft maintained in nude mice.
CC   Doubling time: ~57.8 hours (PubMed=2979201).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   IT-26R21
AC   CVCL_7676
DR   JCRB; IFO50078
DR   Wikidata; Q54898353
RX   PubMed=517453;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   IT-45R1
AC   CVCL_7677
SY   IT-45 R1; IT45-R1
DR   BCRJ; 0282
DR   JCRB; IFO50076
DR   Wikidata; Q54898354
RX   DOI=10.2220/biomedres.2.11;
RX   PubMed=6602403;
RX   PubMed=6977896;
CC   Doubling time: 60 hours (DOI=10.2220/biomedres.2.11).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_7678 ! IT-45R91
OI   CVCL_E2VH ! IT-45R92
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   IT-45R91
AC   CVCL_7678
SY   IT45R91
DR   JCRB; IFO50077
DR   Wikidata; Q54898355
RX   DOI=10.2220/biomedres.2.11;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_7677 ! IT-45R1
OI   CVCL_E2VH ! IT-45R92
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   IT-45R92
AC   CVCL_E2VH
RX   PubMed=6342809;
CC   Doubling time: 24.6 hours (PubMed=6342809).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_7677 ! IT-45R1
OI   CVCL_7678 ! IT-45R91
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   IT-79MTNC3
AC   CVCL_U233
SY   79MTNC3; IT79M1
DR   BTO; BTO_0006263
DR   BCRJ; 0120
DR   JCRB; IFO50248
DR   Wikidata; Q54898356
RX   PubMed=3259930;
CC   Discontinued: BCRJ; 0120; probable.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Thymic nurse cell; CL=CL_4030004.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-10W
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   IT832
AC   CVCL_F945
DR   RCB; RCB2289
DR   TKG; TKG 0586
DR   Wikidata; Q54898361
CC   Population: Japanese.
CC   Discontinued: RCB; RCB2289; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0586
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C7464; Acute leukemia of ambiguous lineage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   ITAC-3
AC   CVCL_A015
SY   Intestinal-Type sinonasal AdenoCarcinoma-3
DR   cancercelllines; CVCL_A015
DR   Wikidata; Q54898362
RX   PubMed=21360264;
CC   Doubling time: ~18 hours (PubMed=21360264).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=21360264).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Heterozygous (PubMed=21360264).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, ethmoid sinus; UBERON=UBERON_0002453.
DI   NCIt; C116316; Sinonasal adenocarcinoma, intestinal-type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   ITC-1
AC   CVCL_F644
DR   Wikidata; Q54898363
RX   CelloPub=CLPUB00561;
RX   CelloPub=CLPUB00564;
RX   PubMed=1311428;
CC   Characteristics: Produces glucagon (PubMed=1311428).
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_GR54 ! In-111-R1
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   ITH6.1
AC   CVCL_A2EU
DR   CCRID; 4201PAT-CCTCC01035
DR   Wikidata; Q105509722
RX   Patent=CN106939300A;
RX   PubMed=32880691;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201740.
CC   Virology: Susceptible to infection by enterovirus type 71 (EV71), but not by hepatitis C virus (HCV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   iTIME.219
AC   CVCL_B6YS
DR   Wikidata; Q111733525
RX   PubMed=33937098;
CC   Characteristics: rKSHV.219 includes a RFP-GFP-PuroR construct that contains RFP under the control of the lytic PAN RNA promoter, GFP under the control of human EF1a promoter and PuroR expressed by the RSV promoter.
CC   Characteristics: Transduced with pRetroX-Tet-On that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and with RetroX-Tight-Hyg-RTA.
CC   Virology: Maintains latent rKSHV.219 as indicated by expression of constitutively expressed (eGFP) but not a lytic phase (RFP) reporter gene. When exposed to either sodium butyrate or doxycycline, the cells are activated to lytic replication and express RFP and KSHV lytic genes and release large quantities of infectious virus (PubMed=33937098).
CC   Virology: Infected with a recombinant human herpesvirus 8 (HHV-8/KSHV) rKSHV.219.
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin, dermis, microvascular endothelium; UBERON=UBERON_0001471+UBERON_0008339.
ST   Source(s): PubMed=33937098
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6YR ! TIME.219
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 10
//
ID   ITK-2
AC   CVCL_A1LP
DR   Wikidata; Q102114250
RX   PubMed=1646075;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human cluster-1 antigen on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   ITK-3
AC   CVCL_A1LQ
DR   Wikidata; Q102114252
RX   PubMed=1646075;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human cluster-1 antigen on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   ITM
AC   CVCL_U244
DR   EFO; EFO_0002061
DR   GEO; GSM42104
DR   GEO; GSM42170
DR   Wikidata; Q54898364
RX   PubMed=16079833;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6840; MAP2K1 (Note=Fused to a modified hormone-binding domain of ER = MEK-ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U243 ! ITV
SX   Female
AG   16FW
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   ITM-E6/E7
AC   CVCL_U245
SY   ITM-E6E7; ITME6E7
DR   EFO; EFO_0002062
DR   GEO; GSM42176
DR   GEO; GSM42177
DR   Wikidata; Q54898365
RX   PubMed=16079833;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6840; MAP2K1 (Note=Fused to a modified hormone-binding domain of ER = MEK-ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U244 ! ITM
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   ITM-E6/E7-ST
AC   CVCL_U246
SY   ITM-E6E7-ST; ITME6E7ST
DR   EFO; EFO_0002063
DR   GEO; GSM42178
DR   GEO; GSM42179
DR   Wikidata; Q54898366
RX   PubMed=16079833;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6840; MAP2K1 (Note=Fused to a modified hormone-binding domain of ER = MEK-ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U244 ! ITM
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   ITM-ST
AC   CVCL_U247
SY   ITMST
DR   EFO; EFO_0002064
DR   GEO; GSM42172
DR   GEO; GSM42175
DR   Wikidata; Q54898367
RX   PubMed=16079833;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6840; MAP2K1 (Note=Fused to a modified hormone-binding domain of ER = MEK-ER).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U244 ! ITM
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   ITO-I
AC   CVCL_WZ70
DR   Wikidata; Q94324985
RX   CelloPub=CLPUB00056;
CC   Population: Japanese.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1315 ! ITO-II
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   ITO-II
AC   CVCL_1315
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03471634
DR   Cosmic; 924164
DR   FANTOM5_SSTAR; 10786-110H3
DR   IARC_TP53; 27696
DR   JCRB; JCRB0613
DR   Wikidata; Q54898368
RX   CelloPub=CLPUB00056;
RX   PubMed=2445169;
RX   PubMed=3618218;
RX   PubMed=20164919;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): JCRB=JCRB0613
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16,21
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ70 ! ITO-I
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   ITO-II cl-5
AC   CVCL_IW42
SY   ITO-II clone-5
DR   Wikidata; Q54898369
RX   PubMed=2445169;
CC   Population: Japanese.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1315 ! ITO-II
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   ITOC-01
AC   CVCL_WS66
SY   Indian Tata memorial centre Oral Cancer-01
DR   cancercelllines; CVCL_WS66
DR   Wikidata; Q94325005
RX   PubMed=31164688;
CC   Population: Indian.
CC   Doubling time: 47.31 hours (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln1214Ter (c.3640C>T); Zygosity=Unspecified (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126His (c.376T>C); ClinVar=VCV001734755; Zygosity=Unspecified (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=31164688).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=31164688
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12.1
ST   D13S317: 10,12
ST   D16S539: 13
ST   D5S818: 10
ST   D7S820: 9.3,12
ST   TH01: 5
ST   TPOX: 7.3
ST   vWA: 15.2,16.1
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   ITOC-02
AC   CVCL_WS67
SY   Indian Tata memorial centre Oral Cancer-02
DR   Wikidata; Q94325007
RX   PubMed=31164688;
CC   Population: Indian.
CC   Doubling time: 51.15 hours (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=31164688).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=31164688
ST   Amelogenin: X
ST   CSF1PO: 10.3,12
ST   D13S317: 13,13.3
ST   D16S539: 12.1,14
ST   D5S818: 9,10.1
ST   D7S820: 8
ST   TH01: 5.3,8.3
ST   TPOX: 9,10.3
ST   vWA: 15.2,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   ITOC-03
AC   CVCL_WS68
SY   Indian Tata memorial centre Oral Cancer-03
DR   cancercelllines; CVCL_WS68
DR   Wikidata; Q94325010
RX   PubMed=31164688;
CC   Population: Indian.
CC   Doubling time: 67.82 hours (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.74+38C>G (IVS2+38C>G); ClinVar=VCV000137691; Zygosity=Unspecified (PubMed=31164688).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=31164688
ST   Amelogenin: X,Y
ST   CSF1PO: 10.3,11.3
ST   D13S317: 11,14.3
ST   D16S539: 11,12.1
ST   D5S818: 10.1
ST   D7S820: 8
ST   TH01: 5.3,7.3
ST   TPOX: 10,10.3
ST   vWA: 15.2,17
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   ITOC-04
AC   CVCL_WS69
SY   Indian Tata memorial centre Oral Cancer-04
DR   cancercelllines; CVCL_WS69
DR   Wikidata; Q94325013
RX   PubMed=31164688;
CC   Population: Indian.
CC   Doubling time: 47.75 hours (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.74+38C>G (IVS2+38C>G); ClinVar=VCV000137691; Zygosity=Unspecified (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.96+41_97-54delCTCCAGGTCCCCAGCC (c.96+41_96+56del16) (IVS3+36_52del16); ClinVar=VCV000440349; Zygosity=Unspecified (PubMed=31164688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=31164688).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=31164688
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12.1
ST   D5S818: 10.1,12.3
ST   D7S820: 9.3,12
ST   TH01: 7,9.1
ST   TPOX: 10.3
ST   vWA: 13,15,17
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   ITOF
AC   CVCL_WY74
DR   Wikidata; Q94325015
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
OX   NCBI_TaxID=8042; ! Parahucho perryi (Japanese huchen)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 4
//
ID   ITPD-iPSC
AC   CVCL_0H83
SY   Infantile-Type Pompe Disease-iPSC
DR   SKIP; SKIP000577
DR   Wikidata; Q54898370
RX   PubMed=24642446;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu176Argfs*45 (c.525delT); ClinVar=VCV000004033; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H82 ! GM20124
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   iTS1
AC   CVCL_T799
SY   A000056#1; HPS0149
DR   RCB; HPS0149
DR   SKIP; SKIP000055
DR   SKIP; SKIP000246
DR   Wikidata; Q54898371
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K263 ! GM2-1TKB
SX   Female
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   iTS2
AC   CVCL_T800
SY   A000056#2; HPS0150
DR   RCB; HPS0150
DR   SKIP; SKIP000056
DR   SKIP; SKIP000247
DR   Wikidata; Q54898372
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K263 ! GM2-1TKB
SX   Female
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   iTS3
AC   CVCL_T801
SY   A000056#3; HPS0151
DR   RCB; HPS0151
DR   SKIP; SKIP000057
DR   SKIP; SKIP000248
DR   Wikidata; Q54898373
CC   Population: Japanese.
CC   Discontinued: RCB; HPS0151; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K263 ! GM2-1TKB
SX   Female
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   ITSM
AC   CVCL_JF86
DR   JCRB; JCRB1635
DR   Wikidata; Q54898374
RX   PubMed=29892436;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1635
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3345; Pseudomyxoma peritonei
DI   ORDO; Orphanet_26790; Pseudomyxoma peritonei
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 7
//
ID   ITV
AC   CVCL_U243
SY   IT
DR   EFO; EFO_0002065
DR   GEO; GSM42080
DR   GEO; GSM42103
DR   Wikidata; Q54898376
RX   PubMed=16079833;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   ITXi001-A
AC   CVCL_B5IP
SY   hERG CT Cl9; UhiPS-ct-1
DR   BioSamples; SAMEA10368003
DR   GEO; GSM1958863
DR   hPSCreg; ITXi001-A
DR   Wikidata; Q110432989
RX   PubMed=26586530;
RX   PubMed=35247835;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   ITXi001-A-1
AC   CVCL_B5QH
SY   hiPSc-GPR146-/-; GPR146-KO Cl2.P4
DR   BioSamples; SAMEA10368000
DR   hPSCreg; ITXi001-A-1
DR   Wikidata; Q111733526
RX   PubMed=35247835;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21718; GPR146.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5IP ! ITXi001-A
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   ITXi002-A
AC   CVCL_B5QD
SY   H166Wt C09; IRX5-Wt
DR   BioSamples; SAMEA11025515
DR   hPSCreg; ITXi002-A
DR   Wikidata; Q111733527
RX   PubMed=34929443;
CC   From: Institut du Thorax; Nantes; France.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ITXi002-A-1
AC   CVCL_B5QE
SY   CRISPR-2 IRX5 F12 Het; IRX5-Het
DR   BioSamples; SAMEA11025520
DR   hPSCreg; ITXi002-A-1
DR   Wikidata; Q111733528
RX   PubMed=34929443;
CC   From: Institut du Thorax; Nantes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14361; IRX5 (Note=1 of 2 alleles).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5QD ! ITXi002-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   ITXi002-A-2
AC   CVCL_B5QF
SY   CRISPR-2 IRX5 D8 KO; IRX5-KO
DR   BioSamples; SAMEA11025521
DR   hPSCreg; ITXi002-A-2
DR   Wikidata; Q111733529
RX   PubMed=34929443;
CC   From: Institut du Thorax; Nantes; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14361; IRX5.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5QD ! ITXi002-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   ITXi002-A-3
AC   CVCL_B5QG
SY   CRISPR-3 IRX5 F6 KI; IRX5-KI
DR   BioSamples; SAMEA11025522
DR   hPSCreg; ITXi002-A-3
DR   Wikidata; Q111733530
RX   PubMed=34929443;
CC   From: Institut du Thorax; Nantes; France.
CC   Characteristics: Using CRISPR/Cas9 a HA tag was introduced at the C-termini of IRX5 (PubMed=34929443).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5QD ! ITXi002-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ITXi003-A
AC   CVCL_B5Q8
SY   MS368
DR   BioSamples; SAMEA11025523
DR   hPSCreg; ITXi003-A
DR   Wikidata; Q111733531
RX   PubMed=34995842;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185245; Familial catecholamine-induced QT prolongation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ITXi004-A
AC   CVCL_B5Q9
SY   MS381
DR   BioSamples; SAMEA11025524
DR   hPSCreg; ITXi004-A
DR   Wikidata; Q111733532
RX   PubMed=34995842;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185245; Familial catecholamine-induced QT prolongation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   ITXi005-A
AC   CVCL_B5Q4
SY   MS573
DR   BioSamples; SAMEA11285998
DR   hPSCreg; ITXi005-A
DR   Wikidata; Q111733533
RX   PubMed=34999420;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian; French.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ITXi006-A
AC   CVCL_B5Q5
SY   WT8288
DR   BioSamples; SAMEA11285997
DR   hPSCreg; ITXi006-A
DR   Wikidata; Q111733534
RX   PubMed=34999420;
RX   PubMed=38522388;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian; French.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   ITXi006-A-1
AC   CVCL_E8YB
SY   IM-R406W
DR   BioSamples; SAMEA115121928
DR   hPSCreg; ITXi006-A-1
RX   PubMed=38522388;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian; French.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple_edited; p.Arg406Trp (c.1216C>T); ClinVar=VCV000016826; Zygosity=Heterozygous; Note=By CRISP/Cas9 (PubMed=38522388).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5Q5 ! ITXi006-A
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ITXi007-A
AC   CVCL_B5Q6
SY   202CT
DR   BioSamples; SAMEA11288410
DR   hPSCreg; ITXi007-A
DR   Wikidata; Q111733535
RX   PubMed=34999420;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian; French.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ITXi008-A
AC   CVCL_B5Q7
SY   SD378M
DR   BioSamples; SAMEA11290066
DR   hPSCreg; ITXi008-A
DR   Wikidata; Q111733536
RX   PubMed=34999420;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian; French.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ITXi009-A
AC   CVCL_B5QA
SY   CPVT068
DR   BioSamples; SAMEA11291308
DR   hPSCreg; ITXi009-A
DR   Wikidata; Q111733537
RX   PubMed=35101670;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Arg4959Glu (c.14876G>A); Zygosity=Heterozygous (PubMed=35101670).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   ITXi010-A
AC   CVCL_B5QB
SY   CPVT249
DR   BioSamples; SAMEA11291310
DR   hPSCreg; ITXi010-A
DR   Wikidata; Q111733538
RX   PubMed=35101670;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Tyr2476Asp (c.7426T>G); Zygosity=Heterozygous (PubMed=35101670).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   ITXi011-A
AC   CVCL_B5QC
SY   CPVT033
DR   BioSamples; SAMEA11291325
DR   hPSCreg; ITXi011-A
DR   Wikidata; Q111733539
RX   PubMed=35101670;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Arg4959Glu (c.14876G>A); Zygosity=Heterozygous (PubMed=35101670).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   ITXi012-A
AC   CVCL_D0GM
SY   Lp(a) Clone 23; Lp(a) Cl23
DR   BioSamples; SAMEA112371431
DR   hPSCreg; ITXi012-A
DR   Wikidata; Q123032756
RX   PubMed=37734317;
CC   From: Institut du Thorax; Nantes; France.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C202076; Lipoprotein(a) quantitative trait locus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ITXi013-A
AC   CVCL_E8Y9
SY   PT-R406W
DR   BioSamples; SAMEA115125141
DR   hPSCreg; ITXi013-A
RX   PubMed=38522388;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Arg406Trp (c.1216C>T); ClinVar=VCV000016826; Zygosity=Heterozygous (PubMed=38522388).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ITXi013-B
AC   CVCL_E8YA
SY   IC-R406
DR   BioSamples; SAMEA115125856
DR   hPSCreg; ITXi013-B
RX   PubMed=38522388;
CC   From: Institut du Thorax; Nantes; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple_corrected; p.Arg406Trp (c.1216C>T); ClinVar=VCV000016826; Zygosity=Heterozygous; Note=By CRISP/Cas9 (PubMed=38522388).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8Y9 ! ITXi013-A
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IU-TAB-1
AC   CVCL_D551
SY   IU-TAB1
DR   ABM; T8001
DR   cancercelllines; CVCL_D551
DR   Cosmic; 2663904
DR   Wikidata; Q54898377
RX   PubMed=22926645;
RX   PubMed=27117832;
CC   Doubling time: 48 hours (PubMed=22926645).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=27117832).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a 35 packs per year smoker (PubMed=22926645).
CC   Derived from site: In situ; Mediastinum; UBERON=UBERON_0003728.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
DI   NCIt; C6885; Thymoma type AB
DI   ORDO; Orphanet_99867; Thymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   IUFi001-A
AC   CVCL_A0JU
SY   IUFi001
DR   BioSamples; SAMEA9273536
DR   hPSCreg; IUFi001-A
DR   Wikidata; Q108820552
RX   PubMed=34271225;
CC   From: Leibniz Research Institute for Environmental Medicine; Dusseldorf; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys337Ter (c.1009A>T) (A1088T); ClinVar=VCV000550722; Zygosity=Heterozygous (PubMed=34271225).
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg857Ter (c.2569C>T); ClinVar=VCV000553383; Zygosity=Heterozygous (PubMed=34271225).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34271225
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 18.3,20
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 14,19
ST   D19S433: 13,14
ST   D1S1656: 16
ST   D21S11: 30,30.2
ST   D2S1338: 18,24
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D6S1043: 17,19
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 19,23
ST   Penta D: 10,15
ST   Penta E: 7,11
ST   TH01: 6,7
ST   TPOX: 8,11
DI   NCIt; C135726; Cockayne syndrome type B
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L471 ! CS1AN
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   IUFi002-A
AC   CVCL_C6Q5
SY   DU179R
DR   BioSamples; SAMEA111528658
DR   hPSCreg; IUFi002-A
DR   Wikidata; Q117704563
RX   PubMed=36403546;
CC   From: Leibniz Research Institute for Environmental Medicine; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7707; NDUFS1; Simple; p.Arg557Ter (c.1671C>T); ClinVar=VCV000050923; Zygosity=Heterozygous (PubMed=36403546).
CC   Sequence variation: Mutation; HGNC; HGNC:7707; NDUFS1; Simple; p.Asp618Asn (c.1854G>A); Zygosity=Heterozygous (PubMed=36403546).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   NCIt; C98994; NADH dehydrogenase deficiency
DI   ORDO; Orphanet_2609; Isolated complex I deficiency
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   IUFi004-A-1
AC   CVCL_D6ML
SY   DU323
DR   BioSamples; SAMEA114577674
DR   hPSCreg; IUFi004-A-1
DR   Wikidata; Q127382394
RX   PubMed=38217996;
CC   From: Leibniz Research Institute for Environmental Medicine; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:132; ACTB; Simple_edited; p.Glu214Ter (c.640G>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38217996).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38217996
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 21,22
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 14,15
ST   D19S433: 15
ST   D1S1656: 13,17.3
ST   D21S11: 28,29
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D6S1043: 12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 2.2,13
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7XH ! iPS12-10
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   IUFi004-A-2
AC   CVCL_D6MM
SY   DU324
DR   BioSamples; SAMEA114577676
DR   hPSCreg; IUFi004-A-2
DR   Wikidata; Q127382395
RX   PubMed=38217996;
CC   From: Leibniz Research Institute for Environmental Medicine; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:132; ACTB; Simple_edited; p.Glu214Ter (c.640G>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38217996).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38217996
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 21,22
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 14,15
ST   D19S433: 15
ST   D1S1656: 13,17.3
ST   D21S11: 28,29
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D6S1043: 12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 2.2,13
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7XH ! iPS12-10
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   IV-A1-j
AC   CVCL_B3UN
SY   IV-AI-j; A1-j
DR   Wikidata; Q110432990
RX   CelloPub=CLPUB00663;
RX   CelloPub=CLPUB00664;
RX   PubMed=1369208;
RX   PubMed=8468364;
CC   Characteristics: Resistant to an insulin-diphtheria-A chain toxic conjugate (DTaI).
CC   Selected for resistance to: Diphtheria A chain:insulin (DTaI).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   IV.3
AC   CVCL_J831
DR   CLO; CLO_0006976
DR   ABCD; ABCD_AS869
DR   ATCC; HB-217
DR   Wikidata; Q54898379
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12318; Human FCGR2A/CD32.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IVA114
AC   CVCL_C8H2
SY   3W-089
DR   Wikidata; Q123032757
RX   CelloPub=CLPUB00741;
RX   PubMed=10730891;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30932; Bovine CD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IVA12
AC   CVCL_G223
DR   CLO; CLO_0006978
DR   ATCC; HB-145
DR   Wikidata; Q54898380
RX   PubMed=3921497;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IVA31
AC   CVCL_C8H0
SY   3W-468
DR   Wikidata; Q123032758
RX   CelloPub=CLPUB00741;
RX   PubMed=10730891;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30932; Bovine CD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IVA50
AC   CVCL_C8H1
SY   3W-538
DR   Wikidata; Q123032759
RX   CelloPub=CLPUB00741;
RX   PubMed=10730891;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30932; Bovine CD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   IVA4
AC   CVCL_C5AY
DR   Wikidata; Q116049592
RX   PubMed=23244329;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; I7AFU8; Bluetongue virus 16 VP7 (Note=Also reacts with all other BPV serotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   IVB4
AC   CVCL_A0PR
DR   Wikidata; Q108820553
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable.
CC   Doubling time: 4-5 days (PubMed=33899125).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   IVB6
AC   CVCL_A0PP
DR   Wikidata; Q108820554
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Brilliant brown; forms cell aggregates; immovable.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   IVBF
AC   CVCL_ZT88
SY   IVB-F
DR   Wikidata; Q98126789
RX   PubMed=1467311;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Heterozygous; Note=Impairs TP53 splicing dramatically (PubMed=1467311).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   IVC4
AC   CVCL_A0PS
DR   Wikidata; Q108820555
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable.
CC   Doubling time: 4-5 days (PubMed=33899125).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   IVC6
AC   CVCL_A0PU
DR   Wikidata; Q108820556
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Bright, vacuoles; immovable, forms cell sheet.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   IVD1
AC   CVCL_A0PT
DR   Wikidata; Q108820557
RX   PubMed=33899125;
CC   Group: Cnidaria cell line.
CC   Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable.
CC   Doubling time: 4-5 days (PubMed=33899125).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=70783; ! Acropora tenuis (Purple tipped acropora)
AG   Planula larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   IVD12
AC   CVCL_G224
DR   CLO; CLO_0006979
DR   ATCC; HB-144
DR   Wikidata; Q54898381
RX   PubMed=6189938;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   IVF-ES-11
AC   CVCL_A1WY
SY   IVF-derived ESC-11; SNUARTe002-A
DR   GEO; GSM3391902
DR   GEO; GSM3391903
DR   GEO; GSM3391904
DR   Wikidata; Q105509724
RX   PubMed=31257130;
RX   PubMed=32160914;
RX   PubMed=33232901;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   IVF-ES-12
AC   CVCL_A1XB
SY   IVF-derived ESC-12
DR   Wikidata; Q105509728
RX   PubMed=31257130;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   IVG-BF/LXSN
AC   CVCL_4417
SY   IVG-BF.LXSN
DR   Wikidata; Q54898382
RX   PubMed=22829774;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0058 but was never intended to be distributed.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   ivi4/27
AC   CVCL_C0EC
DR   Wikidata; Q112929889
DR   Ximbio; 154005
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
CC   Monoclonal antibody target: UniProtKB; P40199; Human CEACAM6/CD66c.
CC   Monoclonal antibody target: UniProtKB; P31997; Human CEACAM8/CD66b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   iVMP C1
AC   CVCL_F0D2
SY   immortalized VM Precursor clone C1; C1
RX   PubMed=20177706;
RX   PubMed=22863662;
CC   Doubling time: 18.3 hours (PubMed=20177706).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Embryonic brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F0D3 ! iVMP C2
OI   CVCL_F0D4 ! iVMP C3
OI   CVCL_F0D5 ! iVMP C4
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   iVMP C2
AC   CVCL_F0D3
SY   immortalized VM Precursor clone C2; C2
RX   PubMed=20177706;
RX   PubMed=22863662;
CC   Doubling time: 14.6 hours (PubMed=20177706).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Embryonic brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F0D2 ! iVMP C1
OI   CVCL_F0D4 ! iVMP C3
OI   CVCL_F0D5 ! iVMP C4
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   iVMP C3
AC   CVCL_F0D4
SY   immortalized VM Precursor clone C3; C3
RX   PubMed=20177706;
RX   PubMed=22863662;
CC   Doubling time: 15.4 hours (PubMed=20177706).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Embryonic brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F0D2 ! iVMP C1
OI   CVCL_F0D3 ! iVMP C2
OI   CVCL_F0D5 ! iVMP C4
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   iVMP C4
AC   CVCL_F0D5
SY   immortalized VM Precursor clone C4; C4
RX   PubMed=20177706;
RX   PubMed=22863662;
CC   Doubling time: 12.7 hours (PubMed=20177706).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Embryonic brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F0D2 ! iVMP C1
OI   CVCL_F0D3 ! iVMP C2
OI   CVCL_F0D4 ! iVMP C3
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   IVR01
AC   CVCL_E5FT
SY   In Vivo Resistant 01
DR   CancerTools; 161758
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Characteristics: Female nude mice were injected IP with the parent cell line. Once tumours were established the mice were treated with carboplatin. This cell line was establishe from one of these in-vivo established resistant tumor cells (PubMed=35918200).
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Misspelling: IVRO1; CancerTools=161758.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FK ! OVCAR4-Luc
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IVR02
AC   CVCL_E5FU
SY   In Vivo Resistant 02
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Characteristics: Female nude mice were injected IP with the parent cell line. Once tumours were established the mice were treated with carboplatin. This cell line was establishe from one of these in-vivo established resistant tumor cells (PubMed=35918200).
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FK ! OVCAR4-Luc
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IW201
AC   CVCL_B4H3
DR   Wikidata; Q110432992
RX   PubMed=2355917;
RX   PubMed=2735652;
RX   PubMed=8043864;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   IW32
AC   CVCL_B4H1
SY   IW.32
DR   Wikidata; Q110432993
RX   Patent=FR2550216A1;
RX   PubMed=2355917;
RX   PubMed=2735652;
RX   PubMed=2766927;
RX   PubMed=3561395;
RX   PubMed=3861324;
RX   PubMed=6578507;
RX   PubMed=6589018;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-234.
CC   Characteristics: Constitutively synthesizes and secretes erythropoietin (PubMed=6578507; PubMed=6589018).
CC   Characteristics: One of the two copies of the EPO locus has undergone rearrangement and amplification (PubMed=2766927; PubMed=3561395).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: ICFW.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   IWARS1
AC   CVCL_E5TU
SY   Immortalized Wild-type AR Schwann cells 1.
DR   ABM; T0799
RX   PubMed=33494154;
CC   Donor information: Established from wild-type littermates of AR-deficient (Akr1b1) C57BL/6 mice.
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   IWB
AC   CVCL_1M72
SY   GM06825; GM06825A
DR   CLO; CLO_0036523
DR   Coriell; GM06825
DR   Wikidata; Q54898383
RX   CelloPub=CLPUB00447;
RX   PubMed=6417008;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*23; B*07; C*w07 (Coriell=GM06825).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 11
//
ID   iWS229
AC   CVCL_EQ35
SY   WS iPSC from AG05229
DR   GEO; GSM1184284
DR   GEO; GSM1184285
DR   Wikidata; Q54898384
RX   PubMed=24749076;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X835 ! AG05229
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   iWS229-p53i-2.1
AC   CVCL_EQ36
SY   WS iPSC iWS229 p53i
DR   GEO; GSM1184294
DR   GEO; GSM1184295
DR   Wikidata; Q54898386
RX   PubMed=24749076;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ35 ! iWS229
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   iWS229T-13
AC   CVCL_EQ37
SY   WS iPSC iWS229 TERT (clone 13)
DR   GEO; GSM1184296
DR   GEO; GSM1184297
DR   Wikidata; Q54898387
RX   PubMed=24749076;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ35 ! iWS229
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   iWS229T-21
AC   CVCL_EQ38
SY   WS iPSC iWS229 TERT (clone 21)
DR   GEO; GSM1184298
DR   GEO; GSM1184299
DR   Wikidata; Q54898388
RX   PubMed=24749076;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ35 ! iWS229
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   iWS300
AC   CVCL_EQ39
SY   WS iPSC from AG06300
DR   GEO; GSM1184286
DR   GEO; GSM1184287
DR   Wikidata; Q54898389
RX   PubMed=24749076;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0J91 ! AG06300
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   iWS780-1.9
AC   CVCL_EQ40
SY   WS iPSC from AG00780 (clone 1.9)
DR   GEO; GSM1184288
DR   GEO; GSM1184289
DR   Wikidata; Q54898390
RX   PubMed=24749076;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=24749076).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U282 ! AG00780
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   iWS780-2.10
AC   CVCL_EQ41
SY   WS iPSC from AG00780 (clone 2.10)
DR   GEO; GSM1184290
DR   GEO; GSM1184291
DR   Wikidata; Q54898391
RX   PubMed=24749076;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=24749076).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U282 ! AG00780
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   iWS797
AC   CVCL_EQ42
SY   WS iPSC from AG12797
DR   GEO; GSM1184292
DR   GEO; GSM1184293
DR   Wikidata; Q54898392
RX   PubMed=24749076;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X769 ! AG12797
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   iWS797T
AC   CVCL_EQ43
SY   WS iPSC iWS797 TERT
DR   GEO; GSM1184300
DR   GEO; GSM1184301
DR   Wikidata; Q54898393
RX   PubMed=24749076;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EQ42 ! iWS797
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   IWT-1
AC   CVCL_A6JG
DR   cancercelllines; CVCL_A6JG
DR   RCB; RCB5003
DR   Wikidata; Q107115483
RX   PubMed=24587255;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; ClinVar=VCV001074338; Zygosity=Unspecified (PubMed=24587255).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   IX-2H7-E10
AC   CVCL_U035
SY   M-2
DR   ECACC; 08041722
DR   Wikidata; Q54898394
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Leishmania amazonensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   IX-5H9-C10
AC   CVCL_U046
SY   M-3; M3
DR   Wikidata; Q54898395
RX   PubMed=3826486;
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania amazonensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   IxN/2b
AC   CVCL_6761
SY   1xN/2b
DR   Wikidata; Q54582916
RX   Patent=US4965195;
RX   PubMed=2324686;
RX   PubMed=3258354;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=1xN%2F2b
CC   Characteristics: IL7 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   IxN/A6
AC   CVCL_C4JG
DR   Wikidata; Q116049593
RX   Patent=US4965195;
RX   PubMed=3258354;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   iyGC
AC   CVCL_E7AR
SY   immortalized yak Granulosa Cells
RX   PubMed=38721150;
CC   Genetic integration: Method=Transduction; Gene=FPbase; 51H85; ZsGreen1 (Note=Green fluorescent protein derived from ZsGreen).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=30521; ! Bos mutus grunniens (Wild yak)
SX   Female
AG   Heifer
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   IZD-Cp 4/13
AC   CVCL_WL82
DR   ICLDB; izd-cp-413
DR   Wikidata; Q94325204
RX   DOI=10.1007/BF02620830;
CC   Group: Insect cell line.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
HI   CVCL_WL80 ! IZD-Cp-2202
CA   Hybrid cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IZD-Cp-0508
AC   CVCL_WL78
SY   IZD-CP0508
DR   ICLDB; izd-cp-0508
DR   Wikidata; Q94325207
RX   CelloPub=CLPUB00496;
RX   DOI=10.1007/BF02620830;
RX   PubMed=26820856;
CC   Group: Insect cell line.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IZD-Cp-1508
AC   CVCL_WL79
SY   IZD-CP1508
DR   ICLDB; izd-cp-1508
DR   Wikidata; Q94325219
RX   CelloPub=CLPUB00496;
RX   PubMed=26820856;
CC   Group: Insect cell line.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IZD-Cp-2202
AC   CVCL_WL80
SY   IZD-CP2202; IZD-Cp 2202
DR   ICLDB; izd-cp-2202
DR   Wikidata; Q94325220
RX   CelloPub=CLPUB00496;
RX   DOI=10.1007/BF02620830;
RX   PubMed=26820856;
CC   Group: Insect cell line.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IZD-Cp-2507
AC   CVCL_WL81
SY   IZD-CP2507
DR   ICLDB; izd-cp-2507
DR   Wikidata; Q94325222
RX   CelloPub=CLPUB00496;
RX   PubMed=26820856;
CC   Group: Insect cell line.
OX   NCBI_TaxID=82600; ! Cydia pomonella (Codling moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   IZD-Ld-1307
AC   CVCL_WL83
SY   IZD-Ld 1307; IZD-LD1307
DR   ICLDB; izd-ld-1307
DR   Wikidata; Q94325223
RX   CelloPub=CLPUB00496;
RX   PubMed=26820856;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   IZD-Ld-1407
AC   CVCL_WL84
SY   IZD-Ld 1407; IZD-LD1407
DR   ICLDB; izd-ld-1407
DR   Wikidata; Q94325227
RX   CelloPub=CLPUB00496;
RX   PubMed=26820856;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   IZD-MB-0503
AC   CVCL_C411
SY   IZD-Mb-0503; IZD-Mb 0503; IZD-MB0503; IZD-Mb0503; MB-0503; Mb-0503; Mb 0503; MB0503
DR   CLO; CLO_0006980
DR   ECACC; 93090714
DR   ICLDB; izd-mb-0503
DR   Wikidata; Q54898396
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1439-0418.1976.tb03417.x;
RX   PubMed=787805;
RX   PubMed=1367489;
RX   PubMed=1369220;
RX   PubMed=8314732;
RX   PubMed=8799737;
RX   PubMed=10585188;
RX   PubMed=12383871;
RX   PubMed=12459194;
RX   PubMed=12753953;
RX   PubMed=14620958;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Mamestra brassicae origin but found to be from Trichoplusia ni (PubMed=8799737). Could be identical to TN-CL1 (Cellosaurus=CVCL_Z257). Originally thought to originate from larval hemocytes.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00603.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8003.
CC   Doubling time: 12-14 hours (DOI=10.1111/j.1439-0418.1976.tb03417.x); 24-26 hours (PubMed=787805); 30 +- 2 hours (Note=In static culture), 24 +- 1 hours (Note=In suspension culture) (PubMed=10585188).
CC   Misspelling: IZB Mb 0507; PubMed=1369220.
CC   Discontinued: ECACC; 93090714; true.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 17
//
ID   IZD-MB-0504
AC   CVCL_C2U7
DR   ICLDB; izd-mb-0504
DR   Wikidata; Q114311772
RX   CelloPub=CLPUB00496;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   IZD-MB-1203
AC   CVCL_AR80
SY   IZD-MB1203; IZD-Mb 1203; Mb 1203
DR   ICLDB; izd-mb-1203
DR   Wikidata; Q54898397
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1439-0418.1976.tb03417.x;
RX   PubMed=787805;
CC   Group: Insect cell line.
CC   Doubling time: 24-26 hours (PubMed=787805).
CC   Derived from site: In situ; Dorsal vessel; UBERON=UBERON_0015231.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Female
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 9
//
ID   IZD-MB-2006
AC   CVCL_AR81
SY   IZD-MB2006; IZD-Mb 2006; Mb 2006
DR   ICLDB; izd-mb-2006
DR   Wikidata; Q54898398
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1439-0418.1976.tb03417.x;
RX   PubMed=787805;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 10
//
ID   IZD-MB-2007
AC   CVCL_AR82
SY   IZD-MB2007; Mb 2007
DR   ICLDB; izd-mb-2007
DR   Wikidata; Q54898399
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1439-0418.1976.tb03417.x;
RX   PubMed=787805;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 10
//
ID   IZD-MB-2506
AC   CVCL_AR83
SY   IZD-MB2506; Mb 2506
DR   ICLDB; izd-mb-2506
DR   Wikidata; Q54898400
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1439-0418.1976.tb03417.x;
RX   PubMed=787805;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 10
//
ID   J 3
AC   CVCL_C334
SY   J3; TE07; TECHe004-A
DR   hPSCreg; TECHe004-A
DR   SKIP; SKIP001862
DR   Wikidata; Q54898401
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   J 3.2
AC   CVCL_C335
SY   J3.2; TE72; TECHe004-A-1
DR   hPSCreg; TECHe004-A-1
DR   SKIP; SKIP002006
DR   Wikidata; Q54898402
CC   From: Technion - Israel Institute of Technology; Haifa; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C334 ! J 3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   J#176-3.2
AC   CVCL_U127
DR   CLO; CLO_0050352
DR   RCB; RCB1918
DR   Wikidata; Q54898433
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P97875; Mouse Jdp2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   J#214.2-2
AC   CVCL_U128
DR   CLO; CLO_0050395
DR   RCB; RCB1919
DR   Wikidata; Q54898434
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P97875; Mouse Jdp2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   J#249.1-1
AC   CVCL_U129
DR   CLO; CLO_0050396
DR   RCB; RCB1920
DR   Wikidata; Q54898435
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P97875; Mouse Jdp2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   J-111
AC   CVCL_2965
SY   J 111; J111; JIII; Oregon J-111
DR   CLO; CLO_0006981
DR   CLO; CLO_0007024
DR   CLDB; cl2915
DR   CLDB; cl2916
DR   ATCC; CCL-24
DR   BioSample; SAMN03151724
DR   Cosmic; 919124
DR   Cosmic; 998751
DR   Cosmic; 1037668
DR   ECACC; 93120824
DR   IARC_TP53; 21413
DR   IZSLER; BS TCL 30
DR   JCRB; IFO50005
DR   JCRB; JCRB0073
DR   Wikidata; Q54898403
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=4894370;
RX   PubMed=5641128;
RX   PubMed=6988327;
RX   PubMed=9290701;
RX   PubMed=9510473;
RX   PubMed=11416159;
RX   PubMed=12592342;
RX   PubMed=13260360;
RX   PubMed=13431913;
RX   PubMed=14185313;
RX   PubMed=20143388;
RX   PubMed=21246756;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Space-flown cell line (cellonaut).
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 25 year old female patient with acute monocytic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00009.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Anecdotal: Have been flown in space on the ISS to study motility and cytoskeletal structures (PubMed=21246756).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0002000000054). It was one of the sources for the STR profile of this entry.
CC   Discontinued: ATCC; CCL-24; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; JCRB=IFO50005; JCRB=JCRB0073; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (JCRB=IFO50005; JCRB=JCRB0073)
ST   D13S317: 12,14 (CCRID)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   J-113
AC   CVCL_UF73
SY   Oregon J-113
DR   Wikidata; Q94325368
RX   PubMed=13260360;
CC   Caution: This cell line was derived in the same laboratory and at the same time as the J-111 and J-96 cell lines which have both later been shown to be contaminated by HeLa. As this cell line was apparently never distributed it is not clear if it was a bona fide leukemia cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   J-87
AC   CVCL_5297
SY   J87
DR   Wikidata; Q54898409
RX   PubMed=2624778;
CC   Characteristics: IL3 or IL5 dependent.
CC   Characteristics: Requires feeder cells. Maintenance of J-87 depends on the presence of cell line ST2 (Cellosaurus=CVCL_2205).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: DBA/2J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   J-96
AC   CVCL_3990
SY   J96; Oregon J-96
DR   BTO; BTO_0002028
DR   CLO; CLO_0007007
DR   CLDB; cl2914
DR   BioSample; SAMN03151725
DR   Wikidata; Q54898410
RX   PubMed=1246601;
RX   PubMed=4472134;
RX   PubMed=13260360;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to originate from a 29 year old male patient with subacute monocytic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00068.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   J-A1886
AC   CVCL_U324
SY   JA-1886
DR   cancercelllines; CVCL_U324
DR   Wikidata; Q54898411
RX   Patent=US5795777;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8130.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   J-beta2.7
AC   CVCL_J124
SY   J-(beta2).7; Jurkat-beta2.7; Jurkat B2.7; J-B2.7; B2.7
DR   cancercelllines; CVCL_J124
DR   Wikidata; Q54898412
RX   PubMed=8977199;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   J-Jhan
AC   CVCL_1H08
SY   J-JHAN; J.Jhan; J Jhan; J JHAN; JJhan; JJHAN
DR   BEI_Resources; ARP-12186
DR   cancercelllines; CVCL_1H08
DR   Wikidata; Q54898413
RX   PubMed=2886841;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   J-Jhan/U1102
AC   CVCL_1H09
DR   cancercelllines; CVCL_1H09
DR   Wikidata; Q54898414
WW   Provider; HHV-6 Foundation; -; https://hhv-6foundation.org/wp-content/uploads/2011/08/J-Jhan-U1102.pdf
CC   Population: Caucasian.
CC   Virology: Infected with human herpesvirus 6A (HHV-6A) strain U1102 (HHV-6 Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H08 ! J-Jhan
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   J-Lat 10.6
AC   CVCL_8281
SY   J-Lat clone 10.6; J-Lat full length clone 10.6
DR   BEI_Resources; ARP-9849
DR   cancercelllines; CVCL_8281
DR   Wikidata; Q54898415
RX   PubMed=12682019;
RX   PubMed=28086908;
RX   PubMed=32354973;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1 strain R7/E-/GFP. The integrated HIV-1 genome is located in SEC16A 2nd intron (PubMed=28086908; PubMed=32354973).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   J-Lat 15.4
AC   CVCL_8282
SY   J-Lat clone 15.4; J-Lat full length clone 15.4
DR   BEI_Resources; ARP-9850
DR   cancercelllines; CVCL_8282
DR   Wikidata; Q54898416
RX   PubMed=12682019;
RX   PubMed=18692772;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1 strain R7/E-/GFP. The integrated HIV-1 genome is located in UBA2 6th intron (PubMed=18692772; PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   J-Lat 6.3
AC   CVCL_8280
SY   J-Lat clone 6.3; J-Lat full length clone 6.3
DR   BEI_Resources; ARP-9846
DR   cancercelllines; CVCL_8280
DR   Lonza; 1300
DR   Wikidata; Q54898417
RX   PubMed=12682019;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Misspelling: J-Lat 6.2; Lonza=1300.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   J-Lat 8.4
AC   CVCL_8284
SY   J-Lat clone 8.4; J-Lat full length clone 8.4
DR   BEI_Resources; ARP-9847
DR   cancercelllines; CVCL_8284
DR   Wikidata; Q54898418
RX   PubMed=12682019;
RX   PubMed=18692772;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1 strain R7/E-/GFP. The integrated HIV-1 genome is located in FUBP1 (PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   J-Lat 9.2
AC   CVCL_8285
SY   J-Lat clone 9.2; J-Lat full length clone 9.2
DR   BEI_Resources; ARP-9848
DR   cancercelllines; CVCL_8285
DR   Wikidata; Q54898419
RX   PubMed=12682019;
RX   PubMed=18692772;
RX   PubMed=26912621;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1 strain R7/E-/GFP. The integrated HIV-1 genome is located in PP5 4th intron (PubMed=18692772; PubMed=26912621; PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   J-Lat GFP Clone A72
AC   CVCL_1H28
DR   BEI_Resources; ARP-9856
DR   cancercelllines; CVCL_1H28
DR   Wikidata; Q54898420
RX   PubMed=12682019;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with a GFP-tagged HIV-1 strain. The integrated HIV-1 genome is located in gene KDM6A (PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   J-Lat Tat-GFP Clone 82
AC   CVCL_1G41
SY   J-Lat tat-GFP 82
DR   BEI_Resources; ARP-9851
DR   cancercelllines; CVCL_1G41
DR   Wikidata; Q54898422
RX   PubMed=12682019;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with a GFP-tagged HIV-1 strain. The integrated HIV-1 genome is located in chromosome 10 (PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Misspelling: J-Lat tat-GFP 8.2; PubMed=28086908.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   J-Lat Tat-GFP Clone A1
AC   CVCL_1G42
SY   J-Lat tat-GFP A1
DR   BEI_Resources; ARP-9852
DR   cancercelllines; CVCL_1G42
DR   Wikidata; Q54898423
RX   PubMed=12682019;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with a GFP-tagged HIV-1 strain. The integrated HIV-1 genome is located in chromosome X (PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   J-Lat Tat-GFP Clone A2
AC   CVCL_1G43
DR   BEI_Resources; ARP-9854
DR   BioGRID_ORCS_Cell_line; 1115
DR   cancercelllines; CVCL_1G43
DR   Wikidata; Q54898424
RX   PubMed=12682019;
CC   Population: Caucasian.
CC   Virology: Latently infected with a GFP-tagged HIV-1 strain.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   J-Lat Tat-GFP Clone A7
AC   CVCL_1G44
DR   BEI_Resources; ARP-9853
DR   cancercelllines; CVCL_1G44
DR   Wikidata; Q54898425
RX   PubMed=12682019;
CC   Population: Caucasian.
CC   Virology: Latently infected with a GFP-tagged HIV-1 strain.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   J-Lat Tat-GFP Clone H2
AC   CVCL_1G45
DR   BEI_Resources; ARP-9855
DR   cancercelllines; CVCL_1G45
DR   Wikidata; Q54898426
RX   PubMed=12682019;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with a GFP-tagged HIV-1 strain. The integrated HIV-1 genome is located in gene SLC25A12 (PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   J.CaM1.6
AC   CVCL_0354
SY   J CaM 1.6; J-CaM-1.6; JCam-1.6; JCaM 1.6; JCAM 1.6; JCaM1.6; Jcam clone 1.6; J.CaM1; JCaM-1; JCaM1; JCAM1; Jurkat-derived Ca2+ mutant no. 1
DR   BTO; BTO_0003314
DR   CLO; CLO_0006983
DR   EFO; EFO_0022656
DR   MCCL; MCC:0000248
DR   CLDB; cl2934
DR   ATCC; CRL-2063
DR   BioSample; SAMN03471427
DR   cancercelllines; CVCL_0354
DR   ECACC; 96060401
DR   Wikidata; Q54898427
RX   PubMed=3263650;
RX   PubMed=3309950;
RX   PubMed=7592872;
RX   PubMed=8626636;
RX   PubMed=11231305;
RX   PubMed=33562083;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-80.html
CC   Population: Caucasian.
CC   Characteristics: Deficient for LCK activity due to a deletion of exon 7.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (PubMed=7592872).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2063; ECACC=96060401
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 13,22
ST   D19S433: 14.2,15
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   J.CaM1.7
AC   CVCL_B7TT
DR   cancercelllines; CVCL_B7TT
DR   Wikidata; Q112929890
RX   PubMed=33562083;
CC   Population: Caucasian.
CC   Characteristics: Deficient for LCK activity due to a deletion of exon 7. Also lacks LAT expression. Can re-express LAT after protein kinase C (PKC) activation (PubMed=33562083).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0354 ! J.CaM1.6
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   J.CaM2
AC   CVCL_R862
SY   JCaM2; JCam2; Jurkat-derived Ca2+ mutant no. 2
DR   cancercelllines; CVCL_R862
DR   Wikidata; Q54898428
RX   PubMed=3263650;
RX   PubMed=9846483;
RX   PubMed=27278128;
RX   PubMed=33562083;
CC   Population: Caucasian.
CC   Characteristics: Lacks LAT expression.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18874; LAT; Simple; p.Thr56Met (c.167C>T); ClinVar=VCV001493770; Zygosity=Heterozygous (PubMed=27278128; PubMed=33562083).
CC   Sequence variation: Mutation; HGNC; HGNC:18874; LAT; Simple; g.237C>T; Zygosity=Heterozygous (PubMed=27278128; PubMed=33562083).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   J.CaM2.5
AC   CVCL_DR61
SY   JCam2.5; JCAM2.5
DR   EFO; EFO_0022540
DR   cancercelllines; CVCL_DR61
DR   PRIDE; PXD000341
DR   Wikidata; Q54898429
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18874; LAT; Simple; p.Thr56Met (c.167C>T); ClinVar=VCV001493770; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18874; LAT; Simple; g.237C>T; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R862 ! J.CaM2
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 20
//
ID   J.gamma1
AC   CVCL_6410
SY   Jgamma1; Jurkat Gamma1
DR   CLO; CLO_0006985
DR   CLO; CLO_0009836
DR   ATCC; CRL-2678
DR   BioSample; SAMN03471763
DR   cancercelllines; CVCL_6410
DR   GEO; GSM827148
DR   LINCS_LDP; LCL-2038
DR   PRIDE; PXD002871
DR   Progenetix; CVCL_6410
DR   Wikidata; Q54898430
RX   PubMed=11094067;
RX   PubMed=20215515;
RX   PubMed=26546556;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2678
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,20
ST   D19S433: 14,15.2
ST   D21S11: 31.2,35.2
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   J.gamma1.WT
AC   CVCL_6411
SY   J.gamma1.WT-1; J.gamma1.wt
DR   CLO; CLO_0006986
DR   CLO; CLO_0009837
DR   ATCC; CRL-2679
DR   BioSample; SAMN03471764
DR   cancercelllines; CVCL_6411
DR   LINCS_LDP; LCL-2039
DR   Wikidata; Q54898431
RX   PubMed=11094067;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9065; PLCG1.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2679
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,20
ST   D19S433: 14,15.2
ST   D21S11: 31.2,35.2
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,9,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6410 ! J.gamma1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 32
//
ID   J.RT3-T3.5
AC   CVCL_1316
AS   CVCL_9725
SY   J.RT3/T3.5; J-RT3-T3-5; JRT3-T3.5; JRT3T3.5; JRT3T35; Jurkat RT3-T3.5; Jurkat/RT3-T3.5
DR   CLO; CLO_0006984
DR   EFO; EFO_0002213
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; TIB-153
DR   BioSample; SAMN03471939
DR   cancercelllines; CVCL_1316
DR   Cell_Model_Passport; SIDM01263
DR   ChEMBL-Cells; CHEMBL3308326
DR   ChEMBL-Targets; CHEMBL2366219
DR   Cosmic; 683538
DR   Cosmic; 907391
DR   Cosmic; 1151780
DR   GDSC; 907391
DR   GEO; GSM1669963
DR   IGRhCellID; JRT3T35
DR   LINCS_LDP; LCL-1014
DR   PharmacoDB; JRT3T35_674_2019
DR   Progenetix; CVCL_1316
DR   PubChem_Cell_line; CVCL_1316
DR   Wikidata; Q54898432
RX   PubMed=6208306;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=23637631;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Caucasian.
CC   Characteristics: Does not express the beta chain of the T cell antigen receptor.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1777; CDK6 + HGNC; HGNC:28629; FAM133B; Name(s)=FAM133B-CDK6 (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=TIB-153
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,20,21
ST   D19S433: 14,14.2,15.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 10
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   J1
AC   CVCL_6412
SY   ES-J1
DR   CLO; CLO_0006987
DR   EFO; EFO_0004990
DR   ATCC; SCRC-1010
DR   CCRID; 3101MOUSCSP219
DR   PRIDE; PXD000589
DR   Wikidata; Q54898436
RX   PubMed=1606615;
RX   PubMed=9353641;
RX   PubMed=25277546;
RX   PubMed=25894527;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   J1-31
AC   CVCL_C555
DR   CLO; CLO_0006989
DR   ATCC; CRL-2253
DR   Wikidata; Q54898437
RX   PubMed=2421799;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   J1.1
AC   CVCL_8279
DR   BEI_Resources; ARP-1340
DR   cancercelllines; CVCL_8279
DR   Wikidata; Q54898438
RX   PubMed=1833465;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1. The two main sites of integrations are in genes DEAF1 and CBX5 (PubMed=28086908).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   J10LN-scidT-II
AC   CVCL_F0XW
RX   PubMed=12707056;
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Donor information: The donor rabbit was innoculated witg virion pellets of 594S cell line (Cellosaurus=CVCL_E151) supernatent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_F0XX ! J10Sp-scidT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   J10Sp-scidT
AC   CVCL_F0XX
RX   PubMed=12707056;
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Donor information: The donor rabbit was innoculated witg virion pellets of 594S cell line (Cellosaurus=CVCL_E151) supernatent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_F0XW ! J10LN-scidT-II
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   J11d
AC   CVCL_JE57
SY   JIId; GM03565; GM3565
DR   Coriell; GM03565
DR   Wikidata; Q54898439
RX   CelloPub=CLPUB00387;
RX   PubMed=6975326;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.
CC   Discontinued: Coriell; GM03565; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   J11d.2
AC   CVCL_9185
DR   CLO; CLO_0006988
DR   ATCC; TIB-183
DR   KCLB; 40183
DR   Wikidata; Q54898440
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_JE57 ! J11d
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   J11LN-scidT
AC   CVCL_F0XY
RX   PubMed=12707056;
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Donor information: The donor rabbit was innoculated witg virion pellets of 594S cell line (Cellosaurus=CVCL_E151) supernatent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_F0XZ ! J11Sp-scid1T
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   J11Sp-scid1T
AC   CVCL_F0XZ
RX   PubMed=12707056;
CC   Karyotypic information: 44,XX,-17,+mar (PubMed=12707056).
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Donor information: The donor rabbit was innoculated witg virion pellets of 594S cell line (Cellosaurus=CVCL_E151) supernatent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_F0XY ! J11LN-scidT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   J13LN-scid2T
AC   CVCL_F0Y0
RX   PubMed=12707056;
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Donor information: The donor rabbit was innoculated witg virion pellets of 594S cell line (Cellosaurus=CVCL_E151) supernatent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_F0Y2 ! J13Sp-scid-livT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   J13LN-scid2T-IInudeT
AC   CVCL_F0Y1
RX   PubMed=12707056;
CC   Characteristics: Established from a transplanted nude mouse tumor of the parent cell line (PubMed=12707056).
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Donor information: The donor rabbit was innoculated witg virion pellets of 594S cell line (Cellosaurus=CVCL_E151) supernatent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_F0Y0 ! J13LN-scid2T
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   J13Sp-scid-livT
AC   CVCL_F0Y2
RX   PubMed=12707056;
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Donor information: The donor rabbit was innoculated witg virion pellets of 594S cell line (Cellosaurus=CVCL_E151) supernatent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_F0Y0 ! J13LN-scid2T
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   J14
AC   CVCL_R861
SY   Jurkat J14; J14-v-29
DR   EFO; EFO_0022542
DR   cancercelllines; CVCL_R861
DR   Millipore; SCC190
DR   Wikidata; Q54898441
RX   PubMed=9665884;
CC   Population: Caucasian.
CC   Characteristics: Deficient in the expression of LCP2 (SLP-76) (PubMed=9665884).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Millipore=SCC190
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,14,15
ST   D16S539: 11
ST   D18S51: 13,21,22
ST   D21S11: 31.2,32.2,33.2
ST   D3S1358: 15,17,18
ST   D5S818: 9
ST   D7S820: 8,11
ST   D8S1179: 12,13,14,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19,20
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   J14-16
AC   CVCL_C5ID
DR   Wikidata; Q116049594
RX   PubMed=8913785;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P11597; Human CETP (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   J143
AC   CVCL_N324
SY   URO1
DR   ATCC; HB-8276
DR   Wikidata; Q54898442
RX   Patent=US4643971;
RX   Patent=US4935344;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8276.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26006; Human ITGA3/CD49c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   J185a
AC   CVCL_Y501
DR   EFO; EFO_0005486
DR   ENCODE; ENCBS181ENC
DR   GEO; GSM450293
DR   Wikidata; Q54898443
RX   PubMed=19952138;
CC   Part of: ENCODE project mouse cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Undefined cell line type
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   J1j.10
AC   CVCL_9186
DR   CLO; CLO_0006990
DR   ATCC; TIB-184
DR   KCLB; 40184
DR   Wikidata; Q54898444
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (Note=Allotype 1.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   J2-BM
AC   CVCL_S484
DR   Wikidata; Q54898445
RX   PubMed=4079980;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   J206L
AC   CVCL_U110
DR   Wikidata; Q54898446
RX   PubMed=16651449;
RX   PubMed=17725806;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5672; Lung large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   J233
AC   CVCL_N325
DR   Wikidata; Q54898447
RX   Patent=US4643971;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8272.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   J26
AC   CVCL_6487
DR   CLO; CLO_0006991
DR   ATCC; CRL-1802
DR   Wikidata; Q54898448
RX   PubMed=6188154;
RX   PubMed=25277546;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   J26-A3
AC   CVCL_RG42
SY   J26.44
DR   Wikidata; Q54898449
RX   PubMed=2409144;
RX   PubMed=7479770;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*03).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6487 ! J26
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   J26-B7
AC   CVCL_RG43
SY   J26.37
DR   Wikidata; Q54898454
RX   PubMed=2409144;
RX   PubMed=7479770;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6487 ! J26
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   J26-G
AC   CVCL_XY24
DR   Wikidata; Q94325838
RX   PubMed=7479770;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6487 ! J26
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   J26Cw3
AC   CVCL_V081
DR   CLO; CLO_0006992
DR   CLDB; cl2917
DR   IHW; 11w 8041
DR   Wikidata; Q54898456
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6487 ! J26
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   J27-B7
AC   CVCL_6488
SY   J27.2-B7
DR   CLO; CLO_0006996
DR   ATCC; CRL-2374
DR   Wikidata; Q54898457
RX   PubMed=7960968;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   J27-neo
AC   CVCL_6489
SY   J27.2-neo
DR   CLO; CLO_0006997
DR   ATCC; CRL-2372
DR   Wikidata; Q54898458
RX   PubMed=7960968;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   J27-sB7
AC   CVCL_V057
SY   J27.2-sB7
DR   ATCC; CRL-2373
DR   Wikidata; Q54898459
RX   PubMed=7960968;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07. Soluble form without TM and cytoplasmic domains).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-2373; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   J27.2
AC   CVCL_K237
DR   Wikidata; Q54898460
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   J27.2 43R
AC   CVCL_V082
DR   CLO; CLO_0006993
DR   CLDB; cl2918
DR   IHW; 11w 8027
DR   Wikidata; Q54898461
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   J27.2 Cw7neo
AC   CVCL_V083
DR   CLO; CLO_0006994
DR   CLDB; cl2919
DR   IHW; 11w 8044
DR   Wikidata; Q54898462
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   J27.2 neoB7
AC   CVCL_V084
DR   CLO; CLO_0006995
DR   CLDB; cl2920
DR   IHW; 11w 8024
DR   Wikidata; Q54898463
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   J2E
AC   CVCL_0355
SY   J2E-1
DR   EFO; EFO_0022772
DR   MCCL; MCC:0000249
DR   Wikidata; Q54898464
RX   PubMed=1688637;
RX   PubMed=2847163;
RX   PubMed=8631947;
CC   Characteristics: Differentiates and synthesizes hemoglobin following exposure to EPO.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Erythroblast; CL=CL_0000765.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   J2E-NR
AC   CVCL_5984
SY   J2E-Non Responder
DR   Wikidata; Q54898465
RX   PubMed=1688637;
RX   PubMed=8631947;
CC   Characteristics: Compared to the parent cell line, does not respond to EPO.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Erythroblast; CL=CL_0000765.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0355 ! J2E
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   J31.13
AC   CVCL_HE55
DR   cancercelllines; CVCL_HE55
DR   Wikidata; Q54898466
RX   PubMed=2901344;
CC   Population: Caucasian.
CC   Characteristics: Does not express CD3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HE54 ! Jurkat clone 77-6.8
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   J3K
AC   CVCL_F762
DR   Wikidata; Q54898467
RX   PubMed=12513117;
CC   Group: Non-human primate cell line.
CC   Doubling time: 17 hours (PubMed=12513117).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Male
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   J3T
AC   CVCL_W822
DR   Wikidata; Q54898468
RX   PubMed=10901232;
RX   PubMed=22120277;
RX   PubMed=25190452;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W826 ! DL3580 clone 2
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   J3T-1
AC   CVCL_W823
DR   Wikidata; Q54898469
RX   PubMed=22120277;
CC   Characteristics: Established from a tumor obtained by subcutaneous implantation of the parent cell line in athymic nude mice (PubMed=22120277).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W822 ! J3T
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 8
//
ID   J3T-2
AC   CVCL_W824
DR   Wikidata; Q54898470
RX   PubMed=22120277;
CC   Characteristics: Established from a tumor obtained by subcutaneous implantation of the parent cell line in athymic nude mice (PubMed=22120277).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W822 ! J3T
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 8
//
ID   J3T-Bg
AC   CVCL_D2PM
SY   J3T-BG; J3TBg; J3TBG
DR   Wikidata; Q127382396
RX   PubMed=22002975;
RX   PubMed=27251041;
RX   PubMed=28480569;
RX   PubMed=37254642;
RX   PubMed=37365849;
CC   Characteristics: Established from a tumor obtained by subcutaneous implantation of the parent cell line in BiegeNude-xid mice (PubMed=22002975).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile carried out by CLS and provided by Schrock, Morgan S. The STR profile has 3 additional loci not in standard set: PEZ2:128,140, PEZ15:208 and PEZ17:202,206.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
ST   Source(s): Direct_author_submission
ST   Dog FHC2010: 229,237
ST   Dog FHC2054: 170,174
ST   Dog FHC2079: 266,278
ST   Dog PEZ1: 114,118
ST   Dog PEZ6: 188,197
ST   Dog PEZ8: 231,235
ST   Dog PEZ12: 294
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_W822 ! J3T
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   J3T-BG/CCNU
AC   CVCL_D2PQ
DR   Wikidata; Q127382397
RX   PubMed=37365849;
CC   Selected for resistance to: ChEBI; CHEBI_6520; Lomustine (CCNU; CeeNU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D2PM ! J3T-Bg
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   J3T-BG/TMZ
AC   CVCL_D2PR
DR   Wikidata; Q127382398
RX   PubMed=37365849;
CC   Selected for resistance to: ChEBI; CHEBI_72564; Temozolomide (TMZ).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boston Terrier; VBO=VBO_0200204.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D2PM ! J3T-Bg
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   J45.01
AC   CVCL_2530
DR   CLO; CLO_0006998
DR   CLDB; cl2921
DR   ATCC; CRL-1990
DR   BCRC; 60255
DR   BioSample; SAMN03470881
DR   cancercelllines; CVCL_2530
DR   ECACC; 93031145
DR   LINCS_LDP; LCL-1029
DR   Wikidata; Q54898471
RX   PubMed=1672451;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Characteristics: CD45-deficient.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-1990; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11,12
ST   D16S539: 11
ST   D18S51: 13,21,22 (PubMed=25877200)
ST   D18S51: 13,22 (ATCC=CRL-1990)
ST   D19S433: 14,15.2
ST   D21S11: 31.2,33.2,34.2
ST   D2S1338: 19,23
ST   D3S1358: 14,17
ST   D5S818: 9
ST   D7S820: 8,9.3,10.3
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 30
//
ID   J5 [Human hepatocellular carcinoma]
AC   CVCL_4Z68
SY   J-5
DR   BTO; BTO_0005057
DR   Wikidata; Q54078803
RX   PubMed=1847999;
RX   PubMed=9747328;
RX   PubMed=9774996;
CC   Population: Chinese.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   J5 [Mouse hybridoma]
AC   CVCL_G198
DR   ECACC; 91072536
DR   Wikidata; Q54898472
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   J5 [Mouse Sertoli cells]
AC   CVCL_U456
DR   Wikidata; Q54898473
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   J5-1
AC   CVCL_G194
DR   CLO; CLO_0006999
DR   ATCC; HB-8297
DR   Wikidata; Q54898474
RX   Patent=US5057598;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8297.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Escherichia coli J5 endotoxin core.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   J5-2
AC   CVCL_G195
DR   CLO; CLO_0007000
DR   ATCC; HB-8298
DR   Wikidata; Q54898475
RX   Patent=US5057598;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8298.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Escherichia coli J5 endotoxin core.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   J53Z1
AC   CVCL_HF88
DR   Wikidata; Q54898477
RX   PubMed=25036984;
CC   Doubling time: ~18 hours (PubMed=25036984).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Breed/subspecies: C57BL/6 JAK2V617F/Trp53-/- transgenic.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 5
//
ID   J558
AC   CVCL_3529
DR   CLO; CLO_0007001
DR   ATCC; TIB-6
DR   BioSample; SAMN11397662
DR   Wikidata; Q28243888
RX   PubMed=5483159;
RX   PubMed=6157734;
RX   PubMed=31220119;
CC   Problematic cell line: Potentially contaminated. The stock distributed by ATCC (TIB-6) has a STR profile that matches at 95% with that of BALB/3T3 clone A31 (Cellosaurus=CVCL_0184). As this is the parent cell line to a cell line J558L (Cellosaurus=CVCL_3949) which is used a fusion cell line for the production of hybridomas ICLAC is currently investigating if authentic stocks of J558 still exist.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgA, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran.
CC   Discontinued: BioSample; SAMN11397662; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 25
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   J558L
AC   CVCL_3949
SY   J 558L; J.558 L
DR   BTO; BTO_0002898
DR   CLO; CLO_0007002
DR   CLDB; cl2922
DR   ECACC; 88032902
DR   Lonza; 14
DR   Wikidata; Q6107580
RX   PubMed=6402777;
RX   PubMed=6409417;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-45.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/J558L_cells
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Has spontaneously lost the expression of Ig heavy chains (PubMed=6402777).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3529 ! J558
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   J558L-CD40L
AC   CVCL_B7TP
SY   CD40L-J558L
DR   Wikidata; Q112929891
RX   PubMed=7615009;
RX   PubMed=8760829;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88337; Cd40lg.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   J558L-OX40L
AC   CVCL_VP27
SY   J558L OX40L
DR   CancerTools; 153661
DR   Wikidata; Q94326158
DR   Ximbio; 153661
RX   PubMed=9670042;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104511; Tnfsf4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   J5F1
AC   CVCL_C4P4
DR   Wikidata; Q116049595
RX   PubMed=30111816;
RX   PubMed=36265360;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   J6
AC   CVCL_W797
DR   Cosmic; 706113
DR   Wikidata; Q54898478
RX   PubMed=9692547;
RX   PubMed=10766161;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   J618
AC   CVCL_C943
DR   Wikidata; Q54898479
WW   Info; NIHhESC; -; https://acd.od.nih.gov/documents/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: VistaGen Therapeutics, Inc.; South San Francisco; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   J7
AC   CVCL_4Z69
SY   J-7
DR   BTO; BTO_0005056
DR   Wikidata; Q54898480
RX   PubMed=8828459;
RX   PubMed=9747328;
CC   Population: Chinese.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   J7.DEF.3
AC   CVCL_0356
DR   MCCL; MCC:0000250
DR   Wikidata; Q54898481
RX   PubMed=7689615;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4770 ! J774.1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 8
//
ID   J713
AC   CVCL_C944
DR   Wikidata; Q54898482
WW   Info; NIHhESC; -; https://acd.od.nih.gov/documents/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: VistaGen Therapeutics, Inc.; South San Francisco; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   J774
AC   CVCL_4692
SY   J-774
DR   BTO; BTO_0002279
DR   CLO; CLO_0007003
DR   CLDB; cl2911
DR   CLDB; cl2913
DR   BioGRID_ORCS_Cell_line; 1720
DR   ChEMBL-Cells; CHEMBL3307540
DR   ChEMBL-Targets; CHEMBL614123
DR   Lonza; 15
DR   PubChem_Cell_line; CVCL_4692
DR   Wikidata; Q54898483
RX   PubMed=1101071;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=J774
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-500.html
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   J774-Dual
AC   CVCL_5I75
DR   InvivoGen; j774d-nfis
DR   Wikidata; Q54898484
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=j774d-nfis).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4770 ! J774.1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   J774.1
AC   CVCL_4770
SY   J-774.1; J774-1
DR   BTO; BTO_0003042
DR   CLO; CLO_0050192
DR   CLO; CLO_0050193
DR   ChEMBL-Cells; CHEMBL4295470
DR   ChEMBL-Targets; CHEMBL4296442
DR   JCRB; JCRB0018
DR   PubChem_Cell_line; CVCL_4770
DR   RCB; RCB0434
DR   RCB; RCB2652
DR   TKG; TKG 0208
DR   Wikidata; Q54898485
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=3622537;
RX   PubMed=3967303;
CC   Doubling time: 26.7 hours (PubMed=3622537); 26.7-27.9 hours (PubMed=3967303).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4692 ! J774
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   J774.1/HNP
AC   CVCL_C6XE
DR   Wikidata; Q117704564
RX   PubMed=8329717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2761; DEFA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4770 ! J774.1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   J774.16
AC   CVCL_HA24
SY   J774 clone 16; J774 1.6; J774-1.6
DR   BCRJ; 0273
DR   Wikidata; Q54898486
RX   PubMed=3792703;
RX   PubMed=6252274;
RX   PubMed=6350185;
RX   PubMed=7045866;
CC   Characteristics: Has a marked increase in the ability to reduce nitroblue tetrazolium (NBT) after stimulation with PMA (PubMed=6252274).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4692 ! J774
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 05-10-23; Version: 7
//
ID   J774.2
AC   CVCL_0357
SY   J774 clone 2
DR   BTO; BTO_0001030
DR   CLO; CLO_0007004
DR   MCCL; MCC:0000251
DR   CLDB; cl2923
DR   ChEMBL-Cells; CHEMBL3307942
DR   ChEMBL-Targets; CHEMBL614484
DR   ECACC; 85011428
DR   PRIDE; PXD000589
DR   PubChem_Cell_line; CVCL_0357
DR   Wikidata; Q54898487
RX   PubMed=6252274;
RX   PubMed=25894527;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4770 ! J774.1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   J774.C3C
AC   CVCL_C1MG
SY   J774 clone C3C
DR   Wikidata; Q114311773
RX   PubMed=6252274;
RX   PubMed=6350185;
RX   PubMed=7045866;
CC   Characteristics: Lacks the ability to produce O2- or H2O2 when stimulated by PMA or aggregated immunoglobulin (PubMed=6252274).
CC   Characteristics: Unable to restrict the growth of epimastigotes or trypomastigotes of Trypanosoma cruzi to a significant degree (PubMed=6350185).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HA24 ! J774.16
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   J774.G8
AC   CVCL_HA26
SY   J774-G8
DR   BCRJ; 0122
DR   Wikidata; Q54898488
RX   PubMed=286323;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4692 ! J774
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 05-10-23; Version: 6
//
ID   J774A1
AC   CVCL_0358
SY   J-774A.1; J774.A1; J774 A1; J774A.1; J 774A.1; J774 A.1
DR   BTO; BTO_0000804
DR   CLO; CLO_0006982
DR   CLO; CLO_0007005
DR   EFO; EFO_0022735
DR   MCCL; MCC:0000252
DR   CLDB; cl2924
DR   CLDB; cl2925
DR   CLDB; cl2926
DR   CLDB; cl2927
DR   CLDB; cl2928
DR   CLDB; cl4914
DR   ATCC; TIB-67
DR   BCRC; 60140
DR   BCRJ; 0121
DR   CCRID; 1101MOU-PUMC000222
DR   CCRID; 1102MOU-NIFDC00043
DR   CCRID; 4201MOU-CCTCC00176
DR   CCTCC; GDC0176
DR   ChEMBL-Cells; CHEMBL3307516
DR   ChEMBL-Targets; CHEMBL614040
DR   CLS; 400220
DR   DSMZ; ACC-170
DR   DSMZCellDive; ACC-170
DR   ECACC; 91051511
DR   ICLC; ATL98011
DR   IZSLER; BS TCL 83
DR   JCRB; IFO50023
DR   JCRB; JCRB9108
DR   KCB; KCB 2010167
DR   KCLB; 40067
DR   Lonza; 645
DR   NCBI_Iran; C483
DR   PubChem_Cell_line; CVCL_0358
DR   Wikidata; Q54898489
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~17 hours (ATCC=TIB-67); ~35 hours (DSMZ=ACC-170).
CC   Discontinued: JCRB; IFO50023; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4692 ! J774
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   J82
AC   CVCL_0359
SY   J-82; J 82; J82COT; J82 COT; J82 CO'T; J82/WT
DR   BTO; BTO_0001671
DR   CLO; CLO_0007006
DR   EFO; EFO_0002210
DR   MCCL; MCC:0000253
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-1
DR   BioSample; SAMN03471085
DR   BioSample; SAMN10987788
DR   cancercelllines; CVCL_0359
DR   CCRID; 1101HUM-PUMC000346
DR   CCRID; 3101HUMTCHu218
DR   CCRID; 4201HUM-CCTCC00225
DR   CCTCC; GDC0225
DR   Cell_Model_Passport; SIDM00693
DR   ChEMBL-Cells; CHEMBL3308508
DR   ChEMBL-Targets; CHEMBL614586
DR   CLS; 305055
DR   Cosmic; 753566
DR   Cosmic; 755399
DR   Cosmic; 760474
DR   Cosmic; 808517
DR   Cosmic; 809378
DR   Cosmic; 845571
DR   Cosmic; 846276
DR   Cosmic; 867838
DR   Cosmic; 943731
DR   Cosmic; 1016887
DR   Cosmic; 1046674
DR   Cosmic; 1093984
DR   Cosmic; 1175827
DR   Cosmic; 1285119
DR   Cosmic; 1285996
DR   Cosmic; 1302362
DR   Cosmic; 1927308
DR   Cosmic; 1995459
DR   Cosmic; 2050445
DR   Cosmic; 2057450
DR   Cosmic; 2444229
DR   Cosmic; 2686097
DR   Cosmic; 2700997
DR   Cosmic-CLP; 753566
DR   DepMap; ACH-000396
DR   EGA; EGAS00001000978
DR   GDSC; 753566
DR   GEO; GSM136231
DR   GEO; GSM492491
DR   GEO; GSM827204
DR   GEO; GSM887167
DR   GEO; GSM888239
DR   GEO; GSM1374575
DR   GEO; GSM1574579
DR   GEO; GSM1669946
DR   IARC_TP53; 3721
DR   IARC_TP53; 21416
DR   IGRhCellID; J82
DR   KCB; KCB 2014052YJ
DR   KCLB; 30001
DR   LiGeA; CCLE_551
DR   LINCS_LDP; LCL-1714
DR   PharmacoDB; J82_675_2019
DR   PRIDE; PXD030304
DR   PRIDE; PXD032049
DR   Progenetix; CVCL_0359
DR   PubChem_Cell_line; CVCL_0359
DR   Wikidata; Q54898490
RX   PubMed=77569;
RX   PubMed=571047;
RX   PubMed=687519;
RX   PubMed=833871;
RX   PubMed=864752;
RX   PubMed=870558;
RX   PubMed=2594029;
RX   PubMed=3413074;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=4057431;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6823318;
RX   PubMed=7787250;
RX   PubMed=8077054;
RX   PubMed=9137463;
RX   PubMed=9850064;
RX   PubMed=11416159;
RX   PubMed=11921286;
RX   PubMed=12127398;
RX   PubMed=14762065;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26589293;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-250.html
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 18 +- 5 hours (PubMed=9137463).
CC   HLA typing: A*02,w32; B*05,12; C*w02,w03 (PubMed=77569).
CC   HLA typing: A*02:01,32:01; B*44:02,51:01; C*05:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser770Pro (c.2308T>C); ClinVar=VCV000140988; Zygosity=Heterozygous (Cosmic-CLP=753566; DepMap=ACH-000396).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro124Leu (c.371C>T); Zygosity=Heterozygous (ATCC=HTB-1; Cosmic-CLP=753566; DepMap=ACH-000396).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs*1 (c.635_1212del578); Zygosity=Homozygous (ATCC=HTB-1).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2107-2A>G; ClinVar=VCV000013077; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=2594029; ATCC=HTB-1; Cosmic-CLP=753566; DepMap=ACH-000396).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (PubMed=7787250; PubMed=9850064; ATCC=HTB-1).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys320Asn (c.960G>C); Zygosity=Heterozygous (PubMed=7787250; PubMed=9850064; ATCC=HTB-1).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.13%; Native American=0%; East Asian, North=2.62%; East Asian, South=0%; South Asian=0.42%; European, North=70.61%; European, South=26.21% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=HTB-1; CCRID; Cosmic-CLP=753566; KCLB=30001; PubMed=11416159; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12 (ATCC=HTB-1; CCRID; Cosmic-CLP=753566; KCLB=30001)
ST   D13S317: 12 (PubMed=27270441)
ST   D16S539: 11,12
ST   D18S51: 10,12 (ATCC=HTB-1)
ST   D18S51: 12 (PubMed=27270441)
ST   D19S433: 12,13
ST   D21S11: 30 (CCRID)
ST   D21S11: 30,31 (ATCC=HTB-1; PubMed=11416159)
ST   D2S1338: 19
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 8,13
ST   FGA: 20,24
ST   Penta D: 9,13
ST   Penta E: 12,15
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5H97 ! J82-EBV
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   J82-EBV
AC   CVCL_5H97
SY   J82EBV
DR   Cell_Model_Passport; SIDM01732
DR   Cosmic; 760488
DR   DepMap; ACH-002379
DR   Wikidata; Q54898491
RX   PubMed=6823318;
RX   PubMed=11921286;
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian; Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0359 ! J82
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   J82-NVB
AC   CVCL_4V98
DR   cancercelllines; CVCL_4V98
DR   Wikidata; Q54898492
RX   PubMed=7981063;
RX   PubMed=9137463;
CC   Population: Caucasian; Swedish.
CC   Doubling time: 19 +- 4 hours (PubMed=9137463).
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser770Pro (c.2308T>C); ClinVar=VCV000140988; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro124Leu (c.371C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs*1 (c.635_1212del578); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2107-2A>G; ClinVar=VCV000013077; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys320Asn (c.960G>C); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0359 ! J82
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   J82/MMC
AC   CVCL_C8D4
DR   Wikidata; Q123032760
RX   PubMed=7729958;
RX   PubMed=8077054;
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser770Pro (c.2308T>C); ClinVar=VCV000140988; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro124Leu (c.371C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs*1 (c.635_1212del578); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2107-2A>G; ClinVar=VCV000013077; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys320Asn (c.960G>C); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0359 ! J82
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   J9F2
AC   CVCL_C4P5
DR   Wikidata; Q116049596
RX   PubMed=30111816;
RX   PubMed=36265360;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Female
AG   6D
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   JA
AC   CVCL_W874
DR   cancercelllines; CVCL_W874
DR   Cosmic; 889004
DR   GEO; GSM219029
DR   Progenetix; CVCL_W874
DR   Wikidata; Q54898493
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 15
//
ID   Ja Bos
AC   CVCL_3304
DR   CLO; CLO_0007008
DR   CLDB; cl2930
DR   ATCC; CRL-1176
DR   Wikidata; Q54898494
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Ja Coo
AC   CVCL_3305
DR   CLO; CLO_0007009
DR   ATCC; CRL-1294
DR   Wikidata; Q54898495
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Ja Lin
AC   CVCL_U778
DR   ATCC; CRL-1380
DR   Wikidata; Q54898498
CC   Discontinued: ATCC; CRL-1380; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   JA-1
AC   CVCL_B411
DR   Wikidata; Q54898499
RX   PubMed=3804493;
CC   Doubling time: 32 +- 2 hours (PubMed=3804493).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   JA-M
AC   CVCL_S855
DR   Cosmic; 928738
DR   Wikidata; Q54898500
RX   PubMed=9354451;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   JA11
AC   CVCL_E5QL
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JA2/R7Hyg
AC   CVCL_X704
DR   BEI_Resources; ARP-2682
DR   cancercelllines; CVCL_X704
DR   Wikidata; Q54898503
RX   PubMed=7523570;
CC   Population: Caucasian.
CC   Characteristics: Transfected with plasmid R7hyg containing a human immunodeficiency virus 1 (HIV-1) isolate HXB2 proviral clone containing HygR in place of the HIV-1 nef gene (PubMed=7523570).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X703 ! Jurkat-A2
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   JAA-F11
AC   CVCL_G196
DR   CLO; CLO_0007010
DR   ATCC; CRL-2381
DR   Wikidata; Q54898504
RX   PubMed=9627057;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_546807; Beta-D-Galp-(1->3)-D-GalpNAc (T-antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 5
//
ID   JAC
AC   CVCL_F562
SY   30089; Extract 233; Extract 505
DR   IPD-IMGT/HLA; 10818
DR   Wikidata; Q54898505
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/355cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,29:02; B*08:01,35:27; C*04:01,07:01; DQA1*03,05; DQB1*02:01,03:02; DRB1*03:01,04:04; DRB3*01:01; DRB4*01:AC (IPD-IMGT/HLA=10818).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   JaCALS LCL 001-0006
AC   CVCL_ZY52
DR   Wikidata; Q102114253
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0009
AC   CVCL_ZY62
DR   Wikidata; Q102114255
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0010
AC   CVCL_ZY55
DR   Wikidata; Q102114256
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0040
AC   CVCL_ZY54
DR   Wikidata; Q102114257
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0058
AC   CVCL_ZY64
DR   Wikidata; Q102114258
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0068
AC   CVCL_ZY56
DR   Wikidata; Q102114259
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0126
AC   CVCL_ZY72
DR   Wikidata; Q102114261
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0218
AC   CVCL_ZY69
DR   Wikidata; Q102114262
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0223
AC   CVCL_ZY63
DR   Wikidata; Q102114263
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0347
AC   CVCL_ZY61
DR   Wikidata; Q102114264
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0351
AC   CVCL_ZY59
DR   Wikidata; Q102114265
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0352
AC   CVCL_ZY58
DR   Wikidata; Q102114266
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0358
AC   CVCL_ZY75
DR   Wikidata; Q102114268
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0361
AC   CVCL_ZY73
DR   Wikidata; Q102114270
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0363
AC   CVCL_ZY57
DR   Wikidata; Q102114271
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0426
AC   CVCL_ZY81
DR   Wikidata; Q102114272
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0431
AC   CVCL_ZY70
DR   Wikidata; Q102114273
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0459
AC   CVCL_ZY68
DR   Wikidata; Q102114274
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0460
AC   CVCL_ZY76
DR   Wikidata; Q102114275
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0478
AC   CVCL_ZY71
DR   Wikidata; Q102114276
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0481
AC   CVCL_ZY74
DR   Wikidata; Q102114277
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 001-0482
AC   CVCL_ZY78
DR   Wikidata; Q102114278
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0009
AC   CVCL_ZY80
DR   Wikidata; Q102114279
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0052
AC   CVCL_ZY53
DR   Wikidata; Q102114280
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0081
AC   CVCL_ZY60
DR   Wikidata; Q102114281
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0083
AC   CVCL_ZY66
DR   Wikidata; Q102114282
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0084
AC   CVCL_ZY65
DR   Wikidata; Q102114283
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0086
AC   CVCL_ZY67
DR   Wikidata; Q102114285
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0089
AC   CVCL_ZY77
DR   Wikidata; Q102114286
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0100
AC   CVCL_ZY82
DR   Wikidata; Q102114287
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0104
AC   CVCL_ZY83
DR   Wikidata; Q102114288
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JaCALS LCL 023-0108
AC   CVCL_ZY79
DR   Wikidata; Q102114290
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   Jacket
AC   CVCL_B6PT
DR   cancercelllines; CVCL_B6PT
DR   Rockland; CB-0301
DR   Wikidata; Q111733540
WW   Info; Cellaria; -; https://web.archive.org/web/20230325101458/https://cellariainc.com/product/jacket-cell-model/
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Phe814Val (c.2440T>G); Zygosity=Hemizygous (Cellaria).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Homozygous (Cellaria).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly477Ser (c.1429G>A); ClinVar=VCV000455136; Zygosity=Heterozygous (Cellaria).
CC   Sequence variation: Mutation; HGNC; HGNC:7527; MUTYH; Simple; p.Val493Met (c.1477G>A) (p.Val468Met, c.1402G>A); ClinVar=VCV000140942; Zygosity=Heterozygous (Cellaria).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Homozygous (Cellaria).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cellaria
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 17
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   Jada-BL
AC   CVCL_7197
SY   Jada
DR   Wikidata; Q54898506
RX   PubMed=9882297;
RX   PubMed=16051863;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   JAG020
AC   CVCL_2H88
SY   NOD.CBALs-Tyr+/LtJ JAG020; NOD.CBALs-Tyr+ JAG020
DR   Wikidata; Q54898507
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/004304P8productspec.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NOD.CBALs-Tyr+/LtJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   JAINi001-A
AC   CVCL_D0GN
SY   01456
DR   BioSamples; SAMEA112655527
DR   hPSCreg; JAINi001-A
DR   Wikidata; Q123032761
CC   From: Jain Foundation; Seattle; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   JAINi002-A
AC   CVCL_D0GP
SY   01457
DR   BioSamples; SAMEA112655529
DR   hPSCreg; JAINi002-A
DR   Wikidata; Q123032762
CC   From: Jain Foundation; Seattle; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   JAINi003-A
AC   CVCL_D0GQ
SY   01458
DR   BioSamples; SAMEA112655531
DR   hPSCreg; JAINi003-A
DR   Wikidata; Q123032763
CC   From: Jain Foundation; Seattle; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   JAINi004-A
AC   CVCL_D0GR
SY   01459
DR   BioSamples; SAMEA112655533
DR   hPSCreg; JAINi004-A
DR   Wikidata; Q123032764
CC   From: Jain Foundation; Seattle; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   JAINi005-A
AC   CVCL_D0GS
SY   01460
DR   BioSamples; SAMEA112655535
DR   hPSCreg; JAINi005-A
DR   Wikidata; Q123032765
CC   From: Jain Foundation; Seattle; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   JAM
AC   CVCL_D239
DR   ChEMBL-Cells; CHEMBL3307834
DR   ChEMBL-Targets; CHEMBL613987
DR   Cosmic; 991318
DR   Cosmic; 1524363
DR   PubChem_Cell_line; CVCL_D239
DR   Wikidata; Q54898508
RX   PubMed=3567897;
CC   Characteristics: Established from a subcutaneous xenografted tumor derived from the parental cell line (PubMed=3567897).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B411 ! JA-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   JAM-ICR
AC   CVCL_A9QB
DR   Wikidata; Q102114291
RX   PubMed=33165868;
CC   Population: Iranian.
CC   Doubling time: 23.9 hours (PubMed=33165868).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=33165868
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,16.2
ST   D21S11: 27,33.2
ST   D2S1338: 20,24
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10
ST   FGA: 22,24
ST   SE33: 16,20
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JAMA-2
AC   CVCL_A593
SY   JAMA2
DR   cancercelllines; CVCL_A593
DR   Cosmic; 1175881
DR   GEO; GSM313694
DR   Progenetix; CVCL_A593
DR   Wikidata; Q54898509
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D239 ! JAM
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 8
//
ID   JAP-NF
AC   CVCL_E714
DR   dbMHC; 48911
DR   ECACC; 94022531
DR   IHW; IHW09227
DR   IPD-IMGT/HLA; 10819
DR   Wikidata; Q54898510
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Jewish; Ashkenazi.
CC   HLA typing: A*02:01,26:01; B*15:17:01:01,38:01:01; C*07:01,12:03; DPB1*02:01:02,03:01 (IPD-IMGT/HLA=10819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   JAR
AC   CVCL_0360
SY   Jar; JAr; JaR
DR   BTO; BTO_0001585
DR   CLO; CLO_0007011
DR   EFO; EFO_0002211
DR   MCCL; MCC:0000254
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-144
DR   BCRC; 60491
DR   BioSample; SAMN01821568
DR   BioSample; SAMN01821637
DR   BioSample; SAMN03472717
DR   cancercelllines; CVCL_0360
DR   CCRID; 3101HUMTCHu156
DR   Cell_Model_Passport; SIDM01039
DR   ChEMBL-Cells; CHEMBL3307657
DR   ChEMBL-Targets; CHEMBL614587
DR   CLS; 300221
DR   Cosmic; 907175
DR   Cosmic; 2077193
DR   Cosmic-CLP; 907175
DR   DepMap; ACH-001529
DR   DSMZ; ACC-462
DR   DSMZCellDive; ACC-462
DR   EGA; EGAS00001000978
DR   GDSC; 907175
DR   GEO; GSM827264
DR   GEO; GSM1669947
DR   IARC_TP53; 21417
DR   IGRhCellID; JAR
DR   IZSLER; BS TCL 182
DR   KCLB; 30144
DR   LINCS_LDP; LCL-1491
DR   PharmacoDB; JAR_676_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0360
DR   PubChem_Cell_line; CVCL_0360
DR   TOKU-E; 2064
DR   Wikidata; Q54898511
RX   DOI=10.1007/0-306-46861-1_8;
RX   DOI=10.1007/BF02619074;
RX   PubMed=2720636;
RX   PubMed=2878840;
RX   PubMed=3518877;
RX   PubMed=4038916;
RX   PubMed=7153601;
RX   PubMed=7716126;
RX   PubMed=7819056;
RX   PubMed=7937597;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=24098444;
RX   PubMed=27397505;
RX   PubMed=28161053;
RX   PubMed=28534963;
RX   PubMed=28724925;
RX   PubMed=30894373;
RX   PubMed=33096371;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Doubling time: 2.40 +- 0.18 days (PubMed=28724925); ~20-30 hours (DSMZ=ACC-462).
CC   Karyotypic information: Near triploid karyotype (PubMed=33096371).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=30.11%; Native American=0.66%; East Asian, North=2.4%; East Asian, South=0%; South Asian=1.4%; European, North=42.28%; European, South=23.14% (PubMed=30894373).
CC   Caution: Established from the trophoblastic tumor of the placenta of a 24 year old woman, but the cell line is from the male fetus.
ST   Source(s): ATCC=HTB-144; CLS=300221; Cosmic-CLP=907175; DSMZ=ACC-462; KCLB=30144
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 13,17 (CLS=300221)
ST   D18S51: 14,15 (ATCC=HTB-144; DSMZ=ACC-462)
ST   D19S433: 12,13
ST   D21S11: 28,29 (ATCC=HTB-144; DSMZ=ACC-462)
ST   D21S11: 30 (CLS=300221)
ST   D2S1338: 20,21
ST   D3S1358: 14 (CLS=300221)
ST   D3S1358: 14,16,17 (DSMZ=ACC-462)
ST   D3S1358: 16,17 (ATCC=HTB-144; KCLB=30144)
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 9,11 (CLS=300221)
ST   Penta D: 9,14 (ATCC=HTB-144; DSMZ=ACC-462)
ST   Penta E: 8,12 (ATCC=HTB-144; DSMZ=ACC-462)
ST   Penta E: 10,12 (CLS=300221)
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   JAR-G1
AC   CVCL_XY25
SY   JAR-G; JAR-HLA-G1
DR   Wikidata; Q94326620
RX   PubMed=7479770;
RX   PubMed=9464826;
RX   PubMed=10429763;
RX   PubMed=10902607;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0360 ! JAR
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   JAR-G1s
AC   CVCL_XY26
SY   JAR-sG1
DR   Wikidata; Q94326625
RX   PubMed=10429763;
RX   PubMed=10902607;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4964; HLA-G (Note=Soluble isoform).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0360 ! JAR
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   Jar-GnT4a
AC   CVCL_C8NY
DR   BTO; BTO_0006502
DR   Wikidata; Q123032767
RX   PubMed=28534963;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7047; MGAT4A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0360 ! JAR
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   JAR-Smad3/c
AC   CVCL_B7MU
SY   JAR-smad3/c
DR   Wikidata; Q112929892
RX   PubMed=12074587;
RX   PubMed=15150278;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6769; SMAD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0360 ! JAR
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   JAR1
AC   CVCL_F0W8
SY   JAR 1
DR   ABCD; ABCD_AD813
RX   PubMed=15100304;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; Q9JXV4; Neisseria meningitidis serogroup B (strain ATCC BAA-335 / MC58) factor H binding protein (fhbP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   JAR3
AC   CVCL_F0W9
SY   JAR 3
DR   ABCD; ABCD_AD814
RX   PubMed=15100304;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q9JXV4; Neisseria meningitidis serogroup B (strain ATCC BAA-335 / MC58) factor H binding protein (fhbP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   JAR4
AC   CVCL_F0WA
SY   JAR 4
DR   ABCD; ABCD_BF035
RX   PubMed=15100304;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JXV4; Neisseria meningitidis serogroup B (strain ATCC BAA-335 / MC58) factor H binding protein (fhbP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   JAR5
AC   CVCL_F0WB
SY   JAR 5
DR   ABCD; ABCD_AD815
RX   PubMed=15100304;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9JXV4; Neisseria meningitidis serogroup B (strain ATCC BAA-335 / MC58) factor H binding protein (fhbP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Jari
AC   CVCL_6F63
DR   Wikidata; Q54898512
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   Jarques
AC   CVCL_L359
DR   BTO; BTO_0005358
DR   Wikidata; Q54898513
RX   PubMed=21552385;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   JAS-R
AC   CVCL_C6JU
DR   Wikidata; Q116049597
RX   PubMed=16619478;
CC   Population: Japanese.
CC   Characteristics: Secretes EPO.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   JaVo
AC   CVCL_E9UZ
RX   PubMed=6096706;
RX   PubMed=6437965;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18M
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JAWSII
AC   CVCL_3727
SY   JawsII; JAWS II
DR   CLO; CLO_0007012
DR   ATCC; CRL-3612
DR   ATCC; CRL-11904
DR   BCRJ; 0347
DR   Wikidata; Q54898514
RX   Patent=US5648219;
RX   PubMed=14513565;
RX   PubMed=17390073;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/crl-11904-morphology-and-culture-condition
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11904.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Discontinued: ATCC; CRL-11904; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6 Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   JAWSII/EGFP
AC   CVCL_A7FX
SY   JAWS II/EGFP
DR   Wikidata; Q107115485
RX   PubMed=17390073;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6 Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3727 ! JAWSII
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   JAWSII/IL-12
AC   CVCL_A7FY
SY   JAWS II/IL-12
DR   Wikidata; Q107115487
RX   PubMed=17390073;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96539; Il12a.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96540; Il12b.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6 Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3727 ! JAWSII
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   Jay Sen
AC   CVCL_3319
DR   CLO; CLO_0007013
DR   CLDB; cl2933
DR   ATCC; CRL-1215
DR   Wikidata; Q54898515
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Jay Ver
AC   CVCL_Y124
DR   ATCC; CRL-1127
DR   Wikidata; Q54898516
CC   Discontinued: ATCC; CRL-1127; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   JB
AC   CVCL_Y434
DR   Wikidata; Q54898517
RX   PubMed=17760811;
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: ~4-6 days (PubMed=17760811).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 10
//
ID   JB/MS
AC   CVCL_E093
DR   Wikidata; Q54898518
RX   PubMed=3698017;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   JB/RH
AC   CVCL_E094
SY   JB-RH; JBRH
DR   Wikidata; Q54898519
RX   PubMed=3698017;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   JB1 [Mouse hybridoma against human HFE]
AC   CVCL_U053
DR   ECACC; 01091808
DR   Wikidata; Q54898520
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   JB1 [Rat hepatocellular carcinoma]
AC   CVCL_HA75
DR   Wikidata; Q54898521
RX   PubMed=3675628;
RX   PubMed=6132685;
RX   PubMed=6150901;
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   JB11
AC   CVCL_E5S4
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68638; Vaccinia virus complement control protein C3 (C3L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JB6 [Human anaplastic large cell lymphoma]
AC   CVCL_H633
SY   JB-6; JB
DR   cancercelllines; CVCL_H633
DR   Cosmic; 850200
DR   Cosmic; 1086363
DR   GEO; GSM1217150
DR   Progenetix; CVCL_H633
DR   Wikidata; Q54898522
RX   CelloPub=CLPUB00058;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8558920;
RX   PubMed=9787181;
RX   PubMed=11021758;
RX   PubMed=15356658;
RX   PubMed=17170727;
RX   PubMed=28356514;
CC   Doubling time: 60 hours (CelloPub=CLPUB00058).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=15356658).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   JB6 [Mouse]
AC   CVCL_B230
SY   JB-6; JB 6
DR   BTO; BTO_0004831
DR   Wikidata; Q54898523
RX   PubMed=2985973;
RX   PubMed=6119803;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Newborn
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   JB6 Cl 25
AC   CVCL_5U34
SY   JB-6 Cl 25; JB6Cl25
DR   Wikidata; Q54898524
RX   PubMed=6119803;
RX   PubMed=6947266;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B230 ! JB6 [Mouse]
SX   Sex unspecified
AG   Newborn
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   JB6 Cl 30-7b
AC   CVCL_0361
SY   JB6 clone 30, subclone 7b; JB6 clone 30; JB6 Cl 30; JB-6 Cl 30; JB6Cl30
DR   CLO; CLO_0007014
DR   MCCL; MCC:0000255
DR   ATCC; CRL-2007
DR   Wikidata; Q54898525
RX   PubMed=6119803;
RX   PubMed=6947266;
CC   Characteristics: Resistant to promotion of transformation (P-) by phorbol esters (PubMed=6119803).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B230 ! JB6 [Mouse]
SX   Sex unspecified
AG   Newborn
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   JB6 Cl 41-5a
AC   CVCL_0362
SY   JB6 clone 41, subclone 5a; JB6 clone 41; JB6 clone41; JB6 Cl41; JB6 Cl 41; JB-6 Cl 41; JB6Cl41
DR   BTO; BTO_0003316
DR   CLO; CLO_0007015
DR   MCCL; MCC:0000256
DR   ATCC; CRL-2010
DR   TOKU-E; 2068
DR   Wikidata; Q54898526
RX   PubMed=2985973;
RX   PubMed=6119803;
RX   PubMed=6947266;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-218.html
CC   Characteristics: Sensitive to promotion of transformation (P+) by phorbol esters (PubMed=6119803).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B230 ! JB6 [Mouse]
SX   Sex unspecified
AG   Newborn
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   JBL-1
AC   CVCL_IW32
SY   JBL1; JBL; Japanese Burkitt's Lymphoma 1
DR   Wikidata; Q54898527
RX   PubMed=201360;
RX   PubMed=7064731;
RX   PubMed=7464876;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 30 hours (PubMed=201360).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 9
//
ID   JBL-2
AC   CVCL_A630
SY   JBL2; Japanese Burkitt's Lymphoma 2
DR   Cosmic; 931123
DR   Wikidata; Q54898529
RX   PubMed=467575;
RX   PubMed=1395095;
RX   PubMed=2470097;
RX   PubMed=2847931;
RX   PubMed=3024964;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=6286514;
RX   PubMed=6327071;
RX   PubMed=6806672;
RX   PubMed=7064731;
RX   PubMed=7464876;
RX   PubMed=9473234;
RX   PubMed=22120970;
RX   PubMed=24590883;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5715; IGK + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGK (PubMed=6806672; PubMed=22120970).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   JBL-3
AC   CVCL_IW51
SY   JBL3; Japanese Burkitt's Lymphoma 3
DR   Wikidata; Q54898530
RX   PubMed=7064731;
RX   PubMed=7464876;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 9
//
ID   JBL-4
AC   CVCL_IW53
SY   JBL4; Japanese Burkitt's Lymphoma 4
DR   Wikidata; Q54898531
RX   PubMed=7064731;
RX   PubMed=7464876;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 9
//
ID   JBL-5
AC   CVCL_IW52
SY   JBL5; Japanese Burkitt's Lymphoma 5
DR   Wikidata; Q54898532
RX   PubMed=7064731;
RX   PubMed=7464876;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 9
//
ID   JBL-6
AC   CVCL_IW54
SY   JBL6; Japanese Burkitt's Lymphoma 6
DR   Wikidata; Q54898533
RX   PubMed=7064731;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   JBSA
AC   CVCL_ZF47
DR   Wikidata; Q98126791
RX   PubMed=7621407;
RX   PubMed=9499454;
CC   Doubling time: 26 hours (PubMed=7621407).
CC   Karyotypic information: Hypotriploid karyotype.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=9499454).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   JBUSH
AC   CVCL_E715
SY   JBush; J BUSH
DR   dbMHC; 48912
DR   ECACC; 88052035
DR   IHW; IHW09035
DR   IPD-IMGT/HLA; 10825
DR   Wikidata; Q54898534
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*32:01:01:01; B*38:01:01; C*12:03:01:01; DPB1*04:01:01; DQA1*05:05; DQB1*03:01:01; DRB1*11:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=10825).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   JC
AC   CVCL_3530
DR   BTO; BTO_0006304
DR   CLO; CLO_0007016
DR   ATCC; CRL-2116
DR   BCRC; 60347
DR   BioSample; SAMN11397641
DR   Cosmic; 1661882
DR   KCLB; 22116
DR   Wikidata; Q54898535
RX   PubMed=2666384;
RX   PubMed=31220119;
RX   PubMed=33526060;
CC   Doubling time: 12-16 hours (ATCC=CRL-2116).
CC   Karyotypic information: Hypo-tetraploid karyotype with 64-66 chromosomes (PubMed=33526060).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cRos.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 14
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 24.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 25
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   JC-1
AC   CVCL_WN03
DR   Wikidata; Q94326931
RX   PubMed=12101352;
CC   Group: Space-flown cell line (cellonaut).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
CC   Anecdotal: Have been flown in space on shuttle flight STS-47 (Spacelab-J) to study antibody production in microgravity (PubMed=12101352).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   JC-20
AC   CVCL_A1EH
SY   JFCR-Colorectal-20
DR   Cosmic; 2811057
DR   Wikidata; Q102114292
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Pro1483fs; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 6
//
ID   JC-32
AC   CVCL_A1EI
SY   JFCR-Colorectal-32
DR   cancercelllines; CVCL_A1EI
DR   Cosmic; 2811058
DR   Wikidata; Q102114294
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Trp553Ter (c.1659G>A); ClinVar=VCV000092340; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   JC-33
AC   CVCL_A1EJ
SY   JFCR-Colorectal-33
DR   cancercelllines; CVCL_A1EJ
DR   Cosmic; 2811059
DR   Wikidata; Q102114295
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1303Ter (c.3907C>T); ClinVar=VCV001076263; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   JC-35
AC   CVCL_A1EK
SY   JFCR-Colorectal-35
DR   Cosmic; 2811060
DR   Wikidata; Q102114296
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1164fs; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 6
//
ID   JC-36
AC   CVCL_A1EL
SY   JFCR-Colorectal-36
DR   cancercelllines; CVCL_A1EL
DR   Cosmic; 2811061
DR   Wikidata; Q102114297
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg805Ter (c.2413C>T); ClinVar=VCV000127281; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 7
//
ID   JC-37
AC   CVCL_A1EM
SY   JFCR-Colorectal-37
DR   cancercelllines; CVCL_A1EM
DR   Cosmic; 2811062
DR   Wikidata; Q102114298
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 7
//
ID   JC-39
AC   CVCL_A1EN
SY   JFCR-Colorectal-39
DR   cancercelllines; CVCL_A1EN
DR   Cosmic; 2811063
DR   Wikidata; Q102114299
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg216Ter (c.646C>T); ClinVar=VCV000127312; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 7
//
ID   JC-410
AC   CVCL_6660
SY   jc-410; JC410
DR   Wikidata; Q54898536
RX   PubMed=9584843;
RX   PubMed=15541573;
CC   Doubling time: 67 hours (PubMed=9584843).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   JC-47
AC   CVCL_A1EP
SY   JFCR-Colorectal-47
DR   Cosmic; 2811064
DR   Wikidata; Q102114300
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Phe1491fs; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 6
//
ID   JC-49
AC   CVCL_A1EQ
SY   JFCR-Colorectal-49
DR   cancercelllines; CVCL_A1EQ
DR   Cosmic; 2811065
DR   Wikidata; Q102114301
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg302Ter (c.904C>T) (R284*); ClinVar=VCV000000798; Zygosity=Unspecified (PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1345Ter (c.4033G>T); ClinVar=VCV000449334; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 7
//
ID   JC-52
AC   CVCL_A1ER
SY   JFCR-Colorectal-52
DR   cancercelllines; CVCL_A1ER
DR   Cosmic; 2811066
DR   Wikidata; Q102114302
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu1342Ter (c.4025T>G); ClinVar=VCV000645602; Zygosity=Unspecified (PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1343Phefs*10 (c.4028_4029delCT); ClinVar=VCV000824521; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   JC-54
AC   CVCL_A1ES
SY   JFCR-Colorectal-54
DR   cancercelllines; CVCL_A1ES
DR   Cosmic; 2811067
DR   Wikidata; Q102114304
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg876Ter (c.2626C>T); ClinVar=VCV000216014; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 7
//
ID   JC-55
AC   CVCL_A1ET
SY   JFCR-Colorectal-55
DR   cancercelllines; CVCL_A1ET
DR   Cosmic; 2811068
DR   Wikidata; Q102114305
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1306Ter (c.3916G>T) (E1288*, c.3862G>T); ClinVar=VCV000376059; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 7
//
ID   JC-56
AC   CVCL_A1EU
SY   JFCR-Colorectal-56
DR   cancercelllines; CVCL_A1EU
DR   Cosmic; 2811069
DR   Wikidata; Q102114306
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1023Asnfs*6 (c.3067dupA); ClinVar=VCV000230713; Zygosity=Unspecified (PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1554Ter (c.4660G>T); ClinVar=VCV000433664; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   JC-58
AC   CVCL_A1EV
SY   JFCR-Colorectal-58
DR   cancercelllines; CVCL_A1EV
DR   Cosmic; 2811070
DR   Wikidata; Q102114307
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1295Ter (c.3883G>T); ClinVar=VCV002102818; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   JC-61
AC   CVCL_A1EW
SY   JFCR-Colorectal-61
DR   Cosmic; 2811071
DR   Wikidata; Q102114308
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu941Ter (c.2821G>T); Zygosity=Unspecified (PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1459fs (c.4375dupA); ClinVar=VCV001740114; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 6
//
ID   JC-7
AC   CVCL_A1EX
SY   JFCR-Colorectal-7
DR   cancercelllines; CVCL_A1EX
DR   Cosmic; 2811056
DR   Wikidata; Q102114309
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg232Ter (c.694C>T); ClinVar=VCV000042248; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 7
//
ID   JC053
AC   CVCL_C5TZ
DR   Wikidata; Q116049598
RX   PubMed=35724767;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=35724767).
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
DI   NCIt; C96156; Colorectal neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   JC053-DR1
AC   CVCL_C5U0
DR   Wikidata; Q116049599
RX   PubMed=35724767;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=35724767).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Ex2-8del; Zygosity=Unspecified (PubMed=35724767).
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
DI   NCIt; C96156; Colorectal neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5TZ ! JC053
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   JC053-DR2
AC   CVCL_C5U1
DR   Wikidata; Q116049600
RX   PubMed=35724767;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=35724767).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Ex3-8del; Zygosity=Heterozygous (PubMed=35724767).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Unexplicit; Ex4-8del; Zygosity=Heterozygous (PubMed=35724767).
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
DI   NCIt; C96156; Colorectal neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5TZ ! JC053
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   JCA-1
AC   CVCL_4015
SY   JCA1
DR   BioSample; SAMN03151947
DR   cancercelllines; CVCL_4015
DR   Wikidata; Q54898538
RX   CelloPub=CLPUB00698;
RX   PubMed=2195744;
RX   PubMed=11304728;
RX   PubMed=11522622;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=11304728; PubMed=11522622; PubMed=20143388; CelloPub=CLPUB00698). Originally thought to originate from a 67 year old male patient with prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00216.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (PubMed=11304728; PubMed=11522622).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (PubMed=11304728; PubMed=11522622).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11304728; PubMed=11522622
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 16,18
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   JCaM1/Lck+
AC   CVCL_XF42
SY   JCaM-1/Lck
DR   cancercelllines; CVCL_XF42
DR   Wikidata; Q94326959
RX   PubMed=8626636;
RX   PubMed=11231305;
CC   Population: Caucasian.
CC   Characteristics: Parent cell line is deficient for LCK activity due to a deletion of exon 7 but this cell line has a restored wild-type LCK activity.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6524; LCK (Note=With p.Arg154Lys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF41 ! JCaM1/TAg
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   JCaM1/LckR154K
AC   CVCL_XF43
SY   JRK 154.6
DR   cancercelllines; CVCL_XF43
DR   Wikidata; Q94326963
RX   PubMed=8626636;
RX   PubMed=11231305;
CC   Population: Caucasian.
CC   Characteristics: Parent cell line is deficient for LCK activity due to a deletion of exon 7. This cell line with a transfected LCK with the p.Arg154Lys substitution within the SH2 domain does not have a restored signaling activity (PubMed=8626636).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6524; LCK (Note=With p.Arg154Lys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF41 ! JCaM1/TAg
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   JCaM1/TAg
AC   CVCL_XF41
DR   cancercelllines; CVCL_XF41
DR   Wikidata; Q94326966
RX   PubMed=8626636;
CC   Population: Caucasian.
CC   Characteristics: Deficient for LCK activity due to a deletion of exon 7.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0354 ! J.CaM1.6
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   JCF-4
AC   CVCL_E7AX
RX   PubMed=40485979;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Val470Glufs*54 (c.1409_1418del); ClinVar=VCV000053250; Zygosity=Homozygous (PubMed=40485979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J695 ! CF1TKB
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   JCK
AC   CVCL_M270
DR   Wikidata; Q54898539
RX   CelloPub=CLPUB00275;
RX   PubMed=11107175;
RX   PubMed=35640676;
CC   Population: Korean.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   JCLRIi001-A
AC   CVCL_QW44
SY   FL-BCP-hiPSC; B-cell-iPSC
DR   hPSCreg; JCLRIi001-A
DR   Wikidata; Q54898542
RX   PubMed=26500142;
RX   PubMed=28677529;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_60_60Deposito_B-cell-iPSC.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_06Anexo_B-cell-iPSC.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pro-B cell; CL=CL_0000826.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19-22FW
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   JCLRIi001-A-1
AC   CVCL_QW45
SY   iCas9-FL-BCP-hiPSC; iCas9-FL-BCL-iPSC
DR   hPSCreg; JCLRIi001-A-1
DR   Wikidata; Q54898543
RX   PubMed=28677529;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_06Deposito_iPSC_CAS9i.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_06_Anexo_iCas9-FL-BCP-iPSC.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Characteristics: Using CRISPR/Cas9 under the control of a tetracycline response element (TRE) promoter has been inserted at the AAVS1 safe harbor locus.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Pro-B cell; CL=CL_0000826.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QW44 ! JCLRIi001-A
SX   Female
AG   19-22FW
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 11
//
ID   JcTaxWT-Neo7
AC   CVCL_B7PR
DR   cancercelllines; CVCL_B7PR
DR   Wikidata; Q112929893
RX   PubMed=9357968;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   JD-MEL
AC   CVCL_GR47
DR   Wikidata; Q54898544
RX   PubMed=7453182;
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (Note=At 7th passage), ~24 hours (Note=At 41th passage) (PubMed=7453182).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   JD13D
AC   CVCL_E299
SY   Pa04C
DR   Cosmic; 1473011
DR   Cosmic; 1509851
DR   Wikidata; Q54898545
RX   PubMed=17912029;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   JD38
AC   CVCL_A631
SY   JD 38
DR   cancercelllines; CVCL_A631
DR   Cosmic; 850209
DR   Cosmic; 931124
DR   IARC_TP53; 167
DR   Wikidata; Q54898546
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=3100061;
RX   PubMed=3921823;
RX   PubMed=6286763;
RX   PubMed=8176200;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=8568269;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9563901;
RX   PubMed=9787181;
RX   PubMed=9973220;
CC   Virology: EBV-negative.
CC   Doubling time: 26 hours (PubMed=8402660).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493; PubMed=8402660).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   JD39
AC   CVCL_W743
SY   JD 39
DR   Wikidata; Q54898547
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=6286763;
RX   PubMed=8176200;
RX   PubMed=8515068;
RX   PubMed=8568269;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   JD40
AC   CVCL_W744
SY   JD 40
DR   Wikidata; Q54898548
RX   PubMed=6286763;
RX   PubMed=9643977;
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=9643977).
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   JDB1
AC   CVCL_U321
DR   ATCC; HB-8143
DR   Wikidata; Q54898549
RX   Patent=US4724211;
RX   PubMed=1751783;
RX   PubMed=3094942;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8143.
CC   Monoclonal antibody isotype: IgG3+IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1075 ! BALL-1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   JDM-iPS1
AC   CVCL_B350
SY   JDM-IPS1
DR   Wikidata; Q54898550
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Native North American; Alaskan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8518 ! GM02416
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   JDM-iPS10
AC   CVCL_B351
SY   JDM-IPS10
DR   Wikidata; Q54898551
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Native North American; Alaskan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8518 ! GM02416
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   JDM-iPS2
AC   CVCL_B352
SY   JDM-IPS2
DR   Wikidata; Q54898552
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Native North American; Alaskan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8518 ! GM02416
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   JDM-iPS4
AC   CVCL_B353
SY   JDM-IPS4
DR   Wikidata; Q54898553
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Native North American; Alaskan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8518 ! GM02416
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   JDSHCC39
AC   CVCL_RP93
SY   HB JDSHCC39
DR   CCRID; 4201PAT-CCTCC00114
DR   Wikidata; Q54898554
RX   Patent=CN1044384C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C94005.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis C virus core protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 8
//
ID   JDSHCE125
AC   CVCL_RP94
SY   HB JDSHCE125; JDSHCE-125
DR   CCRID; 4201PAT-CCTCC00118
DR   Wikidata; Q54898555
RX   Patent=CN1044384C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C94009.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis C virus envelope glycoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 8
//
ID   JDSHCNS3-1
AC   CVCL_RP95
SY   HB JDSHCNS3-1
DR   CCRID; 4201PAT-CCTCC00115
DR   Wikidata; Q54898556
RX   Patent=CN1044384C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C94006.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis C virus protein NS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   JDSHCNS4-93
AC   CVCL_RP96
SY   HB JDSHCNS4-93
DR   CCRID; 4201PAT-CCTCC00116
DR   Wikidata; Q54898557
RX   Patent=CN1044384C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C94007.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis C virus protein NS4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   JDSHCNS5-1
AC   CVCL_RP97
SY   HB JDSHCNS5-1
DR   CCRID; 4201PAT-CCTCC00117
DR   Wikidata; Q54898558
RX   Patent=CN1044384C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C94008.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Hepatitis C virus protein NS5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   JDU
AC   CVCL_T280
DR   ATCC; CCL-118
DR   Wikidata; Q54898559
RX   DOI=10.1007/BF02618370;
RX   PubMed=13754521;
CC   Discontinued: ATCC; CCL-118; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   Je Kin
AC   CVCL_Y306
DR   ATCC; CRL-1232
DR   Wikidata; Q54898560
RX   PubMed=3860870;
CC   Discontinued: ATCC; CRL-1232; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   JE-1
AC   CVCL_VH02
SY   Junctional Epithelium-1
DR   Wikidata; Q54898561
RX   PubMed=29428727;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic oral cavity, gingiva, epithelium; UBERON=UBERON_0001949.
CC   Cell type: Epithelial cell of gingiva; CL=CL_0002621.
CC   Breed/subspecies: C57BL/6N-Tg(CAG-EGFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   JE-2
AC   CVCL_VH03
SY   Junctional Epithelium-2
DR   Wikidata; Q54898562
RX   PubMed=29428727;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic oral cavity, gingiva, epithelium; UBERON=UBERON_0001949.
CC   Cell type: Epithelial cell of gingiva; CL=CL_0002621.
CC   Breed/subspecies: C57BL/6N-Tg(CAG-EGFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   JE1
AC   CVCL_E5RB
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JE10
AC   CVCL_E5QG
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JE11
AC   CVCL_E5QH
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JE4
AC   CVCL_E5QQ
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JE6-1REP-iNKT
AC   CVCL_WN97
DR   cancercelllines; CVCL_WN97
DR   Wikidata; Q94327309
RX   PubMed=31092850;
CC   Population: Caucasian.
CC   Characteristics: Fluorescence-based iNKT-TCR reporter system, applicable for screening potential new lipid antigens that infuence iNKT cell activation.
CC   Characteristics: The eGFP reporter gene is under control of a NF-kappaB promoter element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12027; TRA (Note=iNKT-TCR V-alpha24).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12155; TRB (Note=iNKT-TCR V-beta11).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN96 ! Jurkat E6.1 NF-kappaB::eGFP
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 14
//
ID   JEE-2
AC   CVCL_F1BH
SY   Japanese Eel Endothelial-2
RX   PubMed=40254890;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 25-30 Celsius. Slower growth at 35 and 37 Celsius (PubMed=40254890).
CC   Virology: Susceptible to Japanese eel endothelial cell virus (JEECV); virus replicated with cytopathic effects (PubMed=40254890).
CC   Doubling time: 66 hours (Note=At 25 Celsius), 40 hours (Note=At 30 Celsius), 45 hours (Note=At 35 Celsius), 107 hours (Note=At 37 Celsius) (PubMed=40254890).
CC   Derived from site: In situ; Heart, bulbus arteriosus; UBERON=UBERON_0004152.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   JEEC
AC   CVCL_F1BI
SY   JEE; Japanese Eel Endothelial Cell line
RX   DOI=10.3147/jsfp.42.191;
CC   Group: Fish cell line.
CC   Virology: Susceptible to Japanese eel endothelial cell virus (JEECV) (DOI=10.3147/jsfp.42.191).
CC   Derived from site: In situ; Heart, bulbus arteriosus; UBERON=UBERON_0004152.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   JEG-3
AC   CVCL_0363
SY   Jeg-3; JEG3; Jeg3; jeg3
DR   BTO; BTO_0002269
DR   CLO; CLO_0007017
DR   EFO; EFO_0002066
DR   MCCL; MCC:0000257
DR   CLDB; cl2935
DR   CLDB; cl2936
DR   ABM; T8976
DR   AddexBio; C0030003/4940
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-36
DR   BCRC; 60428
DR   BCRJ; 0123
DR   BioSample; SAMN01821538
DR   BioSample; SAMN01821638
DR   cancercelllines; CVCL_0363
DR   CCRID; 1101HUM-PUMC000071
DR   CCRID; 3101HUMTCHu195
DR   CCRID; 4201HUM-CCTCC00320
DR   CCTCC; GDC0320
DR   Cell_Model_Passport; SIDM01218
DR   ChEMBL-Cells; CHEMBL3308202
DR   ChEMBL-Targets; CHEMBL2366348
DR   CLS; 300222
DR   Cosmic; 683654
DR   Cosmic; 907176
DR   Cosmic; 1312288
DR   Cosmic; 2077192
DR   Cosmic-CLP; 907176
DR   DepMap; ACH-001530
DR   DSMZ; ACC-463
DR   DSMZCellDive; ACC-463
DR   ECACC; 92120308
DR   EGA; EGAS00001000978
DR   GDSC; 907176
DR   GEO; GSM48266
DR   GEO; GSM48267
DR   GEO; GSM48268
DR   GEO; GSM1669948
DR   IARC_TP53; 4344
DR   IARC_TP53; 21418
DR   IGRhCellID; JEG3
DR   IZSLER; BS TCL 181
DR   KCLB; 30036
DR   LINCS_LDP; LCL-1492
DR   NCBI_Iran; C544
DR   PharmacoDB; JEG3_677_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0363
DR   PubChem_Cell_line; CVCL_0363
DR   TOKU-E; 2070
DR   Wikidata; Q54898563
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=62839;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2878840;
RX   PubMed=3518877;
RX   PubMed=5103722;
RX   PubMed=6220172;
RX   PubMed=7459858;
RX   PubMed=7753552;
RX   PubMed=7819056;
RX   PubMed=7937597;
RX   PubMed=11994546;
RX   PubMed=12966428;
RX   PubMed=16797695;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=28161053;
RX   PubMed=28724925;
RX   PubMed=30894373;
RX   PubMed=33096371;
RX   PubMed=33810901;
RX   PubMed=35839778;
WW   Info; -; -; https://web.archive.org/web/20141104150727/http://www2.kumc.edu/soalab/LabLinks/cell%20lines/jeg3.htm
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-251.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Characteristics: Established by serial cloning into hamster cheek pouches.
CC   Doubling time: 2.52 +- 0.24 days (PubMed=28724925); ~36 hours (CLS=300222); ~24 hours (DSMZ=ACC-463).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=33096371).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.01%; Native American=0.09%; East Asian, North=0.97%; East Asian, South=0%; South Asian=0.9%; European, North=71.88%; European, South=26.16% (PubMed=30894373).
CC   Caution: A TP53 mutation is indicated as being at p.Gln167His (c.501G>T) in PubMed=7819056 but has not been confirmed by CCLE and Cosmic-CLP.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
ST   Source(s): AddexBio=C0030003/4940; ATCC=HTB-36; CCRID; CLS=300222; Cosmic-CLP=907176; DepMap=ACH-001530; DSMZ=ACC-463; KCLB=30036; PubMed=33810901
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 17,24
ST   D13S317: 9,11
ST   D16S539: 13,14
ST   D18S51: 14
ST   D19S433: 13,15
ST   D1S1656: 14,16
ST   D21S11: 30
ST   D22S1045: 15
ST   D2S1338: 24
ST   D2S441: 14,15
ST   D3S1358: 15 (CLS=300222)
ST   D3S1358: 15,16 (ATCC=HTB-36; CCRID; DepMap=ACH-001530; DSMZ=ACC-463; KCLB=30036; PubMed=33810901)
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 8,12
ST   SE33: 15,25.2
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   JEG-3/A3-1A7
AC   CVCL_IV65
SY   A3-1A7
DR   Wikidata; Q54898565
RX   PubMed=6683274;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45327; Adenine arabinoside (Vidarabine; 9-beta-D-arabinofuranosyladenine; ara-A).
CC   Selected for resistance to: ChEBI; CHEBI_46515; 9-beta-D-xylofuranosyl adenine (xyl-A).
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   JEG-3/VP16
AC   CVCL_6922
SY   jeg3/vp16
DR   Wikidata; Q54898566
RX   PubMed=17884151;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000072). It was the sole source for the STR profile of this entry.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 13,14
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 21,23,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   JEG-3/VP16-IL-2
AC   CVCL_6923
DR   Wikidata; Q54898567
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000073). It was the sole source of information for this entry.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 13,14
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 21,23,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6922 ! JEG-3/VP16
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   JEG-3/VP16-TNFa
AC   CVCL_6924
SY   JEG-3-VP16-TNFa
DR   Wikidata; Q54898568
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11892; TNF.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000074). It was the sole source of information for this entry.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6922 ! JEG-3/VP16
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   JEI-001
AC   CVCL_B3MS
SY   Jiaotong Ear Institute-001
DR   CCRID; 4201PAT-CCTCC01456
DR   Wikidata; Q110432994
RX   Patent=CN110904051B;
RX   PubMed=34539995;
RX   PubMed=35359340;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019182.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; c.515delG; Zygosity=Heterozygous (PubMed=34539995).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=34539995
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D12S391: 17,18
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 15,15.2
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D6S1043: 11,20
ST   D7S820: 10,12
ST   D8S1179: 15,16
ST   FGA: 22,23
ST   Penta D: 9.1,11
ST   Penta E: 16,23
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 15,19
DI   NCIt; C3276; Vestibular schwannoma
DI   ORDO; Orphanet_252175; Vestibular schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   JEI-002
AC   CVCL_E7HB
SY   Jiaotong Ear Institute-002
RX   Patent=CN114807043A;
RX   PubMed=35359340;
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Lys80Lys (c.240G>A); ClinVar=VCV000451710; Zygosity=Heterozygous; Note=Has an effect on splicing (PubMed=35359340).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=35359340
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 19,21
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 13,18
ST   D19S433: 13.2,14
ST   D21S11: 30,32.2
ST   D2S1338: 18,25
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D6S1043: 11,22
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 14,21
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C3276; Vestibular schwannoma
DI   ORDO; Orphanet_252175; Vestibular schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   JEK
AC   CVCL_E7Z2
SY   Japanese Eel Kidney
RX   DOI=10.2331/suisan.50.1617;
WW   Info; KAKEN; 60560207; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-60560207/
CC   Group: Fish cell line.
CC   Characteristics: Can grow at temperatures ranging from 15 to 30 Celsius (KAKEN=60560207).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JeKo-1
AC   CVCL_1865
SY   Jeko-1; JEKO-1; JeKo 1; Jeko1; JEKO1; JEKO
DR   BTO; BTO_0006444
DR   EFO; EFO_0005387
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-3006
DR   BioGRID_ORCS_Cell_line; 1542
DR   BioSample; SAMN01821569
DR   BioSample; SAMN01821639
DR   BioSample; SAMN03473289
DR   BioSample; SAMN10988454
DR   cancercelllines; CVCL_1865
DR   CCRID; 3101HUMTCHu194
DR   Cell_Model_Passport; SIDM01038
DR   ChEMBL-Cells; CHEMBL4295383
DR   ChEMBL-Targets; CHEMBL4296445
DR   CLS; 305078
DR   Cosmic; 1047110
DR   Cosmic; 1881781
DR   Cosmic; 2088016
DR   Cosmic; 2296999
DR   Cosmic; 2756237
DR   Cosmic-CLP; 1327765
DR   DepMap; ACH-000357
DR   DSMZ; ACC-553
DR   DSMZCellDive; ACC-553
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1327765
DR   GEO; GSM95563
DR   GEO; GSM104460
DR   GEO; GSM119537
DR   GEO; GSM155081
DR   GEO; GSM155082
DR   GEO; GSM155083
DR   GEO; GSM629490
DR   GEO; GSM629491
DR   GEO; GSM887168
DR   GEO; GSM888240
DR   GEO; GSM907519
DR   GEO; GSM1044966
DR   GEO; GSM1044967
DR   GEO; GSM1044968
DR   GEO; GSM1044969
DR   GEO; GSM1374577
DR   GEO; GSM1669949
DR   GEO; GSM2322619
DR   GEO; GSM3150246
DR   IARC_TP53; 25017
DR   LiGeA; CCLE_844
DR   Lonza; 1060
DR   PharmacoDB; JeKo1_678_2019
DR   PRIDE; PXD004746
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1865
DR   PubChem_Cell_line; CVCL_1865
DR   Wikidata; Q54898569
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9753063;
RX   PubMed=12683869;
RX   PubMed=16448697;
RX   PubMed=16960149;
RX   PubMed=17332242;
RX   PubMed=21746927;
RX   PubMed=22460905;
RX   PubMed=25315077;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26194763;
RX   PubMed=26439697;
RX   PubMed=27397505;
RX   PubMed=27697772;
RX   PubMed=28196595;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Korean.
CC   Doubling time: 33 hours (PubMed=9753063); 26 hours (PubMed=25315077); 26.1 +- 1.1 hours (PubMed=26439697); ~50 hours (DSMZ=ACC-553).
CC   HLA typing: A*02:06,11:01; B*51:01,51:01; C*14:02,14:02; DQA1*03:02,03:02; DQB1*04:01,04:01; DRB1*04:05,14:103 (PubMed=25960936).
CC   HLA typing: A*02; B*51; C*14 (PubMed=25688540).
CC   HLA typing: A*02:06:01,02:06:01; B*51:01:01,51:01:01; C*14:02:01,14:02:01; DPA1*02:02:02,02:02:02; DPB1*05:01:01,05:01:01; DQA1*03:03:01,03:03:01; DQB1*04:01:01,04:01:01; DRA*01:01:01,01:01:01; DRB1*04:05:01,04:05:01 (DSMZCellDive=ACC-553).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=16448697).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=16448697).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro58Glnfs*65 (c.173delC); ClinVar=VCV001394451; Zygosity=Heterozygous (PubMed=16448697).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.41%; Native American=0%; East Asian, North=63.65%; East Asian, South=31.67%; South Asian=0%; European, North=0%; European, South=2.27% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3006; CCRID=3101HUMTCHu194; Cosmic-CLP=1327765; DSMZ=ACC-553; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 13
ST   D21S11: 30,33.2
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 21,24
ST   Penta D: 12
ST   Penta E: 17,21
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   JEKO-1 R
AC   CVCL_HF56
DR   Wikidata; Q54898570
RX   PubMed=26439697;
CC   Population: Korean.
CC   Doubling time: 20.5 +- 1.2 hours (PubMed=26439697).
CC   Selected for resistance to: ChEBI; CHEBI_91385; PF-00477736.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro58Glnfs*65 (c.173delC); ClinVar=VCV001394451; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1865 ! JeKo-1
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   JEM493
AC   CVCL_RP37
DR   ABM; T8260
DR   cancercelllines; CVCL_RP37
DR   Wikidata; Q54898571
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000160364; Zygosity=Homozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:17087; ICOSLG; Simple; p.Glu153Ter (c.457G>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,19
ST   D21S11: 28,29
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 12
ST   D8S1179: 11,14
ST   FGA: 19,24
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   Jenny
AC   CVCL_0D15
SY   JENNY; JEN
DR   Wikidata; Q54898572
RX   PubMed=11467477;
RX   PubMed=12944992;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   Jensen sarcoma
AC   CVCL_3531
SY   Jensen Sarcoma; Jensen
DR   CLO; CLO_0007018
DR   CLDB; cl2938
DR   CLDB; cl2939
DR   ATCC; CCL-45
DR   ChEMBL-Cells; CHEMBL3307260
DR   ChEMBL-Targets; CHEMBL613511
DR   ECACC; 90111913
DR   IZSLER; BS TCL 31
DR   PubChem_Cell_line; CVCL_3531
DR   Wikidata; Q54898573
RX   PubMed=5765412;
CC   Characteristics: Used in studies of amino acid requirements and L-asparagine metabolism (IZSLER=BS TCL 31).
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   JES3-19F1.1.1
AC   CVCL_9187
DR   CLO; CLO_0007019
DR   ATCC; HB-10487
DR   Wikidata; Q54898574
RX   Patent=US5231012;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10487.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P22301; Human IL10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   JESTHOM
AC   CVCL_E716
SY   JestThom; JES THOM; JThom
DR   dbMHC; 48915
DR   ECACC; 88052004
DR   IHW; IHW09004
DR   IPD-IMGT/HLA; 11635
DR   Wikidata; Q54898575
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Scandinavian.
CC   HLA typing: A*02:01:01:01; B*27:05:02; C*01:02:01; DPA1*01; DPB1*04:01:01; DQA1*01:01; DQB1*05:01:01; DRA*01:01; DRB1*01:01:01; DRB6*01:01 (IPD-IMGT/HLA=11635).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5UW ! LG-2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 19
//
ID   JEV_1
AC   CVCL_A0IH
SY   J5
DR   Wikidata; Q108820558
RX   Patent=KR101364130B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00258.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27395; Japanese encephalitis virus (JEV) polyprotein (Note=AA 1-105 = Capsid protein C).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   JEV_2
AC   CVCL_A0II
SY   J17
DR   Wikidata; Q108820559
RX   Patent=KR101364130B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00259.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27395; Japanese encephalitis virus (JEV) polyprotein (Note=AA 1-105 = Capsid protein C).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   JF
AC   CVCL_R878
SY   Jarbua Fin
DR   Wikidata; Q54898577
RX   CelloPub=CLPUB00059;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=163131; ! Terapon jarbua (Jarbua terapon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   JF1
AC   CVCL_L879
DR   CLO; CLO_0007020
DR   CLDB; cl2940
DR   Wikidata; Q54898578
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3531 ! Jensen sarcoma
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   JF11
AC   CVCL_E5QF
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JF186
AC   CVCL_D3UN
DR   Wikidata; Q127382399
RX   PubMed=2824821;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8AZK7; Epstein-Barr virus (strain B95-8) nuclear antigen 5 (EBNA-5/EBNA-LP) (Note=Reacts with many different strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 3
//
ID   JF5
AC   CVCL_V085
DR   CLO; CLO_0007021
DR   CLDB; cl2941
DR   IHW; 11w 8005
DR   Wikidata; Q54898579
RX   PubMed=3894226;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*11).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K237 ! J27.2
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   JFCF-6
AC   CVCL_4418
SY   JFCF6; Jejunal Fibroblast Cystic Fibrosis-6
DR   Wikidata; Q54898580
RX   PubMed=19935656;
RX   PubMed=20143388;
RX   PubMed=22829774;
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
ST   Source(s): PubMed=20143388
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JFCF-6/T.1D
AC   CVCL_4419
SY   JFCF-6/T1.D
DR   Wikidata; Q54898581
RX   PubMed=20143388;
RX   PubMed=22829774;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0044 but was never intended to be distributed.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
ST   Source(s): PubMed=20143388
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 13
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 14
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   JFCF-6/T.1J/1.3C
AC   CVCL_4420
SY   JFCF-6/T.1J/1-3C; JFCF-6/T1.J/1.3C; JFCF6/T.1J/1.3C; JFCF6-3C
DR   Wikidata; Q54898582
RX   PubMed=20143388;
RX   PubMed=22829774;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0042 but was never intended to be distributed.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
ST   Source(s): PubMed=20143388
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   JFCF-6/T.1J/11E
AC   CVCL_4422
SY   JFCF6-T.1J/11E
DR   Wikidata; Q54898583
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JFCF-6/T.1J/1D
AC   CVCL_4421
DR   Wikidata; Q54898587
RX   PubMed=19468068;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   JFCF-6/T.1J/5H
AC   CVCL_4423
DR   Wikidata; Q54898588
RX   PubMed=22829774;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0043 but was never intended to be distributed.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JFCF-6/T.1J/6B
AC   CVCL_4424
SY   JFCF-6/T1.J/6B; JFCF6/T1.J/6B; JFCF6-6B
DR   Wikidata; Q54898589
RX   PubMed=19468068;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   JFCF-6/T.1L
AC   CVCL_4425
DR   Wikidata; Q54898590
RX   PubMed=22829774;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0045 but was never intended to be distributed.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JFCF-6/T.1M
AC   CVCL_4426
DR   Wikidata; Q54898591
RX   PubMed=22829774;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0046 but was never intended to be distributed.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JFCF-6/T.1P
AC   CVCL_RW27
SY   JFCF-6/T.1/P
DR   Wikidata; Q54898592
RX   PubMed=19935656;
RX   PubMed=26001292;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   JFCF-6/T.1Q
AC   CVCL_4427
SY   JFCF-6/T1.Q
DR   Wikidata; Q54898593
RX   PubMed=20143388;
RX   PubMed=22829774;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0047 but was never intended to be distributed.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
ST   Source(s): PubMed=20143388
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 19
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   JFCF-6/T.1R
AC   CVCL_4428
DR   Wikidata; Q54898594
RX   PubMed=19935656;
RX   PubMed=22829774;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0041 but was never intended to be distributed.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   JFCF-6/T.5B
AC   CVCL_4430
DR   Wikidata; Q54898595
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   JFCF-6/T.5K
AC   CVCL_RW28
DR   Wikidata; Q54898596
RX   PubMed=26001292;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   JFCF-6/T22.5M
AC   CVCL_4429
SY   JFCF6/T22.5M
DR   Wikidata; Q54898597
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   JFCR-OCCA-1
AC   CVCL_A1ID
DR   Wikidata; Q102114310
RX   DOI=10.5795/jjscc.30.473;
CC   Population: Japanese.
CC   Doubling time: ~53 hours (DOI=10.5795/jjscc.30.473).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the originating institute (Japanese Foundation for Cancer Research) and cell line description (ovarian clear cell adenocarcinoma).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   JFE-21
AC   CVCL_E6ME
RX   PubMed=39878900;
CC   Population: Japanese.
CC   Doubling time: 55.8 +- 7.0 hours (PubMed=39878900).
CC   Karyotypic information: Near tetraploid karytotype (PubMed=39878900).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=39878900
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 29,30
ST   D3S1358: 14,17
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 5,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   JFEN
AC   CVCL_X151
SY   CB-JFEN
DR   Wikidata; Q54898598
RX   PubMed=2841669;
RX   PubMed=8577710;
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=8577710).
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,18
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 20,24
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 20,25
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3789; Olfactory neuroblastoma
DI   ORDO; Orphanet_1957; Esthesioneuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   JFF07-1
AC   CVCL_R909
SY   Japanese Flounder Fin 07-1
DR   Wikidata; Q54898599
RX   DOI=10.3147/jsfp.46.11;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   JFHZ1
AC   CVCL_AS33
SY   JF10
DR   SKIP; SKIP004454
DR   WiCell; jfhz1
DR   Wikidata; Q54898600
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfhz1).
CC   Discontinued: WiCell; jfhz1; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS34 ! JFHZ2
OI   CVCL_AS35 ! JFHZ3
OI   CVCL_UA40 ! JFHZ4
OI   CVCL_UA41 ! JFHZ5
OI   CVCL_UA42 ! JFHZ6
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   JFHZ2
AC   CVCL_AS34
DR   SKIP; SKIP004452
DR   WiCell; jfhz2
DR   Wikidata; Q54898601
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfhz2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS33 ! JFHZ1
OI   CVCL_AS35 ! JFHZ3
OI   CVCL_UA40 ! JFHZ4
OI   CVCL_UA41 ! JFHZ5
OI   CVCL_UA42 ! JFHZ6
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   JFHZ3
AC   CVCL_AS35
DR   SKIP; SKIP004453
DR   WiCell; jfhz3
DR   Wikidata; Q54898602
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfhz3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS33 ! JFHZ1
OI   CVCL_AS34 ! JFHZ2
OI   CVCL_UA40 ! JFHZ4
OI   CVCL_UA41 ! JFHZ5
OI   CVCL_UA42 ! JFHZ6
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   JFHZ4
AC   CVCL_UA40
DR   WiCell; jfhz4
DR   Wikidata; Q94327666
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfhz4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS33 ! JFHZ1
OI   CVCL_AS34 ! JFHZ2
OI   CVCL_AS35 ! JFHZ3
OI   CVCL_UA41 ! JFHZ5
OI   CVCL_UA42 ! JFHZ6
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   JFHZ5
AC   CVCL_UA41
DR   WiCell; jfhz5
DR   Wikidata; Q94327671
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfhz5).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS33 ! JFHZ1
OI   CVCL_AS34 ! JFHZ2
OI   CVCL_AS35 ! JFHZ3
OI   CVCL_UA40 ! JFHZ4
OI   CVCL_UA42 ! JFHZ6
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   JFHZ6
AC   CVCL_UA42
DR   WiCell; jfhz6
DR   Wikidata; Q94327675
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfhz6).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS33 ! JFHZ1
OI   CVCL_AS34 ! JFHZ2
OI   CVCL_AS35 ! JFHZ3
OI   CVCL_UA40 ! JFHZ4
OI   CVCL_UA41 ! JFHZ5
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   JFMD1
AC   CVCL_AS36
DR   SKIP; SKIP004459
DR   WiCell; jfmd1
DR   Wikidata; Q54898603
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Asp295Glyfs*45 (c.879_883dupGACAG); Zygosity=Heterozygous (WiCell=jfmd1).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Unexplicit; Ex52del; Zygosity=Heterozygous (WiCell=jfmd1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS37 ! JFMD2
OI   CVCL_AS38 ! JFMD3
OI   CVCL_AS39 ! JFMD4
OI   CVCL_AS40 ! JFMD5
OI   CVCL_UA43 ! JFMD6
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   JFMD2
AC   CVCL_AS37
DR   SKIP; SKIP004457
DR   WiCell; jfmd2
DR   Wikidata; Q54898604
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Asp295Glyfs*45 (c.879_883dupGACAG); Zygosity=Heterozygous (WiCell=jfmd2).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Unexplicit; Ex52del; Zygosity=Heterozygous (WiCell=jfmd2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS36 ! JFMD1
OI   CVCL_AS38 ! JFMD3
OI   CVCL_AS39 ! JFMD4
OI   CVCL_AS40 ! JFMD5
OI   CVCL_UA43 ! JFMD6
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   JFMD3
AC   CVCL_AS38
DR   SKIP; SKIP004458
DR   WiCell; jfmd3
DR   Wikidata; Q54898605
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Asp295Glyfs*45 (c.879_883dupGACAG); Zygosity=Heterozygous (WiCell=jfmd3).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Unexplicit; Ex52del; Zygosity=Heterozygous (WiCell=jfmd3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS36 ! JFMD1
OI   CVCL_AS37 ! JFMD2
OI   CVCL_AS39 ! JFMD4
OI   CVCL_AS40 ! JFMD5
OI   CVCL_UA43 ! JFMD6
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   JFMD4
AC   CVCL_AS39
DR   SKIP; SKIP004456
DR   WiCell; jfmd4
DR   Wikidata; Q54898606
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Asp295Glyfs*45 (c.879_883dupGACAG); Zygosity=Heterozygous (WiCell=jfmd4).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Unexplicit; Ex52del; Zygosity=Heterozygous (WiCell=jfmd4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS36 ! JFMD1
OI   CVCL_AS37 ! JFMD2
OI   CVCL_AS38 ! JFMD3
OI   CVCL_AS40 ! JFMD5
OI   CVCL_UA43 ! JFMD6
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   JFMD5
AC   CVCL_AS40
DR   SKIP; SKIP004460
DR   WiCell; jfmd5
DR   Wikidata; Q54898607
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Asp295Glyfs*45 (c.879_883dupGACAG); Zygosity=Heterozygous (WiCell=jfmd5).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Unexplicit; Ex52del; Zygosity=Heterozygous (WiCell=jfmd5).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS36 ! JFMD1
OI   CVCL_AS37 ! JFMD2
OI   CVCL_AS38 ! JFMD3
OI   CVCL_AS39 ! JFMD4
OI   CVCL_UA43 ! JFMD6
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   JFMD6
AC   CVCL_UA43
DR   WiCell; jfmd6
DR   Wikidata; Q94327747
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Asp295Glyfs*45 (c.879_883dupGACAG); Zygosity=Heterozygous (WiCell=jfmd6).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Unexplicit; Ex52del; Zygosity=Heterozygous (WiCell=jfmd6).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS36 ! JFMD1
OI   CVCL_AS37 ! JFMD2
OI   CVCL_AS38 ! JFMD3
OI   CVCL_AS39 ! JFMD4
OI   CVCL_AS40 ! JFMD5
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   JFNY1
AC   CVCL_AS41
SY   JF25
DR   SKIP; SKIP004455
DR   WiCell; jfny1
DR   Wikidata; Q54898608
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Ser1173Phefs*2 (c.3517dupT) (p.Ser1191Phefs*2, c.3571dupT); ClinVar=VCV000370730; Zygosity=Heterozygous (WiCell=jfny1).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfny1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UA44 ! JFNY2
OI   CVCL_UA45 ! JFNY3
OI   CVCL_UA46 ! JFNY4
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   JFNY2
AC   CVCL_UA44
DR   WiCell; jfny2
DR   Wikidata; Q94327758
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Ser1173Phefs*2 (c.3517dupT) (p.Ser1191Phefs*2, c.3571dupT); ClinVar=VCV000370730; Zygosity=Heterozygous (WiCell=jfny2).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfny2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS41 ! JFNY1
OI   CVCL_UA45 ! JFNY3
OI   CVCL_UA46 ! JFNY4
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   JFNY3
AC   CVCL_UA45
DR   WiCell; jfny3
DR   Wikidata; Q94327761
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Ser1173Phefs*2 (c.3517dupT) (p.Ser1191Phefs*2, c.3571dupT); ClinVar=VCV000370730; Zygosity=Heterozygous (WiCell=jfny3).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfny3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS41 ! JFNY1
OI   CVCL_UA44 ! JFNY2
OI   CVCL_UA46 ! JFNY4
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   JFNY4
AC   CVCL_UA46
DR   WiCell; jfny4
DR   Wikidata; Q94327765
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Ser1173Phefs*2 (c.3517dupT) (p.Ser1191Phefs*2, c.3571dupT); ClinVar=VCV000370730; Zygosity=Heterozygous (WiCell=jfny4).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1905Ter (c.5713C>T) (p.Arg1944Ter, c.5830C>T); ClinVar=VCV000006676; Zygosity=Heterozygous (WiCell=jfny4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS41 ! JFNY1
OI   CVCL_UA44 ! JFNY2
OI   CVCL_UA45 ! JFNY3
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   JFP-J1
AC   CVCL_C478
DR   CLO; CLO_0050521
DR   RCB; RCB2309
DR   Wikidata; Q54898609
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   JFP-J5
AC   CVCL_C479
DR   CLO; CLO_0050524
DR   RCB; RCB2310
DR   Wikidata; Q54898610
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   JFP-K2
AC   CVCL_C480
DR   CLO; CLO_0050522
DR   RCB; RCB2311
DR   Wikidata; Q54898611
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   JFRBi1
AC   CVCL_AS42
DR   SKIP; SKIP004462
DR   WiCell; jfrbi1
DR   Wikidata; Q54898612
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Glu1833Ter (c.5497G>T) (p.Glu1872Ter, c.5614G>T); ClinVar=VCV000094339; Zygosity=Heterozygous (WiCell=jfrbi1).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.6063+1G>A (c.5946+1G>A); ClinVar=VCV000094349; Zygosity=Heterozygous; Note=Splice donor mutation (WiCell=jfrbi1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS43 ! JFRBi2
OI   CVCL_AS44 ! JFRBi3
OI   CVCL_AS45 ! JFRBi4
OI   CVCL_UA47 ! JFRBi5
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 18
//
ID   JFRBi2
AC   CVCL_AS43
DR   SKIP; SKIP004463
DR   WiCell; jfrbi2
DR   Wikidata; Q54898613
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Glu1833Ter (c.5497G>T) (p.Glu1872Ter, c.5614G>T); ClinVar=VCV000094339; Zygosity=Heterozygous (WiCell=jfrbi2).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.6063+1G>A (c.5946+1G>A); ClinVar=VCV000094349; Zygosity=Heterozygous; Note=Splice donor mutation (WiCell=jfrbi2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS42 ! JFRBi1
OI   CVCL_AS44 ! JFRBi3
OI   CVCL_AS45 ! JFRBi4
OI   CVCL_UA47 ! JFRBi5
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 18
//
ID   JFRBi3
AC   CVCL_AS44
DR   SKIP; SKIP004464
DR   WiCell; jfrbi3
DR   Wikidata; Q54898614
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Glu1833Ter (c.5497G>T) (p.Glu1872Ter, c.5614G>T); ClinVar=VCV000094339; Zygosity=Heterozygous (WiCell=jfrbi3).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.6063+1G>A (c.5946+1G>A); ClinVar=VCV000094349; Zygosity=Heterozygous; Note=Splice donor mutation (WiCell=jfrbi3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS42 ! JFRBi1
OI   CVCL_AS43 ! JFRBi2
OI   CVCL_AS45 ! JFRBi4
OI   CVCL_UA47 ! JFRBi5
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 18
//
ID   JFRBi4
AC   CVCL_AS45
DR   SKIP; SKIP004461
DR   WiCell; jfrbi4
DR   Wikidata; Q54898615
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Glu1833Ter (c.5497G>T) (p.Glu1872Ter, c.5614G>T); ClinVar=VCV000094339; Zygosity=Heterozygous (WiCell=jfrbi4).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.6063+1G>A (c.5946+1G>A); ClinVar=VCV000094349; Zygosity=Heterozygous; Note=Splice donor mutation (WiCell=jfrbi4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS42 ! JFRBi1
OI   CVCL_AS43 ! JFRBi2
OI   CVCL_AS44 ! JFRBi3
OI   CVCL_UA47 ! JFRBi5
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 18
//
ID   JFRBi5
AC   CVCL_UA47
DR   WiCell; jfrbi5
DR   Wikidata; Q94327834
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Glu1833Ter (c.5497G>T) (p.Glu1872Ter, c.5614G>T); ClinVar=VCV000094339; Zygosity=Heterozygous (WiCell=jfrbi5).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.6063+1G>A (c.5946+1G>A); ClinVar=VCV000094349; Zygosity=Heterozygous; Note=Splice donor mutation (WiCell=jfrbi5).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS42 ! JFRBi1
OI   CVCL_AS43 ! JFRBi2
OI   CVCL_AS44 ! JFRBi3
OI   CVCL_AS45 ! JFRBi4
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   JFSK_alb
AC   CVCL_A8VZ
SY   Japanese flounder SKin_albino
DR   Wikidata; Q108820560
RX   PubMed=28698966;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 18 to 30 Celsius, the optimal temperature is 24 Celsius (PubMed=28698966).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Albinos.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   JFSP
AC   CVCL_C5WP
SY   Japanese Flounder SPleen
DR   Wikidata; Q116049601
RX   PubMed=36552207;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 11 to 29 Celsius (PubMed=36552207).
CC   Virology: Susceptible to infection by Bohle virus (BIV), viral hemorrhagic septicemia virus (VHSV), hirame rhabdovirus (HIRRV), infectious hematopoietic necrosis virus (IHNV) and lymphocystis disease virus (LCDV) (PubMed=36552207).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 5
//
ID   JFSK_wt
AC   CVCL_A8WA
SY   Japanese flounder SKin_wild type
DR   Wikidata; Q108820561
RX   PubMed=28698966;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 18 to 30 Celsius, the optimal temperature is 24 Celsius (PubMed=28698966).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   JFWT1
AC   CVCL_AS46
DR   SKIP; SKIP004466
DR   WiCell; jfwt1
DR   Wikidata; Q54898616
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS47 ! JFWT2
OI   CVCL_AS48 ! JFWT3
OI   CVCL_UA37 ! JFWT4
OI   CVCL_UA38 ! JFWT5
OI   CVCL_UA39 ! JFWT6
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 12
//
ID   JFWT2
AC   CVCL_AS47
DR   SKIP; SKIP004467
DR   WiCell; jfwt2
DR   Wikidata; Q54898617
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS46 ! JFWT1
OI   CVCL_AS48 ! JFWT3
OI   CVCL_UA37 ! JFWT4
OI   CVCL_UA38 ! JFWT5
OI   CVCL_UA39 ! JFWT6
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 12
//
ID   JFWT3
AC   CVCL_AS48
DR   SKIP; SKIP004465
DR   WiCell; jfwt3
DR   Wikidata; Q54898618
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS46 ! JFWT1
OI   CVCL_AS47 ! JFWT2
OI   CVCL_UA37 ! JFWT4
OI   CVCL_UA38 ! JFWT5
OI   CVCL_UA39 ! JFWT6
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 12
//
ID   JFWT4
AC   CVCL_UA37
DR   WiCell; jfwt4
DR   Wikidata; Q94327884
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS46 ! JFWT1
OI   CVCL_AS47 ! JFWT2
OI   CVCL_AS48 ! JFWT3
OI   CVCL_UA38 ! JFWT5
OI   CVCL_UA39 ! JFWT6
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   JFWT5
AC   CVCL_UA38
DR   WiCell; jfwt5
DR   Wikidata; Q94327888
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS46 ! JFWT1
OI   CVCL_AS47 ! JFWT2
OI   CVCL_AS48 ! JFWT3
OI   CVCL_UA37 ! JFWT4
OI   CVCL_UA39 ! JFWT6
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   JFWT6
AC   CVCL_UA39
DR   WiCell; jfwt6
DR   Wikidata; Q94327892
CC   From: Jain Foundation; Seattle; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS46 ! JFWT1
OI   CVCL_AS47 ! JFWT2
OI   CVCL_AS48 ! JFWT3
OI   CVCL_UA37 ! JFWT4
OI   CVCL_UA38 ! JFWT5
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   JG1.1.20
AC   CVCL_KB75
SY   JG1; JG1.2
DR   DSHB; JG1-1-20
DR   Wikidata; Q54898619
RX   PubMed=9466573;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: Human addressin (PNAd).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   JG2/1
AC   CVCL_T960
SY   JG2.1; IO/JG2/1
DR   Wikidata; Q54898620
RX   DOI=10.1007/978-1-4757-9489-2_46;
RX   Patent=US6878544;
RX   PubMed=8982103;
RX   PubMed=10734001;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1695.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Retinal endothelial cell; CL=CL_0002585.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   JG8
AC   CVCL_E5R8
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JGFP1
AC   CVCL_XF35
DR   cancercelllines; CVCL_XF35
DR   Wikidata; Q94327929
RX   PubMed=12154356;
CC   Population: Caucasian.
CC   Characteristics: Expression of the eGFP reporter gene is under the control of four tandem copies of the NF-kappaB response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 13
//
ID   JGG
AC   CVCL_GU02
SY   Jining Grey Goat
DR   Wikidata; Q54898621
RX   DOI=10.3906/vet-1106-15;
CC   Doubling time: ~48 hours (DOI=10.3906/vet-1106-15).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Jining Grey; VBO=VBO_0009438.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Mixed sex
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   JGR 29
AC   CVCL_A2XB
DR   Wikidata; Q105509731
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on neurons and neurofibrillary tangles.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2XC ! JGR 38
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   JGR 38
AC   CVCL_A2XC
DR   Wikidata; Q105509734
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on neurons, glia and neurofibrillary tangles.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2XB ! JGR 29
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   JH
AC   CVCL_S102
DR   Wikidata; Q54898622
RX   PubMed=7073944;
CC   Doubling time: 35.7 hours (PubMed=7073944).
CC   Derived from site: In situ; Mesentery; UBERON=UBERON_0002095.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   JH-2/TPA
AC   CVCL_V634
SY   JH-2
DR   cancercelllines; CVCL_V634
DR   CCRID; 4201PAT-CCTCC00148
DR   Wikidata; Q54898623
RX   Patent=US7632677;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200006.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9051; PLAT.
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 22
//
ID   JH-EsoAd1
AC   CVCL_8098
SY   JHEsoAD1; JHesoAD1; JHESOAD1; EsoAd1; Johns Hopkins-Esophageal Adenocarcinoma 1
DR   BioSample; SAMN10988422
DR   cancercelllines; CVCL_8098
DR   Cell_Model_Passport; SIDM01731
DR   Cosmic; 1599340
DR   DepMap; ACH-000216
DR   PharmacoDB; JHEsoAd1_679_2019
DR   Wikidata; Q54898624
RX   PubMed=18787394;
RX   PubMed=18981730;
RX   PubMed=20075370;
RX   PubMed=23795680;
RX   PubMed=25984343;
RX   PubMed=27594985;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 20 hours (PubMed=18787394); 29 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Homozygous (PubMed=18787394; PubMed=20075370; DepMap=ACH-000216).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0.64%; Native American=0%; East Asian, North=1.94%; East Asian, South=0%; South Asian=0%; European, North=58.42%; European, South=38.99% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): PubMed=18787394; PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 12
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10
ST   FGA: 24
ST   Penta D: 14
ST   Penta E: 11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18,19 (PubMed=20075370)
ST   vWA: 19 (PubMed=18787394)
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   JH024
AC   CVCL_E279
SY   Pa43C
DR   Wikidata; Q54898625
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   JH029
AC   CVCL_E280
SY   Pa11C
DR   Wikidata; Q54898626
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   JH4
AC   CVCL_E5RY
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07240; Vaccinia virus eNvelope protein OPG108 (H3L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   JH4 clone 1
AC   CVCL_4229
SY   JH 4 clone 1
DR   CLO; CLO_0007022
DR   CLDB; cl2942
DR   CLDB; cl2943
DR   ATCC; CCL-158
DR   BCRJ; 0385
DR   ECACC; 86070201
DR   ECACC; 93120825
DR   IZSLER; BS CL 54
DR   Wikidata; Q54898631
RX   PubMed=7065527;
RX   PubMed=32226606;
CC   Senescence: Capable of at least 69 population doublings without showing overt signs of senescence (ECACC=86070201).
CC   Virology: Susceptible to infection and early propagation by guinea pig adenovirus (GPAdV) (PubMed=32226606).
CC   Discontinued: ECACC; 93120825; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Strain 13; VBO=VBO_0017523.
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   JHAF
AC   CVCL_E717
SY   JHF; JHA
DR   dbMHC; 48913
DR   ECACC; 88052030
DR   IHW; IHW09030
DR   IPD-IMGT/HLA; 10845
DR   Wikidata; Q54898632
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; English.
CC   HLA typing: A*31:01:02:01; B*51:01:01:01; C*15:02:01:01; DPA1*01:03; DPB1*03:01:01; DQA1*03:01; DQB1*03:01:01; DRB1*04:07:01/04:92; DRB4*01:03:01:01 (IPD-IMGT/HLA=10845).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Discontinued: ECACC; 88052030; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   JHC
AC   CVCL_M093
SY   JHCA
DR   BioSample; SAMN03151726
DR   Wikidata; Q54898633
RX   PubMed=11178;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=11178; PubMed=6451928; PubMed=20143388). Originally thought to be a normal placenta cell line.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00069.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   JHC-2
AC   CVCL_M097
DR   Wikidata; Q54898634
RX   PubMed=9168447;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   JHC7
AC   CVCL_L154
SY   Johns Hopkins Chordoma line 7
DR   ATCC; CRL-3267
DR   cancercelllines; CVCL_L154
DR   Cell_Model_Passport; SIDM01802
DR   Cosmic; 2663862
DR   DepMap; ACH-001955
DR   Wikidata; Q54898635
RX   CelloPub=CLPUB00390;
RX   PubMed=21699479;
RX   PubMed=27102572;
RX   PubMed=28835717;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/jhc7/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~5 days (PubMed=21699479); 3.5-4 days (Chordoma Foundation).
CC   HLA typing: A*24 (Chordoma Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Leu (c.638G>T); ClinVar=VCV000376650; Zygosity=Unspecified (DepMap=ACH-001955).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Anecdotal: Established in 2009 from a chordoma tumor sample originating from Susan L. Garbett who wrote about her successful fight against cancer in an autobiographical book (CelloPub=CLPUB00390).
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=CRL-3267; PubMed=27102572; PubMed=28835717
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13,13.2
ST   D21S11: 27,31.2
ST   D2S1338: 18,20
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 6,11
ST   Penta E: 15
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 25
//
ID   JHCA-ov
AC   CVCL_E075
DR   CLO; CLO_0050631
DR   BioSample; SAMN03472065
DR   RCB; RCB1705
DR   Wikidata; Q54898636
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): RCB=RCB1705
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   JHCOLOYI
AC   CVCL_E076
DR   CLO; CLO_0051400
DR   BioSample; SAMN03472066
DR   RCB; RCB1706
DR   Wikidata; Q54898637
CC   Population: Japanese.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): RCB=RCB1706
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   JHE
AC   CVCL_5I40
DR   Kerafast; EMN013-FP
DR   Wikidata; Q54898638
RX   PubMed=24582862;
CC   Doubling time: ~72 hours (Kerafast=EMN013-FP).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_5I41 ! JLI
OI   CVCL_5I42 ! JLU
OI   CVCL_RG68 ! JSP
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 12
//
ID   JHH-1
AC   CVCL_2785
SY   Jhh-1; JHH1
DR   CLO; CLO_0009990
DR   EFO; EFO_0006599
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 635
DR   BioSample; SAMN03473248
DR   BioSample; SAMN10987777
DR   cancercelllines; CVCL_2785
DR   Cell_Model_Passport; SIDM00618
DR   Cosmic; 1187334
DR   Cosmic; 1995460
DR   Cosmic; 2009536
DR   Cosmic; 2023872
DR   Cosmic-CLP; 1298151
DR   DepMap; ACH-000620
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298151
DR   GEO; GSM827297
DR   GEO; GSM887169
DR   GEO; GSM888241
DR   GEO; GSM936764
DR   GEO; GSM1669950
DR   GEO; GSM2551571
DR   IARC_TP53; 30080
DR   JCRB; JCRB1062
DR   JCRB; NIHS0056
DR   JCRB; NIHS0329
DR   LiGeA; CCLE_289
DR   LIMORE; JHH1
DR   LINCS_LDP; LCL-1928
DR   PharmacoDB; JHH1_680_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2785
DR   Wikidata; Q54898639
RX   CelloPub=CLPUB00469;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=1701409;
RX   PubMed=8835345;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=15767549;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/JHH1
CC   Problematic cell line: Partially contaminated. Some JCRB stocks were found to be from mouse (PubMed=20143388). Stock bought in 2013 was shown to be human by exome sequencing (personal communication of Rebouissou, Sandra).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00353.
CC   Population: Japanese.
CC   Doubling time: 44-50 hours (CelloPub=CLPUB00469); 21.99 hours (PubMed=31378681); ~55 hours (Note=Lot 03262008), ~53 hours (Note=Lot 05262011) (JCRB=JCRB1062).
CC   HLA typing: A*02:07,02:07; B*15:01,46:01; C*01:02,01:02; DQA1*01:02,03:02; DQB1*03:02,03:02; DRB1*11:02,15:30 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.93%; East Asian, South=18.06%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; JCRB1062; probable.
CC   Discontinued: JCRB; NIHS0056; true.
CC   Discontinued: JCRB; NIHS0329; true.
ST   Source(s): JCRB=JCRB1062; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D5S818: 11 (JCRB=JCRB1062)
ST   D5S818: 11,13 (PubMed=31378681)
ST   D7S820: 9
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   JHH-136
AC   CVCL_VT28
DR   Wikidata; Q94328131
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 29,30
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-2
AC   CVCL_2786
SY   Jhh-2; JHH2
DR   CLO; CLO_0009991
DR   EFO; EFO_0006600
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473249
DR   BioSample; SAMN10988364
DR   cancercelllines; CVCL_2786
DR   Cell_Model_Passport; SIDM00617
DR   Cosmic; 1995461
DR   Cosmic; 2023873
DR   Cosmic-CLP; 1240157
DR   DepMap; ACH-000577
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240157
DR   GEO; GSM827249
DR   GEO; GSM887170
DR   GEO; GSM888242
DR   GEO; GSM936765
DR   GEO; GSM1669951
DR   GEO; GSM2551572
DR   IARC_TP53; 30081
DR   JCRB; JCRB1028
DR   JCRB; NIHS0058
DR   LiGeA; CCLE_333
DR   LIMORE; JHH2
DR   LINCS_LDP; LCL-1929
DR   PharmacoDB; JHH2_681_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2786
DR   Wikidata; Q54898640
RX   CelloPub=CLPUB00469;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=1701409;
RX   PubMed=8835345;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/JHH2
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 150 hours (CelloPub=CLPUB00469); 60.12 hours (PubMed=31378681); 35-70 hours (Note=Lot 01222008), ~2 days (Note=Lot 11022010), ~33 hours (Note=Lot 09072011), ~59 hours (Note=Lot 05022018) (JCRB=JCRB1028).
CC   HLA typing: A*24:02,26:01; B*52:01,67:02; C*08:01,12:02; DQA1*03:02,03:02; DQB1*06:07,06:07; DRB1*11:09,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (PubMed=31378681; DepMap=ACH-000577).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.375+2T>G (IVS4+2T>G); ClinVar=VCV000482210; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=31378681; Cosmic-CLP=1240157; DepMap=ACH-000577).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.15%; Native American=0.24%; East Asian, North=82.5%; East Asian, South=16.41%; South Asian=0%; European, North=0%; European, South=0.7% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0058; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1240157; JCRB=JCRB1028; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 13
ST   D21S11: 29,32.2
ST   D3S1358: 17
ST   D5S818: 9,13
ST   D7S820: 10
ST   D8S1179: 11,16
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 21
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   JHH-211
AC   CVCL_VT29
DR   Wikidata; Q94328147
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 12
ST   D21S11: 30,31
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-227
AC   CVCL_VT30
DR   Wikidata; Q94328152
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right periatrial region.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,14
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 17,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-245
AC   CVCL_VT31
DR   Wikidata; Q94328155
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 9,11
ST   D21S11: 30
ST   D5S818: 10,14
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-4
AC   CVCL_2787
SY   Jhh-4; JHH4
DR   CLO; CLO_0009992
DR   EFO; EFO_0006601
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 634
DR   BioSample; SAMN03473220
DR   BioSample; SAMN10987774
DR   cancercelllines; CVCL_2787
DR   Cell_Model_Passport; SIDM00616
DR   Cosmic; 1187335
DR   Cosmic; 1995462
DR   Cosmic; 2009537
DR   Cosmic; 2023874
DR   Cosmic-CLP; 1240158
DR   DepMap; ACH-000476
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240158
DR   GEO; GSM827207
DR   GEO; GSM887171
DR   GEO; GSM888243
DR   GEO; GSM936766
DR   GEO; GSM1669952
DR   GEO; GSM2551573
DR   IARC_TP53; 28299
DR   JCRB; JCRB0435
DR   JCRB; NIHS0057
DR   LiGeA; CCLE_566
DR   LIMORE; JHH4
DR   LINCS_LDP; LCL-1930
DR   PharmacoDB; JHH4_682_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2787
DR   Wikidata; Q54898641
RX   CelloPub=CLPUB00469;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=1701409;
RX   PubMed=2543327;
RX   PubMed=2856444;
RX   PubMed=8835345;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/JHH4
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 55 hours (CelloPub=CLPUB00469); 32.99 hours (PubMed=31378681); ~40.5 hours (Note=Lot 04142005), ~32 hours (Note=Lot 01242022) (JCRB=JCRB0435).
CC   HLA typing: A*02:10,24:94; B*13:01,40:06; C*03:04,08:01; DQA1*02:01,03:02; DQB1*04:01,04:01; DRB1*04:05,04:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Cys78Ter (c.234T>A); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (Cosmic-CLP=1240158; DepMap=ACH-000476).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.12%; Native American=0%; East Asian, North=81.09%; East Asian, South=16.25%; South Asian=0%; European, North=0%; European, South=2.54% (PubMed=30894373).
CC   Caution: FLC-4 (Cellosaurus=CVCL_D204) is often stated to be synonymous with JHH-4, but a FLC-4 patent reference (Patent=US5804441) seems to indicate that it is derived from JHH-4 and has a different karyotype.
CC   Discontinued: JCRB; NIHS0057; true.
ST   Source(s): Cosmic-CLP=1240158; JCRB=JCRB0435; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   D8S1179: 17
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 5,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   JHH-5
AC   CVCL_0364
AS   CVCL_0263
SY   Jhh-5; JHH5; FLC-5; FLC5; Functional Liver Cell-5
DR   EFO; EFO_0006602
DR   MCCL; MCC:0000154
DR   MCCL; MCC:0000258
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 633
DR   BioSample; SAMN03473192
DR   BioSample; SAMN10987783
DR   cancercelllines; CVCL_0364
DR   Cell_Model_Passport; SIDM01569
DR   Cosmic; 2023875
DR   DepMap; ACH-000734
DR   EGA; EGAS00001000610
DR   GEO; GSM887172
DR   GEO; GSM888244
DR   GEO; GSM936767
DR   GEO; GSM2551574
DR   IARC_TP53; 28347
DR   JCRB; JCRB1029
DR   JCRB; NIHS0279
DR   LiGeA; CCLE_881
DR   LIMORE; JHH5
DR   PharmacoDB; JHH5_683_2019
DR   Progenetix; CVCL_0364
DR   Wikidata; Q54898642
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=1701409;
RX   PubMed=8835345;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=10933057;
RX   PubMed=17241388;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=36724073;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/JHH5
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 30.39 hours (PubMed=31378681); ~40 hours (Note=Lot 03112003), ~2 days (Note=Lot 03022011), ~29 hours (Note=Lot 09272018), ~1 day (Note=Lot 08252021) (JCRB=JCRB1029).
CC   HLA typing: A*24:02,24:02; B*08:01,67:02; C*01:02,12:02; DQA1*01:02,01:02; DQB1*03:02,03:02; DRB1*11:12,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Gln6Argfs*22 (c.17_18delAG); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700; PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190_His193del (c.569_580del12); Zygosity=Unspecified (DepMap=ACH-000734).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=0.04%; East Asian, North=81.84%; East Asian, South=17.72%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0279; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1029; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 13
ST   D21S11: 31.2
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 19
ST   Penta D: 11
ST   Penta E: 17,20
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   JHH-5-Luc
AC   CVCL_JF88
DR   JCRB; JCRB1638
DR   Wikidata; Q54898643
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Gln6Argfs*22 (c.17_18delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190_His193del (c.569_580del12); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1638
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 9
ST   D16S539: 9,10
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0364 ! JHH-5
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 16
//
ID   JHH-505
AC   CVCL_VT32
DR   Wikidata; Q94328201
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D21S11: 28,31
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 15,19
DI   NCIt; C3058; Glioblastoma
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_360; Glioblastoma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-520
AC   CVCL_VT33
DR   Wikidata; Q94328205
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-6
AC   CVCL_2788
SY   Jhh-6; JHH6
DR   CLO; CLO_0009993
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472917
DR   BioSample; SAMN10987997
DR   cancercelllines; CVCL_2788
DR   Cell_Model_Passport; SIDM00615
DR   Cosmic; 1995463
DR   Cosmic; 2023876
DR   Cosmic-CLP; 1240159
DR   DepMap; ACH-000217
DR   EGA; EGAS00001000978
DR   GDSC; 1240159
DR   GEO; GSM827199
DR   GEO; GSM887173
DR   GEO; GSM888245
DR   GEO; GSM936768
DR   GEO; GSM1669953
DR   GEO; GSM2551575
DR   IARC_TP53; 30082
DR   JCRB; JCRB1030
DR   JCRB; NIHS0280
DR   LiGeA; CCLE_137
DR   LIMORE; JHH6
DR   LINCS_HMS; 50021
DR   LINCS_LDP; LCL-1923
DR   PharmacoDB; JHH6_684_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2788
DR   Wikidata; Q54898644
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=1701409;
RX   PubMed=8835345;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=10933057;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/JHH6
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 22.32 hours (PubMed=31378681); ~30 hours (Note=Lot 03282003), ~21 hours (Note=Lot 05182017) (JCRB=JCRB1030).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700; PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Aspfs*7 (c.1008_1018delGCGCTTCGAGA); Zygosity=Heterozygous (PubMed=31378681; Cosmic-CLP=1240159; DepMap=ACH-000217).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.29%; East Asian, North=84.12%; East Asian, South=15.16%; South Asian=0%; European, North=0%; European, South=0.43% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0280; true.
ST   Source(s): Cosmic-CLP=1240159; JCRB=JCRB1030; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12,13
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 13
ST   D21S11: 31,32.2
ST   D2S1338: 19,24
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 15
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   JHH-66
AC   CVCL_VT34
DR   Wikidata; Q94328223
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-7
AC   CVCL_2805
SY   Jhh-7; JHH7; FLC-7; FLC7; Functional Liver Cell-7
DR   CLO; CLO_0009994
DR   EFO; EFO_0006603
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 632
DR   BioSample; SAMN03471923
DR   BioSample; SAMN10987656
DR   cancercelllines; CVCL_2805
DR   Cell_Model_Passport; SIDM00614
DR   Cosmic; 1187336
DR   Cosmic; 1995464
DR   Cosmic; 2023877
DR   Cosmic; 2771600
DR   Cosmic-CLP; 1240160
DR   DepMap; ACH-000848
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240160
DR   GEO; GSM887174
DR   GEO; GSM888246
DR   GEO; GSM936769
DR   GEO; GSM1669954
DR   GEO; GSM2551576
DR   IARC_TP53; 28292
DR   JCRB; JCRB1031
DR   JCRB; NIHS0281
DR   LiGeA; CCLE_125
DR   LIMORE; JHH7
DR   LINCS_LDP; LCL-1931
DR   PharmacoDB; JHH7_685_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2805
DR   Wikidata; Q54898645
RX   PubMed=1701409;
RX   PubMed=1707654;
RX   PubMed=2174476;
RX   PubMed=8835345;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=10933057;
RX   PubMed=17241388;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29892436;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/JHH7
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Virology: Contains 2 copies of integrated incomplete hepatitis B virus (HBV) genomes. Does not secrete hepatitis virus B surface antigen (HBsAg) (PubMed=1701409; PubMed=2174476).
CC   Doubling time: 26.4 hours (PubMed=1707654); 17.1 hours (PubMed=31378681); 30 hours (Note=Lot 06252008), ~29 hours (Note=Lot 10312012), ~26 hours (Note=Lot 01182016) (JCRB=JCRB1031).
CC   HLA typing: A*24:02,31:01; B*51:01,67:02; C*14:02,14:02; DQB1*06:01,06:01; DRB1*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700; PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Pro (c.800G>C); ClinVar=VCV000428867; Zygosity=Unspecified (PubMed=31378681; DepMap=ACH-000848).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=86.04%; East Asian, South=12.59%; South Asian=1.36%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0281; true.
ST   Source(s): Cosmic-CLP=1240160; JCRB=JCRB1031; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 17
ST   D21S11: 29,33.2
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 10,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   JHH-75
AC   CVCL_VT35
DR   Wikidata; Q94328243
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 31.2
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 10,12
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   JHH-DIPG-1
AC   CVCL_IT47
SY   JHH-DIPG-01; JHH-DIPG1; JHH DIPG1; JHH DIPG; Johns Hopkins Hospital-Diffuse Intrinsic Pontine Glioma-1
DR   cancercelllines; CVCL_IT47
DR   Wikidata; Q54898646
RX   PubMed=25939062;
RX   PubMed=26115193;
RX   PubMed=28947132;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062; PubMed=26115193).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   JHH_ONB_1903
AC   CVCL_ZU38
DR   Wikidata; Q98126792
RX   DOI=10.1055/s-0040-1702639;
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
DI   NCIt; C3789; Olfactory neuroblastoma
DI   ORDO; Orphanet_1957; Esthesioneuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   JHH_ONB_1904
AC   CVCL_ZU39
DR   Wikidata; Q98126793
RX   DOI=10.1055/s-0040-1702639;
CC   Derived from site: In situ; Brain, cranial cavity; UBERON=UBERON_0013411.
DI   NCIt; C3789; Olfactory neuroblastoma
DI   ORDO; Orphanet_1957; Esthesioneuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   JHJ
AC   CVCL_B6ZJ
DR   Wikidata; Q111733542
RX   Patent=CN113637642B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.22329.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_34692; Dicofol (Kelthane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   JHK-3
AC   CVCL_0U23
SY   JHK3
DR   ATCC; CRL-10991
DR   BioSample; SAMN03471325
DR   Wikidata; Q54898647
RX   Patent=US5545550;
RX   PubMed=9201810;
RX   PubMed=24159361;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10991.
CC   Virology: Infected by the JHK retrovirus (JHKV), a murine leukemia-related retrovirus.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient with a 3-year history of chronic fatigue syndrome (PubMed=9201810).
CC   Discontinued: ATCC; CRL-10991; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-10991
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 9
//
ID   JHOC-5
AC   CVCL_4640
SY   JHOC5
DR   CLO; CLO_0051439
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 631
DR   BioSample; SAMN03472149
DR   BioSample; SAMN10987704
DR   cancercelllines; CVCL_4640
DR   Cell_Model_Passport; SIDM01570
DR   Cosmic; 1066214
DR   Cosmic; 1223321
DR   Cosmic; 1328070
DR   Cosmic; 1708381
DR   Cosmic; 2074241
DR   Cosmic; 2582800
DR   DepMap; ACH-000324
DR   FANTOM5_SSTAR; 10638-108I8
DR   GEO; GSM887175
DR   GEO; GSM888247
DR   GEO; GSM1176277
DR   GEO; GSM2474976
DR   IARC_TP53; 30083
DR   LiGeA; CCLE_609
DR   PharmacoDB; JHOC5_686_2019
DR   Progenetix; CVCL_4640
DR   RCB; RCB1520
DR   Wikidata; Q54898648
RX   PubMed=10695020;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25846456;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28273451;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32612269;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=10695020); 30 hours (PubMed=25984343).
CC   HLA typing: A*02:01; B*35:01,46:01; C*01:02,03:03 (PubMed=25960936).
CC   HLA typing: A*02:07,02:07; B*35:01,46:01; C*01:02,03:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.38%; Native American=0%; East Asian, North=85.18%; East Asian, South=14.43%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): RCB=RCB1520
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 10
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   JHOC-6
AC   CVCL_M712
SY   JHOC6
DR   Wikidata; Q54898649
RX   PubMed=10695020;
CC   Population: Japanese.
CC   Doubling time: 70 hours (PubMed=10695020).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   JHOC-7
AC   CVCL_4641
SY   JHOC7
DR   CLO; CLO_0051445
DR   BioSample; SAMN03472120
DR   cancercelllines; CVCL_4641
DR   Cosmic; 1707562
DR   Cosmic; 2582797
DR   GEO; GSM1176278
DR   Progenetix; CVCL_4641
DR   RCB; RCB1688
DR   Wikidata; Q54898650
RX   PubMed=24023729;
RX   PubMed=25846456;
RX   PubMed=25960936;
CC   Population: Japanese.
CC   HLA typing: B*07:02,48:01; C*07:02,08:01 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Val540Leu (c.1618G>C) (G1606C); ClinVar=VCV000409741; Zygosity=Unspecified (PubMed=25846456).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=25846456).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): RCB=RCB1688
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   JHOC-8
AC   CVCL_4642
SY   JHOC8
DR   CLO; CLO_0051446
DR   BioSample; SAMN03472070
DR   cancercelllines; CVCL_4642
DR   Cosmic; 2582798
DR   RCB; RCB1723
DR   Wikidata; Q54898651
RX   PubMed=25846456;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Unspecified (PubMed=25846456).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25846456).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): RCB=RCB1723
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   JHOC-9
AC   CVCL_4643
SY   JHOC9
DR   CLO; CLO_0051447
DR   BioSample; SAMN03472024
DR   cancercelllines; CVCL_4643
DR   Cosmic; 1708380
DR   Cosmic; 2582796
DR   GEO; GSM1176279
DR   GEO; GSM2474977
DR   Progenetix; CVCL_4643
DR   RCB; RCB2226
DR   Wikidata; Q54898652
RX   PubMed=22705003;
RX   PubMed=24023729;
RX   PubMed=25846456;
RX   PubMed=25960936;
RX   PubMed=28273451;
CC   Population: Japanese.
CC   HLA typing: A*24:02,11:01; B*35:08,40:01; C*07:02,04:01; DRB1*08:01,08:01 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=22705003; PubMed=25846456; PubMed=28273451).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB2226
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   JHOM-1
AC   CVCL_4644
SY   JHOM1
DR   CLO; CLO_0051441
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 630
DR   BioSample; SAMN03472113
DR   BioSample; SAMN10987700
DR   cancercelllines; CVCL_4644
DR   Cell_Model_Passport; SIDM01571
DR   Cosmic; 1707566
DR   Cosmic; 2429299
DR   DepMap; ACH-000237
DR   FANTOM5_SSTAR; 10648-109A9
DR   GEO; GSM887176
DR   GEO; GSM888248
DR   IARC_TP53; 28337
DR   LiGeA; CCLE_746
DR   PharmacoDB; JHOM1_687_2019
DR   Progenetix; CVCL_4644
DR   RCB; RCB1676
DR   Wikidata; Q54898653
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=25984343).
CC   HLA typing: A*33:03,33:03; B*07:02,44:03; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (DepMap=ACH-000237).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.03%; Native American=0%; East Asian, North=82.29%; East Asian, South=16.67%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=30485824; RCB=RCB1676
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 10
ST   D7S820: 10.3,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   JHOM-2B
AC   CVCL_4645
SY   JHOM2B
DR   CLO; CLO_0051444
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472119
DR   BioSample; SAMN10987763
DR   cancercelllines; CVCL_4645
DR   Cell_Model_Passport; SIDM01730
DR   Cosmic; 2429300
DR   DepMap; ACH-000333
DR   GEO; GSM887177
DR   GEO; GSM888249
DR   IARC_TP53; 28284
DR   LiGeA; CCLE_567
DR   PharmacoDB; JHOM2B_688_2019
DR   Progenetix; CVCL_4645
DR   RCB; RCB1682
DR   Wikidata; Q54898655
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*26:01,26:01; B*35:01,35:01; C*03:03,03:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000333).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg552Ter (c.1654C>T); ClinVar=VCV000126840; Zygosity=Homozygous (DepMap=ACH-000333).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Phe (c.824G>T); ClinVar=VCV000376582; Zygosity=Homozygous (DepMap=ACH-000333).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.86%; Native American=0.7%; East Asian, North=79.5%; East Asian, South=18.16%; South Asian=0.74%; European, North=0%; European, South=0.04% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): RCB=RCB1682
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   JHONA
AC   CVCL_4646
DR   CLO; CLO_0051449
DR   BioSample; SAMN03471916
DR   RCB; RCB2365
DR   Wikidata; Q54898656
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB2365
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C40093; Ovarian squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   JHOS-2
AC   CVCL_4647
SY   JHOS2
DR   CLO; CLO_0051440
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 904
DR   BioSample; SAMN03472150
DR   BioSample; SAMN10988178
DR   cancercelllines; CVCL_4647
DR   Cell_Model_Passport; SIDM00305
DR   Cosmic; 1066215
DR   Cosmic-CLP; 1479995
DR   DepMap; ACH-000132
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10639-108I9
DR   GDSC; 1479995
DR   GEO; GSM711695
DR   GEO; GSM887178
DR   GEO; GSM888250
DR   GEO; GSM1669955
DR   IARC_TP53; 28295
DR   LiGeA; CCLE_154
DR   PharmacoDB; JHOS2_689_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_4647
DR   RCB; RCB1521
DR   Wikidata; Q54898657
RX   PubMed=10695020;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 61 hours (PubMed=10695020).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.767_782+4delTGACCTGGAGTCTTCCAGTG; Zygosity=Unspecified (Cosmic-CLP=1479995; DepMap=ACH-000132).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.18%; East Asian, North=83.51%; East Asian, South=14.94%; South Asian=0.69%; European, North=0%; European, South=0.68% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1479995; PubMed=30485824; RCB=RCB1521
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 13
ST   D21S11: 31,31.2
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   JHOS-3
AC   CVCL_4648
SY   JHOS3
DR   CLO; CLO_0051450
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472097
DR   cancercelllines; CVCL_4648
DR   Cell_Model_Passport; SIDM00304
DR   Cosmic-CLP; 1480358
DR   DepMap; ACH-002146
DR   EGA; EGAS00001000978
DR   GDSC; 1480358
DR   GEO; GSM1669956
DR   PharmacoDB; JHOS3_690_2019
DR   PRIDE; PXD030304
DR   RCB; RCB1546
DR   Wikidata; Q54898658
RX   PubMed=27397505;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.55%; East Asian, South=16.2%; South Asian=0.24%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1480358; PubMed=30485824; RCB=RCB1546
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 9,12
ST   D21S11: 29
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 9,11 (Cosmic-CLP=1480358; RCB=RCB1546)
ST   TPOX: 11 (PubMed=30485824)
ST   vWA: 18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   JHOS-4
AC   CVCL_4649
SY   JHOS4
DR   CLO; CLO_0051443
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 903
DR   BioSample; SAMN03472117
DR   BioSample; SAMN10987614
DR   cancercelllines; CVCL_4649
DR   Cell_Model_Passport; SIDM00303
DR   Cosmic-CLP; 1480359
DR   DepMap; ACH-000584
DR   EGA; EGAS00001000978
DR   GDSC; 1480359
DR   GEO; GSM887179
DR   GEO; GSM888251
DR   GEO; GSM1669957
DR   IARC_TP53; 28380
DR   LiGeA; CCLE_693
DR   PharmacoDB; JHOS4_691_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_4649
DR   RCB; RCB1678
DR   Wikidata; Q54898659
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 70 hours (PubMed=25984343).
CC   HLA typing: A*24:02,33:03; B*44:03,52:01; C*12:02,14:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val147Gly (c.440T>G); Zygosity=Homozygous (Cosmic-CLP=1480359; DepMap=ACH-000584).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.71%; Native American=0%; East Asian, North=82.16%; East Asian, South=13.28%; South Asian=1.31%; European, North=0%; European, South=2.54% (PubMed=30894373).
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): Cosmic-CLP=1480359; PubMed=30485824; RCB=RCB1678
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,10
ST   D21S11: 29,31.2
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 14
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   JHP-1
AC   CVCL_W523
DR   Wikidata; Q54898660
RX   PubMed=2979202;
CC   Population: Japanese.
CC   Doubling time: 22 hours (PubMed=2979202).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   JHPI-1 clone-16
AC   CVCL_1T11
SY   Clone-16
DR   BioSample; SAMN03152006
DR   Wikidata; Q54898661
RX   PubMed=2903855;
RX   PubMed=6125140;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from hamster (PubMed=2903855; PubMed=20143388). Originally thought to originate from fetal pancreatic islets.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00037.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   JHSK-rec
AC   CVCL_6661
DR   CLO; CLO_0051399
DR   BioSample; SAMN03472071
DR   RCB; RCB1724
DR   Wikidata; Q54898662
CC   Population: Japanese.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): RCB=RCB1724
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   JHT
AC   CVCL_M620
DR   BioSample; SAMN03151727
DR   Wikidata; Q54898663
RX   PubMed=11178;
RX   PubMed=1246601;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (JHC) has been shown to be a HeLa derivative (PubMed=11178; PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00070.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M093 ! JHC
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   JHTK-1
AC   CVCL_S903
DR   Wikidata; Q54898664
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=2556605;
RX   PubMed=3820395;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=3820395).
DI   NCIt; C7733; Testicular choriocarcinoma
DI   ORDO; Orphanet_363504; Germ cell tumor of testis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   JHTKI-col-L
AC   CVCL_H734
DR   CLO; CLO_0051048
DR   BioSample; SAMN03472094
DR   RCB; RCB1543
DR   Wikidata; Q54898665
CC   Population: Japanese.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): RCB=RCB1543
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 9,10,11
ST   D7S820: 10,11,12
ST   TH01: 6
ST   TPOX: 11,13
ST   vWA: 14,16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   JHTSK-col-L
AC   CVCL_E077
DR   CLO; CLO_0051049
DR   BioSample; SAMN03472067
DR   RCB; RCB1708
DR   Wikidata; Q54898666
CC   Population: Japanese.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): RCB=RCB1708
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   JHU-011
AC   CVCL_5986
SY   JHU 011; JHU-011-SCC; JHU-O11; JHU011; HNSCC 011; O11; 011; 11; Johns Hopkins University-011
DR   BTO; BTO_0003891
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2719
DR   BioGRID_ORCS_Cell_line; 905
DR   BioSample; SAMN03471775
DR   cancercelllines; CVCL_5986
DR   Cell_Model_Passport; SIDM00128
DR   Cosmic-CLP; 1240161
DR   DepMap; ACH-002249
DR   EGA; EGAS00001000978
DR   GDSC; 1240161
DR   GEO; GSM1669958
DR   PharmacoDB; JHU011_692_2019
DR   PRIDE; PXD002132
DR   PRIDE; PXD030304
DR   Wikidata; Q54898667
RX   PubMed=12925955;
RX   PubMed=12963126;
RX   PubMed=21868764;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=2.03%; Native American=0%; East Asian, North=2.06%; East Asian, South=0%; South Asian=0.29%; European, North=66.03%; European, South=29.59% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-2719; true.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): ATCC=CRL-2719; Cosmic-CLP=1240161; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,14
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   JHU-012
AC   CVCL_5987
SY   JHU 012; JHU-O12; JHU012; SCC012; HNSCC 012; O12; 012; Johns Hopkins University-012
DR   ATCC; CRL-2720
DR   BioSample; SAMN03151804
DR   Cosmic; 1122669
DR   Cosmic; 1530746
DR   Wikidata; Q54898668
RX   PubMed=12925955;
RX   PubMed=12963126;
RX   PubMed=17848307;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764). Originally thought to originate from the lymph node of a metastatic floor of mouth carcinoma in a 62 year old female patient.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00403.
CC   Population: Caucasian.
CC   Misspelling: JHU-112; Cosmic=1530746.
CC   Discontinued: ATCC; CRL-2720; true.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): ATCC=CRL-2720; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5991 ! JHU-022
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   JHU-013
AC   CVCL_5988
SY   JHU 013; JHU013; JHU-O13; JHU-13; O13; Johns Hopkins University-013
DR   BTO; BTO_0003890
DR   BioSample; SAMN03151639
DR   cancercelllines; CVCL_5988
DR   Cosmic; 1122670
DR   Cosmic; 1530747
DR   PharmacoDB; JHU013_693_2019
DR   Wikidata; Q54898669
RX   PubMed=12925955;
RX   PubMed=12963126;
RX   PubMed=17848307;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00404.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Lys3277Asnfs*4 (c.9828delG) (p.Gly3276fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=21868764
ST   Amelogenin: Not_detected
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1218 ! FaDu
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   JHU-019
AC   CVCL_5989
SY   JHU 019; JHU-O19; JHU019; O19; 019; 19; Johns Hopkins University-019
DR   BTO; BTO_0003889
DR   ATCC; CRL-2721
DR   BioSample; SAMN03151893
DR   BioSample; SAMN03471776
DR   cancercelllines; CVCL_5989
DR   PharmacoDB; JHU019_694_2019
DR   Wikidata; Q54898670
RX   PubMed=12925955;
RX   PubMed=12963126;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 58 year old female patient with oropharyngeal squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00405.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2721; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-2721; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 9,13 (ATCC=CRL-2721)
ST   D5S818: 13 (PubMed=21868764)
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   JHU-020
AC   CVCL_5990
SY   JHU-020-SCC; JHU020
DR   Wikidata; Q54898671
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   JHU-022
AC   CVCL_5991
SY   JHU-022-SCC; JHU022; JHU-O22; JHU-22; HNSCC 022; O22; 022; Johns Hopkins University-022
DR   BTO; BTO_0003887
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2722
DR   BioGRID_ORCS_Cell_line; 907
DR   cancercelllines; CVCL_5991
DR   Cell_Model_Passport; SIDM00127
DR   Cosmic; 1122671
DR   Cosmic; 1530748
DR   Cosmic; 2131848
DR   Cosmic-CLP; 1240162
DR   DepMap; ACH-002250
DR   EGA; EGAS00001000978
DR   GDSC; 1240162
DR   GEO; GSM1669959
DR   PharmacoDB; JHU022_695_2019
DR   PRIDE; PXD002132
DR   PRIDE; PXD030304
DR   Wikidata; Q54898674
RX   PubMed=12925955;
RX   PubMed=12963126;
RX   PubMed=17848307;
RX   PubMed=21868764;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0.81%; Native American=0.12%; East Asian, North=1.81%; East Asian, South=0%; South Asian=0%; European, North=63.12%; European, South=34.14% (PubMed=30894373).
CC   Misspelling: JUH022; Cosmic=2131848.
CC   Discontinued: ATCC; CRL-2722; true.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): ATCC=CRL-2722; Cosmic-CLP=1240162; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   JHU-028
AC   CVCL_5992
SY   JHU 028; JHU028; SCC028; HNSCC 028; O28; Johns Hopkins University-028
DR   BTO; BTO_0006404
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03151610
DR   cancercelllines; CVCL_5992
DR   Cell_Model_Passport; SIDM00902
DR   DepMap; ACH-002337
DR   EGA; EGAS00001000978
DR   GDSC; 1298154
DR   PharmacoDB; JHU028_696_2019
DR   PRIDE; PXD002132
DR   Wikidata; Q54898675
RX   PubMed=12925955;
RX   PubMed=12963126;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a A-549 derivative (PubMed=21868764). Originally thought to originate from a base of tongue squamous cell carcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00406.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (DepMap=ACH-002337).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (DepMap=ACH-002337).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   JHU-029
AC   CVCL_5993
SY   JHU-O29; JHU029; HNSCC 029; 029; Johns Hopkins University-029
DR   BTO; BTO_0003888
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2723
DR   BioGRID_ORCS_Cell_line; 908
DR   cancercelllines; CVCL_5993
DR   Cell_Model_Passport; SIDM00690
DR   Cosmic-CLP; 1298156
DR   DepMap; ACH-002251
DR   EGA; EGAS00001000978
DR   GDSC; 1298156
DR   PharmacoDB; JHU029_697_2019
DR   PRIDE; PXD002132
DR   PRIDE; PXD030304
DR   Wikidata; Q54898676
RX   PubMed=21868764;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=92.58%; Native American=0%; East Asian, North=2.96%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=4.45% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-2723; true.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): Cosmic-CLP=1298156; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 13,15
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 15
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   JHU-06
AC   CVCL_5985
SY   JHU006; HNSCC 06; 006; 6; Johns Hopkins University-06
DR   ATCC; CRL-2718
DR   BioSample; SAMN03471774
DR   Wikidata; Q54898677
CC   Discontinued: ATCC; CRL-2718; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-2718
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   JHU-0879
AC   CVCL_VT36
SY   Johns Hopkins University-0879
DR   Wikidata; Q94328581
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D21S11: 31.2,33.2
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   JHU-0937
AC   CVCL_VT37
SY   Johns Hopkins University-0937
DR   Wikidata; Q94328583
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D21S11: 28,30
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   JHU-1014
AC   CVCL_VT38
SY   Johns Hopkins University-1014
DR   Wikidata; Q94328587
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 30,33.2
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   JHU-1016A
AC   CVCL_VT39
SY   Johns Hopkins University-1016A
DR   Wikidata; Q94328590
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT40 ! JHU-1016B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   JHU-1016B
AC   CVCL_VT40
SY   Johns Hopkins University-1016B
DR   Wikidata; Q94328593
RX   PubMed=27028405;
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=27028405
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT39 ! JHU-1016A
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   JHU-ESS1
AC   CVCL_S824
SY   Johns Hopkins University-Endometrial Stromal Sarcoma 1
DR   Cosmic; 2008738
DR   Wikidata; Q54898678
RX   PubMed=1591708;
RX   PubMed=18722875;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C8973; Endometrioid stromal sarcoma
DI   ORDO; Orphanet_213711; Endometrial stromal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 9
//
ID   JHU-LNCaP-SM
AC   CVCL_C0Z9
DR   cancercelllines; CVCL_C0Z9
DR   Wikidata; Q114311775
RX   PubMed=26499105;
RX   PubMed=36261691;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent. Forms subcutaneous tumors in male athymic nude mice and reliably metastasize to the lymph nodes (PubMed=26499105).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (PubMed=26499105).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): PubMed=26499105
ST   Amelogenin: X
ST   CSF1PO: 9,10,11,12
ST   D13S317: 9,11,12,13
ST   D16S539: 10,11
ST   D5S818: 10,11,12,13
ST   D7S820: 9.1,10.1,10.2,10.3
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 15,16,17,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   JHU001i
AC   CVCL_JT24
SY   P001
DR   SKIP; SKIP004639
DR   WiCell; jhu001i
DR   Wikidata; Q54898679
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU002i-1
AC   CVCL_JT25
SY   P002A
DR   SKIP; SKIP004657
DR   WiCell; jhu002i-1
DR   Wikidata; Q54898680
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU004i-2
AC   CVCL_JT26
SY   P004B
DR   SKIP; SKIP004625
DR   WiCell; jhu004i-2
DR   Wikidata; Q54898681
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU006i-1
AC   CVCL_UA48
SY   P006A
DR   WiCell; jhu006i-1
DR   Wikidata; Q94328627
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   JHU012i-2
AC   CVCL_JT27
SY   P012B
DR   SKIP; SKIP004595
DR   WiCell; jhu012i-2
DR   Wikidata; Q54898682
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Discontinued: WiCell; jhu012i-2; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   JHU013i-2
AC   CVCL_JT28
SY   P013B
DR   SKIP; SKIP004592
DR   WiCell; jhu013i-2
DR   Wikidata; Q54898683
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU017i
AC   CVCL_JT29
SY   P017
DR   SKIP; SKIP004662
DR   WiCell; jhu017i
DR   Wikidata; Q54898684
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU018i
AC   CVCL_JT30
SY   P018
DR   SKIP; SKIP004630
DR   WiCell; jhu018i
DR   Wikidata; Q54898685
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU019i
AC   CVCL_JT31
SY   P019
DR   SKIP; SKIP004628
DR   WiCell; jhu019i
DR   Wikidata; Q54898686
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU022i
AC   CVCL_JT32
SY   P022
DR   SKIP; SKIP004509
DR   WiCell; jhu022i
DR   Wikidata; Q54898687
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU023i
AC   CVCL_JT33
SY   P023
DR   SKIP; SKIP004623
DR   WiCell; jhu023i
DR   Wikidata; Q54898688
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU024i
AC   CVCL_JT34
SY   P024
DR   SKIP; SKIP004606
DR   WiCell; jhu024i
DR   Wikidata; Q54898689
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU027i
AC   CVCL_JT35
SY   P027
DR   SKIP; SKIP004648
DR   WiCell; jhu027i
DR   Wikidata; Q54898690
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU032i
AC   CVCL_JT36
SY   P032
DR   SKIP; SKIP004590
DR   WiCell; jhu032i
DR   Wikidata; Q54898691
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU033i
AC   CVCL_JT37
SY   P033
DR   SKIP; SKIP004577
DR   WiCell; jhu033i
DR   Wikidata; Q54898692
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU035i
AC   CVCL_JT38
SY   P035
DR   SKIP; SKIP004618
DR   WiCell; jhu035i
DR   Wikidata; Q54898693
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Discontinued: WiCell; jhu035i; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   JHU036i
AC   CVCL_JT39
SY   P036
DR   SKIP; SKIP004510
DR   WiCell; jhu036i
DR   Wikidata; Q54898694
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU037i
AC   CVCL_JT40
SY   P037
DR   SKIP; SKIP004488
DR   WiCell; jhu037i
DR   Wikidata; Q54898695
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Discontinued: WiCell; jhu037i; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   JHU038i
AC   CVCL_JT41
SY   P038
DR   SKIP; SKIP004599
DR   WiCell; jhu038i
DR   Wikidata; Q54898696
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU039i
AC   CVCL_JT42
SY   P039
DR   SKIP; SKIP004560
DR   WiCell; jhu039i
DR   Wikidata; Q54898697
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU040i
AC   CVCL_JT43
SY   P040
DR   SKIP; SKIP004602
DR   WiCell; jhu040i
DR   Wikidata; Q54898698
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU042i
AC   CVCL_JT44
SY   P042
DR   SKIP; SKIP004610
DR   WiCell; jhu042i
DR   Wikidata; Q54898699
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU043i
AC   CVCL_JT45
SY   P043
DR   SKIP; SKIP004611
DR   WiCell; jhu043i
DR   Wikidata; Q54898701
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU044i
AC   CVCL_JT46
SY   P044
DR   SKIP; SKIP004624
DR   WiCell; jhu044i
DR   Wikidata; Q54898702
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU045i
AC   CVCL_JT47
SY   P045
DR   SKIP; SKIP004596
DR   WiCell; jhu045i
DR   Wikidata; Q54898703
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU047i
AC   CVCL_JT48
SY   P047
DR   SKIP; SKIP004508
DR   WiCell; jhu047i
DR   Wikidata; Q54898704
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU048i
AC   CVCL_JT49
SY   P048
DR   SKIP; SKIP004627
DR   WiCell; jhu048i
DR   Wikidata; Q54898705
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU049i
AC   CVCL_JT50
SY   P049
DR   SKIP; SKIP004609
DR   WiCell; jhu049i
DR   Wikidata; Q54898706
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU050i
AC   CVCL_JT51
SY   P050
DR   SKIP; SKIP004518
DR   WiCell; jhu050i
DR   Wikidata; Q54898707
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU052i
AC   CVCL_JT52
SY   P052
DR   SKIP; SKIP004573
DR   WiCell; jhu052i
DR   Wikidata; Q54898708
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Discontinued: WiCell; jhu052i; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   JHU053i
AC   CVCL_JT53
SY   P053
DR   SKIP; SKIP004567
DR   WiCell; jhu053i
DR   Wikidata; Q54898709
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU054i
AC   CVCL_JT54
SY   P054
DR   SKIP; SKIP004620
DR   WiCell; jhu054i
DR   Wikidata; Q54898710
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU055i
AC   CVCL_JT55
SY   P055
DR   SKIP; SKIP004519
DR   WiCell; jhu055i
DR   Wikidata; Q54898711
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU056i
AC   CVCL_JT56
SY   P056
DR   SKIP; SKIP004535
DR   WiCell; jhu056i
DR   Wikidata; Q54898712
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU057i
AC   CVCL_JT57
SY   P057
DR   SKIP; SKIP004480
DR   WiCell; jhu057i
DR   Wikidata; Q54898713
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Discontinued: WiCell; jhu057i; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   JHU058i
AC   CVCL_JT58
SY   P058
DR   SKIP; SKIP004469
DR   WiCell; jhu058i
DR   Wikidata; Q54898714
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU060i-2
AC   CVCL_JT59
SY   P060B
DR   SKIP; SKIP004537
DR   WiCell; jhu060i-2
DR   Wikidata; Q54898718
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU062i
AC   CVCL_JT60
SY   P062
DR   SKIP; SKIP004646
DR   WiCell; jhu062i
DR   Wikidata; Q54898719
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU063i
AC   CVCL_JT61
SY   P063
DR   SKIP; SKIP004565
DR   WiCell; jhu063i
DR   Wikidata; Q54898720
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU064i
AC   CVCL_JT62
SY   P064
DR   SKIP; SKIP004658
DR   WiCell; jhu064i
DR   Wikidata; Q54898721
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU065i
AC   CVCL_JT63
SY   P065
DR   SKIP; SKIP004474
DR   WiCell; jhu065i
DR   Wikidata; Q54898722
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU066i
AC   CVCL_JT64
SY   P066
DR   SKIP; SKIP004477
DR   WiCell; jhu066i
DR   Wikidata; Q54898723
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU067i
AC   CVCL_JT65
SY   P067
DR   SKIP; SKIP004652
DR   WiCell; jhu067i
DR   Wikidata; Q54898724
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU070i
AC   CVCL_JT66
SY   P070
DR   SKIP; SKIP004555
DR   WiCell; jhu070i
DR   Wikidata; Q54898725
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU071i
AC   CVCL_JT67
SY   P071
DR   SKIP; SKIP004556
DR   WiCell; jhu071i
DR   Wikidata; Q54898727
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU072i
AC   CVCL_JT68
SY   P072
DR   SKIP; SKIP004540
DR   WiCell; jhu072i
DR   Wikidata; Q54898728
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU073i
AC   CVCL_JT69
SY   P073
DR   SKIP; SKIP004531
DR   WiCell; jhu073i
DR   Wikidata; Q54898729
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU074i
AC   CVCL_JT70
SY   P074
DR   SKIP; SKIP004580
DR   WiCell; jhu074i
DR   Wikidata; Q54898730
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU075i
AC   CVCL_JT71
SY   P075
DR   SKIP; SKIP004506
DR   WiCell; jhu075i
DR   Wikidata; Q54898731
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU077i
AC   CVCL_JT72
SY   P077
DR   SKIP; SKIP004486
DR   WiCell; jhu077i
DR   Wikidata; Q54898733
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU078i
AC   CVCL_JT73
SY   P078
DR   SKIP; SKIP004666
DR   WiCell; jhu078i
DR   Wikidata; Q54898734
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU079i
AC   CVCL_JT74
SY   P079
DR   SKIP; SKIP004589
DR   WiCell; jhu079i
DR   Wikidata; Q54898735
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU080i
AC   CVCL_JT75
SY   P080
DR   SKIP; SKIP004578
DR   WiCell; jhu080i
DR   Wikidata; Q54898736
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU081i
AC   CVCL_JT76
SY   P081
DR   SKIP; SKIP004579
DR   WiCell; jhu081i
DR   Wikidata; Q54898737
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU082i
AC   CVCL_JT77
SY   P082
DR   SKIP; SKIP004526
DR   WiCell; jhu082i
DR   Wikidata; Q54898738
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU083i
AC   CVCL_JT78
SY   P083
DR   SKIP; SKIP004653
DR   WiCell; jhu083i
DR   Wikidata; Q54898739
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU084i
AC   CVCL_JT79
SY   P084
DR   SKIP; SKIP004497
DR   WiCell; jhu084i
DR   Wikidata; Q54898740
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU085i
AC   CVCL_JT80
SY   P085
DR   SKIP; SKIP004575
DR   WiCell; jhu085i
DR   Wikidata; Q54898741
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU086i
AC   CVCL_JT81
SY   P086
DR   SKIP; SKIP004644
DR   WiCell; jhu086i
DR   Wikidata; Q54898742
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU087i
AC   CVCL_JT82
SY   P087
DR   SKIP; SKIP004498
DR   WiCell; jhu087i
DR   Wikidata; Q54898743
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU088i
AC   CVCL_JT83
SY   P088
DR   SKIP; SKIP004640
DR   WiCell; jhu088i
DR   Wikidata; Q54898744
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU089i
AC   CVCL_JT84
SY   P089
DR   SKIP; SKIP004558
DR   WiCell; jhu089i
DR   Wikidata; Q54898745
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU090i
AC   CVCL_JT85
SY   P090
DR   SKIP; SKIP004588
DR   WiCell; jhu090i
DR   Wikidata; Q54898746
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU091i
AC   CVCL_JT86
SY   P091
DR   SKIP; SKIP004490
DR   WiCell; jhu091i
DR   Wikidata; Q54898747
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU093i
AC   CVCL_JT87
SY   P093
DR   SKIP; SKIP004496
DR   WiCell; jhu093i
DR   Wikidata; Q54898748
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU094i
AC   CVCL_JT88
SY   P094
DR   SKIP; SKIP004554
DR   WiCell; jhu094i
DR   Wikidata; Q54898749
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU095i
AC   CVCL_JT89
SY   P095
DR   SKIP; SKIP004661
DR   WiCell; jhu095i
DR   Wikidata; Q54898750
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU096i
AC   CVCL_JT90
SY   P096
DR   SKIP; SKIP004566
DR   WiCell; jhu096i
DR   Wikidata; Q54898751
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU097i
AC   CVCL_JT91
SY   P097
DR   SKIP; SKIP004504
DR   WiCell; jhu097i
DR   Wikidata; Q54898752
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU098i
AC   CVCL_JT92
SY   P098
DR   SKIP; SKIP004546
DR   WiCell; jhu098i
DR   Wikidata; Q54898753
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU099i
AC   CVCL_JT93
SY   P099
DR   SKIP; SKIP004649
DR   WiCell; jhu099i
DR   Wikidata; Q54898754
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU100i
AC   CVCL_JT94
SY   P100
DR   SKIP; SKIP004650
DR   WiCell; jhu100i
DR   Wikidata; Q54898755
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU101i
AC   CVCL_JT95
SY   P101
DR   SKIP; SKIP004523
DR   WiCell; jhu101i
DR   Wikidata; Q54898756
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU102i
AC   CVCL_JT96
SY   P102
DR   SKIP; SKIP004548
DR   WiCell; jhu102i
DR   Wikidata; Q54898757
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU103i
AC   CVCL_JT97
SY   P103
DR   SKIP; SKIP004645
DR   WiCell; jhu103i
DR   Wikidata; Q54898758
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU104i
AC   CVCL_JT98
SY   P104
DR   SKIP; SKIP004485
DR   WiCell; jhu104i
DR   Wikidata; Q54898759
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU105i
AC   CVCL_JT99
SY   P105
DR   SKIP; SKIP004541
DR   WiCell; jhu105i
DR   Wikidata; Q54898763
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU106i
AC   CVCL_JU00
SY   P106
DR   SKIP; SKIP004547
DR   WiCell; jhu106i
DR   Wikidata; Q54898764
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU107i
AC   CVCL_JU01
SY   P107
DR   SKIP; SKIP004663
DR   WiCell; jhu107i
DR   Wikidata; Q54898765
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU108i
AC   CVCL_JU02
SY   P108
DR   SKIP; SKIP004564
DR   WiCell; jhu108i
DR   Wikidata; Q54898766
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU111i
AC   CVCL_JU03
SY   P111
DR   SKIP; SKIP004468
DR   WiCell; jhu111i
DR   Wikidata; Q54898767
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU114i
AC   CVCL_JU04
SY   P114
DR   SKIP; SKIP004542
DR   WiCell; jhu114i
DR   Wikidata; Q54898768
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU115i
AC   CVCL_JU05
SY   P115
DR   SKIP; SKIP004532
DR   WiCell; jhu115i
DR   Wikidata; Q54898769
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU116i
AC   CVCL_JU06
SY   P116
DR   SKIP; SKIP004544
DR   WiCell; jhu116i
DR   Wikidata; Q54898770
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU117i
AC   CVCL_JU07
SY   P117
DR   SKIP; SKIP004664
DR   WiCell; jhu117i
DR   Wikidata; Q54898771
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU119i
AC   CVCL_JU08
SY   P119
DR   SKIP; SKIP004660
DR   WiCell; jhu119i
DR   Wikidata; Q54898772
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU121i
AC   CVCL_JU09
SY   P121
DR   SKIP; SKIP004659
DR   WiCell; jhu121i
DR   Wikidata; Q54898773
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU122i
AC   CVCL_JU10
SY   P122
DR   SKIP; SKIP004665
DR   WiCell; jhu122i
DR   Wikidata; Q54898774
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU123i
AC   CVCL_JU11
SY   P123
DR   SKIP; SKIP004549
DR   WiCell; jhu123i
DR   Wikidata; Q54898775
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU124i
AC   CVCL_JU12
SY   P124
DR   SKIP; SKIP004483
DR   WiCell; jhu124i
DR   Wikidata; Q54898776
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU125i
AC   CVCL_JU13
SY   P125
DR   SKIP; SKIP004484
DR   WiCell; jhu125i
DR   Wikidata; Q54898777
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU126i
AC   CVCL_JU14
SY   P126
DR   SKIP; SKIP004561
DR   WiCell; jhu126i
DR   Wikidata; Q54898778
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU127i
AC   CVCL_JU15
SY   P127
DR   SKIP; SKIP004545
DR   WiCell; jhu127i
DR   Wikidata; Q54898779
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU128i
AC   CVCL_JU16
SY   P128
DR   SKIP; SKIP004574
DR   WiCell; jhu128i
DR   Wikidata; Q54898780
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU129i
AC   CVCL_JU17
SY   P129
DR   SKIP; SKIP004520
DR   WiCell; jhu129i
DR   Wikidata; Q54898781
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU130i
AC   CVCL_JU18
SY   P130
DR   SKIP; SKIP004654
DR   WiCell; jhu130i
DR   Wikidata; Q54898782
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU131i
AC   CVCL_JU19
SY   P131
DR   SKIP; SKIP004492
DR   WiCell; jhu131i
DR   Wikidata; Q54898783
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU132i
AC   CVCL_JU20
SY   P132
DR   SKIP; SKIP004495
DR   WiCell; jhu132i
DR   Wikidata; Q54898784
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU133i
AC   CVCL_JU21
SY   P133
DR   SKIP; SKIP004608
DR   WiCell; jhu133i
DR   Wikidata; Q54898785
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU139i
AC   CVCL_JU22
SY   P139
DR   SKIP; SKIP004473
DR   WiCell; jhu139i
DR   Wikidata; Q54898786
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU140i
AC   CVCL_JU23
SY   P140
DR   SKIP; SKIP004522
DR   WiCell; jhu140i
DR   Wikidata; Q54898787
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU141i
AC   CVCL_JU24
SY   P141
DR   SKIP; SKIP004655
DR   WiCell; jhu141i
DR   Wikidata; Q54898788
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU142i
AC   CVCL_JU25
SY   P142
DR   SKIP; SKIP004643
DR   WiCell; jhu142i
DR   Wikidata; Q54898789
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU143i
AC   CVCL_JU26
SY   P143
DR   SKIP; SKIP004470
DR   WiCell; jhu143i
DR   Wikidata; Q54898790
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU145i
AC   CVCL_JU27
SY   P145
DR   SKIP; SKIP004471
DR   WiCell; jhu145i
DR   Wikidata; Q54898791
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU146i
AC   CVCL_JU28
SY   P146
DR   SKIP; SKIP004472
DR   WiCell; jhu146i
DR   Wikidata; Q54898792
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU148i
AC   CVCL_JU29
SY   P148
DR   SKIP; SKIP004656
DR   WiCell; jhu148i
DR   Wikidata; Q54898793
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU149i
AC   CVCL_JU30
SY   P149
DR   SKIP; SKIP004512
DR   WiCell; jhu149i
DR   Wikidata; Q54898794
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU150i
AC   CVCL_JU31
SY   P150
DR   SKIP; SKIP004476
DR   WiCell; jhu150i
DR   Wikidata; Q54898795
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU151i
AC   CVCL_JU32
SY   P151
DR   SKIP; SKIP004511
DR   WiCell; jhu151i
DR   Wikidata; Q54898796
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU152i
AC   CVCL_JU33
SY   P152
DR   SKIP; SKIP004481
DR   WiCell; jhu152i
DR   Wikidata; Q54898798
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU153i
AC   CVCL_JU34
SY   P153
DR   SKIP; SKIP004550
DR   WiCell; jhu153i
DR   Wikidata; Q54898799
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU154i
AC   CVCL_JV22
SY   P154
DR   SKIP; SKIP004551
DR   Wikidata; Q54898800
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   JHU155i
AC   CVCL_JU35
SY   P155
DR   SKIP; SKIP004552
DR   WiCell; jhu155i
DR   Wikidata; Q54898801
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU156i
AC   CVCL_JU36
SY   P156
DR   SKIP; SKIP004641
DR   WiCell; jhu156i
DR   Wikidata; Q54898802
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU157i
AC   CVCL_JU37
SY   P157
DR   SKIP; SKIP004619
DR   WiCell; jhu157i
DR   Wikidata; Q54898804
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU158i
AC   CVCL_JU38
SY   P158
DR   SKIP; SKIP004633
DR   WiCell; jhu158i
DR   Wikidata; Q54898809
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU159i
AC   CVCL_JU39
SY   P159
DR   SKIP; SKIP004538
DR   WiCell; jhu159i
DR   Wikidata; Q54898810
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU160i
AC   CVCL_JU40
SY   P160
DR   SKIP; SKIP004642
DR   WiCell; jhu160i
DR   Wikidata; Q54898811
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU162i
AC   CVCL_JU41
SY   P162
DR   SKIP; SKIP004584
DR   WiCell; jhu162i
DR   Wikidata; Q54898812
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Discontinued: WiCell; jhu162i; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   JHU163i
AC   CVCL_JU42
SY   P163
DR   SKIP; SKIP004557
DR   WiCell; jhu163i
DR   Wikidata; Q54898813
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU164i
AC   CVCL_JU43
SY   P164
DR   SKIP; SKIP004634
DR   WiCell; jhu164i
DR   Wikidata; Q54898814
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU165i
AC   CVCL_JU44
SY   P165
DR   SKIP; SKIP004489
DR   WiCell; jhu165i
DR   Wikidata; Q54898815
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU166i
AC   CVCL_JU45
SY   P166
DR   SKIP; SKIP004487
DR   WiCell; jhu166i
DR   Wikidata; Q54898816
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU167i
AC   CVCL_JU46
SY   P167
DR   SKIP; SKIP004568
DR   WiCell; jhu167i
DR   Wikidata; Q54898817
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU170i
AC   CVCL_JU47
SY   P170
DR   SKIP; SKIP004524
DR   WiCell; jhu170i
DR   Wikidata; Q54898818
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU171i
AC   CVCL_JU48
SY   P171
DR   SKIP; SKIP004482
DR   WiCell; jhu171i
DR   Wikidata; Q54898819
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU172i
AC   CVCL_JU49
SY   P172
DR   SKIP; SKIP004503
DR   WiCell; jhu172i
DR   Wikidata; Q54898820
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU173i
AC   CVCL_JU50
SY   P173
DR   SKIP; SKIP004593
DR   WiCell; jhu173i
DR   Wikidata; Q54898821
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU174i
AC   CVCL_JU51
SY   P174
DR   SKIP; SKIP004475
DR   WiCell; jhu174i
DR   Wikidata; Q54898822
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU176i
AC   CVCL_JU52
SY   P176
DR   SKIP; SKIP004478
DR   WiCell; jhu176i
DR   Wikidata; Q54898823
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU177i
AC   CVCL_JU53
SY   P177
DR   SKIP; SKIP004636
DR   WiCell; jhu177i
DR   Wikidata; Q54898824
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU178i
AC   CVCL_JU54
SY   P178
DR   SKIP; SKIP004505
DR   WiCell; jhu178i
DR   Wikidata; Q54898825
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU180i
AC   CVCL_JU55
SY   P180
DR   SKIP; SKIP004536
DR   WiCell; jhu180i
DR   Wikidata; Q54898826
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU181i
AC   CVCL_JU56
SY   P181
DR   SKIP; SKIP004581
DR   WiCell; jhu181i
DR   Wikidata; Q54898827
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU183i
AC   CVCL_JU57
SY   P183
DR   SKIP; SKIP004615
DR   WiCell; jhu183i
DR   Wikidata; Q54898828
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU184i
AC   CVCL_JU58
SY   P184
DR   SKIP; SKIP004514
DR   WiCell; jhu184i
DR   Wikidata; Q54898829
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU185i
AC   CVCL_JU59
SY   P185
DR   SKIP; SKIP004569
DR   WiCell; jhu185i
DR   Wikidata; Q54898830
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU186i
AC   CVCL_JU60
SY   P186
DR   SKIP; SKIP004513
DR   WiCell; jhu186i
DR   Wikidata; Q54898831
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU187i
AC   CVCL_JU61
SY   P187
DR   SKIP; SKIP004597
DR   WiCell; jhu187i
DR   Wikidata; Q54898832
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU188i
AC   CVCL_JU62
SY   P188
DR   SKIP; SKIP004632
DR   WiCell; jhu188i
DR   Wikidata; Q54898833
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU189i
AC   CVCL_JU63
SY   P189
DR   SKIP; SKIP004570
DR   WiCell; jhu189i
DR   Wikidata; Q54898834
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU190i
AC   CVCL_JU64
SY   P190
DR   SKIP; SKIP004601
DR   WiCell; jhu190i
DR   Wikidata; Q54898835
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU191i
AC   CVCL_JU65
SY   P191
DR   SKIP; SKIP004507
DR   WiCell; jhu191i
DR   Wikidata; Q54898836
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU192i
AC   CVCL_JU66
SY   P192
DR   SKIP; SKIP004571
DR   WiCell; jhu192i
DR   Wikidata; Q54898837
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU194i
AC   CVCL_JU67
SY   P194
DR   SKIP; SKIP004534
DR   WiCell; jhu194i
DR   Wikidata; Q54898838
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU196i
AC   CVCL_JU68
SY   P196
DR   SKIP; SKIP004494
DR   WiCell; jhu196i
DR   Wikidata; Q54898839
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU197i
AC   CVCL_JU69
SY   P197
DR   SKIP; SKIP004529
DR   WiCell; jhu197i
DR   Wikidata; Q54898840
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU198i
AC   CVCL_JU70
SY   P198
DR   SKIP; SKIP004617
DR   WiCell; jhu198i
DR   Wikidata; Q54898841
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   JHU199i
AC   CVCL_JU71
SY   P199
DR   SKIP; SKIP004607
DR   WiCell; jhu199i
DR   Wikidata; Q54898842
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU200i
AC   CVCL_JU72
SY   P200
DR   SKIP; SKIP004502
DR   WiCell; jhu200i
DR   Wikidata; Q54898843
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU201i
AC   CVCL_JU73
SY   P201
DR   SKIP; SKIP004543
DR   WiCell; jhu201i
DR   Wikidata; Q54898844
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU203i
AC   CVCL_JU74
SY   P203
DR   SKIP; SKIP004585
DR   WiCell; jhu203i
DR   Wikidata; Q54898845
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU204i
AC   CVCL_JU75
SY   P204
DR   SKIP; SKIP004647
DR   WiCell; jhu204i
DR   Wikidata; Q54898846
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU205i
AC   CVCL_JU76
SY   P205
DR   SKIP; SKIP004559
DR   WiCell; jhu205i
DR   Wikidata; Q54898847
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU206i
AC   CVCL_JU77
SY   P206
DR   SKIP; SKIP004613
DR   WiCell; jhu206i
DR   Wikidata; Q54898848
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU207i
AC   CVCL_JU78
SY   P207
DR   SKIP; SKIP004603
DR   WiCell; jhu207i
DR   Wikidata; Q54898854
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU208i
AC   CVCL_JU79
SY   P208
DR   SKIP; SKIP004499
DR   WiCell; jhu208i
DR   Wikidata; Q54898855
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU209i
AC   CVCL_JU80
SY   P209
DR   SKIP; SKIP004516
DR   WiCell; jhu209i
DR   Wikidata; Q54898856
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU210i
AC   CVCL_JU81
SY   P210
DR   SKIP; SKIP004539
DR   WiCell; jhu210i
DR   Wikidata; Q54898857
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU214i
AC   CVCL_JU82
SY   P214
DR   SKIP; SKIP004631
DR   WiCell; jhu214i
DR   Wikidata; Q54898858
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU215i
AC   CVCL_JU83
SY   P215
DR   SKIP; SKIP004626
DR   WiCell; jhu215i
DR   Wikidata; Q54898859
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU216i
AC   CVCL_JU84
SY   P216
DR   SKIP; SKIP004517
DR   WiCell; jhu216i
DR   Wikidata; Q54898861
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU217i
AC   CVCL_JU85
SY   P217
DR   SKIP; SKIP004651
DR   WiCell; jhu217i
DR   Wikidata; Q54898862
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Discontinued: WiCell; jhu217i; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   JHU218i
AC   CVCL_JU86
SY   P218
DR   SKIP; SKIP004563
DR   WiCell; jhu218i
DR   Wikidata; Q54898863
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU219i
AC   CVCL_JU87
SY   P219
DR   SKIP; SKIP004562
DR   WiCell; jhu219i
DR   Wikidata; Q54898864
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU220i
AC   CVCL_JU88
SY   P220
DR   SKIP; SKIP004493
DR   WiCell; jhu220i
DR   Wikidata; Q54898865
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU221i
AC   CVCL_JU89
SY   P221
DR   SKIP; SKIP004576
DR   WiCell; jhu221i
DR   Wikidata; Q54898866
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU222i
AC   CVCL_JU90
SY   P222
DR   SKIP; SKIP004528
DR   WiCell; jhu222i
DR   Wikidata; Q54898867
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU224i
AC   CVCL_JU91
SY   P224
DR   SKIP; SKIP004586
DR   WiCell; jhu224i
DR   Wikidata; Q54898868
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU225i
AC   CVCL_JU92
SY   P225
DR   SKIP; SKIP004553
DR   WiCell; jhu225i
DR   Wikidata; Q54898869
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU226i
AC   CVCL_JU93
SY   P226
DR   SKIP; SKIP004622
DR   WiCell; jhu226i
DR   Wikidata; Q54898870
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU227i
AC   CVCL_JU94
SY   P227
DR   SKIP; SKIP004612
DR   WiCell; jhu227i
DR   Wikidata; Q54898871
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU228i
AC   CVCL_JU95
SY   P228
DR   SKIP; SKIP004521
DR   WiCell; jhu228i
DR   Wikidata; Q54898872
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU229i
AC   CVCL_JU96
SY   P229
DR   SKIP; SKIP004582
DR   WiCell; jhu229i
DR   Wikidata; Q54898873
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU230i
AC   CVCL_JU97
SY   P230
DR   SKIP; SKIP004604
DR   WiCell; jhu230i
DR   Wikidata; Q54898874
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU231i
AC   CVCL_JU98
SY   P231
DR   SKIP; SKIP004525
DR   WiCell; jhu231i
DR   Wikidata; Q54898875
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU232i
AC   CVCL_JU99
SY   P232
DR   SKIP; SKIP004591
DR   WiCell; jhu232i
DR   Wikidata; Q54898876
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU233i
AC   CVCL_JV00
SY   P233
DR   SKIP; SKIP004598
DR   WiCell; jhu233i
DR   Wikidata; Q54898877
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU234i
AC   CVCL_JV01
SY   P234
DR   SKIP; SKIP004515
DR   WiCell; jhu234i
DR   Wikidata; Q54898878
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU235i
AC   CVCL_JV02
SY   P235
DR   SKIP; SKIP004600
DR   WiCell; jhu235i
DR   Wikidata; Q54898879
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU236i
AC   CVCL_JV03
SY   P236
DR   SKIP; SKIP004587
DR   WiCell; jhu236i
DR   Wikidata; Q54898880
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU237i
AC   CVCL_JV04
SY   P237
DR   SKIP; SKIP004530
DR   WiCell; jhu237i
DR   Wikidata; Q54898881
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU238i
AC   CVCL_JV05
SY   P238
DR   SKIP; SKIP004594
DR   WiCell; jhu238i
DR   Wikidata; Q54898882
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU240i
AC   CVCL_JV06
SY   P240
DR   SKIP; SKIP004635
DR   WiCell; jhu240i
DR   Wikidata; Q54898883
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU242i
AC   CVCL_JV07
SY   P242
DR   SKIP; SKIP004614
DR   WiCell; jhu242i
DR   Wikidata; Q54898884
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU243i
AC   CVCL_JV08
SY   P243
DR   SKIP; SKIP004572
DR   WiCell; jhu243i
DR   Wikidata; Q54898885
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU244i
AC   CVCL_JV09
SY   P244
DR   SKIP; SKIP004533
DR   WiCell; jhu244i
DR   Wikidata; Q54898886
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU245i
AC   CVCL_JV10
SY   P245
DR   SKIP; SKIP004629
DR   WiCell; jhu245i
DR   Wikidata; Q54898887
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU246i
AC   CVCL_JV11
SY   P246
DR   SKIP; SKIP004479
DR   WiCell; jhu246i
DR   Wikidata; Q54898888
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU247i
AC   CVCL_JV12
SY   P247
DR   SKIP; SKIP004527
DR   WiCell; jhu247i
DR   Wikidata; Q54898889
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU248i
AC   CVCL_JV13
SY   P248
DR   SKIP; SKIP004605
DR   WiCell; jhu248i
DR   Wikidata; Q54898890
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU250i
AC   CVCL_JV14
SY   P250
DR   SKIP; SKIP004491
DR   WiCell; jhu250i
DR   Wikidata; Q54898891
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU251i
AC   CVCL_JV15
SY   P251
DR   SKIP; SKIP004500
DR   WiCell; jhu251i
DR   Wikidata; Q54898892
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU252i
AC   CVCL_JV16
SY   P252
DR   SKIP; SKIP004501
DR   WiCell; jhu252i
DR   Wikidata; Q54898893
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU253i
AC   CVCL_JV17
SY   P253
DR   SKIP; SKIP004583
DR   WiCell; jhu253i
DR   Wikidata; Q54898894
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU255i
AC   CVCL_JV18
SY   P255
DR   SKIP; SKIP004637
DR   WiCell; jhu255i
DR   Wikidata; Q54898904
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU256i
AC   CVCL_JV19
SY   P256
DR   SKIP; SKIP004638
DR   WiCell; jhu256i
DR   Wikidata; Q54898905
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU257i
AC   CVCL_JV20
SY   P257
DR   SKIP; SKIP004616
DR   WiCell; jhu257i
DR   Wikidata; Q54898906
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHU259i
AC   CVCL_JV21
SY   P259
DR   SKIP; SKIP004621
DR   WiCell; jhu259i
DR   Wikidata; Q54898907
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Becker, Lewis Charles; Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 11
//
ID   JHUAS-1
AC   CVCL_4650
DR   CLO; CLO_0050878
DR   BioSample; SAMN03472095
DR   RCB; RCB1544
DR   Wikidata; Q54898908
CC   Population: Japanese.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB1544
ST   Amelogenin: X
ST   CSF1PO: 7,13
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C4519; Cervical adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   JHUAS-2-L
AC   CVCL_4651
DR   CLO; CLO_0051047
DR   BioSample; SAMN03472096
DR   RCB; RCB1545
DR   Wikidata; Q54898909
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB1545
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,14
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4519; Cervical adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   JHUCS-1
AC   CVCL_4652
SY   JHUCS_1
DR   CLO; CLO_0050879
DR   BioSample; SAMN03472098
DR   FANTOM5_SSTAR; 10642-109A3
DR   GEO; GSM3161716
DR   GEO; GSM3161717
DR   RCB; RCB1547
DR   Wikidata; Q54898910
RX   PubMed=15859159;
CC   Population: Japanese.
CC   Doubling time: 30 hours (Note=At 25th passage) (PubMed=15859159).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): RCB=RCB1547
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 8,13
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   JHUCS-3
AC   CVCL_4653
DR   CLO; CLO_0050926
DR   BioSample; SAMN03472069
DR   RCB; RCB1721
DR   Wikidata; Q54898911
CC   Population: Japanese.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB1721
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   JHUEM-1
AC   CVCL_4655
SY   JHUEM1
DR   CLO; CLO_0050873
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472099
DR   BioSample; SAMN10987934
DR   cancercelllines; CVCL_4655
DR   Cell_Model_Passport; SIDM01572
DR   DepMap; ACH-000928
DR   FANTOM5_SSTAR; 10643-109A4
DR   GEO; GSM887180
DR   GEO; GSM888252
DR   IARC_TP53; 30084
DR   LiGeA; CCLE_414
DR   PharmacoDB; JHUEM1_698_2019
DR   Progenetix; CVCL_4655
DR   RCB; RCB1548
DR   Wikidata; Q54898912
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (DepMap=ACH-000928).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (DepMap=ACH-000928).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=76.96%; East Asian, South=23.04%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1548
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   TH01: 6
ST   TPOX: 7,8
ST   vWA: 17,18,19
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   JHUEM-14
AC   CVCL_4654
SY   JHUEM14
DR   CLO; CLO_0050877
DR   BioSample; SAMN03472023
DR   RCB; RCB2225
DR   Wikidata; Q54898913
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB2225
ST   Amelogenin: X
ST   CSF1PO: 12,13,14
ST   D13S317: 8,10
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,10
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   JHUEM-14 Prex2a shRNA type 1
AC   CVCL_A8Q4
SY   JHUEM14, Prex2a shRNA type 1; JHUEM14_Prex2a_shRNA1
DR   GEO; GSM2599686
DR   GEO; GSM2599687
DR   Wikidata; Q102114311
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:22950; PREX2.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4654 ! JHUEM-14
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   JHUEM-14 Prex2a shRNA type 2
AC   CVCL_A8Q5
SY   JHUEM14, Prex2a shRNA type 2; JHUEM14_Prex2a_shRNA2
DR   GEO; GSM2599688
DR   GEO; GSM2599689
DR   Wikidata; Q102114312
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:22950; PREX2.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4654 ! JHUEM-14
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   JHUEM-2
AC   CVCL_4656
SY   JHUEM2
DR   CLO; CLO_0050874
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472101
DR   BioSample; SAMN10988295
DR   cancercelllines; CVCL_4656
DR   Cell_Model_Passport; SIDM01729
DR   DepMap; ACH-000909
DR   GEO; GSM887181
DR   GEO; GSM888253
DR   IARC_TP53; 30085
DR   LiGeA; CCLE_024
DR   PharmacoDB; JHUEM2_699_2019
DR   Progenetix; CVCL_4656
DR   RCB; RCB1551
DR   Wikidata; Q54898914
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*11:01,31:01; B*15:01,51:01; C*04:01,14:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.43%; East Asian, South=17.67%; South Asian=0.89%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1551
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,9,11
ST   vWA: 14
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   JHUEM-3
AC   CVCL_4657
SY   JHUEM3
DR   CLO; CLO_0050875
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472102
DR   BioSample; SAMN10987748
DR   cancercelllines; CVCL_4657
DR   Cell_Model_Passport; SIDM01728
DR   Cosmic; 2030476
DR   DepMap; ACH-000173
DR   GEO; GSM887182
DR   GEO; GSM888254
DR   IARC_TP53; 30086
DR   LiGeA; CCLE_816
DR   PharmacoDB; JHUEM3_700_2019
DR   Progenetix; CVCL_4657
DR   RCB; RCB1552
DR   Wikidata; Q54898915
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Heterozygous (DepMap=ACH-000173).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Asp33Glu (c.99T>A); Zygosity=Heterozygous (DepMap=ACH-000173).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln167Ter (c.499C>T); ClinVar=VCV000528250; Zygosity=Unspecified (DepMap=ACH-000173).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.23%; Native American=0%; East Asian, North=84.53%; East Asian, South=12.99%; South Asian=0%; European, North=0%; European, South=2.25% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1552
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,19,20
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   JHUEM-7
AC   CVCL_4658
SY   JHUEM7
DR   CLO; CLO_0050876
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472114
DR   BioSample; SAMN10989576
DR   cancercelllines; CVCL_4658
DR   Cell_Model_Passport; SIDM01588
DR   DepMap; ACH-000993
DR   GEO; GSM888255
DR   IARC_TP53; 30087
DR   LiGeA; CCLE_466
DR   PharmacoDB; JHUEM7_701_2019
DR   Progenetix; CVCL_4658
DR   RCB; RCB1677
DR   Wikidata; Q54898916
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:01; B*46:01,52:01; C*01:02,01:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2204Ter (c.6610C>T); ClinVar=VCV000236632; Zygosity=Heterozygous (DepMap=ACH-000993).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Arg1989Ter (c.5965C>T); ClinVar=VCV000225842; Zygosity=Heterozygous (DepMap=ACH-000993).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.1%; East Asian, South=22.67%; South Asian=0.22%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1677
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   JHUi001-A
AC   CVCL_QX77
SY   BA08.1
DR   hPSCreg; JHUi001-A
DR   Wikidata; Q54898917
RX   PubMed=29034890;
CC   From: Johns Hopkins University; Baltimore; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34421; Biliary atresia
DI   ORDO; Orphanet_30391; Isolated biliary atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   JHUi002-A
AC   CVCL_A9XG
DR   hPSCreg; JHUi002-A
DR   Wikidata; Q102114313
RX   PubMed=32916633;
CC   From: Johns Hopkins University; Baltimore; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=32916633).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   JHUi003-A
AC   CVCL_A8HK
SY   380iC73-7B
DR   hPSCreg; JHUi003-A
DR   Wikidata; Q107115489
RX   PubMed=34087983;
CC   From: Johns Hopkins University; Baltimore; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion; CAG[69]; ClinVar=VCV000005614; Zygosity=Heterozygous (PubMed=34087983).
CC   Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion_edited; CAG[72]; ClinVar=VCV000005614; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087983).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154316; Spinocerebellar ataxia type 12
DI   ORDO; Orphanet_98762; Spinocerebellar ataxia type 12
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   JHUS-nk1
AC   CVCL_3729
DR   CLO; CLO_0050925
DR   BioSample; SAMN03472103
DR   FANTOM5_SSTAR; 10646-109A7
DR   RCB; RCB1558
DR   Wikidata; Q54898918
CC   Population: Japanese.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB1558
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 9
ST   D7S820: 10,13
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   JI
AC   CVCL_W934
DR   Cosmic; 931125
DR   Cosmic; 2804868
DR   Wikidata; Q54898919
RX   PubMed=2470097;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3458667;
RX   PubMed=6231253;
RX   PubMed=6244869;
RX   PubMed=6547209;
RX   PubMed=6806672;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=24590883;
CC   Population: Caucasian; German.
CC   Virology: Contains 25 copies of the EBV genome (PubMed=6244869).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5715; IGK + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGK (PubMed=3458667; PubMed=6806672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   JIH-3
AC   CVCL_8884
DR   Wikidata; Q54898920
RX   PubMed=22340903;
CC   Population: Chinese.
CC   Doubling time: ~102.5 hours (PubMed=22340903).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   JIH-4
AC   CVCL_A454
DR   Wikidata; Q54898921
RX   PubMed=21536242;
CC   Population: Chinese.
CC   Doubling time: ~84.4 hours (PubMed=21536242).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=21536242).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   JIH-5
AC   CVCL_EQ76
DR   DSMZ; ACC-788
DR   DSMZCellDive; ACC-788
DR   Wikidata; Q54898922
RX   PubMed=26293203;
CC   Population: Chinese.
CC   Doubling time: 97 hours (PubMed=26293203); ~5-7 days (DSMZ=ACC-788).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-788
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 16
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4673; Acute biphenotypic leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 02-05-24; Version: 11
//
ID   JII1
AC   CVCL_V086
DR   CLO; CLO_0007023
DR   CLDB; cl2944
DR   IHW; 11w 8031
DR   Wikidata; Q54898923
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   JIL-2266
AC   CVCL_A1TT
SY   JIL-O
DR   Wikidata; Q105509737
RX   DOI=10.1530/endoabs.70.AEP83;
RX   PubMed=33830941;
RX   PubMed=35764904;
CC   Doubling time: ~39 hours (DOI=10.1530/endoabs.70.AEP83); 41 hours (PubMed=33830941).
CC   Sequence variation: Mutation; HGNC; HGNC:7527; MUTYH; Simple; p.Arg106Trp (c.316C>T) (p.Arg81Trp, c.241C>T); ClinVar=VCV000183896; Zygosity=Heterozygous; Note=Germline (PubMed=33830941).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Hemizygous (DOI=10.1530/endoabs.70.AEP83; PubMed=33830941).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): PubMed=33830941
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 13
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 8
ST   TPOX: 12
ST   vWA: 18
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   JIM1
AC   CVCL_2532
SY   JIM-1
DR   CancerTools; 151449
DR   Cosmic; 888015
DR   ECACC; 10032303
DR   Wikidata; Q54898924
DR   Ximbio; 151449
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1943229;
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=11021758;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5905; IGLV3-21; Name(s)=IGLV3-21-IGLJ3 (CelloPub=CLPUB00604).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 10032303; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2533 ! JIM3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   JIM11
AC   CVCL_C3B3
DR   Wikidata; Q114311776
RX   DOI=10.1046/j.1365-313X.1994.05020237.x;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Arabinogalactan type I.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM12
AC   CVCL_C3B4
DR   Wikidata; Q114311777
RX   DOI=10.1046/j.1365-313X.1994.05020237.x;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type II.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM13
AC   CVCL_C3B5
DR   Wikidata; Q114311778
RX   DOI=10.1046/j.1365-313X.1994.05020237.x;
RX   PubMed=20363856;
RX   PubMed=21736649;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type IV.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM14
AC   CVCL_C3B6
DR   Wikidata; Q114311779
RX   PubMed=20363856;
RX   PubMed=21736649;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type II.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM15
AC   CVCL_C3B7
DR   Wikidata; Q114311780
RX   PubMed=20363856;
RX   PubMed=21736649;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM16
AC   CVCL_C3B8
DR   Wikidata; Q114311781
RX   PubMed=20363856;
RX   PubMed=21736649;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rhamnogalacturonan I/arabinogalactan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM17
AC   CVCL_C3B9
DR   Wikidata; Q114311782
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM20
AC   CVCL_C3BA
DR   Wikidata; Q114311783
RX   DOI=10.1046/j.1365-313X.1994.05020237.x;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type I.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM3
AC   CVCL_2533
SY   JIM-3; Jim3
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_2533
DR   CancerTools; 151450
DR   Cosmic; 720770
DR   Cosmic; 850217
DR   Cosmic; 888016
DR   Cosmic; 2081384
DR   Cosmic; 2367268
DR   Cosmic; 2809767
DR   ECACC; 10081204
DR   IARC_TP53; 28517
DR   Wikidata; Q54898926
DR   Ximbio; 151450
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1943229;
RX   PubMed=8943038;
RX   PubMed=9787181;
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=21173094;
RX   PubMed=25688540;
RX   PubMed=30545397;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   HLA typing: A*02; B*27,40; C*02,03 (PubMed=25688540).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5905; IGLV3-21; Name(s)=IGLV3-21-IGLJ3 (CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=11157491; PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ECACC; 10081204; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2532 ! JIM1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   JIM3 [Rat hybridoma against rhamnogalacturonan]
AC   CVCL_C3BB
DR   Wikidata; Q114311784
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Linseed mucilage rhamnogalacturonan I.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM4
AC   CVCL_C3BC
DR   Wikidata; Q114311785
RX   PubMed=20363856;
RX   PubMed=21736649;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM5
AC   CVCL_C3BD
DR   Wikidata; Q114311786
RX   PubMed=20363856;
RX   PubMed=24196931;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM7
AC   CVCL_C3BE
DR   Wikidata; Q114311787
RX   PubMed=20363856;
RX   PubMed=24196931;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Pectin backbone.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIM8
AC   CVCL_C3BF
DR   Wikidata; Q114311789
RX   PubMed=20363856;
RX   PubMed=21736649;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   JIMT-1
AC   CVCL_2077
SY   JIMT1; JIMT
DR   BTO; BTO_0004312
DR   CLO; CLO_0009912
DR   EFO; EFO_0005388
DR   AddexBio; C0006005/50
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 627
DR   BioSample; SAMN03473040
DR   BioSample; SAMN10989571
DR   cancercelllines; CVCL_2077
DR   Cell_Model_Passport; SIDM01037
DR   ChEMBL-Cells; CHEMBL4295430
DR   ChEMBL-Targets; CHEMBL4296443
DR   Cosmic; 1348959
DR   Cosmic; 2165010
DR   Cosmic-CLP; 1298157
DR   DepMap; ACH-000711
DR   DSMZ; ACC-589
DR   DSMZCellDive; ACC-589
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1298157
DR   GEO; GSM155212
DR   GEO; GSM274696
DR   GEO; GSM274707
DR   GEO; GSM783975
DR   GEO; GSM827173
DR   GEO; GSM847393
DR   GEO; GSM847489
DR   GEO; GSM887183
DR   GEO; GSM888256
DR   GEO; GSM1172878
DR   GEO; GSM1172971
DR   GEO; GSM1374578
DR   IARC_TP53; 28224
DR   LiGeA; CCLE_176
DR   LINCS_HMS; 51118
DR   LINCS_LDP; LCL-1482
DR   PharmacoDB; JIMT1_702_2019
DR   PRIDE; PXD000691
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2077
DR   PubChem_Cell_line; CVCL_2077
DR   SLKBase; 3562
DR   Ubigene; YC-C046
DR   Wikidata; Q54898927
RX   PubMed=15634652;
RX   PubMed=17334996;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26055192;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: ER-negative. Has amplified ERBB2 and is insensitive to trastuzumab (Herceptin) (PubMed=15634652).
CC   Doubling time: ~30-40 hours (DSMZ=ACC-589); 35.39 hours (JWGray panel).
CC   HLA typing: A*03:01,68:01; B*08:01,35:08; C*03:04,07:06 (PubMed=25960936).
CC   HLA typing: A*03:01,68:01; B*08:01,40:01; C*03:04,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (DepMap=ACH-000711).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (DepMap=ACH-000711).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.6%; Native American=0.79%; East Asian, North=7.75%; East Asian, South=0%; South Asian=0%; European, North=71.27%; European, South=16.59% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006005/50; Cosmic-CLP=1298157; DSMZ=ACC-589; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 16
ST   D12S391: 17
ST   D13S317: 8,13
ST   D16S539: 11
ST   D18S51: 10
ST   D19S433: 12,13
ST   D1S1656: 11
ST   D21S11: 27,31.2
ST   D22S1045: 11,16
ST   D2S1338: 24
ST   D2S441: 11.3,14
ST   D3S1358: 18
ST   D5S818: 12,13,14
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 7,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   JIMT-1-Luc
AC   CVCL_C8V0
DR   Ubigene; YC-C046-Luc-P
DR   Wikidata; Q123032768
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2077 ! JIMT-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   JinB8
AC   CVCL_1Y74
SY   JINB8
DR   EFO; EFO_0006281
DR   cancercelllines; CVCL_1Y74
DR   Wikidata; Q54898928
RX   PubMed=10330276;
CC   Population: Caucasian.
CC   Characteristics: CD47-deficient.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 17
//
ID   Jiyoye
AC   CVCL_1317
SY   JIYOYE; Jijoye; JIJOYE; P-2003; P3 (Jiyoye); P-3-Jijoye; P3-Jiyoye; P-3J; P3J; Jiyoye(P-2003); Jiyoye (P-2003); JiyoyeP-2003; JIYOYEP2003; OB2; GM04678
DR   CLO; CLO_0007025
DR   CLO; CLO_0019011
DR   EFO; EFO_0002215
DR   CLDB; cl2945
DR   CLDB; cl2946
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-87
DR   ATCC; CRL-7933
DR   BioGRID_ORCS_Cell_line; 270
DR   BioSample; SAMN01821570
DR   BioSample; SAMN01821640
DR   BioSample; SAMN03471289
DR   cancercelllines; CVCL_1317
DR   Cell_Model_Passport; SIDM00808
DR   ChEMBL-Cells; CHEMBL3307658
DR   ChEMBL-Targets; CHEMBL614588
DR   CLS; 300366
DR   Coriell; GM04678
DR   Cosmic; 687846
DR   Cosmic; 907268
DR   Cosmic; 931105
DR   Cosmic; 1818344
DR   Cosmic; 2822950
DR   Cosmic-CLP; 907268
DR   DepMap; ACH-002252
DR   DSMZ; ACC-590
DR   DSMZCellDive; ACC-590
DR   ECACC; 88071302
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907268
DR   GEO; GSM1669960
DR   IARC_TP53; 702
DR   IGRhCellID; Jiyoye
DR   IZSLER; BS TCL 32
DR   KCLB; 10087
DR   LINCS_LDP; LCL-2021
DR   NCBI_Iran; C117
DR   PharmacoDB; Jiyoye_703_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1317
DR   PubChem_Cell_line; CVCL_1317
DR   Wikidata; Q54898929
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/BF02618370;
RX   PubMed=1915267;
RX   PubMed=2998993;
RX   PubMed=3026973;
RX   PubMed=3518877;
RX   PubMed=4169243;
RX   PubMed=4321017;
RX   PubMed=4321974;
RX   PubMed=4736620;
RX   PubMed=4894370;
RX   PubMed=5260617;
RX   PubMed=5786183;
RX   PubMed=6018567;
RX   PubMed=6231253;
RX   PubMed=6500159;
RX   PubMed=7316467;
RX   PubMed=8108117;
RX   PubMed=8515068;
RX   PubMed=9473234;
RX   PubMed=17254797;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=25485619;
RX   PubMed=25787276;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African; Nigerian.
CC   Virology: Contains a complete EBV genome (strain Jiyoye) which has been sequenced (PubMed=25787276).
CC   Doubling time: ~30-60 hours (DSMZ=ACC-590).
CC   HLA typing: A*03:01,74:01; B*53:01,58:01; C*04:01,04:01; DQA1*01:02,05:01; DQB1*03:01,06:02; DRB1*11:02,15:03 (PubMed=26589293).
CC   HLA typing: A*03:01:01,74:01:01; B*53:01:01,58:01:01; C*04:01:01; DPB1*01:01:01,02:01:02; DQA1*01:02:01,05:05:01; DQB1*03:19:01,06:02:01; DRB1*11:02:01,15:03:01 (CLS=300366).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (PubMed=1915267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=92.69%; Native American=0%; East Asian, North=2.15%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=5.16% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7933; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-87; CLS=300366; Cosmic-CLP=907268; DSMZ=ACC-590; ECACC=88071302; IZSLER=BS TCL 32; KCLB=10087; PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,10 (PubMed=17254797)
ST   D16S539: 10,11 (ATCC=CCL-87; CLS=300366; Cosmic-CLP=907268; DSMZ=ACC-590; ECACC=88071302; IZSLER=BS TCL 32; KCLB=10087)
ST   D18S51: 12
ST   D19S433: 12,15
ST   D21S11: 27 (PubMed=17254797)
ST   D21S11: 28,36 (ATCC=CCL-87; CLS=300366; DSMZ=ACC-590; IZSLER=BS TCL 32)
ST   D2S1338: 21
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   Penta D: 2.2,12 (ATCC=CCL-87; CLS=300366)
ST   Penta D: 3,12 (DSMZ=ACC-590)
ST   Penta E: 8,12
ST   TH01: 7,9
ST   TPOX: 6,8
ST   vWA: 15,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   JJ0016
AC   CVCL_8X72
DR   ECACC; 90091401
DR   Wikidata; Q54898930
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X)(q27) (ECACC=90091401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0035
AC   CVCL_8X73
DR   ECACC; 91071906
DR   Wikidata; Q54898931
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X)(q27.3) 10% in 70 metaphases (ECACC=91071906).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   JJ0038
AC   CVCL_8X74
DR   ECACC; 91080806
DR   Wikidata; Q54898932
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X)(q27) (ECACC=91080806).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0039
AC   CVCL_8X75
DR   ECACC; 91082130
DR   Wikidata; Q54898933
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(16;17)(p13;q12) (ECACC=91082130).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91082130; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   JJ0040
AC   CVCL_8X76
DR   ECACC; 91091106
DR   Wikidata; Q54898934
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0042
AC   CVCL_8X77
DR   ECACC; 91102601
DR   Wikidata; Q54898935
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,Y,r(X)(p22.3;q28) (ECACC=91102601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125488; Seckel syndrome
DI   ORDO; Orphanet_808; Seckel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0048
AC   CVCL_8X78
DR   ECACC; 92012303
DR   Wikidata; Q54898936
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X)(q27) (ECACC=92012303).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0049
AC   CVCL_8X79
DR   ECACC; 92012304
DR   Wikidata; Q54898937
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X)(q27) (ECACC=92012304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0051
AC   CVCL_8X80
DR   ECACC; 92012306
DR   Wikidata; Q54898938
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0052
AC   CVCL_8X81
DR   ECACC; 92012307
DR   Wikidata; Q54898940
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X)(q27) (ECACC=92012307).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0053
AC   CVCL_8X82
DR   ECACC; 92020605
DR   Wikidata; Q54898941
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,fra(X)(q27.3) (ECACC=92020605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0054
AC   CVCL_8X83
DR   ECACC; 92041013
DR   Wikidata; Q54898942
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,fra(X)(q27.3) (ECACC=92041013).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0055
AC   CVCL_8X84
DR   ECACC; 92041014
DR   Wikidata; Q54898943
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,fra(X)(q27.3) (ECACC=92041014).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92041014; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   JJ0056
AC   CVCL_8X85
DR   ECACC; 92072312
DR   Wikidata; Q54898944
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92072312; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   JJ0057
AC   CVCL_8X86
DR   ECACC; 92080607
DR   Wikidata; Q54898945
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   JJ0060
AC   CVCL_8X87
DR   ECACC; 92080610
DR   Wikidata; Q54898948
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,+fra(X) (ECACC=92080610).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ0061
AC   CVCL_8X88
DR   ECACC; 92080611
DR   Wikidata; Q54898949
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,+fra(X) (ECACC=92080611).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   JJ012
AC   CVCL_D605
SY   JJO12; JJ
DR   BTO; BTO_0005168
DR   EFO; EFO_0006604
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03470880
DR   cancercelllines; CVCL_D605
DR   Cosmic; 1602476
DR   Cosmic; 1992323
DR   EGA; EGAS00001000610
DR   GEO; GSM1676351
DR   GEO; GSM1701681
DR   IARC_TP53; 27035
DR   PharmacoDB; JJ012_705_2019
DR   Wikidata; Q54898950
RX   PubMed=8689637;
RX   PubMed=10906887;
RX   PubMed=12168675;
RX   PubMed=12354749;
RX   PubMed=19787792;
RX   PubMed=22057234;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26368816;
RX   PubMed=26589293;
CC   Doubling time: 0.9 day (PubMed=12168675).
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Gly (c.394C>G); ClinVar=VCV000375892; Zygosity=Heterozygous (PubMed=22057234; PubMed=26368816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly199Val (c.596G>T); ClinVar=VCV000451799; Zygosity=Unspecified (PubMed=19787792).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=19787792; PubMed=25877200
ST   Amelogenin: X (PubMed=25877200)
ST   Amelogenin: X,Y (PubMed=19787792)
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15 (PubMed=25877200)
ST   D18S51: 15,17 (PubMed=19787792)
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 15,16,17,18 (PubMed=25877200)
ST   D3S1358: 16,17 (PubMed=19787792)
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 11,13
ST   Penta E: 7,15
ST   SE33: 20.2,21
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 15,16 (PubMed=25877200)
ST   vWA: 15,19 (PubMed=19787792)
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 28
//
ID   JJ012-TS4
AC   CVCL_D901
DR   BTO; BTO_0003043
DR   cancercelllines; CVCL_D901
DR   Wikidata; Q54898951
RX   PubMed=11796708;
RX   PubMed=14701864;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Gly (c.394C>G); ClinVar=VCV000375892; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly199Val (c.596G>T); ClinVar=VCV000451799; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:220; ADAMTS4.
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D605 ! JJ012
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   JJ316
AC   CVCL_E9W7
RX   PubMed=9022025;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31042; Rat Cd28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JJ319
AC   CVCL_E9W8
RX   PubMed=7730618;
RX   PubMed=9022025;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P31042; Rat Cd28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JJN-1
AC   CVCL_L066
SY   JJN1
DR   Wikidata; Q54898952
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2495201;
RX   PubMed=10936422;
CC   Population: Caucasian.
CC   Characteristics: Produces IgA1 kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 10 days (PubMed=2495201).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   JJN-2
AC   CVCL_L067
SY   JJN2
DR   Wikidata; Q54898953
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2495201;
RX   PubMed=10936422;
CC   Population: Caucasian.
CC   Characteristics: Produces IgA1 kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 3-4 days (PubMed=2495201).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L066 ! JJN-1
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   JJN-3
AC   CVCL_2078
SY   JJN3
DR   CLO; CLO_0037173
DR   EFO; EFO_0006605
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-1088
DR   BioSample; SAMN03472931
DR   BioSample; SAMN10988455
DR   cancercelllines; CVCL_2078
DR   Cell_Model_Passport; SIDM01036
DR   ChEMBL-Cells; CHEMBL4295422
DR   ChEMBL-Targets; CHEMBL4296444
DR   Cosmic; 720788
DR   Cosmic; 742956
DR   Cosmic; 888017
DR   Cosmic; 1483076
DR   Cosmic; 1889516
DR   Cosmic; 2081385
DR   Cosmic; 2131563
DR   Cosmic; 2302418
DR   Cosmic; 2367283
DR   Cosmic; 2391793
DR   Cosmic; 2809765
DR   Cosmic-CLP; 1327766
DR   DepMap; ACH-000653
DR   DSMZ; ACC-541
DR   DSMZCellDive; ACC-541
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002414
DR   GDSC; 1327766
DR   GEO; GSM143339
DR   GEO; GSM290291
DR   GEO; GSM1374579
DR   GEO; GSM1669961
DR   IARC_TP53; 30088
DR   LiGeA; CCLE_598
DR   LINCS_LDP; LCL-2052
DR   PharmacoDB; JJN3_706_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_2078
DR   Wikidata; Q54898954
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=1943229;
RX   PubMed=8943038;
RX   PubMed=10087940;
RX   PubMed=10557056;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=11154231;
RX   PubMed=11157491;
RX   PubMed=11429052;
RX   PubMed=16956823;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=21173094;
RX   PubMed=22806891;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=JJN-3
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Produces IgA1 kappa.
CC   Characteristics: IL6 independent.
CC   Doubling time: 24 hours (PubMed=25984343); ~20-35 hours (DSMZ=ACC-541).
CC   HLA typing: A*03,33; B*07,14:02/03; C*07,08:02 (Direct_author_submission).
CC   HLA typing: A*03:01,33:01; B*07:02,14:02; C*07:02,08:02; DQA1*01:02,01:02; DQB1*05:01,06:02; DRB1*01:02,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1327766; DepMap=ACH-000653).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.8%; Native American=0%; East Asian, North=2.53%; East Asian, South=0%; South Asian=0%; European, North=64.14%; European, South=32.53% (PubMed=30894373).
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=1327766; DSMZ=ACC-541; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 28,33.2
ST   D2S1338: 19,22
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   Penta D: 11,12
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L066 ! JJN-1
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   JK [Boa]
AC   CVCL_T683
SY   Juliet's Kidneys
DR   Wikidata; Q54898955
RX   PubMed=22893382;
WW   Info; -; -; https://www.ucsf.edu/news/2012/08/12545/mysterious-snake-disease-decoded
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   JK [Human anaplastic large cell lymphoma]
AC   CVCL_H635
DR   Wikidata; Q54898957
RX   PubMed=10515889;
RX   PubMed=15356658;
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   JK-1
AC   CVCL_2079
SY   JK1
DR   CLO; CLO_0007026
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473358
DR   BioSample; SAMN10988504
DR   cancercelllines; CVCL_2079
DR   Cell_Model_Passport; SIDM01727
DR   Cosmic; 787494
DR   Cosmic; 924046
DR   Cosmic; 1012071
DR   DepMap; ACH-000241
DR   DSMZ; ACC-347
DR   DSMZCellDive; ACC-347
DR   GEO; GSM887184
DR   GEO; GSM888257
DR   LiGeA; CCLE_718
DR   PharmacoDB; JK1_707_2019
DR   Progenetix; CVCL_2079
DR   Wikidata; Q54898958
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2169992;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20809971;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=2169992); ~50 hours (DSMZ=ACC-347).
CC   HLA typing: A*31:01,31:01; B*15:11,58:01; C*03:02,03:02; DQA1*02:01,05:02; DQB1*06:04,06:04; DRB1*13:02,14:05 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=20809971; DepMap=ACH-000241).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=74.72%; East Asian, South=25.28%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): DSMZ=ACC-347
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 9,13
ST   D18S51: 14,19
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 13
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 11,14
ST   Penta E: 16,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   JK-6
AC   CVCL_M534
DR   Wikidata; Q54898959
RX   CelloPub=CLPUB00060;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   JK-6L
AC   CVCL_0C41
SY   JK6L; JK-6 IL6-independent
DR   cancercelllines; CVCL_0C41
DR   Cosmic; 2081386
DR   DSMZ; ACC-860
DR   DSMZCellDive; ACC-860
DR   Wikidata; Q54898960
RX   CelloPub=CLPUB00604;
RX   PubMed=17308121;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=19621390;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: Compared to the parent cell line, it is no longer IL6 dependent.
CC   Doubling time: ~48 hours (DSMZ=ACC-860).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (DSMZ=ACC-860).
CC   Sequence variation: Mutation; HGNC; HGNC:7795; NFKB2; Simple; p.Arg725Glufs*18 (c.2171delC); Zygosity=Homozygous (PubMed=17692805).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Tyr64Asp (c.190T>G); dbSNP=rs752508313; Zygosity=Unspecified (DSMZ=ACC-860).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Caution: Indicated as JK-6 in DSMZ, but the original JK-6 was IL-dependent and the IL-6 independent subline was called JK-6L (PubMed=19621390).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-860
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,13,16
ST   D19S433: 13,14
ST   D21S11: 31.2,32
ST   D2S1338: 16,17
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 10,14
ST   FGA: 19,23
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M534 ! JK-6
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 18
//
ID   JK-6L.31H
AC   CVCL_A5DY
DR   cancercelllines; CVCL_A5DY
DR   Wikidata; Q107115492
RX   PubMed=17308121;
CC   Characteristics: Produces high quantity of IgG kappa.
CC   Characteristics: IL6 independent.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7795; NFKB2; Simple; p.Arg725Glufs*18 (c.2171delC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Tyr64Asp (c.190T>G); dbSNP=rs752508313; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0C41 ! JK-6L
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   JK-6L.39L
AC   CVCL_A5DZ
DR   cancercelllines; CVCL_A5DZ
DR   Wikidata; Q107115494
RX   PubMed=17308121;
CC   Characteristics: Produces low quantity of IgG kappa.
CC   Characteristics: IL6 independent.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7795; NFKB2; Simple; p.Arg725Glufs*18 (c.2171delC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Tyr64Asp (c.190T>G); dbSNP=rs752508313; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0C41 ! JK-6L
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   JK-GMS
AC   CVCL_T755
DR   Wikidata; Q54898961
RX   PubMed=11850535;
RX   PubMed=14694527;
CC   Population: Korean.
CC   Doubling time: 38.4 hours (PubMed=11850535).
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   JK-NB1
AC   CVCL_W474
DR   Wikidata; Q54898962
RX   PubMed=8148311;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=8148311).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   JK-T1
AC   CVCL_DD43
DR   Wikidata; Q54898963
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1333881;
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=1333881).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   JK1
AC   CVCL_JZ08
SY   EmbryoMax JK1
DR   Cell_Biolabs; CBA-315
DR   Millipore; SCC169
DR   Wikidata; Q54898964
RX   PubMed=18669907;
CC   Characteristics: Supports the long-term proliferation of stem cells. May be used to culture a variety of cell types including ES cells, germ-line derived stem cells and primordial germ cell-derived EG cells.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   JK28
AC   CVCL_JL97
SY   JKBulk clone 28
DR   ATCC; CRL-3358
DR   cancercelllines; CVCL_JL97
DR   Wikidata; Q54898965
RX   PubMed=27057542;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a dCas9-BFP-KRAB construct.
CC   Doubling time: ~48 hours (ATCC=CRL-3358).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; SDS4K; BFP (Note=Blue fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-3358
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 7.3,8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL96 ! JKBulk
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 19
//
ID   JKB-1
AC   CVCL_QW92
SY   JKB1
DR   Wikidata; Q54898966
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8172177;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=8172177).
CC   Caution: The exact relationship between JKB-1 and JKB-2 is not explicited in the papers reporting their respective establishment.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QW93 ! JKB-2
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   JKB-2
AC   CVCL_QW93
SY   JKB2
DR   Wikidata; Q54898967
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8847892;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=8847892).
CC   Caution: The exact relationship between JKB-1 and JKB-2 is not explicited in the papers reporting their respective establishment.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QW92 ! JKB-1
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   JKBulk
AC   CVCL_JL96
DR   cancercelllines; CVCL_JL96
DR   Wikidata; Q54898968
RX   PubMed=27057542;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a dCas9-BFP-KRAB construct.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; SDS4K; BFP (Note=Blue fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 18
//
ID   JKM
AC   CVCL_A3AE
DR   CCLV; CCLV-RIE 0795
DR   Wikidata; Q105509740
RX   PubMed=25565633;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   JKM86-4
AC   CVCL_D7DT
RX   PubMed=1394095;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Leg, hypodermis; UBERON=UBERON_0000978+UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   JKM86-5
AC   CVCL_D7DU
RX   PubMed=1394095;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Greater omentum; UBERON=UBERON_0005448.
DI   NCIt; C9151; Lentigo maligna melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   JKM86-8
AC   CVCL_D7DV
RX   PubMed=1394095;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   JKM86-9
AC   CVCL_D7DW
RX   PubMed=1394095;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   JKT-1
AC   CVCL_T011
SY   JKT1
DR   Wikidata; Q54898970
RX   PubMed=9624562;
RX   PubMed=10210573;
RX   PubMed=17705808;
RX   PubMed=18008088;
RX   PubMed=23374840;
CC   Problematic cell line: Misclassified. Originally thought to be a seminoma cell line but shown not to be from germ cells. Its real nature is not clear (PubMed=17705808; PubMed=18008088).
CC   Population: Japanese.
CC   Doubling time: 28.5 hours (PubMed=10210573).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 15
//
ID   JKT-beta-del
AC   CVCL_2966
DR   CLO; CLO_0037174
DR   BioSample; SAMN03470812
DR   cancercelllines; CVCL_2966
DR   Cell_Model_Passport; SIDM01221
DR   JCRB; JCRB0147
DR   JCRB; NIHS0224
DR   LINCS_LDP; LCL-2060
DR   Wikidata; Q54898969
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0224; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB0147
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10,11
ST   D16S539: 11,12
ST   D5S818: 9
ST   D7S820: 8,10
ST   TH01: 6,10
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   JKT-HM
AC   CVCL_T014
DR   Wikidata; Q54898972
RX   PubMed=10210573;
RX   PubMed=17705808;
RX   PubMed=18008088;
CC   Problematic cell line: Misclassified. Parent cell line (JKT-1) was originally thought to be a seminoma cell line but shown not to be from germ cells. Its real nature is not clear (PubMed=17705808; PubMed=18008088).
CC   Population: Japanese.
CC   Doubling time: 27.9 hours (PubMed=10210573).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T011 ! JKT-1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   JL-1
AC   CVCL_2080
SY   JL1
DR   EFO; EFO_0006448
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473060
DR   BioSample; SAMN10988459
DR   cancercelllines; CVCL_2080
DR   Cell_Model_Passport; SIDM01696
DR   DepMap; ACH-000645
DR   DSMZ; ACC-596
DR   DSMZCellDive; ACC-596
DR   EGA; EGAS00001000610
DR   GEO; GSM887185
DR   GEO; GSM888258
DR   LiGeA; CCLE_059
DR   PharmacoDB; JL1_708_2019
DR   Progenetix; CVCL_2080
DR   Wikidata; Q54898973
RX   PubMed=15372243;
RX   PubMed=22460905;
RX   PubMed=23840376;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=33567673;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 47 hours (PubMed=23840376); ~70-80 hours (DSMZ=ACC-596).
CC   HLA typing: A*02:05,03:01; B*49:01,55:01; C*03:04,07:01; DQA1*05:02,05:02; DQB1*06:04,06:04; DRB1*04:05,11:30 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.03%; Native American=0%; East Asian, North=3.05%; East Asian, South=0%; South Asian=2.74%; European, North=56.74%; European, South=37.42% (PubMed=30894373).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): DSMZ=ACC-596; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 15
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 11,13
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   JL/AMSA
AC   CVCL_4V24
SY   JL AMSA
DR   cancercelllines; CVCL_4V24
DR   Wikidata; Q54898974
RX   PubMed=1989661;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2687; Amsacrine.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   JLI
AC   CVCL_5I41
DR   GEO; GSM1122232
DR   Wikidata; Q54898975
RX   PubMed=24582862;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_5I40 ! JHE
OI   CVCL_5I42 ! JLU
OI   CVCL_RG68 ! JSP
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   JLP
AC   CVCL_N703
SY   JLP(C)
DR   Cosmic; 2808229
DR   Wikidata; Q54898977
RX   PubMed=1325212;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6286763;
RX   PubMed=8176200;
RX   PubMed=8220424;
RX   PubMed=8515068;
RX   PubMed=8568269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   JLPC119
AC   CVCL_W748
SY   JLP(C)119; JLPC 119; JLPc119; JLP119
DR   Wikidata; Q54898978
RX   PubMed=3100061;
RX   PubMed=6286763;
RX   PubMed=8176200;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8568269;
RX   PubMed=9192833;
RX   PubMed=9973220;
CC   Virology: EBV-negative.
CC   Doubling time: 22 hours (PubMed=8402660).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   JLS-V5
AC   CVCL_2534
SY   JLS V5; JLSV5
DR   CLO; CLO_0007027
DR   ATCC; CRL-6359
DR   Wikidata; Q54898979
RX   PubMed=58965;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6359; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   21-31D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   JLS-V9
AC   CVCL_2535
SY   JLSV-9; JLSV9
DR   CLO; CLO_0007028
DR   CLO; CLO_0051026
DR   CLDB; cl2947
DR   ATCC; CRL-6360
DR   RCB; RCB2651
DR   TKG; TKG 0355
DR   Wikidata; Q54898980
RX   PubMed=4129475;
RX   PubMed=6057678;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Can be used to produce Rauscher leukemia virus (PubMed=4129475).
CC   Discontinued: ATCC; CRL-6360; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   21-31D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   JLS-V9 6TG
AC   CVCL_B949
DR   CLO; CLO_0050197
DR   RCB; RCB2896
DR   TKG; TKG 0350
DR   Wikidata; Q54898981
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2535 ! JLS-V9
SX   Sex unspecified
AG   21-31D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   JLS-V9 BudR
AC   CVCL_F944
DR   CLO; CLO_0051027
DR   RCB; RCB2644
DR   RCB; RCB3515
DR   TKG; TKG 0356
DR   Wikidata; Q54898982
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Discontinued: RCB; RCB2644; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2535 ! JLS-V9
SX   Sex unspecified
AG   21-31D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   JLS-V9R
AC   CVCL_HA49
SY   JLS-V10
DR   Wikidata; Q54898983
RX   PubMed=58965;
RX   PubMed=6057678;
CC   Virology: In vitro infected by R-MuLV.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2535 ! JLS-V9
SX   Sex unspecified
AG   21-31D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   JLTRG
AC   CVCL_1E01
SY   JLTR-RS; Jurkat LTR-GFP
DR   BEI_Resources; ARP-11587
DR   cancercelllines; CVCL_1E01
DR   Wikidata; Q54898984
RX   PubMed=15105117;
RX   PubMed=16454046;
CC   Population: Caucasian.
CC   Virology: Reporter cell line that expresses eGFP as a direct and quantitative marker of HIV-1 infection. The expression of eGFP is under the control of a HIV-1 LTR.
CC   Doubling time: 24-48 hours (BEI_Resources=ARP-11587).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 22
//
ID   JLTRG-R5
AC   CVCL_1E02
SY   Jurkat LTR-GFP CCR5+
DR   BEI_Resources; ARP-11586
DR   cancercelllines; CVCL_1E02
DR   Wikidata; Q54898985
RX   PubMed=16454046;
CC   Population: Caucasian.
CC   Virology: Reporter cell line that expresses eGFP as a direct and quantitative marker of HIV-1 infection. The expression of eGFP is under the control of a HIV-1 LTR.
CC   Doubling time: 24-48 hours (BEI_Resources=ARP-11586).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E01 ! JLTRG
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 20
//
ID   JLU
AC   CVCL_5I42
DR   GEO; GSM1122230
DR   Wikidata; Q54898986
RX   PubMed=24582862;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_5I40 ! JHE
OI   CVCL_5I41 ! JLI
OI   CVCL_RG68 ! JSP
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   JLUe003-A
AC   CVCL_B7BT
SY   WA01-GFI1-flag-KI
DR   BioSamples; SAMEA12941065
DR   hPSCreg; JLUe003-A
DR   Wikidata; Q112929895
RX   PubMed=35248880;
CC   From: Jilin University; Changchun; China.
CC   Characteristics: Using CRISPR/Cas9 two FLAG tags were introduced at the C-terminus of one allele of GFI1 (PubMed=35248880).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 6
//
ID   JLUEYEi001-A
AC   CVCL_A5QB
SY   SticklerIPSC1
DR   hPSCreg; JLUEYEi001-A
DR   Wikidata; Q107115496
RX   PubMed=33647874;
CC   From: Eye Center of Second Hospital, Jilin University; Changchun; China.
CC   Population: Mongolian.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Unexplicit; IVS22-1C>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33647874).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168733; Stickler syndrome type 1
DI   ORDO; Orphanet_90653; Stickler syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   JLUEYEi002-A
AC   CVCL_A5QF
SY   Healthyctrl1
DR   hPSCreg; JLUEYEi002-A
DR   Wikidata; Q107115498
RX   PubMed=33677395;
CC   From: Eye Center of Second Hospital, Jilin University; Changchun; China.
CC   Population: Mongolian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   JM [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC21
SY   McA
DR   Wikidata; Q98126794
RX   PubMed=16099873;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   JM [Human neuroblastoma]
AC   CVCL_S103
DR   Wikidata; Q54898987
RX   PubMed=7073944;
CC   Doubling time: 35.2 hours (PubMed=7073944).
CC   Derived from site: In situ; Mesentery; UBERON=UBERON_0002095.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   JM-1
AC   CVCL_3532
SY   JM1
DR   CLO; CLO_0007030
DR   EFO; EFO_0002212
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-10423
DR   BCRC; 60513
DR   BioSample; SAMN03471300
DR   BioSample; SAMN10987951
DR   cancercelllines; CVCL_3532
DR   Cell_Model_Passport; SIDM00689
DR   ChEMBL-Cells; CHEMBL3308496
DR   ChEMBL-Targets; CHEMBL614589
DR   Cosmic; 2491096
DR   Cosmic-CLP; 1327768
DR   DepMap; ACH-000151
DR   EGA; EGAS00001000978
DR   GDSC; 1327768
DR   GEO; GSM887186
DR   GEO; GSM888259
DR   GEO; GSM1669962
DR   IARC_TP53; 30091
DR   IGRhCellID; JM1
DR   LiGeA; CCLE_153
DR   LINCS_LDP; LCL-1947
DR   PharmacoDB; JM1_709_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3532
DR   PubChem_Cell_line; CVCL_3532
DR   Wikidata; Q54898988
RX   Patent=US5976860;
RX   PubMed=2647717;
RX   PubMed=9067587;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10423.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*07:02,51:01; C*07:02,16:01; DQA1*03:02,04:01; DQB1*03:03,04:02; DRB1*08:01,09:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.68%; East Asian, South=0%; South Asian=0%; European, North=66.6%; European, South=31.71% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-10423; BCRC=60513; Cosmic-CLP=1327768
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13,17
ST   D19S433: 15,16.2
ST   D21S11: 30
ST   D2S1338: 19,22
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 8,9
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   JM1
AC   CVCL_F242
DR   Wikidata; Q54898989
RX   PubMed=6131863;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_3384 ! JM2
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   JM2
AC   CVCL_3384
DR   CLO; CLO_0007031
DR   CLDB; cl4959
DR   ICLC; ATL99009
DR   Wikidata; Q54898994
RX   PubMed=6131863;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F242 ! JM1
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   JM8
AC   CVCL_J957
DR   MMRRC; MMRRC:050957-UCD
DR   Wikidata; Q54898995
RX   PubMed=19525957;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   JM8.F6
AC   CVCL_J961
DR   BioGRID_ORCS_Cell_line; 751
DR   MMRRC; MMRRC:050958-UCD
DR   Wikidata; Q54899000
RX   PubMed=19525957;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J957 ! JM8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   JM8.N4
AC   CVCL_J962
DR   4DN; 4DNSRHAXQ8PG
DR   MMRRC; MMRRC:050959-UCD
DR   Wikidata; Q54899001
RX   PubMed=19525957;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J957 ! JM8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   JM86
AC   CVCL_X916
SY   JM-86; Japanese Monkey 86
DR   Wikidata; Q54898996
RX   PubMed=2579038;
RX   PubMed=6093374;
RX   PubMed=7535998;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   JM8A1.N3
AC   CVCL_J958
DR   MMRRC; MMRRC:050962-UCD
DR   Wikidata; Q54898997
WW   Info; MMRRC; -; https://mmrrc.ucdavis.edu/doc/MMRRC%20Cell%20Culturing%20Protocol%20for%20JM8A.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J957 ! JM8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   JM8A3
AC   CVCL_J959
SY   JM8.A3
DR   MMRRC; MMRRC:050960-UCD
DR   Wikidata; Q54898998
RX   PubMed=19525957;
RX   PubMed=25277546;
WW   Info; MMRRC; -; https://mmrrc.ucdavis.edu/doc/MMRRC%20Cell%20Culturing%20Protocol%20for%20JM8A.pdf
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J957 ! JM8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   JM8A3.N1
AC   CVCL_J960
DR   MMRRC; MMRRC:050961-UCD
DR   Wikidata; Q54898999
WW   Info; MMRRC; -; https://mmrrc.ucdavis.edu/doc/MMRRC%20Cell%20Culturing%20Protocol%20for%20JM8A.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J959 ! JM8A3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   JMA
AC   CVCL_HA40
DR   BCRJ; 0124
DR   Wikidata; Q54899002
RX   PubMed=23257665;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): BCRJ=0124
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 8,12
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 16,23
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 11,14
ST   FGA: 24,25
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: Not_detected
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 02-05-24; Version: 8
//
ID   JMAM-1
AC   CVCL_F0HB
RX   PubMed=33625287;
RX   PubMed=33625289;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JMAR
AC   CVCL_1Q86
DR   BioSample; SAMN03151990
DR   Wikidata; Q54899003
RX   PubMed=12907203;
RX   PubMed=16978912;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00407.
CC   Population: Caucasian.
CC   Characteristics: Anoikis-resistant (PubMed=12907203).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12,13
ST   D13S317: 8,11,12
ST   D16S539: 8,9,12,13
ST   D5S818: 10,12,13
ST   D7S820: 9,10,12
ST   TH01: 6,8
ST   TPOX: 8,10,11
ST   vWA: 15,16,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   JMAR C39
AC   CVCL_WI16
SY   JMARC39; C39
DR   Wikidata; Q94331049
RX   PubMed=16978912;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
CC   Population: Caucasian.
CC   Characteristics: Anoikis-resistant (PubMed=16978912).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 7
//
ID   JMAR C42
AC   CVCL_WI17
SY   JMARC42; C42
DR   Wikidata; Q94331053
RX   PubMed=16978912;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
CC   Population: Caucasian.
CC   Characteristics: Anoikis-resistant (PubMed=16978912).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 7
//
ID   JMC1
AC   CVCL_RK82
DR   SKIP; SKIP001701
DR   Wikidata; Q54899005
RX   PubMed=28089908;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   JME/CF 12
AC   CVCL_IN69
SY   JME/CF12
DR   Wikidata; Q54899006
RX   PubMed=1701980;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=1701980).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 17
//
ID   JME/CF 15
AC   CVCL_IN70
SY   JME/CF15
DR   Wikidata; Q54899007
RX   PubMed=1701980;
RX   PubMed=15463957;
RX   PubMed=19584307;
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=1701980).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 17
//
ID   JME/Nl 13
AC   CVCL_A8X3
DR   Wikidata; Q102114315
RX   PubMed=1701980;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   JME/Nl 7
AC   CVCL_A8X2
DR   Wikidata; Q102114316
RX   PubMed=1701980;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   JMMT-1-Luc#10
AC   CVCL_XD23
DR   JCRB; JCRB1793
DR   JCRB; NIHS1216
DR   Wikidata; Q94331094
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; JCRB1793; probable.
CC   Discontinued: JCRB; NIHS1216; true.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   JMN
AC   CVCL_M005
DR   BioSamples; SAMEA100956
DR   cancercelllines; CVCL_M005
DR   Cosmic; 733818
DR   Cosmic; 1522776
DR   Cosmic; 1541210
DR   GEO; GSM726271
DR   IARC_TP53; 942
DR   Progenetix; CVCL_M005
DR   Wikidata; Q54899008
RX   PubMed=1568228;
RX   PubMed=3334988;
RX   PubMed=7106748;
RX   PubMed=21642991;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=1568228).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   JMN-1B
AC   CVCL_M006
SY   JMN 1B; JMN1B
DR   GEO; GSM49617
DR   Wikidata; Q54899009
RX   PubMed=2787682;
RX   PubMed=15920167;
RX   PubMed=19853261;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M005 ! JMN
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   JMP-1
AC   CVCL_UJ14
SY   JMP1
DR   ATCC; CRL-3378
DR   Wikidata; Q94331135
RX   PubMed=16497967;
RX   PubMed=29666304;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3378
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 6
//
ID   JMRD3
AC   CVCL_D592
DR   Wikidata; Q54899010
RX   PubMed=7994044;
RX   PubMed=8635507;
CC   Selected for resistance to: ChEBI; CHEBI_73558; Vitamin D3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D591 ! RWLeu-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   JMS-3
AC   CVCL_ZF27
DR   Wikidata; Q98126795
RX   PubMed=22246506;
RX   PubMed=25180691;
RX   PubMed=32358867;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   JMSU-1
AC   CVCL_2081
SY   JMSU1
DR   CLO; CLO_0050846
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 626
DR   BioSample; SAMN03472026
DR   BioSample; SAMN03473570
DR   BioSample; SAMN10988102
DR   cancercelllines; CVCL_2081
DR   Cell_Model_Passport; SIDM01587
DR   Cosmic; 1285120
DR   Cosmic; 2050446
DR   Cosmic; 2057451
DR   Cosmic; 2444245
DR   Cosmic; 2686098
DR   DepMap; ACH-000753
DR   DSMZ; ACC-505
DR   DSMZCellDive; ACC-505
DR   FANTOM5_SSTAR; 10492-107B6
DR   GEO; GSM887187
DR   GEO; GSM888260
DR   IARC_TP53; 28279
DR   LiGeA; CCLE_366
DR   PharmacoDB; JMSU1_710_2019
DR   Progenetix; CVCL_2081
DR   RCB; RCB2227
DR   Wikidata; Q54899011
RX   PubMed=7483139;
RX   PubMed=22460905;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=26589293;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=7483139); ~30 hours (DSMZ=ACC-505).
CC   HLA typing: A*31:01,31:01; B*67:01,67:01; C*07:02,07:02; DQA1*03:02,04:01; DQB1*02:02,03:04; DRB1*04:08,04:08 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (DepMap=ACH-000753).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.12%; Native American=0.3%; East Asian, North=80.58%; East Asian, South=16.26%; South Asian=0%; European, North=0%; European, South=1.75% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-505; RCB=RCB2227
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8 (RCB=RCB2227)
ST   D13S317: 8,12 (DSMZ=ACC-505)
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 16
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,18 (DSMZ=ACC-505)
ST   vWA: 14,19 (RCB=RCB2227)
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   JMU-RTK-1
AC   CVCL_4W57
SY   JMURTK1
DR   Wikidata; Q54899012
RX   PubMed=19383826;
CC   Population: Japanese.
CC   Doubling time: ~9 hours (PubMed=19383826).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   JMU-RTK-2
AC   CVCL_4W58
SY   JMURTK2
DR   cancercelllines; CVCL_4W58
DR   Cell_Model_Passport; SIDM01586
DR   DepMap; ACH-001532
DR   JCRB; JCRB1484
DR   Wikidata; Q54899014
RX   PubMed=19383826;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~18 hours (PubMed=19383826); ~36 hours (Note=Lot 11242017) (JCRB=JCRB1484).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
ST   Source(s): DepMap=ACH-001532; JCRB=JCRB1484
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 10,15
ST   FGA: 23,26
ST   Penta D: 9,13
ST   Penta E: 12,15
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   JMUi001-A
AC   CVCL_ZL58
SY   FS hiPSC clone 2
DR   hPSCreg; JMUi001-A
DR   Wikidata; Q98126796
RX   PubMed=28382727;
RX   PubMed=33560471;
CC   From: Institute of Anatomy, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0GT ! JMUi001-B
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 7
//
ID   JMUi001-A-1
AC   CVCL_ZL59
SY   DNAJC19tv; UKWCHFi002-A-1
DR   hPSCreg; JMUi001-A-1
DR   Wikidata; Q98126798
RX   PubMed=32521499;
CC   From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30528; DNAJC19.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C173146; 3-methylglutaconic aciduria type 5
DI   ORDO; Orphanet_66634; Dilated cardiomyopathy with ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZL58 ! JMUi001-A
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   JMUi001-A-2
AC   CVCL_A5QH
SY   PKP2-KO; UKWCHFi002-A-2
DR   hPSCreg; JMUi001-A-2
DR   Wikidata; Q107115500
RX   PubMed=33640690;
CC   From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9024; PKP2.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZL58 ! JMUi001-A
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   JMUi001-A-3
AC   CVCL_A5QI
SY   DSG2-KO; UKWCHFi002-A-3
DR   hPSCreg; JMUi001-A-3
DR   Wikidata; Q107115501
RX   PubMed=33640690;
CC   From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C177248; Familial arrhythmogenic right ventricular dysplasia 10
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZL58 ! JMUi001-A
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   JMUi001-A-4
AC   CVCL_D6KN
SY   JUP-KO; UKWCHFi002-A-4
DR   hPSCreg; JMUi001-A-4
DR   Wikidata; Q127382400
RX   PubMed=37995437;
CC   From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6207; JUP.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C206112; Naxos disease
DI   ORDO; Orphanet_34217; Naxos disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZL58 ! JMUi001-A
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   JMUi001-B
AC   CVCL_D0GT
DR   hPSCreg; JMUi001-B
DR   Wikidata; Q123032769
CC   From: Institute of Anatomy, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL58 ! JMUi001-A
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   JMW
AC   CVCL_YQ05
SY   JMW-1; JMW1
DR   Wikidata; Q94331206
RX   CelloPub=CLPUB00604;
RX   DOI=10.1182/blood.V112.11.2732.2732;
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 8
//
ID   JN-DSRCT-1
AC   CVCL_9W68
SY   JN-DSRCT
DR   cancercelllines; CVCL_9W68
DR   Cosmic; 1718818
DR   Wikidata; Q54899015
RX   PubMed=12218078;
RX   PubMed=15782132;
RX   PubMed=22142829;
RX   PubMed=34413129;
RX   PubMed=34841430;
CC   Population: Japanese.
CC   Doubling time: ~38 hours (PubMed=12218078); 22 hours (PubMed=34841430).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex10-WT1 Ex8 fusion (PubMed=12218078; PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Arg1443Alafs*11; Zygosity=Unspecified (PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Arg367Ter (c.1099C>T); ClinVar=VCV000016626; Zygosity=Unspecified (PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg621Ser (c.1861C>A); ClinVar=VCV000135120; Zygosity=Unspecified (PubMed=34841430).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C27372; Childhood desmoplastic small round cell tumor
DI   ORDO; Orphanet_83469; Desmoplastic small round cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   JN-DSRCT-SLFN11-KO
AC   CVCL_C6N7
DR   Wikidata; Q116049602
RX   PubMed=34413129;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex10-WT1 Ex8 fusion (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Arg1443Alafs*11; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Arg367Ter (c.1099C>T); ClinVar=VCV000016626; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg621Ser (c.1861C>A); ClinVar=VCV000135120; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C27372; Childhood desmoplastic small round cell tumor
DI   ORDO; Orphanet_83469; Desmoplastic small round cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W68 ! JN-DSRCT-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   JN-M
AC   CVCL_0C15
DR   Wikidata; Q54899016
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9815546;
RX   PubMed=10100721;
CC   Doubling time: 48 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   JNCHi001-A
AC   CVCL_E4HC
DR   hPSCreg; JNCHi001-A
RX   PubMed=39332134;
CC   From: Jinan Children's Hospital; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.730+3A>C; Zygosity=Heterozygous (PubMed=39332134).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   JNCHi002-A
AC   CVCL_E4HD
DR   BioSamples; SAMEA116096868
DR   hPSCreg; JNCHi002-A
RX   PubMed=39908959;
CC   From: Jinan Children's Hospital; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Asp129fs (c.387delC); Zygosity=Heterozygous (PubMed=39908959).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   JNMUi001-A
AC   CVCL_E4DS
DR   BioSamples; SAMEA115877057
DR   hPSCreg; JNMUi001-A
CC   From: Jining Medical University; Jining City; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   JNMUi002-A
AC   CVCL_E4DT
SY   iPSCs-PB-SCZ-65#-C9P14
DR   BioSamples; SAMEA116001076
DR   hPSCreg; JNMUi002-A
RX   PubMed=39368271;
CC   From: Jining Medical University; Jining City; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   JNMUi003-A
AC   CVCL_E4DU
SY   iPSCs-PB-SCZ-70#-C1P19
DR   BioSamples; SAMEA116050864
DR   hPSCreg; JNMUi003-A
CC   From: Jining Medical University; Jining City; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   JNU-hES-01
AC   CVCL_X171
DR   Wikidata; Q54899017
RX   PubMed=24159464;
CC   From: Jeju National University Stem Cell Research Center; Jeju; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010049.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   JNU-hES-02
AC   CVCL_X172
DR   Wikidata; Q54899018
RX   PubMed=24159464;
CC   From: Jeju National University Stem Cell Research Center; Jeju; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010050.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   JNUBK-3
AC   CVCL_AP73
SY   Jeju National University Bovine Kidney-3
DR   Wikidata; Q54899019
RX   DOI=10.13041/jpvm.2014.38.1.15;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Breed from personal communication of Hwang, Kyu-Kye.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hanwoo; VBO=VBO_0000229.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_AP74 ! JNUBK-4
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   JNUBK-4
AC   CVCL_AP74
SY   Jeju National University Bovine Kidney-4
DR   Wikidata; Q54899020
RX   DOI=10.13041/jpvm.2014.38.1.15;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Breed from personal communication of Hwang, Kyu-Kye.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hanwoo; VBO=VBO_0000229.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_AP73 ! JNUBK-3
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   JNUCK-1
AC   CVCL_AP71
SY   Jeju National University Canine Kidney-1
DR   Wikidata; Q54899021
RX   DOI=10.12729/jbr.2015.16.1.006;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_AP72 ! JNUCK-2
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   JNUCK-2
AC   CVCL_AP72
SY   Jeju National University Canine Kidney-2
DR   Wikidata; Q54899022
RX   DOI=10.12729/jbr.2015.16.1.006;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_AP71 ! JNUCK-1
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   Jo Cav
AC   CVCL_U675
DR   ATCC; CRL-1387
DR   Wikidata; Q54899023
CC   Discontinued: ATCC; CRL-1387; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118636; Stiff skin syndrome
DI   ORDO; Orphanet_2833; Stiff skin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Jo Per
AC   CVCL_3320
DR   CLO; CLO_0007032
DR   ATCC; CRL-1332
DR   Wikidata; Q54899024
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Jo Zan
AC   CVCL_U779
DR   ATCC; CRL-1197
DR   Wikidata; Q54899026
CC   Discontinued: ATCC; CRL-1197; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   JO-E
AC   CVCL_0C16
DR   Cosmic; 2239099
DR   Wikidata; Q54899027
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Doubling time: 79.2 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   JO1-1
AC   CVCL_G197
SY   JO1.1
DR   CLO; CLO_0007033
DR   ATCC; HB-8638
DR   Wikidata; Q54899028
RX   Patent=US4769320;
RX   PubMed=6209271;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8638.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00734; Human F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   JO38
AC   CVCL_RP10
DR   Wikidata; Q54899029
RX   PubMed=27605433;
RX   PubMed=28387650;
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Proteomics; Subcellular; Secretome.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 5
//
ID   JO528239
AC   CVCL_E713
SY   J0528239; JO 528239
DR   dbMHC; 48910
DR   ECACC; 88052041
DR   IHW; IHW09041
DR   IPD-IMGT/HLA; 11636
DR   Wikidata; Q54899031
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*01:01:01:01; B*35:02:01:01; C*04:01:01:06; DPB1*04:02:01,11:01:01; DQA1*05:01; DQB1*03:01:01; DRB1*11:04:01; DRB3*02:02 (IPD-IMGT/HLA=11636).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   Joey-HSA
AC   CVCL_0C98
SY   JOEY; Joey
DR   GEO; GSM377406
DR   Wikidata; Q54899032
RX   PubMed=19461996;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   JOG-9
AC   CVCL_0P35
DR   Wikidata; Q54899033
RX   PubMed=2424598;
CC   Population: Japanese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   JOK-1 [Human gastric epithelial]
AC   CVCL_9813
DR   Wikidata; Q54899034
RX   PubMed=10852347;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   JOK-1 [Human hairy cell leukemia]
AC   CVCL_M706
SY   JOK1
DR   cancercelllines; CVCL_M706
DR   Cosmic; 999765
DR   Cosmic; 2756296
DR   Wikidata; Q54899035
RX   CelloPub=CLPUB00061;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=7141737;
RX   PubMed=10739008;
RX   PubMed=11060441;
RX   PubMed=11226526;
RX   PubMed=21504579;
RX   PubMed=29989027;
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (PubMed=29989027).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (PubMed=29989027).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   JOK-1/5.3
AC   CVCL_A5ZI
SY   JOK1/5.3; JOK1-5.3; JOK1 5.3
DR   Wikidata; Q107115504
RX   PubMed=21504579;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1685; CD5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M706 ! JOK-1 [Human hairy cell leukemia]
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   JON
AC   CVCL_M891
SY   JO'N; J'O.N.; J.O.N.; J.O.'N.; JO N; JO-N; J ON
DR   cancercelllines; CVCL_M891
DR   Cosmic; 715706
DR   Cosmic; 760472
DR   Cosmic; 845567
DR   Cosmic; 1016891
DR   Cosmic; 1285121
DR   Cosmic; 1285999
DR   Cosmic; 2037948
DR   Cosmic; 2050447
DR   Cosmic; 2057452
DR   Cosmic; 2444249
DR   Cosmic; 2686099
DR   GEO; GSM136254
DR   GEO; GSM763025
DR   Progenetix; CVCL_M891
DR   Wikidata; Q54899036
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=11921286;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26621286;
RX   PubMed=27270441;
RX   PubMed=29732388;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (PubMed=27270441).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (PubMed=27270441).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   JoN
AC   CVCL_D785
DR   Wikidata; Q54899039
RX   PubMed=2156601;
RX   PubMed=2713809;
RX   PubMed=2903136;
CC   Doubling time: 33 hours (PubMed=2156601; PubMed=2903136).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   JoN HDF
AC   CVCL_D786
SY   JoN High Density Fraction
DR   Wikidata; Q54899040
RX   PubMed=2903136;
CC   Doubling time: 26 hours (PubMed=2903136).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D785 ! JoN
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   JoN LDF
AC   CVCL_D787
SY   JoN Low Density Fraction
DR   Wikidata; Q54899041
RX   PubMed=2903136;
CC   Doubling time: 36 hours (PubMed=2903136).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D785 ! JoN
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   Jones
AC   CVCL_DN28
SY   JONES
DR   GEO; GSM1974791
DR   Wikidata; Q54899042
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 14 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:38196; ASXL1; Simple; p.Gly618fs (c.1850dupG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:43959; NRAS; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=27197945; PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:44567; PTEN; Simple; p.Asp246fs (c.734dupA); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235,239
ST   Dog FHC2054: 168,172
ST   Dog FHC2079: 271,279
ST   Dog PEZ1: 123
ST   Dog PEZ3: 127,129
ST   Dog PEZ5: 103,111
ST   Dog PEZ6: 183,191
ST   Dog PEZ8: 240
ST   Dog PEZ12: 267,270
ST   Dog PEZ20: 180
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   JoPaca-1
AC   CVCL_S507
SY   JOPACA-1; JOPACA1; JoPaca1
DR   cancercelllines; CVCL_S507
DR   Cell_Model_Passport; SIDM01585
DR   DepMap; ACH-001353
DR   DSMZ; ACC-744
DR   DSMZCellDive; ACC-744
DR   Wikidata; Q28872926
RX   PubMed=23152778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 28 hours (PubMed=23152778); ~3-4 days (DSMZ=ACC-744).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=23152778; DepMap=ACH-001353).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): DepMap=ACH-001353; DSMZ=ACC-744
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 10
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22.2,24
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   Josh 4
AC   CVCL_8248
SY   JOSH-4
DR   Wikidata; Q54899043
RX   PubMed=6256462;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5YG ! Josh 5
OI   CVCL_8249 ! Josh 7
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Josh 5
AC   CVCL_B5YG
DR   Wikidata; Q111733543
RX   PubMed=230517;
RX   PubMed=6256462;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8248 ! Josh 4
OI   CVCL_8249 ! Josh 7
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   Josh 7
AC   CVCL_8249
SY   JOSH-7
DR   Wikidata; Q54899044
RX   PubMed=230517;
RX   PubMed=6256462;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8248 ! Josh 4
OI   CVCL_B5YG ! Josh 5
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JOSK-I
AC   CVCL_2082
DR   CLO; CLO_0007034
DR   CLDB; cl2951
DR   BioSample; SAMN03151980
DR   cancercelllines; CVCL_2082
DR   Cosmic; 787438
DR   Cosmic; 919120
DR   Cosmic; 947371
DR   DSMZ; ACC-155
DR   DSMZCellDive; ACC-155
DR   Wikidata; Q54899045
RX   PubMed=3486043;
RX   PubMed=9510473;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00135.
CC   Population: Caucasian.
CC   Doubling time: ~28-35 hours (DSMZ=ACC-155).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Misspelling: JOSK-1; Cosmic=947371.
CC   Discontinued: DSMZ; ACC-155; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-155
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 14,16
ST   D21S11: 27,29
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   JOSK-K
AC   CVCL_8141
DR   BioSample; SAMN03151981
DR   cancercelllines; CVCL_8141
DR   Cosmic; 919121
DR   Wikidata; Q54899046
RX   PubMed=3486043;
RX   PubMed=9510473;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00136.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   JOSK-M
AC   CVCL_2083
DR   CLO; CLO_0007035
DR   CLDB; cl2952
DR   BioSample; SAMN03151982
DR   BioSample; SAMN03473345
DR   cancercelllines; CVCL_2083
DR   Cosmic; 787439
DR   Cosmic; 999773
DR   DSMZ; ACC-30
DR   DSMZCellDive; ACC-30
DR   IARC_TP53; 961
DR   Wikidata; Q54899047
RX   PubMed=3486043;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00137.
CC   Population: Caucasian.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-30).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: DSMZ; ACC-30; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-30
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,16
ST   D21S11: 27,29
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 11,16
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   JOSK-S
AC   CVCL_8142
DR   BioSample; SAMN03151983
DR   cancercelllines; CVCL_8142
DR   Wikidata; Q54899048
RX   PubMed=3486043;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00138.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Journey-HSA
AC   CVCL_0C99
SY   JOURNEY; Journey
DR   GEO; GSM377402
DR   Wikidata; Q54899049
RX   PubMed=19461996;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   JOV675
AC   CVCL_8250
DR   Cosmic; 845148
DR   Wikidata; Q54899050
RX   PubMed=9625810;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 7
//
ID   JoVa
AC   CVCL_B5PY
DR   Wikidata; Q111733544
RX   PubMed=36611;
RX   PubMed=559490;
RX   PubMed=1192829;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   JP165
AC   CVCL_N326
DR   ATCC; HB-8280
DR   Wikidata; Q54899051
RX   Patent=US4643971;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8280.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   JPKO
AC   CVCL_6F54
DR   IPD-IMGT/HLA; 15828
DR   Wikidata; Q54899052
RX   PubMed=16702430;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (IPD-IMGT/HLA=15828).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 10
//
ID   JPM50.6
AC   CVCL_XF36
SY   JPM 50.6; Jurkat PMA-deficient Mutant clone 50.6
DR   EFO; EFO_0022541
DR   cancercelllines; CVCL_XF36
DR   Wikidata; Q94331692
RX   PubMed=12154356;
CC   Population: Caucasian.
CC   Characteristics: CARMA1-deficient mutant.
CC   Characteristics: The eGFP reporter gene is under the control of four tandem copies of the NF-kappaB response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF35 ! JGFP1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   JPO2
AC   CVCL_VL74
DR   Wikidata; Q94331695
RX   PubMed=7836899;
RX   PubMed=7912172;
RX   PubMed=9691974;
CC   Characteristics: Control cell line for JPO9 (Cellosaurus=CVCL_VL73).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   JPR3
AC   CVCL_C0TX
DR   Wikidata; Q112929897
RX   PubMed=17303380;
CC   Group: Bird cell line.
CC   Characteristics: Using homologous recombination a 3xFLAG-2xHis6 construct was integrated at the C-terminus of one allele of PIP4K2B (PubMed=17303380).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   JPX-9
AC   CVCL_0D86
SY   Jpx-9; JPX9; JPX 9-4
DR   cancercelllines; CVCL_0D86
DR   Wikidata; Q54899053
RX   PubMed=2501514;
RX   PubMed=2784206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 19
//
ID   JR
AC   CVCL_RT33
DR   cancercelllines; CVCL_RT33
DR   Cell_Model_Passport; SIDM01584
DR   Cosmic; 1718363
DR   Cosmic; 2356032
DR   DepMap; ACH-001096
DR   PRIDE; PXD039480
DR   Wikidata; Q54899054
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=36768928;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Subcellular; Cell surface.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   JR-1
AC   CVCL_J063
SY   JR1
DR   Cosmic; 687952
DR   PRIDE; PXD007755
DR   Wikidata; Q54899056
RX   CelloPub=CLPUB00569;
RX   PubMed=3730258;
RX   PubMed=23882450;
RX   PubMed=31448612;
CC   Doubling time: ~29 hours (PubMed=3730258).
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   JR-2(82)
AC   CVCL_5298
SY   JR-2-82; JR-2
DR   Wikidata; Q54899057
RX   PubMed=3110293;
RX   PubMed=6306101;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=JR-2-82
CC   Characteristics: Partially IL4 dependent. Only dies in the absence of IL4 if seeded at 1 X 1000 cells per well or less.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   JR-St
AC   CVCL_0365
AS   CVCL_W525
SY   JRST; JR-1
DR   MCCL; MCC:0000259
DR   cancercelllines; CVCL_0365
DR   Cosmic; 877045
DR   Cosmic; 918494
DR   IARC_TP53; 970
DR   Wikidata; Q54899058
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1370612;
RX   PubMed=1848829;
RX   PubMed=2562403;
CC   Population: Japanese.
CC   Doubling time: 72 hours (Note=At 20th passage) (PubMed=2562403); 35 hours (Note=At 30th passage) (PubMed=1848829).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Met (c.517G>A); ClinVar=VCV000233951; Zygosity=Unspecified (PubMed=1370612).
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   JR#000646
AC   CVCL_ZL15
DR   Wikidata; Q98126799
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   JR#000664
AC   CVCL_ZL17
DR   Wikidata; Q98126800
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   JR#000928
AC   CVCL_ZL18
DR   Wikidata; Q98126802
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: CAST/EiJ.
OX   NCBI_TaxID=10091; ! Mus musculus castaneus (Southeastern Asian house mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   JR#001145
AC   CVCL_ZL20
DR   Wikidata; Q98126803
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: WSB/EiJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   JR#002105
AC   CVCL_ZL21
DR   Wikidata; Q98126804
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NZO/HlLtJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   JR#002448
AC   CVCL_ZL22
DR   Wikidata; Q98126806
RX   DOI=10.1101/552059;
RX   PubMed=24504480;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S1/SvImJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   JR023
AC   CVCL_A9A3
SY   IDI-PD 2 fibroblasts
DR   GEO; GSM1291212
DR   Wikidata; Q102114317
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   JR036
AC   CVCL_A8Y5
DR   GEO; GSM2055811
DR   Wikidata; Q102114318
RX   PubMed=28096185;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=28096185).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   JR053
AC   CVCL_A8Z1
DR   GEO; GSM2644502
DR   Wikidata; Q102114319
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   JR1
AC   CVCL_L880
SY   JR 1
DR   CLO; CLO_0007036
DR   CLDB; cl2953
DR   Wikidata; Q54899055
RX   CelloPub=CLPUB00441;
RX   PubMed=21863025;
CC   Derived from site: Metastatic; Pretracheal lymph node; UBERON=UBERON_0038932.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5780 ! JR8
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 7
//
ID   JR1cmyc5
AC   CVCL_A8SL
DR   Wikidata; Q108820562
RX   PubMed=11306486;
CC   Characteristics: Expresses MYC under the control of the CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J063 ! JR-1
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   JR1neo20
AC   CVCL_A8SI
DR   Wikidata; Q108820563
RX   PubMed=10933967;
RX   PubMed=11306486;
CC   Characteristics: Control cell line for JR1Nmyc6 (Cellosaurus=CVCL_A8SJ) and JR1Nmyc9 (Cellosaurus=CVCL_A8SK) (PubMed=10933967).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J063 ! JR-1
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   JR1Nmyc6
AC   CVCL_A8SJ
DR   Wikidata; Q108820564
RX   PubMed=10933967;
RX   PubMed=11306486;
CC   Characteristics: Expresses MYCN under the control of the CMV promoter (PubMed=10933967).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J063 ! JR-1
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   JR1Nmyc9
AC   CVCL_A8SK
DR   Wikidata; Q108820565
RX   PubMed=10933967;
CC   Characteristics: Expresses MYCN under the control of the CMV promoter (PubMed=10933967).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J063 ! JR-1
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   JR8
AC   CVCL_5780
SY   JR 8
DR   BTO; BTO_0002969
DR   CLO; CLO_0007037
DR   CLDB; cl2955
DR   Wikidata; Q54899059
RX   CelloPub=CLPUB00441;
RX   PubMed=8618233;
RX   PubMed=21863025;
CC   Misspelling: IR8; Note=Occasionally.
CC   Misspelling: IR-8; BTO=BTO_0002969; Note=And occasionally in publications.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L880 ! JR1
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   JRO1-27
AC   CVCL_V087
DR   CLO; CLO_0007038
DR   CLDB; cl2956
DR   IHW; 11w 8026
DR   Wikidata; Q54899060
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   JRPAY
AC   CVCL_VU45
DR   IPD-IMGT/HLA; 13545
DR   Wikidata; Q94331811
RX   PubMed=16189666;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*39:06:02,48:01; DPB1*05:01,09:01; DRB1*04:01:01,09:01:02; DRB4*01:03 (IPD-IMGT/HLA=13545).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 6
//
ID   JS
AC   CVCL_E718
DR   dbMHC; 48914
DR   ECACC; 94022532
DR   IHW; IHW09228
DR   IPD-IMGT/HLA; 10872
DR   Wikidata; Q54899061
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*30:03,03:01:01:01; B*07:02:01,18:01:01:01; C*05:01:01:01,07:02:01:03; DPA1*01:03:01:05,01:03:01:01; DPB1*02:02,04:02:01:02; DQA1*01:02:01:01,05:01:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01:01,15:01:01; DRB3*02:02:01:01; DRB5*01:01:01 (IPD-IMGT/HLA=10872).
CC   HLA typing: A*03:01:01:01,30:03; B*07:02:01,18:01:01:01; C*05:01:01:01,07:02:01:03; DPA1*01:03:01:01,01:03:01:05; DPB1*02:02,04:02:01:02; DQA1*01:02:01,05:01:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01; DRB3*02:02:01:01; DRB5*01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   JS-1
AC   CVCL_B6RW
DR   Wikidata; Q111733545
RX   CelloPub=CLPUB00684;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   JS-73
AC   CVCL_9711
DR   Wikidata; Q54899062
RX   PubMed=11004677;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   JS-E
AC   CVCL_0C17
DR   Cosmic; 2239092
DR   Wikidata; Q54899063
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   JS1
AC   CVCL_C7PL
DR   Wikidata; Q117704565
RX   PubMed=19085953;
RX   PubMed=22240484;
RX   PubMed=23207150;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   JS2
AC   CVCL_C7PK
DR   Wikidata; Q117704566
RX   PubMed=19085953;
RX   PubMed=23207150;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   JS2 TLR4-/- D299G
AC   CVCL_5L03
SY   TLR4-/- D299G; TLR4-/- 299
DR   Kerafast; EMS401
DR   Wikidata; Q54972634
RX   PubMed=19085953;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11850; TLR4 (Note=With p.Asp299Gly).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7PK ! JS2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   JS2 TLR4-/- D299G/T399I
AC   CVCL_5L05
SY   TLR4-/- D299G/T399I; TLR4-/- 299/399; TLR4-/- Dual SNP
DR   Kerafast; EMS403
DR   Wikidata; Q54972635
RX   PubMed=19085953;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11850; TLR4 (Note=With p.Asp299Gly and p.Thr399Ile).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7PK ! JS2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   JS2 TLR4-/- T399I
AC   CVCL_5L04
SY   TLR4-/- T399I; TLR4-/- 399
DR   Kerafast; EMS402
DR   Wikidata; Q54972637
RX   PubMed=19085953;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11850; TLR4 (Note=With p.Thr399Ile).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7PK ! JS2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 11
//
ID   JS2 TLR4-/- WT
AC   CVCL_5L02
SY   TLR4-/- WT
DR   Kerafast; EMS404
DR   Wikidata; Q54972638
RX   PubMed=19085953;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11850; TLR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7PK ! JS2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   JS20/27
AC   CVCL_C4CJ
DR   Wikidata; Q116049603
RX   PubMed=7159574;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49884; Bovine ESR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   JS28/32
AC   CVCL_C4CK
DR   ABCD; ABCD_AJ204
DR   Wikidata; Q116049604
RX   PubMed=7159574;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49884; Bovine ESR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   JS3
AC   CVCL_C7PM
DR   Wikidata; Q117704567
RX   PubMed=19085953;
RX   PubMed=23207150;
CC   Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   JS30/1
AC   CVCL_C4CL
DR   Wikidata; Q116049605
RX   PubMed=7159574;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P49884; Bovine ESR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   JS34/32
AC   CVCL_C4CM
DR   ABCD; ABCD_AJ203
DR   Wikidata; Q116049606
RX   PubMed=7159574;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P49884; Bovine ESR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   JS3/35
AC   CVCL_C4CN
DR   Wikidata; Q116049607
RX   PubMed=7159574;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49884; Bovine ESR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   JSa1
AC   CVCL_6E04
SY   Jaw Sparus aurata 1
DR   Wikidata; Q54899064
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone, jaw; UBERON=UBERON_0001708.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   JSB-1
AC   CVCL_B0FK
DR   Wikidata; Q108820566
RX   PubMed=2458323;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   JSC-1
AC   CVCL_3728
AS   CVCL_B054
SY   JSC1; JSC
DR   CLO; CLO_0007039
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2769
DR   ATCC; JHU-32
DR   BioSample; SAMN03471783
DR   cancercelllines; CVCL_3728
DR   Cell_Model_Passport; SIDM00688
DR   Cosmic; 1588564
DR   Cosmic-CLP; 1327769
DR   DepMap; ACH-002253
DR   EGA; EGAS00001000978
DR   GDSC; 1327769
DR   GEO; GSM634739
DR   GEO; GSM710424
DR   GEO; GSM710440
DR   GEO; GSM827379
DR   GEO; GSM1669964
DR   GEO; GSM3150247
DR   IARC_TP53; 23657
DR   LINCS_LDP; LCL-1959
DR   PharmacoDB; JSC1_711_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3728
DR   Wikidata; Q54899065
RX   PubMed=11024147;
RX   PubMed=15613351;
RX   PubMed=17121789;
RX   PubMed=20215515;
RX   PubMed=21685375;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=36094314;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/6066-JSC1.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=11024147).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1327769; DepMap=ACH-002253).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.79%; Native American=0.09%; East Asian, North=0.94%; East Asian, South=0%; South Asian=1.9%; European, North=65.05%; European, South=31.24% (PubMed=30894373).
CC   Misspelling: JCS-1; Note=Occasionally.
CC   Discontinued: ATCC; CRL-2769; true.
CC   Discontinued: ATCC; JHU-32; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-2769; Cosmic-CLP=1327769
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   JSK-1
AC   CVCL_JX16
DR   Wikidata; Q54899066
RX   PubMed=8380785;
CC   From: Sasaki, Hiroshi; Jikei University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI   NCIt; C6343; Cervical endometrioid adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   JSKG
AC   CVCL_R910
SY   Japanese Striped Knifejaw Gonad
DR   Wikidata; Q54899067
RX   DOI=10.1577/1548-8667(1993)005<0127:COTCCL>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=163134; ! Oplegnathus fasciatus (Barred knifejaw)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   JSL1
AC   CVCL_XF44
SY   Jurkat splicing line 1
DR   EFO; EFO_0022507
DR   cancercelllines; CVCL_XF44
DR   Wikidata; Q94331890
RX   PubMed=10594010;
CC   Population: Caucasian.
CC   Characteristics: Expresses relatively high levels of the larger PTPRC/CD45 isoforms relative to isoform CD45R0 (PubMed=10594010).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   JSL4
AC   CVCL_XF45
SY   Jurkat splicing line 4
DR   cancercelllines; CVCL_XF45
DR   Wikidata; Q94331894
RX   PubMed=10594010;
CC   Population: Caucasian.
CC   Characteristics: Expresses relatively high levels of the larger PTPRC/CD45 isoforms relative to isoform CD45R0 (PubMed=10594010).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   JSNK-1
AC   CVCL_A5ZW
DR   Wikidata; Q107115506
RX   PubMed=20955660;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   JSP
AC   CVCL_RG68
DR   Wikidata; Q54899068
RX   PubMed=24582862;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_5I40 ! JHE
OI   CVCL_5I41 ! JLI
OI   CVCL_5I42 ! JLU
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   JSPHi001-A
AC   CVCL_A7JD
DR   hPSCreg; JSPHi001-A
DR   Wikidata; Q107115509
RX   PubMed=33887581;
CC   From: Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg335Trp (c.1003C>T); ClinVar=VCV000036473; Zygosity=Heterozygous (PubMed=33887581).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   JSPHi002-A
AC   CVCL_C0JJ
DR   hPSCreg; JSPHi002-A
DR   Wikidata; Q112929900
RX   PubMed=35580545;
CC   From: Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.His258Leu (c.773A>T); Zygosity=Heterozygous (PubMed=35580545).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   JSPHi003-A
AC   CVCL_C1TT
DR   hPSCreg; JSPHi003-A
DR   Wikidata; Q114311790
RX   PubMed=36095892;
CC   From: Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Ser437Hisfs*2 (c.1304_1307dupGCAC); ClinVar=VCV000066803; Zygosity=Heterozygous (PubMed=36095892).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   JSQ-11
AC   CVCL_RK13
SY   JSQ11
DR   Wikidata; Q54899069
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   JSQ-13
AC   CVCL_RK12
SY   JSQ 13; JSQ13
DR   cancercelllines; CVCL_RK12
DR   IARC_TP53; 6402
DR   Wikidata; Q54899070
RX   PubMed=1574572;
RX   PubMed=8339273;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=8339273).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   JSQ-3
AC   CVCL_L892
SY   JSQ 3; JSQ3
DR   cancercelllines; CVCL_L892
DR   IARC_TP53; 1690
DR   Wikidata; Q54899071
RX   PubMed=1423286;
RX   PubMed=1574572;
RX   PubMed=2004949;
RX   PubMed=2573646;
RX   PubMed=3182330;
RX   PubMed=3417487;
RX   PubMed=8339273;
RX   PubMed=9054521;
RX   PubMed=17312569;
CC   Characteristics: Radioresistant (PubMed=2004949).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (PubMed=1423286; PubMed=8339273).
CC   Derived from site: In situ; Nose, nasal cavity, nasal vestibule; UBERON=UBERON_0000402.
DI   NCIt; C8192; Nasal cavity squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   JSQ-3B
AC   CVCL_V281
DR   cancercelllines; CVCL_V281
DR   Wikidata; Q54899072
RX   PubMed=2004949;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Nose, nasal cavity, nasal vestibule; UBERON=UBERON_0000402.
DI   NCIt; C8192; Nasal cavity squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L892 ! JSQ-3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   JT
AC   CVCL_UI97
DR   Wikidata; Q94331963
RX   PubMed=2155676;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   JT1
AC   CVCL_GY09
DR   Wikidata; Q54899073
RX   PubMed=7108207;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   JT1-1D7
AC   CVCL_9U14
SY   JT-1-1D7; JT1-D7
DR   CCRID; 4201PAT-CCTCC00026
DR   Wikidata; Q54899074
RX   Patent=US5180660;
RX   Patent=US5217895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1685.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9U15 ! JT1-1F3
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 8
//
ID   JT1-1F3
AC   CVCL_9U15
DR   CCRID; 4201PAT-CCTCC00021
DR   Wikidata; Q54899075
RX   Patent=US5180660;
RX   Patent=US5217895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 87062501.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   JT1-1F3-E5
AC   CVCL_9U16
DR   CCRID; 4201PAT-CCTCC00020
DR   Wikidata; Q54899076
RX   Patent=US5180660;
RX   Patent=US5217895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 87062502.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9U15 ! JT1-1F3
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   JT2-N15
AC   CVCL_9U17
DR   CCRID; 4201PAT-CCTCC00025
DR   Wikidata; Q54899077
RX   Patent=US5180660;
RX   Patent=US5217895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1684.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 8
//
ID   JT4C12
AC   CVCL_9U18
DR   CCRID; 4201PAT-CCTCC00023
DR   Wikidata; Q54899078
RX   Patent=US5180660;
RX   Patent=US5217895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9387.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Misspelling: 12; CCRID=4201PAT-CCTCC00023.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   JT4C16
AC   CVCL_9U19
DR   CCRID; 4201PAT-CCTCC00024
DR   Wikidata; Q54899080
RX   Patent=US5180660;
RX   Patent=US5217895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9386.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   JT4C8
AC   CVCL_9U20
DR   CCRID; 4201PAT-CCTCC00022
DR   Wikidata; Q54899081
RX   Patent=US5180660;
RX   Patent=US5217895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9385.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Misspelling: JT4C3; CCRID=4201PAT-CCTCC00022.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   JTC-1
AC   CVCL_M884
SY   Japanese Tissue Culture-1
DR   Wikidata; Q54899082
RX   DOI=10.11418/jtca1981.11.3_287;
RX   PubMed=171466;
RX   PubMed=4358144;
RX   PubMed=4359557;
RX   PubMed=4361510;
RX   PubMed=8390914;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4367 ! AH130
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   JTC-11
AC   CVCL_5299
SY   Ehrlich-Lettre ascites strain K; Japanese Tissue Culture-11
DR   JCRB; JCRB0424
DR   Wikidata; Q54899083
RX   DOI=10.4044/joma1947.76.1-3_1;
RX   DOI=10.4044/joma1947.76.4-6_215;
RX   PubMed=3983491;
RX   PubMed=4229239;
RX   PubMed=14497414;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3873 ! Ehrlich-Lettre ascites strain E
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   JTC-12
AC   CVCL_3631
SY   MK; Monkey Kidney; Japanese Tissue Culture-12
DR   CLO; CLO_0050517
DR   CLO; CLO_0050518
DR   RCB; RCB0456
DR   RCB; RCB1485
DR   Wikidata; Q54899084
RX   DOI=10.2187/bss.6.147;
RX   PubMed=4328993;
RX   PubMed=12101351;
RX   PubMed=13984589;
CC   Group: Non-human primate cell line.
CC   Group: Space-flown cell line (cellonaut).
CC   Anecdotal: Have been flown in space on shuttle flight STS-47 (Spacelab-J) to study growth in microgravity (DOI=10.2187/bss.6.147; PubMed=12101351).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   JTC-12.P3
AC   CVCL_5483
SY   JTC-12 P3; MK.P3; Japanese Tissue Culture-12.P3
DR   JCRB; JCRB0607.1
DR   JCRB; NIHS0354
DR   Wikidata; Q54899085
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=2993257;
RX   PubMed=3242846;
RX   PubMed=4328993;
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Discontinued: JCRB; NIHS0354; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
HI   CVCL_3631 ! JTC-12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   JTC-12.P3(F)
AC   CVCL_5484
SY   MK.P3(F)
DR   JCRB; JCRB0607
DR   Wikidata; Q54899086
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
HI   CVCL_3631 ! JTC-12
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JTC-13
AC   CVCL_IN85
SY   Japanese Tissue Culture-13
DR   Wikidata; Q54899087
RX   PubMed=4181158;
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 3
//
ID   JTC-14
AC   CVCL_IN86
SY   Japanese Tissue Culture-14
DR   Wikidata; Q54899088
RX   PubMed=4157883;
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 3
//
ID   JTC-15
AC   CVCL_2084
SY   Japanese Tissue Culture-15
DR   BTO; BTO_0000455
DR   CLO; CLO_0007040
DR   CLO; CLO_0050814
DR   CLO; CLO_0050816
DR   DSMZ; ACC-329
DR   DSMZCellDive; ACC-329
DR   RCB; RCB0063
DR   RCB; RCB1461
DR   Wikidata; Q54899089
RX   PubMed=171466;
RX   PubMed=4312683;
RX   PubMed=4358144;
RX   PubMed=8390914;
CC   Doubling time: ~30 hours (DSMZ=ACC-329).
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4368 ! AH66-TC
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   JTC-15 AC-4
AC   CVCL_WI78
SY   Japanese Tissue Culture-15 Agar Culture-4
DR   Wikidata; Q94332129
RX   PubMed=171466;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2084 ! JTC-15
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 5
//
ID   JTC-15 AC-5
AC   CVCL_WI79
SY   Japanese Tissue Culture-15 Agar Culture-5
DR   Wikidata; Q94332134
RX   PubMed=171466;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2084 ! JTC-15
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 5
//
ID   JTC-16
AC   CVCL_8360
SY   JTC16; Japanese Tissue Culture-16
DR   Wikidata; Q54899090
RX   PubMed=171466;
RX   PubMed=4312683;
RX   PubMed=4328993;
RX   PubMed=4358144;
RX   PubMed=8390914;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F989 ! AH7974-TC
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   JTC-16.P3
AC   CVCL_8361
SY   JTC-16-P3; JTC-16 P3; JTC 16P3; AH-7974.P3; Japanese Tissue Culture-16.P3
DR   JCRB; JCRB0714
DR   JCRB; JCRB0714.1
DR   JCRB; NIHS0368
DR   Wikidata; Q54899091
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=3242846;
RX   PubMed=4328993;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Discontinued: JCRB; NIHS0368; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8360 ! JTC-16
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   JTC-17
AC   CVCL_8362
SY   Japanese Tissue Culture-17
DR   BioSample; SAMN03151728
DR   JCRB; NIHS0009
DR   Wikidata; Q54899092
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00139.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: JCRB; NIHS0009; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   JTC-19
AC   CVCL_3632
SY   JTC19; Japanese Tissue Culture-19; RLG-1
DR   CLO; CLO_0007041
DR   CLO; CLO_0050817
DR   CLO; CLO_0050818
DR   CLDB; cl2957
DR   ECACC; 87111902
DR   JCRB; JCRB0608
DR   RCB; RCB0074
DR   RCB; RCB1486
DR   Wikidata; Q54899093
RX   PubMed=171466;
RX   PubMed=6085955;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   JTC-2
AC   CVCL_M885
SY   Japanese Tissue Culture-2
DR   Wikidata; Q54899094
RX   DOI=10.11418/jtca1981.11.3_287;
RX   PubMed=171466;
RX   PubMed=4358144;
RX   PubMed=4359557;
RX   PubMed=4361510;
RX   PubMed=8390914;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4367 ! AH130
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   JTC-2 Co-2
AC   CVCL_WI77
DR   Wikidata; Q94332205
RX   PubMed=171466;
CC   Selected for resistance to: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M885 ! JTC-2
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 5
//
ID   JTC-20
AC   CVCL_WH69
SY   RTH-1; Japanese Tissue Culture-20
DR   Wikidata; Q94332210
RX   PubMed=4328993;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   JTC-20.P3
AC   CVCL_IN91
SY   RTH-1.P3; Japanese Tissue Culture-20.P3
DR   Wikidata; Q54899095
RX   PubMed=4328993;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH69 ! JTC-20
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   JTC-21
AC   CVCL_WH63
AS   CVCL_WI66
SY   RLH-1; Japanese Tissue Culture-21
DR   Wikidata; Q94332230
RX   PubMed=4328993;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI63 ! RLC-2
SX   Sex unspecified
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   JTC-21.P3
AC   CVCL_IN87
SY   JTC-21 P3; RLH-1.P3; Japanese Tissue Culture-21.P3
DR   Wikidata; Q54899096
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=2993257;
RX   PubMed=4328993;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH63 ! JTC-21
SX   Sex unspecified
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   JTC-22
AC   CVCL_WH64
AS   CVCL_WI67
SY   RLH-2; Japanese Tissue Culture-22
DR   Wikidata; Q94332246
RX   PubMed=4328993;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI63 ! RLC-2
SX   Sex unspecified
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   JTC-22.P3
AC   CVCL_IN88
SY   RLH-2.P3; Japanese Tissue Culture-22.P3
DR   Wikidata; Q54899097
RX   PubMed=4328993;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH64 ! JTC-22
SX   Sex unspecified
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   JTC-23
AC   CVCL_WH65
AS   CVCL_WI68
SY   RLH-3; Japanese Tissue Culture-23
DR   Wikidata; Q94332259
RX   PubMed=4328993;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI38 ! RLC-3
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   JTC-23.P3
AC   CVCL_IN89
SY   RLH-3.P3; Japanese Tissue Culture-23.P3
DR   Wikidata; Q54899098
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=4328993;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH65 ! JTC-23
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   JTC-24
AC   CVCL_WH66
AS   CVCL_WI69
SY   RLH-4; Japanese Tissue Culture-24
DR   Wikidata; Q94332274
RX   PubMed=4328993;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI63 ! RLC-2
SX   Sex unspecified
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   JTC-24.P3
AC   CVCL_IN90
SY   RLH-4.P3; Japanese Tissue Culture-24.P3
DR   Wikidata; Q54899099
RX   PubMed=4328993;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH66 ! JTC-24
SX   Sex unspecified
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   JTC-25
AC   CVCL_WH67
SY   RLH-5; Japanese Tissue Culture-25
DR   Wikidata; Q94332285
RX   PubMed=4328993;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   JTC-25.P3
AC   CVCL_M886
SY   JTC-25 P3; JTC-25-P3; JTC-25P3; RLH-5.P3; Japanese Tissue Culture-25.P3
DR   Wikidata; Q54899100
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=240686;
RX   PubMed=2993257;
RX   PubMed=4328993;
RX   PubMed=4358144;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH67 ! JTC-25
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   JTC-27
AC   CVCL_2085
AS   CVCL_F993
SY   AH601(JTC27); AH-601(JTC-27); Japanese Tissue Culture-27; AH601-TC; AH601; AH-601; AH 601
DR   BTO; BTO_0000528
DR   CLO; CLO_0007042
DR   CLO; CLO_0050813
DR   CLO; CLO_0050815
DR   CLDB; cl2958
DR   CLDB; cl4942
DR   DSMZ; ACC-330
DR   DSMZCellDive; ACC-330
DR   ECACC; 94042255
DR   ICLC; ATL98013
DR   JCRB; JCRB0132.1
DR   JCRB; NIHS0227
DR   RCB; RCB0065
DR   RCB; RCB1479
DR   TKG; TKG 0073
DR   TKG; TKG 0538
DR   Wikidata; Q54899101
RX   PubMed=171466;
RX   PubMed=4340679;
RX   PubMed=4358144;
RX   PubMed=8390914;
CC   Doubling time: ~37 hours (DSMZ=ACC-330).
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Discontinued: JCRB; NIHS0227; true.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   JTC-29
AC   CVCL_M876
SY   Japanese Tissue Culture-29
DR   Wikidata; Q54899102
RX   PubMed=2607719;
RX   PubMed=3938823;
RX   PubMed=6684098;
CC   Population: Japanese.
CC   Doubling time: 34.6 hours (PubMed=6684098).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   JTC-3
AC   CVCL_A034
SY   Japanese Tissue Culture-3
DR   BioSample; SAMN03151729
DR   Wikidata; Q54899103
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00140.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   JTC-30
AC   CVCL_M877
SY   JTC30; Japanese Tissue Culture-30
DR   Wikidata; Q54899104
RX   PubMed=2607719;
RX   PubMed=3938823;
RX   PubMed=6684098;
RX   PubMed=7474403;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Doubling time: 69.2 hours (PubMed=6684098).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   JTC-31
AC   CVCL_M878
SY   Japanese Tissue Culture-31
DR   Wikidata; Q54899105
RX   PubMed=3938823;
RX   PubMed=6684098;
CC   Population: Japanese.
CC   Doubling time: 59.4 hours (PubMed=6684098).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   JTC-32
AC   CVCL_M879
SY   JTC32; Japanese Tissue Culture-32
DR   Wikidata; Q54899106
RX   PubMed=2607719;
RX   PubMed=3938823;
RX   PubMed=6684098;
RX   PubMed=7474403;
RX   PubMed=10640149;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Doubling time: 86.7 hours (PubMed=6684098).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   JTC-33
AC   CVCL_M880
SY   Japanese Tissue Culture-33
DR   Wikidata; Q54899107
RX   PubMed=3938823;
RX   PubMed=6684098;
CC   Population: Japanese.
CC   Doubling time: 43.2 hours (PubMed=6684098).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   JTC-34
AC   CVCL_M881
SY   Japanese Tissue Culture-34
DR   Wikidata; Q54899109
RX   PubMed=3938823;
RX   PubMed=6684098;
CC   Population: Japanese.
CC   Doubling time: 42.0 hours (PubMed=6684098).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   JTC-35
AC   CVCL_4560
SY   Japanese Tissue Culture-35
DR   CLO; CLO_0050471
DR   RCB; RCB2686
DR   Wikidata; Q54899110
RX   CelloPub=CLPUB00576;
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   JTC-4
AC   CVCL_M883
SY   JTC4; Japanese Tissue Culture-4
DR   Wikidata; Q54899111
RX   PubMed=13836647;
RX   PubMed=13980350;
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   JTC-4D
AC   CVCL_WH77
DR   Wikidata; Q94332455
RX   DOI=10.11418/jtca1981.11.3_287;
CC   Characteristics: Passaged with EDTA.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M883 ! JTC-4
SX   Sex unspecified
AG   2D
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   JTC-6
AC   CVCL_IN92
SY   Japanese Tissue Culture-6
DR   Wikidata; Q54899112
RX   PubMed=13774936;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   JTG-1
AC   CVCL_0P33
DR   Wikidata; Q54899113
RX   PubMed=2424598;
RX   PubMed=6178868;
CC   Miscellaneous: This is not a cell line but a xenograft.
DI   NCIt; C8000; Testicular yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   JTK-LCL
AC   CVCL_8724
DR   CLO; CLO_0050226
DR   BioSample; SAMN03472079
DR   RCB; RCB1873
DR   TKG; TKG 0585
DR   Wikidata; Q54899114
CC   HLA typing: A*02:06,24:02 (RCB=RCB1873).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1873; TKG=TKG 0585
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   JTUi001-A
AC   CVCL_YP16
DR   BioSamples; SAMEA6602307
DR   hPSCreg; JTUi001-A
DR   SKIP; SKIP005786
DR   Wikidata; Q94332505
RX   PubMed=32247258;
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Leu1151Glyfs*17 (c.3449_3450delTC); Zygosity=Heterozygous; Note=De novo mutation (PubMed=32247258).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   JTUi002-A
AC   CVCL_YP17
DR   BioSamples; SAMEA6613349
DR   hPSCreg; JTUi002-A
DR   SKIP; SKIP005810
DR   Wikidata; Q94332510
RX   PubMed=32199281;
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Heterozygous (PubMed=32199281).
CC   Sequence variation: Mutation; HGNC; HGNC:11190; SOX10; Simple; p.Tyr313Argfs*85 (c.937_947delTACTCAGCAGGC); Zygosity=Heterozygous (PubMed=32199281).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32199281
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,20
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 16,20
ST   D19S433: 13,15.2
ST   D1S1656: 15,16,17
ST   D21S11: 30
ST   D2S1338: 17,22
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D6S1043: 10,14
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 19,23
ST   Penta D: 11,12
ST   Penta E: 5,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   JTUi003-A
AC   CVCL_A8LP
DR   BioSamples; SAMEA8913818
DR   hPSCreg; JTUi003-A
DR   Wikidata; Q108820568
RX   PubMed=35063912;
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185242; Otosclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   JTUi004-A
AC   CVCL_A8LQ
DR   BioSamples; SAMEA11356179
DR   hPSCreg; JTUi004-A
DR   Wikidata; Q108820569
RX   PubMed=35413565;
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185242; Otosclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   JTUi005-A
AC   CVCL_A0JP
DR   BioSamples; SAMEA9213771
DR   hPSCreg; JTUi005-A
DR   Wikidata; Q108820570
RX   PubMed=36244083;
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=62 GGC repeats (PubMed=36244083).
CC   Sequence variation: Mutation; HGNC; HGNC:53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=100 GGC repeats (PubMed=36244083).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122655; Neuronal intranuclear inclusion disease
DI   ORDO; Orphanet_2289; Neuronal intranuclear inclusion disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   JTUi007-A
AC   CVCL_B0UQ
DR   BioSamples; SAMEA9697106
DR   hPSCreg; JTUi007-A
DR   Wikidata; Q108820571
RX   PubMed=34837774;
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2433; CSF1R; Simple; p.Ile794Thr (c.2381T>C); ClinVar=VCV000029813; Zygosity=Heterozygous (PubMed=34837774).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   JTUi008-A
AC   CVCL_B5GG
DR   BioSamples; SAMEA11460268
DR   hPSCreg; JTUi008-A
DR   Wikidata; Q110432995
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 4
//
ID   JTUi009-A
AC   CVCL_B5GH
DR   hPSCreg; JTUi009-A
DR   Wikidata; Q110432996
CC   From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   JU-PI
AC   CVCL_WY82
DR   Wikidata; Q94332514
RX   PubMed=29788803;
CC   Doubling time: 1.1 days (PubMed=29788803).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: Metastatic; Groin; UBERON=UBERON_0008337.
DI   NCIt; C49025; Myxoinflammatory fibroblastic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   JU77
AC   CVCL_2536
DR   BioSample; SAMN07624409
DR   BioSamples; SAMEA100897
DR   cancercelllines; CVCL_2536
DR   CBA; CBA-0140
DR   Cosmic; 1522780
DR   Cosmic; 1963329
DR   ECACC; 10092309
DR   GEO; GSM726272
DR   Progenetix; CVCL_2536
DR   Wikidata; Q54899115
RX   PubMed=1703129;
RX   PubMed=21642991;
RX   PubMed=27605433;
RX   PubMed=28387650;
CC   Doubling time: 25 hours (PubMed=1703129).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CBA=CBA-0140
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,26
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   JUCGRMi001-A
AC   CVCL_C0GD
SY   VPS35A4
DR   BioSamples; SAMEA13076453
DR   hPSCreg; JUCGRMi001-A
DR   Wikidata; Q112929903
RX   PubMed=35247840;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:13487; VPS35; Simple; p.Asp620Asn (c.1858G>A); ClinVar=VCV000030196; Zygosity=Heterozygous (PubMed=35247840).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201520; Parkinson disease 17
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0GE ! JUCGRMi001-B
OI   CVCL_C0GF ! JUCGRMi001-C
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUCGRMi001-B
AC   CVCL_C0GE
SY   VPS35A5
DR   BioSamples; SAMEA13076456
DR   hPSCreg; JUCGRMi001-B
DR   Wikidata; Q112929906
RX   PubMed=35247840;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:13487; VPS35; Simple; p.Asp620Asn (c.1858G>A); ClinVar=VCV000030196; Zygosity=Heterozygous (PubMed=35247840).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201520; Parkinson disease 17
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0GD ! JUCGRMi001-A
OI   CVCL_C0GF ! JUCGRMi001-C
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUCGRMi001-C
AC   CVCL_C0GF
SY   VPS35A8
DR   BioSamples; SAMEA13076457
DR   hPSCreg; JUCGRMi001-C
DR   Wikidata; Q112929909
RX   PubMed=35247840;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:13487; VPS35; Simple; p.Asp620Asn (c.1858G>A); ClinVar=VCV000030196; Zygosity=Heterozygous (PubMed=35247840).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201520; Parkinson disease 17
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0GD ! JUCGRMi001-A
OI   CVCL_C0GE ! JUCGRMi001-B
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUCGRMi002-A
AC   CVCL_C0GG
SY   DupA5
DR   BioSamples; SAMEA113970329
DR   hPSCreg; JUCGRMi002-A
DR   Wikidata; Q112929911
RX   PubMed=38154385;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=38154385).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0GH ! JUCGRMi002-B
OI   CVCL_C0GI ! JUCGRMi002-C
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUCGRMi002-B
AC   CVCL_C0GH
SY   DupA13
DR   BioSamples; SAMEA113970932
DR   hPSCreg; JUCGRMi002-B
DR   Wikidata; Q112929912
RX   PubMed=38154385;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=38154385).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0GG ! JUCGRMi002-A
OI   CVCL_C0GI ! JUCGRMi002-C
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUCGRMi002-C
AC   CVCL_C0GI
SY   DupA18
DR   BioSamples; SAMEA113970934
DR   hPSCreg; JUCGRMi002-C
DR   Wikidata; Q112929913
RX   PubMed=38154385;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=38154385).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0GG ! JUCGRMi002-A
OI   CVCL_C0GH ! JUCGRMi002-B
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUCGRMi003-A
AC   CVCL_D0GX
SY   PH13
DR   BioSamples; SAMEA113970990
DR   hPSCreg; JUCGRMi003-A
DR   Wikidata; Q123032771
RX   PubMed=38309147;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Homozygous (PubMed=38309147).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   JUCGRMi004-A
AC   CVCL_D0GU
SY   CMTA6
DR   BioSamples; SAMEA113971000
DR   hPSCreg; JUCGRMi004-A
DR   Wikidata; Q123032772
RX   PubMed=38537501;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Heterozygous (PubMed=38537501).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   JUCGRMi005-A
AC   CVCL_D0GV
SY   JA5
DR   BioSamples; SAMEA113981826
DR   hPSCreg; JUCGRMi005-A
DR   Wikidata; Q123032773
RX   PubMed=38100917;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   JUCGRMi006-A
AC   CVCL_D0GW
SY   JB6
DR   BioSamples; SAMEA113981827
DR   hPSCreg; JUCGRMi006-A
DR   Wikidata; Q123032774
RX   PubMed=38100911;
CC   From: Center for Genomic and Regenerative Medicine, Juntendo University; Tokyo; Japan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   JUCTCi001-A
AC   CVCL_YT31
DR   BioSamples; SAMEA6703536
DR   hPSCreg; JUCTCi001-A
DR   Wikidata; Q94332538
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT32 ! JUCTCi001-B
OI   CVCL_YT33 ! JUCTCi001-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   JUCTCi001-B
AC   CVCL_YT32
DR   hPSCreg; JUCTCi001-B
DR   Wikidata; Q94332545
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT31 ! JUCTCi001-A
OI   CVCL_YT33 ! JUCTCi001-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   JUCTCi001-C
AC   CVCL_YT33
DR   hPSCreg; JUCTCi001-C
DR   Wikidata; Q94332551
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT31 ! JUCTCi001-A
OI   CVCL_YT32 ! JUCTCi001-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   JUCTCi002-A
AC   CVCL_A9I3
SY   iPSC-APTX-02-01
DR   hPSCreg; JUCTCi002-A
DR   SKIP; SKIP005816
DR   Wikidata; Q102114321
RX   PubMed=32769066;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (PubMed=32769066).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9I4 ! JUCTCi002-B
OI   CVCL_A9I5 ! JUCTCi002-C
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   JUCTCi002-B
AC   CVCL_A9I4
DR   hPSCreg; JUCTCi002-B
DR   Wikidata; Q102114322
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (from autologous cell line JUCTCi002-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9I3 ! JUCTCi002-A
OI   CVCL_A9I5 ! JUCTCi002-C
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi002-C
AC   CVCL_A9I5
DR   hPSCreg; JUCTCi002-C
DR   Wikidata; Q102114323
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Trp279Ter (c.837G>A); ClinVar=VCV000004431; Zygosity=Homozygous (from autologous cell line JUCTCi002-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9I3 ! JUCTCi002-A
OI   CVCL_A9I4 ! JUCTCi002-B
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi007-A
AC   CVCL_ZZ62
DR   hPSCreg; JUCTCi007-A
DR   SKIP; SKIP005863
DR   Wikidata; Q102114324
RX   PubMed=32645605;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:1966; CHRNE; Simple; p.Arg331Trp (c.991C>T); ClinVar=VCV000018358; Zygosity=Homozygous (PubMed=32645605).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174216; Congenital myasthenic syndrome-4C
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ63 ! JUCTCi007-B
OI   CVCL_ZZ64 ! JUCTCi007-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   JUCTCi007-B
AC   CVCL_ZZ63
DR   hPSCreg; JUCTCi007-B
DR   Wikidata; Q102114327
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:1966; CHRNE; Simple; p.Arg331Trp (c.991C>T); ClinVar=VCV000018358; Zygosity=Homozygous (from autologous cell line JUCTCi007-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174216; Congenital myasthenic syndrome-4C
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ62 ! JUCTCi007-A
OI   CVCL_ZZ64 ! JUCTCi007-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi007-C
AC   CVCL_ZZ64
DR   hPSCreg; JUCTCi007-C
DR   Wikidata; Q102114328
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:1966; CHRNE; Simple; p.Arg331Trp (c.991C>T); ClinVar=VCV000018358; Zygosity=Homozygous (from autologous cell line JUCTCi007-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174216; Congenital myasthenic syndrome-4C
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ62 ! JUCTCi007-A
OI   CVCL_ZZ63 ! JUCTCi007-B
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi010-A
AC   CVCL_ZV36
SY   iPSC-Ctrl-02-01
DR   hPSCreg; JUCTCi010-A
DR   SKIP; SKIP005859
DR   Wikidata; Q98126807
RX   PubMed=32622344;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZV37 ! JUCTCi010-B
OI   CVCL_ZV38 ! JUCTCi010-C
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   JUCTCi010-B
AC   CVCL_ZV37
DR   hPSCreg; JUCTCi010-B
DR   Wikidata; Q98126808
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZV36 ! JUCTCi010-A
OI   CVCL_ZV38 ! JUCTCi010-C
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi010-C
AC   CVCL_ZV38
DR   hPSCreg; JUCTCi010-C
DR   Wikidata; Q98126809
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZV36 ! JUCTCi010-A
OI   CVCL_ZV37 ! JUCTCi010-B
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi011-A
AC   CVCL_A9I0
SY   iPSC-Ctrl-01-01
DR   hPSCreg; JUCTCi011-A
DR   SKIP; SKIP005824
DR   Wikidata; Q102114329
RX   PubMed=32771906;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9I1 ! JUCTCi011-B
OI   CVCL_A9I2 ! JUCTCi011-C
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi011-B
AC   CVCL_A9I1
DR   hPSCreg; JUCTCi011-B
DR   Wikidata; Q102114330
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9I0 ! JUCTCi011-A
OI   CVCL_A9I2 ! JUCTCi011-C
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi011-C
AC   CVCL_A9I2
DR   hPSCreg; JUCTCi011-C
DR   Wikidata; Q102114332
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9I0 ! JUCTCi011-A
OI   CVCL_A9I1 ! JUCTCi011-B
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi012-A
AC   CVCL_A9XI
DR   hPSCreg; JUCTCi012-A
DR   Wikidata; Q102114333
RX   PubMed=32916636;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg707Trp (c.2119C>T); ClinVar=VCV000002280; Zygosity=Homozygous (PubMed=32916636).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4392; Cervical symmetrical lipomatosis
DI   ORDO; Orphanet_2398; Multiple symmetric lipomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XJ ! JUCTCi012-B
OI   CVCL_A9XK ! JUCTCi012-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   JUCTCi012-B
AC   CVCL_A9XJ
DR   hPSCreg; JUCTCi012-B
DR   Wikidata; Q102114334
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg707Trp (c.2119C>T); ClinVar=VCV000002280; Zygosity=Homozygous (from autologous cell line JUCTCi012-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4392; Cervical symmetrical lipomatosis
DI   ORDO; Orphanet_2398; Multiple symmetric lipomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XI ! JUCTCi012-A
OI   CVCL_A9XK ! JUCTCi012-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi012-C
AC   CVCL_A9XK
DR   hPSCreg; JUCTCi012-C
DR   Wikidata; Q102114335
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg707Trp (c.2119C>T); ClinVar=VCV000002280; Zygosity=Homozygous (from autologous cell line JUCTCi012-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4392; Cervical symmetrical lipomatosis
DI   ORDO; Orphanet_2398; Multiple symmetric lipomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XI ! JUCTCi012-A
OI   CVCL_A9XJ ! JUCTCi012-B
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi014-A
AC   CVCL_A1PL
SY   iPSC-BM-01-01
DR   hPSCreg; JUCTCi014-A
DR   Wikidata; Q102114336
RX   PubMed=33010679;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PM ! JUCTCi014-B
OI   CVCL_A1PN ! JUCTCi014-C
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi014-B
AC   CVCL_A1PM
DR   hPSCreg; JUCTCi014-B
DR   Wikidata; Q102114337
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PL ! JUCTCi014-A
OI   CVCL_A1PN ! JUCTCi014-C
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi014-C
AC   CVCL_A1PN
DR   hPSCreg; JUCTCi014-C
DR   Wikidata; Q102114338
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PL ! JUCTCi014-A
OI   CVCL_A1PM ! JUCTCi014-B
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   JUCTCi015-A
AC   CVCL_A1PP
SY   iPSC-AT-01-01
DR   hPSCreg; JUCTCi015-A
DR   Wikidata; Q102114339
RX   PubMed=33010679;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PQ ! JUCTCi015-B
OI   CVCL_A1PR ! JUCTCi015-C
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   JUCTCi015-B
AC   CVCL_A1PQ
DR   hPSCreg; JUCTCi015-B
DR   Wikidata; Q102114341
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PP ! JUCTCi015-A
OI   CVCL_A1PR ! JUCTCi015-C
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   JUCTCi015-C
AC   CVCL_A1PR
DR   hPSCreg; JUCTCi015-C
DR   Wikidata; Q102114344
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PP ! JUCTCi015-A
OI   CVCL_A1PQ ! JUCTCi015-B
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   JUCTCi016-A
AC   CVCL_A1PS
SY   iPSC-WJ-01-01
DR   hPSCreg; JUCTCi016-A
DR   Wikidata; Q102114345
RX   PubMed=33010679;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Caution: Indicated as originating from a 35 year old female donor, but as this is an umbilical cord-derived cell line this is not possible.
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
CC   Cell type: Mesenchymal stem cell of Wharton's jelly; CL=CL_0002568.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PT ! JUCTCi016-B
OI   CVCL_A1PU ! JUCTCi016-C
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   JUCTCi016-B
AC   CVCL_A1PT
DR   hPSCreg; JUCTCi016-B
DR   Wikidata; Q102114346
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Caution: Indicated as originating from a 35 year old female donor, but as this is an umbilical cord-derived cell line this is not possible.
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
CC   Cell type: Mesenchymal stem cell of Wharton's jelly; CL=CL_0002568.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PS ! JUCTCi016-A
OI   CVCL_A1PU ! JUCTCi016-C
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   JUCTCi016-C
AC   CVCL_A1PU
DR   hPSCreg; JUCTCi016-C
DR   Wikidata; Q102114347
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Caution: Indicated as originating from a 35 year old female donor, but as this is an umbilical cord-derived cell line this is not possible.
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
CC   Cell type: Mesenchymal stem cell of Wharton's jelly; CL=CL_0002568.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PS ! JUCTCi016-A
OI   CVCL_A1PT ! JUCTCi016-B
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   JUCTCi017-A
AC   CVCL_A9AA
SY   iPSC-SGCB-01-01
DR   hPSCreg; JUCTCi017-A
DR   Wikidata; Q108820572
RX   PubMed=34087734;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:10806; SGCB; Simple; p.Leu287Serfs*14 (c.859delC); ClinVar=VCV000534946; Zygosity=Homozygous (PubMed=34087734).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C180849; Autosomal recessive limb-girdle muscular dystrophy-4
DI   ORDO; Orphanet_119; Beta-sarcoglycan-related limb-girdle muscular dystrophy R4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9AB ! JUCTCi017-B
OI   CVCL_A9AC ! JUCTCi017-C
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   JUCTCi017-B
AC   CVCL_A9AB
DR   hPSCreg; JUCTCi017-B
DR   Wikidata; Q108820573
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:10806; SGCB; Simple; p.Leu287Serfs*14 (c.859delC); ClinVar=VCV000534946; Zygosity=Homozygous (from autologous cell line JUCTCi017-A).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C180849; Autosomal recessive limb-girdle muscular dystrophy-4
DI   ORDO; Orphanet_119; Beta-sarcoglycan-related limb-girdle muscular dystrophy R4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9AA ! JUCTCi017-A
OI   CVCL_A9AC ! JUCTCi017-C
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi017-C
AC   CVCL_A9AC
DR   hPSCreg; JUCTCi017-C
DR   Wikidata; Q108820574
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:10806; SGCB; Simple; p.Leu287Serfs*14 (c.859delC); ClinVar=VCV000534946; Zygosity=Homozygous (from autologous cell line JUCTCi017-A).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C180849; Autosomal recessive limb-girdle muscular dystrophy-4
DI   ORDO; Orphanet_119; Beta-sarcoglycan-related limb-girdle muscular dystrophy R4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9AA ! JUCTCi017-A
OI   CVCL_A9AB ! JUCTCi017-B
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   JUCTCi018-A
AC   CVCL_C0J5
SY   iPSC-MPV17-01-01
DR   BioSamples; SAMEA13882714
DR   hPSCreg; JUCTCi018-A
DR   Wikidata; Q112929914
RX   PubMed=39461114;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:7224; MPV17; Simple; p.Arg41Gln (c.122G>A); ClinVar=VCV000626263; Zygosity=Homozygous (PubMed=39461114).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C212863; Charcot-Marie-Tooth disease type 2EE
DI   ORDO; Orphanet_91024; Autosomal recessive axonal hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0J6 ! JUCTCi018-B
OI   CVCL_C0J7 ! JUCTCi018-C
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   JUCTCi018-B
AC   CVCL_C0J6
DR   hPSCreg; JUCTCi018-B
DR   Wikidata; Q112929915
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:7224; MPV17; Simple; p.Arg41Gln (c.122G>A); ClinVar=VCV000626263; Zygosity=Homozygous (from autologous cell line JUCTCi018-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C212863; Charcot-Marie-Tooth disease type 2EE
DI   ORDO; Orphanet_91024; Autosomal recessive axonal hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0J5 ! JUCTCi018-A
OI   CVCL_C0J7 ! JUCTCi018-C
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   JUCTCi018-C
AC   CVCL_C0J7
DR   hPSCreg; JUCTCi018-C
DR   Wikidata; Q112929916
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Population: Jordanian.
CC   Sequence variation: Mutation; HGNC; HGNC:7224; MPV17; Simple; p.Arg41Gln (c.122G>A); ClinVar=VCV000626263; Zygosity=Homozygous (from autologous cell line JUCTCi018-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C212863; Charcot-Marie-Tooth disease type 2EE
DI   ORDO; Orphanet_91024; Autosomal recessive axonal hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0J5 ! JUCTCi018-A
OI   CVCL_C0J6 ! JUCTCi018-B
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   JUCTCi019-A
AC   CVCL_C0J2
SY   iPSC-MFN2-02-01
DR   BioSamples; SAMEA13882919
DR   hPSCreg; JUCTCi019-A
DR   Wikidata; Q112929917
RX   PubMed=35468369;
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg707Trp (c.2119C>T); ClinVar=VCV000002280; Zygosity=Heterozygous (PubMed=35468369).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35468369
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,10
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 24,25
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0J3 ! JUCTCi019-B
OI   CVCL_C0J4 ! JUCTCi019-C
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   JUCTCi019-B
AC   CVCL_C0J3
DR   hPSCreg; JUCTCi019-B
DR   Wikidata; Q112929918
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg707Trp (c.2119C>T); ClinVar=VCV000002280; Zygosity=Heterozygous (from autologous cell line JUCTCi019-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0J2 ! JUCTCi019-A
OI   CVCL_C0J4 ! JUCTCi019-C
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUCTCi019-C
AC   CVCL_C0J4
DR   hPSCreg; JUCTCi019-C
DR   Wikidata; Q112929919
CC   From: Cell Therapy Center, University of Jordan; Amman; Jordan.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg707Trp (c.2119C>T); ClinVar=VCV000002280; Zygosity=Heterozygous (from autologous cell line JUCTCi019-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0J2 ! JUCTCi019-A
OI   CVCL_C0J3 ! JUCTCi019-B
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   JUFMDOi001-A
AC   CVCL_YM37
SY   GP001
DR   hPSCreg; JUFMDOi001-A
DR   Wikidata; Q94332557
RX   PubMed=33780732;
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly45Glu (c.134G>A); ClinVar=VCV000017033; Zygosity=Homozygous (PubMed=33780732).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Tyr136Ter (c.408C>A); ClinVar=VCV000189092; Zygosity=Homozygous (PubMed=33780732).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   JUFMDOi002-A
AC   CVCL_YM38
SY   GC002
DR   hPSCreg; JUFMDOi002-A
DR   Wikidata; Q94332563
RX   PubMed=33780732;
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Gly45Glu (c.134G>A); ClinVar=VCV000017033; Zygosity=Heterozygous (PubMed=33780732).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Tyr136Ter (c.408C>A); ClinVar=VCV000189092; Zygosity=Heterozygous (PubMed=33780732).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   JUFMDOi003-A
AC   CVCL_YM39
DR   hPSCreg; JUFMDOi003-A
DR   Wikidata; Q94332568
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   JUFMDOi004-A
AC   CVCL_YM40
SY   GP004
DR   hPSCreg; JUFMDOi004-A
DR   SKIP; SKIP005606
DR   Wikidata; Q94332577
RX   PubMed=31926383;
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Val37Ile (c.109G>A); ClinVar=VCV000017023; Zygosity=Homozygous (PubMed=31926383).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   JUFMDOi005-A
AC   CVCL_YM41
SY   GP005
DR   hPSCreg; JUFMDOi005-A
DR   Wikidata; Q94332581
RX   PubMed=32745712;
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Homozygous (PubMed=32745712).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32745712
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,14
ST   D16S539: 10,11
ST   D18S51: 13,15
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   JUFMDOi006-A
AC   CVCL_YM42
SY   GP006
DR   hPSCreg; JUFMDOi006-A
DR   Wikidata; Q94332587
RX   PubMed=32745712;
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Homozygous (PubMed=32745712).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32745712
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,13
ST   D16S539: 9,10
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 12,17
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   JUFMDOi007-A
AC   CVCL_D0GY
SY   UP007
DR   BioSamples; SAMEA112896423
DR   hPSCreg; JUFMDOi007-A
DR   Wikidata; Q123032775
RX   PubMed=37099934;
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.AspValCys636_638ValThrGly (c.1907_1912ATGTTT>TCACAG); Zygosity=Heterozygous (PubMed=37099934).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Leu2276fs*12 (c.8328_8329delAA); Zygosity=Heterozygous (PubMed=37099934).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   JUFMDOi008-A
AC   CVCL_D0GZ
SY   CP009
DR   BioSamples; SAMEA114231529
DR   hPSCreg; JUFMDOi008-A
DR   Wikidata; Q123032776
RX   PubMed=38878669;
CC   From: Department of Otorhinolaryngology, Juntendo University Faculty of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:13733; CDH23; Simple; p.Pro240Leu (c.719C>T); ClinVar=VCV000004928; Zygosity=Heterozygous (PubMed=38878669).
CC   Sequence variation: Mutation; HGNC; HGNC:13733; CDH23; Simple; p.Arg2029Trp (c.6085C>T); ClinVar=VCV000446446; Zygosity=Heterozygous (PubMed=38878669).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201586; Deafness, autosomal recessive 12
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Juma
AC   CVCL_ZU74
SY   NK24; NK 24
DR   Wikidata; Q98126810
RX   PubMed=4178827;
RX   PubMed=4878906;
RX   PubMed=5021706;
CC   Population: African; Kenyan.
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 6
//
ID   Jump-In T-REx CHO-K1
AC   CVCL_YL73
DR   Wikidata; Q94332592
WW   Provider; Thermo Fisher; A15007; https://www.thermofisher.com/order/catalog/product/A15007
CC   Characteristics: Generated by integration of an R4 acceptor site and a promoterless Geneticin antibiotic resistance gene (Neo) using the Jump-In cell engineering technology.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D586 ! T-REx-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 9
//
ID   Jump-In T-REx HEK 293
AC   CVCL_YL74
SY   Jump-In-T-REx HEK293
DR   BTO; BTO_0006322
DR   Wikidata; Q94332596
WW   Provider; Thermo Fisher; A15008; https://www.thermofisher.com/order/catalog/product/A15008
CC   Characteristics: Generated by integration of an R4 acceptor site and a promoterless geneticin antibiotic resistance gene (Neo) using the Jump-In cell engineering technology.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   Jup-GFP, DSas-4 line 127
AC   CVCL_Z867
SY   DSas-4-/- line 127
DR   DGRC; 215
DR   FlyBase_Cell_line; FBtc0000215
DR   Wikidata; Q54899116
RX   PubMed=23519377;
CC   Group: Insect cell line.
CC   Characteristics: Constitutively lacks centrioles (PubMed=23519377).
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Doubling time: 60 hours (DGRC=215).
CC   Knockout cell: Method=Null mutation; FlyBase_Gene; FBgn0011020; Sas-4.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   Jup-GFP, DSas-4 line 131
AC   CVCL_Z868
SY   DSas-4-/- line 131
DR   DGRC; 216
DR   FlyBase_Cell_line; FBtc0000216
DR   Wikidata; Q54899117
RX   PubMed=23519377;
CC   Group: Insect cell line.
CC   Characteristics: Constitutively lacks centrioles (PubMed=23519377).
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Doubling time: 28 hours (DGRC=216).
CC   Knockout cell: Method=Null mutation; FlyBase_Gene; FBgn0011020; Sas-4.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   Jup-GFP, DSas-4 line 69
AC   CVCL_Z869
SY   DSas-4-/- line 69
DR   DGRC; 211
DR   FlyBase_Cell_line; FBtc0000211
DR   Wikidata; Q54899118
RX   PubMed=23519377;
CC   Group: Insect cell line.
CC   Characteristics: Constitutively lacks centrioles (PubMed=23519377).
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Doubling time: 440 hours (DGRC=211).
CC   Knockout cell: Method=Null mutation; FlyBase_Gene; FBgn0011020; Sas-4.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   Jup-GFP, DSas-4 line 70
AC   CVCL_Z870
SY   DSas-4-/- line 70
DR   DGRC; 212
DR   FlyBase_Cell_line; FBtc0000212
DR   Wikidata; Q54899119
RX   PubMed=23519377;
CC   Group: Insect cell line.
CC   Characteristics: Constitutively lacks centrioles (PubMed=23519377).
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Doubling time: 100 hours (DGRC=212).
CC   Knockout cell: Method=Null mutation; FlyBase_Gene; FBgn0011020; Sas-4.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   Jup-GFP, DSas-4 line 84
AC   CVCL_Z871
SY   DSas-4-/- line 84
DR   DGRC; 213
DR   FlyBase_Cell_line; FBtc0000213
DR   Wikidata; Q54899120
RX   PubMed=23519377;
CC   Group: Insect cell line.
CC   Characteristics: Constitutively lacks centrioles (PubMed=23519377).
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Doubling time: 6 days (DGRC=213).
CC   Knockout cell: Method=Null mutation; FlyBase_Gene; FBgn0011020; Sas-4.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   Jup-GFP, DSas-4 line 96
AC   CVCL_Z872
SY   DSas-4-/- line 96
DR   DGRC; 214
DR   FlyBase_Cell_line; FBtc0000214
DR   Wikidata; Q54899122
RX   PubMed=23519377;
CC   Group: Insect cell line.
CC   Characteristics: Constitutively lacks centrioles (PubMed=23519377).
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Doubling time: 48 hours (DGRC=214).
CC   Knockout cell: Method=Null mutation; FlyBase_Gene; FBgn0011020; Sas-4.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   Jupiter
AC   CVCL_Z785
DR   DGRC; 178
DR   FlyBase_Cell_line; FBtc0000178
DR   Wikidata; Q54899124
RX   PubMed=16518797;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Doubling time: 103 hours (DGRC=178).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Jurkat
AC   CVCL_0065
SY   JURKAT; JM; JM-Jurkat; Jurkat-FHCRC; Jurkat FHCRC; FHCRC-11; FHCRC subclone 11; FCCH1024
DR   BTO; BTO_0000661
DR   CLO; CLO_0007029
DR   CLO; CLO_0007043
DR   CLO; CLO_0050978
DR   CLO; CLO_0050993
DR   CLO; CLO_0051001
DR   EFO; EFO_0002796
DR   MCCL; MCC:0000503
DR   CLDB; cl2950
DR   CLDB; cl2959
DR   CLDB; cl2960
DR   CLDB; cl2961
DR   CLDB; cl5212
DR   Abcam; ab271143
DR   Abcam; ab275468
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BEI_Resources; ARP-4668
DR   BioGRID_ORCS_Cell_line; 1255
DR   BioSample; SAMN03472181
DR   BioSample; SAMN03472286
DR   BioSample; SAMN03473341
DR   BioSample; SAMN10988565
DR   cancercelllines; CVCL_0065
DR   CCRID; 1101HUM-PUMC000347
DR   Cell_Model_Passport; SIDM01016
DR   ChEMBL-Cells; CHEMBL3307526
DR   ChEMBL-Targets; CHEMBL397
DR   CLS; 302147
DR   CLS; 305018
DR   Cosmic; 683539
DR   Cosmic; 721707
DR   Cosmic; 755289
DR   Cosmic; 801727
DR   Cosmic; 850196
DR   Cosmic; 913426
DR   Cosmic; 919152
DR   Cosmic; 922675
DR   Cosmic; 933540
DR   Cosmic; 991544
DR   Cosmic; 998737
DR   Cosmic; 999757
DR   Cosmic; 1012072
DR   Cosmic; 1037693
DR   Cosmic; 1115592
DR   Cosmic; 1118463
DR   Cosmic; 1118464
DR   Cosmic; 1127262
DR   Cosmic; 1130236
DR   Cosmic; 1132774
DR   Cosmic; 1175129
DR   Cosmic; 1191689
DR   Cosmic; 1224368
DR   Cosmic; 1226860
DR   Cosmic; 1330489
DR   Cosmic; 1375588
DR   Cosmic; 1483364
DR   Cosmic; 1524798
DR   Cosmic; 1639637
DR   Cosmic; 1641380
DR   Cosmic; 1664522
DR   Cosmic; 1760524
DR   Cosmic; 1811157
DR   Cosmic; 2039520
DR   Cosmic; 2165713
DR   Cosmic; 2301569
DR   Cosmic; 2361366
DR   Cosmic; 2602916
DR   Cosmic; 2750872
DR   Cosmic-CLP; 998184
DR   DepMap; ACH-000995
DR   DSMZ; ACC-282
DR   DSMZCellDive; ACC-282
DR   ECACC; 86010201
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10464-106H5
DR   GDSC; 998184
DR   GEO; GSM1991
DR   GEO; GSM236783
DR   GEO; GSM236819
DR   GEO; GSM482494
DR   GEO; GSM749672
DR   GEO; GSM887188
DR   GEO; GSM888261
DR   GEO; GSM1040307
DR   GEO; GSM1040377
DR   GEO; GSM1374580
DR   GEO; GSM1669965
DR   GEO; GSM5137718
DR   GEO; GSM5534218
DR   GEO; GSM5534219
DR   GEO; GSM5534220
DR   GEO; GSM5534221
DR   GEO; GSM5534222
DR   GEO; GSM5534223
DR   GEO; GSM7701387
DR   GEO; GSM7701388
DR   IARC_TP53; 186
DR   IBRC; C10155
DR   ICLC; HTL01002
DR   IHW; IHW00002
DR   IZSLER; BS CL 131
DR   KCB; KCB 94018YJ
DR   LiGeA; CCLE_029
DR   LINCS_LDP; LCL-2107
DR   Lonza; 142
DR   MeSH; D019169
DR   NCBI_Iran; C120
DR   PharmacoDB; JURKAT_712_2019
DR   PRIDE; PRD000008
DR   PRIDE; PRD000013
DR   PRIDE; PRD000787
DR   PRIDE; PXD000426
DR   PRIDE; PXD000443
DR   PRIDE; PXD001428
DR   PRIDE; PXD001872
DR   PRIDE; PXD002091
DR   PRIDE; PXD002395
DR   PRIDE; PXD006201
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0065
DR   PubChem_Cell_line; CVCL_0065
DR   RCB; RCB0537
DR   RCB; RCB0806
DR   RCB; RCB3052
DR   TKG; TKG 0209
DR   TOKU-E; 3710
DR   Wikidata; Q1632589
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=68013;
RX   PubMed=204546;
RX   PubMed=1086134;
RX   PubMed=1103999;
RX   PubMed=1915666;
RX   PubMed=2144611;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3165345;
RX   PubMed=3874327;
RX   PubMed=8127147;
RX   PubMed=8547074;
RX   PubMed=8558913;
RX   PubMed=8641406;
RX   PubMed=8957066;
RX   PubMed=9510473;
RX   PubMed=9583678;
RX   PubMed=9685479;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=9933131;
RX   PubMed=10071127;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=15028022;
RX   PubMed=15472075;
RX   PubMed=16408098;
RX   PubMed=17117183;
RX   PubMed=17170727;
RX   PubMed=19220422;
RX   PubMed=19473701;
RX   PubMed=19608861;
RX   PubMed=22278370;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=22944676;
RX   PubMed=23325432;
RX   PubMed=24618588;
RX   PubMed=26074081;
RX   PubMed=27397505;
RX   PubMed=28357668;
RX   PubMed=29967540;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30844424;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Jurkat
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Jurkat_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/jurkat/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-7.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Jurkat_cells
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=17117183); ~25-35 hours (DSMZ=ACC-282).
CC   HLA typing: A*03:01:01,03:01:01; B*07:02:01,35:03:01; C*04:01:01,07:02:01; DQB1*06:03:01,06:03:01 (DSMZCellDive=ACC-282).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=11226526; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (PubMed=9583678).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (PubMed=9583678).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=998184).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (PubMed=19473701).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (PubMed=19473701).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (PubMed=9583678).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (PubMed=9510473).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Arg1627His (c.4880G>A); ClinVar=VCV000409067; Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (PubMed=2144611; PubMed=10071127; PubMed=19220422; PubMed=22675565; Cosmic-CLP=998184).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; PTM; Acetylation.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Ubiquitination.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.4%; Native American=0%; East Asian, North=0.13%; East Asian, South=1.21%; South Asian=1.08%; European, North=70.73%; European, South=26.45% (PubMed=30894373).
CC   Anecdotal: Have been flown in space on Cosmos-2044 to study the inhibition of phorbol ester-induced cell activation in microgravity (PubMed=1915666).
CC   Misspelling: Jurcat; Note=Occasionally.
CC   Misspelling: JURKET; PubMed=313568.
CC   Discontinued: CLS; 305018; true.
CC   Discontinued: ICLC; HTL01002; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): CCRID=1101HUM-PUMC000347; COG; Cosmic-CLP=998184; DSMZ=ACC-282; ECACC=86010201; PubMed=28357668; RCB=RCB0537; RCB=RCB0806; TKG=TKG 0209
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10,11 (RCB=RCB0537)
ST   CSF1PO: 10,11 (Cosmic-CLP=998184; DSMZ=ACC-282)
ST   CSF1PO: 10,12 (ECACC=86010201)
ST   CSF1PO: 11 (RCB=RCB0806)
ST   CSF1PO: 11,12 (CCRID=1101HUM-PUMC000347; COG; PubMed=28357668; TKG=TKG 0209)
ST   D13S317: 8,10,11 (TKG=TKG 0209)
ST   D13S317: 8,11 (COG; Cosmic-CLP=998184; DSMZ=ACC-282; ECACC=86010201; RCB=RCB0537)
ST   D13S317: 8,11,12 (RCB=RCB0806)
ST   D13S317: 8,12 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
ST   D16S539: 10,11 (ECACC=86010201; RCB=RCB0537)
ST   D16S539: 11 (CCRID=1101HUM-PUMC000347; COG; Cosmic-CLP=998184; DSMZ=ACC-282; PubMed=28357668; RCB=RCB0806; TKG=TKG 0209)
ST   D18S51: 13,14,20,21 (DSMZ=ACC-282)
ST   D18S51: 13,21 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
ST   D19S433: 13,15.2 (COG; PubMed=28357668)
ST   D19S433: 13,16 (DSMZ=ACC-282)
ST   D19S433: 14,15.2 (CCRID=1101HUM-PUMC000347)
ST   D21S11: 31.2,32.2 (COG)
ST   D21S11: 31.2,32.2,33.2 (DSMZ=ACC-282)
ST   D21S11: 31.2,33.2 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
ST   D2S1338: 19,23 (CCRID=1101HUM-PUMC000347; COG)
ST   D2S1338: 19,23,24 (DSMZ=ACC-282)
ST   D3S1358: 15 (CCRID=1101HUM-PUMC000347)
ST   D3S1358: 15,16,17 (COG; DSMZ=ACC-282)
ST   D3S1358: 15,17 (PubMed=28357668)
ST   D5S818: 9
ST   D7S820: 8,10 (CCRID=1101HUM-PUMC000347; COG; ECACC=86010201; RCB=RCB0537; TKG=TKG 0209)
ST   D7S820: 8,10,11 (Cosmic-CLP=998184; DSMZ=ACC-282; RCB=RCB0806)
ST   D7S820: 8,12 (PubMed=28357668)
ST   D8S1179: 12,14,15 (COG)
ST   D8S1179: 13 (DSMZ=ACC-282)
ST   D8S1179: 13,14 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
ST   FGA: 20,21 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
ST   FGA: 20,21,22 (DSMZ=ACC-282)
ST   FGA: 20,22 (COG)
ST   Penta D: 11,13
ST   Penta E: 9,10,12 (DSMZ=ACC-282)
ST   Penta E: 10,12 (PubMed=28357668)
ST   TH01: 6,9.3
ST   TPOX: 8,9,10 (RCB=RCB0537)
ST   TPOX: 8,10 (CCRID=1101HUM-PUMC000347; COG; Cosmic-CLP=998184; DSMZ=ACC-282; ECACC=86010201; PubMed=28357668; RCB=RCB0806; TKG=TKG 0209)
ST   vWA: 16,17,18 (RCB=RCB0537; RCB=RCB0806)
ST   vWA: 16,17,19,20 (ECACC=86010201)
ST   vWA: 17,18,19 (COG)
ST   vWA: 17,18,19,20 (DSMZ=ACC-282)
ST   vWA: 18 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
ST   vWA: 18,19,20 (Cosmic-CLP=998184)
ST   vWA: 18,20 (TKG=TKG 0209)
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   Jurkat 1F2
AC   CVCL_LH47
SY   1F2
DR   cancercelllines; CVCL_LH47
DR   Wikidata; Q54899126
RX   PubMed=28847736;
CC   Population: Caucasian.
CC   Characteristics: One of the two IL2 alleles was inactived by CRISPR/Cas9 and a luciferase reporter gene was inserted in the loci thus expressing the luciferase reporter gene under the control of endogenous IL2 promoter.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6001; IL2 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 19
//
ID   Jurkat 1F2-hGITR
AC   CVCL_LH48
SY   1F2-hGITR
DR   cancercelllines; CVCL_LH48
DR   Wikidata; Q54899128
RX   PubMed=28847736;
CC   Population: Caucasian.
CC   Characteristics: One of the two IL2 alleles was inactived by CRISPR/Cas9 and a luciferase reporter gene was inserted in the loci thus expressing the luciferase gene under the control of endogenous IL2 promoter.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6001; IL2 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11914; TNFRSF18.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LH47 ! Jurkat 1F2
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 19
//
ID   Jurkat 1G4
AC   CVCL_IR10
SY   Jurkat-1G4
DR   cancercelllines; CVCL_IR10
DR   PRIDE; PXD001410
DR   Wikidata; Q54899129
RX   PubMed=23177477;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=Human T-cell receptor 1G4 (TCR 1G4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 18
//
ID   Jurkat 2H4
AC   CVCL_D5JP
SY   2H4; #2H4
DR   TKG; TKG 0806
DR   Wikidata; Q127382402
RX   PubMed=21569788;
RX   PubMed=24603311;
RX   PubMed=29594315;
CC   Population: Caucasian.
CC   Characteristics: Part of an immunotoxicity assay system, the MultiImmunoTox Assay (MITA) (PubMed=24603311).
CC   Characteristics: Transfected with three constructs, one expressing green-light luciferase (SLG) under the control of an IL2 promoter, one expressing orange-light luciferase (SLO) under the control of an IFNG promoter and the third expressing red-light luciferase (SLR) under the control of a GAPDH promoter (PubMed=21569788).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9U4U8; Phrixothrix hirtus green luciferase (Note=SLG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9U4U8; Phrixothrix hirtus green luciferase (Note=With p.Thr226Asn = SLO, orange).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9U4U7; Phrixothrix hirtus red luciferase (Note=SLR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): TKG=TKG 0806
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   Jurkat B2M KO
AC   CVCL_C3CE
DR   cancercelllines; CVCL_C3CE
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311791
CC   Population: Caucasian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Sigma-Aldrich=HLA002
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 13,22
ST   D21S11: 31.2,33.2
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat C11
AC   CVCL_C8ZJ
SY   C11
DR   BioGRID_ORCS_Cell_line; 1385
DR   Wikidata; Q123030836
RX   PubMed=23804764;
RX   PubMed=32924251;
CC   Population: Caucasian.
CC   Virology: Latently infected with the HIV-1 pseudovirus NL4-3-EGFP where the expression of EGFP is under the control of the HIV-1 LTR. The HIV-1 genome is singly integrated at 16p13.3 (PubMed=23804764).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Jurkat Cas9
AC   CVCL_DX76
DR   Horizon_Discovery; HD+Cas9-004
DR   Wikidata; Q127382403
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-004).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U617 ! BCL2 Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   Jurkat clone 77-6.8
AC   CVCL_HE54
SY   J77-6.8; J77.6.8; JURKAT clone 6.8
DR   cancercelllines; CVCL_HE54
DR   Wikidata; Q54899130
RX   PubMed=3098894;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DS01 ! Jurkat J77
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   Jurkat clone A3
AC   CVCL_1061
SY   A3
DR   BTO; BTO_0001342
DR   CLO; CLO_0001577
DR   ATCC; CRL-2570
DR   BCRC; 60485
DR   BioSample; SAMN03471678
DR   cancercelllines; CVCL_1061
DR   CCRID; 3101HUMTCHu96
DR   Cell_Model_Passport; SIDM01243
DR   CLS; 305143
DR   GEO; GSM5137705
DR   KCB; KCB 2010084YJ
DR   LINCS_LDP; LCL-1026
DR   MetaboLights; MTBLS226
DR   PRIDE; PXD023662
DR   Wikidata; Q54606726
RX   PubMed=8972182;
RX   PubMed=10616904;
RX   PubMed=35354797;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Metabolomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2570
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 13,21
ST   D19S433: 13,15.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 19,22
ST   Penta D: 11
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Jurkat D1.1
AC   CVCL_3502
SY   D1.1; D1-1
DR   CLO; CLO_0002658
DR   ATCC; CRL-3600
DR   ATCC; CRL-10915
DR   BioSample; SAMN03471307
DR   cancercelllines; CVCL_3502
DR   Cosmic; 683659
DR   GEO; GSM827149
DR   Progenetix; CVCL_3502
DR   Wikidata; Q54899131
RX   Patent=US6331433;
RX   PubMed=1834738;
RX   PubMed=20215515;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=D1.1
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/d1-1/
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10915.
CC   Population: Caucasian.
CC   Characteristics: CD4 negative subclone of Jurkat. Induces B cells to express surfac CD 23 molecules, a marker of B cell activation and to proliferate and terminally differentiate into Ig-secreting cells in the presence of T cell dependent B cell mitogens (PubMed=1834738).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-10915; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-3600
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 12,13,20,21
ST   D19S433: 13,14.2,15.2
ST   D21S11: 31.2,32.2,33.2,34.2
ST   D2S1338: 19,23
ST   D3S1358: 13,15,16,17
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 19,20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19,20
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   Jurkat E6.1
AC   CVCL_0367
AS   CVCL_4530
SY   JurkatE6-1; Jurkat E6-1; Jurkat, Clone E6-1; Jurkat Clone E6-1; Jurkat (clone E6-1); JURKAT E-6.1; JURKAT E-61; Jurkat-CloneE61; Jurkat-E6; Jurkat E6; J.E6-1; E6-1; Jurkat J6
DR   BTO; BTO_0001948
DR   CLO; CLO_0007044
DR   CLO; CLO_0007045
DR   MCCL; MCC:0000260
DR   CLDB; cl2962
DR   CLDB; cl5213
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; TIB-152
DR   BCRC; 60424
DR   BCRJ; 0125
DR   BEI_Resources; ARP-177
DR   BioSample; SAMN03472194
DR   cancercelllines; CVCL_0367
DR   CCRID; 1101HUM-PUMC000075
DR   CCRID; 1101HUM-PUMC000348
DR   CCRID; 1102HUM-NIFDC00049
DR   CCRID; 3101HUMSCSP513
DR   CCRID; 3101HUMTCHU123
DR   CCRID; 4201HUM-CCTCC00094
DR   CCTCC; GDC0094
DR   Cell_Model_Passport; SIDM01244
DR   ChEMBL-Cells; CHEMBL4295390
DR   ChEMBL-Targets; CHEMBL4296446
DR   CLS; 300223
DR   Cosmic; 913419
DR   ECACC; 88042803
DR   EGA; EGAS00001000610
DR   ENCODE; ENCBS407ENC
DR   ENCODE; ENCBS429ENC
DR   ENCODE; ENCBS550BVM
DR   ENCODE; ENCBS551ZKL
DR   ENCODE; ENCBS606GXJ
DR   ENCODE; ENCBS661UFZ
DR   ENCODE; ENCBS732UVO
DR   ENCODE; ENCBS755XWL
DR   GEO; GSE101101
DR   GEO; GSM472928
DR   GEO; GSM510511
DR   GEO; GSM827151
DR   GEO; GSM923424
DR   GEO; GSM945267
DR   GEO; GSM945268
DR   IZSLER; BS TCL 110
DR   KCB; KCB 94008YJ
DR   KCLB; 40152
DR   LINCS_LDP; LCL-1030
DR   MetaboLights; MTBLS789
DR   NCBI_Iran; C121
DR   PharmacoDB; Jurkat_Clone_E61_713_2019
DR   PRIDE; PRD000345
DR   PRIDE; PXD000148
DR   PRIDE; PXD000589
DR   PRIDE; PXD002871
DR   PRIDE; PXD004415
DR   PRIDE; PXD010176
DR   PRIDE; PXD032302
DR   Progenetix; CVCL_0367
DR   PubChem_Cell_line; CVCL_0367
DR   TOKU-E; 2081
DR   Ubigene; YC-D012
DR   Wikidata; Q54899132
RX   PubMed=7592872;
RX   PubMed=8316623;
RX   PubMed=9707173;
RX   PubMed=10468210;
RX   PubMed=10832058;
RX   PubMed=11416159;
RX   PubMed=11481229;
RX   PubMed=11669127;
RX   PubMed=15472075;
RX   PubMed=18842727;
RX   PubMed=20215515;
RX   PubMed=23933134;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=26546556;
RX   PubMed=26589293;
RX   PubMed=28464451;
RX   PubMed=29739316;
RX   PubMed=32938764;
WW   Provider; NIBSC; 0027; http://www.nibsc.org/Default.aspx?pageid=597&id=0027&theme=default
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Caucasian.
CC   Doubling time: 20.7 +- 2.2 hours (PubMed=10468210).
CC   HLA typing: A*03:01,03:01; B*07:02,35:03; C*04:01,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (PubMed=29739316).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (PubMed=29739316).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (PubMed=29739316).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (PubMed=29739316).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (PubMed=29739316).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (PubMed=7592872; PubMed=29739316).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (PubMed=29739316).
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: Have been flown in space on shuttle flights STS-76, STS-80 and STS-95 to study apoptosis and cytoskeleton modifications (PubMed=9707173; PubMed=10832058; PubMed=11481229; PubMed=11669127).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=TIB-152; CCRID; CLS=300223; ECACC=88042803; KCLB=40152; PubMed=11416159; PubMed=25877200; PubMed=32938764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12,13 (PubMed=32938764)
ST   CSF1PO: 11,12 (ATCC=TIB-152; CCRID; CLS=300223; ECACC=88042803; KCLB=40152; PubMed=25877200)
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 12,13,20,21 (PubMed=32938764)
ST   D18S51: 13,21 (CCRID; CLS=300223; PubMed=11416159; PubMed=25877200)
ST   D19S433: 14,15.2
ST   D21S11: 30.2,31.2,33.2 (PubMed=32938764)
ST   D21S11: 31.2,33.2 (CCRID; CLS=300223; PubMed=11416159; PubMed=25877200)
ST   D2S1338: 19,23
ST   D3S1358: 15 (CCRID; KCLB=40152)
ST   D3S1358: 15,17 (CLS=300223; PubMed=25877200; PubMed=32938764)
ST   D5S818: 9
ST   D7S820: 8,10 (CLS=300223; ECACC=88042803)
ST   D7S820: 8,12 (ATCC=TIB-152; CCRID; KCLB=40152; PubMed=25877200; PubMed=32938764)
ST   D8S1179: 12,13,14,15 (PubMed=32938764)
ST   D8S1179: 13,14 (CCRID; PubMed=11416159; PubMed=25877200)
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18 (ATCC=TIB-152; CCRID; CLS=300223; ECACC=88042803; KCLB=40152; PubMed=11416159; PubMed=25877200)
ST   vWA: 18,19 (PubMed=32938764)
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Jurkat E6.1 NF-kappaB::eGFP
AC   CVCL_WN96
DR   cancercelllines; CVCL_WN96
DR   Wikidata; Q94332818
RX   PubMed=25500904;
RX   PubMed=29029399;
RX   PubMed=31092850;
CC   Population: Caucasian.
CC   Characteristics: The eGFP reporter gene is under control of a NF-kappaB promoter element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   Jurkat HLA-A*01:01
AC   CVCL_C3CQ
DR   cancercelllines; CVCL_C3CQ
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311792
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*01:01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-A*02:01
AC   CVCL_C3CR
DR   cancercelllines; CVCL_C3CR
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311793
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02:01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-A*03:01
AC   CVCL_C3CS
DR   cancercelllines; CVCL_C3CS
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311794
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*03:01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-A*11:01
AC   CVCL_C3CT
DR   cancercelllines; CVCL_C3CT
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311795
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*11:01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-A*24:02
AC   CVCL_C3CU
DR   cancercelllines; CVCL_C3CU
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311796
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*24:02).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-B*07:02
AC   CVCL_C3CV
DR   cancercelllines; CVCL_C3CV
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311797
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07:02).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-B*08:01
AC   CVCL_C3CW
DR   cancercelllines; CVCL_C3CW
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311798
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*08:01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-B*15:10
AC   CVCL_C3CX
DR   cancercelllines; CVCL_C3CX
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311799
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*15:10).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-B*35:01
AC   CVCL_C3CY
DR   cancercelllines; CVCL_C3CY
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311800
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat HLA-B*40:01
AC   CVCL_C3CZ
DR   cancercelllines; CVCL_C3CZ
DR   Sigma-Aldrich; HLA002
DR   Wikidata; Q114311801
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA002).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*40:01).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CE ! Jurkat B2M KO
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat J77
AC   CVCL_DS01
SY   Jurkat/J77; J77
DR   cancercelllines; CVCL_DS01
DR   Wikidata; Q54899134
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   Jurkat J77 cl20
AC   CVCL_DS02
SY   Jurkat J77cl20; J77 clone 20; J77cl20; J77.20
DR   cancercelllines; CVCL_DS02
DR   PRIDE; PXD001549
DR   Wikidata; Q54899135
RX   PubMed=7759540;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DS01 ! Jurkat J77
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 17
//
ID   Jurkat KZ142 clone #24
AC   CVCL_KU30
SY   Jurkat TACI/KZ142
DR   cancercelllines; CVCL_KU30
DR   Wikidata; Q54899136
CC   From: ZymoGenetics, Inc.; Seattle; USA.
CC   Population: Caucasian.
CC   Characteristics: Expression of TNFRSF13B/TACI is control of the CMV promoter.
CC   Characteristics: Expression of luciferase is under the control of the NF-KappaB/AP-1 promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18153; TNFRSF13B.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   Jurkat-NFAT-Luc2-ACVR2B-KO-CD16-V158-OE
AC   CVCL_E8IH
DR   KYinno; KC-4639
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~26 hours (KYinno=KC-4639).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IG ! Jurkat-NFAT-Luc2-CD16a-V158
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-B2M-KO-1A4
AC   CVCL_E8IJ
DR   KYinno; KC-1813
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD16a-F158
AC   CVCL_E8IF
DR   KYinno; KC-1506
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~26 hours (KYinno=KC-1506).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD16a-V158
AC   CVCL_E8IG
SY   Jurkat-NFAT-Luc2-CD16-V158-OE
DR   KYinno; KC-1507
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~26 hours (KYinno=KC-1507).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD2-KO-1B4
AC   CVCL_E8IK
DR   KYinno; KC-4023
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1639; CD2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD2-KO-2A2
AC   CVCL_E8IL
DR   KYinno; KC-4024
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~26 hours (KYinno=KC-4024).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1639; CD2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD28-KO-3A4
AC   CVCL_E8IM
DR   KYinno; KC-4692
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD28-KO-4A2
AC   CVCL_E8IN
DR   KYinno; KC-4693
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD3D-KO-1B1
AC   CVCL_E8IY
DR   KYinno; KC-4083
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~26 hours (KYinno=KC-4083).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1673; CD3D.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD3D-CD3E-KO-1C4
AC   CVCL_E8IP
DR   KYinno; KC-4177
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1673; CD3D.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IY ! Jurkat-NFAT-Luc2-CD3D-KO-1B1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD3D-CD3E-KO-2A3
AC   CVCL_E8IQ
DR   KYinno; KC-4225
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~26 hours (KYinno=KC-4225).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1673; CD3D.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IY ! Jurkat-NFAT-Luc2-CD3D-KO-1B1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD3E-KO-1A1
AC   CVCL_E8IR
DR   KYinno; KC-4175
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD3E-KO-1B3
AC   CVCL_E8IS
DR   KYinno; KC-4176
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD47-KO-1B3
AC   CVCL_E8IT
DR   KYinno; KC-1609
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD47-KO-1C2
AC   CVCL_E8IU
DR   KYinno; KC-1610
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-CD7-KO-3A4
AC   CVCL_E8IV
DR   KYinno; KC-3984
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~30 hours (KYinno=KC-3984).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1695; CD7.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-HPK1-KO-2B1
AC   CVCL_E8IW
DR   KYinno; KC-1728
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~26 hours (KYinno=KC-1728).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6863; MAP4K1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2 reporter
AC   CVCL_E8IE
DR   KYinno; KC-1458
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (KYinno=KC-1458).
CC   Doubling time: ~30 hours (KYinno=KC-1458).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-ROR1-KO-CD16-V158 clone 2A6
AC   CVCL_E8II
DR   KYinno; KC-4814
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Doubling time: ~30 hours (KYinno=KC-4814).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10256; ROR1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IG ! Jurkat-NFAT-Luc2-CD16a-V158
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-NFAT-Luc2-TRAC-KO-1A2
AC   CVCL_E8IX
DR   KYinno; KC-1995
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the control of NFAT response element (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12029; TRAC.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8IE ! Jurkat-NFAT-Luc2 reporter
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat NucLight Red
AC   CVCL_DF51
DR   cancercelllines; CVCL_DF51
DR   Wikidata; Q54899137
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4613.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 22
//
ID   Jurkat pNFAT-EGFP
AC   CVCL_YB71
DR   cancercelllines; CVCL_YB71
DR   Wikidata; Q94332900
RX   PubMed=22820255;
CC   Population: Caucasian.
CC   Characteristics: Expression of the eGFP reporter gene is under control of the NFAT response element.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   Jurkat R3.25
AC   CVCL_EG05
SY   R3.25
DR   cancercelllines; CVCL_EG05
DR   Wikidata; Q54899138
RX   PubMed=9300530;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   Jurkat RB1-KO
AC   CVCL_C3G2
DR   cancercelllines; CVCL_C3G2
DR   GEO; GSM5534224
DR   GEO; GSM5534225
DR   GEO; GSM5534226
DR   GEO; GSM5534227
DR   GEO; GSM5534228
DR   GEO; GSM5534229
DR   Wikidata; Q114311802
RX   PubMed=33990344;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   Jurkat Safe Harbor Landing Pad
AC   CVCL_C3EZ
DR   cancercelllines; CVCL_C3EZ
DR   Sigma-Aldrich; CLL1221
DR   Wikidata; Q114311803
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a fluorescent mKATE2 tag flanked by Cre-lox sites (LoxN-EF1a-Lox2272-mKATE2-LoxP) was introduced in the AAVS1 safe harbor locus. The mKATE2 tag can be exchanged for a payload of the user's choice using Cre recombinase and a targeting vector with appropriate lox sites (Sigma-Aldrich=CLL1221).
CC   Doubling time: ~22 hours (Sigma-Aldrich=CLL1221).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   Jurkat Tet-Off
AC   CVCL_KU38
DR   cancercelllines; CVCL_KU38
DR   Wikidata; Q54899139
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630909.
CC   Discontinued: Takara/Clontech; Catalog number 631135.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   Jurkat Tet-On
AC   CVCL_KU35
DR   cancercelllines; CVCL_KU35
DR   Wikidata; Q54899140
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630915.
CC   Discontinued: Takara/Clontech; Catalog number 631140.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   Jurkat Tet-On 3G
AC   CVCL_V356
DR   cancercelllines; CVCL_V356
DR   Wikidata; Q54899141
WW   Provider; Takara Bio; 631181; https://www.takarabio.com/documents/Components%20List/631181-PA154491.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 21
//
ID   Jurkat tet-on clone 1
AC   CVCL_W813
DR   cancercelllines; CVCL_W813
DR   Wikidata; Q54899143
RX   DOI=10.1007/BF02887100;
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 20
//
ID   Jurkat tet-on clone 2
AC   CVCL_W814
DR   cancercelllines; CVCL_W814
DR   Wikidata; Q54899144
RX   DOI=10.1007/BF02887100;
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 20
//
ID   Jurkat Wurzburg
AC   CVCL_0584
SY   Wurzburg; Jurkat JR; JR
DR   MCCL; MCC:0000490
DR   cancercelllines; CVCL_0584
DR   Wikidata; Q54899145
RX   PubMed=7526398;
RX   PubMed=10468210;
CC   Population: Caucasian.
CC   Doubling time: 16.6 +- 2 hours (PubMed=10468210).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   Jurkat Zip6KO
AC   CVCL_E5FJ
DR   CancerTools; 161686
RX   PubMed=30552163;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18607; SLC39A6.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Jurkat, Clone E6-1-Luc
AC   CVCL_C8Z3
DR   Ubigene; YC-D012-Luc-P
DR   Wikidata; Q123032777
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Jurkat-111
AC   CVCL_U326
SY   Jurkat 111; J-111
DR   ATCC; CRL-8129
DR   BioSample; SAMN03471193
DR   cancercelllines; CVCL_U326
DR   Wikidata; Q54899146
RX   Patent=EP0142268A1;
RX   Patent=US5795777;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8129.
CC   Population: Caucasian.
CC   Characteristics: Highly increased IL2 expression.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8129
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10,11
ST   D16S539: 11,12
ST   D5S818: 9
ST   D7S820: 8,10,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 23
//
ID   Jurkat-508/511 RR/SS
AC   CVCL_E3JF
RX   PubMed=8627650;
CC   Population: Caucasian.
CC   Characteristics: Expresses HIV-1 Rev and Env when tetracycline is removed from the medium. Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 (PubMed=8627650).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=With p.Arg508Ser and p.Arg509Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04618; HIV-1 isolate HXB2 rev.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Jurkat-522 F/Y
AC   CVCL_1G47
DR   BEI_Resources; ARP-3955
DR   cancercelllines; CVCL_1G47
DR   Wikidata; Q54899147
RX   PubMed=8627650;
CC   Population: Caucasian.
CC   Characteristics: Expresses HIV-1 Rev and Env when tetracycline is removed from the medium. Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 (PubMed=8627650).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=With p.Phe522Tyr).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04618; HIV-1 isolate HXB2 rev.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 20
//
ID   Jurkat-713 STOP
AC   CVCL_1G48
DR   BEI_Resources; ARP-3956
DR   cancercelllines; CVCL_1G48
DR   Wikidata; Q54899148
RX   PubMed=8627650;
CC   Population: Caucasian.
CC   Characteristics: Expresses HIV-1 Rev and Env when tetracycline is removed from the medium. Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 (PubMed=8627650).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=With p.Ser713_Leu856del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04618; HIV-1 isolate HXB2 rev.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Misspelling: Jurkat-7/3 STOP; BEI_Resources=ARP-3956.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 20
//
ID   Jurkat-77
AC   CVCL_6925
SY   JURKAT-77; Jurkat 77; Jurkat77
DR   cancercelllines; CVCL_6925
DR   CCRID; 1101HUM-PUMC000162
DR   Wikidata; Q54899149
RX   PubMed=6600440;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): CCRID=1101HUM-PUMC000162
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 13,21
ST   D19S433: 13,15.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,16,17
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 19,20,21,22
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   Jurkat-99
AC   CVCL_U323
SY   Jurkat 99; J-99
DR   cancercelllines; CVCL_U323
DR   Wikidata; Q54899150
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8131.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   Jurkat-A2
AC   CVCL_X703
SY   Jurkat A2; JA2
DR   cancercelllines; CVCL_X703
DR   Wikidata; Q54899151
RX   PubMed=2477484;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 18
//
ID   Jurkat-deltaKS
AC   CVCL_1G46
DR   BEI_Resources; ARP-3954
DR   cancercelllines; CVCL_1G46
DR   Wikidata; Q54899152
RX   PubMed=8627650;
CC   Population: Caucasian.
CC   Characteristics: Expresses HIV-1 Rev when tetracycline is removed from the medium. Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 (PubMed=8627650).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04618; HIV-1 isolate HXB2 rev.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 20
//
ID   Jurkat-Dual
AC   CVCL_X593
DR   cancercelllines; CVCL_X593
DR   InvivoGen; jktd-isnf
DR   Wikidata; Q54899153
CC   Population: Caucasian.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites (InvivoGen=jktd-isnf).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 20
//
ID   Jurkat-F9-1906LUC
AC   CVCL_JZ99
SY   J-1906-F9
DR   cancercelllines; CVCL_JZ99
DR   Wikidata; Q54899155
RX   Patent=US20040152126;
RX   Patent=WO2001004350A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 99032405.
CC   Population: Caucasian.
CC   Characteristics: Transfected with luciferase under the control of the PTGS2/COX-2 promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   Jurkat-FADD-/-
AC   CVCL_HF44
SY   E1
DR   cancercelllines; CVCL_HF44
DR   Wikidata; Q54899156
RX   PubMed=10616904;
RX   PubMed=15637111;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=15637111
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 13,22
ST   D21S11: 31.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,9.3
ST   D8S1179: 12,14
ST   FGA: 19,22
ST   Penta D: 11
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1061 ! Jurkat clone A3
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 17
//
ID   Jurkat-hART4
AC   CVCL_E8VR
RX   PubMed=16168396;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:726; ART4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Jurkat-HXBc2(4)
AC   CVCL_1F94
DR   BEI_Resources; ARP-3952
DR   cancercelllines; CVCL_1F94
DR   Wikidata; Q54899157
RX   PubMed=8627650;
CC   Population: Caucasian.
CC   Characteristics: Expresses HIV-1 Rev and Env when tetracycline is removed from the medium. Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 (PubMed=8627650).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04618; HIV-1 isolate HXB2 rev.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 20
//
ID   Jurkat-HXBc2(6)
AC   CVCL_1F95
DR   BEI_Resources; ARP-3953
DR   cancercelllines; CVCL_1F95
DR   Wikidata; Q54899158
RX   PubMed=8627650;
CC   Population: Caucasian.
CC   Characteristics: Expresses HIV-1 Rev and Env when tetracycline is removed from the medium. Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 (PubMed=8627650).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04578; HIV-1 isolate HXB2 env.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04618; HIV-1 isolate HXB2 rev.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: BEI_Resources; ARP-3953; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 20
//
ID   Jurkat-JMN
AC   CVCL_B332
SY   Jurkat JMN; JMN
DR   cancercelllines; CVCL_B332
DR   Wikidata; Q54899159
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Jurkat-LTRGT
AC   CVCL_XX92
DR   cancercelllines; CVCL_XX92
DR   CCRID; 4201PAT-CCTCC00247
DR   Wikidata; Q94333182
RX   Patent=CN101372707B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200821.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   Jurkat-Luc-RFP
AC   CVCL_B7NZ
SY   Luciferase/tdTomato Dual-Reporter Jurkat Cell Line
DR   cancercelllines; CVCL_B7NZ
DR   Wikidata; Q112929920
WW   Provider; ALSTEM; LRL06; https://www.alstembio.com/web/product_details.php?id=34
CC   Population: Caucasian.
CC   Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   Jurkat-Lucia h4-1BB
AC   CVCL_E8F0
DR   InvivoGen; jktl-41bb
CC   Population: Caucasian.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of a NF-kappaB response element (InvivoGen=jktl-41bb).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Jurkat-Lucia hCD27
AC   CVCL_E8F1
DR   InvivoGen; jktl-cd27
CC   Population: Caucasian.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of a NF-kappaB response element (InvivoGen=jktl-cd27).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11922; CD27.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Jurkat-Lucia NFAT
AC   CVCL_KS47
DR   cancercelllines; CVCL_KS47
DR   InvivoGen; jktl-nfat
DR   Wikidata; Q54899160
CC   Population: Caucasian.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements (InvivoGen=jktl-nfat).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   Jurkat-Lucia NFAT-CD16
AC   CVCL_A7ZT
DR   cancercelllines; CVCL_A7ZT
DR   InvivoGen; jktl-nfat-cd16
DR   Wikidata; Q107115511
CC   Population: Caucasian.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements (InvivoGen=jktl-nfat-cd16).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS47 ! Jurkat-Lucia NFAT
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   Jurkat-Lucia NFAT-CD16-Low
AC   CVCL_E8EZ
DR   InvivoGen; jktl-nfat-cd16lo
CC   Population: Caucasian.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements (InvivoGen=jktl-nfat-cd16lo).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS47 ! Jurkat-Lucia NFAT
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Jurkat-Lucia NFAT-CD28
AC   CVCL_E3JD
DR   InvivoGen; jktl-nfat-cd28
CC   Population: Caucasian.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements (InvivoGen=jktl-nfat-cd28).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1653; CD28.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS47 ! Jurkat-Lucia NFAT
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Jurkat-Lucia NFAT-CD32
AC   CVCL_A7ZU
DR   cancercelllines; CVCL_A7ZU
DR   InvivoGen; jktl-nfat-cd32
DR   Wikidata; Q107115513
CC   Population: Caucasian.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements (InvivoGen=jktl-nfat-cd32).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3616; FCGR2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS47 ! Jurkat-Lucia NFAT
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   Jurkat-Lucia TCR-hPD-1
AC   CVCL_E3JE
DR   InvivoGen; rajkt-hpd1
CC   Population: Caucasian.
CC   Biotechnology: Used in the Jurkat-Raji PD-1/PD-L1 assay (Bio-IC) specifically designed for screening antibody-, Fc-fusion protein-, or small-molecule antagonists of the PD-1/PD-L1 immune checkpoint (IC) axis (Invivogen=rajkt-hpd1).
CC   Characteristics: Express a specific TCR and PDCD1 (PD-1) along with the Lucia luciferase reporter gene under the control of an ISG54 minimal promoter fused to six NFAT response elements (InvivoGen=rajkt-hpd1).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS47 ! Jurkat-Lucia NFAT
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Jurkat-TAg
AC   CVCL_C831
SY   Jurkat TAg; Jurkat Tag
DR   cancercelllines; CVCL_C831
DR   PRIDE; PXD018330
DR   Wikidata; Q54899161
RX   PubMed=8428966;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   Jurkat-tat
AC   CVCL_X692
DR   BEI_Resources; ARP-1399
DR   cancercelllines; CVCL_X692
DR   Wikidata; Q54899162
RX   Patent=US4981790;
RX   PubMed=2156043;
CC   Group: Patented cell line.
CC   Population: Caucasian.
CC   Doubling time: 25 hours (BEI_Resources=ARP-1399).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 19
//
ID   Jurkat/A4
AC   CVCL_AR84
SY   Jurkat-A4
DR   cancercelllines; CVCL_AR84
DR   Wikidata; Q54899163
RX   CelloPub=CLPUB00316;
RX   PubMed=20693966;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   Jurkat/Cas9-hyg
AC   CVCL_C9F1
DR   GeneCopoeia; SL555
DR   Wikidata; Q123032778
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL555).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   JURL-MK1
AC   CVCL_2086
SY   JURLMK1
DR   BTO; BTO_0005909
DR   CLO; CLO_0009838
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473526
DR   BioSample; SAMN10988501
DR   cancercelllines; CVCL_2086
DR   Cell_Model_Passport; SIDM01015
DR   CGH-DB; 9214-4
DR   Cosmic; 1012073
DR   Cosmic; 1078719
DR   Cosmic-CLP; 1327771
DR   DepMap; ACH-000326
DR   DSMZ; ACC-532
DR   DSMZCellDive; ACC-532
DR   EGA; EGAS00001000978
DR   GDSC; 1327771
DR   GEO; GSM887189
DR   GEO; GSM888262
DR   GEO; GSM1669966
DR   IARC_TP53; 28238
DR   LiGeA; CCLE_124
DR   LINCS_LDP; LCL-1101
DR   PharmacoDB; JURLMK1_714_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2086
DR   Wikidata; Q54899164
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9305612;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=9305612); ~48 hours (DSMZ=ACC-532).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=9305612; PubMed=10071072; PubMed=10576511; DepMap=ACH-000326).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Tyr1495Ter (c.4485C>A); ClinVar=VCV000521871; Zygosity=Homozygous (Cosmic-CLP=1327771; DepMap=ACH-000326).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (Cosmic-CLP=1327771; DepMap=ACH-000326).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.4%; Native American=0%; East Asian, North=1.62%; East Asian, South=0%; South Asian=8.59%; European, North=29.18%; European, South=57.22% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1327771; DSMZ=ACC-532
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 27,29
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 14
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 14,16
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2087 ! JURL-MK2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   JURL-MK2
AC   CVCL_2087
SY   JURLMK2
DR   BTO; BTO_0005910
DR   CLO; CLO_0009839
DR   BioSample; SAMN03473527
DR   Cell_Model_Passport; SIDM01014
DR   CGH-DB; 9219-4
DR   DSMZ; ACC-533
DR   DSMZCellDive; ACC-533
DR   LINCS_LDP; LCL-1102
DR   Wikidata; Q54899165
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9305612;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=9305612); ~72 hours (DSMZ=ACC-533).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=9305612; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-533
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 27,29
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 14,16
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2086 ! JURL-MK1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 27
//
ID   JUT-4
AC   CVCL_E7RX
RX   Patent=US8759091;
CC   Population: Caucasian.
CC   Characteristics: Can be used in a reporter assay capable of detecting and quantifying low levels of TNF-alpha in a highly specific manner (Patent=US8759091).
CC   Characteristics: The luciferase reporter gene is under the control of 5 tandem copies of the NF-kappaB response element (Patent=US8759091).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   JVC
AC   CVCL_R734
DR   Wikidata; Q54899167
RX   PubMed=6437669;
RX   PubMed=7329817;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 6
//
ID   JVE015
AC   CVCL_EG16
SY   JVE-015
DR   cancercelllines; CVCL_EG16
DR   DepMap; ACH-002654
DR   DSMZ; ACC-786
DR   DSMZCellDive; ACC-786
DR   GEO; GSM1655597
DR   GEO; GSM1655623
DR   Wikidata; Q54899171
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~3-4 days (DSMZ=ACC-786).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (PubMed=26894854; DepMap=ACH-002654).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=26894854; DepMap=ACH-002654).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (DepMap=ACH-002654).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): DSMZ=ACC-786; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30 (PubMed=26894854)
ST   D21S11: 30,32.2 (DSMZ=ACC-786)
ST   D2S1338: 18,19
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   JVE017
AC   CVCL_IZ58
SY   JVE-017
DR   cancercelllines; CVCL_IZ58
DR   DSMZ; ACC-803
DR   DSMZCellDive; ACC-803
DR   GEO; GSM1655598
DR   GEO; GSM1655618
DR   Wikidata; Q54899172
RX   PubMed=28931069;
CC   Doubling time: ~40-60 hours (DSMZ=ACC-803).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=28931069).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=28931069).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283Pro (c.848G>C); ClinVar=VCV000486555; Zygosity=Unspecified (PubMed=28931069).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): DSMZ=ACC-803
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 17,20
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   JVE044
AC   CVCL_EG17
SY   JVE-044
DR   cancercelllines; CVCL_EG17
DR   GEO; GSM1655599
DR   GEO; GSM1655619
DR   Wikidata; Q54899173
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 13,14
ST   D16S539: 9,10
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   JVE059
AC   CVCL_EG18
SY   JVE-059
DR   DSMZ; ACC-806
DR   DSMZCellDive; ACC-806
DR   GEO; GSM1655600
DR   GEO; GSM1655624
DR   Wikidata; Q54899174
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~3-4 days (DSMZ=ACC-806).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
ST   Source(s): DSMZ=ACC-806; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12 (PubMed=26894854)
ST   D13S317: 12,13 (DSMZ=ACC-806)
ST   D16S539: 12
ST   D18S51: 14,17,18
ST   D19S433: 12,14
ST   D21S11: 29,30.2
ST   D2S1338: 17,21
ST   D3S1358: 13,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,17
ST   FGA: 17,21
ST   Penta D: 10,15
ST   Penta E: 5,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   JVE103
AC   CVCL_EG19
SY   JVE-103
DR   DSMZ; ACC-807
DR   DSMZCellDive; ACC-807
DR   GEO; GSM1655601
DR   GEO; GSM1655625
DR   Wikidata; Q54899175
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~10-14 days (DSMZ=ACC-807).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DSMZ=ACC-807; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 28,31 (PubMed=26894854)
ST   D21S11: 31 (DSMZ=ACC-807)
ST   D2S1338: 21
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 15
ST   FGA: 20
ST   Penta D: 12,14
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   JVE109
AC   CVCL_EG20
SY   JVE-109
DR   ABM; T8225
DR   cancercelllines; CVCL_EG20
DR   DSMZ; ACC-809
DR   DSMZCellDive; ACC-809
DR   GEO; GSM1655602
DR   GEO; GSM1655626
DR   Wikidata; Q54899176
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~50 hours (DSMZ=ACC-809).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, hepatic flexure; UBERON=UBERON_0022277.
ST   Source(s): DSMZ=ACC-809; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 11,14
ST   D19S433: 14,16
ST   D21S11: 28
ST   D2S1338: 18
ST   D3S1358: 13,14
ST   D5S818: 11,12
ST   D7S820: 8,9 (DSMZ=ACC-809)
ST   D7S820: 9 (PubMed=26894854)
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 16,18
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,22
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   JVE114
AC   CVCL_EG21
SY   JVE-114
DR   DSMZ; ACC-812
DR   DSMZCellDive; ACC-812
DR   GEO; GSM1655603
DR   GEO; GSM1655620
DR   Wikidata; Q54899177
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~3-5 days (DSMZ=ACC-812).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DSMZ=ACC-812; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 17,23
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 14,16
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   JVE127
AC   CVCL_EG22
SY   JVE-127
DR   cancercelllines; CVCL_EG22
DR   DepMap; ACH-002659
DR   DSMZ; ACC-813
DR   DSMZCellDive; ACC-813
DR   GEO; GSM1655604
DR   GEO; GSM1655627
DR   Wikidata; Q54899178
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~2-3 days (DSMZ=ACC-813).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DSMZ=ACC-813; PubMed=26894854
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,13
ST   D16S539: 12,13
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 18,19
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 10
ST   Penta E: 4,16
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 18
//
ID   JVE187
AC   CVCL_EG23
SY   JVE-187
DR   cancercelllines; CVCL_EG23
DR   DSMZ; ACC-818
DR   DSMZCellDive; ACC-818
DR   GEO; GSM1655605
DR   GEO; GSM1655628
DR   Wikidata; Q54899179
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~3-5 days (DSMZ=ACC-818).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Lys117Asn (c.351A>C); ClinVar=VCV000375965; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DSMZ=ACC-818; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 19
ST   D19S433: 12
ST   D21S11: 31,32.2
ST   D2S1338: 20,22
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 20,24
ST   Penta D: 20
ST   Penta E: 12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   JVE192
AC   CVCL_EG24
SY   JVE-192
DR   cancercelllines; CVCL_EG24
DR   DSMZ; ACC-819
DR   DSMZCellDive; ACC-819
DR   GEO; GSM1655606
DR   GEO; GSM1655621
DR   Wikidata; Q54899180
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~50 hours (DSMZ=ACC-819).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DSMZ=ACC-819; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 9,10,13 (PubMed=26894854)
ST   CSF1PO: 10,13 (DSMZ=ACC-819)
ST   D13S317: 10,11
ST   D16S539: 10,12 (DSMZ=ACC-819)
ST   D16S539: 10,12,14 (PubMed=26894854)
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 31,33.2
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 9,9.3,10 (DSMZ=ACC-819)
ST   D7S820: 9,10 (PubMed=26894854)
ST   D8S1179: 12,16,17
ST   FGA: 21,22,23
ST   Penta D: 13,14
ST   Penta E: 5,7
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   JVE207
AC   CVCL_EG25
SY   JVE-207
DR   cancercelllines; CVCL_EG25
DR   DepMap; ACH-002662
DR   DSMZ; ACC-820
DR   DSMZCellDive; ACC-820
DR   GEO; GSM1655607
DR   GEO; GSM1655629
DR   Wikidata; Q54899181
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~30-50 hours (DSMZ=ACC-820).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
ST   Source(s): DSMZ=ACC-820; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 17,21
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 13,14
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 18
//
ID   JVE222
AC   CVCL_EG26
SY   JVE-222
DR   cancercelllines; CVCL_EG26
DR   DSMZ; ACC-821
DR   DSMZCellDive; ACC-821
DR   GEO; GSM1655608
DR   GEO; GSM1655630
DR   Wikidata; Q54899182
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~70 hours (DSMZ=ACC-821).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DSMZ=ACC-821; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12 (PubMed=26894854)
ST   D13S317: 12 (DSMZ=ACC-821)
ST   D16S539: 9,12
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 29,32 (DSMZ=ACC-821)
ST   D21S11: 29,32.2 (PubMed=26894854)
ST   D2S1338: 17,23
ST   D3S1358: 16,18
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 5,11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   JVE241
AC   CVCL_EG27
SY   JVE-241
DR   cancercelllines; CVCL_EG27
DR   DSMZ; ACC-822
DR   DSMZCellDive; ACC-822
DR   GEO; GSM1655609
DR   GEO; GSM1655631
DR   Wikidata; Q54899183
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~8-10 days (DSMZ=ACC-822).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): DSMZ=ACC-822; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 10,11
ST   D16S539: 13
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 29,30.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 13,14
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18 (PubMed=26894854)
ST   vWA: 18 (DSMZ=ACC-822)
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   JVE253
AC   CVCL_EG28
SY   JVE-253
DR   cancercelllines; CVCL_EG28
DR   DepMap; ACH-002664
DR   DSMZ; ACC-823
DR   DSMZCellDive; ACC-823
DR   GEO; GSM1655610
DR   GEO; GSM1655632
DR   Wikidata; Q54899184
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~40 hours (DSMZ=ACC-823).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DSMZ=ACC-823; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 11
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 20,22
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 20,26
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 18,19
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   JVE367
AC   CVCL_EG29
SY   JVE-367
DR   cancercelllines; CVCL_EG29
DR   DSMZ; ACC-829
DR   DSMZCellDive; ACC-829
DR   GEO; GSM1655611
DR   GEO; GSM1655633
DR   Wikidata; Q54899185
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~4-5 days (DSMZ=ACC-829).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Intestine, ileocecal junction; UBERON=UBERON_0001073.
ST   Source(s): DSMZ=ACC-829; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 11,12 (PubMed=26894854)
ST   CSF1PO: 12 (DSMZ=ACC-829)
ST   D13S317: 9
ST   D16S539: 13
ST   D18S51: 19
ST   D19S433: 14
ST   D21S11: 31.2 (DSMZ=ACC-829)
ST   D21S11: 33.2 (PubMed=26894854)
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 26
ST   Penta D: 8
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 10
ST   vWA: 21
DI   NCIt; C96157; Colorectal large cell neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   JVE371
AC   CVCL_EG30
SY   JVE-371
DR   cancercelllines; CVCL_EG30
DR   DSMZ; ACC-825
DR   DSMZCellDive; ACC-825
DR   GEO; GSM1655612
DR   GEO; GSM1655634
DR   Wikidata; Q54899186
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~3-5 days (DSMZ=ACC-825).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DSMZ=ACC-825; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 19
ST   D21S11: 33.2
ST   D2S1338: 19,25
ST   D3S1358: 14,15
ST   D5S818: 10
ST   D7S820: 9,12
ST   D8S1179: 14
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 14
ST   TH01: 8 (DSMZ=ACC-825)
ST   TH01: 8,10 (PubMed=26894854)
ST   TPOX: 9,11
ST   vWA: 18 (PubMed=26894854)
ST   vWA: 18,19 (DSMZ=ACC-825)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   JVE528
AC   CVCL_EG31
SY   JVE-528
DR   cancercelllines; CVCL_EG31
DR   DSMZ; ACC-826
DR   DSMZCellDive; ACC-826
DR   GEO; GSM1655613
DR   GEO; GSM1655635
DR   Wikidata; Q54899187
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Doubling time: ~4 days (DSMZ=ACC-826).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DSMZ=ACC-826; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 15
ST   D21S11: 28,31 (PubMed=26894854)
ST   D21S11: 30,31 (DSMZ=ACC-826)
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 3
ST   Penta E: 8
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   JVE774
AC   CVCL_EG32
SY   JVE-774
DR   cancercelllines; CVCL_EG32
DR   GEO; GSM1655614
DR   GEO; GSM1655636
DR   Wikidata; Q54899188
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln22Lys (c.64C>A); ClinVar=VCV000376325; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=26894854
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D21S11: 28,29
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   JVM
AC   CVCL_E719
SY   GM06819
DR   CLO; CLO_0036527
DR   Coriell; GM06819
DR   dbMHC; 48916
DR   ECACC; 85051629
DR   IHW; IHW09039
DR   IPD-IMGT/HLA; 10879
DR   Lonza; 592
DR   Wikidata; Q54899189
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*02:01:01:01; B*18:01:01:01; C*05:01:01:01; DPA1*01; DPB1*02:01:02/02:01:19; DQA1*05:05; DQB1*03:01:01; DRA*01:01; DRB1*11:02:01; DRB3*02:02 (IPD-IMGT/HLA=10879).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Caution: Erroneously indicated as being a B-cell leukemia cell line in Lonza=592.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   JVM-13
AC   CVCL_1318
SY   JVM 13; JVM13
DR   CLO; CLO_0007046
DR   CLDB; cl2964
DR   CLDB; cl5073
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-3003
DR   BioSample; SAMN01821571
DR   BioSample; SAMN01821641
DR   BioSample; SAMN03471707
DR   DSMZ; ACC-19
DR   DSMZCellDive; ACC-19
DR   ECACC; 96090516
DR   GEO; GSM1266785
DR   GEO; GSM1266786
DR   Wikidata; Q54899190
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3262465;
RX   PubMed=20454443;
RX   PubMed=24362935;
RX   PubMed=25315077;
RX   PubMed=25960936;
RX   PubMed=28196595;
RX   PubMed=29666304;
RX   PubMed=31160637;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 58 hours (PubMed=25315077); ~70 hours (DSMZ=ACC-19).
CC   HLA typing: A*02:01,03:01; B*15:01,56:01; C*01:02,03:03; DQA1*01:03,01:03; DQB1*06:03,06:03; DRB1*13:01,03:38 (PubMed=25960936).
CC   HLA typing: A*02:01:01,03:01:01; B*15:01:01,56:01:01; C*01:02:01,03:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,06:01; DQA1*01:03:01,01:03:01; DQB1*06:03:01,06:03:01; DRA*01:02:02,01:02:02; DRB1*13:01:01,13:01:01 (DSMZCellDive=ACC-19).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3003; DSMZ=ACC-19; ECACC=96090516
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 14,19
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 18,20
ST   D3S1358: 15,19
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13,13.2
ST   FGA: 22,24
ST   Penta D: 10
ST   Penta E: 9,10
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   JVM-14
AC   CVCL_B333
DR   Wikidata; Q54899191
RX   PubMed=3262465;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   JVM-2
AC   CVCL_1319
SY   JVM2
DR   CLO; CLO_0007047
DR   EFO; EFO_0005476
DR   CLDB; cl2965
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-3002
DR   BioSample; SAMN03471706
DR   BioSample; SAMN10988575
DR   cancercelllines; CVCL_1319
DR   CCRID; 4201HUM-CCTCC00302
DR   CCTCC; GDC0302
DR   Cell_Model_Passport; SIDM01013
DR   ChEMBL-Cells; CHEMBL3308530
DR   ChEMBL-Targets; CHEMBL2366359
DR   Cosmic; 907269
DR   Cosmic; 2088017
DR   Cosmic; 2296995
DR   Cosmic; 2756234
DR   Cosmic-CLP; 907269
DR   DepMap; ACH-000106
DR   DSMZ; ACC-12
DR   DSMZCellDive; ACC-12
DR   ECACC; 96090515
DR   EGA; EGAS00001000978
DR   GDSC; 907269
DR   GEO; GSM115805
DR   GEO; GSM629492
DR   GEO; GSM629493
DR   GEO; GSM887190
DR   GEO; GSM888263
DR   GEO; GSM907524
DR   GEO; GSM1266783
DR   GEO; GSM1266784
DR   GEO; GSM1374581
DR   GEO; GSM1669967
DR   GEO; GSM2322620
DR   GEO; GSM3150248
DR   IARC_TP53; 21422
DR   LiGeA; CCLE_045
DR   LINCS_LDP; LCL-1099
DR   Lonza; 1399
DR   PharmacoDB; JVM2_715_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1319
DR   PubChem_Cell_line; CVCL_1319
DR   Wikidata; Q54899192
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3093393;
RX   PubMed=3262465;
RX   PubMed=7849311;
RX   PubMed=16183118;
RX   PubMed=16448697;
RX   PubMed=16960149;
RX   PubMed=20164919;
RX   PubMed=20454443;
RX   PubMed=21746927;
RX   PubMed=22460905;
RX   PubMed=24362935;
RX   PubMed=25315077;
RX   PubMed=25688540;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=25315077); ~50-70 hours (DSMZ=ACC-12).
CC   HLA typing: A*24:02,26:01; B*38:01,44:02; C*05:01,12:03; DQA1*01:02,01:02; DQB1*06:03,05:01; DRB1*13:01,01:01 (PubMed=25960936).
CC   HLA typing: A*02,68; B*07,55; C*03,07 (PubMed=25688540).
CC   HLA typing: A*02:01,68:01; B*07:02,55:01; C*03:03,07:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,68:01:02; B*07:02:01,55:01:01; C*03:03:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*02:01:01,05:05:01; DQB1*02:02:01,03:01:01; DRA*01:01:01,01:01:01; DRB1*07:01:01,11:01:01 (DSMZCellDive=ACC-12).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16448697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=0.51%; East Asian, North=0.25%; East Asian, South=0%; South Asian=0.43%; European, North=67.89%; European, South=30.59% (PubMed=30894373).
CC   Misspelling: JUM2; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3002; Cosmic-CLP=907269; DSMZ=ACC-12; ECACC=96090515
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 13,18
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   JVM-3
AC   CVCL_1320
SY   JVM3
DR   BTO; BTO_0006032
DR   CLO; CLO_0007048
DR   EFO; EFO_0002214
DR   CLDB; cl2966
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473365
DR   BioSample; SAMN10988549
DR   cancercelllines; CVCL_1320
DR   Cell_Model_Passport; SIDM01012
DR   ChEMBL-Cells; CHEMBL3308203
DR   ChEMBL-Targets; CHEMBL2366372
DR   Cosmic; 907270
DR   Cosmic; 2756297
DR   Cosmic-CLP; 907270
DR   DepMap; ACH-000346
DR   DSMZ; ACC-18
DR   DSMZCellDive; ACC-18
DR   EGA; EGAS00001000978
DR   GDSC; 907270
DR   GEO; GSM887191
DR   GEO; GSM888264
DR   GEO; GSM1374582
DR   GEO; GSM1669968
DR   IARC_TP53; 21423
DR   IGRhCellID; JVM3
DR   LiGeA; CCLE_187
DR   LINCS_LDP; LCL-1100
DR   PharmacoDB; JVM3_716_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1320
DR   PubChem_Cell_line; CVCL_1320
DR   Wikidata; Q54899193
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3093393;
RX   PubMed=3262465;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29989027;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (DSMZ=ACC-18).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,01:01:01; B*08:01:01,08:01:01; C*07:01:01,07:01:01; DPA1*01:03:01,02:01:02; DPB1*04:01:01,01:01:01; DQA1*05:01:01,05:01:01; DQB1*02:01:01,02:01:01; DRA*01:02:02,01:02:02; DRB1*03:01:01,03:01:01 (DSMZCellDive=ACC-18).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Pro1435Leu (c.4304C>T); Zygosity=Heterozygous (PubMed=29989027; DepMap=ACH-000346).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (PubMed=29989027; Cosmic-CLP=907270; DepMap=ACH-000346).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.28%; Native American=0.22%; East Asian, North=1.54%; East Asian, South=0%; South Asian=0%; European, North=70.02%; European, South=27.94% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=907270; DSMZ=ACC-18
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 24,26
ST   Penta D: 12,13
ST   Penta E: 14,16
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,18,19 (DSMZ=ACC-18)
ST   vWA: 17,19 (Cosmic-CLP=907270)
DI   NCIt; C4753; B-cell prolymphocytic leukemia
DI   ORDO; Orphanet_86852; B-cell prolymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   JW18
AC   CVCL_A5UW
DR   FlyBase_Cell_line; FBtc9000069
DR   Wikidata; Q107115515
RX   PubMed=23028321;
RX   PubMed=28159754;
RX   PubMed=30422992;
CC   Group: Insect cell line.
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Characteristics: Constitutively infected with Wolbachia.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   JW18DOX
AC   CVCL_A5UX
SY   JW18-DOX; JW18TET
DR   FlyBase_Cell_line; FBtc9000070
DR   Wikidata; Q107115517
RX   PubMed=23028321;
RX   PubMed=28159754;
RX   PubMed=30422992;
CC   Group: Insect cell line.
CC   Characteristics: Expresses a Jupiter-GFP fusion protein.
CC   Characteristics: Cured of Wolbachia infection through doxycycline treatment.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_A5UW ! JW18
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   JW183/5/1
AC   CVCL_M108
DR   ECACC; 87080703
DR   Wikidata; Q54899195
RX   PubMed=3500259;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 7
//
ID   JW184/2/1
AC   CVCL_M109
DR   ECACC; 87080704
DR   Wikidata; Q54899196
RX   PubMed=3500259;
CC   Monoclonal antibody isotype: IgG4.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 7
//
ID   JW393/A
AC   CVCL_M110
DR   ECACC; 87080702
DR   Wikidata; Q54899197
RX   PubMed=3500259;
CC   Monoclonal antibody isotype: IgA2.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 7
//
ID   JW8/5/13
AC   CVCL_M111
DR   ECACC; 87080706
DR   Wikidata; Q54899198
RX   PubMed=3500259;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 7
//
ID   JWR-22h
AC   CVCL_1S89
SY   JWR-22H; GM14854
DR   CLO; CLO_0031927
DR   Coriell; GM14854
DR   Wikidata; Q54847477
RX   PubMed=1192829;
RX   PubMed=6548703;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5PY ! JoVa
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 8
//
ID   JWR-26c
AC   CVCL_B5PZ
DR   Wikidata; Q111733546
RX   PubMed=1192829;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5PY ! JoVa
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   JWR-5
AC   CVCL_B5Q0
DR   Wikidata; Q111733547
RX   PubMed=1192829;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5PY ! JoVa
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   JX-G
AC   CVCL_M085
DR   Wikidata; Q54899199
RX   PubMed=8287127;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4162; Juxtaglomerular cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   JX17
AC   CVCL_JL99
SY   JXBulk clone 17
DR   ATCC; CRL-3360
DR   cancercelllines; CVCL_JL99
DR   Wikidata; Q54899201
RX   PubMed=27057542;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-3360
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL98 ! JXBulk
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 18
//
ID   JXBulk
AC   CVCL_JL98
DR   cancercelllines; CVCL_JL98
DR   Wikidata; Q54899200
RX   PubMed=27057542;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 17
//
ID   JXQ-3D-001
AC   CVCL_E4KB
RX   PubMed=28029662;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=28029662
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C5838; Gallbladder sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4KC ! JXQ-3D-002
OI   CVCL_E4KD ! JXQ-3D-003
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   JXQ-3D-002
AC   CVCL_E4KC
RX   PubMed=28029662;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=28029662
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C5838; Gallbladder sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4KB ! JXQ-3D-001
OI   CVCL_E4KD ! JXQ-3D-003
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   JXQ-3D-003
AC   CVCL_E4KD
RX   PubMed=28029662;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=28029662
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C5838; Gallbladder sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4KB ! JXQ-3D-001
OI   CVCL_E4KC ! JXQ-3D-002
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   JXQ-3D-1279R1
AC   CVCL_A8TC
DR   Wikidata; Q108820575
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TJ ! JXQ-3D-1279R8
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R2
AC   CVCL_A8TD
DR   Wikidata; Q108820576
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TJ ! JXQ-3D-1279R8
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R3
AC   CVCL_A8TE
DR   Wikidata; Q108820577
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TJ ! JXQ-3D-1279R8
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R4
AC   CVCL_A8TF
DR   Wikidata; Q108820578
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TJ ! JXQ-3D-1279R8
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R5
AC   CVCL_A8TG
DR   Wikidata; Q108820579
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TJ ! JXQ-3D-1279R8
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R6
AC   CVCL_A8TH
DR   Wikidata; Q108820580
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D19S433: 13.2
ST   D21S11: 29,32.2
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TJ ! JXQ-3D-1279R8
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R7
AC   CVCL_A8TI
DR   Wikidata; Q108820581
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TJ ! JXQ-3D-1279R8
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R8
AC   CVCL_A8TJ
DR   Wikidata; Q108820582
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TK ! JXQ-3D-1279R9
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1279R9
AC   CVCL_A8TK
DR   Wikidata; Q108820583
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D12S391: 17
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13.2
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,14
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TC ! JXQ-3D-1279R1
OI   CVCL_A8TD ! JXQ-3D-1279R2
OI   CVCL_A8TE ! JXQ-3D-1279R3
OI   CVCL_A8TF ! JXQ-3D-1279R4
OI   CVCL_A8TG ! JXQ-3D-1279R5
OI   CVCL_A8TH ! JXQ-3D-1279R6
OI   CVCL_A8TI ! JXQ-3D-1279R7
OI   CVCL_A8TJ ! JXQ-3D-1279R8
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1405R1
AC   CVCL_A8TL
DR   Wikidata; Q108820584
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 9,14
ST   D12S391: 18
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 22,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 19
ST   D7S820: 8,9
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 17,18.4
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TM ! JXQ-3D-1405R2
OI   CVCL_A8TN ! JXQ-3D-1405R3
OI   CVCL_A8TP ! JXQ-3D-1405R4
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1405R2
AC   CVCL_A8TM
DR   Wikidata; Q108820585
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D12S391: 18
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 22,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 19
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 17,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TL ! JXQ-3D-1405R1
OI   CVCL_A8TN ! JXQ-3D-1405R3
OI   CVCL_A8TP ! JXQ-3D-1405R4
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1405R3
AC   CVCL_A8TN
DR   Wikidata; Q108820586
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D12S391: 18
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 22,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 19
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 17,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TL ! JXQ-3D-1405R1
OI   CVCL_A8TM ! JXQ-3D-1405R2
OI   CVCL_A8TP ! JXQ-3D-1405R4
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1405R4
AC   CVCL_A8TP
DR   Wikidata; Q108820587
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D12S391: 18
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 22,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 19
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 17,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TL ! JXQ-3D-1405R1
OI   CVCL_A8TM ! JXQ-3D-1405R2
OI   CVCL_A8TN ! JXQ-3D-1405R3
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1436R1
AC   CVCL_A8TQ
DR   Wikidata; Q108820588
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 15,17
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D6S1043: 17,20
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TR ! JXQ-3D-1436R2
OI   CVCL_A8TS ! JXQ-3D-1436R3
OI   CVCL_A8TT ! JXQ-3D-1436R4
OI   CVCL_A8TU ! JXQ-3D-1436R5
OI   CVCL_A8TV ! JXQ-3D-1436R6
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1436R2
AC   CVCL_A8TR
DR   Wikidata; Q108820589
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 15,17
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D6S1043: 17,20
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TQ ! JXQ-3D-1436R1
OI   CVCL_A8TS ! JXQ-3D-1436R3
OI   CVCL_A8TT ! JXQ-3D-1436R4
OI   CVCL_A8TU ! JXQ-3D-1436R5
OI   CVCL_A8TV ! JXQ-3D-1436R6
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1436R3
AC   CVCL_A8TS
DR   Wikidata; Q108820590
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 15,17
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D6S1043: 17,20
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TQ ! JXQ-3D-1436R1
OI   CVCL_A8TR ! JXQ-3D-1436R2
OI   CVCL_A8TT ! JXQ-3D-1436R4
OI   CVCL_A8TU ! JXQ-3D-1436R5
OI   CVCL_A8TV ! JXQ-3D-1436R6
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1436R4
AC   CVCL_A8TT
DR   Wikidata; Q108820591
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 15,17
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D6S1043: 17,20
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TQ ! JXQ-3D-1436R1
OI   CVCL_A8TR ! JXQ-3D-1436R2
OI   CVCL_A8TS ! JXQ-3D-1436R3
OI   CVCL_A8TU ! JXQ-3D-1436R5
OI   CVCL_A8TV ! JXQ-3D-1436R6
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1436R5
AC   CVCL_A8TU
DR   Wikidata; Q108820592
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 15,17
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D6S1043: 17,20
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TQ ! JXQ-3D-1436R1
OI   CVCL_A8TR ! JXQ-3D-1436R2
OI   CVCL_A8TS ! JXQ-3D-1436R3
OI   CVCL_A8TT ! JXQ-3D-1436R4
OI   CVCL_A8TV ! JXQ-3D-1436R6
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-1436R6
AC   CVCL_A8TV
DR   Wikidata; Q108820593
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 15,17
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D6S1043: 17,20
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TQ ! JXQ-3D-1436R1
OI   CVCL_A8TR ! JXQ-3D-1436R2
OI   CVCL_A8TS ! JXQ-3D-1436R3
OI   CVCL_A8TT ! JXQ-3D-1436R4
OI   CVCL_A8TU ! JXQ-3D-1436R5
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-3748R1
AC   CVCL_F0K3
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Characteristics: Not tumorigenic when transplanted subcutaneously into nude mice (PubMed=38113975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D12S391: 20,23
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 29,31
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 18
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K4 ! JXQ-3D-3748R2
OI   CVCL_F0K5 ! JXQ-3D-3748R3
OI   CVCL_F0K6 ! JXQ-3D-3748R4
OI   CVCL_F0K7 ! JXQ-3D-3748R5
OI   CVCL_F0K8 ! JXQ-3D-3748R6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3748R2
AC   CVCL_F0K4
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D12S391: 20,23
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 31
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 18
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K3 ! JXQ-3D-3748R1
OI   CVCL_F0K5 ! JXQ-3D-3748R3
OI   CVCL_F0K6 ! JXQ-3D-3748R4
OI   CVCL_F0K7 ! JXQ-3D-3748R5
OI   CVCL_F0K8 ! JXQ-3D-3748R6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3748R3
AC   CVCL_F0K5
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D12S391: 20,23
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 31
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 18
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K3 ! JXQ-3D-3748R1
OI   CVCL_F0K4 ! JXQ-3D-3748R2
OI   CVCL_F0K6 ! JXQ-3D-3748R4
OI   CVCL_F0K7 ! JXQ-3D-3748R5
OI   CVCL_F0K8 ! JXQ-3D-3748R6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3748R4
AC   CVCL_F0K6
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D12S391: 20,23
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 18
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K3 ! JXQ-3D-3748R1
OI   CVCL_F0K4 ! JXQ-3D-3748R2
OI   CVCL_F0K5 ! JXQ-3D-3748R3
OI   CVCL_F0K7 ! JXQ-3D-3748R5
OI   CVCL_F0K8 ! JXQ-3D-3748R6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3748R5
AC   CVCL_F0K7
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D12S391: 20,23
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 29,31
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 18
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K3 ! JXQ-3D-3748R1
OI   CVCL_F0K4 ! JXQ-3D-3748R2
OI   CVCL_F0K5 ! JXQ-3D-3748R3
OI   CVCL_F0K6 ! JXQ-3D-3748R4
OI   CVCL_F0K8 ! JXQ-3D-3748R6
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3748R6
AC   CVCL_F0K8
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D12S391: 20,23
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 29,31
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 18
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K3 ! JXQ-3D-3748R1
OI   CVCL_F0K4 ! JXQ-3D-3748R2
OI   CVCL_F0K5 ! JXQ-3D-3748R3
OI   CVCL_F0K6 ! JXQ-3D-3748R4
OI   CVCL_F0K7 ! JXQ-3D-3748R5
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3975R1
AC   CVCL_F0K9
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Leu976Pro (c.2927T>C); Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.His502Leu (c.1505A>T); Zygosity=Unspecified (PubMed=38113975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 19
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14,15.2
ST   D21S11: 28,29
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 19
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 15,22
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0KA ! JXQ-3D-3975R2
OI   CVCL_F0KB ! JXQ-3D-3975R3
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3975R2
AC   CVCL_F0KA
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Leu976Pro (c.2927T>C); Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.His502Leu (c.1505A>T); Zygosity=Unspecified (PubMed=38113975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 19
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 19
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 15,22
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K9 ! JXQ-3D-3975R1
OI   CVCL_F0KB ! JXQ-3D-3975R3
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-3975R3
AC   CVCL_F0KB
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Characteristics: Highly tumorigenic when transplanted subcutaneously into nude mice (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Leu976Pro (c.2927T>C); Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.His502Leu (c.1505A>T); Zygosity=Unspecified (PubMed=38113975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 19
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14,15.2
ST   D21S11: 28,29
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D6S1043: 19
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 15,22
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K9 ! JXQ-3D-3975R1
OI   CVCL_F0KA ! JXQ-3D-3975R2
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-4160R1
AC   CVCL_A8UF
DR   Wikidata; Q108820594
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 19
ST   D13S317: 8
ST   D16S539: 10,13
ST   D18S51: 19
ST   D19S433: 14,15.2
ST   D21S11: 28,33.2
ST   D2S1338: 20,23
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D6S1043: 13,20
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UG ! JXQ-3D-4160R2
OI   CVCL_A8UH ! JXQ-3D-4160R3
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-4160R2
AC   CVCL_A8UG
DR   Wikidata; Q108820595
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 19,21
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 11,15
ST   D19S433: 13,14
ST   D21S11: 28,33.2
ST   D2S1338: 20,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 13,18
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UF ! JXQ-3D-4160R1
OI   CVCL_A8UH ! JXQ-3D-4160R3
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-4160R3
AC   CVCL_A8UH
DR   Wikidata; Q108820597
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 19
ST   D13S317: 8
ST   D16S539: 10,13
ST   D18S51: 19
ST   D19S433: 14,15.2
ST   D21S11: 28,33.2
ST   D2S1338: 20,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 13,20
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UF ! JXQ-3D-4160R1
OI   CVCL_A8UG ! JXQ-3D-4160R2
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-4256R1
AC   CVCL_A8UI
DR   Wikidata; Q108820598
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 18
ST   D13S317: 9
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 14.2
ST   D21S11: 31.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 18
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 11,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UJ ! JXQ-3D-4256R2
OI   CVCL_A8UK ! JXQ-3D-4256R3
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-4256R2
AC   CVCL_A8UJ
DR   Wikidata; Q108820599
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 18
ST   D13S317: 9
ST   D16S539: 10
ST   D18S51: 20
ST   D19S433: 14.2
ST   D21S11: 31.2
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 14,18
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 11,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UI ! JXQ-3D-4256R1
OI   CVCL_A8UK ! JXQ-3D-4256R3
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-4256R3
AC   CVCL_A8UK
DR   Wikidata; Q108820600
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8UI ! JXQ-3D-4256R1
OI   CVCL_A8UJ ! JXQ-3D-4256R2
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-668R1
AC   CVCL_A8SY
DR   Wikidata; Q108820601
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,26
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,15.2
ST   D21S11: 31.2
ST   D2S1338: 19,26
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D6S1043: 14
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 24.2
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8SZ ! JXQ-3D-668R2
OI   CVCL_A8TA ! JXQ-3D-668R3
OI   CVCL_A8TB ! JXQ-3D-668R4
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-668R2
AC   CVCL_A8SZ
DR   Wikidata; Q108820602
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,26
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,15.2
ST   D21S11: 31.2
ST   D2S1338: 19,26
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D6S1043: 14
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 22,24.2
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8SY ! JXQ-3D-668R1
OI   CVCL_A8TA ! JXQ-3D-668R3
OI   CVCL_A8TB ! JXQ-3D-668R4
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-668R3
AC   CVCL_A8TA
DR   Wikidata; Q108820603
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19,26
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,15.2
ST   D21S11: 31.2
ST   D2S1338: 19,26
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D6S1043: 14
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 24.2
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8SY ! JXQ-3D-668R1
OI   CVCL_A8SZ ! JXQ-3D-668R2
OI   CVCL_A8TB ! JXQ-3D-668R4
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-668R4
AC   CVCL_A8TB
DR   Wikidata; Q108820604
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 19,26
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,15.2
ST   D21S11: 31.2
ST   D2S1338: 19,26
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D6S1043: 14
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 22,24.2
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8SY ! JXQ-3D-668R1
OI   CVCL_A8SZ ! JXQ-3D-668R2
OI   CVCL_A8TA ! JXQ-3D-668R3
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-783R1
AC   CVCL_F0K0
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Characteristics: Tumorigenic when transplanted subcutaneously into nude mice (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys1593Serfs*57 (c.4778del); ClinVar=VCV000486786; Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Arg403His (c.1208G>A); ClinVar=VCV000803543; Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Pro3380Thr (c.10138C>A); Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser269Alafs*82 (c.805del); Zygosity=Unspecified (PubMed=38113975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 15
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13,14.2
ST   D21S11: 28,30
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 15
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,22.2
ST   Penta D: 9
ST   Penta E: 11,16
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K1 ! JXQ-3D-783R2
OI   CVCL_F0K2 ! JXQ-3D-783R3
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-783R2
AC   CVCL_F0K1
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys1593Serfs*57 (c.4778del); ClinVar=VCV000486786; Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Arg403His (c.1208G>A); ClinVar=VCV000803543; Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Pro3380Thr (c.10138C>A); Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser269Alafs*82 (c.805del); Zygosity=Unspecified (PubMed=38113975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 15
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 15
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,22.2
ST   Penta D: 9
ST   Penta E: 11,16
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K0 ! JXQ-3D-783R1
OI   CVCL_F0K2 ! JXQ-3D-783R3
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-783R3
AC   CVCL_F0K2
RX   PubMed=38113975;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys1593Serfs*57 (c.4778del); ClinVar=VCV000486786; Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Arg403His (c.1208G>A); ClinVar=VCV000803543; Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Pro3380Thr (c.10138C>A); Zygosity=Unspecified (PubMed=38113975).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser269Alafs*82 (c.805del); Zygosity=Unspecified (PubMed=38113975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=38113975
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 15
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 15
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,22.2
ST   Penta D: 9
ST   Penta E: 11,16
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0K0 ! JXQ-3D-783R1
OI   CVCL_F0K1 ! JXQ-3D-783R2
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   JXQ-3D-902R1
AC   CVCL_A8TW
DR   Wikidata; Q108820605
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UD ! JXQ-3D-902R8
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R2
AC   CVCL_A8TX
DR   Wikidata; Q108820606
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UD ! JXQ-3D-902R8
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R3
AC   CVCL_A8TY
DR   Wikidata; Q108820607
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UD ! JXQ-3D-902R8
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R4
AC   CVCL_A8TZ
DR   Wikidata; Q108820608
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UD ! JXQ-3D-902R8
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R5
AC   CVCL_A8UA
DR   Wikidata; Q108820609
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12,13
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UD ! JXQ-3D-902R8
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R6
AC   CVCL_A8UB
DR   Wikidata; Q108820610
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UD ! JXQ-3D-902R8
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R7
AC   CVCL_A8UC
DR   Wikidata; Q108820611
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UD ! JXQ-3D-902R8
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R8
AC   CVCL_A8UD
DR   Wikidata; Q108820612
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UE ! JXQ-3D-902R9
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JXQ-3D-902R9
AC   CVCL_A8UE
DR   Wikidata; Q108820613
RX   PubMed=33813726;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): PubMed=33813726
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 15.2
ST   D21S11: 31,32
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8TW ! JXQ-3D-902R1
OI   CVCL_A8TX ! JXQ-3D-902R2
OI   CVCL_A8TY ! JXQ-3D-902R3
OI   CVCL_A8TZ ! JXQ-3D-902R4
OI   CVCL_A8UA ! JXQ-3D-902R5
OI   CVCL_A8UB ! JXQ-3D-902R6
OI   CVCL_A8UC ! JXQ-3D-902R7
OI   CVCL_A8UD ! JXQ-3D-902R8
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   JY
AC   CVCL_0108
SY   JY-S
DR   BTO; BTO_0003044
DR   CLO; CLO_0037202
DR   ChEMBL-Cells; CHEMBL3308061
DR   ChEMBL-Targets; CHEMBL613833
DR   dbMHC; 48917
DR   ECACC; 94022533
DR   IHW; IHW09287
DR   IPD-IMGT/HLA; 10882
DR   PRIDE; PXD000394
DR   PRIDE; PXD001872
DR   PRIDE; PXD006939
DR   PRIDE; PXD028633
DR   PRIDE; PXD028874
DR   PubChem_Cell_line; CVCL_0108
DR   Wikidata; Q6109290
RX   PubMed=6294325;
RX   PubMed=6417007;
RX   PubMed=7523570;
RX   PubMed=22238296;
RX   PubMed=23619976;
RX   PubMed=25576301;
RX   PubMed=25960936;
RX   PubMed=28360230;
RX   PubMed=29242379;
RX   PubMed=30844424;
RX   PubMed=34925382;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-50.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/JY_cell_line
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Amish.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (PubMed=22238296).
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02; DQA1*03:02,01:03; DQB1*06:11,03:02; DRB1*04:04,13:01 (PubMed=25960936).
CC   HLA typing: A*02:01:01:01; B*07:02:01:01; C*07:02:01:01,07:02:01:03; DPA1*01:03; DPB1*02:01:02:01,04:01; DQA1*01:03,03:01:01; DQB1*03:02;06:03; DRA*01:01:01:01,01:02:01; DRB1*04:04,13:01 (IPD-IMGT/HLA=10882).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   JY-I
AC   CVCL_XK35
DR   Wikidata; Q94333589
RX   Patent=CN101792738B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200947.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_100241; Ciprofloxacin (CIP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   JY/R7hyg
AC   CVCL_E3D6
RX   PubMed=7523570;
CC   Population: Caucasian; Amish.
CC   Characteristics: Transfected with plasmid R7hyg containing a human immunodeficiency virus 1 (HIV-1) isolate HXB2 proviral clone containing HygR in place of the HIV-1 nef gene (PubMed=7523570).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0108 ! JY
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Jyg-MC(A)
AC   CVCL_H216
SY   JygMC(A); JYG-MC A; JYG-MC type A; JYG-A
DR   CLO; CLO_0050966
DR   RCB; RCB0526
DR   Wikidata; Q54899202
RX   PubMed=2071538;
RX   PubMed=7757963;
CC   Breed/subspecies: JYG.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_H217 ! Jyg-MC(B)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   Jyg-MC(B)
AC   CVCL_H217
SY   JygMC(B); JYG-MC B; JYG-MC type B; JYG-B
DR   CLO; CLO_0050965
DR   RCB; RCB0527
DR   Wikidata; Q54899203
RX   PubMed=2071538;
RX   PubMed=7757963;
CC   Breed/subspecies: JYG.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_H216 ! Jyg-MC(A)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   K 114
AC   CVCL_G225
SY   K114; K1114; M-16
DR   CLO; CLO_0007049
DR   Wikidata; Q54899204
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8444.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   K#1 50K
AC   CVCL_1H11
SY   K#1 50k; K #1 50K; CD8+ K#1 50K
DR   Wikidata; Q54899230
RX   Patent=US6358511;
RX   PubMed=11752148;
RX   PubMed=16940531;
CC   Characteristics: Has potent HIV-1-inhibitory activity.
CC   Doubling time: 2 days (Patent=US6358511).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   K#2 (sc-)
AC   CVCL_C4UR
DR   Wikidata; Q116049608
RX   PubMed=11752148;
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   K-1.fl
AC   CVCL_F499
DR   CLO; CLO_0050785
DR   RCB; RCB0559
DR   Wikidata; Q54899208
RX   PubMed=1071084;
CC   Breed/subspecies: DDD.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4312 ! T-3-Cl-2
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   K-1034
AC   CVCL_8251
SY   K-1034 RPE; RPE-K1034; K 1034; K1034
DR   BTO; BTO_0002899
DR   Wikidata; Q54899205
RX   PubMed=7933691;
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   K-119
AC   CVCL_6292
DR   Wikidata; Q54899207
RX   PubMed=7689076;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=K-119__REFERENCES
CC   Population: Japanese.
CC   Characteristics: Produces and secretes large amount of CSF3.
CC   Doubling time: 26 hours (PubMed=7689076).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   K-21
AC   CVCL_A2GQ
DR   Wikidata; Q105509743
RX   DOI=10.11482/KMJ-E7(2)81;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   K-22 [Human leukemia]
AC   CVCL_A2GR
DR   Wikidata; Q105509745
RX   DOI=10.11482/KMJ-E7(2)81;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   K-22 [Rat liver]
AC   CVCL_6D68
SY   K22
DR   Wikidata; Q54899209
RX   PubMed=162864;
RX   PubMed=6865990;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   6-8W
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   K-23-L
AC   CVCL_A2GS
DR   Wikidata; Q105509749
RX   DOI=10.11482/KMJ-E7(2)81;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WN73 ! K-23-M
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   K-23-M
AC   CVCL_WN73
DR   Wikidata; Q94333670
RX   DOI=10.11482/KMJ-E7(2)81;
RX   PubMed=6321044;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2GS ! K-23-L
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   K-231
AC   CVCL_F959
DR   TKG; TKG 0129
DR   Wikidata; Q54899210
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   K-251
AC   CVCL_5141
DR   CLO; CLO_0050616
DR   RCB; RCB2859
DR   TKG; TKG 0130
DR   Wikidata; Q54899213
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   K-3501
AC   CVCL_B7RN
DR   Wikidata; Q112929921
RX   PubMed=18802091;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:01).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   K-3502
AC   CVCL_B7RP
DR   Wikidata; Q112929922
RX   PubMed=18802091;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:02).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   K-3503
AC   CVCL_B7RQ
DR   Wikidata; Q112929925
RX   PubMed=18802091;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:03).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   K-3504
AC   CVCL_B7RR
DR   Wikidata; Q112929928
RX   PubMed=18802091;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:04).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   K-3506
AC   CVCL_B7RS
DR   Wikidata; Q112929932
RX   PubMed=18802091;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:06).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   K-3508
AC   CVCL_B7RT
DR   Wikidata; Q112929935
RX   PubMed=18802091;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:08).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   K-562
AC   CVCL_0004
SY   K562; K.562; K 562; KO; GM05372; GM05372E
DR   BTO; BTO_0000664
DR   CLO; CLO_0007050
DR   CLO; CLO_0007059
DR   CLO; CLO_0024880
DR   CLO; CLO_0050123
DR   CLO; CLO_0050124
DR   CLO; CLO_0050126
DR   EFO; EFO_0002067
DR   MCCL; MCC:0000261
DR   CLDB; cl2967
DR   CLDB; cl2969
DR   CLDB; cl2970
DR   CLDB; cl2971
DR   CLDB; cl2972
DR   CLDB; cl2973
DR   CLDB; cl2974
DR   CLDB; cl2976
DR   CLDB; cl2978
DR   CLDB; cl2979
DR   CLDB; cl2980
DR   CLDB; cl2981
DR   CLDB; cl2982
DR   CLDB; cl2984
DR   4DN; 4DNSRP5XBV7W
DR   4DN; 4DNSRWQFKJYO
DR   Abcam; ab275469
DR   AddexBio; C0003004/52
DR   ArrayExpress; E-MEXP-2623
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-5197
DR   ArrayExpress; E-MTAB-7061
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CCL-243
DR   BCRC; 60007
DR   BCRJ; 0126
DR   BioGRID_ORCS_Cell_line; 98
DR   BioSample; SAMN03472111
DR   BioSample; SAMN03473172
DR   BioSample; SAMN03473407
DR   BioSample; SAMN10988357
DR   cancercelllines; CVCL_0004
DR   CCLV; CCLV-RIE 0439
DR   CCRID; 1101HUM-PUMC000039
DR   CCRID; 1102HUM-NIFDC00026
DR   CCRID; 3101HUMSCSP5054
DR   CCRID; 3101HUMTCHu191
DR   CCRID; 4201HUM-CCTCC00037
DR   CCRID; 5301HUM-KCB93038YJ
DR   CCTCC; GDC0037
DR   Cell_Model_Passport; SIDM00791
DR   CGH-DB; 9215-4
DR   ChEMBL-Cells; CHEMBL3308378
DR   ChEMBL-Targets; CHEMBL385
DR   CLS; 300224
DR   Coriell; GM05372
DR   Cosmic; 683655
DR   Cosmic; 755290
DR   Cosmic; 759897
DR   Cosmic; 760646
DR   Cosmic; 787495
DR   Cosmic; 798223
DR   Cosmic; 798664
DR   Cosmic; 850384
DR   Cosmic; 851999
DR   Cosmic; 875864
DR   Cosmic; 897450
DR   Cosmic; 905940
DR   Cosmic; 919127
DR   Cosmic; 922682
DR   Cosmic; 924039
DR   Cosmic; 932771
DR   Cosmic; 949095
DR   Cosmic; 974253
DR   Cosmic; 991559
DR   Cosmic; 994173
DR   Cosmic; 998760
DR   Cosmic; 999774
DR   Cosmic; 1012074
DR   Cosmic; 1019830
DR   Cosmic; 1026565
DR   Cosmic; 1037680
DR   Cosmic; 1044253
DR   Cosmic; 1067445
DR   Cosmic; 1070699
DR   Cosmic; 1078718
DR   Cosmic; 1089521
DR   Cosmic; 1092608
DR   Cosmic; 1107181
DR   Cosmic; 1118473
DR   Cosmic; 1127251
DR   Cosmic; 1175856
DR   Cosmic; 1176584
DR   Cosmic; 1191694
DR   Cosmic; 1226862
DR   Cosmic; 1305338
DR   Cosmic; 1312324
DR   Cosmic; 1319552
DR   Cosmic; 1325761
DR   Cosmic; 1465965
DR   Cosmic; 1516632
DR   Cosmic; 1523829
DR   Cosmic; 1524846
DR   Cosmic; 1601068
DR   Cosmic; 1604867
DR   Cosmic; 1779132
DR   Cosmic; 1998450
DR   Cosmic; 2009516
DR   Cosmic; 2024372
DR   Cosmic; 2089675
DR   Cosmic; 2301564
DR   Cosmic; 2649242
DR   Cosmic; 2651386
DR   Cosmic; 2750873
DR   Cosmic-CLP; 905940
DR   DepMap; ACH-000551
DR   DSMZ; ACC-10
DR   DSMZCellDive; ACC-10
DR   ECACC; 89121407
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS000CDD
DR   ENCODE; ENCBS001TOZ
DR   ENCODE; ENCBS001ZKL
DR   ENCODE; ENCBS004ALC
DR   ENCODE; ENCBS005AIZ
DR   ENCODE; ENCBS005ZXA
DR   ENCODE; ENCBS007IVF
DR   ENCODE; ENCBS007KQB
DR   ENCODE; ENCBS007ZNT
DR   ENCODE; ENCBS008XYP
DR   ENCODE; ENCBS010SYB
DR   ENCODE; ENCBS011IBX
DR   ENCODE; ENCBS012WJD
DR   ENCODE; ENCBS013BQD
DR   ENCODE; ENCBS013ENT
DR   ENCODE; ENCBS013GDO
DR   ENCODE; ENCBS013VIB
DR   ENCODE; ENCBS014ZBK
DR   ENCODE; ENCBS014ZUQ
DR   ENCODE; ENCBS016BTC
DR   ENCODE; ENCBS016SET
DR   ENCODE; ENCBS016SXN
DR   ENCODE; ENCBS016YMK
DR   ENCODE; ENCBS017GMY
DR   ENCODE; ENCBS017IKU
DR   ENCODE; ENCBS017YLT
DR   ENCODE; ENCBS018CRO
DR   ENCODE; ENCBS019QZZ
DR   ENCODE; ENCBS020IUG
DR   ENCODE; ENCBS021PJN
DR   ENCODE; ENCBS022LAM
DR   ENCODE; ENCBS022SQU
DR   ENCODE; ENCBS023DBL
DR   ENCODE; ENCBS023ECI
DR   ENCODE; ENCBS023EVI
DR   ENCODE; ENCBS023XVB
DR   ENCODE; ENCBS023YVH
DR   ENCODE; ENCBS024UMN
DR   ENCODE; ENCBS024ZBK
DR   ENCODE; ENCBS025CUE
DR   ENCODE; ENCBS025ONJ
DR   ENCODE; ENCBS026DNX
DR   ENCODE; ENCBS026IRF
DR   ENCODE; ENCBS026LKC
DR   ENCODE; ENCBS027GJN
DR   ENCODE; ENCBS029GNW
DR   ENCODE; ENCBS029KIU
DR   ENCODE; ENCBS031HYV
DR   ENCODE; ENCBS031KNX
DR   ENCODE; ENCBS031YPZ
DR   ENCODE; ENCBS036OIX
DR   ENCODE; ENCBS037RBR
DR   ENCODE; ENCBS038EDJ
DR   ENCODE; ENCBS038KVF
DR   ENCODE; ENCBS038TWG
DR   ENCODE; ENCBS039CVO
DR   ENCODE; ENCBS039ENC
DR   ENCODE; ENCBS039FPC
DR   ENCODE; ENCBS040EUG
DR   ENCODE; ENCBS040IKC
DR   ENCODE; ENCBS041GBQ
DR   ENCODE; ENCBS044UVO
DR   ENCODE; ENCBS044WJW
DR   ENCODE; ENCBS048GNZ
DR   ENCODE; ENCBS049QOP
DR   ENCODE; ENCBS049ZAC
DR   ENCODE; ENCBS051ABU
DR   ENCODE; ENCBS051ELN
DR   ENCODE; ENCBS051OXV
DR   ENCODE; ENCBS052FEF
DR   ENCODE; ENCBS053JIZ
DR   ENCODE; ENCBS055ZTI
DR   ENCODE; ENCBS056HKT
DR   ENCODE; ENCBS058KXV
DR   ENCODE; ENCBS058MBJ
DR   ENCODE; ENCBS058XGI
DR   ENCODE; ENCBS060HRB
DR   ENCODE; ENCBS061SQD
DR   ENCODE; ENCBS061XBB
DR   ENCODE; ENCBS063NCT
DR   ENCODE; ENCBS063ROH
DR   ENCODE; ENCBS065RXZ
DR   ENCODE; ENCBS070OMK
DR   ENCODE; ENCBS071UNK
DR   ENCODE; ENCBS073JAL
DR   ENCODE; ENCBS074HIZ
DR   ENCODE; ENCBS074NGX
DR   ENCODE; ENCBS075XHE
DR   ENCODE; ENCBS078NQM
DR   ENCODE; ENCBS078OYF
DR   ENCODE; ENCBS079AJY
DR   ENCODE; ENCBS079MXX
DR   ENCODE; ENCBS081NLE
DR   ENCODE; ENCBS082JCQ
DR   ENCODE; ENCBS082JRQ
DR   ENCODE; ENCBS083ACT
DR   ENCODE; ENCBS083CLD
DR   ENCODE; ENCBS083VWQ
DR   ENCODE; ENCBS084MBW
DR   ENCODE; ENCBS086JQA
DR   ENCODE; ENCBS087RNA
DR   ENCODE; ENCBS088RNA
DR   ENCODE; ENCBS089OTW
DR   ENCODE; ENCBS091YRZ
DR   ENCODE; ENCBS092VTJ
DR   ENCODE; ENCBS093NNC
DR   ENCODE; ENCBS094YFT
DR   ENCODE; ENCBS097LJT
DR   ENCODE; ENCBS099HZF
DR   ENCODE; ENCBS101QRF
DR   ENCODE; ENCBS103HEN
DR   ENCODE; ENCBS106FRJ
DR   ENCODE; ENCBS107DSY
DR   ENCODE; ENCBS109ENC
DR   ENCODE; ENCBS109VHI
DR   ENCODE; ENCBS110VVJ
DR   ENCODE; ENCBS111BRF
DR   ENCODE; ENCBS111GYT
DR   ENCODE; ENCBS111RFA
DR   ENCODE; ENCBS111WEH
DR   ENCODE; ENCBS113YMQ
DR   ENCODE; ENCBS118YJZ
DR   ENCODE; ENCBS119EVP
DR   ENCODE; ENCBS119WDQ
DR   ENCODE; ENCBS122OOP
DR   ENCODE; ENCBS123DAX
DR   ENCODE; ENCBS123QRB
DR   ENCODE; ENCBS123YCA
DR   ENCODE; ENCBS125ACM
DR   ENCODE; ENCBS125WRA
DR   ENCODE; ENCBS126AJR
DR   ENCODE; ENCBS127DTE
DR   ENCODE; ENCBS128EWC
DR   ENCODE; ENCBS128UKH
DR   ENCODE; ENCBS131FDE
DR   ENCODE; ENCBS132EBC
DR   ENCODE; ENCBS133VWK
DR   ENCODE; ENCBS136ZNW
DR   ENCODE; ENCBS138SLH
DR   ENCODE; ENCBS139SNH
DR   ENCODE; ENCBS140MLH
DR   ENCODE; ENCBS140NYG
DR   ENCODE; ENCBS142DQA
DR   ENCODE; ENCBS143LJI
DR   ENCODE; ENCBS143XSU
DR   ENCODE; ENCBS144YDQ
DR   ENCODE; ENCBS145BAM
DR   ENCODE; ENCBS145IJT
DR   ENCODE; ENCBS146WJY
DR   ENCODE; ENCBS148ZBT
DR   ENCODE; ENCBS149SJX
DR   ENCODE; ENCBS151LUO
DR   ENCODE; ENCBS152EMG
DR   ENCODE; ENCBS152WCA
DR   ENCODE; ENCBS152XKV
DR   ENCODE; ENCBS153VBF
DR   ENCODE; ENCBS154XYR
DR   ENCODE; ENCBS155KGP
DR   ENCODE; ENCBS156XSD
DR   ENCODE; ENCBS158FRU
DR   ENCODE; ENCBS158KSS
DR   ENCODE; ENCBS158SWP
DR   ENCODE; ENCBS159KYP
DR   ENCODE; ENCBS159UIB
DR   ENCODE; ENCBS162AGB
DR   ENCODE; ENCBS162UQR
DR   ENCODE; ENCBS164AGP
DR   ENCODE; ENCBS164ITK
DR   ENCODE; ENCBS165ART
DR   ENCODE; ENCBS165NPS
DR   ENCODE; ENCBS166BGG
DR   ENCODE; ENCBS166SNL
DR   ENCODE; ENCBS168OEK
DR   ENCODE; ENCBS169BBI
DR   ENCODE; ENCBS170ZQG
DR   ENCODE; ENCBS171PLV
DR   ENCODE; ENCBS172RAU
DR   ENCODE; ENCBS173WPT
DR   ENCODE; ENCBS174LOJ
DR   ENCODE; ENCBS174YKM
DR   ENCODE; ENCBS175JIH
DR   ENCODE; ENCBS175LWC
DR   ENCODE; ENCBS175LZM
DR   ENCODE; ENCBS177FZX
DR   ENCODE; ENCBS177LGN
DR   ENCODE; ENCBS180BMC
DR   ENCODE; ENCBS181AJG
DR   ENCODE; ENCBS182ISG
DR   ENCODE; ENCBS182RTT
DR   ENCODE; ENCBS182SAO
DR   ENCODE; ENCBS184UCR
DR   ENCODE; ENCBS185MQS
DR   ENCODE; ENCBS185RGL
DR   ENCODE; ENCBS187ZIN
DR   ENCODE; ENCBS190DUB
DR   ENCODE; ENCBS190TRO
DR   ENCODE; ENCBS190WBQ
DR   ENCODE; ENCBS192SEZ
DR   ENCODE; ENCBS193JEH
DR   ENCODE; ENCBS193QNA
DR   ENCODE; ENCBS193WKG
DR   ENCODE; ENCBS195ZWQ
DR   ENCODE; ENCBS198UTW
DR   ENCODE; ENCBS198YII
DR   ENCODE; ENCBS199SKB
DR   ENCODE; ENCBS200VZF
DR   ENCODE; ENCBS201EIP
DR   ENCODE; ENCBS201LYR
DR   ENCODE; ENCBS203BUH
DR   ENCODE; ENCBS204NMW
DR   ENCODE; ENCBS205QYW
DR   ENCODE; ENCBS207UAM
DR   ENCODE; ENCBS209FBZ
DR   ENCODE; ENCBS209TDT
DR   ENCODE; ENCBS209TSR
DR   ENCODE; ENCBS210WPX
DR   ENCODE; ENCBS211WEE
DR   ENCODE; ENCBS215KUV
DR   ENCODE; ENCBS216WMI
DR   ENCODE; ENCBS217DFO
DR   ENCODE; ENCBS217XCN
DR   ENCODE; ENCBS218LCA
DR   ENCODE; ENCBS218QRN
DR   ENCODE; ENCBS218ZAA
DR   ENCODE; ENCBS220ZHX
DR   ENCODE; ENCBS221UJD
DR   ENCODE; ENCBS221YFO
DR   ENCODE; ENCBS222CHH
DR   ENCODE; ENCBS222QCU
DR   ENCODE; ENCBS225YVR
DR   ENCODE; ENCBS226YIA
DR   ENCODE; ENCBS228CEB
DR   ENCODE; ENCBS230JWL
DR   ENCODE; ENCBS232KKV
DR   ENCODE; ENCBS236EJI
DR   ENCODE; ENCBS237BHV
DR   ENCODE; ENCBS237MFM
DR   ENCODE; ENCBS237RBH
DR   ENCODE; ENCBS243YEC
DR   ENCODE; ENCBS243YPN
DR   ENCODE; ENCBS244ZUD
DR   ENCODE; ENCBS245AME
DR   ENCODE; ENCBS246UOA
DR   ENCODE; ENCBS249MAT
DR   ENCODE; ENCBS250CMV
DR   ENCODE; ENCBS250HLF
DR   ENCODE; ENCBS250IAJ
DR   ENCODE; ENCBS252OWV
DR   ENCODE; ENCBS253VOZ
DR   ENCODE; ENCBS254JMT
DR   ENCODE; ENCBS254KOX
DR   ENCODE; ENCBS254WUV
DR   ENCODE; ENCBS257HMY
DR   ENCODE; ENCBS257PZA
DR   ENCODE; ENCBS261MYX
DR   ENCODE; ENCBS262OLW
DR   ENCODE; ENCBS263GNB
DR   ENCODE; ENCBS267LNH
DR   ENCODE; ENCBS268LPU
DR   ENCODE; ENCBS268OJH
DR   ENCODE; ENCBS270GGH
DR   ENCODE; ENCBS270OAE
DR   ENCODE; ENCBS271BPH
DR   ENCODE; ENCBS271QIL
DR   ENCODE; ENCBS271WWU
DR   ENCODE; ENCBS272SXA
DR   ENCODE; ENCBS274TTW
DR   ENCODE; ENCBS274WIM
DR   ENCODE; ENCBS275HBP
DR   ENCODE; ENCBS277GLZ
DR   ENCODE; ENCBS278ISQ
DR   ENCODE; ENCBS278LNR
DR   ENCODE; ENCBS280PHL
DR   ENCODE; ENCBS283QAE
DR   ENCODE; ENCBS283TEI
DR   ENCODE; ENCBS284MJG
DR   ENCODE; ENCBS285VBM
DR   ENCODE; ENCBS287TWJ
DR   ENCODE; ENCBS287XKX
DR   ENCODE; ENCBS288EEL
DR   ENCODE; ENCBS290ACU
DR   ENCODE; ENCBS290OFW
DR   ENCODE; ENCBS292NBI
DR   ENCODE; ENCBS292UVA
DR   ENCODE; ENCBS293BDC
DR   ENCODE; ENCBS293ZDP
DR   ENCODE; ENCBS298PAM
DR   ENCODE; ENCBS298QZZ
DR   ENCODE; ENCBS301EZU
DR   ENCODE; ENCBS302IGJ
DR   ENCODE; ENCBS305KEA
DR   ENCODE; ENCBS306NPK
DR   ENCODE; ENCBS311LNQ
DR   ENCODE; ENCBS312CFO
DR   ENCODE; ENCBS313HKT
DR   ENCODE; ENCBS316CKF
DR   ENCODE; ENCBS317FST
DR   ENCODE; ENCBS318IMK
DR   ENCODE; ENCBS320BUL
DR   ENCODE; ENCBS322JPK
DR   ENCODE; ENCBS323NUL
DR   ENCODE; ENCBS323WRW
DR   ENCODE; ENCBS324XGY
DR   ENCODE; ENCBS324YAG
DR   ENCODE; ENCBS326ULG
DR   ENCODE; ENCBS328LML
DR   ENCODE; ENCBS330LHC
DR   ENCODE; ENCBS331LZB
DR   ENCODE; ENCBS331OZE
DR   ENCODE; ENCBS333OTT
DR   ENCODE; ENCBS334VOL
DR   ENCODE; ENCBS339WIS
DR   ENCODE; ENCBS340AMO
DR   ENCODE; ENCBS341TAT
DR   ENCODE; ENCBS344LIE
DR   ENCODE; ENCBS344MAK
DR   ENCODE; ENCBS344ZTN
DR   ENCODE; ENCBS345PNA
DR   ENCODE; ENCBS346YOL
DR   ENCODE; ENCBS348UOE
DR   ENCODE; ENCBS349ULG
DR   ENCODE; ENCBS351GWD
DR   ENCODE; ENCBS352EMA
DR   ENCODE; ENCBS352MRW
DR   ENCODE; ENCBS354IWX
DR   ENCODE; ENCBS354VJM
DR   ENCODE; ENCBS355BRH
DR   ENCODE; ENCBS356NKY
DR   ENCODE; ENCBS357GME
DR   ENCODE; ENCBS357NWO
DR   ENCODE; ENCBS358PHP
DR   ENCODE; ENCBS359TRM
DR   ENCODE; ENCBS360VVZ
DR   ENCODE; ENCBS360YEH
DR   ENCODE; ENCBS361MEX
DR   ENCODE; ENCBS362YBS
DR   ENCODE; ENCBS363HPO
DR   ENCODE; ENCBS364BHZ
DR   ENCODE; ENCBS365DFQ
DR   ENCODE; ENCBS366CLP
DR   ENCODE; ENCBS366EQO
DR   ENCODE; ENCBS368MWR
DR   ENCODE; ENCBS370BJT
DR   ENCODE; ENCBS370QIM
DR   ENCODE; ENCBS370ZIR
DR   ENCODE; ENCBS371NDR
DR   ENCODE; ENCBS373HMN
DR   ENCODE; ENCBS374DHY
DR   ENCODE; ENCBS376UCQ
DR   ENCODE; ENCBS378DFU
DR   ENCODE; ENCBS379NWT
DR   ENCODE; ENCBS379OMY
DR   ENCODE; ENCBS380BDK
DR   ENCODE; ENCBS380IYL
DR   ENCODE; ENCBS380NDS
DR   ENCODE; ENCBS383JPN
DR   ENCODE; ENCBS383VKK
DR   ENCODE; ENCBS387VPF
DR   ENCODE; ENCBS388NGV
DR   ENCODE; ENCBS388YAM
DR   ENCODE; ENCBS388ZVM
DR   ENCODE; ENCBS389PVA
DR   ENCODE; ENCBS392QEL
DR   ENCODE; ENCBS392ZOW
DR   ENCODE; ENCBS393YUA
DR   ENCODE; ENCBS394LTC
DR   ENCODE; ENCBS396JPQ
DR   ENCODE; ENCBS396WFI
DR   ENCODE; ENCBS397GXE
DR   ENCODE; ENCBS397OLQ
DR   ENCODE; ENCBS398HUM
DR   ENCODE; ENCBS398SSI
DR   ENCODE; ENCBS400CRG
DR   ENCODE; ENCBS400HFL
DR   ENCODE; ENCBS400IMH
DR   ENCODE; ENCBS400MFJ
DR   ENCODE; ENCBS401NIV
DR   ENCODE; ENCBS402AEU
DR   ENCODE; ENCBS403VZZ
DR   ENCODE; ENCBS405GDI
DR   ENCODE; ENCBS406BAI
DR   ENCODE; ENCBS406RFF
DR   ENCODE; ENCBS407GJQ
DR   ENCODE; ENCBS409CCX
DR   ENCODE; ENCBS409HCD
DR   ENCODE; ENCBS410EIF
DR   ENCODE; ENCBS411BWT
DR   ENCODE; ENCBS413TJM
DR   ENCODE; ENCBS413UCH
DR   ENCODE; ENCBS415LMS
DR   ENCODE; ENCBS415MYO
DR   ENCODE; ENCBS416JZI
DR   ENCODE; ENCBS416ZWV
DR   ENCODE; ENCBS417FMB
DR   ENCODE; ENCBS417QMS
DR   ENCODE; ENCBS418OCT
DR   ENCODE; ENCBS419NSL
DR   ENCODE; ENCBS422KVR
DR   ENCODE; ENCBS423LSA
DR   ENCODE; ENCBS424RFS
DR   ENCODE; ENCBS425BSQ
DR   ENCODE; ENCBS425EWY
DR   ENCODE; ENCBS425QDI
DR   ENCODE; ENCBS426CWP
DR   ENCODE; ENCBS426MFA
DR   ENCODE; ENCBS426ZIK
DR   ENCODE; ENCBS430DZA
DR   ENCODE; ENCBS430OPI
DR   ENCODE; ENCBS431YNM
DR   ENCODE; ENCBS432FLT
DR   ENCODE; ENCBS433HMF
DR   ENCODE; ENCBS433OVV
DR   ENCODE; ENCBS433WAM
DR   ENCODE; ENCBS438DSC
DR   ENCODE; ENCBS440DGS
DR   ENCODE; ENCBS441EZC
DR   ENCODE; ENCBS441PSF
DR   ENCODE; ENCBS442NXE
DR   ENCODE; ENCBS442VLY
DR   ENCODE; ENCBS443DUP
DR   ENCODE; ENCBS445GUZ
DR   ENCODE; ENCBS448ECS
DR   ENCODE; ENCBS449AEF
DR   ENCODE; ENCBS449PYL
DR   ENCODE; ENCBS450ITK
DR   ENCODE; ENCBS451AJS
DR   ENCODE; ENCBS452HCE
DR   ENCODE; ENCBS453AZN
DR   ENCODE; ENCBS453KQD
DR   ENCODE; ENCBS455LFT
DR   ENCODE; ENCBS456EWO
DR   ENCODE; ENCBS456TNJ
DR   ENCODE; ENCBS460WQH
DR   ENCODE; ENCBS461TCT
DR   ENCODE; ENCBS463ABO
DR   ENCODE; ENCBS463GGK
DR   ENCODE; ENCBS464DIX
DR   ENCODE; ENCBS464YJN
DR   ENCODE; ENCBS465MWC
DR   ENCODE; ENCBS465RFQ
DR   ENCODE; ENCBS468YAY
DR   ENCODE; ENCBS472YQF
DR   ENCODE; ENCBS474CTB
DR   ENCODE; ENCBS474HJS
DR   ENCODE; ENCBS474XLY
DR   ENCODE; ENCBS476AUA
DR   ENCODE; ENCBS476AXH
DR   ENCODE; ENCBS476WAQ
DR   ENCODE; ENCBS477JCG
DR   ENCODE; ENCBS477MKD
DR   ENCODE; ENCBS478PEF
DR   ENCODE; ENCBS478TXQ
DR   ENCODE; ENCBS478USZ
DR   ENCODE; ENCBS482NAM
DR   ENCODE; ENCBS484NBA
DR   ENCODE; ENCBS486UBH
DR   ENCODE; ENCBS487XCP
DR   ENCODE; ENCBS488IUR
DR   ENCODE; ENCBS488ZQI
DR   ENCODE; ENCBS489AXI
DR   ENCODE; ENCBS489LOC
DR   ENCODE; ENCBS489PTQ
DR   ENCODE; ENCBS489ZOH
DR   ENCODE; ENCBS491FIM
DR   ENCODE; ENCBS492BQN
DR   ENCODE; ENCBS492SXA
DR   ENCODE; ENCBS493QSQ
DR   ENCODE; ENCBS494YUP
DR   ENCODE; ENCBS495MNB
DR   ENCODE; ENCBS497UCZ
DR   ENCODE; ENCBS498NIQ
DR   ENCODE; ENCBS499AAA
DR   ENCODE; ENCBS499ZBY
DR   ENCODE; ENCBS500AAA
DR   ENCODE; ENCBS501AAA
DR   ENCODE; ENCBS501AJP
DR   ENCODE; ENCBS501VGA
DR   ENCODE; ENCBS502AAA
DR   ENCODE; ENCBS502SUO
DR   ENCODE; ENCBS503AAA
DR   ENCODE; ENCBS504AAA
DR   ENCODE; ENCBS504EOJ
DR   ENCODE; ENCBS504MPM
DR   ENCODE; ENCBS504SHW
DR   ENCODE; ENCBS505AAA
DR   ENCODE; ENCBS505ILK
DR   ENCODE; ENCBS506VSB
DR   ENCODE; ENCBS508YPA
DR   ENCODE; ENCBS509AAA
DR   ENCODE; ENCBS510AAA
DR   ENCODE; ENCBS511UGF
DR   ENCODE; ENCBS511YCF
DR   ENCODE; ENCBS511YLK
DR   ENCODE; ENCBS512JXB
DR   ENCODE; ENCBS515TJK
DR   ENCODE; ENCBS516DKF
DR   ENCODE; ENCBS517UIR
DR   ENCODE; ENCBS517XSM
DR   ENCODE; ENCBS519PER
DR   ENCODE; ENCBS519VAI
DR   ENCODE; ENCBS520IYS
DR   ENCODE; ENCBS521FNT
DR   ENCODE; ENCBS521IJY
DR   ENCODE; ENCBS522JIE
DR   ENCODE; ENCBS523GIC
DR   ENCODE; ENCBS524AAA
DR   ENCODE; ENCBS526FPZ
DR   ENCODE; ENCBS526GWV
DR   ENCODE; ENCBS528AAA
DR   ENCODE; ENCBS530DUV
DR   ENCODE; ENCBS530IBU
DR   ENCODE; ENCBS530JOQ
DR   ENCODE; ENCBS530MLH
DR   ENCODE; ENCBS531SJK
DR   ENCODE; ENCBS532KVA
DR   ENCODE; ENCBS533ETT
DR   ENCODE; ENCBS534MHY
DR   ENCODE; ENCBS534VZR
DR   ENCODE; ENCBS534WDC
DR   ENCODE; ENCBS537KCG
DR   ENCODE; ENCBS538DYC
DR   ENCODE; ENCBS538WJZ
DR   ENCODE; ENCBS540TUC
DR   ENCODE; ENCBS540UNM
DR   ENCODE; ENCBS542KXR
DR   ENCODE; ENCBS543YEP
DR   ENCODE; ENCBS544JRU
DR   ENCODE; ENCBS545WKJ
DR   ENCODE; ENCBS548BNW
DR   ENCODE; ENCBS549CBF
DR   ENCODE; ENCBS549CIX
DR   ENCODE; ENCBS551TRA
DR   ENCODE; ENCBS552DXA
DR   ENCODE; ENCBS552IDC
DR   ENCODE; ENCBS552LNH
DR   ENCODE; ENCBS555BIW
DR   ENCODE; ENCBS555BYH
DR   ENCODE; ENCBS555MCX
DR   ENCODE; ENCBS556RPW
DR   ENCODE; ENCBS559ERW
DR   ENCODE; ENCBS559ZAU
DR   ENCODE; ENCBS560YCY
DR   ENCODE; ENCBS561DIS
DR   ENCODE; ENCBS562NAQ
DR   ENCODE; ENCBS563BBS
DR   ENCODE; ENCBS565ULH
DR   ENCODE; ENCBS565XGU
DR   ENCODE; ENCBS566AKW
DR   ENCODE; ENCBS566NIL
DR   ENCODE; ENCBS566SQN
DR   ENCODE; ENCBS567ZFF
DR   ENCODE; ENCBS569AYK
DR   ENCODE; ENCBS569WDT
DR   ENCODE; ENCBS572YNK
DR   ENCODE; ENCBS573CFY
DR   ENCODE; ENCBS574JXP
DR   ENCODE; ENCBS575FXP
DR   ENCODE; ENCBS576EJU
DR   ENCODE; ENCBS576ESJ
DR   ENCODE; ENCBS577JGM
DR   ENCODE; ENCBS577QZL
DR   ENCODE; ENCBS579CNZ
DR   ENCODE; ENCBS588YDJ
DR   ENCODE; ENCBS590KAM
DR   ENCODE; ENCBS590PKD
DR   ENCODE; ENCBS591LWJ
DR   ENCODE; ENCBS593BIQ
DR   ENCODE; ENCBS593CFU
DR   ENCODE; ENCBS594GNK
DR   ENCODE; ENCBS595QXS
DR   ENCODE; ENCBS596DHR
DR   ENCODE; ENCBS598STC
DR   ENCODE; ENCBS599BAS
DR   ENCODE; ENCBS600AAA
DR   ENCODE; ENCBS600EDY
DR   ENCODE; ENCBS601AAA
DR   ENCODE; ENCBS601MXN
DR   ENCODE; ENCBS602AAA
DR   ENCODE; ENCBS602RSX
DR   ENCODE; ENCBS602TPG
DR   ENCODE; ENCBS603CUX
DR   ENCODE; ENCBS603PMU
DR   ENCODE; ENCBS609MYU
DR   ENCODE; ENCBS611GYD
DR   ENCODE; ENCBS612SGW
DR   ENCODE; ENCBS613LBH
DR   ENCODE; ENCBS614RYV
DR   ENCODE; ENCBS615ZVR
DR   ENCODE; ENCBS617ILH
DR   ENCODE; ENCBS617TOY
DR   ENCODE; ENCBS619EFN
DR   ENCODE; ENCBS619KUS
DR   ENCODE; ENCBS619VEE
DR   ENCODE; ENCBS621XIY
DR   ENCODE; ENCBS622KGA
DR   ENCODE; ENCBS624RXT
DR   ENCODE; ENCBS626KTH
DR   ENCODE; ENCBS626OHB
DR   ENCODE; ENCBS626TPH
DR   ENCODE; ENCBS626VGF
DR   ENCODE; ENCBS627GSN
DR   ENCODE; ENCBS628JQT
DR   ENCODE; ENCBS629DNR
DR   ENCODE; ENCBS630MQK
DR   ENCODE; ENCBS630NVQ
DR   ENCODE; ENCBS630OAS
DR   ENCODE; ENCBS631FGS
DR   ENCODE; ENCBS632QPM
DR   ENCODE; ENCBS636RQT
DR   ENCODE; ENCBS637RKV
DR   ENCODE; ENCBS638EYY
DR   ENCODE; ENCBS638OEZ
DR   ENCODE; ENCBS638QCL
DR   ENCODE; ENCBS638TGE
DR   ENCODE; ENCBS639AAA
DR   ENCODE; ENCBS641AAS
DR   ENCODE; ENCBS642DEU
DR   ENCODE; ENCBS643CHR
DR   ENCODE; ENCBS643OWK
DR   ENCODE; ENCBS644RCS
DR   ENCODE; ENCBS645RVR
DR   ENCODE; ENCBS647KYQ
DR   ENCODE; ENCBS649DTO
DR   ENCODE; ENCBS649VHZ
DR   ENCODE; ENCBS651RVZ
DR   ENCODE; ENCBS652YOG
DR   ENCODE; ENCBS654OPT
DR   ENCODE; ENCBS654PMT
DR   ENCODE; ENCBS654VZH
DR   ENCODE; ENCBS655HQL
DR   ENCODE; ENCBS656VZE
DR   ENCODE; ENCBS657MGB
DR   ENCODE; ENCBS657ZYP
DR   ENCODE; ENCBS658KIL
DR   ENCODE; ENCBS658RMI
DR   ENCODE; ENCBS659SAO
DR   ENCODE; ENCBS661YYO
DR   ENCODE; ENCBS662URL
DR   ENCODE; ENCBS664AAA
DR   ENCODE; ENCBS664AUV
DR   ENCODE; ENCBS664NTU
DR   ENCODE; ENCBS664VDB
DR   ENCODE; ENCBS666SJB
DR   ENCODE; ENCBS667AAA
DR   ENCODE; ENCBS667PRV
DR   ENCODE; ENCBS670BDF
DR   ENCODE; ENCBS670KPG
DR   ENCODE; ENCBS673MZQ
DR   ENCODE; ENCBS674MPN
DR   ENCODE; ENCBS674VNC
DR   ENCODE; ENCBS675OVW
DR   ENCODE; ENCBS676KLB
DR   ENCODE; ENCBS676XGX
DR   ENCODE; ENCBS677BWZ
DR   ENCODE; ENCBS677GYI
DR   ENCODE; ENCBS677HPS
DR   ENCODE; ENCBS677KBE
DR   ENCODE; ENCBS679MDQ
DR   ENCODE; ENCBS680QCR
DR   ENCODE; ENCBS681CCH
DR   ENCODE; ENCBS684JMW
DR   ENCODE; ENCBS686VDZ
DR   ENCODE; ENCBS688EQJ
DR   ENCODE; ENCBS688QTO
DR   ENCODE; ENCBS688VYK
DR   ENCODE; ENCBS690NWI
DR   ENCODE; ENCBS691GWJ
DR   ENCODE; ENCBS693EWC
DR   ENCODE; ENCBS695KRB
DR   ENCODE; ENCBS696KRM
DR   ENCODE; ENCBS697QYY
DR   ENCODE; ENCBS697XFI
DR   ENCODE; ENCBS698AAA
DR   ENCODE; ENCBS698OWO
DR   ENCODE; ENCBS698ZKR
DR   ENCODE; ENCBS699AAA
DR   ENCODE; ENCBS700AAA
DR   ENCODE; ENCBS701AAA
DR   ENCODE; ENCBS701BIM
DR   ENCODE; ENCBS701VZK
DR   ENCODE; ENCBS702AAA
DR   ENCODE; ENCBS703AAA
DR   ENCODE; ENCBS703API
DR   ENCODE; ENCBS704AAA
DR   ENCODE; ENCBS704IXT
DR   ENCODE; ENCBS704YXA
DR   ENCODE; ENCBS705ZOS
DR   ENCODE; ENCBS708KJA
DR   ENCODE; ENCBS709SOB
DR   ENCODE; ENCBS709TUN
DR   ENCODE; ENCBS713VDJ
DR   ENCODE; ENCBS714PSX
DR   ENCODE; ENCBS714TRH
DR   ENCODE; ENCBS715AAA
DR   ENCODE; ENCBS715BML
DR   ENCODE; ENCBS715XGH
DR   ENCODE; ENCBS716JYS
DR   ENCODE; ENCBS717VYS
DR   ENCODE; ENCBS718GJU
DR   ENCODE; ENCBS719UQU
DR   ENCODE; ENCBS719YVT
DR   ENCODE; ENCBS720HYG
DR   ENCODE; ENCBS720UTF
DR   ENCODE; ENCBS721AAA
DR   ENCODE; ENCBS721MSZ
DR   ENCODE; ENCBS721OCY
DR   ENCODE; ENCBS722AAA
DR   ENCODE; ENCBS723AAA
DR   ENCODE; ENCBS723ZIW
DR   ENCODE; ENCBS724AAA
DR   ENCODE; ENCBS725AAA
DR   ENCODE; ENCBS726AAA
DR   ENCODE; ENCBS726ZFM
DR   ENCODE; ENCBS727RLP
DR   ENCODE; ENCBS728WBV
DR   ENCODE; ENCBS729ELF
DR   ENCODE; ENCBS729IGE
DR   ENCODE; ENCBS730QNJ
DR   ENCODE; ENCBS731EBS
DR   ENCODE; ENCBS731WEZ
DR   ENCODE; ENCBS731WGV
DR   ENCODE; ENCBS732IZQ
DR   ENCODE; ENCBS732XZP
DR   ENCODE; ENCBS733PPV
DR   ENCODE; ENCBS734NZL
DR   ENCODE; ENCBS735VTB
DR   ENCODE; ENCBS736PRC
DR   ENCODE; ENCBS737CUP
DR   ENCODE; ENCBS739OBP
DR   ENCODE; ENCBS739ZIJ
DR   ENCODE; ENCBS741EFJ
DR   ENCODE; ENCBS741VGS
DR   ENCODE; ENCBS742ILR
DR   ENCODE; ENCBS744CXB
DR   ENCODE; ENCBS745CIF
DR   ENCODE; ENCBS745UXY
DR   ENCODE; ENCBS746GKH
DR   ENCODE; ENCBS746KYH
DR   ENCODE; ENCBS746YXR
DR   ENCODE; ENCBS747AAA
DR   ENCODE; ENCBS748AAA
DR   ENCODE; ENCBS748FCA
DR   ENCODE; ENCBS749AAA
DR   ENCODE; ENCBS749FNX
DR   ENCODE; ENCBS750AAA
DR   ENCODE; ENCBS751AAA
DR   ENCODE; ENCBS751EBU
DR   ENCODE; ENCBS751SXP
DR   ENCODE; ENCBS751WKI
DR   ENCODE; ENCBS752AAA
DR   ENCODE; ENCBS753DCN
DR   ENCODE; ENCBS753LXR
DR   ENCODE; ENCBS754HFN
DR   ENCODE; ENCBS757EXI
DR   ENCODE; ENCBS757HMX
DR   ENCODE; ENCBS764AAA
DR   ENCODE; ENCBS765AAA
DR   ENCODE; ENCBS765OBZ
DR   ENCODE; ENCBS766AAA
DR   ENCODE; ENCBS767AAA
DR   ENCODE; ENCBS767HRR
DR   ENCODE; ENCBS767XGD
DR   ENCODE; ENCBS768AAA
DR   ENCODE; ENCBS769AAA
DR   ENCODE; ENCBS770AAA
DR   ENCODE; ENCBS770VHR
DR   ENCODE; ENCBS771AAA
DR   ENCODE; ENCBS771FYB
DR   ENCODE; ENCBS771FYZ
DR   ENCODE; ENCBS771NTZ
DR   ENCODE; ENCBS772AAA
DR   ENCODE; ENCBS772SKD
DR   ENCODE; ENCBS772VHK
DR   ENCODE; ENCBS774KGY
DR   ENCODE; ENCBS775AAA
DR   ENCODE; ENCBS775HUY
DR   ENCODE; ENCBS775RXB
DR   ENCODE; ENCBS776AAA
DR   ENCODE; ENCBS776WTE
DR   ENCODE; ENCBS777AAA
DR   ENCODE; ENCBS778AAA
DR   ENCODE; ENCBS779AAA
DR   ENCODE; ENCBS779EKH
DR   ENCODE; ENCBS782AAA
DR   ENCODE; ENCBS782UIO
DR   ENCODE; ENCBS783AAA
DR   ENCODE; ENCBS783CHO
DR   ENCODE; ENCBS783CHQ
DR   ENCODE; ENCBS783PTA
DR   ENCODE; ENCBS783WYV
DR   ENCODE; ENCBS784AAA
DR   ENCODE; ENCBS785AAA
DR   ENCODE; ENCBS786AAA
DR   ENCODE; ENCBS787AAA
DR   ENCODE; ENCBS788AAA
DR   ENCODE; ENCBS788CSD
DR   ENCODE; ENCBS789AAA
DR   ENCODE; ENCBS789DTV
DR   ENCODE; ENCBS789RGF
DR   ENCODE; ENCBS790AAA
DR   ENCODE; ENCBS790JBM
DR   ENCODE; ENCBS790YFX
DR   ENCODE; ENCBS791AAA
DR   ENCODE; ENCBS792SRL
DR   ENCODE; ENCBS797SGL
DR   ENCODE; ENCBS798HJU
DR   ENCODE; ENCBS799TLB
DR   ENCODE; ENCBS800RVX
DR   ENCODE; ENCBS802AYH
DR   ENCODE; ENCBS803KFY
DR   ENCODE; ENCBS806UYV
DR   ENCODE; ENCBS808AAA
DR   ENCODE; ENCBS808FZK
DR   ENCODE; ENCBS808KRH
DR   ENCODE; ENCBS808ZQB
DR   ENCODE; ENCBS809AAA
DR   ENCODE; ENCBS809CIO
DR   ENCODE; ENCBS809UHL
DR   ENCODE; ENCBS810AAA
DR   ENCODE; ENCBS811AAA
DR   ENCODE; ENCBS812AAA
DR   ENCODE; ENCBS812OIJ
DR   ENCODE; ENCBS813AAA
DR   ENCODE; ENCBS813JVE
DR   ENCODE; ENCBS814AAA
DR   ENCODE; ENCBS815AAA
DR   ENCODE; ENCBS815LSY
DR   ENCODE; ENCBS816AAA
DR   ENCODE; ENCBS818EBR
DR   ENCODE; ENCBS818WVG
DR   ENCODE; ENCBS819AUE
DR   ENCODE; ENCBS820QHU
DR   ENCODE; ENCBS821KLW
DR   ENCODE; ENCBS822TRA
DR   ENCODE; ENCBS823LKQ
DR   ENCODE; ENCBS824PND
DR   ENCODE; ENCBS827AAA
DR   ENCODE; ENCBS827YSZ
DR   ENCODE; ENCBS828AAA
DR   ENCODE; ENCBS828OIW
DR   ENCODE; ENCBS828SMC
DR   ENCODE; ENCBS829AAA
DR   ENCODE; ENCBS829QEL
DR   ENCODE; ENCBS829VJO
DR   ENCODE; ENCBS830AAA
DR   ENCODE; ENCBS830FSQ
DR   ENCODE; ENCBS831AAA
DR   ENCODE; ENCBS831ATS
DR   ENCODE; ENCBS831COV
DR   ENCODE; ENCBS831RAD
DR   ENCODE; ENCBS832AAA
DR   ENCODE; ENCBS833AAA
DR   ENCODE; ENCBS833OVZ
DR   ENCODE; ENCBS836YTS
DR   ENCODE; ENCBS837GDT
DR   ENCODE; ENCBS837LPV
DR   ENCODE; ENCBS839CNN
DR   ENCODE; ENCBS839QBD
DR   ENCODE; ENCBS839VND
DR   ENCODE; ENCBS840AAA
DR   ENCODE; ENCBS841AAA
DR   ENCODE; ENCBS841YJV
DR   ENCODE; ENCBS842AAA
DR   ENCODE; ENCBS843AAA
DR   ENCODE; ENCBS843LHE
DR   ENCODE; ENCBS843ZIK
DR   ENCODE; ENCBS844AAA
DR   ENCODE; ENCBS846HWI
DR   ENCODE; ENCBS847CMA
DR   ENCODE; ENCBS849BJE
DR   ENCODE; ENCBS849TDY
DR   ENCODE; ENCBS850BRB
DR   ENCODE; ENCBS850LWJ
DR   ENCODE; ENCBS850QNJ
DR   ENCODE; ENCBS851FLL
DR   ENCODE; ENCBS851WPL
DR   ENCODE; ENCBS852AAA
DR   ENCODE; ENCBS852JTF
DR   ENCODE; ENCBS852VOH
DR   ENCODE; ENCBS854WQM
DR   ENCODE; ENCBS855MYK
DR   ENCODE; ENCBS855ZEG
DR   ENCODE; ENCBS857RNB
DR   ENCODE; ENCBS859NNO
DR   ENCODE; ENCBS861PFY
DR   ENCODE; ENCBS862HGJ
DR   ENCODE; ENCBS862RBC
DR   ENCODE; ENCBS863CBS
DR   ENCODE; ENCBS863MAI
DR   ENCODE; ENCBS864MCX
DR   ENCODE; ENCBS864OKZ
DR   ENCODE; ENCBS865CZC
DR   ENCODE; ENCBS865HYV
DR   ENCODE; ENCBS865KGU
DR   ENCODE; ENCBS865VEQ
DR   ENCODE; ENCBS869IGF
DR   ENCODE; ENCBS869ORH
DR   ENCODE; ENCBS870PSR
DR   ENCODE; ENCBS870SMK
DR   ENCODE; ENCBS870VQI
DR   ENCODE; ENCBS871KRX
DR   ENCODE; ENCBS871MOK
DR   ENCODE; ENCBS871QLJ
DR   ENCODE; ENCBS872JXE
DR   ENCODE; ENCBS873YKY
DR   ENCODE; ENCBS876FQG
DR   ENCODE; ENCBS877QTV
DR   ENCODE; ENCBS877RXF
DR   ENCODE; ENCBS878WRC
DR   ENCODE; ENCBS884PXY
DR   ENCODE; ENCBS885HUO
DR   ENCODE; ENCBS885ULI
DR   ENCODE; ENCBS886PEW
DR   ENCODE; ENCBS887FSB
DR   ENCODE; ENCBS889HPN
DR   ENCODE; ENCBS889HVK
DR   ENCODE; ENCBS889MQU
DR   ENCODE; ENCBS891EMR
DR   ENCODE; ENCBS894CLK
DR   ENCODE; ENCBS895IMG
DR   ENCODE; ENCBS895KNQ
DR   ENCODE; ENCBS897EVB
DR   ENCODE; ENCBS897PRR
DR   ENCODE; ENCBS903MJI
DR   ENCODE; ENCBS903OGK
DR   ENCODE; ENCBS904ISV
DR   ENCODE; ENCBS904ULB
DR   ENCODE; ENCBS905JDP
DR   ENCODE; ENCBS905KZI
DR   ENCODE; ENCBS905LQS
DR   ENCODE; ENCBS906KIP
DR   ENCODE; ENCBS907QMF
DR   ENCODE; ENCBS910CTC
DR   ENCODE; ENCBS910WHE
DR   ENCODE; ENCBS917PHA
DR   ENCODE; ENCBS918DLF
DR   ENCODE; ENCBS918UWM
DR   ENCODE; ENCBS922LYA
DR   ENCODE; ENCBS922RYG
DR   ENCODE; ENCBS923TYZ
DR   ENCODE; ENCBS925ENT
DR   ENCODE; ENCBS926CWO
DR   ENCODE; ENCBS931MQO
DR   ENCODE; ENCBS934FPI
DR   ENCODE; ENCBS935ZOW
DR   ENCODE; ENCBS936VOR
DR   ENCODE; ENCBS937TYX
DR   ENCODE; ENCBS937ULR
DR   ENCODE; ENCBS941WQP
DR   ENCODE; ENCBS943ICN
DR   ENCODE; ENCBS943ODH
DR   ENCODE; ENCBS946FNG
DR   ENCODE; ENCBS946SUX
DR   ENCODE; ENCBS946YFO
DR   ENCODE; ENCBS947EGW
DR   ENCODE; ENCBS947VKK
DR   ENCODE; ENCBS947YKG
DR   ENCODE; ENCBS948HVW
DR   ENCODE; ENCBS948PVM
DR   ENCODE; ENCBS948QXW
DR   ENCODE; ENCBS948ZNZ
DR   ENCODE; ENCBS949ESX
DR   ENCODE; ENCBS949FLF
DR   ENCODE; ENCBS952HNJ
DR   ENCODE; ENCBS953HJY
DR   ENCODE; ENCBS953YBZ
DR   ENCODE; ENCBS954RIE
DR   ENCODE; ENCBS957NCU
DR   ENCODE; ENCBS957QHW
DR   ENCODE; ENCBS958AOA
DR   ENCODE; ENCBS958BUA
DR   ENCODE; ENCBS960IYL
DR   ENCODE; ENCBS962ZXU
DR   ENCODE; ENCBS963QYF
DR   ENCODE; ENCBS963XMS
DR   ENCODE; ENCBS964MCW
DR   ENCODE; ENCBS964WYU
DR   ENCODE; ENCBS964YGP
DR   ENCODE; ENCBS967BUS
DR   ENCODE; ENCBS967GAK
DR   ENCODE; ENCBS967ZYE
DR   ENCODE; ENCBS969AZO
DR   ENCODE; ENCBS972JLR
DR   ENCODE; ENCBS972KMH
DR   ENCODE; ENCBS973CSB
DR   ENCODE; ENCBS973MAW
DR   ENCODE; ENCBS973NFP
DR   ENCODE; ENCBS975JQF
DR   ENCODE; ENCBS978JIM
DR   ENCODE; ENCBS979EXE
DR   ENCODE; ENCBS979ZKW
DR   ENCODE; ENCBS980HYW
DR   ENCODE; ENCBS980VTX
DR   ENCODE; ENCBS982AOH
DR   ENCODE; ENCBS983KMD
DR   ENCODE; ENCBS983TNS
DR   ENCODE; ENCBS984GCA
DR   ENCODE; ENCBS984PPX
DR   ENCODE; ENCBS984VNR
DR   ENCODE; ENCBS985INM
DR   ENCODE; ENCBS990OSB
DR   ENCODE; ENCBS990XUV
DR   ENCODE; ENCBS992FSA
DR   ENCODE; ENCBS992SGT
DR   ENCODE; ENCBS993NMB
DR   ENCODE; ENCBS994EIH
DR   ENCODE; ENCBS994NNW
DR   ENCODE; ENCBS994WPS
DR   ENCODE; ENCBS995UMN
DR   ENCODE; ENCBS997MUA
DR   ENCODE; ENCBS998FPD
DR   ENCODE; ENCBS998ZJJ
DR   ENCODE; ENCBS999HDT
DR   FANTOM5_SSTAR; 10454-106G4
DR   FANTOM5_SSTAR; 10824-111C5
DR   FANTOM5_SSTAR; 10825-111C6
DR   FANTOM5_SSTAR; 10826-111C7
DR   GDSC; 905940
DR   GEO; GSM2134
DR   GEO; GSM2136
DR   GEO; GSM2172
DR   GEO; GSM50195
DR   GEO; GSM50259
DR   GEO; GSM236784
DR   GEO; GSM236820
DR   GEO; GSM472910
DR   GEO; GSM472926
DR   GEO; GSM472927
DR   GEO; GSM482508
DR   GEO; GSM733651
DR   GEO; GSM733653
DR   GEO; GSM733656
DR   GEO; GSM733658
DR   GEO; GSM733675
DR   GEO; GSM733680
DR   GEO; GSM733692
DR   GEO; GSM733714
DR   GEO; GSM733719
DR   GEO; GSM733776
DR   GEO; GSM733777
DR   GEO; GSM733778
DR   GEO; GSM733786
DR   GEO; GSM736566
DR   GEO; GSM736629
DR   GEO; GSM743459
DR   GEO; GSM749690
DR   GEO; GSM749719
DR   GEO; GSM749733
DR   GEO; GSM750811
DR   GEO; GSM788082
DR   GEO; GSM788085
DR   GEO; GSM788087
DR   GEO; GSM788088
DR   GEO; GSM799347
DR   GEO; GSM799410
DR   GEO; GSM803378
DR   GEO; GSM803379
DR   GEO; GSM803380
DR   GEO; GSM803383
DR   GEO; GSM803384
DR   GEO; GSM803401
DR   GEO; GSM803402
DR   GEO; GSM803407
DR   GEO; GSM803408
DR   GEO; GSM803410
DR   GEO; GSM803414
DR   GEO; GSM803431
DR   GEO; GSM803439
DR   GEO; GSM803440
DR   GEO; GSM803441
DR   GEO; GSM803442
DR   GEO; GSM803443
DR   GEO; GSM803446
DR   GEO; GSM803447
DR   GEO; GSM803469
DR   GEO; GSM803470
DR   GEO; GSM803471
DR   GEO; GSM803473
DR   GEO; GSM803494
DR   GEO; GSM803504
DR   GEO; GSM803505
DR   GEO; GSM803515
DR   GEO; GSM803520
DR   GEO; GSM803523
DR   GEO; GSM803524
DR   GEO; GSM803525
DR   GEO; GSM803540
DR   GEO; GSM816655
DR   GEO; GSM822275
DR   GEO; GSM822310
DR   GEO; GSM822311
DR   GEO; GSM887193
DR   GEO; GSM888266
DR   GEO; GSM923448
DR   GEO; GSM935310
DR   GEO; GSM935311
DR   GEO; GSM935319
DR   GEO; GSM935336
DR   GEO; GSM935337
DR   GEO; GSM935338
DR   GEO; GSM935340
DR   GEO; GSM935343
DR   GEO; GSM935344
DR   GEO; GSM935355
DR   GEO; GSM935356
DR   GEO; GSM935358
DR   GEO; GSM935361
DR   GEO; GSM935368
DR   GEO; GSM935371
DR   GEO; GSM935372
DR   GEO; GSM935373
DR   GEO; GSM935374
DR   GEO; GSM935385
DR   GEO; GSM935392
DR   GEO; GSM935394
DR   GEO; GSM935401
DR   GEO; GSM935402
DR   GEO; GSM935407
DR   GEO; GSM935410
DR   GEO; GSM935411
DR   GEO; GSM935414
DR   GEO; GSM935425
DR   GEO; GSM935429
DR   GEO; GSM935433
DR   GEO; GSM935439
DR   GEO; GSM935464
DR   GEO; GSM935479
DR   GEO; GSM935481
DR   GEO; GSM935490
DR   GEO; GSM935494
DR   GEO; GSM935495
DR   GEO; GSM935496
DR   GEO; GSM935497
DR   GEO; GSM935499
DR   GEO; GSM935501
DR   GEO; GSM935502
DR   GEO; GSM935503
DR   GEO; GSM935516
DR   GEO; GSM935520
DR   GEO; GSM935532
DR   GEO; GSM935539
DR   GEO; GSM935540
DR   GEO; GSM935544
DR   GEO; GSM935547
DR   GEO; GSM935565
DR   GEO; GSM935568
DR   GEO; GSM935569
DR   GEO; GSM935574
DR   GEO; GSM935575
DR   GEO; GSM935576
DR   GEO; GSM935594
DR   GEO; GSM935595
DR   GEO; GSM935597
DR   GEO; GSM935598
DR   GEO; GSM935600
DR   GEO; GSM935616
DR   GEO; GSM935632
DR   GEO; GSM935633
DR   GEO; GSM935634
DR   GEO; GSM935642
DR   GEO; GSM935645
DR   GEO; GSM945165
DR   GEO; GSM945228
DR   GEO; GSM945294
DR   GEO; GSM945302
DR   GEO; GSM1003445
DR   GEO; GSM1003447
DR   GEO; GSM1003448
DR   GEO; GSM1003449
DR   GEO; GSM1003450
DR   GEO; GSM1003452
DR   GEO; GSM1003478
DR   GEO; GSM1003492
DR   GEO; GSM1003504
DR   GEO; GSM1003507
DR   GEO; GSM1003510
DR   GEO; GSM1003545
DR   GEO; GSM1003560
DR   GEO; GSM1003563
DR   GEO; GSM1003565
DR   GEO; GSM1003566
DR   GEO; GSM1003567
DR   GEO; GSM1003568
DR   GEO; GSM1003569
DR   GEO; GSM1003570
DR   GEO; GSM1003574
DR   GEO; GSM1003575
DR   GEO; GSM1003576
DR   GEO; GSM1003583
DR   GEO; GSM1003586
DR   GEO; GSM1003608
DR   GEO; GSM1003609
DR   GEO; GSM1003610
DR   GEO; GSM1003611
DR   GEO; GSM1003620
DR   GEO; GSM1003621
DR   GEO; GSM1003622
DR   GEO; GSM1003625
DR   GEO; GSM1008558
DR   GEO; GSM1008567
DR   GEO; GSM1008580
DR   GEO; GSM1008601
DR   GEO; GSM1008602
DR   GEO; GSM1010722
DR   GEO; GSM1010732
DR   GEO; GSM1010782
DR   GEO; GSM1010820
DR   GEO; GSM1010849
DR   GEO; GSM1010877
DR   GEO; GSM1010878
DR   GEO; GSM1010890
DR   GEO; GSM1010895
DR   GEO; GSM1010906
DR   GEO; GSM1153418
DR   GEO; GSM1178274
DR   GEO; GSM1178275
DR   GEO; GSM1178276
DR   GEO; GSM1181317
DR   GEO; GSM1181332
DR   GEO; GSM1374583
DR   GEO; GSM1669971
DR   GEO; GSM2124641
DR   GEO; GSM4471875
DR   GEO; GSM7701375
DR   GEO; GSM7701376
DR   IARC_TP53; 1985
DR   IARC_TP53; 21424
DR   IARC_TP53; 30210
DR   IBRC; C10081
DR   ICLC; HTL94001
DR   IGRhCellID; K562
DR   IZSLER; BS TCL 33
DR   JCRB; JCRB0019
DR   KCB; KCB 90029YJ
DR   KCB; KCB 93038YJ
DR   KCLB; 10243
DR   LiGeA; CCLE_012
DR   LINCS_LDP; LCL-1103
DR   Lonza; 101
DR   MeSH; D020014
DR   NCBI_Iran; C122
DR   NCI-DTP; K-562
DR   PharmacoDB; K562_717_2019
DR   PRIDE; PRD000032
DR   PRIDE; PRD000229
DR   PRIDE; PRD000345
DR   PRIDE; PRD000782
DR   PRIDE; PXD000216
DR   PRIDE; PXD001352
DR   PRIDE; PXD002383
DR   PRIDE; PXD002395
DR   PRIDE; PXD002836
DR   PRIDE; PXD003539
DR   PRIDE; PXD003664
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD010335
DR   PRIDE; PXD018565
DR   PRIDE; PXD027221
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0004
DR   PubChem_Cell_line; CVCL_0004
DR   RCB; RCB0027
DR   RCB; RCB1635
DR   RCB; RCB1897
DR   SKY/M-FISH/CGH; 2811
DR   TKG; TKG 0210
DR   TOKU-E; 2086
DR   TOKU-E; 3631
DR   Ubigene; YC-C023
DR   Wikidata; Q6324626
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00761;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=163658;
RX   PubMed=367973;
RX   PubMed=528075;
RX   PubMed=570644;
RX   PubMed=924690;
RX   PubMed=2041050;
RX   PubMed=2140233;
RX   PubMed=2446768;
RX   PubMed=2465826;
RX   PubMed=2568171;
RX   PubMed=2985879;
RX   PubMed=3023859;
RX   PubMed=3159941;
RX   PubMed=3332852;
RX   PubMed=3335022;
RX   PubMed=3856862;
RX   PubMed=3857109;
RX   PubMed=3874327;
RX   PubMed=3930277;
RX   PubMed=6091813;
RX   PubMed=6582512;
RX   PubMed=6954533;
RX   PubMed=6996765;
RX   PubMed=7194480;
RX   PubMed=8142256;
RX   PubMed=8558913;
RX   PubMed=9290701;
RX   PubMed=9331090;
RX   PubMed=9510473;
RX   PubMed=9738977;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10700174;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=11248328;
RX   PubMed=11416159;
RX   PubMed=12506034;
RX   PubMed=12859996;
RX   PubMed=14642717;
RX   PubMed=15637111;
RX   PubMed=15748285;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20809971;
RX   PubMed=21269460;
RX   PubMed=21552520;
RX   PubMed=22068913;
RX   PubMed=22278370;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23325432;
RX   PubMed=23671654;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=23955599;
RX   PubMed=24279929;
RX   PubMed=24618588;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29509191;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30737237;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32449352;
RX   PubMed=35819189;
RX   PubMed=35839778;
RX   PubMed=36982453;
RX   PubMed=38861359;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/K562_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=30
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-69.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/K562_cells
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/leukemia-xenograft-model/k562-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 1.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 17 hours (CelloPub=CLPUB00761); 47 hours (PubMed=25984343); 18 hours (PubMed=8142256); ~30-40 hours (DSMZ=ACC-10); 19.6 hours (NCI-DTP=K-562).
CC   HLA typing: A*11:01:01,31:01:02; B*18,40; C*03; DPB1*04:01,04:02; DQB1*02:01,03:02; DRB1*03,04 (PubMed=15748285).
CC   HLA typing: A*11; B*40,35/39; C*03,05 (PubMed=25960936).
CC   HLA typing: A*31:01:02,31:01:02; B*40:01:01,50:01:01; C*03:04:01,05:01:01 (DSMZCellDive=ACC-10).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; PubMed=23671654; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10071072; PubMed=12506034; PubMed=20809971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (PubMed=17088437; PubMed=18277095).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H2A.Z.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me1.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; ChIP-seq; Pol2.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.19%; Native American=0%; East Asian, North=8.4%; East Asian, South=0%; South Asian=0%; European, North=43.44%; European, South=42.97% (PubMed=30894373).
CC   Misspelling: K-652; Cosmic=1523829.
CC   Misspelling: K652; Cosmic=1516632; Cosmic=2024372.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0003004/52; ATCC=CCL-243; CCRID; CLS=300224; Cosmic-CLP=905940; COG; DSMZ=ACC-10; ECACC=89121407; JCRB=JCRB0019; KCLB=10243; PubMed=11416159; PubMed=14642717; PubMed=15637111; PubMed=19372543; PubMed=25877200; RCB=RCB1635; Technion Genomics Center; TKG=TKG 0210
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D10S1248: 12
ST   D12S391: 23
ST   D13S317: 8
ST   D16S539: 11,12 (AddexBio=C0003004/52; ATCC=CCL-243; CCRID; CLS=300224; Cosmic-CLP=905940; COG; ECACC=89121407; JCRB=JCRB0019; PubMed=14642717; PubMed=15637111; PubMed=19372543; PubMed=25877200; Technion Genomics Center; TKG=TKG 0210)
ST   D16S539: 11,12,13 (DSMZ=ACC-10; RCB=RCB1635)
ST   D18S51: 15 (CLS=300224)
ST   D18S51: 15,16 (ATCC=CCL-243; CCRID; PubMed=14642717; PubMed=15637111; PubMed=19372543; Technion Genomics Center)
ST   D18S51: 16 (DSMZ=ACC-10)
ST   D19S433: 14,14.2 (ATCC=CCL-243; CCRID; CLS=300224; PubMed=14642717; PubMed=19372543; Technion Genomics Center)
ST   D19S433: 14,15 (DSMZ=ACC-10)
ST   D1S1656: 15,16
ST   D21S11: 29,30 (CLS=300224; DSMZ=ACC-10; PubMed=15637111)
ST   D21S11: 29,30,31 (ATCC=CCL-243; PubMed=14642717; PubMed=19372543; PubMed=25877200; Technion Genomics Center)
ST   D21S11: 29,31 (CCRID)
ST   D22S1045: 16
ST   D2S1338: 17
ST   D2S441: 10,14
ST   D3S1358: 14,16 (DSMZ=ACC-10)
ST   D3S1358: 16 (ATCC=CCL-243; CCRID; CLS=300224; PubMed=14642717; PubMed=19372543; PubMed=25877200; Technion Genomics Center)
ST   D5S818: 11,12 (AddexBio=C0003004/52; ATCC=CCL-243; CCRID; CLS=300224; Cosmic-CLP=905940; COG; DSMZ=ACC-10; ECACC=89121407; JCRB=JCRB0019; KCLB=10243; PubMed=14642717; PubMed=15637111; PubMed=19372543; PubMed=25877200; Technion Genomics Center; TKG=TKG 0210)
ST   D5S818: 11,12,13 (RCB=RCB1635)
ST   D7S820: 9,11
ST   D8S1179: 12
ST   DXS101: 23,24
ST   FGA: 21,24
ST   Penta D: 9,13
ST   Penta E: 5,14
ST   SE33: 26.2,28.2
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 54
//
ID   K-562 Cas9
AC   CVCL_DX77
DR   Horizon_Discovery; HD+Cas9-005
DR   Wikidata; Q127382404
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-005).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 6
//
ID   K-562 CRISPRa
AC   CVCL_RY26
SY   K562 dCas9-SunTag-VP64
DR   Wikidata; Q54899214
RX   PubMed=25307933;
CC   Population: Caucasian.
CC   Characteristics: This cell line is transfected by a nuclease-deficient mutant of SpCas9 (dCas9) under the control of a promoter containing 4 copies of the activating domain of HSV-1 VP16 (termed VP64) and to 24 copies of a short peptide epitope (from yeast GCN4) which is termed SunTag.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 15
//
ID   K-562 CRISPRa+SaCas9 clone C11
AC   CVCL_RY28
DR   Wikidata; Q54899215
RX   PubMed=29334369;
CC   Population: Caucasian.
CC   Characteristics: This cell line is transfected by a nuclease-deficient mutant of SpCas9 (dCas9) under the control of a promoter containing 4 copies of the activating domain of HSV-1 VP16 (termed VP64) and to 24 copies of a short peptide epitope (from yeast GCN4) which is termed SunTag.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; J7RUA5; Staphylococcus aureus Cas9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY26 ! K-562 CRISPRa
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   K-562 CRISPRa+SaCas9 clone C7
AC   CVCL_RY27
DR   Wikidata; Q54899216
RX   PubMed=29334369;
CC   Population: Caucasian.
CC   Characteristics: This cell line is transfected by a nuclease-deficient mutant of SpCas9 (dCas9) under the control of a promoter containing 4 copies of the activating domain of HSV-1 VP16 (termed VP64) and to 24 copies of a short peptide epitope (from yeast GCN4) which is termed SunTag.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; J7RUA5; Staphylococcus aureus Cas9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY26 ! K-562 CRISPRa
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 14
//
ID   K-562 dCas9-VPR
AC   CVCL_DX78
DR   Horizon_Discovery; HD+dCas9-VPR-005
DR   Wikidata; Q127382405
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-dCas9-VPR-WPRE, where VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA (Horizon_Discovery=HD+dCas9-VPR-005).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 6
//
ID   K-562 GATA2 clone G2-1
AC   CVCL_F0X2
SY   G2-1
RX   PubMed=11146164;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4171; GATA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K-562 GATA2 clone G2-2
AC   CVCL_F0X3
SY   G2-2
RX   PubMed=11146164;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4171; GATA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K-562 GATA2 clone G2-3
AC   CVCL_F0X4
SY   G2-3
RX   PubMed=11146164;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4171; GATA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K-562 GATA2 clone G2-4
AC   CVCL_F0X5
SY   G2-4
RX   PubMed=11146164;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4171; GATA2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K-562 KC/16
AC   CVCL_E4AH
SY   KC/16
RX   PubMed=7535698;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6149; ITGAM.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6155; ITGB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   K-562 KL/4
AC   CVCL_E4AI
SY   KL/4
RX   PubMed=7535698;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6148; ITGAL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6155; ITGB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   K-562 P/5
AC   CVCL_E4AJ
SY   P/5
RX   PubMed=7535698;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6152; ITGAX.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6155; ITGB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   K-562 SimpleCell O-GalNAc
AC   CVCL_S029
SY   K562 SimpleCell; K562 SC
DR   Wikidata; Q54899217
RX   PubMed=21983924;
RX   PubMed=23399548;
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 22
//
ID   K-562 VPS13A/VPS13C DKO clone 1
AC   CVCL_E9XV
SY   K562 VPS13A/VPS13C DKO clone#1
RX   PubMed=40463036;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1908; VPS13A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K-562 VPS13A/VPS13C DKO clone 2
AC   CVCL_E9XW
SY   K562 VPS13A/VPS13C DKO clone#2
RX   PubMed=40463036;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas12a; HGNC; HGNC:1908; VPS13A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K-562-B1-V-2 p17
AC   CVCL_LH52
DR   Wikidata; Q54899218
RX   PubMed=2446768;
RX   PubMed=2465826;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   K-562-C-1 p365
AC   CVCL_LH51
DR   Wikidata; Q54899219
RX   PubMed=2446768;
RX   PubMed=2465826;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   K-562-GFP
AC   CVCL_JM00
DR   ATCC; CCL-243-GFP
DR   Wikidata; Q54899220
RX   CelloPub=CLPUB00577;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/population-doubling-time-of-k-562-gfp
CC   Population: Caucasian.
CC   Characteristics: Stably expresses GFP under the control of the human EF1a promoter.
CC   Doubling time: 18-24 hours (ATCC=CCL-243-GFP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CCL-243-GFP
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 21
//
ID   K-562-Luc
AC   CVCL_C8Y5
DR   Ubigene; YC-C023-Luc-P
DR   Wikidata; Q123032779
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   K-562-luc2
AC   CVCL_UR39
DR   ATCC; CCL-243-LUC2
DR   Wikidata; Q94333790
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-243-LUC2).
CC   Doubling time: 18 +- 2 hours (ATCC=CCL-243-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CCL-243-LUC2
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12,13
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 16
//
ID   K-562-RH
AC   CVCL_LH50
DR   Wikidata; Q54899221
RX   PubMed=2446768;
RX   PubMed=2465826;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   K-562R
AC   CVCL_5950
SY   K562R; K562-R
DR   BTO; BTO_0004462
DR   ChEMBL-Cells; CHEMBL4295438
DR   ChEMBL-Targets; CHEMBL4296447
DR   PubChem_Cell_line; CVCL_5950
DR   Wikidata; Q54899222
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   K-6
AC   CVCL_JL39
SY   K6
DR   Wikidata; Q54899223
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   K-9
AC   CVCL_4614
SY   Clone 9
DR   CLO; CLO_0002504
DR   CLDB; cl798
DR   ATCC; CRL-1439
DR   BCRC; 60201
DR   ECACC; 88072203
DR   FCS-free; 248-21-502-1-16-12
DR   TOKU-E; 971
DR   Wikidata; Q54899224
RX   PubMed=162864;
RX   PubMed=18575780;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   K-BALB
AC   CVCL_4350
SY   KBALB; K-234; K234
DR   CLO; CLO_0007078
DR   CLDB; cl2987
DR   ATCC; CCL-163.3
DR   BCRC; 60090
DR   ChEMBL-Cells; CHEMBL3307846
DR   ChEMBL-Targets; CHEMBL614009
DR   ECACC; 89092101
DR   KCLB; 10163.3
DR   PubChem_Cell_line; CVCL_4350
DR   Wikidata; Q54899225
RX   PubMed=4550769;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   K-EW1
AC   CVCL_VK45
DR   Cosmic; 1085903
DR   Wikidata; Q94333838
RX   PubMed=9738976;
RX   PubMed=12054564;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=9738976).
CC   Derived from site: In situ; Pelvic cavity; UBERON=UBERON_0008203.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   K-EW2
AC   CVCL_VK49
DR   Wikidata; Q94333842
RX   PubMed=12054564;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, fibula; UBERON=UBERON_0001446.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   K-EW3
AC   CVCL_VK50
DR   Wikidata; Q94333847
RX   PubMed=12054564;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   K-KT
AC   CVCL_J419
DR   IPD-IMGT/HLA; 10892
DR   Wikidata; Q54899226
RX   PubMed=10372549;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Korean.
CC   HLA typing: A*03,24; B*44,61; DRB1*12:06 (IPD-IMGT/HLA=10892).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 13
//
ID   K-MFH-1
AC   CVCL_M820
DR   Wikidata; Q54899227
RX   PubMed=1710493;
CC   Population: Japanese.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   K-MK-2
AC   CVCL_WH99
DR   Wikidata; Q94334028
RX   PubMed=23267887;
CC   Population: Japanese.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   K-T1
AC   CVCL_F690
DR   Wikidata; Q54899228
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
RX   PubMed=3004618;
RX   PubMed=17170727;
CC   Doubling time: 68 hours (PubMed=3004618); 36 hours (PubMed=2786436).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   K-T1a
AC   CVCL_RL82
DR   Wikidata; Q54899229
RX   PubMed=2786436;
CC   Doubling time: 56 hours (PubMed=2786436).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F690 ! K-T1
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   K-TL-1
AC   CVCL_A7PB
SY   KTL-1
DR   Wikidata; Q107115519
RX   PubMed=2365902;
RX   PubMed=2789154;
RX   PubMed=6165463;
CC   Population: Japanese.
CC   Doubling time: 10 days (PubMed=6165463).
CC   Derived from site: In situ; Hair follicle, outer root sheath; UBERON=UBERON_0005942.
DI   NCIt; C4113; Trichilemmoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   K.I.
AC   CVCL_F564
SY   TER137; Extract 286
DR   IPD-IMGT/HLA; 10886
DR   Wikidata; Q54899231
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02; B*15:26N; C*04:01 (IPD-IMGT/HLA=10886).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   K:Molv NIH/3T3
AC   CVCL_6662
DR   CLO; CLO_0007051
DR   ATCC; CRL-6361
DR   Wikidata; Q54899232
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   K/VP.5
AC   CVCL_C6JT
DR   Wikidata; Q116049609
RX   PubMed=8058057;
RX   PubMed=8142256;
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=8142256).
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   K008
AC   CVCL_5142
DR   cancercelllines; CVCL_5142
DR   Cosmic; 1178186
DR   GEO; GSM202004
DR   IGRhCellID; K008%20GEO
DR   Progenetix; CVCL_5142
DR   Wikidata; Q54899233
RX   PubMed=23418523;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   K028
AC   CVCL_M764
DR   cancercelllines; CVCL_M764
DR   Wikidata; Q54899234
RX   PubMed=23418523;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23418523).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   K029
AC   CVCL_5143
DR   cancercelllines; CVCL_5143
DR   Cell_Model_Passport; SIDM01583
DR   Cosmic; 1244760
DR   GEO; GSM202032
DR   IGRhCellID; K029%20GEO
DR   Progenetix; CVCL_5143
DR   Wikidata; Q54899235
RX   PubMed=23418523;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23418523).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   K029AX
AC   CVCL_8784
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 720
DR   BioSample; SAMN10988224
DR   cancercelllines; CVCL_8784
DR   Cell_Model_Passport; SIDM01629
DR   DepMap; ACH-000404
DR   GEO; GSM887192
DR   GEO; GSM888265
DR   IARC_TP53; 30092
DR   LiGeA; CCLE_591
DR   PharmacoDB; K029AX_718_2019
DR   Progenetix; CVCL_8784
DR   Wikidata; Q54899236
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*08:01,14:02; C*07:01,08:03; DQB1*02:02,06:07; DRB1*03:01,13:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000404).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=0%; East Asian, North=1.49%; East Asian, South=0%; South Asian=0%; European, North=67.33%; European, South=30.86% (PubMed=30894373).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5143 ! K029
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 28
//
ID   K033
AC   CVCL_8785
DR   cancercelllines; CVCL_8785
DR   Wikidata; Q54899237
RX   PubMed=23418523;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23418523).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   K1
AC   CVCL_2537
SY   K-1
DR   BTO; BTO_0006405
DR   CLO; CLO_0007052
DR   EFO; EFO_0022674
DR   CLDB; cl2988
DR   AddexBio; C0025003/51
DR   BCRJ; 0292
DR   BioSample; SAMN03151643
DR   cancercelllines; CVCL_2537
DR   Cosmic; 928833
DR   Cosmic; 1084280
DR   Cosmic; 1132597
DR   Cosmic; 1162845
DR   Cosmic; 1239966
DR   Cosmic; 1280046
DR   Cosmic; 1507368
DR   Cosmic; 1533546
DR   Cosmic; 1536121
DR   Cosmic; 1889001
DR   Cosmic; 2036691
DR   Cosmic; 2319846
DR   Cosmic; 2613254
DR   Cosmic; 2791088
DR   ECACC; 92030501
DR   ENCODE; ENCBS044KRF
DR   ENCODE; ENCBS536QZY
DR   IARC_TP53; 25012
DR   PharmacoDB; K1_720_2019
DR   Wikidata; Q54899238
RX   PubMed=9054892;
RX   PubMed=17725429;
RX   PubMed=18713817;
RX   PubMed=19087340;
RX   PubMed=20143388;
RX   PubMed=22087789;
RX   PubMed=23162534;
RX   PubMed=25675381;
RX   PubMed=30737244;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a GLAG-66 derivative (PubMed=19087340; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00218.
CC   Population: Caucasian; Italian.
CC   Doubling time: 24 hours (PubMed=9054892).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): ECACC=92030501; PubMed=18713817; PubMed=23162534; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 18
ST   D21S11: 30,31.2
ST   D2S1338: 20,23
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 21,24
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9918 ! GLAG-66
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   K1 [D.carota]
AC   CVCL_D5H5
DR   Wikidata; Q127382406
RX   PubMed=15760374;
CC   Group: Plant cell line.
CC   Characteristics: Nonpigmented cell line derived from callus (PubMed=15760374).
CC   Derived from site: In situ; Callus; PO=PO_0005052.
CC   Breed/subspecies: Cultivar Flakkese.
OX   NCBI_TaxID=79200; ! Daucus carota subsp. sativus (Carrot)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   K1-Mel
AC   CVCL_V409
SY   K1-MEL; K1
DR   cancercelllines; CVCL_V409
DR   Cosmic; 888855
DR   Cosmic; 897497
DR   Wikidata; Q54899239
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   K107-Ep
AC   CVCL_UZ33
SY   K107
DR   Wikidata; Q94334180
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 55 PDL (PubMed=12077343).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly101Trp (c.301G>T) (p.Arg115Leu, c.344G>T); ClinVar=VCV000009412; Zygosity=Heterozygous (PubMed=12077343).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   K107-Ep/p53DD/TERT
AC   CVCL_UZ34
SY   K107/p53DD/TERT
DR   Wikidata; Q94334184
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly101Trp (c.301G>T) (p.Arg115Leu, c.344G>T); ClinVar=VCV000009412; Zygosity=Hemizygous (PubMed=12077343).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ33 ! K107-Ep
SX   Female
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   K107946
AC   CVCL_V375
DR   IPD-IMGT/HLA; 14471
DR   Wikidata; Q54899240
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01,29:02; B*40:01,44:03; C*03:04,16:01; DPB1*01:01,04:01; DQB1*02:02,06:04; DRB1*07:01:01,13:74; DRB3*03; DRB4*01:TMB (IPD-IMGT/HLA=14471).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   K10M15
AC   CVCL_QX20
SY   K10-M15
DR   GEO; GSM1227435
DR   GEO; GSM1227436
DR   Wikidata; Q54899241
RX   PubMed=21347327;
RX   PubMed=24527394;
CC   Sequence variation: Mutation; HGNC; HGNC:10288; RP9; Simple; p.His137Leu (c.410A>T); ClinVar=VCV000003334; Zygosity=Unspecified (PubMed=21347327).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T832 ! K10M5
OI   CVCL_T830 ! K10M17
OI   CVCL_T831 ! K10M19
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   K10M17
AC   CVCL_T830
SY   K10-M17; HPS0104
DR   RCB; HPS0104
DR   SKIP; SKIP000135
DR   Wikidata; Q54899242
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:10288; RP9; Simple; p.His137Leu (c.410A>T); ClinVar=VCV000003334; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T832 ! K10M5
OI   CVCL_QX20 ! K10M15
OI   CVCL_T831 ! K10M19
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   K10M19
AC   CVCL_T831
SY   K10-M19; HPS0105
DR   RCB; HPS0105
DR   SKIP; SKIP000136
DR   Wikidata; Q54899243
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:10288; RP9; Simple; p.His137Leu (c.410A>T); ClinVar=VCV000003334; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T832 ! K10M5
OI   CVCL_QX20 ! K10M15
OI   CVCL_T830 ! K10M17
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   K10M5
AC   CVCL_T832
SY   K10-M05; HPS0062
DR   RCB; HPS0062
DR   SKIP; SKIP000134
DR   Wikidata; Q54899244
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:10288; RP9; Simple; p.His137Leu (c.410A>T); ClinVar=VCV000003334; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX20 ! K10M15
OI   CVCL_T830 ! K10M17
OI   CVCL_T831 ! K10M19
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   K117 [Human ESC]
AC   CVCL_C945
DR   Wikidata; Q54899245
WW   Info; NIHhESC; -; https://acd.od.nih.gov/documents/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: VistaGen Therapeutics, Inc.; South San Francisco; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   K117 [Mouse hybridoma against human THY1]
AC   CVCL_G226
DR   CLO; CLO_0007053
DR   ATCC; HB-8553
DR   Wikidata; Q54899246
RX   Patent=US5059523;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8553.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04216; Human THY1/CD90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   K117RM
AC   CVCL_XX69
DR   Wikidata; Q94334272
RX   PubMed=21112256;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   K11M4
AC   CVCL_T833
SY   K11-M4; HPS0107
DR   RCB; HPS0107
DR   SKIP; SKIP000137
DR   Wikidata; Q54899247
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:10288; RP9; Simple; p.His137Leu (c.410A>T); ClinVar=VCV000003334; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T834 ! K11PD17
OI   CVCL_T835 ! K11PD18
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   K11PD17
AC   CVCL_T834
SY   K11-P17; HPS0072
DR   GEO; GSM1227437
DR   RCB; HPS0072
DR   SKIP; SKIP000138
DR   Wikidata; Q54899248
RX   Patent=US10519422;
RX   PubMed=21347327;
RX   PubMed=24527394;
CC   Sequence variation: Mutation; HGNC; HGNC:10288; RP9; Simple; p.His137Leu (c.410A>T); ClinVar=VCV000003334; Zygosity=Unspecified (PubMed=21347327).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T833 ! K11M4
OI   CVCL_T835 ! K11PD18
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   K11PD18
AC   CVCL_T835
SY   K11-P18; HPS0106
DR   RCB; HPS0106
DR   SKIP; SKIP000139
DR   Wikidata; Q54899249
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:10288; RP9; Simple; p.His137Leu (c.410A>T); ClinVar=VCV000003334; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T833 ! K11M4
OI   CVCL_T834 ! K11PD17
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   K12 [Hamster]
AC   CVCL_0F73
DR   Wikidata; Q54899250
RX   PubMed=762193;
RX   PubMed=4359531;
RX   PubMed=7085753;
RX   PubMed=7204505;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0F72 ! Wg-1A
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   K12 [Mouse osteosarcoma]
AC   CVCL_W625
SY   K 12
DR   Wikidata; Q54899251
RX   PubMed=3243385;
RX   PubMed=10841188;
RX   PubMed=26320182;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_W626 ! K14
OI   CVCL_W627 ! K37
OI   CVCL_W624 ! K7 [Mouse osteosarcoma]
OI   CVCL_W628 ! K8 [Mouse osteosarcoma]
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   K12-72.1
AC   CVCL_IX41
SY   K12
DR   Wikidata; Q54899252
RX   PubMed=2055947;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   K129SV
AC   CVCL_F270
DR   CLO; CLO_0007054
DR   CLDB; cl2989
DR   Wikidata; Q54899254
RX   PubMed=87443;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   K13/31
AC   CVCL_E9EE
DR   ABCD; ABCD_AU831
DR   DSHB; K13-31
DR   MMRRC; MMRRC:065950-UCD
RX   PubMed=8938716;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K13_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15385; Rat Kcna4 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K135RM
AC   CVCL_XX70
DR   Wikidata; Q94334351
RX   PubMed=21112256;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   K138RM
AC   CVCL_XX72
DR   Wikidata; Q94334352
RX   PubMed=21112256;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   K14
AC   CVCL_W626
SY   K 14
DR   Wikidata; Q54899255
RX   PubMed=3243385;
RX   PubMed=10841188;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_W624 ! K7 [Mouse osteosarcoma]
OI   CVCL_W628 ! K8 [Mouse osteosarcoma]
OI   CVCL_W625 ! K12 [Mouse osteosarcoma]
OI   CVCL_W627 ! K37
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   K14/16
AC   CVCL_E9EF
DR   ABCD; ABCD_AU832
DR   DSHB; K14-16
DR   MMRRC; MMRRC:065948-UCD
RX   PubMed=8938716;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K14_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P63142; Rat Kcna2 (Note=Also reacts with human, mouse, zebrafish and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K14D
AC   CVCL_E7F2
DR   ABM; T8333
RX   PubMed=31215094;
CC   Characteristics: Low malignancy potential (PubMed=31215094).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C63892; Squamous cell carcinoma of the rat esophagus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K17/70
AC   CVCL_E9EG
DR   ABCD; ABCD_AU833
DR   DSHB; K17-70
DR   MMRRC; MMRRC:065958-UCD
RX   PubMed=8938716;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K17_70.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P62483; Rat Kcnab2 (Note=Also reacts with human, mouse and zebrafish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K1735
AC   CVCL_F828
SY   K-1735
DR   KCLB; 80013
DR   Wikidata; Q54899256
RX   PubMed=3370643;
RX   PubMed=6944560;
RX   PubMed=7527298;
RX   PubMed=7907126;
RX   PubMed=12839934;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (PubMed=12839934).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   K1735-2B2
AC   CVCL_C8S1
SY   K-1735 2B-2
DR   Wikidata; Q123032780
RX   PubMed=3370643;
CC   Characteristics: Derived from a melanotic brain metastasis produced by intravenous injection of the parental cell line (PubMed=3370643).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   K1735-B7
AC   CVCL_B6PM
SY   B7-K1735
DR   Wikidata; Q111733548
RX   PubMed=7527298;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   K1735-BB1
AC   CVCL_C8S2
SY   K-1735 BB-1; BB-1
DR   Wikidata; Q123032781
RX   PubMed=1826230;
CC   Characteristics: Derived from a melanotic brain metastasis produced by intravenous injection of the parental cell line (PubMed=1826230).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   K1735-C10
AC   CVCL_C8S3
SY   K-1735 C-10; C-10; K-1735 clone 10
DR   Wikidata; Q123032782
RX   PubMed=1826230;
RX   PubMed=6944560;
CC   Characteristics: Non-metastatic.
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   K1735-C11
AC   CVCL_0J42
SY   K-1735 C-11; K1735-Cl.11; K1735-Cl11; K-1735 clone 11
DR   Wikidata; Q54899257
RX   PubMed=6944560;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 5
//
ID   K1735-C16
AC   CVCL_0J45
SY   K-1735 C-16; K1735-Cl16; K1735-C116; K1735c116; K-1735 clone 16
DR   Wikidata; Q54899258
RX   PubMed=2703275;
RX   PubMed=6944560;
RX   PubMed=11820393;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   K1735-C19
AC   CVCL_C8S4
SY   K-1735 C-19; C-19; K-1735 clone 19
DR   Wikidata; Q123032783
RX   PubMed=3370643;
RX   PubMed=3756870;
RX   PubMed=6944560;
CC   Characteristics: Tumorigenic but non-metastatic.
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   K1735-C23
AC   CVCL_F829
SY   K-1735 C-23; K1735C23; K1735-Cl23; K1735-C123; C-23; K-1735 clone 23
DR   Wikidata; Q54899259
RX   PubMed=6944560;
RX   PubMed=11820393;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   K1735-C26
AC   CVCL_0J43
SY   K-1735 C-26; K-1735 cl26; K-1735 clone 26
DR   Wikidata; Q54899260
RX   PubMed=6944560;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   K1735-C4
AC   CVCL_E7ZF
SY   K-1735 C4; K-1735 clone 4; K1735C4; C4; C4.P
RX   PubMed=6944560;
RX   PubMed=7535333;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Characteristics: Highly metastatic. Produces melanotic lung metastases in syngeneic mice.
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   K1735-C4.Neo.3
AC   CVCL_E7ZH
SY   C4.Neo.3
RX   PubMed=7535333;
CC   Characteristics: Control cell line for K1735-C4.S2-3 (Cellosaurus=CVCL_E7ZJ) and K1735-C4.S2-3 (Cellosaurus=CVCL_E7ZJ) (PubMed=7535333).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E7ZF ! K1735-C4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   K1735-C4.L8.5
AC   CVCL_E7ZI
SY   C4.L8.5
RX   PubMed=7535333;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97361; Nos2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E7ZF ! K1735-C4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   K1735-C4.S2-3
AC   CVCL_E7ZJ
SY   C4.S2.3
RX   PubMed=7535333;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97361; Nos2 (Note=With p.Ser1113_Leu1144 replaced with ASVLLNPQNN; inactive).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E7ZF ! K1735-C4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   K1735-M1
AC   CVCL_0J41
SY   K1735M1
DR   Wikidata; Q54899261
RX   PubMed=2703275;
RX   PubMed=6750200;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   K1735-M2
AC   CVCL_F684
SY   K-1735 M2; K-1735 M-2; K-1735-M-2; K1735M2; K1735 Met 2; M-2; K-1735 subclone M2
DR   Wikidata; Q54899262
RX   PubMed=1826230;
RX   PubMed=3370643;
RX   PubMed=3756870;
RX   PubMed=6750200;
RX   PubMed=9449709;
RX   PubMed=11820393;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Characteristics: Highly tumorigenic and metastatic. Derived from a lung metastasis produced by the parent tumor-growing subcutaneously.
CC   Doubling time: 13.8 hours (PubMed=9449709).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 10
//
ID   K1735-M2 Elm1.0-1
AC   CVCL_F0SC
SY   M-2.Elm1.0-1
RX   PubMed=9449709;
CC   Doubling time: 15.0 hours (PubMed=9449709).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1197008; Ccn4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K1735-M2 Elm1.20-2
AC   CVCL_F0SD
SY   M-2.Elm1.20-2
RX   PubMed=9449709;
CC   Doubling time: 13.5 hours (PubMed=9449709).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1197008; Ccn4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K1735-M2 Elm1.20-3
AC   CVCL_F0SE
SY   M-2.Elm1.20-3
RX   PubMed=9449709;
CC   Doubling time: 16.1 hours (PubMed=9449709).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1197008; Ccn4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K1735-M2 Elm1.23-1
AC   CVCL_F0SF
SY   M-2.Elm1.23-1
RX   PubMed=9449709;
CC   Characteristics: High expression of Ccn4/Elm1 (PubMed=9449709).
CC   Doubling time: 16.0 hours (PubMed=9449709).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1197008; Ccn4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K1735-M2 Elm1.6-2
AC   CVCL_F0SG
SY   M-2.Elm1.6-2
RX   PubMed=9449709;
CC   Doubling time: 13.3 hours (PubMed=9449709).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1197008; Ccn4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K1735-M2 Elm1.8-3
AC   CVCL_F0SH
SY   M-2.Elm1.8-3
RX   PubMed=9449709;
CC   Characteristics: Does not express Ccn4/Elm1 (PubMed=9449709).
CC   Doubling time: 13.1 hours (PubMed=9449709).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1197008; Ccn4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K1735-SW1
AC   CVCL_C8S5
SY   K-1735 SW-1; K1735-SW-1; SW-1; SW1
DR   Wikidata; Q123032785
RX   PubMed=2297053;
RX   PubMed=3370643;
RX   PubMed=12208865;
CC   Characteristics: Highly metastatic. Established from a nonpigmented spontaneous lung metastasis produced by the parent tumor-growing subcutaneously (PubMed=3370643).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Miscellaneous: Direct author submission of STR profile from Fakhardo A.; STR performed by Labcorp Cell Line Testing.
CC   Breed/subspecies: C3H/HeN.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 26.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F828 ! K1735
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   K1735-Xmet-21
AC   CVCL_E7ZG
SY   K-1735-Xmet-21; X-21
RX   PubMed=3756870;
CC   Characteristics: Highly tumorigenic and metastatic. The parent cell line was X-ray irradiated (650 Rad) then implanted into the footpads of syngeneic mice. When the resulting The cell line was established from well-isolated solitary spontaneous pulmonary metastases (PubMed=3756870).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   K177
AC   CVCL_5I63
SY   K-177
DR   ChEMBL-Cells; CHEMBL3308619
DR   ChEMBL-Targets; CHEMBL614687
DR   PubChem_Cell_line; CVCL_5I63
DR   Wikidata; Q54899263
RX   PubMed=8558445;
RX   PubMed=8987816;
RX   PubMed=11245666;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1958; CHRNA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1962; CHRNB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 14
//
ID   K19
AC   CVCL_W796
DR   cancercelllines; CVCL_W796
DR   Cosmic; 706092
DR   Cosmic; 888836
DR   Cosmic; 897475
DR   GDSC; 1298159
DR   PharmacoDB; K19_721_2019
DR   Wikidata; Q54899264
RX   PubMed=10766161;
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=10766161; PubMed=15009714).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 15
//
ID   K19/36
AC   CVCL_E9EH
DR   ABCD; ABCD_AU834
DR   DSHB; K19-36
DR   MMRRC; MMRRC:065952-UCD
RX   PubMed=8938716;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K19_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P17659; Rat Kcna6 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K1K
AC   CVCL_S935
DR   Wikidata; Q54899265
RX   CelloPub=CLPUB00706;
RX   DOI=10.1139/f81-125;
RX   Patent=US4219543;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by channel catfish virus (CelloPub=CLPUB00706; DOI=10.1139/f81-125).
CC   Misspelling: KIK; Note=Occasionally.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=59899; ! Clarias batrachus (Walking catfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   K2 [Human melanoma]
AC   CVCL_AT85
DR   CLO; CLO_0037127
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_AT85
DR   Cell_Model_Passport; SIDM00126
DR   Cosmic; 888867
DR   Cosmic-CLP; 1298160
DR   DepMap; ACH-002147
DR   EGA; EGAS00001000978
DR   GDSC; 1298160
DR   LINCS_HMS; 51100
DR   LINCS_LDP; LCL-2091
DR   PharmacoDB; K2_722_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54899266
RX   PubMed=15009714;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=1298160; DepMap=ACH-002147; PubMed=15009714).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.06%; Native American=0%; East Asian, North=0%; East Asian, South=1.34%; South Asian=0.87%; European, North=67.62%; European, South=30.11% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1298160
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 21
//
ID   K2 [Human thyroid carcinoma]
AC   CVCL_6308
DR   BioSample; SAMN03151644
DR   cancercelllines; CVCL_6308
DR   Cosmic; 928834
DR   Cosmic; 1162846
DR   Cosmic; 1789443
DR   Wikidata; Q54899267
RX   PubMed=9054892;
RX   PubMed=10646882;
RX   PubMed=18713817;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a GLAG-66 derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00219.
CC   Population: Caucasian; Italian.
CC   Doubling time: 23 hours (PubMed=9054892).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 18
ST   D21S11: 30,31.2
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 21,24
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9918 ! GLAG-66
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   K20-iPSC
AC   CVCL_DD62
DR   Wikidata; Q54899268
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (PubMed=27191603).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 8,13
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD50 ! ND29802
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   K20/78
AC   CVCL_E9EI
DR   ABCD; ABCD_AU835
DR   DSHB; K20-78
DR   MMRRC; MMRRC:065947-UCD
RX   PubMed=8938716;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K20_78.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10499; Rat Kcna1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K204
AC   CVCL_8961
DR   CLO; CLO_0007055
DR   ATCC; HB-221
DR   Wikidata; Q54899269
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   K209
AC   CVCL_W340
SY   A549 (K209)
DR   cancercelllines; CVCL_W340
DR   Wikidata; Q54899270
RX   PubMed=11991756;
CC   Group: Adeno-associated virus packaging cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   K21
AC   CVCL_CW35
SY   K 21; AGK21
DR   ATCC; HB-8549
DR   Wikidata; Q54899271
RX   Patent=US4762800;
RX   Patent=US5168043;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8549.
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: ATCC; HB-8549; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 6
//
ID   K21S4
AC   CVCL_T836
SY   K21-S04; HPS0073
DR   GEO; GSM1227438
DR   GEO; GSM1227439
DR   RCB; HPS0073
DR   SKIP; SKIP000140
DR   Wikidata; Q54899272
RX   Patent=US10519422;
RX   PubMed=21347327;
RX   PubMed=24527394;
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Leu721Profs*2 (c.2161dupC) (c.2161_2162insC); Zygosity=Unspecified (PubMed=21347327).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: SKIP; SKIP000140; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   K23
AC   CVCL_C5R2
DR   Wikidata; Q116049610
RX   PubMed=2580015;
RX   PubMed=3079807;
RX   PubMed=3104323;
RX   PubMed=6339616;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   K24-3b
AC   CVCL_DC94
DR   Wikidata; Q54899273
RX   Patent=US6190871;
RX   PubMed=1694449;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a HIV-1 infected adult.
CC   Miscellaneous: Cell line has been lost (PubMed=1694449).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   K248C
AC   CVCL_T998
DR   Wikidata; Q54899274
RX   PubMed=1649697;
RX   PubMed=1921332;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Siamese; VBO=VBO_0100221.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_T999 ! K248P
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   K248P
AC   CVCL_T999
DR   Wikidata; Q54899275
RX   PubMed=1649697;
RX   PubMed=1921332;
RX   PubMed=15705889;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Siamese; VBO=VBO_0100221.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_T998 ! K248C
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   K25-iPSC
AC   CVCL_DD63
DR   Wikidata; Q54899276
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (PubMed=27191603).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 8,13
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD50 ! ND29802
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   K25/73
AC   CVCL_E9EJ
DR   ABCD; ABCD_AU836
DR   DSHB; K25-73
DR   MMRRC; MMRRC:066310-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K25_73.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13303; Human KCNAB2 (Note=Also recognizes KCNAB1. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K28
AC   CVCL_F0SQ
RX   PubMed=7589218;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1960; CHRNA7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K28/43
AC   CVCL_E9EK
DR   ABCD; ABCD_AU837
DR   DSHB; K28-43
DR   MMRRC; MMRRC:065968-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K28_43.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P78352; Human DLG4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K28/74
AC   CVCL_E9EL
DR   ABCD; ABCD_AU894
DR   DSHB; K28-74
DR   MMRRC; MMRRC:066267-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K28_74.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P78352; Human DLG4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K28/86
AC   CVCL_E9EM
DR   ABCD; ABCD_AU895
DR   DSHB; K28-86
DR   MMRRC; MMRRC:065969-UCD
RX   PubMed=10629225;
RX   PubMed=26644354;
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K28_86.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P78352; Human DLG4 (Note=Also recognizes DLG1, DLG2 and DLG3. Also reacts with mouse, rat, zebrafish, Xenopus and C.elegans).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K2B-12H
AC   CVCL_V088
SY   K2B-12H-G7
DR   CLO; CLO_0007058
DR   CLDB; cl2992
DR   IHW; 11w 8008
DR   Wikidata; Q54899277
RX   PubMed=1655684;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*24).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   K3OHD
AC   CVCL_E2WG
SY   K 3 OHD; K3 OHD
DR   BTO; BTO_0005622
RX   DOI=10.1007/BF02933754;
RX   PubMed=17265224;
RX   PubMed=20514608;
CC   Group: Plant cell line.
CC   Characteristics: Used to transform digitoxin into deacetyllanatoside C, a precursor of digoxin (DOI=10.1007/BF02933754).
CC   Derived from site: In situ; Vascular leaf; PO=PO_0009025.
CC   Breed/subspecies: Cultivar EHRH.
OX   NCBI_TaxID=49450; ! Digitalis lanata (Grecian foxglove)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   K31M28
AC   CVCL_T838
SY   HPS0074
DR   GEO; GSM1227440
DR   GEO; GSM1227441
DR   RCB; HPS0074
DR   SKIP; SKIP000141
DR   Wikidata; Q54899278
RX   Patent=US10519422;
RX   PubMed=24527394;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: SKIP; SKIP000141; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   K32M17
AC   CVCL_T839
SY   HPS0075
DR   RCB; HPS0075
DR   SKIP; SKIP000142
DR   Wikidata; Q54899279
RX   Patent=US10519422;
CC   Population: Japanese.
CC   Discontinued: SKIP; SKIP000142; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 13
//
ID   K33N
AC   CVCL_C4CF
DR   ABCD; ABCD_AP564
DR   Wikidata; Q116049611
RX   Patent=US9040295;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10830.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q13797; Human ITGA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   K36/15
AC   CVCL_E9EN
DR   ABCD; ABCD_AU838
DR   DSHB; K36-15
DR   MMRRC; MMRRC:066027-UCD
RX   PubMed=10629225;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K36_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10499; Rat Kcna1 (Note=Also reacts with mouse).
CC   Caution: Isotype is wrongly indicated as IgG2a in PubMed=10629225.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K37
AC   CVCL_W627
SY   K 37
DR   Wikidata; Q54899280
RX   PubMed=3243385;
RX   PubMed=10841188;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_W624 ! K7 [Mouse osteosarcoma]
OI   CVCL_W628 ! K8 [Mouse osteosarcoma]
OI   CVCL_W625 ! K12 [Mouse osteosarcoma]
OI   CVCL_W626 ! K14
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   K37/89
AC   CVCL_E9EP
DR   ABCD; ABCD_AU896
DR   DSHB; K37-89
DR   MMRRC; MMRRC:065954-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K37_89.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92953; Human KCNB2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K38
AC   CVCL_W141
DR   CancerTools; 151682
DR   ECACC; 11090602
DR   Wikidata; Q54899281
DR   Ximbio; 151682
RX   PubMed=19907996;
CC   Discontinued: ECACC; 11090602; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   K39/25
AC   CVCL_E9EQ
DR   ABCD; ABCD_AU839
DR   DSHB; K39-25
DR   MMRRC; MMRRC:066079-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K39_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14721; Human KCNB1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K3T
AC   CVCL_B7P2
DR   Wikidata; Q112929936
RX   PubMed=1472476;
RX   PubMed=1719236;
RX   PubMed=9357968;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   K3T103
AC   CVCL_IU36
DR   Wikidata; Q54899282
RX   PubMed=3710619;
RX   PubMed=6591445;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU35 ! KD2.3
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 4
//
ID   K4 [Human melanoma]
AC   CVCL_AT86
DR   cancercelllines; CVCL_AT86
DR   Cosmic; 888865
DR   Cosmic; 897479
DR   PharmacoDB; K4_723_2019
DR   Wikidata; Q54899283
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   K4 [Mouse hybridoma]
AC   CVCL_CW36
SY   AGK4
DR   ATCC; HB-8550
DR   Wikidata; Q54899284
RX   Patent=US4762800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8550.
CC   Monoclonal antibody isotype: IgG1.
CC   Discontinued: ATCC; HB-8550; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 6
//
ID   K40/17
AC   CVCL_E9ER
DR   ABCD; ABCD_AU897
DR   DSHB; K40-17
DR   MMRRC; MMRRC:066028-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K40_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P63144; Rat Kcnab1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K420L
AC   CVCL_TZ80
DR   Wikidata; Q54899285
RX   PubMed=17725806;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   K457
AC   CVCL_IP01
SY   K-457
DR   BTO; BTO_0005848
DR   Wikidata; Q54899286
RX   PubMed=22249266;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   K46
AC   CVCL_K163
DR   Wikidata; Q54899287
RX   PubMed=310843;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-44.html
CC   Doubling time: 19 hours (PubMed=310843).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   K47/42
AC   CVCL_E9ES
DR   ABCD; ABCD_AU898
DR   DSHB; K47-42
DR   MMRRC; MMRRC:066019-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K47_42.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14722; Human KCNAB1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K4IM
AC   CVCL_9V29
SY   K4 IM; K4; K4 IMmortalized
DR   NCBI_Iran; C616
DR   Wikidata; Q54899289
RX   PubMed=9106935;
RX   PubMed=29770602;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient suffering from a meniscus lesion (PubMed=9106935).
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast-like synoviocyte; CL=CL_0002301.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   K5
AC   CVCL_1322
DR   CLO; CLO_0037154
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1322
DR   Cell_Model_Passport; SIDM00056
DR   ChEMBL-Cells; CHEMBL3308144
DR   ChEMBL-Targets; CHEMBL2366152
DR   Cosmic; 924238
DR   Cosmic; 928832
DR   Cosmic; 1162843
DR   Cosmic; 1507370
DR   Cosmic; 1533547
DR   Cosmic; 1536123
DR   Cosmic; 1789444
DR   Cosmic; 1889002
DR   Cosmic; 2791090
DR   Cosmic-CLP; 924238
DR   DepMap; ACH-002148
DR   EGA; EGAS00001000978
DR   GDSC; 924238
DR   GEO; GSM1669970
DR   IARC_TP53; 27559
DR   LINCS_LDP; LCL-1692
DR   PharmacoDB; K5_724_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1322
DR   Wikidata; Q54899290
RX   PubMed=10646882;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a GLAG-66 derivative (STR profile and somatic mutations from Cosmic-CLP).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00590.
CC   Population: Caucasian; Italian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=924238; DepMap=ACH-002148).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (Cosmic-CLP=924238; DepMap=ACH-002148).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.75%; Native American=0%; East Asian, North=0%; East Asian, South=1.37%; South Asian=7.25%; European, North=35.45%; European, South=54.17% (PubMed=30894373).
CC   Derived from site: Metastatic; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=924238
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9918 ! GLAG-66
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   K5-107
AC   CVCL_A0IN
DR   Wikidata; Q108820614
RX   Patent=US9670287;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11252.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   K5-116-2-1
AC   CVCL_A0IP
DR   Wikidata; Q108820615
RX   Patent=US9670287;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11253.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   K5-70
AC   CVCL_A0IQ
DR   Wikidata; Q108820616
RX   Patent=US9670287;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11251.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   K51/1
AC   CVCL_E9ET
DR   ABCD; ABCD_AU840
DR   DSHB; K51-1
DR   MMRRC; MMRRC:065976-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K51_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O35964; Rat Sh3gl1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K55/7
AC   CVCL_E9EU
DR   DSHB; K55-7
DR   MMRRC; MMRRC:065959-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K55_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8R426; Rat Kcnip1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K55/82
AC   CVCL_E9EV
DR   ABCD; ABCD_AU899
DR   DSHB; K55-82
DR   MMRRC; MMRRC:065962-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K55_82.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8R426; Rat Kcnip1 (Note=Also recognizes Kcnip2, Kcnip3 and Kcnip4. Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K562 #10 NIL
AC   CVCL_E6IG
RX   PubMed=27536777;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 #6 NIL
AC   CVCL_E6IH
RX   PubMed=27536777;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 AZQR
AC   CVCL_2967
SY   K562-AZQR; K562AZQR; AZQR
DR   CancerTools; 153252
DR   CCRID; 5301HUM-KCB15019YJ
DR   ECACC; 93112521
DR   KCB; KCB 2015019YJ
DR   Wikidata; Q54899291
DR   Ximbio; 153252
RX   PubMed=7646550;
RX   PubMed=11416159;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90185; Diaziquone (AZQ).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 93112521; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 15,17
ST   D21S11: 29,30
ST   D8S1179: 12
ST   FGA: 21,24
ST   TH01: 9.3
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 28
//
ID   K562 BZQR
AC   CVCL_B502
SY   K562BZQR; BZQR
DR   Wikidata; Q54899292
RX   PubMed=7646550;
RX   PubMed=11416159;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90193; NSC-224070 (BZQ; 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16
ST   D21S11: 29,30
ST   D8S1179: 12
ST   FGA: 21,24
ST   TH01: 9.3
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   K562 cl.6
AC   CVCL_2968
DR   CLO; CLO_0007060
DR   CLDB; cl2993
DR   ECACC; 85011407
DR   Wikidata; Q54899294
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   K562 DAS
AC   CVCL_E6HX
SY   K562 200nM DAS
RX   PubMed=21718141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Thr315Ile (c.944C>T) (c.1001C>T); ClinVar=VCV000012624; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 Dox
AC   CVCL_E6HY
SY   K562-Dox; K562/DOX; K562/Dox
RX   PubMed=21718141;
RX   PubMed=27536777;
CC   From: Ashman, Leonie K.; University of Newcastle; Adelaide; Australia.
CC   Population: Caucasian.
CC   Characteristics: Stably overexpresses ABCB1 (PubMed=21718141).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 Dox DAS
AC   CVCL_E6HZ
SY   K562 Dox 200nM DAS
RX   PubMed=21718141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val299Leu (c.895G>C); ClinVar=VCV003906852; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6HY ! K562 Dox
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   K562 Dox IM1
AC   CVCL_E6I0
SY   K562 Dox 2microM IM1
RX   PubMed=21718141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6HY ! K562 Dox
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 Dox IM2
AC   CVCL_E6I1
SY   K562 Dox 2microM IM2
RX   PubMed=21718141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6HY ! K562 Dox
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 Dox IM3
AC   CVCL_E6I2
SY   K562 Dox 2microM IM3
RX   PubMed=21718141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6HY ! K562 Dox
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 Dox #5 NIL
AC   CVCL_E6IE
SY   K562-Dox #5 NIL
RX   PubMed=27536777;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6HY ! K562 Dox
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 Dox #8 NIL
AC   CVCL_E6IF
SY   K562-Dox #8 NIL
RX   PubMed=27536777;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6HY ! K562 Dox
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 eGFP-ADNP
AC   CVCL_GZ75
DR   ENCODE; ENCBS037KCN
DR   ENCODE; ENCBS559UBQ
DR   ENCODE; ENCBS995QNX
DR   GEO; GSM2827324
DR   GEO; GSM2827325
DR   GEO; GSM2828787
DR   Wikidata; Q54899296
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15766; ADNP.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-ATF1
AC   CVCL_AW13
DR   ENCODE; ENCBS377AAA
DR   ENCODE; ENCBS405AAA
DR   ENCODE; ENCBS821FOP
DR   GEO; GSM2422985
DR   GEO; GSM2422986
DR   GEO; GSM2423003
DR   Wikidata; Q54899297
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:783; ATF1.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-ATF3
AC   CVCL_GZ76
DR   ENCODE; ENCBS397AAA
DR   ENCODE; ENCBS458AAA
DR   ENCODE; ENCBS660SLH
DR   GEO; GSM2423679
DR   GEO; GSM2423680
DR   GEO; GSM2423770
DR   Wikidata; Q54899298
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:785; ATF3.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-BACH1
AC   CVCL_AW14
DR   ENCODE; ENCBS024CCL
DR   ENCODE; ENCBS083LQN
DR   ENCODE; ENCBS706JJD
DR   ENCODE; ENCBS746PBJ
DR   GEO; GSM2828783
DR   GEO; GSM2828784
DR   GEO; GSM2828790
DR   Wikidata; Q54899300
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:935; BACH1.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 20
//
ID   K562 eGFP-CEBPB
AC   CVCL_AW15
DR   ENCODE; ENCBS378AAA
DR   ENCODE; ENCBS406AAA
DR   ENCODE; ENCBS818FPM
DR   GEO; GSM2423459
DR   GEO; GSM2423460
DR   GEO; GSM2424112
DR   Wikidata; Q54899301
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1834; CEBPB.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-CEBPG
AC   CVCL_GZ77
DR   ENCODE; ENCBS008URG
DR   ENCODE; ENCBS054WRH
DR   ENCODE; ENCBS274CBC
DR   ENCODE; ENCBS476TFU
DR   ENCODE; ENCBS760ONP
DR   ENCODE; ENCBS788JQH
DR   GEO; GSM2825497
DR   GEO; GSM2827259
DR   GEO; GSM2827260
DR   GEO; GSM2827559
DR   GEO; GSM2827560
DR   GEO; GSM2828552
DR   Wikidata; Q54899303
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1837; CEBPG.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-CREB3
AC   CVCL_AW16
DR   ENCODE; ENCBS312MPK
DR   ENCODE; ENCBS411NIF
DR   ENCODE; ENCBS753IIO
DR   Wikidata; Q54899304
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2347; CREB3.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-CUX1
AC   CVCL_GZ78
DR   ENCODE; ENCBS544POC
DR   ENCODE; ENCBS613PZU
DR   ENCODE; ENCBS846OZP
DR   Wikidata; Q54899305
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2557; CUX1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-DDX20
AC   CVCL_AW17
DR   ENCODE; ENCBS026JDH
DR   ENCODE; ENCBS196WDN
DR   ENCODE; ENCBS216ZMH
DR   Wikidata; Q54899306
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2743; DDX20.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-DIDO1
AC   CVCL_AW18
DR   ENCODE; ENCBS055YUW
DR   ENCODE; ENCBS197ROV
DR   ENCODE; ENCBS454ZTQ
DR   Wikidata; Q54899307
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2680; DIDO1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-E2F1
AC   CVCL_AW19
DR   ENCODE; ENCBS062QLP
DR   ENCODE; ENCBS554TJR
DR   Wikidata; Q54899308
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3113; E2F1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-E2F4
AC   CVCL_GZ79
DR   ENCODE; ENCBS107UAM
DR   Wikidata; Q54899309
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3118; E2F4.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-E2F5
AC   CVCL_GZ80
DR   ENCODE; ENCBS165WTA
DR   ENCODE; ENCBS889YTW
DR   ENCODE; ENCBS925NOW
DR   Wikidata; Q54899310
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3119; E2F5.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ELF1
AC   CVCL_GZ81
DR   ENCODE; ENCBS556OQY
DR   ENCODE; ENCBS861JYZ
DR   ENCODE; ENCBS872CIK
DR   Wikidata; Q54899311
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3316; ELF1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ELK1
AC   CVCL_GZ82
DR   ENCODE; ENCBS168TVX
DR   ENCODE; ENCBS913AGK
DR   ENCODE; ENCBS996OLB
DR   Wikidata; Q54899312
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3321; ELK1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ETS2
AC   CVCL_GZ83
DR   ENCODE; ENCBS381AAA
DR   ENCODE; ENCBS413AAA
DR   ENCODE; ENCBS506IZD
DR   Wikidata; Q54899313
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3489; ETS2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ETV1
AC   CVCL_AW20
DR   ENCODE; ENCBS302KJF
DR   ENCODE; ENCBS398XYI
DR   ENCODE; ENCBS750HFY
DR   Wikidata; Q54899314
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3490; ETV1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-FOS
AC   CVCL_AW21
DR   ENCODE; ENCBS366WZA
DR   ENCODE; ENCBS607WST
DR   ENCODE; ENCBS799VSJ
DR   Wikidata; Q54899315
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-FOSL1
AC   CVCL_GZ84
DR   ENCODE; ENCBS129EER
DR   ENCODE; ENCBS392SQX
DR   ENCODE; ENCBS894HTX
DR   GEO; GSM777644
DR   Wikidata; Q54899316
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13718; FOSL1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-FOXJ2
AC   CVCL_GZ85
DR   ENCODE; ENCBS032TNV
DR   ENCODE; ENCBS039TGQ
DR   ENCODE; ENCBS507YTF
DR   Wikidata; Q54899317
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24818; FOXJ2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-GABPA
AC   CVCL_GZ86
DR   ENCODE; ENCBS021UXC
DR   ENCODE; ENCBS084QBR
DR   ENCODE; ENCBS164UBJ
DR   Wikidata; Q54899318
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4071; GABPA.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-GATA2
AC   CVCL_AW22
DR   ENCODE; ENCBS746ASY
DR   ENCODE; ENCBS903OXA
DR   Wikidata; Q54899319
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4171; GATA2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-GTF2A2
AC   CVCL_GZ87
DR   ENCODE; ENCBS656LOQ
DR   ENCODE; ENCBS725FFW
DR   ENCODE; ENCBS839DWI
DR   Wikidata; Q54899320
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4647; GTF2A2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-GTF2E2
AC   CVCL_GZ88
DR   ENCODE; ENCBS182OZC
DR   ENCODE; ENCBS231GMV
DR   ENCODE; ENCBS936ECY
DR   Wikidata; Q54899321
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4651; GTF2E2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-HDAC8
AC   CVCL_AW23
DR   ENCODE; ENCBS055CUX
DR   ENCODE; ENCBS383AAA
DR   ENCODE; ENCBS422AAA
DR   ENCODE; ENCBS443JHG
DR   ENCODE; ENCBS903WFV
DR   GEO; GSM777640
DR   Wikidata; Q54899322
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13315; HDAC8.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-HINFP
AC   CVCL_AW24
DR   ENCODE; ENCBS422ZTW
DR   ENCODE; ENCBS436RZW
DR   ENCODE; ENCBS595XIW
DR   Wikidata; Q54899323
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17850; HINFP.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-HMGB1
AC   CVCL_AW25
DR   ENCODE; ENCBS332OKQ
DR   ENCODE; ENCBS772IOG
DR   Wikidata; Q54899324
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4983; HMGB1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ID3
AC   CVCL_AW26
DR   ENCODE; ENCBS384AAA
DR   ENCODE; ENCBS425AAA
DR   ENCODE; ENCBS579QSJ
DR   Wikidata; Q54899325
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5362; ID3.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ILK
AC   CVCL_AW27
DR   ENCODE; ENCBS002PZY
DR   ENCODE; ENCBS076AAA
DR   ENCODE; ENCBS428AAA
DR   Wikidata; Q54899326
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6040; ILK.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-IRF1
AC   CVCL_AW28
DR   ENCODE; ENCBS329CYL
DR   ENCODE; ENCBS385AAA
DR   ENCODE; ENCBS429AAA
DR   Wikidata; Q54899327
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6116; IRF1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-IRF9
AC   CVCL_AW29
DR   ENCODE; ENCBS134NRZ
DR   ENCODE; ENCBS264ETB
DR   ENCODE; ENCBS951JJK
DR   Wikidata; Q54899328
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6131; IRF9.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-JUNB
AC   CVCL_AW30
SY   K562 eGFP-JunB
DR   ENCODE; ENCBS038ENC
DR   ENCODE; ENCBS353XCU
DR   ENCODE; ENCBS775URE
DR   GEO; GSM777638
DR   Wikidata; Q54899329
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6205; JUNB.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-JUND
AC   CVCL_AW31
DR   ENCODE; ENCBS349TGF
DR   ENCODE; ENCBS770RPE
DR   ENCODE; ENCBS919IGK
DR   Wikidata; Q54899330
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6206; JUND.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-KLF1
AC   CVCL_AW32
DR   ENCODE; ENCBS386AAA
DR   ENCODE; ENCBS431AAA
DR   ENCODE; ENCBS481LVE
DR   Wikidata; Q54899331
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6345; KLF1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-KLF13
AC   CVCL_AW33
DR   ENCODE; ENCBS078AAA
DR   ENCODE; ENCBS432AAA
DR   ENCODE; ENCBS703NZF
DR   Wikidata; Q54899332
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13672; KLF13.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-MAFG
AC   CVCL_AW34
DR   ENCODE; ENCBS062KUE
DR   ENCODE; ENCBS584ZNF
DR   ENCODE; ENCBS683EBC
DR   Wikidata; Q54899333
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6781; MAFG.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-MEF2D
AC   CVCL_GZ89
DR   ENCODE; ENCBS163FHT
DR   ENCODE; ENCBS207FBE
DR   ENCODE; ENCBS902TFF
DR   Wikidata; Q54899334
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6997; MEF2D.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-NFE2
AC   CVCL_GZ90
DR   ENCODE; ENCBS085AAA
DR   ENCODE; ENCBS443AAA
DR   ENCODE; ENCBS903THP
DR   Wikidata; Q54899335
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7780; NFE2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-NFE2L1
AC   CVCL_AW35
DR   ENCODE; ENCBS108AEM
DR   ENCODE; ENCBS151LVY
DR   ENCODE; ENCBS378YNT
DR   ENCODE; ENCBS500RHB
DR   ENCODE; ENCBS670PDV
DR   ENCODE; ENCBS918KOX
DR   Wikidata; Q54899336
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7781; NFE2L1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-NR2C1
AC   CVCL_AW36
DR   ENCODE; ENCBS706YBL
DR   ENCODE; ENCBS707WFI
DR   ENCODE; ENCBS936SUX
DR   Wikidata; Q54899338
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7971; NR2C1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-NR2C2
AC   CVCL_GZ91
DR   ENCODE; ENCBS168GXP
DR   ENCODE; ENCBS250NTO
DR   ENCODE; ENCBS923ZGZ
DR   Wikidata; Q54899342
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7972; NR2C2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-NR4A1
AC   CVCL_AW37
DR   ENCODE; ENCBS392AAA
DR   ENCODE; ENCBS445AAA
DR   ENCODE; ENCBS715EUG
DR   ENCODE; ENCBS862GKZ
DR   ENCODE; ENCBS875VQC
DR   GEO; GSM777637
DR   Wikidata; Q54899343
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7980; NR4A1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 20
//
ID   K562 eGFP-PBX2
AC   CVCL_GZ92
DR   ENCODE; ENCBS655BEX
DR   ENCODE; ENCBS753ZIZ
DR   ENCODE; ENCBS860ULO
DR   Wikidata; Q54899344
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8633; PBX2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-POLR2H
AC   CVCL_GZ93
DR   ENCODE; ENCBS188WMP
DR   ENCODE; ENCBS420IWT
DR   ENCODE; ENCBS687TWN
DR   Wikidata; Q54899346
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9195; POLR2H.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-PTRF
AC   CVCL_AW38
DR   ENCODE; ENCBS258BIP
DR   ENCODE; ENCBS544EAP
DR   ENCODE; ENCBS931QBF
DR   Wikidata; Q54899347
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9688; CAVIN1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-PTTG1
AC   CVCL_AW39
DR   ENCODE; ENCBS405IFW
DR   ENCODE; ENCBS430AYP
DR   ENCODE; ENCBS473LEX
DR   Wikidata; Q54899348
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9690; PTTG1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-PYGO2
AC   CVCL_AW40
DR   ENCODE; ENCBS102NQC
DR   ENCODE; ENCBS203NBV
DR   ENCODE; ENCBS500RNP
DR   Wikidata; Q54899349
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:30257; PYGO2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-RELA
AC   CVCL_AW41
DR   ENCODE; ENCBS394AAA
DR   ENCODE; ENCBS450AAA
DR   ENCODE; ENCBS557OXO
DR   Wikidata; Q54899350
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9955; RELA.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-SMARCA1
AC   CVCL_AW42
DR   ENCODE; ENCBS334LCL
DR   ENCODE; ENCBS927HXP
DR   Wikidata; Q54899351
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11097; SMARCA1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-SMARCA2
AC   CVCL_AW43
DR   ENCODE; ENCBS776EGG
DR   ENCODE; ENCBS961JJQ
DR   Wikidata; Q54899352
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11098; SMARCA2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-TAF7
AC   CVCL_AW44
DR   ENCODE; ENCBS115OID
DR   ENCODE; ENCBS350VSG
DR   ENCODE; ENCBS360JZL
DR   Wikidata; Q54899353
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11541; TAF7.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-TEAD2
AC   CVCL_AW45
DR   ENCODE; ENCBS528ZIT
DR   ENCODE; ENCBS661EXX
DR   ENCODE; ENCBS723GLY
DR   Wikidata; Q54899355
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11715; TEAD2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-TFDP1
AC   CVCL_GZ94
DR   ENCODE; ENCBS546RMD
DR   ENCODE; ENCBS670LTO
DR   ENCODE; ENCBS931GIA
DR   Wikidata; Q54899356
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11749; TFDP1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-TSC22D4
AC   CVCL_AW46
DR   ENCODE; ENCBS340PVD
DR   ENCODE; ENCBS528FGG
DR   ENCODE; ENCBS587AHU
DR   Wikidata; Q54899357
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:21696; TSC22D4.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-USF2
AC   CVCL_GZ95
DR   ENCODE; ENCBS105RVN
DR   ENCODE; ENCBS266WUA
DR   ENCODE; ENCBS889FGM
DR   Wikidata; Q54899358
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12594; USF2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZBTB11
AC   CVCL_GZ96
DR   ENCODE; ENCBS075MLD
DR   ENCODE; ENCBS170SCN
DR   ENCODE; ENCBS991MRU
DR   Wikidata; Q54899359
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16740; ZBTB11.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZFX
AC   CVCL_GZ97
DR   ENCODE; ENCBS205YAO
DR   ENCODE; ENCBS458HHF
DR   ENCODE; ENCBS675IUA
DR   Wikidata; Q54899360
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12869; ZFX.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZKSCAN8
AC   CVCL_GZ98
DR   ENCODE; ENCBS539IPB
DR   ENCODE; ENCBS541VKI
DR   ENCODE; ENCBS669BXB
DR   Wikidata; Q54899361
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12983; ZKSCAN8.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF148
AC   CVCL_GZ99
DR   ENCODE; ENCBS061XWL
DR   ENCODE; ENCBS091XYE
DR   ENCODE; ENCBS397IBL
DR   ENCODE; ENCBS538KOD
DR   ENCODE; ENCBS915LIT
DR   Wikidata; Q54899362
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12933; ZNF148.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 19
//
ID   K562 eGFP-ZNF175
AC   CVCL_HA00
DR   ENCODE; ENCBS098BHX
DR   ENCODE; ENCBS200VWP
DR   ENCODE; ENCBS241XDL
DR   Wikidata; Q54899363
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12964; ZNF175.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF197
AC   CVCL_HA01
DR   ENCODE; ENCBS261OYC
DR   ENCODE; ENCBS309IBB
DR   ENCODE; ENCBS437BJN
DR   Wikidata; Q54899364
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12988; ZNF197.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF24
AC   CVCL_AW47
DR   ENCODE; ENCBS016MLC
DR   ENCODE; ENCBS778QBL
DR   ENCODE; ENCBS985SCL
DR   Wikidata; Q54899365
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13032; ZNF24.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF354B
AC   CVCL_XW96
DR   ENCODE; ENCBS691VMX
DR   ENCODE; ENCBS852SOK
DR   ENCODE; ENCBS933IRC
DR   Wikidata; Q94335514
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17197; ZNF354B.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   K562 eGFP-ZNF395
AC   CVCL_HA02
DR   ENCODE; ENCBS343LRB
DR   Wikidata; Q54899366
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18737; ZNF395.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF507
AC   CVCL_XW97
DR   ENCODE; ENCBS042PVO
DR   ENCODE; ENCBS466GBM
DR   ENCODE; ENCBS962GKO
DR   Wikidata; Q94335522
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:23783; ZNF507.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   K562 eGFP-ZNF512
AC   CVCL_HA03
DR   ENCODE; ENCBS259DFK
DR   ENCODE; ENCBS725WFV
DR   ENCODE; ENCBS874FAG
DR   Wikidata; Q54899367
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29380; ZNF512.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF584
AC   CVCL_HA04
DR   ENCODE; ENCBS027DJL
DR   ENCODE; ENCBS101CXP
DR   ENCODE; ENCBS922MVL
DR   Wikidata; Q54899368
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:27318; ZNF584.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF589
AC   CVCL_HA05
DR   ENCODE; ENCBS070CNU
DR   ENCODE; ENCBS609DLP
DR   ENCODE; ENCBS912VQO
DR   Wikidata; Q54899369
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16747; ZNF589.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF639
AC   CVCL_HA06
DR   ENCODE; ENCBS215BGQ
DR   ENCODE; ENCBS851CNL
DR   ENCODE; ENCBS967JDE
DR   Wikidata; Q54899370
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:30950; ZNF639.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF644
AC   CVCL_HA07
DR   ENCODE; ENCBS204XMM
DR   ENCODE; ENCBS885SBO
DR   ENCODE; ENCBS923DEI
DR   Wikidata; Q54899371
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29222; ZNF644.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 17
//
ID   K562 eGFP-ZNF740
AC   CVCL_HA08
DR   ENCODE; ENCBS020CGZ
DR   ENCODE; ENCBS160YCN
DR   ENCODE; ENCBS353NLF
DR   ENCODE; ENCBS450DNI
DR   ENCODE; ENCBS523ORN
DR   ENCODE; ENCBS928AAC
DR   Wikidata; Q54899372
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:27465; ZNF740.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF766
AC   CVCL_HA09
DR   ENCODE; ENCBS105ZBV
DR   ENCODE; ENCBS570ZDR
DR   ENCODE; ENCBS605NSN
DR   Wikidata; Q54899373
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:28063; ZNF766.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZNF83
AC   CVCL_HA10
DR   ENCODE; ENCBS285PHZ
DR   ENCODE; ENCBS340DSB
DR   ENCODE; ENCBS949ZPT
DR   Wikidata; Q54899374
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13158; ZNF83.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   K562 eGFP-ZSCAN9
AC   CVCL_AW48
DR   ENCODE; ENCBS371OXN
DR   ENCODE; ENCBS458HON
DR   Wikidata; Q54899375
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12984; ZSCAN9.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 19
//
ID   K562 HHT
AC   CVCL_IM25
SY   K562-HHT; K562HHT
DR   Wikidata; Q54899376
RX   PubMed=7987716;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 17
//
ID   K562 IM1
AC   CVCL_E6I3
SY   K562 2microM IM1
RX   PubMed=21718141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 IM2
AC   CVCL_E6I4
SY   K562 2microM IM2
RX   PubMed=21718141;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562 NGLY1 KO c15
AC   CVCL_ZL53
SY   K562 NGLY1 KO clone 15; NGLY1c15
DR   ArrayExpress; E-MTAB-7061
DR   PRIDE; PXD010335
DR   Wikidata; Q98126811
RX   PubMed=31659326;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   K562 NGLY1 KO c20
AC   CVCL_ZL54
SY   NGLY1 KO clone 20; NGLY1c20
DR   ArrayExpress; E-MTAB-7061
DR   PRIDE; PXD010335
DR   Wikidata; Q98126812
RX   PubMed=31659326;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   K562(A)
AC   CVCL_9120
SY   K-562 clone A; K-562, clone A
DR   CLO; CLO_0007061
DR   CLDB; cl2985
DR   Wikidata; Q54899420
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   K562(Bcl-xL)
AC   CVCL_E6HV
RX   PubMed=12881321;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   K562(Pgp)
AC   CVCL_E6HW
RX   PubMed=12881321;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   K562(S)
AC   CVCL_9119
SY   K-562 clone S; K-562, clone S
DR   CLO; CLO_0007062
DR   CLDB; cl2986
DR   Wikidata; Q54899421
RX   PubMed=6934848;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   K562-ARA-C
AC   CVCL_Z732
SY   K/araC
DR   Wikidata; Q54899377
RX   PubMed=10500836;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   K562-AVB3
AC   CVCL_JX91
SY   K562-avb3; K562 aVb3; K562-alphaVbeta3; avb3-K562; alphaVbeta3-K562
DR   Wikidata; Q54899379
RX   PubMed=7525603;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6156; ITGB3.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   K562-BMS-R
AC   CVCL_4V54
SY   K562 BMS-R
DR   Wikidata; Q54899380
RX   PubMed=18829496;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   K562-CdA
AC   CVCL_Z733
SY   K/2cdA
DR   Wikidata; Q54899381
RX   PubMed=10500836;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_567361; Cladribine (2-chlorodeoxyadenosine; CdA).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   K562-DAS[r]
AC   CVCL_4V59
DR   Wikidata; Q54899382
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10011C.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   K562-eGFP-Puro
AC   CVCL_D5KH
DR   Imanis; CL170
DR   Wikidata; Q127382407
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL170).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   K562-Fluc-EmGFP
AC   CVCL_D5KJ
DR   Imanis; CL169
DR   Wikidata; Q127382408
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-SFFV-Luc2-P2A-EmGFP vector encoding for luciferase linked via a P2A cleavage site to emerald green fluorescent protein (emGFP) and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL169).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   K562-Fluc-Puro
AC   CVCL_D5KI
DR   Imanis; CL171
DR   Wikidata; Q127382409
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL171).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   K562-Fluc-Puro/HuBCMA-Neo
AC   CVCL_E4BI
DR   Imanis; CL192
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (from parent cell line).
CC   Characteristics: Transduced with a human TNFRS17/BCMA and neo encoding lentivirus (Imanis=CL192).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11913; TNFRSF17.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5KI ! K562-Fluc-Puro
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   K562-Fluc-Puro/HuCD19-Puro
AC   CVCL_E4BJ
DR   Imanis; CL190
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (from parent cell line).
CC   Characteristics: Transduced with a human CD19 and PuroR encoding lentivirus (Imanis=CL190).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5KI ! K562-Fluc-Puro
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   K562-Fluc-Puro/HuCD20-Neo
AC   CVCL_E4BK
DR   Imanis; CL191
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (from parent cell line).
CC   Characteristics: Transduced with a human CD20 and neo encoding lentivirus (Imanis=CL191).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1640; CD20.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5KI ! K562-Fluc-Puro
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   K562-FLUD
AC   CVCL_Z734
SY   K/flud; K/fluda
DR   Wikidata; Q54899383
RX   PubMed=10500836;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63599; Fludarabine phosphate.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   K562-GEM
AC   CVCL_Z735
SY   K562/Gem; K/gem
DR   Wikidata; Q54899384
RX   PubMed=10500836;
RX   PubMed=11802204;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   K562-H
AC   CVCL_9121
DR   Wikidata; Q54899388
RX   PubMed=7689892;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   K562-IMA[r]
AC   CVCL_4V60
DR   ChEMBL-Cells; CHEMBL4483151
DR   ChEMBL-Targets; CHEMBL4483249
DR   PubChem_Cell_line; CVCL_4V60
DR   Wikidata; Q54899389
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10013C.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   K562-IMA[r]+DAS[r]
AC   CVCL_4V61
DR   Wikidata; Q54899390
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10015C.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   K562-IMA[r]+PON[r]
AC   CVCL_4V62
DR   Wikidata; Q54899391
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Selected for resistance to: ChEBI; CHEBI_78543; Ponatinib (AP24534; Iclusig).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10014C.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   K562-IMR
AC   CVCL_D201
SY   K562-IM-R; K562 IMR; K562/IMR
DR   Wikidata; Q54899392
RX   PubMed=18829496;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   K562-L
AC   CVCL_9122
DR   Wikidata; Q54899393
RX   PubMed=7689892;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   K562-Luc
AC   CVCL_J257
SY   K-562-Luc
DR   JCRB; JCRB1402
DR   JCRB; NIHS0657
DR   Wikidata; Q54899394
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0657; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1402
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   K562-luc2
AC   CVCL_5J21
SY   K-562-luc2
DR   Revvity/PerkinElmer; 124735
DR   Wikidata; Q54899395
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124735; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 19
//
ID   K562-Lucena 1
AC   CVCL_D162
SY   K562-Lucena; K562-LUCENA; Lucena 1; Lucena
DR   BCRJ; 0127
DR   ChEMBL-Cells; CHEMBL4630604
DR   ChEMBL-Targets; CHEMBL4630704
DR   PubChem_Cell_line; CVCL_D162
DR   Wikidata; Q54899396
RX   PubMed=11246270;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   K562-mb15
AC   CVCL_C7IL
DR   Wikidata; Q117704568
RX   PubMed=15755898;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5977; IL15 (Note=Membrane bound, contains the signal peptide of CD8A, the mature part of IL15 and the transmembrane domain of CD8A).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   K562-mb15-41BBL
AC   CVCL_C7IM
DR   Wikidata; Q117704569
RX   PubMed=15755898;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5977; IL15 (Note=Membrane bound, contains the signal peptide of CD8A, the mature part of IL15 and the transmembrane domain of CD8A).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11939; TNFSF9.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7IL ! K562-mb15
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   K562 NF-kappab-Luc2 reporter
AC   CVCL_XZ57
SY   Jurkat NF-kb luciferase reporter
DR   cancercelllines; CVCL_XZ57
DR   KYinno; KC-0149
DR   Wikidata; Q94332884
CC   Problematic cell line: Misidentified. Was originally thought to originate from the Jurkat cell line. STR profiling carried out at KYinno has shown it was derived from K-562. Be aware of this issue if you obtained this cell line before it was indicated as being derived from K-562.
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of the NF-kappaB response element (KYinno=KC-0149).
CC   Doubling time: ~48 hours (KYinno=KC-0149).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   K562-NIL[r]
AC   CVCL_4V63
DR   Wikidata; Q54899397
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10012C.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   K562-PON[r]
AC   CVCL_4V64
DR   Wikidata; Q54899398
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_78543; Ponatinib (AP24534; Iclusig).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10010C.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   K562-r
AC   CVCL_UC14
DR   ATCC; CRL-3344
DR   Wikidata; Q94335706
RX   PubMed=10910924;
CC   Population: Caucasian.
CC   Doubling time: ~24-30 hours (ATCC=CRL-3344).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3344
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   K562-R
AC   CVCL_B0FH
DR   Wikidata; Q108820617
RX   PubMed=2568171;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   K562-Red-FLuc
AC   CVCL_5J01
SY   K562 Red-FLuc; Bioware Brite K562 Red-FLuc; IVISbrite K562 Red F-luc
DR   Revvity/PerkinElmer; BW124735
DR   Wikidata; Q54899399
CC   Population: Caucasian.
CC   Doubling time: 15 hours (Revvity/PerkinElmer=BW124735).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   K562-rn
AC   CVCL_DP55
DR   Wikidata; Q54899400
RX   PubMed=19047160;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   K562-s
AC   CVCL_UC15
DR   ATCC; CRL-3343
DR   Wikidata; Q94335726
RX   PubMed=10910924;
CC   Population: Caucasian.
CC   Characteristics: Clone of K-562 used as a control cell line for studies using K562-s which is resistant to imatinib.
CC   Doubling time: ~24-30 hours (ATCC=CRL-3343).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3343
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   K562-Wnt5a
AC   CVCL_XE50
DR   CCRID; 4201PAT-CCTCC00313
DR   Wikidata; Q94335728
RX   Patent=CN101724603A;
RX   PubMed=21069266;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200958.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12784; WNT5A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   K562/A02
AC   CVCL_0368
DR   MCCL; MCC:0000262
DR   ChEMBL-Cells; CHEMBL4295416
DR   ChEMBL-Targets; CHEMBL4296448
DR   PubChem_Cell_line; CVCL_0368
DR   Wikidata; Q54899401
RX   PubMed=7668104;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   K562/A*0201
AC   CVCL_B7RM
DR   Wikidata; Q112929937
RX   PubMed=11730845;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   K562/AC
AC   CVCL_Y198
DR   CGH-DB; 9121-4
DR   Wikidata; Q54899402
RX   PubMed=10781689;
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 18
//
ID   K562/Adr
AC   CVCL_3827
AS   CVCL_2808
SY   K562/adr; K-562adr; K562adr; K562/ADM
DR   BTO; BTO_0002554
DR   CLO; CLO_0009840
DR   CLO; CLO_0050121
DR   cancercelllines; CVCL_3827
DR   ChEMBL-Cells; CHEMBL3833721
DR   ChEMBL-Targets; CHEMBL4296449
DR   GEO; GSM827221
DR   JCRB; JCRB1002
DR   JCRB; NIHS0053
DR   LINCS_LDP; LCL-1104
DR   Progenetix; CVCL_3827
DR   PubChem_Cell_line; CVCL_3827
DR   RCB; RCB1898
DR   TKG; TKG 0211
DR   Wikidata; Q54899403
RX   PubMed=3091555;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0053; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1002; RCB=RCB1898; TKG=TKG 0211
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   K562/ara-C
AC   CVCL_4V20
DR   Wikidata; Q54899404
RX   PubMed=21290089;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   K562/AS-3
AC   CVCL_4V84
DR   Wikidata; Q54899405
RX   PubMed=17261498;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_30621; Diarsenic trioxide (ATO; As2O3).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   K562/AS2
AC   CVCL_4V85
DR   Wikidata; Q54899406
RX   CelloPub=CLPUB00269;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_30621; Diarsenic trioxide (ATO; As2O3).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   K562/Cas9-hyg
AC   CVCL_C9F0
DR   GeneCopoeia; SL552
DR   Wikidata; Q123032786
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL552).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 6
//
ID   K562/CP
AC   CVCL_AZ73
SY   K-562/CP
DR   BTO; BTO_0005801
DR   Wikidata; Q54899407
RX   PubMed=25356864;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   K562/D1-9
AC   CVCL_D205
DR   Wikidata; Q54899408
RX   PubMed=8687117;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   K562/DAC
AC   CVCL_WI19
DR   Wikidata; Q94335820
RX   PubMed=30793488;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50131; 5-aza-2'-deoxycytidine (Decitabine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 13
//
ID   K562/DNR
AC   CVCL_4T87
DR   Wikidata; Q54899409
RX   PubMed=8787550;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 17
//
ID   K562/etop20
AC   CVCL_Y168
DR   CGH-DB; 9122-4
DR   Wikidata; Q54899410
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 17
//
ID   K562/etop80
AC   CVCL_Y169
DR   CGH-DB; 9123-4
DR   Wikidata; Q54899411
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 17
//
ID   K562/fes clone WS-1
AC   CVCL_C8IN
SY   K562/WS-1; WS-1
DR   Wikidata; Q123032787
RX   PubMed=2656706;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12841; YES1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   K562/fes clone WS-5
AC   CVCL_C8IP
SY   K562/WS-5; WS-5
DR   Wikidata; Q123032788
RX   PubMed=2656706;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12841; YES1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   K562/fes clone WS-6
AC   CVCL_C8IQ
SY   K562/WS-6; WS-6
DR   Wikidata; Q123032789
RX   PubMed=2656706;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12841; YES1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   K562/FLM
AC   CVCL_E7CM
RX   PubMed=39046364;
CC   Population: Caucasian.
CC   Characteristics: Resistant to about 50 nmol/L of flumatinib. Also resistant to imatinib and doxorubicin (PubMed=39046364).
CC   Selected for resistance to: ChEBI; CHEBI_233593; Flumatinib.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=39046364).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   K562/G
AC   CVCL_C0HT
DR   Wikidata; Q112929938
RX   PubMed=21122350;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   K562/G01
AC   CVCL_4V47
DR   Wikidata; Q54899413
RX   PubMed=15308010;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   K562/GM-CSF
AC   CVCL_A8HT
SY   K562 GM-CSF; K562GM-CSF; GM-K562
DR   Wikidata; Q107115522
RX   PubMed=10466632;
RX   PubMed=23170257;
RX   PubMed=32289117;
CC   Population: Caucasian.
CC   Biotechnology: Used for the production of the Sorento Therapeutics STI-6991 SARS-CoV-2 (COVID-19) vaccine candidate. The cell line which is lethally irradiated is used to produce the recombinant SARS-CoV-2 spike protein rSARS-CoV-2 which is the active part of the vaccine formulation (PubMed=32289117).
CC   Characteristics: Does not express HLA class I or II antigens, potentially decreasing the magnitude of the alloresponses generated on repeated immunizations (PubMed=10466632).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 9
//
ID   K562/HHT
AC   CVCL_A9BR
DR   Wikidata; Q108820618
RX   CelloPub=CLPUB00641;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   K562/MTX-1
AC   CVCL_F1X6
RX   PubMed=2465288;
CC   Population: Caucasian.
CC   Doubling time: 31.5 +- 3.5 hours (PubMed=2465288).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K562/MTX-2
AC   CVCL_5144
DR   CLO; CLO_0050119
DR   BioSample; SAMN03472320
DR   RCB; RCB0474
DR   Wikidata; Q54899414
RX   PubMed=2465288;
CC   Population: Caucasian.
CC   Doubling time: 35.6 +- 2.6 hours (PubMed=2465288).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB0474
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   K562/MTX-3
AC   CVCL_F1X7
RX   PubMed=2465288;
CC   Population: Caucasian.
CC   Doubling time: 27.2 +- 4.2 hours (PubMed=2465288).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K562/MTX-4
AC   CVCL_F1X8
RX   PubMed=2465288;
CC   Population: Caucasian.
CC   Doubling time: 59.5 +- 1.3 hours (PubMed=2465288).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K562/MTX-5
AC   CVCL_F1X9
RX   PubMed=2465288;
CC   Population: Caucasian.
CC   Doubling time: 47.2 +- 3.4 hours (PubMed=2465288).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   K562/NFAT-luc
AC   CVCL_KS44
DR   Wikidata; Q54899415
RX   PubMed=16834536;
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NFAT response element (PubMed=16834536).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0009.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 19
//
ID   K562/NIL-50
AC   CVCL_4V51
DR   Wikidata; Q54899416
RX   PubMed=22712605;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   K562/R7
AC   CVCL_D573
SY   K-562/R7; RK562
DR   BTO; BTO_0005195
DR   ChEMBL-Cells; CHEMBL3833705
DR   PubChem_Cell_line; CVCL_D573
DR   Wikidata; Q54899417
RX   CelloPub=CLPUB00273;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   K562/Vin
AC   CVCL_5145
SY   K562/VCR; K562 H-1; H-1
DR   CLO; CLO_0050125
DR   ChEMBL-Cells; CHEMBL4295433
DR   ChEMBL-Targets; CHEMBL4296450
DR   PubChem_Cell_line; CVCL_5145
DR   RCB; RCB2111
DR   TKG; TKG 0212
DR   Wikidata; Q54899418
RX   PubMed=6580255;
RX   PubMed=6684716;
CC   Population: Caucasian.
CC   Doubling time: 24.1 +- 1.8 hours (PubMed=6580255).
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB2111; TKG=TKG 0212
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   K562/ZD1694.C
AC   CVCL_S663
SY   K562/ZD1694 x C
DR   Wikidata; Q54899419
RX   PubMed=8576277;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_5847; ICI D1694 (Tomudex; ZD1694).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   K562YO
AC   CVCL_0369
DR   MCCL; MCC:0000263
DR   Wikidata; Q54899422
RX   PubMed=7506674;
RX   PubMed=7534132;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   K56A/50
AC   CVCL_E9EW
DR   ABCD; ABCD_AW919
DR   DSHB; K56A-50
DR   MMRRC; MMRRC:065971-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K56A_50.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14936; Human CASK (Note=Also reacts with mouse, rat, zebrafish and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K57/1
AC   CVCL_E9EX
DR   ABCD; ABCD_AU841
DR   DSHB; K57-1
DR   MMRRC; MMRRC:065955-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K57_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZV8; Human KCND2 (Note=Also reacts with mouse, rat and C.elegans).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K58/35
AC   CVCL_E9DY
DR   ABCD; ABCD_AU892
RX   PubMed=10460258;
RX   PubMed=30667360;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35498; Human SCN1A (Note=Immunized with 1501-TEEQKKYYNAMKKLGSKK-1518. Also recognizes all other Na+ channel protein thus the name "Pan-Nav channel antibody" given to the mAB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   K6-2
AC   CVCL_DB44
DR   Wikidata; Q54899423
WW   Provider; Creative Diagnostics; CSC-H1080; https://www.creative-diagnostics.com/Anti-J5-EndoToxin-Core-Hybridoma-136717-197.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Escherichia coli J5 endotoxin core.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 5
//
ID   K6.1
AC   CVCL_A0AV
DR   Wikidata; Q108820619
RX   Patent=WO1994002016A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11085.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P28906; Human CD34.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   K60/73
AC   CVCL_E9EY
DR   ABCD; ABCD_AU900
DR   DSHB; K60-73
DR   MMRRC; MMRRC:065960-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K60_73.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JM59; Rat Kcnip2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K63
AC   CVCL_6D69
DR   Wikidata; Q54899424
RX   PubMed=21706466;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   K64/15
AC   CVCL_E9EZ
DR   ABCD; ABCD_AU842
DR   DSHB; K64-15
DR   MMRRC; MMRRC:065970-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K64_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62696; Rat Dlg1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K65/35
AC   CVCL_E9F0
DR   ABCD; ABCD_AU901
DR   DSHB; K65-35
DR   MMRRC; MMRRC:065975-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K65_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P97846; Rat Cntnap1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K66
AC   CVCL_G227
DR   CLO; CLO_0007063
DR   Wikidata; Q54899425
RX   Patent=US4851332;
RX   PubMed=2580800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8767.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   K66/38
AC   CVCL_E9F1
DR   ABCD; ABCD_AU843
DR   DSHB; K66-38
DR   MMRRC; MMRRC:065961-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K66_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JM47; Rat Kcnip3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K67/25
AC   CVCL_E9F2
DR   ABCD; ABCD_AU902
DR   DSHB; K67-25
DR   MMRRC; MMRRC:066001-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K67_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UHC6; Human CNTNAP2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K69/3
AC   CVCL_E9F3
DR   ABCD; ABCD_AU903
DR   DSHB; K69-3
DR   MMRRC; MMRRC:065965-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K69_3.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04775; Rat Scn2a (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K6H6/B5
AC   CVCL_2538
SY   K6H6-B5; K6H6B5
DR   BTO; BTO_0002208
DR   CLO; CLO_0007064
DR   CLDB; cl2994
DR   AddexBio; C0033002/4944
DR   ATCC; CRL-1823
DR   ECACC; 89101606
DR   Wikidata; Q54899426
RX   PubMed=1651789;
RX   PubMed=3084658;
RX   PubMed=7492749;
RX   PubMed=18514220;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of P3/NS1/1-Ag4.1 with malignant B-cells from a patient with nodular lymphoma (PubMed=3084658).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   K7 [Human thyroid carcinoma]
AC   CVCL_6307
DR   Cosmic; 1789445
DR   Wikidata; Q54899427
RX   PubMed=9054892;
RX   PubMed=10646882;
CC   Doubling time: 22 hours (PubMed=9054892).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   K7 [Mouse osteosarcoma]
AC   CVCL_W624
SY   K 7
DR   BTO; BTO_0006408
DR   Wikidata; Q54899428
RX   PubMed=3243385;
RX   PubMed=10841188;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_W628 ! K8 [Mouse osteosarcoma]
OI   CVCL_W625 ! K12 [Mouse osteosarcoma]
OI   CVCL_W626 ! K14
OI   CVCL_W627 ! K37
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   K7/45
AC   CVCL_E9F4
DR   ABCD; ABCD_AU844
DR   DSHB; K7-45
DR   MMRRC; MMRRC:065951-UCD
RX   PubMed=8938716;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K7_45.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19024; Rat Kcna5 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K72/8
AC   CVCL_E9F5
DR   ABCD; ABCD_AU845
DR   DSHB; K72-8
DR   MMRRC; MMRRC:065993-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K72_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UKL0; Human RCOR1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K73/20
AC   CVCL_E9F6
DR   ABCD; ABCD_AU904
DR   DSHB; K73-20
DR   MMRRC; MMRRC:065994-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K73_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63198; Rat Cntn1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K74/71
AC   CVCL_E9F7
DR   ABCD; ABCD_AU846
DR   DSHB; K74-71
DR   MMRRC; MMRRC:065964-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K74_71.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04774; Rat Scn1a (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K75/30
AC   CVCL_E9F8
DR   ABCD; ABCD_AU905
DR   DSHB; K75-30
DR   MMRRC; MMRRC:066417-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K75_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q62897; Rat Kcnd3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K75/41
AC   CVCL_E9F9
DR   ABCD; ABCD_AU847
DR   DSHB; K75-41
DR   MMRRC; MMRRC:065956-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K75_41.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62897; Rat Kcnd3 (Note=Also reacts with human, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K7701
AC   CVCL_C5ZB
DR   Wikidata; Q116049612
RX   PubMed=12409633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   K78/29
AC   CVCL_E9FA
DR   ABCD; ABCD_AU906
DR   DSHB; K78-29
DR   MMRRC; MMRRC:066318-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K78_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P70604; Rat Kcnn2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K7L
AC   CVCL_C8R5
DR   Wikidata; Q123032790
RX   PubMed=3491792;
CC   Characteristics: Initially had L1210-specific cytolytic activity but lost it after 99 days in culture. Continues to have L1210-specific tumor-growth-inhibitory activity (PubMed=3491792).
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   K7M2-pCI Neo
AC   CVCL_V454
DR   ATCC; CRL-2837
DR   Wikidata; Q54899431
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V455 ! K7M2-WT
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 14
//
ID   K7M2-WT
AC   CVCL_V455
SY   K7M2 wt; K7M2
DR   BTO; BTO_0006407
DR   ATCC; CRL-2836
DR   CCRID; 1101MOU-PUMC000820
DR   CCRID; 3101MOUTCM38
DR   CLS; 305188
DR   Wikidata; Q54899432
RX   PubMed=11315100;
RX   PubMed=17671136;
RX   PubMed=26320182;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W624 ! K7 [Mouse osteosarcoma]
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   K7M3
AC   CVCL_XG68
DR   Wikidata; Q94336003
RX   PubMed=17671136;
RX   PubMed=24136885;
CC   Characteristics: Established by intravenous injection of parent cell line into mice and then harvesting the lung metastases.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V455 ! K7M2-WT
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   K8 [Human melanoma]
AC   CVCL_EQ75
DR   GDSC; 1298162
DR   Wikidata; Q54899433
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 5
//
ID   K8 [Human thyroid carcinoma]
AC   CVCL_EI75
DR   Cosmic; 1789446
DR   Wikidata; Q54899434
RX   PubMed=10646882;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   K8 [Mouse hybridoma]
AC   CVCL_LH64
DR   Wikidata; Q54899435
RX   Patent=US4851332;
RX   PubMed=2580800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8765.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human choriocarcinoma tumor cell 68 kDa glycoprotein antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   K8 [Mouse osteosarcoma]
AC   CVCL_W628
SY   K 8
DR   Wikidata; Q54899436
RX   PubMed=3243385;
RX   PubMed=10841188;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_W624 ! K7 [Mouse osteosarcoma]
OI   CVCL_W625 ! K12 [Mouse osteosarcoma]
OI   CVCL_W626 ! K14
OI   CVCL_W627 ! K37
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   K8450B
AC   CVCL_C5ZC
DR   Wikidata; Q116049613
RX   PubMed=12409633;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P37231; Human PPARG (Note=Isoform 2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 3
//
ID   K8484
AC   CVCL_XD12
DR   Wikidata; Q94336044
RX   PubMed=19460966;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R270H:Pdx1-Cre (KPC).
ST   Source(s): CRUK Cambridge RICS
ST   Mouse STR 1-1: 10,16
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 18.3
ST   Mouse STR 5-5: 13,17
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 14,15
ST   Mouse STR 12-1: 18
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 12,16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   K87A/10
AC   CVCL_E9FB
DR   ABCD; ABCD_AU907
DR   DSHB; K87A-10
DR   MMRRC; MMRRC:065966-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K87A_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O88420; Rat Scn8a (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K88/64
AC   CVCL_E9FC
DR   ABCD; ABCD_AU908
DR   DSHB; K88-64
DR   MMRRC; MMRRC:066021-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K88_64.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NRL3; Human STRN4 (Note=Also rects with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K89/34
AC   CVCL_E9FD
DR   ABCD; ABCD_AU848
DR   DSHB; K89-34
DR   MMRRC; MMRRC:065953-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K89_34.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K89/41
AC   CVCL_E9DZ
DR   ABCD; ABCD_AW918
RX   PubMed=16566008;
RX   PubMed=37758930;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K8675
AC   CVCL_XD13
DR   Wikidata; Q94336048
RX   PubMed=19460966;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R270H:Pdx1-Cre (KPC).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   K9
AC   CVCL_A8XZ
DR   GEO; GSM4616528
DR   Wikidata; Q108820620
RX   PubMed=33798453;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   K9 iPSC #1
AC   CVCL_A8YA
SY   K9 iPSC no. 1; K9_1_iPS
DR   GEO; GSM4616525
DR   Wikidata; Q108820621
RX   PubMed=33798453;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A8XZ ! K9
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   K9 iPSC #2
AC   CVCL_A8YB
SY   K9 iPSC no. 2; K9_2_iPS
DR   GEO; GSM4616526
DR   Wikidata; Q108820622
RX   PubMed=33798453;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A8XZ ! K9
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   K9 iPSC #3
AC   CVCL_A8YC
SY   K9 iPSC no. 3; K9_3_iPS_P8
DR   GEO; GSM4616527
DR   Wikidata; Q108820623
RX   PubMed=33798453;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A8XZ ! K9
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   K9/40
AC   CVCL_E9FE
DR   ABCD; ABCD_AU849
DR   DSHB; K9-40
DR   MMRRC; MMRRC:065957-UCD
RX   PubMed=8938716;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K9_40.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P63144; Rat Kcnab1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K91/36
AC   CVCL_E9FF
DR   ABCD; ABCD_AU850
DR   DSHB; K91-36
DR   MMRRC; MMRRC:065974-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K91_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92558; Human WASF1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K96/7
AC   CVCL_E9FG
DR   ABCD; ABCD_AU909
DR   DSHB; K96-7
DR   MMRRC; MMRRC:065997-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/K96_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99784; Human OLFM1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   K9OSCC-Abby
AC   CVCL_IZ42
DR   Wikidata; Q54899437
RX   PubMed=24631063;
CC   Doubling time: 32.7 hours (PubMed=24631063).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Shih Tzu; VBO=VBO_0201223.
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   K9STS
AC   CVCL_A5JV
SY   STS
DR   Wikidata; Q107115525
RX   PubMed=7653891;
RX   PubMed=18562222;
CC   Doubling time: 35.04 +- 8.1 hours (PubMed=18562222).
DI   NCIt; C132276; Canine soft tissue sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 4
//
ID   K9TCC
AC   CVCL_DN18
SY   TCC
DR   GEO; GSM1974792
DR   Wikidata; Q54899438
RX   PubMed=7653891;
RX   PubMed=18562222;
RX   PubMed=26401343;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=29732388;
CC   Doubling time: 24.0 +- 0.7 hours (PubMed=18562222); 18 hours (PubMed=27257868).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Caution: Was indicated to be part of the FACC canine tumor cell line panel in early version of PubMed=27197945, but was later removed.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   K9TCC#1Lillie
AC   CVCL_1R35
DR   Wikidata; Q54899447
RX   PubMed=24964787;
RX   PubMed=29732388;
CC   Doubling time: 47.4 hours (PubMed=24964787).
CC   Derived from site: In situ; Urethra; UBERON=UBERON_0000057.
CC   Breed/subspecies: Pointer; VBO=VBO_0201029.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   K9TCC#2Dakota
AC   CVCL_1R36
DR   Wikidata; Q54899448
RX   PubMed=24964787;
RX   PubMed=29732388;
CC   Doubling time: 31.96 hours (PubMed=24964787).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Bichon Fries; VBO=VBO_0200163.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   K9TCC#4Molly
AC   CVCL_1R37
DR   Wikidata; Q54899449
RX   PubMed=24964787;
RX   PubMed=29732388;
CC   Doubling time: 44.69 hours (PubMed=24964787).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   K9TCC#5Lilly
AC   CVCL_1R38
DR   Wikidata; Q54899450
RX   PubMed=24964787;
CC   Doubling time: 48.3 hours (PubMed=24964787).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   K9TCC-PU-An
AC   CVCL_DN19
DR   Wikidata; Q54899439
RX   PubMed=26401343;
CC   Breed/subspecies: Scottish Terrier; VBO=VBO_0201198.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 5
//
ID   K9TCC-PU-AxA
AC   CVCL_DN20
SY   K9TCC-AxA
DR   Wikidata; Q54899440
RX   PubMed=18562222;
RX   PubMed=29732388;
CC   Doubling time: 23.5 +- 1.9 hours (PubMed=18562222).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_DN21 ! K9TCC-PU-AxC
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   K9TCC-PU-AxC
AC   CVCL_DN21
DR   Wikidata; Q54899441
RX   PubMed=18562222;
RX   PubMed=29732388;
CC   Doubling time: 36.2 +- 2.9 hours (PubMed=18562222).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_DN20 ! K9TCC-PU-AxA
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   K9TCC-PU-In
AC   CVCL_DN22
SY   K9TCC-In
DR   Wikidata; Q54899442
RX   PubMed=18562222;
RX   PubMed=26401343;
RX   PubMed=29732388;
CC   Doubling time: 41.2 +- 12.2 hours (PubMed=18562222).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   K9TCC-PU-Mx
AC   CVCL_DN23
DR   Wikidata; Q54899443
RX   PubMed=18562222;
RX   PubMed=26401343;
RX   PubMed=29732388;
CC   Doubling time: 23.5 +- 1.3 hours (PubMed=18562222).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   K9TCC-PU-Nk
AC   CVCL_DN24
SY   K9TCC-NK
DR   Wikidata; Q54899444
RX   PubMed=18562222;
RX   PubMed=29732388;
CC   Doubling time: 58.4 +- 2.3 hours (PubMed=18562222).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   K9TCC-PU-Pu
AC   CVCL_DN25
DR   Wikidata; Q54899445
RX   PubMed=18562222;
CC   Doubling time: 51.8 +- 1.0 hours (PubMed=18562222).
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   K9TCC-PU-Sh
AC   CVCL_DN26
SY   K9TCC-Sh
DR   Wikidata; Q54899446
RX   PubMed=18562222;
RX   PubMed=26401343;
RX   PubMed=29732388;
CC   Doubling time: 29.1 +- 3.4 hours (PubMed=18562222).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Collie; VBO=VBO_0200375.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   Ka Dan
AC   CVCL_U780
DR   ATCC; CRL-1137
DR   Wikidata; Q54899451
CC   Discontinued: ATCC; CRL-1137; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Ka-LCL
AC   CVCL_6D79
DR   Wikidata; Q54899452
RX   PubMed=8127151;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KA-S1
AC   CVCL_8363
DR   JCRB; JCRB1013
DR   Wikidata; Q54899453
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse.
CC   Discontinued: JCRB; JCRB1013; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   KA(DF)
AC   CVCL_ZX86
SY   DF(KA); KA(Dermal Fibroblast)
DR   GEO; GSM2185129
DR   Wikidata; Q102114348
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX85 ! KA(LCL)
OI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KA(LCL)
AC   CVCL_ZX85
SY   LCL(KA)
DR   GEO; GSM2185120
DR   Wikidata; Q102114349
RX   PubMed=27716287;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX86 ! KA(DF)
OI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   KA(T-cell)
AC   CVCL_ZX87
SY   T-cell(KA)
DR   GEO; GSM2185126
DR   Wikidata; Q102114350
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX86 ! KA(DF)
OI   CVCL_ZX85 ! KA(LCL)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KA10
AC   CVCL_E5S1
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P68617; Vaccinia virus protein OPG161 (A33R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KA11
AC   CVCL_RH49
SY   iPS_KA11; DF(KA)-derived iPSC, clone #11
DR   GEO; GSM2038539
DR   GEO; GSM2038561
DR   GEO; GSM2185131
DR   SKIP; SKIP000825
DR   Wikidata; Q54899455
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX86 ! KA(DF)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   KA23
AC   CVCL_RH50
SY   iPS_KA23
DR   GEO; GSM2038540
DR   GEO; GSM2038562
DR   SKIP; SKIP000826
DR   Wikidata; Q54899456
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX86 ! KA(DF)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   KA31
AC   CVCL_0A31
SY   KA 31; KA-31
DR   Wikidata; Q54899457
RX   PubMed=6245299;
RX   PubMed=6409394;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4350 ! K-BALB
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   KAB6
AC   CVCL_E5VZ
RX   PubMed=24444128;
WW   Info; EGTC; -; https://egtc.jp/celllines/KAB6%20(Albino%20B6)
CC   Characteristics: Feeder dependent (PubMed=24444128).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: B6(Cg)-Tyrc-2J/JCard.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KAH-R
AC   CVCL_XH14
DR   CCLV; CCLV-RIE 0066
DR   Wikidata; Q94336240
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   KAI3
AC   CVCL_2969
DR   BioSample; SAMN03472803
DR   Cosmic; 1542077
DR   Cosmic; 2390216
DR   GEO; GSM471999
DR   JCRB; IFO50518
DR   Wikidata; Q54899458
RX   PubMed=10193407;
RX   PubMed=19194464;
RX   PubMed=21052088;
RX   PubMed=25586472;
RX   PubMed=29892436;
RX   PubMed=36094314;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: 3.5 days (Note=Lot 03082007), ~76 hours (Note=Lot 07312015) (JCRB=IFO50518).
CC   Karyotypic information: 46,XY,add(6)(p23),der(6)add(6)(p23)add(6)(q21) (PubMed=10193407).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from a donor with severe hypersensitivity to mosquito bite (HMB) (PubMed=10193407).
CC   Misspelling: KA13; Cosmic=2390216.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
ST   Source(s): JCRB=IFO50518
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   KAIMRC1
AC   CVCL_RW19
SY   King Abdullah International Medical Research Center 1
DR   Wikidata; Q54899460
RX   PubMed=29187162;
CC   Population: Arab; Saudi Arabian.
CC   Characteristics: ER-positive, PR-positive and ERBB2-negative.
CC   Doubling time: ~24 hours (PubMed=29187162).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   KAIMRC2
AC   CVCL_B7K2
SY   King Abdullah International Medical Research Center 2
DR   Wikidata; Q112929939
RX   PubMed=34073849;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Arab; Saudi Arabian.
CC   Doubling time: ~16 hours (PubMed=34073849).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   KAIMRCi001-A
AC   CVCL_C0CR
DR   hPSCreg; KAIMRCi001-A
DR   Wikidata; Q112929940
RX   PubMed=34592601;
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   KAIMRCi002-A
AC   CVCL_D0H0
SY   HLA-iPSC#1; HLA-universal iPSC#1
DR   BioSamples; SAMEA113570217
DR   hPSCreg; KAIMRCi002-A
DR   Wikidata; Q123032791
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H1 ! KAIMRCi002-B
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   KAIMRCi002-B
AC   CVCL_D0H1
SY   HLA-iPSC#2; HLA-universal iPSC#2
DR   BioSamples; SAMEA114383985
DR   hPSCreg; KAIMRCi002-B
DR   Wikidata; Q123032792
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H0 ! KAIMRCi002-A
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   KAIMRCi003-A
AC   CVCL_D0H2
SY   KAIMRCi003A; DRVT-iPSC#1
DR   BioSamples; SAMEA114382631
DR   hPSCreg; KAIMRCi003-A
DR   Wikidata; Q123032793
RX   PubMed=38110787;
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:2309; CPLX1; Simple; p.Glu2Lys (c.4G>A); Zygosity=Homozygous (PubMed=38110787).
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ser1111_Glu1115del (c.3332_3346delCAAGCTCCTCAGAGT); Zygosity=Heterozygous (PubMed=38110787).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
ST   Source(s): PubMed=38110787
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 14.2
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3020; Seizure disorder
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H3 ! KAIMRCi003-B
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   KAIMRCi003-B
AC   CVCL_D0H3
SY   KAIMRCi003B; DRVT-iPSC#2
DR   BioSamples; SAMEA114382885
DR   hPSCreg; KAIMRCi003-B
DR   Wikidata; Q123032794
RX   PubMed=38110787;
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:2309; CPLX1; Simple; p.Glu2Lys (c.4G>A); Zygosity=Homozygous (PubMed=38110787).
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ser1111_Glu1115del (c.3332_3346delCAAGCTCCTCAGAGT); Zygosity=Heterozygous (PubMed=38110787).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
ST   Source(s): PubMed=38110787
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 14.2
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3020; Seizure disorder
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H2 ! KAIMRCi003-A
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   KAIMRCi004-A
AC   CVCL_E4C4
SY   BTBGD-iPSC#1
DR   BioSamples; SAMEA115112560
DR   hPSCreg; KAIMRCi004-A
RX   PubMed=38980565;
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:16266; SLC19A3; Simple; p.Thr422Ala (c.1264A>G); ClinVar=VCV000004563; Zygosity=Homozygous (PubMed=38980565).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
ST   Source(s): PubMed=38980565
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D18S51: 12,13
ST   D19S433: 13.2,14.2
ST   D21S11: 29,32.2
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 11
ST   FGA: 18,20
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C212885; Biotin-thiamine-responsive basal ganglia disease
DI   ORDO; Orphanet_65284; Biotin-thiamine-responsive basal ganglia disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4C5 ! KAIMRCi004-B
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KAIMRCi004-B
AC   CVCL_E4C5
SY   BTBGD-iPSC#2
DR   BioSamples; SAMEA115112566
DR   hPSCreg; KAIMRCi004-B
RX   PubMed=38980565;
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:16266; SLC19A3; Simple; p.Thr422Ala (c.1264A>G); ClinVar=VCV000004563; Zygosity=Homozygous (PubMed=38980565).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
ST   Source(s): PubMed=38980565
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D18S51: 12,13
ST   D19S433: 13.2,14.2
ST   D21S11: 29,32.2
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 11
ST   FGA: 18,20
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C212885; Biotin-thiamine-responsive basal ganglia disease
DI   ORDO; Orphanet_65284; Biotin-thiamine-responsive basal ganglia disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4C4 ! KAIMRCi004-A
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KAISTe001-A
AC   CVCL_YS97
DR   BioSamples; SAMEA6240745
DR   hPSCreg; KAISTe001-A
DR   Wikidata; Q94336260
CC   From: Korea Advanced Institute of Science and Technology; Daejeon; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   KAK-1
AC   CVCL_6301
SY   KAK1; KAK
DR   BioSample; SAMN03151788
DR   cancercelllines; CVCL_6301
DR   Cosmic; 886555
DR   Cosmic; 888090
DR   Cosmic; 913245
DR   Wikidata; Q54899461
RX   PubMed=9177396;
RX   PubMed=11439348;
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland follicular carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00220.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   KAL-1
AC   CVCL_QY03
DR   Wikidata; Q54899462
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1913659;
RX   PubMed=8320183;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=1913659).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   KAL-R
AC   CVCL_XH15
DR   CCLV; CCLV-RIE 0064
DR   Wikidata; Q94336279
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   KALS-1
AC   CVCL_1323
SY   KALS1
DR   CLO; CLO_0009892
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 625
DR   BioSample; SAMN03470951
DR   BioSample; SAMN10987840
DR   cancercelllines; CVCL_1323
DR   Cell_Model_Passport; SIDM00613
DR   CGH-DB; 142-1
DR   ChEMBL-Cells; CHEMBL3308235
DR   ChEMBL-Targets; CHEMBL2366155
DR   Cosmic; 687572
DR   Cosmic; 907271
DR   Cosmic; 2367530
DR   Cosmic; 2516020
DR   Cosmic-CLP; 907271
DR   DepMap; ACH-000231
DR   EGA; EGAS00001000978
DR   GDSC; 907271
DR   GEO; GSM887194
DR   GEO; GSM888267
DR   GEO; GSM1669972
DR   IARC_TP53; 21426
DR   JCRB; IFO50434
DR   LiGeA; CCLE_316
DR   LINCS_LDP; LCL-1380
DR   PharmacoDB; KALS1_726_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1323
DR   PubChem_Cell_line; CVCL_1323
DR   Wikidata; Q54899463
RX   CelloPub=CLPUB00062;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 90 hours (PubMed=25984343); ~38 hours (Note=Lot 09142016) (JCRB=IFO50434).
CC   HLA typing: A*24:02,26:01; B*51:01,51:01; C*01:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (Cosmic-CLP=907271; DepMap=ACH-000231).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Homozygous (Cosmic-CLP=907271; DepMap=ACH-000231).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.68%; Native American=0%; East Asian, North=78.93%; East Asian, South=16.7%; South Asian=1.01%; European, North=0%; European, South=1.68% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=907271; JCRB=IFO50434; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 10
ST   D16S539: 11,13
ST   D18S51: 14,19
ST   D19S433: 13,15.2
ST   D21S11: 29,32
ST   D2S1338: 18,22
ST   D3S1358: 16,18
ST   D5S818: 9
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 9,10
ST   Penta E: 12,15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   KaMi
AC   CVCL_W532
DR   Wikidata; Q54899464
RX   PubMed=1279943;
CC   Population: Japanese.
CC   Doubling time: 20.6 hours (PubMed=1279943).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   Kamoti
AC   CVCL_IU58
DR   Wikidata; Q54899465
RX   PubMed=170370;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 7
//
ID   Kampong
AC   CVCL_6F59
DR   Wikidata; Q54899466
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   Kan-BL
AC   CVCL_7198
SY   Kan
DR   Wikidata; Q54899467
RX   PubMed=9882297;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   KAN-ES
AC   CVCL_1F87
DR   Wikidata; Q54899468
RX   PubMed=10795747;
CC   Population: Japanese.
CC   Doubling time: 35.1 hours (Note=At 55th passage) (PubMed=10795747).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 8
//
ID   KAN-R
AC   CVCL_RW68
DR   CCLV; CCLV-RIE 1000
DR   Wikidata; Q54899469
RX   PubMed=24973239;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=413582; ! Notamacropus parma (Parma wallaby)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   KAO
AC   CVCL_W455
SY   Kao
DR   Cosmic; 1093167
DR   Wikidata; Q54899470
RX   PubMed=9247632;
RX   PubMed=12966428;
RX   PubMed=15150091;
CC   Population: Japanese.
CC   Doubling time: ~34 hours (PubMed=9247632).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=15150091).
CC   Omics: Transcriptomics; Microarray.
CC   Anecdotal: Cell line name derived from the first name (Kaori) of the patient from which it was established.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 15
//
ID   Kap 13
AC   CVCL_LK73
DR   Wikidata; Q54899471
RX   PubMed=4346014;
CC   Population: African; Ugandan.
DI   NCIt; C35874; Endemic African Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   Kap 16
AC   CVCL_LK74
DR   Wikidata; Q54899472
RX   PubMed=4346014;
CC   Population: African; Ugandan.
DI   NCIt; C35874; Endemic African Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   Kap 19
AC   CVCL_LK75
DR   Wikidata; Q54899476
RX   PubMed=4346014;
CC   Population: African; Ugandan.
DI   NCIt; C35874; Endemic African Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   Kap 22
AC   CVCL_LK76
DR   Wikidata; Q54899477
RX   PubMed=4346014;
CC   Population: African; Congolian.
DI   NCIt; C35874; Endemic African Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   Kap 9
AC   CVCL_LK77
DR   Wikidata; Q54899478
RX   PubMed=4346014;
CC   Population: African; Congolian.
DI   NCIt; C35874; Endemic African Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   KaRi
AC   CVCL_LC72
DR   Wikidata; Q54899479
RX   PubMed=23563200;
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   KARO1
AC   CVCL_WR09
SY   KIe034-A
DR   BioSamples; SAMEA5883077
DR   hPSCreg; KIe034-A
DR   Wikidata; Q94339418
RX   PubMed=32339905;
CC   Group: Clinical grade pluripotent cell line.
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   Karpas-1106A
AC   CVCL_QY35
DR   Wikidata; Q54899480
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7949096;
CC   Population: Caucasian.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9280; Primary mediastinal (thymic) large B-cell lymphoma
DI   ORDO; Orphanet_98838; Primary mediastinal large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1821 ! Karpas-1106P
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 7
//
ID   Karpas-1106P
AC   CVCL_1821
SY   Karpas-1106p; KARPAS-1106P; Karpas 1106P; KARPAS 1106P; KARPAS1106P; Karpas1106P; Karpas-1106; Karpas 1106; Karpas1106; K1106
DR   EFO; EFO_0006606
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470811
DR   cancercelllines; CVCL_1821
DR   Cell_Model_Passport; SIDM01011
DR   ChEMBL-Cells; CHEMBL4523588
DR   ChEMBL-Targets; CHEMBL4523591
DR   Cosmic; 1013890
DR   Cosmic; 1278829
DR   Cosmic; 1289975
DR   Cosmic; 2276324
DR   Cosmic; 2297035
DR   Cosmic; 2437271
DR   Cosmic; 2479248
DR   Cosmic-CLP; 1327773
DR   DepMap; ACH-002254
DR   DSMZ; ACC-545
DR   DSMZCellDive; ACC-545
DR   ECACC; 06072607
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1327773
DR   GEO; GSM119503
DR   GEO; GSM157143
DR   GEO; GSM380128
DR   GEO; GSM552445
DR   GEO; GSM1374584
DR   GEO; GSM1374585
DR   GEO; GSM1669973
DR   GEO; GSM1897961
DR   Lonza; 1123
DR   PharmacoDB; KARPAS1106P_727_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1821
DR   PubChem_Cell_line; CVCL_1821
DR   Wikidata; Q54899481
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7849311;
RX   PubMed=7949096;
RX   PubMed=9724100;
RX   PubMed=16960149;
RX   PubMed=19278952;
RX   PubMed=20628145;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-1106p-human-b-cell-non-hodgkins-lymphoma-cell-line/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~60-100 hours (ECACC=06072607).
CC   HLA typing: A*03:01,24:02; B*35:01,51:01; C*04:01,16:02; DQA1*03:02,05:01; DQB1*03:02,03:02; DRB1*03:17,03:17 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:16841; LITAF; Zygosity=Homozygous (PubMed=16960149).
CC   Sequence variation: Gene deletion; HGNC; HGNC:19383; SOCS1; Zygosity=Homozygous (PubMed=16960149).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.68%; Native American=0.48%; East Asian, North=0.25%; East Asian, South=1.18%; South Asian=11.86%; European, North=19.43%; European, South=65.12% (PubMed=30894373).
CC   Discontinued: DSMZ; ACC-545; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Cosmic-CLP=1327773; DSMZ=ACC-545; ECACC=06072607; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 21
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 8,14
ST   D7S820: 9,13
ST   D8S1179: 8,15
ST   FGA: 21,22
ST   Penta D: 8,11
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 18,20
DI   NCIt; C9280; Primary mediastinal (thymic) large B-cell lymphoma
DI   ORDO; Orphanet_98838; Primary mediastinal large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY35 ! Karpas-1106A
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 36
//
ID   Karpas-111
AC   CVCL_UM19
SY   Karpas 111
DR   Wikidata; Q94336428
RX   DOI=10.1007/978-1-4613-2823-0_29;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Karpas-117
AC   CVCL_UM20
SY   Karpas 117
DR   Wikidata; Q94336431
RX   DOI=10.1007/978-1-4613-2823-0_29;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Karpas-118
AC   CVCL_UM21
SY   Karpas 118
DR   Wikidata; Q94336433
RX   DOI=10.1007/978-1-4613-2823-0_29;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Karpas-120
AC   CVCL_9Y63
SY   Karpas 120; Line 120
DR   Wikidata; Q54899482
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   DOI=10.1016/0145-2126(77)90063-7;
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   Karpas-1272
AC   CVCL_9554
SY   Karpas 1272; Karpas1272
DR   cancercelllines; CVCL_9554
DR   Cosmic; 720772
DR   Wikidata; Q54899483
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=15621787;
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-1272-human-myeloma-cell-line/
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (PubMed=11157491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   Karpas-160
AC   CVCL_QZ00
SY   Karpas 160; K160
DR   Wikidata; Q54899484
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   PubMed=300025;
RX   PubMed=412508;
RX   PubMed=1591220;
RX   PubMed=2784005;
CC   Characteristics: Highly cytotoxic (PubMed=300025).
CC   Characteristics: Produces lymphotoxin-alpha (PubMed=2784005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   Karpas-160b
AC   CVCL_QZ01
SY   Karpas 160b; K160b; 160b
DR   Wikidata; Q54899485
RX   PubMed=1591220;
RX   PubMed=2784005;
CC   Characteristics: Produces lymphotoxin-alpha (PubMed=2784005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QZ00 ! Karpas-160
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Karpas-1718
AC   CVCL_2539
SY   KARPAS-1718; Karpas 1718; KARPAS 1718; K1718
DR   cancercelllines; CVCL_2539
DR   Cosmic; 1291155
DR   Cosmic; 2297034
DR   DepMap; ACH-001533
DR   ECACC; 08072401
DR   GEO; GSM115991
DR   GEO; GSM866164
DR   GEO; GSM1035343
DR   GEO; GSM1035344
DR   Progenetix; CVCL_2539
DR   Wikidata; Q54899486
DR   Ximbio; 152423
RX   PubMed=15126345;
RX   PubMed=16960149;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Misspelling: Kapas 1718; Cosmic=1291155.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=08072401
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4663; Splenic marginal zone lymphoma
DI   ORDO; Orphanet_86854; Splenic marginal zone lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Karpas-181
AC   CVCL_QZ02
SY   Karpas 181
DR   Wikidata; Q54899487
RX   PubMed=1591220;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Karpas-190
AC   CVCL_RM21
SY   Karpas 190; Line 190
DR   Wikidata; Q54899488
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=199225;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3167; Acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Karpas-230
AC   CVCL_7705
SY   Karpas 230; KARPAS 230; Line 230
DR   Wikidata; Q54899489
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   PubMed=272914;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Karpas-231
AC   CVCL_1822
SY   KARPAS-231; Karpas 231; KARPAS 231; KARPAS231; K231
DR   CLO; CLO_0037175
DR   EFO; EFO_0005389
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473540
DR   cancercelllines; CVCL_1822
DR   Cell_Model_Passport; SIDM01017
DR   Cosmic; 1281371
DR   Cosmic; 2297008
DR   Cosmic-CLP; 1327774
DR   DepMap; ACH-002255
DR   DSMZ; ACC-562
DR   DSMZCellDive; ACC-562
DR   ECACC; 06120601
DR   EGA; EGAS00001000978
DR   GDSC; 1327774
DR   GEO; GSM115820
DR   GEO; GSM1035318
DR   GEO; GSM1374586
DR   GEO; GSM1374587
DR   GEO; GSM1669974
DR   LINCS_LDP; LCL-1087
DR   PharmacoDB; KARPAS231_728_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1822
DR   Wikidata; Q54899491
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7849311;
RX   PubMed=8324225;
RX   PubMed=8574789;
RX   PubMed=8618432;
RX   PubMed=16960149;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-562); ~60 hours (ECACC=06120601).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1001; BCL6 + HGNC; HGNC:9211; POU2AF1; Name(s)=POU2AF1-BCL6, BOB1-LAZ3 (PubMed=8574789; PubMed=8618432).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.09%; East Asian, South=0%; South Asian=0.51%; European, North=68.07%; European, South=30.33% (PubMed=30894373).
CC   Miscellaneous: Originally assigned to be from a B-cell acute lymphoblastic leukemia (ALL-L3).
CC   Discontinued: DSMZ; ACC-562; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1327774; DSMZ=ACC-562
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 27,31.2
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,12
ST   FGA: 20
ST   Penta D: 12,14
ST   Penta E: 7,14
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   Karpas-241
AC   CVCL_7706
SY   Karpas 241; KARPAS 241; Line 241
DR   Wikidata; Q54899492
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   DOI=10.1016/0739-6260(87)90032-3;
RX   PubMed=6966506;
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-241-human-monoblastic-cell-line/
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   Karpas-247
AC   CVCL_0T65
SY   Karpas 247
DR   Wikidata; Q54899493
RX   PubMed=7849311;
DI   NCIt; C4753; B-cell prolymphocytic leukemia
DI   ORDO; Orphanet_86852; B-cell prolymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 4
//
ID   Karpas-25
AC   CVCL_2540
SY   KARPAS-25; Karpas 25; KARPAS 25; Karpas25
DR   ECACC; 06072601
DR   Wikidata; Q54899494
DR   Ximbio; 152420
RX   CelloPub=CLPUB00604;
RX   PubMed=10936422;
RX   PubMed=15621787;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/
CC   Doubling time: ~30 hours (ECACC=06072601; Ximbio=152420).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   Karpas-299
AC   CVCL_1324
SY   KARPAS-299; Karpas 299; KARPAS 299; Karpas299; KARPAS299; K299
DR   BTO; BTO_0002829
DR   CLO; CLO_0007065
DR   EFO; EFO_0005390
DR   CLDB; cl2995
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 624
DR   BioSample; SAMN03473348
DR   BioSample; SAMN10988031
DR   cancercelllines; CVCL_1324
DR   Cell_Model_Passport; SIDM01010
DR   ChEMBL-Cells; CHEMBL3308327
DR   ChEMBL-Targets; CHEMBL2366156
DR   Cosmic; 850199
DR   Cosmic; 907273
DR   Cosmic; 1086364
DR   Cosmic; 1086752
DR   Cosmic; 1509203
DR   Cosmic; 1995466
DR   Cosmic; 2674498
DR   Cosmic-CLP; 907273
DR   DepMap; ACH-000053
DR   DSMZ; ACC-31
DR   DSMZCellDive; ACC-31
DR   ECACC; 06072604
DR   EGA; EGAS00001000978
DR   GDSC; 907273
DR   GEO; GSM887195
DR   GEO; GSM888268
DR   GEO; GSM1217153
DR   GEO; GSM1669975
DR   IARC_TP53; 21427
DR   LiGeA; CCLE_563
DR   LINCS_LDP; LCL-1117
DR   Lonza; 18
DR   PharmacoDB; KARPAS299_729_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1324
DR   PubChem_Cell_line; CVCL_1324
DR   Wikidata; Q54899495
DR   Ximbio; 152418
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3260522;
RX   PubMed=8558920;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=11021758;
RX   PubMed=11494142;
RX   PubMed=15356658;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=20922763;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=26657151;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28356514;
RX   PubMed=29899875;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/karpas-299-xenograft-model/
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=20922763); ~30 hours (ECACC=06072604).
CC   HLA typing: A*03:01,11:01; B*07:02,35:01; C*04:01,07:02; DQA1*01:02,01:02; DQB1*05:01,06:13; DRB1*01:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=26657151; PubMed=29899875).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (Cosmic-CLP=907273).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.22%; Native American=0.18%; East Asian, North=0%; East Asian, South=0%; South Asian=1.17%; European, North=67.06%; European, South=31.36% (PubMed=30894373).
CC   Misspelling: Karpass299; PubMed=28356514.
CC   Discontinued: DSMZ; ACC-31; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=907273; COG; DSMZ=ACC-31; ECACC=06072604; PubMed=20922763
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 16,18
ST   D19S433: 14,15.2 (COG; PubMed=20922763)
ST   D19S433: 14,16 (DSMZ=ACC-31)
ST   D21S11: 27,29
ST   D2S1338: 16,17
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 21,22
ST   Penta D: 10,14
ST   Penta E: 12,16
ST   TH01: 7,8.3 (COG; ECACC=06072604; PubMed=20922763)
ST   TH01: 7,9 (Cosmic-CLP=907273; DSMZ=ACC-31)
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   Karpas-299-CR06
AC   CVCL_V404
SY   KARPAS-299-CR06; K299CR06
DR   cancercelllines; CVCL_V404
DR   Cosmic; 1849569
DR   Wikidata; Q54899496
RX   PubMed=23239810;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1324 ! Karpas-299
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   Karpas-330
AC   CVCL_E9Y5
SY   Karpas 330
RX   PubMed=6932956;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9Y6 ! Wien 330
SX   Male
AG   7-8Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Karpas-353
AC   CVCL_9553
SY   KARPAS-353; Karpas 353; KARPAS 353; K353
DR   cancercelllines; CVCL_9553
DR   Cosmic; 2297005
DR   GEO; GSM119483
DR   Progenetix; CVCL_9553
DR   Wikidata; Q54899497
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7849311;
RX   PubMed=8324225;
RX   PubMed=16960149;
RX   PubMed=26727417;
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-353-human-b-cell-leukaemia-cell-line/
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Originally assigned to be from a B-cell acute lymphoblastic leukemia (ALL-L2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   Karpas-384
AC   CVCL_2541
SY   Karpas 384; KARPAS 384; KARPAS384
DR   cancercelllines; CVCL_2541
DR   Cell_Model_Passport; SIDM01737
DR   DepMap; ACH-001097
DR   ECACC; 06120602
DR   Wikidata; Q54899498
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7849311;
RX   PubMed=8391614;
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-384-human-t-cell-non-hodgkins-lymphoma-cell-line/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~60 hours (ECACC=06120602).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (DepMap=ACH-001097).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Karpas-417
AC   CVCL_2542
SY   Karpas 417; KARPAS 417; Karpas417
DR   ECACC; 06100302
DR   Wikidata; Q54899499
DR   Ximbio; 152421
RX   CelloPub=CLPUB00604;
RX   PubMed=15621787;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-417-human-myeloma-cell-line/
CC   Doubling time: ~60 hours (ECACC=06100302; Ximbio=152421).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   Karpas-422
AC   CVCL_1325
SY   KARPAS-422; Karpas 422; KARPAS 422; Karpas422; KARPAS422; K422
DR   BTO; BTO_0004981
DR   CLO; CLO_0007066
DR   EFO; EFO_0005719
DR   CLDB; cl2996
DR   CLDB; cl4975
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471099
DR   BioSample; SAMN10988506
DR   cancercelllines; CVCL_1325
DR   Cell_Model_Passport; SIDM01008
DR   ChEMBL-Cells; CHEMBL3308328
DR   ChEMBL-Targets; CHEMBL2366368
DR   Cosmic; 907274
DR   Cosmic; 1086338
DR   Cosmic; 1329088
DR   Cosmic; 1629930
DR   Cosmic; 1714156
DR   Cosmic; 1945182
DR   Cosmic; 1995467
DR   Cosmic; 2276323
DR   Cosmic; 2297003
DR   Cosmic; 2361372
DR   Cosmic; 2437320
DR   Cosmic-CLP; 907274
DR   DepMap; ACH-000315
DR   DSMZ; ACC-32
DR   DSMZCellDive; ACC-32
DR   ECACC; 06101702
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS171YVY
DR   ENCODE; ENCBS301UOD
DR   ENCODE; ENCBS530UDH
DR   ENCODE; ENCBS850UIV
DR   ENCODE; ENCBS869AAA
DR   ENCODE; ENCBS870AAA
DR   ENCODE; ENCBS992KXS
DR   GDSC; 907274
DR   GEO; GSM115821
DR   GEO; GSM201346
DR   GEO; GSM380129
DR   GEO; GSM552444
DR   GEO; GSM907518
DR   GEO; GSM1035313
DR   GEO; GSM1059807
DR   GEO; GSM1374588
DR   GEO; GSM1669976
DR   GEO; GSM3150249
DR   IARC_TP53; 27172
DR   ICLC; HTL99023
DR   LiGeA; CCLE_680
DR   LINCS_LDP; LCL-1120
DR   PharmacoDB; KARPAS422_730_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1325
DR   PubChem_Cell_line; CVCL_1325
DR   Wikidata; Q54899500
DR   Ximbio; 152419
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=2297573;
RX   PubMed=7849311;
RX   PubMed=8547074;
RX   PubMed=8558920;
RX   PubMed=9738977;
RX   PubMed=12169673;
RX   PubMed=16960149;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20164919;
RX   PubMed=20628145;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=23699601;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/karpas-422/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-422-human-b-cell-non-hodgkins-lymphoma-cell-line/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Quite popular cell line because of its resistance to chemotherapy.
CC   Doubling time: ~60-90 hours (ECACC=06101702; Ximbio=152419).
CC   HLA typing: B*56/73,56/39; DQA1*03:02,03:02; DRB1*15:01,04:05 (PubMed=25960936).
CC   HLA typing: A*02:01,03:01; B*07:02,27:05; C*04:01,07:02; DQA1*01:02,03:02; DQB1*03:01,05:02; DRB1*04:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gln2176fs*48 (c.6527_6528delAG); Zygosity=Heterozygous (Cosmic-CLP=907274; DepMap=ACH-000315).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (Cosmic-CLP=907274; DepMap=ACH-000315).
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.49%; East Asian, North=0%; East Asian, South=0%; South Asian=0.34%; European, North=71.53%; European, South=27.64% (PubMed=30894373).
CC   Misspelling: Karpass422; PubMed=23292937.
CC   Discontinued: DSMZ; ACC-32; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=907274; DSMZ=ACC-32; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 12,14
ST   D19S433: 14,16
ST   D21S11: 29 (DSMZ=ACC-32)
ST   D21S11: 29,32.2 (PubMed=25877200)
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 11,15
ST   FGA: 23,27
ST   Penta D: 9,12
ST   Penta E: 7,17
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Karpas-45
AC   CVCL_1326
SY   KARPAS-45; Karpas 45; KARPAS 45; KARPAS45; K45; T-45; T45; Line 45
DR   CLO; CLO_0007067
DR   CLDB; cl35
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473409
DR   cancercelllines; CVCL_1326
DR   Cell_Model_Passport; SIDM01007
DR   ChEMBL-Cells; CHEMBL3308305
DR   ChEMBL-Targets; CHEMBL2366305
DR   Cosmic; 907272
DR   Cosmic; 913413
DR   Cosmic; 1012075
DR   Cosmic; 1151781
DR   Cosmic; 1175130
DR   Cosmic; 1191704
DR   Cosmic; 1281370
DR   Cosmic; 1330505
DR   Cosmic; 1524799
DR   Cosmic; 1664523
DR   Cosmic; 1760525
DR   Cosmic; 2165714
DR   Cosmic; 2391812
DR   Cosmic; 2602917
DR   Cosmic-CLP; 907272
DR   DepMap; ACH-002256
DR   DSMZ; ACC-105
DR   DSMZCellDive; ACC-105
DR   ECACC; 06072602
DR   EGA; EGAS00001000978
DR   GDSC; 907272
DR   GEO; GSM1669977
DR   GEO; GSM5137719
DR   IARC_TP53; 27173
DR   LINCS_LDP; LCL-1015
DR   NCBI_Iran; C180
DR   PharmacoDB; KARPAS45_731_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1326
DR   Wikidata; Q54899501
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   DOI=10.1016/0145-2126(77)90063-7;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3264071;
RX   PubMed=9933131;
RX   PubMed=14671638;
RX   PubMed=15472075;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22675565;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/additionalcells/karpas-45/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 50-100 hours (ECACC=06072602).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7139; FOXO4 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-FOXO4, MLL-MLLT7, MLL-AFX1 (PubMed=14671638; PubMed=15843827).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Val2194Ala (c.6581T>C); ClinVar=VCV000565658; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Ala586Gly (c.1757C>G); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:3495; ETV6; Simple; p.His328Tyr (c.982C>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:3689; FGFR2; Simple; p.Met584Arg (c.1751T>G) (p.Met585Arg, c.1754T>G); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Arg962His (c.2885G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp131Asn (c.391G>A); ClinVar=VCV000409719; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Ala48Thr (c.142G>A); ClinVar=VCV000454188; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Glu157Gly (c.470A>G); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Gly221Val (c.662G>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp1852Asn (c.5554G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Val2045Ile (c.6133G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:8804; PDGFRB; Simple; p.His277Gln (c.831C>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Asn879Ser (c.2636A>G); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Asn288Lys (c.864C>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272; DepMap=ACH-002256).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg394Gln (c.1181G>A) (p.Arg467Gln, c.1400G>A); ClinVar=VCV000419332; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907272).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.06%; Native American=0.47%; East Asian, North=0.03%; East Asian, South=0%; South Asian=2.75%; European, North=68.54%; European, South=28.16% (PubMed=30894373).
CC   Discontinued: DSMZ; ACC-105; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=907272; DSMZ=ACC-105
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 9,14
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 17,26
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,15
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 5,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Karpas-620
AC   CVCL_1823
SY   KARPAS-620; Karpas 620; KARPAS 620; Karpas620; KARPAS620; K620
DR   CLO; CLO_0037176
DR   EFO; EFO_0006449
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-1088
DR   BioSample; SAMN03473162
DR   BioSample; SAMN10989552
DR   cancercelllines; CVCL_1823
DR   Cell_Model_Passport; SIDM01006
DR   Cosmic; 720777
DR   Cosmic; 2081387
DR   Cosmic; 2131564
DR   Cosmic; 2367275
DR   Cosmic; 2809762
DR   Cosmic-CLP; 1327775
DR   DepMap; ACH-000193
DR   DSMZ; ACC-514
DR   DSMZCellDive; ACC-514
DR   ECACC; 22110802
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1327775
DR   GEO; GSM887196
DR   GEO; GSM888269
DR   GEO; GSM1374589
DR   GEO; GSM1669978
DR   IARC_TP53; 28386
DR   LiGeA; CCLE_349
DR   LINCS_LDP; LCL-2053
DR   PharmacoDB; KARPAS620_732_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1823
DR   Wikidata; Q54899502
DR   Ximbio; 152425
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2310698;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=19064000;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Characteristics: Produces IgG kappa.
CC   HLA typing: A*02:01; B*44; C*05:01 (Direct_author_submission).
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01; DQA1*05:01,05:01; DQB1*03:01,03:01; DRB1*03:17,11:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=11157491; PubMed=21173094; Cosmic-CLP=1327775; DepMap=ACH-000193).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Tyr (c.404G>A); ClinVar=VCV000141762; Zygosity=Homozygous (PubMed=21173094; Cosmic-CLP=1327775; DepMap=ACH-000193).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.6%; Native American=0%; East Asian, North=2.67%; East Asian, South=0%; South Asian=0%; European, North=63.77%; European, South=31.96% (PubMed=30894373).
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Discontinued: DSMZ; ACC-514; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=1327775; DSMZ=ACC-514; ECACC=22110802; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D19S433: 12,13
ST   D21S11: 29,31.2
ST   D2S1338: 18,19
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 9
ST   D8S1179: 10 (DSMZ=ACC-514)
ST   D8S1179: 10,15 (ECACC=22110802; PubMed=25877200)
ST   FGA: 26
ST   Penta D: 10,13
ST   Penta E: 14,15
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 17,19
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   Karpas-707
AC   CVCL_0010
SY   KARPAS-707; Karpas 707; KARPAS 707; Karpas707
DR   ECACC; 22110801
DR   GEO; GSM7701422
DR   GEO; GSM7701423
DR   NCBI_Iran; C505
DR   Wikidata; Q54899503
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3332852;
RX   PubMed=7079750;
RX   PubMed=10936422;
RX   PubMed=11172031;
RX   PubMed=16957166;
RX   PubMed=17254797;
RX   PubMed=23074853;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: 35 hours (PubMed=11172031).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: PubMed=17254797 reports a totally different STR profile which we believe to be erroneous. It is: CSF1PO=10,13; D13S317=11; D16S539=12; D18S51=16,18; D21S11=30,31; D3S1358=15; D5S818=11; D7S820=8; D8S1179=12,13; FGA=18,26; TH01=6,10; TPOX=8; vWA=17,18.
CC   Misspelling: CARPAS 707; PubMed=17254797.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ECACC=22110801
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 11,15
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 18,23
ST   Penta D: 9,10
ST   Penta E: 9,10
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 20,21
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   Karpas-707H
AC   CVCL_9552
SY   Karpas 707H; KARPAS 707H
DR   Wikidata; Q54899504
DR   Ximbio; 152424
RX   PubMed=11172031;
RX   PubMed=11839246;
RX   PubMed=18514220;
WW   Provider; Cambridge Enterprise; -; https://www.enterprise.cam.ac.uk/reagents/karpas-707h-human-myeloma-cell-line/
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Produces Ig lambda.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0010 ! Karpas-707
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 20
//
ID   Karpas-929
AC   CVCL_2543
SY   KARPAS-929; Karpas 929; KARPAS 929
DR   ECACC; 06072606
DR   Wikidata; Q54899505
DR   Ximbio; 152422
RX   CelloPub=CLPUB00604;
RX   PubMed=15621787;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Doubling time: ~30 hours (ECACC=06072606; Ximbio=152422).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   Karyochi-1
AC   CVCL_E2UQ
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of a normal human B-cell was transferred into the cytoplasm of the FP0-AgR-neo cell line (Patent=US8859278).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UD ! FP0-AgR-neo
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Karyochi-2
AC   CVCL_E2UR
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of a normal human B-cell was transferred into the cytoplasm of the RPMI-8226 cell line (Patent=US8859278).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Karyochi-3
AC   CVCL_E2US
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP1.0 cell line was transferred into the cytoplasm of the FP3 cell line (Patent=US8859278).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UE ! FP1.0
HI   CVCL_E2UP ! FP3
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Karyochi-4
AC   CVCL_E2UT
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP2 cell line was transferred into the cytoplasm of the FP3 cell line (Patent=US8859278).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UF ! FP2
HI   CVCL_E2UP ! FP3
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Karyochi-5
AC   CVCL_E2UU
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP3 cell line was transferred into the cytoplasm of the RPMI-8226 cell line (Patent=US8859278).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UP ! FP3
HI   CVCL_0014 ! RPMI-8226
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Karyochi-6
AC   CVCL_E2UV
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the cytoplasm of the FP2 cell line (Patent=US8859278).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UD ! FP0-AgR-neo
HI   CVCL_E2UF ! FP2
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Karyochi-7
AC   CVCL_E2UJ
SY   Karyochi-XX-7
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7467.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the cytoplasm of the FP1.0 cell line (from parent cell line).
CC   Doubling time: 20-22 hours (Patent=US8859278).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UI ! Karyochi-XX
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Karyochi-XX
AC   CVCL_E2UI
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7468.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the cytoplasm of the FP1.0 cell line (Patent=US8859278).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UD ! FP0-AgR-neo
HI   CVCL_E2UE ! FP1.0
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Karyochi-XX-1
AC   CVCL_E2UK
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the cytoplasm of the FP1.0 cell line (from parent cell line).
CC   Doubling time: 20-22 hours (Patent=US8859278).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UI ! Karyochi-XX
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Karyochi-XX-10
AC   CVCL_E2UN
SY   Karyochi-XX.10
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the cytoplasm of the FP1.0 cell line (from parent cell line).
CC   Doubling time: 24-26 hours (Patent=US8859278).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UI ! Karyochi-XX
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Karyochi-XX-3
AC   CVCL_E2UL
SY   Karyochi-XX.3
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the cytoplasm of the FP1.0 cell line (from parent cell line).
CC   Doubling time: 30-32 hours (Patent=US8859278).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UI ! Karyochi-XX
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Karyochi-XX-5
AC   CVCL_E2UM
SY   Karyochi-XX.5
RX   Patent=US8859278;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: The nucleus of FP0-Agr-Neo cell line was transferred into the cytoplasm of the FP1.0 cell line (from parent cell line).
CC   Doubling time: 20 hours (Patent=US8859278).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2UI ! Karyochi-XX
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   KAS
AC   CVCL_E2TN
DR   EGA; EGAD00001008611
RX   PubMed=12527906;
RX   PubMed=28745431;
RX   PubMed=36959380;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 3 (PubMed=12527906; PubMed=28745431).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=36959380
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D21S11: 30,31
ST   D3S1358: 15,19
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   D8S1179: 10,15
ST   FGA: 19,20
ST   Penta D: 12,13
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   KAS-6/1
AC   CVCL_9544
SY   KAS 6/1; KAS6/1; KAS-6; KAS61
DR   Wikidata; Q54899506
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1182/blood.V112.11.2732.2732;
RX   PubMed=8656685;
RX   PubMed=10936422;
RX   PubMed=18647998;
RX   PubMed=24013424;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M524 ! KAS-6/2
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   KAS-6/2
AC   CVCL_M524
DR   Wikidata; Q54899507
RX   DOI=10.1182/blood.V112.11.2732.2732;
RX   PubMed=8656685;
RX   PubMed=10936422;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9544 ! KAS-6/1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   KAS01 #2
AC   CVCL_T900
SY   KAS01-#2
DR   Wikidata; Q54899508
RX   PubMed=23364790;
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)47 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (PubMed=23364790).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T901 ! KAS01 #3
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   KAS01 #3
AC   CVCL_T901
SY   KAS01-#3
DR   SKIP; SKIP000224
DR   Wikidata; Q54899509
RX   PubMed=23364790;
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)47 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (PubMed=23364790).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T900 ! KAS01 #2
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   KAS011
AC   CVCL_E720
SY   KAS-011; KAS 011; KASOII
DR   dbMHC; 48918
DR   ECACC; 94070704
DR   IHW; IHW09009
DR   IPD-IMGT/HLA; 10901
DR   Wikidata; Q54899510
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Yugoslavian.
CC   HLA typing: A*01:01:01:01; B*37:01:01; C*06:02:01:01; DPA1*01:03:01,02:01:02; DPB1*04:01:01,14:01:01; DQA1*01:02:02; DQB1*05:02:01; DRA*01:01; DRB1*16:01:01; DRB5*02; DRB6*02:02 (IPD-IMGT/HLA=10901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   KAS116
AC   CVCL_E721
SY   KAS-116; KAS 116; TER508; TER-508; Ter-508; Ter 508
DR   dbMHC; 48919
DR   ECACC; 88052003
DR   IHW; IHW09003
DR   IPD-IMGT/HLA; 10902
DR   Wikidata; Q54899511
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/383cx.pdf
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Yugoslavian.
CC   HLA typing: A*24:02:01:01; B*51:01:01:03; C*12:03:01:01; DPA1*02:01; DPB1*13:01:01/107:01; DQA1*01:01:01; DQB1*05:01:01; DRA*01:01; DRB1*01:01:01; DRB6*01:01 (IPD-IMGT/HLA=10902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   Kasey
AC   CVCL_6F64
DR   Wikidata; Q54899512
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   Kasumi-1
AC   CVCL_0589
SY   KASUMI-1; Kasumi 1; KASUMI1; Kasumi1
DR   BTO; BTO_0004136
DR   CLO; CLO_0007068
DR   CLO; CLO_0007069
DR   EFO; EFO_0006607
DR   MCCL; MCC:0000264
DR   CLDB; cl2998
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2724
DR   BCRC; 60505
DR   BCRJ; 0305
DR   BioGRID_ORCS_Cell_line; 1617
DR   BioSample; SAMN01821572
DR   BioSample; SAMN01821642
DR   BioSample; SAMN01821688
DR   BioSample; SAMN03473161
DR   BioSample; SAMN10988020
DR   cancercelllines; CVCL_0589
DR   CCRID; 3101HUMSCSP5015
DR   CCRID; 3101HUMTCHu202
DR   CCRID; 4201HUM-CCTCC00296
DR   CCTCC; GDC0296
DR   Cell_Model_Passport; SIDM01005
DR   ChEMBL-Cells; CHEMBL3307835
DR   ChEMBL-Targets; CHEMBL613988
DR   CLS; 300226
DR   Cosmic; 787441
DR   Cosmic; 907275
DR   Cosmic; 975258
DR   Cosmic; 981579
DR   Cosmic; 987968
DR   Cosmic; 1012076
DR   Cosmic; 1078725
DR   Cosmic; 1149336
DR   Cosmic; 1181600
DR   Cosmic; 1451847
DR   Cosmic; 1476423
DR   Cosmic; 1509202
DR   Cosmic; 1516633
DR   Cosmic; 1524831
DR   Cosmic; 1623636
DR   Cosmic; 1779131
DR   Cosmic; 2089650
DR   Cosmic; 2131540
DR   Cosmic; 2306211
DR   Cosmic; 2690663
DR   Cosmic; 2701742
DR   Cosmic; 2750859
DR   Cosmic-CLP; 907275
DR   DepMap; ACH-000263
DR   DSMZ; ACC-220
DR   DSMZCellDive; ACC-220
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10788-110H5
DR   GDSC; 907275
DR   GEO; GSM236785
DR   GEO; GSM236821
DR   GEO; GSM482490
DR   GEO; GSM506744
DR   GEO; GSM506867
DR   GEO; GSM506973
DR   GEO; GSM743409
DR   GEO; GSM887197
DR   GEO; GSM888270
DR   GEO; GSM955189
DR   GEO; GSM955190
DR   GEO; GSM955191
DR   GEO; GSM1374590
DR   GEO; GSM1446745
DR   GEO; GSM1669979
DR   GEO; GSM2716744
DR   GEO; GSM2716745
DR   GEO; GSM2716746
DR   GEO; GSM2716747
DR   GEO; GSM4254129
DR   IARC_TP53; 21428
DR   IZSLER; BS TCL 242
DR   JCRB; JCRB1003
DR   JCRB; NIHS0235
DR   LiGeA; CCLE_291
DR   LINCS_LDP; LCL-1055
DR   PharmacoDB; KASUMI1_733_2019
DR   PRIDE; PXD000185
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0589
DR   PubChem_Cell_line; CVCL_0589
DR   Wikidata; Q38098914
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2018839;
RX   PubMed=8558913;
RX   PubMed=9738977;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=11753612;
RX   PubMed=12111653;
RX   PubMed=15621809;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=16523483;
RX   PubMed=18292219;
RX   PubMed=18385756;
RX   PubMed=20164919;
RX   PubMed=20227111;
RX   PubMed=20922763;
RX   PubMed=22068913;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=24211243;
RX   PubMed=24976338;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28109323;
RX   PubMed=28196595;
RX   PubMed=29491412;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=32180206;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Japanese.
CC   Doubling time: 40-45 hours (PubMed=2018839); 40 hours (PubMed=25984343); 53 hours (PubMed=20922763); ~48-72 hours (DSMZ=ACC-220).
CC   HLA typing: A*26:01,26:01; B*40:06,40:06; C*03:03,08:01 (PubMed=26589293).
CC   HLA typing: A*26:02:01,26:01:01; B*40:06:01,48:01:01; C*03:03:01,08:01:01; DPB1*02:01:02,02:01:02; DRA*01:01:01,01:01:01; DRB1*14:54:01,09:01:02 (DSMZCellDive=ACC-220).
CC   Karyotypic information: Has lost chromosome Y (PubMed=2018839).
CC   Karyotypic information: Some chromosome Y fragments are integrated into other chromosomes (PubMed=18292219).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10471; RUNX1 + HGNC; HGNC:1535; RUNX1T1; Name(s)=RUNX1-RUNX1T1, AML1-ETO (PubMed=11753612; PubMed=15843827; PubMed=24976338; PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asn822Lys (c.2466T>A) (N818K); ClinVar=VCV000375931; Zygosity=Heterozygous (PubMed=12111653; PubMed=18385756).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Lys330Profs*6 (c.987insCCGG); Zygosity=Unspecified (PubMed=23955599).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=907275).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.19%; Native American=0%; East Asian, North=74.84%; East Asian, South=22.29%; South Asian=0%; European, North=0%; European, South=1.67% (PubMed=30894373).
CC   Misspelling: Kusami-1; Cosmic=1516633; Cosmic=1623636; Cosmic=2750859.
CC   Misspelling: KUSAMI-1; Cosmic=2306211.
CC   Discontinued: JCRB; NIHS0235; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2724; CLS=300226; Cosmic-CLP=907275; COG; DSMZ=ACC-220; JCRB=JCRB1003; PubMed=20922763; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 13,15
ST   D12S391: 20
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D19S433: 13,15.2 (ATCC=CRL-2724; COG; PubMed=20922763; Technion Genomics Center)
ST   D19S433: 13,16 (DSMZ=ACC-220)
ST   D1S1656: 14,16
ST   D21S11: 30,31
ST   D22S1045: 17
ST   D2S1338: 19
ST   D2S441: 11,14
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14 (ATCC=CRL-2724; CLS=300226; Cosmic-CLP=907275; DSMZ=ACC-220; JCRB=JCRB1003; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
ST   vWA: 14,18 (COG)
DI   NCIt; C9381; Childhood acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 52
//
ID   Kasumi-1 PR48
AC   CVCL_JY45
SY   PR48
DR   cancercelllines; CVCL_JY45
DR   GEO; GSM955195
DR   GEO; GSM955196
DR   GEO; GSM955197
DR   Wikidata; Q54899513
RX   PubMed=24211243;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10471; RUNX1 + HGNC; HGNC:1535; RUNX1T1; Name(s)=RUNX1-RUNX1T1, AML1-ETO (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asn822Lys (c.2466T>A) (N818K); ClinVar=VCV000375931; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Lys330Profs*6 (c.987insCCGG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9381; Childhood acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JY44 ! Kasumi-1 R48
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   Kasumi-1 R48
AC   CVCL_JY44
SY   R48
DR   cancercelllines; CVCL_JY44
DR   GEO; GSM955192
DR   GEO; GSM955193
DR   GEO; GSM955194
DR   Wikidata; Q54899514
RX   PubMed=24211243;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49375; Dasatinib (BMS-354825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10471; RUNX1 + HGNC; HGNC:1535; RUNX1T1; Name(s)=RUNX1-RUNX1T1, AML1-ETO (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asn822Lys (c.2466T>A) (N818K); ClinVar=VCV000375931; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Lys330Profs*6 (c.987insCCGG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9381; Childhood acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0589 ! Kasumi-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   Kasumi-10
AC   CVCL_8485
SY   KASUMI-10
DR   GEO; GSM4254138
DR   GEO; GSM5137757
DR   JCRB; JCRB1410
DR   PRIDE; PXD023662
DR   Wikidata; Q54899515
RX   PubMed=32180206;
RX   PubMed=35354797;
CC   Population: Japanese and Korean.
CC   Karyotypic information: While originating from a female patient, it has a XXY karyotype that could be explained by a disorder of sexual development (PubMed=32180206).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=32180206; PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=32180206).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Leo, Isabelle Rose.
ST   Source(s): JCRB=JCRB1410; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 12,15
ST   D12S391: 18,22
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 15.2,16
ST   D1S1656: 15,17
ST   D21S11: 30
ST   D22S1045: 15,17
ST   D2S1338: 19,24
ST   D2S441: 11,11.3
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   DYS391: 9
ST   FGA: 22,27.2
ST   SE33: 20,26.2
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 17,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Kasumi-2
AC   CVCL_0590
SY   KASUMI-2; KASUMI2; Kasumi2
DR   EFO; EFO_0002224
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473522
DR   BioSample; SAMN10988450
DR   cancercelllines; CVCL_0590
DR   Cell_Model_Passport; SIDM01694
DR   Cosmic; 1130249
DR   Cosmic; 1524843
DR   DepMap; ACH-000728
DR   DSMZ; ACC-526
DR   DSMZCellDive; ACC-526
DR   GEO; GSM236786
DR   GEO; GSM236822
DR   GEO; GSM887198
DR   GEO; GSM888271
DR   GEO; GSM4254130
DR   GEO; GSM5137720
DR   GEO; GSM5137758
DR   IARC_TP53; 28402
DR   IGRhCellID; Kasumi2
DR   JCRB; JCRB1395
DR   LiGeA; CCLE_042
DR   PharmacoDB; KASUMI2_734_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_0590
DR   Wikidata; Q54899516
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29786757;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31305009;
RX   PubMed=31978347;
RX   PubMed=32180206;
RX   PubMed=35124168;
RX   PubMed=35354797;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: ~30 hours (DSMZ=ACC-526); ~45 hours (Note=Lot 01182019) (JCRB=JCRB1395).
CC   HLA typing: A*24:02,26:02; B*40:06,54:01; C*01:02,08:01; DQA1*03:02,04:01; DQB1*03:04,03:04; DRB1*09:01,11:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=32180206; PubMed=35354797; DepMap=ACH-000728).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Ser (c.37G>A); ClinVar=VCV000376323; Zygosity=Heterozygous (DepMap=ACH-000728).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Val14Leu (c.40G>T); Zygosity=Heterozygous (DepMap=ACH-000728).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Heterozygous (DepMap=ACH-000728).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.35%; East Asian, North=80.22%; East Asian, South=17.64%; South Asian=0%; European, North=1.01%; European, South=0.78% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-526; JCRB=JCRB1395
ST   Amelogenin: X (DSMZ=ACC-526)
ST   Amelogenin: X,Y (JCRB=JCRB1395)
ST   CSF1PO: 10,11
ST   D13S317: 8,12,13
ST   D16S539: 9,13
ST   D18S51: 12,13
ST   D19S433: 12,13
ST   D21S11: 31.2,32.2
ST   D2S1338: 17,24
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 11,16
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   Kasumi-3
AC   CVCL_0612
SY   KASUMI-3; Kasumi 3; Kasumi3; KASUMI3
DR   CLO; CLO_0007070
DR   ATCC; CRL-2725
DR   BioSample; SAMN01821573
DR   BioSample; SAMN01821689
DR   BioSample; SAMN03471777
DR   BioSample; SAMN03472527
DR   BioSample; SAMN03473397
DR   Cosmic; 787442
DR   Cosmic; 975259
DR   Cosmic; 996310
DR   Cosmic; 1037659
DR   Cosmic; 2089647
DR   Cosmic; 2750860
DR   DSMZ; ACC-714
DR   DSMZCellDive; ACC-714
DR   FANTOM5_SSTAR; 10789-110H6
DR   GDSC; 1327776
DR   GEO; GSM1374591
DR   GEO; GSM4254131
DR   JCRB; JCRB1004
DR   JCRB; NIHS0236
DR   PharmacoDB; Kasumi3_735_2019
DR   Wikidata; Q54899520
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8613429;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=23955599;
RX   PubMed=28196595;
RX   PubMed=32180206;
RX   PubMed=36982453;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 55-60 hours (PubMed=8613429); ~3-4 days (DSMZ=ACC-714).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: Kusami-3; Cosmic=2750860.
CC   Discontinued: JCRB; NIHS0236; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Myeloblast; CL=CL_0000835.
ST   Source(s): ATCC=CRL-2725; DSMZ=ACC-714; JCRB=JCRB1004
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11 (ATCC=CRL-2725; JCRB=JCRB1004)
ST   D16S539: 11 (DSMZ=ACC-714)
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 18,26
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 20,24
ST   Penta D: 9,11
ST   Penta E: 16
ST   TH01: 6,9 (DSMZ=ACC-714; JCRB=JCRB1004)
ST   TH01: 6,9,11 (ATCC=CRL-2725)
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C8303; Adult acute myeloid leukemia with minimal differentiation
DI   ORDO; Orphanet_98832; Acute myeloid leukemia with minimal differentiation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   Kasumi-4
AC   CVCL_0613
SY   KASUMI-4; Kasumi 4
DR   CLO; CLO_0007071
DR   ATCC; CRL-2726
DR   BioSample; SAMN03471778
DR   DSMZ; ACC-715
DR   DSMZCellDive; ACC-715
DR   GEO; GSM4254132
DR   JCRB; JCRB0161
DR   JCRB; NIHS0237
DR   Wikidata; Q54899521
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8611478;
RX   PubMed=10071072;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=32180206;
CC   Population: Japanese.
CC   Doubling time: ~55 hours (PubMed=8611478).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072; PubMed=32180206).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: DSMZ; ACC-715; true.
CC   Discontinued: JCRB; NIHS0237; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2726; DSMZ=ACC-715; JCRB=JCRB0161
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 20,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 19,23
ST   Penta D: 9,14
ST   Penta E: 16,17
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Kasumi-5
AC   CVCL_6864
DR   Cosmic; 981580
DR   GEO; GSM4254133
DR   JCRB; JCRB1398
DR   Wikidata; Q54899522
RX   PubMed=32180206;
CC   Population: Chinese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8068; NUP98 + HGNC; HGNC:9859; RAP1GDS1; Name(s)=NUP98-RAP1GDS1 (PubMed=32180206).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB1398
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   Kasumi-6
AC   CVCL_0614
SY   KASUMI-6; KASUMI6
DR   CLO; CLO_0007072
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2775
DR   BioSample; SAMN03471785
DR   BioSample; SAMN10988477
DR   cancercelllines; CVCL_0614
DR   Cell_Model_Passport; SIDM01695
DR   DepMap; ACH-000166
DR   DSMZ; ACC-686
DR   DSMZCellDive; ACC-686
DR   FANTOM5_SSTAR; 10792-110H9
DR   GEO; GSM743415
DR   GEO; GSM887199
DR   GEO; GSM888272
DR   GEO; GSM1374592
DR   GEO; GSM4254134
DR   IARC_TP53; 28325
DR   JCRB; JCRB1024
DR   JCRB; NIHS0314
DR   LiGeA; CCLE_218
DR   PharmacoDB; Kasumi6_736_2019
DR   Progenetix; CVCL_0614
DR   Wikidata; Q54899523
RX   PubMed=12508245;
RX   PubMed=22460905;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=32180206;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese and Korean.
CC   Doubling time: ~70 hours (DSMZ=ACC-686).
CC   Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Arg306Pro (c.917G>C); Zygosity=Heterozygous (PubMed=12508245; DepMap=ACH-000166).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=32180206).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Asp (c.700T>G); ClinVar=VCV000219759; Zygosity=Homozygous (DepMap=ACH-000166).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.79%; Native American=0%; East Asian, North=75.55%; East Asian, South=23.65%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0314; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2775; DSMZ=ACC-686; JCRB=JCRB1024
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 30,30.2
ST   D2S1338: 17,22
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta D: 11,12
ST   Penta E: 5,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   Kasumi-7
AC   CVCL_8486
SY   Kasumi 7; Kasumi7
DR   GEO; GSM4254135
DR   JCRB; JCRB1401
DR   Wikidata; Q54899524
RX   PubMed=32180206;
RX   PubMed=32504922;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32180206).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6997; MEF2D + HGNC; HGNC:17011; HNRNPUL1; Name(s)=MEF2D-HNRNPUL1 (PubMed=32504922).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1401
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Kasumi-8
AC   CVCL_8487
SY   Kasumi8
DR   GEO; GSM4254136
DR   JCRB; JCRB1403
DR   Wikidata; Q54899525
RX   PubMed=32180206;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32180206).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=32180206).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1403
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Kasumi-9
AC   CVCL_8488
SY   KASUMI-9; Kasumi9
DR   GEO; GSM4254137
DR   GEO; GSM5137721
DR   GEO; GSM5137759
DR   JCRB; JCRB1409
DR   PRIDE; PXD023662
DR   Wikidata; Q54899526
RX   PubMed=32180206;
RX   PubMed=32504922;
RX   PubMed=35124168;
RX   PubMed=35354797;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32180206).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6997; MEF2D + HGNC; HGNC:17011; HNRNPUL1; Name(s)=MEF2D-HNRNPUL1 (PubMed=32504922; PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Leo, Isabelle Rose.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1409; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 12,14
ST   D12S391: 19,24
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D19S433: 13,14.2
ST   D1S1656: 16,18.3
ST   D21S11: 30
ST   D22S1045: 15,16
ST   D2S1338: 17,19
ST   D2S441: 10,14
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14,17
ST   DYS391: 10
ST   FGA: 22,23
ST   SE33: 26.2,30.2
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   KasumiA-541
AC   CVCL_8523
DR   JCRB; JCRB1411
DR   Wikidata; Q54899527
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1411
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C82179; Mixed phenotype acute leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   KasumiA-554
AC   CVCL_8524
DR   JCRB; JCRB1416
DR   Wikidata; Q54899528
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1416
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 16,18
DI   NCIt; C25765; Secondary acute myeloid leukemia
DI   ORDO; Orphanet_86846; Therapy related acute myeloid leukemia and myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   KasumiA-568
AC   CVCL_8525
DR   JCRB; JCRB1415
DR   Wikidata; Q54899529
CC   Characteristics: CSF2 dependent (JCRB=JCRB1415).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1415
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8923; Acute erythroid leukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   KAT-10
AC   CVCL_6302
SY   KAT10
DR   BioSample; SAMN03151789
DR   cancercelllines; CVCL_6302
DR   Cosmic; 886546
DR   Cosmic; 888093
DR   Cosmic; 913248
DR   Wikidata; Q54899530
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00221.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,22
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   KAT-18
AC   CVCL_6303
SY   KAT18; Kat18
DR   BTO; BTO_0005161
DR   cancercelllines; CVCL_6303
DR   Cosmic; 886552
DR   Cosmic; 1152121
DR   Cosmic; 1239983
DR   Cosmic; 1280049
DR   Cosmic; 1507378
DR   Cosmic; 1533555
DR   Cosmic; 1536131
DR   Cosmic; 1889010
DR   Cosmic; 2054101
DR   Cosmic; 2319854
DR   Cosmic; 2791087
DR   IARC_TP53; 27016
DR   Wikidata; Q54899531
RX   PubMed=18713817;
RX   PubMed=19825993;
RX   PubMed=21868764;
RX   PubMed=23833040;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:7230; MRE11; Simple; p.Leu57Ter (c.170T>G); ClinVar=VCV000479719; Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly199Val (c.596G>T); ClinVar=VCV000451799; Zygosity=Homozygous (PubMed=19825993; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=18713817; PubMed=21868764; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 20,21
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   KAT-4
AC   CVCL_6304
SY   KAT 4; KAT4
DR   BioSample; SAMN03151790
DR   cancercelllines; CVCL_6304
DR   ChEMBL-Cells; CHEMBL3307845
DR   ChEMBL-Targets; CHEMBL614008
DR   Cosmic; 886548
DR   Cosmic; 891253
DR   Cosmic; 1068626
DR   Cosmic; 1162839
DR   Cosmic; 2050372
DR   IARC_TP53; 21624
DR   PubChem_Cell_line; CVCL_6304
DR   Wikidata; Q54899532
RX   PubMed=12481943;
RX   PubMed=14522906;
RX   PubMed=17465858;
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00222.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=14522906).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=17465858; PubMed=18713817; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11 (PubMed=17465858; PubMed=18713817)
ST   D13S317: 11,13 (PubMed=21868764)
ST   D16S539: 9,11,12
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,10,12 (PubMed=21868764)
ST   D7S820: 10 (PubMed=17465858; PubMed=18713817)
ST   D8S1179: 10 (PubMed=17465858)
ST   D8S1179: 10,16 (PubMed=18713817)
ST   FGA: 20,22
ST   TH01: 6,7
ST   TPOX: 8,9,11
ST   vWA: 16,17,18,19 (PubMed=21868764)
ST   vWA: 17,19 (PubMed=17465858; PubMed=18713817)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   KAT-5
AC   CVCL_0370
SY   KAT5
DR   MCCL; MCC:0000265
DR   BioSample; SAMN03151791
DR   cancercelllines; CVCL_0370
DR   Cosmic; 888091
DR   Cosmic; 913246
DR   Wikidata; Q54899533
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00223.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,22
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   KAT-50
AC   CVCL_6305
SY   KAT50
DR   BioSample; SAMN03151792
DR   cancercelllines; CVCL_6305
DR   Wikidata; Q54899534
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00224.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   KAT-7
AC   CVCL_6306
SY   KAT7
DR   BioSample; SAMN03151793
DR   cancercelllines; CVCL_6306
DR   Cosmic; 888092
DR   Cosmic; 913247
DR   Wikidata; Q54899535
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00225.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   KAT1
AC   CVCL_YE07
DR   Wikidata; Q94336804
RX   CelloPub=CLPUB00548;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   KAT45
AC   CVCL_S308
DR   Wikidata; Q54899536
RX   PubMed=9449645;
RX   PubMed=9629269;
RX   PubMed=15541571;
CC   Characteristics: Produces corticotropin-releasing hormone (PubMed=9449645).
CC   Doubling time: 24-48 hours (PubMed=9449645).
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
DI   NCIt; C3326; Adrenal gland pheochromocytoma
DI   ORDO; Orphanet_276621; Sporadic pheochromocytoma/secreting paraganglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 14
//
ID   Katata
AC   CVCL_M551
DR   Wikidata; Q54899537
RX   PubMed=9242553;
RX   PubMed=9753061;
CC   Population: Japanese.
CC   Virology: Contains a chromosomally integrated HHV-6B (CI-HHV-6B).
CC   Doubling time: 24 hours (PubMed=9242553).
CC   Transformant: NCBI_TaxID; 32604; Human herpesvirus 6B (HHV-6B).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   KATO II
AC   CVCL_M882
SY   KATO-II; Kato-II
DR   Wikidata; Q54899538
RX   PubMed=209229;
CC   Population: Japanese.
CC   Doubling time: 74 hours (PubMed=209229).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   KATO III
AC   CVCL_0371
SY   Kato III; Kato-III; KATO-III; KATOIII; KatoIII; KATO 3; JTC-28; Japanese Tissue Culture-28
DR   BTO; BTO_0001092
DR   CLO; CLO_0007073
DR   CLO; CLO_0050790
DR   EFO; EFO_0002217
DR   MCCL; MCC:0000266
DR   CLDB; cl3000
DR   CLDB; cl5214
DR   AddexBio; C0023001/53
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-103
DR   BCRC; 60200
DR   BCRJ; 0318
DR   BioGRID_ORCS_Cell_line; 909
DR   BioSample; SAMN01821574
DR   BioSample; SAMN01821690
DR   BioSample; SAMN03471089
DR   BioSample; SAMN03473264
DR   BioSample; SAMN10988331
DR   cancercelllines; CVCL_0371
DR   CCRID; 3101HUMSCSP573
DR   CCRID; 3101HUMTCHu229
DR   CCTCC; GDC0253
DR   Cell_Model_Passport; SIDM00687
DR   CGH-DB; 122-1
DR   CGH-DB; 9024-4
DR   ChEMBL-Cells; CHEMBL3308432
DR   ChEMBL-Targets; CHEMBL612700
DR   CLS; 300381
DR   Cosmic; 685595
DR   Cosmic; 687555
DR   Cosmic; 755614
DR   Cosmic; 801336
DR   Cosmic; 848150
DR   Cosmic; 848375
DR   Cosmic; 877044
DR   Cosmic; 887248
DR   Cosmic; 888823
DR   Cosmic; 889107
DR   Cosmic; 907276
DR   Cosmic; 922690
DR   Cosmic; 926118
DR   Cosmic; 968350
DR   Cosmic; 1001657
DR   Cosmic; 1067210
DR   Cosmic; 1090464
DR   Cosmic; 1093302
DR   Cosmic; 1187279
DR   Cosmic; 1223583
DR   Cosmic; 1518254
DR   Cosmic; 1571766
DR   Cosmic; 1627262
DR   Cosmic; 1890472
DR   Cosmic; 2009529
DR   Cosmic; 2036664
DR   Cosmic; 2069771
DR   Cosmic; 2484964
DR   Cosmic; 2807629
DR   Cosmic; 2823224
DR   Cosmic-CLP; 907276
DR   DepMap; ACH-000793
DR   ECACC; 86093004
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10436-106E4
DR   GDSC; 907276
DR   GEO; GSM267419
DR   GEO; GSM267426
DR   GEO; GSM267433
DR   GEO; GSM267440
DR   GEO; GSM552362
DR   GEO; GSM562404
DR   GEO; GSM827547
DR   GEO; GSM828835
DR   GEO; GSM844573
DR   GEO; GSM887200
DR   GEO; GSM888273
DR   GEO; GSM1237676
DR   GEO; GSM1237701
DR   GEO; GSM1250898
DR   GEO; GSM1250899
DR   GEO; GSM1250900
DR   GEO; GSM1250901
DR   GEO; GSM1374593
DR   GEO; GSM1374594
DR   GEO; GSM1669980
DR   IARC_TP53; 21648
DR   IGRhCellID; KATOIII
DR   IZSLER; BS TCL 151
DR   JCRB; JCRB0611
DR   JCRB; NIHS0052
DR   KCB; KCB 2014045YJ
DR   KCLB; 30103
DR   LiGeA; CCLE_710
DR   LINCS_HMS; 50022
DR   LINCS_LDP; LCL-2003
DR   NCBI_Iran; C640
DR   PharmacoDB; KATOIII_737_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0371
DR   PubChem_Cell_line; CVCL_0371
DR   RCB; RCB2088
DR   TKG; TKG 0213
DR   Wikidata; Q54899539
RX   CelloPub=CLPUB00581;
RX   CelloPub=CLPUB00584;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=209229;
RX   PubMed=1370612;
RX   PubMed=1778766;
RX   PubMed=1933850;
RX   PubMed=3518877;
RX   PubMed=3962675;
RX   PubMed=6862145;
RX   PubMed=9023415;
RX   PubMed=9247707;
RX   PubMed=9290701;
RX   PubMed=11107048;
RX   PubMed=11314020;
RX   PubMed=15723654;
RX   PubMed=17505008;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24587255;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32028591;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=209229); 32-34 hours (PubMed=3962675); 36 hours (PubMed=29435981); 37-41 hours (CelloPub=CLPUB00584); 1.5 days (Note=Lot 06302003), 32 hours (Note=Lot 05232008) (JCRB=JCRB0611).
CC   HLA typing: A*02,24:02; B*15:01,46:01; C*01:02,03:03 (PubMed=9023415).
CC   HLA typing: A*02:07,02:07; B*15:01,46:01; C*01:02,01:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*08:03,15:01 (PubMed=25960936).
CC   HLA typing: A*02:07,02:07; B*15:01,46:01; C*01:02,03:03; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*08:03,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=1370612; PubMed=1933850; PubMed=11107048).
CC   Omics: Genomics; ChIP-seq; GATA4.
CC   Omics: Genomics; ChIP-seq; GATA6.
CC   Omics: Genomics; ChIP-seq; KLF5.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.78%; Native American=0%; East Asian, North=78.55%; East Asian, South=19.58%; South Asian=1.02%; European, North=0.06%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0052; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0023001/53; ATCC=HTB-103; CLS=300381; Cosmic-CLP=907276; ECACC=86093004; JCRB=JCRB0611; KCLB=30103; PubMed=25877200; RCB=RCB2088; TKG=TKG 0213
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 12
ST   D19S433: 13,16
ST   D21S11: 30,31
ST   D2S1338: 18,20
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 8,12 (AddexBio=C0023001/53; ATCC=HTB-103; CLS=300381; Cosmic-CLP=907276; ECACC=86093004; JCRB=JCRB0611; KCLB=30103; RCB=RCB2088; TKG=TKG 0213)
ST   D7S820: 12 (PubMed=25877200)
ST   D8S1179: 13,14
ST   FGA: 23,24 (ATCC=HTB-103; CLS=300381; KCLB=30103)
ST   FGA: 23,25 (PubMed=25877200)
ST   Penta D: 13,14
ST   Penta E: 13,18,19
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M882 ! KATO II
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 50
//
ID   KATO III human CLDN18.2
AC   CVCL_E8JK
SY   KATOIII-CLDN18.2
DR   KYinno; KC-1453
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-1453).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0371 ! KATO III
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KATO III Ola-R
AC   CVCL_C1ND
SY   KATO-III/olaparib-resistant; Olaparib-resistant KATO-III
DR   Wikidata; Q114311804
RX   PubMed=32028591;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_83766; Olaparib.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0371 ! KATO III
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KATO III/CMV-Luc
AC   CVCL_M251
SY   KATOIII/CMV-Luc
DR   JCRB; JCRB1487
DR   JCRB; NIHS0713
DR   Wikidata; Q54899540
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1487).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0713; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1487
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0371 ! KATO III
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 23
//
ID   KATOIII/Cas9-hyg
AC   CVCL_C9DL
DR   GeneCopoeia; SL527
DR   Wikidata; Q123032795
CC   Population: Japanese.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL527).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0371 ! KATO III
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   KAUSTi001-A
AC   CVCL_A9PT
SY   KS7-iPSC#A
DR   BioSamples; SAMEA7248749
DR   hPSCreg; KAUSTi001-A
DR   Wikidata; Q102114351
RX   PubMed=33254093;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185635; 49,XXXXY syndrome
DI   ORDO; Orphanet_96264; 49,XXXXY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V753 ! GM00157
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi001-B
AC   CVCL_A9PU
SY   KS7-iPSC#B; KAUSTi002-A
DR   BioSamples; SAMEA7405466
DR   hPSCreg; KAUSTi001-B
DR   Wikidata; Q102114352
RX   PubMed=33254093;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185635; 49,XXXXY syndrome
DI   ORDO; Orphanet_96264; 49,XXXXY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V753 ! GM00157
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi003-A
AC   CVCL_A9PV
SY   KS1-iPSC#D
DR   BioSamples; SAMEA7373898
DR   hPSCreg; KAUSTi003-A
DR   Wikidata; Q102114353
RX   PubMed=32987351;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185635; 49,XXXXY syndrome
DI   ORDO; Orphanet_96264; 49,XXXXY syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D341 ! GM00326
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi004-A
AC   CVCL_A9PW
SY   HM-iPSC#A
DR   BioSamples; SAMEA7381959
DR   hPSCreg; KAUSTi004-A
DR   Wikidata; Q102114354
RX   PubMed=32987351;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7279 ! GM00321
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi004-B
AC   CVCL_A9PX
SY   HM-iPSC#B
DR   BioSamples; SAMEA7381961
DR   hPSCreg; KAUSTi004-B
DR   Wikidata; Q102114355
RX   PubMed=32987351;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7279 ! GM00321
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi005-A
AC   CVCL_A9PY
SY   HB-iPSC#A
DR   BioSamples; SAMEA7390784
DR   hPSCreg; KAUSTi005-A
DR   Wikidata; Q102114356
RX   PubMed=32987351;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7280 ! GM00323
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi005-B
AC   CVCL_A9PZ
SY   HB-iPSC#B
DR   BioSamples; SAMEA7390801
DR   hPSCreg; KAUSTi005-B
DR   Wikidata; Q102114357
RX   PubMed=32987351;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7280 ! GM00323
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi005-C
AC   CVCL_A9SW
SY   HB-iPSC#C
DR   BioSamples; SAMEA7390802
DR   hPSCreg; KAUSTi005-C
DR   Wikidata; Q102114358
RX   PubMed=32987351;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian; Sardinian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7280 ! GM00323
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi006-A
AC   CVCL_A9SU
SY   KS6-iPSC#A
DR   BioSamples; SAMEA7416688
DR   hPSCreg; KAUSTi006-A
DR   Wikidata; Q102114360
RX   PubMed=33096382;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Karyotypic information: 46-XY from a mosaic patient which has both 46-XY and 47-XXY cells (Cellosaurus=CVCL_A9SV).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Y4 ! TNGB-64137
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi006-B
AC   CVCL_A9SV
SY   KS6-iPSC#B
DR   BioSamples; SAMEA7416690
DR   hPSCreg; KAUSTi006-B
DR   Wikidata; Q102114361
RX   PubMed=33096382;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Karyotypic information: 47-XXY from a mosaic patient which has both 46-XY (Cellosaurus=CVCL_A9SU) and 47-XXY cells.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Y4 ! TNGB-64137
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi007-A
AC   CVCL_A9YC
SY   KS2-iPSC#A
DR   BioSamples; SAMEA7462428
DR   hPSCreg; KAUSTi007-A
DR   Wikidata; Q102114362
RX   PubMed=33068889;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9YD ! FFF0312002
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi007-B
AC   CVCL_A9YE
SY   KS2-iPSC#B
DR   BioSamples; SAMEA7462433
DR   hPSCreg; KAUSTi007-B
DR   Wikidata; Q102114363
RX   PubMed=33068889;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9YD ! FFF0312002
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi008-A
AC   CVCL_A9Y6
SY   KS4-iPSC#A
DR   BioSamples; SAMEA7485352
DR   hPSCreg; KAUSTi008-A
DR   Wikidata; Q102114364
RX   PubMed=33333453;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY cell line originating from the 47,XXY patient fibroblast (PubMed=33333453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   KAUSTi008-B
AC   CVCL_A9Y7
SY   KS4-iPSC#B
DR   BioSamples; SAMEA7628693
DR   hPSCreg; KAUSTi008-B
DR   Wikidata; Q102114366
RX   PubMed=33333453;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY cell line originating from the 47,XXY patient fibroblast (PubMed=33333453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   KAUSTi008-C
AC   CVCL_A9Y8
SY   KS4-iPSC#C
DR   BioSamples; SAMEA7574347
DR   hPSCreg; KAUSTi008-C
DR   Wikidata; Q102114367
RX   PubMed=33333453;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XXY (PubMed=33333453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   KAUSTi008-D
AC   CVCL_A9Y9
SY   KS4-iPSC#D
DR   BioSamples; SAMEA7628694
DR   hPSCreg; KAUSTi008-D
DR   Wikidata; Q102114368
RX   PubMed=33333453;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XXY (PubMed=33333453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   KAUSTi008-E
AC   CVCL_A9YA
SY   KS4-iPSC#E
DR   BioSamples; SAMEA7628695
DR   hPSCreg; KAUSTi008-E
DR   Wikidata; Q102114369
RX   PubMed=33333453;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XXY (PubMed=33333453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   KAUSTi008-F
AC   CVCL_A9YB
SY   KS4-iPSC#F
DR   BioSamples; SAMEA7485350
DR   hPSCreg; KAUSTi008-F
DR   Wikidata; Q102114371
RX   PubMed=33333453;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XXY (PubMed=33333453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   KAUSTi008-G
AC   CVCL_A9YF
SY   KS4-iPSC#G
DR   BioSamples; SAMEA7628696
DR   hPSCreg; KAUSTi008-G
DR   Wikidata; Q102114372
RX   PubMed=33333453;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XXY (PubMed=33333453).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H189 ! GM03102
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 7
//
ID   KAUSTi009-A
AC   CVCL_A9ZB
SY   KS3-iPSC#A
DR   BioSamples; SAMEA7462437
DR   hPSCreg; KAUSTi009-A
DR   Wikidata; Q102114374
RX   PubMed=33068889;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9ZD ! TNGB-66257
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi009-B
AC   CVCL_A9ZC
SY   KS3-iPSC#B
DR   BioSamples; SAMEA7513363
DR   hPSCreg; KAUSTi009-B
DR   Wikidata; Q102114375
RX   PubMed=33068889;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9ZD ! TNGB-66257
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi010-A
AC   CVCL_A9ZE
SY   KS5-iPSC#A
DR   BioSamples; SAMEA7462883
DR   hPSCreg; KAUSTi010-A
DR   Wikidata; Q102114377
RX   PubMed=33068889;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9ZG ! TNGB-78816
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi010-B
AC   CVCL_A9ZF
SY   KS5-iPSC#B
DR   BioSamples; SAMEA7462885
DR   hPSCreg; KAUSTi010-B
DR   Wikidata; Q102114379
RX   PubMed=33068889;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9ZG ! TNGB-78816
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KAUSTi011-A
AC   CVCL_A1WG
SY   iPSC-GLP1R-KO-C1
DR   BioSamples; SAMEA7679540
DR   hPSCreg; KAUSTi011-A
DR   Wikidata; Q105509753
RX   PubMed=33421754;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4324; GLP1R; Simple; c.402+3delG (p.Val95Glufs*72) (Ex4del); Zygosity=Homozygous (PubMed=33421754).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122814; Developmental and epileptic encephalopathy
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WH ! KAUSTi011-B
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   KAUSTi011-B
AC   CVCL_A1WH
SY   iPSC-GLP1R-KO-H4
DR   BioSamples; SAMEA7679542
DR   hPSCreg; KAUSTi011-B
DR   Wikidata; Q105509755
RX   PubMed=33421754;
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Population: Arab; Saudi Arabian.
CC   Sequence variation: Mutation; HGNC; HGNC:4324; GLP1R; Simple; c.402+3delG (p.Val95Glufs*72) (Ex4del); Zygosity=Homozygous (PubMed=33421754).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122814; Developmental and epileptic encephalopathy
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WG ! KAUSTi011-A
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   KAWASAKI
AC   CVCL_E722
DR   dbMHC; 48920
DR   ECACC; 94082243
DR   IHW; IHW09143
DR   IPD-IMGT/HLA; 11686
DR   Wikidata; Q54899541
RX   PubMed=8307784;
RX   PubMed=28360230;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01; B*52:01:01; DPB1*09:01; DQA1*01:03; DQB1*06:01:01; DRB1*15:02:01; DRB5*01:02 (IPD-IMGT/HLA=11686).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   KAY-10
AC   CVCL_E4AC
SY   Kay-10
RX   Patent=US6946255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5334.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P41047; Mouse Faslg/Cd178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KB
AC   CVCL_0372
SY   KB (HeLa derivative); HeLa-KB; Strain KB
DR   BTO; BTO_0000665
DR   CLO; CLO_0007074
DR   MCCL; MCC:0000267
DR   CLDB; cl3001
DR   CLDB; cl3002
DR   CLDB; cl3003
DR   CLDB; cl3004
DR   CLDB; cl3005
DR   CLDB; cl3006
DR   ATCC; CCL-17
DR   ATCC; CRL-3596
DR   BCRC; 60017
DR   BCRJ; 0128
DR   BioSample; SAMN03151730
DR   CCLV; CCLV-RIE 0016
DR   CCRID; 1101HUM-PUMC000163
DR   ChEMBL-Cells; CHEMBL3307959
DR   ChEMBL-Targets; CHEMBL398
DR   CLS; 300446
DR   Cosmic; 753567
DR   Cosmic; 1042301
DR   Cosmic; 1339927
DR   Cosmic; 1969496
DR   Cosmic; 2301581
DR   Cosmic; 2546843
DR   DSMZ; ACC-136
DR   DSMZCellDive; ACC-136
DR   ECACC; 86103004
DR   ECACC; 94050408
DR   GEO; GSM1374595
DR   GEO; GSM1374596
DR   ICLC; HTL96014
DR   IZSLER; BS TCL 34
DR   JCRB; JCRB9027
DR   KCB; KCB 94020YJ
DR   KCLB; 10017
DR   MeSH; D007624
DR   NCBI_Iran; C152
DR   PubChem_Cell_line; CVCL_0372
DR   RCB; RCB1888
DR   TKG; TKG 0401
DR   TOKU-E; 2094
DR   Wikidata; Q28334825
RX   CelloPub=CLPUB00484;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=656543;
RX   PubMed=1246601;
RX   PubMed=4203458;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=5668122;
RX   PubMed=6988327;
RX   PubMed=8397027;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=13254761;
RX   PubMed=13322936;
RX   PubMed=13431913;
RX   PubMed=14185313;
RX   PubMed=17254797;
RX   PubMed=17325662;
RX   PubMed=20143388;
RX   PubMed=23925245;
RX   PubMed=28455420;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-494.html
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=1246601; PubMed=20143388). Originally thought to originate from an epidermal carcinoma of the mouth.
CC   Part of: KuDOS 95 cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00010.
CC   Population: African American.
CC   Doubling time: ~30 hours (DSMZ=ACC-136).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CCL-17; true.
CC   Discontinued: BCRC; 60017; true.
CC   Discontinued: DSMZ; ACC-136; true.
CC   Discontinued: ECACC; 86103004; true.
CC   Discontinued: ICLC; HTL96014; true.
CC   Discontinued: RCB; RCB1888; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-3596; CCRID=1101HUM-PUMC000163; CLS=300446; DSMZ=ACC-136; JCRB=JCRB9027; KCLB=10017; PubMed=11416159; PubMed=17254797; TKG=TKG 0401
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (ATCC=CRL-3596; CLS=300446; DSMZ=ACC-136; JCRB=JCRB9027; KCLB=10017; TKG=TKG 0401)
ST   D13S317: 12,14 (CCRID=1101HUM-PUMC000163; PubMed=17254797)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   KB [Cyprinus]
AC   CVCL_RK38
SY   Koi Brain
DR   Wikidata; Q54899542
RX   PubMed=29064103;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by koi herpesvirus (KHV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   KB 16
AC   CVCL_D680
DR   BCRJ; 0129
DR   Wikidata; Q54899543
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): BCRJ=0129
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   KB 18
AC   CVCL_D681
DR   BCRJ; 0130
DR   Wikidata; Q54899544
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): BCRJ=0130
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   KB N10
AC   CVCL_C4YP
SY   N10
DR   Wikidata; Q116049614
RX   PubMed=9439682;
RX   PubMed=9659517;
RX   PubMed=9930366;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Characteristics: Radioresistant: 1.50 to 3.75-fold more resistant to X-irradiation than the parental cell line (PubMed=9659517).
CC   Selected for resistance to: ChEBI; CHEBI_22907; Bleomycin.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   KB-26.5
AC   CVCL_B6DU
DR   Wikidata; Q111733549
RX   DOI=10.1007/BF01051776;
RX   PubMed=7764578;
RX   PubMed=19003358;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_62485; Blood group A antigen type 1 (Alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   KB-3-1
AC   CVCL_2088
SY   KB 3-1; KB3-1; KB31
DR   BTO; BTO_0003918
DR   CLO; CLO_0007076
DR   CLDB; cl3008
DR   BioSample; SAMN03151731
DR   ChEMBL-Cells; CHEMBL3307659
DR   ChEMBL-Targets; CHEMBL614590
DR   DSMZ; ACC-158
DR   DSMZCellDive; ACC-158
DR   GEO; GSM743501
DR   PubChem_Cell_line; CVCL_2088
DR   TOKU-E; 4096
DR   Wikidata; Q54899545
RX   PubMed=2897240;
RX   PubMed=3856953;
RX   PubMed=7865904;
RX   PubMed=22118813;
RX   PubMed=24317338;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; NIH OTT; E-006-2006/0-5; https://web.archive.org/web/20150922131738/http://www.ott.nih.gov/erma/multidrug-resistant-epidermal-carcinoma-cell-line-kb-3-1
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00372.
CC   Population: African American.
CC   Doubling time: ~40 hours (DSMZ=ACC-158).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DSMZ=ACC-158; PubMed=22118813
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (DSMZ=ACC-158)
ST   D13S317: 12,14 (PubMed=22118813)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   KB-A1
AC   CVCL_1D82
SY   KB-A-1; KBA 1; KBA1
DR   Wikidata; Q54899546
RX   PubMed=2897240;
RX   PubMed=3711108;
RX   PubMed=15202936;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   KB-BLMr
AC   CVCL_F0BE
RX   PubMed=2450630;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_22907; Bleomycin.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KB-C1-R1
AC   CVCL_1D83
DR   Wikidata; Q54899549
RX   PubMed=3711108;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M125 ! KB-ChR-8-5-11-24
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   KB-C1.5
AC   CVCL_1D80
SY   KBC1.5
DR   Wikidata; Q54899547
RX   PubMed=3711108;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Sequence variation: Mutation; HGNC; HGNC:40; ABCB1; Simple; p.Gly185Val (c.554_555GA>TT); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M125 ! KB-ChR-8-5-11-24
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   KB-C2
AC   CVCL_D600
SY   KBC2
DR   BTO; BTO_0005215
DR   Wikidata; Q54899550
RX   PubMed=3711108;
RX   PubMed=3857583;
RX   PubMed=11509122;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Sequence variation: Mutation; HGNC; HGNC:40; ABCB1; Simple; p.Gly185Val (c.554_555GA>TT); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D80 ! KB-C1.5
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   KB-C2.5
AC   CVCL_1D81
SY   KBC2.5
DR   Wikidata; Q54899551
RX   PubMed=2897240;
RX   PubMed=3711108;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Sequence variation: Mutation; HGNC; HGNC:40; ABCB1; Simple; p.Gly185Val (c.554_555GA>TT); Zygosity=Unspecified (PubMed=2897240).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D600 ! KB-C2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   KB-ChR-8
AC   CVCL_E3EU
SY   KB-8
RX   PubMed=2897240;
RX   PubMed=3711108;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KB-ChR-8-5
AC   CVCL_5994
SY   KB-CH[R]-8-5; KBCh(R)-8-5; KB-8-5; KB 8-5; KB8-5
DR   BTO; BTO_0003919
DR   Wikidata; Q54899552
RX   PubMed=2897240;
RX   PubMed=3711108;
RX   PubMed=3856953;
RX   PubMed=7865904;
WW   Provider; NIH OTT; E-005-2006/0-4; https://web.archive.org/web/20150922074206/http://www.ott.nih.gov/erma/multidrug-resistant-epidermal-carcinoma-cell-line-kb-8-5-and-kb-8-11
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3EU ! KB-ChR-8
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   KB-ChR-8-5-11
AC   CVCL_5997
SY   KB-8-5-11
DR   Wikidata; Q54899553
RX   PubMed=2897240;
RX   PubMed=3711108;
RX   PubMed=3856953;
RX   PubMed=24403508;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Characteristics: Resistant to paclitaxel and many other chemotherapy agents as it overexpresses the P-glycoprotein (ABCB1).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5994 ! KB-ChR-8-5
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   KB-ChR-8-5-11-24
AC   CVCL_M125
SY   KB-ChR-24; KB-8-5-11-24; KB-C1; KBC-1
DR   Wikidata; Q54899554
RX   PubMed=2897240;
RX   PubMed=3711108;
RX   PubMed=3856953;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Sequence variation: Mutation; HGNC; HGNC:40; ABCB1; Simple; p.Gly185Val (c.554_555GA>TT); Zygosity=Unspecified (PubMed=2897240).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5997 ! KB-ChR-8-5-11
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 19
//
ID   KB-CP.5
AC   CVCL_IP04
SY   KCP.5
DR   BTO; BTO_0005849
DR   GEO; GSM743497
DR   Wikidata; Q54899555
RX   PubMed=22571463;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   KB-CP10
AC   CVCL_IP05
DR   BTO; BTO_0006410
DR   Wikidata; Q54899556
RX   PubMed=7710928;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IP17 ! KB-CP5
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   KB-CP20
AC   CVCL_IP06
DR   BTO; BTO_0006409
DR   GEO; GSM743499
DR   Wikidata; Q54899557
RX   PubMed=7710928;
RX   PubMed=9443404;
RX   PubMed=22571463;
CC   Problematic cell line: Contaminated. Ancestral cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IP05 ! KB-CP10
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   KB-CP5
AC   CVCL_IP17
DR   BTO; BTO_0006411
DR   Wikidata; Q54899558
RX   PubMed=7710928;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   KB-CV60
AC   CVCL_X335
SY   KBCV60; CV60
DR   Wikidata; Q54899559
RX   PubMed=11509122;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   KB-D8
AC   CVCL_1Q75
DR   RCB; RCB2724
DR   Wikidata; Q54899560
RX   PubMed=12070602;
CC   Doubling time: 19.1 hours (PubMed=12070602).
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1Q74 ! KB-P
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   KB-P
AC   CVCL_1Q74
DR   Wikidata; Q54899565
RX   PubMed=12070602;
CC   Doubling time: 20.3 hours (PubMed=12070602).
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   KB-R
AC   CVCL_M096
DR   Wikidata; Q54899566
RX   PubMed=17487352;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   KB-V1
AC   CVCL_2089
SY   KB-v1; KB-V-1; KBV1
DR   BTO; BTO_0003917
DR   CLO; CLO_0007077
DR   CLDB; cl3009
DR   BioSample; SAMN03151732
DR   ChEMBL-Cells; CHEMBL4295414
DR   ChEMBL-Targets; CHEMBL4296451
DR   DSMZ; ACC-149
DR   DSMZCellDive; ACC-149
DR   PubChem_Cell_line; CVCL_2089
DR   Wikidata; Q54899567
RX   PubMed=2897240;
RX   PubMed=3711108;
RX   PubMed=7865904;
RX   PubMed=22118813;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; NIH OTT; E-007-2006/0-6; https://web.archive.org/web/20150922130003/http://www.ott.nih.gov/erma/multidrug-resistant-epidermal-carcinoma-cell-line-kb-v-1
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00373.
CC   Population: African American.
CC   Doubling time: ~50 hours (DSMZ=ACC-149).
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DSMZ=ACC-149; PubMed=22118813
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (DSMZ=ACC-149)
ST   D13S317: 12,14 (PubMed=22118813)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,17,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KB/BF-1
AC   CVCL_HA90
DR   Wikidata; Q54899568
RX   PubMed=1597488;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_48080; Brefeldin A (BFA).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 10
//
ID   KB/BF-2
AC   CVCL_HA91
DR   Wikidata; Q54899569
RX   PubMed=1597488;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_48080; Brefeldin A (BFA).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 10
//
ID   KB/cSV
AC   CVCL_0I92
DR   CLO; CLO_0007075
DR   CLDB; cl3010
DR   Wikidata; Q54899570
RX   PubMed=87443;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   KB/STP-1
AC   CVCL_AE00
DR   Wikidata; Q54899571
RX   PubMed=8625310;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_91276; Saintopin.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   KB/STP-2
AC   CVCL_AE01
DR   Wikidata; Q54899572
RX   PubMed=8625310;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_91276; Saintopin.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   KB1
AC   CVCL_E5RT
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68440; Vaccinia virus scaffold protein OPG125 (D13L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KB10025
AC   CVCL_A9ZU
SY   KB_10025
DR   GEO; GSM6366
DR   GEO; GSM6391
DR   Wikidata; Q102114380
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.4 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB10460
AC   CVCL_A1AN
DR   Wikidata; Q102114381
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KB10460 iPSC colony 1
AC   CVCL_DA13
DR   Wikidata; Q54899573
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
HI   CVCL_A1AN ! KB10460
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   KB10460 iPSC colony 2
AC   CVCL_DA14
DR   Wikidata; Q54899574
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
HI   CVCL_A1AN ! KB10460
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   KB10460 iPSC colony 3
AC   CVCL_DA15
DR   Wikidata; Q54899575
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
HI   CVCL_A1AN ! KB10460
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   KB10973
AC   CVCL_A1AP
DR   Wikidata; Q102114382
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KB10973 iPSC colony 1
AC   CVCL_DA16
DR   Wikidata; Q54899576
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
HI   CVCL_A1AP ! KB10973
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   KB10973 iPSC colony 2
AC   CVCL_DA17
DR   Wikidata; Q54899577
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
HI   CVCL_A1AP ! KB10973
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   KB10973 iPSC colony 3
AC   CVCL_DA18
DR   Wikidata; Q54899578
RX   PubMed=26475477;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
HI   CVCL_A1AP ! KB10973
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   KB319
AC   CVCL_C1K3
DR   Wikidata; Q114311805
RX   PubMed=1972815;
RX   PubMed=7957062;
RX   PubMed=8423817;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062; PubMed=8423817).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1HU ! LM217
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E
AC   CVCL_C1K4
DR   Wikidata; Q114311806
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K3 ! KB319
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E1
AC   CVCL_C1K5
DR   Wikidata; Q114311807
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K4 ! KB319 subclone E
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E1-6
AC   CVCL_C1K8
DR   Wikidata; Q114311808
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K5 ! KB319 subclone E1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E1-7
AC   CVCL_C1K9
DR   Wikidata; Q114311809
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K5 ! KB319 subclone E1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E8
AC   CVCL_C1K6
DR   Wikidata; Q114311810
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K4 ! KB319 subclone E
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E8-2
AC   CVCL_C1KA
DR   Wikidata; Q114311811
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K6 ! KB319 subclone E8
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E8-4
AC   CVCL_C1KB
DR   Wikidata; Q114311812
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K6 ! KB319 subclone E8
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E9
AC   CVCL_C1K7
DR   Wikidata; Q114311813
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K4 ! KB319 subclone E
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E9-2
AC   CVCL_C1KC
DR   Wikidata; Q114311814
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K7 ! KB319 subclone E9
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB319 subclone E9-6
AC   CVCL_C1KD
DR   Wikidata; Q114311815
RX   PubMed=7957062;
CC   Population: African American.
CC   Characteristics: The transfected plasmid pMSTKneo DNA was integrated at the telomere of chromosome 13 (PubMed=7957062).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1K7 ! KB319 subclone E9
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   KB4512
AC   CVCL_A9ZW
SY   KB_4512
DR   GEO; GSM6365
DR   Wikidata; Q102114386
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.6 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB5047
AC   CVCL_A1AG
SY   KB_5047
DR   GEO; GSM6375
DR   Wikidata; Q102114387
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.0 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB521
AC   CVCL_0A32
DR   Wikidata; Q54899579
RX   PubMed=6245299;
RX   PubMed=6409394;
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4350 ! K-BALB
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   KB5275
AC   CVCL_A9ZT
SY   KB_5275
DR   GEO; GSM6367
DR   Wikidata; Q102114388
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.4 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB5828
AC   CVCL_A9ZX
SY   KB_5828
DR   GEO; GSM6368
DR   Wikidata; Q102114389
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.7 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB6268
AC   CVCL_A1AF
SY   KB_6268
DR   GEO; GSM6376
DR   Wikidata; Q102114390
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.0 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB6278
AC   CVCL_A1AM
SY   KB_6278
DR   GEO; GSM6377
DR   Wikidata; Q102114391
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 1.9 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB6884
AC   CVCL_A9ZS
SY   KB_6884
DR   GEO; GSM6369
DR   Wikidata; Q102114392
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.0 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB7033
AC   CVCL_A9ZV
SY   KB_7033
DR   GEO; GSM6370
DR   Wikidata; Q102114393
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.1 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB7189
AC   CVCL_A1AB
SY   KB_7189
DR   GEO; GSM6371
DR   Wikidata; Q102114394
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.8 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB7500
AC   CVCL_A1AH
SY   KB_7500
DR   GEO; GSM6378
DR   Wikidata; Q102114395
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 1.8 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB7621
AC   CVCL_A1AK
SY   KB_7621
DR   GEO; GSM6379
DR   GEO; GSM6392
DR   Wikidata; Q102114396
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.3 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB7801
AC   CVCL_A1AI
SY   KB_7801
DR   GEO; GSM6380
DR   Wikidata; Q102114397
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 1.9 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB7998
AC   CVCL_A9ZY
SY   KB_7998
DR   GEO; GSM6372
DR   Wikidata; Q102114399
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.0 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB8021
AC   CVCL_A1AJ
SY   KB_8021
DR   GEO; GSM6381
DR   Wikidata; Q102114400
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.4 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB8024
AC   CVCL_A1AA
SY   KB_8024
DR   GEO; GSM6373
DR   Wikidata; Q102114401
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.3 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB8025
AC   CVCL_A9ZZ
SY   KB_8025
DR   GEO; GSM6374
DR   Wikidata; Q102114402
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.0 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB8592
AC   CVCL_A1AE
SY   KB_8592
DR   GEO; GSM6382
DR   Wikidata; Q102114403
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 1.9 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB8594
AC   CVCL_A1AL
SY   KB_8594
DR   GEO; GSM6383
DR   Wikidata; Q102114405
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 1.6 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB8840
AC   CVCL_A1AC
SY   KB_8840
DR   GEO; GSM6384
DR   Wikidata; Q102114406
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.5 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KB9047
AC   CVCL_A1AD
SY   KB_9047
DR   GEO; GSM6385
DR   Wikidata; Q102114407
RX   PubMed=12840040;
CC   Group: Non-human primate cell line.
CC   From: Center for Reproduction of Endangered Species, Zoological Society of San Diego; San Diego; USA.
CC   Doubling time: 2.4 days (PubMed=12840040).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   KBDC-11
AC   CVCL_E5UP
SY   Kobe Bile Duct Cancer-11
DR   ABM; T8200
RX   PubMed=24778022;
CC   Population: Japanese.
CC   Derived from site: In situ; Bile duct, hepatic duct; UBERON=UBERON_0005171.
DI   NCIt; C6881; Bile duct intraductal papillary neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KBF11
AC   CVCL_0F75
SY   KBF 11
DR   ATCC; CRL-2788
DR   Wikidata; Q54899580
RX   PubMed=2612208;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: ATCC; CRL-2788; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9116 ! NIH 3T3-TK-
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   KBH5.0
AC   CVCL_D644
DR   BTO; BTO_0005296
DR   Wikidata; Q54899581
RX   PubMed=14679002;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_51232; 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole (Hoechst 33342; Hoe 33342).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   KBM-3
AC   CVCL_A425
SY   KBM3
DR   EFO; EFO_0022523
DR   cancercelllines; CVCL_A425
DR   ChEMBL-Cells; CHEMBL3307847
DR   ChEMBL-Targets; CHEMBL614010
DR   Cosmic; 975260
DR   IARC_TP53; 4651
DR   PubChem_Cell_line; CVCL_A425
DR   Wikidata; Q54899582
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1568450;
RX   PubMed=1995877;
RX   PubMed=7627932;
CC   Doubling time: 22.9 hours (Note=At 255th passage) (PubMed=1568450).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=7627932).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   KBM-3/AMSA
AC   CVCL_IP19
DR   cancercelllines; CVCL_IP19
DR   Wikidata; Q54899583
RX   PubMed=1311390;
CC   Selected for resistance to: ChEBI; CHEBI_2687; Amsacrine.
CC   Sequence variation: Mutation; HGNC; HGNC:11989; TOP2A; Simple; p.Arg487Lys (c.1460G>A); ClinVar=VCV000016772; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=1311390).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A425 ! KBM-3
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 15
//
ID   KBM-3/DOX
AC   CVCL_H688
DR   cancercelllines; CVCL_H688
DR   ChEMBL-Cells; CHEMBL3307838
DR   ChEMBL-Targets; CHEMBL613994
DR   PubChem_Cell_line; CVCL_H688
DR   Wikidata; Q54899584
RX   PubMed=1995877;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A425 ! KBM-3
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   KBM-5
AC   CVCL_0373
SY   KBM5
DR   BTO; BTO_0002546
DR   MCCL; MCC:0000268
DR   cancercelllines; CVCL_0373
DR   ChEMBL-Cells; CHEMBL4483148
DR   ChEMBL-Targets; CHEMBL4483250
DR   IARC_TP53; 4652
DR   PubChem_Cell_line; CVCL_0373
DR   Wikidata; Q54899585
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3332852;
RX   PubMed=7627932;
RX   PubMed=8339266;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=26623729;
CC   Doubling time: 24-60 hours (PubMed=8339266).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=8339266; PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Gly710Ter (c.2128G>T); Zygosity=Homozygous (PubMed=26623729).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=7627932; PubMed=26623729).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   KBM-7
AC   CVCL_A426
SY   KBM7; KBM-7/Hap8
DR   BTO; BTO_0005775
DR   EFO; EFO_0005903
DR   4DN; 4DNSRYBIH9HS
DR   BioGRID_ORCS_Cell_line; 43
DR   BioSample; SAMN03473259
DR   cancercelllines; CVCL_A426
DR   Cosmic; 787496
DR   ENCODE; ENCBS322FGS
DR   ENCODE; ENCBS815EDC
DR   Horizon_Discovery; C628
DR   IARC_TP53; 4653
DR   PRIDE; PXD006614
DR   Wikidata; Q18392835
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7627932;
RX   PubMed=8609723;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=23861985;
RX   PubMed=24161985;
RX   PubMed=24644259;
RX   PubMed=25877200;
RX   PubMed=29474001;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/KBM-7_cells
WW   Provider; Tufts TTIC; T001034; https://viceprovost.tufts.edu/research-tool-cell-line-near-haploid-mammalian-cell-line
CC   Group: Haploid karyotype cell line.
CC   Doubling time: 22 hours (PubMed=8609723).
CC   Karyotypic information: Haploid except for a disomy of chromosome 8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=8609723; PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (PubMed=7627932; PubMed=24161985).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: KMB-7; Note=Occasionally.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 18
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 8,14
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   KBM-7 P1-55
AC   CVCL_B253
SY   P1-55
DR   cancercelllines; CVCL_B253
DR   Wikidata; Q54899586
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10527618;
CC   Group: Haploid karyotype cell line.
CC   Karyotypic information: Haploid except for a disomy of chromosome 8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A426 ! KBM-7
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   KBM-7/B5
AC   CVCL_B254
SY   KBM-7-B5; KBM7B5
DR   cancercelllines; CVCL_B254
DR   Wikidata; Q54899587
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8609723;
RX   PubMed=9783811;
CC   Group: Haploid karyotype cell line.
CC   Karyotypic information: Haploid except for a disomy of chromosome 8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A426 ! KBM-7
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   KBM-7/B5-1803
AC   CVCL_8Z14
SY   KBM7-B5-1803; KBM-7/B5 clone 1803
DR   cancercelllines; CVCL_8Z14
DR   Wikidata; Q54899588
RX   PubMed=9783811;
CC   Group: Haploid karyotype cell line.
CC   Karyotypic information: Haploid except for a disomy of chromosome 8.
CC   Selected for resistance to: ChEBI; CHEBI_4027; Cyclophosphamide (CP; Endoxan).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B254 ! KBM-7/B5
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 17
//
ID   KBv200
AC   CVCL_D599
SY   KBV200
DR   BTO; BTO_0005196
DR   Wikidata; Q54899589
RX   PubMed=7909748;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   Kc
AC   CVCL_Z833
SY   KC; K C
DR   BTO; BTO_0000382
DR   CLO; CLO_0007079
DR   EFO; EFO_0002068
DR   CLDB; cl3011
DR   ECACC; 90070550
DR   FlyBase_Cell_line; FBtc0000998
DR   FlyBase_Cell_line; FBtc9000002
DR   Wikidata; Q54899590
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00568;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=811480;
RX   PubMed=3084259;
RX   PubMed=5577860;
RX   PubMed=24434506;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-283.html
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z832 ! Line K
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 18
//
ID   Kc clone 89K
AC   CVCL_C9EM
DR   Wikidata; Q123032796
RX   PubMed=3005047;
RX   PubMed=6778694;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Kc clone 89K transformed cells I
AC   CVCL_C9EN
DR   Wikidata; Q123032797
RX   PubMed=3005047;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_C9EM ! Kc clone 89K
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Kc clone 89K transformed cells II
AC   CVCL_C9EP
DR   Wikidata; Q123032798
RX   PubMed=3005047;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_C9EM ! Kc clone 89K
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   KC-1 [Human colon carcinoma]
AC   CVCL_W475
DR   cancercelllines; CVCL_W475
DR   Wikidata; Q54899593
RX   PubMed=7873502;
CC   Population: Japanese.
CC   Doubling time: 56.6 hours (PubMed=7873502).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Unspecified (PubMed=7873502).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   KC-1 [Koala]
AC   CVCL_IK54
SY   Koala Conjunctiva-1
DR   Wikidata; Q54899594
RX   PubMed=14505439;
CC   Group: Marsupial cell line.
CC   Doubling time: 16.5 hours (Note=In 10% FCS), 26.5 hours (Note=In 2% FCS), 86 hours (Note=In absence of FCS) (PubMed=14505439).
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
OX   NCBI_TaxID=38626; ! Phascolarctos cinereus (Koala)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   KC-16
AC   CVCL_RP98
SY   HB KC-16(IgG1); KC-16(IgG1)
DR   CCRID; 4201PAT-CCTCC00005
DR   Wikidata; Q54899595
RX   Patent=US4752563;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8994.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   KC-48
AC   CVCL_XC66
SY   HB KC-48
DR   ATCC; HB-9584
DR   CCRID; 4201PAT-CCTCC00028
DR   Wikidata; Q94337162
RX   Patent=US4865971;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9584.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on neutrophils and eosinophils.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   KC-4G3
AC   CVCL_G228
SY   KC-4(IgG3); HB KC-4G3; KC4G3
DR   CLO; CLO_0007080
DR   ABCD; ABCD_AF058
DR   ATCC; HB-8709
DR   CCRID; 4201PAT-CCTCC00001
DR   Wikidata; Q54899596
RX   Patent=US4708930;
RX   PubMed=8244420;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8709.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   KC-4M1
AC   CVCL_G229
SY   KC-4(IgM)
DR   CLO; CLO_0007081
DR   ATCC; HB-8710
DR   CCRID; 4201PAT-CCTCC00002
DR   Wikidata; Q54899597
RX   Patent=US4708930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8710.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   KC-57
AC   CVCL_XC67
SY   HB KC-57
DR   ATCC; HB-9585
DR   CCRID; 4201PAT-CCTCC00029
DR   Wikidata; Q94337173
RX   Patent=US4886742;
RX   Patent=US4888290;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9585.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03347; HIV-1 isolate BH10 gag (Note=Also reacts with other isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   KC-88
AC   CVCL_B0T7
DR   Wikidata; Q108820624
RX   Patent=US5164293;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10562.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HTLV-1, HTLV-2 (Note=Also bind to STLV-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Kc-H
AC   CVCL_Z837
SY   KC-H; KcH
DR   FlyBase_Cell_line; FBtc9000004
DR   Wikidata; Q54899598
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=877552;
RX   PubMed=6780196;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   Kc-HP
AC   CVCL_Z838
SY   Kc HP; KcHP; KcAlo
DR   FlyBase_Cell_line; FBtc9000033
DR   Wikidata; Q54899599
RX   PubMed=886199;
CC   Group: Insect cell line.
CC   Caution: We are not certain that Kc-HP and KcAlo are the same cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   Kc0
AC   CVCL_Z840
SY   KcO; KC-O
DR   CLO; CLO_0007086
DR   CLDB; cl3015
DR   FlyBase_Cell_line; FBtc9000065
DR   Wikidata; Q54899600
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   KC02-44D
AC   CVCL_E224
DR   ATCC; SC-6000
DR   Wikidata; Q54899601
RX   PubMed=21801462;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Donor information: Established from a patient who had undergone total hysterectomy because of leiomyoma (PubMed=21801462).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ATCC=SC-6000
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   Kc1
AC   CVCL_C9EH
DR   Wikidata; Q123032799
RX   PubMed=811480;
CC   Group: Insect cell line.
CC   Karyotypic information: Has an unusual percentage of tetraploid cells (about 30%) (PubMed=811480).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   KC12
AC   CVCL_X904
SY   KC 12; KC-12
DR   cancercelllines; CVCL_X904
DR   CGH-DB; 9334-4
DR   Cosmic; 849373
DR   Cosmic; 2520638
DR   GEO; GSM374460
DR   Progenetix; CVCL_X904
DR   Wikidata; Q54899602
RX   PubMed=8105119;
RX   PubMed=10761702;
RX   PubMed=11146448;
RX   PubMed=22949125;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=8105119).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_217071; Renal cell carcinoma
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 12
//
ID   KC13-2
AC   CVCL_UF16
SY   Kupffer Cells 13-2
DR   Wikidata; Q94337197
RX   PubMed=12832442;
RX   PubMed=19835055;
WW   Info; -; -; https://www.forschung3r.ch/en/publications/bu26.html
CC   Characteristics: Useful for the study of drug delivery, of phagocytosis of pathogens and apoptotic cells and of the role of Kupffer cells in transplantation (PubMed=19835055).
CC   Characteristics: Grows stably at 33 Celsius without gamma-interferon. Also grows, more slowly, at 37 Celsius (PubMed=12832442).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Kupffer cell; CL=CL_0000091.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   Kc167
AC   CVCL_Z834
SY   KC167; Kc 167; Kc-167; Kc(167); Kc clone 167
DR   BTO; BTO_0003920
DR   EFO; EFO_0005819
DR   DGRC; 1
DR   ENCODE; ENCBS015VGB
DR   ENCODE; ENCBS135ZQF
DR   ENCODE; ENCBS182VSZ
DR   ENCODE; ENCBS204IEG
DR   ENCODE; ENCBS205EQM
DR   ENCODE; ENCBS225MFU
DR   ENCODE; ENCBS252ADJ
DR   ENCODE; ENCBS254GKI
DR   ENCODE; ENCBS329ISE
DR   ENCODE; ENCBS330RPK
DR   ENCODE; ENCBS382VFL
DR   ENCODE; ENCBS394RBY
DR   ENCODE; ENCBS428NFS
DR   ENCODE; ENCBS478PEU
DR   ENCODE; ENCBS486FOA
DR   ENCODE; ENCBS535RCG
DR   ENCODE; ENCBS539YYB
DR   ENCODE; ENCBS603LDU
DR   ENCODE; ENCBS669SLI
DR   ENCODE; ENCBS675YSX
DR   ENCODE; ENCBS719PGH
DR   ENCODE; ENCBS729BWH
DR   ENCODE; ENCBS780AES
DR   ENCODE; ENCBS796GIW
DR   ENCODE; ENCBS803AIQ
DR   ENCODE; ENCBS836UXA
DR   ENCODE; ENCBS851EXM
DR   ENCODE; ENCBS862SKE
DR   ENCODE; ENCBS878BZF
DR   ENCODE; ENCBS880SDK
DR   ENCODE; ENCBS890JHV
DR   ENCODE; ENCBS931HGX
DR   ENCODE; ENCBS942QVO
DR   ENCODE; ENCBS985UDR
DR   FlyBase_Cell_line; FBtc0000001
DR   Wikidata; Q54899603
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   DOI=10.4172/2472-1115.1000103;
RX   PubMed=6194991;
RX   PubMed=17890361;
RX   PubMed=21177962;
RX   PubMed=21958154;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
RX   PubMed=27789612;
RX   PubMed=33028628;
WW   Info; -; -; https://palivec.entu.cas.cz/zurovec/eng/research/cultures.html
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 22-24 hours (Note=Depending on growth medium) (DGRC=1).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   Kc167-(M3)
AC   CVCL_A5UP
SY   Kc167 (M3); Kc167 M3
DR   DGRC; 312
DR   FlyBase_Cell_line; FBtc0000312
DR   Wikidata; Q107115527
RX   PubMed=33028628;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in M3 medium.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   Kc167-(M3-FEx-2.5%)
AC   CVCL_A5UQ
SY   Kc167 (M3 FEx 2.5%); Kc167 FEx2.5%
DR   DGRC; 313
DR   FlyBase_Cell_line; FBtc0000313
DR   Wikidata; Q107115529
RX   PubMed=33028628;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in M3 + 2.5% Fly Extract (FEx) medium.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   Kc167-(M3BPYE-FEx2.5%)
AC   CVCL_A5UR
SY   Kc167 (M3BPYE FEx2.5%); Kc167 MBFEx2.5%
DR   DGRC; 314
DR   FlyBase_Cell_line; FBtc0000314
DR   Wikidata; Q107115532
RX   PubMed=33028628;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in M3 + BPYE + 2.5% Fly Extract (FEx) medium.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   Kc167-attP-25C6
AC   CVCL_A5US
SY   Kc167-attP-25C6-; Kc167-attP-25C6-Clone 35; Kc167-attP-25C6-Clone35
DR   DGRC; 317
DR   FlyBase_Cell_line; FBtc0000317
DR   Wikidata; Q107115534
RX   PubMed=33963853;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   Kc167-attP-99F8
AC   CVCL_A5UT
SY   Kc167-attP-99F8 Clone 71
DR   DGRC; 318
DR   FlyBase_Cell_line; FBtc0000318
DR   Wikidata; Q107115535
RX   PubMed=33963853;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 99F8 locus (PubMed=33963853).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   Kc167-IPPI-66D
AC   CVCL_5I02
DR   DGRC; 233
DR   FlyBase_Cell_line; FBtc0000233
DR   Wikidata; Q54899604
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Characteristics: Has a nuclear eGFP targeted to phiC31 docking site.
CC   Doubling time: ~1 day (DGRC=233).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-IPPI-66D-Mt-mCherry
AC   CVCL_5I03
DR   DGRC; 244
DR   FlyBase_Cell_line; FBtc0000244
DR   Wikidata; Q54899607
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Characteristics: Has Mt-mCherry targeted to phiC31 docking site.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_5I02 ! Kc167-IPPI-66D
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-Mt-mCherry-c1
AC   CVCL_5I04
DR   DGRC; 246
DR   FlyBase_Cell_line; FBtc0000246
DR   Wikidata; Q54899608
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_5I15 ! Kc167-PP-93E
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-Mt-mCherry-c2
AC   CVCL_5I05
DR   DGRC; 247
DR   FlyBase_Cell_line; FBtc0000247
DR   Wikidata; Q54899609
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_5I15 ! Kc167-PP-93E
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-Mt-mCherry-c3
AC   CVCL_5I06
DR   DGRC; 248
DR   FlyBase_Cell_line; FBtc0000248
DR   Wikidata; Q54899610
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_5I15 ! Kc167-PP-93E
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-16F
AC   CVCL_5I07
DR   DGRC; 219
DR   FlyBase_Cell_line; FBtc0000219
DR   Wikidata; Q54899611
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=219).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-21B
AC   CVCL_5I08
DR   DGRC; 220
DR   FlyBase_Cell_line; FBtc0000220
DR   Wikidata; Q54899612
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=220).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-21D
AC   CVCL_5I09
DR   DGRC; 221
DR   FlyBase_Cell_line; FBtc0000221
DR   Wikidata; Q54899613
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 8
//
ID   Kc167-PP-50Aa
AC   CVCL_5I10
DR   DGRC; 222
DR   FlyBase_Cell_line; FBtc0000222
DR   Wikidata; Q54899614
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=222).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-50Ab
AC   CVCL_5I11
DR   DGRC; 223
DR   FlyBase_Cell_line; FBtc0000223
DR   Wikidata; Q54899615
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=223).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-52E
AC   CVCL_5I12
DR   DGRC; 224
DR   FlyBase_Cell_line; FBtc0000224
DR   Wikidata; Q54899616
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=224).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-61C
AC   CVCL_5I13
DR   DGRC; 225
DR   FlyBase_Cell_line; FBtc0000225
DR   Wikidata; Q54899617
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=225).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-89B
AC   CVCL_5I14
DR   DGRC; 226
DR   FlyBase_Cell_line; FBtc0000226
DR   Wikidata; Q54899618
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=226).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-93E
AC   CVCL_5I15
DR   DGRC; 227
DR   FlyBase_Cell_line; FBtc0000227
DR   Wikidata; Q54899619
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=227).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-93E-Mt-mCherry
AC   CVCL_5I16
DR   DGRC; 245
DR   FlyBase_Cell_line; FBtc0000245
DR   Wikidata; Q54899620
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_5I15 ! Kc167-PP-93E
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc167-PP-99A
AC   CVCL_5I17
DR   DGRC; 228
DR   FlyBase_Cell_line; FBtc0000228
DR   Wikidata; Q54899621
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Doubling time: ~1 day (DGRC=228).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Kc2
AC   CVCL_C9EI
DR   Wikidata; Q123032801
RX   PubMed=811480;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Kc23
AC   CVCL_Z900
SY   Kc 23
DR   FlyBase_Cell_line; FBtc9000012
DR   Wikidata; Q54899622
RX   PubMed=2515901;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   KC2H3
AC   CVCL_M608
DR   Wikidata; Q54899623
RX   PubMed=1836174;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M605 ! 105KC
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Kc3
AC   CVCL_C9EJ
DR   Wikidata; Q123032803
RX   PubMed=811480;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Kc3 clone F6
AC   CVCL_C9EK
DR   Wikidata; Q123032805
RX   PubMed=811480;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_C9EJ ! Kc3
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Kc3 clone F6 subclone FC
AC   CVCL_C9EL
SY   Kc clone FC
DR   Wikidata; Q123032807
RX   PubMed=811480;
RX   PubMed=6778694;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_C9EK ! Kc3 clone F6
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Kc7E10
AC   CVCL_Z835
SY   Kc 7E10
DR   DGRC; 182
DR   FlyBase_Cell_line; FBtc0000182
DR   Wikidata; Q54899624
RX   PubMed=7760738;
RX   PubMed=8062820;
CC   Group: Insect cell line.
CC   Doubling time: 4 days (DGRC=182).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z833 ! Kc
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   KCA190
AC   CVCL_C4DD
DR   ABCD; ABCD_AQ261
DR   Wikidata; Q116049615
RX   DOI=10.1002/(SICI)1096-9063(1998110)54:3<189::AID-PS812>3.0.CO;2-A;
RX   Patent=JP2001037481A;
RX   Patent=JPH0937784A;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_3680; Chrysanthemic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   KCA226
AC   CVCL_C4DE
SY   KCA 226
DR   ABCD; ABCD_AQ262
DR   Wikidata; Q116049617
RX   DOI=10.1002/(SICI)1096-9063(1998110)54:3<189::AID-PS812>3.0.CO;2-A;
RX   Patent=JP2001037481A;
RX   Patent=JPH0937784A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15051.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_3680; Chrysanthemic acid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   KCB 200004
AC   CVCL_A2XN
DR   KCB; KCB 200004
DR   Wikidata; Q105509758
RX   DOI=10.3724/SP.J.1141.2008.00225;
RX   PubMed=16443346;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=71854; ! Muntiacus crinifrons (Black muntjac)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   KCB 200203
AC   CVCL_YA01
DR   KCB; KCB 200203
DR   Wikidata; Q94337309
RX   PubMed=16850210;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9860; ! Cervus elaphus (Red deer)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200208
AC   CVCL_YA00
DR   KCB; KCB 200208
DR   Wikidata; Q94337311
RX   PubMed=16850210;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9863; ! Cervus nippon (Sika deer)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200224
AC   CVCL_XZ74
DR   KCB; KCB 200224
DR   Wikidata; Q94337317
RX   PubMed=22086079;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9654; ! Procyon lotor (Raccoon)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200250
AC   CVCL_YA02
DR   KCB; KCB 200250
DR   Wikidata; Q94337318
RX   PubMed=16850210;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=109298; ! Elaphodus cephalophus (Tufted deer)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200311S
AC   CVCL_XZ78
SY   KCB 200311
DR   KCB; KCB 200311S
DR   Wikidata; Q94337320
RX   PubMed=16628499;
RX   PubMed=19283495;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9974; ! Manis javanica (Malayan pangolin)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   KCB 200317
AC   CVCL_YA03
DR   KCB; KCB 200317
DR   Wikidata; Q94337322
RX   PubMed=15973503;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=34865; ! Capricornis sumatraensis (Sumatran serow)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200405
AC   CVCL_XZ75
DR   KCB; KCB 200405
DR   Wikidata; Q94337325
RX   PubMed=22086079;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9646; ! Ailuropoda melanoleuca (Giant panda)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200547L
AC   CVCL_YA05
DR   KCB; KCB 200547L
DR   Wikidata; Q94337328
RX   PubMed=19283495;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=143292; ! Manis pentadactyla (Chinese pangolin)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200632
AC   CVCL_XZ76
DR   KCB; KCB 200632
DR   Wikidata; Q94337330
RX   PubMed=22086079;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=71117; ! Paradoxurus hermaphroditus (Asian palm civet)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 200820
AC   CVCL_XZ77
DR   KCB; KCB 200820
DR   Wikidata; Q94337332
RX   PubMed=22086079;
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=1706337; ! Neophocaena asiaeorientalis asiaeorientalis (Yangtze finless porpoise)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 2012053S
AC   CVCL_BS82
DR   KCB; KCB 2012053S
DR   Wikidata; Q54899625
RX   PubMed=23266978;
CC   Group: Endangered species/breed cell line.
CC   Group: Bird cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=128390; ! Nipponia nippon (Crested ibis)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   KCB 2012055S
AC   CVCL_BS83
DR   KCB; KCB 2012055S
DR   Wikidata; Q54899626
RX   PubMed=23266978;
CC   Group: Endangered species/breed cell line.
CC   Group: Bird cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=128390; ! Nipponia nippon (Crested ibis)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   KCB 83003
AC   CVCL_XZ93
DR   KCB; KCB 83003
DR   Wikidata; Q94337345
RX   PubMed=22086079;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=140016; ! Herpestes javanicus (Small Indian mongoose)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 86005M
AC   CVCL_XZ80
DR   KCB; KCB 86005M
DR   Wikidata; Q94337348
RX   PubMed=11901994;
RX   PubMed=12067210;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9649; ! Ailurus fulgens (Himalayan red panda)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 87020
AC   CVCL_XZ85
DR   KCB; KCB 87020
DR   Wikidata; Q94337351
RX   PubMed=12067210;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=204267; ! Melogale moschata (Chinese ferret-badger)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 88002
AC   CVCL_XZ96
DR   KCB; KCB 88002
DR   Wikidata; Q94337353
RX   PubMed=15973503;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=1088030; ! Naemorhedus baileyi (Red goral)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 88003
AC   CVCL_A2XP
DR   KCB; KCB 88003
DR   Wikidata; Q105509763
RX   DOI=10.3724/SP.J.1141.2008.00225;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=145526; ! Muntiacus gongshanensis (Gongshan muntjac)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   KCB 88006L
AC   CVCL_XZ81
DR   KCB; KCB 88006L
DR   Wikidata; Q94337355
RX   PubMed=14712859;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=192959; ! Nyctereutes procyonoides procyonoides (Chinese raccoon dog)
OI   CVCL_XZ82 ! KCB 88006T
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   KCB 88006T
AC   CVCL_XZ82
DR   KCB; KCB 88006T
DR   Wikidata; Q94337361
OX   NCBI_TaxID=192959; ! Nyctereutes procyonoides procyonoides (Chinese raccoon dog)
OI   CVCL_XZ81 ! KCB 88006L
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   KCB 88023
AC   CVCL_XZ79
DR   KCB; KCB 88023
DR   Wikidata; Q94337363
RX   PubMed=16628499;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=217708; ! Hemiechinus auritus (Long-eared hedgehog)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   KCB 89001
AC   CVCL_4231
DR   CLO; CLO_0007083
DR   CLDB; cl3013
DR   ECACC; 93052109
DR   KCB; KCB 89001
DR   Wikidata; Q54899627
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=662561; ! Rusa unicolor (Sambar)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   KCB 89011
AC   CVCL_XZ95
DR   KCB; KCB 89011
DR   Wikidata; Q94337371
RX   PubMed=14984103;
CC   Caution: Indicated to be KCB 89010 in PubMed=14984103, but this corresponds to another cell line in the KCB collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9793; ! Equus asinus (Donkey)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   KCB 90004
AC   CVCL_XZ92
DR   KCB; KCB 90004
DR   Wikidata; Q94337374
RX   PubMed=14984102;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9689; ! Panthera leo (Lion)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   KCB 90008
AC   CVCL_4233
DR   CLO; CLO_0007084
DR   CLDB; cl3014
DR   ECACC; 94042031
DR   KCB; KCB 90008
DR   Wikidata; Q54899628
CC   Discontinued: ECACC; 94042031; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9612; ! Canis lupus (Gray wolf)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   KCB 91001
AC   CVCL_A2XQ
DR   KCB; KCB 91001
DR   Wikidata; Q105509766
RX   DOI=10.3724/SP.J.1141.2008.00225;
RX   PubMed=16443346;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9886; ! Muntiacus reevesi (Reeves' muntjac)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   KCB 91006
AC   CVCL_A2XR
DR   KCB; KCB 91006
DR   Wikidata; Q105509770
RX   DOI=10.3724/SP.J.1141.2008.00225;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=71855; ! Muntiacus feae (Fea's muntjac)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   KCB 96008
AC   CVCL_WL30
DR   KCB; KCB 96008
DR   Wikidata; Q94337382
RX   CelloPub=CLPUB00501;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9783; ! Elephas maximus (Indian elephant)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KCB 99002
AC   CVCL_XZ68
DR   KCB; KCB 99002
DR   Wikidata; Q94337384
RX   PubMed=18267302;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61853; ! Nomascus leucogenys (Northern white-cheeked gibbon)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   KCB1
AC   CVCL_D3ZE
DR   Wikidata; Q127382410
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29786757; PubMed=35124168).
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   8Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KCB10
AC   CVCL_D3ZK
DR   Wikidata; Q127382411
RX   PubMed=32144432;
RX   PubMed=34275013;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KCB2
AC   CVCL_D3ZF
DR   Wikidata; Q127382412
RX   PubMed=32144432;
RX   PubMed=34275013;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=32144432; PubMed=34275013).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KCB4
AC   CVCL_D3ZG
DR   Wikidata; Q127382413
RX   PubMed=29786757;
RX   PubMed=32144432;
RX   PubMed=34275013;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y11M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KCB6
AC   CVCL_D3ZH
DR   Wikidata; Q127382414
RX   PubMed=32144432;
RX   PubMed=34275013;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=32144432; PubMed=34275013).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KCB7
AC   CVCL_D3ZI
DR   Wikidata; Q127382415
RX   PubMed=32144432;
RX   PubMed=34275013;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=32144432; PubMed=34275013).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y3M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KCB9
AC   CVCL_D3ZJ
DR   Wikidata; Q127382416
RX   PubMed=32144432;
RX   PubMed=34275013;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1008; BCL9 + HGNC; HGNC:6997; MEF2D; Name(s)=MEF2D-BCL9 (PubMed=32144432; PubMed=34275013).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y5M
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KCC-L871
AC   CVCL_7961
SY   KCC L871
DR   Cosmic; 1136976
DR   Cosmic; 1556192
DR   Wikidata; Q54899629
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 23.14 hours (PubMed=21362583).
CC   HLA typing: A*24:02,31:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 15,16
ST   D21S11: 31.2
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 19,23
ST   Penta D: 11
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   KCC-M871
AC   CVCL_7962
SY   KCC M871
DR   Cosmic; 1136973
DR   Cosmic; 1556191
DR   GEO; GSM1643588
DR   Wikidata; Q54899630
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 23.67 hours (PubMed=21362583).
CC   HLA typing: A*24:02 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 15
ST   D21S11: 32.1
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 16,19
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KCC-MS871
AC   CVCL_7963
SY   KCC MS871
DR   Cosmic; 1136971
DR   Cosmic; 1556185
DR   Wikidata; Q54899631
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26780976;
RX   PubMed=26781072;
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from a maxillary sinus squamous cell carcinoma.
CC   Population: African American.
CC   Doubling time: 27.17 hours (PubMed=21362583).
CC   HLA typing: A*68:02 (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   KCC-T871
AC   CVCL_7964
SY   KCC T871
DR   Cosmic; 1136963
DR   Cosmic; 1556184
DR   GEO; GSM1643585
DR   Wikidata; Q54899632
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 23.49 hours (PubMed=21362583).
CC   HLA typing: A*02:01 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 5
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KCC-T873
AC   CVCL_7965
SY   KCC T873
DR   Cosmic; 1136964
DR   Cosmic; 1556193
DR   Wikidata; Q54899633
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 13.95 hours (PubMed=21362583).
CC   HLA typing: A*11:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 19
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 20,24
ST   Penta D: 10,12
ST   Penta E: 10,21
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7967 ! KCC-TCM902
OI   CVCL_7968 ! KCC-TCM903
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   KCC-TCM901
AC   CVCL_7966
SY   KCC TCM901
DR   Cosmic; 1136965
DR   Cosmic; 1556194
DR   Wikidata; Q54899635
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26780976;
RX   PubMed=26781072;
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from a lung metastasis of a tongue squamous cell carcinoma.
CC   Population: African American.
CC   Doubling time: 12.59 hours (PubMed=21362583).
CC   HLA typing: A*68:02 (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   KCC-TCM902
AC   CVCL_7967
SY   KCC TCM902
DR   Cosmic; 1136966
DR   Cosmic; 1556195
DR   Wikidata; Q54899636
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
CC   Population: Japanese.
CC   Doubling time: 12.05 hours (PubMed=21362583).
CC   HLA typing: A*11:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 19
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 20,24
ST   Penta D: 10,12
ST   Penta E: 10,21
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7965 ! KCC-T873
OI   CVCL_7968 ! KCC-TCM903
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   KCC-TCM903
AC   CVCL_7968
SY   KCC TCM903
DR   Cosmic; 1136967
DR   Cosmic; 1556196
DR   Wikidata; Q54899637
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
CC   Population: Japanese.
CC   Doubling time: 21.39 hours (PubMed=21362583).
CC   HLA typing: A*11:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 19
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 20,24
ST   Penta D: 10,12
ST   Penta E: 10,21
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7965 ! KCC-T873
OI   CVCL_7967 ! KCC-TCM902
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   KCCF1
AC   CVCL_M157
SY   Kids Cancer Care Foundation 1
DR   Wikidata; Q54899638
RX   PubMed=18651103;
RX   PubMed=22206574;
WW   Info; -; -; https://web.archive.org/web/20101125071215/http://medicine.ucalgary.ca/about/kids_cancer
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 9
//
ID   KCE
AC   CVCL_C6JK
SY   Koi Carp Eye
DR   Wikidata; Q116049619
WW   Provider; AAHL; -; https://aahl.res.in/koi-carp-cyprinus-carpio-carpio-eye-kce-cell-line/
CC   Group: Fish cell line.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   KCEK
AC   CVCL_1L46
DR   Wikidata; Q54899639
RX   PubMed=21213599;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   20-21FD
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 9
//
ID   KCEL
AC   CVCL_1L47
DR   Wikidata; Q54899640
RX   PubMed=21213599;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   20-21FD
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 9
//
ID   KCF-1
AC   CVCL_W097
SY   Koi Caudal Fin-1
DR   Wikidata; Q54899641
RX   PubMed=21839788;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   KCGMHi001-A
AC   CVCL_E4DV
SY   KCGMH-CEP85L-K303-A4
DR   BioSamples; SAMEA116099400
DR   hPSCreg; KCGMHi001-A
CC   From: Kaohsiung Chang Gung Memorial Hospital; Kaohsiung; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103921; Lissencephaly
DI   ORDO; Orphanet_48471; Lissencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KCGMHi002-A
AC   CVCL_E4DW
SY   KCGMH-MAST1-K2271-A1
DR   BioSamples; SAMEA116304710
DR   hPSCreg; KCGMHi002-A
CC   From: Kaohsiung Chang Gung Memorial Hospital; Kaohsiung; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212888; Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KCI-MENG1-HP
AC   CVCL_2H42
SY   KCI-MENG1-High Passage
DR   Wikidata; Q54899642
RX   PubMed=26174772;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, olfactory groove; UBERON=UBERON_0002772.
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H40 ! KCI-MENG1-LP
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 6
//
ID   KCI-MENG1-HPSX-CL
AC   CVCL_2H43
DR   Wikidata; Q54899643
RX   PubMed=26174772;
CC   Characteristics: Established from a xenograft obtained by subcutaneous injection of the parent cell line (PubMed=26174772).
CC   Derived from site: In situ; Brain, olfactory groove; UBERON=UBERON_0002772.
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H42 ! KCI-MENG1-HP
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 6
//
ID   KCI-MENG1-LP
AC   CVCL_2H40
SY   KCI-MENG1-Low Passage
DR   Wikidata; Q54899644
RX   PubMed=26174772;
CC   Doubling time: 58.77 hours (Note=At 6th passage), 29.37 hours (Note=At 9th passage), 27.33 hours (Note=At 75th passage) (PubMed=26174772).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, olfactory groove; UBERON=UBERON_0002772.
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 6
//
ID   KCI-MENG1-LPSX-CL
AC   CVCL_2H41
DR   Wikidata; Q54899645
RX   PubMed=26174772;
CC   Characteristics: Established from a xenograft obtained by subcutaneous injection of the parent cell line (PubMed=26174772).
CC   Derived from site: In situ; Brain, olfactory groove; UBERON=UBERON_0002772.
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H40 ! KCI-MENG1-LP
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 6
//
ID   KCI-MOH1
AC   CVCL_2090
SY   KciMoh-1; KCIMOH1; WSU-MOH1
DR   EFO; EFO_0006608
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03151779
DR   cancercelllines; CVCL_2090
DR   Cell_Model_Passport; SIDM01933
DR   DepMap; ACH-001098
DR   DSMZ; ACC-498
DR   DSMZCellDive; ACC-498
DR   EGA; EGAS00001000610
DR   GEO; GSM887201
DR   GEO; GSM888274
DR   PharmacoDB; KCIMOH1_738_2019
DR   Progenetix; CVCL_2090
DR   Wikidata; Q54899646
RX   DOI=10.22029/jlupub-12385;
RX   PubMed=9436858;
RX   PubMed=15770730;
RX   PubMed=20143388;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HPAC derivative (PubMed=20143388). Originally thought to originate from a 74 year old male patient with a moderately differentiated adenocarcinoma of the head of the pancreas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00322.
CC   Population: Caucasian.
CC   Doubling time: ~70 hours (DSMZ=ACC-498).
CC   HLA typing: A*03:01,03:01; B*14:02,14:02; C*08:02,08:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.11%; East Asian, North=2.33%; East Asian, South=0%; South Asian=0%; European, North=65.07%; European, South=32.5% (PubMed=30894373).
CC   Discontinued: BioIVT/Asterand Bioscience; Catalog number WSU-MOH1.
CC   Discontinued: DSMZ; ACC-498; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
ST   Source(s): DSMZ=ACC-498
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 15
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 15,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3517 ! HPAC
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   KCi001-A
AC   CVCL_VP78
SY   BBS1 Clone 10; BBS1 Clone10
DR   hPSCreg; KCi001-A
DR   Wikidata; Q94337483
RX   PubMed=30142598;
CC   From: Kennedy Centret, Rigshospitalet; Glostrup; Denmark.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:966; BBS1; Simple; p.Gly379Arg (c.1135G>C); Zygosity=Heterozygous (PubMed=30142598).
CC   Sequence variation: Mutation; HGNC; HGNC:966; BBS1; Simple; p.Met390Arg (c.1169T>G); ClinVar=VCV000012143; Zygosity=Heterozygous (PubMed=30142598).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 13
//
ID   KCi002-A
AC   CVCL_UG22
SY   BBS10 Clone1A; BBS-10 Clone1A
DR   hPSCreg; KCi002-A
DR   Wikidata; Q94337486
RX   PubMed=30312873;
CC   From: Kennedy Centret, Rigshospitalet; Glostrup; Denmark.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:26291; BBS10; Simple; p.Cys91Leufs*5 (c.271dupT) (271insT); ClinVar=VCV000001328; Zygosity=Homozygous (PubMed=30312873).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   KCi003-A
AC   CVCL_YC31
SY   BBS5 clone 3A; BBS5 cl. 3A
DR   hPSCreg; KCi003-A
DR   Wikidata; Q94337487
RX   PubMed=31760295;
CC   From: Kennedy Centret, Rigshospitalet; Glostrup; Denmark.
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:970; BBS5; Simple; p.Gly72Ser (c.214G>A); ClinVar=VCV000006161; Zygosity=Homozygous (PubMed=31760295).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC32 ! KCi003-B
OI   CVCL_YC33 ! KCi003-C
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   KCi003-B
AC   CVCL_YC32
SY   BBS5 clone 4A; BBS5 cl. 4A
DR   hPSCreg; KCi003-B
DR   Wikidata; Q94337489
RX   PubMed=31760295;
CC   From: Kennedy Centret, Rigshospitalet; Glostrup; Denmark.
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:970; BBS5; Simple; p.Gly72Ser (c.214G>A); ClinVar=VCV000006161; Zygosity=Homozygous (PubMed=31760295).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC31 ! KCi003-A
OI   CVCL_YC33 ! KCi003-C
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   KCi003-C
AC   CVCL_YC33
SY   BBS5 clone 5A; BBS5 cl. 5A
DR   hPSCreg; KCi003-C
DR   Wikidata; Q94337492
RX   PubMed=31760295;
CC   From: Kennedy Centret, Rigshospitalet; Glostrup; Denmark.
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:970; BBS5; Simple; p.Gly72Ser (c.214G>A); ClinVar=VCV000006161; Zygosity=Homozygous (PubMed=31760295).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118632; Bardet-Biedl syndrome
DI   ORDO; Orphanet_110; Bardet-Biedl syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC31 ! KCi003-A
OI   CVCL_YC32 ! KCi003-B
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   KCi004-A
AC   CVCL_C9ID
SY   Pink1 c2512, clone Cl1B; Pink1-Cl1B-c2512
DR   hPSCreg; KCi004-A
DR   Wikidata; Q123032809
RX   PubMed=37524028;
CC   From: Kennedy Centret, Rigshospitalet; Glostrup; Denmark.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Gln456Ter (c.1366C>T); ClinVar=VCV000002415; Zygosity=Homozygous (PubMed=37524028).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9IC ! FFF-051
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KCi005-A
AC   CVCL_D6L6
SY   Pink1 P0947, clone Cl11B; Pink1-Cl11B-P0947
DR   hPSCreg; KCi005-A
DR   Wikidata; Q127382417
RX   PubMed=38103334;
CC   From: Kennedy Centret, Rigshospitalet; Glostrup; Denmark.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Gln456Ter (c.1366C>T); ClinVar=VCV000002415; Zygosity=Homozygous (PubMed=38103334).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   KCL-22
AC   CVCL_2091
SY   KCL22; Kcl22; KCL22S; KCL22-S; KCL22-s
DR   BTO; BTO_0004137
DR   CLO; CLO_0009841
DR   EFO; EFO_0022565
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-3349
DR   BioSample; SAMN03472399
DR   BioSample; SAMN03473517
DR   BioSample; SAMN10988558
DR   cancercelllines; CVCL_2091
DR   Cell_Model_Passport; SIDM01004
DR   ChEMBL-Cells; CHEMBL4295403
DR   ChEMBL-Targets; CHEMBL4296452
DR   Cosmic; 919142
DR   Cosmic; 924053
DR   Cosmic; 1019832
DR   Cosmic; 1026566
DR   Cosmic; 1070700
DR   Cosmic; 1078720
DR   Cosmic; 1176585
DR   Cosmic; 1436596
DR   Cosmic; 1498417
DR   Cosmic; 2009517
DR   Cosmic-CLP; 1330931
DR   DepMap; ACH-000983
DR   DSMZ; ACC-519
DR   DSMZCellDive; ACC-519
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10801-110I9
DR   GDSC; 1330931
DR   GEO; GSM887202
DR   GEO; GSM888275
DR   GEO; GSM1669981
DR   IARC_TP53; 2223
DR   JCRB; JCRB1317
DR   JCRB; NIHS0534
DR   LiGeA; CCLE_363
DR   LINCS_LDP; LCL-1105
DR   NCBI_Iran; C574
DR   PharmacoDB; KCL22_739_2019
DR   PRIDE; PXD000030
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2091
DR   PubChem_Cell_line; CVCL_2091
DR   Wikidata; Q54899647
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3332852;
RX   PubMed=6321612;
RX   PubMed=6576961;
RX   PubMed=9510473;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=17549412;
RX   PubMed=20417730;
RX   PubMed=22460905;
RX   PubMed=23754495;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=6321612); 24-30 hours (ATCC=CRL-3349); ~24 hours (DSMZ=ACC-519); ~39 hours (Note=Lot 12092010) (JCRB=JCRB1317).
CC   HLA typing: A*24:02,26:03; B*15:01,40:06; C*03:03,03:03 (PubMed=26589293).
CC   HLA typing: A*24:02:01,26:03:01; B*15:01:01,40:06:01; C*03:03:01,03:03:01 (DSMZCellDive=ACC-519).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=9510473; PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; DepMap=ACH-000983).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (PubMed=9510473).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Leufs*5 (c.3261dupC) (3261_3262insC); ClinVar=VCV000089364; Zygosity=Heterozygous (PubMed=9510473; Cosmic-CLP=1330931; DepMap=ACH-000983).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Homozygous (DepMap=ACH-000983).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.5%; East Asian, North=75.25%; East Asian, South=24.24%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0534; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3349; Cosmic-CLP=1330931; DSMZ=ACC-519; JCRB=JCRB1317
ST   Amelogenin: X
ST   CSF1PO: 11,12 (ATCC=CRL-3349)
ST   CSF1PO: 12 (Cosmic-CLP=1330931; DSMZ=ACC-519; JCRB=JCRB1317)
ST   D13S317: 8 (ATCC=CRL-3349)
ST   D13S317: 8,11 (Cosmic-CLP=1330931; DSMZ=ACC-519)
ST   D13S317: 8,12 (JCRB=JCRB1317)
ST   D16S539: 11,12 (ATCC=CRL-3349)
ST   D16S539: 12 (Cosmic-CLP=1330931; DSMZ=ACC-519; JCRB=JCRB1317)
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 29,34.2
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 10,11 (ATCC=CRL-3349; JCRB=JCRB1317)
ST   D5S818: 10,12 (Cosmic-CLP=1330931; DSMZ=ACC-519)
ST   D7S820: 11,12 (JCRB=JCRB1317)
ST   D7S820: 12 (ATCC=CRL-3349; Cosmic-CLP=1330931; DSMZ=ACC-519)
ST   D8S1179: 10,11,13,14
ST   FGA: 22,26
ST   Penta D: 9,13
ST   Penta E: 17,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   KCL001
AC   CVCL_A237
SY   KCL001(WT3); KCL-001; WT-3; WT3; KCLe001-A
DR   hPSCreg; KCLe001-A
DR   SKIP; SKIP001880
DR   Wikidata; Q54899650
RX   PubMed=14653899;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0019.
CC   Registration: UK Stem Cell Bank (UKSCB); R-04-017, Steering comm. appl. SCSC03-08.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   KCL002
AC   CVCL_A238
SY   KCL002(WT4); KCL-002; WT-4; WT4; KCL002/WT4; KCLe002-A
DR   hPSCreg; KCLe002-A
DR   SKIP; SKIP001881
DR   Wikidata; Q54899651
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/kcl002-wt4.aspx
CC   From: King's College London; London; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0018.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-028, Steering comm. appl. SCSC-06-28(1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   KCL003
AC   CVCL_A239
SY   KCL003(CF1); KCL-003; CF-1; CF1; KCL003/CF-1; KCL-003-CF-1; KCL003_CF1; KCLe003-A
DR   hPSCreg; KCLe003-A
DR   SKIP; SKIP001882
DR   Wikidata; Q54899653
RX   PubMed=15820050;
RX   PubMed=17572666;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/kcl003-cf-1.aspx
CC   From: King's College London; London; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0017.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-027, Steering comm. appl. SCSC-06-28(2).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=15820050).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   KCL004
AC   CVCL_A240
SY   KCL-004; KCLe005-A
DR   hPSCreg; KCLe005-A
DR   SKIP; SKIP002334
DR   Wikidata; Q54899654
RX   PubMed=20178004;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   KCL005
AC   CVCL_A241
SY   KCL005(HD1); KCL-005; HD-1; KCL005-HD1; KCL005_HD1; KCLe004-A
DR   hPSCreg; KCLe004-A
DR   SKIP; SKIP001894
DR   Wikidata; Q54899655
RX   PubMed=20178004;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-013, Steering comm. appl. SCSC07-11.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   KCL006
AC   CVCL_A242
SY   KCL-006; KCLe006-A
DR   hPSCreg; KCLe006-A
DR   SKIP; SKIP002335
DR   Wikidata; Q54899656
RX   PubMed=20178004;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   KCL008
AC   CVCL_A243
SY   KCL008(HD2); KCL-008; HD-2; KCL008-HD2; KCL008_HD2; KCLe007-A
DR   hPSCreg; KCLe007-A
DR   SKIP; SKIP002336
DR   Wikidata; Q27570645
RX   PubMed=20178004;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-010, Steering comm. appl. SCSC07-49.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (PubMed=20178004).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   KCL009
AC   CVCL_A244
SY   KCL009(trans-1); KCL-009-trans1; KCL009-trans1; KCL009/trans-1; KCLe008-A
DR   hPSCreg; KCLe008-A
DR   SKIP; SKIP002337
DR   Wikidata; Q54899657
RX   PubMed=20178004;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/kcl009-trans-1.aspx
CC   From: King's College London; London; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-011, Steering comm. appl. SCSC07-49(2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   KCL011
AC   CVCL_A245
SY   KCL-011; KCLe015-A
DR   hPSCreg; KCLe015-A
DR   NIHhESC; NIHhESC-13-0212
DR   SKIP; SKIP002412
DR   Wikidata; Q54899659
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0212.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-001, Steering comm. appl. SCSC10-31.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KCL012
AC   CVCL_A246
SY   KCL012(HD3); KCL-012; HD-3; HD3; KCL012_HD3; KCLe009-A
DR   hPSCreg; KCLe009-A
DR   NIHhESC; NIHhESC-13-0213
DR   SKIP; SKIP002357
DR   Wikidata; Q54899660
RX   PubMed=27345979;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0213.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-002, Steering comm. appl. SCSC10-32.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=27345979).
CC   Donor information: Embryo is sibling to that giving rise to KCL013 (Cellosaurus=CVCL_A247).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   KCL013
AC   CVCL_A247
SY   KCL013(HD4); KCL-013; HD-4; HD4; KCL013_HD4; KCLe010-A
DR   hPSCreg; KCLe010-A
DR   NIHhESC; NIHhESC-13-0214
DR   SKIP; SKIP002358
DR   Wikidata; Q54899661
RX   PubMed=27345987;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0214.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-003, Steering comm. appl. SCSC10-33.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=27345987).
CC   Donor information: Embryo is sibling to that giving rise to KCL012 (Cellosaurus=CVCL_A246).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   KCL015
AC   CVCL_A248
SY   KCL015(VHL2); KCL-015; VHL2; KCL015_VHL2; KCLe011-A
DR   hPSCreg; KCLe011-A
DR   NIHhESC; NIHhESC-13-0215
DR   SKIP; SKIP002359
DR   Wikidata; Q54899662
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0215.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-004, Steering comm. appl. SCSC10-36.
CC   Donor information: Embryo is sibling to those giving rise to KCL016 (Cellosaurus=CVCL_A249) and KCL017 (Cellosaurus=CVCL_A250).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   KCL016
AC   CVCL_A249
SY   KCL016(VHL3); KCL-016; VHL3; KCL016_VHL3; KCLe012-A
DR   hPSCreg; KCLe012-A
DR   NIHhESC; NIHhESC-13-0216
DR   SKIP; SKIP002360
DR   Wikidata; Q54899663
RX   PubMed=27345783;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0216.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-005, Steering comm. appl. SCSC10-35.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; c.676+3A>T; Zygosity=Heterozygous (PubMed=27345783).
CC   Donor information: Embryo is sibling to those giving rise to KCL015 (Cellosaurus=CVCL_A248) and KCL017 (Cellosaurus=CVCL_A250).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   KCL017
AC   CVCL_A250
SY   KCL017(VHL4); KCL-017; VHL4; KCL017_VHL4; KCLe013-A
DR   hPSCreg; KCLe013-A
DR   NIHhESC; NIHhESC-13-0217
DR   SKIP; SKIP002361
DR   Wikidata; Q54899664
RX   PubMed=27345980;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0217.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-006, Steering comm. appl. SCSC10-34.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; c.676+3A>T; Zygosity=Heterozygous (PubMed=27345980).
CC   Donor information: Embryo is sibling to those giving rise to KCL015 (Cellosaurus=CVCL_A248) and KCL016 (Cellosaurus=CVCL_A249).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   KCL018
AC   CVCL_A251
SY   KCL018(MD1); KCL-018; KCL018_MD1; MD1; KCLe014-A
DR   hPSCreg; KCLe014-A
DR   NIHhESC; NIHhESC-13-0218
DR   SKIP; SKIP002362
DR   Wikidata; Q54899665
RX   PubMed=27346000;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0218.
CC   Registration: UK Stem Cell Bank (UKSCB); R-13-006, Steering comm. appl. SCSC10-30.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~2200] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (PubMed=27346000).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   KCL019
AC   CVCL_A252
SY   KCL-019
DR   NIHhESC; NIHhESC-14-0270
DR   Wikidata; Q54899666
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0270.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-007, Steering comm. appl. SCSC11-13.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KCL020
AC   CVCL_A253
SY   KCL-020
DR   NIHhESC; NIHhESC-14-0271
DR   Wikidata; Q54899667
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0271.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-008, Steering comm. appl. SCSC11-13.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KCL021
AC   CVCL_A254
SY   KCL021(CF2); KCL-021; KCL021_CF2
DR   NIHhESC; NIHhESC-13-0219
DR   Wikidata; Q38515502
RX   PubMed=27345808;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0219.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-009, Steering comm. appl. SCSC11-14.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=27345808).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   KCL022
AC   CVCL_A255
SY   KCL-022
DR   NIHhESC; NIHhESC-14-0264
DR   Wikidata; Q54899669
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0264.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-010, Steering comm. appl. SCSC11-13.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KCL023
AC   CVCL_A256
SY   KCL-023
DR   NIHhESC; NIHhESC-14-0262
DR   Wikidata; Q54899670
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0262.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-011, Steering comm. appl. SCSC11-13.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   KCL024
AC   CVCL_A257
SY   KCL024(NF1_1); KCL-024; KCL024_NF1-1
DR   NIHhESC; NIHhESC-13-0220
DR   Wikidata; Q54899671
RX   PubMed=27345975;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0220.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-012, Steering comm. appl. SCSC11-48.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (PubMed=27345975).
CC   Donor information: Embryo is sibling to that giving rise to KCL025 (Cellosaurus=CVCL_A258).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   KCL025
AC   CVCL_A258
SY   KCL025(NF1_2); KCL-025; KCL024_NF1-2
DR   NIHhESC; NIHhESC-13-0221
DR   Wikidata; Q38513631
RX   PubMed=27345978;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0221.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-013, Steering comm. appl. SCSC11-48.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (PubMed=27345978).
CC   Donor information: Embryo is sibling to that giving rise to KCL024 (Cellosaurus=CVCL_A257).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   KCL026
AC   CVCL_A259
SY   KCL026(SMA); KCL-026; KCL026_SMA
DR   NIHhESC; NIHhESC-13-0222
DR   Wikidata; Q54899672
RX   PubMed=27345977;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0222.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-014, Steering comm. appl. SCSC11-49.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (PubMed=27345977).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   KCL027
AC   CVCL_A260
SY   KCL027(HD5); KCL-027; HD-5; HD5; KCL027_HD5
DR   NIHhESC; NIHhESC-13-0223
DR   Wikidata; Q54899673
RX   PubMed=27345982;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0223.
CC   Registration: UK Stem Cell Bank (UKSCB); R-13-009, Steering comm. appl. SCSC11-47.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=27345982).
CC   Donor information: Embryo is sibling to that giving rise to KCL028 (Cellosaurus=CVCL_A261).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   KCL028
AC   CVCL_A261
SY   KCL028(HD6); KCL-028; KCL028_HD6
DR   NIHhESC; NIHhESC-13-0224
DR   Wikidata; Q54899674
RX   PubMed=27345983;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0224.
CC   Registration: UK Stem Cell Bank (UKSCB); R-13-008, Steering comm. appl. SCSC11-47.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=27345983).
CC   Donor information: Embryo is sibling to that giving rise to KCL027 (Cellosaurus=CVCL_A260).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   KCL029
AC   CVCL_A262
SY   KCL029(CFWAS); KCL-029; KCL029_CFWAS
DR   NIHhESC; NIHhESC-13-0225
DR   Wikidata; Q54899675
RX   PubMed=27345811;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0225.
CC   Registration: UK Stem Cell Bank (UKSCB); R-13-007, Steering comm. appl. SCSC11-46.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asp1152His (c.3454G>C); ClinVar=VCV000035867; Zygosity=Heterozygous (PubMed=27345811).
CC   Sequence variation: Mutation; HGNC; HGNC:12731; WAS; Simple; p.Ser272Pro (c.814T>C); ClinVar=VCV000029966; Zygosity=Hemizygous (PubMed=27345811).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   KCL030
AC   CVCL_A263
SY   KCL030(BT1); KCL-030; KCL030_BT1
DR   NIHhESC; NIHhESC-13-0226
DR   Wikidata; Q54899676
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0226.
CC   Registration: UK Stem Cell Bank (UKSCB); R-13-010, Steering comm. appl. SCSC12-45.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   KCL031
AC   CVCL_A264
SY   KCL-031
DR   NIHhESC; NIHhESC-14-0263
DR   Wikidata; Q54899677
RX   PubMed=23161805;
RX   PubMed=26607962;
RX   PubMed=27345813;
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0263.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-011, Steering comm. appl. SCSC11-58-(d).
CC   HLA typing: A*02,24; B*51,52:01/04/07/13; C*14:01/07N/11/14,12:02/17/22/30; DRB1*11,15 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   KCL032
AC   CVCL_A265
SY   KCL-032
DR   NIHhESC; NIHhESC-14-0266
DR   Wikidata; Q54899678
RX   PubMed=23161805;
RX   PubMed=26607962;
RX   PubMed=27345778;
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0266.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-012, Steering comm. appl. SCSC11-58-(d).
CC   HLA typing: A*02,11; B*15,51; C*03.04; DRB1*04:07,12:02/39/73/96 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   KCL033
AC   CVCL_A266
SY   KCL-033
DR   NIHhESC; NIHhESC-14-0267
DR   Wikidata; Q54899679
RX   PubMed=23161805;
RX   PubMed=25122690;
RX   PubMed=26607962;
RX   PubMed=27345988;
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0267.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-013, Steering comm. appl. SCSC11-54.
CC   HLA typing: A*11,29; B*44,51; C*16,04; DRB1*04:07,07 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to KCL034 (Cellosaurus=CVCL_A267).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   KCL034
AC   CVCL_A267
SY   KCL-034
DR   NIHhESC; NIHhESC-14-0268
DR   Wikidata; Q54899681
RX   PubMed=23161805;
RX   PubMed=25122690;
RX   PubMed=26607962;
RX   PubMed=27345810;
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0268.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-014, Steering comm. appl. SCSC11-54.
CC   HLA typing: A*11,29; B*44,51; C*16,04; DRB1*04:07,07 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to KCL033 (Cellosaurus=CVCL_A266).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   KCL035
AC   CVCL_A268
SY   KCL-035
DR   NIHhESC; NIHhESC-13-0227
DR   Wikidata; Q54899682
RX   PubMed=27345970;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0227.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-015, Steering comm. appl. SCSC12-38.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KCL036
AC   CVCL_A269
SY   KCL-036
DR   NIHhESC; NIHhESC-13-0241
DR   Wikidata; Q54899684
RX   PubMed=27346001;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0241.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-016, Steering comm. appl. SCSC12-38.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   KCL037
AC   CVCL_A270
SY   KCL-037
DR   NIHhESC; NIHhESC-14-0269
DR   Wikidata; Q54899685
RX   PubMed=23161805;
RX   PubMed=26607962;
RX   PubMed=27345800;
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0269.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-015, Steering comm. appl. SCSC11-58-(d).
CC   HLA typing: A*02,03; B*35,40; C*03,04; DRB1*01,12:02/39/73/96 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   KCL038
AC   CVCL_A271
SY   KCL-038
DR   NIHhESC; NIHhESC-14-0265
DR   Wikidata; Q54899686
RX   PubMed=23161805;
RX   PubMed=26607962;
RX   PubMed=27345799;
RX   PubMed=28445466;
WW   Provider; KCL; -; https://www.kcl.ac.uk/research/stem-cell-research
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0265.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-016, Steering comm. appl. SCSC12-37.
CC   HLA typing: A*03,11; B*07,15; C*03.07; DRB1*14,15 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   KCL039
AC   CVCL_A272
SY   KCL-039
DR   NIHhESC; NIHhESC-14-0274
DR   Wikidata; Q54899687
RX   PubMed=23161805;
RX   PubMed=26607962;
RX   PubMed=27345806;
RX   PubMed=28445466;
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0274.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-017, Steering comm. appl. SCSC12-37.
CC   HLA typing: A*01,24; B*35:02/83,49:01/06/08; C*04.07; DRB1*3 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   KCL040
AC   CVCL_A273
SY   KCL-040
DR   NIHhESC; NIHhESC-14-0272
DR   Wikidata; Q54899688
RX   PubMed=23161805;
RX   PubMed=26607962;
RX   PubMed=27345807;
RX   PubMed=28445466;
CC   Group: Clinical grade pluripotent cell line.
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0272.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-018, Steering comm. appl. SCSC12-37.
CC   HLA typing: A*03,24; B*07,15; C*03,07; DRB1*04:04/23/42/56/0,15 (PubMed=23161805).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   KCL041
AC   CVCL_A274
SY   KCL-041
DR   NIHhESC; NIHhESC-14-0273
DR   Wikidata; Q54899689
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0273.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-017, Steering comm. appl. SCSC12-38.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KCL042
AC   CVCL_E085
SY   KCL-042
DR   NIHhESC; NIHhESC-13-0242
DR   Wikidata; Q54899691
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0242.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-018, Steering comm. appl. SCSC12-38.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   KCL043
AC   CVCL_E086
SY   KCL-043
DR   NIHhESC; NIHhESC-13-0243
DR   Wikidata; Q54899692
CC   From: King's College London; London; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0243.
CC   Registration: UK Stem Cell Bank (UKSCB); R-14-019, Steering comm. appl. SCSC12-38.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   KCL22-r
AC   CVCL_DP58
SY   KCL22-R; KCL22R
DR   ATCC; CRL-3350
DR   cancercelllines; CVCL_DP58
DR   PRIDE; PXD000030
DR   Wikidata; Q54899693
RX   PubMed=10910924;
RX   PubMed=17549412;
RX   PubMed=20417730;
RX   PubMed=23754495;
CC   Population: Japanese.
CC   Doubling time: ~24-30 hours (ATCC=CRL-3350).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Leufs*5 (c.3261dupC) (3261_3262insC); ClinVar=VCV000089364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3350
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2091 ! KCL-22
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   KCL22/SR
AC   CVCL_4V46
DR   cancercelllines; CVCL_4V46
DR   Wikidata; Q54899694
RX   PubMed=12743326;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Leufs*5 (c.3261dupC) (3261_3262insC); ClinVar=VCV000089364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2091 ! KCL-22
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   KCLi001-A
AC   CVCL_VN39
SY   iOP118
DR   BioSamples; SAMEA4932834
DR   hPSCreg; KCLi001-A
DR   Wikidata; Q94337744
RX   PubMed=30075366;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3748; FLG; Simple; p.Ser761Cysfs*36 (c.2278_2281CAGT[1]) (c.2282_2285delCAGT); ClinVar=VCV000016320; Zygosity=Heterozygous (PubMed=30075366).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C3001; Eczema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   KCLi002-A
AC   CVCL_UK21
SY   iOP107
DR   BioSamples; SAMEA4932836
DR   hPSCreg; KCLi002-A
DR   Wikidata; Q94337748
RX   PubMed=31103941;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3748; FLG; Simple; p.Arg2447Ter (c.7339C>T); ClinVar=VCV000050932; Zygosity=Heterozygous (PubMed=31103941).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C3001; Eczema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   KCLi003-A
AC   CVCL_UK22
SY   iOP101
DR   BioSamples; SAMEA4932838
DR   hPSCreg; KCLi003-A
DR   Wikidata; Q94337752
RX   PubMed=31408836;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3748; FLG; Simple; p.Arg501Ter (c.1501C>T); ClinVar=VCV000016319; Zygosity=Heterozygous (PubMed=31408836).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C3001; Eczema
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   KCLi004-A
AC   CVCL_ZB58
DR   hPSCreg; KCLi004-A
DR   Wikidata; Q98126814
CC   From: King's College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   KCLi005-A
AC   CVCL_ZY37
SY   iKCL037A
DR   BioSamples; SAMEA7002452
DR   hPSCreg; KCLi005-A
DR   Wikidata; Q102114408
CC   From: King's College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   KCLi006-A
AC   CVCL_ZX58
SY   iKCL037B
DR   hPSCreg; KCLi006-A
DR   Wikidata; Q102114410
CC   From: King's College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   KCLi007-A
AC   CVCL_A9Q3
SY   iKCL12; iPSC12
DR   hPSCreg; KCLi007-A
DR   Wikidata; Q102114411
CC   From: King's College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   KCLi008-A
AC   CVCL_A5QY
DR   hPSCreg; KCLi008-A
DR   Wikidata; Q107115540
RX   PubMed=33610019;
CC   From: King's College London; London; United Kingdom.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Gln519Glu (c.1555C>G); ClinVar=VCV000650787; Zygosity=Heterozygous (PubMed=33610019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   KCLi009-A
AC   CVCL_A5QZ
DR   hPSCreg; KCLi009-A
DR   Wikidata; Q107115543
RX   PubMed=33610019;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521His (c.1562G>A); ClinVar=VCV000016225; Zygosity=Heterozygous (PubMed=33610019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   KCLi010-A
AC   CVCL_A5RA
DR   hPSCreg; KCLi010-A
DR   Wikidata; Q107115544
RX   PubMed=33610019;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg522Gly (c.1564A>G); ClinVar=VCV000540279; Zygosity=Heterozygous (PubMed=33610019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   KCLi011-A
AC   CVCL_A5RB
DR   hPSCreg; KCLi011-A
DR   Wikidata; Q107115546
RX   PubMed=33610019;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple; p.Gly38Arg (c.112G>A); ClinVar=VCV000488354; Zygosity=Heterozygous (PubMed=33610019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   KCLi012-A
AC   CVCL_A5RC
DR   hPSCreg; KCLi012-A
DR   Wikidata; Q107115549
RX   PubMed=33610019;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple; p.Asp40Gly (c.119A>G); ClinVar=VCV000488353; Zygosity=Heterozygous (PubMed=33610019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   KCLi013-A
AC   CVCL_A5RD
DR   hPSCreg; KCLi013-A
DR   Wikidata; Q107115551
RX   PubMed=33610019;
CC   From: King's College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple; p.Arg235Gln (c.704G>A); dbSNP=rs765489119; Zygosity=Heterozygous (PubMed=33610019).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   KCMC-1379
AC   CVCL_4W59
DR   JCRB; JCRB1511
DR   Wikidata; Q54899695
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1511
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C123813; Beare-Stevenson cutis gyrata syndrome
DI   ORDO; Orphanet_1555; Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 8
//
ID   KCMC-1528
AC   CVCL_4W60
DR   JCRB; JCRB1541
DR   Wikidata; Q54899697
RX   PubMed=29892436;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1541
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 10,11,12
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 17,18
DI   NCIt; C75466; Rubinstein-Taybi syndrome
DI   ORDO; Orphanet_783; Rubinstein-Taybi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 9
//
ID   KCMC-1694
AC   CVCL_4W61
DR   JCRB; JCRB1540
DR   Wikidata; Q54899698
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ile500Thr (c.1499T>C); ClinVar=VCV000030149; Zygosity=Unspecified (JCRB=JCRB1540).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1540
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C123815; Myhre syndrome
DI   ORDO; Orphanet_2588; Myhre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   KCMC-2060
AC   CVCL_A9J6
DR   JCRB; NIHS1042
DR   Wikidata; Q102114413
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg239Cys (c.729C>T); ClinVar=VCV000016167; Zygosity=Unspecified (JCRB=NIHS1042).
CC   Discontinued: JCRB; NIHS1042; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   KCMC-T
AC   CVCL_A632
DR   Cosmic; 996308
DR   Cosmic; 1037694
DR   Wikidata; Q54899699
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
CC   Microsatellite instability: Instable (MSI) (PubMed=10739008; PubMed=11226526).
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 8
//
ID   KCP-4
AC   CVCL_M123
DR   Wikidata; Q54899700
RX   PubMed=8200854;
RX   PubMed=22562377;
RX   PubMed=24317338;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2088 ! KB-3-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   KCSV
AC   CVCL_5781
DR   CLO; CLO_0007087
DR   CLDB; cl3016
DR   Wikidata; Q54899701
RX   PubMed=87443;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   KD [Human abdomen rhabdoid tumor]
AC   CVCL_U757
DR   BioSample; SAMN10989606
DR   cancercelllines; CVCL_U757
DR   Cell_Model_Passport; SIDM01663
DR   Cosmic; 802251
DR   DepMap; ACH-001099
DR   Wikidata; Q54899702
RX   PubMed=9671307;
RX   PubMed=10397258;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   KD [Human lip fibroblast]
AC   CVCL_2970
SY   Karen Day
DR   ATCC; CRL-1295
DR   JCRB; JCRB9103
DR   Wikidata; Q54899703
RX   PubMed=418410;
RX   PubMed=450131;
RX   PubMed=2463881;
RX   PubMed=2902939;
RX   PubMed=3724780;
RX   PubMed=3860870;
RX   PubMed=4842250;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=6622549;
RX   PubMed=7301938;
RX   PubMed=22282976;
CC   Population: Caucasian.
CC   Senescence: Senesces at 38-40 PDL (JCRB=JCRB9103).
CC   Doubling time: 51-70 hours (Note=Lot 06232003), ~27 hours (Note=Lot 11052009), ~36 hours (Note=Lot 12112017) (JCRB=JCRB9103).
CC   Discontinued: ATCC; CRL-1295; true.
CC   Derived from site: In situ; Oral cavity, lip; UBERON=UBERON_0001833.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KD iPS
AC   CVCL_WL00
SY   KDiPS
DR   GEO; GSM2802511
DR   GEO; GSM2802512
DR   Wikidata; Q94337810
RX   PubMed=29088246;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, lip; UBERON=UBERON_0001833.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2970 ! KD [Human lip fibroblast]
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   KD-164
AC   CVCL_WE28
DR   IBRC; C10223
DR   Wikidata; Q94337813
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-168
AC   CVCL_WE29
DR   IBRC; C10224
DR   Wikidata; Q94337817
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-184
AC   CVCL_WE30
DR   IBRC; C10254
DR   Wikidata; Q94337823
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-1-R
AC   CVCL_XH32
DR   CCLV; CCLV-RIE 0052
DR   Wikidata; Q94337824
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   KD-215
AC   CVCL_WE31
DR   IBRC; C10388
DR   Wikidata; Q94337829
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-223
AC   CVCL_WE32
DR   IBRC; C10396
DR   Wikidata; Q94337834
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-285
AC   CVCL_WE33
DR   IBRC; C10551
DR   Wikidata; Q94337836
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-299
AC   CVCL_WE34
DR   IBRC; C10762
DR   Wikidata; Q94337840
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-301
AC   CVCL_WE35
DR   IBRC; C10764
DR   Wikidata; Q94337845
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-305
AC   CVCL_WE36
DR   IBRC; C10701
DR   Wikidata; Q94337850
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-322
AC   CVCL_WE37
DR   IBRC; C10790
DR   Wikidata; Q94337852
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-332
AC   CVCL_WE38
DR   IBRC; C10757
DR   Wikidata; Q94337857
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-334
AC   CVCL_WE39
DR   IBRC; C10778
DR   Wikidata; Q94337859
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-347
AC   CVCL_WE40
DR   IBRC; C11163
DR   Wikidata; Q94337862
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-351
AC   CVCL_WE41
DR   IBRC; C11162
DR   Wikidata; Q94337864
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-353
AC   CVCL_WE42
DR   IBRC; C11128
DR   Wikidata; Q94337867
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-354
AC   CVCL_WE43
DR   IBRC; C11129
DR   Wikidata; Q94337869
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-355
AC   CVCL_WE44
DR   IBRC; C11124
DR   Wikidata; Q94337871
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-357
AC   CVCL_WE45
DR   IBRC; C11103
DR   Wikidata; Q94337873
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-358
AC   CVCL_WE46
DR   IBRC; C11098
DR   Wikidata; Q94337876
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-359
AC   CVCL_WE47
DR   IBRC; C11125
DR   Wikidata; Q94337880
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-360
AC   CVCL_WE48
DR   IBRC; C11099
DR   Wikidata; Q94337881
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-361
AC   CVCL_WE49
DR   IBRC; C11126
DR   Wikidata; Q94337883
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-363
AC   CVCL_WE50
DR   IBRC; C11127
DR   Wikidata; Q94337885
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-364
AC   CVCL_WE51
DR   IBRC; C11102
DR   Wikidata; Q94337889
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-365
AC   CVCL_WE52
DR   IBRC; C12104
DR   Wikidata; Q94337890
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-373
AC   CVCL_WE53
DR   IBRC; C11187
DR   Wikidata; Q94337893
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-374
AC   CVCL_WE54
DR   IBRC; C11188
DR   Wikidata; Q94337894
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-376
AC   CVCL_WE55
DR   IBRC; C11172
DR   Wikidata; Q94337898
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-378
AC   CVCL_WE56
DR   IBRC; C11173
DR   Wikidata; Q94337902
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-379
AC   CVCL_WE57
DR   IBRC; C11174
DR   Wikidata; Q94337904
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-382
AC   CVCL_WE58
DR   IBRC; C11175
DR   Wikidata; Q94337906
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-389
AC   CVCL_WE59
DR   IBRC; C11176
DR   Wikidata; Q94337908
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-391
AC   CVCL_WE60
DR   IBRC; C11180
DR   Wikidata; Q94337911
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-394
AC   CVCL_WE61
DR   IBRC; C11189
DR   Wikidata; Q94337914
RX   PubMed=32358742;
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-399
AC   CVCL_WE62
DR   IBRC; C11190
DR   Wikidata; Q94337915
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KD-406
AC   CVCL_ZJ71
DR   IBRC; C11260
DR   Wikidata; Q98126815
RX   PubMed=32358742;
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   KD-408
AC   CVCL_ZJ72
DR   IBRC; C11261
DR   Wikidata; Q98126816
RX   PubMed=32358742;
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   KD-417
AC   CVCL_ZJ73
DR   IBRC; C11223
DR   Wikidata; Q98126817
RX   PubMed=32358742;
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   KD-420
AC   CVCL_ZJ74
DR   IBRC; C11222
DR   Wikidata; Q98126818
RX   PubMed=32358742;
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   KD2.3
AC   CVCL_IU35
SY   KD2-3
DR   Wikidata; Q54899704
RX   PubMed=6591445;
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S411 ! MDAY-D2
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 3
//
ID   KD2SV
AC   CVCL_F243
DR   CLO; CLO_0007088
DR   CLDB; cl3017
DR   Wikidata; Q54899705
RX   PubMed=87443;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C57BL/10 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   KD8
AC   CVCL_E5R3
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KD83
AC   CVCL_5300
DR   Wikidata; Q54899706
RX   PubMed=3871362;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KD83
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-160.html
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4001 ! MOPC-104E
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   KDF
AC   CVCL_B7JL
SY   KiDney Fibroblast
DR   Wikidata; Q112929941
RX   DOI=10.46754/jssm.2021.06.008;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: 20.45 hours (Note=At 5th passage), 22.35 hours (Note=At 10th and 15th passages) (DOI=10.46754/jssm.2021.06.008).
CC   Donor information: Established from a rhinoceros named Puntung, the second last Sumatran rhinoceros to survive in captivity in Malaysia and died in 2017 of terminal cancer.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=89632; ! Dicerorhinus sumatrensis (Sumatran rhinoceros)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   KDH-8
AC   CVCL_HX29
DR   Wikidata; Q54899707
RX   PubMed=8635193;
RX   PubMed=12192538;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   KDI/20
AC   CVCL_9V30
DR   NCBI_Iran; C637
DR   Wikidata; Q54899708
RX   PubMed=17852455;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   KDM/JuA1
AC   CVCL_A5ST
SY   JuA1
DR   Wikidata; Q107115554
RX   PubMed=22839755;
CC   Characteristics: Established from the xenograft Ju.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5SU ! KDM/JuB2
OI   CVCL_A5SV ! KDM/JuB4
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   KDM/JuB2
AC   CVCL_A5SU
SY   JuB2
DR   Wikidata; Q107115555
RX   PubMed=22839755;
CC   Characteristics: Established from the xenograft Ju.
CC   Doubling time: 31.6 hours (PubMed=22839755).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5ST ! KDM/JuA1
OI   CVCL_A5SV ! KDM/JuB4
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   KDM/JuB4
AC   CVCL_A5SV
SY   JuB4
DR   Wikidata; Q107115557
RX   PubMed=22839755;
CC   Characteristics: Established from the xenograft Ju.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5ST ! KDM/JuA1
OI   CVCL_A5SU ! KDM/JuB2
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   KDM/Re12
AC   CVCL_A5SW
SY   Re12
DR   Wikidata; Q107115560
RX   PubMed=22839755;
CC   Characteristics: Established from the xenograft Re.
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5SX ! KDM/Re21
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   KDM/Re21
AC   CVCL_A5SX
SY   Re21
DR   Wikidata; Q107115563
RX   PubMed=22839755;
CC   Characteristics: Established from the xenograft Re.
CC   Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5SW ! KDM/Re12
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   KDM/Ud2
AC   CVCL_A5SY
SY   Ud2
DR   Wikidata; Q107115565
RX   PubMed=22839755;
CC   Characteristics: Established from the xenograft Ud.
CC   Doubling time: 23.5 hours (PubMed=22839755).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Papillion; VBO=VBO_0200985.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5SZ ! KDM/Ud6
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   KDM/Ud6
AC   CVCL_A5SZ
SY   Ud6
DR   Wikidata; Q107115566
RX   PubMed=22839755;
CC   Characteristics: Established from the xenograft Ud.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Papillion; VBO=VBO_0200985.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A5SY ! KDM/Ud2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   KDS 101-1
AC   CVCL_A6JV
DR   Wikidata; Q107115571
RX   PubMed=3584611;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02788; Human LTF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   KDS 101-2
AC   CVCL_A6JW
DR   Wikidata; Q107115572
RX   PubMed=3584611;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02788; Human LTF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   KDS 301-1
AC   CVCL_A6JX
SY   HB8852
DR   ATCC; HB-8852
DR   Wikidata; Q107115574
RX   DOI=10.1007/978-94-011-2044-9_55;
RX   DOI=10.1007/BF01086327;
RX   Patent=US4668771;
RX   PubMed=3584611;
RX   PubMed=19153770;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8852.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P24627; Bovine LTF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   KDT
AC   CVCL_VL78
SY   KD Transformed; NG-T-3
DR   Wikidata; Q94337945
RX   PubMed=418410;
RX   PubMed=22282976;
CC   Population: Caucasian.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Oral cavity, lip; UBERON=UBERON_0001833.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2970 ! KD [Human lip fibroblast]
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   KDT3
AC   CVCL_TZ64
SY   Kidney Distal Tubule 3
DR   ABM; T0641
DR   Wikidata; Q54899710
RX   PubMed=18682499;
CC   Derived from site: In situ; Kidney, distal tubule; UBERON=UBERON_0004135.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   KE
AC   CVCL_ZV52
DR   cancercelllines; CVCL_ZV52
DR   Cosmic; 850739
DR   Cosmic; 1014069
DR   Wikidata; Q98126819
RX   PubMed=2964515;
RX   PubMed=9070656;
RX   PubMed=9090379;
RX   PubMed=10698499;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; c.(2062_3114)ins?; Zygosity=Unspecified (PubMed=10698499).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly36Glu (c.107G>A); ClinVar=VCV000486972; Zygosity=Unspecified (PubMed=9090379).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   KE #1
AC   CVCL_C7SC
DR   Wikidata; Q117704570
RX   PubMed=4524119;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   KE 37.3.2
AC   CVCL_L699
SY   KE37.3.2; KE37 3.2
DR   cancercelllines; CVCL_L699
DR   Wikidata; Q54899711
RX   PubMed=6983562;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1327 ! KE-37
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   KE-10
AC   CVCL_WK75
SY   KE10
DR   Wikidata; Q94337963
RX   PubMed=14532970;
RX   PubMed=20515944;
RX   PubMed=26512696;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KE-24
AC   CVCL_W476
SY   KE24
DR   Wikidata; Q54899713
RX   PubMed=1958633;
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 32.4 hours (PubMed=15016319).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   KE-3
AC   CVCL_D883
SY   KE3
DR   JCRB; JCRB1883
DR   Wikidata; Q54899714
RX   PubMed=7671230;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=11115554;
RX   PubMed=14532970;
RX   PubMed=20515944;
RX   PubMed=26512696;
CC   Population: Japanese.
CC   HLA typing: A*02:24; B*07,61; C*07 (PubMed=7671230).
CC   HLA typing: A*02:06,24:02; C*04:01,15:02 (PubMed=9023415).
CC   HLA typing: A*02:06,24:02; B*07,61; C*01:02,03:02 (PubMed=9178645).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1883
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,10,12
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 10
//
ID   KE-37
AC   CVCL_1327
SY   KE 37; KE37
DR   BTO; BTO_0002547
DR   CLO; CLO_0007089
DR   CLDB; cl3018
DR   CLDB; cl3019
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988503
DR   cancercelllines; CVCL_1327
DR   Cell_Model_Passport; SIDM01003
DR   ChEMBL-Cells; CHEMBL3308872
DR   ChEMBL-Targets; CHEMBL2366287
DR   Cosmic; 907277
DR   Cosmic; 998735
DR   Cosmic; 1012077
DR   Cosmic; 1151782
DR   Cosmic; 1281372
DR   Cosmic; 1330502
DR   Cosmic; 1524800
DR   Cosmic; 1664524
DR   Cosmic; 1760526
DR   Cosmic; 2165719
DR   Cosmic; 2602918
DR   Cosmic-CLP; 907277
DR   DepMap; ACH-000101
DR   DSMZ; ACC-46
DR   DSMZCellDive; ACC-46
DR   EGA; EGAS00001000978
DR   GDSC; 907277
DR   GEO; GSM887203
DR   GEO; GSM888276
DR   GEO; GSM1669982
DR   IARC_TP53; 21430
DR   LiGeA; CCLE_542
DR   LINCS_LDP; LCL-1016
DR   Lonza; 1260
DR   NCBI_Iran; C181
DR   PharmacoDB; KE37_740_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1327
DR   PubChem_Cell_line; CVCL_1327
DR   Wikidata; Q54899715
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=8957066;
RX   PubMed=9933131;
RX   PubMed=15472075;
RX   PubMed=16408098;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (DSMZ=ACC-46).
CC   HLA typing: A*11:01,30:01; B*35:01,44:02; C*04:01,05:01; DQB1*03:02,05:01; DRB1*01:03,11:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (DepMap=ACH-000101).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907277; DepMap=ACH-000101).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907277; DepMap=ACH-000101).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=907277).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (Cosmic-CLP=907277; DepMap=ACH-000101).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.86%; Native American=0.41%; East Asian, North=0.97%; East Asian, South=0%; South Asian=0.18%; European, North=66.92%; European, South=30.66% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=907277; DSMZ=ACC-46
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 19,25
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 11
ST   FGA: 24,25
ST   Penta D: 11,15
ST   Penta E: 5,14
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   KE-39
AC   CVCL_3385
SY   KE39
DR   CLO; CLO_0050802
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470990
DR   BioSample; SAMN03472139
DR   BioSample; SAMN10987859
DR   cancercelllines; CVCL_3385
DR   Cell_Model_Passport; SIDM01582
DR   Cosmic; 1187280
DR   DepMap; ACH-000507
DR   GEO; GSM887204
DR   GEO; GSM888277
DR   IARC_TP53; 28288
DR   LiGeA; CCLE_164
DR   PharmacoDB; KE39_741_2019
DR   Progenetix; CVCL_3385
DR   RCB; RCB1434
DR   Wikidata; Q54899716
RX   PubMed=7599112;
RX   PubMed=22460905;
RX   PubMed=24587255;
RX   PubMed=24807215;
RX   PubMed=25877200;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~38.4 hours (PubMed=7599112).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Asn (c.94G>A); ClinVar=VCV000376228; Zygosity=Heterozygous (DepMap=ACH-000507).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Leu (c.814G>T); ClinVar=VCV000012358; Zygosity=Homozygous (DepMap=ACH-000507).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.5%; Native American=0%; East Asian, North=89.52%; East Asian, South=4.53%; South Asian=0%; European, North=0%; European, South=4.45% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=25877200; RCB=RCB1434
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14.2,16.2
ST   D21S11: 30
ST   D2S1338: 22
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 11,16
ST   FGA: 22,23
ST   Penta D: 11
ST   Penta E: 18,23
ST   TH01: 7 (PubMed=25877200)
ST   TH01: 7,9.3 (RCB=RCB1434)
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KE-4
AC   CVCL_D884
SY   KE4
DR   JCRB; JCRB1887
DR   Wikidata; Q54899717
RX   PubMed=7671230;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=11115554;
RX   PubMed=14532970;
RX   PubMed=20515944;
RX   PubMed=26512696;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*54,60; C*01,03 (PubMed=7671230).
CC   HLA typing: A*24:02,26:01; C*01:01,03:02 (PubMed=9023415).
CC   HLA typing: A*24:02,26:01; B*54,60; C*04:01,15:02 (PubMed=9178645).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1887
ST   Amelogenin: X
ST   CSF1PO: 9,11,12
ST   D13S317: 10,11
ST   D16S539: 9,10,11
ST   D5S818: 11,12,14
ST   D7S820: 11,12
ST   TH01: 6,7,9
ST   TPOX: 9,11
ST   vWA: 14,17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 10
//
ID   KE-43
AC   CVCL_W477
SY   KE43
DR   Wikidata; Q54899718
RX   PubMed=1390419;
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 22.5 hours (Note=At 105th passage) (PubMed=1390419); 33.6 hours (PubMed=15016319).
CC   Microsatellite instability: Stable (MSS) (PubMed=15016319).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   KE-43C4
AC   CVCL_W478
DR   Wikidata; Q54899719
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 63.6 hours (PubMed=15016319).
CC   Microsatellite instability: Stable (MSS) (PubMed=15016319).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W477 ! KE-43
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   KE-5
AC   CVCL_WK76
SY   KE5
DR   JCRB; JCRB1911
DR   Wikidata; Q94338019
RX   PubMed=14532970;
RX   PubMed=20515944;
RX   PubMed=26512696;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1911
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 7
//
ID   KE-6
AC   CVCL_WK77
SY   KE6
DR   JCRB; JCRB1915
DR   Wikidata; Q94338022
RX   PubMed=14532970;
RX   PubMed=20515944;
RX   PubMed=26512696;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1915
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 7
//
ID   KE-7
AC   CVCL_WK78
SY   KE7
DR   Wikidata; Q94338025
RX   PubMed=14532970;
RX   PubMed=20515944;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KE-8
AC   CVCL_WK79
SY   KE8
DR   Wikidata; Q94338027
RX   PubMed=14532970;
RX   PubMed=20515944;
RX   PubMed=26512696;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KE-9
AC   CVCL_C7UN
SY   KE9
DR   Wikidata; Q123032810
RX   PubMed=14532970;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   KE-97
AC   CVCL_3386
SY   KE97
DR   CLO; CLO_0050806
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470997
DR   BioSample; SAMN10987861
DR   cancercelllines; CVCL_3386
DR   Cell_Model_Passport; SIDM01589
DR   Cosmic; 1187281
DR   DepMap; ACH-000167
DR   EGA; EGAS00001002554
DR   GEO; GSM887205
DR   GEO; GSM888278
DR   IARC_TP53; 30093
DR   LiGeA; CCLE_884
DR   PharmacoDB; KE97_742_2019
DR   Progenetix; CVCL_3386
DR   RCB; RCB1435
DR   Wikidata; Q54899720
RX   PubMed=7861622;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25877200;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a mucinous gastric adenocarcinoma cell line from a 52 year old male patient but is a B-lymphoblastoid cell line (DSMZ; PubMed=30285677).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~28.8 hours (PubMed=7861622).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=80.49%; East Asian, South=19.51%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): PubMed=25877200; RCB=RCB1435
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 12,14
ST   D21S11: 31,32.2
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 10,15
ST   FGA: 18,24
ST   Penta D: 9,13
ST   Penta E: 5
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KE-F11
AC   CVCL_1Q77
DR   RCB; RCB2726
DR   Wikidata; Q54899721
RX   PubMed=12811582;
CC   Doubling time: 20.0 hours (Note=At 10th passage), 16.5 hours (Note=At 20th passage), 19.0 hours (Note=At 30th passage) (PubMed=12811582).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1Q76 ! KE-P
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   KE-P
AC   CVCL_1Q76
DR   Wikidata; Q54899722
RX   PubMed=12811582;
CC   Doubling time: 20.9 hours (Note=At 10th passage), 19.7 hours (Note=At 20th passage), 20.5 hours (Note=At 30th passage), 18.4 hours (Note=At 50th passage) (PubMed=12811582).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   KE-R
AC   CVCL_0I57
DR   CCLV; CCLV-RIE 0138
DR   Wikidata; Q54899723
RX   PubMed=19941903;
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   KE2a
AC   CVCL_U657
DR   Wikidata; Q54899724
RX   PubMed=8648763;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   KE37/1
AC   CVCL_B7RK
SY   KE37-1
DR   cancercelllines; CVCL_B7RK
DR   Wikidata; Q112929942
RX   PubMed=6151082;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1327 ! KE-37
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   KE37/1-IIIB
AC   CVCL_C0UC
DR   cancercelllines; CVCL_C0UC
DR   Wikidata; Q112929943
RX   PubMed=1373627;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1 isolate LAI.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7RK ! KE37/1
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir100
AC   CVCL_LP16
DR   MMRRC; MMRRC:036879-UCD
DR   Wikidata; Q54899725
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619057; Mir100.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir10b
AC   CVCL_LP17
DR   MMRRC; MMRRC:036838-UCD
DR   Wikidata; Q54899726
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676804; Mir10b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir124-2
AC   CVCL_LP18
DR   MMRRC; MMRRC:036867-UCD
DR   Wikidata; Q54899727
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618700; Mir124a-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir124a-3
AC   CVCL_LP19
DR   MMRRC; MMRRC:036883-UCD
DR   Wikidata; Q54899728
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618704; Mir124a-3.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir125b-2
AC   CVCL_LP20
DR   MMRRC; MMRRC:036868-UCD
DR   Wikidata; Q54899729
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618706; Mir125b-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir126
AC   CVCL_LP21
DR   MMRRC; MMRRC:036880-UCD
DR   Wikidata; Q54899730
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676811; Mir126a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir129-1
AC   CVCL_LP22
DR   MMRRC; MMRRC:036860-UCD
DR   Wikidata; Q54899731
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676815; Mir129-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir130a
AC   CVCL_LP23
DR   MMRRC; MMRRC:036827-UCD
DR   Wikidata; Q54899732
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676816; Mir130a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir135a-1
AC   CVCL_LP24
DR   MMRRC; MMRRC:036861-UCD
DR   Wikidata; Q54899733
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676820; Mir135a-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir135b
AC   CVCL_LP25
DR   MMRRC; MMRRC:036829-UCD
DR   Wikidata; Q54899734
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618732; Mir135b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir137
AC   CVCL_LP26
DR   MMRRC; MMRRC:036869-UCD
DR   Wikidata; Q54899735
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676822; Mir137.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir138-1
AC   CVCL_LP27
DR   MMRRC; MMRRC:036839-UCD
DR   Wikidata; Q54899736
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676823; Mir138-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir138-2
AC   CVCL_LP28
DR   MMRRC; MMRRC:036856-UCD
DR   Wikidata; Q54899737
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618733; Mir138-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir146a
AC   CVCL_LP29
DR   MMRRC; MMRRC:036857-UCD
DR   Wikidata; Q54899739
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676831; Mir146.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir150
AC   CVCL_LP30
DR   MMRRC; MMRRC:036830-UCD
DR   Wikidata; Q54899745
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676835; Mir150.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir155
AC   CVCL_LP31
DR   MMRRC; MMRRC:036881-UCD
DR   Wikidata; Q54899746
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676840; Mir155.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir185
AC   CVCL_LP32
DR   MMRRC; MMRRC:036841-UCD
DR   Wikidata; Q54899747
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676849; Mir185.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir187
AC   CVCL_LP33
DR   MMRRC; MMRRC:036842-UCD
DR   Wikidata; Q54899748
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676851; Mir187.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir188
AC   CVCL_LP34
DR   MMRRC; MMRRC:036862-UCD
DR   Wikidata; Q54899749
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676852; Mir188.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir196a-1
AC   CVCL_LP35
DR   MMRRC; MMRRC:036843-UCD
DR   Wikidata; Q54899751
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676860; Mir196a-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir199a-1
AC   CVCL_LP36
DR   MMRRC; MMRRC:036873-UCD
DR   Wikidata; Q54899752
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676863; Mir199a-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir205
AC   CVCL_LP37
DR   MMRRC; MMRRC:036844-UCD
DR   Wikidata; Q54899753
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676880; Mir205.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir21
AC   CVCL_LP38
DR   MMRRC; MMRRC:036845-UCD
DR   Wikidata; Q54899754
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676885; Mir21a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir210
AC   CVCL_LP39
DR   MMRRC; MMRRC:036846-UCD
DR   Wikidata; Q54899755
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676886; Mir210.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir219-1
AC   CVCL_LP40
DR   MMRRC; MMRRC:036882-UCD
DR   Wikidata; Q54899756
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618753; Mir219a-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir219-2
AC   CVCL_LP41
DR   MMRRC; MMRRC:036831-UCD
DR   Wikidata; Q54899757
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618754; Mir219a-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir301
AC   CVCL_LP42
DR   MMRRC; MMRRC:036833-UCD
DR   Wikidata; Q54899758
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619324; Mir301.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir30e
AC   CVCL_LP43
DR   MMRRC; MMRRC:036853-UCD
DR   Wikidata; Q54899759
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619329; Mir30e.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir320
AC   CVCL_LP44
DR   MMRRC; MMRRC:036835-UCD
DR   Wikidata; Q54899760
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619332; Mir320.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir325
AC   CVCL_LP45
DR   MMRRC; MMRRC:036858-UCD
DR   Wikidata; Q54899761
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619336; Mir325.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir339
AC   CVCL_LP46
DR   MMRRC; MMRRC:036848-UCD
DR   Wikidata; Q54899763
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619354; Mir339.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir34a
AC   CVCL_LP47
DR   MMRRC; MMRRC:036876-UCD
DR   Wikidata; Q54899764
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619363; Mir34a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir688
AC   CVCL_LP48
DR   MMRRC; MMRRC:036836-UCD
DR   Wikidata; Q54899765
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3629926; Mir688.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir7-2
AC   CVCL_LP50
DR   MMRRC; MMRRC:036849-UCD
DR   Wikidata; Q54899767
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619437; Mir7-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir711
AC   CVCL_LP49
DR   MMRRC; MMRRC:036875-UCD
DR   Wikidata; Q54899766
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3629883; Mir711.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir7b
AC   CVCL_LP51
DR   MMRRC; MMRRC:036850-UCD
DR   Wikidata; Q54899768
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619435; Mir7b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir9-1
AC   CVCL_LP52
DR   MMRRC; MMRRC:036837-UCD
DR   Wikidata; Q54899769
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676911; Mir9-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mir9-2
AC   CVCL_LP53
DR   MMRRC; MMRRC:036851-UCD
DR   Wikidata; Q54899770
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619442; Mir9-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc10
AC   CVCL_LP54
DR   MMRRC; MMRRC:036871-UCD
DR   Wikidata; Q54899771
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676842; Mir15b.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618690; Mir16-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc12
AC   CVCL_LP55
DR   MMRRC; MMRRC:036870-UCD
DR   Wikidata; Q54899772
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676829; Mir144.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619412; Mir451a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc13
AC   CVCL_LP56
DR   MMRRC; MMRRC:036840-UCD
DR   Wikidata; Q54899774
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676826; Mir141.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618750; Mir200c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc17
AC   CVCL_LP57
DR   MMRRC; MMRRC:036863-UCD
DR   Wikidata; Q54899775
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676856; Mir192.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618738; Mir194-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc22
AC   CVCL_LP58
DR   MMRRC; MMRRC:036865-UCD
DR   Wikidata; Q54899776
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676898; Mir23b.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676899; Mir24-1.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676903; Mir27b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc24
AC   CVCL_LP59
DR   MMRRC; MMRRC:036864-UCD
DR   Wikidata; Q54899777
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619333; Mir322.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619367; Mir351.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619428; Mir503.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc25
AC   CVCL_LP60
DR   MMRRC; MMRRC:036828-UCD
DR   Wikidata; Q54899779
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3618716; Mir130b.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3691602; Mir301b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc26
AC   CVCL_LP61
DR   MMRRC; MMRRC:036834-UCD
DR   Wikidata; Q54899780
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676908; Mir30b.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676910; Mir30d.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc27
AC   CVCL_LP62
DR   MMRRC; MMRRC:036854-UCD
DR   Wikidata; Q54899781
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676859; Mir195a.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3629886; Mir497.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc28
AC   CVCL_LP63
DR   MMRRC; MMRRC:036832-UCD
DR   Wikidata; Q54899783
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619269; Mir296.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619321; Mir298.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc29
AC   CVCL_LP64
DR   MMRRC; MMRRC:036847-UCD
DR   Wikidata; Q54899784
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619047; Mir29b-2.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676906; Mir29c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc30
AC   CVCL_LP65
DR   MMRRC; MMRRC:036872-UCD
DR   Wikidata; Q54899785
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676841; Mir15a.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676843; Mir16-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc31
AC   CVCL_LP66
DR   MMRRC; MMRRC:036859-UCD
DR   Wikidata; Q54899786
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676794; Mirlet7b.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619050; Mirlet7c-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc35
AC   CVCL_LP67
SY   Keck MirKO ES cell line Mir-182/Mir-96/Mir-183
DR   MMRRC; MMRRC:036877-UCD
DR   Wikidata; Q54899788
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619440; Mir96.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676846; Mir182.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676847; Mir183.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc6
AC   CVCL_LP68
DR   MMRRC; MMRRC:036855-UCD
DR   Wikidata; Q54899789
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:5049944; Mirc6.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirc8
AC   CVCL_LP69
DR   MMRRC; MMRRC:036826-UCD
DR   Wikidata; Q54899790
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676793; Mirlet7a-1.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676796; Mirlet7d.
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:2676798; Mirlet7f-1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   Keck MirKO ES cell line Mirlet7a-2
AC   CVCL_LP70
DR   MMRRC; MMRRC:036878-UCD
DR   Wikidata; Q54899800
RX   PubMed=22570807;
CC   Knockout cell: Method=Knockout-first conditional; MGI; MGI:3619049; Mirlet7a-2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y481 ! ES-E14TG2a.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 6
//
ID   KEIOi001-A
AC   CVCL_ZY38
SY   SM4-4-5
DR   BioSamples; SAMEA6907386
DR   hPSCreg; KEIOi001-A
DR   SKIP; SKIP005865
DR   Wikidata; Q102114414
RX   PubMed=32659732;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Asn345Lys (c.1035C>G); Zygosity=Heterozygous (PubMed=32659732).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   KEIOi002-A
AC   CVCL_A8LR
SY   YG-iPS
DR   hPSCreg; KEIOi002-A
DR   Wikidata; Q108820625
RX   PubMed=34598113;
CC   From: Keio University; Tokyo; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   KEIOi003-A
AC   CVCL_C0JG
SY   SM9-1
DR   hPSCreg; KEIOi003-A
DR   Wikidata; Q112929945
RX   PubMed=37009886;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9476; HTRA1; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV001332825; Zygosity=Heterozygous (PubMed=37009886).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37009886
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C202018; Autosomal recessive cerebral arteriopathy with subcortical infarcts and leukoencephalopathy
DI   ORDO; Orphanet_199354; Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   KEIOi004-A
AC   CVCL_C0JH
DR   hPSCreg; KEIOi004-A
DR   Wikidata; Q112929946
CC   From: Keio University; Tokyo; Japan.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   KEIOi005-A
AC   CVCL_C0JF
SY   KAD-0001; EK-0076
DR   BioSamples; SAMEA12816595
DR   hPSCreg; KEIOi005-A
DR   Wikidata; Q112929947
RX   PubMed=35537244;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1052; BIN1; Simple; chr2:g.127894615A>G; dbSNP=rs744373; Zygosity=Heterozygous (PubMed=35537244).
CC   Sequence variation: Mutation; HGNC; HGNC:13375; MS4A6A; Simple; chr11:g.60171834T>G; dbSNP=rs610932; Zygosity=Homozygous (PubMed=35537244).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   KEIUi001-A
AC   CVCL_A1YC
SY   LA5-GC TALEN
DR   hPSCreg; KEIUi001-A
DR   Wikidata; Q105509773
RX   PubMed=33181472;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous; Note=By TALEN (PubMed=33181472).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y949 ! LA5 [Human iPSC]
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   KEIUi002-A
AC   CVCL_C6Q9
SY   KOMENT-A
DR   BioSamples; SAMEA112253861
DR   hPSCreg; KEIUi002-A
DR   Wikidata; Q117704571
RX   PubMed=36630839;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   KEIUi003-A
AC   CVCL_C6QA
SY   KOMENT-B
DR   BioSamples; SAMEA112253862
DR   hPSCreg; KEIUi003-A
DR   Wikidata; Q117704572
RX   PubMed=36630839;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   KEIUi004-A
AC   CVCL_E4DX
SY   EYA4-1
DR   BioSamples; SAMEA115396970
DR   hPSCreg; KEIUi004-A
RX   PubMed=39002249;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3522; EYA4; Simple; p.Pro323Glufs*80 (c.960_963del4); Zygosity=Heterozygous (PubMed=39002249).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212887; Deafness, autosomal dominant 10
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KEIUi005-A
AC   CVCL_E4DY
SY   EYA4-2
DR   BioSamples; SAMEA115396986
DR   hPSCreg; KEIUi005-A
RX   PubMed=39002249;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3522; EYA4; Simple; p.Gln393Ter (c.1177C>T); Zygosity=Heterozygous (PubMed=39002249).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212887; Deafness, autosomal dominant 10
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KEIUi006-A
AC   CVCL_E4DZ
SY   EYA4-3
DR   BioSamples; SAMEA115396981
DR   hPSCreg; KEIUi006-A
RX   PubMed=39002249;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3522; EYA4; Simple; p.Leu416Pro (c.1247T>C); Zygosity=Heterozygous (PubMed=39002249).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212887; Deafness, autosomal dominant 10
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KEIUi007-A
AC   CVCL_E4E0
SY   EYA4-4
DR   BioSamples; SAMEA115396988
DR   hPSCreg; KEIUi007-A
RX   PubMed=39002249;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3522; EYA4; Simple; c.580+1G>T; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=39002249).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212887; Deafness, autosomal dominant 10
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KEIUi008-A
AC   CVCL_E4E1
SY   A1555G
DR   BioSamples; SAMEA115405392
DR   hPSCreg; KEIUi008-A
RX   PubMed=38815527;
CC   From: Keio University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7470; MT-RNR1; Simple; m.1555A>G; ClinVar=VCV000009628; Zygosity=Homoplasmic (PubMed=38815527).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148321; Mitochondrially inherited nonsyndromic sensorineural deafness
DI   ORDO; Orphanet_90641; Mitochondrial non-syndromic sensorineural deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KEK-92
AC   CVCL_A5YB
DR   Wikidata; Q107115576
WW   Provider; RCCC-V; -; https://web.archive.org/web/20200220021323/http://www.sevin.ru/collections/cellcolls/rcccm/lines_list.html
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   KEL FIB
AC   CVCL_3730
SY   KELFIB; KEL-FIB; Keloid fibroblast
DR   BTO; BTO_0006088
DR   CLO; CLO_0007090
DR   ATCC; CRL-1762
DR   BCRC; 60345
DR   BCRJ; 0279
DR   BioSample; SAMN03471419
DR   Wikidata; Q54899801
CC   Population: African American.
CC   Senescence: Senesces at ~10 PDL (ATCC=CRL-1762).
CC   Discontinued: BCRJ; 0279; probable.
CC   Derived from site: In situ; Skin; Note=From a keloid; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1762; BCRC=60345
ST   Amelogenin: X
ST   CSF1PO: 8,12
ST   D13S317: 11,13
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   Kelly
AC   CVCL_2092
AS   CVCL_B322
SY   KELLY; NB19; NB-19; NB19-RIKEN
DR   BTO; BTO_0006213
DR   CLO; CLO_0007091
DR   CLO; CLO_0051540
DR   EFO; EFO_0002069
DR   CLDB; cl3020
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 623
DR   BioSample; SAMN03472324
DR   BioSample; SAMN03473084
DR   BioSample; SAMN03473316
DR   BioSample; SAMN10988299
DR   cancercelllines; CVCL_2092
DR   Cell_Model_Passport; SIDM01009
DR   ChEMBL-Cells; CHEMBL4651376
DR   CLS; 300317
DR   Cosmic; 688077
DR   Cosmic; 753618
DR   Cosmic; 801738
DR   Cosmic; 920246
DR   Cosmic; 947704
DR   Cosmic; 1037341
DR   Cosmic; 1099138
DR   Cosmic; 1109365
DR   Cosmic; 1153786
DR   Cosmic; 1161990
DR   Cosmic; 1167409
DR   Cosmic; 1167987
DR   Cosmic; 1212537
DR   Cosmic; 1995468
DR   Cosmic; 2058107
DR   Cosmic; 2131576
DR   Cosmic; 2393634
DR   Cosmic; 2485945
DR   Cosmic-CLP; 753618
DR   DepMap; ACH-000259
DR   DSMZ; ACC-355
DR   DSMZCellDive; ACC-355
DR   ECACC; 92110411
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753618
DR   GEO; GSM313805
DR   GEO; GSM313806
DR   GEO; GSM333801
DR   GEO; GSM563354
DR   GEO; GSM887206
DR   GEO; GSM888279
DR   GEO; GSM1366407
DR   GEO; GSM1669983
DR   GEO; GSM2371238
DR   GEO; GSM2394386
DR   GEO; GSM3145616
DR   GEO; GSM3145714
DR   GEO; GSM4104577
DR   GEO; GSM4104578
DR   GEO; GSM4104626
DR   GEO; GSM4104627
DR   GEO; GSM4105308
DR   GEO; GSM4105309
DR   GEO; GSM4105310
DR   GEO; GSM4105311
DR   GEO; GSM4105312
DR   IARC_TP53; 28354
DR   LiGeA; CCLE_776
DR   LINCS_LDP; LCL-1966
DR   Lonza; 1024
DR   PharmacoDB; KELLY_743_2019
DR   PRIDE; PXD003596
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2092
DR   Progenetix; CVCL_B322
DR   PubChem_Cell_line; CVCL_2092
DR   RCB; RCB0479
DR   Wikidata; Q54899802
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2846152;
RX   PubMed=6888561;
RX   PubMed=7139592;
RX   PubMed=10630978;
RX   PubMed=11668190;
RX   PubMed=17506115;
RX   PubMed=18082704;
RX   PubMed=18724359;
RX   PubMed=18923524;
RX   PubMed=22460905;
RX   PubMed=24466371;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=33525507;
RX   PubMed=35839778;
RX   PubMed=39255063;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Characteristics: MYCN-amplified NBL cell line.
CC   Virology: Infected with a murine leukemia virus-related virus (PubMed=30629668).
CC   Doubling time: ~30 hours (CLS=300317); ~30-40 hours (DSMZ=ACC-355).
CC   HLA typing: A*01:01,01:01; B*08:01,51:01; C*03:03,07:01; DQA1*03:02,03:02; DRB1*07:01,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=18724359; PubMed=28350380; Cosmic-CLP=753618; DepMap=ACH-000259).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro177Thr (c.529C>A); ClinVar=VCV000482220; Zygosity=Homozygous (Cosmic-CLP=753618; DepMap=ACH-000259).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.15%; Native American=0%; East Asian, North=2.95%; East Asian, South=0%; South Asian=0%; European, North=61.68%; European, South=33.22% (PubMed=30894373).
CC   Discontinued: RCB; RCB0479; probable.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=753618; DSMZ=ACC-355; ECACC=92110411; PubMed=25877200; RCB=RCB0479; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,14
ST   D12S391: 19,20
ST   D13S317: 10,14 (ECACC=92110411; RCB=RCB0479; Technion Genomics Center)
ST   D13S317: 14 (Cosmic-CLP=753618; DSMZ=ACC-355; PubMed=25877200)
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D19S433: 12,15.2 (Technion Genomics Center)
ST   D19S433: 12,16 (DSMZ=ACC-355)
ST   D1S1656: 11,13
ST   D21S11: 28,30
ST   D22S1045: 16
ST   D2S1338: 17,20
ST   D2S441: 10,14
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 14
ST   FGA: 20,21
ST   Penta D: 9,14
ST   Penta E: 12,16
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,18 (ECACC=92110411; RCB=RCB0479; Technion Genomics Center)
ST   vWA: 18 (Cosmic-CLP=753618; DSMZ=ACC-355; PubMed=25877200)
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   Kem-BL
AC   CVCL_7199
SY   Kem; Kem-I
DR   GEO; GSM1604062
DR   GEO; GSM1604063
DR   GEO; GSM1604064
DR   Wikidata; Q54899803
RX   PubMed=9882297;
RX   PubMed=12219084;
RX   PubMed=21088132;
RX   PubMed=28960205;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   KEN
AC   CVCL_B7MB
DR   Wikidata; Q112929948
RX   PubMed=7699327;
RX   PubMed=8642248;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Arg149Gln (c.446G>A); ClinVar=VCV000007648; Zygosity=Homozygous (from familial inference of KER).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   KEN-3
AC   CVCL_W124
SY   KEN3; Ken3
DR   Wikidata; Q54899804
RX   PubMed=1351514;
RX   PubMed=8718548;
RX   PubMed=15677628;
CC   Population: Japanese.
CC   Doubling time: 76.9 hours (PubMed=1351514).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5233; Ovarian fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   KEP1
AC   CVCL_DR13
SY   Kep1
DR   GEO; GSM1489214
DR   GEO; GSM1489244
DR   GEO; GSM1489454
DR   Wikidata; Q54899806
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR14 ! KRV1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   KER
AC   CVCL_B7LP
SY   Ker
DR   Wikidata; Q112929952
RX   PubMed=7699327;
RX   PubMed=8642248;
RX   PubMed=12368908;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Arg149Gln (c.446G>A); ClinVar=VCV000007648; Zygosity=Homozygous (PubMed=12368908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Ker-CT
AC   CVCL_S877
DR   ATCC; CRL-4048
DR   PRIDE; PXD028647
DR   Wikidata; Q54899807
RX   DOI=10.13140/RG.2.2.17700.88960;
RX   PubMed=12545164;
RX   PubMed=19936293;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): ATCC=CRL-4048
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   Ker-CT-Ras
AC   CVCL_4T86
DR   Wikidata; Q54899808
RX   PubMed=19936293;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S877 ! Ker-CT
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   Ker-CT-Ras-p53
AC   CVCL_E3DC
RX   PubMed=19936293;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4T86 ! Ker-CT-Ras
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Kera-308
AC   CVCL_5782
AS   CVCL_0116
SY   KERA-308; 308; Line 308
DR   MCCL; MCC:0000008
DR   CLS; 400429
DR   Wikidata; Q54899809
RX   PubMed=3121168;
RX   PubMed=6791032;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21803; Papilloma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   KERA-BP4
AC   CVCL_5783
SY   BP-4; BP4; BALB/c Papilloma 4
DR   Wikidata; Q54899810
RX   PubMed=3121168;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21803; Papilloma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   KERA-LC14
AC   CVCL_5784
SY   LC14
DR   Wikidata; Q54899811
RX   PubMed=3121168;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   KERA-SP1
AC   CVCL_5785
SY   SP-1; SP1; SENCAR Papilloma 1
DR   CLS; 400430
DR   Wikidata; Q54899812
RX   PubMed=1711471;
RX   PubMed=3121168;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: CLS; 400430; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: SENCAR.
DI   NCIt; C21803; Papilloma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Kera5
AC   CVCL_ER29
DR   Wikidata; Q54899813
RX   PubMed=27533138;
CC   Transformant: ChEBI; CHEBI_75393; Y-27632.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=35658; ! Mastomys coucha (Southern multimammate mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   Ketr-3
AC   CVCL_H579
SY   KETR-3; ketr 3; Ketr3; KETR3
DR   ChEMBL-Cells; CHEMBL3307668
DR   ChEMBL-Targets; CHEMBL614637
DR   PubChem_Cell_line; CVCL_H579
DR   Wikidata; Q54899814
RX   PubMed=21574149;
CC   Population: Chinese.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   KF
AC   CVCL_5M20
DR   Wikidata; Q54899815
RX   PubMed=4735239;
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_5M21 ! MB
OI   CVCL_5M22 ! TD
OI   CVCL_5M23 ! WE
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   KF-1
AC   CVCL_F843
SY   KF
DR   Cosmic; 931367
DR   Cosmic; 2482709
DR   Wikidata; Q54899816
RX   PubMed=6541042;
RX   PubMed=7844449;
RX   PubMed=8375936;
CC   Population: Japanese.
CC   Doubling time: 16 hours (PubMed=6541042); 18 hours (PubMed=8375936).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   KF-101
AC   CVCL_Z507
SY   Koi Fin-101
DR   Wikidata; Q54899817
RX   PubMed=23731143;
CC   Group: Fish cell line.
CC   Doubling time: ~41 hours (PubMed=23731143).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   KF-RMS-1
AC   CVCL_S636
DR   Wikidata; Q54899818
RX   PubMed=12670897;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   KF1
AC   CVCL_W095
SY   Koi Fin-1; KF-1
DR   CCLV; CCLV-RIE 0843
DR   ECACC; 10072801
DR   Wikidata; Q54899819
RX   PubMed=19941903;
RX   PubMed=28880775;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 12
//
ID   KF1SV
AC   CVCL_5786
DR   CLO; CLO_0007092
DR   CLDB; cl3021
DR   Wikidata; Q54899820
RX   PubMed=87443;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   KF28
AC   CVCL_V533
SY   KF-28
DR   CGH-DB; 340-2
DR   Wikidata; Q54899821
RX   PubMed=10741911;
RX   PubMed=11185891;
RX   PubMed=17671176;
RX   PubMed=18319717;
RX   PubMed=18483383;
CC   Population: Japanese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F843 ! KF-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   KF28Tx
AC   CVCL_X936
SY   KF28 TX
DR   CGH-DB; 382-2
DR   Wikidata; Q54899822
RX   PubMed=10741911;
RX   PubMed=18483383;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V533 ! KF28
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 9
//
ID   KF4
AC   CVCL_E5QV
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KF4009-1
AC   CVCL_RJ30
DR   SKIP; SKIP000818
DR   Wikidata; Q54899823
RX   PubMed=25231866;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   KFC
AC   CVCL_0I51
SY   Koi Fin Cell line
DR   CCLV; CCLV-RIE 1112
DR   Wikidata; Q54899824
RX   PubMed=19941903;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   KFE-5
AC   CVCL_KR29
SY   KilliFish Embryo-5
DR   Wikidata; Q54899825
RX   PubMed=24836542;
CC   Group: Fish cell line.
CC   Doubling time: ~3 days (PubMed=24836542).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8078; ! Fundulus heteroclitus (Killifish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   KFR
AC   CVCL_S637
DR   Wikidata; Q54899826
RX   PubMed=8180967;
RX   PubMed=12670897;
RX   PubMed=23665679;
RX   PubMed=23882450;
RX   PubMed=25749379;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   KFr13
AC   CVCL_V534
SY   KFr
DR   CGH-DB; 327-2
DR   CGH-DB; 349-3
DR   Wikidata; Q54899827
RX   PubMed=3467111;
RX   PubMed=10741911;
RX   PubMed=11185891;
RX   PubMed=17671176;
RX   PubMed=18319717;
RX   PubMed=18483383;
CC   Population: Japanese.
CC   Doubling time: 24.8 hours (Note=In presence of 0.5 mug cisplatin/ml), 27.2 hours (Note=In presence of 1 mug cisplatin/ml) (PubMed=3467111).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V533 ! KF28
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   KFr13Tx
AC   CVCL_V535
SY   KFr13 TX; KFr13TX
DR   Wikidata; Q54899828
RX   PubMed=10741911;
RX   PubMed=18319717;
RX   PubMed=18483383;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V534 ! KFr13
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   KFra
AC   CVCL_M713
DR   Wikidata; Q54899829
RX   PubMed=7844449;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F843 ! KF-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   KFrb
AC   CVCL_M714
DR   Wikidata; Q54899830
RX   PubMed=7844449;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F843 ! KF-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   KFRrVCR10
AC   CVCL_RR38
DR   Wikidata; Q54899831
RX   PubMed=25749379;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S637 ! KFR
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   KFT-R
AC   CVCL_0I58
DR   CCLV; CCLV-RIE 1014
DR   Wikidata; Q54899832
RX   PubMed=19941903;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   KG-1
AC   CVCL_0374
SY   KG1
DR   BTO; BTO_0000670
DR   CLO; CLO_0007093
DR   CLO; CLO_0007094
DR   CLO; CLO_0051560
DR   EFO; EFO_0002218
DR   MCCL; MCC:0000269
DR   CLDB; cl3022
DR   CLDB; cl3023
DR   CLDB; cl3024
DR   CLDB; cl3025
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CCL-246
DR   ATCC; CRL-8031
DR   BCRC; 60158
DR   BCRJ; 0132
DR   BioSample; SAMN01821643
DR   BioSample; SAMN03473103
DR   BioSample; SAMN10988135
DR   cancercelllines; CVCL_0374
DR   CCRID; 4201HUM-CCTCC00121
DR   CCTCC; GDC0121
DR   Cell_Model_Passport; SIDM00785
DR   ChEMBL-Cells; CHEMBL3307794
DR   ChEMBL-Targets; CHEMBL612264
DR   CLS; 300208
DR   Cosmic; 683545
DR   Cosmic; 717682
DR   Cosmic; 787443
DR   Cosmic; 850386
DR   Cosmic; 851998
DR   Cosmic; 907278
DR   Cosmic; 919118
DR   Cosmic; 924047
DR   Cosmic; 947365
DR   Cosmic; 975261
DR   Cosmic; 981581
DR   Cosmic; 985581
DR   Cosmic; 996311
DR   Cosmic; 998743
DR   Cosmic; 999726
DR   Cosmic; 1012078
DR   Cosmic; 1019831
DR   Cosmic; 1037660
DR   Cosmic; 1070689
DR   Cosmic; 1078730
DR   Cosmic; 1107180
DR   Cosmic; 1127253
DR   Cosmic; 1150903
DR   Cosmic; 1176582
DR   Cosmic; 1181606
DR   Cosmic; 1197928
DR   Cosmic; 1281321
DR   Cosmic; 1308223
DR   Cosmic; 1523823
DR   Cosmic; 1524832
DR   Cosmic; 1582389
DR   Cosmic; 1623637
DR   Cosmic; 2060796
DR   Cosmic; 2089672
DR   Cosmic; 2131541
DR   Cosmic; 2306212
DR   Cosmic; 2750861
DR   Cosmic-CLP; 907278
DR   DepMap; ACH-000386
DR   DSMZ; ACC-14
DR   DSMZCellDive; ACC-14
DR   ECACC; 86111306
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10827-111C8
DR   GDSC; 907278
DR   GEO; GSM236787
DR   GEO; GSM236823
DR   GEO; GSM887208
DR   GEO; GSM888281
DR   GEO; GSM1374597
DR   GEO; GSM1446744
DR   GEO; GSM1669984
DR   IARC_TP53; 2195
DR   IGRhCellID; KG1
DR   IZSLER; BS TCL 190
DR   JCRB; JCRB0065
DR   JCRB; JCRB9051
DR   KCB; KCB 200552YJ
DR   KCLB; 10246
DR   LiGeA; CCLE_811
DR   LINCS_LDP; LCL-1056
DR   Lonza; 746
DR   NCBI_Iran; C119
DR   PharmacoDB; KG1_744_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0374
DR   PubChem_Cell_line; CVCL_0374
DR   RCB; RCB1166
DR   RCB; RCB1944
DR   TKG; TKG 0400
DR   Wikidata; Q54899833
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=306682;
RX   PubMed=1571549;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3094604;
RX   PubMed=3159941;
RX   PubMed=3856862;
RX   PubMed=3874327;
RX   PubMed=6582512;
RX   PubMed=6954533;
RX   PubMed=6996765;
RX   PubMed=8558913;
RX   PubMed=9290701;
RX   PubMed=9379676;
RX   PubMed=9510473;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=17254797;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22844360;
RX   PubMed=23955599;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31395879;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KG-1
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-169.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8031.
CC   Population: Caucasian.
CC   Characteristics: Mostly at the myeloblast or promyelocyte stage of maturation.
CC   Doubling time: 45 hours (CLS=300208); ~38 hours (DSMZ=ACC-14).
CC   HLA typing: A*30:02,30:02; B*53:01,78:01; C*04:01,16:01; DQA1*01:02,05:02; DQB1*03:04,06:11; DRB1*03:17,11:01 (PubMed=26589293).
CC   HLA typing: A*30:02:01,30:02:01; B*53:01:01,78:01:01; C*04:01:01,16:01:01; DPA1*01:03:01,02:01:01; DPB1*11:01:01,105:01; DQB1*06:02:01,06:02:01; DRA*01:01:01,01:02:02; DRB1*11:01:02,14:54:01 (DSMZCellDive=ACC-14).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3688; FGFR1 + HGNC; HGNC:23098; FGFR1OP2; Name(s)=FGFR1OP2-FGFR1 (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=9379676).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=1571549; Cosmic-CLP=907278; DepMap=ACH-000386).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=84.82%; Native American=0%; East Asian, North=3.33%; East Asian, South=0%; South Asian=0.57%; European, North=3.95%; European, South=7.34% (PubMed=30894373).
CC   Discontinued: RCB; RCB1944; true.
CC   Discontinued: TKG; TKG 0400; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CCL-246; ATCC=CRL-8031; CLS=300208; Cosmic-CLP=907278; DSMZ=ACC-14; ECACC=86111306; JCRB=JCRB0065; JCRB=JCRB9051; KCLB=10246; PubMed=17254797; PubMed=25877200; RCB=RCB1166
ST   Amelogenin: X,Y
ST   CSF1PO: 7
ST   D13S317: 11,12
ST   D16S539: 10,11 (ATCC=CCL-246; ATCC=CRL-8031; Cosmic-CLP=907278; DSMZ=ACC-14; ECACC=86111306; JCRB=JCRB0065; JCRB=JCRB9051; KCLB=10246; PubMed=17254797; PubMed=25877200; RCB=RCB1166)
ST   D16S539: 11 (CLS=300208)
ST   D18S51: 10,18 (PubMed=17254797)
ST   D18S51: 10.2,18 (ATCC=CCL-246; ATCC=CRL-8031; CLS=300208; PubMed=25877200)
ST   D18S51: 11,18 (DSMZ=ACC-14)
ST   D19S433: 11,16.2 (ATCC=CCL-246; ATCC=CRL-8031)
ST   D19S433: 11,17 (DSMZ=ACC-14)
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 13,14 (ATCC=CCL-246; ATCC=CRL-8031; CLS=300208; PubMed=17254797; PubMed=25877200)
ST   D8S1179: 14 (DSMZ=ACC-14)
ST   FGA: 22
ST   Penta D: 8,9
ST   Penta E: 7,13
ST   TH01: 7,8
ST   TPOX: 7,9
ST   vWA: 14,19
DI   NCIt; C3249; Acute myeloid leukemia without maturation
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   KG-1-C
AC   CVCL_2971
SY   KG-1C; KG1C; KG-1
DR   CLO; CLO_0050639
DR   ArrayExpress; E-MTAB-2770
DR   BCRJ; 0378
DR   BioSample; SAMN03471662
DR   BioSample; SAMN10987833
DR   cancercelllines; CVCL_2971
DR   Cell_Model_Passport; SIDM00784
DR   Cosmic; 685872
DR   Cosmic; 1746964
DR   Cosmic; 2302336
DR   DepMap; ACH-000126
DR   GDSC; 1240164
DR   GEO; GSM326250
DR   GEO; GSM827298
DR   GEO; GSM887207
DR   GEO; GSM888280
DR   IARC_TP53; 30094
DR   JCRB; JCRB0236
DR   LiGeA; CCLE_728
DR   LINCS_LDP; LCL-1801
DR   PharmacoDB; KG1C_745_2019
DR   Progenetix; CVCL_2971
DR   RCB; RCB0270
DR   Wikidata; Q54899834
RX   PubMed=222111;
RX   PubMed=4093122;
RX   PubMed=9290701;
RX   PubMed=12068308;
RX   PubMed=14618099;
RX   PubMed=15900046;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~41 hours (PubMed=222111); 5-6 days (Note=Lot 041698), 3.5 days (Note=Lot 03012016) (JCRB=JCRB0236).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=8%; Native American=0%; East Asian, North=84.74%; East Asian, South=0.27%; South Asian=0%; European, North=0%; European, South=6.98% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=JCRB0236; RCB=RCB0270
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   KG-1a
AC   CVCL_1824
SY   KG-1A; KG1A; KG1a
DR   BTO; BTO_0005076
DR   CLO; CLO_0007095
DR   CLO; CLO_0051561
DR   CLDB; cl3026
DR   CLDB; cl3027
DR   ATCC; CCL-246.1
DR   BCRC; 60224
DR   BioSample; SAMN01821644
DR   BioSample; SAMN03470993
DR   cancercelllines; CVCL_1824
DR   CCRID; 1102HUM-NIFDC00028
DR   ChEMBL-Cells; CHEMBL4295408
DR   ChEMBL-Targets; CHEMBL4296453
DR   CLS; 300234
DR   Cosmic; 787444
DR   Cosmic; 821042
DR   Cosmic; 850388
DR   Cosmic; 985582
DR   Cosmic; 994174
DR   Cosmic; 1127254
DR   Cosmic; 1319553
DR   DSMZ; ACC-421
DR   DSMZCellDive; ACC-421
DR   ECACC; 91030101
DR   GEO; GSM1374598
DR   GEO; GSM1446747
DR   IZSLER; BS TCL 196
DR   LINCS_LDP; LCL-1057
DR   Lonza; 835
DR   NCBI_Iran; C520
DR   PubChem_Cell_line; CVCL_1824
DR   RCB; RCB1928
DR   TKG; TKG 0402
DR   Ubigene; YC-C083
DR   Wikidata; Q54899835
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3094604;
RX   PubMed=6967340;
RX   PubMed=8558913;
RX   PubMed=11416159;
RX   PubMed=22844360;
RX   PubMed=25877200;
RX   PubMed=36982453;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/description-of-normal-growth-and-morphology-of-atcc-ccl-246-1
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KG-1
CC   Population: Caucasian.
CC   Characteristics: Less differentiated subline of KG-1, composed of undifferentiated promyeloblasts.
CC   Doubling time: ~45 hours (CLS=300234); ~50 hours (DSMZ=ACC-421).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3688; FGFR1 + HGNC; HGNC:23098; FGFR1OP2; Name(s)=FGFR1OP2-FGFR1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CCL-246.1; CCRID=1102HUM-NIFDC00028; CLS=300234; COG; DSMZ=ACC-421; ECACC=91030101; PubMed=11416159; PubMed=25877200; RCB=RCB1928; TKG=TKG 0402
ST   Amelogenin: X,Y
ST   CSF1PO: 7
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 10.2,18
ST   D19S433: 11,16.2 (ATCC=CCL-246.1; COG)
ST   D19S433: 11,17 (DSMZ=ACC-421)
ST   D19S433: 16.2 (PubMed=25877200)
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 13,14 (ATCC=CCL-246.1; CCRID=1102HUM-NIFDC00028; CLS=300234; DSMZ=ACC-421; PubMed=11416159; PubMed=25877200)
ST   D8S1179: 14 (COG)
ST   FGA: 22
ST   Penta D: 8,9
ST   Penta E: 7,13
ST   TH01: 7,8
ST   TPOX: 7 (PubMed=25877200)
ST   TPOX: 7,9 (ATCC=CCL-246.1; CCRID=1102HUM-NIFDC00028; CLS=300234; COG; DSMZ=ACC-421; ECACC=91030101; RCB=RCB1928; TKG=TKG 0402)
ST   vWA: 14,19
DI   NCIt; C3249; Acute myeloid leukemia without maturation
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0374 ! KG-1
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   KG-R
AC   CVCL_0I71
DR   CCLV; CCLV-RIE 0252
DR   Wikidata; Q54899836
RX   PubMed=25565633;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   KG1
AC   CVCL_UD72
SY   Kidney-Gli1
DR   Wikidata; Q94338847
RX   PubMed=30303712;
CC   Characteristics: Kidney Gli1-positive mesenchymal stem cell-like.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Gli1-CreERt2 x R26tdTomato/WT x H-2kbSV40tsA58/WT (Immortomouse) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   KG55T
AC   CVCL_W464
SY   KG 55T; KG-55-T
DR   Wikidata; Q54899837
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=6194659;
RX   PubMed=6310497;
CC   Population: Japanese.
CC   Virology: Contains multiple copies of integrated hepatitis B virus (HBV) genomes.
CC   Doubling time: 50-60 hours (Note=At 12th passage) (PubMed=6194659).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   KGC-1
AC   CVCL_UC77
DR   Wikidata; Q94338862
RX   PubMed=6767657;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 6
//
ID   KGF
AC   CVCL_E5JW
SY   Kissing Gourami Fin
DR   NRFC; NRFC080
WW   Provider; NRFC; NRFC080; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC080.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=243708; ! Helostoma temminkii (Kissing gourami)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KGH9/G12
AC   CVCL_E8WR
RX   PubMed=3084658;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Fusion of P3/NS1/1-Ag4.1 with malignant B-cells from a patient with nodular lymphoma (PubMed=3084658).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybrid cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KGK
AC   CVCL_C1CT
DR   Wikidata; Q114311816
RX   DOI=10.5794/jjoms.39.367;
CC   Population: Japanese.
CC   Doubling time: 19 hours (DOI=10.5794/jjoms.39.367).
CC   Derived from site: Metastatic; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   KGL-1
AC   CVCL_UC78
DR   Wikidata; Q94338868
RX   DOI=10.1266/jjg.51.65;
RX   PubMed=6767657;
CC   Group: Fish cell line.
CC   Doubling time: ~2 days (DOI=10.1266/jjg.51.65).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Derived from site: In situ; Scale; UBERON=UBERON_0002542.
OX   NCBI_TaxID=138676; ! Carassius langsdorfii (Japanese silver crucian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   KGN
AC   CVCL_0375
DR   BTO; BTO_0005671
DR   CLO; CLO_0051454
DR   EFO; EFO_0022440
DR   MCCL; MCC:0000270
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472163
DR   cancercelllines; CVCL_0375
DR   Cell_Model_Passport; SIDM00302
DR   ChEMBL-Cells; CHEMBL3308155
DR   ChEMBL-Targets; CHEMBL2366154
DR   Cosmic; 924186
DR   Cosmic; 1149409
DR   Cosmic; 1213591
DR   Cosmic; 1305320
DR   Cosmic; 1312287
DR   Cosmic; 1429993
DR   Cosmic; 2368538
DR   Cosmic; 2697832
DR   Cosmic-CLP; 924186
DR   DepMap; ACH-002149
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10624-108H3
DR   GDSC; 924186
DR   GEO; GSM1669985
DR   IARC_TP53; 27560
DR   KYinno; KC-3936
DR   LINCS_LDP; LCL-1297
DR   PharmacoDB; KGN_746_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_0375
DR   RCB; RCB1154
DR   Ubigene; YC-C051
DR   Wikidata; Q54899838
RX   PubMed=11145608;
RX   PubMed=15541573;
RX   PubMed=18980698;
RX   PubMed=19956657;
RX   PubMed=20098707;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 46.4 hours (PubMed=11145608).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1092; FOXL2; Simple; p.Cys134Trp (c.402C>G); ClinVar=VCV000376348; Zygosity=Heterozygous (PubMed=19956657; PubMed=20098707).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.09%; East Asian, North=73.92%; East Asian, South=24.17%; South Asian=1.82%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
ST   Source(s): Cosmic-CLP=924186; RCB=RCB1154
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   KGN-EGFP
AC   CVCL_C8VY
DR   Ubigene; YC-C051-EGFP-P
DR   Wikidata; Q123032812
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1092; FOXL2; Simple; p.Cys134Trp (c.402C>G); ClinVar=VCV000376348; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0375 ! KGN
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   KGN-MXIV
AC   CVCL_E3DH
RX   PubMed=24389730;
CC   Population: Japanese.
CC   Characteristics: Control cell line for KGN-YAP (Cellosaurus=CVCL_E3DI) and KGN-YAP(S127A) (Cellosaurus=CVCL_E3DJ). Transduced with an empty vector (PubMed=24389730).
CC   Sequence variation: Mutation; HGNC; HGNC:1092; FOXL2; Simple; p.Cys134Trp (c.402C>G); ClinVar=VCV000376348; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser127Ala).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0375 ! KGN
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   KGN-YAP
AC   CVCL_E3DI
RX   PubMed=24389730;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1092; FOXL2; Simple; p.Cys134Trp (c.402C>G); ClinVar=VCV000376348; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0375 ! KGN
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   KGN-YAP(S127A)
AC   CVCL_E3DJ
SY   KGN-YAPS127A
RX   PubMed=24389730;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1092; FOXL2; Simple; p.Cys134Trp (c.402C>G); ClinVar=VCV000376348; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser127Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
DI   NCIt; C6261; Ovarian granulosa cell tumor
DI   ORDO; Orphanet_99915; Maligant granulosa cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0375 ! KGN
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   KGU
AC   CVCL_E723
DR   dbMHC; 48921
DR   ECACC; 94050339
DR   IHW; IHW09309
DR   IPD-IMGT/HLA; 10910
DR   Wikidata; Q54899840
RX   PubMed=28360230;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Indian.
CC   HLA typing: A*11; B*35; C*35; DPB1*04:01; DQA1*01:04:02; DRB1*14:04 (IPD-IMGT/HLA=10910).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   KGUi001-A
AC   CVCL_VR57
SY   AR1023 hiPSC; AR1023 iPSC
DR   BioSamples; SAMEA4861682
DR   hPSCreg; KGUi001-A
DR   Wikidata; Q94338892
RX   PubMed=30266033;
CC   From: Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt; Frankfurt Am Main; Germany.
CC   Population: Caucasian; Polish.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   KGUi002-A
AC   CVCL_VR58
SY   AR1034 hiPSC; AR1034 iPSC
DR   BioSamples; SAMEA4861683
DR   hPSCreg; KGUi002-A
DR   Wikidata; Q94338896
RX   PubMed=30266033;
CC   From: Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt; Frankfurt Am Main; Germany.
CC   Population: Caucasian; German.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   KgV
AC   CVCL_5T73
SY   Kgv
DR   Wikidata; Q54899841
RX   PubMed=1717631;
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c H-2k.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 8
//
ID   KH OS R1
AC   CVCL_T431
DR   cancercelllines; CVCL_T431
DR   Wikidata; Q54899846
RX   PubMed=17096323;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2546 ! KHOS/NP
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   KH OS R2
AC   CVCL_T432
SY   KHOSR2; KHOS(R2); KHOS R2; KHOSMR
DR   cancercelllines; CVCL_T432
DR   Wikidata; Q54899847
RX   PubMed=17096323;
RX   PubMed=19638450;
RX   PubMed=24866169;
RX   PubMed=25236161;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T431 ! KH OS R1
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   KH OS R3
AC   CVCL_T433
DR   cancercelllines; CVCL_T433
DR   Wikidata; Q54899848
RX   PubMed=17096323;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T432 ! KH OS R2
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   KH-1
AC   CVCL_JF66
DR   Wikidata; Q54899849
RX   PubMed=6982237;
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=6982237).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   KH-100
AC   CVCL_D5CY
DR   Wikidata; Q127382418
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Doubling time: 26 hours (CelloPub=CLPUB00761).
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5CX ! KH-85
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-150
AC   CVCL_D5CZ
DR   Wikidata; Q127382419
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5CY ! KH-100
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-2
AC   CVCL_JF67
DR   Wikidata; Q54899850
RX   PubMed=6982237;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=6982237).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   KH-200
AC   CVCL_D5D0
DR   Wikidata; Q127382420
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5CZ ! KH-150
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-25
AC   CVCL_D5D3
DR   Wikidata; Q127382421
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-250
AC   CVCL_D5D1
DR   Wikidata; Q127382422
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5D0 ! KH-200
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-300
AC   CVCL_D5AW
SY   KH300
DR   Wikidata; Q127382423
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Doubling time: 50 hours (CelloPub=CLPUB00761).
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5D1 ! KH-250
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-375
AC   CVCL_D5D2
DR   Wikidata; Q127382424
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5AW ! KH-300
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-39
AC   CVCL_W214
SY   KH39
DR   Cosmic; 845929
DR   Wikidata; Q54899851
RX   PubMed=7154478;
RX   PubMed=8621251;
RX   PubMed=10723130;
RX   PubMed=10929426;
RX   PubMed=27993170;
CC   Population: Japanese.
CC   Doubling time: 16.0 hours (PubMed=7154478).
CC   Misspelling: KN-39; Note=Occasionally.
CC   Misspelling: KN39; Note=Occasionally.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   KH-3A
AC   CVCL_QW94
DR   Wikidata; Q54899852
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3128506;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=3128506).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QW95 ! KH-3B
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   KH-3B
AC   CVCL_QW95
DR   Wikidata; Q54899853
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3128506;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=3128506).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QW94 ! KH-3A
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   KH-4
AC   CVCL_QW96
DR   Wikidata; Q54899855
RX   PubMed=3128506;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=3128506).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   KH-450
AC   CVCL_D5AX
SY   KH450
DR   Wikidata; Q127382425
RX   CelloPub=CLPUB00761;
RX   PubMed=3622008;
CC   Population: Caucasian.
CC   Doubling time: 65 hours (CelloPub=CLPUB00761).
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5D2 ! KH-375
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-50
AC   CVCL_D5CW
DR   Wikidata; Q127382426
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5D3 ! KH-25
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-85
AC   CVCL_D5CX
DR   Wikidata; Q127382427
RX   CelloPub=CLPUB00761;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5CW ! KH-50
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KH-AML-B2
AC   CVCL_JK50
DR   cancercelllines; CVCL_JK50
DR   JCRB; KURB2759
DR   Wikidata; Q54899858
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted. This cell line contains both the mutated allele and the reverted allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Ter (c.8504C>G) (8732C>A); ClinVar=VCV000267091; Zygosity=Heterozygous; Note=Mutated. This cell line contains both the mutated allele and the reverted allele (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JH26 ! FA-AML1A
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   KH-R
AC   CVCL_G348
DR   CCLV; CCLV-RIE 0090
DR   Wikidata; Q54899859
RX   PubMed=12670509;
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   KH184
AC   CVCL_RM08
DR   Wikidata; Q54899860
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8167181;
CC   Population: Japanese.
CC   Doubling time: 36-60 hours (PubMed=8167181).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3170; Acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   KH2
AC   CVCL_C317
DR   BTO; BTO_0004414
DR   Wikidata; Q54899862
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   KH88
AC   CVCL_G364
SY   KH-88
DR   TKG; TKG 0704
DR   Wikidata; Q54899863
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289484;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from child cell lines KH88 B4D6; KH88 C2F8).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0704
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D5S818: 11,14
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   KH88 B4D6
AC   CVCL_V005
SY   KH88-B4D6; KH88 subclone B4D6; KH88B4D6; B4D6
DR   Cosmic; 949097
DR   Wikidata; Q54899864
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289484;
RX   PubMed=9644295;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14603991;
CC   Population: Japanese.
CC   Doubling time: 20-26 hours (PubMed=8289484).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G364 ! KH88
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   KH88 C2F8
AC   CVCL_W721
SY   KH88-C2F8; KH88 subclone C2F8; C2F8
DR   Cosmic; 949098
DR   Wikidata; Q54899865
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289484;
RX   PubMed=9644295;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Population: Japanese.
CC   Doubling time: 20-26 hours (PubMed=8289484).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G364 ! KH88
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   KHAGNI
AC   CVCL_E724
DR   dbMHC; 48922
DR   ECACC; 94022534
DR   IHW; IHW09248
DR   IPD-IMGT/HLA; 10912
DR   Wikidata; Q54899867
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Iranian.
CC   HLA typing: A*11:01:01:01,26:01:01:01; B*15:08:01,52:01:01:02; C*01:02:01,12:02:02:01; DPB1*04:01:01; DQB1*06:01:01/06:01:15,02:02:01; DRB1*15:02:01,07:01:01 (IPD-IMGT/HLA=10912).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   KhES-1
AC   CVCL_B231
SY   KHES-1; KhES1; KUIMSe001-A
DR   GEO; GSM1040238
DR   GEO; GSM1040308
DR   GEO; GSM1489246
DR   GEO; GSM1489457
DR   hPSCreg; KUIMSe001-A
DR   NIHhESC; NIHhESC-22-0487
DR   RCB; HES0001
DR   SKIP; SKIP000147
DR   SKIP; SKIP001952
DR   Wikidata; Q54899868
RX   PubMed=17572666;
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=27476965;
RX   PubMed=33059130;
RX   PubMed=33225099;
CC   From: Institute for Frontier Medical Sciences, Kyoto University; Kyoto; Japan.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0487.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: SKIP; SKIP000147; probable.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   KhES-1 CAG-EGFP
AC   CVCL_T924
DR   SKIP; SKIP000150
DR   Wikidata; Q54899869
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: SKIP; SKIP000150; probable.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B231 ! KhES-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   KhES-1 subline 1
AC   CVCL_T917
DR   Wikidata; Q54899870
RX   PubMed=16931777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B231 ! KhES-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   KhES-1 subline 2
AC   CVCL_T918
DR   Wikidata; Q54899871
RX   PubMed=16931777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B231 ! KhES-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   KhES-1 subline 3
AC   CVCL_T919
DR   Wikidata; Q54899872
RX   PubMed=16931777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B231 ! KhES-1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   KhES-2
AC   CVCL_B232
SY   KHES-2; KhES2; KUIMSe002-A
DR   GEO; GSM1519868
DR   hPSCreg; KUIMSe002-A
DR   RCB; HES0002
DR   SKIP; SKIP000151
DR   SKIP; SKIP001953
DR   Wikidata; Q54899873
RX   PubMed=17572666;
RX   PubMed=33059130;
RX   PubMed=33225099;
CC   From: Institute for Frontier Medical Sciences, Kyoto University; Kyoto; Japan.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   KhES-2 subline 1
AC   CVCL_T920
DR   Wikidata; Q54899875
RX   PubMed=16931777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B232 ! KhES-2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   KhES-2 subline 2
AC   CVCL_T921
DR   Wikidata; Q54899876
RX   PubMed=16931777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B232 ! KhES-2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   KhES-3
AC   CVCL_B233
SY   KHES-3; KhES3; KUIMSe003-A
DR   GEO; GSM1040239
DR   GEO; GSM1040309
DR   GEO; GSM1489247
DR   GEO; GSM1489259
DR   GEO; GSM1489458
DR   GEO; GSM1942576
DR   GEO; GSM1942580
DR   GEO; GSM1942581
DR   GEO; GSM1942582
DR   GEO; GSM1942583
DR   GEO; GSM1942584
DR   GEO; GSM1942585
DR   GEO; GSM1942586
DR   GEO; GSM1942587
DR   hPSCreg; KUIMSe003-A
DR   RCB; HES0003
DR   SKIP; SKIP000152
DR   SKIP; SKIP001954
DR   Wikidata; Q54899877
RX   PubMed=17572666;
RX   PubMed=21098095;
RX   PubMed=21460823;
RX   PubMed=22802639;
RX   PubMed=24259714;
RX   PubMed=25665923;
RX   PubMed=27476965;
RX   PubMed=33059130;
RX   PubMed=33225099;
RX   PubMed=35754715;
CC   From: Institute for Frontier Medical Sciences, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   KhES-3 subline 1
AC   CVCL_T922
SY   KUIMSe003-A-1
DR   hPSCreg; KUIMSe003-A-1
DR   SKIP; SKIP002452
DR   Wikidata; Q54899878
RX   PubMed=16931777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B233 ! KhES-3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   KhES-3 subline 2
AC   CVCL_T923
DR   Wikidata; Q54899879
RX   PubMed=16931777;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B233 ! KhES-3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   KhES-4
AC   CVCL_T797
SY   KHES-4; KhES4
DR   GEO; GSM1040240
DR   GEO; GSM1040310
DR   RCB; HES0004
DR   SKIP; SKIP000154
DR   Wikidata; Q54899880
RX   PubMed=24259714;
RX   PubMed=33059130;
RX   PubMed=33225099;
CC   From: Institute for Frontier Medical Sciences, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   KhES-5
AC   CVCL_T798
SY   KHES-5; KhES5
DR   GEO; GSM1040241
DR   GEO; GSM1040311
DR   RCB; HES0005
DR   SKIP; SKIP000156
DR   Wikidata; Q54899881
RX   PubMed=24259714;
RX   PubMed=33059130;
RX   PubMed=33225099;
CC   From: Institute for Frontier Medical Sciences, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   KHm-1
AC   CVCL_W210
SY   KHm1
DR   Wikidata; Q54899883
RX   PubMed=29705;
RX   PubMed=197244;
RX   PubMed=286091;
RX   PubMed=10629075;
CC   Population: Caucasian.
CC   Doubling time: 34 hours (PubMed=197244).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   KHM-10B
AC   CVCL_2973
SY   KHM10B
DR   cancercelllines; CVCL_2973
DR   Cosmic; 2297032
DR   GEO; GSM119555
DR   JCRB; JCRB0165
DR   JCRB; NIHS0195
DR   Progenetix; CVCL_2973
DR   Wikidata; Q54899884
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8609722;
RX   PubMed=16960149;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 24 hours (PubMed=8609722).
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: JCRB; NIHS0195; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB0165
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   KHM-11
AC   CVCL_A633
SY   KHM11
DR   cancercelllines; CVCL_A633
DR   Cosmic; 720771
DR   Cosmic; 2081388
DR   Cosmic; 2367278
DR   Wikidata; Q54899885
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=7934174;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=11157491).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 22
//
ID   KHM-11ad
AC   CVCL_A634
SY   11ad
DR   Wikidata; Q54899886
RX   PubMed=10352328;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A633 ! KHM-11
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   KHM-1A
AC   CVCL_9546
SY   KHM1A
DR   Wikidata; Q54899887
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2458153;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA lambda.
CC   Doubling time: ~5 days (PubMed=2458153).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2972 ! KHM-1B
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   KHM-1B
AC   CVCL_2972
SY   KHM1B
DR   EFO; EFO_0006609
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472941
DR   BioSample; SAMN10987831
DR   cancercelllines; CVCL_2972
DR   Cell_Model_Passport; SIDM01662
DR   Cosmic; 2081389
DR   DepMap; ACH-000564
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM887209
DR   GEO; GSM888282
DR   IARC_TP53; 30095
DR   JCRB; JCRB0133
DR   JCRB; NIHS0190
DR   LiGeA; CCLE_310
DR   PharmacoDB; KHM1B_747_2019
DR   Progenetix; CVCL_2972
DR   Wikidata; Q54899888
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1701504;
RX   PubMed=2458153;
RX   PubMed=10936422;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Produces IgA lambda.
CC   Doubling time: ~2 days (PubMed=2458153).
CC   HLA typing: A*24:02,24:02; B*39:01,52:01; C*07:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (DepMap=ACH-000564).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (DepMap=ACH-000564).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.34%; Native American=0%; East Asian, North=77.81%; East Asian, South=17.18%; South Asian=0%; European, North=0%; European, South=4.66% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0190; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB0133; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16,18
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 8,16
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9546 ! KHM-1A
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   KHM-2B
AC   CVCL_8526
SY   KHM2B
DR   JCRB; JCRB1394
DR   Wikidata; Q54899890
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2123067;
RX   PubMed=7849311;
RX   PubMed=26727417;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1394
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 9,10
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18,20
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   KHm-3
AC   CVCL_W211
SY   KHm3
DR   Wikidata; Q54899891
RX   PubMed=286091;
RX   PubMed=10629075;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   KHM-3S
AC   CVCL_2974
DR   CLO; CLO_0037017
DR   BioSample; SAMN03470805
DR   BioSample; SAMN03470833
DR   cancercelllines; CVCL_2974
DR   GEO; GSM827196
DR   JCRB; JCRB0138
DR   JCRB; NIHS0192
DR   LINCS_LDP; LCL-1876
DR   Progenetix; CVCL_2974
DR   Wikidata; Q54899892
RX   PubMed=1319985;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Doubling time: ~2 days (Note=Lot 03052003) (JCRB=JCRB0138).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0192; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB0138; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9,13 (JCRB=JCRB0138)
ST   D16S539: 9,13,14 (PubMed=25877200)
ST   D18S51: 12,16
ST   D21S11: 30
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 20
ST   Penta D: 10,11
ST   Penta E: 5,22
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   KHm-4
AC   CVCL_VP58
SY   KHm4
DR   Wikidata; Q94339197
RX   PubMed=10629075;
RX   PubMed=11606052;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   KHM-4
AC   CVCL_9545
SY   KHM4
DR   CGH-DB; 9160-4
DR   Wikidata; Q54899905
RX   PubMed=1611184;
RX   PubMed=10936422;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   KHm-5
AC   CVCL_W212
SY   KHm5
DR   Wikidata; Q54899906
RX   PubMed=286091;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   KHM-5M
AC   CVCL_2975
SY   KHM/5M; KHM5M
DR   BioSample; SAMN03470813
DR   BioSample; SAMN03470887
DR   cancercelllines; CVCL_2975
DR   CCRID; 3101HUMSCSP549
DR   CGH-DB; 57-1
DR   CLS; 305148
DR   Cosmic; 2054085
DR   FANTOM5_SSTAR; 10776-110G2
DR   JCRB; JCRB0148
DR   JCRB; NIHS0194
DR   Wikidata; Q54899907
RX   PubMed=1728417;
RX   PubMed=16924234;
RX   PubMed=23833040;
RX   PubMed=25877200;
RX   PubMed=30737244;
CC   Population: Japanese.
CC   Doubling time: 27 hours (Note=Lot 09272002) (JCRB=JCRB0148).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0194; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB0148; PubMed=25877200; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11.3,12.3 (JCRB=JCRB0148)
ST   CSF1PO: 12,13 (PubMed=25877200; PubMed=30737244)
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 16,19
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 11,18
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   KHm-6
AC   CVCL_W213
SY   KHm6
DR   Wikidata; Q54899908
RX   PubMed=286091;
RX   PubMed=10629075;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 4
//
ID   KHM1106
AC   CVCL_YD71
DR   MetaboLights; MTBLS812
DR   Wikidata; Q94339229
RX   PubMed=31037374;
CC   Omics: Metabolomics.
CC   Miscellaneous: Age/sex of donor, disease and category of cell line from personal communication of Wittel, Uwe A.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54-55Y
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   KHO-R
AC   CVCL_XH21
DR   CCLV; CCLV-RIE 0041
DR   Wikidata; Q94339234
CC   Senescence: Senesces at 100 PDL (CCLV=CCLV-RIE 0041).
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   8FM
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   KHOS-240S
AC   CVCL_2544
SY   KHOS240S; 240S
DR   BTO; BTO_0003923
DR   CLO; CLO_0007098
DR   EFO; EFO_0002219
DR   CLDB; cl3028
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-1545
DR   cancercelllines; CVCL_2544
DR   CCTCC; GDC0254
DR   CLS; 300433
DR   Cosmic; 1074392
DR   ECACC; 86112810
DR   GEO; GSM186426
DR   GEO; GSM186427
DR   GEO; GSM827381
DR   GEO; GSM1676358
DR   GEO; GSM1701688
DR   IGRhCellID; KHOS240S
DR   LINCS_LDP; LCL-1426
DR   Progenetix; CVCL_2544
DR   Wikidata; Q54899909
RX   PubMed=62397;
RX   PubMed=2233717;
RX   PubMed=2978869;
RX   PubMed=20215515;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-1545; CLS=300433; ECACC=86112810
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2546 ! KHOS/NP
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   KHOS-312H
AC   CVCL_2545
SY   KHOS312H
DR   BTO; BTO_0003924
DR   CLO; CLO_0007099
DR   CLO; CLO_0007100
DR   CLDB; cl3029
DR   ATCC; CRL-1546
DR   cancercelllines; CVCL_2545
DR   ChEMBL-Cells; CHEMBL3308382
DR   ChEMBL-Targets; CHEMBL614591
DR   CLS; 300447
DR   Cosmic; 1074400
DR   ECACC; 86112811
DR   GEO; GSM827383
DR   GEO; GSM1676359
DR   GEO; GSM1701689
DR   LINCS_LDP; LCL-1427
DR   Progenetix; CVCL_2545
DR   PubChem_Cell_line; CVCL_2545
DR   Wikidata; Q54899910
RX   PubMed=62397;
RX   PubMed=2233717;
RX   PubMed=20215515;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: KHOS-321H; Note=Due to an error in some ATCC catalogs, this cell line has been referred to as KHOS-321H by ATCC and in the literature.
CC   Misspelling: KHOS321H; Note=Due to an error in some ATCC catalogs.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-1546; CLS=300447; ECACC=86112811
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14,17
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2546 ! KHOS/NP
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   KHOS/NP
AC   CVCL_2546
SY   KHOS-NP; KHOS NP; KHOSNP; R-970-5; KHOS
DR   BTO; BTO_0003922
DR   CLO; CLO_0007096
DR   CLO; CLO_0007097
DR   CLO; CLO_0008725
DR   CLDB; cl3030
DR   CLDB; cl3031
DR   ATCC; CRL-1544
DR   ATCC; CRL-7723
DR   cancercelllines; CVCL_2546
DR   ChEMBL-Cells; CHEMBL3308001
DR   ChEMBL-Targets; CHEMBL612598
DR   CLS; 300235
DR   Cosmic; 1044083
DR   Cosmic; 1074393
DR   ECACC; 84102903
DR   GEO; GSM186428
DR   GEO; GSM186429
DR   GEO; GSM827385
DR   GEO; GSM1676341
DR   GEO; GSM1701672
DR   IZSLER; BS TCL 80
DR   LINCS_LDP; LCL-1425
DR   Progenetix; CVCL_2546
DR   PubChem_Cell_line; CVCL_2546
DR   Wikidata; Q54899911
RX   PubMed=2233717;
RX   PubMed=2978869;
RX   PubMed=20215515;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Characteristics: Tumorigenic.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7723; true.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-1544; CLS=300235; ECACC=84102903
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14,17 (ATCC=CRL-1544)
ST   D18S51: 17 (CLS=300235)
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 33
//
ID   KHY
AC   CVCL_A3AF
DR   CCLV; CCLV-RIE 0239
DR   Wikidata; Q105509776
RX   PubMed=25565633;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   KHYG-1
AC   CVCL_2976
SY   KHYG1; KHYG
DR   EFO; EFO_0022649
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   cancercelllines; CVCL_2976
DR   Cell_Model_Passport; SIDM01661
DR   Cosmic; 1534877
DR   Cosmic; 1542070
DR   Cosmic; 2025323
DR   Cosmic; 2390214
DR   Cosmic; 2785203
DR   DepMap; ACH-001100
DR   DSMZ; ACC-725
DR   DSMZCellDive; ACC-725
DR   FANTOM5_SSTAR; 10777-110G3
DR   GEO; GSM472000
DR   IARC_TP53; 13193
DR   JCRB; JCRB0156
DR   JCRB; NIHS0226
DR   Lonza; 733
DR   Wikidata; Q54899912
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10803505;
RX   PubMed=10803526;
RX   PubMed=16827800;
RX   PubMed=19194464;
RX   PubMed=21052088;
RX   PubMed=25586472;
RX   PubMed=31160637;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/KHYG-1
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: 24-48 hours (PubMed=10803526); ~30-40 hours (DSMZ=ACC-725); ~54 hours (Note=Lot 11012010), ~30 hours (Note=Lots 07242006 and 11202015), ~25 hours (Note=Lot 10182016) (JCRB=JCRB0156).
CC   HLA typing: A*11:01:01,24:02:01; B*35:01:01,54:01:01; C*01:02:01,03:03:01; DPA1*02:01:01,02:01:01; DPB1*19:01,14:01:01; DQA1*01:03:01,01:03:01; DRA*01:01:01,01:02:02; DRB1*08:03:02,11:01:01 (DSMZCellDive=ACC-725).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (DepMap=ACH-001100).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=10803526; DepMap=ACH-001100).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: JCRB; NIHS0226; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-725; JCRB=JCRB0156
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 9
ST   D18S51: 13,18
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,13
ST   Penta E: 5
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   KI
AC   CVCL_E725
DR   dbMHC; 48923
DR   ECACC; 94071423
DR   IHW; IHW09333
DR   IPD-IMGT/HLA; 10914
DR   Wikidata; Q54899913
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02; B*13,55; C*01,03; DRB1*12:02:01 (IPD-IMGT/HLA=10914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Ki-2
AC   CVCL_WT39
DR   Wikidata; Q94339288
RX   PubMed=7530238;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28908; Human TNFRSF8/CD30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-3
AC   CVCL_WT40
DR   ABCD; ABCD_AA883
DR   Wikidata; Q94339291
RX   PubMed=7530238;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P28908; Human TNFRSF8/CD30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-4
AC   CVCL_WT41
DR   ABCD; ABCD_AA882
DR   Wikidata; Q94339294
RX   PubMed=7530238;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28908; Human TNFRSF8/CD30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-5
AC   CVCL_WT42
DR   Wikidata; Q94339299
RX   PubMed=7530238;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28908; Human TNFRSF8/CD30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-6
AC   CVCL_WT43
DR   Wikidata; Q94339301
RX   PubMed=7530238;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28908; Human TNFRSF8/CD30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-67
AC   CVCL_C7XR
DR   Wikidata; Q123032814
RX   PubMed=1484317;
RX   PubMed=6339421;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Ki-7
AC   CVCL_WT44
DR   Wikidata; Q94339306
RX   PubMed=7530238;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P28908; Human TNFRSF8/CD30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-B3
AC   CVCL_D6FS
DR   Wikidata; Q127382428
RX   PubMed=3304458;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human formalin resistant antigen on normal and neoplastic B-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Ki-B5
AC   CVCL_D6FT
DR   Wikidata; Q127382429
RX   PubMed=1704265;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on normal and neoplastic B-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   Ki-JK
AC   CVCL_2093
SY   KI-JK; KIJK
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 721
DR   BioSample; SAMN10987838
DR   cancercelllines; CVCL_2093
DR   Cell_Model_Passport; SIDM01581
DR   Cosmic; 850202
DR   Cosmic; 1086365
DR   DepMap; ACH-000773
DR   DSMZ; ACC-695
DR   DSMZCellDive; ACC-695
DR   FANTOM5_SSTAR; 10795-110I3
DR   GEO; GSM887210
DR   GEO; GSM888283
DR   IARC_TP53; 30096
DR   JCRB; JCRB1065
DR   JCRB; NIHS0222
DR   LiGeA; CCLE_340
DR   PharmacoDB; KiJK_748_2019
DR   Progenetix; CVCL_2093
DR   Wikidata; Q54899914
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8169113;
RX   PubMed=8558920;
RX   PubMed=9787181;
RX   PubMed=15356658;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=8169113); ~50-70 hours (DSMZ=ACC-695).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=15356658).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.29%; Native American=0%; East Asian, North=78.51%; East Asian, South=20.22%; South Asian=0%; European, North=0%; European, South=0.97% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0222; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-695; JCRB=JCRB1065
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9,12
ST   D16S539: 10
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 20,28
ST   Penta D: 10
ST   Penta E: 5
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   Ki-M1
AC   CVCL_WT25
DR   Wikidata; Q94339316
RX   PubMed=6357485;
RX   PubMed=6391190;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on interdigitating reticulum cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 4
//
ID   Ki-M2
AC   CVCL_WT26
DR   Wikidata; Q94339319
RX   PubMed=6357485;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on Kupffer cells and splenic macrophages.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 4
//
ID   Ki-M3
AC   CVCL_WT27
DR   Wikidata; Q94339324
RX   PubMed=6357485;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-M4
AC   CVCL_WT24
DR   Wikidata; Q94339330
RX   PubMed=6192857;
RX   PubMed=6357485;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human antigen on follicular dendritic cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 4
//
ID   Ki-M6
AC   CVCL_WT31
DR   Wikidata; Q94339333
RX   PubMed=3777131;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P34810; Human CD68.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-M7
AC   CVCL_WT29
DR   Wikidata; Q94339337
RX   PubMed=3476670;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P34810; Human CD68.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-M8
AC   CVCL_WT28
DR   Wikidata; Q94339340
RX   PubMed=3032305;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-M9
AC   CVCL_WT32
DR   Wikidata; Q94339342
RX   PubMed=9250155;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 70 kDa protein on sinus-lining dendritic cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-Mcm6
AC   CVCL_WT36
SY   Ki-MCM6
DR   Wikidata; Q94339345
RX   PubMed=11502867;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14566; Human MCM6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-PeCa-L1
AC   CVCL_C022
DR   Wikidata; Q54899915
RX   PubMed=22503055;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C023 ! Ki-PeCa-P1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Ki-PeCa-P1
AC   CVCL_C023
DR   Wikidata; Q54899916
RX   PubMed=22503055;
CC   Derived from site: In situ; Penis; UBERON=UBERON_0000989.
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C022 ! Ki-PeCa-L1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   Ki-S3
AC   CVCL_WT37
DR   Wikidata; Q94339371
RX   PubMed=8883465;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Ki-S5
AC   CVCL_WT38
DR   Wikidata; Q94339375
RX   PubMed=7685150;
RX   PubMed=8883465;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   Kia
AC   CVCL_X928
SY   KIA
DR   BEI_Resources; ARP-2771
DR   Wikidata; Q54899917
RX   PubMed=7535998;
CC   Group: Non-human primate cell line.
CC   Doubling time: ~20 hours (PubMed=7535998).
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9556; ! Papio cynocephalus (Yellow baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 11
//
ID   Kichil
AC   CVCL_VL67
DR   Wikidata; Q94339393
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   KICRi001-A
AC   CVCL_YD65
SY   KICRi-001-A; #10; clone #10
DR   hPSCreg; KICRi001-A
DR   Wikidata; Q94339397
CC   From: Department of Neuroscience, Karolinska Institutet; Stockholm; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   KICRi002-A
AC   CVCL_JL73
AS   CVCL_YT06
SY   KICRi002A; Ctrl-10-I; CTRL-10-I; CTL10-I
DR   hPSCreg; KICRi002-A
DR   Wikidata; Q54814766
RX   PubMed=28395796;
CC   From: Department of Neuroscience, Karolinska Institutet; Stockholm; Sweden.
CC   Donor information: Established from monozygotic twin of CTRL-9-II (Cellosaurus=CVCL_JL74).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28395796
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 20,23
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D1S1656: 15.3,17.3
ST   D21S11: 28,29
ST   D2S1338: 20,22
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D6S1043: 12,18
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 9,12
ST   Penta E: 11,16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   KICRi002-A-1
AC   CVCL_YZ88
SY   10-I nemo K.O.7; UUIGPi012-A-1
DR   hPSCreg; KICRi002-A-1
DR   Wikidata; Q98126820
RX   PubMed=32126327;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL73 ! KICRi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   KICRi002-A-2
AC   CVCL_YZ89
SY   10-I gpkow K.O.18; UUIGPi012-A-2
DR   hPSCreg; KICRi002-A-2
DR   Wikidata; Q98126821
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30677; GPKOW.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL73 ! KICRi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   KICRi002-A-3
AC   CVCL_YZ87
SY   10-I ncdn K.O.10; UUIGPi012-A-3
DR   hPSCreg; KICRi002-A-3
DR   Wikidata; Q98126822
RX   PubMed=32203915;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17597; NCDN.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL73 ! KICRi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   KICRi002-A-4
AC   CVCL_B5S1
SY   10-I ZEB2 K.O.23; UUIGPi012-A-4
DR   hPSCreg; KICRi002-A-4
DR   Wikidata; Q111733550
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL73 ! KICRi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   KICRi002-A-5
AC   CVCL_B5S2
SY   10-I POLR2A K.D.2; UUIGPi002A-5; UUIGPi012A-5; UUIGPi012-A-5
DR   hPSCreg; KICRi002-A-5
DR   Wikidata; Q111733551
RX   PubMed=34688129;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9187; POLR2A (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL73 ! KICRi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   Kid92
AC   CVCL_A088
SY   KID-92; Kid-92
DR   Cosmic; 999752
DR   Wikidata; Q54899919
RX   PubMed=8847894;
RX   PubMed=9680106;
RX   PubMed=14671638;
CC   Population: Japanese.
CC   Doubling time: 36.5 hours (PubMed=8847894).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Caution: Indicated as originating from a 16 year old male patient in text of PubMed=8847894 and from a 28 year old in table 1 of same paper.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Kie-BL
AC   CVCL_W937
SY   KIE-BL; KIE
DR   Wikidata; Q54899920
RX   PubMed=2824665;
RX   PubMed=2943927;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 12
//
ID   Kif-5
AC   CVCL_Y515
SY   KiF-5; Kif5; KIF5
DR   EFO; EFO_0002712
DR   Wikidata; Q54899921
RX   PubMed=11238448;
RX   PubMed=18298655;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 8
//
ID   KIi001-A
AC   CVCL_UL54
SY   NB1-II
DR   BioSamples; SAMEA5070576
DR   hPSCreg; KIi001-A
DR   Wikidata; Q94339429
RX   PubMed=30605844;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Heterozygous; Note=Germline (PubMed=30605844).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   KIi002-A
AC   CVCL_UL55
SY   NB2-III
DR   BioSamples; SAMEA5071210
DR   hPSCreg; KIi002-A
DR   Wikidata; Q94339434
RX   PubMed=30605844;
CC   From: Karolinska Institutet; Stockholm; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Heterozygous; Note=Germline (PubMed=30605844).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   KIJ265T
AC   CVCL_AV54
SY   KIJ-265T; KIJ-265
DR   BTO; BTO_0006214
DR   ABM; T8249
DR   Wikidata; Q54899922
RX   PubMed=20502531;
RX   PubMed=22826467;
RX   PubMed=23633458;
CC   Miscellaneous: STR profile from personal communication of Marlow, Laura A.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,14
ST   D18S51: 15
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 24
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   KIJ308T
AC   CVCL_A4ZZ
SY   KIJ-308T; KIJ-308
DR   BTO; BTO_0006215
DR   Wikidata; Q107115578
RX   PubMed=20502531;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   KIK4
AC   CVCL_UZ96
DR   JCRB; JCRB1725
DR   Wikidata; Q94339450
RX   PubMed=7588706;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.1845+2T>C; ClinVar=VCV000252070; Zygosity=Homozygous; Note=Splice donor mutation (JCRB=JCRB1725).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1725
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 12
ST   vWA: 17,18
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   KiKu
AC   CVCL_D885
SY   KIKU
DR   Wikidata; Q54899923
RX   CelloPub=CLPUB00063;
RX   PubMed=2450650;
RX   PubMed=3164747;
RX   PubMed=15289353;
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*40:06,52:01; C*08:01,12:02 (PubMed=15289353).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T738 ! KiKu-M
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   KiKu-M
AC   CVCL_T738
SY   KIKU-M
DR   Wikidata; Q54899924
RX   CelloPub=CLPUB00063;
RX   PubMed=2450650;
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D885 ! KiKu
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   KIL
AC   CVCL_HC59
SY   KIL C.2
DR   Kerafast; EUH001
DR   Wikidata; Q54899925
RX   Patent=US9121008;
RX   PubMed=15650053;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6651.
CC   Characteristics: Established from co-cultures of post-5-fluorouracil bone marrow mononuclear cells and OP-9S/LMJSN (Cellosaurus=CVCL_HC58).
CC   Characteristics: IL7 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   KIM-1
AC   CVCL_7969
DR   Wikidata; Q54899926
RX   DOI=10.2957/kanzo.25.532;
RX   PubMed=7537711;
RX   PubMed=9178645;
RX   PubMed=10347112;
RX   PubMed=27329724;
CC   Population: Japanese.
CC   HLA typing: A*11:01,26:03; B*15:01,67:01; C*03:03,07:02; DQA1*01:02,03:01; DQB1*04:01,05:02; DRB1*04:05,16:02 (PubMed=9178645).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   KIM127
AC   CVCL_0F09
SY   KIM 127
DR   ATCC; CRL-2838
DR   Wikidata; Q54899927
RX   PubMed=1371129;
RX   PubMed=7535698;
RX   PubMed=7690325;
CC   Doubling time: 18 hours (ATCC=CRL-2838).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   KIM185
AC   CVCL_0F10
SY   KIM 185
DR   ATCC; CRL-2839
DR   Wikidata; Q54899928
RX   PubMed=7535698;
RX   PubMed=7690325;
CC   Doubling time: 20 hours (ATCC=CRL-2839).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   KIME
AC   CVCL_E726
SY   KIM-ND
DR   dbMHC; 48924
DR   ECACC; 94022535
DR   IHW; IHW09212
DR   IPD-IMGT/HLA; 10915
DR   Wikidata; Q54899929
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Southeast Asian.
CC   HLA typing: A*02:11:01,32:01:01:10; B*52:01,46:01; C*12:02:02:01,15:02:01:01; DPB1*04:01:01; DQB1*02:01:01,03:03:02:02; DRB1*03,07:01:01 (IPD-IMGT/HLA=10915).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   KIMI-1
AC   CVCL_W479
DR   Wikidata; Q54899930
RX   PubMed=2085478;
CC   Population: Japanese.
CC   Characteristics: Established from nude mice transplanted tumors.
CC   Doubling time: 50 hours (PubMed=2085478).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W480 ! KIMI-2
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   KIMI-2
AC   CVCL_W480
DR   Wikidata; Q54899931
RX   PubMed=2085478;
CC   Population: Japanese.
CC   Characteristics: Established from nude mice transplanted tumors.
CC   Doubling time: 31 hours (PubMed=2085478).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W479 ! KIMI-1
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Kimura
AC   CVCL_IU38
DR   Wikidata; Q54899932
RX   PubMed=9454894;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=9454894; PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   Kin Sun
AC   CVCL_Y125
DR   ATCC; CRL-1241
DR   Wikidata; Q54899933
CC   Discontinued: ATCC; CRL-1241; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   KINGS-1
AC   CVCL_1328
SY   Kings-1; KINGS1
DR   CLO; CLO_0009893
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 910
DR   BioSample; SAMN03470889
DR   cancercelllines; CVCL_1328
DR   Cell_Model_Passport; SIDM00612
DR   CGH-DB; 143-1
DR   ChEMBL-Cells; CHEMBL3308264
DR   ChEMBL-Targets; CHEMBL2366229
DR   Cosmic; 907279
DR   Cosmic; 2367531
DR   Cosmic-CLP; 907279
DR   DepMap; ACH-002257
DR   EGA; EGAS00001000978
DR   GDSC; 907279
DR   GEO; GSM1669986
DR   IARC_TP53; 21432
DR   JCRB; IFO50435
DR   LINCS_LDP; LCL-1381
DR   PharmacoDB; KINGS1_749_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1328
DR   Wikidata; Q54899934
RX   CelloPub=CLPUB00151;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Heterozygous (Cosmic-CLP=907279).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=907279).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=73.94%; East Asian, South=26.06%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Caution: Indicated as originating from a 67 year old male patient in CelloPub=CLPUB00151 and from a 72 year old in JCRB=IFO50435.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=907279; JCRB=IFO50435; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 18,26
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,16
ST   FGA: 23,24
ST   Penta D: 10,13
ST   Penta E: 16,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   Kinsey
AC   CVCL_WS62
DR   Wikidata; Q94339571
RX   PubMed=31175136;
CC   Omics: Genomics; Whole exome sequencing.
CC   Breed/subspecies: Australian Shepherd; VBO=VBO_0200095.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 227,231
ST   Dog FHC2054: 151,168
ST   Dog FHC2079: 279
ST   Dog PEZ1: 107,115
ST   Dog PEZ3: 137,141
ST   Dog PEZ5: 103
ST   Dog PEZ6: 179
ST   Dog PEZ8: 224,228
ST   Dog PEZ12: 267,301
ST   Dog PEZ20: 176,184
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 5
//
ID   KIOMi001-A
AC   CVCL_VN34
SY   SK-C-SNCA-iPSC
DR   Wikidata; Q94339573
RX   PubMed=29906669;
CC   From: Korea Institute of Oriental Medicine; Daejeon; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By homologous recombination (PubMed=29906669).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   KIOMi002-A
AC   CVCL_YM74
SY   SK-C-LRRK2-iPSC
DR   SKIP; SKIP005587
DR   Wikidata; Q94339578
RX   PubMed=31731184;
CC   From: Korea Institute of Oriental Medicine; Daejeon; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By homologous recombination (PubMed=31731184).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   KiPS3F-7
AC   CVCL_C994
SY   [K]iPS3F-7; ESi028-A-1; ESi008-B
DR   BioSamples; SAMEA7774168
DR   BioSamples; SAMEA104132770
DR   hPSCreg; ESi008-B
DR   SKIP; SKIP002382
DR   Wikidata; Q54899935
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/KiPS3F-7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/KiPS3F_7.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS_KiPS3F7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   KiPS3F1
AC   CVCL_C995
SY   KIPS3F1
DR   Wikidata; Q54899936
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C996 ! KiPS3F2
OI   CVCL_C999 ! KiPS4F1
OI   CVCL_D000 ! KiPS4F2
OI   CVCL_D001 ! KiPS4F3
OI   CVCL_D002 ! KiPS4F4
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   KiPS3F2
AC   CVCL_C996
SY   KIPS3F2
DR   Wikidata; Q54899937
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C995 ! KiPS3F1
OI   CVCL_C999 ! KiPS4F1
OI   CVCL_D000 ! KiPS4F2
OI   CVCL_D001 ! KiPS4F3
OI   CVCL_D002 ! KiPS4F4
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   KiPS4F-1
AC   CVCL_C997
SY   [K]iPS4F-1; ESi028-A
DR   BioSamples; SAMEA7790668
DR   hPSCreg; ESi028-A
DR   SKIP; SKIP002381
DR   Wikidata; Q54899938
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/KiPS4F-12.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/KiPS4f_1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS_KiPS4F_1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C998 ! KiPS4F-8
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   KiPS4F-8
AC   CVCL_C998
SY   [K]iPS4F-8; ESi008-A
DR   BioSamples; SAMEA3303318
DR   EBiSC; ESi008-A
DR   ECACC; 66540066
DR   hPSCreg; ESi008-A
DR   SKIP; SKIP002383
DR   Wikidata; Q54899939
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/KiPS4F-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/KiPS4F_8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/ANEXOS_KiPS4F_8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Discontinued: ECACC; 66540066; true.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C997 ! KiPS4F-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   KiPS4F1
AC   CVCL_C999
SY   KIPS4F1
DR   Wikidata; Q54899940
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C995 ! KiPS3F1
OI   CVCL_C996 ! KiPS3F2
OI   CVCL_D000 ! KiPS4F2
OI   CVCL_D001 ! KiPS4F3
OI   CVCL_D002 ! KiPS4F4
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   KiPS4F2
AC   CVCL_D000
SY   KIPS4F2
DR   Wikidata; Q54899941
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C995 ! KiPS3F1
OI   CVCL_C996 ! KiPS3F2
OI   CVCL_C999 ! KiPS4F1
OI   CVCL_D001 ! KiPS4F3
OI   CVCL_D002 ! KiPS4F4
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   KiPS4F3
AC   CVCL_D001
SY   KIPS4F3
DR   Wikidata; Q54899942
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C995 ! KiPS3F1
OI   CVCL_C996 ! KiPS3F2
OI   CVCL_C999 ! KiPS4F1
OI   CVCL_D000 ! KiPS4F2
OI   CVCL_D002 ! KiPS4F4
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   KiPS4F4
AC   CVCL_D002
SY   KIPS4F4
DR   Wikidata; Q54899943
RX   PubMed=18931654;
CC   From: The Salk Institute for Biological Studies; San Diego; USA.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C995 ! KiPS3F1
OI   CVCL_C996 ! KiPS3F2
OI   CVCL_C999 ! KiPS4F1
OI   CVCL_D000 ! KiPS4F2
OI   CVCL_D001 ! KiPS4F3
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   Kirkman insulinoma clone 10
AC   CVCL_ZP59
DR   Wikidata; Q98126823
RX   PubMed=227554;
CC   Characteristics: Tumorigenic. Does not produces insulin when grown in culture but does so when grown in tumors (PubMed=227554).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_ZP60 ! Kirkman insulinoma clone 13
OI   CVCL_ZP61 ! Kirkman insulinoma clone 27
OI   CVCL_ZP62 ! Kirkman insulinoma clone 30
OI   CVCL_ZP63 ! Kirkman insulinoma clone 35
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   Kirkman insulinoma clone 13
AC   CVCL_ZP60
DR   Wikidata; Q98126825
RX   PubMed=227554;
CC   Characteristics: Tumorigenic. Does not produces insulin when grown in culture but does so when grown in tumors (PubMed=227554).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_ZP59 ! Kirkman insulinoma clone 10
OI   CVCL_ZP61 ! Kirkman insulinoma clone 27
OI   CVCL_ZP62 ! Kirkman insulinoma clone 30
OI   CVCL_ZP63 ! Kirkman insulinoma clone 35
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   Kirkman insulinoma clone 27
AC   CVCL_ZP61
DR   Wikidata; Q98126826
RX   PubMed=227554;
CC   Characteristics: Tumorigenic. Does not produces insulin when grown in culture but does so when grown in tumors (PubMed=227554).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_ZP59 ! Kirkman insulinoma clone 10
OI   CVCL_ZP60 ! Kirkman insulinoma clone 13
OI   CVCL_ZP62 ! Kirkman insulinoma clone 30
OI   CVCL_ZP63 ! Kirkman insulinoma clone 35
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   Kirkman insulinoma clone 30
AC   CVCL_ZP62
DR   Wikidata; Q98126829
RX   PubMed=227554;
CC   Characteristics: Tumorigenic. Does not produces insulin when grown in culture but does so when grown in tumors (PubMed=227554).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_ZP59 ! Kirkman insulinoma clone 10
OI   CVCL_ZP60 ! Kirkman insulinoma clone 13
OI   CVCL_ZP61 ! Kirkman insulinoma clone 27
OI   CVCL_ZP63 ! Kirkman insulinoma clone 35
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   Kirkman insulinoma clone 35
AC   CVCL_ZP63
DR   Wikidata; Q98126830
RX   PubMed=227554;
CC   Characteristics: Tumorigenic. Does not produces insulin when grown in culture but does so when grown in tumors (PubMed=227554).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C134946; Hamster insulinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_ZP59 ! Kirkman insulinoma clone 10
OI   CVCL_ZP60 ! Kirkman insulinoma clone 13
OI   CVCL_ZP61 ! Kirkman insulinoma clone 27
OI   CVCL_ZP62 ! Kirkman insulinoma clone 30
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   KIS-1
AC   CVCL_M506
DR   DSMZ; ACC-947
DR   Wikidata; Q54899944
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2852183;
RX   PubMed=3034807;
RX   PubMed=8650231;
RX   PubMed=19358282;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=2852183); ~24-48 hours (DSMZ=ACC-947).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:8619; PAX5; Name(s)=PAX5-IGH (PubMed=8650231).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-947
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 14
ST   D18S51: 13,20
ST   D19S433: 14
ST   D21S11: 29,32
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 15,17
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   KISCOi001-A
AC   CVCL_ZA73
SY   iPS-JIN-001; iPSC-JIN01
DR   BioSamples; SAMEA8660438
DR   hPSCreg; KISCOi001-A
DR   Wikidata; Q98126831
RX   PubMed=33517122;
CC   From: Stem Cell and Organoid Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   Kit225
AC   CVCL_5443
SY   KIT225; Kit-225; Kit 225; KIT 225
DR   EFO; EFO_0022543
DR   GEO; GSM1374599
DR   JCRB; JCRB1972
DR   Lonza; 331
DR   Wikidata; Q54899946
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3115332;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Kit225
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB1972
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4752; T-cell prolymphocytic leukemia
DI   ORDO; Orphanet_86871; T-cell prolymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Kit225/K6
AC   CVCL_5445
SY   Kit-225-K6; Kit 225-K6; Kit 225 K6; Kit225-K6; Kit225-k6; Kit225 K6; KIT225 K6
DR   Wikidata; Q54899951
RX   PubMed=9371812;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0002000000021). It was the sole source for the STR profile of this entry.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 11,14
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 10,11,12
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4752; T-cell prolymphocytic leukemia
DI   ORDO; Orphanet_86871; T-cell prolymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5443 ! Kit225
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   KITi001-A
AC   CVCL_VE24
SY   HDF01
DR   BioSamples; SAMEA112624127
DR   hPSCreg; KITi001-A
DR   Wikidata; Q54899952
RX   PubMed=29247817;
CC   From: Korea Institute of Toxicology; Daejeon; South Korea.
CC   Population: Asian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29247817
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14,16.2
ST   D21S11: 30,31
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 19
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 8
//
ID   KITi001-A-1
AC   CVCL_D0H4
SY   PDGFRB-mCherry PSC 2-6; PDGFRB-mCherry clone 2-6
DR   hPSCreg; KITi001-A-1
DR   Wikidata; Q123032816
RX   PubMed=37001365;
CC   From: Korea Institute of Toxicology; Daejeon; South Korea.
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a mCherry-polyA-PGKp-neo construct was integrated at the C-terminus of one allele of PDGFRB (PubMed=37001365).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   KITi001-A-35
AC   CVCL_VE25
SY   PXR-mCherry hiPSC 3-5
DR   SKIP; SKIP003086
DR   Wikidata; Q54899953
RX   PubMed=29247817;
CC   From: Korea Institute of Toxicology; Daejeon; South Korea.
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a mCherry-polyA-PGKp-neo construct was integrated at the C-terminus of NR1I2/PXR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29247817
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14,16.2
ST   D21S11: 30,31
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 19
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VE24 ! KITi001-A
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 12
//
ID   KITi001-C-41
AC   CVCL_B0PH
SY   ACTA2-EGFP hiPSC 3-41; ACTA2-EGFP clone 3-41
DR   Wikidata; Q108820626
RX   PubMed=34481189;
CC   From: Korea Institute of Toxicology; Daejeon; South Korea.
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a EGFP-polyA-PGKp-neo construct was introduced at the C-terminus of one allele of ACTA2 (PubMed=34481189).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VE24 ! KITi001-A
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   Kitra-SRS
AC   CVCL_YI69
DR   Wikidata; Q94339704
RX   PubMed=31676869;
CC   Population: Japanese.
CC   Doubling time: ~43 hours (PubMed=31676869).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14214; CIC + HGNC; HGNC:50800; DUX4; Name(s)=CIC-DUX4 (PubMed=31676869).
ST   Source(s): PubMed=31676869
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D21S11: 29,32.2
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C165663; CIC-DUX4 sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   KIV-116
AC   CVCL_LN30
SY   KIV116
DR   Wikidata; Q54899954
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   KIZ-7901
AC   CVCL_WL31
SY   Kunming Institute of Zoology-7901
DR   KCB; KCB 79001
DR   Wikidata; Q94339715
RX   CelloPub=CLPUB00502;
RX   CelloPub=CLPUB00503;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Male
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KIZ-81A
AC   CVCL_0A01
SY   Kunming Institute of Zoology-81A; Tufted Deer
DR   CLO; CLO_0009446
DR   CLDB; cl4573
DR   ECACC; 96011147
DR   KCB; KCB 81001
DR   Wikidata; Q54899955
RX   CelloPub=CLPUB00215;
CC   Problematic cell line: Misidentified. Originally thought to be of tufted deer origin (Elaphodus cephalophus) but seems to be (see ECACC 96011147) from another yet undefined deer species.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9850; ! Cervidae (Deer)
SX   Male
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   KIZ-8401
AC   CVCL_WL32
SY   Kunming Institute of Zoology-8401; RM/lt-MNNG
DR   KCB; KCB 84003
DR   Wikidata; Q94339730
RX   CelloPub=CLPUB00503;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_WL31 ! KIZ-7901
SX   Male
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   KJ 16
AC   CVCL_D668
SY   KJ-16; KJ16
DR   BCRJ; 0133
DR   Wikidata; Q54899956
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-beta-8.1/8.2.
CC   Discontinued: BCRJ; 0133; probable.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   KJ 23
AC   CVCL_D669
SY   KJ-23
DR   BCRJ; 0134
DR   Wikidata; Q54899957
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-beta-17.
CC   Discontinued: BCRJ; 0134; probable.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   KJ 25
AC   CVCL_D670
SY   KJ-25
DR   BCRJ; 0135
DR   Wikidata; Q54899958
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-beta-3.
CC   Discontinued: BCRJ; 0135; probable.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   KJ-A
AC   CVCL_1Q78
DR   RCB; RCB2725
DR   Wikidata; Q54899959
RX   PubMed=17317792;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 5
//
ID   Kj-LCL
AC   CVCL_6D80
DR   Wikidata; Q54899960
RX   PubMed=8127151;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KJ-SV40
AC   CVCL_9W54
DR   Wikidata; Q54899961
RX   PubMed=6314331;
CC   Doubling time: 48 hours (Note=At 33th passage) (PubMed=6314331).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KJ29
AC   CVCL_8252
SY   KJ-29
DR   BTO; BTO_0002971
DR   Wikidata; Q54899962
RX   DOI=10.1016/S0309-1651(86)80049-2;
RX   PubMed=8572614;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   KJON
AC   CVCL_WZ45
DR   cancercelllines; CVCL_WZ45
DR   Wikidata; Q94339814
RX   PubMed=22806891;
RX   PubMed=23936203;
RX   PubMed=27311012;
CC   Doubling time: ~72 hours (PubMed=27311012).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (PubMed=27311012).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Ter (c.702C>A); Zygosity=Hemizygous (PubMed=27311012).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   KJOS-II
AC   CVCL_M781
DR   Wikidata; Q54899963
RX   PubMed=19424640;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   KK
AC   CVCL_F844
DR   CGH-DB; 328-2
DR   Cosmic; 931361
DR   Cosmic; 1223313
DR   Cosmic; 1328072
DR   Cosmic; 1434897
DR   Cosmic; 2074242
DR   Cosmic; 2482702
DR   GEO; GSM416676
DR   GEO; GSM659379
DR   Wikidata; Q54899964
RX   PubMed=7844449;
RX   PubMed=8148309;
RX   PubMed=8375936;
RX   PubMed=15677628;
RX   PubMed=17671176;
RX   PubMed=20081105;
RX   PubMed=28196595;
RX   PubMed=30485824;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: ~4 days (Note=At 70th passage) (PubMed=8148309); 31 hours (PubMed=8375936).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   KK-1 [Human leukemia]
AC   CVCL_X908
SY   KK1
DR   cancercelllines; CVCL_X908
DR   CGH-DB; 9028-4
DR   IARC_TP53; 26998
DR   Wikidata; Q54899965
RX   CelloPub=CLPUB00592;
RX   PubMed=1861543;
RX   PubMed=9172809;
RX   PubMed=9596675;
RX   PubMed=10190897;
RX   PubMed=10570904;
RX   PubMed=15638862;
RX   PubMed=19220422;
RX   PubMed=19710698;
RX   PubMed=27193821;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Ser345Phe (c.1034C>T); Zygosity=Heterozygous (CelloPub=CLPUB00592).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val31Ile (c.91G>A); ClinVar=VCV000127827; Zygosity=Unspecified (PubMed=19220422; PubMed=19710698).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Arg (c.455C>G); ClinVar=VCV000824998; Zygosity=Unspecified (PubMed=19220422; PubMed=19710698).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X909 ! KK-5
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   KK-1 [Mouse granulosa]
AC   CVCL_6663
SY   KK1
DR   Wikidata; Q54899966
RX   PubMed=7565808;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: Inha promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   KK-2
AC   CVCL_VK46
DR   Cosmic; 1085914
DR   JCRB; IFO50494
DR   Wikidata; Q94339858
RX   PubMed=1323907;
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=1323907).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=9738976).
CC   Discontinued: JCRB; IFO50494; true.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   KK-3
AC   CVCL_6664
DR   Wikidata; Q54899967
RX   PubMed=7565808;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Inha promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   KK-5
AC   CVCL_X909
DR   Wikidata; Q54899969
RX   PubMed=1861543;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X908 ! KK-1 [Human leukemia]
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   KK-Luc
AC   CVCL_E7RV
RX   PubMed=21910993;
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene is under the control of 5 tandem copies of the NF-kappaB response element (PubMed=21910993).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KK-m
AC   CVCL_HF89
SY   KKm
DR   Wikidata; Q54899970
RX   CelloPub=CLPUB00362;
RX   PubMed=12738951;
RX   PubMed=16127291;
CC   Population: Japanese.
CC   Doubling time: 20-79 hours (CelloPub=CLPUB00362).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HF90 ! KK-p
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   KK-p
AC   CVCL_HF90
SY   KKp
DR   Wikidata; Q54899971
RX   CelloPub=CLPUB00362;
RX   PubMed=12738951;
RX   PubMed=16127291;
CC   Population: Japanese.
CC   Virology: HPV16 in only detected in early passages.
CC   Doubling time: 14-48 hours (CelloPub=CLPUB00362).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HF89 ! KK-m
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   KK0127
AC   CVCL_8X90
DR   ECACC; 89061801
DR   Wikidata; Q54899972
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89061801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   KK0206
AC   CVCL_Z615
DR   IARC_TP53; 26416
DR   Wikidata; Q54899973
RX   PubMed=17374419;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=17374419).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Gly (c.466C>G); ClinVar=VCV001517870; Zygosity=Unspecified (PubMed=17374419).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   KK0560
AC   CVCL_8X91
DR   ECACC; 92090407
DR   Wikidata; Q54899974
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92090407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   KK0713
AC   CVCL_8X92
DR   ECACC; 95112206
DR   Wikidata; Q54899975
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95112206; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8X93 ! KK0920
SX   Female
AG   69Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   KK0920
AC   CVCL_8X93
DR   ECACC; 97090907
DR   Wikidata; Q54899976
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 97090907; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8X92 ! KK0713
SX   Female
AG   69Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   KK1050
AC   CVCL_8X94
DR   ECACC; 98061804
DR   Wikidata; Q54899977
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98061804; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   KK124
AC   CVCL_N704
SY   KK 124
DR   cancercelllines; CVCL_N704
DR   Wikidata; Q54899978
RX   PubMed=1325212;
RX   PubMed=3018508;
RX   PubMed=3026973;
RX   PubMed=3100061;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=6286763;
RX   PubMed=8176200;
RX   PubMed=8220424;
RX   PubMed=8344493;
RX   PubMed=8568269;
RX   PubMed=9192833;
RX   PubMed=9973220;
RX   PubMed=24590883;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=8344493).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: It is possible that KK124 and KK125 (Cellosaurus=CVCL_B495) are the same cell line.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B495 ! KK125
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   KK125
AC   CVCL_B495
SY   KK 125
DR   cancercelllines; CVCL_B495
DR   Cosmic; 931126
DR   IARC_TP53; 168
DR   Wikidata; Q54899979
RX   PubMed=2052620;
RX   PubMed=9473234;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=2052620).
CC   Caution: It is possible that KK124 (Cellosaurus=CVCL_N704) and KK125 are the same cell line.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N704 ! KK124
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   KK47
AC   CVCL_8253
SY   KK-47
DR   BTO; BTO_0003552
DR   EFO; EFO_0022544
DR   cancercelllines; CVCL_8253
DR   ChEMBL-Cells; CHEMBL3308615
DR   ChEMBL-Targets; CHEMBL614674
DR   Cosmic; 925824
DR   Cosmic; 2037949
DR   GEO; GSM136247
DR   GEO; GSM492492
DR   GEO; GSM1374600
DR   GEO; GSM1574547
DR   Progenetix; CVCL_8253
DR   PubChem_Cell_line; CVCL_8253
DR   TKG; TKG 0663
DR   Wikidata; Q54899980
RX   PubMed=470258;
RX   PubMed=604596;
RX   PubMed=1353119;
RX   PubMed=3708594;
RX   PubMed=6244232;
RX   PubMed=6620776;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Japanese.
CC   Doubling time: 23.5 hours (PubMed=470258); 27 hours (PubMed=1353119).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: TKG; TKG 0663; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): TKG=TKG 0663
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D5S818: 11,12,13
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   KK47/ADM
AC   CVCL_8254
DR   Wikidata; Q54899981
RX   PubMed=1353119;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=1353119).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8253 ! KK47
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   KK47/DDP10
AC   CVCL_8255
DR   CGH-DB; 9111-4
DR   Wikidata; Q54899982
RX   PubMed=9072542;
RX   PubMed=14973057;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8253 ! KK47
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   KK47/DDP20
AC   CVCL_8256
DR   CGH-DB; 9112-4
DR   Wikidata; Q54899983
RX   PubMed=9072542;
RX   PubMed=14973057;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8253 ! KK47
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   KKA
AC   CVCL_5T72
DR   Wikidata; Q54899984
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c H-2k.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 8
//
ID   KKB
AC   CVCL_J855
DR   CLO; CLO_0050221
DR   RCB; RCB1601
DR   Wikidata; Q54899985
RX   PubMed=1717631;
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c H-2k.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 9
//
ID   KKC
AC   CVCL_J856
DR   CLO; CLO_0050219
DR   RCB; RCB1597
DR   Wikidata; Q54899986
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c H-2k.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 9
//
ID   KKE
AC   CVCL_B6HD
DR   Wikidata; Q111733552
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c H-2k.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   KKF
AC   CVCL_J857
DR   CLO; CLO_0050220
DR   RCB; RCB1600
DR   Wikidata; Q54899987
RX   PubMed=1717631;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: Thymocyte; CL=CL_0000893.
CC   Breed/subspecies: BALB.K.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   KKK-D049
AC   CVCL_XD17
SY   KKK-D049H3
DR   JCRB; JCRB1771
DR   Wikidata; Q94340042
RX   PubMed=31126020;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Established from a third generation xenograft established in BALB/c Rag-2-/-/Jak3-/- mice.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB=JCRB1771; PubMed=31126020
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 13 (JCRB=JCRB1771)
ST   D16S539: 13,14 (PubMed=31126020)
ST   D18S51: 11
ST   D19S433: 13,15.2
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 12,17
ST   FGA: 23,24.2
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   KKK-D068
AC   CVCL_XD18
SY   KKK-D068H1
DR   JCRB; JCRB1775
DR   Wikidata; Q94340046
RX   PubMed=31077409;
RX   PubMed=31126020;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Established from a first generation xenograft established in BALB/c Rag-2-/-/Jak3-/- mice.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB=JCRB1775; PubMed=31126020
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 14,14.2
ST   D21S11: 30,33.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,16
ST   FGA: 23,25
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 8
//
ID   KKK-D131
AC   CVCL_XD19
SY   KKK-D131H1
DR   JCRB; JCRB1777
DR   Wikidata; Q94340049
RX   PubMed=31077409;
RX   PubMed=31126020;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Established from a first generation xenograft established in BALB/c Rag-2-/-/Jak3-/- mice.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): PubMed=31126020
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 13.2
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   KKK-D138
AC   CVCL_XD20
SY   KKK-D131H2
DR   JCRB; JCRB1779
DR   Wikidata; Q94340052
RX   PubMed=31077409;
RX   PubMed=31126020;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Established from a second generation xenograft established in BALB/c Rag-2-/-/Jak3-/- mice.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB=JCRB1779; PubMed=31126020
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 13.2,14.2
ST   D21S11: 29
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 18,24.2
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 8
//
ID   KKLS
AC   CVCL_1B37
DR   ChEMBL-Cells; CHEMBL3307839
DR   ChEMBL-Targets; CHEMBL613996
DR   PubChem_Cell_line; CVCL_1B37
DR   Wikidata; Q54899988
RX   CelloPub=CLPUB00239;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=8608561;
CC   Population: Japanese.
CC   Doubling time: 25-30 hours (CelloPub=CLPUB00239).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   KKM-A
AC   CVCL_X152
DR   Wikidata; Q54899989
RX   PubMed=1696435;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X153 ! KKM-B
OI   CVCL_X154 ! KKM-C
OI   CVCL_X155 ! KKM-D
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   KKM-B
AC   CVCL_X153
DR   Wikidata; Q54899990
RX   PubMed=1696435;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X152 ! KKM-A
OI   CVCL_X154 ! KKM-C
OI   CVCL_X155 ! KKM-D
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   KKM-C
AC   CVCL_X154
DR   Wikidata; Q54899991
RX   PubMed=1696435;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X152 ! KKM-A
OI   CVCL_X153 ! KKM-B
OI   CVCL_X155 ! KKM-D
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   KKM-D
AC   CVCL_X155
DR   Wikidata; Q54899995
RX   PubMed=1696435;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X152 ! KKM-A
OI   CVCL_X153 ! KKM-B
OI   CVCL_X154 ! KKM-C
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   KKN 122
AC   CVCL_A2XA
DR   Wikidata; Q105509780
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on neurons and neurofibrillary tangles.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2WY ! KKN 7
OI   CVCL_A2WZ ! KKN 92
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   KKN 7
AC   CVCL_A2WY
DR   Wikidata; Q105509783
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on neurons and neurofibrillary tangles.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2WZ ! KKN 92
OI   CVCL_A2XA ! KKN 122
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   KKN 92
AC   CVCL_A2WZ
DR   Wikidata; Q105509786
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human astrocytes and neurofibrillary tangles.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2WY ! KKN 7
OI   CVCL_A2XA ! KKN 122
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   KKNS-1
AC   CVCL_VG86
DR   Wikidata; Q54899996
RX   PubMed=3171271;
RX   PubMed=3658923;
CC   Population: Japanese.
CC   Doubling time: ~35 hours (PubMed=3171271).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG87 ! KKNS-2
OI   CVCL_VG88 ! KKNS-3
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   KKNS-2
AC   CVCL_VG87
DR   Wikidata; Q54899997
RX   PubMed=3171271;
RX   PubMed=3658923;
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=3171271).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG86 ! KKNS-1
OI   CVCL_VG88 ! KKNS-3
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   KKNS-3
AC   CVCL_VG88
DR   Wikidata; Q54899998
RX   PubMed=3171271;
RX   PubMed=3658923;
CC   Population: Japanese.
CC   Doubling time: ~28 hours (PubMed=3171271).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG86 ! KKNS-1
OI   CVCL_VG87 ! KKNS-2
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   KKO
AC   CVCL_E9UW
DR   ABCD; ABCD_AG953
RX   Patent=US7728115;
RX   PubMed=10688805;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6133.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P02776; Human PF4 (Note=Recognizes the complex of PF4 with heparin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KKP
AC   CVCL_WH05
DR   cancercelllines; CVCL_WH05
DR   Wikidata; Q94340154
RX   PubMed=9689929;
RX   PubMed=10841287;
RX   PubMed=26919099;
CC   Doubling time: 48 hours (PubMed=9689929); 30 hours (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Ser903Arg (c.2709T>G); Zygosity=Unspecified (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1170Ala (c.3508C>G); ClinVar=VCV000134082; Zygosity=Unspecified (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (PubMed=26919099).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   KKP HR
AC   CVCL_WH06
DR   Wikidata; Q94340160
RX   PubMed=26919099;
CC   Doubling time: 27 hours (PubMed=26919099).
CC   Selected for resistance to: DrugBank; DB00072; Trastuzumab (Herceptin).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Ser903Arg (c.2709T>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1170Ala (c.3508C>G); ClinVar=VCV000134082; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WH05 ! KKP
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   KKPS5
AC   CVCL_6E28
DR   Wikidata; Q54899999
RX   PubMed=26111446;
CC   Characteristics: Arid3a deficient cells seem to be multipotent, developmentally plastic cells.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1328360; Arid3a.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KKS-2
AC   CVCL_Y277
DR   Wikidata; Q54900000
RX   PubMed=9177455;
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 6
//
ID   KKU-023
AC   CVCL_VF98
SY   KKU023; Khon Kaen University-023
DR   cancercelllines; CVCL_VF98
DR   JCRB; JCRB1778
DR   Wikidata; Q54900001
RX   PubMed=29110582;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 34.8 hours (PubMed=29110582).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=29110582).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB=JCRB1778
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 10,13,14
ST   D5S818: 10,12
ST   D7S820: 8,10,11
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17,21,22
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   KKU-100
AC   CVCL_3996
SY   KKU100; K100; Khon Kaen University-100
DR   BTO; BTO_0003934
DR   cancercelllines; CVCL_3996
DR   Cell_Model_Passport; SIDM01579
DR   DepMap; ACH-001536
DR   JCRB; JCRB1568
DR   Wikidata; Q54900002
RX   CelloPub=CLPUB00275;
RX   PubMed=12587840;
RX   PubMed=15884115;
RX   PubMed=15948244;
RX   PubMed=16475706;
RX   PubMed=20493868;
RX   PubMed=21871105;
RX   PubMed=29110582;
RX   PubMed=31077409;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Southeast Asian; Thai.
CC   Doubling time: ~72 hours (PubMed=15948244).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=29110582; DepMap=ACH-001536).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): DepMap=ACH-001536; JCRB=JCRB1568
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 10,11
ST   D18S51: 13
ST   D21S11: 31.2,33.2
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 22,25
ST   Penta D: 11
ST   Penta E: 9,11
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   KKU-213A
AC   CVCL_M261
SY   KKU-M213; KKUM213; M213; KKU-213; KKU213; Khon Kaen University-M213
DR   cancercelllines; CVCL_M261
DR   Cell_Model_Passport; SIDM01801
DR   DepMap; ACH-001538
DR   JCRB; JCRB1557
DR   Wikidata; Q54900008
RX   PubMed=20493868;
RX   PubMed=21871105;
RX   PubMed=22926522;
RX   PubMed=27461717;
RX   PubMed=31077409;
RX   PubMed=32207095;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 23.3 +- 0.8 hours (PubMed=32207095); 23.4 hours (PubMed=27461717).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (DepMap=ACH-001538).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: After JCRB found out that KKU-M156 and KKU-M214 were derived from KKU-M213, these three cell lines were renamed by the lab which established them: KKU-M213 became KKU-213A, KKU-M214 became KKU-M213B and KKU-M156 became KKU-M213C (PubMed=32207095).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001538; JCRB=JCRB1557; PubMed=32207095
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 16 (DepMap=ACH-001538)
ST   FGA: 16,19 (PubMed=32207095)
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   KKU-213B
AC   CVCL_M264
SY   KKU-M214; KKUM214; M214; KKU-214; KKU214; Khon Kaen University-M214
DR   JCRB; JCRB1556
DR   Wikidata; Q54900011
RX   PubMed=15884115;
RX   PubMed=16475706;
RX   PubMed=18714155;
RX   PubMed=21871105;
RX   PubMed=22926522;
RX   PubMed=25998688;
RX   PubMed=31077409;
RX   PubMed=32207095;
RX   PubMed=35640676;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a KKU-213A derivative (PubMed=32207095 and JCRB web site).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00592.
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 22.68 +- 2.20 hours (PubMed=25998688); 24.5 +- 0.2 hours (PubMed=32207095).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: After JCRB found out that KKU-M156 and KKU-M214 were derived from KKU-M213, these three cell lines were renamed by the lab which established them: KKU-M213 became KKU-213A, KKU-M214 became KKU-M213B and KKU-M156 became KKU-M213C (PubMed=32207095).
CC   Discontinued: JCRB; JCRB1556; probable.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=32207095
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 22,23,24
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 16,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M261 ! KKU-213A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   KKU-213C
AC   CVCL_M260
SY   KKU-M156; KKUM156; M156; KKU-156; Khon Kaen University-M156
DR   JCRB; JCRB1561
DR   Wikidata; Q54900007
RX   PubMed=15884115;
RX   PubMed=16475706;
RX   PubMed=20493868;
RX   PubMed=21871105;
RX   PubMed=22926522;
RX   PubMed=31077409;
RX   PubMed=32207095;
RX   PubMed=35640676;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a KKU-213A derivative (PubMed=32207095 and JCRB web site).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00591.
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 25.6 +- 0.2 hours (PubMed=32207095).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: After JCRB found out that KKU-M156 and KKU-M214 were derived from KKU-M213, these three cell lines were renamed by the lab which established them: KKU-M213 became KKU-213A, KKU-M214 became KKU-M213B and KKU-M156 became KKU-M213C (PubMed=32207095).
CC   Discontinued: JCRB; JCRB1561; probable.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=32207095
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 22,24
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 16,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M261 ! KKU-213A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   KKU-213L5
AC   CVCL_C6MZ
SY   KKU213L5; KKU-213 Lung metastatic variant 5
DR   Wikidata; Q116049620
RX   PubMed=27461717;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Highly metastatic. Established from the parent cell line passaged in a NOD/scid/Jak3 mice (NOJ mice).
CC   Doubling time: 20.3 hours (PubMed=27461717).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M261 ! KKU-213A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   KKU-452
AC   CVCL_VF99
SY   KKU452; Khon Kaen University-452
DR   cancercelllines; CVCL_VF99
DR   JCRB; JCRB1772
DR   Wikidata; Q54900003
RX   PubMed=29110582;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 17.9 hours (PubMed=29110582).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=29110582).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Unspecified (PubMed=29110582).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB=JCRB1772
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 19,20
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   KKU-M055
AC   CVCL_M258
SY   KKUM055; M055; KKU-055; KKU055; Khon Kaen University-M055
DR   DepMap; ACH-001537
DR   JCRB; JCRB1551
DR   Wikidata; Q54900004
RX   PubMed=15884115;
RX   PubMed=18714155;
RX   PubMed=21871105;
RX   PubMed=22926522;
RX   PubMed=31077409;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): JCRB=JCRB1551
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 7,8
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   KKU-M055/46
AC   CVCL_C1L4
SY   M055/46
DR   Wikidata; Q114311817
RX   PubMed=18714155;
CC   Population: Southeast Asian; Thai.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M258 ! KKU-M055
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KKU-M055/8
AC   CVCL_C1L5
SY   M055/8
DR   Wikidata; Q114311818
RX   PubMed=18714155;
CC   Population: Southeast Asian; Thai.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M258 ! KKU-M055
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KKU-M139
AC   CVCL_M259
SY   KKUM139; M139; KKU-139; Khon Kaen University-M139
DR   BTO; BTO_0005467
DR   Wikidata; Q54900005
RX   PubMed=16475706;
RX   PubMed=20493868;
RX   PubMed=21871105;
RX   PubMed=22926522;
RX   PubMed=25998688;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 17.36 +- 1.26 hours (PubMed=25998688).
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   KKU-M139/GEM
AC   CVCL_HF57
DR   Wikidata; Q54900006
RX   PubMed=25998688;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 20.32 +- 2.79 hours (PubMed=25998688).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M259 ! KKU-M139
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 6
//
ID   KKU-M213L0H
AC   CVCL_M262
DR   Wikidata; Q54900009
RX   PubMed=22926522;
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M261 ! KKU-213A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   KKU-M213L5H
AC   CVCL_M263
DR   Wikidata; Q54900010
RX   PubMed=22926522;
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M261 ! KKU-213A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   KKU-M214/246
AC   CVCL_C1L6
SY   M214/246
DR   Wikidata; Q114311820
RX   PubMed=18714155;
CC   Problematic cell line: Contaminated. Parent cell line (KKU-213B) shown to be a KKU-M213 derivative.
CC   Population: Southeast Asian; Thai.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M264 ! KKU-213B
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KKU-M214/9
AC   CVCL_C1L7
SY   M214/9
DR   Wikidata; Q114311821
RX   PubMed=18714155;
CC   Problematic cell line: Contaminated. Parent cell line (KKU-213B) shown to be a KKU-M213 derivative.
CC   Population: Southeast Asian; Thai.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M264 ! KKU-213B
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KKU-M214/GEM
AC   CVCL_HF58
DR   Wikidata; Q54900012
RX   PubMed=25998688;
CC   Problematic cell line: Contaminated. Parent cell line (KKU-213B) shown to be a KKU-M213 derivative.
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 25.21 +- 1.88 hours (PubMed=25998688).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M264 ! KKU-213B
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   KKU-OCA17
AC   CVCL_M265
DR   Wikidata; Q54900013
RX   PubMed=15884115;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   KKUi001-A
AC   CVCL_ZZ36
SY   OCT4-EGFP, NANOG-tdTomato BJ-iPSC; ON-iPSC; ONiPSC
DR   hPSCreg; KKUi001-A
DR   Wikidata; Q102114416
RX   PubMed=32777770;
CC   From: School of Medicine, Konkuk University; Seoul; South Korea.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 EGFP and tdTomato reporter genes were inserted repsectively before the stop codon of OCT4 and NANOG (PubMed=32777770).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 8
//
ID   KKUi002-A
AC   CVCL_D0H5
SY   PD-iPSC; PD.iPS.P21 AG20446
DR   BioSamples; SAMEA115358535
DR   hPSCreg; KKUi002-A
DR   Wikidata; Q123032818
RX   PubMed=38615589;
CC   From: School of Medicine, Konkuk University; Seoul; South Korea.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L781 ! AG20446
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   KL-5
AC   CVCL_UZ45
SY   KL5
DR   Wikidata; Q94340303
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 23 PDL (PubMed=19489101).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   KL-5/bmi1/TERT
AC   CVCL_UZ46
DR   Wikidata; Q94340306
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ45 ! KL-5
SX   Female
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   KL277
AC   CVCL_8962
DR   CLO; CLO_0007101
DR   ATCC; CRL-2030
DR   Wikidata; Q54900014
RX   PubMed=1648172;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 7
//
ID   KL295
AC   CVCL_G230
DR   CLO; CLO_0007102
DR   ATCC; CRL-1996
DR   Wikidata; Q54900015
RX   PubMed=1376718;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   KL304
AC   CVCL_G231
DR   CLO; CLO_0007103
DR   ATCC; CRL-2027
DR   Wikidata; Q54900016
RX   PubMed=1376718;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   KL5B
AC   CVCL_T059
DR   Wikidata; Q54900017
RX   PubMed=10069471;
CC   Doubling time: 26 hours (Note=At 19th passage) (PubMed=10069471).
CC   Sequence variation: Mutation; UniProtKB; A0A1U7QTX5; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (PubMed=10069471).
CC   Transformant: ChEBI; CHEBI_134609; Nitrosobis(2-oxopropyl)amine.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_T060 ! KL5N
SX   Male
AG   8-10W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 9
//
ID   KL5N
AC   CVCL_T060
DR   Wikidata; Q54900018
RX   PubMed=10069471;
RX   PubMed=10824687;
CC   Doubling time: 48 hours (PubMed=10069471).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   KLC
AC   CVCL_AS99
SY   GM16726
DR   CLO; CLO_0018423
DR   Coriell; GM16726
DR   Wikidata; Q54900021
RX   PubMed=10509003;
CC   Population: African American.
CC   Karyotypic information: 46,XY,t(8;9)(q13;p24)x2,del(13)(q12;q14) [77%], 46,XY,t(8;9)(q13;p24)x2,del(13)(q12;q14),add(22)(q13.2) [23%] (PubMed=10509003).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   KLC-HSV2
AC   CVCL_AT00
SY   GM16727
DR   CLO; CLO_0018422
DR   Coriell; GM16727
DR   Wikidata; Q54900022
RX   PubMed=10509003;
CC   Population: African American.
CC   Virology: In vitro infected by human herpesvirus 2 (HHV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AS99 ! KLC
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   KLE
AC   CVCL_1329
DR   BTO; BTO_0005079
DR   CLO; CLO_0007104
DR   EFO; EFO_0002220
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1622
DR   BCRJ; 0365
DR   BioGRID_ORCS_Cell_line; 622
DR   BioSample; SAMN03473101
DR   BioSample; SAMN10987617
DR   cancercelllines; CVCL_1329
DR   CCRID; 1101HUM-PUMC000379
DR   CCRID; 4201HUM-CCTCC00115
DR   CCTCC; GDC0115
DR   Cell_Model_Passport; SIDM00686
DR   ChEMBL-Cells; CHEMBL3308518
DR   ChEMBL-Targets; CHEMBL2366239
DR   CLS; 305051
DR   Cosmic; 713476
DR   Cosmic; 713493
DR   Cosmic; 809133
DR   Cosmic; 846179
DR   Cosmic; 871554
DR   Cosmic; 889114
DR   Cosmic; 924187
DR   Cosmic; 980636
DR   Cosmic; 1007161
DR   Cosmic; 1066225
DR   Cosmic; 1070809
DR   Cosmic; 1177622
DR   Cosmic; 1223485
DR   Cosmic; 1241349
DR   Cosmic; 1576461
DR   Cosmic; 1622900
DR   Cosmic; 1696759
DR   Cosmic; 2030477
DR   Cosmic; 2646620
DR   Cosmic; 2702442
DR   Cosmic-CLP; 924187
DR   DepMap; ACH-000293
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 924187
DR   GEO; GSM374973
DR   GEO; GSM375432
DR   GEO; GSM844574
DR   GEO; GSM844575
DR   GEO; GSM887211
DR   GEO; GSM888284
DR   GEO; GSM1669987
DR   GEO; GSM3161718
DR   GEO; GSM3161719
DR   IARC_TP53; 1113
DR   IGRhCellID; KLE
DR   IZSLER; BS TCL 230
DR   LiGeA; CCLE_909
DR   LINCS_LDP; LCL-1505
DR   PharmacoDB; KLE_750_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1329
DR   PubChem_Cell_line; CVCL_1329
DR   Wikidata; Q54900024
RX   PubMed=1541432;
RX   PubMed=2436984;
RX   PubMed=6706226;
RX   PubMed=7798295;
RX   PubMed=8123477;
RX   PubMed=9887230;
RX   PubMed=12893190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=33174010;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 114 hours (PubMed=1541432); 104 hours (PubMed=7798295).
CC   HLA typing: A*02:01,24:02; B*35:02,50:01; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Heterozygous (Cosmic-CLP=924187; DepMap=ACH-000293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=9887230; Cosmic-CLP=924187; DepMap=ACH-000293).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.19%; Native American=0.23%; East Asian, North=3.62%; East Asian, South=0%; South Asian=0.32%; European, North=60.58%; European, South=35.06% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ATCC=CRL-1622; CCRID; Cosmic-CLP=924187; PubMed=25877200; PubMed=33174010
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 15
ST   D21S11: 28,30
ST   D2S1338: 18,19
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 8,14
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C39749; Type II endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   KLE-R
AC   CVCL_XH10
DR   CCLV; CCLV-RIE 0029
DR   Wikidata; Q94340378
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   KLF-01
AC   CVCL_VY45
SY   KLineFelter-01
DR   IBRC; C10644
DR   Wikidata; Q94340381
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KLF-02
AC   CVCL_VY46
SY   KLineFelter-02
DR   IBRC; C10645
DR   Wikidata; Q94340384
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KLF-03
AC   CVCL_VY47
SY   KLineFelter-03
DR   IBRC; C10646
DR   Wikidata; Q94340388
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KLF-04
AC   CVCL_VY48
SY   KLineFelter-04
DR   IBRC; C10642
DR   Wikidata; Q94340392
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KLF-05
AC   CVCL_VY49
SY   KLineFelter-05
DR   IBRC; C10815
DR   Wikidata; Q94340394
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KLF-06
AC   CVCL_VY50
SY   KLineFelter-06
DR   IBRC; C10819
DR   Wikidata; Q94340399
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   KlHe
AC   CVCL_E6XG
RX   PubMed=12836015;
CC   HLA typing: A*01,24; B*07,37; DQB1*03:01,06:02; DRB1*11:04:01,15:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KLM-1
AC   CVCL_5146
SY   KLM1
DR   CLO; CLO_0050104
DR   EFO; EFO_0006610
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472943
DR   cancercelllines; CVCL_5146
DR   Cell_Model_Passport; SIDM01632
DR   DepMap; ACH-001101
DR   EGA; EGAS00001000610
DR   FANTOM5_SSTAR; 10438-106E6
DR   GEO; GSM888285
DR   IARC_TP53; 30097
DR   PharmacoDB; KLM1_751_2019
DR   Progenetix; CVCL_5146
DR   RCB; RCB2138
DR   TKG; TKG 0490
DR   Wikidata; Q54900025
RX   PubMed=8872523;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Established after 2 rounds of injection of cell suspensions of subcutaneous tumors arising from PK-1 in BALB/c nude mice.
CC   Doubling time: 44.1 hours (PubMed=8872523).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (from parent cell line).
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.52%; Native American=0%; East Asian, North=88.41%; East Asian, South=10.63%; South Asian=0.44%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=25877200; RCB=RCB2138; TKG=TKG 0490
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 9,20
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 15,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4717 ! PK-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   KLM-2
AC   CVCL_8257
SY   KLM 2
DR   Wikidata; Q54900026
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=230517;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6978745;
RX   PubMed=9680106;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7171; Acute monoblastic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   KLMab-1
AC   CVCL_C5D8
DR   Wikidata; Q116049621
RX   PubMed=33900816;
RX   PubMed=36306514;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96E93; Human KLRG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   KLN205
AC   CVCL_3533
SY   KLN 205; KLN-205
DR   BTO; BTO_0001589
DR   CLO; CLO_0007105
DR   CLO; CLO_0050214
DR   CLDB; cl3032
DR   ATCC; CRL-1453
DR   BCRC; 60207
DR   CLS; 400419
DR   ECACC; 90110519
DR   RCB; RCB2623
DR   TKG; TKG 0214
DR   Wikidata; Q54900028
RX   DOI=10.20517/2394-4722.2021.59;
RX   PubMed=418873;
RX   PubMed=7419233;
CC   Characteristics: Tumorigenic. Forms metastatic lesions in lungs after inoculation into mice (CLS=400419).
CC   Karyotypic information: Tetraploid karyotype with 77-82 chromosomes per cell (DOI=10.20517/2394-4722.2021.59).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21770; Squamous cell carcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   KLN205-MUC1
AC   CVCL_8725
DR   CLO; CLO_0050213
DR   RCB; RCB2614
DR   TKG; TKG 0473
DR   Wikidata; Q54900029
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21770; Squamous cell carcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3533 ! KLN205
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   KLO
AC   CVCL_E727
DR   dbMHC; 48925
DR   ECACC; 94050324
DR   IHW; IHW09213
DR   IPD-IMGT/HLA; 10919
DR   Wikidata; Q54900030
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:08,01:01:01:01; B*50:01:01,08:01:01; C*07:01:01:01,06:02:01:02; DPA1*01:03:01:02,02:01:02; DPB1*01:01:01,104:01; DQA1*02:01,05:01:01:02; DQB1*02:01:01,02:02:01; DRB1*03:01:01:01,07:01:01:01; DRB3*01:01:02:01; DRB4*01:03:01 (IPD-IMGT/HLA=10919).
CC   HLA typing: A*01:01:01:01,02:08; B*08:01:01:01,50:01:01; C*06:02:01:02,07:01:01:01; DPA1*01:03:01:02,02:01:02; DPB1*01:01:01,104:01; DQA1*02:01:01,05:01:01:02; DQB1*02:01:01,02:02:01:01; DRB1*03:01:01,07:01:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   KLRMMEi001-A
AC   CVCL_VE03
SY   CJ127-iPS
DR   BioSamples; SAMEA104626790
DR   hPSCreg; KLRMMEi001-A
DR   Wikidata; Q54900031
RX   PubMed=29660607;
CC   From: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Pro3043del (c.9127_9129delTCC); ClinVar=VCV000556050; Zygosity=Homozygous (PubMed=29660607).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=29660607
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 29,32
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   KLRMMEi002-A
AC   CVCL_B6RR
SY   XT142-iPS
DR   BioSamples; SAMEA11644680
DR   hPSCreg; KLRMMEi002-A
DR   Wikidata; Q111733553
RX   PubMed=35152177;
CC   From: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; c.8559-2A>G (p.Tyr2854_Arg2894del); ClinVar=VCV000048604; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=35152177).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   KLRMMEi003-A
AC   CVCL_C6QB
SY   XM146-iPS
DR   BioSamples; SAMEA112202912
DR   hPSCreg; KLRMMEi003-A
DR   Wikidata; Q117704573
RX   PubMed=36863132;
CC   From: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; c.8559-2A>G (p.Tyr2854_Arg2894del); ClinVar=VCV000048604; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=36863132).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   KLRMMEi004-A
AC   CVCL_C6QC
DR   hPSCreg; KLRMMEi004-A
DR   Wikidata; Q117704575
CC   From: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   KLU-1-R
AC   CVCL_XH31
DR   CCLV; CCLV-RIE 0051
DR   Wikidata; Q94340461
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   KLU-2-R
AC   CVCL_A3AS
DR   CCLV; CCLV-RIE 0091
DR   Wikidata; Q105509788
RX   DOI=10.5282/edoc.19690;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   KLu-R
AC   CVCL_RX40
SY   KLU-R
DR   CCLV; CCLV-RIE 0031
DR   Wikidata; Q54900032
RX   PubMed=24457147;
CC   Senescence: Senesces at <50 PDL (CCLV=CCLV-RIE 0031).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   KM [Cyprinus]
AC   CVCL_E7AU
SY   Koi Muscle
RX   PubMed=39538029;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 20 to 30 Celsius, the optimal temperature is 25 Celsius (PubMed=39538029).
CC   Virology: Highly susceptible to infection by spring viremia of carp virus (SVCV) (PubMed=39538029).
CC   Virology: Not susceptible to infection by carp edema virus (CEV), grass carp reovirus (GCRV) and koi herpesvirus (KHV) (PubMed=39538029).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KM [Human leukemia]
AC   CVCL_Y114
SY   Kin and Maru
DR   Wikidata; Q54900033
RX   PubMed=11676982;
CC   Doubling time: 16 hours (PubMed=11676982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Cell line name corresponds to the first letters of the names of the first and last authors.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 7
//
ID   KM-1
AC   CVCL_W405
SY   KM1
DR   CGH-DB; 14-1
DR   CGH-DB; 9126-4
DR   Wikidata; Q54900034
RX   PubMed=9738977;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   KM-10
AC   CVCL_B0PV
DR   Wikidata; Q108820627
RX   Patent=EP0131415A2;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02769; Bovine ALB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   KM-101
AC   CVCL_DE25
SY   KM 101; KM101
DR   Wikidata; Q54900035
RX   PubMed=2347717;
RX   PubMed=3182348;
RX   PubMed=3858834;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0376 ! KM-102
OI   CVCL_DE26 ! KM-103
OI   CVCL_DE27 ! KM-104
OI   CVCL_DE28 ! KM-105
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   KM-101 pSVX 8
AC   CVCL_E6MI
SY   KM 101 pSVX 8
RX   PubMed=2347717;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DE25 ! KM-101
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KM-102
AC   CVCL_0376
SY   KM 102; KM102
DR   MCCL; MCC:0000271
DR   Wikidata; Q54900036
RX   PubMed=3182348;
RX   PubMed=3858834;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KM102
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DE25 ! KM-101
OI   CVCL_DE26 ! KM-103
OI   CVCL_DE27 ! KM-104
OI   CVCL_DE28 ! KM-105
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   KM-103
AC   CVCL_DE26
SY   KM 103; KM103
DR   Wikidata; Q54900037
RX   PubMed=3182348;
RX   PubMed=3858834;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DE25 ! KM-101
OI   CVCL_0376 ! KM-102
OI   CVCL_DE27 ! KM-104
OI   CVCL_DE28 ! KM-105
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   KM-104
AC   CVCL_DE27
SY   KM 104; KM104
DR   Wikidata; Q54900039
RX   PubMed=2347717;
RX   PubMed=3182348;
RX   PubMed=3858834;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DE25 ! KM-101
OI   CVCL_0376 ! KM-102
OI   CVCL_DE26 ! KM-103
OI   CVCL_DE28 ! KM-105
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   KM-104 pSVX 2.
AC   CVCL_E6MJ
SY   KM 104 pSVX 2.
RX   PubMed=2347717;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DE27 ! KM-104
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KM-105
AC   CVCL_DE28
SY   KM 105; KM105
DR   Wikidata; Q54900040
RX   PubMed=3182348;
RX   PubMed=3858834;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DE25 ! KM-101
OI   CVCL_0376 ! KM-102
OI   CVCL_DE26 ! KM-103
OI   CVCL_DE27 ! KM-104
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   KM-11
AC   CVCL_W410
DR   CGH-DB; 18-1
DR   CGH-DB; 9131-4
DR   Wikidata; Q54900041
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   KM-1-R
AC   CVCL_XH34
DR   CCLV; CCLV-RIE 0061
DR   Wikidata; Q94340542
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   KM-2-R
AC   CVCL_A3AG
DR   CCLV; CCLV-RIE 0089
DR   Wikidata; Q105509791
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   KM-201
AC   CVCL_E8EM
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Tuberculin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KM-202
AC   CVCL_E8EN
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Tuberculin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KM-203
AC   CVCL_E8EP
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Tuberculin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KM-204
AC   CVCL_E8EQ
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Tuberculin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KM-205
AC   CVCL_E8ER
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Tuberculin.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KM-3
AC   CVCL_0011
SY   KM3; Km3
DR   BTO; BTO_0000681
DR   BioSample; SAMN03151905
DR   cancercelllines; CVCL_0011
DR   Wikidata; Q54900042
RX   PubMed=68013;
RX   PubMed=204546;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6954533;
RX   PubMed=12592342;
RX   PubMed=16957166;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 12 year old male patient with acute lymphoblastic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00226.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1650 ! Reh
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   KM-32
AC   CVCL_D3PA
SY   KM 32
DR   Wikidata; Q127382430
RX   PubMed=3530436;
RX   PubMed=3545444;
RX   PubMed=3731100;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human glycoprotein antigen KA-32.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM-34
AC   CVCL_D3PB
DR   Wikidata; Q127382432
RX   PubMed=3731100;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human lung squamous cell carcinoma glycoprotein antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM-4 [Human gingival carcinoma]
AC   CVCL_C1CU
DR   Wikidata; Q114311822
RX   DOI=10.5794/jjoms.39.1143;
CC   Population: Japanese.
CC   Characteristics: May have originated as a lung small cell carcinoma.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   KM-4 [Human plasma cell myeloma]
AC   CVCL_W406
SY   KM4
DR   CGH-DB; 15-1
DR   CGH-DB; 9127-4
DR   GEO; GSM143341
DR   GEO; GSM290292
DR   Wikidata; Q54900043
RX   PubMed=11429052;
RX   PubMed=15215163;
RX   PubMed=17171682;
RX   PubMed=18700954;
RX   PubMed=19306352;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   KM-5
AC   CVCL_W407
SY   KM5
DR   CGH-DB; 16-1
DR   CGH-DB; 9128-4
DR   Wikidata; Q54900044
RX   PubMed=10557056;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   KM-52
AC   CVCL_D3PC
DR   Wikidata; Q127382433
RX   PubMed=3545444;
RX   PubMed=3731100;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human glycoprotein antigen KA-52.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM-6
AC   CVCL_W408
SY   KM6
DR   CGH-DB; 17-1
DR   CGH-DB; 9129-4
DR   Wikidata; Q54900045
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   KM-7
AC   CVCL_W409
SY   KM7
DR   CGH-DB; 19-1
DR   CGH-DB; 9130-4
DR   Wikidata; Q54900047
RX   PubMed=11429052;
RX   PubMed=15215163;
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   KM-93
AC   CVCL_D3PD
SY   KM 93
DR   Wikidata; Q127382434
RX   PubMed=3545444;
RX   PubMed=3731100;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human lung adenocarcinoma associated antigen KA-93.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM-H2
AC   CVCL_1330
AS   CVCL_2978
SY   KM H-2; KMH2
DR   BTO; BTO_0004972
DR   CLO; CLO_0007112
DR   CLDB; cl3033
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473401
DR   BioSample; SAMN10988578
DR   cancercelllines; CVCL_1330
DR   Cell_Model_Passport; SIDM01018
DR   ChEMBL-Cells; CHEMBL3308204
DR   ChEMBL-Targets; CHEMBL2366250
DR   Cosmic; 909976
DR   Cosmic; 988704
DR   Cosmic; 1013910
DR   Cosmic; 1086357
DR   Cosmic; 1191707
DR   Cosmic; 1289700
DR   Cosmic; 1290219
DR   Cosmic; 1432041
DR   Cosmic; 2276325
DR   Cosmic; 2361388
DR   Cosmic; 2464308
DR   Cosmic-CLP; 909976
DR   DepMap; ACH-000815
DR   DSMZ; ACC-8
DR   DSMZCellDive; ACC-8
DR   EGA; EGAS00001000978
DR   GDSC; 909976
DR   GEO; GSM335391
DR   GEO; GSM499723
DR   GEO; GSM499731
DR   GEO; GSM552446
DR   GEO; GSM637987
DR   GEO; GSM646533
DR   GEO; GSM887214
DR   GEO; GSM888288
DR   GEO; GSM1669990
DR   IARC_TP53; 21433
DR   IARC_TP53; 23616
DR   IPD-IMGT/HLA; 15116
DR   LiGeA; CCLE_432
DR   LINCS_LDP; LCL-2009
DR   Lonza; 21
DR   PharmacoDB; KMH2_752_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1330
DR   PubChem_Cell_line; CVCL_1330
DR   Wikidata; Q54900048
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2602653;
RX   PubMed=2690233;
RX   PubMed=3013343;
RX   PubMed=3359046;
RX   PubMed=8547074;
RX   PubMed=8558920;
RX   PubMed=11372738;
RX   PubMed=17065008;
RX   PubMed=18194364;
RX   PubMed=19380639;
RX   PubMed=20164919;
RX   PubMed=20628145;
RX   PubMed=21368758;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25894527;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29533902;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (DSMZ=ACC-8).
CC   HLA typing: A*24:02; B*15:01,52:01; C*04:01,12:02; DPB1*02:01,05:01; DQA1*03:01,05:05; DQB1*03:01,03:02; DRB1*04:65,11:01; DRB3*02:02; DRB4*01:03 (IPD-IMGT/HLA=15116).
CC   HLA typing: A*11:01,24:02; B*15:01,52:01; C*04:01,12:02; DQA1*03:02,05:01; DQB1*03:03,03:03; DRB1*04:06,11:01 (PubMed=26589293).
CC   HLA typing: A*11:01:01,24:02:01; B*15:01:01,52:01:01; C*04:01:01,12:02:02; DPA1*01:03:01,02:02:02; DPB1*05:01:01,02:01:02; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRA*01:01:01,01:01:01; DRB1*04:06:01,11:01:01 (DSMZCellDive=ACC-8).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11896; TNFAIP3; Zygosity=Heterozygous (PubMed=19380639).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7067; CIITA + HGNC; HGNC:44654; PIERCE2; Name(s)=CIITA-C15orf65, CIITA-PIERCE2 (PubMed=21368758).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7059; MGMT + HGNC; HGNC:28121; PRRC2B; Name(s)=PRRC2B-MGMT, BAT2L1-MGMT (PubMed=21368758).
CC   Sequence variation: Mutation; HGNC; HGNC:11896; TNFAIP3; Unexplicit; In2-Ex6 del; Zygosity=Heterozygous (PubMed=19380639).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.68%; Native American=0%; East Asian, North=78.89%; East Asian, South=17.68%; South Asian=0%; European, North=0%; European, South=1.75% (PubMed=30894373).
CC   Misspelling: KHM2/171877; IPD-IMGT/HLA=15116; Note=In old versions.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=909976; DSMZ=ACC-8
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,16
ST   D21S11: 30,31.2,32.2
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11,12
ST   D8S1179: 10
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 15,18
ST   TH01: 7,9
ST   TPOX: 8,10,11,12 (DSMZ=ACC-8)
ST   TPOX: 8,11,12 (Cosmic-CLP=909976)
ST   vWA: 17,18
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   KM-Luc/GFP
AC   CVCL_F0Y6
RX   PubMed=23405215;
CC   Characteristics: Transfected with a pEGFPLuc vector that contains a fusion of EGFP and luciferase (PubMed=23405215).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MRL/Mp Tn-gld/gld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5J6 ! MRL/N-1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   KM-R
AC   CVCL_XH11
DR   CCLV; CCLV-RIE 0030
DR   Wikidata; Q94426167
RX   PubMed=19941903;
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   KM0027
AC   CVCL_8X95
DR   ECACC; 01033027
DR   Wikidata; Q54900049
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01033027; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KM105
AC   CVCL_G371
DR   TKG; TKG 0215
DR   Wikidata; Q54900050
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   KM1074
AC   CVCL_D3M2
DR   Wikidata; Q127382435
RX   Patent=US7238354;
RX   PubMed=19478395;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01344; Human IL5RA/CD125.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM114
AC   CVCL_9188
DR   CLO; CLO_0007106
DR   ATCC; TIB-242
DR   Wikidata; Q54900051
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   KM12
AC   CVCL_1331
SY   KM-12; KM.12
DR   BTO; BTO_0003172
DR   CLO; CLO_0009965
DR   EFO; EFO_0006282
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 412
DR   BioSample; SAMN03471909
DR   BioSample; SAMN10988369
DR   cancercelllines; CVCL_1331
DR   Cell_Model_Passport; SIDM00150
DR   ChEMBL-Cells; CHEMBL3307689
DR   ChEMBL-Targets; CHEMBL614709
DR   ColonAtlas; KM12
DR   Cosmic; 875903
DR   Cosmic; 887227
DR   Cosmic; 905989
DR   Cosmic; 974247
DR   Cosmic; 1092609
DR   Cosmic; 1175843
DR   Cosmic; 1305356
DR   Cosmic; 1312340
DR   Cosmic; 1436018
DR   Cosmic; 1479631
DR   Cosmic; 1676739
DR   Cosmic; 1805256
DR   Cosmic; 1995469
DR   Cosmic; 1998451
DR   Cosmic; 2301990
DR   Cosmic; 2650775
DR   Cosmic; 2667973
DR   Cosmic; 2811053
DR   Cosmic-CLP; 905989
DR   DepMap; ACH-000969
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905989
DR   GEO; GSM2130
DR   GEO; GSM50191
DR   GEO; GSM50255
DR   GEO; GSM206516
DR   GEO; GSM274781
DR   GEO; GSM743446
DR   GEO; GSM750797
DR   GEO; GSM799334
DR   GEO; GSM799397
DR   GEO; GSM844576
DR   GEO; GSM844577
DR   GEO; GSM846361
DR   GEO; GSM887212
DR   GEO; GSM888286
DR   GEO; GSM1153404
DR   GEO; GSM1178291
DR   GEO; GSM1178292
DR   GEO; GSM1178293
DR   GEO; GSM1181253
DR   GEO; GSM1181266
DR   GEO; GSM1346877
DR   GEO; GSM1448073
DR   GEO; GSM1669988
DR   GEO; GSM2124659
DR   GEO; GSM2550006
DR   IARC_TP53; 18072
DR   IARC_TP53; 21119
DR   LiGeA; CCLE_206
DR   LINCS_LDP; LCL-1192
DR   MetaboLights; MTBLS227
DR   NCI-DTP; KM-12
DR   PharmacoDB; KM12_753_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005235
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1331
DR   PubChem_Cell_line; CVCL_1331
DR   SKY/M-FISH/CGH; 2795
DR   Wikidata; Q54900052
RX   PubMed=2041050;
RX   PubMed=9331090;
RX   PubMed=9515795;
RX   PubMed=10700174;
RX   PubMed=11416159;
RX   PubMed=12615714;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24755471;
RX   PubMed=24962792;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28179481;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=21
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/km-12-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 34.11 hours (PubMed=25944804); 23 hours (PubMed=25984343); 23.7 hours (NCI-DTP=KM-12).
CC   HLA typing: A*02; B*07:02:01; C*07:02:01; DPB1*13:01; DQB1*03:02; DRB1*04:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=24755471; PubMed=25926053; PubMed=28683746; PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (PubMed=24962792; PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (PubMed=17088437; PubMed=28179481).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Ala404Cysfs*9 (c.1208dupC) (p.Pro403fs); dbSNP=rs777474487; Zygosity=Heterozygous (PubMed=28683746; DepMap=ACH-000969).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (PubMed=17088437; PubMed=28683746; DepMap=ACH-000969).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (PubMed=17088437; PubMed=28683746; DepMap=ACH-000969).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (PubMed=15900046; PubMed=17088437; PubMed=28683746; Cosmic-CLP=905989; DepMap=ACH-000969).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (PubMed=9331090; PubMed=15900046; PubMed=17088437; PubMed=28683746; Cosmic-CLP=905989; DepMap=ACH-000969).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.84%; Native American=0.44%; East Asian, North=1.48%; East Asian, South=0%; South Asian=0.59%; European, North=63.68%; European, South=32.97% (PubMed=30894373).
CC   Misspelling: KIM12; GEO=GSM846361.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=905989; PubMed=11416159; PubMed=19372543; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,15
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 11,14
ST   D21S11: 27
ST   D3S1358: 14
ST   D5S818: 10 (PubMed=25877200; PubMed=25926053)
ST   D5S818: 10,17 (Cosmic-CLP=905989)
ST   D5S818: 10,18 (PubMed=19372543)
ST   D7S820: 8,8.3 (PubMed=19372543; PubMed=25877200; PubMed=25926053)
ST   D7S820: 8,9 (Cosmic-CLP=905989)
ST   D8S1179: 11,13
ST   FGA: 20,22
ST   Penta D: 12
ST   Penta E: 14,18
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 17 (PubMed=11416159)
ST   vWA: 17,19 (Cosmic-CLP=905989; PubMed=19372543; PubMed=25877200; PubMed=25926053)
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 45
//
ID   KM12 MX10
AC   CVCL_LB66
DR   cancercelllines; CVCL_LB66
DR   Wikidata; Q54900053
RX   PubMed=11406094;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 10 nM of mitoxantrone (PubMed=11406094).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1331 ! KM12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 14
//
ID   KM12-C
AC   CVCL_9547
SY   KM12 C; KM-12C; KM12C; KM12c; Km12C
DR   BTO; BTO_0003312
DR   EFO; EFO_0022404
DR   cancercelllines; CVCL_9547
DR   ChEMBL-Cells; CHEMBL4632322
DR   ChEMBL-Targets; CHEMBL4632329
DR   Cosmic; 2820474
DR   GEO; GSM1448186
DR   GEO; GSM2299786
DR   KCLB; 80015
DR   PRIDE; PXD006662
DR   PubChem_Cell_line; CVCL_9547
DR   Wikidata; Q54900054
RX   PubMed=2846163;
RX   PubMed=3349467;
RX   PubMed=10091941;
RX   PubMed=15170669;
RX   PubMed=25926053;
RX   PubMed=29131639;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12533.
CC   Registration: Chiron Master Culture Collection; CMCC 11611 (CMCC #11611).
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Subcellular; Nucleus.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,15
ST   D16S539: 11
ST   D21S11: 27,34.2
ST   D5S818: 10
ST   D7S820: 8,9
ST   TH01: 10
ST   TPOX: 11,12
ST   vWA: 17
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1331 ! KM12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   KM12-HX
AC   CVCL_4M93
SY   KM12HX
DR   cancercelllines; CVCL_4M93
DR   Wikidata; Q54900055
RX   PubMed=1679016;
RX   PubMed=7529188;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9547 ! KM12-C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   KM12-L4
AC   CVCL_5946
SY   KM12L4; Km12L4; KM12 L4; Km 12 L4
DR   cancercelllines; CVCL_5946
DR   GEO; GSM1448187
DR   KCLB; 80014
DR   Wikidata; Q54900057
RX   PubMed=2846163;
RX   PubMed=3349467;
RX   PubMed=8909255;
RX   PubMed=10091941;
RX   PubMed=25926053;
CC   Population: Caucasian.
CC   Characteristics: Highly liver metastatic. Established after four passages into the cecum of nude mice (PubMed=3349467).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13,15
ST   D16S539: 11,12
ST   D21S11: 27,34
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 10
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1331 ! KM12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   KM12-L4A
AC   CVCL_W220
SY   Km 12 L4A; KM12L4-A; KM12L4A; KM12L4a
DR   cancercelllines; CVCL_W220
DR   Wikidata; Q54900058
RX   PubMed=3349467;
RX   PubMed=15170669;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12496.
CC   Registration: Chiron Master Culture Collection; CMCC 11606 (CMCC #11606).
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5946 ! KM12-L4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   KM12-Luc
AC   CVCL_J258
SY   KM-12-Luc
DR   cancercelllines; CVCL_J258
DR   JCRB; JCRB1389
DR   JCRB; NIHS0647
DR   Wikidata; Q54900059
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0647; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): JCRB=JCRB1389
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,15,16
ST   D16S539: 11
ST   D5S818: 10,18,19
ST   D7S820: 8,8.3
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 17,19
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1331 ! KM12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 21
//
ID   KM12-LX
AC   CVCL_4M94
SY   KM12LX
DR   cancercelllines; CVCL_4M94
DR   Wikidata; Q54900060
RX   PubMed=1679016;
RX   PubMed=7529188;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9547 ! KM12-C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 14
//
ID   KM12-OxR
AC   CVCL_5920
SY   KM12L4 OxR
DR   cancercelllines; CVCL_5920
DR   Wikidata; Q54900061
RX   PubMed=16857785;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5946 ! KM12-L4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   KM12-SM
AC   CVCL_9548
SY   KM12SM; KM12 SM
DR   cancercelllines; CVCL_9548
DR   Cosmic; 1524332
DR   Cosmic; 2820475
DR   GEO; GSM1448188
DR   GEO; GSM2299787
DR   KCLB; 80016
DR   PRIDE; PXD006662
DR   TOKU-E; 3802
DR   Wikidata; Q54900062
RX   PubMed=2846163;
RX   PubMed=10091941;
RX   PubMed=10987313;
RX   PubMed=15170669;
RX   PubMed=25926053;
RX   PubMed=29131639;
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Subcellular; Nucleus.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13,15
ST   D16S539: 11,12
ST   D21S11: 27,34.2
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9547 ! KM12-C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   KM1256
AC   CVCL_D3P2
DR   Wikidata; Q127382436
RX   PubMed=19478395;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01344; Human IL5RA/CD125.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1257
AC   CVCL_D3P3
DR   Wikidata; Q127382437
RX   Patent=US7238354;
RX   PubMed=19478395;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5133.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01344; Human IL5RA/CD125.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1259
AC   CVCL_D3P4
DR   Wikidata; Q127382439
RX   Patent=US7238354;
RX   PubMed=19478395;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5134.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized benralizumab (MEDI-563; Fasenra) therapeutic antibody used for the treatment of severe eosinophilic asthma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01344; Human IL5RA/CD125.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1266
AC   CVCL_D3P5
DR   Wikidata; Q127382440
RX   PubMed=19478395;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01344; Human IL5RA/CD125.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM12L4/OXR
AC   CVCL_AU12
DR   cancercelllines; CVCL_AU12
DR   Wikidata; Q54900063
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5946 ! KM12-L4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   KM1334
AC   CVCL_D3LC
DR   ABCD; ABCD_AQ232
DR   Wikidata; Q127382441
RX   Patent=US7241568;
RX   PubMed=9605740;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5451.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P55075; Human FGF8 (Note=Isoform FGF-8B. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   KM1421
AC   CVCL_E9XS
RX   PubMed=38832025;
WW   Provider; Institut de Myologie; -; https://www.institut-myologie.org/wp-content/uploads/2024/08/2024-Cells-Myoline-1.pdf
CC   Part of: MyoLine cell line collection.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, paravertebral; UBERON=UBERON_0002462.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KM1468
AC   CVCL_D3MZ
DR   ABCD; ABCD_BA627
DR   Wikidata; Q127382442
RX   Patent=US7438911;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7978.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05019; Human IGF1.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KM1469
AC   CVCL_D3N0
DR   Wikidata; Q127382443
RX   Patent=US7438911;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05019; Human IGF1.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1470
AC   CVCL_D3N1
DR   Wikidata; Q127382444
RX   Patent=US7438911;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05019; Human IGF1.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1471
AC   CVCL_D3N2
DR   Wikidata; Q127382445
RX   Patent=US7438911;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05019; Human IGF1.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1472
AC   CVCL_D3N3
DR   Wikidata; Q127382446
RX   Patent=US7438911;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05019; Human IGF1.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1473
AC   CVCL_D3N4
DR   Wikidata; Q127382447
RX   Patent=US7438911;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05019; Human IGF1.
CC   Monoclonal antibody target: UniProtKB; P01344; Human IGF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1486
AC   CVCL_D3P6
DR   Wikidata; Q127382449
RX   Patent=US7238354;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5651.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01344; Human IL5RA/CD125.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1515
AC   CVCL_D3LD
DR   Wikidata; Q127382450
RX   Patent=JP2000086700A;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q11206; Human ST3GAL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1516
AC   CVCL_D3LE
DR   Wikidata; Q127382451
RX   Patent=JP2000086700A;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q11206; Human ST3GAL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1517
AC   CVCL_D3LF
DR   Wikidata; Q127382452
RX   Patent=JP2000086700A;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q11206; Human ST3GAL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1518
AC   CVCL_D3LG
DR   Wikidata; Q127382453
RX   Patent=JP2000086700A;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q11206; Human ST3GAL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM155C25
AC   CVCL_6B24
SY   C25Cl48; KM155C25 Clone 48
DR   Wikidata; Q54808108
RX   PubMed=17565380;
RX   PubMed=22040608;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle, semitendinosus; UBERON=UBERON_0001375.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   25Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   KM162C14Q
AC   CVCL_B4I4
DR   Wikidata; Q110432997
RX   PubMed=17565380;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   14Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   KM1648
AC   CVCL_D3LH
DR   Wikidata; Q127382454
RX   Patent=JP2000086700A;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q11206; Human ST3GAL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1651
AC   CVCL_D3LI
DR   Wikidata; Q127382455
RX   Patent=JP2000086700A;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q11206; Human ST3GAL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1652
AC   CVCL_D3LJ
SY   KM1,652
DR   Wikidata; Q127382456
RX   Patent=JP2000086700A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6422.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q11206; Human ST3GAL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1730
AC   CVCL_D3LK
DR   Wikidata; Q127382457
RX   Patent=US7615215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5697.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1731
AC   CVCL_D3LL
DR   Wikidata; Q127382458
RX   Patent=US7615215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5718.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1732
AC   CVCL_D3LM
DR   ABCD; ABCD_AS015
DR   Wikidata; Q127382459
RX   Patent=US7615215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5698.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1733
AC   CVCL_D3LN
DR   Wikidata; Q127382460
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1735
AC   CVCL_D3LP
DR   Wikidata; Q127382461
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1736
AC   CVCL_D3LQ
DR   Wikidata; Q127382462
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1737
AC   CVCL_D3LR
DR   Wikidata; Q127382463
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1739
AC   CVCL_D3LS
DR   Wikidata; Q127382465
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1740
AC   CVCL_D3LT
DR   Wikidata; Q127382466
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1742
AC   CVCL_D3LU
DR   Wikidata; Q127382467
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1743
AC   CVCL_D3LV
DR   Wikidata; Q127382468
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1745
AC   CVCL_D3LW
DR   Wikidata; Q127382470
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1746
AC   CVCL_D3LX
DR   Wikidata; Q127382471
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1747
AC   CVCL_D3LY
DR   Wikidata; Q127382473
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1748
AC   CVCL_D3LZ
DR   Wikidata; Q127382474
RX   Patent=US7615215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5699.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1749
AC   CVCL_D3M0
DR   Wikidata; Q127382476
RX   Patent=US7615215;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1750
AC   CVCL_D3M1
DR   ABCD; ABCD_AS017
DR   Wikidata; Q127382478
RX   Patent=US7615215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5700.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17948; Human FLT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM1978
AC   CVCL_A6ZV
DR   RCB; RCB5396
DR   Wikidata; Q107115581
RX   PubMed=10831073;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15197; Human EPHB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   KM20
AC   CVCL_L095
SY   KM-20
DR   BioSample; SAMN06481114
DR   cancercelllines; CVCL_L095
DR   GEO; GSM1448074
DR   KCLB; 80017
DR   Wikidata; Q54900064
RX   PubMed=2846163;
RX   PubMed=12060639;
RX   PubMed=25926053;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (ICLAC; an early sample of KM20 had been tested by the core facility where the cell line was established and the STR profile corresponds to that of HT-29).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00513.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: KCLB; 80017; probable.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 24
//
ID   KM20-C
AC   CVCL_0B38
SY   KM20C; KM20c; KM-20C
DR   BTO; BTO_0005615
DR   cancercelllines; CVCL_0B38
DR   Wikidata; Q54900065
RX   PubMed=3349467;
CC   Problematic cell line: Contaminated. Parent cell line (KM20) has been shown to be a HT-29 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L095 ! KM20
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 19
//
ID   KM201
AC   CVCL_9189
SY   KM 201
DR   CLO; CLO_0007107
DR   ATCC; TIB-240
DR   ECACC; 93081113
DR   Wikidata; Q54900066
RX   PubMed=2406365;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ECACC; 93081113; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 9
//
ID   KM2048
AC   CVCL_A6ZW
DR   RCB; RCB5397
DR   Wikidata; Q107115584
RX   PubMed=10831073;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15197; Human EPHB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   KM2051
AC   CVCL_A6ZX
DR   RCB; RCB5398
DR   Wikidata; Q107115587
RX   PubMed=10831073;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15197; Human EPHB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   KM20L2
AC   CVCL_D889
SY   KM-20L2; KM 20L2; KM 2012
DR   BTO; BTO_0005911
DR   BioSample; SAMN06481115
DR   cancercelllines; CVCL_D889
DR   ChEMBL-Cells; CHEMBL3307782
DR   ChEMBL-Targets; CHEMBL614791
DR   IARC_TP53; 28215
DR   NCI-DTP; KM 20L2
DR   PubChem_Cell_line; CVCL_D889
DR   Wikidata; Q54900067
RX   PubMed=2041050;
RX   PubMed=3349467;
RX   PubMed=15703300;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=15703300; resulting in a decision not to include the cell line in the NCI-60 panel).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00514.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: KM202L; Note=Occasionally.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 33
//
ID   KM22
AC   CVCL_WJ11
SY   KM-22
DR   Wikidata; Q94426665
RX   PubMed=12836015;
RX   PubMed=19414332;
RX   PubMed=21965729;
RX   PubMed=22399590;
CC   HLA typing: A*02,32; B*07,27; DQB1*03:01,04:02; DRB1*08:01,11:03 (PubMed=12836015).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   KM2277
AC   CVCL_D3M3
DR   Wikidata; Q127382479
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2278
AC   CVCL_D3M4
DR   Wikidata; Q127382480
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2279
AC   CVCL_D3M5
DR   Wikidata; Q127382481
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2280
AC   CVCL_D3M6
DR   Wikidata; Q127382482
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2281
AC   CVCL_D3M7
DR   Wikidata; Q127382484
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2282
AC   CVCL_D3M8
DR   Wikidata; Q127382486
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2283
AC   CVCL_D3M9
DR   Wikidata; Q127382487
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2284
AC   CVCL_D3MA
DR   Wikidata; Q127382489
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2294
AC   CVCL_D3MB
DR   Wikidata; Q127382490
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2295
AC   CVCL_D3MC
DR   Wikidata; Q127382492
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2296
AC   CVCL_D3MD
DR   Wikidata; Q127382493
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2297
AC   CVCL_D3ME
DR   Wikidata; Q127382494
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2298
AC   CVCL_D3MF
DR   Wikidata; Q127382495
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2299
AC   CVCL_D3MG
DR   Wikidata; Q127382496
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2300
AC   CVCL_D3MH
DR   Wikidata; Q127382497
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2301
AC   CVCL_D3MI
DR   Wikidata; Q127382498
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2302
AC   CVCL_D3MJ
DR   Wikidata; Q127382500
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2303
AC   CVCL_D3MK
DR   Wikidata; Q127382501
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2304
AC   CVCL_D3ML
DR   Wikidata; Q127382502
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2305
AC   CVCL_D3MM
DR   Wikidata; Q127382503
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2306
AC   CVCL_D3MN
DR   Wikidata; Q127382504
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2307
AC   CVCL_D3MP
DR   Wikidata; Q127382506
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2308
AC   CVCL_D3MQ
DR   Wikidata; Q127382507
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2309
AC   CVCL_D3MR
DR   Wikidata; Q127382509
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2310
AC   CVCL_D3MS
DR   Wikidata; Q127382510
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2311
AC   CVCL_D3MT
DR   Wikidata; Q127382511
RX   Patent=US6639057;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6306.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2312
AC   CVCL_D3MU
DR   Wikidata; Q127382513
RX   Patent=US6639057;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2582
AC   CVCL_D3MV
DR   Wikidata; Q127382514
RX   Patent=US6639057;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6663.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2590
AC   CVCL_D3MW
DR   Wikidata; Q127382515
RX   Patent=US6639057;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6683.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2591
AC   CVCL_D3MX
DR   Wikidata; Q127382516
RX   Patent=US6639057;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6684.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM2604
AC   CVCL_D3MY
DR   Wikidata; Q127382517
RX   Patent=US6639057;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6664.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3 [Contaminated human melanoma]
AC   CVCL_1R51
SY   Mel-Km3; Km3
DR   BioSample; SAMN03151998
DR   Wikidata; Q54900068
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9120293;
RX   PubMed=12740908;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin (astrocytoma) but found to be from rat (PubMed=12740908; PubMed=20143388). Originally thought to originate from a woman patient lymph nodes metastases of a melanoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00227.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   KM3 [Human myeloma]
AC   CVCL_GZ65
SY   KM-3
DR   Wikidata; Q54900069
RX   PubMed=11769679;
RX   PubMed=15198896;
RX   PubMed=16706120;
CC   Population: Chinese.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   KM3/BTZ
AC   CVCL_GZ66
DR   ChEMBL-Cells; CHEMBL4483150
DR   ChEMBL-Targets; CHEMBL4483251
DR   PubChem_Cell_line; CVCL_GZ66
DR   Wikidata; Q54900070
RX   DOI=10.1182/blood.V124.21.5226.5226;
RX   DOI=10.6040/j.issn.1671-7554.2013.02.007;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GZ65 ! KM3 [Human myeloma]
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 10
//
ID   KM3/DDP
AC   CVCL_GZ71
DR   Wikidata; Q54900071
RX   PubMed=26045737;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GZ65 ! KM3 [Human myeloma]
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   KM3842
AC   CVCL_D3PE
DR   Wikidata; Q127382518
RX   Patent=US8945870;
RX   PubMed=27865832;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15758; Human SLC1A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3900
AC   CVCL_D3PS
DR   ABCD; ABCD_AI949
DR   Wikidata; Q127382519
RX   Patent=US8076458;
RX   PubMed=19555390;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10751.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3907
AC   CVCL_D3PT
DR   ABCD; ABCD_AI950
DR   Wikidata; Q127382520
RX   Patent=US8076458;
RX   PubMed=21115905;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10885.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
CC   Monoclonal antibody target: UniProtKB; O14493; Human CLDN4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3933
AC   CVCL_D3PU
DR   Wikidata; Q127382521
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3 (Note=Also recognizes CLDN5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3936
AC   CVCL_D3PV
DR   Wikidata; Q127382522
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3937
AC   CVCL_D3PW
DR   Wikidata; Q127382523
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3938
AC   CVCL_D3PX
DR   Wikidata; Q127382525
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3939
AC   CVCL_D3PY
DR   Wikidata; Q127382526
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3 (Note=Also recognizes CLDN6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3952
AC   CVCL_D3PZ
DR   Wikidata; Q127382527
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3 (Note=Also recognizes CLDN4, CLDN6 and CLDN9).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3953
AC   CVCL_D3Q0
DR   Wikidata; Q127382528
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3954
AC   CVCL_D3Q1
DR   Wikidata; Q127382529
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3955
AC   CVCL_D3Q2
DR   Wikidata; Q127382530
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3956
AC   CVCL_D3Q3
DR   Wikidata; Q127382532
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3 (Note=Also recognizes CLDN6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3957
AC   CVCL_D3Q4
DR   Wikidata; Q127382533
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3958
AC   CVCL_D3Q5
DR   Wikidata; Q127382534
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3 (Note=Also recognizes CLDN4 and CLDN6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3959
AC   CVCL_D3Q6
DR   Wikidata; Q127382536
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3960
AC   CVCL_D3Q7
DR   Wikidata; Q127382537
RX   PubMed=25744656;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15551; Human CLDN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM3998
AC   CVCL_D3PJ
DR   Wikidata; Q127382538
RX   Patent=US8945870;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15758; Human SLC1A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM4000
AC   CVCL_D3PK
DR   Wikidata; Q127382539
RX   Patent=US8945870;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15758; Human SLC1A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM4001
AC   CVCL_D3PL
DR   Wikidata; Q127382541
RX   Patent=US8945870;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15758; Human SLC1A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM4008
AC   CVCL_D3PF
DR   ABCD; ABCD_AA565
DR   Wikidata; Q127382543
RX   Patent=US8945870;
RX   PubMed=27865832;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10962.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q15758; Human SLC1A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM4012
AC   CVCL_D3PG
DR   ABCD; ABCD_AA564
DR   Wikidata; Q127382545
RX   Patent=US8945870;
RX   PubMed=27865832;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10963.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15758; Human SLC1A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM4018
AC   CVCL_D3PH
DR   ABCD; ABCD_AA563
DR   Wikidata; Q127382546
RX   Patent=US8945870;
RX   PubMed=27865832;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15758; Human SLC1A5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KM45
AC   CVCL_D5FP
DR   Wikidata; Q127382547
RX   PubMed=3100421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   KM48
AC   CVCL_D5FQ
DR   Wikidata; Q127382549
RX   PubMed=3100421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   KM55
AC   CVCL_E8HK
RX   PubMed=26109484;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01876; Human IGHA1 (Note=Reacts with galactose-deficient IGHA1 or Gd-IgA1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KM61
AC   CVCL_D5FR
DR   Wikidata; Q127382550
RX   PubMed=3100421;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01579; Human IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   KM641
AC   CVCL_D3P7
SY   KM-641
DR   Wikidata; Q127382552
RX   Patent=EP0493686B1;
RX   PubMed=8439988;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3116.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the chimeric (mouse/human) ecromeximab (KM871) therapeutic antibody developed for the treatment of malignant melanoma.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KM643
AC   CVCL_D3P8
SY   KM-643
DR   Wikidata; Q127382555
RX   Patent=EP0493686B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3117.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KM644
AC   CVCL_D3P9
SY   KM-644
DR   Wikidata; Q127382556
RX   Patent=EP0493686B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3118.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KM703
AC   CVCL_9190
SY   KM 703
DR   CLO; CLO_0007108
DR   ATCC; CRL-1896
DR   BCRJ; 0137
DR   ECACC; 94090613
DR   Wikidata; Q54900072
RX   PubMed=2406365;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: BCRJ; 0137; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   KM8
AC   CVCL_RY75
DR   JCRB; JCRB1713
DR   Wikidata; Q54900073
RX   PubMed=1446662;
RX   PubMed=3391611;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Asp433His (c.1297G>C); ClinVar=VCV000003732; Zygosity=Homozygous (PubMed=1446662).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1713
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,14
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   KM81
AC   CVCL_9191
DR   CLO; CLO_0007109
DR   ATCC; TIB-241
DR   Wikidata; Q54900074
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   KM9304
AC   CVCL_BS96
DR   KCB; KCB 93048M
DR   Wikidata; Q54900075
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 7
//
ID   KM932
AC   CVCL_JE90
DR   CCRID; 5301HUM-KCB93009ZJ
DR   KCB; KCB 93009ZJ
DR   Wikidata; Q54900076
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   KM933
AC   CVCL_JE89
DR   CCRID; 5301HUM-KCB93010ZJ
DR   KCB; KCB 93010ZJ
DR   Wikidata; Q54900077
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KM934
AC   CVCL_JE88
DR   CCRID; 5301HUM-KCB93048ZJ
DR   KCB; KCB 93048ZJ
DR   Wikidata; Q54900078
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   KM9401
AC   CVCL_JE87
DR   CCRID; 5301HUM-KCB94001ZJ
DR   KCB; KCB 94001ZJ
DR   Wikidata; Q54900079
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   KM9402
AC   CVCL_JE86
DR   CCRID; 5301HUM-KCB94002ZJ
DR   KCB; KCB 94002ZJ
DR   Wikidata; Q54900080
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KM9403
AC   CVCL_JE85
DR   CCRID; 5301HUM-KCB94004ZJ
DR   KCB; KCB 94004ZJ
DR   Wikidata; Q54900090
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KM9405
AC   CVCL_BS92
DR   CCRID; 5301HUM-KCB94005ZJ
DR   KCB; KCB 94005ZJ
DR   KCB; KCB 94013
DR   Wikidata; Q54900091
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   KM9406
AC   CVCL_JE84
DR   CCRID; 5301HUM-KCB94014ZJ
DR   KCB; KCB 94014ZJ
DR   Wikidata; Q54900092
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KM9801
AC   CVCL_JE82
DR   CCRID; 5301HUM-KCB98001ZJ
DR   KCB; KCB 98001ZJ
DR   Wikidata; Q54900094
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KM9803
AC   CVCL_JE83
DR   CCRID; 5301HUM-KCB98005ZJ
DR   KCB; KCB 98005ZJ
DR   Wikidata; Q54900096
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KMA
AC   CVCL_6413
DR   CLO; CLO_0007110
DR   ATCC; CRL-9856
DR   BioSample; SAMN03471079
DR   Wikidata; Q54900097
RX   Patent=US5447861;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9856.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-9856; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-9856
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   KMab-1
AC   CVCL_D3E2
DR   Wikidata; Q127382557
RX   PubMed=23376717;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2 (Note=With p.Arg172Lys).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   KMB-17
AC   CVCL_6836
SY   KMB 17; KMB17
DR   CCRID; 4201HUM-CCTCC00005
DR   CCRID; 5301HUM-KCB04010YJ
DR   CCTCC; GDC0005
DR   KCB; KCB 200410YJ
DR   Wikidata; Q54900098
RX   PubMed=6459859;
RX   PubMed=26116706;
CC   Population: Chinese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 20,27
ST   Penta D: 9,13
ST   Penta E: 12,15
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KMB6-6
AC   CVCL_E5VY
RX   PubMed=24444128;
WW   Info; EGTC; -; https://egtc.jp/celllines/KMB6-6
CC   Characteristics: Feeder free (PubMed=24444128).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KMBC
AC   CVCL_M267
DR   BTO; BTO_0003309
DR   Cosmic; 924010
DR   Wikidata; Q54900100
RX   CelloPub=CLPUB00275;
RX   PubMed=1312890;
RX   PubMed=7537711;
RX   PubMed=9824643;
RX   PubMed=21533411;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=1312890); 67 hours (PubMed=9824643).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   KMBC-2
AC   CVCL_2977
SY   KMBC2
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 722
DR   BioSample; SAMN03472464
DR   BioSample; SAMN10987835
DR   cancercelllines; CVCL_2977
DR   Cell_Model_Passport; SIDM01578
DR   DepMap; ACH-000862
DR   GEO; GSM887213
DR   GEO; GSM888287
DR   IARC_TP53; 28280
DR   JCRB; JCRB1148
DR   JCRB; NIHS0440
DR   LiGeA; CCLE_334
DR   PharmacoDB; KMBC2_754_2019
DR   Progenetix; CVCL_2977
DR   Wikidata; Q54900102
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~68 hours (Note=Lot 02082017) (JCRB=JCRB1148).
CC   HLA typing: A*24:02,24:02; B*07:02,07:02; C*07:02,07:02; DRB1*01:01;01:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gly (c.388C>G); ClinVar=VCV000375958; Zygosity=Homozygous (DepMap=ACH-000862).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (DepMap=ACH-000862).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.09%; Native American=0.61%; East Asian, North=77.27%; East Asian, South=21.21%; South Asian=0%; European, North=0%; European, South=0.81% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0440; true.
ST   Source(s): JCRB=JCRB1148
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   KMBC-Hep
AC   CVCL_0T72
DR   Wikidata; Q54900103
RX   PubMed=9824643;
CC   Population: Japanese.
CC   Characteristics: Established from the liver metastasis of a nude mice subcutaneously injected with the parent cell line.
CC   Doubling time: 45 hours (PubMed=9824643).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M267 ! KMBC
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   KMC-1
AC   CVCL_B269
DR   EFO; EFO_0022353
DR   Wikidata; Q54900104
RX   CelloPub=CLPUB00275;
RX   PubMed=1332997;
RX   PubMed=7537711;
RX   PubMed=9178645;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 54 hours (Note=At 31th passage) (PubMed=1332997).
CC   HLA typing: A*24:02; B*40:06,52:01; C*08:01,12:02; DRB1*12:01,15:02 (PubMed=9178645).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   KMC-2
AC   CVCL_A635
DR   Wikidata; Q54900105
RX   PubMed=7742926;
CC   Population: Japanese.
CC   Characteristics: Established from a serially transplantable tumor established in nude mouse (nuKMC-2).
CC   Doubling time: 29.5 hours (Note=On plastic dish), 35.4 hours (Note=In collagen gel mixture) (PubMed=7742926).
DI   NCIt; C118630; Liver adenosquamous carcinoma
DI   ORDO; Orphanet_424975; Squamous cell carcinoma of liver and intrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   KMC8.8
AC   CVCL_9192
DR   CLO; CLO_0007111
DR   ATCC; CRL-2212
DR   Wikidata; Q54900107
RX   PubMed=8630385;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P40240; Mouse Cd9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   KMCH-1
AC   CVCL_7970
SY   KMCH1; KMCH
DR   BTO; BTO_0003310
DR   cancercelllines; CVCL_7970
DR   Cell_Model_Passport; SIDM01800
DR   DepMap; ACH-001853
DR   Wikidata; Q54900108
RX   CelloPub=CLPUB00275;
RX   PubMed=3032760;
RX   PubMed=7537711;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=10347112;
RX   PubMed=32899426;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~39 hours (PubMed=3032760).
CC   HLA typing: A*11:01,31:01; B*51:01; C*14:02; DRB1*08:02 (PubMed=9178645).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr346Cys (c.1037A>G); ClinVar=VCV000480380; Zygosity=Unspecified (DepMap=ACH-001853).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001853
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 11,18
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3828; Combined hepatocellular carcinoma and cholangiocarcinoma
DI   ORDO; Orphanet_529852; Combined hepatocellular carcinoma and cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   KMCH-2
AC   CVCL_7971
DR   Wikidata; Q54900109
RX   CelloPub=CLPUB00275;
RX   PubMed=7537711;
RX   PubMed=8738727;
RX   PubMed=10347112;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: ~44 hours (Note=At 20th passage), ~32 hours (Note=At 55th passage) (PubMed=8738727).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3828; Combined hepatocellular carcinoma and cholangiocarcinoma
DI   ORDO; Orphanet_529852; Combined hepatocellular carcinoma and cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   KMeC
AC   CVCL_L360
DR   Wikidata; Q54900110
RX   PubMed=15585963;
RX   PubMed=24035468;
RX   PubMed=28283079;
CC   Doubling time: 37.1 +- 1.35 hours (PubMed=15585963).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   KMF-1
AC   CVCL_AR98
DR   BioSample; SAMN03472370
DR   JCRB; NIHS0349
DR   Wikidata; Q54900111
CC   Discontinued: JCRB; NIHS0349; true.
ST   Source(s): JCRB=NIHS0349
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 4
//
ID   KMG-14
AC   CVCL_A1KQ
DR   Wikidata; Q102114418
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-15
AC   CVCL_A1KR
DR   Wikidata; Q102114419
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-16
AC   CVCL_A1KS
DR   Wikidata; Q102114420
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-17
AC   CVCL_A1KT
DR   Wikidata; Q102114421
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-2
AC   CVCL_A1KK
DR   Wikidata; Q102114422
RX   CelloPub=CLPUB00587;
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Doubling time: 38 hours (Note=At 72th passage) (CelloPub=CLPUB00587).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-3
AC   CVCL_A1KL
DR   Wikidata; Q102114423
RX   CelloPub=CLPUB00587;
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Doubling time: 48 hours (Note=At 39th passage) (CelloPub=CLPUB00587).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-4
AC   CVCL_JZ69
SY   KMG4
DR   Wikidata; Q54900115
RX   CelloPub=CLPUB00587;
RX   DOI=10.1007/978-4-431-68150-2_51;
RX   PubMed=1541975;
RX   PubMed=1564545;
RX   PubMed=17825249;
CC   Population: Japanese.
CC   Doubling time: 29 hours (Note=At 74th passage) (CelloPub=CLPUB00587).
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   KMG-5
AC   CVCL_A1KM
DR   Wikidata; Q102114424
RX   CelloPub=CLPUB00587;
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Doubling time: 100 hours (Note=At 31th passage) (CelloPub=CLPUB00587).
CC   Derived from site: In situ; Brain, fronto-temporal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-8
AC   CVCL_A1KN
DR   Wikidata; Q102114425
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-9
AC   CVCL_A1KP
DR   Wikidata; Q102114426
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMG-A
AC   CVCL_D882
DR   Wikidata; Q54900112
RX   PubMed=2450224;
RX   PubMed=9023415;
RX   PubMed=21544480;
CC   Population: Japanese.
CC   Characteristics: Established from a tumor transplanted in athymic nude mice (PubMed=2450224).
CC   Doubling time: 28.5 hours (PubMed=2450224); 26 hours (PubMed=21544480).
CC   HLA typing: A*26:01; B*40:02; C*03:04 (PubMed=9023415).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M735 ! KMG-C
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   KMG-C
AC   CVCL_M735
SY   KMGC
DR   Wikidata; Q54900113
RX   PubMed=21544480;
CC   Population: Japanese.
CC   Characteristics: Established from the 9th passage of the transplanted tumor in athymic nude mice (PubMed=21544480).
CC   Doubling time: 19 hours (PubMed=21544480).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D882 ! KMG-A
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   KMH-2
AC   CVCL_S641
SY   KMHDASH2; KMH2
DR   CLO; CLO_0037155
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472496
DR   cancercelllines; CVCL_S641
DR   CCRID; 3101HUMSCSP551
DR   Cell_Model_Passport; SIDM00619
DR   CLS; 305142
DR   Cosmic; 2054094
DR   Cosmic-CLP; 1298167
DR   DepMap; ACH-002397
DR   EGA; EGAS00001000978
DR   GDSC; 1298167
DR   GEO; GSM827259
DR   GEO; GSM1669989
DR   JCRB; JCRB1066
DR   JCRB; NIHS0268
DR   LINCS_LDP; LCL-1684
DR   PharmacoDB; KMH2_755_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_S641
DR   Wikidata; Q54900116
RX   PubMed=11686581;
RX   PubMed=20215515;
RX   PubMed=23833040;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 58 hours (PubMed=11686581).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244; DepMap=ACH-002397).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.62%; Native American=0.61%; East Asian, North=81.17%; East Asian, South=14.36%; South Asian=0%; European, North=0.83%; European, South=1.41% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0268; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=1298167; JCRB=JCRB1066; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 20,22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 34
//
ID   KMI6
AC   CVCL_9193
AS   CVCL_F274
SY   KM16
DR   CLO; CLO_0007113
DR   ATCC; CRL-2179
DR   BCRJ; 0136
DR   Wikidata; Q54900117
RX   PubMed=7532155;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09055; Mouse Itgb1/Cd29.
CC   Discontinued: BCRJ; 0136; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   KMITL-HA-E1
AC   CVCL_Z388
SY   KMITL-HA-E 1
DR   ICLDB; kmitl-ha-e1
DR   Wikidata; Q54900118
RX   CelloPub=CLPUB00168;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   KMITL-PX-E1
AC   CVCL_Z386
DR   ICLDB; kmitl-px-e1
DR   Wikidata; Q54900119
RX   CelloPub=CLPUB00169;
CC   Group: Insect cell line.
CC   Doubling time: 61.22 hours (Note=At 18th passage) (CelloPub=CLPUB00169).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   KMK-2
AC   CVCL_A1IZ
DR   Wikidata; Q102114427
RX   PubMed=1701504;
RX   PubMed=6154167;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   KMK-41
AC   CVCL_B6CM
DR   Wikidata; Q111733554
RX   PubMed=1368811;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   KMK-R
AC   CVCL_0I59
SY   KMK
DR   CCLV; CCLV-RIE 0901
DR   Wikidata; Q54900120
RX   PubMed=19941903;
RX   PubMed=25565633;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   KML-1
AC   CVCL_2979
SY   KML1
DR   cancercelllines; CVCL_2979
DR   Cell_Model_Passport; SIDM01799
DR   DepMap; ACH-001539
DR   JCRB; JCRB1347
DR   JCRB; NIHS0547
DR   Wikidata; Q54900121
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7572991;
RX   PubMed=34584567;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0547; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001539; JCRB=JCRB1347
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 29,32.2
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 11,12
ST   Penta E: 17,19
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   KML1
AC   CVCL_4J73
DR   Wikidata; Q54900122
RX   DOI=10.1159/000415049;
RX   Patent=US5132222;
RX   PubMed=3091508;
CC   Doubling time: 24 hours (PubMed=3091508).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: MRL/lpr.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 6
//
ID   KML1-7
AC   CVCL_4J74
DR   Wikidata; Q54900123
RX   Patent=US5132222;
RX   PubMed=2197220;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 86091801.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: MRL/lpr.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4J73 ! KML1
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   KMLS-1
AC   CVCL_2980
SY   KMLS1
DR   cancercelllines; CVCL_2980
DR   Cell_Model_Passport; SIDM01798
DR   DepMap; ACH-001540
DR   FANTOM5_SSTAR; 10782-110G8
DR   JCRB; JCRB0200
DR   Wikidata; Q54900124
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 88-175 hours (Note=Lot 04142008) (JCRB=JCRB0200).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): DepMap=ACH-001540; JCRB=JCRB0200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   D8S1179: 10,13
ST   FGA: 24.2,28
ST   Penta D: 10,11
ST   Penta E: 12,20
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   KMM-1
AC   CVCL_2981
SY   KMM1
DR   CLO; CLO_0050164
DR   EFO; EFO_0006611
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-TABM-1088
DR   BioSample; SAMN03472343
DR   BioSample; SAMN03472922
DR   BioSample; SAMN10987870
DR   cancercelllines; CVCL_2981
DR   Cell_Model_Passport; SIDM01577
DR   CGH-DB; 27-1
DR   CGH-DB; 9159-4
DR   ChEMBL-Cells; CHEMBL4802060
DR   Cosmic; 720778
DR   Cosmic; 759908
DR   Cosmic; 760396
DR   Cosmic; 2081390
DR   Cosmic; 2367282
DR   Cosmic; 2809757
DR   DepMap; ACH-000889
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM143349
DR   GEO; GSM290293
DR   GEO; GSM562809
DR   GEO; GSM887215
DR   GEO; GSM888289
DR   IARC_TP53; 28313
DR   JCRB; JCRB1180
DR   JCRB; NIHS0481
DR   LiGeA; CCLE_590
DR   PharmacoDB; KMM1_756_2019
DR   Progenetix; CVCL_2981
DR   PubChem_Cell_line; CVCL_2981
DR   RCB; RCB0193
DR   Wikidata; Q54900126
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2519219;
RX   PubMed=2768132;
RX   PubMed=8943038;
RX   PubMed=9290701;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=15215163;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=23992230;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: 29 hours (PubMed=2519219).
CC   HLA typing: A*02,24; B*40,52; C*03,12 (PubMed=25688540).
CC   HLA typing: A*02:01,24:02; B*40:02,52:01; C*03:04,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Val9Ile (c.25G>A); Zygosity=Heterozygous (DepMap=ACH-000889).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Homozygous (PubMed=11157491; PubMed=21173094; DepMap=ACH-000889).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (DepMap=ACH-000889).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.62%; East Asian, South=17.61%; South Asian=0.77%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0481; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1180; PubMed=25877200; RCB=RCB0193
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9 (RCB=RCB0193)
ST   D13S317: 9,12 (JCRB=JCRB1180; PubMed=25877200)
ST   D16S539: 11
ST   D18S51: 12,14
ST   D21S11: 32.2
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 12,16
ST   FGA: 23,26
ST   Penta D: 11
ST   Penta E: 11,15
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 38
//
ID   KMM-56
AC   CVCL_M491
SY   KMM 56
DR   Wikidata; Q54900127
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=6429256;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   KMM-L1
AC   CVCL_XB77
SY   KMML1; MML1
DR   CCRID; 5301MOU-KCB84001ZJ
DR   KCB; KCB 84001ZJ
DR   Wikidata; Q95990343
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Kunming.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   KMM-L2
AC   CVCL_A9GW
DR   CCRID; 5301MOU-KCB110109L
DR   KCB; KCB 2011109L
DR   Wikidata; Q108820628
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Kunming.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   KMM-M1
AC   CVCL_WI03
SY   MUS-M1
DR   CCRID; 5301MOU-KCB09001ZJ
DR   KCB; KCB 200901ZJ
DR   Wikidata; Q95991519
CC   Derived from site: In situ; Small intestine, smooth muscle; UBERON=UBERON_0004239.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
CC   Breed/subspecies: Kunming.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   KMO-90
AC   CVCL_A636
DR   cancercelllines; CVCL_A636
DR   Cosmic; 710458
DR   IARC_TP53; 962
DR   IARC_TP53; 3944
DR   Wikidata; Q54900128
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7727782;
RX   PubMed=8372807;
RX   PubMed=8412323;
RX   PubMed=10637496;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=8412323).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=8412323).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro177Leu (c.530C>T); ClinVar=VCV000406583; Zygosity=Unspecified (PubMed=7727782; PubMed=8412323).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QW97 ! KMO-R
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   KMO-R
AC   CVCL_QW97
DR   Wikidata; Q54900129
RX   PubMed=8372807;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A636 ! KMO-90
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   KMOE-1
AC   CVCL_W022
DR   Wikidata; Q54900130
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6949905;
CC   Population: Japanese.
CC   Doubling time: 48.3 hours (PubMed=6949905).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1332 ! KMOE-2
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   KMOE-2
AC   CVCL_1332
SY   KMOE2; Kmoe2
DR   CLO; CLO_0007114
DR   CLDB; cl3034
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473322
DR   cancercelllines; CVCL_1332
DR   Cell_Model_Passport; SIDM01019
DR   ChEMBL-Cells; CHEMBL3308236
DR   ChEMBL-Targets; CHEMBL2366347
DR   Cosmic; 787445
DR   Cosmic; 907280
DR   Cosmic; 975262
DR   Cosmic; 1012079
DR   Cosmic; 1465969
DR   Cosmic; 2131542
DR   Cosmic; 2306213
DR   Cosmic-CLP; 907280
DR   DepMap; ACH-002258
DR   DSMZ; ACC-37
DR   DSMZCellDive; ACC-37
DR   EGA; EGAS00001000978
DR   GDSC; 907280
DR   GEO; GSM1446748
DR   GEO; GSM1669991
DR   IARC_TP53; 21434
DR   LINCS_LDP; LCL-1058
DR   PharmacoDB; KMOE2_757_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1332
DR   Wikidata; Q54900132
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6949905;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 24.2 hours (PubMed=6949905); ~40-50 hours (DSMZ=ACC-37).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (Cosmic-CLP=907280; DepMap=ACH-002258).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Homozygous (Cosmic-CLP=907280; DepMap=ACH-002258).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=0.02%; East Asian, North=78.12%; East Asian, South=19.8%; South Asian=1.43%; European, North=0.23%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=907280; DSMZ=ACC-37
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 18,22
ST   D19S433: 13,16
ST   D21S11: 28,29
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 8,10
ST   D7S820: 10
ST   D8S1179: 13,16
ST   FGA: 19,22
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W022 ! KMOE-1
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   KMOE-2/05
AC   CVCL_UF71
DR   cancercelllines; CVCL_UF71
DR   JCRB; NIHS0051
DR   Wikidata; Q94427646
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=2416764;
RX   PubMed=6203576;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0051; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1332 ! KMOE-2
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   KMOE-3N
AC   CVCL_W023
DR   Wikidata; Q54900133
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6949905;
CC   Population: Japanese.
CC   Characteristics: Established after one tumor passage of KMOE-1 in nude mice.
CC   Doubling time: 24.6 hours (PubMed=6949905).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W022 ! KMOE-1
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   KMP
AC   CVCL_4531
DR   CLO; CLO_0007115
DR   CLDB; cl5215
DR   IZSLER; BS CL 147
DR   Wikidata; Q54900134
RX   PubMed=9208425;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   KMP-1 [Human pancreatic adenocarcinoma]
AC   CVCL_8489
SY   KMP1
DR   Cosmic; 916479
DR   Wikidata; Q54900136
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10091760;
CC   Population: Japanese.
CC   Doubling time: 70.4 hours (PubMed=10091760).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   KMP-1 [Mouse hybridoma against P.polycephalum tubulin alpha-1]
AC   CVCL_F0IZ
RX   PubMed=4018260;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P50258; Physarum polycephalum tubulin alpha-1 chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KMP-2
AC   CVCL_8490
SY   KMP2
DR   CGH-DB; 167-1
DR   Cosmic; 916480
DR   JCRB; JCRB1427
DR   Wikidata; Q54900138
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10091760;
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Doubling time: 16.6 hours (PubMed=10091760).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=18380791).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1427
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   KMP-3
AC   CVCL_8491
SY   KMP3
DR   CGH-DB; 168-1
DR   Cosmic; 916481
DR   JCRB; JCRB1440
DR   Wikidata; Q54900139
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10091760;
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Doubling time: 23 hours (PubMed=10091760).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1440
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   KMP-4
AC   CVCL_8492
SY   KMP4
DR   CGH-DB; 169-1
DR   Cosmic; 916482
DR   Wikidata; Q54900145
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10091760;
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Doubling time: 57 hours (PubMed=10091760).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   KMP-5
AC   CVCL_8493
SY   KMP5
DR   CGH-DB; 170-1
DR   Cosmic; 916483
DR   JCRB; JCRB1464
DR   Wikidata; Q54900146
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10091760;
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Doubling time: 28.9 hours (PubMed=10091760).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1464
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D5S818: 10,13
ST   D7S820: 8,13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   KMP-6
AC   CVCL_8494
SY   KMP6
DR   Cosmic; 916484
DR   Wikidata; Q54900147
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10091760;
CC   Population: Japanese.
CC   Doubling time: 32.5 hours (PubMed=10091760).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KMP-7
AC   CVCL_8495
SY   KMP7
DR   CGH-DB; 171-1
DR   JCRB; JCRB1429
DR   Wikidata; Q54900148
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1429
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   KMP-8
AC   CVCL_8496
SY   KMP8
DR   CGH-DB; 172-1
DR   JCRB; JCRB1461
DR   Wikidata; Q54900150
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Doubling time: ~33 hours (Note=Lot 12202016) (JCRB=JCRB1461).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1461
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   KMP5-Luc#9
AC   CVCL_XD22
DR   JCRB; JCRB1774
DR   JCRB; NIHS1214
DR   Wikidata; Q94427853
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1214; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1774
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D5S818: 10,13
ST   D7S820: 8,13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8493 ! KMP-5
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   KMP8-Luc#8
AC   CVCL_XD24
DR   JCRB; JCRB1799
DR   JCRB; NIHS1215
DR   Wikidata; Q94427862
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; JCRB1799; probable.
CC   Discontinued: JCRB; NIHS1215; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1799
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8496 ! KMP-8
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   KMPC-3
AC   CVCL_2982
DR   BioSample; SAMN03472465
DR   JCRB; JCRB1150
DR   Wikidata; Q54900151
CC   Population: Japanese.
CC   Doubling time: ~40 hours (JCRB=JCRB1150).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
ST   Source(s): JCRB=JCRB1150
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   KMPG-1
AC   CVCL_SA46
DR   Wikidata; Q54900152
RX   PubMed=194867;
RX   PubMed=823042;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C134766; Baboon lymphoma
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
OI   CVCL_SA47 ! SPG-1
SX   Female
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 4
//
ID   KMRC-1
AC   CVCL_2983
SY   KMRC1
DR   CLO; CLO_0009977
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 620
DR   BioSample; SAMN03470891
DR   BioSample; SAMN10988368
DR   cancercelllines; CVCL_2983
DR   Cell_Model_Passport; SIDM00611
DR   Cosmic; 1995470
DR   Cosmic-CLP; 1298168
DR   DepMap; ACH-000684
DR   EGA; EGAS00001000978
DR   GDSC; 1298168
DR   GEO; GSM827174
DR   GEO; GSM887216
DR   GEO; GSM888290
DR   GEO; GSM1669992
DR   IARC_TP53; 30098
DR   JCRB; JCRB1010
DR   JCRB; NIHS0271
DR   LiGeA; CCLE_854
DR   LINCS_LDP; LCL-1775
DR   PharmacoDB; KMRC1_758_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2983
DR   Wikidata; Q54900153
RX   PubMed=20215515;
RX   PubMed=22185343;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~1.2 days (Note=Lot 04212005), ~29 hours (Note=Lot 06082018), ~41 hours (Note=Lot 04042022) (JCRB=JCRB1010).
CC   HLA typing: A*02:19,24:02; B*54:01,54:01; C*01:02,01:02; DQA1*03:02,03:02; DQB1*04:01,06:01; DRB1*11:30,14:103 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Phe76del (c.227_229delTCT); Zygosity=Homozygous (DepMap=ACH-000684).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.41%; East Asian, North=74.54%; East Asian, South=25.05%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0271; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=1298168; JCRB=JCRB1010; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 30,32.1
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 21,22,23
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   KMRC-2
AC   CVCL_2984
SY   KMRC2
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470950
DR   BioSample; SAMN10988363
DR   cancercelllines; CVCL_2984
DR   Cell_Model_Passport; SIDM01660
DR   DepMap; ACH-000709
DR   GEO; GSM827291
DR   GEO; GSM887218
DR   GEO; GSM888292
DR   IARC_TP53; 30099
DR   JCRB; JCRB1011
DR   JCRB; NIHS0272
DR   LiGeA; CCLE_248
DR   PharmacoDB; KMRC2_759_2019
DR   Progenetix; CVCL_2984
DR   Wikidata; Q54900154
RX   PubMed=20215515;
RX   PubMed=22185343;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 43 hours (Note=Lot 09262007), ~57 hours (Note=Lot 03182019) (JCRB=JCRB1011).
CC   HLA typing: A*11:01,24:02; B*54:01,59:05; C*01:02,01:02; DQA1*03:02,04:01; DQB1*04:01,04:01; DRB1*07:01,12:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.74%; East Asian, North=73.3%; East Asian, South=25.71%; South Asian=0.24%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0272; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1011; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D19S433: 13.2,14
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 11,14
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   Penta D: 12
ST   Penta E: 19,20
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   KMRC-20
AC   CVCL_2986
SY   KMRC20
DR   CLO; CLO_0009978
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 619
DR   BioSample; SAMN03470962
DR   BioSample; SAMN10987836
DR   cancercelllines; CVCL_2986
DR   Cell_Model_Passport; SIDM00609
DR   Cosmic; 1995471
DR   Cosmic-CLP; 1298169
DR   DepMap; ACH-000250
DR   EGA; EGAS00001000978
DR   GDSC; 1298169
DR   GEO; GSM827175
DR   GEO; GSM887217
DR   GEO; GSM888291
DR   GEO; GSM1669993
DR   IARC_TP53; 28328
DR   JCRB; JCRB1071
DR   LiGeA; CCLE_223
DR   LINCS_HMS; 50023
DR   LINCS_LDP; LCL-1755
DR   PharmacoDB; KMRC20_760_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2986
DR   Wikidata; Q54900155
RX   PubMed=20215515;
RX   PubMed=22185343;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~41 hours (Note=Lot 01202020) (JCRB=JCRB1071).
CC   HLA typing: A*02:01,24:02; B*46:01,51:01; C*01:03,01:03; DQA1*01:02,05:02; DQB1*03:02,06:01; DRB1*04:04,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>T; ClinVar=VCV000630765; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=1298169; DepMap=ACH-000250).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.3%; Native American=0%; East Asian, North=77.74%; East Asian, South=14.66%; South Asian=0%; European, North=0%; European, South=4.3% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=1298169; JCRB=JCRB1071; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 13,13.2
ST   D21S11: 28,30
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 10,16
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   KMRC-21
AC   CVCL_AR99
DR   BioSample; SAMN03472372
DR   JCRB; NIHS0351
DR   Wikidata; Q54900156
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0351; true.
ST   Source(s): JCRB=NIHS0351
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15,20
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 7
//
ID   KMRC-3
AC   CVCL_2985
SY   KMRC3
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472532
DR   BioSample; SAMN10988116
DR   cancercelllines; CVCL_2985
DR   Cell_Model_Passport; SIDM01659
DR   DepMap; ACH-000313
DR   GEO; GSM887219
DR   GEO; GSM888293
DR   IARC_TP53; 30100
DR   JCRB; JCRB1012
DR   JCRB; NIHS0273
DR   LiGeA; CCLE_073
DR   PharmacoDB; KMRC3_761_2019
DR   Progenetix; CVCL_2985
DR   Wikidata; Q54900157
RX   PubMed=22185343;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~7-8 days (Note=Lot 10222007), ~6 days (Note=Lot 07042016) (JCRB=JCRB1012).
CC   HLA typing: A*11:01,24:02; B*51:01,55:02; C*03:03,14:02; DQA1*03:02,05:02; DQB1*03:02,06:13; DRB1*08:02,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; c.340+2T>C; ClinVar=VCV000635395; Zygosity=Homozygous; Note=Splice donor mutation (DepMap=ACH-000313).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.13%; Native American=0%; East Asian, North=78.77%; East Asian, South=17.63%; South Asian=0%; European, North=0%; European, South=2.47% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0273; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): JCRB=JCRB1012
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   KMRC-5
AC   CVCL_2987
DR   JCRB; JCRB1007
DR   Wikidata; Q54900158
CC   Population: Japanese.
CC   Discontinued: JCRB; JCRB1007; probable.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   KMRM-A1
AC   CVCL_AS00
DR   BioSample; SAMN03472371
DR   JCRB; NIHS0350
DR   Wikidata; Q54900159
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0350; true.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): JCRB=NIHS0350
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 9,13
ST   D5S818: 10,11
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 9
//
ID   KMRM-M1
AC   CVCL_2988
DR   BioSample; SAMN03470949
DR   JCRB; JCRB1014
DR   Wikidata; Q54900160
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Muscle; UBERON=UBERON_0001630.
ST   Source(s): JCRB=JCRB1014; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 18,19
ST   D19S433: 12,14
ST   D21S11: 30,31
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 12,25
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   KMRM-S2
AC   CVCL_4W62
DR   Wikidata; Q54900161
RX   PubMed=23379954;
CC   Population: Japanese.
CC   Doubling time: 51 hours (PubMed=23379954).
CC   Karyotypic information: Hypertriploid karyotype. Has lost chromosome Y (PubMed=23379954).
CC   Derived from site: Metastatic; Head, skin; UBERON=UBERON_0001084.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   KMS II
AC   CVCL_A1KI
DR   Wikidata; Q102114428
RX   CelloPub=CLPUB00587;
RX   PubMed=1541975;
CC   Population: Japanese.
CC   Doubling time: 24 hours (Note=At 117th passage) (CelloPub=CLPUB00587).
CC   Derived from site: In situ; Brain, fourth ventricle; UBERON=UBERON_0002422.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KMS-11
AC   CVCL_2989
SY   KMS11; kms11; kms 11; Kawasaki Medical School-11
DR   BTO; BTO_0003932
DR   EFO; EFO_0005694
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-1088
DR   BioGRID_ORCS_Cell_line; 911
DR   BioSample; SAMN03473171
DR   BioSample; SAMN10987857
DR   cancercelllines; CVCL_2989
DR   CCRID; 1101HUM-PUMC000682
DR   Cell_Model_Passport; SIDM00608
DR   CGH-DB; 21-1
DR   CGH-DB; 9133-4
DR   ChEMBL-Cells; CHEMBL4295454
DR   ChEMBL-Targets; CHEMBL4296454
DR   Cosmic; 720765
DR   Cosmic; 759900
DR   Cosmic; 759906
DR   Cosmic; 760389
DR   Cosmic; 760402
DR   Cosmic; 760645
DR   Cosmic; 850216
DR   Cosmic; 1740213
DR   Cosmic; 2081391
DR   Cosmic; 2302410
DR   Cosmic; 2367280
DR   Cosmic; 2391798
DR   Cosmic; 2809763
DR   Cosmic-CLP; 1659817
DR   DepMap; ACH-000714
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002414
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS682HMC
DR   ENCODE; ENCBS987CHP
DR   GDSC; 1659817
DR   GEO; GSM143337
DR   GEO; GSM290294
DR   GEO; GSM562810
DR   GEO; GSM887220
DR   GEO; GSM888294
DR   GEO; GSM1666387
DR   GEO; GSM1692593
DR   GEO; GSM1692594
DR   GEO; GSM1692595
DR   JCRB; JCRB1179
DR   JCRB; NIHS0482
DR   LiGeA; CCLE_189
DR   PharmacoDB; KMS11_762_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2989
DR   PubChem_Cell_line; CVCL_2989
DR   Wikidata; Q54900162
RX   CelloPub=CLPUB00604;
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2519219;
RX   PubMed=2768132;
RX   PubMed=8943038;
RX   PubMed=9787181;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=15215163;
RX   PubMed=15491288;
RX   PubMed=16956823;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: 36 hours (PubMed=2519219); 70 hours (PubMed=25984343); 50 hours (Note=Lot 03062008), ~2 days (Note=Lot 10142009), ~31 hours (Note=Lot 10072016), ~39 hours (Note=Lot 10222021) (JCRB=JCRB1179).
CC   HLA typing: A*24; B*51,54; C*01,14 (PubMed=25688540).
CC   HLA typing: A*24:02,24:02; B*51:01,54:01; C*01:02,14:02; DQA1*03:02,05:01; DQB1*03:01,04:01; DRB1*04:05,14:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (PubMed=11157491; CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (PubMed=17692805).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.44%; Native American=0.01%; East Asian, North=82.62%; East Asian, South=10.11%; South Asian=0%; European, North=0%; European, South=2.81% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0482; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=1659817; JCRB=JCRB1179; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 13,14
ST   D21S11: 28,30
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 15,16
ST   TH01: 6,9
ST   TPOX: 12
ST   vWA: 17,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   KMS-11 WHSC1(+/-)
AC   CVCL_HE02
SY   WHSC1 (+/-) KMS-11; KMS-11 MMSET T-KO; KMS-11/TKO; KMS11/TKO; TKO
DR   BTO; BTO_0005876
DR   cancercelllines; CVCL_HE02
DR   Horizon_Discovery; HD+108-002
DR   Wikidata; Q54900163
RX   PubMed=17942756;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: In KMS-11 one of the two WHSC1 alleles is translocated. This cell line is KO for the translocated allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12766; NSD2 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2989 ! KMS-11
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 17
//
ID   KMS-11 WHSC1(trans/-)
AC   CVCL_HE03
SY   WHSC1 (trans/-) KMS-11; KMS-11 MMSET Non-T-KO; KMS-11/NTKO; KMS11/NTKO; NTKO
DR   BTO; BTO_0005875
DR   cancercelllines; CVCL_HE03
DR   Horizon_Discovery; HD+108-001
DR   Wikidata; Q54900164
RX   PubMed=17942756;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: In KMS-11 one of the two WHSC1 alleles is translocated. This cell line is KO for the non-translocated allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12766; NSD2 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2989 ! KMS-11
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 17
//
ID   KMS-11/BR
AC   CVCL_VJ34
SY   KMS11/BR
DR   cancercelllines; CVCL_VJ34
DR   Wikidata; Q94428155
RX   PubMed=25382610;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2989 ! KMS-11
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   KMS-11/BTZ
AC   CVCL_4V71
SY   KMS11/BTZ
DR   cancercelllines; CVCL_4V71
DR   JCRB; JCRB1642
DR   Wikidata; Q54900165
RX   PubMed=20555361;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1642
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 12
ST   vWA: 17,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2989 ! KMS-11
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   KMS-11/Cfz
AC   CVCL_IQ84
DR   cancercelllines; CVCL_IQ84
DR   GEO; GSM1692587
DR   GEO; GSM1692588
DR   GEO; GSM1692589
DR   Wikidata; Q54900166
RX   PubMed=26109433;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Selected for resistance to: ChEBI; CHEBI_65347; Carfilzomib (Kyprolis; PX-171-007).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2989 ! KMS-11
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 14
//
ID   KMS-11R
AC   CVCL_D705
DR   cancercelllines; CVCL_D705
DR   Cosmic; 1740214
DR   Wikidata; Q54900167
RX   PubMed=22869148;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Selected for resistance to: AZ12908010 (AZ8010).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2989 ! KMS-11
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   KMS-12-BM
AC   CVCL_1334
SY   KMS 12 BM; KMS-12BM; KMS12-BM; KMS12BM; KMS-12; KMS12; Kawasaki Medical School-12-Bone Marrow
DR   BTO; BTO_0006459
DR   CLO; CLO_0009842
DR   EFO; EFO_0006612
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ArrayExpress; E-TABM-1088
DR   BioSample; SAMN01821691
DR   BioSample; SAMN03472933
DR   BioSample; SAMN10988243
DR   cancercelllines; CVCL_1334
DR   Cell_Model_Passport; SIDM01020
DR   CGH-DB; 28-1
DR   CGH-DB; 9141-4
DR   ChEMBL-Cells; CHEMBL4295426
DR   ChEMBL-Targets; CHEMBL4296455
DR   CLS; 300287
DR   Cosmic; 2081425
DR   Cosmic; 2367302
DR   Cosmic-CLP; 907281
DR   DepMap; ACH-000380
DR   DSMZ; ACC-551
DR   DSMZCellDive; ACC-551
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907281
DR   GEO; GSM99382
DR   GEO; GSM143346
DR   GEO; GSM290295
DR   GEO; GSM562812
DR   GEO; GSM887221
DR   GEO; GSM888295
DR   GEO; GSM1374601
DR   GEO; GSM1669994
DR   IARC_TP53; 21435
DR   IZSLER; BS TCL 240
DR   JCRB; JCRB0429
DR   LiGeA; CCLE_244
DR   LINCS_LDP; LCL-2043
DR   PharmacoDB; KMS12BM_763_2019
DR   PRIDE; PXD030239
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1334
DR   PubChem_Cell_line; CVCL_1334
DR   Wikidata; Q54900168
RX   CelloPub=CLPUB00604;
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2479409;
RX   PubMed=2519219;
RX   PubMed=2768132;
RX   PubMed=8695815;
RX   PubMed=9290701;
RX   PubMed=10936422;
RX   PubMed=11039672;
RX   PubMed=15215163;
RX   PubMed=16956823;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=22806891;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 58 hours (PubMed=2519219); 60 hours (PubMed=25984343); ~60 hours (DSMZ=ACC-551); ~37 hours (Note=Lot 04072005), ~32 hours (Note=Lot 02142011), 1.5-4 days (Note=Lot 08172016) (JCRB=JCRB0429).
CC   HLA typing: A*26,33; B*35,44; C*03,14 (PubMed=25688540).
CC   HLA typing: A*26:01,33:03; B*35:01,44:03; C*03:03,14:03; DQA1*03:02,03:02; DQB1*04:01,04:01 (PubMed=26589293).
CC   HLA typing: A*26:01:01,33:03:01; B*35:01:01,44:03:01; C*03:03:01,14:03; DQA1*01:02:01,03:03:01; DRA*01:01:01,01:02:02; DRB1*04:10:01,13:02:01 (DSMZCellDive=ACC-551).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Leu (c.1010G>T); ClinVar=VCV000142828; Zygosity=Homozygous (PubMed=21173094; Cosmic-CLP=907281; DepMap=ACH-000380).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.01%; Native American=0%; East Asian, North=81.71%; East Asian, South=16.28%; South Asian=0%; European, North=0%; European, South=2% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=907281; DSMZ=ACC-551; JCRB=JCRB0429; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 30.2,32.2
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 14
ST   D7S820: 11
ST   D8S1179: 10,16
ST   FGA: 20
ST   Penta D: 14
ST   Penta E: 12,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1333 ! KMS-12-PE
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   KMS-12-PE
AC   CVCL_1333
SY   KMS 12 PE; KMS-12_PE; KMS-12PE; KMS12-PE; KMS12PE; Kawasaki Medical School-12-Pleural Effusion
DR   BTO; BTO_0006460
DR   CLO; CLO_0009843
DR   EFO; EFO_0006613
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-TABM-1088
DR   BioSample; SAMN01821645
DR   BioSample; SAMN01821692
DR   BioSample; SAMN03472936
DR   cancercelllines; CVCL_1333
DR   Cell_Model_Passport; SIDM01035
DR   CGH-DB; 29-1
DR   CGH-DB; 9140-4
DR   ChEMBL-Cells; CHEMBL3308553
DR   ChEMBL-Targets; CHEMBL2366257
DR   CLS; 300286
DR   Cosmic; 753568
DR   Cosmic; 2081426
DR   Cosmic; 2367301
DR   Cosmic; 2809764
DR   DSMZ; ACC-606
DR   DSMZCellDive; ACC-606
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM99383
DR   GEO; GSM562811
DR   GEO; GSM827273
DR   IARC_TP53; 28504
DR   IZSLER; BS TCL 239
DR   JCRB; JCRB0430
DR   LINCS_LDP; LCL-2044
DR   PharmacoDB; KMS12PE_764_2019
DR   Progenetix; CVCL_1333
DR   PubChem_Cell_line; CVCL_1333
DR   Wikidata; Q54900169
RX   CelloPub=CLPUB00604;
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2479409;
RX   PubMed=2519219;
RX   PubMed=2768132;
RX   PubMed=9290701;
RX   PubMed=9738977;
RX   PubMed=10936422;
RX   PubMed=11039672;
RX   PubMed=15215163;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21173094;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30545397;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 62 hours (PubMed=2519219); ~60-80 hours (DSMZ=ACC-606).
CC   HLA typing: A*26,33; B*35,44; C*03,14 (PubMed=25688540).
CC   HLA typing: A*26:01,33:03; B*35:01,44:03; C*03:03,14:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Leu (c.1010G>T); ClinVar=VCV000142828; Zygosity=Homozygous (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-606; JCRB=JCRB0430; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 14,15 (DSMZ=ACC-606)
ST   D18S51: 15 (PubMed=25877200)
ST   D19S433: 14
ST   D21S11: 30.2,32.2
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 14
ST   D7S820: 11,12
ST   D8S1179: 16
ST   FGA: 20
ST   Penta D: 14
ST   Penta E: 12,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1334 ! KMS-12-BM
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   KMS-15
AC   CVCL_D6US
SY   KMS15; Kawasaki Medical School-15
DR   ABM; T0133
RX   PubMed=15491288;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   KMS-18
AC   CVCL_A637
SY   KMS18; Kawasaki Medical School-18
DR   BioSample; SAMN10987762
DR   cancercelllines; CVCL_A637
DR   Cell_Model_Passport; SIDM01576
DR   CGH-DB; 22-1
DR   CGH-DB; 9134-4
DR   Cosmic; 759902
DR   Cosmic; 2081392
DR   Cosmic; 2081439
DR   Cosmic; 2367277
DR   Cosmic; 2391797
DR   DepMap; ACH-000658
DR   GEO; GSM143334
DR   GEO; GSM290296
DR   GEO; GSM887222
DR   GEO; GSM888296
DR   IARC_TP53; 30102
DR   JCRB; NIHS0483
DR   PharmacoDB; KMS18_765_2019
DR   Progenetix; CVCL_A637
DR   Wikidata; Q54900170
RX   CelloPub=CLPUB00604;
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9472091;
RX   PubMed=10936422;
RX   PubMed=11368454;
RX   PubMed=15215163;
RX   PubMed=16956823;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=22460905;
RX   PubMed=24504345;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Produces IgA lambda.
CC   Doubling time: ~72 hours (PubMed=9472091).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6545; COG1 + HGNC; HGNC:37659; RNA28S5; Name(s)=COG1-RNA28S5, COG1-RN28S1 (PubMed=24504345).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Unspecified (DepMap=ACH-000658).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.47%; East Asian, South=18.53%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0483; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 34
//
ID   KMS-20
AC   CVCL_2990
SY   KMS20; Kawasaki Medical School-20
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472431
DR   BioSample; SAMN10988070
DR   cancercelllines; CVCL_2990
DR   Cell_Model_Passport; SIDM01575
DR   CGH-DB; 23-1
DR   CGH-DB; 9135-4
DR   Cosmic; 2081393
DR   DepMap; ACH-000426
DR   GEO; GSM143350
DR   GEO; GSM290297
DR   GEO; GSM887223
DR   GEO; GSM888297
DR   IARC_TP53; 28391
DR   JCRB; JCRB1196
DR   JCRB; NIHS0484
DR   LiGeA; CCLE_068
DR   PharmacoDB; KMS20_766_2019
DR   Progenetix; CVCL_2990
DR   Wikidata; Q54900171
RX   CelloPub=CLPUB00604;
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   PubMed=15215163;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=25984343).
CC   HLA typing: A*11:01,26:01; B*40:01,67:01; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (DepMap=ACH-000426).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Unspecified (DepMap=ACH-000426).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.24%; East Asian, North=84.32%; East Asian, South=14.3%; South Asian=0.32%; European, North=0%; European, South=0.81% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0484; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1196
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 9,13
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   KMS-21-BM
AC   CVCL_2991
SY   KMS-21BM; KMS21BM; Kawasaki Medical School-21-Bone Marrow
DR   EFO; EFO_0006614
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03152019
DR   BioSample; SAMN03472923
DR   BioSample; SAMN10987817
DR   cancercelllines; CVCL_2991
DR   Cell_Model_Passport; SIDM01658
DR   CGH-DB; 30-1
DR   CGH-DB; 9143-4
DR   DepMap; ACH-000598
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM887224
DR   GEO; GSM888298
DR   IARC_TP53; 30103
DR   JCRB; JCRB1185
DR   JCRB; NIHS0485
DR   LiGeA; CCLE_778
DR   PharmacoDB; KMS21BM_767_2019
DR   Progenetix; CVCL_2991
DR   Wikidata; Q54900172
RX   CelloPub=CLPUB00604;
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   PubMed=11697507;
RX   PubMed=12592342;
RX   PubMed=15215163;
RX   PubMed=20143388;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line and to be a sister line to KMS-21-PE (Cellosaurus=CVCL_A445) but this does not seem to be the case (PubMed=12592342; PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00228.
CC   Population: Japanese.
CC   HLA typing: A*24:02,24:02; B*40:01,40:01; C*01:02,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (DepMap=ACH-000598).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.63%; East Asian, South=21.2%; South Asian=0.16%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0485; true.
ST   Source(s): JCRB=JCRB1185; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,14
ST   D16S539: 9
ST   D18S51: 13
ST   D21S11: 31,32.2
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,13
ST   D8S1179: 12
ST   FGA: 19,22,23
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   KMS-21-PE
AC   CVCL_A445
SY   KMS-21PE; KMS21PE; Kawasaki Medical School-21-Pleural Effusion
DR   CGH-DB; 31-1
DR   CGH-DB; 9142-4
DR   Wikidata; Q54900173
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   PubMed=11697507;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   KMS-24
AC   CVCL_8312
SY   KMS24; Kawasaki Medical School-24
DR   CGH-DB; 9136-4
DR   JCRB; JCRB1184
DR   Wikidata; Q54900174
RX   PubMed=15215163;
RX   PubMed=15491288;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa (JCRB=JCRB1184).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1184
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,14
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 8,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   KMS-26
AC   CVCL_2992
SY   KMS26; Kawasaki Medical School-26
DR   BTO; BTO_0006461
DR   EFO; EFO_0006615
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472894
DR   BioSample; SAMN10987818
DR   cancercelllines; CVCL_2992
DR   Cell_Model_Passport; SIDM01574
DR   CGH-DB; 24-1
DR   CGH-DB; 9137-4
DR   Cosmic; 2081394
DR   Cosmic; 2391799
DR   DepMap; ACH-000588
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM143338
DR   GEO; GSM290298
DR   GEO; GSM887225
DR   GEO; GSM888299
DR   IARC_TP53; 28217
DR   JCRB; JCRB1187
DR   JCRB; NIHS0487
DR   LiGeA; CCLE_629
DR   PharmacoDB; KMS26_768_2019
DR   Progenetix; CVCL_2992
DR   Wikidata; Q54900175
RX   CelloPub=CLPUB00604;
RX   DOI=10.1002/1438-826X(200005)1:1<48::AID-GNFD48>3.0.CO;2-B;
RX   PubMed=15215163;
RX   PubMed=15491288;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 35 hours (PubMed=25984343).
CC   HLA typing: A*02:01,31:01; B*40:02,51:01; C*03:04,14:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (DepMap=ACH-000588).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.51%; Native American=0%; East Asian, North=82.18%; East Asian, South=11.23%; South Asian=0%; European, North=0%; European, South=5.08% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0487; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1187; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 13,20
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 12
ST   TH01: 7,8
ST   TPOX: 11,12
ST   vWA: 17,20
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   KMS-27
AC   CVCL_2993
SY   KMS27; Kawasaki Medical School-27
DR   EFO; EFO_0006616
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472924
DR   BioSample; SAMN10987819
DR   cancercelllines; CVCL_2993
DR   Cell_Model_Passport; SIDM01573
DR   CGH-DB; 25-1
DR   CGH-DB; 9138-4
DR   Cosmic; 2391811
DR   DepMap; ACH-000576
DR   EGA; EGAS00001000610
DR   GEO; GSM143347
DR   GEO; GSM290299
DR   GEO; GSM887226
DR   GEO; GSM888300
DR   IARC_TP53; 30104
DR   JCRB; JCRB1188
DR   JCRB; NIHS0488
DR   LiGeA; CCLE_594
DR   PharmacoDB; KMS27_769_2019
DR   Progenetix; CVCL_2993
DR   Wikidata; Q54900176
RX   CelloPub=CLPUB00604;
RX   PubMed=15215163;
RX   PubMed=15491288;
RX   PubMed=17171682;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   HLA typing: A*02:01,26:01; B*40:03,40:03; C*03:04,03:04 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.28%; East Asian, North=76.27%; East Asian, South=23.45%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0488; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1188; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D21S11: 30,32.2
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 13,18.4
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   KMS-28BM
AC   CVCL_2994
SY   KMS-28-BM; KMS28BM; KMS-28; KMS28; Kawasaki Medical School-28-Bone Marrow
DR   EFO; EFO_0006617
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472925
DR   BioSample; SAMN10987821
DR   cancercelllines; CVCL_2994
DR   Cell_Model_Passport; SIDM01657
DR   CGH-DB; 32-1
DR   CGH-DB; 9145-4
DR   Cosmic; 2081427
DR   Cosmic; 2367288
DR   DepMap; ACH-000419
DR   EGA; EGAS00001000610
DR   GEO; GSM143331
DR   GEO; GSM290300
DR   GEO; GSM887227
DR   GEO; GSM888301
DR   IARC_TP53; 30105
DR   JCRB; JCRB1192
DR   JCRB; NIHS0490
DR   LiGeA; CCLE_827
DR   PharmacoDB; KMS28BM_770_2019
DR   Progenetix; CVCL_2994
DR   Wikidata; Q54900177
RX   CelloPub=CLPUB00604;
RX   PubMed=15215163;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*24:02,24:02; B*40:02,52:01; C*03:04,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Homozygous (DepMap=ACH-000419).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly105Arg (c.313G>C); ClinVar=VCV000406574; Zygosity=Homozygous (DepMap=ACH-000419).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.75%; Native American=0%; East Asian, North=76.63%; East Asian, South=19.7%; South Asian=0%; European, North=0%; European, South=0.91% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0490; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1192; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 14
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 12,15
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2995 ! KMS-28PE
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   KMS-28PE
AC   CVCL_2995
SY   KMS-28-PE; KMS28PE; Kawasaki Medical School-28-Pleural Effusion
DR   EFO; EFO_0006618
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_2995
DR   Cell_Model_Passport; SIDM01656
DR   Cell_Model_Passport; SIDM01797
DR   CGH-DB; 33-1
DR   CGH-DB; 9144-4
DR   Cosmic; 2081428
DR   Cosmic; 2081440
DR   Cosmic; 2367289
DR   DepMap; ACH-001541
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM621589
DR   JCRB; JCRB1191
DR   JCRB; NIHS0489
DR   Lonza; 1429
DR   PharmacoDB; KMS28PE_771_2019
DR   Progenetix; CVCL_2995
DR   Wikidata; Q54900178
RX   CelloPub=CLPUB00604;
RX   PubMed=15215163;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*24:02,24:02; B*40:02,52:01; C*03:04,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Homozygous (DepMap=ACH-001541).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly105Arg (c.313G>C); ClinVar=VCV000406574; Zygosity=Homozygous (DepMap=ACH-001541).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0489; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DepMap=ACH-001541; JCRB=JCRB1191
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 14
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 12,15
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2994 ! KMS-28BM
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   KMS-33
AC   CVCL_8527
SY   KMS33; Kawasaki Medical School-33
DR   JCRB; JCRB1391
DR   JCRB; NIHS0491
DR   Wikidata; Q54900180
RX   PubMed=15491288;
CC   Population: Japanese.
CC   Characteristics: Produces IgG lambda (JCRB=JCRB1391).
CC   Characteristics: Requires a feeder layer of bone marrow stromal cells Both are irradiated with 20 Gy to maintain constant proliferation. After their release from the feeder layer, the cells dies within several days. The addition of IL6 immediately after the release enables the cells to survive a few weeks (PubMed=15491288).
CC   Discontinued: JCRB; NIHS0491; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1391
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 10
ST   D5S818: 10
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   KMS-34
AC   CVCL_2996
SY   KMS34; Kawasaki Medical School-34
DR   EFO; EFO_0006619
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472430
DR   BioSample; SAMN03472927
DR   BioSample; SAMN10987826
DR   cancercelllines; CVCL_2996
DR   Cell_Model_Passport; SIDM01473
DR   CGH-DB; 26-1
DR   CGH-DB; 9139-4
DR   Cosmic; 2081395
DR   Cosmic; 2367284
DR   Cosmic; 2391796
DR   DepMap; ACH-000541
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM143332
DR   GEO; GSM290301
DR   GEO; GSM887228
DR   GEO; GSM888302
DR   GEO; GSM1692596
DR   GEO; GSM1692597
DR   GEO; GSM1692598
DR   IARC_TP53; 28382
DR   JCRB; JCRB1195
DR   LiGeA; CCLE_142
DR   PharmacoDB; KMS34_772_2019
DR   Progenetix; CVCL_2996
DR   Wikidata; Q54900182
RX   CelloPub=CLPUB00604;
RX   PubMed=15215163;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: 100 hours (PubMed=25984343).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (DepMap=ACH-000541).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.47%; East Asian, North=71.46%; East Asian, South=28.03%; South Asian=0%; European, North=0.05%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): JCRB=JCRB1195; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10,13 (PubMed=25877200)
ST   D16S539: 10,13,14 (JCRB=JCRB1195)
ST   D18S51: 13,15
ST   D21S11: 32.2
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 14,16
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14 (JCRB=JCRB1195)
ST   vWA: 14,17 (PubMed=25877200)
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   KMS-34/Cfz
AC   CVCL_IQ85
DR   cancercelllines; CVCL_IQ85
DR   GEO; GSM1692590
DR   GEO; GSM1692591
DR   GEO; GSM1692592
DR   Wikidata; Q54900183
RX   PubMed=26109433;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Selected for resistance to: ChEBI; CHEBI_65347; Carfilzomib (Kyprolis; PX-171-007).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2996 ! KMS-34
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 14
//
ID   KMS-34-SCC1
AC   CVCL_A5SA
SY   KMS34-SCC1; SCC1
DR   cancercelllines; CVCL_A5SA
DR   Wikidata; Q107115591
RX   PubMed=29045832;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2996 ! KMS-34
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   KMS-34-SCC2
AC   CVCL_A5SB
SY   KMS34-SCC2; SCC2
DR   cancercelllines; CVCL_A5SB
DR   Wikidata; Q107115594
RX   PubMed=29045832;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2996 ! KMS-34
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   KMS-4
AC   CVCL_D657
SY   S55194; KMS4; Kawasaki Medical School-4
DR   ColonAtlas; KMS-4
DR   Cosmic; 735616
DR   Wikidata; Q54900184
RX   PubMed=3021699;
RX   PubMed=6654524;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Right supraclavicular lymph node; UBERON=UBERON_8480057.
DI   NCIt; C4910; Colon carcinoma
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   KMS-5
AC   CVCL_A446
SY   KMS5; Kawasaki Medical School-5
DR   CGH-DB; 20-1
DR   CGH-DB; 9132-4
DR   Cosmic; 850215
DR   Wikidata; Q54900185
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2519219;
RX   PubMed=2768132;
RX   PubMed=9290701;
RX   PubMed=9787181;
RX   PubMed=10936422;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Doubling time: 24 hours (PubMed=2519219).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   KMS-6
AC   CVCL_2997
SY   KMS6; Kawasaki Medical School-6
DR   BTO; BTO_0002041
DR   BioSample; SAMN03471628
DR   JCRB; JCRB0432
DR   Wikidata; Q54900186
RX   DOI=10.11418/jtca1981.12.4_313;
RX   PubMed=3140712;
RX   PubMed=3972471;
RX   PubMed=8790940;
RX   PubMed=9290701;
CC   Population: Japanese.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB0432
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 9
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   KMS-9
AC   CVCL_D6UT
SY   KMS9; Kawasaki Medical School-9
DR   ABM; T0132
RX   PubMed=15491288;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   KMST-6
AC   CVCL_2998
SY   KMST6; Kawasaki Medical School Transformed-6
DR   BTO; BTO_0002039
DR   CLO; CLO_0050468
DR   BioSample; SAMN03471629
DR   BioSample; SAMN03472044
DR   IARC_TP53; 5358
DR   JCRB; JCRB0433
DR   RCB; RCB1955
DR   TKG; TKG 0482
DR   Wikidata; Q54900187
RX   CelloPub=CLPUB00712;
RX   DOI=10.11418/jtca1981.12.4_313;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=1537630;
RX   PubMed=2423124;
RX   PubMed=3140712;
RX   PubMed=3972471;
RX   PubMed=8105370;
RX   PubMed=8148305;
RX   PubMed=8557247;
RX   PubMed=8790940;
RX   PubMed=9290701;
RX   PubMed=9359923;
RX   PubMed=19935656;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-172.html
CC   Population: Japanese.
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Doubling time: 38 +- 4.6 hours (Note=In 10% FBS), 54 +- 2.9 hours (Note=In 1% FBS) (PubMed=1537630); ~26 hours (Note=Lot 12242014) (JCRB=JCRB0433).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Pro (c.536A>C); ClinVar=VCV000376611; Zygosity=Heterozygous (PubMed=8790940).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB0433; RCB=RCB1955; TKG=TKG 0482
ST   Amelogenin: X
ST   CSF1PO: 9,12 (JCRB=JCRB0433)
ST   CSF1PO: 12 (RCB=RCB1955; TKG=TKG 0482)
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 9
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2997 ! KMS-6
SX   Female
AG   9FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   KMST-6/p53
AC   CVCL_WH81
DR   Wikidata; Q94428564
RX   DOI=10.11418/jtca1981.12.4_313;
RX   PubMed=8148305;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Pro (c.536A>C); ClinVar=VCV000376611; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2998 ! KMST-6
SX   Female
AG   9FW
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 12
//
ID   KMST-6/RAS
AC   CVCL_M810
SY   KMST-6-Ras
DR   Wikidata; Q54900190
RX   DOI=10.11418/jtca1981.12.4_313;
RX   PubMed=3140712;
RX   PubMed=7520808;
RX   PubMed=7524638;
RX   PubMed=7540958;
RX   PubMed=8118610;
RX   PubMed=8148305;
RX   PubMed=8601579;
RX   PubMed=9290701;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Pro (c.536A>C); ClinVar=VCV000376611; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2998 ! KMST-6
SX   Female
AG   9FW
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 21
//
ID   KMST-6/T
AC   CVCL_2999
DR   BTO; BTO_0002040
DR   JCRB; JCRB0434
DR   Wikidata; Q54900191
RX   PubMed=1537630;
RX   PubMed=8601579;
RX   PubMed=9290701;
CC   Population: Japanese.
CC   Characteristics: Tumorigenic. Established from 2nd-passage tumors obtained in nude mice by transplanting one of the primary tumors produced by subcutaneous inoculation of KMST-6 cells into nude mice.
CC   Doubling time: 37 +- 4.6 hours (Note=In 10% FBS), 47 +- 2.9 hours (Note=In 1% FBS) (PubMed=1537630).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Pro (c.536A>C); ClinVar=VCV000376611; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Discontinued: JCRB; JCRB0434; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2998 ! KMST-6
SX   Female
AG   9FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   KMST-6/TNF
AC   CVCL_A447
SY   KMST-6-TNF; KMST-6 TNF
DR   DSMZ; ACC-824
DR   DSMZCellDive; ACC-824
DR   Wikidata; Q54900192
RX   PubMed=9661049;
CC   Population: Japanese.
CC   Doubling time: ~50 hours (DSMZ=ACC-824).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Pro (c.536A>C); ClinVar=VCV000376611; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11892; TNF.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): DSMZ=ACC-824
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 23,25
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 12,15
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2998 ! KMST-6
SX   Female
AG   9FW
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   KMT-17 clone A3
AC   CVCL_0U14
SY   KMT-17 clone A-3; KMT-17 cl A-3
DR   Wikidata; Q54900193
RX   PubMed=3632916;
RX   PubMed=3815375;
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
DI   NCIt; C60403; Rat fibrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   KMT-2
AC   CVCL_5301
DR   BioSample; SAMN03151819
DR   cancercelllines; CVCL_5301
DR   RCB; RCB0712
DR   Wikidata; Q54900194
RX   PubMed=2198959;
RX   PubMed=9195772;
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KMT-2
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a KG-1 derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from umbilical cord blood cells.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00229.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3688; FGFR1 + HGNC; HGNC:23098; FGFR1OP2; Name(s)=FGFR1OP2-FGFR1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Discontinued: RCB; RCB0712; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3249; Acute myeloid leukemia without maturation
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0374 ! KG-1
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   KMU-CS12
AC   CVCL_W482
SY   CS12
DR   ABM; T0661
DR   Wikidata; Q54900195
RX   PubMed=19424076;
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W483 ! KMU-CSN
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 7
//
ID   KMU-CSN
AC   CVCL_W483
SY   CSN; GI2CS-
DR   Wikidata; Q54900196
RX   PubMed=19424076;
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W484 ! KMU-GI2
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 7
//
ID   KMU-GI2
AC   CVCL_W484
DR   Wikidata; Q54900197
RX   PubMed=17645461;
CC   Doubling time: 72.6 hours (PubMed=17645461).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Somatic stem cell
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 7
//
ID   KMU-R
AC   CVCL_0I72
DR   CCLV; CCLV-RIE 0098
DR   Wikidata; Q54900198
RX   PubMed=25565633;
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   KMU100
AC   CVCL_W481
SY   KMU-100
DR   Wikidata; Q54900199
RX   PubMed=8025023;
CC   Population: Japanese.
CC   Doubling time: 15 hours (Note=At 490th passage) (PubMed=8025023).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   KMUe001-A
AC   CVCL_C747
SY   hES-T1; T1
DR   hPSCreg; KMUe001-A
DR   SKIP; SKIP002078
DR   Wikidata; Q54900200
RX   PubMed=16978057;
CC   From: Kaohsiung Medical University; Kaohsiung; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   KMUe002-A
AC   CVCL_C748
SY   hES-T2; T2
DR   hPSCreg; KMUe002-A
DR   SKIP; SKIP002079
DR   Wikidata; Q54900201
RX   PubMed=16978057;
CC   From: Kaohsiung Medical University; Kaohsiung; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   KMUe003-A
AC   CVCL_C749
SY   hES-T3; T3
DR   hPSCreg; KMUe003-A
DR   SKIP; SKIP002080
DR   Wikidata; Q54900202
RX   PubMed=16978057;
CC   From: Kaohsiung Medical University; Kaohsiung; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   KMUe004-A
AC   CVCL_C750
SY   hES-T4; T4
DR   hPSCreg; KMUe004-A
DR   SKIP; SKIP002081
DR   Wikidata; Q54900203
RX   PubMed=16978057;
CC   From: Kaohsiung Medical University; Kaohsiung; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   KMUe005-A
AC   CVCL_C751
SY   hES-T5; T5
DR   hPSCreg; KMUe005-A
DR   SKIP; SKIP002082
DR   Wikidata; Q54900204
RX   PubMed=16978057;
CC   From: Kaohsiung Medical University; Kaohsiung; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   KMUGMCi001-A
AC   CVCL_B0W8
SY   KMUGMCi001ACVRL1
DR   BioSamples; SAMEA10129972
DR   hPSCreg; KMUGMCi001-A
DR   Wikidata; Q108820629
RX   PubMed=35279593;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple; p.Phe259Lysfs*28 (c.772+3_772+4dup); Zygosity=Heterozygous (PubMed=35279593).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   KMUGMCi002-A
AC   CVCL_C1LL
SY   KMUGMCi002NIPBL
DR   BioSamples; SAMEA11294984
DR   hPSCreg; KMUGMCi002-A
DR   Wikidata; Q114311823
RX   PubMed=35834947;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:28862; NIPBL; Simple; p.Lys2121del (c.6362_6364delAAA); ClinVar=VCV000159190; Zygosity=Heterozygous (PubMed=35834947).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KMUGMCi003-A
AC   CVCL_C1LM
SY   KMUGMCi003ERCC2; KN610
DR   BioSamples; SAMEA110211493
DR   hPSCreg; KMUGMCi003-A
DR   Wikidata; Q114311824
RX   PubMed=35944311;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg26Pro (c.77G>C); Zygosity=Heterozygous (PubMed=35944311).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly47Arg (c.139G>A); ClinVar=VCV001176084; Zygosity=Heterozygous (PubMed=35944311).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KMUGMCi004-A
AC   CVCL_C1LN
SY   KMUGMCi004APC; KN615
DR   BioSamples; SAMEA110131367
DR   hPSCreg; KMUGMCi004-A
DR   Wikidata; Q114311825
RX   PubMed=35868288;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gly611Valfs*19 (c.1832delG); Zygosity=Heterozygous (PubMed=35868288).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KMUGMCi005-A
AC   CVCL_C3QT
SY   KMUGMCi005TMC8; KN627
DR   BioSamples; SAMEA111327963
DR   hPSCreg; KMUGMCi005-A
DR   Wikidata; Q116049622
RX   PubMed=36170758;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:20474; TMC8; Simple; p.Gln51Profs*42 (c.298+1G>A); dbSNP=rs1381151589; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=36170758).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126877; Epidermodysplasia verruciformis
DI   ORDO; Orphanet_302; Epidermodysplasia verruciformis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   KMUGMCi006-A
AC   CVCL_D0H7
SY   TS271 #12 WT
DR   BioSamples; SAMEA112750647
DR   hPSCreg; KMUGMCi006-A
DR   Wikidata; Q123032819
RX   PubMed=37271041;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Characteristics: Established from a patient that is mosaic for a TSC2 p.Glu498Ter mutation, but this cell line does not contain this mutation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H8 ! KMUGMCi006-B
OI   CVCL_D0H9 ! KMUGMCi006-C
OI   CVCL_D0HA ! KMUGMCi006-D
OI   CVCL_D0HB ! KMUGMCi006-E
OI   CVCL_D0HC ! KMUGMCi006-F
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   KMUGMCi006-B
AC   CVCL_D0H8
SY   TS271 #5 MT
DR   BioSamples; SAMEA112774597
DR   hPSCreg; KMUGMCi006-B
DR   Wikidata; Q123032822
RX   PubMed=37271041;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Glu498Ter (c.1492G>T); ClinVar=VCV000049637; Zygosity=Mosaic (PubMed=37271041).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H7 ! KMUGMCi006-A
OI   CVCL_D0H9 ! KMUGMCi006-C
OI   CVCL_D0HA ! KMUGMCi006-D
OI   CVCL_D0HB ! KMUGMCi006-E
OI   CVCL_D0HC ! KMUGMCi006-F
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KMUGMCi006-C
AC   CVCL_D0H9
SY   TS271 #21 WT
DR   BioSamples; SAMEA112774598
DR   hPSCreg; KMUGMCi006-C
DR   Wikidata; Q123032824
RX   PubMed=37271041;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Characteristics: Established from a patient that is mosaic for a TSC2 p.Glu498Ter mutation, but this cell line does not contain this mutation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H7 ! KMUGMCi006-A
OI   CVCL_D0H8 ! KMUGMCi006-B
OI   CVCL_D0HA ! KMUGMCi006-D
OI   CVCL_D0HB ! KMUGMCi006-E
OI   CVCL_D0HC ! KMUGMCi006-F
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   KMUGMCi006-D
AC   CVCL_D0HA
SY   TS271 #23 WT
DR   BioSamples; SAMEA112774601
DR   hPSCreg; KMUGMCi006-D
DR   Wikidata; Q123032826
RX   PubMed=37271041;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Characteristics: Established from a patient that is mosaic for a TSC2 p.Glu498Ter mutation, but this cell line does not contain this mutation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H7 ! KMUGMCi006-A
OI   CVCL_D0H8 ! KMUGMCi006-B
OI   CVCL_D0H9 ! KMUGMCi006-C
OI   CVCL_D0HB ! KMUGMCi006-E
OI   CVCL_D0HC ! KMUGMCi006-F
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   KMUGMCi006-E
AC   CVCL_D0HB
SY   TS271 #4 MT
DR   BioSamples; SAMEA112774602
DR   hPSCreg; KMUGMCi006-E
DR   Wikidata; Q123032827
RX   PubMed=37271041;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Glu498Ter (c.1492G>T); ClinVar=VCV000049637; Zygosity=Mosaic (PubMed=37271041).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H7 ! KMUGMCi006-A
OI   CVCL_D0H8 ! KMUGMCi006-B
OI   CVCL_D0H9 ! KMUGMCi006-C
OI   CVCL_D0HA ! KMUGMCi006-D
OI   CVCL_D0HC ! KMUGMCi006-F
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KMUGMCi006-F
AC   CVCL_D0HC
SY   TS271 #20 MT
DR   BioSamples; SAMEA112774628
DR   hPSCreg; KMUGMCi006-F
DR   Wikidata; Q123032829
RX   PubMed=37271041;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Glu498Ter (c.1492G>T); ClinVar=VCV000049637; Zygosity=Mosaic (PubMed=37271041).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0H7 ! KMUGMCi006-A
OI   CVCL_D0H8 ! KMUGMCi006-B
OI   CVCL_D0H9 ! KMUGMCi006-C
OI   CVCL_D0HA ! KMUGMCi006-D
OI   CVCL_D0HB ! KMUGMCi006-E
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KMUGMCi007-A
AC   CVCL_D0H6
SY   KMUGMCi007PEPD; KN649
DR   BioSamples; SAMEA112292913
DR   hPSCreg; KMUGMCi007-A
DR   Wikidata; Q123032831
RX   PubMed=37023562;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Simple; p.Phe71del (c.207CTT[1]) (c.210_212delCTT); ClinVar=VCV001430020; Zygosity=Homozygous (PubMed=37023562).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KMUGMCi008-A
AC   CVCL_D6PT
SY   KN695
DR   BioSamples; SAMEA115043950
DR   hPSCreg; KMUGMCi008-A
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:17582; KAT6B; Simple; p.Gln1737Hisfs*41 (c.5201_5210dupTGCTGCAGCA); ClinVar=VCV000039002; Zygosity=Heterozygous; Note=De novo mutation (hPSCreg=KMUGMCi008-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206524; Ohdo syndrome, SBBYS variant
DI   ORDO; Orphanet_3047; Blepharophimosis-intellectual disability syndrome, SBBYS type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   KMUGMCi009-A
AC   CVCL_D6PS
SY   KN686
DR   BioSamples; SAMEA115108456
DR   hPSCreg; KMUGMCi009-A
RX   PubMed=38492468;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11957; MED12; Simple; p.Arg296Gln (c.887G>A); ClinVar=VCV000522111; Zygosity=Hemizygous (PubMed=38492468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206528; X-linked Ohdo syndrome
DI   ORDO; Orphanet_293707; Blepharophimosis-intellectual disability syndrome, MKB type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   KMUGMCi010-A
AC   CVCL_D6PR
SY   KN687B
DR   BioSamples; SAMEA115094052
DR   hPSCreg; KMUGMCi010-A
RX   PubMed=38492468;
CC   From: Kanazawa Medical University; Uchinada; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11957; MED12; Simple; p.Arg296Gln (c.887G>A); ClinVar=VCV000522111; Zygosity=Hemizygous (PubMed=38492468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206528; X-linked Ohdo syndrome
DI   ORDO; Orphanet_293707; Blepharophimosis-intellectual disability syndrome, MKB type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   KMX-1
AC   CVCL_F0IY
DR   ECACC; 19072503
RX   PubMed=4018260;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P07436; Physarum polycephalum tubulin beta-1 chain (Note=Also reacts with many beta-tubulins from many other species including human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KMY-1
AC   CVCL_5302
DR   CLO; CLO_0050830
DR   RCB; RCB1754
DR   Wikidata; Q54900205
RX   PubMed=9144584;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C124250; Rat malignant meningioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5305 ! KMY-J
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   KMY-2
AC   CVCL_5303
DR   CLO; CLO_0050832
DR   RCB; RCB1755
DR   Wikidata; Q54900206
RX   PubMed=9144584;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C124250; Rat malignant meningioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5305 ! KMY-J
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   KMY-3
AC   CVCL_5304
DR   CLO; CLO_0050831
DR   RCB; RCB1756
DR   Wikidata; Q54900207
RX   PubMed=9144584;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C124250; Rat malignant meningioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5305 ! KMY-J
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   KMY-J
AC   CVCL_5305
DR   CLO; CLO_0050833
DR   RCB; RCB1753
DR   Wikidata; Q54900208
RX   PubMed=9144584;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C124250; Rat malignant meningioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   KMY0901
AC   CVCL_G258
DR   CCRID; 5301HUM-KCB09015ZJ
DR   KCB; KCB 200915ZJ
DR   Wikidata; Q54900209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0902
AC   CVCL_G259
DR   CCRID; 5301HUM-KCB09018ZJ
DR   KCB; KCB 200918ZJ
DR   Wikidata; Q54900210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0903
AC   CVCL_G260
DR   CCRID; 5301HUM-KCB09017ZJ
DR   KCB; KCB 200917ZJ
DR   Wikidata; Q54900211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0904
AC   CVCL_G261
DR   CCRID; 5301HUM-KCB09023ZJ
DR   KCB; KCB 200923ZJ
DR   Wikidata; Q54900212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0905
AC   CVCL_G262
DR   CCRID; 5301HUM-KCB09024ZJ
DR   KCB; KCB 200924ZJ
DR   Wikidata; Q54900213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0906
AC   CVCL_G263
DR   CCRID; 5301HUM-KCB09029ZJ
DR   KCB; KCB 200929ZJ
DR   Wikidata; Q54900214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0907
AC   CVCL_G264
DR   CCRID; 5301HUM-KCB09031ZJ
DR   KCB; KCB 200931ZJ
DR   Wikidata; Q54900215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0908
AC   CVCL_G265
DR   CCRID; 5301HUM-KCB09032ZJ
DR   KCB; KCB 200932ZJ
DR   Wikidata; Q54900218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0909
AC   CVCL_G266
DR   CCRID; 5301HUM-KCB09030ZJ
DR   KCB; KCB 200930ZJ
DR   Wikidata; Q54900219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0910
AC   CVCL_G267
DR   CCRID; 5301HUM-KCB09028ZJ
DR   KCB; KCB 200928ZJ
DR   Wikidata; Q54900220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0911
AC   CVCL_G268
DR   CCRID; 5301HUM-KCB09027ZJ
DR   KCB; KCB 200927ZJ
DR   Wikidata; Q54900221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0919
AC   CVCL_G269
DR   CCRID; 5301HUM-KCB09034ZJ
DR   KCB; KCB 200934ZJ
DR   Wikidata; Q54900222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY0920
AC   CVCL_G270
DR   CCRID; 5301HUM-KCB09033ZJ
DR   KCB; KCB 200933ZJ
DR   Wikidata; Q54900223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0922
AC   CVCL_G271
DR   CCRID; 5301HUM-KCB09038ZJ
DR   KCB; KCB 200938ZJ
DR   Wikidata; Q54900224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0923
AC   CVCL_G272
DR   CCRID; 5301HUM-KCB09045ZJ
DR   KCB; KCB 200945ZJ
DR   Wikidata; Q54900225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0926
AC   CVCL_G273
DR   CCRID; 5301HUM-KCB09046ZJ
DR   KCB; KCB 200946ZJ
DR   Wikidata; Q54900226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0927
AC   CVCL_G274
DR   CCRID; 5301HUM-KCB09037ZJ
DR   KCB; KCB 200937ZJ
DR   Wikidata; Q54900227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY0928
AC   CVCL_G275
DR   CCRID; 5301HUM-KCB09039ZJ
DR   KCB; KCB 200939ZJ
DR   Wikidata; Q54900228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY1002
AC   CVCL_G276
DR   CCRID; 5301HUM-KCB10010ZJ
DR   KCB; KCB 2010010ZJ
DR   Wikidata; Q54900229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMY1008
AC   CVCL_G277
DR   CCRID; 5301HUM-KCB10016ZJ
DR   KCB; KCB 2010016ZJ
DR   Wikidata; Q54900230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY1022
AC   CVCL_G278
DR   CCRID; 5301HUM-KCB10062ZJ
DR   KCB; KCB 2010062ZJ
DR   Wikidata; Q54900231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMY1036
AC   CVCL_G279
DR   CCRID; 5301HUM-KCB10157ZJ
DR   KCB; KCB 2010157ZJ
DR   Wikidata; Q54900233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80076; Azoospermia
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   KMYB
AC   CVCL_G280
DR   CCRID; 5301HUM-KCB09004ZJ
DR   KCB; KCB 200904ZJ
DR   Wikidata; Q54900234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMYF
AC   CVCL_G281
DR   CCRID; 5301HUM-KCB09003ZJ
DR   KCB; KCB 200903ZJ
DR   Wikidata; Q54900235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KMYM
AC   CVCL_G282
DR   CCRID; 5301HUM-KCB09005ZJ
DR   KCB; KCB 200905ZJ
DR   Wikidata; Q54900236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KN
AC   CVCL_IU95
DR   Cosmic; 2546844
DR   Wikidata; Q54900237
RX   PubMed=17325662;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   KN-41
AC   CVCL_W215
SY   KN41
DR   Wikidata; Q54900238
RX   PubMed=4087630;
RX   PubMed=6620776;
RX   PubMed=7154478;
RX   PubMed=10929426;
CC   Population: Japanese.
CC   Doubling time: 20.9 hours (PubMed=7154478).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   KN-OH1
AC   CVCL_S865
SY   KN-OH-1
DR   Wikidata; Q54900239
RX   PubMed=9393981;
RX   PubMed=12904596;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   KN-R
AC   CVCL_RX41
DR   CCLV; CCLV-RIE 0028
DR   Wikidata; Q54900240
RX   PubMed=24457147;
CC   Senescence: Senesces at 60-80 PDL (CCLV=CCLV-RIE 0028).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   7FM
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   KN0025
AC   CVCL_8X96
DR   ECACC; 98112404
DR   Wikidata; Q54900241
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98112404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82341; Spinocerebellar ataxia
DI   ORDO; Orphanet_183518; Rare hereditary ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   KN0117
AC   CVCL_8X97
DR   ECACC; 99081012
DR   Wikidata; Q54900242
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99081012; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KN0118
AC   CVCL_8X98
DR   ECACC; 99081013
DR   Wikidata; Q54900243
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99081013; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KN0120
AC   CVCL_8X99
DR   ECACC; 99081015
DR   Wikidata; Q54900244
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99081015; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KN7
AC   CVCL_A7DM
DR   RCB; RCB4670
DR   Wikidata; Q107115598
RX   PubMed=15477229;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody TG40-BP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   KN73
AC   CVCL_D7DX
DR   EFO; EFO_0022512
RX   PubMed=12411104;
CC   Virology: Can ve persistently infected by Japanese encephalitis virus (PubMed=12411104).
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   KNA
AC   CVCL_8885
DR   CLO; CLO_0007116
DR   CLDB; cl3035
DR   ECACC; 96020765
DR   Wikidata; Q54900245
RX   PubMed=10640177;
RX   PubMed=15541571;
RX   PubMed=22538498;
CC   Population: Caucasian.
CC   Doubling time: 3.5 days (PubMed=10640177).
CC   Discontinued: ECACC; 96020765; true.
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
DI   NCIt; C3326; Adrenal gland pheochromocytoma
DI   ORDO; Orphanet_276621; Sporadic pheochromocytoma/secreting paraganglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   KNBCCS6
AC   CVCL_IU64
DR   Wikidata; Q54900246
RX   Patent=US20190242874;
RX   PubMed=18679421;
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Pro643Thrfs*11 (c.1925insC) (H652X); Zygosity=Heterozygous (PubMed=18679421).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   KNBCCS6 E6/E7
AC   CVCL_IU65
DR   Wikidata; Q54900247
RX   Patent=US20190242874;
CC   Group: Patented cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Pro643Thrfs*11 (c.1925insC) (H652X); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IU64 ! KNBCCS6
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   KNE
AC   CVCL_E728
DR   dbMHC; 48926
DR   ECACC; 94022536
DR   IHW; IHW09214
DR   IPD-IMGT/HLA; 10923
DR   Wikidata; Q54900248
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*02:07,01:01; C*07,12:02; DPB1*03:01 (IPD-IMGT/HLA=10923).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   KNIHi001-A
AC   CVCL_D0HD
SY   PD01_PBSeiPS
DR   BioSamples; SAMEA112251188
DR   hPSCreg; KNIHi001-A
DR   Wikidata; Q123032833
RX   PubMed=38447455;
CC   From: Korea National Institute of Health; Cheongju-si; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   KNIHi002-A
AC   CVCL_D6NX
DR   BioSamples; SAMEA115082581
DR   hPSCreg; KNIHi002-A
CC   From: Korea National Institute of Health; Cheongju-si; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   KNN-R
AC   CVCL_A3AH
DR   CCLV; CCLV-RIE 0096
DR   Wikidata; Q105509794
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal adrenal gland; UBERON=UBERON_0002369.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   KNRK
AC   CVCL_3731
SY   NRK 1569
DR   CLO; CLO_0007117
DR   CLDB; cl3036
DR   ATCC; CRL-1569
DR   ECACC; 87061001
DR   Wikidata; Q54900249
RX   PubMed=4333712;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-170.html
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   KNS-42
AC   CVCL_0378
SY   KNS42
DR   BTO; BTO_0005859
DR   CLO; CLO_0009894
DR   MCCL; MCC:0000273
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0295
DR   BioGRID_ORCS_Cell_line; 617
DR   BioSample; SAMN03472787
DR   BioSample; SAMN10987931
DR   cancercelllines; CVCL_0378
DR   Cell_Model_Passport; SIDM00607
DR   CGH-DB; 144-1
DR   ChEMBL-Cells; CHEMBL3308538
DR   ChEMBL-Targets; CHEMBL2366261
DR   Cosmic; 687573
DR   Cosmic; 907282
DR   Cosmic; 2367532
DR   Cosmic-CLP; 907282
DR   DepMap; ACH-000622
DR   EGA; EGAS00001000978
DR   GDSC; 907282
DR   GEO; GSM887229
DR   GEO; GSM888303
DR   GEO; GSM1669995
DR   GEO; GSM2197880
DR   GEO; GSM2197881
DR   GEO; GSM2197882
DR   GEO; GSM2197883
DR   GEO; GSM2197884
DR   GEO; GSM2197885
DR   GEO; GSM4969600
DR   GEO; GSM4969601
DR   GEO; GSM4969617
DR   GEO; GSM4969634
DR   GEO; GSM4969635
DR   GEO; GSM4969636
DR   GEO; GSM5356021
DR   IARC_TP53; 21436
DR   JCRB; IFO50356
DR   LiGeA; CCLE_847
DR   LINCS_LDP; LCL-1382
DR   PharmacoDB; KNS42_773_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0378
DR   PubChem_Cell_line; CVCL_0378
DR   Wikidata; Q54900250
RX   CelloPub=CLPUB00152;
RX   PubMed=2448680;
RX   PubMed=16232199;
RX   PubMed=19365568;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25401693;
RX   PubMed=25628092;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34078608;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 48 hours (CelloPub=CLPUB00152; PubMed=19365568).
CC   HLA typing: A*24:02,26:01; B*07:02,54:01; C*01:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser186_Lys187delinsTer (c.557_559delCAA) (S186*); ClinVar=VCV000005455; Zygosity=Heterozygous (Cosmic-CLP=907282; DepMap=ACH-000622).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Val (c.104G>T) (G34V); Zygosity=Heterozygous (DepMap=ACH-000622).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (Cosmic-CLP=907282; DepMap=ACH-000622).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.32%; East Asian, North=85.4%; East Asian, South=14.06%; South Asian=0%; European, North=0%; European, South=0.22% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right fronto-parietal lobe.
ST   Source(s): Cosmic-CLP=907282; JCRB=IFO50356; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,14
ST   D12S391: 19
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 14
ST   D1S1656: 13
ST   D21S11: 30,32
ST   D22S1045: 11
ST   D2S1338: 17,20
ST   D2S441: 10
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 11
ST   FGA: 21.2,24
ST   Penta D: 9,11
ST   Penta E: 12,20
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   KNS-60
AC   CVCL_2798
SY   KNS 60; KNS60
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 723
DR   BioSample; SAMN03470967
DR   BioSample; SAMN03472788
DR   BioSample; SAMN10987822
DR   cancercelllines; CVCL_2798
DR   Cell_Model_Passport; SIDM01494
DR   CGH-DB; 145-1
DR   Cosmic; 687574
DR   Cosmic; 2367533
DR   Cosmic; 2516021
DR   DepMap; ACH-000445
DR   GEO; GSM887230
DR   GEO; GSM888304
DR   IARC_TP53; 28348
DR   JCRB; IFO50357
DR   LiGeA; CCLE_924
DR   PharmacoDB; KNS60_774_2019
DR   Progenetix; CVCL_2798
DR   Wikidata; Q54900251
RX   CelloPub=CLPUB00152;
RX   PubMed=16232199;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 42 hours (CelloPub=CLPUB00152); 38 hours (PubMed=25984343).
CC   HLA typing: A*24:02,24:02; B*52:01,54:01; C*01:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Homozygous (DepMap=ACH-000445).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=80.41%; East Asian, South=18.86%; South Asian=0%; European, North=0%; European, South=0.73% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=IFO50357; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 25
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 9 (PubMed=25877200)
ST   D7S820: 9,12 (JCRB=IFO50357)
ST   D8S1179: 14
ST   FGA: 18
ST   Penta D: 9,10
ST   Penta E: 8
ST   TH01: 7 (PubMed=25877200)
ST   TH01: 7,8 (JCRB=IFO50357)
ST   TPOX: 9
ST   vWA: 15,19
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   KNS-62
AC   CVCL_1335
SY   KNS62
DR   EFO; EFO_0006620
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 616
DR   BioSample; SAMN03472612
DR   BioSample; SAMN10987892
DR   cancercelllines; CVCL_1335
DR   Cell_Model_Passport; SIDM00606
DR   ChEMBL-Cells; CHEMBL3308237
DR   ChEMBL-Targets; CHEMBL2366244
DR   Cosmic; 753569
DR   Cosmic; 1995472
DR   Cosmic; 2060532
DR   Cosmic-CLP; 753569
DR   DepMap; ACH-000858
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10760-110E4
DR   GDSC; 753569
DR   GEO; GSM274672
DR   GEO; GSM887231
DR   GEO; GSM888305
DR   GEO; GSM1669996
DR   IARC_TP53; 21437
DR   JCRB; IFO50358
DR   LiGeA; CCLE_427
DR   PharmacoDB; KNS62_775_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1335
DR   PubChem_Cell_line; CVCL_1335
DR   Wikidata; Q54900252
RX   PubMed=2203882;
RX   PubMed=3518877;
RX   PubMed=6205259;
RX   PubMed=7358770;
RX   PubMed=15746151;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*26:01,26:01; B*15:01,46:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.457+1G>A; ClinVar=VCV000635368; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=753569; DepMap=ACH-000858).
CC   Sequence variation: Mutation; HGNC; HGNC:2974; DNM2; Simple; p.Pro792del (c.2370_2372delGCC); Zygosity=Heterozygous (Cosmic-CLP=753569; DepMap=ACH-000858).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Heterozygous (Cosmic-CLP=753569; DepMap=ACH-000858).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Leu69Pro (c.206T>C); Zygosity=Heterozygous (Cosmic-CLP=753569; DepMap=ACH-000858).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (Cosmic-CLP=753569; DepMap=ACH-000858).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.64%; Native American=0%; East Asian, North=85.09%; East Asian, South=7%; South Asian=0%; European, North=0%; European, South=5.26% (PubMed=30894373).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=753569; JCRB=IFO50358; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 32
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 10,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   KNS-81
AC   CVCL_2799
SY   KNS81
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 724
DR   BioSample; SAMN03470965
DR   BioSample; SAMN10987823
DR   cancercelllines; CVCL_2799
DR   Cell_Model_Passport; SIDM00605
DR   CGH-DB; 146-1
DR   Cosmic; 687575
DR   Cosmic; 2516022
DR   DepMap; ACH-000479
DR   GEO; GSM887232
DR   GEO; GSM888306
DR   IARC_TP53; 30106
DR   JCRB; IFO50359
DR   LiGeA; CCLE_734
DR   PharmacoDB; KNS81_777_2019
DR   Progenetix; CVCL_2799
DR   TOKU-E; 4091
DR   Wikidata; Q54900253
RX   CelloPub=CLPUB00152;
RX   PubMed=16232199;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 54 hours (CelloPub=CLPUB00152); 110 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (DepMap=ACH-000479).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.61%; Native American=1.05%; East Asian, North=78.9%; East Asian, South=17.38%; South Asian=0%; European, North=0%; European, South=2.06% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=IFO50359; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 9
ST   D16S539: 10,12
ST   D18S51: 13,19
ST   D19S433: 13.2,14
ST   D21S11: 29,30
ST   D2S1338: 22,23
ST   D3S1358: 14,16
ST   D5S818: 9,12
ST   D7S820: 11
ST   D8S1179: 11,17
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 11,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   KNS-81-FD
AC   CVCL_1336
SY   KNS-81FD; KNS81FD
DR   CLO; CLO_0009895
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSamples; SAMEA1284015
DR   cancercelllines; CVCL_1336
DR   Cell_Model_Passport; SIDM01210
DR   ChEMBL-Cells; CHEMBL3308306
DR   ChEMBL-Targets; CHEMBL2366203
DR   Cosmic; 924188
DR   Cosmic; 2367534
DR   Cosmic-CLP; 924188
DR   DepMap; ACH-002259
DR   EGA; EGAS00001000978
DR   GDSC; 924188
DR   GEO; GSM1669997
DR   IARC_TP53; 27561
DR   JCRB; IFO50444
DR   LINCS_LDP; LCL-1383
DR   PharmacoDB; KNS81FD_776_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1336
DR   Wikidata; Q54900254
RX   PubMed=20164919;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Group: Serum/protein free medium cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=924188).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.58%; East Asian, North=77.83%; East Asian, South=20.58%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=924188; JCRB=IFO50444; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 9
ST   D16S539: 10,12
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2799 ! KNS-81
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   KNS-89
AC   CVCL_2800
SY   KN-S89; KNS89
DR   BioSample; SAMN03151976
DR   cancercelllines; CVCL_2800
DR   CGH-DB; 147-1
DR   Cosmic; 687576
DR   IARC_TP53; 21438
DR   JCRB; IFO50360
DR   Wikidata; Q54900255
RX   CelloPub=CLPUB00152;
RX   PubMed=16232199;
RX   PubMed=20143388;
RX   PubMed=22570425;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a U-251MG derivative (PubMed=20143388; PubMed=22570425). Originally thought to originate from a 66 year old male patient with a gliosarcoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00323.
CC   Population: Caucasian.
CC   Doubling time: 42 hours (CelloPub=CLPUB00152).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: JCRB; IFO50360; true.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): JCRB=IFO50360
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   KNS-R
AC   CVCL_0I60
SY   KNS
DR   CCLV; CCLV-RIE 0050
DR   Wikidata; Q54900256
RX   PubMed=19941903;
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   KNU-101
AC   CVCL_C9C0
SY   KNU 101
DR   Wikidata; Q123032835
RX   PubMed=29331373;
CC   Population: Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Donor information: Established from a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Scalp, skin, dermis; UBERON=UBERON_8300000+UBERON_0002067.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9C1 ! KNU-102
OI   CVCL_C9C2 ! KNU-103
OI   CVCL_C9C3 ! KNU-201
OI   CVCL_C9C4 ! KNU-202
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   KNU-102
AC   CVCL_C9C1
SY   KNU 102
DR   Wikidata; Q123032836
RX   PubMed=29331373;
CC   Population: Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Donor information: Established from a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Scalp, skin, dermis; UBERON=UBERON_8300000+UBERON_0002067.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9C0 ! KNU-101
OI   CVCL_C9C2 ! KNU-103
OI   CVCL_C9C3 ! KNU-201
OI   CVCL_C9C4 ! KNU-202
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   KNU-103
AC   CVCL_C9C2
SY   KNU 103
DR   Wikidata; Q123032838
RX   PubMed=29331373;
CC   Population: Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Donor information: Established from a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Scalp, skin, dermis; UBERON=UBERON_8300000+UBERON_0002067.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9C0 ! KNU-101
OI   CVCL_C9C1 ! KNU-102
OI   CVCL_C9C3 ! KNU-201
OI   CVCL_C9C4 ! KNU-202
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   KNU-201
AC   CVCL_C9C3
SY   KNU 201; KNU201
DR   ABM; T0736
DR   Wikidata; Q123032840
RX   PubMed=29331373;
CC   Population: Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Donor information: Established from a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Scalp, skin, dermis; UBERON=UBERON_8300000+UBERON_0002067.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9C0 ! KNU-101
OI   CVCL_C9C1 ! KNU-102
OI   CVCL_C9C2 ! KNU-103
OI   CVCL_C9C4 ! KNU-202
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   KNU-202
AC   CVCL_C9C4
SY   KNU 202
DR   Wikidata; Q123032842
RX   PubMed=29331373;
CC   Population: Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Donor information: Established from a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Scalp, skin, dermis; UBERON=UBERON_8300000+UBERON_0002067.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9C0 ! KNU-101
OI   CVCL_C9C1 ! KNU-102
OI   CVCL_C9C2 ! KNU-103
OI   CVCL_C9C3 ! KNU-201
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   KO-001-19
AC   CVCL_W538
DR   SKIP; SKIP000289
DR   Wikidata; Q54900257
RX   PubMed=24389010;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W539 ! KO-001-25
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   KO-001-25
AC   CVCL_W539
DR   SKIP; SKIP000277
DR   Wikidata; Q54900258
RX   PubMed=24389010;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W538 ! KO-001-19
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   KO-1
AC   CVCL_J425
DR   Wikidata; Q54900259
RX   PubMed=15541796;
CC   Doubling time: 50 hours (PubMed=15541796).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: Domestic shorthair.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   KO-6
AC   CVCL_R824
SY   Kokanee Ovary-6
DR   Wikidata; Q54900260
RX   CelloPub=CLPUB00103;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=6542066;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=8023; ! Oncorhynchus nerka (Sockeye salmon)
SX   Female
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   KO-RCC-1
AC   CVCL_WI01
SY   KObe-Renal Cell Carcinoma-1
DR   Wikidata; Q95962148
RX   PubMed=3747314;
CC   Population: Japanese.
CC   Doubling time: ~38 hours (PubMed=3747314).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KO240
AC   CVCL_A2HK
DR   Wikidata; Q105509797
RX   PubMed=12644300;
RX   PubMed=23681781;
RX   PubMed=24239860;
CC   Doubling time: 15.8 hours (Note=Non-treated), 16.1 hours (Note=1,25D3 treated) (PubMed=12644300).
CC   Knockout cell: Method=KO mouse; MGI; MGI:103076; Vdr.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6J Vdrtm1Mbd.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   KO288
AC   CVCL_A2HL
DR   Wikidata; Q105509802
RX   PubMed=12644300;
CC   Doubling time: 23.1 hours (Note=Non-treated), 24.1 hours (Note=1,25D3 treated) (PubMed=12644300).
CC   Knockout cell: Method=KO mouse; MGI; MGI:103076; Vdr.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6J Vdrtm1Mbd.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   KO51
AC   CVCL_3000
AS   CVCL_8454
SY   K051; K-051
DR   BioSample; SAMN03151809
DR   Cosmic; 749072
DR   Cosmic; 787440
DR   Cosmic; 975257
DR   Cosmic; 1281320
DR   JCRB; JCRB0122
DR   JCRB; NIHS0163
DR   JCRB; NIHS0244
DR   Wikidata; Q54900261
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7693050;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of 46 year old male patient with acute myeloid leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00217.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0163; true.
CC   Discontinued: JCRB; NIHS0244; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB0122
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   KO52
AC   CVCL_1321
AS   CVCL_8455
SY   K052; K-052
DR   CLO; CLO_0037177
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470799
DR   BioSample; SAMN10987820
DR   cancercelllines; CVCL_1321
DR   Cell_Model_Passport; SIDM00018
DR   ChEMBL-Cells; CHEMBL3308169
DR   ChEMBL-Targets; CHEMBL2366354
DR   Cosmic; 749073
DR   Cosmic; 907284
DR   Cosmic; 2131543
DR   Cosmic; 2306214
DR   Cosmic-CLP; 1330932
DR   DepMap; ACH-000498
DR   EGA; EGAS00001000978
DR   GDSC; 907284
DR   GEO; GSM827240
DR   GEO; GSM887233
DR   GEO; GSM888307
DR   GEO; GSM1669969
DR   GEO; GSM1669998
DR   IARC_TP53; 21425
DR   IARC_TP53; 28223
DR   JCRB; JCRB0123
DR   JCRB; NIHS0164
DR   LINCS_LDP; LCL-1080
DR   PharmacoDB; K052_719_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1321
DR   PubChem_Cell_line; CVCL_1321
DR   Wikidata; Q54900262
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7693050;
RX   PubMed=10637496;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=7693050).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882His (c.2645G>A); ClinVar=VCV000375881; Zygosity=Heterozygous (Cosmic-CLP=1330932; DepMap=ACH-000498).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Heterozygous (PubMed=7693050; Cosmic-CLP=1330932; DepMap=ACH-000498).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=7693050; Cosmic-CLP=1330932; DepMap=ACH-000498).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.61%; Native American=0.74%; East Asian, North=70.18%; East Asian, South=27.99%; South Asian=0%; European, North=0%; European, South=0.49% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0164; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=1330932; JCRB=JCRB0123
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   KOA-1
AC   CVCL_L997
DR   Wikidata; Q54900263
RX   Patent=EP0679888A2;
RX   PubMed=12594358;
RX   PubMed=15316547;
RX   PubMed=16501317;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4631.
CC   Population: Japanese.
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   59Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 11
//
ID   KOA-1L3
AC   CVCL_L998
DR   Wikidata; Q54900264
RX   PubMed=15316547;
CC   Population: Japanese.
CC   Characteristics: Established after 3 passages of the parent cell line into nude mice.
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L997 ! KOA-1
SX   Sex unspecified
AG   59Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   KOB
AC   CVCL_VN49
DR   Cosmic; 2765562
DR   IARC_TP53; 26999
DR   Wikidata; Q95962168
RX   CelloPub=CLPUB00592;
RX   PubMed=10190897;
RX   PubMed=15638862;
RX   PubMed=19220422;
RX   PubMed=19710698;
RX   PubMed=27193821;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11920; FAS; Simple; p.Leu229Tyrfs (c.686_705delTGAGTAAATATATCACCACT); Zygosity=Heterozygous (PubMed=10190897).
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Arg48Trp (c.142C>T); Zygosity=Heterozygous (CelloPub=CLPUB00592).
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Met750Val (c.2248A>G); Zygosity=Heterozygous (CelloPub=CLPUB00592).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   Kobayashi
AC   CVCL_J354
DR   BTO; BTO_0002532
DR   Wikidata; Q54900265
RX   PubMed=3034807;
RX   PubMed=8847894;
RX   PubMed=9454894;
RX   PubMed=12967475;
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 22.5 hours (PubMed=8847894).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=9454894; PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   KOBK-101
AC   CVCL_W265
SY   KOBK101
DR   CGH-DB; 9200-4
DR   Wikidata; Q54900266
RX   DOI=10.2177/jsci.6.279;
RX   PubMed=1999287;
RX   PubMed=3082812;
RX   PubMed=10360377;
RX   PubMed=10995006;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 9
//
ID   KOBK-130
AC   CVCL_W266
SY   KOBK130
DR   Wikidata; Q54900267
RX   PubMed=10995006;
RX   PubMed=20519628;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 7
//
ID   KOBK-134
AC   CVCL_W270
DR   Wikidata; Q54900268
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 7
//
ID   KOBK-96
AC   CVCL_W269
DR   Wikidata; Q54900269
RX   DOI=10.2177/jsci.6.279;
RX   PubMed=10360377;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 7
//
ID   KOC-1S
AC   CVCL_L701
DR   Wikidata; Q54900270
RX   CelloPub=CLPUB00065;
RX   PubMed=8428685;
CC   Population: Japanese.
CC   Doubling time: 43.5 hours (Note=At 102th passage) (PubMed=8428685).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   KOC-2S
AC   CVCL_L702
DR   Cosmic; 2482710
DR   Wikidata; Q54900271
RX   CelloPub=CLPUB00066;
RX   PubMed=8428685;
CC   Population: Japanese.
CC   Doubling time: 29.0 hours (Note=At 34th passage) (PubMed=8428685).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   KOC-4C
AC   CVCL_L703
SY   KOC-4c
DR   Wikidata; Q54900272
RX   CelloPub=CLPUB00067;
CC   Population: Japanese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   KOC-5C
AC   CVCL_5306
SY   KOC-5c
DR   BTO; BTO_0004969
DR   Wikidata; Q54900276
RX   CelloPub=CLPUB00067;
RX   PubMed=15534119;
CC   Population: Japanese.
CC   Doubling time: 97.9 hours (CelloPub=CLPUB00067).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   KOC-7C
AC   CVCL_5307
SY   KOC-7c; KOC7C
DR   BTO; BTO_0004970
DR   BioSample; SAMN02800474
DR   Cosmic; 2074243
DR   Cosmic; 2482706
DR   GEO; GSM659380
DR   PRIDE; PXD000901
DR   Wikidata; Q54900277
RX   CelloPub=CLPUB00067;
RX   PubMed=9023415;
RX   PubMed=15534119;
RX   PubMed=26388441;
RX   PubMed=28196595;
RX   PubMed=30485824;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 45.9 hours (CelloPub=CLPUB00067).
CC   HLA typing: A*02:01,31:01; B*51,52 (PubMed=9023415).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D21S11: 31,32
ST   D5S818: 11
ST   D7S820: 8,11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   KOCL-33
AC   CVCL_3991
SY   KOCL33; KOCL 33; Kocl-33
DR   BTO; BTO_0004937
DR   Cosmic; 996295
DR   Cosmic; 1037745
DR   Cosmic; 2391170
DR   IARC_TP53; 28409
DR   Wikidata; Q54900278
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=14671638; PubMed=15843827).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   KOCL-44
AC   CVCL_3992
SY   KOCL44
DR   BTO; BTO_0004938
DR   Cosmic; 996296
DR   Cosmic; 1037746
DR   Cosmic; 2391171
DR   IARC_TP53; 28410
DR   Wikidata; Q54900279
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Gln527Ter (c.1579C>T) (p.Gln528Ter, c.1582C>T); Zygosity=Homozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   KOCL-45
AC   CVCL_3993
SY   KOCL45
DR   BTO; BTO_0004939
DR   cancercelllines; CVCL_3993
DR   Cosmic; 996297
DR   Cosmic; 1037747
DR   IARC_TP53; 28411
DR   Wikidata; Q54900280
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   KOCL-48
AC   CVCL_6867
SY   KOCL48
DR   Cosmic; 996320
DR   Cosmic; 1037673
DR   Wikidata; Q54900281
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=9738977;
RX   PubMed=14504097;
RX   PubMed=14671638;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   KOCL-50
AC   CVCL_6866
SY   KOCL50
DR   cancercelllines; CVCL_6866
DR   Cosmic; 1037748
DR   IARC_TP53; 28412
DR   Wikidata; Q54900282
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=14671638;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Asn209Alafs*4 (c.624_625insGCCTGCG); Zygosity=Homozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   KOCL-51
AC   CVCL_6865
SY   KOCL51
DR   Cosmic; 1037749
DR   Cosmic; 2391173
DR   IARC_TP53; 28413
DR   Wikidata; Q54900283
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=14671638;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=28569787).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   KOCL-58
AC   CVCL_3994
SY   KOCL58
DR   BTO; BTO_0004940
DR   Cosmic; 996298
DR   Cosmic; 1037750
DR   IARC_TP53; 28414
DR   Wikidata; Q54900284
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   KOCL-69
AC   CVCL_3995
SY   KOCL69
DR   BTO; BTO_0004941
DR   cancercelllines; CVCL_3995
DR   Cosmic; 996299
DR   Cosmic; 1037751
DR   IARC_TP53; 28415
DR   Wikidata; Q54900285
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8180386;
RX   PubMed=9529133;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   KOCL-77
AC   CVCL_D4A1
SY   KOCL77
DR   Wikidata; Q127382559
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Kodiak2016
AC   CVCL_B7DS
DR   Wikidata; Q112929955
RX   CelloPub=CLPUB00694;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Siberian Husky; VBO=VBO_0201233.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   KoG
AC   CVCL_W101
SY   Koi Gill
DR   Wikidata; Q54900286
RX   DOI=10.5897/AJMR2013.5723;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 12
//
ID   KOG-1
AC   CVCL_XY75
DR   Wikidata; Q95962283
RX   PubMed=31583526;
CC   Population: Japanese.
CC   Doubling time: 13.7 hours (PubMed=31583526).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   Koi-Fin
AC   CVCL_V645
DR   Wikidata; Q54900287
RX   Patent=CN102399743A;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201199.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 15
//
ID   KOIA-LCL
AC   CVCL_8726
SY   KOIA-9LCL
DR   CLO; CLO_0051019
DR   BioSample; SAMN03472080
DR   Cosmic; 889111
DR   RCB; RCB1874
DR   TKG; TKG 0506
DR   Wikidata; Q54900288
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Ser (c.725G>C); ClinVar=VCV000647334; Zygosity=Unspecified; Note=Germline (RCB=RCB1874).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1874; TKG=TKG 0506
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D5S818: 8,11
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   KoK
AC   CVCL_UW83
SY   Koi Kidney
DR   Wikidata; Q95962290
RX   PubMed=30537062;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 7
//
ID   KOL01C1TT
AC   CVCL_B7NE
SY   C1
DR   Wikidata; Q112929957
RX   PubMed=27916472;
RX   PubMed=34999422;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   KOL01SB1CC
AC   CVCL_B7NF
SY   SB1
DR   Wikidata; Q112929960
RX   PubMed=27916472;
RX   PubMed=34999422;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5293; HTR2A; Simple; p.Ser34Ser (c.102T>C) (T102C) (rs6313); ClinVar=VCV000515935; Zygosity=Homozygous (PubMed=27916472; PubMed=34999422).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C73511; Bruxism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   KOL02C2TT
AC   CVCL_B7NG
SY   C2
DR   Wikidata; Q112929962
RX   PubMed=27916472;
RX   PubMed=34999422;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   KOL02SB2CC
AC   CVCL_B7NH
SY   SB2
DR   Wikidata; Q112929963
RX   PubMed=27916472;
RX   PubMed=34999422;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5293; HTR2A; Simple; p.Ser34Ser (c.102T>C) (T102C) (rs6313); ClinVar=VCV000515935; Zygosity=Homozygous (PubMed=27916472; PubMed=34999422).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C73511; Bruxism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   KOLF2.1J
AC   CVCL_B5P3
SY   KOLF 2.1J; WTSIi018-B-12; JAXi019-A-12; JIPSC001000; JIPSC1000; MONPSYi001-A
DR   hPSCreg; MONPSYi001-A
DR   hPSCreg; WTSIi018-B-12
DR   Wikidata; Q117704576
RX   PubMed=36459969;
RX   PubMed=38518401;
WW   Provider; JAX; JIPSC001000; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001000
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36459969).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38518401
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,22
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D1S1656: 14,18.3
ST   D21S11: 31,32.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D6S1043: 12,20
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 12,15
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S58 ! HPSI0114i-kolf_2-C1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 7
//
ID   KOLF2.1J AAVS1-TREG3-NGN2
AC   CVCL_D1J6
DR   Wikidata; Q127382561
CC   Population: Caucasian; British.
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KOLF2.1J AAVS1-TREG3-NGN2 ATG12-/-
AC   CVCL_D1KS
SY   KOLF2.1 iPSCs AAVS1-NGN2 ATG12-/-
DR   Wikidata; Q127382562
CC   Population: Caucasian; British.
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:588; ATG12.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1J6 ! KOLF2.1J AAVS1-TREG3-NGN2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KOLF2.1J AAVS1-TREG3-NGN2 CHMP2B I29V/I29V
AC   CVCL_E3Y2
SY   KOLF2.1 iPSCs AAVS1-NGN2 CHMP2B I29V/I29V
CC   Population: Caucasian; British.
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Ile29Val (c.85A>G); ClinVar=VCV000021507; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1J6 ! KOLF2.1J AAVS1-TREG3-NGN2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KOLF2.1J AAVS1-TREG3-NGN2 CHMP2B Q165X/+
AC   CVCL_E3Y1
SY   KOLF2.1 iPSCs AAVS1-NGN2 CHMP2B Q165X/+
CC   Population: Caucasian; British.
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Gln165Ter (c.493C>T); ClinVar=VCV000001655; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1J6 ! KOLF2.1J AAVS1-TREG3-NGN2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KOLF2.1J AAVS1-TREG3-NGN2 CHMP2B-/-
AC   CVCL_E3Y0
SY   KOLF2.1 iPSCs AAVS1-NGN2 CHMP2B-/-
CC   Population: Caucasian; British.
CC   Characteristics: Using CRISPR/Cas9 a TRE3G promoter driven NEUROG2 construct was introduced in the AAVS1 safe harbor locus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Miscellaneous: Cell line information from personal communication of Harper, Jeffrey Wade.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1J6 ! KOLF2.1J AAVS1-TREG3-NGN2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KOLF2.1J ABCA7 24.2kbdel DEL/DEL
AC   CVCL_E4NI
SY   JIPSC001662
WW   Provider; JAX; JIPSC001662; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001662
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37; ABCA7.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ABCA7 E1679X REV/WT
AC   CVCL_E4NJ
SY   JIPSC002014
WW   Provider; JAX; JIPSC002014; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002014
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ABCA7 p.Glu1679Ter (c.5035G>T) cell line (JAX=JIPSC002014).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206083; Alzheimer disease 9, late-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NL ! KOLF2.1J ABCA7 E1679X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ABCA7 E1679X SNV/SNV
AC   CVCL_E4NK
SY   JIPSC002012
WW   Provider; JAX; JIPSC002012; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002012
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:37; ABCA7; Simple_edited; p.Glu1679Ter (c.5035G>T); ClinVar=VCV000870538; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206083; Alzheimer disease 9, late-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ABCA7 E1679X SNV/WT
AC   CVCL_E4NL
SY   JIPSC002010
WW   Provider; JAX; JIPSC002010; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002010
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:37; ABCA7; Simple_edited; p.Glu1679Ter (c.5035G>T); ClinVar=VCV000870538; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206083; Alzheimer disease 9, late-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ABCA7 W1214X REV/WT
AC   CVCL_E4NM
SY   JIPSC003074
WW   Provider; JAX; JIPSC003074; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003074
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ABCA7 p.Trp1214Ter (c.3641G>A) cell line (JAX=JIPSC003074).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206083; Alzheimer disease 9, late-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NP ! KOLF2.1J ABCA7 W1214X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ABCA7 W1214X SNV/SNV
AC   CVCL_E4NN
SY   JIPSC003072
WW   Provider; JAX; JIPSC003072; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003072
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:37; ABCA7; Simple_edited; p.Trp1214Ter (c.3641G>A); ClinVar=VCV000225545; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206083; Alzheimer disease 9, late-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ABCA7 W1214X SNV/WT
AC   CVCL_E4NP
SY   JIPSC003070
WW   Provider; JAX; JIPSC003070; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003070
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:37; ABCA7; Simple_edited; p.Trp1214Ter (c.3641G>A); ClinVar=VCV000225545; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206083; Alzheimer disease 9, late-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ADAM10 PTC PTC/PTC
AC   CVCL_E4TR
SY   JIPSC001930
WW   Provider; JAX; JIPSC001930; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001930
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ADAM10 Q170H REV/WT
AC   CVCL_E7JE
SY   JIPSC003022
WW   Provider; JAX; JIPSC003022; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003022
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ADAM10 p.Gln170His (c.510G>C) cell line (JAX=JIPSC003022).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214853; Alzheimer disease 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7JG ! KOLF2.1J ADAM10 Q170H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ADAM10 Q170H SNV/SNV
AC   CVCL_E7JF
SY   JIPSC003020
WW   Provider; JAX; JIPSC003020; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003020
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:188; ADAM10; Simple_edited; p.Gln170His (c.510G>C); ClinVar=VCV000092163; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214853; Alzheimer disease 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ADAM10 Q170H SNV/WT
AC   CVCL_E7JG
SY   JIPSC003018
WW   Provider; JAX; JIPSC003018; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003018
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:188; ADAM10; Simple_edited; p.Gln170His (c.510G>C); ClinVar=VCV000092163; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214853; Alzheimer disease 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ADAM10 R181G REV/WT
AC   CVCL_E7JH
SY   JIPSC001294
WW   Provider; JAX; JIPSC001294; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001294
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ADAM10 p.Arg181Gly (c.541A>G) cell line (JAX=JIPSC001294).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214853; Alzheimer disease 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7JJ ! KOLF2.1J ADAM10 R181G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ADAM10 R181G SNV/SNV
AC   CVCL_E7JI
SY   JIPSC001278
WW   Provider; JAX; JIPSC001278; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001278
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:188; ADAM10; Simple_edited; p.Arg181Gly (c.541A>G); ClinVar=VCV000092164; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214853; Alzheimer disease 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ADAM10 R181G SNV/WT
AC   CVCL_E7JJ
SY   JIPSC001280
WW   Provider; JAX; JIPSC001280; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001280
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:188; ADAM10; Simple_edited; p.Arg181Gly (c.541A>G); ClinVar=VCV000092164; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214853; Alzheimer disease 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ANG 0.5kbdel DEL/DEL
AC   CVCL_E7NB
SY   JIPSC001630
WW   Provider; JAX; JIPSC001630; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001630
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:483; ANG.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ANG K41I REV/WT
AC   CVCL_E7JK
SY   JIPSC001024
WW   Provider; JAX; JIPSC001024; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001024
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ANG p.Lys41Ile (c.122A>T) cell line (JAX=JIPSC001024).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214854; Amyotrophic lateral sclerosis 9
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7JM ! KOLF2.1J ANG K41I SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ANG K41I SNV/SNV
AC   CVCL_E7JL
SY   JIPSC001020
WW   Provider; JAX; JIPSC001020; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001020
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:483; ANG; Simple_edited; p.Lys41Ile (c.122A>T); ClinVar=VCV000018074; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214854; Amyotrophic lateral sclerosis 9
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ANG K41I SNV/WT
AC   CVCL_E7JM
SY   JIPSC001022
WW   Provider; JAX; JIPSC001022; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001022
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:483; ANG; Simple_edited; p.Lys41Ile (c.122A>T); ClinVar=VCV000018074; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214854; Amyotrophic lateral sclerosis 9
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ANXA11 17.0kbdel DEL/DEL
AC   CVCL_E4NQ
SY   JIPSC001674
WW   Provider; JAX; JIPSC001674; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001674
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:535; ANXA11.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 D40G REV/WT
AC   CVCL_E4NR
SY   JIPSC001778
WW   Provider; JAX; JIPSC001778; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001778
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ANXA11 p.Asp40Gly (c.119A>G) cell line (JAX=JIPSC001778).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NT ! KOLF2.1J ANXA11 D40G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 D40G SNV/SNV
AC   CVCL_E4NS
SY   JIPSC001774
WW   Provider; JAX; JIPSC001774; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001774
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple_edited; p.Asp40Gly (c.119A>G); ClinVar=VCV000488353; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 D40G SNV/WT
AC   CVCL_E4NT
SY   JIPSC001776
WW   Provider; JAX; JIPSC001776; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001776
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple_edited; p.Asp40Gly (c.119A>G); ClinVar=VCV000488353; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 G38R REV/WT
AC   CVCL_E4NU
SY   JIPSC001210
WW   Provider; JAX; JIPSC001210; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001210
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ANXA11 p.Gly38Arg (c.112G>A) cell line (JAX=JIPSC001210).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NW ! KOLF2.1J ANXA11 G38R SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 G38R SNV/SNV
AC   CVCL_E4NV
SY   JIPSC001190
WW   Provider; JAX; JIPSC001190; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001190
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple_edited; p.Gly38Arg (c.112G>A); ClinVar=VCV000488354; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 G38R SNV/WT
AC   CVCL_E4NW
SY   JIPSC001188
WW   Provider; JAX; JIPSC001188; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001188
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple_edited; p.Gly38Arg (c.112G>A); ClinVar=VCV000488354; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 R346C REV/WT
AC   CVCL_E4NX
SY   JIPSC003036
WW   Provider; JAX; JIPSC003036; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003036
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ANXA11 p.Arg346Cys (c.1036C>T) cell line (JAX=JIPSC003036).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4NZ ! KOLF2.1J ANXA11 R346C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ANXA11 R346C SNV/SNV
AC   CVCL_E4NY
SY   JIPSC001218
WW   Provider; JAX; JIPSC001218; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001218
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple_edited; p.Arg346Cys (c.1036C>T); ClinVar=VCV002982289; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   KOLF2.1J ANXA11 R346C SNV/WT
AC   CVCL_E4NZ
SY   JIPSC001220
WW   Provider; JAX; JIPSC001220; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001220
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple_edited; p.Arg346Cys (c.1036C>T); ClinVar=VCV002982289; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178411; Amyotrophic lateral sclerosis 23
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 3
//
ID   KOLF2.1J APOE 2.6kbdel DEL/DEL
AC   CVCL_E4TS
SY   JIPSC001654
WW   Provider; JAX; JIPSC001654; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001654
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J APP 157.7kbdel DEL/DEL
AC   CVCL_E7NC
SY   JIPSC001636
WW   Provider; JAX; JIPSC001636; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001636
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A673T (A) REV/WT
AC   CVCL_E7P7
SY   JIPSC001018
WW   Provider; JAX; JIPSC001018; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001018
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited APP p.Ala673Thr (c.2017G>A) cell line (JAX=JIPSC001018).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7P9 ! KOLF2.1J APP A673T (A) SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A673T (A) SNV/SNV
AC   CVCL_E7P8
SY   JIPSC001014
WW   Provider; JAX; JIPSC001014; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001014
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Ala673Thr (c.2017G>A); ClinVar=VCV000037145; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A673T (A) SNV/WT
AC   CVCL_E7P9
SY   JIPSC001016
WW   Provider; JAX; JIPSC001016; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001016
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Ala673Thr (c.2017G>A); ClinVar=VCV000037145; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A673T (B) REV/WT
AC   CVCL_E7PA
SY   JIPSC001204
WW   Provider; JAX; JIPSC001204; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001204
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PP p.Ala673Thr (c.2017G>A) cell line (JAX=JIPSC001204).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7PC ! KOLF2.1J APP A673T (B) SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A673T (B) SNV/SNV
AC   CVCL_E7PB
SY   JIPSC001176
WW   Provider; JAX; JIPSC001176; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001176
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Ala673Thr (c.2017G>A); ClinVar=VCV000037145; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A673T (B) SNV/WT
AC   CVCL_E7PC
SY   JIPSC001178
WW   Provider; JAX; JIPSC001178; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001178
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Ala673Thr (c.2017G>A); ClinVar=VCV000037145; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A692G REV/WT
AC   CVCL_E7PD
SY   JIPSC002068
WW   Provider; JAX; JIPSC002068; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002068
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited APP p.Ala692Gly (c.2075C>G) cell line (JAX=JIPSC002068).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7PF ! KOLF2.1J APP A692G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A692G SNV/SNV
AC   CVCL_E7PE
SY   JIPSC002064
WW   Provider; JAX; JIPSC002064; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002064
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Ala692Gly (c.2075C>G); ClinVar=VCV000018091; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP A692G SNV/WT
AC   CVCL_E7PF
SY   JIPSC002066
WW   Provider; JAX; JIPSC002066; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002066
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Ala692Gly (c.2075C>G); ClinVar=VCV000018091; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP E693G REV/WT
AC   CVCL_E7PG
SY   JIPSC001102
WW   Provider; JAX; JIPSC001102; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001102
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited APP p.Glu693Gly (c.2078A>G) cell line (JAX=JIPSC001102).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7PI ! KOLF2.1J APP E693G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP E693G SNV/SNV
AC   CVCL_E7PH
SY   JIPSC001086
WW   Provider; JAX; JIPSC001086; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001086
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Glu693Gly (c.2078A>G); ClinVar=VCV000018098; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP E693G SNV/WT
AC   CVCL_E7PI
SY   JIPSC001088
WW   Provider; JAX; JIPSC001088; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001088
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Glu693Gly (c.2078A>G); ClinVar=VCV000018098; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP E693Q REV/WT
AC   CVCL_E7PJ
SY   JIPSC002088
WW   Provider; JAX; JIPSC002088; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002088
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited APP p.Glu693Gln (c.2077G>C) cell line (JAX=JIPSC002088).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7PL ! KOLF2.1J APP E693Q SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP E693Q SNV/SNV
AC   CVCL_E7PK
SY   JIPSC002084
WW   Provider; JAX; JIPSC002084; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002084
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Glu693Gln (c.2077G>C); ClinVar=VCV000018087; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP E693Q SNV/WT
AC   CVCL_E7PL
SY   JIPSC002086
WW   Provider; JAX; JIPSC002086; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002086
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Glu693Gln (c.2077G>C); ClinVar=VCV000018087; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP V717I REV/WT
AC   CVCL_E7PM
SY   JIPSC001212
WW   Provider; JAX; JIPSC001212; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001212
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited APP p.Val717Ile (c.2149G>A) cell line (JAX=JIPSC001212).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7PP ! KOLF2.1J APP V717I SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP V717I SNV/SNV
AC   CVCL_E7PN
SY   JIPSC001202
WW   Provider; JAX; JIPSC001202; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001202
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J APP V717I SNV/WT
AC   CVCL_E7PP
SY   JIPSC001200
WW   Provider; JAX; JIPSC001200; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001200
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_edited; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ATM 60.2kbdel DEL/DEL
AC   CVCL_E4TT
SY   JIPSC001858
WW   Provider; JAX; JIPSC001858; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001858
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ATM K750K REV/REV
AC   CVCL_E7PQ
SY   JIPSC003006
WW   Provider; JAX; JIPSC003006; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003006
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited ATM p.Lys750Lys (c.2250G>A) cell line (JAX=JIPSC003006).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7PR ! KOLF2.1J ATM K750K SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ATM K750K SNV/SNV
AC   CVCL_E7PR
SY   JIPSC003002
WW   Provider; JAX; JIPSC003002; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003002
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple_edited; p.Lys750Lys (c.2250G>A); ClinVar=VCV000003044; Zygosity=Homozygous; Note=By CRISPR/Cas9. Causes skipping of exon 14 (p.Ile709_Lys750del, c.2125_2250del) (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ATM K750K SNV/WT
AC   CVCL_E7PS
SY   JIPSC003004
WW   Provider; JAX; JIPSC003004; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003004
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple_edited; p.Lys750Lys (c.2250G>A); ClinVar=VCV000003044; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Causes skipping of exon 14 (p.Ile709_Lys750del, c.2125_2250del) (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ATP13A2 18.4kbdel DEL/DEL
AC   CVCL_E4TU
SY   JIPSC001650
WW   Provider; JAX; JIPSC001650; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001650
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30213; ATP13A2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J BCAT1 65.2kbdel DEL/DEL
AC   CVCL_E4P0
SY   JIPSC001900
WW   Provider; JAX; JIPSC001900; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001900
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J BLOC1S1 3.7kbdel DEL/DEL
AC   CVCL_E4P1
SY   JIPSC001902
WW   Provider; JAX; JIPSC001902; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001902
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4200; BLOC1S1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CACNA1A 164.6kbdel DEL/WT
AC   CVCL_E4TV
SY   JIPSC001860
WW   Provider; JAX; JIPSC001860; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001860
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1388; CACNA1A (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CACNA1A PTC PTC/PTC
AC   CVCL_E4TW
SY   JIPSC001836
WW   Provider; JAX; JIPSC001836; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001836
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1388; CACNA1A.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CACNA1A R583Q REV/WT
AC   CVCL_E7JN
SY   JIPSC001290
WW   Provider; JAX; JIPSC001290; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001290
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CACNA1A p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A) cell line (JAX=JIPSC001290).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202603; Episodic ataxia type 2
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_97; Familial paroxysmal ataxia
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7JQ ! KOLF2.1J CACNA1A R583Q SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CACNA1A R583Q SNV/SNV
AC   CVCL_E7JP
SY   JIPSC001270
WW   Provider; JAX; JIPSC001270; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001270
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A); ClinVar=VCV000008505; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202603; Episodic ataxia type 2
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_97; Familial paroxysmal ataxia
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CACNA1A R583Q SNV/WT
AC   CVCL_E7JQ
SY   JIPSC001272
WW   Provider; JAX; JIPSC001272; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001272
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_edited; p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A); ClinVar=VCV000008505; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202603; Episodic ataxia type 2
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_97; Familial paroxysmal ataxia
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CACNA1G 58.1kbdel DEL/DEL
AC   CVCL_E4TX
SY   JIPSC001924
WW   Provider; JAX; JIPSC001924; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001924
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1394; CACNA1G.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CACNA1G R1274S REV/WT
AC   CVCL_E7JR
SY   JIPSC001614
WW   Provider; JAX; JIPSC001614; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001614
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CACNA1G p.Arg1274Ser (c.3822C>A) cell line (JAX=JIPSC001614).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171269; Spinocerebellar ataxia type 42
DI   ORDO; Orphanet_458803; Spinocerebellar ataxia type 42
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7JT ! KOLF2.1J CACNA1G R1274S SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CACNA1G R1274S SNV/SNV
AC   CVCL_E7JS
SY   JIPSC001612
WW   Provider; JAX; JIPSC001612; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001612
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1394; CACNA1G; Simple_edited; p.Arg1274Ser (c.3822C>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171269; Spinocerebellar ataxia type 42
DI   ORDO; Orphanet_458803; Spinocerebellar ataxia type 42
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CACNA1G R1274S SNV/WT
AC   CVCL_E7JT
SY   JIPSC001610
WW   Provider; JAX; JIPSC001610; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001610
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1394; CACNA1G; Simple_edited; p.Arg1274Ser (c.3822C>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171269; Spinocerebellar ataxia type 42
DI   ORDO; Orphanet_458803; Spinocerebellar ataxia type 42
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHCHD10 1.8kbdel DEL/DEL
AC   CVCL_E4TY
SY   JIPSC001652
WW   Provider; JAX; JIPSC001652; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001652
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15559; CHCHD10.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CHCHD10 R15L REV/WT
AC   CVCL_E7JU
SY   JIPSC003012
WW   Provider; JAX; JIPSC003012; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003012
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CHCHD10 p.Arg15Leu (c.44_45delinsTT) cell line (JAX=JIPSC003012).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214862; Frontotemporal dementia and/or amyotrophic lateral sclerosis 2
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7JW ! KOLF2.1J CHCHD10 R15L SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHCHD10 R15L SNV/SNV
AC   CVCL_E7JV
SY   JIPSC003008
WW   Provider; JAX; JIPSC003008; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003008
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15559; CHCHD10; Simple_edited; p.Arg15Leu (c.44_45delinsTT); ClinVar=VCV001452852; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214862; Frontotemporal dementia and/or amyotrophic lateral sclerosis 2
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHCHD10 R15L SNV/WT
AC   CVCL_E7JW
SY   JIPSC003010
WW   Provider; JAX; JIPSC003010; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003010
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15559; CHCHD10; Simple_edited; p.Arg15Leu (c.44_45delinsTT); ClinVar=VCV001452852; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214862; Frontotemporal dementia and/or amyotrophic lateral sclerosis 2
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B 26.3kbdel DEL/DEL
AC   CVCL_E4TZ
SY   JIPSC001682
WW   Provider; JAX; JIPSC001682; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001682
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CHMP2B I29V REV/WT
AC   CVCL_E7JX
SY   JIPSC001078
WW   Provider; JAX; JIPSC001078; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001078
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CHMP2B p.Ile29Val (c.85A>G) cell line (JAX=JIPSC001078).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Ile29Val (c.85A>G); ClinVar=VCV000021507; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7JZ ! KOLF2.1J CHMP2B I29V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B I29V SNV/SNV
AC   CVCL_E7JY
SY   JIPSC001074
WW   Provider; JAX; JIPSC001074; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001074
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Ile29Val (c.85A>G); ClinVar=VCV000021507; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B I29V SNV/WT
AC   CVCL_E7JZ
SY   JIPSC001076
WW   Provider; JAX; JIPSC001076; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001076
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B Q165X REV/WT
AC   CVCL_E7K0
SY   JIPSC001296
WW   Provider; JAX; JIPSC001296; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001296
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CHMP2B p.Gln165Ter (c.493C>T) cell line (JAX=JIPSC001296).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7K2 ! KOLF2.1J CHMP2B Q165X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B Q165X SNV/SNV
AC   CVCL_E7K1
SY   JIPSC001282
WW   Provider; JAX; JIPSC001282; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001282
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Gln165Ter (c.493C>T); ClinVar=VCV000001655; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B Q165X SNV/WT
AC   CVCL_E7K2
SY   JIPSC001284
WW   Provider; JAX; JIPSC001284; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001284
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Gln165Ter (c.493C>T); ClinVar=VCV000001655; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B Q206H REV/WT
AC   CVCL_E7K3
SY   JIPSC001584
WW   Provider; JAX; JIPSC001584; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001584
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CHMP2B p.Gln206His (c.618A>C) cell line (JAX=JIPSC001584).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7K5 ! KOLF2.1J CHMP2B Q206H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B Q206H SNV/SNV
AC   CVCL_E7K4
SY   JIPSC001580
WW   Provider; JAX; JIPSC001580; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001580
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Gln206His (c.618A>C); ClinVar=VCV000001654; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CHMP2B Q206H SNV/WT
AC   CVCL_E7K5
SY   JIPSC001582
WW   Provider; JAX; JIPSC001582; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001582
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24537; CHMP2B; Simple_edited; p.Gln206His (c.618A>C); ClinVar=VCV000001654; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214863; Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CLN5 9.1kbdel DEL/DEL
AC   CVCL_E4QP
SY   JIPSC001678
WW   Provider; JAX; JIPSC001678; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001678
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2076; CLN5.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CLN5 W26X REV/REV
AC   CVCL_E4QL
SY   JIPSC001342
WW   Provider; JAX; JIPSC001342; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001342
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited CLN5 p.Trp26Ter (c.78G>A) cell line (JAX=JIPSC001342).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192090; Neuronal ceroid lipofuscinosis type 5
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4QM ! KOLF2.1J CLN5 W26X SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CLN5 W26X SNV/SNV
AC   CVCL_E4QM
SY   JIPSC001158
WW   Provider; JAX; JIPSC001158; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001158
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2076; CLN5; Simple_edited; p.Trp26Ter (c.78G>A); ClinVar=VCV000002565; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192090; Neuronal ceroid lipofuscinosis type 5
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CLN5 W26X SNV/WT
AC   CVCL_E4QN
SY   JIPSC001156
WW   Provider; JAX; JIPSC001156; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001156
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2076; CLN5; Simple_edited; p.Trp26Ter (c.78G>A); ClinVar=VCV000002565; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192090; Neuronal ceroid lipofuscinosis type 5
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CNTNAP2 81.7kbdel DEL/DEL
AC   CVCL_E4QC
SY   JIPSC001992
WW   Provider; JAX; JIPSC001992; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001992
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13830; CNTNAP2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J COMT 21.8kbdel DEL/DEL
AC   CVCL_E7ND
SY   JIPSC001984
WW   Provider; JAX; JIPSC001984; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001984
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2228; COMT.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J COQ2 20.9kbdel DEL/WT
AC   CVCL_E4U0
SY   JIPSC001862
WW   Provider; JAX; JIPSC001862; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001862
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25223; COQ2 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J COQ2 M128V REV/WT
AC   CVCL_E7K6
SY   JIPSC001766
WW   Provider; JAX; JIPSC001766; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001766
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited COQ2 p.Met78Val (c.232A>G) (p.Met128Val, c.382A>G) cell line (JAX=JIPSC001766).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214868; Susceptibility to multiple system atrophy-1
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7K8 ! KOLF2.1J COQ2 M128V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J COQ2 M128V SNV/SNV
AC   CVCL_E7K7
SY   JIPSC001762
WW   Provider; JAX; JIPSC001762; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001762
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:25223; COQ2; Simple_edited; p.Met78Val (c.232A>G) (p.Met128Val, c.382A>G); ClinVar=VCV000060536; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214868; Susceptibility to multiple system atrophy-1
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J COQ2 M128V SNV/WT
AC   CVCL_E7K8
SY   JIPSC001764
WW   Provider; JAX; JIPSC001764; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001764
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:25223; COQ2; Simple_edited; p.Met78Val (c.232A>G) (p.Met128Val, c.382A>G); ClinVar=VCV000060536; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214868; Susceptibility to multiple system atrophy-1
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J CSF1R 27kbdel DEL/DEL
AC   CVCL_E4QD
SY   JIPSC001638
WW   Provider; JAX; JIPSC001638; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001638
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CSF1R A781E REV/WT
AC   CVCL_E4PS
SY   JIPSC001292
WW   Provider; JAX; JIPSC001292; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001292
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CSF1R p.Ala781Glu (c.2342C>A) cell line (JAX=JIPSC001292).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PU ! KOLF2.1J CSF1R A781E SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CSF1R A781E SNV/SNV
AC   CVCL_E4PT
SY   JIPSC001274
WW   Provider; JAX; JIPSC001274; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001274
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2433; CSF1R; Simple_edited; p.Ala781Glu (c.2342C>A); ClinVar=VCV000120324; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CSF1R A781E SNV/WT
AC   CVCL_E4PU
SY   JIPSC001276
WW   Provider; JAX; JIPSC001276; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001276
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2433; CSF1R; Simple_edited; p.Ala781Glu (c.2342C>A); ClinVar=VCV000120324; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CSF1R E633K REV/WT
AC   CVCL_E4PV
SY   JIPSC001048
WW   Provider; JAX; JIPSC001048; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001048
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited CSF1R p.Glu633Lys (c.1897G>A) cell line (JAX=JIPSC001048).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PX ! KOLF2.1J CSF1R E633K SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CSF1R E633K SNV/SNV
AC   CVCL_E4PW
SY   JIPSC001044
WW   Provider; JAX; JIPSC001044; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001044
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2433; CSF1R; Simple_edited; p.Glu633Lys (c.1897G>A); ClinVar=VCV000029811; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J CSF1R E633K SNV/WT
AC   CVCL_E4PX
SY   JIPSC001046
WW   Provider; JAX; JIPSC001046; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001046
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2433; CSF1R; Simple_edited; p.Glu633Lys (c.1897G>A); ClinVar=VCV000029811; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C153289; Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
DI   ORDO; Orphanet_313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J DCTN1 G59S REV/WT
AC   CVCL_E7K9
SY   JIPSC001332
WW   Provider; JAX; JIPSC001332; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001332
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited DCTN1 p.Gly59Ser (c.175G>A) cell line (JAX=JIPSC001332).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214860; Autosomal dominant distal hereditary motor neuronopathy-14
DI   ORDO; Orphanet_139589; Distal hereditary motor neuropathy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KA ! KOLF2.1J DCTN1 G59S SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DCTN1 G59S SNV/WT
AC   CVCL_E7KA
SY   JIPSC001312
WW   Provider; JAX; JIPSC001312; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001312
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2711; DCTN1; Simple_edited; p.Gly59Ser (c.175G>A); ClinVar=VCV000008401; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214860; Autosomal dominant distal hereditary motor neuronopathy-14
DI   ORDO; Orphanet_139589; Distal hereditary motor neuropathy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DCTN1 R785W REV/WT
AC   CVCL_E7KB
SY   JIPSC003094
WW   Provider; JAX; JIPSC003094; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003094
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited DCTN1 p.Arg785Trp (c.2353C>T) cell line (JAX=JIPSC003094).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214860; Autosomal dominant distal hereditary motor neuronopathy-14
DI   ORDO; Orphanet_139589; Distal hereditary motor neuropathy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KD ! KOLF2.1J DCTN1 R785W SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DCTN1 R785W SNV/SNV
AC   CVCL_E7KC
SY   JIPSC003090
WW   Provider; JAX; JIPSC003090; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003090
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2711; DCTN1; Simple_edited; p.Arg785Trp (c.2353C>T); ClinVar=VCV000008404; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214860; Autosomal dominant distal hereditary motor neuronopathy-14
DI   ORDO; Orphanet_139589; Distal hereditary motor neuropathy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DCTN1 R785W SNV/WT
AC   CVCL_E7KD
SY   JIPSC003092
WW   Provider; JAX; JIPSC003092; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003092
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2711; DCTN1; Simple_edited; p.Arg785Trp (c.2353C>T); ClinVar=VCV000008404; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214860; Autosomal dominant distal hereditary motor neuronopathy-14
DI   ORDO; Orphanet_139589; Distal hereditary motor neuropathy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DGCR2 83.5kbdel DEL/DEL
AC   CVCL_E7NE
SY   JIPSC001986
WW   Provider; JAX; JIPSC001986; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001986
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2845; DGCR2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DJ1 L166P clone 1
AC   CVCL_D6I7
DR   Wikidata; Q127382564
RX   PubMed=38200091;
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Leu166Pro (c.497T>C); ClinVar=VCV000007064; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38200091).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KOLF2.1J DJ1 L166P clone 2
AC   CVCL_D6I8
DR   Wikidata; Q127382565
RX   PubMed=38200091;
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Leu166Pro (c.497T>C); ClinVar=VCV000007064; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38200091).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   KOLF2.1J DNAJC6 48.8kbdel DEL/DEL
AC   CVCL_E4QE
SY   JIPSC001884
WW   Provider; JAX; JIPSC001884; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001884
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15469; DNAJC6.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J DNAJC6 S59G REV/REV
AC   CVCL_E7P1
SY   JIPSC003062
WW   Provider; JAX; JIPSC003062; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003062
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited DNAJC6 p.Ser59Gly (c.175A>G) cell line (JAX=JIPSC003062).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198608; Parkinson disease 19A, juvenile-onset
DI   NCIt; C198609; Parkinson disease 19B, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7P2 ! KOLF2.1J DNAJC6 S59G SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DNAJC6 S59G SNV/SNV
AC   CVCL_E7P2
SY   JIPSC003060
WW   Provider; JAX; JIPSC003060; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003060
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; p.Ser59Gly (c.175A>G); ClinVar=VCV000641135; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198608; Parkinson disease 19A, juvenile-onset
DI   NCIt; C198609; Parkinson disease 19B, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DNAJC6 S59G SNV/WT
AC   CVCL_E7P3
SY   JIPSC003058
WW   Provider; JAX; JIPSC003058; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003058
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; p.Ser59Gly (c.175A>G); ClinVar=VCV000641135; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198608; Parkinson disease 19A, juvenile-onset
DI   NCIt; C198609; Parkinson disease 19B, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DNMT1 46.7kbdel DEL/WT
AC   CVCL_E4U1
SY   JIPSC001690
WW   Provider; JAX; JIPSC001690; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001690
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2976; DNMT1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J DNMT1 Y511C REV/WT
AC   CVCL_E7KE
SY   JIPSC001208
WW   Provider; JAX; JIPSC001208; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001208
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited DNMT1 p.Tyr511Cys (c.1532A>G) cell line (JAX=JIPSC001208).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214873; Neuropathy, hereditary sensory, type IE
DI   ORDO; Orphanet_456318; Hereditary sensory neuropathy-deafness-dementia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KG ! KOLF2.1J DNMT1 Y511C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DNMT1 Y511C SNV/SNV
AC   CVCL_E7KF
SY   JIPSC001180
WW   Provider; JAX; JIPSC001180; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001180
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2976; DNMT1; Simple_edited; p.Tyr511Cys (c.1532A>G); VCV000029682; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214873; Neuropathy, hereditary sensory, type IE
DI   ORDO; Orphanet_456318; Hereditary sensory neuropathy-deafness-dementia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J DNMT1 Y511C SNV/WT
AC   CVCL_E7KG
SY   JIPSC001182
WW   Provider; JAX; JIPSC001182; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001182
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2976; DNMT1; Simple_edited; p.Tyr511Cys (c.1532A>G); VCV000029682; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214873; Neuropathy, hereditary sensory, type IE
DI   ORDO; Orphanet_456318; Hereditary sensory neuropathy-deafness-dementia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2AK2 44kbdel DEL/DEL
AC   CVCL_E7NF
SY   JIPSC001886
WW   Provider; JAX; JIPSC001886; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001886
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2AK2 A109V REV/WT
AC   CVCL_E7KH
SY   JIPSC002082
WW   Provider; JAX; JIPSC002082; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002082
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited EIF2AK2 p.Ala109Val (c.326C>T) cell line (JAX=JIPSC002082).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214870; Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KJ ! KOLF2.1J EIF2AK2 A109V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2AK2 A109V SNV/SNV
AC   CVCL_E7KI
SY   JIPSC002080
WW   Provider; JAX; JIPSC002080; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002080
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9437; EIF2AK2; Simple_edited; p.Ala109Val (c.326C>T); ClinVar=VCV000813274; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214870; Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2AK2 A109V SNV/WT
AC   CVCL_E7KJ
SY   JIPSC002078
WW   Provider; JAX; JIPSC002078; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002078
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9437; EIF2AK2; Simple_edited; p.Ala109Val (c.326C>T); ClinVar=VCV000813274; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214870; Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B1 12.3kbdel DEL/WT
AC   CVCL_E4U2
SY   JIPSC001888
WW   Provider; JAX; JIPSC001888; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001888
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3257; EIF2B1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J EIF2B1 V183F REV/REV
AC   CVCL_E7KK
SY   JIPSC001544
WW   Provider; JAX; JIPSC001544; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001544
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited EIF2B1 p.Val183Phe (c.547G>T) cell line (JAX=JIPSC001544).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KL ! KOLF2.1J EIF2B1 V183F SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B1 V183F SNV/SNV
AC   CVCL_E7KL
SY   JIPSC001542
WW   Provider; JAX; JIPSC001542; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001542
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3257; EIF2B1; Simple_edited; p.Val183Phe (c.547G>T); ClinVar=VCV000217277; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B1 V183F SNV/WT
AC   CVCL_E7KM
SY   JIPSC001540
WW   Provider; JAX; JIPSC001540; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001540
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3257; EIF2B1; Simple_edited; p.Val183Phe (c.547G>T); ClinVar=VCV000217277; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B2 1.1kbdel DEL/WT
AC   CVCL_E4QF
SY   JIPSC001890
WW   Provider; JAX; JIPSC001890; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001890
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3258; EIF2B2 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J EIF2B3 I229M REV/REV
AC   CVCL_E7KN
SY   JIPSC001538
WW   Provider; JAX; JIPSC001538; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001538
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited EIF2B3 p.Ile229Met cell line (JAX=JIPSC001538).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KP ! KOLF2.1J EIF2B3 I229M SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B3 I229M SNV/SNV
AC   CVCL_E7KP
SY   JIPSC001534
WW   Provider; JAX; JIPSC001534; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001534
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3259; EIF2B3; Simple_edited; p.Ile229Met (c.687T>G); ClinVar=VCV001691306; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B3 I229M SNV/WT
AC   CVCL_E7KQ
SY   JIPSC001536
WW   Provider; JAX; JIPSC001536; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001536
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3259; EIF2B3; Simple_edited; p.Ile229Met (c.687T>G); ClinVar=VCV001691306; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B3 PTC PTC/WT
AC   CVCL_E7NG
SY   JIPSC001910
WW   Provider; JAX; JIPSC001910; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001910
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3259; EIF2B3 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B4 1.8kbdel DEL/WT
AC   CVCL_E4QG
SY   JIPSC001892
WW   Provider; JAX; JIPSC001892; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001892
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3260; EIF2B4 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J EIF2B5 9.7kbdel DEL/WT
AC   CVCL_E4U3
SY   JIPSC001894
WW   Provider; JAX; JIPSC001894; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001894
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3261; EIF2B5 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J EIF2B5 R195H REV/REV
AC   CVCL_E7KR
SY   JIPSC001550
WW   Provider; JAX; JIPSC001550; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001550
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited EIF2B5 p.Arg195His (c.584G>A) cell line (JAX=JIPSC001550).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KS ! KOLF2.1J EIF2B5 R195H SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B5 R195H SNV/SNV
AC   CVCL_E7KS
SY   JIPSC001548
WW   Provider; JAX; JIPSC001548; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001548
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3261; EIF2B5; Simple_edited; p.Arg195His (c.584G>A); ClinVar=VCV000005946; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF2B5 R195H SNV/WT
AC   CVCL_E7KT
SY   JIPSC001546
WW   Provider; JAX; JIPSC001546; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001546
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3261; EIF2B5; Simple_edited; p.Arg195His (c.584G>A); ClinVar=VCV000005946; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122664; Leukoencephalopathy with vanishing white matter
DI   ORDO; Orphanet_135; CACH syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF4G1 9kbdel DEL/WT
AC   CVCL_E7NH
SY   JIPSC001896
WW   Provider; JAX; JIPSC001896; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001896
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3296; EIF4G1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF4G1 A502V REV/WT
AC   CVCL_E7KU
SY   JIPSC001482
WW   Provider; JAX; JIPSC001482; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001482
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited EIF4G1 p.Ala502Val (c.1505C>T) cell line (JAX=JIPSC001482).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214869; Parkinson disease-18, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KW ! KOLF2.1J EIF4G1 A502V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF4G1 A502V SNV/SNV
AC   CVCL_E7KV
SY   JIPSC001472
WW   Provider; JAX; JIPSC001472; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001472
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3296; EIF4G1; Simple_edited; p.Ala502Val (c.1505C>T); ClinVar=VCV000030073; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214869; Parkinson disease-18, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J EIF4G1 A502V SNV/WT
AC   CVCL_E7KW
SY   JIPSC001470
WW   Provider; JAX; JIPSC001470; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001470
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3296; EIF4G1; Simple_edited; p.Ala502Val (c.1505C>T); ClinVar=VCV000030073; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214869; Parkinson disease-18, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ERBB4 PTC PTC/PTC
AC   CVCL_E4W9
SY   JIPSC001904
WW   Provider; JAX; JIPSC001904; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001904
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3432; ERBB4.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ERBB4 R927Q REV/WT
AC   CVCL_E7KX
SY   JIPSC001298
WW   Provider; JAX; JIPSC001298; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001298
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ERBB4 p.Arg927Gln (c.2780G>A) cell line (JAX=JIPSC001298).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214857; Amyotrophic lateral sclerosis 19
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7KZ ! KOLF2.1J ERBB4 R927Q SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ERBB4 R927Q SNV/SNV
AC   CVCL_E7KY
SY   JIPSC001288
WW   Provider; JAX; JIPSC001288; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001288
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3432; ERBB4; Simple_edited; p.Arg927Gln (c.2780G>A); ClinVar=VCV000064625; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214857; Amyotrophic lateral sclerosis 19
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ERBB4 R927Q SNV/WT
AC   CVCL_E7KZ
SY   JIPSC001286
WW   Provider; JAX; JIPSC001286; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001286
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3432; ERBB4; Simple_edited; p.Arg927Gln (c.2780G>A); ClinVar=VCV000064625; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214857; Amyotrophic lateral sclerosis 19
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J FBXO7 I87T REV/REV
AC   CVCL_E4T2
SY   JIPSC001820
WW   Provider; JAX; JIPSC001820; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001820
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited FBXO7 p.Ile87Thr (c.260T>C) cell line (JAX=JIPSC001820).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198607; Parkinson disease 15, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4T3 ! KOLF2.1J FBXO7 I87T SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FBXO7 I87T SNV/SNV
AC   CVCL_E4T3
SY   JIPSC001818
WW   Provider; JAX; JIPSC001818; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001818
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:13586; FBXO7; Simple_edited; p.Ile87Thr (c.260T>C); ClinVar=VCV000225358; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198607; Parkinson disease 15, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FBXO7 I87T SNV/WT
AC   CVCL_E4T4
SY   JIPSC001816
WW   Provider; JAX; JIPSC001816; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001816
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:13586; FBXO7; Simple_edited; p.Ile87Thr (c.260T>C); ClinVar=VCV000225358; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198607; Parkinson disease 15, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS 7.7kbdel DEL/DEL
AC   CVCL_E7NI
SY   JIPSC001634
WW   Provider; JAX; JIPSC001634; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001634
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J FUS P525L REV/WT
AC   CVCL_E4P2
SY   JIPSC001760
WW   Provider; JAX; JIPSC001760; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001760
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited FUS p.Pro525Leu (c.1574C>T) cell line (JAX=JIPSC001760).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4P4 ! KOLF2.1J FUS P525L SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS P525L SNV/SNV
AC   CVCL_E4P3
SY   JIPSC001756
WW   Provider; JAX; JIPSC001756; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001756
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Pro525Leu (c.1574C>T); ClinVar=VCV000280110; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS P525L SNV/WT
AC   CVCL_E4P4
SY   JIPSC001758
WW   Provider; JAX; JIPSC001758; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001758
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Pro525Leu (c.1574C>T); ClinVar=VCV000280110; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R216C REV/WT
AC   CVCL_E4P5
SY   JIPSC001098
WW   Provider; JAX; JIPSC001098; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001098
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited FUS p.Arg216Cys (c.646C>T) cell line (JAX=JIPSC001098).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4P7 ! KOLF2.1J FUS R216C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R216C SNV/SNV
AC   CVCL_E4P6
SY   JIPSC001056
WW   Provider; JAX; JIPSC001056; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001056
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg216Cys (c.646C>T); ClinVar=VCV000016227; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R216C SNV/WT
AC   CVCL_E4P7
SY   JIPSC001058
WW   Provider; JAX; JIPSC001058; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001058
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg216Cys (c.646C>T); ClinVar=VCV000016227; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R495X REV/WT
AC   CVCL_E4P8
SY   JIPSC001006
WW   Provider; JAX; JIPSC001006; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001006
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited FUS p.Arg495Ter (c.1483C>T) cell line (JAX=JIPSC001006).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PA ! KOLF2.1J FUS R495X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R495X SNV/SNV
AC   CVCL_E4P9
SY   JIPSC001002
WW   Provider; JAX; JIPSC001002; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001002
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg495Ter (c.1483C>T); ClinVar=VCV000029707; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R495X SNV/WT
AC   CVCL_E4PA
SY   JIPSC001004
WW   Provider; JAX; JIPSC001004; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001004
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg495Ter (c.1483C>T); ClinVar=VCV000029707; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R521G REV/wT
AC   CVCL_E4PB
SY   JIPSC001754
WW   Provider; JAX; JIPSC001754; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001754
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited FUS p.Arg521Gly (c.1561C>G) cell line (JAX=JIPSC001754).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PD ! KOLF2.1J FUS R521G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R521G SNV/SNV
AC   CVCL_E4PC
SY   JIPSC001750
WW   Provider; JAX; JIPSC001750; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001750
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R521G SNV/WT
AC   CVCL_E4PD
SY   JIPSC001752
WW   Provider; JAX; JIPSC001752; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001752
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R521H REV/wT
AC   CVCL_E4PE
SY   JIPSC001256
WW   Provider; JAX; JIPSC001256; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001256
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited FUS p.Arg521His (c.1562G>A) cell line (JAX=JIPSC001256).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PG ! KOLF2.1J FUS R521H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R521H SNV/SNV
AC   CVCL_E4PF
SY   JIPSC001242
WW   Provider; JAX; JIPSC001242; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001242
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg521His (c.1562G>A); ClinVar=VCV000016225; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FUS R521H SNV/WT
AC   CVCL_E4PG
SY   JIPSC001244
WW   Provider; JAX; JIPSC001244; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001244
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg521His (c.1562G>A); ClinVar=VCV000016225; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J FXN 37.6kbdel DEL/WT
AC   CVCL_E4PH
SY   JIPSC001856
WW   Provider; JAX; JIPSC001856; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001856
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3951; FXN (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GBA1 5.4kbdel DEL/DEL
AC   CVCL_E4VU
SY   JIPSC001838
WW   Provider; JAX; JIPSC001838; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001838
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GBA1 D448V REV/WT
AC   CVCL_E4VV
SY   JIPSC001216
WW   Provider; JAX; JIPSC001216; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001216
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited GBA1 p.Asp448Val (c.1343A>T) cell line (JAX=JIPSC001216).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4VX ! KOLF2.1J GBA1 D448V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GBA1 D448V SNV/SNV
AC   CVCL_E4VW
SY   JIPSC001834
WW   Provider; JAX; JIPSC001834; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001834
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Asp448Val (c.1343A>T) (D409V); ClinVar=VCV000004294; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GBA1 D448V SNV/WT
AC   CVCL_E4VX
SY   JIPSC001192
WW   Provider; JAX; JIPSC001192; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001192
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Asp448Val (c.1343A>T) (D409V); ClinVar=VCV000004294; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GBA1 E326K REV/WT
AC   CVCL_E4VY
SY   JIPSC002008
WW   Provider; JAX; JIPSC002008; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002008
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited GBA1 p.Glu365Lys (c.1093G>A) cell line (JAX=JIPSC002008).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4W0 ! KOLF2.1J GBA1 E326K SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GBA1 E326K SNV/SNV
AC   CVCL_E4VZ
SY   JIPSC002004
WW   Provider; JAX; JIPSC002004; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002004
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GBA1 E326K SNV/WT
AC   CVCL_E4W0
SY   JIPSC002006
WW   Provider; JAX; JIPSC002006; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002006
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GCH1 1.5kbdel DEL/DEL
AC   CVCL_E4T1
SY   JIPSC001704
WW   Provider; JAX; JIPSC001704; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001704
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4193; GCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GCH1 G201E REV/WT
AC   CVCL_E4SY
SY   JIPSC001478
WW   Provider; JAX; JIPSC001478; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001478
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited GCH1 p.Gly201Glu (c.602G>A) cell line (JAX=JIPSC001478).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116719; Dopa-responsive dystonia
DI   ORDO; Orphanet_255; Dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4T0 ! KOLF2.1J GCH1 G201E SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GCH1 G201E SNV/SNV
AC   CVCL_E4SZ
SY   JIPSC001452
WW   Provider; JAX; JIPSC001452; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001452
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4193; GCH1; Simple_edited; p.Gly201Glu (c.602G>A); ClinVar=VCV000009274; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116719; Dopa-responsive dystonia
DI   ORDO; Orphanet_255; Dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GCH1 G201E SNV/WT
AC   CVCL_E4T0
SY   JIPSC001454
WW   Provider; JAX; JIPSC001454; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001454
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4193; GCH1; Simple_edited; p.Gly201Glu (c.602G>A); ClinVar=VCV000009274; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116719; Dopa-responsive dystonia
DI   ORDO; Orphanet_255; Dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GRN 3.8kbdel DEL/DEL
AC   CVCL_E4YK
SY   JIPSC001644
WW   Provider; JAX; JIPSC001644; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001644
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GRN Q125X REV/REV
AC   CVCL_E4QH
SY   JIPSC001170
WW   Provider; JAX; JIPSC001170; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001170
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited GRN p.Gln125Ter (c.373C>T) cell line (JAX=JIPSC001170).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4QJ ! KOLF2.1J GRN Q125X SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GRN Q125X REV/WT
AC   CVCL_E4QI
SY   JIPSC001100
WW   Provider; JAX; JIPSC001100; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001100
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited GRN p.Gln125Ter (c.373C>T) cell line (JAX=JIPSC001100).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4QK ! KOLF2.1J GRN Q125X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GRN Q125X SNV/SNV
AC   CVCL_E4QJ
SY   JIPSC001060
WW   Provider; JAX; JIPSC001060; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001060
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple_edited; p.Gln125Ter (c.373C>T); ClinVar=VCV000016007; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J GRN Q125X SNV/WT
AC   CVCL_E4QK
SY   JIPSC001062
WW   Provider; JAX; JIPSC001062; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001062
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple_edited; p.Gln125Ter (c.373C>T); ClinVar=VCV000016007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J HNRNPA1 5.1kbdel DEL/WT
AC   CVCL_E4W1
SY   JIPSC001686
WW   Provider; JAX; JIPSC001686; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001686
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5031; HNRNPA1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J HNRNPA1 D262N REV/WT
AC   CVCL_E7L0
SY   JIPSC001042
WW   Provider; JAX; JIPSC001042; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001042
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited HNRNPA1 p.Asp314Asn (c.940G>A) cell line (JAX=JIPSC001042).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214858; Amyotrophic lateral sclerosis 20
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7L2 ! KOLF2.1J HNRNPA1 D262N SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J HNRNPA1 D262N SNV/SNV
AC   CVCL_E7L1
SY   JIPSC001038
WW   Provider; JAX; JIPSC001038; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001038
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5031; HNRNPA1; Simple_edited; p.Asp314Asn (c.940G>A) (D262N); ClinVar=VCV000065452; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214858; Amyotrophic lateral sclerosis 20
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J HNRNPA1 D262N SNV/WT
AC   CVCL_E7L2
SY   JIPSC001040
WW   Provider; JAX; JIPSC001040; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001040
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5031; HNRNPA1; Simple_edited; p.Asp314Asn (c.940G>A) (D262N); ClinVar=VCV000065452; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214858; Amyotrophic lateral sclerosis 20
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J HNRNPA2B1 8.1kbdel DEL/WT
AC   CVCL_E4QB
SY   JIPSC001666
WW   Provider; JAX; JIPSC001666; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001666
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5033; HNRNPA2B1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J ITM2B 28kbdel DEL/DEL
AC   CVCL_E7NJ
SY   JIPSC001916
WW   Provider; JAX; JIPSC001916; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001916
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6174; ITM2B.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ITPR1 N602D REV/WT
AC   CVCL_E7L3
SY   JIPSC001526
WW   Provider; JAX; JIPSC001526; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001526
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited ITPR1 p.Asn602Asp (c.1804A>G) cell line (JAX=JIPSC001526).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214867; Spinocerebellar ataxia type 29
DI   ORDO; Orphanet_208513; Spinocerebellar ataxia type 29
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7L5 ! KOLF2.1J ITPR1 N602D SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ITPR1 N602D SNV/SNV
AC   CVCL_E7L4
SY   JIPSC001524
WW   Provider; JAX; JIPSC001524; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001524
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6180; ITPR1; Simple_edited; p.Asn602Asp (c.1804A>G); ClinVar=VCV000039572; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214867; Spinocerebellar ataxia type 29
DI   ORDO; Orphanet_208513; Spinocerebellar ataxia type 29
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J ITPR1 N602D SNV/WT
AC   CVCL_E7L5
SY   JIPSC001460
WW   Provider; JAX; JIPSC001460; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001460
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6180; ITPR1; Simple_edited; p.Asn602Asp (c.1804A>G); ClinVar=VCV000039572; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214867; Spinocerebellar ataxia type 29
DI   ORDO; Orphanet_208513; Spinocerebellar ataxia type 29
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNA1 R239S REV/WT
AC   CVCL_E7L6
SY   JIPSC001626
WW   Provider; JAX; JIPSC001626; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001626
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited KCNA1 p.Arg239Ser (c.715C>A) cell line (JAX=JIPSC001626).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214852; Episodic ataxia type 1
DI   ORDO; Orphanet_37612; Episodic ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7L8 ! KOLF2.1J KCNA1 R239S SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNA1 R239S SNV/SNV
AC   CVCL_E7L7
SY   JIPSC001624
WW   Provider; JAX; JIPSC001624; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001624
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6218; KCNA1; Simple_edited; p.Arg239Ser (c.715C>A); ClinVar=VCV000013481; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214852; Episodic ataxia type 1
DI   ORDO; Orphanet_37612; Episodic ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNA1 R239S SNV/WT
AC   CVCL_E7L8
SY   JIPSC001622
WW   Provider; JAX; JIPSC001622; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001622
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6218; KCNA1; Simple_edited; p.Arg239Ser (c.715C>A); ClinVar=VCV000013481; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214852; Episodic ataxia type 1
DI   ORDO; Orphanet_37612; Episodic ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNA1 R417X REV/WT
AC   CVCL_E7L9
SY   JIPSC001474
WW   Provider; JAX; JIPSC001474; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001474
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited KCNA1 p.Arg417Ter (c.1249C>T) cell line (JAX=JIPSC001474).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214852; Episodic ataxia type 1
DI   ORDO; Orphanet_37612; Episodic ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LB ! KOLF2.1J KCNA1 R417X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNA1 R417X SNV/SNV
AC   CVCL_E7LA
SY   JIPSC001444
WW   Provider; JAX; JIPSC001444; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001444
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6218; KCNA1; Simple_edited; p.Arg417Ter (c.1249C>T); ClinVar=VCV000013491; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214852; Episodic ataxia type 1
DI   ORDO; Orphanet_37612; Episodic ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNA1 R417X SNV/WT
AC   CVCL_E7LB
SY   JIPSC001446
WW   Provider; JAX; JIPSC001446; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001446
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6218; KCNA1; Simple_edited; p.Arg417Ter (c.1249C>T); ClinVar=VCV000013491; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214852; Episodic ataxia type 1
DI   ORDO; Orphanet_37612; Episodic ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNC3 8.9kbdel DEL/DEL
AC   CVCL_E4WA
SY   JIPSC001672
WW   Provider; JAX; JIPSC001672; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001672
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6235; KCNC3.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KCNC3 R420H REV/WT
AC   CVCL_E7LC
SY   JIPSC002054
WW   Provider; JAX; JIPSC002054; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002054
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited KCNC3 p.Arg420His (c.1259G>A) cell line (JAX=JIPSC002054).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214865; Spinocerebellar ataxia type 13
DI   ORDO; Orphanet_98768; Spinocerebellar ataxia type 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LE ! KOLF2.1J KCNC3 R420H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNC3 R420H SNV/SNV
AC   CVCL_E7LD
SY   JIPSC002050
WW   Provider; JAX; JIPSC002050; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002050
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6235; KCNC3; Simple_edited; p.Arg420His (c.1259G>A); ClinVar=VCV000013473; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214865; Spinocerebellar ataxia type 13
DI   ORDO; Orphanet_98768; Spinocerebellar ataxia type 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCNC3 R420H SNV/WT
AC   CVCL_E7LE
SY   JIPSC002052
WW   Provider; JAX; JIPSC002052; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002052
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6235; KCNC3; Simple_edited; p.Arg420His (c.1259G>A); ClinVar=VCV000013473; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214865; Spinocerebellar ataxia type 13
DI   ORDO; Orphanet_98768; Spinocerebellar ataxia type 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KCND3 1.2kbdel DEL/DEL
AC   CVCL_E4QA
SY   JIPSC001668
WW   Provider; JAX; JIPSC001668; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001668
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6239; KCND3.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KCTD13 PTC PTC/WT
AC   CVCL_E4WB
SY   JIPSC001962
WW   Provider; JAX; JIPSC001962; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001962
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22234; KCTD13 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KCTD13 PTC PTC/PTC
AC   CVCL_E4WC
SY   JIPSC001978
WW   Provider; JAX; JIPSC001978; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001978
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22234; KCTD13.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KIF5A 32.9kbdel DEL/DEL
AC   CVCL_E4WD
SY   JIPSC001702
WW   Provider; JAX; JIPSC001702; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001702
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6323; KIF5A.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KIF5A N256S REV/WT
AC   CVCL_E4WE
SY   JIPSC001330
WW   Provider; JAX; JIPSC001330; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001330
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited KIF5A p.Asn256Ser (c.767A>G) cell line (JAX=JIPSC001330).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4WG ! KOLF2.1J KIF5A N256S SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KIF5A N256S SNV/SNV
AC   CVCL_E4WF
SY   JIPSC001308
WW   Provider; JAX; JIPSC001308; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001308
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple_edited; p.Asn256Ser (c.767A>G); ClinVar=VCV000006806; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KIF5A N256S SNV/WT
AC   CVCL_E4WG
SY   JIPSC001310
WW   Provider; JAX; JIPSC001310; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001310
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple_edited; p.Asn256Ser (c.767A>G); ClinVar=VCV000006806; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J KIF5A R204Q REV/WT
AC   CVCL_E7NY
SY   JIPSC003122
WW   Provider; JAX; JIPSC003122; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003122
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited KIF5A p.Arg204Gln (c.611G>A) cell line (JAX=JIPSC003122).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7P0 ! KOLF2.1J KIF5A R204Q SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KIF5A R204Q SNV/SNV
AC   CVCL_E7NZ
SY   JIPSC003118
WW   Provider; JAX; JIPSC003118; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003118
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple_edited; p.Arg204Gln (c.611G>A); ClinVar=VCV000037129; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J KIF5A R204Q SNV/WT
AC   CVCL_E7P0
SY   JIPSC003120
WW   Provider; JAX; JIPSC003120; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003120
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6323; KIF5A; Simple_edited; p.Arg204Gln (c.611G>A); ClinVar=VCV000037129; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J LRRK2 142.6kbdel DEL/DEL
AC   CVCL_E4T5
SY   JIPSC001684
WW   Provider; JAX; JIPSC001684; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001684
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 I2020T REV/WT
AC   CVCL_E4T6
SY   JIPSC001432
WW   Provider; JAX; JIPSC001432; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001432
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited LRRK2 p.Ile2020Thr (c.6059C>T) cell line (JAX=JIPSC001432).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4T8 ! KOLF2.1J LRRK2 I2020T SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 I2020T SNV/SNV
AC   CVCL_E4T7
SY   JIPSC001406
WW   Provider; JAX; JIPSC001406; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001406
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 I2020T SNV/WT
AC   CVCL_E4T8
SY   JIPSC001408
WW   Provider; JAX; JIPSC001408; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001408
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 N2081D REV/WT
AC   CVCL_E4T9
SY   JIPSC001566
WW   Provider; JAX; JIPSC001566; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001566
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited LRRK2 p.Asn2081Asp (c.6241A>G) cell line (JAX=JIPSC001566).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4TB ! KOLF2.1J LRRK2 N2081D SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 N2081D SNV/SNV
AC   CVCL_E4TA
SY   JIPSC001564
WW   Provider; JAX; JIPSC001564; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001564
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Asn2081Asp (c.6241A>G); ClinVar=VCV000039221; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 N2081D SNV/WT
AC   CVCL_E4TB
SY   JIPSC001562
WW   Provider; JAX; JIPSC001562; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001562
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Asn2081Asp (c.6241A>G); ClinVar=VCV000039221; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441C REV/SNV
AC   CVCL_E4PI
SY   JIPSC001484
WW   Provider; JAX; JIPSC001484; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001484
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited LRRK2 p.Arg1441Cys (c.4321C>T) cell line (JAX=JIPSC001484).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PK ! KOLF2.1J LRRK2 R1441C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441C SNV/SNV
AC   CVCL_E4PJ
SY   JIPSC001464
WW   Provider; JAX; JIPSC001464; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001464
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441C SNV/WT
AC   CVCL_E4PK
SY   JIPSC001462
WW   Provider; JAX; JIPSC001462; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001462
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441G REV/SNV
AC   CVCL_E4PL
SY   JIPSC001138
WW   Provider; JAX; JIPSC001138; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001138
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited LRRK2 p.Arg1441Gly (c.4321C>G) cell line (JAX=JIPSC001138).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PN ! KOLF2.1J LRRK2 R1441G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441G SNV/SNV
AC   CVCL_E4PM
SY   JIPSC001136
WW   Provider; JAX; JIPSC001136; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001136
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441G SNV/WT
AC   CVCL_E4PN
SY   JIPSC001134
WW   Provider; JAX; JIPSC001134; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001134
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441H REV/SNV
AC   CVCL_E4PP
SY   JIPSC001120
WW   Provider; JAX; JIPSC001120; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001120
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited LRRK2 p.Arg1441His (c.4322G>A) cell line (JAX=JIPSC001120).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4PR ! KOLF2.1J LRRK2 R1441H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441H SNV/SNV
AC   CVCL_E4PQ
SY   JIPSC001174
WW   Provider; JAX; JIPSC001174; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001174
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441His (c.4322G>A); ClinVar=VCV000001942; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R1441H SNV/WT
AC   CVCL_E4PR
SY   JIPSC001172
WW   Provider; JAX; JIPSC001172; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001172
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441His (c.4322G>A); ClinVar=VCV000001942; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R793M REV/REV
AC   CVCL_E4TC
SY   JIPSC001712
WW   Provider; JAX; JIPSC001712; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001712
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited LRRK2 p.Arg793Met (c.2378G>T) cell line (JAX=JIPSC001712).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4TD ! KOLF2.1J LRRK2 R793M SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R793M SNV/SNV
AC   CVCL_E4TD
SY   JIPSC001710
WW   Provider; JAX; JIPSC001710; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001710
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg793Met (c.2378G>T); ClinVar=VCV000039149; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 R793M SNV/WT
AC   CVCL_E4TE
SY   JIPSC001708
WW   Provider; JAX; JIPSC001708; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001708
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg793Met (c.2378G>T); ClinVar=VCV000039149; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 Y1699C REV/WT
AC   CVCL_E4TF
SY   JIPSC001554
WW   Provider; JAX; JIPSC001554; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001554
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited LRRK2 p.Tyr1699Cys (c.5096A>G) cell line (JAX=JIPSC001554).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4TG ! KOLF2.1J LRRK2 Y1699C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J LRRK2 Y1699C SNV/WT
AC   CVCL_E4TG
SY   JIPSC001552
WW   Provider; JAX; JIPSC001552; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001552
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Tyr1699Cys (c.5096A>G); ClinVar=VCV000001937; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J MAPT G300R REV/WT
AC   CVCL_E8CT
SY   JIPSC001590
WW   Provider; JAX; JIPSC001590; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001590
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MAPT p.Gly389Arg (c.1165G>A) (G706R, c.2116G>A) (JAX=JIPSC001590).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8CU ! KOLF2.1J MAPT G300R SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MAPT G300R SNV/WT
AC   CVCL_E8CU
SY   JIPSC001588
WW   Provider; JAX; JIPSC001588; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001588
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Gly389Arg (c.1165G>A) (G706R, c.2116G>A); ClinVar=VCV000014255; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MAPT N279K REV/WT
AC   CVCL_E7QY
SY   JIPSC001790
WW   Provider; JAX; JIPSC001790; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001790
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MAPT p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G) cell line (JAX=JIPSC001790).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7R0 ! KOLF2.1J MAPT N279K SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MAPT N279K SNV/SNV
AC   CVCL_E7QZ
SY   JIPSC001786
WW   Provider; JAX; JIPSC001786; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001786
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MAPT N279K SNV/WT
AC   CVCL_E7R0
SY   JIPSC001788
WW   Provider; JAX; JIPSC001788; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001788
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MAPT Q336R REV/SNV
AC   CVCL_E8CV
SY   JIPSC001796
WW   Provider; JAX; JIPSC001796; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001796
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MAPT p.Gln653Arg (c.1958A>G) (p.Gln336Arg, c.1007A>G or p.Gln728Arg, c.2183A>G) cell line (JAX=JIPSC001794).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8CX ! KOLF2.1J MAPT Q336R SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MAPT Q336R SNV/SNV
AC   CVCL_E8CW
SY   JIPSC001792
WW   Provider; JAX; JIPSC001792; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001792
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Gln653Arg (c.1958A>G) (p.Gln336Arg, c.1007A>G or p.Gln728Arg, c.2183A>G); ClinVar=VCV000098230; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MAPT Q336R SNV/WT
AC   CVCL_E8CX
SY   JIPSC001794
WW   Provider; JAX; JIPSC001794; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001794
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Gln653Arg (c.1958A>G) (p.Gln336Arg, c.1007A>G or p.Gln728Arg, c.2183A>G); ClinVar=VCV000098230; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MAPT R5H REV/WT
AC   CVCL_E7R1
SY   JIPSC003088
WW   Provider; JAX; JIPSC003088; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003088
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MAPT p.Arg5His (c.14G>A) cell line (JAX=JIPSC003088).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7R3 ! KOLF2.1J MAPT R5H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MAPT R5H SNV/SNV
AC   CVCL_E7R2
SY   JIPSC002038
WW   Provider; JAX; JIPSC002038; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002038
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Arg5His (c.14G>A); ClinVar=VCV000014261; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MAPT R5H SNV/WT
AC   CVCL_E7R3
SY   JIPSC002040
WW   Provider; JAX; JIPSC002040; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002040
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Arg5His (c.14G>A); ClinVar=VCV000014261; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MAPT V337M REV/WT
AC   CVCL_E7R4
SY   JIPSC003052
WW   Provider; JAX; JIPSC003052; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003052
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MAPT p.Val337Met (c.1009G>A) cell line (JAX=JIPSC003052).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7R5 ! KOLF2.1J MAPT V337M SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MAPT V337M SNV/WT
AC   CVCL_E7R5
SY   JIPSC003050
WW   Provider; JAX; JIPSC003050; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003050
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J MATR3 24.0kbdel DEL/WT
AC   CVCL_E4U4
SY   JIPSC001656
WW   Provider; JAX; JIPSC001656; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001656
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6912; MATR3 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J MATR3 F115C REV/WT
AC   CVCL_E7LF
SY   JIPSC001522
WW   Provider; JAX; JIPSC001522; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001522
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MATR3 p.Phe115Cys (c.344T>G) cell line (JAX=JIPSC001522).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LH ! KOLF2.1J MATR3 F115C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 F115C SNV/SNV
AC   CVCL_E7LG
SY   JIPSC001518
WW   Provider; JAX; JIPSC001518; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001518
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple_edited; p.Phe115Cys (c.344T>G); ClinVar=VCV000126561; Zygosity=Homozygous (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 F115C SNV/WT
AC   CVCL_E7LH
SY   JIPSC001520
WW   Provider; JAX; JIPSC001520; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001520
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple_edited; p.Phe115Cys (c.344T>G); ClinVar=VCV000126561; Zygosity=Heterozygous (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 S85C REV/WT
AC   CVCL_E7LI
SY   JIPSC001248
WW   Provider; JAX; JIPSC001248; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001248
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MATR3 p.Ser85Cys (c.254C>G) cell line (JAX=JIPSC001248).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LK ! KOLF2.1J MATR3 S85C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 S85C SNV/SNV
AC   CVCL_E7LJ
SY   JIPSC001224
WW   Provider; JAX; JIPSC001224; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001224
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple_edited; p.Ser85Cys (c.254C>G); ClinVar=VCV000014002; Zygosity=Homozygous (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 S85C SNV/WT
AC   CVCL_E7LK
SY   JIPSC001222
WW   Provider; JAX; JIPSC001222; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001222
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple_edited; p.Ser85Cys (c.254C>G); ClinVar=VCV000014002; Zygosity=Heterozygous (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 T622A REV/WT
AC   CVCL_E7LL
SY   JIPSC001476
WW   Provider; JAX; JIPSC001476; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001476
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited MATR3 p.Thr622Ala (c.1864A>G) cell line (JAX=JIPSC001476).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LN ! KOLF2.1J MATR3 T622A SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 T622A SNV/SNV
AC   CVCL_E7LM
SY   JIPSC001448
WW   Provider; JAX; JIPSC001448; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001448
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple_edited; p.Thr622Ala (c.1864A>G); ClinVar=VCV000126562; Zygosity=Homozygous (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MATR3 T622A SNV/WT
AC   CVCL_E7LN
SY   JIPSC001450
WW   Provider; JAX; JIPSC001450; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001450
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6912; MATR3; Simple_edited; p.Thr622Ala (c.1864A>G); ClinVar=VCV000126562; Zygosity=Heterozygous (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168755; Amyotrophic lateral sclerosis 21
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J MSMO1 15.9kbdel DEL/WT
AC   CVCL_E4Q9
SY   JIPSC001936
WW   Provider; JAX; JIPSC001936; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001936
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10545; MSMO1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J OPTN 27.8kbdel DEL/DEL
AC   CVCL_E4Q8
SY   JIPSC001698
WW   Provider; JAX; JIPSC001698; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001698
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17142; OPTN.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J OTUD4 30.9kbdel DEL/WT
AC   CVCL_E4Q7
SY   JIPSC001870
WW   Provider; JAX; JIPSC001870; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001870
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24949; OTUD4 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PAH 60.2kbdel DEL/DEL
AC   CVCL_E4U5
SY   JIPSC001990
WW   Provider; JAX; JIPSC001990; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001990
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8582; PAH.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PANK2 28.2kbdel DEL/DEL
AC   CVCL_E4U6
SY   JIPSC001660
WW   Provider; JAX; JIPSC001660; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001660
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15894; PANK2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PANK2 C.1413-1G>T REV/REV
AC   CVCL_E4W6
SY   JIPSC002036
WW   Provider; JAX; JIPSC002036; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002036
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PANK2 c.1413-1G>T cell line (JAX=JIPSC002036).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Homozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C8967; Brain iron accumulation type I syndrome
DI   ORDO; Orphanet_216873; Atypical pantothenate kinase-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4W7 ! KOLF2.1J PANK2 C.1413-1G>T SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   KOLF2.1J PANK2 C.1413-1G>T SNV/SNV
AC   CVCL_E4W7
SY   JIPSC002032
WW   Provider; JAX; JIPSC002032; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002032
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple_edited; c.1413-1G>T; ClinVar=VCV000004559; Zygosity=Homozygous; Note=By CRISPR/Cas9. Splice acceptor mutation (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C8967; Brain iron accumulation type I syndrome
DI   ORDO; Orphanet_216873; Atypical pantothenate kinase-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   KOLF2.1J PANK2 C.1413-1G>T SNV/WT
AC   CVCL_E4W8
SY   JIPSC002034
WW   Provider; JAX; JIPSC002034; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002034
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple_edited; c.1413-1G>T; ClinVar=VCV000004559; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Splice acceptor mutation (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C8967; Brain iron accumulation type I syndrome
DI   ORDO; Orphanet_216873; Atypical pantothenate kinase-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   KOLF2.1J PARK7 15kbdel DEL/DEL
AC   CVCL_E7NK
SY   JIPSC001700
WW   Provider; JAX; JIPSC001700; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001700
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PARK7 D149A REV/REV
AC   CVCL_E4TK
SY   JIPSC002048
WW   Provider; JAX; JIPSC002048; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002048
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PARK7 p.Asp149Ala (c.446A>C) cell line (JAX=JIPSC002048).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4TL ! KOLF2.1J PARK7 D149A SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PARK7 D149A SNV/SNV
AC   CVCL_E4TL
SY   JIPSC002044
WW   Provider; JAX; JIPSC002044; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002044
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Asp149Ala (c.446A>C); ClinVar=VCV000007066; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PARK7 D149A SNV/WT
AC   CVCL_E4TM
SY   JIPSC002046
WW   Provider; JAX; JIPSC002046; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002046
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Asp149Ala (c.446A>C); ClinVar=VCV000007066; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PARK7 L166P REV/REV
AC   CVCL_E4TH
SY   JIPSC001430
WW   Provider; JAX; JIPSC001430; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001430
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PARK7 p.Leu166Pro (c.497T>C) cell line (JAX=JIPSC001430).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4TI ! KOLF2.1J PARK7 L166P SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PARK7 L166P SNV/SNV
AC   CVCL_E4TI
SY   JIPSC001402
WW   Provider; JAX; JIPSC001402; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001402
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Leu166Pro (c.497T>C); ClinVar=VCV000007064; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PARK7 L166P SNV/WT
AC   CVCL_E4TJ
SY   JIPSC001404
WW   Provider; JAX; JIPSC001404; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001404
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Leu166Pro (c.497T>C); ClinVar=VCV000007064; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PDE10A 71.8kbdel DEL/DEL
AC   CVCL_E4Q6
SY   JIPSC001996
WW   Provider; JAX; JIPSC001996; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001996
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8772; PDE10A.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PFN1 C71G REV/WT
AC   CVCL_E7LP
SY   JIPSC001036
WW   Provider; JAX; JIPSC001036; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001036
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PFN1 p.Cys71Gly (c.211T>G) cell line (JAX=JIPSC001036).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214856; Amyotrophic lateral sclerosis 18
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LR ! KOLF2.1J PFN1 C71G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PFN1 C71G SNV/SNV
AC   CVCL_E7LQ
SY   JIPSC001032
WW   Provider; JAX; JIPSC001032; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001032
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8881; PFN1; Simple_edited; p.Cys71Gly (c.211T>G); ClinVar=VCV000037034; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214856; Amyotrophic lateral sclerosis 18
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PFN1 C71G SNV/WT
AC   CVCL_E7LR
SY   JIPSC001034
WW   Provider; JAX; JIPSC001034; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001034
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8881; PFN1; Simple_edited; p.Cys71Gly (c.211T>G); ClinVar=VCV000037034; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214856; Amyotrophic lateral sclerosis 18
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PFN1 G118V REV/WT
AC   CVCL_E7LS
SY   JIPSC001748
WW   Provider; JAX; JIPSC001748; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001748
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PFN1 p.Gly118Val (c.353G>T) cell line (JAX=JIPSC001748).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214856; Amyotrophic lateral sclerosis 18
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LU ! KOLF2.1J PFN1 G118V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PFN1 G118V SNV/SNV
AC   CVCL_E7LT
SY   JIPSC001746
WW   Provider; JAX; JIPSC001746; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001746
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8881; PFN1; Simple_edited; p.Gly118Val (c.353G>T); ClinVar=VCV000037036; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214856; Amyotrophic lateral sclerosis 18
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PFN1 G118V SNV/WT
AC   CVCL_E7LU
SY   JIPSC001744
WW   Provider; JAX; JIPSC001744; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001744
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8881; PFN1; Simple_edited; p.Gly118Val (c.353G>T); ClinVar=VCV000037036; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214856; Amyotrophic lateral sclerosis 18
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PINK1 A217D REV/REV
AC   CVCL_E4WH
SY   JIPSC001492
WW   Provider; JAX; JIPSC001492; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001492
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PINK1 p.Ala217Asp (c.650C>A) cell line (JAX=JIPSC001492).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4WI ! KOLF2.1J PINK1 A217D SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PINK1 A217D SNV/SNV
AC   CVCL_E4WI
SY   JIPSC001488
WW   Provider; JAX; JIPSC001488; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001488
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_edited; p.Ala217Asp (c.650C>A); ClinVar=VCV000002414; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PINK1 A217D SNV/WT
AC   CVCL_E4WJ
SY   JIPSC001490
WW   Provider; JAX; JIPSC001490; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001490
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_edited; p.Ala217Asp (c.650C>A); ClinVar=VCV000002414; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PINK1 P399L REV/REV
AC   CVCL_E4WK
SY   JIPSC001438
WW   Provider; JAX; JIPSC001438; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001438
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PINK1 p.Pro399Leu (c.1196C>T) cell line (JAX=JIPSC001438).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4WL ! KOLF2.1J PINK1 P399L SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PINK1 P399L SNV/SNV
AC   CVCL_E4WL
SY   JIPSC001420
WW   Provider; JAX; JIPSC001420; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001420
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_edited; p.Pro399Leu (c.1196C>T); ClinVar=VCV000002417; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PINK1 P399L SNV/WT
AC   CVCL_E4WM
SY   JIPSC001418
WW   Provider; JAX; JIPSC001418; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001418
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_edited; p.Pro399Leu (c.1196C>T); ClinVar=VCV000002417; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PLAAT4 9.8kbdel DEL/DEL
AC   CVCL_E4U7
SY   JIPSC001928
WW   Provider; JAX; JIPSC001928; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001928
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9869; PLAAT4.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PLEKHG4 8.8kbdel DEL/DEL
AC   CVCL_E4VR
SY   JIPSC001658
WW   Provider; JAX; JIPSC001658; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001658
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24501; PLEKHG4.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PLEKHG4 c16 REV/WT
AC   CVCL_E7LV
SY   JIPSC001620
WW   Provider; JAX; JIPSC001620; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001620
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PLEKHG4 c.-16C>T cell line (JAX=JIPSC001620).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176901; Spinocerebellar ataxia type 31
DI   ORDO; Orphanet_217012; Spinocerebellar ataxia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7LX ! KOLF2.1J PLEKHG4 c16 SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PLEKHG4 c16 SNV/SNV
AC   CVCL_E7LW
SY   JIPSC001618
WW   Provider; JAX; JIPSC001618; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001618
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24501; PLEKHG4; Simple_edited; c.-16C>T; ClinVar=VCV000001635; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176901; Spinocerebellar ataxia type 31
DI   ORDO; Orphanet_217012; Spinocerebellar ataxia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PLEKHG4 c16 SNV/WT
AC   CVCL_E7LX
SY   JIPSC001616
WW   Provider; JAX; JIPSC001616; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001616
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:24501; PLEKHG4; Simple_edited; c.-16C>T; ClinVar=VCV000001635; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176901; Spinocerebellar ataxia type 31
DI   ORDO; Orphanet_217012; Spinocerebellar ataxia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J POLG 17.1kbdel DEL/WT
AC   CVCL_E4VS
SY   JIPSC001854
WW   Provider; JAX; JIPSC001854; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001854
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9179; POLG (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PPM1H KO
AC   CVCL_C7TY
SY   PPM1H KO iPSCs
DR   Wikidata; Q117704577
RX   PubMed=37133994;
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18583; PPM1H.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 4
//
ID   KOLF2.1J PRKAR1B 0.2kbdel DEL/DEL
AC   CVCL_E4Q5
SY   JIPSC001872
WW   Provider; JAX; JIPSC001872; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001872
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9390; PRKAR1B.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKCG 24.4kbdel DEL/DEL
AC   CVCL_E4VT
SY   JIPSC001842
WW   Provider; JAX; JIPSC001842; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001842
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKCG F643L REV/WT
AC   CVCL_E7LY
SY   JIPSC001814
WW   Provider; JAX; JIPSC001814; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001814
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PRKCG p.Phe643Leu (c.1927T>C) cell line (JAX=JIPSC001814).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214866; Spinocerebellar ataxia type 14
DI   ORDO; Orphanet_98763; Spinocerebellar ataxia type 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7M0 ! KOLF2.1J PRKCG F643L SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PRKCG F643L SNV/SNV
AC   CVCL_E7LZ
SY   JIPSC001810
WW   Provider; JAX; JIPSC001810; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001810
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9402; PRKCG; Simple_edited; p.Phe643Leu (c.1927T>C); ClinVar=VCV000013249; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214866; Spinocerebellar ataxia type 14
DI   ORDO; Orphanet_98763; Spinocerebellar ataxia type 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PRKCG F643L SNV/WT
AC   CVCL_E7M0
SY   JIPSC001812
WW   Provider; JAX; JIPSC001812; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001812
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9402; PRKCG; Simple_edited; p.Phe643Leu (c.1927T>C); ClinVar=VCV000013249; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214866; Spinocerebellar ataxia type 14
DI   ORDO; Orphanet_98763; Spinocerebellar ataxia type 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PRKN P437L REV/REV
AC   CVCL_E4UH
SY   JIPSC001436
WW   Provider; JAX; JIPSC001436; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001436
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PRKN p.Pro437Leu (c.1310C>T) cell line (JAX=JIPSC001436).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4UI ! KOLF2.1J PRKN P437L SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN P437L SNV/SNV
AC   CVCL_E4UI
SY   JIPSC001414
WW   Provider; JAX; JIPSC001414; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001414
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Pro437Leu (c.1310C>T); ClinVar=VCV000283504; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN P437L SNV/WT
AC   CVCL_E4UJ
SY   JIPSC001416
WW   Provider; JAX; JIPSC001416; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001416
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Pro437Leu (c.1310C>T); ClinVar=VCV000283504; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN R275W REV/REV
AC   CVCL_E4UK
SY   JIPSC001434
WW   Provider; JAX; JIPSC001434; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001434
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PRKN p.Arg275Trp (c.823C>T) cell line (JAX=JIPSC001434).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4UL ! KOLF2.1J PRKN R275W SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN R275W SNV/SNV
AC   CVCL_E4UL
SY   JIPSC001412
WW   Provider; JAX; JIPSC001412; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001412
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN R275W SNV/WT
AC   CVCL_E4UM
SY   JIPSC001410
WW   Provider; JAX; JIPSC001410; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001410
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN R42P REV/REV
AC   CVCL_E4UN
SY   JIPSC001560
WW   Provider; JAX; JIPSC001560; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001560
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PRKN p.Arg42Pro (c.125G>C) cell line (JAX=JIPSC001560).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4UP ! KOLF2.1J PRKN R42P SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN R42P SNV/SNV
AC   CVCL_E4UP
SY   JIPSC001558
WW   Provider; JAX; JIPSC001558; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001558
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN R42P SNV/WT
AC   CVCL_E4UQ
SY   JIPSC001556
WW   Provider; JAX; JIPSC001556; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001556
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN T240M REV/REV
AC   CVCL_E4UR
SY   JIPSC001498
WW   Provider; JAX; JIPSC001498; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001498
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited PRKN p.Thr240Met (c.719C>T) cell line (JAX=JIPSC001498).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4US ! KOLF2.1J PRKN T240M SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN T240M SNV/SNV
AC   CVCL_E4US
SY   JIPSC001494
WW   Provider; JAX; JIPSC001494; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001494
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Thr240Met (c.719C>T); ClinVar=VCV000007054; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRKN T240M SNV/WT
AC   CVCL_E4UT
SY   JIPSC001496
WW   Provider; JAX; JIPSC001496; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001496
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple_edited; p.Thr240Met (c.719C>T); ClinVar=VCV000007054; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRNP 0.9kbdel DEL/DEL
AC   CVCL_E4UU
SY   JIPSC001850
WW   Provider; JAX; JIPSC001850; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001850
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9449; PRNP.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PRNP Q160X REV/WT
AC   CVCL_E7M1
SY   JIPSC001480
WW   Provider; JAX; JIPSC001480; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001480
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PRNP p.Gln160Ter (c.478C>T) cell line (JAX=JIPSC001480).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214872; Huntington disease-like 1
DI   ORDO; Orphanet_157941; Huntington disease-like 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7M3 ! KOLF2.1J PRNP Q160X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PRNP Q160X SNV/SNV
AC   CVCL_E7M2
SY   JIPSC001456
WW   Provider; JAX; JIPSC001456; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001456
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple_edited; p.Gln160Ter (c.478C>T); ClinVar=VCV000021148; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214872; Huntington disease-like 1
DI   ORDO; Orphanet_157941; Huntington disease-like 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PRNP Q160X SNV/WT
AC   CVCL_E7M3
SY   JIPSC001458
WW   Provider; JAX; JIPSC001458; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001458
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple_edited; p.Gln160Ter (c.478C>T); ClinVar=VCV000021148; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214872; Huntington disease-like 1
DI   ORDO; Orphanet_157941; Huntington disease-like 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PSAT1 32.4kbdel DEL/DEL
AC   CVCL_E4Q4
SY   JIPSC001972
WW   Provider; JAX; JIPSC001972; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001972
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19129; PSAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN1 71.4kbdel DEL/DEL
AC   CVCL_E7NL
SY   JIPSC001688
WW   Provider; JAX; JIPSC001688; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001688
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J PSEN1 E276A REV/WT
AC   CVCL_E4SS
SY   JIPSC001252
WW   Provider; JAX; JIPSC001252; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001252
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PSEN1 p.Glu280Ala (c.839A>C) cell line (JAX=JIPSC001252).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4SU ! KOLF2.1J PSEN1 E276A SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN1 E276A SNV/SNV
AC   CVCL_E4ST
SY   JIPSC001228
WW   Provider; JAX; JIPSC001228; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001228
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Glu280Ala (c.839A>C); ClinVar=VCV000018131; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN1 E276A SNV/WT
AC   CVCL_E4SU
SY   JIPSC001226
WW   Provider; JAX; JIPSC001226; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001226
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Glu280Ala (c.839A>C); ClinVar=VCV000018131; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN1 M146I REV/WT
AC   CVCL_E4SV
SY   JIPSC002002
WW   Provider; JAX; JIPSC002002; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002002
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PSEN1 p.Met146Ile (c.438G>A) cell line (JAX=JIPSC002002).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4SX ! KOLF2.1J PSEN1 M146I SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN1 M146I SNV/SNV
AC   CVCL_E4SW
SY   JIPSC001998
WW   Provider; JAX; JIPSC001998; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001998
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Met146Ile (c.438G>A); ClinVar=VCV000018137; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN1 M146I SNV/WT
AC   CVCL_E4SX
SY   JIPSC002000
WW   Provider; JAX; JIPSC002000; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002000
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_edited; p.Met146Ile (c.438G>A); ClinVar=VCV000018137; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN2 13.7kbdel DEL/DEL
AC   CVCL_E4SR
SY   JIPSC001840
WW   Provider; JAX; JIPSC001840; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001840
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9509; PSEN2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN2 M239I REV/WT
AC   CVCL_E4SN
SY   JIPSC003068
WW   Provider; JAX; JIPSC003068; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003068
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PSEN2 p.Met239Ile (c.717G>A) cell line (JAX=JIPSC003068).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4SQ ! KOLF2.1J PSEN2 M239I SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN2 M239I SNV/SNV
AC   CVCL_E4SP
SY   JIPSC003064
WW   Provider; JAX; JIPSC003064; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003064
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple_edited; p.Met239Ile (c.717G>A); ClinVar=VCV000008850; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN2 M239I SNV/WT
AC   CVCL_E4SQ
SY   JIPSC003066
WW   Provider; JAX; JIPSC003066; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003066
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple_edited; p.Met239Ile (c.717G>A); ClinVar=VCV000008850; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN2 N141I REV/WT
AC   CVCL_E4SK
SY   JIPSC001054
WW   Provider; JAX; JIPSC001054; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001054
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited PSEN2 p.Asn141Ile (c.422A>T) cell line (JAX=JIPSC001054).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4SM ! KOLF2.1J PSEN2 N141I SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN2 N141I SNV/SNV
AC   CVCL_E4SL
SY   JIPSC001050
WW   Provider; JAX; JIPSC001050; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001050
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple_edited; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J PSEN2 N141I SNV/WT
AC   CVCL_E4SM
SY   JIPSC001052
WW   Provider; JAX; JIPSC001052; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001052
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple_edited; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J RAB39B T168K REV/Y
AC   CVCL_E5EE
SY   JIPSC001334
WW   Provider; JAX; JIPSC001334; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001334
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the hemizygously edited RAB39B p.Thr168Lys (c.503C>A) cell line (JAX=JIPSC001334).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184991; Waisman syndrome
DI   ORDO; Orphanet_2379; Early-onset parkinsonism-intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5EF ! KOLF2.1J RAB39B T168K SNV/Y
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J RAB39B T168K SNV/Y
AC   CVCL_E5EF
SY   JIPSC001314
WW   Provider; JAX; JIPSC001314; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001314
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16499; RAB39B; Simple_edited; p.Thr168Lys (c.503C>A); ClinVar=VCV000156532; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184991; Waisman syndrome
DI   ORDO; Orphanet_2379; Early-onset parkinsonism-intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J RANBP1 7.5kbdel DEL/DEL
AC   CVCL_E4Q3
SY   JIPSC001974
WW   Provider; JAX; JIPSC001974; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001974
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9847; RANBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J RNF216 70.9kbdel DEL/DEL
AC   CVCL_E4UV
SY   JIPSC001846
WW   Provider; JAX; JIPSC001846; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001846
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21698; RNF216.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J RNF216 R694C REV/REV
AC   CVCL_E4UW
SY   JIPSC003080
WW   Provider; JAX; JIPSC003080; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003080
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited RNF216 p.Arg694Cys (c.2080C>T) cell line (JAX=JIPSC003080).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C205640; Gordon Holmes syndrome
DI   ORDO; Orphanet_1173; Cerebellar ataxia-hypogonadism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4UX ! KOLF2.1J RNF216 R694C SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J RNF216 R694C SNV/SNV
AC   CVCL_E4UX
SY   JIPSC003076
WW   Provider; JAX; JIPSC003076; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003076
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:21698; RNF216; Simple_edited; p.Arg694Cys (c.2080C>T) (p.Arg751Cys, c.2251C>T); ClinVar=VCV000050912; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C205640; Gordon Holmes syndrome
DI   ORDO; Orphanet_1173; Cerebellar ataxia-hypogonadism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J RNF216 R694C SNV/WT
AC   CVCL_E4UY
SY   JIPSC003078
WW   Provider; JAX; JIPSC003078; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003078
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:21698; RNF216; Simple_edited; p.Arg694Cys (c.2080C>T) (p.Arg751Cys, c.2251C>T); ClinVar=VCV000050912; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C205640; Gordon Holmes syndrome
DI   ORDO; Orphanet_1173; Cerebellar ataxia-hypogonadism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SCN2A 94.3kbdel DEL/DEL
AC   CVCL_E4Q2
SY   JIPSC001994
WW   Provider; JAX; JIPSC001994; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001994
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10588; SCN2A.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SERPINI1 4.6kbdel DEL/DEL
AC   CVCL_E4VD
SY   JIPSC001874
WW   Provider; JAX; JIPSC001874; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001874
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8943; SERPINI1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SERPINI1 S49P REV/WT
AC   CVCL_E7M4
SY   JIPSC002030
WW   Provider; JAX; JIPSC002030; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002030
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SERPINI1 p.Ser49Pro (c.145T>C) cell line (JAX=JIPSC002030).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214861; Familial encephalopathy with neuroserpin inclusion bodies
DI   ORDO; Orphanet_85110; Familial encephalopathy with neuroserpin inclusion bodies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7M6 ! KOLF2.1J SERPINI1 S49P SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SERPINI1 S49P SNV/SNV
AC   CVCL_E7M5
SY   JIPSC002028
WW   Provider; JAX; JIPSC002028; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002028
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8943; SERPINI1; Simple_edited; p.Ser49Pro (c.145T>C); ClinVar=VCV000007086; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214861; Familial encephalopathy with neuroserpin inclusion bodies
DI   ORDO; Orphanet_85110; Familial encephalopathy with neuroserpin inclusion bodies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SERPINI1 S49P SNV/WT
AC   CVCL_E7M6
SY   JIPSC002026
WW   Provider; JAX; JIPSC002026; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002026
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8943; SERPINI1; Simple_edited; p.Ser49Pro (c.145T>C); ClinVar=VCV000007086; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214861; Familial encephalopathy with neuroserpin inclusion bodies
DI   ORDO; Orphanet_85110; Familial encephalopathy with neuroserpin inclusion bodies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SETX L1976R SNV/SNV
AC   CVCL_E7M7
SY   JIPSC003136
WW   Provider; JAX; JIPSC003136; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003136
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; p.Leu1976Arg (c.5927T>G); ClinVar=VCV000002292; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SETX L1976R SNV/WT
AC   CVCL_E7M8
SY   JIPSC003138
WW   Provider; JAX; JIPSC003138; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003138
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; p.Leu1976Arg (c.5927T>G); ClinVar=VCV000002292; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SETX L389S REV/REV
AC   CVCL_E7M9
SY   JIPSC001340
WW   Provider; JAX; JIPSC001340; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001340
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited SETX p.Leu389Ser (c.1166T>C) cell line (JAX=JIPSC001340).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MA ! KOLF2.1J SETX L389S SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SETX L389S SNV/SNV
AC   CVCL_E7MA
SY   JIPSC001324
WW   Provider; JAX; JIPSC001324; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001324
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; p.Leu389Ser (c.1166T>C); ClinVar=VCV000002289; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SETX L389S SNV/WT
AC   CVCL_E7MB
SY   JIPSC001322
WW   Provider; JAX; JIPSC001322; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001322
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; p.Leu389Ser (c.1166T>C); ClinVar=VCV000002289; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SETX PTC PTC/PTC
AC   CVCL_E7NM
SY   JIPSC001906
WW   Provider; JAX; JIPSC001906; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001906
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:445; SETX.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SEZ6L2 28.6kbdel DEL/DEL
AC   CVCL_E4Q1
SY   JIPSC001980
WW   Provider; JAX; JIPSC001980; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001980
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30844; SEZ6L2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SHANK3 36.2kbdel DEL/DEL
AC   CVCL_E7NN
SY   JIPSC001988
WW   Provider; JAX; JIPSC001988; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001988
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14294; SHANK3.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SIGMAR1 2.1kbdel DEL/DEL
AC   CVCL_E4VA
SY   JIPSC001852
WW   Provider; JAX; JIPSC001852; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001852
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SIGMAR1 E102Q REV/REV
AC   CVCL_E7MC
SY   JIPSC002094
WW   Provider; JAX; JIPSC002094; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002094
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited SIGMAR1 p.Glu102Gln (c.304G>C) cell line (JAX=JIPSC002094).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214871; Juvenile amyotrophic lateral sclerosis 16
DI   ORDO; Orphanet_300605; Juvenile amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MD ! KOLF2.1J SIGMAR1 E102Q SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SIGMAR1 E102Q SNV/SNV
AC   CVCL_E7MD
SY   JIPSC002090
WW   Provider; JAX; JIPSC002090; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002090
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8157; SIGMAR1; Simple_edited; p.Glu102Gln (c.304G>C); ClinVar=VCV000030238; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214871; Juvenile amyotrophic lateral sclerosis 16
DI   ORDO; Orphanet_300605; Juvenile amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SIGMAR1 E102Q SNV/WT
AC   CVCL_E7ME
SY   JIPSC002092
WW   Provider; JAX; JIPSC002092; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002092
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8157; SIGMAR1; Simple_edited; p.Glu102Gln (c.304G>C); ClinVar=VCV000030238; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214871; Juvenile amyotrophic lateral sclerosis 16
DI   ORDO; Orphanet_300605; Juvenile amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SLC1A3 15.4kbdel DEL/DEL
AC   CVCL_E4VB
SY   JIPSC001876
WW   Provider; JAX; JIPSC001876; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001876
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10941; SLC1A3.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA 6.2kbdel DEL/DEL
AC   CVCL_E4VC
SY   JIPSC001680
WW   Provider; JAX; JIPSC001680; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001680
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A30G REV/WT
AC   CVCL_E4VE
SY   JIPSC001578
WW   Provider; JAX; JIPSC001578; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001578
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SNCA p.Ala30Gly (c.89C>G) cell line (JAX=JIPSC001578).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4VG ! KOLF2.1J SNCA A30G SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A30G SNV/SNV
AC   CVCL_E4VF
SY   JIPSC001576
WW   Provider; JAX; JIPSC001576; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001576
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Gly (c.89C>G); ClinVar=VCV001678622; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A30G SNV/WT
AC   CVCL_E4VG
SY   JIPSC001574
WW   Provider; JAX; JIPSC001574; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001574
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Gly (c.89C>G); ClinVar=VCV001678622; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A30P REV/WT
AC   CVCL_E4VH
SY   JIPSC001442
WW   Provider; JAX; JIPSC001442; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001442
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SNCA p.Ala30Pro (c.88G>C) cell line (JAX=JIPSC001442).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4VJ ! KOLF2.1J SNCA A30P SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A30P SNV/SNV
AC   CVCL_E4VI
SY   JIPSC001426
WW   Provider; JAX; JIPSC001426; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001426
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A30P SNV/WT
AC   CVCL_E4VJ
SY   JIPSC001428
WW   Provider; JAX; JIPSC001428; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001428
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A53T REV/WT
AC   CVCL_E4VK
SY   JIPSC001132
WW   Provider; JAX; JIPSC001132; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001132
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SNCA p.Ala53Thr (c.157G>A) cell line (JAX=JIPSC001132).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4VM ! KOLF2.1J SNCA A53T SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A53T SNV/SNV
AC   CVCL_E4VL
SY   JIPSC001130
WW   Provider; JAX; JIPSC001130; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001130
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA A53T SNV/WT
AC   CVCL_E4VM
SY   JIPSC001128
WW   Provider; JAX; JIPSC001128; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001128
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA E46K REV/WT
AC   CVCL_E4VN
SY   JIPSC001084
WW   Provider; JAX; JIPSC001084; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001084
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SNCA p.Glu46Lys (c.136G>A) cell line (JAX=JIPSC001084).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4VQ ! KOLF2.1J SNCA E46K SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA E46K SNV/SNV
AC   CVCL_E4VP
SY   JIPSC001080
WW   Provider; JAX; JIPSC001080; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001080
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Glu46Lys (c.136G>A); ClinVar=VCV000014010; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCA E46K SNV/WT
AC   CVCL_E4VQ
SY   JIPSC001082
WW   Provider; JAX; JIPSC001082; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001082
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Glu46Lys (c.136G>A); ClinVar=VCV000014010; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SNCB 9.0kbdel DEL/DEL
AC   CVCL_E7NP
SY   JIPSC001632
WW   Provider; JAX; JIPSC001632; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001632
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11140; SNCB.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SNCB P123H REV/WT
AC   CVCL_E7P4
SY   JIPSC001030
WW   Provider; JAX; JIPSC001030; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001030
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SNCB p.Pro123His (c.368C>A) cell line (JAX=JIPSC001030).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7P6 ! KOLF2.1J SNCB P123H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SNCB P123H SNV/SNV
AC   CVCL_E7P5
SY   JIPSC001026
WW   Provider; JAX; JIPSC001026; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001026
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11140; SNCB; Simple_edited; p.Pro123His (c.368C>A); ClinVar=VCV000007026; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SNCB P123H SNV/WT
AC   CVCL_E7P6
SY   JIPSC001028
WW   Provider; JAX; JIPSC001028; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001028
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11140; SNCB; Simple_edited; p.Pro123His (c.368C>A); ClinVar=VCV000007026; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SOD1 9.2kbdel DEL/WT
AC   CVCL_E4U8
SY   JIPSC001898
WW   Provider; JAX; JIPSC001898; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001898
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11179; SOD1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 A5V REV/WT
AC   CVCL_E4U9
SY   JIPSC001572
WW   Provider; JAX; JIPSC001572; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001572
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SOD1 p.Ala5Val (c.14C>T) cell line (JAX=JIPSC001572).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4UB ! KOLF2.1J SOD1 A5V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 A5V SNV/SNV
AC   CVCL_E4UA
SY   JIPSC001570
WW   Provider; JAX; JIPSC001570; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001570
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 A5V SNV/WT
AC   CVCL_E4UB
SY   JIPSC001568
WW   Provider; JAX; JIPSC001568; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001568
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 D91A REV/REV
AC   CVCL_E4UC
SY   JIPSC001718
WW   Provider; JAX; JIPSC001718; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001718
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited SOD1 p.Asp91Ala (c.272A>C) cell line (JAX=JIPSC001718).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4UD ! KOLF2.1J SOD1 D91A SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 D91A SNV/SNV
AC   CVCL_E4UD
SY   JIPSC001714
WW   Provider; JAX; JIPSC001714; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001714
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 D91A SNV/WT
AC   CVCL_E4UE
SY   JIPSC001716
WW   Provider; JAX; JIPSC001716; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001716
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 I113T REV/WT
AC   CVCL_E4UF
SY   JIPSC002018
WW   Provider; JAX; JIPSC002018; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002018
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SOD1 p.Ile113Thr (c.338T>C) cell line (JAX=JIPSC002018).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4UG ! KOLF2.1J SOD1 I113T SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SOD1 I113T SNV/WT
AC   CVCL_E4UG
SY   JIPSC002016
WW   Provider; JAX; JIPSC002016; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002016
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_edited; p.Ile113Thr (c.338T>C) (I112T); ClinVar=VCV000014762; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SORL1 159.6kbdel DEL/DEL
AC   CVCL_E7NQ
SY   JIPSC001844
WW   Provider; JAX; JIPSC001844; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001844
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11185; SORL1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 G1681D REV/WT
AC   CVCL_E7MF
SY   JIPSC003056
WW   Provider; JAX; JIPSC003056; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003056
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SORL1 p.Gly1681Asp (c.5042G>) cell line (JAX=JIPSC003056).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MG ! KOLF2.1J SORL1 G1681D SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 G1681D SNV/WT
AC   CVCL_E7MG
SY   JIPSC003054
WW   Provider; JAX; JIPSC003054; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003054
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple_edited; p.Gly1681Asp (c.5042G>); dbSNP=rs1565352546; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 T947M REV/WT
AC   CVCL_E7MH
SY   JIPSC001628
WW   Provider; JAX; JIPSC001628; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001628
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SORL1 p.Thr947Met (c.2840C>T) cell line (JAX=JIPSC001628).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MJ ! KOLF2.1J SORL1 T947M SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 T947M SNV/SNV
AC   CVCL_E7MI
SY   JIPSC001230
WW   Provider; JAX; JIPSC001230; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001230
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple_edited; p.Thr947Met (c.2840C>T); ClinVar=VCV001169971; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 T947M SNV/WT
AC   CVCL_E7MJ
SY   JIPSC001232
WW   Provider; JAX; JIPSC001232; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001232
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple_edited; p.Thr947Met (c.2840C>T); ClinVar=VCV001169971; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 Y141C REV/WT
AC   CVCL_E7MK
SY   JIPSC003100
WW   Provider; JAX; JIPSC003100; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003100
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SORL1 p.Tyr141Cys (c.422A>G) cell line (JAX=JIPSC003100).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MM ! KOLF2.1J SORL1 Y141C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 Y141C SNV/SNV
AC   CVCL_E7ML
SY   JIPSC003096
WW   Provider; JAX; JIPSC003096; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003096
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple_edited; p.Tyr141Cys (c.422A>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SORL1 Y141C SNV/WT
AC   CVCL_E7MM
SY   JIPSC003098
WW   Provider; JAX; JIPSC003098; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003098
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple_edited; p.Tyr141Cys (c.422A>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SPG11 PTC PTC/PTC
AC   CVCL_E4W2
SY   JIPSC001908
WW   Provider; JAX; JIPSC001908; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001908
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11226; SPG11.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SPG11 Q1875X REV/REV
AC   CVCL_E4W3
SY   JIPSC001826
WW   Provider; JAX; JIPSC001826; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001826
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited SPG11 p.Gln1875Ter (c.5623C>T) cell line (JAX=JIPSC001826).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4W4 ! KOLF2.1J SPG11 Q1875X SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SPG11 Q1875X SNV/SNV
AC   CVCL_E4W4
SY   JIPSC001824
WW   Provider; JAX; JIPSC001824; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001824
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple_edited; p.Gln1875Ter (c.5623C>T); ClinVar=VCV000001116; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SPG11 Q1875X SNV/WT
AC   CVCL_E4W5
SY   JIPSC001822
WW   Provider; JAX; JIPSC001822; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001822
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple_edited; p.Gln1875Ter (c.5623C>T); ClinVar=VCV000001116; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SPTBN2 25.2kbdel DEL/DEL
AC   CVCL_E7NR
SY   JIPSC001848
WW   Provider; JAX; JIPSC001848; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001848
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11276; SPTBN2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SYNJ1 71.0kbdel DEL/DEL
AC   CVCL_E4UZ
SY   JIPSC001664
WW   Provider; JAX; JIPSC001664; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001664
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11503; SYNJ1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J SYNJ1 R219Q REV/REV
AC   CVCL_E7MN
SY   JIPSC001602
WW   Provider; JAX; JIPSC001602; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001602
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited SYNJ1 p.Arg219Gln (c.656G>A) (p.Arg258Gln, c.773G>A) cell line (JAX=JIPSC001602).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C203535; Parkinson disease 20, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MP ! KOLF2.1J SYNJ1 R219Q SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SYNJ1 R219Q SNV/SNV
AC   CVCL_E7MP
SY   JIPSC001598
WW   Provider; JAX; JIPSC001598; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001598
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11503; SYNJ1; Simple_edited; p.Arg219Gln (c.656G>A) (p.Arg258Gln, c.773G>A); ClinVar=VCV000088844; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C203535; Parkinson disease 20, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J SYNJ1 R219Q SNV/WT
AC   CVCL_E7MQ
SY   JIPSC001600
WW   Provider; JAX; JIPSC001600; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001600
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11503; SYNJ1; Simple_edited; p.Arg219Gln (c.656G>A) (p.Arg258Gln, c.773G>A); ClinVar=VCV000088844; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C203535; Parkinson disease 20, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TARDBP 10.6kbdel DEL/WT
AC   CVCL_E4SJ
SY   JIPSC001640
WW   Provider; JAX; JIPSC001640; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001640
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11571; TARDBP (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TARDBP M337V REV/WT
AC   CVCL_E4SD
SY   JIPSC001110
WW   Provider; JAX; JIPSC001110; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001110
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TARDBP p.Met337Val (c.1009A>G) cell line (JAX=JIPSC001110).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4SF ! KOLF2.1J TARDBP M337V SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TARDBP M337V SNV/SNV
AC   CVCL_E4SE
SY   JIPSC001106
WW   Provider; JAX; JIPSC001106; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001106
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_edited; p.Met337Val (c.1009A>G); ClinVar=VCV000005228; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TARDBP M337V SNV/WT
AC   CVCL_E4SF
SY   JIPSC001108
WW   Provider; JAX; JIPSC001108; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001108
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_edited; p.Met337Val (c.1009A>G); ClinVar=VCV000005228; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TARDBP Q331K REV/WT
AC   CVCL_E4SG
SY   JIPSC001104
WW   Provider; JAX; JIPSC001104; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001104
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TARDBP p.Gln331Lys (c.991C>A) cell line (JAX=JIPSC001104).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4SI ! KOLF2.1J TARDBP Q331K SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TARDBP Q331K SNV/SNV
AC   CVCL_E4SH
SY   JIPSC001064
WW   Provider; JAX; JIPSC001064; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001064
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_edited; p.Gln331Lys (c.991C>A); ClinVar=VCV000005229; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TARDBP Q331K SNV/WT
AC   CVCL_E4SI
SY   JIPSC001066
WW   Provider; JAX; JIPSC001066; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001066
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_edited; p.Gln331Lys (c.991C>A); ClinVar=VCV000005229; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TBK1 41kbdel DEL/DEL
AC   CVCL_E4V0
SY   JIPSC001878
WW   Provider; JAX; JIPSC001878; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001878
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TBK1 E696K REV/WT
AC   CVCL_E7MR
SY   JIPSC001126
WW   Provider; JAX; JIPSC001126; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001126
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TBK1 p.Glu696Lys (c.2086G>A) cell line (JAX=JIPSC001126).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214864; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MT ! KOLF2.1J TBK1 E696K SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TBK1 E696K SNV/SNV
AC   CVCL_E7MS
SY   JIPSC001122
WW   Provider; JAX; JIPSC001122; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001122
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11584; TBK1; Simple_edited; p.Glu696Lys (c.2086G>A); ClinVar=VCV000203440; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214864; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TBK1 E696K SNV/WT
AC   CVCL_E7MT
SY   JIPSC001124
WW   Provider; JAX; JIPSC001124; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001124
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11584; TBK1; Simple_edited; p.Glu696Lys (c.2086G>A); ClinVar=VCV000203440; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214864; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TBK1 G217R REV/WT
AC   CVCL_E7MU
SY   JIPSC001338
WW   Provider; JAX; JIPSC001338; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001338
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TBK1 p.Gly217Arg (c.649G>A) cell line (JAX=JIPSC001338).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214864; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MW ! KOLF2.1J TBK1 G217R SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TBK1 G217R SNV/SNV
AC   CVCL_E7MV
SY   JIPSC001320
WW   Provider; JAX; JIPSC001320; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001320
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11584; TBK1; Simple_edited; p.Gly217Arg (c.649G>A); ClinVar=VCV002910316; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214864; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TBK1 G217R SNV/WT
AC   CVCL_E7MW
SY   JIPSC001318
WW   Provider; JAX; JIPSC001318; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001318
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11584; TBK1; Simple_edited; p.Gly217Arg (c.649G>A); ClinVar=VCV002910316; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214864; Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TH-TdTomato
AC   CVCL_C8FQ
SY   TH-TdTomato KOLF2.1J Reporter line
DR   Wikidata; Q123032843
CC   Population: Caucasian; British.
CC   Characteristics: Fluorescent (tdTomato) reporter cell line for TH expression. Using CRISPR/Cas9 a P2A-tdTomato construct was introduced in the C-terminal end of TH.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Miscellaneous: Cell line information from personal communication of Coccia, Elena.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   KOLF2.1J TIA1 22.2kbdel DEL/DEL
AC   CVCL_E4TN
SY   JIPSC001912
WW   Provider; JAX; JIPSC001912; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001912
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TIA1 P351L REV/WT
AC   CVCL_E7MX
SY   JIPSC001328
WW   Provider; JAX; JIPSC001328; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001328
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TIA1 p.Pro362Leu (c.1085C>T) (p.Pro351Leu, c.1052C>T) cell line (JAX=JIPSC001328).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214859; Amyotrophic lateral sclerosis 26, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7MZ ! KOLF2.1J TIA1 P351L SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TIA1 P351L SNV/SNV
AC   CVCL_E7MY
SY   JIPSC001306
WW   Provider; JAX; JIPSC001306; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001306
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11802; TIA1; Simple_edited; p.Pro362Leu (c.1085C>T) (p.Pro351Leu, c.1052C>T); ClinVar=VCV000992595; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214859; Amyotrophic lateral sclerosis 26, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TIA1 P351L SNV/WT
AC   CVCL_E7MZ
SY   JIPSC001304
WW   Provider; JAX; JIPSC001304; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001304
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11802; TIA1; Simple_edited; p.Pro362Leu (c.1085C>T) (p.Pro351Leu, c.1052C>T); ClinVar=VCV000992595; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214859; Amyotrophic lateral sclerosis 26, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TMEM106B 17.7kbdel DEL/DEL
AC   CVCL_E4Q0
SY   JIPSC001694
WW   Provider; JAX; JIPSC001694; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001694
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22407; TMEM106B.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TMEM175 M393T REV/WT
AC   CVCL_E7R6
SY   JIPSC002076
WW   Provider; JAX; JIPSC002076; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002076
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TMEM175 p.Met393Thr (c.1178T>C) cell line (JAX=JIPSC002076).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7R7 ! KOLF2.1J TMEM175 M393T SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TMEM175 M393T SNV/WT
AC   CVCL_E7R7
SY   JIPSC002074
WW   Provider; JAX; JIPSC002074; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002074
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:28709; TMEM175; Simple_edited; p.Met393Thr (c.1178T>C); ClinVar=VCV001246424; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TREM2 3.0kbdel DEL/DEL
AC   CVCL_E4TP
SY   JIPSC001648
WW   Provider; JAX; JIPSC001648; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001648
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 E151K REV/WT
AC   CVCL_E4V1
SY   JIPSC001784
WW   Provider; JAX; JIPSC001784; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001784
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TREM2 p.Glu151Lys (c.451G>A) cell line (JAX=JIPSC001784).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4V3 ! KOLF2.1J TREM2 E151K SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 E151K SNV/SNV
AC   CVCL_E4V2
SY   JIPSC001780
WW   Provider; JAX; JIPSC001780; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001780
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Glu151Lys (c.451G>A); ClinVar=VCV001517663; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 E151K SNV/WT
AC   CVCL_E4V3
SY   JIPSC001782
WW   Provider; JAX; JIPSC001782; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001782
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Glu151Lys (c.451G>A); ClinVar=VCV001517663; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 Q33X REV/WT
AC   CVCL_E7NT
SY   JIPSC003134
WW   Provider; JAX; JIPSC003134; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003134
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TREM2 p.Gln33Ter (c.97C>T) cell line (JAX=JIPSC003134).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7NV ! KOLF2.1J TREM2 Q33X SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TREM2 Q33X SNV/SNV
AC   CVCL_E7NU
SY   JIPSC003130
WW   Provider; JAX; JIPSC003130; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003130
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Gln33Ter (c.97C>T); ClinVar=VCV000005219; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TREM2 Q33X SNV/WT
AC   CVCL_E7NV
SY   JIPSC003132
WW   Provider; JAX; JIPSC003132; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003132
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Gln33Ter (c.97C>T); ClinVar=VCV000005219; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TREM2 R47H SNV/SNV
AC   CVCL_E7NW
SY   JIPSC003140
WW   Provider; JAX; JIPSC003140; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003140
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TREM2 R47H SNV/WT
AC   CVCL_E7NX
SY   JIPSC003142
WW   Provider; JAX; JIPSC003142; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003142
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J TREM2 R62H REV/WT
AC   CVCL_E4V4
SY   JIPSC003034
WW   Provider; JAX; JIPSC003034; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003034
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited TREM2 p.Arg62His (c.185G>A) cell line (JAX=JIPSC003034).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4V6 ! KOLF2.1J TREM2 R62H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 R62H SNV/SNV
AC   CVCL_E4V5
SY   JIPSC003032
WW   Provider; JAX; JIPSC003032; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003032
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Arg62His (c.185G>A); ClinVar=VCV000445645; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 R62H SNV/WT
AC   CVCL_E4V6
SY   JIPSC003030
WW   Provider; JAX; JIPSC003030; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003030
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Arg62His (c.185G>A); ClinVar=VCV000445645; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 T66M REV/REV
AC   CVCL_E4V7
SY   JIPSC003086
WW   Provider; JAX; JIPSC003086; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003086
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the homozygously edited TREM2 p.Thr66Met (c.197C>T) cell line (JAX=JIPSC003086).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4V8 ! KOLF2.1J TREM2 T66M SNV/SNV
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 T66M SNV/SNV
AC   CVCL_E4V8
SY   JIPSC003084
WW   Provider; JAX; JIPSC003084; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003084
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Thr66Met (c.197C>T); ClinVar=VCV000192242; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J TREM2 T66M SNV/WT
AC   CVCL_E4V9
SY   JIPSC003082
WW   Provider; JAX; JIPSC003082; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003082
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple_edited; p.Thr66Met (c.197C>T); ClinVar=VCV000192242; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J UBQLN2 P497H REV/Y
AC   CVCL_E7N0
SY   JIPSC001336
WW   Provider; JAX; JIPSC001336; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001336
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the hemizygously edited UBQLN2 p.Pro497His (c.1490C>A) cell line (JAX=JIPSC001336).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214855; Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7N1 ! KOLF2.1J UBQLN2 P497H SNV/Y
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J UBQLN2 P497H SNV/Y
AC   CVCL_E7N1
SY   JIPSC001316
WW   Provider; JAX; JIPSC001316; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001316
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12509; UBQLN2; Simple_edited; p.Pro497His (c.1490C>A); ClinVar=VCV000029950; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214855; Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J UBQLN2 P506T REV/Y
AC   CVCL_E7N2
SY   JIPSC001114
WW   Provider; JAX; JIPSC001114; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001114
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the hemizygously edited UBQLN2 p.Pro506Thr (c.1516C>A) cell line (JAX=JIPSC001114).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214855; Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7N3 ! KOLF2.1J UBQLN2 P506T SNV/Y
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J UBQLN2 P506T SNV/Y
AC   CVCL_E7N3
SY   JIPSC001112
WW   Provider; JAX; JIPSC001112; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001112
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12509; UBQLN2; Simple_edited; p.Pro506Thr (c.1516C>A); ClinVar=VCV000029952; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C214855; Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KOLF2.1J VAPB 54.8kbdel DEL/DEL
AC   CVCL_E7NS
SY   JIPSC001880
WW   Provider; JAX; JIPSC001880; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001880
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12649; VAPB.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VAPB D130E REV/WT
AC   CVCL_E7N4
SY   JIPSC001516
WW   Provider; JAX; JIPSC001516; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001516
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited VAPB p.Asp130Glu (c.390T>G) cell line (JAX=JIPSC001516).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168751; Amyotrophic lateral sclerosis 8
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7N6 ! KOLF2.1J VAPB D130E SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VAPB D130E SNV/SNV
AC   CVCL_E7N5
SY   JIPSC001512
WW   Provider; JAX; JIPSC001512; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001512
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12649; VAPB; Simple_edited; p.Asp130Glu (c.390T>G); ClinVar=VCV000259538; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168751; Amyotrophic lateral sclerosis 8
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VAPB D130E SNV/WT
AC   CVCL_E7N6
SY   JIPSC001514
WW   Provider; JAX; JIPSC001514; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001514
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12649; VAPB; Simple_edited; p.Asp130Glu (c.390T>G); ClinVar=VCV000259538; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168751; Amyotrophic lateral sclerosis 8
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VAPB P56S SNV/SNV
AC   CVCL_E7N7
SY   JIPSC003152
WW   Provider; JAX; JIPSC003152; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003152
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12649; VAPB; Simple_edited; p.Pro56Ser (c.166C>T); ClinVar=VCV000004806; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168751; Amyotrophic lateral sclerosis 8
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VAPB P56S SNV/WT
AC   CVCL_E7N8
SY   JIPSC003154
WW   Provider; JAX; JIPSC003154; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003154
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12649; VAPB; Simple_edited; p.Pro56Ser (c.166C>T); ClinVar=VCV000004806; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168751; Amyotrophic lateral sclerosis 8
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VCP 11.4kbdel DEL/WT
AC   CVCL_E4QW
SY   JIPSC001676
WW   Provider; JAX; JIPSC001676; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001676
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12666; VCP (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   KOLF2.1J VCP R155C REV/WT
AC   CVCL_E4QQ
SY   JIPSC003000
WW   Provider; JAX; JIPSC003000; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003000
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited VCP p.Gln125Ter (c.373C>T) cell line (JAX=JIPSC003000).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4QS ! KOLF2.1J VCP R155C SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VCP R155C SNV/SNV
AC   CVCL_E4QR
SY   JIPSC002098
WW   Provider; JAX; JIPSC002098; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002098
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple_edited; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VCP R155C SNV/WT
AC   CVCL_E4QS
SY   JIPSC002096
WW   Provider; JAX; JIPSC002096; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC002096
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple_edited; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VCP R159H REV/WT
AC   CVCL_E4QT
SY   JIPSC001072
WW   Provider; JAX; JIPSC001072; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001072
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited VCP p.Arg159His (c.476G>A) cell line (JAX=JIPSC001072).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4QV ! KOLF2.1J VCP R159H SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VCP R159H SNV/SNV
AC   CVCL_E4QU
SY   JIPSC001068
WW   Provider; JAX; JIPSC001068; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001068
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple_edited; p.Arg159His (c.476G>A); ClinVar=VCV000008474; Zygosity=Homozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VCP R159H SNV/WT
AC   CVCL_E4QV
SY   JIPSC001070
WW   Provider; JAX; JIPSC001070; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001070
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple_edited; p.Arg159His (c.476G>A); ClinVar=VCV000008474; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VIPR2 72.1kbdel DEL/DEL
AC   CVCL_E4PY
SY   JIPSC001982
WW   Provider; JAX; JIPSC001982; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001982
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12695; VIPR2.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VPS13C 103.8kbdel DEL/DEL
AC   CVCL_E4TQ
SY   JIPSC001882
WW   Provider; JAX; JIPSC001882; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001882
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLF2.1J VPS13C c8445 REV/WT
AC   CVCL_E7N9
SY   JIPSC003016
WW   Provider; JAX; JIPSC003016; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003016
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited VPS13C c.8445+2T>G cell line (JAX=JIPSC003016).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7NA ! KOLF2.1J VPS13C c8445 SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VPS13C c8445 SNV/WT
AC   CVCL_E7NA
SY   JIPSC003014
WW   Provider; JAX; JIPSC003014; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC003014
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; c.8445+2T>G; ClinVar=VCV000222067; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Splice donor mutation (JAX).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KOLF2.1J VPS13D 157.2kbdel DEL/WT
AC   CVCL_E4PZ
SY   JIPSC001920
WW   Provider; JAX; JIPSC001920; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001920
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23595; VPS13D (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   KOLT-2
AC   CVCL_VR94
SY   Kolt-2
DR   Wikidata; Q95962291
RX   PubMed=1668677;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10747; Human CD28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   KON
AC   CVCL_3001
DR   CLO; CLO_0009946
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 913
DR   BioSample; SAMN03471653
DR   cancercelllines; CVCL_3001
DR   Cell_Model_Passport; SIDM00604
DR   CGH-DB; 369-2
DR   Cosmic; 1995473
DR   Cosmic-CLP; 1298215
DR   DepMap; ACH-001542
DR   EGA; EGAS00001000978
DR   GDSC; 1298215
DR   GEO; GSM827191
DR   GEO; GSM1669999
DR   JCRB; JCRB0194
DR   LINCS_LDP; LCL-1207
DR   PharmacoDB; KON_778_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3001
DR   Wikidata; Q54900289
RX   DOI=10.5794/jjoms.41.19;
RX   PubMed=17599052;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 32.5 hours (Note=At 28th passage) (DOI=10.5794/jjoms.41.19); 43 hours (Note=Lot 01262007) (JCRB=JCRB0194).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.36%; Native American=0.46%; East Asian, North=79.36%; East Asian, South=18.6%; South Asian=0.7%; European, North=0.27%; European, South=0.25% (PubMed=30894373).
CC   Misspelling: KOS; CGH-DB=369-2.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=1298215; DepMap=ACH-001542; JCRB=JCRB0194
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 12,16
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16,17 (JCRB=JCRB0194)
ST   vWA: 17 (Cosmic-CLP=1298215; DepMap=ACH-001542)
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   KONT
AC   CVCL_F0C6
RX   DOI=10.2183/pjab.54.548;
CC   Population: Japanese.
CC   Characteristics: Tumorigenic in nude mice (DOI=10.2183/pjab.54.548).
CC   Doubling time: ~32 hours (DOI=10.2183/pjab.54.548).
CC   Anecdotal: Cell line name corresponds to the first letters of the names of the first three and of the last authors.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KOP
AC   CVCL_6753
SY   Knockout Of P38
DR   CLO; CLO_0050529
DR   RCB; RCB2148
DR   Wikidata; Q54900290
RX   PubMed=16198317;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346865; Mapk14.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12-13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   KOP-R
AC   CVCL_D289
SY   Kop-R; KOP/R
DR   CCLV; CCLV-RIE 0244
DR   Wikidata; Q54900291
RX   PubMed=17900332;
RX   PubMed=24973239;
RX   PubMed=25565633;
CC   Virology: Not susceptible to infection by wild-type and vaccinal strains of myxoma virus (MYXV) (PubMed=17900332).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   KOPB-26
AC   CVCL_7972
SY   KOPB26
DR   cancercelllines; CVCL_7972
DR   Cosmic; 1150900
DR   IARC_TP53; 28408
DR   Wikidata; Q54900292
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=3491484;
RX   PubMed=8180386;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=14671638;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=14671638).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (PubMed=20575032).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283fs (c.849_861delCACAGAGGAAGAG); Zygosity=Unspecified (PubMed=20575032).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   KOPB-38
AC   CVCL_W277
SY   KOPB38
DR   Wikidata; Q54900293
RX   PubMed=10360377;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 8
//
ID   KOPM-28
AC   CVCL_7973
SY   KOPM28
DR   Cosmic; 787497
DR   Wikidata; Q54900295
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3494166;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=12506034;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=12506034).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   KOPM-30
AC   CVCL_7974
SY   KOPM30
DR   cancercelllines; CVCL_7974
DR   IARC_TP53; 2680
DR   Wikidata; Q54900296
RX   PubMed=8289498;
RX   PubMed=10071072;
RX   PubMed=10637496;
RX   PubMed=10942233;
RX   PubMed=12506034;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072; PubMed=12506034).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Hemizygous (PubMed=8289498).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7976 ! KOPN-30bi
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   KOPM-53
AC   CVCL_7975
SY   KOPM53
DR   Wikidata; Q54900297
RX   PubMed=10942233;
RX   PubMed=12506034;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=12506034).
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   KOPM-88
AC   CVCL_M647
SY   KOPM88
DR   Wikidata; Q54900298
RX   PubMed=17408461;
CC   Population: Japanese.
CC   Misspelling: KOMP88; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   KOPN-1
AC   CVCL_3937
SY   Kopn-1; KOPN1
DR   BTO; BTO_0004944
DR   cancercelllines; CVCL_3937
DR   Cosmic; 996302
DR   Cosmic; 1037721
DR   Cosmic; 2391172
DR   IARC_TP53; 28407
DR   Wikidata; Q54900299
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=8180386;
RX   PubMed=9738977;
RX   PubMed=10360377;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=14671638; PubMed=15843827).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   KOPN-30bi
AC   CVCL_7976
SY   KOPN30bi; KOPN30
DR   IARC_TP53; 28422
DR   Wikidata; Q54900300
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8464237;
RX   PubMed=10071072;
RX   PubMed=10360377;
RX   PubMed=10739008;
RX   PubMed=10942233;
RX   PubMed=10995006;
RX   PubMed=11226526;
RX   PubMed=12506034;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072; PubMed=12506034).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7974 ! KOPM-30
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   KOPN-32
AC   CVCL_A325
SY   Kopn-32; KOPN32; Kopn32
DR   cancercelllines; CVCL_A325
DR   IARC_TP53; 2681
DR   IARC_TP53; 28433
DR   Wikidata; Q54900301
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289498;
RX   PubMed=10360377;
RX   PubMed=10490826;
RX   PubMed=10995006;
RX   PubMed=20575032;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220fs (c.658delT); Zygosity=Unspecified (PubMed=20575032).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Arg (c.733G>C); ClinVar=VCV000376604; Zygosity=Hemizygous (PubMed=8289498).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   KOPN-34
AC   CVCL_A326
SY   KOPN34
DR   IARC_TP53; 28417
DR   Wikidata; Q54900302
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   KOPN-35
AC   CVCL_A327
SY   Kopn-35; KOPN35; Kopn35
DR   cancercelllines; CVCL_A327
DR   IARC_TP53; 2682
DR   Wikidata; Q54900303
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289498;
RX   PubMed=10360377;
RX   PubMed=10490826;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Val (c.769C>G); ClinVar=VCV000827201; Zygosity=Hemizygous (PubMed=8289498; PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   KOPN-36
AC   CVCL_A328
SY   Kopn-36; KOPN36; Kopn36
DR   cancercelllines; CVCL_A328
DR   IARC_TP53; 28418
DR   Wikidata; Q54900304
RX   PubMed=10360377;
RX   PubMed=10490826;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Ala769Thr (c.2305G>A); dbSNP=rs991357362; Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro219Ser (c.655C>T); ClinVar=VCV000245673; Zygosity=Unspecified (PubMed=20575032).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   KOPN-39
AC   CVCL_W273
SY   KOPN39
DR   Wikidata; Q54900305
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10360377;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 9
//
ID   KOPN-40
AC   CVCL_LI34
SY   KOPN40
DR   IARC_TP53; 23569
DR   Wikidata; Q54900306
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289498;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 30-01-24; Version: 9
//
ID   KOPN-41
AC   CVCL_3943
SY   KOPN41
DR   BTO; BTO_0004943
DR   Cosmic; 996301
DR   Cosmic; 1037723
DR   Wikidata; Q54900307
RX   DOI=10.11412/jjph1987.13.86;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=14504097;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=28569787; PubMed=29786757; PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   KOPN-46
AC   CVCL_W274
SY   KOPN46
DR   Wikidata; Q54900308
RX   PubMed=10360377;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 8
//
ID   KOPN-47
AC   CVCL_W275
SY   KOPN47
DR   Wikidata; Q54900309
RX   PubMed=10360377;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 8
//
ID   KOPN-49
AC   CVCL_W276
SY   KOPN49
DR   IARC_TP53; 2683
DR   Wikidata; Q54900310
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289498;
RX   PubMed=10360377;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:14281; CRLF2 + HGNC; HGNC:5477; IGH; Name(s)=CRLF-IgH (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Arg683Gly (c.2047A>G); ClinVar=VCV000375951; Zygosity=Unspecified (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282fs (c.845delGinsCCC); Zygosity=Hemizygous (PubMed=8289498).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   KOPN-54
AC   CVCL_A329
SY   Kopn-54; KOPN54; Kopn54
DR   Wikidata; Q54900311
RX   PubMed=10490826;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=28569787; PubMed=29786757).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   KOPN-55bi
AC   CVCL_7977
SY   KOPN55bi
DR   Wikidata; Q54900312
RX   PubMed=10360377;
RX   PubMed=10739008;
RX   PubMed=10942233;
RX   PubMed=10995006;
RX   PubMed=11226526;
RX   PubMed=12506034;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=12506034).
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   KOPN-56
AC   CVCL_D3Z3
SY   KOPN56
DR   Wikidata; Q127382566
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=29786757).
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   8Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KOPN-57bi
AC   CVCL_7978
SY   KOPN57bi
DR   IARC_TP53; 28423
DR   Wikidata; Q54900313
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10071072;
RX   PubMed=10360377;
RX   PubMed=10942233;
RX   PubMed=10995006;
RX   PubMed=12506034;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072; PubMed=12506034).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   KOPN-60
AC   CVCL_A330
SY   KOPN60
DR   Wikidata; Q54900314
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=20519628;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   KOPN-61
AC   CVCL_A331
SY   KOPN61
DR   IARC_TP53; 28434
DR   Wikidata; Q54900316
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 12
//
ID   KOPN-62
AC   CVCL_A332
SY   KOPN62
DR   Wikidata; Q54900317
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10995006;
RX   PubMed=20519628;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   KOPN-63
AC   CVCL_A333
SY   Kopn-63; KOPN63; Kopn63
DR   cancercelllines; CVCL_A333
DR   IARC_TP53; 2684
DR   IARC_TP53; 28419
DR   Wikidata; Q54900320
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8289498;
RX   PubMed=10360377;
RX   PubMed=10490826;
RX   PubMed=10995006;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209fs (c.627_632del6ins10); Zygosity=Hemizygous (PubMed=8289498).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=20575032).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly293fs (c.879_880insCC); Zygosity=Unspecified (PubMed=20575032).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   KOPN-66bi
AC   CVCL_7979
SY   KOPN66bi
DR   IARC_TP53; 28424
DR   Wikidata; Q54900321
RX   PubMed=10360377;
RX   PubMed=10942233;
RX   PubMed=10995006;
RX   PubMed=12506034;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=12506034).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   KOPN-67
AC   CVCL_7980
SY   KOPN67; KO-PN-67
DR   Wikidata; Q54900322
RX   PubMed=10942233;
RX   PubMed=10995006;
CC   Population: Japanese.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   KOPN-68
AC   CVCL_D3ZV
SY   KOPN68
DR   Wikidata; Q127382567
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=29786757; PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KOPN-70
AC   CVCL_D3ZW
SY   KOPN70
DR   Wikidata; Q127382568
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Ala384Thr (c.1150G>A); dbSNP=rs767422079; Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   KOPN-71
AC   CVCL_D3ZX
SY   KOPN71
DR   Wikidata; Q127382569
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KOPN-72bi
AC   CVCL_7981
SY   KOPN72bi
DR   IARC_TP53; 28425
DR   Wikidata; Q54900323
RX   PubMed=10360377;
RX   PubMed=10942233;
RX   PubMed=10995006;
RX   PubMed=12506034;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=12506034).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   KOPN-75
AC   CVCL_D3Z2
SY   KOPN75
DR   Wikidata; Q127382570
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:8619; PAX5; Name(s)=PAX5-ETV6 (PubMed=29786757; PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KOPN-79
AC   CVCL_A334
SY   KOPN79
DR   Wikidata; Q54900324
RX   PubMed=20519628;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=29786757; PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   KOPN-8
AC   CVCL_1866
SY   Kopn-8; KOPN8
DR   CLO; CLO_0037178
DR   EFO; EFO_0022428
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473535
DR   BioSample; SAMN10988515
DR   cancercelllines; CVCL_1866
DR   Cell_Model_Passport; SIDM01034
DR   ChEMBL-Cells; CHEMBL4295381
DR   ChEMBL-Targets; CHEMBL4296456
DR   Cosmic; 998710
DR   Cosmic; 999747
DR   Cosmic; 1037722
DR   Cosmic; 1130256
DR   Cosmic; 1191708
DR   Cosmic; 2491068
DR   Cosmic; 2542838
DR   Cosmic-CLP; 1330933
DR   DepMap; ACH-001106
DR   DSMZ; ACC-552
DR   DSMZCellDive; ACC-552
DR   EGA; EGAS00001000978
DR   GDSC; 1330933
DR   GEO; GSM887234
DR   GEO; GSM888308
DR   GEO; GSM1670000
DR   GEO; GSM5137722
DR   GEO; GSM5137766
DR   IARC_TP53; 28230
DR   LiGeA; CCLE_069
DR   LINCS_LDP; LCL-1088
DR   PharmacoDB; KOPN8_779_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1866
DR   PubChem_Cell_line; CVCL_1866
DR   Wikidata; Q54900325
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10233379;
RX   PubMed=14671638;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (DSMZ=ACC-552).
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03 (PubMed=26589293).
CC   HLA typing: A*33:03:01,33:03:01; B*44:03:01,44:03:01; C*14:03,14:03; DPA1*01:03:01,02:02:02; DPB1*04:01:01,02:01:02; DQA1*01:02:01,01:02:01; DQB1*06:09:01,06:09:01; DRA*01:02:02,01:02:02; DRB1*13:02:01,13:02:01 (DSMZCellDive=ACC-552).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7134; MLLT1; Name(s)=KMT2A-MLLT1, MLL-MLLT1, MLL-ENL (PubMed=31160637; PubMed=35354797; DSMZ=ACC-552).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=1330933; DepMap=ACH-001106).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=1330933; DepMap=ACH-001106).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.7%; Native American=0%; East Asian, North=80.77%; East Asian, South=13.03%; South Asian=0%; European, North=0%; European, South=2.49% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1330933; DSMZ=ACC-552
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,22
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   D8S1179: 13,16
ST   FGA: 18,21
ST   Penta D: 12,13
ST   Penta E: 12,20
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   KOPN-83bi
AC   CVCL_W271
SY   KOPN83bi
DR   IARC_TP53; 28427
DR   Wikidata; Q54900326
RX   PubMed=10360377;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10360377).
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   KOPN-84
AC   CVCL_A335
SY   KOPN84
DR   Wikidata; Q54900327
RX   PubMed=20519628;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 10
//
ID   KOPN-85
AC   CVCL_D3ZZ
SY   KOPN85
DR   Wikidata; Q127382571
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Trp557Ter (c.1671G>A) (p.Trp558Ter, c.1674G>A); Zygosity=Homozygous (PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KOPN-87
AC   CVCL_D4A0
SY   KOPN87
DR   Wikidata; Q127382573
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   KOPN-K
AC   CVCL_A638
SY   KOPNK
DR   Cosmic; 998695
DR   Cosmic; 1037724
DR   Wikidata; Q54900328
RX   PubMed=9680106;
RX   PubMed=10233379;
RX   PubMed=10360377;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757; PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   KOPT-11
AC   CVCL_A111
SY   KOPT11
DR   Wikidata; Q54900330
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=20519628;
RX   PubMed=28569787;
CC   Population: Japanese.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 9
//
ID   KOPT-4
AC   CVCL_A112
SY   KOPT4
DR   Cosmic; 721702
DR   Cosmic; 1375592
DR   IARC_TP53; 10565
DR   Wikidata; Q54900331
RX   PubMed=10071127;
RX   PubMed=10360377;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Alafs*71 (c.526delT); Zygosity=Hemizygous (PubMed=10071127).
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   KOPT-5
AC   CVCL_A113
SY   KOPT5
DR   Wikidata; Q54900333
RX   DOI=10.2177/jsci.16.338;
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=20519628;
RX   PubMed=28569787;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 14
//
ID   KOPT-6
AC   CVCL_A114
SY   KOPT6
DR   Cosmic; 1281373
DR   Cosmic; 2602919
DR   Wikidata; Q54900334
RX   PubMed=10360377;
RX   PubMed=10995006;
RX   PubMed=20519628;
CC   Population: Japanese.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 9
//
ID   KOPT-K1
AC   CVCL_4965
SY   KOPT-KI; KOPTK-1; KOPTK1; KopTK1; Koptk1
DR   BTO; BTO_0004964
DR   EFO; EFO_0006283
DR   cancercelllines; CVCL_4965
DR   ChEMBL-Cells; CHEMBL4483146
DR   ChEMBL-Targets; CHEMBL4483252
DR   Cosmic; 721714
DR   Cosmic; 913407
DR   Cosmic; 944545
DR   Cosmic; 998730
DR   Cosmic; 1037683
DR   Cosmic; 1115584
DR   Cosmic; 1151783
DR   Cosmic; 1224374
DR   Cosmic; 1524801
DR   Cosmic; 1641389
DR   ENCODE; ENCBS345YKN
DR   ENCODE; ENCBS869LIS
DR   GEO; GSM3145584
DR   GEO; GSM3145713
DR   PubChem_Cell_line; CVCL_4965
DR   Wikidata; Q54900335
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=7475267;
RX   PubMed=8957066;
RX   PubMed=10071127;
RX   PubMed=10360377;
RX   PubMed=10739008;
RX   PubMed=10995006;
RX   PubMed=11226526;
RX   PubMed=15472075;
RX   PubMed=20519628;
RX   PubMed=28569787;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/kopt-k1/
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (PubMed=15472075).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   KOR B-LCL
AC   CVCL_C5VV
DR   Wikidata; Q116049623
RX   PubMed=10843661;
CC   HLA typing: A*24,28; B*27:02,44 (PubMed=10843661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   KOS-001
AC   CVCL_GY89
SY   BWKOS
DR   Wikidata; Q54900336
RX   PubMed=21848623;
RX   PubMed=31640712;
CC   Doubling time: 16.8 hours (PubMed=21848623); 17.02 hours (PubMed=31640712).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
CC   Breed/subspecies: Border Collie; VBO=VBO_0200193.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   7Y7M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   KOS-002
AC   CVCL_GY90
SY   CSKOS
DR   Wikidata; Q54900338
RX   PubMed=21848623;
RX   PubMed=25190452;
CC   Doubling time: 24.7 hours (PubMed=21848623).
CC   Derived from site: In situ; Bone, left distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Irish Setter; VBO=VBO_0200702.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   KOS-003
AC   CVCL_GY91
SY   MCKOS
DR   Wikidata; Q54900339
RX   PubMed=21848623;
RX   PubMed=24416158;
CC   Doubling time: 16.0 hours (PubMed=21848623).
CC   Derived from site: In situ; Bone, right distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Labrador Retriever x Unspecified breed; VBO=VBO_0200800+VBO_0400024.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   7Y6M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   KOS-004
AC   CVCL_GY92
SY   SKKOS
DR   Wikidata; Q54900340
RX   PubMed=21848623;
CC   Doubling time: 12.1 hours (PubMed=21848623).
CC   Derived from site: In situ; Bone, left distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   8Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   KOS-1
AC   CVCL_A7NT
DR   Wikidata; Q107115603
RX   PubMed=10948649;
CC   Population: Japanese.
CC   Doubling time: 27.4 hours (PubMed=10948649).
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   KOS-6-1
AC   CVCL_C0X6
DR   Wikidata; Q114311826
RX   PubMed=4355928;
CC   Transformant: NCBI_TaxID; 10306; Human herpesvirus 1 (strain KOS) (HHV-1).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 5
//
ID   KOS20
AC   CVCL_D4A2
DR   Wikidata; Q127382574
RX   PubMed=29786757;
RX   PubMed=35124168;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KOSC-2
AC   CVCL_1337
SY   KOSC2; KOSC-2 cl3-43; KOSC2CL343; Kobe university Oral Squamous Cell culture-2
DR   BTO; BTO_0005968
DR   CLO; CLO_0009947
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470801
DR   cancercelllines; CVCL_1337
DR   Cell_Model_Passport; SIDM00603
DR   CGH-DB; 371-2
DR   ChEMBL-Cells; CHEMBL3308750
DR   ChEMBL-Targets; CHEMBL1075481
DR   Cosmic; 753570
DR   Cosmic-CLP; 753570
DR   DepMap; ACH-001543
DR   DepMap; ACH-002260
DR   EGA; EGAS00001000978
DR   GDSC; 753570
DR   GEO; GSM827195
DR   GEO; GSM1670001
DR   IARC_TP53; 21439
DR   JCRB; JCRB0126.1
DR   LINCS_LDP; LCL-1227
DR   PharmacoDB; KOSC2_780_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1337
DR   PubChem_Cell_line; CVCL_1337
DR   Wikidata; Q54900341
RX   PubMed=8314315;
RX   PubMed=17599052;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 18.7 hours (PubMed=8314315).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Gln (c.14G>A); ClinVar=VCV000376520; Zygosity=Heterozygous (Cosmic-CLP=753570; DepMap=ACH-001543).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu40Gln (c.118G>C); ClinVar=VCV000376517; Zygosity=Heterozygous (Cosmic-CLP=753570; DepMap=ACH-001543).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln52delinsProTer (c.154_155insCAT); Zygosity=Heterozygous (Cosmic-CLP=753570; DepMap=ACH-001543).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.44%; Native American=0%; East Asian, North=72.8%; East Asian, South=22.55%; South Asian=0%; European, North=0%; European, South=3.2% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-002260; true.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): Cosmic-CLP=753570; DepMap=ACH-001543; JCRB=JCRB0126.1
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13
ST   D21S11: 29,31
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 9,10
ST   Penta E: 15
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   KOSC-3
AC   CVCL_2789
SY   KOSC3; Kobe university Oral Squamous Cell culture-3
DR   BTO; BTO_0005969
DR   BioSample; SAMN03151615
DR   BioSample; SAMN03470802
DR   cancercelllines; CVCL_2789
DR   Cosmic; 753571
DR   Cosmic; 1120706
DR   IARC_TP53; 2969
DR   JCRB; JCRB0127
DR   JCRB; NIHS0166
DR   Wikidata; Q54900342
RX   PubMed=8314315;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a Ca9-22 derivative (PubMed=20143388). Originally thought to originate from a 72 year old female patient with a lower-gingiva squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00324.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=8314315).
CC   Discontinued: JCRB; NIHS0166; true.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): JCRB=JCRB0127
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1102 ! Ca9-22
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   KOSCC-11
AC   CVCL_S681
SY   Korean Oral Squamous Cell Carcinoma cell line-11
DR   Cosmic; 2266789
DR   Wikidata; Q54900343
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=12011992).
CC   Microsatellite instability: Stable (MSS) (PubMed=12011992).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   KOSCC-25A
AC   CVCL_S682
SY   Korean Oral Squamous Cell Carcinoma cell line-25A
DR   cancercelllines; CVCL_S682
DR   Wikidata; Q54900344
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 22 hours (PubMed=12011992).
CC   Microsatellite instability: Stable (MSS) (PubMed=12011992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (PubMed=12011992).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S683 ! KOSCC-25B
OI   CVCL_S684 ! KOSCC-25C
OI   CVCL_S685 ! KOSCC-25D
OI   CVCL_S686 ! KOSCC-25E
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   KOSCC-25B
AC   CVCL_S683
SY   Korean Oral Squamous Cell Carcinoma cell line-25B
DR   cancercelllines; CVCL_S683
DR   Cosmic; 2266790
DR   Wikidata; Q54900345
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 26 hours (PubMed=12011992).
CC   Microsatellite instability: Stable (MSS) (PubMed=12011992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (PubMed=12011992).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S682 ! KOSCC-25A
OI   CVCL_S684 ! KOSCC-25C
OI   CVCL_S685 ! KOSCC-25D
OI   CVCL_S686 ! KOSCC-25E
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   KOSCC-25C
AC   CVCL_S684
SY   Korean Oral Squamous Cell Carcinoma cell line-25C
DR   cancercelllines; CVCL_S684
DR   Wikidata; Q54900346
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=12011992).
CC   Microsatellite instability: Stable (MSS) (PubMed=12011992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (PubMed=12011992).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S682 ! KOSCC-25A
OI   CVCL_S683 ! KOSCC-25B
OI   CVCL_S685 ! KOSCC-25D
OI   CVCL_S686 ! KOSCC-25E
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   KOSCC-25D
AC   CVCL_S685
SY   Korean Oral Squamous Cell Carcinoma cell line-25D
DR   cancercelllines; CVCL_S685
DR   Wikidata; Q54900347
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 18 hours (PubMed=12011992).
CC   Microsatellite instability: Stable (MSS) (PubMed=12011992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (PubMed=12011992).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S682 ! KOSCC-25A
OI   CVCL_S683 ! KOSCC-25B
OI   CVCL_S684 ! KOSCC-25C
OI   CVCL_S686 ! KOSCC-25E
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   KOSCC-25E
AC   CVCL_S686
SY   Korean Oral Squamous Cell Carcinoma cell line-25E
DR   cancercelllines; CVCL_S686
DR   Wikidata; Q54900348
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 28 hours (PubMed=12011992).
CC   Microsatellite instability: Stable (MSS) (PubMed=12011992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (PubMed=12011992).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S682 ! KOSCC-25A
OI   CVCL_S683 ! KOSCC-25B
OI   CVCL_S684 ! KOSCC-25C
OI   CVCL_S685 ! KOSCC-25D
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   KOSCC-33A
AC   CVCL_S687
SY   Korean Oral Squamous Cell Carcinoma cell line-33A
DR   cancercelllines; CVCL_S687
DR   Cosmic; 2266791
DR   Wikidata; Q54900349
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=12011992).
CC   Microsatellite instability: Instable (MSI) (PubMed=12011992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (PubMed=12011992).
CC   Caution: KOSCC-33A and KOSCC-33B originate from the same patient, but in table 1 of PubMed=12011992 KOSCC-33A is indicated to originate from a 64 year old male patient while KOSCC-33B from a 64 year old female patient.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S688 ! KOSCC-33B
SX   Sex unspecified
AG   64Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   KOSCC-33B
AC   CVCL_S688
SY   Korean Oral Squamous Cell Carcinoma cell line-33B
DR   cancercelllines; CVCL_S688
DR   Wikidata; Q54900350
RX   PubMed=12011992;
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=12011992).
CC   Microsatellite instability: Stable (MSS) (PubMed=12011992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (PubMed=12011992).
CC   Caution: KOSCC-33A and KOSCC-33B originate from the same patient, but in table 1 of PubMed=12011992 KOSCC-33A is indicated to originate from a 64 year old male patient while KOSCC-33B from a 64 year old female patient.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S687 ! KOSCC-33A
SX   Sex unspecified
AG   64Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   KOSE
AC   CVCL_E729
DR   EFO; EFO_0022579
DR   dbMHC; 48927
DR   ECACC; 88052056
DR   IHW; IHW09056
DR   IPD-IMGT/HLA; 10927
DR   Wikidata; Q54900351
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; German.
CC   HLA typing: A*02:01:01:01; B*35:03:01:01; C*12:03:01:01; DPA1*01:03:01,02:01:01; DPB1*02:01:02/02:01:19,13:01:01/107:01; DQA1*01:04:01,01:02:01; DQB1*05:03:01,06:04:01; DRA*01:01,01:02; DRB1*13:02:01,14:54:01; DRB3*03:01:01,02:02:01 (IPD-IMGT/HLA=10927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   KOT-1
AC   CVCL_N511
DR   Wikidata; Q54900352
RX   PubMed=9566709;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=9566709).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N512 ! KOT-2
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   KOT-2
AC   CVCL_N512
DR   Wikidata; Q54900353
RX   PubMed=9566709;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=9566709).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N511 ! KOT-1
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   KOT52
AC   CVCL_B5NT
DR   Wikidata; Q111733555
RX   PubMed=10485464;
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   KOT52/D320
AC   CVCL_B5NU
SY   D320
DR   Wikidata; Q111733556
RX   PubMed=10485464;
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Met (c.1445G>T); Zygosity=Heterozygous (PubMed=11956086).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5NT ! KOT52
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   KOT52/D80
AC   CVCL_B5NV
SY   D80
DR   Wikidata; Q111733558
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5NT ! KOT52
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   KOT52/D800
AC   CVCL_B5NW
SY   D800
DR   Wikidata; Q111733559
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Met (c.1445G>T); Zygosity=Heterozygous (PubMed=11956086).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5NT ! KOT52
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   KOWA
AC   CVCL_ZQ39
DR   Wikidata; Q98126832
RX   PubMed=1814424;
RX   PubMed=2778352;
RX   PubMed=7905727;
RX   PubMed=8596539;
RX   PubMed=9580660;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   KOZ
AC   CVCL_E730
SY   TER507; TER-507; Ter-507; Ter 507
DR   dbMHC; 48928
DR   ECACC; 94050341
DR   IHW; IHW09310
DR   IPD-IMGT/HLA; 10928
DR   Wikidata; Q54900354
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/383cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24,26; B*40,54:01; C*01; DPB1*02:01:02; DQA1*03; DQB1*03:03:02 (IPD-IMGT/HLA=10928).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   KP 1
AC   CVCL_A1IF
DR   Wikidata; Q102114429
RX   PubMed=758928;
RX   PubMed=7200272;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=7200272).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KP-1
AC   CVCL_RL94
DR   Wikidata; Q54900355
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8134164;
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=8134164).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   KP-1N
AC   CVCL_3002
SY   Kp-1N; KP-1 N; KP1N; KP1
DR   BTO; BTO_0003549
DR   CLO; CLO_0037105
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 914
DR   BioSample; SAMN03151887
DR   BioSample; SAMN10989578
DR   cancercelllines; CVCL_3002
DR   Cell_Model_Passport; SIDM00583
DR   CGH-DB; 173-1
DR   CGH-DB; 9368-4
DR   Cosmic; 918052
DR   Cosmic; 1122345
DR   Cosmic; 1518234
DR   Cosmic; 1995474
DR   Cosmic-CLP; 1298216
DR   DepMap; ACH-001107
DR   EGA; EGAS00001000978
DR   GDSC; 1298216
DR   GEO; GSM827208
DR   GEO; GSM1670002
DR   IARC_TP53; 30107
DR   JCRB; JCRB0177.0
DR   JCRB; NIHS0274.0
DR   LINCS_LDP; LCL-1793
DR   PharmacoDB; KP1N_781_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3002
DR   Wikidata; Q54900356
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2172194;
RX   PubMed=18380791;
RX   PubMed=20215515;
RX   PubMed=21607521;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PANC-1 derivative.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00374.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=21607521; Cosmic-CLP=1298216; DepMap=ACH-001107).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=21607521; Cosmic-CLP=1298216; DepMap=ACH-001107).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.39%; Native American=0.95%; East Asian, North=0%; East Asian, South=1.14%; South Asian=0.29%; European, North=65.14%; European, South=32.09% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0274.0; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): Cosmic-CLP=1298216; JCRB=JCRB0177.0
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   KP-1NL
AC   CVCL_3003
SY   KP-1N-L; KP-1-NL; KP1-NL; KP1NL
DR   CLO; CLO_0037106
DR   BioSample; SAMN10989577
DR   cancercelllines; CVCL_3003
DR   Cell_Model_Passport; SIDM01755
DR   CGH-DB; 174-1
DR   CGH-DB; 9369-4
DR   Cosmic; 918048
DR   DepMap; ACH-001108
DR   GEO; GSM1588617
DR   GEO; GSM1588629
DR   IARC_TP53; 30108
DR   JCRB; JCRB0177.1
DR   JCRB; NIHS0274.1
DR   LINCS_LDP; LCL-1794
DR   PharmacoDB; KP1NL_782_2019
DR   Wikidata; Q54900357
RX   PubMed=2172194;
RX   PubMed=18380791;
RX   PubMed=21607521;
RX   PubMed=25984343;
RX   PubMed=31068700;
CC   Problematic cell line: Contaminated. Parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 25 hours (PubMed=25984343).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=21607521; DepMap=ACH-001108).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=21607521; DepMap=ACH-001108).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: DepMap; ACH-001108; true.
CC   Discontinued: JCRB; NIHS0274.1; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB0177.1
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3002 ! KP-1N
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   KP-1NL-Luc#2
AC   CVCL_4Y21
SY   KP-1-NL-Luc#2
DR   cancercelllines; CVCL_4Y21
DR   JCRB; NIHS0714
DR   Wikidata; Q54900358
CC   Problematic cell line: Contaminated. Grand-parent cell line (KP-1N) has been shown to be a PANC-1 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0714; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3003 ! KP-1NL
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   KP-2
AC   CVCL_3004
SY   KP2
DR   BTO; BTO_0003550
DR   CLO; CLO_0037107
DR   EFO; EFO_0006621
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 615
DR   BioSample; SAMN03472830
DR   BioSample; SAMN03472944
DR   BioSample; SAMN10988261
DR   cancercelllines; CVCL_3004
DR   Cell_Model_Passport; SIDM00582
DR   CGH-DB; 175-1
DR   CGH-DB; 9370-4
DR   Cosmic; 918057
DR   Cosmic-CLP; 1298218
DR   DepMap; ACH-000281
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298218
DR   GEO; GSM887235
DR   GEO; GSM888309
DR   IARC_TP53; 28361
DR   JCRB; JCRB0181
DR   LiGeA; CCLE_694
DR   LINCS_LDP; LCL-1728
DR   PharmacoDB; KP2_783_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3004
DR   Wikidata; Q54900359
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2172194;
RX   PubMed=18380791;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=25984343).
CC   HLA typing: A*24:02,26:03; B*15:01,52:01; C*03:03,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (Cosmic-CLP=1298218; DepMap=ACH-000281).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp415Glufs*20 (c.1245_1248delCAGA); ClinVar=VCV000142253; Zygosity=Heterozygous (PubMed=18380791; Cosmic-CLP=1298218; DepMap=ACH-000281).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Asp (c.482C>A); ClinVar=VCV000422295; Zygosity=Homozygous (PubMed=21607521; DepMap=ACH-000281).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.37%; Native American=0%; East Asian, North=79.94%; East Asian, South=16.44%; South Asian=0%; European, North=0%; European, South=2.24% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): Cosmic-CLP=1298218; JCRB=JCRB0181; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,10 (JCRB=JCRB0181)
ST   D16S539: 10 (Cosmic-CLP=1298218; PubMed=25877200)
ST   D18S51: 14
ST   D21S11: 31,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   D8S1179: 14,17
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 12,13,15
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   KP-2/CMV-Luc
AC   CVCL_4W98
DR   cancercelllines; CVCL_4W98
DR   JCRB; JCRB1491
DR   JCRB; NIHS0715
DR   Wikidata; Q54900360
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1491).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp415Glufs*20 (c.1245_1248delCAGA); ClinVar=VCV000142253; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Asp (c.482C>A); ClinVar=VCV000422295; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0715; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1491
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3004 ! KP-2
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   KP-2N
AC   CVCL_0U12
DR   cancercelllines; CVCL_0U12
DR   Cosmic; 1122346
DR   Cosmic; 1518238
DR   Wikidata; Q54900361
RX   PubMed=2172194;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp415Glufs*20 (c.1245_1248delCAGA); ClinVar=VCV000142253; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Asp (c.482C>A); ClinVar=VCV000422295; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3004 ! KP-2
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   KP-3
AC   CVCL_3005
SY   KP3
DR   BTO; BTO_0003551
DR   CLO; CLO_0037108
DR   EFO; EFO_0006622
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 614
DR   BioSample; SAMN03471644
DR   BioSample; SAMN03472945
DR   BioSample; SAMN10987829
DR   cancercelllines; CVCL_3005
DR   Cell_Model_Passport; SIDM00571
DR   CGH-DB; 176-1
DR   CGH-DB; 9371-4
DR   Cosmic; 918053
DR   Cosmic-CLP; 1298219
DR   DepMap; ACH-000108
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298219
DR   GEO; GSM827292
DR   GEO; GSM887236
DR   GEO; GSM888310
DR   GEO; GSM1670003
DR   IARC_TP53; 28373
DR   JCRB; JCRB0178.0
DR   JCRB; NIHS0275.0
DR   LiGeA; CCLE_616
DR   LINCS_LDP; LCL-1723
DR   PharmacoDB; KP3_784_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3005
DR   Wikidata; Q54900364
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2172194;
RX   PubMed=18380791;
RX   PubMed=20215515;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=32782605;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~28 hours (Note=Lot 12012006), ~38 hours (Note=Lot 10112019) (JCRB=JCRB0178.0).
CC   HLA typing: A*24:02,24:02; B*35:01,35:01; C*08:01,08:01; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*03:02,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=21607521; Cosmic-CLP=1298219; DepMap=ACH-000108).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Glu538Ter (c.1612G>T); ClinVar=VCV000581974; Zygosity=Homozygous (PubMed=18380791; Cosmic-CLP=1298219; DepMap=ACH-000108).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (Cosmic-CLP=1298219; DepMap=ACH-000108).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=0.8%; East Asian, North=78.29%; East Asian, South=19.41%; South Asian=0.83%; European, North=0.07%; European, South=0.25% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0275.0; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Cosmic-CLP=1298219; JCRB=JCRB0178.0; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 12
ST   D12S391: 14
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 17
ST   D1S1656: 16,17.3
ST   D21S11: 30,32
ST   D22S1045: 11
ST   D2S1338: 18,20
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 15,17
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 17,18 (Cosmic-CLP=1298219; JCRB=JCRB0178.0)
ST   vWA: 18 (PubMed=25877200; Technion Genomics Center)
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   KP-3L
AC   CVCL_3006
SY   KP-3-L; KP3L; KP-3Ls
DR   CLO; CLO_0037109
DR   BioSample; SAMN03472946
DR   cancercelllines; CVCL_3006
DR   Cell_Model_Passport; SIDM00559
DR   CGH-DB; 177-1
DR   CGH-DB; 9372-4
DR   Cosmic; 918049
DR   JCRB; JCRB0178.1
DR   JCRB; NIHS0275.1
DR   LINCS_LDP; LCL-1724
DR   Wikidata; Q54900368
RX   PubMed=2172194;
RX   PubMed=18380791;
RX   PubMed=21607521;
RX   PubMed=25877200;
RX   PubMed=26216984;
CC   Population: Japanese.
CC   Characteristics: Established from parent cell line through a nude mice tumor.
CC   Doubling time: ~34 hours (Note=Lot 03222016), ~2 days (Note=Lot 06292006) (JCRB=JCRB0178.1).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=21607521).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Glu538Ter (c.1612G>T); ClinVar=VCV000581974; Zygosity=Homozygous (PubMed=18380791).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Metabolomics.
CC   Discontinued: JCRB; NIHS0275.1; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB0178.1; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D18S51: 17
ST   D21S11: 30,32,33
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 10,12 (JCRB=JCRB0178.1)
ST   D7S820: 12 (PubMed=25877200)
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 15,17
ST   TH01: 6,9.3 (PubMed=25877200)
ST   TH01: 6,10 (JCRB=JCRB0178.1)
ST   TPOX: 9,11 (JCRB=JCRB0178.1)
ST   TPOX: 11 (PubMed=25877200)
ST   vWA: 17,18 (JCRB=JCRB0178.1)
ST   vWA: 18 (PubMed=25877200)
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3005 ! KP-3
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KP-3L-Luc#5
AC   CVCL_4Y22
DR   cancercelllines; CVCL_4Y22
DR   JCRB; JCRB1542
DR   JCRB; NIHS0716
DR   Wikidata; Q54900369
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Glu538Ter (c.1612G>T); ClinVar=VCV000581974; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0716; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1542
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3006 ! KP-3L
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   KP-3N
AC   CVCL_0U13
DR   cancercelllines; CVCL_0U13
DR   Cell_Model_Passport; SIDM00558
DR   Cosmic; 1122347
DR   Wikidata; Q54900370
RX   PubMed=2172194;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Glu538Ter (c.1612G>T); ClinVar=VCV000581974; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3005 ! KP-3
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   KP-4
AC   CVCL_1338
SY   KP 4; KP4
DR   CLO; CLO_0037110
DR   CLO; CLO_0050109
DR   EFO; EFO_0006623
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 613
DR   BioSample; SAMN03472375
DR   BioSample; SAMN03472831
DR   BioSample; SAMN10987858
DR   cancercelllines; CVCL_1338
DR   Cell_Model_Passport; SIDM00301
DR   CGH-DB; 9373-4
DR   ChEMBL-Cells; CHEMBL3308751
DR   ChEMBL-Targets; CHEMBL1075482
DR   Cosmic; 753572
DR   Cosmic-CLP; 753572
DR   DepMap; ACH-000265
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753572
DR   GEO; GSM827214
DR   GEO; GSM887237
DR   GEO; GSM888311
DR   GEO; GSM1374602
DR   GEO; GSM1670004
DR   JCRB; JCRB0182
DR   LiGeA; CCLE_454
DR   LINCS_LDP; LCL-1725
DR   PharmacoDB; KP4_785_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1338
DR   PubChem_Cell_line; CVCL_1338
DR   RCB; RCB1005
DR   Wikidata; Q54900371
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21559554;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 27 hours (PubMed=25984343).
CC   HLA typing: A*02:06,24:02; B*48:01,51:01; C*08:03,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=753572; DepMap=ACH-000265).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.42%; East Asian, South=20.35%; South Asian=0%; European, North=1.23%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=753572; JCRB=JCRB0182; PubMed=25877200; RCB=RCB1005
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 21,25
ST   Penta D: 9,14
ST   Penta E: 12
ST   TH01: 9,10
ST   TPOX: 9 (PubMed=25877200)
ST   TPOX: 9,11 (Cosmic-CLP=753572; JCRB=JCRB0182)
ST   vWA: 14
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   KP-4-1
AC   CVCL_8727
SY   KP 4-1; KP4-1
DR   CLO; CLO_0050110
DR   cancercelllines; CVCL_8727
DR   GEO; GSM1588609
DR   GEO; GSM1588621
DR   RCB; RCB1006
DR   Wikidata; Q54900372
RX   PubMed=21559554;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB1006
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1338 ! KP-4
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   KP-4-2
AC   CVCL_8728
SY   KP 4-2; KP4-2
DR   CLO; CLO_0050111
DR   cancercelllines; CVCL_8728
DR   RCB; RCB1007
DR   Wikidata; Q54900373
RX   PubMed=21559554;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB1007
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1338 ! KP-4
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   KP-4-3
AC   CVCL_8729
SY   KP 4-3; KP4-3
DR   CLO; CLO_0050108
DR   cancercelllines; CVCL_8729
DR   RCB; RCB1008
DR   Wikidata; Q54900374
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB1008
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1338 ! KP-4
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   KP-4-4
AC   CVCL_Y142
DR   cancercelllines; CVCL_Y142
DR   CGH-DB; 178-1
DR   Cosmic; 918059
DR   Wikidata; Q54900376
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1338 ! KP-4
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   KP-6
AC   CVCL_9543
SY   KP6
DR   Wikidata; Q54900377
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8656685;
RX   PubMed=10936422;
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   KP-Cas9-Clone 7
AC   CVCL_C9B0
DR   BioGRID_ORCS_Cell_line; 1122
DR   Wikidata; Q123032845
RX   PubMed=31744829;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Phenotyping; CRISPR screening.
CC   Breed/subspecies: C57BL/6 KrasLSL-G12D/+, Trp53flox/flox (KP).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C9AY ! KP-Clone 7
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 7
//
ID   KP-Cas9-Clone 9
AC   CVCL_C9B1
DR   Wikidata; Q123032847
RX   PubMed=31744829;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Omics: Phenotyping; CRISPR screening.
CC   Breed/subspecies: C57BL/6 KrasLSL-G12D/+, Trp53flox/flox (KP).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C9AZ ! KP-Clone 9
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 7
//
ID   KP-Clone 7
AC   CVCL_C9AY
DR   Wikidata; Q123032849
RX   PubMed=31744829;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Breed/subspecies: C57BL/6 KrasLSL-G12D/+, Trp53flox/flox (KP).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C9AZ ! KP-Clone 9
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 4
//
ID   KP-Clone 9
AC   CVCL_C9AZ
DR   Wikidata; Q123032851
RX   PubMed=31744829;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Breed/subspecies: C57BL/6 KrasLSL-G12D/+, Trp53flox/flox (KP).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C9AY ! KP-Clone 7
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 4
//
ID   KP-EW-AK
AC   CVCL_A2FR
SY   Kyoto Pediatrics-Ewing sarcoma-AK
DR   Wikidata; Q105509806
RX   CelloPub=CLPUB00599;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, scapula; UBERON=UBERON_0006849.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   KP-EW-MS
AC   CVCL_7982
SY   Kyoto Pediatrics-Ewing sarcoma-MS
DR   BTO; BTO_0004788
DR   Cosmic; 1078364
DR   Wikidata; Q54900378
RX   CelloPub=CLPUB00599;
RX   PubMed=7591257;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=7591257).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   KP-EW-YI
AC   CVCL_7983
SY   KP-EW-Y1; Kyoto Pediatrics-Ewing sarcoma-YI
DR   Cosmic; 1078363
DR   Wikidata; Q54900379
RX   CelloPub=CLPUB00599;
RX   PubMed=7591257;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=7591257).
CC   Derived from site: In situ; Bone, pelvis; UBERON=UBERON_0012179.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   KP-L-RY
AC   CVCL_7984
SY   KPL-RY; K.P.L.RY; KPLRY; Kyoto Pediatrics-Leukemia-RY
DR   EFO; EFO_0022444
DR   Cosmic; 2378133
DR   Wikidata; Q54900380
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12399976;
RX   PubMed=14671638;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:17869; AFF4 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF4, MLL-AF5Q31 (PubMed=12399976; PubMed=14671638).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   KP-L-YN
AC   CVCL_D4AE
SY   Kyoto Pediatrics-Leukemia-YN
DR   Wikidata; Q127382575
RX   PubMed=29786757;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   KP-MO-TS
AC   CVCL_7985
SY   KP-Mo-TS; Kyoto Pediatrics-Monocytoid leukemia-TS
DR   Cosmic; 787446
DR   Cosmic; 975263
DR   Cosmic; 1281322
DR   Wikidata; Q54900381
RX   CelloPub=CLPUB00413;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=12399976;
CC   Population: Japanese.
CC   Doubling time: 48 hours (CelloPub=CLPUB00413).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KP-MRT-HS
AC   CVCL_A2FQ
SY   Kyoto Pediatrics-Malignant Rhabdoid Tumor-HS
DR   Wikidata; Q105509809
RX   PubMed=9920784;
CC   Population: Japanese.
DI   NCIt; C3808; Rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   KP-MRT-KS
AC   CVCL_A2FN
SY   Kyoto Pediatrics-Malignant Rhabdoid Tumor-KS
DR   cancercelllines; CVCL_A2FN
DR   Wikidata; Q105509812
RX   PubMed=33109553;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=33109553).
CC   Karyotypic information: Has a hypo-tetraploid karyotype (PubMed=33109553).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg53Ter (c.157C>T); ClinVar=VCV000944246; Zygosity=Heterozygous (PubMed=33109553).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg190Profs*27 (c.551_569dup19); Zygosity=Heterozygous (PubMed=33109553).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Neck; UBERON=UBERON_0000974.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2FP ! KP-MRT-KSa
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   KP-MRT-KSa
AC   CVCL_A2FP
SY   Kyoto Pediatrics-Malignant Rhabdoid Tumor-KS ascites
DR   cancercelllines; CVCL_A2FP
DR   Wikidata; Q105509815
RX   PubMed=33109553;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=33109553).
CC   Karyotypic information: Has a diploid karyotype with a few chromosomal abnormalities (PubMed=33109553).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg53Ter (c.157C>T); ClinVar=VCV000944246; Zygosity=Heterozygous (PubMed=33109553).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg190Profs*27 (c.551_569dup19); Zygosity=Heterozygous (PubMed=33109553).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2FN ! KP-MRT-KS
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   KP-MRT-NS
AC   CVCL_7050
SY   Kyoto Pediatrics-Malignant Rhabdoid Tumor-NS
DR   Wikidata; Q54900382
RX   CelloPub=CLPUB00599;
RX   PubMed=9920784;
RX   PubMed=10417765;
RX   PubMed=15355927;
RX   PubMed=18281554;
RX   PubMed=21871868;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=10417765).
CC   Karyotypic information: 46,XX,add(10)(q26) [17]; 46,XX,add(10)(q26),dic(1;2)(p22;q31) [3] (PubMed=10417765).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   KP-MRT-RY
AC   CVCL_7051
SY   KPMRTRY; Kyoto Pediatrics-Malignant Rhabdoid Tumor-RY
DR   BioSample; SAMN10989607
DR   cancercelllines; CVCL_7051
DR   Cell_Model_Passport; SIDM01655
DR   DepMap; ACH-001109
DR   Wikidata; Q54900383
RX   CelloPub=CLPUB00599;
RX   PubMed=18281554;
RX   PubMed=21871868;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   KP-MRT-YM
AC   CVCL_7052
SY   Kyoto Pediatrics-Malignant Rhabdoid Tumor-YM
DR   Wikidata; Q54900384
RX   CelloPub=CLPUB00599;
RX   PubMed=15378398;
RX   PubMed=18281554;
RX   PubMed=21871868;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=15378398).
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   KP-N-AY
AC   CVCL_9508
SY   Kyoto Pediatrics-Neuroblastoma-AY
DR   CGH-DB; 9086-4
DR   Cosmic; 848938
DR   Wikidata; Q54900386
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2004854;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9509 ! KP-N-AYR
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   KP-N-AYR
AC   CVCL_9509
SY   Kyoto Pediatrics-Neuroblastoma-AYR
DR   CGH-DB; 83-1
DR   CGH-DB; 9084-4
DR   Cosmic; 848939
DR   Wikidata; Q54900387
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2004854;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Characteristics: KP-N-AYR cell line is 3.0-fold more resistant to adriamycin and 2.7-fold more resistant to cis-platinum compared to KP-N-AY.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9508 ! KP-N-AY
SX   Female
AG   3Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   KP-N-HN
AC   CVCL_Y134
SY   Kyoto Pediatrics-Neuroblastoma-HN
DR   CGH-DB; 66-1
DR   CGH-DB; 9089-4
DR   Wikidata; Q54900388
RX   CelloPub=CLPUB00582;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Misspelling: KP-N-NH; PubMed=12702577.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   4Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   KP-N-NS
AC   CVCL_4771
SY   Kyoto Pediatrics-Neuroblastoma-NS
DR   CLO; CLO_0051416
DR   BioSample; SAMN03472214
DR   CCRID; 1101HUM-PUMC000283
DR   CCRID; 3101HUMTCHu30
DR   Cosmic; 920256
DR   KCB; KCB 2011113YJ
DR   RCB; RCB0687
DR   Wikidata; Q54900389
RX   PubMed=8297818;
CC   Population: Japanese.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=8297818).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): RCB=RCB0687
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 14
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   KP-N-NY
AC   CVCL_Y135
SY   Kyoto Pediatrics-Neuroblastoma-NY
DR   CGH-DB; 67-1
DR   CGH-DB; 9088-4
DR   Wikidata; Q54900390
RX   CelloPub=CLPUB00582;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   5Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   KP-N-RT-BM-1
AC   CVCL_1339
SY   KPNRTBM1; KP-N-RT(BM1); RT-BM-1; RT-BM 1; RTBM1; KP-N-RT-BM; KP-N-RTBM; RT-BM; BM1; KP-N-RT; Kyoto Pediatrics-Neuroblastoma-RT-Bone Marrow
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470963
DR   BioSample; SAMN10987720
DR   cancercelllines; CVCL_1339
DR   Cell_Model_Passport; SIDM00557
DR   CGH-DB; 69-1
DR   CGH-DB; 9079-4
DR   ChEMBL-Cells; CHEMBL3308339
DR   ChEMBL-Targets; CHEMBL2366107
DR   Cosmic; 848926
DR   Cosmic; 924189
DR   Cosmic-CLP; 924189
DR   DepMap; ACH-000345
DR   GDSC; 924189
DR   GEO; GSM887239
DR   GEO; GSM888313
DR   GEO; GSM1670005
DR   IARC_TP53; 27697
DR   JCRB; IFO50432
DR   LiGeA; CCLE_682
DR   PharmacoDB; KPNRTBM1_786_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1339
DR   PubChem_Cell_line; CVCL_1339
DR   Wikidata; Q54900391
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=3731124;
RX   PubMed=10628353;
RX   PubMed=11129446;
RX   PubMed=11501497;
RX   PubMed=12702577;
RX   PubMed=15892104;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23268333;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 42 hours (PubMed=10628353).
CC   HLA typing: A*24:02,31:01; B*35:03,56:01; C*01:02,03:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.43%; Native American=0.27%; East Asian, North=72.99%; East Asian, South=24.04%; South Asian=0%; European, North=0%; European, South=2.27% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=924189; JCRB=IFO50432; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9511 ! KP-N-RT-LN
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   KP-N-RT-LN
AC   CVCL_9511
SY   KP-N-RT(LN); KP-N-RTLN; RT-LN; Kyoto Pediatrics-Neuroblastoma-RT-Lymph node
DR   Wikidata; Q54900392
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=3731124;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1339 ! KP-N-RT-BM-1
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   KP-N-RT-RT-BMV-C6
AC   CVCL_9512
SY   RT-BMV-C6; KPNRT-BMVc6; KP-N-RT-BMV; KPNRT-BMV
DR   Wikidata; Q54900393
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2547728;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1339 ! KP-N-RT-BM-1
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   KP-N-SI(FA)
AC   CVCL_9510
SY   KP-N-SI (FA); KPNSI(FA); KP-N-SIFA
DR   CGH-DB; 65-1
DR   CGH-DB; 9080-4
DR   Cosmic; 848927
DR   Wikidata; Q54900395
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=11129446;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7910 ! KP-N-SI(LA)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   KP-N-SI(LA)
AC   CVCL_7910
AS   CVCL_7909
SY   KP-N-SI (LA); KP-N-SILA; KPNSI(LA); KP-N-SI; KPNSI
DR   BTO; BTO_0003547
DR   CGH-DB; 64-1
DR   CGH-DB; 9081-4
DR   Wikidata; Q54900396
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2486615;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9510 ! KP-N-SI(FA)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   KP-N-SI4n
AC   CVCL_7911
SY   SI4n
DR   Wikidata; Q54900397
RX   PubMed=2019470;
CC   Population: Japanese.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=2019470).
CC   Misspelling: KP-N-SI4s; Note=In Cellosaurus releases 2 to 31.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7910 ! KP-N-SI(LA)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KP-N-SI8s
AC   CVCL_7912
SY   SI8s
DR   Wikidata; Q54900398
RX   PubMed=2019470;
CC   Population: Japanese.
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=2019470).
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7910 ! KP-N-SI(LA)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KP-N-SI9s
AC   CVCL_1340
SY   KP-N-SI9S; KPNSI9s; KPNSI9S; SI9s
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472791
DR   BioSample; SAMN10987824
DR   cancercelllines; CVCL_1340
DR   Cell_Model_Passport; SIDM00016
DR   Cosmic; 907315
DR   DepMap; ACH-000446
DR   GEO; GSM887240
DR   GEO; GSM888314
DR   GEO; GSM1670006
DR   IARC_TP53; 21441
DR   IARC_TP53; 30109
DR   JCRB; IFO50433
DR   LiGeA; CCLE_193
DR   PharmacoDB; KPNS19s_787_2019
DR   Progenetix; CVCL_1340
DR   Wikidata; Q54900399
RX   PubMed=2019470;
RX   PubMed=11129446;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=2019470).
CC   Doubling time: ~49 hours (Note=Lot 12152017) (JCRB=IFO50433).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (DepMap=ACH-000446).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.78%; East Asian, South=24.21%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Misspelling: KP-N-S19s; Note=Occasionally.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): JCRB=IFO50433
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7910 ! KP-N-SI(LA)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   KP-N-SK
AC   CVCL_Y136
SY   Kyoto Pediatrics-Neuroblastoma-SK
DR   Wikidata; Q54900400
RX   CelloPub=CLPUB00582;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2Y2M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   KP-N-TK
AC   CVCL_Y137
SY   Kyoto Pediatrics-Neuroblastoma-TK
DR   CGH-DB; 81-1
DR   CGH-DB; 9085-4
DR   Wikidata; Q54900401
RX   CelloPub=CLPUB00582;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): PubMed=23268333
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11.2
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 8,12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   KP-N-YN
AC   CVCL_1341
SY   KPNYN; Kyoto Pediatrics-Neuroblastoma-YN
DR   BTO; BTO_0003546
DR   CLO; CLO_0037079
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 610
DR   BioSample; SAMN03470961
DR   BioSample; SAMN10988113
DR   cancercelllines; CVCL_1341
DR   Cell_Model_Passport; SIDM00556
DR   CGH-DB; 80-1
DR   CGH-DB; 9082-4
DR   ChEMBL-Cells; CHEMBL3308265
DR   ChEMBL-Targets; CHEMBL2366280
DR   Cosmic; 907314
DR   Cosmic-CLP; 907314
DR   DepMap; ACH-000227
DR   EGA; EGAS00001000978
DR   GDSC; 907314
DR   GEO; GSM887241
DR   GEO; GSM888315
DR   GEO; GSM1670007
DR   IARC_TP53; 21442
DR   JCRB; IFO50431
DR   LiGeA; CCLE_699
DR   LINCS_LDP; LCL-1985
DR   PharmacoDB; KPNYN_788_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1341
DR   PubChem_Cell_line; CVCL_1341
DR   Wikidata; Q54900402
RX   CelloPub=CLPUB00582;
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2019470;
RX   PubMed=12702577;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23268333;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:02; B*40:02,52:01; C*03:04,07:41 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.15%; East Asian, North=73.42%; East Asian, South=25.67%; South Asian=0%; European, North=0%; European, South=0.76% (PubMed=30894373).
CC   Derived from site: Metastatic; Right pararenal lymph node.
ST   Source(s): Cosmic-CLP=907314; JCRB=IFO50431; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 16,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   KP-N-YN1s
AC   CVCL_7913
SY   YN1s
DR   Wikidata; Q54900403
RX   PubMed=2019470;
RX   PubMed=11129446;
CC   Population: Japanese.
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=2019470).
CC   Derived from site: Metastatic; Right pararenal lymph node.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1341 ! KP-N-YN
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   KP-N-YN2n
AC   CVCL_7914
SY   YN2n
DR   Wikidata; Q54900404
RX   PubMed=2019470;
CC   Population: Japanese.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=2019470).
CC   Derived from site: Metastatic; Right pararenal lymph node.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1341 ! KP-N-YN
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   KP-N-YN3s
AC   CVCL_7915
SY   YN3s
DR   Wikidata; Q54900405
RX   PubMed=2019470;
CC   Population: Japanese.
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=2019470).
CC   Derived from site: Metastatic; Right pararenal lymph node.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1341 ! KP-N-YN
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KP-N-YS
AC   CVCL_1342
SY   KPNYS; Kyoto Pediatrics-Neuroblastoma-YS
DR   CLO; CLO_0037080
DR   ArrayExpress; E-MTAB-783
DR   BioGRID_ORCS_Cell_line; 916
DR   cancercelllines; CVCL_1342
DR   Cell_Model_Passport; SIDM00157
DR   CGH-DB; 82-1
DR   CGH-DB; 9083-4
DR   ChEMBL-Cells; CHEMBL3308266
DR   ChEMBL-Targets; CHEMBL2366065
DR   Cosmic; 946363
DR   Cosmic-CLP; 946363
DR   DepMap; ACH-002261
DR   GDSC; 946363
DR   GEO; GSM1670008
DR   IARC_TP53; 27174
DR   LINCS_LDP; LCL-1986
DR   PharmacoDB; KPNYS_789_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1342
DR   Wikidata; Q54900406
RX   CelloPub=CLPUB00582;
RX   PubMed=10363161;
RX   PubMed=11129446;
RX   PubMed=12702577;
RX   PubMed=20164919;
RX   PubMed=23268333;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (Cosmic-CLP=946363).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.29%; East Asian, North=74.96%; East Asian, South=23.74%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=946363
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10
ST   D5S818: 9,13
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   KP-N-YS1n
AC   CVCL_Y132
SY   YS1n
DR   cancercelllines; CVCL_Y132
DR   Wikidata; Q54900407
RX   PubMed=10363161;
RX   PubMed=11129446;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1342 ! KP-N-YS
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   KP-N-YS2s
AC   CVCL_Y133
SY   YS2s
DR   cancercelllines; CVCL_Y133
DR   Wikidata; Q54900408
RX   PubMed=10363161;
RX   PubMed=11129446;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1342 ! KP-N-YS
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   KP-N-YuNo
AC   CVCL_Y138
SY   Kyoto Pediatrics-Neuroblastoma-YuNo
DR   Wikidata; Q54900409
RX   CelloPub=CLPUB00582;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y5M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   KP-NAC8
AC   CVCL_E4I1
RX   CelloPub=CLPUB00582;
RX   PubMed=3567910;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 200 kDa antigen on surface of neuroblastoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   KP-P1
AC   CVCL_D283
DR   BioSample; SAMN03151733
DR   Wikidata; Q54900418
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00071.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   KP-PN-TTBm2
AC   CVCL_5147
SY   KPPNTTBm2
DR   cancercelllines; CVCL_5147
DR   GEO; GSM393040
DR   IGRhCellID; KPPNTTBm2%20GEO
DR   Progenetix; CVCL_5147
DR   Wikidata; Q54900419
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   KP-PNET-TO
AC   CVCL_A2FU
SY   Kyoto Pediatrics-Primitive NeuroEctodermal Tumor-TO
DR   Wikidata; Q105509818
RX   CelloPub=CLPUB00599;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone, iliac spine; UBERON=UBERON_0013707.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   KP-RMS-DH
AC   CVCL_A2FS
SY   Kyoto Pediatrics-RhabdoMyoSarcoma-DH
DR   Wikidata; Q105509820
RX   CelloPub=CLPUB00599;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (CelloPub=CLPUB00599).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   KP-RMS-KH
AC   CVCL_A2FT
SY   Kyoto Pediatrics-RhabdoMyoSarcoma-KH
DR   Wikidata; Q105509823
RX   CelloPub=CLPUB00599;
CC   Population: Japanese.
CC   Derived from site: In situ; Perineum; UBERON=UBERON_0002356.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   KP1#3
AC   CVCL_WH57
SY   Kp1#3
DR   Wikidata; Q95980073
RX   PubMed=11752148;
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   KP283T
AC   CVCL_EG33
DR   cancercelllines; CVCL_EG33
DR   GEO; GSM1655615
DR   GEO; GSM1655637
DR   Wikidata; Q54900421
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   KP363T
AC   CVCL_EG34
SY   KP-363T
DR   cancercelllines; CVCL_EG34
DR   DepMap; ACH-002669
DR   DSMZ; ACC-808
DR   DSMZCellDive; ACC-808
DR   GEO; GSM1655616
DR   GEO; GSM1655622
DR   Wikidata; Q54900422
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~50 hours (DSMZ=ACC-808).
CC   Microsatellite instability: Stable (MSS) (PubMed=26894854).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=26894854).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): DSMZ=ACC-808; PubMed=26894854
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 19,20
ST   TH01: 6,9.3 (PubMed=26894854)
ST   TH01: 6,10 (DSMZ=ACC-808)
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   KP7038T
AC   CVCL_EG35
SY   KP-7038T
DR   DSMZCellDive; KP-7038T
DR   GEO; GSM1655617
DR   GEO; GSM1655638
DR   Wikidata; Q54900423
RX   PubMed=26894854;
RX   PubMed=28931069;
CC   Microsatellite instability: Instable (MSI-high) (PubMed=26894854).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=26894854
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 10,14
ST   D16S539: 10,12
ST   D21S11: 28,34
ST   D5S818: 11
ST   D7S820: 12,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   KP8D4
AC   CVCL_UW59
DR   Wikidata; Q95980080
RX   PubMed=2807990;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Macaca fuscata 84 kDa protein in basal cells of bronchial epithelia (Note=Also reacts with human and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   KPAM1
AC   CVCL_A107
DR   Cosmic; 1206518
DR   Wikidata; Q54900424
RX   PubMed=18830255;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4170; GATA1; Simple; p.Glu13Alafs*26 (c.38_39delAG); Zygosity=Unspecified (PubMed=18830255).
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   KPB-L2
AC   CVCL_W861
DR   Wikidata; Q54900426
RX   CelloPub=CLPUB00375;
RX   PubMed=8704258;
RX   PubMed=9454894;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 24 hours (CelloPub=CLPUB00375).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=9454894; PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   KPB-M15
AC   CVCL_5308
DR   BioSample; SAMN03151821
DR   cancercelllines; CVCL_5308
DR   Wikidata; Q54900427
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3461189;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KPB-M15
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a KYO-1 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 39 year old male patient with chronic myelogenous leukemia, BCR-ABL1 positive.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00230.
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=3461189).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2095 ! KYO-1
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KPB-M8
AC   CVCL_5309
DR   Wikidata; Q54900428
RX   PubMed=3461189;
CC   Population: Japanese.
CC   Doubling time: 18 hours (PubMed=3461189).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=3461189).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   KPB6
AC   CVCL_C0RJ
DR   Wikidata; Q112929964
RX   CelloPub=CLPUB00709;
RX   PubMed=29246442;
CC   From: Quezada, Sergio Andres; University College London; London; United Kingdom.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6 KrasLSL-G12D/+, Trp53flox/flox (KP).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   KPC-32
AC   CVCL_M532
DR   Wikidata; Q54900429
RX   CelloPub=CLPUB00068;
RX   PubMed=8080996;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   KPC-CRISPR/Cas9 empty plasmid
AC   CVCL_UY60
DR   Wikidata; Q95980096
RX   PubMed=33851955;
CC   Characteristics: Control cell line for KPC-IL-6 KO (Cellosaurus=CVCL_UR56). Transfected with a CRISPR/Cas9 empty plasmid.
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R172H:Pdx1-Cre (KPC).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   KPC-IL-6 KO
AC   CVCL_UR56
SY   KPC-IL-6KO
DR   Wikidata; Q95980100
RX   PubMed=33851955;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96559; Il6.
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R172H:Pdx1-Cre (KPC).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   KPC3
AC   CVCL_A9ZK
DR   Wikidata; Q102114430
RX   PubMed=30381448;
RX   PubMed=32690771;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R270H:Pdx1-Cre (KPC).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   KPC3-TRP1
AC   CVCL_A9ZL
DR   Wikidata; Q102114432
RX   PubMed=30381448;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98881; Tyrp1 (Note=With p.Gln512_Val537del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R270H:Pdx1-Cre (KPC).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9ZK ! KPC3
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   KPD
AC   CVCL_B412
SY   KPDXM
DR   BTO; BTO_0006421
DR   cancercelllines; CVCL_B412
DR   Cosmic; 1529900
DR   GEO; GSM879216
DR   IARC_TP53; 27030
DR   Progenetix; CVCL_B412
DR   Wikidata; Q54900430
RX   PubMed=2457439;
RX   PubMed=17354236;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   Doubling time: ~36 hours (PubMed=21519327).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Caution: Indicated as originating from a 7 year old female patient in PubMed=19787792 and from a 8 year old male patient in PubMed=17354236. The STR profile has Amelogenin X,Y.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X,Y
ST   D16S539: 11,13
ST   D18S51: 10,13
ST   D19S433: 13.2,14
ST   D21S11: 30,31.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 9,11
ST   D8S1179: 13,15
ST   FGA: 21
ST   SE33: 27.2
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   KPE
AC   CVCL_E731
DR   dbMHC; 48929
DR   IHW; IHW09242
DR   IPD-IMGT/HLA; 10929
DR   Wikidata; Q54900431
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*24:03:01,11:01; B*07,35; DPB1*04:01 (IPD-IMGT/HLA=10929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   KPK1
AC   CVCL_F947
SY   KPK 1; KPK-1
DR   TKG; TKG 0697
DR   Wikidata; Q54900432
RX   PubMed=7176042;
CC   Population: Japanese.
CC   Doubling time: 29 hours (PubMed=7176042).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): TKG=TKG 0697
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 10,11,12,13
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 18,19,20
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 13
//
ID   KPK13
AC   CVCL_F948
SY   KPK 13
DR   TKG; TKG 0698
DR   Wikidata; Q54900435
RX   PubMed=7176042;
CC   Population: Japanese.
CC   Doubling time: 51 hours (PubMed=7176042).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): TKG=TKG 0698
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,16
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   KPL-1
AC   CVCL_2094
SY   KPL.1; KPL1
DR   CLO; CLO_0007118
DR   EFO; EFO_0002221
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 612
DR   BioSample; SAMN03151840
DR   BioSample; SAMN03473349
DR   BioSample; SAMN10987693
DR   cancercelllines; CVCL_2094
DR   Cell_Model_Passport; SIDM00147
DR   Cosmic; 2165023
DR   Cosmic; 2750517
DR   DepMap; ACH-000028
DR   DSMZ; ACC-317
DR   DSMZCellDive; ACC-317
DR   EGA; EGAS00001000610
DR   GEO; GSM217583
DR   GEO; GSM274642
DR   GEO; GSM274643
DR   GEO; GSM344368
DR   GEO; GSM344418
DR   GEO; GSM459707
DR   GEO; GSM459720
DR   GEO; GSM459721
DR   GEO; GSM783974
DR   GEO; GSM887238
DR   GEO; GSM888312
DR   GEO; GSM1374603
DR   IARC_TP53; 21443
DR   IGRhCellID; KPL1
DR   LiGeA; CCLE_342
DR   LINCS_LDP; LCL-1483
DR   NCBI_Iran; C643
DR   PharmacoDB; KPL1_790_2019
DR   Progenetix; CVCL_2094
DR   SLKBase; 3568
DR   Wikidata; Q54900436
RX   DOI=10.25904/1912/1434;
RX   PubMed=7710953;
RX   PubMed=10969801;
RX   PubMed=15677628;
RX   PubMed=15767549;
RX   PubMed=16142302;
RX   PubMed=18304946;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=28889351;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a MCF-7 derivative (PubMed=18304946; PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00325.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-317).
CC   HLA typing: A*02:01,02:01; B*18:01,44:02; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=15677628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=28889351).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.04%; Native American=0%; East Asian, North=4.61%; East Asian, South=0%; South Asian=0%; European, North=53.32%; European, South=40.02% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-317; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11 (DSMZ=ACC-317)
ST   D13S317: 11 (PubMed=28889351)
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   KPL-3C
AC   CVCL_E122
DR   Wikidata; Q54900437
RX   PubMed=8688322;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=8688322).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   KPL-4
AC   CVCL_5310
SY   KPL4
DR   EFO; EFO_0006624
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-11134
DR   BioSample; SAMN03471036
DR   BioSample; SAMN03473250
DR   cancercelllines; CVCL_5310
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM590107
DR   GEO; GSM1374604
DR   PharmacoDB; KPL4_791_2019
DR   Progenetix; CVCL_5310
DR   Wikidata; Q54900438
RX   DOI=10.4172/2161-0681.1000119;
RX   PubMed=10070858;
RX   PubMed=15767549;
RX   PubMed=21247443;
RX   PubMed=23671654;
RX   PubMed=23784380;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=35042871;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KPL-4
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/kpl-4-xenograft-model/
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive.
CC   Doubling time: ~30 hours (PubMed=10070858).
CC   HLA typing: A*26:02,26:02; B*15:01,15:01; C*03:03,03:03; DQB1*03:02,03:02; DRB1*11:83,11:83 (PubMed=25960936).
CC   HLA typing: A*24:17,26:09; B*15:01,15:01; C*03:03,03:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 29,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 11,16
ST   FGA: 19
ST   Penta D: 10,14
ST   Penta E: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   KPMM1
AC   CVCL_9541
SY   KP-MM1
DR   Wikidata; Q54900440
RX   CelloPub=CLPUB00381;
RX   PubMed=8797890;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   KPMM2
AC   CVCL_5311
SY   KPMM-2
DR   Wikidata; Q54900441
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7723407;
RX   PubMed=8797890;
RX   PubMed=10936422;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KPMM2
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Japanese.
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   Doubling time: ~48 hours (Note=With IL6), ~72 hours (Note=Without IL6) (PubMed=7723407).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   KPNT-1
AC   CVCL_0G02
DR   CGH-DB; 9031-4
DR   Wikidata; Q54900442
RX   PubMed=9738977;
RX   PubMed=10570904;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   KPP-003
AC   CVCL_E6DC
RX   PubMed=37426308;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=37426308).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Kps1
AC   CVCL_ZT10
DR   Wikidata; Q98126834
RX   PubMed=7513056;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Kps2
AC   CVCL_ZP16
DR   Wikidata; Q98126835
RX   PubMed=7513056;
RX   PubMed=8763445;
RX   PubMed=22466610;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29304; UVSSA; Simple; p.Lys123Ter (c.367A>T); ClinVar=VCV000031569; Zygosity=Homozygous (PubMed=22466610).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173107; UV-sensitive syndrome 3
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   Kps23F
AC   CVCL_ZT07
DR   Wikidata; Q98126836
RX   PubMed=7513056;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29304; UVSSA; Simple; p.Lys123Ter (c.367A>T); ClinVar=VCV000031569; Zygosity=Heterozygous (from familial inference of Kps2; Kps3).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   Kps23M
AC   CVCL_ZT08
DR   Wikidata; Q98126838
RX   PubMed=7513056;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29304; UVSSA; Simple; p.Lys123Ter (c.367A>T); ClinVar=VCV000031569; Zygosity=Heterozygous (from familial inference of Kps2; Kps3).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   Kps3
AC   CVCL_ZP15
DR   Wikidata; Q98126839
RX   PubMed=7513056;
RX   PubMed=8763445;
RX   PubMed=19329487;
RX   PubMed=22466610;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29304; UVSSA; Simple; p.Lys123Ter (c.367A>T); ClinVar=VCV000031569; Zygosity=Homozygous (PubMed=22466610).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173107; UV-sensitive syndrome 3
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   Kps4
AC   CVCL_ZT09
DR   Wikidata; Q98126840
RX   PubMed=7513056;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   KPT1
AC   CVCL_TZ65
SY   Kidney Proximal Tubule 1
DR   Wikidata; Q54900443
RX   PubMed=18682499;
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   KPT2
AC   CVCL_TZ66
SY   Kidney Proximal Tubule 2
DR   ABM; T0642
DR   Wikidata; Q54900445
RX   PubMed=18682499;
CC   Discontinued: ABM; T0642; true.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   KPT2-TRPV4
AC   CVCL_TZ67
DR   ABM; T6009
DR   Wikidata; Q54900446
RX   PubMed=18682499;
CC   Genetic integration: Method=Transduction; Gene=RGD; 69337; Trpv4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: ABM; T6009; true.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_TZ66 ! KPT2
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 11
//
ID   KPUM-MS3
AC   CVCL_A1JT
SY   MS-3; Kyoto Prefectural University of Medicine-MS3
DR   Wikidata; Q102114433
RX   PubMed=21640157;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=21640157).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   KPUM-UH1
AC   CVCL_A1JU
SY   UH-1; Kyoto Prefectural University of Medicine-UH1
DR   Wikidata; Q102114434
RX   PubMed=21640157;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=21640157).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   KQ0001
AC   CVCL_8Y00
DR   ECACC; 97120601
DR   Wikidata; Q54900447
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KR-12
AC   CVCL_3732
SY   KR12
DR   CLO; CLO_0007119
DR   ATCC; CRL-8658
DR   BioSample; SAMN03471206
DR   TKG; TKG 0216
DR   Wikidata; Q54900448
RX   Patent=US4693975;
RX   PubMed=3365703;
RX   PubMed=6092464;
RX   PubMed=18514220;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8658.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: ATCC; CRL-8658; true.
CC   Discontinued: TKG; TKG 0216; true.
ST   Source(s): ATCC=CRL-8658
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 10,11,13
ST   D7S820: 9,10
ST   TH01: 8,9,9.3
ST   TPOX: 8
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
HI   CVCL_H617 ! GM1500-6TG-OUB
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   KR-42421
AC   CVCL_A8WG
DR   Wikidata; Q108820630
RX   PubMed=9453489;
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
DI   NCIt; C2891; Barrett esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   KR-92
AC   CVCL_A5YC
DR   Wikidata; Q107115605
WW   Provider; RCCC-V; -; https://web.archive.org/web/20200220021323/http://www.sevin.ru/collections/cellcolls/rcccm/lines_list.html
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   KRA
AC   CVCL_E732
DR   IHW; 9w 0607
DR   Wikidata; Q54900449
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   KRC-005
AC   CVCL_E733
SY   KRC005
DR   dbMHC; 48930
DR   IHW; IHW09360
DR   IPD-IMGT/HLA; 10930
DR   Wikidata; Q54900450
RX   PubMed=9331945;
RX   PubMed=28360230;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Kaingang.
CC   HLA typing: A*02:12; B*51:01:01; C*01:02:01; DPA1*01:03; DPB1*04:02 (IPD-IMGT/HLA=10930).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   KRC-006
AC   CVCL_LN24
SY   KRC006
DR   Wikidata; Q54900452
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   KRC-020
AC   CVCL_LN25
SY   KRC020
DR   Wikidata; Q54900453
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   KRC-032
AC   CVCL_E734
DR   dbMHC; 48931
DR   IHW; IHW09361
DR   IPD-IMGT/HLA; 10931
DR   Wikidata; Q54900454
RX   PubMed=9331945;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Kaingang.
CC   HLA typing: A*24:02:01; B*35:05,35:06; C*04 (IPD-IMGT/HLA=10931).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   KRC-033
AC   CVCL_F542
SY   KRC033
DR   IPD-IMGT/HLA; 10932
DR   Wikidata; Q54900455
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   HLA typing: A*02:12,31:01:02; B*35:05,39:03; C*04:01:01:01,07:02 (IPD-IMGT/HLA=10932).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   KRC-083
AC   CVCL_LN26
SY   KRC083
DR   Wikidata; Q54900456
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   KRC-103
AC   CVCL_E735
SY   KRC103; krc103
DR   dbMHC; 48932
DR   IHW; IHW09358
DR   IPD-IMGT/HLA; 10933
DR   Wikidata; Q54900457
RX   PubMed=9331945;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Kaingang.
CC   HLA typing: A*31:01:02; B*39:05,48:01:01; C*07:02,08:03; DPA1*01:03; DPB1*04:02 (IPD-IMGT/HLA=10933).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   KRC-104
AC   CVCL_LN27
SY   KRC104
DR   Wikidata; Q54900459
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   KRC-110
AC   CVCL_E736
SY   KRC 110; KRC110
DR   dbMHC; 48933
DR   ECACC; 94071446
DR   IHW; IHW09359
DR   IPD-IMGT/HLA; 10934
DR   Wikidata; Q54900460
RX   PubMed=9331945;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Native South American; Kaingang.
CC   HLA typing: A*31:01:02,24:02:01; B*51:01:01,15:20; C*03:04:01 (IPD-IMGT/HLA=10934).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   KRC-112
AC   CVCL_LN28
SY   KRC112
DR   Wikidata; Q54900461
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   KRC-113
AC   CVCL_LN29
SY   KRC113
DR   Wikidata; Q54900462
RX   PubMed=9331945;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native South American; Kaingang.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   KRC-7 [Human RCC]
AC   CVCL_HL92
DR   Wikidata; Q54900463
RX   PubMed=10232606;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C27893; Sarcomatoid renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   KRC-7 [Rat hepatoma]
AC   CVCL_0377
SY   KRC7
DR   MCCL; MCC:0000272
DR   Wikidata; Q54900465
RX   PubMed=7008195;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0285 ! H4-II-E-C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   KRC/Y
AC   CVCL_A448
SY   KRC-Y; KRC Y; KRCY
DR   cancercelllines; CVCL_A448
DR   Cosmic; 877457
DR   Cosmic; 1152535
DR   IARC_TP53; 5612
DR   Wikidata; Q38122405
RX   PubMed=3338971;
RX   PubMed=8621251;
RX   PubMed=10723130;
RX   PubMed=10929426;
CC   Population: Japanese.
CC   Doubling time: 73 hours (Note=At 15th passage) (PubMed=3338971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=8621251).
CC   Misspelling: KRC; PubMed=10929426.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   KRE
AC   CVCL_R911
SY   Kelp and Red spotted grouper Embryo
DR   Wikidata; Q54900467
RX   DOI=10.1577/1548-8667(1993)005<0127:COTCCL>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Epinephelus moara x Epinephelus akaara hybrid.
OX   NCBI_TaxID=300413; ! Epinephelus moara (Kelp grouper)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 11
//
ID   KRE-2
AC   CVCL_6F82
SY   Kelp and Red spotted grouper Embryo-2
DR   Wikidata; Q54900478
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Epinephelus moara x Epinephelus akaara hybrid.
OX   NCBI_TaxID=300413; ! Epinephelus moara (Kelp grouper)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   KRE-3
AC   CVCL_6F83
SY   Kelp and Red spotted grouper Embryo-3
DR   Wikidata; Q54900480
RX   DOI=10.3147/jsfp.29.29;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Epinephelus moara x Epinephelus akaara hybrid.
OX   NCBI_TaxID=300413; ! Epinephelus moara (Kelp grouper)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   KRIB
AC   CVCL_AU05
SY   Krib
DR   BTO; BTO_0006034
DR   cancercelllines; CVCL_AU05
DR   Wikidata; Q54900481
RX   CelloPub=CLPUB00319;
RX   PubMed=8402677;
RX   PubMed=22075555;
RX   PubMed=24136885;
RX   PubMed=26320182;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 18
//
ID   KRIBBi001-A
AC   CVCL_A4YX
SY   BM-iPSC-C3; BM-iPSC C3
DR   hPSCreg; KRIBBi001-A
DR   Wikidata; Q107115606
RX   PubMed=33529979;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Population: Brazilian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   KRIBBi003-A
AC   CVCL_B3V0
SY   GSD IXa iPSCs
DR   hPSCreg; KRIBBi003-A
DR   Wikidata; Q110432999
RX   PubMed=34740118;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:8926; PHKA2; Simple; p.Ala1076Glufs*40 (c.3227_3231del); Zygosity=Hemizygous (PubMed=34740118).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C122662; Glycogen storage disease type IX
DI   ORDO; Orphanet_370; Glycogen storage disease due to phosphorylase kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   KRIBBi004-A
AC   CVCL_B3V1
SY   BM-iPS-Clone 3; BM-iPS-C3
DR   hPSCreg; KRIBBi004-A
DR   Wikidata; Q110433000
RX   PubMed=34736040;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Karyotypic information: 46,XX,t(1;5)(p31.1;p35.1) (PubMed=34736040).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   KRIBBi005-A
AC   CVCL_C0F1
SY   CB-iPS-C7
DR   BioSamples; SAMEA12280460
DR   hPSCreg; KRIBBi005-A
DR   Wikidata; Q112929965
RX   PubMed=35085946;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   KRIBBi006-A
AC   CVCL_C0F2
SY   pbiPSC; PBMC-rep; kiPSCs
DR   hPSCreg; KRIBBi006-A
DR   Wikidata; Q112929966
RX   PubMed=36283271;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   KRIBBi008-A
AC   CVCL_C0F3
DR   hPSCreg; KRIBBi008-A
DR   Wikidata; Q112929967
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   KRIBBi009-A
AC   CVCL_C6QD
SY   KRIBB-BC15
DR   BioSamples; SAMEA112190091
DR   hPSCreg; KRIBBi009-A
DR   Wikidata; Q117704578
RX   PubMed=36925228;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Population: Korean.
CC   Donor information: Established from the normal breast tissue of a patient suffering from breast cancer.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   KRIBBi010-A
AC   CVCL_E5KY
SY   XLRS_R141C
DR   BioSamples; SAMEA116324608
DR   hPSCreg; KRIBBi010-A
RX   PubMed=39893900;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Arg141Cys (c.421C>T); ClinVar=VCV000098959; Zygosity=Hemizygous (PubMed=39893900).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KRIBBi011-A
AC   CVCL_E5KZ
SY   XLRS_E72K
DR   BioSamples; SAMEA116325299
DR   hPSCreg; KRIBBi011-A
RX   PubMed=39893900;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Glu72Lys (c.214G>A); ClinVar=VCV000009888; Zygosity=Hemizygous (PubMed=39893900).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KRIBBi012-A
AC   CVCL_E5L0
SY   XLRS_G44fs
DR   BioSamples; SAMEA116325419
DR   hPSCreg; KRIBBi012-A
RX   PubMed=39893900;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Gly44fs (c.130_140delGGAGGACCCAA); Zygosity=Hemizygous (PubMed=39893900).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KRIX-1
AC   CVCL_XI31
SY   Krix-1; KRIX 1
DR   Wikidata; Q95980221
RX   Patent=US8784816;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 5089CB.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00451; Human F8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   KRJ-I
AC   CVCL_8886
SY   KRJ-1; KRJI; KRJ1
DR   CLO; CLO_0007120
DR   ECACC; 95041223
DR   GEO; GSM600370
DR   GEO; GSM830111
DR   Wikidata; Q54900482
RX   PubMed=17242179;
RX   PubMed=19295186;
RX   PubMed=21544390;
RX   PubMed=22538498;
RX   PubMed=23119007;
RX   PubMed=29444910;
RX   PubMed=31548718;
RX   PubMed=31548719;
CC   Problematic cell line: Misclassified. Originally thought to arise from a multifocal carcinoid of the small intestine but shown to be an EBV-transformed lymphoblastoid cell line (PubMed=29444910; PubMed=31548718). Although misidentified, it has been argued that transcriptional regulation of the cells enough resemble gastroenteropancreatic neuroendocrine tumors to be used in studies (PubMed=31548719).
CC   Population: Caucasian.
CC   Doubling time: 1.8 days (PubMed=21544390).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 95041223; true.
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
ST   Source(s): PubMed=29444910
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 10
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L295 ! KRJ-II
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   KRJ-II
AC   CVCL_L295
DR   Wikidata; Q54900483
RX   PubMed=21544390;
CC   Population: Caucasian.
CC   Caution: The KRJ-I cell line established from the primary tumor of the same patient as KRJ-II was shown to be misidentified and to be an EBV-transformed lymphoblastoid cell line. As KRJ-II does not seem to have ever been distributed its status is uncertain.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8886 ! KRJ-I
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   KrMab-3
AC   CVCL_D3E3
DR   Wikidata; Q127382576
RX   PubMed=23376717;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   KRO3/4
AC   CVCL_E737
SY   KRO3; KRO
DR   IHW; 9w 0505
DR   IPD-IMGT/HLA; 10936
DR   Wikidata; Q54900484
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*02; B*44:02; C*07:04:01; DPB1*02:01,04:01 (IPD-IMGT/HLA=10936).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   KRV1
AC   CVCL_DR14
SY   KRV-1
DR   GEO; GSM1489215
DR   GEO; GSM1489245
DR   GEO; GSM1489455
DR   Wikidata; Q54900486
RX   PubMed=27476965;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DR13 ! KEP1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   KS [C.carpio]
AC   CVCL_IZ44
SY   Koi Snout
DR   Wikidata; Q54900487
RX   DOI=10.1016/j.aquaculture.2014.10.006;
CC   Group: Fish cell line.
CC   Doubling time: 28 hours (DOI=10.1016/j.aquaculture.2014.10.006).
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=1499333; ! Cyprinus carpio var. koi (Koi carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   KS [Human breast carcinoma]
AC   CVCL_E6X5
RX   PubMed=9384677;
RX   PubMed=10359208;
RX   PubMed=10359214;
RX   PubMed=12836015;
RX   PubMed=15365776;
CC   HLA typing: A*02,02; B*35,60; C*03,04; DQA1*01:02,01:02; DQB1*06:02,06:04; DRB1*13:02,15 (PubMed=10359208).
CC   HLA typing: A*02:01,02:01; B*35,40; DQB1*06:02,06:04:01; DRB1*13:02,15:01:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KS Y-1
AC   CVCL_F660
SY   KS Y1; KSY-1
DR   BioSample; SAMN03151948
DR   cancercelllines; CVCL_F660
DR   Wikidata; Q54900488
RX   DOI=10.1007/0-306-46861-1_10;
RX   Patent=US5569602;
RX   PubMed=7629884;
RX   PubMed=22987579;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ksy-1-atcc-crl-11448
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=22987579). Was thought to originate from the pleural effusion of a male AIDS patient with Kaposi sarcoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00408.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11448.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 25
//
ID   KS-0007
AC   CVCL_C1ZW
DR   Wikidata; Q114311827
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0064
AC   CVCL_C1ZX
DR   Wikidata; Q114311828
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0123
AC   CVCL_C1ZY
DR   Wikidata; Q114311830
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0151
AC   CVCL_C1ZZ
DR   Wikidata; Q114311834
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0187
AC   CVCL_C2A0
DR   Wikidata; Q114311836
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0195
AC   CVCL_C2A1
DR   Wikidata; Q114311837
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D5S818: 11,14
ST   D7S820: 11,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0196
AC   CVCL_C2A2
DR   Wikidata; Q114311840
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0206
AC   CVCL_C2A3
DR   Wikidata; Q114311845
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0217
AC   CVCL_C2A4
DR   Wikidata; Q114311847
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0251
AC   CVCL_C2A5
DR   Wikidata; Q114311848
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 6.3,8
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0303
AC   CVCL_C2A6
DR   Wikidata; Q114311849
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0315
AC   CVCL_C2A7
DR   Wikidata; Q114311850
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,14
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-0330
AC   CVCL_C2A8
DR   Wikidata; Q114311851
RX   PubMed=28284873;
CC   From: University of Utah; Salt Lake City; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KS-1 [Human glioblastoma]
AC   CVCL_1343
DR   CLO; CLO_0009896
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 609
DR   BioSample; SAMN03472792
DR   BioSample; SAMN10988292
DR   cancercelllines; CVCL_1343
DR   Cell_Model_Passport; SIDM00555
DR   CGH-DB; 148-1
DR   ChEMBL-Cells; CHEMBL3308170
DR   ChEMBL-Targets; CHEMBL2366228
DR   Cosmic; 687577
DR   Cosmic; 907313
DR   Cosmic; 2367535
DR   Cosmic-CLP; 907313
DR   DepMap; ACH-000631
DR   EGA; EGAS00001000978
DR   GDSC; 907313
DR   GEO; GSM887242
DR   GEO; GSM888316
DR   GEO; GSM1670009
DR   IARC_TP53; 21444
DR   JCRB; IFO50436
DR   LiGeA; CCLE_302
DR   LINCS_LDP; LCL-1384
DR   PharmacoDB; KS1_793_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1343
DR   PubChem_Cell_line; CVCL_1343
DR   Wikidata; Q54900489
RX   PubMed=4334478;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~53 hours (Note=Lot 02232017) (JCRB=IFO50436).
CC   HLA typing: A*02:06,24:02; B*39:01,54:01; C*01:03,07:02; DQA1*01:02,03:02; DQB1*03:02,06:01; DRB1*04:03,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.01%; Native American=0%; East Asian, North=74.63%; East Asian, South=23.63%; South Asian=1.21%; European, North=0%; European, South=0.52% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=907313; JCRB=IFO50436
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 8,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   KS-1 [Human Krukenberg tumour]
AC   CVCL_D284
SY   KS1
DR   cancercelllines; CVCL_D284
DR   GEO; GSM459734
DR   Progenetix; CVCL_D284
DR   Wikidata; Q54900490
RX   PubMed=2331685;
RX   PubMed=2846312;
CC   Doubling time: 28 +- 2 hours (Note=In suspension), 36 +- 2 hours (Note=In monolayer culture) (PubMed=2846312).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C3153; Krukenberg tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 12
//
ID   KS-1 [Human primary effusion lymphoma]
AC   CVCL_4J72
DR   Wikidata; Q54900492
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US6306581;
RX   PubMed=9639499;
RX   PubMed=9766492;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12247.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1080 ! BC-3
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   KS-Bu3
AC   CVCL_W862
DR   Wikidata; Q54900493
RX   PubMed=8704258;
RX   PubMed=9454894;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=9454894; PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   KS-EMPD-1
AC   CVCL_C4LP
DR   Wikidata; Q123032853
RX   PubMed=37432591;
CC   Population: Japanese.
CC   Doubling time: 31.2 +- 0.471 hours (PubMed=37432591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Unspecified (PubMed=37432591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
ST   Source(s): PubMed=37432591
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 13
ST   D16S539: 9,11
ST   D21S11: 30,31
ST   D5S818: 10
ST   D7S820: 10,12
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C3302; Extramammary Paget disease
DI   ORDO; Orphanet_2800; Extramammary Paget disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   KS-IMM
AC   CVCL_9805
SY   KS-Imm; KS IMM; KSIMM; Kaposi Syndrome-IMMortal
DR   BTO; BTO_0002070
DR   EFO; EFO_0002826
DR   Cosmic; 2162544
DR   Wikidata; Q54900494
RX   PubMed=9143602;
RX   PubMed=11238033;
CC   Doubling time: 24 hours (PubMed=9143602).
DI   NCIt; C3992; AIDS-related Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   KS-iPSC-1
AC   CVCL_VT52
DR   Wikidata; Q95980237
RX   PubMed=23019320;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT53 ! KS-iPSC-4
OI   CVCL_VT54 ! KS-iPSC-8
OI   CVCL_VT55 ! KS-iPSC-11
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KS-iPSC-11
AC   CVCL_VT55
DR   Wikidata; Q95980238
RX   PubMed=23019320;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT52 ! KS-iPSC-1
OI   CVCL_VT53 ! KS-iPSC-4
OI   CVCL_VT54 ! KS-iPSC-8
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KS-iPSC-4
AC   CVCL_VT53
DR   Wikidata; Q95980239
RX   PubMed=23019320;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT52 ! KS-iPSC-1
OI   CVCL_VT54 ! KS-iPSC-8
OI   CVCL_VT55 ! KS-iPSC-11
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KS-iPSC-8
AC   CVCL_VT54
DR   Wikidata; Q95980240
RX   PubMed=23019320;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VT52 ! KS-iPSC-1
OI   CVCL_VT53 ! KS-iPSC-4
OI   CVCL_VT55 ! KS-iPSC-11
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KS-RRP
AC   CVCL_C4PK
DR   Wikidata; Q116049624
RX   PubMed=2580779;
RX   PubMed=9537031;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02161; Human RHD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   KS1/17
AC   CVCL_E7ZQ
RX   PubMed=6362852;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KS1/4
AC   CVCL_E7ZR
DR   ABCD; ABCD_BE890
RX   PubMed=2469722;
RX   PubMed=6362852;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was conjugated to to methotrexate (KS1/4-methotrexate) or vinblastine (KS1/4-DAVLB or LY256787) in phase 1 clinical studies in patients with non-small cell lung carcinoma. These studies were stopped because of human anti-murine antibody (HAMA) response.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KS1/9
AC   CVCL_E7ZS
RX   PubMed=6362852;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human unknown membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KS24
AC   CVCL_E6X7
SY   KS 24; KS-CD80
RX   PubMed=9384677;
RX   PubMed=10359208;
RX   PubMed=10359214;
RX   PubMed=15365776;
CC   Characteristics: Transfection of CD80 has resulted in improved primary T cell activation (PubMed=9384677).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6X5 ! KS [Human breast carcinoma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KS24-M1
AC   CVCL_E6XJ
RX   PubMed=10359214;
RX   PubMed=15365776;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q0A2I5; Influenza A virus (strain A/Chicken/Pennsylvania/1/1983 H5N2) matrix protein 1 (M1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6X7 ! KS24
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KS24.22
AC   CVCL_E6X8
RX   PubMed=11358828;
RX   PubMed=15365776;
WW   Info; ClinicalTrials.gov; NCT01127074; https://clinicaltrials.gov/study/NCT01127074
CC   HLA typing: A*02:01 (PubMed=11358828).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6X7 ! KS24
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KS32
AC   CVCL_LC43
DR   JCRB; JCRB1728
DR   Wikidata; Q54900496
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.1845+2T>C; ClinVar=VCV000252070; Zygosity=Heterozygous; Note=Splice donor mutation (JCRB=JCRB1728).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1728
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   KS7
AC   CVCL_E6ZM
RX   PubMed=9384677;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6X5 ! KS [Human breast carcinoma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   KS72
AC   CVCL_WY23
DR   Wikidata; Q95980241
RX   PubMed=3875094;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   KS82
AC   CVCL_WY24
DR   Wikidata; Q95980242
RX   PubMed=3186719;
RX   PubMed=8374900;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   KS86
AC   CVCL_WX84
DR   Wikidata; Q95980244
RX   PubMed=3002731;
RX   PubMed=3875094;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   KSCBi001-A
AC   CVCL_IT62
SY   hUSiPS2
DR   BioSamples; SAMEA104012032
DR   hPSCreg; KSCBi001-A
DR   SKIP; SKIP002914
DR   Wikidata; Q54900497
RX   PubMed=28677537;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=28677537
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 13,19
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 13,16
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 13,17
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   KSCBi002-A
AC   CVCL_IT63
SY   hFSiPS1
DR   BioSamples; SAMEA104012352
DR   hPSCreg; KSCBi002-A
DR   SKIP; SKIP002915
DR   Wikidata; Q54900498
RX   PubMed=28677527;
RX   PubMed=31841972;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28677527
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 30,31.2
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT64 ! KSCBi002-B
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   KSCBi002-A-1
AC   CVCL_YN10
SY   GLA-KO hiPS; DGMIFi003-A-1
DR   hPSCreg; KSCBi002-A-1
DR   SKIP; SKIP005607
DR   Wikidata; Q95980247
RX   PubMed=31841972;
CC   From: Daegu-Gyeongbuk Medical Innovation Foundation; Daegu; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Misspelling: KSBCi002-A-1; Note=In Cellosaurus release 34.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT63 ! KSCBi002-A
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   KSCBi002-A-2
AC   CVCL_C1TW
SY   hFSiPS3-1
DR   GEO; GSM4972458
DR   hPSCreg; KSCBi002-A-2
DR   Wikidata; Q114311852
RX   PubMed=33714852;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT63 ! KSCBi002-A
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   KSCBi002-B
AC   CVCL_IT64
SY   hFmiPS1
DR   BioSamples; SAMEA104012354
DR   hPSCreg; KSCBi002-B
DR   SKIP; SKIP002916
DR   Wikidata; Q54900499
RX   PubMed=29034882;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034882
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 30,31.2
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT63 ! KSCBi002-A
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   KSCBi002-B-1
AC   CVCL_IT65
SY   hFmiPS2
DR   BioSamples; SAMEA104012355
DR   hPSCreg; KSCBi002-B-1
DR   SKIP; SKIP002917
DR   Wikidata; Q54900500
RX   PubMed=29034882;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034882
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 30,31.2
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT64 ! KSCBi002-B
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   KSCBi002-B-2
AC   CVCL_C9IN
SY   TNFRSF11B-KO hiPSCs; CNUi003-A-2
DR   BioSamples; SAMEA114594495
DR   hPSCreg; KSCBi002-B-2
DR   Wikidata; Q123032854
RX   PubMed=37481965;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11909; TNFRSF11B.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131861; Juvenile Paget disease
DI   ORDO; Orphanet_2801; Juvenile Paget disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT64 ! KSCBi002-B
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KSCBi003-A
AC   CVCL_VE04
SY   hAdMSCiPS1; hAdMSiPS1
DR   BioSamples; SAMEA4675624
DR   GEO; GSM4972452
DR   hPSCreg; KSCBi003-A
DR   Wikidata; Q54900501
RX   PubMed=29979972;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   KSCBi005-A-1
AC   CVCL_WR11
SY   CMC-hiPSC-003(Nestin-GFP); CMC-003i-Nestin.EGFP
DR   BioSamples; SAMEA5713482
DR   GEO; GSM4972455
DR   hPSCreg; KSCBi005-A-1
DR   SKIP; SKIP005562
DR   Wikidata; Q95980253
RX   PubMed=31499408;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 NES has been endogenously tagged at the C-terminus with EGFP (PubMed=31499408).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 13
//
ID   KSCBi005-A-10
AC   CVCL_C9DA
SY   hiPSC-HIF-1alphaKO; hiPSC-HIF1alphaKO; hiPSC-HIF1aKO
DR   hPSCreg; KSCBi005-A-10
DR   Wikidata; Q123032856
RX   PubMed=38636267;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
ST   Source(s): PubMed=38636267
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9,14
ST   D18S51: 11,14
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 17,18
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   KSCBi005-A-2
AC   CVCL_WR12
SY   CMC-hiPSC-003(Sox1-GFP); CMC-003i-Sox1.EGFP
DR   BioSamples; SAMEA5837725
DR   hPSCreg; KSCBi005-A-2
DR   Wikidata; Q95980254
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 SOX1 has been endogenously tagged at the C-terminus with EGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 8
//
ID   KSCBi005-A-3
AC   CVCL_WR13
SY   CMC-hiPSC-003(PDX1-GFP); CMC-003i-Pdx1.EGFP
DR   BioSamples; SAMEA5997126
DR   GEO; GSM4972456
DR   hPSCreg; KSCBi005-A-3
DR   SKIP; SKIP005576
DR   Wikidata; Q95980255
RX   PubMed=31683099;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 PDX1 has been endogenously tagged at the C-terminus with EGFP (PubMed=31683099).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 13
//
ID   KSCBi005-A-4
AC   CVCL_WR14
SY   hiPSC-TLR7KO-A59
DR   hPSCreg; KSCBi005-A-4
DR   SKIP; SKIP005551
DR   Wikidata; Q95980256
RX   PubMed=31445394;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15631; TLR7.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   KSCBi005-A-5
AC   CVCL_WR15
SY   iPSC-TLR8KO-A10; TLR8KO-A10
DR   hPSCreg; KSCBi005-A-5
DR   SKIP; SKIP005561
DR   Wikidata; Q95980257
RX   PubMed=31526944;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15632; TLR8.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   KSCBi005-A-6
AC   CVCL_WR16
SY   hiPSC-TLR3KO-A49
DR   hPSCreg; KSCBi005-A-6
DR   Wikidata; Q95980258
RX   PubMed=33582546;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11849; TLR3.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   KSCBi005-A-7
AC   CVCL_WR17
SY   hiPSC-TLR2KO
DR   BioSamples; SAMEA9699777
DR   hPSCreg; KSCBi005-A-7
DR   Wikidata; Q95980259
RX   PubMed=34710836;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   KSCBi005-A-8
AC   CVCL_C9D8
SY   hiPSC-PD-L1KO
DR   hPSCreg; KSCBi005-A-8
DR   Wikidata; Q123032858
RX   PubMed=37690432;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KSCBi005-A-9
AC   CVCL_C9D9
SY   hiPSC-PD1KO
DR   hPSCreg; KSCBi005-A-9
DR   Wikidata; Q123032860
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR10 ! CMC-hiPSC-003
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   KSCBi006-A
AC   CVCL_WR18
SY   KNIH-OI001i-A
DR   BioSamples; SAMEA5712217
DR   hPSCreg; KSCBi006-A
DR   SKIP; SKIP005598
DR   Wikidata; Q95980260
RX   PubMed=31715426;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Asian.
CC   HLA typing: A*24:02,24:02; B*15:01,54:01; DRB1*04:03,15:01 (PubMed=31715426).
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Gly1055Alafs*53 (c.3162delT); ClinVar=VCV000285398; Zygosity=Unspecified (PubMed=31715426).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   KSCBi007-A
AC   CVCL_WR19
SY   KNIH-PWS001i-A
DR   BioSamples; SAMEA5727775
DR   hPSCreg; KSCBi007-A
DR   SKIP; SKIP005590
DR   Wikidata; Q95980261
RX   PubMed=31756696;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 9
//
ID   KSCBi008-A
AC   CVCL_WR20
SY   KNIH-PWS002i-A
DR   hPSCreg; KSCBi008-A
DR   Wikidata; Q95980262
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   KSCBi009-A
AC   CVCL_WR21
SY   KNIH-PWS003i-A
DR   BioSamples; SAMEA5727777
DR   hPSCreg; KSCBi009-A
DR   SKIP; SKIP005770
DR   Wikidata; Q95980263
RX   PubMed=32474395;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   KSCBi010-A
AC   CVCL_WR22
SY   DKH005i-A; DHK-005iA; DKHi005-A
DR   BioSamples; SAMEA5892403
DR   GEO; GSM4972453
DR   hPSCreg; KSCBi010-A
DR   SKIP; SKIP005591
DR   Wikidata; Q95980264
RX   PubMed=31734643;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:18340; WDR19; Simple; p.Arg1178Glu (c.3533G>A); Zygosity=Homozygous (PubMed=31734643).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168588; Senior-Loken syndrome
DI   ORDO; Orphanet_3156; Senior-Loken syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   KSCBi011-A
AC   CVCL_WR23
SY   DKH090i-A; DHK-090iA; DKHi090-A
DR   BioSamples; SAMEA5892784
DR   GEO; GSM4972454
DR   hPSCreg; KSCBi011-A
DR   SKIP; SKIP005692
DR   Wikidata; Q95980266
RX   PubMed=32036247;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:17877; NMNAT1; Simple; p.Arg237Cys (c.709C>T); ClinVar=VCV000845745; Zygosity=Homozygous (PubMed=32036247).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   KSCBi012-A
AC   CVCL_A9Q4
SY   NU01-EiPS07
DR   BioSamples; SAMEA110174003
DR   GEO; GSM4972459
DR   hPSCreg; KSCBi012-A
DR   Wikidata; Q102114435
RX   PubMed=33714852;
RX   PubMed=35700632;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   KSCBi014-A
AC   CVCL_B5RZ
SY   DPHCi01; LQT01-hiPSC
DR   hPSCreg; KSCBi014-A
DR   Wikidata; Q111733560
RX   PubMed=34678663;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Thr152Profs*14 (c.453delC); ClinVar=VCV000200598; Zygosity=Heterozygous (PubMed=34678663).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   KSCBi015-A
AC   CVCL_B0PU
SY   DPHCi08; LQT08-hiPSC
DR   hPSCreg; KSCBi015-A
DR   Wikidata; Q108820631
RX   PubMed=34509919;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg190Gln (c.569G>A) (p.Arg63Gln, c.188G>A); ClinVar=VCV000003117; Zygosity=Heterozygous (PubMed=34509919).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   KSCBi016-A
AC   CVCL_B5S0
SY   DPHCi06; LQT06-hiPSC
DR   hPSCreg; KSCBi016-A
DR   Wikidata; Q111733561
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   KSCBi017-A
AC   CVCL_C1TU
SY   KSCBi013-A; PB01-EiPS21
DR   BioSamples; SAMEA113398693
DR   GEO; GSM4972460
DR   hPSCreg; KSCBi017-A
DR   Wikidata; Q114311853
RX   PubMed=33714852;
RX   PubMed=36403547;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QE ! KSCBi017-B
OI   CVCL_C6QF ! KSCBi017-C
OI   CVCL_C6QG ! KSCBi017-D
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   KSCBi017-A-1
AC   CVCL_D6MJ
SY   PB01-EiPS21_GATA6-EGFP
DR   hPSCreg; KSCBi017-A-1
DR   Wikidata; Q127382577
RX   PubMed=38678980;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 a T2A-eGFP-CMVp-PuroR construct was inserted at the C-terminus of both alleles of GATA6 (PubMed=38678980).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1TU ! KSCBi017-A
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   KSCBi017-A-2
AC   CVCL_D6MI
SY   PB01-EiPS21-EGFP04
DR   Wikidata; Q127382578
RX   PubMed=38211411;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 a T2A-Bsd-CAGp-eGFP construct was introduced in one of the alleles of the AAVS1 safe harbor locus (PubMed=38211411).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1TU ! KSCBi017-A
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   KSCBi017-B
AC   CVCL_C6QE
DR   hPSCreg; KSCBi017-B
DR   Wikidata; Q117704580
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TU ! KSCBi017-A
OI   CVCL_C6QF ! KSCBi017-C
OI   CVCL_C6QG ! KSCBi017-D
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   KSCBi017-C
AC   CVCL_C6QF
DR   hPSCreg; KSCBi017-C
DR   Wikidata; Q117704581
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TU ! KSCBi017-A
OI   CVCL_C6QE ! KSCBi017-B
OI   CVCL_C6QG ! KSCBi017-D
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   KSCBi017-D
AC   CVCL_C6QG
DR   hPSCreg; KSCBi017-D
DR   Wikidata; Q117704582
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1TU ! KSCBi017-A
OI   CVCL_C6QE ! KSCBi017-B
OI   CVCL_C6QF ! KSCBi017-C
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   KSCBi018-A-1
AC   CVCL_C1TV
SY   hiPSC-TPM1_KI; YUCMi019-A-1
DR   hPSCreg; KSCBi018-A-1
DR   Wikidata; Q114311854
RX   PubMed=35917600;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:12010; TPM1; Simple_edited; p.Glu192Lys (c.574G>A); ClinVar=VCV000031882; Zygosity=Heterozygous; Note=By CRISPR/Cas9. The cell also contains c.576G>A which is a silent mutation (PubMed=35917600).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C182076; Familial hypertrophic cardiomyopathy type 3
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR33 ! CMC-hiPSC-011
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KSCBi018-A-2
AC   CVCL_C1TX
SY   hiPSC-TTN_KI; YUCMi019-A-2
DR   hPSCreg; KSCBi018-A-2
DR   Wikidata; Q114311855
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR33 ! CMC-hiPSC-011
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   KSCBi018-A-3
AC   CVCL_C1TY
SY   hiPSC-TTN_KO_1; YUCMi019-A-3
DR   hPSCreg; KSCBi018-A-3
DR   Wikidata; Q114311856
RX   PubMed=36037555;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12403; TTN.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR33 ! CMC-hiPSC-011
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KSCBi018-A-4
AC   CVCL_C1TZ
SY   hiPSC-TTN_KO_2; YUCMi019-A-4
DR   hPSCreg; KSCBi018-A-4
DR   Wikidata; Q114311857
RX   PubMed=36037555;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12403; TTN.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR33 ! CMC-hiPSC-011
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KSCBi018-A-5
AC   CVCL_C1U0
SY   hiPSC-TTN_KO_3; YUCMi019-A-5
DR   hPSCreg; KSCBi018-A-5
DR   Wikidata; Q114311858
RX   PubMed=36037555;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12403; TTN.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR33 ! CMC-hiPSC-011
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KSCBi018-A-6
AC   CVCL_C3LC
SY   hiPSC-PITX2_KO_1; YUCMi019-A-6
DR   hPSCreg; KSCBi018-A-6
DR   Wikidata; Q114311859
RX   PubMed=36260954;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9005; PITX2.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR33 ! CMC-hiPSC-011
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KSCBi018-A-7
AC   CVCL_C3LD
SY   hiPSC-PITX2_KO_2; YUCMi019-A-7
DR   hPSCreg; KSCBi018-A-7
DR   Wikidata; Q114311860
RX   PubMed=36260954;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9005; PITX2.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR33 ! CMC-hiPSC-011
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   KSE-1
AC   CVCL_VJ85
DR   Cosmic; 2650625
DR   Wikidata; Q95980267
RX   PubMed=2224855;
RX   PubMed=2469583;
RX   PubMed=3607755;
CC   Population: Japanese.
CC   Doubling time: ~19.5 hours (PubMed=3607755).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   KSE-2
AC   CVCL_VJ86
DR   Cosmic; 2650626
DR   Wikidata; Q95980268
RX   PubMed=1863354;
RX   PubMed=2224855;
CC   Population: Japanese.
CC   Doubling time: 13.2 hours (Note=Grown on confluent monolayers), 12.1 hours (Note=Grown on fixed-confluent monolayers), 21.9 hours (Note=Grown on plastic dishes) (PubMed=1863354).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   KSG
AC   CVCL_Z505
SY   KSG-1
DR   Wikidata; Q54900503
RX   Patent=JP2008220198A;
RX   PubMed=24399253;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM AP-21161.
CC   Doubling time: 40 hours (PubMed=24399253).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=41446; ! Sebastiscus marmoratus (False kelpfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 10
//
ID   KShS
AC   CVCL_4917
DR   CLO; CLO_0007121
DR   CLDB; cl3037
DR   Wikidata; Q54900504
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   KSNY
AC   CVCL_IW66
DR   Wikidata; Q54900505
RX   PubMed=317053;
CC   Population: Japanese.
CC   Characteristics: Established from a patient-derived xenograft established subcutaneously in nude mice.
CC   Doubling time: 46 hours (PubMed=317053).
CC   Anecdotal: Cell line name corresponds to the first letters of the names of the first three and of the last authors.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   KsOG
AC   CVCL_6557
DR   Wikidata; Q54900506
RX   PubMed=7489827;
RX   PubMed=15541573;
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   26-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   KST
AC   CVCL_6A74
DR   Wikidata; Q54900507
RX   PubMed=24000610;
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   Kst-6
AC   CVCL_6B18
DR   Wikidata; Q54900509
RX   PubMed=1550597;
RX   PubMed=7914196;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 15
//
ID   Kst-V100
AC   CVCL_6B19
DR   Wikidata; Q54900510
RX   PubMed=7914196;
CC   Problematic cell line: Contaminated. Grand-parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6B18 ! Kst-6
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 16
//
ID   KSU
AC   CVCL_T743
SY   KSu
DR   Wikidata; Q54900511
RX   PubMed=1449054;
CC   Population: Japanese.
CC   Doubling time: 58.8 hours (PubMed=1449054).
CC   Derived from site: In situ; Bone, left proximal tibia; UBERON=UBERON_0008772.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   KSU.C3
AC   CVCL_T744
DR   Wikidata; Q54900512
RX   PubMed=8100098;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, left proximal tibia; UBERON=UBERON_0008772.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T743 ! KSU
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   KSUG
AC   CVCL_E2TT
DR   ABCD; ABCD_BA639
RX   PubMed=9592861;
CC   Monoclonal antibody isotype: IgG, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Blood was obtained from a 45 year old woman suffering from systemic lupus erythematosus (PubMed=9592861).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E2TS ! HN9-10
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   KSUN
AC   CVCL_E2TU
DR   ABCD; ABCD_BA640
RX   PubMed=9592861;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_16991; DNA (Note=dsDNA).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Blood was obtained from a 30 year old woman suffering from systemic lupus erythematosus (PubMed=9592861).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E2TS ! HN9-10
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   KT [Human breast carcinoma]
AC   CVCL_M379
DR   Wikidata; Q54900514
RX   PubMed=3147274;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   KT [Human leukemia]
AC   CVCL_LI23
DR   Wikidata; Q54900515
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=9108419;
RX   PubMed=9823951;
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   KT-1 [Human leukemia]
AC   CVCL_D200
SY   KT1
DR   EFO; EFO_0022545
DR   Wikidata; Q54900516
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9427720;
RX   PubMed=10071072;
RX   PubMed=11111114;
RX   PubMed=12842705;
RX   PubMed=15539083;
CC   Population: Japanese.
CC   Characteristics: Sensitive to the antiproliferative and apoptosis-inducing effects of IFN-alpha.
CC   Doubling time: 18-24 hours (PubMed=9427720).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9427720; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   KT-1 [Mouse tongue]
AC   CVCL_HX30
DR   Wikidata; Q54900519
RX   Patent=US20060040255;
RX   PubMed=12513125;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8347.
CC   Doubling time: 4 days (PubMed=12513125).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8-12W
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   KT-1/A3
AC   CVCL_JH29
SY   A3
DR   Wikidata; Q54900520
RX   PubMed=11111114;
RX   PubMed=11506301;
RX   PubMed=12351404;
CC   Population: Japanese.
CC   Characteristics: Interferon-alpha sensitive (PubMed=11111114).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KT-1/A3R
AC   CVCL_JH31
SY   KT-1/A3Ralpha 1000; A3R
DR   Wikidata; Q54900521
RX   PubMed=11506301;
RX   PubMed=12351404;
CC   Population: Japanese.
CC   Characteristics: Interferon-alpha resistant. Can proliferate and is resistant to apoptosis at high concentration of IFN-alpha.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JH29 ! KT-1/A3
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KT-1/B7
AC   CVCL_JH30
SY   B7
DR   Wikidata; Q54900522
RX   PubMed=11111114;
RX   PubMed=12351404;
CC   Population: Japanese.
CC   Characteristics: Slightly interferon-alpha resistant (PubMed=11111114).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   KT-2
AC   CVCL_7055
DR   BTO; BTO_0004153
DR   cancercelllines; CVCL_7055
DR   Cosmic; 1047093
DR   Wikidata; Q54900523
RX   PubMed=17332333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=17332333).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   KT-3
AC   CVCL_6293
DR   Wikidata; Q54900525
RX   PubMed=3052631;
RX   PubMed=3120822;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KT-3
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/k/cell-lines-detail-84.html
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7205; Lymphoepithelioid variant peripheral T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53-54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KT-4
AC   CVCL_7056
DR   BTO; BTO_0004154
DR   cancercelllines; CVCL_7056
DR   Cosmic; 1047094
DR   Wikidata; Q54900526
RX   PubMed=17332333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=17332333).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   KT-5
AC   CVCL_5549
DR   JCRB; IFO50161
DR   Wikidata; Q54900527
RX   CelloPub=CLPUB00482;
CC   Doubling time: 17 hours (CelloPub=CLPUB00482); ~7 days (Note=Lot 03242005) (JCRB=IFO50161).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21932; Mouse astrocytic tumours
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   KT-COLO-8
AC   CVCL_W485
DR   Wikidata; Q54900538
RX   PubMed=7873498;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=7873498).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   KT01
AC   CVCL_X644
SY   KT1
DR   CLO; CLO_0050365
DR   RCB; RCB2367
DR   Wikidata; Q54900539
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT02
AC   CVCL_X645
SY   KT2
DR   CLO; CLO_0050366
DR   DSHB; KT2
DR   RCB; RCB2368
DR   Wikidata; Q54900540
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT03
AC   CVCL_X646
SY   KT3
DR   CLO; CLO_0050367
DR   DSHB; KT3
DR   RCB; RCB2369
DR   Wikidata; Q54900541
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule and body wall muscle.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT04
AC   CVCL_X647
SY   KT4
DR   Wikidata; Q54900543
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT05
AC   CVCL_X648
SY   KT5
DR   Wikidata; Q54900544
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT06
AC   CVCL_X649
SY   KT6
DR   CLO; CLO_0050368
DR   RCB; RCB2372
DR   Wikidata; Q54900545
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule and adult muscle.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT07
AC   CVCL_X650
SY   KT7
DR   Wikidata; Q54900546
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT08
AC   CVCL_X651
SY   KT8
DR   Wikidata; Q54900547
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT09
AC   CVCL_X652
SY   KT9
DR   CLO; CLO_0050369
DR   DSHB; KT9
DR   RCB; RCB2375
DR   Wikidata; Q54900548
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on body muscle.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT10 [Mouse hybridoma against C.elegans]
AC   CVCL_X653
DR   CLO; CLO_0050370
DR   DSHB; KT10
DR   RCB; RCB2376
DR   Wikidata; Q54900550
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on body muscle.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 8
//
ID   KT10 [Rat hepatoma]
AC   CVCL_C7WL
DR   Wikidata; Q123032862
RX   PubMed=11177;
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   KT11 [Human B-cell IHW]
AC   CVCL_E738
DR   IHW; 9w 0610
DR   Wikidata; Q54900551
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*33; B*44 (IHW=9w 0610).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 17
//
ID   KT11 [Mouse hybridoma]
AC   CVCL_X654
DR   CLO; CLO_0050371
DR   DSHB; KT11
DR   RCB; RCB2377
DR   Wikidata; Q54900552
RX   PubMed=18498356;
WW   Provider; DSHB; -; https://web.archive.org/web/20180703012350/http://dshb.biology.uiowa.edu/bodywall-muscle-cells_3
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on body muscle.
CC   Discontinued: DSHB; KT11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 8
//
ID   KT112
AC   CVCL_A3CM
DR   Wikidata; Q105509826
RX   PubMed=1708676;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10300; Mouse Cd8b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   KT12 [Human B-cell IHW]
AC   CVCL_E739
SY   LKT12
DR   dbMHC; 48934
DR   ECACC; 88012503
DR   IHW; IHW09073
DR   IPD-IMGT/HLA; 11000
DR   Wikidata; Q54900553
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01,31:01:02:01; B*35:01:01:01,52:01:01:02; C*04:01:01:01,12:02:02:01; DPB1*04:02:01,05:01:01; DQB1*03:03:02; DRB1*09:01:02/09:21 (IPD-IMGT/HLA=11000).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   KT12 [Mouse hybridoma]
AC   CVCL_X655
DR   CLO; CLO_0050372
DR   DSHB; KT12
DR   RCB; RCB2378
DR   Wikidata; Q54900554
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on body muscle.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT13
AC   CVCL_X656
DR   CLO; CLO_0050373
DR   DSHB; KT13
DR   RCB; RCB2379
DR   Wikidata; Q54900555
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on hypodermis/seam cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT14 [Human B-cell IHW]
AC   CVCL_E740
SY   LKT14; KAS
DR   dbMHC; 48935
DR   ECACC; 88052103
DR   IHW; IHW09103
DR   IPD-IMGT/HLA; 11001
DR   Wikidata; Q54900557
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01,26:02:01; B*51:01:01:01,40:06:01:01; C*08:01:01,14:02:01:01; DPB1*02:01:02/02:01:19,19:01; DQA1*03; DQB1*03:03:02; DRB1*09:01:02/09:21; DRB4*01:03:02 (IPD-IMGT/HLA=11001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   KT14 [Mouse hybridoma]
AC   CVCL_X657
DR   CLO; CLO_0050374
DR   DSHB; KT14
DR   RCB; RCB2380
DR   Wikidata; Q54900558
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx basement membrane.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT15
AC   CVCL_A3CL
DR   ECACC; 19031501
DR   Wikidata; Q105509830
RX   PubMed=1708676;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   KT16
AC   CVCL_X658
DR   CLO; CLO_0050375
DR   DSHB; KT16
DR   RCB; RCB2381
DR   Wikidata; Q54900559
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
CC   Discontinued: DSHB; KT16; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 8
//
ID   KT17 [Human B-cell IHW]
AC   CVCL_E741
SY   LKT17
DR   dbMHC; 48936
DR   ECACC; 88052024
DR   IHW; IHW09024
DR   IPD-IMGT/HLA; 11002
DR   Wikidata; Q54900560
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:06:01:01,11:01:01:01; B*15:01:01:01,35:01:01:02; C*04:01:01:01,03:03:01:01; DPA1*02:02:02; DPB1*05:01:01; DQA1*03:01; DQB1*03:02:01; DRB1*04:03:01,04:06:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=11002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   KT17 [Mouse hybridoma]
AC   CVCL_X659
DR   CLO; CLO_0050364
DR   DSHB; KT17
DR   RCB; RCB2382
DR   Wikidata; Q54900562
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT18
AC   CVCL_X660
DR   CLO; CLO_0050376
DR   RCB; RCB2383
DR   Wikidata; Q54900563
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT19
AC   CVCL_X661
DR   DSHB; KT19
DR   Wikidata; Q54900564
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT2
AC   CVCL_E742
SY   LKT2
DR   dbMHC; 48937
DR   ECACC; 94022538
DR   IHW; IHW09288
DR   IPD-IMGT/HLA; 11003
DR   Wikidata; Q54900565
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01; B*51:01:01; C*14:02:01; DPB1*05:01; DQA1*03; DRB1*04:06:01; DRB4*01:03 (IPD-IMGT/HLA=11003).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94022538; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   KT20
AC   CVCL_X662
DR   DSHB; KT20
DR   Wikidata; Q54900567
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 9
//
ID   KT21
AC   CVCL_X663
DR   CLO; CLO_0050390
DR   RCB; RCB2386
DR   Wikidata; Q54900569
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on intestine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT21-MG1
AC   CVCL_M429
SY   KT21MG1
DR   Wikidata; Q54900570
RX   PubMed=2804914;
CC   Population: Japanese.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: ~24 hours (Note=At 30th passage) (PubMed=2804914).
CC   Derived from site: In situ; Brain, falx cerebri; UBERON=UBERON_0006059.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   KT21-MG1-Luc5D
AC   CVCL_JK00
DR   Wikidata; Q54900571
RX   PubMed=25596744;
RX   PubMed=28469964;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Brain, falx cerebri; UBERON=UBERON_0006059.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M429 ! KT21-MG1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   KT22
AC   CVCL_X664
DR   DSHB; KT22
DR   Wikidata; Q54900572
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT23
AC   CVCL_X665
DR   CLO; CLO_0050398
DR   DSHB; KT23
DR   RCB; RCB2388
DR   Wikidata; Q54900573
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on nuclear membrane.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT26
AC   CVCL_X666
DR   CLO; CLO_0050377
DR   RCB; RCB2389
DR   Wikidata; Q54900575
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on centrosome.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT27
AC   CVCL_X667
DR   CLO; CLO_0050378
DR   DSHB; KT27
DR   RCB; RCB2390
DR   Wikidata; Q54900576
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on dorsal hypodermis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT28
AC   CVCL_X668
DR   Wikidata; Q54900577
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on unidentified structure.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT29
AC   CVCL_X669
DR   CLO; CLO_0050379
DR   RCB; RCB2392
DR   Wikidata; Q54900578
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on eggshell.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT3
AC   CVCL_E743
SY   LKT3; LKT-3; KT-3
DR   dbMHC; 48953
DR   ECACC; 94070705
DR   IHW; IHW09107
DR   IPD-IMGT/HLA; 11004
DR   Wikidata; Q54900579
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=1363422;
RX   PubMed=8813743;
RX   PubMed=16702430;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01,24:02:43; B*54:01:01; C*01:02:01; DPA1*02:02:02; DPB1*05:01:01; DQA1*03:02; DQB1*04:01:01; DRA*01:01:01; DRB1*04:05:01; DRB4*01:02 (IPD-IMGT/HLA=11004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   KT30
AC   CVCL_X670
DR   CLO; CLO_0050381
DR   DSHB; KT30
DR   RCB; RCB2393
DR   Wikidata; Q54900581
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on eggshell.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT31
AC   CVCL_X671
DR   DSHB; KT31
DR   Wikidata; Q54900582
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on sensory cilia and excretory pore.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT32
AC   CVCL_X672
DR   CLO; CLO_0050382
DR   RCB; RCB2395
DR   Wikidata; Q54900583
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule and pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT35
AC   CVCL_X673
DR   Wikidata; Q54900584
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule and centrosome.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT36
AC   CVCL_X674
DR   DSHB; KT36
DR   Wikidata; Q54900585
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 30-01-24; Version: 7
//
ID   KT37
AC   CVCL_X675
DR   Wikidata; Q54900607
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT38
AC   CVCL_X676
DR   Wikidata; Q54900608
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule and pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT50
AC   CVCL_A3CJ
DR   Wikidata; Q105509833
RX   PubMed=2526741;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-alpha-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   KT54
AC   CVCL_X677
DR   CLO; CLO_0050383
DR   RCB; RCB2400
DR   Wikidata; Q54900610
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on P granule and centrosome.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT56
AC   CVCL_X678
DR   Wikidata; Q54900611
RX   PubMed=18498356;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on pharynx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   KT65
AC   CVCL_A3CK
DR   Wikidata; Q105509835
RX   PubMed=2526741;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-alpha-8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   KTA-1
AC   CVCL_9572
SY   KTA1; KTA-I
DR   CGH-DB; 49-1
DR   RCB; RCB5470
DR   Wikidata; Q54900613
RX   Patent=US8029793;
RX   PubMed=8121182;
RX   PubMed=15613457;
RX   PubMed=16924234;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7524.
CC   Population: Japanese.
CC   Doubling time: 52.1 hours (PubMed=8121182).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C46008; Thyroid gland squamous cell carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80-81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   KTA-2
AC   CVCL_9573
SY   KTA2; KTA-II
DR   CGH-DB; 50-1
DR   RCB; RCB5471
DR   Wikidata; Q54900614
RX   Patent=US8029793;
RX   PubMed=8121182;
RX   PubMed=9177455;
RX   PubMed=15613457;
RX   PubMed=16924234;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7525.
CC   Population: Japanese.
CC   Doubling time: 63.1 hours (PubMed=8121182).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   KTA-3
AC   CVCL_9574
SY   KTA3
DR   CGH-DB; 51-1
DR   RCB; RCB5472
DR   Wikidata; Q54900616
RX   Patent=US8029793;
RX   PubMed=15613457;
RX   PubMed=16924234;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7526.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   KTA-4
AC   CVCL_9575
SY   KTA4
DR   CGH-DB; 52-1
DR   RCB; RCB5473
DR   Wikidata; Q54900617
RX   Patent=US8029793;
RX   PubMed=15613457;
RX   PubMed=16924234;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7528.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   KTA7
AC   CVCL_A105
SY   KTA-7
DR   cancercelllines; CVCL_A105
DR   Cosmic; 946051
DR   Wikidata; Q54900618
RX   PubMed=1705538;
RX   PubMed=16105816;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=1705538).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu861Gln (c.2582T>A); ClinVar=VCV000163380; Zygosity=Unspecified (PubMed=16105816).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   KTaR-1
AC   CVCL_VS93
DR   Wikidata; Q95980378
RX   PubMed=27409645;
CC   Characteristics: Kisspeptin-secreting cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus, arcuate nucleus; UBERON=UBERON_0001932.
CC   Breed/subspecies: C57BL/6-Tg(Kiss1-hrGFP)KG26Cfe/J transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VS94 ! KTaV-3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   KTaV-3
AC   CVCL_VS94
DR   Wikidata; Q95980379
RX   PubMed=27409645;
CC   Characteristics: Kisspeptin-secreting cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus, anteroventral periventricular nucleus; UBERON=UBERON_0002690.
CC   Breed/subspecies: C57BL/6-Tg(Kiss1-hrGFP)KG26Cfe/J transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VS93 ! KTaR-1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   KTC-1
AC   CVCL_6300
SY   KTC1; KTC1naive
DR   BTO; BTO_0005144
DR   cancercelllines; CVCL_6300
DR   CCRID; 3101HUMSCSP552
DR   CLS; 305113
DR   Cosmic; 683717
DR   Cosmic; 1239967
DR   Cosmic; 2054106
DR   Cosmic; 2755722
DR   IARC_TP53; 21625
DR   Wikidata; Q54900619
RX   CelloPub=CLPUB00144;
RX   PubMed=10946899;
RX   PubMed=18713817;
RX   PubMed=23833040;
RX   PubMed=25675381;
RX   PubMed=29156680;
RX   PubMed=30737244;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=10946899).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=29156680).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=29156680; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Asp63Val (c.188A>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=18713817; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,13
ST   D21S11: 29
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 23,26
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   KTC-2
AC   CVCL_6476
SY   KTC2
DR   cancercelllines; CVCL_6476
DR   Cosmic; 1239964
DR   Cosmic; 2054080
DR   Wikidata; Q54900621
RX   CelloPub=CLPUB00144;
RX   PubMed=12729473;
RX   PubMed=18713817;
RX   PubMed=23833040;
RX   PubMed=25675381;
RX   PubMed=30737244;
CC   Population: Japanese.
CC   Doubling time: 36 +- 3 hours (PubMed=12729473).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu490Ter (c.1468G>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=18713817; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   KTC-3
AC   CVCL_W911
SY   KTC3
DR   Wikidata; Q54900622
RX   CelloPub=CLPUB00144;
CC   Population: Japanese.
CC   Doubling time: 24 hours (CelloPub=CLPUB00144).
CC   Miscellaneous: STR profile from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 15,17
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   KTC1res.1
AC   CVCL_A2CS
SY   KTC1res_1; Res.1 KTC1
DR   cancercelllines; CVCL_A2CS
DR   Cosmic; 2755723
DR   Wikidata; Q105509839
RX   PubMed=29156680;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=29156680).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=29156680).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys443Glu (c.1327A>G); Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=29156680).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Asp63Val (c.188A>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6300 ! KTC-1
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   KTC1res.2
AC   CVCL_A2CT
SY   KTC1res_2; Res.2 KTC1
DR   cancercelllines; CVCL_A2CT
DR   Cosmic; 2755724
DR   Wikidata; Q105509842
RX   PubMed=29156680;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=29156680).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=29156680).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Asp63Val (c.188A>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6300 ! KTC-1
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   KTCTL-104
AC   CVCL_B273
DR   Wikidata; Q54900623
RX   PubMed=11762795;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   KTCTL-107
AC   CVCL_RW15
DR   Wikidata; Q54900624
RX   PubMed=8086765;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   KTCTL-111
AC   CVCL_B272
SY   KTCTL 111
DR   Wikidata; Q54900625
RX   PubMed=11929824;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   KTCTL-120
AC   CVCL_5883
SY   KTCTL120; RCC-LR
DR   CLS; 300236
DR   Wikidata; Q54900626
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300236
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 12
ST   D18S51: 13,14
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   Penta D: 9,14
ST   Penta E: 12
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   KTCTL-128
AC   CVCL_B274
DR   Wikidata; Q54900628
RX   PubMed=11720477;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   KTCTL-129
AC   CVCL_5885
SY   KTCTL129; RCC-MH; RCCMH
DR   CLS; 300237
DR   Wikidata; Q54900629
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300237
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 9,10
ST   D7S820: 8,12
ST   D8S1179: 9,15
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   KTCTL-13
AC   CVCL_5870
SY   KTCTL13; KTCTL 13; RCC-ER; RCCER
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_5870
DR   Cell_Model_Passport; SIDM00820
DR   CLS; 300238
DR   Cosmic; 972923
DR   Cosmic; 1352060
DR   Cosmic; 1751971
DR   Cosmic-CLP; 1524417
DR   DepMap; ACH-002188
DR   EGA; EGAS00001000978
DR   GDSC; 1524417
DR   GEO; GSM1670361
DR   PharmacoDB; RCCER_1288_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54900630
RX   PubMed=7915601;
RX   PubMed=8086765;
RX   PubMed=11929824;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asp143Glufs*16 (c.429del); Zygosity=Unspecified (PubMed=7915601).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.27%; Native American=0.52%; East Asian, North=1.51%; East Asian, South=0%; South Asian=1.01%; European, North=76.23%; European, South=20.46% (PubMed=30894373).
CC   Misspelling: KTCL13; Cosmic=972923; PubMed=7915601.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300238; Cosmic-CLP=1524417
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 14,17
ST   D19S433: 13.2,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 17,23
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,26
ST   Penta D: 10,12
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   KTCTL-135
AC   CVCL_5869
SY   KTCTL135; RCC-EK
DR   CLS; 300239
DR   Wikidata; Q54900631
CC   Population: Caucasian.
CC   Discontinued: CLS; 300239; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300239
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 14,17
ST   D21S11: 30,31.2
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,26
ST   Penta D: 10,12
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   KTCTL-140
AC   CVCL_5879
SY   KTCTL140; RCC-JF; RCCJF
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_5879
DR   Cell_Model_Passport; SIDM00818
DR   CLS; 300274
DR   Cosmic; 972926
DR   Cosmic; 1352063
DR   Cosmic; 1751974
DR   Cosmic-CLP; 1524415
DR   DepMap; ACH-002190
DR   EGA; EGAS00001000978
DR   GDSC; 1524415
DR   PharmacoDB; RCCJF_1290_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54900633
RX   PubMed=7915601;
RX   PubMed=11762795;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.His115Tyr (c.343C>T); dbSNP=rs5030811; Zygosity=Unspecified (PubMed=7915601).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0.77%; East Asian, North=2.03%; East Asian, South=0%; South Asian=1.72%; European, North=62.07%; European, South=33.41% (PubMed=30894373).
CC   Misspelling: KTCL140; Cosmic=972926; PubMed=7915601.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300274; Cosmic-CLP=1524415
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,15
ST   D21S11: 28,30.2
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 7,8
ST   D8S1179: 12,14
ST   FGA: 18,25
ST   Penta D: 10,13
ST   Penta E: 7,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   KTCTL-185
AC   CVCL_5875
SY   KTCTL185; RCC-GS; RCCGS
DR   CLS; 300241
DR   Wikidata; Q54900634
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300241
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 9,12
ST   D18S51: 14
ST   D21S11: 31
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 8,11
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 8,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   KTCTL-187
AC   CVCL_B275
DR   Wikidata; Q54900635
RX   PubMed=11762795;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   KTCTL-195
AC   CVCL_5880
SY   KTCTL195; RCC-JW; RCCJW
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_5880
DR   Cell_Model_Passport; SIDM00817
DR   CLS; 300244
DR   Cosmic; 1352064
DR   Cosmic; 1751975
DR   Cosmic-CLP; 1524416
DR   DepMap; ACH-002191
DR   EGA; EGAS00001000978
DR   GDSC; 1524416
DR   GEO; GSM1670363
DR   PharmacoDB; RCCJW_1291_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54900636
RX   PubMed=11762795;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=1.71%; East Asian, North=0%; East Asian, South=0%; South Asian=1.93%; European, North=62.95%; European, South=33.4% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300244; Cosmic-CLP=1524416
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 16
ST   D21S11: 28,30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   KTCTL-1M
AC   CVCL_5884
SY   KTCTL1M; RCC-MF; RCCMF
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_5884
DR   Cell_Model_Passport; SIDM00816
DR   CLS; 300245
DR   Cosmic; 1352065
DR   Cosmic; 1751976
DR   Cosmic-CLP; 1524419
DR   DepMap; ACH-002192
DR   EGA; EGAS00001000978
DR   GDSC; 1524419
DR   GEO; GSM1670364
DR   PharmacoDB; RCCMF_1292_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54900638
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=35902118;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:30064; PBRM1; Simple; p.Asn528Metfs*41 (c.1583del); Zygosity=Homozygous (PubMed=35902118).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0.82%; South Asian=1.22%; European, North=63.61%; European, South=34.35% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300245; Cosmic-CLP=1524419
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 13
ST   D18S51: 13,15
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 20
ST   Penta D: 12,16
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   KTCTL-2
AC   CVCL_5871
SY   KTCTL2; KTCTL 2; RCC-EW
DR   cancercelllines; CVCL_5871
DR   CLS; 300246
DR   Cosmic; 972922
DR   Wikidata; Q54900639
RX   PubMed=7915601;
RX   PubMed=8086765;
RX   PubMed=10190320;
RX   PubMed=11720477;
RX   PubMed=11929824;
RX   PubMed=15977034;
CC   Problematic cell line: Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; c.341-2A>T; ClinVar=VCV002034796; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=7915601).
CC   Misspelling: KTCL2; Cosmic=972922; PubMed=7915601.
CC   Discontinued: CLS; 300246; true.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5878 ! KTCTL-30
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   KTCTL-20
AC   CVCL_RV73
DR   Wikidata; Q54900640
RX   PubMed=8086765;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   KTCTL-21
AC   CVCL_5868
SY   KTCTL21; RCC-AB; RCCAB
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_5868
DR   Cell_Model_Passport; SIDM00821
DR   CLS; 300247
DR   Cosmic; 1352059
DR   Cosmic; 1751970
DR   Cosmic-CLP; 1524418
DR   DepMap; ACH-002187
DR   EGA; EGAS00001000978
DR   GDSC; 1524418
DR   GEO; GSM1670360
DR   PharmacoDB; RCCAB_1287_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54900641
RX   PubMed=8086765;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0.07%; East Asian, North=0.03%; East Asian, South=0%; South Asian=1.41%; European, North=62.87%; European, South=35.62% (PubMed=30894373).
CC   Discontinued: CLS; 300247; true.
ST   Source(s): CLS=300247; Cosmic-CLP=1524418
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 30,33.2
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,15
ST   FGA: 22,25
ST   Penta D: 10,12
ST   Penta E: 7
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KTCTL-26
AC   CVCL_5872
SY   KTCTL26; RCC-FG1; RCCFG1
DR   CLS; 300248
DR   Wikidata; Q54900642
RX   PubMed=8086765;
RX   PubMed=10190320;
RX   PubMed=15977034;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300248
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 10,11,12
ST   D7S820: 10,11,12
ST   D8S1179: 12,13,15
ST   FGA: 19,23
ST   Penta D: 9,13
ST   Penta E: 12,17,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5873 ! KTCTL-26A
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   KTCTL-26A
AC   CVCL_5873
SY   KTCTL-26a; KTCTL26A; RCC-FG2; RCCFG2
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 995
DR   cancercelllines; CVCL_5873
DR   Cell_Model_Passport; SIDM00819
DR   CLS; 300249
DR   Cosmic; 972924
DR   Cosmic; 1352061
DR   Cosmic; 1751972
DR   Cosmic-CLP; 1524414
DR   DepMap; ACH-002189
DR   EGA; EGAS00001000978
DR   GDSC; 1524414
DR   GEO; GSM1670362
DR   PharmacoDB; RCCFG2_1289_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54900643
RX   PubMed=7828150;
RX   PubMed=7915601;
RX   PubMed=8086765;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31267758;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-low) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Phe148Leufs*11 (c.444delT); ClinVar=VCV000223212; Zygosity=Unspecified (PubMed=7915601).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0.87%; East Asian, North=1.55%; East Asian, South=0%; South Asian=1.66%; European, North=66.58%; European, South=29.34% (PubMed=30894373).
CC   Misspelling: KTCL26A; Cosmic=972924; PubMed=7915601.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300249; Cosmic-CLP=1524414
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 15,17
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 12,15
ST   FGA: 19,23
ST   Penta D: 9,13
ST   Penta E: 12,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5872 ! KTCTL-26
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   KTCTL-28
AC   CVCL_B276
DR   Wikidata; Q54900645
RX   PubMed=11720477;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   KTCTL-30
AC   CVCL_5878
SY   KTCTL30; KTCTL 30; RCC-HS
DR   CLS; 300250
DR   Cosmic; 1352062
DR   Cosmic; 1751973
DR   Wikidata; Q54900646
RX   PubMed=8086765;
RX   PubMed=11762795;
RX   PubMed=11929824;
CC   Problematic cell line: Contaminated. KTCTL-2 and KTCTL-30 have been shown to be identical (CLS; on the basis of STR profile).
CC   Discontinued: CLS; 300250; true.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5871 ! KTCTL-2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   KTCTL-31
AC   CVCL_RW13
DR   Wikidata; Q54900647
RX   PubMed=8086765;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   KTCTL-33
AC   CVCL_B277
DR   Wikidata; Q54900648
RX   PubMed=8086765;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   KTCTL-48
AC   CVCL_5877
SY   KTCTL48; RCC-HB; RCCHB
DR   CLS; 300253
DR   Wikidata; Q54900649
RX   PubMed=8086765;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300253
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 14,16
ST   D21S11: 28,30
ST   D3S1358: 18
ST   D5S818: 10
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 18,24
ST   Penta D: 11,13
ST   Penta E: 16
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   KTCTL-53
AC   CVCL_5882
SY   KTCTL53; KTCTL 53; RCC-KP
DR   CLS; 300254
DR   Cosmic; 972925
DR   Wikidata; Q54900650
RX   PubMed=7915601;
RX   PubMed=8086765;
RX   PubMed=11929824;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Val84Profs*73 (c.250_256del); Zygosity=Unspecified (PubMed=7915601).
CC   Misspelling: KTCL53; Cosmic=972925; PubMed=7915601.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300254
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   KTCTL-54
AC   CVCL_5886
SY   KTCTL54; RCC-OF1
DR   CLS; 300255
DR   Wikidata; Q54900651
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300255
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 16
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 19,21
ST   Penta D: 9,13
ST   Penta E: 13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   KTCTL-61
AC   CVCL_RW14
DR   Wikidata; Q54900654
RX   PubMed=8086765;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   KTCTL-84
AC   CVCL_B278
DR   Wikidata; Q54900655
RX   PubMed=8086765;
RX   PubMed=11720477;
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   KTCTL-87
AC   CVCL_5888
SY   KTCTL87; RCC-WK; RCCWK
DR   CLS; 300243
DR   Wikidata; Q54900656
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300243
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 17
ST   D21S11: 28,31.2
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 11,12
ST   FGA: 21,23
ST   Penta D: 12,15
ST   Penta E: 5,16
ST   TH01: 8,9
ST   TPOX: 9,12
ST   vWA: 14,16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   KthES11
AC   CVCL_UM06
SY   KUIMSe004-A
DR   hPSCreg; KUIMSe004-A
DR   Wikidata; Q95980472
RX   PubMed=33059130;
RX   PubMed=33225099;
RX   PubMed=34126558;
WW   Info; Kyoto University; -; http://www2.infront.kyoto-u.ac.jp/es01/KthES11.htm
CC   Group: Clinical grade pluripotent cell line.
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   KthES12
AC   CVCL_A1MP
SY   KUIMSe005-A
DR   hPSCreg; KUIMSe005-A
DR   Wikidata; Q102114436
RX   PubMed=33059130;
RX   PubMed=33225099;
WW   Info; Kyoto University; -; http://www2.infront.kyoto-u.ac.jp/es01/KthES12.htm
CC   Group: Clinical grade pluripotent cell line.
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   KthES13
AC   CVCL_A1MQ
SY   KUIMSe006-A
DR   hPSCreg; KUIMSe006-A
DR   Wikidata; Q102114438
RX   PubMed=33059130;
RX   PubMed=33225099;
WW   Info; Kyoto University; -; http://www2.infront.kyoto-u.ac.jp/es01/KthES13.htm
CC   Group: Clinical grade pluripotent cell line.
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   KthES14
AC   CVCL_A1MR
SY   KUIMSe007-A
DR   hPSCreg; KUIMSe007-A
DR   Wikidata; Q102114440
RX   PubMed=33059130;
RX   PubMed=33225099;
WW   Info; Kyoto University; -; http://www2.infront.kyoto-u.ac.jp/es01/KthES14.htm
CC   Group: Clinical grade pluripotent cell line.
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   KthES15
AC   CVCL_C1U3
SY   KUIMSe008-A
DR   hPSCreg; KUIMSe008-A
DR   Wikidata; Q114311861
WW   Info; Kyoto University; -; http://www2.infront.kyoto-u.ac.jp/es01/KthES15.htm
CC   Group: Clinical grade pluripotent cell line.
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   KthES16
AC   CVCL_C1U4
SY   KUIMSe009-A
DR   hPSCreg; KUIMSe009-A
DR   Wikidata; Q114311862
WW   Info; Kyoto University; -; http://www2.infront.kyoto-u.ac.jp/es01/KthES16.htm
CC   Group: Clinical grade pluripotent cell line.
CC   From: Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   KTHOS
AC   CVCL_T737
DR   ABM; T8012
DR   Wikidata; Q54900664
RX   PubMed=15693848;
CC   Population: Japanese.
CC   Doubling time: 35.6 hours (PubMed=15693848).
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   KTN-R
AC   CVCL_XH19
DR   CCLV; CCLV-RIE 0046
DR   Wikidata; Q95980430
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   KTOR1
AC   CVCL_E6D6
RX   PubMed=31900393;
CC   Population: Japanese.
CC   Doubling time: 85.8 hours (PubMed=31900393).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=31900393).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=31900393).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6D7 ! KTOR1-RE
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTOR1-RE
AC   CVCL_E6D7
RX   PubMed=31900393;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=31900393).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=31900393).
CC   Donor information: Established from the patient after relapse and acquired resistance to ALK inhibitors (PubMed=31900393).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6D6 ! KTOR1
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTOR2
AC   CVCL_E6D8
RX   PubMed=31900393;
CC   Population: Japanese.
CC   Doubling time: 75.6 hours (PubMed=31900393).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=31900393).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6D9 ! KTOR2-RE
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTOR2-RE
AC   CVCL_E6D9
RX   PubMed=31900393;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=31900393).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Leu1196Met (c.3586C>A); ClinVar=VCV000376135; Zygosity=Unspecified (PubMed=31900393).
CC   Donor information: Established from the patient after relapse and acquired resistance to ALK inhibitors (PubMed=31900393).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6D8 ! KTOR2
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTOR3
AC   CVCL_E6DA
RX   PubMed=31900393;
CC   Population: Japanese.
CC   Doubling time: 164.5 hours (PubMed=31900393).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=31900393).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTOSA5
AC   CVCL_GY93
DR   Wikidata; Q54900665
RX   PubMed=24416158;
RX   PubMed=25190452;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, right hindlimb; UBERON=UBERON_0003464.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   KTP
AC   CVCL_4918
DR   CLO; CLO_0007122
DR   CLDB; cl3069
DR   Wikidata; Q54900666
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 7
//
ID   KTPU10
AC   CVCL_E5VW
RX   PubMed=24444128;
WW   Info; EGTC; -; https://egtc.jp/celllines/KTPU10
CC   Characteristics: Feeder free (PubMed=24444128).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C318 ! TT2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTPU8
AC   CVCL_E5VX
RX   PubMed=23604909;
RX   PubMed=24444128;
WW   Info; EGTC; -; https://egtc.jp/celllines/KTPU8
CC   Characteristics: Feeder free (PubMed=24444128).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C318 ! TT2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTR-1-R
AC   CVCL_XH30
DR   CCLV; CCLV-RIE 0049
DR   Wikidata; Q95980431
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   KTR-R
AC   CVCL_0R17
DR   CCLV; CCLV-RIE 0060
DR   Wikidata; Q54900667
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   3FW
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   KTR1
AC   CVCL_E9WD
RX   PubMed=12842705;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KTR2
AC   CVCL_E9WE
RX   PubMed=12842705;
RX   PubMed=15539083;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KTR3
AC   CVCL_E9WF
RX   PubMed=12842705;
RX   PubMed=15539083;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KTR4
AC   CVCL_E9WG
RX   PubMed=12842705;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KTR5
AC   CVCL_E9WH
RX   PubMed=12842705;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KTR6
AC   CVCL_E9WI
RX   PubMed=12842705;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KTR7
AC   CVCL_E9WJ
RX   PubMed=12842705;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KTRC CITED1:mCherry
AC   CVCL_VU00
SY   Kidney Translational Research Center CITED1:mCherry reporter iPSC
DR   Wikidata; Q93302350
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=Q-2CW4
CC   Population: Caucasian.
CC   Characteristics: Identifies early intermediate mesoderm and mesenchymal nephron progenitors (NPs), early nephron populations (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 CITED1 has been endogenously tagged at the C-terminal of its single allele with mCherry (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   KTRC GATA3:mCherry
AC   CVCL_E5VR
SY   Kidney Translational Research Center GATA3:mCherry iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=14-3QDC
CC   Population: Caucasian.
CC   Characteristics: Identifies connecting segment (SLC12A1-), collecting duct, GATA3+ interstitial population (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 GATA3 has been endogenously tagged at the N-terminal of one allele with mCherry (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC HNF4A:YFP
AC   CVCL_E5VV
SY   Kidney Translational Research Center KTRC HNF4A:YFP iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=16-1YZG
CC   Characteristics: Identifies proximal tubule (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 HNF4A has been endogenously tagged at the C-terminal of both alleles with YFP (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC LRP2:mTagBFP2
AC   CVCL_E5VT
SY   Kidney Translational Research Center LRP2:mTagBFP2 iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=16-DYT2
CC   Population: Caucasian.
CC   Characteristics: Identifies proximal tubule (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 LRP2 has been endogenously tagged at the C-terminal of one allele with mTagBFP2 (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZO7NN; mTagBFP2 (Note=Blue fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC MAFB:mTagBFP2
AC   CVCL_E5VS
SY   Kidney Translational Research Center MAFB:mTagBFP2 iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=Q-2CW2
CC   Population: Caucasian.
CC   Characteristics: Identifies podocytes (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 MAFB has been endogenously tagged at the N-terminal of one allele with mTagBFP2 (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZO7NN; mTagBFP2 (Note=Blue fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC MAFB:mTagBFP2/GATA3:mCherry
AC   CVCL_E5VU
SY   Kidney Translational Research Center MAFB:mTagBFP2/GATA3:mCherry iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=14-3QDG
CC   Population: Caucasian.
CC   Characteristics: Identifies podocytes (MAFB+), collecting duct/connecting segment (GATA3+), GATA3+ interstitial population (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 MAFB has been endogenously tagged at the N-terminal of one allele with mTagBFP2 and GATA3 has been endogenously tagged at the C-terminal in one allele with mCherry (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZO7NN; mTagBFP2 (Note=Blue fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5VS ! KTRC MAFB:mTagBFP2
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC SIX2:Cre
AC   CVCL_E5YX
SY   Kidney Translational Research Center SIX2:Cre iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=16-E08J
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a T2A-Cre construct has been inserted at the C-terminal of both alleles of SIX2 mCherry (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06956; Escherichia phage P1 cre.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC SIX2:Cre/GAPDH:dual
AC   CVCL_E6IJ
SY   Kidney Translational Research Center SIX2:Cre/GAPDH:dual iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=16-1YZT
CC   Population: Caucasian.
CC   Characteristics: Endogenous SIX2 activation results in the activation of the Cre recombinase that activate the removal of EGFP and results in permanent switching of expression to mCherry (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 a T2A-Cre construct has been inserted at the C-terminal of both alleles of SIX2 mCherry and a T2A-loxP-EGFP-loxP-mCherry construct has been inserted at the C-terminal of one allele of GAPDH (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06956; Escherichia phage P1 cre.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5YX ! KTRC SIX2:Cre
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC SIX2:CreERT2
AC   CVCL_E5YY
SY   Kidney Translational Research Center SIX2:CreERT2 iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=16-E08P
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a T2A-CreERT2 construct has been inserted at the C-terminal of both alleles of SIX2 mCherry (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC SIX2:CreERT2/GAPDH:dual
AC   CVCL_E6IK
SY   Kidney Translational Research Center SIX2:CreERT2/GAPDH:dual iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=16-DYTA
CC   Population: Caucasian.
CC   Characteristics: Endogenous SIX2 activation combined with tamoxifen results in the activation of the Cre recombinase that activate the removal of EGFP and results in permanent switching of expression to mCherry (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 a T2A-CreERT2 construct has been inserted at the C-terminal of both alleles of SIX2 mCherry and a T2A-loxP-EGFP-loxP-mCherry construct has been inserted at the C-terminal of one allele of GAPDH (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5YY ! KTRC SIX2:CreERT2
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTRC SIX2:EGFP
AC   CVCL_VU01
SY   2429iPS SIX2:EGFP; Kidney Translational Research Center SIX2:EGFP iPSC
DR   Wikidata; Q93302352
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=14-3QDM
CC   Population: Caucasian.
CC   Characteristics: Identifies mesenchymal nephron progenitors (NPs), early nephron populations (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 SIX2 has been endogenously tagged at the C-terminal of both alleles with EGFP (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   KTRC SIX2:EGFP/CITED1:mCherry
AC   CVCL_E5VQ
SY   Kidney Translational Research Center SIX2:EGFP/CITED1:mCherry iPSC
RX   PubMed=31492807;
WW   Provider; KTRC; -; https://www.atlas-d2k.org/chaise/record/#2/Cell_Line:Reporter_Cell_Line/RID=14-3QDR
CC   Population: Caucasian.
CC   Characteristics: Identifies mesenchymal nephron progenitors (NPs), early nephron populations (PubMed=31492807).
CC   Characteristics: Using CRISPR/Cas9 CITED1 has been endogenously tagged at the C-terminal of its single allele with mCherry and SIX2 has been endogenously tagged at the C-terminal of both alleles with EGFP (PubMed=31492807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VU01 ! KTRC SIX2:EGFP
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KTS
AC   CVCL_B6Y5
SY   Korea fin Tissue from Sea flounder
DR   Wikidata; Q111733562
RX   DOI=10.1016/j.aquaculture.2020.735534;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 23 to 30 Celsius, the optimal temperature is 27 Celsius (DOI=10.1016/j.aquaculture.2020.735534).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   KTSq-1
AC   CVCL_A106
DR   cancercelllines; CVCL_A106
DR   Cosmic; 946070
DR   Wikidata; Q54900668
RX   PubMed=16105816;
CC   From: Kameya, Toru; Kitasato University; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Unspecified (PubMed=16105816).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   KU-1
AC   CVCL_4712
SY   KU 1; KU1; Keio University-1
DR   BTO; BTO_0003545
DR   Wikidata; Q54900669
RX   PubMed=758928;
RX   PubMed=3154018;
RX   PubMed=7185004;
RX   PubMed=7200272;
RX   PubMed=10496353;
RX   PubMed=29732388;
CC   Population: Japanese.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   KU-19-19
AC   CVCL_1344
SY   KU 19-19; KU19-19; KU1919; Keio University-19-19
DR   CLO; CLO_0007123
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 608
DR   BioSample; SAMN03473576
DR   BioSample; SAMN10988557
DR   cancercelllines; CVCL_1344
DR   Cell_Model_Passport; SIDM01033
DR   ChEMBL-Cells; CHEMBL3308111
DR   ChEMBL-Targets; CHEMBL1075483
DR   Cosmic; 907312
DR   Cosmic; 1046693
DR   Cosmic; 1285122
DR   Cosmic; 1286001
DR   Cosmic; 2050448
DR   Cosmic; 2057453
DR   Cosmic; 2444234
DR   Cosmic; 2686100
DR   Cosmic-CLP; 907312
DR   DepMap; ACH-000486
DR   DSMZ; ACC-395
DR   DSMZCellDive; ACC-395
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS304FRD
DR   ENCODE; ENCBS497ZHB
DR   GDSC; 907312
DR   GEO; GSM887243
DR   GEO; GSM888317
DR   GEO; GSM1374605
DR   GEO; GSM1670010
DR   IARC_TP53; 21445
DR   LiGeA; CCLE_760
DR   LINCS_LDP; LCL-1715
DR   PharmacoDB; KU1919_794_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1344
DR   PubChem_Cell_line; CVCL_1344
DR   Wikidata; Q54900670
RX   PubMed=7542171;
RX   PubMed=9464244;
RX   PubMed=10022529;
RX   PubMed=10496353;
RX   PubMed=19802009;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KU-19-19
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (DSMZ=ACC-395).
CC   HLA typing: A*31:01,33:03; B*15:01,37:01; C*03:03,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:391; AKT1; Simple; p.Glu17Lys (c.49G>A); ClinVar=VCV000013983; Zygosity=Unspecified (PubMed=19802009).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.87%; East Asian, South=21.55%; South Asian=0%; European, North=0%; European, South=0.57% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Cosmic-CLP=907312; DSMZ=ACC-395
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 17,20
ST   D19S433: 13,15
ST   D21S11: 30,32
ST   D2S1338: 19
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 10,15
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   KU-19-20
AC   CVCL_5213
SY   KU 19-20; KU19-20; Keio University-19-20
DR   cancercelllines; CVCL_5213
DR   GEO; GSM374461
DR   Progenetix; CVCL_5213
DR   Wikidata; Q54900671
RX   PubMed=10496353;
RX   PubMed=10994781;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KU-19-20
CC   Population: Japanese.
CC   Doubling time: 58.7 hours (Note=At 50th passage) (PubMed=10994781).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KU-2
AC   CVCL_D267
SY   Ku-2; KU2; Keio University-2
DR   ChEMBL-Cells; CHEMBL3307795
DR   ChEMBL-Targets; CHEMBL612265
DR   PubChem_Cell_line; CVCL_D267
DR   Wikidata; Q54900673
RX   PubMed=311392;
RX   PubMed=661038;
RX   PubMed=1263309;
RX   PubMed=3012186;
RX   PubMed=3022569;
RX   PubMed=7185005;
RX   PubMed=10496353;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft maintained in nude mice.
CC   Doubling time: 26 hours (PubMed=661038).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   KU-20-01
AC   CVCL_5212
SY   KU 20-01; KU20-01; Keio University-20-01
DR   Wikidata; Q54900674
RX   PubMed=15247770;
CC   Population: Japanese.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   KU-7
AC   CVCL_4714
SY   KU7; Keio University-7
DR   BTO; BTO_0003544
DR   BioSample; SAMN03151734
DR   Cosmic; 1082646
DR   Cosmic; 1302356
DR   GEO; GSM136238
DR   Wikidata; Q54900675
RX   PubMed=3154018;
RX   PubMed=7185004;
RX   PubMed=19375735;
RX   PubMed=23500642;
WW   Info; -; -; https://retractionwatch.com/2013/03/11/more-hela-problems-for-decades-a-widely-used-bladder-cancer-line-hasnt-been-what-scientists-thought/
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=23500642). Was thought to originate from an urinary bladder papillary carcinoma.
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00480.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KU-7-luc2-GFP
AC   CVCL_M894
DR   Revvity/PerkinElmer; 128091
DR   Wikidata; Q54900676
CC   Problematic cell line: Contaminated. Parent cell line (KU-7) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Revvity/PerkinElmer; 128091; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4714 ! KU-7
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 21
//
ID   KU-8
AC   CVCL_E330
SY   Keio University-8
DR   Wikidata; Q54900677
RX   PubMed=2585941;
CC   Population: Japanese.
CC   Doubling time: ~20 hours (PubMed=2585941).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   KU-9
AC   CVCL_JM01
SY   Keio University-9
DR   Cosmic; 1085913
DR   Wikidata; Q54900678
RX   PubMed=8636006;
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Doubling time: ~50 hours (PubMed=8636006).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=9738976).
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C9341; Peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   KU-CAS3
AC   CVCL_B7HY
SY   Korea University-Cutaneous AngioSarcoma 3
DR   ABM; T8028
DR   Wikidata; Q112929968
RX   PubMed=34693591;
CC   Population: Korean.
CC   Doubling time: 34 hours (PubMed=34693591).
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
ST   Source(s): PubMed=34693591
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 23,26
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 8,9
ST   D8S1179: 9,13
ST   FGA: 23,26
ST   Penta D: 12,13
ST   Penta E: 5,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   KU-CAS5
AC   CVCL_B7HZ
SY   Korea University-Cutaneous AngioSarcoma 5
DR   ABM; T8029
DR   Wikidata; Q112929969
RX   PubMed=34693591;
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=34693591).
CC   Caution: Originally the supplementary figure 1 of PubMed=34693591 displayed a STR profile for KU-CAS5 which was identical to that of KU-CAS3. But the file was updated on January 13, 2023 with the currently displayed STR profile.
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
ST   Source(s): PubMed=34693591
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 10,12
ST   D16S539: 10,11
ST   D18S51: 18,19
ST   D19S433: 13,15.2
ST   D21S11: 30,33.2
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 9,10
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 9,13
ST   Penta E: 19,20
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   KU-CTCC-001
AC   CVCL_E5T0
SY   Konkuk University-Canine Transitional Cell Carcinoma-001
DR   ABM; T8165
RX   PubMed=34502061;
CC   Doubling time: 17.7 +- 1.2 hours (PubMed=34502061).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Unspecified (PubMed=34502061).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Urethra; UBERON=UBERON_0000057.
CC   Breed/subspecies: Jindo; VBO=VBO_0008065.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_E5T1 ! KU-CTCC-001-LM3
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KU-CTCC-001-LM3
AC   CVCL_E5T1
SY   Konkuk University-Canine Transitional Cell Carcinoma-001-LM3
DR   ABM; T8167
RX   PubMed=34502061;
CC   Doubling time: 19.1 +- 1.2 hours (PubMed=34502061).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Unspecified (PubMed=34502061).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Jindo; VBO=VBO_0008065.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_E5T0 ! KU-CTCC-001
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KU-CTCC-002
AC   CVCL_E5T2
SY   Konkuk University-Canine Transitional Cell Carcinoma-002
DR   ABM; T8166
RX   PubMed=34502061;
CC   Doubling time: 20.0 +- 1.5 hours (PubMed=34502061).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Unspecified (PubMed=34502061).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ku-Ep
AC   CVCL_X903
DR   Wikidata; Q54900679
RX   PubMed=10761702;
CC   Population: Japanese.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   KU-HaAO1
AC   CVCL_AV31
SY   HaAO1; Kasetsart University-Helicoverpa armigera Adult Ovary 1
DR   ICLDB; ku-haao1
DR   Wikidata; Q54900680
RX   DOI=10.11416/jibs.77.1_25;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Helicoverpa armigera nucleopolyhedrovirus (HearNPV) (DOI=10.11416/jibs.77.1_25).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   KU-HaEmb1
AC   CVCL_AV32
SY   HaEmb1; Kasetsart University-Helicoverpa armigera Embryo 1
DR   ICLDB; ku-haemb1
DR   Wikidata; Q54900681
RX   DOI=10.11416/jibs.77.1_25;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   KU-HaEmb2
AC   CVCL_AV33
SY   HaEmb2; Kasetsart University-Helicoverpa armigera Embryo 2
DR   ICLDB; ku-haemb2
DR   Wikidata; Q54900682
RX   DOI=10.11416/jibs.77.1_25;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   KU-HaPO1
AC   CVCL_AV34
SY   HaPO1; Kasetsart University-Helicoverpa armigera Pupal Ovary 1
DR   ICLDB; ku-hapo1
DR   Wikidata; Q54900683
RX   DOI=10.11416/jibs.77.1_25;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   KU-HaPO2
AC   CVCL_AV35
SY   HaPO2; Kasetsart University-Helicoverpa armigera Pupal Ovary 2
DR   ICLDB; ku-hapo2
DR   Wikidata; Q54900684
RX   DOI=10.11416/jibs.77.1_25;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   KU-Lad-001
AC   CVCL_C4AH
DR   Wikidata; Q116049625
RX   PubMed=26344721;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27824; Human CANX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   KU-Lu-1
AC   CVCL_C4AJ
DR   Wikidata; Q116049626
RX   PubMed=29751934;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q07065; Human CKAP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   KU-Lu-3
AC   CVCL_C4AK
DR   Wikidata; Q116049627
RX   PubMed=19892429;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P63244; Human RACK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   KU-Lu-5
AC   CVCL_C4AG
DR   Wikidata; Q116049628
RX   PubMed=22439015;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O43570; Human CA12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   KU-Lu-6
AC   CVCL_C4AS
DR   Wikidata; Q116049629
RX   PubMed=25826333;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P35579; Human MYH9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   KU-Lu-7
AC   CVCL_C4AU
DR   Wikidata; Q116049630
RX   PubMed=25733373;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HC84; Human MUC5B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   KU-Lu-8
AC   CVCL_C4AT
DR   Wikidata; Q116049631
RX   PubMed=29431238;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   KU-Lu-MPPt3
AC   CVCL_QW81
DR   JCRB; JCRB1792
DR   Wikidata; Q54900685
RX   PubMed=29090354;
RX   PubMed=34796907;
CC   Population: Japanese.
CC   Doubling time: 59.2-74.5 hours (PubMed=29090354).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Heterozygous (PubMed=29090354).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1792
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 10
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C128847; Lung micropapillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   KU-Lu-MPPt3 AD
AC   CVCL_B7AS
SY   KU-Lu-MPPt3 ADhesive
DR   GEO; GSM5599282
DR   Wikidata; Q111733563
RX   PubMed=34796907;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C128847; Lung micropapillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QW81 ! KU-Lu-MPPt3
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   KU-Lu-MPPt3 CS
AC   CVCL_B7AT
SY   KU-Lu-MPPt3 Clumpy and Suspended
DR   GEO; GSM5599284
DR   Wikidata; Q111733564
RX   PubMed=34796907;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C128847; Lung micropapillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QW81 ! KU-Lu-MPPt3
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   KU-MELTC-1
AC   CVCL_GS50
DR   Wikidata; Q54900686
RX   PubMed=15160996;
CC   From: Ikeda, Hideyuki; Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 5
//
ID   KU-SENL-1
AC   CVCL_IW45
SY   SENL1; Kasetsart University-Spodoptera Exigua Neonate Larva-1
DR   ICLDB; ku-senl-1
DR   Wikidata; Q54900687
RX   DOI=10.18178/joaat.3.4.231-238;
RX   DOI=10.18178/joaat.5.3.236-244;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Autographa californica multiple nucleopolyhedrovirus (AcMNPV) (DOI=10.18178/joaat.3.4.231-238).
CC   Doubling time: 45 hours (DOI=10.18178/joaat.3.4.231-238).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 8
//
ID   KU-SEPO-1
AC   CVCL_UR22
SY   SEPO1; Kasetsart University-Spodoptera Exigua Pupal Ovary-1
DR   ICLDB; ku-sepo-1
DR   Wikidata; Q95980457
RX   DOI=10.18178/joaat.5.4.281-288;
CC   Group: Insect cell line.
CC   Doubling time: 57 hours (DOI=10.18178/joaat.5.4.281-288).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   KU-SEPO-2
AC   CVCL_UR23
SY   SEPO2; Kasetsart University-Spodoptera Exigua Pupal Ovary-2
DR   ICLDB; ku-sepo-2
DR   Wikidata; Q95980458
RX   DOI=10.18178/joaat.5.4.281-288;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV) (DOI=10.18178/joaat.5.4.281-288).
CC   Doubling time: 46 hours (DOI=10.18178/joaat.5.4.281-288).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   KU-SEPO-3
AC   CVCL_UR24
SY   SEPO3; Kasetsart University-Spodoptera Exigua Pupal Ovary-3
DR   ICLDB; ku-sepo-3
DR   Wikidata; Q95980459
RX   DOI=10.18178/joaat.5.4.281-288;
CC   Group: Insect cell line.
CC   Doubling time: 59 hours (DOI=10.18178/joaat.5.4.281-288).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   KU-SEPO-4
AC   CVCL_UR25
SY   SEPO4; Kasetsart University-Spodoptera Exigua Pupal Ovary-4
DR   ICLDB; ku-sepo-4
DR   Wikidata; Q95980460
RX   DOI=10.18178/joaat.5.4.281-288;
CC   Group: Insect cell line.
CC   Doubling time: 55 hours (DOI=10.18178/joaat.5.4.281-288).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   KU-SN
AC   CVCL_8730
DR   CLO; CLO_0050141
DR   BioSample; SAMN03472129
DR   FANTOM5_SSTAR; 10697-109G4
DR   RCB; RCB1317
DR   Wikidata; Q54900688
RX   PubMed=1379122;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB1317
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 9
ST   D5S818: 9,11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   KU-SS-1
AC   CVCL_E118
DR   Wikidata; Q54900689
RX   PubMed=10961176;
CC   Population: Japanese.
CC   Doubling time: 93.8 hours (Note=At 40th passage) (PubMed=10961176).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=10961176).
DI   NCIt; C4277; Spindle cell synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   KU-T1
AC   CVCL_D7DZ
RX   PubMed=18036395;
CC   Population: Japanese.
CC   Doubling time: ~70 hours (PubMed=18036395).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   KU-YS
AC   CVCL_E131
DR   BioSample; SAMN03151820
DR   RCB; RCB1318
DR   Wikidata; Q54900690
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a KU-SN derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00326.
CC   Population: Japanese.
CC   Discontinued: RCB; RCB1318; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8730 ! KU-SN
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   KU_FMF_iPSC_1
AC   CVCL_9U21
DR   Wikidata; Q54900691
RX   PubMed=26987928;
CC   From: School of Medicine, Koc University; Istanbul; Turkey.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:6998; MEFV; Simple; p.Met694Val (c.2080A>G); ClinVar=VCV000002538; Zygosity=Homozygous (PubMed=26987928).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   KU2-TP15
AC   CVCL_W867
DR   Wikidata; Q54900692
RX   PubMed=11291085;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3148; TYMP.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D267 ! KU-2
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   KU42.33C
AC   CVCL_C7WG
DR   Wikidata; Q123032864
RX   PubMed=29731998;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6YHK3; Human CD109.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   KU43.13A
AC   CVCL_C7WH
DR   Wikidata; Q123032865
RX   PubMed=29731998;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6YHK3; Human CD109.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   KU44.13B
AC   CVCL_C7H3
DR   Wikidata; Q117704583
RX   PubMed=31953437;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   KU44.22B
AC   CVCL_C7H4
DR   Wikidata; Q117704584
RX   PubMed=31953437;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26006; Human ITGA3/CD49c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Ku80+/+ MEF
AC   CVCL_UJ15
SY   Ku80+/+
DR   ATCC; CRL-3262
DR   Wikidata; Q95980465
RX   PubMed=10761921;
CC   Characteristics: Control cell line for Ku80-/-.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   Ku80-/- MEF
AC   CVCL_UJ16
SY   Ku80-/-
DR   ATCC; CRL-3261
DR   CLS; 305258
DR   Wikidata; Q95980466
RX   PubMed=10761921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104517; Xrcc5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   Ku812
AC   CVCL_0379
SY   KU812; KU-812; KU.812; KU 812
DR   BTO; BTO_0000732
DR   CLO; CLO_0007124
DR   CLO; CLO_0007125
DR   CLO; CLO_0050989
DR   EFO; EFO_0002222
DR   MCCL; MCC:0000274
DR   CLDB; cl3070
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2099
DR   BCRC; 60502
DR   BCRJ; 0261
DR   BioSample; SAMN01821693
DR   BioSample; SAMN01821733
DR   BioSample; SAMN03472893
DR   BioSample; SAMN10988528
DR   cancercelllines; CVCL_0379
DR   CCRID; 1101HUM-PUMC000522
DR   CCRID; 3101HUMTCHu189
DR   Cell_Model_Passport; SIDM00308
DR   CGH-DB; 9211-4
DR   ChEMBL-Cells; CHEMBL3308504
DR   ChEMBL-Targets; CHEMBL613997
DR   Cosmic; 787498
DR   Cosmic; 907311
DR   Cosmic; 919119
DR   Cosmic; 922163
DR   Cosmic; 924052
DR   Cosmic; 949096
DR   Cosmic; 991560
DR   Cosmic; 999778
DR   Cosmic; 1012080
DR   Cosmic; 1026568
DR   Cosmic; 1067444
DR   Cosmic; 1078716
DR   Cosmic; 1519164
DR   Cosmic; 2009518
DR   Cosmic-CLP; 907311
DR   DepMap; ACH-000074
DR   DSMZ; ACC-378
DR   DSMZCellDive; ACC-378
DR   ECACC; 90071807
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10409-106B4
DR   GDSC; 907311
DR   GEO; GSM887244
DR   GEO; GSM888318
DR   GEO; GSM1374606
DR   GEO; GSM1670011
DR   IARC_TP53; 342
DR   IARC_TP53; 21446
DR   IGRhCellID; KU812
DR   JCRB; IFO50363
DR   JCRB; JCRB0104
DR   LiGeA; CCLE_172
DR   LINCS_LDP; LCL-1106
DR   Lonza; 1207
DR   PharmacoDB; KU812_795_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0379
DR   PubChem_Cell_line; CVCL_0379
DR   RCB; RCB0495
DR   Wikidata; Q54900693
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=2540861;
RX   PubMed=3332852;
RX   PubMed=3858609;
RX   PubMed=9290701;
RX   PubMed=9510473;
RX   PubMed=9644295;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=11264164;
RX   PubMed=11416159;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20809971;
RX   PubMed=22460905;
RX   PubMed=25149487;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 25 +- 2 hours (PubMed=11264164); ~20-30 hours (ATCC=CRL-2099); ~80-100 hours (DSMZ=ACC-378).
CC   HLA typing: A*24:02,26:01; B*40:02,40:02; C*03:04,04:01; DQA1*03:02,03:02; DQB1*02:02,06:04; DRB1*10:01,14:05 (PubMed=26589293).
CC   HLA typing: A*24:02:01,26:01:01; B*40:01:02,40:02:01; C*03:04:01,04:82 (DSMZCellDive=ACC-378).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=20809971; DepMap=ACH-000074).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (Cosmic-CLP=907311).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.62%; East Asian, North=85.34%; East Asian, South=12.57%; South Asian=0.16%; European, North=0.88%; European, South=0.42% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil progenitor cell; CL=CL_0000613.
ST   Source(s): ATCC=CRL-2099; Cosmic-CLP=907311; DSMZ=ACC-378; ECACC=90071807; JCRB=IFO50363; JCRB=JCRB0104; PubMed=11416159; PubMed=25877200; RCB=RCB0495
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 18
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 15
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   KU812 IM1
AC   CVCL_E6I5
SY   KU812 2microM IM1
RX   PubMed=21718141;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Glu450Gln (c.1348G>C); Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Glu459Lys (c.1375G>A); Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Glu470Lys (c.1408G>A); Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil progenitor cell; CL=CL_0000613.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0379 ! Ku812
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KU812 IM2
AC   CVCL_E6I6
SY   KU812 3microM IM2
RX   PubMed=21718141;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Glu459Lys (c.1375G>A); Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Glu462Lys (c.1384G>A); Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil progenitor cell; CL=CL_0000613.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0379 ! Ku812
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   KU812 IM3
AC   CVCL_E6I7
SY   KU812 2microM IM3
RX   PubMed=21718141;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Phe359Cys (c.1076T>G); dbSNP=rs1057519775; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=21718141).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil progenitor cell; CL=CL_0000613.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0379 ! Ku812
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ku812E
AC   CVCL_0615
SY   KU812E; KU-812E; KU 812E
DR   CLO; CLO_0007126
DR   CLO; CLO_0051000
DR   CLDB; cl3071
DR   ATCC; CRL-2100
DR   BioSample; SAMN01821694
DR   cancercelllines; CVCL_0615
DR   CCRID; 1102HUM-NIFDC00110
DR   ECACC; 90071803
DR   JCRB; JCRB0104.1
DR   LINCS_LDP; LCL-1107
DR   RCB; RCB0496
DR   Wikidata; Q54900695
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2540861;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil progenitor cell; CL=CL_0000613.
ST   Source(s): ATCC=CRL-2100; CCRID=1102HUM-NIFDC00110; JCRB=JCRB0104.1; RCB=RCB0496
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 18
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 15
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0379 ! Ku812
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 27
//
ID   Ku812F
AC   CVCL_0616
SY   KU812F; KU-812-F; KU-812F; KU 812F; KU812-F
DR   BTO; BTO_0003142
DR   CLO; CLO_0007127
DR   CLO; CLO_0050974
DR   CLO; CLO_0051002
DR   CLDB; cl3072
DR   ATCC; CRL-2101
DR   BioSample; SAMN01821695
DR   cancercelllines; CVCL_0616
DR   ECACC; 90071804
DR   JCRB; JCRB0104.2
DR   LINCS_LDP; LCL-1108
DR   RCB; RCB0497
DR   RCB; RCB3053
DR   TKG; TKG 0304
DR   Wikidata; Q54900696
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2540861;
RX   PubMed=3304457;
RX   PubMed=11416159;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: RCB; RCB3053; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil progenitor cell; CL=CL_0000613.
ST   Source(s): ATCC=CRL-2101; ECACC=90071804; JCRB=JCRB0104.2; PubMed=11416159; RCB=RCB0497; Technion Genomics Center; TKG=TKG 0304
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D10S1248: 14
ST   D12S391: 17
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,14
ST   D1S1656: 16,18
ST   D21S11: 30,31.2
ST   D22S1045: 11
ST   D2S1338: 18
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 11,15
ST   DYS391: 10
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 15
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0379 ! Ku812
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   KUCaP13
AC   CVCL_C0UV
SY   Kyoto University Cancer Prostate 13
DR   cancercelllines; CVCL_C0UV
DR   Wikidata; Q112929970
RX   PubMed=33960594;
CC   Population: Japanese.
CC   Characteristics: Established via a mouse xenograft.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1915; CHD1; Zygosity=Homozygous (PubMed=33960594).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His61Arg (c.182A>G); ClinVar=VCV000189402; Zygosity=Unspecified (PubMed=33960594).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (PubMed=33960594).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Penis; UBERON=UBERON_0000989.
ST   Source(s): PubMed=33960594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 16,18
ST   D21S11: 32.2,33.2
ST   D3S1358: 14,15
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,14,15
ST   FGA: 22
ST   Penta D: 10,11
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C158913; Metastatic prostate neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   KUCFRi001-A
AC   CVCL_QX60
SY   GM04594 iPSC
DR   hPSCreg; KUCFRi001-A
DR   Wikidata; Q54900697
RX   PubMed=28677541;
CC   From: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University; Seoul; South Korea.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Val139Met (c.415G>A); ClinVar=VCV000010433; Zygosity=Heterozygous (PubMed=28677541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28677541
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 13,16
ST   D21S11: 29,32.2
ST   D2S1338: 19,24
ST   D3S1358: 11,17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,15
ST   Penta E: 7,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GY21 ! GM04594
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   KUCFRi002-A
AC   CVCL_QX72
SY   GM23721 iPSC
DR   hPSCreg; KUCFRi002-A
DR   Wikidata; Q54900698
RX   PubMed=29034895;
CC   From: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University; Seoul; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Ser140Thr (c.418T>A); ClinVar=VCV000447730; Zygosity=Heterozygous (PubMed=29034895).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034895
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 22,25
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 7,15
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 14,15
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M916 ! GM23721
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   KUCFRi003-A
AC   CVCL_A8WI
SY   GM03672 iPSC
DR   hPSCreg; KUCFRi003-A
DR   Wikidata; Q108820632
RX   PubMed=34091428;
CC   From: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University; Seoul; South Korea.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7427; MT-CYB; Simple; p.Asp171Asn (m.15257G>A); ClinVar=VCV000009674; Zygosity=Heteroplasmic (PubMed=34091428).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8A60 ! GM03672
SX   Female
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   KUCFRi004-A
AC   CVCL_D0HE
DR   hPSCreg; KUCFRi004-A
DR   Wikidata; Q123032867
CC   From: Korea University Cell Function Regulation Lab; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   KUCFRi005-A
AC   CVCL_C1U1
DR   BioSamples; SAMEA110644817
DR   hPSCreg; KUCFRi005-A
DR   Wikidata; Q114311863
CC   From: Korea University Cell Function Regulation Lab; Seoul; South Korea.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   KUCFRi005-A-1
AC   CVCL_C1U2
DR   BioSamples; SAMEA110644876
DR   hPSCreg; KUCFRi005-A-1
DR   Wikidata; Q114311864
CC   From: Korea University Cell Function Regulation Lab; Seoul; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:86395; CD2.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C1U1 ! KUCFRi005-A
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   KUCKY
AC   CVCL_WH53
DR   Wikidata; Q95980469
RX   PubMed=30268330;
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   Kudi
AC   CVCL_V743
SY   P2-Kudi; P2(OB-1)-Kudi; OB1; OB 1; OB-1
DR   Wikidata; Q54900699
RX   PubMed=4169243;
RX   PubMed=4321974;
RX   PubMed=4866767;
RX   PubMed=4894370;
RX   PubMed=6018567;
CC   Population: African; Nigerian.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Bone, jaw; UBERON=UBERON_0001708.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 12
//
ID   KUi012-A
AC   CVCL_D6PD
SY   JM09
DR   BioSamples; SAMEA114437924
DR   hPSCreg; KUi012-A
RX   PubMed=38458029;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4084; GABRD; Simple; p.Thr291Ile (c.872C>T); Zygosity=Heterozygous (PubMed=38458029).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206526; Susceptibility to idiopathic generalized epilepsy-10
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   KUi012-A-1
AC   CVCL_D6PE
SY   JM09 GC
DR   BioSamples; SAMEA114438234
DR   hPSCreg; KUi012-A-1
RX   PubMed=38458029;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4084; GABRD; Simple_corrected; p.Thr291Ile (c.872C>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38458029).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206526; Susceptibility to idiopathic generalized epilepsy-10
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6PD ! KUi012-A
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   KUi013-A
AC   CVCL_D6PF
SY   SK
DR   BioSamples; SAMEA114440045
DR   hPSCreg; KUi013-A
RX   PubMed=38458029;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4084; GABRD; Simple; p.Thr291Ile (c.872C>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=38458029).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206526; Susceptibility to idiopathic generalized epilepsy-10
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   KUi013-A-1
AC   CVCL_D6PG
SY   SK GC
DR   BioSamples; SAMEA114440046
DR   hPSCreg; KUi013-A-1
RX   PubMed=38458029;
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4084; GABRD; Simple_corrected; p.Thr291Ile (c.872C>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38458029).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206526; Susceptibility to idiopathic generalized epilepsy-10
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6PF ! KUi013-A
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   KUIMSi012-A-1
AC   CVCL_B6RF
SY   GAPDH-tdT1
DR   hPSCreg; KUIMSi012-A-1
DR   Wikidata; Q111733566
RX   PubMed=35176664;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 a 2A-tdTomato construct was integrated at the C-terminus of one allele of GAPDH (PubMed=35176664).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35176664
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D21S11: 31
ST   D3S1358: 14,15
ST   D5S818: 13,14
ST   D7S820: 9,10
ST   D8S1179: 13,17
ST   FGA: 24,25
ST   Penta D: 2.2,13
ST   Penta E: 12,14
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ39 ! 1231A3
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   KUIMSi012-A-2
AC   CVCL_B6RG
SY   GAPDH-tdT2
DR   hPSCreg; KUIMSi012-A-2
DR   Wikidata; Q111733567
RX   PubMed=35176664;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 a 2A-tdTomato construct was integrated at the C-terminus of both alleles of GAPDH (PubMed=35176664).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35176664
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D21S11: 31
ST   D3S1358: 14,15
ST   D5S818: 13,14
ST   D7S820: 9,10
ST   D8S1179: 13,17
ST   FGA: 24,25
ST   Penta D: 2.2,13
ST   Penta E: 12,14
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ39 ! 1231A3
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   KUIMSi012-A-3
AC   CVCL_B6RH
SY   SOX10-tdT
DR   hPSCreg; KUIMSi012-A-3
DR   Wikidata; Q111733568
RX   PubMed=35144211;
CC   From: Kyoto University; Kyoto; Japan.
CC   Population: African American.
CC   Characteristics: Using CRISPR/Cas9 a 2A-tdTomato construct in combination with a PGKp-hygroR-pA construct was integrated at the C-terminus of both alleles of SOX10 (PubMed=35144211).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LJ39 ! 1231A3
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   KUL84-MEL
AC   CVCL_VU99
DR   cancercelllines; CVCL_VU99
DR   Wikidata; Q95980473
RX   PubMed=20099279;
RX   PubMed=22850568;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22850568).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   KUL98-MELA
AC   CVCL_A8QM
DR   cancercelllines; CVCL_A8QM
DR   Wikidata; Q108820633
RX   PubMed=28765120;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=28765120).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8QN ! KUL98-MELB
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   KUL98-MELB
AC   CVCL_A8QN
DR   Wikidata; Q108820634
RX   PubMed=28765120;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8QM ! KUL98-MELA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   KULi003-A
AC   CVCL_C1U7
DR   BioSamples; SAMEA110177409
DR   hPSCreg; KULi003-A
DR   Wikidata; Q114311865
CC   From: KU Leuven; Leuven; Belgium.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   KUM.LK-2
AC   CVCL_W526
SY   KUM-LK-2
DR   Wikidata; Q54900700
RX   CelloPub=CLPUB00431;
RX   DOI=10.2491/jjsth1970.19.280;
RX   DOI=10.2491/jjsth1970.19.283;
RX   PubMed=1676353;
RX   PubMed=2486663;
RX   PubMed=3221828;
CC   Population: Japanese.
CC   Characteristics: Established after 2 tumor passages in nude mice.
CC   Characteristics: Produces lung metastases in nude mice.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   KUM10
AC   CVCL_5148
SY   KUM1; KUM-1
DR   CLO; CLO_0051045
DR   JCRB; JCRB1176
DR   JCRB; NIHS0493
DR   RCB; RCB2295
DR   Wikidata; Q54900701
RX   PubMed=1373147;
RX   PubMed=15996824;
CC   Discontinued: JCRB; NIHS0493; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KUM3
AC   CVCL_5149
SY   KUM 3; KUM-3
DR   CLO; CLO_0051034
DR   JCRB; JCRB1134
DR   RCB; RCB2147
DR   Wikidata; Q54900702
RX   PubMed=1373147;
RX   PubMed=15996824;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KUM4
AC   CVCL_5150
SY   KUM 4; KUM-4
DR   CLO; CLO_0051031
DR   JCRB; JCRB1135
DR   RCB; RCB2112
DR   Wikidata; Q54900703
RX   PubMed=1373147;
RX   PubMed=15996824;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KUM5
AC   CVCL_5151
SY   KUM 5; KUM-5
DR   CLO; CLO_0051035
DR   JCRB; JCRB1178
DR   RCB; RCB2322
DR   Wikidata; Q54900704
RX   PubMed=1373147;
RX   PubMed=15996824;
RX   PubMed=21155951;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   KUM6
AC   CVCL_5152
SY   KUM 6; KUM-6
DR   CLO; CLO_0051032
DR   JCRB; JCRB1202
DR   RCB; RCB2113
DR   Wikidata; Q54900705
RX   PubMed=1373147;
RX   PubMed=15996824;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KUM7
AC   CVCL_5153
SY   KUM 7; KUM-7
DR   CLO; CLO_0051037
DR   JCRB; JCRB1204
DR   RCB; RCB2114
DR   Wikidata; Q54900710
RX   PubMed=1373147;
RX   PubMed=15996824;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KUM9
AC   CVCL_5154
SY   KUM 9; KUM-9
DR   CLO; CLO_0051033
DR   JCRB; JCRB1139
DR   RCB; RCB2115
DR   Wikidata; Q54900711
RX   PubMed=1373147;
RX   PubMed=15996824;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KUMA-1
AC   CVCL_W512
SY   Kuma-1
DR   Wikidata; Q54900712
RX   PubMed=7591301;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=23992541;
CC   Population: Japanese.
CC   HLA typing: A*26:03,33:02; B*15:03,44:03:01; C*03:03,14:03 (PubMed=9178645).
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   KUMA-2
AC   CVCL_W513
DR   Wikidata; Q54900713
RX   PubMed=7591301;
CC   Population: Japanese.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   KUMA-3
AC   CVCL_SA77
SY   Kuma-3
DR   cancercelllines; CVCL_SA77
DR   IARC_TP53; 28405
DR   Wikidata; Q54900714
RX   PubMed=10741724;
CC   Population: Japanese.
CC   HLA typing: A*24:02,11:01 (PubMed=10741724).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=10741724).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   KUMCi001-A
AC   CVCL_ZX64
SY   ALLCD34+
DR   BioSamples; SAMEA3128119
DR   hPSCreg; KUMCi001-A
DR   Wikidata; Q102114441
RX   PubMed=32707488;
CC   From: Korea University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=32707488
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   KUMCi002-A
AC   CVCL_A9YG
SY   MM_CD34+iPSCs; MMCD34+_iPSCs
DR   BioSamples; SAMEA7462430
DR   hPSCreg; KUMCi002-A
DR   Wikidata; Q102114442
RX   PubMed=33142253;
CC   From: Korea University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): PubMed=33142253
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 14.2,15.2
ST   D21S11: 30
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   TH01: 6,10
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   KUMCi004-A
AC   CVCL_D0HF
DR   hPSCreg; KUMCi004-A
DR   Wikidata; Q123032869
CC   From: Korea University College of Medicine; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   KUMi001-A
AC   CVCL_A0MG
SY   KUMi001-A_CML(Ph+); KUMi001-A_CML(Ph + )
DR   BioSamples; SAMEA9147487
DR   hPSCreg; KUMi001-A
DR   Wikidata; Q108820635
RX   PubMed=34280890;
CC   From: Korea University Medical School Hospital; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=34280890).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   KUMi002-A
AC   CVCL_A0MF
SY   CD34+ CML (Ph-) hiPSCs
DR   BioSamples; SAMEA9149195
DR   hPSCreg; KUMi002-A
DR   Wikidata; Q108820636
RX   PubMed=34303284;
CC   From: Korea University Medical School Hospital; Seoul; South Korea.
CC   Population: Korean.
CC   Donor information: Established from a patient suffering from chronic myeloid leukemia with BCR-ABL but has a normal karyotype.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   KUMi003-A
AC   CVCL_B3T7
SY   KUMi003-A_APL(M3)
DR   BioSamples; SAMEA10580157
DR   hPSCreg; KUMi003-A
DR   Wikidata; Q110433001
RX   PubMed=35905670;
CC   From: Korea University Medical School Hospital; Seoul; South Korea.
CC   Population: Korean.
CC   Donor information: Established from a patient suffering from acute promyelocytic leukemia but as a normal karyotype.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 6
//
ID   KUMi004-A
AC   CVCL_C0EZ
SY   KUMi004_CLL
DR   BioSamples; SAMEA12063014
DR   hPSCreg; KUMi004-A
DR   Wikidata; Q112929971
RX   PubMed=35066240;
CC   From: Korea University Medical School Hospital; Seoul; South Korea.
CC   Population: Korean.
CC   Karyotypic information: 46,XX,t(13;14)(q32;q11.2->q24.3) (PubMed=35066240).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   KUMi005-A
AC   CVCL_C0H8
SY   KUMi005-A_MM#1
DR   BioSamples; SAMEA12927525
DR   hPSCreg; KUMi005-A
DR   Wikidata; Q112929972
RX   PubMed=36332466;
CC   From: Korea University Medical School Hospital; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Hematopoietic cell; CL=CL_1001610.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   KUMi006-A
AC   CVCL_C0H9
SY   KUMi006
DR   BioSamples; SAMEA13252926
DR   hPSCreg; KUMi006-A
DR   Wikidata; Q112929973
CC   From: Korea University Medical School Hospital; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   KUN-DH-14
AC   CVCL_Z530
SY   Dh 14; DH14; Dh14
DR   CLO; CLO_0002770
DR   CLO; CLO_0002772
DR   CLDB; cl1053
DR   CLDB; cl1055
DR   ECACC; 90070551
DR   FlyBase_Cell_line; FBtc9000060
DR   Wikidata; Q54900715
RX   PubMed=7450782;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7224; ! Drosophila hydei (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   KUN-DH-15
AC   CVCL_Z531
SY   DH15
DR   CLO; CLO_0002773
DR   CLDB; cl1056
DR   ECACC; 90070549
DR   FlyBase_Cell_line; FBtc9000061
DR   Wikidata; Q54900716
RX   PubMed=7450782;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7224; ! Drosophila hydei (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   KUN-DH-33
AC   CVCL_Z532
SY   DH-33; Dh 33; DH33; Dh33
DR   CLO; CLO_0002771
DR   CLO; CLO_0002774
DR   CLDB; cl1054
DR   CLDB; cl1057
DR   DGRC; 23
DR   ECACC; 90070559
DR   FlyBase_Cell_line; FBtc0000023
DR   Wikidata; Q54900717
RX   PubMed=7450782;
RX   PubMed=17890361;
CC   Group: Insect cell line.
CC   Doubling time: 22-24 hours (Note=Depending on growth medium) (DGRC=23).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7224; ! Drosophila hydei (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   KUN-DH-47
AC   CVCL_Z533
DR   FlyBase_Cell_line; FBtc9000062
DR   Wikidata; Q54900718
RX   PubMed=7450782;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7224; ! Drosophila hydei (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   Kuna 14
AC   CVCL_DQ73
SY   KUNA 14
DR   IPD-IMGT/HLA; 10945
DR   Wikidata; Q54900719
RX   PubMed=9331947;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: B*35:43,51:10 (IPD-IMGT/HLA=10945).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 9
//
ID   Kuna 20
AC   CVCL_DQ74
SY   KUNA 20
DR   IPD-IMGT/HLA; 10946
DR   Wikidata; Q54900720
RX   PubMed=9331947;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: B*39:11 (IPD-IMGT/HLA=10946).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 9
//
ID   KUP5
AC   CVCL_6C88
DR   RCB; RCB4627
DR   Wikidata; Q54900721
RX   PubMed=25379377;
CC   Doubling time: ~19 hours (PubMed=25379377).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Kupffer cell; CL=CL_0000091.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   KUR-11
AC   CVCL_WK63
SY   Kur-11; Kurume University Renal-11
DR   Wikidata; Q95980495
RX   PubMed=7671230;
RX   PubMed=9023415;
RX   PubMed=10929426;
RX   PubMed=17212712;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03 (PubMed=7671230).
CC   HLA typing: A*24:02,33:02 (PubMed=9023415).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KUR-20
AC   CVCL_WK64
SY   Kurume University Renal-20
DR   Wikidata; Q95980496
RX   PubMed=7671230;
RX   PubMed=9023415;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:11 (PubMed=7671230).
CC   HLA typing: A*02:01,02:10 (PubMed=9023415).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KUR-21
AC   CVCL_WK65
SY   Kurume University Renal-21
DR   Wikidata; Q95980498
RX   PubMed=7671230;
CC   Population: Japanese.
CC   HLA typing: A*02:01 (PubMed=7671230).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   KUR-62
AC   CVCL_WK66
SY   Kurume University Renal-62
DR   Wikidata; Q95980500
RX   PubMed=17212712;
CC   Population: Japanese.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   Kuramochi
AC   CVCL_1345
SY   KURAMOCHI
DR   CLO; CLO_0037093
DR   EFO; EFO_0006625
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 578
DR   BioSample; SAMN03471055
DR   BioSample; SAMN10988052
DR   cancercelllines; CVCL_1345
DR   Cell_Model_Passport; SIDM00554
DR   CGH-DB; 9357-4
DR   ChEMBL-Cells; CHEMBL3308307
DR   ChEMBL-Targets; CHEMBL2366119
DR   Cosmic; 809116
DR   Cosmic; 909975
DR   Cosmic; 931364
DR   Cosmic-CLP; 909975
DR   DepMap; ACH-000524
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909975
DR   GEO; GSM186430
DR   GEO; GSM186431
DR   GEO; GSM659381
DR   GEO; GSM888319
DR   GEO; GSM1670012
DR   IARC_TP53; 1415
DR   JCRB; JCRB0098
DR   LiGeA; CCLE_899
DR   LINCS_LDP; LCL-1701
DR   PharmacoDB; KURAMOCHI_796_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1345
DR   PubChem_Cell_line; CVCL_1345
DR   Wikidata; Q54900722
RX   PubMed=6268719;
RX   PubMed=7069245;
RX   PubMed=9290701;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=32612269;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 24-27 hours (PubMed=6268719); 82 hours (PubMed=25984343); 60 hours (Note=Lot 10242008), ~43 hours (Note=Lot 06302015), ~40 hours (Note=Lot 06152016), ~2 days (Note=Lot 09042020) (JCRB=JCRB0098).
CC   HLA typing: A*26:02,26:02; B*40:06,40:06; C*08:01,08:01; DRB1*12:05,12:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Tyr (c.841G>T); ClinVar=VCV000376585; Zygosity=Homozygous (PubMed=24023729).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=85.58%; East Asian, South=11.82%; South Asian=0.12%; European, North=0%; European, South=2.48% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=909975; JCRB=JCRB0098; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10
ST   D18S51: 13
ST   D21S11: 30,32.2
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   FGA: 21,23
ST   Penta D: 10,13
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   KURATOU
AC   CVCL_YP90
DR   Wikidata; Q95980504
RX   PubMed=2584814;
CC   Population: Japanese.
CC   Doubling time: ~10 days (PubMed=2584814).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8106; Ovarian dysgerminoma
DI   ORDO; Orphanet_99912; Malignant dysgerminomatous germ cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   KURNDi005-A
AC   CVCL_QY98
SY   CCALD 5 iPSC
DR   Wikidata; Q54900723
RX   PubMed=29128817;
CC   From: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Arg554His (c.1661G>A); ClinVar=VCV000166625; Zygosity=Hemizygous (PubMed=29128817).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29128817
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 16,19
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 18,20
ST   D3S1358: 15,16
ST   D5S818: 7,13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 18,24
ST   Penta D: 12,13
ST   Penta E: 18,21
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   KURNDi007-A
AC   CVCL_WK25
SY   acALD7
DR   Wikidata; Q95980505
RX   PubMed=30921588;
CC   From: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; c.1240_1253delGGCTACACAGCCCGinsCCGTCC; Zygosity=Hemizygous (PubMed=30921588).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=30921588
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12,13
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D19S433: 13,15.2
ST   D21S11: 30
ST   D2S1338: 18,22
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 19,21
ST   Penta D: 9,13
ST   Penta E: 5,16
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   KUROIWA
AC   CVCL_E744
DR   dbMHC; 48938
DR   ECACC; 94082230
DR   IHW; IHW09131
DR   IPD-IMGT/HLA; 11674
DR   Wikidata; Q54900724
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24; B*07; C*07; DPB1*04:01,04:02; DQA1*01:01; DQB1*05:01; DRB1*01:01 (IPD-IMGT/HLA=11674).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   KUSA
AC   CVCL_L287
SY   KUM2; KUM 2; KUM-2
DR   Wikidata; Q54900725
RX   PubMed=1373147;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Somatic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   KUSA-A1
AC   CVCL_4848
SY   KUSA/A1
DR   JCRB; JCRB1119
DR   JCRB; NIHS0427
DR   RCB; RCB2081
DR   Wikidata; Q27671685
RX   PubMed=1373147;
RX   PubMed=15996824;
RX   PubMed=21155951;
CC   Doubling time: ~21 hours (Note=Lot 11092015) (JCRB=JCRB1119).
CC   Discontinued: JCRB; NIHS0427; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L287 ! KUSA
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   KUSA-D
AC   CVCL_L288
SY   KUSA/D
DR   Wikidata; Q54900726
RX   PubMed=1373147;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L287 ! KUSA
SX   Female
CA   Somatic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   KUSA-H1
AC   CVCL_5222
SY   KUSA/H1
DR   CLO; CLO_0051029
DR   JCRB; JCRB1129
DR   RCB; RCB1990
DR   Wikidata; Q54900727
RX   PubMed=1373147;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L287 ! KUSA
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   KUSA-MTAg
AC   CVCL_L286
DR   Wikidata; Q54900728
RX   PubMed=1373147;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L287 ! KUSA
SX   Female
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 11
//
ID   KUSA-O
AC   CVCL_5223
SY   KUSA/O; KUSA-0
DR   CLO; CLO_0051030
DR   JCRB; JCRB1132
DR   RCB; RCB1991
DR   Wikidata; Q54900729
RX   PubMed=1373147;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L287 ! KUSA
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   KUST_CyESCcyc_WT1tdt
AC   CVCL_E9XX
SY   WT1-205; cyc-WT1-tdt; WT1-Ki-cyc; WT1-2A-tdTomato cyESC
RX   PubMed=40466381;
CC   Group: Non-human primate cell line.
CC   Characteristics: Using CRISPR/Cas9 as T2A-tdTomato construct was introduced at the C-terminus of the WT1 gene (PubMed=40466381).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Caution: The parent ESC cell line is not indicated in the publication.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   KUSTi001-A
AC   CVCL_C1LJ
SY   UAE001
DR   hPSCreg; KUSTi001-A
DR   Wikidata; Q114311866
RX   PubMed=35816920;
CC   From: Khalifa University of Science and Technology (KUST); Abu Dhabi; United Arab Emirates.
CC   Population: Arab.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   KUT-1
AC   CVCL_G036
DR   Wikidata; Q54900730
RX   CelloPub=CLPUB00380;
RX   PubMed=3026522;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   KUT-2
AC   CVCL_G037
DR   Wikidata; Q54900731
RX   CelloPub=CLPUB00380;
RX   PubMed=3026522;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   KUT-3
AC   CVCL_G038
DR   Wikidata; Q54900732
RX   CelloPub=CLPUB00380;
RX   PubMed=3026522;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   KUTTAMi001-A
AC   CVCL_A0KH
SY   KU-FRDA3-1; KUTTAM-FRDA3-1
DR   hPSCreg; KUTTAMi001-A
DR   Wikidata; Q108820637
RX   PubMed=34214898;
CC   From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   KUTTAMi002-A
AC   CVCL_A0KI
SY   KU-FRDA4-1
DR   hPSCreg; KUTTAMi002-A
DR   Wikidata; Q108820638
RX   PubMed=34214898;
CC   From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   KUTTAMi003-A
AC   CVCL_A0KJ
SY   KU-FRDA5-2
DR   hPSCreg; KUTTAMi003-A
DR   Wikidata; Q108820639
RX   PubMed=34214898;
CC   From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   KV0006
AC   CVCL_8X89
DR   ECACC; 98071613
DR   Wikidata; Q54900733
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98071613; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   KV6
AC   CVCL_W940
DR   Cosmic; 877455
DR   Cosmic; 1152533
DR   Wikidata; Q54900734
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 5
//
ID   KVL-1
AC   CVCL_0380
SY   KVL1
DR   MCCL; MCC:0000275
DR   Wikidata; Q54900735
RX   PubMed=15665117;
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   KW-103
AC   CVCL_W216
DR   Wikidata; Q54900736
RX   PubMed=7154478;
CC   Population: Japanese.
CC   Doubling time: 16.0 hours (PubMed=7154478).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   KW0001
AC   CVCL_8Y01
DR   ECACC; 98040607
DR   Wikidata; Q54900737
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(7)(q22.1;q31.2) (ECACC=98040607).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116942; Developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   KW0002
AC   CVCL_8Y02
DR   ECACC; 98040608
DR   Wikidata; Q54900738
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 98040608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   KW0008
AC   CVCL_8Y03
DR   ECACC; 99030102
DR   Wikidata; Q54900739
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(5;7)(q22;q31.2) (ECACC=99030102).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   KW0009
AC   CVCL_8Y04
DR   ECACC; 00062901
DR   Wikidata; Q54900740
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92562; Expressive language disorder
DI   ORDO; Orphanet_211053; Specific language disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   KW0010
AC   CVCL_8Y05
DR   ECACC; 00062902
DR   Wikidata; Q54900741
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(2;11)(q35;p15.1) (ECACC=00062902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92562; Expressive language disorder
DI   ORDO; Orphanet_211053; Specific language disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   KW0011
AC   CVCL_8Y06
DR   ECACC; 00062903
DR   Wikidata; Q54900742
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(1;11)(q35;p15.1) (ECACC=00062903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C92562; Expressive language disorder
DI   ORDO; Orphanet_211053; Specific language disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   KW0012
AC   CVCL_8Y07
DR   ECACC; 00062904
DR   Wikidata; Q54900743
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00062904; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   KW1
AC   CVCL_0B93
DR   Cosmic; 2239106
DR   Wikidata; Q54900745
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW10
AC   CVCL_0B94
DR   Cosmic; 2239112
DR   Wikidata; Q54900746
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW13
AC   CVCL_0B95
DR   Cosmic; 2239113
DR   Wikidata; Q54900747
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW15
AC   CVCL_0B96
DR   Cosmic; 2239114
DR   Wikidata; Q54900748
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW17
AC   CVCL_0B97
DR   Cosmic; 2239115
DR   Wikidata; Q54900749
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW2
AC   CVCL_0B98
DR   Cosmic; 2239107
DR   Wikidata; Q54900750
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW22
AC   CVCL_0B99
DR   Cosmic; 2239116
DR   Wikidata; Q54900754
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW24
AC   CVCL_0C00
DR   Cosmic; 2239117
DR   Wikidata; Q54900755
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW3
AC   CVCL_0C01
DR   Cosmic; 2239108
DR   Wikidata; Q54900756
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW6
AC   CVCL_0C02
DR   Cosmic; 2239109
DR   Wikidata; Q54900757
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW7
AC   CVCL_0C03
DR   Cosmic; 2239110
DR   Wikidata; Q54900758
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KW9
AC   CVCL_0C04
DR   Cosmic; 2239111
DR   Wikidata; Q54900759
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   KWA-RC
AC   CVCL_X541
DR   Cosmic; 849375
DR   Wikidata; Q54900760
RX   PubMed=11146448;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   KWS-I
AC   CVCL_9816
SY   KWS-1; KWS
DR   cancercelllines; CVCL_9816
DR   Cosmic; 848374
DR   IARC_TP53; 971
DR   Wikidata; Q54900762
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1370612;
RX   PubMed=3962675;
RX   PubMed=9023415;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 35-38 hours (PubMed=3962675).
CC   HLA typing: A*02:06; B*13:01; C*03:03 (PubMed=9023415).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Ala (c.518T>C); ClinVar=VCV000376017; Zygosity=Homozygous (PubMed=1370612).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KXa7R1
AC   CVCL_F0SR
SY   KXalpha7R1
RX   PubMed=19448648;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2348; Chrna7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   KY [Human B-cell 09IHW]
AC   CVCL_E745
DR   IHW; 9w 1402
DR   Wikidata; Q54900763
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*31; B*60; C*w03; DQA1*03; DQB1*03:02 (IHW=9w 1402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   KY [Human B-cell 12IHW]
AC   CVCL_E746
DR   dbMHC; 48939
DR   ECACC; 94022539
DR   IHW; IHW09222
DR   IPD-IMGT/HLA; 10949
DR   Wikidata; Q54900764
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*59:01; C*01; DPB1*04:02,05:01 (IPD-IMGT/HLA=10949).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   KY-1
AC   CVCL_LH78
DR   Wikidata; Q54900765
RX   PubMed=21325069;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH79 ! KY-2
OI   CVCL_LH80 ! KY-3
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   KY-2
AC   CVCL_LH79
DR   Wikidata; Q54900766
RX   PubMed=21325069;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH78 ! KY-1
OI   CVCL_LH80 ! KY-3
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   KY-3
AC   CVCL_LH80
DR   Wikidata; Q54900767
RX   PubMed=21325069;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH78 ! KY-1
OI   CVCL_LH79 ! KY-2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   KY-ADR1
AC   CVCL_Z939
DR   Wikidata; Q54900768
RX   PubMed=7934146;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W294 ! KY-Ra
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   KY-ADR2
AC   CVCL_Z940
DR   cancercelllines; CVCL_Z940
DR   Wikidata; Q54900769
RX   PubMed=7934146;
RX   PubMed=12716468;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1346 ! KY821
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   KY-mBNP-I
AC   CVCL_B0CZ
DR   Wikidata; Q108820640
RX   PubMed=11288818;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P40753; Mouse Nppb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   KY-MTX
AC   CVCL_W293
SY   KY821/MTX
DR   cancercelllines; CVCL_W293
DR   Wikidata; Q54900770
RX   PubMed=1560671;
RX   PubMed=8387619;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1346 ! KY821
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   KY-Ra
AC   CVCL_W294
DR   cancercelllines; CVCL_W294
DR   Wikidata; Q54900771
RX   CelloPub=CLPUB00209;
RX   PubMed=8387619;
RX   PubMed=12716468;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1346 ! KY821
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   KY-Rb
AC   CVCL_5A05
DR   cancercelllines; CVCL_5A05
DR   Wikidata; Q54900772
RX   CelloPub=CLPUB00209;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1346 ! KY821
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   KY-RC-1
AC   CVCL_A1TP
DR   Wikidata; Q123032871
RX   PubMed=7591954;
CC   Population: Japanese.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   KY-VCR
AC   CVCL_W295
DR   cancercelllines; CVCL_W295
DR   Wikidata; Q54900773
RX   PubMed=1472928;
RX   PubMed=8387619;
RX   PubMed=12716468;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1346 ! KY821
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   KY821
AC   CVCL_1346
SY   KY-821
DR   CLO; CLO_0009844
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470792
DR   cancercelllines; CVCL_1346
DR   Cell_Model_Passport; SIDM00553
DR   ChEMBL-Cells; CHEMBL3308834
DR   ChEMBL-Targets; CHEMBL2366190
DR   Cosmic; 907300
DR   Cosmic; 975264
DR   Cosmic; 2089651
DR   Cosmic; 2131567
DR   Cosmic-CLP; 907300
DR   DepMap; ACH-002262
DR   EGA; EGAS00001000978
DR   GDSC; 907300
DR   GEO; GSM827265
DR   GEO; GSM1670013
DR   IARC_TP53; 2196
DR   IARC_TP53; 21447
DR   JCRB; JCRB0105
DR   LINCS_LDP; LCL-1004
DR   PharmacoDB; KY821_797_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1346
DR   PubChem_Cell_line; CVCL_1346
DR   Wikidata; Q54900774
RX   CelloPub=CLPUB00069;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1560671;
RX   PubMed=1571549;
RX   PubMed=8387619;
RX   PubMed=9747033;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21552520;
RX   PubMed=23955599;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~2 days (Note=Lot 11022006) (JCRB=JCRB0105).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (Cosmic-CLP=907300; DepMap=ACH-002262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=1571549; Cosmic-CLP=907300; DepMap=ACH-002262).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=76.02%; East Asian, South=23.98%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
ST   Source(s): Cosmic-CLP=907300; JCRB=JCRB0105
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D5S818: 10,13
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   KY821A3
AC   CVCL_2806
DR   CLO; CLO_0009845
DR   BioSample; SAMN03470793
DR   cancercelllines; CVCL_2806
DR   JCRB; JCRB0105.1
DR   LINCS_LDP; LCL-2040
DR   Wikidata; Q54900775
RX   PubMed=1560671;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
ST   Source(s): JCRB=JCRB0105.1
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9,11
ST   D16S539: 10,11,12
ST   D5S818: 9,10,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17,18
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1346 ! KY821
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   KYAE-1
AC   CVCL_1825
SY   KYAE1; KYAE
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 917
DR   cancercelllines; CVCL_1825
DR   Cell_Model_Passport; SIDM00530
DR   Cosmic; 1599341
DR   Cosmic-CLP; 1503368
DR   DepMap; ACH-001544
DR   DSMZ; ACC-703
DR   DSMZCellDive; ACC-703
DR   ECACC; 11012002
DR   EGA; EGAS00001000978
DR   GDSC; 1503368
DR   GEO; GSM1670014
DR   JCRB; JCRB1483
DR   PharmacoDB; KYAE1_798_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54900776
RX   PubMed=11520067;
RX   PubMed=20075370;
RX   PubMed=23795680;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~3-4 days (DSMZ=ACC-703).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Unspecified (PubMed=20075370).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=1.72%; East Asian, North=76.1%; East Asian, South=22.17%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1503368; DSMZ=ACC-703; ECACC=11012002; JCRB=JCRB1483; PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 20
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 18
ST   Penta D: 9,10
ST   Penta E: 5,8
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 12,14 (DSMZ=ACC-703)
ST   vWA: 14 (Cosmic-CLP=1503368; ECACC=11012002; JCRB=JCRB1483; PubMed=20075370)
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   KYAE-2
AC   CVCL_4W63
DR   JCRB; JCRB1595
DR   Wikidata; Q54900777
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1595
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 16
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   KYD-10
AC   CVCL_JY12
DR   Wikidata; Q54900778
RX   PubMed=9209432;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Hemizygous (PubMed=9209432).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   KYD-12
AC   CVCL_JY13
DR   Wikidata; Q54900779
RX   PubMed=9209432;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   KYD-17
AC   CVCL_JY14
DR   Wikidata; Q54900780
RX   PubMed=9209432;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Hemizygous (PubMed=9209432).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   KYD-32
AC   CVCL_JY15
DR   Wikidata; Q54900781
RX   PubMed=9209432;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Heterozygous (PubMed=9209432).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   KYD-38
AC   CVCL_JY16
DR   Wikidata; Q54900783
RX   PubMed=9209432;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Heterozygous (PubMed=9209432).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   KYD-44A
AC   CVCL_JY17
DR   Wikidata; Q54900784
RX   PubMed=9209432;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Hemizygous (PubMed=9209432).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_JY18 ! KYD-44B
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   KYD-44B
AC   CVCL_JY18
DR   Wikidata; Q54900785
RX   PubMed=9209432;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Hemizygous (PubMed=9209432).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_JY17 ! KYD-44A
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   KYD-49
AC   CVCL_JY19
DR   Wikidata; Q54900786
RX   PubMed=9209432;
CC   Sequence variation: Mutation; RGD; 3205; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Hemizygous (PubMed=9209432).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C135722; Rat erythroleukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   KYM-1
AC   CVCL_3007
SY   Kym-1; KYM1
DR   CLO; CLO_0037073
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471640
DR   BioSample; SAMN10988099
DR   cancercelllines; CVCL_3007
DR   Cell_Model_Passport; SIDM00552
DR   Cosmic; 801759
DR   Cosmic; 1995475
DR   Cosmic; 2144781
DR   Cosmic-CLP; 1240166
DR   DepMap; ACH-000607
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10787-110H4
DR   GDSC; 1240166
DR   GEO; GSM827283
DR   GEO; GSM887245
DR   GEO; GSM888320
DR   GEO; GSM1670015
DR   IARC_TP53; 30110
DR   JCRB; JCRB0627
DR   LiGeA; CCLE_614
DR   LINCS_LDP; LCL-1412
DR   PharmacoDB; KYM1_799_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3007
DR   Wikidata; Q54900787
RX   CelloPub=CLPUB00569;
RX   PubMed=1960402;
RX   PubMed=3830265;
RX   PubMed=9290701;
RX   PubMed=11921280;
RX   PubMed=17471488;
RX   PubMed=18082704;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23665679;
RX   PubMed=23828214;
RX   PubMed=24418192;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32758582;
RX   PubMed=35839778;
CC   Problematic cell line: Possibly misclassified. It is not certain that this cell line originate from a alveolar rhabdomyosarcoma (ARMS). It lacks the PAXA3-FOXO1 gene fusion characteristics of ARMS. Many papers classify it as an embryonal rhabdomyosarcoma (ERMS) and we accordingly describe it as such.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~75 hours (Note=At 30th passage) (PubMed=3830265); ~41 hours (Note=Lot 030499), ~26 hours (Note=Lot 02142012) (JCRB=JCRB0627).
CC   HLA typing: A*11:01,26:01; B*35:01,40:02; C*03:04,03:04; DQA1*05:02,05:02; DQB1*06:01,06:01; DRB1*04:04,13:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=11921280).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=74.54%; East Asian, South=24.94%; South Asian=0.51%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Neck; UBERON=UBERON_0000974.
ST   Source(s): Cosmic-CLP=1240166; JCRB=JCRB0627
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 11,14
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   KYM-1D4
AC   CVCL_5616
DR   Wikidata; Q54900788
RX   PubMed=1960402;
RX   PubMed=10485267;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KYM-1D4
CC   Problematic cell line: Possibly misclassified. It is not certain that the parent cell line originate from a alveolar rhabdomyosarcoma (ARMS). It lacks the PAXA3-FOXO1 gene fusion characteristics of ARMS. Many papers classify it as an embryonal rhabdomyosarcoma (ERMS) and we accordingly describe it as such.
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Neck; UBERON=UBERON_0000974.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3007 ! KYM-1
SX   Male
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   KYMM-1
AC   CVCL_UZ50
DR   Wikidata; Q95980571
RX   PubMed=22766978;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa (PubMed=22766978).
CC   Characteristics: Has a very low expression of SDC1/CD138 (PubMed=22766978).
CC   Miscellaneous: STR profile from personal communication of Hata, Hiroyuki.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UZ51 ! KYMM-2
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   KYMM-2
AC   CVCL_UZ51
DR   Wikidata; Q95980572
RX   PubMed=22766978;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa (PubMed=22766978).
CC   Characteristics: Compared to the autologous cell line KYMM-1, has a 5-fold higher expression of SDC1/CD138 (PubMed=22766978).
CC   Miscellaneous: STR profile from personal communication of Hata, Hiroyuki.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UZ50 ! KYMM-1
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   KYN-1
AC   CVCL_7925
SY   KYN1
DR   Wikidata; Q54900789
RX   PubMed=2430933;
RX   PubMed=7537711;
RX   PubMed=9178645;
RX   PubMed=10347112;
RX   PubMed=27329724;
CC   Population: Japanese.
CC   Doubling time: 10-11 days (Note=At 17th passage) (PubMed=2430933).
CC   HLA typing: A*24:02,24; B*54:01; C*01:02; DQA1*03:01; DQB1*04:01; DRB1*04:05 (PubMed=9178645).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   KYN-2
AC   CVCL_0381
SY   KYN2
DR   MCCL; MCC:0000276
DR   Wikidata; Q54900790
RX   PubMed=2847482;
RX   PubMed=7537711;
RX   PubMed=8738480;
RX   PubMed=9178645;
RX   PubMed=10347112;
RX   PubMed=27329724;
CC   Population: Japanese.
CC   Doubling time: 28 hours (Note=In DMEMA + 10% FBS), 68 hours (Note=In HB101), 42 hours (Note=In CDM medium) (PubMed=2847482).
CC   HLA typing: A*24:02,24:02; B*52:01; C*12:02; DQA1*01:02,03:01; DQB1*04:01,05:02; DRB1*04:05,16:02 (PubMed=9178645).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KYN-3
AC   CVCL_7926
SY   KYN3
DR   Wikidata; Q54900791
RX   CelloPub=CLPUB00070;
RX   PubMed=7537711;
RX   PubMed=9178645;
RX   PubMed=10347112;
RX   PubMed=27329724;
CC   Population: Japanese.
CC   Doubling time: ~56 hours (CelloPub=CLPUB00070).
CC   HLA typing: A*11:01,24:02; B*52:01,54:01; C*01:02,12:02; DQA1*01:03,03:01; DQB1*04:01,06:01; DRB1*04:05,15:02 (PubMed=9178645).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   KYO-1
AC   CVCL_2095
SY   KYO1; Kyoto 1
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473497
DR   BioSample; SAMN10988458
DR   cancercelllines; CVCL_2095
DR   Cell_Model_Passport; SIDM01471
DR   CGH-DB; 9209-4
DR   Cosmic; 787499
DR   Cosmic; 1026567
DR   DepMap; ACH-000604
DR   DSMZ; ACC-601
DR   DSMZCellDive; ACC-601
DR   GEO; GSM887246
DR   GEO; GSM888321
DR   IARC_TP53; 2224
DR   LiGeA; CCLE_093
DR   PharmacoDB; KYO1_800_2019
DR   Progenetix; CVCL_2095
DR   Wikidata; Q54900792
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3332852;
RX   PubMed=3860700;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~22 hours (PubMed=3860700); ~40-50 hours (DSMZ=ACC-601).
CC   HLA typing: A*24:02,24:02; B*54:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=3860700; PubMed=10071072; PubMed=10576511; DepMap=ACH-000604).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DepMap=ACH-000604).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.73%; Native American=0%; East Asian, North=78.04%; East Asian, South=12.39%; South Asian=0%; European, North=0%; European, South=5.83% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-601
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 18,25
ST   Penta D: 10,11
ST   Penta E: 11,15,17
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   KYSE-110
AC   CVCL_1643
AS   CVCL_9817
SY   KYSE 110; KYSE110; KY-110; KY110
DR   cancercelllines; CVCL_1643
DR   CGH-DB; 276-1
DR   CGH-DB; 9225-4
DR   Cosmic; 929522
DR   Cosmic; 1043239
DR   Cosmic; 1123336
DR   Cosmic; 1581071
DR   Cosmic; 2395001
DR   Cosmic; 2650629
DR   Cosmic; 2698432
DR   IARC_TP53; 7674
DR   JCRB; JCRB1064
DR   Wikidata; Q54900793
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Doubling time: 19.1 hours (PubMed=1728357).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000142536; Zygosity=Unspecified (PubMed=8575860).
CC   Discontinued: JCRB; JCRB1064; probable.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   KYSE-1140
AC   CVCL_A097
SY   KYSE 1140; KYSE1140
DR   cancercelllines; CVCL_A097
DR   Cosmic; 918543
DR   IARC_TP53; 7695
DR   JCRB; JCRB1449
DR   Wikidata; Q54900794
RX   PubMed=8575860;
RX   PubMed=9033652;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>T; ClinVar=VCV000649747; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=8575860).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1449
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 13
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   KYSE-1170
AC   CVCL_A098
SY   KYSE 1170; KYSE1170
DR   cancercelllines; CVCL_A098
DR   CGH-DB; 296-1
DR   CGH-DB; 9245-4
DR   Cosmic; 918544
DR   Cosmic; 2698451
DR   GEO; GSM590300
DR   IARC_TP53; 7675
DR   JCRB; JCRB1457
DR   Wikidata; Q54900795
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=16832412;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (PubMed=8575860).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Val (c.763A>G); Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1457
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   KYSE-1190
AC   CVCL_8501
SY   KYSE 1190; KYSE1190
DR   CGH-DB; 297-1
DR   CGH-DB; 9246-4
DR   Cosmic; 918545
DR   Cosmic; 2698452
DR   GEO; GSM590301
DR   JCRB; JCRB1421
DR   Wikidata; Q54900798
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1421
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   KYSE-1230
AC   CVCL_8502
SY   KYSE 1230; KYSE1230
DR   JCRB; JCRB1444
DR   Wikidata; Q54900799
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1444
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   KYSE-1240
AC   CVCL_A099
SY   KYSE 1240; KYSE1240
DR   CGH-DB; 298-1
DR   CGH-DB; 9247-4
DR   Cosmic; 918546
DR   Cosmic; 2698453
DR   GEO; GSM590302
DR   IARC_TP53; 7676
DR   JCRB; JCRB1456
DR   Wikidata; Q54900800
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Val (c.580C>G); Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1456
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   KYSE-1250
AC   CVCL_A100
SY   KYSE 1250; KYSE1250
DR   cancercelllines; CVCL_A100
DR   CGH-DB; 299-1
DR   CGH-DB; 9248-4
DR   Cosmic; 918547
DR   Cosmic; 2698454
DR   IARC_TP53; 7677
DR   JCRB; JCRB1462
DR   Wikidata; Q54900801
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (PubMed=8575860).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1462
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   KYSE-1260
AC   CVCL_8503
SY   KYSE 1260; KYSE1260
DR   CGH-DB; 300-1
DR   CGH-DB; 9249-4
DR   Cosmic; 918548
DR   Cosmic; 2698455
DR   IARC_TP53; 7678
DR   JCRB; JCRB1434
DR   Wikidata; Q54900802
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342fs*2 (c.1024_1030del7); Zygosity=Unspecified (PubMed=8575860).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1434
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   KYSE-140
AC   CVCL_1347
SY   KYSE 140; Kyse-140; KYSE140; Kyse140
DR   BTO; BTO_0006197
DR   CLO; CLO_0007128
DR   EFO; EFO_0006626
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 918
DR   BioSample; SAMN03471046
DR   BioSample; SAMN10987809
DR   cancercelllines; CVCL_1347
DR   Cell_Model_Passport; SIDM01032
DR   CGH-DB; 277-1
DR   CGH-DB; 9226-4
DR   ChEMBL-Cells; CHEMBL3308752
DR   ChEMBL-Targets; CHEMBL1075484
DR   Cosmic; 753573
DR   Cosmic; 801330
DR   Cosmic; 918524
DR   Cosmic; 1123337
DR   Cosmic; 1581072
DR   Cosmic; 2267698
DR   Cosmic; 2698433
DR   Cosmic-CLP; 753573
DR   DepMap; ACH-000823
DR   DSMZ; ACC-348
DR   DSMZCellDive; ACC-348
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753573
DR   GEO; GSM590303
DR   GEO; GSM827546
DR   GEO; GSM887247
DR   GEO; GSM888322
DR   GEO; GSM1374607
DR   GEO; GSM1670016
DR   IARC_TP53; 7679
DR   JCRB; JCRB1063
DR   LiGeA; CCLE_467
DR   LINCS_HMS; 50024
DR   LINCS_LDP; LCL-1547
DR   PharmacoDB; KYSE140_801_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1347
DR   PubChem_Cell_line; CVCL_1347
DR   Wikidata; Q54900803
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 27.4 hours (PubMed=1728357); ~24 hours (DSMZ=ACC-348).
CC   HLA typing: A*02:07,26:02; B*40:06,46:01; C*01:02,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.5%; Native American=0%; East Asian, North=83.8%; East Asian, South=6.46%; South Asian=0%; European, North=0%; European, South=6.23% (PubMed=30894373).
CC   Discontinued: JCRB; JCRB1063; probable.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753573; DSMZ=ACC-348; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 10
ST   D7S820: 10 (DSMZ=ACC-348; PubMed=25877200)
ST   D7S820: 10,11 (Cosmic-CLP=753573)
ST   D8S1179: 10
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 16,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   KYSE-1440
AC   CVCL_8504
SY   KYSE 1440; KYSE1440
DR   CGH-DB; 301-1
DR   CGH-DB; 9346-4
DR   Cosmic; 918549
DR   Cosmic; 2698456
DR   JCRB; JCRB1432
DR   Wikidata; Q54900804
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1432
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   KYSE-150
AC   CVCL_1348
SY   KYSE 150; KYSE150; Kyse150; KY150
DR   BTO; BTO_0002427
DR   CLO; CLO_0007129
DR   EFO; EFO_0006627
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 919
DR   BioSample; SAMN03471047
DR   BioSample; SAMN10988383
DR   cancercelllines; CVCL_1348
DR   CCRID; 3101HUMTCHu236
DR   Cell_Model_Passport; SIDM01031
DR   CGH-DB; 278-1
DR   CGH-DB; 9227-4
DR   ChEMBL-Cells; CHEMBL3307840
DR   ChEMBL-Targets; CHEMBL613998
DR   CLS; 305087
DR   Cosmic; 907317
DR   Cosmic; 918525
DR   Cosmic; 929523
DR   Cosmic; 1123338
DR   Cosmic; 1581073
DR   Cosmic; 1876252
DR   Cosmic; 2267699
DR   Cosmic; 2395002
DR   Cosmic; 2650630
DR   Cosmic; 2698434
DR   Cosmic-CLP; 907317
DR   DepMap; ACH-000855
DR   DSMZ; ACC-375
DR   DSMZCellDive; ACC-375
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907317
DR   GEO; GSM718289
DR   GEO; GSM827545
DR   GEO; GSM887248
DR   GEO; GSM888323
DR   GEO; GSM1670017
DR   IARC_TP53; 21448
DR   JCRB; JCRB1095
DR   LiGeA; CCLE_818
DR   LINCS_HMS; 50025
DR   LINCS_LDP; LCL-1548
DR   PharmacoDB; KYSE150_802_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1348
DR   PubChem_Cell_line; CVCL_1348
DR   Ubigene; YC-B002
DR   Wikidata; Q54900805
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=16832412;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21191746;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36090890;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 13.7 hours (PubMed=1728357); 23 hours (PubMed=25984343); <25 hours (Note=Less when serum amount is increased) (DSMZ=ACC-375).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=907317).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=0%; East Asian, North=79.69%; East Asian, South=18.82%; South Asian=0%; European, North=0%; European, South=1.08% (PubMed=30894373).
CC   Discontinued: JCRB; JCRB1095; probable.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=907317; DSMZ=ACC-375; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 15
ST   D21S11: 30,31
ST   D2S1338: 25
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 10,15 (PubMed=25877200)
ST   D8S1179: 15 (DSMZ=ACC-375)
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 12,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   KYSE-150-Luc
AC   CVCL_C8V1
DR   Ubigene; YC-B002-Luc-P
DR   Wikidata; Q123032874
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   KYSE-150R
AC   CVCL_C3LZ
DR   Wikidata; Q116049632
RX   PubMed=36090890;
CC   Population: Japanese.
CC   Characteristics: Radioresistant. Was irradiated at 1 Gy three times, at 2 Gy three times and 4 Gy three times (PubMed=36090890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   KYSE-170
AC   CVCL_1358
SY   KYSE 170; KYSE170; KYSE0170
DR   BioSample; SAMN03472369
DR   BioSample; SAMN03472501
DR   cancercelllines; CVCL_1358
DR   CGH-DB; 279-1
DR   CGH-DB; 9228-4
DR   Cosmic; 801331
DR   Cosmic; 918526
DR   Cosmic; 1581074
DR   Cosmic; 1876245
DR   Cosmic; 2698435
DR   GEO; GSM590304
DR   IARC_TP53; 7680
DR   JCRB; JCRB1082
DR   JCRB; NIHS0346
DR   Wikidata; Q54900806
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=16832412;
CC   Population: Japanese.
CC   Doubling time: 32.5 hours (PubMed=1728357).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.796G>C); ClinVar=VCV000376605; Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0346; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1082
ST   Amelogenin: X
ST   CSF1PO: 10,12,13
ST   D13S317: 9
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   KYSE-180
AC   CVCL_1349
SY   KYSE 180; KYSE180; Kyse180; KY180
DR   CLO; CLO_0007130
DR   EFO; EFO_0006628
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 577
DR   BioSample; SAMN03471048
DR   BioSample; SAMN03472502
DR   BioSample; SAMN03473326
DR   BioSample; SAMN10987810
DR   cancercelllines; CVCL_1349
DR   Cell_Model_Passport; SIDM01030
DR   CGH-DB; 280-1
DR   CGH-DB; 9229-4
DR   ChEMBL-Cells; CHEMBL3308389
DR   ChEMBL-Targets; CHEMBL1075485
DR   Cosmic; 801332
DR   Cosmic; 907318
DR   Cosmic; 918527
DR   Cosmic; 1123339
DR   Cosmic; 1581075
DR   Cosmic; 1876246
DR   Cosmic; 2267700
DR   Cosmic; 2395003
DR   Cosmic; 2650631
DR   Cosmic; 2698436
DR   Cosmic-CLP; 907318
DR   DepMap; ACH-000693
DR   DSMZ; ACC-379
DR   DSMZCellDive; ACC-379
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907318
DR   GEO; GSM827544
DR   GEO; GSM887249
DR   GEO; GSM888324
DR   GEO; GSM1374608
DR   GEO; GSM1670018
DR   IARC_TP53; 21449
DR   JCRB; JCRB1083
DR   JCRB; NIHS0347
DR   LiGeA; CCLE_086
DR   LINCS_HMS; 50026
DR   LINCS_LDP; LCL-1549
DR   PharmacoDB; KYSE180_803_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1349
DR   PubChem_Cell_line; CVCL_1349
DR   Wikidata; Q54900807
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 15.2 hours (PubMed=1728357); ~40-50 hours (DSMZ=ACC-379).
CC   HLA typing: A*03:02,24:02; B*13:02,59:01; C*01:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Homozygous (Cosmic-CLP=907318; DepMap=ACH-000693).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.43%; East Asian, South=22.18%; South Asian=2.35%; European, North=0%; European, South=0.04% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0347; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=907318; DSMZ=ACC-379; JCRB=JCRB1083; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,12
ST   D16S539: 9 (PubMed=25877200)
ST   D16S539: 9,10 (Cosmic-CLP=907318; DSMZ=ACC-379; JCRB=JCRB1083)
ST   D18S51: 20
ST   D19S433: 14
ST   D21S11: 30 (PubMed=25877200)
ST   D21S11: 30,33 (DSMZ=ACC-379)
ST   D2S1338: 27
ST   D3S1358: 15
ST   D5S818: 8,11
ST   D7S820: 9,12 (DSMZ=ACC-379; JCRB=JCRB1083; PubMed=25877200)
ST   D7S820: 12 (Cosmic-CLP=907318)
ST   D8S1179: 10,12 (PubMed=25877200)
ST   D8S1179: 12 (DSMZ=ACC-379)
ST   FGA: 19,21
ST   Penta D: 9
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   KYSE-1860
AC   CVCL_A101
SY   KYSE 1860; KYSE1860
DR   Cosmic; 918550
DR   JCRB; JCRB1460
DR   Wikidata; Q54900808
RX   PubMed=9033652;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1460
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   KYSE-190
AC   CVCL_8301
AS   CVCL_9818
SY   KYSE 190; KYSE190; KY-190
DR   cancercelllines; CVCL_8301
DR   CGH-DB; 281-1
DR   CGH-DB; 9230-4
DR   Cosmic; 918528
DR   Cosmic; 929524
DR   Cosmic; 1043240
DR   Cosmic; 2698437
DR   GEO; GSM590305
DR   IARC_TP53; 7681
DR   JCRB; JCRB1084
DR   JCRB; JCRB1426
DR   JCRB; NIHS0348
DR   Wikidata; Q54900809
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Doubling time: 75.6 hours (PubMed=1728357); ~31 hours (Note=Lot 12172018) (JCRB=JCRB1426).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val203Leu (c.607G>C); ClinVar=VCV000482235; Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; JCRB1084; probable.
CC   Discontinued: JCRB; NIHS0348; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1426
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   KYSE-200
AC   CVCL_G698
SY   KYSE 200; KYSE200
DR   BioSample; SAMN03472503
DR   cancercelllines; CVCL_G698
DR   CGH-DB; 282-1
DR   CGH-DB; 9231-4
DR   Cosmic; 2650632
DR   Cosmic; 2698438
DR   IARC_TP53; 7682
DR   JCRB; JCRB1085
DR   JCRB; NIHS0364
DR   Wikidata; Q54900810
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Doubling time: 23.5 hours (PubMed=1728357).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000142536; Zygosity=Unspecified (PubMed=8575860).
CC   Discontinued: JCRB; JCRB1085; probable.
CC   Discontinued: JCRB; NIHS0364; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1085
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 23
//
ID   KYSE-201
AC   CVCL_A102
SY   KYSE 201; KYSE201
DR   Cosmic; 918529
DR   Wikidata; Q54900811
RX   PubMed=9033652;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110fs*36; Zygosity=Unspecified (PubMed=9033652).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   KYSE-220
AC   CVCL_1359
AS   CVCL_9819
SY   KYSE 220; KYSE220; KY-220
DR   CLO; CLO_0009933
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 920
DR   BioSample; SAMN03472505
DR   cancercelllines; CVCL_1359
DR   Cell_Model_Passport; SIDM00551
DR   CGH-DB; 283-1
DR   CGH-DB; 9232-4
DR   Cosmic; 918530
DR   Cosmic; 1043241
DR   Cosmic; 1581076
DR   Cosmic; 1995476
DR   Cosmic; 2650633
DR   Cosmic; 2698439
DR   Cosmic-CLP; 1240167
DR   DepMap; ACH-002263
DR   EGA; EGAS00001000978
DR   GDSC; 1240167
DR   GEO; GSM827502
DR   GEO; GSM1670019
DR   IARC_TP53; 7683
DR   JCRB; JCRB1086
DR   JCRB; NIHS0365
DR   LINCS_LDP; LCL-1559
DR   PharmacoDB; KYSE220_804_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1359
DR   Wikidata; Q54900812
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 20.5 hours (PubMed=1728357).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (PubMed=9033652).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.96%; Native American=0%; East Asian, North=75.9%; East Asian, South=20.19%; South Asian=0%; European, North=1.79%; European, South=1.15% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0365; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=1240167; JCRB=JCRB1086
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   KYSE-2270
AC   CVCL_J284
SY   KYSE 2270; KYSE2270
DR   CGH-DB; 302-1
DR   CGH-DB; 9250-4
DR   Cosmic; 2698457
DR   JCRB; JCRB1468
DR   Wikidata; Q54900813
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1468
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 13
//
ID   KYSE-2300
AC   CVCL_4W14
SY   KYSE 2300; KYSE2300
DR   JCRB; JCRB1472
DR   Wikidata; Q54900814
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1472
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   KYSE-2400
AC   CVCL_8505
SY   KYSE2400
DR   CGH-DB; 303-1
DR   CGH-DB; 9251-4
DR   Cosmic; 2698458
DR   JCRB; JCRB1424
DR   Wikidata; Q54900815
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1424
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KYSE-2650
AC   CVCL_Y278
SY   KYSE 2650; KYSE2650
DR   CGH-DB; 304-1
DR   CGH-DB; 9252-4
DR   Cosmic; 2698459
DR   Wikidata; Q54900816
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   KYSE-270
AC   CVCL_1350
AS   CVCL_9820
SY   KYSE 270; KYSE270; Kyse270; KY-270
DR   CLO; CLO_0007131
DR   EFO; EFO_0006629
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 576
DR   BioSample; SAMN01821696
DR   BioSample; SAMN03471049
DR   BioSample; SAMN03473328
DR   BioSample; SAMN10987933
DR   cancercelllines; CVCL_1350
DR   Cell_Model_Passport; SIDM01029
DR   CGH-DB; 284-1
DR   CGH-DB; 9233-4
DR   ChEMBL-Cells; CHEMBL3308753
DR   ChEMBL-Targets; CHEMBL1075486
DR   Cosmic; 907319
DR   Cosmic; 1043242
DR   Cosmic; 1123340
DR   Cosmic; 1581077
DR   Cosmic; 1876247
DR   Cosmic; 2698440
DR   Cosmic-CLP; 907319
DR   DepMap; ACH-000873
DR   DSMZ; ACC-380
DR   DSMZCellDive; ACC-380
DR   ECACC; 94072021
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907319
DR   GEO; GSM827543
DR   GEO; GSM887250
DR   GEO; GSM888325
DR   GEO; GSM1670020
DR   IARC_TP53; 21450
DR   JCRB; JCRB1087
DR   JCRB; NIHS0366
DR   LiGeA; CCLE_575
DR   LINCS_LDP; LCL-1552
DR   PharmacoDB; KYSE270_805_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1350
DR   PubChem_Cell_line; CVCL_1350
DR   Wikidata; Q54900817
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 29.9 hours (PubMed=1728357); ~24 hours (DSMZ=ACC-380); 24 hours (ECACC=94072021).
CC   HLA typing: A*11:01,11:01; B*13:01,13:01; C*03:04,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-25del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=907319).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.68%; East Asian, South=20.54%; South Asian=0%; European, North=0%; European, South=0.78% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0366; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=907319; DSMZ=ACC-380; JCRB=JCRB1087; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 14
ST   D18S51: 14
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 16
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 19
ST   Penta D: 15
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17 (Cosmic-CLP=907319; DSMZ=ACC-380; JCRB=JCRB1087)
ST   vWA: 17 (PubMed=25877200)
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   KYSE-2710
AC   CVCL_4W15
SY   KYSE 2710; KYSE2710
DR   JCRB; JCRB1467
DR   Wikidata; Q54900818
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1467
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   KYSE-273
AC   CVCL_A104
SY   KYSE 273; KYSE273
DR   cancercelllines; CVCL_A104
DR   Cosmic; 918531
DR   IARC_TP53; 7692
DR   Wikidata; Q54900819
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=10719051;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=8575860).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   KYSE-2780
AC   CVCL_J283
SY   KYSE 2780; KYSE2780
DR   JCRB; JCRB1452
DR   Wikidata; Q54900820
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1452
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   KYSE-280
AC   CVCL_S527
SY   KYSE 280; KYSE280
DR   Wikidata; Q54900821
RX   PubMed=1728357;
CC   Population: Japanese.
CC   Doubling time: 17.7 hours (PubMed=1728357).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   KYSE-2880
AC   CVCL_4W16
SY   KYSE 2880; KYSE2880
DR   JCRB; JCRB1469
DR   Wikidata; Q54900822
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1469
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   KYSE-30
AC   CVCL_1351
SY   Kyse-30; KYSE 30; KYSE30; Kyse30; KYSE0030
DR   BTO; BTO_0004461
DR   CLO; CLO_0007132
DR   EFO; EFO_0002223
DR   CLDB; cl3073
DR   CLDB; cl3074
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BCRJ; 0404
DR   BioGRID_ORCS_Cell_line; 411
DR   BioSample; SAMN03471050
DR   BioSample; SAMN03471648
DR   BioSample; SAMN03473314
DR   BioSample; SAMN10988382
DR   cancercelllines; CVCL_1351
DR   Cell_Model_Passport; SIDM00015
DR   CGH-DB; 274-1
DR   CGH-DB; 9223-4
DR   ChEMBL-Cells; CHEMBL4513120
DR   ChEMBL-Targets; CHEMBL4513130
DR   CLS; 305094
DR   Cosmic; 801333
DR   Cosmic; 918521
DR   Cosmic; 1123333
DR   Cosmic; 1298221
DR   Cosmic; 1339921
DR   Cosmic; 1581068
DR   Cosmic; 1876249
DR   Cosmic; 2267697
DR   Cosmic; 2395004
DR   Cosmic; 2650627
DR   Cosmic; 2698430
DR   DepMap; ACH-000777
DR   DSMZ; ACC-351
DR   DSMZCellDive; ACC-351
DR   ECACC; 94072011
DR   EGA; EGAS00001000610
DR   GDSC; 1298221
DR   GEO; GSM827542
DR   GEO; GSM887251
DR   GEO; GSM888326
DR   GEO; GSM1374609
DR   GEO; GSM1374610
DR   GEO; GSM1374611
DR   IARC_TP53; 7691
DR   ICLC; HTL97022
DR   IGRhCellID; KYSE30
DR   JCRB; JCRB0188
DR   LiGeA; CCLE_634
DR   LINCS_LDP; LCL-1553
DR   NCBI_Iran; C584
DR   PharmacoDB; KYSE30_806_2019
DR   Progenetix; CVCL_1351
DR   PubChem_Cell_line; CVCL_1351
DR   Ubigene; YC-C054
DR   Wikidata; Q54900823
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=12963126;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=16364037;
RX   PubMed=20215515;
RX   PubMed=21191746;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Japanese.
CC   Doubling time: 20.8 hours (PubMed=1728357); 22 hours (PubMed=25984343); ~30 hours (DSMZ=ACC-351).
CC   HLA typing: A*02:06,24:02; B*15:58,54:01; C*04:01,08:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (PubMed=9033652; DepMap=ACH-000777).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (DepMap=ACH-000777).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=8575860).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.07%; East Asian, South=24.93%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Misspelling: KYSE-300; Cosmic=801333.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): DSMZ=ACC-351; JCRB=JCRB0188; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 15,16
ST   D21S11: 28
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11,11.3 (JCRB=JCRB0188; PubMed=25877200)
ST   D7S820: 11,12 (DSMZ=ACC-351)
ST   D8S1179: 12,15
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 13
ST   TH01: 9
ST   TPOX: 8,9 (JCRB=JCRB0188)
ST   TPOX: 9 (DSMZ=ACC-351; PubMed=25877200)
ST   vWA: 16,18 (DSMZ=ACC-351)
ST   vWA: 16,18,19 (JCRB=JCRB0188; PubMed=25877200)
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   KYSE-30-EGFP
AC   CVCL_E3F6
DR   Ubigene; YC-C054-EGFP-P
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   KYSE-3210
AC   CVCL_J285
SY   KYSE 3210; KYSE3210
DR   JCRB; JCRB1463
DR   Wikidata; Q54900824
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1463
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 13
//
ID   KYSE-3410
AC   CVCL_8506
SY   KYSE 3410; KYSE3410
DR   GEO; GSM590306
DR   JCRB; JCRB1425
DR   Wikidata; Q54900825
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1425
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 9,14
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   KYSE-350
AC   CVCL_8507
SY   KYSE 350; KYSE350
DR   cancercelllines; CVCL_8507
DR   CGH-DB; 285-1
DR   CGH-DB; 9234-4
DR   Cosmic; 918532
DR   Cosmic; 929525
DR   Cosmic; 2698441
DR   IARC_TP53; 7684
DR   JCRB; JCRB1428
DR   Wikidata; Q54900826
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Doubling time: 37.7 hours (PubMed=1728357).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=8575860).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1428
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 9
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   KYSE-360
AC   CVCL_G699
SY   KYSE 360; KYSE360
DR   Wikidata; Q54900827
RX   PubMed=1728357;
RX   PubMed=7913084;
CC   Population: Japanese.
CC   Doubling time: 61.6 hours (PubMed=1728357).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   KYSE-3650
AC   CVCL_M252
SY   KYSE 3650; KYSE3650
DR   JCRB; JCRB1495
DR   Wikidata; Q54900828
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1495
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 13
//
ID   KYSE-3940
AC   CVCL_4W17
SY   KYSE 3940; KYSE3940
DR   JCRB; JCRB1481
DR   Wikidata; Q54900829
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1481
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   KYSE-410
AC   CVCL_1352
SY   KYSE 410; KYSE410; Kyse410; KYSE0410
DR   CLO; CLO_0007133
DR   EFO; EFO_0022509
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 575
DR   BioSample; SAMN03470945
DR   BioSample; SAMN10987801
DR   cancercelllines; CVCL_1352
DR   Cell_Model_Passport; SIDM01028
DR   CGH-DB; 286-1
DR   CGH-DB; 9235-4
DR   ChEMBL-Cells; CHEMBL3308754
DR   ChEMBL-Targets; CHEMBL1075487
DR   CLS; 305122
DR   Cosmic; 753574
DR   Cosmic; 918533
DR   Cosmic; 929526
DR   Cosmic; 1123341
DR   Cosmic; 2267701
DR   Cosmic; 2650634
DR   Cosmic; 2698442
DR   Cosmic-CLP; 753574
DR   DepMap; ACH-000809
DR   DSMZ; ACC-381
DR   DSMZCellDive; ACC-381
DR   ECACC; 94072023
DR   EGA; EGAS00001000978
DR   GDSC; 753574
DR   GEO; GSM827541
DR   GEO; GSM887252
DR   GEO; GSM888327
DR   GEO; GSM1670021
DR   IARC_TP53; 21451
DR   IARC_TP53; 30211
DR   JCRB; JCRB1419
DR   LiGeA; CCLE_896
DR   LINCS_LDP; LCL-1554
DR   PharmacoDB; KYSE410_807_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1352
DR   PubChem_Cell_line; CVCL_1352
DR   Wikidata; Q54900830
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=12963126;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26699196;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 24.2 hours (PubMed=1728357); ~45 hours (DSMZ=ACC-381); ~45 hours (ECACC=94072023); ~19 hours (Note=Lot 07202016) (JCRB=JCRB1419).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (Cosmic-CLP=753574; DepMap=ACH-000809).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000142536; Zygosity=Homozygous (Cosmic-CLP=753574; DepMap=ACH-000809).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.02%; Native American=0%; East Asian, North=79.58%; East Asian, South=19.99%; South Asian=0.41%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753574; DSMZ=ACC-381; ECACC=94072023; JCRB=JCRB1419; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 20
ST   Penta D: 11
ST   Penta E: 8,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   KYSE-450
AC   CVCL_1353
SY   KYSE 450; KYSE450; Kyse450
DR   CLO; CLO_0007134
DR   EFO; EFO_0006630
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 574
DR   BioSample; SAMN03471051
DR   BioSample; SAMN10987615
DR   cancercelllines; CVCL_1353
DR   Cell_Model_Passport; SIDM01027
DR   CGH-DB; 287-1
DR   CGH-DB; 9236-4
DR   ChEMBL-Cells; CHEMBL3308755
DR   ChEMBL-Targets; CHEMBL1075488
DR   Cosmic; 801334
DR   Cosmic; 907320
DR   Cosmic; 918534
DR   Cosmic; 983846
DR   Cosmic; 1123342
DR   Cosmic; 1339910
DR   Cosmic; 2267702
DR   Cosmic; 2395005
DR   Cosmic; 2650635
DR   Cosmic; 2698443
DR   Cosmic-CLP; 907320
DR   DepMap; ACH-000865
DR   DSMZ; ACC-387
DR   DSMZCellDive; ACC-387
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907320
DR   GEO; GSM827540
DR   GEO; GSM887253
DR   GEO; GSM888328
DR   GEO; GSM1374612
DR   GEO; GSM1670022
DR   IARC_TP53; 7685
DR   IARC_TP53; 21452
DR   JCRB; JCRB1430
DR   LiGeA; CCLE_901
DR   LINCS_HMS; 50027
DR   LINCS_LDP; LCL-1550
DR   PharmacoDB; KYSE450_808_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1353
DR   PubChem_Cell_line; CVCL_1353
DR   Wikidata; Q54900831
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26512696;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 24.4 hours (PubMed=1728357); 23 hours (PubMed=25984343); ~30 hours (DSMZ=ACC-387).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (PubMed=8575860; Cosmic-CLP=907320; DepMap=ACH-000865).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu339Ter (c.1015G>T); ClinVar=VCV000438708; Zygosity=Heterozygous (PubMed=8575860; Cosmic-CLP=907320; DepMap=ACH-000865).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.35%; Native American=0%; East Asian, North=79%; East Asian, South=19.85%; South Asian=0.58%; European, North=0%; European, South=0.21% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=907320; DSMZ=ACC-387; JCRB=JCRB1430; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 18
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 11,16
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   KYSE-50
AC   CVCL_1360
AS   CVCL_9821
SY   KYSE 50; KYSE50; KY-50
DR   CLO; CLO_0009934
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471649
DR   cancercelllines; CVCL_1360
DR   Cell_Model_Passport; SIDM00550
DR   Cosmic; 918522
DR   Cosmic; 929520
DR   Cosmic; 1043238
DR   Cosmic; 1123334
DR   Cosmic; 1581069
DR   Cosmic; 1876250
DR   Cosmic; 1995477
DR   Cosmic; 2395006
DR   Cosmic; 2650628
DR   Cosmic-CLP; 1298222
DR   DepMap; ACH-002264
DR   EGA; EGAS00001000978
DR   GDSC; 1298222
DR   GEO; GSM827503
DR   GEO; GSM1670023
DR   JCRB; JCRB0189
DR   LINCS_LDP; LCL-1560
DR   PharmacoDB; KYSE50_809_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1360
DR   Wikidata; Q54900832
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=9033652;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 28.2 hours (PubMed=1728357); ~2-3 days (Note=Lot 02182005) (JCRB=JCRB0189).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Glu539Ter (c.1615G>T); Zygosity=Homozygous (Cosmic-CLP=1298222; DepMap=ACH-002264).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Gly17Val (c.50G>T); Zygosity=Heterozygous (Cosmic-CLP=1298222; DepMap=ACH-002264).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys101Ter (c.301A>T); Zygosity=Homozygous (Cosmic-CLP=1298222; DepMap=ACH-002264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=0%; East Asian, North=73.2%; East Asian, South=24.47%; South Asian=2.01%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=1298222; JCRB=JCRB0189
ST   Amelogenin: X
ST   CSF1PO: 11,12 (JCRB=JCRB0189)
ST   CSF1PO: 12 (Cosmic-CLP=1298222)
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   KYSE-510
AC   CVCL_1354
SY   KYSE 510; Kyse-510; KYSE510; Kyse510
DR   CLO; CLO_0007135
DR   EFO; EFO_0006631
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 921
DR   BioSample; SAMN03471052
DR   BioSample; SAMN03473323
DR   BioSample; SAMN10988378
DR   cancercelllines; CVCL_1354
DR   Cell_Model_Passport; SIDM01026
DR   CGH-DB; 288-1
DR   CGH-DB; 9237-4
DR   ChEMBL-Cells; CHEMBL3308081
DR   ChEMBL-Targets; CHEMBL613868
DR   Cosmic; 907321
DR   Cosmic; 918535
DR   Cosmic; 929527
DR   Cosmic; 1123343
DR   Cosmic; 2267703
DR   Cosmic; 2395007
DR   Cosmic; 2698444
DR   Cosmic-CLP; 907321
DR   DepMap; ACH-000824
DR   DSMZ; ACC-374
DR   DSMZCellDive; ACC-374
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 907321
DR   GEO; GSM827539
DR   GEO; GSM887254
DR   GEO; GSM888329
DR   GEO; GSM1670024
DR   IARC_TP53; 7686
DR   IARC_TP53; 21453
DR   JCRB; JCRB1436
DR   LiGeA; CCLE_857
DR   LINCS_LDP; LCL-1555
DR   PharmacoDB; KYSE510_810_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1354
DR   PubChem_Cell_line; CVCL_1354
DR   Wikidata; Q54900833
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 26.4 hours (PubMed=1728357); 30 hours (PubMed=25984343); ~30 hours (DSMZ=ACC-374).
CC   HLA typing: A*33:03,33:03; B*35:01,44:03; C*14:03,14:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (DepMap=ACH-000824).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.721_752del32; Zygosity=Unspecified (PubMed=8575860).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu343Ter (c.1027G>T); Zygosity=Heterozygous (DepMap=ACH-000824).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.71%; Native American=0%; East Asian, North=82.59%; East Asian, South=14.53%; South Asian=0%; European, North=0%; European, South=2.16% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=907321; DSMZ=ACC-374; JCRB=JCRB1436; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11 (DSMZ=ACC-374)
ST   CSF1PO: 11,13 (Cosmic-CLP=907321; JCRB=JCRB1436; PubMed=25877200)
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   KYSE-520
AC   CVCL_1355
SY   KYSE 520; KYSE520; Kyse520; KYSE0520
DR   CLO; CLO_0007136
DR   EFO; EFO_0006632
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 922
DR   BioSample; SAMN03471053
DR   BioSample; SAMN10987932
DR   cancercelllines; CVCL_1355
DR   Cell_Model_Passport; SIDM01025
DR   CGH-DB; 289-1
DR   CGH-DB; 9238-4
DR   ChEMBL-Cells; CHEMBL3307804
DR   ChEMBL-Targets; CHEMBL612701
DR   Cosmic; 753575
DR   Cosmic; 918536
DR   Cosmic; 929528
DR   Cosmic; 1123344
DR   Cosmic; 2009521
DR   Cosmic; 2698445
DR   Cosmic-CLP; 753575
DR   DepMap; ACH-000637
DR   DSMZ; ACC-371
DR   DSMZCellDive; ACC-371
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753575
DR   GEO; GSM590307
DR   GEO; GSM827538
DR   GEO; GSM887255
DR   GEO; GSM888330
DR   GEO; GSM1670025
DR   IARC_TP53; 7693
DR   JCRB; JCRB1439
DR   LiGeA; CCLE_661
DR   LINCS_LDP; LCL-1556
DR   PharmacoDB; KYSE520_811_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1355
DR   PubChem_Cell_line; CVCL_1355
DR   Wikidata; Q54900834
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=12963126;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 30.2 hours (PubMed=1728357); ~30 hours (DSMZ=ACC-371).
CC   HLA typing: A*24:20,24:20; B*54:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-2A>T; ClinVar=VCV000458540; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=8575860).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.52%; Native American=1.16%; East Asian, North=82.25%; East Asian, South=12.37%; South Asian=0%; European, North=0%; European, South=2.7% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753575; DSMZ=ACC-371; JCRB=JCRB1439; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 11
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   KYSE-590
AC   CVCL_8508
SY   KYSE 590; KYSE590; KYSE0590
DR   cancercelllines; CVCL_8508
DR   CGH-DB; 290-1
DR   CGH-DB; 9239-4
DR   Cosmic; 918537
DR   Cosmic; 2698446
DR   GEO; GSM590308
DR   IARC_TP53; 7687
DR   JCRB; JCRB1443
DR   Wikidata; Q54900835
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=9033652).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.796G>C); ClinVar=VCV000376605; Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1443
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   KYSE-70
AC   CVCL_1356
SY   KYSE 70; KYSE70; Kyse70; KY70
DR   CLO; CLO_0007137
DR   EFO; EFO_0006633
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 573
DR   BioSample; SAMN03471054
DR   BioSample; SAMN03471650
DR   BioSample; SAMN10988277
DR   cancercelllines; CVCL_1356
DR   Cell_Model_Passport; SIDM01024
DR   CGH-DB; 275-1
DR   CGH-DB; 9224-4
DR   ChEMBL-Cells; CHEMBL3308390
DR   ChEMBL-Targets; CHEMBL614012
DR   Cosmic; 753576
DR   Cosmic; 918523
DR   Cosmic; 929521
DR   Cosmic; 1123335
DR   Cosmic; 1581070
DR   Cosmic; 1876251
DR   Cosmic; 2395008
DR   Cosmic; 2698431
DR   Cosmic-CLP; 753576
DR   DepMap; ACH-000784
DR   DSMZ; ACC-363
DR   DSMZCellDive; ACC-363
DR   ECACC; 94072012
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753576
DR   GEO; GSM590309
DR   GEO; GSM827537
DR   GEO; GSM887256
DR   GEO; GSM888331
DR   GEO; GSM1374613
DR   GEO; GSM1670026
DR   IARC_TP53; 7690
DR   IARC_TP53; 21454
DR   JCRB; JCRB0190
DR   LiGeA; CCLE_812
DR   LINCS_LDP; LCL-1557
DR   PharmacoDB; KYSE70_812_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1356
DR   PubChem_Cell_line; CVCL_1356
DR   Wikidata; Q54900836
RX   PubMed=1728357;
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21191746;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26512696;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Virology: Infected with a murine leukemia virus-related virus (PubMed=30629668).
CC   Doubling time: 17.1 hours (PubMed=1728357); ~35 hours (DSMZ=ACC-363; ECACC=94072012); ~25 hours (Note=Lot 06102005) (JCRB=JCRB0190).
CC   HLA typing: A*26:01,26:01; B*08:01,56:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Arg1989Ter (c.5965C>T); ClinVar=VCV000225842; Zygosity=Homozygous (Cosmic-CLP=753576; DepMap=ACH-000784).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys120Asn (c.360G>T); Zygosity=Heterozygous (Cosmic-CLP=753576; DepMap=ACH-000784).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*13 (c.751_752insA); Zygosity=Heterozygous (Cosmic-CLP=753576; DepMap=ACH-000784).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.22%; Native American=0%; East Asian, North=75.55%; East Asian, South=23.91%; South Asian=0.33%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Caution: TP53 mutation indicated as c.750_751insC in PubMed=8575860.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753576; DSMZ=ACC-363; ECACC=94072012; JCRB=JCRB0190; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13,16
ST   D21S11: 30
ST   D2S1338: 16
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   KYSE-770
AC   CVCL_8509
SY   KYSE 770; KYSE770; KYSE0770
DR   cancercelllines; CVCL_8509
DR   CGH-DB; 291-1
DR   CGH-DB; 9240-4
DR   Cosmic; 918538
DR   Cosmic; 2698447
DR   GEO; GSM590310
DR   IARC_TP53; 7694
DR   JCRB; JCRB1445
DR   Wikidata; Q54900837
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>A; ClinVar=VCV000634769; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1445
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   KYSE-790
AC   CVCL_8510
SY   KYSE 790; KYSE790
DR   CGH-DB; 292-1
DR   CGH-DB; 9241-4
DR   Cosmic; 918539
DR   Cosmic; 2698448
DR   JCRB; JCRB1418
DR   Wikidata; Q54900840
RX   PubMed=7913084;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Doubling time: 24-83 hours (Note=Lot 12022016) (JCRB=JCRB1418).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1418
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   KYSE-850
AC   CVCL_8511
SY   KYSE 850; KYSE850; Kyse 850
DR   cancercelllines; CVCL_8511
DR   CGH-DB; 293-1
DR   CGH-DB; 9242-4
DR   Cosmic; 918540
DR   Cosmic; 2698449
DR   GEO; GSM590311
DR   IARC_TP53; 7688
DR   JCRB; JCRB1422
DR   Wikidata; Q54900841
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1422
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   KYSE-890
AC   CVCL_A103
SY   KYSE 890; KYSE890; KYSE0890
DR   cancercelllines; CVCL_A103
DR   CGH-DB; 294-1
DR   CGH-DB; 9243-4
DR   Cosmic; 918541
DR   Cosmic; 2698450
DR   GEO; GSM590312
DR   IARC_TP53; 7689
DR   JCRB; JCRB1643
DR   Wikidata; Q54900842
RX   PubMed=7913084;
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1643
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   KYSE-960
AC   CVCL_8512
SY   KYSE 960; KYSE960; KYSE0960
DR   CGH-DB; 295-1
DR   CGH-DB; 9244-4
DR   Cosmic; 918542
DR   Cosmic; 2698460
DR   GEO; GSM590313
DR   IARC_TP53; 23583
DR   JCRB; JCRB1417
DR   Wikidata; Q54900843
RX   PubMed=8575860;
RX   PubMed=9033652;
RX   PubMed=11092977;
RX   PubMed=11520067;
RX   PubMed=15172977;
RX   PubMed=16045545;
CC   Population: Japanese.
CC   Doubling time: ~30 hours (Note=Lot 10072016) (JCRB=JCRB1417).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8575860).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1417
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 10,11,12
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Kyu-BL
AC   CVCL_W938
SY   KYU-BL; KYU
DR   Wikidata; Q54900844
RX   PubMed=2824665;
RX   PubMed=2943927;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 10
//
ID   KZ-1
AC   CVCL_D6V9
SY   KZ-I
RX   PubMed=1721039;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   KZ-R
AC   CVCL_0I73
DR   CCLV; CCLV-RIE 0093
DR   Wikidata; Q54900845
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   L 101
AC   CVCL_J756
SY   L101; M-20
DR   CLO; CLO_0007149
DR   Wikidata; Q54900846
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8447.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   L 230
AC   CVCL_J017
SY   L230; L2-30; M-23
DR   CLO; CLO_0007177
DR   ATCC; HB-8448
DR   Wikidata; Q54900847
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8448.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   L 235
AC   CVCL_J018
SY   L235; M-19
DR   CLO; CLO_0007179
DR   Wikidata; Q54900848
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8446.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   L 660
AC   CVCL_IV20
SY   L-660; L660; IARC/L660
DR   Wikidata; Q54900849
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3905596;
RX   PubMed=6592381;
RX   PubMed=6957401;
RX   PubMed=7519050;
RX   PubMed=29533902;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 12
//
ID   L alpha
AC   CVCL_U992
DR   JCRB; JCRB0125
DR   JCRB; NIHS0189
DR   Wikidata; Q54900850
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Discontinued: JCRB; NIHS0189; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   L Cells (TK+, HBS Ag+)
AC   CVCL_8887
SY   Mouse L Cells (TK+, HBS Ag+); MOUSE L CELLS (TK+, HBS Ag+); MOUSE L CELLS (TK+,HBsAg+)
DR   CLO; CLO_0007837
DR   CLDB; cl3542
DR   ECACC; 90110101
DR   NCBI_Iran; C147
DR   Wikidata; Q54900851
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   L Wnt-3A
AC   CVCL_0635
SY   L-Wnt-3A; L-Wnt3A; LWnt3A; LWnt-3A
DR   BTO; BTO_0006037
DR   CLO; CLO_0007145
DR   AddexBio; S0011001/4919
DR   ATCC; CRL-2647
DR   BCRC; 60506
DR   CCRID; 3101MOUGNM27
DR   CCRID; 3101MOUSCSP522
DR   CLS; 305184
DR   Wikidata; Q54900852
RX   PubMed=12717451;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98956; Wnt3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   L Wnt-5A
AC   CVCL_0636
SY   L-Wnt-5a; L-Wnt5A; LWnt5A
DR   CLO; CLO_0007146
DR   ATCC; CRL-2814
DR   Wikidata; Q54900853
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98958; Wnt5a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   L-02
AC   CVCL_6926
SY   L02; LO2; HL-7702; HL7702; Liver-02; Human Liver-7702
DR   BTO; BTO_0005965
DR   ChEMBL-Cells; CHEMBL4295475
DR   ChEMBL-Targets; CHEMBL4296457
DR   GEO; GSM936770
DR   KCB; KCB 200511YJ
DR   PubChem_Cell_line; CVCL_6926
DR   TOKU-E; 3606
DR   Ubigene; YC-D004
DR   Wikidata; Q54900854
RX   PubMed=23498809;
RX   PubMed=23505090;
RX   PubMed=26116706;
RX   PubMed=26143199;
RX   PubMed=27027780;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Quora; -; https://www.quora.com/How-does-the-L-02-cell-line-compare-with-the-TAMH-cell-line-How-closely-do-these-two-cell-lines-resemble-actual-human-hepatocytes
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a normal fetal liver.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00575.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   L-1 [Bovine mammary gland]
AC   CVCL_HG39
DR   Wikidata; Q54900855
RX   PubMed=12418925;
CC   Derived from site: In situ; Mammary gland, udder; UBERON=UBERON_0013216.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_HG38 ! H-7
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
ID   L-1 [Human ovarian carcinoma]
AC   CVCL_S918
DR   Wikidata; Q54900856
RX   PubMed=2480932;
CC   Doubling time: 11.8 hours (PubMed=2480932).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   L-1062
AC   CVCL_M348
DR   cancercelllines; CVCL_M348
DR   Wikidata; Q54900857
RX   PubMed=16631476;
RX   PubMed=26428435;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=16631476).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Unspecified (PubMed=26428435).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   L-1091
AC   CVCL_W858
DR   Wikidata; Q54900858
RX   PubMed=3034807;
RX   PubMed=8704258;
RX   PubMed=9454894;
CC   Population: Japanese.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   L-1236
AC   CVCL_2096
AS   CVCL_5155
SY   L1236; L 1236
DR   CLO; CLO_0037179
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473524
DR   BioSample; SAMN10987806
DR   cancercelllines; CVCL_2096
DR   Cell_Model_Passport; SIDM00313
DR   Cosmic; 988702
DR   Cosmic; 1013908
DR   Cosmic; 1289701
DR   Cosmic; 1432037
DR   Cosmic; 2276328
DR   Cosmic; 2464306
DR   Cosmic-CLP; 1330935
DR   DepMap; ACH-000702
DR   DSMZ; ACC-530
DR   DSMZCellDive; ACC-530
DR   EGA; EGAS00001000978
DR   GDSC; 1330935
DR   GEO; GSM381297
DR   GEO; GSM499722
DR   GEO; GSM499730
DR   GEO; GSM552449
DR   GEO; GSM646531
DR   GEO; GSM646536
DR   GEO; GSM887257
DR   GEO; GSM888332
DR   GEO; GSM1670027
DR   IARC_TP53; 23617
DR   IGRhCellID; L1236
DR   LiGeA; CCLE_723
DR   LINCS_LDP; LCL-2010
DR   Lonza; 25
DR   PharmacoDB; L1236_813_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2096
DR   Wikidata; Q54900859
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8605360;
RX   PubMed=12865944;
RX   PubMed=17065008;
RX   PubMed=19380639;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (DSMZ=ACC-530).
CC   HLA typing: A*02:01,02:01; B*51:01,51:01; C*02:02,02:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,02:01:01; B*51:01:01,51:01:01; C*02:02:02,02:02:02; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:01,01:04:01; DQB1*05:03:01,05:03:01; DRA*01:01:01,01:01:01; DRB1*14:54:01,14:54:01 (DSMZCellDive=ACC-530).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11896; TNFAIP3; Zygosity=Heterozygous (PubMed=19380639).
CC   Sequence variation: Mutation; HGNC; HGNC:11896; TNFAIP3; Simple; p.Trp142Ter (c.425G>A) (G491A); ClinVar=VCV002577872; Zygosity=Heterozygous (PubMed=19380639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Fusion of Ex9 wiith an Alu-element; Zygosity=Unspecified (PubMed=17065008).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.96%; East Asian, South=0%; South Asian=0.15%; European, North=70.78%; European, South=27.1% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1330935; DSMZ=ACC-530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 13
ST   D16S539: 9,13
ST   D18S51: 15,19
ST   D19S433: 14,17
ST   D21S11: 27
ST   D2S1338: 18
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 10
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 40
//
ID   L-132
AC   CVCL_1908
SY   L132; L 132
DR   CLO; CLO_0007140
DR   CLO; CLO_0007158
DR   CLO; CLO_0007159
DR   CLDB; cl3076
DR   CLDB; cl3077
DR   CLDB; cl3078
DR   ATCC; CCL-5
DR   BCRJ; 0139
DR   BioSample; SAMN03151735
DR   ChEMBL-Cells; CHEMBL3307504
DR   ChEMBL-Targets; CHEMBL613999
DR   ECACC; 89111004
DR   IZSLER; BS CL 55
DR   JCRB; NIHS0050
DR   KCLB; 10005
DR   PubChem_Cell_line; CVCL_1908
DR   Wikidata; Q54900860
RX   CelloPub=CLPUB00071;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=5641128;
RX   PubMed=14185313;
RX   PubMed=20143388;
RX   PubMed=23925245;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to be a lung embryonic cell line.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00025.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Discontinued: JCRB; NIHS0050; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-5; ECACC=89111004; KCLB=10005
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (ATCC=CCL-5; KCLB=10005)
ST   D13S317: 12,14 (ECACC=89111004)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   L-14
AC   CVCL_J013
SY   L-14-SCRF 55.1; SCRF 55.1
DR   CLO; CLO_0007162
DR   ATCC; HB-8554
DR   Wikidata; Q54900861
RX   Patent=US4818678;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8554.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human cytomegalovirus immediate-early antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   L-2F7
AC   CVCL_C9FM
DR   Wikidata; Q123032875
RX   PubMed=36387215;
CC   Doubling time: 23.0 hours (PubMed=36387215).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from a patient suffering from cholecystitis.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
CC   Cell type: Epithelial cell of gallbladder; CL=CL_1000415.
ST   Source(s): PubMed=36387215
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18,26
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 14,22
ST   D19S433: 13,15
ST   D1S1656: 15,17
ST   D21S11: 29,31.2
ST   D2S1338: 19,21
ST   D3S1358: 16,18
ST   D5S818: 7,13
ST   D6S1043: 14,19
ST   D7S820: 10,11
ST   D8S1179: 11,17
ST   FGA: 18,23
ST   Penta D: 9,12
ST   Penta E: 5,11
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   L-2/M delta 2-3
AC   CVCL_Z260
SY   L-2.M.delta2-3; MTdelta2-3
DR   CLO; CLO_0007171
DR   FlyBase_Cell_line; FBtc9000041
DR   Wikidata; Q54900863
RX   PubMed=2553268;
CC   Group: Insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10191.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0013311; P\T.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   L-363
AC   CVCL_1357
SY   L 363; L363
DR   BTO; BTO_0003308
DR   CLO; CLO_0007186
DR   EFO; EFO_0006450
DR   CLDB; cl3080
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ArrayExpress; E-TABM-937
DR   BioGRID_ORCS_Cell_line; 923
DR   BioSample; SAMN03472932
DR   BioSample; SAMN10988577
DR   cancercelllines; CVCL_1357
DR   Cell_Model_Passport; SIDM00312
DR   CGH-DB; 9157-4
DR   ChEMBL-Cells; CHEMBL3308205
DR   ChEMBL-Targets; CHEMBL2366267
DR   Cosmic; 720779
DR   Cosmic; 924239
DR   Cosmic; 1889517
DR   Cosmic; 2081396
DR   Cosmic; 2367279
DR   Cosmic; 2809755
DR   Cosmic-CLP; 924239
DR   DepMap; ACH-000183
DR   DSMZ; ACC-49
DR   DSMZCellDive; ACC-49
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002414
DR   EGA; EGAS00001002554
DR   GDSC; 924239
DR   GEO; GSM887259
DR   GEO; GSM888334
DR   GEO; GSM1374615
DR   GEO; GSM1670028
DR   IARC_TP53; 27175
DR   LiGeA; CCLE_630
DR   LINCS_LDP; LCL-2045
DR   Lonza; 1421
DR   PharmacoDB; L363_814_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1357
DR   PubChem_Cell_line; CVCL_1357
DR   Wikidata; Q54900864
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=207377;
RX   PubMed=2537114;
RX   PubMed=10087940;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=15215163;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=20164919;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=23074853;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 65-75 hours (PubMed=207377); 25 hours (PubMed=25984343); ~25 hours (DSMZ=ACC-49).
CC   HLA typing: A*02:01,31; B*07,40:01; C*03:02/04,07 (Direct_author_submission).
CC   HLA typing: A*02:01,31:01; B*07:02,40:01; C*03:04,07:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,31:01:02; B*07:02:01,40:01:02; C*03:04:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:02:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:02:01; DRA*01:01:01,01:02:03; DRB1*04:04:01,15:01:01 (DSMZCellDive=ACC-49).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (PubMed=11157491; PubMed=21173094; Cosmic-CLP=924239; DepMap=ACH-000183).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=924239; DepMap=ACH-000183).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser261Thr (c.782G>C); ClinVar=VCV000187005; Zygosity=Homozygous (Cosmic-CLP=924239; DepMap=ACH-000183).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.73%; Native American=0.14%; East Asian, North=1.89%; East Asian, South=0%; South Asian=0%; European, North=70.35%; European, South=26.89% (PubMed=30894373).
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=924239; DSMZ=ACC-49; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 30,32.2
ST   D2S1338: 18,26
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 19,22
ST   Penta D: 9,13
ST   Penta E: 13,16
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN08 ! L-363 + EBV
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   L-363 + EBV
AC   CVCL_LN08
SY   L 363 + EBV
DR   Wikidata; Q54900865
RX   PubMed=207377;
CC   Population: Caucasian.
CC   Doubling time: 46-50 hours (PubMed=207377).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1357 ! L-363
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 7
//
ID   L-41
AC   CVCL_7170
DR   BioSample; SAMN03151736
DR   ECACC; 96121716
DR   Wikidata; Q54900866
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (J-96) has been shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00327.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3990 ! J-96
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   L-428
AC   CVCL_1361
SY   L 428; L428
DR   BTO; BTO_0000406
DR   CLO; CLO_0007189
DR   EFO; EFO_0002225
DR   CLDB; cl3081
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473371
DR   BioSample; SAMN10988569
DR   cancercelllines; CVCL_1361
DR   Cell_Model_Passport; SIDM00327
DR   ChEMBL-Cells; CHEMBL3308873
DR   ChEMBL-Targets; CHEMBL2366233
DR   CLS; 300200
DR   Cosmic; 850218
DR   Cosmic; 907322
DR   Cosmic; 988703
DR   Cosmic; 1013907
DR   Cosmic; 1086358
DR   Cosmic; 1278830
DR   Cosmic; 1289698
DR   Cosmic; 1432036
DR   Cosmic; 1714161
DR   Cosmic; 2276326
DR   Cosmic; 2361389
DR   Cosmic; 2464304
DR   Cosmic; 2804876
DR   Cosmic-CLP; 907322
DR   DepMap; ACH-000754
DR   DSMZ; ACC-197
DR   DSMZCellDive; ACC-197
DR   EGA; EGAS00001000978
DR   GDSC; 907322
DR   GEO; GSM499721
DR   GEO; GSM499729
DR   GEO; GSM552447
DR   GEO; GSM637988
DR   GEO; GSM887260
DR   GEO; GSM888335
DR   GEO; GSM1670029
DR   IARC_TP53; 21455
DR   IARC_TP53; 23612
DR   IGRhCellID; L428
DR   LiGeA; CCLE_448
DR   LINCS_LDP; LCL-2011
DR   Lonza; 924
DR   PharmacoDB; L428_815_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1361
DR   PubChem_Cell_line; CVCL_1361
DR   Wikidata; Q54900867
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=2898211;
RX   PubMed=3713248;
RX   PubMed=6303739;
RX   PubMed=6305805;
RX   PubMed=7216541;
RX   PubMed=7276066;
RX   PubMed=8547074;
RX   PubMed=8558920;
RX   PubMed=9685479;
RX   PubMed=9787181;
RX   PubMed=11021758;
RX   PubMed=12133989;
RX   PubMed=17065008;
RX   PubMed=19380639;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25894527;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 42-46 hours (PubMed=7216541); ~35 hours (DSMZ=ACC-197).
CC   HLA typing: A*03:01; B*35:03; C*04:01/03/05/07; DQB1*03:01/09; DRB1*12:01/06; DRB3*02 (PubMed=12133989).
CC   HLA typing: A*03:01,03:01; B*35:03,35:03; C*04:01,04:01; DQA1*05:01,05:01; DQB1*03:01,03:01; DRB1*03:17,12:01 (PubMed=26589293).
CC   HLA typing: A*03:01:01,03:01:01; B*35:03:01,35:03:01; C*04:01:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:01; DRA*01:02:02,01:02:02; DRB1*12:01:01,12:01:01 (DSMZCellDive=ACC-197).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11896; TNFAIP3; Zygosity=Heterozygous (PubMed=19380639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly112_Val122del11 (c.334_366del33); Zygosity=Heterozygous (PubMed=17065008; Cosmic-CLP=907322).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.16%; Native American=0%; East Asian, North=3.23%; East Asian, South=0%; South Asian=0%; European, North=65.81%; European, South=28.79% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=907322; DSMZ=ACC-197
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 14
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 17,19
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 19,25,26
ST   Penta D: 8,9
ST   Penta E: 10,17
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   L-428 KS
AC   CVCL_X206
SY   L 428 KS; L428 KS; L428KS
DR   Wikidata; Q54900868
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=6303739;
CC   Population: Caucasian.
CC   Characteristics: Adapted to growth in calf serum (PubMed=2690233; PubMed=6303739).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly112_Val122del11 (c.334_366del33); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1361 ! L-428
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 14
//
ID   L-428 KSA
AC   CVCL_X207
SY   L 428 KSA; L428 KSA
DR   Wikidata; Q54900869
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=6303739;
CC   Population: Caucasian.
CC   Characteristics: Adapted to growth in calf serum and adherent (PubMed=2690233; PubMed=6303739).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly112_Val122del11 (c.334_366del33); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X206 ! L-428 KS
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
ID   L-439
AC   CVCL_M699
SY   L 439; L439
DR   Wikidata; Q54900870
RX   PubMed=6305805;
RX   PubMed=7216541;
RX   PubMed=7276066;
RX   PubMed=29533902;
CC   Doubling time: 48-72 hours (PubMed=7216541).
CC   Miscellaneous: Cell line has been lost (PubMed=7216541; PubMed=6305805).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   L-5178-Y
AC   CVCL_2097
SY   L5178Y; LY
DR   BTO; BTO_0000795
DR   CLO; CLO_0007195
DR   CLO; CLO_0050168
DR   CLDB; cl3133
DR   ArrayExpress; E-TOXM-1
DR   ArrayExpress; E-TOXM-2
DR   ArrayExpress; E-TOXM-3
DR   ArrayExpress; E-TOXM-4
DR   ArrayExpress; E-TOXM-5
DR   ArrayExpress; E-TOXM-6
DR   ArrayExpress; E-TOXM-7
DR   ArrayExpress; E-TOXM-8
DR   ArrayExpress; E-TOXM-9
DR   ChEMBL-Cells; CHEMBL3307690
DR   ChEMBL-Targets; CHEMBL614720
DR   DSMZ; ACC-320
DR   DSMZCellDive; ACC-320
DR   ECACC; 87111908
DR   JCRB; JCRB0709
DR   Lonza; 1262
DR   PubChem_Cell_line; CVCL_2097
DR   RCB; RCB0135
DR   Wikidata; Q54900871
RX   PubMed=221956;
RX   PubMed=4321087;
RX   PubMed=6173370;
RX   PubMed=6413855;
RX   PubMed=6724617;
RX   PubMed=7565900;
RX   PubMed=15033590;
CC   Doubling time: 14.1 +- 1.6 hours (PubMed=221956); 11.3 hours (PubMed=6173370); ~20 hours (DSMZ=ACC-320); 10 hours (Note=Lot 07032005) (JCRB=JCRB0709).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   L-5178-Y-R
AC   CVCL_4234
SY   L5178Y-R; L5178YR; L5178-R; LY-R; LYR
DR   CLO; CLO_0007193
DR   CLO; CLO_0007197
DR   CLDB; cl3135
DR   ATCC; CRL-1722
DR   CLS; 400258
DR   ECACC; 90062802
DR   KCLB; 21722
DR   Wikidata; Q54900872
RX   PubMed=3012566;
RX   PubMed=3876312;
RX   PubMed=6883332;
CC   Characteristics: Resistant to X-rays, but sensitive to ultraviolet radiation.
CC   Doubling time: ~12-15 hours (PubMed=6883332).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   L-5178-Y-S
AC   CVCL_4235
SY   L5178Y-S; L5178YS; L5178-S; LY-S
DR   CLO; CLO_0007194
DR   CLO; CLO_0007198
DR   CLDB; cl3137
DR   ATCC; CRL-1723
DR   ECACC; 93050408
DR   KCLB; 21723
DR   RCB; RCB2636
DR   TKG; TKG 0576
DR   Wikidata; Q54900873
RX   PubMed=3012566;
RX   PubMed=3876312;
RX   PubMed=6883332;
CC   Characteristics: Compared to the parent cell line, this cell line is sensitive to X-rays.
CC   Doubling time: 10 hours (PubMed=6883332).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: RCB; RCB2636; true.
CC   Discontinued: TKG; TKG 0576; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4234 ! L-5178-Y-R
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   L-5222
AC   CVCL_5787
SY   L 5222; L5222
DR   CLS; 500259
DR   Wikidata; Q54900874
RX   PubMed=4616492;
CC   Discontinued: CLS; 500259; true.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   L-538
AC   CVCL_M700
SY   L 538; L538
DR   Wikidata; Q54900875
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=6303739;
RX   PubMed=6305805;
RX   PubMed=7276066;
RX   PubMed=29533902;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1362 ! L-540
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   L-540
AC   CVCL_1362
SY   L 540; L540
DR   BTO; BTO_0005176
DR   CLO; CLO_0007201
DR   EFO; EFO_0022416
DR   CLDB; cl455
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473399
DR   BioSample; SAMN10988507
DR   cancercelllines; CVCL_1362
DR   Cell_Model_Passport; SIDM00329
DR   ChEMBL-Cells; CHEMBL3308531
DR   ChEMBL-Targets; CHEMBL2366153
DR   CLS; 300201
DR   Cosmic; 907323
DR   Cosmic; 988705
DR   Cosmic; 1013911
DR   Cosmic; 1086359
DR   Cosmic; 1432039
DR   Cosmic; 2276327
DR   Cosmic; 2464307
DR   Cosmic-CLP; 907323
DR   DepMap; ACH-000806
DR   DSMZ; ACC-72
DR   DSMZCellDive; ACC-72
DR   EGA; EGAS00001000978
DR   GDSC; 907323
DR   GEO; GSM335392
DR   GEO; GSM499725
DR   GEO; GSM499726
DR   GEO; GSM552448
DR   GEO; GSM646532
DR   GEO; GSM646535
DR   GEO; GSM887261
DR   GEO; GSM888336
DR   GEO; GSM1670030
DR   IARC_TP53; 21456
DR   IARC_TP53; 23615
DR   LiGeA; CCLE_220
DR   LINCS_LDP; LCL-2012
DR   PharmacoDB; L540_816_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1362
DR   PubChem_Cell_line; CVCL_1362
DR   Wikidata; Q54900876
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=6303739;
RX   PubMed=6305805;
RX   PubMed=7276066;
RX   PubMed=7530238;
RX   PubMed=8558920;
RX   PubMed=11021758;
RX   PubMed=12581897;
RX   PubMed=17065008;
RX   PubMed=20164919;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25894527;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~70 hours (DSMZ=ACC-72).
CC   HLA typing: A*03:01,11:01; B*51:01,51:01; C*02:02,15:02; DQA1*03:02,05:01; DQB1*03:03,03:03; DRB1*04:04,11:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.11%; East Asian, South=0.61%; South Asian=0.05%; European, North=70.77%; European, South=27.46% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=907323; DSMZ=ACC-72
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 11,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 20,21
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 9,10
ST   vWA: 17,18
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M700 ! L-538
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   L-591
AC   CVCL_1867
SY   L 591; L591
DR   BioSample; SAMN03473498
DR   CLS; 300202
DR   Cosmic; 1289697
DR   Cosmic; 1432038
DR   Cosmic; 2464305
DR   DSMZ; ACC-602
DR   DSMZCellDive; ACC-602
DR   IARC_TP53; 23614
DR   Wikidata; Q54900877
RX   PubMed=2690233;
RX   PubMed=6303739;
RX   PubMed=6305805;
RX   PubMed=12437638;
RX   PubMed=17065008;
RX   PubMed=19380639;
RX   PubMed=20454443;
RX   PubMed=25787276;
RX   PubMed=28196595;
RX   PubMed=29533902;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Contains a complete EBV genome (strain L591) which has been sequenced (PubMed=25787276).
CC   Doubling time: ~72 hours (DSMZ=ACC-602).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-602
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 7,13
ST   D16S539: 9,12
ST   D18S51: 12,19
ST   D19S433: 12,16
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   D8S1179: 12,13
ST   FGA: 21,26
ST   Penta D: 10,12
ST   Penta E: 12,15
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,21
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   L-68
AC   CVCL_8888
DR   CLO; CLO_0007209
DR   ECACC; 97050223
DR   Wikidata; Q54900878
RX   PubMed=3824526;
CC   Discontinued: ECACC; 97050223; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   11FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   L-82
AC   CVCL_2098
SY   L82
DR   BioSample; SAMN03473494
DR   cancercelllines; CVCL_2098
DR   Cell_Model_Passport; SIDM01392
DR   DepMap; ACH-001111
DR   DSMZ; ACC-597
DR   DSMZCellDive; ACC-597
DR   GEO; GSM1217154
DR   GEO; GSM3021103
DR   Progenetix; CVCL_2098
DR   Wikidata; Q54900879
RX   PubMed=11908723;
RX   PubMed=15356658;
RX   PubMed=29899875;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~40 hours (DSMZ=ACC-597).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=29899875).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-597
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D19S433: 12,14
ST   D21S11: 31.2,33.2
ST   D2S1338: 22,25
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 19,27
ST   Penta D: 10,11
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   L-872
AC   CVCL_M347
DR   cancercelllines; CVCL_M347
DR   Wikidata; Q54900882
RX   PubMed=16631476;
RX   PubMed=26428435;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=16631476).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Unspecified (PubMed=26428435).
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   L-8A
AC   CVCL_CW08
DR   ATCC; CRL-6363
DR   Wikidata; Q54900883
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6363; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   L-929 D
AC   CVCL_IW04
DR   Wikidata; Q54900884
RX   PubMed=823777;
CC   Doubling time: 20.8 hours (PubMed=823777).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   L-929 E
AC   CVCL_IW05
DR   Wikidata; Q54900885
RX   PubMed=823777;
CC   Doubling time: 22.9 hours (PubMed=823777).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   L-929 F
AC   CVCL_IW06
DR   Wikidata; Q54900886
RX   PubMed=823777;
CC   Doubling time: 24.9 hours (PubMed=823777).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   L-929 HH
AC   CVCL_IW07
DR   Wikidata; Q54900887
RX   PubMed=823777;
CC   Doubling time: 23.4 hours (PubMed=823777).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   L-alpha-1a L-cells
AC   CVCL_9111
DR   CLO; CLO_0007235
DR   ATCC; CRL-11138
DR   Wikidata; Q54900888
RX   Patent=US5780485;
RX   Patent=US6075038;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11138.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:280; ADRA1D.
CC   Discontinued: ATCC; CRL-11138; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   L-alpha-1b L-cells
AC   CVCL_9110
SY   L-a-1b
DR   CLO; CLO_0007436
DR   ATCC; CRL-11139
DR   Wikidata; Q54900889
RX   Patent=US5780485;
RX   Patent=US6075038;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11139.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:278; ADRA1B.
CC   Discontinued: ATCC; CRL-11139; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   L-alpha-1c L-cells
AC   CVCL_DD01
DR   Wikidata; Q54900890
RX   Patent=US5780485;
RX   Patent=US6075038;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11140.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:277; ADRA1A.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   L-alpha-2A L-cells
AC   CVCL_9112
DR   CLO; CLO_0007236
DR   ATCC; CRL-11180
DR   Wikidata; Q54900891
RX   Patent=US5780485;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11180.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:281; ADRA2A.
CC   Discontinued: ATCC; CRL-11180; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   L-alpha-2C L-cells
AC   CVCL_9113
DR   CLO; CLO_0007237
DR   ATCC; CRL-11181
DR   Wikidata; Q54900892
RX   Patent=US5780485;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11181.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:283; ADRA2C.
CC   Discontinued: ATCC; CRL-11181; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   L-ASK
AC   CVCL_D3ZU
DR   Wikidata; Q127382579
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   13Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   L-B7
AC   CVCL_V089
DR   CLO; CLO_0007264
DR   CLDB; cl3083
DR   IHW; 11w 8023
DR   Wikidata; Q54900893
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L-bFGF-5
AC   CVCL_A9DW
DR   CCRID; 4201PAT-CCTCC00013
DR   Wikidata; Q108820641
RX   Patent=EP0237966A2;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50092.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3676; FGF2.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   L-BGH-4-3
AC   CVCL_F0TU
RX   Patent=US4686098;
RX   PubMed=2982557;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8537.
CC   Characteristics: Co-transfected with pBGH-4 plasmid that contains bovine GH1 under the control of the RSV LTR and pTK with HSV-1 TK (PubMed=2982557).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01246; Bovine GH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0P16 ! L-M(TK-,APRT-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   L-BGH-4-5
AC   CVCL_F0TV
RX   PubMed=2982557;
CC   Characteristics: Co-transfected with pBGH-4 plasmid that contains bovine GH1 under the control of the RSV LTR and pTK with HSV-1 TK (PubMed=2982557).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01246; Bovine GH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0P16 ! L-M(TK-,APRT-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   L-bFGF-6
AC   CVCL_A9DX
DR   Wikidata; Q108820642
RX   Patent=EP0237966A2;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3676; FGF2.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   L-DQw1-Dw12
AC   CVCL_V090
DR   CLO; CLO_0007288
DR   CLDB; cl3085
DR   IHW; 11w 8201
DR   Wikidata; Q54900894
RX   PubMed=1429033;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   L-DQw4-Dw15
AC   CVCL_V091
DR   CLO; CLO_0007289
DR   CLDB; cl3086
DR   IHW; 11w 8206
DR   Wikidata; Q54900895
RX   PubMed=1429033;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   L-DR2-Dw12
AC   CVCL_V092
DR   CLO; CLO_0007293
DR   CLDB; cl3087
DR   IHW; 11w 8110
DR   Wikidata; Q54900896
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L-DR4-Dw15
AC   CVCL_V093
DR   CLO; CLO_0007294
DR   CLDB; cl3088
DR   IHW; 11w 8120
DR   Wikidata; Q54900897
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L-DRw53-Dw15
AC   CVCL_V094
DR   CLO; CLO_0007299
DR   CLDB; cl3091
DR   IHW; 11w 8137
DR   Wikidata; Q54900898
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L-G
AC   CVCL_WX25
DR   Wikidata; Q95980670
RX   PubMed=1708811;
CC   Characteristics: Can differentiate into neutrophils in the presence of CSF3.
CC   Characteristics: IL3 or CSF3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5433 ! LyD9
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   L-GM
AC   CVCL_WX26
DR   Wikidata; Q95980671
RX   PubMed=1708811;
RX   PubMed=8246993;
CC   Characteristics: Can differentiate into macrophages and granulocytes in the presence of CSF2.
CC   Characteristics: IL3 or CSF2 dependent.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5433 ! LyD9
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   L-HIRO
AC   CVCL_UI52
DR   Wikidata; Q95980673
RX   PubMed=8558913;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 6
//
ID   L-HSO2
AC   CVCL_V095
DR   CLO; CLO_0007313
DR   CLDB; cl3093
DR   IHW; 11w 8043
DR   Wikidata; Q54900899
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L-IS11 IgE-9
AC   CVCL_A9EA
DR   Wikidata; Q108820643
RX   Patent=US4935352;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50056.
CC   Characteristics: Transfected with an IgE expression vector having the IL-2 leader sequence (Patent=US4935352).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4535 ! L-M
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   L-KAW
AC   CVCL_A639
DR   cancercelllines; CVCL_A639
DR   Cosmic; 721709
DR   Cosmic; 1375585
DR   IARC_TP53; 10571
DR   Wikidata; Q54900900
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7543637;
RX   PubMed=8558913;
RX   PubMed=10071127;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=7543637).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Hemizygous (PubMed=10071127).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   L-KAZ
AC   CVCL_UI53
DR   Wikidata; Q95980674
RX   PubMed=8558913;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 6
//
ID   L-KUM
AC   CVCL_UI54
DR   Wikidata; Q95980675
RX   PubMed=8558913;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   13Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 7
//
ID   L-M
AC   CVCL_4535
SY   LM from NCTC clone 929; LM; L-M 929; LM-929; LM929
DR   CLO; CLO_0007336
DR   CLO; CLO_0007351
DR   EFO; EFO_0022726
DR   CLDB; cl3094
DR   CLDB; cl3095
DR   ATCC; CCL-1.2
DR   BCRC; 60405
DR   ECACC; 87032401
DR   IZSLER; BS CL 59
DR   KCLB; 10001.2
DR   Wikidata; Q54900901
RX   DOI=10.1007/BF02618370;
RX   PubMed=8125155;
RX   PubMed=14033129;
RX   PubMed=14033130;
RX   PubMed=14056989;
RX   PubMed=14185313;
RX   PubMed=14472756;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=L-M
CC   Group: Serum/protein free medium cell line.
CC   Group: Space-flown cell line (cellonaut).
CC   Anecdotal: Have been flown in space on shuttle flights STS-50 (USML-1), STS-54 and STS-57 (Spacehab-1) to study TNF-mediated cytotoxicity in microgravity (PubMed=8125155).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   L-M(BU-25)
AC   CVCL_DE17
SY   L-M (BU-25); LM BU25
DR   Wikidata; Q54900902
RX   PubMed=14033130;
RX   PubMed=14056989;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4535 ! L-M
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   L-M(TK-)
AC   CVCL_4536
AS   CVCL_0634
SY   L-M[TK-]; LM TK negative; L-M (TK-); L M (TK-); LM(TK-); LM(tk-); LM-TK-; LMTK-; L cells (TK-); L(TK-); L(tk-)
DR   CLO; CLO_0007138
DR   CLO; CLO_0007337
DR   CLO; CLO_0007352
DR   CLO; CLO_0007353
DR   CLDB; cl3075
DR   CLDB; cl3096
DR   CLDB; cl3097
DR   CLDB; cl3098
DR   ATCC; CCL-1.3
DR   ATCC; CRL-2648
DR   BCRC; 60072
DR   BCRJ; 0148
DR   CCRID; 1102MOU-NIFDC00044
DR   CCRID; 4201MOU-CCTCC00002
DR   CCTCC; GDC0002
DR   CLS; 305176
DR   ECACC; 90083001
DR   IZSLER; BS CL 60
DR   TOKU-E; 2213
DR   TOKU-E; 3995
DR   Wikidata; Q54900903
RX   PubMed=14056989;
RX   PubMed=14109133;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-49.html
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Discontinued: BCRJ; 0148; probable.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DE17 ! L-M(BU-25)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   L-M(TK-)1D
AC   CVCL_F739
SY   L M (TK-) 1D; LM (TK-) 1D; LM(TK-)1D; L-M(TK-) clone 1D; LM(TK(-)) Cl 1D; TK-LM clone 1D; L cl 1D; Cl 1D; Cl1D; Clone 1D; GM12516
DR   CLO; CLO_0009359
DR   CLO; CLO_0017849
DR   CLDB; cl4518
DR   Coriell; GM12516
DR   JCRB; JCRB0722
DR   Wikidata; Q54900904
RX   PubMed=14109133;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   L-M(TK-,APRT-)
AC   CVCL_0P16
SY   TK- APRT- L cells
DR   CLO; CLO_0007354
DR   CLDB; cl3099
DR   Wikidata; Q54900905
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 10
//
ID   L-MAT
AC   CVCL_A640
DR   Cosmic; 721717
DR   Cosmic; 1375580
DR   IARC_TP53; 10572
DR   Wikidata; Q54900906
RX   PubMed=8558913;
RX   PubMed=10071127;
RX   PubMed=15691325;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Glufs*51 (c.586delC); Zygosity=Unspecified (PubMed=10071127).
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   L-MEG
AC   CVCL_UI55
DR   Wikidata; Q95980700
RX   PubMed=8558913;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   L-NGC-5HT2 L-cells
AC   CVCL_6498
SY   L-NGC-5HT2
DR   CLO; CLO_0007368
DR   ATCC; CRL-10287
DR   Wikidata; Q54900908
RX   Patent=US5780485;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10287.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5293; HTR2A.
CC   Discontinued: ATCC; CRL-10287; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   L-NGC-alpha2B L-cells
AC   CVCL_9114
DR   CLO; CLO_0007369
DR   ATCC; CRL-10275
DR   Wikidata; Q54900909
RX   Patent=US5780485;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10275.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:282; ADRA2B.
CC   Discontinued: ATCC; CRL-10275; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   L-OL
AC   CVCL_WH00
DR   Wikidata; Q95980706
RX   PubMed=4576460;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WG98 ! ICI 106
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   L-PdL-BGH4-13
AC   CVCL_F0TW
SY   L-Pdlambda-BGH4-13; L-BGH-4-13
RX   Patent=US4686098;
RX   PubMed=2982557;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8536.
CC   Characteristics: Secrete bovine GH1 at a rate of 75 muG per 5 x 10^6 cells per 24 hours. Co-transfected with pBGH-4 plasmid that contains bovine GH1 under the control of the RSV LTR and pDlambdaAT-3 that contains hamster Aprt and HSV-1 TK (PubMed=2982557).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01246; Bovine GH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P47952; Cricetulus griseus Aprt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0P16 ! L-M(TK-,APRT-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   L-SAK
AC   CVCL_A641
DR   cancercelllines; CVCL_A641
DR   Cosmic; 721718
DR   Cosmic; 998733
DR   Cosmic; 1037691
DR   Cosmic; 1375593
DR   IARC_TP53; 10573
DR   Wikidata; Q54900910
RX   PubMed=8558913;
RX   PubMed=10071127;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Hemizygous (PubMed=10071127).
CC   Misspelling: L-SMK; Cosmic=998733; PubMed=10233379.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   L-SMY
AC   CVCL_A642
DR   Cosmic; 721713
DR   Cosmic; 998734
DR   Cosmic; 1037692
DR   Wikidata; Q54900911
RX   PubMed=10071127;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   L-STS
AC   CVCL_L297
SY   LSTS
DR   cancercelllines; CVCL_L297
DR   GEO; GSM966944
DR   Progenetix; CVCL_L297
DR   Wikidata; Q54900912
RX   PubMed=19528452;
RX   PubMed=29444910;
RX   PubMed=31548718;
CC   Problematic cell line: Misclassified. Originally thought to arise from a metastatic carcinoid of the terminal ileum but shown to be an EBV-transformed lymphoblastoid cell line (PubMed=29444910; PubMed=31548718).
CC   Doubling time: ~2 days (PubMed=19528452).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=29444910
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13,14
ST   D16S539: 12,13
ST   D21S11: 28,29,30
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9,9.3
ST   TPOX: 8
ST   vWA: 14,17,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L296 ! H-STS
OI   CVCL_L298 ! P-STS
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   L-WR
AC   CVCL_DA05
SY   L-Wnt3a/R-spondin
DR   Wikidata; Q54900913
RX   PubMed=24232249;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1920030; Rspo3.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98956; Wnt3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0635 ! L Wnt-3A
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   L-WRN
AC   CVCL_DA06
SY   L-Wnt3a/R-spondin/Noggin
DR   AddexBio; S0011002/4939
DR   ATCC; CRL-3276
DR   CLS; 300641
DR   Wikidata; Q54900914
RX   PubMed=24232249;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104327; Nog.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1920030; Rspo3.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98956; Wnt3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
ST   Source(s): CLS=300641
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 17,19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25,26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15,16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 24.3,25.3
ST   Mouse STR 17-2: 14,15
ST   Mouse STR 18-3: 15,16
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0635 ! L Wnt-3A
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   L. J.
AC   CVCL_C8NS
DR   Wikidata; Q123032877
RX   PubMed=1374683;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   L.14
AC   CVCL_5U28
SY   L-14; L14; Line 14
DR   Wikidata; Q54900862
RX   DOI=10.1016/B978-0-12-249920-3.50038-7;
RX   PubMed=2408903;
RX   PubMed=2523424;
RX   PubMed=3100639;
CC   Characteristics: IL2 dependent.
CC   Characteristics: Recognizes the terpolymer Glu60-Ala30-Tyr10, known as GAT.
CC   Cell type: Helper T-cell; CL=CL_0000912.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   L.17
AC   CVCL_D6UC
RX   PubMed=6332057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Chicken bursa and thymus-derived lymphocytes 210/180 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L.22
AC   CVCL_D6UD
SY   L22
RX   PubMed=3499381;
RX   PubMed=6332057;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q90746; Chicken Bu-1a alloantigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L.43
AC   CVCL_D6UE
RX   PubMed=6332057;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Chicken antigen on B cells, macrophages and fibroblasts 23 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   L.N. 4159
AC   CVCL_6414
DR   CLO; CLO_0007147
DR   ATCC; CRL-10998
DR   Wikidata; Q54900918
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10998.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-10998; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   L.P3
AC   CVCL_U990
SY   L P3
DR   CLO; CLO_0050231
DR   JCRB; JCRB0648
DR   RCB; RCB0101
DR   Wikidata; Q54900919
RX   DOI=10.11418/jtca1981.10.2_23;
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=978597;
RX   PubMed=2993257;
RX   PubMed=3242846;
RX   PubMed=4328993;
RX   PubMed=4560675;
RX   PubMed=5452761;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   L.P3 Co-2
AC   CVCL_WI40
DR   Wikidata; Q95980728
RX   PubMed=4560675;
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U990 ! L.P3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   L.P3 Co-3
AC   CVCL_WH72
DR   Wikidata; Q95980731
RX   DOI=10.1247/csf.5.315;
RX   PubMed=171466;
RX   PubMed=978597;
RX   PubMed=4560675;
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U990 ! L.P3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   L.P3 Q-2
AC   CVCL_WI41
DR   Wikidata; Q95980732
RX   PubMed=4560675;
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U990 ! L.P3
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   L.P3 Q-3
AC   CVCL_WI42
DR   Wikidata; Q95980733
RX   PubMed=4560675;
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U990 ! L.P3
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   L.P3(S)
AC   CVCL_U991
DR   JCRB; JCRB0605
DR   Wikidata; Q54900920
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U990 ! L.P3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   L.P3.31
AC   CVCL_WH79
DR   Wikidata; Q95980737
RX   DOI=10.11418/jtca1981.10.2_23;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Proliferates at 31 Celsius.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U990 ! L.P3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   L.R.
AC   CVCL_U239
DR   ATCC; CRL-6307
DR   Wikidata; Q54900921
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6307; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30588; ! Leontopithecus rosalia (Golden lion tamarin)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   L/1C2
AC   CVCL_V649
DR   CCRID; 4201PAT-CCTCC00039
DR   Wikidata; Q54900915
RX   Patent=US5171666;
RX   PubMed=2654003;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9682.
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   L/neo
AC   CVCL_V096
DR   CLO; CLO_0007148
DR   CLDB; cl3106
DR   IHW; 11w 8400
DR   Wikidata; Q54900917
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   L0301
AC   CVCL_1F89
SY   LO301
DR   Wikidata; Q54900922
RX   DOI=10.2482/haigan.32.223;
RX   PubMed=1484432;
CC   Population: Japanese.
CC   Doubling time: 201 hours (DOI=10.2482/haigan.32.223).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   L0301/CDDP
AC   CVCL_1F90
DR   Wikidata; Q54900923
RX   DOI=10.2482/haigan.32.223;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1F89 ! L0301
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 8
//
ID   L1
AC   CVCL_D7AV
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L1-1GC1
AC   CVCL_W595
DR   Wikidata; Q54900926
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By ZFN (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W597 ! L1-1Mut
SX   Female
AG   53-55Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L1-1GC2
AC   CVCL_W596
DR   SKIP; SKIP000293
DR   Wikidata; Q54900927
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By ZFN (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W597 ! L1-1Mut
SX   Female
AG   53-55Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L1-1Mut
AC   CVCL_W597
SY   T4; MPIi002-A
DR   BioSamples; SAMEA104382070
DR   hPSCreg; MPIi002-A
DR   SKIP; SKIP000290
DR   Wikidata; Q54900928
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W599 ! L1-2Mut
SX   Female
AG   53-55Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L1-2
AC   CVCL_9576
SY   L1.2
DR   ChEMBL-Cells; CHEMBL3307981
DR   ChEMBL-Targets; CHEMBL612572
DR   Lonza; 24
DR   PubChem_Cell_line; CVCL_9576
DR   TOKU-E; 4087
DR   Wikidata; Q54900933
RX   PubMed=6297724;
WW   Provider; Tufts TTIC; T000710; https://web.archive.org/web/20150225055738/http://www.tufts.biz/cgi-bin/tech_search.cgi?r=1&case=T000710
CC   From: Rosenberg, Naomi E.; Tufts University; Boston; USA.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: C57L.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   L1-2 FPR
AC   CVCL_E4JG
DR   ABM; T8297
RX   PubMed=7511663;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3826; FPR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: C57L.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9576 ! L1-2
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   L1-2/pMRB101
AC   CVCL_E4JH
SY   L1-2/vector; L1-2 vector cells
RX   PubMed=1374233;
RX   PubMed=1712790;
RX   PubMed=1714447;
CC   Characteristics: Control cell line for L1-2/pMRB107 (Cellosaurus=CVCL_E4JI) and L1-2/pMRB112 (Cellosaurus=CVCL_E4JJ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: C57L.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9576 ! L1-2
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   L1-2/pMRB107
AC   CVCL_E4JI
SY   L1-2(ELAM-1); L1-2(E-selectin)
RX   PubMed=1374233;
RX   PubMed=1714447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10718; SELE.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: C57L.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9576 ! L1-2
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   L1-2/pMRB112
AC   CVCL_E4JJ
SY   L1-2(LECAM-1); L1-2(L-selectin)
RX   PubMed=1374233;
RX   PubMed=1712790;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98279; Sell.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: C57L.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9576 ! L1-2
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   L1-2GC
AC   CVCL_W598
DR   Wikidata; Q54900929
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By ZFN (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W599 ! L1-2Mut
SX   Female
AG   53-55Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L1-2Mut
AC   CVCL_W599
DR   SKIP; SKIP000292
DR   Wikidata; Q54900930
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W597 ! L1-1Mut
SX   Female
AG   53-55Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L1-C4
AC   CVCL_WV80
SY   L1-iPSCs
DR   Wikidata; Q95980747
RX   PubMed=31226583;
CC   From: Peking University; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.605-2A>G; ClinVar=VCV001342708; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31226583).
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly272Asp (c.815G>A) (p.Gly145Asp, c.434G>A); ClinVar=VCV000053109; Zygosity=Heterozygous (PubMed=31226583).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV81 ! L1-C5
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   L1-C5
AC   CVCL_WV81
DR   Wikidata; Q95980748
RX   PubMed=31226583;
CC   From: Peking University; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.605-2A>G; ClinVar=VCV001342708; Zygosity=Heterozygous; Note=Splice acceptor mutation (from autologous cell line L1-C4).
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly272Asp (c.815G>A) (p.Gly145Asp, c.434G>A); ClinVar=VCV000053109; Zygosity=Heterozygous (from autologous cell line L1-C4).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WV80 ! L1-C4
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 13
//
ID   L1-iPS1
AC   CVCL_C6VB
DR   Wikidata; Q117704585
RX   PubMed=20535210;
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Thr468Met (c.1403C>T); ClinVar=VCV000013331; Zygosity=Heterozygous (PubMed=20535210).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6VC ! L1-iPS6
OI   CVCL_C6VD ! L1-iPS13
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   L1-iPS13
AC   CVCL_C6VD
DR   Wikidata; Q117704587
RX   PubMed=20535210;
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Thr468Met (c.1403C>T); ClinVar=VCV000013331; Zygosity=Heterozygous (PubMed=20535210).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6VB ! L1-iPS1
OI   CVCL_C6VC ! L1-iPS6
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   L1-iPS6
AC   CVCL_C6VC
DR   Wikidata; Q117704588
RX   PubMed=20535210;
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Thr468Met (c.1403C>T); ClinVar=VCV000013331; Zygosity=Heterozygous (PubMed=20535210).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6VB ! L1-iPS1
OI   CVCL_C6VD ! L1-iPS13
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   L1-KS
AC   CVCL_E7ZT
RX   Patent=US5264341;
RX   PubMed=2344798;
RX   PubMed=2784353;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L1-S8
AC   CVCL_AV88
DR   EFO; EFO_0007599
DR   BioSample; SAMN06044779
DR   ENCODE; ENCBS259CUZ
DR   ENCODE; ENCBS266IJZ
DR   Wikidata; Q54900931
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   L1-S8R
AC   CVCL_AV89
DR   EFO; EFO_0007600
DR   BioSample; SAMN06044775
DR   ENCODE; ENCBS023FES
DR   ENCODE; ENCBS293PZC
DR   Wikidata; Q54900932
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AV88 ! L1-S8
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   L1.02
AC   CVCL_E7V2
SY   LND2
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Leu125Phefs (c.371insTT); Zygosity=Hemizygous (PubMed=33875724).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L1.04
AC   CVCL_E7V3
SY   LND4
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Leu125Phefs (c.371insTT); Zygosity=Hemizygous (PubMed=33875724).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L1.6
AC   CVCL_A7WI
DR   BEI_Resources; MRA-667
DR   Wikidata; Q107115610
RX   PubMed=3539609;
RX   PubMed=9108554;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q25645; Plasmodium berghei merozoite surface protein 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   L10
AC   CVCL_D7AW
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L10-90
AC   CVCL_9U22
DR   Wikidata; Q54900935
RX   PubMed=7586804;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Kunming.
DI   NCIt; C24068; Mouse cervical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9U43 ! P11-90
OI   CVCL_9U56 ! U14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   L10.A
AC   CVCL_K165
DR   Wikidata; Q54900936
RX   PubMed=310843;
CC   Doubling time: 26 hours (PubMed=310843).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   L10.A 2J
AC   CVCL_K166
SY   L10A2J; L10A/2J
DR   Wikidata; Q54900937
RX   PubMed=3495708;
RX   PubMed=6170720;
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K165 ! L10.A
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   L100
AC   CVCL_0C34
DR   Cosmic; 2239101
DR   Wikidata; Q54900938
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   L102/45
AC   CVCL_E9FH
DR   ABCD; ABCD_AU910
DR   DSHB; L102-45
DR   MMRRC; MMRRC:066325-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L102_45.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6MG82; Rat Prrt1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L1023L
AC   CVCL_TZ81
DR   Wikidata; Q54900939
RX   PubMed=17725806;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   L105.1
AC   CVCL_V097
DR   CLO; CLO_0007150
DR   CLDB; cl3107
DR   IHW; 11w 8135
DR   Wikidata; Q54900940
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L106/4
AC   CVCL_E9FI
DR   DSHB; L106-4
DR   MMRRC; MMRRC:066379-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L106_4.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NQX3; Human GPHN (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L106/83
AC   CVCL_E9FJ
DR   ABCD; ABCD_AU911
DR   ABCD; ABCD_AU912
DR   DSHB; L106-83
DR   MMRRC; MMRRC:066357-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L106_83.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NQX3; Human GPHN (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L106/93
AC   CVCL_E9FK
DR   ABCD; ABCD_AU913
DR   DSHB; L106-93
DR   MMRRC; MMRRC:066358-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L106_93.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NQX3; Human GPHN (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L107/39
AC   CVCL_E9FL
DR   ABCD; ABCD_AU914
DR   DSHB; L107-39
DR   MMRRC; MMRRC:066365-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L107_39.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q69ZK9; Mouse Nlgn2 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L108/92
AC   CVCL_E9FM
DR   ABCD; ABCD_AU915
DR   DSHB; L108-92
DR   MMRRC; MMRRC:066361-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L108_92.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01282; Human VIP (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L109/39
AC   CVCL_E9FN
DR   ABCD; ABCD_AU916
DR   MMRRC; MMRRC:066366-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L109_39.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05937; Human CALB1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L109/57
AC   CVCL_E9FP
DR   ABCD; ABCD_AU917
DR   DSHB; L109-57
DR   MMRRC; MMRRC:066362-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L109_57.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05937; Human CALB1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L10BIOBR
AC   CVCL_V171
DR   Wikidata; Q54900941
RX   PubMed=12514183;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: B10.BR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   L10BIOBR-GFP
AC   CVCL_V172
DR   ATCC; CRL-2770
DR   Wikidata; Q54900942
RX   PubMed=12514183;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: B10.BR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V171 ! L10BIOBR
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   L10BIOBR-MAPKK
AC   CVCL_V173
DR   ATCC; CRL-2771
DR   Wikidata; Q54900943
RX   PubMed=12514183;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1346866; Map2k1 (Note=Constitutively activated form).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: B10.BR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V171 ! L10BIOBR
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   L11
AC   CVCL_JX44
DR   Cosmic; 1017702
DR   Wikidata; Q54900944
RX   PubMed=10338002;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; c.895-2A>C; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=10338002).
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   L11-1A1
AC   CVCL_C5LN
DR   ABCD; ABCD_AE193
DR   Wikidata; Q116049633
RX   PubMed=2108213;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   L11-2E2
AC   CVCL_C5LP
DR   ABCD; ABCD_AE204
DR   Wikidata; Q116049634
RX   PubMed=1908881;
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   L11.3
AC   CVCL_V098
DR   CLO; CLO_0007151
DR   CLDB; cl3108
DR   IHW; 11w 8303
DR   Wikidata; Q54900946
RX   PubMed=3517859;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4940; HLA-DPB1.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L11/135
AC   CVCL_J012
DR   CLO; CLO_0007152
DR   ATCC; TIB-188
DR   Wikidata; Q54900945
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   L111/118
AC   CVCL_E9FQ
DR   ABCD; ABCD_AU919
DR   DSHB; L111-118
DR   MMRRC; MMRRC:066418-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L111_118.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61278; Human SST (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L113/13
AC   CVCL_E9FR
DR   ABCD; ABCD_AU920
DR   DSHB; L113-13
DR   MMRRC; MMRRC:066405-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L113_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z2Y3; Mouse Homer1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L113/130
AC   CVCL_E9FS
DR   ABCD; ABCD_AU921
DR   DSHB; L113-130
DR   MMRRC; MMRRC:066368-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L113_130.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z2Y3; Mouse Homer1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L113/27
AC   CVCL_E9FT
DR   ABCD; ABCD_AU922
DR   ABCD; ABCD_AU923
DR   DSHB; L113-27
DR   MMRRC; MMRRC:066367-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L113_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Z2Y3; Mouse Homer1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L114/3
AC   CVCL_E9FU
DR   ABCD; ABCD_AU925
DR   DSHB; L114-3
DR   MMRRC; MMRRC:066369-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L114_3.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02625; Rat Pvalb (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L114/81
AC   CVCL_E9FV
DR   ABCD; ABCD_AU926
DR   ABCD; ABCD_AU927
DR   ABCD; ABCD_AU928
DR   DSHB; L114-81
DR   MMRRC; MMRRC:066393-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L114_81.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02625; Rat Pvalb (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L115/13
AC   CVCL_E9FW
DR   ABCD; ABCD_AU929
DR   DSHB; L115-13
DR   MMRRC; MMRRC:066370-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L115_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01303; Human NPY (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L117/1
AC   CVCL_E9FX
DR   ABCD; ABCD_AU930
DR   DSHB; L117-1
DR   MMRRC; MMRRC:066363-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L117_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UQB8; Human BAIAP2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L118/66
AC   CVCL_E9FY
DR   ABCD; ABCD_AU931
DR   DSHB; L118-66
DR   MMRRC; MMRRC:066392-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L118_66.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O35633; Mouse Slc32a1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L118/80
AC   CVCL_E9FZ
DR   ABCD; ABCD_AU932
DR   DSHB; L118-80
DR   MMRRC; MMRRC:066371-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L118_80.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O35633; Mouse Slc32a1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L119/106
AC   CVCL_E9G0
DR   DSHB; L119-106
DR   MMRRC; MMRRC:066374-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L119_106.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P49146; Human NPY2R (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L11A/41
AC   CVCL_E9G1
SY   L11A/41.6
DR   DSHB; L11A-41
DR   MMRRC; MMRRC:065973-UCD
RX   PubMed=15056697;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L11A_41.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P97685; Rat Nfasc (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L12.2
AC   CVCL_V099
DR   CLO; CLO_0007154
DR   CLDB; cl3110
DR   IHW; 11w 8128
DR   Wikidata; Q54900947
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L12.28-1/1
AC   CVCL_4W64
DR   JCRB; JCRB1615
DR   Wikidata; Q54900948
CC   Transformant: Unknown.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1615
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   L12.9-2(1)
AC   CVCL_U651
DR   CLO; CLO_0050062
DR   RCB; RCB2834
DR   Wikidata; Q54900949
CC   Transformant: Unknown.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   L120/12
AC   CVCL_E9G2
DR   ABCD; ABCD_AU933
DR   DSHB; L120-12
DR   MMRRC; MMRRC:066390-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L120_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9QX73; Rat Arhgef9 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L120/30
AC   CVCL_E9G3
DR   ABCD; ABCD_AU934
DR   DSHB; L120-30
DR   MMRRC; MMRRC:066396-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L120_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9QX73; Rat Arhgef9 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L121/25
AC   CVCL_E9G4
DR   ABCD; ABCD_AU935
DR   DSHB; L121-25
DR   MMRRC; MMRRC:066394-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L121_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P29475; Human NOS1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L121/42
AC   CVCL_E9G5
DR   ABCD; ABCD_AU936
DR   DSHB; L121-42
DR   MMRRC; MMRRC:066395-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L121_42.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P29475; Human NOS1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L1210
AC   CVCL_0382
SY   L 1210; L-1210; Leukemic 1210; Leukemia 1210; Leukemia L1210
DR   BTO; BTO_0000702
DR   CLO; CLO_0007139
DR   CLO; CLO_0007155
DR   CLO; CLO_0007156
DR   EFO; EFO_0005284
DR   MCCL; MCC:0000277
DR   CLDB; cl3111
DR   CLDB; cl3112
DR   CLDB; cl3113
DR   CLDB; cl3114
DR   CLDB; cl3115
DR   CLDB; cl4936
DR   CLDB; cl5219
DR   ATCC; CCL-219
DR   BCRC; 60049
DR   BCRJ; 0138
DR   BioSample; SAMN11397625
DR   CCRID; 1101MOU-PUMC000191
DR   CCRID; 3101MOUTCM22
DR   CCRID; 4201MOU-CCTCC00203
DR   CCRID; 6101MOU-CERC000108
DR   CCTCC; GDC0203
DR   ChEMBL-Cells; CHEMBL3308391
DR   ChEMBL-Targets; CHEMBL386
DR   CLS; 400257
DR   DSMZ; ACC-123
DR   DSMZCellDive; ACC-123
DR   ECACC; 87092804
DR   ENCODE; ENCBS116ENC
DR   GEO; GSM1112425
DR   GEO; GSM1112426
DR   ICLC; ATL99002
DR   IZSLER; BS TCL 152
DR   JCRB; JCRB9026
DR   KCB; KCB 200774YJ
DR   KCLB; 10219
DR   MeSH; D007939
DR   PubChem_Cell_line; CVCL_0382
DR   TKG; TKG 0154
DR   Wikidata; Q6456824
RX   PubMed=6182115;
RX   PubMed=6850600;
RX   PubMed=6890814;
RX   PubMed=6970130;
RX   PubMed=13804596;
RX   PubMed=18630317;
RX   PubMed=25277546;
RX   PubMed=31220119;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-479.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/L1210_cells
CC   Part of: ENCODE project mouse cell lines.
CC   Characteristics: Used for the initial screening of antitumor agents. Its sensitivity to the majority of clinically useful antitumor drugs makes it a potentially suitable model for detailed studies of the mechanisms of action of these drugs (PubMed=6850600).
CC   Doubling time: 10-12 hours (CLS=400257); ~50 hours (DSMZ=ACC-123).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: CLS; 400257; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,17
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 13
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 13
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 27,28
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 27
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   L1210 dGuo-R
AC   CVCL_C8R6
DR   Wikidata; Q123032879
RX   PubMed=8380161;
CC   Selected for resistance to: ChEBI; CHEBI_17172; 2'-deoxyguanosine (dGuo).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   L1210 HHT
AC   CVCL_IM26
SY   L1210-HHT; L1210HHT
DR   Wikidata; Q54900950
RX   PubMed=7987716;
CC   Selected for resistance to: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   L1210 TGR3
AC   CVCL_F929
DR   TKG; TKG 0477
DR   Wikidata; Q54900951
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   L1210 TGR4
AC   CVCL_C511
DR   CLO; CLO_0050212
DR   RCB; RCB2844
DR   TKG; TKG 0478
DR   Wikidata; Q54900952
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   L1210-46.1
AC   CVCL_E9WK
SY   Subclone 46.1
RX   PubMed=6850600;
CC   Characteristics: Less sensitive to treatment with dexamethasone than parent cell line (PubMed=6850600).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L1210-56.3
AC   CVCL_E9WL
SY   Subclone 56.3
RX   PubMed=6850600;
CC   Characteristics: More sensitive to treatment with dexamethasone, 1-beta-D-arabinofuranosyl cytosine, vincristine, and X-irradiation than parent cell line (PubMed=6850600).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L1210-5FU-R-TC
AC   CVCL_C513
AS   CVCL_C512
SY   L1210-5FU-R
DR   CLO; CLO_0050781
DR   RCB; RCB2845
DR   TKG; TKG 0155
DR   TKG; TKG 0409
DR   Wikidata; Q54900953
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   L1210-6MP-R-TC
AC   CVCL_H699
SY   L1210-6MP-R
DR   TKG; TKG 0156
DR   TKG; TKG 0410
DR   Wikidata; Q54900954
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   L1210/0
AC   CVCL_Y418
DR   Wikidata; Q54900955
RX   PubMed=3167012;
RX   PubMed=3664938;
RX   PubMed=3828995;
RX   PubMed=6541096;
RX   PubMed=6890814;
RX   PubMed=10200488;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   L1210/6MP
AC   CVCL_E2YE
SY   L1210/MP
RX   PubMed=6890814;
RX   PubMed=13804596;
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   L1210/6TG
AC   CVCL_E2YF
SY   L1210/TG
RX   PubMed=6890814;
RX   PubMed=13804596;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   L1210/8-Aza
AC   CVCL_E2YD
RX   PubMed=13804596;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y418 ! L1210/0
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   L1210/Ara-C
AC   CVCL_R996
SY   L1210/ARA-C; L1210/ara C
DR   ChEMBL-Cells; CHEMBL3307421
DR   ChEMBL-Targets; CHEMBL614716
DR   PubChem_Cell_line; CVCL_R996
DR   Wikidata; Q54900956
RX   PubMed=6182115;
CC   From: Khwaja, Tasneem A.; University of California, Los Angeles; Los Angeles; USA.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   L1210/CPA
AC   CVCL_4Y57
DR   Wikidata; Q54900957
RX   PubMed=6354439;
CC   Selected for resistance to: ChEBI; CHEBI_4027; Cyclophosphamide (CP; Endoxan).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   L1210/DACH
AC   CVCL_Y419
SY   L1210(DACH); L1210 (DACH); L1210DACH
DR   ChEMBL-Cells; CHEMBL3308408
DR   ChEMBL-Targets; CHEMBL614041
DR   PubChem_Cell_line; CVCL_Y419
DR   Wikidata; Q54900958
RX   PubMed=1986276;
RX   PubMed=3335002;
RX   PubMed=3828995;
RX   PubMed=6541096;
CC   Selected for resistance to: ChEBI; CHEBI_90269; Dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y418 ! L1210/0
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   L1210/DDP
AC   CVCL_1B40
SY   L-1210/DDP
DR   Wikidata; Q54900959
RX   PubMed=1556003;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   L1210/DDP10
AC   CVCL_Y420
SY   L1210/DDP
DR   Wikidata; Q54900960
RX   PubMed=1986276;
RX   PubMed=3167012;
RX   PubMed=3828995;
RX   PubMed=6541096;
RX   PubMed=10200488;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y418 ! L1210/0
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   L1210/DDP2
AC   CVCL_Y421
DR   Wikidata; Q54900961
RX   PubMed=3167012;
RX   PubMed=10200488;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   L1210/DDP5
AC   CVCL_Y422
SY   L1210(DDP5); L1210 (DDP5); L1210DDP5
DR   ChEMBL-Cells; CHEMBL3307477
DR   ChEMBL-Targets; CHEMBL613512
DR   PubChem_Cell_line; CVCL_Y422
DR   Wikidata; Q54900962
RX   PubMed=1986276;
RX   PubMed=3167012;
RX   PubMed=3335002;
RX   PubMed=3828995;
RX   PubMed=6541096;
RX   PubMed=10200488;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   L1210/DDPt
AC   CVCL_E2YG
RX   PubMed=3664938;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y418 ! L1210/0
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   L1210/PtR4
AC   CVCL_4V14
SY   L1210 PtR4; L1210PtR4; L1210 (PtR4); L1210(PTR4)
DR   ChEMBL-Cells; CHEMBL3307416
DR   ChEMBL-Targets; CHEMBL614711
DR   PubChem_Cell_line; CVCL_4V14
DR   Wikidata; Q54900963
RX   PubMed=3335002;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   L1210/R71
AC   CVCL_N029
SY   L1210:R71
DR   Wikidata; Q54900964
RX   PubMed=3965926;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   L1210/R81
AC   CVCL_N028
SY   L1210 (R81)
DR   ChEMBL-Cells; CHEMBL3307415
DR   ChEMBL-Targets; CHEMBL614710
DR   PubChem_Cell_line; CVCL_N028
DR   Wikidata; Q54900965
RX   PubMed=3965926;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   L1210/TGO
AC   CVCL_Y423
DR   Wikidata; Q54900966
RX   PubMed=3828995;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y418 ! L1210/0
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 13
//
ID   L1210/TZR
AC   CVCL_4Y62
SY   TZR
DR   Wikidata; Q54900969
RX   PubMed=9328141;
CC   Doubling time: ~13 hours (PubMed=9328141).
CC   Selected for resistance to: ChEBI; CHEBI_90239; Tiazofurine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   L1210/VMDRC.06
AC   CVCL_C8R8
DR   Wikidata; Q123032881
RX   PubMed=8094615;
RX   PubMed=15294454;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   L1210:RD1694
AC   CVCL_Y424
SY   L1210 (RD1694); L1210(RD1694)
DR   ChEMBL-Cells; CHEMBL3307418
DR   ChEMBL-Targets; CHEMBL614713
DR   PubChem_Cell_line; CVCL_Y424
DR   Wikidata; Q54900970
RX   PubMed=7537518;
CC   Selected for resistance to: ChEBI; CHEBI_5847; ICI D1694 (Tomudex; ZD1694).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   L122/6
AC   CVCL_E9G6
DR   ABCD; ABCD_AU937
DR   DSHB; L122-6
DR   MMRRC; MMRRC:066401-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L122_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P22676; Human CALB2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L122/68
AC   CVCL_E9G7
DR   ABCD; ABCD_AU938
DR   MMRRC; MMRRC:066402-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L122_68.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P22676; Human CALB2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L123/109
AC   CVCL_E9G8
DR   ABCD; ABCD_AU940
DR   ABCD; ABCD_AU941
DR   MMRRC; MMRRC:066406-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L123_109.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UN88; Human GABRQ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L124/59
AC   CVCL_E9G9
DR   ABCD; ABCD_AU942
DR   MMRRC; MMRRC:066404-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L124_59.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O88778; Rat Bsn (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L125/121
AC   CVCL_E9GA
DR   ABCD; ABCD_AV204
DR   DSHB; L125-121
DR   MMRRC; MMRRC:066407-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L125_121.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14994; Human SYN3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L125/129
AC   CVCL_E9GB
DR   ABCD; ABCD_AV205
DR   DSHB; L125-129
DR   MMRRC; MMRRC:066410-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L125_129.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14994; Human SYN3 (Note=Also recognizes SYN1 and SYN2. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L126/93
AC   CVCL_E9GC
DR   ABCD; ABCD_AV206
DR   DSHB; L126-93
DR   MMRRC; MMRRC:066415-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L126_93.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6PFD5; Mouse Dlgap3 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L127/12
AC   CVCL_E9GD
DR   ABCD; ABCD_AV207
DR   DSHB; L127-12
DR   MMRRC; MMRRC:066421-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L127_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99259; Human GAD1 (Note=Also recognizes GAD2. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L127/8
AC   CVCL_E9GE
DR   ABCD; ABCD_AV208
DR   DSHB; L127-8
DR   MMRRC; MMRRC:066420-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L127_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99259; Human GAD1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L127D6
AC   CVCL_Z824
DR   DGRC; 163
DR   FlyBase_Cell_line; FBtc0000163
DR   Wikidata; Q54900971
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   L128
AC   CVCL_C5U3
SY   L-128
DR   GEO; GSM629494
DR   GEO; GSM629495
DR   PRIDE; PXD004746
DR   Wikidata; Q116049635
RX   PubMed=21746927;
RX   PubMed=26194763;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   L128/43
AC   CVCL_E9GF
DR   MMRRC; MMRRC:066426-UCD
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8R138; Mouse Tmem119.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L129/93
AC   CVCL_E9GG
DR   ABCD; ABCD_AV209
DR   MMRRC; MMRRC:066424-UCD
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7TN74; Mouse Ppp1r9a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L129/96
AC   CVCL_E9GH
DR   ABCD; ABCD_AV210
DR   MMRRC; MMRRC:066425-UCD
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7TN74; Mouse Ppp1r9a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L13
AC   CVCL_D7AX
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L130/1
AC   CVCL_E9GI
DR   ABCD; ABCD_AV211
DR   MMRRC; MMRRC:066427-UCD
RX   PubMed=37758930;
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q60610; Mouse Tiam1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L131/17
AC   CVCL_E9GJ
DR   ABCD; ABCD_AW917
DR   DSHB; L131-17
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L131_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6NSW3; Mouse Sphkap (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L131/20
AC   CVCL_E9TJ
DR   ABCD; ABCD_AW916
RX   PubMed=37758930;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q6NSW3; Mouse Sphkap.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L131/27
AC   CVCL_E9GK
DR   ABCD; ABCD_AW915
DR   DSHB; L131-27
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L131_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6NSW3; Mouse Sphkap (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L132 clone G-38-7
AC   CVCL_M623
SY   G-38-7
DR   Wikidata; Q54900972
RX   PubMed=1246601;
RX   PubMed=4134499;
CC   Problematic cell line: Contaminated. Parent cell line (L-132) has been shown to be a HeLa derivative (PubMed=1246601).
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1908 ! L-132
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   L132/18
AC   CVCL_E9GL
DR   DSHB; L132-18
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L132_18.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13936; Human CACNA1C (Note=Immunized with 1918-RSASLGRRASFHLE-1931 with phospho p.Ser1928. Also reacts with mouse, rabbit and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L132/68
AC   CVCL_E9GM
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L132_68.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13936; Human CACNA1C (Note=Immunized with 1918-RSASLGRRASFHLE-1931 with phospho p.Ser1928. Also reacts with mouse, rabbit and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L134/44
AC   CVCL_E9GN
DR   DSHB; L134-44
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L134_44.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7TSH7; Mouse Kcnf1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L134/81
AC   CVCL_E9GP
DR   DSHB; L134-81
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L134_81.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7TSH7; Mouse Kcnf1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L136
AC   CVCL_ZT76
DR   Wikidata; Q98126841
RX   PubMed=15044383;
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Glu232Glyfs*38 (c.689dupT) (167insT) (689insT); ClinVar=VCV000004425; Zygosity=Heterozygous (PubMed=15044383).
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Ser281Leufs*8 (c.841delT) (318delT) (840delT); ClinVar=VCV000004427; Zygosity=Heterozygous (PubMed=15044383).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   L138.8A
AC   CVCL_2100
DR   CLO; CLO_0007160
DR   CLDB; cl3118
DR   DSMZ; ACC-114
DR   DSMZCellDive; ACC-114
DR   Wikidata; Q54900973
RX   PubMed=2788129;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=L138.8A
CC   Characteristics: IL3 dependent.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-114).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   L13D6
AC   CVCL_A8N9
DR   Wikidata; Q102114444
RX   PubMed=10361731;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22225; Trypanosoma brucei brucei PFRA/PFRB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   L14 [Human leukemia]
AC   CVCL_JX45
DR   Cosmic; 1017703
DR   Wikidata; Q54900974
RX   PubMed=10338002;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.His397Gln (c.1191C>A); Zygosity=Heterozygous (PubMed=10338002).
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   L14 [Mouse hybridoma against human NECTIN2]
AC   CVCL_C0BZ
DR   Wikidata; Q112929976
RX   PubMed=12913096;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92692; Human NECTIN2/CD112.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   L14 [Pig]
AC   CVCL_3828
SY   B1 subline L14
DR   CLO; CLO_0007161
DR   CLDB; cl3119
DR   ECACC; 91012317
DR   Wikidata; Q54900975
RX   PubMed=2394515;
RX   PubMed=7951345;
CC   Doubling time: 23 hours (PubMed=2394515).
CC   Karyotypic information: Diploid with a monosomy of chromosome 18 (PubMed=2394515).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_F749 ! B1 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   L14-hCD80(5)
AC   CVCL_C4TQ
DR   Wikidata; Q116049636
RX   PubMed=10500750;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_3828 ! L14 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   L14-hCD86(13)
AC   CVCL_C4TR
DR   Wikidata; Q116049637
RX   PubMed=10500750;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1705; CD86.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_3828 ! L14 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   L14-hICAM1(10)
AC   CVCL_C4TS
DR   Wikidata; Q116049638
RX   PubMed=10500750;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5344; ICAM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_3828 ! L14 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   L142
AC   CVCL_F737
DR   Wikidata; Q54900976
RX   PubMed=1667778;
RX   PubMed=7951345;
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 19-20 hours (PubMed=1667778).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_3828 ! L14 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 13
//
ID   L164.11
AC   CVCL_V100
DR   CLO; CLO_0007163
DR   CLDB; cl3120
DR   IHW; 11w 8116
DR   Wikidata; Q54900978
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L165.6
AC   CVCL_V101
DR   CLO; CLO_0007164
DR   CLDB; cl3121
DR   IHW; 11w 8118
DR   Wikidata; Q54900979
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L166.1
AC   CVCL_V102
DR   CLO; CLO_0007165
DR   CLDB; cl3122
DR   IHW; 11w 8119
DR   Wikidata; Q54900980
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L168.2
AC   CVCL_V103
DR   CLO; CLO_0007166
DR   CLDB; cl3123
DR   IHW; 11w 8112
DR   Wikidata; Q54900981
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L17.8
AC   CVCL_V104
DR   CLO; CLO_0007167
DR   CLDB; cl3124
DR   IHW; 11w 8138
DR   Wikidata; Q54900982
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L18 [Mouse hybridoma against human NSCLC]
AC   CVCL_J014
DR   CLO; CLO_0007168
DR   ATCC; HB-8628
DR   Wikidata; Q54900983
RX   Patent=US4737579;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8628.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on non-small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   L18 [Mouse/rat hybridoma against mouse Cd207]
AC   CVCL_D7AY
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L180/1
AC   CVCL_M046
DR   ECACC; 91060558
DR   Wikidata; Q54900984
RX   PubMed=2411842;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; W5QG77; Sheep CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   L18A/3
AC   CVCL_E9GQ
DR   ABCD; ABCD_AU851
DR   DSHB; L18A-3
DR   MMRRC; MMRRC:066009-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L18A_3.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JIN6; Mouse Kcnmb4 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L1C6
AC   CVCL_A8N8
DR   ECACC; 19072504
DR   Wikidata; Q102114446
RX   PubMed=17267688;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Trypanosoma brucei brucei nucleolar-specific antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   L1H4
AC   CVCL_F1WR
RX   Patent=US7494650;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   L1M1
AC   CVCL_FG74
DR   Wikidata; Q54900985
RX   PubMed=1727655;
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FG73 ! G1M2
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   L1Mab-13
AC   CVCL_D2S4
DR   Wikidata; Q127382580
RX   PubMed=29608408;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   L1Mab-352
AC   CVCL_D2S7
DR   Wikidata; Q127382581
RX   PubMed=38237003;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   L1Mab-354
AC   CVCL_D2S8
DR   Wikidata; Q127382582
RX   PubMed=38237003;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; E2RKZ5; Dog CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   L2
AC   CVCL_0383
SY   L-2
DR   CLO; CLO_0007169
DR   CLO; CLO_0007170
DR   MCCL; MCC:0000278
DR   CLDB; cl3079
DR   ATCC; CCL-149
DR   BCRC; 60276
DR   ECACC; 90112811
DR   IZSLER; BS CL 180
DR   JCRB; JCRB9053
DR   KCLB; 10149
DR   Wikidata; Q54900986
RX   PubMed=4616002;
RX   PubMed=7065527;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   L2-10C1
AC   CVCL_C5LQ
DR   ABCD; ABCD_AE209
DR   Wikidata; Q116049639
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   L2-1GC
AC   CVCL_W600
DR   SKIP; SKIP000300
DR   Wikidata; Q54900987
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By ZFN (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W601 ! L2-1Mut
SX   Female
AG   80-82Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L2-1Mut
AC   CVCL_W601
DR   SKIP; SKIP000297
DR   Wikidata; Q54900988
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W603 ! L2-2Mut
OI   CVCL_W605 ! L2-3Mut
SX   Female
AG   80-82Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L2-2GC
AC   CVCL_W602
SY   IM2GC; MPIi003-A-1
DR   BioSamples; SAMEA104383130
DR   hPSCreg; MPIi003-A-1
DR   SKIP; SKIP000301
DR   Wikidata; Q54900989
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By ZFN (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W603 ! L2-2Mut
SX   Female
AG   80-82Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L2-2Mut
AC   CVCL_W603
SY   IM2; MPIi003-A
DR   BioSamples; SAMEA104382072
DR   hPSCreg; MPIi003-A
DR   SKIP; SKIP000298
DR   Wikidata; Q54900990
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W601 ! L2-1Mut
OI   CVCL_W605 ! L2-3Mut
SX   Female
AG   80-82Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L2-3GC
AC   CVCL_W604
DR   SKIP; SKIP000302
DR   Wikidata; Q54900991
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By ZFN (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W605 ! L2-3Mut
SX   Female
AG   80-82Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L2-3Mut
AC   CVCL_W605
DR   SKIP; SKIP000299
DR   Wikidata; Q54900992
RX   PubMed=23472874;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=23472874).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W601 ! L2-1Mut
OI   CVCL_W603 ! L2-2Mut
SX   Female
AG   80-82Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L2-5D2
AC   CVCL_C5LR
DR   Wikidata; Q116049640
RX   PubMed=2118933;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   L2-iPS16
AC   CVCL_C6VF
DR   Wikidata; Q117704589
RX   PubMed=20535210;
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Thr468Met (c.1403C>T); ClinVar=VCV000013331; Zygosity=Heterozygous (PubMed=20535210).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6VE ! L2-iPS6
OI   CVCL_C6VG ! L2-iPS18
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   L2-iPS18
AC   CVCL_C6VG
DR   Wikidata; Q117704590
RX   PubMed=20535210;
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Thr468Met (c.1403C>T); ClinVar=VCV000013331; Zygosity=Heterozygous (PubMed=20535210).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6VE ! L2-iPS6
OI   CVCL_C6VF ! L2-iPS16
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   L2-iPS6
AC   CVCL_C6VE
DR   Wikidata; Q117704591
RX   PubMed=20535210;
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Thr468Met (c.1403C>T); ClinVar=VCV000013331; Zygosity=Heterozygous (PubMed=20535210).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6VF ! L2-iPS16
OI   CVCL_C6VG ! L2-iPS18
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   L2-KS
AC   CVCL_E7ZU
RX   Patent=US5264341;
RX   PubMed=2344798;
RX   PubMed=2784353;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L2-RYC
AC   CVCL_3534
SY   L2; L2-Rat Yolk sac Carcinoma
DR   CLO; CLO_0007183
DR   ATCC; CRL-2180
DR   Wikidata; Q54900993
RX   PubMed=7141105;
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60530; Rat yolk sac carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   L2.09
AC   CVCL_E7V4
SY   LND9
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg170Ter (c.508C>T); ClinVar=VCV000010063; Zygosity=Hemizygous (PubMed=33875724).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L2.12
AC   CVCL_E7V5
SY   LND12
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg170Ter (c.508C>T); ClinVar=VCV000010063; Zygosity=Hemizygous (PubMed=33875724).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L2(2/1)
AC   CVCL_C5W4
DR   Wikidata; Q116049641
RX   PubMed=18724815;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95436; Human SLC34A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   L2(20/3)
AC   CVCL_C5W5
DR   Wikidata; Q116049642
RX   PubMed=18724815;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95436; Human SLC34A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   L20 [Mouse hybridoma against human CD276]
AC   CVCL_A0QN
SY   Hb L20
DR   CCRID; 4201PAT-CCTCC00014
DR   Wikidata; Q108820644
RX   Patent=US5185432;
RX   Patent=US5204244;
RX   PubMed=3731064;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8913.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   L20 [Mouse/rat hybridoma against mouse Cd207]
AC   CVCL_D7AZ
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L20/3
AC   CVCL_A0QB
DR   Wikidata; Q108820645
RX   PubMed=2146321;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08603; Human CFH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   L20/8
AC   CVCL_E9GR
DR   ABCD; ABCD_AU852
DR   DSHB; L20-8
DR   MMRRC; MMRRC:065972-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L20_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NRD5; Human PICK1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L201.15
AC   CVCL_V105
DR   CLO; CLO_0007172
DR   CLDB; cl3125
DR   IHW; 11w 8045
DR   Wikidata; Q54900994
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L203
AC   CVCL_J015
DR   CLO; CLO_0007173
DR   ATCC; HB-171
DR   Wikidata; Q54900995
RX   PubMed=6966655;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   L21/32
AC   CVCL_E9GS
DR   ABCD; ABCD_AX012
DR   DSHB; L21-32
DR   MMRRC; MMRRC:065967-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L21_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19491; Rat Gria2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L21.3
AC   CVCL_V106
DR   CLO; CLO_0007174
DR   CLDB; cl3126
DR   IHW; 11w 8204
DR   Wikidata; Q54900996
RX   PubMed=1429033;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   L22.12.4
AC   CVCL_D6UG
RX   PubMed=6432679;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse lambda light chain (Note=Recognizes lambda1, lambda2 and lambda3 isotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L22.18.2
AC   CVCL_D6UK
RX   PubMed=6432679;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse lambda1 isotype light chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L22.7.6
AC   CVCL_D6UF
RX   PubMed=6432679;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Mouse IgM heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L22.8.1
AC   CVCL_D6TT
RX   PubMed=6432679;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: Mouse IgA heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L227
AC   CVCL_J016
DR   CLO; CLO_0007175
DR   ATCC; HB-96
DR   Wikidata; Q54900997
RX   PubMed=6966655;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   L23
AC   CVCL_3829
SY   B1 subline L23
DR   CLO; CLO_0007176
DR   CLDB; cl3127
DR   ECACC; 91012318
DR   Wikidata; Q54900998
RX   PubMed=2394515;
RX   PubMed=7951345;
CC   Doubling time: 16.8 hours (PubMed=2394515).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_F749 ! B1 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   L23/27
AC   CVCL_E9GT
DR   ABCD; ABCD_AW914
DR   DSHB; L23-27
DR   MMRRC; MMRRC:065949-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L23_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15384; Rat Kcna3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L231
AC   CVCL_3830
DR   CLO; CLO_0007178
DR   CLDB; cl3128
DR   ECACC; 92040118
DR   Wikidata; Q54900999
RX   PubMed=1667778;
RX   PubMed=7951345;
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 19-20 hours (PubMed=1667778).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Discontinued: ECACC; 92040118; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_3829 ! L23
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   L23immo
AC   CVCL_U661
DR   CLO; CLO_0050063
DR   BioSample; SAMN03471933
DR   RCB; RCB2833
DR   Wikidata; Q54901000
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): RCB=RCB2833
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 11
//
ID   L24/18
AC   CVCL_E9GU
DR   ABCD; ABCD_AV212
DR   DSHB; L24-18
DR   MMRRC; MMRRC:066020-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L24_18.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29994; Rat Itpr1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L243
AC   CVCL_4533
SY   L 243
DR   CLO; CLO_0007142
DR   CLO; CLO_0007180
DR   CLDB; cl5218
DR   ATCC; HB-55
DR   IZSLER; BS Hy 17
DR   Wikidata; Q54901001
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   L25
AC   CVCL_D7B0
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L25.4
AC   CVCL_V107
DR   CLO; CLO_0007181
DR   CLDB; cl3129
DR   IHW; 11w 8305
DR   Wikidata; Q54901002
RX   PubMed=1429033;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   L266
AC   CVCL_0C35
DR   Cosmic; 2239102
DR   Wikidata; Q54901003
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   L27
AC   CVCL_W926
DR   Cosmic; 1154604
DR   Cosmic; 1571727
DR   Wikidata; Q54901004
RX   PubMed=11891209;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 6
//
ID   L28/4
AC   CVCL_E9GV
DR   ABCD; ABCD_AU853
DR   DSHB; L28-4
DR   MMRRC; MMRRC:066277-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L28_4.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63881; Rat Kcnd2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L282F-hiPSC
AC   CVCL_IJ22
DR   SKIP; SKIP001291
DR   Wikidata; Q54901005
RX   PubMed=27789396;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Leu282Phe (c.844C>T); Zygosity=Heterozygous (PubMed=27789396).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   L2975
AC   CVCL_D706
DR   cancercelllines; CVCL_D706
DR   Cosmic; 1602481
DR   Cosmic; 1755115
DR   Wikidata; Q54901006
RX   PubMed=22057234;
RX   PubMed=22928481;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22928481).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple; p.Arg172Trp (c.514A>T); ClinVar=VCV000376438; Zygosity=Heterozygous (PubMed=22057234; PubMed=22928481).
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: STR profile from personal communication of Cleton-Jansen, Anne-Marie.
CC   Derived from site: Metastatic; Bone, spine; UBERON=UBERON_0001130.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 28,29
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   L2987
AC   CVCL_H586
DR   ChEMBL-Cells; CHEMBL3307776
DR   ChEMBL-Targets; CHEMBL614650
DR   PubChem_Cell_line; CVCL_H586
DR   Wikidata; Q54901007
RX   PubMed=7535774;
CC   From: Bristol-Myers Squibb Pharmaceutical Research Institute; Seattle; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   L2C
AC   CVCL_2547
DR   JCRB; IFO50210
DR   Wikidata; Q54901008
RX   PubMed=4550467;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
DI   NCIt; C134564; Guinea pig leukemia
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   L2C7
AC   CVCL_F1WS
RX   Patent=US7494650;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   L2G7
AC   CVCL_F1WT
RX   Patent=US7494650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5162.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the HuL2G7 humanized (TAK-701) therapeutic antibody investigated as a potential anti-cancer drug that works by binding to HGF to block the c-Met signaling pathway, which is involved in tumor growth, survival, and metastasis.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   L2I-6
AC   CVCL_4532
SY   L 21.6
DR   CLO; CLO_0007141
DR   CLO; CLO_0007182
DR   CLDB; cl5217
DR   ATCC; HB-8705
DR   IZSLER; BS Hy 28
DR   Wikidata; Q54901013
RX   Patent=EP0193431A1;
RX   PubMed=6425219;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8705.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Chlamydia trachomatis LPS (Note=Also reacts with other Chlamydial species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   L3 [Human A-T patient lymphoblastoid]
AC   CVCL_M915
DR   Wikidata; Q54901014
RX   PubMed=9168117;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   L3 [Mouse hybridoma against human NSCLC]
AC   CVCL_K217
DR   Wikidata; Q54901015
RX   Patent=US4737579;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8626.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on non-small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   L3 [Mouse/rat hybridoma against mouse Cd207]
AC   CVCL_D7B1
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L3-1-54
AC   CVCL_WG73
SY   HB L3-1-54
DR   CCRID; 4201PAT-CCTCC00120
DR   Wikidata; Q95980999
RX   Patent=EP0859010A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C95002.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4955.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P40225; Human THPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   L3-5
AC   CVCL_Z624
SY   L35
DR   BEI_Resources; MRA-920
DR   Wikidata; Q54901016
RX   PubMed=23382679;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: BEI_Resources; MRA-920; probable.
CC   Breed/subspecies: L3-5.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   L3-5-3
AC   CVCL_Z625
DR   BTO; BTO_0002634
DR   Wikidata; Q54901017
RX   PubMed=12626708;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Breed/subspecies: L3-5.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
HI   CVCL_Z624 ! L3-5
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   L3.1
AC   CVCL_8149
DR   cancercelllines; CVCL_8149
DR   Wikidata; Q54901018
RX   PubMed=1544114;
RX   PubMed=15235133;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8196 ! COLO 357/FG
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   L3.2
AC   CVCL_8148
DR   cancercelllines; CVCL_8148
DR   Wikidata; Q54901019
RX   PubMed=1544114;
RX   PubMed=15235133;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8149 ! L3.1
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   L3.29
AC   CVCL_E7V6
SY   LND29
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg51Ter (c.151C>T); ClinVar=VCV000010060; Zygosity=Hemizygous (PubMed=33875724).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L3.3
AC   CVCL_8147
SY   L33
DR   BTO; BTO_0004571
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 180
DR   BioSample; SAMN10988255
DR   cancercelllines; CVCL_8147
DR   Cell_Model_Passport; SIDM01752
DR   DepMap; ACH-000685
DR   GEO; GSM887258
DR   GEO; GSM888333
DR   LiGeA; CCLE_547
DR   PharmacoDB; L3_3_817_2019
DR   Progenetix; CVCL_8147
DR   Wikidata; Q54901020
RX   PubMed=1544114;
RX   PubMed=15235133;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Doubling time: 35 hours (PubMed=25984343).
CC   HLA typing: A*24:07,24:07; B*35:05,35:05; C*04:01,04:01; DQA1*04:01,04:01; DQB1*03:04,03:04; DRB1*12:02,14:46 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (DepMap=ACH-000685).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=82.98%; Native American=2.01%; East Asian, North=6.2%; East Asian, South=0%; South Asian=0%; European, North=2.94%; European, South=5.87% (PubMed=30894373).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8148 ! L3.2
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   L3.30
AC   CVCL_E7V7
SY   LND30
RX   PubMed=33875724;
WW   Provider; Emory OTT; 17210; https://emoryott.technologypublisher.com/techcase/17210
CC   Population: African American.
CC   Karyotypic information: 46,XY [51]; 46,XY,t(1:10)(p36.3;q11.1) [51] (PubMed=33875724).
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg51Ter (c.151C>T); ClinVar=VCV000010060; Zygosity=Hemizygous (PubMed=33875724).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L3.4
AC   CVCL_8146
DR   cancercelllines; CVCL_8146
DR   Wikidata; Q54901021
RX   PubMed=1544114;
RX   PubMed=15235133;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8147 ! L3.3
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   L3.5
AC   CVCL_8145
DR   cancercelllines; CVCL_8145
DR   Wikidata; Q54901022
RX   PubMed=1544114;
RX   PubMed=15235133;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8146 ! L3.4
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   L3.6.2
AC   CVCL_V108
DR   CLO; CLO_0007184
DR   CLDB; cl3130
DR   IHW; 11w 8301
DR   Wikidata; Q54901023
RX   PubMed=3517859;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4940; HLA-DPB1.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   L3.6pl
AC   CVCL_0384
SY   L3.6PL; L3_6PL; L3.6 pancreas-liver; Colo357L3.6pl
DR   BTO; BTO_0003441
DR   MCCL; MCC:0000279
DR   cancercelllines; CVCL_0384
DR   ChEMBL-Cells; CHEMBL4630602
DR   ChEMBL-Targets; CHEMBL4630703
DR   Cosmic; 1198211
DR   PubChem_Cell_line; CVCL_0384
DR   Wikidata; Q54901024
RX   PubMed=10935470;
RX   PubMed=20037478;
CC   Population: African American.
CC   Doubling time: 16 hours (PubMed=10935470).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8147 ! L3.3
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   L3.6sl
AC   CVCL_8144
SY   L3.6SL; L3.6 spleen-liver
DR   cancercelllines; CVCL_8144
DR   Lonza; 915
DR   Wikidata; Q54901025
RX   PubMed=10935470;
CC   Population: African American.
CC   Doubling time: 20 hours (PubMed=10935470).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Celiac axis lymph node; UBERON=UBERON_0002508.
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8147 ! L3.3
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   L3(28/1)
AC   CVCL_C5W6
DR   Wikidata; Q116049643
RX   PubMed=18724815;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95436; Human SLC34A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   L3055
AC   CVCL_9668
DR   EFO; EFO_0001198
DR   Wikidata; Q54901026
RX   PubMed=8896424;
RX   PubMed=10604993;
CC   Population: Arab.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   L31
AC   CVCL_D7B2
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L32
AC   CVCL_0C36
DR   Cosmic; 2239100
DR   Wikidata; Q54901027
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   L3252
AC   CVCL_D707
DR   Cosmic; 1755116
DR   Wikidata; Q54901028
RX   PubMed=22928481;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22928481).
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: STR profile from personal communication of Cleton-Jansen, Anne-Marie.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 12
ST   D21S11: 28,31.2
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 12
ST   vWA: 16
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   L33-6-1
AC   CVCL_JA31
DR   Wikidata; Q54901029
RX   PubMed=216485;
RX   PubMed=4504337;
RX   PubMed=4599625;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HA64 ! PGLC-33H
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 8
//
ID   L35
AC   CVCL_3831
SY   B1 subline L35
DR   CLO; CLO_0007185
DR   CLDB; cl3131
DR   ECACC; 91012319
DR   Wikidata; Q54901030
RX   PubMed=2394515;
RX   PubMed=7951345;
CC   Doubling time: 27.5 hours (PubMed=2394515).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_F749 ! B1 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   L36
AC   CVCL_D7B3
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L36/12
AC   CVCL_E9GW
DR   ABCD; ABCD_AV213
DR   DSHB; L36-12
DR   MMRRC; MMRRC:066029-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L36_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q804I6; Carassius auratus cyclic nucleotide-gated channel (Note=Also recognizes CNCG1 and CNCG3. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L361
AC   CVCL_0C37
DR   Cosmic; 2239104
DR   Wikidata; Q54901031
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   L368
AC   CVCL_E981
DR   CLO; CLO_0007187
DR   ATCC; HB-149
DR   Wikidata; Q54901032
RX   PubMed=6187860;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   L37
AC   CVCL_D7B4
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L39-17
AC   CVCL_2Z39
SY   WC00006
DR   CLO; CLO_0013432
DR   BioSamples; SAME17769
DR   Coriell; WC00006
DR   Wikidata; Q54901033
CC   Monoclonal antibody isotype: Not specified.
CC   Discontinued: Coriell; WC00006; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 6
//
ID   L3B2
AC   CVCL_A8P0
DR   Wikidata; Q102114447
RX   PubMed=10361731;
RX   PubMed=17945531;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q585H6; Trypanosoma brucei brucei FAZ1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   L4-1-31
AC   CVCL_WG74
SY   HB L4-1-31
DR   CCRID; 4201PAT-CCTCC00121
DR   Wikidata; Q95981014
RX   Patent=EP0859010A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C95003.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4956.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P40225; Human THPO.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   L4-KS
AC   CVCL_E7ZV
RX   Patent=US5264341;
RX   PubMed=2344798;
RX   PubMed=2784353;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L4.14.21
AC   CVCL_D6UI
RX   PubMed=6432679;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse lambda light chain (Note=Recognizes both lambda1 and lambda2 isotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L4.17.2
AC   CVCL_D6UH
RX   PubMed=6432679;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse lambda light chain (Note=Recognizes both lambda1 and lambda2 isotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L4.4.7
AC   CVCL_D6UJ
RX   PubMed=6432679;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse lambda light chain (Note=Recognizes both lambda1 and lambda2 isotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L4.5
AC   CVCL_0D72
DR   DSMZ; ACC-772
DR   DSMZCellDive; ACC-772
DR   Wikidata; Q54901034
RX   PubMed=8675236;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-772).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88337; Cd40lg.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   L40
AC   CVCL_M973
SY   L-40
DR   Wikidata; Q54901035
RX   PubMed=12080467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   L42/17
AC   CVCL_E9GX
DR   ABCD; ABCD_AU854
DR   DSHB; L42-17
DR   MMRRC; MMRRC:066170-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L42_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A2ANU3; Mouse Syndig1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L43/40
AC   CVCL_E9GY
DR   ABCD; ABCD_AU855
DR   DSHB; L43-40
DR   MMRRC; MMRRC:066018-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L43_40.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P56177; Human DLX1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L45 [Mouse hybridoma against human ALCAM]
AC   CVCL_WZ59
DR   Wikidata; Q95981017
RX   Patent=US5134075;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9804.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13740; Human ALCAM/CD166.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 5
//
ID   L45 [Pig]
AC   CVCL_3832
SY   B1 subline L45
DR   CLO; CLO_0007190
DR   CLDB; cl3132
DR   ECACC; 91012320
DR   Wikidata; Q54901036
RX   PubMed=2394515;
RX   PubMed=7951345;
CC   Doubling time: 23 hours (PubMed=2394515).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_F749 ! B1 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   L45/30
AC   CVCL_E9GZ
DR   ABCD; ABCD_AW913
DR   DSHB; L45-30
DR   MMRRC; MMRRC:066042-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L45_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8R5M8; Mouse Cadm1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L48A/9
AC   CVCL_E9H0
DR   ABCD; ABCD_AV214
DR   DSHB; L48A-9
DR   MMRRC; MMRRC:066037-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L48A_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P27732; Rat Cacna1d (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L5
AC   CVCL_K218
DR   CLO; CLO_0007191
DR   ATCC; HB-8627
DR   Wikidata; Q54901037
RX   Patent=US4737579;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8627.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on non-small cell lung carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   L5/1
AC   CVCL_E9H1
DR   ABCD; ABCD_AU856
DR   DSHB; L5-1
DR   MMRRC; MMRRC:065989-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L5_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21818; Rat Stmn2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L5.1
AC   CVCL_4534
SY   L 5.1
DR   CLO; CLO_0007143
DR   CLO; CLO_0007192
DR   CLDB; cl5216
DR   ATCC; HB-84
DR   IZSLER; BS Hy 9
DR   Wikidata; Q54901038
RX   PubMed=7059675;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   L51/82
AC   CVCL_E9H2
DR   ABCD; ABCD_AU857
DR   DSHB; L51-82
DR   MMRRC; MMRRC:066056-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L51_82.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P50282; Rat Mmp9 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L5178Y Adh
AC   CVCL_C8YC
DR   Wikidata; Q123032883
RX   PubMed=557321;
CC   Characteristics: Can grow either attached to a substratum or as a suspension (PubMed=557321).
CC   Doubling time: 13 hours (PubMed=557321).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   L5178Y BLM-A2-R
AC   CVCL_UZ88
DR   Wikidata; Q95981026
RX   PubMed=6173370;
CC   Doubling time: 14.7 hours (PubMed=6173370).
CC   Selected for resistance to: ChEBI; CHEBI_3139; Bleomycin A2.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the resistance phenotype.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   L5178Y LX821
AC   CVCL_L282
SY   LX821
DR   Wikidata; Q54903300
RX   PubMed=6413855;
CC   Characteristics: X-ray sensitive (PubMed=6413855).
CC   Doubling time: 16 hours (PubMed=6413855).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   L5178Y LX827
AC   CVCL_L283
SY   LX827
DR   Wikidata; Q54903301
RX   PubMed=6413855;
CC   Characteristics: X-ray sensitive (PubMed=6413855).
CC   Doubling time: 16 hours (PubMed=6413855).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   L5178Y LX830
AC   CVCL_7882
SY   LX830; LX-830
DR   CLO; CLO_0050169
DR   ChEMBL-Cells; CHEMBL3308624
DR   ChEMBL-Targets; CHEMBL614695
DR   PubChem_Cell_line; CVCL_7882
DR   RCB; RCB0138
DR   Wikidata; Q54903303
RX   PubMed=6413855;
CC   Characteristics: X-ray sensitive (PubMed=6413855).
CC   Doubling time: 14 hours (PubMed=6413855).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   L5178Y M10
AC   CVCL_L284
SY   M10
DR   CLO; CLO_0050171
DR   RCB; RCB0136
DR   Wikidata; Q54903453
RX   PubMed=221956;
RX   PubMed=6413855;
CC   Characteristics: Sensitive to methyl methanesulfonate (MMS) and X-rRays (PubMed=221956).
CC   Doubling time: 14.9 +- 1.7 hours (PubMed=221956).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   L5178Y M10^(-)
AC   CVCL_L285
SY   M10^(-)
DR   CLO; CLO_0050170
DR   RCB; RCB0137
DR   Wikidata; Q54903454
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L284 ! L5178Y M10
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   L5178Y TK+/- (clone 3.7.2C)
AC   CVCL_6665
SY   L5178Y clone 3.7.2C; L5178Y TK+/- 3.7.2C; L5178Y TK+/-3.7.2c; TK+/- (clone 3.7.2C)
DR   CLO; CLO_0007196
DR   ATCC; CRL-9518
DR   BCRC; 60112
DR   BCRJ; 0140
DR   CCRID; 1101MOU-PUMC000816
DR   CCRID; 3101MOUTCM33
DR   JCRB; FDSC0053
DR   JCRB; JCRB0709.1
DR   Wikidata; Q54901039
RX   PubMed=1093012;
RX   PubMed=4047078;
RX   PubMed=4047079;
RX   PubMed=4360720;
RX   PubMed=7329431;
RX   PubMed=27692294;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9518.
CC   Biotechnology: Used for mutation assays to predict the carcinogenic potential of chemicals. Allows the quantitation of forward mutations at the thymidine kinase (TK) locus. These TK heterozygous cells are treated with a range of doses of the test substance. The cells are incubated, washed free of tests substance and allowed time for the phenotypic expression of newly induced mutations (PubMed=1093012; PubMed=3416837; PubMed=4360720; PubMed=7329431).
CC   Doubling time: ~10 hours (Note=Lot 02052008) (JCRB=JCRB0709.1).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: JCRB; FDSC0053; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4235 ! L-5178-Y-S
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   L5178Y TK+/- (clone 3.7.2C) (IVGT)
AC   CVCL_4W65
SY   L5178Y tk+/- 3.7.2c (IVGT); L5178Y TK +/-3.7.2c (IVGT)
DR   ECACC; 12080201
DR   JCRB; JCRB0709.2
DR   Wikidata; Q54901040
RX   PubMed=27692294;
CC   Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
CC   Biotechnology: Used for mutation assays to predict the carcinogenic potential of chemicals. Allows the quantitation of forward mutations at the thymidine kinase (TK) locus. These TK heterozygous cells are treated with a range of doses of the test substance. The cells are incubated, washed free of tests substance and allowed time for the phenotypic expression of newly induced mutations (from parent cell line).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6665 ! L5178Y TK+/- (clone 3.7.2C)
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   L5178Y ts2
AC   CVCL_J373
SY   ts2
DR   JCRB; JCRB0723
DR   Wikidata; Q54901041
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   L5178Y ts39
AC   CVCL_J374
SY   ts39
DR   JCRB; JCRB0724
DR   Wikidata; Q54901042
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   L5178Y VCRR
AC   CVCL_AZ79
SY   L5178Y VCR-resistant
DR   Wikidata; Q54901043
RX   PubMed=7105380;
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 7
//
ID   L5178Y VDSR
AC   CVCL_AZ80
SY   L5178Y VDS-resistant
DR   Wikidata; Q54901044
RX   PubMed=7105380;
CC   Selected for resistance to: ChEBI; CHEBI_36373; Vindesine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 7
//
ID   L5178Y(A)
AC   CVCL_C8YD
DR   Wikidata; Q123032884
RX   PubMed=6724617;
CC   Selected for resistance to: DrugBank; DB00023; Escherichia coli asparaginase.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   L5178Y/ASP
AC   CVCL_C8YE
SY   L5178Y(Asnase); L5178YF/A-ase
DR   Wikidata; Q123032885
RX   PubMed=6724617;
RX   PubMed=11945363;
CC   Selected for resistance to: DrugBank; DB00023; Escherichia coli asparaginase.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8YG ! L5718YF
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   L5178Y/D
AC   CVCL_C8YF
SY   L5178YF/Act D
DR   Wikidata; Q123032886
RX   PubMed=4321087;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8YG ! L5718YF
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   L5178Y/hFASL
AC   CVCL_E4AB
SY   hFasL/L5178Y
RX   PubMed=7500022;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11936; FASLG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   L57/23
AC   CVCL_E9H3
DR   ABCD; ABCD_AW912
RX   PubMed=37758930;
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15381; Rabbit CACNA1C (Note=Also reacts with human, mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L57/46
AC   CVCL_E9H4
DR   ABCD; ABCD_AV215
DR   DSHB; L57-46
DR   MMRRC; MMRRC:065979-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L57_46.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15381; Rabbit CACNA1C (Note=Also reacts with human, mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L5718YF
AC   CVCL_C8YG
DR   Wikidata; Q123032887
RX   PubMed=5444625;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   L52
AC   CVCL_3833
SY   B1 subline L52
DR   CLO; CLO_0007199
DR   CLDB; cl3138
DR   ECACC; 91012321
DR   Wikidata; Q54901045
RX   PubMed=2394515;
RX   PubMed=7951345;
CC   Doubling time: 23 hours (PubMed=2394515).
CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_F749 ! B1 [Pig]
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   L53-10
AC   CVCL_3737
DR   CLO; CLO_0007405
DR   ATCC; CRL-7720
DR   Wikidata; Q54901046
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Misspelling: LS3-10; Note=Occasionally.
CC   Discontinued: ATCC; CRL-7720; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C2869; Anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   L54.5
AC   CVCL_V109
DR   CLO; CLO_0007200
DR   CLDB; cl3140
DR   IHW; 11w 8205
DR   Wikidata; Q54901047
RX   PubMed=1429033;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   L542
AC   CVCL_VU88
DR   Cell_Model_Passport; SIDM01653
DR   DepMap; ACH-002351
DR   Wikidata; Q95981037
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1164 ! D-542MG
SX   Female
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   L55
AC   CVCL_C4KM
SY   anti-OFA-I-1
DR   Wikidata; Q116049644
RX   PubMed=6193515;
RX   PubMed=6291057;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60327; Ganglioside GM2.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from melanoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   L55-81
AC   CVCL_C4KP
DR   ABCD; ABCD_AF197
DR   Wikidata; Q116049645
RX   PubMed=9601948;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60327; Ganglioside GM2.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from melanoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4KM ! L55
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   L56Br-C1
AC   CVCL_DF84
SY   L56-BR-C1; L56BrC1
DR   BTO; BTO_0004832
DR   cancercelllines; CVCL_DF84
DR   GEO; GSM155216
DR   Progenetix; CVCL_DF84
DR   Wikidata; Q54901048
RX   PubMed=11846806;
RX   PubMed=12649339;
RX   PubMed=17334996;
CC   Characteristics: Established from the xenograft L56Br-X1 (PubMed=12649339).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln563Ter (c.1687C>T) (1806C>T); ClinVar=VCV000037426; Zygosity=Hemizygous (PubMed=12649339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Unspecified (PubMed=12649339).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C36100; BRCA1 syndrome
DI   NCIt; C4872; Breast carcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   L57-3-11
AC   CVCL_Z908
DR   BTO; BTO_0003935
DR   DGRC; 2
DR   FlyBase_Cell_line; FBtc0000002
DR   Wikidata; Q54901049
RX   PubMed=9071589;
CC   Group: Insect cell line.
CC   Doubling time: 31 hours (DGRC=2).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z834 ! Kc167
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   L57.23
AC   CVCL_V110
DR   CLO; CLO_0007202
DR   CLDB; cl3141
DR   IHW; 11w 8101
DR   Wikidata; Q54901050
RX   PubMed=1429033;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   L6
AC   CVCL_0385
SY   L-6; L-6 myoblast
DR   BTO; BTO_0002809
DR   CLO; CLO_0007203
DR   EFO; EFO_0022767
DR   MCCL; MCC:0000280
DR   CLDB; cl3142
DR   CLDB; cl5220
DR   ABM; T0771
DR   ATCC; CRL-1458
DR   BCRJ; 0141
DR   CCRID; 1101RAT-PUMC000192
DR   CCRID; 3101RATGNR4
DR   ChEMBL-Cells; CHEMBL3308469
DR   ChEMBL-Targets; CHEMBL614793
DR   CLS; 305231
DR   IZSLER; BS CL 134
DR   JCRB; IFO50364
DR   JCRB; JCRB9081
DR   KCLB; 21458
DR   Kerafast; ESK201-FP
DR   Lonza; 927
DR   PRIDE; PXD002557
DR   PubChem_Cell_line; CVCL_0385
DR   Wikidata; Q54901051
RX   PubMed=1311324;
RX   PubMed=5245982;
RX   PubMed=5481965;
RX   PubMed=7297605;
RX   PubMed=10484371;
RX   PubMed=33117511;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-130.html
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Anecdotal: Called L6 by David Yaffe because he and Sara Neuman established the cell line during the Six-Day war in 1967 (PubMed=33117511).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   L6 [Mouse hybridoma against human NOB1]
AC   CVCL_E6J0
RX   PubMed=27097067;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9ULX3; Human NOB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   L6 Azar1
AC   CVCL_C8RF
DR   Wikidata; Q123032888
RX   PubMed=4478259;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8RB ! L6D
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   L6 Azar2
AC   CVCL_C8RG
DR   Wikidata; Q123032890
RX   PubMed=4478259;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8RB ! L6D
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   L6 Azar3
AC   CVCL_C8RH
DR   Wikidata; Q123032891
RX   PubMed=4478259;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8RB ! L6D
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   L6-20-4
AC   CVCL_CW49
SY   L6
DR   ABCD; ABCD_AF498
DR   Wikidata; Q54901052
RX   Patent=US4906562;
RX   Patent=US4975278;
RX   Patent=US5204244;
RX   PubMed=3731064;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8677.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P30408; Human TM4SF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 6
//
ID   L6-GLUT4myc
AC   CVCL_0P25
SY   L6-GLUT-4myc; L6 GLUT4myc
DR   ABM; T0772
DR   Kerafast; ESK202-FP
DR   Wikidata; Q54901054
RX   PubMed=9607310;
RX   PubMed=10484371;
RX   PubMed=29218526;
CC   Characteristics: Stably expresses Slc2a4/Glut4 containing a 14 amino-acid epitope of human MYC within its first exofacial loop. This construct allows the study of Slc2a4 translocation (PubMed=9607310; PubMed=10484371).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2711; Slc2a4 (Note=With a Myc tag in the 1st ectodomain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   L6/23
AC   CVCL_E9H5
DR   ABCD; ABCD_AU858
DR   DSHB; L6-23
DR   MMRRC; MMRRC:066324-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L6_23.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08460; Mouse Kcnma1 (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L6/48
AC   CVCL_E9H6
DR   ABCD; ABCD_AV216
DR   DSHB; L6-48
DR   MMRRC; MMRRC:066337-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L6_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08460; Mouse Kcnma1 (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L6/60
AC   CVCL_E9H7
DR   ABCD; ABCD_AW911
DR   DSHB; L6-60
DR   MMRRC; MMRRC:065963-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L6_60.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q08460; Mouse Kcnma1 (Note=Also react with human, rat and zebrafish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L6.C10
AC   CVCL_3834
SY   L6-C10
DR   CLO; CLO_0007204
DR   CLDB; cl3143
DR   ECACC; 92102118
DR   Wikidata; Q54901055
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: ECACC; 92102118; true.
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   L6.C11
AC   CVCL_3835
SY   L6-C11
DR   CLO; CLO_0007205
DR   CLDB; cl3144
DR   ECACC; 92102119
DR   Wikidata; Q54901056
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   L6.G8
AC   CVCL_3836
DR   CLO; CLO_0007206
DR   CLDB; cl3145
DR   ECACC; 92102117
DR   Wikidata; Q54901057
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   L6.G8.C5
AC   CVCL_3837
SY   L6G8C5
DR   CLO; CLO_0007207
DR   CLDB; cl3146
DR   ECACC; 92121114
DR   NCBI_Iran; C601
DR   Wikidata; Q54901058
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   L60/4
AC   CVCL_E9H8
DR   ABCD; ABCD_AK449
DR   DSHB; L60-4
DR   MMRRC; MMRRC:066063-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L60_4.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q04656; Human ATP7A (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L61/14
AC   CVCL_E9E0
DR   ABCD; ABCD_AU893
RX   PubMed=24962901;
RX   PubMed=30667360;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1 (Note=Imunnized with 595-PEATRFSH[pS]PLASLSSKAGSST-616 with phospho-p.Ser603).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L612
AC   CVCL_3733
DR   CLO; CLO_0007208
DR   ABCD; ABCD_AF198
DR   Wikidata; Q54901823
RX   Patent=US5419904;
RX   PubMed=7916649;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10724.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_84118; Ganglioside GM3.
CC   Monoclonal antibody target: ChEBI; CHEBI_27499; Ganglioside GM4.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a breast carcinoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   L615K
AC   CVCL_0J69
DR   Wikidata; Q54901824
RX   PubMed=2502521;
CC   Breed/subspecies: Kunming.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   L619L
AC   CVCL_TZ82
DR   Wikidata; Q54901825
RX   PubMed=17725806;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   L61C/30R
AC   CVCL_E9TK
DR   ABCD; ABCD_AW909
RX   PubMed=37758930;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1 (Note=Immunized with 595-CPEATRFSHSPLASLSSKAGSS-616 with phospho p.Ser604. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L62/29
AC   CVCL_E9H9
DR   MMRRC; MMRRC:066064-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L62_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35670; Human ATP7B (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L645
AC   CVCL_C8XI
SY   L-645; L 645; HFDL-645
DR   Wikidata; Q123032892
RX   PubMed=16316754;
RX   PubMed=16948503;
RX   PubMed=17460053;
RX   PubMed=18469530;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   L6565
AC   CVCL_A9NB
DR   CCRID; 3101MOUTCM6
DR   CLS; 305189
DR   Wikidata; Q108820646
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   L6A4
AC   CVCL_C569
SY   L6-A4
DR   Wikidata; Q54901826
RX   PubMed=8393277;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   L6B3
AC   CVCL_A8P1
DR   Wikidata; Q102114448
RX   PubMed=10361731;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q585H6; Trypanosoma brucei brucei FAZ1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   L6C5
AC   CVCL_3387
SY   L6-C5
DR   CLO; CLO_0007210
DR   CLDB; cl4987
DR   ICLC; AL00001
DR   Wikidata; Q54901828
RX   PubMed=8393277;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   L6C9
AC   CVCL_C570
SY   L6-C9
DR   Wikidata; Q54901830
RX   PubMed=8393277;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   L6Cl1
AC   CVCL_UI07
SY   L6CL1; L6 clone 1
DR   Wikidata; Q95981054
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl1V20
AC   CVCL_UI11
SY   L6CL1V20
DR   Wikidata; Q95981056
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI07 ! L6Cl1
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl2
AC   CVCL_UI08
SY   L6CL2; L6 clone 2
DR   Wikidata; Q95981057
RX   CelloPub=CLPUB00454;
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl2V1
AC   CVCL_UI12
SY   L6CL2V1
DR   Wikidata; Q95981059
RX   CelloPub=CLPUB00454;
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI08 ! L6Cl2
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl5
AC   CVCL_UI09
SY   L6CL5; L6 clone 5
DR   Wikidata; Q95981062
RX   CelloPub=CLPUB00454;
RX   PubMed=2503404;
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl5V1
AC   CVCL_UI13
SY   L6CL5V1
DR   Wikidata; Q95981063
RX   CelloPub=CLPUB00454;
RX   PubMed=2503404;
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI09 ! L6Cl5
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl6
AC   CVCL_UI10
SY   L6CL6; L6 clone 6
DR   Wikidata; Q95981064
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl6V1
AC   CVCL_UI14
SY   L6CL6V1
DR   Wikidata; Q95981065
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI10 ! L6Cl6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl6V3
AC   CVCL_UI15
SY   L6CL6V3
DR   Wikidata; Q95981066
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI10 ! L6Cl6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl6V4
AC   CVCL_UI16
SY   L6CL6V4
DR   Wikidata; Q95981067
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI10 ! L6Cl6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl6V5
AC   CVCL_UI17
SY   L6CL6V5
DR   Wikidata; Q95981068
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI10 ! L6Cl6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6Cl6V6
AC   CVCL_UI18
SY   L6CL6V6
DR   Wikidata; Q95981069
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI10 ! L6Cl6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   L6D
AC   CVCL_C8RB
DR   Wikidata; Q123032893
RX   PubMed=730773;
RX   PubMed=4201445;
RX   PubMed=4478259;
RX   PubMed=4510285;
CC   Doubling time: ~24 hours (PubMed=4201445).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Misspelling: L6 Do; PubMed=730773.
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8RC ! L6E
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   L6E
AC   CVCL_C8RC
DR   Wikidata; Q123032894
RX   PubMed=4510285;
RX   PubMed=4655024;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   L6E strain E3
AC   CVCL_C8RD
SY   Strain E3
DR   Wikidata; Q123032895
RX   PubMed=4510285;
CC   Characteristics: Grows well at both 37 and 41 Celsius but fails to differentiate into myotubes at 41 Celsius, while differentiating normally at 37 Celsius (PubMed=4510285).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8RC ! L6E
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   L6E strain H6
AC   CVCL_C8RE
SY   Strain H6
DR   Wikidata; Q123032896
RX   PubMed=4510285;
CC   Characteristics: Grows well at both 37 and 41 Celsius but fails to differentiate into myotubes at 37 Celsius, while differentiating normally at 41 Celsius (PubMed=4510285).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8RC ! L6E
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   L6E9
AC   CVCL_0386
SY   L6-E9
DR   BTO; BTO_0003307
DR   MCCL; MCC:0000281
DR   Wikidata; Q54901831
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-171.html
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   L6H2
AC   CVCL_3388
SY   L6-H2
DR   CLO; CLO_0007211
DR   CLDB; cl4986
DR   ICLC; ATL00001
DR   Wikidata; Q54901832
RX   PubMed=8393277;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   L6J1
AC   CVCL_6F18
DR   CLO; CLO_0007212
DR   CLDB; cl3147
DR   Wikidata; Q54901833
RX   PubMed=374099;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   L6TG
AC   CVCL_C565
DR   JCRB; JCRB0209
DR   Wikidata; Q54901834
RX   CelloPub=CLPUB00072;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0385 ! L6
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   L6TG Cap
AC   CVCL_C566
SY   L6TG.CAP; L6TG.CAPr; L6TGcapr; L6TG Cap-r
DR   JCRB; JCRB0210
DR   Wikidata; Q54901835
RX   CelloPub=CLPUB00072;
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C565 ! L6TG
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   L71/5
AC   CVCL_E9HA
DR   ABCD; ABCD_AV217
DR   DSHB; L71-5
DR   MMRRC; MMRRC:066232-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L71_5.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15385; Rat Kcna4 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L72
AC   CVCL_C4KN
SY   anti-OFA-I-2
DR   Wikidata; Q116049646
RX   PubMed=6291057;
RX   PubMed=6296843;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from melanoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   L7212K
AC   CVCL_0J70
DR   Wikidata; Q54901836
RX   PubMed=2502521;
CC   Breed/subspecies: Kunming.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   L749.1
AC   CVCL_DR24
DR   Wikidata; Q54901837
RX   PubMed=27346203;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_SOLICITUD_DE_DEPOSITO_L749_1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigaciones Biomedicas Alberto Sols; Madrid; Spain.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Unspecified (PubMed=27346203).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8A61 ! GM13411
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   L76/36
AC   CVCL_E9HB
DR   ABCD; ABCD_AV218
DR   ABCD; ABCD_AV219
DR   DSHB; L76-36
DR   MMRRC; MMRRC:066233-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L76_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16389; Human KCNA2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L8 [Mouse/rat hybridoma against mouse Cd207]
AC   CVCL_D7B5
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   L8 [Rat muscle]
AC   CVCL_4236
SY   L-8
DR   BTO; BTO_0002810
DR   CLO; CLO_0007213
DR   CLDB; cl3148
DR   ATCC; CRL-1769
DR   ECACC; 95102434
DR   IZSLER; BS CL 172
DR   Wikidata; Q54901838
RX   PubMed=269441;
RX   PubMed=558123;
RX   PubMed=5481965;
RX   PubMed=6243570;
RX   PubMed=7962182;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-341.html
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Upon becoming confluent, will fuse to form cross striated multinucleated muscle fibers (ATCC=CRL-1769).
CC   Doubling time: 19.1 +- 2.7 hours (Note=In 10% serum), 25.1 +- 3.5 hours (Note=In 1% serum) (PubMed=269441).
CC   Anecdotal: Have been flown in space on shuttle flight STS-45 to study growth in microgravity (PubMed=7962182).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   L8 E63
AC   CVCL_0252
SY   L8E63; E63
DR   MCCL; MCC:0000143
DR   Wikidata; Q54831716
RX   PubMed=1315319;
RX   PubMed=3889014;
RX   PubMed=6243570;
RX   PubMed=8028596;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   L8 fu-1
AC   CVCL_C4KT
SY   fu-1
DR   Wikidata; Q116049647
RX   PubMed=269441;
RX   PubMed=3889014;
RX   PubMed=6243570;
RX   PubMed=8028596;
CC   Characteristics: Non-fusing variant (PubMed=269441).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=269441; PubMed=6243570).
CC   Doubling time: 14.8 +- 1.2 hours (Note=In 10% serum), 16.6 +- 2.0 hours (Note=In 1% serum) (PubMed=269441).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-13
AC   CVCL_C4L2
SY   fu-13
DR   Wikidata; Q116049648
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 30.4 hours (Note=In 10% serum), 38.0 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-14
AC   CVCL_C4L3
SY   fu-14
DR   Wikidata; Q116049649
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 22.2 hours (Note=In 10% serum), 79.8 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-15
AC   CVCL_C4L4
SY   fu-15
DR   Wikidata; Q116049650
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 19.7 hours (Note=In 10% serum), 29.4 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-16
AC   CVCL_C4L5
SY   fu-16
DR   Wikidata; Q116049651
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Doubling time: 23.9 hours (Note=In 10% serum), 30.0 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-2
AC   CVCL_C4KU
SY   fu-2
DR   Wikidata; Q116049653
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 14.5 hours (Note=In 10% serum), 18.9 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-3
AC   CVCL_C4KV
SY   fu-3
DR   Wikidata; Q116049654
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 14.5 hours (Note=In 10% serum), 22.3 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-4
AC   CVCL_C4KW
SY   fu-4
DR   Wikidata; Q116049655
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 17.9 hours (Note=In 10% serum), 21.9 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-5
AC   CVCL_C4KX
SY   fu-5
DR   Wikidata; Q116049656
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Doubling time: 14.0 hours (Note=In 10% serum), 18.8 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-6
AC   CVCL_C4KY
SY   fu-6
DR   Wikidata; Q116049657
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 30.5 hours (Note=In 10% serum), 71.3 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-7
AC   CVCL_C4KZ
SY   fu-7
DR   Wikidata; Q116049658
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 16.0 hours (Note=In 10% serum), 18.8 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-8
AC   CVCL_C4L0
SY   fu-8
DR   Wikidata; Q116049659
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 22.8 hours (Note=In 10% serum), 34.4 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8 fu-9
AC   CVCL_C4L1
SY   fu-9
DR   Wikidata; Q116049660
RX   PubMed=6243570;
CC   Characteristics: Non-fusing variant (PubMed=6243570).
CC   Virology: Expresses a C-type rat retrovirus (PubMed=6243570).
CC   Doubling time: 17.0 hours (Note=In 10% serum), 26.0 hours (Note=In 1% serum) (PubMed=6243570).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   L8/15
AC   CVCL_E9HC
DR   ABCD; ABCD_AU859
DR   DSHB; L8-15
DR   MMRRC; MMRRC:065998-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L8_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95295; Human SNAPIN (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L80/21
AC   CVCL_E9HD
DR   ABCD; ABCD_AV220
DR   MMRRC; MMRRC:066234-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L80_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L804L
AC   CVCL_Y197
DR   Cosmic; 1513409
DR   Wikidata; Q54901840
RX   PubMed=17725806;
RX   PubMed=21498706;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   L8057
AC   CVCL_E074
SY   L-8057
DR   EFO; EFO_0022787
DR   Lonza; 1389
DR   Wikidata; Q54901841
RX   PubMed=3457087;
RX   PubMed=7678813;
CC   Characteristics: Can be induced to differentiate along the megakaryocite/platelet lineage.
CC   Doubling time: 24-27 hours (PubMed=7678813).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   L83/11
AC   CVCL_E9HE
DR   ABCD; ABCD_AW910
DR   MMRRC; MMRRC:066254-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L83_11.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15387; Rat Kcnb1 (Note=Immunized with 554-SKPPEELEMSSMPSPVAPLPA-574 with phospho p.Ser563).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L835
AC   CVCL_D708
DR   cancercelllines; CVCL_D708
DR   Cosmic; 1602479
DR   Cosmic; 1755114
DR   Wikidata; Q54901842
RX   PubMed=22057234;
RX   PubMed=22928481;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22928481).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (PubMed=22928481).
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: STR profile from personal communication of Cleton-Jansen, Anne-Marie.
CC   Derived from site: Metastatic; Bone, left distal radius; UBERON=UBERON_0004407.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,13
ST   D16S539: 11
ST   D21S11: 28,29
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27482; Secondary chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   L84
AC   CVCL_C571
DR   Wikidata; Q54901843
RX   PubMed=558123;
CC   Characteristics: Non-fusing variant. Continue to proliferate until a very high cell density is reached, but do not fuse (PubMed=558123).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   L86/33
AC   CVCL_E9HF
DR   ABCD; ABCD_AV221
DR   ABCD; ABCD_AV222
DR   MMRRC; MMRRC:066235-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L86_33.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86WK6; Human AMIGO1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L86/36
AC   CVCL_E9HG
DR   ABCD; ABCD_AV223
DR   MMRRC; MMRRC:066236-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L86_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86WK6; Human AMIGO1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L86A/37
AC   CVCL_E9HH
DR   ABCD; ABCD_AV224
DR   DSHB; L86A-37
DR   MMRRC; MMRRC:066248-UCD
RX   PubMed=24962901;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L86A_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86WK6; Human AMIGO1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L87/4
AC   CVCL_6837
DR   BTO; BTO_0005051
DR   Lonza; 1287
DR   Wikidata; Q54901844
RX   PubMed=8142648;
RX   PubMed=8536785;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=L87%2F4
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6838 ! L88/5
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   L88/5
AC   CVCL_6838
DR   BTO; BTO_0005052
DR   Wikidata; Q54901845
RX   PubMed=8142648;
RX   PubMed=8536785;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=L88%2F5
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6837 ! L87/4
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   L88/86
AC   CVCL_E9HI
DR   ABCD; ABCD_AV225
DR   MMRRC; MMRRC:066414-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L88_86.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q8TD43; Human TRPM4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L8824
AC   CVCL_WJ25
DR   CCRID; 4201FIS-CCTCC00085
DR   CCTCC; GDC0085
DR   Wikidata; Q95981081
RX   PubMed=31316478;
RX   PubMed=34427827;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 9
//
ID   L89.2
AC   CVCL_V111
DR   CLO; CLO_0007214
DR   CLDB; cl3149
DR   IHW; 11w 8183
DR   Wikidata; Q54901846
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L8C4
AC   CVCL_A8P2
DR   Wikidata; Q102114449
RX   PubMed=10361731;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22225; Trypanosoma brucei brucei PFRA/PFRB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 4
//
ID   L8SF
AC   CVCL_WN49
SY   L8 Space Flown
DR   Wikidata; Q95981084
RX   PubMed=7962182;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Has lost the capacity to fuse and differentiate into myotubes.
CC   Anecdotal: Have arisen from the parent cell line during the space shuttle flight STS-45.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4236 ! L8 [Rat muscle]
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   L9
AC   CVCL_C2X7
DR   Wikidata; Q114311867
RX   PubMed=2471598;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   L91.7
AC   CVCL_V112
DR   CLO; CLO_0007218
DR   CLDB; cl3153
DR   IHW; 11w 8125
DR   Wikidata; Q54901847
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V055 ! DAP.3
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   L929/A
AC   CVCL_AR58
DR   ECACC; 14112101
DR   Wikidata; Q54901849
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 7
//
ID   L929/CD275
AC   CVCL_E2Z7
SY   L929/GL50
RX   PubMed=21851236;
RX   PubMed=26788906;
CC   Characteristics: Transfected with a pIRES2-EGFP-ICOSLG construct (PubMed=21851236).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17087; ICOSLG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   L929/CD83
AC   CVCL_C5ES
DR   Wikidata; Q116049661
RX   PubMed=21707366;
CC   Characteristics: Transfected with a pIRES2-EGFP-CD83 construct (PubMed=21707366).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1703; CD83.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   L929/R
AC   CVCL_4237
DR   ECACC; 04102001
DR   Wikidata; Q54901850
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   L929S
AC   CVCL_4238
DR   CLO; CLO_0007222
DR   CLDB; cl3161
DR   ECACC; 86032004
DR   Wikidata; Q54901851
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   L938
AC   CVCL_ZT77
DR   Wikidata; Q98126842
RX   PubMed=15044383;
RX   PubMed=17347666;
RX   PubMed=17562789;
RX   PubMed=19643912;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Pro206Leu (c.617C>T); ClinVar=VCV000004426; Zygosity=Homozygous (PubMed=15044383).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   L939
AC   CVCL_ZT78
DR   Wikidata; Q98126843
RX   PubMed=15044383;
RX   PubMed=17562789;
RX   PubMed=19643912;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Pro206Leu (c.617C>T); ClinVar=VCV000004426; Zygosity=Heterozygous (PubMed=15044383).
CC   Sequence variation: Mutation; HGNC; HGNC:15984; APTX; Simple; p.Val263Gly (c.788T>G); ClinVar=VCV000004428; Zygosity=Heterozygous (PubMed=15044383).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   L94/54
AC   CVCL_E9HJ
DR   ABCD; ABCD_AV226
DR   DSHB; L94-54
DR   MMRRC; MMRRC:066328-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/L94_54.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q63345; Rat Mog.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   L95
AC   CVCL_C0C0
DR   Wikidata; Q112929978
RX   PubMed=12913096;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P15151; Human PVR/CD155.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   L96
AC   CVCL_0C38
DR   Cosmic; 2239103
DR   Wikidata; Q54901852
RX   PubMed=9559344;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   L990
AC   CVCL_ZT79
DR   Wikidata; Q98126844
RX   PubMed=15044383;
RX   PubMed=17347666;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   L991
AC   CVCL_ZT80
DR   Wikidata; Q98126845
RX   PubMed=15044383;
RX   PubMed=17347666;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173401; Ataxia-oculomotor apraxia type 1
DI   ORDO; Orphanet_1168; Ataxia-oculomotor apraxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   L9981
AC   CVCL_X188
SY   L-9981
DR   Wikidata; Q54901853
RX   PubMed=20731927;
RX   PubMed=21310132;
RX   PubMed=28920308;
RX   PubMed=30950202;
CC   Population: Chinese.
CC   Characteristics: Has a high tumorigenic potential and lung metastatic ability in nude mice (PubMed=21310132).
CC   Omics: Proteomics; Subcellular; Mitochondrion; 2DE-MS.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X186 ! WCQH-9801
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 7
//
ID   L9981-BoM
AC   CVCL_X190
DR   Wikidata; Q54901854
RX   PubMed=24667252;
CC   Population: Chinese.
CC   Characteristics: Metastatic to bone. Established by inoculation of the parent cell line in the armpit of nude mice (PubMed=24667252).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X189 ! L9981-Luc
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   L9981-BrM
AC   CVCL_X191
DR   Wikidata; Q54901855
RX   PubMed=24667252;
CC   Population: Chinese.
CC   Characteristics: Metastatic to brain. Established by inoculation of the parent cell line in the armpit of nude mice (PubMed=24667252).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X189 ! L9981-Luc
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   L9981-LnM
AC   CVCL_X192
DR   Wikidata; Q54901856
RX   PubMed=24667252;
CC   Population: Chinese.
CC   Characteristics: Metastatic to lymph nodes. Established by inoculation of the parent cell line in the armpit of nude mice (PubMed=24667252).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X189 ! L9981-Luc
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   L9981-Luc
AC   CVCL_X189
DR   Wikidata; Q54901858
RX   PubMed=20731927;
RX   PubMed=24667252;
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X188 ! L9981
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   L9981-LuM
AC   CVCL_X193
DR   Wikidata; Q54901859
RX   PubMed=24667252;
CC   Population: Chinese.
CC   Characteristics: Metastatic to lung. Established by inoculation of the parent cell line in the armpit of nude mice (PubMed=24667252).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X189 ! L9981-Luc
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   La Bel
AC   CVCL_3734
DR   CLO; CLO_0007225
DR   ATCC; CRL-1179
DR   Wikidata; Q54901861
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125700; Ehlers-Danlos syndrome, type VI
DI   ORDO; Orphanet_536545; Kyphoscoliotic Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3735 ! La Bel II
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   La Bel II
AC   CVCL_3735
DR   CLO; CLO_0007226
DR   ATCC; CRL-1195
DR   Wikidata; Q54901862
CC   Discontinued: ATCC; CRL-1195; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125700; Ehlers-Danlos syndrome, type VI
DI   ORDO; Orphanet_536545; Kyphoscoliotic Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3734 ! La Bel
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   La Col
AC   CVCL_0F49
DR   ATCC; CRL-1119
DR   Wikidata; Q54901863
RX   PubMed=273925;
RX   PubMed=6409440;
CC   Discontinued: ATCC; CRL-1119; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   La Gay
AC   CVCL_0F64
DR   ATCC; CRL-1109
DR   Wikidata; Q54901864
CC   Discontinued: ATCC; CRL-1109; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   LA-2
AC   CVCL_WX15
DR   Wikidata; Q95981104
RX   Patent=US5856447;
RX   Patent=US6613331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89091302.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; B7IZU3; Borreliella burgdorferi (strain ZS7) outer surface protein A (ospA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 6
//
ID   LA-25.1
AC   CVCL_WX17
DR   Wikidata; Q95981105
RX   Patent=US5856447;
RX   Patent=US6613331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 90050405.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A0A0H3BZK9; Borreliella burgdorferi (strain ZS7) outer surface protein B (ospB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 6
//
ID   LA-26.1
AC   CVCL_WX16
DR   Wikidata; Q95981106
RX   Patent=US5856447;
RX   Patent=US6613331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 90050406.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B7IZU3; Borreliella burgdorferi (strain ZS7) outer surface protein A (ospA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 6
//
ID   LA-27.1
AC   CVCL_WX18
DR   Wikidata; Q95981107
RX   Patent=US5856447;
RX   Patent=US6613331;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 90050407.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A0H3BZK9; Borreliella burgdorferi (strain ZS7) outer surface protein B (ospB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 6
//
ID   LA-350
AC   CVCL_AR50
SY   LA 350; LA350
DR   Wikidata; Q54901865
RX   PubMed=1643757;
RX   PubMed=2827896;
RX   PubMed=3033590;
RX   PubMed=3257418;
CC   From: Seeger, Robert C.; UCLA Center for Health Sciences; Los Angeles; USA.
CC   Characteristics: Secretes IgM kappa.
CC   Doubling time: 12-18 hours (PubMed=3033590).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: On the basis that LA-350 and LA-N-5 (Cellosaurus=CVCL_0389) are both established by Seeger R.C., that they share identical STR profiles and that LA-350 is said to originate from a patient suffering from neuroblastoma we have annotated them as being autologous cell lines.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 17,22
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 21,27
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0389 ! LA-N-5
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 9
//
ID   LA-4 [Mouse hybridoma against lipid A]
AC   CVCL_N290
DR   ATCC; HB-8480
DR   Wikidata; Q54901866
RX   Patent=US4683196;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8480.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_47040; Lipid A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 7
//
ID   LA-4 [Mouse lung adenoma]
AC   CVCL_3535
SY   LA 4; LA4
DR   CLO; CLO_0007229
DR   CLDB; cl3163
DR   ATCC; CCL-196
DR   BCRC; 60239
DR   ECACC; 90040512
DR   KCLB; 10196
DR   Wikidata; Q54901867
RX   PubMed=167947;
RX   PubMed=7065527;
RX   PubMed=9347924;
RX   PubMed=34881029;
CC   Karyotypic information: 85 to 93 chromosomes; hyper-tetraploid karyotype (PubMed=34881029).
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: A/He.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   28W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   LA-49
AC   CVCL_M531
SY   LA 49
DR   Wikidata; Q54901871
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=4858717;
RX   PubMed=10936422;
CC   Characteristics: Produces IgD lambda.
CC   Miscellaneous: Cell line has been lost (PubMed=10936422).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   LA-5
AC   CVCL_N291
DR   ATCC; HB-8479
DR   Wikidata; Q54901872
RX   Patent=US4683196;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8479.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_47040; Lipid A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 7
//
ID   LA-795
AC   CVCL_G363
SY   LA795
DR   CCRID; 1101MOU-PUMC000193
DR   CCRID; 1101MOU-PUMC000318
DR   CLS; 300472
DR   Wikidata; Q54901873
RX   PubMed=2249590;
RX   PubMed=3250825;
CC   Breed/subspecies: T739.
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   LA-9
AC   CVCL_4Z39
SY   LA9
DR   BCRJ; 0142
DR   Wikidata; Q54901874
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   La-K4D
AC   CVCL_E3SL
SY   Lowland anoa K4D
RX   PubMed=27449922;
CC   Group: Endangered species/breed cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Caution: Title and abstract of paper (PubMed=27449922) states that cell line is from Bubalus quarlesi, but text correctly indicates this cell line is from Bubalus depressicornis.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=27596; ! Bubalus depressicornis (Lowland anoa)
OI   CVCL_JH76 ! La-K4DT
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   La-K4DT
AC   CVCL_JH76
SY   Lowland anoa K4DT
DR   Wikidata; Q54899288
RX   PubMed=27449922;
CC   Group: Endangered species/breed cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Caution: Title and abstract of paper (PubMed=27449922) states that cell line is from Bubalus quarlesi, but text correctly indicates this cell line is from Bubalus depressicornis.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=27596; ! Bubalus depressicornis (Lowland anoa)
OI   CVCL_E3SL ! La-K4D
SX   Female
AG   31Y
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   LA-N-1
AC   CVCL_1827
SY   LAN-1; LAN1; Lan1
DR   BTO; BTO_0003542
DR   CLO; CLO_0007240
DR   CLO; CLO_0051542
DR   EFO; EFO_0005391
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03472327
DR   BioSample; SAMN03473468
DR   cancercelllines; CVCL_1827
DR   Cosmic; 801740
DR   Cosmic; 920240
DR   Cosmic; 947710
DR   Cosmic; 1019927
DR   Cosmic; 1037343
DR   Cosmic; 1099140
DR   Cosmic; 1109118
DR   Cosmic; 1153781
DR   Cosmic; 1153809
DR   Cosmic; 1161991
DR   Cosmic; 1167411
DR   Cosmic; 1526627
DR   Cosmic; 2131578
DR   Cosmic; 2239461
DR   Cosmic; 2301574
DR   Cosmic; 2393635
DR   Cosmic; 2485946
DR   DSMZ; ACC-655
DR   DSMZCellDive; ACC-655
DR   ECACC; 06041201
DR   GEO; GSM313802
DR   GEO; GSM333797
DR   GEO; GSM563355
DR   GEO; GSM692872
DR   GEO; GSM1366408
DR   IARC_TP53; 21458
DR   ICLC; HTL98005
DR   Progenetix; CVCL_1827
DR   RCB; RCB0483
DR   TOKU-E; 4118
DR   Wikidata; Q54901875
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=856461;
RX   PubMed=2535691;
RX   PubMed=7037175;
RX   PubMed=7838528;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18082704;
RX   PubMed=18165268;
RX   PubMed=18724359;
RX   PubMed=18923523;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=20655465;
RX   PubMed=22213050;
CC   Doubling time: 32 +- 9 hours (PubMed=856461); ~100 hours (DSMZ=ACC-655); ~2 days (ECACC=06041201).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=18724359; PubMed=18923523).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ICLC; HTL98005; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG; DSMZ=ACC-655; ECACC=06041201; RCB=RCB0483
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,36
ST   D2S1338: 16,21
ST   D3S1358: 16,16.2
ST   D5S818: 12
ST   D7S820: 10 (COG)
ST   D7S820: 10,11 (DSMZ=ACC-655; ECACC=06041201; RCB=RCB0483)
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 9,13
ST   Penta E: 11,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 36
//
ID   LA-N-2
AC   CVCL_1829
SY   LAN-2; LAN2
DR   CLO; CLO_0050262
DR   BioSample; SAMN03472328
DR   BioSample; SAMN03473426
DR   cancercelllines; CVCL_1829
DR   Cell_Model_Passport; SIDM01370
DR   Cosmic; 801741
DR   Cosmic; 920241
DR   Cosmic; 947711
DR   Cosmic; 1037344
DR   Cosmic; 1099141
DR   Cosmic; 1109103
DR   Cosmic; 1153782
DR   Cosmic; 1526628
DR   Cosmic; 2131579
DR   Cosmic; 2301575
DR   Cosmic; 2485947
DR   DepMap; ACH-001354
DR   DSMZ; ACC-671
DR   DSMZCellDive; ACC-671
DR   ECACC; 06041202
DR   GEO; GSM313803
DR   GEO; GSM333798
DR   Lonza; 1195
DR   Progenetix; CVCL_1829
DR   RCB; RCB0484
DR   Wikidata; Q54901876
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=856461;
RX   PubMed=7037175;
RX   PubMed=15720811;
RX   PubMed=18923524;
RX   PubMed=24466371;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
CC   Doubling time: 56 +- 9 hours (PubMed=856461); ~50-70 hours (Note=But longer after recovery from liquid nitrogen freezing) (DSMZ=ACC-671).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000142536; Zygosity=Unspecified (DepMap=ACH-001354).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): COG; DepMap=ACH-001354; DSMZ=ACC-671; ECACC=06041202; RCB=RCB0484
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 15,18
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 11,12
ST   Penta E: 11,17
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 29
//
ID   LA-N-4
AC   CVCL_M158
SY   LAN-4
DR   Wikidata; Q54901877
RX   PubMed=6172518;
CC   Caution: Only mentioned as a neuroblastoma cell line in PubMed=6172518, could be a misspelling of LA-N-2.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   LA-N-5
AC   CVCL_0389
SY   LAN-5; Lan-5; LAN5; Lan5; NBLAN5T
DR   BTO; BTO_0000935
DR   CLO; CLO_0007242
DR   CLO; CLO_0050264
DR   EFO; EFO_0022688
DR   MCCL; MCC:0000284
DR   CLDB; cl3170
DR   CLDB; cl3171
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03472329
DR   BioSample; SAMN03473428
DR   cancercelllines; CVCL_0389
DR   Cosmic; 801742
DR   Cosmic; 920242
DR   Cosmic; 923828
DR   Cosmic; 930066
DR   Cosmic; 947705
DR   Cosmic; 1037345
DR   Cosmic; 1099142
DR   Cosmic; 1109122
DR   Cosmic; 1153783
DR   Cosmic; 1161992
DR   Cosmic; 1167989
DR   Cosmic; 1212538
DR   Cosmic; 1518068
DR   Cosmic; 1526629
DR   Cosmic; 1890201
DR   Cosmic; 2131580
DR   Cosmic; 2239462
DR   Cosmic; 2301576
DR   Cosmic; 2393636
DR   DSMZ; ACC-673
DR   DSMZCellDive; ACC-673
DR   GEO; GSM313804
DR   GEO; GSM333799
DR   GEO; GSM692871
DR   GEO; GSM2371239
DR   GEO; GSM2394369
DR   GEO; GSM4104579
DR   GEO; GSM4104580
DR   GEO; GSM4104628
DR   GEO; GSM4104629
DR   GEO; GSM4105313
DR   GEO; GSM4105314
DR   GEO; GSM4105315
DR   GEO; GSM4105316
DR   GEO; GSM4105317
DR   IARC_TP53; 21459
DR   ICLC; HTL96022
DR   LINCS_LDP; LCL-1987
DR   Lonza; 1157
DR   NCBI_Iran; C613
DR   Progenetix; CVCL_0389
DR   RCB; RCB0485
DR   Wikidata; Q54901878
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=6172518;
RX   PubMed=15892104;
RX   PubMed=18082704;
RX   PubMed=18724359;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=23202128;
RX   PubMed=24466371;
RX   PubMed=24792489;
RX   PubMed=28350380;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-481.html
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/LA-N-5_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Doubling time: ~100 hours (DSMZ=ACC-673).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (PubMed=18724359; PubMed=28350380).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: On the basis that LA-350 (Cellosaurus=CVCL_AR50) and LA-N-5 are both established by Seeger R.C., that they share identical STR profiles and that LA-350 is said to originate from a patient suffering from neuroblastoma we have annotated them as being autologous cell lines.
CC   Misspelling: LAN-3; Cosmic=920242.
CC   Discontinued: ICLC; HTL96022; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG; DSMZ=ACC-673; RCB=RCB0485
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (COG)
ST   CSF1PO: 10,11 (DSMZ=ACC-673; RCB=RCB0485)
ST   D13S317: 9,12
ST   D16S539: 9 (DSMZ=ACC-673)
ST   D16S539: 9,12 (COG; RCB=RCB0485)
ST   D18S51: 17,22
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 21,27
ST   Penta D: 11,13
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AR50 ! LA-350
SX   Male
AG   4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   LA-N-6
AC   CVCL_1363
SY   LAN-6; LAN6; LA-N-6(OAN)
DR   CLO; CLO_0037081
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473429
DR   cancercelllines; CVCL_1363
DR   Cell_Model_Passport; SIDM00330
DR   ChEMBL-Cells; CHEMBL3308206
DR   ChEMBL-Targets; CHEMBL2366123
DR   Cosmic; 697283
DR   Cosmic; 717430
DR   Cosmic; 848929
DR   Cosmic; 930067
DR   Cosmic; 949170
DR   Cosmic; 1019942
DR   Cosmic; 1109105
DR   Cosmic; 1109366
DR   Cosmic; 1161993
DR   Cosmic; 1167408
DR   Cosmic; 1526630
DR   Cosmic; 1890102
DR   Cosmic; 2301577
DR   Cosmic; 2393637
DR   Cosmic-CLP; 949170
DR   DepMap; ACH-001355
DR   DSMZ; ACC-674
DR   DSMZCellDive; ACC-674
DR   EGA; EGAS00001000978
DR   GDSC; 949170
DR   GEO; GSM1670032
DR   GEO; GSM2371240
DR   GEO; GSM2394373
DR   IARC_TP53; 23822
DR   IARC_TP53; 27562
DR   LINCS_LDP; LCL-1988
DR   PharmacoDB; LAN6_819_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1363
DR   Wikidata; Q54901879
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8242562;
RX   PubMed=11507071;
RX   PubMed=15150091;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=20164919;
RX   PubMed=23202128;
RX   PubMed=24792489;
RX   PubMed=25884760;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=28636942;
RX   PubMed=30894373;
RX   PubMed=31631027;
RX   PubMed=35839778;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/LA-N-6_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Characteristics: Has long and heterogeneous telomeres and no telomerase activity. Its telomeres shortens continuously at an average rate of 55 base pairs per population doubling (PubMed=28636942).
CC   Doubling time: 3 days (PubMed=28636942); ~1 week (DSMZ=ACC-674).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=28636942).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Asp1091Asn (c.3271G>A); ClinVar=VCV000218628; Zygosity=Heterozygous (PubMed=18724359; Cosmic-CLP=949170; DepMap=ACH-001355).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (Cosmic-CLP=949170; DepMap=ACH-001355).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (Cosmic-CLP=949170; DepMap=ACH-001355).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Tyrosine phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.47%; Native American=23.6%; East Asian, North=3.12%; East Asian, South=0%; South Asian=0%; European, North=42.61%; European, South=28.2% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG; Cosmic-CLP=949170; DepMap=ACH-001355; DSMZ=ACC-674
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 18,21
ST   Penta D: 13
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   LA-N-6 MUT p53
AC   CVCL_C1HR
DR   cancercelllines; CVCL_C1HR
DR   Wikidata; Q114311869
RX   PubMed=28636942;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=28636942).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Asp1091Asn (c.3271G>A); ClinVar=VCV000218628; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Ter (c.708C>A); Zygosity=Heterozygous; Note=Acquired spontaneously at 90 PDL (PubMed=28636942).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1363 ! LA-N-6
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   LA0001
AC   CVCL_8Y08
DR   ECACC; 98061805
DR   Wikidata; Q54901880
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
DI   NCIt; C85874; Microcephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   LA0002
AC   CVCL_8Y09
DR   ECACC; 98061806
DR   Wikidata; Q54901881
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
DI   NCIt; C85874; Microcephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   La1
AC   CVCL_J832
SY   anti-La/SSB
DR   CLO; CLO_0007227
DR   ATCC; HB-8609
DR   Wikidata; Q54901882
RX   Patent=US4784942;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8609.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P10881; Bovine SSB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   LA1-55n
AC   CVCL_2548
DR   BTO; BTO_0005860
DR   ECACC; 06041203
DR   Wikidata; Q54901883
RX   PubMed=10485488;
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Doubling time: ~2 days (ECACC=06041203).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2549 ! LA1-5s
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   LA1-5s
AC   CVCL_2549
DR   ECACC; 06041204
DR   Wikidata; Q54901884
RX   PubMed=2535691;
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=15720811).
CC   Doubling time: ~2 days (ECACC=06041204).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1827 ! LA-N-1
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   LA10
AC   CVCL_E5S5
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q01227; Vaccinia virus protein OPG190 (B5R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LA10-1
AC   CVCL_A1ZZ
SY   LA10
DR   Wikidata; Q105509845
RX   PubMed=14978140;
CC   From: Repasky, Elizabeth A.; Roswell Park Cancer Center; Buffalo; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 4
//
ID   LA11 [Human iPSC]
AC   CVCL_Y951
SY   PARK8-LA11; HPS0103
DR   SKIP; SKIP000992
DR   Wikidata; Q54901885
RX   PubMed=26056228;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous (PubMed=26056228).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T963 ! LA3
OI   CVCL_Y949 ! LA5 [Human iPSC]
OI   CVCL_Y950 ! LA8
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   LA11 [Mouse hybridoma against vaccinia A33R]
AC   CVCL_E5S2
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P68617; Vaccinia virus protein OPG161 (A33R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LA20207
AC   CVCL_WZ41
SY   LA 20207
DR   Wikidata; Q95981167
RX   Patent=US5250297;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10224.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human lung adenocarcinoma tumor antigen of 50-80 kDa.
CC   Misspelling: LA2O207; Note=In European patent EP0424107A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 5
//
ID   LA3
AC   CVCL_T963
SY   HPS0100
DR   Wikidata; Q54901886
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous (from autologous cell lines LA5 [Human iPSC]; LA11 [Human iPSC]).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y949 ! LA5 [Human iPSC]
OI   CVCL_Y950 ! LA8
OI   CVCL_Y951 ! LA11 [Human iPSC]
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   LA3 beta2mHC2
AC   CVCL_V113
DR   CLO; CLO_0007228
DR   CLDB; cl3165
DR   IHW; 11w 8004
DR   Wikidata; Q54901887
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LA5 [Human iPSC]
AC   CVCL_Y949
SY   PARK8-LA5; HPS0101
DR   SKIP; SKIP000991
DR   Wikidata; Q54901888
RX   PubMed=26056228;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous (PubMed=26056228).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T963 ! LA3
OI   CVCL_Y950 ! LA8
OI   CVCL_Y951 ! LA11 [Human iPSC]
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   LA5 [Mouse hybridoma against vaccinia D8L]
AC   CVCL_E5QP
DR   ABCD; ABCD_AA359
RX   PubMed=21056889;
RX   PubMed=22623786;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04195; Vaccinia virus carbonic anhydrase homolog OPG105 (D8L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LA7
AC   CVCL_3838
DR   CLO; CLO_0007230
DR   CLDB; cl3164
DR   ATCC; CRL-2283
DR   ECACC; 96081411
DR   Wikidata; Q54901889
RX   PubMed=375233;
RX   PubMed=1717432;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LA7
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: ECACC; 96081411; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y673 ! Rama 25
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   LA8
AC   CVCL_Y950
SY   HPS0102
DR   Wikidata; Q54901890
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous (from autologous cell lines LA5 [Human iPSC]; LA11 [Human iPSC]).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T963 ! LA3
OI   CVCL_Y949 ! LA5 [Human iPSC]
OI   CVCL_Y951 ! LA11 [Human iPSC]
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   LA9-IS11 EGF-2
AC   CVCL_A9DZ
DR   Wikidata; Q108820647
RX   Patent=US4935352;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50057.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3229; EGF.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4Z39 ! LA-9
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   LAB KO (C57)
AC   CVCL_C0L9
SY   LAB KO (C57) Macrophage Cell Line
DR   Kerafast; ENH177-FP
DR   Wikidata; Q112929981
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1926479; Lat2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   LACC-1
AC   CVCL_9U23
SY   Lacrimal gland Adenoid Cystic Carcinoma-1
DR   Wikidata; Q54901891
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=25962898;
CC   Population: Chinese.
CC   Doubling time: ~37.1 hours (PubMed=25962898).
CC   Derived from site: In situ; Lacrimal gland; UBERON=UBERON_0001817.
DI   NCIt; C4540; Lacrimal gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   LACF-NaNaI
AC   CVCL_B944
DR   CLO; CLO_0051621
DR   RCB; RCB2319
DR   Wikidata; Q54901892
CC   Donor information: Established from Nana, an elephant kept in Asahiyama Zoo in Japan and that died in 2006.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9785; ! Loxodonta africana (African elephant)
OI   CVCL_B945 ! LACF-NaNaII
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   LACF-NaNaII
AC   CVCL_B945
DR   CLO; CLO_0050000
DR   RCB; RCB2320
DR   Wikidata; Q54901893
CC   Donor information: Established from Nana, an elephant kept in Asahiyama Zoo in Japan and that died in 2006.
CC   Derived from site: In situ; Ear; UBERON=UBERON_0001690.
OX   NCBI_TaxID=9785; ! Loxodonta africana (African elephant)
OI   CVCL_B944 ! LACF-NaNaI
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   LACO16
AC   CVCL_T956
DR   Wikidata; Q54901894
RX   PubMed=8494788;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T954 ! HET16
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   LACO3
AC   CVCL_T957
DR   Wikidata; Q54901895
RX   PubMed=8494788;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T953 ! HET15
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   LAD 1
AC   CVCL_5220
SY   LAD1; LADR; Laboratory of Allergic Diseases 1
DR   ABM; T8156
DR   Wikidata; Q54901896
RX   DOI=10.1016/j.jaci.2018.12.550;
RX   PubMed=12801524;
RX   PubMed=25149487;
RX   PubMed=31698677;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LAD1
CC   Characteristics: KITLG dependent.
CC   Doubling time: ~28 days (DOI=10.1016/j.jaci.2018.12.550).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0387 ! LAD 2
SX   Male
AG   44Y
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   LAD 2
AC   CVCL_0387
SY   LAD2; LAD-2; Laboratory of Allergic Diseases 2
DR   BTO; BTO_0004139
DR   MCCL; MCC:0000282
DR   ABM; T8157
DR   ChEMBL-Cells; CHEMBL4483145
DR   ChEMBL-Targets; CHEMBL4483253
DR   PubChem_Cell_line; CVCL_0387
DR   Wikidata; Q54901897
RX   DOI=10.1016/j.jaci.2013.12.226;
RX   DOI=10.1016/j.jaci.2018.12.550;
RX   PubMed=12801524;
RX   PubMed=20814942;
RX   PubMed=25149487;
RX   PubMed=25195635;
RX   PubMed=31698677;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LAD2
CC   Characteristics: KITLG dependent.
CC   Doubling time: ~14 days (DOI=10.1016/j.jaci.2018.12.550).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5220 ! LAD 1
SX   Male
AG   44Y
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   LAD-02
AC   CVCL_WA89
SY   Leukocyte Adhesion Deficiency-02
DR   IBRC; C10966
DR   Wikidata; Q95981181
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27874; Leukocyte adhesion deficiency
DI   ORDO; Orphanet_2968; Leukocyte adhesion deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   LAD-03
AC   CVCL_WA90
SY   Leukocyte Adhesion Deficiency-03
DR   IBRC; C10971
DR   Wikidata; Q95981183
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27874; Leukocyte adhesion deficiency
DI   ORDO; Orphanet_2968; Leukocyte adhesion deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   LAD-III LCL family 1 father
AC   CVCL_VP08
DR   CancerTools; 153765
DR   Wikidata; Q95981184
DR   Ximbio; 153765
RX   PubMed=19234463;
CC   Population: Maltese.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Unexplicit; IVS13AS,A-G,-2; ClinVar=VCV000002708; Zygosity=Heterozygous; Note=Frameshift mutation (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LAD-III LCL family 1 mother
AC   CVCL_VP09
DR   CancerTools; 153764
DR   Wikidata; Q95981186
DR   Ximbio; 153764
RX   PubMed=19234463;
CC   Population: Maltese.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Unexplicit; IVS13AS,A-G,-2; ClinVar=VCV000002708; Zygosity=Heterozygous; Note=Frameshift mutation (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LAD-III LCL family 1 sibling
AC   CVCL_VP10
DR   CancerTools; 153763
DR   Wikidata; Q95981187
DR   Ximbio; 153763
RX   PubMed=19234463;
CC   Population: Maltese.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Unexplicit; IVS13AS,A-G,-2; ClinVar=VCV000002708; Zygosity=Heterozygous; Note=Frameshift mutation (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LAD-III LCL family 1 subject
AC   CVCL_VP11
DR   CancerTools; 153766
DR   Wikidata; Q95981189
DR   Ximbio; 153766
RX   PubMed=19234463;
CC   Population: Maltese.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Unexplicit; IVS13AS,A-G,-2; ClinVar=VCV000002708; Zygosity=Homozygous; Note=Frameshift mutation (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154615; Leukocyte adhesion deficiency type 3
DI   ORDO; Orphanet_99844; Leukocyte adhesion deficiency type III
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   LAD-III LCL family 2 father
AC   CVCL_VP14
DR   CancerTools; 153770
DR   Wikidata; Q95981190
DR   Ximbio; 153770
RX   PubMed=19234463;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Simple; p.Arg513Ter (c.1537C>T) (R509*); ClinVar=VCV000002712; Zygosity=Heterozygous (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LAD-III LCL family 2 mother
AC   CVCL_VP15
DR   CancerTools; 153772
DR   Wikidata; Q95981191
DR   Ximbio; 153772
RX   PubMed=19234463;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Simple; p.Arg513Ter (c.1537C>T) (R509*); ClinVar=VCV000002712; Zygosity=Heterozygous (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LAD-III LCL family 2 sibling
AC   CVCL_VP16
DR   CancerTools; 153771
DR   Wikidata; Q95981192
DR   Ximbio; 153771
RX   PubMed=19234463;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Simple; p.Arg513Ter (c.1537C>T) (R509*); ClinVar=VCV000002712; Zygosity=Heterozygous (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LAD-III LCL family 2 subject
AC   CVCL_VP17
DR   CancerTools; 153769
DR   Wikidata; Q95981193
DR   Ximbio; 153769
RX   PubMed=19234463;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Simple; p.Arg513Ter (c.1537C>T) (R509*); ClinVar=VCV000002712; Zygosity=Homozygous (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154615; Leukocyte adhesion deficiency type 3
DI   ORDO; Orphanet_99844; Leukocyte adhesion deficiency type III
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   LAD-III LCL family 3 father
AC   CVCL_VP12
DR   CancerTools; 153768
DR   Wikidata; Q95981194
DR   Ximbio; 153768
RX   PubMed=19234463;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Simple; p.Arg513Ter (c.1537C>T) (R509*); ClinVar=VCV000002712; Zygosity=Heterozygous (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LAD-III LCL family 3 subject
AC   CVCL_VP13
DR   CancerTools; 153767
DR   Wikidata; Q95981196
DR   Ximbio; 153767
RX   PubMed=19234463;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:23151; FERMT3; Simple; p.Arg513Ter (c.1537C>T) (R509*); ClinVar=VCV000002712; Zygosity=Homozygous (PubMed=19234463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C154615; Leukocyte adhesion deficiency type 3
DI   ORDO; Orphanet_99844; Leukocyte adhesion deficiency type III
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   LADA
AC   CVCL_E748
SY   5193; 18176
DR   dbMHC; 48941
DR   ECACC; 94071405
DR   IHW; IHW09273
DR   IPD-IMGT/HLA; 10959
DR   Wikidata; Q54901898
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*02:01:01:01,80:01; B*07:02:01,57:03:01; C*07:02:01:01,08:02; DPA1*01:03:01,02:01:01; DPB1*03:01:01,17:01; DQA1*01:01:01,03:01:01; DQB1*02:02,05:01:01; DRB1*09:01:02,12:01:01; DRB3*02:02:01; DRB4*01:01:01 (IPD-IMGT/HLA=10959).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   LADMAC
AC   CVCL_2550
DR   CLO; CLO_0007234
DR   ATCC; CRL-2420
DR   BCRC; 60489
DR   Wikidata; Q54901899
RX   PubMed=3877730;
RX   PubMed=7769247;
CC   Characteristics: Secretes CSF1.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   LAG
AC   CVCL_B950
SY   L(AG)
DR   CLO; CLO_0050236
DR   RCB; RCB2758
DR   TKG; TKG 0218
DR   Wikidata; Q54901900
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   LAG-MUC1
AC   CVCL_B951
DR   CLO; CLO_0050237
DR   RCB; RCB2846
DR   TKG; TKG 0466
DR   Wikidata; Q54901901
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B950 ! LAG
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   LAH1
AC   CVCL_6666
DR   CLO; CLO_0050155
DR   RCB; RCB1733
DR   Wikidata; Q54901902
RX   DOI=10.2108/zsj.18.483;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; RCB; -; https://web.archive.org/web/20230328160254/https://cell.brc.riken.jp/en/DNA_barcoding
CC   Group: Amphibian cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Pelophylax nigromaculatus origin but found to be from Bufo japonicus formosus (RCB=RCB1733).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00568.
CC   Doubling time: 28.8 days (Note=At 33th passage) (DOI=10.2108/zsj.18.483).
CC   Discontinued: RCB; RCB1733; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanotic melanocyte; CL=CL_0002566.
OX   NCBI_TaxID=400544; ! Bufo japonicus formosus (Eastern-Japanese common toad)
SX   Sex unspecified
AG   Froglet
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   LAH2
AC   CVCL_6667
DR   CLO; CLO_0050159
DR   RCB; RCB1735
DR   Wikidata; Q54901903
RX   DOI=10.2108/zsj.18.483;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; RCB; -; https://web.archive.org/web/20230328160254/https://cell.brc.riken.jp/en/DNA_barcoding
CC   Group: Amphibian cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Pelophylax nigromaculatus origin but found to be from Pelophylax porosus brevipodus. LAH2 may be identical to LAH3 (Cellosaurus=CVCL_6668) (RCB=RCB1735).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00569.
CC   Doubling time: 7.7 days (Note=At 39th passage) (DOI=10.2108/zsj.18.483).
CC   Discontinued: RCB; RCB1735; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Amelanotic melanocyte; CL=CL_0002567.
CC   Breed/subspecies: KM stock.
OX   NCBI_TaxID=88447; ! Pelophylax porosus brevipodus (Nagoya Daruma pond frog)
SX   Sex unspecified
AG   Froglet
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   LAH3
AC   CVCL_6668
DR   CLO; CLO_0050156
DR   RCB; RCB1734
DR   Wikidata; Q54901904
RX   DOI=10.2108/zsj.18.483;
CC   Group: Amphibian cell line.
CC   Doubling time: 3.7 days (Note=At 113th passage) (DOI=10.2108/zsj.18.483).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Amelanotic melanocyte; CL=CL_0002567.
CC   Breed/subspecies: BR stock.
OX   NCBI_TaxID=88447; ! Pelophylax porosus brevipodus (Nagoya Daruma pond frog)
SX   Sex unspecified
AG   Froglet
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   LAL-B
AC   CVCL_A1LR
DR   Wikidata; Q102114450
RX   PubMed=29367285;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   LAL-B#2
AC   CVCL_A1LS
SY   LAL-B #2
DR   Wikidata; Q102114451
RX   PubMed=29367285;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   LAL-B#3
AC   CVCL_A1LT
DR   Wikidata; Q102114452
RX   PubMed=29367285;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   LALW-2
AC   CVCL_K244
DR   Wikidata; Q54901905
RX   PubMed=2720561;
RX   PubMed=6609263;
CC   Characteristics: Established from a xenograft.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   LAM
AC   CVCL_E749
DR   dbMHC; 48942
DR   ECACC; 94050345
DR   IHW; IHW09271
DR   IPD-IMGT/HLA; 10960
DR   Wikidata; Q54901906
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*29:02:01; B*44:03; C*16 (IPD-IMGT/HLA=10960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94050345; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   LAM-I
AC   CVCL_9152
SY   LAM I; 2AB1-IA10
DR   CLO; CLO_0001242
DR   ATCC; HB-8210
DR   Wikidata; Q54901907
RX   Patent=US4642293;
RX   PubMed=6632775;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8210.
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: Mouse laminin GP-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LAM-II
AC   CVCL_KB72
SY   LAM II; 3HA6-D6
DR   Wikidata; Q54901908
RX   Patent=US4642293;
RX   PubMed=6632775;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse laminin GP-2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   LAM1
AC   CVCL_W912
SY   LAM-1; Lam-1
DR   ABM; T8255
DR   cancercelllines; CVCL_W912
DR   Cosmic; 1054587
DR   Wikidata; Q54901909
RX   PubMed=17199440;
RX   PubMed=25675381;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Ile85Serfs*33 (c.249_252delGTCT) (p.Leu83fs); ClinVar=VCV000016693; Zygosity=Unspecified (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:28958; NUP93; Simple; p.Gln15Ter (c.43C>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9822; RAD51B; Simple; p.Gln270Ter (c.808C>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154del (c.460_462delGGC); Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left subcarinal lymph node; UBERON=UBERON_8480055.
ST   Source(s): PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 8,12
ST   D18S51: 15
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 19,22
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   LAM136
AC   CVCL_RP38
DR   ABM; T8256
DR   cancercelllines; CVCL_RP38
DR   Wikidata; Q54901910
RX   PubMed=25675381;
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Heterozygous (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 10,13
ST   D21S11: 31.2,32.2
ST   D3S1358: 14,18
ST   D5S818: 8,11
ST   D7S820: 9,11
ST   D8S1179: 10,12
ST   FGA: 22,26
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   LAM2
AC   CVCL_D3L2
DR   Wikidata; Q127382583
RX   PubMed=2439198;
RX   PubMed=2578439;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human 100-120 kDa glycoprotein on membrane of lung small cell and squamous carcinomas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   LAM8
AC   CVCL_D3L3
DR   Wikidata; Q127382584
RX   PubMed=2439198;
RX   PubMed=3004719;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human sialoglycoprotein antigen sGP90-135 on membrane of lung small cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   LAMA-84
AC   CVCL_0388
SY   Lama-84; LAMA84; Lama84
DR   BTO; BTO_0004465
DR   CLO; CLO_0007238
DR   MCCL; MCC:0000283
DR   CLDB; cl3168
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473363
DR   BioSample; SAMN10988484
DR   cancercelllines; CVCL_0388
DR   CCRID; 1101HUM-PUMC000685
DR   Cell_Model_Passport; SIDM00346
DR   ChEMBL-Cells; CHEMBL3308267
DR   ChEMBL-Targets; CHEMBL2366090
DR   CLS; 300261
DR   Cosmic; 787500
DR   Cosmic; 907783
DR   Cosmic; 1012081
DR   Cosmic; 1019834
DR   Cosmic; 1026569
DR   Cosmic; 1078729
DR   Cosmic-CLP; 907783
DR   DepMap; ACH-000301
DR   DSMZ; ACC-168
DR   DSMZCellDive; ACC-168
DR   EGA; EGAS00001000978
DR   GDSC; 907783
DR   GEO; GSM887262
DR   GEO; GSM888337
DR   GEO; GSM1670031
DR   IARC_TP53; 21457
DR   LiGeA; CCLE_403
DR   LINCS_LDP; LCL-1109
DR   Lonza; 961
DR   Millipore; SCC140
DR   PharmacoDB; LAMA84_818_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0388
DR   PubChem_Cell_line; CVCL_0388
DR   Wikidata; Q54901914
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3476310;
RX   PubMed=7996872;
RX   PubMed=8693292;
RX   PubMed=9257809;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=20809971;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Doubling time: 48 hours (PubMed=3476310); 36 hours (PubMed=25984343); ~50 hours (DSMZ=ACC-168).
CC   HLA typing: A*02:01:01,25:01:01; B*18:01:01,44:02:01; C*05:01:01,12:03:01; DPA1*01:03:01,02:01:01; DQB1*06:02:01,06:02:01; DRA*01:01:01,01:02:03; DRB1*15:01:01,15:01:01 (DSMZCellDive=ACC-168).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=20809971; DepMap=ACH-000301).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (Cosmic-CLP=907783; DepMap=ACH-000301).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=14.08%; Native American=0%; East Asian, North=1.13%; East Asian, South=1.46%; South Asian=1.64%; European, North=29.64%; European, South=52.05% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): CCRID=1101HUM-PUMC000685; CLS=300261; Cosmic-CLP=907783; DSMZ=ACC-168; Millipore=SCC140
ST   Amelogenin: X
ST   CSF1PO: 8,11,12 (DSMZ=ACC-168)
ST   CSF1PO: 11,12 (CCRID=1101HUM-PUMC000685; Cosmic-CLP=907783; Millipore=SCC140)
ST   CSF1PO: 11,12,13 (CLS=300261)
ST   D12S391: 18,24
ST   D13S317: 11 (CLS=300261; Cosmic-CLP=907783; DSMZ=ACC-168; Millipore=SCC140)
ST   D13S317: 11,12 (CCRID=1101HUM-PUMC000685)
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 15,15.3
ST   D21S11: 29,30,31 (CLS=300261; DSMZ=ACC-168)
ST   D21S11: 29,31 (CCRID=1101HUM-PUMC000685; Millipore=SCC140)
ST   D2S1338: 17 (CLS=300261; DSMZ=ACC-168)
ST   D2S1338: 17,19 (CCRID=1101HUM-PUMC000685)
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D6S1043: 10,20
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 10 (CLS=300261; Cosmic-CLP=907783; DSMZ=ACC-168)
ST   TPOX: 10,11 (CCRID=1101HUM-PUMC000685; Millipore=SCC140)
ST   vWA: 14,17
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   LAMA-87
AC   CVCL_1826
SY   Lama-87; LAMA87
DR   BTO; BTO_0004466
DR   CLO; CLO_0007239
DR   CLDB; cl55
DR   BioSample; SAMN03473337
DR   Cell_Model_Passport; SIDM01230
DR   Cosmic; 787501
DR   DSMZ; ACC-270
DR   DSMZCellDive; ACC-270
DR   Millipore; SCC138
DR   Wikidata; Q54901915
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7996872;
RX   PubMed=9257809;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Characteristics: Established after subcutaneous transplantation of parent cells into estrone-treated nude mice.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-270).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-270; Millipore=SCC138
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 10
ST   vWA: 14,17
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0388 ! LAMA-84
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   LAMA-88
AC   CVCL_9540
SY   Lama-88; LAMA88
DR   Wikidata; Q54901916
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7996872;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0388 ! LAMA-84
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   LAMA84-r
AC   CVCL_DP57
DR   ATCC; CRL-3348
DR   Wikidata; Q54901917
RX   PubMed=10910924;
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3348
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 10
ST   vWA: 14,17
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0388 ! LAMA-84
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   LAMA84-rn
AC   CVCL_DP54
DR   Wikidata; Q54901918
RX   PubMed=19047160;
CC   Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0388 ! LAMA-84
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   LAMA84-s
AC   CVCL_UE08
DR   ATCC; CRL-3347
DR   Wikidata; Q95981211
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3347
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0388 ! LAMA-84
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   LAMA84R
AC   CVCL_AE17
SY   LAMA84-R
DR   Wikidata; Q54901919
RX   PubMed=10688835;
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys319Ter (c.955A>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0388 ! LAMA-84
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   LAN-188
AC   CVCL_1828
DR   CLO; CLO_0007241
DR   CLDB; cl3169
DR   Wikidata; Q54901920
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Population: Caucasian.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   LaNCE hiPSC-07
AC   CVCL_WR66
SY   hiPSC-07
DR   Wikidata; Q95981214
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 12,19
ST   D19S433: 12.2,13
ST   D21S11: 28,29
ST   D2S1338: 17,20
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 19,23
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-08
AC   CVCL_WR67
SY   hiPSC-08
DR   Wikidata; Q95981215
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D19S433: 12,14
ST   D21S11: 28,31.2
ST   D2S1338: 16,19
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-09
AC   CVCL_WR68
SY   hiPSC-09
DR   Wikidata; Q95981217
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 15,17
ST   D19S433: 13,16
ST   D21S11: 30,32.2
ST   D2S1338: 17,22
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-12
AC   CVCL_WR69
SY   hiPSC-12
DR   Wikidata; Q95981218
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,16
ST   FGA: 21,24
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-15
AC   CVCL_WR70
SY   hiPSC-15
DR   Wikidata; Q95981219
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 9,10
ST   D18S51: 16,17
ST   D19S433: 11,14
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-16
AC   CVCL_WR71
SY   hiPSC-16; IPSC16; iPS-16; LANCEi020-A
DR   hPSCreg; LANCEi020-A
DR   Wikidata; Q95981220
RX   PubMed=29433076;
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,16
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   LaNCE hiPSC-17
AC   CVCL_WR72
SY   hiPSC-17
DR   Wikidata; Q95981221
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D18S51: 16,18
ST   D19S433: 12,15
ST   D21S11: 29,33.2
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 12
ST   FGA: 20,24
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-18
AC   CVCL_WR73
SY   hiPSC-18
DR   Wikidata; Q95981222
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 16,22
ST   D19S433: 11,16.2
ST   D21S11: 29,30
ST   D2S1338: 16,17
ST   D3S1358: 14,16
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-20
AC   CVCL_WR74
SY   hiPSC-20
DR   Wikidata; Q95981223
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 12,16
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 24,26
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-21
AC   CVCL_WR75
SY   hiPSC-21
DR   Wikidata; Q95981225
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 27,29
ST   D2S1338: 17,21
ST   D3S1358: 13,15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   TH01: 7,8
ST   TPOX: 10,12
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-22
AC   CVCL_WR76
SY   hiPSC-22
DR   Wikidata; Q95981226
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 22,28
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-23
AC   CVCL_WR77
SY   hiPSC-23
DR   Wikidata; Q95981229
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 8,11
ST   D18S51: 15,18
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 23.2,27.2
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-24
AC   CVCL_WR78
SY   hiPSC-24
DR   Wikidata; Q95981230
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 10,14
ST   FGA: 21,26
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-26
AC   CVCL_WR79
SY   hiPSC-26
DR   Wikidata; Q95981231
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,18
ST   D19S433: 13.2,14
ST   D21S11: 28,29
ST   D2S1338: 23,24
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 9,13
ST   D8S1179: 14,15
ST   FGA: 19,24
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-27
AC   CVCL_WR80
SY   hiPSC-27
DR   Wikidata; Q95981234
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 8,13
ST   D18S51: 15,16
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 23,28.2
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-28
AC   CVCL_WR81
SY   hiPSC-28; iPS-28; hiPS 28; iPS-HT4; iPS 28 - HT4; LANCEi029-A
DR   hPSCreg; LANCEi029-A
DR   Wikidata; Q95981235
RX   PubMed=29433076;
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 20
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3117; Hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   LaNCE hiPSC-29
AC   CVCL_WR82
SY   hiPSC-29
DR   Wikidata; Q95981236
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D19S433: 13,15.2
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-30
AC   CVCL_WR83
SY   hiPSC-30
DR   Wikidata; Q95981239
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 13,15.2
ST   D21S11: 28,31
ST   D2S1338: 24,25
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 21,24
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-31
AC   CVCL_WR84
SY   hiPSC-31
DR   Wikidata; Q95981240
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 12,14
ST   D19S433: 12.2,12.3
ST   D21S11: 28,31
ST   D2S1338: 16,21
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-32
AC   CVCL_WR85
SY   hiPSC-32; LANCEi007-A
DR   hPSCreg; LANCEi007-A
DR   Wikidata; Q95981241
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D19S433: 15,17.2
ST   D21S11: 28
ST   D2S1338: 17,24
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 20,22
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 11,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-33
AC   CVCL_WR86
SY   hiPSC-33
DR   Wikidata; Q95981243
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 13,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 22,26
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-34
AC   CVCL_WR87
SY   hiPSC-34; LANCEi009-A
DR   hPSCreg; LANCEi009-A
DR   Wikidata; Q95981244
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 12,19
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 21,22
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-35
AC   CVCL_XD80
SY   LANCEi011-A; iPS-35; iPS-35-LCS; iPS-PD/GD
DR   hPSCreg; LANCEi011-A
DR   Wikidata; Q95981245
RX   PubMed=31401455;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=31401455).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31401455).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 12
//
ID   LaNCE hiPSC-36
AC   CVCL_XD81
SY   LANCEi012-A; iPS-36; iPS-36-EB; iPS-PD/GBA1
DR   hPSCreg; LANCEi012-A
DR   Wikidata; Q95981246
RX   PubMed=31401455;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31401455).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   LaNCE hiPSC-37
AC   CVCL_XD82
SY   LANCEi013-A; iPS-37; iPS-37-GFN; iPS-PD/GBA2
DR   hPSCreg; LANCEi013-A
DR   Wikidata; Q95981247
RX   PubMed=31401455;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (PubMed=31401455).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=31401455).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 11
//
ID   LaNCE hiPSC-38
AC   CVCL_WR88
SY   hiPSC-38; iPS-38; iPS-38-HBS; iPS-PD1; LANCEi014-A
DR   hPSCreg; LANCEi014-A
DR   Wikidata; Q95981249
RX   PubMed=29433076;
RX   PubMed=31710912;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 15
ST   D21S11: 28,31.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,13
ST   FGA: 20,22
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   LaNCE hiPSC-39
AC   CVCL_WR89
SY   hiPSC-39; iPS-39-PLS; iPS-39; iPS-PD2; LANCEi015-A
DR   hPSCreg; LANCEi015-A
DR   Wikidata; Q95981250
RX   PubMed=29433076;
RX   PubMed=31710912;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 19,28
ST   TH01: 8,9
ST   TPOX: 9
ST   vWA: 15,18
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   LaNCE hiPSC-40
AC   CVCL_WR90
SY   hiPSC-40; iPS-40-ACA; iPS-40; iPS-PD3; LANCEi016-A
DR   hPSCreg; LANCEi016-A
DR   Wikidata; Q95981251
RX   PubMed=29433076;
RX   PubMed=31710912;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 10
ST   D18S51: 15,18
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 16,22
ST   D3S1358: 16,17
ST   D5S818: 7,12
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   LaNCE hiPSC-41
AC   CVCL_WR91
SY   hiPSC-41; iPS-41-MHO; iPS-41; iPS-CT1; LANCEi017-A
DR   hPSCreg; LANCEi017-A
DR   Wikidata; Q95981252
RX   PubMed=29433076;
RX   PubMed=31710912;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 25
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-42
AC   CVCL_WR92
SY   hiPSC-42; iPS-42-MCA; iPS-42; iPS-CT2; LANCEi018-A
DR   hPSCreg; LANCEi018-A
DR   Wikidata; Q95981253
RX   PubMed=29433076;
RX   PubMed=31710912;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 11,13
ST   D21S11: 30,32.2
ST   D2S1338: 19,20
ST   D3S1358: 14,17
ST   D5S818: 10,13
ST   D7S820: 8,9
ST   D8S1179: 14
ST   FGA: 23,26
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-43
AC   CVCL_WR93
SY   hiPSC-43
DR   Wikidata; Q95981254
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 14.2,15
ST   D21S11: 31.2
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-44
AC   CVCL_WR94
SY   hiPSC-44
DR   Wikidata; Q95981256
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D19S433: 14,15.2
ST   D21S11: 27,29
ST   D2S1338: 17,23
ST   D3S1358: 16,18
ST   D5S818: 11,14
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 19,22
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-45
AC   CVCL_WR95
SY   hiPSC-45
DR   Wikidata; Q95981257
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 18,22
ST   D3S1358: 16
ST   D5S818: 11,14
ST   D7S820: 8,14
ST   D8S1179: 11,14
ST   FGA: 23,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-46
AC   CVCL_WR96
SY   hiPSC-46
DR   Wikidata; Q95981259
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 15.2
ST   D21S11: 29,31.2
ST   D2S1338: 20
ST   D3S1358: 16,18
ST   D5S818: 12,14
ST   D7S820: 8,9
ST   D8S1179: 14,15
ST   FGA: 22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-47
AC   CVCL_WR97
SY   hiPSC-47
DR   Wikidata; Q95981260
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 8,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 16,18.2
ST   D21S11: 30,34
ST   D2S1338: 17,25
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,25
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-49
AC   CVCL_WR98
SY   hiPSC-49
DR   Wikidata; Q95981261
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 10.2,14
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 9,12
ST   D8S1179: 11,13
ST   FGA: 22
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 11,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-50
AC   CVCL_WR99
SY   hiPSC-50
DR   Wikidata; Q95981263
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 12,15
ST   D21S11: 28,31.2
ST   D2S1338: 24,25
ST   D3S1358: 14,17
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-51
AC   CVCL_WS00
SY   hiPSC-51
DR   Wikidata; Q95981264
RX   PubMed=29433076;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 8,10
ST   D18S51: 16,17
ST   D19S433: 10.2,13.2
ST   D21S11: 29,32.2
ST   D2S1338: 19,22
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   LaNCE hiPSC-55
AC   CVCL_A8XC
SY   iPS-55; hiPS 55; iPS-HT1; iPS 55 - HT1; LANCEi026-A
DR   hPSCreg; LANCEi026-A
DR   Wikidata; Q108820648
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3117; Hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LaNCE hiPSC-56
AC   CVCL_A8XD
SY   iPS-56; hiPS 56; iPS-HT2; iPS 56 - HT2; LANCEi027-A
DR   hPSCreg; LANCEi027-A
DR   Wikidata; Q108820649
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3117; Hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LaNCE hiPSC-57
AC   CVCL_A8XG
SY   iPS-57; hiPS 57; iPS-HT5; iPS 57 - HT5; LANCEi030-A
DR   hPSCreg; LANCEi030-A
DR   Wikidata; Q108820650
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3117; Hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LaNCE hiPSC-58
AC   CVCL_A8WZ
SY   iPS-58; hiPS 58; iPS-NT1; iPS 58 - NT1; LANCEi023-A
DR   hPSCreg; LANCEi023-A
DR   Wikidata; Q108820651
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LaNCE hiPSC-59
AC   CVCL_A8XE
SY   iPS-59; hiPS 59; iPS-HT3; iPS 59 - HT3; LANCEi028-A
DR   hPSCreg; LANCEi028-A
DR   Wikidata; Q108820652
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3117; Hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LaNCE hiPSC-60
AC   CVCL_A8XH
SY   iPS-60; hiPS 60; iPS-HT6; iPS 60 - HT6; LANCEi031-A
DR   hPSCreg; LANCEi031-A
DR   Wikidata; Q108820653
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3117; Hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LaNCE hiPSC-61
AC   CVCL_A8XA
SY   iPS-61; hiPS 61; iPS-NT2; iPS 61 - NT2; LANCEi024-A
DR   hPSCreg; LANCEi024-A
DR   Wikidata; Q108820654
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LaNCE hiPSC-62
AC   CVCL_A8XB
SY   iPS-62; hiPS 62; iPS-NT3; iPS 62 - NT3; LANCEi025-A
DR   hPSCreg; LANCEi025-A
DR   Wikidata; Q108820655
RX   PubMed=34088012;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LAnCE hiPSC-63
AC   CVCL_WS01
SY   hiPSC-63; LANCEi008-A
DR   hPSCreg; LANCEi008-A
DR   Wikidata; Q95981265
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   LAnCE hiPSC-64
AC   CVCL_WS02
SY   hiPSC-64; LANCEi003-A
DR   hPSCreg; LANCEi003-A
DR   Wikidata; Q95981267
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   LAnCE hiPSC-65
AC   CVCL_WS03
SY   hiPSC-65; LANCEi004-A
DR   hPSCreg; LANCEi004-A
DR   Wikidata; Q95981268
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   LAnCE hiPSC-66
AC   CVCL_WS04
SY   hiPSC-66; LANCEi002-A
DR   hPSCreg; LANCEi002-A
DR   Wikidata; Q95981269
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   LAnCE hiPSC-68
AC   CVCL_WS05
SY   hiPSC-68; LANCEi005-A
DR   hPSCreg; LANCEi005-A
DR   Wikidata; Q95981271
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   LAnCE hiPSC-69
AC   CVCL_WS06
SY   hiPSC-69; LANCEi010-A
DR   hPSCreg; LANCEi010-A
DR   Wikidata; Q95981273
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   LAnCE hiPSC-70
AC   CVCL_WS07
SY   hiPSC-70; LANCEi006-A
DR   hPSCreg; LANCEi006-A
DR   Wikidata; Q95981274
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   LANCEi020-A-1
AC   CVCL_A0KT
SY   iPS-16-WT1; IPSC16-WT1
DR   hPSCreg; LANCEi020-A-1
DR   Wikidata; Q108820656
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LANCEi020-A-10
AC   CVCL_A0KU
SY   iPS-16-FBN1-DN/DN; IPSC16-FBN1-DN/DN
DR   hPSCreg; LANCEi020-A-10
DR   Wikidata; Q108820657
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776).
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-30_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LANCEi020-A-2
AC   CVCL_A0KV
SY   iPS-16-WT2; IPSC16-WT2
DR   hPSCreg; LANCEi020-A-2
DR   Wikidata; Q108820658
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LANCEi020-A-3
AC   CVCL_A0KW
SY   iPS-16-WT3; IPSC16-WT3
DR   hPSCreg; LANCEi020-A-3
DR   Wikidata; Q108820659
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LANCEi020-A-4
AC   CVCL_A0KX
SY   iPS-16-FBN1-HI1; IPSC16-FBN1-HI1
DR   hPSCreg; LANCEi020-A-4
DR   Wikidata; Q108820660
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   LANCEi020-A-5
AC   CVCL_A0KY
SY   iPS-16-FBN1-HI2; IPSC16-FBN1-HI2
DR   hPSCreg; LANCEi020-A-5
DR   Wikidata; Q108820661
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   LANCEi020-A-6
AC   CVCL_A0KZ
SY   iPS-16-FBN1-HI3; IPSC16-FBN1-HI3
DR   hPSCreg; LANCEi020-A-6
DR   Wikidata; Q108820662
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   LANCEi020-A-7
AC   CVCL_A0LA
SY   iPS-16-FBN1-DN1; IPSC16-FBN1-DN1
DR   hPSCreg; LANCEi020-A-7
DR   Wikidata; Q108820663
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LANCEi020-A-8
AC   CVCL_A0LB
SY   iPS-16-FBN1-DN2; IPSC16-FBN1-DN2
DR   hPSCreg; LANCEi020-A-8
DR   Wikidata; Q108820664
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LANCEi020-A-9
AC   CVCL_A0LC
SY   iPS-16-FBN1-KO; IPSC16-FBN1-KO
DR   hPSCreg; LANCEi020-A-9
DR   Wikidata; Q108820665
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WR71 ! LaNCE hiPSC-16
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   LANCEi021-A
AC   CVCL_A9AD
SY   IPSC2; iPS-2; iPS-MFS1
DR   hPSCreg; LANCEi021-A
DR   Wikidata; Q108820666
RX   PubMed=34062330;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Tyr2272Asp (c.6814T>G); Zygosity=Heterozygous (PubMed=34062330).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LANCEi022-A
AC   CVCL_A9AE
SY   IPSC3; iPS-3; iPS-MFS2
DR   hPSCreg; LANCEi022-A
DR   Wikidata; Q108820667
RX   PubMed=34062330;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys617Terfs (c.1851_1852delTG); Zygosity=Heterozygous (PubMed=34062330).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   laNK
AC   CVCL_VN54
SY   low affinity NK; CD16-F158.NK-92.05
DR   Wikidata; Q95981275
WW   Provider; Brink Biologics; -; https://brinkbiologics.com/platform/
CC   Population: Caucasian.
CC   Characteristics: No longer dependent on IL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers for this cell line. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
ID   laNK GFP
AC   CVCL_VN55
SY   GFP laNK; GFP+CD16-F158.NK-92.05
DR   Wikidata; Q95981276
WW   Provider; Brink Biologics; -; https://brinkbiologics.com/platform/
CC   Population: Caucasian.
CC   Characteristics: No longer dependent on IL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers for this cell line. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN54 ! laNK
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
ID   LanthaScreen Akt HEK 293E
AC   CVCL_ZJ07
SY   LanthaScreen AKT HEK293E; LanthaScreen Akt HEK293E
DR   Wikidata; Q98126846
RX   PubMed=19196698;
WW   Provider; Thermo Fisher; K1615; https://www.thermofisher.com/order/catalog/product/K1615
CC   Characteristics: Transfected with an EmGFP-AKT1 construct whose expression is under the control of a CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LanthaScreen ATF2 (19-106) A549
AC   CVCL_ZI99
DR   cancercelllines; CVCL_ZI99
DR   Wikidata; Q98126848
WW   Provider; Thermo Fisher; K1679B; https://www.thermofisher.com/order/catalog/product/K1679B
CC   Population: Caucasian.
CC   Characteristics: Transfected with an EmGFP-ATF2(19-106) construct whose expression is under the control of a CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:784; ATF2 (Note=With p.Met1_Asn18del and p.Met107_Ser505del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LanthaScreen c-Jun (1-79) HeLa
AC   CVCL_ZJ09
DR   Wikidata; Q98126849
WW   Provider; Thermo Fisher; K1680; https://www.thermofisher.com/order/catalog/product/K1680
CC   Population: African American.
CC   Characteristics: Transfected with an EmGFP-JUN(1-79) construct whose expression is under the control of a CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6204; JUN (Note=With p.Ile80_Phe331del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1425.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   LanthaScreen ERK2 A375
AC   CVCL_ZJ05
DR   cancercelllines; CVCL_ZJ05
DR   Wikidata; Q98126851
WW   Provider; Thermo Fisher; K1798; https://www.thermofisher.com/order/catalog/product/K1798
CC   Population: Caucasian.
CC   Characteristics: Transfected with an EmGFP-MAPK1/ERK2 construct whose expression is under the control of a CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6871; MAPK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   LanthaScreen ERK2 U2OS
AC   CVCL_ZJ00
DR   Wikidata; Q98126852
WW   Provider; Thermo Fisher; K1587; https://www.thermofisher.com/order/catalog/product/K1587
CC   Population: Caucasian.
CC   Characteristics: Transfected with an EmGFP-MAPK1/ERK2 construct whose expression is under the control of a CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6871; MAPK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LanthaScreen IGF-1R GripTite
AC   CVCL_ZJ03
DR   Wikidata; Q98126853
WW   Provider; Thermo Fisher; K1834; https://www.thermofisher.com/order/catalog/product/K1834
CC   Characteristics: Transfected with an IGF1R-YFP construct whose expression is under the control of a CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5465; IGF1R.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U428 ! GripTite 293 MSR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   LanthaScreen IkB alpha GripTite
AC   CVCL_ZI97
DR   Wikidata; Q98126854
WW   Provider; Thermo Fisher; K1681B; https://www.thermofisher.com/order/catalog/product/K1681B
CC   Characteristics: Transfected with an EmGFP-NFKBIA construct whose expression is under the control of a CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U428 ! GripTite 293 MSR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   LanthaScreen PDCD4 HEK 293E
AC   CVCL_ZJ06
SY   LanthaScreen PDCD4 HEK293E
DR   Wikidata; Q98126855
RX   PubMed=19196698;
WW   Provider; Thermo Fisher; K1593; https://www.thermofisher.com/order/catalog/product/K1593
CC   Characteristics: Transfected with an EmGFP-PDCD4 construct whose expression is under the control of a CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8763; PDCD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LanthaScreen PRAS40 HEK 293E
AC   CVCL_ZJ08
SY   LanthaScreen PRAS40 HEK293E; LanthaScreen PRAS40 293E
DR   Wikidata; Q98126856
RX   PubMed=19196698;
WW   Provider; Thermo Fisher; K1528; https://www.thermofisher.com/order/catalog/product/K1528
CC   Characteristics: Transfected with an EmGFP-AKT1S1/PRAS40 construct whose expression is under the control of a CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28426; AKT1S1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LanthaScreen STAT1 U2OS
AC   CVCL_ZJ04
DR   Wikidata; Q98126857
WW   Provider; Thermo Fisher; K1469; https://www.thermofisher.com/order/catalog/product/K1469
CC   Population: Caucasian.
CC   Characteristics: Transfected with an EmGFP-STAT1 construct whose expression is under the control of a CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11362; STAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LanthaScreen STAT3 GripTite
AC   CVCL_ZI98
DR   Wikidata; Q98126859
WW   Provider; Thermo Fisher; K1488; https://www.thermofisher.com/order/catalog/product/K1488
CC   Characteristics: Transfected with an EmGFP-STAT3 construct whose expression is under the control of a CMV promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U428 ! GripTite 293 MSR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   LanthaScreen STAT5 (JAK2 V617F) U2OS
AC   CVCL_ZJ10
DR   Wikidata; Q98126860
WW   Provider; Thermo Fisher; K1588; https://www.thermofisher.com/order/catalog/product/K1588
CC   Population: Caucasian.
CC   Characteristics: Transduced with a EmGFP-STAT5A construct and transfected with a GST-JAK2(V617F) construct whose expression are under the control of a CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11366; STAT5A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6192; JAK2 (Note=With p.Val617Phe).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LanthaScreen STAT5 TF-1
AC   CVCL_ZJ11
DR   cancercelllines; CVCL_ZJ11
DR   Wikidata; Q98126861
WW   Provider; Thermo Fisher; K1598; https://www.thermofisher.com/order/catalog/product/K1598
CC   Population: Japanese.
CC   Characteristics: Transduced with an EmGFP-STAT5A construct whose expression is under the control of a CMV promoter.
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11366; STAT5A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   LAP 4108-6
AC   CVCL_V114
DR   CLO; CLO_0007244
DR   CLDB; cl3174
DR   IHW; 11w 8306
DR   Wikidata; Q54901921
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LAP-35
AC   CVCL_A096
SY   LAP35; IOR/LAP-35; IOR-LAP-35
DR   Cosmic; 1078388
DR   Cosmic; 1082509
DR   Wikidata; Q54901922
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.5282/edoc.27750;
RX   PubMed=2177080;
RX   PubMed=8040301;
RX   PubMed=8617485;
RX   PubMed=11423975;
RX   PubMed=11891184;
RX   PubMed=18160777;
CC   From: Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli; Bologna; Italy.
CC   Doubling time: 49 hours (PubMed=2177080).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=8040301; PubMed=11423975; PubMed=11891184).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   LAP1
AC   CVCL_JY58
SY   LAP-1
DR   Wikidata; Q54901923
RX   PubMed=2536298;
RX   PubMed=3025840;
CC   Characteristics: Has a complete defect in Na+/H+ antiporter activity.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   LAPC-3
AC   CVCL_4743
SY   LAPC3; Los Angeles Prostate Cancer-3
DR   Wikidata; Q54901925
RX   Patent=US6365797;
RX   PubMed=9095173;
RX   PubMed=10861745;
RX   PubMed=12725112;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1440.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   LAPC-4
AC   CVCL_4744
SY   LAPC4; Los Angeles Prostate Cancer-4
DR   BTO; BTO_0002997
DR   EFO; EFO_0005392
DR   ATCC; CRL-13009
DR   BioSample; SAMN03471350
DR   cancercelllines; CVCL_4744
DR   ChEMBL-Cells; CHEMBL3308023
DR   ChEMBL-Targets; CHEMBL613292
DR   Cosmic; 1330913
DR   Cosmic; 1689711
DR   Cosmic; 2537793
DR   Cosmic; 2580299
DR   GEO; GSM91931
DR   GEO; GSM648820
DR   GEO; GSM1374616
DR   GEO; GSM1633305
DR   GEO; GSM1633306
DR   GEO; GSM1633307
DR   GEO; GSM2069506
DR   GEO; GSM2069507
DR   GEO; GSM2069508
DR   GEO; GSM2069509
DR   GEO; GSM2069510
DR   GEO; GSM2069511
DR   GEO; GSM2069512
DR   GEO; GSM2069513
DR   GEO; GSM2649999
DR   GEO; GSM2650000
DR   GEO; GSM2650001
DR   GEO; GSM2650002
DR   GEO; GSM2650003
DR   GEO; GSM2650004
DR   GEO; GSM3145593
DR   GEO; GSM3145715
DR   GEO; GSM5402198
DR   IARC_TP53; 18889
DR   PRIDE; PXD006561
DR   Progenetix; CVCL_4744
DR   PubChem_Cell_line; CVCL_4744
DR   Wikidata; Q29565860
RX   CelloPub=CLPUB00698;
RX   Patent=US6365797;
RX   PubMed=9095173;
RX   PubMed=10861745;
RX   PubMed=11304728;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=15486987;
RX   PubMed=15643173;
RX   PubMed=21698104;
RX   PubMed=21750403;
RX   PubMed=25960936;
RX   PubMed=28145883;
RX   PubMed=29194687;
RX   PubMed=29739788;
RX   PubMed=34402095;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/LAPC4
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1441.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (PubMed=21698104; PubMed=21750403).
CC   Doubling time: 60.87 hours (JWGray panel).
CC   HLA typing: A*01:01,02:01; B*14:06,46:01; C*05:01,05:01 (PubMed=25960936).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=11304728; PubMed=14518029).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ATCC; CRL-13009; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-13009; PubMed=11304728; PubMed=14518029
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9,10,11,12 (ATCC=CRL-13009)
ST   D13S317: 10,12 (PubMed=11304728; PubMed=14518029)
ST   D16S539: 9
ST   D18S51: 14,15,22
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 11,13 (PubMed=11304728; PubMed=14518029)
ST   D5S818: 12 (ATCC=CRL-13009)
ST   D7S820: 10,10.3,11 (ATCC=CRL-13009)
ST   D7S820: 11 (PubMed=11304728; PubMed=14518029)
ST   D8S1179: 13
ST   FGA: 21,22
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,16 (ATCC=CRL-13009)
ST   vWA: 16 (PubMed=11304728; PubMed=14518029)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   LAPC-4*2
AC   CVCL_4745
SY   LAPC4*2; LAPC-4(2); LAPC-4 squared
DR   cancercelllines; CVCL_4745
DR   Wikidata; Q54901927
RX   PubMed=12894499;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4744 ! LAPC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   LAPC-4-EnzR
AC   CVCL_RA56
DR   cancercelllines; CVCL_RA56
DR   GEO; GSM2069514
DR   GEO; GSM2069515
DR   GEO; GSM2069516
DR   GEO; GSM2069517
DR   Wikidata; Q54901926
RX   PubMed=27036029;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4744 ! LAPC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   LAPC-9
AC   CVCL_4746
SY   LAPC9; Los Angeles Prostate Cancer-9
DR   EFO; EFO_0005393
DR   Cosmic; 2580123
DR   Wikidata; Q54901928
RX   Patent=US6365797;
RX   PubMed=10519419;
RX   PubMed=10861745;
RX   PubMed=15643173;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1442.
CC   Derived from site: Metastatic; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   LAPC4-AR
AC   CVCL_C7X9
DR   Wikidata; Q123032897
RX   PubMed=14702632;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4744 ! LAPC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   LAPC4-CR
AC   CVCL_A0BW
DR   cancercelllines; CVCL_A0BW
DR   GEO; GSM5402199
DR   Wikidata; Q108820668
RX   PubMed=34402095;
CC   Characteristics: Derived after 4 passages of the parent cell line in castrated nude mice.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Doubling time: ~50 hours (PubMed=34402095).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4744 ! LAPC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 10
//
ID   LAPC4-PDR1
AC   CVCL_C0RQ
SY   LAPC4 PDR1; L4-PDR1
DR   cancercelllines; CVCL_C0RQ
DR   GEO; GSM2649993
DR   GEO; GSM2649994
DR   GEO; GSM2649995
DR   GEO; GSM2649996
DR   GEO; GSM2649997
DR   GEO; GSM2649998
DR   PRIDE; PXD006561
DR   Wikidata; Q112929984
RX   PubMed=29739788;
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4744 ! LAPC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 9
//
ID   LAPC4-SL
AC   CVCL_WZ26
SY   Stem-Like LAPC4; LAPC4-Stem Like
DR   cancercelllines; CVCL_WZ26
DR   GEO; GSM1633308
DR   GEO; GSM1633309
DR   GEO; GSM1633310
DR   Wikidata; Q95981289
RX   PubMed=28145883;
CC   Characteristics: Reprogrammed to, maintained and propagated as cancer stem-like cells (CSCs) by growth in androgen-free neural/neural crest (N/NC) stem medium.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4744 ! LAPC-4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 11
//
ID   LAQ 8251
AC   CVCL_V115
DR   CLO; CLO_0007245
DR   CLDB; cl3175
DR   IHW; 11w 8202
DR   Wikidata; Q54901929
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LARB1 1212
AC   CVCL_V116
SY   LARB1-1212
DR   CLO; CLO_0007246
DR   CLDB; cl3176
DR   IHW; 11w 8111
DR   Wikidata; Q54901930
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LASCPC-01
AC   CVCL_UE17
DR   ATCC; CRL-3356
DR   cancercelllines; CVCL_UE17
DR   GEO; GSM2050760
DR   Progenetix; CVCL_UE17
DR   Wikidata; Q95981291
RX   PubMed=27050099;
CC   Population: Caucasian.
CC   Doubling time: ~18 hours (PubMed=27050099); ~24 hours (ATCC=CRL-3356).
CC   Omics: Variations; SNP array analysis.
ST   Source(s): ATCC=CRL-3356
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C39903; Prostate adenocarcinoma with neuroendocrine differentiation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-80Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LAT
AC   CVCL_2101
SY   Lamb Aortic Tissue
DR   CLO; CLO_0007247
DR   DSMZ; ACC-349
DR   DSMZCellDive; ACC-349
DR   Wikidata; Q54901931
CC   Doubling time: ~30-50 hours (DSMZ=ACC-349).
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   Lamb
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   LAT 1
AC   CVCL_8365
DR   CLO; CLO_0007248
DR   CLDB; cl3177
DR   Wikidata; Q54901932
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 4
//
ID   LAT II
AC   CVCL_8366
DR   CLO; CLO_0007249
DR   CLDB; cl3178
DR   Wikidata; Q54901933
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 4
//
ID   LAT/LAB KO (C57)
AC   CVCL_C0LA
SY   LAT/LAB KO (C57) Macrophage Cell Line
DR   Kerafast; ENH178-FP
DR   Wikidata; Q112929987
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1342293; Lat.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1926479; Lat2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   LATIF
AC   CVCL_E750
DR   dbMHC; 48943
DR   ECACC; 94022540
DR   IHW; IHW09247
DR   IPD-IMGT/HLA; 10961
DR   Wikidata; Q54901934
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Indian.
CC   HLA typing: A*11:01:01:01,31:01:02:01; B*15:08:01,51:01:01; C*01:02:01,16:02:01; DPA1*01:03:01,02:02:02; DPB1*04:01:01:01,13:01; DQA1*02:01,03:02; DQB1*02:02:01:01,03:02:01; DRB1*07:01:01,09:01:02; DRB4*01:03:01,01:03:02 (IPD-IMGT/HLA=10961).
CC   HLA typing: A*11:01:01:01,31:01:02:01; B*15:08:01,51:01:01:01; C*01:02:01;16:02:01; DPA1*01:03:01:02,02:02:02; DPB1*04:01:01:01(350:01),13:01:01; DQA1*03:02,02:01:01; DQB1*03:02:01,02:02:01:01; DRB1*09:01:02,07:01:01; DRB4*01:03:01,01:03:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   LAU-Me190
AC   CVCL_IP27
DR   cancercelllines; CVCL_IP27
DR   Wikidata; Q54901935
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 10
//
ID   LAU-Me200
AC   CVCL_IP28
DR   cancercelllines; CVCL_IP28
DR   Wikidata; Q54901936
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-Me204.A1
AC   CVCL_IP29
DR   cancercelllines; CVCL_IP29
DR   Wikidata; Q54901937
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-Me215
AC   CVCL_IP30
DR   Wikidata; Q54901938
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   LAU-Me235
AC   CVCL_DI17
SY   LAU63
DR   cancercelllines; CVCL_DI17
DR   Cosmic; 1675358
DR   GEO; GSM566249
DR   GEO; GSM568791
DR   Progenetix; CVCL_DI17
DR   Wikidata; Q54901939
RX   PubMed=20862285;
RX   PubMed=21494657;
RX   PubMed=22197931;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Glu (c.1801A>G); ClinVar=VCV000013966; Zygosity=Unspecified (PubMed=20862285).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   LAU-Me242.B1
AC   CVCL_IP31
DR   Wikidata; Q54901940
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   LAU-Me243
AC   CVCL_IP32
DR   Wikidata; Q54901943
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   LAU-Me246.M1
AC   CVCL_DI18
SY   LAU-Me246M1; LAU108
DR   cancercelllines; CVCL_DI18
DR   Cosmic; 1675359
DR   GEO; GSM566253
DR   GEO; GSM568792
DR   Progenetix; CVCL_DI18
DR   Wikidata; Q54901941
RX   PubMed=20862285;
RX   PubMed=21494657;
RX   PubMed=22197931;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI24 ! LAU-Me246.M1-LCL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 13
//
ID   LAU-Me246.M1-LCL
AC   CVCL_DI24
SY   EBV transformed lymphoblastoid cells patient LAU108
DR   cancercelllines; CVCL_DI24
DR   GEO; GSM568786
DR   Progenetix; CVCL_DI24
DR   Wikidata; Q54901942
RX   PubMed=21494657;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI18 ! LAU-Me246.M1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   LAU-Me248.3
AC   CVCL_IP33
DR   Wikidata; Q54901945
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   LAU-Me256
AC   CVCL_S595
SY   Me 256
DR   Wikidata; Q54901946
RX   PubMed=9469433;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   LAU-Me260.LN
AC   CVCL_S596
SY   LAUMe260.LN; Me 260
DR   cancercelllines; CVCL_S596
DR   Wikidata; Q54901947
RX   PubMed=9469433;
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI21 ! LAU-T149D
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   LAU-Me261
AC   CVCL_IP34
DR   cancercelllines; CVCL_IP34
DR   Wikidata; Q54901948
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP51 ! LAU-T42B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-Me275
AC   CVCL_S597
AS   CVCL_DI19
SY   LAUMe275; Me275; Me 275; LAU50_1
DR   cancercelllines; CVCL_S597
DR   Cosmic; 1675356
DR   GEO; GSM566196
DR   GEO; GSM566255
DR   GEO; GSM566256
DR   GEO; GSM566257
DR   GEO; GSM566258
DR   GEO; GSM568793
DR   Progenetix; CVCL_DI19
DR   Progenetix; CVCL_S597
DR   Wikidata; Q54901949
RX   PubMed=9469433;
RX   PubMed=20862285;
RX   PubMed=21494657;
RX   PubMed=22197931;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI22 ! LAU-T50B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   LAU-Me276
AC   CVCL_IP35
DR   cancercelllines; CVCL_IP35
DR   Wikidata; Q54901950
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-Me280.R.LN
AC   CVCL_DI20
SY   LAU165
DR   cancercelllines; CVCL_DI20
DR   Cosmic; 1675361
DR   GEO; GSM566250
DR   GEO; GSM568783
DR   Progenetix; CVCL_DI20
DR   Wikidata; Q54901951
RX   PubMed=20862285;
RX   PubMed=21494657;
RX   PubMed=22197931;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Unspecified (PubMed=20862285).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI25 ! LAU-Me280.R.LN-LCL
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   LAU-Me280.R.LN-LCL
AC   CVCL_DI25
SY   EBV transformed lymphoblastoid cells patient LAU165
DR   cancercelllines; CVCL_DI25
DR   GEO; GSM568782
DR   Progenetix; CVCL_DI25
DR   Wikidata; Q54901952
RX   PubMed=21494657;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI20 ! LAU-Me280.R.LN
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   LAU-Me281.M1
AC   CVCL_IP36
DR   cancercelllines; CVCL_IP36
DR   Wikidata; Q54901953
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP37 ! LAU-Me281.M3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 10
//
ID   LAU-Me281.M3
AC   CVCL_IP37
DR   cancercelllines; CVCL_IP37
DR   Wikidata; Q54901954
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP36 ! LAU-Me281.M1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 10
//
ID   LAU-Me290
AC   CVCL_S598
SY   Me 290; Me290
DR   Wikidata; Q54901955
RX   PubMed=9469433;
RX   PubMed=20862285;
RX   PubMed=24581590;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   LAU-Me300
AC   CVCL_IP38
DR   cancercelllines; CVCL_IP38
DR   Wikidata; Q54901960
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   LAU-Me305
AC   CVCL_IP39
DR   cancercelllines; CVCL_IP39
DR   Wikidata; Q54901961
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP41 ! LAU-Me317
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-Me312
AC   CVCL_IP40
DR   cancercelllines; CVCL_IP40
DR   Wikidata; Q54901962
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 10
//
ID   LAU-Me317
AC   CVCL_IP41
SY   LAU-Me317.M2
DR   cancercelllines; CVCL_IP41
DR   Wikidata; Q54901963
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP39 ! LAU-Me305
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 10
//
ID   LAU-Me337
AC   CVCL_IP42
DR   Wikidata; Q54901965
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   LAU-T1255A.b1
AC   CVCL_IP43
DR   cancercelllines; CVCL_IP43
DR   Wikidata; Q54901966
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP44 ! LAU-T1255A.g2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-T1255A.g2
AC   CVCL_IP44
DR   cancercelllines; CVCL_IP44
DR   Wikidata; Q54901967
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP43 ! LAU-T1255A.b1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-T1257A
AC   CVCL_IP45
SY   LAUT1257A
DR   Wikidata; Q54901968
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP46 ! LAU-T1257C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   LAU-T1257C
AC   CVCL_IP46
DR   Wikidata; Q54901969
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP45 ! LAU-T1257A
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   LAU-T1262A
AC   CVCL_IP47
SY   LAU-T1262 A
DR   Wikidata; Q54901970
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP48 ! LAU-T1262B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   LAU-T1262B
AC   CVCL_IP48
SY   LAU-T1262 B
DR   Wikidata; Q54901971
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP47 ! LAU-T1262A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   LAU-T149D
AC   CVCL_DI21
SY   LAU149
DR   cancercelllines; CVCL_DI21
DR   Cosmic; 1675360
DR   GEO; GSM566251
DR   GEO; GSM568790
DR   Progenetix; CVCL_DI21
DR   Wikidata; Q54901972
RX   PubMed=20862285;
RX   PubMed=21494657;
RX   PubMed=22197931;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Viscera; UBERON=UBERON_0002075.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S596 ! LAU-Me260.LN
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   LAU-T331A
AC   CVCL_IP49
DR   Wikidata; Q54901973
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   LAU-T333A
AC   CVCL_IP50
DR   Wikidata; Q54901974
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   LAU-T42B
AC   CVCL_IP51
DR   cancercelllines; CVCL_IP51
DR   Wikidata; Q54901976
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=20862285).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IP34 ! LAU-Me261
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   LAU-T441A
AC   CVCL_IP52
DR   Wikidata; Q54901977
RX   PubMed=20862285;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   LAU-T50B
AC   CVCL_DI22
SY   LAU50_2
DR   cancercelllines; CVCL_DI22
DR   Cosmic; 1675357
DR   GEO; GSM566254
DR   GEO; GSM568794
DR   Progenetix; CVCL_DI22
DR   Wikidata; Q54901979
RX   PubMed=20862285;
RX   PubMed=21494657;
RX   PubMed=22197931;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20862285).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S597 ! LAU-Me275
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   LAU-T618A
AC   CVCL_DI23
SY   LAU618
DR   cancercelllines; CVCL_DI23
DR   Cosmic; 1675362
DR   GEO; GSM566252
DR   GEO; GSM568789
DR   Progenetix; CVCL_DI23
DR   Wikidata; Q54901980
RX   PubMed=20862285;
RX   PubMed=21494657;
RX   PubMed=22197931;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   LAW1
AC   CVCL_C1J9
DR   Wikidata; Q114311870
RX   PubMed=4333769;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic myeloid leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1JA ! LAW2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   LAW2
AC   CVCL_C1JA
DR   Wikidata; Q114311871
RX   PubMed=4333769;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic myeloid leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1J9 ! LAW1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   LAZ-007
AC   CVCL_IQ25
SY   LAZ 007; Laz 007; LAZ007
DR   Wikidata; Q54901981
RX   PubMed=6346879;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 7
//
ID   LAZ-149
AC   CVCL_BT08
SY   LAZ 149; LAZ149; GM10610
DR   CLO; CLO_0024280
DR   BioSample; SAMN00800101
DR   Coriell; GM10610
DR   Wikidata; Q54901982
RX   CelloPub=CLPUB00447;
RX   PubMed=947544;
RX   PubMed=6196781;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4823; HBA1; Zygosity=Heterozygous (Coriell=GM10610).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4827; HBB; Zygosity=Homozygous (Coriell=GM10610).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   LAZ-156
AC   CVCL_IQ24
SY   Laz-156; LAZ 156; Laz 156; Laz156
DR   Wikidata; Q54901983
RX   Patent=US4550086;
RX   PubMed=7108207;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 8
//
ID   LAZ-166
AC   CVCL_GY05
SY   LAZ 166; LAZ166
DR   Wikidata; Q54901984
RX   PubMed=209464;
RX   PubMed=3123521;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 9
//
ID   LAZ-177
AC   CVCL_GY94
SY   LAZ 177; LAZ177; HPFH-2
DR   Wikidata; Q54901985
RX   PubMed=6196781;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Population: African American.
CC   Sequence variation: Gene deletion; HGNC; HGNC:4827; HBB; Zygosity=Homozygous (PubMed=6196781).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4829; HBD; Zygosity=Homozygous (PubMed=6196781).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129072; Hereditary persistence of fetal hemoglobin
DI   ORDO; Orphanet_46532; Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   LAZ-187
AC   CVCL_GY06
SY   LAZ 187; LAZ187; GM17552
DR   CLO; CLO_0013029
DR   Coriell; GM17552
DR   Wikidata; Q54901986
RX   PubMed=7011617;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129074; Immunodeficiency with hyper-IgM type 2
DI   ORDO; Orphanet_101089; Hyper-IgM syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 10
//
ID   LAZ-221
AC   CVCL_1830
SY   Laz-221; LAZ 221; Laz 221; LAZ221; Laz221
DR   Cosmic; 798667
DR   Cosmic; 801716
DR   Cosmic; 994181
DR   Cosmic; 998709
DR   Cosmic; 1037710
DR   Cosmic; 2491081
DR   DSMZ; ACC-716
DR   DSMZCellDive; ACC-716
DR   Lonza; 126
DR   Wikidata; Q54901987
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US4550086;
RX   PubMed=205365;
RX   PubMed=2939141;
RX   PubMed=7108207;
RX   PubMed=8315353;
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=21326318;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Population: Caucasian.
CC   Doubling time: ~4 days (PubMed=205365); ~50-80 hours (DSMZ=ACC-716).
CC   HLA typing: A*01,24; B*22,35 (PubMed=2939141).
CC   Karyotypic information: 45,XX,-9,-12,+t(9q;12q) (PubMed=205365).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-716
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 17,22
ST   D19S433: 12,15
ST   D21S11: 30,31
ST   D2S1338: 18
ST   D3S1358: 16,17
ST   D5S818: 11,14
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GY04 ! LAZ-388
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   LAZ-248
AC   CVCL_GY07
SY   LAZ 248; LAZ248; GM17557
DR   CLO; CLO_0013031
DR   Coriell; GM17557
DR   Wikidata; Q54901988
RX   PubMed=7011617;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129074; Immunodeficiency with hyper-IgM type 2
DI   ORDO; Orphanet_101089; Hyper-IgM syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 10
//
ID   LAZ-256
AC   CVCL_IQ26
SY   Laz 256
DR   Wikidata; Q54901989
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   LAZ-388
AC   CVCL_GY04
SY   Laz-388; LAZ 388; Laz 388; LAZ388; Laz388
DR   Wikidata; Q54901990
RX   PubMed=2939141;
RX   PubMed=3884668;
RX   PubMed=7108207;
RX   PubMed=8315353;
RX   PubMed=21326318;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Population: Caucasian.
CC   HLA typing: A*01,24; B*22,35 (PubMed=2939141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1830 ! LAZ-221
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 10
//
ID   LAZ-434
AC   CVCL_IQ29
SY   LAZ 434
DR   Wikidata; Q54901991
RX   PubMed=6346879;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Doubling time: 24 hours (PubMed=6346879).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   LAZ-444
AC   CVCL_IQ32
SY   LAZ 444; LAZ44
DR   Wikidata; Q54901992
RX   PubMed=7028788;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0475 ! OVCA433
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   LAZ-446
AC   CVCL_IQ28
SY   LAZ 446
DR   Wikidata; Q54901993
RX   PubMed=6346879;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3769 ! OVCA432
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 8
//
ID   LAZ-461
AC   CVCL_IQ23
SY   Laz-461; LAZ 461; Laz 461; Laz461
DR   Wikidata; Q54901994
RX   PubMed=3884668;
RX   PubMed=7108207;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 8
//
ID   LAZ-467
AC   CVCL_JY69
SY   Laz467
DR   Wikidata; Q54901995
RX   PubMed=6609821;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   LAZ-470
AC   CVCL_JY70
SY   Laz470
DR   Wikidata; Q54901996
RX   PubMed=6609821;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   LAZ-471
AC   CVCL_IQ27
SY   LAZ 471; Laz 471
DR   Wikidata; Q54901997
RX   Patent=US4550086;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   LAZ-475
AC   CVCL_JY71
SY   Laz475
DR   Wikidata; Q54901998
RX   PubMed=6609821;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   LAZ-509
AC   CVCL_IQ22
SY   LAZ 509; Laz 509; LAZ509; Laz509
DR   Wikidata; Q54901999
RX   Patent=US4550086;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   LAZ-67
AC   CVCL_GY08
SY   LAZ 67; Laz 67; LAZ67
DR   Wikidata; Q54902000
RX   PubMed=209464;
RX   PubMed=7011617;
CC   From: Lazarus, Herbert; Dana-Farber Cancer Institute; Boston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   LB
AC   CVCL_E751
SY   LB-S; LBS
DR   dbMHC; 48944
DR   ECACC; 94022541
DR   IHW; IHW09289
DR   IPD-IMGT/HLA; 10964
DR   Wikidata; Q54902001
RX   PubMed=6200433;
RX   PubMed=6752724;
RX   PubMed=6961940;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Swedish.
CC   HLA typing: A*68:01:01:01; B*40:01:01; C*03:04; DPA1*01:03:01:01; DPB1*02:01:02:01,04:02; DQA1*01:02:01:01 (IPD-IMGT/HLA=10964).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Lb 224
AC   CVCL_J297
DR   CLO; CLO_0007250
DR   CLDB; cl3179
DR   Wikidata; Q54902002
CC   From: Laboratorio Biochimica e Biologia Cellulare, Dip. Biochimica Biotecnologie Mediche, Universita' degli Studi; Napoli; Italy.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Lb 23
AC   CVCL_J298
DR   CLO; CLO_0007251
DR   CLDB; cl3180
DR   Wikidata; Q54902005
RX   PubMed=2567642;
CC   From: Laboratorio Biochimica e Biologia Cellulare, Dip. Biochimica Biotecnologie Mediche, Universita' degli Studi; Napoli; Italy.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   Lb 24
AC   CVCL_J299
DR   CLO; CLO_0007252
DR   CLDB; cl3181
DR   Wikidata; Q54902006
RX   PubMed=2567642;
CC   From: Laboratorio Biochimica e Biologia Cellulare, Dip. Biochimica Biotecnologie Mediche, Universita' degli Studi; Napoli; Italy.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   LB 27.4
AC   CVCL_K219
SY   LB 15.13; LB-15.13
DR   CLO; CLO_0007253
DR   ATCC; HB-99
DR   Wikidata; Q54902007
RX   PubMed=6980413;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K166 ! L10.A 2J
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   Lb 752
AC   CVCL_J300
DR   CLO; CLO_0007254
DR   CLDB; cl3182
DR   Wikidata; Q54902008
CC   From: Laboratorio Biochimica e Biologia Cellulare, Dip. Biochimica Biotecnologie Mediche, Universita' degli Studi; Napoli; Italy.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   LB 84-1
AC   CVCL_M514
SY   LB84.1
DR   Wikidata; Q54902009
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2492835;
RX   PubMed=2537114;
RX   PubMed=10936422;
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: 34.2 hours (PubMed=2492835).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   LB 84-2
AC   CVCL_W399
SY   LB84.2; LB-842; LB842
DR   Wikidata; Q54902010
RX   PubMed=2783661;
RX   PubMed=10936422;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   LB 84-3
AC   CVCL_W400
SY   LB84.3; LB-843; LB843
DR   Wikidata; Q54902011
RX   PubMed=2537114;
RX   PubMed=2783661;
RX   PubMed=10936422;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   LB 84-4
AC   CVCL_W401
SY   LB84.4; LB-844; LB844
DR   Wikidata; Q54902012
RX   PubMed=2783661;
RX   PubMed=10936422;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   LB 84-5
AC   CVCL_W402
SY   LB84.5; LB-845; LB845
DR   Wikidata; Q54902013
RX   PubMed=2537114;
RX   PubMed=2783661;
RX   PubMed=10936422;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   LB 85-1
AC   CVCL_W403
SY   LB85.1; LB-851
DR   Wikidata; Q54902014
RX   PubMed=2537114;
RX   PubMed=10936422;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   LB-831
AC   CVCL_E903
SY   LB-83-1
DR   Cosmic; 742954
DR   IARC_TP53; 359
DR   Wikidata; Q54902015
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=3927997;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: 38.37 hours (PubMed=3927997).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp184Tyr (c.550G>T); Zygosity=Unspecified (PubMed=1373872).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E904 ! LB-832
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   LB-832
AC   CVCL_E904
DR   Wikidata; Q54902017
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3927997;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~48 hours (PubMed=3927997).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E903 ! LB-831
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   LB-B7
AC   CVCL_3390
DR   CLDB; cl7170
DR   ICLC; HTL05007
DR   Wikidata; Q54902018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ICLC=HTL05007
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 8,12
ST   D21S11: 29,31.2
ST   D5S818: 9
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3391 ! LB-F9
OI   CVCL_3389 ! LB4
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   LB-F9
AC   CVCL_3391
DR   CLDB; cl7169
DR   ICLC; HTL05004
DR   Wikidata; Q54902019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ICLC=HTL05004
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 8,12
ST   D21S11: 29,31.2
ST   D5S818: 9
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3390 ! LB-B7
OI   CVCL_3389 ! LB4
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   LB-MEL-1
AC   CVCL_C5UE
SY   LB-MEL 1
DR   Wikidata; Q116049662
RX   PubMed=3972469;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LB-MEL-2
AC   CVCL_C5UF
SY   LB-MEL 2
DR   Wikidata; Q116049663
RX   PubMed=3972469;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LB-MEL-3
AC   CVCL_C5UG
SY   LB-MEL 3
DR   Wikidata; Q116049664
RX   PubMed=3972469;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LB-MEL-4
AC   CVCL_C5UH
SY   LB-MEL 4
DR   Wikidata; Q116049665
RX   PubMed=3972469;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LB-MEL-5
AC   CVCL_C5UI
SY   LB-MEL 5
DR   Wikidata; Q116049666
RX   PubMed=3972469;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LB-MEL-6
AC   CVCL_C5UJ
SY   LB-MEL 6
DR   Wikidata; Q116049667
RX   PubMed=3972469;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LB102
AC   CVCL_ZN25
SY   102
DR   Wikidata; Q98126862
RX   PubMed=1372096;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN49 ! 205BR
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LB10.Bm
AC   CVCL_5312
DR   CLO; CLO_0007255
DR   ATCC; CRL-6060
DR   Wikidata; Q54902020
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6060; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5313 ! LB10.K
OI   CVCL_5314 ! LB10.Ln
OI   CVCL_5315 ! LB10.Sp
OI   CVCL_5316 ! LB10.Thy
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   LB10.K
AC   CVCL_5313
DR   CLO; CLO_0007256
DR   ATCC; CRL-6061
DR   Wikidata; Q54902021
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5312 ! LB10.Bm
OI   CVCL_5314 ! LB10.Ln
OI   CVCL_5315 ! LB10.Sp
OI   CVCL_5316 ! LB10.Thy
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   LB10.Ln
AC   CVCL_5314
DR   CLO; CLO_0007257
DR   ATCC; CRL-6062
DR   Wikidata; Q54902022
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6062; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5312 ! LB10.Bm
OI   CVCL_5313 ! LB10.K
OI   CVCL_5315 ! LB10.Sp
OI   CVCL_5316 ! LB10.Thy
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   LB10.Sp
AC   CVCL_5315
DR   CLO; CLO_0007258
DR   ATCC; CRL-6063
DR   Wikidata; Q54902023
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6063; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5312 ! LB10.Bm
OI   CVCL_5313 ! LB10.K
OI   CVCL_5314 ! LB10.Ln
OI   CVCL_5316 ! LB10.Thy
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LB10.Thy
AC   CVCL_5316
DR   CLO; CLO_0007259
DR   ATCC; CRL-6064
DR   Wikidata; Q54902024
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6064; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5312 ! LB10.Bm
OI   CVCL_5313 ! LB10.K
OI   CVCL_5314 ! LB10.Ln
OI   CVCL_5315 ! LB10.Sp
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LB1017-HNSC
AC   CVCL_F234
SY   LB1017-ORL; LB1017
DR   Wikidata; Q54902025
RX   PubMed=14762065;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   LB1047-EBV
AC   CVCL_E908
SY   LB1047EBV
DR   Cell_Model_Passport; SIDM01652
DR   DepMap; ACH-002352
DR   Wikidata; Q54902026
RX   PubMed=11369790;
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1364 ! LB1047-RCC
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   LB1047-RCC
AC   CVCL_1364
SY   LB1047RCC; LB1047
DR   CLO; CLO_0009979
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 924
DR   cancercelllines; CVCL_1364
DR   Cell_Model_Passport; SIDM00187
DR   ChEMBL-Cells; CHEMBL3308329
DR   ChEMBL-Targets; CHEMBL2366136
DR   Cosmic; 753577
DR   Cosmic-CLP; 753577
DR   DepMap; ACH-002150
DR   EGA; EGAS00001000978
DR   GDSC; 753577
DR   GEO; GSM1670033
DR   IARC_TP53; 21460
DR   LINCS_LDP; LCL-1765
DR   PharmacoDB; LB1047RCC_820_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1364
DR   Wikidata; Q54902027
RX   PubMed=10074909;
RX   PubMed=11369790;
RX   PubMed=18698046;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02:101; B*35:01,51; C*04:01,16:02 (PubMed=11369790).
CC   Microsatellite instability: Instable (MSI-high) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.9%; Native American=0%; East Asian, North=0.45%; East Asian, South=0%; South Asian=20.18%; European, North=20.14%; European, South=58.33% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=753577
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 9
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E908 ! LB1047-EBV
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   LB11-SCLC/OC1
AC   CVCL_VV00
SY   LB11/OC1; OC1
DR   Wikidata; Q95981436
RX   PubMed=11751535;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   LB11.Bm
AC   CVCL_N503
DR   ATCC; CRL-6065
DR   Wikidata; Q54902028
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6065; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5317 ! LB11.Ln
OI   CVCL_5318 ! LB11.Sp
OI   CVCL_5319 ! LB11.Thy
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   LB11.Ln
AC   CVCL_5317
DR   CLO; CLO_0007260
DR   ATCC; CRL-6066
DR   Wikidata; Q54902029
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6066; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_N503 ! LB11.Bm
OI   CVCL_5318 ! LB11.Sp
OI   CVCL_5319 ! LB11.Thy
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   LB11.Sp
AC   CVCL_5318
DR   CLO; CLO_0007261
DR   ATCC; CRL-6067
DR   Wikidata; Q54902030
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6067; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_N503 ! LB11.Bm
OI   CVCL_5317 ! LB11.Ln
OI   CVCL_5319 ! LB11.Thy
SX   Male
AG   4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   LB11.Thy
AC   CVCL_5319
DR   CLO; CLO_0007262
DR   ATCC; CRL-6068
DR   Wikidata; Q54902031
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6068; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_N503 ! LB11.Bm
OI   CVCL_5317 ! LB11.Ln
OI   CVCL_5318 ! LB11.Sp
SX   Male
AG   4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   LB12-SCLC/OC2
AC   CVCL_VV01
DR   Wikidata; Q95981442
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   LB126-SCLC
AC   CVCL_F235
DR   Wikidata; Q54902032
WW   Info; MethDB; -; http://methdb.univ-perp.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===lung%20-%20LB126-SCLC%20cells&-Find
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   LB129-SLCL
AC   CVCL_DQ75
SY   LB-129-SLCL
DR   IPD-IMGT/HLA; 10966
DR   Wikidata; Q54902033
RX   PubMed=9872818;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*02:01; B*44:02; C*05:01:01,07:11 (IPD-IMGT/HLA=10966).
CC   Derived from site: Metastatic; Mediastinal lymph node; UBERON=UBERON_0002524.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   LB13-SCLC/OC3
AC   CVCL_VV02
DR   Wikidata; Q95981444
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   LB1319-MEL
AC   CVCL_F239
DR   Wikidata; Q54902034
RX   PubMed=23493799;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   LB1358-RCC
AC   CVCL_RY29
SY   LB1368
DR   Wikidata; Q54902035
RX   PubMed=10074909;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   LB14-EBV
AC   CVCL_C5UT
SY   LB-14-EBV
DR   Wikidata; Q116049668
RX   PubMed=2209693;
RX   PubMed=2967757;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LB1448-MEL.2
AC   CVCL_VV03
DR   Wikidata; Q95981448
RX   PubMed=11751535;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   LB146
AC   CVCL_ZN24
SY   146
DR   Wikidata; Q98126863
RX   PubMed=1372096;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN50 ! 128BR
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LB16
AC   CVCL_A1YD
SY   PARK8-LB16
DR   SKIP; SKIP000993
DR   Wikidata; Q105509848
RX   PubMed=26056228;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous (PubMed=26056228).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YE ! LB21
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LB1610-MEL
AC   CVCL_E915
DR   cancercelllines; CVCL_E915
DR   Wikidata; Q54902036
RX   PubMed=28765120;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=28765120).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=28765120).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   LB1622-MEL
AC   CVCL_F238
DR   Cosmic; 2759410
DR   Wikidata; Q54902037
RX   PubMed=9894850;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Skin; Note=In-transit between skin and lymph node; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LB173
AC   CVCL_2551
SY   173
DR   ECACC; 98062316
DR   Wikidata; Q54902038
RX   PubMed=1372096;
RX   PubMed=1672363;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8779 ! 144BR
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   LB1751-EBV
AC   CVCL_VV04
SY   LB1751EBV
DR   Wikidata; Q95981453
RX   PubMed=10352307;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV05 ! LB1751-MEL
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   LB1751-MEL
AC   CVCL_VV05
DR   Wikidata; Q95981454
RX   PubMed=10352307;
RX   PubMed=11751535;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV04 ! LB1751-EBV
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LB1781-MEL
AC   CVCL_VV06
DR   Wikidata; Q95981455
RX   PubMed=11751535;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   LB182
AC   CVCL_2552
SY   182
DR   ECACC; 98062317
DR   Wikidata; Q54902039
RX   PubMed=1372096;
RX   PubMed=1672363;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2271 ! 149BR
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   LB1828-RCC
AC   CVCL_VV07
SY   LB1828; TREP
DR   Wikidata; Q95981459
RX   PubMed=11751535;
RX   PubMed=15585611;
RX   PubMed=18698046;
RX   PubMed=22892449;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*02,66; B*41,56; C*01,17 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 6
//
ID   LB185
AC   CVCL_2553
DR   ECACC; 98062318
DR   Wikidata; Q54902040
RX   PubMed=1672363;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=98062318
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2272 ! 153BR
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   LB188
AC   CVCL_B4ID
DR   Wikidata; Q110433002
RX   PubMed=1372096;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2273 ! 155BR
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   LB188-SAR
AC   CVCL_F232
SY   LB188-SARC; LB188
DR   Wikidata; Q54902041
RX   PubMed=28765120;
WW   Info; MethDB; -; http://methdb.univ-perp.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===LB188-SARC%20cells&-Find
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   LB2033-MEL
AC   CVCL_DD44
DR   Wikidata; Q54902044
RX   PubMed=23493799;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   LB2077-MELA
AC   CVCL_ZG19
DR   Wikidata; Q98126864
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZG20 ! LB2077-MELB
OI   CVCL_ZG21 ! LB2077-MELC
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB2077-MELB
AC   CVCL_ZG20
DR   Wikidata; Q98126865
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZG19 ! LB2077-MELA
OI   CVCL_ZG21 ! LB2077-MELC
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LB2077-MELC
AC   CVCL_ZG21
DR   Wikidata; Q98126866
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Heart; UBERON=UBERON_0000948.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZG19 ! LB2077-MELA
OI   CVCL_ZG20 ! LB2077-MELB
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LB21
AC   CVCL_A1YE
SY   PARK8-LB21
DR   SKIP; SKIP000994
DR   Wikidata; Q105509854
RX   PubMed=26056228;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous (PubMed=26056228).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YD ! LB16
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LB2117-MEL
AC   CVCL_VV08
DR   GEO; GSM483289
DR   GEO; GSM483290
DR   GEO; GSM483291
DR   GEO; GSM483292
DR   Wikidata; Q95981469
RX   PubMed=20099279;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   LB2241-EBV
AC   CVCL_VU68
SY   LB2241EBV
DR   Cell_Model_Passport; SIDM01651
DR   DepMap; ACH-002353
DR   Wikidata; Q95981471
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1365 ! LB2241-RCC
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   LB2241-RCC
AC   CVCL_1365
SY   LB2241RCC
DR   CLO; CLO_0009980
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1365
DR   Cell_Model_Passport; SIDM00186
DR   ChEMBL-Cells; CHEMBL3308330
DR   ChEMBL-Targets; CHEMBL2366330
DR   Cosmic; 753578
DR   Cosmic-CLP; 753578
DR   DepMap; ACH-002151
DR   EGA; EGAS00001000978
DR   GDSC; 753578
DR   GEO; GSM1670034
DR   IARC_TP53; 21461
DR   LINCS_LDP; LCL-1766
DR   PharmacoDB; LB2241RCC_821_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1365
DR   Wikidata; Q54902047
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=1.3%; East Asian, North=0%; East Asian, South=0.65%; South Asian=1.75%; European, North=69.13%; European, South=27.17% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=753578
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU68 ! LB2241-EBV
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   LB2259-MEL
AC   CVCL_VV09
DR   GEO; GSM483293
DR   GEO; GSM483294
DR   GEO; GSM483295
DR   GEO; GSM483296
DR   Wikidata; Q95981474
RX   PubMed=20099279;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   LB23-SAR
AC   CVCL_E936
SY   LB23-SARC
DR   Wikidata; Q54902048
RX   PubMed=10919659;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   LB2304
AC   CVCL_A1UA
SY   LB 2304
DR   Wikidata; Q105509857
RX   PubMed=11779494;
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg580Ter (c.1738C>T); ClinVar=VCV000007672; Zygosity=Heterozygous (PubMed=11779494).
CC   Sequence variation: Mutation; HGNC; HGNC:6601; LIG4; Simple; p.Arg814Ter (c.2440C>T); ClinVar=VCV000007673; Zygosity=Heterozygous (PubMed=11779494).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122657; LIG4 syndrome
DI   ORDO; Orphanet_99812; LIG4 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   48Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   LB24-MEL
AC   CVCL_E932
SY   LB-24-Mel; LB-24-MEL; LB-24; LB24
DR   BTO; BTO_0006007
DR   Cosmic; 1295339
DR   Cosmic; 2647639
DR   Wikidata; Q54902049
RX   PubMed=8340755;
RX   PubMed=11121133;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   LB2518-EBV
AC   CVCL_E914
SY   LB2518EBV
DR   Cell_Model_Passport; SIDM01650
DR   DepMap; ACH-002354
DR   Wikidata; Q54902051
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1366 ! LB2518-MEL
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   LB2518-MEL
AC   CVCL_1366
SY   LB2518MEL
DR   CLO; CLO_0037128
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1366
DR   Cell_Model_Passport; SIDM00185
DR   ChEMBL-Cells; CHEMBL3308331
DR   ChEMBL-Targets; CHEMBL2366335
DR   Cosmic; 753579
DR   Cosmic-CLP; 753579
DR   DepMap; ACH-002152
DR   EGA; EGAS00001000978
DR   GDSC; 753579
DR   GEO; GSM1670035
DR   IARC_TP53; 21462
DR   LINCS_LDP; LCL-1274
DR   PharmacoDB; LB2518MEL_822_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1366
DR   Wikidata; Q54902052
RX   PubMed=14762065;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=753579; DepMap=ACH-002152).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.84%; Native American=0%; East Asian, North=0%; East Asian, South=0.68%; South Asian=1.95%; European, North=61.82%; European, South=34.71% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753579
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E914 ! LB2518-EBV
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   LB2531-MEL-Z
AC   CVCL_V410
DR   Cosmic; 753580
DR   IARC_TP53; 21463
DR   Wikidata; Q54902054
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   LB2586-MEL
AC   CVCL_VV10
DR   GEO; GSM483277
DR   GEO; GSM483278
DR   GEO; GSM483279
DR   GEO; GSM483280
DR   Wikidata; Q95981486
RX   PubMed=20099279;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   LB265-MEL
AC   CVCL_VV11
DR   Wikidata; Q95981489
RX   PubMed=8752841;
RX   PubMed=11751535;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*02,03; B*07,62; C*w07,w09 (PubMed=8752841).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LB2687-MEL
AC   CVCL_ZG26
DR   Wikidata; Q98126867
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB277
AC   CVCL_2559
DR   ECACC; 98062331
DR   Wikidata; Q54902055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   LB2784-MEL
AC   CVCL_ZG22
DR   Wikidata; Q98126868
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB2805-MEL
AC   CVCL_ZG23
DR   Wikidata; Q98126870
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB2813-MEL
AC   CVCL_ZG24
DR   Wikidata; Q98126871
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB2840-MEL
AC   CVCL_ZG25
DR   Wikidata; Q98126872
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB2870-MEL
AC   CVCL_ZG27
DR   Wikidata; Q98126873
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB2901-MEL
AC   CVCL_ZG28
DR   Wikidata; Q98126874
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   LB2929-MEL
AC   CVCL_ZG29
DR   Wikidata; Q98126875
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   LB3.1
AC   CVCL_G667
DR   CLO; CLO_0007263
DR   ATCC; HB-298
DR   Wikidata; Q54902056
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   LB30-MEL
AC   CVCL_E935
DR   Wikidata; Q54902057
WW   Info; MethDB; -; http://methdb.univ-perp.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB30-MEL%20cells&-Find
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   LB3080-MELA
AC   CVCL_ZG30
DR   Wikidata; Q98126876
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LB3110-MEL
AC   CVCL_ZG31
DR   Wikidata; Q98126877
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB3129-MELA
AC   CVCL_ZG32
DR   Wikidata; Q98126878
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZG33 ! LB3129-MELB
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LB3129-MELB
AC   CVCL_ZG33
DR   Wikidata; Q98126879
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZG32 ! LB3129-MELA
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB33-MELA
AC   CVCL_E933
SY   LB33-MEL.A
DR   Wikidata; Q54902059
RX   PubMed=7875194;
RX   PubMed=8566071;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E934 ! LB33-MELB
OI   CVCL_ZG34 ! LB33-MELC
OI   CVCL_ZG35 ! LB33-MELD
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   LB33-MELB
AC   CVCL_E934
SY   LB33-MEL.B
DR   Wikidata; Q54902060
RX   PubMed=7875194;
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E933 ! LB33-MELA
OI   CVCL_ZG34 ! LB33-MELC
OI   CVCL_ZG35 ! LB33-MELD
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   LB33-MELC
AC   CVCL_ZG34
DR   Wikidata; Q98126881
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E933 ! LB33-MELA
OI   CVCL_E934 ! LB33-MELB
OI   CVCL_ZG35 ! LB33-MELD
SX   Female
AG   >48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB33-MELD
AC   CVCL_ZG35
DR   Wikidata; Q98126882
RX   PubMed=28636941;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28636941).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E933 ! LB33-MELA
OI   CVCL_E934 ! LB33-MELB
OI   CVCL_ZG34 ! LB33-MELC
SX   Female
AG   >48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LB37-NSLCL
AC   CVCL_DQ76
SY   LB-37-NSLCL
DR   Wikidata; Q54902061
RX   PubMed=9872818;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*02,26; B*08,51; C*w02,w07 (PubMed=9872818).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   LB373-EBV
AC   CVCL_E917
SY   LB373EBV
DR   Cell_Model_Passport; SIDM01649
DR   DepMap; ACH-002355
DR   Wikidata; Q54902062
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E918 ! LB373-MEL
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   LB373-MEL
AC   CVCL_E918
SY   LB373
DR   Cell_Model_Passport; SIDM01754
DR   LINCS_LDP; LCL-1275
DR   Wikidata; Q54902063
RX   PubMed=10352307;
RX   PubMed=11751535;
RX   PubMed=14762065;
RX   PubMed=14871852;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E917 ! LB373-EBV
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   LB373-MEL-D
AC   CVCL_1367
SY   LB373MELD
DR   CLO; CLO_0037129
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1367
DR   Cell_Model_Passport; SIDM00184
DR   ChEMBL-Cells; CHEMBL3308336
DR   ChEMBL-Targets; CHEMBL2366296
DR   Cosmic; 753581
DR   Cosmic-CLP; 753581
DR   DepMap; ACH-002153
DR   EGA; EGAS00001000978
DR   GDSC; 753581
DR   GEO; GSM1670036
DR   IARC_TP53; 21464
DR   PharmacoDB; LB373MELD_823_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1367
DR   Wikidata; Q54902064
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=753581; DepMap=ACH-002153).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.8%; Native American=0.56%; East Asian, North=0.8%; East Asian, South=0%; South Asian=0.51%; European, North=65.32%; European, South=31.01% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753581
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E918 ! LB373-MEL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   LB39-MEL
AC   CVCL_F240
SY   LB39
DR   Wikidata; Q54902065
RX   PubMed=10661410;
RX   PubMed=12747757;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Characteristics: Established via a mouse xenograft.
CC   HLA typing: A*02,24; B*07,51; C*w01,w07 (PubMed=12747757).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LB4
AC   CVCL_3389
DR   CLDB; cl7168
DR   ICLC; HTL05003
DR   Wikidata; Q54902066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ICLC=HTL05003
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 8,12
ST   D21S11: 29,31.2
ST   D5S818: 9
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C61233; Paroxysmal nocturnal hemoglobinuria
DI   ORDO; Orphanet_447; Paroxysmal nocturnal hemoglobinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3390 ! LB-B7
OI   CVCL_3391 ! LB-F9
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   LB4-MEL
AC   CVCL_F241
DR   Wikidata; Q54902067
RX   PubMed=10661410;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   LB42
AC   CVCL_2561
SY   42
DR   ECACC; 98062313
DR   Wikidata; Q54902068
RX   PubMed=7825573;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=98062313
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   LB43-MEL
AC   CVCL_VV12
DR   Wikidata; Q95981501
RX   PubMed=8752841;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   LB44
AC   CVCL_B0GW
DR   Wikidata; Q108820669
RX   PubMed=10397714;
CC   Doubling time: 34.5 hours (PubMed=10397714).
CC   Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (PubMed=10397714).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12591; UROD.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84754; Hepatoerythropoietic porphyria
DI   ORDO; Orphanet_95159; Hepatoerythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   LB44-LUDSN11
AC   CVCL_B0GX
DR   Wikidata; Q108820670
RX   PubMed=10397714;
CC   Doubling time: 19.4 hours (PubMed=10397714).
CC   Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84754; Hepatoerythropoietic porphyria
DI   ORDO; Orphanet_95159; Hepatoerythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0GW ! LB44
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LB45
AC   CVCL_B0GY
DR   Wikidata; Q108820671
RX   PubMed=10397714;
CC   Doubling time: 32.5 hours (PubMed=10397714).
CC   Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (PubMed=10397714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84754; Hepatoerythropoietic porphyria
DI   ORDO; Orphanet_95159; Hepatoerythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LB45-LUDSN11
AC   CVCL_B0GZ
DR   Wikidata; Q108820672
RX   PubMed=10397714;
CC   Doubling time: 21 hours (PubMed=10397714).
CC   Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (PubMed=10397714).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12591; UROD.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84754; Hepatoerythropoietic porphyria
DI   ORDO; Orphanet_95159; Hepatoerythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0GY ! LB45
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   LB45-MEL
AC   CVCL_E937
DR   Wikidata; Q54902070
WW   Info; MethDB; -; http://methdb.univ-perp.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB45-MEL%20cells&-Find
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   LB583-MEL
AC   CVCL_DD45
DR   Wikidata; Q54902074
RX   PubMed=23493799;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   LB583-MEL.6
AC   CVCL_VV13
DR   Wikidata; Q95981505
RX   PubMed=11751535;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD45 ! LB583-MEL
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   LB5848-LYMP
AC   CVCL_WV41
DR   cancercelllines; CVCL_WV41
DR   DSMZ; ACC-870
DR   DSMZCellDive; ACC-870
DR   Wikidata; Q95981506
RX   PubMed=30277098;
CC   Doubling time: 54 hours (PubMed=30277098); ~50-70 hours (DSMZ=ACC-870).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=30277098).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=30277098).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Hemizygous (PubMed=30277098).
CC   Derived from site: In situ; Parotid lymph node; UBERON=UBERON_0015857.
ST   Source(s): DSMZ=ACC-870; PubMed=30277098
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 17,22
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,25
ST   Penta D: 12,16
ST   Penta E: 10,11
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 13
//
ID   LB5871-LYMP
AC   CVCL_WV42
DR   cancercelllines; CVCL_WV42
DR   DSMZ; ACC-869
DR   DSMZCellDive; ACC-869
DR   Wikidata; Q95981508
RX   PubMed=30277098;
CC   Doubling time: 62 hours (PubMed=30277098); ~70 hours (DSMZ=ACC-869).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=30277098).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=30277098).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro2139fs (c.6415_6424delCCCCCCTTCA); Zygosity=Heterozygous (PubMed=30277098).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Tyr1467Asp (c.4399T>G); Zygosity=Heterozygous (PubMed=30277098).
CC   Sequence variation: Mutation; HGNC; HGNC:11912; TNFRSF14; Simple; p.Trp7Ter (c.20G>A); Zygosity=Heterozygous (PubMed=30277098).
CC   Sequence variation: Mutation; HGNC; HGNC:11912; TNFRSF14; Simple; p.Ala194fs (c.578dup); Zygosity=Heterozygous (PubMed=30277098).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Arg (c.526T>C); ClinVar=VCV000376573; Zygosity=Hemizygous (PubMed=30277098).
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): DSMZ=ACC-869; PubMed=30277098
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16,17 (DSMZ=ACC-869)
ST   D3S1358: 17 (PubMed=30277098)
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 8,13
ST   FGA: 22,25
ST   Penta D: 9,10 (DSMZ=ACC-869)
ST   Penta D: 10 (PubMed=30277098)
ST   Penta E: 7,11 (PubMed=30277098)
ST   Penta E: 11 (DSMZ=ACC-869)
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   LB59Ly
AC   CVCL_E902
DR   Wikidata; Q54902075
RX   PubMed=6270254;
CC   Breed/subspecies: Prim'Holstein; VBO=VBO_0003169.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 7
//
ID   LB647-PBL
AC   CVCL_VU82
SY   LB647PBL
DR   Cell_Model_Passport; SIDM01648
DR   DepMap; ACH-002356
DR   Wikidata; Q95981510
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1368 ! LB647-SCLC
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   LB647-SCLC
AC   CVCL_1368
SY   LB647SCLC
DR   CLO; CLO_0037018
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1368
DR   Cell_Model_Passport; SIDM00183
DR   ChEMBL-Cells; CHEMBL3308332
DR   ChEMBL-Targets; CHEMBL2366140
DR   Cosmic; 753582
DR   Cosmic; 1995478
DR   Cosmic-CLP; 753582
DR   DepMap; ACH-002154
DR   EGA; EGAS00001000978
DR   GDSC; 753582
DR   GEO; GSM1670037
DR   IARC_TP53; 21465
DR   LINCS_LDP; LCL-1870
DR   PharmacoDB; LB647SCLC_824_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1368
DR   Wikidata; Q54902076
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Serfs*51 (c.880delG); ClinVar=VCV002461858; Zygosity=Heterozygous (Cosmic-CLP=753582; DepMap=ACH-002154).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.14%; East Asian, North=0%; East Asian, South=0.99%; South Asian=0.19%; European, North=66.53%; European, South=32.15% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753582
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU82 ! LB647-PBL
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   LB687
AC   CVCL_2565
DR   ECACC; 98062335
DR   Wikidata; Q54902077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   LB7
AC   CVCL_2566
DR   ECACC; 98062312
DR   Wikidata; Q54902078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   LB70-MEL
AC   CVCL_F237
DR   Wikidata; Q54902079
WW   Info; MethDB; -; http://methdb.univ-perp.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB70-MEL&-Find
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Characteristics: Established via a mouse xenograft.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   LB707
AC   CVCL_2567
DR   ECACC; 98062336
DR   Wikidata; Q54902080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   LB708
AC   CVCL_2568
DR   ECACC; 98062337
DR   Wikidata; Q54902081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   LB750
AC   CVCL_2569
DR   ECACC; 98062323
DR   Wikidata; Q54902082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   LB771-HNC
AC   CVCL_1369
SY   LB771-HNSCC; LB771HNC; LB771-ORL
DR   CLO; CLO_0009948
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 926
DR   cancercelllines; CVCL_1369
DR   Cell_Model_Passport; SIDM00182
DR   ChEMBL-Cells; CHEMBL3308308
DR   ChEMBL-Targets; CHEMBL2366099
DR   Cosmic; 753583
DR   Cosmic-CLP; 753583
DR   DepMap; ACH-002265
DR   EGA; EGAS00001000160
DR   EGA; EGAS00001000978
DR   GDSC; 753583
DR   GEO; GSM1670038
DR   IARC_TP53; 21466
DR   LINCS_LDP; LCL-1575
DR   PharmacoDB; LB771HNC_825_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1369
DR   Wikidata; Q54902083
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu94fs (c.281delT); Zygosity=Homozygous (Cosmic-CLP=753583; DepMap=ACH-002265).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Homozygous (Cosmic-CLP=753583; DepMap=ACH-002265).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.73%; Native American=0.55%; East Asian, North=0.07%; East Asian, South=0.71%; South Asian=0.51%; European, North=59.61%; European, South=37.83% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=753583
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 7,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU87 ! LB771-PBL
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   LB771-PBL
AC   CVCL_VU87
SY   LB771PBL
DR   Cell_Model_Passport; SIDM01647
DR   DepMap; ACH-002357
DR   EGA; EGAS00001000160
DR   Wikidata; Q95981512
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1369 ! LB771-HNC
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   LB796-BLC
AC   CVCL_E906
SY   LB796
DR   Wikidata; Q54902084
RX   PubMed=11051255;
RX   PubMed=29732388;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   LB7alpha2mC25
AC   CVCL_V117
DR   CLO; CLO_0007265
DR   CLDB; cl3183
DR   IHW; 11w 8022
DR   Wikidata; Q54902085
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LB8
AC   CVCL_E5QZ
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LB804-ALL
AC   CVCL_F236
SY   LB804-LEU; LB804
DR   Wikidata; Q54902086
WW   Info; MethDB; -; http://methdb.univ-perp.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===LB804-LEU%20cells&-Find
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3167; Acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   LB81
AC   CVCL_2570
SY   XPG81
DR   ECACC; 98062327
DR   Wikidata; Q54902087
RX   PubMed=7951246;
RX   PubMed=8483504;
RX   PubMed=9096355;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala792Val (c.2375C>T) (2572C>T); ClinVar=VCV000016567; Zygosity=Heterozygous (PubMed=7951246).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   LB823
AC   CVCL_2571
DR   ECACC; 98062338
DR   Wikidata; Q54902091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   LB831-BLC
AC   CVCL_1370
SY   LB831BLC; LB831
DR   CLO; CLO_0037159
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1370
DR   Cell_Model_Passport; SIDM00181
DR   ChEMBL-Cells; CHEMBL3308853
DR   ChEMBL-Targets; CHEMBL2366222
DR   Cosmic; 753584
DR   Cosmic-CLP; 753584
DR   DepMap; ACH-002266
DR   EGA; EGAS00001000978
DR   GDSC; 753584
DR   GEO; GSM1670039
DR   IARC_TP53; 21467
DR   LINCS_LDP; LCL-1707
DR   PharmacoDB; LB831BLC_826_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1370
DR   TOKU-E; 3997
DR   Wikidata; Q54902093
RX   PubMed=9637538;
RX   PubMed=11051255;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   HLA typing: A*03,24:03; B*44:03,49:01; C*04:01,07 (PubMed=9637538).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Tyr (c.722C>A); ClinVar=VCV000376663; Zygosity=Homozygous (Cosmic-CLP=753584; DepMap=ACH-002266).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.49%; East Asian, North=0%; East Asian, South=0.01%; South Asian=2.75%; European, North=63.52%; European, South=33.23% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Cosmic-CLP=753584
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E913 ! LB831-EBV
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   LB831-EBV
AC   CVCL_E913
SY   LB831EBV
DR   Cell_Model_Passport; SIDM01646
DR   DepMap; ACH-002358
DR   Wikidata; Q54902094
RX   PubMed=9637538;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1370 ! LB831-BLC
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   LB86
AC   CVCL_B0H0
DR   Wikidata; Q108820673
RX   PubMed=10397714;
CC   Doubling time: 38.25 hours (PubMed=10397714).
CC   Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Phe46Leu (c.138T>A); ClinVar=VCV001325337; Zygosity=Homozygous (PubMed=10397714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84754; Hepatoerythropoietic porphyria
DI   ORDO; Orphanet_95159; Hepatoerythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 6
//
ID   LB86-LUDSN11
AC   CVCL_B0H1
DR   Wikidata; Q108820674
RX   PubMed=10397714;
CC   Doubling time: 21.1 hours (PubMed=10397714).
CC   Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Phe46Leu (c.138T>A); ClinVar=VCV001325337; Zygosity=Homozygous (PubMed=10397714).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12591; UROD.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84754; Hepatoerythropoietic porphyria
DI   ORDO; Orphanet_95159; Hepatoerythropoietic porphyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0H0 ! LB86
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 8
//
ID   LB9.Bm
AC   CVCL_5320
DR   CLO; CLO_0007266
DR   ATCC; CRL-6053
DR   Wikidata; Q54902095
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5321 ! LB9.D
OI   CVCL_S344 ! LB9.K
OI   CVCL_S343 ! LB9.Li
OI   CVCL_5322 ! LB9.Ln
OI   CVCL_5323 ! LB9.Sp
OI   CVCL_5324 ! LB9.Sp/Thy/Bm
OI   CVCL_5325 ! LB9.Thy
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LB9.D
AC   CVCL_5321
SY   LB9.Sk
DR   CLO; CLO_0007267
DR   ATCC; CRL-6054
DR   Wikidata; Q54902096
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5320 ! LB9.Bm
OI   CVCL_S344 ! LB9.K
OI   CVCL_S343 ! LB9.Li
OI   CVCL_5322 ! LB9.Ln
OI   CVCL_5323 ! LB9.Sp
OI   CVCL_5324 ! LB9.Sp/Thy/Bm
OI   CVCL_5325 ! LB9.Thy
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   LB9.K
AC   CVCL_S344
DR   ATCC; CRL-6055
DR   Wikidata; Q54902097
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6055; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5320 ! LB9.Bm
OI   CVCL_5321 ! LB9.D
OI   CVCL_S343 ! LB9.Li
OI   CVCL_5322 ! LB9.Ln
OI   CVCL_5323 ! LB9.Sp
OI   CVCL_5324 ! LB9.Sp/Thy/Bm
OI   CVCL_5325 ! LB9.Thy
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   LB9.Li
AC   CVCL_S343
DR   ATCC; CRL-6056
DR   Wikidata; Q54902098
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6056; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5320 ! LB9.Bm
OI   CVCL_5321 ! LB9.D
OI   CVCL_S344 ! LB9.K
OI   CVCL_5322 ! LB9.Ln
OI   CVCL_5323 ! LB9.Sp
OI   CVCL_5324 ! LB9.Sp/Thy/Bm
OI   CVCL_5325 ! LB9.Thy
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   LB9.Ln
AC   CVCL_5322
DR   CLO; CLO_0007268
DR   ATCC; CRL-6057
DR   Wikidata; Q54902099
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6057; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5320 ! LB9.Bm
OI   CVCL_5321 ! LB9.D
OI   CVCL_S344 ! LB9.K
OI   CVCL_S343 ! LB9.Li
OI   CVCL_5323 ! LB9.Sp
OI   CVCL_5324 ! LB9.Sp/Thy/Bm
OI   CVCL_5325 ! LB9.Thy
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   LB9.Sp
AC   CVCL_5323
DR   CLO; CLO_0007269
DR   ATCC; CRL-6058
DR   Wikidata; Q54902100
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6058; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5320 ! LB9.Bm
OI   CVCL_5321 ! LB9.D
OI   CVCL_S344 ! LB9.K
OI   CVCL_S343 ! LB9.Li
OI   CVCL_5322 ! LB9.Ln
OI   CVCL_5324 ! LB9.Sp/Thy/Bm
OI   CVCL_5325 ! LB9.Thy
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LB9.Sp/Thy/Bm
AC   CVCL_5324
SY   LB9.Sp/Thy
DR   CLO; CLO_0007270
DR   ATCC; CRL-6052
DR   Wikidata; Q54902101
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6052; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
DI   NCIt; C134767; Bovine lymphosarcoma
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5320 ! LB9.Bm
OI   CVCL_5321 ! LB9.D
OI   CVCL_S344 ! LB9.K
OI   CVCL_S343 ! LB9.Li
OI   CVCL_5322 ! LB9.Ln
OI   CVCL_5323 ! LB9.Sp
OI   CVCL_5325 ! LB9.Thy
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   LB9.Thy
AC   CVCL_5325
DR   CLO; CLO_0007271
DR   ATCC; CRL-6059
DR   Wikidata; Q54902102
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6059; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_5320 ! LB9.Bm
OI   CVCL_5321 ! LB9.D
OI   CVCL_S344 ! LB9.K
OI   CVCL_S343 ! LB9.Li
OI   CVCL_5322 ! LB9.Ln
OI   CVCL_5323 ! LB9.Sp
OI   CVCL_5324 ! LB9.Sp/Thy/Bm
SX   Female
AG   3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LB905-BLC
AC   CVCL_E905
SY   LB905
DR   Wikidata; Q54902103
RX   PubMed=9637538;
RX   PubMed=11051255;
RX   PubMed=11751535;
RX   PubMed=29732388;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LB919-SCCHN
AC   CVCL_A8QP
DR   cancercelllines; CVCL_A8QP
DR   Wikidata; Q108820675
RX   PubMed=28765120;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Ile655Val (c.1963A>G); ClinVar=VCV000013873; Zygosity=Unspecified (PubMed=28765120).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LB929-MEL
AC   CVCL_F233
SY   LB929
DR   Wikidata; Q54902104
WW   Info; MethDB; -; http://methdb.univ-perp.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===skin%20-%20LB929-MEL&-Find
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   LB951-MEL
AC   CVCL_E916
DR   Wikidata; Q54902105
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   LB96-SAR
AC   CVCL_F721
DR   IPD-IMGT/HLA; 10968
DR   Wikidata; Q54902106
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*35:01,38:01:01; C*04:01 (IPD-IMGT/HLA=10968).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   LB996-EBV
AC   CVCL_E912
SY   LB996EBV
DR   Cell_Model_Passport; SIDM01645
DR   DepMap; ACH-002359
DR   Wikidata; Q54902107
RX   PubMed=14762065;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1371 ! LB996-RCC
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   LB996-RCC
AC   CVCL_1371
SY   LB996RCC; LB996; LOBE
DR   CLO; CLO_0009981
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1371
DR   Cell_Model_Passport; SIDM00180
DR   ChEMBL-Cells; CHEMBL3308309
DR   ChEMBL-Targets; CHEMBL2366110
DR   Cosmic; 753585
DR   Cosmic-CLP; 753585
DR   DepMap; ACH-002155
DR   EGA; EGAS00001000978
DR   GDSC; 753585
DR   GEO; GSM1670040
DR   IARC_TP53; 21468
DR   LINCS_LDP; LCL-1767
DR   PharmacoDB; LB996RCC_827_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1371
DR   Wikidata; Q54902108
RX   PubMed=10074909;
RX   PubMed=14762065;
RX   PubMed=15585611;
RX   PubMed=18698046;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.05%; East Asian, North=0%; East Asian, South=0.4%; South Asian=2.91%; European, North=45.92%; European, South=49.72% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=753585
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E912 ! LB996-EBV
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   LBB
AC   CVCL_A9D8
SY   L.B.B.
DR   Wikidata; Q102114453
RX   PubMed=2822736;
RX   PubMed=3374507;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   LbetaT2
AC   CVCL_0398
SY   L-beta-T2; L beta T2; Lbeta T2; L{beta}T2; Lbetat2; LbT2
DR   BTO; BTO_0004467
DR   EFO; EFO_0002070
DR   MCCL; MCC:0000292
DR   Lonza; 1263
DR   Millipore; SCC412
DR   TOKU-E; 4079
DR   Wikidata; Q54902109
RX   PubMed=8770922;
RX   PubMed=8898243;
RX   PubMed=11356674;
RX   PubMed=15541569;
RX   PubMed=31020055;
CC   Characteristics: Widely used as an in vitro model for the study of gonadotropin gene regulation and GnRH signaling (Millipore=SCC412).
CC   Characteristics: Expresses CGA, GnRH-R and the alpha and beta subunits of LH (PubMed=8770922).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6 x BALB/c transgenic.
ST   Source(s): Millipore=SCC412
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 13,17
ST   Mouse STR 6-4: 19,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16,18
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   LbetaT4
AC   CVCL_U354
SY   L-beta-T4
DR   Wikidata; Q54902110
RX   PubMed=8898243;
RX   PubMed=15541569;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6 x BALB/c transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   LBF
AC   CVCL_E752
SY   LBUF; GM03163; GM3163
DR   CLO; CLO_0013548
DR   Coriell; GM03163
DR   dbMHC; 48945
DR   dbMHC; 48946
DR   ECACC; 88052096
DR   IHW; IHW09048
DR   IHW; IHW09096
DR   IPD-IMGT/HLA; 10969
DR   Wikidata; Q54902111
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=6808075;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; English.
CC   HLA typing: A*30:01:01; B*13:02:01:01; C*06:02:01:01; DPA1*02:01:01; DPB1*17:01; DQA1*02:01; DQB1*02:02:01; DRA*01:01; DRB1*07:01:01; DRB4*01:01:01 (IPD-IMGT/HLA=10969).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Discontinued: ECACC; 88052096; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 25
//
ID   LBF-2
AC   CVCL_R977
DR   Wikidata; Q54902112
RX   PubMed=6767657;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal trunk; UBERON=UBERON_0002100+UBERON_0006071.
OX   NCBI_TaxID=27706; ! Micropterus salmoides (Largemouth bass)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   LBHEL
AC   CVCL_JZ98
DR   Wikidata; Q54902113
RX   Patent=US5952227;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 0127BP.
CC   Virology: Highly susceptible to infection by Human herpesvirus 3 (HHV-3).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   LBi001-A
AC   CVCL_C6QH
SY   iLB-268bfs4; PH-BL-001 Clone 4
DR   BioSamples; SAMEA111454102
DR   hPSCreg; LBi001-A
DR   Wikidata; Q117704592
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi001-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi001-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QI ! LBi001-B
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi001-B
AC   CVCL_C6QI
SY   iLB-268bfs9; PH-BL-001 Clone 9
DR   BioSamples; SAMEA111454103
DR   hPSCreg; LBi001-B
DR   Wikidata; Q117704593
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.1225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi001-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi001-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QH ! LBi001-A
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   LBi002-A
AC   CVCL_C6QJ
SY   iLB-272bfs2; PH-BL-002 Clone 2
DR   BioSamples; SAMEA111509488
DR   hPSCreg; LBi002-A
DR   Wikidata; Q117704594
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi002-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi002-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QK ! LBi002-B
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi002-B
AC   CVCL_C6QK
SY   iLB-272bfs9; PH-BL-002 Clone 9
DR   BioSamples; SAMEA111509489
DR   hPSCreg; LBi002-B
DR   Wikidata; Q117704595
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi002-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi002-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QJ ! LBi002-A
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi003-A
AC   CVCL_C6QL
SY   iLB-273bms57; PH-BL-003 Clone 57
DR   BioSamples; SAMEA111509490
DR   hPSCreg; LBi003-A
DR   Wikidata; Q117704596
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi003-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QM ! LBi003-B
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi003-B
AC   CVCL_C6QM
SY   iLB-273bms61; PH-BL-003 Clone 61
DR   BioSamples; SAMEA111509491
DR   hPSCreg; LBi003-B
DR   Wikidata; Q117704597
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi003-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi003-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QL ! LBi003-A
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi004-A
AC   CVCL_C6QN
SY   iLB-278bfs210; PH-BL-204 Clone 210
DR   BioSamples; SAMEA111509492
DR   hPSCreg; LBi004-A
DR   Wikidata; Q117704598
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi004-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi004-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QP ! LBi004-B
SX   Female
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi004-B
AC   CVCL_C6QP
SY   iLB-278bfs211; PH-BL-204 Clone 211
DR   BioSamples; SAMEA111509493
DR   hPSCreg; LBi004-B
DR   Wikidata; Q117704599
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi004-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi004-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QN ! LBi004-A
SX   Female
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi005-A
AC   CVCL_C6QQ
SY   iLB-293bms257; PH-BL-411 Clone 257
DR   BioSamples; SAMEA111509494
DR   hPSCreg; LBi005-A
DR   Wikidata; Q117704600
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi005-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi005-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QR ! LBi005-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi005-B
AC   CVCL_C6QR
SY   iLB-293bms258; PH-BL-411 Clone 258
DR   BioSamples; SAMEA111509495
DR   hPSCreg; LBi005-B
DR   Wikidata; Q117704602
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Heterozygous (hPSCreg=LBi005-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Heterozygous (hPSCreg=LBi005-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QQ ! LBi005-A
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi006-A
AC   CVCL_C6QS
SY   iLB-269bms16; PH-BL-102 Clone 16
DR   BioSamples; SAMEA111511677
DR   hPSCreg; LBi006-A
DR   Wikidata; Q117704603
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi006-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi006-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QT ! LBi006-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi006-B
AC   CVCL_C6QT
SY   iLB-269bms8; PH-BL-102 Clone 8
DR   BioSamples; SAMEA111511678
DR   hPSCreg; LBi006-B
DR   Wikidata; Q117704604
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi006-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi006-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QS ! LBi006-A
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi007-A
AC   CVCL_C6QU
SY   iLB-285bfs98; PH-BL-406 Clone 98
DR   BioSamples; SAMEA111511679
DR   hPSCreg; LBi007-A
DR   Wikidata; Q117704605
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi007-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi007-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QV ! LBi007-B
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi007-B
AC   CVCL_C6QV
SY   iLB-285bfs99; PH-BL-406 Clone 99
DR   BioSamples; SAMEA111511680
DR   hPSCreg; LBi007-B
DR   Wikidata; Q117704606
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi007-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi007-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QU ! LBi007-A
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi008-A
AC   CVCL_C6QW
SY   iLB-289bms128; PH-BL-407 Clone 128
DR   BioSamples; SAMEA111511681
DR   hPSCreg; LBi008-A
DR   Wikidata; Q117704608
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi008-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi008-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QX ! LBi008-B
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi008-B
AC   CVCL_C6QX
SY   iLB-289bms145; PH-BL-407 Clone 145
DR   BioSamples; SAMEA111511682
DR   hPSCreg; LBi008-B
DR   Wikidata; Q117704609
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi008-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi008-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QW ! LBi008-A
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi009-A
AC   CVCL_C6QY
SY   iLB-284bms174; PH-BL-405 Clone 174
DR   BioSamples; SAMEA111511683
DR   hPSCreg; LBi009-A
DR   Wikidata; Q117704610
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi009-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi009-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QZ ! LBi009-B
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi009-B
AC   CVCL_C6QZ
SY   iLB-284bms179; PH-BL-405 Clone 179
DR   BioSamples; SAMEA111511684
DR   hPSCreg; LBi009-B
DR   Wikidata; Q117704611
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi009-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi009-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6QY ! LBi009-A
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi010-A
AC   CVCL_C6R0
SY   iLB-282bfs275; PH-BL-403 Clone 275
DR   BioSamples; SAMEA111511685
DR   hPSCreg; LBi010-A
DR   Wikidata; Q117704612
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi010-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi010-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R1 ! LBi010-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi010-B
AC   CVCL_C6R1
SY   iLB-282bfs283; PH-BL-403 Clone 283
DR   BioSamples; SAMEA111511692
DR   hPSCreg; LBi010-B
DR   Wikidata; Q117704613
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi010-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi010-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R0 ! LBi010-A
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi011-A
AC   CVCL_C6R2
SY   iLB-274bfs14; PH-BL-004 Clone 14
DR   BioSamples; SAMEA111521225
DR   hPSCreg; LBi011-A
DR   Wikidata; Q117704614
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi011-A).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi011-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R3 ! LBi011-B
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi011-B
AC   CVCL_C6R3
SY   iLB-274bfs17; PH-BL-004 Clone 17
DR   BioSamples; SAMEA111521226
DR   hPSCreg; LBi011-B
DR   Wikidata; Q117704615
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; p.Ala14Val (c.41C>T) (chr19:g.51225221C>T); ClinVar=VCV001275129; Zygosity=Homozygous (hPSCreg=LBi011-B).
CC   Sequence variation: Mutation; HGNC; HGNC:1659; CD33; Simple; chr19:g.51224706C>A; dbSNP=rs3865444; Zygosity=Homozygous (hPSCreg=LBi011-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R2 ! LBi011-A
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LBi012-A
AC   CVCL_C6R4
SY   iLB-292bms74; PH-BL-410 Clone 74
DR   BioSamples; SAMEA111521227
DR   hPSCreg; LBi012-A
DR   Wikidata; Q117704616
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R5 ! LBi012-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   LBi012-B
AC   CVCL_C6R5
SY   iLB-292bms80; PH-BL-410 Clone 80
DR   BioSamples; SAMEA111521228
DR   hPSCreg; LBi012-B
DR   Wikidata; Q117704617
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R4 ! LBi012-A
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   LBi013-A
AC   CVCL_C6R6
SY   iLB-279bfs117; PH-BL-304 Clone 117
DR   BioSamples; SAMEA111521229
DR   hPSCreg; LBi013-A
DR   Wikidata; Q117704618
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   LBi014-A
AC   CVCL_C6R7
SY   iLB-281bfs191; PH-BL-402 Clone 191
DR   BioSamples; SAMEA111521230
DR   hPSCreg; LBi014-A
DR   Wikidata; Q117704619
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R8 ! LBi014-B
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   LBi014-B
AC   CVCL_C6R8
SY   iLB-281bfs192; PH-BL-402 Clone 192
DR   BioSamples; SAMEA111521231
DR   hPSCreg; LBi014-B
DR   Wikidata; Q117704620
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R7 ! LBi014-A
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   LBi015-A
AC   CVCL_C6R9
SY   iLB-277bms227; PH-BL-303 Clone 227
DR   BioSamples; SAMEA111521232
DR   hPSCreg; LBi015-A
DR   Wikidata; Q117704621
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RA ! LBi015-B
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   LBi015-B
AC   CVCL_C6RA
SY   iLB-277bms234; PH-BL-303 Clone 234
DR   BioSamples; SAMEA111521233
DR   hPSCreg; LBi015-B
DR   Wikidata; Q117704622
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6R9 ! LBi015-A
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   LBi016-A
AC   CVCL_C6RB
SY   iLB-296bfs10; PH-BL-414 Clone 10
DR   BioSamples; SAMEA111531213
DR   hPSCreg; LBi016-A
DR   Wikidata; Q117704623
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi016-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RC ! LBi016-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi016-B
AC   CVCL_C6RC
SY   iLB-296bfs16; PH-BL-414 Clone 16
DR   BioSamples; SAMEA111531214
DR   hPSCreg; LBi016-B
DR   Wikidata; Q117704624
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi016-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RB ! LBi016-A
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi017-A
AC   CVCL_C6RD
SY   iLB-280bfs22; PH-BL-401 Clone 22
DR   BioSamples; SAMEA111531215
DR   hPSCreg; LBi017-A
DR   Wikidata; Q117704625
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi017-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RE ! LBi017-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi017-B
AC   CVCL_C6RE
SY   iLB-280bfs36; PH-BL-401 Clone 36
DR   BioSamples; SAMEA111531216
DR   hPSCreg; LBi017-B
DR   Wikidata; Q117704626
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi017-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RD ! LBi017-A
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi018-A
AC   CVCL_C6RF
SY   iLB-291bfs43; PH-BL-409 Clone 43
DR   BioSamples; SAMEA111531217
DR   hPSCreg; LBi018-A
DR   Wikidata; Q117704627
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi018-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RG ! LBi018-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi018-B
AC   CVCL_C6RG
SY   iLB-291bfs45; PH-BL-409 Clone 45
DR   BioSamples; SAMEA111531218
DR   hPSCreg; LBi018-B
DR   Wikidata; Q117704628
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi018-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RF ! LBi018-A
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi019-A
AC   CVCL_C6RH
SY   iLB-275bms154; PH-BL-901 Clone 154
DR   BioSamples; SAMEA111531219
DR   hPSCreg; LBi019-A
DR   Wikidata; Q117704629
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi019-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RI ! LBi019-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi019-B
AC   CVCL_C6RI
SY   iLB-275bms162; PH-BL-901 Clone 162
DR   BioSamples; SAMEA111531220
DR   hPSCreg; LBi019-B
DR   Wikidata; Q117704630
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi019-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RH ! LBi019-A
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBi020-A
AC   CVCL_C6RJ
SY   iLB-294bms22; PH-BL-412 Clone 238
DR   BioSamples; SAMEA111531221
DR   hPSCreg; LBi020-A
DR   Wikidata; Q117704631
CC   From: Life & Brain GmbH; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (hPSCreg=LBi020-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   LBLN
AC   CVCL_5326
DR   CLO; CLO_0007273
DR   ATCC; CRL-6046
DR   Wikidata; Q54902114
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6046; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   LBRM-33
AC   CVCL_K174
SY   LBRM 33; LBRM33
DR   Wikidata; Q54902115
RX   PubMed=6968790;
RX   PubMed=6975944;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC   Characteristics: Produces IL2 in response to phytohemagglutinin (PHA) and concanavalin A (ConA) (PubMed=6975944).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: B10.BR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   LBRM-33 clone 1A5
AC   CVCL_3839
SY   LBRM-33-1A5; LBRM-33 1A5; LBRM-33 1 A-5; 1A5
DR   CLO; CLO_0007276
DR   CLDB; cl3185
DR   ATCC; CRL-8079
DR   ECACC; 86060302
DR   KCLB; 28079
DR   Wikidata; Q54902116
RX   Patent=US4404280;
RX   PubMed=6968790;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8079.
CC   Characteristics: Produces IL2 in response to IL1 and can be used to assay IL1 activity (ATCC=CRL-8079).
CC   Discontinued: ATCC; CRL-8079; true.
CC   Discontinued: KCLB; 28079; probable.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: B10.BR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K174 ! LBRM-33
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   LBRM-33 clone 4A2
AC   CVCL_6490
SY   LBRM-33-4A2; LBRM-33 4A2; 4A2
DR   CLO; CLO_0007275
DR   ATCC; TIB-155
DR   Wikidata; Q54902117
RX   Patent=US4404280;
RX   PubMed=6968790;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: B10.BR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K174 ! LBRM-33
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   LBRM-33 clone 5A4
AC   CVCL_K175
SY   LBRM-33-5A4; LBRM-33 5A4; 5A4
DR   Wikidata; Q54902118
RX   Patent=US4404280;
RX   PubMed=6968790;
RX   PubMed=6975944;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8080.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: B10.BR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K174 ! LBRM-33
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   LBRM-TG6
AC   CVCL_4239
SY   LBRM TG6
DR   CLO; CLO_0007274
DR   ATCC; CRL-1778
DR   ECACC; 96020937
DR   Wikidata; Q54902119
RX   PubMed=3873500;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-TG6
CC   Characteristics: Produces IL2 in response to IL1 and PHA. Can be used to assay IL1 activity (ECACC=96020937).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: B10.BR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6490 ! LBRM-33 clone 4A2
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   LC-06-JCK
AC   CVCL_D550
SY   LC06JCK
DR   Wikidata; Q54902120
RX   PubMed=7691144;
RX   PubMed=19265263;
CC   Population: Japanese.
CC   Miscellaneous: This is not a cell line but a xenograft.
DI   NCIt; C45516; Lung clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   LC-1/sq
AC   CVCL_3008
SY   LC-1 sq; LC-1-sq; LC-1Sq; LC-1sq; LC1/Sq; LC1-Sq; LC1-sq; LC1sq; Lc1sq; LC1SQ; Lung cancer-1/squamous; LC-1; LC1
DR   CLO; CLO_0037019
DR   CLO; CLO_0050045
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 927
DR   BioSample; SAMN03471667
DR   cancercelllines; CVCL_3008
DR   Cell_Model_Passport; SIDM00300
DR   CGH-DB; 188-1
DR   CGH-DB; 9178-4
DR   Cosmic; 713858
DR   Cosmic; 801579
DR   Cosmic; 844843
DR   Cosmic; 876169
DR   Cosmic; 889102
DR   Cosmic; 917979
DR   Cosmic; 929146
DR   Cosmic; 932926
DR   Cosmic; 1219072
DR   Cosmic; 1239906
DR   Cosmic; 2668326
DR   Cosmic-CLP; 1298223
DR   DepMap; ACH-002156
DR   EGA; EGAS00001000978
DR   GDSC; 1298223
DR   GEO; GSM784280
DR   GEO; GSM827201
DR   GEO; GSM1374618
DR   GEO; GSM1670042
DR   IARC_TP53; 2382
DR   JCRB; JCRB0258
DR   LINCS_LDP; LCL-1586
DR   PharmacoDB; LC1sq_828_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3008
DR   RCB; RCB0455
DR   Wikidata; Q54902121
RX   PubMed=1917142;
RX   PubMed=8263009;
RX   PubMed=8348978;
RX   PubMed=9023415;
RX   PubMed=9538136;
RX   PubMed=9673367;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=24002593;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 64.6 hours (PubMed=1917142); ~75 hours (Note=Lot 11122004) (JCRB=JCRB0258).
CC   HLA typing: A*11,24:02; B*44:03:01; C*12:03,16:01 (PubMed=9023415).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9673367).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Arg1475Ter (c.4423C>T); Zygosity=Heterozygous (Cosmic-CLP=1298223; DepMap=ACH-002156).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (PubMed=8263009; PubMed=10536175; PubMed=20557307; Cosmic-CLP=1298223; DepMap=ACH-002156).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=0%; East Asian, North=91.84%; East Asian, South=7.55%; South Asian=0.28%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1298223; JCRB=JCRB0258; RCB=RCB0455
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   LC-1/sq-SF
AC   CVCL_5480
SY   LC1_sq-SF; LC-1-sq-SF; LC1SQSF; LC-1/sq-Serum Free
DR   CLO; CLO_0050066
DR   BioSample; SAMN10988019
DR   cancercelllines; CVCL_5480
DR   Cell_Model_Passport; SIDM01226
DR   Cosmic; 2125266
DR   DepMap; ACH-001113
DR   GEO; GSM887263
DR   GEO; GSM888338
DR   IARC_TP53; 30112
DR   PharmacoDB; LC1_sqSF_829_2019
DR   Progenetix; CVCL_5480
DR   RCB; RCB0438
DR   Wikidata; Q54902122
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Group: Serum/protein free medium cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Arg1475Ter (c.4423C>T); Zygosity=Heterozygous (DepMap=ACH-001113).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (DepMap=ACH-001113).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.68%; Native American=0%; East Asian, North=96.94%; East Asian, South=1.38%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB0438
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3008 ! LC-1/sq
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   LC-1F
AC   CVCL_1372
SY   LC1F; Lung cancer-1/squamous, floating variant
DR   CLO; CLO_0050026
DR   EFO; EFO_0002827
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472313
DR   BioSample; SAMN10988100
DR   cancercelllines; CVCL_1372
DR   Cell_Model_Passport; SIDM00298
DR   ChEMBL-Cells; CHEMBL3308207
DR   ChEMBL-Targets; CHEMBL2366216
DR   Cosmic; 907785
DR   Cosmic; 1995479
DR   DepMap; ACH-000705
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10457-106G7
DR   GDSC; 907785
DR   GEO; GSM1670041
DR   IARC_TP53; 21469
DR   LiGeA; CCLE_913
DR   LINCS_LDP; LCL-1595
DR   PharmacoDB; LC1F_830_2019
DR   Progenetix; CVCL_1372
DR   PubChem_Cell_line; CVCL_1372
DR   RCB; RCB0439
DR   Wikidata; Q54902123
RX   PubMed=24002593;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*39:01,46:01; C*04:01,07:02; DQA1*01:02,05:02; DQB1*05:01,06:02; DRB1*11:30,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Arg1475Ter (c.4423C>T); Zygosity=Heterozygous (DepMap=ACH-000705).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (DepMap=ACH-000705).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=6.24%; Native American=0%; East Asian, North=88.7%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=5.06% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB0439
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3008 ! LC-1/sq
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   LC-2/ad
AC   CVCL_1373
SY   LC-2-Ad; LC-2-ad; LC-2 ad; LC2/Ad; LC2/AD; LC2AD
DR   BTO; BTO_0006466
DR   CLO; CLO_0037020
DR   CLO; CLO_0050073
DR   EFO; EFO_0003140
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472314
DR   cancercelllines; CVCL_1373
DR   Cell_Model_Passport; SIDM00297
DR   ChEMBL-Cells; CHEMBL3308545
DR   ChEMBL-Targets; CHEMBL2366260
DR   Cosmic; 907786
DR   Cosmic; 946052
DR   Cosmic; 1154602
DR   Cosmic; 1571726
DR   Cosmic; 1656903
DR   Cosmic; 1995480
DR   Cosmic-CLP; 907786
DR   DepMap; ACH-002157
DR   ECACC; 94072247
DR   EGA; EGAS00001000978
DR   GDSC; 907786
DR   GEO; GSM1670043
DR   IARC_TP53; 21470
DR   LINCS_LDP; LCL-1667
DR   PharmacoDB; LC2ad_831_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1373
DR   RCB; RCB0440
DR   Wikidata; Q54902124
RX   PubMed=8291444;
RX   PubMed=8348978;
RX   PubMed=16105816;
RX   PubMed=20164919;
RX   PubMed=22313637;
RX   PubMed=23154560;
RX   PubMed=23578175;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 58 hours (Note=At 32th passage) (PubMed=8291444).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (PubMed=23578175).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Homozygous (Cosmic-CLP=907786; DepMap=ACH-002157).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.51%; Native American=0.63%; East Asian, North=76.2%; East Asian, South=13.98%; South Asian=0.14%; European, North=0.91%; European, South=4.65% (PubMed=30894373).
CC   Caution: Indicated to have a EGFR p.Leu858Arg (c.2573T>G) mutation according to PubMed=16105816) but this is in contradiction of results of exome sequencing in Cosmic-CLP and DepMap.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=907786; ECACC=94072247; RCB=RCB0440
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   LC-2/ad-cis
AC   CVCL_C4AM
DR   Wikidata; Q116049669
RX   PubMed=25826333;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1373 ! LC-2/ad
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   LC-540
AC   CVCL_3536
SY   LC540; LC 540
DR   BTO; BTO_0006548
DR   CLO; CLO_0007277
DR   CLO; CLO_0007278
DR   CLO; CLO_0007279
DR   CLDB; cl3188
DR   CLDB; cl3189
DR   ATCC; CCL-43
DR   BCRC; 60509
DR   CLS; 500262
DR   ECACC; 89031604
DR   IZSLER; BS TCL 35
DR   JCRB; JCRB9064
DR   KCLB; 10043
DR   Wikidata; Q54902125
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60429; Rat Leydig cell adenoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   LC-65A
AC   CVCL_A1KU
SY   LC65A
DR   Wikidata; Q102114454
RX   PubMed=7671230;
RX   PubMed=9023415;
RX   PubMed=9538136;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*40:02; C*03:04 (PubMed=9023415).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   LC-99A
AC   CVCL_A1KV
SY   LC99A
DR   Wikidata; Q102114455
RX   PubMed=7671230;
RX   PubMed=9023415;
RX   PubMed=9538136;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01,54:01; C*01:02,12:02 (PubMed=9023415).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   LC-D1
AC   CVCL_B7J8
DR   Wikidata; Q112929988
RX   PubMed=9892213;
CC   HLA typing: DRB1*03,13 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   LC-L1
AC   CVCL_A9GJ
SY   LCL1
DR   CCRID; 5301MAM-KCB85019ZJ
DR   KCB; KCB 85019ZJ
DR   Wikidata; Q108820676
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9691; ! Panthera pardus (Leopard)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LC-L2
AC   CVCL_A9GK
SY   LCL2
DR   CCRID; 5301MAM-KCB00010ZJ
DR   KCB; KCB 200010ZJ
DR   Wikidata; Q108820677
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9691; ! Panthera pardus (Leopard)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LC-L3
AC   CVCL_A9GL
SY   LCL3
DR   CCRID; 5301MAM-KCB00011ZJ
DR   KCB; KCB 200011ZJ
DR   Wikidata; Q108820678
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9691; ! Panthera pardus (Leopard)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LC-L4
AC   CVCL_A9GM
SY   LCL4
DR   CCRID; 5301MAM-KCB0413LZJ
DR   KCB; KCB 200413LZJ
DR   Wikidata; Q108820679
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9691; ! Panthera pardus (Leopard)
OI   CVCL_A9GN ! LC-M4
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LC-M1
AC   CVCL_B7J9
DR   Wikidata; Q112929989
RX   PubMed=9892213;
CC   HLA typing: DRB1*09,11 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   LC-M4
AC   CVCL_A9GN
SY   LCM4
DR   CCRID; 5301MAM-KCB0413MZJ
DR   KCB; KCB 200413MZJ
DR   Wikidata; Q108820680
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9691; ! Panthera pardus (Leopard)
OI   CVCL_A9GM ! LC-L4
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   Lc-OSKMNL-iPSCs_1
AC   CVCL_E7BB
RX   PubMed=39249631;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
HI   CVCL_YE16 ! LYCMS
SX   Sex unspecified
AG   Fry
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Lc-OSKMNL-iPSCs_2
AC   CVCL_E7BC
RX   PubMed=39249631;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
HI   CVCL_YE16 ! LYCMS
SX   Sex unspecified
AG   Fry
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Lc-OSKMNL-iPSCs_3
AC   CVCL_E7BD
RX   PubMed=39249631;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
HI   CVCL_YE16 ! LYCMS
SX   Sex unspecified
AG   Fry
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Lc-OSNL-iPSCs_1
AC   CVCL_E7B8
RX   PubMed=39249631;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
HI   CVCL_YE16 ! LYCMS
SX   Sex unspecified
AG   Fry
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Lc-OSNL-iPSCs_2
AC   CVCL_E7B9
RX   PubMed=39249631;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
HI   CVCL_YE16 ! LYCMS
SX   Sex unspecified
AG   Fry
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Lc-OSNL-iPSCs_3
AC   CVCL_E7BA
RX   PubMed=39249631;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
HI   CVCL_YE16 ! LYCMS
SX   Sex unspecified
AG   Fry
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LC-S5
AC   CVCL_A9GP
SY   LCS5
DR   CCRID; 5301MAM-KCB04029ZJ
DR   KCB; KCB 200429ZJ
DR   Wikidata; Q108820681
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9691; ! Panthera pardus (Leopard)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LC-T
AC   CVCL_0B64
DR   Wikidata; Q54902126
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=10100721;
CC   Doubling time: 41.4 hours (PubMed=1311980).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   LC0009
AC   CVCL_VA92
DR   ECACC; 15092909
DR   Wikidata; Q54902127
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0049
AC   CVCL_VA93
DR   ECACC; 15102941
DR   Wikidata; Q54902128
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC01
AC   CVCL_Y146
DR   CGH-DB; 424-3
DR   Wikidata; Q54902129
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC0169
AC   CVCL_VA94
DR   ECACC; 15102942
DR   Wikidata; Q54902130
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0170
AC   CVCL_VA95
DR   ECACC; 15092910
DR   Wikidata; Q54902134
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC02
AC   CVCL_Y147
DR   CGH-DB; 400-3
DR   CGH-DB; 414-3
DR   Wikidata; Q54902135
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC02-No.2
AC   CVCL_Y148
DR   CGH-DB; 404-3
DR   Wikidata; Q54902136
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC0209
AC   CVCL_VA96
DR   ECACC; 15092911
DR   Wikidata; Q54902137
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0216
AC   CVCL_VA97
DR   ECACC; 15092912
DR   Wikidata; Q54902138
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0226
AC   CVCL_VA98
DR   ECACC; 15102943
DR   Wikidata; Q54902139
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0270
AC   CVCL_VA99
DR   ECACC; 15102944
DR   Wikidata; Q54902140
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0282
AC   CVCL_VB00
DR   ECACC; 15102945
DR   Wikidata; Q54902142
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0291
AC   CVCL_VB01
DR   ECACC; 15102946
DR   Wikidata; Q54902143
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0293
AC   CVCL_VB02
DR   ECACC; 15102947
DR   Wikidata; Q54902144
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC03
AC   CVCL_Y149
DR   CGH-DB; 436-3
DR   Wikidata; Q54902145
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC0371
AC   CVCL_VB03
DR   ECACC; 15102948
DR   Wikidata; Q54902146
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0389
AC   CVCL_VB04
DR   ECACC; 15102949
DR   Wikidata; Q54902147
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC04
AC   CVCL_Y150
DR   CGH-DB; 437-3
DR   Wikidata; Q54902148
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC0404
AC   CVCL_VB05
DR   ECACC; 15102950
DR   Wikidata; Q54902149
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC05
AC   CVCL_Y151
DR   CGH-DB; 438-3
DR   Wikidata; Q54902150
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC0501
AC   CVCL_VB06
DR   ECACC; 15092913
DR   Wikidata; Q54902151
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0579
AC   CVCL_VB07
DR   ECACC; 15092914
DR   Wikidata; Q54902152
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC06
AC   CVCL_Y152
DR   CGH-DB; 399-3
DR   CGH-DB; 415-3
DR   Wikidata; Q54902153
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC0658
AC   CVCL_VB08
DR   ECACC; 15102951
DR   Wikidata; Q54902154
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC0696
AC   CVCL_VB09
DR   ECACC; 15102952
DR   Wikidata; Q54902155
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LC07
AC   CVCL_Y153
DR   CGH-DB; 402-3
DR   CGH-DB; 421-3
DR   Wikidata; Q54902156
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC08
AC   CVCL_Y154
DR   CGH-DB; 401-3
DR   CGH-DB; 417-3
DR   Wikidata; Q54902157
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC09
AC   CVCL_Y155
DR   CGH-DB; 425-3
DR   Wikidata; Q54902158
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC10 [Human hepatocellular carcinoma]
AC   CVCL_Y156
DR   CGH-DB; 426-3
DR   Wikidata; Q54902159
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 6
//
ID   LC10 [Mouse hybridoma against vaccinia A56R]
AC   CVCL_E5RZ
RX   PubMed=21056889;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01218; Vaccinia virus hemagglutinin OPG185 (A56R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LC11
AC   CVCL_Y157
DR   CGH-DB; 427-3
DR   Wikidata; Q54902160
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC114
AC   CVCL_W458
DR   Wikidata; Q54902161
RX   PubMed=20724021;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3732; Pulmonary blastoma
DI   ORDO; Orphanet_64741; Pulmonary blastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   LC15
AC   CVCL_Y158
DR   CGH-DB; 418-3
DR   Wikidata; Q54902162
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC16
AC   CVCL_Y159
DR   CGH-DB; 419-3
DR   Wikidata; Q54902163
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC17
AC   CVCL_Y160
DR   CGH-DB; 420-3
DR   Wikidata; Q54902164
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC18
AC   CVCL_Y161
DR   CGH-DB; 428-3
DR   Wikidata; Q54902165
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC20
AC   CVCL_Y162
DR   CGH-DB; 429-3
DR   Wikidata; Q54902166
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC21
AC   CVCL_Y163
DR   CGH-DB; 439-3
DR   Wikidata; Q54902167
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC23
AC   CVCL_Y164
DR   CGH-DB; 430-3
DR   Wikidata; Q54902168
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC25
AC   CVCL_Y165
DR   CGH-DB; 449-3
DR   Wikidata; Q54902169
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC26
AC   CVCL_Y166
DR   CGH-DB; 450-3
DR   Wikidata; Q54902170
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC27
AC   CVCL_Y167
DR   CGH-DB; 451-3
DR   Wikidata; Q54902171
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   LC4-1
AC   CVCL_1374
SY   LC41
DR   BTO; BTO_0004945
DR   CLO; CLO_0009846
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470796
DR   cancercelllines; CVCL_1374
DR   Cell_Model_Passport; SIDM00549
DR   ChEMBL-Cells; CHEMBL3308835
DR   ChEMBL-Targets; CHEMBL2366091
DR   Cosmic; 907787
DR   Cosmic; 996283
DR   Cosmic; 998692
DR   Cosmic; 1037719
DR   Cosmic-CLP; 907787
DR   DepMap; ACH-002267
DR   EGA; EGAS00001000978
DR   GDSC; 907787
DR   GEO; GSM827293
DR   GEO; GSM1670044
DR   GEO; GSM5137723
DR   GEO; GSM5137760
DR   IARC_TP53; 21471
DR   JCRB; JCRB0114
DR   LINCS_LDP; LCL-1037
DR   PharmacoDB; LC41_832_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1374
DR   PubChem_Cell_line; CVCL_1374
DR   Wikidata; Q54902172
RX   PubMed=3115091;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35124168;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6997; MEF2D + HGNC; HGNC:17011; HNRNPUL1; Name(s)=MEF2D-HNRNPUL1 (PubMed=35354797).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.57%; East Asian, South=23.72%; South Asian=0.71%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of Leo, Isabelle Rose.
CC   Misspelling: LC4-L1; PubMed=35124168.
ST   Source(s): Cosmic-CLP=907787; JCRB=JCRB0114; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D10S1248: 13
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D1S1656: 15
ST   D21S11: 29,30
ST   D22S1045: 11,16
ST   D2S1338: 18,25
ST   D2S441: 13,14
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 23,25
ST   SE33: 17
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   LC5
AC   CVCL_5G52
DR   BioSample; SAMN06481116
DR   Wikidata; Q54902173
RX   Patent=US5582967;
RX   PubMed=2201317;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Parent cell line (L-132) has been shown to be a HeLa derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00515.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-842.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1908 ! L-132
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   LC5-HIV
AC   CVCL_5G53
DR   BioSample; SAMN06481117
DR   Wikidata; Q54902174
RX   Patent=US5582967;
RX   PubMed=1373627;
RX   PubMed=2201317;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Grand-parent cell line (L-132) has been shown to be a HeLa derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00516.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-843.
CC   Population: African American.
CC   Virology: HIV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G52 ! LC5
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   LCa0020
AC   CVCL_VB10
DR   ECACC; 15102953
DR   Wikidata; Q54902179
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCa0026
AC   CVCL_VB11
DR   ECACC; 15102954
DR   Wikidata; Q54902180
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LCa0042
AC   CVCL_VB12
DR   ECACC; 15092915
DR   Wikidata; Q54902181
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCa0111
AC   CVCL_VB13
DR   ECACC; 15102955
DR   Wikidata; Q54902182
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LCA1-hiPSC1
AC   CVCL_C814
SY   LCA.1.H.iPSC.1; LCA-hiPSC1; RIi010-A
DR   hPSCreg; RIi010-A
DR   RSCB; RSCB0096
DR   SKIP; SKIP002405
DR   SKIP; SKIP005845
DR   Wikidata; Q54902183
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C815 ! LCA1-hiPSC2
OI   CVCL_C816 ! LCA1-hiPSC3
OI   CVCL_C817 ! LCA1-hiPSC4
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   LCA1-hiPSC2
AC   CVCL_C815
SY   LCA.1.H.iPSC.2; LCA-hiPSC2
DR   RSCB; RSCB0097
DR   Wikidata; Q54902184
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C814 ! LCA1-hiPSC1
OI   CVCL_C816 ! LCA1-hiPSC3
OI   CVCL_C817 ! LCA1-hiPSC4
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LCA1-hiPSC3
AC   CVCL_C816
SY   LCA.1.H.iPSC.3; LCA-hiPSC3
DR   RSCB; RSCB0098
DR   Wikidata; Q54902185
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C814 ! LCA1-hiPSC1
OI   CVCL_C815 ! LCA1-hiPSC2
OI   CVCL_C817 ! LCA1-hiPSC4
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LCA1-hiPSC4
AC   CVCL_C817
SY   LCA.1.H.iPSC.4; LCA-hiPSC4
DR   RSCB; RSCB0099
DR   Wikidata; Q54902186
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C814 ! LCA1-hiPSC1
OI   CVCL_C815 ! LCA1-hiPSC2
OI   CVCL_C816 ! LCA1-hiPSC3
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LCAM1
AC   CVCL_E062
SY   LCAM
DR   CLO; CLO_0050034
DR   BioSample; SAMN03472135
DR   DepMap; ACH-002035
DR   RCB; RCB1425
DR   Wikidata; Q54902187
RX   PubMed=9142195;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Korean.
CC   Doubling time: 6.9 hours (PubMed=9142195).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB1425
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,13
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 15,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   LCC-18
AC   CVCL_W648
SY   LCC18
DR   TOKU-E; 4056
DR   Wikidata; Q54902188
RX   PubMed=1782079;
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (PubMed=1782079).
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
DI   NCIt; C96156; Colorectal neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   LCD3
AC   CVCL_ZW30
DR   Wikidata; Q102114457
RX   PubMed=2276735;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome X mapping. Contains a complete copy of chromosome X.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V244 ! RJK88
CA   Hybrid cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   LCDV-E1
AC   CVCL_XC23
DR   Wikidata; Q95981671
RX   Patent=CN1312180C;
RX   Patent=CN1322008C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200419.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Lymphocystis disease virus 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 5
//
ID   LCDV-E2
AC   CVCL_XC24
DR   Wikidata; Q95981672
RX   Patent=CN1312180C;
RX   Patent=CN1322008C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200420.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Lymphocystis disease virus 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 5
//
ID   LCDV-V
AC   CVCL_XC25
DR   CCRID; 4201PAT-CCTCC00193
DR   Wikidata; Q95981674
RX   Patent=CN100404554C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200619.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P22176; Lymphocystis disease virus 1 capsid protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   LCE
AC   CVCL_S937
SY   Lates Calcarifer Epitheloid cells
DR   Wikidata; Q54902189
RX   DOI=10.1111/j.1365-2109.2005.01387.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 11
//
ID   LCF [Labeo]
AC   CVCL_C1L9
SY   Labeo Calbasu Fin
DR   NRFC; NRFC063
DR   Wikidata; Q114311872
RX   PubMed=35535632;
WW   Provider; NRFC; NRFC063; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC063.
CC   Characteristics: Grows well from 24 to 32 Celsius, the optimal growth temperature is 28 Celsius.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=177615; ! Labeo calbasu (Orangefin labeo)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   LCF [Lates]
AC   CVCL_S938
SY   Lates Calcarifer Fibroblastic cells
DR   Wikidata; Q54902190
RX   DOI=10.1111/j.1365-2109.2005.01387.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   LCG-F
AC   CVCL_IJ27
SY   Liaoning Cashmere Goat Fibroblast
DR   Wikidata; Q54902191
RX   PubMed=23065271;
CC   Doubling time: 65.5 hours (PubMed=23065271).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Liaoning cashmere; VBO=VBO_0009441.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 9
//
ID   LCHi001-A
AC   CVCL_A6XM
SY   MLAR-004.03
DR   hPSCreg; LCHi001-A
DR   Wikidata; Q107115614
RX   PubMed=34233262;
CC   From: Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Ile900Phe (c.2698A>T); ClinVar=VCV000464801; Zygosity=Hemizygous (PubMed=34233262).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120191; Complete androgen insensitivity syndrome
DI   ORDO; Orphanet_99429; Complete androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6XN ! LCHi001-B
SX   Male
AG   15-16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   LCHi001-B
AC   CVCL_A6XN
SY   MLAR-004.04
DR   hPSCreg; LCHi001-B
DR   Wikidata; Q107115615
RX   PubMed=34233262;
CC   From: Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Ile900Phe (c.2698A>T); ClinVar=VCV000464801; Zygosity=Hemizygous (PubMed=34233262).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120191; Complete androgen insensitivity syndrome
DI   ORDO; Orphanet_99429; Complete androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6XM ! LCHi001-A
SX   Male
AG   15-16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   LCHi002-A
AC   CVCL_A6XP
SY   MLAR-005.03
DR   hPSCreg; LCHi002-A
DR   Wikidata; Q107115618
CC   From: Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2962; DYNC2H1; Simple; p.Thr3836Ile (c.11507C>T); Zygosity=Heterozygous (from autologous cell line LCHi002-A).
CC   Sequence variation: Mutation; HGNC; HGNC:7983; NR5A1; Unexplicit; Ex3del and part of Ex4; Zygosity=Heterozygous (from autologous cell line LCHi002-A).
CC   Sequence variation: Mutation; HGNC; HGNC:8783; PDE4D; Simple; p.Gly93Ser (c.277G>A); Zygosity=Heterozygous (from autologous cell line LCHi002-A).
CC   Sequence variation: Mutation; HGNC; HGNC:16700; ZFPM2; Simple; p.Asn1087Ser (c.3260A>G); Zygosity=Heterozygous (from autologous cell line LCHi002-A).
CC   Discontinued: hPSCreg; LCHi002-A; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103186; Sexual differentiation disorder
DI   ORDO; Orphanet_90771; Disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6XQ ! LCHi002-B
SX   Male
AG   15-16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   LCHi002-B
AC   CVCL_A6XQ
SY   MLAR-005.04
DR   hPSCreg; LCHi002-B
DR   Wikidata; Q107115622
RX   PubMed=37413951;
CC   From: Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2962; DYNC2H1; Simple; p.Thr3836Ile (c.11507C>T); Zygosity=Heterozygous (PubMed=37413951).
CC   Sequence variation: Mutation; HGNC; HGNC:7983; NR5A1; Unexplicit; Ex3del and part of Ex4; Zygosity=Heterozygous (PubMed=37413951).
CC   Sequence variation: Mutation; HGNC; HGNC:8783; PDE4D; Simple; p.Gly93Ser (c.277G>A); Zygosity=Heterozygous (PubMed=37413951).
CC   Sequence variation: Mutation; HGNC; HGNC:16700; ZFPM2; Simple; p.Asn1087Ser (c.3260A>G); Zygosity=Heterozygous (PubMed=37413951).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103186; Sexual differentiation disorder
DI   ORDO; Orphanet_90771; Disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6XP ! LCHi002-A
SX   Male
AG   15-16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   LCHi003-A
AC   CVCL_C1U8
SY   SKMT001-22
DR   hPSCreg; LCHi003-A
DR   Wikidata; Q114311873
RX   PubMed=37086582;
CC   From: Lurie Children's Hospital of Chicago; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2973; DNM1L; Simple; p.Gly401Ser (c.1201G>A); ClinVar=VCV001299485; Zygosity=Heterozygous (PubMed=37086582).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   LCK
AC   CVCL_E753
DR   dbMHC; 48947
DR   IHW; IHW09367
DR   IPD-IMGT/HLA; 25978
DR   Wikidata; Q54902192
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*02:03,11:02; B*38:02:01,46:01; C*07:02,12:02; DPA1*02:02:02; DPB1*05:01; DQA1*03; DQB1*03:03:02,05:02:01; DRB1*09:01; DRB4*01:03:01:01,01:03:02 (IPD-IMGT/HLA=25978).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   LCL 10151
AC   CVCL_C5VG
DR   Wikidata; Q116049671
RX   PubMed=25740711;
RX   PubMed=27110896;
CC   HLA typing: A*02,31; B*15,27:05; C*02,03 (PubMed=27110896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LCL 1080
AC   CVCL_SA61
DR   Wikidata; Q54902193
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 1275
AC   CVCL_SA62
DR   Wikidata; Q54902194
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 1460
AC   CVCL_SA63
DR   Wikidata; Q54902195
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 15510
AC   CVCL_C5VH
DR   Wikidata; Q116049672
RX   PubMed=25740711;
RX   PubMed=27110896;
CC   HLA typing: A*01,11; B*27:05,37; C*01,06 (PubMed=27110896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LCL 1615
AC   CVCL_SA64
DR   Wikidata; Q54902196
RX   PubMed=1602455;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 1620
AC   CVCL_SA65
DR   Wikidata; Q54902197
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 1659
AC   CVCL_SA66
DR   Wikidata; Q54902198
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 1660
AC   CVCL_SA67
DR   Wikidata; Q54902199
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 1856
AC   CVCL_SA68
DR   Wikidata; Q54902200
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 1948
AC   CVCL_SA69
DR   Wikidata; Q54902201
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 2005
AC   CVCL_SA70
DR   Wikidata; Q54902202
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 2011
AC   CVCL_SA71
DR   Wikidata; Q54902203
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 2147
AC   CVCL_SA72
DR   Wikidata; Q54902204
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 6370
AC   CVCL_C5VI
DR   PRIDE; PXD008500
DR   Wikidata; Q116049673
RX   PubMed=25740711;
RX   PubMed=27110896;
CC   HLA typing: A*02,68; B*27:05,44; C*02,07 (PubMed=27110896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LCL 721
AC   CVCL_2102
SY   LCL-721; 721; 721 LCL; B-LCL 721; LCL721
DR   BTO; BTO_0006531
DR   dbMHC; 48948
DR   ECACC; 09071301
DR   IHW; IHW09249
DR   IPD-IMGT/HLA; 10972
DR   Wikidata; Q54902205
RX   PubMed=6933474;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*01:01:01:01,02:01:01:01; B*08:01:01,51:01:01; C*07:01:01,01:02:01; DPA1*01:03,02:01:02; DPB1*02:01:02,04:01; DQB1*05:01:01; DRB1*01:01 (IPD-IMGT/HLA=10972).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   LCL 721.114
AC   CVCL_D326
SY   721.114; .114
DR   Wikidata; Q54902206
RX   PubMed=2785140;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   LCL 721.127
AC   CVCL_D329
SY   721.127; .127
DR   Wikidata; Q54902207
RX   PubMed=2785140;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   LCL 721.144
AC   CVCL_D328
SY   721.144; .144
DR   Wikidata; Q54902209
RX   PubMed=2785140;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   LCL 721.174
AC   CVCL_6260
SY   721.174
DR   Lonza; 174
DR   Wikidata; Q54902210
RX   PubMed=6092300;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   LCL 721.180
AC   CVCL_6261
SY   721.180; .180
DR   Wikidata; Q54902211
RX   PubMed=6092300;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   LCL 721.184
AC   CVCL_D327
SY   721.184; .184
DR   Wikidata; Q54902212
RX   PubMed=2785140;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 12
//
ID   LCL 721.22
AC   CVCL_6262
SY   721.22; .22
DR   Wikidata; Q54902213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   LCL 721.220
AC   CVCL_D325
SY   721.220; .220
DR   Wikidata; Q54902214
RX   PubMed=2785140;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 12
//
ID   LCL 721.221
AC   CVCL_6263
SY   721.221; .221
DR   EFO; EFO_0022622
DR   ATCC; CRL-1855
DR   BioSample; SAMN03471255
DR   CCRID; 1101HUM-PUMC000517
DR   IHW; IHW00001
DR   Lonza; 176
DR   Millipore; SCC275
DR   PRIDE; PXD006455
DR   PRIDE; PXD025499
DR   TOKU-E; 4103
DR   Wikidata; Q54902215
RX   PubMed=2785140;
RX   PubMed=3257565;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/lcl-721-221-atcc-crl-1855
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Characteristics: Does not express HLA-A, HLA-B and HLA-C. The absence of class I HLA expression allows for functional analysis of individual classI antigens via transformation with individual HLA genes (Millipore=SCC275).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Misspelling: NTCC721.221; CCRID=1101HUM-PUMC000517.
CC   Discontinued: ATCC; CRL-1855; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1855; CCRID=1101HUM-PUMC000517; Millipore=SCC275; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14,15
ST   D12S391: 20,24
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 12,14
ST   D1S1656: 12,13
ST   D21S11: 28
ST   D22S1045: 15
ST   D2S1338: 19,24
ST   D2S441: 10,15
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D6S1043: 11,14
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 23
ST   Penta D: 11,14
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 14,17 (ATCC=CRL-1855; CCRID=1101HUM-PUMC000517; Technion Genomics Center)
ST   vWA: 17 (Millipore=SCC275)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D327 ! LCL 721.184
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   LCL 721.45
AC   CVCL_E420
SY   LCL721.45; 721.45; .45
DR   IPD-IMGT/HLA; 13327
DR   Wikidata; Q54902216
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2102 ! LCL 721
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 12
//
ID   LCL 8664
AC   CVCL_3464
SY   LCL/8664; LCL8664
DR   CLO; CLO_0007281
DR   ATCC; CRL-1805
DR   Wikidata; Q54902217
RX   PubMed=3017870;
RX   PubMed=17324269;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 45455; Rhesus lymphocryptovirus (Macacine herpesvirus 4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C134783; Rhesus monkey lymphoma
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   LCL 871
AC   CVCL_SA73
DR   Wikidata; Q54902218
RX   PubMed=1602455;
RX   PubMed=1905425;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL 919
AC   CVCL_SA74
DR   Wikidata; Q54902223
RX   PubMed=1602455;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LCL A1-1
AC   CVCL_ZU40
SY   A1-1
DR   Wikidata; Q98126884
RX   PubMed=32108534;
CC   Karyotypic information: Aberrant karyotype, 50,XX,+5,+10,+12,+12,add(15)(p11.2) (PubMed=32108534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU41 ! LCL A1-2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL A1-2
AC   CVCL_ZU41
SY   A1-2
DR   Wikidata; Q98126885
RX   PubMed=32108534;
CC   Karyotypic information: Aberrant karyotype.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU40 ! LCL A1-1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL A2
AC   CVCL_ZU42
SY   A2
DR   Wikidata; Q98126886
RX   PubMed=32108534;
CC   Karyotypic information: Aberrant karyotype, 47,XY,t(13;14)(q31;q21),+12 (PubMed=32108534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL A3
AC   CVCL_ZU43
SY   A3
DR   Wikidata; Q98126887
RX   PubMed=32108534;
CC   Karyotypic information: Aberrant karyotype, 47,X,i(Y)(q11.21),+12 (PubMed=32108534).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL ASNS H205P
AC   CVCL_E8E3
RX   PubMed=36873094;
CC   Population: Cuban.
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.His205Pro (c.614A>C); ClinVar=VCV001486990; Zygosity=Heterozygous (PubMed=36873094).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LCL ASNS H205P+Y398Lfs*4
AC   CVCL_E8E4
RX   PubMed=36873094;
CC   Population: Caucasian; Italian and Cuban.
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.His205Pro (c.614A>C); ClinVar=VCV001486990; Zygosity=Heterozygous (PubMed=36873094).
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Tyr398Leufs*4 (c.1192dupT); ClinVar=VCV000377228; Zygosity=Heterozygous (PubMed=36873094).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168586; Asparagine synthetase deficiency
DI   ORDO; Orphanet_391376; Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4-6Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LCL ASNS Y398Lfs*4
AC   CVCL_E8E5
RX   PubMed=36873094;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:753; ASNS; Simple; p.Tyr398Leufs*4 (c.1192dupT); ClinVar=VCV000377228; Zygosity=Heterozygous (PubMed=36873094).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LCL CL-PI 50
AC   CVCL_9V46
DR   NCBI_Iran; C488
DR   Wikidata; Q54902224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9V72 ! HCL BMF-PI 51
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   LCL M1
AC   CVCL_ZU44
SY   M1
DR   Wikidata; Q98126888
RX   PubMed=32108534;
CC   Karyotypic information: Has a marker chromosome present (der(22)).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL M2-1
AC   CVCL_ZU45
SY   M2-1
DR   Wikidata; Q98126889
RX   PubMed=32108534;
CC   Karyotypic information: Has a marker chromosome present (der(8)).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU46 ! LCL M2-2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL M2-2
AC   CVCL_ZU46
SY   M2-2
DR   Wikidata; Q98126890
RX   PubMed=32108534;
CC   Karyotypic information: Has a marker chromosome present (der(8)).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU45 ! LCL M2-1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL N1
AC   CVCL_ZU47
SY   N1
DR   Wikidata; Q98126891
RX   PubMed=32108534;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL N2
AC   CVCL_ZU48
SY   N2
DR   Wikidata; Q98126893
RX   PubMed=32108534;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL N3
AC   CVCL_ZU49
SY   N3
DR   Wikidata; Q98126894
RX   PubMed=32108534;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LCL Orang Asli K1
AC   CVCL_C8AH
SY   K1
DR   Wikidata; Q123032898
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K10
AC   CVCL_C8AI
SY   K10
DR   Wikidata; Q123032899
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K11
AC   CVCL_C8AJ
SY   K11
DR   Wikidata; Q123032900
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K12
AC   CVCL_C8AK
SY   K12
DR   Wikidata; Q123032901
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K16
AC   CVCL_C8AL
SY   K16
DR   Wikidata; Q123032902
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K18
AC   CVCL_C8AM
SY   K18
DR   Wikidata; Q123032903
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K2
AC   CVCL_C8AN
SY   K2
DR   Wikidata; Q123032904
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K22
AC   CVCL_C8AP
SY   K22
DR   Wikidata; Q123032905
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K23
AC   CVCL_C8AQ
SY   K23
DR   Wikidata; Q123032906
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K25
AC   CVCL_C8AR
SY   K25
DR   Wikidata; Q123032907
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K26
AC   CVCL_C8AS
SY   K26
DR   Wikidata; Q123032908
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K28
AC   CVCL_C8AT
SY   K28
DR   Wikidata; Q123032909
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K31
AC   CVCL_C8AU
SY   K31
DR   Wikidata; Q123032910
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K32
AC   CVCL_C8AV
SY   K32
DR   Wikidata; Q123032911
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K36
AC   CVCL_C8AW
SY   K36
DR   Wikidata; Q123032912
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K37
AC   CVCL_C8AX
SY   K37
DR   Wikidata; Q123032913
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K4
AC   CVCL_C8AY
SY   K4
DR   Wikidata; Q123032914
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K40
AC   CVCL_C8AZ
SY   K40
DR   Wikidata; Q123032915
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K5
AC   CVCL_C8B0
SY   K5
DR   Wikidata; Q123032916
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K6
AC   CVCL_C8B1
SY   K6
DR   Wikidata; Q123032917
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K7
AC   CVCL_C8B2
SY   K7
DR   Wikidata; Q123032918
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K8
AC   CVCL_C8B3
SY   K8
DR   Wikidata; Q123032920
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli K9
AC   CVCL_C8B4
SY   K9
DR   Wikidata; Q123032921
RX   CelloPub=CLPUB00737;
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Mendriq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli P11
AC   CVCL_C8B5
SY   P11
DR   Wikidata; Q123032922
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli P12
AC   CVCL_C8B6
SY   P12
DR   Wikidata; Q123032923
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli P19
AC   CVCL_C8B7
SY   P19
DR   Wikidata; Q123032924
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli P22
AC   CVCL_C8B8
SY   P22
DR   Wikidata; Q123032925
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli P23
AC   CVCL_C8B9
SY   P23
DR   Wikidata; Q123032926
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli S10
AC   CVCL_C8BA
SY   S10
DR   Wikidata; Q123032927
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli S2
AC   CVCL_C8BB
SY   S2
DR   Wikidata; Q123032929
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL Orang Asli S3
AC   CVCL_C8BC
SY   S3
DR   Wikidata; Q123032930
RX   DOI=10.23937/2378-3648/1410028;
CC   Population: Malaysian; Orang Asli; Negrito-Bateq.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   LCL-21353.1B2
AC   CVCL_XJ93
SY   21353.1B2
DR   Wikidata; Q95981725
RX   PubMed=31516393;
CC   Transformant: NCBI_TaxID; 199308; Porcine lymphotropic herpesvirus 3.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
DI   NCIt; C134786; Porcine lymphoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_XJ94 ! LCL-21353.2F8
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   LCL-21353.2F8
AC   CVCL_XJ94
SY   21353.2F8
DR   Wikidata; Q95981727
RX   PubMed=31516393;
CC   Transformant: NCBI_TaxID; 199308; Porcine lymphotropic herpesvirus 3.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
DI   NCIt; C134786; Porcine lymphoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_XJ93 ! LCL-21353.1B2
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   LCL-21353.2F8-23482
AC   CVCL_XJ95
SY   21353.2F8-23482
DR   Wikidata; Q95981728
RX   PubMed=31516393;
CC   Characteristics: Established after passage of parent cell line into a immunosuppressed MHC-matching pig.
CC   Transformant: NCBI_TaxID; 199308; Porcine lymphotropic herpesvirus 3.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
DI   NCIt; C134786; Porcine lymphoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_XJ94 ! LCL-21353.2F8
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   LCL-26
AC   CVCL_C3HP
DR   Wikidata; Q114311874
RX   PubMed=11175312;
RX   PubMed=15755994;
RX   PubMed=16045799;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ70 ! RCC-26
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   LCL-CB-PI 49
AC   CVCL_CW03
DR   NCBI_Iran; C487
DR   Wikidata; Q54902225
RX   PubMed=17254797;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: NCBI_Iran; C487; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 15,21
ST   D21S11: 27,31
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 19,20
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   LCL-Ho
AC   CVCL_1868
SY   LCL-HO; LCL Ho
DR   CLO; CLO_0007285
DR   CLDB; cl3192
DR   BioSample; SAMN03473367
DR   DSMZ; ACC-185
DR   DSMZCellDive; ACC-185
DR   Wikidata; Q54902226
RX   PubMed=10508494;
RX   PubMed=20454443;
CC   Doubling time: ~30 hours (DSMZ=ACC-185).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: This cell line was reported to be isogenic with MEL-Ho (Cellosaurus=CVCL_1402) but it does not have the same STR profile (PubMed=10508494).
ST   Source(s): DSMZ=ACC-185
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 13
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 13,16
ST   D21S11: 28,32.2
ST   D2S1338: 17,18
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 16
ST   FGA: 22,23
ST   Penta D: 9,15
ST   Penta E: 5,7
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   LCL-IDDM-PI258
AC   CVCL_B0QN
SY   LCL-IDDM-PI 258
DR   NCBI_Iran; C20041
DR   Wikidata; Q108820682
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI259
AC   CVCL_B0QP
SY   LCL-IDDM-PI 259
DR   NCBI_Iran; C20042
DR   Wikidata; Q108820683
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI260
AC   CVCL_B0QQ
SY   LCL-IDDM-PI 260
DR   NCBI_Iran; C20043
DR   Wikidata; Q108820684
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI268
AC   CVCL_B0QR
SY   LCL-IDDM-PI 268
DR   NCBI_Iran; C20044
DR   Wikidata; Q108820685
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI269
AC   CVCL_B0QS
SY   LCL-IDDM-PI 269
DR   NCBI_Iran; C20045
DR   Wikidata; Q108820686
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI270
AC   CVCL_B0QT
SY   LCL-IDDM-PI 270
DR   NCBI_Iran; C20046
DR   Wikidata; Q108820687
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI271
AC   CVCL_B0QU
SY   LCL-IDDM-PI 271
DR   NCBI_Iran; C20047
DR   Wikidata; Q108820688
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI284
AC   CVCL_B0QV
SY   LCL-IDDM-PI 284
DR   NCBI_Iran; C20057
DR   Wikidata; Q108820689
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI285
AC   CVCL_B0QW
SY   LCL-IDDM-PI 285
DR   NCBI_Iran; C20060
DR   Wikidata; Q108820690
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI286
AC   CVCL_B0QX
SY   LCL-IDDM-PI 286
DR   NCBI_Iran; C20061
DR   Wikidata; Q108820691
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI287
AC   CVCL_B0QY
SY   LCL-IDDM-PI 287
DR   NCBI_Iran; C20048
DR   Wikidata; Q108820692
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI288
AC   CVCL_B0QZ
SY   LCL-IDDM-PI 288
DR   NCBI_Iran; C20051
DR   Wikidata; Q108820694
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI289
AC   CVCL_B0R0
SY   LCL-IDDM-PI 289
DR   NCBI_Iran; C20052
DR   Wikidata; Q108820695
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI290
AC   CVCL_B0R1
SY   LCL-IDDM-PI 290
DR   NCBI_Iran; C20001
DR   Wikidata; Q108820697
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI291
AC   CVCL_B0R2
SY   LCL-IDDM-PI 291
DR   NCBI_Iran; C20002
DR   Wikidata; Q108820698
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI292
AC   CVCL_B0R3
SY   LCL-IDDM-PI 292
DR   NCBI_Iran; C20003
DR   Wikidata; Q108820699
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI293
AC   CVCL_B0R4
SY   LCL-IDDM-PI 293
DR   NCBI_Iran; C20004
DR   Wikidata; Q108820700
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI294
AC   CVCL_B0R5
SY   LCL-IDDM-PI 294
DR   NCBI_Iran; C20005
DR   Wikidata; Q108820701
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI295
AC   CVCL_B0R6
SY   LCL-IDDM-PI 295
DR   NCBI_Iran; C20006
DR   Wikidata; Q108820702
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI296
AC   CVCL_B0R7
SY   LCL-IDDM-PI 296
DR   NCBI_Iran; C20007
DR   Wikidata; Q108820703
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI297
AC   CVCL_B0R8
SY   LCL-IDDM-PI 297
DR   NCBI_Iran; C20008
DR   Wikidata; Q108820704
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI298
AC   CVCL_B0R9
SY   LCL-IDDM-PI 298
DR   NCBI_Iran; C20009
DR   Wikidata; Q108820705
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI299
AC   CVCL_B0RA
SY   LCL-IDDM-PI 299
DR   NCBI_Iran; C20010
DR   Wikidata; Q108820706
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI300
AC   CVCL_B0RB
SY   LCL-IDDM-PI 300
DR   NCBI_Iran; C20011
DR   Wikidata; Q108820707
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI301
AC   CVCL_B0RC
SY   LCL-IDDM-PI 301
DR   NCBI_Iran; C20014
DR   Wikidata; Q108820708
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI302
AC   CVCL_B0RD
SY   LCL-IDDM-PI 302
DR   NCBI_Iran; C20015
DR   Wikidata; Q108820709
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI303
AC   CVCL_B0RE
SY   LCL-IDDM-PI 303
DR   NCBI_Iran; C20016
DR   Wikidata; Q108820710
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI304
AC   CVCL_B0RF
SY   LCL-IDDM-PI 304
DR   NCBI_Iran; C20017
DR   Wikidata; Q108820711
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI305
AC   CVCL_B0RG
SY   LCL-IDDM-PI 305
DR   NCBI_Iran; C20012
DR   Wikidata; Q108820712
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI306
AC   CVCL_B0RH
SY   LCL-IDDM-PI 306
DR   NCBI_Iran; C20013
DR   Wikidata; Q108820713
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI307
AC   CVCL_B0RI
SY   LCL-IDDM-PI 307
DR   NCBI_Iran; C20018
DR   Wikidata; Q108820714
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI308
AC   CVCL_B0RJ
SY   LCL-IDDM-PI 308
DR   NCBI_Iran; C20019
DR   Wikidata; Q108820715
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI309
AC   CVCL_B0RK
SY   LCL-IDDM-PI 309
DR   NCBI_Iran; C20020
DR   Wikidata; Q108820716
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI310
AC   CVCL_B0RL
SY   LCL-IDDM-PI 310
DR   NCBI_Iran; C20021
DR   Wikidata; Q108820717
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI311
AC   CVCL_B0RM
SY   LCL-IDDM-PI 311
DR   NCBI_Iran; C20022
DR   Wikidata; Q108820718
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI312
AC   CVCL_B0RN
SY   LCL-IDDM-PI 312
DR   NCBI_Iran; C20023
DR   Wikidata; Q108820719
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI313
AC   CVCL_B0RP
SY   LCL-IDDM-PI 313
DR   NCBI_Iran; C20024
DR   Wikidata; Q108820720
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI314
AC   CVCL_B0RQ
SY   LCL-IDDM-PI 314
DR   NCBI_Iran; C20025
DR   Wikidata; Q108820721
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI315
AC   CVCL_B0RR
SY   LCL-IDDM-PI 315
DR   NCBI_Iran; C20026
DR   Wikidata; Q108820722
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI316
AC   CVCL_B0RS
SY   LCL-IDDM-PI 316
DR   NCBI_Iran; C20027
DR   Wikidata; Q108820723
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI317
AC   CVCL_B0RT
SY   LCL-IDDM-PI 317
DR   NCBI_Iran; C20028
DR   Wikidata; Q108820724
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI318
AC   CVCL_B0RU
SY   LCL-IDDM-PI 318
DR   NCBI_Iran; C20029
DR   Wikidata; Q108820725
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI319
AC   CVCL_B0RV
SY   LCL-IDDM-PI 319
DR   NCBI_Iran; C20030
DR   Wikidata; Q108820726
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI320
AC   CVCL_B0RW
SY   LCL-IDDM-PI 320
DR   NCBI_Iran; C20031
DR   Wikidata; Q108820727
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI321
AC   CVCL_B0RX
SY   LCL-IDDM-PI 321
DR   NCBI_Iran; C20032
DR   Wikidata; Q108820728
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI322
AC   CVCL_B0RY
SY   LCL-IDDM-PI 322
DR   NCBI_Iran; C20033
DR   Wikidata; Q108820729
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI323
AC   CVCL_B0RZ
SY   LCL-IDDM-PI 323
DR   NCBI_Iran; C20034
DR   Wikidata; Q108820730
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI324
AC   CVCL_B0S0
SY   LCL-IDDM-PI 324
DR   NCBI_Iran; C20035
DR   Wikidata; Q108820731
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI325
AC   CVCL_B0S1
SY   LCL-IDDM-PI 325
DR   NCBI_Iran; C20036
DR   Wikidata; Q108820732
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI326
AC   CVCL_B0S2
SY   LCL-IDDM-PI 326
DR   NCBI_Iran; C20037
DR   Wikidata; Q108820733
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI327
AC   CVCL_B0S3
SY   LCL-IDDM-PI 327
DR   NCBI_Iran; C20038
DR   Wikidata; Q108820734
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI328
AC   CVCL_B0S4
SY   LCL-IDDM-PI 328
DR   NCBI_Iran; C20039
DR   Wikidata; Q108820735
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI329
AC   CVCL_B0S5
SY   LCL-IDDM-PI 329
DR   NCBI_Iran; C20040
DR   Wikidata; Q108820736
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI330
AC   CVCL_B0S6
SY   LCL-IDDM-PI 330
DR   NCBI_Iran; C20055
DR   Wikidata; Q108820737
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI331
AC   CVCL_B0S8
SY   LCL-IDDM-PI 331
DR   NCBI_Iran; C20056
DR   Wikidata; Q108820739
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI401
AC   CVCL_B0S7
SY   LCL-IDDM-PI 401
DR   NCBI_Iran; C20064
DR   Wikidata; Q108820738
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI421
AC   CVCL_B0S9
SY   LCL-IDDM-PI 421
DR   NCBI_Iran; C20059
DR   Wikidata; Q108820740
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI427
AC   CVCL_B0SA
SY   LCL-IDDM-PI 427
DR   NCBI_Iran; C20066
DR   Wikidata; Q108820741
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI437
AC   CVCL_B0SB
SY   LCL-IDDM-PI 437
DR   NCBI_Iran; C20062
DR   Wikidata; Q108820742
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI440
AC   CVCL_B0SC
SY   LCL-IDDM-PI 440
DR   NCBI_Iran; C20054
DR   Wikidata; Q108820743
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI443
AC   CVCL_B0SD
SY   LCL-IDDM-PI 443
DR   NCBI_Iran; C20058
DR   Wikidata; Q108820744
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI444
AC   CVCL_B0SE
SY   LCL-IDDM-PI 444
DR   NCBI_Iran; C20049
DR   Wikidata; Q108820745
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI445
AC   CVCL_B0SF
SY   LCL-IDDM-PI 445
DR   NCBI_Iran; C20050
DR   Wikidata; Q108820746
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI446
AC   CVCL_B0SG
SY   LCL-IDDM-PI 446
DR   NCBI_Iran; C20063
DR   Wikidata; Q108820747
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI447
AC   CVCL_B0SH
SY   LCL-IDDM-PI 447
DR   NCBI_Iran; C20065
DR   Wikidata; Q108820748
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-IDDM-PI450
AC   CVCL_B0SI
SY   LCL-IDDM-PI 450
DR   NCBI_Iran; C20053
DR   Wikidata; Q108820749
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-Mor8
AC   CVCL_UG48
DR   Wikidata; Q95981731
RX   PubMed=6088403;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F910 ! ILT-Mor
OI   CVCL_G011 ! TCL-Mor
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   LCL-OHN
AC   CVCL_W859
DR   Wikidata; Q54902227
RX   PubMed=3034807;
RX   PubMed=12967475;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   LCL-partial trisomy 12p13
AC   CVCL_GR58
DR   Wikidata; Q54902228
RX   PubMed=223966;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 1
AC   CVCL_9V47
DR   NCBI_Iran; C159
DR   Wikidata; Q54902229
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D21S11: 32,33
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 100
AC   CVCL_CV96
DR   NCBI_Iran; C311
DR   Wikidata; Q54902231
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 101
AC   CVCL_9V60
DR   NCBI_Iran; C312
DR   Wikidata; Q54902232
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 8,11
ST   D18S51: 15,16
ST   D21S11: 29,33
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 11,15
ST   FGA: 22,24
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 103
AC   CVCL_CV98
DR   NCBI_Iran; C314
DR   Wikidata; Q54902233
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 104
AC   CVCL_9V61
DR   NCBI_Iran; C315
DR   Wikidata; Q54902234
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 15,19
ST   D21S11: 28,31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 13,15
ST   FGA: 19,24
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 105
AC   CVCL_CW00
DR   NCBI_Iran; C316
DR   Wikidata; Q54902235
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 106
AC   CVCL_CW01
DR   NCBI_Iran; C317
DR   Wikidata; Q54902236
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 11
AC   CVCL_9V53
DR   NCBI_Iran; C177
DR   Wikidata; Q54902237
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   LCL-PI 116
AC   CVCL_CW02
DR   NCBI_Iran; C327
DR   Wikidata; Q54902238
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 117
AC   CVCL_9V62
DR   NCBI_Iran; C328
DR   Wikidata; Q54902239
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,15
ST   D21S11: 27,31
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 26
ST   TH01: 6,10
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 118
AC   CVCL_CW04
DR   NCBI_Iran; C329
DR   Wikidata; Q54902240
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 12
AC   CVCL_9V54
DR   NCBI_Iran; C178
DR   Wikidata; Q54902241
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,18
ST   D21S11: 27,28
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 15,16
ST   FGA: 19
ST   TH01: 6
ST   TPOX: 7,8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 120
AC   CVCL_CW05
DR   NCBI_Iran; C331
DR   Wikidata; Q54902242
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 122
AC   CVCL_CW06
DR   NCBI_Iran; C333
DR   Wikidata; Q54902243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   LCL-PI 129
AC   CVCL_9V63
DR   NCBI_Iran; C340
DR   Wikidata; Q54902244
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 8,10
ST   D18S51: 15,16
ST   D21S11: 30,31
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 13,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 133
AC   CVCL_9V64
DR   NCBI_Iran; C344
DR   Wikidata; Q54902245
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D16S539: 9,11
ST   D18S51: 12
ST   D21S11: 28,32
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 21,25
ST   TH01: 6,10
ST   TPOX: 8,12
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 135
AC   CVCL_CW09
DR   NCBI_Iran; C346
DR   Wikidata; Q54902246
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 14
AC   CVCL_CV53
DR   NCBI_Iran; C225
DR   Wikidata; Q54902247
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 140
AC   CVCL_CW10
DR   NCBI_Iran; C351
DR   Wikidata; Q54902248
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 141
AC   CVCL_CW11
SY   LCL-PI141
DR   NCBI_Iran; C423
DR   Wikidata; Q54902249
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 145
AC   CVCL_CW12
DR   NCBI_Iran; C356
DR   Wikidata; Q54902250
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 146
AC   CVCL_9V65
DR   NCBI_Iran; C357
DR   Wikidata; Q54902251
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 8,12
ST   D18S51: 14,16
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 20
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 147
AC   CVCL_CW13
DR   NCBI_Iran; C358
DR   Wikidata; Q54902252
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 15
AC   CVCL_B0Q7
DR   NCBI_Iran; C20067
DR   Wikidata; Q108820750
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84783; Immunodeficiency with hyper-IgM
DI   ORDO; Orphanet_101088; X-linked hyper-IgM syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 158
AC   CVCL_CW14
DR   NCBI_Iran; C369
DR   Wikidata; Q54902253
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 16
AC   CVCL_B0Q8
DR   NCBI_Iran; C20068
DR   Wikidata; Q108820751
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84783; Immunodeficiency with hyper-IgM
DI   ORDO; Orphanet_101088; X-linked hyper-IgM syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 162
AC   CVCL_9V66
DR   NCBI_Iran; C373
DR   Wikidata; Q54902254
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D21S11: 27,32
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 11,15
ST   FGA: 22,25
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 17
AC   CVCL_B0Q9
DR   NCBI_Iran; C20069
DR   Wikidata; Q108820752
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 170
AC   CVCL_9V67
DR   NCBI_Iran; C381
DR   Wikidata; Q54902255
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 11,13
ST   D21S11: 28,29
ST   D3S1358: 16,19
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 10
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 10,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 171
AC   CVCL_9V68
DR   NCBI_Iran; C382
DR   Wikidata; Q54902256
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15,21
ST   D21S11: 29,31
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 172
AC   CVCL_CW17
DR   NCBI_Iran; C383
DR   Wikidata; Q54902257
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 173
AC   CVCL_CW18
DR   NCBI_Iran; C384
DR   Wikidata; Q54902258
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 178
AC   CVCL_CW19
DR   NCBI_Iran; C389
DR   Wikidata; Q54902259
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 179
AC   CVCL_9V69
DR   NCBI_Iran; C390
DR   Wikidata; Q54902260
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D21S11: 31
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   D8S1179: 12,14
ST   FGA: 18,24
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 18
AC   CVCL_CV54
DR   NCBI_Iran; C229
DR   Wikidata; Q54902261
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 184
AC   CVCL_9V70
DR   NCBI_Iran; C395
DR   Wikidata; Q54902262
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 12,15
ST   D21S11: 26,27
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 185
AC   CVCL_CW22
DR   NCBI_Iran; C396
DR   Wikidata; Q54902263
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 186
AC   CVCL_B0QI
DR   NCBI_Iran; C20078
DR   Wikidata; Q108820753
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 187
AC   CVCL_CW23
DR   NCBI_Iran; C398
DR   Wikidata; Q54902268
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 188
AC   CVCL_CW24
DR   NCBI_Iran; C399
DR   Wikidata; Q54902269
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 196
AC   CVCL_B0QJ
DR   NCBI_Iran; C20079
DR   Wikidata; Q108820754
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 199
AC   CVCL_CW25
DR   NCBI_Iran; C410
DR   Wikidata; Q54902270
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 20
AC   CVCL_CV55
DR   NCBI_Iran; C231
DR   Wikidata; Q54902271
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 200
AC   CVCL_CW26
DR   NCBI_Iran; C411
DR   Wikidata; Q54902272
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 201
AC   CVCL_B0QK
DR   NCBI_Iran; C20080
DR   Wikidata; Q108820755
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 202
AC   CVCL_B0QL
DR   NCBI_Iran; C20081
DR   Wikidata; Q108820756
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 203
AC   CVCL_CW29
SY   LCL-PI203
DR   NCBI_Iran; C424
DR   Wikidata; Q54902273
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 205
AC   CVCL_B0QM
DR   NCBI_Iran; C20082
DR   Wikidata; Q108820757
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 207
AC   CVCL_CW27
DR   NCBI_Iran; C418
DR   Wikidata; Q54902274
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 21
AC   CVCL_CV56
DR   NCBI_Iran; C232
DR   Wikidata; Q54902275
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 210
AC   CVCL_CW28
DR   NCBI_Iran; C421
DR   Wikidata; Q54902276
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 211
AC   CVCL_CV66
DR   NCBI_Iran; C422
DR   Wikidata; Q54902277
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be 3 distinct cell lines which were assigned NCBI_Iran catalog number C422.
CC   Discontinued: NCBI_Iran; C422; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 19,20
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 24
AC   CVCL_B0QA
DR   NCBI_Iran; C20070
DR   Wikidata; Q108820758
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 25
AC   CVCL_CV57
SY   LCL-PI25
DR   NCBI_Iran; C426
DR   Wikidata; Q54902278
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C426.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   LCL-PI 28
AC   CVCL_CV58
DR   NCBI_Iran; C239
DR   Wikidata; Q54902279
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 29
AC   CVCL_CV59
DR   NCBI_Iran; C240
DR   Wikidata; Q54902280
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 30
AC   CVCL_CV60
DR   NCBI_Iran; C241
DR   Wikidata; Q54902281
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 31
AC   CVCL_CV61
DR   NCBI_Iran; C242
DR   Wikidata; Q54902282
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 311
AC   CVCL_CV97
DR   NCBI_Iran; C522
DR   Wikidata; Q54902284
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C522.
CC   Discontinued: NCBI_Iran; C522; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,14
ST   D16S539: 12,13
ST   D18S51: 11,19
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 19,25
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 316
AC   CVCL_CV99
DR   NCBI_Iran; C527
DR   Wikidata; Q54902285
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C527.
CC   Discontinued: NCBI_Iran; C527; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 15,17
ST   D21S11: 30,32
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 19,22
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 33
AC   CVCL_9V55
DR   NCBI_Iran; C244
DR   Wikidata; Q54902286
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D21S11: 29,31
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 34
AC   CVCL_CV62
DR   NCBI_Iran; C245
DR   Wikidata; Q54902287
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 35
AC   CVCL_9V56
SY   LCL PI 35
DR   NCBI_Iran; C246
DR   Wikidata; Q54902288
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   LCL-PI 36
AC   CVCL_CV63
DR   NCBI_Iran; C247
DR   Wikidata; Q54902289
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 37
AC   CVCL_CV64
DR   NCBI_Iran; C248
DR   Wikidata; Q54902290
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 4
AC   CVCL_9V48
SY   LCL PI 4
DR   NCBI_Iran; C173
DR   Wikidata; Q54902291
RX   CelloPub=CLPUB00310;
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 12
ST   D21S11: 29,31
ST   D3S1358: 16,18
ST   D5S818: 12,14
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 23,26
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 43
AC   CVCL_B0QB
DR   NCBI_Iran; C20071
DR   Wikidata; Q108820759
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 44
AC   CVCL_B0QC
DR   NCBI_Iran; C20072
DR   Wikidata; Q108820760
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84783; Immunodeficiency with hyper-IgM
DI   ORDO; Orphanet_101088; X-linked hyper-IgM syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 49
AC   CVCL_CV65
DR   NCBI_Iran; C260
DR   Wikidata; Q54902292
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 5
AC   CVCL_9V49
DR   NCBI_Iran; C174
DR   Wikidata; Q54902293
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 50
AC   CVCL_B0QD
DR   NCBI_Iran; C20073
DR   Wikidata; Q108820761
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 51
AC   CVCL_CV67
DR   NCBI_Iran; C262
DR   Wikidata; Q54902294
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 52
AC   CVCL_CV68
DR   NCBI_Iran; C263
DR   Wikidata; Q54902295
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 54 [From CVI female patient]
AC   CVCL_B0QE
DR   NCBI_Iran; C20074
DR   Wikidata; Q108820762
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be two distinct cell lines which were assigned by NCBI_Iran the name LCL-PI 54.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 8
ST   D18S51: 11,13
ST   D21S11: 27
ST   D3S1358: 15,18
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 7,11
ST   vWA: 16,17
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LCL-PI 54 [From normal adult female]
AC   CVCL_CV51
DR   NCBI_Iran; C265
DR   Wikidata; Q54902296
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be two distinct cell lines which were assigned by NCBI_Iran the name LCL-PI 54.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   LCL-PI 55
AC   CVCL_CV69
DR   NCBI_Iran; C266
DR   Wikidata; Q54902297
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 56
AC   CVCL_CV70
DR   NCBI_Iran; C267
DR   Wikidata; Q54902298
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 57
AC   CVCL_CV71
DR   NCBI_Iran; C268
DR   Wikidata; Q54902299
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 58
AC   CVCL_9V57
DR   NCBI_Iran; C269
DR   Wikidata; Q54902300
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13,15
ST   FGA: 22,24
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 6
AC   CVCL_9V50
SY   LCL PI 6
DR   NCBI_Iran; C219
DR   Wikidata; Q54902301
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 61
AC   CVCL_CV72
SY   LCL-PI61
DR   NCBI_Iran; C427
DR   Wikidata; Q54902302
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C427.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   LCL-PI 62
AC   CVCL_CV73
DR   NCBI_Iran; C273
DR   Wikidata; Q54902303
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 63
AC   CVCL_CV74
DR   NCBI_Iran; C274
DR   Wikidata; Q54902304
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 64
AC   CVCL_B0QF
DR   NCBI_Iran; C20075
DR   Wikidata; Q108820763
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 65
AC   CVCL_9V58
DR   NCBI_Iran; C249
DR   Wikidata; Q54902305
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 30,33
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 20,23
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   LCL-PI 66
AC   CVCL_CV75
DR   NCBI_Iran; C277
DR   Wikidata; Q54902306
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 67
AC   CVCL_CV76
DR   NCBI_Iran; C278
DR   Wikidata; Q54902307
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 68
AC   CVCL_CV77
DR   NCBI_Iran; C279
DR   Wikidata; Q54902308
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 69
AC   CVCL_B0QG
DR   NCBI_Iran; C20076
DR   Wikidata; Q108820764
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 7
AC   CVCL_9V51
DR   NCBI_Iran; C175
DR   Wikidata; Q54902314
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 70
AC   CVCL_CV78
DR   NCBI_Iran; C281
DR   Wikidata; Q54902315
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 71
AC   CVCL_CV79
DR   NCBI_Iran; C282
DR   Wikidata; Q54902316
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 73
AC   CVCL_CV80
DR   NCBI_Iran; C284
DR   Wikidata; Q54902317
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 74
AC   CVCL_CV81
DR   NCBI_Iran; C285
DR   Wikidata; Q54902318
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 76
AC   CVCL_CV82
DR   NCBI_Iran; C287
DR   Wikidata; Q54902319
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 78
AC   CVCL_9V59
DR   NCBI_Iran; C289
DR   Wikidata; Q54902320
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Indicated as originating from a healthy female in NCBI_Iran=C289, but the STR profile is that of a male.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 27,30
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 10,14
ST   FGA: 20,25
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   LCL-PI 79
AC   CVCL_CV83
DR   NCBI_Iran; C290
DR   Wikidata; Q54902321
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 8
AC   CVCL_9V52
DR   NCBI_Iran; C176
DR   Wikidata; Q54902322
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 81
AC   CVCL_CV84
DR   NCBI_Iran; C292
DR   Wikidata; Q54902323
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 82
AC   CVCL_CV85
DR   NCBI_Iran; C293
DR   Wikidata; Q54902324
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 83
AC   CVCL_CV86
DR   NCBI_Iran; C294
DR   Wikidata; Q54902325
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 84
AC   CVCL_CV87
DR   NCBI_Iran; C422
DR   Wikidata; Q54902326
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: There seem to be 3 distinct cell lines which were assigned NCBI_Iran catalog number C422.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   LCL-PI 85
AC   CVCL_CV88
DR   NCBI_Iran; C296
DR   Wikidata; Q54902327
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 87
AC   CVCL_CV89
DR   NCBI_Iran; C298
DR   Wikidata; Q54902328
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 9
AC   CVCL_CV52
DR   NCBI_Iran; C220
DR   Wikidata; Q54902329
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 90
AC   CVCL_B0QH
DR   NCBI_Iran; C20077
DR   Wikidata; Q108820765
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26725; Common variable immunodeficiency
DI   ORDO; Orphanet_1572; Common variable immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-PI 92
AC   CVCL_CV90
DR   NCBI_Iran; C303
DR   Wikidata; Q54902330
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 94
AC   CVCL_CV91
DR   NCBI_Iran; C305
DR   Wikidata; Q54902331
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 95
AC   CVCL_CV92
DR   NCBI_Iran; C306
DR   Wikidata; Q54902332
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 97
AC   CVCL_CV93
DR   NCBI_Iran; C308
DR   Wikidata; Q54902333
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 98
AC   CVCL_CV94
DR   NCBI_Iran; C309
DR   Wikidata; Q54902334
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-PI 99
AC   CVCL_CV95
DR   NCBI_Iran; C310
DR   Wikidata; Q54902335
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   LCL-Ter50
AC   CVCL_UH25
DR   Wikidata; Q95981936
RX   PubMed=6088403;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F914 ! ILT-Ter
OI   CVCL_G012 ! TCL-Ter
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   LCL-U-DCS
AC   CVCL_A2YA
DR   Wikidata; Q105509862
RX   PubMed=33277516;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2XZ ! U-DCS
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   LCL-Wei
AC   CVCL_1869
SY   LCL-WEI; LCL Wei
DR   CLO; CLO_0007287
DR   CLDB; cl3194
DR   BioSample; SAMN03473378
DR   DSMZ; ACC-218
DR   DSMZCellDive; ACC-218
DR   Wikidata; Q54902336
RX   PubMed=10508494;
RX   PubMed=20454443;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-218).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: This cell line was reported to be isogenic with MEL-Wei (Cellosaurus=CVCL_3981) but it does not have the same STR profile (PubMed=10508494).
ST   Source(s): DSMZ=ACC-218
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 12,16
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 20,25
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   LCL1
AC   CVCL_C0HY
SY   Lymphoblastoid cell line 1
DR   Wikidata; Q112929990
RX   PubMed=19881539;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   LCL10538
AC   CVCL_C690
DR   Wikidata; Q54902337
RX   PubMed=8459226;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A648 ! INT-MEL-12
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LCL15392
AC   CVCL_HE34
SY   LCL 15392
DR   Wikidata; Q54902338
RX   PubMed=9973437;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C604 ! Me15392
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 6
//
ID   LCL1811
AC   CVCL_C689
DR   Wikidata; Q54902339
RX   PubMed=8459226;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C675 ! Me1811
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   LCL2
AC   CVCL_C0HZ
SY   Lymphoblastoid cell line 2
DR   EFO; EFO_0022445
DR   Wikidata; Q112929991
RX   PubMed=19881539;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   LCL22
AC   CVCL_B5YI
SY   LCL 22
DR   Wikidata; Q111733570
RX   PubMed=1326002;
CC   Characteristics: Expresses membrane IgM and IgD, together with lower levels of IgG and IgA, with expression of kappa and lambda light chains; both IgM kappa and lambda were present in the cytoplasm (PubMed=1326002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   LCL41
AC   CVCL_5995
SY   LCL 41
DR   Wikidata; Q54902340
RX   PubMed=1326002;
RX   PubMed=8189054;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LCL41
CC   Characteristics: Expresses only IgM, with principally kappa light chain on the membrane and cytoplasmic IgM kappa (PubMed=1326002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   LCL4405
AC   CVCL_C688
DR   Wikidata; Q54902341
RX   PubMed=8459226;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C680 ! INT-MEL-17
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LCL48
AC   CVCL_5996
SY   LCL 48
DR   Wikidata; Q54902342
RX   PubMed=1326002;
RX   PubMed=8189054;
CC   Characteristics: Expresses membrane IgM lambda and IgD and synthesizes IgM lambda (PubMed=1326002).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   LCL5810
AC   CVCL_C687
DR   Wikidata; Q54902343
RX   PubMed=8459226;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C682 ! INT-MEL-1
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LCL9742
AC   CVCL_C686
DR   Wikidata; Q54902344
RX   PubMed=8459226;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C685 ! INT-MEL-59/1
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LCLC-103H
AC   CVCL_1375
SY   LCLC103H; Large Cell Lung Cancer-103H
DR   CLO; CLO_0007282
DR   EFO; EFO_0006634
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 572
DR   BioSample; SAMN03473087
DR   BioSample; SAMN03473330
DR   BioSample; SAMN10988564
DR   cancercelllines; CVCL_1375
DR   Cell_Model_Passport; SIDM00345
DR   ChEMBL-Cells; CHEMBL3307853
DR   ChEMBL-Targets; CHEMBL614066
DR   CLS; 300169
DR   Cosmic; 753586
DR   Cosmic; 1146947
DR   Cosmic; 1995481
DR   Cosmic-CLP; 753586
DR   DepMap; ACH-000627
DR   DSMZ; ACC-384
DR   DSMZCellDive; ACC-384
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753586
DR   GEO; GSM434287
DR   GEO; GSM784240
DR   GEO; GSM827374
DR   GEO; GSM887264
DR   GEO; GSM888339
DR   GEO; GSM1670045
DR   IARC_TP53; 21472
DR   IGRhCellID; LCLC103HGEO
DR   LiGeA; CCLE_051
DR   LINCS_LDP; LCL-1781
DR   PharmacoDB; LCLC103H_833_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1375
DR   PubChem_Cell_line; CVCL_1375
DR   Wikidata; Q54902345
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2840315;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=2840315); 26 hours (CLS=300169); ~40 hours (DSMZ=ACC-384).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02; DQA1*03:02,05:01; DQB1*02:02,02:02; DRB1*04:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Leu (c.646G>T); ClinVar=VCV000376670; Zygosity=Homozygous (Cosmic-CLP=753586; DepMap=ACH-000627).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.78%; Native American=0%; East Asian, North=3.13%; East Asian, South=0%; South Asian=0%; European, North=61.54%; European, South=33.55% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300169; Cosmic-CLP=753586; DSMZ=ACC-384; PubMed=25877200
ST   Amelogenin: X (CLS=300169)
ST   Amelogenin: X,Y (Cosmic-CLP=753586; DSMZ=ACC-384; PubMed=25877200)
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 19
ST   D19S433: 15
ST   D21S11: 29,31.2
ST   D2S1338: 16,19
ST   D3S1358: 16,17
ST   D5S818: 11,12 (Cosmic-CLP=753586; DSMZ=ACC-384)
ST   D5S818: 12 (CLS=300169; PubMed=25877200)
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 16
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   LCLC-97TM1
AC   CVCL_1376
SY   LCLC97TM1; Large Cell Lung Cancer-97TM1
DR   CLO; CLO_0007283
DR   EFO; EFO_0006635
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 928
DR   BioSample; SAMN03473042
DR   BioSample; SAMN03473572
DR   BioSample; SAMN10988572
DR   cancercelllines; CVCL_1376
DR   Cell_Model_Passport; SIDM00344
DR   ChEMBL-Cells; CHEMBL3308112
DR   ChEMBL-Targets; CHEMBL1075489
DR   CLS; 300409
DR   Cosmic; 946361
DR   Cosmic; 1146948
DR   Cosmic; 1995482
DR   Cosmic-CLP; 946361
DR   DepMap; ACH-000596
DR   DSMZ; ACC-388
DR   DSMZCellDive; ACC-388
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 946361
DR   GEO; GSM434288
DR   GEO; GSM784234
DR   GEO; GSM887265
DR   GEO; GSM888340
DR   GEO; GSM1670046
DR   IARC_TP53; 27176
DR   IGRhCellID; LCLC97TM1GEO
DR   LiGeA; CCLE_643
DR   LINCS_LDP; LCL-1782
DR   PharmacoDB; LCLC97TM1_834_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1376
DR   PubChem_Cell_line; CVCL_1376
DR   Wikidata; Q54902346
RX   PubMed=2840315;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=2840315); >50 hours (DSMZ=ACC-388).
CC   HLA typing: A*02:19,24:02; B*15:01,18:01; C*03:03,12:03; DQA1*01:02,03:02; DQB1*03:02,05:01; DRB1*01:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=946361; DepMap=ACH-000596).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Cysfs*9 (c.102delC); ClinVar=VCV001072141; Zygosity=Heterozygous (Cosmic-CLP=946361; DepMap=ACH-000596).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.96%; Native American=0.5%; East Asian, North=5.82%; East Asian, South=0%; South Asian=0%; European, North=49.41%; European, South=39.32% (PubMed=30894373).
CC   Misspelling: LCL97TM; PubMed=26361996.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=300409; Cosmic-CLP=946361; DSMZ=ACC-388; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 15
ST   D21S11: 27,30
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10,10.2,11 (PubMed=25877200)
ST   D7S820: 10,11 (CLS=300409; Cosmic-CLP=946361; DSMZ=ACC-388)
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 12,15
ST   Penta E: 15
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 19,20
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   LCM-Mel
AC   CVCL_M742
DR   cancercelllines; CVCL_M742
DR   Cosmic; 1295335
DR   Cosmic; 2647643
DR   Wikidata; Q54902347
RX   PubMed=11121133;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   From: Guadagni, Fiorella; Regina Elena Institute for Cancer Research; Rome; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7053 ! LCP-Mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   LCM07
AC   CVCL_XH40
SY   Larimichthys Crocea Macrophage 07
DR   Wikidata; Q95981954
RX   PubMed=31470020;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   LCM10
AC   CVCL_XH41
SY   Larimichthys Crocea Macrophage 10
DR   Wikidata; Q95981957
RX   PubMed=31470020;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   LCN1
AC   CVCL_C4AI
DR   Wikidata; Q116049675
RX   PubMed=14657947;
RX   PubMed=20082272;
RX   PubMed=22439015;
RX   PubMed=25826333;
RX   PubMed=29751934;
CC   Population: Japanese.
DI   NCIt; C5672; Lung large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LCN1-cis
AC   CVCL_C4AL
DR   Wikidata; Q116049676
RX   PubMed=25826333;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C5672; Lung large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4AI ! LCN1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   LCN2
AC   CVCL_C4AR
DR   Wikidata; Q116049678
RX   PubMed=20082272;
CC   Population: Japanese.
DI   NCIt; C5672; Lung large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LCP-Mel
AC   CVCL_7053
DR   cancercelllines; CVCL_7053
DR   Cosmic; 1109807
DR   Cosmic; 1295328
DR   Cosmic; 1949556
DR   Cosmic; 2647641
DR   Wikidata; Q54902348
RX   PubMed=11121133;
RX   PubMed=18384130;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   From: Guadagni, Fiorella; Regina Elena Institute for Cancer Research; Rome; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M742 ! LCM-Mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   LCPHi001-A
AC   CVCL_A0SU
DR   BioSamples; SAMEA9406020
DR   hPSCreg; LCPHi001-A
DR   Wikidata; Q108820766
RX   PubMed=34464855;
CC   From: The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital; Liaocheng; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=34464855).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Ala495Pro (c.1483G>C) (A456P); ClinVar=VCV000093450; Zygosity=Heterozygous (PubMed=34464855).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Val499Val (c.1497G>C) (V460V); ClinVar=VCV000093451; Zygosity=Heterozygous (PubMed=34464855).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   LCPHi002-A
AC   CVCL_B5G5
DR   BioSamples; SAMEA10558482
DR   hPSCreg; LCPHi002-A
DR   Wikidata; Q110433003
RX   PubMed=35093716;
CC   From: The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital; Liaocheng; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1908; VPS13A; Simple; p.Ala1428fs (c.4282_4289delinsA); Zygosity=Heterozygous (PubMed=35093716).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   LCPHi003-A
AC   CVCL_D0HG
DR   BioSamples; SAMEA113404182
DR   hPSCreg; LCPHi003-A
DR   Wikidata; Q123032931
RX   PubMed=38460235;
CC   From: The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital; Liaocheng; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14553; LRP10; Simple; p.Arg230Trp (c.688C>T); Zygosity=Heterozygous (PubMed=38460235).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   LCSBi001-A
AC   CVCL_YD64
SY   VPS35 1_2; VPS35 Clone 33
DR   BioSamples; SAMEA6673733
DR   hPSCreg; LCSBi001-A
DR   Wikidata; Q95981963
RX   CelloPub=CLPUB00553;
RX   PubMed=32387898;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:13487; VPS35; Simple; p.Asp620Asn (c.1858G>A); ClinVar=VCV000030196; Zygosity=Heterozygous (CelloPub=CLPUB00553; PubMed=32387898).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C201520; Parkinson disease 17
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   LCSBi002-A
AC   CVCL_A8LT
SY   ND40066-PINK1/PARK6-ILE368ASN-clone 2; ND40066-PINK1-ILE368ASN-clone 2; ND40066-clone 2; ND40066-2
DR   hPSCreg; LCSBi002-A
DR   Wikidata; Q108820767
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ44 ! ND40066
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   LCSBi002-B
AC   CVCL_A8LU
SY   ND40066-PINK1/PARK6-ILE368ASN-clone 7; ND40066-PINK1-ILE368ASN-clone 7; ND40066-clone 7; ND40066-7
DR   BioSamples; SAMEA13093853
DR   hPSCreg; LCSBi002-B
DR   Wikidata; Q108820768
RX   PubMed=35378365;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (PubMed=35378365).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ44 ! ND40066
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   LCSBi002-C
AC   CVCL_A8LV
SY   ND40066-PINK1/PARK6-ILE368ASN-clone 8; ND40066-PINK1-ILE368ASN-clone 8; ND40066-clone 8; ND40066-8
DR   BioSamples; SAMEA13151242
DR   hPSCreg; LCSBi002-C
DR   Wikidata; Q108820769
RX   PubMed=35378365;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (PubMed=35378365).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ44 ! ND40066
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   LCSBi003-A
AC   CVCL_A8LW
SY   ND40996-PARK1/SNCA-A53T-clone 1; ND40996-SNCA-A53T-clone 1; ND40996-clone 1
DR   hPSCreg; LCSBi003-A
DR   Wikidata; Q108820770
RX   PubMed=34826737;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=34826737).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY33 ! ND40996
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LCSBi003-B
AC   CVCL_A8LX
SY   ND40996-PARK1/SNCA-A53T-clone 7; ND40996-SNCA-A53T-clone 7; ND40996-clone 7
DR   hPSCreg; LCSBi003-B
DR   Wikidata; Q108820771
RX   PubMed=34826737;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY33 ! ND40996
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LCSBi003-C
AC   CVCL_A8LY
SY   ND40996-PARK1/SNCA-A53T-clone 10; ND40996-SNCA-A53T-clone 10; ND40996-clone 10
DR   hPSCreg; LCSBi003-C
DR   Wikidata; Q108820772
RX   PubMed=34826737;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=34826737).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY33 ! ND40996
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LCSBi004-A
AC   CVCL_A8LZ
SY   ND29369-PARKIN/PRKN/PARK2-R275W-clone 1; ND29369-PARKIN/PARK2-R275W-clone 1; ND29369-clone 1; ND29369-1
DR   BioSamples; SAMEA13152473
DR   hPSCreg; LCSBi004-A
DR   Wikidata; Q108820773
RX   PubMed=35378365;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=35378365).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD48 ! ND29369
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   LCSBi004-B
AC   CVCL_A8MA
SY   ND29369-PARKIN/PRKN/PARK2-R275W-clone 4; ND29369-PARKIN/PARK2-R275W-clone 4; ND29369-clone 4; ND29369-4
DR   BioSamples; SAMEA13166758
DR   hPSCreg; LCSBi004-B
DR   Wikidata; Q108820774
RX   PubMed=35378365;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=35378365).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD48 ! ND29369
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   LCSBi005-A
AC   CVCL_A8MB
SY   ND29542-LRRK2/PARK8-G2019S-clone 3; ND29542-LRRK2-clone 3; ND29542-clone 3; ND29542-3
DR   hPSCreg; LCSBi005-A
DR   Wikidata; Q108820775
RX   PubMed=34736041;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=34736041).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD52 ! ND29542
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   LCSBi005-B
AC   CVCL_A8MC
SY   ND29542-LRRK2/PARK8-G2019S-clone 7; ND29542-LRRK2-clone 7; ND29542-clone 7; ND29542-7
DR   hPSCreg; LCSBi005-B
DR   Wikidata; Q108820776
RX   PubMed=34736041;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=34736041).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD52 ! ND29542
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LCSBi006-A
AC   CVCL_A8MD
SY   ND34267-LRRK2/PARK8-G2019S-clone 8; ND34267-LRRK2-clone 8; ND34267-clone 8; ND34267-8
DR   BioSamples; SAMEA10585991
DR   hPSCreg; LCSBi006-A
DR   Wikidata; Q108820777
RX   PubMed=34736041;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=34736041).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ01 ! ND34267
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   LCSBi007-A
AC   CVCL_A8ME
SY   ND27760-PARK1/SNCA-triplication-clone 2; ND27760-SNCA-triplication-clone 2; ND27760-SNCA3x clone 2; ND27760-clone 2
DR   hPSCreg; LCSBi007-A
DR   Wikidata; Q108820778
RX   PubMed=34826737;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=34826737).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LCSBi007-B
AC   CVCL_A8MF
SY   ND27760-PARK1/SNCA-triplication-clone 3; ND27760-SNCA-triplication-clone 3; ND27760-SNCA3x clone 3; ND27760-clone 3
DR   hPSCreg; LCSBi007-B
DR   Wikidata; Q108820779
RX   PubMed=34826737;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=34826737).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LCSBi008-A
AC   CVCL_C0J9
SY   DJ-1-delP; delP
DR   BioSamples; SAMEA13793746
DR   hPSCreg; LCSBi008-A
DR   Wikidata; Q112929992
RX   PubMed=35500378;
RX   PubMed=35617842;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple; p.Pro158del (c.471_473delGCC); ClinVar=VCV000987356; Zygosity=Homozygous (PubMed=35500378).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   LCSBi008-A-1
AC   CVCL_C0JA
SY   DJ-1-delP GC13; delP GC13
DR   BioSamples; SAMEA13914317
DR   hPSCreg; LCSBi008-A-1
DR   Wikidata; Q112929993
RX   PubMed=35617842;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_corrected; p.Pro158del (c.471_473delGCC); ClinVar=VCV000987356; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=35617842).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0J9 ! LCSBi008-A
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   LCSBi009-A
AC   CVCL_C8G3
SY   RHOT1_R272Q_clone1_PD
DR   BioSamples; SAMEA112885173
DR   hPSCreg; LCSBi009-A
DR   Wikidata; Q123032932
RX   PubMed=37364399;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple; p.Arg272Gln (c.815G>A); Zygosity=Heterozygous (PubMed=37364399).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi009-A-1
AC   CVCL_C8G4
SY   RHOT1_R272Q_clone18_IsogenicControl
DR   BioSamples; SAMEA112885175
DR   hPSCreg; LCSBi009-A-1
DR   Wikidata; Q123032933
RX   PubMed=37364399;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_corrected; p.Arg272Gln (c.815G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37364399).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8G3 ! LCSBi009-A
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi010-A
AC   CVCL_C8G5
SY   RHOT1_R450C_clone5_PD
DR   BioSamples; SAMEA112885176
DR   hPSCreg; LCSBi010-A
DR   Wikidata; Q123032934
RX   PubMed=37364399;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple; p.Arg450Cys (c.1348C>T); Zygosity=Heterozygous (PubMed=37364399).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi010-A-1
AC   CVCL_C8G6
SY   RHOT1_R450C_clone6_IsogenicControl
DR   BioSamples; SAMEA112885178
DR   hPSCreg; LCSBi010-A-1
DR   Wikidata; Q123032935
RX   PubMed=37364399;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_corrected; p.Arg450Cys (c.1348C>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37364399).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8G5 ! LCSBi010-A
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi010-A-2
AC   CVCL_C8G7
SY   RHOT1_R450C_clone10_IsogenicControl
DR   BioSamples; SAMEA112885265
DR   hPSCreg; LCSBi010-A-2
DR   Wikidata; Q123032936
RX   PubMed=37364399;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_corrected; p.Arg450Cys (c.1348C>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37364399).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8G5 ! LCSBi010-A
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi011-A
AC   CVCL_D0HH
SY   RHOT1_T351A_clone1_PD
DR   BioSamples; SAMEA112816690
DR   hPSCreg; LCSBi011-A
DR   Wikidata; Q123032937
RX   PubMed=37003181;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple; p.Thr351Ala (c.1290A>G); Zygosity=Heterozygous (PubMed=37003181).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi011-A-1
AC   CVCL_D0HI
SY   RHOT1_T351A_clone25.2_IsogenicControl
DR   BioSamples; SAMEA112817516
DR   hPSCreg; LCSBi011-A-1
DR   Wikidata; Q123032938
RX   PubMed=37003181;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_corrected; p.Thr351Ala (c.1290A>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37003181).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0HH ! LCSBi011-A
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi012-A
AC   CVCL_D0HJ
SY   RHOT1_T610A_clone6_PD
DR   BioSamples; SAMEA112817621
DR   hPSCreg; LCSBi012-A
DR   Wikidata; Q123032940
RX   PubMed=37003181;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple; p.Thr610Ala (c.2067A>G); Zygosity=Heterozygous (PubMed=37003181).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi012-A-1
AC   CVCL_D0HK
SY   RHOT1_T610A_clone62.19.37_IsogenicControl
DR   BioSamples; SAMEA112818019
DR   hPSCreg; LCSBi012-A-1
DR   Wikidata; Q123032941
RX   PubMed=37003181;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_corrected; p.Thr610Ala (c.2067A>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37003181).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0HJ ! LCSBi012-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   LCSBi013-A
AC   CVCL_D0HL
SY   GL2; iPSC F0245 CL1_1
DR   BioSamples; SAMEA113634167
DR   hPSCreg; LCSBi013-A
DR   Wikidata; Q123032942
RX   PubMed=37832355;
CC   From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=37832355).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=37832355).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LCSC#1
AC   CVCL_A643
SY   LCSC-1
DR   cancercelllines; CVCL_A643
DR   Cosmic; 946053
DR   Cosmic; 1066160
DR   Cosmic; 1571724
DR   Cosmic; 1656899
DR   Wikidata; Q54902361
RX   PubMed=9416778;
RX   PubMed=16105816;
RX   PubMed=22313637;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=16105816).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   LCSC#2
AC   CVCL_A644
SY   LCSC-2
DR   Cosmic; 946054
DR   Cosmic; 1066161
DR   Cosmic; 1571725
DR   Cosmic; 1656900
DR   Wikidata; Q54902363
RX   PubMed=9416778;
RX   PubMed=16105816;
RX   PubMed=22313637;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   LCSC-1
AC   CVCL_5U55
DR   Wikidata; Q54902349
RX   CelloPub=CLPUB00282;
RX   PubMed=19446912;
CC   Doubling time: 18 hours (CelloPub=CLPUB00282).
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   LCSC-2
AC   CVCL_5U56
DR   Wikidata; Q54902350
RX   PubMed=19446912;
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   LCSC-3
AC   CVCL_5U57
DR   Wikidata; Q54902351
RX   PubMed=19446912;
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   LCSC-4
AC   CVCL_5U58
DR   Wikidata; Q54902352
RX   PubMed=19446912;
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   LCSC-5
AC   CVCL_5U59
DR   Wikidata; Q54902353
RX   PubMed=19446912;
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   LCSC-6
AC   CVCL_5U60
DR   Wikidata; Q54902360
RX   PubMed=19446912;
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   LCT-5
AC   CVCL_E2Y8
DR   Cosmic; 929149
RX   PubMed=9673367;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9673367).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   LCT-6
AC   CVCL_A5XF
DR   Wikidata; Q107115624
RX   PubMed=3489826;
CC   Population: Japanese.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   LCTCC
AC   CVCL_WH28
DR   Wikidata; Q95981970
RX   PubMed=25773167;
RX   PubMed=30246405;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   LCZ8A3
AC   CVCL_B0F5
DR   CCRID; 4201PAT-CCTCC01428
DR   Wikidata; Q108820780
RX   Patent=WO2021056906A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019144.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human prostatic exosomal protein (PSEP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   LD
AC   CVCL_Y435
DR   Wikidata; Q54902364
RX   PubMed=17760811;
CC   Characteristics: Produces IgA lambda.
CC   Doubling time: ~10 days (PubMed=17760811).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 10
//
ID   LD FiPS18338-Ep6F-3
AC   CVCL_E7A9
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+LD+FiPS18338-Ep6F-3+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/LD%2520FiPS18338-Ep6F-3%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 31.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 14,15
DI   NCIt; C61253; Leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LD-1
AC   CVCL_C7SL
SY   LD1
DR   Kerafast; ECD039-FP
DR   Wikidata; Q117704632
RX   PubMed=33323397;
RX   PubMed=34033968;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87986; Akt1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:103262; Yap1.
CC   Transformant: Akt1 and Yap1.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   LD-T
AC   CVCL_0C18
DR   Cosmic; 2239088
DR   Wikidata; Q54902365
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
RX   PubMed=10100721;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   LD1
AC   CVCL_C4TH
DR   Wikidata; Q116049679
RX   PubMed=2258612;
CC   Characteristics: IL4 dependent.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5T94 ! C30.1 line 1
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LD137
AC   CVCL_EJ12
DR   cancercelllines; CVCL_EJ12
DR   Cosmic; 943736
DR   Wikidata; Q54902366
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 8
//
ID   LD2B
AC   CVCL_E754
DR   dbMHC; 48949
DR   ECACC; 94122026
DR   IHW; IHW09083
DR   IPD-IMGT/HLA; 11638
DR   Wikidata; Q54902367
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01; DPB1*04:01:01; DQA1*01:02:01; DQB1*06:02:01; DRA*01:02; DRB1*15:01:01; DRB5*01:01; DRB6*02:01 (IPD-IMGT/HLA=11638).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   LD583
AC   CVCL_EJ13
DR   Cosmic; 943747
DR   IARC_TP53; 21073
DR   Wikidata; Q54902368
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ16 ! LD611
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   LD600
AC   CVCL_EJ14
DR   cancercelllines; CVCL_EJ14
DR   Cosmic; 943740
DR   Wikidata; Q54902369
RX   PubMed=9850064;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Gln (c.239G>A) (p.Pro94Pro, c.282G>A); ClinVar=VCV000376385; Zygosity=Unspecified (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   LD605
AC   CVCL_EJ15
DR   Cosmic; 943745
DR   Wikidata; Q54902370
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 8
//
ID   LD611
AC   CVCL_EJ16
DR   Cosmic; 943748
DR   IARC_TP53; 21074
DR   Wikidata; Q54902371
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ13 ! LD583
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   LD627
AC   CVCL_EJ17
DR   cancercelllines; CVCL_EJ17
DR   Cosmic; 943737
DR   IARC_TP53; 10278
DR   Wikidata; Q54902372
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   LD630
AC   CVCL_EJ18
DR   cancercelllines; CVCL_EJ18
DR   Cosmic; 943741
DR   IARC_TP53; 10282
DR   Wikidata; Q54902373
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   LD660
AC   CVCL_EJ19
DR   cancercelllines; CVCL_EJ19
DR   Cosmic; 943738
DR   IARC_TP53; 10279
DR   Wikidata; Q54902374
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ20 ! LD692
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   LD692
AC   CVCL_EJ20
DR   cancercelllines; CVCL_EJ20
DR   Cosmic; 943739
DR   IARC_TP53; 10280
DR   Wikidata; Q54902375
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9850064).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ19 ! LD660
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   LD7/4
AC   CVCL_T961
SY   LD7.4; IO/LD7/4
DR   Wikidata; Q54902376
RX   Patent=US6878544;
RX   PubMed=8982103;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1694.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: PVG; RS=RS_0000224.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6-8D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   LD700
AC   CVCL_EJ21
DR   cancercelllines; CVCL_EJ21
DR   Cosmic; 943735
DR   IARC_TP53; 10276
DR   Wikidata; Q54902377
RX   PubMed=9850064;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Unspecified (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   LD71
AC   CVCL_EJ22
DR   Cosmic; 943746
DR   IARC_TP53; 21075
DR   Wikidata; Q54902378
RX   PubMed=9850064;
RX   PubMed=29732388;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 9
//
ID   LD8
AC   CVCL_K251
SY   LD-8
DR   BCRJ; 0144
DR   Wikidata; Q54902379
RX   PubMed=2258612;
CC   Characteristics: IL4 dependent.
CC   Discontinued: BCRJ; 0144; probable.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5T94 ! C30.1 line 1
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   LDA1
AC   CVCL_Z248
DR   Wikidata; Q54902380
RX   PubMed=11928998;
CC   Group: Insect cell line.
CC   Doubling time: 81.1 hours (Note=At 28th passage), 78.1 hours (Note=At 67th passage) (PubMed=11928998).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LDA2
AC   CVCL_Z249
DR   Wikidata; Q54902381
RX   PubMed=11928998;
CC   Group: Insect cell line.
CC   Doubling time: 64 hours (Note=At 42th passage), 47 hours (Note=At 45th passage) (PubMed=11928998).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LDE1
AC   CVCL_Z250
DR   Wikidata; Q54902382
RX   PubMed=11928998;
CC   Group: Insect cell line.
CC   Doubling time: 113.6 hours (Note=At 112th passage) (PubMed=11928998).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   LDG-1
AC   CVCL_XC03
SY   LDS-1
DR   CCRID; 5301OVI-KCB9009LZJ
DR   KCB; KCB 90009LZJ
DR   Wikidata; Q95981995
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Jianzhou big-eared; VBO=VBO_0017513.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_A9FE ! LDG-2
OI   CVCL_XC04 ! LDG-3
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   LDG-2
AC   CVCL_A9FE
DR   CCRID; 5301OVI-KCB9009KZJ
DR   KCB; KCB 90009KZJ
DR   Wikidata; Q108820781
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Jianzhou big-eared; VBO=VBO_0017513.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_XC03 ! LDG-1
OI   CVCL_XC04 ! LDG-3
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   LDG-3
AC   CVCL_XC04
SY   LDS-3
DR   CCRID; 5301OVI-KCB9009SZJ
DR   KCB; KCB 90009SZJ
DR   Wikidata; Q95981996
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Jianzhou big-eared; VBO=VBO_0017513.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_XC03 ! LDG-1
OI   CVCL_A9FE ! LDG-2
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   LDL1
AC   CVCL_Z251
DR   Wikidata; Q54902383
RX   PubMed=11928998;
CC   Group: Insect cell line.
CC   Doubling time: 31 hours (Note=At 29th passage), 40.2 hours (Note=At 31th passage) (PubMed=11928998).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   LdlD
AC   CVCL_1V03
SY   ldlD; CHO ldlD; LDLD
DR   Wikidata; Q54902384
RX   PubMed=3380796;
RX   PubMed=3948246;
RX   PubMed=6089204;
CC   Characteristics: Defective in UDP-Gal/UDP-GalNAc 4-epimerase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 9
//
ID   LdlF
AC   CVCL_JY00
SY   ldlF; CHO ldlF
DR   Wikidata; Q54902385
RX   PubMed=8063714;
RX   PubMed=8207054;
RX   PubMed=8626666;
CC   Characteristics: At the non-permissive temperature of 39.5 Celsius exhibits rapid degradation of LDLRs, disruption of ER-through Golgi transport and disintegration of the Golgi apparatus.
CC   Sequence variation: Mutation; UniProtKB; Q60445; Cope; Simple; p.Glu251Lys (c.751C>T); Zygosity=Homozygous (PubMed=8626666).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 12
//
ID   LDR+25
AC   CVCL_V118
DR   CLO; CLO_0007290
DR   CLDB; cl3195
DR   IHW; 11w 8121
DR   Wikidata; Q54902386
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LDR2a
AC   CVCL_V119
SY   LDR2A
DR   CLO; CLO_0007291
DR   CLDB; cl3196
DR   IHW; 11w 8105
DR   Wikidata; Q54902387
RX   PubMed=3128633;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4947; HLA-DRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4953; HLA-DRB5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   LDR2b
AC   CVCL_V120
SY   LDR2B
DR   CLO; CLO_0007292
DR   CLDB; cl3197
DR   IHW; 11w 8108
DR   Wikidata; Q54902389
RX   PubMed=3128633;
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4947; HLA-DRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DR15).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   LDR7
AC   CVCL_V121
DR   CLO; CLO_0007295
DR   CLDB; cl3198
DR   IHW; 11w 8129
DR   Wikidata; Q54902390
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LDR8
AC   CVCL_V122
DR   CLO; CLO_0007296
DR   CLDB; cl3199
DR   IHW; 11w 8130
DR   Wikidata; Q54902391
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LDS 73/LW1
AC   CVCL_L704
SY   LW1
DR   ECACC; 96050401
DR   Wikidata; Q54902392
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46418; Rat Gsta5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   LDS-Falck 01
AC   CVCL_T756
SY   LDS-Falck01
DR   Cosmic; 1092551
DR   Wikidata; Q54902393
RX   PubMed=17970070;
CC   Doubling time: <24 hours (PubMed=17970070).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=17970070).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   LDS-iPSC8
AC   CVCL_DQ94
DR   Wikidata; Q54902394
RX   PubMed=27346194;
CC   From: Department of Dermatology, Jikei University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3801; FOXC2; Simple; c.724_727delCGCAinsAG; Zygosity=Unspecified (PubMed=27346194).
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C128191; Lymphedema-distichiasis syndrome
DI   ORDO; Orphanet_33001; Lymphedema-distichiasis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   LDV/7
AC   CVCL_D268
SY   LDV-7; LDV7
DR   ChEMBL-Cells; CHEMBL3307854
DR   ChEMBL-Targets; CHEMBL614079
DR   PubChem_Cell_line; CVCL_D268
DR   Wikidata; Q54902395
RX   Patent=US4316962;
RX   PubMed=6983077;
CC   Group: Patented cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   Le Ana
AC   CVCL_3438
DR   CLO; CLO_0007300
DR   ATCC; CRL-1192
DR   Wikidata; Q54902396
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Le Fin
AC   CVCL_0F65
DR   ATCC; CRL-1115
DR   Wikidata; Q54902397
CC   Discontinued: ATCC; CRL-1115; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   Le Mor
AC   CVCL_X714
DR   ATCC; CRL-1224
DR   Wikidata; Q54902398
RX   PubMed=450131;
RX   PubMed=3860870;
CC   Discontinued: ATCC; CRL-1224; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 8
//
ID   Le Pat
AC   CVCL_U782
DR   ATCC; CRL-1136
DR   Wikidata; Q54902399
CC   Discontinued: ATCC; CRL-1136; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Le San
AC   CVCL_X715
DR   ATCC; CRL-1229
DR   Wikidata; Q54902400
CC   Discontinued: ATCC; CRL-1229; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   Le-H-HNU7
AC   CVCL_Z572
SY   Le H HNU7
DR   ICLDB; le-h-hnu7
DR   Wikidata; Q54902401
RX   DOI=10.3923/jas.2007.4040.4043;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LE-II
AC   CVCL_U334
SY   LE II; LEII
DR   CLO; CLO_0007305
DR   CLDB; cl3201
DR   Wikidata; Q54902405
RX   PubMed=1696271;
RX   PubMed=4023180;
CC   From: Curtis, Adam Sebastian Genevieve; University of Glasgow; Glasgow; United Kingdom.
CC   Derived from site: In situ; Lung, capillary; UBERON=UBERON_0016405.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: AKR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   LE-L2C
AC   CVCL_JX22
DR   Wikidata; Q54902406
RX   PubMed=864758;
RX   PubMed=1262783;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
DI   NCIt; C134564; Guinea pig leukemia
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
HI   CVCL_2547 ! L2C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 7
//
ID   LE/2
AC   CVCL_C8XG
DR   Wikidata; Q123032943
RX   PubMed=2440558;
CC   Doubling time: ~24 hours (PubMed=2440558).
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic oval stem cell; CL=CL_0002196.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8-10W
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   LE/6
AC   CVCL_C8XH
DR   Wikidata; Q123032945
RX   PubMed=2440558;
RX   PubMed=2647288;
CC   Doubling time: 24 hours (Note=At <=20 passages), 16 hours (Note=At >=50 passages) (PubMed=2440558).
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic oval stem cell; CL=CL_0002196.
CC   Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   12-14W
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   LE023
AC   CVCL_E755
SY   LEO23; TER237; TER-237; Ter 237; Extract 90; Extract 179; Extract 564
DR   dbMHC; 48950
DR   IHW; IHW09267
DR   IPD-IMGT/HLA; 10979
DR   Wikidata; Q54902407
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/369cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Spanish.
CC   HLA typing: A*66:01,32:01:01; B*51:01:01,73:01; C*01:02:01,15:05:01; DPA1*01:03:01:04; DPB1*04:01:01:01,30:01; DQA1*01:02:01:06,01:03:01:02; DQB1*06:03:01,06:04:01; DRB1*13:01:01,13:02:01; DRB3*01:01:02:01,03:01:01 (IPD-IMGT/HLA=10979).
CC   HLA typing: A*32:01:01,66:01:01; B*73:01,51:01:01:01; C*15:05:01,01:02:01; DPA1*01:03:01:01,01:03:01:04; DPB1*30:01,04:01:01:01; DQA1*01:02:01,01:03:01; DQB1*06:03:01(06:39),06:04:01(06:41); DRB1*13:01:01,13:02:01; DRB3*01:01:02,03:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   LE11
AC   CVCL_E5R4
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LE8915-EBV
AC   CVCL_RA51
SY   LE-8915-EBV
DR   Wikidata; Q54902408
RX   PubMed=9413942;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RA47 ! LE8915-RCC
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   LE8915-RCC
AC   CVCL_RA47
SY   LE-8915-RCC; LE8915
DR   Wikidata; Q54902409
RX   PubMed=8900424;
RX   PubMed=10074909;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RA51 ! LE8915-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
//
ID   LE9001-RCC
AC   CVCL_RA48
SY   LE-9001-RCC
DR   Wikidata; Q54902410
RX   PubMed=8900424;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
//
ID   LE9004-RCC
AC   CVCL_RY30
SY   LE9004
DR   Wikidata; Q54902412
RX   PubMed=10074909;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 5
//
ID   LE9104-RCC
AC   CVCL_RA49
SY   LE-9104-RCC
DR   Wikidata; Q54902413
RX   PubMed=8900424;
RX   PubMed=9413942;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
//
ID   LE9211-EBV
AC   CVCL_E910
DR   Wikidata; Q54902414
RX   PubMed=11369790;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E911 ! LE9211-RCC
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   LE9211-RCC
AC   CVCL_E911
SY   LE-9211-RCC; LE9211
DR   Wikidata; Q54902415
RX   PubMed=8781117;
RX   PubMed=8900424;
RX   PubMed=9413942;
RX   PubMed=10074909;
RX   PubMed=11369790;
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   HLA typing: A*03; B*07,35; C*04,07 (PubMed=8781117).
CC   HLA typing: A*03; B*07,35; C*04,07 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E910 ! LE9211-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   LE9415-RCC
AC   CVCL_RA50
SY   LE-9415-RCC
DR   Wikidata; Q54902416
RX   PubMed=9413942;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   LEADING LIGHT Wnt Reporter
AC   CVCL_E5ZT
WW   Provider; Enzo; ENZ-61002-0001; https://www.enzo.com/product/leading-light-wnt-reporter-cell-line/
CC   Characteristics: Expresses the firefly luciferase reporter gene under the control of Wnt-responsive promoters (TCF/LEF) (Enzo=ENZ-61002-0001).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Lec1
AC   CVCL_3440
SY   CHO-Lec1; CHO Lec1; Pro-Lec1.3C; Pro-5 Lec1.3c; Pro-5WgaRI3C
DR   CLO; CLO_0007301
DR   ATCC; CRL-1735
DR   CCRID; 3101HAMGNHa8
DR   CLS; 305010
DR   Wikidata; Q54902418
RX   PubMed=1182798;
RX   PubMed=3785164;
RX   PubMed=6623313;
RX   PubMed=8910379;
RX   PubMed=24078077;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-202.html
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Arg; Zygosity=Unspecified (PubMed=8910379).
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Lys401Arg; Zygosity=Unspecified (PubMed=8910379).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Lec1/hPDPN
AC   CVCL_D2U0
DR   Wikidata; Q127382585
RX   Patent=US10227407;
RX   PubMed=25080943;
RX   PubMed=26937552;
RX   PubMed=27328060;
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Arg; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Lys401Arg; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3440 ! Lec1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   Lec1/PODXL
AC   CVCL_D2TQ
DR   Wikidata; Q127382586
RX   PubMed=28384052;
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Arg; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Lys401Arg; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9171; PODXL.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3440 ! Lec1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Lec1/TROP2
AC   CVCL_B7JU
DR   Wikidata; Q112929994
RX   PubMed=33300065;
RX   PubMed=33490649;
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Arg; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Lys401Arg; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3440 ! Lec1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Lec13
AC   CVCL_KA69
SY   CHO-Lec13; Pro-Lec13.6a
DR   Wikidata; Q54902419
RX   PubMed=2428310;
RX   PubMed=3456174;
RX   PubMed=11986321;
RX   PubMed=16609957;
CC   Characteristics: Useful for the production of fucose-negative antibodies.
CC   Characteristics: Deficient in GDP-mannose 4,6 dehydratase (GMDS).
CC   Selected for resistance to: UniProtKB; P02867; Pisum sativum lectin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 7
//
ID   Lec13/PODXL
AC   CVCL_D2TR
DR   Wikidata; Q127382587
RX   PubMed=28384052;
CC   Characteristics: Deficient in GDP-mannose 4,6 dehydratase (GMDS) (from parent cell line).
CC   Selected for resistance to: UniProtKB; P02867; Pisum sativum lectin.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9171; PODXL.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_KA69 ! Lec13
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Lec13A
AC   CVCL_KA79
SY   CHO-Lec13A
DR   Wikidata; Q54902421
RX   PubMed=2428310;
RX   PubMed=3456174;
CC   Selected for resistance to: UniProtKB; P02867; Pisum sativum lectin.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 7
//
ID   LEC14
AC   CVCL_VU62
SY   CHO-LEC14; Pro-LEC14.4A
DR   Wikidata; Q95982028
RX   PubMed=3456174;
RX   PubMed=8631778;
RX   PubMed=9603907;
CC   Selected for resistance to: UniProtKB; P02867; Pisum sativum lectin.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   Lec15.1
AC   CVCL_7054
AS   CVCL_DD08
SY   CHO Lec15.1; Lec15.1 CHO; B4-2-1; B421
DR   BTO; BTO_0002430
DR   Wikidata; Q54902422
RX   PubMed=1986234;
RX   PubMed=2105319;
RX   PubMed=2267628;
RX   PubMed=6270122;
RX   PubMed=9753618;
RX   PubMed=14680801;
RX   PubMed=20331963;
CC   Sequence variation: Mutation; UniProtKB; Q9Z1P1; Dpm2; Simple; p.Gly10Glu (c.29G>A); Zygosity=Unspecified (PubMed=14680801).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DD06 ! N211-1-8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   LEC18
AC   CVCL_VU63
SY   CHO-LEC18; Pro-LEC18.21B
DR   Wikidata; Q95982029
RX   PubMed=3456174;
RX   PubMed=9603907;
CC   Selected for resistance to: UniProtKB; P02867; Pisum sativum lectin.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   Lec2
AC   CVCL_3442
SY   CHO-Lec2; CHO Lec2; Pro-Lec2.6A; Pro-5WgaRII6A
DR   CLO; CLO_0007302
DR   ATCC; CRL-1736
DR   TOKU-E; 2189
DR   Wikidata; Q54902423
RX   PubMed=3785164;
RX   PubMed=6623313;
RX   PubMed=9279382;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-191.html
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Lec2/hPDPN
AC   CVCL_D2U1
DR   Wikidata; Q127382588
RX   Patent=US10227407;
RX   PubMed=25080943;
RX   PubMed=26937552;
RX   PubMed=27328060;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3442 ! Lec2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   Lec2/PODXL
AC   CVCL_D2TS
DR   Wikidata; Q127382589
RX   PubMed=28384052;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9171; PODXL.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3442 ! Lec2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Lec2/TROP2
AC   CVCL_B7JV
DR   Wikidata; Q112929995
RX   PubMed=33300065;
RX   PubMed=33490649;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3442 ! Lec2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Lec23
AC   CVCL_VU64
SY   CHO-Lec23; Pro-Lec23.11C
DR   Wikidata; Q95982032
RX   PubMed=1660460;
RX   PubMed=2360093;
RX   PubMed=15383536;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Sequence variation: Mutation; UniProtKB; G3I7V6; Mogs; Simple; p.Ser330Phe (c.989C>T); Zygosity=Unspecified; Note=Position based on a sequence which is probably not full length (PubMed=15383536).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   Lec3.2.8.1
AC   CVCL_K173
SY   CHO-Lec3.2.8.1; CHO-Lec 3.2.8.1; CHO Lec3.2.8.1; Lec 3.2.8.1
DR   Wikidata; Q54902424
RX   PubMed=2710109;
RX   PubMed=22174749;
RX   PubMed=25804355;
CC   Characteristics: Produces glycoproteins with high-mannose type glycans.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 10
//
ID   Lec4
AC   CVCL_IP61
SY   CHO-Lec4; CHO Lec4; Gat~Lec4.2D; Pro~5.Lec4.7B
DR   BTO; BTO_0005988
DR   Wikidata; Q54902425
RX   PubMed=2530238;
RX   PubMed=6295280;
RX   PubMed=6623313;
RX   PubMed=8910328;
RX   PubMed=24078077;
CC   Sequence variation: Mutation; UniProtKB; P97259; Mgat5; Simple; p.Asp135Valfs*22; Zygosity=Unspecified; Note=Truncated protein lacking enzymatic activity (PubMed=8910328).
CC   Sequence variation: Mutation; UniProtKB; P97259; Mgat5; Simple; p.Ile598fs; Zygosity=Unspecified; Note=Truncated protein lacking enzymatic activity (PubMed=8910328).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   Lec4A
AC   CVCL_IP62
SY   CHO-Lec4A; CHO Lec4A; Pro~Lec4.12-2; Pro~Lec4A.12-2; ProLec4A.12.2
DR   BTO; BTO_0005989
DR   Wikidata; Q54902426
RX   PubMed=2530238;
RX   PubMed=6295280;
RX   PubMed=8910328;
RX   PubMed=24078077;
CC   Sequence variation: Mutation; UniProtKB; P97259; Mgat5; Simple; p.Leu188Arg (c.563T>G); Zygosity=Homozygous; Note=Causes mistargeting of the protein to the ER (PubMed=8910328).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   Lec8
AC   CVCL_3443
SY   CHO-Lec8; CHO Lec8; Pro-Lec8.D3; Pro-5WgaRVIII3D
DR   BTO; BTO_0006507
DR   CLO; CLO_0007303
DR   ATCC; CRL-1737
DR   Wikidata; Q54902427
RX   PubMed=3785164;
RX   PubMed=9279382;
RX   PubMed=11319223;
CC   Sequence variation: Mutation; UniProtKB; Q99PG7; Slc35a2; Simple; p.Gly92Ter (c.275_374del); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Lec8/hPDPN
AC   CVCL_D2U2
DR   Wikidata; Q127382590
RX   Patent=US10227407;
RX   PubMed=25080943;
RX   PubMed=26937552;
RX   PubMed=27328060;
CC   Sequence variation: Mutation; UniProtKB; Q99PG7; Slc35a2; Simple; p.Gly92Ter (c.275_374del); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3443 ! Lec8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   Lec8/PODXL
AC   CVCL_D2TT
DR   Wikidata; Q127382591
RX   PubMed=28384052;
CC   Sequence variation: Mutation; UniProtKB; Q99PG7; Slc35a2; Simple; p.Gly92Ter (c.275_374del); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9171; PODXL.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3443 ! Lec8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Lec8/TROP2
AC   CVCL_B7JW
DR   Wikidata; Q112929996
RX   PubMed=33300065;
RX   PubMed=33490649;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3443 ! Lec8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Lec9
AC   CVCL_DD12
SY   Lec9.12A; Pro-Lec9.12A
DR   Wikidata; Q54902428
RX   PubMed=2267628;
RX   PubMed=3785164;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4382 ! CHO Pro-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   LeCa 19.4
AC   CVCL_1E34
SY   LeCa 19-4; 19.4; LeCa, strain 19-4; LeCa Str 19-4; M-7
DR   Wikidata; Q54902429
RX   CelloPub=CLPUB00255;
RX   CelloPub=CLPUB00474;
RX   PubMed=1127734;
RX   PubMed=5487065;
CC   Characteristics: Highly pigmented.
CC   Doubling time: 38 hours (PubMed=1127734).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E35 ! LeCa 26.5
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   LeCa 26.5
AC   CVCL_1E35
SY   LeCa 26-5
DR   Wikidata; Q54902430
RX   CelloPub=CLPUB00255;
RX   CelloPub=CLPUB00474;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E34 ! LeCa 19.4
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Led-106
AC   CVCL_XX45
SY   Led 106; LedL-106; L-106; Lederle 106
DR   Wikidata; Q95982040
RX   PubMed=14207842;
RX   PubMed=14230407;
CC   Senescence: Senesces at 30 PDL (PubMed=14207842).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   Led-130
AC   CVCL_1E38
SY   Led 130; LedL-130; L-130; Lederle 130
DR   Wikidata; Q54902431
RX   PubMed=4203458;
RX   PubMed=4304349;
RX   PubMed=14207842;
RX   PubMed=14230407;
RX   PubMed=14328924;
CC   Senescence: Senesces at 50 PDL (PubMed=14207842).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   Led-T1
AC   CVCL_8438
SY   LED-T1; LED-Ti; T1; Lederle T1
DR   BioSample; SAMN03151737
DR   Wikidata; Q54902432
RX   PubMed=4203458;
RX   PubMed=6451928;
RX   PubMed=14328924;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to be a transformed Led-30 (Cellosaurus=CVCL_1E38) cell line.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00072.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   LEE-1
AC   CVCL_6F84
SY   Leucoraja Erinacea Embryo-1
DR   Wikidata; Q54902433
RX   PubMed=18407792;
RX   PubMed=20471924;
RX   PubMed=22497417;
CC   Group: Fish cell line.
CC   Doubling time: ~10 days (PubMed=18407792).
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7782; ! Leucoraja erinacea (Little skate)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   LEE743
AC   CVCL_F722
DR   IPD-IMGT/HLA; 10980
DR   Wikidata; Q54902434
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*15:11:01 (IPD-IMGT/HLA=10980).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   Leeporter Ba/F3 STAT3 luciferase
AC   CVCL_D6ZD
SY   STAT3 Leeporter Luciferase Reporter-Ba/F3
DR   Abeomics; 14-147ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT3 responsive promoter (Abeomics=14-147ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter Ba/F3 STAT4 luciferase
AC   CVCL_D6ZE
SY   STAT4 Leeporter Luciferase Reporter-Ba/F3
DR   Abeomics; 14-145ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT4 responsive promoter (Abeomics=14-145ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter Ba/F3 STAT5 luciferase
AC   CVCL_D6ZF
SY   STAT5 Leeporter Luciferase Reporter-Ba/F3
DR   Abeomics; 14-135ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT5 responsive promoter (Abeomics=14-135ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter Ba/F3 STAT6 luciferase
AC   CVCL_D6ZG
SY   STAT6 Leeporter Luciferase Reporter-Ba/F3
DR   Abeomics; 14-146ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT6 responsive promoter (Abeomics=14-146ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 AP-1 luciferase
AC   CVCL_D6ZH
SY   AP-1 Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-102ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the activator protein 1 response element (AP-1) (Abeomics=14-102ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 CRE luciferase
AC   CVCL_D6ZI
SY   CRE Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-134ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the cAMP response element (CRE) (Abeomics=14-134ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 GATA3 luciferase
AC   CVCL_D6ZJ
SY   GATA3 Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-109ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the GATA3 response element (Abeomics=14-109ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 ISRE luciferase
AC   CVCL_D6ZK
SY   ISRE Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-143ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the interferon stimulated response element (ISRE) (Abeomics=14-143ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 MIP-2 luciferase
AC   CVCL_D6ZL
SY   MIP-2 Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-103ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the CXCL2/MIP-2 promoter (Abeomics=14-103ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 MRE luciferase
AC   CVCL_D6ZM
SY   MRE Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-137ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the metal response element (MRE) (Abeomics=14-137ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 NF-kb GFP
AC   CVCL_D6ZN
SY   NF-kB Leeporter GFP Reporter-HEK293
DR   Abeomics; 14-700ACL
CC   Characteristics: Expresses eGFP under the transcriptional control of the NF-kB response element (Abeomics=14-700ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 NF-kB luciferase
AC   CVCL_D6ZP
SY   NF-kB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-125ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-125ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 NFAT luciferase
AC   CVCL_D6ZQ
SY   NFAT Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-110ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the NFAT response element (Abeomics=14-110ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 SBE luciferase
AC   CVCL_D6ZR
SY   SBE Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-136ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the SMAD binding element (SBE) (Abeomics=14-136ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 SRE luciferase
AC   CVCL_D6ZS
SY   SRE Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-132ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the serum response element (SRE) (Abeomics=14-132ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 SRF-RE luciferase
AC   CVCL_D6ZT
SY   SRF-RE Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-133ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the serum response factor-response element (SRF-RE) (Abeomics=14-133ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 STAT3 luciferase
AC   CVCL_D6ZU
SY   STAT3 Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-114ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT3 responsive promoter (Abeomics=14-114ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 STAT4 luciferase
AC   CVCL_D6ZV
SY   STAT4 Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-140ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT4 responsive promoter (Abeomics=14-140ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 TCF/LEF luciferase
AC   CVCL_D6ZW
SY   TCF/LEF Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-119ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the TCF/LEF response element (Abeomics=14-119ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 TLR2/NF-kB luciferase
AC   CVCL_D6ZX
SY   TLR2/NF-kB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-127ACL
CC   Characteristics: Expresses TLR2 and Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-127ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11848; TLR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR3/IFNB luciferase
AC   CVCL_D6ZY
SY   TLR3/IFNB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-122ACL
CC   Characteristics: Expresses TLR3 and Renilla luciferase under the transcriptional control of the IFN-beta (IFNB) promoter (Abeomics=14-122ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR3/ISRE luciferase
AC   CVCL_D6ZZ
SY   TLR3/ISRE Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-123ACL
CC   Characteristics: Expresses TLR3 and Renilla luciferase under the transcriptional control of the interferon stimulated response element (ISRE) (Abeomics=14-123ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR3/NF-kB GFP
AC   CVCL_D7A0
SY   TLR3/NF-kB Leeporter GFP Reporter-HEK293
DR   Abeomics; 14-701ACL
CC   Characteristics: Expresses TLR3 and eGFP under the transcriptional control of the NF-kB response element (Abeomics=14-701ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR3/NF-kB luciferase
AC   CVCL_D7A1
SY   TLR3/NF-kB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-128ACL
CC   Characteristics: Expresses TLR3 and Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-128ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR5/NF-kB luciferase
AC   CVCL_D7A2
SY   TLR5/NF-kB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-139ACL
CC   Characteristics: Expresses TLR5 and Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-139ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11851; TLR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR7/NF-kB luciferase
AC   CVCL_D7A3
SY   TLR7/NF-kB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-129ACL
CC   Characteristics: Expresses TLR7 and Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-129ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15631; TLR7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR8/NF-kB luciferase
AC   CVCL_D7A4
SY   TLR8/NF-kB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-130ACL
CC   Characteristics: Expresses TLR8 and Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-130ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15632; TLR8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TLR9/NF-kB luciferase
AC   CVCL_D7A5
SY   TLR9/NF-kB Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-131ACL
CC   Characteristics: Expresses TLR9 and Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-131ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293 TNF-alpha luciferase
AC   CVCL_D7A6
SY   TNF-alpha Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-105ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the TNF-alpha promoter (Abeomics=14-105ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293 TNF-beta luciferase
AC   CVCL_D7A7
SY   TNF-beta Leeporter Luciferase Reporter-HEK293
DR   Abeomics; 14-107ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the TNF-beta promoter (Abeomics=14-107ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter HEK293T MDA5/NF-kB luciferase
AC   CVCL_D7A8
SY   MDA5/NF-kB Leeporter Luciferase Reporter-HEK293T
DR   Abeomics; 14-121ACL
CC   Characteristics: Expresses IFIH1/MDA5 and Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-121ACL).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18873; IFIH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HEK293T RIG-I/NF-kB luciferase
AC   CVCL_D7A9
SY   RIG-I/NF-kB Leeporter Luciferase Reporter-HEK293T
DR   Abeomics; 14-120ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the NF-kB response elementTCF/LEF response element (Abeomics=14-120ACL).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:19102; RIGI.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter HeLa ATF6 luciferase
AC   CVCL_D7AA
SY   ATF6 Leeporter Luciferase Reporter-HeLa
DR   Abeomics; 14-138ACL
CC   Population: African American.
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the activating transcription factor 6 (ATF6)-response element (Abeomics=14-138ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Leeporter HeLa HRE luciferase
AC   CVCL_D7AU
SY   HRE Leeporter Luciferase Reporter-HeLa
DR   Abeomics; 14-118ACL
CC   Population: African American.
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the hypoxia response element (HRE) (Abeomics=14-118ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Leeporter HeLa p53 luciferase
AC   CVCL_D7AB
SY   p53 Leeporter Luciferase Reporter-HeLa
DR   Abeomics; 14-126ACL
CC   Population: African American.
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the p53 response element (Abeomics=14-126ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Leeporter HeLa STAT1 luciferase
AC   CVCL_D7AC
SY   STAT1 Leeporter Luciferase Reporter-HeLa
DR   Abeomics; 14-112ACL
CC   Population: African American.
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT1 response element (Abeomics=14-112ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Leeporter HeLa TLR4/IL-8 luciferase
AC   CVCL_D7AD
SY   TLR4/IL-8 Leeporter Luciferase Reporter-HeLa
DR   Abeomics; 14-124ACL
CC   Population: African American.
CC   Characteristics: Expresses TLR4, CD14, LY96 and Renilla luciferase under the transcriptional control of the IL-8 promoter (Abeomics=14-124ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11850; TLR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Leeporter Jurkat FOXP3 luciferase
AC   CVCL_D7AE
SY   FOXP3 Leeporter Luciferase Reporter-Jurkat
DR   Abeomics; 14-144ACL
CC   Population: Caucasian.
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the FOXP3 promoter (Abeomics=14-144ACL).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Leeporter Jurkat NF-kB luciferase
AC   CVCL_D7AF
SY   NF-kB Leeporter Luciferase Reporter-Jurkat
DR   Abeomics; 14-142ACL
CC   Population: Caucasian.
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-142ACL).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Leeporter MCF7 Nrf2 luciferase
AC   CVCL_D7AT
SY   Nrf2 Leeporter Luciferase Reporter-MCF7
DR   Abeomics; 14-117ACL
CC   Population: Caucasian.
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the antioxidant response element (ARE) (Abeomics=14-117ACL).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Leeporter NIH 3T3 IL-6 luciferase
AC   CVCL_D7AG
SY   IL-6 Leeporter Luciferase Reporter-NIH 3T3
DR   Abeomics; 14-116ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the IL6 promoter (Abeomics=14-116ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter NIH 3T3 STAT3 luciferase
AC   CVCL_D7AH
SY   STAT3 Leeporter Luciferase Reporter-NIH 3T3
DR   Abeomics; 14-149ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT3 responsive promoter (Abeomics=14-149ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 IL-8 luciferase
AC   CVCL_D7AI
SY   IL-8 Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-101ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the IL8 promoter (Abeomics=14-101ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 INOS luciferase
AC   CVCL_D7AJ
SY   INOS Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-115ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the iNOS/NOS2 promoter (Abeomics=14-115ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 ISRE luciferase
AC   CVCL_D7AK
SY   ISRE Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-141ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the interferon-stimulated response element (ISRE) (Abeomics=14-141ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 MIP-2 luciferase
AC   CVCL_D7AL
SY   MIP-2 Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-104ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the CXCL2/MIP-2 promoter (Abeomics=14-104ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 NF-kB luciferase
AC   CVCL_D7AM
SY   NF-kB Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-100ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the NF-kB response element (Abeomics=14-100ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 NFAT luciferase
AC   CVCL_D7AN
SY   NFAT Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-111ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the NFAT response element (Abeomics=14-111ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 STAT1 luciferase
AC   CVCL_D7AP
SY   STAT1 Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-113ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT1 response element (Abeomics=14-113ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 STAT3 luciferase
AC   CVCL_D7AQ
SY   STAT3 Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-148ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the STAT3 responsive promoter (Abeomics=14-148ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 TNF-alpha luciferase
AC   CVCL_D7AR
SY   TNF-alpha Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-106ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the TNF-alpha promoter (Abeomics=14-106ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Leeporter RAW264.7 TNF-beta luciferase
AC   CVCL_D7AS
SY   TNF-beta Leeporter Luciferase Reporter-RAW264.7
DR   Abeomics; 14-108ACL
CC   Characteristics: Expresses Renilla luciferase under the transcriptional control of the TNF-beta promoter (Abeomics=14-108ACL).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   LEF1
AC   CVCL_QW98
SY   LEF-1
DR   Wikidata; Q54902435
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2143794;
RX   PubMed=10071072;
CC   Karyotypic information: 46,XX,t(9;22)(q34;q11) (PubMed=2143794).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=2143794; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   Lei Cap
AC   CVCL_3444
DR   CLO; CLO_0007304
DR   ATCC; CRL-1098
DR   Wikidata; Q54902436
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84665; Darier disease
DI   ORDO; Orphanet_218; Darier disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   LEIi004-A
AC   CVCL_VE61
SY   L4-A
DR   BioSamples; SAMEA104626352
DR   hPSCreg; LEIi004-A
DR   Wikidata; Q54902437
RX   PubMed=29753273;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000950856; Zygosity=Heterozygous (PubMed=29753273).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (PubMed=29753273).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   LEIi004-A-1
AC   CVCL_VE94
SY   L4-A-1
DR   BioSamples; SAMEA4760675
DR   hPSCreg; LEIi004-A-1
DR   Wikidata; Q54902438
RX   PubMed=29753273;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple_corrected; p.Ala59Thr (c.175G>A); ClinVar=VCV000950856; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=29753273).
CC   Sequence variation: Mutation; HGNC; HGNC:2074; CLN3; Simple; c.461-280_677+382del (1.02-kb del); ClinVar=VCV000003552; Zygosity=Heterozygous (PubMed=29753273).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VE61 ! LEIi004-A
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   LEIi005-A
AC   CVCL_VE62
DR   BioSamples; SAMEA4675564
DR   hPSCreg; LEIi005-A
DR   Wikidata; Q54902439
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Glu700Ter (c.2098G>T); Zygosity=Heterozygous (from autologous cell line LEIi005-B).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ45 ! LEIi005-B
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   LEIi005-B
AC   CVCL_WJ45
SY   RP1ips6
DR   hPSCreg; LEIi005-B
DR   Wikidata; Q95982053
RX   PubMed=31059986;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10263; RP1; Simple; p.Glu700Ter (c.2098G>T); Zygosity=Heterozygous (PubMed=31059986).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE62 ! LEIi005-A
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   LEIi006-A
AC   CVCL_VN41
SY   1004CRB1iPS6
DR   BioSamples; SAMEA4760627
DR   hPSCreg; LEIi006-A
DR   Wikidata; Q95982054
RX   PubMed=30092450;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Tyr631Cys (c.1892A>G); ClinVar=VCV000636015; Zygosity=Heterozygous (PubMed=30092450).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Gly850Ser (c.2548G>A); ClinVar=VCV000565382; Zygosity=Heterozygous (PubMed=30092450).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   LEIi007-A
AC   CVCL_UM07
SY   1082ips10; 1082IPS10
DR   hPSCreg; LEIi007-A
DR   Wikidata; Q95982055
RX   PubMed=30634128;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Pro1380Leu (c.4139C>T); ClinVar=VCV000007904; Zygosity=Heterozygous (PubMed=30634128).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5461-10T>C; ClinVar=VCV000092870; Zygosity=Heterozygous (PubMed=30634128).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   LEIi008-A
AC   CVCL_UK23
SY   1093ips4; 1093IPSC_4P4
DR   hPSCreg; LEIi008-A
DR   Wikidata; Q95982056
RX   PubMed=30611018;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Aboriginal Australian.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Ser402Ter (c.1205C>A); ClinVar=VCV002419172; Zygosity=Heterozygous (PubMed=30611018).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   LEIi009-A
AC   CVCL_UK24
SY   1374ips1; 1374IPSC_1P10
DR   hPSCreg; LEIi009-A
DR   Wikidata; Q95982057
RX   PubMed=30611018;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Aboriginal Australian.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Ser402Ter (c.1205C>A); ClinVar=VCV002419172; Zygosity=Heterozygous (PubMed=30611018).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   LEIi010-A
AC   CVCL_WJ43
SY   1011ips1
DR   hPSCreg; LEIi010-A
DR   Wikidata; Q95982058
RX   PubMed=30904819;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Tyr318Cysfs*17 (c.949C>A); Zygosity=Heterozygous (PubMed=30904819).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys419Phe (c.1256G>T); ClinVar=VCV000002359; Zygosity=Heterozygous (PubMed=30904819).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ44 ! LEIi010-B
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   LEIi010-B
AC   CVCL_WJ44
SY   1011ips2
DR   BioSamples; SAMEA5696685
DR   hPSCreg; LEIi010-B
DR   Wikidata; Q95982060
RX   PubMed=30904819;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Tyr318Cysfs*17 (c.949C>A); Zygosity=Heterozygous (PubMed=30904819).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys419Phe (c.1256G>T); ClinVar=VCV000002359; Zygosity=Heterozygous (PubMed=30904819).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ43 ! LEIi010-A
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   LEIi011-A
AC   CVCL_XI39
SY   1466ips1
DR   BioSamples; SAMEA6014779
DR   hPSCreg; LEIi011-A
DR   Wikidata; Q95982061
RX   PubMed=31494449;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Chinese; Singaporian.
CC   Sequence variation: Mutation; HGNC; HGNC:18243; RCBTB1; Simple; p.Gly57Glufs*12 (c.170delG); ClinVar=VCV000840798; Zygosity=Heterozygous (PubMed=31494449).
CC   Sequence variation: Mutation; HGNC; HGNC:18243; RCBTB1; Simple; p.Asn236Thrfs*11 (c.707delA); ClinVar=VCV000224622; Zygosity=Heterozygous (PubMed=31494449).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164155; Retinal dystrophy with or without extraocular anomalies
DI   ORDO; Orphanet_99002; Reticular dystrophy of the retinal pigment epithelium
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI40 ! LEIi011-B
OI   CVCL_XI41 ! LEIi011-C
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   LEIi011-B
AC   CVCL_XI40
SY   1466ips2
DR   hPSCreg; LEIi011-B
DR   Wikidata; Q95982062
RX   PubMed=31494449;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Chinese; Singaporian.
CC   Sequence variation: Mutation; HGNC; HGNC:18243; RCBTB1; Simple; p.Gly57Glufs*12 (c.170delG); ClinVar=VCV000840798; Zygosity=Heterozygous (PubMed=31494449).
CC   Sequence variation: Mutation; HGNC; HGNC:18243; RCBTB1; Simple; p.Asn236Thrfs*11 (c.707delA); ClinVar=VCV000224622; Zygosity=Heterozygous (PubMed=31494449).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164155; Retinal dystrophy with or without extraocular anomalies
DI   ORDO; Orphanet_99002; Reticular dystrophy of the retinal pigment epithelium
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI39 ! LEIi011-A
OI   CVCL_XI41 ! LEIi011-C
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   LEIi011-C
AC   CVCL_XI41
SY   1466ips3
DR   hPSCreg; LEIi011-C
DR   Wikidata; Q95982063
RX   PubMed=31494449;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Chinese; Singaporian.
CC   Sequence variation: Mutation; HGNC; HGNC:18243; RCBTB1; Simple; p.Gly57Glufs*12 (c.170delG); ClinVar=VCV000840798; Zygosity=Heterozygous (PubMed=31494449).
CC   Sequence variation: Mutation; HGNC; HGNC:18243; RCBTB1; Simple; p.Asn236Thrfs*11 (c.707delA); ClinVar=VCV000224622; Zygosity=Heterozygous (PubMed=31494449).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164155; Retinal dystrophy with or without extraocular anomalies
DI   ORDO; Orphanet_99002; Reticular dystrophy of the retinal pigment epithelium
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI39 ! LEIi011-A
OI   CVCL_XI40 ! LEIi011-B
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   LEIi012-A
AC   CVCL_YT07
SY   1357ips5
DR   BioSamples; SAMEA6438549
DR   hPSCreg; LEIi012-A
DR   Wikidata; Q95982064
RX   PubMed=32810830;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Val256Val (c.768G>T); ClinVar=VCV000099505; Zygosity=Heterozygous; Note=Affects splicing (PubMed=32810830).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu2027Phe (c.6079C>T); ClinVar=VCV000007882; Zygosity=Heterozygous (PubMed=32810830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT08 ! LEIi012-B
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   LEIi012-B
AC   CVCL_YT08
SY   1357iPS11
DR   hPSCreg; LEIi012-B
DR   Wikidata; Q95982065
RX   PubMed=32810830;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Val256Val (c.768G>T); ClinVar=VCV000099505; Zygosity=Heterozygous; Note=Affects splicing (PubMed=32810830).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu2027Phe (c.6079C>T); ClinVar=VCV000007882; Zygosity=Heterozygous (PubMed=32810830).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT07 ! LEIi012-A
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   LEIi014-A
AC   CVCL_A4CQ
SY   1012ips9
DR   hPSCreg; LEIi014-A
DR   Wikidata; Q105509865
RX   PubMed=33360097;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Tyr318Cysfs*17 (c.949C>A); Zygosity=Heterozygous (PubMed=33360097).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys419Phe (c.1256G>T); ClinVar=VCV000002359; Zygosity=Heterozygous (PubMed=33360097).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4CR ! LEIi014-B
OI   CVCL_A4CS ! LEIi014-C
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi014-B
AC   CVCL_A4CR
SY   1012ips10
DR   hPSCreg; LEIi014-B
DR   Wikidata; Q105509869
RX   PubMed=33360097;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Tyr318Cysfs*17 (c.949C>A); Zygosity=Heterozygous (PubMed=33360097).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys419Phe (c.1256G>T); ClinVar=VCV000002359; Zygosity=Heterozygous (PubMed=33360097).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4CQ ! LEIi014-A
OI   CVCL_A4CS ! LEIi014-C
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi014-C
AC   CVCL_A4CS
SY   1012ips11
DR   hPSCreg; LEIi014-C
DR   Wikidata; Q105509875
RX   PubMed=33360097;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Tyr318Cysfs*17 (c.949C>A); Zygosity=Heterozygous (PubMed=33360097).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys419Phe (c.1256G>T); ClinVar=VCV000002359; Zygosity=Heterozygous (PubMed=33360097).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4CQ ! LEIi014-A
OI   CVCL_A4CR ! LEIi014-B
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi015-A
AC   CVCL_A4CN
SY   1042ips1
DR   hPSCreg; LEIi015-A
DR   Wikidata; Q105509879
RX   PubMed=33429167;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30859; SNRNP200; Simple; p.Arg598Cys (c.1792C>T); ClinVar=VCV000839536; Zygosity=Heterozygous (PubMed=33429167).
CC   Sequence variation: Mutation; HGNC; HGNC:30859; SNRNP200; Simple; p.Leu1114Pro (c.3341T>C); Zygosity=Heterozygous (PubMed=33429167).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4CP ! LEIi015-B
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi015-B
AC   CVCL_A4CP
SY   1042ips4
DR   hPSCreg; LEIi015-B
DR   Wikidata; Q105509882
RX   PubMed=33429167;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30859; SNRNP200; Simple; p.Arg598Cys (c.1792C>T); ClinVar=VCV000839536; Zygosity=Heterozygous (PubMed=33429167).
CC   Sequence variation: Mutation; HGNC; HGNC:30859; SNRNP200; Simple; p.Leu1114Pro (c.3341T>C); Zygosity=Heterozygous (PubMed=33429167).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4CN ! LEIi015-A
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi016-A
AC   CVCL_A8MG
SY   1418ips3
DR   hPSCreg; LEIi016-A
DR   Wikidata; Q108820782
RX   PubMed=34034222;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Ile852Thr (c.2555T>C); ClinVar=VCV000099883; Zygosity=Heterozygous (PubMed=34034222).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Asp1005Val (c.3014A>T); ClinVar=VCV000846589; Zygosity=Heterozygous (PubMed=34034222).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8MH ! LEIi016-B
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi016-B
AC   CVCL_A8MH
SY   1418ips6
DR   hPSCreg; LEIi016-B
DR   Wikidata; Q108820783
RX   PubMed=34034222;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Ile852Thr (c.2555T>C); ClinVar=VCV000099883; Zygosity=Heterozygous (PubMed=34034222).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Asp1005Val (c.3014A>T); ClinVar=VCV000846589; Zygosity=Heterozygous (PubMed=34034222).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8MG ! LEIi016-A
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi017-A
AC   CVCL_A8MI
SY   1629ips9
DR   hPSCreg; LEIi017-A
DR   Wikidata; Q108820784
RX   PubMed=34198153;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg152Gln (c.455G>A); ClinVar=VCV000099301; Zygosity=Heterozygous (PubMed=34198153).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu1388Pro (c.4163T>C); ClinVar=VCV000099254; Zygosity=Heterozygous (PubMed=34198153).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5461-10T>C; ClinVar=VCV000092870; Zygosity=Heterozygous (PubMed=34198153).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Asn1868Ile (c.5603A>T); ClinVar=VCV000099390; Zygosity=Heterozygous (PubMed=34198153).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8MJ ! LEIi017-B
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi017-B
AC   CVCL_A8MJ
SY   1629ips11
DR   hPSCreg; LEIi017-B
DR   Wikidata; Q108820785
RX   PubMed=34198153;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg152Gln (c.455G>A); ClinVar=VCV000099301; Zygosity=Heterozygous (PubMed=34198153).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu1388Pro (c.4163T>C); ClinVar=VCV000099254; Zygosity=Heterozygous (PubMed=34198153).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5461-10T>C; ClinVar=VCV000092870; Zygosity=Heterozygous (PubMed=34198153).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Asn1868Ile (c.5603A>T); ClinVar=VCV000099390; Zygosity=Heterozygous (PubMed=34198153).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8MI ! LEIi017-A
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi018-A
AC   CVCL_A8MK
SY   1607ips6
DR   hPSCreg; LEIi018-A
DR   Wikidata; Q108820786
RX   PubMed=34214897;
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5461-10T>C; ClinVar=VCV000092870; Zygosity=Heterozygous (PubMed=34214897).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Asn1868Ile (c.5603A>T); ClinVar=VCV000099390; Zygosity=Heterozygous (PubMed=34214897).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu2026Pro (c.6077T>C); ClinVar=VCV000236144; Zygosity=Heterozygous (PubMed=34214897).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   LEIi019-A
AC   CVCL_C1UC
SY   1020ips1
DR   hPSCreg; LEIi019-A
DR   Wikidata; Q114311875
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LEIi020-A
AC   CVCL_C1UD
SY   1049ips2
DR   hPSCreg; LEIi020-A
DR   Wikidata; Q114311876
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UE ! LEIi020-B
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LEIi020-B
AC   CVCL_C1UE
DR   hPSCreg; LEIi020-B
DR   Wikidata; Q114311877
CC   From: Lions Eye Institute, University of Western Australia; Nedlands; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UD ! LEIi020-A
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LEIO-2
AC   CVCL_W486
DR   Wikidata; Q54902440
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C27200; Gastric leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   LEK
AC   CVCL_F742
SY   Legkoye Embrion Korova
DR   CLO; CLO_0007306
DR   CLDB; cl3202
DR   Wikidata; Q54902441
RX   PubMed=24000610;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   LEM-CQ-01
AC   CVCL_Z240
DR   Wikidata; Q54902442
RX   PubMed=22310541;
CC   Group: Insect cell line.
CC   Miscellaneous: Provisional name until main author of paper respond to request to assign a name to the cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7176; ! Culex quinquefasciatus (Southern house mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   LEMf
AC   CVCL_YQ03
SY   Landrace Ear Marginal fibroblasts
DR   Wikidata; Q95982067
RX   PubMed=20297920;
CC   Doubling time: ~24 hours (PubMed=20297920).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   Lena
AC   CVCL_0E93
SY   LENA
DR   ATCC; CRL-1868
DR   Wikidata; Q54902443
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-1868; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   LentiPro26
AC   CVCL_YZ81
DR   Wikidata; Q98126895
RX   PubMed=29588490;
CC   Characteristics: Transfected with the pGP(T26S)P-blast plasmid containing HIV-1 Gag-Pro(Thr514Ser)-Pol-bsr and the pREV-hygro-WPRE plasmid containing Rev-hph and a woodchuck hepatitis post-transcriptional regulatory element (WPRE).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12493; HIV-1 isolate NY5 gag.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P12497; HIV-1 isolate NY5 pol (Note=With p.Thr514Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04325; HIV-1 isolate PCV12 rev.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   LentiPro26-4070A
AC   CVCL_YZ82
DR   Wikidata; Q98126896
RX   PubMed=29588490;
CC   Characteristics: Transfected with the pGP(T26S)P-blast plasmid containing HIV-1 Gag-Pro(Thr514Ser)-Pol-bsr, the pREV-hygro-WPRE plasmid containing Rev-hph and a woodchuck hepatitis post-transcriptional regulatory element (WPRE) and the pMONO-zeo-4070A plasmid containing a ferritin heavy chain promoter fused with SV40 enhancer followed by MLV 4070A env, IRES and ble.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12493; HIV-1 isolate NY5 gag.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12497; HIV-1 isolate NY5 pol (Note=With p.Thr514Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04325; HIV-1 isolate PCV12 rev.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q89683; Murine leukemia virus (isolate 4070A) env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ81 ! LentiPro26
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   LentiPro26-4070A-mCPGFP
AC   CVCL_YZ83
DR   Wikidata; Q98126897
RX   PubMed=29588490;
CC   Characteristics: Transfected with the pGP(T26S)P-blast plasmid containing HIV-1 Gag-Pro(Thr514Ser)-Pol-bsr, the pREV-hygro-WPRE plasmid containing Rev-hph and a woodchuck hepatitis post-transcriptional regulatory element (WPRE), the pMONO-zeo-4070A plasmid containing a ferritin heavy chain promoter fused with SV40 enhancer followed by MLV 4070A env, IRES and ble and the pRRLSIN-mCP-GFP plasmid containing mCherry, pac, the human phosphoglycerate kinase promoter, GFP and WPRE.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12493; HIV-1 isolate NY5 gag.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12497; HIV-1 isolate NY5 pol (Note=With p.Thr514Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04325; HIV-1 isolate PCV12 rev.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q89683; Murine leukemia virus (isolate 4070A) env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ82 ! LentiPro26-4070A
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   LentiPro26-A59
AC   CVCL_YZ84
SY   LentiPro26-4070A-mCPGFP clone 59
DR   Wikidata; Q98126898
RX   PubMed=29588490;
CC   Characteristics: Transfected with the pGP(T26S)P-blast plasmid containing HIV-1 Gag-Pro(Thr514Ser)-Pol-bsr, the pREV-hygro-WPRE plasmid containing Rev-hph and a woodchuck hepatitis post-transcriptional regulatory element (WPRE), the pMONO-zeo-4070A plasmid containing a ferritin heavy chain promoter fused with SV40 enhancer followed by MLV 4070A env, IRES and ble and the pRRLSIN-mCP-GFP plasmid containing mCherry, pac, the human phosphoglycerate kinase promoter, GFP and WPRE.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12493; HIV-1 isolate NY5 gag.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P12497; HIV-1 isolate NY5 pol (Note=With p.Thr514Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04325; HIV-1 isolate PCV12 rev.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q89683; Murine leukemia virus (isolate 4070A) env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ83 ! LentiPro26-4070A-mCPGFP
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Leo
AC   CVCL_A016
DR   ABM; T8278
DR   Wikidata; Q54902444
RX   PubMed=21321976;
CC   Doubling time: ~38 hours (PubMed=21321976).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   Leo-YFPLuc
AC   CVCL_E5V1
SY   Leo-YFP/Luc
DR   ABM; T8279
RX   PubMed=21321976;
CC   Characteristics: Transduced with a YFP-luciferase fusion protein whose expression is under the control of a CMV promoter (PubMed=21321976).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A016 ! Leo
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   LEO-10
AC   CVCL_A7RJ
DR   IHW; IHW09481
DR   Wikidata; Q107115627
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*03:01:01:01; B*07:02:01; C*07:02:01:03; DPA1*01:03:01:02; DPB1*04:01:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   LEPI
AC   CVCL_YP10
SY   LEPI-1
DR   Wikidata; Q95982069
RX   PubMed=31412689;
CC   Characteristics: Rapidly forms cobblestone morphology, clear microvilli and tight barrier in simple culture conditions (PubMed=31412689).
CC   Doubling time: ~20 hours (PubMed=31412689).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
ST   Source(s): PubMed=31412689
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   LERS-1
AC   CVCL_A5ZT
SY   LEwis Rat Spleen-1
DR   Wikidata; Q107115630
RX   PubMed=2788356;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Miscellaneous: Cell line has been lost (PubMed=2788356).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   LERT-1
AC   CVCL_A5ZU
SY   LEwis Rat Thymus-1
DR   Wikidata; Q107115634
RX   PubMed=2788356;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   LES
AC   CVCL_D524
DR   Wikidata; Q54902445
RX   PubMed=7949178;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   Leslie
AC   CVCL_VL63
DR   Wikidata; Q95982070
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   LET1
AC   CVCL_A7VS
SY   Let1; Lung Epithelial Type 1
DR   BEI_Resources; NR-42941
DR   Wikidata; Q107115636
RX   PubMed=24243730;
CC   Virology: Supports spreading influenza virus infection in the absence of exogenous protease (PubMed=24243730).
CC   Doubling time: <24 hours (PubMed=24243730).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   LEW311
AC   CVCL_E756
DR   dbMHC; 48951
DR   IHW; IHW09396
DR   IPD-IMGT/HLA; 26000
DR   Wikidata; Q54902446
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:01,74:01; B*18:01,40:16; C*08:02,15:05; DQB1*02:01; DRB1*07:01; DRB4*01:01 (IPD-IMGT/HLA=26000).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   Lex-1
AC   CVCL_C696
SY   Lex1; LEX1
DR   Wikidata; Q54902447
WW   Info; MMRRC; -; https://mmrrc.ucdavis.edu/files/protocols/ESC-culture-Lex1.pdf
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S5/SvEvBrd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   Lex-2
AC   CVCL_0J18
SY   Lex2
DR   Wikidata; Q54902450
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S5/SvEvBrd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   LF
AC   CVCL_WY77
SY   Loach Fin
DR   Wikidata; Q95982075
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75329; ! Misgurnus anguillicaudatus (Oriental weatherloach)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   LF-1
AC   CVCL_B6MR
SY   DF-1 clone 604
DR   Wikidata; Q111733571
RX   Patent=US20200179507;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-123527.
CC   Virology: Compared to the parent cell line, has a 1.5 fold improvement in supporting the replication of Marek's disease virus (Patent=US20200179507).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0570 ! UMNSAH/DF-1
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   LF-BK
AC   CVCL_RX26
SY   LFBK
DR   Wikidata; Q54902451
RX   Patent=US9121010;
RX   PubMed=2847400;
RX   PubMed=23515553;
RX   PubMed=25617444;
RX   PubMed=25787111;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of bovine fetal kidney origin but found to be from pig (PubMed=25617444; PubMed=25787111).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00612.
CC   Virology: Susceptible to infection by foot-and-mouth disease virus.
CC   Omics: Transcriptomics; ESTs sequencing.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   LF-CL2A
AC   CVCL_2103
SY   LF Cl.2A; LFCl2A; LF clone 2A; Lafarge-Frayssinet clone 2A
DR   CLO; CLO_0007309
DR   CLDB; cl3204
DR   ChEMBL-Cells; CHEMBL3308563
DR   ChEMBL-Targets; CHEMBL614690
DR   DSMZ; ACC-195
DR   DSMZCellDive; ACC-195
DR   PubChem_Cell_line; CVCL_2103
DR   Wikidata; Q54902453
RX   PubMed=1309725;
CC   Doubling time: ~20-25 hours (DSMZ=ACC-195).
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar Commentry.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   LF/TERT309
AC   CVCL_B5TI
DR   Evercyte; CHT-067-0309
DR   Wikidata; Q111733572
CC   Doubling time: ~36 hours (Evercyte=CHT-067-0309).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Sex and age of donor from personal communication of Evercyte.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): Evercyte=CHT-067-0309
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   LF1 [Human fetal lung]
AC   CVCL_C120
SY   Lung Fibroblast 1
DR   Wikidata; Q54902454
RX   PubMed=9242615;
CC   Senescence: Senesces at 48 PDL (PubMed=9242615).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13-28FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   LF1 [Human lung myofibroblast]
AC   CVCL_A8QT
DR   BTO; BTO_0005638
DR   GEO; GSM157046
DR   Wikidata; Q108820787
RX   PubMed=17986007;
CC   Doubling time: ~2 days (PubMed=17986007).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Myofibroblast; CL=CL_0000186.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LF2 [Human lung myofibroblast]
AC   CVCL_A8QU
DR   BTO; BTO_0005639
DR   GEO; GSM157047
DR   Wikidata; Q108820788
RX   PubMed=17986007;
CC   Doubling time: ~3 days (PubMed=17986007).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Myofibroblast; CL=CL_0000186.
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LF2 [Mouse ESC]
AC   CVCL_AS05
DR   CancerTools; 152568
DR   ECACC; 16022532
DR   GEO; GSM397408
DR   GEO; GSM397409
DR   GEO; GSM413114
DR   GEO; GSM413115
DR   GEO; GSM413116
DR   GEO; GSM413120
DR   GEO; GSM413121
DR   GEO; GSM413122
DR   GEO; GSM413126
DR   GEO; GSM413127
DR   GEO; GSM413128
DR   GEO; GSM413132
DR   GEO; GSM413133
DR   GEO; GSM413134
DR   GEO; GSM413138
DR   GEO; GSM413139
DR   GEO; GSM413140
DR   GEO; GSM413144
DR   GEO; GSM413145
DR   GEO; GSM413146
DR   GEO; GSM413150
DR   GEO; GSM413151
DR   GEO; GSM413152
DR   GEO; GSM413156
DR   GEO; GSM413157
DR   GEO; GSM413158
DR   Wikidata; Q54902455
DR   Ximbio; 152568
RX   PubMed=2129226;
RX   PubMed=16244654;
RX   PubMed=19581487;
RX   PubMed=23850244;
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me2.
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: ECACC; 16022532; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   LFBK-alphaVbeta6
AC   CVCL_RX27
SY   LFBK alphaVbeta6; LFBKalphaVbeta6; LF-BK alphaVbeta6; LFBK-alpha(v)beta(6); LFBK-aVb6; LFBK-AvB6; LFBKaVB6; LFBKavb6
DR   Wikidata; Q54902456
RX   Patent=US9121010;
RX   PubMed=23515553;
RX   PubMed=25617444;
RX   PubMed=26082457;
RX   PubMed=32851014;
RX   PubMed=34092457;
RX   PubMed=34458357;
RX   PubMed=34737324;
RX   PubMed=35112907;
RX   PubMed=36146682;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Parent cell line (LF-BK) was originally thought to be of bovine fetal kidney origin but originates from pig (PubMed=25617444). The derived cell line has also been shown to originate from pig (PubMed=34737324).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00613.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-13047.
CC   Virology: More susceptible to infection by foot-and-mouth disease virus than parent cell line.
CC   Virology: Susceptible to infection by senecavirus A (SVA) which can be used as a surrogate for studies of goot-and-mouth disease virus (PubMed=36146682).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=34092457; PubMed=34458357; PubMed=35112907).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30323; Bovine ITGAV.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30331; Bovine ITGB6.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_RX26 ! LF-BK
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   LFC12.Sp
AC   CVCL_S342
SY   FCZsp
DR   ATCC; CRL-6172
DR   Wikidata; Q54902457
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6172; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   LFC16.Ln
AC   CVCL_6415
SY   FC16.Ln
DR   CLO; CLO_0007308
DR   ATCC; CRL-6173
DR   Wikidata; Q54902458
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6173; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_4944 ! FC16.Sp
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   LFS-05F-24
AC   CVCL_C1HP
DR   Wikidata; Q114311878
RX   PubMed=19935656;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (PubMed=19935656).
CC   Senescence: Became immortalized at 48-50 PDL (PubMed=19935656).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   37Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   LFUfd
AC   CVCL_E7AY
RX   PubMed=39536417;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Forelimb digit; UBERON=UBERON_0002389.
OX   NCBI_TaxID=238119; ! Leptodactylus fuscus (Whistling grass frog)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LG-1
AC   CVCL_B5YY
SY   Lumpfish Gill-1
DR   Wikidata; Q111733573
RX   PubMed=34572091;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by salmonid alphavirus 1 (SAV1) (PubMed=34572091).
CC   Doubling time: 14 days (Note=At 20 Celsius) (PubMed=34572091).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8103; ! Cyclopterus lumpus (Lumpsucker)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   LG-10
AC   CVCL_F0WQ
SY   LG10; Mou; 7W516; Leibold-Gatti-10
DR   IPD-IMGT/HLA; 10983
RX   PubMed=84414;
RX   PubMed=6698819;
RX   PubMed=6808075;
CC   HLA typing: A*29; B*12 (PubMed=6808075).
CC   HLA typing: DQA1*02:01:01:01 (IPD-IMGT/HLA=10983).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LG-11
AC   CVCL_ZV48
SY   LG11
DR   Wikidata; Q98126900
RX   PubMed=8971176;
RX   PubMed=9070656;
RX   PubMed=9090379;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=9090379).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LG-14
AC   CVCL_F0WR
SY   XIII: AHM van Lt; ALT; Leibold-Gatti-14
RX   PubMed=84414;
RX   PubMed=6808075;
CC   HLA typing: A*01; B*08; C*06 (PubMed=6808075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LG-2
AC   CVCL_C5UW
SY   LG2; J. Thom; JB; 7W502; Leibold-Gatti-2
DR   IPD-IMGT/HLA; 10984
DR   PRIDE; PXD008500
DR   PRIDE; PXD010301
DR   Wikidata; Q116049680
RX   PubMed=84414;
RX   PubMed=2824477;
RX   PubMed=6808075;
RX   PubMed=12133989;
RX   PubMed=25469497;
RX   PubMed=30573663;
CC   Population: Caucasian; Scandinavian.
CC   HLA typing: A*02; B*27:05; C*01 (PubMed=25469497).
CC   HLA typing: A*02; B*27:05:02; C*01; DPA1*01:01; DPB1*02:01; DQA1*01:01; DQB1*05:01; DRB1*01:01 (PubMed=12133989).
CC   HLA typing: B*02:01,27:05; DPA1*01:03:01:01; DQA1*01:01:01:01; DQB1*05:01:01:01; DRB1*01:01:01:01 (IPD-IMGT/HLA=10984).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E716 ! JESTHOM
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 5
//
ID   LG-36
AC   CVCL_F0WS
SY   HMi; 7W517; Leibold-Gatti-36
RX   PubMed=84414;
RX   PubMed=6808075;
CC   HLA typing: A*23; B*12; C*04 (PubMed=6808075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LG-L2C
AC   CVCL_JX23
DR   Wikidata; Q54902459
RX   PubMed=1034020;
RX   PubMed=1262783;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Strain 2; VBO=VBO_0017522.
DI   NCIt; C134564; Guinea pig leukemia
OX   NCBI_TaxID=10141; ! Cavia porcellus (Guinea pig)
HI   CVCL_2547 ! L2C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 7
//
ID   LG-T
AC   CVCL_0C19
DR   Wikidata; Q54902460
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9815546;
CC   Doubling time: 60 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LG1
AC   CVCL_XG18
DR   Wikidata; Q95982081
RX   PubMed=1915659;
RX   PubMed=2643097;
RX   PubMed=11888918;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   LG2 DO-KO-1
AC   CVCL_C5VJ
SY   DO-KO-1
DR   PRIDE; PXD010301
DR   Wikidata; Q116049681
RX   PubMed=30573663;
CC   Population: Caucasian; Scandinavian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4937; HLA-DOB.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UW ! LG-2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 6
//
ID   LG2 DO-KO-2
AC   CVCL_C5VK
SY   DO-KO-2
DR   PRIDE; PXD010301
DR   Wikidata; Q116049682
RX   PubMed=30573663;
CC   Population: Caucasian; Scandinavian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4937; HLA-DOB.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UW ! LG-2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 6
//
ID   LG2-EBV
AC   CVCL_C5U9
SY   LG2EBV; LG-2-EBV
DR   Wikidata; Q116049683
RX   PubMed=2967757;
RX   PubMed=8566071;
RX   PubMed=12747754;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5U8 ! LG2-MEL
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LG2-MEL
AC   CVCL_C5U8
SY   LG-2-MEL
DR   Wikidata; Q116049684
RX   PubMed=2209693;
RX   PubMed=2967757;
RX   PubMed=8566071;
RX   PubMed=12747754;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Heterozygous (PubMed=12747754).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5U9 ! LG2-EBV
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-205
AC   CVCL_C5UA
SY   LG-2-MEL-205
DR   Wikidata; Q116049685
RX   PubMed=2209693;
RX   PubMed=2967757;
RX   PubMed=12747754;
CC   Doubling time: 35 hours (PubMed=12747754).
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (PubMed=12747754).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U8 ! LG2-MEL
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-206
AC   CVCL_C5UB
SY   LG-2-MEL-206
DR   Wikidata; Q116049686
RX   PubMed=2967757;
RX   PubMed=12747754;
CC   Doubling time: 78 hours (PubMed=12747754).
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Heterozygous (PubMed=12747754).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U8 ! LG2-MEL
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-207
AC   CVCL_C5UC
SY   LG-2-MEL-207
DR   Wikidata; Q116049687
RX   PubMed=2967757;
RX   PubMed=12747754;
CC   Doubling time: 40 hours (PubMed=12747754).
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Heterozygous (PubMed=12747754).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U8 ! LG2-MEL
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-220
AC   CVCL_C5VA
SY   LG-2-MEL-220
DR   Wikidata; Q116049689
RX   PubMed=2967757;
RX   PubMed=12747754;
CC   Characteristics: Has lost the HLA-A*24, HLA-B*35 and HLA-C*4 alleles of the parent cell line (PubMed=12747754).
CC   Doubling time: 38 hours (PubMed=12747754).
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (PubMed=12747754).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U8 ! LG2-MEL
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-28
AC   CVCL_C5UV
DR   Wikidata; Q116049690
RX   PubMed=2209693;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U8 ! LG2-MEL
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-21
AC   CVCL_C5UK
SY   LG-2-MEL-5-21; MEL-5-21
DR   Wikidata; Q116049692
RX   PubMed=2967757;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-22
AC   CVCL_C5UL
SY   LG-2-MEL-5-22; MEL-5-22
DR   Wikidata; Q116049693
RX   PubMed=2209693;
RX   PubMed=2967757;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-23
AC   CVCL_C5UM
SY   LG-2-MEL-5-23; MEL-5-23
DR   Wikidata; Q116049694
RX   PubMed=2967757;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-30
AC   CVCL_C5UN
SY   LG-2-MEL-5-30; MEL-5-30
DR   Wikidata; Q116049695
RX   PubMed=2967757;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-31
AC   CVCL_C5UP
SY   LG-2-MEL-5-31; MEL-5-31
DR   Wikidata; Q116049696
RX   PubMed=2209693;
RX   PubMed=2967757;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-32
AC   CVCL_C5UQ
SY   LG-2-MEL-5-32; MEL-5-32
DR   Wikidata; Q116049697
RX   PubMed=2209693;
RX   PubMed=2967757;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-35
AC   CVCL_C5UR
SY   LG-2-MEL-5-35; MEL-5-35
DR   Wikidata; Q116049698
RX   PubMed=2209693;
RX   PubMed=2967757;
RX   PubMed=12747754;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-35isc3.1.1
AC   CVCL_C5UU
DR   Wikidata; Q116049699
RX   PubMed=12747754;
CC   Characteristics: Obtained by in vitro immunoselection of the parent cell line with the anti-LG2-B CTL clones (PubMed=12747754).
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UR ! LG2-MEL-5-35
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LG2-MEL-5-36
AC   CVCL_C5US
SY   LG-2-MEL-5-36; MEL-5-36
DR   Wikidata; Q116049700
RX   PubMed=2967757;
CC   Sequence variation: Mutation; HGNC; HGNC:16994; OS9; Simple; p.Pro446Leu (c.1337C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UA ! LG2-MEL-205
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LGK-1-R
AC   CVCL_RX42
DR   CCLV; CCLV-RIE 1224
DR   Wikidata; Q54902461
RX   PubMed=24457147;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=30538; ! Vicugna pacos (Alpaca)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   LGLL-CL1
AC   CVCL_A7QU
SY   Large Granular Lymphocyte Lymphocytosis cell line-1
DR   Wikidata; Q107115638
RX   PubMed=1835534;
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C39591; Chronic lymphoproliferative disorder of NK-cells
DI   ORDO; Orphanet_512017; Chronic lymphoproliferative disorder of natural killer cells
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LGLL-2
AC   CVCL_A7QV
SY   Large Granular Lymphocyte Lymphocytosis cell line-2
DR   Wikidata; Q107115641
RX   PubMed=1835534;
CC   Population: African; Ethiopian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C39591; Chronic lymphoproliferative disorder of NK-cells
DI   ORDO; Orphanet_512017; Chronic lymphoproliferative disorder of natural killer cells
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LGM-1
AC   CVCL_WX27
SY   LGM1
DR   Wikidata; Q95982082
RX   PubMed=7489718;
CC   Characteristics: IL3 or CSF2 dependent.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WX26 ! L-GM
AG   4W
CA   Factor-dependent cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   LGMD2Cl11
AC   CVCL_6B28
DR   Wikidata; Q54902462
RX   PubMed=22040608;
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.*107T>A; ClinVar=VCV000290170; Zygosity=Heterozygous; Note=3'UTR mutation (PubMed=22040608).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Ser483Ter (c.1448C>A) (p.Ser515Ter, c.1544C>A); ClinVar=VCV000554057; Zygosity=Heterozygous (PubMed=22040608).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   40Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   LGMN-1
AC   CVCL_XH96
DR   Wikidata; Q95982085
RX   Patent=CN108226508B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.12994.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99538; Human LGMN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   LGMN-2
AC   CVCL_XH97
DR   Wikidata; Q95982086
RX   Patent=CN108226508B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.12995.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99538; Human LGMN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   LGS90625
AC   CVCL_VI10
DR   Wikidata; Q54902463
RX   PubMed=10606667;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   LGS90635
AC   CVCL_VI11
DR   Wikidata; Q54902464
RX   PubMed=10606667;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   LGW01
AC   CVCL_W910
SY   LGWO1
DR   Cosmic; 1016882
DR   Wikidata; Q54902465
RX   PubMed=16885334;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   LGW01-G600
AC   CVCL_0C33
SY   LGWO1 G600; LGWO 1 G600; LGWO1G600
DR   cancercelllines; CVCL_0C33
DR   Cosmic; 2037950
DR   GEO; GSM1567854
DR   GEO; GSM1574572
DR   Wikidata; Q54902467
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=25997541).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W910 ! LGW01
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   LH6215
AC   CVCL_0B86
DR   Wikidata; Q54902468
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D2S1338: 20->17,20, FGA: 22,23->23, D18S51: 13->13,17 and D19S433: 13,14->14.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   LH86
AC   CVCL_8889
SY   LH-86
DR   BTO; BTO_0004142
DR   Wikidata; Q54902469
RX   Patent=US8017391;
RX   PubMed=17983809;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7435.
CC   Doubling time: ~42 hours (Patent=US8017391).
CC   HLA typing: A*24,25; B*07 (Patent=US8017391).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   LhAT1-D6
AC   CVCL_E7HM
RX   PubMed=8047068;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:336; AGTR1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   LHB-L2
AC   CVCL_A9HZ
SY   LHBL2
DR   CCRID; 5301MAM-KCB04052ZJ
DR   KCB; KCB 200452ZJ
DR   Wikidata; Q108820789
CC   Group: Bat cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=159858; ! Rhinolophus pusillus (Least horseshoe bat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LHB-M4
AC   CVCL_A9IA
SY   LHBM4
DR   CCRID; 5301MAM-KCB05058ZJ
DR   KCB; KCB 200558ZJ
DR   Wikidata; Q108820790
CC   Group: Bat cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=159858; ! Rhinolophus pusillus (Least horseshoe bat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LHB-S3
AC   CVCL_A9IB
SY   LHBS3
DR   CCRID; 5301MAM-KCB05012ZJ
DR   KCB; KCB 200512ZJ
DR   Wikidata; Q108820791
CC   Group: Bat cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=159858; ! Rhinolophus pusillus (Least horseshoe bat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LHCN-M2
AC   CVCL_8890
SY   LHCN-Myogenic clone no.2
DR   BTO; BTO_0005046
DR   EFO; EFO_0005714
DR   ABM; T0756
DR   ENCODE; ENCBS143YWW
DR   ENCODE; ENCBS167FNB
DR   ENCODE; ENCBS205JRH
DR   ENCODE; ENCBS231AAA
DR   ENCODE; ENCBS232AAA
DR   ENCODE; ENCBS233AAA
DR   ENCODE; ENCBS465BRM
DR   ENCODE; ENCBS538OZY
DR   ENCODE; ENCBS632MTU
DR   ENCODE; ENCBS810TWL
DR   ENCODE; ENCBS836YFM
DR   Evercyte; CkHT-040-231-2
DR   GEO; GSM7701474
DR   GEO; GSM7701475
DR   Wikidata; Q54902470
RX   PubMed=17559502;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/LHCNM2_Wold_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: ENCODE project common cell types; tier 2.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Doubling time: 35-40 hours (Evercyte=CkHT-040-231-2).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Muscle, pectoralis major; UBERON=UBERON_0002381.
CC   Cell type: Myoblast; CL=CL_0000056.
ST   Source(s): Evercyte=CkHT-040-231-2
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Telomerase immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 26
//
ID   LHK2
AC   CVCL_D228
SY   LHK-2
DR   Wikidata; Q54902471
RX   PubMed=12060610;
RX   PubMed=19818766;
CC   Population: Japanese.
CC   HLA typing: A*02:07,24:02; B*46:01,48:01; C*01:02 (PubMed=19818766).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LHN13
AC   CVCL_C5DP
SY   LHN 13
DR   Wikidata; Q116049701
RX   PubMed=279400;
RX   PubMed=3866637;
RX   PubMed=4583147;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LHN17
AC   CVCL_C5DQ
DR   Wikidata; Q116049702
RX   PubMed=4583147;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LHN6
AC   CVCL_C5DR
DR   Wikidata; Q116049703
RX   PubMed=4583147;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LHON1-hiPSC1
AC   CVCL_C880
SY   LHON.1.H.iPSC.1; LHON-hiPSC1
DR   RSCB; RSCB0127
DR   Wikidata; Q54902472
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:7462; MT-ND6; Simple; p.Met64Val (m.14484T>C); ClinVar=VCV000009688; Zygosity=Unspecified (PubMed=22145677).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C881 ! LHON1-hiPSC2
OI   CVCL_C882 ! LHON1-hiPSC4
OI   CVCL_C883 ! LHON1-hiPSC5
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   LHON1-hiPSC2
AC   CVCL_C881
SY   LHON.1.H.iPSC.2; LHON-hiPSC2
DR   RSCB; RSCB0128
DR   Wikidata; Q54902473
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:7462; MT-ND6; Simple; p.Met64Val (m.14484T>C); ClinVar=VCV000009688; Zygosity=Unspecified (PubMed=22145677).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C880 ! LHON1-hiPSC1
OI   CVCL_C882 ! LHON1-hiPSC4
OI   CVCL_C883 ! LHON1-hiPSC5
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   LHON1-hiPSC4
AC   CVCL_C882
SY   LHON.1.H.iPSC.4; LHON-hiPSC4
DR   RSCB; RSCB0129
DR   Wikidata; Q54902474
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:7462; MT-ND6; Simple; p.Met64Val (m.14484T>C); ClinVar=VCV000009688; Zygosity=Unspecified (PubMed=22145677).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C880 ! LHON1-hiPSC1
OI   CVCL_C881 ! LHON1-hiPSC2
OI   CVCL_C883 ! LHON1-hiPSC5
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   LHON1-hiPSC5
AC   CVCL_C883
SY   LHON.1.H.iPSC.5; LHON-hiPSC5; RIi014-A
DR   hPSCreg; RIi014-A
DR   RSCB; RSCB0130
DR   SKIP; SKIP002409
DR   SKIP; SKIP005847
DR   Wikidata; Q54902475
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:7462; MT-ND6; Simple; p.Met64Val (m.14484T>C); ClinVar=VCV000009688; Zygosity=Unspecified (PubMed=22145677).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C880 ! LHON1-hiPSC1
OI   CVCL_C881 ! LHON1-hiPSC2
OI   CVCL_C882 ! LHON1-hiPSC4
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   LHR-1055
AC   CVCL_G205
SY   LHR1055
DR   CLO; CLO_0007310
DR   ATCC; CRL-2687
DR   Wikidata; Q54902476
RX   PubMed=9041186;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22888; Human LHCGR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   LHR-29
AC   CVCL_G206
SY   LHR29
DR   CLO; CLO_0007311
DR   ATCC; CRL-2685
DR   Wikidata; Q54902477
RX   PubMed=9041186;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22888; Human LHCGR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   LHR-74
AC   CVCL_G207
DR   CLO; CLO_0007312
DR   ATCC; CRL-2686
DR   Wikidata; Q54902478
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22888; Human LHCGR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   LHY-821
AC   CVCL_D698
DR   Wikidata; Q54902479
RX   PubMed=22806968;
CC   Population: Chinese.
CC   Doubling time: 44.6-47.7 hours (PubMed=22806968).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LI
AC   CVCL_L881
DR   CLO; CLO_0007314
DR   CLDB; cl3206
DR   Wikidata; Q54902480
RX   PubMed=3225639;
CC   Doubling time: 24 hours (Note=At 34th passage), 27 hours (Note=At 86th passage) (PubMed=3225639).
CC   Anecdotal: Cell line name corresponds to the initials of the patient from which it was established.
CC   Derived from site: In situ; Brain, fronto-temporal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 9
//
ID   LI 27
AC   CVCL_J159
SY   L1-27; L127; L 127; M-1
DR   CLO; CLO_0007315
DR   Wikidata; Q54902481
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8437.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   LI 66
AC   CVCL_J160
SY   L166; L 166; M-12
DR   CLO; CLO_0007316
DR   Wikidata; Q54902482
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8442.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanoma cell surface antigen M-12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   Li mAb(7)
AC   CVCL_C5F1
SY   LimAb7
DR   Wikidata; Q116049704
RX   PubMed=14757202;
RX   PubMed=26970375;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0CE81; Loxosceles intermedia dermonecrotic toxin LiSicTox-alphaIA1bi.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LI-1
AC   CVCL_F1IL
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LI-10
AC   CVCL_F1IV
RX   PubMed=6165019;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Li-10
AC   CVCL_E898
SY   Liver-10; LI 10
DR   Wikidata; Q54902483
RX   PubMed=436973;
RX   PubMed=7067703;
CC   Misspelling: LI-IO; Note=Once in text of PubMed 20144999.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   LI-11
AC   CVCL_F1IW
RX   PubMed=6165019;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LI-12
AC   CVCL_F1IX
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LI-13
AC   CVCL_F1IY
RX   PubMed=6165019;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Li-136/SV40
AC   CVCL_V295
DR   Wikidata; Q54902484
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3192; Lipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   Li-14/SV40
AC   CVCL_V296
SY   Li-14-SV40
DR   Cosmic; 1430274
DR   Wikidata; Q54902485
RX   PubMed=1326410;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3192; Lipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   LI-2
AC   CVCL_F1IM
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Li-21
AC   CVCL_VN24
SY   Li21; C-Li21; C-Li-21
DR   Cosmic; 721063
DR   Cosmic; 1001663
DR   Wikidata; Q95982128
RX   PubMed=1721615;
RX   PubMed=2542205;
RX   PubMed=7832798;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   Li-22
AC   CVCL_VN25
SY   Li22; C-Li22; C-Li-22
DR   Cosmic; 721064
DR   Wikidata; Q95982130
RX   PubMed=2542205;
RX   PubMed=7832798;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   Li-23
AC   CVCL_VN26
SY   Li23; C-Li23; C-Li-23
DR   BTO; BTO_0006070
DR   Wikidata; Q95982131
RX   PubMed=7832798;
RX   PubMed=19720094;
CC   Population: Japanese.
CC   Characteristics: Supports HCV replication.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   Li-24
AC   CVCL_VN27
SY   Li24; C-Li24; C-Li-24
DR   Cosmic; 721065
DR   Wikidata; Q95982133
RX   PubMed=2542205;
RX   PubMed=7832798;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   LI-3
AC   CVCL_F1IN
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LI-3H2-G6
AC   CVCL_U036
SY   D-13
DR   ECACC; 08041714
DR   Wikidata; Q54902486
RX   PubMed=6373932;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   LI-4
AC   CVCL_F1IP
RX   PubMed=6165019;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LI-5
AC   CVCL_F1IQ
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Li-501/SV40
AC   CVCL_V297
SY   Li-501-SV40
DR   Cosmic; 1430275
DR   Wikidata; Q54902487
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3192; Lipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   Li-502/SV40
AC   CVCL_V298
DR   Wikidata; Q54902488
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3192; Lipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   Li-506/SV40
AC   CVCL_V299
DR   Wikidata; Q54902489
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3192; Lipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   Li-538/SV40
AC   CVCL_V300
SY   Li-538-SV40
DR   Cosmic; 1430276
DR   Wikidata; Q54902490
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3192; Lipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   LI-6
AC   CVCL_F1IR
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LI-7
AC   CVCL_F1IS
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Li-7
AC   CVCL_3840
SY   LI7; Li7; C-Li-7
DR   CLO; CLO_0050854
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 571
DR   BioSample; SAMN03470992
DR   BioSample; SAMN10987749
DR   cancercelllines; CVCL_3840
DR   CCRID; 1101HUM-PUMC000678
DR   CCRID; 3101HUMSCSP5062
DR   CCRID; 3101HUMTCHu183
DR   Cell_Model_Passport; SIDM01472
DR   CGH-DB; 9074-4
DR   CLS; 305102
DR   Cosmic; 721062
DR   Cosmic; 2023862
DR   Cosmic; 2162529
DR   Cosmic; 2771607
DR   DepMap; ACH-000471
DR   FANTOM5_SSTAR; 10484-107A7
DR   GEO; GSM565882
DR   GEO; GSM887266
DR   GEO; GSM888341
DR   GEO; GSM2551577
DR   IARC_TP53; 30113
DR   LiGeA; CCLE_219
DR   LIMORE; Li7
DR   PharmacoDB; Li7_835_2019
DR   PRIDE; PXD002486
DR   Progenetix; CVCL_3840
DR   RCB; RCB1941
DR   TKG; TKG 0368
DR   Wikidata; Q54902491
RX   PubMed=85491;
RX   PubMed=2542205;
RX   PubMed=12029633;
RX   PubMed=15767549;
RX   PubMed=22460905;
RX   PubMed=23887712;
RX   PubMed=25877200;
RX   PubMed=30784169;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=37610679;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/Li7
WW   Provider; BRICS; BRICS0080; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3894
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.93%; East Asian, North=80.68%; East Asian, South=17.95%; South Asian=0%; European, North=0.44%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID; PubMed=25877200; PubMed=31378681; RCB=RCB1941; TKG=TKG 0368
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 5
ST   TH01: 7
ST   TPOX: 8 (TKG=TKG 0368)
ST   TPOX: 8,11 (CCRID; PubMed=25877200; PubMed=31378681; RCB=RCB1941)
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   Li-7-Cas9-751
AC   CVCL_XE71
DR   CCRID; 1101HUM-PUMC000751
DR   Wikidata; Q95982142
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000751
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-752
AC   CVCL_XE72
DR   CCRID; 1101HUM-PUMC000752
DR   Wikidata; Q95982143
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000752
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-753
AC   CVCL_XE73
DR   CCRID; 1101HUM-PUMC000753
DR   Wikidata; Q95982145
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000753
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-754
AC   CVCL_XE74
DR   CCRID; 1101HUM-PUMC000754
DR   Wikidata; Q95982146
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000754
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-755
AC   CVCL_XE75
DR   CCRID; 1101HUM-PUMC000755
DR   Wikidata; Q95982148
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000755
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-756
AC   CVCL_XE76
DR   CCRID; 1101HUM-PUMC000756
DR   Wikidata; Q95982149
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000756
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-757
AC   CVCL_XE77
DR   CCRID; 1101HUM-PUMC000757
DR   Wikidata; Q95982150
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000757
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-758
AC   CVCL_XE78
DR   CCRID; 1101HUM-PUMC000758
DR   Wikidata; Q95982151
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000758
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-759
AC   CVCL_XE79
DR   CCRID; 1101HUM-PUMC000759
DR   Wikidata; Q95982154
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000759
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Cas9-760
AC   CVCL_XE80
DR   CCRID; 1101HUM-PUMC000760
DR   Wikidata; Q95982156
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000760
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5,19
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   Li-7-Luc2-tdT
AC   CVCL_XE70
DR   CCRID; 1101HUM-PUMC000803
DR   Wikidata; Q95982157
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000803
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 22,24
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D6S1043: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta E: 5
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3840 ! Li-7
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 15
//
ID   LI-8
AC   CVCL_F1IT
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LI-9
AC   CVCL_F1IU
RX   Patent=CH651476A5;
RX   PubMed=6165019;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Li106
AC   CVCL_C3QA
SY   Li 106
DR   Wikidata; Q116049705
RX   PubMed=420857;
RX   PubMed=7471105;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LI90
AC   CVCL_0390
SY   LI 90; LI-90
DR   BTO; BTO_0003519
DR   MCCL; MCC:0000285
DR   BioSample; SAMN03470815
DR   cancercelllines; CVCL_0390
DR   FANTOM5_SSTAR; 10778-110G4
DR   GEO; GSM827257
DR   JCRB; JCRB0160
DR   JCRB; NIHS0234
DR   Progenetix; CVCL_0390
DR   TKG; TKG 0507
DR   Wikidata; Q54902494
RX   PubMed=7540235;
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: ~3 days (Note=Lots 05222023 and 09212010), ~58 hours (Note=Lot 02282020), ~2 days (Note=Lots 06082012 and 03042011), ~3-4 days (Note=Lot 11072011), ~54 hours (Note=Lot 06172011), 61 hours (Note=Lot 11122009) (JCRB=JCRB0160).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0234; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
ST   Source(s): JCRB=JCRB0160; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D10S1248: 14
ST   D12S391: 20
ST   D13S317: 11,12 (JCRB=JCRB0160)
ST   D13S317: 12 (Technion Genomics Center)
ST   D16S539: 9,10
ST   D18S51: 13,21
ST   D19S433: 14,15
ST   D1S1656: 14,18.3
ST   D21S11: 30,31
ST   D22S1045: 11,15
ST   D2S1338: 17,19
ST   D2S441: 11,12
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3800; Epithelioid hemangioendothelioma
DI   ORDO; Orphanet_157791; Epithelioid hemangioendothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   LIB
AC   CVCL_H209
DR   Wikidata; Q54902495
RX   PubMed=15122589;
CC   From: Al Saati, Talal; Hopital de Purpan, Centre Hospitalier Universitaire de Toulouse; Toulouse; France.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   LIB-BFNB52
AC   CVCL_C8KU
DR   Wikidata; Q123032946
RX   PubMed=10794653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34611; Carbofuran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-BFNB62
AC   CVCL_C8KV
DR   Wikidata; Q123032948
RX   PubMed=10794653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34611; Carbofuran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-BFNB67
AC   CVCL_C8KW
DR   Wikidata; Q123032949
RX   PubMed=10794653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34611; Carbofuran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-BFNP21
AC   CVCL_C8KX
DR   Wikidata; Q123032950
RX   PubMed=10794653;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34611; Carbofuran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-CNA38
AC   CVCL_C8L5
DR   Wikidata; Q123032951
RX   DOI=10.1021/jf9506904;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_3390; Carbaryl (Sevin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-CNH32
AC   CVCL_C8L6
DR   Wikidata; Q123032952
RX   DOI=10.1021/jf9506904;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_3390; Carbaryl (Sevin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-CNH33
AC   CVCL_C8L7
DR   Wikidata; Q123032953
RX   DOI=10.1021/jf9506904;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_3390; Carbaryl (Sevin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-CNH36
AC   CVCL_C8KY
SY   LIB/CNH-3.6
DR   Wikidata; Q123032954
RX   DOI=10.1021/jf00044a047;
RX   DOI=10.1021/jf9506904;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_3390; Carbaryl (Sevin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-CNH37
AC   CVCL_C8L8
DR   Wikidata; Q123032955
RX   DOI=10.1021/jf9506904;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_3390; Carbaryl (Sevin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-CNH45
AC   CVCL_C8L9
DR   Wikidata; Q123032956
RX   DOI=10.1021/jf9506904;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_3390; Carbaryl (Sevin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-MXNB31
AC   CVCL_C8KZ
DR   Wikidata; Q123032957
RX   DOI=10.1021/jf980077v;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38508; Methiocarb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-MXNB33
AC   CVCL_C8L0
DR   Wikidata; Q123032959
RX   DOI=10.1021/jf980077v;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38508; Methiocarb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-MXNH14
AC   CVCL_C8L1
DR   Wikidata; Q123032960
RX   DOI=10.1021/jf980077v;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38508; Methiocarb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-MXNH15
AC   CVCL_C8L2
DR   Wikidata; Q123032961
RX   DOI=10.1021/jf980077v;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38508; Methiocarb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-MXNH22
AC   CVCL_C8L3
DR   Wikidata; Q123032962
RX   DOI=10.1021/jf980077v;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38508; Methiocarb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-MXNP22
AC   CVCL_C8L4
DR   Wikidata; Q123032963
RX   DOI=10.1021/jf980077v;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_38508; Methiocarb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-PRNB21
AC   CVCL_C8KI
DR   Wikidata; Q123032964
RX   PubMed=11170562;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34938; Propoxur (Baygon).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-PRNB33
AC   CVCL_C8KJ
DR   Wikidata; Q123032965
RX   PubMed=11170562;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34938; Propoxur (Baygon).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-PRNP15
AC   CVCL_C8KK
DR   Wikidata; Q123032966
RX   PubMed=11170562;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34938; Propoxur (Baygon).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIB-PRNP21
AC   CVCL_C8KL
DR   Wikidata; Q123032967
RX   PubMed=11170562;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_34938; Propoxur (Baygon).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LIBDi001-A
AC   CVCL_ZE38
SY   LIBD1c8
DR   hPSCreg; LIBDi001-A
DR   Wikidata; Q98126901
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LIBDi002-A
AC   CVCL_ZE39
SY   LIBD2c1; LIBD2C1
DR   hPSCreg; LIBDi002-A
DR   Wikidata; Q98126902
RX   PubMed=32446240;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   LIBDi003-A
AC   CVCL_ZE40
DR   hPSCreg; LIBDi003-A
DR   Wikidata; Q98126903
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LIBDi004-A
AC   CVCL_ZE41
DR   hPSCreg; LIBDi004-A
DR   Wikidata; Q98126905
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LIBDi005-A
AC   CVCL_ZE42
DR   hPSCreg; LIBDi005-A
DR   Wikidata; Q98126906
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LIBDi006-A
AC   CVCL_ZE43
SY   LIBD6c2
DR   hPSCreg; LIBDi006-A
DR   Wikidata; Q98126907
RX   PubMed=32446240;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   LIBDi007-A
AC   CVCL_ZE44
SY   LIBD7c6
DR   hPSCreg; LIBDi007-A
DR   Wikidata; Q98126908
RX   PubMed=32446240;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   LIBDi008-A
AC   CVCL_ZE45
DR   hPSCreg; LIBDi008-A
DR   Wikidata; Q98126909
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LIBDi009-A
AC   CVCL_ZE46
SY   LIBD9c1
DR   hPSCreg; LIBDi009-A
DR   Wikidata; Q98126910
RX   PubMed=32446240;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   LIBDi010-A
AC   CVCL_A4WW
SY   WT1021.01
DR   hPSCreg; LIBDi010-A
DR   Wikidata; Q107115644
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LIBDi011-A
AC   CVCL_A4WM
SY   PTHS1022.05
DR   hPSCreg; LIBDi011-A
DR   Wikidata; Q107115647
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg76Ter; Zygosity=Heterozygous (PubMed=32971458).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LIBDi012-A
AC   CVCL_A4WN
SY   PTHS1023.05
DR   hPSCreg; LIBDi012-A
DR   Wikidata; Q107115649
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg385Ter (c.1153C>T); ClinVar=VCV000007372; Zygosity=Heterozygous (PubMed=32971458).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LIBDi013-A
AC   CVCL_A4WP
SY   WT1024.01
DR   hPSCreg; LIBDi013-A
DR   Wikidata; Q107115651
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LIBDi014-A
AC   CVCL_A4WQ
SY   PTHS1025.05
DR   hPSCreg; LIBDi014-A
DR   Wikidata; Q107115653
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11634; TCF4; Zygosity=Heterozygous (PubMed=32971458).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LIBDi015-A
AC   CVCL_A4WR
SY   WT1026.01
DR   hPSCreg; LIBDi015-A
DR   Wikidata; Q107115656
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LIBDi016-A
AC   CVCL_A4WS
SY   PTHS3001.04
DR   hPSCreg; LIBDi016-A
DR   Wikidata; Q107115657
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; c.922+3G>T; ClinVar=VCV001204043; Zygosity=Heterozygous (PubMed=32971458).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   LIBDi017-A
AC   CVCL_A4WT
SY   WT3002.01
DR   hPSCreg; LIBDi017-A
DR   Wikidata; Q107115659
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LIBDi018-A
AC   CVCL_A4WU
SY   WT3003.06
DR   hPSCreg; LIBDi018-A
DR   Wikidata; Q107115662
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LIBDi019-A
AC   CVCL_A4WV
SY   PTHS3004.08
DR   hPSCreg; LIBDi019-A
DR   Wikidata; Q107115664
RX   PubMed=32971458;
CC   From: Lieber Institute for Brain Development; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11634; TCF4; Zygosity=Heterozygous (PubMed=32971458).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129872; Pitt-Hopkins syndrome
DI   ORDO; Orphanet_2896; Pitt-Hopkins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LIBUCi001-A
AC   CVCL_ZL56
SY   DCMAP1
DR   hPSCreg; LIBUCi001-A
DR   Wikidata; Q98126911
RX   PubMed=32521499;
CC   From: Libin Cardiovascular Institute of Alberta, University of Calgary; Calgary; Canada.
CC   Population: Caucasian; Canadian Dariusleut Hutterite.
CC   Sequence variation: Mutation; HGNC; HGNC:30528; DNAJC19; Simple; c.130-1G>C; ClinVar=VCV000001951; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=32521499).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173146; 3-methylglutaconic aciduria type 5
DI   ORDO; Orphanet_66634; Dilated cardiomyopathy with ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LIBUCi002-A
AC   CVCL_ZL57
SY   DCMAP2
DR   hPSCreg; LIBUCi002-A
DR   Wikidata; Q98126912
RX   PubMed=32521499;
CC   From: Libin Cardiovascular Institute of Alberta, University of Calgary; Calgary; Canada.
CC   Population: Caucasian; Canadian Dariusleut Hutterite.
CC   Sequence variation: Mutation; HGNC; HGNC:30528; DNAJC19; Simple; c.130-1G>C; ClinVar=VCV000001951; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=32521499).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173146; 3-methylglutaconic aciduria type 5
DI   ORDO; Orphanet_66634; Dilated cardiomyopathy with ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LICM 107
AC   CVCL_JZ84
SY   LICM107
DR   Wikidata; Q54902496
RX   PubMed=2457430;
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JZ79 ! LICM 95
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 124
AC   CVCL_JZ85
SY   LICM124
DR   Wikidata; Q54902497
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 154
AC   CVCL_JZ86
SY   LICM154
DR   Wikidata; Q54902498
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 158
AC   CVCL_JZ87
SY   LICM158
DR   Wikidata; Q54902499
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 196
AC   CVCL_JZ88
SY   LICM196
DR   Wikidata; Q54902500
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 204
AC   CVCL_JZ89
SY   LICM204
DR   Wikidata; Q54902501
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 209
AC   CVCL_JZ90
SY   LICM209
DR   Wikidata; Q54902502
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 222
AC   CVCL_JZ78
SY   GEM222
DR   Wikidata; Q54902503
RX   PubMed=2457430;
RX   PubMed=2839290;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 44
AC   CVCL_JZ82
SY   LICM44
DR   Wikidata; Q54902505
RX   PubMed=2457430;
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 56
AC   CVCL_JZ83
SY   LICM56
DR   Wikidata; Q54902506
RX   PubMed=2457430;
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LICM 95
AC   CVCL_JZ79
SY   LICM95; GEM95
DR   Wikidata; Q54902507
RX   PubMed=2839290;
RX   PubMed=3034409;
CC   Derived from site: Metastatic; Spinal cord; UBERON=UBERON_0002240.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JZ84 ! LICM 107
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   LiCo 16-86
AC   CVCL_0U49
SY   LICO 16-86
DR   ATCC; HB-8496
DR   Wikidata; Q54902508
RX   Patent=US4997762;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8496.
CC   Monoclonal antibody isotype: IgM.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=HB-8496
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U50 ! LiCo 16-88
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 8
//
ID   LiCo 16-88
AC   CVCL_0U50
SY   LICO 16-88
DR   ATCC; HB-8495
DR   BioSample; SAMN03471082
DR   Wikidata; Q54902509
RX   Patent=US4997762;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8495.
CC   Monoclonal antibody isotype: IgM.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=HB-8495
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0U49 ! LiCo 16-86
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 8
//
ID   LiCo 6a3-1
AC   CVCL_0U47
SY   LiCo6a3-1; LICO 6A3-1
DR   ATCC; HB-8493
DR   Wikidata; Q54902510
RX   Patent=US4997762;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8493.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   LiCo 7a4
AC   CVCL_0U48
SY   LICO 7A4
DR   ATCC; HB-8494
DR   Wikidata; Q54902511
RX   Patent=US4997762;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8494.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   Lico D-23
AC   CVCL_B6QS
SY   LICO D-23
DR   ATCC; HB-8492
DR   Wikidata; Q112929997
RX   Patent=US4997762;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8492.
CC   Characteristics: Mixture of 23 cell lines.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Mixed sex
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   LICR LON TR2CL
AC   CVCL_Y901
SY   TR2CL
DR   Wikidata; Q54902512
RX   PubMed=7073949;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   LICR-HN2 R10.3
AC   CVCL_LI54
DR   Wikidata; Q54902513
RX   PubMed=26269754;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8125 ! HN-2
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   LICR-HN5 R9.1
AC   CVCL_LI55
DR   Wikidata; Q54902514
RX   PubMed=26269754;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8128 ! HN-5
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   LICR-LON-Fib-75
AC   CVCL_XH45
SY   LICR-LON-Fib 75; LICR-LON-FIB75; LICR-LOND Fib 75; LICR-LOND-Fib 75; Fib-75-H; Fib-75; FIB 75
DR   Wikidata; Q95982181
RX   Patent=US5003046;
RX   PubMed=3894386;
RX   PubMed=7222219;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-211.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human 19 kDa cell surface glycoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   LICR-LON-Fib-86
AC   CVCL_XH75
SY   LICR LON/FIB 86; LICR-LON-FIB86; FIB 86
DR   Wikidata; Q95982182
RX   PubMed=3894386;
RX   PubMed=7222219;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on breast cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   LICR-LON-M18
AC   CVCL_XH46
DR   Wikidata; Q95982184
RX   PubMed=2443736;
RX   PubMed=3894386;
RX   PubMed=6371134;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Oligosaccharide with a Gal-beta-1,4-GlcNAc-beta1,6 sequence.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   LICR-LON-M24
AC   CVCL_XH47
SY   LICR LON M24
DR   Wikidata; Q95982185
RX   PubMed=3894386;
RX   PubMed=6371134;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   LICR-LON-M8
AC   CVCL_XH48
DR   Wikidata; Q95982187
RX   PubMed=3894386;
RX   PubMed=6371134;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   LiD1mAb16
AC   CVCL_C5FZ
DR   Wikidata; Q116049706
RX   PubMed=24565754;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0CE81; Loxosceles intermedia dermonecrotic toxin LiSicTox-alphaIA1bi (Note=Also reacts with other related toxins in both L.intermedia and other Loxosceles species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LIE
AC   CVCL_F729
DR   IPD-IMGT/HLA; 10987
DR   Wikidata; Q54902515
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02,11; B*27:06,51; C*03:04,14; DPB1*13:01,28:01 (IPD-IMGT/HLA=10987).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   LiF-EP
AC   CVCL_UZ58
DR   Wikidata; Q95982190
RX   PubMed=10648628;
RX   PubMed=10980596;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at ~35 PDL (PubMed=10648628).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1delG (IVS9+1delG); ClinVar=VCV000428898; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10980596).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   LiF-EP/TERT-1
AC   CVCL_UZ59
DR   Wikidata; Q95982192
RX   PubMed=10648628;
RX   PubMed=10980596;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=10648628).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1delG (IVS9+1delG); ClinVar=VCV000428898; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10980596).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ58 ! LiF-EP
SX   Female
AG   60Y
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   LIGHT-CHO
AC   CVCL_A9P5
DR   Wikidata; Q102114458
WW   Provider; BPS Bioscience; 79262; https://bpsbioscience.com/light-cho-cell-line-79262
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11930; TNFSF14.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   LiLa-1
AC   CVCL_7987
SY   LILA-1
DR   Cosmic; 1130239
DR   Cosmic; 2491069
DR   Wikidata; Q54902516
RX   PubMed=1378917;
RX   PubMed=9067587;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   LIM1215
AC   CVCL_2574
SY   Lim1215; LIM 1215; LIM-1215
DR   BTO; BTO_0001916
DR   EFO; EFO_0022437
DR   BioSample; SAMN07624413
DR   cancercelllines; CVCL_2574
DR   CBA; CBA-0161
DR   Cell_Model_Passport; SIDM00014
DR   ColonAtlas; LIM1215
DR   Cosmic; 869795
DR   Cosmic; 1184335
DR   Cosmic; 1238050
DR   Cosmic; 1479632
DR   Cosmic; 1482515
DR   Cosmic; 1486135
DR   Cosmic; 1524335
DR   Cosmic; 1676746
DR   Cosmic; 1805257
DR   Cosmic; 2301991
DR   Cosmic; 2667967
DR   Cosmic; 2787550
DR   Cosmic; 2841366
DR   Cosmic-CLP; 2162949
DR   DepMap; ACH-001546
DR   ECACC; 10092301
DR   GDSC; 869795
DR   GDSC; 2162949
DR   GEO; GSM741246
DR   GEO; GSM1346878
DR   GEO; GSM1448118
DR   IARC_TP53; 22464
DR   PharmacoDB; LIM1215_836_2019
DR   PRIDE; PXD000120
DR   PRIDE; PXD005235
DR   Wikidata; Q54902517
RX   PubMed=1427983;
RX   PubMed=3857372;
RX   PubMed=9328464;
RX   PubMed=9515795;
RX   PubMed=11416159;
RX   PubMed=12615714;
RX   PubMed=19378335;
RX   PubMed=20570890;
RX   PubMed=22722830;
RX   PubMed=23458625;
RX   PubMed=24295106;
RX   PubMed=24755471;
RX   PubMed=25623215;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=28854368;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Population: Caucasian.
CC   Doubling time: 32 hours (Note=At 8th passage) (PubMed=3857372); 28 hours (PubMed=1427983); 29.52 hours (PubMed=25944804).
CC   Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (PubMed=24755471; Cosmic-CLP=2162949; DepMap=ACH-001546).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=5.72%; Native American=0%; East Asian, North=3.18%; East Asian, South=0%; South Asian=6.91%; European, North=26.95%; European, South=57.24% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-001546; true.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): CBA=CBA-0161; PubMed=11416159; PubMed=25926053
ST   Amelogenin: X (PubMed=11416159)
ST   Amelogenin: X,Y (CBA=CBA-0161; PubMed=25926053)
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 8,9,11,12 (PubMed=25926053)
ST   D16S539: 8,12 (CBA=CBA-0161)
ST   D18S51: 12,18
ST   D19S433: 10,15.2
ST   D21S11: 29,31
ST   D2S1338: 16,21
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 9,10.3
ST   D8S1179: 11,13 (PubMed=11416159)
ST   D8S1179: 13 (CBA=CBA-0161)
ST   FGA: 21,23,24
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 15,16 (PubMed=25926053)
ST   vWA: 16 (CBA=CBA-0161; PubMed=11416159)
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   LIM1215 IR
AC   CVCL_E7AP
SY   LIM 1215 IR
RX   CelloPub=CLPUB00787;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LIM1215 KRAS (G12A/+)
AC   CVCL_LC77
SY   KRAS (G12A/+) LIM1215
DR   cancercelllines; CVCL_LC77
DR   Horizon_Discovery; HD+116-003
DR   Wikidata; Q54902518
RX   PubMed=22722830;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-003).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   LIM1215 KRAS (G12C/+)
AC   CVCL_LC81
SY   KRAS (G12C/+) LIM1215
DR   cancercelllines; CVCL_LC81
DR   Horizon_Discovery; HD+116-007
DR   Wikidata; Q54902519
RX   PubMed=22722830;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-007).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   LIM1215 KRAS (G12D/+)
AC   CVCL_LC80
SY   KRAS (G12D/+) LIM1215
DR   cancercelllines; CVCL_LC80
DR   Horizon_Discovery; HD+116-005
DR   Wikidata; Q54902520
RX   PubMed=22722830;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-005).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   LIM1215 KRAS (G12R/+)
AC   CVCL_LC76
SY   KRAS (G12R/+) LIM1215
DR   cancercelllines; CVCL_LC76
DR   Horizon_Discovery; HD+116-002
DR   Wikidata; Q54902522
RX   PubMed=22722830;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-002).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   LIM1215 KRAS (G12S/+)
AC   CVCL_LC78
SY   KRAS (G12S/+) LIM1215
DR   cancercelllines; CVCL_LC78
DR   Horizon_Discovery; HD+116-001
DR   Wikidata; Q54902523
RX   PubMed=22722830;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   LIM1215 KRAS (G12V/+)
AC   CVCL_LC79
SY   KRAS (G12V/+) LIM1215
DR   cancercelllines; CVCL_LC79
DR   Horizon_Discovery; HD+116-006
DR   Wikidata; Q54902524
RX   PubMed=22722830;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-006).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   LIM1215 KRAS (G13D/+)
AC   CVCL_LC82
SY   KRAS (G13D/+) LIM1215
DR   cancercelllines; CVCL_LC82
DR   Horizon_Discovery; HD+116-009
DR   Wikidata; Q54902525
RX   PubMed=22722830;
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-009).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   LIM1215 PIK3CA (H1047R/+)
AC   CVCL_A4IG
SY   PIK3CA (H1047R/+) LIM1215
DR   cancercelllines; CVCL_A4IG
DR   Horizon_Discovery; HD+116-012
DR   Wikidata; Q105509886
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-012).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LIM1215 PIK3CA (E545K/+)
AC   CVCL_A4IH
SY   PIK3CA (E545K/+) LIM1215
DR   cancercelllines; CVCL_A4IH
DR   Horizon_Discovery; HD+116-013
DR   Wikidata; Q105509891
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+116-013).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LIM1215 R1 Cetux
AC   CVCL_A2CA
DR   cancercelllines; CVCL_A2CA
DR   Cosmic; 2841367
DR   Wikidata; Q105509894
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ile491Met (c.1473A>G); ClinVar=VCV001404733; Zygosity=Heterozygous; Note=Acquired during resistance selection process (PubMed=25623215).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   LIM1215 R2 Cetux
AC   CVCL_A2CB
DR   cancercelllines; CVCL_A2CB
DR   Cosmic; 2841368
DR   Wikidata; Q105509897
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LIM1215 R3 Cetux
AC   CVCL_A2CC
DR   cancercelllines; CVCL_A2CC
DR   Cosmic; 2841369
DR   Wikidata; Q105509901
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LIM1215 R4 Cetux
AC   CVCL_A2CD
DR   cancercelllines; CVCL_A2CD
DR   Cosmic; 2841370
DR   Wikidata; Q105509908
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LIM1215 R5 Cetux
AC   CVCL_A2CE
DR   cancercelllines; CVCL_A2CE
DR   Cosmic; 2841371
DR   Wikidata; Q105509910
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Pro423Gln (c.1268C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gly465Arg (c.1393G>A); ClinVar=VCV002011745; Zygosity=Heterozygous; Note=Acquired during resistance selection process (PubMed=25623215).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2574 ! LIM1215
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   LIM1839
AC   CVCL_4433
SY   LIM 1839; LIM-1839
DR   Cosmic; 1482527
DR   Cosmic; 1524336
DR   Wikidata; Q54902526
RX   PubMed=1693565;
RX   PubMed=2606577;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=2606577).
CC   Derived from site: In situ; Stomach, cardia; UBERON=UBERON_0001162.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   LIM1863
AC   CVCL_4434
SY   Lim1863; LIM 1863; LIM-1863
DR   BTO; BTO_0001918
DR   BioSample; SAMN07624437
DR   cancercelllines; CVCL_4434
DR   CBA; CBA-0162
DR   ColonAtlas; LIM1863
DR   Cosmic; 948846
DR   Cosmic; 1043818
DR   Cosmic; 1184327
DR   Cosmic; 1238051
DR   Cosmic; 1482516
DR   Cosmic; 1524337
DR   Cosmic; 1805258
DR   Cosmic; 2760090
DR   IARC_TP53; 21740
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54902527
RX   PubMed=1427983;
RX   PubMed=3567898;
RX   PubMed=8464898;
RX   PubMed=11226274;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=19378335;
RX   PubMed=20606684;
RX   PubMed=29101300;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/LIM1863.html
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: 53 hours (PubMed=1427983); 2-3 days (CBA=CBA-0162).
CC   HLA typing: A*03,11 (PubMed=8464898).
CC   Microsatellite instability: Stable (MSS) (PubMed=19378335).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Unspecified (PubMed=16418264; PubMed=19378335).
CC   Omics: Proteomics.
CC   Misspelling: LIM21-1863; Cosmic=948846.
CC   Misspelling: LM1863; Cosmic=1043818.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CBA=CBA-0162
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 14,16
ST   D21S11: 32
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 10,14,15
ST   FGA: 19,21
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   LIM1899
AC   CVCL_4435
SY   Lim1899; LIM 1899; LIM-1899
DR   BioSample; SAMN07624414
DR   cancercelllines; CVCL_4435
DR   CBA; CBA-0163
DR   ColonAtlas; LIM1899
DR   Cosmic; 1238052
DR   Cosmic; 1482517
DR   Cosmic; 1486136
DR   Cosmic; 1805259
DR   Cosmic; 2301992
DR   ECACC; 12062001
DR   GEO; GSM1346879
DR   GEO; GSM1448136
DR   GEO; GSM3145610
DR   GEO; GSM3145716
DR   PRIDE; PXD000120
DR   Wikidata; Q54902528
RX   PubMed=1427983;
RX   PubMed=2386931;
RX   PubMed=12068308;
RX   PubMed=19378335;
RX   PubMed=23458625;
RX   PubMed=24295106;
RX   PubMed=24755471;
RX   PubMed=25926053;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: 48 hours (PubMed=1427983).
CC   Microsatellite instability: Stable (MSS) (PubMed=19378335).
CC   Microsatellite instability: Instable (MSI) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=12068308; PubMed=19378335; PubMed=24755471).
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CBA=CBA-0163; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (PubMed=25926053)
ST   CSF1PO: 10,11 (CBA=CBA-0163)
ST   D13S317: 9,12
ST   D16S539: 11 (PubMed=25926053)
ST   D16S539: 11,12 (CBA=CBA-0163)
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 29 (PubMed=25926053)
ST   D21S11: 29,30 (CBA=CBA-0163)
ST   D2S1338: 20,24
ST   D3S1358: 13,15,16
ST   D5S818: 11,12,14 (CBA=CBA-0163)
ST   D5S818: 11,14 (PubMed=25926053)
ST   D7S820: 8,9
ST   D8S1179: 10,11
ST   FGA: 19,20,22
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 17,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   LIM2045
AC   CVCL_DG01
SY   Lim2045
DR   cancercelllines; CVCL_DG01
DR   GEO; GSM784015
DR   Progenetix; CVCL_DG01
DR   Wikidata; Q54902529
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 6
//
ID   LIM2099
AC   CVCL_4436
SY   LIM 2099; LIM-2099
DR   BioSample; SAMN07624415
DR   cancercelllines; CVCL_4436
DR   CBA; CBA-0164
DR   ColonAtlas; LIM2099
DR   Cosmic; 1238053
DR   Cosmic; 1524326
DR   Cosmic; 1805260
DR   Cosmic; 2301993
DR   ECACC; 12062002
DR   GEO; GSM1346846
DR   GEO; GSM1448137
DR   Wikidata; Q54902530
RX   PubMed=1427983;
RX   PubMed=19378335;
RX   PubMed=24755471;
RX   PubMed=25926053;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: 36 hours (PubMed=1427983).
CC   Microsatellite instability: Stable (MSS) (PubMed=19378335; PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=19378335; PubMed=24755471).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): CBA=CBA-0164; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 13.2,14
ST   D21S11: 29,30
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 13
ST   D8S1179: 10,13
ST   FGA: 19,25
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   LIM2358
AC   CVCL_G358
SY   LIM 2358; LIM-2358
DR   Wikidata; Q54902531
RX   PubMed=1427983;
CC   Doubling time: >4 days (PubMed=1427983).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   LIM2405
AC   CVCL_4437
SY   LIM 2405; LIM-2405
DR   BioSample; SAMN07624416
DR   cancercelllines; CVCL_4437
DR   CBA; CBA-0165
DR   ColonAtlas; LIM2405
DR   Cosmic; 1238054
DR   Cosmic; 1482518
DR   Cosmic; 1486137
DR   Cosmic; 1524339
DR   Cosmic; 1676726
DR   Cosmic; 1805261
DR   Cosmic; 2301994
DR   ECACC; 12062003
DR   GEO; GSM1346880
DR   GEO; GSM1448126
DR   GEO; GSM3145611
DR   GEO; GSM3145717
DR   PRIDE; PXD000120
DR   Wikidata; Q54902532
RX   PubMed=1427983;
RX   PubMed=19378335;
RX   PubMed=23458625;
RX   PubMed=24295106;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=25944804;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: 24 hours (PubMed=1427983); 30.72 hours (PubMed=25944804).
CC   Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala697Val (c.2090C>T); ClinVar=VCV000216153; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Val2194Phefs*5 (c.6579delA); ClinVar=VCV001446272; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=19378335; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val290fs*8 (c.867_868insA); Zygosity=Unspecified (PubMed=24755471).
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CBA=CBA-0165; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 14,15
ST   D13S317: 8,11
ST   D16S539: 14,15
ST   D18S51: 12,18
ST   D19S433: 13,14.2,15.2
ST   D21S11: 29,30 (PubMed=25926053)
ST   D21S11: 29,31 (CBA=CBA-0165)
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 7,8
ST   D8S1179: 10,12
ST   FGA: 19,21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18 (PubMed=25926053)
ST   vWA: 14,18,19 (CBA=CBA-0165)
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   LIM2408
AC   CVCL_4438
SY   LIM 2408; LIM-2408
DR   cancercelllines; CVCL_4438
DR   ColonAtlas; LIM2408
DR   Cosmic; 1238055
DR   Cosmic; 1486138
DR   Wikidata; Q54902533
RX   PubMed=1427983;
RX   PubMed=19378335;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: >4 days (PubMed=1427983).
CC   Microsatellite instability: Instable (MSI) (PubMed=19378335).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=19378335).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0166 but was never distributed.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   LIM2412
AC   CVCL_4439
SY   Lim2412; LIM 2412; LIM-2412
DR   BTO; BTO_0001917
DR   cancercelllines; CVCL_4439
DR   ColonAtlas; LIM2412
DR   Cosmic; 1482519
DR   Cosmic; 1524340
DR   Cosmic; 2667974
DR   GEO; GSM741245
DR   GEO; GSM1448075
DR   Wikidata; Q54902534
RX   PubMed=1427983;
RX   PubMed=12615714;
RX   PubMed=25926053;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: 30 hours (PubMed=1427983).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D21S11: 28,29,30
ST   D5S818: 10
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 7,8,9
ST   vWA: 14,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   LIM2463
AC   CVCL_4440
SY   LIM 2463; LIM-2463
DR   cancercelllines; CVCL_4440
DR   ColonAtlas; LIM2463
DR   Wikidata; Q54902535
RX   PubMed=1676989;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from child cell line LIM2463B).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (from child cell line LIM2463B).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0167 but was never distributed.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   LIM2463B
AC   CVCL_A456
SY   LIM-2463B; LIM 2463B
DR   cancercelllines; CVCL_A456
DR   ColonAtlas; LIM2463B
DR   Cosmic; 1238056
DR   Wikidata; Q54902537
RX   PubMed=19378335;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Microsatellite instability: Stable (MSS) (PubMed=19378335).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=19378335).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous (PubMed=19378335).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4440 ! LIM2463
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   LIM2537
AC   CVCL_4441
SY   LIM 2537; LIM-2537
DR   BioSample; SAMN07624438
DR   cancercelllines; CVCL_4441
DR   CBA; CBA-0168
DR   ColonAtlas; LIM2537
DR   Cosmic; 1238057
DR   Cosmic; 1482514
DR   Cosmic; 1486139
DR   Cosmic; 1524338
DR   ECACC; 21102106
DR   GEO; GSM1448135
DR   Wikidata; Q54902538
RX   PubMed=11606375;
RX   PubMed=19378335;
RX   PubMed=25926053;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: 30 hours (CBA=CBA-0168).
CC   Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=19378335).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=19378335).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CBA=CBA-0168; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8,13,14 (CBA=CBA-0168)
ST   D13S317: 8,14 (PubMed=25926053)
ST   D16S539: 12
ST   D18S51: 16,17,18,19
ST   D19S433: 12,14
ST   D21S11: 28,29,30
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 12,13,14
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   LIM2550
AC   CVCL_4442
SY   LIM 2550; LIM-2550
DR   BioSample; SAMN07624417
DR   cancercelllines; CVCL_4442
DR   CBA; CBA-0169
DR   ColonAtlas; LIM2550
DR   Cosmic; 1238058
DR   Cosmic; 1486140
DR   Cosmic; 1805262
DR   ECACC; 12070504
DR   GEO; GSM1448168
DR   Wikidata; Q54902540
RX   PubMed=19378335;
RX   PubMed=25926053;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous (PubMed=19378335).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=19378335).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=19378335).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CBA=CBA-0169; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,15
ST   D16S539: 9,14
ST   D18S51: 13,14
ST   D19S433: 11,14
ST   D21S11: 29,31.2
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   LIM2551
AC   CVCL_4443
SY   LIM 2551; LIM-2551
DR   BioSample; SAMN07624418
DR   cancercelllines; CVCL_4443
DR   CBA; CBA-0170
DR   ColonAtlas; LIM2551
DR   Cosmic; 1238059
DR   Cosmic; 1486141
DR   Cosmic; 1803947
DR   Cosmic; 2301995
DR   ECACC; 12070505
DR   GEO; GSM1346881
DR   GEO; GSM1448076
DR   GEO; GSM3145612
DR   GEO; GSM3145718
DR   Wikidata; Q54902541
RX   PubMed=19378335;
RX   PubMed=24755471;
RX   PubMed=25926053;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=19378335; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Thr578Pro (c.1732A>C); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6769; SMAD3; Simple; p.Ala202Thr (c.604G>A); ClinVar=VCV001171415; Zygosity=Unspecified (PubMed=24755471).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sex of donor from original lab book of Whitehead, Robert H. and from patient surgeon through a personal communication of Capes-Davis, Amanda.
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
ST   Source(s): CBA=CBA-0170; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 12
ST   D21S11: 28,33.2
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 12,16
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,23,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   LiM6
AC   CVCL_D240
SY   LIM6; LiM-6; LS-LiM6; Ls-LiM6; LS LiM 6; LS LiM6; LSLiM6
DR   BTO; BTO_0004866
DR   cancercelllines; CVCL_D240
DR   Cosmic; 1132697
DR   Wikidata; Q54902542
RX   PubMed=1999484;
RX   PubMed=3032811;
RX   PubMed=21941373;
CC   Population: Caucasian.
CC   Characteristics: Has high liver-metastasizing ability during cecal growth, was established from parent cell line by serially selecting cells which metastasized from cecum to liver (PubMed=1999484).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   LIM6-TR
AC   CVCL_B6NT
SY   LIM6-TRAIL Resistant
DR   cancercelllines; CVCL_B6NT
DR   Wikidata; Q112929998
RX   PubMed=21941373;
CC   Population: Caucasian.
CC   Characteristics: Has high liver-metastasizing ability during cecal growth (from parent cell line).
CC   Selected for resistance to: UniProtKB; P50591; Human TNFSF10/CD253.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D240 ! LiM6
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   LIMA 97
AC   CVCL_VQ01
SY   LIMA97; LIMA
DR   Wikidata; Q95982210
RX   PubMed=10837406;
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   LIMFRi001-A
AC   CVCL_D0HM
SY   LIMFR-A
DR   BioSamples; SAMEA113583540
DR   hPSCreg; LIMFRi001-A
DR   Wikidata; Q123032968
CC   From: University of Limoges; Limoges; France.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   LIMM-NBE1
AC   CVCL_9Y83
SY   NBE1; Leeds Institute of Molecular Medicine-Normal Bronchial Epithelium 1
DR   Wikidata; Q54902543
RX   PubMed=23226101;
RX   PubMed=24244370;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   Line 1
AC   CVCL_5V03
DR   Wikidata; Q54902544
RX   PubMed=1691690;
RX   PubMed=4366938;
RX   PubMed=9347924;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   Line 12
AC   CVCL_WG95
DR   Wikidata; Q95982214
RX   PubMed=6451031;
CC   Doubling time: 24-36 hours (PubMed=6451031).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   Line 14
AC   CVCL_V123
DR   CLO; CLO_0007317
DR   CLDB; cl3207
DR   IHW; 11w 81O4
DR   Wikidata; Q54902545
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Line C
AC   CVCL_Z861
SY   Line-C; C
DR   FlyBase_Cell_line; FBtc9000064
DR   Wikidata; Q54902546
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=5002052;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   Line K
AC   CVCL_Z832
SY   K
DR   Wikidata; Q54902547
RX   PubMed=4976834;
RX   PubMed=5002052;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   LINTERNA 3T3
AC   CVCL_YJ88
SY   LINTERNA-3T3
DR   Innoprot; P20105
DR   Wikidata; Q95982215
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 7
//
ID   LINTERNA A375
AC   CVCL_YJ74
SY   LINTERNA-A375
DR   cancercelllines; CVCL_YJ74
DR   Innoprot; P20122
DR   Wikidata; Q95982216
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   LINTERNA A549
AC   CVCL_YJ75
SY   LINTERNA-A549; TurboGFP A549
DR   cancercelllines; CVCL_YJ75
DR   Innoprot; P20118
DR   Wikidata; Q95982217
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   LINTERNA B16-F10
AC   CVCL_YJ76
SY   LINTERNA-B16-F10; LINTERNA B16; TurboGFP-B16-F10
DR   Innoprot; P20121
DR   Wikidata; Q95982218
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   LINTERNA CHO-K1
AC   CVCL_YJ77
SY   LINTERNA-CHO-K1; tGFP-CHO K1
DR   Innoprot; P20102
DR   Wikidata; Q95982219
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   LINTERNA COS-7
AC   CVCL_YJ78
SY   LINTERNA-COS-7; tGFP-COS 7
DR   Innoprot; P20110
DR   Wikidata; Q95982221
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   LINTERNA CT-26
AC   CVCL_YJ79
SY   LINTERNA-CT-26; tGFP-CT26
DR   Innoprot; P20114
DR   Wikidata; Q95982222
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7254 ! CT26
SX   Female
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   LINTERNA HEK293
AC   CVCL_YJ80
SY   LINTERNA-HEK293; tGFP-HEK293; tGFP-HEK/293
DR   Innoprot; P20108
DR   Wikidata; Q95982223
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   LINTERNA HeLa
AC   CVCL_YJ81
SY   LINTERNA-HELA; tGFP-HELA
DR   Innoprot; P20107
DR   Wikidata; Q95982224
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   LINTERNA HEP-G2
AC   CVCL_YJ82
SY   LINTERNA-HEP-G2; tGFP-HEP-G2
DR   cancercelllines; CVCL_YJ82
DR   Innoprot; P20111
DR   Wikidata; Q95982225
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   LINTERNA HT-29
AC   CVCL_YJ83
SY   LINTERNA-HT29
DR   cancercelllines; CVCL_YJ83
DR   Innoprot; P20123
DR   Wikidata; Q95982227
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   LINTERNA Jurkat
AC   CVCL_YJ84
SY   LINTERNA JURKAT; LINTERNA-Jurkat; TurboGFP Jurkat
DR   cancercelllines; CVCL_YJ84
DR   Innoprot; P20128
DR   Wikidata; Q95982228
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   LINTERNA LS 174
AC   CVCL_YJ85
SY   LINTERNA-LS174
DR   cancercelllines; CVCL_YJ85
DR   Innoprot; P20124
DR   Wikidata; Q95982229
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   LINTERNA MDA-MB-231
AC   CVCL_YJ86
SY   LINTERNA-MDA-MB-231; TurboGFP MDA-MB-231
DR   cancercelllines; CVCL_YJ86
DR   Innoprot; P20117
DR   Wikidata; Q95982231
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   LINTERNA MDCK
AC   CVCL_YJ87
SY   LINTERNA-MDCK; tGFP-MDCK
DR   Innoprot; P20106
DR   Wikidata; Q95982232
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   LINTERNA PC-12
AC   CVCL_YJ89
SY   tGFP-PC-12
DR   Innoprot; P20109
DR   Wikidata; Q95982233
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   LINTERNA PC-3
AC   CVCL_YJ90
SY   LINTERNA-PC-3; TurboGFP-PC-3
DR   cancercelllines; CVCL_YJ90
DR   Innoprot; P20115
DR   Wikidata; Q95982235
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   LINTERNA SH-SY5Y
AC   CVCL_YJ91
SY   LINTERNA-SH-SY5Y; tGFP-SH-SY5Y
DR   cancercelllines; CVCL_YJ91
DR   Innoprot; P20103
DR   Wikidata; Q95982236
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 11
//
ID   LINTERNA SK-BR-3
AC   CVCL_YJ92
SY   LINTERNA-SK-BR-3; TurboGFP SK-BR-3
DR   cancercelllines; CVCL_YJ92
DR   Innoprot; P20129
DR   Wikidata; Q95982237
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   LINTERNA SK-LU-1
AC   CVCL_YJ93
SY   LINTERNA-SK-LU-1
DR   cancercelllines; CVCL_YJ93
DR   Innoprot; P20127
DR   Wikidata; Q95982238
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asn1253fs*16 (c.3753delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0629 ! SK-LU-1
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   LINTERNA SK-OV-3
AC   CVCL_YJ94
SY   LINTERNA-SKOV3; TurboGFP SK-OV-3
DR   cancercelllines; CVCL_YJ94
DR   Innoprot; P20119
DR   Wikidata; Q95982239
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   LINTERNA U2OS
AC   CVCL_YJ95
SY   LINTERNA-U2OS; TurboGFP U-2 OS
DR   Innoprot; P20116
DR   Wikidata; Q95982240
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   Lipo-DUE1
AC   CVCL_4U68
DR   Wikidata; Q54902549
RX   PubMed=26373732;
CC   Doubling time: ~2.8 days (PubMed=26373732).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26373732
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 20,22
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 12,18
ST   D19S433: 15
ST   D1S1656: 17.3,18.3
ST   D21S11: 29,34.2
ST   D22S1045: 15
ST   D2S1338: 20,24
ST   D2S441: 10,11
ST   D3S1358: 14,16
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 22
ST   SE33: 26.2,28.2
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   Lipo191
AC   CVCL_4U70
DR   Wikidata; Q54902550
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo203
AC   CVCL_4U71
DR   Wikidata; Q54902551
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Lipo224
AC   CVCL_4U72
SY   lipo224
DR   Wikidata; Q54902552
RX   PubMed=21060307;
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Lipo246
AC   CVCL_4U73
SY   lipo246
DR   Wikidata; Q54902553
RX   PubMed=21060307;
RX   PubMed=26373732;
CC   Doubling time: ~1.7 days (PubMed=26373732).
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo256
AC   CVCL_4U74
DR   Wikidata; Q54902554
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Lipo276
AC   CVCL_4U75
DR   Wikidata; Q54902555
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo314
AC   CVCL_4U76
DR   Wikidata; Q54902557
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo355
AC   CVCL_4U77
DR   Wikidata; Q54902558
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo502
AC   CVCL_4U78
DR   Wikidata; Q54902559
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo514
AC   CVCL_4U79
DR   Wikidata; Q54902560
RX   PubMed=21060307;
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Lipo573
AC   CVCL_4U80
DR   Wikidata; Q54902562
RX   PubMed=21060307;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   Lipo585
AC   CVCL_4U81
DR   Wikidata; Q54902563
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo601
AC   CVCL_4U82
DR   Wikidata; Q54902564
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo624
AC   CVCL_4U83
DR   Wikidata; Q54902565
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo651
AC   CVCL_4U84
DR   Wikidata; Q54902566
RX   PubMed=21060307;
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo675
AC   CVCL_4U85
DR   Wikidata; Q54902567
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo723
AC   CVCL_4U86
DR   Wikidata; Q54902568
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   Lipo815
AC   CVCL_4U87
DR   Wikidata; Q54902569
RX   PubMed=21060307;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   Lipo863
AC   CVCL_4U88
DR   Wikidata; Q54902570
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Lipo956
AC   CVCL_4U89
DR   Wikidata; Q54902571
RX   PubMed=21060307;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   LiPSC-ER2.1
AC   CVCL_RL62
DR   Wikidata; Q54902572
RX   PubMed=26411904;
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Caucasian.
CC   HLA typing: A*03,24; B*27,27; C*01,05; DQB1*03,05; DRB1*01,11 (PubMed=27283945).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=27283945
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 24.2,30.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL63 ! LiPSC-ER2.2
OI   CVCL_RL64 ! LiPSC-ER2.3
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   LiPSC-ER2.2
AC   CVCL_RL63
DR   Wikidata; Q54902573
RX   PubMed=26411904;
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Caucasian.
CC   HLA typing: A*03,24; B*27,27; C*01,05; DQB1*03,05; DRB1*01,11 (PubMed=27283945).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=27283945
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 24.2,30.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL62 ! LiPSC-ER2.1
OI   CVCL_RL64 ! LiPSC-ER2.3
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   LiPSC-ER2.3
AC   CVCL_RL64
DR   Wikidata; Q54902574
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Caucasian.
CC   HLA typing: A*03,24; B*27,27; C*01,05; DQB1*03,05; DRB1*01,11 (PubMed=27283945).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=27283945
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 24.2,30.2
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL62 ! LiPSC-ER2.1
OI   CVCL_RL63 ! LiPSC-ER2.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   LiPSC-GR1.1
AC   CVCL_RL65
SY   50-001-02A
DR   GEO; GSM1854269
DR   Wikidata; Q54902575
RX   PubMed=26411904;
RX   PubMed=27283945;
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Hispanic.
CC   HLA typing: A*02,03; B*07,39; C*07,15; DQB1*03,04; DRB1*04,08 (PubMed=27283945).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=27283945
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 31.2,33.2
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 18,25
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL66 ! LiPSC-GR1.2
OI   CVCL_RH35 ! ND50038
OI   CVCL_RH36 ! ND50039
OI   CVCL_UX45 ! NH50191
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   LiPSC-GR1.2
AC   CVCL_RL66
SY   50-001-02D
DR   GEO; GSM1854270
DR   Wikidata; Q54902576
RX   PubMed=26411904;
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Hispanic.
CC   HLA typing: A*02,03; B*07,39; C*07,15; DQB1*03,04; DRB1*04,08 (PubMed=27283945).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=27283945
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 31.2,33.2
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 18,25
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL65 ! LiPSC-GR1.1
OI   CVCL_RH35 ! ND50038
OI   CVCL_RH36 ! ND50039
OI   CVCL_UX45 ! NH50191
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   LiPSC-PR1.0
AC   CVCL_RL67
SY   LiPSC-PR1
DR   GEO; GSM1854264
DR   Wikidata; Q54902577
RX   PubMed=26411904;
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL68 ! LiPSC-PR2.0
OI   CVCL_RL69 ! LiPSC-PR3.0
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   LiPSC-PR2.0
AC   CVCL_RL68
SY   LiPSC-PR2
DR   GEO; GSM1854265
DR   Wikidata; Q54902578
RX   PubMed=26411904;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL67 ! LiPSC-PR1.0
OI   CVCL_RL69 ! LiPSC-PR3.0
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   LiPSC-PR3.0
AC   CVCL_RL69
SY   LiPSC-PR3
DR   GEO; GSM1854266
DR   Wikidata; Q54902579
RX   PubMed=26411904;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL67 ! LiPSC-PR1.0
OI   CVCL_RL68 ! LiPSC-PR2.0
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   LiPSC-TR1.1
AC   CVCL_RL70
SY   LiPSC TR1
DR   GEO; GSM1854259
DR   Wikidata; Q54902580
RX   PubMed=26411904;
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=26411904
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D18S51: 12,18
ST   D21S11: 28,30
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 9,12
ST   Penta E: 15
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL71 ! LiPSC-TR1.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   LiPSC-TR1.2
AC   CVCL_RL71
SY   LiPSC TR2
DR   GEO; GSM1854260
DR   Wikidata; Q54902584
RX   PubMed=26411904;
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL70 ! LiPSC-TR1.1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   LIS-3/SV40
AC   CVCL_V301
DR   Wikidata; Q54902585
RX   PubMed=8020967;
RX   PubMed=8428517;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   LIS-3/SV40/A9-B4
AC   CVCL_V310
DR   Wikidata; Q54902586
RX   PubMed=8428517;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
HI   CVCL_V301 ! LIS-3/SV40
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Lis01_HEFX
AC   CVCL_B923
DR   NIHhESC; NIHhESC-15-0329
DR   Wikidata; Q54902587
RX   PubMed=20186514;
RX   PubMed=21585244;
RX   PubMed=27690107;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0329.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[180]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Lis02_FXS2
AC   CVCL_B924
SY   Lis02_FXS_2
DR   NIHhESC; NIHhESC-15-0330
DR   Wikidata; Q54902588
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0330.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[300]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Lis03_FXS4
AC   CVCL_B925
SY   Lis03_FXS_4
DR   NIHhESC; NIHhESC-15-0331
DR   Wikidata; Q54902589
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0331.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[250]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Lis04_Twist1
AC   CVCL_B926
SY   Lis04_Twist
DR   NIHhESC; NIHhESC-15-0332
DR   Wikidata; Q54902590
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0332.
CC   Sequence variation: Mutation; HGNC; HGNC:12428; TWIST1; Simple; p.Ala129Pro (c.385G>C); Zygosity=Unspecified (PubMed=20186514; PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75034; Type III acrocephalosyndactyly
DI   ORDO; Orphanet_794; Saethre-Chotzen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Lis05_t(11,22)
AC   CVCL_B927
DR   NIHhESC; NIHhESC-15-0333
DR   Wikidata; Q54902591
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0333.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   Lis06_Gaucher1
AC   CVCL_B928
SY   Lis06_Gaucher_1
DR   Wikidata; Q54902592
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (PubMed=20186514; PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Lis07_AIS1
AC   CVCL_B929
SY   Lis07_AIS_1
DR   NIHhESC; NIHhESC-15-0334
DR   Wikidata; Q54902593
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0334.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Unexplicit; Ex5 small deletion; Zygosity=Unspecified (PubMed=20186514).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   Lis08_AIS2
AC   CVCL_B930
SY   Lis08_AIS_2
DR   NIHhESC; NIHhESC-15-0335
DR   Wikidata; Q54902594
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0335.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Unexplicit; Ex5 small deletion; Zygosity=Unspecified (PubMed=20186514).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C27226; Androgen insensitivity syndrome
DI   ORDO; Orphanet_754; Androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   Lis09_DYS1
AC   CVCL_B931
SY   Lis09_DYS_1
DR   NIHhESC; NIHhESC-15-0336
DR   Wikidata; Q54902595
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0336.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   Lis1
AC   CVCL_B932
DR   Wikidata; Q54902596
RX   PubMed=20186514;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   Lis10_DMD1
AC   CVCL_B933
SY   Lis10_DMD_1
DR   NIHhESC; NIHhESC-15-0337
DR   Wikidata; Q54902597
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0337.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex44-47del; Zygosity=Heterozygous (PubMed=20186514).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   Lis11_DMD2
AC   CVCL_B934
SY   Lis11_DMD_2
DR   NIHhESC; NIHhESC-15-0338
DR   Wikidata; Q54902598
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0338.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex44-47del; Zygosity=Hemizygous (PubMed=20186514).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Lis12_DM1
AC   CVCL_B935
SY   Lis12_DM_1
DR   NIHhESC; NIHhESC-15-0339
DR   Wikidata; Q54902599
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0339.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   Lis13_Alport2
AC   CVCL_B936
SY   Lis13_Alport_2
DR   Wikidata; Q54902600
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   Lis14_Alport3
AC   CVCL_B937
SY   Lis14_Alport_3
DR   NIHhESC; NIHhESC-15-0340
DR   Wikidata; Q54902601
RX   PubMed=20186514;
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0340.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   Lis15_t(1;12)
AC   CVCL_Y342
DR   NIHhESC; NIHhESC-15-0341
DR   Wikidata; Q54902602
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0341.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis17_Connexin1
AC   CVCL_Y343
SY   Lis17_Connexin_1
DR   NIHhESC; NIHhESC-15-0342
DR   Wikidata; Q54902603
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0342.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis18_Connexin2
AC   CVCL_Y344
SY   Lis18_Connexin_2
DR   NIHhESC; NIHhESC-15-0343
DR   Wikidata; Q54902604
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0343.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   Lis19_DM2
AC   CVCL_Y345
SY   Lis19_DM_2
DR   NIHhESC; NIHhESC-15-0344
DR   Wikidata; Q54902605
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0344.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis20_DMD3
AC   CVCL_Y346
SY   Lis20_DMD_3
DR   NIHhESC; NIHhESC-15-0345
DR   Wikidata; Q54902606
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0345.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Arg2870Ter (c.8608C>T); ClinVar=VCV000094810; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   Lis21_Noonan1
AC   CVCL_Y347
SY   Lis21_Noonan_1; Lis21_noonan
DR   NIHhESC; NIHhESC-15-0346
DR   Wikidata; Q54902607
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0346.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis22_DMD4
AC   CVCL_Y348
SY   Lis22_DMD_4
DR   NIHhESC; NIHhESC-15-0347
DR   Wikidata; Q54902608
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0347.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Arg2870Ter (c.8608C>T); ClinVar=VCV000094810; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   Lis23_DMD5
AC   CVCL_Y349
SY   Lis23_DMD_5
DR   NIHhESC; NIHhESC-15-0328
DR   Wikidata; Q54902609
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0328.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Arg2870Ter (c.8608C>T); ClinVar=VCV000094810; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   Lis24_FXS5
AC   CVCL_Y350
SY   Lis24_FXS_5
DR   NIHhESC; NIHhESC-15-0348
DR   Wikidata; Q54902610
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0348.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis25_FAP1
AC   CVCL_Y351
SY   Lis25_FAP_1; Lis25_FAP
DR   NIHhESC; NIHhESC-15-0349
DR   Wikidata; Q54902611
RX   PubMed=21585244;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0349.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg332Ter (c.994C>T); ClinVar=VCV000184937; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   Lis26_FXS6
AC   CVCL_Y352
SY   Lis26_FXS_6
DR   NIHhESC; NIHhESC-15-0350
DR   Wikidata; Q54902612
RX   PubMed=27690107;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0350.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[50-600]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   Lis27_t(Y;14)1
AC   CVCL_Y353
SY   Lis27_t(Y;14)_1
DR   NIHhESC; NIHhESC-15-0351
DR   Wikidata; Q54902613
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0351.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   Lis28_t(Y;14)2
AC   CVCL_Y354
SY   Lis28_t(Y;14)_2
DR   NIHhESC; NIHhESC-15-0327
DR   Wikidata; Q54902614
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0327.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   Lis29_FXS7
AC   CVCL_Y355
SY   Lis29_FXS_7
DR   NIHhESC; NIHhESC-15-0326
DR   Wikidata; Q54902615
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0326.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis30_FAP2
AC   CVCL_Y356
SY   Lis30_FAP_2
DR   NIHhESC; NIHhESC-15-0325
DR   Wikidata; Q54902616
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0325.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis31_DM3
AC   CVCL_Y357
SY   Lis31_DM_3
DR   Wikidata; Q54902617
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   Lis32_DM4
AC   CVCL_Y358
SY   Lis32_DM_4
DR   Wikidata; Q54902618
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   Lis33_Norrie
AC   CVCL_Y359
DR   Wikidata; Q54902619
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118634; Norrie syndrome
DI   ORDO; Orphanet_649; Norrie disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   Lis34_FAP3
AC   CVCL_Y360
SY   Lis34_FAP_3
DR   NIHhESC; NIHhESC-15-0324
DR   Wikidata; Q54902620
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0324.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis35_Hydrocephaly1
AC   CVCL_Y361
SY   Lis35_Hydrocephaly_1
DR   NIHhESC; NIHhESC-15-0323
DR   Wikidata; Q54902621
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0323.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis36_t(11;20)N
AC   CVCL_Y362
SY   Lis36_t(11;20)_N
DR   NIHhESC; NIHhESC-15-0322
DR   Wikidata; Q54902622
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0322.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis37_FXS10
AC   CVCL_Y363
SY   Lis37_FXS_10
DR   NIHhESC; NIHhESC-15-0321
DR   Wikidata; Q54902623
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0321.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis38_FXS7N
AC   CVCL_Y364
SY   Lis38_FXS_7_N; LIS38; LIS1
DR   NIHhESC; NIHhESC-15-0320
DR   Wikidata; Q54902625
RX   PubMed=24172903;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0320.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis39_FXS8N
AC   CVCL_Y365
SY   Lis39_FXS_8_N; LIS39; LIS2
DR   GEO; GSM1571895
DR   GEO; GSM1571896
DR   GEO; GSM1571897
DR   GEO; GSM1571898
DR   GEO; GSM1571899
DR   GEO; GSM1571900
DR   GEO; GSM1571901
DR   GEO; GSM1571902
DR   GEO; GSM1571903
DR   GEO; GSM1571904
DR   GEO; GSM1571905
DR   GEO; GSM1571906
DR   NIHhESC; NIHhESC-15-0319
DR   Wikidata; Q54902626
RX   PubMed=24172903;
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0319.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   Lis40_t(13;14)N
AC   CVCL_Y366
SY   Lis40_t(13;14)_N
DR   NIHhESC; NIHhESC-15-0318
DR   Wikidata; Q54902627
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0318.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis41_LTBL_N
AC   CVCL_Y367
DR   NIHhESC; NIHhESC-15-0317
DR   Wikidata; Q54902628
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0317.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis42_NF1_1N
AC   CVCL_Y368
SY   Lis42_NF1_1_N
DR   NIHhESC; NIHhESC-15-0316
DR   Wikidata; Q54902629
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0316.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis43_Connexin3N
AC   CVCL_Y369
SY   Lis43_Connexin_3_N
DR   NIHhESC; NIHhESC-15-0315
DR   Wikidata; Q54902630
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0315.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis44_t(13;14)2N
AC   CVCL_Y370
SY   Lis44_t(13;14)_2_N
DR   Wikidata; Q54902631
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   Lis45_Ichthyosis1N
AC   CVCL_Y371
SY   Lis45_Ichthyosis_1_N
DR   NIHhESC; NIHhESC-15-0314
DR   Wikidata; Q54902632
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0314.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis46_Ichthyosis2N
AC   CVCL_Y372
SY   Lis46_Ichthyosis_2_N
DR   NIHhESC; NIHhESC-15-0313
DR   Wikidata; Q54902633
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0313.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis47_NF1_2N
AC   CVCL_Y373
SY   Lis47_NF1_2_N
DR   NIHhESC; NIHhESC-15-0312
DR   Wikidata; Q54902634
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0312.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis48_DMD6N
AC   CVCL_Y374
SY   Lis48_DMD_6_N
DR   NIHhESC; NIHhESC-15-0311
DR   Wikidata; Q54902636
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0311.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   Lis49_Hydrocephaly2N
AC   CVCL_Y375
SY   Lis49_Hydrocephaly_2_N
DR   NIHhESC; NIHhESC-15-0310
DR   Wikidata; Q54902637
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0310.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis50_Hydrocephaly3N
AC   CVCL_Y376
SY   Lis50_Hydrocephaly_3_N
DR   NIHhESC; NIHhESC-15-0308
DR   Wikidata; Q54902638
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0308.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   Lis51_FXS9N
AC   CVCL_Y377
SY   Lis51_FXS_9_N
DR   NIHhESC; NIHhESC-15-0309
DR   Wikidata; Q54902639
CC   From: Tel-Aviv Sourasky Medical Center; Tel-Aviv; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0309.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
ID   LiSa-2
AC   CVCL_M821
SY   LISA-2
DR   cancercelllines; CVCL_M821
DR   Cosmic; 2307721
DR   Cosmic; 2800522
DR   GEO; GSE3643
DR   GEO; GSM482515
DR   Progenetix; CVCL_M821
DR   Wikidata; Q54902640
RX   PubMed=11093810;
RX   PubMed=18283285;
RX   PubMed=20197395;
RX   PubMed=22911243;
RX   PubMed=24726063;
RX   PubMed=26643872;
CC   Characteristics: Can be differentiated into mature adipocytes.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu348Ser (c.1043T>C); Zygosity=Unspecified (PubMed=26643872).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3705; Pleomorphic liposarcoma
DI   ORDO; Orphanet_99969; Pleomorphic liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   LISP-1
AC   CVCL_9U24
SY   Lisp-1; LISP-I; LISP1; Ludwig Institute Sao Paulo-1
DR   Cosmic; 1184336
DR   Cosmic; 2787547
DR   Wikidata; Q54902641
RX   PubMed=1389533;
RX   PubMed=7790122;
RX   PubMed=11323753;
RX   PubMed=11414198;
RX   PubMed=12886464;
CC   Doubling time: 20 +- 1 hours (PubMed=12886464).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   LISP-A10
AC   CVCL_9U25
DR   Wikidata; Q54902642
RX   PubMed=11323753;
CC   Doubling time: 38.3 hours (PubMed=11323753).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U24 ! LISP-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   LISP-E11
AC   CVCL_9U26
DR   Wikidata; Q54902643
RX   PubMed=11323753;
CC   Doubling time: 30.4 hours (PubMed=11323753).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U24 ! LISP-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   LIU-LSC-1
AC   CVCL_E5DZ
RX   PubMed=36438491;
CC   Population: Chinese.
CC   Characteristics: Highly tumorigenic. Has a dysregulated activity of mTORC1 (PubMed=36438491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=36438491
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 15,22
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 20
ST   D19S433: 15.2,16.2
ST   D21S11: 29
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 16,22
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   LIU-LSC-1 ITGA5 KO1
AC   CVCL_E5E0
RX   PubMed=36438491;
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5DZ ! LIU-LSC-1
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LIU-LSC-1 ITGA5 KO2
AC   CVCL_E5E1
RX   PubMed=36438491;
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5DZ ! LIU-LSC-1
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Liv-BL
AC   CVCL_W939
SY   LIV-BL; LIV; Liv
DR   Wikidata; Q54902644
RX   PubMed=2824665;
RX   PubMed=2943927;
RX   PubMed=2985508;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 10
//
ID   LIV27
AC   CVCL_C4LN
DR   Wikidata; Q116049708
RX   PubMed=26956050;
RX   PubMed=36291862;
CC   Population: Caucasian.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Characteristics: Highly tumorigenic.
CC   Doubling time: 57.8 hours (Note=At 14th passage) (PubMed=36291862).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=36291862
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 8,12
ST   D21S11: 29
ST   D5S818: 13
ST   D7S820: 8,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Liver iPS 1
AC   CVCL_A1DD
DR   SKIP; SKIP001436
DR   Wikidata; Q102114459
RX   PubMed=20670273;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A1DB ! Liver iPS A
OI   CVCL_A1DC ! Liver iPS B
OI   CVCL_A1DE ! Liver iPS 7
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   Liver iPS 7
AC   CVCL_A1DE
DR   SKIP; SKIP001437
DR   Wikidata; Q102114460
RX   PubMed=20670273;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A1DB ! Liver iPS A
OI   CVCL_A1DC ! Liver iPS B
OI   CVCL_A1DD ! Liver iPS 1
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   Liver iPS A
AC   CVCL_A1DB
DR   SKIP; SKIP001434
DR   Wikidata; Q102114461
RX   PubMed=20670273;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A1DC ! Liver iPS B
OI   CVCL_A1DD ! Liver iPS 1
OI   CVCL_A1DE ! Liver iPS 7
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   Liver iPS B
AC   CVCL_A1DC
DR   SKIP; SKIP001435
DR   Wikidata; Q102114463
RX   PubMed=20670273;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A1DB ! Liver iPS A
OI   CVCL_A1DD ! Liver iPS 1
OI   CVCL_A1DE ! Liver iPS 7
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   LIX 7
AC   CVCL_0F76
SY   LIX7
DR   ATCC; CRL-2793
DR   Wikidata; Q54902645
RX   PubMed=3136074;
CC   Group: Human/rodent somatic cell hybrid.
CC   Discontinued: ATCC; CRL-2793; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N128 ! GM04618
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   LIXC002
AC   CVCL_V627
SY   LIXC-002
DR   CCRID; 4201PAT-CCTCC00382
DR   Wikidata; Q54902646
RX   Patent=CN102465113B;
RX   PubMed=24416385;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201072.
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 44.71 +- 0.38 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,14
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 15
//
ID   LIXC003
AC   CVCL_V628
DR   Wikidata; Q54902647
RX   PubMed=24416385;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201112.
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 24.95 +- 0.43 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 10
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   LIXC004
AC   CVCL_V629
SY   LIXC-004
DR   CCRID; 4201PAT-CCTCC00383
DR   Wikidata; Q54902648
RX   PubMed=24416385;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201073.
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 36.02 +- 1.41 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,20
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   LIXC006
AC   CVCL_V630
DR   Wikidata; Q54902649
RX   PubMed=24416385;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013182.
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 52.82 +- 0.93 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 9,11
ST   D7S820: 7,10
ST   TH01: 8
ST   TPOX: 7
ST   vWA: 13,15
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   LIXC011
AC   CVCL_V631
DR   Wikidata; Q54902650
RX   PubMed=24416385;
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 110.6 +- 17.88 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   LIXC012
AC   CVCL_V632
DR   Wikidata; Q54902651
RX   PubMed=24416385;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201114.
CC   Population: Chinese.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 76.68 +- 4.16 hours (PubMed=24416385).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24416385
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 8
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 7,10
ST   vWA: 13,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   LIXC127
AC   CVCL_B7AQ
SY   LIXC-127
DR   CCRID; 4201PAT-CCTCC00868
DR   Wikidata; Q112930000
RX   Patent=CN107541494B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201662.
CC   Population: Chinese; Han.
CC   Doubling time: 43.6 hours (Patent=CN107541494B).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   LIZ1
AC   CVCL_YE08
DR   Wikidata; Q95982369
RX   CelloPub=CLPUB00548;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   LJB
AC   CVCL_RA59
SY   Lateolabrax Japonicus Brain
DR   Wikidata; Q54902652
RX   PubMed=28707225;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
//
ID   LJES1
AC   CVCL_M753
SY   Lateolabrax Japonicus Embryonic Stem cell 1
DR   Wikidata; Q54902658
RX   DOI=10.1016/S0044-8486(02)00570-7;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   LJH-1
AC   CVCL_Z510
SY   Lateolabrax Japonicus Heart-1
DR   Wikidata; Q54902653
RX   DOI=10.1111/j.1095-8649.2006.01155.x;
CC   Group: Fish cell line.
CC   Doubling time: 54.9 hours (DOI=10.1111/j.1095-8649.2006.01155.x).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
OI   CVCL_Z511 ! LJH-2
OI   CVCL_Z512 ! LJHK
OI   CVCL_Z513 ! LJL
OI   CVCL_Z514 ! LJS
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   LJH-2
AC   CVCL_Z511
SY   Lateolabrax Japonicus Heart-2
DR   Wikidata; Q54902654
RX   DOI=10.1111/j.1095-8649.2006.01155.x;
CC   Group: Fish cell line.
CC   Doubling time: 58.7 hours (DOI=10.1111/j.1095-8649.2006.01155.x).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
OI   CVCL_Z510 ! LJH-1
OI   CVCL_Z512 ! LJHK
OI   CVCL_Z513 ! LJL
OI   CVCL_Z514 ! LJS
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   LJHK
AC   CVCL_Z512
SY   Lateolabrax Japonicus Head Kidney
DR   Wikidata; Q54902655
RX   DOI=10.1111/j.1095-8649.2006.01155.x;
CC   Group: Fish cell line.
CC   Doubling time: 66 hours (DOI=10.1111/j.1095-8649.2006.01155.x).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
OI   CVCL_Z510 ! LJH-1
OI   CVCL_Z511 ! LJH-2
OI   CVCL_Z513 ! LJL
OI   CVCL_Z514 ! LJS
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   LJL
AC   CVCL_Z513
SY   Lateolabrax Japonicus Liver
DR   Wikidata; Q54902656
RX   DOI=10.1111/j.1095-8649.2006.01155.x;
CC   Group: Fish cell line.
CC   Doubling time: 57 hours (DOI=10.1111/j.1095-8649.2006.01155.x).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
OI   CVCL_Z510 ! LJH-1
OI   CVCL_Z511 ! LJH-2
OI   CVCL_Z512 ! LJHK
OI   CVCL_Z514 ! LJS
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   LJS
AC   CVCL_Z514
SY   Lateolabrax Japonicus Spleen
DR   Wikidata; Q54902657
RX   DOI=10.1111/j.1095-8649.2006.01155.x;
CC   Group: Fish cell line.
CC   Doubling time: 52.7 hours (DOI=10.1111/j.1095-8649.2006.01155.x).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
OI   CVCL_Z510 ! LJH-1
OI   CVCL_Z511 ! LJH-2
OI   CVCL_Z512 ! LJHK
OI   CVCL_Z513 ! LJL
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   LK 35.2
AC   CVCL_9473
SY   LK-35.2
DR   CLO; CLO_0007318
DR   ATCC; HB-98
DR   Wikidata; Q54902659
RX   PubMed=6980413;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K166 ! L10.A 2J
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LK-1
AC   CVCL_8652
SY   LK1
DR   Cosmic; 1656902
DR   Wikidata; Q54902660
RX   PubMed=22313637;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   LK-17
AC   CVCL_W487
DR   Wikidata; Q54902661
RX   PubMed=8297820;
CC   Population: Japanese.
CC   Doubling time: 43.2 hours (PubMed=8297820).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   LK-2
AC   CVCL_1377
SY   LK 2; LK2
DR   CLO; CLO_0050064
DR   EFO; EFO_0003141
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 569
DR   BioSample; SAMN01821697
DR   BioSample; SAMN03472522
DR   BioSample; SAMN10988232
DR   cancercelllines; CVCL_1377
DR   Cell_Model_Passport; SIDM00548
DR   CGH-DB; 189-1
DR   CGH-DB; 9174-4
DR   ChEMBL-Cells; CHEMBL3308472
DR   ChEMBL-Targets; CHEMBL1075490
DR   Cosmic; 687787
DR   Cosmic; 889104
DR   Cosmic; 946071
DR   Cosmic; 1048221
DR   Cosmic; 1219073
DR   Cosmic; 1239907
DR   Cosmic; 1336878
DR   Cosmic; 1571742
DR   Cosmic; 1656906
DR   Cosmic; 1995483
DR   Cosmic; 2060534
DR   Cosmic; 2125267
DR   Cosmic; 2645024
DR   Cosmic-CLP; 687787
DR   DepMap; ACH-000769
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10541-107H1
DR   GDSC; 687787
DR   GEO; GSM784281
DR   GEO; GSM827376
DR   GEO; GSM887267
DR   GEO; GSM888342
DR   GEO; GSM1374619
DR   GEO; GSM1670047
DR   IARC_TP53; 21473
DR   JCRB; JCRB0829
DR   LiGeA; CCLE_610
DR   LINCS_LDP; LCL-1587
DR   PharmacoDB; LK2_837_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1377
DR   PubChem_Cell_line; CVCL_1377
DR   RCB; RCB1970
DR   TKG; TKG 0494
DR   TOKU-E; 4154
DR   Wikidata; Q54902662
RX   CelloPub=CLPUB00586;
RX   PubMed=9290701;
RX   PubMed=10358721;
RX   PubMed=14581340;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22313637;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=25984343); ~27 hours (Note=Lot 04162009), ~26 hours (Note=Lot 11142016) (JCRB=JCRB0829).
CC   HLA typing: A*11:01,11:01; B*51:01,51:01; C*15:02,15:02; DRB1*14:13,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Trp685Ter (c.2055G>A); Zygosity=Homozygous (Cosmic-CLP=687787; DepMap=ACH-000769).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (Cosmic-CLP=687787; DepMap=ACH-000769).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=687787; DepMap=ACH-000769).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.42%; Native American=0%; East Asian, North=82.35%; East Asian, South=16.15%; South Asian=0%; European, North=0%; European, South=1.08% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=687787; JCRB=JCRB0829; RCB=RCB1970; TKG=TKG 0494
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 12 (Cosmic-CLP=687787; JCRB=JCRB0829; RCB=RCB1970)
ST   D5S818: 12,15 (TKG=TKG 0494)
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   LK-306
AC   CVCL_WE63
DR   IBRC; C10698
DR   Wikidata; Q95982393
RX   PubMed=32358742;
CC   Population: Iranian; Laks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LK-4
AC   CVCL_G208
DR   CLO; CLO_0007319
DR   ATCC; CRL-2345
DR   Wikidata; Q54902663
RX   PubMed=1384161;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   LK-52
AC   CVCL_W488
DR   Wikidata; Q54902664
RX   PubMed=1467328;
CC   Population: Japanese.
CC   Doubling time: 38 hours (PubMed=1467328).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   LK0412
AC   CVCL_DG35
SY   LinKoping 0412
DR   GEO; GSM966999
DR   GEO; GSM967000
DR   GEO; GSM967001
DR   GEO; GSM967002
DR   GEO; GSM967003
DR   GEO; GSM967004
DR   IARC_TP53; 26966
DR   Wikidata; Q54902665
RX   CelloPub=CLPUB00346;
RX   PubMed=18452551;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=18452551).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   LK1 [Human ovarian carcinoma]
AC   CVCL_W131
SY   LK-1
DR   cancercelllines; CVCL_W131
DR   Cosmic; 724832
DR   Cosmic; 1609534
DR   GEO; GSM313698
DR   Progenetix; CVCL_W131
DR   Wikidata; Q54902669
RX   PubMed=1892748;
RX   PubMed=12068308;
RX   PubMed=15677628;
CC   Microsatellite instability: Stable (MSS) (PubMed=15677628).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=12068308).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   LK1 [Mouse ESC]
AC   CVCL_A0GF
DR   Wikidata; Q108820792
RX   PubMed=17701442;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   LK17
AC   CVCL_B6NV
DR   Wikidata; Q112930003
RX   PubMed=3039504;
CC   Characteristics: Hybrid of 6-week-old BALB/c mice Leydig cells with a tioguanine resistant clone of MA-10.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NU ! MA-10 mutant clone LK
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   LK17 clone K9
AC   CVCL_B6NW
SY   K9
DR   Wikidata; Q112930006
RX   PubMed=3039504;
CC   Characteristics: Produces high level of testosterone.
CC   Characteristics: The parent cell line is an hybrid of 6-week-old BALB/c mice Leydig cells with a tioguanine resistant clone of MA-10.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6NV ! LK17
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   LK1D
AC   CVCL_ZV67
SY   LK 1D
DR   Wikidata; Q98126913
RX   PubMed=4169243;
RX   PubMed=4177061;
RX   PubMed=4866767;
RX   PubMed=5229350;
RX   PubMed=5232513;
RX   PubMed=5640868;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 5
//
ID   LK2
AC   CVCL_W132
DR   cancercelllines; CVCL_W132
DR   Cosmic; 1609531
DR   GEO; GSM313666
DR   Progenetix; CVCL_W132
DR   Wikidata; Q54902670
RX   PubMed=1892748;
RX   PubMed=15677628;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
ID   LK24
AC   CVCL_LH65
DR   ATCC; HB-8769
DR   Wikidata; Q54902671
RX   Patent=US4851332;
RX   PubMed=2580800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8769.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human choriocarcinoma/breast tumor cell antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   LK26
AC   CVCL_LH62
DR   Wikidata; Q54902672
RX   Patent=US4851332;
RX   PubMed=2580800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8764.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized MORAb-003 (Farletuzumab) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   LK57
AC   CVCL_ZV68
DR   Wikidata; Q98126915
RX   PubMed=5229350;
RX   PubMed=5232513;
RX   PubMed=5640868;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-6Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LK60
AC   CVCL_ZV69
DR   Wikidata; Q98126916
RX   PubMed=5229350;
RX   PubMed=5232513;
RX   PubMed=5640868;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3-4Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LK63 [Melbourne]
AC   CVCL_7986
SY   Lk63; LK-63
DR   BTO; BTO_0000606
DR   Cosmic; 1130240
DR   Cosmic; 2491070
DR   GEO; GSM2373800
DR   GEO; GSM2373801
DR   Wikidata; Q54902673
RX   PubMed=1378917;
RX   PubMed=9067587;
RX   PubMed=27922598;
CC   Doubling time: 13 hours (PubMed=1378917).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   LK63 [Philadelphia]
AC   CVCL_ZV70
DR   Wikidata; Q98126919
RX   PubMed=5640868;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LK63/A3KD
AC   CVCL_ZV65
SY   LK63 EphA3-knockdown; LK63-EphA3 knockdown
DR   GEO; GSM2373802
DR   GEO; GSM2373803
DR   Wikidata; Q98126922
RX   PubMed=27922598;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:3387; EPHA3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7986 ! LK63 [Melbourne]
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   LK707
AC   CVCL_E757
DR   dbMHC; 48952
DR   ECACC; 94071417
DR   IHW; IHW09280
DR   IPD-IMGT/HLA; 10999
DR   Wikidata; Q54902674
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01; B*52:01:01,73:01; C*07:01,15:05; DRB1*15:02/80N,04:05 (IPD-IMGT/HLA=10999).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   LK79
AC   CVCL_A645
SY   LK-79
DR   Cosmic; 889091
DR   Cosmic; 946072
DR   Cosmic; 1066162
DR   Cosmic; 1656905
DR   Wikidata; Q54902675
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9416778;
RX   PubMed=9538136;
RX   PubMed=16105816;
RX   PubMed=22313637;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*40:02; C*03:03 (PubMed=9178645).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   LK87
AC   CVCL_A646
SY   LK-87
DR   BTO; BTO_0006038
DR   Cosmic; 889092
DR   Cosmic; 946055
DR   Cosmic; 1066163
DR   Cosmic; 1656901
DR   Wikidata; Q54902676
RX   PubMed=9416778;
RX   PubMed=9538136;
RX   PubMed=16105816;
RX   PubMed=22313637;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 9
//
ID   LK87A
AC   CVCL_ZV71
DR   Wikidata; Q98126924
RX   PubMed=5640868;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LK91
AC   CVCL_ZV72
DR   Wikidata; Q98126926
RX   PubMed=5640868;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   Lk9dL
AC   CVCL_WX07
SY   LK9d(L); Lk 9 dL
DR   Wikidata; Q95982402
RX   PubMed=9914777;
RX   PubMed=11011112;
RX   PubMed=11115552;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from autologous cell line Lk9dR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WX08 ! Lk9dR
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   Lk9dR
AC   CVCL_WX08
SY   LK9d(R); Lk9D; LK9D; LK9d; lk9d
DR   Wikidata; Q95982403
RX   PubMed=7559744;
RX   PubMed=7704028;
RX   PubMed=11011112;
RX   PubMed=11115552;
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (PubMed=7704028).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WX07 ! Lk9dL
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   LKA10
AC   CVCL_ZX82
DR   Wikidata; Q102114464
RX   PubMed=27716287;
RX   PubMed=30127392;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX85 ! KA(LCL)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   LKA29
AC   CVCL_ZX83
SY   LCL(KA)-derived iPSC, clone #29
DR   GEO; GSM2185122
DR   Wikidata; Q102114465
RX   PubMed=27716287;
RX   PubMed=30127392;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX85 ! KA(LCL)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   LKA36
AC   CVCL_ZX84
SY   LCL(KA)-derived iPSC, clone #36
DR   GEO; GSM2185123
DR   Wikidata; Q102114466
RX   PubMed=27716287;
RX   PubMed=30127392;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX85 ! KA(LCL)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   LL-5
AC   CVCL_Z842
SY   LL5; Lutzomyia Longipalpis-5
DR   Wikidata; Q54902677
RX   PubMed=6842527;
RX   PubMed=11126533;
RX   PubMed=27098567;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7200; ! Lutzomyia longipalpis (Sand fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LL-iPSC-AECII
AC   CVCL_VR37
SY   (LL)-iPSC-AECII; Long-Lasting-iPSC derived Alveolar Epithelial Cells type II
DR   Wikidata; Q95982405
RX   PubMed=30211653;
CC   Population: Caucasian.
CC   Characteristics: This cell line was established in a three step process: 1) iPSCs were generated from the parent fibroblast cell line; 2) these iPSCs were differentiated into alveolar type II epithelial cells (AEC type II); 3) these AEC type II cells were immortalized by transduction with human BMI1 and TERT (PubMed=30211653).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Alveolar type 2 fibroblast; CL=CL_4028006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   LL/2 (LLC1)
AC   CVCL_4358
SY   LL/2 (LLc1); LL/2(LLc1); LL/2; LL2; LLC1; LLC; Lewis lung carcinoma line 1; Lewis lung carcinoma; Lewis Lung Cancer; Lewis-Lung; Lewis Lung
DR   BTO; BTO_0000181
DR   BTO; BTO_0000745
DR   CLO; CLO_0007325
DR   CLO; CLO_0050167
DR   CLDB; cl3208
DR   AddexBio; C0016030/5000
DR   ATCC; CRL-1642
DR   BCRC; 60050
DR   BCRJ; 0145
DR   BioGRID_ORCS_Cell_line; 1628
DR   BioSample; SAMN11397632
DR   CCRID; 1101MOU-PUMC000673
DR   CCRID; 3101MOUTCM7
DR   ChEMBL-Cells; CHEMBL3307859
DR   ChEMBL-Targets; CHEMBL614088
DR   CLS; 305311
DR   CLS; 400263
DR   ECACC; 90020104
DR   GEO; GSE84108
DR   IZSLER; BS TCL 216
DR   KCB; KCB 200781YJ
DR   NCBI_Iran; C587
DR   PRIDE; PXD008733
DR   PubChem_Cell_line; CVCL_4358
DR   RCB; RCB0558
DR   TKG; TKG 0153
DR   TOKU-E; 2205
DR   Ubigene; YC-C018
DR   Wikidata; Q54902678
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=7226139;
RX   PubMed=28599420;
RX   PubMed=30084848;
RX   PubMed=31220119;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-352.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/ll2-xenograft-model/
CC   Doubling time: 21 hours (PubMed=7226139); 21 hours (CLS=400263).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Could be identical to 3LL (Cellosaurus=CVCL_5653).
CC   Discontinued: CLS; 400263; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): PubMed=31220119; Ubigene=YC-C018
ST   Mouse STR 1-1: 15,17,18
ST   Mouse STR 1-2: 18,19,20
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 20.3,21.3,23.3 (PubMed=31220119)
ST   Mouse STR 4-2: 21.3,23.3 (Ubigene=YC-C018)
ST   Mouse STR 5-5: 16,17 (Ubigene=YC-C018)
ST   Mouse STR 5-5: 16,17,18 (PubMed=31220119)
ST   Mouse STR 6-4: 17,18 (PubMed=31220119)
ST   Mouse STR 6-4: 18 (Ubigene=YC-C018)
ST   Mouse STR 6-7: 14,15,16 (PubMed=31220119)
ST   Mouse STR 6-7: 15 (Ubigene=YC-C018)
ST   Mouse STR 7-1: 26.2,27.2,28.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 13.3,14.3,15.3,16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17,18
ST   Mouse STR 15-3: 22.3,24.3 (PubMed=31220119)
ST   Mouse STR 15-3: 24.3,25.3 (Ubigene=YC-C018)
ST   Mouse STR 17-2: 14,15,16
ST   Mouse STR 18-3: 15,16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 24,26,28 (PubMed=31220119)
ST   Mouse STR X-1: 25,25.3 (Ubigene=YC-C018)
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 37
//
ID   LL/2-eGFP-Puro
AC   CVCL_RA22
DR   Imanis; CL051
DR   Wikidata; Q54902679
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL051).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   LL/2-Fluc-Neo/eGFP-Puro
AC   CVCL_RA23
DR   Imanis; CL073
DR   Wikidata; Q54902681
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL073).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   LL/2-Fluc-Puro
AC   CVCL_RA24
DR   Imanis; CL050
DR   Wikidata; Q54902682
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL050).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   LL/2-iRFP-Puro
AC   CVCL_RA25
DR   Imanis; CL111
DR   Wikidata; Q54902683
CC   Characteristics: Reporter cell line, transduced with the LV-iRFP-P2A-Puro vector encoding for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL111).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   LL/2-luc-M38
AC   CVCL_5J40
SY   LL2/luc-M38
DR   Revvity/PerkinElmer; 119267
DR   Wikidata; Q54902684
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119267; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   LL/2-Luc2
AC   CVCL_A4CM
DR   ATCC; CRL-1642-LUC2
DR   Wikidata; Q105509912
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1642-LUC2).
CC   Doubling time: ~13 hours (ATCC=CRL-1642-LUC2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   LL/2-mNIS (monoclonal)
AC   CVCL_RA26
DR   Imanis; CL114
DR   Wikidata; Q54902685
RX   PubMed=30674994;
CC   Characteristics: Transduced with the LV-mNIS vector encoding mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL114).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   LL/2-mNIS-Neo/eGFP-Puro
AC   CVCL_RA27
DR   Imanis; CL071
DR   Wikidata; Q54902686
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL071).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   LL/2-mNIS-Neo/Fluc-Puro
AC   CVCL_RA28
DR   Imanis; CL072
DR   Wikidata; Q54902687
CC   Characteristics: Reporter cell line, transduced with both the LV-mNIS-P2A-Neo and LV-Fluc-P2A-Puro vectors. LV-mNIS-P2A-Neo encodes for mouse Slc5a5 linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL072).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   LL/2-mNIS-Puro
AC   CVCL_RA29
DR   Imanis; CL054
DR   Wikidata; Q54902688
CC   Characteristics: Reporter cell line, transduced with the LV-mNIS-PGKp-Puro vector encoding for mouse Slc5a5 under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL054).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:2149330; Slc5a5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   LL/2-Red-FLuc
AC   CVCL_5J02
SY   LL/2 Red-FLuc; Bioware Brite LL/2 Red-FLuc; IVISbrite LL/2 Red F-luc
DR   Revvity/PerkinElmer; BW119267
DR   Wikidata; Q54902689
CC   Doubling time: 24 hours (Revvity/PerkinElmer=BW119267).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   LL1
AC   CVCL_C4MN
SY   EPB-1; EPB1
DR   ABCD; ABCD_AD421
DR   Wikidata; Q116049709
RX   PubMed=2663143;
RX   PubMed=8947500;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized milatuzumab (hLL1; MEDI-115) therapeutic antibody used for the treatment of multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia. When conjugated with doxorubicin, milatuzumab is known as IMMU-110 (hLL1-Dox) and is used for the treatment of relapsed multiple myeloma.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04233; Human CD74.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LL2
AC   CVCL_C4MM
SY   EPB-2; EPB2
DR   ABCD; ABCD_AE447
DR   Wikidata; Q116049710
RX   PubMed=2663143;
RX   PubMed=7691407;
RX   PubMed=7737671;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma when labelled with the radioactive isotope technetium-99m is known as bectumomab (LymphoScan) and is used to detect non-Hodgkin's lymphoma.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P20273; Human CD22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LL24
AC   CVCL_2575
SY   LL 24
DR   BTO; BTO_0005077
DR   CLO; CLO_0007320
DR   CLO; CLO_0007326
DR   CLDB; cl3209
DR   ATCC; CCL-151
DR   BioSample; SAMN03471456
DR   ECACC; 90073001
DR   KCLB; 10151
DR   Wikidata; Q54902690
RX   PubMed=7065527;
CC   Population: Caucasian.
CC   Senescence: Can undergo 25 PDL (ECACC=90073001).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-151; KCLB=10151
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 27,30
ST   D2S1338: 19,21
ST   D3S1358: 14,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 18.2,24
ST   Penta D: 5,11
ST   Penta E: 7,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   LL29 (AnHa)
AC   CVCL_2576
SY   LL29; LL 29 (AnHa); LL 29
DR   CLO; CLO_0007321
DR   CLO; CLO_0007327
DR   CLDB; cl3210
DR   ATCC; CCL-134
DR   BioSample; SAMN03472707
DR   ECACC; 87112508
DR   KCLB; 10134
DR   Wikidata; Q54902691
RX   PubMed=7065527;
CC   Population: Caucasian.
CC   Senescence: Can undergo 9 PDL.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-134; ECACC=87112508
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 19,25
ST   D3S1358: 14
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 14,16
ST   FGA: 21,25
ST   Penta D: 8,9
ST   Penta E: 5,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   LL47 (MaDo)
AC   CVCL_2577
SY   LL47; LL 47 (MaDo); LL 47
DR   CLO; CLO_0007322
DR   CLO; CLO_0007328
DR   CLDB; cl3211
DR   ATCC; CCL-135
DR   BioSample; SAMN03472708
DR   ECACC; 90102538
DR   GEO; GSM426291
DR   KCLB; 10135
DR   Wikidata; Q54902692
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: African American.
CC   Senescence: Can undergo 15 PDL.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a patient with osteosarcoma (ATCC=CCL-135).
CC   Discontinued: KCLB; 10135; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-135; ECACC=90102538
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 15,20
ST   D19S433: 12.2,15
ST   D21S11: 28,29
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 10,12
ST   Penta E: 9,11
ST   TH01: 7,9.3
ST   TPOX: 9,10
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   LL58
AC   CVCL_8258
DR   BEI_Resources; ARP-811
DR   Wikidata; Q54902693
RX   Patent=US5178999;
RX   PubMed=3033285;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9693.
CC   Virology: Chronically infected with HIV-1.
CC   Doubling time: 24-48 hours (BEI_Resources=ARP-811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8277 ! X50-7
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   LL86 (LeSa)
AC   CVCL_2578
SY   LL86; LL 86 (LeSa); LL 86
DR   CLO; CLO_0007323
DR   CLO; CLO_0007329
DR   CLDB; cl3212
DR   ATCC; CCL-190
DR   BioSample; SAMN03472823
DR   ECACC; 90102541
DR   GEO; GSM426292
DR   KCLB; 10190
DR   Wikidata; Q54902694
RX   PubMed=7065527;
RX   PubMed=19727395;
CC   Population: Caucasian.
CC   Senescence: Can undergo 10 PDL.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-190; ECACC=90102541
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 19,22
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 5,8
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   LL97A (AlMy)
AC   CVCL_3736
SY   LL97A; LL 97A (AlMy); LL 97A
DR   CLO; CLO_0007324
DR   ATCC; CCL-191
DR   BioSample; SAMN03472824
DR   Wikidata; Q54902695
RX   PubMed=7065527;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-191
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 27,33.2
ST   D2S1338: 20,21
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 15,16
ST   FGA: 21,23
ST   Penta D: 10,11
ST   Penta E: 9,13
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C35716; Idiopathic pulmonary fibrosis
DI   ORDO; Orphanet_2032; Idiopathic pulmonary fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   LLAK
AC   CVCL_H949
DR   Wikidata; Q54902696
RX   PubMed=3474463;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   LLC-AS180
AC   CVCL_A9AV
SY   Lilly Laboratories Cell-AS180
DR   Wikidata; Q108820793
RX   PubMed=14449902;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   LLC-GA5
AC   CVCL_U206
DR   Wikidata; Q54902697
RX   PubMed=1359120;
RX   PubMed=1360010;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87916; Ada.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   LLC-GA5-CoL150
AC   CVCL_U207
DR   CLO; CLO_0050906
DR   ChEMBL-Cells; CHEMBL3833701
DR   PubChem_Cell_line; CVCL_U207
DR   RCB; RCB0871
DR   Wikidata; Q54902698
RX   PubMed=1359120;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87916; Ada.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_U206 ! LLC-GA5
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   LLC-GA5-CoL300
AC   CVCL_U208
DR   CLO; CLO_0050907
DR   RCB; RCB0872
DR   Wikidata; Q54902699
RX   PubMed=1360010;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87916; Ada.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_U206 ! LLC-GA5
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   LLC-HE1
AC   CVCL_A9AU
SY   LLC-H1; Lilly Laboratories Culture-Human Embryo 1
DR   Wikidata; Q108820794
RX   DOI=10.1002/jbmte.390020304;
RX   PubMed=14449902;
CC   Derived from site: In situ; Fetal trunk; UBERON=UBERON_0002100.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LLC-M1
AC   CVCL_A9AW
SY   LLC-M-1; Lilly Laboratories Culture-Mouse 1
DR   Wikidata; Q108820795
RX   DOI=10.1002/jbmte.390020304;
RX   PubMed=13431913;
RX   PubMed=14449902;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   LLC-M3
AC   CVCL_A9AX
SY   Lilly Laboratories Culture-Mouse 3
DR   Wikidata; Q108820796
RX   PubMed=14449902;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   LLC-MK1
AC   CVCL_L987
SY   Llc-Mk1; LLCMK1; Lilly Laboratories Culture-Monkey Kidney 1
DR   Wikidata; Q54902700
RX   DOI=10.1002/jbmte.390020304;
RX   PubMed=14449901;
RX   PubMed=14449902;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   LLC-MK2
AC   CVCL_3009
SY   Llc-Mk2; LLC-MK-2; LLC-MK2 Original; LLCMK2; LLcMK2; Lilly Laboratories Culture-Monkey Kidney 2; MK2
DR   CLO; CLO_0007330
DR   CLDB; cl3214
DR   CLDB; cl3215
DR   CLDB; cl3218
DR   CLDB; cl3219
DR   CLDB; cl3220
DR   AddexBio; P0014004/4952
DR   ATCC; CCL-7
DR   ATCC; CCL-7.1
DR   BCRC; 60092
DR   BCRC; 60365
DR   BCRJ; 0146
DR   CCRID; 1102MON-NIFDC00078
DR   CCRID; 3101MONGNO6
DR   CCRID; 4201MON-CCTCC00156
DR   CCTCC; GDC0156
DR   ChEMBL-Cells; CHEMBL3307684
DR   ChEMBL-Targets; CHEMBL614691
DR   CLS; 305149
DR   ECACC; 85062804
DR   IZSLER; BS CL 57
DR   Lonza; 128
DR   PubChem_Cell_line; CVCL_3009
DR   Wikidata; Q54902701
RX   DOI=10.1002/jbmte.390020304;
RX   DOI=10.1007/BF02618370;
RX   Patent=US3904480;
RX   PubMed=4203458;
RX   PubMed=6298990;
RX   PubMed=13821019;
RX   PubMed=14185313;
RX   PubMed=14449901;
RX   PubMed=14449902;
RX   PubMed=14473108;
RX   PubMed=16494729;
RX   PubMed=18605421;
RX   PubMed=28046048;
RX   PubMed=33389257;
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
WW   Provider; Vircell; -; https://www.vircell.com/en/products/llc-mk2-cell-line
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-7.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-7.1.
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=16494729).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Donor information: Derived from the trypsinization of a pool of kidneys from 6 adult rhesus monkeys.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   LLC-MS180
AC   CVCL_A9AY
SY   Lilly Laboratories Cell-MS180
DR   Wikidata; Q108820797
RX   DOI=10.1002/jbmte.390020304;
RX   PubMed=14449902;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_2874 ! CCRF S-180 II
OI   CVCL_3598 ! Sarcoma 180
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   LLC-PK1
AC   CVCL_0391
AS   CVCL_K238
SY   LLC-PK(1); LLC-PK-1; LLC PK-1; LLc-PK1; LLC PK1; LLCPK1; Lilly Laboratories Culture-Porcine Kidney 1
DR   BTO; BTO_0000760
DR   CLO; CLO_0007331
DR   MCCL; MCC:0000286
DR   CLDB; cl3221
DR   CLDB; cl5221
DR   ABM; T9045
DR   ATCC; CL-101
DR   ATCC; CRL-1392
DR   BCRC; 60080
DR   BCRJ; 0147
DR   CCRID; 1101SWI-PUMC000111
DR   CCRID; 4201SWI-CCTCC00612
DR   ChEMBL-Cells; CHEMBL3307655
DR   ChEMBL-Targets; CHEMBL614577
DR   CLS; 607264
DR   DSMZ; ACC-637
DR   DSMZCellDive; ACC-637
DR   ECACC; 86121112
DR   GEO; GSM4009059
DR   GEO; GSM4009060
DR   GEO; GSM4009061
DR   IZSLER; BS CL 111
DR   JCRB; JCRB0060
DR   Lonza; 844
DR   MeSH; D018374
DR   PRIDE; PXD007891
DR   PubChem_Cell_line; CVCL_0391
DR   TOKU-E; 2208
DR   Wikidata; Q28334936
RX   Patent=US3904480;
RX   PubMed=828141;
RX   PubMed=8097873;
RX   PubMed=14449902;
RX   PubMed=17337088;
RX   PubMed=17389150;
RX   PubMed=19508353;
RX   PubMed=20555413;
RX   PubMed=23460964;
RX   PubMed=33122286;
RX   PubMed=34737324;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/llcpk1/llcpk1cells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-cl-101-vs-atcc-cl-101-1
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-150.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-101.
CC   Doubling time: 25.7 hours (PubMed=23460964); ~24 hours (DSMZ=ACC-637).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-1392; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 37
//
ID   LLC-PK1-GR101
AC   CVCL_U970
SY   LLC-PK-1-GR101; LLC-PK(1)-GR101
DR   BTO; BTO_0002538
DR   Wikidata; Q54902703
RX   PubMed=9227432;
RX   PubMed=14612386;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2741; Nr3c1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   LLC-PK1/BCRP
AC   CVCL_IJ30
DR   Wikidata; Q54902704
RX   PubMed=23460964;
CC   Doubling time: 27.2 hours (PubMed=23460964).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:74; ABCG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 12
//
ID   LLC-PK1/Cl4
AC   CVCL_IP75
SY   LLC-PK1-Cl4; LLC-PK1-CL4; LLC-PK1/Cl 4; LLC-PK1/clone 4; LLC-PK1 clone 4; CL4
DR   Wikidata; Q54902702
RX   PubMed=2578475;
RX   PubMed=2845797;
RX   PubMed=3022596;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 8
//
ID   LLC-PK1/NRa1
AC   CVCL_B7MP
SY   NRa1
DR   Wikidata; Q112930007
RX   PubMed=8097873;
CC   Selected for resistance to: ChEBI; CHEBI_7507; Neomycin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   LLC-PK1/NRa3
AC   CVCL_B7MQ
SY   NRa3
DR   Wikidata; Q112930008
RX   PubMed=8097873;
CC   Selected for resistance to: ChEBI; CHEBI_7507; Neomycin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   LLC-PK10
AC   CVCL_9577
SY   LLC-PK(10)
DR   Lonza; 357
DR   Wikidata; Q54902705
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   LLC-PK1A
AC   CVCL_6331
DR   CLO; CLO_0007332
DR   ATCC; CL-101.1
DR   Wikidata; Q54902706
RX   Patent=US3904480;
RX   PubMed=828141;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-cl-101-vs-atcc-cl-101-1
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-101.1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0391 ! LLC-PK1
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   LLC-RK1
AC   CVCL_2579
SY   Lilly Laboratories Cell-Rabbit Kidney 1
DR   BTO; BTO_0002175
DR   CLO; CLO_0007333
DR   CLO; CLO_0007334
DR   CLDB; cl3222
DR   CLDB; cl3223
DR   ATCC; CCL-106
DR   BCRC; 60329
DR   ECACC; 89050907
DR   IZSLER; BS CL 58
DR   JCRB; JCRB9034
DR   KCLB; 10106
DR   Wikidata; Q54902707
RX   DOI=10.1007/BF00438195;
RX   DOI=10.1007/BF02618370;
RX   PubMed=14277663;
RX   PubMed=14449902;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   3W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   LLC-WRC 256
AC   CVCL_3537
SY   LLC-WRC256; Walker/LLC-WRC 256; Walker-256; Walker-Ca.256; Walker 256; W256; Lilly Laboratories Culture-Walker Rat Culture 256
DR   BTO; BTO_0005080
DR   CLO; CLO_0007335
DR   CLDB; cl3224
DR   CLDB; cl3225
DR   ATCC; CCL-38
DR   CCRID; 1101RAT-PUMC000316
DR   CCRID; 4201RAT-CCTCC00060
DR   CCTCC; GDC0060
DR   ChEMBL-Cells; CHEMBL3307248
DR   ChEMBL-Targets; CHEMBL612803
DR   CLS; 500375
DR   ECACC; 87061101
DR   IZSLER; BS TCL 36
DR   PubChem_Cell_line; CVCL_3537
DR   TKG; TKG 0138
DR   Wikidata; Q54902708
RX   DOI=10.1002/jbmte.390020304;
RX   DOI=10.1007/BF02618370;
RX   PubMed=14449902;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   LLD 135
AC   CVCL_D7CM
SY   LLD135
RX   PubMed=8340107;
CC   Doubling time: ~30 hours (PubMed=8340107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LLD 138
AC   CVCL_D7CN
SY   LLD138
RX   PubMed=7987813;
RX   PubMed=8340107;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LLE/LULS40
AC   CVCL_UD49
DR   Wikidata; Q95982442
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Strain Campo Grande.
OX   NCBI_TaxID=7200; ! Lutzomyia longipalpis (Sand fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LLE/LULS45
AC   CVCL_C1YJ
DR   Wikidata; Q114311879
RX   PubMed=34680640;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Strain Jacobina.
OX   NCBI_TaxID=7200; ! Lutzomyia longipalpis (Sand fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   LLKF
AC   CVCL_A6SF
SY   Lagurus Lagurus Kidney Fibroblast
DR   RCB; RCB3517
DR   Wikidata; Q107115666
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=175522; ! Lagurus lagurus (Steppe lemming)
SX   Male
CA   Undefined cell line type
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   LLL/LULS52
AC   CVCL_C1YK
DR   Wikidata; Q114311880
RX   PubMed=34680640;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Breed/subspecies: Strain Sobral.
OX   NCBI_TaxID=7200; ! Lutzomyia longipalpis (Sand fly)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   LLN-40
AC   CVCL_D7E7
RX   CelloPub=CLPUB00770;
RX   PubMed=1612780;
CC   Doubling time: 5 +- 2 days (PubMed=1612780).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   42Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   LLN-40 C17-11
AC   CVCL_D7E8
SY   C17-11
RX   PubMed=1612780;
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7E7 ! LLN-40
SX   Sex unspecified
AG   42Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   LLTC
AC   CVCL_H948
DR   ChEMBL-Cells; CHEMBL3307861
DR   ChEMBL-Targets; CHEMBL614093
DR   PubChem_Cell_line; CVCL_H948
DR   Wikidata; Q54902709
RX   PubMed=3474463;
CC   Selected for resistance to: ChEBI; CHEBI_90239; Tiazofurine.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   LM
AC   CVCL_B3QF
DR   Cosmic; 802252
DR   Wikidata; Q110433004
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C96847; Extrarenal rhabdoid tumor of the liver
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   LM 112
AC   CVCL_D5EF
DR   Wikidata; Q127382593
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=36963; ! Rhyparobia maderae (Madeira cockroach)
SX   Female
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LM 17/19
AC   CVCL_B6WT
DR   Wikidata; Q112930009
RX   PubMed=6526151;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=Recognizes both M and N blood group antigens).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   LM 17/20
AC   CVCL_B6WU
DR   Wikidata; Q112930010
RX   PubMed=6526151;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=Recognizes both M and N blood group antigens).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   LM 42
AC   CVCL_D5EE
DR   Wikidata; Q127382594
RX   CelloPub=CLPUB00763;
RX   DOI=10.1007/BF02623290;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Dorsal vessel; UBERON=UBERON_0015231.
OX   NCBI_TaxID=36963; ! Rhyparobia maderae (Madeira cockroach)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LM 75
AC   CVCL_D5EG
DR   Wikidata; Q127382595
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=4198695;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Dorsal vessel; UBERON=UBERON_0015231.
OX   NCBI_TaxID=36963; ! Rhyparobia maderae (Madeira cockroach)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LM-1 [Human osteosarcoma]
AC   CVCL_V416
DR   Wikidata; Q54902713
RX   PubMed=6575958;
RX   PubMed=6940833;
CC   Population: African American.
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   LM-1 [Human/mouse hybridoma against human NONO]
AC   CVCL_XI20
SY   LM-I
DR   ABCD; ABCD_AV472
DR   Wikidata; Q95982446
RX   Patent=US9783599;
RX   Patent=WO2009104100A2;
RX   PubMed=12775891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2623.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; Q15233; Human NONO.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   LM-1-SF
AC   CVCL_YE13
DR   Wikidata; Q95982447
RX   PubMed=6575958;
CC   Group: Serum/protein free medium cell line.
CC   Population: African American.
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V416 ! LM-1 [Human osteosarcoma]
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   LM-100/SV40
AC   CVCL_V302
DR   Wikidata; Q54902714
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-30.1/SV40
AC   CVCL_V303
DR   Wikidata; Q54902715
RX   PubMed=1884354;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-5.1/SV40
AC   CVCL_V304
DR   Wikidata; Q54902716
RX   PubMed=1884354;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-600/SV40
AC   CVCL_V305
DR   Wikidata; Q54902717
RX   PubMed=1884354;
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-605/SV40
AC   CVCL_V306
DR   Wikidata; Q54902718
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-608/SV40
AC   CVCL_V307
DR   Wikidata; Q54902719
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-609/SV40
AC   CVCL_V308
DR   Wikidata; Q54902720
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-65/SV40
AC   CVCL_V309
DR   Wikidata; Q54902721
RX   PubMed=8020967;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-100
AC   CVCL_UC71
SY   LM-Mel-100; Ludwig Melbourne-MELanoma-100
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371796
DR   Wikidata; Q95982486
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02,11; B*15,55; C*03 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Glu (c.1801A>G); ClinVar=VCV000013966; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D21S11: 28,30
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-101
AC   CVCL_UC72
SY   LM-Mel-101; Ludwig Melbourne-MELanoma-101
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC72
DR   GEO; GSM2371797
DR   Wikidata; Q95982487
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02,30; B*13,15; C*03,06 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 29,31
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UH50 ! LM-MEL-102
OI   CVCL_UH51 ! LM-MEL-103
OI   CVCL_UH52 ! LM-MEL-104
OI   CVCL_UH53 ! LM-MEL-105
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   LM-MEL-102
AC   CVCL_UH50
SY   LM-Mel-102; Ludwig Melbourne-MELanoma-102
DR   cancercelllines; CVCL_UH50
DR   Wikidata; Q95982488
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 29,31
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC72 ! LM-MEL-101
OI   CVCL_UH51 ! LM-MEL-103
OI   CVCL_UH52 ! LM-MEL-104
OI   CVCL_UH53 ! LM-MEL-105
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   LM-MEL-103
AC   CVCL_UH51
SY   LM-Mel-103; Ludwig Melbourne-MELanoma-103
DR   cancercelllines; CVCL_UH51
DR   Wikidata; Q95982489
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 29,31
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC72 ! LM-MEL-101
OI   CVCL_UH50 ! LM-MEL-102
OI   CVCL_UH52 ! LM-MEL-104
OI   CVCL_UH53 ! LM-MEL-105
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   LM-MEL-104
AC   CVCL_UH52
SY   LM-Mel-104; Ludwig Melbourne-MELanoma-104
DR   cancercelllines; CVCL_UH52
DR   Wikidata; Q95982490
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 29,31
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC72 ! LM-MEL-101
OI   CVCL_UH50 ! LM-MEL-102
OI   CVCL_UH51 ! LM-MEL-103
OI   CVCL_UH53 ! LM-MEL-105
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   LM-MEL-105
AC   CVCL_UH53
SY   LM-Mel-105; Ludwig Melbourne-MELanoma-105
DR   Wikidata; Q95982491
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Miscellaneous: Cell line information from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 29,31
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC72 ! LM-MEL-101
OI   CVCL_UH50 ! LM-MEL-102
OI   CVCL_UH51 ! LM-MEL-103
OI   CVCL_UH52 ! LM-MEL-104
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 5
//
ID   LM-MEL-12
AC   CVCL_UC25
SY   LM-Mel-12; Ludwig Melbourne-MELanoma-12
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371750
DR   Wikidata; Q95982492
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,33:03; B*08:01,35:03; C*04:01,07:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 28
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-14
AC   CVCL_UC26
SY   LM-Mel-14; Ludwig Melbourne-MELanoma-14
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC26
DR   GEO; GSM2371751
DR   Wikidata; Q95982493
RX   PubMed=18413770;
RX   PubMed=19221743;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*23:01,24:02; B*15:01,44:03; C*03:03,04:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D21S11: 28
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-15
AC   CVCL_UC27
SY   LM-Mel-15; Ludwig Melbourne-MELanoma-15
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371752
DR   Wikidata; Q95982494
RX   PubMed=19221743;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*26:01,68:01; B*44:02,51:01; C*05:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   LM-MEL-16
AC   CVCL_UC28
SY   LM-Mel-16; Ludwig Melbourne-MELanoma-16
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC28
DR   GEO; GSM2371753
DR   Wikidata; Q95982495
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,03:01; B*65,57:01; C*05:01,06:11 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,13
ST   D16S539: 10,13
ST   D21S11: 27,29
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-17
AC   CVCL_UC29
SY   LM-Mel-17; Ludwig Melbourne-MELanoma-17
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC29
DR   GEO; GSM2371754
DR   Wikidata; Q95982496
RX   PubMed=18413770;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,02; B*44,15:01; C*03:04,05 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor and STR profile from personal communication of Cardwell, Tracy.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 12
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-19
AC   CVCL_UC30
SY   LM-Mel-19; Ludwig Melbourne-MELanoma-19
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3328
DR   cancercelllines; CVCL_UC30
DR   GEO; GSM2371755
DR   Wikidata; Q95982497
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~40 hours (ATCC=CRL-3328).
CC   HLA typing: A*01:01,02:01; B*08:01,15:01; C*03:04,07:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3328; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 8,13
ST   D13S317: 12,13
ST   D16S539: 11
ST   D21S11: 32.2
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-1a
AC   CVCL_UC16
SY   LM-Mel-1a; LM-MEL-1; Ludwig Melbourne-MELanoma-1a
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3329
DR   cancercelllines; CVCL_UC16
DR   GEO; GSM2371741
DR   Wikidata; Q95982498
RX   PubMed=18413770;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~40 hours (ATCC=CRL-3329).
CC   HLA typing: A*02,24; B*07:02,70; C*07:04,12:03 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): ATCC=CRL-3329; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D21S11: 28,30
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-2
AC   CVCL_UC17
SY   LM-Mel-2; Ludwig Melbourne-MELanoma-2
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC17
DR   GEO; GSM2371742
DR   Wikidata; Q95982501
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01; B*51:01; C*14:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D21S11: 28,30
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-20
AC   CVCL_UC31
SY   LM-Mel-20; Ludwig Melbourne-MELanoma-20
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC31
DR   GEO; GSM2371756
DR   Wikidata; Q95982504
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02,32:01; B*44:02,62; C*03,05:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: KRAS mutation and STR profile from personal communication of Cardwell, Tracy.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D21S11: 27,30
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-24
AC   CVCL_UC32
SY   LM-Mel-24; Ludwig Melbourne-MELanoma-24
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC32
DR   GEO; GSM2371757
DR   Wikidata; Q95982508
RX   PubMed=18413770;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01,02; B*08,44; C*05,07 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 11,12
ST   D21S11: 30,30.2
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 8
ST   TPOX: 10,12
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-25
AC   CVCL_UC33
SY   LM-Mel-25; Ludwig Melbourne-MELanoma-25
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3330
DR   GEO; GSM2371758
DR   Wikidata; Q95982511
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: >70 hours (ATCC=CRL-3330).
CC   HLA typing: A*01:01,23:01; B*08:01,27:05; C*01:02,07:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Lung, left lower lobe; UBERON=UBERON_0008953.
ST   Source(s): ATCC=CRL-3330; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D21S11: 30,31.2
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-26
AC   CVCL_UC34
SY   LM-Mel-26; Ludwig Melbourne-MELanoma-26
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC34
DR   GEO; GSM2371759
DR   Wikidata; Q95982512
RX   PubMed=18413770;
RX   PubMed=18957296;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,24:02; B*07:02,27:05; C*01:02,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Thr992Ile (c.2975C>T) (p.Thr1010Ile, c.3029C>T); ClinVar=VCV000041624; Zygosity=Heterozygous (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: MET mutation and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   LM-MEL-27
AC   CVCL_UC35
SY   LM-Mel-27; Ludwig Melbourne-MELanoma-27
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371760
DR   Wikidata; Q95982513
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*11:01,33:01; B*08:01,35:01; C*04:01,07:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,13
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-28
AC   CVCL_UC36
SY   LM-Mel-28; Ludwig Melbourne-MELanoma-28
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3331
DR   cancercelllines; CVCL_UC36
DR   GEO; GSM2371761
DR   Wikidata; Q95982515
RX   PubMed=18413770;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: 45-55 hours (ATCC=CRL-3331).
CC   HLA typing: A*02:01; B*15:01,57:01; C*03:04,07:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): ATCC=CRL-3331; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D21S11: 28,29,32
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-29
AC   CVCL_UC37
SY   LM-Mel-29; Ludwig Melbourne-MELanoma-29
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371762
DR   Wikidata; Q95982517
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01; B*08:01; C*07:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D21S11: 28,29,30
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-3
AC   CVCL_UC18
SY   LM-Mel-3; Ludwig Melbourne-MELanoma-3
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC18
DR   GEO; GSM2371743
DR   Wikidata; Q95982518
RX   PubMed=18957296;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,24:02; B*07:02,08:01; C*07:01,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Pro124Leu (c.371C>T); ClinVar=VCV000040744; Zygosity=Heterozygous (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: MAP2K1 mutation, metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 13
//
ID   LM-MEL-30
AC   CVCL_UC38
SY   LM-Mel-30; Ludwig Melbourne-MELanoma-30
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3332
DR   cancercelllines; CVCL_UC38
DR   GEO; GSM2371763
DR   Wikidata; Q95982520
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,31:01; B*51:01,35:03; C*04:01,12:03 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ATCC=CRL-3332; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,14
ST   D16S539: 11,12
ST   D21S11: 30,31
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 9.3,10
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-31
AC   CVCL_UC39
SY   LM-Mel-31; Ludwig Melbourne-MELanoma-31
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC39
DR   GEO; GSM2371764
DR   Wikidata; Q95982521
RX   PubMed=18413770;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,24:02; B*44:03,40:01; C*03:04,04:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 8,13
ST   D21S11: 30,30.2
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-33
AC   CVCL_UC40
SY   LM-Mel-33; Ludwig Melbourne-MELanoma-33
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3333
DR   cancercelllines; CVCL_UC40
DR   GEO; GSM2371765
DR   Wikidata; Q95982522
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~55 hours (ATCC=CRL-3333).
CC   HLA typing: A*02:01,03:01; B*60,47; C*03:04,06:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): ATCC=CRL-3333; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,13
ST   D16S539: 12
ST   D21S11: 30,32.2
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-34
AC   CVCL_UC41
SY   LM-Mel-34; Ludwig Melbourne-MELanoma-34
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371766
DR   Wikidata; Q95982523
RX   PubMed=18413770;
RX   PubMed=19221743;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,26:01; B*27:03,56:01; C*01:02,03:03 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D21S11: 29,32.2
ST   D5S818: 8,12
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   LM-MEL-35
AC   CVCL_UC42
SY   LM-Mel-35; Ludwig Melbourne-MELanoma-35
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC42
DR   GEO; GSM2371767
DR   Wikidata; Q95982524
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,26:01; B*08:01,27:05; C*01:02,07:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D21S11: 29,30,31.2,33
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-36
AC   CVCL_UC43
SY   LM-Mel-36; Ludwig Melbourne-MELanoma-36
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC43
DR   GEO; GSM2371768
DR   Wikidata; Q95982526
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*24:02,25:01; B*39:01,39:06; C*07:02,12:03 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D21S11: 29,30
ST   D5S818: 10
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-38a
AC   CVCL_UC44
SY   LM-Mel-38a; LM-MEL-38; Ludwig Melbourne-MELanoma-38a
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC44
DR   GEO; GSM2371769
DR   Wikidata; Q95982528
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,03:01; B*07:02,57.01; C*06,07 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D21S11: 32
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC50 ! LM-MEL-45
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-39
AC   CVCL_UC45
SY   LM-Mel-39; Ludwig Melbourne-MELanoma-39
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371770
DR   Wikidata; Q95982529
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*03:01,32:01; B*15:01,40:01; C*03:03,03.04 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-4
AC   CVCL_UC19
SY   LM-Mel-4; Ludwig Melbourne-MELanoma-4
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC19
DR   GEO; GSM2371744
DR   Wikidata; Q95982531
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*68:01,11:01; B*07:02,08:01; C*07:02,07:04 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 8
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-40
AC   CVCL_UC46
SY   LM-Mel-40; Ludwig Melbourne-MELanoma-40
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC46
DR   GEO; GSM2371771
DR   Wikidata; Q95982532
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*32:01; B*08:01,51:01; C*07:01,14:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Glu (c.1406G>A) (p.Gly509Glu, c.1526G>A); ClinVar=VCV000013974; Zygosity=Unspecified (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D21S11: 27,28
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-41
AC   CVCL_UC47
SY   LM-Mel-41; Ludwig Melbourne-MELanoma-41
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3334
DR   cancercelllines; CVCL_UC47
DR   GEO; GSM2371772
DR   Wikidata; Q95982534
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,02:01; B*49:01,51:01; C*06:02,14:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): ATCC=CRL-3334; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D21S11: 28,31.2
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-42
AC   CVCL_UC48
SY   LM-Mel-42; Ludwig Melbourne-MELanoma-42
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3335
DR   cancercelllines; CVCL_UC48
DR   GEO; GSM2371773
DR   Wikidata; Q95982535
RX   PubMed=19221743;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~38 hours (ATCC=CRL-3335).
CC   HLA typing: A*11:01,02:01; B*55,27; C*03 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-3335; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 29
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-44
AC   CVCL_UC49
SY   LM-Mel-44; Ludwig Melbourne-MELanoma-44
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371774
DR   Wikidata; Q95982537
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01; B*60,44:02; C*03:04,05:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9,13
ST   D16S539: 12
ST   D21S11: 28,30,32,33
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC56 ! LM-MEL-53
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   LM-MEL-45
AC   CVCL_UC50
SY   LM-Mel-45; Ludwig Melbourne-MELanoma-45
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3336
DR   cancercelllines; CVCL_UC50
DR   GEO; GSM2371775
DR   Wikidata; Q95982538
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~40 hours (ATCC=CRL-3336).
CC   HLA typing: A*02:01,03:01; B*07:02,57:01; C*06:02,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Brain, right occipital lobe; UBERON=UBERON_0002807.
ST   Source(s): ATCC=CRL-3336; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D21S11: 32
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC44 ! LM-MEL-38a
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-46
AC   CVCL_UC51
SY   LM-Mel-46; Ludwig Melbourne-MELanoma-46
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC51
DR   GEO; GSM2371776
DR   Wikidata; Q95982539
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,03:01; B*45:01,62; C*03:04,06:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Heart; UBERON=UBERON_0000948.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,15
ST   D21S11: 27,30
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-47
AC   CVCL_UC52
SY   LM-Mel-47; Ludwig Melbourne-MELanoma-47
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC52
DR   GEO; GSM2371777
DR   Wikidata; Q95982541
RX   PubMed=18413770;
RX   PubMed=19221743;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01; B*62; C*03:04 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 27
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-48
AC   CVCL_UC53
SY   LM-Mel-48; Ludwig Melbourne-MELanoma-48
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371778
DR   Wikidata; Q95982543
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01,32; B*08,14; C*07,08 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D21S11: 27,31
ST   D5S818: 12,14
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   LM-MEL-49
AC   CVCL_UC54
SY   LM-Mel-49; Ludwig Melbourne-MELanoma-49
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC54
DR   GEO; GSM2371779
DR   Wikidata; Q95982544
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*29,32; B*65,44; C*08,16 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 28,29
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-50
AC   CVCL_UC55
SY   LM-Mel-50; Ludwig Melbourne-MELanoma-50
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC55
DR   GEO; GSM2371780
DR   Wikidata; Q95982545
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*29:02,68:01; B*65,44:03; C*08:02,16:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D21S11: 28,32
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   LM-MEL-51
AC   CVCL_UH54
SY   LM-Mel-51; Ludwig Melbourne-MELanoma-51
DR   Wikidata; Q95982546
RX   PubMed=22970293;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Miscellaneous: Cell line information from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 32.2
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 6
//
ID   LM-MEL-53
AC   CVCL_UC56
SY   LM-Mel-53; Ludwig Melbourne-MELanoma-53
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3337
DR   GEO; GSM2371781
DR   Wikidata; Q95982547
RX   PubMed=18413770;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~40 hours (ATCC=CRL-3337).
CC   HLA typing: A*02:01; B*60,44:02; C*03:04,05:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
ST   Source(s): ATCC=CRL-3337; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9,13
ST   D16S539: 12
ST   D21S11: 28,30,32,33
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC49 ! LM-MEL-44
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-57
AC   CVCL_UC57
SY   LM-Mel-57; Ludwig Melbourne-MELanoma-57
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3338
DR   GEO; GSM2371782
DR   Wikidata; Q95982551
RX   PubMed=22102544;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,02:01; B*08:01,57:01; C*06:02,07:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Lung, right upper lobe; UBERON=UBERON_0002170.
ST   Source(s): ATCC=CRL-3338; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   LM-MEL-59
AC   CVCL_UC58
SY   LM-Mel-59; Ludwig Melbourne-MELanoma-59
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371783
DR   Wikidata; Q95982553
RX   PubMed=22102544;
RX   PubMed=22970293;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*11:01,24:02; B*18:01,52:01; C*07:01,12:02 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-5a
AC   CVCL_UC20
SY   LM-Mel-5a; LM-MEL-5; Ludwig Melbourne-MELanoma-5a
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC20
DR   GEO; GSM2371745
DR   Wikidata; Q95982554
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,03:01; B*07:02,57:01; C*06:02,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor, metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D21S11: 29,30
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-6
AC   CVCL_UC21
SY   LM-Mel-6; Ludwig Melbourne-MELanoma-6
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC21
DR   GEO; GSM2371746
DR   Wikidata; Q95982555
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*03:01,68:01; B*61,53:01; C*02:02,04:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 12,13
ST   D16S539: 11
ST   D21S11: 28,31,31.2
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-60
AC   CVCL_UC59
SY   LM-Mel-60; Ludwig Melbourne-MELanoma-60
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC59
DR   GEO; GSM2371784
DR   Wikidata; Q95982556
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*24:02; B*08:01,35:03; C*07,04 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D21S11: 28,30
ST   D5S818: 9
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   LM-MEL-62
AC   CVCL_UC60
SY   LM-Mel-62; Ludwig Melbourne-MELanoma-62
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3339
DR   cancercelllines; CVCL_UC60
DR   GEO; GSM2371785
DR   Wikidata; Q95982557
RX   PubMed=19221743;
RX   PubMed=22102544;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~38 hours (ATCC=CRL-3339).
CC   HLA typing: A*02:01,31:01; B*07:02,60; C*03:04,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Glu (c.1406G>A) (p.Gly509Glu, c.1526G>A); ClinVar=VCV000013974; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ATCC=CRL-3339; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 10
ST   D21S11: 29,30
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   LM-MEL-64
AC   CVCL_UC61
SY   LM-Mel-64; Ludwig Melbourne-MELanoma-64
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC61
DR   GEO; GSM2371786
DR   Wikidata; Q95982559
RX   PubMed=22102544;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,11:01; B*15:01,27:05; C*01:02,03:03 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 13
ST   D21S11: 31,31.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC63 ! LM-MEL-70
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-69
AC   CVCL_UC62
SY   LM-Mel-69; Ludwig Melbourne-MELanoma-69
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371787
DR   Wikidata; Q95982561
RX   PubMed=22102544;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01; B*39:01,60; C*03:04,12:03 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D21S11: 28,29
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-7
AC   CVCL_UC22
SY   LM-Mel-7; Ludwig Melbourne-MELanoma-7
DR   GEO; GSM2371747
DR   Wikidata; Q95982563
RX   PubMed=18413770;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*11,30; B*18,56; C*w01,w05; DRB1*02,03 (Direct_author_submission).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site, HLA typing and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 28,30
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-70
AC   CVCL_UC63
SY   LM-Mel-70; Ludwig Melbourne-MELanoma-70
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC63
DR   GEO; GSM2371788
DR   Wikidata; Q95982564
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01,11; B*15,27; C*01,03:03 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 13
ST   D21S11: 31,31.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UC61 ! LM-MEL-64
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-71
AC   CVCL_UC64
SY   LM-Mel-71; Ludwig Melbourne-MELanoma-71
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3340
DR   cancercelllines; CVCL_UC64
DR   GEO; GSM2371789
DR   Wikidata; Q95982565
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: ~45-50 hours (ATCC=CRL-3340).
CC   HLA typing: A*02:01; B*07:02,44:02; C*05:01,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Brain, right occipital lobe; UBERON=UBERON_0002807.
ST   Source(s): ATCC=CRL-3340; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   LM-MEL-73
AC   CVCL_UC65
SY   LM-Mel-73; Ludwig Melbourne-MELanoma-73
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC65
DR   GEO; GSM2371790
DR   Wikidata; Q95982566
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,03:01; B*27:05,44:02; C*02:02,05:01 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: PTK2B mutation, metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D21S11: 29,30,31
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 14,15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 13
//
ID   LM-MEL-75
AC   CVCL_UC66
SY   LM-Mel-75; Ludwig Melbourne-MELanoma-75
DR   ArrayExpress; E-MTAB-1496
DR   ATCC; CRL-3341
DR   GEO; GSM2371791
DR   Wikidata; Q95982567
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   Doubling time: 70 hours (ATCC=CRL-3341).
CC   HLA typing: A*24:02,29:02; B*38:01,44:03; C*12:03,16:01 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ATCC=CRL-3341; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D21S11: 28
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   LM-MEL-77
AC   CVCL_UC67
SY   LM-Mel-77; Ludwig Melbourne-MELanoma-77
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371792
DR   Wikidata; Q95982568
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01,02; B*08; C*07 (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   LM-MEL-8
AC   CVCL_UC23
SY   LM-Mel-8; Ludwig Melbourne-MELanoma-8
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC23
DR   GEO; GSM2371748
DR   Wikidata; Q95982569
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,29:02; B*07:02,08:01; C*07:01,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D21S11: 29,30,31
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-MEL-82
AC   CVCL_UC68
SY   LM-Mel-82; Ludwig Melbourne-MELanoma-82
DR   GEO; GSM2371793
DR   Wikidata; Q95982571
RX   PubMed=22102544;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01; B*08,40; C*03,07; DRB1*04,15 (Direct_author_submission).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age/sex of donor, metastatic site, HLA typing and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 10
ST   D21S11: 28
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   LM-MEL-9
AC   CVCL_UC24
SY   LM-Mel-9; Ludwig Melbourne-MELanoma-9
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC24
DR   GEO; GSM2371749
DR   Wikidata; Q95982573
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*01:01,11:01; B*51:01,57:01; C*06:02,15:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: Age of donor, metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   LM-MEL-97
AC   CVCL_UC69
SY   LM-Mel-97; Ludwig Melbourne-MELanoma-97
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC69
DR   GEO; GSM2371794
DR   Wikidata; Q95982574
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02,11; B*15,35; C*03,04 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Leu576Pro (c.1727T>C); ClinVar=VCV000375919; Zygosity=Heterozygous (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: KIT mutation, metastatic site and STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D21S11: 28
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   LM-MEL-98
AC   CVCL_UC70
SY   LM-Mel-98; Ludwig Melbourne-MELanoma-98
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC70
DR   GEO; GSM2371795
DR   Wikidata; Q95982575
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02,24; B*15,57; C*06,07 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell, Tracy.
CC   Derived from site: Metastatic; Bone, spine; UBERON=UBERON_0001130.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15,16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 9
//
ID   LM-NSC008
AC   CVCL_LJ42
SY   LM008; L-MYC-Neural Stem Cell 008
DR   ABM; T0682
DR   GEO; GSM2228431
DR   GEO; GSM2228432
DR   GEO; GSM2228435
DR   Kerafast; ECH002
DR   Wikidata; Q54902722
RX   PubMed=27546534;
RX   PubMed=30071048;
CC   Doubling time: ~30 hours (PubMed=27546534).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7555; MYCL.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Discontinued: ABM; T0682; true.
CC   Discontinued: Kerafast; ECH002; true.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-14FW
CA   Somatic stem cell
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 15
//
ID   LM-Y1
AC   CVCL_VN50
SY   LMY1
DR   IARC_TP53; 27000
DR   Wikidata; Q95982579
RX   CelloPub=CLPUB00592;
RX   PubMed=15638862;
RX   PubMed=19220422;
RX   PubMed=19710698;
RX   PubMed=27193821;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Asn1171del (c.3512_3514delATT); Zygosity=Heterozygous (CelloPub=CLPUB00592).
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Arg1252Pro (c.3755G>C); Zygosity=Heterozygous (CelloPub=CLPUB00592).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   LM-Y2
AC   CVCL_VN51
SY   LMY2
DR   Wikidata; Q95982580
RX   PubMed=15638862;
RX   PubMed=27193821;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   LM/DM
AC   CVCL_E9XH
RX   PubMed=4333773;
CC   Group: Non-human primate cell line.
CC   Doubling time: 28-32 hours (PubMed=4333773).
CC   Transformant: ChEBI; CHEBI_71417; Procarbazine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C222358; Rhesus monkey leukemia
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   5-6Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   LM00001
AC   CVCL_9Z21
DR   CLO; CLO_0030021
DR   Coriell; LM00001
DR   Wikidata; Q54902723
WW   Info; Coriell; LM00001; https://catalog.coriell.org/0/PDF/LMS/LM00001.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00001; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00002
AC   CVCL_9Z22
DR   CLO; CLO_0030009
DR   Coriell; LM00002
DR   Wikidata; Q54902724
WW   Info; Coriell; LM00002; https://catalog.coriell.org/0/PDF/LMS/LM00002.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00002; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00004
AC   CVCL_9Z23
DR   CLO; CLO_0030012
DR   Coriell; LM00004
DR   Wikidata; Q54902725
WW   Info; Coriell; LM00004; https://catalog.coriell.org/0/PDF/LMS/LM00004.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00004; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00005
AC   CVCL_9Z24
DR   CLO; CLO_0030014
DR   Coriell; LM00005
DR   Wikidata; Q54902726
WW   Info; Coriell; LM00005; https://catalog.coriell.org/0/PDF/LMS/LM00005.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00005; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00006
AC   CVCL_9Z25
DR   CLO; CLO_0030016
DR   Coriell; LM00006
DR   Wikidata; Q54902727
WW   Info; Coriell; LM00006; https://catalog.coriell.org/0/PDF/LMS/LM00006.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00006; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00007
AC   CVCL_9Z26
DR   CLO; CLO_0030023
DR   Coriell; LM00007
DR   Wikidata; Q54902728
WW   Info; Coriell; LM00007; https://catalog.coriell.org/0/PDF/LMS/LM00007.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00007; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00008
AC   CVCL_9Z27
DR   CLO; CLO_0030025
DR   Coriell; LM00008
DR   Wikidata; Q54902729
WW   Info; Coriell; LM00008; https://catalog.coriell.org/0/PDF/LMS/LM00008.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00008; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00010
AC   CVCL_9Z28
DR   CLO; CLO_0030084
DR   Coriell; LM00010
DR   Wikidata; Q54902730
WW   Info; Coriell; LM00010; https://catalog.coriell.org/0/PDF/LMS/LM00010.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00010; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00011
AC   CVCL_9Z29
DR   CLO; CLO_0030092
DR   Coriell; LM00011
DR   Wikidata; Q54902731
WW   Info; Coriell; LM00011; https://catalog.coriell.org/0/PDF/LMS/LM00011.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00011; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00013
AC   CVCL_9Z30
DR   CLO; CLO_0030091
DR   Coriell; LM00013
DR   Wikidata; Q54902732
WW   Info; Coriell; LM00013; https://catalog.coriell.org/0/PDF/LMS/LM00013.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00013; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00014
AC   CVCL_9Z31
DR   CLO; CLO_0030090
DR   Coriell; LM00014
DR   Wikidata; Q54902733
WW   Info; Coriell; LM00014; https://catalog.coriell.org/0/PDF/LMS/LM00014.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00014; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00015
AC   CVCL_9Z32
DR   CLO; CLO_0030089
DR   Coriell; LM00015
DR   Wikidata; Q54902734
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00015; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   LM00016
AC   CVCL_9Z33
DR   CLO; CLO_0030097
DR   Coriell; LM00016
DR   Wikidata; Q54902735
WW   Info; Coriell; LM00016; https://catalog.coriell.org/0/PDF/LMS/LM00016.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00016; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 6
//
ID   LM00020
AC   CVCL_9Z34
DR   CLO; CLO_0030095
DR   Coriell; LM00020
DR   Wikidata; Q54902736
WW   Info; Coriell; LM00020; https://catalog.coriell.org/0/PDF/LMS/LM00020.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00020; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 5
//
ID   LM00021
AC   CVCL_9Z35
DR   CLO; CLO_0030094
DR   Coriell; LM00021
DR   Wikidata; Q54902737
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00021; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   LM00023
AC   CVCL_9Z36
DR   CLO; CLO_0030093
DR   Coriell; LM00023
DR   Wikidata; Q54902738
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00023; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   LM00024
AC   CVCL_9Z37
DR   CLO; CLO_0030088
DR   Coriell; LM00024
DR   Wikidata; Q54902739
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00024; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   LM00027
AC   CVCL_9Z38
DR   CLO; CLO_0030056
DR   Coriell; LM00027
DR   Wikidata; Q54902740
WW   Info; Coriell; LM00027; https://catalog.coriell.org/0/PDF/LMS/LM00027.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00027; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 5
//
ID   LM00031
AC   CVCL_9Z39
DR   CLO; CLO_0030061
DR   Coriell; LM00031
DR   Wikidata; Q54902741
WW   Info; Coriell; LM00031; https://catalog.coriell.org/0/PDF/LMS/LM00031.pdf
CC   Part of: Leiomyosarcoma cell and DNA repository.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; LM00031; probable.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 5
//
ID   LM1 [Mouse lung adenoma]
AC   CVCL_5V01
DR   Wikidata; Q54902742
RX   PubMed=9347924;
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: A/J.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 6
//
ID   LM1 [Rat hybridoma against arabinogalactan]
AC   CVCL_C3BG
DR   Wikidata; Q114311881
RX   PubMed=7544182;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LM10
AC   CVCL_C3BH
DR   Wikidata; Q114311882
RX   PubMed=15805428;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LM11
AC   CVCL_C3BI
DR   Wikidata; Q114311883
RX   PubMed=15805428;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Xylan-4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LM142
AC   CVCL_KS88
SY   mAb 142
DR   Wikidata; Q54902743
RX   Patent=WO1989005155A1;
RX   PubMed=2442758;
RX   PubMed=2447074;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   LM156
AC   CVCL_VL38
DR   ABM; T8332
DR   cancercelllines; CVCL_VL38
DR   Cosmic; 2806958
DR   Wikidata; Q95982619
RX   PubMed=29880898;
CC   Population: Chinese.
CC   Doubling time: 34.43 hours (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=29880898).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=29880898
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   LM17
AC   CVCL_0A66
DR   Wikidata; Q54902744
RX   PubMed=11089883;
CC   Characteristics: Highly metastatic to lung.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   LM2
AC   CVCL_5V02
DR   Wikidata; Q54902745
RX   PubMed=9347924;
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: A/J.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 6
//
ID   LM2/1.6.11
AC   CVCL_J833
SY   LM2/1
DR   CLO; CLO_0007355
DR   ATCC; HB-204
DR   NCBI_Iran; H159
DR   Wikidata; Q54902746
RX   PubMed=2428876;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   LM205
AC   CVCL_C1HS
DR   Wikidata; Q114311884
RX   PubMed=1972815;
RX   PubMed=2431271;
RX   PubMed=2835823;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0335 ! Hs27
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   LM205 subclone RS-4
AC   CVCL_D4CA
SY   RS-4
DR   Wikidata; Q127382596
RX   PubMed=2835823;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_42768; Geneticin (G418).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1HS ! LM205
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LM216
AC   CVCL_C1HT
DR   Wikidata; Q114311885
RX   PubMed=2431271;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0335 ! Hs27
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   LM217
AC   CVCL_C1HU
DR   Wikidata; Q114311887
RX   PubMed=1972815;
RX   PubMed=2431271;
RX   PubMed=8423817;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLR309).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0335 ! Hs27
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   LM3
AC   CVCL_D269
DR   Wikidata; Q54902747
RX   PubMed=21528237;
CC   Characteristics: Established from the M3 transplantable tumor.
CC   Doubling time: 19 +- 0.5 hours (PubMed=21528237).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D270 ! LMM3
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LM38-D2
AC   CVCL_B7PZ
DR   Wikidata; Q112930011
RX   PubMed=14979922;
CC   Doubling time: 33 +- 2.4 hours (PubMed=14979922).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7PY ! LM38-LP
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   LM38-HP
AC   CVCL_B7PX
SY   LM38-High Passage
DR   Wikidata; Q112930012
RX   PubMed=14979922;
CC   Characteristics: Established from the mouse M38 transplantable tumor. M38 is a spontaneously arising well differentiated ductal papillary adenocarcinoma (PubMed=14979922).
CC   Doubling time: 10 +- 0.6 hours (PubMed=14979922).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B7PY ! LM38-LP
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 5
//
ID   LM38-LP
AC   CVCL_B7PY
SY   LM38-Low Passage
DR   Wikidata; Q112930013
RX   PubMed=14979922;
RX   PubMed=33723318;
CC   Characteristics: Established from the mouse M38 transplantable tumor. M38 is a spontaneously arising well differentiated ductal papillary adenocarcinoma (PubMed=14979922).
CC   Doubling time: 18 +- 1.1 hours (PubMed=14979922).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B7PX ! LM38-HP
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   LM5
AC   CVCL_C3BJ
DR   Wikidata; Q114311888
RX   PubMed=12223681;
RX   PubMed=20363856;
RX   PubMed=27855335;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_62776; (1->4)-beta-D-galactan (Beta-1,4-galactan).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   LM6
AC   CVCL_C3BL
DR   Wikidata; Q114311889
RX   PubMed=9675359;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Pectic polysaccharide, alpha-1,5-arabinan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LM609
AC   CVCL_KS89
DR   Wikidata; Q54902748
RX   Patent=WO1989005155A1;
RX   PubMed=2442758;
RX   PubMed=2447074;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9537.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   LM9
AC   CVCL_C3BK
DR   Wikidata; Q114311890
RX   PubMed=15221383;
RX   PubMed=20363856;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Feruloylated beta-1,4-galactan.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LMab-1
AC   CVCL_D3E4
DR   Wikidata; Q127382597
RX   PubMed=23750482;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132Leu).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   LMB-L
AC   CVCL_C6N8
SY   Lateolabrax Maculatus Brain-L
DR   Wikidata; Q116049711
RX   PubMed=36028055;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by Lateolabrax maculatus iridovirus (LMIV) (PubMed=36028055).
CC   Donor information: Established from brains pooled from three individuals (PubMed=36028055).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=315492; ! Lateolabrax maculatus (Spotted sea bass)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LMB-M
AC   CVCL_C6N9
SY   Lateolabrax Maculatus Brain-M
DR   Wikidata; Q116049712
RX   PubMed=36028055;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Lateolabrax maculatus iridovirus (LMIV) (PubMed=36028055).
CC   Donor information: Established from brains pooled from three individuals (PubMed=36028055).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=315492; ! Lateolabrax maculatus (Spotted sea bass)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LMB-S
AC   CVCL_C6NA
SY   Lateolabrax Maculatus Brain-S
DR   Wikidata; Q116049713
RX   PubMed=36028055;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Lateolabrax maculatus iridovirus (LMIV) (PubMed=36028055).
CC   Donor information: Established from brains pooled from three individuals (PubMed=36028055).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=315492; ! Lateolabrax maculatus (Spotted sea bass)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LMBG
AC   CVCL_Y084
SY   LargeMouth Bass Gonad
DR   Wikidata; Q54902750
RX   PubMed=25229492;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=27706; ! Micropterus salmoides (Largemouth bass)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   LMCAT
AC   CVCL_WY44
DR   Wikidata; Q95982628
RX   PubMed=7681058;
RX   PubMed=9712407;
CC   Characteristics: Transfected with the pMMTV-CAT plasmid.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   LmcMF
AC   CVCL_T066
DR   Wikidata; Q54902751
RX   PubMed=23674870;
CC   Doubling time: 19.1 hours (PubMed=23674870).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
CC   Cell type: Myofibroblast; CL=CL_0000186.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   LMeC
AC   CVCL_L361
DR   Wikidata; Q54902752
RX   PubMed=15585963;
RX   PubMed=24035468;
RX   PubMed=28283079;
RX   PubMed=30268330;
CC   Doubling time: 34.1 +- 5.61 hours (PubMed=15585963).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   LMF3
AC   CVCL_W514
DR   Wikidata; Q54902755
RX   PubMed=2585303;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1288 ! HSC-3
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   LMF4
AC   CVCL_W515
DR   Wikidata; Q54902756
RX   PubMed=2585303;
RX   PubMed=11755821;
RX   PubMed=16127291;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1288 ! HSC-3
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   LMF5
AC   CVCL_W516
DR   Wikidata; Q54902757
RX   PubMed=2585303;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1288 ! HSC-3
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   LMH
AC   CVCL_2580
SY   Leghorn Male Hepatoma cell line
DR   CLO; CLO_0007359
DR   ATCC; CRL-2117
DR   BCRC; 60320
DR   CCLV; CCLV-RIE 0417
DR   CLS; 601411
DR   JCRB; JCRB0237
DR   NCBI_Iran; C592
DR   TOKU-E; 2215
DR   Wikidata; Q54902758
RX   PubMed=2330000;
RX   PubMed=2352324;
RX   PubMed=3607775;
RX   PubMed=10564780;
RX   PubMed=19941903;
RX   PubMed=29720272;
RX   PubMed=34737324;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-71.html
CC   Group: Bird cell line.
CC   Virology: Efficient cell line for duck hepatitis B virus (DHBV) DNA synthesis following transfection with viral constructs (PubMed=2352324).
CC   Virology: Efficiently supports the replication of avian leukosis virus subgroup J (ALV-J) (PubMed=29720272).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: White Leghorn L-M.
DI   NCIt; C134558; Chicken hepatoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   LMH serum-free suspension
AC   CVCL_A3FF
DR   CCRID; 4201PAT-CCTCC01809
DR   Wikidata; Q105509915
RX   Patent=CN111548996A;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202072.
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: White Leghorn L-M.
DI   NCIt; C134558; Chicken hepatoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_2580 ! LMH
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   LMH/2A
AC   CVCL_3465
SY   LMH2A
DR   CLO; CLO_0007360
DR   ATCC; CRL-2118
DR   Wikidata; Q54902759
RX   PubMed=2330000;
CC   Group: Bird cell line.
CC   Genetic integration: Method=Transfection; Gene=CGNC; 9821; ESR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: White Leghorn L-M.
DI   NCIt; C134558; Chicken hepatoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_2580 ! LMH
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   LMH17
AC   CVCL_B3UP
DR   Wikidata; Q110433005
RX   CelloPub=CLPUB00665;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   LMK
AC   CVCL_E7BL
SY   Lateolabrax Maculatus Kidney
RX   DOI=10.1016/j.aquaculture.2024.741612;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by largemouth bass ranavirus (LMBV) and red sea bream iridovirus (RSIV) (DOI=10.1016/j.aquaculture.2024.741612).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=315492; ! Lateolabrax maculatus (Spotted sea bass)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LMM102
AC   CVCL_B3QS
DR   Wikidata; Q110433006
RX   PubMed=1706312;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   LMM111
AC   CVCL_B3QT
DR   Wikidata; Q110433007
RX   PubMed=1706312;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   LMM117
AC   CVCL_B3QU
DR   Wikidata; Q110433008
RX   PubMed=1706312;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   LMM3
AC   CVCL_D270
DR   ChEMBL-Cells; CHEMBL3307862
DR   ChEMBL-Targets; CHEMBL614095
DR   PubChem_Cell_line; CVCL_D270
DR   Wikidata; Q54902760
RX   PubMed=9754657;
RX   PubMed=10417775;
RX   PubMed=21528237;
CC   Characteristics: Established from the MM3 variant of the M3 transplantable tumor.
CC   Doubling time: 19 +- 0.5 hours (PubMed=21528237).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D269 ! LM3
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   LMM3 FN RGD/LAV
AC   CVCL_C0I3
SY   FN RGD/LAV
DR   Wikidata; Q112930014
RX   PubMed=9754657;
RX   PubMed=10417775;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3778; FN1 (Note=With p.Arg1615Leu, p.Gly1616Ala and p.Asp1617Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D270 ! LMM3
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   LMM3 FN RGD/LGD
AC   CVCL_C0I4
SY   FN RGD/LGD
DR   Wikidata; Q112930015
RX   PubMed=9754657;
RX   PubMed=10417775;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3778; FN1 (Note=With p.Arg1615Leu).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D270 ! LMM3
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   LMM3 FNwt10
AC   CVCL_C0I2
SY   FNwt10
DR   Wikidata; Q112930016
RX   PubMed=9754657;
RX   PubMed=10417775;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3778; FN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D270 ! LMM3
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   LMM3 FNwt2
AC   CVCL_C0I1
SY   FNwt2
DR   Wikidata; Q112930018
RX   PubMed=9754657;
RX   PubMed=10417775;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3778; FN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D270 ! LMM3
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   LMS03
AC   CVCL_5H98
DR   Cosmic; 1834894
DR   Wikidata; Q54902761
RX   PubMed=19706776;
RX   PubMed=22919280;
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 4
//
ID   LMS04
AC   CVCL_5H99
DR   Cosmic; 1834893
DR   Wikidata; Q54902762
RX   PubMed=22294416;
RX   PubMed=22919280;
DI   NCIt; C27904; Retroperitoneal leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 4
//
ID   LMS05
AC   CVCL_5I00
DR   cancercelllines; CVCL_5I00
DR   Cosmic; 1834892
DR   GEO; GSM482504
DR   Progenetix; CVCL_5I00
DR   Wikidata; Q54902763
RX   PubMed=22294416;
RX   PubMed=22919280;
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 7
//
ID   LMS148L
AC   CVCL_M822
DR   Cosmic; 1608986
DR   GEO; GSM623743
DR   Wikidata; Q54902764
RX   PubMed=19276386;
RX   PubMed=22080063;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C27904; Retroperitoneal leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   LMS6-93
AC   CVCL_WV02
DR   IARC_TP53; 10309
DR   Wikidata; Q95982648
RX   PubMed=9664117;
RX   PubMed=10737722;
CC   Doubling time: 20.3 +- 5.1 hours (PubMed=9664117).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214fs (c.642_643insG); Zygosity=Heterozygous (PubMed=9664117).
CC   Derived from site: In situ; Lung, smooth muscle; UBERON=UBERON_0004225.
DI   NCIt; C5667; Lung leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 7
//
ID   LMSU
AC   CVCL_4849
DR   CLO; CLO_0050800
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472154
DR   BioSample; SAMN10987709
DR   cancercelllines; CVCL_4849
DR   Cell_Model_Passport; SIDM01368
DR   DepMap; ACH-000255
DR   GEO; GSM887268
DR   GEO; GSM888343
DR   IARC_TP53; 28355
DR   LiGeA; CCLE_522
DR   PharmacoDB; LMSU_838_2019
DR   Progenetix; CVCL_4849
DR   RCB; RCB1062
DR   Wikidata; Q54902765
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*13:01,52:01; C*03:04,12:02; DQA1*03:02,05:02; DQB1*02:02,03:04; DRB1*12:01,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (DepMap=ACH-000255).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.29%; Native American=0.32%; East Asian, North=85.74%; East Asian, South=12.36%; South Asian=0.58%; European, North=0%; European, South=0.71% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB1062
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 16
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   LMWT5
AC   CVCL_VN52
DR   Wikidata; Q95982649
RX   CelloPub=CLPUB00592;
RX   PubMed=27193821;
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Ser520Phe (c.1559C>T); Zygosity=Heterozygous (CelloPub=CLPUB00592).
CC   Sequence variation: Mutation; HGNC; HGNC:9065; PLCG1; Simple; p.Arg748His (c.2243G>A); Zygosity=Heterozygous (CelloPub=CLPUB00592).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   LN 14832
AC   CVCL_1T05
DR   Wikidata; Q54902766
RX   Patent=US6994861;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Grand-parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12231.
CC   Characteristics: In vitro infected by the NC-1 strain of Neospora caninum.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_4540 ! MARC-145
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 17
//
ID   LN-1049
AC   CVCL_LI20
DR   Wikidata; Q54902767
RX   PubMed=2989064;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=2989064).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=2989064).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI21 ! PB-1049
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   LN-18
AC   CVCL_0392
SY   LN 18; LN18; LN018
DR   BTO; BTO_0002005
DR   CLO; CLO_0007362
DR   EFO; EFO_0006636
DR   MCCL; MCC:0000287
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2610
DR   BCRJ; 0420
DR   BioGRID_ORCS_Cell_line; 410
DR   BioSample; SAMN03471122
DR   BioSample; SAMN10988197
DR   cancercelllines; CVCL_0392
DR   Cell_Model_Passport; SIDM00685
DR   ChEMBL-Cells; CHEMBL4295405
DR   ChEMBL-Targets; CHEMBL4296458
DR   Cosmic; 849858
DR   Cosmic; 1746957
DR   Cosmic; 1995484
DR   Cosmic; 2302322
DR   Cosmic; 2367489
DR   Cosmic; 2491101
DR   Cosmic-CLP; 1240168
DR   DepMap; ACH-000819
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240168
DR   GEO; GSM326196
DR   GEO; GSM397661
DR   GEO; GSM397662
DR   GEO; GSM887269
DR   GEO; GSM888344
DR   GEO; GSM1374620
DR   GEO; GSM1670048
DR   IARC_TP53; 2570
DR   LiGeA; CCLE_635
DR   LINCS_LDP; LCL-1353
DR   Lonza; 1681
DR   PharmacoDB; LN18_839_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0392
DR   PubChem_Cell_line; CVCL_0392
DR   Wikidata; Q54902768
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7211194;
RX   PubMed=7693337;
RX   PubMed=7732013;
RX   PubMed=8509230;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=21406405;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=26496030;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=7211194); 33 hours (PubMed=9842975).
CC   HLA typing: A*02:01,24:02; B*35:03,51:01; C*04:01,14:02; DQA1*03:02,05:02; DQB1*04:02,04:02; DRB1*14:05,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975).
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Glu1051Lys (c.3151G>A); Zygosity=Homozygous (Cosmic-CLP=1240168; DepMap=ACH-000819).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Ser (c.713G>C); ClinVar=VCV000376575; Zygosity=Homozygous (PubMed=7732013; PubMed=10416987; PubMed=14614447; Cosmic-CLP=1240168; DepMap=ACH-000819).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.83%; Native American=0.22%; East Asian, North=3.7%; East Asian, South=0%; South Asian=0.94%; European, North=53.19%; European, South=41.12% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): ATCC=CRL-2610; Cosmic-CLP=1240168; PubMed=22570425; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 17,19
ST   D19S433: 12,15
ST   D21S11: 28
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 19,23
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   LN-215
AC   CVCL_3954
SY   LN 215; LN215
DR   BTO; BTO_0004456
DR   BioSample; SAMN10988402
DR   cancercelllines; CVCL_3954
DR   Cell_Model_Passport; SIDM01644
DR   Cosmic; 849860
DR   Cosmic; 2367490
DR   Cosmic; 2516024
DR   DepMap; ACH-000328
DR   GEO; GSM397663
DR   GEO; GSM397664
DR   PharmacoDB; LN215_840_2019
DR   Wikidata; Q54902769
RX   PubMed=2990147;
RX   PubMed=7693337;
RX   PubMed=8509230;
RX   PubMed=10416987;
RX   PubMed=21406405;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 28 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191_Gln192del; Zygosity=Heterozygous (PubMed=10416987; DepMap=ACH-000328).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, temporo-occipital lobe.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 29
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 7,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   LN-2207
AC   CVCL_S442
DR   GEO; GSM2794470
DR   GEO; GSM2794471
DR   GEO; GSM2794472
DR   GEO; GSM2889487
DR   Wikidata; Q54902770
RX   PubMed=22570425;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from autologous cell line LN-2207GS).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 11,14
ST   D21S11: 30,31
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS27 ! LN-2207GS
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   LN-2207GS
AC   CVCL_WS27
DR   GEO; GSM1469038
DR   GEO; GSM2794458
DR   GEO; GSM2794459
DR   GEO; GSM2794460
DR   GEO; GSM2889486
DR   Wikidata; Q95982660
RX   PubMed=21097691;
RX   PubMed=22570425;
RX   PubMed=25622821;
CC   Characteristics: Glioma-derived sphere line. Non-tumorigenic in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=22570425).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: STR profile from personal communication of Gusyatiner, Olga.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D10S1248: 14
ST   D12S391: 18,19
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 11,14
ST   D19S433: 13,14
ST   D1S1656: 17.3
ST   D21S11: 30,31
ST   D22S1045: 15,16
ST   D2S1338: 19,25
ST   D2S441: 11
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 11,13
ST   DYS391: 10
ST   DYS570: 18
ST   DYS576: 17
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 11,12
ST   SE33: 17
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S442 ! LN-2207
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   LN-229
AC   CVCL_0393
SY   LN 229; LN229; LNT-229
DR   BTO; BTO_0002004
DR   CLO; CLO_0007363
DR   EFO; EFO_0006637
DR   MCCL; MCC:0000288
DR   AddexBio; C0005017/4993
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2611
DR   BioGRID_ORCS_Cell_line; 929
DR   BioSample; SAMN03471191
DR   BioSample; SAMN03471692
DR   BioSample; SAMN10987619
DR   cancercelllines; CVCL_0393
DR   Cell_Model_Passport; SIDM00684
DR   ChEMBL-Cells; CHEMBL4295402
DR   ChEMBL-Targets; CHEMBL4296459
DR   CLS; 305043
DR   Cosmic; 849861
DR   Cosmic; 1746958
DR   Cosmic; 1995485
DR   Cosmic; 2302323
DR   Cosmic; 2367492
DR   Cosmic; 2491102
DR   Cosmic; 2516025
DR   Cosmic; 2580915
DR   Cosmic-CLP; 1240169
DR   DepMap; ACH-000595
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240169
DR   GEO; GSM101615
DR   GEO; GSM101616
DR   GEO; GSM326200
DR   GEO; GSM397665
DR   GEO; GSM397666
DR   GEO; GSM481416
DR   GEO; GSM887270
DR   GEO; GSM888345
DR   GEO; GSM1374621
DR   GEO; GSM1670049
DR   GEO; GSM2113428
DR   GEO; GSM2113429
DR   GEO; GSM2113430
DR   GEO; GSM2113431
DR   IARC_TP53; 30212
DR   LiGeA; CCLE_871
DR   LINCS_LDP; LCL-1354
DR   Lonza; 1322
DR   PharmacoDB; LN229_841_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD003790
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0393
DR   PubChem_Cell_line; CVCL_0393
DR   Ubigene; YC-A021
DR   Wikidata; Q54902771
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7693337;
RX   PubMed=8509230;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=16697959;
RX   PubMed=17595512;
RX   PubMed=19365568;
RX   PubMed=20504876;
RX   PubMed=21406405;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=25485619;
RX   PubMed=25772239;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25984343;
RX   PubMed=26496030;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27412690;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/ln-229-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=9842975); 31 hours (PubMed=25984343).
CC   HLA typing: A*03:01:01; B*35:01; C*04:01:01 (PubMed=27412690).
CC   HLA typing: A*03:01,03:01; B*35:01,35:01; C*04:01,04:01; DQA1*01:01,01:01; DQB1*05:01,05:01; DRB1*01:01,11:19 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975).
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (Cosmic-CLP=1240169).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (Cosmic-CLP=1240169).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (PubMed=10416987; Cosmic-CLP=1240169).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.23%; East Asian, South=0%; South Asian=0.02%; European, North=59.47%; European, South=38.27% (PubMed=30894373).
CC   Misspelling: LN22; Cosmic=2580915.
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
ST   Source(s): AddexBio=C0005017/4993; ATCC=CRL-2611; Cosmic-CLP=1240169; PubMed=22570425; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 16
ST   D12S391: 20,22
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,17.2
ST   D1S1656: 14,17
ST   D21S11: 29,30
ST   D22S1045: 15,16
ST   D2S1338: 19,20
ST   D2S441: 10,11
ST   D3S1358: 16,17
ST   D5S818: 11 (PubMed=25877200)
ST   D5S818: 11,12 (AddexBio=C0005017/4993; ATCC=CRL-2611; Cosmic-CLP=1240169; PubMed=22570425; Technion Genomics Center)
ST   D7S820: 8,11 (AddexBio=C0005017/4993; ATCC=CRL-2611; Cosmic-CLP=1240169; PubMed=22570425; Technion Genomics Center)
ST   D7S820: 11 (PubMed=25877200)
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 10,11
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   LN-229-EGFP
AC   CVCL_D7FE
DR   Ubigene; YC-A021-EGFP-P
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   LN-229-Luc
AC   CVCL_D7FD
SY   LN-229-LUC
DR   Ubigene; YC-A021-Luc-P
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   LN-229_indWIF1
AC   CVCL_WS33
DR   cancercelllines; CVCL_WS33
DR   Wikidata; Q95982661
RX   PubMed=25772239;
CC   Population: Caucasian.
CC   Characteristics: Dox-induced expression (using rtTA) of WIF1 and dsRED.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18081; WIF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 13
//
ID   LN-235
AC   CVCL_3957
SY   LN 235; LN235
DR   BTO; BTO_0004448
DR   BioGRID_ORCS_Cell_line; 409
DR   BioSample; SAMN10988392
DR   cancercelllines; CVCL_3957
DR   Cell_Model_Passport; SIDM01367
DR   Cosmic; 849862
DR   Cosmic; 2367491
DR   Cosmic; 2516026
DR   DepMap; ACH-000591
DR   PharmacoDB; LN235_842_2019
DR   Wikidata; Q54902773
RX   PubMed=2990147;
RX   PubMed=7693337;
RX   PubMed=8509230;
RX   PubMed=10416987;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 37 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (DepMap=ACH-000591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.526T>A); ClinVar=VCV000376570; Zygosity=Unspecified (PubMed=10416987).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=3.32%; Native American=0.31%; East Asian, North=4.46%; East Asian, South=0%; South Asian=3.28%; European, North=23.54%; European, South=65.09% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right fronto-temporal lobe.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 13,16
ST   D21S11: 29,32.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 14,15
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   LN-2540GS
AC   CVCL_WS28
DR   cancercelllines; CVCL_WS28
DR   GEO; GSM1469039
DR   GEO; GSM2794461
DR   GEO; GSM2794462
DR   GEO; GSM2794463
DR   GEO; GSM2889485
DR   Wikidata; Q95982662
RX   PubMed=21097691;
RX   PubMed=22570425;
RX   PubMed=25622821;
RX   PubMed=27717037;
CC   Characteristics: Glioma-derived sphere line. Tumorigenic in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Hemizygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+5G>A; ClinVar=VCV000427618; Zygosity=Heterozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Unexplicit; Ex1-9del; Zygosity=Heterozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=22570425).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 16
ST   D21S11: 29,31
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 8,10
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   LN-2669
AC   CVCL_S443
DR   GEO; GSM2794473
DR   GEO; GSM2794474
DR   GEO; GSM2794475
DR   GEO; GSM2889489
DR   Wikidata; Q54902774
RX   PubMed=22570425;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from autologous cell line LN-2669GS).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323Valfs*19; Zygosity=Homozygous (from autologous cell line LN-2669GS).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 16
ST   D21S11: 30,31.2
ST   D3S1358: 14,15,16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS29 ! LN-2669GS
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   LN-2669GS
AC   CVCL_WS29
DR   GEO; GSM1469040
DR   GEO; GSM2794464
DR   GEO; GSM2794465
DR   GEO; GSM2794466
DR   GEO; GSM2889490
DR   Wikidata; Q95982664
RX   PubMed=21097691;
RX   PubMed=22570425;
RX   PubMed=25622821;
RX   PubMed=25772239;
RX   PubMed=27717037;
CC   Characteristics: Glioma-derived sphere line. Tumorigenic in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323Valfs*19; Zygosity=Homozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=22570425).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: STR profile from personal communication of Gusyatiner, Olga.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D10S1248: 17
ST   D12S391: 19,21
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 16
ST   D19S433: 15.2,16
ST   D1S1656: 13,15
ST   D21S11: 30,31.2
ST   D22S1045: 16
ST   D2S1338: 16,17
ST   D2S441: 10,15
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   DYS391: 11
ST   DYS570: 18
ST   DYS576: 19
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 12
ST   SE33: 21.2,27.2
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S443 ! LN-2669
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   LN-2669GS_WIF1
AC   CVCL_WS32
DR   Wikidata; Q95982665
RX   PubMed=25772239;
CC   Characteristics: Glioma-derived sphere line. Tumorigenic in nude mice (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp323Valfs*19; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18081; WIF1.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS29 ! LN-2669GS
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   LN-2683GS
AC   CVCL_WS30
DR   cancercelllines; CVCL_WS30
DR   GEO; GSM1469041
DR   GEO; GSM2794467
DR   GEO; GSM2794468
DR   GEO; GSM2794469
DR   GEO; GSM2889488
DR   Wikidata; Q95982666
RX   PubMed=21097691;
RX   PubMed=22570425;
RX   PubMed=25622821;
CC   Characteristics: Glioma-derived sphere line. Tumorigenic in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Unexplicit; Ex1-9del; Zygosity=Heterozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Lys (c.670G>A); ClinVar=VCV000480767; Zygosity=Heterozygous (PubMed=22570425).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro250Leu (c.749C>T); ClinVar=VCV000420136; Zygosity=Heterozygous (PubMed=22570425).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 12
ST   D18S51: 16,19
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 22,23.2
ST   Penta D: 13,14
ST   Penta E: 10
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   LN-2826GS
AC   CVCL_WS31
DR   Wikidata; Q95982667
RX   PubMed=22570425;
CC   Characteristics: Glioma-derived sphere line.
CC   Miscellaneous: Cell line has been lost (Direct_author_submission).
CC   Miscellaneous: Loss of cell line from personal communication of Gusyatiner, Olga.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 12,20
ST   D21S11: 28,31.2
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 11
ST   Penta E: 5,11
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 7
//
ID   LN-308
AC   CVCL_0394
SY   LN 308; LN308; LNZ-308; LNZ 308; LNZ308; LN-Z308
DR   BTO; BTO_0004457
DR   EFO; EFO_0022714
DR   MCCL; MCC:0000289
DR   BioGRID_ORCS_Cell_line; 406
DR   BioSample; SAMN10988416
DR   cancercelllines; CVCL_0394
DR   Cell_Model_Passport; SIDM00682
DR   Cosmic; 849863
DR   Cosmic; 2367499
DR   Cosmic; 2516023
DR   DepMap; ACH-000760
DR   IARC_TP53; 22502
DR   PharmacoDB; LNZ308_852_2019
DR   PRIDE; PXD008984
DR   Wikidata; Q54902775
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2990147;
RX   PubMed=7693337;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=11351043;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=20504876;
RX   PubMed=20593219;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 59 hours (PubMed=9842975); 30 hours (PubMed=25984343).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=10416987; PubMed=14614447).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0.02%; Native American=0.47%; East Asian, North=2.42%; East Asian, South=0%; South Asian=0%; European, North=44.33%; European, South=52.76% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 13,19
ST   D21S11: 31,31.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 8,13
ST   FGA: 18,20
ST   Penta D: 9,11
ST   Penta E: 7,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   LN-319
AC   CVCL_3958
SY   LN 319; LN319
DR   BTO; BTO_0002215
DR   AddexBio; C0005001/54
DR   BioSample; SAMN03151824
DR   BioSample; SAMN10988411
DR   cancercelllines; CVCL_3958
DR   Cell_Model_Passport; SIDM01626
DR   Cosmic; 849864
DR   Cosmic; 2367493
DR   Cosmic; 2516027
DR   DepMap; ACH-000128
DR   GEO; GSM397667
DR   GEO; GSM397668
DR   IARC_TP53; 2572
DR   PharmacoDB; LN319_843_2019
DR   Wikidata; Q54902776
RX   PubMed=7693337;
RX   PubMed=7732013;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=21406405;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a LN-992 derivative (PubMed=22570425).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00450.
CC   Population: Caucasian.
CC   Doubling time: 51 hours (PubMed=9842975); 45 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg15Ile (c.44G>T); Zygosity=Homozygous (DepMap=ACH-000128).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=7732013; PubMed=10416987; PubMed=14614447; DepMap=ACH-000128).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=1.07%; Native American=0.71%; East Asian, North=1.65%; East Asian, South=0%; South Asian=1.15%; European, North=65.6%; European, South=29.81% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14,19
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 12
ST   FGA: 19,26
ST   Penta D: 9,13
ST   Penta E: 15,17
ST   TH01: 9,9.3
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6845 ! LN-992
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   LN-340
AC   CVCL_3955
SY   LN 340; LN340
DR   BTO; BTO_0004458
DR   BioSample; SAMN10988417
DR   cancercelllines; CVCL_3955
DR   Cell_Model_Passport; SIDM01643
DR   Cosmic; 849865
DR   Cosmic; 2367494
DR   Cosmic; 2516028
DR   DepMap; ACH-000634
DR   PharmacoDB; LN340_844_2019
DR   Wikidata; Q54902777
RX   PubMed=7693337;
RX   PubMed=10416987;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Pro (c.542G>C); ClinVar=VCV000825729; Zygosity=Homozygous (PubMed=10416987; DepMap=ACH-000634).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0.66%; Native American=0%; East Asian, North=3.84%; East Asian, South=0%; South Asian=0%; European, North=54.01%; European, South=41.49% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 14,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 21,25
ST   Penta D: 12,15
ST   Penta E: 5,9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   LN-382
AC   CVCL_3956
SY   LN 382; LN382
DR   BTO; BTO_0004459
DR   BioGRID_ORCS_Cell_line; 408
DR   BioSample; SAMN10988413
DR   cancercelllines; CVCL_3956
DR   Cell_Model_Passport; SIDM01365
DR   Cosmic; 2516029
DR   DepMap; ACH-000215
DR   PharmacoDB; LN382_849_2019
DR   Wikidata; Q54902778
RX   PubMed=7693337;
RX   PubMed=8509230;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 52 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Unspecified (DepMap=ACH-000215).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val197Leu (c.589G>T); ClinVar=VCV000216468; Zygosity=Homozygous (DepMap=ACH-000215).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=1%; East Asian, South=0.55%; South Asian=0.62%; European, North=59.11%; European, South=38.35% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right fronto-parietal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   LN-382T
AC   CVCL_6839
SY   LN 382T; LN382T
DR   cancercelllines; CVCL_6839
DR   Cosmic; 849866
DR   Cosmic; 2367495
DR   Wikidata; Q54902779
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val197Leu (c.589G>T); ClinVar=VCV000216468; Zygosity=Homozygous (PubMed=10416987).
CC   Derived from site: In situ; Brain, right fronto-parietal lobe.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D21S11: 30,31.2
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 9,13
ST   FGA: 24,25
ST   Penta D: 12
ST   Penta E: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3956 ! LN-382
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   LN-401
AC   CVCL_6840
SY   LN 401; LN401
DR   cancercelllines; CVCL_6840
DR   Cosmic; 849867
DR   Wikidata; Q54902780
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 9
ST   D18S51: 18
ST   D21S11: 31.2
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 13,15
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   LN-405
AC   CVCL_1378
SY   LN 405; LN405
DR   CLO; CLO_0007364
DR   CLDB; cl3242
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473369
DR   cancercelllines; CVCL_1378
DR   Cell_Model_Passport; SIDM00343
DR   ChEMBL-Cells; CHEMBL3308756
DR   ChEMBL-Targets; CHEMBL1075491
DR   Cosmic; 687578
DR   Cosmic; 849868
DR   Cosmic; 910694
DR   Cosmic; 1746949
DR   Cosmic; 2302332
DR   Cosmic; 2367536
DR   Cosmic; 2580914
DR   Cosmic-CLP; 910694
DR   DepMap; ACH-002268
DR   DSMZ; ACC-189
DR   DSMZCellDive; ACC-189
DR   EGA; EGAS00001000978
DR   GDSC; 910694
DR   GEO; GSM326241
DR   GEO; GSM1670050
DR   IARC_TP53; 21474
DR   LINCS_LDP; LCL-1395
DR   PharmacoDB; LN405_845_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1378
DR   PubChem_Cell_line; CVCL_1378
DR   Wikidata; Q54902781
RX   PubMed=10416987;
RX   PubMed=11416159;
RX   PubMed=20164919;
RX   PubMed=21406405;
RX   PubMed=22570425;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-189).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu62Arg (c.185T>G); ClinVar=VCV003257900; Zygosity=Heterozygous (Cosmic-CLP=910694; DepMap=ACH-002268).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (Cosmic-CLP=910694; DepMap=ACH-002268).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (PubMed=10416987; Cosmic-CLP=910694; DepMap=ACH-002268).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.81%; Native American=0%; East Asian, North=1.39%; East Asian, South=0%; South Asian=3.12%; European, North=55.54%; European, South=38.13% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left fronto-temporal lobe.
ST   Source(s): Cosmic-CLP=910694; DSMZ=ACC-189; PubMed=11416159; PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 10
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,22
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 8,11
ST   Penta E: 17
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   LN-427
AC   CVCL_6841
SY   LN 427; LN427
DR   cancercelllines; CVCL_6841
DR   Cosmic; 849869
DR   Wikidata; Q54902782
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.526T>A); ClinVar=VCV000376570; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 23,24
ST   Penta D: 8,9
ST   Penta E: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   LN-428
AC   CVCL_3959
SY   LN 428; LN428
DR   BTO; BTO_0002216
DR   EFO; EFO_0022712
DR   BioSample; SAMN10988393
DR   cancercelllines; CVCL_3959
DR   Cell_Model_Passport; SIDM01642
DR   Cosmic; 849870
DR   Cosmic; 2516030
DR   DepMap; ACH-000455
DR   GEO; GSM1638653
DR   GEO; GSM1638654
DR   GEO; GSM1638655
DR   IARC_TP53; 2573
DR   PharmacoDB; LN428_846_2019
DR   Wikidata; Q54902783
RX   PubMed=7693337;
RX   PubMed=7732013;
RX   PubMed=8509230;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 51 hours (PubMed=9842975); 24 hours (PubMed=25984343).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Met (c.517G>A); ClinVar=VCV000233951; Zygosity=Heterozygous (PubMed=7732013; PubMed=10416987; PubMed=14614447; DepMap=ACH-000455).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=7732013; PubMed=10416987; PubMed=14614447; DepMap=ACH-000455).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 13,17
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,25
ST   Penta D: 13
ST   Penta E: 14,16
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   LN-443
AC   CVCL_3960
SY   LN 443; LN443
DR   BTO; BTO_0004449
DR   BioGRID_ORCS_Cell_line; 407
DR   BioSample; SAMN03151823
DR   BioSample; SAMN10988388
DR   cancercelllines; CVCL_3960
DR   Cell_Model_Passport; SIDM01371
DR   Cosmic; 849871
DR   Cosmic; 2367496
DR   Cosmic; 2516031
DR   DepMap; ACH-000673
DR   PharmacoDB; LN443_847_2019
DR   Wikidata; Q54902784
RX   PubMed=7693337;
RX   PubMed=8509230;
RX   PubMed=10416987;
RX   PubMed=20593219;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a LN-444 derivative (PubMed=22570425). Originally thought to originate from a 66 year old male patient with a glioblastoma at the right fronto-temporal lobe.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00451.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Homozygous (DepMap=ACH-000673).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=3.39%; Native American=0%; East Asian, North=4.23%; East Asian, South=0%; South Asian=4.37%; European, North=27.1%; European, South=60.91% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 7,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3961 ! LN-444
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   LN-444
AC   CVCL_3961
SY   LN 444; LN444
DR   BTO; BTO_0004450
DR   Cell_Model_Passport; SIDM01364
DR   Cosmic; 849872
DR   Cosmic; 2367497
DR   GEO; GSM1638656
DR   GEO; GSM1638657
DR   Wikidata; Q54902785
RX   PubMed=7693337;
RX   PubMed=8509230;
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 7,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   LN-464
AC   CVCL_3962
SY   LN 464; LN464
DR   BTO; BTO_0004451
DR   BioSample; SAMN10988403
DR   cancercelllines; CVCL_3962
DR   Cell_Model_Passport; SIDM00058
DR   Cosmic; 849873
DR   Cosmic; 2367498
DR   Cosmic; 2516032
DR   DepMap; ACH-000676
DR   PharmacoDB; LN464_848_2019
DR   Wikidata; Q54902786
RX   PubMed=7693337;
RX   PubMed=8509230;
RX   PubMed=10416987;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. The STR profile of ACN and LN-464 are identical. SNP analysis (DepMap) also shows identity of both cell lines. Personal communication of Hegi, Monika E. confirms the mismatch between the STR profile of this cell line and of the patient from which LN-464 was established. We believe this is a melanoma cell line based on the RNASeq expression profile of LN-464 (DepMap) which clusters with that of melanoma patient samples. The presence of the BRAF V600E while present at low frequency in gliomas is also a hallmark of melanomas. Originally thought to originate from the brain right parieto-occipital lobe of a 67 year old male patient with a glioblastoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00624.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000676).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn184fs*6 (c.545_546insA); Zygosity=Heterozygous (PubMed=10416987; DepMap=ACH-000676).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Homozygous (PubMed=10416987; DepMap=ACH-000676).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 10,14
ST   TH01: 9
ST   TPOX: 9,12
ST   vWA: 14,17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1068 ! ACN
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   LN-702
AC   CVCL_3963
SY   LN 702; LN702
DR   BTO; BTO_0004452
DR   Wikidata; Q54902787
RX   PubMed=7693337;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   LN-71
AC   CVCL_6842
SY   LN 71; LN71
DR   BTO; BTO_0005776
DR   cancercelllines; CVCL_6842
DR   Cosmic; 849859
DR   Wikidata; Q54902788
RX   PubMed=10416987;
RX   PubMed=21406405;
RX   PubMed=22570425;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 13
ST   D21S11: 29,31.2
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 12,14
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   LN-751
AC   CVCL_3964
SY   LN 751; LN751
DR   BTO; BTO_0004453
DR   cancercelllines; CVCL_3964
DR   Cosmic; 849874
DR   Wikidata; Q54902789
RX   PubMed=7693337;
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D21S11: 30,32.2,33.2
ST   D3S1358: 17
ST   D5S818: 9,11
ST   D7S820: 9,10,12
ST   D8S1179: 13,14
ST   FGA: 18,22
ST   Penta D: 11,13.1,14
ST   Penta E: 14,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   LN-774
AC   CVCL_3965
SY   LN 774; LN774
DR   BTO; BTO_0004454
DR   Wikidata; Q54902790
RX   PubMed=7693337;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   LN-784
AC   CVCL_3966
SY   LN 784; LN784
DR   BTO; BTO_0004455
DR   Wikidata; Q54902791
RX   PubMed=7693337;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   LN-827
AC   CVCL_6843
SY   LN 827; LN827
DR   cancercelllines; CVCL_6843
DR   Cosmic; 849875
DR   Wikidata; Q54902792
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12
ST   D21S11: 28,32
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   LN-859
AC   CVCL_6844
SY   LN 859; LN859
DR   cancercelllines; CVCL_6844
DR   Cosmic; 849876
DR   Wikidata; Q54902793
RX   PubMed=10416987;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   LN-992
AC   CVCL_6845
SY   LN 992; LN992
DR   cancercelllines; CVCL_6845
DR   Cell_Model_Passport; SIDM01366
DR   Cosmic; 849877
DR   Wikidata; Q54902794
RX   PubMed=2990147;
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14,19
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 12,12.2
ST   FGA: 19
ST   Penta D: 9,13
ST   Penta E: 15,17
ST   TH01: 9,9.3
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   LN-V
AC   CVCL_VI00
DR   Wikidata; Q54902795
RX   PubMed=2878433;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   LN1
AC   CVCL_9U28
DR   Wikidata; Q54902802
RX   PubMed=9196889;
RX   PubMed=9196895;
RX   PubMed=16044626;
CC   Group: Space-flown cell line (cellonaut).
CC   Doubling time: 33 hours (PubMed=9196889).
CC   Anecdotal: Have been flown in space on the ISS in 2001 and 2011 to study growth in microgravity (PubMed=16044626).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   LN1590
AC   CVCL_0C60
DR   cancercelllines; CVCL_0C60
DR   Wikidata; Q54902803
RX   PubMed=11156375;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>A); ClinVar=VCV000480961; Zygosity=Unspecified (PubMed=11156375).
CC   Caution: TP53 mutation indicated (PubMed=11156375) to change a His-176 into Arg, but the DNA change corresponds to the mutation reported in this entry.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C61 ! PT1590
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   LN22R8
AC   CVCL_C4C2
DR   ABCD; ABCD_AR155
DR   Wikidata; Q116049714
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   LN229-CHID1
AC   CVCL_E8NR
RX   PubMed=30657411;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:28474; CHID1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LN229/CD133
AC   CVCL_D2RW
DR   Wikidata; Q127382598
RX   PubMed=28910211;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9454; PROM1 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal with a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/CD19
AC   CVCL_D2TH
DR   Wikidata; Q127382600
RX   PubMed=32271687;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1633; CD19 (Note=With a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/CD19ec
AC   CVCL_D2TI
DR   Wikidata; Q127382602
RX   PubMed=32271687;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1633; CD19 (Note=Extracellular domain, with a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/CD20
AC   CVCL_A8V5
DR   cancercelllines; CVCL_A8V5
DR   Wikidata; Q102114467
RX   PubMed=32667234;
RX   PubMed=32724441;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7315; MS4A1 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   LN229/ectodomain-PODXL
AC   CVCL_D2TV
DR   Wikidata; Q127382603
RX   PubMed=28384052;
RX   PubMed=33088928;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9171; PODXL (Note=Ectodomain).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LN229/EGFR
AC   CVCL_D2SN
DR   Wikidata; Q127382604
RX   PubMed=29090976;
RX   PubMed=32218834;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal with a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/HER2
AC   CVCL_D2T3
DR   Wikidata; Q127382605
RX   PubMed=28700270;
RX   PubMed=29172998;
RX   PubMed=29315012;
RX   PubMed=31199696;
RX   PubMed=32765652;
RX   PubMed=34424764;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/hPD-L1
AC   CVCL_D2S5
DR   Wikidata; Q127382606
RX   PubMed=29608408;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17635; CD274 (Note=With a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   LN229/hPDPN
AC   CVCL_D2U6
DR   Wikidata; Q127382607
RX   Patent=US10227407;
RX   PubMed=25080943;
RX   PubMed=26492619;
RX   PubMed=26937552;
RX   PubMed=27031228;
RX   PubMed=27328060;
RX   PubMed=27564251;
RX   PubMed=28101903;
RX   PubMed=28387591;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/mCCR3
AC   CVCL_D2R8
DR   Wikidata; Q127382608
RX   PubMed=35471049;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:104616; Ccr3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   LN229/mCD39
AC   CVCL_D2RM
DR   Wikidata; Q127382609
RX   PubMed=38197855;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:102805; Entpd1 (Note=With a N-terminal GVAMPGAEDDVV = PA-tag and a C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/mEGFR
AC   CVCL_D2SJ
DR   Wikidata; Q127382610
RX   PubMed=37489364;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95294; Egfr (Note=With a N-terminal GVAMPGAEDDVV = PA-tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   LN229/mHER2
AC   CVCL_D2SR
DR   Wikidata; Q127382611
RX   DOI=10.3390/ijtm3030022;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95410; Erbb2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LN229/PODXL
AC   CVCL_D2TU
SY   LN229/hPODXL
DR   Wikidata; Q127382613
RX   Patent=US10906972;
RX   PubMed=28384052;
RX   PubMed=33088928;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9171; PODXL.
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LN6216c
AC   CVCL_0C58
DR   cancercelllines; CVCL_0C58
DR   Cosmic; 2218355
DR   Wikidata; Q54902804
RX   PubMed=25070024;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=25070024).
CC   Derived from site: Metastatic; Subcarinal lymph node; UBERON=UBERON_8480055.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C59 ! PT6216
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   LNC
AC   CVCL_9578
DR   Lonza; 1305
DR   Wikidata; Q54902805
RX   PubMed=8046247;
CC   Breed/subspecies: NZB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   LNC.2
AC   CVCL_E120
DR   Wikidata; Q54902806
RX   PubMed=2120063;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   LNC.4
AC   CVCL_E121
DR   Wikidata; Q54902808
RX   PubMed=2120063;
CC   Characteristics: IL4 dependent.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   LNCaP
AC   CVCL_0395
SY   LNCAP; LNCap; Ln-Cap; LNCaP-RPCI; Lymph Node Carcinoma of the prostate
DR   BTO; BTO_0001321
DR   CLO; CLO_0007365
DR   CLO; CLO_0037116
DR   EFO; EFO_0002071
DR   MCCL; MCC:0000290
DR   CLDB; cl3243
DR   ArrayExpress; E-MTAB-2706
DR   BioGRID_ORCS_Cell_line; 182
DR   BioSample; SAMN03472386
DR   cancercelllines; CVCL_0395
DR   CCRID; 1101HUM-PUMC000040
DR   CCTCC; GDC0283
DR   CCTCC; GDC0284
DR   ChEMBL-Cells; CHEMBL3307965
DR   ChEMBL-Targets; CHEMBL612518
DR   CLS; 300265
DR   Cosmic; 704848
DR   Cosmic; 721368
DR   Cosmic; 721555
DR   Cosmic; 755298
DR   Cosmic; 759895
DR   Cosmic; 801348
DR   Cosmic; 850413
DR   Cosmic; 850745
DR   Cosmic; 850821
DR   Cosmic; 869155
DR   Cosmic; 918500
DR   Cosmic; 920967
DR   Cosmic; 921047
DR   Cosmic; 922553
DR   Cosmic; 923955
DR   Cosmic; 943176
DR   Cosmic; 948076
DR   Cosmic; 949248
DR   Cosmic; 1028648
DR   Cosmic; 1028701
DR   Cosmic; 1066237
DR   Cosmic; 1070886
DR   Cosmic; 1071481
DR   Cosmic; 1071906
DR   Cosmic; 1075275
DR   Cosmic; 1172626
DR   Cosmic; 1176618
DR   Cosmic; 1330909
DR   Cosmic; 1556120
DR   Cosmic; 1689708
DR   Cosmic; 1995486
DR   Cosmic; 2537792
DR   Cosmic; 2580128
DR   Cosmic; 2585151
DR   Cosmic; 2585228
DR   Cosmic; 2621168
DR   Cosmic; 2651770
DR   Cosmic; 2669169
DR   Cosmic; 2816221
DR   DSMZ; ACC-256
DR   DSMZCellDive; ACC-256
DR   EGA; EGAS00001000610
DR   GEO; GSE99795
DR   GEO; GSM91927
DR   GEO; GSM142457
DR   GEO; GSM142458
DR   GEO; GSM383948
DR   GEO; GSM383953
DR   GEO; GSM482669
DR   GEO; GSM525800
DR   GEO; GSM784790
DR   GEO; GSM816634
DR   GEO; GSM816637
DR   GEO; GSM844579
DR   GEO; GSM945240
DR   GEO; GSM945282
DR   GEO; GSM1022672
DR   GEO; GSM1029460
DR   GEO; GSM1029461
DR   GEO; GSM1029462
DR   GEO; GSM1029463
DR   GEO; GSM1029464
DR   GEO; GSM1029465
DR   GEO; GSM1029466
DR   GEO; GSM1029467
DR   GEO; GSM1374622
DR   GEO; GSM1374626
DR   GEO; GSM2069518
DR   GEO; GSM2069519
DR   GEO; GSM2069520
DR   GEO; GSM2069521
DR   GEO; GSM2069522
DR   GEO; GSM2069523
DR   GEO; GSM2069524
DR   GEO; GSM2069525
DR   GEO; GSM2650017
DR   GEO; GSM2650018
DR   GEO; GSM2650019
DR   GEO; GSM2650020
DR   GEO; GSM2650021
DR   GEO; GSM2650022
DR   GEO; GSM3145602
DR   GEO; GSM3145720
DR   IARC_TP53; 21076
DR   LINCS_LDP; LCL-1298
DR   Lonza; 109
DR   PharmacoDB; LNCAP_850_2019
DR   PRIDE; PXD000953
DR   PRIDE; PXD000985
DR   PRIDE; PXD002107
DR   PRIDE; PXD002395
DR   PRIDE; PXD003105
DR   PRIDE; PXD003262
DR   PRIDE; PXD006561
DR   PRIDE; PXD032264
DR   Progenetix; CVCL_0395
DR   PubChem_Cell_line; CVCL_0395
DR   TOKU-E; 3599
DR   Wikidata; Q6459234
RX   CelloPub=CLPUB00410;
RX   CelloPub=CLPUB00698;
RX   PubMed=2734981;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6831420;
RX   PubMed=8687134;
RX   PubMed=9018337;
RX   PubMed=9090379;
RX   PubMed=9460501;
RX   PubMed=10702678;
RX   PubMed=10972993;
RX   PubMed=11135431;
RX   PubMed=11172901;
RX   PubMed=11304728;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=12606952;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=15162376;
RX   PubMed=15486987;
RX   PubMed=22213130;
RX   PubMed=22278370;
RX   PubMed=23671654;
RX   PubMed=24587179;
RX   PubMed=24618588;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26256267;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27036029;
RX   PubMed=27141528;
RX   PubMed=29194687;
RX   PubMed=29233929;
RX   PubMed=29660373;
RX   PubMed=29739788;
RX   PubMed=30787054;
RX   PubMed=35502546;
RX   PubMed=38892296;
WW   Info; -; -; https://lncap.com/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/LNCaP_Crawford_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-136.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/LNCaP
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/prostate-cancer-xenograft/lncap-xenograft-model/
WW   Provider; CH3 Biosystems; 940002; https://ch3biosystems.com/shop/lncap/
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-256).
CC   HLA typing: A*01:01,02:01; B*08:01,37:04; C*06:02,07:01; DQB1*05:01,05:01; DRB1*10:01,10:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=23671654).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (PubMed=22213130).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from child cell line LNCaP clone FGC).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from child cell line LNCaP clone FGC).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (PubMed=9090379).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=14518029).
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): CCRID=1101HUM-PUMC000040; CLS=300265; DSMZ=ACC-256; PubMed=11416159; PubMed=14518029; PubMed=25877200
ST   Amelogenin: X (CLS=300265)
ST   Amelogenin: X,Y (CCRID=1101HUM-PUMC000040; DSMZ=ACC-256; PubMed=11416159; PubMed=14518029; PubMed=25877200)
ST   CSF1PO: 10,11
ST   D13S317: 10,11,12,13 (PubMed=14518029)
ST   D13S317: 10,12 (CCRID=1101HUM-PUMC000040; CLS=300265; DSMZ=ACC-256; PubMed=25877200)
ST   D16S539: 11
ST   D18S51: 9,11,12 (CCRID=1101HUM-PUMC000040)
ST   D18S51: 11,12 (CLS=300265; DSMZ=ACC-256; PubMed=14518029; PubMed=25877200)
ST   D19S433: 13.2,15 (CCRID=1101HUM-PUMC000040)
ST   D19S433: 14,15 (DSMZ=ACC-256)
ST   D21S11: 28,29,31.2 (PubMed=25877200)
ST   D21S11: 29,31.2 (CLS=300265)
ST   D21S11: 29,31.2,32.2 (DSMZ=ACC-256; PubMed=11416159)
ST   D21S11: 29,32.2 (CCRID=1101HUM-PUMC000040; PubMed=14518029)
ST   D2S1338: 16 (DSMZ=ACC-256)
ST   D2S1338: 16,17 (CCRID=1101HUM-PUMC000040)
ST   D3S1358: 16
ST   D5S818: 11,12 (CCRID=1101HUM-PUMC000040; CLS=300265; DSMZ=ACC-256; PubMed=14518029)
ST   D5S818: 11,12,13 (PubMed=25877200)
ST   D7S820: 8.1,9.1,10.3 (CCRID=1101HUM-PUMC000040; PubMed=25877200)
ST   D7S820: 9,11 (PubMed=14518029)
ST   D7S820: 9.1,10.3 (CLS=300265; DSMZ=ACC-256)
ST   D8S1179: 12,13,14 (DSMZ=ACC-256; PubMed=11416159)
ST   D8S1179: 12,14 (CCRID=1101HUM-PUMC000040; CLS=300265; PubMed=14518029; PubMed=25877200)
ST   FGA: 19,20 (CCRID=1101HUM-PUMC000040; CLS=300265; PubMed=14518029; PubMed=25877200)
ST   FGA: 19,20,21 (DSMZ=ACC-256; PubMed=11416159)
ST   Penta D: 12,12.4
ST   Penta E: 12,16 (CLS=300265; DSMZ=ACC-256)
ST   Penta E: 16 (PubMed=25877200)
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   LNCaP 104-R1
AC   CVCL_M127
SY   LNCaP-104-R1; 104-R1; LNCaP 104-R; 104-R
DR   cancercelllines; CVCL_M127
DR   Wikidata; Q54902809
RX   PubMed=7511045;
RX   PubMed=9658399;
RX   PubMed=16015608;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M126 ! LNCaP 104-S
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP 104-R2
AC   CVCL_M128
SY   LNCaP-104-R2; 104-R2; R2
DR   cancercelllines; CVCL_M128
DR   Wikidata; Q54902810
RX   PubMed=9658399;
RX   PubMed=16015608;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M127 ! LNCaP 104-R1
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   LNCaP 104-S
AC   CVCL_M126
SY   LNCaP-104S; LNCaP 104S; LNCaP104S; 104-S
DR   cancercelllines; CVCL_M126
DR   Cosmic; 2580129
DR   GEO; GSM525801
DR   Wikidata; Q54902811
RX   PubMed=7511045;
RX   PubMed=9658399;
RX   PubMed=16015608;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   LNCaP AR-NTD/pHage
AC   CVCL_A1BN
SY   LNCaPAR-NTD/pHage
DR   cancercelllines; CVCL_A1BN
DR   Wikidata; Q102114469
RX   PubMed=25008967;
CC   Population: Caucasian.
CC   Characteristics: Inducibly expresses AR N-terminal domain (AR-NTD).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR (Note=With p.Thr661_Gln920del = AR-NTD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   LNCaP AR-V7/pHage
AC   CVCL_A1BM
SY   LNCaPAR-V7/pHage
DR   cancercelllines; CVCL_A1BM
DR   Wikidata; Q102114471
RX   PubMed=25008967;
CC   Population: Caucasian.
CC   Characteristics: Inducibly expresses AR variant 7 (ARv7).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR (Note=Isoform ARv7).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   LNCaP AR-V7/pLenti
AC   CVCL_A1BL
SY   LNCaPAR-V7/pLenti
DR   cancercelllines; CVCL_A1BL
DR   Wikidata; Q102114472
RX   PubMed=25008967;
CC   Population: Caucasian.
CC   Characteristics: Inducibly expresses AR variant 7 (ARv7). Developed with the T-REx lentiviral Gateway expression system. Addition of doxycycline (Dox) relieves repression by tetR thus permitting ARv7 induction.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR (Note=Isoform ARv7).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   LNCaP C-33
AC   CVCL_M129
SY   LNCaP-C33; C-33; C33
DR   cancercelllines; CVCL_M129
DR   Wikidata; Q54902812
RX   PubMed=11705865;
RX   PubMed=11870800;
RX   PubMed=17977648;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   LNCaP C-51
AC   CVCL_M130
SY   LNCaP-C51 C-51; C51
DR   cancercelllines; CVCL_M130
DR   Wikidata; Q54902823
RX   PubMed=11705865;
RX   PubMed=11870800;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M129 ! LNCaP C-33
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP C-81
AC   CVCL_M131
SY   LNCaP-C81 C-81; C81
DR   cancercelllines; CVCL_M131
DR   Wikidata; Q54902824
RX   PubMed=11705865;
RX   PubMed=11870800;
RX   PubMed=17977648;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M129 ! LNCaP C-33
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   LNCaP C4
AC   CVCL_4783
SY   LNCaP-C4; LNCaPC4; LNCaP subline C4; C4
DR   BTO; BTO_0005868
DR   ATCC; CRL-3313
DR   cancercelllines; CVCL_4783
DR   Wikidata; Q54902813
RX   PubMed=8169003;
RX   PubMed=12725112;
RX   PubMed=35502546;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/LNCaP
CC   Population: Caucasian.
CC   Characteristics: Derived from a tumor that developed in castrated nude mice injected with LNCaP cells.
CC   Doubling time: ~24-36 hours (ATCC=CRL-3313); 26.30 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): ATCC=CRL-3313
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 9,9.1,10.3
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   LNCaP C4-2
AC   CVCL_4782
SY   LNCaP-C4-2; LNCaP subline C4-2; C4-2; C42; Sp 2817
DR   BTO; BTO_0005672
DR   ATCC; CRL-3314
DR   cancercelllines; CVCL_4782
DR   ChEMBL-Cells; CHEMBL4295439
DR   ChEMBL-Targets; CHEMBL4296460
DR   Cosmic; 1330914
DR   GEO; GSM3145590
DR   GEO; GSM3145694
DR   PubChem_Cell_line; CVCL_4782
DR   Wikidata; Q54902814
RX   PubMed=8169003;
RX   PubMed=15162376;
RX   PubMed=26499105;
RX   PubMed=29194687;
RX   PubMed=35502546;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20150602153438/http://capcelllines.ca:80/details.asp?id=52
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-464.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/LNCaP
CC   Population: Caucasian.
CC   Characteristics: Exhibits androgen-independent growth associated with skeletal metastasis, produces metastases when injected either subcutaneously or orthotopically in intact or castrated mice.
CC   Doubling time: ~24-36 hours (ATCC=CRL-3314); 28.96 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (PubMed=26499105).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): PubMed=26499105
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10,11,12
ST   D13S317: 10,11,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 9.1,9.3,10.3
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4783 ! LNCaP C4
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   LNCaP C4-2 AR-V7
AC   CVCL_F0L4
SY   C4-2 AR-V7
RX   PubMed=24740322;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:644; AR (Note=Isoform ARv7).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4782 ! LNCaP C4-2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LNCaP C4-2 neo
AC   CVCL_F0L3
SY   C4-2 neo
RX   PubMed=24740322;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for LNCaP C4-2 AR-V7 (Cellosaurus=CVCL_F0L4) (PubMed=24740322).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4782 ! LNCaP C4-2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LNCaP C4-2B
AC   CVCL_4784
SY   C4-2B; C4-2 B; C4-2 Bone metastatic
DR   BTO; BTO_0004959
DR   EFO; EFO_0006365
DR   ATCC; CRL-3315
DR   cancercelllines; CVCL_4784
DR   ChEMBL-Cells; CHEMBL4295450
DR   ChEMBL-Targets; CHEMBL4296461
DR   Cosmic; 1689709
DR   ENCODE; ENCBS002MOV
DR   ENCODE; ENCBS108UKE
DR   ENCODE; ENCBS109FVF
DR   ENCODE; ENCBS159HRH
DR   ENCODE; ENCBS328CYG
DR   ENCODE; ENCBS391IVJ
DR   ENCODE; ENCBS440KYC
DR   ENCODE; ENCBS582KTC
DR   ENCODE; ENCBS728XMM
DR   ENCODE; ENCBS947VNK
DR   GEO; GSM648816
DR   GEO; GSM3145591
DR   GEO; GSM3145695
DR   Progenetix; CVCL_4784
DR   PubChem_Cell_line; CVCL_4784
DR   Wikidata; Q54902815
RX   PubMed=8168083;
RX   PubMed=15162376;
RX   PubMed=24587179;
RX   PubMed=33298586;
RX   PubMed=35502546;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/LNCaP
CC   Population: Caucasian.
CC   Characteristics: Bone metastatic.
CC   Doubling time: ~24-36 hours (ATCC=CRL-3315).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): ATCC=CRL-3315
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10,11
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8.1,9.1,10.3
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4782 ! LNCaP C4-2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   LNCaP C4-2B MDVR
AC   CVCL_F0L5
SY   C4-2B MDVR; LNCaP C4-2B MR; C4-2B MR
RX   PubMed=24740322;
RX   PubMed=28500234;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 20 mmol/L of enzalutamide (PubMed=24740322).
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LNCaP C4-2B TaxR
AC   CVCL_F0LA
SY   TaxR
RX   PubMed=23861346;
CC   Population: Caucasian.
CC   Characteristics: Overexpresses ABCB1 (PubMed=23861346).
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LNCaP C4-2B2
AC   CVCL_4785
SY   LNCaP-C4-2 B2; C4-2B2; Sp 2815
DR   cancercelllines; CVCL_4785
DR   Wikidata; Q54902816
RX   PubMed=10881018;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200703/http://capcelllines.ca:80/details.asp?id=165
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   LNCaP C4-2B3
AC   CVCL_4786
SY   LNCaP-C4-2 B3; C4-2B3; Sp 2672
DR   cancercelllines; CVCL_4786
DR   Wikidata; Q54902817
RX   PubMed=10881018;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200703/http://capcelllines.ca:80/details.asp?id=165
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   LNCaP C4-2B4
AC   CVCL_4787
SY   LNCaP-C4-2 B4; LNCaP-C42B4; C4-2B4; Sp 2816
DR   cancercelllines; CVCL_4787
DR   Wikidata; Q54902818
RX   PubMed=10881018;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200703/http://capcelllines.ca:80/details.asp?id=165
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   LNCaP C4-2B5
AC   CVCL_4788
SY   LNCaP-C4-2 B5; C4-2B5; Sp 2670
DR   cancercelllines; CVCL_4788
DR   Wikidata; Q54902819
RX   PubMed=10881018;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160703200703/http://capcelllines.ca:80/details.asp?id=165
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   LNCaP C4-2BR
AC   CVCL_F0L8
SY   C4-2BR
RX   PubMed=33799432;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LNCaP C4-2Ln
AC   CVCL_6E92
SY   C4-2Ln; C4-2 Ln; C4-2 Lymph node metastasis
DR   cancercelllines; CVCL_6E92
DR   Wikidata; Q54902820
RX   PubMed=8168083;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4782 ! LNCaP C4-2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   LNCaP C4-2Pr
AC   CVCL_6E93
SY   C4-2Pr; C4-2 Pr; C4-2 Primary tumor
DR   cancercelllines; CVCL_6E93
DR   Wikidata; Q54902821
RX   PubMed=8168083;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4782 ! LNCaP C4-2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   LNCaP C5
AC   CVCL_M132
SY   LNCaP-C5; LNCaP subline C5; C5
DR   cancercelllines; CVCL_M132
DR   Wikidata; Q54902822
RX   PubMed=8169003;
RX   PubMed=35502546;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/LNCaP
CC   Population: Caucasian.
CC   Characteristics: Derived from a tumor that developed in castrated nude mice injected with LNCaP cells.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   LNCaP clone FGC
AC   CVCL_1379
SY   LNCaP-Clone-FGC; LNCaP.FGC; LNCaP-FGC; LNCaP FGC; LNCAPCLONEFGC; LNCaP-ATCC; LNCaP Fast Growing Colony
DR   BTO; BTO_0006095
DR   CLO; CLO_0007366
DR   CLO; CLO_0007367
DR   CLO; CLO_0051537
DR   EFO; EFO_0005726
DR   CLDB; cl3245
DR   CLDB; cl4960
DR   CLDB; cl5222
DR   4DN; 4DNSR4OQOB67
DR   Abcam; ab275470
DR   AddexBio; C0019003/4953
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1740
DR   BCRC; 60088
DR   BCRJ; 0149
DR   BioGRID_ORCS_Cell_line; 930
DR   BioSample; SAMN03471417
DR   BioSample; SAMN03472018
DR   BioSample; SAMN05292444
DR   BioSample; SAMN10988285
DR   cancercelllines; CVCL_1379
DR   CCRID; 3101HUMSCSP5021
DR   CCRID; 3101HUMTCHu173
DR   Cell_Model_Passport; SIDM00683
DR   ChEMBL-Cells; CHEMBL3308342
DR   ChEMBL-Targets; CHEMBL2366172
DR   CLS; 305220
DR   Cosmic; 688117
DR   Cosmic; 907788
DR   Cosmic-CLP; 907788
DR   DepMap; ACH-000977
DR   ECACC; 89110211
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS089RMT
DR   ENCODE; ENCBS184PDN
DR   ENCODE; ENCBS235TSM
DR   ENCODE; ENCBS260TRO
DR   ENCODE; ENCBS386ENC
DR   ENCODE; ENCBS387ENC
DR   ENCODE; ENCBS418ENC
DR   ENCODE; ENCBS421PUJ
DR   ENCODE; ENCBS422ENC
DR   ENCODE; ENCBS535BWO
DR   ENCODE; ENCBS668DEO
DR   ENCODE; ENCBS680JNS
DR   ENCODE; ENCBS687TQL
DR   ENCODE; ENCBS849SWQ
DR   ENCODE; ENCBS851ZZS
DR   ENCODE; ENCBS918PKZ
DR   GDSC; 907788
DR   GEO; GSM383954
DR   GEO; GSM383955
DR   GEO; GSM383956
DR   GEO; GSM651578
DR   GEO; GSM651579
DR   GEO; GSM827569
DR   GEO; GSM887271
DR   GEO; GSM888346
DR   GEO; GSM1633299
DR   GEO; GSM1633300
DR   GEO; GSM1633301
DR   GEO; GSM1633323
DR   GEO; GSM1633324
DR   GEO; GSM1633325
DR   GEO; GSM1670051
DR   GEO; GSM3407130
DR   GEO; GSM3407131
DR   GEO; GSM3407132
DR   GEO; GSM3407133
DR   GEO; GSM3407134
DR   GEO; GSM3407135
DR   IARC_TP53; 27698
DR   ICLC; HTL99011
DR   IZSLER; BS TCL 148
DR   KCB; KCB 200732YJ
DR   KCLB; 21740
DR   LiGeA; CCLE_749
DR   PharmacoDB; LNCaPCloneFGC_851_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1379
DR   PubChem_Cell_line; CVCL_1379
DR   RCB; RCB2144
DR   TKG; TKG 0603
DR   Ubigene; YC-C009
DR   Wikidata; Q54902825
RX   PubMed=2734981;
RX   PubMed=8104329;
RX   PubMed=10092147;
RX   PubMed=11172901;
RX   PubMed=12725112;
RX   PubMed=15389782;
RX   PubMed=15833837;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23117885;
RX   PubMed=23325432;
RX   PubMed=27397505;
RX   PubMed=28145883;
RX   PubMed=30305041;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/crl-1740-growth-and-morphology
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-rate-of-atcc-crl-1740
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544554
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 43 hours (PubMed=15389782); ~34 hours (ATCC=CRL-1740); ~36 hours (PBCF); 38.71 hours (JWGray panel).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (Cosmic-CLP=907788; DepMap=ACH-000977).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (Cosmic-CLP=907788; DepMap=ACH-000977).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (Cosmic-CLP=907788; DepMap=ACH-000977).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (DepMap=ACH-000977).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.89%; Native American=0.31%; East Asian, North=0%; East Asian, South=2.4%; South Asian=8.61%; European, North=28.39%; European, South=57.41% (PubMed=30894373).
CC   Misspelling: LNCaP.FCG; Note=Occasionally.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): AddexBio=C0019003/4953; ATCC=CRL-1740; CCRID=3101HUMSCSP5021; CLS=305220; Cosmic-CLP=907788; ECACC=89110211; KCLB=21740; RCB=RCB2144; TKG=TKG 0603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 11,12
ST   D19S433: 13.2,15
ST   D21S11: 29,32.2
ST   D2S1338: 16
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9 (RCB=RCB2144)
ST   D7S820: 9,11 (ECACC=89110211; KCLB=21740)
ST   D7S820: 9.1,10.3 (AddexBio=C0019003/4953; ATCC=CRL-1740; CCRID=3101HUMSCSP5021; CLS=305220; TKG=TKG 0603)
ST   D7S820: 11 (Cosmic-CLP=907788)
ST   D8S1179: 12,14
ST   FGA: 19,20 (ATCC=CRL-1740)
ST   FGA: 19,20,21 (CLS=305220)
ST   Penta D: 12,12.4
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17,18 (RCB=RCB2144)
ST   vWA: 16,18 (AddexBio=C0019003/4953; ATCC=CRL-1740; CCRID=3101HUMSCSP5021; CLS=305220; Cosmic-CLP=907788; ECACC=89110211; KCLB=21740; TKG=TKG 0603)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   LNCaP Clone FGC-EGFP
AC   CVCL_C8W7
DR   Ubigene; YC-C009-EGFP-P
DR   Wikidata; Q123032970
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   LNCaP clone FGC-Luc2
AC   CVCL_A4BQ
DR   ATCC; CRL-1740-LUC2
DR   cancercelllines; CVCL_A4BQ
DR   Wikidata; Q105509918
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1740-LUC2).
CC   Doubling time: 40.8 hours (ATCC=CRL-1740-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): ATCC=CRL-1740-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 9.1,10.3
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   LNCaP clone FGC.10
AC   CVCL_W668
SY   LNCaP clone FGC-10; LNCaP-FGC-10; LNcap-FGC-10; LNCaP FGC-10
DR   cancercelllines; CVCL_W668
DR   IZSLER; BS TCL 187
DR   NCBI_Iran; C439
DR   Wikidata; Q54902826
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10995.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): IZSLER=BS TCL 187
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13
ST   D16S539: 11,12
ST   D21S11: 29,32.2
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   LNCaP clone FGC(Cas9)
AC   CVCL_E7J8
WW   Provider; BRICS; ECC3033; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3967
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LNCaP M
AC   CVCL_M133
SY   LNCaP-M; LNCaP subline M; M
DR   cancercelllines; CVCL_M133
DR   Wikidata; Q54902827
RX   PubMed=8169003;
RX   PubMed=35502546;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/LNCaP
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   LNCaP-17
AC   CVCL_B413
DR   BTO; BTO_0005044
DR   cancercelllines; CVCL_B413
DR   Wikidata; Q54902828
RX   PubMed=16908524;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5155; HPN.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   LNCaP-19
AC   CVCL_WW88
SY   LNCaP cells from passage 19
DR   cancercelllines; CVCL_WW88
DR   Wikidata; Q95982755
RX   PubMed=15389782;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 46 hours (PubMed=15389782); 50.00 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   LNCaP-34
AC   CVCL_B414
DR   BTO; BTO_0005045
DR   cancercelllines; CVCL_B414
DR   Wikidata; Q54902829
RX   PubMed=16908524;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5155; HPN.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   LNCaP-95
AC   CVCL_ZC87
SY   LNCaP 95; LNCaP95; LN95
DR   BTO; BTO_0006264
DR   cancercelllines; CVCL_ZC87
DR   Wikidata; Q98126929
RX   PubMed=10420156;
RX   PubMed=28928128;
RX   PubMed=32954481;
RX   PubMed=38892296;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 52.2 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (PubMed=28928128).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   LNCAP-AAR
AC   CVCL_ZX07
DR   cancercelllines; CVCL_ZX07
DR   Wikidata; Q102114473
RX   CelloPub=CLPUB00570;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68639; Abiraterone acetate.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   LNCaP-abl
AC   CVCL_4793
SY   LNCaP-ABL; LNCaP-androgen ablation
DR   BTO; BTO_0006467
DR   cancercelllines; CVCL_4793
DR   GEO; GSM3145603
DR   GEO; GSM3145719
DR   GEO; GSM5402195
DR   Wikidata; Q54902830
RX   PubMed=10496349;
RX   PubMed=34402095;
RX   PubMed=38892296;
CC   Population: Caucasian.
CC   Characteristics: Established after 10 months of propagation of LNCaP in steroid-depleted medium.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: LNCaP-abI; BTO=BTO_0006467.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   LNCaP-AI
AC   CVCL_4791
SY   LNCAPAI; LNCaP-Androgen-Independent
DR   cancercelllines; CVCL_4791
DR   GEO; GSM1374623
DR   Wikidata; Q54902831
RX   PubMed=10537131;
RX   PubMed=35502546;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   LNCaP-AR
AC   CVCL_C7XA
DR   Wikidata; Q123032971
RX   PubMed=14702632;
RX   PubMed=35502546;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   LNCaP-BicR
AC   CVCL_F0L7
RX   PubMed=28500234;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 40 mmol/L of bicalutamide (PubMed=28500234).
CC   Selected for resistance to: ChEBI; CHEBI_3090; Bicalutamide.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LNCaP-CL1
AC   CVCL_3872
SY   CL1; CL-1
DR   BTO; BTO_0005673
DR   cancercelllines; CVCL_3872
DR   Wikidata; Q54902832
RX   PubMed=10992426;
RX   PubMed=11038142;
RX   PubMed=15162376;
RX   PubMed=15833837;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent. Has highly locally invasive and metastatic properties.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   LNCaP-CL1-GFP
AC   CVCL_4924
SY   CL1-GFP
DR   cancercelllines; CVCL_4924
DR   Wikidata; Q54902833
RX   PubMed=10992426;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent. Has highly locally invasive and metastatic properties (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3872 ! LNCaP-CL1
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   LNCaP-CL2
AC   CVCL_RK71
SY   CL2; CL-2
DR   cancercelllines; CVCL_RK71
DR   Wikidata; Q54902834
RX   PubMed=11038142;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3872 ! LNCaP-CL1
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   LNCaP-CR
AC   CVCL_8986
DR   cancercelllines; CVCL_8986
DR   Wikidata; Q54902835
RX   PubMed=16377078;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   LNCaP-CS10
AC   CVCL_V260
DR   cancercelllines; CVCL_V260
DR   Wikidata; Q54902836
RX   PubMed=19902465;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent (PubMed=19902465).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   LNCaP-EnzR
AC   CVCL_RA57
DR   cancercelllines; CVCL_RA57
DR   GEO; GSM2069526
DR   GEO; GSM2069527
DR   GEO; GSM2069528
DR   GEO; GSM2069529
DR   Wikidata; Q54902837
RX   PubMed=27036029;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   LNCaP-LN1
AC   CVCL_L160
DR   cancercelllines; CVCL_L160
DR   Wikidata; Q54902838
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-LN2
AC   CVCL_L161
DR   cancercelllines; CVCL_L161
DR   Wikidata; Q54902839
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L160 ! LNCaP-LN1
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-LN3
AC   CVCL_L162
SY   LNCaP-LN-3
DR   cancercelllines; CVCL_L162
DR   KCLB; 80018
DR   Wikidata; Q54902840
RX   PubMed=9816342;
RX   PubMed=12725112;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L161 ! LNCaP-LN2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-LN4
AC   CVCL_L163
DR   cancercelllines; CVCL_L163
DR   Wikidata; Q54902841
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L162 ! LNCaP-LN3
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-luc-M6
AC   CVCL_5J30
DR   cancercelllines; CVCL_5J30
DR   Revvity/PerkinElmer; 119271
DR   Wikidata; Q54902842
RX   PubMed=15042605;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119271; true.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   LNCaP-luc2
AC   CVCL_5J24
DR   cancercelllines; CVCL_5J24
DR   Revvity/PerkinElmer; 125055
DR   Wikidata; Q54902844
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 125055; true.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   LNCaP-OM
AC   CVCL_9U27
DR   cancercelllines; CVCL_9U27
DR   Wikidata; Q54902845
RX   PubMed=9112118;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   LNCaP-PDR1
AC   CVCL_C0RR
SY   LNCaP PDR1; LN-PDR1
DR   cancercelllines; CVCL_C0RR
DR   GEO; GSM2650005
DR   GEO; GSM2650006
DR   GEO; GSM2650007
DR   GEO; GSM2650008
DR   GEO; GSM2650009
DR   GEO; GSM2650010
DR   PRIDE; PXD006561
DR   Wikidata; Q112930019
RX   PubMed=29739788;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   LNCaP-PDR2
AC   CVCL_C0RS
SY   LNCaP PDR2; LN-PDR2
DR   cancercelllines; CVCL_C0RS
DR   GEO; GSM2650011
DR   GEO; GSM2650012
DR   GEO; GSM2650013
DR   GEO; GSM2650014
DR   GEO; GSM2650015
DR   GEO; GSM2650016
DR   PRIDE; PXD006561
DR   Wikidata; Q112930020
RX   PubMed=29739788;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   LNCaP-Pro1
AC   CVCL_L164
DR   cancercelllines; CVCL_L164
DR   Wikidata; Q54902846
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-Pro2
AC   CVCL_L165
DR   cancercelllines; CVCL_L165
DR   Wikidata; Q54902847
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L164 ! LNCaP-Pro1
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-Pro3
AC   CVCL_L166
DR   cancercelllines; CVCL_L166
DR   Wikidata; Q54902848
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L165 ! LNCaP-Pro2
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-Pro4
AC   CVCL_L167
DR   cancercelllines; CVCL_L167
DR   Wikidata; Q54902849
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L166 ! LNCaP-Pro3
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-Pro5
AC   CVCL_L168
DR   cancercelllines; CVCL_L168
DR   Wikidata; Q54902851
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L167 ! LNCaP-Pro4
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   LNCaP-r
AC   CVCL_D3W5
DR   Wikidata; Q127382614
RX   PubMed=2734981;
RX   PubMed=4048015;
RX   PubMed=10092147;
CC   Population: Caucasian.
CC   Characteristics: Resistant to androgen (PubMed=4048015).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   LNCaP-Red-FLuc
AC   CVCL_5J03
SY   LNCaP Red-FLuc; Bioware Brite LNCaP Red-FLuc; IVISbrite LNCaP Red F-luc
DR   cancercelllines; CVCL_5J03
DR   Revvity/PerkinElmer; BW125055
DR   Wikidata; Q54902852
CC   Population: Caucasian.
CC   Doubling time: 60 hours (Revvity/PerkinElmer=BW125055).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   LNCaP-Rf
AC   CVCL_4792
SY   LNCaP-RF
DR   cancercelllines; CVCL_4792
DR   Wikidata; Q54902853
RX   PubMed=11861374;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160322000315/http://capcelllines.ca/details.asp?id=175
CC   Population: Caucasian.
CC   Doubling time: 34.14 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   LNCaP-SL
AC   CVCL_WZ25
SY   Stem-Like LNCaP; LNCaP-Stem Like
DR   cancercelllines; CVCL_WZ25
DR   GEO; GSM1633302
DR   GEO; GSM1633303
DR   GEO; GSM1633304
DR   Wikidata; Q95982793
RX   PubMed=28145883;
CC   Population: Caucasian.
CC   Characteristics: Reprogrammed to, maintained and propagated as cancer stem-like cells (CSCs) by growth in androgen-free neural/neural crest (N/NC) stem medium.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 10
//
ID   LNCaP95 clone 2-C6
AC   CVCL_A4DX
DR   cancercelllines; CVCL_A4DX
DR   Wikidata; Q105509920
RX   PubMed=32954481;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 57.6 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC87 ! LNCaP-95
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LNCaP95 clone 2-D3
AC   CVCL_A4DY
DR   cancercelllines; CVCL_A4DY
DR   Wikidata; Q105509923
RX   PubMed=32954481;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 52.9 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC87 ! LNCaP-95
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LNCaP95 clone A7
AC   CVCL_A4DZ
DR   cancercelllines; CVCL_A4DZ
DR   Wikidata; Q105509926
RX   PubMed=32954481;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 71.0 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC87 ! LNCaP-95
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LNCaP95 clone D2
AC   CVCL_A4EA
DR   cancercelllines; CVCL_A4EA
DR   Wikidata; Q105509928
RX   PubMed=32954481;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 68.6 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC87 ! LNCaP-95
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LNCaP95 clone D3
AC   CVCL_A4EB
DR   cancercelllines; CVCL_A4EB
DR   Wikidata; Q105509931
RX   PubMed=32954481;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 55.7 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC87 ! LNCaP-95
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LNCaP95 clone E2
AC   CVCL_A4EC
DR   cancercelllines; CVCL_A4EC
DR   Wikidata; Q105509935
RX   PubMed=32954481;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 64.1 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC87 ! LNCaP-95
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LNCaP95 clone F2
AC   CVCL_A4ED
DR   cancercelllines; CVCL_A4ED
DR   Wikidata; Q105509940
RX   PubMed=32954481;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent.
CC   Doubling time: 85.3 hours (PubMed=32954481).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZC87 ! LNCaP-95
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   LNCaPR
AC   CVCL_F0L9
RX   PubMed=33799432;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LND1
AC   CVCL_J076
DR   cancercelllines; CVCL_J076
DR   Cosmic; 2051679
DR   Wikidata; Q54902854
RX   PubMed=23489693;
RX   PubMed=25623468;
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Unspecified (PubMed=23489693).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   LND554SV.3
AC   CVCL_AB83
DR   Wikidata; Q54902855
RX   PubMed=27345786;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/4dbbb515-3176-3216-a9d5-6548c6777273
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigaciones Biomedicas Alberto Sols; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7461; MT-ND5; Simple; p.Asp393Asn (m.13513G>A); ClinVar=VCV000009702; Zygosity=Heteroplasmic (PubMed=27345786).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   LNDWCHi001-A
AC   CVCL_D0HN
SY   LNDWCH-iPS-PD-PLA2G6-001
DR   BioSamples; SAMEA114009739
DR   hPSCreg; LNDWCHi001-A
DR   Wikidata; Q123032972
RX   PubMed=38215561;
CC   From: Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Ala633Val (c.1898C>T); ClinVar=VCV001180788; Zygosity=Homozygous (PubMed=38215561).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   NCIt; C201519; Parkinson disease 14, autosomal recessive
DI   ORDO; Orphanet_199351; Adult-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   LNDWCHi002-A
AC   CVCL_E8E6
SY   LNDWCH-iPS-ALS-TARDBP-001
DR   BioSamples; SAMEA115098523
DR   hPSCreg; LNDWCHi002-A
CC   From: Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan university; Chengdu; China.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LNGK9
AC   CVCL_D575
SY   LNGK-9 PCa; LNGK-9; LnGK9
DR   BTO; BTO_0005217
DR   cancercelllines; CVCL_D575
DR   Wikidata; Q54902856
RX   PubMed=9365544;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   LNH-1
AC   CVCL_WB44
SY   Lesch-NyHan-1
DR   IBRC; C10546
DR   Wikidata; Q95982796
RX   PubMed=32358742;
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   LNh0030
AC   CVCL_VB14
DR   ECACC; 15102956
DR   Wikidata; Q54902857
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LNh0050
AC   CVCL_VB15
DR   ECACC; 15082807
DR   Wikidata; Q54902858
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LNh0072
AC   CVCL_VB16
DR   ECACC; 15092916
DR   Wikidata; Q54902859
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LNh0101
AC   CVCL_VB17
DR   ECACC; 15102957
DR   Wikidata; Q54902860
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LNh0108
AC   CVCL_VB18
DR   ECACC; 15092917
DR   Wikidata; Q54902861
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LNISi001-A
AC   CVCL_D6IS
DR   BioSamples; SAMEA14029853
DR   hPSCreg; LNISi001-A
DR   Wikidata; Q127382615
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IT ! LNISi001-B
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNISi001-B
AC   CVCL_D6IT
DR   hPSCreg; LNISi001-B
DR   Wikidata; Q127382617
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IS ! LNISi001-A
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNISi002-A
AC   CVCL_D6IU
DR   hPSCreg; LNISi002-A
DR   Wikidata; Q127382618
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IV ! LNISi002-B
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNISi002-B
AC   CVCL_D6IV
DR   hPSCreg; LNISi002-B
DR   Wikidata; Q127382619
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IU ! LNISi002-A
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNISi003-A
AC   CVCL_D6IW
DR   hPSCreg; LNISi003-A
DR   Wikidata; Q127382620
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IX ! LNISi003-B
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNISi003-B
AC   CVCL_D6IX
DR   hPSCreg; LNISi003-B
DR   Wikidata; Q127382621
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IW ! LNISi003-A
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNISi004-A
AC   CVCL_D6IY
DR   hPSCreg; LNISi004-A
DR   Wikidata; Q127382622
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IZ ! LNISi004-B
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNISi004-B
AC   CVCL_D6IZ
DR   hPSCreg; LNISi004-B
DR   Wikidata; Q127382623
RX   PubMed=37875964;
CC   From: Laboratory of NeuroImmunology, Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6IY ! LNISi004-A
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   LNSc-iPS1
AC   CVCL_C793
DR   Wikidata; Q54902862
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8514 ! GM00013
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   LNSc-iPS2
AC   CVCL_C794
SY   LNSC-IPS2
DR   Wikidata; Q54902863
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8514 ! GM00013
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   LNY1
AC   CVCL_D229
SY   LNY-1
DR   Wikidata; Q54902864
RX   PubMed=12060610;
RX   PubMed=19818766;
CC   Population: Japanese.
CC   HLA typing: A*26,31; B*51,54; C*04,10 (PubMed=19818766).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   LNZTA3WT11
AC   CVCL_3539
SY   LNZTA3p53WT11; WT11
DR   CLO; CLO_0007370
DR   ATCC; CRL-11544
DR   LINCS_LDP; LCL-1355
DR   Wikidata; Q54902865
RX   Patent=US5807731;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11544.
CC   Population: Caucasian.
CC   Characteristics: The expression of the luciferase reporter gene as well as the TP53 gene are under the control of a tetO operator.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: ATCC; CRL-11544; true.
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
ST   Source(s): ATCC=CRL-11544
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0394 ! LN-308
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   LNZTA3WT4
AC   CVCL_3540
SY   LNZTA3p53WT4; WT4
DR   CLO; CLO_0007371
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-11543
DR   BioGRID_ORCS_Cell_line; 931
DR   BioSample; SAMN03471340
DR   cancercelllines; CVCL_3540
DR   Cell_Model_Passport; SIDM01220
DR   Cosmic; 1995487
DR   Cosmic-CLP; 1240170
DR   DepMap; ACH-002269
DR   EGA; EGAS00001000978
DR   GDSC; 1240170
DR   GEO; GSM1670052
DR   LINCS_HMS; 50028
DR   LINCS_LDP; LCL-1345
DR   PharmacoDB; LNZTA3WT4_853_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54902866
RX   Patent=US5807731;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11543.
CC   Population: Caucasian.
CC   Characteristics: The expression of the luciferase reporter gene as well as the TP53 gene are under the control of a tetO operator.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=1.42%; Native American=1.36%; East Asian, North=1.52%; East Asian, South=0%; South Asian=1.65%; European, North=44.35%; European, South=49.7% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-11543; true.
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
ST   Source(s): ATCC=CRL-11543; Cosmic-CLP=1240170
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0394 ! LN-308
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   LO #2
AC   CVCL_C7SD
DR   Wikidata; Q117704633
RX   PubMed=994214;
RX   PubMed=4524119;
CC   Doubling time: 32 hours (Note=At 32th passage), 29 hours (Note=At 52th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Scapula, skin; UBERON=UBERON_8480073.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   Lo Ren
AC   CVCL_3541
DR   CLO; CLO_0007372
DR   ATCC; CRL-1130
DR   Wikidata; Q54902867
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Lo Wen
AC   CVCL_3542
DR   CLO; CLO_0007373
DR   ATCC; CRL-1159
DR   Wikidata; Q54902868
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   LO-22
AC   CVCL_C519
DR   CLO; CLO_0007374
DR   Wikidata; Q54902869
RX   Patent=US4902618;
RX   PubMed=6209347;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8619.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 7
//
ID   LO-BG-1
AC   CVCL_A6FQ
DR   Wikidata; Q107115668
RX   CelloPub=CLPUB00622;
RX   CelloPub=CLPUB00624;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Porphyromonas gingivalis (strain ATCC 33277 / DSM 20709 / CIP 103683 / JCM 12257 / NCTC 11834 / 2561).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   LO-CD1-a
AC   CVCL_A6CJ
DR   Wikidata; Q107115670
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06126; Human CD1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-CD2a
AC   CVCL_A6CS
SY   LO-CD2A; Lo-CD2a; LO-CD2-act; Lo-CD2-act; BTI-322
DR   ABCD; ABCD_AH427
DR   ATCC; CRL-3535
DR   Wikidata; Q107115673
RX   CelloPub=CLPUB00617;
RX   Patent=US6849258;
RX   Patent=US7592006;
RX   PubMed=7627995;
RX   PubMed=8757956;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11423.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized siplizumab (MEDI-507) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   LO-CD2b
AC   CVCL_A6FU
DR   Wikidata; Q107115675
RX   Patent=US7250167;
RX   PubMed=10910286;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-802.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 4
//
ID   LO-CD4-a
AC   CVCL_A6CT
SY   LO-CD4a
DR   Wikidata; Q107115677
RX   CelloPub=CLPUB00617;
RX   CelloPub=CLPUB00622;
RX   Patent=EP0380018B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89012101.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-CD4-b
AC   CVCL_A6CU
SY   LO-CD4b
DR   Wikidata; Q107115679
RX   CelloPub=CLPUB00617;
RX   CelloPub=CLPUB00622;
RX   Patent=EP0380018B1;
RX   PubMed=7627995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89012102.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-CD5-a
AC   CVCL_A6CK
DR   Wikidata; Q107115682
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-CD6-a
AC   CVCL_A6CV
DR   Wikidata; Q107115684
RX   CelloPub=CLPUB00617;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-DNP-1
AC   CVCL_A6GH
SY   HDB0232
DR   Wikidata; Q107115686
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-10
AC   CVCL_A6GP
SY   HDB7063
DR   Wikidata; Q107115688
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgE, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-11
AC   CVCL_A6GL
SY   HDB7064
DR   Wikidata; Q107115691
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-15
AC   CVCL_A6GT
SY   HDB7068
DR   Wikidata; Q107115693
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-16
AC   CVCL_A6GJ
SY   HDB7069
DR   Wikidata; Q107115695
RX   CelloPub=CLPUB00622;
RX   PubMed=2643569;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-2
AC   CVCL_A6GI
SY   HDB7055
DR   Wikidata; Q107115697
RX   CelloPub=CLPUB00622;
RX   PubMed=2643569;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-20
AC   CVCL_A6GU
SY   HDB7073
DR   Wikidata; Q107115699
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-22
AC   CVCL_A6GV
SY   HDB7075
DR   Wikidata; Q107115702
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-3
AC   CVCL_A6GW
SY   HDB7056
DR   Wikidata; Q107115704
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-30
AC   CVCL_A6GQ
SY   HDB7083
DR   Wikidata; Q107115705
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgE, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-34
AC   CVCL_A6GR
SY   HDB7087
DR   Wikidata; Q107115706
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-39
AC   CVCL_A6GX
SY   HDB7092
DR   Wikidata; Q107115709
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-4
AC   CVCL_A6GY
SY   HDB7057
DR   Wikidata; Q107115710
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-40
AC   CVCL_A6GS
SY   HDB7093
DR   Wikidata; Q107115712
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-41
AC   CVCL_A6HL
SY   HDB7094
DR   Wikidata; Q107115713
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-44
AC   CVCL_A6GZ
SY   HDB7097
DR   Wikidata; Q107115715
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-45
AC   CVCL_A6GG
SY   HDB7098
DR   Wikidata; Q107115716
RX   CelloPub=CLPUB00622;
RX   PubMed=2643569;
RX   PubMed=3220507;
RX   PubMed=3701070;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-47
AC   CVCL_A6HA
SY   HDB7100
DR   Wikidata; Q107115719
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
RX   PubMed=3701070;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-48
AC   CVCL_A6HB
SY   HDB7101
DR   Wikidata; Q107115720
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-49
AC   CVCL_A6HC
SY   HDB7102
DR   Wikidata; Q107115721
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
RX   PubMed=3701070;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-51
AC   CVCL_A6HD
SY   HDB7104
DR   Wikidata; Q107115722
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
RX   PubMed=3701070;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-55
AC   CVCL_A6HE
SY   HDB7108
DR   Wikidata; Q107115723
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-56
AC   CVCL_A6HF
SY   HDB7109
DR   Wikidata; Q107115726
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-57
AC   CVCL_A6GM
SY   HDB7110
DR   Wikidata; Q107115727
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-58
AC   CVCL_A6HM
SY   HDB7111
DR   Wikidata; Q107115728
RX   CelloPub=CLPUB00622;
RX   PubMed=2643569;
RX   PubMed=3701070;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-61
AC   CVCL_A6GK
SY   HDB7114
DR   Wikidata; Q107115729
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-62
AC   CVCL_A6HG
SY   HDB7115
DR   Wikidata; Q107115731
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-64
AC   CVCL_A6GN
SY   64 hybridoma; HDB7117
DR   Wikidata; Q107115734
RX   CelloPub=CLPUB00622;
RX   PubMed=2643569;
RX   PubMed=3701070;
RX   PubMed=8525997;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-65
AC   CVCL_A6HP
SY   HDB7118
DR   Wikidata; Q107115737
RX   CelloPub=CLPUB00622;
RX   PubMed=2643569;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-66
AC   CVCL_A6HH
SY   HDB7119
DR   Wikidata; Q107115738
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-67
AC   CVCL_A6HN
SY   67 hybridoma; HDB7120
DR   Wikidata; Q107115739
RX   CelloPub=CLPUB00622;
RX   PubMed=3701070;
RX   PubMed=8525997;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-68
AC   CVCL_A6HI
SY   HDB7121
DR   Wikidata; Q107115741
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
RX   PubMed=3701070;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-7
AC   CVCL_A6HJ
SY   HDB7060
DR   Wikidata; Q107115743
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DNP-9
AC   CVCL_A6HK
SY   HDB7062
DR   Wikidata; Q107115745
RX   CelloPub=CLPUB00622;
RX   PubMed=3220507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   LO-DR-a
AC   CVCL_A6CR
SY   LO-DRa
DR   Wikidata; Q107115747
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human HLA-DR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-Ea-10
AC   CVCL_A6DQ
SY   LOuvain-Erwinia amylovora-10
DR   Wikidata; Q107115749
RX   CelloPub=CLPUB00621;
RX   CelloPub=CLPUB00622;
RX   DOI=10.17660/ActaHortic.1987.217.9;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Erwinia amylovora.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-Ea-15
AC   CVCL_A6DR
SY   LOuvain-Erwinia amylovora-15
DR   Wikidata; Q107115752
RX   CelloPub=CLPUB00621;
RX   CelloPub=CLPUB00622;
RX   DOI=10.17660/ActaHortic.1987.217.9;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Erwinia amylovora.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-Ea-18
AC   CVCL_A6DS
SY   LOuvain-Erwinia amylovora-18
DR   Wikidata; Q107115757
RX   CelloPub=CLPUB00621;
RX   CelloPub=CLPUB00622;
RX   DOI=10.17660/ActaHortic.1987.217.9;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Erwinia amylovora.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HA-1
AC   CVCL_A6BK
DR   Wikidata; Q107115760
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HA-2
AC   CVCL_A6BL
DR   Wikidata; Q107115762
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HA-3
AC   CVCL_A6BM
DR   Wikidata; Q107115765
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1.
CC   Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HA-4
AC   CVCL_A6BN
DR   Wikidata; Q107115768
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1.
CC   Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HA-5
AC   CVCL_A6BP
DR   Wikidata; Q107115772
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1.
CC   Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HA-6
AC   CVCL_A6BQ
DR   Wikidata; Q107115775
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1.
CC   Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HA-9
AC   CVCL_A6GF
SY   LO-hA-9
DR   Wikidata; Q107115778
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1.
CC   Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HApoB-1
AC   CVCL_A6BD
SY   LOH-ApoB1
DR   Wikidata; Q107115780
RX   CelloPub=CLPUB00613;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HApoB-2
AC   CVCL_A6BE
SY   LOH-ApoB2
DR   Wikidata; Q107115781
RX   CelloPub=CLPUB00613;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HApoB-3
AC   CVCL_A6BF
SY   LOH-ApoB3
DR   Wikidata; Q107115782
RX   CelloPub=CLPUB00613;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HApoB-4
AC   CVCL_A6BG
SY   LOH-ApoB4
DR   Wikidata; Q107115783
RX   CelloPub=CLPUB00613;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HApoB-5
AC   CVCL_A6BH
SY   LOH-ApoB5
DR   Wikidata; Q107115784
RX   CelloPub=CLPUB00613;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HApoB-6
AC   CVCL_A6BI
SY   LOH-ApoB6
DR   Wikidata; Q107115786
RX   CelloPub=CLPUB00613;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HD-1
AC   CVCL_A6AP
SY   HDB7125
DR   Wikidata; Q107115787
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01880; Human immunoglobulin heavy chain delta.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HD-3
AC   CVCL_A6AQ
SY   HDB7126
DR   Wikidata; Q107115788
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01880; Human immunoglobulin heavy chain delta.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HE-7
AC   CVCL_A6BR
SY   HDB7130
DR   Wikidata; Q107115789
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01854; Human immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-1
AC   CVCL_A6AR
SY   HDB7131
DR   Wikidata; Q107115791
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-19
AC   CVCL_A6AV
DR   Wikidata; Q107115793
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-20
AC   CVCL_A6AW
SY   LO-hG-20
DR   Wikidata; Q107115794
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-21
AC   CVCL_A6AX
DR   Wikidata; Q107115797
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-22
AC   CVCL_A6AY
SY   LO-hG-22; LO-HG22
DR   Wikidata; Q107115798
RX   CelloPub=CLPUB00612;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-23
AC   CVCL_A6AZ
DR   Wikidata; Q107115799
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-3
AC   CVCL_A6AS
DR   Wikidata; Q107115800
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-6
AC   CVCL_A6AT
SY   HDB7134
DR   Wikidata; Q107115801
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HG-7
AC   CVCL_A6AU
SY   HDB7135
DR   Wikidata; Q107115802
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human IgG (all 4 classes).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HK-1
AC   CVCL_A6BS
SY   HDB7136
DR   Wikidata; Q107115803
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human Ig kappa light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HK-3
AC   CVCL_A6BT
SY   LO-hK-3
DR   Wikidata; Q107115805
RX   CelloPub=CLPUB00612;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Ig kappa light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HL-1
AC   CVCL_A6BU
DR   Wikidata; Q107115806
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: Human Ig lambda light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HL-2
AC   CVCL_A6BA
SY   LO-hL-2
DR   Wikidata; Q107115808
RX   CelloPub=CLPUB00612;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Ig lambda light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HL-3
AC   CVCL_A6BB
DR   Wikidata; Q107115809
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: Human Ig lambda light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HL-4
AC   CVCL_A6BC
DR   Wikidata; Q107115810
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human Ig lambda light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HM-2
AC   CVCL_A6AM
SY   HDB7121
DR   Wikidata; Q107115811
RX   CelloPub=CLPUB00612;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HM-7
AC   CVCL_A5ZQ
SY   LO-hM-7
DR   Wikidata; Q107115812
RX   CelloPub=CLPUB00612;
RX   Patent=US5858359;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HM-8
AC   CVCL_A6AN
DR   Wikidata; Q107115813
RX   CelloPub=CLPUB00612;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-10
AC   CVCL_A6BX
DR   Wikidata; Q107115814
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-12
AC   CVCL_A6BY
DR   Wikidata; Q107115815
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-13
AC   CVCL_A6BZ
DR   Wikidata; Q107115816
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-14
AC   CVCL_A6CA
DR   Wikidata; Q107115817
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-15
AC   CVCL_A6CB
DR   Wikidata; Q107115818
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-16
AC   CVCL_A6CC
DR   Wikidata; Q107115819
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-17
AC   CVCL_A6CD
DR   Wikidata; Q107115821
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-18
AC   CVCL_A6CE
DR   Wikidata; Q107115823
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-19
AC   CVCL_A6CF
DR   Wikidata; Q107115824
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-8
AC   CVCL_A6BV
DR   Wikidata; Q107115825
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-HRP-9
AC   CVCL_A6BW
DR   Wikidata; Q107115826
RX   CelloPub=CLPUB00614;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MA-10
AC   CVCL_A6GB
DR   Wikidata; Q107115827
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01878; Mouse immunoglobulin heavy chain alpha.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MA-7
AC   CVCL_A6GA
DR   Wikidata; Q107115828
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01878; Mouse immunoglobulin heavy chain alpha.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MD-6
AC   CVCL_A6FW
DR   Wikidata; Q107115829
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01881; Mouse immunoglobulin heavy chain delta.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MD-8
AC   CVCL_A6FX
DR   Wikidata; Q107115830
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01881; Mouse immunoglobulin heavy chain delta.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-ME-2
AC   CVCL_A6DN
DR   Wikidata; Q107115831
RX   CelloPub=CLPUB00620;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-ME-3
AC   CVCL_A6DP
DR   Wikidata; Q107115832
RX   CelloPub=CLPUB00620;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG1-13
AC   CVCL_A6FH
DR   Wikidata; Q107115833
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG1-15
AC   CVCL_A6FI
DR   Wikidata; Q107115834
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG1-2
AC   CVCL_A6DF
SY   HDB7138
DR   Wikidata; Q107115835
RX   CelloPub=CLPUB00619;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG2a-2
AC   CVCL_A6DG
SY   HDB7143
DR   Wikidata; Q107115837
RX   CelloPub=CLPUB00619;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse Ig heavy chain gamma-2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG2a-3
AC   CVCL_A6FJ
SY   HDB7144
DR   Wikidata; Q107115838
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse Ig heavy chain gamma-2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG2a-7
AC   CVCL_A6FK
DR   Wikidata; Q107115839
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mouse Ig heavy chain gamma-2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG2a-9
AC   CVCL_A6FY
DR   Wikidata; Q107115840
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mouse Ig heavy chain gamma-2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG2b-1
AC   CVCL_A6FL
DR   Wikidata; Q107115841
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01867; Mouse immunoglobulin heavy chain gamma-2b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG2b-2
AC   CVCL_A6DH
SY   HDB7145
DR   Wikidata; Q107115842
RX   CelloPub=CLPUB00619;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01867; Mouse immunoglobulin heavy chain gamma-2b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG3-13
AC   CVCL_A6FZ
DR   Wikidata; Q107115843
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03987; Mouse immunoglobulin heavy chain gamma-3.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG3-7
AC   CVCL_A6DI
DR   Wikidata; Q107115844
RX   CelloPub=CLPUB00619;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03987; Mouse immunoglobulin heavy chain gamma-3.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MG-7
AC   CVCL_A6GD
SY   HDB7147
DR   Wikidata; Q107115845
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Mouse Ig heavy chain gamma.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MK-1
AC   CVCL_A6DJ
SY   HDB7150
DR   Wikidata; Q107115846
RX   CelloPub=CLPUB00619;
RX   CelloPub=CLPUB00622;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse Ig kappa light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MK-2
AC   CVCL_A6FN
SY   HDB7151
DR   Wikidata; Q107115847
RX   CelloPub=CLPUB00622;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mouse Ig kappa light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MK-3
AC   CVCL_A6FP
SY   HDB7152
DR   Wikidata; Q107115848
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Mouse Ig kappa light chains.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MM-3
AC   CVCL_A6DL
DR   Wikidata; Q107115849
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MM-8
AC   CVCL_A6DM
DR   Wikidata; Q107115850
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MM-9
AC   CVCL_A6DK
SY   HDB7054
DR   Wikidata; Q107115851
RX   CelloPub=CLPUB00619;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-MO-1
AC   CVCL_A6FV
SY   LO-MO1
DR   Wikidata; Q107115852
RX   CelloPub=CLPUB00622;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-panB-a
AC   CVCL_A6FT
SY   LO-PanB-a; LO-panB
DR   Wikidata; Q107115853
RX   CelloPub=CLPUB00622;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human antigen on leucocytes.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 4
//
ID   LO-PL3-a
AC   CVCL_A6CL
DR   Wikidata; Q107115854
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   LO-PL3-b
AC   CVCL_A6CM
DR   Wikidata; Q107115855
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   LO-PL4
AC   CVCL_A6CN
DR   Wikidata; Q107115856
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21926; Human CD9.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-RG-1
AC   CVCL_A6AL
DR   Wikidata; Q107115857
RX   CelloPub=CLPUB00611;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Rabbit IgG heavy chain.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-RK-1a-1
AC   CVCL_A6AI
SY   LO-RK1a-1
DR   Wikidata; Q107115858
RX   CelloPub=CLPUB00610;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (IgK-1a allotype).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-RK-1b-1
AC   CVCL_A6AJ
SY   LO-RK1b-1; HDB7153
DR   Wikidata; Q107115859
RX   CelloPub=CLPUB00610;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-RK-1b-2
AC   CVCL_A6AK
SY   LO-RK1b-2; HDB7154
DR   Wikidata; Q107115860
RX   CelloPub=CLPUB00610;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-SM-11
AC   CVCL_A6FS
DR   Wikidata; Q107115861
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Streptococcus mutans cell wall antigens.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-SM-2
AC   CVCL_A6FR
DR   Wikidata; Q107115862
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Streptococcus mutans cell wall antigens.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-Tact-1
AC   CVCL_A6CP
SY   LO-Tact1
DR   Wikidata; Q107115863
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-Tact-2
AC   CVCL_A6CQ
SY   LO-Tact2
DR   Wikidata; Q107115864
RX   CelloPub=CLPUB00616;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-Tmat
AC   CVCL_A6CW
DR   Wikidata; Q107115865
RX   CelloPub=CLPUB00617;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-VG1
AC   CVCL_A6CG
DR   Wikidata; Q107115866
RX   CelloPub=CLPUB00615;
RX   CelloPub=CLPUB00623;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: Xenopus laevis vitellogenin.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-VG2
AC   CVCL_A6CH
DR   Wikidata; Q107115868
RX   CelloPub=CLPUB00615;
RX   CelloPub=CLPUB00623;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Xenopus laevis vitellogenin.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-VG3
AC   CVCL_A6CI
DR   Wikidata; Q107115869
RX   CelloPub=CLPUB00615;
RX   CelloPub=CLPUB00623;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Xenopus laevis vitellogenin.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-VX-10
AC   CVCL_A6DT
SY   LOuvain-potato Virus X-10
DR   Wikidata; Q107115870
RX   CelloPub=CLPUB00621;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Potato virus X.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-VX-4
AC   CVCL_A6DU
SY   LOuvain-potato Virus X-4
DR   Wikidata; Q107115871
RX   CelloPub=CLPUB00621;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Potato virus X.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-VX-6
AC   CVCL_A6DV
SY   LOuvain-potato Virus X-6
DR   Wikidata; Q107115872
RX   CelloPub=CLPUB00621;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Potato virus X.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO-VX-9
AC   CVCL_A6DW
SY   LOuvain-potato Virus X-9
DR   Wikidata; Q107115873
RX   CelloPub=CLPUB00621;
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Potato virus X.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   LO081785
AC   CVCL_E747
SY   LO 081785; L0081785
DR   dbMHC; 48954
DR   ECACC; 88052018
DR   IHW; IHW09018
DR   IPD-IMGT/HLA; 11637
DR   Wikidata; Q54902870
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01:01,24:02:01:01; B*18:01:01:01; C*05:01:01:01; DPA1*01; DPB1*03:01:01; DQA1*05:01:01; DQB1*02:01:01; DRA*01:01; DRB1*03:01:01; DRB3*02:02 (IPD-IMGT/HLA=11637).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   LO1.Fas
AC   CVCL_S324
SY   LO1Faa
DR   ATCC; CRL-6554
DR   Wikidata; Q54902871
CC   Group: Reptilian cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6554; true.
CC   Derived from site: In situ; Fascia; UBERON=UBERON_0008982.
OX   NCBI_TaxID=27788; ! Lepidochelys olivacea (Olive Ridley Sea turtle)
OI   CVCL_S325 ! LO1.GAK
OI   CVCL_S326 ! LO1.HT
OI   CVCL_S327 ! LO1.Lu
OI   CVCL_S328 ! LO1.Mu
SX   Sex unspecified
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   LO1.GAK
AC   CVCL_S325
SY   LO1GAK
DR   ATCC; CRL-6555
DR   Wikidata; Q54902872
CC   Group: Reptilian cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6555; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=27788; ! Lepidochelys olivacea (Olive Ridley Sea turtle)
OI   CVCL_S324 ! LO1.Fas
OI   CVCL_S326 ! LO1.HT
OI   CVCL_S327 ! LO1.Lu
OI   CVCL_S328 ! LO1.Mu
SX   Sex unspecified
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   LO1.HT
AC   CVCL_S326
SY   LO1HT
DR   ATCC; CRL-6556
DR   Wikidata; Q54902873
CC   Group: Reptilian cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6556; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=27788; ! Lepidochelys olivacea (Olive Ridley Sea turtle)
OI   CVCL_S324 ! LO1.Fas
OI   CVCL_S325 ! LO1.GAK
OI   CVCL_S327 ! LO1.Lu
OI   CVCL_S328 ! LO1.Mu
SX   Sex unspecified
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   LO1.Lu
AC   CVCL_S327
SY   LO1Lu
DR   ATCC; CRL-6557
DR   Wikidata; Q54902874
CC   Group: Reptilian cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6557; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=27788; ! Lepidochelys olivacea (Olive Ridley Sea turtle)
OI   CVCL_S324 ! LO1.Fas
OI   CVCL_S325 ! LO1.GAK
OI   CVCL_S326 ! LO1.HT
OI   CVCL_S328 ! LO1.Mu
SX   Sex unspecified
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   LO1.Mu
AC   CVCL_S328
SY   LO1Mu
DR   ATCC; CRL-6558
DR   Wikidata; Q54902875
CC   Group: Reptilian cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6558; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=27788; ! Lepidochelys olivacea (Olive Ridley Sea turtle)
OI   CVCL_S324 ! LO1.Fas
OI   CVCL_S325 ! LO1.GAK
OI   CVCL_S326 ! LO1.HT
OI   CVCL_S327 ! LO1.Lu
SX   Sex unspecified
AG   2M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   LO541265
AC   CVCL_E758
SY   L0541265; LO 541265
DR   dbMHC; 48940
DR   ECACC; 95052211
DR   IHW; IHW09086
DR   IPD-IMGT/HLA; 11639
DR   Wikidata; Q54902876
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01:01; B*08:01:01:01; C*07:01:01:01; DPA1*01,02:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01; DQB1*02:01:01; DRA*01:02; DRB1*03:01:01; DRB3*01:01 (IPD-IMGT/HLA=11639).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   LO68
AC   CVCL_2581
DR   BioSample; SAMN07624410
DR   BioSamples; SAMEA100921
DR   cancercelllines; CVCL_2581
DR   CBA; CBA-0141
DR   Cosmic; 1522778
DR   Cosmic; 1963330
DR   DepMap; ACH-001547
DR   ECACC; 10092311
DR   GEO; GSM726273
DR   Progenetix; CVCL_2581
DR   Wikidata; Q54902877
RX   PubMed=1703129;
RX   PubMed=21642991;
RX   PubMed=25902174;
RX   PubMed=27605433;
RX   PubMed=28387650;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CBA=CBA-0141
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 12,15
ST   D19S433: 13,15.2
ST   D21S11: 30,30.2
ST   D2S1338: 20,24
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 20,22
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   LOC
AC   CVCL_K268
DR   Wikidata; Q54902878
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   Lof-proHYGRO
AC   CVCL_C8FH
DR   Wikidata; Q123032973
RX   PubMed=11725070;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E555 ! Lof(11-10)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   Lof-proNEO
AC   CVCL_C8FI
DR   Wikidata; Q123032974
RX   PubMed=11725070;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E555 ! Lof(11-10)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   Lof(11-10)
AC   CVCL_E555
DR   Wikidata; Q54902879
RX   PubMed=11725070;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   LOHG-F
AC   CVCL_LI09
DR   Wikidata; Q54902880
RX   PubMed=10375592;
RX   PubMed=15753990;
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (PubMed=15753990).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (PubMed=10375592).
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C5394; Solitary adult fibroma
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI10 ! LOHG-I
OI   CVCL_LI11 ! LOHG-L
OI   CVCL_LI12 ! LOHG-NSA
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   LOHG-I
AC   CVCL_LI10
DR   cancercelllines; CVCL_LI10
DR   Wikidata; Q54902881
RX   PubMed=10375592;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (PubMed=10375592).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C95598; Pancreatic insulinoma
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_97279; Insulinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI09 ! LOHG-F
OI   CVCL_LI11 ! LOHG-L
OI   CVCL_LI12 ! LOHG-NSA
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   LOHG-L
AC   CVCL_LI11
DR   Wikidata; Q54902882
RX   PubMed=10375592;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (PubMed=10375592).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C4038; Lung carcinoid tumor
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI09 ! LOHG-F
OI   CVCL_LI10 ! LOHG-I
OI   CVCL_LI12 ! LOHG-NSA
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   LOHG-NSA
AC   CVCL_LI12
DR   Wikidata; Q54902883
RX   PubMed=10375592;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (PubMed=10375592).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C156757; Parathyroid gland adenoma
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI09 ! LOHG-F
OI   CVCL_LI10 ! LOHG-I
OI   CVCL_LI11 ! LOHG-L
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   LoKe
AC   CVCL_F001
DR   cancercelllines; CVCL_F001
DR   Cosmic; 1699821
DR   GEO; GSM1904843
DR   Progenetix; CVCL_F001
DR   Wikidata; Q54902884
RX   PubMed=22363598;
RX   PubMed=23563200;
RX   PubMed=27121059;
RX   PubMed=30873613;
CC   Doubling time: 4 days (PubMed=30873613).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 12,24
ST   D21S11: 28.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   LOMARS pedigree sibling #1 LCL
AC   CVCL_D7EQ
RX   PubMed=33432339;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Simple; c.4463+1G>A; ClinVar=VCV000225541; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33432339).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Simple; p.Phe2717Leu (c.8151T>A) (p.Phe2719Leu, c.8157>A); ClinVar=VCV000225542; Zygosity=Heterozygous (PubMed=33432339).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C210872; Lopes-Maciel-Rodan syndrome
DI   ORDO; Orphanet_528084; Non-specific syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   LOPRA-1
AC   CVCL_M481
SY   LOPRA1
DR   Wikidata; Q54902886
RX   CelloPub=CLPUB00448;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3136791;
CC   Characteristics: Produces IgA2 kappa.
CC   Caution: Not cloned cell line. Two cloned cell lines were derived, LOPRA-1/4 (Cellosaurus=CVCL_M482) and LOPRA-1/5 (Cellosaurus=CVCL_M483), the later being most probably the cell line distributed by DSMZ as LOPRA-1.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   LOPRA-1/4
AC   CVCL_M482
DR   Wikidata; Q54902887
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3136791;
CC   Characteristics: Produces IgA2 kappa.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M481 ! LOPRA-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   LOPRA-1/5
AC   CVCL_M483
SY   LOPRA-1
DR   DSMZ; ACC-778
DR   DSMZCellDive; ACC-778
DR   Wikidata; Q54902888
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3136791;
RX   PubMed=10936422;
CC   Characteristics: Produces IgA2 kappa.
CC   Doubling time: ~5 days (DSMZ=ACC-778).
CC   Caution: On the basis of its characteristics it seems that LOPRA-1 from DSMZ correspond to the clone described as LOPRA-1/5 in the original publication (PubMed=3136791).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-778
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 14
ST   D18S51: 12,17
ST   D19S433: 14,17
ST   D21S11: 28,33.2
ST   D2S1338: 20,26
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M481 ! LOPRA-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   LOPRA-2
AC   CVCL_M533
SY   LOPRA2
DR   Wikidata; Q54902889
RX   CelloPub=CLPUB00073;
RX   CelloPub=CLPUB00448;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG1 lambda.
CC   Characteristics: Has a defect in the GPI-anchoring pathway.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   LOPRA-3
AC   CVCL_UE00
SY   LOPRA3
DR   Wikidata; Q95982836
RX   CelloPub=CLPUB00448;
CC   Characteristics: Produces IgG3 kappa.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   Lord
AC   CVCL_A0WW
DR   Wikidata; Q108820798
RX   PubMed=22704137;
RX   PubMed=31816142;
RX   PubMed=34079834;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia.
CC   Derived from site: In situ; Bone, distal tibia; UBERON=UBERON_0004405.
CC   Breed/subspecies: Cane corso; VBO=VBO_0200712.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   LOTPD-iPSC
AC   CVCL_0H84
SY   Late-Onset-Type Pompe Disease-iPSC
DR   SKIP; SKIP000578
DR   Wikidata; Q54902890
RX   PubMed=24642446;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.-32-13T>G (IVS1-13T>G); ClinVar=VCV000004027; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Unexplicit; Ex18del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H81 ! GM11661
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   LOU-NH91
AC   CVCL_2104
SY   LOU-NH-91; LOUNH91; LouNH91
DR   CLO; CLO_0007376
DR   EFO; EFO_0006638
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 932
DR   BioSample; SAMN03473186
DR   BioSample; SAMN10988231
DR   cancercelllines; CVCL_2104
DR   Cell_Model_Passport; SIDM00341
DR   Cosmic; 1146949
DR   Cosmic; 2060535
DR   Cosmic-CLP; 1298226
DR   DepMap; ACH-000176
DR   DSMZ; ACC-393
DR   DSMZCellDive; ACC-393
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298226
DR   GEO; GSM434289
DR   GEO; GSM827577
DR   GEO; GSM887273
DR   GEO; GSM888348
DR   GEO; GSM1670054
DR   IARC_TP53; 28384
DR   IGRhCellID; LouNH91GEO
DR   LiGeA; CCLE_535
DR   LINCS_LDP; LCL-1588
DR   PharmacoDB; LOUNH91_854_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2104
DR   Wikidata; Q54902891
RX   PubMed=7692946;
RX   PubMed=18083107;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~80 hours (DSMZ=ACC-393).
CC   HLA typing: A*02:01,02:01; B*15:01,15:01; C*03:03,03:03; DQA1*01:02,02:01; DQB1*06:11,06:11; DRB1*03:17,11:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Pro257Argfs*39 (c.770del) (p.Phe256fs); Zygosity=Heterozygous (Cosmic-CLP=1298226; DepMap=ACH-000176).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu726Lys (c.2176G>A); ClinVar=VCV000376476; Zygosity=Homozygous (Cosmic-CLP=1298226; DepMap=ACH-000176).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Met (c.427G>A); ClinVar=VCV000142657; Zygosity=Homozygous (Cosmic-CLP=1298226; DepMap=ACH-000176).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.6%; Native American=0%; East Asian, North=3.36%; East Asian, South=0%; South Asian=0.43%; European, North=58.24%; European, South=37.36% (PubMed=30894373).
CC   Derived from site: In situ; Lung, right lower lobe; UBERON=UBERON_0002171.
ST   Source(s): Cosmic-CLP=1298226; DSMZ=ACC-393; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 25
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 11
ST   FGA: 21
ST   Penta D: 15
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   Loucy
AC   CVCL_1380
SY   LOUCY
DR   CLO; CLO_0007375
DR   EFO; EFO_0007112
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2629
DR   BioSample; SAMN03471756
DR   BioSample; SAMN03473575
DR   BioSample; SAMN10988140
DR   cancercelllines; CVCL_1380
DR   Cell_Model_Passport; SIDM00342
DR   ChEMBL-Cells; CHEMBL3308208
DR   ChEMBL-Targets; CHEMBL2366252
DR   Cosmic; 907789
DR   Cosmic; 913420
DR   Cosmic; 1115598
DR   Cosmic; 1151784
DR   Cosmic; 1175133
DR   Cosmic; 1330496
DR   Cosmic; 1524802
DR   Cosmic; 1641381
DR   Cosmic; 1664525
DR   Cosmic; 1760527
DR   Cosmic; 2165717
DR   Cosmic; 2588705
DR   Cosmic; 2588710
DR   Cosmic; 2602920
DR   Cosmic-CLP; 907789
DR   DepMap; ACH-000104
DR   DSMZ; ACC-394
DR   DSMZCellDive; ACC-394
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS080PZG
DR   ENCODE; ENCBS170DPY
DR   ENCODE; ENCBS708EFA
DR   GDSC; 907789
DR   GEO; GSM887272
DR   GEO; GSM888347
DR   GEO; GSM1670053
DR   GEO; GSM2037136
DR   GEO; GSM2037137
DR   IARC_TP53; 9767
DR   LiGeA; CCLE_359
DR   LINCS_LDP; LCL-1017
DR   PharmacoDB; LOUCY_855_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1380
DR   PubChem_Cell_line; CVCL_1380
DR   Wikidata; Q54902892
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2208060;
RX   PubMed=15472075;
RX   PubMed=17170727;
RX   PubMed=19166587;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Loucy_Bernstein_protocol.pdf
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/loucy/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (PubMed=2208060); ~60 hours (DSMZ=ACC-394).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8064; NUP214 + HGNC; HGNC:10760; SET; Name(s)=SET-NUP214 (PubMed=19166587).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Homozygous (PubMed=22675565; Cosmic-CLP=907789).
CC   Omics: Genomics; ChIP-seq; H3K79me1.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.63%; Native American=0.51%; East Asian, North=1.01%; East Asian, South=2.78%; South Asian=9.99%; European, North=26.95%; European, South=58.12% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2629; Cosmic-CLP=907789; DSMZ=ACC-394; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14
ST   D12S391: 19
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 14
ST   D1S1656: 14,15
ST   D21S11: 27,30
ST   D22S1045: 15,16
ST   D2S1338: 21,22
ST   D2S441: 10,12
ST   D3S1358: 15,19
ST   D5S818: 11,12 (DSMZ=ACC-394)
ST   D5S818: 12 (ATCC=CRL-2629; Cosmic-CLP=907789; Technion Genomics Center)
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 7,13
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Loukes
AC   CVCL_8259
SY   LOUCKES; Louckes; Loucks
DR   cancercelllines; CVCL_8259
DR   IARC_TP53; 703
DR   NCBI_Iran; C160
DR   Wikidata; Q54902893
RX   PubMed=1915267;
RX   PubMed=3026973;
RX   PubMed=6112750;
RX   PubMed=6231253;
RX   PubMed=8896424;
RX   PubMed=9192833;
RX   PubMed=9973220;
RX   PubMed=17254797;
RX   PubMed=24590883;
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Unspecified (PubMed=1915267).
CC   Misspelling: Luckes; NCBI_Iran=C160; PubMed=17254797.
CC   Misspelling: Lukes; PubMed=3026973; PubMed=6231253.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 15
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 19,20
ST   TH01: 8,10,11
ST   TPOX: 9
ST   vWA: 16,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   Love
AC   CVCL_WH24
DR   Wikidata; Q95982838
RX   PubMed=28283079;
RX   PubMed=30246405;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   LoVo
AC   CVCL_0399
SY   LOVO
DR   BTO; BTO_0000666
DR   CLO; CLO_0007377
DR   CLO; CLO_0007378
DR   CLO; CLO_0050632
DR   EFO; EFO_0006639
DR   MCCL; MCC:0000293
DR   CLDB; cl3248
DR   CLDB; cl3249
DR   CLDB; cl3250
DR   CLDB; cl4981
DR   AddexBio; C0009011/380
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-229
DR   BCRC; 60148
DR   BCRJ; 0332
DR   BioGRID_ORCS_Cell_line; 405
DR   BioSample; SAMN03470964
DR   BioSample; SAMN03471476
DR   BioSample; SAMN03472104
DR   BioSample; SAMN03472362
DR   BioSample; SAMN03473360
DR   BioSample; SAMN05292432
DR   BioSample; SAMN10988310
DR   cancercelllines; CVCL_0399
DR   CCLV; CCLV-RIE 1151
DR   CCRID; 1101HUM-PUMC000164
DR   CCRID; 3101HUMSCSP514
DR   CCRID; 3101HUMTCHu82
DR   CCRID; 4201HUM-CCTCC00646
DR   CCTCC; GDC0186
DR   Cell_Model_Passport; SIDM00839
DR   ChEMBL-Cells; CHEMBL3307691
DR   ChEMBL-Targets; CHEMBL614721
DR   CLS; 300266
DR   ColonAtlas; LOVO
DR   Cosmic; 711256
DR   Cosmic; 720330
DR   Cosmic; 724842
DR   Cosmic; 738931
DR   Cosmic; 873702
DR   Cosmic; 876724
DR   Cosmic; 887220
DR   Cosmic; 889534
DR   Cosmic; 897741
DR   Cosmic; 905003
DR   Cosmic; 907790
DR   Cosmic; 913886
DR   Cosmic; 948858
DR   Cosmic; 985997
DR   Cosmic; 995396
DR   Cosmic; 1043567
DR   Cosmic; 1057754
DR   Cosmic; 1066209
DR   Cosmic; 1122327
DR   Cosmic; 1132566
DR   Cosmic; 1132691
DR   Cosmic; 1184084
DR   Cosmic; 1184329
DR   Cosmic; 1187308
DR   Cosmic; 1223145
DR   Cosmic; 1312303
DR   Cosmic; 1466817
DR   Cosmic; 1479597
DR   Cosmic; 1482522
DR   Cosmic; 1486133
DR   Cosmic; 1524331
DR   Cosmic; 1552182
DR   Cosmic; 1571770
DR   Cosmic; 1609489
DR   Cosmic; 1676729
DR   Cosmic; 1708412
DR   Cosmic; 1803948
DR   Cosmic; 1927244
DR   Cosmic; 1945867
DR   Cosmic; 1995488
DR   Cosmic; 2267319
DR   Cosmic; 2301996
DR   Cosmic; 2389574
DR   Cosmic; 2588707
DR   Cosmic; 2646767
DR   Cosmic; 2651865
DR   Cosmic; 2664049
DR   Cosmic; 2667975
DR   Cosmic; 2760062
DR   Cosmic; 2787548
DR   Cosmic; 2800576
DR   Cosmic-CLP; 907790
DR   DepMap; ACH-000950
DR   DSMZ; ACC-350
DR   DSMZCellDive; ACC-350
DR   ECACC; 87060101
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS024NHD
DR   ENCODE; ENCBS080BPN
DR   GDSC; 907790
DR   GEO; GSM206517
DR   GEO; GSM274719
DR   GEO; GSM274720
DR   GEO; GSM274729
DR   GEO; GSM513820
DR   GEO; GSM514296
DR   GEO; GSM741268
DR   GEO; GSM784014
DR   GEO; GSM887274
DR   GEO; GSM888349
DR   GEO; GSM1346882
DR   GEO; GSM1374627
DR   GEO; GSM1374628
DR   GEO; GSM1374629
DR   GEO; GSM1374630
DR   GEO; GSM1448163
DR   GEO; GSM1670055
DR   GEO; GSM2550007
DR   GEO; GSM3591765
DR   IARC_TP53; 21485
DR   ICLC; HTL99028
DR   IZSLER; BS TCL 205
DR   JCRB; IFO50067
DR   JCRB; JCRB9083
DR   KCB; KCB 200718YJ
DR   KCLB; 10229
DR   LiGeA; CCLE_421
DR   LINCS_LDP; LCL-1181
DR   Lonza; 1021
DR   MetaboLights; MTBLS227
DR   NCI-DTP; LOVO
DR   PharmacoDB; LoVo_856_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0399
DR   PubChem_Cell_line; CVCL_0399
DR   RCB; RCB1639
DR   SKY/M-FISH/CGH; 2878
DR   TKG; TKG 0344
DR   Ubigene; YC-C137
DR   Wikidata; Q54902894
RX   PubMed=1260746;
RX   PubMed=3335022;
RX   PubMed=7104989;
RX   PubMed=7651727;
RX   PubMed=8197130;
RX   PubMed=8464898;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9290701;
RX   PubMed=9294210;
RX   PubMed=9515795;
RX   PubMed=9715273;
RX   PubMed=10612807;
RX   PubMed=10674020;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11314036;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11526487;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=12584437;
RX   PubMed=12615714;
RX   PubMed=12661003;
RX   PubMed=15771911;
RX   PubMed=15900046;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=19941903;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=20831567;
RX   PubMed=22460905;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=32172478;
RX   PubMed=34320349;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/LoVo.html
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544586
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-208.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/lovo-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 37 hours (PubMed=1260746); 33.16 hours (PubMed=25944804); 52 hours (PubMed=25984343); ~48 hours (DSMZ=ACC-350); ~34 hours (PBCF).
CC   HLA typing: A*01:01,32:01; B*27:08,57:01; C*06:02,06:02; DQA1*03:02,05:02; DQB1*06:13,06:13; DRB1*09:07,13:10 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=9000147; PubMed=10674020; PubMed=12661003; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (PubMed=12615714; Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (PubMed=8197130; Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907790; DepMap=ACH-000950).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9715273; PubMed=15900046; PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0.96%; European, North=71.69%; European, South=27.34% (PubMed=30894373).
CC   Discontinued: TKG; TKG 0344; probable.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): AddexBio=C0009011/380; ATCC=CCL-229; CCRID; CLS=300266; Cosmic-CLP=907790; DSMZ=ACC-350; ECACC=87060101; JCRB=IFO50067; JCRB=JCRB9083; KCLB=10229; PubMed=11416159; PubMed=15771911; PubMed=25877200; PubMed=25926053; RCB=RCB1639
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,13,14 (AddexBio=C0009011/380; CCRID; CLS=300266; PubMed=25877200)
ST   CSF1PO: 10,14 (KCLB=10229)
ST   CSF1PO: 11,12,13 (RCB=RCB1639)
ST   CSF1PO: 11,12,13,14,15 (DSMZ=ACC-350)
ST   CSF1PO: 11,13,14 (ATCC=CCL-229; ECACC=87060101; JCRB=IFO50067; JCRB=JCRB9083; PubMed=25926053)
ST   CSF1PO: 11,14 (Cosmic-CLP=907790)
ST   D13S317: 8,11
ST   D16S539: 9,11,12 (DSMZ=ACC-350)
ST   D16S539: 9,12 (AddexBio=C0009011/380; ATCC=CCL-229; CCRID; CLS=300266; Cosmic-CLP=907790; ECACC=87060101; JCRB=IFO50067; JCRB=JCRB9083; PubMed=15771911; PubMed=25877200; PubMed=25926053; RCB=RCB1639)
ST   D18S51: 13,17,18 (DSMZ=ACC-350; PubMed=11416159)
ST   D18S51: 13,18 (ATCC=CCL-229; CCRID; CLS=300266; PubMed=15771911; PubMed=25877200)
ST   D19S433: 14,15 (ATCC=CCL-229; CCRID; DSMZ=ACC-350; PubMed=25877200)
ST   D19S433: 15 (PubMed=15771911)
ST   D21S11: 29,31.2 (ATCC=CCL-229; CCRID; DSMZ=ACC-350; PubMed=15771911; PubMed=25877200; PubMed=25926053)
ST   D21S11: 29,31.2,32.2 (CLS=300266)
ST   D2S1338: 16,17,18 (DSMZ=ACC-350; PubMed=15771911)
ST   D2S1338: 17,18 (ATCC=CCL-229; CCRID; PubMed=25877200)
ST   D3S1358: 14,15,16,17 (ATCC=CCL-229)
ST   D3S1358: 14,16 (PubMed=15771911)
ST   D3S1358: 14,16,17 (DSMZ=ACC-350)
ST   D3S1358: 14,16,17,18 (CCRID)
ST   D3S1358: 14,17 (PubMed=25877200_130903)
ST   D3S1358: 14,18 (KCLB=10229; PubMed=25877200_584429)
ST   D5S818: 11,12,13 (AddexBio=C0009011/380; ATCC=CCL-229; DSMZ=ACC-350; JCRB=IFO50067; JCRB=JCRB9083; PubMed=25926053; RCB=RCB1639)
ST   D5S818: 11,13 (CCRID; CLS=300266; Cosmic-CLP=907790; ECACC=87060101; KCLB=10229; PubMed=25877200)
ST   D7S820: 9.3,10,11 (AddexBio=C0009011/380; ATCC=CCL-229; CCRID; DSMZ=ACC-350; JCRB=IFO50067; PubMed=25877200; PubMed=25926053)
ST   D7S820: 10,11 (CLS=300266; Cosmic-CLP=907790; ECACC=87060101; JCRB=JCRB9083; KCLB=10229; RCB=RCB1639)
ST   D8S1179: 9,10 (DSMZ=ACC-350; PubMed=15771911)
ST   D8S1179: 10 (ATCC=CCL-229; CCRID; PubMed=25877200)
ST   FGA: 18,19,20 (DSMZ=ACC-350; PubMed=15771911)
ST   FGA: 18,20 (ATCC=CCL-229; CCRID; CLS=300266; PubMed=11416159; PubMed=25877200)
ST   Penta D: 9,10,14 (CLS=300266)
ST   Penta D: 10,14 (ATCC=CCL-229; DSMZ=ACC-350; PubMed=25877200)
ST   Penta E: 9,16 (DSMZ=ACC-350)
ST   Penta E: 10,16 (ATCC=CCL-229; CLS=300266; PubMed=25877200)
ST   SE33: 19.2,20.2,25.2
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,17,18,19 (DSMZ=ACC-350)
ST   vWA: 17,18 (AddexBio=C0009011/380; ATCC=CCL-229; CCRID; CLS=300266; Cosmic-CLP=907790; ECACC=87060101; JCRB=IFO50067; JCRB=JCRB9083; KCLB=10229; PubMed=11416159; PubMed=25877200; PubMed=25926053; RCB=RCB1639)
ST   vWA: 17,19 (PubMed=15771911)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 50
//
ID   Lovo-143X19
AC   CVCL_6A75
SY   143X19
DR   cancercelllines; CVCL_6A75
DR   Wikidata; Q54902895
RX   PubMed=8632910;
RX   PubMed=9989828;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5237 ! LoVo-92
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 17
//
ID   Lovo-143X3
AC   CVCL_6A76
SY   143X3
DR   cancercelllines; CVCL_6A76
DR   Wikidata; Q54902896
RX   PubMed=8632910;
RX   PubMed=9989828;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5237 ! LoVo-92
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 17
//
ID   Lovo-175X2
AC   CVCL_5235
SY   Lovo 175X2; Lovo175X2; Lovo175x2; 175X2
DR   BTO; BTO_0004143
DR   cancercelllines; CVCL_5235
DR   Wikidata; Q54902897
RX   PubMed=8632910;
RX   PubMed=17339891;
RX   PubMed=18600534;
CC   Population: Caucasian.
CC   Doubling time: 46.5 +- 5.5 hours (PubMed=17339891).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg175His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5237 ! LoVo-92
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   Lovo-273X17
AC   CVCL_5236
SY   Lovo273X17; 273X17
DR   BTO; BTO_0004144
DR   cancercelllines; CVCL_5236
DR   Wikidata; Q54902898
RX   PubMed=8632910;
RX   PubMed=18600534;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5237 ! LoVo-92
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   LoVo-6-luc-1
AC   CVCL_5J42
SY   LOVO-6-Luc-1
DR   cancercelllines; CVCL_5J42
DR   Revvity/PerkinElmer; 119265
DR   Wikidata; Q54902899
RX   CelloPub=CLPUB00279;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119265; true.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   LoVo-92
AC   CVCL_5237
SY   Lovo-92; Lovo 92; Lovo92
DR   BTO; BTO_0004146
DR   cancercelllines; CVCL_5237
DR   GEO; GSM503149
DR   Progenetix; CVCL_5237
DR   Wikidata; Q54902900
RX   PubMed=8632910;
RX   PubMed=9989828;
RX   PubMed=17339891;
RX   PubMed=18600534;
CC   Population: Caucasian.
CC   Doubling time: 34.5 +- 3.4 hours (PubMed=17339891).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 22
//
ID   LoVo-li
AC   CVCL_5238
SY   Lovo-li; LoVo-Li; Lovo li
DR   BTO; BTO_0004145
DR   cancercelllines; CVCL_5238
DR   GEO; GSM503256
DR   Progenetix; CVCL_5238
DR   Wikidata; Q54902901
RX   PubMed=8632910;
RX   PubMed=17339891;
RX   PubMed=18600534;
CC   Population: Caucasian.
CC   Doubling time: 41.7 +- 4.2 hours (PubMed=17339891).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5237 ! LoVo-92
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 22
//
ID   LoVo-Luc#2
AC   CVCL_4Y03
DR   cancercelllines; CVCL_4Y03
DR   JCRB; JCRB1537
DR   JCRB; NIHS0717
DR   Wikidata; Q54902902
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0717; true.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): JCRB=JCRB1537
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13,14
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9.3,10,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 19
//
ID   LoVo-MEK-R
AC   CVCL_V402
DR   cancercelllines; CVCL_V402
DR   Cosmic; 1927245
DR   Wikidata; Q54902903
RX   PubMed=22402123;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88249; 391210-10-9 (PD0325901).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   LoVo/Cas9-hyg
AC   CVCL_C9ES
DR   GeneCopoeia; SL525
DR   Wikidata; Q123032975
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL525).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   LoVo/DR5
AC   CVCL_6C49
DR   cancercelllines; CVCL_6C49
DR   Wikidata; Q54902904
RX   PubMed=1673331;
RX   PubMed=2896069;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   LoVo/irinotecan
AC   CVCL_4V50
DR   cancercelllines; CVCL_4V50
DR   Wikidata; Q54902905
RX   PubMed=21289438;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 17
//
ID   LoVo/L-OHP
AC   CVCL_4V75
DR   cancercelllines; CVCL_4V75
DR   Wikidata; Q54902906
RX   PubMed=20591218;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   LoVo_6244R
AC   CVCL_C3GL
SY   L6244-R
DR   cancercelllines; CVCL_C3GL
DR   GEO; GSM3591766
DR   Wikidata; Q114311891
RX   PubMed=31048689;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   LOX-IMVI
AC   CVCL_1381
SY   LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX
DR   BTO; BTO_0004151
DR   CLO; CLO_0037130
DR   EFO; EFO_0006284
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470824
DR   BioSample; SAMN10988372
DR   cancercelllines; CVCL_1381
DR   Cell_Model_Passport; SIDM00149
DR   ChEMBL-Cells; CHEMBL3307535
DR   ChEMBL-Targets; CHEMBL614096
DR   Cosmic; 687446
DR   Cosmic; 875883
DR   Cosmic; 897466
DR   Cosmic; 905974
DR   Cosmic; 922393
DR   Cosmic; 974255
DR   Cosmic; 1044264
DR   Cosmic; 1092610
DR   Cosmic; 1175868
DR   Cosmic; 1238117
DR   Cosmic; 1303039
DR   Cosmic; 1305363
DR   Cosmic; 1312346
DR   Cosmic; 1436046
DR   Cosmic; 1477412
DR   Cosmic; 1669121
DR   Cosmic; 1998452
DR   Cosmic; 2060808
DR   Cosmic; 2651879
DR   Cosmic-CLP; 905974
DR   DepMap; ACH-000750
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 905974
DR   GEO; GSM2170
DR   GEO; GSM50200
DR   GEO; GSM50262
DR   GEO; GSM206518
DR   GEO; GSM274687
DR   GEO; GSM743463
DR   GEO; GSM750808
DR   GEO; GSM799351
DR   GEO; GSM799414
DR   GEO; GSM846362
DR   GEO; GSM887275
DR   GEO; GSM888350
DR   GEO; GSM1153421
DR   GEO; GSM1178309
DR   GEO; GSM1178310
DR   GEO; GSM1181291
DR   GEO; GSM1181335
DR   GEO; GSM1670056
DR   GEO; GSM2124660
DR   IARC_TP53; 21077
DR   LiGeA; CCLE_361
DR   LINCS_HMS; 50988
DR   LINCS_LDP; LCL-1276
DR   Millipore; SCC201
DR   NCI-DTP; LOX IMVI
DR   PharmacoDB; LOXIMVI_857_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1381
DR   PubChem_Cell_line; CVCL_1381
DR   SKY/M-FISH/CGH; 2812
DR   Wikidata; Q54902908
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=3346110;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12068308;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=19727395;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=43
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/lox-imv1-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Established from a subcutaneous xenograft in nude mice.
CC   Doubling time: 25 hours (PubMed=7718330); 35 hours (PubMed=8631022); 19.9 hours (PubMed=22628656); 20.5 hours (NCI-DTP=LOX IMVI).
CC   HLA typing: A*11:01:01,29:02; B*07:02:01,44:03:01; C*07:02:01,16:01; DPB1*04:01,11:01:01; DQB1*02:02,06:02; DRB1*07:01,15:01:01 (PubMed=15748285).
CC   HLA typing: A*11:01,29:02; B*07:02,44:03; C*07:02,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; Cosmic-CLP=905974; DepMap=ACH-000750).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=905974; DepMap=ACH-000750).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.11%; Native American=0%; East Asian, North=2.55%; East Asian, South=0%; South Asian=0%; European, North=67.19%; European, South=29.14% (PubMed=30894373).
CC   Misspelling: LOXMVII; Cosmic=1044264.
CC   Misspelling: LOXIN-VI; Cosmic=687446; Cosmic=897466; PubMed=12068308.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Cosmic-CLP=905974; Millipore=SCC201; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12 (Cosmic-CLP=905974; PubMed=19372543; PubMed=25877200)
ST   CSF1PO: 10,12,13 (Millipore=SCC201)
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 15,18
ST   D19S433: 14.2
ST   D21S11: 28,31
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 21,22 (Millipore=SCC201)
ST   FGA: 22 (PubMed=19372543; PubMed=25877200)
ST   Penta D: 9,11
ST   Penta E: 5,7
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   LP [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC22
DR   Wikidata; Q98126932
RX   PubMed=16099873;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30165192;
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LP [Human kidney rhabdoid tumor]
AC   CVCL_U761
DR   Cosmic; 802239
DR   Wikidata; Q54902909
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LP [Human LCL]
AC   CVCL_C4PI
DR   Wikidata; Q116049716
RX   PubMed=198669;
RX   PubMed=2580779;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_194097; 3,5-dinitro-4-hydroxyphenylacetic acid (NNP).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   LP-1
AC   CVCL_0012
SY   LP1
DR   BTO; BTO_0005912
DR   CLO; CLO_0007379
DR   EFO; EFO_0003055
DR   CLDB; cl3252
DR   AddexBio; C0003006/55
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ArrayExpress; E-TABM-937
DR   BioGRID_ORCS_Cell_line; 933
DR   BioSample; SAMN03472929
DR   BioSample; SAMN10988493
DR   cancercelllines; CVCL_0012
DR   Cell_Model_Passport; SIDM00340
DR   ChEMBL-Cells; CHEMBL3308171
DR   ChEMBL-Targets; CHEMBL2366066
DR   CLS; 300321
DR   Cosmic; 720763
DR   Cosmic; 759910
DR   Cosmic; 907791
DR   Cosmic; 2081397
DR   Cosmic; 2367290
DR   Cosmic; 2391810
DR   Cosmic; 2809761
DR   Cosmic-CLP; 907791
DR   DepMap; ACH-000204
DR   DSMZ; ACC-41
DR   DSMZCellDive; ACC-41
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 907791
DR   GEO; GSM143335
DR   GEO; GSM290302
DR   GEO; GSM562813
DR   GEO; GSM887276
DR   GEO; GSM888351
DR   GEO; GSM1374631
DR   GEO; GSM1670057
DR   IARC_TP53; 21475
DR   LiGeA; CCLE_549
DR   LINCS_LDP; LCL-2046
DR   Lonza; 129
DR   PharmacoDB; LP1_858_2019
DR   PRIDE; PXD030239
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0012
DR   PubChem_Cell_line; CVCL_0012
DR   Wikidata; Q54902910
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2784066;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=16956823;
RX   PubMed=16957166;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=20164919;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Produces IgG lambda.
CC   Doubling time: 50 hours (PubMed=2784066); 48 hours (PubMed=25984343); 35-80 hours (Note=Depending on cell density) (DSMZ=ACC-41).
CC   HLA typing: A*03,24; B*07,18; C*07 (PubMed=25688540).
CC   HLA typing: A*26:01,30:01; B*18:01,35:03; C*04:01,07:01; DQA1*03:02,05:01; DQB1*03:02,03:02; DRB1*04:03,11:04 (PubMed=26589293).
CC   HLA typing: A*26:01:01,30:01:01; B*18:01:01,35:03:01; C*04:01:01;07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,04:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRA*01:01:01,01:01:01; DRB1*04:03:01,11:04:01 (DSMZCellDive=ACC-41).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:12766; NSD2; Name(s)=IGH-NSD2, IGH-WHSC1 (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Phe384Leu (c.1150T>C) (F386L); ClinVar=VCV000134404; Zygosity=Unspecified (PubMed=11157491).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Homozygous (PubMed=21173094; Cosmic-CLP=907791).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys286Ilefs*7 (c.857_870delAGAGCATACAAAGT); Zygosity=Homozygous (PubMed=17692805).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.21%; Native American=0%; East Asian, North=3.2%; East Asian, South=0%; South Asian=2.32%; European, North=42.82%; European, South=51.44% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=907791; DSMZ=ACC-41; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 18
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 18,26
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13 (DSMZ=ACC-41)
ST   D8S1179: 13,15 (PubMed=25877200)
ST   FGA: 20,21
ST   Penta D: 12
ST   Penta E: 10,11
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   LP-2
AC   CVCL_0N49
DR   Wikidata; Q54902911
RX   PubMed=6186388;
RX   PubMed=6192933;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   LP-3
AC   CVCL_0N48
SY   AG07090; AG07090A; AG07090B
DR   CLO; CLO_0035654
DR   Coriell; AG07090
DR   Wikidata; Q54902912
RX   CelloPub=CLPUB00597;
RX   PubMed=6186388;
RX   PubMed=6192933;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LP-9
AC   CVCL_E109
SY   LP9; AG07086; AG07086A
DR   BTO; BTO_0006469
DR   CLO; CLO_0035653
DR   Coriell; AG07086
DR   Wikidata; Q54902913
RX   CelloPub=CLPUB00597;
RX   PubMed=3130603;
RX   PubMed=6186388;
RX   PubMed=6192933;
RX   PubMed=9382953;
RX   PubMed=10648628;
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at ~50-60 PDL (PubMed=6192933; PubMed=10648628).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   LP0008
AC   CVCL_VB19
DR   ECACC; 15102958
DR   Wikidata; Q54902914
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0013
AC   CVCL_VB20
DR   ECACC; 15102959
DR   Wikidata; Q54902915
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0048
AC   CVCL_VB21
DR   ECACC; 15082808
DR   Wikidata; Q54902916
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0051
AC   CVCL_VB22
DR   ECACC; 15082809
DR   Wikidata; Q54902917
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0073
AC   CVCL_VB23
DR   ECACC; 15102960
DR   Wikidata; Q54902918
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0075
AC   CVCL_VB24
DR   ECACC; 15082810
DR   Wikidata; Q54902919
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0091
AC   CVCL_VB25
DR   ECACC; 15102961
DR   Wikidata; Q54902920
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0125
AC   CVCL_VB26
DR   ECACC; 15102962
DR   Wikidata; Q54902923
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0137
AC   CVCL_VB27
DR   ECACC; 15082811
DR   Wikidata; Q54902924
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0148
AC   CVCL_VB28
DR   ECACC; 15102963
DR   Wikidata; Q54902925
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0157
AC   CVCL_VB29
DR   ECACC; 15102964
DR   Wikidata; Q54902926
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0168
AC   CVCL_VB30
DR   ECACC; 15082812
DR   Wikidata; Q54902927
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0225
AC   CVCL_VB31
DR   ECACC; 15082813
DR   Wikidata; Q54902928
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0303
AC   CVCL_VB32
DR   ECACC; 15082814
DR   Wikidata; Q54902931
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0305
AC   CVCL_VB33
DR   ECACC; 15102965
DR   Wikidata; Q54902932
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0328
AC   CVCL_VB34
DR   ECACC; 15102966
DR   Wikidata; Q54902933
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0393
AC   CVCL_VB35
DR   ECACC; 15082815
DR   Wikidata; Q54902935
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0405
AC   CVCL_VB36
DR   ECACC; 15082816
DR   Wikidata; Q54902936
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0437
AC   CVCL_VB37
DR   ECACC; 15102967
DR   Wikidata; Q54902937
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0456
AC   CVCL_VB38
DR   ECACC; 15102968
DR   Wikidata; Q54902938
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0475
AC   CVCL_VB39
DR   ECACC; 15102969
DR   Wikidata; Q54902939
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0480
AC   CVCL_VB40
DR   ECACC; 15102970
DR   Wikidata; Q54902940
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0568
AC   CVCL_VB41
DR   ECACC; 15102971
DR   Wikidata; Q54902941
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0582
AC   CVCL_VB42
DR   ECACC; 15082818
DR   Wikidata; Q54902942
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0584
AC   CVCL_VB43
DR   ECACC; 15082819
DR   Wikidata; Q54902943
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0614
AC   CVCL_VB44
DR   ECACC; 15082820
DR   Wikidata; Q54902944
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0618
AC   CVCL_VB45
DR   ECACC; 15102972
DR   Wikidata; Q54902945
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0637
AC   CVCL_VB46
DR   ECACC; 15102973
DR   Wikidata; Q54902947
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0657
AC   CVCL_VB47
DR   ECACC; 15102974
DR   Wikidata; Q54902948
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0663
AC   CVCL_VB48
DR   ECACC; 15082821
DR   Wikidata; Q54902949
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0665
AC   CVCL_VB49
DR   ECACC; 15102975
DR   Wikidata; Q54902950
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP0682
AC   CVCL_VB50
DR   ECACC; 15102976
DR   Wikidata; Q54902951
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LP07
AC   CVCL_W868
DR   Wikidata; Q54902952
RX   PubMed=11179499;
CC   Doubling time: 25.1 +- 4 hours (Note=In MEM with 10% FCS) (PubMed=11179499).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 5
//
ID   LP1
AC   CVCL_E2V5
RX   CelloPub=CLPUB00775;
RX   PubMed=6296279;
RX   PubMed=6308140;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P68336; Human herpesvirus 2 (HHV-2) tegument protein VP16 (Note=Also reacts with human herpesvirus 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Lp1 MAB 1
AC   CVCL_E982
DR   CLO; CLO_0007380
DR   ATCC; CRL-1765
DR   Wikidata; Q54902953
RX   PubMed=6356714;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Legionella pneumophila serogroup 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   Lp1 MAB 2
AC   CVCL_E983
DR   CLO; CLO_0007381
DR   ATCC; CRL-1770
DR   Wikidata; Q54902955
RX   PubMed=6356714;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Legionella pneumophila serogroup 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   Lp1 MAB 3
AC   CVCL_E984
DR   CLO; CLO_0007382
DR   ATCC; CRL-1767
DR   Wikidata; Q54902956
RX   PubMed=6356714;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Legionella pneumophila serogroup 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   LP10
AC   CVCL_E2V6
RX   PubMed=6319591;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q69091; Human herpesvirus 1 (strain 17) glycoprotein D (gD).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP101
AC   CVCL_B5X2
SY   LP 101
DR   Wikidata; Q112930021
RX   PubMed=8187845;
RX   PubMed=9009094;
RX   PubMed=10706070;
RX   PubMed=15492858;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   LP11
AC   CVCL_E2V7
RX   PubMed=6319591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10211; Human herpesvirus 1 (strain 17) glycoprotein B (gB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP2
AC   CVCL_E2V8
RX   CelloPub=CLPUB00775;
RX   PubMed=6308140;
RX   PubMed=6319591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q69467; Human herpesvirus 2 (HHV-2) glycoprotein D (gD) (Note=Also reacts with human herpesvirus 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP3
AC   CVCL_E2V9
RX   CelloPub=CLPUB00775;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q69467; Human herpesvirus 2 (HHV-2) glycoprotein D (gD) (Note=Also reacts with human herpesvirus 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP3IIG2
AC   CVCL_J834
SY   LP3-IIG2
DR   CLO; CLO_0007383
DR   ATCC; HB-8472
DR   Wikidata; Q54902957
RX   Patent=US4851333;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8472.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   LP4
AC   CVCL_E2VA
RX   CelloPub=CLPUB00775;
RX   PubMed=6296279;
RX   PubMed=6308140;
RX   PubMed=6319591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P89452; Human herpesvirus 2 (HHV-2) major DNA-binding protein (DBP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP4.4
AC   CVCL_J835
SY   LP4
DR   CLO; CLO_0007384
DR   ATCC; HB-232
DR   Wikidata; Q54902958
RX   PubMed=1701760;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human IgM lambda light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   LP5
AC   CVCL_E2VB
RX   CelloPub=CLPUB00775;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q89730; Human herpesvirus 2 (HHV-2) envelope glycoprotein C (gC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP6 [Human dedifferentiated liposarcoma]
AC   CVCL_V413
DR   Cosmic; 2800527
DR   Wikidata; Q54902959
RX   PubMed=19449367;
RX   PubMed=21930930;
RX   PubMed=26643872;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 8
//
ID   LP6 [Mouse hybridoma against HSV-2 gE]
AC   CVCL_E2VC
RX   CelloPub=CLPUB00775;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P89475; Human herpesvirus 2 (HHV-2) envelope glycoprotein E (gE).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP7
AC   CVCL_E2VD
RX   CelloPub=CLPUB00775;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human herpesvirus 2 (HHV-2) unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP8
AC   CVCL_E2VE
RX   CelloPub=CLPUB00775;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human herpesvirus 2 (HHV-2) unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP9
AC   CVCL_E2VF
RX   CelloPub=CLPUB00775;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human herpesvirus 2 (HHV-2) unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LP9/TERT-1
AC   CVCL_E108
DR   GEO; GSM352314
DR   GEO; GSM352315
DR   GEO; GSM352316
DR   GEO; GSM352317
DR   GEO; GSM352318
DR   GEO; GSM352319
DR   GEO; GSM352320
DR   GEO; GSM352321
DR   GEO; GSM352322
DR   GEO; GSM352323
DR   GEO; GSM352324
DR   GEO; GSM352325
DR   GEO; GSM352326
DR   GEO; GSM352327
DR   GEO; GSM352328
DR   GEO; GSM352329
DR   GEO; GSM352330
DR   GEO; GSM352331
DR   GEO; GSM352332
DR   GEO; GSM352333
DR   GEO; GSM352334
DR   GEO; GSM352335
DR   GEO; GSM352336
DR   GEO; GSM352337
DR   GEO; GSM352338
DR   GEO; GSM352339
DR   GEO; GSM352340
DR   GEO; GSM352341
DR   GEO; GSM352342
DR   GEO; GSM352343
DR   GEO; GSM352344
DR   GEO; GSM352345
DR   GEO; GSM352346
DR   Wikidata; Q54902960
RX   PubMed=10648628;
RX   PubMed=20155583;
RX   PubMed=20831825;
RX   PubMed=21454801;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E109 ! LP-9
SX   Female
AG   26Y
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   LPA-H1
AC   CVCL_A9GS
DR   CCRID; 5301MAM-KCB1513HZJ
DR   KCB; KCB 2015013HZJ
DR   Wikidata; Q108820799
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=30538; ! Vicugna pacos (Alpaca)
OI   CVCL_A9GT ! LPA-K1
OI   CVCL_A9GU ! LPA-L1
OI   CVCL_A9GV ! LPA-M1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LPA-K1
AC   CVCL_A9GT
DR   CCRID; 5301MAM-KCB1513KZJ
DR   KCB; KCB 2015013KZJ
DR   Wikidata; Q108820800
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=30538; ! Vicugna pacos (Alpaca)
OI   CVCL_A9GS ! LPA-H1
OI   CVCL_A9GU ! LPA-L1
OI   CVCL_A9GV ! LPA-M1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   LPA-L1
AC   CVCL_A9GU
DR   CCRID; 5301MAM-KCB1513LZJ
DR   KCB; KCB 2015013LZJ
DR   Wikidata; Q108820801
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=30538; ! Vicugna pacos (Alpaca)
OI   CVCL_A9GS ! LPA-H1
OI   CVCL_A9GT ! LPA-K1
OI   CVCL_A9GV ! LPA-M1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LPA-M1
AC   CVCL_A9GV
DR   CCRID; 5301MAM-KCB1513MZJ
DR   KCB; KCB 2015013MZJ
DR   Wikidata; Q108820802
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
OX   NCBI_TaxID=30538; ! Vicugna pacos (Alpaca)
OI   CVCL_A9GS ! LPA-H1
OI   CVCL_A9GT ! LPA-K1
OI   CVCL_A9GU ! LPA-L1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   LPB1
AC   CVCL_ZX91
SY   LiPSC_LPB1; LCL(PB)-derived iPSC, clone #1
DR   GEO; GSM2185124
DR   Wikidata; Q102114474
RX   PubMed=27716287;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX88 ! PB(LCL)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   LPB3
AC   CVCL_ZX93
SY   LiPSC_LPB3
DR   Wikidata; Q102114477
RX   PubMed=27716287;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX88 ! PB(LCL)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   LPB7
AC   CVCL_ZX92
SY   LiPSC_LPB7; LCL(PB)-derived iPSC, clone #7
DR   GEO; GSM2185125
DR   Wikidata; Q102114478
RX   PubMed=27716287;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX88 ! PB(LCL)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   LPB8
AC   CVCL_ZX94
SY   LiPSC_LPB8
DR   Wikidata; Q102114479
RX   PubMed=27716287;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX88 ! PB(LCL)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   LPC-Aa98-19
AC   CVCL_Z322
DR   Wikidata; Q54902961
RX   PubMed=11212139;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=57095; ! Anacridium aegyptium (Egyptian locust)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   LPC-Aa98-20
AC   CVCL_Z323
DR   Wikidata; Q54902962
RX   PubMed=11212139;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=57095; ! Anacridium aegyptium (Egyptian locust)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   LPC10m
AC   CVCL_1Y62
DR   Cosmic; 947643
DR   Cosmic; 2649498
DR   Wikidata; Q54902964
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   LPC11m
AC   CVCL_1Y63
DR   Cosmic; 947633
DR   Cosmic; 2649510
DR   Wikidata; Q54902965
RX   PubMed=9892110;
RX   PubMed=15126341;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y64 ! LPC11p
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   LPC11p
AC   CVCL_1Y64
DR   Cosmic; 947632
DR   Cosmic; 2649509
DR   Wikidata; Q54902966
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Y63 ! LPC11m
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   LPC12m
AC   CVCL_1Y65
DR   cancercelllines; CVCL_1Y65
DR   Cosmic; 947644
DR   Cosmic; 2649511
DR   Wikidata; Q54902967
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ala406Thr (c.1216G>A); ClinVar=VCV000193679; Zygosity=Hemizygous (PubMed=9892110).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   LPC13p
AC   CVCL_1Y66
DR   Cosmic; 2649512
DR   Wikidata; Q54902969
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   LPC14p
AC   CVCL_1Y67
DR   Wikidata; Q54902970
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   LPC15p
AC   CVCL_1Y68
DR   Wikidata; Q54902971
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   LPC1p
AC   CVCL_1Y53
DR   Cosmic; 947634
DR   Cosmic; 2649489
DR   Wikidata; Q54902963
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=9892110).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   LPC2p
AC   CVCL_1Y54
DR   Cosmic; 947635
DR   Cosmic; 2649490
DR   Wikidata; Q54902972
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   LPC3p
AC   CVCL_1Y55
DR   Cosmic; 947636
DR   Cosmic; 2649491
DR   Wikidata; Q54902973
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu43Ser (c.128T>C); Zygosity=Hemizygous (PubMed=9892110).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C38342; Pancreatic intraductal papillary-mucinous neoplasm
DI   ORDO; Orphanet_424058; Intraductal papillary mucinous carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   LPC43
AC   CVCL_A1AQ
DR   Wikidata; Q102114481
RX   PubMed=25784717;
RX   PubMed=32903271;
CC   Characteristics: Established from the patient-derived xenograft PHLC178/ADC6.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 4
//
ID   LPC4p
AC   CVCL_1Y56
DR   Cosmic; 947637
DR   Cosmic; 2649492
DR   Wikidata; Q54902974
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Tyr162fs*3; Zygosity=Hemizygous (PubMed=9892110).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   LPC5m
AC   CVCL_1Y57
DR   Cosmic; 947638
DR   Cosmic; 2649493
DR   Wikidata; Q54902980
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   LPC6p
AC   CVCL_1Y58
DR   Cosmic; 947639
DR   Cosmic; 2649494
DR   Wikidata; Q54902981
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 7
//
ID   LPC7m
AC   CVCL_1Y59
DR   Cosmic; 947640
DR   Cosmic; 2649495
DR   Wikidata; Q54902982
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   LPC8p
AC   CVCL_1Y60
DR   Cosmic; 947641
DR   Cosmic; 2649496
DR   Wikidata; Q54902983
RX   PubMed=9892110;
RX   PubMed=15126341;
RX   PubMed=15688027;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   LPC9p
AC   CVCL_1Y61
DR   Cosmic; 947642
DR   Cosmic; 2649497
DR   Wikidata; Q54902984
RX   PubMed=9892110;
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Tyr195fs*1 (c.585delC); Zygosity=Hemizygous (PubMed=9892110).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   LpMab-1
AC   CVCL_D2UC
DR   Wikidata; Q127382625
RX   PubMed=25080943;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-10
AC   CVCL_D2UD
DR   Wikidata; Q127382626
RX   PubMed=26492619;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-12
AC   CVCL_D2UE
DR   Wikidata; Q127382627
RX   PubMed=27031228;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN (Note=Recognizes the sialylated glycan on Thr-52).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-13
AC   CVCL_D2UJ
DR   Wikidata; Q127382628
RX   PubMed=27328060;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-17
AC   CVCL_D2UG
DR   Wikidata; Q127382629
RX   PubMed=26937552;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-19
AC   CVCL_D2UI
DR   Wikidata; Q127382630
RX   PubMed=27564251;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN (Note=Recognizes the sialylated glycan on Thr-76).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-2
AC   CVCL_D2U7
DR   ABCD; ABCD_AG214
DR   Wikidata; Q127382631
RX   Patent=US10227407;
RX   PubMed=25080943;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN (Note=Recognizes aberrantly glycosylated PDPN).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-21
AC   CVCL_D2UF
DR   Wikidata; Q127382632
RX   PubMed=28101903;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-23
AC   CVCL_D2UB
DR   ABCD; ABCD_AG210
DR   Wikidata; Q127382633
RX   Patent=US10227407;
RX   PubMed=28387591;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-3
AC   CVCL_D2U8
DR   ABCD; ABCD_AG213
DR   Wikidata; Q127382634
RX   Patent=US10227407;
RX   PubMed=25080943;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN (Note=Recognizes the O-glycosylated Thr-76).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-7
AC   CVCL_D2U9
DR   ABCD; ABCD_AG212
DR   Wikidata; Q127382635
RX   Patent=US10227407;
RX   PubMed=25080943;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN (Note=Recognizes and binds to the RIEDL pentapeptide used as a protein purification tag).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LpMab-9
AC   CVCL_D2UA
DR   ABCD; ABCD_AG211
DR   Wikidata; Q127382637
RX   Patent=US10227407;
RX   PubMed=25080943;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN (Note=Recognizes the O-glycosylated Thr-25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LPo0036
AC   CVCL_VB51
DR   ECACC; 15102977
DR   Wikidata; Q54902985
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LPP 3-6
AC   CVCL_V124
DR   CLO; CLO_0007386
DR   CLDB; cl3254
DR   IHW; 11w 8304
DR   Wikidata; Q54902986
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LPRB3 112
AC   CVCL_V125
DR   CLO; CLO_0007387
DR   CLDB; cl3255
DR   IHW; 11w 8106
DR   Wikidata; Q54902987
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LPS067
AC   CVCL_A1UY
DR   cancercelllines; CVCL_A1UY
DR   DepMap; ACH-001807
DR   Wikidata; Q105509942
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
ST   Source(s): DepMap=ACH-001807
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D21S11: 29
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 7,17
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 6
//
ID   LPS1
AC   CVCL_SA54
SY   LP1
DR   Cosmic; 2800524
DR   Wikidata; Q54902988
RX   PubMed=23230188;
RX   PubMed=23416162;
RX   PubMed=26643872;
CC   Characteristics: Derived from LPSX1, a mouse xenograft of a transplanted human liposarcoma.
CC   Omics: Metabolomics.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   LPS141
AC   CVCL_M823
SY   LS141
DR   cancercelllines; CVCL_M823
DR   Cell_Model_Passport; SIDM01796
DR   Cosmic; 2800523
DR   DepMap; ACH-001799
DR   GEO; GSM529098
DR   GEO; GSM1228009
DR   GEO; GSM1676337
DR   GEO; GSM1701669
DR   Progenetix; CVCL_M823
DR   Wikidata; Q54902989
RX   PubMed=19449367;
RX   PubMed=19706776;
RX   PubMed=20713527;
RX   PubMed=21335544;
RX   PubMed=21693658;
RX   PubMed=22170698;
RX   PubMed=22328974;
RX   PubMed=22911243;
RX   PubMed=26351324;
RX   PubMed=26643872;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): DepMap=ACH-001799
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 12,14
ST   D18S51: 11,14
ST   D21S11: 28,29
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   LPS2
AC   CVCL_SA55
SY   LP2
DR   Cosmic; 2800525
DR   Wikidata; Q54902990
RX   PubMed=23230188;
RX   PubMed=23416162;
RX   PubMed=26643872;
CC   Characteristics: Derived from LPSX2, a mouse xenograft of a transplanted human liposarcoma.
CC   Omics: Metabolomics.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   LPS224
AC   CVCL_AU06
DR   Wikidata; Q54902991
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 5
//
ID   LPS246
AC   CVCL_AU07
DR   Wikidata; Q54902992
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 5
//
ID   LPS27
AC   CVCL_A1VQ
DR   cancercelllines; CVCL_A1VQ
DR   Cell_Model_Passport; SIDM01974
DR   DepMap; ACH-001793
DR   Wikidata; Q105509944
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
ST   Source(s): DepMap=ACH-001793
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,15
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 7,11
ST   TH01: 9,10
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 6
//
ID   LPS3
AC   CVCL_SA56
SY   LP3
DR   Cosmic; 2800526
DR   Wikidata; Q54902993
RX   PubMed=23230188;
RX   PubMed=23416162;
RX   PubMed=26643872;
CC   Characteristics: Derived from LPSX3, a mouse xenograft of a transplanted human liposarcoma.
CC   Omics: Metabolomics.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   LPS510
AC   CVCL_V414
DR   cancercelllines; CVCL_V414
DR   Cell_Model_Passport; SIDM01795
DR   DepMap; ACH-001804
DR   Wikidata; Q54902994
RX   PubMed=23549872;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
ST   Source(s): DepMap=ACH-001804
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,14
ST   D18S51: 14,16
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 17
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   LPS6
AC   CVCL_A1VR
DR   cancercelllines; CVCL_A1VR
DR   Cell_Model_Passport; SIDM01973
DR   DepMap; ACH-001791
DR   Wikidata; Q105509945
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
ST   Source(s): DepMap=ACH-001791
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,14
ST   D18S51: 16,17
ST   D21S11: 27,30
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 8,11.1
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 9,10
ST   Penta E: 11,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 6
//
ID   LPS695
AC   CVCL_E2VG
RX   PubMed=19449367;
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   LPS853
AC   CVCL_V415
DR   cancercelllines; CVCL_V415
DR   Cell_Model_Passport; SIDM01971
DR   DepMap; ACH-001802
DR   Wikidata; Q54902995
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
ST   Source(s): DepMap=ACH-001802
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 16,17
ST   D21S11: 29,30.2
ST   D3S1358: 14,19
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 14
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   LPS863
AC   CVCL_AU08
DR   Wikidata; Q54902996
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 6
//
ID   LPy0018
AC   CVCL_VB52
DR   ECACC; 15102978
DR   Wikidata; Q54902998
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LQ0001
AC   CVCL_8Y10
DR   ECACC; 99072145
DR   Wikidata; Q54902999
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(3;7)(p21.3;q11.21) (ECACC=99072145).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   LQTS1-iPSC a1
AC   CVCL_T879
SY   LQTS1 a1
DR   SKIP; SKIP000200
DR   Wikidata; Q54903001
RX   PubMed=22739119;
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Pro631fs*33 (c.1893delC); Zygosity=Heterozygous (PubMed=22739119).
CC   Discontinued: SKIP; SKIP000200; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T880 ! LQTS1-iPSC k1
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   LQTS1-iPSC k1
AC   CVCL_T880
SY   LQTS1 k1
DR   SKIP; SKIP000201
DR   Wikidata; Q54903002
RX   PubMed=22739119;
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Pro631fs*33 (c.1893delC); Zygosity=Heterozygous (PubMed=22739119).
CC   Discontinued: SKIP; SKIP000201; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T879 ! LQTS1-iPSC a1
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   LR
AC   CVCL_ZC23
DR   Wikidata; Q98126934
RX   PubMed=16099873;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LR-161
AC   CVCL_WE64
DR   IBRC; C10354
DR   Wikidata; Q95982966
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-166
AC   CVCL_WE65
DR   IBRC; C10237
DR   Wikidata; Q95982967
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-178
AC   CVCL_WE66
DR   IBRC; C10242
DR   Wikidata; Q95982968
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-202
AC   CVCL_WE67
DR   IBRC; C10360
DR   Wikidata; Q95982969
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-214
AC   CVCL_WE68
DR   IBRC; C10387
DR   Wikidata; Q95982971
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-216
AC   CVCL_WE69
DR   IBRC; C10389
DR   Wikidata; Q95982972
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-227
AC   CVCL_WE70
DR   IBRC; C10491
DR   Wikidata; Q95982973
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-228
AC   CVCL_WE71
DR   IBRC; C10492
DR   Wikidata; Q95982975
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-229
AC   CVCL_WE72
DR   IBRC; C10493
DR   Wikidata; Q95982977
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-230
AC   CVCL_WE73
DR   IBRC; C10494
DR   Wikidata; Q95982979
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-240
AC   CVCL_WE74
DR   IBRC; C10504
DR   Wikidata; Q95982981
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-246
AC   CVCL_WE75
DR   IBRC; C10515
DR   Wikidata; Q95982982
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-249
AC   CVCL_WE76
DR   IBRC; C10518
DR   Wikidata; Q95982985
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-252
AC   CVCL_WE77
DR   IBRC; C10521
DR   Wikidata; Q95982987
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-253
AC   CVCL_WE78
DR   IBRC; C10522
DR   Wikidata; Q95982988
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-254
AC   CVCL_WE79
DR   IBRC; C10523
DR   Wikidata; Q95982990
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-258
AC   CVCL_WE80
DR   IBRC; C10558
DR   Wikidata; Q95982991
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-259
AC   CVCL_WE81
DR   IBRC; C10550
DR   Wikidata; Q95982992
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-272
AC   CVCL_WE82
DR   IBRC; C10532
DR   Wikidata; Q95982994
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-273
AC   CVCL_WE83
DR   IBRC; C10554
DR   Wikidata; Q95982995
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-274
AC   CVCL_WE84
DR   IBRC; C10542
DR   Wikidata; Q95982997
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-275
AC   CVCL_WE85
DR   IBRC; C10535
DR   Wikidata; Q95982999
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-277
AC   CVCL_WE86
DR   IBRC; C10544
DR   Wikidata; Q95983000
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-283
AC   CVCL_WE87
DR   IBRC; C10533
DR   Wikidata; Q95983001
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-3
AC   CVCL_J836
DR   ECACC; 93062221
DR   Wikidata; Q54903003
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   LR-320
AC   CVCL_WE88
DR   IBRC; C10798
DR   Wikidata; Q95983003
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-323
AC   CVCL_WE89
DR   IBRC; C10791
DR   Wikidata; Q95983004
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-326
AC   CVCL_WE90
DR   IBRC; C10812
DR   Wikidata; Q95983005
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-366
AC   CVCL_WE91
DR   IBRC; C11122
DR   Wikidata; Q95983006
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-367
AC   CVCL_WE92
DR   IBRC; C11153
DR   Wikidata; Q95983007
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-370
AC   CVCL_WE93
DR   IBRC; C11144
DR   Wikidata; Q95983008
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LR-402
AC   CVCL_ZJ62
DR   IBRC; C11257
DR   Wikidata; Q98126937
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-405
AC   CVCL_ZJ63
DR   IBRC; C11203
DR   Wikidata; Q98126940
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-409
AC   CVCL_ZJ64
DR   IBRC; C11217
DR   Wikidata; Q98126943
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-410
AC   CVCL_ZJ65
DR   IBRC; C11225
DR   Wikidata; Q98126945
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-411
AC   CVCL_ZJ66
DR   IBRC; C11226
DR   Wikidata; Q98126947
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-412
AC   CVCL_ZJ67
DR   IBRC; C11218
DR   Wikidata; Q98126950
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-413
AC   CVCL_ZJ68
DR   IBRC; C11219
DR   Wikidata; Q98126952
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-414
AC   CVCL_ZJ69
DR   IBRC; C11258
DR   Wikidata; Q98126954
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-416
AC   CVCL_ZJ70
DR   IBRC; C11259
DR   Wikidata; Q98126957
RX   PubMed=32358742;
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   LR-BT474
AC   CVCL_A2GH
DR   cancercelllines; CVCL_A2GH
DR   Wikidata; Q105509947
RX   PubMed=32942617;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0179 ! BT-474
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   LR-SKBR3
AC   CVCL_A2GI
DR   cancercelllines; CVCL_A2GI
DR   Wikidata; Q105509950
RX   PubMed=32942617;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   LR.4
AC   CVCL_F0B5
RX   PubMed=1627535;
RX   PubMed=9104580;
CC   Characteristics: MHC H-2 deficient due to loss of transcription of B2m and class I H-2 genes (PubMed=1627535).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2097 ! L-5178-Y
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LR0001
AC   CVCL_8Y11
DR   ECACC; 99073034
DR   Wikidata; Q54903004
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 99073034; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   LR10.6
AC   CVCL_8260
DR   BioSample; SAMN03151851
DR   cancercelllines; CVCL_8260
DR   Wikidata; Q54903005
RX   PubMed=9204988;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NALM-6 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00141.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   LR3.1/3
AC   CVCL_V126
DR   CLO; CLO_0007388
DR   CLDB; cl3256
DR   IHW; 11w 8113
DR   Wikidata; Q54903006
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LR6.2/52a
AC   CVCL_V127
DR   CLO; CLO_0007389
DR   CLDB; cl3257
DR   IHW; 11w 8132
DR   Wikidata; Q54903007
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LR6.3/52C
AC   CVCL_V128
DR   CLO; CLO_0007390
DR   CLDB; cl3258
DR   IHW; 11w 8136
DR   Wikidata; Q54903008
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   LRB
AC   CVCL_A9D9
SY   L.R.B.
DR   Wikidata; Q102114482
RX   PubMed=2822736;
RX   PubMed=3374507;
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   LRB01
AC   CVCL_B236
SY   LRB001; KUe001-A
DR   hPSCreg; KUe001-A
DR   SKIP; SKIP001863
DR   Wikidata; Q54903009
RX   PubMed=17623545;
RX   PubMed=22140133;
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   LRB02
AC   CVCL_B237
SY   LRB002; KUe002-A
DR   hPSCreg; KUe002-A
DR   SKIP; SKIP001864
DR   Wikidata; Q54903010
RX   PubMed=17623545;
RX   PubMed=22140133;
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB03
AC   CVCL_B238
SY   LRB003; KUe003-A
DR   hPSCreg; KUe003-A
DR   SKIP; SKIP001865
DR   Wikidata; Q54903011
RX   PubMed=17623545;
RX   PubMed=22140133;
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC08-16.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   LRB04
AC   CVCL_B239
SY   LRB004; KUe004-A
DR   hPSCreg; KUe004-A
DR   SKIP; SKIP001866
DR   Wikidata; Q54903012
RX   PubMed=17623545;
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB05
AC   CVCL_B240
SY   LRB005; KUe005-A
DR   hPSCreg; KUe005-A
DR   SKIP; SKIP001867
DR   Wikidata; Q54903013
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB06
AC   CVCL_B241
SY   LRB006; KUe006-A
DR   hPSCreg; KUe006-A
DR   SKIP; SKIP001868
DR   Wikidata; Q54903014
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB07
AC   CVCL_B242
SY   LRB007; KUe007-A
DR   hPSCreg; KUe007-A
DR   SKIP; SKIP001869
DR   Wikidata; Q54903015
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB08
AC   CVCL_B243
SY   LRB008; KUe008-A
DR   hPSCreg; KUe008-A
DR   SKIP; SKIP001870
DR   Wikidata; Q54903016
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-05.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   LRB09
AC   CVCL_B244
SY   LRB009; KUe009-A
DR   hPSCreg; KUe009-A
DR   SKIP; SKIP001871
DR   Wikidata; Q54903017
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB10
AC   CVCL_B245
SY   LRB010
DR   Wikidata; Q54903018
RX   PubMed=22140133;
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-51.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   LRB11
AC   CVCL_B246
SY   LRB011; KUe010-A
DR   hPSCreg; KUe010-A
DR   SKIP; SKIP001872
DR   Wikidata; Q54903019
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-51.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   LRB13
AC   CVCL_B247
SY   LRB013; KUe011-A
DR   hPSCreg; KUe011-A
DR   SKIP; SKIP001979
DR   Wikidata; Q54903020
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB14
AC   CVCL_B248
SY   LRB014; KUe012-A
DR   hPSCreg; KUe012-A
DR   SKIP; SKIP001980
DR   Wikidata; Q54903023
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB16
AC   CVCL_B249
SY   LRB016; KUe013-A
DR   hPSCreg; KUe013-A
DR   SKIP; SKIP001981
DR   Wikidata; Q54903025
RX   PubMed=22140133;
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   LRB17
AC   CVCL_B250
SY   LRB017; KUe014-A
DR   hPSCreg; KUe014-A
DR   SKIP; SKIP001982
DR   Wikidata; Q54903026
RX   PubMed=22140133;
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   LRB18
AC   CVCL_B251
SY   LRB018; KUe015-A
DR   hPSCreg; KUe015-A
DR   SKIP; SKIP002294
DR   Wikidata; Q54903027
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   LRB21
AC   CVCL_BW87
SY   LRB021
DR   Wikidata; Q54903028
CC   From: University Hospital of Copenhagen; Copenhagen; Denmark.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-25.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   LRD
AC   CVCL_5T96
DR   Wikidata; Q54903029
RX   PubMed=2098280;
CC   Breed/subspecies: C3H/J.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   LREX'
AC   CVCL_UD76
SY   LnCaP/AR Resistant to Enzalutamide Xenograft derived
DR   cancercelllines; CVCL_UD76
DR   Wikidata; Q95983040
RX   PubMed=24315100;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   LRG
AC   CVCL_R827
SY   Labeo Rohita Gill
DR   NRFC; NRFC023
DR   Wikidata; Q54903030
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=23224722;
RX   PubMed=25052522;
WW   Provider; AAHL; -; https://aahl.res.in/rohu-labeo-rohita-eye-re-and-gill-lrg-cell-lines/
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC023.
CC   Miscellaneous: Cell line is available for distribution but not authenticated (NRFC=NRFC023).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   LRM
AC   CVCL_C8G9
SY   Labeo Rohita Muscle
DR   Wikidata; Q123032976
RX   PubMed=37179501;
RX   PubMed=37389130;
CC   Group: Fish cell line.
CC   Characteristics: Sensitive to extracellular products (ECPs) of A. hydrophila, E. tarda, and six heavy metals (Hg, Cd, Zn, Cu, Pb and Ni) (PubMed=37179501).
CC   Characteristics: Capable of growing from 24 to 32 Celsius, the optimal temperature is 28 Celsius (PubMed=37389130).
CC   Doubling time: 28 hours (Note=At 18th passage) (PubMed=37389130).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   LRo0022
AC   CVCL_VB53
DR   ECACC; 15102979
DR   Wikidata; Q54903031
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   LRoF-1
AC   CVCL_C5YR
SY   Labeo rohita Fin-1
DR   NRFC; NRFC070
DR   Wikidata; Q116049717
WW   Provider; NRFC; NRFC070; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC070.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   LRPM
AC   CVCL_T033
SY   Labeo Rohita Peritoneal Macrophages
DR   Wikidata; Q54903032
RX   PubMed=24248274;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 11
//
ID   LRTM
AC   CVCL_R828
SY   Labeo Rohita Thymic Macrophages
DR   Wikidata; Q54903033
RX   PubMed=23955429;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Thymic macrophage; CL=CL_0000866.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   LRVA-4
AC   CVCL_A5PI
DR   Wikidata; Q107115874
RX   PubMed=2448499;
RX   PubMed=14518029;
CC   Miscellaneous: Cell line has been lost (PubMed=14518029).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   LRWZ
AC   CVCL_WH68
DR   Wikidata; Q95983046
RX   PubMed=10841287;
RX   PubMed=12699884;
CC   Doubling time: 42 hours (PubMed=12699884).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   LS
AC   CVCL_2105
DR   BioSample; SAMN03473430
DR   cancercelllines; CVCL_2105
DR   Cell_Model_Passport; SIDM01794
DR   Cosmic; 2058108
DR   DepMap; ACH-001548
DR   DSMZ; ACC-675
DR   DSMZCellDive; ACC-675
DR   GEO; GSM3145569
DR   GEO; GSM3145721
DR   Wikidata; Q54903034
RX   PubMed=2026421;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~45 hours (DSMZ=ACC-675).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): DepMap=ACH-001548; DSMZ=ACC-675
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 24,25
ST   Penta D: 10,13
ST   Penta E: 11,14
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   LS 102.9
AC   CVCL_K220
SY   LS-102.9
DR   CLO; CLO_0007391
DR   ATCC; HB-97
DR   Wikidata; Q54903035
RX   PubMed=6980413;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K166 ! L10.A 2J
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   LS-136
AC   CVCL_J814
SY   LS 136
DR   CLO; CLO_0007402
DR   ATCC; TIB-157
DR   Wikidata; Q54903036
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mouse Ig lambda 1 light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   LS-CLS
AC   CVCL_5789
DR   CLS; 605390
DR   Wikidata; Q54903037
DI   NCIt; C134777; Hamster lymphosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   LS030609
AC   CVCL_IW35
SY   LPS2
DR   Wikidata; Q54903038
RX   PubMed=23978446;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   LS060208
AC   CVCL_IW36
SY   LPS1
DR   Wikidata; Q54903039
RX   PubMed=23978446;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   LS1
AC   CVCL_E7GZ
RX   PubMed=7427939;
CC   Characteristics: Tumorigenic. The parent cell line was cultivated in the peritoneal cavity of allogeneic non-immune BALB/c mice for 3 days. The cells that survived and propagated caused tumors in a number of C3Hf mice after subcutaneaous inoculation. Using one of these tumors, 8 passages in vivo in syngeneic mice were carried out to obtain this cell line (PubMed=7427939).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LS1034
AC   CVCL_1382
SY   LS 1034; LS-1034
DR   CLO; CLO_0007396
DR   CLO; CLO_0009966
DR   EFO; EFO_0002226
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2158
DR   BCRC; 60353
DR   BioGRID_ORCS_Cell_line; 711
DR   BioSample; SAMN03472348
DR   BioSample; SAMN10988322
DR   cancercelllines; CVCL_1382
DR   Cell_Model_Passport; SIDM00681
DR   ChEMBL-Cells; CHEMBL3308846
DR   ChEMBL-Targets; CHEMBL2366072
DR   ColonAtlas; LS1034
DR   Cosmic; 711266
DR   Cosmic; 887236
DR   Cosmic; 917486
DR   Cosmic; 948850
DR   Cosmic; 983741
DR   Cosmic; 985655
DR   Cosmic; 986015
DR   Cosmic; 995409
DR   Cosmic; 1043819
DR   Cosmic; 1310933
DR   Cosmic; 1479603
DR   Cosmic; 1609483
DR   Cosmic; 1708400
DR   Cosmic; 1995489
DR   Cosmic; 2760089
DR   Cosmic; 2800569
DR   Cosmic-CLP; 917486
DR   DepMap; ACH-000252
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 917486
DR   GEO; GSM206519
DR   GEO; GSM463045
DR   GEO; GSM513912
DR   GEO; GSM514298
DR   GEO; GSM784018
DR   GEO; GSM887277
DR   GEO; GSM888352
DR   GEO; GSM1006216
DR   GEO; GSM1006217
DR   GEO; GSM1006218
DR   GEO; GSM1448112
DR   GEO; GSM1670058
DR   GEO; GSM2550008
DR   IARC_TP53; 6483
DR   IARC_TP53; 21476
DR   IARC_TP53; 21741
DR   IGRhCellID; LS1034
DR   KCLB; 22158
DR   LiGeA; CCLE_585
DR   LINCS_LDP; LCL-1336
DR   PharmacoDB; LS1034_860_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1382
DR   PubChem_Cell_line; CVCL_1382
DR   Wikidata; Q54903040
RX   PubMed=1389533;
RX   PubMed=1617643;
RX   PubMed=8464898;
RX   PubMed=8895552;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=10737795;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=16418264;
RX   PubMed=16969076;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23932154;
RX   PubMed=24042735;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 40.79 hours (PubMed=25944804).
CC   HLA typing: A*02:01,26:01; B*08:01,27:05; C*02:02,07:06; DQA1*05:02,05:02; DRB1*04:03,11:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1309Aspfs*4 (c.3927_3931delAAAGA); ClinVar=VCV000000816; Zygosity=Homozygous (ATCC=CRL-2158).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Homozygous (PubMed=16969076; PubMed=20570890; PubMed=28683746; Cosmic-CLP=917486; DepMap=ACH-000252).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=9000147; PubMed=16418264; PubMed=28683746; Cosmic-CLP=917486; DepMap=ACH-000252).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.06%; East Asian, North=0.24%; East Asian, South=1.27%; South Asian=0.11%; European, North=62.34%; European, South=34.98% (PubMed=30894373).
CC   Misspelling: LS103A; GEO=GSM784018.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): ATCC=CRL-2158; Cosmic-CLP=917486; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 20
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 5,13
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV29 ! LS1034-PBL
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   LS1034-PBL
AC   CVCL_VV29
DR   Cell_Model_Passport; SIDM01641
DR   DepMap; ACH-002376
DR   Wikidata; Q95983054
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1382 ! LS1034
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   LS106
AC   CVCL_1D76
DR   Wikidata; Q54903041
RX   CelloPub=CLPUB00250;
RX   PubMed=10523844;
CC   Derived from site: In situ; Lung, bronchus; UBERON=UBERON_0002185.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 6
//
ID   LS111
AC   CVCL_1D77
DR   Wikidata; Q54903042
RX   CelloPub=CLPUB00250;
RX   PubMed=10523844;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 9
//
ID   LS112
AC   CVCL_1D79
DR   Wikidata; Q54903043
RX   CelloPub=CLPUB00250;
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 8
//
ID   LS123
AC   CVCL_1383
SY   Ls123; LS 123; LS-123; Laboratory of Surgery 123
DR   CLO; CLO_0007392
DR   CLO; CLO_0007397
DR   CLO; CLO_0009967
DR   CLDB; cl3260
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-255
DR   BCRC; 60536
DR   BioGRID_ORCS_Cell_line; 934
DR   BioSample; SAMN03470983
DR   BioSample; SAMN10987696
DR   cancercelllines; CVCL_1383
DR   Cell_Model_Passport; SIDM00776
DR   ChEMBL-Cells; CHEMBL3308874
DR   ChEMBL-Targets; CHEMBL2366334
DR   ColonAtlas; LS123
DR   Cosmic; 687530
DR   Cosmic; 907792
DR   Cosmic; 1187309
DR   Cosmic; 1310934
DR   Cosmic; 1312304
DR   Cosmic; 1466818
DR   Cosmic; 1708399
DR   Cosmic; 1995490
DR   Cosmic; 2647534
DR   Cosmic-CLP; 907792
DR   DepMap; ACH-000501
DR   ECACC; 94120801
DR   EGA; EGAS00001000978
DR   GDSC; 907792
DR   GEO; GSM784016
DR   GEO; GSM827450
DR   GEO; GSM844580
DR   GEO; GSM844581
DR   GEO; GSM887278
DR   GEO; GSM888353
DR   GEO; GSM1448138
DR   GEO; GSM1670059
DR   IARC_TP53; 21477
DR   IARC_TP53; 21742
DR   LiGeA; CCLE_123
DR   LINCS_LDP; LCL-1193
DR   PharmacoDB; LS123_861_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1383
DR   PubChem_Cell_line; CVCL_1383
DR   Wikidata; Q54903044
RX   PubMed=6826200;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 21-42 hours (PubMed=6826200).
CC   HLA typing: A*03:01,24:02; B*07:02,07:02; C*07:02,07:02; DQA1*02:01,02:01; DQB1*06:02,06:02; DRB1*13:26,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln625Ter (c.1873C>T); ClinVar=VCV000232045; Zygosity=Heterozygous (ATCC=CCL-255; Cosmic-CLP=907792; DepMap=ACH-000501).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Heterozygous (ATCC=CCL-255; Cosmic-CLP=907792; DepMap=ACH-000501).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous (Cosmic-CLP=907792; DepMap=ACH-000501).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=16418264; Cosmic-CLP=907792; DepMap=ACH-000501).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.17%; East Asian, South=0%; South Asian=0%; European, North=70.48%; European, South=28.34% (PubMed=30894373).
CC   Misspelling: LS153; GEO=GSM844581.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-255; Cosmic-CLP=907792; ECACC=94120801; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 13
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 30 (PubMed=25877200)
ST   D21S11: 30,31 (ATCC=CCL-255; PubMed=25926053)
ST   D2S1338: 19
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13,16
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 5,12
ST   TH01: 7,8
ST   TPOX: 9
ST   vWA: 16 (ECACC=94120801)
ST   vWA: 16,17 (ATCC=CCL-255; Cosmic-CLP=907792; PubMed=25877200; PubMed=25926053)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   LS125-2D4-11-10-1
AC   CVCL_L599
SY   LS-125-2D4-11-10-1; 2D4
DR   CLO; CLO_0007398
DR   ATCC; HB-12644
DR   Wikidata; Q54903045
RX   Patent=US6329510;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12644.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P32246; Human CCR1/CD191.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   LS129-3C3-E3-1
AC   CVCL_L600
SY   3C3
DR   CLO; CLO_0007399
DR   ATCC; HB-12653
DR   Wikidata; Q54903046
RX   Patent=US6329159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12653.
CC   Doubling time: 18 hours (ATCC=HB-12653).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P51686; Human CCR9/CD199.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 30-01-24; Version: 8
//
ID   LS132.1D9
AC   CVCL_L540
SY   1D9
DR   CLO; CLO_0007400
DR   ABCD; ABCD_AA762
DR   ATCC; HB-12549
DR   Wikidata; Q54903047
RX   Patent=US6312689;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12549.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P41597; Human CCR2/CD192.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   LS132.8G2
AC   CVCL_L541
SY   8G2
DR   CLO; CLO_0007401
DR   ATCC; HB-12550
DR   Wikidata; Q54903049
RX   Patent=US6312689;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12550.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P41597; Human CCR2/CD192.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   LS14
AC   CVCL_DH87
DR   cancercelllines; CVCL_DH87
DR   GEO; GSM482561
DR   Progenetix; CVCL_DH87
DR   Wikidata; Q54903050
RX   PubMed=16195405;
RX   PubMed=17426441;
WW   Provider; UC 1819 Innovation Hub; 106025; https://web.archive.org/web/20160818055736/http://www.ipo.uc.edu/index.cfm?fuseaction=technologies.results&item_number=106025
CC   Characteristics: Exhibits a gene expression pattern similar to that in primary preadipocytes and are capable of terminal differentiation. Can be considered as partially-differentiated preadipocytes that can be induce to terminally differentiate and accumulate lipid droplets following incubation in serum-free medium which contains a combination of adipogenic-inducing compounds (PubMed=16195405).
CC   Doubling time: ~96 hours (PubMed=16195405).
CC   Cell type: Preadipocyte; CL=CL_0002334.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   LS141-1G1-65-15-1
AC   CVCL_DC02
SY   1G1
DR   CLO; CLO_0001164
DR   ATCC; HB-12624
DR   Wikidata; Q54903051
RX   Patent=US6488930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12624.
CC   Doubling time: 19 hours (ATCC=HB-12624).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P51679; Human CCR4/CD194.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   LS174T
AC   CVCL_1384
AS   CVCL_D190
SY   Ls174T; LS174t; Ls-174-T; LS-174-T; LS 174 T; LS-174T; Ls-174T; LS 174T; LS-174; LS174; Laboratory of Surgery 174T
DR   BTO; BTO_0001553
DR   CLO; CLO_0007393
DR   CLO; CLO_0007403
DR   EFO; EFO_0002227
DR   MCCL; MCC:0000504
DR   CLDB; cl3261
DR   AddexBio; C0009013/379
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CCL-188
DR   ATCC; CL-188
DR   BCRC; 60053
DR   BioSample; SAMN03470826
DR   BioSample; SAMN03471296
DR   cancercelllines; CVCL_1384
DR   CCRID; 1101HUM-PUMC000248
DR   CCRID; 3101HUMTCHu32
DR   CCRID; 4201HUM-CCTCC00135
DR   CCTCC; GDC0135
DR   Cell_Model_Passport; SIDM01200
DR   ChEMBL-Cells; CHEMBL3307536
DR   ChEMBL-Targets; CHEMBL614097
DR   CLS; 300392
DR   ColonAtlas; LS174T
DR   Cosmic; 711255
DR   Cosmic; 719679
DR   Cosmic; 724843
DR   Cosmic; 738927
DR   Cosmic; 873703
DR   Cosmic; 875424
DR   Cosmic; 876717
DR   Cosmic; 887219
DR   Cosmic; 889533
DR   Cosmic; 907793
DR   Cosmic; 934563
DR   Cosmic; 948131
DR   Cosmic; 948856
DR   Cosmic; 985998
DR   Cosmic; 995405
DR   Cosmic; 1043822
DR   Cosmic; 1057755
DR   Cosmic; 1066210
DR   Cosmic; 1122328
DR   Cosmic; 1132565
DR   Cosmic; 1132692
DR   Cosmic; 1184087
DR   Cosmic; 1184334
DR   Cosmic; 1187310
DR   Cosmic; 1312305
DR   Cosmic; 1479573
DR   Cosmic; 1486134
DR   Cosmic; 1524341
DR   Cosmic; 1676738
DR   Cosmic; 1708419
DR   Cosmic; 1805263
DR   Cosmic; 2301546
DR   Cosmic; 2301997
DR   Cosmic; 2646768
DR   Cosmic; 2651866
DR   Cosmic; 2668256
DR   Cosmic; 2760087
DR   Cosmic; 2787546
DR   DSMZ; ACC-759
DR   DSMZCellDive; ACC-759
DR   ECACC; 87060401
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM513911
DR   GEO; GSM514297
DR   GEO; GSM741264
DR   GEO; GSM784021
DR   GEO; GSM827345
DR   GEO; GSM1346883
DR   GEO; GSM1374632
DR   GEO; GSM1374633
DR   GEO; GSM1448164
DR   GEO; GSM2550009
DR   IARC_TP53; 21478
DR   IARC_TP53; 21708
DR   IGRhCellID; LS174T
DR   KCB; KCB 200829YJ
DR   KCLB; 10188
DR   LINCS_LDP; LCL-1182
DR   Lonza; 1127
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C568
DR   PharmacoDB; LS174T_862_2019
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Progenetix; CVCL_1384
DR   PubChem_Cell_line; CVCL_1384
DR   RCB; RCB1961
DR   TKG; TKG 0406
DR   TOKU-E; 2235
DR   Ubigene; YC-C088
DR   Wikidata; Q54903053
RX   Patent=US4228236;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1262041;
RX   PubMed=1999484;
RX   PubMed=3335022;
RX   PubMed=3349466;
RX   PubMed=3518877;
RX   PubMed=3664476;
RX   PubMed=6401685;
RX   PubMed=6652615;
RX   PubMed=6935474;
RX   PubMed=7370982;
RX   PubMed=7459858;
RX   PubMed=7972006;
RX   PubMed=8422623;
RX   PubMed=8464898;
RX   PubMed=8895552;
RX   PubMed=9000147;
RX   PubMed=9290701;
RX   PubMed=9294210;
RX   PubMed=10674020;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11526487;
RX   PubMed=12068308;
RX   PubMed=12606785;
RX   PubMed=15900046;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=18258742;
RX   PubMed=19132987;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=24840470;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=29101300;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/LS174T.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/ls174t-xenograft-model/
CC   Group: Patented cell line.
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-188.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (Note=At 20th passage) (PubMed=1262041); 18-20 hours (PubMed=7370982); 38.01 hours (PubMed=25944804); ~30-40 hours (DSMZ=ACC-759).
CC   HLA typing: A*02; B*13,50 (ATCC=CL-188).
CC   HLA typing: A*02,30 (PubMed=8464898).
CC   HLA typing: A*30:01,30:01; B*15:50,35:114; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=9000147; PubMed=10674020; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (PubMed=24755471; ATCC=CL-188).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24042735; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=20570890; PubMed=24042735; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046; PubMed=16418264; PubMed=24042735).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Glycomics; O-glycan profiling.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: LV1747; Cosmic=1187310; PubMed=19132987.
CC   Misspelling: L5174T; Note=Occasionally.
CC   Discontinued: ATCC; CCL-188; true.
CC   Discontinued: RCB; RCB1961; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): AddexBio=C0009013/379; ATCC=CL-188; CCRID; CLS=300392; DSMZ=ACC-759; KCLB=10188; PubMed=11416159; PubMed=25877200; PubMed=25926053; TKG=TKG 0406
ST   Amelogenin: X
ST   CSF1PO: 10,11,13,14 (DSMZ=ACC-759)
ST   CSF1PO: 10,13,14 (AddexBio=C0009013/379; ATCC=CL-188; PubMed=25926053)
ST   CSF1PO: 10,14 (CCRID; CLS=300392; KCLB=10188; PubMed=25877200; TKG=TKG 0406)
ST   D13S317: 9,10,11 (DSMZ=ACC-759)
ST   D13S317: 10 (AddexBio=C0009013/379; ATCC=CL-188; CCRID; PubMed=25877200; PubMed=25926053)
ST   D13S317: 10,11 (CLS=300392; KCLB=10188; TKG=TKG 0406)
ST   D16S539: 11,12,13 (DSMZ=ACC-759)
ST   D16S539: 11,13 (AddexBio=C0009013/379; ATCC=CL-188; CCRID; CLS=300392; PubMed=25877200; PubMed=25926053; TKG=TKG 0406)
ST   D18S51: 11,12,13 (DSMZ=ACC-759)
ST   D18S51: 11,13 (ATCC=CL-188; CLS=300392; PubMed=25877200)
ST   D19S433: 13,14,15 (CLS=300392)
ST   D19S433: 13,15,23 (DSMZ=ACC-759)
ST   D19S433: 14,15 (ATCC=CL-188)
ST   D21S11: 29,30,31 (CLS=300392)
ST   D21S11: 29,31 (ATCC=CL-188; PubMed=11416159; PubMed=25877200; PubMed=25926053)
ST   D21S11: 30,31,31.3,32,32.3,33 (DSMZ=ACC-759)
ST   D2S1338: 18,21,22 (ATCC=CL-188; DSMZ=ACC-759)
ST   D2S1338: 18,22 (CLS=300392)
ST   D3S1358: 14,15,16,17 (DSMZ=ACC-759)
ST   D3S1358: 15,17 (ATCC=CL-188; CLS=300392; KCLB=10188; PubMed=25877200)
ST   D5S818: 11,14,15 (DSMZ=ACC-759)
ST   D5S818: 11,15 (AddexBio=C0009013/379; CCRID; CLS=300392; KCLB=10188; PubMed=25877200; PubMed=25926053; TKG=TKG 0406)
ST   D5S818: 11,15,16 (ATCC=CL-188)
ST   D7S820: 10,10.3 (TKG=TKG 0406)
ST   D7S820: 10.3,11 (ATCC=CL-188; DSMZ=ACC-759; PubMed=25877200)
ST   D7S820: 11 (AddexBio=C0009013/379; CCRID; CLS=300392; KCLB=10188; PubMed=25926053)
ST   D8S1179: 11,12,16 (CLS=300392)
ST   D8S1179: 12,15 (DSMZ=ACC-759)
ST   D8S1179: 12,15,16 (ATCC=CL-188)
ST   D8S1179: 12,16 (PubMed=25877200)
ST   FGA: 14,20,21,22 (DSMZ=ACC-759)
ST   FGA: 21,22 (ATCC=CL-188; CLS=300392; KCLB=10188; PubMed=25877200)
ST   Penta D: 10
ST   Penta E: 14,15,16 (ATCC=CL-188; DSMZ=ACC-759)
ST   Penta E: 15,16 (CLS=300392; PubMed=25877200)
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 15,16,17,18,19 (DSMZ=ACC-759)
ST   vWA: 15,17 (AddexBio=C0009013/379; CCRID; CLS=300392; KCLB=10188; PubMed=11416159; PubMed=25877200; PubMed=25926053; TKG=TKG 0406)
ST   vWA: 15,17,18 (ATCC=CL-188)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   LS174T-FX-R
AC   CVCL_C4RY
DR   Wikidata; Q116049718
RX   PubMed=36230735;
CC   Population: Caucasian.
CC   Characteristics: Resistant to FOLFOXIRI, the combination of 5-FU, folinic acic, oxaliplatin and SN-38.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Selected for resistance to: ChEBI; CHEBI_15640; 5-formyltetrahydrofolic acid (Folinic acid; Leucovorin).
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   LS174T-HM3
AC   CVCL_0306
SY   HM3; HM3-MUC2; LS174T-High Mucin 3
DR   MCCL; MCC:0000198
DR   cancercelllines; CVCL_0306
DR   Wikidata; Q54903054
RX   PubMed=3664476;
CC   Population: Caucasian.
CC   Characteristics: Produces high amount of mucin in culture (PubMed=3664476).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   LS174T-HM7
AC   CVCL_6670
SY   HM7; HM-7; HM 7; LS174T-High Mucin 7
DR   BTO; BTO_0002921
DR   EFO; EFO_0006787
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472364
DR   cancercelllines; CVCL_6670
DR   ColonAtlas; HM7
DR   EGA; EGAS00001000610
DR   PharmacoDB; HM7_551_2019
DR   Wikidata; Q54903055
RX   PubMed=1999484;
RX   PubMed=3664476;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Caucasian.
CC   Characteristics: Produces high amount of mucin in culture (PubMed=3664476).
CC   HLA typing: A*30:01,30:01; B*15:34,35:03; C*04:01,06:02; DQB1*05:01,05:01; DRB1*01:01,01:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 11,12
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 11,16
ST   D7S820: 10.3,11
ST   D8S1179: 12,16
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 15,16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   LS174T-LM12
AC   CVCL_B6NS
SY   LM12; LM 12; LS174T-Low Mucin 12
DR   cancercelllines; CVCL_B6NS
DR   Wikidata; Q112930022
RX   PubMed=1999484;
RX   PubMed=3664476;
CC   Population: Caucasian.
CC   Characteristics: Produces low amount of mucin in culture (PubMed=3664476).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   LS174T-W4
AC   CVCL_J074
SY   Ls174T-W4; W4
DR   cancercelllines; CVCL_J074
DR   Wikidata; Q54903056
RX   PubMed=19386264;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   LS174T/R
AC   CVCL_A5BI
SY   LS 174T/R
DR   cancercelllines; CVCL_A5BI
DR   Wikidata; Q107115875
RX   PubMed=12606785;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LS180
AC   CVCL_0397
SY   LS-180; LS 180; Laboratory of Surgery 180
DR   BTO; BTO_0001609
DR   CLO; CLO_0007394
DR   CLO; CLO_0007404
DR   EFO; EFO_0006640
DR   MCCL; MCC:0000291
DR   CLDB; cl3262
DR   CLDB; cl3263
DR   CLDB; cl7120
DR   AddexBio; C0009006/56
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-187
DR   ATCC; CL-187
DR   BCRC; 60100
DR   BioGRID_ORCS_Cell_line; 564
DR   BioSample; SAMN03472231
DR   BioSample; SAMN10988327
DR   cancercelllines; CVCL_0397
DR   CCRID; 1101HUM-PUMC000284
DR   Cell_Model_Passport; SIDM00680
DR   ChEMBL-Cells; CHEMBL4295398
DR   ChEMBL-Targets; CHEMBL4296462
DR   ColonAtlas; LS180
DR   Cosmic; 869793
DR   Cosmic; 913893
DR   Cosmic; 948854
DR   Cosmic; 995378
DR   Cosmic; 1043820
DR   Cosmic; 1184098
DR   Cosmic; 1187311
DR   Cosmic; 1466819
DR   Cosmic; 1479574
DR   Cosmic; 1708417
DR   Cosmic; 2052595
DR   Cosmic; 2301998
DR   Cosmic; 2667976
DR   Cosmic; 2727472
DR   Cosmic-CLP; 998189
DR   DepMap; ACH-000957
DR   ECACC; 87021202
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 998189
DR   GEO; GSM206520
DR   GEO; GSM513928
DR   GEO; GSM514299
DR   GEO; GSM741271
DR   GEO; GSM784017
DR   GEO; GSM827346
DR   GEO; GSM887279
DR   GEO; GSM888354
DR   GEO; GSM1346847
DR   GEO; GSM1374634
DR   GEO; GSM1374635
DR   GEO; GSM1374636
DR   GEO; GSM1448139
DR   GEO; GSM1670060
DR   IARC_TP53; 21766
DR   ICLC; HTL01016
DR   IZSLER; BS TCL 82
DR   LiGeA; CCLE_023
DR   LINCS_LDP; LCL-1183
DR   Lonza; 348
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C508
DR   PharmacoDB; LS180_859_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0397
DR   PubChem_Cell_line; CVCL_0397
DR   Wikidata; Q54903057
RX   Patent=US4228236;
RX   PubMed=1262041;
RX   PubMed=6652615;
RX   PubMed=7370982;
RX   PubMed=9515795;
RX   PubMed=10737795;
RX   PubMed=11314036;
RX   PubMed=12615714;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Group: Patented cell line.
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-187.
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=7370982).
CC   HLA typing: A*02; B*13,50 (ATCC=CL-187).
CC   HLA typing: A*30:01,30:01; B*07:12,15:50; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=24755471; PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (PubMed=24755471; Cosmic-CLP=998189; DepMap=ACH-000957).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=20570890; PubMed=24755471; ATCC=CL-187).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.1%; Native American=0%; East Asian, North=0.33%; East Asian, South=0.79%; South Asian=7.05%; European, North=35.25%; European, South=55.48% (PubMed=30894373).
CC   Discontinued: ATCC; CCL-187; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): AddexBio=C0009006/56; ATCC=CL-187; CCRID=1101HUM-PUMC000284; Cosmic-CLP=998189; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,12 (CCRID=1101HUM-PUMC000284)
ST   CSF1PO: 10,13 (AddexBio=C0009006/56; ATCC=CL-187; Cosmic-CLP=998189; PubMed=25877200; PubMed=25926053)
ST   D13S317: 10
ST   D16S539: 11,12 (CCRID=1101HUM-PUMC000284)
ST   D16S539: 11,13 (AddexBio=C0009006/56; ATCC=CL-187; Cosmic-CLP=998189; PubMed=25877200; PubMed=25926053)
ST   D18S51: 11,13
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 18,22
ST   D3S1358: 15,17
ST   D5S818: 10,15
ST   D7S820: 9.3,11 (AddexBio=C0009006/56; ATCC=CL-187; Cosmic-CLP=998189; PubMed=25877200)
ST   D7S820: 10,11 (PubMed=25926053)
ST   D7S820: 10.3,11 (CCRID=1101HUM-PUMC000284)
ST   D8S1179: 12,16
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 15,16
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   LS185-2B10-4-1
AC   CVCL_DC03
SY   2B10
DR   ATCC; HB-12625
DR   Wikidata; Q54903058
RX   Patent=US6488930;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12625.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P51679; Human CCR4/CD194.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   LS180-MFSD3-KO-c4
AC   CVCL_D4V2
SY   CE00PE-T
DR   Wikidata; Q127382638
WW   Info; RESOLUTE; CE00PE-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25157; MFSD3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-MFSD3-KO-c6
AC   CVCL_D4V3
SY   CE00PF-F
DR   Wikidata; Q127382639
WW   Info; RESOLUTE; CE00PF-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25157; MFSD3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-NIPAL1-KO-c11
AC   CVCL_D4V4
SY   CE06GN-W
DR   Wikidata; Q127382640
WW   Info; RESOLUTE; CE06GN-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27194; NIPAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-NIPAL1-KO-c3
AC   CVCL_D4V5
SY   CE06GK-5
DR   Wikidata; Q127382641
WW   Info; RESOLUTE; CE06GK-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27194; NIPAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC10A6-KO-c3
AC   CVCL_D4V6
SY   CE04F7-Q
DR   Wikidata; Q127382642
WW   Info; RESOLUTE; CE04F7-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30603; SLC10A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC10A6-KO-c8
AC   CVCL_D4V7
SY   CE04F9-0
DR   Wikidata; Q127382643
WW   Info; RESOLUTE; CE04F9-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30603; SLC10A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC12A2-KO-c11
AC   CVCL_D4V8
SY   CE078X-0
DR   Wikidata; Q127382644
WW   Info; RESOLUTE; CE078X-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10911; SLC12A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC12A2-KO-c9
AC   CVCL_D4V9
SY   CE078Z-6
DR   Wikidata; Q127382645
WW   Info; RESOLUTE; CE078Z-6; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10911; SLC12A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC16A14-KO-c1
AC   CVCL_D4VA
SY   CE00PP-Z
DR   Wikidata; Q127382646
WW   Info; RESOLUTE; CE00PP-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26417; SLC16A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC16A14-KO-c8
AC   CVCL_D4VB
SY   CE00PR-P
DR   Wikidata; Q127382648
WW   Info; RESOLUTE; CE00PR-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26417; SLC16A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC1A4-KO-c6
AC   CVCL_D4VC
SY   CE05EW-7
DR   Wikidata; Q127382649
WW   Info; RESOLUTE; CE05EW-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10942; SLC1A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC1A4-KO-c9
AC   CVCL_D4VD
SY   CE05EX-Q
DR   Wikidata; Q127382650
WW   Info; RESOLUTE; CE05EX-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10942; SLC1A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC22A18-KO-c3
AC   CVCL_D4VE
SY   CE0598-5
DR   Wikidata; Q127382651
WW   Info; RESOLUTE; CE0598-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10964; SLC22A18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC22A18-KO-c5
AC   CVCL_D4VF
SY   CE0599-1
DR   Wikidata; Q127382652
WW   Info; RESOLUTE; CE0599-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10964; SLC22A18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC25A35-KO-c2
AC   CVCL_D4VG
SY   CE06HC-9
DR   Wikidata; Q127382653
WW   Info; RESOLUTE; CE06HC-9; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31921; SLC25A35.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC25A35-KO-c3
AC   CVCL_D4VH
SY   CE06HE-V
DR   Wikidata; Q127382654
WW   Info; RESOLUTE; CE06HE-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31921; SLC25A35.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC27A3-KO-c1
AC   CVCL_D4VI
SY   CE05EZ-U
DR   Wikidata; Q127382655
WW   Info; RESOLUTE; CE05EZ-U; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10997; SLC27A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC27A3-KO-c6
AC   CVCL_D4VJ
SY   CE05F0-0
DR   Wikidata; Q127382656
WW   Info; RESOLUTE; CE05F0-0; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10997; SLC27A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC28A2-KO-c1
AC   CVCL_D4VK
SY   CE054T-C
DR   Wikidata; Q127382657
WW   Info; RESOLUTE; CE054T-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11002; SLC28A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC28A2-KO-c3
AC   CVCL_D4VL
SY   CE054V-5
DR   Wikidata; Q127382658
WW   Info; RESOLUTE; CE054V-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11002; SLC28A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC28A3-KO-c13
AC   CVCL_D4VM
SY   CE061W-M
DR   Wikidata; Q127382659
WW   Info; RESOLUTE; CE061W-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16484; SLC28A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC28A3-KO-c19
AC   CVCL_D4VN
SY   CE061Z-F
DR   Wikidata; Q127382660
WW   Info; RESOLUTE; CE061Z-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16484; SLC28A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A12-KO-c3
AC   CVCL_D4VP
SY   CE0551-7
DR   Wikidata; Q127382661
WW   Info; RESOLUTE; CE0551-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18067; SLC2A12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A12-KO-c4
AC   CVCL_D4VQ
SY   CE0552-Q
DR   Wikidata; Q127382662
WW   Info; RESOLUTE; CE0552-Q; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18067; SLC2A12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A4-KO-c5
AC   CVCL_D4VR
SY   CE05F2-2
DR   Wikidata; Q127382663
WW   Info; RESOLUTE; CE05F2-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11009; SLC2A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A4-KO-c7
AC   CVCL_D4VS
SY   CE05F4-K
DR   Wikidata; Q127382664
WW   Info; RESOLUTE; CE05F4-K; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11009; SLC2A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A5-KO-c6
AC   CVCL_D4VT
SY   CE05F6-A
DR   Wikidata; Q127382666
WW   Info; RESOLUTE; CE05F6-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11010; SLC2A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A5-KO-c7
AC   CVCL_D4VU
SY   CE05F7-X
DR   Wikidata; Q127382667
WW   Info; RESOLUTE; CE05F7-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11010; SLC2A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A9-KO-c2
AC   CVCL_D4VV
SY   CE051A-H
DR   Wikidata; Q127382668
WW   Info; RESOLUTE; CE051A-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13446; SLC2A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC2A9-KO-c3
AC   CVCL_D4VW
SY   CE051B-Z
DR   Wikidata; Q127382669
WW   Info; RESOLUTE; CE051B-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13446; SLC2A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC37A1-KO-c2
AC   CVCL_D4VX
SY   CE0790-2
DR   Wikidata; Q127382670
WW   Info; RESOLUTE; CE0790-2; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11024; SLC37A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC37A1-KO-c3
AC   CVCL_D4VY
SY   CE0791-4
DR   Wikidata; Q127382671
WW   Info; RESOLUTE; CE0791-4; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11024; SLC37A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC46A3-KO-c1
AC   CVCL_D4VZ
SY   CE06KV-1
DR   Wikidata; Q127382672
WW   Info; RESOLUTE; CE06KV-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27501; SLC46A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC46A3-KO-c5
AC   CVCL_D4W0
SY   CE051F-C
DR   Wikidata; Q127382673
WW   Info; RESOLUTE; CE051F-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27501; SLC46A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC52A1-KO-c6
AC   CVCL_D4W1
SY   CE05SB-H
DR   Wikidata; Q127382674
WW   Info; RESOLUTE; CE05SB-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30225; SLC52A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC52A1-KO-c8
AC   CVCL_D4W2
SY   CE05SC-Z
DR   Wikidata; Q127382676
WW   Info; RESOLUTE; CE05SC-Z; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30225; SLC52A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC52A3-KO-c10
AC   CVCL_D4W3
SY   CE07BW-R
DR   Wikidata; Q127382677
WW   Info; RESOLUTE; CE07BW-R; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16187; SLC52A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC52A3-KO-c13
AC   CVCL_D4W4
SY   CE07BZ-5
DR   Wikidata; Q127382679
WW   Info; RESOLUTE; CE07BZ-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16187; SLC52A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC5A1-KO-c4
AC   CVCL_D4W5
SY   CE05FA-3
DR   Wikidata; Q127382680
WW   Info; RESOLUTE; CE05FA-3; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11036; SLC5A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC5A1-KO-c5
AC   CVCL_D4W6
SY   CE05FB-M
DR   Wikidata; Q127382681
WW   Info; RESOLUTE; CE05FB-M; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11036; SLC5A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC6A14-KO-c13
AC   CVCL_D4W7
SY   CE07C1-W
DR   Wikidata; Q127382682
WW   Info; RESOLUTE; CE07C1-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11047; SLC6A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC6A14-KO-c5
AC   CVCL_D4W8
SY   CE07C2-E
DR   Wikidata; Q127382683
WW   Info; RESOLUTE; CE07C2-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11047; SLC6A14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC6A20-KO-c2
AC   CVCL_D4W9
SY   CE0591-V
DR   Wikidata; Q127382684
WW   Info; RESOLUTE; CE0591-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30927; SLC6A20.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC6A20-KO-c4
AC   CVCL_D4WA
SY   CE0593-H
DR   Wikidata; Q127382685
WW   Info; RESOLUTE; CE0593-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30927; SLC6A20.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC7A4-KO-c3
AC   CVCL_D4WB
SY   CE05ER-1
DR   Wikidata; Q127382686
WW   Info; RESOLUTE; CE05ER-1; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11062; SLC7A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC7A4-KO-c4
AC   CVCL_D4WC
SY   CE05ES-W
DR   Wikidata; Q127382688
WW   Info; RESOLUTE; CE05ES-W; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11062; SLC7A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC9A2-KO-c2
AC   CVCL_D4WD
SY   CE053V-E
DR   Wikidata; Q127382690
WW   Info; RESOLUTE; CE053V-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11072; SLC9A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLC9A2-KO-c8
AC   CVCL_D4WE
SY   CE053X-7
DR   Wikidata; Q127382691
WW   Info; RESOLUTE; CE053X-7; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11072; SLC9A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLCO1B3-KO-c10
AC   CVCL_D4WF
SY   CE00C3-E
DR   Wikidata; Q127382693
WW   Info; RESOLUTE; CE00C3-E; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10961; SLCO1B3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLCO1B3-KO-c7
AC   CVCL_D4WG
SY   CE00C0-5
DR   Wikidata; Q127382694
WW   Info; RESOLUTE; CE00C0-5; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10961; SLCO1B3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLCO3A1-KO-c7
AC   CVCL_D4WH
SY   CE05FH-V
DR   Wikidata; Q127382695
WW   Info; RESOLUTE; CE05FH-V; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10952; SLCO3A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLCO3A1-KO-c9
AC   CVCL_D4WI
SY   CE05FK-N
DR   Wikidata; Q127382696
WW   Info; RESOLUTE; CE05FK-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10952; SLCO3A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLCO5A1-KO-c2
AC   CVCL_D4WJ
SY   CE0595-P
DR   Wikidata; Q127382697
WW   Info; RESOLUTE; CE0595-P; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19046; SLCO5A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SLCO5A1-KO-c9
AC   CVCL_D4WK
SY   CE0597-C
DR   Wikidata; Q127382698
WW   Info; RESOLUTE; CE0597-C; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19046; SLCO5A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SPNS2-KO-c15
AC   CVCL_D4WL
SY   CE0794-A
DR   Wikidata; Q127382700
WW   Info; RESOLUTE; CE0794-A; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26992; SPNS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SPNS2-KO-c19
AC   CVCL_D4WM
SY   CE0795-X
DR   Wikidata; Q127382701
WW   Info; RESOLUTE; CE0795-X; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26992; SPNS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SPNS3-KO-c3
AC   CVCL_D4WN
SY   CE05FC-T
DR   Wikidata; Q127382702
WW   Info; RESOLUTE; CE05FC-T; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28433; SPNS3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS180-SPNS3-KO-c6
AC   CVCL_D4WP
SY   CE05FE-F
DR   Wikidata; Q127382704
WW   Info; RESOLUTE; CE05FE-F; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28433; SPNS3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0397 ! LS180
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   LS2 [Human liposarcoma]
AC   CVCL_D3X8
DR   GEO; GSM484740
DR   GEO; GSM484741
DR   GEO; GSM484742
DR   GEO; GSM484745
DR   GEO; GSM484746
DR   Wikidata; Q127382706
RX   PubMed=20197395;
CC   Population: African American.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
DI   NCIt; C3705; Pleomorphic liposarcoma
DI   ORDO; Orphanet_99969; Pleomorphic liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   LS2 [Mouse fibroblast]
AC   CVCL_E7H0
RX   PubMed=7427939;
CC   Characteristics: Non tumorigenic. The parent cell line was cultivated in the peritoneal cavity of allogeneic non-immune BALB/c mice for 3 days. The cells that survived and propagated caused tumors in a number of C3Hf mice after subcutaneaous inoculation. Using one of these tumors, 8 passages in vivo in syngeneic mice were carried out to obtain this cell line (PubMed=7427939).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LS212-4A11-30-8
AC   CVCL_U729
SY   4A11
DR   ATCC; CRL-13015
DR   Wikidata; Q54903059
RX   Patent=US7038018;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-991.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
CC   Discontinued: ATCC; CRL-13015; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   LS212-7A2-32-1
AC   CVCL_U719
SY   7A2
DR   ATCC; CRL-13016
DR   Wikidata; Q54903060
RX   Patent=US7038018;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-992.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
CC   Discontinued: ATCC; CRL-13016; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   LS212-7F3-8-7
AC   CVCL_U730
SY   7F3
DR   ATCC; CRL-13014
DR   Wikidata; Q54903061
RX   Patent=US7038018;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-990.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
CC   Discontinued: ATCC; CRL-13014; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   LS212-9G2-7-2
AC   CVCL_U731
SY   9G2
DR   Wikidata; Q54903062
RX   Patent=US7038018;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O00574; Human CXCR6/CD186/Bonzo.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   LS274
AC   CVCL_N595
DR   Wikidata; Q54903063
RX   CelloPub=CLPUB00250;
RX   PubMed=10523844;
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N596 ! LS310
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   LS277
AC   CVCL_1D78
DR   Wikidata; Q54903064
RX   CelloPub=CLPUB00250;
RX   PubMed=10523844;
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   LS3
AC   CVCL_E7H1
RX   PubMed=7427939;
CC   Characteristics: Tumorigenic. The parent cell line was cultivated in the peritoneal cavity of allogeneic non-immune BALB/c mice for 3 days. The cells that survived and propagated caused tumors in a number of C3Hf mice after subcutaneaous inoculation. Using one of these tumors, 8 passages in vivo in syngeneic mice were carried out to obtain this cell line (PubMed=7427939).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LS310
AC   CVCL_N596
DR   Wikidata; Q54903065
RX   CelloPub=CLPUB00250;
RX   PubMed=10523844;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N595 ! LS274
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   LS4
AC   CVCL_E7H2
RX   PubMed=7427939;
CC   Characteristics: Tumorigenic. The parent cell line was cultivated in the peritoneal cavity of allogeneic non-immune BALB/c mice for 3 days. The cells that survived and propagated caused tumors in a number of C3Hf mice after subcutaneaous inoculation. Using one of these tumors, 8 passages in vivo in syngeneic mice were carried out to obtain this cell line (PubMed=7427939).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LS40
AC   CVCL_E759
DR   dbMHC; 48955
DR   ECACC; 85102910
DR   IHW; IHW09300
DR   IPD-IMGT/HLA; 11007
DR   Wikidata; Q54903068
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,26; B*27:05,40:01; C*02:02,03:04; DPB1*02:01,03:01; DRB1*04:04; DRB4*01:03 (IPD-IMGT/HLA=11007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   LS411N
AC   CVCL_1385
SY   LS-411N; LS-411; LS 411; LS411
DR   CLO; CLO_0007406
DR   CLO; CLO_0009968
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2159
DR   BioGRID_ORCS_Cell_line; 935
DR   BioSample; SAMN03472557
DR   BioSample; SAMN10988286
DR   cancercelllines; CVCL_1385
DR   Cell_Model_Passport; SIDM00660
DR   ChEMBL-Cells; CHEMBL3308268
DR   ChEMBL-Targets; CHEMBL2366189
DR   ColonAtlas; LS411
DR   Cosmic; 685868
DR   Cosmic; 887215
DR   Cosmic; 907794
DR   Cosmic; 948862
DR   Cosmic; 985999
DR   Cosmic; 995401
DR   Cosmic; 1043821
DR   Cosmic; 1310951
DR   Cosmic; 1312306
DR   Cosmic; 1479613
DR   Cosmic; 1995491
DR   Cosmic; 2301999
DR   Cosmic; 2760088
DR   Cosmic; 2800575
DR   Cosmic-CLP; 907794
DR   DepMap; ACH-000985
DR   EGA; EGAS00001000978
DR   GDSC; 907794
DR   GEO; GSM513913
DR   GEO; GSM514300
DR   GEO; GSM741269
DR   GEO; GSM887280
DR   GEO; GSM888355
DR   GEO; GSM1006219
DR   GEO; GSM1006220
DR   GEO; GSM1006221
DR   GEO; GSM1346848
DR   GEO; GSM1374637
DR   GEO; GSM1448140
DR   GEO; GSM1670061
DR   IARC_TP53; 21479
DR   IARC_TP53; 21751
DR   LiGeA; CCLE_191
DR   LINCS_LDP; LCL-1337
DR   MetaboLights; MTBLS227
DR   PharmacoDB; LS411N_863_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1385
DR   PubChem_Cell_line; CVCL_1385
DR   SKY/M-FISH/CGH; 5011
DR   Wikidata; Q54903069
RX   PubMed=1389533;
RX   PubMed=1617643;
RX   PubMed=8464898;
RX   PubMed=8895552;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11414198;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=23932154;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/LS411.html
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=25984343); ~24 hours (ATCC=CRL-2159).
CC   HLA typing: A*02:40,30:01; B*18:01,56:01; C*01:02,07:06; DQA1*03:02,05:02; DQB1*03:02,03:02; DRB1*11:04,13:47 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=24755471; PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln789Ter (c.2365C>T); ClinVar=VCV000092341; Zygosity=Heterozygous (PubMed=24755471; ATCC=CRL-2159; Cosmic-CLP=907794; DepMap=ACH-000985).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (PubMed=24755471; ATCC=CRL-2159; Cosmic-CLP=907794; DepMap=ACH-000985).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; ATCC=CRL-2159; Cosmic-CLP=907794; DepMap=ACH-000985).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys105Valfs*8 (c.313delT); ClinVar=VCV000940879; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907794; DepMap=ACH-000985).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys164Argfs*3 (c.491delA); ClinVar=VCV000189448; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=907794; DepMap=ACH-000985).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (PubMed=16418264; PubMed=24755471; Cosmic-CLP=907794; DepMap=ACH-000985).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.71%; Native American=0%; East Asian, North=2.86%; East Asian, South=0%; South Asian=7.57%; European, North=27.91%; European, South=59.95% (PubMed=30894373).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): ATCC=CRL-2159; Cosmic-CLP=907794; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10 (PubMed=25926053)
ST   CSF1PO: 10,11 (Cosmic-CLP=907794)
ST   CSF1PO: 10,11,12 (ATCC=CRL-2159)
ST   D13S317: 12,13,14 (Cosmic-CLP=907794; PubMed=25926053)
ST   D13S317: 12,13,14,16 (ATCC=CRL-2159)
ST   D16S539: 11,12 (Cosmic-CLP=907794; PubMed=25926053)
ST   D16S539: 11,12,13 (ATCC=CRL-2159)
ST   D18S51: 10,11
ST   D19S433: 13,14
ST   D21S11: 29,32,34
ST   D2S1338: 17,23,24
ST   D3S1358: 14,15
ST   D5S818: 9,15 (Cosmic-CLP=907794)
ST   D5S818: 9,15,16,17 (ATCC=CRL-2159)
ST   D5S818: 9,16 (PubMed=25926053)
ST   D7S820: 7.3,9.3 (ATCC=CRL-2159; PubMed=25926053)
ST   D7S820: 8,10 (Cosmic-CLP=907794)
ST   D8S1179: 11,12
ST   FGA: 18,22,24
ST   Penta D: 9,11
ST   Penta E: 10,12,19
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,16 (Cosmic-CLP=907794)
ST   vWA: 15,16,17 (ATCC=CRL-2159)
ST   vWA: 16,17 (PubMed=25926053)
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   LS411N/Cas9-hyg
AC   CVCL_C9EX
DR   GeneCopoeia; SL532
DR   Wikidata; Q123032977
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL532).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln789Ter (c.2365C>T); ClinVar=VCV000092341; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys105Valfs*8 (c.313delT); ClinVar=VCV000940879; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys164Argfs*3 (c.491delA); ClinVar=VCV000189448; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1385 ! LS411N
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   LS5
AC   CVCL_E7H3
RX   PubMed=7427939;
CC   Characteristics: Tumorigenic. The parent cell line was cultivated in the peritoneal cavity of allogeneic non-immune BALB/c mice for 3 days. The cells that survived and propagated caused tumors in a number of C3Hf mice after subcutaneaous inoculation. Using one of these tumors, 8 passages in vivo in syngeneic mice were carried out to obtain this cell line (PubMed=7427939).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LS501
AC   CVCL_B5X3
DR   Wikidata; Q112930024
RX   PubMed=8187845;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Donor information: Established from a patient suffering from acute nonlymphocytic leukemia.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 6
//
ID   LS513
AC   CVCL_1386
SY   LS-513; LS 513
DR   CLO; CLO_0007407
DR   CLO; CLO_0009969
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2134
DR   BioGRID_ORCS_Cell_line; 563
DR   BioSample; SAMN03472554
DR   BioSample; SAMN10987976
DR   cancercelllines; CVCL_1386
DR   CCRID; 3101HUMTCHu237
DR   Cell_Model_Passport; SIDM00677
DR   ChEMBL-Cells; CHEMBL3308841
DR   ChEMBL-Targets; CHEMBL2366311
DR   CLS; 300457
DR   ColonAtlas; LS513
DR   Cosmic; 711275
DR   Cosmic; 724844
DR   Cosmic; 887230
DR   Cosmic; 907795
DR   Cosmic; 983740
DR   Cosmic; 1132570
DR   Cosmic; 1310942
DR   Cosmic; 1479582
DR   Cosmic; 1609478
DR   Cosmic; 1708410
DR   Cosmic; 1995492
DR   Cosmic; 2302000
DR   Cosmic-CLP; 907795
DR   DepMap; ACH-000007
DR   EGA; EGAS00001000978
DR   GDSC; 907795
DR   GEO; GSM513914
DR   GEO; GSM514301
DR   GEO; GSM887281
DR   GEO; GSM888356
DR   GEO; GSM1006222
DR   GEO; GSM1006223
DR   GEO; GSM1006224
DR   GEO; GSM1346849
DR   GEO; GSM1374638
DR   GEO; GSM1448141
DR   GEO; GSM1670062
DR   IARC_TP53; 21480
DR   KCLB; 22134
DR   LiGeA; CCLE_369
DR   LINCS_LDP; LCL-1338
DR   PharmacoDB; LS513_864_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1386
DR   PubChem_Cell_line; CVCL_1386
DR   Wikidata; Q54903070
RX   PubMed=1389533;
RX   PubMed=1617643;
RX   PubMed=8895552;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=23932154;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 33.93 hours (PubMed=25944804); 20 hours (PubMed=25984343).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24755471; PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (ATCC=CRL-2134).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.3%; Native American=0%; East Asian, North=4.01%; East Asian, South=0%; South Asian=0%; European, North=52.68%; European, South=43% (PubMed=30894373).
CC   Derived from site: In situ; Intestine, ileocecal valve; UBERON=UBERON_0000569.
ST   Source(s): ATCC=CRL-2134; CLS=300457; Cosmic-CLP=907795; KCLB=22134; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (CLS=300457)
ST   CSF1PO: 10,13 (ATCC=CRL-2134; Cosmic-CLP=907795; KCLB=22134; PubMed=25926053)
ST   D13S317: 9,10
ST   D16S539: 12,13
ST   D18S51: 12,18
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 9,11 (ATCC=CRL-2134; Cosmic-CLP=907795; KCLB=22134; PubMed=25926053)
ST   D5S818: 11 (CLS=300457)
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 19,21
ST   Penta D: 9,14
ST   Penta E: 5,18
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   LS6
AC   CVCL_E7H4
RX   PubMed=7427939;
CC   Characteristics: Tumorigenic. The parent cell line was cultivated in the peritoneal cavity of allogeneic non-immune BALB/c mice for 3 days. The cells that survived and propagated caused tumors in a number of C3Hf mice after subcutaneaous inoculation. Using one of these tumors, 8 passages in vivo in syngeneic mice were carried out to obtain this cell line (PubMed=7427939).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LS7
AC   CVCL_E7H5
RX   PubMed=7427939;
CC   Characteristics: Tumorigenic. The parent cell line was cultivated in the peritoneal cavity of allogeneic non-immune BALB/c mice for 3 days. The cells that survived and propagated caused tumors in a number of C3Hf mice after subcutaneaous inoculation. Using one of these tumors, 8 passages in vivo in syngeneic mice were carried out to obtain this cell line (PubMed=7427939).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LS77-1C6
AC   CVCL_J161
SY   1C6
DR   CLO; CLO_0001159
DR   ATCC; HB-12330
DR   Wikidata; Q54903071
RX   Patent=US6184358;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12330.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49682; Human CXCR3/CD183.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   LS8
AC   CVCL_RW38
DR   Wikidata; Q54903072
RX   PubMed=1444889;
RX   PubMed=25120490;
RX   PubMed=30529249;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Tooth, enamel organ, dental epithelium; UBERON=UBERON_0003843.
CC   Cell type: Ameloblast; CL=CL_0000059.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Newborn
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   LS801
AC   CVCL_B5WX
DR   Wikidata; Q112930025
RX   PubMed=10706070;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
DI   NCIt; C2872; Refractory anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5WY ! LS802
OI   CVCL_B5WZ ! LS803
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   LS802
AC   CVCL_B5WY
DR   Wikidata; Q112930026
RX   PubMed=10706070;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
DI   NCIt; C2872; Refractory anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5WX ! LS801
OI   CVCL_B5WZ ! LS803
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   LS803
AC   CVCL_B5WZ
DR   Wikidata; Q112930027
RX   PubMed=10706070;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
DI   NCIt; C2872; Refractory anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5WX ! LS801
OI   CVCL_B5WY ! LS802
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   LSA-1
AC   CVCL_U410
SY   LSA-I
DR   Wikidata; Q54903073
RX   PubMed=1377975;
RX   PubMed=3006326;
WW   Info; EMA; -; https://www.ema.europa.eu/en/documents/scientific-discussion/virbagen-omega-epar-scientific-discussion_en.pdf
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9462.
CC   Characteristics: Secretes interferon-alpha.
CC   Transformant: NCBI_TaxID; 11780; Feline sarcoma virus (strain Snyder-Theilen).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   1Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   LSA-D4-C
AC   CVCL_A7MY
DR   Wikidata; Q107115876
RX   PubMed=1377975;
CC   Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity.
CC   Transformant: NCBI_TaxID; 11780; Feline sarcoma virus (strain Snyder-Theilen).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_U410 ! LSA-1
SX   Sex unspecified
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   LSA-D4-K17
AC   CVCL_A7MZ
DR   Wikidata; Q107115877
RX   PubMed=1377975;
CC   Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity.
CC   Transformant: NCBI_TaxID; 11780; Feline sarcoma virus (strain Snyder-Theilen).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_U410 ! LSA-1
SX   Sex unspecified
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   LSA-D6
AC   CVCL_A7NA
DR   Wikidata; Q107115878
RX   PubMed=1377975;
CC   Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity.
CC   Transformant: NCBI_TaxID; 11780; Feline sarcoma virus (strain Snyder-Theilen).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_A7MZ ! LSA-D4-K17
SX   Sex unspecified
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   LSB-AA695BB
AC   CVCL_Z279
DR   Wikidata; Q54903074
RX   PubMed=9302423;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Doubling time: ~24 hours (PubMed=9302423).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7167; ! Anopheles albimanus (New world malaria mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 8
//
ID   LSC-1
AC   CVCL_9U29
DR   Wikidata; Q54903075
RX   PubMed=26722391;
CC   Doubling time: 46 hours (PubMed=26722391).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   LSC-AXC-C/3
AC   CVCL_5H89
SY   C/3; C3
DR   Wikidata; Q54903076
RX   PubMed=2786746;
RX   PubMed=6713398;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   LSC-AXC-T/5
AC   CVCL_5H88
SY   T/5; T5
DR   ChEMBL-Cells; CHEMBL3307913
DR   ChEMBL-Targets; CHEMBL614306
DR   PubChem_Cell_line; CVCL_5H88
DR   Wikidata; Q54903078
RX   PubMed=2786746;
RX   PubMed=6713398;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   Lscc-02
AC   CVCL_E320
DR   Wikidata; Q54903079
RX   PubMed=16383303;
CC   Population: Chinese.
CC   Characteristics: Established from tumor tissue after 2 passages in nude mice.
CC   Doubling time: ~39.1 hours (PubMed=16383303).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LSCC-1104B1
AC   CVCL_T678
SY   LSCC-1104-B1; LSCC-1104-B-1; 1104B-1; 1104B1; 1104-B; 1104B
DR   Wikidata; Q54903080
RX   PubMed=69431;
RX   PubMed=797387;
RX   PubMed=3273463;
RX   PubMed=4375792;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 11.0 hours (PubMed=3273463).
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: White Leghorn line 15.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T679 ! LSCC-1104X5
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   LSCC-1104X5
AC   CVCL_T679
SY   1104-X-5; 1104-X5
DR   Wikidata; Q54903081
RX   PubMed=69431;
RX   PubMed=4375792;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: White Leghorn line 15.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T678 ! LSCC-1104B1
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   LSCC-BK2
AC   CVCL_T475
SY   BK 4480; BK2
DR   Wikidata; Q54903082
RX   PubMed=6268044;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: White Leghorn line BK.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   LSCC-BK25
AC   CVCL_WI28
SY   BK25; Bk25; BK2544-1
DR   Wikidata; Q95983128
RX   PubMed=2425031;
RX   PubMed=3855549;
RX   PubMed=6190569;
RX   PubMed=9032273;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: White Leghorn line BK.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   LSCC-BK3
AC   CVCL_T476
SY   BK 4484; BK3
DR   Wikidata; Q54903083
RX   PubMed=6268044;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: White Leghorn line BK.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   LSCC-BK3A
AC   CVCL_T680
SY   LSCC-BK3 clone A; BK3A; BK3a
DR   Wikidata; Q54903084
RX   PubMed=2425031;
RX   PubMed=3855549;
RX   PubMed=9032273;
RX   PubMed=9524935;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: White Leghorn line BK.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_T476 ! LSCC-BK3
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   LSCC-BK3C2
AC   CVCL_T681
SY   LSCC-BK3 clone C2; BK3C2
DR   Wikidata; Q54903085
RX   PubMed=9524935;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Breed/subspecies: White Leghorn line BK.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_T476 ! LSCC-BK3
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   LSCC-H32
AC   CVCL_D161
DR   Wikidata; Q54903086
RX   PubMed=2581511;
RX   PubMed=6293961;
RX   PubMed=10954914;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of chicken origin but found to be from quail (PubMed=10954914).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_D160 ! CEC-32
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   LSCC-HD11
AC   CVCL_4685
SY   LSCC HD11; HD-11; HD11
DR   BTO; BTO_0003643
DR   BCRJ; 0099
DR   Wikidata; Q54903087
RX   PubMed=227607;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   LSCC-HD2
AC   CVCL_6A89
SY   LSCC HD2; HD2
DR   Wikidata; Q54903088
RX   PubMed=6279674;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   LSCC-HD3
AC   CVCL_H256
SY   LSCC HD3; HD3
DR   Wikidata; Q54903089
RX   PubMed=6279674;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   LSCC-HD4
AC   CVCL_6A90
SY   LSCC HD4; HD4
DR   Wikidata; Q54903090
RX   PubMed=6279674;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   LSCC-NV1
AC   CVCL_T643
SY   NV1
DR   Wikidata; Q54903091
RX   PubMed=6605442;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   LSCC-PR2
AC   CVCL_T644
SY   PR2
DR   Wikidata; Q54903092
RX   PubMed=18766641;
RX   PubMed=18770161;
CC   Group: Bird cell line.
CC   Doubling time: 1.1 days (PubMed=18770161).
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C134558; Chicken hepatoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   LSCC-RP12
AC   CVCL_T443
SY   RP12; RP-12
DR   Wikidata; Q54903093
RX   PubMed=18766641;
RX   PubMed=18770270;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11948; Rous-associated virus type 2.
DI   NCIt; C135004; Chicken lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T444 ! LSCC-RP9
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   LSCC-RP9
AC   CVCL_T444
SY   RP9; RP-9
DR   CLO; CLO_0037204
DR   Wikidata; Q54903094
RX   PubMed=3496613;
RX   PubMed=3855549;
RX   PubMed=6190569;
RX   PubMed=18766641;
RX   PubMed=18770270;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11948; Rous-associated virus type 2.
DI   NCIt; C135004; Chicken lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T443 ! LSCC-RP12
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   LSCC-SF-Mc29
AC   CVCL_T445
SY   LSCC-SF-MC29; LSCC-SF(Mc29)
DR   Wikidata; Q54903095
RX   CelloPub=CLPUB00134;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C134558; Chicken hepatoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   LSCC-VA1
AC   CVCL_T478
DR   Wikidata; Q54903096
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   LSCC-VA2
AC   CVCL_T479
DR   Wikidata; Q54903097
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11866; Avian myeloblastosis virus (AMV).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   LSCEF61
AC   CVCL_X636
SY   LangShan Chicken Embryonic Fibroblast 61
DR   Wikidata; Q54903099
RX   PubMed=20447061;
CC   Group: Bird cell line.
CC   Doubling time: 49.5 hours (PubMed=20447061).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Langshan; VBO=VBO_0000558.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
AG   9FD
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   LSCTRi001-A
AC   CVCL_VE29
SY   LSCTR-LiPSC-6
DR   hPSCreg; LSCTRi001-A
DR   SKIP; SKIP002983
DR   Wikidata; Q54903100
RX   PubMed=29310059;
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Homozygous; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (PubMed=29310059).
CC   Sequence variation: Mutation; HGNC; HGNC:2638; CYP3A5; Simple; c.219-237G>A; ClinVar=VCV000226021; Zygosity=Homozygous; Note=Aberrant splice site. CYP3A5*3C allele (PubMed=29310059).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   LSCTRi002-A
AC   CVCL_VE30
SY   LSCTR-LiPSC-2
DR   hPSCreg; LSCTRi002-A
DR   Wikidata; Q54903101
RX   PubMed=30071395;
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2638; CYP3A5; Simple; c.219-237G>A; ClinVar=VCV000226021; Zygosity=Homozygous; Note=Aberrant splice site. CYP3A5*3C allele (PubMed=30071395).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   LSCTRi003-A
AC   CVCL_VE31
SY   LSCTR-LiPSC-3
DR   hPSCreg; LSCTRi003-A
DR   Wikidata; Q54903102
RX   PubMed=30071395;
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Homozygous; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (PubMed=30071395).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   LSCTRi004-A
AC   CVCL_VE32
SY   LSCTR-LiPSC-10
DR   hPSCreg; LSCTRi004-A
DR   Wikidata; Q54903103
RX   PubMed=30071395;
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   LSCTRi005-A
AC   CVCL_UM08
SY   LSCTR-LiPSC-1; i1
DR   hPSCreg; LSCTRi005-A
DR   Wikidata; Q95983154
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   LSCTRi006-A
AC   CVCL_UM09
SY   LSCTR-LiPSC-4; i4
DR   BioSamples; SAMEA111456267
DR   hPSCreg; LSCTRi006-A
DR   Wikidata; Q95983156
RX   PubMed=36399926;
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Pro34Ser (c.100C>T); ClinVar=VCV000016893; Zygosity=Homozygous; Note=CYP2D6*10 allele (PubMed=36399926).
CC   Sequence variation: Mutation; HGNC; HGNC:2638; CYP3A5; Simple; c.219-237G>A; ClinVar=VCV000226021; Zygosity=Homozygous; Note=Aberrant splice site. CYP3A5*3C allele (PubMed=36399926).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   LSCTRi007-A
AC   CVCL_UM10
SY   LSCTR-LiPSC-5; i5
DR   BioSamples; SAMEA111533748
DR   hPSCreg; LSCTRi007-A
DR   Wikidata; Q95983158
RX   PubMed=36399926;
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2621; CYP2C19; Simple; p.Pro227Pro (c.681G>A); ClinVar=VCV000016897; Zygosity=Homozygous; Note=Cryptic splice acceptor activation. CYP2C19*2 allele (PubMed=36399926).
CC   Sequence variation: Mutation; HGNC; HGNC:2625; CYP2D6; Simple; p.Pro34Ser (c.100C>T); ClinVar=VCV000016893; Zygosity=Homozygous; Note=CYP2D6*10 allele (PubMed=36399926).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   LSCTRi008-A
AC   CVCL_UM11
SY   LSCTR-LiPSC-7; i7
DR   hPSCreg; LSCTRi008-A
DR   Wikidata; Q95983160
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   LSCTRi009-A
AC   CVCL_UM12
SY   LSCTR-LiPSC-8; i8
DR   hPSCreg; LSCTRi009-A
DR   Wikidata; Q95983163
CC   From: Laboratory of Stem Cells and Tissue Regeneration, Korea University; Seoul; South Korea.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   LSD-5
AC   CVCL_D7EC
RX   CelloPub=CLPUB00770;
RX   PubMed=1612780;
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   35Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   LSEC line
AC   CVCL_QY34
SY   Liver Sinusoidal Endothelial Cell line
DR   Wikidata; Q54903098
RX   PubMed=20302755;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   LSh0038
AC   CVCL_VB54
DR   ECACC; 15102980
DR   Wikidata; Q54903104
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   LSHM7
AC   CVCL_J319
DR   Cosmic; 687533
DR   Wikidata; Q54903105
RX   PubMed=12068308;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   LSJ-1
AC   CVCL_EG97
SY   LSJ1
DR   Wikidata; Q54903106
RX   PubMed=18442641;
WW   Provider; HESC; -; https://med.stanford.edu/hesc/research/corefacility/distributions.html
CC   From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   LSJ-2
AC   CVCL_EG98
SY   LSJ2
DR   GEO; GSM738199
DR   GEO; GSM738202
DR   Wikidata; Q54903107
RX   PubMed=18442641;
WW   Provider; HESC; -; https://med.stanford.edu/hesc/research/corefacility/distributions.html
CC   From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   LSJ-3
AC   CVCL_EG99
DR   Wikidata; Q54903108
CC   From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   LSJ-4
AC   CVCL_EH00
DR   Wikidata; Q54903112
CC   From: Stanford University Center for Human Embryonic Stem Cell Research and Education; Stanford; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   LSM 2.7
AC   CVCL_IU06
DR   Wikidata; Q54903113
RX   Patent=US4529694;
RX   PubMed=6365856;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8121.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2516 ! HS-Sultan
CA   Hybrid cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 5
//
ID   LSP.M2
AC   CVCL_EG59
SY   LSP M2; LSPM2
DR   GEO; GSM78846
DR   GEO; GSM78847
DR   GEO; GSM78848
DR   GEO; GSM78849
DR   GEO; GSM78850
DR   GEO; GSM78851
DR   Wikidata; Q54903114
CC   From: Boyd, Andrew Wallace; Queensland Institute of Medical Research; Brisbane; Australia.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 5
//
ID   LSQC-1
AC   CVCL_T631
DR   Wikidata; Q54903115
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-11
AC   CVCL_T638
DR   Wikidata; Q54903116
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-14
AC   CVCL_T639
DR   Wikidata; Q54903117
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-17
AC   CVCL_T640
DR   Wikidata; Q54903118
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-18
AC   CVCL_T641
DR   Wikidata; Q54903119
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-1C
AC   CVCL_T632
DR   Wikidata; Q54903120
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-2
AC   CVCL_T633
DR   Wikidata; Q54903121
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-23
AC   CVCL_T642
DR   Wikidata; Q54903122
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-3C
AC   CVCL_T634
DR   Wikidata; Q54903123
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-6
AC   CVCL_T635
DR   Wikidata; Q54903124
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-7
AC   CVCL_T636
DR   Wikidata; Q54903125
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-9C
AC   CVCL_T637
SY   OK10 QDP 9C; 9C
DR   Wikidata; Q54903126
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   LSQC-OK10QB5
AC   CVCL_9Y57
SY   OK10 QB5; OK10 Q B5
DR   Wikidata; Q54903127
RX   PubMed=6158166;
RX   PubMed=6202653;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11871; Avian myelocytomatosis virus OK10.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Q/BCD.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   LSR-SF (SR)
AC   CVCL_0J67
SY   LSR-SF-SR
DR   Wikidata; Q54903128
RX   CelloPub=CLPUB00235;
RX   PubMed=8678827;
CC   Doubling time: ~48 hours (CelloPub=CLPUB00235).
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 7
//
ID   LSR-SF (SR)-D12
AC   CVCL_C8YH
SY   D12
DR   Wikidata; Q123032978
RX   PubMed=8678827;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0J67 ! LSR-SF (SR)
SX   Male
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   LSR-SF (SR)-F7
AC   CVCL_C8YI
SY   F7
DR   Wikidata; Q123032979
RX   PubMed=8678827;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0J67 ! LSR-SF (SR)
SX   Male
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   LST-R1
AC   CVCL_E054
SY   Laterally Spreading Tumor-Rectum 1
DR   Wikidata; Q54903129
RX   PubMed=18300345;
CC   Population: Chinese.
CC   Doubling time: 36 hours (PubMed=18300345).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   LSTM-AA-20
AC   CVCL_Z353
SY   Mos. 20; Mos 20; Mos-20; Mos20; Mosquito tissue culture No. 20; A20
DR   Wikidata; Q54903130
RX   DOI=10.1007/BF00919719;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=5360492;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   LSTM-AA-20A
AC   CVCL_Z354
SY   Mos. 20A; Mos 20(A); Mos 20 A; Mos 20A; Mos-20A; Mosquito tissue culture No. 20A; AA-20A; 20A
DR   Wikidata; Q54903131
RX   CelloPub=CLPUB00466;
RX   DOI=10.1007/BF00919719;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   DOI=10.17037/PUBS.04656048;
RX   PubMed=5360492;
CC   Group: Insect cell line.
CC   Doubling time: ~24 hours (Note=In MM/VP12 medium), ~24 hours (Note=In L-15 medium) (DOI=10.17037/PUBS.04656048).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
HI   CVCL_Z353 ! LSTM-AA-20
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 13
//
ID   LSTM-AA-29
AC   CVCL_Z355
SY   Mos. 29; Mos 29; Mos-29; Mosquito tissue culture No. 29
DR   Wikidata; Q54903132
RX   DOI=10.1007/BF00919719;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   PubMed=5360492;
CC   Group: Insect cell line.
CC   Doubling time: 29 hours (PubMed=5360492).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   LSTM-AA-63
AC   CVCL_Z363
DR   Wikidata; Q54903133
RX   DOI=10.1007/BF00919719;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   LSTM-AG-55
AC   CVCL_Z360
SY   Mos. 55; Mos 55; Mos-55; Mos.55; Mos55; MOS-55; Mosquito tissue culture No. 55; An. gambiae 55; AG-55; AG55; Ag55; MSQ55; MSQ 55; 55
DR   Wikidata; Q54903134
RX   CelloPub=CLPUB00466;
RX   DOI=10.1007/BF00919719;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   DOI=10.17037/PUBS.04656048;
RX   PubMed=2563994;
RX   PubMed=4150034;
RX   PubMed=5048073;
RX   PubMed=9662473;
RX   PubMed=18836024;
RX   PubMed=20338056;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_1c16f776df
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_819b6b9a4d
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Virology: Susceptible to infection by Tahyna orthobunyavirus (TAHV). Not susceptible to infection by Calovo virus (CVOV) and tick-borne encephalitis virus (TBEV) (PubMed=4150034).
CC   Doubling time: ~6 hours (Note=In MM/VP12 medium), ~18 hours (Note=In L-15 medium) (DOI=10.17037/PUBS.04656048).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7165; ! Anopheles gambiae (African malaria mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   LSTM-AM-60
AC   CVCL_Z361
SY   Mos. 60; Mos 60; Mos-60; Mosquito tissue culture No. 60; AM-60; AM60; 60
DR   Wikidata; Q54903135
RX   CelloPub=CLPUB00466;
RX   DOI=10.1007/BF00919719;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.17037/PUBS.04656048;
RX   PubMed=4458148;
CC   Group: Insect cell line.
CC   Doubling time: ~36 hours (Note=In MM/VP12 medium), ~32 hours (Note=In L-15 medium) (DOI=10.17037/PUBS.04656048).
OX   NCBI_TaxID=1424567; ! Aedes malayensis (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LSTM-AP-61
AC   CVCL_Z362
SY   Mos. 61; Mos 61; Mos-61; Mosquito tissue culture No. 61; AP-61; AP61; 61
DR   Wikidata; Q54903136
RX   CelloPub=CLPUB00466;
RX   DOI=10.1007/BF00919719;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.17037/PUBS.04656048;
RX   PubMed=5385;
RX   PubMed=2563994;
RX   PubMed=2861916;
RX   PubMed=4458148;
RX   PubMed=6126429;
RX   PubMed=6137452;
RX   PubMed=9768212;
CC   Group: Insect cell line.
CC   Doubling time: ~36 hours (Note=In MM/VP12 medium), ~44 hours (Note=In L-15 medium) (DOI=10.17037/PUBS.04656048).
OX   NCBI_TaxID=316597; ! Aedes pseudoscutellaris (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   LSTM-AS-43
AC   CVCL_Z356
SY   Mos. 43; Mos 43; Mos-43; Mos.43; Mosquito tissue culture No. 43; MSQ43; An. stephensi 43; AS-43; As43; 43
DR   BEI_Resources; MRA-858
DR   Wikidata; Q54903137
RX   CelloPub=CLPUB00466;
RX   DOI=10.1007/BF00919719;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   DOI=10.17037/PUBS.04656048;
RX   PubMed=2563994;
RX   PubMed=5545029;
RX   PubMed=6126429;
RX   PubMed=20338056;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_66ad477873
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_90f70641c5
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_b9acc342df
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Doubling time: ~15 hours (Note=In MM/VP12 medium), ~15 hours (Note=In L-15 medium) (DOI=10.17037/PUBS.04656048).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=30069; ! Anopheles stephensi (Indo-Pakistan malaria mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   LSTM-AS-44
AC   CVCL_Z357
SY   Mos. 44; Mos 44; Mos-44; Mosquito tissue culture No. 44
DR   Wikidata; Q54903139
RX   DOI=10.1007/BF00919719;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
OX   NCBI_TaxID=30069; ! Anopheles stephensi (Indo-Pakistan malaria mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 6
//
ID   LSTM-AS-45
AC   CVCL_Z358
SY   Mos. 45; Mos 45; Mos-45; Mosquito tissue culture No. 45
DR   Wikidata; Q54903140
RX   DOI=10.1007/BF00919719;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
OX   NCBI_TaxID=30069; ! Anopheles stephensi (Indo-Pakistan malaria mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 6
//
ID   LSTM-AS-46
AC   CVCL_Z359
SY   Mos. 46; Mos 46; Mos-46; Mosquito tissue culture No. 46
DR   Wikidata; Q54903141
RX   DOI=10.1007/BF00919719;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
OX   NCBI_TaxID=30069; ! Anopheles stephensi (Indo-Pakistan malaria mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 6
//
ID   LSTM-BM-256
AC   CVCL_Z139
SY   BM-256; TTC-256
DR   Wikidata; Q54903142
RX   PubMed=4760627;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line no longer available (personal communication of Pudney, Mary to Bell-Sakyi, Lesley).
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   LSTM-BM-270
AC   CVCL_Z138
SY   BM-270; BM270
DR   Wikidata; Q54903143
RX   CelloPub=CLPUB00496;
RX   DOI=10.1007/BF00919720;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line no longer available (personal communication of Pudney, Mary to Bell-Sakyi, Lesley).
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   LSTM-RA-219
AC   CVCL_Z135
SY   RA-219; TTC-219
DR   Wikidata; Q54903144
RX   PubMed=1123829;
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line probably no longer available; no published report since 1987 (personal communication of Bell-Sakyi, Lesley).
OX   NCBI_TaxID=34631; ! Rhipicephalus appendiculatus (Brown ear tick)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   LSTM-RA-243
AC   CVCL_Z136
SY   RA-243; RA 243; RA243; TTC-243; TTC 243
DR   Wikidata; Q54903145
RX   DOI=10.1007/BF00919720;
RX   PubMed=1123829;
RX   PubMed=6126429;
RX   PubMed=7131199;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34631; ! Rhipicephalus appendiculatus (Brown ear tick)
SX   Sex unspecified
AG   Moulting nymph
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   LSTM-RA-257
AC   CVCL_Z137
SY   RA-257; RA257; TTC-257
DR   Wikidata; Q54903146
RX   PubMed=1123829;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34631; ! Rhipicephalus appendiculatus (Brown ear tick)
SX   Sex unspecified
AG   Moulting nymph
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   LSTM-TI-32
AC   CVCL_Z352
SY   TI-32; BTC-32; BTC 32
DR   Wikidata; Q54903147
RX   DOI=10.1111/j.1550-7408.1983.tb05338.x;
RX   PubMed=43891;
RX   PubMed=322623;
RX   PubMed=3333490;
CC   Group: Insect cell line.
CC   Doubling time: 48 hours (PubMed=322623).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=30076; ! Triatoma infestans (Assassin bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   LSTRA
AC   CVCL_J301
DR   Wikidata; Q54903148
RX   PubMed=75945;
RX   PubMed=185295;
RX   PubMed=315438;
RX   PubMed=564410;
RX   PubMed=4867923;
RX   PubMed=6064953;
RX   PubMed=6327281;
RX   PubMed=6543243;
RX   PubMed=6970130;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 8
//
ID   LSV5
AC   CVCL_E3C4
RX   PubMed=8612705;
CC   Doubling time: 18 hours (PubMed=8612705).
CC   Sequence variation: Mutation; HGNC; HGNC:6493; LAMC2; Simple; p.Arg95Ter (c.283C>T); ClinVar=VCV000014555; Zygosity=Homozygous (PubMed=8612705).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain 323).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C210893; Severe junctional epidermolysis bullosa 3B
DI   ORDO; Orphanet_79404; Severe generalized junctional epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   LT
AC   CVCL_8891
DR   CLO; CLO_0007408
DR   ECACC; 96061947
DR   Wikidata; Q54903149
CC   Discontinued: ECACC; 96061947; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Smooth muscle cell; CL=CL_0000192.
DI   NCIt; C38153; Lung lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   LT C-7
AC   CVCL_Z618
SY   LT-C7
DR   Wikidata; Q54903150
RX   DOI=10.1002/arch.940030307;
RX   PubMed=196393;
RX   PubMed=6287221;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z223 ! ATC-15
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   LT-1 [Contaminated frog cell line]
AC   CVCL_1R49
DR   BioSample; SAMN03151968
DR   Wikidata; Q54903151
RX   PubMed=304896;
RX   PubMed=4367239;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Fish cell line.
CC   Group: Reptilian cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Lithobates pipiens (frog) origin but found to be a complex mixture of Pimephales promelas FHM and Terrapene carolina TH-1 (PubMed=304896; PubMed=6451928; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00073.
OX   NCBI_TaxID=90988; ! Pimephales promelas (Fathead minnow)
OX   NCBI_TaxID=158814; ! Terrapene carolina (Eastern box turtle)
HI   CVCL_3820 ! FHM
HI   CVCL_4324 ! TH-1 subline B1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   LT-1 [Mouse]
AC   CVCL_8062
DR   Wikidata; Q54903152
RX   PubMed=2785856;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LT-1
CC   Characteristics: Expression of Il4 is under the control of a promoter/enhancer from M-MuLV LTR (PubMed=2785856).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96556; Il4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   LT003
AC   CVCL_F0B3
SY   14C12
DR   CCRID; 4201PAT-CCTCC00711
RX   Patent=US12076398;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015105.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LT006
AC   CVCL_A0NX
SY   IL-17A-13E9
DR   CCRID; 4201PAT-CCTCC01087
DR   Wikidata; Q108820803
RX   Patent=US20210122815;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017102.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16552; Human IL17A.
CC   Misspelling: T006; CCRID=4201PAT-CCTCC01087.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   LT007
AC   CVCL_A0NY
SY   IL-17A-2G2
DR   CCRID; 4201PAT-CCTCC01088
DR   Wikidata; Q108820804
RX   Patent=US20210122815;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017165.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q16552; Human IL17A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   LT012
AC   CVCL_C4MK
SY   6F7; CD47-6F7
DR   CCRID; 4201PAT-CCTCC01255
DR   Wikidata; Q116049719
RX   Patent=WO2022218384A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018135.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q08722; Human CD47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LT05s-p
AC   CVCL_F1GY
WW   Provider; ARI-TOX MWCB; LT05s-p; https://aritox.com/mwcb/mwcb-lt05s-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=8467; ! Caretta caretta (Loggerhead sea turtle)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LT06b-p
AC   CVCL_F1GZ
WW   Provider; ARI-TOX MWCB; LT06b-p; https://aritox.com/mwcb/mwcb-lt06b-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8467; ! Caretta caretta (Loggerhead sea turtle)
OI   CVCL_F1H0 ! LT06h-p
OI   CVCL_F1H1 ! LT06s-p
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LT06h-p
AC   CVCL_F1H0
WW   Provider; ARI-TOX MWCB; LT06h-p; https://aritox.com/mwcb/mwcb-lt06h-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=8467; ! Caretta caretta (Loggerhead sea turtle)
OI   CVCL_F1GZ ! LT06b-p
OI   CVCL_F1H1 ! LT06s-p
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LT06s-p
AC   CVCL_F1H1
WW   Provider; ARI-TOX MWCB; LT06s-p; https://aritox.com/mwcb/mwcb-lt06s-p/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=8467; ! Caretta caretta (Loggerhead sea turtle)
OI   CVCL_F1GZ ! LT06b-p
OI   CVCL_F1H0 ! LT06h-p
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LT1/41-H1
AC   CVCL_9Y76
DR   Wikidata; Q54903155
RX   Patent=US5087557;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9128.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 8
//
ID   LT12
AC   CVCL_D271
SY   LT-12; IPC-81
DR   ChEMBL-Cells; CHEMBL3307863
DR   ChEMBL-Targets; CHEMBL614098
DR   PubChem_Cell_line; CVCL_D271
DR   Wikidata; Q54903156
RX   PubMed=2195239;
RX   PubMed=3480794;
RX   PubMed=6574296;
CC   Breed/subspecies: Brown Norway; RS=RS_0000113.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   LT1e-OLIG2GFP
AC   CVCL_U170
SY   R-Olig2
DR   WiCell; lt1e-olig2gfp
DR   Wikidata; Q54903157
RX   PubMed=19544414;
CC   Characteristics: An EGFP cassette is inserted to the OLIG2 locus via homologous recombination.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=lt1e-olig2gfp
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9726 ! BG01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 13
//
ID   LT2 [Human immortalized pancreatic mesenchymal]
AC   CVCL_E923
DR   Millipore; SCR013
DR   Wikidata; Q54903158
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   LT2 [Human vulvar squamous cell carcinoma]
AC   CVCL_HX23
DR   Wikidata; Q54903159
RX   PubMed=686047;
CC   Doubling time: ~32 hours (PubMed=686047).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   LT215
AC   CVCL_VU35
SY   Lung Tumor 215
DR   Wikidata; Q95983214
RX   PubMed=26514616;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 5
//
ID   LT259
AC   CVCL_VU36
SY   Lung Tumor 259
DR   Wikidata; Q95983216
RX   PubMed=26514616;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C45540; Lung sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 5
//
ID   LT2e-H9CAGGFP
AC   CVCL_U171
DR   WiCell; lt2e-h9caggfp
DR   Wikidata; Q54903160
RX   PubMed=21699412;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=lt2e-h9caggfp
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   LT4
AC   CVCL_T727
DR   Wikidata; Q54903161
RX   PubMed=3079807;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Factor-dependent cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   LT4Tr
AC   CVCL_T728
DR   CLO; CLO_0050772
DR   RCB; RCB0120
DR   Wikidata; Q54903162
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T727 ! LT4
SX   Female
CA   Factor-dependent cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   LT73
AC   CVCL_VU37
SY   Lung Tumor 73
DR   Wikidata; Q95983252
RX   PubMed=26141860;
RX   PubMed=26514616;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   LT97
AC   CVCL_A9BJ
SY   LT97-1
DR   cancercelllines; CVCL_A9BJ
DR   IARC_TP53; 25023
DR   Wikidata; Q108820805
RX   DOI=10.25365/thesis.6275;
RX   PubMed=12204677;
RX   PubMed=12714179;
RX   PubMed=17708598;
RX   PubMed=27996158;
CC   Characteristics: Contains 2 subpopulations of cells, one CD44+, the other CD44- (PubMed=17708598).
CC   Doubling time: ~96 hours (DOI=10.25365/thesis.6275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:583; APC; Zygosity=Homozygous (PubMed=12204677).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12204677; PubMed=17708598).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Arg (c.770T>G); ClinVar=VCV000142134; Zygosity=Heterozygous (PubMed=17708598).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1100+30A>T; ClinVar=VCV000810938; Zygosity=Heterozygous (PubMed=17708598).
CC   Miscellaneous: STR profile mentioned in PubMed=27996158 but obtained from personal communication of Schlormann, Wiebke.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=27996158
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C5673; Colorectal adenoma
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   LT97-2
AC   CVCL_D5XV
DR   Wikidata; Q127382707
RX   DOI=10.25365/thesis.6275;
CC   Characteristics: Are 10-70% CD44+ (DOI=10.25365/thesis.6275).
CC   Doubling time: 72-96 hours (DOI=10.25365/thesis.6275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:583; APC; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Arg (c.770T>G); ClinVar=VCV000142134; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1100+30A>T; ClinVar=VCV000810938; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C5673; Colorectal adenoma
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9BJ ! LT97
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LT97-3
AC   CVCL_D5XW
DR   Wikidata; Q127382708
RX   DOI=10.25365/thesis.6275;
CC   Characteristics: Are 90-100% CD44+ (DOI=10.25365/thesis.6275).
CC   Doubling time: 48-72 hours (DOI=10.25365/thesis.6275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:583; APC; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Arg (c.770T>G); ClinVar=VCV000142134; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1100+30A>T; ClinVar=VCV000810938; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C5673; Colorectal adenoma
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5XV ! LT97-2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LTAg2B
AC   CVCL_M430
DR   Wikidata; Q54903163
RX   PubMed=1724784;
CC   Doubling time: ~24 hours (PubMed=1724784).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TEX).
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   LTAg2B subclone cl.1D
AC   CVCL_C4TI
DR   Wikidata; Q116049720
RX   PubMed=1724784;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TEX).
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M430 ! LTAg2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   LTAg2B subclone cl.2C
AC   CVCL_C4TJ
DR   Wikidata; Q116049721
RX   PubMed=1724784;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TEX).
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M430 ! LTAg2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   LTAg2B subclone cl.4C
AC   CVCL_C4TK
DR   Wikidata; Q116049722
RX   PubMed=1724784;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TEX).
CC   Derived from site: In situ; Brain, leptomeninges; UBERON=UBERON_0000391.
CC   Cell type: Leptomeningeal cell; CL=CL_0000708.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M430 ! LTAg2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   LTC 86
AC   CVCL_6D55
SY   LTC86
DR   Wikidata; Q54903164
RX   PubMed=16089086;
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60376; Rat chondrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_S123 ! RCS-LTC
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   LTC 93
AC   CVCL_6D56
SY   LTC93
DR   Wikidata; Q54903165
RX   PubMed=16089086;
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60376; Rat chondrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_S123 ! RCS-LTC
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   LTC clone Ng
AC   CVCL_6D57
SY   Ng
DR   Wikidata; Q54903166
RX   PubMed=12874833;
RX   PubMed=16089086;
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60376; Rat chondrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_S123 ! RCS-LTC
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   LTC clone Rex
AC   CVCL_6D58
SY   Rex
DR   Wikidata; Q54903167
RX   PubMed=12874833;
RX   PubMed=16089086;
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60376; Rat chondrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_S123 ! RCS-LTC
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   LTC-14
AC   CVCL_DF07
SY   Large T immortalized Cells-14
DR   Wikidata; Q54903168
RX   PubMed=14977634;
CC   Doubling time: 20.6 +- 2.9 hours (PubMed=14977634).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: Lewis LEW.1W.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   LTC-7
AC   CVCL_DF08
SY   Large T immortalized Cells-7
DR   Wikidata; Q54903169
RX   PubMed=14977634;
CC   Doubling time: 15.4 +- 3.2 hours (PubMed=14977634).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: Lewis LEW.1W.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   LTEP-78
AC   CVCL_6927
SY   LTEP78
DR   Wikidata; Q54903170
RX   PubMed=7297395;
CC   Population: Chinese.
CC   Doubling time: 96 hours (PubMed=7297395).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   LTEP-a1
AC   CVCL_6928
SY   LTEP-A1; LTEP-a-1
DR   Wikidata; Q54903171
RX   PubMed=2988714;
RX   PubMed=3471311;
RX   PubMed=6872840;
CC   Population: Chinese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   LTEP-a2
AC   CVCL_6929
SY   LTEP-A2; LTEP a2; LTEP-a-2; LTEPa2
DR   CCTCC; GDC0209
DR   Cosmic; 2664118
DR   Wikidata; Q54903172
RX   PubMed=1889334;
RX   PubMed=2988714;
RX   PubMed=3471311;
RX   PubMed=6872840;
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 46 year old female patient with a lung adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00576.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000700033). It was one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   LTEP-a3
AC   CVCL_HA47
DR   Wikidata; Q54903173
RX   PubMed=2988714;
CC   Population: Chinese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 6
//
ID   LTEP-s
AC   CVCL_6930
SY   LTEP-S
DR   CCRID; 1101HUM-PUMC000330
DR   CCRID; 4201HUM-CCTCC00317
DR   CCTCC; GDC0317
DR   Wikidata; Q54903174
RX   PubMed=2988714;
CC   Population: Chinese.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 8,9
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 32.2,33.2
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 15,17
ST   FGA: 24
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 14
//
ID   LTEP-sm
AC   CVCL_6931
SY   LTEP-sm 1; LTEPsm
DR   Wikidata; Q54903175
RX   PubMed=1966333;
RX   PubMed=2854776;
RX   PubMed=2988714;
CC   Population: Chinese.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000286). It was the sole source for the STR profile of this entry.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 12,15
ST   FGA: 20,27
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 17
//
ID   LTK
AC   CVCL_R978
SY   Lake Trout Kidney
DR   Wikidata; Q54903176
RX   DOI=10.1577/1548-8667(1993)005<0119:DOCCDF>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8040; ! Salvelinus namaycush (Lake trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   LTK-
AC   CVCL_3392
DR   CLO; CLO_0007411
DR   CLO; CLO_0050232
DR   CLDB; cl3267
DR   CLDB; cl3268
DR   ECACC; 85011432
DR   ICLC; AL97001
DR   KCB; KCB 87015YJ
DR   KCB; KCB 94012YJ
DR   RCB; RCB0208
DR   Wikidata; Q54903177
RX   PubMed=3558490;
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4535 ! L-M
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Ltk-11
AC   CVCL_3738
DR   CLO; CLO_0007412
DR   CCRID; 1101MOU-PUMC000194
DR   Wikidata; Q54903178
RX   Patent=US6706716;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10422.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5289; HTR1D.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   Ltk-8-30-84
AC   CVCL_K239
DR   Wikidata; Q54903180
RX   Patent=US6706716;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10421.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5287; HTR1B.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   LTK-MOG
AC   CVCL_LC63
SY   MOG LTK-
DR   Wikidata; Q54903181
RX   PubMed=10408984;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7197; MOG.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3392 ! LTK-
SX   Male
AG   100D
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   LTL
AC   CVCL_R979
SY   Lake Trout Liver
DR   Wikidata; Q54903182
RX   DOI=10.1577/1548-8667(1993)005<0119:DOCCDF>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8040; ! Salvelinus namaycush (Lake trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   LTPA
AC   CVCL_3538
DR   CLO; CLO_0007413
DR   ATCC; CRL-2389
DR   Wikidata; Q54903183
RX   PubMed=205354;
RX   PubMed=25492535;
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Caution: The authors of PubMed=25492535 indicate that they have sequenced the mitochondrial genome of the 'rat' cell line LTPA. Their submitted DNA sequence (KM820833.1) is indeed a rat sequence but is labelled as originating from 'rat isolate 671'.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LT/Sv.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   LTR228
AC   CVCL_6416
SY   LTR 228; LTR 228-TG; LTR 228 TG
DR   CLO; CLO_0007414
DR   ATCC; HB-8502
DR   Wikidata; Q54903184
RX   Patent=US4624921;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8502.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=HB-8502
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2761 ! WIL2 NS
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   LU
AC   CVCL_M631
DR   BioSample; SAMN03151738
DR   Wikidata; Q54903185
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from fetal lung.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00074.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   Lu 106
AC   CVCL_8892
SY   LU 106; Lu106; LU/106
DR   BioSample; SAMN03151739
DR   Wikidata; Q54903186
RX   PubMed=5587101;
RX   PubMed=6451928;
RX   PubMed=13715157;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928; PubMed=20143388). Originally thought to originate from embryonic lung.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00075.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Lu Gan
AC   CVCL_U783
DR   ATCC; CRL-1264
DR   Wikidata; Q54903187
CC   Discontinued: ATCC; CRL-1264; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84663; Cutis laxa
DI   ORDO; Orphanet_209; Cutis laxa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Lu Rob
AC   CVCL_3010
DR   CLO; CLO_0007415
DR   ATCC; CRL-1397
DR   BioSample; SAMN03472818
DR   Wikidata; Q54903188
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1397
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 28,31
ST   D2S1338: 19,24
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 22,22.2
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 15,16
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0FY ! Lu Rob 2
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   Lu Rob 2
AC   CVCL_F0FY
DR   ATCC; CRL-1384
RX   PubMed=2722184;
RX   PubMed=3337712;
CC   Caution: The cell line is indicated by PubMed=2722184 to originate from the same patient as Lu-Rob (Cellosaurus=CVCL_3010) but no name is given, just the initials "L.R". We have thus named it Lu Rob 2 as we could not find any ATCC document indicating its name.
CC   Discontinued: ATCC; CRL-1384; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3010 ! Lu Rob
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Lu Vin
AC   CVCL_3011
DR   CLO; CLO_0007416
DR   ATCC; CRL-1144
DR   Wikidata; Q54903189
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Lu-130
AC   CVCL_6862
SY   NCC-c-Lu-130; LU-130; Lu130
DR   EFO; EFO_0003142
DR   BioSample; SAMN03151826
DR   cancercelllines; CVCL_6862
DR   CGH-DB; 89-1
DR   CGH-DB; 9058-4
DR   Cosmic; 809118
DR   Cosmic; 844807
DR   Cosmic; 918004
DR   Cosmic; 1212192
DR   Cosmic; 1571748
DR   Cosmic; 2668337
DR   GEO; GSM17309
DR   IARC_TP53; 1013
DR   RCB; RCB0465
DR   Wikidata; Q54903190
RX   PubMed=1312700;
RX   PubMed=3022030;
RX   PubMed=10536175;
RX   PubMed=12107105;
RX   PubMed=15016488;
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; RCB; -; https://cell.brc.riken.jp/ja/quality/str/origin/confirm_report/confirm_table4
CC   Problematic cell line: Contaminated. Shown to be a Lu-134-A (or Lu-134-B) derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 61 year old male patient with small cell lung carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00232.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (PubMed=1312700; PubMed=10536175).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: RCB; RCB0465; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1387 ! Lu-134-A
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Lu-134-A
AC   CVCL_1387
AS   CVCL_2790
SY   Lu-134-a; LU-134-A; LU-134A; Lu-134A; Lu134A; LU-134; Lu-134; Lu134; NCC-c-Lu-134-A-H; Lu-134-A-H; LU-134-A-H; Lu-134-AH; LU-134-AH; Lu134-A-H; Lu134-AH; Lu134AH
DR   CLO; CLO_0037021
DR   CLO; CLO_0037022
DR   CLO; CLO_0050028
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471661
DR   cancercelllines; CVCL_1387
DR   Cell_Model_Passport; SIDM00296
DR   CGH-DB; 100-1
DR   CGH-DB; 9059-4
DR   ChEMBL-Cells; CHEMBL3308292
DR   ChEMBL-Targets; CHEMBL2366236
DR   Cosmic; 713881
DR   Cosmic; 753588
DR   Cosmic; 801604
DR   Cosmic; 809119
DR   Cosmic; 844808
DR   Cosmic; 876158
DR   Cosmic; 918005
DR   Cosmic; 929157
DR   Cosmic; 1212193
DR   Cosmic; 1219094
DR   Cosmic; 1239929
DR   Cosmic; 1571749
DR   Cosmic; 1995493
DR   Cosmic; 2125172
DR   Cosmic; 2668338
DR   Cosmic-CLP; 753588
DR   DepMap; ACH-002051
DR   EGA; EGAS00001000978
DR   GDSC; 753588
DR   GEO; GSM17310
DR   GEO; GSM1670063
DR   IARC_TP53; 1014
DR   JCRB; JCRB0235
DR   LINCS_LDP; LCL-1871
DR   LINCS_LDP; LCL-1877
DR   PharmacoDB; LU134A_865_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1387
DR   RCB; RCB0466
DR   Wikidata; Q54903191
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=1312700;
RX   PubMed=1847845;
RX   PubMed=3022030;
RX   PubMed=6098504;
RX   PubMed=8263009;
RX   PubMed=8286010;
RX   PubMed=9413215;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12107105;
RX   PubMed=15016488;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=23716474;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=3022030; PubMed=6098504); 51.9 hours (PubMed=8286010).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (PubMed=1312700; PubMed=8263009; PubMed=10536175; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.6%; Native American=0%; East Asian, North=73.6%; East Asian, South=23.8%; South Asian=1.7%; European, North=0.3%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=753588; JCRB=JCRB0235; RCB=RCB0466
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1388 ! Lu-134-B
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Lu-134-B
AC   CVCL_1388
SY   NCC-c-Lu-134-B-S; Lu-134-b; LU-134-B; LU-134B; Lu-134B; Lu134B
DR   BTO; BTO_0005439
DR   CLO; CLO_0050029
DR   cancercelllines; CVCL_1388
DR   Cell_Model_Passport; SIDM00295
DR   CGH-DB; 90-1
DR   CGH-DB; 9060-4
DR   Cosmic; 1212194
DR   Cosmic; 1571750
DR   GEO; GSM827209
DR   JCRB; FDSC0038
DR   JCRB; JCRB0169
DR   LINCS_LDP; LCL-1834
DR   Progenetix; CVCL_1388
DR   RCB; RCB0467
DR   Wikidata; Q54903192
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=3022030;
RX   PubMed=6098504;
RX   PubMed=12107105;
RX   PubMed=19394761;
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: 57 hours (PubMed=3022030; PubMed=6098504).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp1029Tyr (c.3085G>T); Zygosity=Heterozygous (PubMed=19394761).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; FDSC0038; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0169; RCB=RCB0467
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1387 ! Lu-134-A
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Lu-135
AC   CVCL_1389
SY   NCC-c-Lu-135; LU-135; LU135; Lu135
DR   CLO; CLO_0050030
DR   EFO; EFO_0002828
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470818
DR   cancercelllines; CVCL_1389
DR   Cell_Model_Passport; SIDM00294
DR   CGH-DB; 9061-4
DR   CGH-DB; 91-1
DR   ChEMBL-Cells; CHEMBL3308136
DR   ChEMBL-Targets; CHEMBL1075492
DR   Cosmic; 713899
DR   Cosmic; 801605
DR   Cosmic; 809120
DR   Cosmic; 844821
DR   Cosmic; 876157
DR   Cosmic; 918006
DR   Cosmic; 929159
DR   Cosmic; 1239930
DR   Cosmic; 1995494
DR   Cosmic; 2125203
DR   Cosmic; 2668339
DR   Cosmic-CLP; 713899
DR   DepMap; ACH-001549
DR   EGA; EGAS00001000978
DR   GDSC; 713899
DR   GEO; GSM1670064
DR   IARC_TP53; 1015
DR   JCRB; FDSC0039
DR   JCRB; JCRB0170
DR   LINCS_LDP; LCL-1809
DR   PharmacoDB; LU135_866_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1389
DR   RCB; RCB0468
DR   Wikidata; Q54903193
RX   PubMed=1312700;
RX   PubMed=1847845;
RX   PubMed=3022030;
RX   PubMed=8263009;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12107105;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=23716474;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 88 hours (PubMed=3022030).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg661fs*1 (c.1980_1983delCCGG); Zygosity=Homozygous (PubMed=8263009; DepMap=ACH-001549).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Cys (c.730G>T); ClinVar=VCV000376599; Zygosity=Heterozygous (PubMed=1312700; PubMed=8263009; PubMed=10536175; PubMed=20557307; DepMap=ACH-001549).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.7%; Native American=0.34%; East Asian, North=77.4%; East Asian, South=17.05%; South Asian=0%; European, North=0%; European, South=3.52% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0039; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=713899; DepMap=ACH-001549; JCRB=JCRB0170; RCB=RCB0468
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 7
ST   D16S539: 11
ST   D18S51: 17,19
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,15
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Lu-138
AC   CVCL_3350
SY   NCC-c-Lu-138; LU-138
DR   CLO; CLO_0050037
DR   BioSample; SAMN03472077
DR   cancercelllines; CVCL_3350
DR   CGH-DB; 9062-4
DR   CGH-DB; 92-1
DR   Cosmic; 801606
DR   Cosmic; 809122
DR   IARC_TP53; 1016
DR   RCB; RCB1785
DR   Wikidata; Q54903194
RX   PubMed=1312700;
RX   PubMed=3022030;
RX   PubMed=10536175;
RX   PubMed=12107105;
RX   PubMed=38639832;
CC   Population: Chinese.
CC   Doubling time: 72 hours (PubMed=3022030).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Unspecified (PubMed=1312700; PubMed=10536175).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB1785
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Lu-139
AC   CVCL_1390
SY   NCC-c-Lu-139; LU-139; Lu139; LU139
DR   CLO; CLO_0037023
DR   CLO; CLO_0050031
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472318
DR   cancercelllines; CVCL_1390
DR   Cell_Model_Passport; SIDM00293
DR   CGH-DB; 9063-4
DR   CGH-DB; 93-1
DR   ChEMBL-Cells; CHEMBL3308238
DR   ChEMBL-Targets; CHEMBL2366248
DR   Cosmic; 713878
DR   Cosmic; 801607
DR   Cosmic; 809123
DR   Cosmic; 844822
DR   Cosmic; 876156
DR   Cosmic; 918007
DR   Cosmic; 929158
DR   Cosmic; 1212195
DR   Cosmic; 1239931
DR   Cosmic; 1571751
DR   Cosmic; 1995495
DR   Cosmic; 2125268
DR   Cosmic; 2668340
DR   Cosmic-CLP; 713878
DR   DepMap; ACH-002052
DR   EGA; EGAS00001000978
DR   GDSC; 713878
DR   GEO; GSM1670065
DR   IARC_TP53; 1017
DR   LINCS_LDP; LCL-1872
DR   PharmacoDB; LU139_867_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1390
DR   RCB; RCB0469
DR   Wikidata; Q54903195
RX   PubMed=1312700;
RX   PubMed=1847845;
RX   PubMed=3022030;
RX   PubMed=8263009;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12107105;
RX   PubMed=15901131;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=23716474;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 29 hours (PubMed=3022030).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Unspecified (PubMed=1312700; PubMed=8263009; PubMed=10536175; PubMed=15901131; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.34%; Native American=0%; East Asian, North=86.97%; East Asian, South=5.88%; South Asian=2.89%; European, North=2.93%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=713878; RCB=RCB0469
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   Lu-140
AC   CVCL_3335
SY   NCC-c-Lu-140; LU-140
DR   CLO; CLO_0050032
DR   BioSample; SAMN03472319
DR   CGH-DB; 101-1
DR   CGH-DB; 9064-4
DR   Cosmic; 801608
DR   Cosmic; 809124
DR   Cosmic; 918008
DR   Cosmic; 1212196
DR   Cosmic; 1571752
DR   IARC_TP53; 1018
DR   RCB; RCB0470
DR   Wikidata; Q54903201
RX   PubMed=1312700;
RX   PubMed=3022030;
RX   PubMed=10536175;
RX   PubMed=12107105;
RX   PubMed=38639832;
CC   Population: Chinese/Asian ethnic group; Hakka and Japanese.
CC   Doubling time: 144 hours (PubMed=3022030).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Glnfs*3 (c.1025delG); Zygosity=Unspecified (PubMed=1312700; PubMed=10536175).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB0470
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10
ST   D5S818: 9
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   Lu-141
AC   CVCL_3347
SY   LU-141; Lu141
DR   CLO; CLO_0050070
DR   BioSample; SAMN03472075
DR   cancercelllines; CVCL_3347
DR   CGH-DB; 9065-4
DR   CGH-DB; 94-1
DR   Cosmic; 801609
DR   Cosmic; 809125
DR   Cosmic; 918009
DR   Cosmic; 929981
DR   IARC_TP53; 1019
DR   RCB; RCB1772
DR   Wikidata; Q54903202
RX   PubMed=1312700;
RX   PubMed=10536175;
RX   PubMed=12107105;
RX   PubMed=38639832;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Unspecified (PubMed=1312700; PubMed=10536175).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB1772
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Lu-143
AC   CVCL_3348
DR   CLO; CLO_0050036
DR   BioSample; SAMN03472076
DR   cancercelllines; CVCL_3348
DR   CGH-DB; 102-1
DR   CGH-DB; 9066-4
DR   Cosmic; 809126
DR   IARC_TP53; 1020
DR   RCB; RCB1773
DR   Wikidata; Q54903203
RX   PubMed=1312700;
RX   PubMed=12107105;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.782+1G>T; ClinVar=VCV000496048; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=1312700).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB1773
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,20
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   Lu-165
AC   CVCL_1391
SY   LU-165; LU165
DR   CLO; CLO_0037024
DR   CLO; CLO_0050069
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472172
DR   cancercelllines; CVCL_1391
DR   Cell_Model_Passport; SIDM00292
DR   CGH-DB; 9067-4
DR   CGH-DB; 99-1
DR   ChEMBL-Cells; CHEMBL3308239
DR   ChEMBL-Targets; CHEMBL2366132
DR   Cosmic; 753589
DR   Cosmic; 1212197
DR   Cosmic; 1571740
DR   Cosmic; 1995496
DR   Cosmic; 2125173
DR   Cosmic-CLP; 753589
DR   DepMap; ACH-002077
DR   EGA; EGAS00001000978
DR   GDSC; 753589
DR   GEO; GSM1670066
DR   IARC_TP53; 21481
DR   LINCS_LDP; LCL-1873
DR   PharmacoDB; LU165_868_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1391
DR   RCB; RCB1184
DR   Wikidata; Q54903204
RX   PubMed=8071114;
RX   PubMed=12107105;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Indonesian.
CC   Characteristics: Produces high level of vasopressin.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly36Arg (c.106G>A); ClinVar=VCV001334551; Zygosity=Heterozygous (Cosmic-CLP=753589; DepMap=ACH-002077).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Profs*9 (c.468_480delCGTCCGCGCCATG); Zygosity=Heterozygous (Cosmic-CLP=753589; DepMap=ACH-002077).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.53%; East Asian, North=28.73%; East Asian, South=70.74%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=753589; RCB=RCB1184
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9,11
ST   D5S818: 9,13
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   Lu-24
AC   CVCL_3349
SY   NCC-c-Lu-24; LU-24; Lu24
DR   CLO; CLO_0050035
DR   BioSample; SAMN03472074
DR   CGH-DB; 9057-4
DR   CGH-DB; 98-1
DR   Cosmic; 801603
DR   Cosmic; 809117
DR   Cosmic; 844893
DR   Cosmic; 876159
DR   Cosmic; 918003
DR   Cosmic; 1239928
DR   Cosmic; 2125269
DR   Cosmic; 2668336
DR   IARC_TP53; 28448
DR   RCB; RCB1771
DR   Wikidata; Q54903205
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=1312700;
RX   PubMed=3022030;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12107105;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=23716474;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Doubling time: 102 hours (PubMed=3022030).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1312700; PubMed=10536175; PubMed=20557307).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB1771
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 10
ST   D5S818: 9
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Lu-65
AC   CVCL_1392
SY   LU-65M; LU-65; LU65; Lu65; Lu 65; C-Lu-65; C-Lu65
DR   CLO; CLO_0050059
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 936
DR   BioSample; SAMN03471065
DR   BioSample; SAMN03472047
DR   BioSample; SAMN10987648
DR   cancercelllines; CVCL_1392
DR   Cell_Model_Passport; SIDM00547
DR   CGH-DB; 197-1
DR   CGH-DB; 9183-4
DR   ChEMBL-Cells; CHEMBL3308623
DR   ChEMBL-Targets; CHEMBL614694
DR   Cosmic; 713875
DR   Cosmic; 716171
DR   Cosmic; 724863
DR   Cosmic; 733170
DR   Cosmic; 801584
DR   Cosmic; 808502
DR   Cosmic; 809127
DR   Cosmic; 844827
DR   Cosmic; 876175
DR   Cosmic; 889093
DR   Cosmic; 917989
DR   Cosmic; 929151
DR   Cosmic; 932930
DR   Cosmic; 946067
DR   Cosmic; 1066164
DR   Cosmic; 1219074
DR   Cosmic; 1239918
DR   Cosmic; 1571732
DR   Cosmic; 1995497
DR   Cosmic; 2125204
DR   Cosmic; 2668333
DR   Cosmic-CLP; 724863
DR   DepMap; ACH-000438
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10487-107B1
DR   GDSC; 724863
DR   GEO; GSM827382
DR   GEO; GSM887282
DR   GEO; GSM888357
DR   GEO; GSM1670067
DR   IARC_TP53; 11877
DR   JCRB; JCRB0079
DR   LiGeA; CCLE_344
DR   LINCS_LDP; LCL-1904
DR   PharmacoDB; LU65_869_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1392
DR   PubChem_Cell_line; CVCL_1392
DR   RCB; RCB1967
DR   TKG; TKG 0442
DR   Wikidata; Q54903206
RX   PubMed=3935627;
RX   PubMed=7116286;
RX   PubMed=8263009;
RX   PubMed=9290701;
RX   PubMed=9673367;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12068308;
RX   PubMed=12569360;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: 21.7 hours (Note=Lot 101093), 35-40 hours (Note=Lot 12162008), ~46 hours (Note=Lot 01192016), ~27 hours (Note=Lot 01192022) (JCRB=JCRB0079).
CC   HLA typing: A*24:02,24:02; B*15:01,52:01; C*12:02,12:02; DQA1*01:03,03:02; DQB1*03:03,06:01; DRB1*04:06,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=In 10% of cells (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=8263009; PubMed=12068308; Cosmic-CLP=724863; DepMap=ACH-000438).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser82Ter (c.245C>A); ClinVar=VCV000837710; Zygosity=Homozygous (Cosmic-CLP=724863; DepMap=ACH-000438).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Homozygous (PubMed=10536175; PubMed=20557307; Cosmic-CLP=724863; DepMap=ACH-000438).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=79.97%; East Asian, South=18.08%; South Asian=0.48%; European, North=0.3%; European, South=1.17% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=724863; JCRB=JCRB0079; RCB=RCB1967; TKG=TKG 0442
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18 (RCB=RCB1967)
ST   vWA: 18 (Cosmic-CLP=724863; JCRB=JCRB0079; TKG=TKG 0442)
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   Lu-65A
AC   CVCL_3012
SY   LU-65A; LU65A
DR   CLO; CLO_0037025
DR   BioSample; SAMN03472811
DR   cancercelllines; CVCL_3012
DR   Cosmic; 753590
DR   Cosmic; 1001659
DR   GEO; GSM827386
DR   JCRB; JCRB0054
DR   LINCS_LDP; LCL-1905
DR   Progenetix; CVCL_3012
DR   Wikidata; Q54903207
RX   PubMed=9023415;
RX   PubMed=9290701;
RX   PubMed=20215515;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*40:02; C*03:04 (PubMed=9023415).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser82Ter (c.245C>A); ClinVar=VCV000837710; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Homozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: LC-95A; PubMed=9023415.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0054
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1392 ! Lu-65
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   Lu-65B
AC   CVCL_3013
SY   LU-65B; LU65B
DR   CLO; CLO_0037026
DR   cancercelllines; CVCL_3013
DR   GEO; GSM827384
DR   JCRB; JCRB0055
DR   LINCS_LDP; LCL-1906
DR   Progenetix; CVCL_3013
DR   Wikidata; Q54903208
RX   PubMed=9290701;
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser82Ter (c.245C>A); ClinVar=VCV000837710; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Homozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0055
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1392 ! Lu-65
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Lu-65C
AC   CVCL_3014
SY   LU-65C; LU65C
DR   CLO; CLO_0037027
DR   cancercelllines; CVCL_3014
DR   JCRB; JCRB0056
DR   LINCS_LDP; LCL-1907
DR   Wikidata; Q54903209
RX   PubMed=9290701;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser82Ter (c.245C>A); ClinVar=VCV000837710; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0056
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1392 ! Lu-65
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   Lu-75(c)
AC   CVCL_GS27
SY   LU-75(c); Lu-75
DR   Wikidata; Q54903210
RX   PubMed=2580800;
RX   PubMed=6956527;
CC   Population: Japanese.
CC   HLA typing: A*02; B*w35,w39 (PubMed=6956527).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   Lu-99
AC   CVCL_3015
SY   LU-99; Lu 99; Lu99; LU99; C-Lu99
DR   BTO; BTO_0006141
DR   CLO; CLO_0050038
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03471066
DR   BioSample; SAMN10987825
DR   cancercelllines; CVCL_3015
DR   Cell_Model_Passport; SIDM00546
DR   ChEMBL-Cells; CHEMBL3308600
DR   ChEMBL-Targets; CHEMBL614651
DR   Cosmic; 801578
DR   Cosmic; 808503
DR   Cosmic; 844828
DR   Cosmic; 876174
DR   Cosmic; 946068
DR   Cosmic; 1048224
DR   Cosmic; 1571756
DR   Cosmic; 1656907
DR   Cosmic; 2125270
DR   DepMap; ACH-000444
DR   GEO; GSM887283
DR   GEO; GSM888358
DR   IARC_TP53; 30114
DR   JCRB; JCRB0080
DR   LiGeA; CCLE_430
DR   Progenetix; CVCL_3015
DR   PubChem_Cell_line; CVCL_3015
DR   RCB; RCB1900
DR   TKG; TKG 0495
DR   Wikidata; Q54903211
RX   PubMed=3935627;
RX   PubMed=9290701;
RX   PubMed=11005564;
RX   PubMed=12569360;
RX   PubMed=16105816;
RX   PubMed=22313637;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese and Korean.
CC   Doubling time: 21.1 hours (Note=Lot 061891), ~25 hours (Note=Lot 10092014) (JCRB=JCRB0080).
CC   HLA typing: A*24:02,24:02; B*52:01,54:01; C*01:02,01:02; DQA1*05:02,05:02; DRB1*03:19,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (DepMap=ACH-000444).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.25%; Native American=0%; East Asian, North=84.63%; East Asian, South=13.5%; South Asian=0%; European, North=0%; European, South=1.62% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0080; RCB=RCB1900; TKG=TKG 0495
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Lu-99A
AC   CVCL_1393
SY   LU-99A; Lu99A; LU99A
DR   CLO; CLO_0037028
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 937
DR   cancercelllines; CVCL_1393
DR   Cell_Model_Passport; SIDM01219
DR   CGH-DB; 198-1
DR   CGH-DB; 9187-4
DR   ChEMBL-Cells; CHEMBL3308757
DR   ChEMBL-Targets; CHEMBL1075493
DR   Cosmic; 889094
DR   Cosmic; 907796
DR   Cosmic; 917980
DR   Cosmic; 932925
DR   Cosmic; 1066165
DR   Cosmic; 1239919
DR   Cosmic; 1995498
DR   Cosmic; 2668334
DR   Cosmic-CLP; 907796
DR   DepMap; ACH-002158
DR   EGA; EGAS00001000978
DR   GDSC; 907796
DR   GEO; GSM827578
DR   GEO; GSM1670068
DR   IARC_TP53; 21482
DR   JCRB; JCRB0044
DR   LINCS_LDP; LCL-1908
DR   PharmacoDB; LU99A_870_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1393
DR   PubChem_Cell_line; CVCL_1393
DR   Wikidata; Q54903212
RX   PubMed=10536175;
RX   PubMed=15746151;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese and Korean.
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (Cosmic-CLP=907796; DepMap=ACH-002158).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (Cosmic-CLP=907796; DepMap=ACH-002158).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.88%; Native American=0%; East Asian, North=75.94%; East Asian, South=8.76%; South Asian=0%; European, North=2.28%; European, South=7.13% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=907796; JCRB=JCRB0044
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3015 ! Lu-99
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Lu-99B
AC   CVCL_2801
SY   LU-99B; Lu99B; LU99B
DR   CLO; CLO_0037029
DR   CLO; CLO_0050042
DR   cancercelllines; CVCL_2801
DR   Cosmic; 1066166
DR   FANTOM5_SSTAR; 10433-106E1
DR   JCRB; JCRB0057
DR   LINCS_LDP; LCL-1909
DR   RCB; RCB1971
DR   TKG; TKG 0496
DR   Wikidata; Q54903213
RX   PubMed=9290701;
CC   Population: Japanese and Korean.
CC   Doubling time: 18.2 hours (Note=Lot 062294) (JCRB=JCRB0057).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0057; RCB=RCB1971; TKG=TKG 0496
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3015 ! Lu-99
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Lu-99C
AC   CVCL_2802
SY   LU-99C; Lu99C; LU99C
DR   CLO; CLO_0037030
DR   cancercelllines; CVCL_2802
DR   JCRB; JCRB0058
DR   LINCS_LDP; LCL-1910
DR   Wikidata; Q54903214
RX   PubMed=10358721;
RX   PubMed=15185009;
RX   PubMed=25120651;
CC   Population: Japanese and Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0058
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3015 ! Lu-99
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   LU-HNSCC-3
AC   CVCL_L178
SY   LU-HNSCC 3; LU-HNxSCC-3; HN-3
DR   IARC_TP53; 26988
DR   Wikidata; Q54903216
RX   PubMed=19216775;
CC   Doubling time: 1.8 +- 0.4 days (PubMed=19216775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19216775).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   LU-HNSCC-4
AC   CVCL_L179
SY   LU-HNSCC 4; LU-HNxSCC-4; HN-4
DR   cancercelllines; CVCL_L179
DR   IARC_TP53; 26989
DR   Wikidata; Q54903217
RX   PubMed=19216775;
CC   Doubling time: 1.1 +- 0.1 days (PubMed=19216775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Unspecified (PubMed=19216775).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   LU-HNSCC-5
AC   CVCL_L180
SY   LU-HNSCC 5; LU-HNxSCC-5; HN-5
DR   IARC_TP53; 26990
DR   Wikidata; Q54903218
RX   PubMed=19216775;
CC   Doubling time: 1.6 +- 0.2 days (PubMed=19216775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His168Pro (c.503A>C); Zygosity=Unspecified (PubMed=19216775).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   LU-HNSCC-6
AC   CVCL_L181
SY   LU-HNSCC 6; LU-HNxSCC-6; HN-6
DR   IARC_TP53; 26991
DR   Wikidata; Q54903219
RX   PubMed=19216775;
CC   Doubling time: 1.3 +- 0.4 days (PubMed=19216775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19216775).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   LU-HNSCC-7
AC   CVCL_L182
SY   LU-HNSCC 7; LU-HNxSCC-7; HN-7
DR   IARC_TP53; 26992
DR   Wikidata; Q54903220
RX   PubMed=19216775;
CC   Doubling time: 2.2 +- 0.2 days (PubMed=19216775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19216775).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   LU-HNSCC-8
AC   CVCL_L183
SY   LU-HNSCC 8; LU-HNxSCC-8; HN-8
DR   cancercelllines; CVCL_L183
DR   IARC_TP53; 26993
DR   Wikidata; Q54903221
RX   PubMed=19216775;
CC   Doubling time: 1.4 +- 0.3 days (PubMed=19216775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu252del (c.754_756delCTC); ClinVar=VCV000998484; Zygosity=Unspecified (PubMed=19216775).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   Lu-YePa
AC   CVCL_W819
DR   Wikidata; Q54903222
RX   PubMed=3652912;
CC   Population: Japanese.
CC   Doubling time: 34.6 hours (PubMed=3652912).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   Lu2
AC   CVCL_T983
DR   ECACC; 99043003
DR   Wikidata; Q54903223
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   Lu6
AC   CVCL_T984
DR   ECACC; 99043004
DR   Wikidata; Q54903224
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   LUBi001-A
AC   CVCL_VE41
SY   RCFB58 c12.5; RCi195; PGRN8310; PGRN-8310
DR   BioSamples; SAMEA4096428
DR   EBiSC; LUBi001-A
DR   ECACC; 66540226
DR   hPSCreg; LUBi001-A
DR   Wikidata; Q54903225
CC   From: H. Lundbeck A/S; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (hPSCreg=LUBi001-A).
CC   Discontinued: EBiSC; LUBi001-A; true.
CC   Discontinued: ECACC; 66540226; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_II98 ! LUBi001-B
OI   CVCL_II99 ! LUBi001-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   LUBi001-B
AC   CVCL_II98
SY   RCFB58 c4.4; RCi194; PGRN8310; PGRN-8310
DR   BioSamples; SAMEA4309630
DR   EBiSC; LUBi001-B
DR   ECACC; 66540258
DR   hPSCreg; LUBi001-B
DR   SKIP; SKIP002785
DR   Wikidata; Q54903226
CC   From: H. Lundbeck A/S; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (hPSCreg=LUBi001-B).
CC   Discontinued: ECACC; 66540258; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE41 ! LUBi001-A
OI   CVCL_II99 ! LUBi001-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   LUBi001-C
AC   CVCL_II99
SY   RCFB58 c3.7; RCi200; PGRN8310; PGRN-8310
DR   BioSamples; SAMEA4309665
DR   EBiSC; LUBi001-C
DR   ECACC; 66540259
DR   hPSCreg; LUBi001-C
DR   SKIP; SKIP002786
DR   Wikidata; Q54903227
CC   From: H. Lundbeck A/S; Copenhagen; Denmark.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (hPSCreg=LUBi001-C).
CC   Discontinued: ECACC; 66540259; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE41 ! LUBi001-A
OI   CVCL_II98 ! LUBi001-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   Luc-LM8
AC   CVCL_RL04
SY   DLM8-Luc
DR   Wikidata; Q54903228
RX   PubMed=22866095;
RX   PubMed=26018200;
CC   Characteristics: The luciferase reporter gene is under the control of a minimal TATA promoter with multiple copies of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: C3H/HeJ.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6669 ! DLM8
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   Luc63.2.22
AC   CVCL_UW14
SY   Luc63; MuLuc63
DR   Wikidata; Q95983312
RX   Patent=US8461306;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5950.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized elotuzumab (HuLuc63; Empliciti) therapeutic antibody. It was developed for the treatment of multiple myeloma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NQ25; Human SLAMF7/CD319.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   Luc9.1
AC   CVCL_GY95
DR   Wikidata; Q54903229
RX   PubMed=20504984;
CC   Virology: Reporter cell line for rapid isolation and detection of replicating influenza A virus.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 10
//
ID   Luc90
AC   CVCL_UW15
SY   MuLuc90
DR   Wikidata; Q95983315
RX   Patent=US8461306;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5091.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NQ25; Human SLAMF7/CD319.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   LuCa2
AC   CVCL_RQ28
DR   Wikidata; Q54903230
RX   PubMed=4005855;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 135 kDa protein on lung squamous cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   LuCa3
AC   CVCL_RQ29
DR   Wikidata; Q54903231
RX   PubMed=4005855;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 230/240 kDa protein on lung squamous cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   LuCa4
AC   CVCL_RQ30
DR   Wikidata; Q54903232
RX   PubMed=4005855;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 150 kDa protein on lung squamous cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   LuCaP 23.1
AC   CVCL_4850
DR   Wikidata; Q54903233
RX   PubMed=9816265;
RX   PubMed=10861745;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4851 ! LuCaP 23.12
OI   CVCL_4852 ! LuCaP 23.8
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LuCaP 23.12
AC   CVCL_4851
DR   Wikidata; Q54903234
RX   PubMed=9816265;
RX   PubMed=10861745;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4850 ! LuCaP 23.1
OI   CVCL_4852 ! LuCaP 23.8
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   LuCaP 23.8
AC   CVCL_4852
DR   Wikidata; Q54903235
RX   PubMed=9816265;
RX   PubMed=10861745;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4850 ! LuCaP 23.1
OI   CVCL_4851 ! LuCaP 23.12
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LuCaP 35
AC   CVCL_4853
SY   LuCAP35
DR   Cosmic; 2580125
DR   Wikidata; Q54903236
RX   PubMed=12712403;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4854 ! LuCaP 35V
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   LuCaP 35V
AC   CVCL_4854
DR   Wikidata; Q54903237
RX   PubMed=12712403;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4853 ! LuCaP 35
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   LuCaP 41
AC   CVCL_4855
DR   Wikidata; Q54903238
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   LuCaP 49
AC   CVCL_4750
DR   Wikidata; Q54903240
RX   PubMed=12163395;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   LuCaP 58
AC   CVCL_4857
DR   Wikidata; Q54903241
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   LuCap 73
AC   CVCL_4858
DR   Wikidata; Q54903242
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   LUCC1
AC   CVCL_W892
DR   Cosmic; 1175828
DR   Cosmic; 1286008
DR   Cosmic; 2050449
DR   Cosmic; 2686101
DR   Wikidata; Q54903247
RX   PubMed=19802009;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C7899; Recurrent bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCC2
AC   CVCL_W893
DR   Cosmic; 1175829
DR   Cosmic; 1286009
DR   Cosmic; 1819321
DR   Cosmic; 2050450
DR   Cosmic; 2686102
DR   Wikidata; Q54903248
RX   PubMed=19802009;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C7899; Recurrent bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCC3
AC   CVCL_W894
DR   Cosmic; 1286010
DR   Cosmic; 2050451
DR   Cosmic; 2686103
DR   Wikidata; Q54903249
RX   PubMed=19802009;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Glu507Gln (c.1519G>C); Zygosity=Unspecified (PubMed=24367658).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg557Pro (c.1670G>C); Zygosity=Unspecified (PubMed=24367658).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCC4
AC   CVCL_W895
DR   Cosmic; 1286011
DR   Cosmic; 2050452
DR   Cosmic; 2686104
DR   Wikidata; Q54903250
RX   PubMed=19802009;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCC5
AC   CVCL_W896
DR   Cosmic; 1286012
DR   Cosmic; 2050453
DR   Cosmic; 2686105
DR   Wikidata; Q54903251
RX   PubMed=19802009;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCC6
AC   CVCL_W897
DR   Cosmic; 2050454
DR   Cosmic; 2686106
DR   Wikidata; Q54903252
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCC7
AC   CVCL_W898
DR   cancercelllines; CVCL_W898
DR   Cosmic; 2050455
DR   Cosmic; 2686107
DR   Wikidata; Q54903253
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8Y0 ! LUCC7EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   LUCC7EBV
AC   CVCL_A8Y0
DR   Wikidata; Q102114483
RX   PubMed=24035680;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W898 ! LUCC7
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   LUCC8
AC   CVCL_W899
DR   Cosmic; 2050456
DR   Cosmic; 2686108
DR   Cosmic; 2772713
DR   Wikidata; Q54903254
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCC9
AC   CVCL_W900
DR   Cosmic; 2050457
DR   Cosmic; 2686109
DR   Wikidata; Q54903255
RX   PubMed=24035680;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   LUCE
AC   CVCL_E760
DR   dbMHC; 48956
DR   IHW; IHW09393
DR   IPD-IMGT/HLA; 17343
DR   Wikidata; Q54903256
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*11:01:01:01,02:01:01:01; B*35:03:01:01,27:02:01:01; C*12:03:01:01,02:02:02:03; DPB1*03:01:01,04:02:01; DQB1*05:02:01,03:01:01; DRB1*16:01:01,11:04:01 (IPD-IMGT/HLA=17343).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Lucky 1.1
AC   CVCL_ZC98
DR   Wikidata; Q98126961
RX   Patent=US6538126;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10949.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q68285; Hepatitis C virus subtype 1b (Korean isolate) (Note=AA 1192-1457 = NS3 fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 7
//
ID   Lucky 1.2
AC   CVCL_ZC99
DR   Wikidata; Q98126963
RX   Patent=US6538126;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10950.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q68285; Hepatitis C virus subtype 1b (Korean isolate) (Note=AA 1192-1457 = NS3 fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 7
//
ID   Lucky 1.3
AC   CVCL_ZD00
DR   Wikidata; Q98126966
RX   Patent=US6538126;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q68285; Hepatitis C virus subtype 1b (Korean isolate) (Note=AA 1192-1457 = NS3 fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   Lucky 1.4
AC   CVCL_ZD01
DR   Wikidata; Q98126968
RX   Patent=US6538126;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q68285; Hepatitis C virus subtype 1b (Korean isolate) (Note=AA 1192-1457 = NS3 fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   LUDLU-1
AC   CVCL_2582
SY   Ludlu-1; LUDLU 1; LUDLU1
DR   CLO; CLO_0007417
DR   CLDB; cl3269
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 561
DR   BioSample; SAMN03473041
DR   BioSample; SAMN10987864
DR   cancercelllines; CVCL_2582
DR   Cell_Model_Passport; SIDM01363
DR   Cosmic; 753591
DR   Cosmic; 2060536
DR   DepMap; ACH-000390
DR   ECACC; 92012463
DR   EGA; EGAS00001002554
DR   GEO; GSM827451
DR   GEO; GSM887284
DR   GEO; GSM888359
DR   GEO; GSM1374639
DR   IARC_TP53; 21483
DR   LiGeA; CCLE_553
DR   LINCS_LDP; LCL-1589
DR   PharmacoDB; LUDLU1_871_2019
DR   Progenetix; CVCL_2582
DR   Wikidata; Q54903257
RX   PubMed=2577272;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23226101;
RX   PubMed=24002593;
RX   PubMed=24244370;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*15:01,18:01; C*05:01,07:02; DQA1*01:02,02:01; DRB1*11:30,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (DepMap=ACH-000390).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.82%; Native American=0.66%; East Asian, North=3.82%; East Asian, South=0%; South Asian=0%; European, North=56.05%; European, South=37.65% (PubMed=30894373).
ST   Source(s): ECACC=92012463; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13,14
ST   D18S51: 18
ST   D21S11: 28
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 8,15
ST   FGA: 25
ST   Penta D: 10
ST   Penta E: 12,19
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2296 ! AGLCL [Human 1989]
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   LUDLU-23
AC   CVCL_E340
DR   Wikidata; Q54903258
CC   Population: Caucasian.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2763 ! WILCL
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   LUEi001-A
AC   CVCL_UG30
SY   iPS-L-3735-5
DR   hPSCreg; LUEi001-A
DR   Wikidata; Q95983340
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Lys158Asnfs*23 (c.474delA); ClinVar=VCV000001650; Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK75 ! LUEi001-B
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   LUEi001-B
AC   CVCL_UK75
SY   iPS-L-3735-21
DR   hPSCreg; LUEi001-B
DR   Wikidata; Q95983341
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Lys158Asnfs*23 (c.474delA); ClinVar=VCV000001650; Zygosity=Heterozygous (from autologous cell line LUEi001-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG30 ! LUEi001-A
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   LUEi002-A
AC   CVCL_UG31
SY   iPS-L-3736-13
DR   hPSCreg; LUEi002-A
DR   Wikidata; Q95983342
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Lys158Asnfs*23 (c.474delA); ClinVar=VCV000001650; Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG32 ! LUEi002-B
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   LUEi002-B
AC   CVCL_UG32
SY   iPS-L-3736-17
DR   hPSCreg; LUEi002-B
DR   Wikidata; Q95983343
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Lys158Asnfs*23 (c.474delA); ClinVar=VCV000001650; Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG31 ! LUEi002-A
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   LUEi003-A
AC   CVCL_UG33
SY   iPS-L-3737-1
DR   hPSCreg; LUEi003-A
DR   Wikidata; Q95983344
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Lys158Asnfs*23 (c.474delA); ClinVar=VCV000001650; Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK76 ! LUEi003-B
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   LUEi003-B
AC   CVCL_UK76
SY   iPS-L-3737-3
DR   hPSCreg; LUEi003-B
DR   Wikidata; Q95983345
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Lys158Asnfs*23 (c.474delA); ClinVar=VCV000001650; Zygosity=Heterozygous (from autologous cell line LUEi003-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG33 ! LUEi003-A
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   LUEi004-A
AC   CVCL_UG34
SY   iPS-L-3969-2
DR   hPSCreg; LUEi004-A
DR   Wikidata; Q95983346
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Arg13His (c.38G>A); Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG35 ! LUEi004-B
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   LUEi004-B
AC   CVCL_UG35
SY   iPS-L-3969-7
DR   hPSCreg; LUEi004-B
DR   Wikidata; Q95983347
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Arg13His (c.38G>A); Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG34 ! LUEi004-A
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   LUEi005-A
AC   CVCL_UG36
SY   iPS-L-4011-1
DR   hPSCreg; LUEi005-A
DR   Wikidata; Q95983348
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Arg13His (c.38G>A); Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG37 ! LUEi005-B
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   LUEi005-B
AC   CVCL_UG37
SY   iPS-L-4011-2
DR   hPSCreg; LUEi005-B
DR   Wikidata; Q95983350
RX   PubMed=30316041;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Arg13His (c.38G>A); Zygosity=Heterozygous (PubMed=30316041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG36 ! LUEi005-A
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   LUEi006-A
AC   CVCL_YC35
SY   iPS-L-11147-8
DR   hPSCreg; LUEi006-A
DR   Wikidata; Q95983351
RX   PubMed=31706098;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Donor information: Established from monozygotic twin of LUEi007-A (Cellosaurus=CVCL_YC36).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   LUEi007-A
AC   CVCL_YC36
SY   iPS-L-11148-4
DR   hPSCreg; LUEi007-A
DR   Wikidata; Q95983352
RX   PubMed=31706098;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Donor information: Established from monozygotic twin of LUEi006-A (Cellosaurus=CVCL_YC35).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   LUEi008-A
AC   CVCL_YC37
SY   iPS-L-11155-3
DR   hPSCreg; LUEi008-A
DR   Wikidata; Q95983353
RX   PubMed=31706098;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Donor information: Established from monozygotic twin of LUEi009-A (Cellosaurus=CVCL_YC38).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   LUEi009-A
AC   CVCL_YC38
SY   iPS-L-11156-7
DR   hPSCreg; LUEi009-A
DR   Wikidata; Q95983354
RX   PubMed=31706098;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Donor information: Established from monozygotic twin of LUEi008-A (Cellosaurus=CVCL_YC37).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   LUEi010-A
AC   CVCL_YC39
SY   iPS-L-11166-3
DR   hPSCreg; LUEi010-A
DR   Wikidata; Q95983355
RX   PubMed=31706098;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Donor information: Established from monozygotic twin of LUEi011-A (Cellosaurus=CVCL_YC40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   LUEi011-A
AC   CVCL_YC40
SY   iPS-L-11167-11
DR   hPSCreg; LUEi011-A
DR   Wikidata; Q95983356
RX   PubMed=31706098;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Donor information: Established from monozygotic twin of LUEi010-A (Cellosaurus=CVCL_YC39).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   LUEi012-A
AC   CVCL_A1TH
SY   iPS-L-2131
DR   BioSamples; SAMEA7679546
DR   hPSCreg; LUEi012-A
DR   Wikidata; Q105509953
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   LUEi013-A
AC   CVCL_A1MW
SY   iPS-L-2135
DR   BioSamples; SAMEA7601551
DR   hPSCreg; LUEi013-A
DR   Wikidata; Q102114484
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   LUEi014-A
AC   CVCL_A1TG
SY   iPS-B-125
DR   BioSamples; SAMEA7683805
DR   hPSCreg; LUEi014-A
DR   Wikidata; Q105509956
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   LUEi015-A
AC   CVCL_A1WI
SY   iPS-B-11
DR   BioSamples; SAMEA7683939
DR   hPSCreg; LUEi015-A
DR   Wikidata; Q105509960
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   LUEi016-A
AC   CVCL_A1WJ
SY   iPS-B-300
DR   hPSCreg; LUEi016-A
DR   Wikidata; Q105509962
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   LUEi017-A
AC   CVCL_A1WK
SY   iPS-L-2122
DR   BioSamples; SAMEA7683942
DR   hPSCreg; LUEi017-A
DR   Wikidata; Q105509965
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   LUEi018-A
AC   CVCL_A1WL
SY   iPS-L-2124
DR   BioSamples; SAMEA7683943
DR   hPSCreg; LUEi018-A
DR   Wikidata; Q105509970
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   LUEi019-A
AC   CVCL_A1GS
SY   iPS-L-8172-1
DR   BioSamples; SAMEA7513376
DR   hPSCreg; LUEi019-A
DR   Wikidata; Q102114485
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1GT ! LUEi019-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   LUEi019-B
AC   CVCL_A1GT
SY   iPS-L-8172-2
DR   BioSamples; SAMEA7683947
DR   hPSCreg; LUEi019-B
DR   Wikidata; Q102114487
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175210; Neurodegeneration with brain iron accumulation 5
DI   ORDO; Orphanet_329284; Beta-propeller protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1GS ! LUEi019-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   LUEi020-A
AC   CVCL_E4H0
SY   iPS-L9827-6
DR   hPSCreg; LUEi020-A
RX   PubMed=32516804;
RX   PubMed=39490211;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (PubMed=32516804).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUEi020-A-1
AC   CVCL_E4H1
SY   iPS-L9827-6_TOR1A_WT-3xFLAG/dGAG
DR   hPSCreg; LUEi020-A-1
RX   PubMed=39490211;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Characteristics: Using CRISPR/Cas9 a 3xFLAG tag was inserted at the C-terminus of the non-mutated TOR1A allele (PubMed=39490211).
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4H0 ! LUEi020-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUEi020-A-2
AC   CVCL_E4H2
SY   iPS-L9827-6_TOR1A_WT-3xFLAG/WT-3xFLAG
DR   hPSCreg; LUEi020-A-2
RX   PubMed=39490211;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Characteristics: Using CRISPR/Cas9 a 3xFLAG tag was inserted at the C-terminus of both the non-mutated and corrected TOR1A alleles (PubMed=39490211).
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_corrected; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISP/Cas9 (PubMed=39490211).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4H0 ! LUEi020-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUEi020-A-3
AC   CVCL_E4H3
SY   iPS-L9827-6_TOR1A_dGAG-3xFLAG/dGAG
DR   hPSCreg; LUEi020-A-3
RX   PubMed=39490211;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Characteristics: Using CRISPR/Cas9 a 3xFLAG tag was inserted at the C-terminus of both the mutated TOR1A allele and an edited mutated second allele (PubMed=39490211).
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_edited; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISP/Cas9 (PubMed=39490211).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4H0 ! LUEi020-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUEi020-A-4
AC   CVCL_E4H4
SY   iPS-L9827-6_TOR1A_WT/dGAG-3xFLAG
DR   hPSCreg; LUEi020-A-4
RX   PubMed=39490211;
CC   From: Institute of Neurogenetics, University of Lubeck; Lubeck; Germany.
CC   Characteristics: Using CRISPR/Cas9 a 3xFLAG tag was inserted at the C-terminus of the mutated TOR1A allele (PubMed=39490211).
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4H0 ! LUEi020-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUEL5748i-2
AC   CVCL_YZ11
SY   L-5748-2; 5748-2; iPS-L-5748-2
DR   WiCell; luel5748i-2
DR   Wikidata; Q98126972
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7149i-1
AC   CVCL_YZ12
SY   L-7149-1; 7149-1; iPS-L-7149-2
DR   WiCell; luel7149i-1
DR   Wikidata; Q98126975
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ13 ! LUEL7149i-2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7149i-2
AC   CVCL_YZ13
SY   L-7149-2; 7149-2
DR   WiCell; luel7149i-2
DR   Wikidata; Q98126978
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ12 ! LUEL7149i-1
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7153i-1
AC   CVCL_YZ14
DR   WiCell; luel7153i-1
DR   Wikidata; Q98126980
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7159i-16
AC   CVCL_YZ15
DR   WiCell; luel7159i-16
DR   Wikidata; Q98126983
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ16 ! LUEL7159i-7
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7159i-7
AC   CVCL_YZ16
DR   WiCell; luel7159i-7
DR   Wikidata; Q98126985
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ15 ! LUEL7159i-16
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7673i-3
AC   CVCL_YZ17
DR   WiCell; luel7673i-3
DR   Wikidata; Q98126987
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7756i-2
AC   CVCL_YZ18
DR   WiCell; luel7756i-2
DR   Wikidata; Q98126990
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ19 ! LUEL7756i-4
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7756i-4
AC   CVCL_YZ19
DR   WiCell; luel7756i-4
DR   Wikidata; Q98126993
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ18 ! LUEL7756i-2
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7991i-1
AC   CVCL_YZ20
DR   WiCell; luel7991i-1
DR   Wikidata; Q98126996
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ21 ! LUEL7991i-4
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7991i-4
AC   CVCL_YZ21
DR   WiCell; luel7991i-4
DR   Wikidata; Q98126998
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ20 ! LUEL7991i-1
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7994i-1
AC   CVCL_YZ22
SY   L-7994-1; 7994-1; iPS-L-7994-1
DR   WiCell; luel7994i-1
DR   Wikidata; Q98127000
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ23 ! LUEL7994i-2
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7994i-2
AC   CVCL_YZ23
SY   L-7994-2; 7994-2
DR   WiCell; luel7994i-2
DR   Wikidata; Q98127004
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ22 ! LUEL7994i-1
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7996i-10
AC   CVCL_YZ24
DR   WiCell; luel7996i-10
DR   Wikidata; Q98127008
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ25 ! LUEL7996i-2
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL7996i-2
AC   CVCL_YZ25
DR   WiCell; luel7996i-2
DR   Wikidata; Q98127010
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ24 ! LUEL7996i-10
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8312i-1
AC   CVCL_YZ26
DR   WiCell; luel8312i-1
DR   Wikidata; Q98127012
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ27 ! LUEL8312i-4
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8312i-4
AC   CVCL_YZ27
DR   WiCell; luel8312i-4
DR   Wikidata; Q98127015
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ26 ! LUEL8312i-1
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8357i-2
AC   CVCL_YZ28
SY   L8357-2; 8357-2; iPS-L-8357-2
DR   WiCell; luel8357i-2
DR   Wikidata; Q98127017
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ29 ! LUEL8357i-3
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8357i-3
AC   CVCL_YZ29
SY   L8357-3; 8357-3
DR   WiCell; luel8357i-3
DR   Wikidata; Q98127021
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ28 ! LUEL8357i-2
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8360i-2
AC   CVCL_YZ30
SY   L8360-2; 8360-2
DR   WiCell; luel8360i-2
DR   Wikidata; Q98127023
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ31 ! LUEL8360i-5
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8360i-5
AC   CVCL_YZ31
SY   L8360-5; 8360-5; iPS-L-8360-5
DR   WiCell; luel8360i-5
DR   Wikidata; Q98127026
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ30 ! LUEL8360i-2
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8361i-1
AC   CVCL_YZ32
SY   L8361-1; 8361-1
DR   WiCell; luel8361i-1
DR   Wikidata; Q98127028
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ33 ! LUEL8361i-2
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8361i-2
AC   CVCL_YZ33
SY   L8361-2; 8361-2; iPS-L-8361-2
DR   WiCell; luel8361i-2
DR   Wikidata; Q98127030
RX   PubMed=29944858;
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ32 ! LUEL8361i-1
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8363i-2
AC   CVCL_YZ34
DR   WiCell; luel8363i-2
DR   Wikidata; Q98127034
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ35 ! LUEL8363i-3
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8363i-3
AC   CVCL_YZ35
DR   WiCell; luel8363i-3
DR   Wikidata; Q98127036
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YZ34 ! LUEL8363i-2
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8364i-1
AC   CVCL_YZ36
DR   WiCell; luel8364i-1
DR   Wikidata; Q98127039
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUEL8679i-4
AC   CVCL_YZ37
DR   WiCell; luel8679i-4
DR   Wikidata; Q98127041
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUHMES
AC   CVCL_B056
SY   LUnd Human MESencephalic
DR   ABM; T0284
DR   ATCC; CRL-2927
DR   BioSample; SAMN03471701
DR   BioSample; SAMN08723614
DR   Wikidata; Q54903259
RX   PubMed=16000623;
RX   PubMed=21434924;
RX   PubMed=24173167;
RX   PubMed=30602607;
RX   PubMed=32150624;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-and-morphology-of-luhmes-crl-2927
CC   Characteristics: Embryonic neuronal precursor cells that can be maintained as proliferating cells due to the expression of a tetracycline-regulatable (Tet-Off) v-myc transgene. Can be differentiated to post-mitotic neurons by the addition of tetracycline, GDNF and dibutyryl cAMP.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
ST   Source(s): ATCC=CRL-2927
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 11,13
ST   D8S1179: 12,13
ST   FGA: 19,21
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B061 ! MESC2.10
SX   Female
AG   8FW
CA   Conditionally immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   LUHMES IDS KO clone 13
AC   CVCL_D2PI
DR   Wikidata; Q127382709
RX   PubMed=37357221;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5389; IDS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B056 ! LUHMES
SX   Female
AG   8FW
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LUHMES IDS KO clone 18
AC   CVCL_D2PJ
DR   Wikidata; Q127382710
RX   PubMed=37357221;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5389; IDS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B056 ! LUHMES
SX   Female
AG   8FW
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   LuKII
AC   CVCL_LK86
SY   Luk II
DR   Wikidata; Q54903260
RX   PubMed=3863119;
RX   PubMed=6160588;
RX   PubMed=6193516;
CC   Problematic cell line: Misidentified. Originally thought to derive from RPMI-8866 but, based on differences in phosphoglucomutase-1 isozyme fingerprints, was determined not to be originating from that cell line (PubMed=6160588).
CC   Characteristics: Produces TNF.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   Lulo
AC   CVCL_Z241
DR   Wikidata; Q54903261
RX   PubMed=10656714;
RX   PubMed=22082050;
CC   Group: Insect cell line.
CC   Characteristics: The promastigote form of species from the subgenera Leishmania and Viannia can adhere to Lulo cells (PubMed=22082050).
CC   Doubling time: 24.7 hours (PubMed=10656714).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7200; ! Lutzomyia longipalpis (Sand fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   LuM1
AC   CVCL_X013
DR   Wikidata; Q54903262
RX   PubMed=8609053;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0240 ! MC-26
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
ID   LuMa
AC   CVCL_ZE80
DR   ABM; T8284
DR   Wikidata; Q98127045
RX   PubMed=32348616;
CC   Characteristics: Metastasizes to the appendicular and axial skeleton after injection into the left cardiac ventricle in mice and produce osteoblastic bone metastases.
CC   Doubling time: 30.8 +- 1.4 hours (PubMed=32348616).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   LuMa-Luc
AC   CVCL_ZE81
DR   ABM; T8285
DR   Wikidata; Q98127048
RX   PubMed=32348616;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_ZE80 ! LuMa
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   LUMC-C38
AC   CVCL_JE01
DR   IPD-IMGT/HLA; 15413
DR   Wikidata; Q54903263
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01; B*08:01,58:01; C*07:01,07:18; DPB1*01:01,17:01; DQA1*02:01,05:01; DQB1*02:01,02:02; DRB1*03:01,07:01; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=15413).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 9
//
ID   LUMCe001-A
AC   CVCL_C777
SY   HESC-NL1
DR   hPSCreg; LUMCe001-A
DR   SKIP; SKIP001836
DR   Wikidata; Q54903264
RX   PubMed=18391958;
RX   PubMed=18772870;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   LUMCe002-A
AC   CVCL_C778
SY   HESC-NL2
DR   hPSCreg; LUMCe002-A
DR   SKIP; SKIP001837
DR   Wikidata; Q54903265
RX   PubMed=18391958;
RX   PubMed=18772870;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   LUMCe003-A
AC   CVCL_C779
SY   HESC-NL3
DR   hPSCreg; LUMCe003-A
DR   SKIP; SKIP001838
DR   Wikidata; Q54903266
RX   PubMed=18096723;
RX   PubMed=18391958;
RX   PubMed=18772870;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   LUMCe004-A
AC   CVCL_C780
SY   HESC-NL4
DR   hPSCreg; LUMCe004-A
DR   SKIP; SKIP001839
DR   Wikidata; Q54903267
RX   PubMed=18096723;
RX   PubMed=18391958;
RX   PubMed=18772870;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   LUMCi001-A
AC   CVCL_9S26
SY   LUMC0054iCTRL02
DR   BioSamples; SAMEA6438551
DR   hPSCreg; LUMCi001-A
DR   SKIP; SKIP002634
DR   Wikidata; Q54903268
RX   PubMed=29657098;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S27 ! LUMCi001-B
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   LUMCi001-B
AC   CVCL_9S27
SY   LUMC0054iCTRL03; LUMCi001-A-1
DR   BioSamples; SAMEA6673737
DR   hPSCreg; LUMCi001-B
DR   SKIP; SKIP002666
DR   Wikidata; Q54903269
RX   PubMed=29657098;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S26 ! LUMCi001-A
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   LUMCi002-A
AC   CVCL_VE42
SY   LUMC0113iATAX06; 113-6
DR   BioSamples; SAMEA6456115
DR   hPSCreg; LUMCi002-A
DR   SKIP; SKIP003231
DR   Wikidata; Q54903270
RX   PubMed=29656178;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[46]; Zygosity=Heterozygous; Note=The other allele has 29 repeats (PubMed=29656178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE43 ! LUMCi002-B
OI   CVCL_VE44 ! LUMCi002-C
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   LUMCi002-B
AC   CVCL_VE43
SY   LUMC0113iATAX07; 113-7
DR   BioSamples; SAMEA6456116
DR   hPSCreg; LUMCi002-B
DR   SKIP; SKIP003232
DR   Wikidata; Q54903271
RX   PubMed=29656178;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[46]; Zygosity=Heterozygous; Note=The other allele has 29 repeats (PubMed=29656178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE42 ! LUMCi002-A
OI   CVCL_VE44 ! LUMCi002-C
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   LUMCi002-C
AC   CVCL_VE44
SY   LUMC0113iATAX08; 113-8
DR   BioSamples; SAMEA6456117
DR   hPSCreg; LUMCi002-C
DR   SKIP; SKIP003233
DR   Wikidata; Q54903272
RX   PubMed=29656178;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[47]; Zygosity=Heterozygous; Note=The other allele has 29 repeats (PubMed=29656178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE42 ! LUMCi002-A
OI   CVCL_VE43 ! LUMCi002-B
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   LUMCi003-A
AC   CVCL_VE45
SY   LUMC0114iCTRL01; 114-1
DR   BioSamples; SAMEA6456118
DR   hPSCreg; LUMCi003-A
DR   SKIP; SKIP003234
DR   Wikidata; Q54903273
RX   PubMed=29656178;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE46 ! LUMCi003-B
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 10
//
ID   LUMCi003-B
AC   CVCL_VE46
SY   LUMC0114iCTRL02; 114-2
DR   BioSamples; SAMEA6456120
DR   hPSCreg; LUMCi003-B
DR   SKIP; SKIP003235
DR   Wikidata; Q54903274
RX   PubMed=29656178;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE45 ! LUMCi003-A
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 10
//
ID   LUMCi004-A
AC   CVCL_UK77
SY   LUMC0099iCTRL04; LUMC99
DR   BioSamples; SAMEA5032583
DR   hPSCreg; LUMCi004-A
DR   Wikidata; Q95983436
RX   PubMed=29503086;
RX   PubMed=31945612;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA00 ! LUMCi004-B
OI   CVCL_ZA01 ! LUMCi004-C
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   LUMCi004-A-1
AC   CVCL_C6UC
SY   LU99_AAVS1-bxb-v2
DR   BioSamples; SAMEA112164540
DR   hPSCreg; LUMCi004-A-1
DR   Wikidata; Q117704634
RX   PubMed=36495703;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Characteristics: Contains a platform to precisely integrate DNA payloads into the cell genome. Using CRISPR/Cas9 a STRAIGHT-IN v2 construct (loxP-EBFP2-attP(bxb1)-BleoR-lox257) was introduced in one of the alleles of the AAVS1 safe harbor locus (PubMed=36495703).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; DVMQ7; EBFP2 (Note=Blue fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK77 ! LUMCi004-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   LUMCi004-A-2
AC   CVCL_C6UD
SY   LU99_CLYBL-bxb-v2
DR   BioSamples; SAMEA112164541
DR   hPSCreg; LUMCi004-A-2
DR   Wikidata; Q117704635
RX   PubMed=36495703;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Characteristics: Contains a platform to precisely integrate DNA payloads into the cell genome. Using TALEN a STRAIGHT-IN v2 construct (loxP-EBFP2-attP(bxb1)-BleoR-lox257) was introduced in one of the alleles of CLYBL (PubMed=36495703).
CC   Genetic integration: Method=TALEN; Gene=FPbase; DVMQ7; EBFP2 (Note=Blue fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK77 ! LUMCi004-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   LUMCi004-A-3
AC   CVCL_E3P8
SY   IsoLUMC0099iXPA-B8; LUMCi099_XPA_B8
DR   BioSamples; SAMEA115580244
DR   hPSCreg; LUMCi004-A-3
RX   PubMed=39321748;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple_edited; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=39321748).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK77 ! LUMCi004-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi004-A-4
AC   CVCL_E4H5
SY   LUMCi099_XPC_D10
DR   BioSamples; SAMEA115580245
DR   hPSCreg; LUMCi004-A-4
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple_edited; p.Gln467Ter (c.1399C>T); ClinVar=VCV003240754; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=LUMCi004-A-4).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK77 ! LUMCi004-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi004-A-5
AC   CVCL_E4H6
SY   LU99_SCN5A-R282H_cis
DR   BioSamples; SAMEA116100393
DR   hPSCreg; LUMCi004-A-5
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple_edited; p.Arg282His (c.845G>A); ClinVar=VCV000068048; Zygosity=Unspecified; Note=By CRISPR/Cas9 (hPSCreg=LUMCi004-A-5).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK77 ! LUMCi004-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi004-A-6
AC   CVCL_E4H7
SY   LU99_SCN5A-R282H_trans
DR   BioSamples; SAMEA116100394
DR   hPSCreg; LUMCi004-A-6
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple_edited; p.Arg282His (c.845G>A); ClinVar=VCV000068048; Zygosity=Unspecified; Note=By CRISPR/Cas9 (hPSCreg=LUMCi004-A-6).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK77 ! LUMCi004-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi004-B
AC   CVCL_ZA00
SY   LUMC0030iCTRL12
DR   BioSamples; SAMEA6879680
DR   hPSCreg; LUMCi004-B
DR   Wikidata; Q98127050
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK77 ! LUMCi004-A
OI   CVCL_ZA01 ! LUMCi004-C
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LUMCi004-C
AC   CVCL_ZA01
SY   LUMC0031iCTRL08
DR   BioSamples; SAMEA6880363
DR   hPSCreg; LUMCi004-C
DR   Wikidata; Q98127052
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK77 ! LUMCi004-A
OI   CVCL_ZA00 ! LUMCi004-B
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   LUMCi005-A
AC   CVCL_UK78
SY   LUMC0074iHCHWAD01; Lu074i#1
DR   hPSCreg; LUMCi005-A
DR   Wikidata; Q95983438
RX   PubMed=30611017;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Glu693Gln (c.2077G>C); ClinVar=VCV000018087; Zygosity=Heterozygous (PubMed=30611017).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK79 ! LUMCi005-B
OI   CVCL_UK80 ! LUMCi005-C
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   LUMCi005-A-3
AC   CVCL_C9HL
SY   Iso1LUMC0074iHCHWAD01
DR   hPSCreg; LUMCi005-A-3
DR   Wikidata; Q123032980
RX   PubMed=37603921;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_corrected; p.Glu693Gln (c.2077G>C); ClinVar=VCV000018087; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37603921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK78 ! LUMCi005-A
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LUMCi005-A-4
AC   CVCL_C9HM
SY   Iso3LUMC0074iHCHWAD01
DR   hPSCreg; LUMCi005-A-4
DR   Wikidata; Q123032981
RX   PubMed=37603921;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_corrected; p.Glu693Gln (c.2077G>C); ClinVar=VCV000018087; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37603921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK78 ! LUMCi005-A
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LUMCi005-B
AC   CVCL_UK79
SY   LUMC0074iHCHWAD03; Lu074i#3
DR   hPSCreg; LUMCi005-B
DR   Wikidata; Q95983440
RX   PubMed=30611017;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Glu693Gln (c.2077G>C); ClinVar=VCV000018087; Zygosity=Heterozygous (PubMed=30611017).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK78 ! LUMCi005-A
OI   CVCL_UK80 ! LUMCi005-C
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   LUMCi005-C
AC   CVCL_UK80
SY   LUMC0074iHCHWAD07; Lu074i#7
DR   hPSCreg; LUMCi005-C
DR   Wikidata; Q95983442
RX   PubMed=30611017;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Glu693Gln (c.2077G>C); ClinVar=VCV000018087; Zygosity=Heterozygous (PubMed=30611017).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157147; Cerebral amyloid angiopathy, APP-related
DI   ORDO; Orphanet_85458; Hereditary cerebral hemorrhage with amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK78 ! LUMCi005-A
OI   CVCL_UK79 ! LUMCi005-B
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   LUMCi007-A
AC   CVCL_WR59
SY   LUMC0151iHD01; 151-1
DR   BioSamples; SAMEA6456121
DR   hPSCreg; LUMCi007-A
DR   Wikidata; Q95983444
RX   PubMed=31326748;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=31326748).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WR60 ! LUMCi007-B
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   LUMCi007-B
AC   CVCL_WR60
SY   LUMC0151iHD05; 151-5
DR   BioSamples; SAMEA6456123
DR   hPSCreg; LUMCi007-B
DR   Wikidata; Q95983448
RX   PubMed=31326748;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=31326748).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WR59 ! LUMCi007-A
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   LUMCi008-A
AC   CVCL_WR61
SY   LUMC0152iHD02; 152-2
DR   BioSamples; SAMEA6456124
DR   hPSCreg; LUMCi008-A
DR   Wikidata; Q95983451
RX   PubMed=31326748;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=31326748).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WR62 ! LUMCi008-B
OI   CVCL_WR63 ! LUMCi008-C
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   LUMCi008-B
AC   CVCL_WR62
SY   LUMC0152iHD03; 152-3
DR   BioSamples; SAMEA6456126
DR   hPSCreg; LUMCi008-B
DR   Wikidata; Q95983453
RX   PubMed=31326748;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=31326748).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WR61 ! LUMCi008-A
OI   CVCL_WR63 ! LUMCi008-C
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   LUMCi008-C
AC   CVCL_WR63
SY   LUMC0152iHD04; 152-4
DR   BioSamples; SAMEA6456127
DR   hPSCreg; LUMCi008-C
DR   Wikidata; Q95983455
RX   PubMed=31326748;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=31326748).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WR61 ! LUMCi008-A
OI   CVCL_WR62 ! LUMCi008-B
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   LUMCi009-A
AC   CVCL_WR64
SY   LUMC0085iCTRL; LUMC0085
DR   hPSCreg; LUMCi009-A
DR   Wikidata; Q95983457
RX   PubMed=31733439;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   LUMCi010-A
AC   CVCL_WR65
SY   LUMC0084iFOP; LUMC0084
DR   hPSCreg; LUMCi010-A
DR   Wikidata; Q95983460
RX   PubMed=31733439;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=31733439).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   LUMCi011-A
AC   CVCL_XJ82
SY   LUMC0162iCTRL05; 0162-CTRL05
DR   hPSCreg; LUMCi011-A
DR   Wikidata; Q95983463
RX   PubMed=31518905;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The fibroblast from which this iPSC was derived is normal (PubMed=31518905).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ83 ! LUMCi011-B
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   LUMCi011-B
AC   CVCL_XJ83
SY   LUMC0162iFSHD04; 0162-FSHD04
DR   hPSCreg; LUMCi011-B
DR   Wikidata; Q95983466
RX   PubMed=31518905;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Mosaic; Note=D4Z4 repeat contraction (to 3 repeats) (PubMed=31518905).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The fibroblast from which this iPSC was derived bears the contraction (PubMed=31518905).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ82 ! LUMCi011-A
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   LUMCi012-A
AC   CVCL_XJ84
SY   LUMC0163iCTRL05; 0163-CTRL05
DR   hPSCreg; LUMCi012-A
DR   Wikidata; Q95983468
RX   PubMed=31518905;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The fibroblast from which this iPSC was derived is normal (PubMed=31518905).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ85 ! LUMCi012-B
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   LUMCi012-B
AC   CVCL_XJ85
SY   LUMC0163iFSHD04; 0163-FSHD04
DR   hPSCreg; LUMCi012-B
DR   Wikidata; Q95983470
RX   PubMed=31518905;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Mosaic; Note=D4Z4 repeat contraction (to 2 repeats) (PubMed=31518905).
CC   Donor information: While the patient is suffering from facioscapulohumeral muscular dystrophy 1 he is mosaic for the D4Z4 repeat contraction. The fibroblast from which this iPSC was derived bears the contraction (PubMed=31518905).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ84 ! LUMCi012-A
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   LUMCi013-A
AC   CVCL_YD60
SY   LUMC0133iCTRL06; L01
DR   BioSamples; SAMEA6285354
DR   hPSCreg; LUMCi013-A
DR   Wikidata; Q95983472
RX   PubMed=31734644;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 8
//
ID   LUMCi014-A
AC   CVCL_YD61
SY   LUMC0134iCTRL29; L02
DR   BioSamples; SAMEA6285355
DR   hPSCreg; LUMCi014-A
DR   Wikidata; Q95983475
RX   PubMed=31734644;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   LUMCi015-A
AC   CVCL_YD62
SY   LUMC0135iCTRL01; L03
DR   BioSamples; SAMEA6285357
DR   hPSCreg; LUMCi015-A
DR   Wikidata; Q95983478
RX   PubMed=31734644;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of LUMCi016-A (Cellosaurus=CVCL_YD63).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   LUMCi016-A
AC   CVCL_YD63
SY   LUMC0136iCTRL09; L04
DR   BioSamples; SAMEA6285359
DR   hPSCreg; LUMCi016-A
DR   Wikidata; Q95983480
RX   PubMed=31734644;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of LUMCi015-A (Cellosaurus=CVCL_YD62).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   LUMCi017-A
AC   CVCL_ZA21
SY   LUMC0111iALK; LUMC0111iALK07
DR   BioSamples; SAMEA5966783
DR   hPSCreg; LUMCi017-A
DR   Wikidata; Q98127054
RX   PubMed=40876070;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple; p.Asp348Thrfs*6 (c.1042delG); ClinVar=VCV000569067; Zygosity=Heterozygous (PubMed=40876070).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 4
//
ID   LUMCi017-A-1
AC   CVCL_F1J4
SY   Iso01LUMC0111iALK07
DR   BioSamples; SAMEA118676637
DR   hPSCreg; LUMCi017-A-1
RX   PubMed=40876070;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple_corrected; p.Asp348Thrfs*6 (c.1042delG); ClinVar=VCV000569067; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=40876070).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA21 ! LUMCi017-A
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi017-A-2
AC   CVCL_F1J5
SY   Iso02LUMC0111iALK07
DR   BioSamples; SAMEA118678315
DR   hPSCreg; LUMCi017-A-2
RX   PubMed=40876070;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple_corrected; p.Asp348Thrfs*6 (c.1042delG); ClinVar=VCV000569067; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=40876070).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA21 ! LUMCi017-A
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi018-A
AC   CVCL_ZA22
SY   LUMC0112iALK; LUMC0112iALK08
DR   BioSamples; SAMEA118679128
DR   hPSCreg; LUMCi018-A
DR   Wikidata; Q98127057
RX   PubMed=40876070;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple; p.Asp348Thrfs*6 (c.1042delG); ClinVar=VCV000569067; Zygosity=Heterozygous (PubMed=40876070).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 4
//
ID   LUMCi018-A-1
AC   CVCL_F1J6
SY   Iso01LUMC0112iALK08
DR   BioSamples; SAMEA118679261
DR   hPSCreg; LUMCi018-A-1
RX   PubMed=40876070;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple_corrected; p.Asp348Thrfs*6 (c.1042delG); ClinVar=VCV000569067; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=40876070).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA22 ! LUMCi018-A
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi018-A-2
AC   CVCL_F1J7
SY   Iso02LUMC0112iALK08
DR   BioSamples; SAMEA118679402
DR   hPSCreg; LUMCi018-A-2
RX   PubMed=40876070;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple_corrected; p.Asp348Thrfs*6 (c.1042delG); ClinVar=VCV000569067; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=40876070).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA22 ! LUMCi018-A
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi020-A
AC   CVCL_ZA20
SY   LUMC0159iRYR08
DR   BioSamples; SAMEA6659009
DR   hPSCreg; LUMCi020-A
DR   Wikidata; Q98127062
RX   PubMed=32315959;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Arg4147Ser (c.12441G>T); Zygosity=Heterozygous (PubMed=32315959).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LUMCi021-A
AC   CVCL_ZA15
SY   LUMC0160iRYR01
DR   hPSCreg; LUMCi021-A
DR   Wikidata; Q98127064
RX   PubMed=32315959;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Tyr4962Cys (c.14885A>G); ClinVar=VCV000201405; Zygosity=Heterozygous (PubMed=32315959).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LUMCi022-A
AC   CVCL_ZA11
SY   LUMC0115iATAX01; 115-1
DR   BioSamples; SAMEA6468139
DR   hPSCreg; LUMCi022-A
DR   Wikidata; Q98127068
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA12 ! LUMCi022-B
OI   CVCL_ZA13 ! LUMCi022-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUMCi022-B
AC   CVCL_ZA12
SY   LUMC0115iATAX02; 115-2
DR   BioSamples; SAMEA6468208
DR   hPSCreg; LUMCi022-B
DR   Wikidata; Q98127070
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA11 ! LUMCi022-A
OI   CVCL_ZA13 ! LUMCi022-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUMCi022-C
AC   CVCL_ZA13
SY   LUMC0115iATAX07; 115-7
DR   BioSamples; SAMEA6468209
DR   hPSCreg; LUMCi022-C
DR   Wikidata; Q98127072
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA11 ! LUMCi022-A
OI   CVCL_ZA12 ! LUMCi022-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUMCi023-A
AC   CVCL_ZA14
SY   LUMC0125iCTRL06; 125-6
DR   BioSamples; SAMEA6468595
DR   hPSCreg; LUMCi023-A
DR   Wikidata; Q98127075
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUMCi024-A
AC   CVCL_ZA16
SY   LUMC0057iAARS03
DR   hPSCreg; LUMCi024-A
DR   Wikidata; Q98127078
RX   PubMed=34088003;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21022; AARS2; Simple; p.Arg592Trp (c.1774C>T); ClinVar=VCV000030940; Zygosity=Heterozygous (PubMed=34088003).
CC   Sequence variation: Mutation; HGNC; HGNC:21022; AARS2; Simple; p.Val730Met (c.2188G>A); ClinVar=VCV000136214; Zygosity=Heterozygous (PubMed=34088003).
CC   Sequence variation: Mutation; HGNC; HGNC:21022; AARS2; Simple; p.Arg958Ter (c.2872C>T); ClinVar=VCV002385967; Zygosity=Heterozygous (PubMed=34088003).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C180851; Combined oxidative phosphorylation deficiency 8
DI   ORDO; Orphanet_319504; Combined oxidative phosphorylation defect type 8
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 8
//
ID   LUMCi025-A
AC   CVCL_ZA17
SY   LUMC0058iAARS01
DR   hPSCreg; LUMCi025-A
DR   Wikidata; Q98127080
RX   PubMed=34088003;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21022; AARS2; Simple; p.Arg592Trp (c.1774C>T); ClinVar=VCV000030940; Zygosity=Heterozygous (PubMed=34088003).
CC   Sequence variation: Mutation; HGNC; HGNC:21022; AARS2; Simple; p.Val730Met (c.2188G>A); ClinVar=VCV000136214; Zygosity=Heterozygous (PubMed=34088003).
CC   Sequence variation: Mutation; HGNC; HGNC:21022; AARS2; Simple; p.Arg958Ter (c.2872C>T); ClinVar=VCV002385967; Zygosity=Heterozygous (PubMed=34088003).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C180851; Combined oxidative phosphorylation deficiency 8
DI   ORDO; Orphanet_319504; Combined oxidative phosphorylation defect type 8
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 8
//
ID   LUMCi026-A
AC   CVCL_ZA24
SY   LUMC0059iCTRL03
DR   hPSCreg; LUMCi026-A
DR   Wikidata; Q98127083
RX   PubMed=34088003;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21022; AARS2; Simple; p.Arg958Ter (c.2872C>T); ClinVar=VCV002385967; Zygosity=Heterozygous (PubMed=34088003).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 8
//
ID   LUMCi027-A
AC   CVCL_ZA18
SY   LUMC0153iPKP03
DR   BioSamples; SAMEA6724119
DR   hPSCreg; LUMCi027-A
DR   Wikidata; Q98127085
RX   PubMed=32485643;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Lys672Argfs*12 (c.2013delC); ClinVar=VCV000202022; Zygosity=Heterozygous (PubMed=32485643).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LUMCi027-A-1
AC   CVCL_ZA19
SY   iso01LUMC0153iPKP03; LUMC0153iPKP03corr#22
DR   BioSamples; SAMEA8073006
DR   hPSCreg; LUMCi027-A-1
DR   Wikidata; Q98127087
RX   PubMed=32485643;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple_corrected; p.Lys672Argfs*12 (c.2013delC); ClinVar=VCV000202022; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32485643).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA18 ! LUMCi027-A
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LUMCi028-A
AC   CVCL_ZA25
AS   CVCL_YN01
SY   LUMC0020iCTRL06; LUMC0020iCTRL; LUMC20; FLB6; WT2-iPSC
DR   BioSamples; SAMEA6673735
DR   hPSCreg; LUMCi028-A
DR   Wikidata; Q98127090
RX   PubMed=25453094;
RX   PubMed=31945612;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   LUMCi029-A
AC   CVCL_ZA09
SY   LUMC0072iCTRL01
DR   BioSamples; SAMEA6673738
DR   hPSCreg; LUMCi029-A
DR   Wikidata; Q98127093
RX   PubMed=29503086;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA10 ! LUMCi029-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUMCi029-B
AC   CVCL_ZA10
SY   LUMC0004iCTRL10
DR   BioSamples; SAMEA6878157
DR   hPSCreg; LUMCi029-B
DR   Wikidata; Q98127096
RX   PubMed=30956116;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA09 ! LUMCi029-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 6
//
ID   LUMCi029-B-1
AC   CVCL_D0XK
SY   ABCA4.KO.G3
DR   hPSCreg; LUMCi029-B-1
DR   Wikidata; Q123032982
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34; ABCA4.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA10 ! LUMCi029-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LUMCi029-B-2
AC   CVCL_D0XL
SY   ABCA4.KO.H10
DR   hPSCreg; LUMCi029-B-2
DR   Wikidata; Q123032983
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34; ABCA4.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA10 ! LUMCi029-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   LUMCi030-A
AC   CVCL_ZA38
AS   CVCL_ZA23
SY   LUMC0110iALK04; LUMCi019-A
DR   BioSamples; SAMEA6712310
DR   hPSCreg; LUMCi030-A
DR   Wikidata; Q98127060
RX   PubMed=32485642;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple; p.Arg374_Glu379del (c.1120_1137del18) (c.1120del18); Zygosity=Heterozygous (PubMed=32485642).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA39 ! LUMCi030-B
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   LUMCi030-A-1
AC   CVCL_ZL47
SY   iso03LUMC0110iALK04
DR   BioSamples; SAMEA6712312
DR   hPSCreg; LUMCi030-A-1
DR   Wikidata; Q98127101
RX   PubMed=32485642;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple_corrected; p.Arg374_Glu379del (c.1120_1137del18); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32485642).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA38 ! LUMCi030-A
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LUMCi030-B
AC   CVCL_ZA39
SY   LUMC0110iALK10
DR   BioSamples; SAMEA6878126
DR   hPSCreg; LUMCi030-B
DR   Wikidata; Q98127103
RX   PubMed=32485642;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple; p.Arg374_Glu379del (c.1120_1137del18) (c.1120del18); Zygosity=Heterozygous (PubMed=32485642).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA38 ! LUMCi030-A
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LUMCi030-B-1
AC   CVCL_ZL48
SY   iso01LUMC0110iALK10
DR   BioSamples; SAMEA6878128
DR   hPSCreg; LUMCi030-B-1
DR   Wikidata; Q98127105
RX   PubMed=32485642;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple_corrected; p.Arg374_Glu379del (c.1120_1137del18); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32485642).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA39 ! LUMCi030-B
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   LUMCi031-A
AC   CVCL_ZB57
SY   LUMC0065iCTRL08
DR   BioSamples; SAMEA6880364
DR   hPSCreg; LUMCi031-A
DR   Wikidata; Q98127108
RX   PubMed=32218519;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian; Dutch.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   LUMCi039-A
AC   CVCL_A7QT
SY   LQT1-1781G/A hiPSC; iPSC LQT1R594Q; LUMC0021iKCNQ-30
DR   BioSamples; SAMEA8307098
DR   hPSCreg; LUMCi039-A
DR   Wikidata; Q107115879
RX   PubMed=27470144;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg594Gln (c.1781G>A); ClinVar=VCV000053018; Zygosity=Heterozygous (PubMed=27470144).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   LUMCi040-A
AC   CVCL_D0XM
SY   LUMC0053iSCN01B
DR   BioSamples; SAMEA8359793
DR   hPSCreg; LUMCi040-A
DR   Wikidata; Q123032984
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   LUMCi045-A
AC   CVCL_A7QR
SY   LUMC0145iKLHL01
DR   BioSamples; SAMEA8868389
DR   hPSCreg; LUMCi045-A
DR   Wikidata; Q107115880
RX   PubMed=34688992;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Chilean.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple; p.Met1Arg (c.2T>G); Zygosity=Heterozygous (PubMed=34688992).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LUMCi045-A-1
AC   CVCL_A7RY
SY   iso01LUMC0145iKLHL01
DR   BioSamples; SAMEA8868395
DR   hPSCreg; LUMCi045-A-1
DR   Wikidata; Q107115881
RX   PubMed=34688992;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Chilean.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_corrected; p.Met1Arg (c.2T>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992).
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_edited; p.Val2Val (c.6A>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7QR ! LUMCi045-A
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LUMCi046-A
AC   CVCL_A7QS
SY   LUMC0146iKLHL10
DR   BioSamples; SAMEA8868391
DR   hPSCreg; LUMCi046-A
DR   Wikidata; Q107115883
RX   PubMed=34688992;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Chilean.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple; p.Met1Arg (c.2T>G); Zygosity=Heterozygous (PubMed=34688992).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LUMCi046-A-1
AC   CVCL_A7RZ
SY   iso2LUMC0146iKLHL10
DR   BioSamples; SAMEA8868396
DR   hPSCreg; LUMCi046-A-1
DR   Wikidata; Q107115884
RX   PubMed=34688992;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Chilean.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_edited; c.-3A>G; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992).
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_corrected; p.Met1Arg (c.2T>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7QS ! LUMCi046-A
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   LUMCi048-A
AC   CVCL_C1UF
SY   LUMCi048CTRL-A; 48CTRL-A; 48CTRL-3
DR   BioSamples; SAMEA12121561
DR   hPSCreg; LUMCi048-A
DR   Wikidata; Q114311892
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UG ! LUMCi048-B
OI   CVCL_C1UH ! LUMCi048-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   LUMCi048-B
AC   CVCL_C1UG
SY   LUMCi048CTRL-B; 48CTRL-B; 48CTRL-6
DR   BioSamples; SAMEA115368949
DR   hPSCreg; LUMCi048-B
DR   Wikidata; Q114311893
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UF ! LUMCi048-A
OI   CVCL_C1UH ! LUMCi048-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   LUMCi048-C
AC   CVCL_C1UH
SY   LUMCi048CTRL-C; 48CTRL-C; 48CTRL-8
DR   BioSamples; SAMEA115368950
DR   hPSCreg; LUMCi048-C
DR   Wikidata; Q114311894
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UF ! LUMCi048-A
OI   CVCL_C1UG ! LUMCi048-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   LUMCi049-A
AC   CVCL_C1UI
SY   LUMCi049SCA3-A; 49SCA3-A; 49SCA3-1
DR   BioSamples; SAMEA115362326
DR   hPSCreg; LUMCi049-A
DR   Wikidata; Q114311895
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UJ ! LUMCi049-B
OI   CVCL_C1UK ! LUMCi049-C
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   LUMCi049-B
AC   CVCL_C1UJ
SY   LUMCi049SCA3-B; 49SCA3-B; 49SCA3-2
DR   BioSamples; SAMEA115362328
DR   hPSCreg; LUMCi049-B
DR   Wikidata; Q114311896
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UI ! LUMCi049-A
OI   CVCL_C1UK ! LUMCi049-C
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   LUMCi049-C
AC   CVCL_C1UK
SY   LUMCi049SCA3-C; 49SCA3-C; 49SCA3-4
DR   BioSamples; SAMEA115362329
DR   hPSCreg; LUMCi049-C
DR   Wikidata; Q114311897
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UI ! LUMCi049-A
OI   CVCL_C1UJ ! LUMCi049-B
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   LUMCi050-A
AC   CVCL_C1UL
SY   LUMCi050jHD-A; 50jHD-A; 50jHD-2
DR   hPSCreg; LUMCi050-A
DR   Wikidata; Q114311898
CC   From: Leiden University Medical Center; Leiden; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UM ! LUMCi050-B
OI   CVCL_C1UN ! LUMCi050-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LUMCi050-B
AC   CVCL_C1UM
SY   LUMCi050jHD-B; 50jHD-B; 50jHD-4
DR   hPSCreg; LUMCi050-B
DR   Wikidata; Q114311899
CC   From: Leiden University Medical Center; Leiden; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UL ! LUMCi050-A
OI   CVCL_C1UN ! LUMCi050-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LUMCi050-C
AC   CVCL_C1UN
SY   LUMCi050jHD-C; 50jHD-C; 50jHD-5
DR   hPSCreg; LUMCi050-C
DR   Wikidata; Q114311900
CC   From: Leiden University Medical Center; Leiden; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UL ! LUMCi050-A
OI   CVCL_C1UM ! LUMCi050-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   LUMCi051-A
AC   CVCL_D6SI
SY   Lu051i#1
DR   BioSamples; SAMEA114552803
DR   hPSCreg; LUMCi051-A
RX   PubMed=38851031;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[61] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous; Note=The other allele has 10 repeats (PubMed=38851031).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6SM ! LUMCi051-B
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   LUMCi051-B
AC   CVCL_D6SM
SY   Lu051i#2
DR   BioSamples; SAMEA115402240
DR   hPSCreg; LUMCi051-B
RX   PubMed=38851031;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[63] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous; Note=The other allele has 10 repeats (PubMed=38851031).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6SI ! LUMCi051-A
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   LUMCi052-A
AC   CVCL_D6SJ
SY   Lu052i#1
DR   BioSamples; SAMEA115400114
DR   hPSCreg; LUMCi052-A
RX   PubMed=38851031;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[60] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous; Note=The other allele has 10 repeats (PubMed=38851031).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6SK ! LUMCi052-B
OI   CVCL_D6SL ! LUMCi052-C
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   LUMCi052-B
AC   CVCL_D6SK
SY   Lu052i#2
DR   BioSamples; SAMEA115400113
DR   hPSCreg; LUMCi052-B
RX   PubMed=38851031;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[66] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous; Note=The other allele has 10 repeats (PubMed=38851031).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6SJ ! LUMCi052-A
OI   CVCL_D6SL ! LUMCi052-C
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   LUMCi052-C
AC   CVCL_D6SL
SY   Lu052i#3
DR   BioSamples; SAMEA115402354
DR   hPSCreg; LUMCi052-C
RX   PubMed=38851031;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[60] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Heterozygous; Note=The other allele has 10 repeats (PubMed=38851031).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6SJ ! LUMCi052-A
OI   CVCL_D6SK ! LUMCi052-B
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   LUMCi053-A
AC   CVCL_D6SN
SY   LUMC0157iCTRL02; iPHCTRL02
DR   BioSamples; SAMEA114705414
DR   hPSCreg; LUMCi053-A
CC   From: Leiden University Medical Center; Leiden; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   LUMCi054-A
AC   CVCL_F1JI
SY   LUMC0116iCRB09; LUMC0116iCRB clone 9; P116
DR   BioSamples; SAMEA115120807
DR   hPSCreg; LUMCi054-A
RX   PubMed=30956116;
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Homozygous (PubMed=30956116).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi054-A-1
AC   CVCL_F1JJ
SY   LUMC0116iCRB09 ISO-02; iso02LUMC0116iCRB09
DR   BioSamples; SAMEA115120809
DR   hPSCreg; LUMCi054-A-1
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple_corrected; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37541258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1JI ! LUMCi054-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi054-A-2
AC   CVCL_F1JK
SY   LUMC0116iCRB09 ISO-03; iso03LUMC0116iCRB09; ISO-03 P116
DR   BioSamples; SAMEA115121927
DR   hPSCreg; LUMCi054-A-2
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous (hPSCreg=LUMCi054-A-2).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple_corrected; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37541258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1JI ! LUMCi054-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi054-A-3
AC   CVCL_F1W9
SY   LUMC0116iCRB09 ISO-04; iso04LUMC0116iCRB09
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous (PubMed=37541258).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple_corrected; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37541258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1JI ! LUMCi054-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi055-A
AC   CVCL_F1JL
SY   LUMC0117iCRB01; LUMC0117iCRB clone 1; P117
DR   BioSamples; SAMEA115121930
DR   hPSCreg; LUMCi055-A
RX   PubMed=30956116;
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Tyr631Cys (c.1892A>G); ClinVar=VCV000636015; Zygosity=Heterozygous (PubMed=30956116).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Glu995Ter (c.2983G>T); ClinVar=VCV000005731; Zygosity=Heterozygous (PubMed=30956116).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi056-A
AC   CVCL_F1JM
SY   LUMC0128iCRB01; LUMC0128iCRB clone 1; P128
DR   BioSamples; SAMEA115121932
DR   hPSCreg; LUMCi056-A
RX   PubMed=30956116;
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Cys948Tyr (c.2843G>A); ClinVar=VCV000039614; Zygosity=Heterozygous (PubMed=30956116).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous (PubMed=30956116).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi056-A-1
AC   CVCL_F1WA
SY   LUMC0128iCRB01 ISO-02; iso02LUMC0128iCRB01; iso02-128iCRB01; ISO-02 P128
DR   BioSamples; SAMEA115124392
DR   hPSCreg; LUMCi056-A-1
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Cys948Tyr (c.2843G>A); ClinVar=VCV000039614; Zygosity=Heterozygous (PubMed=37541258).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple_corrected; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37541258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1JM ! LUMCi056-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi056-A-2
AC   CVCL_F1WB
SY   LUMC0128iCRB01 ISO-01; iso01LUMC0128iCRB01
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Cys948Tyr (c.2843G>A); ClinVar=VCV000039614; Zygosity=Heterozygous (PubMed=37541258).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple_corrected; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37541258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1JM ! LUMCi056-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi056-A-3
AC   CVCL_F1WC
SY   LUMC0128iCRB01 ISO-05; iso05LUMC0128iCRB01
RX   PubMed=37541258;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Cys948Tyr (c.2843G>A); ClinVar=VCV000039614; Zygosity=Heterozygous (PubMed=37541258).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple_corrected; p.Met1041Thr (c.3122T>C); ClinVar=VCV000005730; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37541258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1JM ! LUMCi056-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi058-A
AC   CVCL_E3P9
SY   LUMCi231KLHL03
DR   BioSamples; SAMEA115597184
DR   hPSCreg; LUMCi058-A
RX   PubMed=39317060;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000264648; Zygosity=Heterozygous (PubMed=39317060).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi058-A-1
AC   CVCL_E3PA
SY   Iso35LUMCi231KLHL03
DR   BioSamples; SAMEA115597186
DR   hPSCreg; LUMCi058-A-1
RX   PubMed=39317060;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_corrected; p.Met1Val (c.1A>G); ClinVar=VCV000264648; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39317060).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3P9 ! LUMCi058-A
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi059-A
AC   CVCL_E3PB
SY   LUMCi232KLHL01
DR   BioSamples; SAMEA115597185
DR   hPSCreg; LUMCi059-A
RX   PubMed=39317060;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000370042; Zygosity=Heterozygous (PubMed=39317060).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi059-A-1
AC   CVCL_E3PC
SY   Iso71LUMCi232KLHL01
DR   BioSamples; SAMEA115597187
DR   hPSCreg; LUMCi059-A-1
RX   PubMed=39317060;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_corrected; p.Met1Thr (c.2T>C); ClinVar=VCV000370042; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39317060).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179709; Intermediate epidermolysis bullosa simplex with cardiomyopathy
DI   ORDO; Orphanet_508529; Intermediate epidermolysis bullosa simplex with cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3PB ! LUMCi059-A
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LUMCi062-A
AC   CVCL_F1WD
SY   LUMC0322iFOPA-03
DR   BioSamples; SAMEA117637321
DR   hPSCreg; LUMCi062-A
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Tyr633His (c.1897T>C); ClinVar=VCV001319116; Zygosity=Heterozygous (hPSCreg=LUMCi062-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1WE ! LUMCi062-B
OI   CVCL_F1WF ! LUMCi062-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi062-B
AC   CVCL_F1WE
SY   LUMC0322iFOPA-05
DR   BioSamples; SAMEA117648522
DR   hPSCreg; LUMCi062-B
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Tyr633His (c.1897T>C); ClinVar=VCV001319116; Zygosity=Heterozygous (hPSCreg=LUMCi062-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1WD ! LUMCi062-A
OI   CVCL_F1WF ! LUMCi062-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LUMCi062-C
AC   CVCL_F1WF
SY   LUMC0322iFOPA-06
DR   hPSCreg; LUMCi062-C
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Tyr633His (c.1897T>C); ClinVar=VCV001319116; Zygosity=Heterozygous (hPSCreg=LUMCi062-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85202; Tricuspid valve atresia
DI   ORDO; Orphanet_1209; Tricuspid atresia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1WD ! LUMCi062-A
OI   CVCL_F1WE ! LUMCi062-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   LuNm01
AC   CVCL_C4YH
SY   LuNmO1
DR   ABCD; ABCD_AE591
DR   Wikidata; Q116049723
RX   PubMed=1385548;
RX   PubMed=8500770;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q51228; Neisseria meningitidis class 5c outer membrane protein.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LuNm03
AC   CVCL_C4YI
SY   LuNmO3
DR   ABCD; ABCD_AE592
DR   Wikidata; Q116049724
RX   PubMed=1385548;
RX   PubMed=8500770;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q51228; Neisseria meningitidis class 5c outer membrane protein.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   LUPI
AC   CVCL_E5UA
SY   sample 8
RX   PubMed=8168993;
RX   PubMed=26909615;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=8168993).
CC   Caution: The relationship between sample 8 from PubMed=8168993 and LUPI from PubMed=26909615 originates from an email communication between Pfeifer, John D. & Van Tine, Brian Andrew. As this cell line is devoid of information relative to the patient from which it was derived and has no STR profile its use should be avoided.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   LuSIV
AC   CVCL_1H04
DR   BEI_Resources; ARP-5460
DR   Wikidata; Q54903275
RX   PubMed=10915601;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/5827-LuSIV-Cells-a-Highly-Sensitive-Detection-System-for-I.html
CC   Characteristics: Transfected with a construct containing firefly luciferase under the control of the SIVmac239 LTR. Activation requires the viral transactivating protein Tat to drive expression of the luciferase reporter gene from the LTR (PubMed=10915601).
CC   Virology: Can be used for the quantitative measurement of HIV/SIV infection within a single replication cycle (PubMed=10915601).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7904 ! T1
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   LUTC-1
AC   CVCL_RP41
SY   Lund University Thyroid Carcinoma-1
DR   Wikidata; Q54903276
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25212604
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 13
ST   D21S11: 28
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D5S818: 8,12
ST   D7S820: 10,13
ST   D8S1179: 9,12
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   LUTC-10
AC   CVCL_RP46
SY   Lund University Thyroid Carcinoma-10
DR   Wikidata; Q54903277
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25212604
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   LUTC-12
AC   CVCL_RP47
SY   Lund University Thyroid Carcinoma-12
DR   Wikidata; Q54903279
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25212604
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 21,24
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   LUTC-13
AC   CVCL_RP48
SY   Lund University Thyroid Carcinoma-13
DR   Wikidata; Q54903280
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   LUTC-14
AC   CVCL_RP49
SY   Lund University Thyroid Carcinoma-14
DR   Wikidata; Q54903281
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25212604
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 8,13
ST   D18S51: 12,15
ST   D19S433: 13.2,16
ST   D21S11: 28
ST   D2S1338: 17,23
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 12,15
ST   FGA: 22
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   LUTC-17
AC   CVCL_RP50
SY   Lund University Thyroid Carcinoma-17
DR   Wikidata; Q54903282
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   LUTC-2
AC   CVCL_RP42
SY   Lund University Thyroid Carcinoma-2
DR   Wikidata; Q54903283
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25212604
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 23,26
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 19,22.2
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   LUTC-4
AC   CVCL_RP43
SY   Lund University Thyroid Carcinoma-4
DR   Wikidata; Q54903284
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   LUTC-5
AC   CVCL_RP44
SY   Lund University Thyroid Carcinoma-5
DR   Wikidata; Q54903285
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   LUTC-8
AC   CVCL_RP45
SY   Lund University Thyroid Carcinoma-8
DR   Wikidata; Q54903286
RX   PubMed=25212604;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25212604
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 14
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,11
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   LUVA
AC   CVCL_5G48
SY   Laboratory of University of VirginiA
DR   ABM; T0843
DR   Kerafast; EG1701-FP
DR   Millipore; SCC205
DR   Wikidata; Q54903287
RX   PubMed=21281958;
RX   PubMed=25149487;
CC   Doubling time: 54.0 +- 0.5 hours (Note=In the absence of SCF), 43.3 +- 2.9 hours (Note=In the presence of SCF) (PubMed=21281958).
CC   Donor information: Established from a donor with aspirin-exacerbated respiratory disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 10
//
ID   LUY
AC   CVCL_E761
DR   dbMHC; 48957
DR   ECACC; 85121705
DR   IHW; IHW09070
DR   IPD-IMGT/HLA; 11011
DR   Wikidata; Q54903289
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=11782282;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*02:01:01:01; B*51:01:01:01; C*14:02:01:01; DPA1*01:03,02:01:02; DPB1*01:01:01,04:01:01; DQA1*04:01,06:01:01; DQB1*03:01:01; DRA*01:02; DRB1*08:03:02 (IPD-IMGT/HLA=11011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   LV-E
AC   CVCL_0C20
DR   Wikidata; Q54903290
RX   PubMed=7736387;
RX   PubMed=9815546;
RX   PubMed=10037197;
RX   PubMed=10100721;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   LVNC-FiPS-MIB1Ctrl-WTm6
AC   CVCL_UM99
DR   Wikidata; Q95983551
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Doc-Deposito-LVNC-FiPS-MIB1Ctrl-WTm6_V3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_LVNC-FiPS-MIB1Ctrl-WTm6_V3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Nacional de Investigaciones Cardiovasculares; Madrid; Spain.
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   LVNC-FiPS-MIB1STOP1
AC   CVCL_UN00
DR   Wikidata; Q95983554
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Doc-deposito-LVNC-FiPS-MIB1STOP1_V3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_LVNC-FiPS-MIB1STOP1_V3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Nacional de Investigaciones Cardiovasculares; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:21086; MIB1; Simple; p.Arg530Ter (c.1588C>T); ClinVar=VCV000040092; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D21S11: 30.2,32.2
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C157266; Left ventricular noncompaction 7
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   LVNC-FiPS-MIB1VF2
AC   CVCL_UN01
DR   Wikidata; Q95983556
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Doc-deposito-LVNC-FiPS-MIB1VF2_v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_LVNC-FiPS-MIB1VF2_V3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro Nacional de Investigaciones Cardiovasculares; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:21086; MIB1; Simple; p.Val943Phe (c.2827G>T); ClinVar=VCV000040091; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C157266; Left ventricular noncompaction 7
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   LVP-03
AC   CVCL_ZC24
DR   Wikidata; Q98127110
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   LVPEIi001-A
AC   CVCL_C1UP
SY   hiPSC-F2-3F1
DR   BioSamples; SAMEA14207085
DR   hPSCreg; LVPEIi001-A
DR   Wikidata; Q114311901
RX   PubMed=28559289;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Derived from site: In situ; Ear, skin, dermis; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4X7 ! LVPEIi001-B
OI   CVCL_E4X8 ! LVPEIi001-C
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   LVPEIi001-B
AC   CVCL_E4X7
SY   LVIP02-NC-F2-1
DR   BioSamples; SAMEA115158771
DR   hPSCreg; LVPEIi001-B
RX   PubMed=38942756;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Derived from site: In situ; Ear, skin, dermis; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UP ! LVPEIi001-A
OI   CVCL_E4X8 ! LVPEIi001-C
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LVPEIi001-C
AC   CVCL_E4X8
SY   LVIP04-NC-F2-1
DR   hPSCreg; LVPEIi001-C
CC   Group: Clinical grade pluripotent cell line.
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Derived from site: In situ; Ear, skin, dermis; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1UP ! LVPEIi001-A
OI   CVCL_E4X7 ! LVPEIi001-B
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LVPEIi002-A
AC   CVCL_D0HP
SY   LVIP02-RB-1
DR   BioSamples; SAMEA114314621
DR   hPSCreg; LVPEIi002-A
DR   Wikidata; Q123032985
RX   PubMed=38335663;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000126785; Zygosity=Heterozygous (PubMed=38335663).
CC   Derived from site: In situ; Eye, orbital adipose tissue; UBERON=UBERON_0006671.
CC   Cell type: Mesenchymal stem cell of orbital adipose tissue; CL=CL_4040004.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   LVPEIi004-A
AC   CVCL_D0HQ
SY   LVIP02-LC2-1
DR   BioSamples; SAMEA114539332
DR   hPSCreg; LVPEIi004-A
DR   Wikidata; Q123032986
RX   PubMed=38631180;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple; p.Lys216Ter (c.646A>T); ClinVar=VCV002949504; Zygosity=Homozygous (PubMed=38631180).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   LVPEIi005-A
AC   CVCL_D6MU
SY   LVIP02-LC2-2
DR   BioSamples; SAMEA115159979
DR   hPSCreg; LVPEIi005-A
DR   Wikidata; Q127382711
RX   PubMed=38631180;
RX   PubMed=38942756;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple; p.Trp331Ter (c.992G>A); ClinVar=VCV001702637; Zygosity=Homozygous (PubMed=38631180).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LVPEIi005-A-1
AC   CVCL_E4X9
SY   LCA2-2-BE1
DR   hPSCreg; LVPEIi005-A-1
RX   PubMed=38942756;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple_corrected; p.Trp331Ter (c.992G>A); ClinVar=VCV001702637; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38942756).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6MU ! LVPEIi005-A
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   LVPEIi006-A
AC   CVCL_D6M4
SY   LVIP02-LC12-1
DR   BioSamples; SAMEA115157827
DR   hPSCreg; LVPEIi006-A
DR   Wikidata; Q127382712
RX   PubMed=38479331;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:19689; RD3; Simple; p.Arg99Argfs*1 (c.296+1G>A); ClinVar=VCV000013121; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=38479331).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38479331
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,10
ST   D16S539: 8,12
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 13,16
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6MZ ! LVPEIi006-B
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LVPEIi006-B
AC   CVCL_D6MZ
SY   LVIP04-LC12-1
DR   hPSCreg; LVPEIi006-B
DR   Wikidata; Q127382713
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:19689; RD3; Simple; p.Arg99Argfs*1 (c.296+1G>A); ClinVar=VCV000013121; Zygosity=Homozygous; Note=Splice donor mutation (hPSCreg=LVPEIi006-B).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M4 ! LVPEIi006-A
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LVPEIi007-A
AC   CVCL_D6MV
SY   LVIP01-SD1-1; ABCA4-/-C1
DR   BioSamples; SAMEA115082726
DR   hPSCreg; LVPEIi007-A
DR   Wikidata; Q127382714
RX   PubMed=36306781;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg2030Ter (c.6088C>T); ClinVar=VCV000007907; Zygosity=Homozygous (PubMed=36306781).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6MY ! LVPEIi007-B
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LVPEIi007-B
AC   CVCL_D6MY
SY   LVIP04-SD1-1
DR   BioSamples; SAMEA115170415
DR   hPSCreg; LVPEIi007-B
DR   Wikidata; Q127382715
RX   PubMed=38615588;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg2030Ter (c.6088C>T); ClinVar=VCV000007907; Zygosity=Homozygous (PubMed=38615588).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6MV ! LVPEIi007-A
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LVPEIi008-A
AC   CVCL_D6MW
SY   LVIP01-SD1-2; ABCA4-/-C2
DR   BioSamples; SAMEA115085113
DR   hPSCreg; LVPEIi008-A
DR   Wikidata; Q127382717
RX   PubMed=36306781;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg2030Ter (c.6088C>T); ClinVar=VCV000007907; Zygosity=Homozygous (PubMed=36306781).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6MX ! LVPEIi008-B
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LVPEIi008-B
AC   CVCL_D6MX
SY   LVIP04-SD1-2
DR   BioSamples; SAMEA115172670
DR   hPSCreg; LVPEIi008-B
DR   Wikidata; Q127382718
RX   PubMed=38615588;
CC   From: LV Prasad Eye Institute; Banjara Hills; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg2030Ter (c.6088C>T); ClinVar=VCV000007907; Zygosity=Homozygous (PubMed=38615588).
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6MW ! LVPEIi008-A
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   LW/SO
AC   CVCL_RL90
DR   Wikidata; Q54903291
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8645743;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   LW878
AC   CVCL_IV44
DR   Wikidata; Q54903292
RX   PubMed=9973220;
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   LWAGS
AC   CVCL_E762
DR   dbMHC; 48958
DR   ECACC; 88052078
DR   IHW; IHW09079
DR   IPD-IMGT/HLA; 11013
DR   Wikidata; Q54903293
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Jewish; Ashkenazi.
CC   HLA typing: A*33:01:01:01; B*14:02:01:01; C*08:02:01:01; DPA1*01:03; DPB1*104:01,04:01:01; DQA1*01:01:02; DQB1*05:01:01; DRA*01:01; DRB1*01:02:01; DRB6*01 (IPD-IMGT/HLA=11013).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   LWFN
AC   CVCL_Z516
SY   Leopard Wrass FiN
DR   Wikidata; Q54903294
RX   PubMed=23991874;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=241318; ! Macropharyngodon geoffroy (Geoffroy's wrasse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   LWSK
AC   CVCL_Z517
SY   Leopard Wrass SKin
DR   Wikidata; Q54903295
RX   PubMed=23991874;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=241318; ! Macropharyngodon geoffroy (Geoffroy's wrasse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   LX-1 [Human HSC]
AC   CVCL_5790
SY   Lieming Xu-1
DR   BTO; BTO_0003515
DR   Wikidata; Q54903296
RX   PubMed=15591520;
RX   PubMed=17760834;
CC   Doubling time: 24 hours (PubMed=15591520).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Anecdotal: Cell line name is derived from the name of the first author of the original paper.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   LX-1 [Human lung carcinoma]
AC   CVCL_5791
DR   ChEMBL-Cells; CHEMBL3307613
DR   ChEMBL-Targets; CHEMBL614389
DR   CLS; 300268
DR   PubChem_Cell_line; CVCL_5791
DR   Wikidata; Q54903297
RX   PubMed=3147984;
RX   PubMed=12601555;
CC   Discontinued: CLS; 300268; true.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   LX-2
AC   CVCL_5792
SY   Lieming Xu-2
DR   BTO; BTO_0003516
DR   EFO; EFO_0022711
DR   ChEMBL-Cells; CHEMBL4879539
DR   CLS; 305039
DR   Lonza; 616
DR   Millipore; SCC064
DR   PRIDE; PRD000680
DR   PRIDE; PXD029121
DR   SKY/M-FISH/CGH; 5853
DR   Wikidata; Q54903298
RX   PubMed=15591520;
RX   PubMed=17760834;
RX   PubMed=19085953;
RX   PubMed=21930125;
RX   PubMed=22694338;
RX   PubMed=24116068;
RX   PubMed=34884585;
CC   Characteristics: Able to grow under reduced serum conditions (1% FBS) (PubMed=15591520).
CC   Doubling time: ~3-4 days (PubMed=15591520); 53.3 +- 2.3 hours (PubMed=21930125).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Extracellular matrix.
CC   Anecdotal: Cell line name is derived from the name of the first author of the original paper.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
ST   Source(s): Millipore=SCC064; PubMed=24116068; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13
ST   D12S391: 15,17
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 13,15.2
ST   D1S1656: 12
ST   D21S11: 28,31
ST   D22S1045: 16
ST   D2S1338: 17
ST   D2S441: 11,14
ST   D3S1358: 13,15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   DYS391: 10
ST   FGA: 21,26
ST   Penta D: 12,13,15
ST   Penta E: 5,21
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5790 ! LX-1 [Human HSC]
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   LXF 2478L
AC   CVCL_E6EL
SY   LXFE 2478
RX   DOI=10.1158/1535-7163.TARG-19-LB-B05;
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Characteristics: Established from a patient-derived xenograft established in nude mice (DOI=10.1158/1535-7163.TARG-19-LB-B05).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Val769_Asp770insAlaSerVal (c.2308_2309insCCAGCGTGG) (c.2300_2308dup) (M766_A767insASV) (p.Ala767_Val769dupAlaSerVal) (A767_V769dupASV); ClinVar=VCV000177678; Zygosity=Heterozygous (DOI=10.1158/1535-7163.TARG-19-LB-B05).
CC   Donor information: Established from a patient whose tumor was resistant to erlotinib (DOI=10.1158/1535-7163.TARG-19-LB-B05).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LXF 289
AC   CVCL_1394
SY   LXF289; LXF-289; LXF 289L
DR   CLO; CLO_0007424
DR   EFO; EFO_0006641
DR   CLDB; cl3278
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 560
DR   BioSample; SAMN03473043
DR   BioSample; SAMN10988494
DR   cancercelllines; CVCL_1394
DR   Cell_Model_Passport; SIDM00339
DR   ChEMBL-Cells; CHEMBL3307871
DR   ChEMBL-Targets; CHEMBL614107
DR   CLS; 300269
DR   Cosmic; 753592
DR   Cosmic; 1995499
DR   Cosmic-CLP; 753592
DR   DepMap; ACH-000787
DR   DSMZ; ACC-265
DR   DSMZCellDive; ACC-265
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 753592
DR   GEO; GSM513972
DR   GEO; GSM514324
DR   GEO; GSM784227
DR   GEO; GSM887285
DR   GEO; GSM888360
DR   GEO; GSM1670069
DR   IARC_TP53; 21484
DR   LiGeA; CCLE_089
DR   LINCS_LDP; LCL-1668
DR   PharmacoDB; LXF289_872_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1394
DR   PubChem_Cell_line; CVCL_1394
DR   Wikidata; Q54903304
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: Infected with a murine leukemia virus-related virus (PubMed=30629668).
CC   Doubling time: 24-48 hours (CLS=300269); ~50 hours (DSMZ=ACC-265).
CC   HLA typing: A*32:01,32:01; B*38:01,38:01; C*12:03,12:03; DQA1*01:02,03:02; DQB1*06:11,06:11; DRB1*13:01,13:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (Cosmic-CLP=753592).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.04%; East Asian, South=0%; South Asian=0.14%; European, North=66.88%; European, South=30.93% (PubMed=30894373).
CC   Misspelling: LX-289; Note=Occasionally.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=300269; Cosmic-CLP=753592; DSMZ=ACC-265; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 15
ST   D21S11: 30,31
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 24,25
ST   Penta D: 10,13
ST   Penta E: 10,20
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   LXF 297
AC   CVCL_5901
SY   LXF297; LXF-297
DR   Wikidata; Q54903305
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 7
//
ID   LXFA 629L
AC   CVCL_D189
SY   LXFA629; LXFA 629; LXF 629L
DR   ChEMBL-Cells; CHEMBL3308621
DR   ChEMBL-Targets; CHEMBL614689
DR   PubChem_Cell_line; CVCL_D189
DR   Wikidata; Q54903306
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   LXFL 529L
AC   CVCL_D085
SY   LXFL-529L; LXFL529L; LXF 529 L; LXFL-529; LXFL 529; LXFL529; LXF 529
DR   EFO; EFO_0006642
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472856
DR   ChEMBL-Cells; CHEMBL3307537
DR   ChEMBL-Targets; CHEMBL614110
DR   Cosmic; 1802292
DR   Cosmic; 1870262
DR   EGA; EGAS00001000610
DR   GEO; GSM206521
DR   GEO; GSM274791
DR   GEO; GSM274825
DR   NCI-DTP; LXFL 529
DR   PharmacoDB; LXFL529_873_2019
DR   PubChem_Cell_line; CVCL_D085
DR   Wikidata; Q54903307
RX   PubMed=2041050;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   HLA typing: A*01:01,01:01; B*14:02,37:01; C*06:02,06:02 (PubMed=26589293).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: LXPL 529; Note=Occasionally.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 13
ST   D21S11: 28,29
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   LXFS 605L
AC   CVCL_E7EL
SY   LXFS-605L
DR   GEO; GSM1887923
DR   GEO; GSM1887996
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=32586373;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LXFS 650L
AC   CVCL_E7EM
SY   LXFS-650L
DR   GEO; GSM1887925
DR   GEO; GSM1888006
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=32586373;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   LXKC40
AC   CVCL_HE56
DR   Wikidata; Q54903308
RX   PubMed=8365721;
CC   Group: Human/rodent somatic cell hybrid.
CC   Transformant: NCIt; C17262; X-Ray.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1R79 ! GM06318
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 3
//
ID   LXKC50
AC   CVCL_HE57
DR   Wikidata; Q54903309
RX   PubMed=8365721;
CC   Group: Human/rodent somatic cell hybrid.
CC   Transformant: NCIt; C17262; X-Ray.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1R79 ! GM06318
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 3
//
ID   LXKC56
AC   CVCL_HE58
DR   Wikidata; Q54903310
RX   PubMed=8365721;
CC   Group: Human/rodent somatic cell hybrid.
CC   Transformant: NCIt; C17262; X-Ray.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1R79 ! GM06318
HI   CVCL_F739 ! L-M(TK-)1D
CA   Hybrid cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 3
//
ID   LXVI-5A5-C7
AC   CVCL_B0XQ
SY   M13
DR   Wikidata; Q108820806
RX   PubMed=3826486;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania mexicana venezuelensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   LXVIII-1D7-B8
AC   CVCL_U047
SY   M-7; M7
DR   Wikidata; Q54903311
RX   PubMed=3826486;
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania mexicana.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   LXVIII-4D8-E3
AC   CVCL_U037
SY   M-8
DR   ECACC; 08041712
DR   Wikidata; Q54903312
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Leishmania mexicana.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   LXXIX-1G12-G7
AC   CVCL_U052
SY   XXIX-1G12-G7; D-14
DR   ECACC; 08041715
DR   Wikidata; Q54903313
RX   PubMed=6373932;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Leishmania donovani.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   LXXVIII-2E5-A8
AC   CVCL_U038
SY   D-2; D2
DR   Wikidata; Q54903314
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania chagasi.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   LY B-LCL
AC   CVCL_C5VW
DR   Wikidata; Q116049725
RX   PubMed=10843661;
CC   HLA typing: A*01,24; B*27:02,35 (PubMed=10843661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   LY-336-TC
AC   CVCL_F930
SY   LY-336; LY336
DR   TKG; TKG 0110
DR   TKG; TKG 0652
DR   Wikidata; Q54903315
RX   PubMed=7829394;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   LY-5-TC
AC   CVCL_F931
SY   LY-5; Ly-5
DR   TKG; TKG 0102
DR   TKG; TKG 0635
DR   Wikidata; Q54903316
RX   PubMed=21085;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   LY-52-TC
AC   CVCL_F932
SY   LY-52
DR   TKG; TKG 0105
DR   TKG; TKG 0649
DR   Wikidata; Q54903317
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   LY-54-TC
AC   CVCL_F933
SY   LY-54
DR   TKG; TKG 0106
DR   TKG; TKG 0650
DR   Wikidata; Q54903318
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   LY-6-TC
AC   CVCL_5327
SY   LY-6; LY6
DR   CLO; CLO_0050825
DR   RCB; RCB2910
DR   TKG; TKG 0103
DR   TKG; TKG 0648
DR   Wikidata; Q54903319
RX   PubMed=7829394;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   LY-7-TC
AC   CVCL_F934
SY   LY-7
DR   TKG; TKG 0104
DR   TKG; TKG 0636
DR   Wikidata; Q54903320
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   LY-80-TC
AC   CVCL_F935
SY   LY-80
DR   TKG; TKG 0107
DR   TKG; TKG 0651
DR   Wikidata; Q54903321
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   LY-A/hCERT
AC   CVCL_L555
DR   CLO; CLO_0050418
DR   RCB; RCB1870
DR   Wikidata; Q54903322
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2205; CERT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_J422 ! CHO-LY-A
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   LY-H12
AC   CVCL_1Q79
DR   RCB; RCB2728
DR   Wikidata; Q54903323
RX   PubMed=17537454;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C125415; Rat malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_1Q80 ! LY-PPB6
SX   Female
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   LY-PPB6
AC   CVCL_1Q80
DR   RCB; RCB2729
DR   Wikidata; Q54903324
RX   PubMed=17537454;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C125415; Rat malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_1Q79 ! LY-H12
SX   Female
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   Ly1
AC   CVCL_ZU83
SY   LY1; LY 1; LY-1
DR   Wikidata; Q98127112
RX   PubMed=4122458;
RX   PubMed=4922896;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   Ly11
AC   CVCL_ZU81
SY   LY11; LY 11; LY-11
DR   Wikidata; Q98127116
RX   PubMed=4347031;
RX   PubMed=4922896;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   Ly2
AC   CVCL_ZU84
SY   LY2; LY 2; LY-2
DR   Wikidata; Q98127119
RX   PubMed=4122458;
RX   PubMed=4922896;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   Ly28
AC   CVCL_ZU82
SY   LY28; LY 28; LY-28; HKLY-28; HKLY28; HK LY-28
DR   Wikidata; Q98127122
RX   PubMed=175025;
RX   PubMed=4347031;
RX   PubMed=4922896;
RX   PubMed=6245632;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: Ly38; PubMed=6245632.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 5
//
ID   Ly46
AC   CVCL_IU21
SY   LY46; LY 46; LY-46; IARC/LY 46; IARC/LY46; IARC/Ly46
DR   Wikidata; Q54903325
RX   PubMed=170370;
RX   PubMed=3027441;
RX   PubMed=4122458;
RX   PubMed=4364259;
RX   PubMed=6286514;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   Ly47
AC   CVCL_N273
SY   LY47; LY 47; LY-47; IARC/LY 47; IARC/LY47; IARC/Ly47; GM08688; GM17349
DR   CLO; CLO_0010611
DR   CLO; CLO_0013750
DR   BioSample; SAMN00798136
DR   Coriell; GM08688
DR   Coriell; GM17349
DR   Wikidata; Q54903326
RX   CelloPub=CLPUB00447;
RX   PubMed=2847931;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3905596;
RX   PubMed=6286514;
RX   PubMed=6592381;
RX   PubMed=6806672;
RX   PubMed=7519050;
RX   PubMed=24590883;
CC   Part of: Human variation panel.
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African; Ugandan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=6806672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 21
//
ID   Ly65
AC   CVCL_IU48
SY   LY65; IARC/LY 65; IARC/LY65; IARC/Ly65
DR   Wikidata; Q54903327
RX   PubMed=3027441;
RX   PubMed=6286514;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   Ly66
AC   CVCL_N274
SY   LY66; LY 66; LY-66; IARC/LY 66; IARC/LY66; IARC/Ly66
DR   Wikidata; Q54903328
RX   PubMed=1395095;
RX   PubMed=2470097;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3458667;
RX   PubMed=6231253;
RX   PubMed=6286514;
RX   PubMed=6441706;
RX   PubMed=6806672;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African; Kenyan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5715; IGK + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGK (PubMed=3458667; PubMed=6441706; PubMed=6806672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   Ly67
AC   CVCL_N275
SY   LY67; LY 67; LY-67; IARC/LY 67; IARC/LY67; IARC/Ly67
DR   Cosmic; 931127
DR   Cosmic; 2804863
DR   Wikidata; Q54903329
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3905596;
RX   PubMed=6231253;
RX   PubMed=6286514;
RX   PubMed=6547209;
RX   PubMed=6592381;
RX   PubMed=6806672;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African; Kenyan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=6806672).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Ser77Pro (c.229T>C); Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   Ly74
AC   CVCL_IU49
SY   LY74; IARC/LY 74; IARC/LY74; IARC/Ly74
DR   Wikidata; Q54903330
RX   PubMed=3027441;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   Ly81
AC   CVCL_E8TW
SY   LY81; IARC/LY 81; IARC/LY81; IARC/Ly81
RX   PubMed=6286514;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   LY9
AC   CVCL_U065
DR   ECACC; 99061826
DR   Wikidata; Q54903334
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   Ly91
AC   CVCL_N276
SY   LY91; LY 91; LY-91; IARC/LY 91; IARC/LY91; IARC/Ly91; GM08689
DR   CLO; CLO_0010425
DR   BioSample; SAMN00798138
DR   Coriell; GM08689
DR   Wikidata; Q54903335
RX   PubMed=1395095;
RX   PubMed=2470097;
RX   PubMed=2847931;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=3905596;
RX   PubMed=6231253;
RX   PubMed=6286514;
RX   PubMed=6441706;
RX   PubMed=6547209;
RX   PubMed=6592381;
RX   PubMed=6806672;
RX   PubMed=24590883;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African; Ugandan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5715; IGK + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGK (PubMed=6441706; PubMed=6806672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   LyB9
AC   CVCL_6232
SY   Lyb9
DR   Wikidata; Q54903336
RX   PubMed=2784769;
RX   PubMed=3501371;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5433 ! LyD9
OI   CVCL_6231 ! LyH7
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   LYCB
AC   CVCL_XE34
SY   Large Yellow Croaker Brain
DR   Wikidata; Q95983778
RX   Patent=CN104004706A;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013156.
CC   Miscellaneous: As no cell line name was provided in the patent, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Sex unspecified
AG   7M
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   LYCK
AC   CVCL_HP90
SY   Large Yellow Croaker Kidney
DR   Wikidata; Q54903337
RX   Patent=CN103484425B;
RX   PubMed=24773544;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013113.
CC   Doubling time: 29.5 hours (PubMed=24773544).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 11
//
ID   LYCL
AC   CVCL_YI66
SY   Large Yellow Croaker Liver
DR   Wikidata; Q95983783
RX   Patent=CN103992981A;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013157.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   LYCMS
AC   CVCL_YE16
SY   LYCMs; Large Yellow Croaker MuScle
DR   Wikidata; Q95983785
RX   Patent=CN104004707A;
RX   PubMed=32126245;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013158.
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   LYCO
AC   CVCL_B7IZ
SY   Large Yellow Croaker Ovary
DR   Wikidata; Q112930028
RX   DOI=10.1016/j.aquaculture.2021.737300;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Female
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   LYCS-1
AC   CVCL_M751
SY   Large Yellow Croaker Spleen-1; LYCS
DR   Wikidata; Q54903338
RX   DOI=10.1007/s11802-011-1778-5;
CC   Group: Fish cell line.
CC   Doubling time: 48.7 hours (DOI=10.1007/s11802-011-1778-5).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   LYCT
AC   CVCL_B7J0
SY   Large Yellow Croaker Testis
DR   Wikidata; Q112930029
RX   DOI=10.1016/j.aquaculture.2021.737300;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=215358; ! Larimichthys crocea (Large yellow croaker)
SX   Male
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   LyD9
AC   CVCL_5433
SY   Lyd9
DR   Wikidata; Q54903339
RX   PubMed=1969653;
RX   PubMed=2784769;
RX   PubMed=3501371;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LyD9
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6232 ! LyB9
OI   CVCL_6231 ! LyH7
AG   4W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   LyD9 K-4
AC   CVCL_6061
SY   K-4
DR   Wikidata; Q54903340
RX   PubMed=1969653;
RX   PubMed=2487673;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=K-4
CC   Characteristics: IL4 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5433 ! LyD9
AG   4W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   LyD9 K-5
AC   CVCL_6063
SY   K-5
DR   Wikidata; Q54903341
RX   PubMed=2112086;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=K-5
CC   Characteristics: IL5 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5433 ! LyD9
AG   4W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   LyD9 K-GM
AC   CVCL_6086
SY   K-GM
DR   Wikidata; Q54903342
RX   PubMed=2487673;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=K-GM
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5433 ! LyD9
AG   4W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   LyD9 LS-1
AC   CVCL_6212
SY   LS-1
DR   Wikidata; Q54903343
RX   PubMed=2487673;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LS-1
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5433 ! LyD9
AG   4W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   LyH7
AC   CVCL_6231
DR   Wikidata; Q54903344
RX   PubMed=3501371;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CBA/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6232 ! LyB9
OI   CVCL_5433 ! LyD9
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   LYK-1
AC   CVCL_9194
DR   CLO; CLO_0007425
DR   ATCC; HB-306
DR   Wikidata; Q54903345
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LYK-10
AC   CVCL_DB35
DR   ATCC; HB-314
DR   Wikidata; Q54903346
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-314; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   LYK-11
AC   CVCL_DB36
DR   ATCC; HB-315
DR   Wikidata; Q54903347
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-315; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   LYK-12
AC   CVCL_9195
DR   CLO; CLO_0007426
DR   ATCC; HB-316
DR   Wikidata; Q54903348
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LYK-14
AC   CVCL_KB70
DR   ATCC; HB-317
DR   Wikidata; Q54903349
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-317; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   LYK-15
AC   CVCL_KB71
DR   ATCC; HB-318
DR   Wikidata; Q54903350
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-318; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   LYK-16
AC   CVCL_9196
DR   CLO; CLO_0007427
DR   ATCC; HB-319
DR   Wikidata; Q54903351
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LYK-2
AC   CVCL_DB33
DR   ATCC; HB-307
DR   Wikidata; Q54903352
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-307; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   LYK-3
AC   CVCL_KB69
DR   ATCC; HB-308
DR   Wikidata; Q54903353
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-308; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   LYK-4
AC   CVCL_DB34
DR   ATCC; HB-309
DR   Wikidata; Q54903354
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-309; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   LYK-5
AC   CVCL_9197
DR   CLO; CLO_0007428
DR   ATCC; HB-310
DR   Wikidata; Q54903355
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LYK-6
AC   CVCL_DB37
DR   ATCC; HB-320
DR   Wikidata; Q54903356
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
CC   Discontinued: ATCC; HB-320; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   LYK-7
AC   CVCL_9198
DR   CLO; CLO_0007429
DR   ATCC; HB-311
DR   Wikidata; Q54903357
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LYK-8
AC   CVCL_9199
DR   CLO; CLO_0007430
DR   ATCC; HB-312
DR   Wikidata; Q54903358
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   LYK-9
AC   CVCL_9200
DR   CLO; CLO_0007431
DR   ATCC; HB-313
DR   Wikidata; Q54903359
RX   PubMed=9070314;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P15379; Mouse Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   Lym-1
AC   CVCL_E985
DR   CLO; CLO_0007432
DR   ATCC; HB-8612
DR   Wikidata; Q54903360
RX   Patent=US4724213;
RX   PubMed=3542194;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8612.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on normal B cells and derived malignancies.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 7
//
ID   LYM-1
AC   CVCL_4859
DR   CLO; CLO_0050819
DR   CLO; CLO_0050820
DR   RCB; RCB0076
DR   RCB; RCB1473
DR   Wikidata; Q54903361
RX   CelloPub=CLPUB00074;
RX   PubMed=9511820;
CC   Doubling time: 19 hours (CelloPub=CLPUB00074).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: JAR-2.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   5-6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   LYM-1.P3
AC   CVCL_U213
DR   JCRB; JCRB0144.1
DR   JCRB; NIHS0225
DR   Wikidata; Q54903362
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Discontinued: JCRB; NIHS0225; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: JAR-2.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4859 ! LYM-1
SX   Female
AG   5-6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   LYM-1.P3B
AC   CVCL_U214
DR   JCRB; JCRB0144.1B
DR   JCRB; NIHS0359
DR   Wikidata; Q54903363
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Discontinued: JCRB; NIHS0359; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: JAR-2.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U213 ! LYM-1.P3
SX   Female
AG   5-6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   LYM-1.P3D
AC   CVCL_U215
DR   JCRB; JCRB0144.1D
DR   JCRB; JCRB0144.2D
DR   JCRB; NIHS0360
DR   Wikidata; Q54903364
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Discontinued: JCRB; NIHS0360; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: JAR-2.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U213 ! LYM-1.P3
SX   Female
AG   5-6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   Lym-2
AC   CVCL_E986
DR   CLO; CLO_0007433
DR   ATCC; HB-8613
DR   Wikidata; Q54903365
RX   Patent=US4724212;
RX   PubMed=3542194;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8613.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on chronic lymphocytic leukemia cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   LYMM
AC   CVCL_YQ06
DR   Wikidata; Q95983827
RX   PubMed=25015330;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 5
//
ID   Lymph10-AD1-iPS
AC   CVCL_IK93
SY   AD1-CR10 iPSC
DR   SKIP; SKIP003223
DR   Wikidata; Q54608597
RX   PubMed=27789410;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   Lymph14-AD1-iPS
AC   CVCL_IK94
SY   AD1-CR14 iPSC
DR   SKIP; SKIP003224
DR   Wikidata; Q54608695
RX   PubMed=27789410;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   Lymph2-AD2-iPS
AC   CVCL_AB84
SY   AD2-2 iPSC
DR   SKIP; SKIP003221
DR   Wikidata; Q54903366
RX   PubMed=27345793;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (PubMed=27345793).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   Lymph4-AD2-iPS
AC   CVCL_IK95
SY   AD2-4 iPSC
DR   SKIP; SKIP003220
DR   Wikidata; Q54608717
RX   PubMed=27789408;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:17761; TREM2; Simple; p.Arg47His (c.140G>A); ClinVar=VCV000195350; Zygosity=Heterozygous (PubMed=27789408).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169104; Alzheimer's disease 17
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   Lymph8-iPS
AC   CVCL_9U80
DR   SKIP; SKIP003222
DR   Wikidata; Q54903367
RX   PubMed=27345781;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U76 ! CON8
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   LYOG
AC   CVCL_C8GP
DR   Wikidata; Q123032987
RX   PubMed=18698046;
CC   From: Childs, Richard W.; National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   Lyon-1
AC   CVCL_D4C3
SY   Lyon
DR   Wikidata; Q127382719
RX   PubMed=2523930;
RX   PubMed=8436182;
CC   From: Boylston, Arthur W.; University of Leeds; Leeds; United Kingdom.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   LYON-ES1
AC   CVCL_XV40
SY   LYON-ES
DR   Wikidata; Q95983831
RX   PubMed=18356572;
RX   PubMed=26999759;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   LYON-ES1 GFP
AC   CVCL_XV59
SY   GFP LYON-ES1; GFP LYON-ES
DR   Wikidata; Q95983832
RX   PubMed=18356572;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_XV40 ! LYON-ES1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   LYON-ES1 Tau-GFP
AC   CVCL_XV41
SY   Tau-GFP LYON-ES1; Tau-GFP LYON-ES
DR   Wikidata; Q95983834
RX   PubMed=18356572;
CC   Group: Non-human primate cell line.
CC   Characteristics: Transfected with construct expressing a MAPT/Tau-GFP fusion protein.
CC   Genetic integration: Method=Transfection; Gene=FPbase; CQ6UF; MmGFP (mmGFP6; derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:57143; Bovine MAPT.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_XV40 ! LYON-ES1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   LZ6+10
AC   CVCL_B5R8
SY   4F CB-iPSC-MSC, LZ6+10; PCBC03hsi2014031106; SC14-074
DR   Wikidata; Q112930030
RX   PubMed=27293150;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5R6 ! LZ6+2
OI   CVCL_B5R7 ! LZ6+3
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   LZ6+2
AC   CVCL_B5R6
SY   4F CB-iPSC-MSC, LZ6+2; PCBC03hsi2014031104; SC14-072
DR   GEO; GSM1589807
DR   GEO; GSM1589819
DR   GEO; GSM1589939
DR   GEO; GSM1589951
DR   Wikidata; Q112930031
RX   PubMed=27293150;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5R7 ! LZ6+3
OI   CVCL_B5R8 ! LZ6+10
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   LZ6+3
AC   CVCL_B5R7
SY   4F CB-iPSC-MSC, LZ6+3; PCBC03hsi2014031105; SC14-073
DR   Wikidata; Q112930032
RX   PubMed=27293150;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5R6 ! LZ6+2
OI   CVCL_B5R8 ! LZ6+10
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   LZL
AC   CVCL_E763
DR   dbMHC; 48959
DR   ECACC; 88052099
DR   IHW; IHW09099
DR   IPD-IMGT/HLA; 11014
DR   Wikidata; Q54903368
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Native South American; Warao.
CC   HLA typing: A*02:17:02; B*15:01:01:01; C*03:03:01:01; DPA1*01; DPB1*04:02:01; DQA1*05:03; DQB1*03:01:01; DRA*01:02; DRB1*14:02:01; DRB3*01:01 (IPD-IMGT/HLA=11014).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   LZUi001-A
AC   CVCL_C0H6
DR   hPSCreg; LZUi001-A
DR   Wikidata; Q112930033
CC   From: Lanzhou University Second Hospital; Lanzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   LZUi002-A
AC   CVCL_C0H7
SY   iPSC 81
DR   hPSCreg; LZUi002-A
DR   Wikidata; Q112930034
RX   PubMed=35339883;
CC   From: Lanzhou University Second Hospital; Lanzhou; China.
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Sequence variation: Mutation; HGNC; HGNC:11585; TBL1X; Simple; c.342_343insGCGGCG; Zygosity=Hemizygous (PubMed=35339883).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27644; Deafness
DI   ORDO; Orphanet_87884; Non-syndromic genetic deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   LZUSHI001-A
AC   CVCL_C0IG
SY   iPS98; ips98
DR   BioSamples; SAMEA10768119
DR   hPSCreg; LZUSHI001-A
DR   Wikidata; Q112930035
RX   PubMed=35421845;
CC   From: Lanzhou University Second Hospital; Lanzhou; China.
CC   Population: Chinese/Asian ethnic group: Hui.
CC   Sequence variation: Mutation; HGNC; HGNC:2853; DGKG; Simple; p.Arg681Gln (c.2042G>A); Zygosity=Heterozygous (PubMed=35421845).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   LZUSHI002-A
AC   CVCL_C1UQ
SY   iPS-129
DR   BioSamples; SAMEA111310767
DR   hPSCreg; LZUSHI002-A
DR   Wikidata; Q114311902
RX   PubMed=36162333;
CC   From: Lanzhou University Second Hospital; Lanzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3483; ETFDH; Simple; p.Ser457Pro (c.1369T>C); ClinVar=VCV001040865; Zygosity=Heterozygous (PubMed=36162333).
CC   Sequence variation: Mutation; HGNC; HGNC:3483; ETFDH; Simple; p.Met617Ile (c.1851G>A); Zygosity=Heterozygous (PubMed=36162333).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84907; Multiple acyl-CoA dehydrogenase deficiency
DI   ORDO; Orphanet_26791; Multiple acyl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   LZUSHI003-A
AC   CVCL_E4XA
SY   DMD-27-delG
DR   BioSamples; SAMEA117820860
DR   hPSCreg; LZUSHI003-A
RX   PubMed=40816202;
CC   From: Lanzhou University Second Hospital; Lanzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Ala1228fs (c.3682delG); Zygosity=Hemizygous (PubMed=40816202).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   M [Dog melanoma]
AC   CVCL_0D70
SY   Cell line M
DR   Wikidata; Q54903369
RX   Patent=US3432595;
RX   PubMed=14266865;
RX   PubMed=29991117;
CC   Group: Patented cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 11
//
ID   M [Rat]
AC   CVCL_5550
DR   CLO; CLO_0050607
DR   CLO; CLO_0050613
DR   JCRB; JCRB0152.1
DR   JCRB; NIHS0228
DR   RCB; RCB0067
DR   RCB; RCB1472
DR   Wikidata; Q54903370
RX   PubMed=8390914;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Discontinued: JCRB; NIHS0228; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI38 ! RLC-3
SX   Sex unspecified
AG   10D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   M 111
AC   CVCL_J757
SY   M111; M III; M-4
DR   CLO; CLO_0007438
DR   ATCC; HB-8438
DR   Wikidata; Q54903371
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8438.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanocytes cell surface antigen M-4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   M 138
AC   CVCL_J758
AS   CVCL_5788
SY   M138; M-24 (M138); M-24; L-138; L138
DR   CLO; CLO_0007472
DR   CLS; 400384
DR   Wikidata; Q54903372
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8449.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanocytes cell surface antigen M-24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 13
//
ID   M 144
AC   CVCL_J759
SY   M144; M-10
DR   CLO; CLO_0007439
DR   Wikidata; Q54903373
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8440.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanocytes cell surface antigen M-26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   M 368
AC   CVCL_C507
SY   M368; M3-68; L368 M68; M-25; M25
DR   CLO; CLO_0007188
DR   Wikidata; Q54903376
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8450.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human melanocytes cell surface antigen M-26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   M. dunni (Clone III8C)
AC   CVCL_9125
SY   M. dunni clone III8C; M.dunni(Clone III8C); Clone IIIC8
DR   CLO; CLO_0007440
DR   CLO; CLO_0007441
DR   CLDB; cl3306
DR   ATCC; CRL-2017
DR   BCRC; 60203
DR   ECACC; 94101211
DR   JCRB; JCRB9124
DR   Wikidata; Q54903377
RX   PubMed=6092693;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=254704; ! Mus terricolor (Earth-colored mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   M. F.
AC   CVCL_C8NT
DR   Wikidata; Q123032989
RX   PubMed=1374683;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   M-07
AC   CVCL_D630
SY   M-O7
DR   BTO; BTO_0005249
DR   Wikidata; Q54903378
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3261598;
RX   PubMed=9195772;
RX   PubMed=36982453;
CC   Population: Caucasian.
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   M-07e
AC   CVCL_2106
SY   M-07E; M-O7e; M07-e; M07e; Mo7e; MO7e; M07E; MO7E
DR   BTO; BTO_0005248
DR   CLO; CLO_0007447
DR   EFO; EFO_0022426
DR   CLDB; cl3281
DR   CLDB; cl7156
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473408
DR   BioSample; SAMN10988568
DR   cancercelllines; CVCL_2106
DR   CCRID; 1101HUM-PUMC000112
DR   Cell_Model_Passport; SIDM01640
DR   CLS; 305105
DR   Cosmic; 787447
DR   Cosmic; 975265
DR   Cosmic; 999723
DR   Cosmic; 1012082
DR   Cosmic; 1181607
DR   Cosmic; 1281323
DR   Cosmic; 1524835
DR   Cosmic; 1633511
DR   Cosmic; 2306215
DR   DepMap; ACH-000602
DR   DSMZ; ACC-104
DR   DSMZCellDive; ACC-104
DR   GEO; GSM236792
DR   GEO; GSM236828
DR   GEO; GSM743416
DR   GEO; GSM887287
DR   GEO; GSM888362
DR   GEO; GSM1446743
DR   IARC_TP53; 30115
DR   ICLC; HTL04002
DR   LiGeA; CCLE_603
DR   Lonza; 485
DR   NCBI_Iran; C621
DR   PharmacoDB; M07e_875_2019
DR   Progenetix; CVCL_2106
DR   Wikidata; Q54903379
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2273055;
RX   PubMed=9096695;
RX   PubMed=11414198;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=28109323;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MO7E
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 46 +- 12 hours (PubMed=9096695); ~40 hours (DSMZ=ACC-104).
CC   HLA typing: A*24:02:01,66:01:01; B*13:02:01,49:01:01; C*06:02:01;07:01:01 (DSMZCellDive=ACC-104).
CC   Sequence variation: Gene fusion; HGNC; HGNC:31677; ANO7 + HGNC; HGNC:17887; DHDH; Name(s)=ANO7-DHDH (PubMed=31160637).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1537; CBFA2T3 + HGNC; HGNC:29450; GLIS2; Name(s)=CBFA2T3-GLIS2, ETO2-GLIS2 (PubMed=28109323).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000602).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=8.96%; Native American=0%; East Asian, North=0.92%; East Asian, South=0%; South Asian=3.01%; European, North=45.47%; European, South=41.63% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): CCRID=1101HUM-PUMC000112; DSMZ=ACC-104
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 15,20
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 19,25
ST   D3S1358: 16,19
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13 (DSMZ=ACC-104)
ST   D8S1179: 13,16 (CCRID=1101HUM-PUMC000112)
ST   FGA: 18,22
ST   Penta D: 9
ST   Penta E: 12,14
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D630 ! M-07
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   M-07e/TPO
AC   CVCL_RM07
DR   cancercelllines; CVCL_RM07
DR   Wikidata; Q54903380
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096695;
CC   Population: Caucasian.
CC   Characteristics: TPO dependent.
CC   Doubling time: 59 +- 10 hours (PubMed=9096695).
CC   Sequence variation: Gene fusion; HGNC; HGNC:31677; ANO7 + HGNC; HGNC:17887; DHDH; Name(s)=ANO7-DHDH (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1537; CBFA2T3 + HGNC; HGNC:29450; GLIS2; Name(s)=CBFA2T3-GLIS2, ETO2-GLIS2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2106 ! M-07e
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   M-1 [Human mantle cell lymphoma]
AC   CVCL_9494
DR   Wikidata; Q54903381
RX   PubMed=15360009;
CC   Doubling time: 36 hours (PubMed=15360009).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   M-1 [Mouse kidney]
AC   CVCL_8786
SY   M1-CCD
DR   BTO; BTO_0004545
DR   CLO; CLO_0007449
DR   ATCC; CRL-2038
DR   BCRC; 60297
DR   BioSample; SAMN11397639
DR   CCRID; 1101MOU-PUMC000223
DR   ECACC; 95092201
DR   Wikidata; Q54903382
RX   PubMed=1654478;
RX   PubMed=31220119;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: Tg(SV40E)Bri/7 transgenic.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 15
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   M-17
AC   CVCL_D028
DR   cancercelllines; CVCL_D028
DR   Cosmic; 2163788
DR   ESTDAB; ESTDAB-039
DR   Wikidata; Q54903383
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-039
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 10,13
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   M-2
AC   CVCL_F0T8
RX   PubMed=5225150;
RX   PubMed=5225151;
CC   Doubling time: ~24 hours (PubMed=5225150).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic myelogenous leukemia, BCR-ABL1 positive.
CC   Caution: As it is indicated in PubMed=5225151 that this cell line harbors an herpes-like virus and that many leukemia cell lines from this period were later found to be EBV-transformed cell lines, we have annotated it as such.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   M-2478
AC   CVCL_A7QW
DR   Wikidata; Q107115885
RX   PubMed=6401921;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   M-27
AC   CVCL_M065
DR   Wikidata; Q54903384
RX   PubMed=3697987;
CC   Characteristics: Metastatic specifically to the lung (PubMed=3697987).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M064 ! M-3LL
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   M-2E6
AC   CVCL_4537
DR   CLO; CLO_0007473
DR   CLDB; cl5223
DR   ATCC; HB-138
DR   IZSLER; BS Hy 26
DR   Wikidata; Q54903385
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   M-3405
AC   CVCL_B5MA
DR   Wikidata; Q112930036
RX   PubMed=6418414;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   M-3773
AC   CVCL_A7QX
DR   Wikidata; Q107115886
RX   PubMed=6401921;
RX   PubMed=6418414;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   >30Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   M-3LL
AC   CVCL_M064
DR   Wikidata; Q54903386
RX   PubMed=3697987;
CC   Characteristics: Developed from a lung metastasis of the parent cell line. Metastatic specifically to the lung (PubMed=3697987).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   M-4581
AC   CVCL_A7QY
DR   Wikidata; Q107115887
RX   PubMed=6401921;
RX   PubMed=6418414;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   M-7
AC   CVCL_6491
SY   M-7 [Mutatect]
DR   CLO; CLO_0007485
DR   ATCC; CRL-2804
DR   Wikidata; Q54903387
RX   PubMed=14732341;
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4982 ! MC-TGS17-51
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   M-FetMSC
AC   CVCL_6F28
DR   Wikidata; Q54903388
RX   PubMed=25697001;
CC   Doubling time: 25.0 +- 0.1 hours (PubMed=25697001).
CC   Derived from site: In situ; Fetal limb, muscle; UBERON=UBERON_0003661.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6F27 ! FetMSC
SX   Male
AG   5-6FW
CA   Somatic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   M-G1120
AC   CVCL_B7QW
DR   Wikidata; Q112930037
RX   DOI=10.1007/978-3-642-68857-7_18;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 5
//
ID   m-ICcl2
AC   CVCL_AW03
SY   mICcl2
DR   Wikidata; Q54903389
RX   PubMed=8764149;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: m-ICc12; Note=Occasionally.
CC   Derived from site: In situ; Embryonic small intestine, ileum, intestinal crypt; UBERON=UBERON_0013481.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: (C57BL/6 x DBA) L-PK/TAg1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   20FW
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   M-KID 2
AC   CVCL_C8GG
DR   Wikidata; Q123032990
RX   PubMed=1816072;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26006; Human ITGA3/CD49c.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   M-M522
AC   CVCL_B7QX
SY   M-M5.22; M522
DR   Wikidata; Q112930038
RX   DOI=10.1007/978-3-642-68857-7_18;
RX   PubMed=7035187;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   M-M67
AC   CVCL_B7QY
DR   Wikidata; Q112930039
RX   DOI=10.1007/978-3-642-68857-7_18;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on monocytes (CDw12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 4
//
ID   M-MOK
AC   CVCL_8731
DR   CLO; CLO_0051548
DR   BioSample; SAMN03471920
DR   Cosmic; 787456
DR   Cosmic; 975273
DR   Cosmic; 1281331
DR   FANTOM5_SSTAR; 10699-109G6
DR   RCB; RCB2534
DR   TKG; TKG 0458
DR   Wikidata; Q38518614
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7589286;
RX   PubMed=8558913;
RX   PubMed=9096695;
WW   Info; KAKEN; 03454260; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-03454260/
CC   Population: Japanese.
CC   Characteristics: Requires human fibroblast feeder cells for its viability.
CC   Characteristics: CSF2 dependent.
CC   Doubling time: 45 +- 6 hours (PubMed=9096695).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): RCB=RCB2534; TKG=TKG 0458
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 10,12
ST   D5S818: 9,11
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 11,12
ST   vWA: 17,18
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   M-MOK/TPO
AC   CVCL_RM05
DR   Wikidata; Q54903391
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096695;
CC   Population: Japanese.
CC   Characteristics: TPO dependent.
CC   Doubling time: 54 +- 11 hours (PubMed=9096695).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7972; Childhood acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8731 ! M-MOK
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   M-MSV-BALB/3T3
AC   CVCL_5793
SY   M-MSV-Balb/3T3
DR   CLO; CLO_0007805
DR   CLDB; cl3295
DR   CLDB; cl3296
DR   ATCC; CCL-163.2
DR   CLS; 400458
DR   ECACC; 90030802
DR   KCLB; 10163.2
DR   Wikidata; Q54903392
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   M-N72
AC   CVCL_B7QZ
DR   Wikidata; Q112930040
RX   DOI=10.1007/978-3-642-68857-7_18;
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   M-NBT-II
AC   CVCL_M906
DR   Wikidata; Q54903393
RX   PubMed=7929634;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0453 ! NBT-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   M-OS
AC   CVCL_R727
DR   Wikidata; Q54903394
RX   PubMed=22833358;
CC   Doubling time: ~48 hours (PubMed=22833358).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   M-T1020
AC   CVCL_B7R0
DR   Wikidata; Q112930041
RX   DOI=10.1007/978-3-642-68857-7_18;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on T-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 4
//
ID   M-T151
AC   CVCL_B7R1
SY   M-T15-1
DR   Wikidata; Q112930043
RX   DOI=10.1007/978-3-642-68857-7_18;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   M-T321
AC   CVCL_B7R2
SY   M-T32.1
DR   Wikidata; Q112930047
RX   DOI=10.1007/978-3-642-68857-7_18;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   M-T411
AC   CVCL_B7QU
SY   T411
DR   Wikidata; Q112930048
RX   DOI=10.1007/978-3-642-68857-7_18;
RX   PubMed=6237975;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   M-T61
AC   CVCL_B7R3
DR   Wikidata; Q112930049
RX   DOI=10.1007/978-3-642-68857-7_18;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Human antigen on T-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 4
//
ID   M-T811
AC   CVCL_B7QV
SY   T811
DR   Wikidata; Q112930050
RX   DOI=10.1007/978-3-642-68857-7_18;
RX   PubMed=6237975;
RX   PubMed=7035187;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01732; Human CD8A.
CC   Monoclonal antibody target: UniProtKB; P10966; Human CD8B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   M-TAT
AC   CVCL_1Q82
DR   Wikidata; Q54903395
RX   PubMed=7961690;
RX   PubMed=8558913;
RX   PubMed=19344951;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   M.A.
AC   CVCL_E764
DR   dbMHC; 48960
DR   IHW; IHW09324
DR   IPD-IMGT/HLA; 11015
DR   Wikidata; Q54903398
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DQA1*03:01:01,01:01; DQB1*03:05:01,05:01; DRB1*04:03,01 (IPD-IMGT/HLA=11015).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   M.M.
AC   CVCL_E765
DR   dbMHC; 48961
DR   IHW; IHW09335
DR   IPD-IMGT/HLA; 11020
DR   Wikidata; Q54903399
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DQA1*05:01,01:02; DQB1*03:04,05:02; DRB1*11,16:01 (IPD-IMGT/HLA=11020).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   M.P3
AC   CVCL_5551
DR   JCRB; JCRB0152.2
DR   JCRB; JCRB0152.3
DR   JCRB; NIHS0228.1
DR   JCRB; NIHS0356
DR   Wikidata; Q54903400
RX   DOI=10.1247/csf.5.315;
CC   Group: Serum/protein free medium cell line.
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Discontinued: JCRB; NIHS0228.1; true.
CC   Discontinued: JCRB; NIHS0356; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5550 ! M [Rat]
SX   Sex unspecified
AG   10D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   M.R.
AC   CVCL_E766
DR   dbMHC; 48962
DR   ECACC; 94050308
DR   IHW; IHW09316
DR   IPD-IMGT/HLA; 11022
DR   Wikidata; Q54903401
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Belgian.
CC   HLA typing: DPB1*02:01,03:01; DQA1*03,05:01; DRB1*04:01,03:01:02; DRB3*02; DRB4*01:01 (IPD-IMGT/HLA=11022).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   M/K-1.9
AC   CVCL_9201
SY   M/K-1
DR   CLO; CLO_0007442
DR   ATCC; CRL-1910
DR   Wikidata; Q54903396
RX   PubMed=1713592;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P29533; Mouse Vcam1/Cd106.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M/K-2.7
AC   CVCL_9202
AS   CVCL_D671
SY   M/K-2; M/K2; MK2
DR   CLO; CLO_0007443
DR   ATCC; CRL-1909
DR   BCRJ; 0150
DR   Wikidata; Q54903397
RX   PubMed=1713592;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P29533; Mouse Vcam1/Cd106.
CC   Discontinued: BCRJ; 0150; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M0-91
AC   CVCL_0086
SY   MO-91; MO91; M091
DR   BTO; BTO_0005491
DR   Wikidata; Q54903402
RX   PubMed=8632663;
RX   PubMed=17252008;
CC   Population: Japanese.
DI   NCIt; C8460; Acute myeloid leukemia with minimal differentiation
DI   ORDO; Orphanet_98832; Acute myeloid leukemia with minimal differentiation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   M000216
AC   CVCL_S806
DR   cancercelllines; CVCL_S806
DR   GEO; GSM108373
DR   GEO; GSM108384
DR   Wikidata; Q54903403
RX   PubMed=16827748;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   M000907
AC   CVCL_S807
DR   cancercelllines; CVCL_S807
DR   GEO; GSM108375
DR   GEO; GSM108386
DR   GEO; GSM482457
DR   Progenetix; CVCL_S807
DR   Wikidata; Q54903404
RX   PubMed=16827748;
RX   PubMed=18245463;
RX   PubMed=22336146;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Unspecified (URPP Biobank).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Shoulder; UBERON=UBERON_0001467.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   M000921
AC   CVCL_S808
SY   M00921
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_S808
DR   Cell_Model_Passport; SIDM00178
DR   Cosmic; 1723793
DR   DepMap; ACH-002386
DR   EGA; EGAS00001000978
DR   GEO; GSM108381
DR   GEO; GSM108391
DR   GEO; GSM433916
DR   IGRhCellID; M000921
DR   PharmacoDB; M00921_876_2019
DR   Progenetix; CVCL_S808
DR   Wikidata; Q54903405
RX   PubMed=16827748;
RX   PubMed=22336146;
RX   PubMed=24581590;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; DepMap=ACH-002386).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Epigastrium; UBERON=UBERON_0035276.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 22
//
ID   M010119
AC   CVCL_S671
DR   GEO; GSM108377
DR   GEO; GSM108387
DR   Wikidata; Q54903406
RX   PubMed=16827748;
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Shoulder; UBERON=UBERON_0001467.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   M010308
AC   CVCL_S809
DR   cancercelllines; CVCL_S809
DR   GEO; GSM108376
DR   GEO; GSM108395
DR   Wikidata; Q54903407
RX   PubMed=16827748;
RX   PubMed=18245463;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (URPP Biobank).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=16827748).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Occipital lymph node; UBERON=UBERON_0035204.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   M010322
AC   CVCL_S672
DR   cancercelllines; CVCL_S672
DR   GEO; GSM108374
DR   GEO; GSM108385
DR   Wikidata; Q54903408
RX   PubMed=16827748;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   M010718
AC   CVCL_S673
DR   cancercelllines; CVCL_S673
DR   GEO; GSM108379
DR   GEO; GSM108389
DR   Wikidata; Q54903409
RX   PubMed=16827748;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=16827748).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   M010817
AC   CVCL_S674
DR   cancercelllines; CVCL_S674
DR   GEO; GSM108378
DR   GEO; GSM108388
DR   Wikidata; Q54903410
RX   PubMed=16827748;
RX   PubMed=22336146;
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=16827748).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Upper arm; UBERON=UBERON_0003822.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   M019i
AC   CVCL_JM64
DR   PRIDE; PXD002394
DR   Wikidata; Q54903411
RX   PubMed=28455291;
RX   PubMed=28473707;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   M019iCis
AC   CVCL_JM65
DR   PRIDE; PXD002394
DR   Wikidata; Q54903412
RX   PubMed=28455291;
RX   PubMed=28473707;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JM64 ! M019i
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   M02/01/01
AC   CVCL_C6LT
DR   ABCD; ABCD_AF246
DR   Wikidata; Q116049726
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M02/02/01
AC   CVCL_C6LU
DR   ABCD; ABCD_AF247
DR   Wikidata; Q116049727
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M02/04/01
AC   CVCL_C6LV
DR   Wikidata; Q116049728
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M02/05/01
AC   CVCL_C6LW
DR   ABCD; ABCD_AF251
DR   Wikidata; Q116049729
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M02/09/01
AC   CVCL_C6LX
DR   Wikidata; Q116049730
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M02/10/01
AC   CVCL_C6LY
DR   ABCD; ABCD_AF248
DR   Wikidata; Q116049732
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M02/11/01
AC   CVCL_C6LZ
DR   ABCD; ABCD_AF252
DR   Wikidata; Q116049733
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M03/01/01
AC   CVCL_C6M0
SY   03/01/01
DR   ABCD; ABCD_AF245
DR   Wikidata; Q116049734
RX   PubMed=9761676;
RX   PubMed=10525411;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_63781; Traseolide (6-acetyl-1-isopropyl-2,3,3,5-tetramethylindane).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   M040416
AC   CVCL_A1UF
DR   cancercelllines; CVCL_A1UF
DR   DepMap; ACH-002510
DR   Wikidata; Q105509973
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-002510).
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): DepMap=ACH-002510
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 20,22
ST   Penta D: 13,14
ST   Penta E: 10,16
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   M0505
AC   CVCL_HP91
DR   GEO; GSM1320306
DR   GEO; GSM1320307
DR   GEO; GSM1320308
DR   Wikidata; Q54903413
RX   PubMed=24672774;
CC   Doubling time: 48 hours (PubMed=24672774).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   M050829
AC   CVCL_AT59
DR   Wikidata; Q54903414
RX   PubMed=22336146;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Retroauricular region; UBERON=UBERON_8480047.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   M0545YM029S2
AC   CVCL_B0GB
SY   M0545YM029; NimoAb108; Ab029
DR   Wikidata; Q108820807
RX   Patent=US11008405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2657.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00187; Human MASP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   M0545YM035S2
AC   CVCL_B0GC
SY   M0545YM035; NimoAb104; Ab035
DR   Wikidata; Q108820808
RX   Patent=US11008405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2660.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00187; Human MASP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   M0545YM046S2
AC   CVCL_B0GD
SY   M0545YM046; NimoAb109; Ab046
DR   Wikidata; Q108820809
RX   Patent=US11008405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2658.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00187; Human MASP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   M0545YM048S2
AC   CVCL_B0GE
SY   M0545YM048; NimoAb110; Ab048
DR   Wikidata; Q108820810
RX   Patent=US11008405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2659.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00187; Human MASP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   M059J
AC   CVCL_0400
SY   Mo 59J; MO59J
DR   CLO; CLO_0007445
DR   EFO; EFO_0005697
DR   MCCL; MCC:0000294
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2366
DR   BCRC; 60382
DR   BCRJ; 0151
DR   BioSample; SAMN03471832
DR   BioSample; SAMN03473044
DR   cancercelllines; CVCL_0400
DR   Cell_Model_Passport; SIDM00659
DR   ChEMBL-Cells; CHEMBL3308113
DR   ChEMBL-Targets; CHEMBL1075494
DR   Cosmic; 949094
DR   Cosmic; 1746953
DR   Cosmic; 2367537
DR   Cosmic-CLP; 949094
DR   DepMap; ACH-001118
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS062ILC
DR   ENCODE; ENCBS235AAA
DR   ENCODE; ENCBS304XWS
DR   ENCODE; ENCBS370AFW
DR   GDSC; 949094
DR   GEO; GSM326251
DR   GEO; GSM1374640
DR   GEO; GSM1670070
DR   IARC_TP53; 13244
DR   LINCS_LDP; LCL-1356
DR   PharmacoDB; M059J_877_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0400
DR   PubChem_Cell_line; CVCL_0400
DR   Wikidata; Q54903415
RX   PubMed=7494872;
RX   PubMed=8316628;
RX   PubMed=10629611;
RX   PubMed=11023613;
RX   PubMed=11418067;
RX   PubMed=12105990;
RX   PubMed=18757420;
RX   PubMed=20164919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/M059J_Stam_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Characteristics: Radiosensitive (PubMed=7494872).
CC   HLA typing: A*01:01,02:01; B*08:01,40:01; C*03:04,07:01; DQB1*06:04,06:04; DRB1*14:19,14:19 (PubMed=26589293).
CC   Karyotypic information: Has a near pentaploid phenotype.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9413; PRKDC; Simple; p.Thr1351Profs*8 (c.4051delA); Zygosity=Heterozygous (PubMed=11418067; DepMap=ACH-001118).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro204fs*17 (c.610delC); Zygosity=Homozygous (ATCC=CRL-2366; Cosmic-CLP=949094; DepMap=ACH-001118).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286lys (c.856G>A); Zygosity=Homozygous (PubMed=11023613; Cosmic-CLP=949094; DepMap=ACH-001118).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.01%; Native American=0%; East Asian, North=2.75%; East Asian, South=0%; South Asian=0%; European, North=67.68%; European, South=28.55% (PubMed=30894373).
CC   Caution: Was incorrectly stated to have deleterious mutations in ATM in PubMed=12105990.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-2366; Cosmic-CLP=949094; PubMed=25877200
ST   Amelogenin: X (PubMed=25877200)
ST   Amelogenin: X,Y (ATCC=CRL-2366; Cosmic-CLP=949094)
ST   CSF1PO: 10 (PubMed=25877200)
ST   CSF1PO: 10,12 (ATCC=CRL-2366; Cosmic-CLP=949094)
ST   D13S317: 14
ST   D16S539: 10,12
ST   D18S51: 15,19
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 20,24
ST   D3S1358: 14 (PubMed=25877200)
ST   D3S1358: 14,15 (ATCC=CRL-2366)
ST   D5S818: 11,12 (ATCC=CRL-2366; Cosmic-CLP=949094)
ST   D5S818: 12 (PubMed=25877200)
ST   D7S820: 10 (PubMed=25877200)
ST   D7S820: 10,12 (ATCC=CRL-2366; Cosmic-CLP=949094)
ST   D8S1179: 15
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0401 ! M059K
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   M059K
AC   CVCL_0401
DR   CLO; CLO_0007446
DR   EFO; EFO_0006451
DR   MCCL; MCC:0000295
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2365
DR   BCRC; 60381
DR   BioGRID_ORCS_Cell_line; 559
DR   BioSample; SAMN03473046
DR   BioSample; SAMN10987790
DR   cancercelllines; CVCL_0401
DR   Cell_Model_Passport; SIDM00639
DR   Cosmic; 897445
DR   Cosmic; 1237543
DR   DepMap; ACH-000152
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GEO; GSM887286
DR   GEO; GSM888361
DR   GEO; GSM1374641
DR   GEO; GSM1670071
DR   IARC_TP53; 28272
DR   LiGeA; CCLE_918
DR   LINCS_LDP; LCL-1362
DR   PharmacoDB; M059K_878_2019
DR   Progenetix; CVCL_0401
DR   Wikidata; Q54903416
RX   PubMed=7494872;
RX   PubMed=8316628;
RX   PubMed=10629611;
RX   PubMed=11023613;
RX   PubMed=12105990;
RX   PubMed=18077418;
RX   PubMed=21406405;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: Radioresistant (PubMed=7494872).
CC   HLA typing: A*01:01,02:01; B*08:01,40:01; C*03:04,07:01; DQA1*02:01,04:01; DRB1*11:01,11:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro204fs*17 (c.610delC); Zygosity=Homozygous (DepMap=ACH-000152).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286lys (c.856G>A); Zygosity=Homozygous (PubMed=11023613; DepMap=ACH-000152).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.16%; Native American=0%; East Asian, North=2.3%; East Asian, South=0%; South Asian=0%; European, North=69.38%; European, South=28.16% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-2365; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 10,12
ST   D18S51: 15,19
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 20,24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 20,26
ST   Penta D: 12,13
ST   Penta E: 7,15
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0400 ! M059J
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   M060125
AC   CVCL_AT44
DR   Wikidata; Q54903420
RX   PubMed=22336146;
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Bone, scapula; UBERON=UBERON_0006849.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   M060621
AC   CVCL_AT45
DR   Wikidata; Q54903421
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 7
//
ID   M061103
AC   CVCL_AT60
DR   Wikidata; Q54903422
RX   PubMed=22336146;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Vertex; UBERON=UBERON_1000019.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   M070112
AC   CVCL_AT46
DR   Wikidata; Q54903423
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 7
//
ID   M080201
AC   CVCL_AT61
DR   Wikidata; Q54903424
RX   PubMed=22336146;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   M080214
AC   CVCL_AT62
DR   cancercelllines; CVCL_AT62
DR   Wikidata; Q54903425
RX   PubMed=22336146;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (URPP Biobank).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Thigh; UBERON=UBERON_0000376.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   M080221
AC   CVCL_AT47
DR   cancercelllines; CVCL_AT47
DR   Wikidata; Q54903426
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (URPP Biobank).
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   M080228
AC   CVCL_AT48
DR   cancercelllines; CVCL_AT48
DR   Wikidata; Q54903427
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (URPP Biobank).
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   M080306
AC   CVCL_AT49
DR   Wikidata; Q54903428
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 7
//
ID   M080310
AC   CVCL_AT63
DR   Wikidata; Q54903429
RX   PubMed=22336146;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   M080326
AC   CVCL_AT50
DR   cancercelllines; CVCL_AT50
DR   Wikidata; Q54903430
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (URPP Biobank).
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 11
//
ID   M080423
AC   CVCL_AT51
DR   Wikidata; Q54903431
RX   PubMed=22336146;
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   M080729
AC   CVCL_AT52
DR   Wikidata; Q54903432
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 7
//
ID   M080904
AC   CVCL_AT53
DR   Wikidata; Q54903433
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AT54 ! M080904B
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 7
//
ID   M080904B
AC   CVCL_AT54
DR   Wikidata; Q54903434
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AT53 ! M080904
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   M081008
AC   CVCL_AT64
DR   Wikidata; Q54903435
RX   PubMed=22336146;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Bone, temporal bone; UBERON=UBERON_0001678.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   M081021
AC   CVCL_AT55
DR   cancercelllines; CVCL_AT55
DR   Wikidata; Q54903436
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (URPP Biobank).
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Abdomen, skin; UBERON=UBERON_0001416.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   M081028
AC   CVCL_AT56
DR   Wikidata; Q54903437
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 7
//
ID   M1
AC   CVCL_2107
SY   M 1; M-1 myeloid leukemia
DR   BTO; BTO_0002037
DR   CLO; CLO_0007437
DR   CLO; CLO_0007448
DR   CLO; CLO_0050175
DR   CLDB; cl3308
DR   CLDB; cl3309
DR   CLDB; cl5166
DR   ATCC; TIB-192
DR   BioSample; SAMN11397656
DR   CLS; 305261
DR   DSMZ; ACC-331
DR   DSMZCellDive; ACC-331
DR   ECACC; 91110711
DR   ECACC; 93120826
DR   IZSLER; BS TCL 71
DR   JCRB; IFO50006
DR   KCLB; 40192
DR   RCB; RCB0169
DR   TOKU-E; 2269
DR   Wikidata; Q54903438
RX   PubMed=4187945;
RX   PubMed=25277546;
RX   PubMed=31220119;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=M1
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~25-50 hours (DSMZ=ACC-331).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: SL.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 12
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 16.3
ST   Mouse STR 6-7: 16
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 15,16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 12
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 13,14
ST   Mouse STR X-1: 26
DI   NCIt; C21889; Mouse myeloid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   M1(D+)
AC   CVCL_C021
DR   CLO; CLO_0050222
DR   RCB; RCB2621
DR   TKG; TKG 0319
DR   Wikidata; Q54903451
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: SL.
DI   NCIt; C21889; Mouse myeloid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2107 ! M1
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   M1-1
AC   CVCL_E7IL
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00424; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m1-1/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia high subcategory (PNsarc2) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 95 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   M1-4HSC
AC   CVCL_M114
DR   BTO; BTO_0003531
DR   Wikidata; Q54903439
RX   PubMed=15878400;
RX   PubMed=17760834;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4M
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   M1-T22
AC   CVCL_8368
SY   M1 clone T22
DR   JCRB; JCRB0110
DR   Wikidata; Q54903441
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: SL.
DI   NCIt; C21889; Mouse myeloid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2107 ! M1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   M1.4
AC   CVCL_9203
DR   CLO; CLO_0007450
DR   ATCC; CRL-2464
DR   Wikidata; Q54903442
RX   PubMed=9609824;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q62005; Mouse Zp1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   M1/22.25.8.HL
AC   CVCL_9204
SY   M1 clone 22.25
DR   CLO; CLO_0007451
DR   ATCC; TIB-121
DR   Wikidata; Q54903443
RX   PubMed=81133;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M1/42.3.9.8.HLK
AC   CVCL_9205
DR   CLO; CLO_0007452
DR   ATCC; TIB-126
DR   Wikidata; Q54903444
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   M1/69.16.11.HL
AC   CVCL_9206
SY   M1 clone 69.16
DR   CLO; CLO_0007453
DR   ATCC; TIB-125
DR   Wikidata; Q54903445
RX   PubMed=81133;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M1/70.15.11.5.HL
AC   CVCL_9207
SY   M1 clone 70.15
DR   CLO; CLO_0007454
DR   ATCC; TIB-128
DR   BCRJ; 0152
DR   Wikidata; Q54903446
RX   PubMed=81133;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   M1/75.16.4.HLK
AC   CVCL_9208
DR   CLO; CLO_0007455
DR   ATCC; TIB-127
DR   Wikidata; Q54903447
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M1/87.27.7.HLK
AC   CVCL_9209
SY   M1 clone 82.27
DR   CLO; CLO_0007456
DR   ATCC; TIB-123
DR   Wikidata; Q54903448
RX   PubMed=81133;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M1/89.18.7.HK
AC   CVCL_9210
SY   M1 clone 89.18
DR   CLO; CLO_0007457
DR   ATCC; TIB-124
DR   Wikidata; Q54903449
RX   PubMed=81133;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M1/9.3.4.HL.2
AC   CVCL_9211
SY   M1 clone 9.3
DR   CLO; CLO_0007458
DR   ATCC; TIB-122
DR   Wikidata; Q54903450
RX   PubMed=81133;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M10
AC   CVCL_4715
SY   UCLA-SO-M10; UCLA SO M10; UCLA-SO-10; UCLASO-M10; Melanoma 10
DR   BTO; BTO_0002965
DR   Wikidata; Q54903452
RX   Patent=US5840317;
RX   Patent=US5993828;
RX   PubMed=56444;
RX   PubMed=204583;
RX   PubMed=945229;
RX   PubMed=954005;
RX   PubMed=6500744;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12269.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ZT ! MF10
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   M101 [Human melanoma]
AC   CVCL_L438
SY   UCLA-SO-M101
DR   Wikidata; Q54903455
RX   Patent=US5840317;
RX   Patent=US5993828;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12271.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 9
//
ID   M101 [Mouse hybridoma against human FCRLA]
AC   CVCL_B6UE
DR   Wikidata; Q112930051
RX   PubMed=17451355;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   M109
AC   CVCL_H602
SY   Madison 109; Madison lung; Madison; MADISON LUNG TA-109; MAD109
DR   CLO; CLO_0007527
DR   CLDB; cl3333
DR   ChEMBL-Cells; CHEMBL3307527
DR   ChEMBL-Targets; CHEMBL614073
DR   PubChem_Cell_line; CVCL_H602
DR   Wikidata; Q54903456
RX   PubMed=194826;
CC   Doubling time: 18.6 hours (Note=At 6th passage), 19.2 hours (Note=At 21th passage) (PubMed=194826).
CC   Karyotypic information: Hypotetraploid. Has from 69 to 79 chromosomes (PubMed=194826).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   M10K
AC   CVCL_8100
DR   Cosmic; 733821
DR   Cosmic; 933013
DR   IARC_TP53; 23628
DR   Wikidata; Q54903457
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=2323006;
RX   PubMed=11283936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   M10T
AC   CVCL_M094
DR   BioSample; SAMN03151740
DR   Wikidata; Q54903458
RX   PubMed=1246601;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00076.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   M116
AC   CVCL_A0IT
SY   Anti-EGFR G719A
DR   Wikidata; Q108820811
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201301.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly719Ala).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   M117-10
AC   CVCL_A0IU
SY   M117_10; Anti-EGFR N826S
DR   Wikidata; Q108820812
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201320.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Asn826Ser).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   M118#7
AC   CVCL_A0IV
SY   Anti-EGFR A839T
DR   Wikidata; Q108820813
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201302.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Ala839Thr).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   M12 [Human melanoma]
AC   CVCL_5T78
SY   UCLA-SO-M12; UCLASO-M12; Melanoma 12
DR   Wikidata; Q54903459
RX   PubMed=56444;
RX   PubMed=945229;
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 16,17
ST   D12S391: 19,23
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D1S1656: 15,17
ST   D21S11: 28,29
ST   D22S1045: 15,16
ST   D2S1338: 18,20
ST   D2S441: 12,14
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 13
ST   DYS391: 11
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ZU ! MF12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   M12
AC   CVCL_IU99
DR   Wikidata; Q54903465
RX   PubMed=310843;
CC   Doubling time: 26 hours (PubMed=310843).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   M12.4
AC   CVCL_IV00
SY   m12.4
DR   Wikidata; Q54903468
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-387.html
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU99 ! M12
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 8
//
ID   M12.4.1
AC   CVCL_0402
SY   M1241
DR   MCCL; MCC:0000296
DR   Wikidata; Q54903469
RX   PubMed=6809823;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IV00 ! M12.4
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   M12.4.5
AC   CVCL_0403
SY   M1245
DR   MCCL; MCC:0000297
DR   Wikidata; Q54903470
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IV00 ! M12.4
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   M120
AC   CVCL_A0IW
SY   Anti-EGFR G863D
DR   Wikidata; Q108820814
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201304.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly863Asp).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   M120326_2
AC   CVCL_VS55
DR   Cell_Model_Passport; SIDM00012
DR   Wikidata; Q95983999
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS56 ! M120327_3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 4
//
ID   M120327_3
AC   CVCL_VS56
SY   M1203273
DR   cancercelllines; CVCL_VS56
DR   Cell_Model_Passport; SIDM00013
DR   Cosmic; 1754025
DR   DepMap; ACH-002387
DR   Wikidata; Q95984001
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-002387).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS55 ! M120326_2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   M121#1
AC   CVCL_A0IX
SY   Anti-EGFR D761Y
DR   Wikidata; Q108820815
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201303.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Asp761Tyr).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   M121008
AC   CVCL_C3FK
DR   GEO; GSM4933080
DR   Wikidata; Q114311903
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   M121102
AC   CVCL_C3FI
DR   GEO; GSM4933078
DR   Wikidata; Q114311904
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FJ ! M130107
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   M122#1
AC   CVCL_A0IY
SY   Anti-EGFR V769L
DR   Wikidata; Q108820816
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201316.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Val769Leu (c.2305G>T)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   M12353
AC   CVCL_B0ST
DR   CCRID; 4201PAT-CCTCC00749
DR   Wikidata; Q108820817
RX   Patent=CN105343897B;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015142.
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C182077; Macaca mulatta hepatocellular carcinoma
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   M12C1
AC   CVCL_C7RN
DR   Wikidata; Q117704636
RX   PubMed=1974862;
CC   Doubling time: 36 hours (Note=At 15th passage) (PubMed=1974862).
CC   Caution: It is possible that M12C1 and NRM 1 (Cellosaurus=CVCL_C7RQ) are the same cell line.
CC   Derived from site: In situ; Lung, parietal pleura; UBERON=UBERON_0002400.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   M12C2
AC   CVCL_C7RP
DR   Wikidata; Q117704637
RX   PubMed=1974862;
CC   Doubling time: 33 hours (Note=At 12th passage) (PubMed=1974862).
CC   Caution: It is possible that M12C1 and NRM 2 (Cellosaurus=CVCL_C7RS) are the same cell line.
CC   Derived from site: In situ; Lung, parietal pleura; UBERON=UBERON_0002400.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   M13
AC   CVCL_A1FE
DR   Wikidata; Q102114488
RX   PubMed=8688321;
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 5
//
ID   M13/12
AC   CVCL_A0QC
DR   Wikidata; Q108820818
RX   PubMed=2146321;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00751; Human CFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   M130107
AC   CVCL_C3FJ
DR   GEO; GSM4933079
DR   Wikidata; Q114311905
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Back; UBERON=UBERON_0001137.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FI ! M121102
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   M130420
AC   CVCL_C3FV
DR   GEO; GSM4933093
DR   Wikidata; Q114311906
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FW ! M130421
OI   CVCL_C3FX ! M130425
OI   CVCL_C3FY ! MM130427
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   M130421
AC   CVCL_C3FW
DR   GEO; GSM4933094
DR   Wikidata; Q114311907
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FV ! M130420
OI   CVCL_C3FX ! M130425
OI   CVCL_C3FY ! MM130427
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   M130425
AC   CVCL_C3FX
DR   GEO; GSM4933095
DR   Wikidata; Q114311908
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FV ! M130420
OI   CVCL_C3FW ! M130421
OI   CVCL_C3FY ! MM130427
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   M130830
AC   CVCL_C3FU
DR   GEO; GSM4933090
DR   Wikidata; Q114311909
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Arm; UBERON=UBERON_0001460.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FT ! MM140902
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   M14
AC   CVCL_1395
SY   M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14
DR   BTO; BTO_0002805
DR   EFO; EFO_0003056
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN06129842
DR   cancercelllines; CVCL_1395
DR   Cell_Model_Passport; SIDM00003
DR   ChEMBL-Cells; CHEMBL3307591
DR   ChEMBL-Targets; CHEMBL614317
DR   CLS; 302163
DR   Cosmic; 686479
DR   Cosmic; 687445
DR   Cosmic; 875889
DR   Cosmic; 897467
DR   Cosmic; 905975
DR   Cosmic; 974068
DR   Cosmic; 974261
DR   Cosmic; 1022278
DR   Cosmic; 1044265
DR   Cosmic; 1092611
DR   Cosmic; 1109808
DR   Cosmic; 1132591
DR   Cosmic; 1158815
DR   Cosmic; 1295340
DR   Cosmic; 1303040
DR   Cosmic; 1305365
DR   Cosmic; 1312348
DR   Cosmic; 1459642
DR   Cosmic; 1537485
DR   Cosmic; 1888913
DR   Cosmic; 1998453
DR   Cosmic; 2791112
DR   Cosmic-CLP; 905975
DR   DepMap; ACH-002159
DR   EGA; EGAS00001000978
DR   GDSC; 905975
DR   GEO; GSM2140
DR   GEO; GSM50201
DR   GEO; GSM50263
DR   GEO; GSM188222
DR   GEO; GSM188252
DR   GEO; GSM188311
DR   GEO; GSM743464
DR   GEO; GSM750799
DR   GEO; GSM799352
DR   GEO; GSM799415
DR   GEO; GSM844583
DR   GEO; GSM847034
DR   GEO; GSM1153422
DR   GEO; GSM1178326
DR   GEO; GSM1178327
DR   GEO; GSM1181292
DR   GEO; GSM1181336
DR   GEO; GSM1670072
DR   GEO; GSM2124668
DR   IARC_TP53; 18085
DR   NCI-DTP; M14
DR   PharmacoDB; M14_879_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   Progenetix; CVCL_1395
DR   PubChem_Cell_line; CVCL_1395
DR   SKY/M-FISH/CGH; 2813
DR   Wikidata; Q51838638
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=56444;
RX   PubMed=204583;
RX   PubMed=945229;
RX   PubMed=954005;
RX   PubMed=1260767;
RX   PubMed=1918136;
RX   PubMed=2041050;
RX   PubMed=2060184;
RX   PubMed=3046746;
RX   PubMed=3658923;
RX   PubMed=3674770;
RX   PubMed=6470027;
RX   PubMed=6500744;
RX   PubMed=6876798;
RX   PubMed=8618233;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=11121133;
RX   PubMed=12068308;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=19549886;
RX   PubMed=19727395;
RX   PubMed=19799798;
RX   PubMed=21863025;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28940260;
RX   PubMed=29492214;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31733513;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=48
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=8631022); 26.3 hours (NCI-DTP=M14).
CC   HLA typing: A*11:01:01,24:02:01; B*15,35; C*03:03:01,04; DPB1*13:01,19:01; DQB1*03:02,06:03; DRB1*04:05:01,13:01:01 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=19799798; PubMed=29492214; Cosmic-CLP=905975; DepMap=ACH-002159).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=19799798; PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (PubMed=19799798; PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095; Cosmic-CLP=905975; DepMap=ACH-002159).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.64%; Native American=0%; East Asian, North=0%; East Asian, South=1.08%; South Asian=0%; European, North=67.89%; European, South=30.39% (PubMed=30894373).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): Cosmic-CLP=905975; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=28940260
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14
ST   D12S391: 18,19
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D1S1656: 11,12
ST   D21S11: 30
ST   D22S1045: 15
ST   D2S1338: 19,24
ST   D2S441: 11,14
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   SE33: 15,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI53 ! MF14
OI   CVCL_DI50 ! ML14 [Human LCL]
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   M14-10
AC   CVCL_A8FV
DR   TKG; TKG 0791
DR   Wikidata; Q107115888
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   M14-11
AC   CVCL_A8FW
DR   TKG; TKG 0792
DR   Wikidata; Q107115889
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   M14-14
AC   CVCL_A8FX
DR   TKG; TKG 0793
DR   Wikidata; Q107115890
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   M14-16
AC   CVCL_A8FY
DR   TKG; TKG 0794
DR   Wikidata; Q107115891
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   M14-17
AC   CVCL_A8FZ
DR   TKG; TKG 0795
DR   Wikidata; Q107115893
RX   PubMed=20133493;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   M14-21
AC   CVCL_A8GA
DR   TKG; TKG 0796
DR   Wikidata; Q107115894
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   M14-23
AC   CVCL_A8GB
DR   Wikidata; Q107115896
RX   PubMed=20133493;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   M14-26
AC   CVCL_A8GC
DR   TKG; TKG 0797
DR   Wikidata; Q107115898
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   M14-29
AC   CVCL_A8GD
DR   TKG; TKG 0798
DR   Wikidata; Q107115901
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   M14-9
AC   CVCL_A8FU
DR   TKG; TKG 0790
DR   Wikidata; Q107115902
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   M14-A
AC   CVCL_A779
SY   M14-ascitic form
DR   cancercelllines; CVCL_A779
DR   Wikidata; Q54903472
RX   PubMed=6470027;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   M14-CDM
AC   CVCL_ZZ71
SY   M14 CDM; M14-Chemically Defined Medium
DR   cancercelllines; CVCL_ZZ71
DR   Wikidata; Q102114489
RX   PubMed=1260767;
RX   PubMed=6386801;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   M140325
AC   CVCL_A1UE
DR   cancercelllines; CVCL_A1UE
DR   DepMap; ACH-002511
DR   Wikidata; Q105509976
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 7
//
ID   M146I-hiPSC
AC   CVCL_DQ95
DR   SKIP; SKIP001286
DR   Wikidata; Q54903473
RX   PubMed=27345998;
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Ile (c.438G>A); ClinVar=VCV000018137; Zygosity=Heterozygous (PubMed=27345998).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   M14939#3
AC   CVCL_B5FK
DR   GEO; GSM5027867
DR   GEO; GSM5027868
DR   GEO; GSM5027869
DR   GEO; GSM5027870
DR   GEO; GSM5027902
DR   GEO; GSM5027903
DR   GEO; GSM5027904
DR   GEO; GSM5027908
DR   GEO; GSM5027909
DR   GEO; GSM5027910
DR   GEO; GSM5027914
DR   GEO; GSM5027915
DR   GEO; GSM5027916
DR   GEO; GSM5027920
DR   GEO; GSM5027921
DR   GEO; GSM5027922
DR   GEO; GSM5027932
DR   GEO; GSM5027933
DR   GEO; GSM5027934
DR   GEO; GSM5027957
DR   GEO; GSM5027958
DR   GEO; GSM5027959
DR   GEO; GSM5027960
DR   GEO; GSM5027961
DR   GEO; GSM5027962
DR   Wikidata; Q110433009
RX   PubMed=34864219;
CC   Group: Non-human primate cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 5
//
ID   M14K
AC   CVCL_8102
AS   CVCL_M199
SY   M-14-K; M14
DR   BTO; BTO_0003999
DR   Cosmic; 733822
DR   IARC_TP53; 23629
DR   Wikidata; Q54903474
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=2323006;
RX   PubMed=9533946;
RX   PubMed=11251971;
RX   PubMed=11283936;
RX   PubMed=23840376;
RX   PubMed=33567673;
CC   Doubling time: 55 hours (PubMed=23840376).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U345 ! M14P
OI   CVCL_8103 ! M20 [Human mesothelioma]
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   M14M
AC   CVCL_U460
DR   Cosmic; 733824
DR   Cosmic; 934557
DR   Wikidata; Q54903475
RX   PubMed=1568228;
RX   PubMed=7972006;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U345 ! M14P
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   M14P
AC   CVCL_U345
SY   M14
DR   Cosmic; 733823
DR   IARC_TP53; 23630
DR   Wikidata; Q54903476
RX   PubMed=1568228;
RX   PubMed=2323006;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8102 ! M14K
OI   CVCL_8103 ! M20 [Human mesothelioma]
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   M15 [Human melanoma]
AC   CVCL_D5ZV
SY   UCLA-SO-M15; UCLASO-M15; Melanoma 15
DR   Wikidata; Q127382720
RX   PubMed=56444;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ZW ! MF15
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   M15 [Human mesothelioma]
AC   CVCL_U344
DR   cancercelllines; CVCL_U344
DR   Cosmic; 733825
DR   IARC_TP53; 943
DR   Wikidata; Q54903477
RX   PubMed=1568228;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Heterozygous (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   M15 [Mouse]
AC   CVCL_3841
SY   Meso15
DR   CLO; CLO_0007461
DR   CLDB; cl3312
DR   ECACC; 95102517
DR   Wikidata; Q54903480
RX   PubMed=7736591;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Mesonephros; UBERON=UBERON_0000080.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   M15 10F7.1
AC   CVCL_KR71
DR   Wikidata; Q54903481
RX   Patent=US8444987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-592.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   M15 1B4.1
AC   CVCL_KR72
DR   Wikidata; Q54903482
RX   Patent=US8444987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-588.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   M15 203.1
AC   CVCL_KR73
DR   Wikidata; Q54903483
RX   Patent=US8444987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-591.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   M15 3F7.3
AC   CVCL_KR74
DR   Wikidata; Q54903484
RX   Patent=US8444987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-593.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   M15 5A16.1
AC   CVCL_KR75
DR   Wikidata; Q54903485
RX   Patent=US8444987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-587.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   M15 9F11.1
AC   CVCL_KR76
DR   Wikidata; Q54903486
RX   Patent=US8444987;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-590.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   M150404
AC   CVCL_C3G0
DR   GEO; GSM4933086
DR   Wikidata; Q114311910
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FZ ! MM150405
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   M1536-B3
AC   CVCL_KB73
SY   M 1536-B3; M-1536-B3; M1536B3
DR   Wikidata; Q54903487
RX   PubMed=558822;
RX   PubMed=6173246;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5911 ! PCC4-F
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   M16
AC   CVCL_C6KN
DR   ABCD; ABCD_AF131
DR   Wikidata; Q116049735
RX   PubMed=9126991;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01308; Human INS (Note=Also reacts with bovine, pig and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   M160
AC   CVCL_E3EC
CC   Population: Caucasian, not Hispanic.
CC   Doubling time: 24-36 hours (Direct_author_submission).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Cys2112Arg (c.6334T>C); Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Jenkins, Russell William.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   m17.ASC
AC   CVCL_G357
DR   ECACC; 11112201
DR   Wikidata; Q54903488
RX   Patent=US8835165;
RX   PubMed=23777308;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 10001.
CC   Doubling time: 32 hours (PubMed=23777308).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Somatic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   M17/4.2
AC   CVCL_UW10
DR   Wikidata; Q95984044
RX   PubMed=6983917;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P24063; Mouse Itgal/Cd11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   M17/4.4.11.9
AC   CVCL_9212
DR   CLO; CLO_0007463
DR   ATCC; TIB-217
DR   Wikidata; Q54903489
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P24063; Mouse Itgal/Cd11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UW10 ! M17/4.2
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M17/5.2
AC   CVCL_9213
SY   M17/5
DR   CLO; CLO_0007464
DR   ATCC; TIB-237
DR   Wikidata; Q54903490
RX   PubMed=6983917;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P24063; Mouse Itgal/Cd11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   M18
AC   CVCL_D029
SY   EST133
DR   cancercelllines; CVCL_D029
DR   Cosmic; 1047644
DR   Cosmic; 2163832
DR   ESTDAB; ESTDAB-133
DR   GEO; GSM156004
DR   IARC_TP53; 26071
DR   Progenetix; CVCL_D029
DR   Wikidata; Q54903491
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   HLA typing: A*29:02,29:02; B*49:01,49:01; C*07:01:01,07:01:01; DPB1*02:01:02,03:01; DQB1*03:02,06:01:01; DRB1*04:01,ND (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ESTDAB=ESTDAB-133
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 8
ST   FGA: 21,23
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   M18/2.a.12.7
AC   CVCL_7681
DR   CLO; CLO_0007465
DR   ATCC; TIB-218
DR   Wikidata; Q54903492
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G215 ! M18/2.a.8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   M18/2.a.8
AC   CVCL_G215
DR   Wikidata; Q54903493
RX   PubMed=6193226;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   M18/B7
AC   CVCL_D030
DR   cancercelllines; CVCL_D030
DR   ESTDAB; ESTDAB-041
DR   Wikidata; Q54903494
RX   PubMed=15592718;
RX   PubMed=19340423;
CC   HLA typing: A*29:02:01,29:02:01; B*49:01,49:01; C*07:01:01,07:01:01; DPB1*02:01:02,03:01:01; DQB1*03:02,03:01:01; DRB1*04:05:01,04:07:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
ST   Source(s): ESTDAB=ESTDAB-041
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 8
ST   FGA: 21,23
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D029 ! M18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   M19
AC   CVCL_M198
DR   Cosmic; 733827
DR   Cosmic; 934558
DR   IARC_TP53; 23632
DR   Wikidata; Q54903495
RX   PubMed=1568228;
RX   PubMed=2323006;
RX   PubMed=7972006;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Donor information: No history of asbestos exposure (PubMed=2323006).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M197 ! M22K
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   M19-MEL
AC   CVCL_B415
SY   M-19; M19
DR   ChEMBL-Cells; CHEMBL3307506
DR   ChEMBL-Targets; CHEMBL614019
DR   Cosmic; 1181741
DR   Cosmic; 1303041
DR   NCI-DTP; M19-MEL
DR   PubChem_Cell_line; CVCL_B415
DR   Wikidata; Q54903496
RX   PubMed=2041050;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=9488600;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Doubling time: 35 hours (PubMed=7718330); 24 hours (PubMed=9488600).
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   M195
AC   CVCL_L542
DR   CLO; CLO_0007466
DR   Wikidata; Q54903498
RX   Patent=US5730982;
RX   Patent=US6007814;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10306.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20138; Human CD33.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   M1Do
AC   CVCL_W290
SY   M1 (Do.); M1
DR   Wikidata; Q54903499
RX   DOI=10.1007/BF01753729;
RX   DOI=10.1159/000417159;
RX   PubMed=3882112;
RX   PubMed=8012932;
CC   Characteristics: Non-pigmented (DOI=10.1007/BF01753729).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   M1RW
AC   CVCL_4Z11
SY   MIRW
DR   Wikidata; Q54903500
RX   PubMed=6770995;
RX   PubMed=6773878;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=6770995); 23.6 hours (PubMed=6773878).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   M1RW5
AC   CVCL_4Z12
SY   MIRW5
DR   Wikidata; Q54903501
RX   PubMed=3079741;
RX   PubMed=3667379;
RX   PubMed=3698005;
RX   PubMed=3864528;
RX   PubMed=6581509;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z11 ! M1RW
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   M1WT2
AC   CVCL_3842
SY   CHO-M1WT2
DR   CLO; CLO_0007467
DR   ATCC; CRL-1984
DR   Wikidata; Q54903502
RX   PubMed=2175603;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2342; Chrm1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   M1WT3
AC   CVCL_3843
SY   CHO-M1WT3
DR   CLO; CLO_0007468
DR   CLDB; cl3314
DR   ATCC; CRL-1985
DR   ECACC; 940822109
DR   Wikidata; Q54903503
RX   PubMed=2175603;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2342; Chrm1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   M1WT5
AC   CVCL_3844
SY   CHO-M1WT5
DR   CLO; CLO_0007469
DR   ATCC; CRL-1986
DR   Wikidata; Q54903504
RX   PubMed=2175603;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2342; Chrm1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   M2-0
AC   CVCL_E7IM
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00425; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m2-0/
CC   Characteristics: Has an epithelioid morphology; subnormal subcategory (Sbnl) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 42 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   M2-1 [Mouse hybridoma]
AC   CVCL_2Z36
SY   WC00001
DR   CLO; CLO_0013435
DR   BioSamples; SAME17773
DR   Coriell; WC00001
DR   Wikidata; Q54903505
CC   Monoclonal antibody isotype: Not specified.
CC   Discontinued: Coriell; WC00001; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 30-01-24; Version: 7
//
ID   M2-1 [Rat mesothelial]
AC   CVCL_RG50
DR   PRIDE; PXD060521
DR   Wikidata; Q54903506
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00430; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m2-1/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia low subcategory (PNsarc1) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 44 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   M2-10B4
AC   CVCL_5794
SY   M210B4
DR   CLO; CLO_0007470
DR   ATCC; CRL-1972
DR   BCRC; 60228
DR   CCRID; 4201MOU-CCTCC00305
DR   CCTCC; GDC0305
DR   CLS; 400428
DR   IZSLER; BS CL 199
DR   KCLB; 21972
DR   Wikidata; Q54903507
RX   PubMed=3261251;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6J x C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   M2-1C6-4R3
AC   CVCL_4538
SY   M2-1C6; M2-1C6-5; WC00017
DR   CLO; CLO_0007471
DR   CLO; CLO_0012695
DR   CLDB; cl5224
DR   ATCC; HB-64
DR   BioSamples; SAME17713
DR   Coriell; WC00017
DR   IZSLER; BS Hy 29
DR   Wikidata; Q54903508
RX   PubMed=7217668;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Influenza A virus matrix protein (M).
CC   Discontinued: Coriell; WC00017; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   M2-2
AC   CVCL_E7IN
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00426; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m2-2/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia high subcategory (PNsarc2) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 65 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   M2-21-4.6
AC   CVCL_5K10
SY   WC00028
DR   CLO; CLO_0012716
DR   BioSamples; SAME17797
DR   Coriell; WC00028
DR   Wikidata; Q54903510
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Influenza A virus matrix protein (M).
CC   Discontinued: Coriell; WC00028; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 7
//
ID   M2-3
AC   CVCL_E7IP
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00427; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m2-3/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia high subcategory (PNsarc2) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 24 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   M2-40
AC   CVCL_5K04
SY   WC00016
DR   CLO; CLO_0012694
DR   BioSamples; SAME17709
DR   Coriell; WC00016
DR   Wikidata; Q54903511
CC   Monoclonal antibody isotype: Not specified.
CC   Discontinued: Coriell; WC00016; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 6
//
ID   M2-58
AC   CVCL_5K05
SY   WC00043
DR   CLO; CLO_0012734
DR   BioSamples; SAME17829
DR   Coriell; WC00043
DR   Wikidata; Q54903512
CC   Monoclonal antibody isotype: Not specified.
CC   Discontinued: Coriell; WC00043; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 30-01-24; Version: 6
//
ID   M2-CD83
AC   CVCL_C8SK
DR   Wikidata; Q123032991
RX   PubMed=15051893;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1328316; Cd83.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F684 ! K1735-M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   M2.7.1
AC   CVCL_JZ44
DR   Wikidata; Q54903514
RX   DOI=10.1590/S1415-47572000000300031;
CC   Group: Marsupial cell line.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
HI   CVCL_0514 ! Pt K2
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   M20 [Human melanoma]
AC   CVCL_DI51
SY   M-20; UCLA-SO-M20
DR   Wikidata; Q54903515
RX   PubMed=954005;
RX   PubMed=6876798;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI54 ! MF20
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   M20 [Human mesothelioma]
AC   CVCL_8103
DR   Cosmic; 733828
DR   IARC_TP53; 23631
DR   Wikidata; Q54903516
RX   PubMed=1568228;
RX   PubMed=2323006;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Donor information: Established after the patient had undergone chemotherapy (PubMed=2323006).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8102 ! M14K
OI   CVCL_U345 ! M14P
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   M20-18
AC   CVCL_A0IZ
SY   M20_18; Anti-EGFR G719S
DR   Wikidata; Q108820819
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012118.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly719Ser (c.2155G>A)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   M202
AC   CVCL_D746
DR   cancercelllines; CVCL_D746
DR   Cosmic; 1425343
DR   Cosmic; 1459667
DR   Cosmic; 1665002
DR   Wikidata; Q54903517
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=25645078;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 26.1 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20406486; PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=20406486; PubMed=25645078).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   M204
AC   CVCL_B6UF
DR   Wikidata; Q112930052
RX   PubMed=17451355;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   M207
AC   CVCL_D747
DR   cancercelllines; CVCL_D747
DR   Cosmic; 1425344
DR   Cosmic; 1459669
DR   Cosmic; 1665003
DR   Wikidata; Q54903518
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=25645078;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 25.2 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=20406486; PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Pro753delinsSer (c.2240_2257del); ClinVar=VCV000016608; Zygosity=Unspecified (PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=20406486; PubMed=25645078).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   M21
AC   CVCL_D031
SY   UCLA-SO-M21; UCLA SO M21
DR   cancercelllines; CVCL_D031
DR   ChEMBL-Cells; CHEMBL3307769
DR   ChEMBL-Targets; CHEMBL614117
DR   Cosmic; 928695
DR   Cosmic; 2757120
DR   ESTDAB; ESTDAB-042
DR   PubChem_Cell_line; CVCL_D031
DR   Wikidata; Q54903519
RX   PubMed=1376331;
RX   PubMed=2447074;
RX   PubMed=6386801;
RX   PubMed=15592718;
RX   PubMed=24732172;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-388.html
CC   HLA typing: A*03:01,02:01; B*07:02; C*07:02; DPB1*04:01; DQB1*06:02,03:01:01; DRB1*11:01,15:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24732172).
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): ESTDAB=ESTDAB-042
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D3S1358: 14,18
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   FGA: 20
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   M213-2O
AC   CVCL_E5TG
DR   ABM; T0356
RX   PubMed=8287936;
CC   Characteristics: Has GABAgeric properties with multiple nucleoli, and no contact inhibition features. At the permissive temperature (33 Celsius) expresses glutamate decarboxylase (GAD). At the nonpermissive temperature (39.3 Celsius) also expresses MAP2 (PubMed=8287936).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   M21L
AC   CVCL_JZ12
SY   M21-L; M21-Low
DR   cancercelllines; CVCL_JZ12
DR   Wikidata; Q54903521
RX   PubMed=1376331;
RX   PubMed=2447074;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-389.html
CC   Characteristics: Lacks expression of integrin alpha-V (ITGAV).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D031 ! M21
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   M21L22
AC   CVCL_JZ14
SY   M21-L22; M21-L variant 12
DR   cancercelllines; CVCL_JZ14
DR   Wikidata; Q54903522
RX   PubMed=1376331;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JZ12 ! M21L
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   M21L4
AC   CVCL_JZ13
SY   M21-L4; M21-L variant 4
DR   cancercelllines; CVCL_JZ13
DR   Wikidata; Q54903523
RX   PubMed=1376331;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-390.html
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6150; ITGAV.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JZ12 ! M21L
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   M21R
AC   CVCL_A1FB
SY   M21-R
DR   cancercelllines; CVCL_A1FB
DR   Cosmic; 2757121
DR   Wikidata; Q102114490
RX   PubMed=24732172;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24732172).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D031 ! M21
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   M22
AC   CVCL_U978
DR   BTO; BTO_0002197
DR   Wikidata; Q54903524
RX   PubMed=11751433;
RX   PubMed=12075625;
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic oval stem cell; CL=CL_0002196.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U976 ! OC/CDE 22
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   M227
AC   CVCL_VQ59
DR   RCB; RCB0012
DR   Wikidata; Q95984127
CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV) (Note=ts mutant).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   M229
AC   CVCL_D748
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_D748
DR   Cosmic; 1425351
DR   Cosmic; 1459649
DR   Cosmic; 1665011
DR   GEO; GSM612085
DR   GEO; GSM612086
DR   GEO; GSM1588914
DR   Progenetix; CVCL_D748
DR   Wikidata; Q54903526
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22194965;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=28196595;
RX   PubMed=29229836;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 27.9 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=20406486; PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=20406486; PubMed=22194965).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   M229 R1
AC   CVCL_EI76
DR   cancercelllines; CVCL_EI76
DR   Cosmic; 1545601
DR   Wikidata; Q54903527
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R10
AC   CVCL_EI77
DR   cancercelllines; CVCL_EI77
DR   Cosmic; 1545610
DR   Wikidata; Q54903528
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R11
AC   CVCL_EI78
DR   cancercelllines; CVCL_EI78
DR   Cosmic; 1545611
DR   Wikidata; Q54903529
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R12
AC   CVCL_EI79
DR   cancercelllines; CVCL_EI79
DR   Cosmic; 1545612
DR   Wikidata; Q54903530
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R13
AC   CVCL_EI80
DR   cancercelllines; CVCL_EI80
DR   Cosmic; 1545613
DR   Wikidata; Q54903531
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R14
AC   CVCL_EI81
DR   cancercelllines; CVCL_EI81
DR   Cosmic; 1545614
DR   Wikidata; Q54903532
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R15
AC   CVCL_EI82
DR   cancercelllines; CVCL_EI82
DR   Cosmic; 1545615
DR   Wikidata; Q54903533
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R2
AC   CVCL_EI83
DR   cancercelllines; CVCL_EI83
DR   Cosmic; 1545602
DR   Wikidata; Q54903534
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R3
AC   CVCL_EI84
DR   cancercelllines; CVCL_EI84
DR   Cosmic; 1545603
DR   Wikidata; Q54903535
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R4
AC   CVCL_EI85
DR   cancercelllines; CVCL_EI85
DR   Cosmic; 1545604
DR   Wikidata; Q54903536
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R5
AC   CVCL_EI86
DR   cancercelllines; CVCL_EI86
DR   Cosmic; 1545605
DR   Wikidata; Q54903537
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R6
AC   CVCL_EI87
DR   cancercelllines; CVCL_EI87
DR   Cosmic; 1545606
DR   Wikidata; Q54903538
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R7
AC   CVCL_EI88
DR   cancercelllines; CVCL_EI88
DR   Cosmic; 1545607
DR   Wikidata; Q54903539
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R8
AC   CVCL_EI89
DR   cancercelllines; CVCL_EI89
DR   Cosmic; 1545608
DR   Wikidata; Q54903540
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M229 R9
AC   CVCL_EI90
SY   M229-AR9; M229AR9
DR   cancercelllines; CVCL_EI90
DR   Cosmic; 1545609
DR   Wikidata; Q54903541
RX   PubMed=21107323;
RX   PubMed=22194965;
RX   PubMed=24735930;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=22194965).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   M229DDRpoly-PLXAZD
AC   CVCL_IM72
DR   cancercelllines; CVCL_IM72
DR   GEO; GSM1588916
DR   Wikidata; Q54903542
RX   PubMed=26359985;
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   M229R5-PLX
AC   CVCL_IM73
DR   cancercelllines; CVCL_IM73
DR   GEO; GSM1588915
DR   Wikidata; Q54903543
RX   PubMed=26359985;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D748 ! M229
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   M26-1F
AC   CVCL_E5TF
DR   ABM; T0357
RX   PubMed=8287936;
CC   Characteristics: Has GABAgeric properties with multiple nucleoli, and no contact inhibition features (PubMed=8287936).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   M22K
AC   CVCL_M197
DR   Wikidata; Q54903544
RX   PubMed=2323006;
CC   Donor information: No history of asbestos exposure (PubMed=2323006).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M198 ! M19
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   M23
AC   CVCL_RT32
DR   cancercelllines; CVCL_RT32
DR   Wikidata; Q54903547
RX   PubMed=23418523;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23418523).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   M23(CLB)
AC   CVCL_UH30
DR   ATCC; CRL-6365
DR   Wikidata; Q95984152
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6365; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   11W
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   M230
AC   CVCL_D749
DR   Cosmic; 1665177
DR   Wikidata; Q54903548
RX   PubMed=22515704;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   M233
AC   CVCL_D750
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_D750
DR   Cosmic; 1425345
DR   Cosmic; 1459657
DR   Cosmic; 1665012
DR   Wikidata; Q54903549
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22194965;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=28196595;
RX   PubMed=29229836;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 29.6 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=20406486; PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20406486; PubMed=22194965).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   M238
AC   CVCL_D751
DR   cancercelllines; CVCL_D751
DR   Cosmic; 1425352
DR   Cosmic; 1459647
DR   Cosmic; 1665013
DR   GEO; GSM612087
DR   GEO; GSM612088
DR   GEO; GSM1588917
DR   Progenetix; CVCL_D751
DR   Wikidata; Q54903550
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22194965;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=28196595;
RX   PubMed=29229836;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 28.1 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=20406486; PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20406486; PubMed=22194965).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   M238 R1
AC   CVCL_EI91
DR   cancercelllines; CVCL_EI91
DR   Cosmic; 1545616
DR   Wikidata; Q54903551
RX   PubMed=21107323;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D751 ! M238
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   M238 R2
AC   CVCL_EI92
SY   M238-AR2; M238AR
DR   cancercelllines; CVCL_EI92
DR   Cosmic; 1545617
DR   Wikidata; Q54903553
RX   PubMed=21107323;
RX   PubMed=22194965;
RX   PubMed=24735930;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22194965).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D751 ! M238
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   M238R1-PLX
AC   CVCL_IM74
DR   cancercelllines; CVCL_IM74
DR   GEO; GSM1588918
DR   Wikidata; Q54903557
RX   PubMed=26359985;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D751 ! M238
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   M24
AC   CVCL_D032
SY   UCLA-SO-M24; UCLA-SO-24
DR   cancercelllines; CVCL_D032
DR   Cosmic; 2163789
DR   ESTDAB; ESTDAB-043
DR   ESTDAB; ESTDAB-134
DR   Wikidata; Q54903558
RX   Patent=US5840317;
RX   Patent=US5993828;
RX   PubMed=2009538;
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12270.
CC   HLA typing: A*02:01,68:01:01; B*40:01:01,40:02; C*03:04,02:02:02; DPB1*04:01; DQB1*03:01:01,05:02; DRB1*04:01:01,16:02 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-043; ESTDAB=ESTDAB-134
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D3S1358: 14,16
ST   D5S818: 13
ST   D7S820: 9
ST   FGA: 18,19
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   M243
AC   CVCL_D752
DR   cancercelllines; CVCL_D752
DR   Cosmic; 1459663
DR   Cosmic; 1665004
DR   Wikidata; Q54903559
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=25645078;
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Tyr (c.94G>T); ClinVar=VCV000017581; Zygosity=Unspecified (PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Homozygous (PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu353Gly (c.1058A>G) (p.Glu156Gly, c.467A>G); ClinVar=VCV000237638; Zygosity=Heterozygous (PubMed=25645078).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   M244
AC   CVCL_D753
DR   cancercelllines; CVCL_D753
DR   Cosmic; 1459664
DR   Cosmic; 1665006
DR   Wikidata; Q54903560
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=25645078;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=25645078).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   M245
AC   CVCL_D754
DR   cancercelllines; CVCL_D754
DR   Cosmic; 1459661
DR   Cosmic; 1665005
DR   Wikidata; Q54903561
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=25645078;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=25645078).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   M245 LCL
AC   CVCL_D5B1
DR   Wikidata; Q127382721
RX   PubMed=8388232;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   M245-mycl23
AC   CVCL_D5B2
DR   Wikidata; Q127382722
RX   PubMed=8388232;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_D5B1 ! M245 LCL
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   M249
AC   CVCL_D755
DR   EFO; EFO_0022586
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_D755
DR   Cosmic; 1425353
DR   Cosmic; 1459652
DR   Cosmic; 1545618
DR   Cosmic; 1665014
DR   Wikidata; Q54903562
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22194965;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Doubling time: 21.2 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=20406486; PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20406486; PubMed=22194965).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   M249 R4
AC   CVCL_EI93
SY   M249-AR4; M249AR4
DR   cancercelllines; CVCL_EI93
DR   Cosmic; 1545619
DR   Wikidata; Q54903563
RX   PubMed=21107323;
RX   PubMed=22194965;
RX   PubMed=25645078;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=22194965; PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22194965; PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=21107323; PubMed=22194965; PubMed=25645078).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D755 ! M249
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   M24K
AC   CVCL_8104
DR   Cosmic; 733829
DR   Cosmic; 933012
DR   Cosmic; 934556
DR   Cosmic; 2668293
DR   IARC_TP53; 23633
DR   Wikidata; Q54903564
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=7972006;
RX   PubMed=11251971;
RX   PubMed=11283936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: M24; Cosmic=2668293.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   M24met
AC   CVCL_3915
SY   M24 met
DR   Wikidata; Q54903565
RX   PubMed=2009538;
CC   Characteristics: Established from M24 cell line after a passage in nude mice.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D032 ! M24
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   M24met H1.11
AC   CVCL_3916
DR   Wikidata; Q54903566
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3915 ! M24met
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   M25
AC   CVCL_WH32
DR   GEO; GSM2597277
DR   GEO; GSM2597278
DR   GEO; GSM2597279
DR   Wikidata; Q95984173
RX   PubMed=28834169;
CC   Doubling time: 42.8 hours (PubMed=28834169).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Breed and age of donor from personal communication of Cordeiro, Yonara Gouveia.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Rough Collie; VBO=VBO_0200376.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   M25.18A1
AC   CVCL_S554
SY   M25
DR   ATCC; HB-12152
DR   Wikidata; Q54903567
RX   Patent=US5955311;
RX   Patent=US6365157;
RX   Patent=US6448077;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12152.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35918; Mouse Kdr/Cd309.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   M255
AC   CVCL_D756
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_D756
DR   Cosmic; 1425346
DR   Cosmic; 1665015
DR   Wikidata; Q54903568
RX   PubMed=20406486;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Doubling time: 48.6 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20406486).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20406486).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   M257
AC   CVCL_D757
DR   Cosmic; 1425342
DR   Cosmic; 1459668
DR   Cosmic; 1665178
DR   Cosmic; 1949555
DR   Wikidata; Q54903569
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 31.4 hours (PubMed=20406486).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   M2590
AC   CVCL_KA00
DR   Wikidata; Q54903570
RX   PubMed=3940532;
RX   PubMed=6206164;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_84118; Ganglioside GM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 4
//
ID   M25K
AC   CVCL_8105
DR   Cosmic; 733830
DR   IARC_TP53; 23634
DR   Wikidata; Q54903571
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=11251971;
RX   PubMed=11283936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: No history of asbestos exposure (PubMed=1568228).
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   M26
AC   CVCL_B416
DR   Cosmic; 1181765
DR   Wikidata; Q54903572
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   M262
AC   CVCL_D758
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_D758
DR   Cosmic; 1425354
DR   Cosmic; 1459641
DR   Cosmic; 1665016
DR   Wikidata; Q54903573
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=28196595;
RX   PubMed=29229836;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 47.4 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20406486).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=20406486).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   M263
AC   CVCL_D759
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_D759
DR   Cosmic; 1425348
DR   Cosmic; 1459658
DR   Cosmic; 1665017
DR   Wikidata; Q54903574
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22194965;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=28196595;
RX   PubMed=29229836;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 23.3 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=20406486).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20406486; PubMed=22194965).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   M275
AC   CVCL_D760
DR   Cosmic; 1459646
DR   Cosmic; 1665018
DR   Wikidata; Q54903575
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   M27H4
AC   CVCL_A4AS
DR   Wikidata; Q105509979
RX   PubMed=12602905;
CC   Characteristics: Weakly tumorigenic (PubMed=12602905).
CC   Doubling time: 25 hours (PubMed=12602905).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the promoter of rat Psbpc3/Scgb2a2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB-Tg(C3-1-TAg)cJeg/JegJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   M285
AC   CVCL_D761
DR   Cosmic; 1665179
DR   Wikidata; Q54903576
RX   PubMed=22515704;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   M288
AC   CVCL_D762
DR   Cosmic; 1459640
DR   Wikidata; Q54903577
RX   PubMed=20689758;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   M28K
AC   CVCL_8106
SY   M-28-K; M28
DR   BTO; BTO_0004000
DR   Cosmic; 733831
DR   IARC_TP53; 23635
DR   Lonza; 704
DR   Wikidata; Q54903578
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=11283936;
RX   PubMed=12707267;
RX   PubMed=23422483;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   M28N2
AC   CVCL_A4AT
DR   Wikidata; Q105509982
RX   PubMed=12602905;
CC   Characteristics: Weakly tumorigenic (PubMed=12602905).
CC   Doubling time: 37 hours (PubMed=12602905).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the promoter of rat Psbpc3/Scgb2a2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB-Tg(C3-1-TAg)cJeg/JegJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   M290
AC   CVCL_L705
DR   ECACC; 93012001
DR   Wikidata; Q54903579
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q60677; Mouse Itgae/Cd103.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   M296
AC   CVCL_D763
DR   cancercelllines; CVCL_D763
DR   Cosmic; 1459670
DR   Cosmic; 1665007
DR   Wikidata; Q54903580
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=25645078;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=25645078).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   M297
AC   CVCL_D764
DR   Cosmic; 1665019
DR   Wikidata; Q54903581
RX   PubMed=22515704;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   M299
AC   CVCL_D765
DR   cancercelllines; CVCL_D765
DR   Cosmic; 1459654
DR   Cosmic; 1665020
DR   Wikidata; Q54903582
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   M2A5
AC   CVCL_D4YG
SY   A5
DR   Wikidata; Q127382723
RX   PubMed=1549777;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3754; FLNA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M543 ! RPM-MC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   M2A7
AC   CVCL_3486
SY   A7
DR   CLO; CLO_0001608
DR   EFO; EFO_0002107
DR   CLDB; cl212
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2500
DR   BioSample; SAMN03471597
DR   IGRhCellID; A7
DR   Wikidata; Q54903583
RX   PubMed=1549777;
RX   PubMed=20215515;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3754; FLNA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-2500
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 29,31
ST   D2S1338: 16,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 16
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 10,14
ST   TH01: 7
ST   TPOX: 7
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M543 ! RPM-MC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   M2B
AC   CVCL_DD25
DR   Wikidata; Q54903584
RX   PubMed=25647616;
CC   Characteristics: Persistently infected with proteinase K resistant BSE (PrP(BSE)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:33356; Bovine PRNP.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   M2C24,
AC   CVCL_C0C1
DR   Wikidata; Q112930053
RX   PubMed=12913096;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P15151; Human PVR/CD155.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   M2D1
AC   CVCL_D3F7
DR   Wikidata; Q127382724
RX   PubMed=1500069;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Istiophorus platypterus albumin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   M2DE8
AC   CVCL_F0V3
RX   PubMed=2312132;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_49771; D-erythro-neopterin (Note=Also recognizes monapterin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   M2Ge
AC   CVCL_W291
SY   M2 (Ge.); M2Ge.; M2GeB; M2
DR   Wikidata; Q54903585
RX   DOI=10.1007/BF01753729;
RX   DOI=10.1159/000417159;
RX   PubMed=3882112;
CC   Characteristics: Non-pigmented (DOI=10.1007/BF01753729).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   M3
AC   CVCL_4Y25
DR   BCRJ; 0154
DR   Wikidata; Q54903586
RX   PubMed=8691844;
CC   Doubling time: 19.2 hours (PubMed=8691844).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 7
//
ID   M3-1 [Hamster]
AC   CVCL_RG48
DR   Wikidata; Q54903587
RX   DOI=10.2172/4683311;
RX   PubMed=688393;
RX   PubMed=730780;
RX   PubMed=1055399;
RX   PubMed=1167420;
RX   PubMed=5660764;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   M3-1 [Rat mesothelial]
AC   CVCL_RG51
DR   PRIDE; PXD060521
DR   Wikidata; Q54903588
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00428; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m3-1/
CC   Characteristics: Has an epithelioid morphology; preneoplastic epithelioid category (PNep) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 70 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   M3-1 clone 650A
AC   CVCL_A5XV
SY   650A; Clone 650A
DR   Wikidata; Q107115904
RX   PubMed=1055399;
RX   PubMed=1170959;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG48 ! M3-1 [Hamster]
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   M3-1 clone 650AB
AC   CVCL_A5XW
SY   650AB; Clone 650AB
DR   Wikidata; Q107115908
RX   PubMed=1170959;
CC   Characteristics: Obtained after irradiation of parent cell line (650A).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5XV ! M3-1 clone 650A
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   M3-2
AC   CVCL_E7IQ
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00429; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m3-2/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); hypoxia low subcategory (PNsarc1) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 98 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   M3/38.1.2.8 HL.2
AC   CVCL_7683
SY   M3/38.1.2.8.HL.2; M3/38
DR   CLO; CLO_0007475
DR   ATCC; TIB-166
DR   BCRJ; 0155
DR   Wikidata; Q54903590
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P16110; Mouse Lgals3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   M3/84.6.34
AC   CVCL_9214
SY   M3/84
DR   CLO; CLO_0007476
DR   ATCC; TIB-168
DR   BCRJ; 0156
DR   Wikidata; Q54903591
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P17047; Mouse Lamp2/Cd107b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   M305
AC   CVCL_B6UG
DR   Wikidata; Q112930054
RX   PubMed=17451355;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   M308
AC   CVCL_D766
DR   cancercelllines; CVCL_D766
DR   Cosmic; 1425347
DR   Cosmic; 1459666
DR   Cosmic; 1665021
DR   Wikidata; Q54903592
RX   PubMed=20406486;
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=24735930;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 35.0 hours (PubMed=20406486).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=20406486).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20406486).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   M311 [Human leukemia]
AC   CVCL_M771
DR   BEI_Resources; ARP-1295
DR   cancercelllines; CVCL_M771
DR   Wikidata; Q54903593
RX   PubMed=3422113;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 22
//
ID   M311 [Human melanoma]
AC   CVCL_B4KR
DR   cancercelllines; CVCL_B4KR
DR   Wikidata; Q110433010
RX   PubMed=25645078;
RX   PubMed=27533468;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (PubMed=25645078; PubMed=27533468).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   M318
AC   CVCL_D767
DR   cancercelllines; CVCL_D767
DR   Cosmic; 1459660
DR   Cosmic; 1665008
DR   Wikidata; Q54903594
RX   PubMed=20689758;
RX   PubMed=22515704;
RX   PubMed=25645078;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=25645078).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   M32-8
AC   CVCL_A0JA
SY   M32_8; Anti-EGFR G719C
DR   Wikidata; Q108820820
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012127.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly719Cys).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   M321
AC   CVCL_D768
DR   cancercelllines; CVCL_D768
DR   Cosmic; 1425349
DR   Cosmic; 1459653
DR   Wikidata; Q54903595
RX   PubMed=20406486;
RX   PubMed=20689758;
CC   Doubling time: 34.1 hours (PubMed=20406486).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=20406486).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   M328
AC   CVCL_IW41
DR   Wikidata; Q54903597
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   M32K
AC   CVCL_U343
DR   Cosmic; 733832
DR   IARC_TP53; 23636
DR   Wikidata; Q54903603
RX   PubMed=1568228;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   M337V iPSC clone 1
AC   CVCL_WR47
SY   M337V-1
DR   Wikidata; Q95984221
RX   PubMed=22451909;
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Met337Val (c.1009A>G); ClinVar=VCV000005228; Zygosity=Heterozygous (PubMed=22451909).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WR48 ! M337V iPSC clone 2
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   M337V iPSC clone 2
AC   CVCL_WR48
SY   M337V-2
DR   Wikidata; Q95984223
RX   PubMed=22451909;
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Met337Val (c.1009A>G); ClinVar=VCV000005228; Zygosity=Heterozygous (PubMed=22451909).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WR47 ! M337V iPSC clone 1
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   M33K
AC   CVCL_8107
DR   Cosmic; 733833
DR   Cosmic; 933011
DR   Cosmic; 934559
DR   IARC_TP53; 23637
DR   Wikidata; Q54903604
RX   CelloPub=CLPUB00243;
RX   PubMed=1568228;
RX   PubMed=2323006;
RX   PubMed=7972006;
RX   PubMed=11283936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   M34
AC   CVCL_S680
DR   cancercelllines; CVCL_S680
DR   ChEMBL-Cells; CHEMBL4632327
DR   ChEMBL-Targets; CHEMBL4632334
DR   Cosmic; 1244761
DR   GEO; GSM202112
DR   IGRhCellID; M34%20GEO
DR   Progenetix; CVCL_S680
DR   PubChem_Cell_line; CVCL_S680
DR   Wikidata; Q54903605
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 9
//
ID   M340
AC   CVCL_KS80
DR   Wikidata; Q54903589
RX   PubMed=2550359;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on neuroblastoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   M35/01
AC   CVCL_M577
DR   Wikidata; Q54903606
RX   PubMed=16368560;
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 7
//
ID   M35A
AC   CVCL_C4CG
DR   ABCD; ABCD_AP565
DR   Wikidata; Q116049736
RX   Patent=US9040295;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10831.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q13797; Human ITGA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   M368
AC   CVCL_D769
DR   Cosmic; 1665180
DR   Wikidata; Q54903607
RX   PubMed=22515704;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   M370
AC   CVCL_XJ97
DR   cancercelllines; CVCL_XJ97
DR   Wikidata; Q95984236
RX   PubMed=22194965;
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22194965; PubMed=24735930).
CC   Derived from site: Metastatic; Heart; UBERON=UBERON_0000948.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   M375
AC   CVCL_D770
DR   Cosmic; 1665181
DR   Wikidata; Q54903608
RX   PubMed=22515704;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   M376
AC   CVCL_XK11
DR   cancercelllines; CVCL_XK11
DR   Wikidata; Q95984239
RX   PubMed=22194965;
RX   PubMed=27533468;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22194965; PubMed=27533468).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=22194965; PubMed=27533468).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   M380
AC   CVCL_XK12
DR   cancercelllines; CVCL_XK12
DR   Wikidata; Q95984241
RX   PubMed=22194965;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22194965).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M381
AC   CVCL_XJ98
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_XJ98
DR   Wikidata; Q95984243
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29229836).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   M38K
AC   CVCL_8108
DR   Wikidata; Q54903610
RX   CelloPub=CLPUB00243;
RX   PubMed=2323006;
RX   PubMed=9533946;
RX   PubMed=11251971;
RX   PubMed=11283936;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   M390
AC   CVCL_XK07
DR   cancercelllines; CVCL_XK07
DR   Wikidata; Q95984246
RX   PubMed=24735930;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M395
AC   CVCL_XJ99
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_XJ99
DR   Wikidata; Q95984249
RX   PubMed=22194965;
RX   PubMed=29229836;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22194965).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=22194965; PubMed=29229836).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   M397
AC   CVCL_XK00
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_XK00
DR   Wikidata; Q95984250
RX   PubMed=24735930;
RX   PubMed=29229836;
RX   PubMed=32393797;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   M397-AR
AC   CVCL_XK13
SY   M397AR
DR   cancercelllines; CVCL_XK13
DR   Wikidata; Q95984253
RX   PubMed=24735930;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XK00 ! M397
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M399
AC   CVCL_XK01
DR   cancercelllines; CVCL_XK01
DR   Wikidata; Q95984256
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M3A5
AC   CVCL_D5JT
DR   Wikidata; Q127382725
RX   PubMed=3536963;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P53618; Human COPB1 (Note=Immunized with goose protein. Also recognizes rat, avian, bovine, chicken, dog, hamster, monkey, primate and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   M3Da
AC   CVCL_8336
SY   M3 (Da.); M3Da.; M3Dau; M3
DR   Wikidata; Q54903611
RX   DOI=10.1007/BF01753729;
RX   DOI=10.1159/000417159;
RX   PubMed=3882112;
RX   PubMed=8012932;
RX   PubMed=8125107;
CC   Characteristics: Non-pigmented (DOI=10.1007/BF01753729).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   M3E3/C3
AC   CVCL_2108
DR   CLO; CLO_0007477
DR   DSMZ; ACC-340
DR   DSMZCellDive; ACC-340
DR   Wikidata; Q54903612
RX   PubMed=6890064;
RX   PubMed=7863527;
RX   PubMed=11206576;
CC   Doubling time: 11 hours (PubMed=6890064); ~40 hours (DSMZ=ACC-340).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Female
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   M3F-1
AC   CVCL_0H19
DR   SKIP; SKIP000611
DR   Wikidata; Q54903613
RX   PubMed=19269371;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Heterozygous (from familial inference of GM01774; GM01775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G94 ! GM01786
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   M3F-2
AC   CVCL_0H20
DR   SKIP; SKIP000612
DR   Wikidata; Q54903614
RX   PubMed=19269371;
CC   Sequence variation: Mutation; HGNC; HGNC:2890; DKC1; Simple; p.Leu37del (c.109_111delCTT); ClinVar=VCV000011583; Zygosity=Heterozygous (from familial inference of GM01774; GM01775).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G94 ! GM01786
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   M3O-lenti-iPSC-LIF(-)
AC   CVCL_A4VP
DR   Wikidata; Q107115909
RX   PubMed=26318720;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   M3WT4
AC   CVCL_4579
SY   CHO M3WT4; CHO-M3WT4
DR   CLO; CLO_0007478
DR   ATCC; CRL-1981
DR   Wikidata; Q54903615
RX   PubMed=2175603;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2343; Chrm3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   M3WT5
AC   CVCL_4580
SY   CHO M3WT5; CHO-M3WT5
DR   CLO; CLO_0007479
DR   ATCC; CRL-1982
DR   Wikidata; Q54903616
RX   PubMed=2175603;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2343; Chrm3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   M3WT8
AC   CVCL_4581
SY   CHO M3WT8; CHO-M3WT8
DR   CLO; CLO_0007480
DR   ATCC; CRL-1983
DR   Wikidata; Q54903617
RX   PubMed=2175603;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2343; Chrm3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   M4 [Human melanoma]
AC   CVCL_D5ZX
SY   UCLA-SO-M4; UCLASO-M4; Melanoma 4
DR   Wikidata; Q127382726
RX   PubMed=56444;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ZY ! MF4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   M4 [Human ovarian carcinoma]
AC   CVCL_E2Y0
RX   PubMed=37621847;
CC   Population: Southeast Asian; Vietnamese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   M4 [Mouse hybridoma against chicken IgM]
AC   CVCL_U812
SY   M-4
DR   CLO; CLO_0050289
DR   RCB; RCB1611
DR   Wikidata; Q54903618
RX   PubMed=6183338;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chicken IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   M4 [Mouse hybridoma against human CKLF]
AC   CVCL_C5A7
DR   Wikidata; Q116049737
RX   PubMed=16332197;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UBR5; Human CKLF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   M4-1
AC   CVCL_RG60
DR   PRIDE; PXD060521
DR   Wikidata; Q54903619
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00432; https://technology-offers.inserm-transfert.com/offer/rat-mesothelial-cell-line-m4-1/
CC   Characteristics: Has a sarcomatoid morphology (PNsarc); miscellaneous category (PNMisc) (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 200 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   M40
AC   CVCL_V744
SY   MEL40
DR   cancercelllines; CVCL_V744
DR   Cosmic; 1244758
DR   GEO; GSM202135
DR   IGRhCellID; MEL40%20GEO
DR   Progenetix; CVCL_V744
DR   Wikidata; Q54903620
RX   PubMed=19047099;
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   M403
AC   CVCL_XK02
DR   cancercelllines; CVCL_XK02
DR   Wikidata; Q95984283
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29229836).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M406
AC   CVCL_XK03
DR   cancercelllines; CVCL_XK03
DR   Wikidata; Q95984285
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M407
AC   CVCL_XK08
DR   cancercelllines; CVCL_XK08
DR   Wikidata; Q95984288
RX   PubMed=24735930;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M408
AC   CVCL_B4KS
DR   cancercelllines; CVCL_B4KS
DR   Wikidata; Q110433011
RX   PubMed=25645078;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=25645078).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   M409 [Human melanoma]
AC   CVCL_XK04
DR   ArrayExpress; E-MTAB-5493
DR   cancercelllines; CVCL_XK04
DR   Wikidata; Q95984289
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   M409 [Mouse hybridoma against human FCRLA]
AC   CVCL_B6UH
DR   Wikidata; Q112930055
RX   PubMed=17451355;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   M409-AR
AC   CVCL_XK14
SY   M409AR
DR   cancercelllines; CVCL_XK14
DR   Wikidata; Q95984290
RX   PubMed=24735930;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XK04 ! M409 [Human melanoma]
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   M410
AC   CVCL_XK05
DR   cancercelllines; CVCL_XK05
DR   Wikidata; Q95984293
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M411
AC   CVCL_XK06
DR   cancercelllines; CVCL_XK06
DR   Wikidata; Q95984294
RX   PubMed=24735930;
RX   PubMed=29229836;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   M413
AC   CVCL_F0T7
RX   PubMed=1255758;
RX   PubMed=6173755;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   M414
AC   CVCL_XK09
DR   cancercelllines; CVCL_XK09
DR   Wikidata; Q95984297
RX   PubMed=24735930;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   M424
AC   CVCL_XK10
DR   cancercelllines; CVCL_XK10
DR   Wikidata; Q95984299
RX   PubMed=24735930;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=24735930).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   M426
AC   CVCL_D7DR
DR   EFO; EFO_0022499
RX   PubMed=2915979;
RX   PubMed=4300880;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   M494
AC   CVCL_JL80
DR   Wikidata; Q54903621
RX   PubMed=28395806;
CC   Sequence variation: Mutation; HGNC; HGNC:7217; MPL; Simple; p.Val501Leu (c.1501G>C); Zygosity=Heterozygous (PubMed=28395806).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3407; Essential thrombocythemia
DI   ORDO; Orphanet_3318; Essential thrombocythemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   M4A1-M2B9
AC   CVCL_D4AF
DR   DSMZ; ACC-967
DR   EGA; EGAD00001009758
DR   EGA; EGAD00001009759
DR   Wikidata; Q127382727
RX   PubMed=37051743;
CC   Characteristics: Established from a patient-derived xenograft obtained by intrafemoral injection in NOD scid mice (PubMed=37051743).
CC   Doubling time: 56.8 hours (Note=In 20% FCS) (PubMed=37051743); ~48 hours (DSMZ=ACC-967).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=37051743).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=37051743).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1008; BCL9 + HGNC; HGNC:6997; MEF2D; Name(s)=MEF2D-BCL9 (PubMed=37051743).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-967
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 8,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   M4A4
AC   CVCL_B057
SY   M-4A4
DR   ATCC; CRL-2914
DR   BioSample; SAMN03151831
DR   BioSample; SAMN03471696
DR   cancercelllines; CVCL_B057
DR   Wikidata; Q54903622
RX   PubMed=14506175;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-derivative
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00375.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (ATCC=CRL-2914); 35.00 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ATCC=CRL-2914
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 32
//
ID   M4A4 GFP
AC   CVCL_B058
SY   M4A4-GFP; M-4A4-GFP
DR   ATCC; CRL-2915
DR   cancercelllines; CVCL_B058
DR   Wikidata; Q54903623
RX   PubMed=14506175;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-derivative
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00561.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ATCC=CRL-2915
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B057 ! M4A4
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 31
//
ID   M4A4 LM3-2 GFP
AC   CVCL_B059
DR   ATCC; CRL-2916
DR   cancercelllines; CVCL_B059
DR   Wikidata; Q54903624
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-derivative
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Ancestral cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00562.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ATCC=CRL-2916
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B058 ! M4A4 GFP
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 30
//
ID   M4A4 LM3-4 CL16 GFP
AC   CVCL_B060
DR   BTO; BTO_0006142
DR   ATCC; CRL-2917
DR   cancercelllines; CVCL_B060
DR   Wikidata; Q54903625
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-derivative
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Ancestral cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00563.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ATCC=CRL-2917
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B058 ! M4A4 GFP
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 30
//
ID   M4b
AC   CVCL_9W66
DR   ABM; T0674
DR   Wikidata; Q54903626
RX   PubMed=11933048;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic spinal cord; UBERON=UBERON_0006241.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-14D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 7
//
ID   M4Be
AC   CVCL_8337
SY   M4 (Be.); M4 (Beu); M4Be.; M4Beu; M4Beu.; M4
DR   ChEMBL-Cells; CHEMBL3307798
DR   ChEMBL-Targets; CHEMBL612270
DR   PubChem_Cell_line; CVCL_8337
DR   Wikidata; Q54903627
RX   DOI=10.1007/BF01753729;
RX   DOI=10.1159/000417158;
RX   DOI=10.1159/000417159;
RX   PubMed=1503405;
RX   PubMed=1937961;
RX   PubMed=3882112;
RX   PubMed=7874696;
RX   PubMed=8012932;
RX   PubMed=8125107;
RX   PubMed=8175891;
RX   PubMed=8471837;
RX   PubMed=9043018;
RX   PubMed=17970093;
CC   Characteristics: Pigmented (DOI=10.1007/BF01753729).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   M4Be 0PP20
AC   CVCL_C3PN
SY   0PP20
DR   Wikidata; Q116049738
RX   PubMed=1503405;
RX   PubMed=8175891;
CC   Characteristics: Low metastatic potential.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 4PP70
AC   CVCL_C3R3
SY   4PP70
DR   Wikidata; Q116049739
RX   PubMed=1503405;
CC   Characteristics: Was obtained after 5 successive subcutaneous passages of cells harvested from tumors of the parental cell line in immunodepressed newborn rats.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 4TP46
AC   CVCL_C3R7
SY   4TP46
DR   Wikidata; Q116049740
RX   PubMed=1503405;
CC   Characteristics: Was obtained after 5 successive subcutaneous passages of cells harvested from tumors of the parental cell line in immunodepressed newborn rats.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 6PP177
AC   CVCL_C3PP
SY   6PP177
DR   Wikidata; Q116049741
RX   PubMed=1503405;
RX   PubMed=8175891;
CC   Characteristics: Highly metastatic.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 7GC21
AC   CVCL_C3R6
SY   7GC21
DR   Wikidata; Q116049742
RX   PubMed=1503405;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8332 ! M4Be 7GP122
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 7GC6
AC   CVCL_C3R5
SY   7GC6
DR   Wikidata; Q116049743
RX   PubMed=1503405;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8332 ! M4Be 7GP122
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 7GP
AC   CVCL_8331
SY   7GP
DR   Wikidata; Q54605132
RX   PubMed=8125107;
CC   Characteristics: Highly metastatic. Was obtained after 8 sequential transplantation of the parental cell line in immunodepressed newborn rats.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   M4Be 7GP122
AC   CVCL_8332
SY   7GP122; 7Gp122
DR   Wikidata; Q54605134
RX   PubMed=1503405;
RX   PubMed=8175891;
RX   PubMed=11059782;
CC   Characteristics: Highly metastatic.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8331 ! M4Be 7GP
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   M4Be 9GP217
AC   CVCL_C3R9
SY   9GP217
DR   Wikidata; Q116049744
RX   PubMed=1503405;
CC   Characteristics: Was obtained after 10 successive subcutaneous passages of cells harvested from tumors of the parental cell line in immunodepressed newborn rats.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 9PP257-262
AC   CVCL_C3PQ
SY   9PP257-262
DR   Wikidata; Q116049745
RX   PubMed=1503405;
RX   PubMed=8175891;
CC   Characteristics: Low metastatic potential. Was obtained after 10 successive subcutaneous passages of cells harvested from tumors of the parental cell line in immunodepressed newborn rats.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be 9TP180
AC   CVCL_C3R4
SY   9TP180
DR   Wikidata; Q116049746
RX   PubMed=1503405;
CC   Characteristics: Was obtained after 10 successive subcutaneous passages of cells harvested from tumors of the parental cell line in immunodepressed newborn rats.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be G1
AC   CVCL_C3PS
SY   G1
DR   Wikidata; Q116049747
RX   DOI=10.1159/000417158;
RX   DOI=10.1159/000417159;
RX   PubMed=1503405;
RX   PubMed=1937961;
CC   Characteristics: Highly metastatic.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be G9
AC   CVCL_C3PT
SY   G9
DR   Wikidata; Q116049749
RX   DOI=10.1159/000417158;
RX   DOI=10.1159/000417159;
RX   PubMed=1503405;
RX   PubMed=1937961;
CC   Characteristics: Highly metastatic.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be IC8
AC   CVCL_C3PR
SY   IC8; Clone 1
DR   Wikidata; Q116049750
RX   DOI=10.1159/000417158;
RX   DOI=10.1159/000417159;
RX   PubMed=1503405;
RX   PubMed=1937961;
RX   PubMed=7874696;
RX   PubMed=8012932;
RX   PubMed=8175891;
RX   PubMed=9043018;
CC   Characteristics: Low metastatic potential.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be P4
AC   CVCL_C3RA
SY   P4
DR   Wikidata; Q116049751
RX   PubMed=1503405;
RX   PubMed=1937961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be T1C11
AC   CVCL_C3PV
SY   T1C11; Clone 2
DR   Wikidata; Q116049752
RX   PubMed=7874696;
RX   PubMed=9043018;
CC   Characteristics: Intermediate metastatic potential.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8333 ! M4Be T1P26
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be T1C3
AC   CVCL_C3PM
SY   T1C3; Clone 4
DR   Wikidata; Q116049753
RX   PubMed=7874696;
RX   PubMed=8012932;
RX   PubMed=8175891;
RX   PubMed=9043018;
CC   Characteristics: Highly metastatic.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8333 ! M4Be T1P26
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be T1C3L
AC   CVCL_C3R8
SY   T1C3L
DR   Wikidata; Q116049754
RX   PubMed=1503405;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3PM ! M4Be T1C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be T1C3R
AC   CVCL_C3PX
SY   T1C3R
DR   Wikidata; Q116049755
RX   PubMed=8012932;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3PM ! M4Be T1C3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be T1C6
AC   CVCL_C3PU
SY   T1C6; Clone 3
DR   Wikidata; Q116049756
RX   PubMed=7874696;
RX   PubMed=9043018;
CC   Characteristics: Intermediate metastatic potential.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8333 ! M4Be T1P26
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be T1P26
AC   CVCL_8333
SY   T1P26; T1p26; Variant 1
DR   Wikidata; Q54971427
RX   PubMed=1503405;
RX   PubMed=7874696;
RX   PubMed=8125107;
RX   PubMed=8175891;
RX   PubMed=9043018;
CC   Characteristics: Highly metastatic. Was obtained after 2 sequential transplantation of the parental cell line in immunodepressed newborn rats.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   M4Be T1P26L
AC   CVCL_8334
SY   T1P26L; T1p26L; T1P26 Left peak; Subvariant 1-
DR   Wikidata; Q54971428
RX   PubMed=1503405;
RX   PubMed=7874696;
RX   PubMed=8175891;
RX   PubMed=9043018;
RX   PubMed=11059782;
CC   Characteristics: Intermediate metastatic potential.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8333 ! M4Be T1P26
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   M4Be T1P26R
AC   CVCL_8335
SY   T1P26R; T1p26R; T1P26 Right peak; Subvariant 1+
DR   Wikidata; Q54971429
RX   PubMed=1503405;
RX   PubMed=7874696;
RX   PubMed=8012932;
RX   PubMed=8175891;
RX   PubMed=9043018;
RX   PubMed=11059782;
CC   Characteristics: Highly metastatic. More metastatic than T1P26L.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8333 ! M4Be T1P26
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   M4Be T9P76
AC   CVCL_C3RB
SY   T9P76
DR   Wikidata; Q116049757
RX   PubMed=1503405;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8337 ! M4Be
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   M4Be Tw2
AC   CVCL_C3PW
SY   TW2; Tw2
DR   Wikidata; Q116049758
RX   PubMed=8012932;
RX   PubMed=17970093;
CC   Characteristics: Highly metastatic.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8333 ! M4Be T1P26
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   M4T.4
AC   CVCL_DR62
SY   M4T4
DR   Wikidata; Q54903628
RX   PubMed=12948546;
RX   PubMed=21961028;
CC   Doubling time: ~24 hours (PubMed=12948546).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_DR63 ! M4T.6
SX   Male
AG   1-3D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   M4T.6
AC   CVCL_DR63
DR   Wikidata; Q54903629
RX   PubMed=12948546;
CC   Doubling time: ~24 hours (PubMed=12948546).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_DR62 ! M4T.4
SX   Male
AG   1-3D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   M5
AC   CVCL_WH33
DR   GEO; GSM2597274
DR   GEO; GSM2597275
DR   GEO; GSM2597276
DR   Wikidata; Q95984358
RX   PubMed=28834169;
CC   Doubling time: 26 hours (PubMed=28834169).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Breed and age of donor from personal communication of Cordeiro, Yonara Gouveia.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   M5-T1
AC   CVCL_E7IR
RX   PubMed=27129173;
RX   PubMed=32290283;
CC   Characteristics: Neoplastic. Invasive phenotype (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 18 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   M5-T2
AC   CVCL_E7IS
DR   PRIDE; PXD060521
RX   PubMed=27129173;
RX   PubMed=32290283;
WW   Provider; Inserm Transfert; RT00418; https://technology-offers.inserm-transfert.com/offer/rat-mesothelioma-cell-line-m5-t2/
CC   Characteristics: Neoplastic. Noninvasive phenotype (PubMed=27129173; PubMed=32290283).
CC   Doubling time: 28 hours (PubMed=27129173).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   M5/114.15.2
AC   CVCL_9215
DR   CLO; CLO_0007482
DR   ATCC; TIB-120
DR   Wikidata; Q54903631
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   M5/49.4.1
AC   CVCL_9216
DR   CLO; CLO_0007483
DR   ATCC; TIB-238
DR   BCRC; 60190
DR   Wikidata; Q54903632
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   M5/CDDP
AC   CVCL_5T74
DR   Wikidata; Q54903633
RX   PubMed=8943689;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C30056; Mouse ovarian histiocytic sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3997 ! M5076
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 6
//
ID   M5/CDDPc
AC   CVCL_5T75
DR   Wikidata; Q54903634
RX   PubMed=8943689;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C30056; Mouse ovarian histiocytic sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3997 ! M5076
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 6
//
ID   M5076
AC   CVCL_3997
SY   M5
DR   BTO; BTO_0001915
DR   CLO; CLO_0007484
DR   CLDB; cl3317
DR   CCRID; 1101MOU-PUMC000287
DR   ChEMBL-Cells; CHEMBL3307538
DR   ChEMBL-Targets; CHEMBL614120
DR   KCLB; 80019
DR   NCI-DTP; M5076
DR   PubChem_Cell_line; CVCL_3997
DR   Wikidata; Q54903635
RX   PubMed=7011532;
RX   PubMed=8943689;
CC   Discontinued: KCLB; 80019; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C30056; Mouse ovarian histiocytic sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   M515
AC   CVCL_B6UI
DR   Wikidata; Q112930056
RX   PubMed=17451355;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   M562
AC   CVCL_KA01
DR   Wikidata; Q54903636
RX   PubMed=6206164;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on melanoma cell line B16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   M565
AC   CVCL_F0B7
RX   PubMed=29440125;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: KrasG12D/wtPtenloxP/loxPCD95loxP/loxPAmhr2-Cre transgenic.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   M5A10
AC   CVCL_C0C2
DR   Wikidata; Q112930057
RX   PubMed=12913096;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15151; Human PVR/CD155.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   m5S
AC   CVCL_6417
DR   JCRB; JCRB1322
DR   Wikidata; Q54903637
RX   PubMed=3571334;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: ICR/Jcl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   17-18FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   m5S/1M
AC   CVCL_A1SU
SY   m5S clone 1M
DR   Wikidata; Q105509987
RX   CelloPub=CLPUB00593;
RX   PubMed=1483264;
RX   PubMed=2298824;
RX   PubMed=3108217;
RX   PubMed=3571334;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: ICR/Jcl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6417 ! m5S
SX   Male
AG   17-18FD
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 5
//
ID   m5S/1M cl.4103
AC   CVCL_A1SV
SY   cl.4103
DR   Wikidata; Q105509990
RX   CelloPub=CLPUB00593;
RX   PubMed=1483264;
RX   PubMed=3108217;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: ICR/Jcl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6417 ! m5S
SX   Male
AG   17-18FD
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 5
//
ID   m5S/1M cl.6310
AC   CVCL_A1SW
SY   cl.6310
DR   Wikidata; Q105509993
RX   CelloPub=CLPUB00593;
RX   PubMed=1483264;
RX   PubMed=3108217;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: ICR/Jcl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6417 ! m5S
SX   Male
AG   17-18FD
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 5
//
ID   M6
AC   CVCL_A4AU
DR   ATCC; CRL-3441
DR   Wikidata; Q105509997
RX   PubMed=12602905;
CC   Doubling time: 18 hours (PubMed=12602905).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the promoter of rat Psbpc3/Scgb2a2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB-Tg(C3-1-TAg)cJeg/JegJ transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   M6/B7
AC   CVCL_D034
SY   EST45
DR   cancercelllines; CVCL_D034
DR   Cosmic; 1047646
DR   Cosmic; 2163790
DR   ESTDAB; ESTDAB-045
DR   GEO; GSM156007
DR   IARC_TP53; 26073
DR   Progenetix; CVCL_D034
DR   Wikidata; Q54903638
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*01:01,23:01; B*07:02,49:01; C*07:01:01,07:02; DPB1*04:01,03:01; DQB1*06:02; DRB1*01:01,15:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ESTDAB=ESTDAB-045
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   FGA: 23,23.2
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T324 ! CaCL 73-36
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   M616
AC   CVCL_B6UJ
DR   Wikidata; Q112930058
RX   PubMed=17451355;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   M619
AC   CVCL_8472
DR   CancerTools; 160514
DR   Wikidata; Q54903639
RX   PubMed=18689700;
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000224). It was one of the sources for the STR profile of this entry.
ST   Source(s): CCRID; PubMed=18689700
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8471 ! C918
OI   CVCL_3447 ! MuM-2B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   M622
AC   CVCL_KA02
DR   Wikidata; Q54903640
RX   PubMed=6206164;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on melanoma cell line B16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   M6C
AC   CVCL_A4AV
DR   Wikidata; Q105510001
RX   PubMed=12602905;
CC   Characteristics: Metastatic. Established from a nude mice lung metastasis obtained by subcutaneous injection of the parent cell line (PubMed=12602905).
CC   Doubling time: 15 hours (PubMed=12602905).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the promoter of rat Psbpc3/Scgb2a2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB-Tg(C3-1-TAg)cJeg/JegJ transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A4AU ! M6
SX   Female
AG   5-6M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   M7 [Human B-cell IHW]
AC   CVCL_E767
DR   dbMHC; 48963
DR   ECACC; 94022543
DR   IHW; IHW09215
DR   IPD-IMGT/HLA; 11030
DR   Wikidata; Q54903641
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*02:02,03:01:01; B*35:01,53:01; C*04:01; DPB1*02:01:02,17:01; DQB1*02:01,02:02; DRB1*03:01:01,07:01:01; DRB3*02:02:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=11030).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   M7 [Human melanoma Berlin]
AC   CVCL_A1FF
DR   Wikidata; Q102114491
RX   PubMed=8688321;
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 5
//
ID   M7 [Human melanoma UCLA]
AC   CVCL_DI52
SY   M-7; UCLA-SO-M7
DR   Wikidata; Q54903642
RX   PubMed=6876798;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   M7/105
AC   CVCL_C9BD
DR   Wikidata; Q123032992
RX   PubMed=6339043;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on breast cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   M72 [C.jacchus LCL]
AC   CVCL_D5CP
DR   Wikidata; Q127382728
RX   PubMed=187263;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line Ly28 (Cellosaurus=CVCL_ZU82).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   M72 [Mouse hybridoma against human EPCAM]
AC   CVCL_B4NN
DR   Wikidata; Q110433012
RX   Patent=US6444207;
RX   PubMed=2427436;
RX   PubMed=3721623;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   M73.24
AC   CVCL_S555
SY   M73
DR   ATCC; HB-12153
DR   Wikidata; Q54903643
RX   Patent=US5955311;
RX   Patent=US6365157;
RX   Patent=US6448077;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12153.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35918; Mouse Kdr/Cd309.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   M74
AC   CVCL_B4NP
DR   Wikidata; Q110433013
RX   Patent=US6444207;
RX   PubMed=2427436;
RX   PubMed=2460221;
RX   PubMed=3721623;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   M7609
AC   CVCL_IW14
SY   M-7609; M 7609
DR   Wikidata; Q54903644
RX   PubMed=6998824;
RX   PubMed=8758929;
CC   Population: Japanese.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   M7609/ADR
AC   CVCL_IW15
DR   Wikidata; Q54903648
RX   PubMed=8758929;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW14 ! M7609
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 5
//
ID   M77
AC   CVCL_B4NQ
DR   Wikidata; Q110433014
RX   Patent=US6444207;
RX   PubMed=2427436;
RX   PubMed=2460221;
RX   PubMed=3721623;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   M79
AC   CVCL_B4NR
DR   Wikidata; Q110433015
RX   Patent=US6444207;
RX   PubMed=2427436;
RX   PubMed=2460221;
RX   PubMed=3721623;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   M7TS90
AC   CVCL_0404
DR   MCCL; MCC:0000298
DR   cancercelllines; CVCL_0404
DR   Wikidata; Q54903649
RX   PubMed=11980662;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   M80-14
AC   CVCL_A0JB
SY   M80_14; Anti-EGFR L861Q
DR   Wikidata; Q108820821
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201315.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Leu861Gln (c.2582T>A)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   M81
AC   CVCL_D5CQ
DR   Wikidata; Q127382729
RX   PubMed=187263;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line Ly28 (Cellosaurus=CVCL_ZU82).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   M8166
AC   CVCL_1H07
DR   BEI_Resources; ARP-11395
DR   Wikidata; Q54903650
RX   PubMed=32938764;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=32938764
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D21S11: 27,30
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 11,14
ST   FGA: 21,22
ST   Penta D: 11,15
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1099 ! C8166
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   M85-13
AC   CVCL_A0JC
SY   M85_13; Anti-EGFR L858R
DR   Wikidata; Q108820822
RX   Patent=WO2014169494A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012125.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Leu858Arg (c.2573T>G)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   M88
AC   CVCL_D035
SY   EST135
DR   cancercelllines; CVCL_D035
DR   Cosmic; 1047645
DR   Cosmic; 2163833
DR   ESTDAB; ESTDAB-135
DR   GEO; GSM156018
DR   IARC_TP53; 26072
DR   Progenetix; CVCL_D035
DR   Wikidata; Q54903651
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ESTDAB=ESTDAB-135
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 12
ST   FGA: 25
ST   TH01: 6
ST   TPOX: 10
ST   vWA: 16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   M9-ENL1
AC   CVCL_A8IE
SY   M9 ENL1; M9ENL1
DR   GEO; GSM838434
DR   GEO; GSM838435
DR   GEO; GSM838436
DR   Wikidata; Q107115912
RX   PubMed=22160482;
CC   Characteristics: Expresses a transfected KMT2A-MLLT1 (MLL-ENL) fusion protein. Mimics the features of primary human pro-B cell acute lymphoblastic leukemia (PubMed=22160482).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: KMT2A-MLLT1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   M91-054
AC   CVCL_1G26
SY   M91 054
DR   Cosmic; 1211154
DR   Wikidata; Q54903652
RX   PubMed=10952317;
RX   PubMed=23039341;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   M92-001
AC   CVCL_1G27
SY   M92 001
DR   Cosmic; 1211152
DR   Wikidata; Q54903653
RX   PubMed=10952317;
RX   PubMed=23039341;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LM77 ! M93-007
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   M93-007
AC   CVCL_LM77
DR   Wikidata; Q54903654
RX   PubMed=23039341;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1G27 ! M92-001
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   M93-047
AC   CVCL_G298
DR   BTO; BTO_0005062
DR   Wikidata; Q54903655
RX   PubMed=10952317;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   M950322
AC   CVCL_DI46
DR   cancercelllines; CVCL_DI46
DR   GEO; GSM482469
DR   Progenetix; CVCL_DI46
DR   Wikidata; Q54903656
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   M950504
AC   CVCL_DI47
DR   cancercelllines; CVCL_DI47
DR   GEO; GSM482470
DR   Progenetix; CVCL_DI47
DR   Wikidata; Q54903657
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   M961121
AC   CVCL_DI48
DR   cancercelllines; CVCL_DI48
DR   GEO; GSM482477
DR   Progenetix; CVCL_DI48
DR   Wikidata; Q54903658
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   M970109
AC   CVCL_DI43
DR   cancercelllines; CVCL_DI43
DR   GEO; GSM482478
DR   Progenetix; CVCL_DI43
DR   Wikidata; Q54903659
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 9
//
ID   M970131
AC   CVCL_DI44
DR   cancercelllines; CVCL_DI44
DR   GEO; GSM482480
DR   Progenetix; CVCL_DI44
DR   Wikidata; Q54903660
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   M970805
AC   CVCL_DI45
DR   cancercelllines; CVCL_DI45
DR   GEO; GSM482481
DR   Progenetix; CVCL_DI45
DR   Wikidata; Q54903661
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   M971219
AC   CVCL_AT57
DR   Wikidata; Q54903662
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 7
//
ID   M980513
AC   CVCL_S675
DR   cancercelllines; CVCL_S675
DR   Cell_Model_Passport; SIDM00177
DR   Cosmic; 1723794
DR   DepMap; ACH-002338
DR   GEO; GSM108371
DR   GEO; GSM108382
DR   GEO; GSM4933088
DR   PharmacoDB; M980513_880_2019
DR   Wikidata; Q54903663
RX   PubMed=16827748;
RX   PubMed=18245463;
RX   PubMed=22336146;
RX   PubMed=33445472;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; DepMap=ACH-002338).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Iliac lymph node; UBERON=UBERON_0015878.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 22
//
ID   M990115
AC   CVCL_S676
DR   GEO; GSM108372
DR   GEO; GSM108383
DR   Wikidata; Q54903664
RX   PubMed=16827748;
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   M990203
AC   CVCL_AT58
DR   Wikidata; Q54903666
RX   PubMed=24581590;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Miscellaneous: Age/sex of donor from personal communication of URPP Biobank.
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 8
//
ID   M990514
AC   CVCL_S677
DR   cancercelllines; CVCL_S677
DR   GEO; GSM108380
DR   GEO; GSM108390
DR   Wikidata; Q54903667
RX   PubMed=16827748;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=16827748).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   M990802
AC   CVCL_S678
DR   cancercelllines; CVCL_S678
DR   GEO; GSM433917
DR   IGRhCellID; M990802
DR   Progenetix; CVCL_S678
DR   Wikidata; Q54903668
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (URPP Biobank).
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   M991121
AC   CVCL_S679
DR   GEO; GSM108396
DR   GEO; GSM108397
DR   Wikidata; Q54903669
RX   PubMed=16827748;
RX   PubMed=18245463;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of URPP Biobank.
CC   Derived from site: Metastatic; Lower leg; UBERON=UBERON_0003823.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   M9A
AC   CVCL_B417
DR   BTO; BTO_0005074
DR   Wikidata; Q54903670
RX   PubMed=19116209;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   M9K
AC   CVCL_8109
SY   M-9-K
DR   BTO; BTO_0004001
DR   Cosmic; 733820
DR   Cosmic; 933010
DR   Cosmic; 934555
DR   Cosmic; 2668292
DR   IARC_TP53; 23627
DR   Wikidata; Q54903671
RX   PubMed=1568228;
RX   PubMed=2323006;
RX   PubMed=7972006;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MA 2
AC   CVCL_7057
DR   Wikidata; Q54903672
RX   PubMed=9131270;
CC   Doubling time: 70 hours (PubMed=9131270).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MA 3
AC   CVCL_7058
DR   Wikidata; Q54903673
RX   PubMed=9131270;
CC   Doubling time: 78 hours (PubMed=9131270).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MA IV
AC   CVCL_WT59
SY   MAIV
DR   Wikidata; Q95984404
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=2834415;
RX   PubMed=2997265;
RX   PubMed=3027119;
CC   Population: Japanese.
CC   Doubling time: 33.6 hours (PubMed=2997265).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   Ma Not
AC   CVCL_U784
DR   ATCC; CRL-1263
DR   Wikidata; Q54903674
CC   Discontinued: ATCC; CRL-1263; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Ma San
AC   CVCL_3739
SY   MaSan
DR   CLO; CLO_0007493
DR   ATCC; CRL-1148
DR   Wikidata; Q54903675
RX   DOI=10.1016/B978-012361946-4/50009-0;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Ma Tru
AC   CVCL_U785
DR   ATCC; CRL-1309
DR   Wikidata; Q54903676
CC   Discontinued: ATCC; CRL-1309; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   MA-002
AC   CVCL_D2WX
SY   MA002; MA-002S-1
DR   GEO; GSM4182824
DR   GEO; GSM4182836
DR   GEO; GSM4182848
DR   Wikidata; Q127382730
RX   PubMed=32619491;
WW   Provider; CReM; 544; https://stemcellbank.bu.edu/Catalog/Item/Details/544
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MA-011
AC   CVCL_D2WY
SY   MA011; MA011-S-6
DR   GEO; GSM4182789
DR   GEO; GSM4182860
DR   GEO; GSM4182872
DR   Wikidata; Q127382732
RX   PubMed=32619491;
WW   Provider; CReM; 545; https://stemcellbank.bu.edu/Catalog/Item/Details/545
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MA-012
AC   CVCL_D2WZ
SY   MA012; MA-012-1
DR   Wikidata; Q127382733
RX   PubMed=32619491;
WW   Provider; CReM; 772; https://stemcellbank.bu.edu/Catalog/Item/Details/772
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MA-1 [Human contaminated lymphoma]
AC   CVCL_M665
SY   Ma-1
DR   BioSample; SAMN03151897
DR   cancercelllines; CVCL_M665
DR   Wikidata; Q54903677
RX   PubMed=21837708;
RX   PubMed=23508748;
RX   PubMed=23508779;
RX   PubMed=23907998;
RX   PubMed=24285409;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Pfeiffer derivative (PubMed=23907998) and not a mucosa-associated lymphoid tissue (MALT) lymphoma cell line. This finding is disputed by the original authors (PubMed=24285409).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00471.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1171Cys (c.3511C>T); ClinVar=VCV000133518; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3326 ! Pfeiffer
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   MA-1 [Mouse hybridoma against M.arginini]
AC   CVCL_A0RB
DR   Wikidata; Q108820823
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Mycoplasmopsis arginini.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ma-1
AC   CVCL_7059
SY   Ma1
DR   BTO; BTO_0004160
DR   cancercelllines; CVCL_7059
DR   Cosmic; 801593
DR   Cosmic; 844836
DR   Cosmic; 876145
DR   Cosmic; 917983
DR   Cosmic; 1047095
DR   Cosmic; 1128252
DR   Cosmic; 1239874
DR   Cosmic; 1656895
DR   Cosmic; 2125271
DR   Cosmic; 2668313
DR   IARC_TP53; 11879
DR   Wikidata; Q54903678
RX   PubMed=1650680;
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=17332333;
RX   PubMed=19472407;
RX   PubMed=22313637;
CC   Population: Japanese.
CC   Doubling time: 25.9 hours (PubMed=1650680).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (PubMed=17332333).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=10536175).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   Ma-10
AC   CVCL_7061
SY   Ma10
DR   cancercelllines; CVCL_7061
DR   Cosmic; 801596
DR   Cosmic; 844838
DR   Cosmic; 876146
DR   Cosmic; 917994
DR   Cosmic; 1239875
DR   Cosmic; 1656897
DR   Cosmic; 2125272
DR   Cosmic; 2668315
DR   IARC_TP53; 11882
DR   Wikidata; Q54903679
RX   PubMed=1650680;
RX   PubMed=9393586;
RX   PubMed=11005564;
RX   PubMed=15802814;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=22313637;
CC   Population: Japanese.
CC   Doubling time: 75.0 hours (PubMed=1650680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (PubMed=20557307).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   MA-10
AC   CVCL_D789
SY   MA10
DR   BTO; BTO_0003050
DR   ATCC; CRL-3050
DR   Wikidata; Q54903680
RX   PubMed=6257492;
RX   PubMed=15541572;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MA-10_cell
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_U444 ! MA-12
OI   CVCL_3544 ! MLTC-1
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MA-10 mutant clone LK
AC   CVCL_B6NU
SY   LK
DR   Wikidata; Q112930059
RX   PubMed=3039504;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D789 ! MA-10
SX   Male
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   MA-101
AC   CVCL_0A70
SY   MA 101; MA101; Microbiological Associates-101
DR   Wikidata; Q54903681
RX   PubMed=4626908;
RX   PubMed=6500159;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   MA-104
AC   CVCL_3845
SY   Ma-104; MA 104; MA104; Microbiological Associates-104
DR   BTO; BTO_0004983
DR   CLO; CLO_0007492
DR   CLO; CLO_0007494
DR   CLO; CLO_0051423
DR   EFO; EFO_0022811
DR   CLDB; cl3324
DR   CLDB; cl3325
DR   CLDB; cl3326
DR   CLDB; cl3327
DR   ATCC; CRL-2378
DR   BCRJ; 0157
DR   BioSample; SAMN03152038
DR   CCLV; CCLV-RIE 0142
DR   CCRID; 4201MON-CCTCC00041
DR   CCTCC; GDC0041
DR   CLS; 305007
DR   ECACC; 85102918
DR   GEO; GSM758845
DR   GEO; GSM758846
DR   GEO; GSM758847
DR   GEO; GSM758848
DR   GEO; GSM758849
DR   GEO; GSM758850
DR   GEO; GSM758851
DR   GEO; GSM758852
DR   GEO; GSM758853
DR   GEO; GSM758854
DR   GEO; GSM758855
DR   GEO; GSM758856
DR   GEO; GSM758857
DR   GEO; GSM758858
DR   GEO; GSM758859
DR   IZSLER; BS CL 61
DR   KCB; KCB 2010001YJ
DR   NCBI_Iran; C486
DR   RCB; RCB0994
DR   Wikidata; Q54903682
RX   PubMed=4043530;
RX   PubMed=4626908;
RX   PubMed=15731278;
RX   PubMed=16494729;
RX   PubMed=19941903;
RX   PubMed=20143388;
RX   PubMed=26235236;
RX   PubMed=28046048;
RX   PubMed=33389257;
RX   PubMed=34737324;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ma-104-atcc-crl-2378
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-391.html
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Rhesus macaque origin but found to be from African Green monkey (PubMed=4043530; PubMed=20143388) and more precisely from Chlorocebus pygerythrus (PubMed=34737324).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00077.
CC   Virology: Susceptible to infection by many viruses (arboviruses, reoviruses, rotaviruses, etc.).
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV). Produces a lytic infection (PubMed=15731278; PubMed=16494729).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Discontinued: ATCC; CRL-2378; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   MA-104 Clone 1
AC   CVCL_3846
DR   CLO; CLO_0007495
DR   ATCC; CRL-2378.1
DR   Wikidata; Q54903683
RX   PubMed=32731642;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ma-104-atcc-crl-2378
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   Virology: Suitable for the isolation of African swine fever virus (ASFV) in field samples (PubMed=32731642).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_3845 ! MA-104
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MA-108
AC   CVCL_B3ST
SY   MA 108; MA108; Microbiological Associates-108
DR   Wikidata; Q110433016
RX   PubMed=4626908;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   Ma-11
AC   CVCL_D064
SY   Ma11
DR   Wikidata; Q54903684
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 41.3 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MA-111
AC   CVCL_U963
SY   MA 111; MA111; Microbiological Associates-111
DR   BioSample; SAMN03152039
DR   Wikidata; Q54903685
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of rabbit origin but found to be from African Green monkey (PubMed=20143388). Originally thought to originate from kidney. Could be a VERO derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00078.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
CA   Undefined cell line type
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   Ma-12
AC   CVCL_7062
SY   MA12; Ma12
DR   Cosmic; 801597
DR   Cosmic; 876147
DR   Cosmic; 917997
DR   Cosmic; 1239876
DR   Cosmic; 2125273
DR   Cosmic; 2668316
DR   IARC_TP53; 28438
DR   Wikidata; Q54903686
RX   PubMed=1650680;
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   Population: Japanese.
CC   Doubling time: 23.0 hours (PubMed=1650680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=20557307).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MA-12
AC   CVCL_U444
DR   Wikidata; Q54903687
RX   PubMed=6257492;
RX   PubMed=15541572;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D789 ! MA-10
OI   CVCL_3544 ! MLTC-1
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Ma-13
AC   CVCL_D065
SY   Ma13
DR   Wikidata; Q54903688
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 71.9 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   Ma-14
AC   CVCL_D066
SY   Ma14
DR   Wikidata; Q54903692
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 21.0 hours (PubMed=1650680).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-15
AC   CVCL_D067
SY   Ma15
DR   Wikidata; Q54903693
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 29.5 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-16
AC   CVCL_D068
SY   Ma16
DR   Wikidata; Q54903694
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 33.2 hours (PubMed=1650680).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MA-160
AC   CVCL_8261
SY   MA 160; MA160; Microbiological Associates-160
DR   BioSample; SAMN03151741
DR   Wikidata; Q54903695
RX   CelloPub=CLPUB00262;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=66218;
RX   PubMed=87387;
RX   PubMed=93571;
RX   PubMed=535908;
RX   PubMed=1246601;
RX   PubMed=4319198;
RX   PubMed=4469665;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=66218; PubMed=93571; PubMed=1246601; PubMed=4469665; PubMed=6451928; PubMed=20143388). Originally thought to originate from a benign prostatic hyperplasia biopsy from Monroe Vincent one of the authors of the original paper.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00026.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Ma-17
AC   CVCL_7063
SY   Ma17
DR   cancercelllines; CVCL_7063
DR   Cosmic; 801598
DR   Cosmic; 844839
DR   Cosmic; 876148
DR   Cosmic; 917977
DR   Cosmic; 1239877
DR   Cosmic; 2125274
DR   Cosmic; 2668317
DR   IARC_TP53; 28439
DR   Wikidata; Q54903696
RX   PubMed=1650680;
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   Population: Japanese.
CC   Doubling time: 63.4 hours (PubMed=1650680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (PubMed=20557307).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   Ma-18
AC   CVCL_D069
SY   Ma18
DR   Wikidata; Q54903697
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 37.0 hours (PubMed=1650680).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   Ma-19
AC   CVCL_D070
SY   Ma19
DR   Wikidata; Q54903698
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 36.0 hours (PubMed=1650680).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   MA-2
AC   CVCL_A0RC
DR   Wikidata; Q108820824
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Mycoplasmopsis arginini.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ma-2
AC   CVCL_7060
SY   Ma2
DR   cancercelllines; CVCL_7060
DR   Cosmic; 801594
DR   Cosmic; 844837
DR   Cosmic; 876177
DR   Cosmic; 917990
DR   Cosmic; 1239920
DR   Cosmic; 2125275
DR   Cosmic; 2668331
DR   IARC_TP53; 11880
DR   Wikidata; Q54903699
RX   PubMed=1650680;
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   Population: Japanese.
CC   Doubling time: 22.8 hours (PubMed=1650680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   Ma-20
AC   CVCL_D071
SY   Ma20
DR   Wikidata; Q54903700
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 42.2 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-24
AC   CVCL_7064
SY   Ma24
DR   cancercelllines; CVCL_7064
DR   Cosmic; 801599
DR   Cosmic; 876149
DR   Cosmic; 917978
DR   Cosmic; 1239878
DR   Cosmic; 2125276
DR   Cosmic; 2668318
DR   IARC_TP53; 11883
DR   Wikidata; Q54903701
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000142536; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Ma-25
AC   CVCL_7065
SY   Ma25
DR   BTO; BTO_0004155
DR   cancercelllines; CVCL_7065
DR   Cosmic; 801600
DR   Cosmic; 844840
DR   Cosmic; 876178
DR   Cosmic; 917981
DR   Cosmic; 1047101
DR   Cosmic; 1239921
DR   Cosmic; 2125277
DR   Cosmic; 2668335
DR   IARC_TP53; 11884
DR   IARC_TP53; 28447
DR   Wikidata; Q54903702
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=17332333;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   Ma-26
AC   CVCL_7066
SY   Ma26
DR   Cosmic; 801601
DR   Cosmic; 844841
DR   Cosmic; 876150
DR   Cosmic; 917998
DR   Cosmic; 1239879
DR   Cosmic; 2125278
DR   Cosmic; 2668319
DR   IARC_TP53; 28440
DR   Wikidata; Q54903703
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2701; DCC; Simple; p.Asp832Asn (c.2494G>A); Zygosity=Heterozygous (PubMed=11005564).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=20557307).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   Ma-29
AC   CVCL_7067
SY   Ma29
DR   Cosmic; 801602
DR   Cosmic; 844842
DR   Cosmic; 876151
DR   Cosmic; 917982
DR   Cosmic; 1219059
DR   Cosmic; 1239880
DR   Cosmic; 1656898
DR   Cosmic; 2125189
DR   Cosmic; 2668320
DR   IARC_TP53; 11885
DR   IARC_TP53; 28441
DR   Wikidata; Q54903704
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=22313637;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser121fs (c.361delT); Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   MA-3
AC   CVCL_A0RD
DR   Wikidata; Q108820825
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Mycoplasmopsis arginini.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ma-3
AC   CVCL_7068
SY   Ma3
DR   cancercelllines; CVCL_7068
DR   Cosmic; 801595
DR   Cosmic; 844814
DR   Cosmic; 917986
DR   Cosmic; 2668314
DR   IARC_TP53; 11881
DR   Wikidata; Q54903705
RX   PubMed=1650680;
RX   PubMed=9393586;
RX   PubMed=10536175;
CC   Population: Japanese.
CC   Doubling time: 31.6 hours (PubMed=1650680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified (PubMed=10536175).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Ma-31
AC   CVCL_7069
DR   BTO; BTO_0004156
DR   Cosmic; 1047107
DR   Wikidata; Q54903706
RX   PubMed=9393586;
RX   PubMed=15802814;
RX   PubMed=17332333;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   MA-31750
AC   CVCL_F565
SY   31750; TER355; TER-355; Ter 355; Extract 283; Extract 456
DR   IPD-IMGT/HLA; 11939
DR   Wikidata; Q54903707
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/342cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:03,02:01; B*39:10; C*12:03:01; DPB1*02:01,11:01; DQA1*02:01,05:05; DQB1*02:02,03:01; DRB1*07:01,08:04; DRB4*01:03 (IPD-IMGT/HLA=11939).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   Ma-34
AC   CVCL_7070
DR   BTO; BTO_0004157
DR   Cosmic; 1047105
DR   Wikidata; Q54903708
RX   PubMed=17332333;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   MA-4
AC   CVCL_A0RE
DR   Wikidata; Q108820826
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mycoplasmopsis arginini.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ma-4
AC   CVCL_D058
SY   Ma4
DR   Wikidata; Q54903709
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 49.1 hours (PubMed=1650680).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-43
AC   CVCL_IQ46
DR   Wikidata; Q54903710
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   Ma-44
AC   CVCL_7071
SY   Ma44
DR   Wikidata; Q54903711
RX   PubMed=10769649;
CC   Population: Japanese.
CC   Characteristics: Highly tumorigenic.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Ma-45
AC   CVCL_7072
DR   BTO; BTO_0004158
DR   Cosmic; 1047103
DR   Wikidata; Q54903712
RX   PubMed=9393586;
RX   PubMed=17332333;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   Ma-46
AC   CVCL_7073
DR   Wikidata; Q54903713
RX   PubMed=9393586;
RX   PubMed=15802814;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   Ma-5
AC   CVCL_D059
SY   Ma5
DR   Wikidata; Q54903714
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 61.0 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-53
AC   CVCL_7074
DR   BTO; BTO_0004159
DR   Cosmic; 1047104
DR   Wikidata; Q54903715
RX   PubMed=17332333;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   Ma-6
AC   CVCL_D060
SY   Ma6
DR   Wikidata; Q54903716
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   Ma-7
AC   CVCL_D061
SY   Ma7
DR   Wikidata; Q54903717
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 28.7 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-8
AC   CVCL_D062
SY   Ma8
DR   Wikidata; Q54903718
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 50.0 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MA-89
AC   CVCL_J293
DR   JCRB; IFO50293
DR   Wikidata; Q54903719
CC   Doubling time: 24-36 hours (Note=Lots 623 and 625) (JCRB=IFO50293).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1-3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Ma-9
AC   CVCL_D063
SY   Ma9
DR   Wikidata; Q54903721
RX   PubMed=1650680;
CC   Population: Japanese.
CC   Doubling time: 65.5 hours (PubMed=1650680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MA-Balb
AC   CVCL_5795
SY   Ma-Balb
DR   CLS; 400270
DR   Wikidata; Q54903722
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MA-CLS-2
AC   CVCL_4571
SY   MACLS-2; MACLS2
DR   CLS; 300271
DR   DepMap; ACH-002326
DR   PharmacoDB; MACLS2_881_2019
DR   Wikidata; Q54903723
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300271
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   Ma-Mel-01
AC   CVCL_A115
SY   Ma-Mel-1
DR   BTO; BTO_0005336
DR   cancercelllines; CVCL_A115
DR   Cosmic; 2686321
DR   ESTDAB; ESTDAB-142
DR   Wikidata; Q54903724
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-142
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   FGA: 23,26
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   Ma-Mel-02
AC   CVCL_A116
SY   Ma-Mel-2; MaMel02
DR   cancercelllines; CVCL_A116
DR   Cosmic; 1181742
DR   Cosmic; 1467735
DR   Cosmic; 2686322
DR   ESTDAB; ESTDAB-148
DR   GEO; GSM436986
DR   Progenetix; CVCL_A116
DR   Wikidata; Q54903725
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=20544847).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-148
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C9151; Lentigo maligna melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Ma-Mel-04
AC   CVCL_A117
SY   Ma-Mel_04; Ma-Mel-4; MaMel4
DR   BTO; BTO_0005337
DR   cancercelllines; CVCL_A117
DR   Cosmic; 1846562
DR   Cosmic; 2686323
DR   ECACC; 13012519
DR   ESTDAB; ESTDAB-209
DR   GEO; GSM109050
DR   Wikidata; Q54903726
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ECACC=13012519; ESTDAB=ESTDAB-209
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   FGA: 20,24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   Ma-Mel-05
AC   CVCL_A118
SY   Ma-Mel-5; MaMel-05; MaMel05; MaMel5
DR   BTO; BTO_0005338
DR   cancercelllines; CVCL_A118
DR   Cosmic; 1181768
DR   Cosmic; 1467736
DR   Cosmic; 1846563
DR   Cosmic; 2163838
DR   Cosmic; 2686324
DR   ECACC; 13012461
DR   ESTDAB; ESTDAB-149
DR   GEO; GSM436987
DR   Progenetix; CVCL_A118
DR   Wikidata; Q54903727
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128Asn (c.384G>T); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012461; ESTDAB=ESTDAB-149
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 8,13
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 11
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   Ma-Mel-06
AC   CVCL_A119
SY   Ma-Mel_06; Ma-Mel 06; Ma-Mel-6; MaMel06; MaMel6
DR   cancercelllines; CVCL_A119
DR   Cosmic; 1467737
DR   Cosmic; 1846564
DR   Cosmic; 2163839
DR   Cosmic; 2686326
DR   ECACC; 13012465
DR   ESTDAB; ESTDAB-150
DR   GEO; GSM109051
DR   GEO; GSM436988
DR   Progenetix; CVCL_A119
DR   Wikidata; Q54903728
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=13012465; ESTDAB=ESTDAB-150
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10
ST   FGA: 22,26
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   Ma-Mel-07
AC   CVCL_A120
SY   Ma-Mel_07; Ma-Mel 07; Ma-Mel-7; MaMel7
DR   cancercelllines; CVCL_A120
DR   Cosmic; 1846565
DR   Cosmic; 2163835
DR   Cosmic; 2686328
DR   ECACC; 13012459
DR   ESTDAB; ESTDAB-137
DR   GEO; GSM109052
DR   Wikidata; Q54903729
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=13012459; ESTDAB=ESTDAB-137
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9,12
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   FGA: 24,25
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 28
//
ID   Ma-Mel-08a
AC   CVCL_A121
SY   Ma-Mel-8a; MaMel-08a; MaMel08a
DR   cancercelllines; CVCL_A121
DR   Cosmic; 1467738
DR   Cosmic; 1846566
DR   Cosmic; 2163818
DR   Cosmic; 2686330
DR   ECACC; 13012434
DR   ESTDAB; ESTDAB-105
DR   GEO; GSM436989
DR   Progenetix; CVCL_A121
DR   Wikidata; Q54903730
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu157Ter (c.469G>T); ClinVar=VCV000007814; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp162Val (c.485A>T); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283Cys (c.847C>T); ClinVar=VCV000127824; Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012434; ESTDAB=ESTDAB-105
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A122 ! Ma-Mel-08b
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-08b
AC   CVCL_A122
SY   Ma-Mel_08b; Ma-Mel-8b
DR   Cosmic; 1846567
DR   Cosmic; 2686332
DR   ESTDAB; ESTDAB-190
DR   GEO; GSM109053
DR   Wikidata; Q54903731
RX   PubMed=16827748;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): ESTDAB=ESTDAB-190
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A121 ! Ma-Mel-08a
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Ma-Mel-10
AC   CVCL_A123
SY   MaMel10
DR   cancercelllines; CVCL_A123
DR   Cosmic; 1467739
DR   Cosmic; 2686334
DR   ESTDAB; ESTDAB-151
DR   GEO; GSM436990
DR   Progenetix; CVCL_A123
DR   Wikidata; Q54903732
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Omics: Variations; SNP array analysis.
ST   Source(s): ESTDAB=ESTDAB-151
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   FGA: 23,26
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 13,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   Ma-Mel-100a
AC   CVCL_A124
SY   Ma-Mel-100; MaMel100
DR   cancercelllines; CVCL_A124
DR   Cosmic; 1846569
DR   Cosmic; 2686335
DR   Cosmic; 2757116
DR   GEO; GSM1467849
DR   Progenetix; CVCL_A124
DR   Wikidata; Q54903735
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=25294904;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Heterozygous (PubMed=25294904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1DY ! Ma-Mel-100b
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   Ma-Mel-100b
AC   CVCL_A1DY
DR   Cosmic; 2757117
DR   GEO; GSM1467850
DR   Wikidata; Q102114492
RX   PubMed=25294904;
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Heterozygous (PubMed=25294904).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu60_Glu64delinsGln (c.179_190del); Zygosity=Heterozygous (PubMed=25294904).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A124 ! Ma-Mel-100a
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   Ma-Mel-101
AC   CVCL_A125
SY   MaMel101
DR   cancercelllines; CVCL_A125
DR   Cosmic; 1467782
DR   Cosmic; 1846570
DR   Cosmic; 2686337
DR   GEO; GSM437032
DR   IGRhCellID; MaMel101
DR   Progenetix; CVCL_A125
DR   Wikidata; Q54903736
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-102a
AC   CVCL_A126
SY   Ma-Mel-102
DR   cancercelllines; CVCL_A126
DR   Cosmic; 1846571
DR   Cosmic; 2686339
DR   Wikidata; Q54903737
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=28561041;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11362; STAT1; Simple; p.Ser316Leu (c.947C>T); Zygosity=Homozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Ma-Mel-103a
AC   CVCL_A127
SY   MaMel-103a; MaMel103a
DR   cancercelllines; CVCL_A127
DR   Cosmic; 1467783
DR   Cosmic; 1846572
DR   Cosmic; 2686341
DR   GEO; GSM437033
DR   IGRhCellID; MaMel103anew
DR   Progenetix; CVCL_A127
DR   Wikidata; Q54903738
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A128 ! Ma-Mel-103b
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   Ma-Mel-103b
AC   CVCL_A128
DR   Cosmic; 1846573
DR   Cosmic; 2686342
DR   Wikidata; Q54903739
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A127 ! Ma-Mel-103a
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   Ma-Mel-104
AC   CVCL_A129
DR   Cosmic; 2686344
DR   Wikidata; Q54903740
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-105
AC   CVCL_A130
DR   cancercelllines; CVCL_A130
DR   Cosmic; 1846575
DR   Cosmic; 2686345
DR   Wikidata; Q54903741
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-126C>T (c.230C>T) (C230T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   Ma-Mel-107
AC   CVCL_A131
SY   MaMel107
DR   cancercelllines; CVCL_A131
DR   Cosmic; 1467784
DR   Cosmic; 2686347
DR   GEO; GSM437034
DR   IGRhCellID; MaMel107
DR   Progenetix; CVCL_A131
DR   Wikidata; Q54903742
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Ma-Mel-108
AC   CVCL_A132
SY   Ma-mel-108
DR   cancercelllines; CVCL_A132
DR   Cosmic; 1846577
DR   Cosmic; 2686348
DR   Wikidata; Q54903743
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Ma-Mel-11
AC   CVCL_A133
SY   MaMel-11; MaMel11
DR   BTO; BTO_0005339
DR   cancercelllines; CVCL_A133
DR   Cosmic; 1467740
DR   Cosmic; 1846578
DR   Cosmic; 2163820
DR   Cosmic; 2686350
DR   ESTDAB; ESTDAB-108
DR   GEO; GSM436991
DR   Progenetix; CVCL_A133
DR   Wikidata; Q54903744
RX   PubMed=19340423;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Phe90_Pro95delinsLeu (c.270_284del); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-108
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 10
ST   FGA: 25,26
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 24
//
ID   Ma-Mel-110
AC   CVCL_A134
SY   MaMel-110; MaMel110
DR   cancercelllines; CVCL_A134
DR   Cosmic; 1467785
DR   Cosmic; 1846579
DR   Cosmic; 2686351
DR   GEO; GSM437035
DR   IGRhCellID; MaMel110
DR   Progenetix; CVCL_A134
DR   Wikidata; Q54903745
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   Ma-Mel-112
AC   CVCL_A135
DR   Cosmic; 2686352
DR   Wikidata; Q54903746
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Ma-Mel-113
AC   CVCL_A136
SY   MaMel113
DR   cancercelllines; CVCL_A136
DR   Cosmic; 1467786
DR   Cosmic; 2686353
DR   GEO; GSM437036
DR   IGRhCellID; MaMel113
DR   Progenetix; CVCL_A136
DR   Wikidata; Q54903747
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Ma-Mel-114
AC   CVCL_A137
SY   MaMel114
DR   cancercelllines; CVCL_A137
DR   Cosmic; 1467787
DR   Cosmic; 1846582
DR   Cosmic; 2686354
DR   GEO; GSM437037
DR   IGRhCellID; MaMel114new
DR   Progenetix; CVCL_A137
DR   Wikidata; Q54903748
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu130Arg (c.389T>G); Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-101C>T (c.205C>T) (C101T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Unspecified (PubMed=20544847).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   Ma-Mel-119
AC   CVCL_A138
SY   MaMel119
DR   cancercelllines; CVCL_A138
DR   Cosmic; 1467788
DR   Cosmic; 1846583
DR   Cosmic; 2686356
DR   GEO; GSM437038
DR   IGRhCellID; MaMel119
DR   Progenetix; CVCL_A138
DR   Wikidata; Q54903749
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=20544847).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   Ma-Mel-12
AC   CVCL_A139
SY   Ma-Mel_12; Ma-Mel 12; MaMel12
DR   BTO; BTO_0005340
DR   cancercelllines; CVCL_A139
DR   Cosmic; 1467741
DR   Cosmic; 1846584
DR   Cosmic; 2686357
DR   ESTDAB; ESTDAB-103
DR   GEO; GSM109054
DR   GEO; GSM436992
DR   Progenetix; CVCL_A139
DR   Wikidata; Q54903750
RX   PubMed=16827748;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   Ma-Mel-120
AC   CVCL_A140
DR   cancercelllines; CVCL_A140
DR   Cosmic; 1846585
DR   Cosmic; 2686358
DR   Wikidata; Q54903751
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Ma-Mel-121a
AC   CVCL_A141
DR   Cosmic; 2686360
DR   Wikidata; Q54903752
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Ma-Mel-122
AC   CVCL_A142
SY   Ma-mel-122; MaMel-122; MaMel122
DR   cancercelllines; CVCL_A142
DR   Cosmic; 1846587
DR   Cosmic; 2686361
DR   Wikidata; Q54903753
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Ma-Mel-123
AC   CVCL_A143
DR   Cosmic; 2686363
DR   Wikidata; Q54903754
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-126
AC   CVCL_A144
SY   MaMel126
DR   cancercelllines; CVCL_A144
DR   Cosmic; 1467789
DR   Cosmic; 1846589
DR   Cosmic; 2686364
DR   GEO; GSM437039
DR   IGRhCellID; MaMel126
DR   Progenetix; CVCL_A144
DR   Wikidata; Q54903755
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Unspecified (PubMed=20544847).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   Ma-Mel-128a
AC   CVCL_A145
SY   MaMel128a
DR   cancercelllines; CVCL_A145
DR   Cosmic; 1467790
DR   Cosmic; 1846590
DR   Cosmic; 2686365
DR   GEO; GSM437040
DR   IGRhCellID; MaMel128a
DR   Progenetix; CVCL_A145
DR   Wikidata; Q54903756
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   Ma-Mel-13
AC   CVCL_A146
SY   MaMel-13; MaMel13
DR   cancercelllines; CVCL_A146
DR   Cosmic; 1181754
DR   Cosmic; 1467742
DR   Cosmic; 1846591
DR   Cosmic; 2686366
DR   GEO; GSM436993
DR   Progenetix; CVCL_A146
DR   Wikidata; Q54903757
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=20544847).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   Ma-Mel-130
AC   CVCL_A147
SY   MaMel130
DR   cancercelllines; CVCL_A147
DR   Cosmic; 1467791
DR   Cosmic; 1846592
DR   Cosmic; 2686368
DR   GEO; GSM437042
DR   IGRhCellID; MaMel130
DR   Progenetix; CVCL_A147
DR   Wikidata; Q54903758
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   Ma-Mel-134
AC   CVCL_A148
SY   MaMel134
DR   cancercelllines; CVCL_A148
DR   Cosmic; 1467792
DR   Cosmic; 1846593
DR   Cosmic; 2686369
DR   GEO; GSM437043
DR   IGRhCellID; MaMel134
DR   Progenetix; CVCL_A148
DR   Wikidata; Q54903759
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Pro (c.323T>C); ClinVar=VCV000418436; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   Ma-Mel-136
AC   CVCL_A149
SY   MaMel136
DR   cancercelllines; CVCL_A149
DR   Cosmic; 1467793
DR   Cosmic; 2686370
DR   GEO; GSM437044
DR   IGRhCellID; MaMel136
DR   Progenetix; CVCL_A149
DR   Wikidata; Q54903760
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   Ma-Mel-14
AC   CVCL_A150
DR   cancercelllines; CVCL_A150
DR   Cosmic; 1181758
DR   Cosmic; 1846595
DR   Cosmic; 2686371
DR   ESTDAB; ESTDAB-210
DR   Wikidata; Q54903761
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-210
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,10
ST   FGA: 20,23
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Ma-Mel-144aI
AC   CVCL_E4B4
SY   Ma-Mel 144aI; MaMel-144a; MaMel144aI
RX   PubMed=21595858;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Ser476Ile (c.1427G>T); Zygosity=Heterozygous; Note=Activating mutation (PubMed=21595858).
CC   Miscellaneous: Sex and age of donor from personal communication of Schadendorf, Dirk through Yeh, Iwei.
CC   Miscellaneous: STR profile from personal communication of Yeh, Iwei.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 18,19
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 10,14
ST   Penta E: 7,17
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 19
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ma-Mel-15
AC   CVCL_A151
SY   Ma-Mel_15; Ma-mel-15; Ma-Mel 15
DR   Cosmic; 1181744
DR   Cosmic; 2686372
DR   ECACC; 13012520
DR   ESTDAB; ESTDAB-138
DR   GEO; GSM109055
DR   Wikidata; Q54903762
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=13012520; ESTDAB=ESTDAB-138
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   FGA: 21
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   Ma-Mel-150a
AC   CVCL_A152
SY   MaMel150a
DR   cancercelllines; CVCL_A152
DR   Cosmic; 1467794
DR   Cosmic; 1846597
DR   Cosmic; 2686373
DR   GEO; GSM437045
DR   IGRhCellID; MaMel150a
DR   Progenetix; CVCL_A152
DR   Wikidata; Q54903763
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro38Ser (c.112C>T); ClinVar=VCV000127688; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   Ma-Mel-152aI
AC   CVCL_E4AG
SY   MaMel-152aI; MaMel152aI
CC   Miscellaneous: Cell line information from personal communication of Schadendorf, Dirk through Yeh, Iwei.
CC   Miscellaneous: STR profile from personal communication of Yeh, Iwei.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D19S433: 13,17.2
ST   D21S11: 29,30
ST   D2S1338: 17,21
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,24,25
ST   Penta D: 8,12
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Ma-Mel-16
AC   CVCL_A153
DR   cancercelllines; CVCL_A153
DR   Cosmic; 1181756
DR   Cosmic; 1846598
DR   Cosmic; 2686374
DR   ESTDAB; ESTDAB-165
DR   Wikidata; Q54903764
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A154 ! Ma-Mel-16a
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Ma-Mel-16a
AC   CVCL_A154
DR   Cosmic; 906460
DR   Wikidata; Q54903765
RX   PubMed=15760917;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A153 ! Ma-Mel-16
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   Ma-Mel-17
AC   CVCL_A155
SY   MaMel17
DR   BTO; BTO_0005341
DR   cancercelllines; CVCL_A155
DR   Cosmic; 1181757
DR   Cosmic; 1467743
DR   Cosmic; 1846599
DR   Cosmic; 2686376
DR   GEO; GSM436994
DR   Progenetix; CVCL_A155
DR   Wikidata; Q54903766
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=20544847).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   Ma-Mel-19
AC   CVCL_A156
SY   MaMel-19; MaMel19
DR   BTO; BTO_0005342
DR   cancercelllines; CVCL_A156
DR   Cosmic; 1181750
DR   Cosmic; 1467744
DR   Cosmic; 1846600
DR   Cosmic; 2163840
DR   Cosmic; 2686377
DR   ECACC; 13012460
DR   ESTDAB; ESTDAB-152
DR   GEO; GSM436995
DR   Progenetix; CVCL_A156
DR   Wikidata; Q54903767
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His118Leu (c.353A>T); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012460; ESTDAB=ESTDAB-152
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   FGA: 18,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   Ma-Mel-20
AC   CVCL_A157
DR   cancercelllines; CVCL_A157
DR   Cosmic; 1846601
DR   Cosmic; 2163841
DR   Cosmic; 2686379
DR   ESTDAB; ESTDAB-153
DR   Wikidata; Q54903768
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-153
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   FGA: 23
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   Ma-Mel-21
AC   CVCL_A158
SY   MaMel21
DR   cancercelllines; CVCL_A158
DR   Cosmic; 1467745
DR   Cosmic; 1846602
DR   Cosmic; 2163842
DR   Cosmic; 2686381
DR   ESTDAB; ESTDAB-154
DR   GEO; GSM436996
DR   Progenetix; CVCL_A158
DR   Wikidata; Q54903769
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
ST   Source(s): ESTDAB=ESTDAB-154
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   FGA: 23,24
ST   TH01: 7
ST   TPOX: 11,12
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   Ma-Mel-22
AC   CVCL_A159
DR   cancercelllines; CVCL_A159
DR   Cosmic; 1846603
DR   Cosmic; 2686382
DR   ECACC; 13012452
DR   ESTDAB; ESTDAB-143
DR   Wikidata; Q54903770
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=13012452
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Ma-Mel-23
AC   CVCL_A160
SY   MaMel23
DR   cancercelllines; CVCL_A160
DR   Cosmic; 1467746
DR   Cosmic; 2163843
DR   Cosmic; 2686384
DR   ESTDAB; ESTDAB-155
DR   GEO; GSM436997
DR   Progenetix; CVCL_A160
DR   Wikidata; Q54903771
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys71Trp (c.213 T>G); Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Variations; SNP array analysis.
ST   Source(s): ESTDAB=ESTDAB-155
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9
ST   FGA: 21
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   Ma-Mel-24
AC   CVCL_N784
SY   MaMel24
DR   cancercelllines; CVCL_N784
DR   Cosmic; 1846605
DR   Cosmic; 2686385
DR   Wikidata; Q54903772
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   Ma-Mel-25
AC   CVCL_A161
SY   Ma-Mel_25; Ma-Mel 25
DR   cancercelllines; CVCL_A161
DR   Cosmic; 2163851
DR   Cosmic; 2686386
DR   ESTDAB; ESTDAB-167
DR   GEO; GSM109056
DR   Wikidata; Q54903773
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-167
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   FGA: 21,25
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   Ma-Mel-26a
AC   CVCL_A162
SY   Ma-Mel_26A; Ma-Mel-26A; Ma-Mel 26a; MaMel26a
DR   cancercelllines; CVCL_A162
DR   Cosmic; 1181764
DR   Cosmic; 1467747
DR   Cosmic; 1846607
DR   Cosmic; 2686387
DR   ESTDAB; ESTDAB-156
DR   GEO; GSM109057
DR   GEO; GSM436998
DR   Progenetix; CVCL_A162
DR   Wikidata; Q54903774
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (PubMed=20544847).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N785 ! Ma-Mel-26b
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-26b
AC   CVCL_N785
DR   cancercelllines; CVCL_N785
DR   Cosmic; 1846608
DR   Cosmic; 2686388
DR   Wikidata; Q54903780
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A162 ! Ma-Mel-26a
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   Ma-Mel-27
AC   CVCL_A163
SY   Ma-Mel_27; Ma-Mel 27; MaMel27
DR   cancercelllines; CVCL_A163
DR   Cosmic; 1181769
DR   Cosmic; 1467748
DR   Cosmic; 2163852
DR   Cosmic; 2686390
DR   ECACC; 13012485
DR   ESTDAB; ESTDAB-168
DR   GEO; GSM109058
DR   GEO; GSM436999
DR   Progenetix; CVCL_A163
DR   Wikidata; Q54903781
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012485; ESTDAB=ESTDAB-168
ST   Amelogenin: X
ST   CSF1PO: 10 (ESTDAB=ESTDAB-168)
ST   CSF1PO: 10,13 (ECACC=13012485)
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   Ma-Mel-28
AC   CVCL_A164
SY   Ma-Mel_28; Ma-mel-28; MaMel28
DR   cancercelllines; CVCL_A164
DR   Cosmic; 906465
DR   Cosmic; 1181763
DR   Cosmic; 2163816
DR   Cosmic; 2686391
DR   ECACC; 13012515
DR   ESTDAB; ESTDAB-102
DR   GEO; GSM109059
DR   Wikidata; Q54903782
RX   PubMed=15592718;
RX   PubMed=15760917;
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   HLA typing: A*02:01,03:01; B*18:01,40:01; C*03:04,07:01:01; DPB1*04:01,03:01; DQB1*06:04,03:02; DRB1*04:01,13:02 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012515; ESTDAB=ESTDAB-102
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 8,12
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 8
ST   FGA: 19,21
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Ma-Mel-30
AC   CVCL_A165
SY   Ma-Mel_30; Ma-Mel 30; MaMel-30; MaMel30
DR   cancercelllines; CVCL_A165
DR   Cosmic; 1467749
DR   Cosmic; 2163817
DR   Cosmic; 2686392
DR   ESTDAB; ESTDAB-104
DR   GEO; GSM109060
DR   GEO; GSM437000
DR   Progenetix; CVCL_A165
DR   Wikidata; Q54903783
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=26909863;
CC   HLA typing: A*02:01,26:12; B*57:01; C*06:02; DPB1*04:01,03:01; DQB1*03:03:02; DRB1*07:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asp594Asn (c.1780G>A); ClinVar=VCV000044813; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-104
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,11
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11
ST   FGA: 21,23.2
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-31
AC   CVCL_A166
DR   cancercelllines; CVCL_A166
DR   Cosmic; 1846612
DR   Cosmic; 2686393
DR   Wikidata; Q54903784
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Ma-Mel-32
AC   CVCL_A167
SY   MaMel32
DR   cancercelllines; CVCL_A167
DR   Cosmic; 1467750
DR   Cosmic; 1846613
DR   Cosmic; 2163853
DR   Cosmic; 2686395
DR   ESTDAB; ESTDAB-170
DR   GEO; GSM437001
DR   IGRhCellID; MaMel32new
DR   Progenetix; CVCL_A167
DR   Wikidata; Q54903785
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro38Leu (c.113C>T); ClinVar=VCV000818421; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-170
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 9,10
ST   FGA: 20
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   Ma-Mel-33
AC   CVCL_A168
DR   cancercelllines; CVCL_A168
DR   Cosmic; 1846614
DR   Cosmic; 2686396
DR   ESTDAB; ESTDAB-139
DR   Wikidata; Q54903786
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Ma-Mel-34
AC   CVCL_A169
DR   Wikidata; Q54903787
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 6
//
ID   Ma-Mel-35
AC   CVCL_A170
SY   Ma-Mel_35; Ma-Mel 35; MaMel35
DR   cancercelllines; CVCL_A170
DR   Cosmic; 1467751
DR   Cosmic; 2686397
DR   GEO; GSM109061
DR   GEO; GSM437002
DR   IGRhCellID; MaMel35
DR   Progenetix; CVCL_A170
DR   Wikidata; Q54903788
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   Ma-Mel-36
AC   CVCL_A171
SY   Ma-Mel_36; Ma-Mel 36; MaMel-36; MaMel36
DR   cancercelllines; CVCL_A171
DR   Cosmic; 1467752
DR   Cosmic; 1846616
DR   Cosmic; 2686398
DR   ESTDAB; ESTDAB-144
DR   GEO; GSM109062
DR   GEO; GSM437003
DR   GEO; GSM2545599
DR   GEO; GSM2545600
DR   GEO; GSM2545601
DR   IGRhCellID; MaMel36new
DR   Progenetix; CVCL_A171
DR   Wikidata; Q54903789
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Tyr281Ter (c.843C>A); Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1GP ! Ma-Mel-36-EBV
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-36-EBV
AC   CVCL_A1GP
DR   GEO; GSM2545602
DR   Wikidata; Q102114494
RX   PubMed=28561041;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A171 ! Ma-Mel-36
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   Ma-Mel-37a
AC   CVCL_A172
SY   MaMel37a
DR   cancercelllines; CVCL_A172
DR   Cosmic; 1467753
DR   Cosmic; 1846617
DR   Cosmic; 2686400
DR   GEO; GSM437004
DR   IGRhCellID; MaMel37a
DR   Progenetix; CVCL_A172
DR   Wikidata; Q54903790
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gln50Ter (c.148C>T); ClinVar=VCV000220711; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A173 ! Ma-Mel-37b
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   Ma-Mel-37b
AC   CVCL_A173
DR   BTO; BTO_0005343
DR   cancercelllines; CVCL_A173
DR   Cosmic; 1846618
DR   Cosmic; 2686401
DR   ESTDAB; ESTDAB-211
DR   Wikidata; Q54903791
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-211
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 9,11
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   FGA: 21,25
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A172 ! Ma-Mel-37a
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Ma-Mel-38
AC   CVCL_A174
SY   MaMel38
DR   cancercelllines; CVCL_A174
DR   Cosmic; 1467754
DR   Cosmic; 1846619
DR   Cosmic; 2163854
DR   Cosmic; 2686403
DR   ESTDAB; ESTDAB-171
DR   GEO; GSM437005
DR   IGRhCellID; MaMel38
DR   Progenetix; CVCL_A174
DR   Wikidata; Q54903792
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala60fs (c.181_202delinsAC) (p.Gly75fs, c.224_45delinsACG); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gln (c.389G>A); ClinVar=VCV000007829; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-171
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,10
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   FGA: 25
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   Ma-Mel-39a
AC   CVCL_A175
SY   Ma-Mel_39a; Ma-Mel-39A; Ma-Mel 39a; MaMel39a
DR   cancercelllines; CVCL_A175
DR   Cosmic; 1467755
DR   Cosmic; 1846620
DR   Cosmic; 2163855
DR   Cosmic; 2686404
DR   ECACC; 13012489
DR   ESTDAB; ESTDAB-172
DR   GEO; GSM109063
DR   GEO; GSM437006
DR   IGRhCellID; MaMel39a
DR   Progenetix; CVCL_A175
DR   Wikidata; Q54903793
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24His (c.71G>A); ClinVar=VCV000016929; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012489; ESTDAB=ESTDAB-172
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 13
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   Ma-Mel-40
AC   CVCL_A176
SY   Ma-Mel_40; Ma-Mel 40; MaMel40
DR   cancercelllines; CVCL_A176
DR   Cosmic; 1467756
DR   Cosmic; 1846621
DR   Cosmic; 2686405
DR   ESTDAB; ESTDAB-212
DR   GEO; GSM109064
DR   GEO; GSM437007
DR   IGRhCellID; MaMel40
DR   Progenetix; CVCL_A176
DR   Wikidata; Q54903794
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-212
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D3S1358: 16,17
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   Ma-Mel-41
AC   CVCL_A177
DR   cancercelllines; CVCL_A177
DR   Cosmic; 2686406
DR   Wikidata; Q54903796
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   Ma-Mel-42
AC   CVCL_A178
DR   Cosmic; 2686407
DR   Wikidata; Q54903797
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C572 ! Ma-Mel-42a
OI   CVCL_C287 ! Ma-Mel-42b
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-42a
AC   CVCL_C572
SY   Ma-Mel_42A; Ma-Mel 4; Ma-Mel-42A
DR   ESTDAB; ESTDAB-140
DR   GEO; GSM109065
DR   Wikidata; Q54903798
RX   PubMed=16827748;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): ESTDAB=ESTDAB-140
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   FGA: 19,22
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A178 ! Ma-Mel-42
OI   CVCL_C287 ! Ma-Mel-42b
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   Ma-Mel-42b
AC   CVCL_C287
DR   BTO; BTO_0005344
DR   ESTDAB; ESTDAB-213
DR   Wikidata; Q54903799
ST   Source(s): ESTDAB=ESTDAB-213
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   FGA: 19,22
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A178 ! Ma-Mel-42
OI   CVCL_C572 ! Ma-Mel-42a
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   Ma-Mel-43
AC   CVCL_A179
DR   cancercelllines; CVCL_A179
DR   Cosmic; 906466
DR   Cosmic; 2686408
DR   Wikidata; Q54903800
RX   PubMed=15760917;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   Ma-Mel-45a
AC   CVCL_A180
SY   Ma-Mel_45A; Ma-Mel-45A; Ma-Mel 45a; MaMel45a
DR   cancercelllines; CVCL_A180
DR   Cosmic; 1467757
DR   Cosmic; 1846625
DR   Cosmic; 2163856
DR   Cosmic; 2686409
DR   ECACC; 13012486
DR   ESTDAB; ESTDAB-173
DR   GEO; GSM109066
DR   GEO; GSM437008
DR   IGRhCellID; MaMel45a
DR   Progenetix; CVCL_A180
DR   Wikidata; Q54903801
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys13Argfs*10 (c.38_41del); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): ECACC=13012486; ESTDAB=ESTDAB-173
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 9,13
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C262 ! Ma-Mel-45b
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   Ma-Mel-45b
AC   CVCL_C262
DR   cancercelllines; CVCL_C262
DR   Cosmic; 1846626
DR   Cosmic; 2686411
DR   ESTDAB; ESTDAB-193
DR   Wikidata; Q54903802
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-193
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 9,13
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A180 ! Ma-Mel-45a
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   Ma-Mel-46
AC   CVCL_A181
SY   Ma-Mel_46; Ma-Mel 46
DR   cancercelllines; CVCL_A181
DR   Cosmic; 1846627
DR   Cosmic; 2686413
DR   ESTDAB; ESTDAB-214
DR   GEO; GSM109067
DR   Wikidata; Q54903803
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-214
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,10
ST   FGA: 19,25
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-47
AC   CVCL_A182
DR   BTO; BTO_0005345
DR   cancercelllines; CVCL_A182
DR   Cosmic; 1846628
DR   Cosmic; 2163862
DR   Cosmic; 2686415
DR   ESTDAB; ESTDAB-194
DR   Wikidata; Q54903804
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu65Pro (c.194T>C); ClinVar=VCV000820351; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-194
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   Ma-Mel-48a
AC   CVCL_A183
SY   Ma-Mel_48A; Ma-Mel-48A; Ma-Mel 48a
DR   cancercelllines; CVCL_A183
DR   Cosmic; 1846629
DR   Cosmic; 2163863
DR   Cosmic; 2686417
DR   Cosmic; 2757113
DR   ESTDAB; ESTDAB-195
DR   GEO; GSM109068
DR   GEO; GSM1467846
DR   Progenetix; CVCL_A183
DR   Wikidata; Q54903805
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=25294904;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Arg (c.1405G>A); ClinVar=VCV000177775; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-195
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 14
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9
ST   FGA: 21,23
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N786 ! Ma-Mel-48b
OI   CVCL_N787 ! Ma-Mel-48c
SX   Male
AG   87Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Ma-Mel-48b
AC   CVCL_N786
DR   cancercelllines; CVCL_N786
DR   Cosmic; 1846630
DR   Cosmic; 2686418
DR   Cosmic; 2757114
DR   GEO; GSM1467847
DR   Progenetix; CVCL_N786
DR   Wikidata; Q54903806
RX   PubMed=23348503;
RX   PubMed=25294904;
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Heterozygous (PubMed=25294904).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Arg (c.1405G>A); ClinVar=VCV000177775; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A183 ! Ma-Mel-48a
OI   CVCL_N787 ! Ma-Mel-48c
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   Ma-Mel-48c
AC   CVCL_N787
DR   cancercelllines; CVCL_N787
DR   Cosmic; 1846631
DR   Cosmic; 2686419
DR   Cosmic; 2757115
DR   GEO; GSM1467848
DR   Progenetix; CVCL_N787
DR   Wikidata; Q54903807
RX   PubMed=23348503;
RX   PubMed=25294904;
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Heterozygous (PubMed=25294904).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Asp96fs*4; Zygosity=Heterozygous (PubMed=25294904).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Arg (c.1405G>A); ClinVar=VCV000177775; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A183 ! Ma-Mel-48a
OI   CVCL_N786 ! Ma-Mel-48b
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   Ma-Mel-49
AC   CVCL_A184
DR   Cosmic; 2686421
DR   Wikidata; Q54903808
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-50
AC   CVCL_A185
DR   Cosmic; 2686422
DR   Wikidata; Q54903809
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN38 ! Ma-Mel-50b
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-50b
AC   CVCL_RN38
SY   Ma-Mel_50B; Ma-Mel 50b
DR   Cosmic; 2686423
DR   GEO; GSM109069
DR   Wikidata; Q54903810
RX   PubMed=16827748;
RX   PubMed=23348503;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A185 ! Ma-Mel-50
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 4
//
ID   Ma-Mel-51
AC   CVCL_A186
SY   MaMel51
DR   cancercelllines; CVCL_A186
DR   Cosmic; 906461
DR   Cosmic; 1467758
DR   Cosmic; 1846635
DR   Cosmic; 2163864
DR   Cosmic; 2686424
DR   ESTDAB; ESTDAB-196
DR   GEO; GSM437009
DR   IGRhCellID; MaMel51
DR   Progenetix; CVCL_A186
DR   Wikidata; Q54903811
RX   PubMed=15760917;
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-196
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 8,9
ST   FGA: 24,25
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   Ma-Mel-52
AC   CVCL_A187
SY   Ma-Mel_52; Ma-Mel 52
DR   BTO; BTO_0005346
DR   cancercelllines; CVCL_A187
DR   Cosmic; 1846636
DR   Cosmic; 2686425
DR   ESTDAB; ESTDAB-197
DR   GEO; GSM109070
DR   Wikidata; Q54903812
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-197
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D3S1358: 14,16
ST   D5S818: Not_detected
ST   D7S820: 8,14
ST   FGA: 20,21
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   Ma-Mel-53
AC   CVCL_A188
SY   MaMel-53; MaMel53; Ma-Mel-53a; Ma-Mel 53a
DR   cancercelllines; CVCL_A188
DR   Cosmic; 1467759
DR   Cosmic; 1846637
DR   Cosmic; 2686427
DR   ESTDAB; ESTDAB-198
DR   GEO; GSM437010
DR   IGRhCellID; MaMel53
DR   Progenetix; CVCL_A188
DR   Wikidata; Q54903813
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Gly780Arg (c.2338G>A); Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Arg68Thr (c.203G>C); ClinVar=VCV000933172; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-198
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 10
ST   FGA: 20,23
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Ma-Mel-54a
AC   CVCL_A189
SY   Ma-Mel_54a; Ma-Mel 54a
DR   cancercelllines; CVCL_A189
DR   Cosmic; 1846639
DR   Cosmic; 2163857
DR   Cosmic; 2686429
DR   ECACC; 13012484
DR   ESTDAB; ESTDAB-174
DR   GEO; GSM109072
DR   GEO; GSM2545603
DR   Progenetix; CVCL_A189
DR   Wikidata; Q54903814
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=28561041;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Gln959Pro (c.2876A>C); Zygosity=Homozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000007827; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=13012484; ESTDAB=ESTDAB-174
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 12 (ESTDAB=ESTDAB-174)
ST   D7S820: 12,13 (ECACC=13012484)
ST   FGA: 22,22.2
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C288 ! Ma-Mel-54b
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   Ma-Mel-54b
AC   CVCL_C288
DR   cancercelllines; CVCL_C288
DR   ESTDAB; ESTDAB-215
DR   GEO; GSM2545604
DR   Progenetix; CVCL_C288
DR   Wikidata; Q54903815
RX   PubMed=28561041;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Gln959Pro (c.2876A>C); Zygosity=Homozygous (PubMed=28561041).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
ST   Source(s): ESTDAB=ESTDAB-215
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   FGA: 22
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A189 ! Ma-Mel-54a
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   Ma-Mel-55
AC   CVCL_A190
DR   cancercelllines; CVCL_A190
DR   Cosmic; 1846640
DR   Cosmic; 2163865
DR   Cosmic; 2686431
DR   ESTDAB; ESTDAB-199
DR   Wikidata; Q54903816
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-199
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   FGA: 23,24
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 24
//
ID   Ma-Mel-56
AC   CVCL_A191
DR   cancercelllines; CVCL_A191
DR   Cosmic; 1846641
DR   Cosmic; 2163866
DR   Cosmic; 2686433
DR   ESTDAB; ESTDAB-200
DR   Wikidata; Q54903817
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   FGA: 25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   Ma-Mel-57
AC   CVCL_A192
SY   Ma-Mel_57; Ma-Mel 57; MaMel57
DR   cancercelllines; CVCL_A192
DR   Cosmic; 906462
DR   Cosmic; 1467760
DR   Cosmic; 1846642
DR   Cosmic; 2686435
DR   GEO; GSM109073
DR   GEO; GSM437011
DR   IGRhCellID; MaMel57
DR   Progenetix; CVCL_A192
DR   Wikidata; Q54903819
RX   PubMed=15760917;
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Ma-Mel-58
AC   CVCL_A193
SY   Ma-Mel_58; Ma-Mel 58; MaMel58
DR   cancercelllines; CVCL_A193
DR   Cosmic; 1467761
DR   Cosmic; 2686437
DR   GEO; GSM109074
DR   GEO; GSM437012
DR   IGRhCellID; MaMel58
DR   Progenetix; CVCL_A193
DR   Wikidata; Q54903820
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Ma-Mel-59a
AC   CVCL_A194
SY   Ma-Mel_59a; Ma-Mel 59a; MaMel59a
DR   cancercelllines; CVCL_A194
DR   Cosmic; 1467762
DR   Cosmic; 1846644
DR   Cosmic; 2686438
DR   ESTDAB; ESTDAB-202
DR   GEO; GSM109075
DR   GEO; GSM437013
DR   IGRhCellID; MaMel59a
DR   Progenetix; CVCL_A194
DR   Wikidata; Q54903821
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gln50Ter (c.148C>T); ClinVar=VCV000220711; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-202
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   FGA: 20,22
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C289 ! Ma-Mel-59b
OI   CVCL_C290 ! Ma-Mel-59c
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   Ma-Mel-59b
AC   CVCL_C289
DR   cancercelllines; CVCL_C289
DR   Cosmic; 1846645
DR   Cosmic; 2686440
DR   ESTDAB; ESTDAB-216
DR   Wikidata; Q54903825
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-216
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   FGA: 20,22
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A194 ! Ma-Mel-59a
OI   CVCL_C290 ! Ma-Mel-59c
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   Ma-Mel-59c
AC   CVCL_C290
DR   cancercelllines; CVCL_C290
DR   Cosmic; 1846646
DR   Cosmic; 2686441
DR   ESTDAB; ESTDAB-217
DR   Wikidata; Q54903826
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-217
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   FGA: 20,22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A194 ! Ma-Mel-59a
OI   CVCL_C289 ! Ma-Mel-59b
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   Ma-Mel-60
AC   CVCL_A195
SY   Ma-Mel_60; Ma-Mel 60; MaMel60
DR   cancercelllines; CVCL_A195
DR   Cosmic; 1467763
DR   Cosmic; 1846647
DR   Cosmic; 2686442
DR   ESTDAB; ESTDAB-203
DR   GEO; GSM109076
DR   GEO; GSM437014
DR   IGRhCellID; MaMel60
DR   Progenetix; CVCL_A195
DR   Wikidata; Q54903827
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.741_742delinsTT) (c.741_742CC>TT); ClinVar=VCV000437017; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn247Lys (c.741C>A); Zygosity=Unspecified (PubMed=20544847).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-203
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D3S1358: 15,16
ST   D5S818: 9
ST   D7S820: 10
ST   FGA: 25
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-61a
AC   CVCL_C291
AS   CVCL_A196
SY   Ma-Mel_61A; Ma-Mel-61A; Ma-Mel 61a; MaMel61a; Ma-Mel-61
DR   cancercelllines; CVCL_C291
DR   Cosmic; 1467764
DR   Cosmic; 1846648
DR   Cosmic; 2686444
DR   ESTDAB; ESTDAB-218
DR   GEO; GSM109077
DR   GEO; GSM437015
DR   GEO; GSM2545593
DR   IGRhCellID; MaMel61a
DR   Progenetix; CVCL_C291
DR   Wikidata; Q54903828
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6190; JAK1; Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C292 ! Ma-Mel-61b
OI   CVCL_S666 ! Ma-Mel-61c
OI   CVCL_S667 ! Ma-Mel-61e
OI   CVCL_S668 ! Ma-Mel-61f
OI   CVCL_S669 ! Ma-Mel-61g
OI   CVCL_S670 ! Ma-Mel-61h
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-61b
AC   CVCL_C292
SY   MaMel61b
DR   cancercelllines; CVCL_C292
DR   Cosmic; 1846649
DR   Cosmic; 2686446
DR   ESTDAB; ESTDAB-219
DR   GEO; GSM2545594
DR   Progenetix; CVCL_C292
DR   Wikidata; Q54903829
RX   PubMed=23348503;
RX   PubMed=26909863;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6190; JAK1; Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
ST   Source(s): ESTDAB=ESTDAB-219
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 12
ST   FGA: 20
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C291 ! Ma-Mel-61a
OI   CVCL_S666 ! Ma-Mel-61c
OI   CVCL_S667 ! Ma-Mel-61e
OI   CVCL_S668 ! Ma-Mel-61f
OI   CVCL_S669 ! Ma-Mel-61g
OI   CVCL_S670 ! Ma-Mel-61h
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   Ma-Mel-61c
AC   CVCL_S666
DR   cancercelllines; CVCL_S666
DR   Cosmic; 2686448
DR   GEO; GSM2545595
DR   Progenetix; CVCL_S666
DR   Wikidata; Q54903830
RX   PubMed=23348503;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6190; JAK1; Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C291 ! Ma-Mel-61a
OI   CVCL_C292 ! Ma-Mel-61b
OI   CVCL_S667 ! Ma-Mel-61e
OI   CVCL_S668 ! Ma-Mel-61f
OI   CVCL_S669 ! Ma-Mel-61g
OI   CVCL_S670 ! Ma-Mel-61h
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   Ma-Mel-61e
AC   CVCL_S667
DR   cancercelllines; CVCL_S667
DR   Cosmic; 1846651
DR   Cosmic; 2686449
DR   GEO; GSM2545596
DR   Progenetix; CVCL_S667
DR   Wikidata; Q54903831
RX   PubMed=23348503;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6190; JAK1; Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C291 ! Ma-Mel-61a
OI   CVCL_C292 ! Ma-Mel-61b
OI   CVCL_S666 ! Ma-Mel-61c
OI   CVCL_S668 ! Ma-Mel-61f
OI   CVCL_S669 ! Ma-Mel-61g
OI   CVCL_S670 ! Ma-Mel-61h
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   Ma-Mel-61f
AC   CVCL_S668
DR   cancercelllines; CVCL_S668
DR   Cosmic; 2686450
DR   Wikidata; Q54903832
RX   PubMed=23348503;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6190; JAK1; Zygosity=Heterozygous (from autologous cell line Ma-Mel-61a).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C291 ! Ma-Mel-61a
OI   CVCL_C292 ! Ma-Mel-61b
OI   CVCL_S666 ! Ma-Mel-61c
OI   CVCL_S667 ! Ma-Mel-61e
OI   CVCL_S669 ! Ma-Mel-61g
OI   CVCL_S670 ! Ma-Mel-61h
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   Ma-Mel-61g
AC   CVCL_S669
DR   cancercelllines; CVCL_S669
DR   Cosmic; 1846653
DR   Cosmic; 2686451
DR   GEO; GSM2545597
DR   Progenetix; CVCL_S669
DR   Wikidata; Q54903833
RX   PubMed=23348503;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6190; JAK1; Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Gly600Trp (c.1798G>T); Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C291 ! Ma-Mel-61a
OI   CVCL_C292 ! Ma-Mel-61b
OI   CVCL_S666 ! Ma-Mel-61c
OI   CVCL_S667 ! Ma-Mel-61e
OI   CVCL_S668 ! Ma-Mel-61f
OI   CVCL_S670 ! Ma-Mel-61h
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   Ma-Mel-61h
AC   CVCL_S670
DR   cancercelllines; CVCL_S670
DR   Cosmic; 1846654
DR   Cosmic; 2686452
DR   GEO; GSM2545598
DR   Progenetix; CVCL_S670
DR   Wikidata; Q54903834
RX   PubMed=23348503;
RX   PubMed=28561041;
CC   Sequence variation: Gene deletion; HGNC; HGNC:6190; JAK1; Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C291 ! Ma-Mel-61a
OI   CVCL_C292 ! Ma-Mel-61b
OI   CVCL_S666 ! Ma-Mel-61c
OI   CVCL_S667 ! Ma-Mel-61e
OI   CVCL_S668 ! Ma-Mel-61f
OI   CVCL_S669 ! Ma-Mel-61g
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   Ma-Mel-62
AC   CVCL_A197
SY   MaMel62
DR   cancercelllines; CVCL_A197
DR   Cosmic; 1467765
DR   Cosmic; 1846655
DR   Cosmic; 2686453
DR   GEO; GSM437016
DR   IGRhCellID; MaMel62
DR   Progenetix; CVCL_A197
DR   Wikidata; Q54903835
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   Ma-Mel-63a
AC   CVCL_A198
SY   Ma-Mel_63A; Ma-Mel-63A; Ma-Mel 63a; MaMel63a
DR   cancercelllines; CVCL_A198
DR   Cosmic; 1181755
DR   Cosmic; 1467766
DR   Cosmic; 1846656
DR   Cosmic; 2686455
DR   GEO; GSM109078
DR   GEO; GSM437017
DR   IGRhCellID; MaMel63a
DR   Progenetix; CVCL_A198
DR   Wikidata; Q54903836
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=16827748).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C293 ! Ma-Mel-63b
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Ma-Mel-63b
AC   CVCL_C293
DR   cancercelllines; CVCL_C293
DR   Cosmic; 1846657
DR   Cosmic; 2686456
DR   ESTDAB; ESTDAB-220
DR   Wikidata; Q54903837
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-220
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   FGA: 22,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A198 ! Ma-Mel-63a
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   Ma-Mel-64
AC   CVCL_A199
DR   Cosmic; 2686458
DR   Wikidata; Q54903838
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-65
AC   CVCL_A200
SY   Ma-Mel_65; Ma-Mel 65
DR   cancercelllines; CVCL_A200
DR   Cosmic; 1846659
DR   Cosmic; 2686459
DR   ESTDAB; ESTDAB-221
DR   GEO; GSM109079
DR   Wikidata; Q54903839
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.204_205CC>TT (-100/101C>T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-221
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D3S1358: 15,17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 19,23
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-66a
AC   CVCL_A201
SY   MaMel66a
DR   cancercelllines; CVCL_A201
DR   Cosmic; 1467767
DR   Cosmic; 1846660
DR   Cosmic; 2686460
DR   GEO; GSM437018
DR   IGRhCellID; MaMel66a
DR   Progenetix; CVCL_A201
DR   Wikidata; Q54903840
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A202 ! Ma-Mel-66b
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-66b
AC   CVCL_A202
SY   Ma-Mel_66b; Ma-Mel 66b
DR   cancercelllines; CVCL_A202
DR   Cosmic; 1846661
DR   Cosmic; 2686462
DR   GEO; GSM109080
DR   Wikidata; Q54903841
RX   PubMed=16827748;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A201 ! Ma-Mel-66a
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Ma-Mel-67
AC   CVCL_A203
SY   Ma-Mel_67; Ma-Mel 67; MaMel67
DR   cancercelllines; CVCL_A203
DR   Cosmic; 1467768
DR   Cosmic; 1846662
DR   Cosmic; 2686463
DR   GEO; GSM109081
DR   GEO; GSM437019
DR   IGRhCellID; MaMel67
DR   Progenetix; CVCL_A203
DR   Wikidata; Q54903842
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-68
AC   CVCL_A204
DR   cancercelllines; CVCL_A204
DR   Cosmic; 1846663
DR   Cosmic; 2686465
DR   Wikidata; Q54903843
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Ma-Mel-69
AC   CVCL_A205
SY   Ma-Mel_69; Ma-Mel 69; MaMel69
DR   cancercelllines; CVCL_A205
DR   Cosmic; 1467769
DR   Cosmic; 1846664
DR   Cosmic; 2686466
DR   GEO; GSM109082
DR   GEO; GSM437020
DR   IGRhCellID; MaMel69
DR   Progenetix; CVCL_A205
DR   Wikidata; Q54903844
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   Ma-Mel-70
AC   CVCL_A206
DR   Cosmic; 1846558
DR   Cosmic; 2686318
DR   Wikidata; Q54903845
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   Ma-Mel-71
AC   CVCL_A207
SY   Ma-Mel_71; Ma-Mel 71; MaMel71
DR   cancercelllines; CVCL_A207
DR   Cosmic; 1181743
DR   Cosmic; 1467770
DR   Cosmic; 2686467
DR   ESTDAB; ESTDAB-205
DR   GEO; GSM109083
DR   GEO; GSM437021
DR   IGRhCellID; MaMel71new
DR   Progenetix; CVCL_A207
DR   Wikidata; Q54903846
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-205
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   FGA: 23
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Ma-Mel-73a
AC   CVCL_A208
SY   Ma-Mel_73a; Ma-Mel 73a; MaMel73a
DR   cancercelllines; CVCL_A208
DR   Cosmic; 1467771
DR   Cosmic; 2686468
DR   ESTDAB; ESTDAB-206
DR   GEO; GSM109084
DR   GEO; GSM437022
DR   IGRhCellID; MaMel73a
DR   Progenetix; CVCL_A208
DR   Wikidata; Q54903847
RX   PubMed=16827748;
RX   PubMed=19340423;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): ESTDAB=ESTDAB-206
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   FGA: 19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A209 ! Ma-Mel-73b
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Ma-Mel-73b
AC   CVCL_A209
DR   Cosmic; 2686320
DR   ESTDAB; ESTDAB-207
DR   Wikidata; Q54903848
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-207
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   FGA: 19,26
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A208 ! Ma-Mel-73a
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   Ma-Mel-74
AC   CVCL_A210
SY   Ma-Mel_74; Ma-Mel 74
DR   cancercelllines; CVCL_A210
DR   Cosmic; 1846667
DR   Cosmic; 2647640
DR   Cosmic; 2686469
DR   ESTDAB; ESTDAB-208
DR   GEO; GSM109085
DR   Wikidata; Q54903849
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-208
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,11
ST   D3S1358: 15
ST   D5S818: 11,13
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   Ma-Mel-75
AC   CVCL_A211
SY   MaMel75
DR   cancercelllines; CVCL_A211
DR   Cosmic; 1467772
DR   Cosmic; 2686470
DR   GEO; GSM437023
DR   IGRhCellID; MaMel75
DR   Progenetix; CVCL_A211
DR   Wikidata; Q54903850
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   Ma-Mel-76
AC   CVCL_A212
SY   Ma-Mel_76; Ma-Mel 76; MaMel76
DR   cancercelllines; CVCL_A212
DR   Cosmic; 1467773
DR   Cosmic; 2686471
DR   GEO; GSM109086
DR   GEO; GSM437024
DR   IGRhCellID; MaMel76
DR   Progenetix; CVCL_A212
DR   Wikidata; Q54903851
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Ma-Mel-79
AC   CVCL_A213
SY   MaMel79
DR   Cosmic; 1181761
DR   Wikidata; Q54903852
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A214 ! Ma-Mel-79b
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Ma-Mel-79b
AC   CVCL_A214
SY   Ma-Mel_79B; Ma-Mel-79B; Ma-Mel 79b; MaMel79b
DR   cancercelllines; CVCL_A214
DR   Cosmic; 1467774
DR   GEO; GSM109087
DR   GEO; GSM437025
DR   IGRhCellID; MaMel79b
DR   Progenetix; CVCL_A214
DR   Wikidata; Q54903853
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A213 ! Ma-Mel-79
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   Ma-Mel-80a
AC   CVCL_A215
SY   Ma-Mel_80a; Ma-Mel 80a; MaMel-80a; MaMel80a
DR   cancercelllines; CVCL_A215
DR   Cosmic; 1181760
DR   Cosmic; 1467775
DR   Cosmic; 1846671
DR   Cosmic; 2686473
DR   GEO; GSM109088
DR   GEO; GSM437026
DR   IGRhCellID; MaMel80anew
DR   Progenetix; CVCL_A215
DR   Wikidata; Q54903854
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Ma-Mel-81
AC   CVCL_A216
DR   Cosmic; 2686475
DR   Wikidata; Q54903855
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-82
AC   CVCL_A217
SY   Ma-Mel_82; Ma-Mel 82; MaMel82
DR   cancercelllines; CVCL_A217
DR   Cosmic; 1846673
DR   Cosmic; 2686476
DR   GEO; GSM109089
DR   Wikidata; Q54903856
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=24581590;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   Ma-Mel-83
AC   CVCL_A218
SY   MaMel-83; MaMel83
DR   cancercelllines; CVCL_A218
DR   Cosmic; 1181751
DR   Cosmic; 1846674
DR   Cosmic; 2686478
DR   Wikidata; Q54903857
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   Ma-Mel-84
AC   CVCL_A219
SY   Ma-Mel_84; Ma-Mel 84
DR   Cosmic; 1846675
DR   Cosmic; 2686480
DR   GEO; GSM109090
DR   Wikidata; Q54903858
RX   PubMed=16827748;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   Ma-Mel-85
AC   CVCL_A220
SY   Ma-Mel_85; Ma-mel-85; Ma-Mel 85; MaMel85
DR   cancercelllines; CVCL_A220
DR   Cosmic; 1181753
DR   Cosmic; 1467776
DR   Cosmic; 1846676
DR   Cosmic; 2686481
DR   GEO; GSM109091
DR   GEO; GSM437027
DR   IGRhCellID; MaMel85
DR   Progenetix; CVCL_A220
DR   Wikidata; Q54903859
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=28561041;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala148Thr (c.442G>A); ClinVar=VCV000041580; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Phe516Leu (c.1548C>A); Zygosity=Heterozygous (PubMed=28561041).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Ma-Mel-86a
AC   CVCL_A221
SY   Ma-Mel_86a; Ma-Mel 86a; MaMel86a
DR   cancercelllines; CVCL_A221
DR   Cosmic; 1181752
DR   Cosmic; 1467777
DR   Cosmic; 1846677
DR   Cosmic; 2686483
DR   GEO; GSM109092
DR   GEO; GSM437028
DR   GEO; GSM2135603
DR   IGRhCellID; MaMel86a
DR   Progenetix; CVCL_A221
DR   Wikidata; Q54903860
RX   PubMed=16827748;
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=27261508;
CC   HLA typing: A*01:01,24:02; B*08:01,15:01; C*03:03,07:01 (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=17311103; PubMed=23348503; PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24His (c.71G>A); ClinVar=VCV000016929; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Pro193Ser (c.577C>T); dbSNP=rs1595884713; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs (c.633_645delAGATCCTCAGTTT); Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.741_742delinsTT) (c.741_742CC>TT); ClinVar=VCV000437017; Zygosity=Unspecified (PubMed=27261508).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A222 ! Ma-Mel-86b
OI   CVCL_C7TP ! Ma-Mel-86c
OI   CVCL_C7TQ ! Ma-Mel-86f
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   Ma-Mel-86b
AC   CVCL_A222
SY   Ma-Mel_86b; Ma-Mel 86b
DR   cancercelllines; CVCL_A222
DR   GEO; GSM109093
DR   GEO; GSM2135604
DR   Progenetix; CVCL_A222
DR   Wikidata; Q54903861
RX   PubMed=16827748;
RX   PubMed=27261508;
CC   Characteristics: Has lost HLA class I surface expression due to the deletion of B2M (PubMed=27261508).
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Homozygous (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24His (c.71G>A); ClinVar=VCV000016929; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Pro193Ser (c.577C>T); dbSNP=rs1595884713; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs (c.633_645delAGATCCTCAGTTT); Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.741_742delinsTT) (c.741_742CC>TT); ClinVar=VCV000437017; Zygosity=Unspecified (PubMed=27261508).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A221 ! Ma-Mel-86a
OI   CVCL_C7TP ! Ma-Mel-86c
OI   CVCL_C7TQ ! Ma-Mel-86f
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Ma-Mel-86c
AC   CVCL_C7TP
DR   GEO; GSM2135605
DR   Progenetix; CVCL_C7TP
DR   Wikidata; Q117704638
RX   PubMed=27261508;
CC   HLA typing: A*01:01; B*08:01; C*07:01 (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24His (c.71G>A); ClinVar=VCV000016929; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Pro193Ser (c.577C>T); dbSNP=rs1595884713; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs (c.633_645delAGATCCTCAGTTT); Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.741_742delinsTT) (c.741_742CC>TT); ClinVar=VCV000437017; Zygosity=Unspecified (PubMed=27261508).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A221 ! Ma-Mel-86a
OI   CVCL_A222 ! Ma-Mel-86b
OI   CVCL_C7TQ ! Ma-Mel-86f
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   Ma-Mel-86f
AC   CVCL_C7TQ
DR   GEO; GSM2135606
DR   Progenetix; CVCL_C7TQ
DR   Wikidata; Q117704639
RX   PubMed=27261508;
CC   Characteristics: Has lost HLA class I surface expression due to the deletion of B2M (PubMed=27261508).
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Homozygous (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24His (c.71G>A); ClinVar=VCV000016929; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Pro193Ser (c.577C>T); dbSNP=rs1595884713; Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn212fs (c.633_645delAGATCCTCAGTTT); Zygosity=Unspecified (PubMed=27261508).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.741_742delinsTT) (c.741_742CC>TT); ClinVar=VCV000437017; Zygosity=Unspecified (PubMed=27261508).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A221 ! Ma-Mel-86a
OI   CVCL_A222 ! Ma-Mel-86b
OI   CVCL_C7TP ! Ma-Mel-86c
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   Ma-Mel-90
AC   CVCL_A223
DR   Cosmic; 2686484
DR   Wikidata; Q54903862
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Ma-Mel-91
AC   CVCL_A224
SY   MaMel91
DR   cancercelllines; CVCL_A224
DR   Cosmic; 1181762
DR   Cosmic; 1846679
DR   Cosmic; 2686485
DR   Wikidata; Q54903863
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Ma-Mel-92
AC   CVCL_A225
SY   MaMel92
DR   Cosmic; 1181759
DR   Wikidata; Q54903864
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 7
//
ID   Ma-Mel-92d
AC   CVCL_A226
DR   cancercelllines; CVCL_A226
DR   Cosmic; 1846680
DR   Cosmic; 2686487
DR   Wikidata; Q54903866
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Ma-Mel-93
AC   CVCL_A227
DR   cancercelllines; CVCL_A227
DR   Wikidata; Q54903867
RX   PubMed=17311103;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Unspecified (PubMed=17311103).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   Ma-Mel-93I
AC   CVCL_VK42
DR   cancercelllines; CVCL_VK42
DR   Cosmic; 2686489
DR   Wikidata; Q95984691
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Unspecified (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A227 ! Ma-Mel-93
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   Ma-Mel-94
AC   CVCL_A228
SY   MaMel94
DR   cancercelllines; CVCL_A228
DR   Cosmic; 1467778
DR   Cosmic; 1846682
DR   Cosmic; 2686490
DR   GEO; GSM437029
DR   IGRhCellID; MaMel94
DR   Progenetix; CVCL_A228
DR   Wikidata; Q54903868
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Unspecified (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   Ma-Mel-95
AC   CVCL_A229
SY   MaMel-95; MaMel95
DR   cancercelllines; CVCL_A229
DR   Cosmic; 1467779
DR   Cosmic; 1846683
DR   Cosmic; 2686491
DR   GEO; GSM437030
DR   IGRhCellID; MaMel95
DR   Progenetix; CVCL_A229
DR   Wikidata; Q54903869
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   Ma-Mel-96
AC   CVCL_A230
DR   cancercelllines; CVCL_A230
DR   Cosmic; 1846684
DR   Cosmic; 2686492
DR   Wikidata; Q54903870
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   Ma-Mel-97
AC   CVCL_A231
DR   cancercelllines; CVCL_A231
DR   Cosmic; 1846685
DR   Cosmic; 2686494
DR   Wikidata; Q54903871
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Ma-Mel-99
AC   CVCL_A232
SY   MaMel99
DR   cancercelllines; CVCL_A232
DR   Cosmic; 1467780
DR   Cosmic; 1846686
DR   Cosmic; 2686496
DR   GEO; GSM437031
DR   IGRhCellID; MaMel99new
DR   Progenetix; CVCL_A232
DR   Wikidata; Q54903872
RX   PubMed=17311103;
RX   PubMed=20544847;
RX   PubMed=23348503;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=20544847).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4225; Cutaneous nodular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   Ma-Mel-KNUD
AC   CVCL_C505
SY   KNUD; MaMel-KNUD; MaMel_KNUD
DR   cancercelllines; CVCL_C505
DR   Cosmic; 1467781
DR   Cosmic; 2163834
DR   Cosmic; 2686498
DR   ESTDAB; ESTDAB-136
DR   GEO; GSM109094
DR   GEO; GSM437046
DR   IGRhCellID; MaMel_KNUD
DR   Progenetix; CVCL_C505
DR   Wikidata; Q54903873
RX   PubMed=16827748;
RX   PubMed=19340423;
RX   PubMed=20544847;
RX   PubMed=23348503;
RX   PubMed=23851445;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu247Ter (c.740T>G); ClinVar=VCV000428210; Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): ESTDAB=ESTDAB-136
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   MA01
AC   CVCL_C341
SY   MA 01; Ma01; ACTe001-A
DR   hPSCreg; ACTe001-A
DR   SKIP; SKIP001923
DR   Wikidata; Q54903874
RX   Patent=US10072243;
RX   PubMed=16929302;
RX   PubMed=18713948;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-38(1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   MA03
AC   CVCL_C342
SY   MA 03
DR   Wikidata; Q54903875
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   MA04
AC   CVCL_C343
SY   MA 04
DR   Wikidata; Q54903876
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   MA09
AC   CVCL_C344
SY   MA 09; Ma09; ACTe002-A
DR   hPSCreg; ACTe002-A
DR   SKIP; SKIP001924
DR   Wikidata; Q54903878
RX   Patent=US10072243;
RX   PubMed=16929302;
RX   PubMed=19521979;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-38(2).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   MA09-hRPE
AC   CVCL_C1LA
SY   MA09-RPE
DR   Wikidata; Q114311911
RX   Patent=US10077424;
RX   PubMed=19521979;
RX   PubMed=22281388;
RX   PubMed=31482011;
WW   Info; LifeMap Discovery; -; https://web.archive.org/web/20250125032248/https://discovery.lifemapsc.com/regenerative-medicine/cell-therapy-applications/eye-ma09-hrpe-human-embryonic-retinal-pigmented-epithelial-cells-for-degenerative-macular-diseases
CC   From: Astellas Institute of Regenerative Medicine (AIRM); Marlborough; USA.
CC   Biotechnology: Used in clinical trials were it is sub-retinaly transplanted in patients with macular degeneration and Stargardt's macular dystrophy. MA09-hRPE can rescue photoreceptors and prevent loss of vision.
CC   Characteristics: The MA09 hESC cell line was terminally differentiated into retinal pigment epithelial (RPE) cells.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C344 ! MA09
SX   Female
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MA1-3
AC   CVCL_J837
DR   Wikidata; Q54903879
RX   PubMed=6809625;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9I4Z4; Pseudomonas aeruginosa oprL (H2) (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   MA1-6
AC   CVCL_J838
DR   CLO; CLO_0007496
DR   ATCC; CRL-1783
DR   Wikidata; Q54903880
RX   PubMed=6809625;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9I4Z4; Pseudomonas aeruginosa oprL (H2) (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   MA1-8
AC   CVCL_J839
DR   Wikidata; Q54903881
RX   PubMed=6809625;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9I4Z4; Pseudomonas aeruginosa oprL (H2) (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   MA11
AC   CVCL_B7HQ
SY   MA-11
DR   Wikidata; Q112930060
RX   PubMed=8938153;
RX   PubMed=11734314;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   MA126
AC   CVCL_B895
SY   MA 126; NED1; NED 1
DR   Wikidata; Q54903882
RX   PubMed=18371431;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   MA127 [Human ESC]
AC   CVCL_B896
SY   MA 127; NED2; NED 2
DR   Wikidata; Q54903883
RX   PubMed=18371431;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   MA127 [Mouse hybridoma against human SLAMF6]
AC   CVCL_C0C3
DR   Wikidata; Q112930061
RX   PubMed=11489943;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96DU3; Human SLAMF6/CD352.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MA128
AC   CVCL_B897
SY   MA 128; NED3; NED 3
DR   Wikidata; Q54903884
RX   PubMed=18371431;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   MA129
AC   CVCL_B898
SY   MA 129; NED4; NED 4
DR   Wikidata; Q54903885
RX   PubMed=18371431;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   MA133
AC   CVCL_B899
SY   MA 133
DR   Wikidata; Q54903886
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   MA135
AC   CVCL_B900
SY   MA 135
DR   NIHhESC; NIHhESC-10-0072
DR   Wikidata; Q54903887
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0072.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   MA136
AC   CVCL_B901
SY   MA 136
DR   Wikidata; Q54903888
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   MA137
AC   CVCL_B902
SY   MA 137
DR   Wikidata; Q54903889
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   MA138
AC   CVCL_B903
SY   MA 138
DR   Wikidata; Q54903890
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   MA139
AC   CVCL_B904
SY   MA 139
DR   Wikidata; Q54903891
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   MA140
AC   CVCL_B905
SY   MA 140
DR   Wikidata; Q54903892
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   MA141
AC   CVCL_C116
SY   MA 141
DR   Wikidata; Q54903893
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   MA148
AC   CVCL_AK47
SY   MA 148; MA-148
DR   Wikidata; Q54903894
RX   PubMed=8640821;
RX   PubMed=10786683;
RX   PubMed=12361951;
RX   PubMed=19926575;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   MA1K
AC   CVCL_S499
DR   ATCC; CRL-6284
DR   Wikidata; Q54903895
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6284; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MA2.1
AC   CVCL_L672
DR   CLO; CLO_0007497
DR   ATCC; HB-54
DR   Wikidata; Q54903896
RX   PubMed=6167544;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   MA214L
AC   CVCL_5I01
SY   RAFT0069
DR   ECACC; 07042302
DR   Wikidata; Q54903897
RX   PubMed=9138163;
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: t(5;6)(q21;q21) (ECACC=07042302).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3267; Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y11M
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   MA2T
AC   CVCL_S500
DR   ATCC; CRL-6285
DR   Wikidata; Q54903898
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6285; true.
DI   NCIt; C134957; Hamster chondrosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   64D
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MA40
AC   CVCL_C337
SY   MA 40
DR   Wikidata; Q54903899
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   MA42
AC   CVCL_C338
SY   MA 42
DR   Wikidata; Q54903900
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   Ma44-3
AC   CVCL_W133
DR   Wikidata; Q54903901
RX   PubMed=15161017;
RX   PubMed=16170033;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7071 ! Ma-44
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Ma44-3-GFP
AC   CVCL_W134
DR   Wikidata; Q54903902
RX   PubMed=15161017;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W133 ! Ma44-3
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   MA50
AC   CVCL_C339
SY   MA 50
DR   Wikidata; Q54903903
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   MA782/5s-8101
AC   CVCL_WJ07
SY   MA782/5S-8101
DR   CCRID; 4201MOU-CCTCC00025
DR   CCTCC; GDC0025
DR   Wikidata; Q95984828
RX   DOI=10.1007/BF02827841;
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   Ma9308
AC   CVCL_E5FE
RX   PubMed=10937834;
RX   PubMed=18594937;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C26915; Vitiligo
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MA99
AC   CVCL_C340
SY   MA 99
DR   Wikidata; Q54903904
RX   PubMed=18713948;
CC   From: Ocata Therapeutics, Inc. (Advanced Cell Technology, Inc.); Marlborough; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   MAb 1-1-11-1
AC   CVCL_B0TA
SY   MAb 1-1-11
DR   Wikidata; Q108820827
RX   Patent=US7682800;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3971.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33261; Human CYP2C19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   MAb 1-5-1-3
AC   CVCL_B0TB
DR   Wikidata; Q108820828
RX   Patent=US7682800;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3969.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33261; Human CYP2C19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   MAb 1-68-11
AC   CVCL_B0TC
DR   Wikidata; Q108820829
RX   PubMed=11602516;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2 and CYP2C9*3. Also recognizes CYP2C8, CYP2C18 and CYP2C19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   MAb 1-7-4-8
AC   CVCL_B0TD
DR   Wikidata; Q108820830
RX   Patent=US7682800;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3970.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33261; Human CYP2C19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Mab 108
AC   CVCL_L581
DR   CLO; CLO_0007502
DR   ATCC; HB-9764
DR   Wikidata; Q54903905
RX   Patent=US6217866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9764.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
CC   Discontinued: ATCC; HB-9764; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 9
//
ID   MAb 11h
AC   CVCL_B6FL
DR   Wikidata; Q112930062
RX   PubMed=19003338;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_79068; Crocin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   Mab 126
AC   CVCL_L582
DR   CLO; CLO_0007503
DR   ATCC; HB-8568
DR   Wikidata; Q54903906
RX   Patent=US4675287;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8568.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 7
//
ID   MAb 12a
AC   CVCL_B6FJ
DR   Wikidata; Q112930063
RX   PubMed=19003338;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_79068; Crocin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   mAb 13-1
AC   CVCL_L583
DR   CLO; CLO_0007504
DR   ATCC; HB-10565
DR   Wikidata; Q54903910
RX   Patent=US5981714;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10565.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   MAb 13-1-3
AC   CVCL_B0TE
DR   Wikidata; Q108820831
RX   PubMed=11602516;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10632; Human CYP2C8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   mAb 13-2
AC   CVCL_L584
DR   Wikidata; Q54903911
RX   Patent=US5981714;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10566.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   MAb 131
AC   CVCL_F0UN
RX   PubMed=1693360;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00693; Barley AMY1.1 (Note=Also recognizes AMY1.2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MAb 151-45-4
AC   CVCL_L585
DR   CLO; CLO_0007505
DR   ATCC; HB-12682
DR   Wikidata; Q54903913
RX   Patent=US6323325;
RX   PubMed=10376770;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12682.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11509; Human CYP2A6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   MAb 16
AC   CVCL_E7D6
SY   16
RX   PubMed=28029330;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BXJ3; Human C1QTNF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MAb 1812-4-8
AC   CVCL_L586
DR   CLO; CLO_0007506
DR   ATCC; HB-12683
DR   Wikidata; Q54903914
RX   Patent=US6335428;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12683.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05177; Human CYP1A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   MAb 1d
AC   CVCL_B6FK
DR   Wikidata; Q112930064
RX   PubMed=19003338;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_79068; Crocin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   Mab 1E8
AC   CVCL_L587
SY   MAB 1E8
DR   CLO; CLO_0007507
DR   ATCC; HB-11490
DR   Wikidata; Q54903915
RX   Patent=US6232080;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11490.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18428; Human LBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   Mab 213
AC   CVCL_C8BT
DR   Wikidata; Q123032993
RX   PubMed=2387305;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Rat 200 kDa apical cell membrane protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   MAb 226
AC   CVCL_F0UP
RX   PubMed=1693360;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00693; Barley AMY1.1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   mAb 239
AC   CVCL_L687
SY   239
DR   Wikidata; Q54903916
RX   Patent=US5009995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8288.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P40189; Human IL6ST/CD130/gp130.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   mAb 24-1
AC   CVCL_L588
SY   mAB 24-1
DR   CLO; CLO_0007508
DR   ATCC; HB-11947
DR   Wikidata; Q54903917
RX   Patent=US5981714;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11947.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   mAb 24-2
AC   CVCL_L589
SY   mAB 24-2
DR   CLO; CLO_0007509
DR   ATCC; HB-11946
DR   Wikidata; Q54903918
RX   Patent=US5981714;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11946.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13569; Human CFTR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   MAb 240
AC   CVCL_F0UQ
RX   PubMed=1693360;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00693; Barley AMY1.1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MAb 26-7-5
AC   CVCL_L590
DR   CLO; CLO_0007510
DR   ATCC; HB-12681
DR   Wikidata; Q54903919
RX   Patent=US6335428;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12681.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05177; Human CYP1A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   mAb 270
AC   CVCL_9217
DR   CLO; CLO_0007511
DR   ATCC; HB-189
DR   DSHB; mAb-270
DR   Wikidata; Q54903920
RX   PubMed=3694260;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Chicken neuronal nicotonic acetylcholine receptor (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 9
//
ID   MAb 281-1-1
AC   CVCL_B0TF
DR   Wikidata; Q108820832
RX   Patent=US7524939;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12648.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10632; Human CYP2C8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAb 292-2-3
AC   CVCL_B0TG
DR   Wikidata; Q108820833
RX   Patent=US7524939;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12645.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Binds and inhibits allele CYP2C9*2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Mab 2B5
AC   CVCL_L591
DR   CLO; CLO_0007512
DR   ATCC; HB-11491
DR   Wikidata; Q54903921
RX   Patent=US6232080;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11491.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P18428; Human LBP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   MAb 327-8-3
AC   CVCL_B0TH
DR   Wikidata; Q108820834
RX   PubMed=11602516;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1 and CYP2C9*2. Also recognizes CYP2C18).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   MAb 33
AC   CVCL_E7D7
SY   33
RX   PubMed=28029330;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BXJ3; Human C1QTNF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MAb 336
AC   CVCL_F0UR
RX   PubMed=1693360;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00693; Barley AMY1.1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MAb 35
AC   CVCL_E7D8
SY   35
RX   PubMed=28029330;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BXJ3; Human C1QTNF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   mAb 35
AC   CVCL_4539
SY   mAB 35; MAB 35; mAb35
DR   CLO; CLO_0007513
DR   CLO; CLO_0007514
DR   CLO; CLO_0007524
DR   CLDB; cl5225
DR   ATCC; HB-8857
DR   ATCC; TIB-175
DR   DSHB; mAb-35
DR   IZSLER; BS Hy 10
DR   Wikidata; Q54903922
RX   Patent=US4789640;
RX   PubMed=3694260;
RX   PubMed=6948300;
CC   Group: Patented cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8857.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09688; Electrophorus electricus chrna1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 14
//
ID   MAb 352
AC   CVCL_F0US
RX   PubMed=1693360;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00693; Barley AMY1.1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MAb 362.50
AC   CVCL_C0DT
SY   mAb 362.50
DR   Wikidata; Q112930065
RX   PubMed=2684401;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16573; Rat Ceacam1/Cd66a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   mAB 493
AC   CVCL_C8BN
DR   Wikidata; Q123032994
RX   PubMed=9842916;
RX   PubMed=11465094;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; O89103; Mouse Cd93.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   MAb 5-1-5
AC   CVCL_B0TI
DR   Wikidata; Q108820835
RX   Patent=US7524939;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12649.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10632; Human CYP2C8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAb 5-7-5
AC   CVCL_B0TJ
DR   Wikidata; Q108820836
RX   Patent=US7524939;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12647.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Binds also to CYP2C18 and CYP2C19).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAb 5.2
AC   CVCL_L592
SY   #5.2
DR   CLO; CLO_0007515
DR   ATCC; HB-9148
DR   Wikidata; Q54903923
RX   Patent=US5376370;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9148.
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   MAb 5.4
AC   CVCL_C0DU
SY   mAb 5.4
DR   Wikidata; Q112930066
RX   PubMed=1988344;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16573; Rat Ceacam1/Cd66a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   Mab 543
AC   CVCL_L593
DR   CLO; CLO_0007516
DR   ABCD; ABCD_AA932
DR   ABCD; ABCD_AI448
DR   ATCC; HB-8592
DR   Wikidata; Q54903924
RX   Patent=US4672044;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8592.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P17927; Human CR1/CD35.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 8
//
ID   MAb 592-2-5
AC   CVCL_B0TK
DR   Wikidata; Q108820837
RX   Patent=US7524939;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12646.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2, CYP2C9*3. Also recognizes CYP2C18).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   Mab 62B1-PC
AC   CVCL_3393
SY   62B1
DR   CLO; CLO_0007517
DR   CLDB; cl4917
DR   ICLC; HYL98001
DR   Wikidata; Q54903925
RX   PubMed=3319299;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unidentified plasma cell-associated antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   mAb 64
AC   CVCL_8963
SY   mAb64
DR   CLO; CLO_0007525
DR   ATCC; HB-8987
DR   Wikidata; Q54903926
RX   Patent=US4789640;
RX   PubMed=6948300;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8987.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02709; Bovine CHRNA1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   MAb 69
AC   CVCL_F0UT
RX   PubMed=1693360;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00693; Barley AMY1.1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MAb 763-15-20
AC   CVCL_B0TL
DR   Wikidata; Q108820838
RX   Patent=US7524939;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1078.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2 and CYP2C9*3. Also binds CYP2C8).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   MAb 763-15-5
AC   CVCL_B0TM
DR   Wikidata; Q108820839
RX   Patent=US7524939;
RX   PubMed=11602516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1079.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2 and CYP2C9*3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   MAb 8
AC   CVCL_F0UU
RX   PubMed=1693360;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00693; Barley AMY1.1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   mAb 829
AC   CVCL_L688
SY   829
DR   Wikidata; Q54903927
RX   Patent=US5009995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8289.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P40189; Human IL6ST/CD130/gp130.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   Mab 8A-PC
AC   CVCL_3394
SY   8A
DR   CLO; CLO_0007518
DR   CLDB; cl4915
DR   ICLC; HYL98002
DR   Wikidata; Q54903928
RX   PubMed=3319299;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unidentified plasma cell-associated antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   Mab 8F6-PC
AC   CVCL_3395
SY   8F6
DR   CLO; CLO_0007519
DR   CLDB; cl4916
DR   ICLC; HYL98003
DR   Wikidata; Q54903929
RX   PubMed=3319299;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unidentified plasma cell-associated antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MAb 951-5-1
AC   CVCL_L594
DR   CLO; CLO_0007520
DR   ATCC; HB-12684
DR   Wikidata; Q54903930
RX   Patent=US6335428;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12684.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05177; Human CYP1A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   Mab 96
AC   CVCL_L595
DR   CLO; CLO_0007521
DR   Wikidata; Q54903931
RX   Patent=US6217866;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9763.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P00533; Human EGFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   mAb 986.35
AC   CVCL_L689
SY   986.35; 986; mAB 986
DR   Wikidata; Q54903932
RX   Patent=US5009995;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9284.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P40189; Human IL6ST/CD130/gp130.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   mAb A1
AC   CVCL_C8K6
SY   A1
DR   Wikidata; Q123032995
RX   PubMed=8960118;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78576; Aflatoxin M1 (AFM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   mAb BB7
AC   CVCL_L596
DR   CLO; CLO_0007522
DR   ATCC; CRL-2501
DR   Wikidata; Q54903933
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P26599; Human PTBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   MAb D10
AC   CVCL_Z990
DR   Wikidata; Q54903934
RX   Patent=US8975030;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.2904.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07900; Human HSP90AA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   MAb E9
AC   CVCL_Z989
DR   Wikidata; Q54903935
RX   Patent=US8975030;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.2903.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07900; Human HSP90AA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   mAb FF32
AC   CVCL_C8K7
SY   FF32
DR   Wikidata; Q123032997
RX   PubMed=8960118;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78576; Aflatoxin M1 (AFM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   mAb N12
AC   CVCL_C8K8
SY   N12
DR   Wikidata; Q123032998
RX   PubMed=8960118;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78576; Aflatoxin M1 (AFM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   mAb R16
AC   CVCL_C8K9
SY   R16
DR   Wikidata; Q123032999
RX   PubMed=8960118;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78576; Aflatoxin M1 (AFM1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Mab-0217
AC   CVCL_D3EK
DR   Wikidata; Q127382734
RX   PubMed=22273439;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_35445; 3,3',5,5'-tetrachlorobiphenyl (Note=Also recognizes other polychlorinated biphenyls (PCBs)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Mab-4444
AC   CVCL_D3EL
DR   ABCD; ABCD_AJ614
DR   Wikidata; Q127382735
RX   PubMed=22273439;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_35445; 3,3',5,5'-tetrachlorobiphenyl (Note=Also recognizes other polychlorinated biphenyls (PCBs)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MAb-G1
AC   CVCL_A6KE
SY   G1
DR   Wikidata; Q107115915
RX   DOI=10.1007/978-94-011-2044-9_84;
RX   PubMed=1572415;
RX   PubMed=2091939;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAb-G2
AC   CVCL_A6KF
SY   G2
DR   Wikidata; Q107115918
RX   DOI=10.1007/978-94-011-2044-9_84;
RX   PubMed=1572415;
RX   PubMed=2091939;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAb-G3
AC   CVCL_A6KG
SY   G3
DR   Wikidata; Q107115920
RX   DOI=10.1007/978-94-011-2044-9_84;
RX   PubMed=1572415;
RX   PubMed=2091939;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAb-G4
AC   CVCL_A6KH
SY   G4
DR   Wikidata; Q107115922
RX   DOI=10.1007/978-94-011-2044-9_84;
RX   PubMed=1572415;
RX   PubMed=2091939;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAb-G6
AC   CVCL_A6KI
SY   G6
DR   Wikidata; Q107115924
RX   DOI=10.1007/978-94-011-2044-9_84;
RX   PubMed=1572415;
RX   PubMed=2091939;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6KD ! RF-S1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mAb005
AC   CVCL_F0HA
DR   ABCD; ABCD_AS297
RX   Patent=US11365255;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mAb1
AC   CVCL_C1IZ
SY   # mAb 1
DR   CCRID; 4201PAT-CCTCC01754
DR   Wikidata; Q114311912
RX   Patent=CN113150133B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2020231.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DTC9; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein (N) (Note=Also reacts with SARS-CoV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MAb104
AC   CVCL_G668
DR   CLO; CLO_0007523
DR   ATCC; CRL-2067
DR   Wikidata; Q54903936
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   mAb158
AC   CVCL_C4UY
DR   Wikidata; Q116049759
RX   PubMed=17623042;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized lecanemab (BAN2401) therapeutic antibody used for the treatmen of Alzheimer disease.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Selectively binds to large, soluble Abeta protofibrils, does not bind native APP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   mAb177
AC   CVCL_E5ME
RX   PubMed=2022189;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02224; Human CENPE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   mAb1C3
AC   CVCL_C4UZ
DR   Wikidata; Q116049761
RX   PubMed=17623042;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   mAb2
AC   CVCL_C1J0
SY   # mAb 2
DR   CCRID; 4201PAT-CCTCC01755
DR   Wikidata; Q114311913
RX   Patent=CN113150133B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2020233.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DTC9; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   MAb2
AC   CVCL_D6UQ
RX   PubMed=25723277;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MAb3D5AB1
AC   CVCL_F0SU
SY   3D5AB1
RX   PubMed=17510399;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06576; Human ATP5F1B (Note=Also reacts with E.coli).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   mAb4
AC   CVCL_C1J1
SY   # mAb 4
DR   CCRID; 4201PAT-CCTCC01756
DR   Wikidata; Q114311914
RX   Patent=CN113150133B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2020234.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DTC9; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   mAb5
AC   CVCL_C1J2
SY   # mAb 5
DR   CCRID; 4201PAT-CCTCC01757
DR   Wikidata; Q114311915
RX   Patent=CN113150133B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2020235.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DTC9; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein (N) (Note=Also reacts with SARS-CoV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   mAbC7
AC   CVCL_LG35
SY   monoclonal AntiBody Clone 7
DR   Wikidata; Q54903937
RX   Patent=US7439330;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6023.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13987; Human CD59 (Note=Glycated on Lys66).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 8
//
ID   Maben
AC   CVCL_X194
DR   Wikidata; Q54903938
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=13258519;
RX   PubMed=13472685;
RX   PubMed=13531635;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   MabHS1
AC   CVCL_XB78
DR   CCRID; 4201PAT-CCTCC00156
DR   Wikidata; Q95985001
RX   Patent=CN1536365A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200304.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_61040; Phosphorylcholine chloride.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   mAbHpu24
AC   CVCL_C3X6
DR   ABCD; ABCD_AG859
DR   Wikidata; Q116049762
RX   PubMed=26778617;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_21858; Hypusine (N6-[(2R)-4-amino-2-hydroxybutyl]-L-lysine).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z068 ! 240E-W
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   mAbHpu91
AC   CVCL_C3X7
DR   Wikidata; Q116049763
RX   PubMed=26778617;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_21858; Hypusine (N6-[(2R)-4-amino-2-hydroxybutyl]-L-lysine).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z068 ! 240E-W
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   mAbHpu98
AC   CVCL_C3X8
DR   ABCD; ABCD_AG858
DR   Wikidata; Q116049765
RX   PubMed=26778617;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_21858; Hypusine (N6-[(2R)-4-amino-2-hydroxybutyl]-L-lysine).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_Z068 ! 240E-W
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   MABS-1
AC   CVCL_RX32
DR   cancercelllines; CVCL_RX32
DR   Wikidata; Q54903939
RX   DOI=10.15369/sujms1989.9.45;
CC   Problematic cell line: Contaminated. Parent cell line (MOBS-1) has been shown to be a U-937 derivative.
CC   Population: Caucasian.
CC   Doubling time: 20 hours (DOI=10.15369/sujms1989.9.45).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8442 ! MOBS-1
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   MAC 13
AC   CVCL_S000
SY   MAC13; Murine Adenocarcinoma of the Colon 13
DR   ChEMBL-Cells; CHEMBL3307283
DR   ChEMBL-Targets; CHEMBL614042
DR   PubChem_Cell_line; CVCL_S000
DR   Wikidata; Q54903940
RX   PubMed=9683789;
RX   PubMed=11440905;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Breed/subspecies: NMRI.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   MAC 15A
AC   CVCL_H587
SY   MAC15A; Murine Adenocarcinoma of the Colon 15A
DR   ChEMBL-Cells; CHEMBL3307539
DR   ChEMBL-Targets; CHEMBL614121
DR   PubChem_Cell_line; CVCL_H587
DR   Wikidata; Q54903941
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Breed/subspecies: NMRI.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   MAC 16
AC   CVCL_S001
SY   MAC16; Murine Adenocarcinoma of the Colon 16
DR   ChEMBL-Cells; CHEMBL3307490
DR   ChEMBL-Targets; CHEMBL614318
DR   PubChem_Cell_line; CVCL_S001
DR   Wikidata; Q54903942
RX   PubMed=9683789;
RX   PubMed=11440905;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Breed/subspecies: NMRI.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   MAC 2-158
AC   CVCL_A0DY
SY   Mac 2-158; MAC2-158; Mac2-158; Mac2.158
DR   Wikidata; Q108820840
RX   Patent=US5077216;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAC 2-48
AC   CVCL_L547
SY   Mac 2-48; MAC2-48; Mac2-48
DR   CLO; CLO_0007526
DR   ATCC; HB-10714
DR   Wikidata; Q54903944
RX   Patent=US5077216;
RX   PubMed=10975989;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10714.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   MAC 26
AC   CVCL_S002
SY   MAC26; Murine Adenocarcinoma of the Colon 26
DR   ChEMBL-Cells; CHEMBL3307878
DR   ChEMBL-Targets; CHEMBL614122
DR   PubChem_Cell_line; CVCL_S002
DR   Wikidata; Q54903945
RX   PubMed=9683789;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Breed/subspecies: NMRI.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   MAC 40/43
AC   CVCL_A6HW
DR   Wikidata; Q107115925
RX   Patent=EP0278160A2;
RX   PubMed=3365703;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 86111001.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human breast cancer cells 47 kDa glycoprotein.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Mac-1
AC   CVCL_H631
SY   MAC-1; MAC1; McG-1
DR   BTO; BTO_0004869
DR   cancercelllines; CVCL_H631
DR   Cell_Model_Passport; SIDM01369
DR   Cosmic; 2013355
DR   Cosmic; 2674499
DR   Cosmic; 2814456
DR   GEO; GSM1217151
DR   GEO; GSM2527945
DR   Progenetix; CVCL_H631
DR   Wikidata; Q54903946
RX   CelloPub=CLPUB00077;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1532439;
RX   PubMed=2456698;
RX   PubMed=2898211;
RX   PubMed=9162223;
RX   PubMed=28356514;
RX   PubMed=29533902;
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H632 ! Mac-2
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   Mac-2
AC   CVCL_H632
SY   MAC-2; McG-2
DR   Wikidata; Q54903947
RX   CelloPub=CLPUB00077;
RX   PubMed=2456698;
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H631 ! Mac-1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   MAC-2
AC   CVCL_S921
DR   Wikidata; Q54903948
RX   PubMed=8039117;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   MAC-21
AC   CVCL_M627
SY   MAC 21
DR   Wikidata; Q54903951
RX   CelloPub=CLPUB00262;
RX   PubMed=13806813;
RX   PubMed=14098906;
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative. Originally thought to originate from a male patient with a lung adenocarcinoma. The original MAC-21 cell line was never tested for contamination. See the colorful description of the MAC-21 contamination story in the book from Michael Gold (CelloPub=CLPUB00262).
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   Mac-2A
AC   CVCL_H637
SY   MAC-2A; MAC2A; McG-2A; PB-2A
DR   cancercelllines; CVCL_H637
DR   Cell_Model_Passport; SIDM01361
DR   Cosmic; 2814457
DR   DepMap; ACH-001119
DR   GEO; GSM2527946
DR   Wikidata; Q54903949
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1532439;
RX   PubMed=2789474;
RX   PubMed=9162223;
RX   PubMed=15356658;
RX   PubMed=28356514;
RX   PubMed=29533902;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H632 ! Mac-2
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   Mac-2B
AC   CVCL_H638
SY   MAC-2B; McG-2B
DR   Cell_Model_Passport; SIDM01552
DR   Cosmic; 2814458
DR   GEO; GSM2527947
DR   Wikidata; Q54903950
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1532439;
RX   PubMed=2789474;
RX   PubMed=9162223;
RX   PubMed=15356658;
RX   PubMed=28356514;
RX   PubMed=29533902;
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H632 ! Mac-2
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   MAC-T
AC   CVCL_U226
SY   Mac-T; MacT; MAC-T3; Mammary Alveolar Cells-large T antigen
DR   BCRJ; 0315
DR   GEO; GSE46476
DR   Wikidata; Q54903957
RX   CelloPub=CLPUB00665;
RX   DOI=10.4172/2329-888X.1000103;
RX   Patent=US5227301;
RX   Patent=US5455164;
RX   PubMed=1423654;
RX   PubMed=1659986;
RX   PubMed=7540186;
RX   PubMed=14550508;
RX   PubMed=26659725;
RX   PubMed=30055215;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10274.
CC   Doubling time: ~17 hours (PubMed=1659986); 48 hours (Note=In serum-free medium) (PubMed=7540186).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Anecdotal: Nexia, a former Canadian biotech company was orignally developed to make lactose-free milk using MAC-T.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_B3UP ! LMH17
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 20
//
ID   MAC-T BLV
AC   CVCL_VN97
DR   Wikidata; Q95985070
RX   PubMed=30055215;
CC   Virology: Stably infected with bovine leukemia virus (BLV) (PubMed=30055215).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   MAC-T CU-1
AC   CVCL_U230
SY   CU-1; MAC-T Cornell University-1
DR   Wikidata; Q54903958
RX   PubMed=7540186;
CC   Doubling time: 16 hours, 78 hours (Note=In serum-free medium) (PubMed=7540186).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: Cell line no longer available (personal communication of Politis, Ioannis).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   MAC-T CU-2
AC   CVCL_U231
SY   CU-2; MAC-T Cornell University-2
DR   Wikidata; Q54903959
RX   PubMed=7540186;
CC   Doubling time: 15 hours, 46 hours (Note=In serum-free medium) (PubMed=7540186).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: Cell line no longer available (personal communication of Politis, Ioannis).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   MAC-T CU-3
AC   CVCL_U232
SY   CU-3; MAC-T Cornell University-3
DR   Wikidata; Q54903960
RX   PubMed=7540186;
CC   Doubling time: 14 hours, 80 hours (Note=In serum-free medium) (PubMed=7540186).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: Cell line no longer available (personal communication of Politis, Ioannis).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   MAC-T spCas9 #1
AC   CVCL_E8BZ
RX   PubMed=36930414;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Codon optimized).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MAC-T spCas9 #2
AC   CVCL_E8C0
RX   PubMed=36930414;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Codon optimized).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MAC-T spCas9 #3
AC   CVCL_E8C1
RX   PubMed=36930414;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Codon optimized).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MAC-T spCas9 #4
AC   CVCL_E8C2
RX   PubMed=36930414;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=Codon optimized).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MaCa 1
AC   CVCL_M375
SY   MaCa1
DR   Wikidata; Q54903961
RX   PubMed=7923078;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MaCa 2
AC   CVCL_M376
SY   MaCa2
DR   Wikidata; Q54903963
RX   PubMed=7923078;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   Machi
AC   CVCL_R796
DR   Wikidata; Q28521737
RX   PubMed=92573;
RX   PubMed=1690682;
RX   PubMed=8891732;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Mack1
AC   CVCL_C2VU
SY   MACK1
DR   Kerafast; ETU008-FP
DR   Wikidata; Q114311916
RX   PubMed=36991012;
CC   Group: Fish cell line.
CC   Characteristics: Possesses the ability to accumulate lipids, demonstrating potential for both fat and muscle phenotypes (PubMed=36991012).
CC   Doubling time: 24.3 +- 4.91 hours (PubMed=36991012); 30-35 hours (Kerafast=ETU008-FP).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=13677; ! Scomber scombrus (Atlantic mackerel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   Mack2
AC   CVCL_C2VV
DR   Wikidata; Q114311917
RX   PubMed=36991012;
CC   Group: Fish cell line.
CC   Doubling time: 22.9 +- 3.99 hours (PubMed=36991012).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=13677; ! Scomber scombrus (Atlantic mackerel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MACKI
AC   CVCL_0A71
SY   Macki
DR   ATCC; CRL-6582
DR   Wikidata; Q54903964
RX   PubMed=6500159;
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-6582; true.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   MacKinley
AC   CVCL_L362
SY   McKinley
DR   GEO; GSM1974793
DR   Wikidata; Q54903965
RX   PubMed=21908323;
RX   PubMed=22916246;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
RX   PubMed=36099278;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 27.6 hours (PubMed=22916246); 28 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:43120; MED12; Simple; p.Leu1938fs (c.5813delT); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:44864; PPM1D; Simple; p.Glu472Ter (c.1414G>T); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Newfoundland; VBO=VBO_0200938.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231,235
ST   Dog FHC2054: 151,156
ST   Dog FHC2079: 271,275
ST   Dog PEZ1: 119,123
ST   Dog PEZ3: 127,131
ST   Dog PEZ5: 103
ST   Dog PEZ6: 187,199
ST   Dog PEZ8: 228
ST   Dog PEZ12: 274,285
ST   Dog PEZ20: 176
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   MACL-1
AC   CVCL_6846
DR   BTO; BTO_0005048
DR   PRIDE; PXD028400
DR   Wikidata; Q54903966
RX   PubMed=19725227;
RX   PubMed=20422346;
RX   PubMed=20664973;
RX   PubMed=23404580;
RX   PubMed=35666001;
CC   Population: Brazilian.
CC   Characteristics: Original tumor belongs to the luminal subtype A; ER+, PR+ and ERBB2-, but cell line is triple negative (PubMed=23404580).
CC   Doubling time: 29 hours (PubMed=19725227).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Age at sampling from personal communication of de Goes, Alfredo Miranda.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   MAD,MF
AC   CVCL_E768
SY   MAD, MF
DR   dbMHC; 48964
DR   ECACC; 94082232
DR   IHW; IHW09133
DR   IPD-IMGT/HLA; 11676
DR   Wikidata; Q54903969
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,03:01:01; B*08:01,57:01:01; C*06,07; DPB1*03:01,04:01; DQA1*05:01,02:01; DQB1*02:01,03:03; DRB1*03:01:01,07; DRB3*01:01:02:01; DRB4*01:01 (IPD-IMGT/HLA=11676).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Mad/C1
AC   CVCL_S501
DR   ATCC; CRL-6366
DR   Wikidata; Q54903967
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6366; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   Mad/C3
AC   CVCL_S502
SY   Mad-C3
DR   ATCC; CRL-6367
DR   Wikidata; Q54903968
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6367; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MAD2
AC   CVCL_E5I5
RX   PubMed=3182109;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MADB100
AC   CVCL_F0WZ
SY   MADB-100
RX   DOI=10.1007/BF00199175;
RX   PubMed=7237438;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MADB105
AC   CVCL_F0X1
SY   MADB-105
RX   PubMed=7237438;
CC   Characteristics: Obtained from a pulmonary metastasis produced by the intra-venous injection of MADB100 tumor cells (PubMed=7237438).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F0WZ ! MADB100
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MADB106
AC   CVCL_BT04
SY   MADB-106; MADB 106
DR   CCRID; 4201RAT-CCTCC00130
DR   CCTCC; GDC0130
DR   CLS; 305205
DR   KCB; KCB 2013045YJ
DR   NCI-DTP; MADB 106
DR   Wikidata; Q54903970
RX   DOI=10.1007/BF00199175;
RX   PubMed=10220071;
CC   Characteristics: Obtained from a pulmonary metastasis produced by the intra-venous injection of MADB100 tumor cells (DOI=10.1007/BF00199175).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F0WZ ! MADB100
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 13
//
ID   MADB200
AC   CVCL_F0X0
SY   MADB-200
RX   PubMed=7237438;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Madsen
AC   CVCL_M139
DR   BTO; BTO_0004329
DR   Wikidata; Q54903971
RX   PubMed=19831134;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   From: Youle, Richard James; National Institutes of Health; Bethesda; USA.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   MADURA
AC   CVCL_E769
SY   MADURA-T; GM08598
DR   CLO; CLO_0010592
DR   BioSample; SAMN00798096
DR   Coriell; GM08598
DR   dbMHC; 48965
DR   ECACC; 88052069
DR   IHW; IHW09069
DR   IPD-IMGT/HLA; 11044
DR   Wikidata; Q54903972
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Danish.
CC   HLA typing: A*02:01:01:01; B*40:01:02:01; C*03:04:01:01; DPA1*01; DPB1*04:01:01; DQA1*04:01; DQB1*04:02:01; DRA*01:02; DRB1*08:01:01 (IPD-IMGT/HLA=11044).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   MAEC
AC   CVCL_U411
SY   Mouse Aortic Endothelial Cell
DR   CLO; CLO_0051046
DR   RCB; RCB2712
DR   Wikidata; Q54903973
RX   PubMed=17215585;
CC   Doubling time: 23.2 hours (PubMed=17215585).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   MAER-S1
AC   CVCL_XC21
DR   CCRID; 4201PAT-CCTCC00140
DR   Wikidata; Q95985151
RX   Patent=CN1195229C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C96005.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P03372; Human ESR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   MAF
AC   CVCL_R844
SY   Megalobrama Amblycephala Fin
DR   Wikidata; Q54903974
RX   PubMed=23532304;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75352; ! Megalobrama amblycephala (Chinese blunt snout bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   MAgEC 10.5
AC   CVCL_A1AX
SY   Mouse Aorta gonad mesonephros Endothelial Cells 10.5 dpc
DR   Wikidata; Q102114495
RX   Patent=US9631178;
RX   PubMed=26577811;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4222.
CC   Characteristics: Displays progenitor endothelial characteristics (PubMed=26577811).
CC   Doubling time: ~24 hours (PubMed=26577811).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: FVB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   MAgEC 11.5
AC   CVCL_A1AY
SY   Mouse Aorta gonad mesonephros Endothelial Cells 11.5 dpc
DR   Wikidata; Q102114496
RX   Patent=US9631178;
RX   PubMed=26577811;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4223.
CC   Characteristics: Displays progenitor endothelial characteristics. Is more differentiated than MAgEC 10.5 (Cellosaurus=CVCL_A1AY) and displays faster angiogenesis in vitro, different response to hypoxia and chemokines (PubMed=26577811).
CC   Doubling time: ~24 hours (PubMed=26577811).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: FVB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   MAGIC-5
AC   CVCL_E8AM
SY   MAGIC-5A 1-10; HeLa/CD4+ cell clone 1-10
RX   PubMed=11158746;
CC   Population: African American.
CC   Characteristics: Transfected with a construct pJK2 containing the HIV-1 LTR fused to a lacZ reporter gene that contains a MPKKKRK N-terminal sequence directing it to the nucleus (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D259 ! HeLa-MAGI
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   mAGS(1)
AC   CVCL_VZ57
DR   cancercelllines; CVCL_VZ57
DR   IBRC; C10085
DR   Wikidata; Q95985154
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line through a nude mice tumor (IBRC=C10085).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   mAGS(2)
AC   CVCL_VZ58
DR   cancercelllines; CVCL_VZ58
DR   IBRC; C10086
DR   Wikidata; Q95985155
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line through a nude mice tumor (IBRC=C10086).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   mAGS(3)
AC   CVCL_VZ59
DR   cancercelllines; CVCL_VZ59
DR   IBRC; C10087
DR   Wikidata; Q95985156
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line through a nude mice tumor (IBRC=C10087).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   mAGS(4)
AC   CVCL_VZ60
DR   cancercelllines; CVCL_VZ60
DR   IBRC; C10088
DR   Wikidata; Q95985158
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line through a nude mice tumor (IBRC=C10088).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   mAGS(5)
AC   CVCL_VZ61
DR   cancercelllines; CVCL_VZ61
DR   IBRC; C10089
DR   Wikidata; Q95985160
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line through a nude mice tumor (IBRC=C10089).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   Mahlavu
AC   CVCL_0405
SY   MAHLAVU
DR   BTO; BTO_0004471
DR   EFO; EFO_0022710
DR   MCCL; MCC:0000299
DR   cancercelllines; CVCL_0405
DR   ChEMBL-Cells; CHEMBL4295417
DR   ChEMBL-Targets; CHEMBL4296473
DR   CLS; 300473
DR   Cosmic; 873398
DR   Cosmic; 948064
DR   Cosmic; 979727
DR   Cosmic; 1019317
DR   Cosmic; 2162534
DR   Cosmic; 2321039
DR   GEO; GSM2551578
DR   IARC_TP53; 2183
DR   LIMORE; Mahlavu
DR   PubChem_Cell_line; CVCL_0405
DR   Wikidata; Q54903975
RX   CelloPub=CLPUB00076;
RX   CelloPub=CLPUB00575;
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=179808;
RX   PubMed=2439335;
RX   PubMed=6268737;
RX   PubMed=6275024;
RX   PubMed=8050184;
RX   PubMed=8224613;
RX   PubMed=23887712;
RX   PubMed=25574106;
RX   PubMed=31063779;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/Mahlavu
WW   Provider; BRICS; BRICS0078; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3892
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: African.
CC   Doubling time: 22.5 hours (CelloPub=CLPUB00076); 52.01 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ile391Met (c.1173A>G); ClinVar=VCV000135038; Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=8224613; PubMed=31063779).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: Malhavu; Note=Occasionally.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CLS=300473; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D12S391: 18
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 11,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,22
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 12
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 28
ST   Penta D: 9,11
ST   Penta E: 8,11
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   MAIL8-19
AC   CVCL_A8GJ
DR   Wikidata; Q107115928
RX   PubMed=15701651;
RX   PubMed=16964285;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16412; NLRC4 (Note=With p.Leu152_Ala1024del, CARD domain, C12N2 construct).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16608; PYCARD.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   MAIL8-3
AC   CVCL_0406
SY   MAIL8
DR   MCCL; MCC:0000300
DR   Wikidata; Q54903976
RX   PubMed=15701651;
RX   PubMed=16964285;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16412; NLRC4 (Note=With p.Leu152_Ala1024del, CARD domain, C12N2 construct).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16608; PYCARD.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   Mais-BL
AC   CVCL_7200
SY   Mais
DR   Wikidata; Q54903977
RX   PubMed=9882297;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Maja
AC   CVCL_F516
SY   MAJA; GM03099; GM3099
DR   CLO; CLO_0013481
DR   Coriell; GM03099
DR   Wikidata; Q54903978
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=6806098;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02; B*35; C*04 (Coriell=GM03099).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   MAK<CD44>M-1.1.12
AC   CVCL_A9EP
DR   Wikidata; Q108820841
RX   Patent=US5879898;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2156.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<CD44>M-2.42.3
AC   CVCL_A9EQ
DR   Wikidata; Q108820842
RX   Patent=US5879898;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2157.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<CD44>M-4.3.16
AC   CVCL_A9ER
DR   Wikidata; Q108820843
RX   Patent=US5879898;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2158.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<NT-proBNP>1.21.3
AC   CVCL_B0XF
SY   MAB<NT-proBNP>1.21.3
DR   Wikidata; Q108820844
RX   Patent=US7807380;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2650.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_B0WT ! 1C10 [Mouse/sheep heteromyeloma]
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<NT-proBNP>10.4.63
AC   CVCL_B0XG
SY   MAB<NT-proBNP>10.4.63
DR   Wikidata; Q108820845
RX   Patent=US7811770;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2654.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<NT-proBNP>16.1.39
AC   CVCL_B0XB
SY   MAB<NT-proBNP>16.1.39
DR   Wikidata; Q108820846
RX   Patent=US7811770;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2590.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<NT-proBNP>17.3.1
AC   CVCL_B0XC
SY   MAB<NT-proBNP>17.3.1
DR   Wikidata; Q108820847
RX   Patent=US7807380;
RX   Patent=US7811770;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2591.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<NT-proBNP>18.29.23
AC   CVCL_B0XE
SY   MAB<NT-proBNP>18.29.23
DR   Wikidata; Q108820848
RX   Patent=US7807380;
RX   Patent=US7811770;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2593.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MAK<NT-proBNP>18.4.34
AC   CVCL_B0XD
SY   MAB<NT-proBNP>18.4.34
DR   Wikidata; Q108820849
RX   Patent=US7807380;
RX   Patent=US7811770;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2592.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P16860; Human NPPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Maku
AC   CVCL_1Q44
AS   CVCL_W929
SY   MAKU; Mak-BL; MAK-BL; MAK; NK-51; NK51
DR   Cosmic; 2804864
DR   Wikidata; Q54903979
RX   PubMed=170370;
RX   PubMed=216485;
RX   PubMed=2824665;
RX   PubMed=2943927;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=4122458;
RX   PubMed=4320167;
RX   PubMed=4347031;
RX   PubMed=4364259;
RX   PubMed=4907973;
RX   PubMed=6231253;
RX   PubMed=6547209;
RX   PubMed=6806672;
RX   PubMed=7316467;
RX   PubMed=7519050;
RX   PubMed=8108117;
RX   PubMed=11515428;
RX   PubMed=24590883;
CC   Population: African; Kenyan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=6806672).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Ser77Pro (c.229T>C); Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   MAL-1
AC   CVCL_C8AF
DR   Wikidata; Q123033000
RX   PubMed=2993124;
RX   PubMed=7503696;
RX   PubMed=15168196;
RX   PubMed=30291474;
CC   Group: Non-human primate cell line.
CC   Virology: Contains a complete Macaca arctoides gammaherpesvirus 1 (HVMA or MarcGHV-1) genome which has been sequenced (PubMed=30291474).
CC   Karyotypic information: Tetraploid (PubMed=30291474).
CC   Transformant: NCBI_TaxID; 2341050; Macaca arctoides gammaherpesvirus 1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Malme-3
AC   CVCL_1437
SY   MALME-3
DR   BTO; BTO_0004161
DR   CLO; CLO_0007528
DR   ATCC; HTB-102
DR   BCRJ; 0286
DR   BioSample; SAMN03471086
DR   Cell_Model_Passport; SIDM00010
DR   Cosmic; 2233661
DR   Wikidata; Q54903980
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=HTB-102
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1438 ! Malme-3M
OI   CVCL_1E90 ! Malme-3S
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   Malme-3M
AC   CVCL_1438
SY   MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer
DR   BTO; BTO_0004162
DR   CLO; CLO_0007529
DR   CLO; CLO_0007530
DR   EFO; EFO_0002243
DR   CLDB; cl3334
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-64
DR   BCRJ; 0287
DR   BioGRID_ORCS_Cell_line; 558
DR   BioSample; SAMN03470851
DR   BioSample; SAMN03472750
DR   BioSample; SAMN10988242
DR   cancercelllines; CVCL_1438
DR   CancerTools; 161910
DR   Cell_Model_Passport; SIDM00011
DR   ChEMBL-Cells; CHEMBL3307507
DR   ChEMBL-Targets; CHEMBL614021
DR   Cosmic; 686474
DR   Cosmic; 687438
DR   Cosmic; 706116
DR   Cosmic; 875884
DR   Cosmic; 888864
DR   Cosmic; 905953
DR   Cosmic; 933002
DR   Cosmic; 974071
DR   Cosmic; 974256
DR   Cosmic; 1006558
DR   Cosmic; 1022281
DR   Cosmic; 1045408
DR   Cosmic; 1067226
DR   Cosmic; 1092616
DR   Cosmic; 1132592
DR   Cosmic; 1155270
DR   Cosmic; 1175870
DR   Cosmic; 1303042
DR   Cosmic; 1305364
DR   Cosmic; 1312347
DR   Cosmic; 1458963
DR   Cosmic; 1459637
DR   Cosmic; 1477403
DR   Cosmic; 1507615
DR   Cosmic; 1669122
DR   Cosmic; 1998458
DR   Cosmic; 2230113
DR   DepMap; ACH-000477
DR   GEO; GSM2118
DR   GEO; GSM50202
DR   GEO; GSM50264
DR   GEO; GSM188223
DR   GEO; GSM188253
DR   GEO; GSM188312
DR   GEO; GSM206522
DR   GEO; GSM743465
DR   GEO; GSM750822
DR   GEO; GSM799353
DR   GEO; GSM799416
DR   GEO; GSM847035
DR   GEO; GSM887288
DR   GEO; GSM888363
DR   GEO; GSM1138789
DR   GEO; GSM1153423
DR   GEO; GSM1178343
DR   GEO; GSM1178344
DR   GEO; GSM1181293
DR   GEO; GSM1181295
DR   GEO; GSM1670073
DR   GEO; GSM2124669
DR   IARC_TP53; 21078
DR   IGRhCellID; Malme3M
DR   KCLB; 30064
DR   LiGeA; CCLE_607
DR   NCI-DTP; MALME-3M
DR   PharmacoDB; Malme3M_882_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   Progenetix; CVCL_1438
DR   PubChem_Cell_line; CVCL_1438
DR   SKY/M-FISH/CGH; 2740
DR   Wikidata; Q54903981
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12068308;
RX   PubMed=15009714;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23285177;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24576830;
RX   PubMed=24670534;
RX   PubMed=25056119;
RX   PubMed=25960936;
RX   PubMed=27377824;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29492214;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31733513;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=44
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/malme-3m-human-melanoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2009-092.
CC   Population: Caucasian.
CC   Doubling time: 43 hours (PubMed=7718330); 35 hours (PubMed=8631022); 46.2 hours (NCI-DTP=MALME-3M).
CC   HLA typing: A*02:01,02:01; B*13:02,40:01; C*06:02,03:04; DQB1*06:02,06:02; DRB1*15:02,15:02 (PubMed=25960936).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=24576830; PubMed=29492214; DepMap=ACH-000477).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (DepMap=ACH-000477).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.63%; Native American=0%; East Asian, North=1.38%; East Asian, South=0%; South Asian=0.35%; European, North=66.47%; European, South=31.17% (PubMed=30894373).
CC   Misspelling: MELM-3M; Cosmic=1458963.
CC   Misspelling: MALME 37; PubMed=29492214.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=HTB-64; KCLB=30064; PubMed=19372543; PubMed=25056119
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30.2,32.2
ST   D2S1338: 24
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 21,22
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1437 ! Malme-3
OI   CVCL_1E90 ! Malme-3S
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   Malme-3S
AC   CVCL_1E90
SY   Malme-3 Suspension
DR   Wikidata; Q54903982
RX   DOI=10.1007/978-1-4757-1647-4_5;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1437 ! Malme-3
OI   CVCL_1438 ! Malme-3M
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   Malpha1
AC   CVCL_C5GH
DR   Wikidata; Q116049766
RX   PubMed=6179537;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01426; Naja pallida short neurotoxin 1 (Neurotoxin alpha).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Malpha2-3
AC   CVCL_C5GG
DR   Wikidata; Q116049767
RX   PubMed=2430832;
RX   PubMed=9295323;
CC   Group: Animal toxin research hybridoma.
CC   Characteristics: The mAb produced by this hybridoma partially mimicks the nicotinic AchR.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01426; Naja pallida short neurotoxin 1 (Neurotoxin alpha) (Note=Reacts with short neurotoxins from many snake species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MAM-6C-8
AC   CVCL_C4ZM
DR   Wikidata; Q116049768
RX   PubMed=11429095;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P06875; Escherichia coli penicillin G acylase (pac).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MAM-3E7
AC   CVCL_E7D3
RX   PubMed=28029332;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P07478; Human PRSS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MAM-6E7
AC   CVCL_E7D4
RX   PubMed=28029332;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P07478; Human PRSS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MAM-6G7
AC   CVCL_E7D5
RX   PubMed=28029332;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P07478; Human PRSS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MAME
AC   CVCL_G035
DR   IPD-IMGT/HLA; 11048
DR   Wikidata; Q54903983
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*57:03:01,82:01 (IPD-IMGT/HLA=11048).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   MaMi
AC   CVCL_5796
DR   Wikidata; Q54903984
RX   PubMed=9740146;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MaMi
CC   Population: Japanese.
CC   Doubling time: 30.2 +- 1.1 hours (PubMed=9740146).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C8973; Endometrioid stromal sarcoma
DI   ORDO; Orphanet_213711; Endometrial stromal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   MAMI-96
AC   CVCL_XX46
DR   Wikidata; Q95985183
RX   DOI=10.1159/000083458;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1-2D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   MAMIYA
AC   CVCL_WK56
DR   Wikidata; Q95985184
RX   PubMed=10929426;
RX   PubMed=17212712;
RX   PubMed=17982631;
CC   Population: Japanese.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   MAMIYA-HLAG
AC   CVCL_WK57
DR   Wikidata; Q95985187
RX   PubMed=17982631;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4964; HLA-G.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WK56 ! MAMIYA
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   Man-1
AC   CVCL_B893
SY   MAN-1; MAN01; UMANe001-A
DR   hPSCreg; UMANe001-A
DR   SKIP; SKIP002048
DR   Wikidata; Q54903985
RX   PubMed=20177994;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/man-1.aspx
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-017, Steering comm. appl. SCSC08-02.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Man-10
AC   CVCL_L198
SY   MAN-10; MAN10; CMFTe005-A
DR   BioSamples; SAMEA5781287
DR   hPSCreg; CMFTe005-A
DR   Wikidata; Q54903986
RX   PubMed=28583200;
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-008, Steering comm. appl. SCSC12-17.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   Man-11
AC   CVCL_L199
SY   MAN-11; Man 11; MAN11; Man11; UMANe003-A
DR   BioSamples; SAMEA4760914
DR   hPSCreg; UMANe003-A
DR   Wikidata; Q54903987
RX   PubMed=26607962;
RX   PubMed=28445466;
RX   PubMed=28583200;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-003, Steering comm. appl. SCSC12-26.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to Man-12 (Cellosaurus=CVCL_L200).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   Man-12
AC   CVCL_L200
SY   MAN-12; Man 12; MAN12; Man12; CMFTe002-A
DR   BioSamples; SAMEA4760722
DR   hPSCreg; CMFTe002-A
DR   Wikidata; Q54903988
RX   PubMed=26607962;
RX   PubMed=28445466;
RX   PubMed=28583200;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-004, Steering comm. appl. SCSC12-27.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to Man-11 (Cellosaurus=CVCL_L199).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   Man-13
AC   CVCL_L201
SY   MAN-13; MAN13; Man13; UMANe002-A
DR   BioSamples; SAMEA7792168
DR   hPSCreg; UMANe002-A
DR   SKIP; SKIP002592
DR   Wikidata; Q54903989
RX   PubMed=28583200;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-005, Steering comm. appl. SCSC12-28.
CC   Population: Caucasian.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   Man-14
AC   CVCL_BW68
SY   MAN-14; MAN14; Man14; CMFTe003-A
DR   BioSamples; SAMEA104619828
DR   hPSCreg; CMFTe003-A
DR   Wikidata; Q54903990
RX   PubMed=28583200;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-006, Steering comm. appl. SCSC14-23.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   Man-15
AC   CVCL_BW69
SY   MAN-15; MAN15; Man15; UMANe004-A
DR   BioSamples; SAMEA104576524
DR   hPSCreg; UMANe004-A
DR   Wikidata; Q54903991
RX   PubMed=28583200;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-007, Steering comm. appl. SCSC14-24.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   Man-16
AC   CVCL_BW70
SY   MAN-16; MAN16; Man16; CMFTe004-A
DR   BioSamples; SAMEA104615891
DR   hPSCreg; CMFTe004-A
DR   Wikidata; Q54903992
RX   PubMed=28583200;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-008, Steering comm. appl. SCSC14-25.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   Man-2
AC   CVCL_B894
SY   MAN-2; MAN02; CMFTe001-A
DR   hPSCreg; CMFTe001-A
DR   SKIP; SKIP002049
DR   Wikidata; Q54903993
RX   PubMed=20177994;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/man-2.aspx
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-09-011, Steering comm. appl. SCSC09-01.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Man-3
AC   CVCL_L191
SY   MAN-3; MAN03
DR   Wikidata; Q54903994
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-001, Steering comm. appl. SCSC12-20.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Man-4
AC   CVCL_L192
SY   MAN-4; MAN04
DR   Wikidata; Q54903995
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-002, Steering comm. appl. SCSC12-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Man-5
AC   CVCL_L193
SY   MAN-5; MAN05
DR   Wikidata; Q54903996
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-003, Steering comm. appl. SCSC12-22.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Man-6
AC   CVCL_L194
SY   MAN-6; MAN06
DR   Wikidata; Q54903998
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-004, Steering comm. appl. SCSC12-23.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Man-7
AC   CVCL_L195
SY   MAN-7; MAN07
DR   Wikidata; Q54904000
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-005, Steering comm. appl. SCSC12-24.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Man-8
AC   CVCL_L196
SY   MAN-8; MAN08
DR   Wikidata; Q54904001
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-006, Steering comm. appl. SCSC12-25.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Man-9
AC   CVCL_L197
SY   MAN-9; MAN09
DR   Wikidata; Q54904002
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-20-007, Steering comm. appl. SCSC12-16.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   MANACA-2
AC   CVCL_B7RH
DR   Wikidata; Q112930067
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MANCHO1-2C7
AC   CVCL_A6QD
SY   MANCHO1(2C7); MANCHO1; 2C7
DR   Wikidata; Q107115931
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANCHO10-9E10
AC   CVCL_A6NH
SY   MANCHO10(9E10); MANCHO10; 9E10
DR   DSHB; MANCHO10-9E10
DR   Wikidata; Q107115933
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO11-9F2
AC   CVCL_A6NI
SY   MANCHO11(9F2); MANCHO11; 9F2
DR   DSHB; MANCHO11-9F2
DR   Wikidata; Q107115935
RX   PubMed=9693008;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO12-1H1
AC   CVCL_C2FW
SY   MANCHO12(1H1); MANCHO12; 1H1
DR   Wikidata; Q114311918
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANCHO13-2G12
AC   CVCL_A6NJ
SY   MANCHO13(2G12); MANCHO13; 2G12
DR   DSHB; MANCHO13-2G12
DR   Wikidata; Q107115937
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO14-4E1
AC   CVCL_A6NK
SY   MANCHO14(4E1); MANCHO14; 4E1
DR   DSHB; MANCHO14-4E1
DR   Wikidata; Q107115939
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO15-5C3
AC   CVCL_A6NL
SY   MANCHO15(5C3); MANCHO15; 5C3
DR   DSHB; MANCHO15-5C3
DR   Wikidata; Q107115943
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO16-9C2
AC   CVCL_A6QG
SY   MANCHO16(9C2); MANCHO16; 9C2
DR   Wikidata; Q107115945
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANCHO17-4C8
AC   CVCL_A6NM
SY   MANCHO17(4C8); MANCHO17; 4C8
DR   DSHB; MANCHO17-4C8
DR   Wikidata; Q107115947
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO18-3C1
AC   CVCL_A6NN
SY   MANCHO18(3C1); MANCHO18; 3C1
DR   DSHB; MANCHO18-3C1
DR   Wikidata; Q107115949
RX   PubMed=9693008;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO19-5D12
AC   CVCL_A6QH
SY   MANCHO19(5D12); MANCHO19; 5D12
DR   Wikidata; Q107115952
RX   PubMed=9693008;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MANCHO2-9G3
AC   CVCL_A6NP
SY   MANCHO2(9G3); MANCHO2; 9G3
DR   DSHB; MANCHO2-9G3
DR   Wikidata; Q107115954
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO3-8A4
AC   CVCL_A6NQ
SY   MANCHO3(8A4); MANCHO3; 8A4
DR   ABCD; ABCD_AW957
DR   DSHB; MANCHO3-8A4
DR   Wikidata; Q107115957
RX   PubMed=9693008;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 6
//
ID   MANCHO4-2G5
AC   CVCL_A6NR
SY   MANCHO4(2G5); MANCHO4; 2G5
DR   DSHB; MANCHO4-2G5
DR   Wikidata; Q107115961
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO5-4F11
AC   CVCL_A6NS
SY   MANCHO5(4F11); MANCHO5; 4F11
DR   DSHB; MANCHO5-4F11
DR   Wikidata; Q107115963
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO6-5A6
AC   CVCL_A6NT
SY   MANCHO6(5A6); MANCHO6; 5A6
DR   DSHB; MANCHO6-5A6
DR   Wikidata; Q107115968
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO7-7F3
AC   CVCL_A6NU
SY   MANCHO7(7F3); MANCHO7; 7F3
DR   DSHB; MANCHO7-7F3
DR   Wikidata; Q107115970
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANCHO8-5C5
AC   CVCL_A6QE
SY   MANCHO8(5C5); MANCHO8; 5C5
DR   Wikidata; Q107115974
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANCHO9-8C10
AC   CVCL_A6QF
SY   MANCHO9(8C10); MANCHO9; 8C10
DR   Wikidata; Q107115975
RX   PubMed=9693008;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANDAG1-7A11
AC   CVCL_A6PM
SY   MANDAG1(7A11); MANDAG1; 7A11
DR   DSHB; MANDAG1-7A11
DR   Wikidata; Q107115977
RX   PubMed=11420143;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MANDAG2-7D11
AC   CVCL_A6PN
SY   MANDAG2(7D11); MANDAG2; 7D11
DR   DSHB; MANDAG2-7D11
DR   Wikidata; Q107115979
RX   PubMed=11420143;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MANDAG3-4F7
AC   CVCL_A6PP
SY   MANDAG3(4F7); MANDAG3; 4F7
DR   Wikidata; Q107115981
RX   PubMed=11420143;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MANDAG4-4G1
AC   CVCL_A6PQ
SY   MANDAG4(4G1); MANDAG4; 4G1
DR   Wikidata; Q107115984
RX   PubMed=11420143;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MANDM1-6G8
AC   CVCL_C2AT
SY   MANDM1(6G8); MANDM1; 6G8
DR   DSHB; MANDM1-6G8
DR   Wikidata; Q114311919
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK (Note=Also reacts with mouse and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM10-2H12
AC   CVCL_C2B2
SY   MANDM10(2H12); MANDM10; 2H12
DR   DSHB; MANDM10-2H12
DR   Wikidata; Q114311920
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM11-6B6
AC   CVCL_C2B3
SY   MANDM11(6B6); MANDM11; 6B6
DR   DSHB; MANDM11-6B6
DR   Wikidata; Q114311921
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM12-7E4G2
AC   CVCL_C2B4
SY   MANDM12(7E4G2); MANDM12; 7E4G2
DR   DSHB; MANDM12-7E4G2
DR   Wikidata; Q114311922
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM13-12A4
AC   CVCL_C2B5
SY   MANDM13(12A4); MANDM13; 12A4
DR   DSHB; MANDM13-12A4
DR   Wikidata; Q114311923
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM14-7E6
AC   CVCL_C2B6
SY   MANDM14(7E6); MANDM14; 7E6
DR   DSHB; MANDM14-7E6
DR   Wikidata; Q114311924
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM15-5C9
AC   CVCL_C2B7
SY   MANDM15(5C9); MANDM15; 5C9
DR   DSHB; MANDM15-5C9
DR   Wikidata; Q114311925
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM16-9A4
AC   CVCL_C2B8
SY   MANDM16(9A4); MANDM16; 9A4
DR   DSHB; MANDM16-9A4
DR   Wikidata; Q114311926
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM2-10A7
AC   CVCL_C2AU
SY   MANDM2(10A7); MANDM2; 10A7
DR   DSHB; MANDM2-10A7
DR   Wikidata; Q114311927
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM3-8B5
AC   CVCL_C2AV
SY   MANDM3(8B5); MANDM3; 8B5
DR   DSHB; MANDM3-8B5
DR   Wikidata; Q114311928
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM4-9H9
AC   CVCL_C2AW
SY   MANDM4(9H9); MANDM4; 9H9
DR   DSHB; MANDM4-9H9
DR   Wikidata; Q114311929
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM5-5G12
AC   CVCL_C2AX
SY   MANDM5(5G12); MANDM5; 5G12
DR   DSHB; MANDM5-5G12
DR   Wikidata; Q114311930
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM6-7E4B7
AC   CVCL_C2AY
SY   MANDM6(7E4B7); MANDM6; 7E4B7
DR   DSHB; MANDM6-7E4B7
DR   Wikidata; Q114311931
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM7-12G5
AC   CVCL_C2AZ
SY   MANDM7(12G5); MANDM7; 12G5
DR   DSHB; MANDM7-12G5
DR   Wikidata; Q114311932
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM8-7E7
AC   CVCL_C2B0
SY   MANDM8(7E7); MANDM8; 7E7
DR   DSHB; MANDM8-7E7
DR   Wikidata; Q114311933
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDM9-3D10
AC   CVCL_C2B1
SY   MANDM9(3D10); MANDM9; 3D10
DR   DSHB; MANDM9-3D10
DR   Wikidata; Q114311934
RX   PubMed=9811941;
RX   PubMed=10958655;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09013; Human DMPK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDOP21-3B9
AC   CVCL_C2B9
SY   MANDOP 21; 3B9
DR   Wikidata; Q114311935
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14416; Human DRD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDOP22-3D9
AC   CVCL_C2BA
SY   MANDOP 22; 3D9
DR   Wikidata; Q114311936
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P14416; Human DRD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDOP31-1D7
AC   CVCL_C2BB
SY   MANDOP 31; 1D7
DR   Wikidata; Q114311937
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35462; Human DRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDOP32-3F1
AC   CVCL_C2BC
SY   MANDOP 32; 3F1
DR   Wikidata; Q114311938
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35462; Human DRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDOP33-3B7
AC   CVCL_C2BD
SY   MANDOP 33; 3B7
DR   Wikidata; Q114311939
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35462; Human DRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDOP34-4D10
AC   CVCL_C2BE
SY   MANDOP 34; 4D10
DR   Wikidata; Q114311940
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35462; Human DRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDOP35-9F4
AC   CVCL_C2BF
SY   MANDOP 35; 9F4
DR   Wikidata; Q114311941
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35462; Human DRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDOP41-2B9
AC   CVCL_C2BG
SY   MANDOP 41; 2B9
DR   Wikidata; Q114311942
RX   PubMed=17593530;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P21917; Human DRD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA1-7A10
AC   CVCL_C2FY
SY   MANDRA1(7A10); MANDRA1; 7A10
DR   DSHB; MANDRA1-7A10
DR   Wikidata; Q114311943
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse, fish and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA10-8E8
AC   CVCL_C2G7
SY   MANDRA10(8E8); MANDRA10; 8E8
DR   Wikidata; Q114311944
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA11-8B11
AC   CVCL_C2G8
SY   MANDRA11(8B11); MANDRA11; 8B11
DR   DSHB; MANDRA11-8B11
DR   Wikidata; Q114311945
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA12-5C5
AC   CVCL_C2G9
SY   MANDRA12(5C5); MANDRA12; 5C5
DR   Wikidata; Q114311946
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA13-7E4
AC   CVCL_C2GA
SY   MANDRA13(7E4); MANDRA13; 7E4
DR   DSHB; MANDRA13-7E4
DR   Wikidata; Q114311947
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA14-2F2
AC   CVCL_C2GB
SY   MANDRA14(2F2); MANDRA14; 2F2
DR   DSHB; MANDRA14-2F2
DR   Wikidata; Q114311948
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA15-3G11
AC   CVCL_C2GC
SY   MANDRA15(3G11); MANDRA15; 3G11
DR   DSHB; MANDRA15-3G11
DR   Wikidata; Q114311949
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse, fish and Xenopus).
CC   Caution: Indicated as producing an IgG2b mAb in PubMed=1281410 and an IgG2a mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA16-4B11
AC   CVCL_C2GD
SY   MANDRA16(4B11); MANDRA16; 4B11
DR   Wikidata; Q114311950
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and fish).
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA17-5C3
AC   CVCL_C2GE
SY   MANDRA17(5C3); MANDRA17; 5C3
DR   DSHB; MANDRA17-5C3
DR   Wikidata; Q114311951
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA18-7H7
AC   CVCL_C2GF
SY   MANDRA18(7H7); MANDRA18; 7H7
DR   DSHB; MANDRA18-7H7
DR   Wikidata; Q114311952
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA19-5G6
AC   CVCL_C2GG
SY   MANDRA19(5G6); MANDRA19; 5G6
DR   Wikidata; Q114311953
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA2-7G12
AC   CVCL_C2FZ
SY   MANDRA2(7G12); MANDRA2; 7G12
DR   DSHB; MANDRA2-7G12
DR   Wikidata; Q114311954
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA3-3F4
AC   CVCL_C2G0
SY   MANDRA3(3F4); MANDRA3; 3F4
DR   Wikidata; Q114311955
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and fish).
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA4-5H7
AC   CVCL_C2G1
SY   MANDRA4(5H7); MANDRA4; 5H7
DR   DSHB; MANDRA4-5H7
DR   Wikidata; Q114311956
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA5-2E2
AC   CVCL_C2G2
SY   MANDRA5(2E2); MANDRA5; 2E2
DR   Wikidata; Q114311957
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA6-8D11
AC   CVCL_C2G3
SY   MANDRA6(8D11); MANDRA6; 8D11
DR   Wikidata; Q114311958
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA7-5A8
AC   CVCL_C2G4
SY   MANDRA7(5A8); MANDRA7; 5A8
DR   DSHB; MANDRA7-5A8
DR   Wikidata; Q114311959
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and fish).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDRA8-6H6
AC   CVCL_C2G5
SY   MANDRA8(6H6); MANDRA8; 6H6
DR   Wikidata; Q114311960
RX   PubMed=1281410;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDRA9-4A2
AC   CVCL_C2G6
SY   MANDRA9(4A2); MANDRA9; 4A2
DR   Wikidata; Q114311961
RX   PubMed=1281410;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS1-3B7
AC   CVCL_A6PB
SY   MANDYS1(3B7); MANDYS1; 3B7
DR   DSHB; MANDYS1-3B7
DR   Wikidata; Q107115986
RX   PubMed=1692289;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse, pig and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANDYS10-2E10
AC   CVCL_A6PC
SY   MANDYS10(2E10); MANDYS10; 2E10
DR   DSHB; MANDYS10-2E10
DR   Wikidata; Q107115987
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANDYS101-7D12
AC   CVCL_C2GR
SY   MANDYS101(7D12); MANDYS101; 7D12
DR   DSHB; MANDYS101-7D12
DR   Wikidata; Q114311962
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS102-7D2
AC   CVCL_C2GS
SY   MANDYS102(7D2); MANDYS102; 7D2
DR   DSHB; MANDYS102-7D2
DR   Wikidata; Q114311963
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
CC   Caution: Indicated as producing an IgG2a mAb in PubMed=1281410 and an IgG1 mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS103-8E11
AC   CVCL_C2GT
SY   MANDYS103(8E11); MANDYS103; 8E11
DR   DSHB; MANDYS103-8E11
DR   Wikidata; Q114311964
RX   PubMed=1281410;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS104-7F7
AC   CVCL_C2GU
SY   MANDYS104(7F7); MANDYS104; 7F7
DR   DSHB; MANDYS104-7F7
DR   Wikidata; Q114311965
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS105-8A4
AC   CVCL_C2GV
SY   MANDYS105(8A4); MANDYS105; 8A4
DR   DSHB; MANDYS105-8A4
DR   Wikidata; Q114311966
RX   PubMed=1281410;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse, chicken and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS106-2C6
AC   CVCL_C2GW
SY   MANDYS106(2C6); MANDYS106; 2C6
DR   DSHB; MANDYS106-2C6
DR   Wikidata; Q114311967
RX   PubMed=1281410;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS107-4H8
AC   CVCL_C2GX
SY   MANDYS107(4H8); MANDYS107; 4H8
DR   DSHB; MANDYS107-4H8
DR   Wikidata; Q114311968
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS108-4D8
AC   CVCL_C2GY
SY   MANDYS108(4D8); MANDYS108; 4D8
DR   DSHB; MANDYS108-4D8
DR   Wikidata; Q114311969
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS109-2H5
AC   CVCL_C2GZ
SY   MANDYS109(2H5); MANDYS109; 2H5
DR   DSHB; MANDYS109-2H5
DR   Wikidata; Q114311970
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS11-1D6
AC   CVCL_C2HP
SY   MANDYS11(1D6); MANDYS11; 1D6
DR   Wikidata; Q114311971
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS110-3H10
AC   CVCL_C2H0
SY   MANDYS110(3H10); MANDYS110; 3H10
DR   DSHB; MANDYS110-3H10
DR   Wikidata; Q114311972
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS111-4F12
AC   CVCL_C2H1
SY   MANDYS111(4F12); MANDYS111; 4F12
DR   Wikidata; Q114311973
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS12-3E1
AC   CVCL_C2HQ
SY   MANDYS12(3E1); MANDYS12; 3E1
DR   DSHB; MANDYS12-3E1
DR   Wikidata; Q114311974
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS121-8C9
AC   CVCL_C2H2
SY   MANDYS121(8C9); MANDYS121; 8C9
DR   DSHB; MANDYS121-8C9
DR   Wikidata; Q114311975
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse, chicken, fish and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS122-8D11
AC   CVCL_C2H3
SY   MANDYS122(8D11); MANDYS122; 8D11
DR   DSHB; MANDYS122-8D11
DR   Wikidata; Q114311977
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS123-4C3
AC   CVCL_C2H4
SY   MANDYS123(4C3); MANDYS123; 4C3
DR   Wikidata; Q114311978
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS124-3H7
AC   CVCL_C2H5
SY   MANDYS124(3H7); MANDYS124; 3H7
DR   DSHB; MANDYS124-3H7
DR   Wikidata; Q114311979
RX   PubMed=1281410;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS125-4F6
AC   CVCL_C2H6
SY   MANDYS125(4F6); MANDYS125; 4F6
DR   DSHB; MANDYS125-4F6
DR   Wikidata; Q114311980
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse, chicken and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS126-3E5C9
AC   CVCL_C2H7
SY   MANDYS126(3E5C9); MANDYS126; 3E5C9
DR   DSHB; MANDYS126-3E5C9
DR   Wikidata; Q114311981
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS127-2G2
AC   CVCL_C2H8
SY   MANDYS127(2G2); MANDYS127; 2G2
DR   Wikidata; Q114311984
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS128-3D5
AC   CVCL_C2H9
SY   MANDYS128(3D5); MANDYS128; 3D5
DR   Wikidata; Q114311985
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS129-3H4
AC   CVCL_C2HA
SY   MANDYS129(3H4); MANDYS129; 3H4
DR   DSHB; MANDYS129-3H4
DR   Wikidata; Q114311986
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS13-6G1
AC   CVCL_C2HR
SY   MANDYS13(6G1); MANDYS13; 6G1
DR   DSHB; MANDYS13-6G1
DR   Wikidata; Q114311987
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS130-2H2
AC   CVCL_C2HB
SY   MANDYS130(2H2); MANDYS130; 2H2
DR   DSHB; MANDYS130-2H2
DR   Wikidata; Q114311988
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS131-3D6
AC   CVCL_C2HC
SY   MANDYS131(3D6); MANDYS131; 3D6
DR   Wikidata; Q114311989
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS14-5E1
AC   CVCL_C2HS
SY   MANDYS14(5E1); MANDYS14; 5E1
DR   Wikidata; Q114311990
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS141-4A12
AC   CVCL_C2HD
SY   MANDYS141(4A12); MANDYS141; 4A12
DR   DSHB; MANDYS141-4A12
DR   Wikidata; Q114311991
RX   PubMed=1281410;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS142-6D4
AC   CVCL_C2HE
SY   MANDYS142(6D4); MANDYS142; 6D4
DR   DSHB; MANDYS142-6D4
DR   Wikidata; Q114311994
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS143-1A11D2
AC   CVCL_C2HF
SY   MANDYS143(1A11D2); MANDYS143; 1A11D2
DR   Wikidata; Q114311996
RX   PubMed=1281410;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS15-6B11
AC   CVCL_C2HT
SY   MANDYS15(6B11); MANDYS15; 6B11
DR   DSHB; MANDYS15-6B11
DR   Wikidata; Q114311998
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS16-1B12
AC   CVCL_C2HU
SY   MANDYS16(1B12); MANDYS16; 1B12
DR   DSHB; MANDYS16-1B12
DR   Wikidata; Q114312002
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS17-3B12
AC   CVCL_C2HV
SY   MANDYS17(3B12); MANDYS17; 3B12
DR   DSHB; MANDYS17-3B12
DR   Wikidata; Q114312004
RX   PubMed=1692289;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS18-5H9
AC   CVCL_C2HW
SY   MANDYS18(5H9); MANDYS18; 5H9
DR   DSHB; MANDYS18-5H9
DR   Wikidata; Q114312006
RX   PubMed=1692289;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS19-8F6
AC   CVCL_C2HX
SY   MANDYS19(8F6); MANDYS19; 8F6
DR   DSHB; MANDYS19-8F6
DR   Wikidata; Q114312012
RX   PubMed=1692289;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS2-5G4
AC   CVCL_C2HH
SY   MANDYS2(5G4); MANDYS2; 5G4
DR   Wikidata; Q114312014
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS3-6A9
AC   CVCL_A6PI
SY   MANDYS3(6A9); MANDYS3; 6A9
DR   Wikidata; Q107115989
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANDYS4-8H4
AC   CVCL_C2HI
SY   MANDYS4(8H4); MANDYS4; 8H4
DR   Wikidata; Q114312017
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS5-7F10
AC   CVCL_C2HJ
SY   MANDYS5(7F10); MANDYS5; 7F10
DR   Wikidata; Q114312019
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS6-7H7
AC   CVCL_C2HK
SY   MANDYS6(7H7); MANDYS6; 7H7
DR   Wikidata; Q114312023
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANDYS7-8D2
AC   CVCL_C2HL
SY   MANDYS7(8D2); MANDYS7; 8D2
DR   DSHB; MANDYS7-8D2
DR   Wikidata; Q114312025
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS8-8H11
AC   CVCL_C2HM
SY   MANDYS8(8H11); MANDYS8; 8H11
DR   DSHB; MANDYS8-8H11
DR   Wikidata; Q114312028
RX   PubMed=1692289;
RX   PubMed=7684887;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANDYS9-4G10
AC   CVCL_C2HN
SY   MANDYS9(4G10); MANDYS9; 4G10
DR   Wikidata; Q114312032
RX   PubMed=1692289;
RX   PubMed=7684887;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEM1-5D10
AC   CVCL_C2BH
SY   MANEM1(5D10); MANEM1; 5D10
DR   DSHB; MANEM1-5D10
DR   Wikidata; Q114312035
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM10-1H9
AC   CVCL_C2BI
SY   MANEM10(1H9); MANEM10; 1H9
DR   DSHB; MANEM10-1H9
DR   Wikidata; Q114312036
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM11-7D9
AC   CVCL_C2BJ
SY   MANEM11(7D9); MANEM11; 7D9
DR   DSHB; MANEM11-7D9
DR   Wikidata; Q114312037
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM12-5B11
AC   CVCL_C2BK
SY   MANEM12(5B11); MANEM12; 5B11
DR   DSHB; MANEM12-5B11
DR   Wikidata; Q114312038
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM13-2D6
AC   CVCL_C2BL
SY   MANEM13(2D6); MANEM13; 2D6
DR   DSHB; MANEM13-2D6
DR   Wikidata; Q114312039
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM14-3C3
AC   CVCL_C2BM
SY   MANEM14(3C3); MANEM14; 3C3
DR   DSHB; MANEM14-3C3
DR   Wikidata; Q114312040
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM15-8E1
AC   CVCL_C2BN
SY   MANEM15(8E1); MANEM15; 8E1
DR   DSHB; MANEM15-8E1
DR   Wikidata; Q114312041
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM16-7A6
AC   CVCL_C2BP
SY   MANEM16(7A6); MANEM16; 7A6
DR   DSHB; MANEM16-7A6
DR   Wikidata; Q114312042
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM2-9B2
AC   CVCL_C2BQ
SY   MANEM2(9B2); MANEM2; 9B2
DR   DSHB; MANEM2-9B2
DR   Wikidata; Q114312043
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM3-6D2
AC   CVCL_C2BR
SY   MANEM3(6D2); MANEM3; 6D2
DR   DSHB; MANEM3-6D2
DR   Wikidata; Q114312044
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM4-6C4
AC   CVCL_C2BS
SY   MANEM4(6C4); MANEM4; 6C4
DR   DSHB; MANEM4-6C4
DR   Wikidata; Q114312046
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM5-8A1
AC   CVCL_C2BT
SY   MANEM5(8A1); MANEM5; 8A1
DR   DSHB; MANEM5-8A1
DR   Wikidata; Q114312047
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM6-8E9
AC   CVCL_C2BU
SY   MANEM6(8E9); MANEM6; 8E9
DR   DSHB; MANEM6-8E9
DR   Wikidata; Q114312048
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM7-7A9
AC   CVCL_C2BV
SY   MANEM7(7A9); MANEM7; 7A9
DR   DSHB; MANEM7-7A9
DR   Wikidata; Q114312049
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM8-7B9
AC   CVCL_C2BW
SY   MANEM8(7B9); MANEM8; 7B9
DR   DSHB; MANEM8-7B9
DR   Wikidata; Q114312051
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEM9-9F8
AC   CVCL_C2BX
SY   MANEM9(9F8); MANEM9; 9F8
DR   DSHB; MANEM9-9F8
DR   Wikidata; Q114312052
RX   PubMed=8776595;
RX   PubMed=9949197;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50402; Human EMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX1011A-8A12
AC   CVCL_C2GH
SY   MANEX1011A(8A12); MANEX1011A; 8A12
DR   Wikidata; Q114312054
RX   PubMed=10835598;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX1011B-1C7
AC   CVCL_C2GI
SY   MANEX1011B(1C7); MANEX1011B; 1C7
DR   DSHB; MANEX1011B-1C7
DR   Wikidata; Q114312056
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX1011C-4F9
AC   CVCL_C2GJ
SY   MANEX1011C(4F9); MANEX1011C; 4F9
DR   DSHB; MANEX1011C-4F9
DR   Wikidata; Q114312057
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX1011D-7G5
AC   CVCL_C2GK
SY   MANEX1011D(7G5); MANEX1011D; 7G5
DR   Wikidata; Q114312059
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX1011E-8H7
AC   CVCL_C2GL
SY   MANEX1011E(8H7); MANEX1011E; 8H7
DR   Wikidata; Q114312060
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX1216A-5A4
AC   CVCL_C2GM
SY   MANEX1216A(5A4); MANEX1216A; 5A4
DR   DSHB; MANEX1216A-5A4
DR   Wikidata; Q114312061
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX1216B-6B11
AC   CVCL_C2GN
SY   MANEX1216B(6B11); MANEX1216B; 6B11
DR   Wikidata; Q114312062
RX   PubMed=10835598;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX1216C-8C8
AC   CVCL_C2GP
SY   MANEX1216C(8C8); MANEX1216C; 8C8
DR   Wikidata; Q114312063
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX1216D-8D11
AC   CVCL_C2GQ
SY   MANEX1216D(8D11); MANEX1216D; 8D11
DR   DSHB; MANEX1216D-8D11
DR   Wikidata; Q114312064
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
CC   Caution: Indicated as producing an IgG1 mAb in PubMed=10835598 and an IgG2a mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX1216E-2G10
AC   CVCL_C2HG
SY   MANEX1216E(2G10); MANEX1216E; 2G10
DR   DSHB; MANEX1216E-2G10
DR   Wikidata; Q114312065
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX1A-4C7
AC   CVCL_A6NZ
SY   MANEX1A(4C7); MANEX1A; 4C7
DR   DSHB; MANEX1A-4C7
DR   Wikidata; Q107115991
RX   PubMed=8317478;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANEX1B-1D6
AC   CVCL_A6PA
SY   MANEX1B(1D6); MANEX1B; 1D6
DR   Wikidata; Q107115993
RX   PubMed=8317478;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANEX44A-5B2
AC   CVCL_C2HY
SY   MANEX44A(5B2); MANEX44A; 5B2
DR   DSHB; MANEX44A-5B2
DR   Wikidata; Q114312066
RX   CelloPub=CLPUB00719;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
CC   Caution: Indicated as producing an IgG2b mAb in glennmorris.org.uk and an IgG1 mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX44B-10G5
AC   CVCL_C2HZ
SY   MANEX44B(10G5); MANEX44B; 10G5
DR   DSHB; MANEX44B-10G5
DR   Wikidata; Q114312067
RX   CelloPub=CLPUB00719;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX45A-8F10
AC   CVCL_C2I0
SY   MANEX45A(8F10); MANEX45A; 8F10
DR   DSHB; MANEX45A-8F10
DR   Wikidata; Q114312068
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX45B-7F8
AC   CVCL_C2I1
SY   MANEX45B(7F8); MANEX45B; 7F8
DR   Wikidata; Q114312069
RX   PubMed=8533812;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX46A-6A6
AC   CVCL_C2I2
SY   MANEX46A(6A6); MANEX46A; 6A6
DR   DSHB; MANEX46A-6A6
DR   Wikidata; Q114312070
RX   PubMed=8533812;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX46B-7G1
AC   CVCL_C2I3
SY   MANEX46B(7G1); MANEX46B; 7G1
DR   DSHB; MANEX46B-7G1
DR   Wikidata; Q114312071
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX46C-3H12
AC   CVCL_C2I4
SY   MANEX46C(3H12); MANEX46C; 3H12
DR   Wikidata; Q114312072
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX46D-8F2
AC   CVCL_C2I5
SY   MANEX46D(8F2); MANEX46D; 8F2
DR   Wikidata; Q114312073
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX46E-8G10
AC   CVCL_C2I6
SY   MANEX46E(8G10); MANEX46E; 8G10
DR   Wikidata; Q114312074
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX46F-6G1
AC   CVCL_C2I7
SY   MANEX46F(6G1); MANEX46F; 6G1
DR   Wikidata; Q114312075
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX47-8B12
AC   CVCL_C2I8
SY   MANEX47(8B12); MANEX47; 8B12
DR   DSHB; MANEX47-8B12
DR   Wikidata; Q114312076
RX   PubMed=8533812;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX4748A-8C1
AC   CVCL_C2I9
SY   MANEX4748A(8C1); MANEX4748A; 8C1
DR   DSHB; MANEX4748A-8C1
DR   Wikidata; Q114312077
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX4748B-8E6
AC   CVCL_C2IA
SY   MANEX4748B(8E6); MANEX4748B; 8E6
DR   DSHB; MANEX4748B-8E6
DR   Wikidata; Q114312078
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX4748C-5G11
AC   CVCL_C2IB
SY   MANEX4748C(5G11); MANEX4748C; 5G11
DR   Wikidata; Q114312079
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX4748D-7A5
AC   CVCL_C2IC
SY   MANEX4748D(7A5); MANEX4748D; 7A5
DR   Wikidata; Q114312082
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX4850A-5E3
AC   CVCL_C2ID
SY   MANEX4850A(5E3); MANEX4850A; 5E3
DR   Wikidata; Q114312085
RX   PubMed=8533812;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX4850B-6A7
AC   CVCL_C2IE
SY   MANEX4850B(6A7); MANEX4850B; 6A7
DR   DSHB; MANEX4850B-6A7
DR   Wikidata; Q114312087
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX4850C-7B8
AC   CVCL_C2IF
SY   MANEX4850C(7B8); MANEX4850C; 7B8
DR   Wikidata; Q114312092
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX4850D-7A10
AC   CVCL_C2IG
SY   MANEX4850D(7A10); MANEX4850D; 7A10
DR   Wikidata; Q114312096
RX   PubMed=8533812;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX4850E-8C5
AC   CVCL_C2IH
SY   MANEX4850E(8C5); MANEX4850E; 8C5
DR   Wikidata; Q114312100
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX4850F-5G2
AC   CVCL_C2II
SY   MANEX4850F(5G2); MANEX4850F; 5G2
DR   Wikidata; Q114312103
RX   PubMed=8533812;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANEX50-6A9
AC   CVCL_C2IJ
SY   MANEX50(6A9); MANEX50; 6A9
DR   DSHB; MANEX50-6A9
DR   Wikidata; Q114312107
RX   PubMed=8533812;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX5556A-2F8
AC   CVCL_C2IK
SY   MANEX5556A(2F8); MANEX5556A; 2F8
DR   DSHB; MANEX5556A-2F8
DR   Wikidata; Q114312109
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX5556B-2G12
AC   CVCL_C2IL
SY   MANEX5556B(2G12); MANEX5556B; 2G12
DR   DSHB; MANEX5556B-2G12
DR   Wikidata; Q114312110
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX58A-2D9
AC   CVCL_C2IM
SY   MANEX58A(2D9); MANEX58A; 2D9
DR   DSHB; MANEX58A-2D9
DR   Wikidata; Q114312111
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX58B-1A5
AC   CVCL_C2IN
SY   MANEX58B(1A5); MANEX58B; 1A5
DR   DSHB; MANEX58B-1A5
DR   Wikidata; Q114312112
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX58C-2D4
AC   CVCL_C2IP
SY   MANEX58C(2D4); MANEX58C; 2D4
DR   DSHB; MANEX58C-2D4
DR   Wikidata; Q114312113
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX58D-7G2
AC   CVCL_C2IQ
SY   MANEX58D(7G2); MANEX58D; 7G2
DR   DSHB; MANEX58D-7G2
DR   Wikidata; Q114312114
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX59A-3H9
AC   CVCL_C2IR
SY   MANEX59A(3H9); MANEX59A; 3H9
DR   DSHB; MANEX59A-3H9
DR   Wikidata; Q114312115
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX59B-4E10
AC   CVCL_C2IS
SY   MANEX59B(4E10); MANEX59B; 4E10
DR   DSHB; MANEX59B-4E10
DR   Wikidata; Q114312117
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX59C-1H5
AC   CVCL_C2IT
SY   MANEX59C(1H5); MANEX59C; 1H5
DR   DSHB; MANEX59C-1H5
DR   Wikidata; Q114312118
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX59D-1G8
AC   CVCL_C2IU
SY   MANEX59D(1G8); MANEX59D; 1G8
DR   DSHB; MANEX59D-1G8
DR   Wikidata; Q114312119
RX   DOI=10.2478/v10134-010-0034-7;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX6-4H4
AC   CVCL_A6PJ
SY   MANEX6(4H4); MANEX6; 4H4
DR   Wikidata; Q107115995
RX   PubMed=10835598;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374A-10A11
AC   CVCL_C2IV
SY   MANEX7374A(10A11); MANEX7374A; 10A11
DR   DSHB; MANEX7374A-10A11
DR   Wikidata; Q114312120
RX   PubMed=7575614;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374B-8G2
AC   CVCL_C2IW
SY   MANEX7374B(8G2); MANEX7374B; 8G2
DR   DSHB; MANEX7374B-8G2
DR   Wikidata; Q114312121
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374C-7F2
AC   CVCL_C2IX
SY   MANEX7374C(7F2); MANEX7374C; 7F2
DR   DSHB; MANEX7374C-7F2
DR   Wikidata; Q114312122
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374D-4G10
AC   CVCL_C2IY
SY   MANEX7374D(4G10); MANEX7374D; 4G10
DR   DSHB; MANEX7374D-4G10
DR   Wikidata; Q114312123
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374E-3D8
AC   CVCL_C2IZ
SY   MANEX7374E(3D8); MANEX7374E; 3D8
DR   DSHB; MANEX7374E-3D8
DR   Wikidata; Q114312124
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374F-8E10
AC   CVCL_C2J0
SY   MANEX7374F(8E10); MANEX7374F; 8E10
DR   DSHB; MANEX7374F-8E10
DR   Wikidata; Q114312125
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374G-8B4
AC   CVCL_C2J1
SY   MANEX7374G(8B4); MANEX7374G; 8B4
DR   DSHB; MANEX7374G-8B4
DR   Wikidata; Q114312126
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374H-8G1
AC   CVCL_C2J2
SY   MANEX7374H(8G1); MANEX7374H; 8G1
DR   DSHB; MANEX7374H-8G1
DR   Wikidata; Q114312127
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374I-6D5
AC   CVCL_C2J3
SY   MANEX7374I(6D5); MANEX7374I; 6D5
DR   DSHB; MANEX7374I-6D5
DR   Wikidata; Q114312128
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374J-8F10
AC   CVCL_C2J4
SY   MANEX7374J(8F10); MANEX7374J; 8F10
DR   DSHB; MANEX7374J-8F10
DR   Wikidata; Q114312129
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374K-9A1
AC   CVCL_C2J5
SY   MANEX7374K(9A1); MANEX7374K; 9A1
DR   DSHB; MANEX7374K-9A1
DR   Wikidata; Q114312130
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374L-7H9
AC   CVCL_C2J6
SY   MANEX7374L(7H9); MANEX7374L; 7H9
DR   DSHB; MANEX7374L-7H9
DR   Wikidata; Q114312131
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374M-7E10
AC   CVCL_C2J7
SY   MANEX7374M(7E10); MANEX7374M; 7E10
DR   DSHB; MANEX7374M-7E10
DR   Wikidata; Q114312132
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374N-10C4
AC   CVCL_C2J8
SY   MANEX7374N(10C4); MANEX7374N; 10C4
DR   DSHB; MANEX7374N-10C4
DR   Wikidata; Q114312133
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374O-9H8
AC   CVCL_C2J9
SY   MANEX7374O(9H8); MANEX7374O; 9H8
DR   DSHB; MANEX7374O-9H8
DR   Wikidata; Q114312134
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374P-7E11
AC   CVCL_C2JA
SY   MANEX7374P(7E11); MANEX7374P; 7E11
DR   DSHB; MANEX7374P-7E11
DR   Wikidata; Q114312135
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374Q-10B12
AC   CVCL_C2JB
SY   MANEX7374Q(10B12); MANEX7374Q; 10B12
DR   DSHB; MANEX7374Q-10B12
DR   Wikidata; Q114312136
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374R-8A12
AC   CVCL_C2JC
SY   MANEX7374R(8A12); MANEX7374R; 8A12
DR   DSHB; MANEX7374R-8A12
DR   Wikidata; Q114312137
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
CC   Caution: Indicated as producing an IgG1 mAb in PubMed=7575614 and an IgG2b mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374S-10A6
AC   CVCL_C2JD
SY   MANEX7374S(10A6); MANEX7374S; 10A6
DR   DSHB; MANEX7374S-10A6
DR   Wikidata; Q114312138
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374T-9A7
AC   CVCL_C2JE
SY   MANEX7374T(9A7); MANEX7374T; 9A7
DR   DSHB; MANEX7374T-9A7
DR   Wikidata; Q114312139
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7374U-9F5
AC   CVCL_C2JF
SY   MANEX7374U(9F5); MANEX7374U; 9F5
DR   DSHB; MANEX7374U-9F5
DR   Wikidata; Q114312140
RX   PubMed=7575614;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANEX7B-8E11
AC   CVCL_A6PK
SY   MANEX7B(8E11); MANEX7B; 8E11
DR   DSHB; MANEX7B-8E11
DR   Wikidata; Q107115997
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANEX7C-6F7
AC   CVCL_A6PL
SY   MANEX7B(6F7); MANEX7C; 6F7
DR   Wikidata; Q107115998
RX   PubMed=10835598;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANFU1-7A2
AC   CVCL_A6MK
SY   MANFU1(7A2); MANFU1; 7A2
DR   DSHB; MANFU1-7A2
DR   Wikidata; Q107116001
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU10-5H10
AC   CVCL_A6MU
SY   MANFU10(5H10); MANFU10; 5H10
DR   DSHB; MANFU10-5H10
DR   Wikidata; Q107116003
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU11-3E4
AC   CVCL_A6MV
SY   MANFU11(3E4); MANFU11; 3E4
DR   DSHB; MANFU11-3E4
DR   Wikidata; Q107116006
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU12-6B5
AC   CVCL_A6MW
SY   MANFU12(6B5); MANFU12; 6B5
DR   DSHB; MANFU12-6B5
DR   Wikidata; Q107116009
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU2-10F9
AC   CVCL_A6ML
SY   MANFU2(10F9); MANFU2; 10F9
DR   DSHB; MANFU2-10F9
DR   Wikidata; Q107116012
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU3-4E6
AC   CVCL_A6MM
SY   MANFU3(4E6); MANFU3; 4E6
DR   DSHB; MANFU3-4E6
DR   Wikidata; Q107116016
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU4-3C7
AC   CVCL_A6MN
SY   MANFU4(3C7); MANFU4; 3C7
DR   DSHB; MANFU4-3C7
DR   Wikidata; Q107116018
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU5-7H2
AC   CVCL_A6MP
SY   MANFU5(7H2); MANFU5; 7H2
DR   DSHB; MANFU5-7H2
DR   Wikidata; Q107116023
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU6-4H8
AC   CVCL_A6MQ
SY   MANFU6(4H8); MANFU6; 4H8
DR   Wikidata; Q107116024
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANFU7-1B5
AC   CVCL_A6MR
SY   MANFU7(1B5); MANFU7; 1B5
DR   DSHB; MANFU7-1B5
DR   Wikidata; Q107116027
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU8-2F5
AC   CVCL_A6MS
SY   MANFU8(2F5); MANFU8; 2F5
DR   DSHB; MANFU8-2F5
DR   Wikidata; Q107116029
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANFU9-4E12
AC   CVCL_A6MT
SY   MANFU9(4E12); MANFU9; 4E12
DR   DSHB; MANFU9-4E12
DR   Wikidata; Q107116030
RX   PubMed=22771323;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Huntingtin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75072; Human FKTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE1A-6F11
AC   CVCL_A6PS
SY   MANHINGE1A(6F11); MANHINGE1A; 6F11
DR   DSHB; MANHINGE1A-6F11
DR   Wikidata; Q107116032
RX   PubMed=9766029;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE1B-10F9
AC   CVCL_A6PT
SY   MANHINGE1B(10F9); MANHINGE1B; 10F9
DR   DSHB; MANHINGE1B-clone-10F9
DR   Wikidata; Q107116034
RX   PubMed=9766029;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE1C-5D12
AC   CVCL_A6PU
SY   MANHINGE1C(5D12); MANHINGE1C; 5D12
DR   DSHB; MANHINGE1C-5D12
DR   Wikidata; Q107116035
RX   PubMed=9766029;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE2A-8B11
AC   CVCL_A6PV
SY   MANHINGE2A(8B11); MANHINGE2A; 8B11
DR   DSHB; MANHINGE2A-8B11
DR   Wikidata; Q107116036
RX   PubMed=9766029;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE2B-9C11
AC   CVCL_A6PW
SY   MANHINGE2B(9C11); MANHINGE2B; 9C11
DR   DSHB; MANHINGE2B-clone-9C11
DR   Wikidata; Q107116037
RX   PubMed=9766029;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE2C-8D11
AC   CVCL_A6PX
SY   MANHINGE2B(8D11); MANHINGE2C; 8D11
DR   Wikidata; Q107116038
RX   PubMed=9766029;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANHINGE3A-6D6
AC   CVCL_A6PY
SY   MANHINGE3A(6D6); MANHINGE3A; 6D6
DR   DSHB; MANHINGE3A-6D6
DR   Wikidata; Q107116039
RX   PubMed=9766029;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE3B-12D2
AC   CVCL_A6PZ
SY   MANHINGE3B(12D2); MANHINGE3B; 12D2
DR   DSHB; MANHINGE3B-12D2
DR   Wikidata; Q107116041
RX   PubMed=9766029;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE3C-10E12
AC   CVCL_A6QA
SY   MANHINGE3C(10E12); MANHINGE3C; 10E12
DR   DSHB; MANHINGE3C-10E12
DR   Wikidata; Q107116043
RX   PubMed=9766029;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE4A-5C11
AC   CVCL_A6PR
SY   MANHINGE4A(5C11); MANHINGE4A; 5C11
DR   DSHB; MANHINGE4A-clone-5C11
DR   Wikidata; Q107116046
RX   PubMed=9766029;
RX   PubMed=11420143;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE4B-9B1
AC   CVCL_A6QB
SY   MANHINGE4B(9B1); MANHINGE4B; 9B1
DR   DSHB; MANHINGE4B-9B1
DR   Wikidata; Q107116048
RX   PubMed=9766029;
RX   PubMed=24516626;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANHINGE4C-10F2
AC   CVCL_A6QC
SY   MANHINGE4C(10F2); MANHINGE4C; 10F2
DR   DSHB; MANHINGE4C-10F2
DR   Wikidata; Q107116051
RX   PubMed=9766029;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11532; Human DMD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANIKA
AC   CVCL_E770
SY   MANIKAM
DR   dbMHC; 48966
DR   ECACC; 94122027
DR   IHW; IHW09106
DR   IPD-IMGT/HLA; 11640
DR   Wikidata; Q54904003
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=11782282;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Indian; Tamil.
CC   HLA typing: A*03:01:01:01; B*50:01:01:01; C*06:02:01:02; DPA1*01,02:01; DPB1*04:01:01,13:01:01/107:01; DQA1*02:01; DQB1*02:02:01,03:03:02; DRA*01:01; DRB1*07:01:01; DRB4*01:01 (IPD-IMGT/HLA=11640).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   MANLAC1-4A7
AC   CVCL_C2EX
SY   MANLAC1(4A7); MANLAC 1; MANLAC1; 4A7
DR   DSHB; MANLAC1-4A7
DR   Wikidata; Q114312141
RX   PubMed=15026149;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02545; Human LMNA (Note=Also reacts with hamster, mouse and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANLAC2-10F8
AC   CVCL_C2EY
SY   MANLAC2(10F8); MANLAC 2; MANLAC2; 10F8
DR   DSHB; MANLAC2-10F8
DR   Wikidata; Q114312142
RX   PubMed=15026149;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02545; Human LMNA (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANLAC3-4C10
AC   CVCL_C2EZ
SY   MANLAC3(4C10); MANLAC 3; MANLAC3; 4C10
DR   DSHB; MANLAC3-4C10
DR   Wikidata; Q114312143
RX   PubMed=15026149;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02545; Human LMNA (Note=Also reacts with mouse and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANLAC4-9G5
AC   CVCL_C2F0
SY   MANLAC4(9G5); MANLAC 4; MANLAC4; 9G5
DR   DSHB; MANLAC4-9G5
DR   Wikidata; Q114312144
RX   PubMed=15026149;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
WW   Provider; DSHB; -; https://web.archive.org/web/20200704142303/https://dshb.biology.uiowa.edu/MANLAC4-9G5
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02545; Human LMNA (Note=Also reacts with rabbit).
CC   Discontinued: DSHB; MANLAC4-9G5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANLAC5-7F12
AC   CVCL_C2F1
SY   MANLAC5(7F12); MANLAC 5; MANLAC5; 7F12
DR   DSHB; MANLAC5-7F12
DR   Wikidata; Q114312145
RX   PubMed=15026149;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02545; Human LMNA (Note=Also reacts with rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES1A-7A12
AC   CVCL_C2BY
SY   MANNES1A(7A12); MANNES1A; 7A12
DR   DSHB; MANNES1A-7A12
DR   Wikidata; Q114312146
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1 (Note=Also reacts with mouse, rat and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES1B-7B2
AC   CVCL_C2BZ
SY   MANNES1B(7B2); MANNES1B; 7B2
DR   DSHB; MANNES1B-7B2
DR   Wikidata; Q114312147
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES1C-6C10
AC   CVCL_C2C0
SY   MANNES1C(6C10); MANNES1C; 6C10
DR   DSHB; MANNES1C-6C10
DR   Wikidata; Q114312148
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1 (Note=Also reacts with mouse, rat and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES1D-8B8
AC   CVCL_C2C1
SY   MANNES1D(8B8); MANNES1D; 8B8
DR   DSHB; MANNES1D-8B8
DR   Wikidata; Q114312149
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES1E-8C3
AC   CVCL_C2C2
SY   MANNES1E(8C3); MANNES1E; 8C3
DR   DSHB; MANNES1E-8C3
DR   Wikidata; Q114312150
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES1F-9G10
AC   CVCL_C2C3
SY   MANNES1F(9G10); MANNES1F; 9G10
DR   Wikidata; Q114312151
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1 (Note=Also reacts with mouse, rat and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNES1G-6G2
AC   CVCL_C2C4
SY   MANNES1G(6G2); MANNES1G; 6G2
DR   Wikidata; Q114312152
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1 (Note=Also reacts with mouse, rat and rabbit).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNES2A-11A3
AC   CVCL_C2C5
SY   MANNES2A(11A3); MANNES2A; 11A3
DR   DSHB; MANNES2A-11A3
DR   Wikidata; Q114312153
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
CC   Caution: Indicated as producing an IgG1 mAb in PubMed=20108321 and an IgG2a mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2B-6A8
AC   CVCL_C2C6
SY   MANNES2B(6A8); MANNES2B; 6A8
DR   DSHB; MANNES2B-6A8
DR   Wikidata; Q114312154
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
CC   Caution: Indicated as producing an IgG2a mAb in PubMed=20108321 and an IgG1 mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2C-12A5
AC   CVCL_C2C7
SY   MANNES2C(12A5); MANNES2C; 12A5
DR   DSHB; MANNES2C-12A5
DR   Wikidata; Q114312155
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
CC   Caution: Indicated as producing an IgG1 mAb in PubMed=20108321 and an IgG2a mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2D-6H5
AC   CVCL_C2C8
SY   MANNES2D(6H5); MANNES2D; 6H5
DR   DSHB; MANNES2D-6H5
DR   Wikidata; Q114312156
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2E-18F7
AC   CVCL_C2C9
SY   MANNES2E(18F7); MANNES2E; 18F7
DR   DSHB; MANNES2E-18F7
DR   Wikidata; Q114312157
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2F-11C5
AC   CVCL_C2CA
SY   MANNES2F(11C5); MANNES2F; 11C5
DR   DSHB; MANNES2F-11C5
DR   Wikidata; Q114312158
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2G-4B5
AC   CVCL_C2CB
SY   MANNES2G(4B5); MANNES2G; 4B5
DR   DSHB; MANNES2G-4B5
DR   Wikidata; Q114312159
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2H-3C4
AC   CVCL_C2CC
SY   MANNES2H(3C4); MANNES2H; 3C4
DR   DSHB; MANNES2H-3C4
DR   Wikidata; Q114312160
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNES2I-4A11
AC   CVCL_C2CD
SY   MANNES2I(4A11); MANNES2I; 4A11
DR   Wikidata; Q114312161
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNES2J-3H4
AC   CVCL_C2CE
SY   MANNES2J(3H4); MANNES2J; 3H4
DR   Wikidata; Q114312162
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNES2K-1A11
AC   CVCL_C2CF
SY   MANNES2K(1A11); MANNES2K; 1A11
DR   Wikidata; Q114312163
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNES2L-17F5
AC   CVCL_C2CG
SY   MANNES2L(17F5); MANNES2L; 17F5
DR   Wikidata; Q114312165
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNES2M-16H2
AC   CVCL_C2CH
SY   MANNES2M(16H2); MANNES2M; 16H2
DR   Wikidata; Q114312167
RX   PubMed=20108321;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXH0; Human SYNE2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNUT1-3B6
AC   CVCL_C2FC
SY   MANNUT1(3B6); MANNUT1; 3B6
DR   DSHB; MANNUT1-3B6
DR   Wikidata; Q114312168
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT10-3C10
AC   CVCL_C2FL
SY   MANNUT10(3C10); MANNUT10; 3C10
DR   Wikidata; Q114312169
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNUT11-3B3
AC   CVCL_C2FM
SY   MANNUT11(3B3); MANNUT11; 3B3
DR   DSHB; MANNUT11-3B3
DR   Wikidata; Q114312170
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT12-4B12
AC   CVCL_C2FN
SY   MANNUT12(4B12); MANNUT12; 4B12
DR   DSHB; MANNUT12-4B12
DR   Wikidata; Q114312171
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT13-2A5
AC   CVCL_C2FP
SY   MANNUT13(2A5); MANNUT13; 2A5
DR   DSHB; MANNUT13-2A5
DR   Wikidata; Q114312172
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT14-8A3
AC   CVCL_C2FQ
SY   MANNUT14(8A3); MANNUT14; 8A3
DR   DSHB; MANNUT14-8A3
DR   Wikidata; Q114312173
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT15-5E10
AC   CVCL_C2FR
SY   MANNUT15(5E10); MANNUT15; 5E10
DR   DSHB; MANNUT15-5E10
DR   Wikidata; Q114312174
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT16-4H12
AC   CVCL_C2FS
SY   MANNUT16(4H12); MANNUT16; 4H12
DR   Wikidata; Q114312175
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
CC   Misspelling: 8H12; Note=In glennmorris.org.uk.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNUT17-6H7
AC   CVCL_C2FT
SY   MANNUT17(6H7); MANNUT17; 6H7
DR   Wikidata; Q114312176
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNUT18-7C7
AC   CVCL_C2FU
SY   MANNUT18(7C7); MANNUT18; 7C7
DR   Wikidata; Q114312177
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNUT19-8B5
AC   CVCL_C2FV
SY   MANNUT19(8B5); MANNUT19; 8B5
DR   Wikidata; Q114312178
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANNUT2-5C9
AC   CVCL_C2FD
SY   MANNUT2(5C9); MANNUT2; 5C9
DR   DSHB; MANNUT2-5C9
DR   Wikidata; Q114312179
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT3-4E3
AC   CVCL_C2FE
SY   MANNUT3(4E3); MANNUT3; 4E3
DR   DSHB; MANNUT3-4E3
DR   Wikidata; Q114312180
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT4-6H4
AC   CVCL_C2FF
SY   MANNUT4(6H4); MANNUT4; 6H4
DR   DSHB; MANNUT4-6H4
DR   Wikidata; Q114312181
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT5-8C11
AC   CVCL_C2FG
SY   MANNUT5(8C11); MANNUT5; 8C11
DR   DSHB; MANNUT5-8C11
DR   Wikidata; Q114312183
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT6-10D4
AC   CVCL_C2FH
SY   MANNUT6(10D4); MANNUT6; 10D4
DR   DSHB; MANNUT6-10D4
DR   Wikidata; Q114312184
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT7-6A10
AC   CVCL_C2FI
SY   MANNUT7(6A10); MANNUT7; 6A10
DR   DSHB; MANNUT7-6A10
DR   Wikidata; Q114312186
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT8-10A7
AC   CVCL_C2FJ
SY   MANNUT8(10A7); MANNUT8; 10A7
DR   DSHB; MANNUT8-10A7
DR   Wikidata; Q114312187
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANNUT9-7C11
AC   CVCL_C2FK
SY   MANNUT9(7C11); MANNUT9; 7C11
DR   DSHB; MANNUT9-7C11
DR   Wikidata; Q114312188
RX   PubMed=7843413;
RX   PubMed=9854033;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Dystrophin.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P46939; Human UTRN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   Mano
AC   CVCL_W901
SY   MANO
DR   Wikidata; Q54904004
RX   PubMed=892930;
RX   PubMed=6826254;
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 4
//
ID   MaNRAS1
AC   CVCL_B9UT
SY   1007
DR   Wikidata; Q112930068
RX   PubMed=31251472;
CC   Characteristics: Established from a tumor engrafted into 2-month-old C57BL/6 mice and collected after growth (PubMed=31251472).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Lys).
CC   Breed/subspecies: ((C57BL/6J x DBA/2) Tg(Tyr-NRAS*Q61K)1Bee transgenic x C57BL/6J) F2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   MaNRAS2
AC   CVCL_B9UU
SY   1014
DR   Wikidata; Q112930069
RX   PubMed=31251472;
CC   Characteristics: Established from a tumor engrafted into 2-month-old C57BL/6 mice and collected after growth (PubMed=31251472).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Lys).
CC   Breed/subspecies: ((C57BL/6J x DBA/2) Tg(Tyr-NRAS*Q61K)1Bee transgenic x C57BL/6J) F2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   MANSIP1A-1G9
AC   CVCL_C2CI
SY   MANSIP1A(1G9); MANSIP1A; 1G9
DR   DSHB; MANSIP1A-1G9
DR   Wikidata; Q114312189
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14893; Human GEMIN2 (Note=Also reacts with mouse and rabbit).
CC   Caution: Indicated as producing an IgG1 mAb in glennmorris.org.uk and an IgG2b mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSIP1B-3F8
AC   CVCL_C2CJ
SY   MANSIP1B(3F8); MANSIP1B; 3F8
DR   DSHB; MANSIP1B-3F8
DR   Wikidata; Q114312190
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14893; Human GEMIN2 (Note=Also reacts with mouse and rabbit).
CC   Caution: Indicated as producing an IgG1 mAb in glennmorris.org.uk and an IgG2b mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSIP1C-6D1
AC   CVCL_C2CK
SY   MANSIP1C(6D1); MANSIP1C; 6D1
DR   DSHB; MANSIP1C-6D1
DR   Wikidata; Q114312191
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14893; Human GEMIN2 (Note=Also reacts with mouse and rabbit).
CC   Caution: Indicated as producing an IgG1 mAb in glennmorris.org.uk and an IgG2b mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSIP1D-7C11
AC   CVCL_C2CL
SY   MANSIP1D(7C11); MANSIP1D; 7C11
DR   DSHB; MANSIP1D-7C11
DR   Wikidata; Q114312192
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14893; Human GEMIN2 (Note=Also reacts with mouse and rabbit).
CC   Caution: Indicated as producing an IgG1 mAb in glennmorris.org.uk and an IgG2b mAb in DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSIX5A1-2A6
AC   CVCL_A6LR
SY   MANSIX5A1(2A6); SIX5A-2A6; MANSIX5A1; 2A6
DR   DSHB; MANSIX5A1-2A6
DR   Wikidata; Q107116929
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A10-4H7
AC   CVCL_A6MA
SY   MANSIX5A10(4H7); SIX5A-4H7; MANSIX5A10; 4H7
DR   DSHB; MANSIX5A10-4H7
DR   Wikidata; Q107116937
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A11-2H1
AC   CVCL_A6MB
SY   MANSIX5A11(2H1); SIX5A-2H1; MANSIX5A11; 2H1
DR   DSHB; MANSIX5A11-2H1
DR   Wikidata; Q107116931
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A12-4E7
AC   CVCL_A6MC
SY   MANSIX5A12(4E7); SIX5A-4E7; MANSIX5A12; 4E7
DR   DSHB; MANSIX5A12-4E7
DR   Wikidata; Q107116936
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A2-3B4
AC   CVCL_A6LS
SY   MANSIX5A2(3B4); SIX5A-3B4; MANSIX5A2; 3B4
DR   DSHB; MANSIX5A2-3B4
DR   Wikidata; Q107116932
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A3-3D9
AC   CVCL_A6LT
SY   MANSIX5A3(3D9); SIX5A-3D9; MANSIX5A3; 3D9
DR   DSHB; MANSIX5A3-3D9
DR   Wikidata; Q107116933
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
CC   Misspelling: MANSIX5A3(3A9); Note=In eagle-i, a resource which has been discontinued.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MANSIX5A4-3E11
AC   CVCL_A6LU
SY   MANSIX5A4(3E11); SIX5A-3E11; MANSIX5A4; 3E11
DR   DSHB; MANSIX5A4-3E11
DR   Wikidata; Q107116934
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A5-10B12
AC   CVCL_A6LV
SY   MANSIX5A5(10B12); SIX5A-10B12; MANSIX5A5; 10B12
DR   DSHB; MANSIX5A5-10B12
DR   Wikidata; Q107116927
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A6-1C11
AC   CVCL_A6LW
SY   MANSIX5A6(1C11); SIX5A-1C11; MANSIX5A6; 1C11
DR   DSHB; MANSIX5A6-1C11
DR   Wikidata; Q107116928
RX   PubMed=15962300;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 5
//
ID   MANSIX5A7-3G10
AC   CVCL_A6LX
SY   MANSIX5A7(3G10); SIX5A-3G10; MANSIX5A7; 3G10
DR   DSHB; MANSIX5A7-3G10
DR   Wikidata; Q107116935
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A8-7G4
AC   CVCL_A6LY
SY   MANSIX5A8(7G4); SIX5A-7G4; MANSIX5A8; 7G4
DR   DSHB; MANSIX5A8-7G4
DR   Wikidata; Q107116939
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5A9-2G8
AC   CVCL_A6LZ
SY   MANSIX5A9(2G8); SIX5A-2G8; MANSIX5A9; 2G8
DR   Wikidata; Q107116930
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANSIX5B1-6E10
AC   CVCL_A6MD
SY   MANSIX5B1(6E10); SIX5B-6E10; MANSIX5B1; 6E10
DR   DSHB; MANSIX5B1-6E10
DR   Wikidata; Q107116942
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5B2-10B3
AC   CVCL_A6ME
SY   MANSIX5B2(10B3); SIX5B-10B3; MANSIX5B2; 10B3
DR   DSHB; MANSIX5B2-10B3
DR   Wikidata; Q107116940
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5B3-10D2
AC   CVCL_A6MF
SY   MANSIX5B3(10D2); SIX5B-10D2; MANSIX5B3; 10D2
DR   DSHB; MANSIX5B3-10D2
DR   Wikidata; Q107116941
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5B4-9G10
AC   CVCL_A6MG
SY   MANSIX5B4(9G10); SIX5B-9G10; MANSIX5B4; 9G10
DR   DSHB; MANSIX5B4-9G10
DR   Wikidata; Q107116944
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5C2a-6C1
AC   CVCL_A6MH
SY   MANSIX5C2a(6C1); SIX5C2-6C1; MANSIX5C2a; 6C1
DR   DSHB; MANSIX5C2a-6C1
DR   Wikidata; Q107116946
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MANSIX5C2b-3A1
AC   CVCL_A6MI
SY   MANSIX5C2b(3A1); SIX5C2-3A1; MANSIX5C2b; 3A1
DR   Wikidata; Q107116945
RX   PubMed=15962300;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   MANSMA1-11F3
AC   CVCL_C2CM
SY   MANSMA1(11F3); MANSMA1; 11F3
DR   DSHB; MANSMA1-11F3
DR   Wikidata; Q114312193
RX   PubMed=10772809;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA10-8A10
AC   CVCL_C2CN
SY   MANSMA10(8A10); MANSMA10; 8A10
DR   DSHB; MANSMA10-8A10
DR   Wikidata; Q114312194
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA11-6G9
AC   CVCL_C2CP
SY   MANSMA11(6G9); MANSMA11; 6G9
DR   DSHB; MANSMA11-6G9
DR   Wikidata; Q114312195
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA12-2E6
AC   CVCL_C2CQ
SY   MANSMA12(2E6); MANSMA12; 2E6
DR   DSHB; MANSMA12-2E6
DR   Wikidata; Q114312196
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA13-5E3
AC   CVCL_C2CR
SY   MANSMA13(5E3); MANSMA13; 5E3
DR   DSHB; MANSMA13-5E3
DR   Wikidata; Q114312197
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA14-6A6
AC   CVCL_C2CS
SY   MANSMA14(6A6); MANSMA14; 6A6
DR   DSHB; MANSMA14-6A6
DR   Wikidata; Q114312198
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA15-6G1
AC   CVCL_C2CT
SY   MANSMA15(6G1); MANSMA15; 6G1
DR   DSHB; MANSMA15-6G1
DR   Wikidata; Q114312199
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA16-8A6
AC   CVCL_C2CU
SY   MANSMA16(8A6); MANSMA16; 8A6
DR   DSHB; MANSMA16-8A6
DR   Wikidata; Q114312200
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA17-8B11
AC   CVCL_C2CV
SY   MANSMA17(8B11); MANSMA17; 8B11
DR   DSHB; MANSMA17-8B11
DR   Wikidata; Q114312201
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA18-8B12
AC   CVCL_C2CW
SY   MANSMA18(8B12); MANSMA18; 8B12
DR   DSHB; MANSMA18-8B12
DR   Wikidata; Q114312203
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA19-7G12
AC   CVCL_C2CX
SY   MANSMA19(7G12); MANSMA19; 7G12
DR   DSHB; MANSMA19-7G12
DR   Wikidata; Q114312204
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA2-8F7
AC   CVCL_C2CY
SY   MANSMA2(8F7); MANSMA2; 8F7
DR   DSHB; MANSMA2-8F7
DR   Wikidata; Q114312205
RX   PubMed=10772809;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA20-8C1
AC   CVCL_C2CZ
SY   MANSMA20(8C1); MANSMA20; 8C1
DR   DSHB; MANSMA20-8C1
DR   Wikidata; Q114312206
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA21-1F1
AC   CVCL_C2D0
SY   MANSMA21(1F1); MANSMA21; 1F1
DR   DSHB; MANSMA21-1F1
DR   Wikidata; Q114312207
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA22-8B3
AC   CVCL_C2D1
SY   MANSMA22(8B3); MANSMA22; 8B3
DR   DSHB; MANSMA22-8B3
DR   Wikidata; Q114312208
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA3-8E1
AC   CVCL_C2D2
SY   MANSMA3(8E1); MANSMA3; 8E1
DR   DSHB; MANSMA3-8E1
DR   Wikidata; Q114312209
RX   PubMed=10772809;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA4-10A8
AC   CVCL_C2D3
SY   MANSMA4(10A8); MANSMA4; 10A8
DR   Wikidata; Q114312210
RX   PubMed=10772809;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   MANSMA5-12G6
AC   CVCL_C2D4
SY   MANSMA5(12G6); MANSMA5; 12G6
DR   DSHB; MANSMA5-12G6
DR   Wikidata; Q114312211
RX   PubMed=10772809;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA6-4H2
AC   CVCL_C2D5
SY   MANSMA6(4H2); MANSMA6; 4H2
DR   DSHB; MANSMA6-4H2
DR   Wikidata; Q114312212
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA7-1B12
AC   CVCL_C2D6
SY   MANSMA7(1B12); MANSMA7; 1B12
DR   DSHB; MANSMA7-1B12
DR   Wikidata; Q114312213
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA8-6H3
AC   CVCL_C2D7
SY   MANSMA8(6H3); MANSMA8; 6H3
DR   DSHB; MANSMA8-6H3
DR   Wikidata; Q114312214
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MANSMA9-9C7
AC   CVCL_C2D8
SY   MANSMA9(9C7); MANSMA9; 9C7
DR   DSHB; MANSMA9-9C7
DR   Wikidata; Q114312215
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16637; Human SMN1/SMN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   Mao
AC   CVCL_BT01
SY   MAO; HEBV-Mao
DR   CCRID; 5301HUM-KCB07011ZJ
DR   KCB; KCB 200711M
DR   Wikidata; Q54904005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MAO A-3C9
AC   CVCL_A6QY
DR   Wikidata; Q107116054
RX   PubMed=2414414;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21397; Human MAOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAO A-4F10
AC   CVCL_A6QZ
DR   Wikidata; Q107116057
RX   PubMed=2414414;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21397; Human MAOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAO A-7B10
AC   CVCL_A6RA
DR   Wikidata; Q107116059
RX   PubMed=2414414;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21397; Human MAOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAO A-7E10
AC   CVCL_A6RB
DR   Wikidata; Q107116062
RX   PubMed=2414414;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21397; Human MAOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAO B-1C2
AC   CVCL_A6QX
SY   MAO-1C2; MAO-1C2 no. 8; MAO-1C2 #8
DR   Wikidata; Q107116066
RX   Patent=US4571381;
RX   PubMed=2414414;
RX   PubMed=6183572;
RX   PubMed=6191193;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8176.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P27338; Human MAOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MaPaC-HS-77
AC   CVCL_LM84
AS   CVCL_A1QN
SY   MAPAC-HS-77; MAPACHS77; MaPac-77; P4-CL; CL4
DR   cancercelllines; CVCL_LM84
DR   DepMap; ACH-002672
DR   DSMZ; ACC-814
DR   DSMZCellDive; ACC-814
DR   GEO; GSM4563058
DR   Wikidata; Q54904006
RX   PubMed=33087752;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 71 hours (PubMed=33087752); ~2 days (DSMZ=ACC-814).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=33087752; DepMap=ACH-002672).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Asp (c.476C>A); ClinVar=VCV001026335; Zygosity=Homozygous (PubMed=33087752; DepMap=ACH-002672).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): DSMZ=ACC-814; PubMed=33087752
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13 (DSMZ=ACC-814)
ST   D13S317: 14,16 (PubMed=33087752)
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 12,15
ST   D21S11: 28
ST   D2S1338: 17,23
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 10,11 (DSMZ=ACC-814)
ST   D7S820: 11,12 (PubMed=33087752)
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   Penta D: 13
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   MAPR-S2
AC   CVCL_XC22
DR   CCRID; 4201PAT-CCTCC00141
DR   Wikidata; Q95985218
RX   Patent=CN1195229C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C96006.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06401; Human PGR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   MAPT N279K-1
AC   CVCL_A4MZ
SY   N279K #1
DR   SKIP; SKIP001339
DR   Wikidata; Q105510005
RX   PubMed=26373282;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (PubMed=26373282).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   MAPT N279K-2
AC   CVCL_A4NA
SY   N279K #2
DR   SKIP; SKIP00134O
DR   Wikidata; Q105510010
RX   PubMed=26373282;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (PubMed=26373282).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   mAQC2
AC   CVCL_5A33
SY   AQ.C2-9
DR   ABCD; ABCD_AG330
DR   Wikidata; Q54904007
RX   Patent=US7358054;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3273.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P56199; Human ITGA1/CD49a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5A32 ! FL653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 7
//
ID   MAR
AC   CVCL_0B87
SY   Mar; MA-R
DR   Cosmic; 2239098
DR   Wikidata; Q54904008
RX   PubMed=3034934;
RX   PubMed=7171457;
RX   PubMed=7736387;
RX   PubMed=9559344;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   MAR 103.6
AC   CVCL_A6GC
SY   MAR103.6; HDB2654
DR   Wikidata; Q107116068
RX   CelloPub=CLPUB00622;
RX   PubMed=6821397;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MAR 18.5
AC   CVCL_D294
SY   MAR18.5; HDB2653
DR   CLO; CLO_0007532
DR   ATCC; TIB-216
DR   BCRJ; 0158
DR   Wikidata; Q54904009
RX   CelloPub=CLPUB00622;
RX   PubMed=6821397;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotypes allotype IgK-1a and IgK-1b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   MAR 80.2
AC   CVCL_A6FM
SY   MAR80; MAR80.2; HDB2655
DR   Wikidata; Q107116071
RX   CelloPub=CLPUB00622;
RX   PubMed=6208121;
RX   PubMed=6821397;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 4
//
ID   Mar Bel
AC   CVCL_G291
SY   Mar-Bel; MAR BEL
DR   ATCC; CRL-1186
DR   ChEMBL-Cells; CHEMBL3308602
DR   ChEMBL-Targets; CHEMBL614653
DR   PubChem_Cell_line; CVCL_G291
DR   Wikidata; Q54904010
RX   PubMed=3335022;
CC   Discontinued: ATCC; CRL-1186; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   Mar Nol
AC   CVCL_3016
DR   CLO; CLO_0007533
DR   ATCC; CRL-1257
DR   Wikidata; Q54904011
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Mar Ton
AC   CVCL_3017
DR   CLO; CLO_0007534
DR   ATCC; CRL-1252
DR   Wikidata; Q54904012
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Mar Vin
AC   CVCL_3018
DR   CLO; CLO_0007535
DR   ATCC; CRL-1138
DR   Wikidata; Q54904013
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MAR-Mel
AC   CVCL_VQ11
SY   MAR
DR   Cosmic; 1295336
DR   Wikidata; Q95985253
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 6
//
ID   MAR00333IN
AC   CVCL_E164
DR   Wikidata; Q54904015
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MAR00334IN
AC   CVCL_E165
DR   Wikidata; Q54904016
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MAR1 [Human LCL]
AC   CVCL_YE09
DR   Wikidata; Q95985287
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=4333769;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   MAR1 [Xenopus lymphoma]
AC   CVCL_E8B3
RX   PubMed=1343098;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: ff.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MAR1 clone B3
AC   CVCL_E8B4
SY   B3
RX   PubMed=1343098;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: ff.
DI   NCIt; C215148; Xenopus thymic lymphoma
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_E8B3 ! MAR1 [Xenopus lymphoma]
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MARA-1
AC   CVCL_A6DX
SY   Mouse Anti-Rat Alpha-1; HDB7023
DR   Wikidata; Q107116073
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat IgA heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARA-2
AC   CVCL_A6DY
SY   Mouse Anti-Rat Alpha-2; HDB7024
DR   Wikidata; Q107116076
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Rat IgA heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARC 29F8
AC   CVCL_L546
SY   29F8
DR   CLO; CLO_0007537
DR   ATCC; CRL-2508
DR   Wikidata; Q54904017
RX   PubMed=9041412;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   MARC 2B7
AC   CVCL_L544
SY   2B7
DR   CLO; CLO_0007538
DR   ATCC; CRL-2509
DR   Wikidata; Q54904018
RX   PubMed=8795222;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9K2Y6; Escherichia coli O157:H7 flagellin (fliC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   MARC 46E9-9
AC   CVCL_L545
SY   46E9-9
DR   Wikidata; Q54904019
RX   PubMed=8795222;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9K2Y6; Escherichia coli O157:H7 flagellin (fliC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   MARC S5
AC   CVCL_L536
SY   S5
DR   CLO; CLO_0007539
DR   ATCC; CRL-2507
DR   Wikidata; Q54904020
RX   PubMed=9041412;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_64637; O-polysaccharide (Escherichia coli O-antigen O157:H7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 7
//
ID   MARC-145
AC   CVCL_4540
SY   Marc-145; MARC 145; Marc 145; MARC145; Marc145; Meat Animal Research Center-145
DR   BTO; BTO_0006549
DR   CLO; CLO_0007536
DR   CLDB; cl5226
DR   CCLV; CCLV-RIE 0277
DR   CCRID; 5301MON-KCB08001YJ
DR   CLS; 305006
DR   GEO; GSM1263300
DR   GEO; GSM1263301
DR   GEO; GSM1263302
DR   GEO; GSM1263303
DR   IZSLER; BS CL 127
DR   KCB; KCB 200801YJ
DR   Wikidata; Q54904021
RX   Patent=US5690940;
RX   PubMed=8257302;
RX   PubMed=17081295;
RX   PubMed=23148668;
RX   PubMed=28046048;
RX   PubMed=29682543;
RX   PubMed=33268540;
RX   PubMed=34205087;
RX   PubMed=34737324;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from African Green monkey instead of Rhesus macaque.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00621.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12219.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12230.
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV).
CC   Doubling time: 21.67 +- 3.30 hours (PubMed=23148668).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_3845 ! MA-104
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 26
//
ID   MARC-145 PBD-1+EGFP clone 9/D6
AC   CVCL_B6C8
SY   9/D6
DR   Wikidata; Q112930070
RX   PubMed=25297006;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Grand-parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   Characteristics: Transfected with a Neo-CMV-DEFB1-IRES-EGFP construct (PubMed=25297006).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:87240; Pig DEFB1.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_4540 ! MARC-145
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   MARC-145 pig CD163
AC   CVCL_VG41
SY   pCD163-MARC
DR   Wikidata; Q54904022
RX   PubMed=29682543;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Grand-parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   Virology: Compared to the parent cell line, has increased susceptibility to infection by porcine reproductive and respiratory syndrome virus (PRRSV).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_4540 ! MARC-145
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 12
//
ID   MARC-Nsp11
AC   CVCL_HA70
SY   MARC-nsp11
DR   GEO; GSM1263298
DR   GEO; GSM1263299
DR   Wikidata; Q54904023
RX   PubMed=24719865;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Grand-parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q6QDR0; Porcine reproductive and respiratory syndrome virus (strain NVSL 97-7895) replicase polyprotein 1ab (Note=AA 1088-1310 = nsp11).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_4540 ! MARC-145
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   MARC.BGCF.1-3
AC   CVCL_0F31
SY   Meat Animal Research Center.Bovine Genome Cow Fibroblasts.1-3
DR   ATCC; CRL-2875
DR   Wikidata; Q54904024
RX   PubMed=20015332;
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ATCC; CRL-2875; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_0F30 ! MARC.BGCF.2
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   MARC.BGCF.2
AC   CVCL_0F30
SY   Meat Animal Research Center.Bovine Genome Cow Fibroblasts.2
DR   ATCC; CRL-2874
DR   Wikidata; Q54904025
RX   PubMed=20015332;
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ATCC; CRL-2874; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_0F31 ! MARC.BGCF.1-3
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   MARC.OKF
AC   CVCL_W365
SY   Meat Animal Research Center.Ovine Kidney Fibroblast; AG19825
DR   Coriell; AG19825
DR   Wikidata; Q54904026
RX   PubMed=18432399;
CC   Discontinued: Coriell; AG19825; probable.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Texel; VBO=VBO_0001641.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_W366 ! MARC.OVSM
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   MARC.OVSM
AC   CVCL_W366
SY   Meat Animal Research Center.Ovine Vascular Smooth Muscle; AG19826
DR   Coriell; AG19826
DR   Wikidata; Q54904027
RX   PubMed=18432399;
CC   Discontinued: Coriell; AG19826; probable.
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
CC   Breed/subspecies: Texel; VBO=VBO_0001641.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_W365 ! MARC.OKF
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   Marcus
AC   CVCL_3019
SY   AJ
DR   BioSample; SAMN03472776
DR   Cell_Model_Passport; SIDM00378
DR   CGH-DB; 149-1
DR   IARC_TP53; 21524
DR   JCRB; IFO50290
DR   Wikidata; Q54904028
RX   PubMed=283420;
RX   PubMed=16232199;
CC   Population: Caucasian.
CC   Discontinued: JCRB; IFO50290; probable.
ST   Source(s): JCRB=IFO50290
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   MARD-3
AC   CVCL_A6DZ
SY   Mouse Anti-Rat Delta-3; HDB7031
DR   Wikidata; Q107116079
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01883; Rat immunoglobulin heavy chain delta.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARE-1
AC   CVCL_A6EA
SY   Mouse Anti-Rat Epsilon-1; HDB7021
DR   Wikidata; Q107116081
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01855; Rat immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG1-1
AC   CVCL_A6EB
SY   Mouse Anti-Rat Gamma1-1; HDB7000
DR   Wikidata; Q107116085
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20759; Rat immunoglobulin heavy chain gamma-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG1-2
AC   CVCL_A6EC
SY   Mouse Anti-Rat Gamma1-2
DR   Wikidata; Q107116087
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20759; Rat immunoglobulin heavy chain gamma-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG2a-7
AC   CVCL_A6EQ
SY   Mouse Anti-Rat Gamma2a-7
DR   Wikidata; Q107116090
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20760; Rat immunoglobulin heavy chain gamma-2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG2a-8
AC   CVCL_A6ED
SY   Mouse Anti-Rat Gamma2a-8; HDB7008
DR   Wikidata; Q107116093
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20760; Rat immunoglobulin heavy chain gamma-2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG2b-3
AC   CVCL_A6EE
SY   Mouse Anti-Rat Gamma2b-3; HDB7010
DR   Wikidata; Q107116095
RX   CelloPub=CLPUB00622;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20761; Rat immunoglobulin heavy chain gamma-2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG2b-8
AC   CVCL_A6EF
SY   Mouse Anti-Rat Gamma2b-8; HDB7014
DR   Wikidata; Q107116098
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20761; Rat immunoglobulin heavy chain gamma-2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG2c-2
AC   CVCL_A6EG
SY   Mouse Anti-Rat Gamma2c-2; HDB7019
DR   Wikidata; Q107116123
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG2c-3
AC   CVCL_A6EH
SY   Mouse Anti-Rat Gamma2c-3; HDB7020
DR   Wikidata; Q107116126
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARG2c-5
AC   CVCL_A6GE
SY   Mouse Anti-Rat Gamma2c-5
DR   Wikidata; Q107116127
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Margret
AC   CVCL_X929
SY   Margaret; NK11; NK 11; NK11a
DR   Wikidata; Q54904029
RX   PubMed=4174339;
RX   PubMed=4178827;
RX   PubMed=4878906;
RX   PubMed=5021706;
RX   PubMed=5786183;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 9
//
ID   Marimo
AC   CVCL_6992
SY   MARIMO
DR   cancercelllines; CVCL_6992
DR   Cosmic; 787448
DR   Cosmic; 975266
DR   Cosmic; 1012083
DR   Cosmic; 1281324
DR   Cosmic; 1465956
DR   Cosmic; 1465959
DR   Cosmic; 2306195
DR   Wikidata; Q54904030
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9406575;
RX   PubMed=16408098;
RX   PubMed=21552520;
RX   PubMed=25249012;
RX   PubMed=30115971;
CC   Characteristics: This cell line is independent of the CALR-MPL-JAK2-STAT5 pathway.
CC   Doubling time: 25-28 hours (PubMed=9406575).
CC   Sequence variation: Mutation; HGNC; HGNC:1455; CALR; Simple; p.Leu367Metfs*43 (c.1099_1159del61); Zygosity=Heterozygous (PubMed=25249012; PubMed=30115971).
CC   Sequence variation: Mutation; HGNC; HGNC:7217; MPL; Simple; p.Ser505Asn (c.1514G>A); ClinVar=VCV000014163; Zygosity=Heterozygous (PubMed=30115971).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=30115971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Tyr (c.404G>A); ClinVar=VCV000141762; Zygosity=Homozygous (PubMed=30115971).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8252; Therapy-related acute myeloid leukemia
DI   ORDO; Orphanet_86846; Therapy related acute myeloid leukemia and myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Marisco
AC   CVCL_L363
SY   Moresco
DR   BTO; BTO_0005359
DR   GEO; GSM1974794
DR   Wikidata; Q54904031
RX   PubMed=21552385;
RX   PubMed=21908323;
RX   PubMed=22916246;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
RX   PubMed=36099278;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 22.1 hours (PubMed=22916246); 22 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:43959; NRAS; Simple; p.Gln61His (c.183A>C); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:49609; RAC1; Simple; p.Pro29Thr (c.85C>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Greyhound; VBO=VBO_0200638.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 227
ST   Dog FHC2054: 156
ST   Dog FHC2079: 271
ST   Dog PEZ1: 107
ST   Dog PEZ3: 119,131
ST   Dog PEZ5: 103
ST   Dog PEZ6: 172,183
ST   Dog PEZ8: 236
ST   Dog PEZ12: 263,297
ST   Dog PEZ20: 200
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   MARK-1
AC   CVCL_A6EI
SY   Mouse Anti-Rat Kappa-1; HDB0230
DR   Wikidata; Q107116129
RX   CelloPub=CLPUB00622;
RX   PubMed=7627995;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARK-2
AC   CVCL_A6EJ
SY   Mouse Anti-Rat Kappa-2
DR   Wikidata; Q107116133
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARK-3
AC   CVCL_KB23
SY   Mark-3; Mark 3; Mouse Anti-Rat Kappa-3; HDB7032
DR   ChEMBL-Cells; CHEMBL3308644
DR   ChEMBL-Targets; CHEMBL614767
DR   PubChem_Cell_line; CVCL_KB23
DR   Wikidata; Q54904033
RX   CelloPub=CLPUB00622;
RX   PubMed=6427352;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1a).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   MARL-15
AC   CVCL_A6EK
SY   Mouse Anti-Rat Lambda-15
DR   Wikidata; Q107116135
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat Ig lambda light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARL-4
AC   CVCL_A6EL
SY   Mouse Anti-Rat Lambda-4; HDB7049
DR   Wikidata; Q107116137
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Rat Ig lambda light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARL-5
AC   CVCL_A6EM
SY   Mouse Anti-Rat Lambda-5; HDB7050
DR   Wikidata; Q107116140
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Rat Ig lambda light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARM-4
AC   CVCL_A6EN
SY   Mouse Anti-Rat Mu-4; HDB7027
DR   Wikidata; Q107116142
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat IgM heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARM-7
AC   CVCL_A6EP
SY   MARM7; Mouse Anti-Rat Mu-7; HDB7030
DR   Wikidata; Q107116145
RX   CelloPub=CLPUB00622;
RX   Patent=US5858359;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Rat IgM heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MARMarg
AC   CVCL_E771
SY   TER236
DR   dbMHC; 48967
DR   ECACC; 94050340
DR   IHW; IHW09307
DR   IPD-IMGT/HLA; 11052
DR   Wikidata; Q54904034
RX   PubMed=29171935;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*01:01:01:01,02:01:01:01; B*35:01:01:01,52:01:01:01; C*04:01:01:01,12:02:02:01; DPB1*04:01:01,03:01:01; DQA1*01:01,01:04; DQB1*05:03:01,05:01:01; DRB1*01:01:01,14:11; DRB3*02:02 (IPD-IMGT/HLA=11052).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   MARMari
AC   CVCL_E772
DR   dbMHC; 48968
DR   IHW; IHW09308
DR   IPD-IMGT/HLA; 11053
DR   Wikidata; Q54904035
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02; B*39,52; C*39,52; DPB1*04:01,02:01; DQA1*01:04,05:01; DQB1*03:01,03:01; DRB1*14:11,11:02; DRB3*02:02,02:02 (IPD-IMGT/HLA=11053).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Marmoset iPSC #15
AC   CVCL_A3BP
DR   SKIP; SKIP001441
DR   Wikidata; Q105510013
RX   PubMed=20363201;
RX   PubMed=26070112;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BQ ! Marmoset iPSC #36
OI   CVCL_A3BR ! Marmoset iPSC #37
OI   CVCL_A3BS ! Marmoset iPSC #81
OI   CVCL_A3BT ! Marmoset iPSC #88
OI   CVCL_A3BU ! Marmoset iPSC #A10
OI   CVCL_A3BV ! Marmoset iPSC #A18
OI   CVCL_A3BW ! Marmoset iPSC #B8
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Marmoset iPSC #36
AC   CVCL_A3BQ
DR   SKIP; SKIP001442
DR   Wikidata; Q105510016
RX   PubMed=20363201;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BP ! Marmoset iPSC #15
OI   CVCL_A3BR ! Marmoset iPSC #37
OI   CVCL_A3BS ! Marmoset iPSC #81
OI   CVCL_A3BT ! Marmoset iPSC #88
OI   CVCL_A3BU ! Marmoset iPSC #A10
OI   CVCL_A3BV ! Marmoset iPSC #A18
OI   CVCL_A3BW ! Marmoset iPSC #B8
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Marmoset iPSC #37
AC   CVCL_A3BR
DR   SKIP; SKIP001443
DR   Wikidata; Q105510019
RX   PubMed=20363201;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BP ! Marmoset iPSC #15
OI   CVCL_A3BQ ! Marmoset iPSC #36
OI   CVCL_A3BS ! Marmoset iPSC #81
OI   CVCL_A3BT ! Marmoset iPSC #88
OI   CVCL_A3BU ! Marmoset iPSC #A10
OI   CVCL_A3BV ! Marmoset iPSC #A18
OI   CVCL_A3BW ! Marmoset iPSC #B8
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Marmoset iPSC #81
AC   CVCL_A3BS
DR   SKIP; SKIP001444
DR   Wikidata; Q105510021
RX   PubMed=20363201;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BP ! Marmoset iPSC #15
OI   CVCL_A3BQ ! Marmoset iPSC #36
OI   CVCL_A3BR ! Marmoset iPSC #37
OI   CVCL_A3BT ! Marmoset iPSC #88
OI   CVCL_A3BU ! Marmoset iPSC #A10
OI   CVCL_A3BV ! Marmoset iPSC #A18
OI   CVCL_A3BW ! Marmoset iPSC #B8
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Marmoset iPSC #88
AC   CVCL_A3BT
DR   SKIP; SKIP001445
DR   Wikidata; Q105510024
RX   PubMed=20363201;
RX   PubMed=26070112;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BP ! Marmoset iPSC #15
OI   CVCL_A3BQ ! Marmoset iPSC #36
OI   CVCL_A3BR ! Marmoset iPSC #37
OI   CVCL_A3BS ! Marmoset iPSC #81
OI   CVCL_A3BU ! Marmoset iPSC #A10
OI   CVCL_A3BV ! Marmoset iPSC #A18
OI   CVCL_A3BW ! Marmoset iPSC #B8
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Marmoset iPSC #A10
AC   CVCL_A3BU
DR   SKIP; SKIP001446
DR   Wikidata; Q105510029
RX   PubMed=20363201;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BP ! Marmoset iPSC #15
OI   CVCL_A3BQ ! Marmoset iPSC #36
OI   CVCL_A3BR ! Marmoset iPSC #37
OI   CVCL_A3BS ! Marmoset iPSC #81
OI   CVCL_A3BT ! Marmoset iPSC #88
OI   CVCL_A3BV ! Marmoset iPSC #A18
OI   CVCL_A3BW ! Marmoset iPSC #B8
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Marmoset iPSC #A18
AC   CVCL_A3BV
DR   SKIP; SKIP001447
DR   Wikidata; Q105510032
RX   PubMed=20363201;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BP ! Marmoset iPSC #15
OI   CVCL_A3BQ ! Marmoset iPSC #36
OI   CVCL_A3BR ! Marmoset iPSC #37
OI   CVCL_A3BS ! Marmoset iPSC #81
OI   CVCL_A3BT ! Marmoset iPSC #88
OI   CVCL_A3BU ! Marmoset iPSC #A10
OI   CVCL_A3BW ! Marmoset iPSC #B8
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Marmoset iPSC #B8
AC   CVCL_A3BW
DR   SKIP; SKIP001448
DR   Wikidata; Q105510034
RX   PubMed=20363201;
RX   PubMed=26070112;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_A3BP ! Marmoset iPSC #15
OI   CVCL_A3BQ ! Marmoset iPSC #36
OI   CVCL_A3BR ! Marmoset iPSC #37
OI   CVCL_A3BS ! Marmoset iPSC #81
OI   CVCL_A3BT ! Marmoset iPSC #88
OI   CVCL_A3BU ! Marmoset iPSC #A10
OI   CVCL_A3BV ! Marmoset iPSC #A18
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   MARO 54
AC   CVCL_VQ02
SY   MARO54
DR   Wikidata; Q95985330
RX   PubMed=10837406;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   MAS
AC   CVCL_B7M9
DR   Wikidata; Q112930071
RX   PubMed=10079298;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln51Metfs*32 (c.151_154delCAAG); Zygosity=Heterozygous (PubMed=10079298).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   MaS-3
AC   CVCL_A8UM
DR   DSMZ; ACC-901
DR   DSMZCellDive; ACC-901
DR   Wikidata; Q108820850
RX   PubMed=33727576;
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=33727576); ~60-80 hours (DSMZ=ACC-901).
CC   Karyotypic information: Hypotriploid to hypertriploid karyotype (PubMed=33727576).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DSMZ=ACC-901; PubMed=33727576
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 8,12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 28
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 11
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C39824; Invasive bladder sarcomatoid urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   MASE
AC   CVCL_HF45
SY   Misgurnus Anguillicaudatus Skin Epidermis
DR   Wikidata; Q54904036
RX   PubMed=27288257;
CC   Group: Fish cell line.
CC   Doubling time: 53.3 hours (PubMed=27288257).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=75329; ! Misgurnus anguillicaudatus (Oriental weatherloach)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   MAsg2
AC   CVCL_D5DN
SY   7B9
DR   Wikidata; Q127382736
RX   PubMed=1383124;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P00655; Aspergillus giganteus alpha-sarcin (Note=Also recognizes clavatin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Mash-1
AC   CVCL_8158
DR   BioSample; SAMN03151848
DR   cancercelllines; CVCL_8158
DR   RCB; RCB1386
DR   Wikidata; Q54904037
RX   PubMed=12366446;
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a MMAc derivative (PubMed=16643607; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00233.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: RCB; RCB1386; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5951 ! MMAc
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Maska-98
AC   CVCL_IW67
DR   DSMZ; ACC-956
DR   Wikidata; Q54904038
RX   PubMed=11279638;
CC   Population: Japanese.
CC   Characteristics: Produces high level of lactate dehydrogenase (LDH) (PubMed=11279638).
CC   Doubling time: 36-48 hours (PubMed=11279638); ~48 hours (DSMZ=ACC-956).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-956
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 13,15
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 10,14
ST   Penta E: 11,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   MAST
AC   CVCL_M374
DR   cancercelllines; CVCL_M374
DR   IARC_TP53; 13987
DR   Wikidata; Q54904039
RX   PubMed=8601577;
RX   PubMed=10841287;
CC   Doubling time: ~68 hours (PubMed=8601577).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ser (c.730G>A); ClinVar=VCV000376600; Zygosity=Unspecified (PubMed=10841287).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   MasterShef1
AC   CVCL_BW74
SY   MasterShef 1; MasterShef01; MstrShef1; MShef1; UOSe001-A
DR   BioSamples; SAMEA104627957
DR   hPSCreg; UOSe001-A
DR   SKIP; SKIP002501
DR   Wikidata; Q54904040
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-14-020, Steering comm. appl. SCSC12-02.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MasterShef10
AC   CVCL_BW82
SY   MasterShef 10; MstrShef10; MShef10; UOSe014-A
DR   BioSamples; SAMEA104627967
DR   hPSCreg; UOSe014-A
DR   Wikidata; Q54904041
RX   PubMed=26607962;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-020, Steering comm. appl. SCSC13-05.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   MasterShef11
AC   CVCL_BW83
SY   MasterShef 11; MstrShef11; MShef11; UOSe015-A
DR   BioSamples; SAMEA104627969
DR   hPSCreg; UOSe015-A
DR   Wikidata; Q54904044
RX   PubMed=26607962;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-021, Steering comm. appl. SCSC13-06.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MasterShef11 CMT2A_Het1
AC   CVCL_E3QL
CC   From: Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield; Sheffield; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple_edited; p.Arg94Gln (c.281G>A); ClinVar=VCV000002268; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Jestice, Lydia H.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW83 ! MasterShef11
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MasterShef11 CMT2A_Het3.1
AC   CVCL_E3QM
CC   From: Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield; Sheffield; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple_edited; p.Arg94Gln (c.281G>A); ClinVar=VCV000002268; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Jestice, Lydia H.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW83 ! MasterShef11
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MasterShef11 CMT2A_Het3.2
AC   CVCL_E3QN
CC   From: Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield; Sheffield; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple_edited; p.Arg94Gln (c.281G>A); ClinVar=VCV000002268; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Jestice, Lydia H.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW83 ! MasterShef11
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MasterShef11 CMT2A_Het4
AC   CVCL_E3QP
CC   From: Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield; Sheffield; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple_edited; p.Arg94Gln (c.281G>A); ClinVar=VCV000002268; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Jestice, Lydia H.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW83 ! MasterShef11
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MasterShef11 CMT2A_Wildtype 2
AC   CVCL_E3QK
CC   From: Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield; Sheffield; United Kingdom.
CC   Characteristics: Undergone CRISPR/Cas9 editing to introduce the p.Arg94Gln mutation in MFN2 but remained wild type (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Jestice, Lydia H.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW83 ! MasterShef11
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MasterShef12
AC   CVCL_BW84
SY   MasterShef 12; MstrShef12; MShef12; UOSe016-A
DR   BioSamples; SAMEA104627971
DR   hPSCreg; UOSe016-A
DR   Wikidata; Q54904045
RX   PubMed=26607962;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-022, Steering comm. appl. SCSC13-07.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MasterShef13
AC   CVCL_BW85
SY   MasterShef 13; MstrShef13; MShef13; UOSe017-A
DR   BioSamples; SAMEA104627973
DR   hPSCreg; UOSe017-A
DR   Wikidata; Q54904046
RX   PubMed=26607962;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-023, Steering comm. appl. SCSC13-08.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MasterShef14
AC   CVCL_BW86
SY   MasterShef 14; MstrShef14; MShef14; UOSe018-A
DR   BioSamples; SAMEA104627975
DR   hPSCreg; UOSe018-A
DR   Wikidata; Q54904047
RX   PubMed=26607962;
RX   PubMed=27829140;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-024, Steering comm. appl. SCSC14-65.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   MasterShef2
AC   CVCL_BW75
SY   MasterShef 2; MasterShef02; MstrShef2; MShef2; UOSe007-A
DR   BioSamples; SAMEA104627959
DR   hPSCreg; UOSe007-A
DR   SKIP; SKIP002783
DR   Wikidata; Q54904048
RX   PubMed=26607962;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-14-021, Steering comm. appl. SCSC12-03.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MasterShef3
AC   CVCL_BW76
SY   MasterShef 3; MasterShef03; MstrShef3; MShef3; UOSe008-A
DR   BioSamples; SAMEA104627961
DR   hPSCreg; UOSe008-A
DR   SKIP; SKIP002784
DR   Wikidata; Q54904049
RX   PubMed=26607962;
RX   PubMed=28445466;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0061.
CC   Registration: UK Stem Cell Bank (UKSCB); C-14-022, Steering comm. appl. SCSC12-04.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   MasterShef4
AC   CVCL_BW77
SY   MasterShef 4; MasterShef04; MstrShef4; MShef4; UOSe009-A
DR   BioSamples; SAMEA104627963
DR   hPSCreg; UOSe009-A
DR   Wikidata; Q54904050
RX   PubMed=26607962;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0062.
CC   Registration: UK Stem Cell Bank (UKSCB); C-14-023, Steering comm. appl. SCSC12-05.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   MasterShef5
AC   CVCL_BW78
SY   MasterShef 5; MasterShef05; MstrShef5; MShef5; UOSe010-A
DR   BioSamples; SAMEA104627955
DR   hPSCreg; UOSe010-A
DR   Wikidata; Q54904051
RX   PubMed=26607962;
RX   PubMed=28445466;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-14-024, Steering comm. appl. SCSC12-06.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to MasterShef8 (Cellosaurus=CVCL_BW81).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   MasterShef6
AC   CVCL_BW79
SY   MasterShef 6; MasterShef06; MstrShef6; MShef6; UOSe011-A
DR   BioSamples; SAMEA104627965
DR   hPSCreg; UOSe011-A
DR   Wikidata; Q54904052
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-013, Steering comm. appl. SCSC12-07.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MasterShef7
AC   CVCL_BW80
SY   MasterShef 7; MasterShef07; MstrShef7; MShef7; MS7; UOSe012-A
DR   BioSamples; SAMEA104627892
DR   hPSCreg; UOSe012-A
DR   Wikidata; Q54904053
RX   PubMed=26607962;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0097.
CC   Registration: UK Stem Cell Bank (UKSCB); C-16-019, Steering comm. appl. SCSC12-08.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   MasterShef8
AC   CVCL_BW81
SY   MasterShef 8; MasterShef08; MstrShef8; MShef8; UOSe013-A
DR   BioSamples; SAMEA104627894
DR   hPSCreg; UOSe013-A
DR   Wikidata; Q54904054
RX   PubMed=26607962;
RX   PubMed=27829140;
RX   PubMed=28445466;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-14-025, Steering comm. appl. SCSC12-09.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to that giving rise to MasterShef5 (Cellosaurus=CVCL_BW78).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   MasterShef9
AC   CVCL_E5ZS
SY   MasterShef 9; MasterShef09
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-18-011, Steering comm. appl. SCSC13-18.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MAT
AC   CVCL_RL79
DR   Cosmic; 933545
DR   Wikidata; Q54904055
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=8957066;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   MAT-28-24
AC   CVCL_J233
DR   TKG; TKG 0224
DR   Wikidata; Q54904056
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MAT-28b-12-11-30
AC   CVCL_J234
DR   TKG; TKG 0225
DR   Wikidata; Q54904057
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MAT-Lu
AC   CVCL_3847
SY   R-3327-MAT-Lu
DR   CLO; CLO_0007540
DR   CLDB; cl3337
DR   ATCC; JHU-4
DR   CancerTools; 156409
DR   ECACC; 94102735
DR   Wikidata; Q54904058
RX   PubMed=3174494;
RX   PubMed=3774632;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/5871-R-3327-AT-1-Rat-Prostatic-Cancer-Cell-Line.html
CC   Discontinued: ATCC; JHU-4; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3568 ! R-3327-AT-1
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   MAT-LyLu
AC   CVCL_3848
AS   CVCL_2168
SY   Mat-Ly-Lu; MATLyLu; R-3327 MAT-LyLu; R3327-MATLyLu; R3327-MatLyLu; Dunning R 3327 MAT LyLu; Metastatic AT tumor able to disseminate to lymph nodes and lung
DR   BTO; BTO_0003306
DR   CLO; CLO_0007541
DR   CLDB; cl3338
DR   ATCC; JHU-5
DR   ATCC; JHU-92
DR   CancerTools; 156410
DR   ChEMBL-Cells; CHEMBL3307987
DR   ChEMBL-Targets; CHEMBL612579
DR   DSMZ; ACC-609
DR   DSMZCellDive; ACC-609
DR   ECACC; 94101454
DR   PubChem_Cell_line; CVCL_3848
DR   Wikidata; Q54904059
RX   PubMed=3174494;
RX   PubMed=3774632;
RX   PubMed=7251319;
RX   PubMed=7910810;
RX   PubMed=8687134;
RX   PubMed=23467722;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/5871-R-3327-AT-1-Rat-Prostatic-Cancer-Cell-Line.html
CC   Doubling time: ~15 hours (DSMZ=ACC-609).
CC   Discontinued: ATCC; JHU-5; true.
CC   Discontinued: ATCC; JHU-92; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3568 ! R-3327-AT-1
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   MAT-LyLu-B-1
AC   CVCL_Y659
SY   MAT-Ly-Lu-B-1; MLLB-1
DR   Wikidata; Q54904060
RX   PubMed=9494564;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3848 ! MAT-LyLu
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   MAT-LyLu-B-2
AC   CVCL_3849
SY   MAT-Ly-Lu-B-2; MLLB-2; MLLB2
DR   CLO; CLO_0007542
DR   ATCC; CRL-2376
DR   Wikidata; Q54904061
RX   PubMed=9494564;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3848 ! MAT-LyLu
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   MATAG 12
AC   CVCL_K144
DR   ATCC; HB-9456
DR   Wikidata; Q54904062
RX   Patent=US5512443;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9456.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human tumor-associated glycoprotein 72 (TAG-72) (CA72-4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   MaTi
AC   CVCL_E999
DR   Wikidata; Q54904063
RX   PubMed=20444890;
CC   Doubling time: 2.5 days (PubMed=20444890).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   Matsu
AC   CVCL_X925
DR   Wikidata; Q54904064
RX   PubMed=7535998;
CC   Group: Non-human primate cell line.
CC   Doubling time: ~20 hours (PubMed=7535998).
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   MaTu
AC   CVCL_5328
SY   MATU; BrCL20
DR   BioSample; SAMN03151742
DR   Cosmic; 1523956
DR   Cosmic; 1523973
DR   Wikidata; Q54904065
RX   PubMed=212193;
RX   PubMed=9150904;
RX   PubMed=10508494;
RX   PubMed=10700188;
RX   PubMed=15677628;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00142.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (PubMed=15677628).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.4790del138 (Ex20-21del); Zygosity=Heterozygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.5061+2T>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=10700188).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   MaTu/Ham
AC   CVCL_5329
DR   Wikidata; Q54904066
RX   PubMed=11044355;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/MaTuHam.html
CC   Problematic cell line: Contaminated. Parent cell line (Matu) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5328 ! MaTu
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   MAVER-1
AC   CVCL_1831
SY   Maver-1; MAVER1; Maver1; MAVER; MAntle cell VERona-1
DR   ATCC; CRL-3008
DR   BioSample; SAMN03471709
DR   cancercelllines; CVCL_1831
DR   ChEMBL-Cells; CHEMBL4482995
DR   ChEMBL-Targets; CHEMBL4483260
DR   Cosmic; 2078182
DR   Cosmic; 2088018
DR   DepMap; ACH-002485
DR   DSMZ; ACC-717
DR   DSMZCellDive; ACC-717
DR   GEO; GSM1044978
DR   GEO; GSM1044979
DR   GEO; GSM1044980
DR   GEO; GSM1044981
DR   GEO; GSM1266781
DR   GEO; GSM1266782
DR   GEO; GSM1266793
DR   GEO; GSM1266794
DR   GEO; GSM1266795
DR   GEO; GSM1266796
DR   GEO; GSM1266797
DR   GEO; GSM1266798
DR   GEO; GSM2322621
DR   IARC_TP53; 24552
DR   PubChem_Cell_line; CVCL_1831
DR   Wikidata; Q54904067
RX   PubMed=16434369;
RX   PubMed=24362935;
RX   PubMed=25315077;
RX   PubMed=25688540;
RX   PubMed=25960936;
RX   PubMed=27697772;
RX   PubMed=29666304;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Doubling time: 24 hours (PubMed=25315077); ~48 hours (DSMZ=ACC-717).
CC   HLA typing: A*68:01,02:01; B*55:01,07:02; C*03:03,07:02; DQA1*05:01,02:01; DQB1*03:01,02:01; DRB1*11:01,07:01 (PubMed=25960936).
CC   HLA typing: A*24,26; B*38,44; C*05,12 (PubMed=25688540).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Glu (c.843C>G); ClinVar=VCV000376587; Zygosity=Hemizygous (PubMed=16434369; DepMap=ACH-002485).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3008; DSMZ=ACC-717
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 16
ST   D21S11: 29,33.2
ST   D2S1338: 17
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 11
ST   FGA: 19,21
ST   Penta D: 10,11
ST   Penta E: 5,12
ST   TH01: 8,9
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   MAVI 74
AC   CVCL_VQ03
SY   MAVI74
DR   Wikidata; Q95985372
RX   PubMed=10837406;
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   MaVo
AC   CVCL_E9V0
RX   PubMed=6437965;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MaWi
AC   CVCL_S810
SY   Mawi; MAWI; MAwi
DR   cancercelllines; CVCL_S810
DR   Cosmic; 687534
DR   Wikidata; Q54904068
RX   PubMed=6686962;
RX   PubMed=8512814;
RX   PubMed=12068308;
CC   Characteristics: Established from a nude mice xenograft.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=12068308).
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Max-ST
AC   CVCL_0D06
DR   Wikidata; Q54904069
WW   Provider; UMN; -; https://web.archive.org/web/20100613061254/http://www.cvm.umn.edu/accr/research/modianolab/scientificresources/reagentsandscientificresources/home.html
DI   NCIt; C132276; Canine soft tissue sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   MAXF 401NL
AC   CVCL_D131
SY   MAXF401; MAXF 401; MAXF-401; 401NL
DR   ChEMBL-Cells; CHEMBL3307805
DR   ChEMBL-Targets; CHEMBL612703
DR   PubChem_Cell_line; CVCL_D131
DR   Wikidata; Q54904070
RX   DOI=10.1016/0165-4608(96)85256-3;
RX   PubMed=21556597;
CC   Characteristics: Developed from a breast tumor xenograft developed in athymic mice.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   MAXF 449
AC   CVCL_D246
SY   MAXF449; MaxF449
DR   Wikidata; Q54904071
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   MAXF 583
AC   CVCL_D245
SY   MAXF-583; MAXF583
DR   Wikidata; Q54904072
RX   DOI=10.1016/0165-4608(96)85256-3;
RX   PubMed=21556597;
CC   Characteristics: Developed from a breast tumor xenograft developed in athymic mice.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   MAXF 713
AC   CVCL_D247
SY   MAXF-713
DR   Wikidata; Q54904073
RX   DOI=10.1016/0165-4608(96)85256-3;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   MAY
AC   CVCL_E773
DR   IHW; IHW09482
DR   Wikidata; Q54904074
RX   PubMed=30844424;
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*26:01:01:01; B*38:01:01; C*12:03:01:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:02:01; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   May Roy
AC   CVCL_1864
DR   CLO; CLO_0007543
DR   ATCC; CRL-1250
DR   Wikidata; Q54904075
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Mayes
AC   CVCL_4Y74
DR   Wikidata; Q54904076
RX   PubMed=13502746;
CC   Miscellaneous: Cell line has been lost.
CC   Derived from site: In situ; Knee joint, synovium; UBERON=UBERON_0001485+UBERON_0007616.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   MAZ1
AC   CVCL_C1JB
DR   Wikidata; Q114312216
RX   PubMed=2998993;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MB
AC   CVCL_5M21
DR   Wikidata; Q54904077
RX   PubMed=4735239;
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_5M20 ! KF
OI   CVCL_5M22 ! TD
OI   CVCL_5M23 ! WE
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   MB III
AC   CVCL_3741
SY   MB-III; de Bruyn-Gey cells
DR   CLO; CLO_0007546
DR   CLO; CLO_0007567
DR   CLDB; cl3345
DR   ATCC; CCL-32
DR   ECACC; 90111914
DR   Wikidata; Q54904078
RX   DOI=10.1007/BF02618370;
CC   Discontinued: ECACC; 90111914; true.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   MB-02
AC   CVCL_7075
SY   MB02; MBO2
DR   BTO; BTO_0004767
DR   cancercelllines; CVCL_7075
DR   Cosmic; 787449
DR   Cosmic; 924045
DR   Cosmic; 975267
DR   Cosmic; 1012052
DR   Cosmic; 1012084
DR   Cosmic; 1281325
DR   Cosmic; 1465957
DR   Cosmic; 2306216
DR   GEO; GSM743417
DR   Wikidata; Q54904079
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1954374;
RX   PubMed=9096695;
RX   PubMed=10516762;
RX   PubMed=16408098;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks were contaminated by HU-3 (PubMed=10516762).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00165.
CC   Characteristics: CSF2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=16408098).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MB-020
AC   CVCL_Z317
DR   CLO; CLO_0007547
DR   CLDB; cl3339
DR   DSMZ; ACC-79
DR   DSMZCellDive; ACC-79
DR   ICLDB; mb-020
DR   Wikidata; Q54904080
RX   DOI=10.1080/03235408909438893;
CC   Group: Insect cell line.
CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI=10.1080/03235408909438893) as the reference for the establishment of this cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_Z314 ! MB-H 260
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 10
//
ID   MB-021
AC   CVCL_Z318
DR   CLO; CLO_0007548
DR   CLDB; cl3340
DR   DSMZ; ACC-85
DR   DSMZCellDive; ACC-85
DR   ICLDB; mb-021
DR   Wikidata; Q54904081
RX   DOI=10.1080/03235408909438893;
CC   Group: Insect cell line.
CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI=10.1080/03235408909438893) as the reference for the establishment of this cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_Z314 ! MB-H 260
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 10
//
ID   MB-03
AC   CVCL_Z319
DR   CLO; CLO_0007549
DR   CLDB; cl3341
DR   DSMZ; ACC-97
DR   DSMZCellDive; ACC-97
DR   ICLDB; mb-03
DR   Wikidata; Q54904082
RX   DOI=10.1080/03235408909438893;
CC   Group: Insect cell line.
CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI=10.1080/03235408909438893) as the reference for the establishment of this cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_Z314 ! MB-H 260
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 10
//
ID   MB-03C4
AC   CVCL_Z501
SY   MB-O3C4
DR   CLO; CLO_0007550
DR   CLDB; cl3342
DR   Wikidata; Q54904083
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=47767; ! Agrotis segetum (Turnip moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   MB-03C5-688
AC   CVCL_Z502
SY   MB-O3C5-688
DR   CLO; CLO_0007551
DR   CLDB; cl3343
DR   Wikidata; Q54904086
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=47767; ! Agrotis segetum (Turnip moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   MB-04
AC   CVCL_Z320
DR   CLO; CLO_0007552
DR   CLDB; cl3344
DR   DSMZ; ACC-122
DR   DSMZCellDive; ACC-122
DR   ICLDB; mb-04
DR   Wikidata; Q54904087
RX   DOI=10.1080/03235408909438893;
CC   Group: Insect cell line.
CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI=10.1080/03235408909438893) as the reference for the establishment of this cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_Z314 ! MB-H 260
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 10
//
ID   MB-1 [Human thyroid carcinoma]
AC   CVCL_2109
SY   MB1
DR   BioSample; SAMN03473455
DR   cancercelllines; CVCL_2109
DR   Cell_Model_Passport; SIDM01639
DR   DepMap; ACH-001356
DR   DSMZ; ACC-638
DR   DSMZCellDive; ACC-638
DR   Wikidata; Q54904088
RX   PubMed=18616678;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=18616678); ~60-100 hours (DSMZ=ACC-638).
CC   Karyotypic information: Has lost chromosome Y (PubMed=18616678).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): DepMap=ACH-001356; DSMZ=ACC-638
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 19
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 20
ST   D3S1358: 14
ST   D5S818: 10
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 15
ST   Penta E: 13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   MB-1 [Mouse hybridoma against human CD37]
AC   CVCL_E5KF
RX   PubMed=3489782;
WW   Provider; Stanford OTL; S11-369; https://stanford.resoluteinnovation.com/technologies/S11-369_monoclonal-antibody-mb-1
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11049; Human CD37.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MB-9812
AC   CVCL_0A72
SY   MB 9812; MB9812; MBA 9812; MBA-9812; Line 9812; 9812
DR   cancercelllines; CVCL_0A72
DR   Cosmic; 2301572
DR   GEO; GSM784229
DR   Progenetix; CVCL_0A72
DR   Wikidata; Q54904090
RX   PubMed=3518877;
RX   PubMed=5431618;
RX   PubMed=6272398;
RX   PubMed=6500159;
RX   PubMed=6935474;
RX   PubMed=7459858;
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 12
//
ID   MB-H 260
AC   CVCL_Z314
DR   ICLDB; mb-h-260
DR   Wikidata; Q54904091
RX   DOI=10.1080/03235408909438893;
CC   Group: Insect cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   MB-IS
AC   CVCL_D3ZR
SY   MBIS; Mie BCP-ALL-IS
DR   Wikidata; Q127382737
RX   PubMed=32862292;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB-IT
AC   CVCL_D3ZA
SY   MBIT; Mie BCP-ALL-IT
DR   Wikidata; Q127382738
RX   PubMed=18599181;
RX   PubMed=32144432;
RX   PubMed=32862292;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Arg776Met (c.2327G>T); Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MB-IT R
AC   CVCL_D3ZB
DR   Wikidata; Q127382739
RX   PubMed=18599181;
CC   Population: Japanese.
CC   Selected for resistance to: UniProtKB; P50591; Human TNFSF10/CD253.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3ZA ! MB-IT
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB-KG
AC   CVCL_D3ZP
SY   MBKG; Mie BCP-ALL-KG
DR   Wikidata; Q127382740
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Tyr668Cys (c.2003A>G); dbSNP=rs1308986047; Zygosity=Heterozygous (PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MB-L11
AC   CVCL_Z315
DR   CLO; CLO_0007568
DR   CLDB; cl3346
DR   DSMZ; ACC-113
DR   DSMZCellDive; ACC-113
DR   ICLDB; mb-l11
DR   Wikidata; Q54904092
RX   DOI=10.1080/03235408909438893;
CC   Group: Insect cell line.
CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI=10.1080/03235408909438893) as the reference for the establishment of this cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_Z314 ! MB-H 260
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   MB-L2
AC   CVCL_Z316
DR   CLO; CLO_0007569
DR   CLDB; cl3347
DR   DSMZ; ACC-76
DR   DSMZCellDive; ACC-76
DR   ICLDB; mb-l2
DR   Wikidata; Q54904093
RX   DOI=10.1080/03235408909438893;
CC   Group: Insect cell line.
CC   Caution: We are not certain that this cell line is derived from MB-H 260. The DSMZ web site points to the original publication of MB-H 260 (DOI=10.1080/03235408909438893) as the reference for the establishment of this cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_Z314 ! MB-H 260
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   MB-MK
AC   CVCL_D3ZL
SY   MBMK; Mie BCP-ALL-MK
DR   Wikidata; Q127382741
RX   PubMed=29786757;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB-MT
AC   CVCL_D3ZM
SY   MBMT; Mie BCP-ALL-MT
DR   Wikidata; Q127382742
RX   PubMed=29786757;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB-MY
AC   CVCL_D3ZQ
SY   MBMY; Mie BCP-ALL-MY
DR   Wikidata; Q127382743
RX   PubMed=32144432;
RX   PubMed=32862292;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB-OD
AC   CVCL_D3ZS
SY   MBOD; Mie BCP-ALL-OD
DR   Wikidata; Q127382744
RX   PubMed=32862292;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB-OK
AC   CVCL_D3ZN
SY   MBOK; Mie BCP-ALL-OK
DR   Wikidata; Q127382745
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB-YU
AC   CVCL_D3ZT
SY   MBYU; Mie BCP-ALL-YU
DR   Wikidata; Q127382746
RX   PubMed=32862292;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MB0002
AC   CVCL_8Y12
DR   ECACC; 00051801
DR   Wikidata; Q54904094
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00051801; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   MB0008
AC   CVCL_8Y13
DR   ECACC; 00110316
DR   Wikidata; Q54904095
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00110316; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8Y14 ! MB0009
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MB0009
AC   CVCL_8Y14
DR   ECACC; 00110317
DR   Wikidata; Q54904096
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00110317; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8Y13 ! MB0008
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MB0012
AC   CVCL_8Y15
DR   ECACC; 00121101
DR   Wikidata; Q54904097
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00121101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84801; Klippel-Trenaunay-Weber syndrome
DI   ORDO; Orphanet_2346; Angioosteohypertrophic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MB0014
AC   CVCL_8Y16
DR   ECACC; 01010504
DR   Wikidata; Q54904098
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01010504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125485; Microcornea
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   MB0015
AC   CVCL_8Y17
DR   ECACC; 01012005
DR   Wikidata; Q54904099
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01012005; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26782; Glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   MB002
AC   CVCL_VU79
SY   SUM-B002; SUMB002
DR   cancercelllines; CVCL_VU79
DR   Cell_Model_Passport; SIDM01834
DR   DepMap; ACH-001201
DR   GEO; GSM1234970
DR   GEO; GSM1234971
DR   Wikidata; Q95985418
RX   PubMed=24297863;
RX   PubMed=25211508;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   MB004
AC   CVCL_VU80
DR   GEO; GSM1234972
DR   GEO; GSM1234973
DR   Wikidata; Q95985420
RX   PubMed=24297863;
RX   PubMed=27498314;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   MB073
AC   CVCL_F1J1
RX   PubMed=29533181;
CC   Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Heterozygous; Note=D4Z4 repeat contraction (to 8 repeats) (PubMed=29533181).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MB1.3.19
AC   CVCL_LI59
DR   Wikidata; Q54904100
RX   PubMed=8262142;
RX   PubMed=8877105;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   20FD
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   MB135
AC   CVCL_F1IZ
RX   PubMed=28171552;
RX   PubMed=29533181;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MB135-iDUX4
AC   CVCL_F1JH
SY   MB135-iDUX4 clone #7
RX   PubMed=28171552;
CC   Characteristics: Transduced with plasmid pCW57.1-DUX4-CA that contains a tetO driven codon altered DUX4 and a hPGK-puroR-T2A-rtTA, where reverse tetracycline-controlled transactivator (rtTA) is a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16. Will produces the codon-altered DUX4 in response to induction by doxycycline (PubMed=28171552).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:50800; DUX4 (Note=Codon-altered).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F1IZ ! MB135
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MB15C11
AC   CVCL_CY50
SY   15C11
DR   Wikidata; Q54904101
RX   PubMed=2475124;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   MB16tsA clone 1B5
AC   CVCL_6499
SY   Mbeta16tsA clone 1B5; Mbeta16tsA, clone 1B5
DR   BTO; BTO_0006291
DR   CLO; CLO_0007553
DR   ATCC; CRL-2307
DR   Wikidata; Q54904102
RX   PubMed=8538772;
CC   Characteristics: The cell line is an isogenic, wild-type cell line to be used in concert with the base excision repair deficient cell line, MB19tsA, clone 2B2 (Cellosaurus=CVCL_6500).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10-11FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   MB19tsA clone 2B2
AC   CVCL_6500
SY   Mbeta19tsA clone 2B2; Mbeta19tsA, clone 2B2
DR   CLO; CLO_0007554
DR   ATCC; CRL-2308
DR   Wikidata; Q54904103
RX   PubMed=8538772;
CC   Characteristics: Deficient in base excision repair due to homozygous deletion of the promoter and exon 1 of polB. The deletion of polB is mediated by the Cre-loxP recombination. This deletion event is reversible and therefore this cell line is ideal for site-specific recombination using the Cre-lox system (ATCC=CRL-2308).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   MB1a-4A8
AC   CVCL_C2EI
SY   MB1a(4A8); MB1a; 4A8
DR   DSHB; MB1a-4A8
DR   Wikidata; Q114312217
RX   PubMed=19095965;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NR56; Human MBNL1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MB1b-5F9
AC   CVCL_C2EJ
SY   MB1b(5F9); MB1b; 5F9
DR   DSHB; MB1b-5F9
DR   Wikidata; Q114312219
RX   PubMed=19095965;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NR56; Human MBNL1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MB200
AC   CVCL_F1J2
RX   PubMed=29533181;
CC   Sequence variation: Mutation; HGNC; HGNC:29090; SMCHD1; Simple; p.Lys204Glu (c.610A>G); Zygosity=Heterozygous (PubMed=29533181).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C172705; Facioscapulohumeral muscular dystrophy 2
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MB23G2
AC   CVCL_9218
DR   CLO; CLO_0007555
DR   ATCC; HB-220
DR   Wikidata; Q54904104
RX   PubMed=2475124;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   MB2401
AC   CVCL_F1J0
RX   PubMed=29533181;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Telomerase immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MB2a-3B4
AC   CVCL_C2EK
SY   MB2a(3B4); MB2a; 3B4
DR   DSHB; MB2a-3B4
DR   Wikidata; Q114312220
RX   PubMed=19095965;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5VZF2; Human MBNL2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MB2b-6A10
AC   CVCL_C2EL
SY   MB2b(6A10); MB2b; 6A10
DR   DSHB; MB2b-6A10
DR   Wikidata; Q114312221
RX   PubMed=19095965;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5VZF2; Human MBNL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MB2c-8B1
AC   CVCL_C2EM
SY   MB2c(8B1); MB2c; 8B1
DR   DSHB; MB2c-8B1
DR   Wikidata; Q114312222
RX   PubMed=19095965;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5VZF2; Human MBNL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   MB2d-9F11
AC   CVCL_C2EN
SY   MB2d(9F11); MB2d; 9F11
DR   Wikidata; Q114312223
RX   PubMed=19095965;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5VZF2; Human MBNL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   MB352
AC   CVCL_6778
DR   CLO; CLO_0007556
DR   ATCC; CRL-2821
DR   Wikidata; Q54904105
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MB355
AC   CVCL_6779
DR   CLO; CLO_0007557
DR   ATCC; CRL-2818
DR   Wikidata; Q54904106
CC   Knockout cell: Method=KO mouse; MGI; MGI:97740; Polb.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MB3a-5A11
AC   CVCL_C2EP
SY   MB3a(5A11); MB3a; 5A11
DR   DSHB; MB3a-5A11
DR   Wikidata; Q114312224
RX   PubMed=19095965;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NUK0; Human MBNL3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   MB3b-2F9
AC   CVCL_C2EQ
SY   MB3b(2F9); MB3b; 2F9
DR   Wikidata; Q114312225
RX   PubMed=19095965;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NUK0; Human MBNL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   MB4.9.2
AC   CVCL_LI58
DR   Wikidata; Q54904107
RX   PubMed=8877105;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   20FD
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   MB40.2
AC   CVCL_G232
SY   MB 40.2
DR   CLO; CLO_0007558
DR   ATCC; HB-59
DR   Wikidata; Q54904108
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MB40.3
AC   CVCL_G233
SY   MB 40.3
DR   CLO; CLO_0007545
DR   ATCC; HB-105
DR   Wikidata; Q54904110
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MB40.5
AC   CVCL_G234
SY   MB 40.5
DR   CLO; CLO_0007559
DR   ATCC; HB-116
DR   Wikidata; Q54904111
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MB49
AC   CVCL_7076
SY   MB-49
DR   BTO; BTO_0003562
DR   AddexBio; C0002004/5005
DR   CancerTools; 153368
DR   CLS; 305240
DR   Millipore; SCC148
DR   Ubigene; YC-C104
DR   Wikidata; Q54904112
DR   Ximbio; 153368
RX   PubMed=107359;
RX   PubMed=19539312;
RX   PubMed=22559978;
RX   PubMed=29732388;
RX   PubMed=29784854;
RX   PubMed=30867744;
CC   Karyotypic information: Has lost chromosome Y (PubMed=22559978).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C57BL/ICRF-a(t).
ST   Source(s): Millipore=SCC148; Ubigene=YC-C104
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 14,15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 28 (Ubigene=YC-C104)
ST   Mouse STR X-1: 28,29 (Millipore=SCC148)
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   MB49-I
AC   CVCL_VL62
DR   Wikidata; Q95985487
RX   PubMed=19539312;
RX   PubMed=22559978;
RX   PubMed=29732388;
RX   PubMed=30867744;
CC   Characteristics: Has an invasive and metastatic phenotype.
CC   Characteristics: Established after 13 consecutive passages of MB49 through subcutaneous injection in the left flank of C57BL/6J male mice.
CC   Karyotypic information: Has lost chromosome Y (PubMed=22559978).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7076 ! MB49
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   MB49luc
AC   CVCL_E8D4
SY   MB49-luciferase; MB49 LucSH+
RX   PubMed=26921031;
WW   Provider; NCI TTC; TAB-4085/E-237-2018-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4085
CC   Characteristics: Transfected with a pSELECT-zeo-LucSh which contains a synthetic CpG-free firefly Luc-Zeocin fusion protein (PubMed=26921031).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7076 ! MB49
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MB4B4
AC   CVCL_9219
DR   CLO; CLO_0007560
DR   ATCC; HB-223
DR   Wikidata; Q54904113
RX   PubMed=2475124;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   MB5
AC   CVCL_A0GX
DR   Wikidata; Q108820852
RX   PubMed=34092457;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0GY ! MC8
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   MB63
AC   CVCL_0F71
DR   Wikidata; Q54904114
RX   PubMed=107359;
RX   PubMed=6724740;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C25806; Mouse urinary tract neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   MB86
AC   CVCL_J274
DR   JCRB; JCRB0090
DR   RCB; RCB4489
DR   Wikidata; Q54904115
RX   PubMed=2420716;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Mouse IgM (allotype Igh6b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   MBA C57.Li
AC   CVCL_P675
DR   ATCC; CRL-6369
DR   Wikidata; Q54904116
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6369; true.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S462 ! MBA C57.Ut
OI   CVCL_6501 ! MBA C57.We
SX   Female
AG   13FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MBA C57.Ut
AC   CVCL_S462
DR   ATCC; CRL-6368
DR   Wikidata; Q54904117
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6368; true.
CC   Derived from site: In situ; Embryonic uterus; UBERON=UBERON_0005795.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_P675 ! MBA C57.Li
OI   CVCL_6501 ! MBA C57.We
SX   Female
AG   13FD
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MBA C57.We
AC   CVCL_6501
DR   CLO; CLO_0007565
DR   ATCC; CRL-6370
DR   Wikidata; Q54904118
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6370; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_P675 ! MBA C57.Li
OI   CVCL_S462 ! MBA C57.Ut
SX   Female
AG   13FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MBA-1
AC   CVCL_B418
DR   Wikidata; Q54904119
RX   PubMed=2981238;
CC   Doubling time: 17 hours (PubMed=2981238).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   MBA-13
AC   CVCL_B419
DR   Wikidata; Q54904120
RX   PubMed=2981238;
CC   Doubling time: 20 hours (PubMed=2981238).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: Nude ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   MBA-14
AC   CVCL_B420
DR   Wikidata; Q54904121
RX   PubMed=2981238;
RX   PubMed=6693503;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   MBA-15
AC   CVCL_B421
DR   BTO; BTO_0003051
DR   Wikidata; Q54904122
RX   PubMed=2981238;
RX   PubMed=6693503;
RX   PubMed=7942158;
CC   Doubling time: 19 hours (PubMed=2981238).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   MBA-2
AC   CVCL_B422
DR   Wikidata; Q54904123
RX   PubMed=2981238;
CC   Doubling time: 26-48 hours (PubMed=2981238).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: RF/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   MBA-2.1
AC   CVCL_B423
DR   Wikidata; Q54904124
RX   PubMed=2981238;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: RF/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B422 ! MBA-2
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   MBA-2.4
AC   CVCL_B424
DR   Wikidata; Q54904125
RX   PubMed=2981238;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: RF/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B422 ! MBA-2
SX   Sex unspecified
AG   6W
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   MBA-HE
AC   CVCL_Y447
DR   ATCC; CRL-6286
DR   Wikidata; Q54904126
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6286; true.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   MBA72
AC   CVCL_A2FY
SY   Mba72
DR   cancercelllines; CVCL_A2FY
DR   Wikidata; Q105510037
RX   DOI=10.1186/1479-5876-12-S1-P7;
RX   PubMed=25623468;
RX   PubMed=27540956;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=25623468).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Val92Met (c.274G>A); ClinVar=VCV000014308; Zygosity=Heterozygous (PubMed=27540956).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Asp294His (c.880G>C); ClinVar=VCV000014307; Zygosity=Heterozygous (PubMed=27540956).
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of Guida, Gabriella.
CC   Derived from site: Metastatic; Right temple; UBERON=UBERON_8480027.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   MBA72R
AC   CVCL_A2FZ
DR   cancercelllines; CVCL_A2FZ
DR   Wikidata; Q105510040
RX   DOI=10.1186/1479-5876-12-S1-P7;
RX   PubMed=25623468;
CC   Selected for resistance to: ChEBI; CHEBI_91367; Barasertib-HQPA (AZD1152-HQPA).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Val92Met (c.274G>A); ClinVar=VCV000014308; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6929; MC1R; Simple; p.Asp294His (c.880G>C); ClinVar=VCV000014307; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Age/sex of donor and metastatic site from personal communication of Guida, Gabriella.
CC   Derived from site: Metastatic; Right temple; UBERON=UBERON_8480027.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2FY ! MBA72
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   mbbm4
AC   CVCL_C7K2
SY   1G7; 1G7-F1
DR   Wikidata; Q117704640
RX   PubMed=2482313;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_62265; Beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcpNAc (Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   MBBR3
AC   CVCL_F1H8
SY   Melanoma Biopsy BRAF Resistance 3
CC   Population: Caucasian.
CC   Doubling time: 60 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Davidsen, Kjersti Tefre.
CC   Derived from site: Metastatic; Back, hypodermis; UBERON=UBERON_0001137+UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MBC-1
AC   CVCL_A7PG
DR   Wikidata; Q107116148
RX   PubMed=7994760;
RX   PubMed=12138894;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   MBC(5)
AC   CVCL_5330
DR   CLO; CLO_0007566
DR   ATCC; CRL-6069
DR   Wikidata; Q54904127
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6069; true.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   MBC02
AC   CVCL_UZ93
DR   Wikidata; Q95985591
RX   PubMed=30828563;
CC   Population: Indian.
CC   Doubling time: ~24 hours (PubMed=30828563).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MBC1
AC   CVCL_T035
SY   Malaysian Breast Carcinoma 1
DR   Wikidata; Q54904131
RX   PubMed=23106969;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Malaysian.
CC   Doubling time: 30.14 hours (PubMed=23106969).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=23106969
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: Not_detected
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 26,27
ST   D3S1358: Not_detected
ST   D5S818: Not_detected
ST   D7S820: 13
ST   D8S1179: 9
ST   FGA: 19,21
ST   TH01: 4,5
ST   TPOX: 6,9
ST   vWA: 15,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   MBC2
AC   CVCL_T036
SY   Malaysian Breast Carcinoma 2
DR   Wikidata; Q54904132
RX   PubMed=23106969;
CC   Population: Chinese; Malaysian.
CC   Doubling time: 35.6 hours (PubMed=23106969).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=23106969
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D21S11: 30,33
ST   D3S1358: 14,17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 20
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 10
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   MBC647
AC   CVCL_UB97
DR   Wikidata; Q95985596
RX   CelloPub=CLPUB00793;
RX   PubMed=25960936;
CC   HLA typing: A*24:02,01:02; B*14:02,49:01; C*02:02,07:01; DQA1*01:02,01:02; DQB1*06:13,05:01; DRB1*15:01,01:02 (PubMed=25960936).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5164; Breast metaplastic carcinoma
DI   ORDO; Orphanet_213531; Metaplastic carcinoma of the breast
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   MBCs
AC   CVCL_YD02
SY   Megalobrama bone cells
DR   Wikidata; Q95985598
RX   DOI=10.11964/jfc.20170310756;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
OX   NCBI_TaxID=75352; ! Megalobrama amblycephala (Chinese blunt snout bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   Mbd3KO
AC   CVCL_AR59
DR   ECACC; 11041301
DR   Wikidata; Q54904133
RX   PubMed=16462733;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1333812; Mbd3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   MBE0918
AC   CVCL_E4ZQ
SY   MBE-00918
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE0953
AC   CVCL_E4ZR
SY   MBE-00953
DR   GEO; GSM7036160
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBE0971
AC   CVCL_E4ZS
SY   MBE-00971
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE0987
AC   CVCL_E4ZT
SY   MBE-00987
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE0994
AC   CVCL_E4ZU
SY   MBE-00994
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE1006
AC   CVCL_E4ZV
SY   MBE-01006
DR   GEO; GSM7036173
DR   GEO; GSM7043202
DR   GEO; GSM7043203
DR   GEO; GSM7043204
DR   GEO; GSM7043205
DR   GEO; GSM7043206
DR   GEO; GSM7043207
DR   GEO; GSM7043208
DR   GEO; GSM7043209
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBE1113
AC   CVCL_E4ZW
SY   MBE-01113
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE1127
AC   CVCL_E4ZX
SY   MBE-01127
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE1135
AC   CVCL_E4ZY
SY   MBE-01135
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE1172
AC   CVCL_E4ZZ
SY   MBE-01172
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE1876
AC   CVCL_E5A0
SY   MBE-01876
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE1880
AC   CVCL_E5A1
SY   MBE-01880
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2055
AC   CVCL_E5A2
SY   MBE-02055
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2073
AC   CVCL_E5A3
SY   MBE-02073
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2077
AC   CVCL_E5A4
SY   MBE-02077
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2085
AC   CVCL_E5A5
SY   MBE-02085
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2089
AC   CVCL_E5A6
SY   MBE-02089
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2091
AC   CVCL_E5A7
SY   MBE-02091
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2157
AC   CVCL_E5A8
SY   MBE-02157
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2612
AC   CVCL_E5A9
SY   MBE-02612
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2533
AC   CVCL_E5AA
SY   MBE-02533
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2817
AC   CVCL_E5AB
SY   MBE-02817
DR   GEO; GSM7036161
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBE2899
AC   CVCL_E5AC
SY   MBE-02899
RX   PubMed=30267684;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBE2900
AC   CVCL_E5AD
SY   MBE-02900
DR   GEO; GSM7036162
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBE2901
AC   CVCL_E5AE
SY   MBE-02901
RX   PubMed=30267684;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBE2905
AC   CVCL_E5AF
SY   MBE-02905
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MBE2906
AC   CVCL_E5AG
SY   MBE-02906
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBE2909
AC   CVCL_E5AH
SY   MBE-02909
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MBEC0
AC   CVCL_B5ZD
DR   Wikidata; Q112930072
RX   PubMed=1356979;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   MBEC2
AC   CVCL_B5ZC
DR   Wikidata; Q112930073
RX   PubMed=1356979;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   MBEC4
AC   CVCL_0407
SY   MBEC-4
DR   MCCL; MCC:0000301
DR   Wikidata; Q54904134
RX   PubMed=1356979;
RX   PubMed=9862771;
RX   PubMed=12958429;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   MBHL-2
AC   CVCL_2I37
DR   CLO; CLO_0050501
DR   RCB; RCB1444
DR   Wikidata; Q54904135
CC   Group: Insect cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 7
//
ID   MBHL-3
AC   CVCL_2I38
DR   CLO; CLO_0050502
DR   ICLDB; mbhl-3
DR   RCB; RCB1445
DR   Wikidata; Q54904136
CC   Group: Insect cell line.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 7
//
ID   MBL-1
AC   CVCL_Z537
DR   Wikidata; Q54904137
RX   PubMed=2120094;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   MBL-2 [Mouse ESC]
AC   CVCL_Z538
DR   Wikidata; Q54904138
RX   PubMed=2120094;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   MBL-2 [Mouse leukemia]
AC   CVCL_J302
SY   MBL2
DR   Wikidata; Q54904139
RX   PubMed=315438;
RX   PubMed=6064953;
RX   PubMed=6970130;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 7
//
ID   MBL-3
AC   CVCL_Z539
DR   Wikidata; Q54904140
RX   PubMed=2120094;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   MbL-3
AC   CVCL_Z542
DR   Wikidata; Q54904141
RX   PubMed=8578995;
CC   Group: Insect cell line.
CC   Doubling time: 33 hours (PubMed=8578995).
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   MBL-4
AC   CVCL_Z540
DR   Wikidata; Q54904142
RX   PubMed=2120094;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   MBL-5
AC   CVCL_Z541
DR   Wikidata; Q54904143
RX   PubMed=2120094;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   MBL-Sm-1A6
AC   CVCL_G235
SY   1A6
DR   CLO; CLO_0007570
DR   ATCC; HB-194
DR   Wikidata; Q54904144
RX   PubMed=2431037;
RX   PubMed=3094144;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06198; Schistosoma mansoni paramyosin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MBL-Sm-4B1
AC   CVCL_G236
SY   4B1
DR   CLO; CLO_0007571
DR   ATCC; HB-193
DR   Wikidata; Q54904145
RX   PubMed=2431037;
RX   PubMed=3094144;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06198; Schistosoma mansoni paramyosin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MBM
AC   CVCL_F271
DR   Wikidata; Q54904146
RX   PubMed=7618261;
CC   Characteristics: IL2 dependent (PubMed=7618261).
CC   Virology: Highly susceptible to infection by feline leukemia virus (FIV) (PubMed=7618261).
CC   Doubling time: ~48 hours (PubMed=7618261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   mBMS-B1
AC   CVCL_6D84
DR   Wikidata; Q54904148
RX   PubMed=9041049;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-6W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   mBMS-B14
AC   CVCL_6D86
DR   Wikidata; Q54904149
RX   PubMed=9041049;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-6W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   mBMS-B18
AC   CVCL_6D87
DR   Wikidata; Q54904150
RX   PubMed=9041049;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-6W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   mBMS-B2
AC   CVCL_6D85
DR   Wikidata; Q54904151
RX   PubMed=9041049;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-6W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   mBMS-B21
AC   CVCL_6D88
DR   Wikidata; Q54904152
RX   PubMed=9041049;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (C57BL/6 x DBA/2) F2-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4-6W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   mbn-2
AC   CVCL_Z706
SY   Mbn-2; mbn2; l(2)mbn; L(2)mbn; Blood II; BII
DR   BTO; BTO_0001898
DR   EFO; EFO_0005820
DR   DGRC; 147
DR   ENCODE; ENCBS358WCU
DR   FlyBase_Cell_line; FBtc0000147
DR   Wikidata; Q54904153
RX   CelloPub=CLPUB00202;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1002/arch.940020307;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=1445351;
RX   PubMed=17890361;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 54 hours (DGRC=147).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   mbn-3
AC   CVCL_0A30
SY   l(3)mbn; Blood III
DR   FlyBase_Cell_line; FBtc9000042
DR   Wikidata; Q54904154
RX   CelloPub=CLPUB00202;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   MBOC79B1
AC   CVCL_C3TU
SY   MBOC79B
DR   Wikidata; Q116049769
RX   Patent=US5171685;
RX   PubMed=2473398;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q17115; Babesia bovis 60 kDa merozoite surface protein rap-1 (Bv60).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MBr1
AC   CVCL_KB25
DR   Wikidata; Q54904155
RX   PubMed=6337705;
RX   PubMed=7506562;
RX   PubMed=9134423;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_59296; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc (Globo-H).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 4
//
ID   MBSa1
AC   CVCL_L364
DR   Wikidata; Q54904156
RX   PubMed=20974873;
CC   Doubling time: ~26 hours (PubMed=20974873).
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C128195; Canine sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   mBstA-Olig1
AC   CVCL_E4KA
RX   PubMed=38788830;
CC   Characteristics: Expresses high level of GFAP (PubMed=38788830).
CC   Doubling time: 2 days (PubMed=38788830).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brainstem; UBERON=UBERON_0002298.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   MBT-2
AC   CVCL_4660
SY   MBT2; Mouse Bladder Tumor line-2
DR   BTO; BTO_0003555
DR   CLO; CLO_0050945
DR   JCRB; IFO50041
DR   RCB; RCB0544
DR   Wikidata; Q54904157
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=406041;
RX   PubMed=16140114;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   MBT-2V
AC   CVCL_VL61
SY   MBT-2 variant
DR   Wikidata; Q95985633
RX   PubMed=16140114;
RX   PubMed=29732388;
CC   Characteristics: High metastatic potential. Established from a lung metastasis nodule in C3H mice implanted with the parent cell line in the leg muscles (PubMed=16140114).
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4660 ! MBT-2
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 7
//
ID   MBU-7
AC   CVCL_B3XU
DR   cancercelllines; CVCL_B3XU
DR   DSMZ; ACC-909
DR   DSMZCellDive; ACC-909
DR   Wikidata; Q110433017
RX   PubMed=34707142;
CC   Population: Caucasian.
CC   Doubling time: 30-40 hours (Direct_author_submission); ~48 hours (DSMZ=ACC-909).
CC   Karyotypic information: Compared to the parent cell line, has a complete trisomy of chromosome 7 (PubMed=34707142).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (PubMed=34707142).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (PubMed=34707142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=34707142).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (PubMed=34707142).
CC   Miscellaneous: Doubling time from personal communication of Diesch, Jeannine.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=34707142
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,16
ST   D21S11: 27,29
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 9
//
ID   MBU-8
AC   CVCL_B3XV
DR   cancercelllines; CVCL_B3XV
DR   DSMZ; ACC-910
DR   DSMZCellDive; ACC-910
DR   Wikidata; Q110433018
RX   PubMed=34707142;
CC   Population: Caucasian.
CC   Doubling time: 30-40 hours (Direct_author_submission); ~30 hours (DSMZ=ACC-910).
CC   Karyotypic information: Compared to the parent cell line, has a complete trisomy of chromosome 18 as well as a partial trisomy of 7 and tetrasomy of 8p (PubMed=34707142).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (PubMed=34707142).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (PubMed=34707142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=34707142).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (PubMed=34707142).
CC   Miscellaneous: Doubling time from personal communication of Diesch, Jeannine.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-910; PubMed=34707142
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,16
ST   D21S11: 27,29
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 10
//
ID   MBU-IM
AC   CVCL_EG12
DR   DSMZ; ACC-796
DR   DSMZCellDive; ACC-796
DR   GEO; GSM1687261
DR   GEO; GSM1687262
DR   GEO; GSM1687263
DR   GEO; GSM1687264
DR   Wikidata; Q54904158
RX   PubMed=27074337;
CC   Doubling time: ~50-60 hours (DSMZ=ACC-796).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): DSMZ=ACC-796
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,34
ST   D2S1338: 24
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9,14
ST   Penta E: 10,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 13,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   MBU-T
AC   CVCL_EG13
DR   DSMZ; ACC-799
DR   DSMZCellDive; ACC-799
DR   GEO; GSM1687265
DR   GEO; GSM1687266
DR   GEO; GSM1687267
DR   GEO; GSM1687268
DR   Wikidata; Q54904160
RX   PubMed=27074337;
CC   Doubling time: ~50-60 hours (DSMZ=ACC-799).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): DSMZ=ACC-799
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,34
ST   D2S1338: 24
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9,14
ST   Penta E: 10,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 13,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EG12 ! MBU-IM
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   MBU-Ts1
AC   CVCL_EG14
SY   MBU-TS1; Ts1
DR   DSMZ; ACC-800
DR   DSMZCellDive; ACC-800
DR   Wikidata; Q54904161
RX   PubMed=27074337;
CC   Characteristics: Derived from a xenograft produced by injection of the parent cell line in nude mice.
CC   Doubling time: ~100-140 hours (DSMZ=ACC-800).
CC   Karyotypic information: 47,XY,der(8)t(5;8)(q13;p21),+20 (PubMed=27074337).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): DSMZ=ACC-800
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,34
ST   D2S1338: 24
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9,14
ST   Penta E: 10,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 13,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EG13 ! MBU-T
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   MBU-Ts4
AC   CVCL_EG15
SY   MBU-TS4; Ts4
DR   DSMZ; ACC-801
DR   DSMZCellDive; ACC-801
DR   GEO; GSM1687269
DR   GEO; GSM1687270
DR   GEO; GSM1687271
DR   Wikidata; Q54904162
RX   PubMed=27074337;
CC   Characteristics: Derived from a xenograft produced by injection of the parent cell line in nude mice.
CC   Doubling time: ~80-100 hours (DSMZ=ACC-801).
CC   Karyotypic information: 47,XY,+20 [5]; 46,XY,-13,+20 [3]; 47,XY,-13,+20,+mar [3] (PubMed=27074337).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): DSMZ=ACC-801
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 24
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9,14
ST   Penta E: 10,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 13,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EG13 ! MBU-T
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   MC
AC   CVCL_W203
DR   Wikidata; Q54904163
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=6986835;
CC   Population: Japanese.
CC   Doubling time: ~12 hours (PubMed=6986835).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   Mc 39-16
AC   CVCL_L537
DR   ECACC; 89072609
DR   Wikidata; Q54904164
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   MC-1 [Human breast carcinoma]
AC   CVCL_LI46
SY   Mammary Carcinoma-1
DR   Wikidata; Q54904165
RX   PubMed=7399746;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   MC-1 [Mouse hybridoma against human MAPT]
AC   CVCL_A2IR
SY   MC1
DR   EFO; EFO_0022790
DR   Wikidata; Q105510043
RX   Patent=US5811310;
RX   PubMed=9130141;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11736.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   MC-1 [Rat fibrosarcoma]
AC   CVCL_A1RG
DR   Wikidata; Q105510046
RX   PubMed=5027480;
CC   Doubling time: ~36 hours (Note=At 48th passage) (PubMed=5027480).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60403; Rat fibrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   MC-1010
AC   CVCL_1396
SY   MC1010
DR   ArrayExpress; E-MTAB-783
DR   cancercelllines; CVCL_1396
DR   Cell_Model_Passport; SIDM00009
DR   Cosmic; 683546
DR   Cosmic; 907798
DR   Cosmic-CLP; 907798
DR   DepMap; ACH-002390
DR   GDSC; 907798
DR   IARC_TP53; 21486
DR   PharmacoDB; MC1010_884_2019
DR   Wikidata; Q54904166
RX   Patent=US5804443;
RX   PubMed=167748;
RX   PubMed=8594420;
RX   PubMed=20164919;
RX   PubMed=30894373;
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12253.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=0.93%; East Asian, North=2.01%; East Asian, South=0%; South Asian=0%; European, North=60.99%; European, South=35.76% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=907798
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D5S818: 11,14
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MC-15
AC   CVCL_A2IW
SY   MC15
DR   Wikidata; Q105510048
RX   Patent=US5811310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11741.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   MC-16
AC   CVCL_A2IX
SY   MC16
DR   Wikidata; Q105510050
RX   Patent=US5811310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11742.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   MC-2
AC   CVCL_A2IS
SY   MC2
DR   Wikidata; Q105510053
RX   Patent=US5811310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11737.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   MC-26
AC   CVCL_0240
SY   MC26; Colon 26; Colon-26; Colon26; C-26; C26
DR   BTO; BTO_0004013
DR   CLO; CLO_0051596
DR   MCCL; MCC:0000130
DR   ChEMBL-Cells; CHEMBL3307623
DR   ChEMBL-Targets; CHEMBL614466
DR   CLS; 400156
DR   NCI-DTP; Colon 26
DR   PubChem_Cell_line; CVCL_0240
DR   RCB; RCB2657
DR   TKG; TKG 0518
DR   Wikidata; Q54904167
RX   PubMed=1149045;
CC   Doubling time: 15-20 hours (CLS=400156).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   MC-3
AC   CVCL_A2IT
SY   MC3
DR   Wikidata; Q105510056
RX   Patent=US5811310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11738.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   MC-38
AC   CVCL_B288
SY   MCA-38; MCA 38; MCA38; MC38; MC-38 B/6; Mouse Colon 38; Murine Carcinoma-38; Colon-38; Colon 38; Colon38; C38
DR   BTO; BTO_0004163
DR   ABM; T8291
DR   CCRID; 1101MOU-PUMC000523
DR   ChEMBL-Cells; CHEMBL3307696
DR   ChEMBL-Targets; CHEMBL612821
DR   CLS; 305223
DR   Kerafast; ENH204-FP
DR   Lonza; 893
DR   Millipore; SCC172
DR   PubChem_Cell_line; CVCL_B288
DR   Ubigene; YC-A002
DR   Wikidata; Q54904168
RX   PubMed=1149045;
RX   PubMed=1255804;
RX   PubMed=16320114;
RX   PubMed=25277546;
RX   PubMed=25428506;
RX   PubMed=25434994;
RX   PubMed=36969213;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/mc38-xenograft-model/
CC   Doubling time: 24.3 hours (PubMed=16320114).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Comparative analysis of MC38 cells obtained from Kerafast (MC38-K) and from Leiden University Medical Center (MC38-L) shows major differences in term of mutations and mRNA expression (PubMed=36969213).
CC   Caution: The authors of PubMed=25434994 indicate that they have sequenced the mitochondrial genome of the 'rat' cell line MCA38. Their submitted DNA sequence (KM820832.1) is indeed a rat sequence but is labelled as originating from 'rat isolate 406'.
CC   Discontinued: CLS; 305223; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC172; Ubigene=YC-A002
ST   Mouse STR 1-1: 15,16,17
ST   Mouse STR 1-2: 18,19,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 16,17 (Ubigene=YC-A002)
ST   Mouse STR 5-5: 17 (Millipore=SCC172)
ST   Mouse STR 6-4: 17,18 (Millipore=SCC172)
ST   Mouse STR 6-4: 18 (Ubigene=YC-A002)
ST   Mouse STR 6-7: 15,16
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16,17,18 (Millipore=SCC172)
ST   Mouse STR 12-1: 17 (Ubigene=YC-A002)
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3 (Millipore=SCC172)
ST   Mouse STR 15-3: 22.3,23.3 (Ubigene=YC-A002)
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 15,16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 26
//
ID   MC-38 B2m-KO
AC   CVCL_D0P4
SY   MC38 B2M-KO
DR   Wikidata; Q123033001
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Miscellaneous: Cell line information from personal communication of Comin-Anduix, Begonya.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 4
//
ID   MC-38-CEA-1
AC   CVCL_5I36
SY   MC-38-cea1
DR   Kerafast; ENH201-FP
DR   Wikidata; Q54904170
RX   PubMed=1712245;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 10
//
ID   MC-38-CEA-2
AC   CVCL_5I37
SY   MC-38-cea2; MC32A
DR   Kerafast; ENH202-FP
DR   Wikidata; Q54904171
RX   PubMed=1712245;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 11
//
ID   MC-38-MUC-1
AC   CVCL_5I38
SY   MC38/MUC1
DR   Kerafast; ENH203-FP
DR   Wikidata; Q54904172
RX   PubMed=9101412;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 10
//
ID   MC-5
AC   CVCL_A2IU
SY   MC5
DR   Wikidata; Q105510059
RX   Patent=US5811310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11739.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   MC-6
AC   CVCL_A2IV
SY   MC6
DR   Wikidata; Q105510062
RX   Patent=US5811310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11740.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   MC-B11/14
AC   CVCL_RN12
SY   MC-B11/14WT
DR   Wikidata; Q54904177
RX   PubMed=29030084;
CC   Characteristics: Produces IgA kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 7
//
ID   MC-B11/14IgA-
AC   CVCL_RN13
DR   Wikidata; Q54904178
RX   PubMed=29030084;
CC   Characteristics: Produces Ig kappa.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5478; IGHA1.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RN12 ! MC-B11/14
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   MC-BR-BTY-0006
AC   CVCL_B7JZ
DR   ABM; T8339
DR   Wikidata; Q112930074
RX   PubMed=34145270;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: Established from a nude mouse xenograft (PubMed=34145270).
CC   Doubling time: 48-72 hours (PubMed=34145270).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Gln2829Leu (c.8486A>C); Zygosity=Homozygous (PubMed=34145270).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174His (c.521G>A); Zygosity=Homozygous (PubMed=34145270).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=34145270
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 14
ST   D7S820: 9,15
ST   D8S1179: 11,13
ST   FGA: 22
ST   Penta D: 13,15
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   MC-BR-BTY-0019
AC   CVCL_B7K0
DR   ABM; T8338
DR   Wikidata; Q112930075
RX   PubMed=34145270;
CC   Characteristics: Established from a nude mouse xenograft (PubMed=34145270).
CC   Characteristics: ER-negative, PR-negative, ERBB2-positive (PubMed=34145270).
CC   Doubling time: 24-48 hours (PubMed=34145270).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34145270).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34145270).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (PubMed=34145270).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Leu2088Profs*11 (c.6261_6262insC); Zygosity=Heterozygous (PubMed=34145270).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (PubMed=34145270).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=34145270
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 14
ST   D21S11: 27,28
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 8,12
ST   FGA: 19,23.2
ST   Penta D: 8,12
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   MC-MA1
AC   CVCL_D025
DR   Wikidata; Q54904173
RX   PubMed=8120418;
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MC-NB-1
AC   CVCL_E058
DR   CLO; CLO_0051541
DR   BioSample; SAMN03472326
DR   RCB; RCB0482
DR   Wikidata; Q54904179
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=6616438;
RX   PubMed=6888561;
CC   Population: Caucasian.
CC   Doubling time: ~35 hours (PubMed=6616438).
CC   Misspelling: MCN-1; PubMed=6888561.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): RCB=RCB0482
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13,14
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 17
//
ID   MC-SV-HUC T-1
AC   CVCL_IP86
SY   MC-SV-HUC T1; MC-T1
DR   Wikidata; Q54904180
RX   PubMed=1767334;
RX   PubMed=2841047;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   MC-SV-HUC T-10
AC   CVCL_IP89
SY   MC-SV-HUC T10
DR   Wikidata; Q54904181
RX   PubMed=2841047;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   MC-SV-HUC T-11
AC   CVCL_IP90
SY   MC-SV-HUC T11
DR   Wikidata; Q54904182
RX   PubMed=2841047;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   MC-SV-HUC T-16
AC   CVCL_IP91
SY   MC-SV-HUC T16; MC-T16
DR   Wikidata; Q54904183
RX   PubMed=1311637;
RX   PubMed=1767334;
RX   PubMed=2841047;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   MC-SV-HUC T-2
AC   CVCL_6418
SY   MC-SV-HUC T2; MC-T2
DR   CLO; CLO_0007620
DR   ATCC; CRL-9519
DR   BCRC; 60409
DR   BioSample; SAMN03471217
DR   Wikidata; Q54904184
RX   Patent=US4980290;
RX   PubMed=2841047;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9519.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-9519
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 17
ST   D5S818: 12,14
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 10,20
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   MC-SV-HUC T-7
AC   CVCL_IP87
SY   MC-SV-HUC T7
DR   Wikidata; Q54904185
RX   PubMed=2841047;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   MC-SV-HUC T-9
AC   CVCL_IP88
SY   MC-SV-HUC T9
DR   Wikidata; Q54904186
RX   PubMed=2841047;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   MC-TGS17-51
AC   CVCL_4982
SY   MC-TGS17-51 [Mutatect]; MC17-51; Mutatect
DR   CLO; CLO_0007579
DR   ATCC; CRL-2799
DR   Wikidata; Q54904187
RX   PubMed=7577474;
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4983 ! MC1A-C1
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MC/8
AC   CVCL_C5RQ
SY   Cl. MC/8
DR   Wikidata; Q116049770
RX   PubMed=6972009;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: C57BL/6 x A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Factor-dependent cell line
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 4
//
ID   MC/9
AC   CVCL_0408
SY   MC9; CL MC/9; Cl. MC/9
DR   CLO; CLO_0007574
DR   MCCL; MCC:0000302
DR   ATCC; CRL-3616
DR   ATCC; CRL-8306
DR   ChEMBL-Cells; CHEMBL3307723
DR   ChEMBL-Targets; CHEMBL614867
DR   Lonza; 1232
DR   NCBI_Iran; C588
DR   PubChem_Cell_line; CVCL_0408
DR   Wikidata; Q54904188
RX   Patent=US4559310;
RX   PubMed=6972009;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MC%2f9
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8306.
CC   Characteristics: IL3 dependent.
CC   Discontinued: ATCC; CRL-8306; true.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: C57BL/6 x A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   MC/9.IL4
AC   CVCL_5428
DR   Wikidata; Q54904189
RX   PubMed=8018917;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MC%2f9%2eIL4
CC   Characteristics: IL4 dependent.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: C57BL/6 x A/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0408 ! MC/9
SX   Sex unspecified
AG   13FD
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   MC/CAR
AC   CVCL_1397
SY   MC-CAR; MCCAR
DR   CLO; CLO_0007575
DR   EFO; EFO_0002229
DR   CLDB; cl5227
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-8083
DR   BioSample; SAMN03471132
DR   CCRID; 4201HUM-CCTCC00324
DR   CCTCC; GDC0324
DR   Cell_Model_Passport; SIDM00636
DR   ChEMBL-Cells; CHEMBL3308240
DR   ChEMBL-Targets; CHEMBL2366274
DR   Cosmic; 683665
DR   Cosmic; 2131565
DR   Cosmic-CLP; 683665
DR   DepMap; ACH-002270
DR   EGA; EGAS00001000978
DR   GDSC; 683665
DR   GEO; GSM1670075
DR   IARC_TP53; 21487
DR   IGRhCellID; MCCAR
DR   IZSLER; BS TCL 134
DR   LINCS_LDP; LCL-1538
DR   PharmacoDB; MCCAR_885_2019
DR   PubChem_Cell_line; CVCL_1397
DR   Wikidata; Q54904190
RX   DOI=10.1007/0-306-46877-8_4;
RX   Patent=US4434230;
RX   PubMed=2537114;
RX   PubMed=10516762;
RX   PubMed=10936422;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10516762).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8083.
CC   Population: Caucasian.
CC   Characteristics: Produces IgG1 kappa.
CC   Doubling time: 19.94 hours (Patent=US4434230).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000160364; Zygosity=Heterozygous (PubMed=12068308; ATCC=CRL-8083).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=66.92%; European, South=32.76% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-8083; Cosmic-CLP=683665; IZSLER=BS TCL 134
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 30 (IZSLER=BS TCL 134)
ST   D21S11: 30,31.2 (ATCC=CRL-8083)
ST   D2S1338: 16,20
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 9,13
ST   D8S1179: 10,13
ST   FGA: 19,20
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   MC/CAR-Z2
AC   CVCL_6671
SY   MC-CAR-Z2; MNS-2
DR   CLO; CLO_0007576
DR   ATCC; CRL-8147
DR   BioSample; SAMN03471194
DR   Cell_Model_Passport; SIDM00635
DR   Wikidata; Q54904191
RX   Patent=US4647535;
CC   Group: Patented cell line.
CC   Problematic cell line: Misclassified. Parent cell line (MC/CAR) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8147.
CC   Population: Caucasian.
CC   Doubling time: ~20-24 hours (ATCC=CRL-8147).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000160364; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-8147
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 16,20
ST   D3S1358: 15,16
ST   D5S818: 11,14,15
ST   D7S820: 9,13
ST   D8S1179: 10,13
ST   FGA: 19,20
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1397 ! MC/CAR
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   MC1
AC   CVCL_H810
DR   Wikidata; Q54904192
CC   From: Johns Hopkins University Transgenic Core Facility; Baltimore; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   MC116
AC   CVCL_1399
SY   MC-116; MC 116
DR   CLO; CLO_0007577
DR   CLO; CLO_0007578
DR   EFO; EFO_0002228
DR   CLDB; cl3354
DR   CLDB; cl3355
DR   AddexBio; C0003021/4914
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1649
DR   BCRC; 60292
DR   BioSample; SAMN03473002
DR   BioSample; SAMN10987876
DR   cancercelllines; CVCL_1399
DR   Cell_Model_Passport; SIDM00637
DR   ChEMBL-Cells; CHEMBL3308210
DR   ChEMBL-Targets; CHEMBL2366256
DR   Cosmic; 687847
DR   Cosmic; 907799
DR   Cosmic; 931128
DR   Cosmic; 1086339
DR   Cosmic-CLP; 907799
DR   DepMap; ACH-000583
DR   DSMZ; ACC-82
DR   DSMZCellDive; ACC-82
DR   ECACC; 90110501
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 907799
DR   GEO; GSM887289
DR   GEO; GSM888364
DR   GEO; GSM1374642
DR   GEO; GSM1670074
DR   IARC_TP53; 174
DR   IGRhCellID; MC116
DR   LiGeA; CCLE_880
DR   LINCS_LDP; LCL-1946
DR   Lonza; 1350
DR   PharmacoDB; MC116_887_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1399
DR   PubChem_Cell_line; CVCL_1399
DR   Wikidata; Q54904193
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=3026973;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=6286763;
RX   PubMed=7757991;
RX   PubMed=8220424;
RX   PubMed=8316623;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8558920;
RX   PubMed=8568269;
RX   PubMed=9473234;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=8402660); ~24-48 hours (DSMZ=ACC-82).
CC   HLA typing: A*01:01,03:01; B*08:01,35:01; C*04:01,07:01; DQA1*01:03,03:02; DQB1*03:09,06:03; DRB1*04:01,13:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.22%; East Asian, South=0%; South Asian=3.09%; European, North=64.91%; European, South=30.78% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): AddexBio=C0003021/4914; ATCC=CRL-1649; Cosmic-CLP=907799; DSMZ=ACC-82; ECACC=90110501; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,24
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 20,26
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 9.3,10
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   MC1A-C1
AC   CVCL_4983
DR   Wikidata; Q54904194
RX   PubMed=7577474;
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MC2/3
AC   CVCL_4588
DR   CLO; CLO_0007580
DR   ATCC; CRL-2143
DR   Wikidata; Q54904195
RX   PubMed=8000142;
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HE53 ! CAK-TK-
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MC21C
AC   CVCL_C3BW
DR   Wikidata; Q114312226
RX   PubMed=1694801;
RX   PubMed=2471655;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_18296; Chondroitin 6'-sulfate (Chondroitin sulfate C).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   MC3
AC   CVCL_0087
SY   MC-3
DR   CLO; CLO_0007581
DR   Cosmic; 787502
DR   Cosmic; 1012085
DR   Wikidata; Q54904196
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1884023;
RX   PubMed=7787756;
RX   PubMed=8632663;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=16408098;
RX   PubMed=20809971;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=7787756; PubMed=10071072; PubMed=10576511; PubMed=20809971).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   MC38 B2m KO clone 1B2
AC   CVCL_E8T9
SY   MC38-mB2M-KO-1B2
DR   KYinno; KC-1081
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MC38 B2m KO clone 1B3
AC   CVCL_E8TA
SY   MC38-mB2M-KO-1B3
DR   KYinno; KC-0962
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MC38 human PDL1
AC   CVCL_XZ58
SY   MC38-PDL1
DR   KYinno; KC-0984
DR   Wikidata; Q95985683
CC   Doubling time: ~48 hours (KYinno=KC-0984).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 10
//
ID   MC38-hCD39-LZ
AC   CVCL_E8H1
SY   genO-MC38-hCD39-LZ
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/mc38-hcd39-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:102805; Entpd1 (Note=With a fully humanized extracellular domain).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MC38-hPD-L1
AC   CVCL_B7NL
DR   Wikidata; Q112930076
WW   Provider; genOway; -; https://www.genoway.com/catalog/cells/cl/mc38-hpd-l1.htm
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7NM ! MC38-PD-L1 KO
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   MC38-hPD-L1-hCD47-LZ
AC   CVCL_E6BK
SY   genO-MC38-hPD-L1-hCD47-LZ
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/mc38-pd-l1-cd47-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1682; CD47.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7Q0 ! MC38-hPD-L1-LZ
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   MC38-hPD-L1-hHER2-LZ
AC   CVCL_E6BJ
SY   genO-MC38-hPD-L1-hHER2-LZ
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/mc38-hpd-l1-hher2-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7Q0 ! MC38-hPD-L1-LZ
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 3
//
ID   MC38-hPD-L1-LZ
AC   CVCL_B7Q0
SY   genO-MC38-hPD-L1-LZ
DR   Wikidata; Q112930077
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/mc38-hpd-l1-lz
CC   Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7NL ! MC38-hPD-L1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   MC38-Luc
AC   CVCL_C8VZ
DR   Ubigene; YC-A002-Luc-P
DR   Wikidata; Q123033002
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   MC38-Luc-RFP
AC   CVCL_B7NQ
SY   Luciferase/tdTomato Dual-Reporter MC38 Cell Line
DR   Wikidata; Q112930078
WW   Provider; ALSTEM; LRL04; https://www.alstembio.com/web/product_details.php?id=41
CC   Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   MC38-PD-L1 KO
AC   CVCL_B7NM
SY   MC38-Pd-l1 Knockout; genO-MC38-Pd-l1KO
DR   Wikidata; Q112930079
WW   Provider; genOway; -; https://www.genoway.com/product/catalog/mc38-pd-l1-ko
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 7
//
ID   MC38-OVA
AC   CVCL_XJ96
DR   BioGRID_ORCS_Cell_line; 1263
DR   Wikidata; Q95985685
RX   PubMed=26453748;
CC   Characteristics: Transduced with a OVA-IRES-EGFP construct (PubMed=26453748).
CC   Genetic integration: Method=Transduction; Gene=CGNC; 49631; OVAL/SERPINB14.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 8
//
ID   MC38/0
AC   CVCL_0A68
DR   Wikidata; Q54904198
RX   PubMed=15055737;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 6
//
ID   MC38/EGFP
AC   CVCL_B9UL
DR   Wikidata; Q112930080
RX   PubMed=15055737;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0A68 ! MC38/0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 7
//
ID   MC38/IL-12
AC   CVCL_0A69
DR   Wikidata; Q54904199
RX   PubMed=15055737;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96539; Il12a.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96540; Il12b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0A68 ! MC38/0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 8
//
ID   MC38Luc1
AC   CVCL_0A67
DR   Wikidata; Q54904200
RX   PubMed=19128467;
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (PubMed=19128467).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   MC38Luc4
AC   CVCL_B9CM
DR   Wikidata; Q112930081
RX   PubMed=19128467;
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (PubMed=19128467).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 7
//
ID   MC38Luc8
AC   CVCL_B9CN
DR   Wikidata; Q112930082
RX   PubMed=19128467;
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (PubMed=19128467).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 7
//
ID   MC3T3
AC   CVCL_0D74
SY   MC-3T3; MC3T3-E
DR   BTO; BTO_0005485
DR   Lonza; 1345
DR   Wikidata; Q6714803
RX   DOI=10.2330/joralbiosci1965.23.899;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MC3T3
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   MC3T3-E1
AC   CVCL_0409
SY   Mc3T3-E1; MC3T3E1; MC-3T3-E1; MC 3T3-E1
DR   BTO; BTO_0001957
DR   CLO; CLO_0007582
DR   CLO; CLO_0050208
DR   MCCL; MCC:0000303
DR   CLDB; cl40
DR   ATCC; CRL-2953
DR   CCRID; 1101MOU-PUMC000012
DR   CCTCC; GDC0188
DR   ChEMBL-Cells; CHEMBL4295391
DR   ChEMBL-Targets; CHEMBL4296463
DR   DSMZ; ACC-210
DR   DSMZCellDive; ACC-210
DR   ECACC; 99072810
DR   FCS-free; 185-5-353-1-3-3
DR   Lonza; 521
DR   PubChem_Cell_line; CVCL_0409
DR   RCB; RCB1126
DR   Wikidata; Q54904201
RX   DOI=10.2330/joralbiosci1965.23.899;
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=6826647;
RX   PubMed=8612673;
RX   PubMed=10352097;
RX   PubMed=11136541;
RX   PubMed=12638602;
RX   PubMed=25277546;
RX   PubMed=37712227;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-393.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MC3T3
CC   Group: Space-flown cell line (cellonaut).
CC   Doubling time: ~1-2 days (DSMZ=ACC-210).
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: Have been flown in space on shuttle flights STS-56, STS-76, STS-81 and STS-84 to study growth and differentiation in microgravity (PubMed=8612673; PubMed=12638602).
CC   Discontinued: ATCC; CRL-2953; true.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): PubMed=37712227
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-7: 17
ST   Mouse STR 12-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 18-3: 15
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0D74 ! MC3T3
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   MC3T3-E1 Subclone 11
AC   CVCL_VT93
DR   Wikidata; Q95985693
RX   PubMed=10352097;
CC   Characteristics: Forms a well mineralized extracellular matrix (ECM).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   MC3T3-E1 Subclone 14
AC   CVCL_5437
SY   MC3T3-E1 SUBCLONE 14
DR   CLO; CLO_0007583
DR   ATCC; CRL-2594
DR   BCRJ; 0285
DR   CCRID; 3101MOUGNM15
DR   CLS; 305185
DR   KCB; KCB 200786YJ
DR   Ubigene; YC-C026
DR   Wikidata; Q54904202
RX   PubMed=10352097;
CC   Characteristics: Exhibits high levels of osteoblast differentiation after growth in ascorbic acid and 3 to 4 mM inorganic phosphate. Forms a well mineralized extracellular matrix (ECM) after 10 days (ATCC=CRL-2594).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Ubigene=YC-C026
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 12-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 18-3: 15
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MC3T3-E1 Subclone 14-Luc
AC   CVCL_C8WY
DR   Ubigene; YC-C026-Luc-P
DR   Wikidata; Q123033003
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5437 ! MC3T3-E1 Subclone 14
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MC3T3-E1 Subclone 17
AC   CVCL_VT94
DR   Wikidata; Q95985695
RX   PubMed=10352097;
CC   Characteristics: Does not form a mineralized extracellular matrix.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   MC3T3-E1 Subclone 20
AC   CVCL_VT95
DR   Wikidata; Q95985696
RX   PubMed=10352097;
CC   Characteristics: Does not form a mineralized extracellular matrix.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   MC3T3-E1 Subclone 24
AC   CVCL_5438
DR   CLO; CLO_0007584
DR   ATCC; CRL-2595
DR   CLS; 305186
DR   IZSLER; BS CL 201
DR   Wikidata; Q54904203
RX   CelloPub=CLPUB00625;
RX   PubMed=10352097;
CC   Characteristics: Exhibits poor osteoblast differentiation after growth in ascorbic acid. Does not form a mineralized extracellular matrix (ATCC=CRL-2595).
CC   Doubling time: 90.5 hours (CelloPub=CLPUB00625).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   MC3T3-E1 Subclone 26
AC   CVCL_VT96
DR   Wikidata; Q95985697
RX   PubMed=10352097;
CC   Characteristics: Forms a well mineralized extracellular matrix (ECM).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   MC3T3-E1 Subclone 30
AC   CVCL_5439
DR   CLO; CLO_0007585
DR   ATCC; CRL-2596
DR   Wikidata; Q54904204
RX   PubMed=10352097;
CC   Characteristics: Exhibits poor osteoblast differentiation after growth in ascorbic acid. Does not form a mineralized extracellular matrix (ATCC=CRL-2596).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MC3T3-E1 Subclone 35
AC   CVCL_VT97
DR   Wikidata; Q95985699
RX   PubMed=10352097;
CC   Characteristics: Does not form a mineralized extracellular matrix.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   MC3T3-E1 Subclone 4
AC   CVCL_5440
SY   MC3T3, E1 subgroup-4 clone; MC3T3-E1(C4); MC-4
DR   BTO; BTO_0004473
DR   CLO; CLO_0007586
DR   ATCC; CRL-2593
DR   IZSLER; BS CL 181
DR   TOKU-E; 2372
DR   Wikidata; Q54904205
RX   CelloPub=CLPUB00625;
RX   PubMed=10352097;
RX   PubMed=23430347;
CC   Characteristics: Exhibits high levels of osteoblast differentiation after growth in ascorbic acid and 3 to 4 mM inorganic phosphate. Forms a well mineralized extracellular matrix (ECM) after 10 days (ATCC=CRL-2593).
CC   Doubling time: 51.6 hours (CelloPub=CLPUB00625); ~38 hours (ATCC=CRL-2593).
CC   Miscellaneous: STR profile from personal communication of Almeida, Jamie L.; PubMed=23430347 has a different value for STR 6-4 (17) than that submitted (18) due to a change in the marker motif.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Direct_author_submission; PubMed=23430347
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 15
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   MC3T3-E1 Subclone 8
AC   CVCL_VT98
DR   Wikidata; Q95985701
RX   PubMed=10352097;
CC   Characteristics: Forms a well mineralized extracellular matrix (ECM).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   MC3T3-G2/PA6
AC   CVCL_5441
SY   MC3T3-G2-PA6; PA6
DR   RCB; RCB1127
DR   Wikidata; Q54904206
RX   PubMed=1708811;
RX   PubMed=2787384;
RX   PubMed=3264531;
RX   PubMed=6699098;
RX   PubMed=7107717;
RX   PubMed=7107718;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PA6
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MC3T3-NM4
AC   CVCL_B6H0
DR   Wikidata; Q112930083
RX   PubMed=11136541;
RX   PubMed=30439569;
CC   Characteristics: Compared to the parent cell line, lost the ability for mineral deposition (PubMed=11136541).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0409 ! MC3T3-E1
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MC4-L1
AC   CVCL_0R48
DR   Wikidata; Q54904207
RX   PubMed=11196177;
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0R49 ! MC4-L2
OI   CVCL_0R50 ! MC4-L3
OI   CVCL_0R51 ! MC4-L5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 7
//
ID   MC4-L2
AC   CVCL_0R49
DR   IBRC; C10167
DR   Wikidata; Q54904208
RX   PubMed=11196177;
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0R48 ! MC4-L1
OI   CVCL_0R50 ! MC4-L3
OI   CVCL_0R51 ! MC4-L5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 8
//
ID   MC4-L3
AC   CVCL_0R50
DR   Wikidata; Q54904209
RX   PubMed=11196177;
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0R48 ! MC4-L1
OI   CVCL_0R49 ! MC4-L2
OI   CVCL_0R51 ! MC4-L5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 7
//
ID   MC4-L5
AC   CVCL_0R51
DR   Wikidata; Q54904210
RX   PubMed=11196177;
CC   Transformant: ChEBI; CHEBI_6716; Medroxyprogesterone acetate (MPA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0R48 ! MC4-L1
OI   CVCL_0R49 ! MC4-L2
OI   CVCL_0R50 ! MC4-L3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 7
//
ID   MC4000
AC   CVCL_5331
SY   MC-4000
DR   BioSample; SAMN03151743
DR   Wikidata; Q54904211
RX   PubMed=9150904;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00143.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MC5
AC   CVCL_1N49
SY   MC-5
DR   Wikidata; Q54904212
RX   PubMed=2687628;
RX   PubMed=7404270;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 8
//
ID   MC5-5
AC   CVCL_LF97
DR   Wikidata; Q54904213
RX   PubMed=4359949;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   MC57G
AC   CVCL_4985
SY   MC57
DR   BTO; BTO_0005218
DR   CLO; CLO_0007587
DR   ATCC; CRL-2295
DR   Lonza; 130
DR   Wikidata; Q54904214
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   MC615
AC   CVCL_0410
DR   MCCL; MCC:0000304
DR   Wikidata; Q54904215
RX   PubMed=7682698;
RX   PubMed=16222708;
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   MC615 4B5
AC   CVCL_H341
SY   4B5
DR   Wikidata; Q54904216
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4C1
AC   CVCL_H342
SY   4C1
DR   Wikidata; Q54904217
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4C3
AC   CVCL_H343
SY   4C3
DR   Wikidata; Q54904219
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4C6
AC   CVCL_H344
SY   4C6
DR   Wikidata; Q54904220
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4C9
AC   CVCL_H345
SY   4C9
DR   Wikidata; Q54904221
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4D5
AC   CVCL_H346
SY   4D5
DR   Wikidata; Q54904222
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4D7
AC   CVCL_H347
SY   4D7
DR   Wikidata; Q54904223
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4E3
AC   CVCL_H348
SY   4E3
DR   Wikidata; Q54904224
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4F6
AC   CVCL_H349
SY   4F6
DR   Wikidata; Q54904225
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4G11
AC   CVCL_H350
SY   4G11
DR   Wikidata; Q54904226
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 4H4
AC   CVCL_H351
SY   4H4
DR   Wikidata; Q54904227
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 5A2
AC   CVCL_H352
SY   5A2
DR   Wikidata; Q54904228
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 5F12
AC   CVCL_H353
SY   5F12
DR   Wikidata; Q54904229
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC615 5F9
AC   CVCL_H354
SY   5F9
DR   Wikidata; Q54904230
RX   PubMed=19670270;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic limb, cartilage; UBERON=UBERON_0010881.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0410 ! MC615
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MC7-2A
AC   CVCL_0R52
DR   Wikidata; Q54904231
RX   PubMed=14758093;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0R53 ! MC7-2B
OI   CVCL_0R54 ! MC7-L1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 4
//
ID   MC7-2B
AC   CVCL_0R53
DR   Wikidata; Q54904232
RX   PubMed=14758093;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0R52 ! MC7-2A
OI   CVCL_0R54 ! MC7-L1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 4
//
ID   MC7-L1
AC   CVCL_0R54
DR   Wikidata; Q54904233
RX   PubMed=11196177;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0R52 ! MC7-2A
OI   CVCL_0R53 ! MC7-2B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 4
//
ID   MC8
AC   CVCL_A0GY
DR   Wikidata; Q108820853
RX   PubMed=34092457;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0GX ! MB5
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   MCA 197
AC   CVCL_A9KD
SY   197
DR   Wikidata; Q108820854
RX   Patent=US6471962;
RX   Patent=WO1991005569A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10158.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MCA 57
AC   CVCL_A9KB
SY   57
DR   Wikidata; Q108820856
RX   Patent=US6471962;
RX   Patent=WO1991005569A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10156.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (isolate GLS) (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MCA 67
AC   CVCL_A9KA
SY   67
DR   ATCC; HB-11122
DR   Wikidata; Q108820857
RX   Patent=US5632989;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11122.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (isolate Delaware) (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MCA 8
AC   CVCL_A9KE
SY   8
DR   Wikidata; Q108820859
RX   Patent=US6471962;
RX   Patent=WO1991005569A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10174.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MCA B29
AC   CVCL_G637
SY   MCA-B29; B29; B-29
DR   CLO; CLO_0001811
DR   ATCC; HB-9746
DR   IZSLER; BS Hy 49
DR   Wikidata; Q54752591
RX   Patent=US5064646;
RX   Patent=WO1991005569A1;
RX   PubMed=2848486;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9746.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (IBDV).
CC   Discontinued: ATCC; HB-9746; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   MCA B69
AC   CVCL_4504
SY   MCA-B69; B69; B-69
DR   CLO; CLO_0001826
DR   CLDB; cl5140
DR   ATCC; HB-9437
DR   IZSLER; BS Hy 44
DR   Wikidata; Q54752742
RX   Patent=US4956452;
RX   Patent=US5064646;
RX   PubMed=2848486;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9437.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   MCA BK70
AC   CVCL_A9JZ
SY   BK70
DR   Wikidata; Q108820860
RX   PubMed=2848486;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MCA BK9
AC   CVCL_A9KC
SY   BK9; BK-9
DR   ATCC; HB-10157
DR   Wikidata; Q108820862
RX   Patent=US5632989;
RX   Patent=US6471962;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10157.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (isolate Delaware) (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MCA R63
AC   CVCL_4551
SY   MCA-R63; R63; R-63
DR   CLO; CLO_0008720
DR   CLDB; cl5251
DR   IZSLER; BS Hy 45
DR   Wikidata; Q54949058
RX   Patent=US4956452;
RX   Patent=US5064646;
RX   PubMed=2848486;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9490.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Avian infectious bursal disease virus (IBDV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   MCA-205
AC   CVCL_VR90
SY   MCA 205; MCA205
DR   Lonza; 1177
DR   Millipore; SCC173
DR   Wikidata; Q95985779
CC   Characteristics: Excellent model for studying the immune responses to tumor cells and for supporting the development of targeted cancer immunotherapies (Millipore=SCC173).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC173
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 14,15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13,14
ST   Mouse STR X-1: 27
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   MCA-B1
AC   CVCL_W820
DR   DSMZ; ACC-828
DR   DSMZCellDive; ACC-828
DR   Wikidata; Q54904234
RX   PubMed=7709052;
CC   Doubling time: 9 hours (PubMed=7709052); ~24 hours (DSMZ=ACC-828).
CC   Breed/subspecies: Akita; VBO=VBO_0200010.
DI   NCIt; C134956; Canine acanthomatous epulis
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 11
//
ID   McA-RH7777
AC   CVCL_0444
SY   McA-RH 7777; MCA-RH 7777; McArdle RH-7777; McARH7777; RH7777; Mc Ardle 7777
DR   BTO; BTO_0000358
DR   CLO; CLO_0007594
DR   CLO; CLO_0007595
DR   EFO; EFO_0022781
DR   MCCL; MCC:0000340
DR   CLDB; cl3362
DR   CLDB; cl3363
DR   CLDB; cl3364
DR   CLDB; cl4991
DR   ATCC; CRL-1601
DR   BCRJ; 0159
DR   ChEMBL-Cells; CHEMBL3307729
DR   ChEMBL-Targets; CHEMBL614876
DR   ECACC; 90021504
DR   ICLC; ATL00002
DR   IZSLER; BS TCL 217
DR   Lonza; 1280
DR   PubChem_Cell_line; CVCL_0444
DR   Wikidata; Q54904235
RX   CelloPub=CLPUB00636;
RX   PubMed=7543018;
RX   PubMed=19386608;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-142.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-595.html
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_2113 ! MH-7777A
OI   CVCL_0F78 ! 7777-14b-aza
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   McA-RH8994
AC   CVCL_3396
SY   McA-RH 8994; RH8994; McArdle RH-8994
DR   CLO; CLO_0007596
DR   ATCC; CRL-1602
DR   BCRC; 60232
DR   Wikidata; Q54904236
RX   CelloPub=CLPUB00636;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-growth-and-morphology-of-crl-1602
CC   Transformant: ChEBI; CHEBI_189411; 4'-(p-fluorophenyl)acetanilide (N-(4'-fluoro-4-biphenyl)acetamide; FBPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   MCa3D
AC   CVCL_5797
SY   MCA3D; MCA-3D; MCA/3D; MCA 3D
DR   CLS; 400437
DR   NCBI_Iran; C619
DR   Wikidata; Q54904239
RX   PubMed=1934268;
RX   PubMed=6196137;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MCa3F
AC   CVCL_5U31
SY   MCA-3F; MCA 3F
DR   Wikidata; Q54904240
RX   PubMed=1934268;
RX   PubMed=6196137;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   MCAS
AC   CVCL_3020
DR   CLO; CLO_0037094
DR   EFO; EFO_0006453
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 557
DR   BioSample; SAMN03472857
DR   BioSample; SAMN10988206
DR   cancercelllines; CVCL_3020
DR   Cell_Model_Passport; SIDM00008
DR   CGH-DB; 343-2
DR   CGH-DB; 9356-4
DR   Cosmic; 849612
DR   Cosmic; 931362
DR   Cosmic; 948290
DR   Cosmic; 1240171
DR   Cosmic; 1707559
DR   Cosmic; 2429301
DR   Cosmic; 2582802
DR   Cosmic; 2674701
DR   DepMap; ACH-000796
DR   EGA; EGAS00001000610
DR   FANTOM5_SSTAR; 10784-110H1
DR   GDSC; 1240171
DR   GEO; GSM659382
DR   GEO; GSM827228
DR   GEO; GSM851924
DR   GEO; GSM887290
DR   GEO; GSM888365
DR   GEO; GSM1340583
DR   JCRB; JCRB0240
DR   LiGeA; CCLE_290
DR   LINCS_LDP; LCL-1493
DR   PharmacoDB; MCAS_888_2019
DR   Progenetix; CVCL_3020
DR   TKG; TKG 0662
DR   Wikidata; Q54904241
RX   PubMed=4056530;
RX   PubMed=9290701;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
RX   PubMed=20215515;
RX   PubMed=22246397;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25846456;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 27 hours (PubMed=4056530); ~28 hours (Note=Lot 03262008), ~20 hours (Note=Lot 01202012), ~39 hours (Note=Lot 08162016) (JCRB=JCRB0240).
CC   HLA typing: A*02:06,24:02; B*40:02,46:01; C*01:02,03:05; DQA1*02:01,03:02; DRB1*03:01,14:82 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (DepMap=ACH-000796).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=25846456; DepMap=ACH-000796).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=25846456; DepMap=ACH-000796).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser504Arg (c.1512T>A); Zygosity=Unspecified (PubMed=25846456).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.1%; East Asian, South=21.89%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): JCRB=JCRB0240; PubMed=22710073; PubMed=25877200; PubMed=30485824; TKG=TKG 0662
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 14.2,15
ST   D21S11: 29,31
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,12
ST   FGA: 18,21
ST   Penta D: 10,12
ST   Penta E: 16
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   MCAS-3
AC   CVCL_U210
DR   cancercelllines; CVCL_U210
DR   Wikidata; Q54904242
RX   PubMed=7882618;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser504Arg (c.1512T>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3020 ! MCAS
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   MCB3901
AC   CVCL_6419
SY   AV12-664; AV12; AV-12
DR   CLO; CLO_0007597
DR   ATCC; CRL-9595
DR   CCRID; 4201PAT-CCTCC00034
DR   Wikidata; Q54904243
RX   Patent=US4975369;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9595.
CC   Doubling time: 14-16 hours (ATCC=CRL-9595).
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12.
CC   Discontinued: ATCC; CRL-9595; true.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   MCC
AC   CVCL_UG10
DR   Wikidata; Q95985790
RX   PubMed=2161827;
RX   PubMed=8138999;
RX   PubMed=21029758;
CC   Doubling time: 39 hours (PubMed=2161827).
CC   Derived from site: In situ; Mesenteric lymph node; UBERON=UBERON_0002509.
CC   Breed/subspecies: American longhair; VBO=VBO_0100013.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 4
//
ID   MCC-1
AC   CVCL_D730
DR   Cosmic; 1623851
DR   Wikidata; Q54904244
RX   PubMed=11319762;
CC   Doubling time: 69 hours (PubMed=11319762).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   MCC-2
AC   CVCL_6B10
DR   Wikidata; Q54904245
RX   PubMed=11329612;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Rib, costal cartilage; UBERON=UBERON_0002236.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MCC-35
AC   CVCL_6B12
DR   Wikidata; Q54904246
RX   PubMed=11329612;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Rib, costal cartilage; UBERON=UBERON_0002236.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MCC-5
AC   CVCL_6B11
DR   Wikidata; Q54904247
RX   PubMed=11329612;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Rib, costal cartilage; UBERON=UBERON_0002236.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MCC-38
AC   CVCL_A1QL
SY   P2-CL; CL2
DR   cancercelllines; CVCL_A1QL
DR   GEO; GSM4563056
DR   Wikidata; Q102114711
RX   PubMed=33087752;
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=33087752).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=33087752
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13,15,16,17
ST   D16S539: 11,13.1
ST   D5S818: 12
ST   D7S820: 8.3,12
ST   TH01: 6,7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   MCC-60
AC   CVCL_LM85
AS   CVCL_A1QM
SY   P3-CL; CL3
DR   cancercelllines; CVCL_LM85
DR   DSMZ; ACC-815
DR   DSMZCellDive; ACC-815
DR   GEO; GSM4563057
DR   Wikidata; Q54904248
RX   PubMed=33087752;
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=33087752); ~70-80 hours (DSMZ=ACC-815).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Heterozygous (PubMed=33087752).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DSMZ=ACC-815; PubMed=33087752
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12 (DSMZ=ACC-815)
ST   CSF1PO: 11,12 (PubMed=33087752)
ST   D13S317: 10 (DSMZ=ACC-815)
ST   D13S317: 13 (PubMed=33087752)
ST   D16S539: 8,14
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 33,34
ST   D2S1338: 17,24
ST   D3S1358: 13,18,19
ST   D5S818: 11,13
ST   D7S820: 9.3,10.3,13 (PubMed=33087752)
ST   D7S820: 12 (DSMZ=ACC-815)
ST   D8S1179: 11,13
ST   FGA: 19,20,22.2
ST   Penta D: 12,14
ST   Penta E: 16
ST   TH01: 7,8,9 (PubMed=33087752)
ST   TH01: 7,9 (DSMZ=ACC-815)
ST   TPOX: 8 (DSMZ=ACC-815)
ST   TPOX: 8,11 (PubMed=33087752)
ST   vWA: 13,18 (PubMed=33087752)
ST   vWA: 14,18 (DSMZ=ACC-815)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   MCC1 [Human Merkel cell carcinoma]
AC   CVCL_4558
SY   MCC1TC; MCC1 TC
DR   Cosmic; 912927
DR   Wikidata; Q54904249
RX   PubMed=8026890;
RX   PubMed=8244578;
RX   PubMed=10994482;
RX   PubMed=11433400;
RX   PubMed=12209986;
CC   Characteristics: Derived from a xenograft (PubMed=8244578).
CC   Doubling time: 6 days (PubMed=8244578).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1335 but was never distributed.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   MCC1 [Human mucinous cystic carcinoma]
AC   CVCL_D729
DR   cancercelllines; CVCL_D729
DR   IARC_TP53; 22831
DR   Wikidata; Q54904250
RX   PubMed=15688169;
CC   Doubling time: 72 +- 12 hours (PubMed=15688169).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=15688169).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=15688169).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Unspecified (PubMed=15688169).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C41247; Pancreatic mucinous-cystic neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   MCC12
AC   CVCL_4446
SY   MCC12TC; MCC12 TC
DR   Wikidata; Q54904251
RX   PubMed=8026890;
RX   PubMed=10994482;
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1337 but was never distributed.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   MCC121c
AC   CVCL_A7AP
DR   RCB; RCB5006
DR   Wikidata; Q107116150
RX   PubMed=31019292;
CC   Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   MCC13
AC   CVCL_2583
SY   MCC13TC; MCC13 TC
DR   BioSample; SAMN07624419
DR   cancercelllines; CVCL_2583
DR   CBA; CBA-1338
DR   Cell_Model_Passport; SIDM00007
DR   Cosmic; 912929
DR   Cosmic; 1693075
DR   Cosmic; 1699815
DR   Cosmic; 2273913
DR   Cosmic-CLP; 1333003
DR   DepMap; ACH-001550
DR   ECACC; 10092302
DR   GDSC; 1333003
DR   IARC_TP53; 12477
DR   PharmacoDB; MCC13_889_2019
DR   PRIDE; PXD004198
DR   PRIDE; PXD008181
DR   Wikidata; Q54904252
RX   PubMed=7814141;
RX   PubMed=8026890;
RX   PubMed=10732753;
RX   PubMed=10994482;
RX   PubMed=11433400;
RX   PubMed=12209986;
RX   PubMed=12209990;
RX   PubMed=20444890;
RX   PubMed=22363598;
RX   PubMed=23563200;
RX   PubMed=27402257;
RX   PubMed=30894373;
RX   PubMed=31889939;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 1 day (PubMed=20444890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Pro (c.721T>C); ClinVar=VCV000376664; Zygosity=Heterozygous (PubMed=10732753; PubMed=23563200).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Heterozygous (PubMed=10732753; PubMed=23563200).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=1.16%; South Asian=3.02%; European, North=64.74%; European, South=31.08% (PubMed=30894373).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): CBA=CBA-1338; DepMap=ACH-001550
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D19S433: 15
ST   D21S11: 30,31
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 9,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 19,20
ST   Penta D: 13,14
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 33
//
ID   MCC138c
AC   CVCL_A7AQ
DR   RCB; RCB5007
DR   Wikidata; Q107116154
RX   PubMed=31019292;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice (PubMed=31019292).
CC   Doubling time: 48 hours (RCB=RCB5007).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   MCC14/1
AC   CVCL_4447
SY   MCC14-1; MCC14/1TC; MCC14/1 TC
DR   Cell_Model_Passport; SIDM01359
DR   Cosmic; 912930
DR   Wikidata; Q54904253
RX   PubMed=7814141;
RX   PubMed=8026890;
RX   PubMed=10994482;
RX   PubMed=11433400;
RX   PubMed=12209986;
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1339 but is not yet ready for distribution.
CC   Derived from site: Metastatic; Iliac lymph node; UBERON=UBERON_0015878.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2584 ! MCC14/2
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   MCC14/2
AC   CVCL_2584
SY   MCC14-2; MCC14/2TC; MCC14/2 TC; MCC142
DR   BioSample; SAMN07624420
DR   cancercelllines; CVCL_2584
DR   CBA; CBA-1340
DR   Cell_Model_Passport; SIDM01360
DR   Cosmic; 912931
DR   Cosmic; 2273914
DR   DepMap; ACH-001551
DR   ECACC; 10092303
DR   IARC_TP53; 12478
DR   Wikidata; Q54904254
RX   PubMed=7814141;
RX   PubMed=8026890;
RX   PubMed=10732753;
RX   PubMed=10994482;
RX   PubMed=11433400;
RX   PubMed=12209986;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Glu (c.815T>A); ClinVar=VCV000376673; Zygosity=Unspecified (PubMed=10732753; DepMap=ACH-001551).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Iliac lymph node; UBERON=UBERON_0015878.
ST   Source(s): CBA=CBA-1340; DepMap=ACH-001551
ST   Amelogenin: X
ST   CSF1PO: 10 (CBA=CBA-1340)
ST   CSF1PO: 10,11 (DepMap=ACH-001551)
ST   D13S317: 13
ST   D16S539: 13
ST   D18S51: 12,15,17 (CBA=CBA-1340)
ST   D18S51: 15,17 (DepMap=ACH-001551)
ST   D19S433: 12,14
ST   D21S11: 29,32.2
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4447 ! MCC14/1
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   MCC148c
AC   CVCL_A7AR
DR   RCB; RCB5008
DR   Wikidata; Q107116156
RX   PubMed=31019292;
RX   PubMed=38639832;
CC   Population: Korean.
CC   Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice (PubMed=31019292).
CC   Doubling time: 48 hours (RCB=RCB5008).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   MCC15
AC   CVCL_D021
SY   MCC15TC; MCC15 TC
DR   Cell_Model_Passport; SIDM01358
DR   Wikidata; Q54904255
RX   PubMed=7814141;
RX   PubMed=8026890;
RX   PubMed=10994482;
RX   PubMed=11433400;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 13
//
ID   MCC19
AC   CVCL_4448
SY   MCC19TC; MCC19 TC
DR   Cosmic; 912932
DR   Wikidata; Q54904256
RX   PubMed=10994482;
RX   PubMed=11433400;
RX   PubMed=12209986;
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1343 but was never distributed.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   MCC2
AC   CVCL_F1G3
RX   PubMed=8244578;
RX   PubMed=10994482;
CC   Doubling time: 7 days (PubMed=8244578).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCC26
AC   CVCL_2585
SY   MCC26TC; MCC26 TC
DR   BioSample; SAMN07624421
DR   cancercelllines; CVCL_2585
DR   CBA; CBA-1341
DR   Cell_Model_Passport; SIDM00006
DR   Cosmic; 912933
DR   Cosmic; 1693076
DR   Cosmic; 1699816
DR   Cosmic; 2273915
DR   Cosmic-CLP; 1298234
DR   DepMap; ACH-001552
DR   ECACC; 10092304
DR   GDSC; 1298234
DR   PharmacoDB; MCC26_890_2019
DR   PRIDE; PXD004198
DR   Wikidata; Q54904257
RX   PubMed=10732753;
RX   PubMed=10994482;
RX   PubMed=12209986;
RX   PubMed=12209990;
RX   PubMed=22363598;
RX   PubMed=23563200;
RX   PubMed=27402257;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Karyotypic information: Hypotriploid karyotype.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (Cosmic-CLP=1298234; DepMap=ACH-001552).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg556Ter (c.1666C>T); ClinVar=VCV000013090; Zygosity=Heterozygous (Cosmic-CLP=1298234; DepMap=ACH-001552).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Genome ancestry: African=0%; Native American=0.82%; East Asian, North=1.72%; East Asian, South=0%; South Asian=0%; European, North=66.7%; European, South=30.75% (PubMed=30894373).
ST   Source(s): CBA=CBA-1341; DepMap=ACH-001552
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13,14
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D19S433: 16
ST   D21S11: 31,32.2
ST   D2S1338: 23,26
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 8,10
ST   FGA: 24,25
ST   Penta D: 12,14
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 31
//
ID   MCC3
AC   CVCL_F1G4
RX   PubMed=8244578;
RX   PubMed=10994482;
CC   Doubling time: 7.5 days (PubMed=8244578).
CC   Derived from site: In situ; Cheek, skin; UBERON=UBERON_0008803.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCC4
AC   CVCL_F1G5
RX   PubMed=8244578;
RX   PubMed=10994482;
CC   Doubling time: 8 days (PubMed=8244578).
CC   Derived from site: In situ; Cheek, skin; UBERON=UBERON_0008803.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCC5
AC   CVCL_4444
SY   MCC5TC; MCC5 TC
DR   Wikidata; Q54904259
RX   PubMed=8026890;
RX   PubMed=8244578;
RX   PubMed=10994482;
RX   PubMed=11433400;
RX   PubMed=12209986;
CC   Doubling time: 7 days (PubMed=8244578).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1336 but was never distributed.
CC   Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   MCC6
AC   CVCL_4445
SY   MCC6TC; MCC6 TC
DR   Cosmic; 912928
DR   ECACC; 21102105
DR   Wikidata; Q54904261
RX   PubMed=8026890;
RX   PubMed=8244578;
RX   PubMed=10994482;
RX   PubMed=11433400;
RX   PubMed=12209986;
CC   Doubling time: 10.5 days (PubMed=8244578).
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1334 but was never distributed.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   mCCDcl1
AC   CVCL_B7HR
SY   mCCD(cl1); mCCD-CL1; mCCD cl1; mouse Cortical Collecting Duct clone 1
DR   ABM; T0620
DR   Wikidata; Q112930084
RX   PubMed=15743993;
RX   PubMed=19297448;
RX   PubMed=21178974;
RX   PubMed=29357433;
CC   Characteristics: Expresses epithelial sodium channels (ENaC) as well as the necessary cellular machinery to enable their stimulation by physiological concentrations of aldosterone, including 11-betahydroxysteroid dehydrogenase (HSD11b2), mineralocorticoid and glucocorticoid receptors and have therefore been used as a model for the study of principal cells physiology (PubMed=15743993; PubMed=29357433).
CC   Doubling time: ~24 hours (Direct_author_submission).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Doubling time from personal communication of Rossier, Bernard Claude.
CC   Miscellaneous: Sex of mouse and STR profile from personal communication of Hummler, Edith.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Cell type: Kidney collecting duct principal cell; CL=CL_1001431.
ST   Source(s): ABM=T0620; Direct_author_submission
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 17.3 (Direct_author_submission)
ST   Mouse STR 6-4: 18 (ABM=T0620)
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 26.2,27.2,31
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,17
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   mCCDcl1 Ed1
AC   CVCL_B7HS
SY   Ed1
DR   Wikidata; Q112930085
RX   PubMed=29357433;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Cell type: Kidney collecting duct principal cell; CL=CL_1001431.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7HR ! mCCDcl1
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   mCCDcl1 Ed2
AC   CVCL_B7HT
SY   Ed2
DR   Wikidata; Q112930086
RX   PubMed=29357433;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Cell type: Kidney collecting duct principal cell; CL=CL_1001431.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7HR ! mCCDcl1
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   mCCDcl1 Ed3
AC   CVCL_B7HU
SY   Ed3
DR   Wikidata; Q112930087
RX   PubMed=29357433;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Cell type: Kidney collecting duct principal cell; CL=CL_1001431.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7HR ! mCCDcl1
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   MCCI0001i-HCM
AC   CVCL_QX48
DR   Wikidata; Q54904262
RX   PubMed=28395744;
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:1391; CACNA1D; Simple; p.Glu827Lys (c.2479G>A) (p.Glu847Lys, c.2539G>A); ClinVar=VCV001371026; Zygosity=Heterozygous (PubMed=28395744).
CC   Sequence variation: Mutation; HGNC; HGNC:12582; UQCRB; Simple; p.Arg34Gln (c.101G>A) (p.Arg2Gln, c.5G>A); Zygosity=Heterozygous (PubMed=28395744).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   MCCI0002i-HCM
AC   CVCL_QX49
DR   Wikidata; Q54904263
RX   PubMed=28395747;
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Val698Ala (c.2093T>C); ClinVar=VCV000042878; Zygosity=Heterozygous (PubMed=28395747).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395747
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 13,14
ST   D18S51: 14,17
ST   D19S433: 12,15
ST   D21S11: 28,29
ST   D2S1338: 17
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 10,12
ST   FGA: 20,24
ST   Penta D: 11,15
ST   Penta E: 13
ST   TH01: 6,7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   MCCI0003i-HCM
AC   CVCL_UG23
SY   IK1
DR   Wikidata; Q95985816
RX   PubMed=30316040;
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg502Trp (c.1504C>T); ClinVar=VCV000042540; Zygosity=Heterozygous (PubMed=30316040).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30316040
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 14,15
ST   D16S539: 11,13.1
ST   D18S51: 17.2,18.2
ST   D21S11: 28,29.1
ST   D3S1358: 14,14.3
ST   D5S818: 15,16
ST   D7S820: 8.2,14
ST   D8S1179: 11,13
ST   FGA: 19,22.3
ST   Penta D: 9.4,12.4
ST   Penta E: 12,20.2
ST   TH01: 6.1,10
ST   TPOX: 8,9
ST   vWA: 15.2,18
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   MCCI0004i-HCM
AC   CVCL_UJ68
SY   VG1
DR   Wikidata; Q95985817
RX   PubMed=30508693;
CC   From: Molecular Cardiology, Centenary Institute of Cancer Medicine and Cell Biology; Camperdown; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg403Gln (c.1208G>A); ClinVar=VCV000014087; Zygosity=Heterozygous (PubMed=30508693).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30508693
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,12.2
ST   D18S51: 14,17
ST   D21S11: 29.1,30.1
ST   D3S1358: 15.3,16.2
ST   D5S818: 14,15
ST   D7S820: 10.3,12
ST   D8S1179: 14,15.3
ST   FGA: 20.3,22.3
ST   Penta D: 10
ST   Penta E: 11.4,14.4
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 14,15.2
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   MCCL-1
AC   CVCL_D026
SY   MC-MA2
DR   Cosmic; 740970
DR   Wikidata; Q54904264
RX   PubMed=8120418;
RX   PubMed=11992403;
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MCCL-2
AC   CVCL_IR17
DR   Cosmic; 740972
DR   Wikidata; Q54904265
RX   PubMed=11992403;
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   MCCL-3
AC   CVCL_IR18
DR   Cosmic; 740975
DR   Wikidata; Q54904266
RX   PubMed=11992403;
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   MCCL-4
AC   CVCL_IR19
DR   Cosmic; 740977
DR   Wikidata; Q54904267
RX   PubMed=11992403;
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   MCCL-5
AC   CVCL_IR20
DR   cancercelllines; CVCL_IR20
DR   Cosmic; 740979
DR   Wikidata; Q54904268
RX   PubMed=11992403;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (PubMed=11992403).
CC   Derived from site: In situ; Left clavicle, skin; UBERON=UBERON_8480025.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   MCCL-6
AC   CVCL_IR21
DR   cancercelllines; CVCL_IR21
DR   Cosmic; 740981
DR   Wikidata; Q54904269
RX   PubMed=11992403;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Unspecified (PubMed=11992403).
CC   Derived from site: In situ; Left calf, skin; UBERON=UBERON_8480050.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   McCoy
AC   CVCL_3742
SY   MCCOY; Mc Coy; McCoy B; McC
DR   CLO; CLO_0007573
DR   CLO; CLO_0007598
DR   CLDB; cl3349
DR   CLDB; cl3350
DR   CLDB; cl3352
DR   ATCC; CRL-1696
DR   BCRC; 60064
DR   BCRJ; 0160
DR   BioSample; SAMN03151926
DR   ECACC; 90010305
DR   IZSLER; BS CL 62
DR   NCBI_Iran; C123
DR   Wikidata; Q54904270
RX   PubMed=2754009;
RX   PubMed=4110420;
RX   PubMed=6451928;
RX   PubMed=13531635;
RX   PubMed=20143388;
RX   PubMed=33389257;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; Vircell; -; https://www.vircell.com/en/products/mccoy-cell-line
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be a mouse NCTC clone 929 derivative (PubMed=6451928; PubMed=20143388). Were thought to originate from the synovial fluid in the knee joint of a patient suffering from degenerative arthritis.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00079.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MCD-1
AC   CVCL_M701
DR   Wikidata; Q54904271
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8971690;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 24 hours (PubMed=8971690).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MCDU1i-EPDC
AC   CVCL_QX41
DR   Wikidata; Q54904272
RX   PubMed=28395740;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Heart, epicardium; UBERON=UBERON_0002348.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX42 ! MCDU2i-EPDC
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   MCDU2i-EPDC
AC   CVCL_QX42
DR   Wikidata; Q54904274
RX   PubMed=28395740;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Heart, epicardium; UBERON=UBERON_0002348.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX41 ! MCDU1i-EPDC
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   MCDV-12
AC   CVCL_C8RM
SY   MCDV12
DR   Wikidata; Q123033004
RX   PubMed=1057174;
RX   PubMed=6064953;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MCE301
AC   CVCL_6B09
SY   MCE 301
DR   Wikidata; Q54904275
RX   PubMed=11235898;
RX   PubMed=11520047;
RX   PubMed=16678170;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Embryonic colon, distal; UBERON=UBERON_0008971.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   17-18FD
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   MCEC
AC   CVCL_D355
SY   Mouse Cardiac Endothelial Cells
DR   ABM; T0722
DR   Wikidata; Q54904276
RX   PubMed=17317723;
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/7ff6adb1-944d-49fc-b07d-55694f206704
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU510.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
CC   Breed/subspecies: FVB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2-5D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   MCEC-1
AC   CVCL_B7G8
SY   Murine Cardiac Endothelial Cell line-1
DR   Wikidata; Q112930088
RX   PubMed=11742799;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   MCF 10A Ecadherin EmGFP
AC   CVCL_A4BW
SY   MCF 10A ECAD-EmGFP
DR   ATCC; CRL-10317EMT
DR   Wikidata; Q105510065
CC   Characteristics: Using CRISPR/Cas9 CDH1 has been tagged in one allele at the C-terminus with EmGFP. Allows to monitor the epithelial-to-mesenchymal transition (EMT) status of cells in vitro by monitoring EmGFP expression.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-10317EMT
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 10
//
ID   MCF 10A-H2B-mCherry
AC   CVCL_IV14
DR   LINCS_HMS; 51124
DR   Wikidata; Q54904277
RX   PubMed=27135972;
CC   Characteristics: Retroviral transformation with an H2B-mCherry expression cassette.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   MCF-10-2A
AC   CVCL_3743
DR   BTO; BTO_0006398
DR   CLO; CLO_0007602
DR   ATCC; CRL-10781
DR   BioSample; SAMN03471306
DR   Wikidata; Q54904278
RX   Patent=US5238840;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10781.
CC   Discontinued: ATCC; CRL-10781; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-10781
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5553 ! MCF-10-2F
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MCF-10-2F
AC   CVCL_5553
DR   ATCC; CRL-10780
DR   BioSample; SAMN03471305
DR   Wikidata; Q54904279
RX   Patent=US5238840;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10780.
CC   Discontinued: ATCC; CRL-10780; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-10780
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3633 ! MCF-10F
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   MCF-10A
AC   CVCL_0598
SY   MCF 10A; MCF.10A; MCF10A; MCF10-A; MCF10a; MCF-10 Attached; Michigan Cancer Foundation-10A
DR   BTO; BTO_0001939
DR   CLO; CLO_0007599
DR   EFO; EFO_0001200
DR   MCCL; MCC:0000305
DR   AddexBio; C0006015/4976
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-10317
DR   BCRJ; 0161
DR   BioGRID_ORCS_Cell_line; 40
DR   BioSample; SAMN03471375
DR   cancercelllines; CVCL_0598
DR   CCRID; 1101HUM-PUMC000406
DR   CCRID; 3101HUMSCSP575
DR   ChEMBL-Cells; CHEMBL3307364
DR   ChEMBL-Targets; CHEMBL614321
DR   CLS; 305026
DR   Cosmic; 1136376
DR   Cosmic; 1176649
DR   Cosmic; 2318371
DR   Cosmic; 2560254
DR   DepMap; ACH-001357
DR   EGA; EGAS00001000610
DR   ENCODE; ENCBS066ENC
DR   ENCODE; ENCBS067ENC
DR   ENCODE; ENCBS317EPD
DR   ENCODE; ENCBS417KGL
DR   ENCODE; ENCBS617ENC
DR   ENCODE; ENCBS618ENC
DR   ENCODE; ENCBS619ENC
DR   ENCODE; ENCBS620ENC
DR   ENCODE; ENCBS621ENC
DR   ENCODE; ENCBS622ENC
DR   ENCODE; ENCBS623ENC
DR   ENCODE; ENCBS868SSJ
DR   GEO; GSM50033
DR   GEO; GSM155217
DR   GEO; GSM320171
DR   GEO; GSM350543
DR   GEO; GSM498022
DR   GEO; GSM498026
DR   GEO; GSM756371
DR   GEO; GSM844584
DR   GEO; GSM845395
DR   GEO; GSM1053724
DR   GEO; GSM1172882
DR   GEO; GSM1172973
DR   GEO; GSM1238116
DR   GEO; GSM1328939
DR   GEO; GSM1328940
DR   GEO; GSM1328941
DR   GEO; GSM2258704
DR   GEO; GSM2258705
DR   GEO; GSM2258706
DR   GEO; GSM2258707
DR   GEO; GSM2258708
DR   GEO; GSM2258709
DR   GEO; GSM2258710
DR   GEO; GSM2258711
DR   GEO; GSM2258712
DR   GEO; GSM2258713
DR   GEO; GSM2258714
DR   GEO; GSM2258715
DR   GEO; GSM2258716
DR   GEO; GSM2258717
DR   GEO; GSM2258718
DR   GEO; GSM2258719
DR   GEO; GSM2258720
DR   GEO; GSM2258721
DR   GEO; GSM2258944
DR   GEO; GSM2258945
DR   GEO; GSM2258946
DR   GEO; GSM2862786
DR   GEO; GSM2862787
DR   GEO; GSM2862788
DR   IARC_TP53; 24292
DR   IBRC; C10788
DR   IGRhCellID; MCF10A
DR   IZSLER; BS CL 174
DR   KCB; KCB 2014066YJ
DR   LINCS_HMS; 50583
DR   LINCS_LDP; LCL-2085
DR   Lonza; 131
DR   MetaboLights; MTBLS401
DR   NCBI_Iran; C609
DR   PharmacoDB; MCF10A_891_2019
DR   PRIDE; PXD000309
DR   PRIDE; PXD000593
DR   PRIDE; PXD000691
DR   PRIDE; PXD003370
DR   PRIDE; PXD005339
DR   PRIDE; PXD008222
DR   PRIDE; PXD009668
DR   PRIDE; PXD028400
DR   Progenetix; CVCL_0598
DR   PubChem_Cell_line; CVCL_0598
DR   TOKU-E; 2378
DR   Wikidata; Q54904280
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   Patent=US5436152;
RX   PubMed=1975513;
RX   PubMed=12661003;
RX   PubMed=15153330;
RX   PubMed=15375546;
RX   PubMed=16271952;
RX   PubMed=17157791;
RX   PubMed=17334996;
RX   PubMed=19582160;
RX   PubMed=20169162;
RX   PubMed=22414580;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24262153;
RX   PubMed=24389870;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26055192;
RX   PubMed=26218769;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28596718;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=29444910;
RX   PubMed=29561695;
RX   PubMed=30787054;
RX   PubMed=32782317;
RX   PubMed=34238275;
RX   PubMed=35666001;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=81
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10317.
CC   Doubling time: 97.4 hours (PubMed=24389870); 20 hours (PubMed=34238275); 26.74 hours (JWGray panel).
CC   HLA typing: A*01:01,33:01; B*40:01,55:01; C*03:03,07:02; DQA1*02:01,03:02; DQB1*03:05,03:05; DRB1*04:02,11:44 (PubMed=25960936).
CC   HLA typing: A*01:01,33:01; B*40:01,55:01; C*03:03,07:02; DRB1*01:01,13:10 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17334996).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=17334996).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): AddexBio=C0006015/4976; ATCC=CRL-10317; CCRID; PubMed=25877200; PubMed=28889351; PubMed=29444910; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14,16
ST   D12S391: 17,20
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 18,19
ST   D19S433: 13,15
ST   D1S1656: 16.3,17.3
ST   D21S11: 28,30
ST   D22S1045: 11,18
ST   D2S1338: 21,26
ST   D2S441: 11,14
ST   D3S1358: 14,18
ST   D5S818: 10,13
ST   D6S1043: 12,18
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3633 ! MCF-10F
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   MCF-10A ARID1A (Q456*/Q456*)
AC   CVCL_A2PV
SY   ARID1A (Q456*/Q456*) MCF10A
DR   Horizon_Discovery; HD+101-022
DR   Wikidata; Q105510067
CC   Characteristics: Homozygous knockin of an ARID1A nonsense mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple_edited; p.Gln456Ter (c.1366C>T); Zygosity=Homozygous; Note=By method not specified (Horizon_Discovery=HD+101-022).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 11
//
ID   MCF-10A BRAF (V600K/+)
AC   CVCL_LD72
SY   BRAF (V600K/+) MCF10A
DR   Horizon_Discovery; HD+101-015
DR   Wikidata; Q54904281
CC   Characteristics: Heterozygous knockin of a BRAF activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-015).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   MCF-10A BRCA1 (185delAG/+)
AC   CVCL_A2PT
SY   BRCA1 (185delAG/+) MCF10A
DR   Horizon_Discovery; HD+101-018
DR   Wikidata; Q105510071
RX   PubMed=21987798;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple_edited; p.Glu23Valfs*17 (c.68_69delAG) (c.66_67AG[1]) (185delAG); ClinVar=VCV000017662; Zygosity=Heterozygous; Note=By homologous recombination (PubMed=21987798).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   MCF-10A CTNNB1 (T41A/+/+)
AC   CVCL_A2PU
SY   CTNNB1 (T41A/+/+) MCF10A
DR   Horizon_Discovery; HD+101-009
DR   Wikidata; Q105510074
CC   Characteristics: Heterozygous knockin of a CTNNB1 activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple_edited; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-009).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 10
//
ID   MCF-10A EGFR (delE746-A750/+)
AC   CVCL_LE03
SY   EGFR (deltaE746-A750/+) MCF10A
DR   Horizon_Discovery; HD+101-010
DR   Wikidata; Q54904282
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Glu746_Ala750del; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-010).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   MCF-10A EGFR (L858R/+)
AC   CVCL_LD15
SY   EGFR (L858R/+) MCF10A
DR   Horizon_Discovery; HD+101-016
DR   Wikidata; Q54904283
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-016).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   MCF-10A EGFR (L861Q/+)
AC   CVCL_LD16
SY   EGFR (L861Q/+) MCF10A
DR   Horizon_Discovery; HD+101-017
DR   Wikidata; Q54904284
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Leu861Gln (c.2582T>A); ClinVar=VCV000163380; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-017).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   MCF-10A EGFR (T790M/+)
AC   CVCL_LD17
SY   EGFR (T790M/+) MCF10A
DR   Horizon_Discovery; HD+101-019
DR   Wikidata; Q54904285
CC   Characteristics: Heterozygous knockin of a EGFR mutation conferring drug resistance.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-019).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   MCF-10A IDH1 (R132H/+)
AC   CVCL_LD73
SY   IDH1 (R132H/+) MCF10A
DR   Horizon_Discovery; HD+101-013
DR   Wikidata; Q54904286
CC   Characteristics: Heterozygous knockin of a IDH1 dominant negative mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple_edited; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-013).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   MCF-10A KRAS (G12V/+)
AC   CVCL_LD74
SY   KRAS (G12V/+) MCF10A
DR   Horizon_Discovery; HD+101-004
DR   Wikidata; Q54904287
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-004).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   MCF-10A PIK3CA (E545K/+)
AC   CVCL_LD75
SY   PIK3CA (E545K/+) MCF10A
DR   Horizon_Discovery; HD+101-002
DR   Wikidata; Q54904288
CC   Characteristics: Heterozygous knockin of a PIK3CA helix domain activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-002).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   MCF-10A PIK3CA (H1047R/+)
AC   CVCL_LD55
SY   PIK3CA (H1047R/+) MCF10A
DR   Horizon_Discovery; HD+101-011
DR   Wikidata; Q54904289
CC   Characteristics: Heterozygous knockin of a PIK3CA kinase domain activating mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-011).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   MCF-10A PTEN(-/-)
AC   CVCL_JM26
SY   PTEN (-/-) MCF10A
DR   Horizon_Discovery; HD+101-006
DR   Wikidata; Q54904290
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   MCF-10A RAC1 (Q61L/+)
AC   CVCL_LD76
SY   RAC1 (Q61L/+) MCF10A
DR   Horizon_Discovery; HD+101-014
DR   Wikidata; Q54904291
CC   Characteristics: Heterozygous knockin of a RAC1 mutation.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple_edited; p.Gln61Leu (c.182A>T); Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+101-014).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 14
//
ID   MCF-10A shPARG
AC   CVCL_RA88
SY   shPARG MCF10A
DR   Wikidata; Q54904292
RX   PubMed=29166620;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   MCF-10A TP53(-/-)
AC   CVCL_JM25
SY   TP53 (-/-) MCF10A
DR   Horizon_Discovery; HD+101-005
DR   Wikidata; Q54904293
RX   PubMed=20562907;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   MCF-10A-erbB-2
AC   CVCL_IP85
SY   MCF-10AerbB-2
DR   Wikidata; Q54904294
RX   PubMed=10433219;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 12
//
ID   MCF-10A-neo
AC   CVCL_6C54
SY   MCF-10A neo; MCF-10ANeo; MCF10A-neo; MCF10Aneo
DR   Wikidata; Q54904295
RX   PubMed=1885681;
RX   PubMed=2009132;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   MCF-10A-neoN
AC   CVCL_6C55
SY   MCF-10A neoN; MCF-10AneoN; MCF10AneoN
DR   Wikidata; Q54904296
RX   PubMed=1885681;
RX   PubMed=2009132;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   MCF-10A-neoT
AC   CVCL_5554
SY   MCF-10A neoT; MCF-10AneoT; MCF10AneoT; MCF10-AneoT
DR   BTO; BTO_0005127
DR   ChEMBL-Cells; CHEMBL4295460
DR   ChEMBL-Targets; CHEMBL4296464
DR   PubChem_Cell_line; CVCL_5554
DR   Wikidata; Q54904297
RX   PubMed=1885681;
RX   PubMed=2009132;
RX   PubMed=11261825;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   MCF-10A/Twist
AC   CVCL_DS00
DR   Wikidata; Q54904298
RX   PubMed=20019840;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12428; TWIST1.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   MCF-10Acherry
AC   CVCL_E2QN
SY   MCF10Acherry
RX   PubMed=29569804;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MCF-10AGFP
AC   CVCL_E2QP
SY   MCF10AGFP
RX   PubMed=29569804;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MCF-10AT
AC   CVCL_5555
SY   MCF10AT
DR   cancercelllines; CVCL_5555
DR   GEO; GSM498023
DR   GEO; GSM498027
DR   IGRhCellID; MCF10AT
DR   Progenetix; CVCL_5555
DR   Wikidata; Q54904299
RX   PubMed=8546221;
RX   PubMed=15375546;
RX   PubMed=20169162;
RX   PubMed=24262153;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5554 ! MCF-10A-neoT
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   MCF-10F
AC   CVCL_3633
SY   MCF 10F; MCF10F; MCF-10 Floating; Michigan Cancer Foundation-10F
DR   BTO; BTO_0003900
DR   CLO; CLO_0007600
DR   ATCC; CRL-10318
DR   Cosmic; 1136377
DR   GEO; GSM115080
DR   GEO; GSM115081
DR   GEO; GSM115082
DR   GEO; GSM1172883
DR   GEO; GSM1172974
DR   LINCS_HMS; 50584
DR   LINCS_LDP; LCL-2102
DR   PharmacoDB; MCF10F_893_2019
DR   Wikidata; Q54904300
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   Patent=US5436152;
RX   PubMed=1975513;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=18056439;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Group: Patented cell line.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10318.
CC   Doubling time: 47.44 hours (JWGray panel).
CC   HLA typing: A*01:01,33:01; B*40:01,55:01; C*07:02,03:03 (PubMed=25960936).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-10318
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5553 ! MCF-10-2F
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   MCF-12A
AC   CVCL_3744
SY   MCF12A; Michigan Cancer Foundation-12A
DR   BTO; BTO_0002544
DR   CLO; CLO_0007603
DR   CLO; CLO_0037180
DR   EFO; EFO_0001202
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-3598
DR   ATCC; CRL-10782
DR   BioSample; SAMN03472816
DR   ChEMBL-Cells; CHEMBL3307365
DR   ChEMBL-Targets; CHEMBL614322
DR   Cosmic; 1017163
DR   Cosmic; 1136378
DR   Cosmic; 1176637
DR   Cosmic; 2560249
DR   DepMap; ACH-002327
DR   GEO; GSM756372
DR   GEO; GSM844585
DR   GEO; GSM845396
DR   GEO; GSM1053717
DR   GEO; GSM1172884
DR   GEO; GSM1172975
DR   GEO; GSM1238117
DR   LINCS_HMS; 51089
DR   LINCS_LDP; LCL-2082
DR   PharmacoDB; MCF12A_894_2019
DR   PRIDE; PXD005339
DR   PubChem_Cell_line; CVCL_3744
DR   TOKU-E; 2381
DR   Wikidata; Q54904301
RX   Patent=US5206165;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25960936;
RX   PubMed=28287265;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-of-the-crl-10782-mcf-12a-cells
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10782.
CC   Population: Caucasian.
CC   Doubling time: ~19 hours (ATCC=CRL-3598); 35.42 hours (JWGray panel).
CC   HLA typing: A*66:01,02:01; B*41:02,18:01/35:08; C*07:01,17:01; DRB1*11:67,11:67 (PubMed=25960936).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-10782; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-3598
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 18
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 23,26
ST   Penta D: 9,12
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3745 ! MCF-12F
SX   Female
AG   63Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   MCF-12F
AC   CVCL_3745
SY   MCF12F; Michigan Cancer Foundation-12F
DR   BTO; BTO_0002545
DR   CLO; CLO_0007604
DR   ATCC; CRL-3599
DR   ATCC; CRL-10783
DR   GEO; GSM756373
DR   Wikidata; Q54904303
RX   Patent=US5206165;
RX   PubMed=24162158;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10783.
CC   Population: Caucasian.
CC   Doubling time: ~20 hours (ATCC=CRL-3599).
CC   Discontinued: ATCC; CRL-10783; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-3599
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3744 ! MCF-12A
SX   Female
AG   63Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   MCF-12F DMBA
AC   CVCL_RI40
SY   MCF-12FDMBA; MCF12FDMBA
DR   Wikidata; Q54904304
RX   PubMed=16195238;
CC   Population: Caucasian.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3745 ! MCF-12F
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF-12F MNU
AC   CVCL_RI41
SY   MCF-12FMNU; MCF12FMNU
DR   Wikidata; Q54904305
RX   PubMed=16195238;
CC   Population: Caucasian.
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3745 ! MCF-12F
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF-7
AC   CVCL_0031
SY   MCF 7; MCF.7; MCF7; Michigan Cancer Foundation-7; ssMCF-7; ssMCF7; MCF7/WT; MCF7-CTRL; IBMF-7
DR   BTO; BTO_0000093
DR   CLO; CLO_0007601
DR   CLO; CLO_0007605
DR   CLO; CLO_0007606
DR   CLO; CLO_0050868
DR   EFO; EFO_0001203
DR   MCCL; MCC:0000307
DR   CLDB; cl3366
DR   CLDB; cl3367
DR   CLDB; cl3368
DR   CLDB; cl3369
DR   CLDB; cl3370
DR   CLDB; cl3371
DR   CLDB; cl3372
DR   CLDB; cl3373
DR   CLDB; cl3375
DR   Abcam; ab257303
DR   Abcam; ab271144
DR   Abcam; ab277916
DR   Abcam; ab288560
DR   ABM; T8978
DR   AddexBio; C0006008/402
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-11134
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-22
DR   BCRC; 60436
DR   BCRJ; 0162
DR   BioGRID_ORCS_Cell_line; 940
DR   BioSample; SAMN01821575
DR   BioSample; SAMN01821646
DR   BioSample; SAMN01821698
DR   BioSample; SAMN03473276
DR   BioSample; SAMN05292458
DR   BioSample; SAMN10988179
DR   cancercelllines; CVCL_0031
DR   CCRID; 1101HUM-PUMC000013
DR   CCRID; 1101HUM-PUMC000328
DR   CCRID; 3101HUMSCSP531
DR   CCRID; 3101HUMTCHu74
DR   CCRID; 4201HUM-CCTCC00055
DR   CCTCC; GDC0055
DR   Cell_Model_Passport; SIDM00148
DR   ChEMBL-Cells; CHEMBL3308403
DR   ChEMBL-Targets; CHEMBL387
DR   CLS; 300273
DR   Cosmic; 687490
DR   Cosmic; 755293
DR   Cosmic; 809239
DR   Cosmic; 871143
DR   Cosmic; 875876
DR   Cosmic; 877449
DR   Cosmic; 894096
DR   Cosmic; 897419
DR   Cosmic; 904373
DR   Cosmic; 905946
DR   Cosmic; 912001
DR   Cosmic; 921976
DR   Cosmic; 923059
DR   Cosmic; 934534
DR   Cosmic; 944293
DR   Cosmic; 947352
DR   Cosmic; 949189
DR   Cosmic; 970089
DR   Cosmic; 979723
DR   Cosmic; 991328
DR   Cosmic; 997916
DR   Cosmic; 1000123
DR   Cosmic; 1010932
DR   Cosmic; 1017161
DR   Cosmic; 1018463
DR   Cosmic; 1019310
DR   Cosmic; 1046936
DR   Cosmic; 1047712
DR   Cosmic; 1066224
DR   Cosmic; 1071901
DR   Cosmic; 1092612
DR   Cosmic; 1102382
DR   Cosmic; 1136341
DR   Cosmic; 1152527
DR   Cosmic; 1175832
DR   Cosmic; 1176603
DR   Cosmic; 1176648
DR   Cosmic; 1183770
DR   Cosmic; 1287893
DR   Cosmic; 1289391
DR   Cosmic; 1305382
DR   Cosmic; 1308991
DR   Cosmic; 1312369
DR   Cosmic; 1326278
DR   Cosmic; 1434950
DR   Cosmic; 1436031
DR   Cosmic; 1477426
DR   Cosmic; 1481420
DR   Cosmic; 1523770
DR   Cosmic; 1524349
DR   Cosmic; 1571788
DR   Cosmic; 1603215
DR   Cosmic; 1609459
DR   Cosmic; 1945860
DR   Cosmic; 1995500
DR   Cosmic; 1998454
DR   Cosmic; 2162161
DR   Cosmic; 2165024
DR   Cosmic; 2301233
DR   Cosmic; 2301526
DR   Cosmic; 2307194
DR   Cosmic; 2318370
DR   Cosmic; 2361358
DR   Cosmic; 2525755
DR   Cosmic; 2553502
DR   Cosmic; 2560248
DR   Cosmic; 2668278
DR   Cosmic; 2750523
DR   Cosmic-CLP; 905946
DR   DepMap; ACH-000019
DR   DSMZ; ACC-115
DR   DSMZCellDive; ACC-115
DR   ECACC; 86012803
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS000AAA
DR   ENCODE; ENCBS000RXG
DR   ENCODE; ENCBS001AAA
DR   ENCODE; ENCBS017ENC
DR   ENCODE; ENCBS028FSB
DR   ENCODE; ENCBS034XKZ
DR   ENCODE; ENCBS035QUK
DR   ENCODE; ENCBS035TSV
DR   ENCODE; ENCBS036ENC
DR   ENCODE; ENCBS037ENC
DR   ENCODE; ENCBS050QMU
DR   ENCODE; ENCBS053YJT
DR   ENCODE; ENCBS056AAA
DR   ENCODE; ENCBS094ENC
DR   ENCODE; ENCBS095ENC
DR   ENCODE; ENCBS096ENC
DR   ENCODE; ENCBS097ENC
DR   ENCODE; ENCBS098ENC
DR   ENCODE; ENCBS102ENC
DR   ENCODE; ENCBS103ENC
DR   ENCODE; ENCBS104ENC
DR   ENCODE; ENCBS105ENC
DR   ENCODE; ENCBS108ENC
DR   ENCODE; ENCBS110CZN
DR   ENCODE; ENCBS123ZGI
DR   ENCODE; ENCBS134PJO
DR   ENCODE; ENCBS135SOE
DR   ENCODE; ENCBS143XXF
DR   ENCODE; ENCBS148TCA
DR   ENCODE; ENCBS155VQC
DR   ENCODE; ENCBS158RRU
DR   ENCODE; ENCBS168ISE
DR   ENCODE; ENCBS174OTK
DR   ENCODE; ENCBS183ZAS
DR   ENCODE; ENCBS195LAY
DR   ENCODE; ENCBS200IWR
DR   ENCODE; ENCBS216AOQ
DR   ENCODE; ENCBS236AAA
DR   ENCODE; ENCBS237AAA
DR   ENCODE; ENCBS240AAA
DR   ENCODE; ENCBS241AAA
DR   ENCODE; ENCBS242AAA
DR   ENCODE; ENCBS243AAA
DR   ENCODE; ENCBS244AAA
DR   ENCODE; ENCBS245AAA
DR   ENCODE; ENCBS246AAA
DR   ENCODE; ENCBS247AAA
DR   ENCODE; ENCBS248AAA
DR   ENCODE; ENCBS249AAA
DR   ENCODE; ENCBS250AAA
DR   ENCODE; ENCBS251AAA
DR   ENCODE; ENCBS252AAA
DR   ENCODE; ENCBS253AAE
DR   ENCODE; ENCBS254AYH
DR   ENCODE; ENCBS267CRP
DR   ENCODE; ENCBS295JCF
DR   ENCODE; ENCBS295PFW
DR   ENCODE; ENCBS308QKF
DR   ENCODE; ENCBS312USZ
DR   ENCODE; ENCBS325VCY
DR   ENCODE; ENCBS328UKJ
DR   ENCODE; ENCBS331EJR
DR   ENCODE; ENCBS345ZJP
DR   ENCODE; ENCBS351GKC
DR   ENCODE; ENCBS402YIK
DR   ENCODE; ENCBS409BSE
DR   ENCODE; ENCBS448KAT
DR   ENCODE; ENCBS488MMM
DR   ENCODE; ENCBS496HCC
DR   ENCODE; ENCBS523HSQ
DR   ENCODE; ENCBS530DHL
DR   ENCODE; ENCBS536NWC
DR   ENCODE; ENCBS540TUZ
DR   ENCODE; ENCBS546VBU
DR   ENCODE; ENCBS547AXB
DR   ENCODE; ENCBS564FRY
DR   ENCODE; ENCBS567IJO
DR   ENCODE; ENCBS573TKZ
DR   ENCODE; ENCBS581MUA
DR   ENCODE; ENCBS584TFV
DR   ENCODE; ENCBS609QTY
DR   ENCODE; ENCBS614ENC
DR   ENCODE; ENCBS615ENC
DR   ENCODE; ENCBS616ENC
DR   ENCODE; ENCBS616MBU
DR   ENCODE; ENCBS637YEV
DR   ENCODE; ENCBS661RDG
DR   ENCODE; ENCBS670IYV
DR   ENCODE; ENCBS697UNO
DR   ENCODE; ENCBS705BBA
DR   ENCODE; ENCBS726ASX
DR   ENCODE; ENCBS737JTX
DR   ENCODE; ENCBS746EOD
DR   ENCODE; ENCBS747ZRJ
DR   ENCODE; ENCBS748WRO
DR   ENCODE; ENCBS758TZQ
DR   ENCODE; ENCBS764AUT
DR   ENCODE; ENCBS764NNP
DR   ENCODE; ENCBS773JGQ
DR   ENCODE; ENCBS778AGF
DR   ENCODE; ENCBS789UPK
DR   ENCODE; ENCBS842TPF
DR   ENCODE; ENCBS866ZXX
DR   ENCODE; ENCBS867ORK
DR   ENCODE; ENCBS868OVR
DR   ENCODE; ENCBS873NNF
DR   ENCODE; ENCBS902LKX
DR   ENCODE; ENCBS912WOF
DR   ENCODE; ENCBS947NBH
DR   ENCODE; ENCBS957OEW
DR   ENCODE; ENCBS959SHH
DR   ENCODE; ENCBS963BLD
DR   ENCODE; ENCBS967MVZ
DR   ENCODE; ENCBS968SNH
DR   ENCODE; ENCBS973EAA
DR   ENCODE; ENCBS974BZV
DR   FANTOM5_SSTAR; 10482-107A5
DR   GDSC; 905946
DR   GEO; GSM1723
DR   GEO; GSM2111
DR   GEO; GSM2137
DR   GEO; GSM2153
DR   GEO; GSM50183
DR   GEO; GSM50247
DR   GEO; GSM69199
DR   GEO; GSM73693
DR   GEO; GSM115111
DR   GEO; GSM155207
DR   GEO; GSM156025
DR   GEO; GSM185091
DR   GEO; GSM185092
DR   GEO; GSM211175
DR   GEO; GSM274640
DR   GEO; GSM276773
DR   GEO; GSM276774
DR   GEO; GSM276775
DR   GEO; GSM276776
DR   GEO; GSM276777
DR   GEO; GSM276778
DR   GEO; GSM276779
DR   GEO; GSM320172
DR   GEO; GSM344347
DR   GEO; GSM344397
DR   GEO; GSM350552
DR   GEO; GSM378140
DR   GEO; GSM383798
DR   GEO; GSM383799
DR   GEO; GSM383800
DR   GEO; GSM388212
DR   GEO; GSM421869
DR   GEO; GSM459726
DR   GEO; GSM472936
DR   GEO; GSM481303
DR   GEO; GSM510510
DR   GEO; GSM533396
DR   GEO; GSM533413
DR   GEO; GSM590108
DR   GEO; GSM679692
DR   GEO; GSM679693
DR   GEO; GSM679694
DR   GEO; GSM736581
DR   GEO; GSM736588
DR   GEO; GSM739996
DR   GEO; GSM739997
DR   GEO; GSM739998
DR   GEO; GSM749760
DR   GEO; GSM750771
DR   GEO; GSM750777
DR   GEO; GSM750778
DR   GEO; GSM750801
DR   GEO; GSM783949
DR   GEO; GSM799320
DR   GEO; GSM799383
DR   GEO; GSM816438
DR   GEO; GSM816627
DR   GEO; GSM816670
DR   GEO; GSM822295
DR   GEO; GSM822305
DR   GEO; GSM825711
DR   GEO; GSM827593
DR   GEO; GSM839033
DR   GEO; GSM844586
DR   GEO; GSM844587
DR   GEO; GSM847394
DR   GEO; GSM847490
DR   GEO; GSM887291
DR   GEO; GSM888366
DR   GEO; GSM923442
DR   GEO; GSM935445
DR   GEO; GSM935477
DR   GEO; GSM935563
DR   GEO; GSM945269
DR   GEO; GSM945274
DR   GEO; GSM945854
DR   GEO; GSM945857
DR   GEO; GSM967819
DR   GEO; GSM967823
DR   GEO; GSM970217
DR   GEO; GSM970218
DR   GEO; GSM987741
DR   GEO; GSM987742
DR   GEO; GSM987743
DR   GEO; GSM1008565
DR   GEO; GSM1008581
DR   GEO; GSM1008603
DR   GEO; GSM1008904
DR   GEO; GSM1010734
DR   GEO; GSM1010764
DR   GEO; GSM1010768
DR   GEO; GSM1010769
DR   GEO; GSM1010783
DR   GEO; GSM1010791
DR   GEO; GSM1010800
DR   GEO; GSM1010811
DR   GEO; GSM1010825
DR   GEO; GSM1010837
DR   GEO; GSM1010838
DR   GEO; GSM1010839
DR   GEO; GSM1010844
DR   GEO; GSM1010860
DR   GEO; GSM1010861
DR   GEO; GSM1010862
DR   GEO; GSM1010863
DR   GEO; GSM1010864
DR   GEO; GSM1010889
DR   GEO; GSM1010891
DR   GEO; GSM1010892
DR   GEO; GSM1022658
DR   GEO; GSM1022663
DR   GEO; GSM1029440
DR   GEO; GSM1029441
DR   GEO; GSM1029442
DR   GEO; GSM1029443
DR   GEO; GSM1029444
DR   GEO; GSM1029445
DR   GEO; GSM1029446
DR   GEO; GSM1029447
DR   GEO; GSM1029448
DR   GEO; GSM1029449
DR   GEO; GSM1040306
DR   GEO; GSM1040376
DR   GEO; GSM1053687
DR   GEO; GSM1068138
DR   GEO; GSM1068139
DR   GEO; GSM1153389
DR   GEO; GSM1172885
DR   GEO; GSM1178359
DR   GEO; GSM1178360
DR   GEO; GSM1181258
DR   GEO; GSM1181263
DR   GEO; GSM1214589
DR   GEO; GSM1238132
DR   GEO; GSM1322270
DR   GEO; GSM1322272
DR   GEO; GSM1322273
DR   GEO; GSM1322274
DR   GEO; GSM1328112
DR   GEO; GSM1374643
DR   GEO; GSM1374644
DR   GEO; GSM1374645
DR   GEO; GSM1401653
DR   GEO; GSM1670076
DR   GEO; GSM1833626
DR   GEO; GSM2046560
DR   GEO; GSM2046561
DR   GEO; GSM2046562
DR   GEO; GSM2046563
DR   GEO; GSM2046564
DR   GEO; GSM2046565
DR   GEO; GSM2046566
DR   GEO; GSM2046567
DR   GEO; GSM2046568
DR   GEO; GSM2046569
DR   GEO; GSM2046570
DR   GEO; GSM2046571
DR   GEO; GSM2046572
DR   GEO; GSM2046573
DR   GEO; GSM2046574
DR   GEO; GSM2046575
DR   GEO; GSM2046576
DR   GEO; GSM2046577
DR   GEO; GSM2046578
DR   GEO; GSM2046579
DR   GEO; GSM2046580
DR   GEO; GSM2046581
DR   GEO; GSM2046582
DR   GEO; GSM2046583
DR   GEO; GSM2046584
DR   GEO; GSM2046585
DR   GEO; GSM2046586
DR   GEO; GSM2046587
DR   GEO; GSM2046588
DR   GEO; GSM2046589
DR   GEO; GSM2046590
DR   GEO; GSM2046591
DR   GEO; GSM2046592
DR   GEO; GSM2046593
DR   GEO; GSM2046594
DR   GEO; GSM2046595
DR   GEO; GSM2046596
DR   GEO; GSM2046597
DR   GEO; GSM2046598
DR   GEO; GSM2046599
DR   GEO; GSM2046600
DR   GEO; GSM2046601
DR   GEO; GSM2046602
DR   GEO; GSM2046603
DR   GEO; GSM2046604
DR   GEO; GSM2046605
DR   GEO; GSM2046606
DR   GEO; GSM2046607
DR   GEO; GSM2095708
DR   GEO; GSM2095709
DR   GEO; GSM2124642
DR   GEO; GSM2136630
DR   GEO; GSM2136631
DR   GEO; GSM2136632
DR   GEO; GSM2136633
DR   GEO; GSM2136634
DR   GEO; GSM2136635
DR   GEO; GSM2176269
DR   GEO; GSM2176270
DR   GEO; GSM2258722
DR   GEO; GSM2258723
DR   GEO; GSM2258724
DR   GEO; GSM2258725
DR   GEO; GSM2258726
DR   GEO; GSM2258727
DR   GEO; GSM2258728
DR   GEO; GSM2258729
DR   GEO; GSM2258730
DR   GEO; GSM2258731
DR   GEO; GSM2258732
DR   GEO; GSM2258733
DR   GEO; GSM2258734
DR   GEO; GSM2258735
DR   GEO; GSM2258736
DR   GEO; GSM2258737
DR   GEO; GSM2258738
DR   GEO; GSM2258739
DR   GEO; GSM2258947
DR   GEO; GSM2258948
DR   GEO; GSM2258949
DR   GEO; GSM7701355
DR   GEO; GSM7701356
DR   IARC_TP53; 21079
DR   IBRC; C10082
DR   IBRC; C10682
DR   ICLC; HTL95021
DR   IGRhCellID; MCF7
DR   IPD-IMGT/HLA; 12401
DR   IZSLER; BS TCL 38
DR   JCRB; JCRB0134
DR   JCRB; NIHS0200
DR   KCB; KCB 200529YJ
DR   KCB; KCB 200831YJ
DR   KCLB; 30022
DR   LiGeA; CCLE_648
DR   LINCS_HMS; 50029
DR   LINCS_LDP; LCL-1460
DR   Lonza; 113
DR   MeSH; D061986
DR   MetaboLights; MTBLS177
DR   MetaboLights; MTBLS182
DR   MetaboLights; MTBLS183
DR   MetaboLights; MTBLS241
DR   MetaboLights; MTBLS337
DR   MetaboLights; MTBLS430
DR   MetaboLights; MTBLS2716
DR   NCBI_Iran; C135
DR   NCI-DTP; MCF7
DR   PharmacoDB; MCF7_895_2019
DR   PRIDE; PXD000275
DR   PRIDE; PXD000281
DR   PRIDE; PXD000309
DR   PRIDE; PXD000442
DR   PRIDE; PXD000623
DR   PRIDE; PXD000691
DR   PRIDE; PXD000815
DR   PRIDE; PXD001274
DR   PRIDE; PXD001352
DR   PRIDE; PXD001812
DR   PRIDE; PXD001863
DR   PRIDE; PXD002104
DR   PRIDE; PXD002192
DR   PRIDE; PXD002395
DR   PRIDE; PXD002421
DR   PRIDE; PXD002998
DR   PRIDE; PXD003539
DR   PRIDE; PXD003704
DR   PRIDE; PXD004051
DR   PRIDE; PXD004085
DR   PRIDE; PXD004357
DR   PRIDE; PXD004452
DR   PRIDE; PXD005032
DR   PRIDE; PXD005390
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD006732
DR   PRIDE; PXD008222
DR   PRIDE; PXD023223
DR   PRIDE; PXD024293
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0031
DR   PubChem_Cell_line; CVCL_0031
DR   RCB; RCB1904
DR   SKY/M-FISH/CGH; 2814
DR   SLKBase; 3572
DR   TKG; TKG 0479
DR   TOKU-E; 2383
DR   TOKU-E; 3748
DR   Ubigene; YC-D006
DR   Wikidata; Q1881253
RX   CelloPub=CLPUB00336;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.1186/gb-2010-11-s1-p8;
RX   DOI=10.25904/1912/1434;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=1000504;
RX   PubMed=1000505;
RX   PubMed=1000506;
RX   PubMed=1911442;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=3702420;
RX   PubMed=4138511;
RX   PubMed=4353636;
RX   PubMed=4357757;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7228867;
RX   PubMed=7498097;
RX   PubMed=7531416;
RX   PubMed=7842014;
RX   PubMed=8626706;
RX   PubMed=8824553;
RX   PubMed=9242427;
RX   PubMed=9331090;
RX   PubMed=9488600;
RX   PubMed=9671407;
RX   PubMed=10381137;
RX   PubMed=10700174;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=11078910;
RX   PubMed=11292682;
RX   PubMed=11343771;
RX   PubMed=11416159;
RX   PubMed=11789735;
RX   PubMed=12353263;
RX   PubMed=12661003;
RX   PubMed=12775708;
RX   PubMed=12800145;
RX   PubMed=15002416;
RX   PubMed=15361840;
RX   PubMed=15677628;
RX   PubMed=15748285;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=16142302;
RX   PubMed=16397213;
RX   PubMed=16417655;
RX   PubMed=16541312;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=17157791;
RX   PubMed=17254797;
RX   PubMed=17334996;
RX   PubMed=18386134;
RX   PubMed=18516279;
RX   PubMed=19372543;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=19727395;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21247443;
RX   PubMed=21378333;
RX   PubMed=22068913;
RX   PubMed=22278370;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22414580;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=23234512;
RX   PubMed=23285151;
RX   PubMed=23325432;
RX   PubMed=23601657;
RX   PubMed=23671654;
RX   PubMed=23770244;
RX   PubMed=23856246;
RX   PubMed=23868472;
RX   PubMed=23933261;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24279929;
RX   PubMed=24389870;
RX   PubMed=24456987;
RX   PubMed=24618588;
RX   PubMed=24670534;
RX   PubMed=25321415;
RX   PubMed=25485619;
RX   PubMed=25807930;
RX   PubMed=25828948;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26026074;
RX   PubMed=26055192;
RX   PubMed=26116361;
RX   PubMed=26330541;
RX   PubMed=26589293;
RX   PubMed=27331101;
RX   PubMed=27362937;
RX   PubMed=27377824;
RX   PubMed=27378269;
RX   PubMed=27397505;
RX   PubMed=27456714;
RX   PubMed=27761513;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28601559;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31698574;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=34238275;
RX   PubMed=34320349;
RX   PubMed=35042871;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; -; -; https://mcf7.com/
WW   Info; -; -; https://www.genboree.org/java-bin/MCF7/index.jsp?isPublic=Yes
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/htb-22-growth-and-morphology
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MCF-7
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/mcf7/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/MCF-7_Crawford_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Nikon Small World; -; https://www.nikonsmallworld.com/galleries/2011-photomicrography-competition/three-dimensional-cell-culture-of-breast-cancer-cells-mcf-7-cell-line
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/mcf7.htm
WW   Info; PBCF; -; https://web.archive.org/web/20210320165028/https://physics.cancer.gov/docs/bioresource/breast/NCI-PBCF-HTB22_MCF7_SOP-508.pdf
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=1
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-36.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MCF-7
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/mcf7-xenograft-model/
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 2.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12584.
CC   Registration: Chiron Master Culture Collection; CMCC 10377 (CMCC #10377).
CC   Population: Caucasian.
CC   Doubling time: 1.8 days (PubMed=9671407); 80 hours (PubMed=25984343); 24 hours (PubMed=9488600); 31.2 hours (PubMed=22628656); 25.3 hours (PubMed=24389870); 24.4 hours (PubMed=34238275); ~50 hours (Note=With a range of 30-72 hours) (DSMZ=ACC-115); 25.4 hours (NCI-DTP=MCF7); ~38 hours (PBCF); 56.47 hours (JWGray panel).
CC   HLA typing: A*02:01:01; B*18,44; C*05; DPB1*02:01:02,04:01; DQB1*02:01,06:02; DRB1*03,15 (PubMed=15748285).
CC   HLA typing: A*02:01,02:01; B*18:01,44:02; C*05:01,05:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*02:01,02:01; B*18:01,35:01; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (PubMed=15361840; Cosmic-CLP=905946; DepMap=ACH-000019).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; PubMed=28889351).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; PTM; Myristoylation.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.74%; Native American=0%; East Asian, North=4.2%; East Asian, South=0%; South Asian=0%; European, North=56.91%; European, South=38.15% (PubMed=30894373).
CC   Anecdotal: First hormone-responsive breast cancer cell line to have been established.
CC   Anecdotal: Have been flown in space on Foton-12 to study cytoskeleton architecture in microgravity (PubMed=11292682; PubMed=15002416).
CC   Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870).
CC   Donor information: Helen Marion Mallon (sister Catherine Frances), the patient from which this cell line is derived was a nun at the Immaculate Heart of Mary convent in Monroe, Michigan (CelloPub=CLPUB00336).
CC   Misspelling: MFC-7; Note=Occasionally.
CC   Misspelling: MFC7; Note=Occasionally.
CC   Discontinued: JCRB; NIHS0200; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006008/402; ATCC=HTB-22; CCRID; CLS=300273; Cosmic-CLP=905946; DSMZ=ACC-115; ECACC=86012803; JCRB=JCRB0134; KCLB=30022; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25321415; PubMed=25877200; PubMed=27456714; PubMed=28889351; RCB=RCB1904; Technion Genomics Center; TKG=TKG 0479
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 14
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D1S1656: 11,15.3
ST   D21S11: 30
ST   D22S1045: 15,16
ST   D2S1338: 21,23
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 11,12 (AddexBio=C0006008/402; ATCC=HTB-22; CCRID; Cosmic-CLP=905946; DSMZ=ACC-115; ECACC=86012803; JCRB=JCRB0134; KCLB=30022; DOI=10.4172/2157-7145.S2-005; PubMed=17254797; PubMed=19372543; PubMed=25321415; PubMed=25877200; PubMed=27456714; PubMed=28889351; RCB=RCB1904; Technion Genomics Center; TKG=TKG 0479)
ST   D5S818: 12 (CLS=300273)
ST   D6S1043: 12,18
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,24,25 (CCRID; DSMZ=ACC-115; Technion Genomics Center)
ST   FGA: 23,25 (CLS=300273; PubMed=17254797; PubMed=19372543; PubMed=25877200)
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N481 ! Hs 631.T
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 54
//
ID   MCF-7 1403
AC   CVCL_D5YB
DR   Wikidata; Q127382747
RX   DOI=10.1016/S0531-5131(03)01154-3;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a firefly luciferase reporter gene under the control of the clusterin promoter (DOI=10.1016/S0531-5131(03)01154-3).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5YA ! MCF-7:WS8
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   MCF-7 A2
AC   CVCL_YX80
SY   MCF7 A2
DR   cancercelllines; CVCL_YX80
DR   Wikidata; Q95985994
RX   PubMed=20386540;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   MCF-7 AC1
AC   CVCL_C8MT
SY   AC-1; Ac-1; AC1; Ac1
DR   Wikidata; Q123033005
RX   PubMed=16885381;
RX   PubMed=17942301;
RX   PubMed=22659283;
RX   PubMed=24472707;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MCF-7 AC1-ExR
AC   CVCL_C8NC
SY   AC1-ExR
DR   Wikidata; Q123033006
RX   DOI=10.1158/1538-7445.AM2013-520;
RX   PubMed=24472707;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4953; Exemestane (Aromasin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8MT ! MCF-7 AC1
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MCF-7 Ad75
AC   CVCL_ZZ17
DR   cancercelllines; CVCL_ZZ17
DR   Wikidata; Q102114497
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 77.3 hours (PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MCF-7 AdP500
AC   CVCL_ZZ18
DR   cancercelllines; CVCL_ZZ18
DR   Wikidata; Q102114498
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MCF-7 clone 33
AC   CVCL_4Y65
DR   cancercelllines; CVCL_4Y65
DR   Wikidata; Q54904306
RX   PubMed=2055945;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7 eGFP-CEBPG
AC   CVCL_HA11
DR   cancercelllines; CVCL_HA11
DR   ENCODE; ENCBS467NVT
DR   ENCODE; ENCBS787WNX
DR   ENCODE; ENCBS948XBF
DR   GEO; GSM2825134
DR   GEO; GSM2825135
DR   GEO; GSM2828719
DR   Wikidata; Q54904308
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1837; CEBPG.
CC   Omics: Genomics; ChIP-seq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   MCF-7 eGFP-E2F4
AC   CVCL_HA12
DR   cancercelllines; CVCL_HA12
DR   ENCODE; ENCBS452IKC
DR   ENCODE; ENCBS660MSK
DR   ENCODE; ENCBS742UIG
DR   Wikidata; Q54904309
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3118; E2F4.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 eGFP-ELF1
AC   CVCL_HA13
DR   cancercelllines; CVCL_HA13
DR   ENCODE; ENCBS370XRA
DR   ENCODE; ENCBS377JBD
DR   ENCODE; ENCBS580NZH
DR   Wikidata; Q54904310
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3316; ELF1.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 eGFP-GABPA
AC   CVCL_HA14
DR   cancercelllines; CVCL_HA14
DR   ENCODE; ENCBS274OZJ
DR   ENCODE; ENCBS368ZAX
DR   ENCODE; ENCBS980KNO
DR   Wikidata; Q54904311
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4071; GABPA.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 eGFP-GTF2E2
AC   CVCL_HA15
DR   cancercelllines; CVCL_HA15
DR   ENCODE; ENCBS071FIF
DR   ENCODE; ENCBS829WBT
DR   ENCODE; ENCBS948MKG
DR   Wikidata; Q54904312
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4651; GTF2E2.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 eGFP-HBP1
AC   CVCL_HA16
DR   cancercelllines; CVCL_HA16
DR   ENCODE; ENCBS812LYE
DR   Wikidata; Q54904313
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:23200; HBP1.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 eGFP-KLF4
AC   CVCL_HA17
DR   cancercelllines; CVCL_HA17
DR   ENCODE; ENCBS033ECJ
DR   ENCODE; ENCBS949BEW
DR   ENCODE; ENCBS984RGW
DR   Wikidata; Q54904314
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6348; KLF4.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 eGFP-KLF9
AC   CVCL_HA18
DR   cancercelllines; CVCL_HA18
DR   ENCODE; ENCBS180ROE
DR   ENCODE; ENCBS183KOB
DR   ENCODE; ENCBS418UGY
DR   Wikidata; Q54904315
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1123; KLF9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 eGFP-ZNF148
AC   CVCL_HA19
DR   cancercelllines; CVCL_HA19
DR   ENCODE; ENCBS004ION
DR   Wikidata; Q54904317
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12933; ZNF148.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 FLV100
AC   CVCL_E5SX
SY   MCF-7-FLV100
DR   ABM; T8033
RX   PubMed=11205902;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 100 nM of flavopiridol (PubMed=11205902).
CC   Selected for resistance to: ChEBI; CHEBI_47344; Alvocidib (Flavopiridol; HMR-1275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCF-7 FLV1000
AC   CVCL_5I64
SY   MCF-7-FLV1000; MCF-7/Flv1000; MCF7-FLV1000; MCF-7FL-1000; MCF-7-FL1000; MCF-7 FL1000; MCF7FL1000; MCF FLV1000
DR   ABM; T8035
DR   cancercelllines; CVCL_5I64
DR   Wikidata; Q54904332
RX   PubMed=11205902;
RX   PubMed=11559526;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 1000 nM of flavopiridol (PubMed=11205902).
CC   Selected for resistance to: ChEBI; CHEBI_47344; Alvocidib (Flavopiridol; HMR-1275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   MCF-7 FLV250
AC   CVCL_E5SY
SY   MCF-7-FLV250
RX   PubMed=11205902;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 250 nM of flavopiridol (PubMed=11205902).
CC   Selected for resistance to: ChEBI; CHEBI_47344; Alvocidib (Flavopiridol; HMR-1275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCF-7 FLV500
AC   CVCL_E5SZ
SY   MCF-7-FLV500
DR   ABM; T8034
RX   PubMed=11205902;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 500 nM of flavopiridol (PubMed=11205902).
CC   Selected for resistance to: ChEBI; CHEBI_47344; Alvocidib (Flavopiridol; HMR-1275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCF-7 Ida6
AC   CVCL_ZZ19
DR   cancercelllines; CVCL_ZZ19
DR   Wikidata; Q102114499
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_42068; Idarubicin.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MCF-7 M13
AC   CVCL_UU87
SY   M13
DR   cancercelllines; CVCL_UU87
DR   Wikidata; Q95986057
RX   PubMed=1727631;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   MCF-7 M21
AC   CVCL_UU88
SY   M21
DR   cancercelllines; CVCL_UU88
DR   Wikidata; Q95986060
RX   PubMed=1727631;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   MCF-7 M27
AC   CVCL_UU89
SY   M27
DR   cancercelllines; CVCL_UU89
DR   Wikidata; Q95986062
RX   PubMed=1727631;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2640; CYP3A7.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   MCF-7 MX100
AC   CVCL_LB54
SY   MCF MX100
DR   cancercelllines; CVCL_LB54
DR   Wikidata; Q54904318
RX   PubMed=11406094;
RX   PubMed=11559526;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 100 nM of mitoxantrone (PubMed=15993268).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LB53 ! MCF-7 MX80
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   MCF-7 MX1000
AC   CVCL_E5T3
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 1000 nM of mitoxantrone (PubMed=12642696).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LB54 ! MCF-7 MX100
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCF-7 MX20
AC   CVCL_LB51
DR   cancercelllines; CVCL_LB51
DR   Wikidata; Q54904319
RX   PubMed=11406094;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   MCF-7 MX40
AC   CVCL_LB52
DR   cancercelllines; CVCL_LB52
DR   Wikidata; Q54904320
RX   PubMed=11406094;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LB51 ! MCF-7 MX20
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   MCF-7 MX8
AC   CVCL_LB50
SY   MCF MX8; MCF-MX8; MCF MX-8
DR   cancercelllines; CVCL_LB50
DR   Wikidata; Q54904321
RX   PubMed=11406094;
RX   PubMed=11559526;
RX   PubMed=12116365;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   MCF-7 MX80
AC   CVCL_LB53
DR   cancercelllines; CVCL_LB53
DR   Wikidata; Q54904322
RX   PubMed=11406094;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LB52 ! MCF-7 MX40
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   MCF-7 PRODH KO
AC   CVCL_B7K1
SY   MCF7POX-KO; PRODH/POX CRISPR/Cas9 knockout MCF7
DR   cancercelllines; CVCL_B7K1
DR   Wikidata; Q112930089
RX   PubMed=35409177;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9453; PRODH.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MCF-7 R27
AC   CVCL_WK73
SY   R27
DR   cancercelllines; CVCL_WK73
DR   Wikidata; Q95986105
RX   PubMed=7228867;
RX   PubMed=9023415;
CC   Population: Caucasian.
CC   HLA typing: A*02:01; B*44:02; C*05:01 (PubMed=9023415).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   MCF-7 R3
AC   CVCL_F1Z2
SY   R3
RX   PubMed=7240250;
CC   Population: Caucasian.
CC   Characteristics: Estrogen-independant (PubMed=7240250).
CC   Doubling time: 2.4 days (PubMed=7240250).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7 RR1
AC   CVCL_IU96
SY   MCF-7_RR1
DR   cancercelllines; CVCL_IU96
DR   Cosmic; 2553503
DR   Cosmic; 2842288
DR   Wikidata; Q54904323
RX   PubMed=27279227;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9168; Sirolimus (Rapamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3942; MTOR; Simple; p.Ala2034Val (c.6101C>T); ClinVar=VCV000948357; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=27279227).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 RR2
AC   CVCL_IU97
SY   MCF-7_RR2
DR   cancercelllines; CVCL_IU97
DR   Cosmic; 2553505
DR   Wikidata; Q54904324
RX   PubMed=27279227;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9168; Sirolimus (Rapamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3942; MTOR; Simple; p.Phe2108Leu; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=27279227).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 shPARG
AC   CVCL_RA89
SY   shPARG MCF7
DR   cancercelllines; CVCL_RA89
DR   Wikidata; Q54904325
RX   PubMed=29166620;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   MCF-7 shWDR12-4
AC   CVCL_YJ25
DR   cancercelllines; CVCL_YJ25
DR   Wikidata; Q95986128
RX   CelloPub=CLPUB00550;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 16-18 hours (CelloPub=CLPUB00550).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:14098; WDR12.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   MCF-7 SimpleCell O-GalNAc
AC   CVCL_S030
SY   MCF-7 SimpleCell; MCF-7 SC
DR   cancercelllines; CVCL_S030
DR   Wikidata; Q54904326
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   MCF-7 Tam1
AC   CVCL_A4AQ
SY   MCF7/TAM1; MCF7:TAM1
DR   ATCC; CRL-3435
DR   cancercelllines; CVCL_A4AQ
DR   ChEMBL-Cells; CHEMBL4630711
DR   ChEMBL-Targets; CHEMBL4630717
DR   PubChem_Cell_line; CVCL_A4AQ
DR   Wikidata; Q105510077
RX   PubMed=27378269;
CC   Population: Caucasian.
CC   Doubling time: ~1-2 weeks (ATCC=CRL-3435).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   MCF-7 TH
AC   CVCL_ZZ16
SY   MCF-7/TH; MCF-7TH; MCF7/TH; MCF7TH; MCF7Th
DR   cancercelllines; CVCL_ZZ16
DR   Wikidata; Q102114500
RX   PubMed=8562478;
RX   PubMed=9815641;
RX   PubMed=10995814;
RX   PubMed=14871996;
CC   Problematic cell line: Contaminated. Shown to be a OVCAR-8 derivative (PubMed=10995814). Originally thought to be a derivative of MCF-7.
CC   Population: Caucasian.
CC   Doubling time: 50.6 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=8562478).
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1629 ! OVCAR-8
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   MCF-7 TKi-R
AC   CVCL_IU98
SY   MCF-7_TKi-R
DR   cancercelllines; CVCL_IU98
DR   Cosmic; 2553506
DR   Cosmic; 2842290
DR   Wikidata; Q54904327
RX   PubMed=27279227;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_91329; AZD8055.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3942; MTOR; Simple; p.Met2327Ile (c.6981G>A); ClinVar=VCV000242349; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=27279227).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   MCF-7 TTE-MBD2
AC   CVCL_A8P5
DR   cancercelllines; CVCL_A8P5
DR   GEO; GSM1322266
DR   GEO; GSM1322268
DR   GEO; GSM1322269
DR   GEO; GSM1388122
DR   GEO; GSM1388124
DR   GEO; GSM1388125
DR   GEO; GSM1388126
DR   GEO; GSM1388127
DR   Wikidata; Q102114501
RX   PubMed=24927503;
CC   Population: Caucasian.
CC   Characteristics: The transfected human MBD2 gene is N-terminally tagged with a Ty1-Ty1-ER (TTE) epitope tag.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6917; MBD2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; ChIP-seq; MBD2.
CC   Omics: Genomics; ChIP-seq; Pol2.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 11
//
ID   MCF-7 Tx200
AC   CVCL_ZZ20
DR   cancercelllines; CVCL_ZZ20
DR   Wikidata; Q102114502
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 79.3 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MCF-7 Tx8
AC   CVCL_ZZ21
DR   cancercelllines; CVCL_ZZ21
DR   Wikidata; Q102114503
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 54.7 hours (PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MCF-7-2a
AC   CVCL_4Y54
SY   MCF-7/2a; MCF7-2A; MCF7-2a; MCF-7.2A
DR   cancercelllines; CVCL_4Y54
DR   ChEMBL-Cells; CHEMBL3307366
DR   ChEMBL-Targets; CHEMBL614323
DR   PubChem_Cell_line; CVCL_4Y54
DR   Wikidata; Q54904328
RX   PubMed=8138561;
RX   PubMed=8903422;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Caution: There is confusion in the literature between estrogen-independent MCF-7:2A (Cellosaurus=CVCL_4Y53), L-mimosine-resistant MCF-7/2a (Cellosaurus=CVCL_0412) and EREwtcluc transfected MCF-7-2a (Cellosaurus=CVCL_4Y54).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   MCF-7-BAG
AC   CVCL_R954
SY   MCF-7 BAG
DR   cancercelllines; CVCL_R954
DR   Wikidata; Q54904330
RX   PubMed=1384607;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   MCF-7-EpiR
AC   CVCL_4V96
DR   cancercelllines; CVCL_4V96
DR   Wikidata; Q54904331
RX   PubMed=23514751;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_47898; 4'-epidoxorubicin (Epirubicin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7-Luc
AC   CVCL_J259
DR   AddexBio; S0006002/4891
DR   cancercelllines; CVCL_J259
DR   JCRB; JCRB1372
DR   JCRB; NIHS0638
DR   Wikidata; Q54904333
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: AddexBio; S0006002/4891; probable.
CC   Discontinued: JCRB; NIHS0638; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1372
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   MCF-7-luc-F5
AC   CVCL_5J35
DR   cancercelllines; CVCL_5J35
DR   Revvity/PerkinElmer; 119262
DR   Wikidata; Q54904334
RX   CelloPub=CLPUB00781;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119262; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   MCF-7-Red-Fluc
AC   CVCL_5J04
SY   MCF7-Red-Fluc; MCF7 Red-Fluc; Bioware Brite MCF7 Red-FLuc; IVISbrite MCF-7 Red F-luc
DR   cancercelllines; CVCL_5J04
DR   Revvity/PerkinElmer; BW119262
DR   Wikidata; Q54904335
CC   Population: Caucasian.
CC   Doubling time: 40 hours (Revvity/PerkinElmer=BW119262).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   MCF-7-TaxR
AC   CVCL_4V97
DR   cancercelllines; CVCL_4V97
DR   Wikidata; Q54904336
RX   PubMed=23514751;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7.5C
AC   CVCL_DC70
SY   MCF7:5C; MCF-7 clone 5C; 5C
DR   cancercelllines; CVCL_DC70
DR   Wikidata; Q54904329
RX   PubMed=1301400;
RX   PubMed=9242427;
RX   PubMed=15862958;
RX   PubMed=16333030;
RX   PubMed=24604139;
RX   PubMed=32453591;
CC   Population: Caucasian.
CC   Characteristics: Undergoes rapid and complete apoptosis in the presence of physiologic concentrations of 17-alpha-estradiol.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   MCF-7/164R-1
AC   CVCL_1D48
SY   MCF7/164R-1; 164R-1
DR   cancercelllines; CVCL_1D48
DR   CancerTools; 152091
DR   Wikidata; Q54904338
DR   Ximbio; 152091
RX   PubMed=7759159;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/164R-4
AC   CVCL_1D49
SY   MCF7/164R-4; 164R-4
DR   cancercelllines; CVCL_1D49
DR   CancerTools; 152101
DR   ECACC; 16022503
DR   Wikidata; Q54904339
DR   Ximbio; 152101
RX   PubMed=7759159;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022503; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022503
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   MCF-7/164R-5
AC   CVCL_1D38
SY   MCF7/164R-5; MCF-7/164(R)-5; 164R-5
DR   cancercelllines; CVCL_1D38
DR   CancerTools; 152102
DR   Wikidata; Q54904340
DR   Ximbio; 152102
RX   PubMed=7759159;
RX   PubMed=16172194;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/164R-7
AC   CVCL_1D39
SY   MCF7/164R-7; 164R-7
DR   cancercelllines; CVCL_1D39
DR   CancerTools; 152103
DR   ECACC; 16022505
DR   Wikidata; Q54904341
DR   Ximbio; 152103
RX   PubMed=7759159;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022505; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022505
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   MCF-7/182R-1
AC   CVCL_1D40
SY   MCF7/182R-1; 182R-1
DR   cancercelllines; CVCL_1D40
DR   CancerTools; 152104
DR   ECACC; 16022529
DR   Wikidata; Q54904342
DR   Ximbio; 152104
RX   PubMed=7759159;
RX   PubMed=16172194;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022529; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   MCF-7/182R-6
AC   CVCL_W536
SY   MCF-7/182(R)-6; MCF7/182R-6; 182R-6
DR   cancercelllines; CVCL_W536
DR   CancerTools; 152105
DR   ECACC; 16022506
DR   Wikidata; Q54904343
DR   Ximbio; 152105
RX   PubMed=7759159;
RX   PubMed=10027303;
RX   PubMed=16172194;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (Note=In estradiol-deprived medium) (PubMed=10027303).
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022506; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022506
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 24
//
ID   MCF-7/182R-7
AC   CVCL_1D41
SY   MCF7/182R-7; 182R-7
DR   cancercelllines; CVCL_1D41
DR   CancerTools; 152106
DR   ECACC; 16022502
DR   Wikidata; Q54904344
DR   Ximbio; 152106
RX   PubMed=7759159;
RX   PubMed=16172194;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022502; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   MCF-7/2a
AC   CVCL_0412
SY   MCF-7/2A; MCF7/2a; MCF-7 clone 2A
DR   BTO; BTO_0002270
DR   MCCL; MCC:0000308
DR   cancercelllines; CVCL_0412
DR   Wikidata; Q54904345
RX   PubMed=10766749;
RX   PubMed=15531579;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_29063; L-mimosine.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Caution: There is confusion in the literature between estrogen-independent MCF-7:2A (Cellosaurus=CVCL_4Y53), L-mimosine-resistant MCF-7/2a (Cellosaurus=CVCL_0412) and EREwtcluc transfected MCF-7-2a (Cellosaurus=CVCL_4Y54).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   MCF-7/4-HC
AC   CVCL_4V53
SY   MCF-7/4-hc; MCF7/4HC; MCF-7/OAP
DR   cancercelllines; CVCL_4V53
DR   Wikidata; Q54904348
RX   PubMed=3180059;
RX   PubMed=8328987;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_196991; 4-hydroperoxycyclophosphamide.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/5-23
AC   CVCL_4V44
SY   MCF 7/5-23; MCF 5-23; 5-23
DR   cancercelllines; CVCL_4V44
DR   Wikidata; Q54904349
RX   PubMed=8244585;
RX   PubMed=10070856;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/6
AC   CVCL_W972
SY   MCF-7-6
DR   cancercelllines; CVCL_W972
DR   Cosmic; 2036670
DR   Wikidata; Q54904350
RX   PubMed=1648947;
RX   PubMed=8528519;
RX   PubMed=22161839;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   MCF-7/AdrVp
AC   CVCL_4Y46
SY   MCF7/AdrVp; MCF-7-ADRVP; MCF-7 AdVp; MCF-7/AdrVp(100)
DR   cancercelllines; CVCL_4Y46
DR   Wikidata; Q54904351
RX   PubMed=1972154;
RX   PubMed=7819048;
RX   PubMed=9865745;
RX   PubMed=14576842;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_9948; Verapamil (VPL).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/AdVp3000
AC   CVCL_KS20
SY   MCF-7 AdVp3000; MCF AdVp3000
DR   cancercelllines; CVCL_KS20
DR   Wikidata; Q54904352
RX   PubMed=9178101;
RX   PubMed=9892175;
RX   PubMed=11406094;
RX   PubMed=11559526;
RX   PubMed=12116365;
RX   PubMed=15901850;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:74; ABCG2; Simple; p.Arg482Thr (c.1445G>C); Zygosity=Unspecified (PubMed=11559526).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Y46 ! MCF-7/AdrVp
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   MCF-7/AnaR-1
AC   CVCL_5A09
SY   MCF7/AnaR-1; AnaR-1
DR   cancercelllines; CVCL_5A09
DR   CancerTools; 152551
DR   ECACC; 16022516
DR   Wikidata; Q54904353
DR   Ximbio; 152551
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2704; Anastrozole (Arimidex).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022516; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022516
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/AnaR-2
AC   CVCL_5A10
SY   MCF7/AnaR-2; AnaR-2
DR   cancercelllines; CVCL_5A10
DR   CancerTools; 152552
DR   ECACC; 16022517
DR   Wikidata; Q54904354
DR   Ximbio; 152552
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2704; Anastrozole (Arimidex).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022517; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022517
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 19,23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/AnaR-3
AC   CVCL_5A11
SY   MCF7/AnaR-3; AnaR-3
DR   cancercelllines; CVCL_5A11
DR   CancerTools; 152553
DR   ECACC; 16022518
DR   Wikidata; Q54904355
DR   Ximbio; 152553
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2704; Anastrozole (Arimidex).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022518; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022518
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/AnaR-4
AC   CVCL_5A12
SY   MCF7/AnaR-4; AnaR-4
DR   cancercelllines; CVCL_5A12
DR   CancerTools; 152554
DR   ECACC; 16022519
DR   Wikidata; Q54904356
DR   Ximbio; 152554
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_2704; Anastrozole (Arimidex).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022519; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022519
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   MCF-7/AZ
AC   CVCL_W971
SY   MCF-7AZ
DR   cancercelllines; CVCL_W971
DR   Cosmic; 2036668
DR   Wikidata; Q54904357
RX   PubMed=1648947;
RX   PubMed=8528519;
RX   PubMed=22161839;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   MCF-7/B2
AC   CVCL_E7HX
RX   PubMed=24647478;
WW   Provider; Inserm Transfert; RT00733; https://technology-offers.inserm-transfert.com/offer/a-breast-cancer-cell-line-expressing-a-bret-biosensor-to-monitor-pi-3-kinase-activity-in-real-time/
CC   Population: Caucasian.
CC   Characteristics: Upon phosphatidyl inositol-3 phosphate (PIP3) production, the recruitment of Luc-Akt-PH to the plasma membrane results in a bioluminescence resonance energy transfer (BRET) between the luciferase and the YFP (PubMed=24647478).
CC   Characteristics: Transfected with a Luc-Akt-PH construct where the PH domain of mouse Akt1 is fused to Renilla luciferase as well as a construct containing YFP fused with a membrane targeting sequence (EYFP-Mem) (PubMed=24647478).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87986; Akt1 (Note=With p.Lys111_Ala480del = PH domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7HW ! MCF-7/Luc-Akt-PH
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MCF-7/BCRP
AC   CVCL_ZZ40
SY   MCF-7/Bcrp
DR   cancercelllines; CVCL_ZZ40
DR   Wikidata; Q102114505
RX   PubMed=15695404;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Myc-tagged ABCG2/BCRP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:74; ABCG2.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   MCF-7/C4-12
AC   CVCL_GX99
SY   MCF-7 C4-12; MCF7 C4-12; MCF-7:C4-12; MCF-7C4-12; C4-12
DR   EFO; EFO_0022701
DR   cancercelllines; CVCL_GX99
DR   TOKU-E; 4086
DR   Wikidata; Q54904358
RX   PubMed=11479214;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/CG-4
AC   CVCL_4D03
SY   CG-4
DR   cancercelllines; CVCL_4D03
DR   Wikidata; Q54904359
RX   PubMed=6575841;
CC   Population: Caucasian.
CC   Characteristics: Estrogen supersensitive (PubMed=6575841).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   MCF-7/CG-5
AC   CVCL_4D04
SY   CG-5; CG5
DR   CLO; CLO_0002398
DR   cancercelllines; CVCL_4D04
DR   Wikidata; Q54904360
RX   PubMed=3516389;
RX   PubMed=6575841;
RX   PubMed=8712686;
CC   Population: Caucasian.
CC   Characteristics: Estrogen supersensitive (PubMed=6575841).
CC   Doubling time: 13 hours (PubMed=8712686).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   MCF-7/CG-5/Dx
AC   CVCL_4D05
SY   CG5/Dx
DR   cancercelllines; CVCL_4D05
DR   Wikidata; Q54811574
RX   PubMed=8712686;
CC   Population: Caucasian.
CC   Doubling time: 47 hours (PubMed=8712686).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4D04 ! MCF-7/CG-5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   MCF-7/CMV
AC   CVCL_E7E7
SY   MCF-7/CMV-1
RX   PubMed=7712469;
RX   PubMed=9563901;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for MCF-7/E6 (Cellosaurus=CVCL_M439) and MCF-7/mu-p53 (Cellosaurus=CVCL_E3DM) (PubMed=7712469; PubMed=9563901).
CC   Doubling time: 25 hours (PubMed=9563901).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MCF-7/E2F1
AC   CVCL_HA20
DR   cancercelllines; CVCL_HA20
DR   ENCODE; ENCBS106ENC
DR   ENCODE; ENCBS107ENC
DR   Wikidata; Q54904361
CC   Population: Caucasian.
CC   Characteristics: Transfected with E2F1 fused at the N-terminus to an HA tag and the estrogen receptor ligand binding domain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3113; E2F1.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 16
//
ID   MCF-7/E6
AC   CVCL_M439
SY   MCF7-E6; MCF 7 E6; MCF-7/E6-1
DR   cancercelllines; CVCL_M439
DR   Wikidata; Q54904362
RX   PubMed=7712469;
RX   PubMed=9563901;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=9563901).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 24
//
ID   MCF-7/ExeR-1
AC   CVCL_5A13
SY   MCF7/ExeR-1; MCF-7/S0.5/ExeR-1; ExeR-1
DR   cancercelllines; CVCL_5A13
DR   CancerTools; 152555
DR   ECACC; 16022520
DR   Wikidata; Q54904363
DR   Ximbio; 152555
RX   PubMed=25625755;
RX   PubMed=25667100;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4953; Exemestane (Aromasin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022520; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022520
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 19,23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/ExeR-2
AC   CVCL_5A14
SY   MCF7/ExeR-2; ExeR-2
DR   cancercelllines; CVCL_5A14
DR   CancerTools; 152556
DR   ECACC; 16022521
DR   Wikidata; Q54904364
DR   Ximbio; 152556
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4953; Exemestane (Aromasin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022521; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022521
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 19,23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/ExeR-3
AC   CVCL_5A15
SY   MCF7/ExeR-3; MCF-7/S0.5/ExeR-3; ExeR-3
DR   cancercelllines; CVCL_5A15
DR   CancerTools; 152557
DR   ECACC; 16022522
DR   Wikidata; Q54904365
DR   Ximbio; 152557
RX   PubMed=25625755;
RX   PubMed=25667100;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4953; Exemestane (Aromasin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022522; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022522
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,21
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 19,23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/ExeR-4
AC   CVCL_5A16
SY   MCF7/ExeR-4; ExeR-4
DR   cancercelllines; CVCL_5A16
DR   CancerTools; 152558
DR   ECACC; 16022523
DR   Wikidata; Q54904366
DR   Ximbio; 152558
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4953; Exemestane (Aromasin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022523; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022523
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   MCF-7/F
AC   CVCL_C5RU
DR   Wikidata; Q116049772
RX   PubMed=17016657;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MCF-7/GFP
AC   CVCL_5J37
DR   cancercelllines; CVCL_5J37
DR   Cell_Biolabs; AKR-211
DR   Wikidata; Q54904367
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   MCF-7/HER2-18
AC   CVCL_0U80
SY   MCF-7 HER2-18; MCF-7/Her2-18; MCF7/HER2-clone 18; MCF7/HER2-18; MCF/HER2-18
DR   BioSample; SAMN03471643
DR   cancercelllines; CVCL_0U80
DR   Wikidata; Q54904368
RX   PubMed=8095168;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   MCF-7/HRG-S2
AC   CVCL_F1C1
SY   MCF-7/S2
RX   PubMed=9563896;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7997; NRG1 (Note=Isoform beta-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/HRG-T2
AC   CVCL_F1C2
SY   MCF-7/T2
RX   PubMed=8764133;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7997; NRG1 (Note=Isoform beta-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/HRG-T4
AC   CVCL_F1C3
SY   MCF-7/T4
RX   PubMed=8764133;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7997; NRG1 (Note=Isoform beta-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/HRG-T5
AC   CVCL_F1C4
SY   MCF-7/T5
RX   PubMed=9563896;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7997; NRG1 (Note=Isoform beta-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/HRG-T6
AC   CVCL_F1C5
SY   MCF-7/T6
RX   PubMed=8764133;
RX   PubMed=9563896;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/HRG-T7
AC   CVCL_F1C6
SY   MCF-7/T7
RX   PubMed=8764133;
RX   PubMed=9563896;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7997; NRG1 (Note=Isoform beta-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/HRG-T8
AC   CVCL_F1C7
SY   MCF-7/T8
RX   PubMed=8764133;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7997; NRG1 (Note=Isoform beta-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/LetR-1
AC   CVCL_5A17
SY   MCF7/LetR-1; MCF-7/S0.5/LetR-1; LetR-1
DR   cancercelllines; CVCL_5A17
DR   CancerTools; 152547
DR   ECACC; 16022524
DR   Wikidata; Q54904369
DR   Ximbio; 152547
RX   PubMed=25625755;
RX   PubMed=25667100;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_6413; Letrozole.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022524; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022524
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   MCF-7/LetR-2
AC   CVCL_5A18
SY   MCF7/LetR-2; LetR-2
DR   cancercelllines; CVCL_5A18
DR   CancerTools; 152548
DR   ECACC; 16022525
DR   Wikidata; Q54904370
DR   Ximbio; 152548
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_6413; Letrozole.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022525; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022525
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/LetR-3
AC   CVCL_5A19
SY   MCF7/LetR-3; MCF-7/S0.5/LetR-3; LetR-3
DR   cancercelllines; CVCL_5A19
DR   CancerTools; 152549
DR   ECACC; 16022526
DR   Wikidata; Q54904371
DR   Ximbio; 152549
RX   PubMed=25625755;
RX   PubMed=25667100;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_6413; Letrozole.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022526; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022526
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/LetR-4
AC   CVCL_5A20
SY   MCF7/LetR-4; LetR-4
DR   cancercelllines; CVCL_5A20
DR   CancerTools; 152550
DR   Wikidata; Q54904372
DR   Ximbio; 152550
RX   PubMed=25625755;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_6413; Letrozole.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   MCF-7/Luc
AC   CVCL_5J36
DR   cancercelllines; CVCL_5J36
DR   Cell_Biolabs; AKR-234
DR   Wikidata; Q54904373
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   MCF-7/Luc-Akt-PH
AC   CVCL_E7HW
SY   MCF-7 Luc-Akt-PH
RX   PubMed=24647478;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Luc-Akt-PH construct where the PH domain of mouse Akt1 is fused to Renilla luciferase (PubMed=24647478).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:87986; Akt1 (Note=With p.Lys111_Ala480del = PH domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MCF-7/LY2
AC   CVCL_9579
SY   LY2; LY-2
DR   CLO; CLO_0009913
DR   EFO; EFO_0001199
DR   ArrayExpress; E-TABM-157
DR   cancercelllines; CVCL_9579
DR   Cosmic; 1136350
DR   DepMap; ACH-002325
DR   GEO; GSM1053705
DR   GEO; GSM1172879
DR   GEO; GSM1172972
DR   LINCS_HMS; 51095
DR   LINCS_LDP; LCL-2076
DR   PharmacoDB; LY2_874_2019
DR   Wikidata; Q54904374
RX   PubMed=4029083;
RX   PubMed=17157791;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 56.10 hours (JWGray panel).
CC   HLA typing: A*02:01,02:01; B*44:02,18:01; C*05:01,05:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   Selected for resistance to: ChEBI; CHEBI_90187; Lilly 117018 (LY 117018).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   MCF-7/MDD2
AC   CVCL_Z704
SY   MDD2
DR   cancercelllines; CVCL_Z704
DR   Wikidata; Q54904375
RX   PubMed=8700512;
RX   PubMed=11802204;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/MN1
AC   CVCL_Z705
SY   MN1; MN-1
DR   EFO; EFO_0022548
DR   cancercelllines; CVCL_Z705
DR   Wikidata; Q54904376
RX   PubMed=8700512;
RX   PubMed=11802204;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   MCF-7/mu-p53
AC   CVCL_E3DM
SY   MCF-7/Mu-p53-5
RX   PubMed=7712469;
RX   PubMed=9563901;
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=9563901).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Ala143Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   MCF-7/PacR
AC   CVCL_B7P7
SY   MCF7/PacR; MCF-7/PAC
DR   cancercelllines; CVCL_B7P7
DR   Wikidata; Q112930090
RX   PubMed=27664577;
RX   PubMed=29625142;
RX   PubMed=31248089;
CC   Population: Caucasian.
CC   Characteristics: Generated by step-increasing drug concentration to 300 nm of paclitaxel. Overexpresses ABCB1 which is amplified and inserted in chromosome 3 (PubMed=27664577; Direct_author_submission).
CC   Doubling time: ~25-30 hours (Direct_author_submission).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Subcellular; Mitochondrion; 2DE-MS.
CC   Miscellaneous: Doubling time, ABCB1 status and STR profile from personal communication of Daniel, Petr.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   MCF-7/PTX
AC   CVCL_C5RS
SY   MCF7/PTX; MCF-7/P
DR   ChEMBL-Cells; CHEMBL4483128
DR   ChEMBL-Targets; CHEMBL4483255
DR   Wikidata; Q116049773
RX   PubMed=24292090;
RX   PubMed=25760096;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MCF-7/RTx6
AC   CVCL_4V43
SY   MCF-7 Rtx6; RTx6; RTX6; RTx-6; Rtx-6
DR   cancercelllines; CVCL_4V43
DR   Wikidata; Q54904377
RX   PubMed=6574477;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/RU58R-1
AC   CVCL_K235
SY   MCF-7/RU58(R)-1; RU58(R)-1; RU58R-1
DR   cancercelllines; CVCL_K235
DR   Wikidata; Q54904378
RX   PubMed=15868441;
RX   PubMed=16172194;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90223; RU 58668.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   MCF-7/S0.5
AC   CVCL_1D47
SY   MCF7/S0.5; MCF7 S0.5
DR   cancercelllines; CVCL_1D47
DR   CancerTools; 152090
DR   ECACC; 16022501
DR   Millipore; SCC100
DR   Wikidata; Q54904379
DR   Ximbio; 152090
RX   PubMed=6362856;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022501; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022501; Millipore=SCC100
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   MCF-7/S7
AC   CVCL_WK28
SY   MCF-7 subline 7
DR   cancercelllines; CVCL_WK28
DR   Wikidata; Q95986458
RX   PubMed=3513694;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   MCF-7/S9
AC   CVCL_AS09
SY   MCF7/S9; MCF-7 subline 9
DR   cancercelllines; CVCL_AS09
DR   CancerTools; 152602
DR   ECACC; 16022530
DR   Wikidata; Q54904380
DR   Ximbio; 152602
RX   PubMed=3513694;
RX   PubMed=12732292;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Doubling time: ~44 hours, 34 hours (Note=When estradiol added in medium) (PubMed=12732292).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022530; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   MCF-7/SB-T-0035R
AC   CVCL_C0CU
SY   MCF7/SB-T-0035R
DR   cancercelllines; CVCL_C0CU
DR   Wikidata; Q112930091
RX   PubMed=29625142;
CC   Population: Caucasian.
CC   Characteristics: Generated by step-increasing drug concentration to 300 nm of SB-T-0035. Overexpresses ABCB1 which is amplified and inserted in chromosome 19 (PubMed=29625142; Direct_author_submission).
CC   Doubling time: ~25-30 hours (Direct_author_submission).
CC   Selected for resistance to: SB-T-0035 (Stony-Brooke Taxane 35).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Doubling time, ABCB1 status and STR profile from personal communication of Daniel, Petr.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 8
//
ID   MCF-7/TAMR-1
AC   CVCL_M436
SY   MCF7/TAMR-1; MCF7 TAMR-1; MCF-7/TAM(R)-1; MCF7-TAMR; TAMR-1; TamR-1; TamR1; AL-1
DR   cancercelllines; CVCL_M436
DR   CancerTools; 152089
DR   ChEMBL-Cells; CHEMBL4513115
DR   Millipore; SCC101
DR   Wikidata; Q54904381
DR   Ximbio; 152089
RX   PubMed=1622627;
RX   PubMed=7664983;
RX   PubMed=16172194;
RX   PubMed=18824559;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Millipore=SCC101
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 25
//
ID   MCF-7/TAMR-4
AC   CVCL_1D42
SY   MCF7/TAMR-4; TAMR-4; TamR-4; TamR4
DR   cancercelllines; CVCL_1D42
DR   CancerTools; 152088
DR   ECACC; 16022528
DR   Wikidata; Q54904382
DR   Ximbio; 152088
RX   PubMed=16172194;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022528; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022528
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   MCF-7/TAMR-7
AC   CVCL_1D43
SY   MCF7/TAMR-7; TAMR-7; TamR7
DR   cancercelllines; CVCL_1D43
DR   CancerTools; 152087
DR   ECACC; 16022509
DR   Wikidata; Q54904383
DR   Ximbio; 152087
RX   PubMed=16172194;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022509; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022509
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   MCF-7/TAMR-8
AC   CVCL_1D44
SY   MCF7/TAMR-8; TAMR-8; TamR8
DR   cancercelllines; CVCL_1D44
DR   CancerTools; 152086
DR   ECACC; 16022510
DR   Wikidata; Q54904384
DR   Ximbio; 152086
RX   PubMed=16172194;
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 16022510; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022510
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14.1
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D47 ! MCF-7/S0.5
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   MCF-7/TAX
AC   CVCL_IJ26
DR   cancercelllines; CVCL_IJ26
DR   Wikidata; Q54904385
RX   PubMed=24289639;
CC   Population: Caucasian.
CC   Doubling time: 44.60 +- 1 hours (PubMed=24289639).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/Taxol
AC   CVCL_M355
DR   cancercelllines; CVCL_M355
DR   Wikidata; Q54904387
RX   PubMed=20926015;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   MCF-7/TMX2
AC   CVCL_4Y63
SY   TMX2
DR   cancercelllines; CVCL_4Y63
DR   Wikidata; Q54904388
RX   PubMed=12943988;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Y65 ! MCF-7 clone 33
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/TMX2-11
AC   CVCL_4Y64
SY   TMX2-11
DR   cancercelllines; CVCL_4Y64
DR   Wikidata; Q54904393
RX   PubMed=12943988;
RX   PubMed=24225485;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Y63 ! MCF-7/TMX2
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   MCF-7/TMX2-28
AC   CVCL_6957
SY   TMX2-28
DR   cancercelllines; CVCL_6957
DR   Wikidata; Q54904394
RX   PubMed=12943988;
RX   PubMed=17189381;
RX   PubMed=24225485;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Y63 ! MCF-7/TMX2
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   MCF-7/TPT300
AC   CVCL_4V42
SY   MCF7/TPT300
DR   cancercelllines; CVCL_4V42
DR   Wikidata; Q54904395
RX   PubMed=10930538;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/Twist
AC   CVCL_DR99
DR   cancercelllines; CVCL_DR99
DR   Wikidata; Q54904396
RX   PubMed=16322226;
RX   PubMed=20019840;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12428; TWIST1.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   MCF-7/VD(R)
AC   CVCL_2Z97
DR   cancercelllines; CVCL_2Z97
DR   Wikidata; Q54904397
RX   PubMed=11500919;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27300; Vitamin D.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   MCF-7/Vector
AC   CVCL_F1C8
SY   MCF-7/Vec; MCF-7/V
RX   PubMed=8764133;
RX   PubMed=9563896;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for the heregulin beta-2 transfected cell lines (PubMed=8764133; PubMed=9563896).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCF-7/VP
AC   CVCL_5I65
SY   MCF7-VP; MCF7/VP; MCF-7 VP-16; MCF-7/VP16; MCF7-VP16
DR   cancercelllines; CVCL_5I65
DR   ChEMBL-Cells; CHEMBL3307299
DR   ChEMBL-Targets; CHEMBL614128
DR   ChEMBL-Targets; CHEMBL614329
DR   PubChem_Cell_line; CVCL_5I65
DR   Wikidata; Q54904398
RX   PubMed=7903202;
RX   PubMed=8562478;
RX   PubMed=11406094;
CC   Population: Caucasian.
CC   Doubling time: 47 hours (PubMed=8562478).
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   MCF-7:2A
AC   CVCL_4Y53
DR   cancercelllines; CVCL_4Y53
DR   Wikidata; Q54904399
RX   PubMed=7780972;
RX   PubMed=8600466;
RX   PubMed=24604139;
CC   Population: Caucasian.
CC   Characteristics: Estrogen independent. Derived from the parental cell line through long-term estrogen deprivation (PubMed=7780972).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3467; ESR1; Unexplicit; Ex6-7 dup; Zygosity=Heterozygous; Note=Produces a protein with 106 additional AA (PubMed=8600466).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Caution: There is confusion in the literature between estrogen-independent MCF-7:2A (Cellosaurus=CVCL_4Y53), L-mimosine-resistant MCF-7/2a (Cellosaurus=CVCL_0412) and EREwtcluc transfected MCF-7-2a (Cellosaurus=CVCL_4Y54).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   MCF-7:CFR
AC   CVCL_C5RV
SY   MCF7:CFR
DR   ChEMBL-Cells; CHEMBL4630713
DR   Wikidata; Q116049774
RX   PubMed=32453591;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DC70 ! MCF-7.5C
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MCF-7:WS8
AC   CVCL_D5YA
DR   Wikidata; Q127382749
RX   PubMed=8600466;
RX   PubMed=15862958;
RX   PubMed=24604139;
CC   Population: Caucasian.
CC   Characteristics: Highly sensitive to estrogen-stimulated growth.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   MCF-7aro
AC   CVCL_9580
SY   MCF-7-Aro; MCF7aro
DR   EFO; EFO_0002072
DR   cancercelllines; CVCL_9580
DR   Wikidata; Q54904400
RX   PubMed=2208160;
RX   PubMed=9449203;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   MCF-7aro Let-R
AC   CVCL_W348
SY   MCF-7aro/LetR; MCF-7-AroR-Let-R; MCF7aroLetR; Let-R
DR   cancercelllines; CVCL_W348
DR   CancerTools; 151781
DR   Wikidata; Q54904401
DR   Ximbio; 151781
RX   CelloPub=CLPUB00802;
RX   DOI=10.1186/1753-6561-6-S4-P3;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_6413; Letrozole.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9580 ! MCF-7aro
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 23
//
ID   MCF-7aro/ERE
AC   CVCL_9581
DR   cancercelllines; CVCL_9581
DR   Wikidata; Q54904403
RX   PubMed=18550029;
CC   Population: Caucasian.
CC   Biotechnology: Can be used in an vitro assay to screen for aromatase inhibitors (AIs) at the same time as estrogen receptor alpha (Era) and ERR-alpha ligands (PubMed=18550029).
CC   Characteristics: Expression of the luciferase gene is under the control of three repeats of estrogen responsive element (ERE) (PubMed=18550029).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9580 ! MCF-7aro
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 22
//
ID   MCF-7B
AC   CVCL_6860
SY   MCF 7B
DR   cancercelllines; CVCL_6860
DR   CCRID; 1101HUM-PUMC000041
DR   Wikidata; Q54904404
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CCRID=1101HUM-PUMC000041
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   MCF-7cherry
AC   CVCL_E2QL
SY   MCF7cherry
RX   PubMed=29569804;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MCF-7D3Res
AC   CVCL_2Z98
DR   cancercelllines; CVCL_2Z98
DR   Wikidata; Q54904405
RX   PubMed=8593782;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27300; Vitamin D.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 15
//
ID   MCF-7GFP
AC   CVCL_E2QM
SY   MCF7GFP
DR   DSMZ; ACC-983
RX   PubMed=29569804;
CC   Population: Caucasian.
CC   Doubling time: ~20-24 hours (DSMZ=ACC-983).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-983
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MCF-7L
AC   CVCL_0088
SY   MCF-7 L
DR   cancercelllines; CVCL_0088
DR   Wikidata; Q54904406
RX   PubMed=10811993;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   MCF-7M
AC   CVCL_6672
SY   MCF-7 M
DR   cancercelllines; CVCL_6672
DR   Wikidata; Q54904407
RX   PubMed=9671407;
RX   PubMed=10811993;
CC   Population: Caucasian.
CC   Doubling time: 1.4 days (PubMed=9671407).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   MCF-7N
AC   CVCL_6673
SY   MCF-7 N; MCF-7n
DR   cancercelllines; CVCL_6673
DR   Wikidata; Q54904408
RX   PubMed=10811993;
RX   PubMed=15138590;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   MCF-7R
AC   CVCL_Y493
SY   MCF7R
DR   cancercelllines; CVCL_Y493
DR   ChEMBL-Cells; CHEMBL3307593
DR   ChEMBL-Targets; CHEMBL614327
DR   PubChem_Cell_line; CVCL_Y493
DR   Wikidata; Q54904409
RX   PubMed=17671737;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 18
//
ID   MCF-7TN-R
AC   CVCL_6674
DR   cancercelllines; CVCL_6674
DR   Wikidata; Q54904410
RX   PubMed=15138590;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6673 ! MCF-7N
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   MCF-hGH
AC   CVCL_9V74
SY   MCF-HGH
DR   cancercelllines; CVCL_9V74
DR   NCBI_Iran; C628
DR   Wikidata; Q54904411
RX   PubMed=10388519;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4261; GH1.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   MCF/MX
AC   CVCL_4Y47
SY   MCF-7/MX; MCF-7/mtxR
DR   cancercelllines; CVCL_4Y47
DR   Wikidata; Q54904412
RX   PubMed=1358431;
RX   PubMed=7664272;
RX   PubMed=9865745;
RX   PubMed=11559526;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   MCF10A AKT2 (-/-)
AC   CVCL_RQ97
SY   MCF10A AKT2 -/-
DR   Sigma-Aldrich; CLLS1063
DR   Wikidata; Q54904413
CC   Knockout cell: Method=ZFN; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A APC (-/-)
AC   CVCL_RQ98
SY   MCF10A APC -/-
DR   Sigma-Aldrich; CLLS1069
DR   Wikidata; Q54904414
CC   Knockout cell: Method=ZFN; HGNC; HGNC:583; APC.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A BCR (-/-)
AC   CVCL_RQ99
SY   MCF10A BCR -/-
DR   Sigma-Aldrich; CLLS1059
DR   Wikidata; Q54904415
CC   Knockout cell: Method=ZFN; HGNC; HGNC:1014; BCR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A BLV
AC   CVCL_B7JN
DR   Wikidata; Q112930093
RX   DOI=10.31487/j.COR.2020.09.03;
CC   Virology: Infected with bovine leukemia virus from the peripheral blood of BLV-infected adult cows. Does not release viral particles into the cell culture supernatant.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   MCF10A CDC25B (-/-)
AC   CVCL_RR08
SY   MCF10A CDC25B -/-
DR   Sigma-Aldrich; CLLS1060
DR   Wikidata; Q54904416
CC   Knockout cell: Method=ZFN; HGNC; HGNC:1726; CDC25B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A CDH1 (-/-)
AC   CVCL_RR00
SY   MCF10A CDH1 -/-
DR   Sigma-Aldrich; CLLS1042
DR   Wikidata; Q54904417
CC   Knockout cell: Method=ZFN; HGNC; HGNC:1748; CDH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A EEF2K (-/-)
AC   CVCL_RR01
SY   MCF10A eEF2K -/-
DR   Sigma-Aldrich; CLLS1051
DR   Wikidata; Q54904418
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24615; EEF2K.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A ESR2 (-/-)
AC   CVCL_RR09
SY   MCF10A ESR2 -/-
DR   Sigma-Aldrich; CLLS1075
DR   Wikidata; Q54904419
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3468; ESR2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A GSK3B (-/-)
AC   CVCL_RR02
SY   MCF10A GSK3B -/-
DR   Sigma-Aldrich; CLLS1044
DR   Wikidata; Q54904420
CC   Knockout cell: Method=ZFN; HGNC; HGNC:4617; GSK3B.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A H2AFX (-/-)
AC   CVCL_RR10
SY   MCF10A H2AFX -/-
DR   Sigma-Aldrich; CLLS1061
DR   Wikidata; Q54904422
CC   Knockout cell: Method=ZFN; HGNC; HGNC:4739; H2AX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   MCF10A HER2 (-/-)
AC   CVCL_RR03
SY   MCF10A HER2 -/-
DR   Sigma-Aldrich; CLLS1045
DR   Wikidata; Q54904421
CC   Knockout cell: Method=ZFN; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A PARP2 (-/-)
AC   CVCL_RR04
SY   MCF10A PARP2 -/-
DR   Sigma-Aldrich; CLLS1066
DR   Wikidata; Q54904423
CC   Knockout cell: Method=ZFN; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A PTEN (-/-)
AC   CVCL_RR05
SY   MCF10A PTEN -/-
DR   Sigma-Aldrich; CLLS1046
DR   Wikidata; Q54904424
CC   Knockout cell: Method=ZFN; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A PVRL4 (-/-)
AC   CVCL_RR11
SY   MCF10A PVRL4 -/-
DR   Sigma-Aldrich; CLLS1211
DR   Wikidata; Q54904425
CC   Knockout cell: Method=ZFN; HGNC; HGNC:19688; NECTIN4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A RFP-TUBA1B
AC   CVCL_RQ96
DR   Sigma-Aldrich; CLL1039
DR   Wikidata; Q54904426
CC   Characteristics: Using ZFN a TagRFP construct was integrated at the N-terminus of the TUBA1B (Sigma-Aldrich=CLL1039).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A RICTOR (-/-)
AC   CVCL_RR12
SY   MCF10A Rictor -/-
DR   Sigma-Aldrich; CLLS1053
DR   Wikidata; Q54904428
CC   Knockout cell: Method=ZFN; HGNC; HGNC:28611; RICTOR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A SYK (-/-)
AC   CVCL_RR07
SY   MCF10A SYK -/-
DR   Sigma-Aldrich; CLLS1048
DR   Wikidata; Q54904429
CC   Knockout cell: Method=ZFN; HGNC; HGNC:11491; SYK.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A TP53 (-/-)
AC   CVCL_RR06
SY   MCF10A TP53 -/-
DR   Sigma-Aldrich; CLLS1049
DR   Wikidata; Q54904430
CC   Knockout cell: Method=ZFN; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MCF10A-AKTm-1
AC   CVCL_C7Q0
SY   MCF10A-AKT1_type-02; 06M09003
DR   CancerTools; 161210
DR   Wikidata; Q117704641
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:391; AKT1 (Note=With p.Glu17Lys (c.49G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-AKTm-Control
AC   CVCL_C7Q1
SY   MCF10A-AKT1_Control; 06M09001
DR   CancerTools; 161209
DR   Wikidata; Q117704642
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:391; AKT1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-1
AC   CVCL_C7Q2
SY   MCF10A-EGFR-1_type-01; 06M01002
DR   CancerTools; 161168
DR   Wikidata; Q117704643
RX   PubMed=27840973;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-10
AC   CVCL_C7QB
SY   MCF10A-EGFR-1_type-22; 06M01027
DR   CancerTools; 161177
DR   Wikidata; Q117704644
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insProHis (c.2319_2320insCCCCAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-11
AC   CVCL_C7QC
SY   MCF10A-EGFR-1_type-26; 06M01031
DR   CancerTools; 161178
DR   Wikidata; Q117704645
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Cys797Ser (c.2389T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-12
AC   CVCL_C7QD
SY   MCF10A-EGFR-1_type-27; 06M01008
DR   CancerTools; 161179
DR   Wikidata; Q117704647
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del (c.2235_2249delGGAATTAAGAGAAGC) and p.Thr785Met (c.2354C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-13
AC   CVCL_C7QE
SY   MCF10A-EGFR-1_type-28; 06M01032
DR   CancerTools; 161180
DR   Wikidata; Q117704648
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del (c.2235_2249delGGAATTAAGAGAAGC) and p.Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-14
AC   CVCL_C7QF
SY   MCF10A-EGFR-1_type-36; 06M01004
DR   CancerTools; 161181
DR   Wikidata; Q117704649
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ala (c.2156G>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-15
AC   CVCL_C7QG
SY   MCF10A-EGFR-1_type-37; 06M01005
DR   CancerTools; 161182
DR   Wikidata; Q117704650
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Ser (c.2155G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-16
AC   CVCL_C7QH
SY   MCF10A-EGFR-1_type-38; 06M01006
DR   CancerTools; 161183
DR   Wikidata; Q117704652
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Gly719Cys (c.2155G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-17
AC   CVCL_C7QI
SY   MCF10A-EGFR-1_type-21; 06M01026
DR   CancerTools; 161184
DR   CancerTools; 161351
DR   Wikidata; Q117704653
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insGly (c.2310_2311insGGT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-18
AC   CVCL_C7QJ
SY   MCF10A-EGFR-1_type-25; 06M01030
DR   CancerTools; 161185
DR   CancerTools; 161352
DR   Wikidata; Q117704654
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-19
AC   CVCL_C7QK
SY   MCF10A-EGFR-1_type-30; 06M01034
DR   CancerTools; 161186
DR   CancerTools; 161353
DR   Wikidata; Q117704655
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr790Met (c.2369C>T), p.Cys797Ser (c.2389T>A) and p.Leu858Arg (c.2573T>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-2
AC   CVCL_C7Q3
SY   MCF10A-EGFR-1_type-02; 06M01007
DR   CancerTools; 161169
DR   Wikidata; Q117704656
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del (c.2235_2249delGGAATTAAGAGAAGC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-20
AC   CVCL_C7QL
SY   MCF10A-EGFR-1_type-31; 06M01035
DR   CancerTools; 161187
DR   CancerTools; 161354
DR   Wikidata; Q117704657
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del (c.2235_2249delGGAATTAAGAGAAGC), p.Thr790Met (c.2354C>T) and Cys797Ser (c.2389T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-21
AC   CVCL_C7QM
SY   MCF10A-EGFR-1_type-42; 06M01043
DR   CancerTools; 161188
DR   CancerTools; 161355
DR   Wikidata; Q117704658
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu709Gly (c.2126A>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-3
AC   CVCL_C7Q4
SY   MCF10A-EGFR-1_type-07; 06M01012
DR   CancerTools; 161170
DR   Wikidata; Q117704659
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu861Gln (c.2582T>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-4
AC   CVCL_C7Q5
SY   MCF10A-EGFR-1_type-13; 06M01009
DR   CancerTools; 161171
DR   Wikidata; Q117704660
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769_Asp770insAlaSerVal (c.2308_2309insCCAGCGTGG)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-5
AC   CVCL_C7Q6
SY   MCF10A-EGFR-1_type-14; 06M01010
DR   CancerTools; 161172
DR   Wikidata; Q117704661
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insSerValAsp (c.2311_2312insGCGTGGACA)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-6
AC   CVCL_C7Q7
SY   MCF10A-EGFR-1_type-15; 06M01011
DR   CancerTools; 161173
DR   Wikidata; Q117704662
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insAsnProHis (c.2319_2320insAACCCCCAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-7
AC   CVCL_C7Q8
SY   MCF10A-EGFR-1_type-18; 06M01023
DR   CancerTools; 161174
DR   Wikidata; Q117704663
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ala763_Tyr764insPheGlnGluAla (c.2290_2291insTCCAGGAAGCCT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-8
AC   CVCL_C7Q9
SY   MCF10A-EGFR-1_type-19; 06M01024
DR   CancerTools; 161175
DR   Wikidata; Q117704664
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insHis (c.2319_2320insCAC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-9
AC   CVCL_C7QA
SY   MCF10A-EGFR-1_type-20; 06M01025
DR   CancerTools; 161176
DR   Wikidata; Q117704665
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val774_Cys775insHisVal (c.2321_2322insCCACGT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-EGFR1m-control
AC   CVCL_C7QN
SY   MCF10A-EGFR-1_Control; 06M01001
DR   CancerTools; 161167
DR   Wikidata; Q117704666
RX   PubMed=27840973;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-Er-Src
AC   CVCL_N805
DR   CLO; CLO_0037240
DR   Wikidata; Q54904431
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/MCF-10A_Struhl_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   MCF10A-ERBB2m-1
AC   CVCL_C7QP
SY   MCF10A-ERBB2_type-01; 06M15006
DR   CancerTools; 161190
DR   Wikidata; Q117704667
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Gly309Ala (c.926G>C)).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-10
AC   CVCL_C7QY
SY   MCF10A-ERBB2_type-11; 06M15005
DR   CancerTools; 161199
DR   Wikidata; Q117704668
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Val842Ile (c.2524G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-11
AC   CVCL_C7QZ
SY   MCF10A-ERBB2_type-12; 06M15013
DR   CancerTools; 161200
DR   Wikidata; Q117704669
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Asp769Tyr (c.2305G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-12
AC   CVCL_C7R0
SY   MCF10A-ERBB2_type-13; 06M15014
DR   CancerTools; 161201
DR   Wikidata; Q117704671
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Arg896Cys (c.2686C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-13
AC   CVCL_C7R1
SY   MCF10A-ERBB2_type-15; 06M15027
DR   CancerTools; 161202
DR   Wikidata; Q117704672
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Pro780_Tyr781insGlySerPro (c.2339_2340insGGGCTCCCC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-2
AC   CVCL_C7QQ
SY   MCF10A-ERBB2_type-02; 06M15002
DR   CancerTools; 161191
DR   Wikidata; Q117704673
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Ser310Phe (c.929C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-3
AC   CVCL_C7QR
SY   MCF10A-ERBB2_type-03; 06M15003
DR   CancerTools; 161192
DR   Wikidata; Q117704674
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Ser310Tyr (c.929C>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-4
AC   CVCL_C7QS
SY   MCF10A-ERBB2_type-04; 06M15007
DR   CancerTools; 161193
DR   Wikidata; Q117704675
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Arg678Gln (c.2033G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-5
AC   CVCL_C7QT
SY   MCF10A-ERBB2_type-06; 06M15009
DR   CancerTools; 161194
DR   Wikidata; Q117704676
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Ala775_Gly776insTyrValMetAla (c.2324_2325insATACGTGATGGC)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-6
AC   CVCL_C7QU
SY   MCF10A-ERBB2_type-07; 06M15010
DR   CancerTools; 161195
DR   Wikidata; Q117704677
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Leu755_Thr759del (c.2263_2277delTTGAGGGAAAACACA)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-7
AC   CVCL_C7QV
SY   MCF10A-ERBB2_type-08; 06M15011
DR   CancerTools; 161196
DR   Wikidata; Q117704678
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Asp769His (c.2305G>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-8
AC   CVCL_C7QW
SY   MCF10A-ERBB2_type-09; 06M15012
DR   CancerTools; 161197
DR   Wikidata; Q117704679
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Gly776ValCys (c.2326_2327insTGT)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERBB2m-9
AC   CVCL_C7QX
SY   MCF10A-ERBB2_type-10; 06M15004
DR   CancerTools; 161198
DR   Wikidata; Q117704680
RX   PubMed=30787176;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2 (Note=With p.Val777Leu (c.2329G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-ERRB2m-Control
AC   CVCL_C7R2
SY   MCF10A-ERBB2_Control; 06M15001
DR   CancerTools; 161189
DR   Wikidata; Q117704681
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-JSB
AC   CVCL_VH36
DR   BioSample; SAMN05292436
DR   Wikidata; Q54904432
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544591
CC   Doubling time: ~16 hours (PBCF).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   MCF10A-KRAS
AC   CVCL_YI68
DR   Wikidata; Q95986682
RX   PubMed=31467290;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): PubMed=31467290
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 18,19
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 21,26
ST   D3S1358: 14,18
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   MCF10A-KRAS-b_Control
AC   CVCL_E3K0
SY   06M00003
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-01
AC   CVCL_E3JI
SY   06M00004
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Asp (c.35G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-02
AC   CVCL_E3JJ
SY   06M00005
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-03
AC   CVCL_E3JK
SY   06M00006
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly13Asp (c.38G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-04
AC   CVCL_E3JL
SY   06M00007
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Cys (c.34G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-05
AC   CVCL_E3JM
SY   06M00008
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Ala (c.35G>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-06
AC   CVCL_E3JN
SY   06M00009
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Ser (c.34G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-07
AC   CVCL_E3JP
SY   06M00010
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Arg (c.34G>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-08
AC   CVCL_E3JQ
SY   06M00011
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly13Cys (c.37G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-09
AC   CVCL_E3JR
SY   06M00012
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gln61His (c.183A>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-10
AC   CVCL_E3JS
SY   06M00013
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gln61Leu (c.182A>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-11
AC   CVCL_E3JT
SY   06M00014
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Ala146Thr (c.436G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-12
AC   CVCL_E3JU
SY   06M00015
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Ala146Val (c.437C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-13
AC   CVCL_E3JV
SY   06M00016
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Val14Ile (c.40G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-14
AC   CVCL_E3JW
SY   06M00017
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Ala59Thr (c.175G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-15
AC   CVCL_E3JX
SY   06M00018
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gln61Pro (c.182A>C)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-16
AC   CVCL_E3JY
SY   06M00019
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Leu19Phe (c.57G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-KRAS-b_type-17
AC   CVCL_E3JZ
SY   06M00020
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gln61Glu (c.181C>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MCF10A-Myc
AC   CVCL_0411
SY   MCF10AMyc
DR   MCCL; MCC:0000306
DR   Wikidata; Q54904433
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   MCF10A-PTENm-1
AC   CVCL_C7R3
SY   MCF10A-PTEN_type-01; 06M17002
DR   CancerTools; 161204
DR   Wikidata; Q117704682
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9588; PTEN (Note=With p.Arg130Gln (c.389G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-PTENm-2
AC   CVCL_C7R4
SY   MCF10A-PTEN_type-04; 06M17005
DR   CancerTools; 161205
DR   Wikidata; Q117704683
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9588; PTEN (Note=With p.Arg130Gly (c.388C>G)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-PTENm-3
AC   CVCL_C7R5
SY   MCF10A-PTEN_type-05; 06M17006
DR   CancerTools; 161206
DR   Wikidata; Q117704684
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9588; PTEN (Note=With p.Arg233Ter (c.697C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-PTENm-4
AC   CVCL_C7R6
SY   MCF10A-PTEN_type-06; 06M17007
DR   CancerTools; 161207
DR   Wikidata; Q117704685
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9588; PTEN (Note=With p.Arg130Ter (c.388C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-PTENm-5
AC   CVCL_C7R7
SY   MCF10A-PTEN_type-12; 06M17013
DR   CancerTools; 161208
DR   Wikidata; Q117704686
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9588; PTEN (Note=With p.Arg335Ter (c.1003C>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A-PTENm-Control
AC   CVCL_C7R8
SY   MCF10A-PTEN_Control; 06M17001
DR   CancerTools; 161203
DR   Wikidata; Q117704687
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/human-gene-overexpressing-cell-lines/
CC   Part of: Fukushima Translational Research Project gene-overexpressing cell lines panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9588; PTEN.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MCF10A_APC_7
AC   CVCL_C0ZJ
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312227
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_APC_735
AC   CVCL_C0ZK
DR   Wikidata; Q114312228
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_APC_753
AC   CVCL_C0ZL
DR   Wikidata; Q114312229
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_ARID1A_B4
AC   CVCL_C0ZM
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312230
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_ARID1A_C11_SC1
AC   CVCL_C0ZN
DR   Wikidata; Q114312231
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_ATRX_718
AC   CVCL_C0ZP
DR   Wikidata; Q114312232
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_ATRX_722
AC   CVCL_C0ZQ
DR   Wikidata; Q114312233
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_ATRX_734
AC   CVCL_C0ZR
DR   Wikidata; Q114312234
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_CDKN2C_161
AC   CVCL_C0ZS
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312235
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1789; CDKN2C.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_CDKN2C_163
AC   CVCL_C0ZT
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312236
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1789; CDKN2C.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_DAXX_703_SC1
AC   CVCL_C0ZU
DR   Wikidata; Q114312237
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_DAXX_704
AC   CVCL_C0ZV
DR   Wikidata; Q114312238
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_DAXX_715
AC   CVCL_C0ZW
DR   Wikidata; Q114312239
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_EZH2_10A3
AC   CVCL_C0ZX
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312240
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_EZH2_10B4
AC   CVCL_C0ZY
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312241
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_EZH2_19
AC   CVCL_C0ZZ
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312242
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_MLH1_4
AC   CVCL_C1A0
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312243
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_MLH1_5
AC   CVCL_C1A1
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312244
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_MLL2_7
AC   CVCL_C1A2
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312245
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_MSH2_104
AC   CVCL_C1A3
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312246
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_MSH2_173
AC   CVCL_C1A4
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312247
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_MSH6_54
AC   CVCL_C1A5
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312248
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_MTAP_15
AC   CVCL_C1CE
DR   Wikidata; Q114312249
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_MTAP_8
AC   CVCL_C1CF
DR   Wikidata; Q114312251
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   MCF10A_NF1_1
AC   CVCL_C1A6
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312253
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_NF1_7A1
AC   CVCL_C1A7
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312254
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_NF1_7B2
AC   CVCL_C1A8
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312255
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_NOTCH1_1
AC   CVCL_C1A9
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312256
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_NOTCH1_14
AC   CVCL_C1AA
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312257
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_PTCH1_2
AC   CVCL_C1AB
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312258
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_PTCH1_5
AC   CVCL_C1AC
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312259
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_PTEN_1
AC   CVCL_C1AD
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312260
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_STAG2_9
AC   CVCL_C1AE
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312261
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_STAG2_A4
AC   CVCL_C1AF
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312263
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_STAG2_C5
AC   CVCL_C1AG
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312264
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_TET2_B3
AC   CVCL_C1AH
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312265
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_TET2_E3
AC   CVCL_C1AI
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312266
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_TET2_E7
AC   CVCL_C1AJ
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312267
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_TP53_137
AC   CVCL_C1AK
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312268
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A_TP53_142
AC   CVCL_C1AL
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312269
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MCF10A1
AC   CVCL_WM99
DR   Wikidata; Q95986692
RX   PubMed=14523048;
RX   PubMed=20543960;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   MCF10AT1k.cl2
AC   CVCL_WM98
SY   MCF10AT1KCl.2; MCF10AT1K
DR   Wikidata; Q95986693
RX   PubMed=11261825;
RX   PubMed=14523048;
RX   PubMed=20543960;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5554 ! MCF-10A-neoT
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   MCF10CA1a
AC   CVCL_6675
DR   cancercelllines; CVCL_6675
DR   GEO; GSM498025
DR   GEO; GSM498029
DR   IGRhCellID; MCF10CA1a
DR   Progenetix; CVCL_6675
DR   Wikidata; Q54904434
RX   PubMed=11261825;
RX   PubMed=15375546;
RX   PubMed=20169162;
RX   PubMed=24262153;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM98 ! MCF10AT1k.cl2
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   MCF10CA1a.cl1
AC   CVCL_6676
DR   Wikidata; Q54904438
RX   PubMed=11261825;
RX   PubMed=14523048;
RX   PubMed=20543960;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6675 ! MCF10CA1a
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   MCF10CA1b
AC   CVCL_6677
DR   Wikidata; Q54904439
RX   PubMed=11261825;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM98 ! MCF10AT1k.cl2
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   MCF10CA1c
AC   CVCL_6678
DR   Wikidata; Q54904441
RX   PubMed=11261825;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM98 ! MCF10AT1k.cl2
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   MCF10CA1d
AC   CVCL_6679
DR   Wikidata; Q54904442
RX   PubMed=11261825;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM98 ! MCF10AT1k.cl2
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   MCF10CA1d.cl1
AC   CVCL_6680
DR   Wikidata; Q54904443
RX   PubMed=11261825;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6679 ! MCF10CA1d
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   MCF10CA1d.cl2
AC   CVCL_6681
DR   Wikidata; Q54904444
RX   PubMed=11261825;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6679 ! MCF10CA1d
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   MCF10CA1d.cl3
AC   CVCL_6682
DR   Wikidata; Q54904445
RX   PubMed=11261825;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6679 ! MCF10CA1d
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   MCF10CA1h
AC   CVCL_6683
DR   cancercelllines; CVCL_6683
DR   GEO; GSM271344
DR   GEO; GSM498024
DR   GEO; GSM498028
DR   IGRhCellID; MCF10CA1h
DR   Progenetix; CVCL_6683
DR   Wikidata; Q54904446
RX   PubMed=11261825;
RX   PubMed=14523048;
RX   PubMed=20169162;
RX   PubMed=20543960;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WM98 ! MCF10AT1k.cl2
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   MCF10DCIS.com
AC   CVCL_5552
SY   MCF10DCIS.COM; MCF10ADCIS.com; MCF10A-DCIS.com; MCF10DCIS; MCFDCIS; DCIS.COM; DCIS
DR   EFO; EFO_0006643
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_5552
DR   Cosmic; 1219447
DR   EGA; EGAS00001000610
DR   GEO; GSM271345
DR   GEO; GSM271398
DR   Lonza; 1619
DR   MetaboLights; MTBLS669
DR   PharmacoDB; MCF10DCIS_com_892_2019
DR   Progenetix; CVCL_5552
DR   Wikidata; Q54904447
RX   PubMed=10904098;
RX   PubMed=18455123;
RX   PubMed=23401782;
RX   PubMed=25485619;
RX   PubMed=34238275;
CC   Characteristics: Derived from a xenograft originating from MCF-10AT cells that were injected into severe combined immune-deficient mice.
CC   Doubling time: 20.5 hours (PubMed=34238275).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=23401782).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5555 ! MCF-10AT
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   MCF3B
AC   CVCL_M373
DR   cancercelllines; CVCL_M373
DR   Wikidata; Q54904448
RX   PubMed=11079502;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 69267; Slc5a5.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   MCF7 AREc32
AC   CVCL_1D32
SY   MCF7/AREc32; AREc32
DR   ABM; T6103
DR   cancercelllines; CVCL_1D32
DR   CancerTools; 151014
DR   ECACC; 16071902
DR   Wikidata; Q54750439
DR   Ximbio; 151014
RX   PubMed=17108137;
RX   PubMed=23032559;
WW   Provider; CXR Biosciences; -; https://web.archive.org/web/20170818205759/http://www.cxrbiosciences.com/technologies/arec32-cell-line/
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing 8 copies of the rat glutathione-S-transferase (GST) antioxidant response element (ARE) linked to the luciferase reporter gene. Induction of the ARE results in luciferase activity (PubMed=17108137).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: ECACC; 16071902; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16071902
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 22
//
ID   MCF7 CD24 KO clone 2A1
AC   CVCL_E8T4
SY   MCF7-CD24-KO-2A1
DR   KYinno; KC-1753
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MCF7 CD24 KO clone 3B2
AC   CVCL_E8T5
SY   MCF7-CD24-KO-3B2
DR   KYinno; KC-1754
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MCF7 CRBN KO clone 2A3
AC   CVCL_E8T6
SY   MCF7-CRBN-KO-2A3
DR   KYinno; KC-3942
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MCF7 dCas9-KRAB
AC   CVCL_A4CH
DR   ATCC; HTB-22dCas9-KRAB
DR   cancercelllines; CVCL_A4CH
DR   Wikidata; Q105510079
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a construct containing KRAB-dCas9-2A-hph-2A-RFP-PA was introduced in the AAVS1 safe harbor locus.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-22dCas9-KRAB
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 11
//
ID   MCF7 NucLight Green
AC   CVCL_DF45
DR   cancercelllines; CVCL_DF45
DR   Wikidata; Q54904449
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4528.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 19
//
ID   MCF7 NucLight Red
AC   CVCL_DF46
DR   cancercelllines; CVCL_DF46
DR   Wikidata; Q54904450
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4524.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 20
//
ID   MCF7 Tet-Off
AC   CVCL_V357
SY   MCF-7 Tet-Off
DR   cancercelllines; CVCL_V357
DR   PRIDE; PXD001202
DR   Wikidata; Q54904451
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630907.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 20
//
ID   MCF7 Tet-Off advanced
AC   CVCL_KU37
SY   MCF-7 Tet-Off advanced
DR   cancercelllines; CVCL_KU37
DR   Wikidata; Q54904452
WW   Provider; Takara Bio; 632109; https://www.takarabio.com/documents/Certificate%20of%20Analysis/632109/632109-051518.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with an advanced tetracycline transactivator (tTA2(S)-M2) protein, a fusion of a mutated E.coli tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   MCF7 Tet-On
AC   CVCL_V332
SY   MCF7 Tet On; MCF-7 Tet-On
DR   cancercelllines; CVCL_V332
DR   Wikidata; Q54904453
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630918.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 20
//
ID   MCF7 Tet-On Advanced
AC   CVCL_KU45
DR   cancercelllines; CVCL_KU45
DR   Wikidata; Q54904454
CC   Population: Caucasian.
CC   Characteristics: Transfected with an advanced reverse tetracycline-controlled transactivator (rtTA2(S)-M2), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 632108.
CC   Discontinued: Takara/Clontech; Catalog number 631153.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   MCF7 tTS
AC   CVCL_V358
DR   cancercelllines; CVCL_V358
DR   Wikidata; Q54904455
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Takara/Clontech; Catalog number 630929.
CC   Discontinued: Takara/Clontech; Catalog number 631148.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   MCF7-382
AC   CVCL_3397
DR   CLO; CLO_0007607
DR   CLDB; cl3376
DR   CLDB; cl3377
DR   cancercelllines; CVCL_3397
DR   ICLC; HTL95018
DR   Wikidata; Q54904456
CC   Population: Caucasian.
CC   Characteristics: Control cell line for MCF7-422 (Cellosaurus=CVCL_3398) and MCF7-432 (Cellosaurus=CVCL_3399); transfected with emtpy vector pBact.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   MCF7-422
AC   CVCL_3398
DR   CLO; CLO_0007608
DR   CLDB; cl3378
DR   CLDB; cl3379
DR   cancercelllines; CVCL_3398
DR   ICLC; HTL95017
DR   Wikidata; Q54904457
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   MCF7-432
AC   CVCL_3399
DR   CLO; CLO_0007609
DR   CLDB; cl3380
DR   CLDB; cl3381
DR   cancercelllines; CVCL_3399
DR   ICLC; HTL95019
DR   Wikidata; Q54904458
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Exon 4 defective).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   MCF7-488X1
AC   CVCL_3400
DR   CLO; CLO_0007610
DR   CLDB; cl3382
DR   CLDB; cl3383
DR   cancercelllines; CVCL_3400
DR   ICLC; HTL96004
DR   Wikidata; Q54904459
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Exon 5 defective).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   MCF7-490X1
AC   CVCL_3401
DR   CLO; CLO_0007611
DR   CLDB; cl3384
DR   CLDB; cl3385
DR   cancercelllines; CVCL_3401
DR   ICLC; HTL96002
DR   Wikidata; Q54904460
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Exon 4 defective).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   MCF7-492X1
AC   CVCL_3402
DR   CLO; CLO_0007612
DR   CLDB; cl3386
DR   cancercelllines; CVCL_3402
DR   ICLC; HTL96028
DR   Wikidata; Q54904461
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   MCF7-AFA[r]
AC   CVCL_4V66
DR   cancercelllines; CVCL_4V66
DR   Wikidata; Q54904462
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_61390; Afatinib (BIBW-2992).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10041C.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 15
//
ID   MCF7-B7-TS
AC   CVCL_VH35
DR   BioSample; SAMN05292459
DR   cancercelllines; CVCL_VH35
DR   Wikidata; Q54904463
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   MCF7-Cas9-542
AC   CVCL_XD68
DR   cancercelllines; CVCL_XD68
DR   CCRID; 1101HUM-PUMC000542
DR   Wikidata; Q95986786
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CCRID=1101HUM-PUMC000542
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 12,18
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,24,25
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   MCF7-Cas9-543
AC   CVCL_XD69
DR   cancercelllines; CVCL_XD69
DR   CCRID; 1101HUM-PUMC000543
DR   Wikidata; Q95986788
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CCRID=1101HUM-PUMC000543
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 12,18
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,24,25
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   MCF7-Cas9-544
AC   CVCL_XD70
DR   cancercelllines; CVCL_XD70
DR   CCRID; 1101HUM-PUMC000544
DR   Wikidata; Q95986789
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CCRID=1101HUM-PUMC000544
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 21,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 12,18
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   MCF7-FGFR1
AC   CVCL_B5PF
SY   MCF7-R1
DR   cancercelllines; CVCL_B5PF
DR   Wikidata; Q112930094
RX   PubMed=34542998;
WW   Provider; I2B; P-101; http://inven2biologics.com/shop/cell-lines/human/mcf7-fgfr1-breast-cancer-cell-line-0
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   MCF7-FGFR4
AC   CVCL_E6ZX
SY   MCF7-R4
WW   Provider; I2B; P-99; http://inven2biologics.com/shop/cell-lines/human/mcf7-fgfr4-breast-cancer-cell-line
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3691; FGFR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MCF7-h14
AC   CVCL_VR08
DR   cancercelllines; CVCL_VR08
DR   Wikidata; Q95986791
RX   CelloPub=CLPUB00443;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4421; GNRHR.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   MCF7-LTED
AC   CVCL_YX84
SY   MCF7 LTED; LTED-I; MCF7-Long Term Estrogen-Deprived
DR   cancercelllines; CVCL_YX84
DR   Wikidata; Q95986792
RX   PubMed=12775708;
RX   PubMed=26116361;
CC   Population: Caucasian.
CC   Characteristics: Derived from parent cell line by long-term culture in the presence of RPMI 1640 medium containing 10% dextran charcoal stripped serum (DCC) (PubMed=26116361).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 11
//
ID   MCF7-Luc
AC   CVCL_C8Y8
DR   Ubigene; YC-D006-Luc-P
DR   Wikidata; Q123033007
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MCF7-Luc2 [ATCC]
AC   CVCL_A4CI
DR   ATCC; HTB-22-LUC2
DR   cancercelllines; CVCL_A4CI
DR   Wikidata; Q105510081
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=HTB-22-LUC2).
CC   Doubling time: ~57 hours (ATCC=HTB-22-LUC2).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-22-LUC2
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   MCF7-Luc2 [KYinno]
AC   CVCL_E8T7
DR   KYinno; KC-1741
CC   Population: Caucasian.
CC   Doubling time: ~38 hours (KYinno=KC-1741).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MCF7-PalR
AC   CVCL_E8T8
DR   KYinno; KC-4080
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MCF7-parkin clone 11
AC   CVCL_C3ID
SY   MCF7-PK11; MCF7-PK#11
DR   cancercelllines; CVCL_C3ID
DR   Wikidata; Q114312270
RX   PubMed=20630868;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   MCF7-parkin clone 5
AC   CVCL_C3IB
SY   MCF7-PK5; MCF7-PK#5
DR   cancercelllines; CVCL_C3IB
DR   Wikidata; Q114312271
RX   PubMed=20630868;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   MCF7-parkin clone 7
AC   CVCL_C3IC
SY   MCF7-PK7; MCF7-PK#7
DR   cancercelllines; CVCL_C3IC
DR   Wikidata; Q114312272
RX   PubMed=20630868;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   MCF7-TamR
AC   CVCL_EG55
DR   cancercelllines; CVCL_EG55
DR   PRIDE; PXD001812
DR   Wikidata; Q54904464
RX   PubMed=26330541;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   MCF7/BUS
AC   CVCL_0413
SY   MCF-7/BUS; MCF-7 BUS; MCF7 BUS
DR   MCCL; MCC:0000309
DR   cancercelllines; CVCL_0413
DR   Millipore; SCC276
DR   Wikidata; Q54904465
RX   PubMed=7498097;
CC   Population: Caucasian.
CC   Characteristics: Shows a very high proliferative response to estradiol-17beta (PubMed=7498097).
CC   Doubling time: 32 +- 1.7 hours (Note=In 10% FBS-DME), 46 +- 3.0 hours (Note=In CDHS-PhR DME) (PubMed=7498097).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Millipore=SCC276
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 23,24,25
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   MCF7/c
AC   CVCL_EQ28
DR   cancercelllines; CVCL_EQ28
DR   GEO; GSM212605
DR   GEO; GSM212606
DR   GEO; GSM212607
DR   Wikidata; Q54904466
RX   PubMed=17660348;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   MCF7/Cas9 AAVS1
AC   CVCL_C9CD
DR   GeneCopoeia; SL514
DR   Wikidata; Q123033008
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL514).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   MCF7/D40
AC   CVCL_M437
SY   MCF-7/D40; MCF-7 Dox40
DR   cancercelllines; CVCL_M437
DR   Wikidata; Q54904467
RX   PubMed=1676902;
RX   PubMed=10825126;
RX   PubMed=11309308;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   MCF7/LCC1
AC   CVCL_DP50
SY   MCF-7/LCC-1; MCF-7/LCC1; LCC1
DR   cancercelllines; CVCL_DP50
DR   Wikidata; Q54904468
RX   PubMed=8324732;
RX   PubMed=8380254;
RX   PubMed=8380760;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP49 ! MCF7/MIII
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   MCF7/LCC2
AC   CVCL_DP51
SY   MCF-7/LCC-2; MCF-7/LCC2; MCF-7-LCC2; LCC2
DR   cancercelllines; CVCL_DP51
DR   PRIDE; PXD000281
DR   Wikidata; Q54904469
RX   PubMed=8324732;
RX   PubMed=11078910;
RX   PubMed=23868472;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44616; Afimoxifene (4-hydroxytamoxifen; 4-OH TAM).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP50 ! MCF7/LCC1
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   MCF7/LCC9
AC   CVCL_DP52
SY   MCF-7/LCC9; LCC9
DR   BTO; BTO_0005970
DR   cancercelllines; CVCL_DP52
DR   Wikidata; Q54904470
RX   PubMed=9270017;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP50 ! MCF7/LCC1
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   MCF7/MIII
AC   CVCL_DP49
SY   MCF-7/MIII; MIII
DR   cancercelllines; CVCL_DP49
DR   Wikidata; Q54904471
RX   PubMed=8380254;
RX   PubMed=8380760;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   MCF7/Mitox
AC   CVCL_M438
SY   MCF-7/Mitox; MCF-7/MITOX; MCF-7 MR
DR   cancercelllines; CVCL_M438
DR   Wikidata; Q54904472
RX   PubMed=1676902;
RX   PubMed=10825126;
RX   PubMed=11309308;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   MCF7/TROP2-KO
AC   CVCL_B7JP
SY   BINDS-29
DR   cancercelllines; CVCL_B7JP
DR   Wikidata; Q112930092
RX   PubMed=33300065;
RX   PubMed=33490649;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MCF7/XBP1
AC   CVCL_EQ29
DR   cancercelllines; CVCL_EQ29
DR   GEO; GSM212608
DR   GEO; GSM212609
DR   GEO; GSM212610
DR   Wikidata; Q54904473
RX   PubMed=17660348;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12801; XBP1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 17
//
ID   MCF-7(DOX/R)
AC   CVCL_C4M9
SY   MCF-7 (DOX/R)
DR   Wikidata; Q116049775
RX   PubMed=15273662;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MCF7(Cas9)
AC   CVCL_E7J9
WW   Provider; BRICS; ECC3035; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3969
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCF7EL
AC   CVCL_JX63
DR   cancercelllines; CVCL_JX63
DR   Wikidata; Q54904474
RX   PubMed=21695458;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Upon doxycycline-induction expresses CCNE1. Transfected with a construct containing pTet(tight)-CCNE1-hygR (PubMed=21695458).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1589; CCNE1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V332 ! MCF7 Tet-On
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   MCF7mp53
AC   CVCL_0415
SY   MCF7 mp53; MCF-7-mp53; MCF-7mp53
DR   MCCL; MCC:0000311
DR   cancercelllines; CVCL_0415
DR   Wikidata; Q54904475
RX   PubMed=11278253;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   MCF7T1
AC   CVCL_JX64
DR   cancercelllines; CVCL_JX64
DR   Wikidata; Q54904476
RX   PubMed=21695458;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Upon doxycycline-induction expresses CCNE1 truncation 1 (T1). Transfected with a construct containing pTet(tight)-CCNE1(T1)-hygR (PubMed=21695458).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1589; CCNE1 (Note=With p.Met1_Arg39del and p.Lys40Met = Truncation 1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V332 ! MCF7 Tet-On
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   MCF7T2
AC   CVCL_JX65
DR   cancercelllines; CVCL_JX65
DR   Wikidata; Q54904477
RX   PubMed=21695458;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Upon doxycycline-induction expresses CCNE1 truncation 2 (T2). Transfected with a construct containing pTet(tight)-CCNE1(T2)-hygR (PubMed=21695458).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1589; CCNE1 (Note=With p.Met1_Asn64del and p.Asn65Met = Truncation 2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V332 ! MCF7 Tet-On
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 16
//
ID   MCG
AC   CVCL_YQ07
DR   Wikidata; Q95986819
RX   PubMed=24013424;
RX   PubMed=25015330;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 5
//
ID   MCH-MN-1
AC   CVCL_C855
SY   Miami Children's Hospital-Mesoblastic Nephroma-1
DR   Cosmic; 1181080
DR   Wikidata; Q54904478
RX   PubMed=11441343;
CC   Population: African American.
CC   Doubling time: 12.4 hours (PubMed=11441343).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6569; Congenital mesoblastic nephroma
DI   ORDO; Orphanet_2665; Congenital mesoblastic nephroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6D
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MCH007
AC   CVCL_UD61
SY   MCH7
DR   Wikidata; Q95986822
RX   PubMed=3880753;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   MCH012
AC   CVCL_B3TV
SY   MCH 12; MCH12
DR   Wikidata; Q110433019
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MCH014
AC   CVCL_B3UD
SY   MCH14
DR   Wikidata; Q110433020
RX   CelloPub=CLPUB00661;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MCH015
AC   CVCL_0D90
SY   MCH 15; MCH15
DR   Wikidata; Q54904482
RX   CelloPub=CLPUB00452;
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   MCH017
AC   CVCL_UH72
SY   MCH 17; MCH17
DR   Wikidata; Q95986825
RX   CelloPub=CLPUB00452;
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   MCH018
AC   CVCL_UH73
SY   MCH 18; MCH18
DR   Wikidata; Q95986826
RX   CelloPub=CLPUB00452;
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
RX   PubMed=6574472;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   MCH020
AC   CVCL_UH85
SY   MCH 20; MC 20
DR   Wikidata; Q95986828
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH023
AC   CVCL_RG71
SY   MCH-23; MCH 23; MCH23
DR   Wikidata; Q54904483
RX   CelloPub=CLPUB00452;
RX   CelloPub=CLPUB00661;
RX   CelloPub=CLPUB00662;
RX   PubMed=6221880;
RX   PubMed=7070882;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   MCH024
AC   CVCL_0F57
SY   MCH 24; MCH24
DR   Wikidata; Q54904484
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00661;
RX   PubMed=1627352;
RX   PubMed=2705457;
RX   PubMed=3478720;
RX   PubMed=6221880;
RX   PubMed=7909321;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   MCH029
AC   CVCL_0D91
SY   MCH 29; MCH29
DR   Wikidata; Q54904485
RX   CelloPub=CLPUB00661;
RX   PubMed=3478720;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   MCH030
AC   CVCL_UD66
SY   MCH 30; MCH30
DR   Wikidata; Q95986834
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
RX   PubMed=6280044;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   MCH031
AC   CVCL_UH86
SY   MCH 31; MC 31
DR   Wikidata; Q95986836
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH033
AC   CVCL_B3TW
SY   MCH 33; MCH33
DR   Wikidata; Q110433021
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MCH035
AC   CVCL_UH87
SY   MCH 35; MC 35
DR   Wikidata; Q95986838
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH039
AC   CVCL_0D92
SY   MCH 39; MCH39
DR   Wikidata; Q54904486
RX   CelloPub=CLPUB00409;
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00662;
RX   CelloPub=CLPUB00668;
RX   PubMed=1437403;
RX   PubMed=1627352;
RX   PubMed=2705457;
RX   PubMed=3478720;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   MCH040
AC   CVCL_RH04
SY   MCH 40; MC 40
DR   Wikidata; Q54904487
RX   CelloPub=CLPUB00452;
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00454;
RX   CelloPub=CLPUB00661;
RX   PubMed=872438;
RX   PubMed=6093571;
RX   PubMed=6574472;
RX   PubMed=6773986;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   MCH041
AC   CVCL_RH05
SY   MCH 41
DR   Wikidata; Q54904488
RX   CelloPub=CLPUB00453;
RX   PubMed=872438;
RX   PubMed=6093571;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   MCH042
AC   CVCL_B3TX
SY   MCH 42; MCH42
DR   Wikidata; Q110433022
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MCH045
AC   CVCL_U483
SY   MCH 45; MCH45
DR   Wikidata; Q54904489
RX   CelloPub=CLPUB00452;
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00661;
RX   PubMed=2705457;
RX   PubMed=3478720;
RX   PubMed=3937470;
RX   PubMed=6221880;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   MCH046
AC   CVCL_0D93
SY   MCH 046; MCH 46; MCH46
DR   Wikidata; Q54904490
RX   CelloPub=CLPUB00661;
RX   CelloPub=CLPUB00670;
RX   PubMed=3478720;
RX   PubMed=6221880;
RX   PubMed=22832074;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   MCH047
AC   CVCL_U484
SY   MCH 47
DR   Wikidata; Q54904491
RX   CelloPub=CLPUB00452;
RX   PubMed=3937470;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   MCH048
AC   CVCL_UD65
SY   MCH 48; MCH48
DR   Wikidata; Q95986854
RX   CelloPub=CLPUB00452;
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00454;
RX   CelloPub=CLPUB00661;
RX   PubMed=3937470;
RX   PubMed=6221880;
RX   PubMed=6280044;
RX   PubMed=6574472;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 8
//
ID   MCH049
AC   CVCL_UH67
SY   MCH 49
DR   Wikidata; Q95986855
RX   CelloPub=CLPUB00452;
RX   PubMed=3937470;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH050
AC   CVCL_UH95
SY   MCH 50
DR   Wikidata; Q95986856
RX   CelloPub=CLPUB00454;
RX   PubMed=6574472;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH051
AC   CVCL_UH99
SY   MCH 51
DR   Wikidata; Q95986858
RX   PubMed=12107847;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH052
AC   CVCL_RG69
SY   MCH-52; MCH 52
DR   Wikidata; Q54904492
RX   CelloPub=CLPUB00454;
RX   PubMed=7070882;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   MCH053
AC   CVCL_RG70
SY   MCH-53; MCH 53; MCH53
DR   Wikidata; Q54904493
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
RX   PubMed=6280044;
RX   PubMed=7070882;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   MCH055
AC   CVCL_U485
SY   MCH-55; MCH55
DR   Wikidata; Q54904494
RX   CelloPub=CLPUB00452;
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00668;
RX   PubMed=6088703;
RX   PubMed=7070882;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   MCH056
AC   CVCL_E3K5
SY   MCH 56
RX   PubMed=6088703;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MCH057
AC   CVCL_UI04
SY   MCH 57
DR   Wikidata; Q95986864
RX   CelloPub=CLPUB00454;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH058
AC   CVCL_U486
SY   MCH 58; MCH58
DR   Wikidata; Q54904495
RX   CelloPub=CLPUB00668;
RX   PubMed=3478720;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M2W
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   MCH059
AC   CVCL_U487
DR   Wikidata; Q54904496
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   MCH060
AC   CVCL_U488
SY   MCH 60
DR   Wikidata; Q54904497
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   MCH064
AC   CVCL_U489
SY   MCH 064; MCH 64; MCH64; M64
DR   Wikidata; Q54904498
RX   CelloPub=CLPUB00662;
RX   CelloPub=CLPUB00668;
RX   CelloPub=CLPUB00670;
RX   PubMed=20524213;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   MCH065
AC   CVCL_U490
SY   MCH 065; MCH 65; MCH65; M65
DR   Wikidata; Q54904499
RX   CelloPub=CLPUB00453;
RX   CelloPub=CLPUB00668;
RX   PubMed=2705457;
RX   PubMed=20524213;
RX   PubMed=20876107;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y6M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   MCH068
AC   CVCL_U491
SY   MCH 68
DR   Wikidata; Q54904500
RX   PubMed=17331252;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   MCH069
AC   CVCL_U492
DR   Wikidata; Q54904501
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   MCH070
AC   CVCL_U493
SY   MCH 70; MCH70
DR   Wikidata; Q54904502
RX   CelloPub=CLPUB00409;
RX   PubMed=1437403;
RX   PubMed=9235907;
RX   PubMed=17331252;
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   MCH071
AC   CVCL_U494
DR   Wikidata; Q54904503
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   MCH072
AC   CVCL_U495
DR   Wikidata; Q54904504
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   MCH073
AC   CVCL_U496
DR   Wikidata; Q54904505
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   MCH074
AC   CVCL_U497
SY   MCH 74
DR   Wikidata; Q54904506
WW   Provider; MCH repository; -; https://web.archive.org/web/20070627165036/http://www.cellbank.mcgill.ca:80/cgi-bin/cellbank/allnormals.cgi
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   MCH075
AC   CVCL_UI00
SY   MCH 75
DR   Wikidata; Q95986934
RX   PubMed=12107847;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCH262A1.D6
AC   CVCL_6C50
SY   MCH-262A1D6; MCH262-A1D6
DR   Wikidata; Q54904507
RX   PubMed=1559705;
RX   PubMed=2300817;
RX   PubMed=8302587;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3984 ! A-9
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   MCH416
AC   CVCL_RK34
DR   Wikidata; Q54904508
RX   PubMed=12057902;
CC   Characteristics: Has high metastatic potential.
CC   Doubling time: 12.0 hours (PubMed=12057902).
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   MCH66
AC   CVCL_RK30
SY   MCH 66
DR   Wikidata; Q54904509
RX   PubMed=12057902;
RX   PubMed=25027251;
CC   Characteristics: Has poor metastatic potential.
CC   Doubling time: 14.4 hours (PubMed=12057902); 21.6 hours (PubMed=25027251).
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   MCH66 Lu1
AC   CVCL_RK32
SY   Lu1
DR   Wikidata; Q54904510
RX   PubMed=25027251;
CC   Characteristics: Has no metastatic potential.
CC   Doubling time: 12.6 hours (PubMed=25027251).
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RK30 ! MCH66
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   MCH66 Lu10
AC   CVCL_RK31
SY   Lu10
DR   Wikidata; Q54904511
RX   PubMed=25027251;
CC   Characteristics: Has high metastatic potential.
CC   Doubling time: 18.6 hours (PubMed=25027251).
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RK30 ! MCH66
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   MCH66 Lu5
AC   CVCL_RK33
SY   Lu5
DR   Wikidata; Q54904512
RX   PubMed=25027251;
CC   Doubling time: 14.4 hours (PubMed=25027251).
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RK30 ! MCH66
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   MCH66C8
AC   CVCL_RK35
DR   Wikidata; Q54904513
RX   PubMed=12057902;
CC   Doubling time: 19.2 hours (PubMed=12057902).
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RK30 ! MCH66
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   MCHR2-SHG-44
AC   CVCL_L602
DR   Wikidata; Q54904514
RX   DOI=10.3724/SP.J.1008.2008.00896;
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:20867; MCHR2.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6728 ! SHG-44
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   MCI7326
AC   CVCL_A9F0
DR   Wikidata; Q102114506
RX   PubMed=7822435;
CC   Population: Japanese.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   MCI7885
AC   CVCL_A9E9
DR   Wikidata; Q102114507
RX   PubMed=7822435;
RX   PubMed=23847654;
CC   Population: Japanese.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   MciA
AC   CVCL_C7F4
SY   Mouse conditionally immortalized Astrocytes
DR   Wikidata; Q117704688
RX   PubMed=19724901;
CC   Doubling time: 36 hours (PubMed=19724901).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   MCIR1
AC   CVCL_A0DE
SY   Mayo Clinic Ibrutinib-Resistant Line 1
DR   Wikidata; Q108820864
RX   PubMed=34214199;
CC   Characteristics: Obtained from a ibrutinib-resistant tumor clone (PubMed=34214199).
CC   Doubling time: 32 hours (PubMed=34214199).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34214199).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34214199).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   MCJB2
AC   CVCL_AV59
DR   Wikidata; Q54904515
RX   DOI=10.1158/1538-7445.AM2014-LB-95;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Doubling time: 55 hours (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 17
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 11,15
ST   FGA: 23
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C71732; Triple-negative breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 6
//
ID   MCL-1
AC   CVCL_UU63
DR   Wikidata; Q95986959
RX   Patent=US5429948;
RX   PubMed=2706743;
RX   PubMed=8236284;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9562.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3401; EPHX1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU62 ! AHH-1 TK+/- L3
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   MCL-2
AC   CVCL_UU64
DR   Wikidata; Q95986960
RX   PubMed=2706743;
RX   PubMed=8236284;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3401; EPHX1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU62 ! AHH-1 TK+/- L3
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   MCL-5
AC   CVCL_5332
DR   CLO; CLO_0007616
DR   ATCC; CRL-10575
DR   Wikidata; Q54904516
RX   Patent=US5429948;
RX   PubMed=1793807;
RX   PubMed=7739402;
RX   PubMed=8841477;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10575.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3401; EPHX1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-10575; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-10575
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 10
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU62 ! AHH-1 TK+/- L3
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   MCM-B2
AC   CVCL_L365
DR   Wikidata; Q54904517
RX   PubMed=7659855;
CC   Doubling time: 8 hours (PubMed=7659855).
CC   Breed/subspecies: Pointer; VBO=VBO_0201029.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   MCM1
AC   CVCL_DH35
DR   cancercelllines; CVCL_DH35
DR   GEO; GSM878881
DR   Progenetix; CVCL_DH35
DR   Wikidata; Q54904518
RX   PubMed=22570180;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22570180).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MCM1G
AC   CVCL_DH36
DR   cancercelllines; CVCL_DH36
DR   Wikidata; Q54904519
RX   PubMed=22570180;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22570180).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH35 ! MCM1
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   McNRAS1
AC   CVCL_B9UV
SY   90; R90; RAS90
DR   Wikidata; Q112930095
RX   PubMed=31251472;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Lys).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: ((C57BL/6J x DBA/2) Tg(Tyr-NRAS*Q61K)1Bee transgenic x C57BL/6J) F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   McNRAS2
AC   CVCL_B9UW
SY   91a; 91A; R91a; RAS91
DR   Wikidata; Q112930096
RX   PubMed=31251472;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Lys).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: ((C57BL/6J x DBA/2) Tg(Tyr-NRAS*Q61K)1Bee transgenic x C57BL/6J) F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   McWT1
AC   CVCL_B9UX
SY   9v; L9
DR   Wikidata; Q112930097
RX   PubMed=18006687;
RX   PubMed=31251472;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   McWT2
AC   CVCL_B9UY
SY   14d; L14
DR   Wikidata; Q112930098
RX   PubMed=18006687;
RX   PubMed=31251472;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   MCO-Y4
AC   CVCL_L366
DR   Wikidata; Q54904520
RX   PubMed=17085882;
CC   Doubling time: 32.39 +- 4.66 hours (Note=At 93th passage) (PubMed=17085882).
CC   Derived from site: Metastatic; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   mCortA-G1
AC   CVCL_E4K9
RX   PubMed=38788830;
CC   Characteristics: Expresses high level of GFAP (PubMed=38788830).
CC   Doubling time: 1-2 days (PubMed=38788830).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Glial cell; CL=CL_0000125.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   MCP-5 [Human cystosarcoma phyllodes]
AC   CVCL_JY20
SY   Malignant Cystosarcoma Phyllodes-5
DR   Wikidata; Q54904521
RX   Patent=US20080153160;
CC   Group: Patented cell line.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4504; Malignant breast phyllodes tumor
DI   ORDO; Orphanet_180261; Phyllodes tumor of the breast
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MCP-5 [Mouse]
AC   CVCL_R863
SY   MCP5
DR   Wikidata; Q54904524
RX   PubMed=7683224;
RX   PubMed=17947660;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   MCP-5.1
AC   CVCL_JY01
DR   Wikidata; Q54904525
RX   PubMed=7683224;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R863 ! MCP-5 [Mouse]
SX   Sex unspecified
AG   6-8W
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MCP-5.2
AC   CVCL_JY02
DR   Wikidata; Q54904526
RX   PubMed=7683224;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R863 ! MCP-5 [Mouse]
SX   Sex unspecified
AG   6-8W
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MCP-5.3
AC   CVCL_JY03
DR   Wikidata; Q54904527
RX   PubMed=7683224;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R863 ! MCP-5 [Mouse]
SX   Sex unspecified
AG   6-8W
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MCP-5.4
AC   CVCL_JY04
DR   Wikidata; Q54904528
RX   PubMed=7683224;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R863 ! MCP-5 [Mouse]
SX   Sex unspecified
AG   6-8W
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MCP-5.5
AC   CVCL_JY05
DR   Wikidata; Q54904529
RX   PubMed=7683224;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R863 ! MCP-5 [Mouse]
SX   Sex unspecified
AG   6-8W
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MCP21
AC   CVCL_L538
DR   ECACC; 96030418
DR   Wikidata; Q54904530
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   MCP6
AC   CVCL_1Q51
SY   MCP-6; GM09191
DR   CLO; CLO_0010632
DR   Coriell; GM09191
DR   Wikidata; Q54904531
RX   CelloPub=CLPUB00447;
RX   PubMed=6641706;
RX   PubMed=6686281;
RX   PubMed=6951167;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1Q46 ! G3.32.2
HI   CVCL_1Q47 ! PCC4AO
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   MCPV-8
AC   CVCL_D803
DR   Wikidata; Q54904532
RX   PubMed=9745959;
RX   PubMed=12382283;
CC   Doubling time: ~34 hours (PubMed=9745959).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Ear, inner ear, cochlea, stria vascularis; UBERON=UBERON_0002282.
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MCRIi001-A
AC   CVCL_UK82
SY   PB001
DR   BioSamples; SAMEA4966484
DR   hPSCreg; MCRIi001-A
DR   Wikidata; Q95986990
RX   PubMed=30605840;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MCRIi001-A-1
AC   CVCL_WN06
SY   MCRIi001-A-OI26; PB001-OI26
DR   BioSamples; SAMEA5873307
DR   hPSCreg; MCRIi001-A-1
DR   Wikidata; Q95986992
RX   PubMed=31075690;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple_edited; p.Val1324Cysfs (c.3969dupT) (c.3969_3970insT); ClinVar=VCV000017308; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31075690).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK82 ! MCRIi001-A
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   MCRIi001-A-2
AC   CVCL_WU54
SY   MCRIi001-A-SOX9tdTom; PB001-SOX9tdTom
DR   BioSamples; SAMEA5873308
DR   hPSCreg; MCRIi001-A-2
DR   Wikidata; Q95986993
RX   PubMed=31884373;
RX   PubMed=32446218;
RX   PubMed=32771907;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 SOX9 has been endogenously tagged at the C-terminus with TdTomato.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK82 ! MCRIi001-A
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 8
//
ID   MCRIi001-A-3
AC   CVCL_A9Z3
SY   SOX9tdTom-TRPV4 p.F273L; MCRIi001-A-2-TRPV4 p.F273L; PB001-SOX9tdTom-TRPV4p.F273L
DR   hPSCreg; MCRIi001-A-3
DR   Wikidata; Q103825216
RX   PubMed=32771907;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 SOX9 has been endogenously tagged at the C-terminus with TdTomato.
CC   Sequence variation: Mutation; HGNC; HGNC:18083; TRPV4; Simple_edited; p.Phe273Leu (c.819C>G); ClinVar=VCV000035511; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32771907).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175208; Familial digital arthropathy-brachydactyly
DI   ORDO; Orphanet_85169; Familial digital arthropathy-brachydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU54 ! MCRIi001-A-2
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   MCRIi001-A-4
AC   CVCL_A9Z4
SY   SOX9tdTom TRPV4 p.P799L; MCRIi001-A-2-TRPV4 p.P799L; PB001-SOX9tdTOM-TRPV4pP799L
DR   hPSCreg; MCRIi001-A-4
DR   Wikidata; Q102114509
RX   PubMed=32771907;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 SOX9 has been endogenously tagged at the C-terminus with TdTomato.
CC   Sequence variation: Mutation; HGNC; HGNC:18083; TRPV4; Simple_edited; p.Pro799Leu (c.2396C>T); ClinVar=VCV000004998; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32771907).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175209; Metatropic dysplasia
DI   ORDO; Orphanet_2635; Metatropic dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU54 ! MCRIi001-A-2
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   MCRIi001-B
AC   CVCL_ZA74
SY   MCRIi001-A-SOX9tdTom-COL2A1p.R989C; PB001-SOX9tdTom-COL2A1p.R989C
DR   BioSamples; SAMEA7211802
DR   hPSCreg; MCRIi001-B
DR   Wikidata; Q98127124
RX   PubMed=32446218;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 SOX9 has been endogenously tagged at the C-terminus with TdTomato.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple_edited; p.Arg989Cys (c.2965C>T); ClinVar=VCV000017366; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32446218).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135088; Spondyloperipheral dysplasia
DI   ORDO; Orphanet_1856; Spondyloperipheral dysplasia-short ulna syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU54 ! MCRIi001-A-2
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   MCRIi002-A
AC   CVCL_UK83
SY   PB002
DR   BioSamples; SAMEA110648277
DR   hPSCreg; MCRIi002-A
DR   Wikidata; Q95986994
RX   PubMed=37150143;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 4
//
ID   MCRIi003-A
AC   CVCL_UK84
SY   PB003
DR   BioSamples; SAMEA110743882
DR   hPSCreg; MCRIi003-A
DR   Wikidata; Q95986995
RX   PubMed=37150143;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 4
//
ID   MCRIi004-A
AC   CVCL_UK85
SY   PB004
DR   BioSamples; SAMEA4966485
DR   hPSCreg; MCRIi004-A
DR   Wikidata; Q95986997
RX   PubMed=30605840;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi005-A
AC   CVCL_UK86
SY   PB005
DR   BioSamples; SAMEA4966486
DR   hPSCreg; MCRIi005-A
DR   Wikidata; Q95987000
RX   PubMed=30605840;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi006-A
AC   CVCL_UK87
SY   PB006
DR   BioSamples; SAMEA4966487
DR   hPSCreg; MCRIi006-A
DR   Wikidata; Q95987001
RX   PubMed=30605840;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi007-A
AC   CVCL_UK88
SY   PB007
DR   BioSamples; SAMEA111461113
DR   hPSCreg; MCRIi007-A
DR   Wikidata; Q95987003
RX   PubMed=37150143;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 4
//
ID   MCRIi008-A
AC   CVCL_UK89
SY   PB008
DR   BioSamples; SAMEA111461115
DR   hPSCreg; MCRIi008-A
DR   Wikidata; Q95987005
RX   PubMed=37150143;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 4
//
ID   MCRIi009-A
AC   CVCL_UK90
SY   PB009
DR   BioSamples; SAMEA111461117
DR   hPSCreg; MCRIi009-A
DR   Wikidata; Q95987006
RX   PubMed=37150143;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 4
//
ID   MCRIi010-A
AC   CVCL_UK91
SY   PB010
DR   BioSamples; SAMEA4966489
DR   hPSCreg; MCRIi010-A
DR   Wikidata; Q95987008
RX   PubMed=30605840;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi010-A-1
AC   CVCL_D6MK
SY   PB010.5-ACTA1tdTom; ACTA1tdTom
DR   hPSCreg; MCRIi010-A-1
DR   Wikidata; Q127382750
RX   PubMed=38277710;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a P2A-tdTomato construct was inserted at the C-terminus of both alleles of ACTA1 (PubMed=38277710).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UK91 ! MCRIi010-A
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MCRIi011-A
AC   CVCL_WN60
SY   ASD2-3.1
DR   hPSCreg; MCRIi011-A
DR   Wikidata; Q95987009
RX   PubMed=31415975;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi012-A
AC   CVCL_WN61
SY   ASD2-6.4
DR   hPSCreg; MCRIi012-A
DR   Wikidata; Q95987010
RX   PubMed=31415975;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi013-A
AC   CVCL_WN62
SY   ASD2-7.1
DR   hPSCreg; MCRIi013-A
DR   Wikidata; Q95987012
RX   PubMed=31415975;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi014-A
AC   CVCL_WN63
SY   ASD2-9.4
DR   hPSCreg; MCRIi014-A
DR   Wikidata; Q95987014
RX   PubMed=31415975;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi015-A
AC   CVCL_WN64
SY   ASD2-11.5
DR   hPSCreg; MCRIi015-A
DR   Wikidata; Q95987015
RX   PubMed=31415975;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi016-A
AC   CVCL_WN65
SY   ASD2-15.1
DR   hPSCreg; MCRIi016-A
DR   Wikidata; Q95987016
RX   PubMed=31415975;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi017-A
AC   CVCL_WN66
SY   ASD2-75.4
DR   hPSCreg; MCRIi017-A
DR   Wikidata; Q95987017
RX   PubMed=31415975;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   MCRIi018-A
AC   CVCL_WN58
SY   OI64-mutant
DR   BioSamples; SAMEA7211803
DR   hPSCreg; MCRIi018-A
DR   Wikidata; Q95987018
RX   PubMed=31082677;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Trp1312Cys (c.3936G>T); ClinVar=VCV000017335; Zygosity=Heterozygous (PubMed=31082677).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WN59 ! MCRIi018-B
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   MCRIi018-B
AC   CVCL_WN59
SY   OI64-control
DR   hPSCreg; MCRIi018-B
DR   Wikidata; Q95987019
RX   PubMed=31082677;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple_corrected; p.Trp1312Cys (c.3936G>T); ClinVar=VCV000017335; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31082677).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WN58 ! MCRIi018-A
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   MCRIi019-A
AC   CVCL_A9XY
SY   1502; 1502.3; MCRIAi001-A
DR   hPSCreg; MCRIi019-A
DR   Wikidata; Q102114510
RX   PubMed=33002832;
RX   PubMed=33316599;
RX   PubMed=34543885;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: African American.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2766 ! WS1
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 8
//
ID   MCRIi019-A-1
AC   CVCL_A4WY
SY   1502.3 miR-26b KO; 1502-miR26b knockout
DR   hPSCreg; MCRIi019-A-1
DR   Wikidata; Q107116159
RX   PubMed=33316599;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31612; MIR26B.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9XY ! MCRIi019-A
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MCRIi019-A-2
AC   CVCL_A9XZ
SY   1502-COL2A1 p.G1170S; 1502.3 COL2A1 p.G1170S
DR   hPSCreg; MCRIi019-A-2
DR   Wikidata; Q102114511
RX   PubMed=33002832;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple_edited; p.Gly1170Ser (c.3508_3510GGT>TCA); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33002832).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34766; Perthes disease
DI   ORDO; Orphanet_2380; Legg-Calve-Perthes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9XY ! MCRIi019-A
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   MCRIi019-A-5
AC   CVCL_D0HS
SY   1502-miR574 knockout
DR   hPSCreg; MCRIi019-A-5
DR   Wikidata; Q123033009
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32830; MIR574.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9XY ! MCRIi019-A
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi019-A-6
AC   CVCL_D0HR
SY   1502-COL2A1 p.R719C; 1502.3 COL2A1 p.R719C
DR   hPSCreg; MCRIi019-A-6
DR   Wikidata; Q123033010
RX   PubMed=36682125;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple_edited; p.Arg719Cys (c.2155C>T); ClinVar=VCV000017353; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36682125).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202115; Osteoarthritis with mild chondrodysplasia
DI   ORDO; Orphanet_93279; Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9XY ! MCRIi019-A
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi019-A-7
AC   CVCL_A1QP
SY   1502-COL2A1 p.G1113C; 1502.3 COL2A1 p.G1113C
DR   hPSCreg; MCRIi019-A-7
DR   Wikidata; Q102114512
RX   PubMed=34543885;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple_edited; p.Gly1113Cys (c.3337G>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34543885).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3816; Type II achondrogenesis
DI   ORDO; Orphanet_93296; Achondrogenesis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9XY ! MCRIi019-A
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   MCRIi020-A
AC   CVCL_A1MD
SY   NF1_043.7
DR   hPSCreg; MCRIi020-A
DR   Wikidata; Q102114513
RX   PubMed=33091851;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MCRIi021-A
AC   CVCL_A1ME
SY   NF1_047.7
DR   hPSCreg; MCRIi021-A
DR   Wikidata; Q102114514
RX   PubMed=33091851;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MCRIi022-A
AC   CVCL_A1MF
SY   NF1_093.2
DR   hPSCreg; MCRIi022-A
DR   Wikidata; Q102114516
RX   PubMed=33091851;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MCRIi023-A
AC   CVCL_A1MG
SY   NF1_162.1
DR   hPSCreg; MCRIi023-A
DR   Wikidata; Q102114517
RX   PubMed=33091851;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MCRIi024-A
AC   CVCL_A0LG
SY   ACTA1.1u
DR   hPSCreg; MCRIi024-A
DR   Wikidata; Q108820865
RX   PubMed=34157503;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Gly148Asp (c.443G>A); Zygosity=Heterozygous (PubMed=34157503).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   MCRIi024-A-1
AC   CVCL_A0LH
SY   ACTA1.Bbc
DR   hPSCreg; MCRIi024-A-1
DR   Wikidata; Q108820867
RX   PubMed=34157503;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple_corrected; p.Gly148Asp (c.443G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34157503).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0LG ! MCRIi024-A
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   MCRIi025-A
AC   CVCL_D0HT
SY   CANVAS1-2; C1-2
DR   BioSamples; SAMEA112322126
DR   hPSCreg; MCRIi025-A
DR   Wikidata; Q123033011
RX   PubMed=36805468;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Homozygous (PubMed=36805468).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C202046; Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
DI   ORDO; Orphanet_504476; Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0HU ! MCRIi025-B
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi025-B
AC   CVCL_D0HU
SY   CANVAS1-2 Het GC; C1-2 Het GC
DR   BioSamples; SAMEA112322128
DR   hPSCreg; MCRIi025-B
DR   Wikidata; Q123033012
RX   PubMed=36805468;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Heterozygous (PubMed=36805468).
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion_corrected; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36805468).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C202046; Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
DI   ORDO; Orphanet_504476; Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0HT ! MCRIi025-A
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi026-A
AC   CVCL_D0HV
SY   CANVAS3-2; C3-2
DR   BioSamples; SAMEA112322129
DR   hPSCreg; MCRIi026-A
DR   Wikidata; Q123033013
RX   PubMed=36805468;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Homozygous (PubMed=36805468).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C202046; Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
DI   ORDO; Orphanet_504476; Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0HW ! MCRIi026-B
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi026-B
AC   CVCL_D0HW
SY   CANVAS3-2 Het GC; C3-2 Het GC
DR   BioSamples; SAMEA112322131
DR   hPSCreg; MCRIi026-B
DR   Wikidata; Q123033014
RX   PubMed=36805468;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Heterozygous (PubMed=36805468).
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion_corrected; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36805468).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C202046; Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
DI   ORDO; Orphanet_504476; Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0HV ! MCRIi026-A
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi027-A
AC   CVCL_D0HX
SY   CANVAS4-6; C4-6
DR   BioSamples; SAMEA112322132
DR   hPSCreg; MCRIi027-A
DR   Wikidata; Q123033015
RX   PubMed=36805468;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian; Greek-Cypriot.
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Homozygous (PubMed=36805468).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C202046; Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
DI   ORDO; Orphanet_504476; Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0HY ! MCRIi027-B
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi027-B
AC   CVCL_D0HY
SY   CANVAS4-6 Het GC; C4-6 Het GC
DR   BioSamples; SAMEA112322134
DR   hPSCreg; MCRIi027-B
DR   Wikidata; Q123033016
RX   PubMed=36805468;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian; Greek-Cypriot.
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Heterozygous (PubMed=36805468).
CC   Sequence variation: Mutation; HGNC; HGNC:9969; RFC1; Repeat_expansion_corrected; chr4:g.39348425AAAGG[10_25]AAGGG[n]; ClinVar=VCV000986302; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36805468).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C202046; Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
DI   ORDO; Orphanet_504476; Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0HX ! MCRIi027-A
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MCRIi029-A
AC   CVCL_D0HZ
SY   808 iPSC
DR   BioSamples; SAMEA114250305
DR   hPSCreg; MCRIi029-A
DR   Wikidata; Q123033019
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   MCRIi030-A
AC   CVCL_D0I0
SY   522 iPSC
DR   hPSCreg; MCRIi030-A
DR   Wikidata; Q123033020
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7414 ! GM04522
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   MCRIi030-A-1
AC   CVCL_D6PH
SY   522/NR2F2-KO_het
DR   hPSCreg; MCRIi030-A-1
RX   PubMed=38458031;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7976; NR2F2 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7414 ! GM04522
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MCRIi030-A-2
AC   CVCL_D6PI
SY   522/NR2F2-KO_hom
DR   hPSCreg; MCRIi030-A-2
RX   PubMed=38458031;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7976; NR2F2.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7414 ! GM04522
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MCRIi031-A
AC   CVCL_D0I1
SY   468 iPSC
DR   hPSCreg; MCRIi031-A
DR   Wikidata; Q123033021
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7389 ! GM03468
SX   Male
AG   5D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   MCRIi031-A-1
AC   CVCL_E4H8
SY   468/SOX9-KO_het
DR   hPSCreg; MCRIi031-A-1
RX   PubMed=38924973;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11204; SOX9 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7389 ! GM03468
SX   Male
AG   5D
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MCRIi031-A-2
AC   CVCL_E4H9
SY   468/SOX9-KO_hom
DR   hPSCreg; MCRIi031-A-2
RX   PubMed=38924973;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11204; SOX9.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7389 ! GM03468
SX   Male
AG   5D
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MCRIi031-A-3
AC   CVCL_E4HA
SY   468/WT1-KO_hom
DR   hPSCreg; MCRIi031-A-3
RX   PubMed=39003885;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7389 ! GM03468
SX   Male
AG   5D
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MCRIi032-A
AC   CVCL_D0I2
SY   SCT 3010 iPSC
DR   BioSamples; SAMEA117550373
DR   hPSCreg; MCRIi032-A
DR   Wikidata; Q123033022
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MCRIi033-A
AC   CVCL_D0I3
SY   SCT 7002 iPSC
DR   BioSamples; SAMEA117550375
DR   hPSCreg; MCRIi033-A
DR   Wikidata; Q123033023
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MCRIi035-A
AC   CVCL_E6WR
SY   MCRIi-UC-cl2; Patient 1-UC-cl2; MCRIi-TC160154-UC-cl2
DR   BioSamples; SAMEA117666668
DR   hPSCreg; MCRIi035-A
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Homozygous (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6WS ! MCRIi035-B
OI   CVCL_E6WT ! MCRIi035-C
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi035-B
AC   CVCL_E6WS
SY   MCRIi-UC-cl5; Patient 1-UC-cl5; MCRIi-TC160154-UC-cl5
DR   hPSCreg; MCRIi035-B
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Homozygous (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6WR ! MCRIi035-A
OI   CVCL_E6WT ! MCRIi035-C
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi035-B-1
AC   CVCL_E6WY
SY   MCRIi-GC-cl5.14.9; Patient 1-GC-cl5.14.9; MCRIi-TC160154-GC-cl5.1.49
DR   hPSCreg; MCRIi035-B-1
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Heterozygous (PubMed=39787667).
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple_corrected; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6WS ! MCRIi035-B
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi035-B-2
AC   CVCL_E6WZ
SY   MCRIi-GC-cl5.30.3; Patient 1-GC-cl5.30.3; MCRIi-TC160154-GC-cl5.30.4
DR   hPSCreg; MCRIi035-B-2
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Heterozygous (PubMed=39787667).
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple_corrected; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6WS ! MCRIi035-B
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi035-C
AC   CVCL_E6WT
SY   MCRIi-UC-cl6; Patient 1-UC-cl6; MCRIi-TC160154-UC-cl6
DR   hPSCreg; MCRIi035-C
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Homozygous (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6WR ! MCRIi035-A
OI   CVCL_E6WS ! MCRIi035-B
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi036-A
AC   CVCL_E6WU
SY   MCRIi-UC-cl4; Patient 2-UC-cl4; MCRIi-TC110367-UC-cl4
DR   hPSCreg; MCRIi036-A
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Homozygous (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6WV ! MCRIi036-B
OI   CVCL_E6WW ! MCRIi036-C
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi036-B
AC   CVCL_E6WV
SY   MCRIi-UC-cl5; Patient 2-UC-cl5; MCRIi-TC110367-UC-cl5
DR   hPSCreg; MCRIi036-B
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Homozygous (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6WU ! MCRIi036-A
OI   CVCL_E6WW ! MCRIi036-C
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi036-B-1
AC   CVCL_E6WX
SY   MCRIi-GC-cl5.64.4.17; Patient 2-GC-cl5.64.4.17; MCRIi-TC110367-GC-cl5.64.4.17
DR   hPSCreg; MCRIi036-B-1
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Heterozygous (PubMed=39787667).
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple_corrected; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6WV ! MCRIi036-B
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCRIi036-C
AC   CVCL_E6WW
SY   MCRIi-UC-cl6; Patient 2-UC-cl6; MCRIi-TC110367-UC-cl6
DR   hPSCreg; MCRIi036-C
RX   PubMed=39787667;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19943; TRAPPC4; Simple; c.454+3A>G; ClinVar=VCV000812649; Zygosity=Homozygous (PubMed=39787667).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215055; Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6WU ! MCRIi036-A
OI   CVCL_E6WV ! MCRIi036-B
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MCS-1 [Hamster chondrosarcoma]
AC   CVCL_JX17
SY   Mesenchymal ChondroSarcoma-1
DR   Wikidata; Q54904533
RX   PubMed=1667204;
RX   PubMed=7498344;
CC   Doubling time: 17.2 hours (PubMed=1667204).
DI   NCIt; C134957; Hamster chondrosarcoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_JX18 ! MCS-8
SX   Female
AG   1Y3M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   MCS-1 [Mouse hybridoma against sialyl Lewis X]
AC   CVCL_A7NU
DR   Wikidata; Q107116165
RX   PubMed=7474856;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   MCS-2 [Human breast carcinoma]
AC   CVCL_R955
DR   BTO; BTO_0002271
DR   cancercelllines; CVCL_R955
DR   Wikidata; Q54904534
RX   PubMed=14623544;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11425; STS.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   MCS-2 [Mouse hybridoma against human ANPEP]
AC   CVCL_A7NV
DR   Wikidata; Q107116168
RX   PubMed=3478135;
RX   PubMed=7474856;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15144; Human ANPEP/CD13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MCS-8
AC   CVCL_JX18
SY   Mesenchymal ChondroSarcoma-8
DR   Wikidata; Q54904535
RX   PubMed=1667204;
RX   PubMed=7498344;
CC   Doubling time: 17.7 hours (PubMed=1667204).
DI   NCIt; C134957; Hamster chondrosarcoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OI   CVCL_JX17 ! MCS-1 [Hamster chondrosarcoma]
SX   Female
AG   1Y3M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   MCS6-27
AC   CVCL_C6GM
DR   ABCD; ABCD_AA515
DR   Wikidata; Q116049777
RX   PubMed=20548779;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P10844; Clostridium botulinum botulinum neurotoxin type B (botB) (Note=AA 442-1291 = Heavy chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   MCT
AC   CVCL_0416
SY   Mouse Cortical Tubule cells
DR   MCCL; MCC:0000312
DR   Wikidata; Q54904536
RX   PubMed=3170633;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Cell type: Kidney cortex tubule cell; CL=CL_0000066.
CC   Breed/subspecies: SJL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   mCT1
AC   CVCL_IN71
DR   Wikidata; Q54904537
RX   PubMed=11121394;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   mCT1-CF
AC   CVCL_IN72
DR   Wikidata; Q54904538
RX   PubMed=11121394;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.
CC   Sequence variation: Mutation; MGI; MGI:88388; Cftr; Simple; p.Ser489Ter (c.1466C>A); Zygosity=Homozygous (PubMed=11121394).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   MCTCC
AC   CVCL_WH29
DR   Wikidata; Q95987033
RX   PubMed=25773167;
RX   PubMed=30246405;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   MCTs
AC   CVCL_A5BF
SY   MCT; Mouse Chondrocytes immortalized by SV40 temperature-sensitive large T antigen
DR   BTO; BTO_0006217
DR   Wikidata; Q107116172
RX   PubMed=7822418;
RX   PubMed=9990041;
CC   Characteristics: Proliferates at the permissive temperature (32 Celsius). Dies at the restrictive temperature (37-39 Celsius) (PubMed=7822418).
CC   Doubling time: ~2 days (Note=At 32 Celsius) (PubMed=7822418).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIPSVtsA58).
CC   Derived from site: In situ; Rib, cartilage; UBERON=UBERON_0006288.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 9
//
ID   MCUV-5
AC   CVCL_F0WU
SY   MCUV5; MCuv5; MCUV
RX   PubMed=3021971;
RX   PubMed=6182100;
RX   PubMed=6983518;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
HI   CVCL_1953 ! B95-8
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MCW001i-40001487
AC   CVCL_UA52
DR   WiCell; mcw001i-40001487
DR   Wikidata; Q95987034
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW002i-40001265
AC   CVCL_UA53
DR   WiCell; mcw002i-40001265
DR   Wikidata; Q95987036
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW003i-40001883
AC   CVCL_UA54
DR   WiCell; mcw003i-40001883
DR   Wikidata; Q95987037
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW004i-40002545
AC   CVCL_UA55
DR   WiCell; mcw004i-40002545
DR   Wikidata; Q95987038
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW005i-40002552
AC   CVCL_UA56
DR   WiCell; mcw005i-40002552
DR   Wikidata; Q95987039
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW006i-40000930
AC   CVCL_UA57
DR   WiCell; mcw006i-40000930
DR   Wikidata; Q95987040
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW007i-U2456
AC   CVCL_UA58
DR   WiCell; mcw007i-u2456
DR   Wikidata; Q95987042
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW008i-40000992
AC   CVCL_UA59
DR   WiCell; mcw008i-40000992
DR   Wikidata; Q95987044
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW009i-40002262
AC   CVCL_UA60
DR   WiCell; mcw009i-40002262
DR   Wikidata; Q95987046
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW010i-40000756
AC   CVCL_UA61
DR   WiCell; mcw010i-40000756
DR   Wikidata; Q95987048
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW011i-40000664
AC   CVCL_UA62
DR   WiCell; mcw011i-40000664
DR   Wikidata; Q95987049
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW012i-A7156
AC   CVCL_UA63
DR   WiCell; mcw012i-a7156
DR   Wikidata; Q95987050
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW013i-A2767
AC   CVCL_UA64
DR   WiCell; mcw013i-a2767
DR   Wikidata; Q95987052
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW014i-50000395
AC   CVCL_UA65
DR   WiCell; mcw014i-50000395
DR   Wikidata; Q95987054
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW015i-A2196
AC   CVCL_UA66
DR   WiCell; mcw015i-a2196
DR   Wikidata; Q95987055
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW016i-A2159
AC   CVCL_UA67
DR   WiCell; mcw016i-a2159
DR   Wikidata; Q95987056
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW017i-A2106
AC   CVCL_UA68
DR   WiCell; mcw017i-a2106
DR   Wikidata; Q95987057
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW018i-A2868
AC   CVCL_UA69
DR   WiCell; mcw018i-a2868
DR   Wikidata; Q95987059
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW019i-A7230
AC   CVCL_UA70
DR   WiCell; mcw019i-a7230
DR   Wikidata; Q95987060
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW020i-A2023
AC   CVCL_UA71
DR   WiCell; mcw020i-a2023
DR   Wikidata; Q95987061
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW021i-50001743
AC   CVCL_UA72
DR   WiCell; mcw021i-50001743
DR   Wikidata; Q95987062
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW022i-A2965
AC   CVCL_UA73
DR   WiCell; mcw022i-a2965
DR   Wikidata; Q95987063
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW023i-A2121
AC   CVCL_UA74
DR   WiCell; mcw023i-a2121
DR   Wikidata; Q95987066
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW024i-A3263
AC   CVCL_UA75
DR   WiCell; mcw024i-a3263
DR   Wikidata; Q95987067
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW025i-A2566
AC   CVCL_UA76
DR   WiCell; mcw025i-a2566
DR   Wikidata; Q95987068
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW026i-50000685
AC   CVCL_UA77
DR   WiCell; mcw026i-50000685
DR   Wikidata; Q95987069
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW027i-50000784
AC   CVCL_UA78
DR   WiCell; mcw027i-50000784
DR   Wikidata; Q95987071
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW028i-A7312
AC   CVCL_UA79
DR   WiCell; mcw028i-a7312
DR   Wikidata; Q95987072
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW029i-A2757
AC   CVCL_UA80
DR   WiCell; mcw029i-a2757
DR   Wikidata; Q95987073
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW030i-A2688
AC   CVCL_UA81
DR   WiCell; mcw030i-a2688
DR   Wikidata; Q95987075
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW031i-A3202
AC   CVCL_UA82
DR   WiCell; mcw031i-a3202
DR   Wikidata; Q95987077
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW032i-A7214
AC   CVCL_UA83
DR   WiCell; mcw032i-a7214
DR   Wikidata; Q95987078
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW033i-A7195
AC   CVCL_UA84
DR   WiCell; mcw033i-a7195
DR   Wikidata; Q95987079
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW034i-A2780
AC   CVCL_UA85
DR   WiCell; mcw034i-a2780
DR   Wikidata; Q95987080
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW035i-A3267
AC   CVCL_UA86
DR   WiCell; mcw035i-a3267
DR   Wikidata; Q95987081
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW036i-A3170
AC   CVCL_UA87
DR   WiCell; mcw036i-a3170
DR   Wikidata; Q95987084
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW037i-50000777
AC   CVCL_UA88
DR   WiCell; mcw037i-50000777
DR   Wikidata; Q95987085
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW038i-40000503
AC   CVCL_UA89
DR   WiCell; mcw038i-40000503
DR   Wikidata; Q95987087
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW039i-40000473
AC   CVCL_UA90
DR   WiCell; mcw039i-40000473
DR   Wikidata; Q95987088
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW040i-40001098
AC   CVCL_UA91
DR   WiCell; mcw040i-40001098
DR   Wikidata; Q95987090
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW041i-U2104
AC   CVCL_UA92
DR   WiCell; mcw041i-u2104
DR   Wikidata; Q95987092
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW042i-40001401
AC   CVCL_UA93
DR   WiCell; mcw042i-40001401
DR   Wikidata; Q95987093
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW043i-U2326
AC   CVCL_UA94
DR   WiCell; mcw043i-u2326
DR   Wikidata; Q95987094
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW044i-U2448
AC   CVCL_UA95
DR   WiCell; mcw044i-u2448
DR   Wikidata; Q95987096
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW045i-U2033
AC   CVCL_UA96
DR   WiCell; mcw045i-u2033
DR   Wikidata; Q95987097
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW046i-U2346
AC   CVCL_UA97
DR   WiCell; mcw046i-u2346
DR   Wikidata; Q95987100
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW047i-U2234
AC   CVCL_UA98
DR   WiCell; mcw047i-u2234
DR   Wikidata; Q95987102
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW048i-40001845
AC   CVCL_UA99
DR   WiCell; mcw048i-40001845
DR   Wikidata; Q95987103
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW049i-40001630
AC   CVCL_UB00
DR   WiCell; mcw049i-40001630
DR   Wikidata; Q95987105
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW050i-40000626
AC   CVCL_UB01
DR   WiCell; mcw050i-40000626
DR   Wikidata; Q95987107
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW051i-40001166
AC   CVCL_UB02
DR   WiCell; mcw051i-40001166
DR   Wikidata; Q95987108
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW052i-40001760
AC   CVCL_UB03
DR   WiCell; mcw052i-40001760
DR   Wikidata; Q95987110
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW053i-U2213
AC   CVCL_UB04
DR   WiCell; mcw053i-u2213
DR   Wikidata; Q95987111
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW054i-U2073
AC   CVCL_UB05
DR   WiCell; mcw054i-u2073
DR   Wikidata; Q95987112
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW055i-U2054
AC   CVCL_UB06
DR   WiCell; mcw055i-u2054
DR   Wikidata; Q95987113
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW056i-U7076
AC   CVCL_UB07
DR   WiCell; mcw056i-u7076
DR   Wikidata; Q95987114
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW057i-A3286
AC   CVCL_UB08
DR   WiCell; mcw057i-a3286
DR   Wikidata; Q95987115
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW058i-U2082
AC   CVCL_UB09
DR   WiCell; mcw058i-u2082
DR   Wikidata; Q95987116
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW059i-40001067
AC   CVCL_UB10
DR   WiCell; mcw059i-40001067
DR   Wikidata; Q95987117
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW060i-U2183
AC   CVCL_UB11
DR   WiCell; mcw060i-u2183
DR   Wikidata; Q95987120
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW061i-40000329
AC   CVCL_UB12
DR   WiCell; mcw061i-40000329
DR   Wikidata; Q95987122
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW062i-U2157
AC   CVCL_UB13
DR   WiCell; mcw062i-u2157
DR   Wikidata; Q95987124
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW063i-40000190
AC   CVCL_UB14
DR   WiCell; mcw063i-40000190
DR   Wikidata; Q95987125
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW064i-40001159
AC   CVCL_UB15
DR   WiCell; mcw064i-40001159
DR   Wikidata; Q95987127
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW065i-40001296
AC   CVCL_UB16
DR   WiCell; mcw065i-40001296
DR   Wikidata; Q95987128
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW066i-U2368
AC   CVCL_UB17
DR   WiCell; mcw066i-u2368
DR   Wikidata; Q95987129
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW067i-40001036
AC   CVCL_UB18
DR   WiCell; mcw067i-40001036
DR   Wikidata; Q95987130
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW068i-40002385
AC   CVCL_UB19
DR   WiCell; mcw068i-40002385
DR   Wikidata; Q95987133
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW069i-40000268
AC   CVCL_UB20
DR   WiCell; mcw069i-40000268
DR   Wikidata; Q95987135
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW070i-40002330
AC   CVCL_UB21
DR   WiCell; mcw070i-40002330
DR   Wikidata; Q95987137
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW071i-U2177
AC   CVCL_UB22
DR   WiCell; mcw071i-u2177
DR   Wikidata; Q95987138
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW072i-40001708
AC   CVCL_UB23
DR   WiCell; mcw072i-40001708
DR   Wikidata; Q95987140
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW073i-40000527
AC   CVCL_UB24
DR   WiCell; mcw073i-40000527
DR   Wikidata; Q95987141
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW074i-40002460
AC   CVCL_UB25
DR   WiCell; mcw074i-40002460
DR   Wikidata; Q95987142
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW075i-U2096
AC   CVCL_UB26
DR   WiCell; mcw075i-u2096
DR   Wikidata; Q95987143
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW076i-U2129
AC   CVCL_UB27
DR   WiCell; mcw076i-u2129
DR   Wikidata; Q95987145
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW077i-40001579
AC   CVCL_UB28
DR   WiCell; mcw077i-40001579
DR   Wikidata; Q95987146
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW078i-40000978
AC   CVCL_UB29
DR   WiCell; mcw078i-40000978
DR   Wikidata; Q95987147
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW080i-U2236
AC   CVCL_UB30
DR   WiCell; mcw080i-u2236
DR   Wikidata; Q95987148
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW081i-U7128
AC   CVCL_UB31
DR   WiCell; mcw081i-u7128
DR   Wikidata; Q95987149
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW082i-U2052
AC   CVCL_UB32
DR   WiCell; mcw082i-u2052
DR   Wikidata; Q95987150
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW083i-40000695
AC   CVCL_UB33
DR   WiCell; mcw083i-40000695
DR   Wikidata; Q95987152
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW084i-U2053
AC   CVCL_UB34
DR   WiCell; mcw084i-u2053
DR   Wikidata; Q95987153
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW085i-40002118
AC   CVCL_UB35
DR   WiCell; mcw085i-40002118
DR   Wikidata; Q95987155
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW086i-40000176
AC   CVCL_UB36
DR   WiCell; mcw086i-40000176
DR   Wikidata; Q95987157
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW088i-40000442
AC   CVCL_UB37
DR   WiCell; mcw088i-40000442
DR   Wikidata; Q95987161
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW089i-40000312
AC   CVCL_UB38
DR   WiCell; mcw089i-40000312
DR   Wikidata; Q95987162
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW090i-40000374
AC   CVCL_UB39
DR   WiCell; mcw090i-40000374
DR   Wikidata; Q95987163
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW091i-U2202
AC   CVCL_UB40
DR   WiCell; mcw091i-u2202
DR   Wikidata; Q95987165
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW092i-U2390
AC   CVCL_UB41
DR   WiCell; mcw092i-u2390
DR   Wikidata; Q95987168
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW093i-40000435
AC   CVCL_UB42
DR   WiCell; mcw093i-40000435
DR   Wikidata; Q95987170
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW094i-U7120
AC   CVCL_UB43
DR   WiCell; mcw094i-u7120
DR   Wikidata; Q95987171
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW095i-U2311
AC   CVCL_UB44
DR   WiCell; mcw095i-u2311
DR   Wikidata; Q95987172
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW096i-40000169
AC   CVCL_UB45
DR   WiCell; mcw096i-40000169
DR   Wikidata; Q95987173
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW097i-40001654
AC   CVCL_UB46
DR   WiCell; mcw097i-40001654
DR   Wikidata; Q95987174
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW098i-40002583
AC   CVCL_UB47
DR   WiCell; mcw098i-40002583
DR   Wikidata; Q95987175
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW100i-U2341
AC   CVCL_UB48
DR   WiCell; mcw100i-u2341
DR   Wikidata; Q95987176
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW101i-40001005
AC   CVCL_UB49
DR   WiCell; mcw101i-40001005
DR   Wikidata; Q95987177
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW102i-UR117
AC   CVCL_UB50
DR   WiCell; mcw102i-ur117
DR   Wikidata; Q95987178
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW103i-40000237
AC   CVCL_UB51
DR   WiCell; mcw103i-40000237
DR   Wikidata; Q95987180
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW104i-U2175
AC   CVCL_UB52
DR   WiCell; mcw104i-u2175
DR   Wikidata; Q95987181
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW105i-U2130
AC   CVCL_UB53
DR   WiCell; mcw105i-u2130
DR   Wikidata; Q95987184
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW106i-U2120
AC   CVCL_UB54
DR   WiCell; mcw106i-u2120
DR   Wikidata; Q95987185
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW107i-40000886
AC   CVCL_UB55
DR   WiCell; mcw107i-40000886
DR   Wikidata; Q95987187
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW109i-40001470
AC   CVCL_UB56
DR   WiCell; mcw109i-40001470
DR   Wikidata; Q95987188
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW110i-U2170
AC   CVCL_UB57
DR   WiCell; mcw110i-u2170
DR   Wikidata; Q95987189
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW111i-40002422
AC   CVCL_UB58
DR   WiCell; mcw111i-40002422
DR   Wikidata; Q95987190
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW112i-40000893
AC   CVCL_UB59
DR   WiCell; mcw112i-40000893
DR   Wikidata; Q95987191
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW113i-U7145
AC   CVCL_UB60
DR   WiCell; mcw113i-u7145
DR   Wikidata; Q95987192
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW114i-U2144
AC   CVCL_UB61
DR   WiCell; mcw114i-u2144
DR   Wikidata; Q95987193
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW115i-U2143
AC   CVCL_UB62
DR   WiCell; mcw115i-u2143
DR   Wikidata; Q95987194
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MCW116i-40001890
AC   CVCL_UB63
DR   WiCell; mcw116i-40001890
DR   Wikidata; Q95987195
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Broeckel, Ulrich; Medical College of Wisconsin; Milwaukee; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   MCW12
AC   CVCL_Z799
DR   DGRC; 160
DR   FlyBase_Cell_line; FBtc0000160
DR   Wikidata; Q54904539
RX   PubMed=16537908;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 70.4 hours (DGRC=160).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   MCW23
AC   CVCL_Z800
DR   DGRC; 161
DR   FlyBase_Cell_line; FBtc0000161
DR   Wikidata; Q54904540
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 161; probable.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   MD
AC   CVCL_6420
DR   CLO; CLO_0007622
DR   ATCC; CRL-3621
DR   ATCC; CRL-9850
DR   BioSample; SAMN03471074
DR   Wikidata; Q54904541
RX   Patent=US5447861;
RX   PubMed=11416159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9850.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-9850; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-3621; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,15
ST   D18S51: 14
ST   D21S11: 27,30
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   MD-IGF-I
AC   CVCL_HG41
DR   Wikidata; Q54904543
RX   Patent=US5455164;
RX   PubMed=1480169;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P10763; Sheep IGF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Mammary alveolar epithelial cell; CL=CL_0002325.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_U226 ! MAC-T
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   MD0003
AC   CVCL_8Y18
DR   ECACC; 00102801
DR   Wikidata; Q54904544
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85068; Russell-Silver syndrome
DI   ORDO; Orphanet_813; Silver-Russell syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MD144
AC   CVCL_J841
SY   MD 144
DR   Wikidata; Q54904542
RX   Patent=US4666845;
RX   Patent=WO1996040295A1;
RX   PubMed=6582512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8409.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   MD155
AC   CVCL_B4UK
DR   Wikidata; Q110433023
RX   PubMed=28832583;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*02:01,24:02; B*15:01,18:01; C*03:03,07:01 (PubMed=28832583).
CC   HLA typing: DQB1*03,06; DRB1*11,13 (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Miscellaneous: HLA class II typing from personal communication of Bassani-Sternberg, Michal.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   MD2
AC   CVCL_9220
DR   CLO; CLO_0007623
DR   ATCC; HB-229
DR   Wikidata; Q54904545
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   MD3
AC   CVCL_C5EB
DR   Wikidata; Q116049778
RX   PubMed=7687399;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A8C0PTS8; Dog SELP/CD62P.
CC   Misspelling: M03; PubMed=7687399; Note=In six instances.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MD901
AC   CVCL_D709
SY   MD-901
DR   cancercelllines; CVCL_D709
DR   Cosmic; 2297016
DR   GEO; GSM119487
DR   GEO; GSM1035304
DR   Progenetix; CVCL_D709
DR   Wikidata; Q54904546
RX   PubMed=8274736;
RX   PubMed=9369442;
RX   PubMed=16960149;
RX   PubMed=26727417;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Originally assigned to be from a Burkitt lymphoma.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MD903
AC   CVCL_D710
SY   MD-903
DR   cancercelllines; CVCL_D710
DR   Cosmic; 1670151
DR   Cosmic; 2297017
DR   GEO; GSM119488
DR   Progenetix; CVCL_D710
DR   Wikidata; Q54904547
RX   PubMed=9369442;
RX   PubMed=16960149;
RX   PubMed=23699601;
RX   PubMed=26727417;
CC   Population: Japanese.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Originally assigned to be from a B-cell acute lymphoblastic leukemia (ALL-L3).
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   MDA 435TR
AC   CVCL_J435
SY   MDA 435(TR)
DR   cancercelllines; CVCL_J435
DR   Wikidata; Q54904548
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 23
//
ID   MDA-1186
AC   CVCL_6977
SY   MDA 1186; MDA1186
DR   BTO; BTO_0002716
DR   cancercelllines; CVCL_6977
DR   Cosmic; 2513917
DR   IARC_TP53; 3546
DR   Wikidata; Q54904549
RX   PubMed=7927946;
RX   PubMed=11389082;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Gly (c.773A>G); ClinVar=VCV000406590; Zygosity=Unspecified (PubMed=7927946).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   MDA-1386
AC   CVCL_6979
SY   MDA 1386; MDA1386
DR   cancercelllines; CVCL_6979
DR   IARC_TP53; 3547
DR   Wikidata; Q54904550
RX   PubMed=7927946;
RX   PubMed=11389082;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Pro (c.838_839AG>CC); Zygosity=Unspecified (PubMed=7927946).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=7927946).
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H541 ! MDA-1386Ln
OI   CVCL_H542 ! MDA-1386Tu
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MDA-1386Ln
AC   CVCL_H541
SY   MDA-1386LN; MDA1386LN; MDA1386Ln; 1386LN; 1386Ln
DR   Cosmic; 2131849
DR   Cosmic; 2439757
DR   Wikidata; Q54904551
RX   PubMed=14724901;
RX   PubMed=15641986;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6979 ! MDA-1386
OI   CVCL_H542 ! MDA-1386Tu
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 20
//
ID   MDA-1386Tu
AC   CVCL_H542
SY   MDA1386TU; MDA1386Tu; 1386TU; 1386Tu
DR   Cosmic; 2131850
DR   Wikidata; Q54904552
RX   PubMed=14724901;
RX   PubMed=15641986;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6979 ! MDA-1386
OI   CVCL_H541 ! MDA-1386Ln
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   MDA-1483
AC   CVCL_6980
SY   MDA 1483; MDA1483; Line 1483; 1483; SCC 1483
DR   BTO; BTO_0003304
DR   Cosmic; 948038
DR   Cosmic; 2131841
DR   Wikidata; Q54904553
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2452013;
RX   PubMed=11389082;
RX   PubMed=21868764;
RX   PubMed=29156801;
CC   Doubling time: ~36 hours (PubMed=2452013).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 7,10
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MDA-1586
AC   CVCL_6981
SY   MDA 1586; MDA1586
DR   cancercelllines; CVCL_6981
DR   Cosmic; 2043892
DR   Cosmic; 2550365
DR   IARC_TP53; 3548
DR   Wikidata; Q54904555
RX   PubMed=7927946;
RX   PubMed=11389082;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=7927946).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 8,9
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   MDA-1686
AC   CVCL_AT79
SY   MDA 1686; MDA1686
DR   cancercelllines; CVCL_AT79
DR   Cosmic; 2131851
DR   IARC_TP53; 3549
DR   Wikidata; Q54904556
RX   PubMed=7927946;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Gly (c.653T>G); ClinVar=VCV000528249; Zygosity=Unspecified (PubMed=7927946).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Hisfs*89 (c.766delA); Zygosity=Unspecified (PubMed=7927946).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   MDA-183
AC   CVCL_6978
SY   MDA 183; MDA183; MDA-183A; Line 183; 183; 183A
DR   Cosmic; 948036
DR   Cosmic; 2602600
DR   Wikidata; Q54904557
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2452013;
RX   PubMed=21868764;
RX   PubMed=29156801;
CC   Doubling time: ~36 hours (PubMed=2452013).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D5S818: 10,13
ST   D7S820: 9
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MDA-1986
AC   CVCL_6982
SY   MDA 1986; MDA1986
DR   Cosmic; 1530749
DR   Wikidata; Q54904558
RX   PubMed=7927946;
RX   PubMed=11389082;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AT80 ! MDA-1986LN
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   MDA-1986LN
AC   CVCL_AT80
SY   MDA 1986LN; MDA1986LN
DR   Wikidata; Q54904559
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=29156801;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00441.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 13
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,19,20
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6982 ! MDA-1986
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   MDA-231#15 rho-0
AC   CVCL_E1F3
DR   CancerTools; 162184
DR   Kerafast; ESA121
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   MDA-299-62A
AC   CVCL_C3PK
DR   Wikidata; Q116049779
RX   PubMed=36139163;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9H999; Human PANK3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MDA-584
AC   CVCL_V278
SY   584A2; 584-A2; 584
DR   Cosmic; 2043889
DR   GEO; GSM960591
DR   GEO; GSM960593
DR   GEO; GSM960596
DR   GEO; GSM960599
DR   GEO; GSM960601
DR   GEO; GSM960603
DR   GEO; GSM960606
DR   Wikidata; Q54904560
RX   PubMed=3148118;
RX   PubMed=11389082;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 6,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   MDA-686
AC   CVCL_6983
SY   MDA 686; MDA686
DR   Wikidata; Q54904561
RX   PubMed=11389082;
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6984 ! MDA-686Ln
OI   CVCL_6985 ! MDA-686Tu
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   MDA-686Ln
AC   CVCL_6984
SY   MDA 686Ln; MDA686Ln; MDA686LN; MDA 686LN; MDA 686-LN; MDA 686 Ln; 686LN; 686Ln
DR   BTO; BTO_0003052
DR   cancercelllines; CVCL_6984
DR   Wikidata; Q54904562
RX   PubMed=7927946;
RX   PubMed=14724901;
RX   PubMed=15641986;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=29156801;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by UM-SCC-1 (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00442.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified (PubMed=7927946).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6983 ! MDA-686
OI   CVCL_6985 ! MDA-686Tu
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   MDA-686Tu
AC   CVCL_6985
SY   MDA 686Tu; MDA686Tu; MDA686TU; 686TU; 686Tu
DR   cancercelllines; CVCL_6985
DR   IARC_TP53; 3550
DR   Wikidata; Q54904563
RX   PubMed=7927946;
RX   PubMed=14724901;
RX   PubMed=15641986;
RX   PubMed=21868764;
RX   PubMed=29156801;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by T404/T406/Tu 1387Tu 158LN/Tu 159/Tu 182/Tu 212/Tu 212LN (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00443.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified (PubMed=7927946).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6983 ! MDA-686
OI   CVCL_6984 ! MDA-686Ln
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   MDA-8788-6
AC   CVCL_H539
SY   MDA8788-6
DR   Wikidata; Q54904564
RX   PubMed=23032744;
CC   Doubling time: ~40 hours (PubMed=23032744).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
ST   Source(s): PubMed=23032744
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C54294; Sinonasal undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H540 ! MDA-8788-7
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   MDA-8788-7
AC   CVCL_H540
SY   MDA8788-7
DR   Wikidata; Q54904568
RX   PubMed=23032744;
CC   Doubling time: ~40 hours (PubMed=23032744).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
ST   Source(s): PubMed=23032744
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C54294; Sinonasal undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H539 ! MDA-8788-6
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   MDA-886
AC   CVCL_6986
SY   MDA 886; MDA886; HN 886
DR   BTO; BTO_0002717
DR   Wikidata; Q54904570
RX   PubMed=7927946;
RX   PubMed=11389082;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   MDA-886Ln
AC   CVCL_6987
SY   MDA 886Ln; MDA-886LN; MDA 886-Ln; MDA886Ln; MDA886LN
DR   Cosmic; 948037
DR   Cosmic; 2602601
DR   Wikidata; Q54904571
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6986 ! MDA-886
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   MDA-ACC-01(hTERT)
AC   CVCL_GZ62
DR   FCS-free; 132-2-226-3-4-3
DR   Wikidata; Q54904572
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=25086988;
CC   Doubling time: 60 hours (PubMed=25086988).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
ST   Source(s): PubMed=25086988
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 9
ST   vWA: 16
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Telomerase immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   MDA-AMP7
AC   CVCL_EI94
SY   MDAAmp-7
DR   PRIDE; PXD002657
DR   Wikidata; Q54904573
RX   PubMed=1582987;
RX   PubMed=26951071;
CC   Doubling time: ~30 hours (PubMed=1582987).
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39-40Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   MDA-BoM-1833
AC   CVCL_DP48
SY   MDA 231 BoM 1833; BoM-1833; 1833 BoM; MDA-MB-231 1833 BoM; MDA-MB-231-1833; MDA-MB-231 subline 1833; MDA-MB-231 Bone Tropic 1833 subclone; 1833
DR   cancercelllines; CVCL_DP48
DR   PRIDE; PXD000397
DR   Wikidata; Q54904574
RX   PubMed=12842083;
RX   PubMed=18425382;
RX   PubMed=26649326;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Established from bone metastasis of nude mice inculated with the parent cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11,16
ST   D19S433: 11
ST   D21S11: 30,33.2
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 20
//
ID   MDA-EJ-1
AC   CVCL_UI82
SY   EJ-1; EJ
DR   ATCC; CRL-3380
DR   Wikidata; Q95987241
RX   PubMed=12808126;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=12808126).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-3380
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,15
ST   D5S818: 13
ST   D7S820: 9,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   MDA-IBC-3
AC   CVCL_HC47
SY   MDA-IBC3; MDAIBC3; MD Anderson-Inflammatory Breast Cancer-3
DR   ArrayExpress; E-MTAB-11134
DR   GEO; GSM1008922
DR   GEO; GSM1215265
DR   GEO; GSM3145605
DR   GEO; GSM3145722
DR   Wikidata; Q54904575
RX   DOI=10.4172/2161-0681.1000119;
RX   PubMed=20808935;
RX   PubMed=23784380;
RX   PubMed=24162158;
RX   PubMed=35042871;
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20808935
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   MDA-kb2
AC   CVCL_6421
SY   MDA-Kb2
DR   CLO; CLO_0007630
DR   ATCC; CRL-2713
DR   cancercelllines; CVCL_6421
DR   CLS; 305108
DR   PubChem_Cell_line; CVCL_6421
DR   Wikidata; Q54904576
RX   PubMed=11861974;
RX   PubMed=20821581;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Biotechnology: Can be used in an vitro assay to screen androgen agonist and antagonists and to characterize its specificity and sensitivity to endocrine disrupting chemicals.
CC   Characteristics: Expresses luciferase under the control of a MMTV promoter that contains glucocorticoid receptor and androgen receptor response elements.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Gln868His (c.2604G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Trp638Ter (c.1913G>A); ClinVar=VCV000599651; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu307Lys (c.919G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex10-11del; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
ST   Source(s): ATCC=CRL-2713
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 15,20
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,12
ST   FGA: 18,23
ST   Penta D: 9,10
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0418 ! MDA-MB-453
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   MDA-MB-134-VI
AC   CVCL_0617
SY   MDA-MB-134 VI; MDA MB 134VI; MDA-MB-134VI; MDAMB134VI; MDA-MB-134; MDAMB134; MDA-134; MDA134; MM134; MD Anderson-Metastatic Breast-134-VI
DR   CLO; CLO_0007631
DR   EFO; EFO_0001205
DR   CLDB; cl3398
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; HTB-23
DR   BioSample; SAMN03471473
DR   BioSample; SAMN10988465
DR   cancercelllines; CVCL_0617
DR   CCRID; 1101HUM-PUMC000380
DR   Cell_Model_Passport; SIDM00005
DR   ChEMBL-Cells; CHEMBL3308340
DR   ChEMBL-Targets; CHEMBL2366242
DR   Cosmic; 687491
DR   Cosmic; 735125
DR   Cosmic; 809233
DR   Cosmic; 904374
DR   Cosmic; 908119
DR   Cosmic; 934525
DR   Cosmic; 997933
DR   Cosmic; 1000129
DR   Cosmic; 1046947
DR   Cosmic; 1047696
DR   Cosmic; 1090333
DR   Cosmic; 1136347
DR   Cosmic; 1152519
DR   Cosmic; 1287908
DR   Cosmic; 1289392
DR   Cosmic; 1603216
DR   DepMap; ACH-000044
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908119
DR   GEO; GSM115107
DR   GEO; GSM186432
DR   GEO; GSM186433
DR   GEO; GSM186434
DR   GEO; GSM217584
DR   GEO; GSM219959
DR   GEO; GSM320180
DR   GEO; GSM350523
DR   GEO; GSM421870
DR   GEO; GSM783960
DR   GEO; GSM847398
DR   GEO; GSM847491
DR   GEO; GSM887292
DR   GEO; GSM888367
DR   GEO; GSM1053695
DR   GEO; GSM1172886
DR   GEO; GSM1172976
DR   GEO; GSM1215268
DR   GEO; GSM1226522
DR   GEO; GSM1226523
DR   GEO; GSM1226524
DR   GEO; GSM1226525
DR   GEO; GSM1226526
DR   GEO; GSM1226527
DR   GEO; GSM1226528
DR   GEO; GSM1226529
DR   GEO; GSM1226530
DR   GEO; GSM1226531
DR   GEO; GSM1226532
DR   GEO; GSM1226533
DR   GEO; GSM1226534
DR   GEO; GSM1226535
DR   GEO; GSM1226536
DR   GEO; GSM1226537
DR   GEO; GSM1226538
DR   GEO; GSM1226539
DR   GEO; GSM1226540
DR   GEO; GSM1226541
DR   GEO; GSM1238133
DR   GEO; GSM1374647
DR   GEO; GSM1401662
DR   GEO; GSM1661981
DR   GEO; GSM1670078
DR   IARC_TP53; 18375
DR   IZSLER; BS TCL 236
DR   LiGeA; CCLE_784
DR   LINCS_HMS; 50327
DR   LINCS_LDP; LCL-1316
DR   PharmacoDB; MDAMB134VI_897_2019
DR   Progenetix; CVCL_0617
DR   PubChem_Cell_line; CVCL_0617
DR   SLKBase; 3582
DR   Wikidata; Q54904577
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=730202;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4412247;
RX   PubMed=6220172;
RX   PubMed=7842014;
RX   PubMed=9331070;
RX   PubMed=9671407;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=11343771;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24425047;
RX   PubMed=25485619;
RX   PubMed=25757734;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=28889351;
RX   PubMed=30228172;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/mda-mb-134.htm
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 6.4 days (PubMed=9671407); 82.67 hours (JWGray panel).
CC   HLA typing: A*11:02,24:02; B*35:01,40:01; C*03:04,04:01; DQB1*03:02,06:02; DRB1*13:27,13:27 (PubMed=25960936).
CC   HLA typing: A*11:01,24:02; B*35:01,40:01; C*03:04,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Leu230fs*4 (c.688_832del145); Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Ser184Leu (c.551C>T); Zygosity=Homozygous (PubMed=9331070; PubMed=19593635; DepMap=ACH-000044).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.96%; Native American=0%; East Asian, North=3.67%; East Asian, South=0%; South Asian=0%; European, North=64.3%; European, South=29.06% (PubMed=30894373).
CC   Misspelling: MDA-MB-134IV; Cosmic=1000129.
CC   Misspelling: MDA-MB-134-IV; Cosmic=1090333; PubMed=9331070.
CC   Misspelling: MDA-MD-134VI; PubMed=16541312.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-23; CCRID=1101HUM-PUMC000380; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 13
ST   D18S51: 10,16
ST   D19S433: 13,15
ST   D21S11: 26,28
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 7,9
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   MDA-MB-157
AC   CVCL_0618
AS   CVCL_3740
SY   MDA-MB157; MDAMB157; MDA-157; MDA157; MB 157; MB157; MD Anderson-Metastatic Breast-157
DR   BTO; BTO_0006218
DR   CLO; CLO_0007544
DR   CLO; CLO_0007632
DR   EFO; EFO_0001206
DR   CLDB; cl3400
DR   CLDB; cl3401
DR   AddexBio; C0006020/4986
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-7721
DR   ATCC; HTB-24
DR   BCRJ; 0319
DR   BioGRID_ORCS_Cell_line; 556
DR   BioSample; SAMN03472739
DR   BioSample; SAMN03473083
DR   BioSample; SAMN10988196
DR   cancercelllines; CVCL_0618
DR   CCRID; 1101HUM-PUMC000077
DR   Cell_Model_Passport; SIDM00529
DR   ChEMBL-Cells; CHEMBL3308759
DR   ChEMBL-Targets; CHEMBL1075496
DR   Cosmic; 687492
DR   Cosmic; 809234
DR   Cosmic; 871144
DR   Cosmic; 897421
DR   Cosmic; 904375
DR   Cosmic; 925338
DR   Cosmic; 934535
DR   Cosmic; 979714
DR   Cosmic; 1010921
DR   Cosmic; 1017166
DR   Cosmic; 1018462
DR   Cosmic; 1027052
DR   Cosmic; 1044207
DR   Cosmic; 1044228
DR   Cosmic; 1046954
DR   Cosmic; 1047692
DR   Cosmic; 1136372
DR   Cosmic; 1176640
DR   Cosmic; 1287919
DR   Cosmic; 1289393
DR   Cosmic; 1477429
DR   Cosmic; 1523776
DR   Cosmic; 1603217
DR   Cosmic; 1609468
DR   Cosmic; 1995501
DR   Cosmic; 2009506
DR   Cosmic; 2301527
DR   Cosmic-CLP; 925338
DR   DepMap; ACH-000621
DR   DepMap; ACH-001120
DR   ECACC; 92020422
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 925338
DR   GEO; GSM73731
DR   GEO; GSM115112
DR   GEO; GSM186435
DR   GEO; GSM186436
DR   GEO; GSM217585
DR   GEO; GSM219942
DR   GEO; GSM350548
DR   GEO; GSM421871
DR   GEO; GSM783948
DR   GEO; GSM783970
DR   GEO; GSM827192
DR   GEO; GSM844591
DR   GEO; GSM847399
DR   GEO; GSM847492
DR   GEO; GSM887293
DR   GEO; GSM888368
DR   GEO; GSM1053729
DR   GEO; GSM1172881
DR   GEO; GSM1172977
DR   GEO; GSM1238139
DR   GEO; GSM1374648
DR   GEO; GSM1374649
DR   GEO; GSM1401671
DR   GEO; GSM1670079
DR   IARC_TP53; 18370
DR   LiGeA; CCLE_925
DR   LINCS_HMS; 50324
DR   LINCS_HMS; 50328
DR   LINCS_LDP; LCL-1484
DR   LINCS_LDP; LCL-1916
DR   PharmacoDB; MDAMB157_898_2019
DR   PRIDE; PXD005292
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0618
DR   PubChem_Cell_line; CVCL_0618
DR   SLKBase; 3596
DR   Wikidata; Q54904578
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=730202;
RX   PubMed=833871;
RX   PubMed=1961733;
RX   PubMed=3518877;
RX   PubMed=4412247;
RX   PubMed=4471183;
RX   PubMed=9671407;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=11343771;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=15153330;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/mda-mb-157.htm
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/mda-mb-157-xenograft-model/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   Doubling time: 2.8 days (PubMed=9671407); 66.98 hours (JWGray panel).
CC   HLA typing: A*11:01,68:02; B*15:03,55:02; C*01:02,02:02 (PubMed=25960936).
CC   HLA typing: A*02:01,30:01; B*53:01,53:01; C*04:01,06:02; DQA1*01:02,03:02; DQB1*06:02,06:02; DRB1*11:09,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=15677628; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Pro42Ser (c.124C>T); ClinVar=VCV000089180; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-000621).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Arg644Ser (c.1932G>C); ClinVar=VCV000089233; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-000621).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro87fs*53 (c.261_286del26) (p.Ala88Cysfs*52); Zygosity=Homozygous (PubMed=16541312; ATCC=HTB-24; DepMap=ACH-000621).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=77.9%; Native American=0%; East Asian, North=4.71%; East Asian, South=0%; South Asian=0%; European, North=1.3%; European, South=16.09% (PubMed=30894373).
CC   Misspelling: MDA-MB-15; Cosmic=897421.
CC   Discontinued: BCRJ; 0319; probable.
CC   Discontinued: DepMap; ACH-001120; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006020/4986; ATCC=CRL-7721; ATCC=HTB-24; CCRID=1101HUM-PUMC000077; Cosmic-CLP=925338; ECACC=92020422; PubMed=20679594; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11 (AddexBio=C0006020/4986; ATCC=CRL-7721; CCRID=1101HUM-PUMC000077; Cosmic-CLP=925338; ECACC=92020422; PubMed=20679594; PubMed=25877200; PubMed=28889351)
ST   D13S317: 11,12 (ATCC=HTB-24)
ST   D16S539: 11
ST   D18S51: 13,16 (ATCC=CRL-7721; ATCC=HTB-24)
ST   D18S51: 16 (CCRID=1101HUM-PUMC000077; PubMed=25877200)
ST   D19S433: 13,14.2 (ATCC=CRL-7721; ATCC=HTB-24)
ST   D19S433: 14.2 (CCRID=1101HUM-PUMC000077)
ST   D21S11: 31,31.2
ST   D2S1338: 25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 22,23 (ATCC=CRL-7721)
ST   FGA: 23 (ATCC=HTB-24; CCRID=1101HUM-PUMC000077; PubMed=25877200)
ST   Penta D: 3.2,9
ST   Penta E: 11
ST   TH01: 7,8
ST   TPOX: 9,11 (AddexBio=C0006020/4986; ATCC=CRL-7721; ATCC=HTB-24; ECACC=92020422; PubMed=20679594; PubMed=25877200; PubMed=28889351)
ST   TPOX: 11 (CCRID=1101HUM-PUMC000077; Cosmic-CLP=925338)
ST   vWA: 15
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   MDA-MB-175-VII
AC   CVCL_1400
SY   MDA MB 175 VII; MDA-MB-175VII; MDAMB175VII; MDA-MB-175; MDAMB175; MDA-175; MDA175; MD Anderson-Metastatic Breast-175-VII
DR   BTO; BTO_0003471
DR   CLO; CLO_0007633
DR   EFO; EFO_0001208
DR   AddexBio; C0006009/4885
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-TABM-157
DR   ATCC; HTB-25
DR   BioSample; SAMN03472690
DR   BioSample; SAMN10987665
DR   cancercelllines; CVCL_1400
DR   CCRID; 1101HUM-PUMC000349
DR   Cell_Model_Passport; SIDM00633
DR   ChEMBL-Cells; CHEMBL3308404
DR   ChEMBL-Targets; CHEMBL1075497
DR   Cosmic; 687493
DR   Cosmic; 809236
DR   Cosmic; 871145
DR   Cosmic; 894086
DR   Cosmic; 897422
DR   Cosmic; 904376
DR   Cosmic; 908120
DR   Cosmic; 934526
DR   Cosmic; 997917
DR   Cosmic; 1010931
DR   Cosmic; 1044227
DR   Cosmic; 1046955
DR   Cosmic; 1047690
DR   Cosmic; 1176646
DR   Cosmic; 1287894
DR   Cosmic; 1289394
DR   Cosmic; 1309001
DR   Cosmic; 1434951
DR   Cosmic; 1603218
DR   Cosmic; 1609470
DR   Cosmic; 2165025
DR   Cosmic; 2750525
DR   Cosmic-CLP; 908120
DR   DepMap; ACH-000759
DR   EGA; EGAS00001000610
DR   GDSC; 908120
DR   GEO; GSM115106
DR   GEO; GSM217586
DR   GEO; GSM219930
DR   GEO; GSM320175
DR   GEO; GSM344348
DR   GEO; GSM344398
DR   GEO; GSM350511
DR   GEO; GSM421872
DR   GEO; GSM466359
DR   GEO; GSM783950
DR   GEO; GSM844592
DR   GEO; GSM844593
DR   GEO; GSM847400
DR   GEO; GSM847493
DR   GEO; GSM887294
DR   GEO; GSM888369
DR   GEO; GSM1053731
DR   GEO; GSM1172888
DR   GEO; GSM1172978
DR   GEO; GSM1238134
DR   GEO; GSM1374650
DR   IARC_TP53; 21080
DR   IGRhCellID; MDAMB175VII
DR   LiGeA; CCLE_228
DR   LINCS_HMS; 50329
DR   LINCS_LDP; LCL-1317
DR   NCBI_Iran; C432
DR   PharmacoDB; MDAMB175VII_899_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1400
DR   PubChem_Cell_line; CVCL_1400
DR   SLKBase; 3590
DR   Wikidata; Q54904579
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=730202;
RX   PubMed=3518877;
RX   PubMed=4412247;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20407441;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=28889351;
RX   PubMed=29610121;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/MDA-MB-175.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 112.26 hours (JWGray panel).
CC   HLA typing: A*24:02,68:02; B*08:01,35:08; C*04:01,07:01; DQB1*05:01,05:01; DRB1*13:02,04:22 (PubMed=25960936).
CC   HLA typing: A*24:02,68:02; B*08:01,53:01; C*04:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7997; NRG1 + HGNC; HGNC:29945; TENM4; Name(s)=TENM4-NRG1, DOC4-NRG1; Note=In frame (PubMed=12800145; PubMed=29610121).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=83.61%; Native American=0%; East Asian, North=5.65%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=10.73% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006009/4885; ATCC=HTB-25; CCRID=1101HUM-PUMC000349; Cosmic-CLP=908120; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 7,8
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 12.2,15
ST   D21S11: 29,30
ST   D2S1338: 22
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 14,17
ST   FGA: 23,26
ST   Penta D: 3.2
ST   Penta E: 8,15
ST   TH01: 7
ST   TPOX: 6,8
ST   vWA: 15,16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   MDA-MB-231
AC   CVCL_0062
SY   MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231
DR   BTO; BTO_0000815
DR   CLO; CLO_0007634
DR   CLO; CLO_0037291
DR   EFO; EFO_0001209
DR   MCCL; MCC:0000313
DR   CLDB; cl3402
DR   CLDB; cl3404
DR   CLDB; cl3405
DR   CLDB; cl4945
DR   AddexBio; C0006002/58
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-11134
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRM-HTB-26
DR   ATCC; HTB-26
DR   BCRC; 60425
DR   BCRJ; 0164
DR   BioGRID_ORCS_Cell_line; 554
DR   BioSample; SAMN03472205
DR   BioSample; SAMN05292460
DR   BioSample; SAMN07710033
DR   BioSample; SAMN07710034
DR   BioSample; SAMN07710035
DR   BioSample; SAMN07710036
DR   BioSample; SAMN07710037
DR   BioSample; SAMN07710038
DR   BioSample; SAMN07710039
DR   BioSample; SAMN10987764
DR   cancercelllines; CVCL_0062
DR   CCRID; 1101HUM-PUMC000014
DR   CCRID; 3101HUMSCSP5043
DR   CCRID; 3101HUMTCHu227
DR   CCRID; 4201HUM-CCTCC00297
DR   CCRID; 5301HUM-KCB07076YJ
DR   CCTCC; GDC0297
DR   Cell_Model_Passport; SIDM00146
DR   ChEMBL-Cells; CHEMBL3307960
DR   ChEMBL-Targets; CHEMBL400
DR   CLS; 300275
DR   Cosmic; 687494
DR   Cosmic; 871146
DR   Cosmic; 875878
DR   Cosmic; 877450
DR   Cosmic; 894087
DR   Cosmic; 897423
DR   Cosmic; 904377
DR   Cosmic; 905960
DR   Cosmic; 934536
DR   Cosmic; 944294
DR   Cosmic; 974235
DR   Cosmic; 991324
DR   Cosmic; 997929
DR   Cosmic; 1010924
DR   Cosmic; 1018477
DR   Cosmic; 1027053
DR   Cosmic; 1044226
DR   Cosmic; 1046950
DR   Cosmic; 1047693
DR   Cosmic; 1071900
DR   Cosmic; 1092613
DR   Cosmic; 1136369
DR   Cosmic; 1152528
DR   Cosmic; 1175833
DR   Cosmic; 1176602
DR   Cosmic; 1176636
DR   Cosmic; 1183773
DR   Cosmic; 1219444
DR   Cosmic; 1287926
DR   Cosmic; 1289395
DR   Cosmic; 1305383
DR   Cosmic; 1309003
DR   Cosmic; 1312370
DR   Cosmic; 1434952
DR   Cosmic; 1436032
DR   Cosmic; 1466805
DR   Cosmic; 1477428
DR   Cosmic; 1481426
DR   Cosmic; 1524347
DR   Cosmic; 1571793
DR   Cosmic; 1609458
DR   Cosmic; 1927242
DR   Cosmic; 1945862
DR   Cosmic; 1998455
DR   Cosmic; 2009512
DR   Cosmic; 2036667
DR   Cosmic; 2164997
DR   Cosmic; 2301528
DR   Cosmic; 2318377
DR   Cosmic; 2361355
DR   Cosmic; 2560256
DR   Cosmic-CLP; 905960
DR   DepMap; ACH-000768
DR   DSMZ; ACC-732
DR   DSMZCellDive; ACC-732
DR   ECACC; 92020424
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FCS-free; 253-2-521-2-3-3
DR   GDSC; 905960
DR   GEO; GSM812
DR   GEO; GSM2124
DR   GEO; GSM49953
DR   GEO; GSM49954
DR   GEO; GSM50184
DR   GEO; GSM50248
DR   GEO; GSM69194
DR   GEO; GSM155213
DR   GEO; GSM185093
DR   GEO; GSM185094
DR   GEO; GSM274653
DR   GEO; GSM344349
DR   GEO; GSM344399
DR   GEO; GSM350547
DR   GEO; GSM378148
DR   GEO; GSM388213
DR   GEO; GSM421873
DR   GEO; GSM459713
DR   GEO; GSM481304
DR   GEO; GSM587393
DR   GEO; GSM587394
DR   GEO; GSM750781
DR   GEO; GSM799321
DR   GEO; GSM799384
DR   GEO; GSM820814
DR   GEO; GSM820815
DR   GEO; GSM820816
DR   GEO; GSM839034
DR   GEO; GSM844594
DR   GEO; GSM844595
DR   GEO; GSM847036
DR   GEO; GSM847401
DR   GEO; GSM887295
DR   GEO; GSM888370
DR   GEO; GSM967818
DR   GEO; GSM1008905
DR   GEO; GSM1053716
DR   GEO; GSM1153390
DR   GEO; GSM1172889
DR   GEO; GSM1172979
DR   GEO; GSM1181242
DR   GEO; GSM1181365
DR   GEO; GSM1214569
DR   GEO; GSM1238120
DR   GEO; GSM1374651
DR   GEO; GSM1374652
DR   GEO; GSM1401658
DR   GEO; GSM1613823
DR   GEO; GSM1670080
DR   GEO; GSM1833624
DR   GEO; GSM2095710
DR   GEO; GSM2095711
DR   GEO; GSM2124643
DR   GEO; GSM2258848
DR   GEO; GSM2258849
DR   GEO; GSM2258850
DR   GEO; GSM2258851
DR   GEO; GSM2258852
DR   GEO; GSM2258853
DR   GEO; GSM2258854
DR   GEO; GSM2258855
DR   GEO; GSM2258856
DR   GEO; GSM2258857
DR   GEO; GSM2258858
DR   GEO; GSM2258859
DR   GEO; GSM2258860
DR   GEO; GSM2258861
DR   GEO; GSM2258862
DR   GEO; GSM2258863
DR   GEO; GSM2258864
DR   GEO; GSM2258865
DR   GEO; GSM2258932
DR   GEO; GSM2258933
DR   GEO; GSM2258934
DR   GEO; GSM3161720
DR   GEO; GSM3161721
DR   IARC_TP53; 6
DR   IBRC; C10684
DR   ICLC; HTL99004
DR   IZSLER; BS TCL 223
DR   KCB; KCB 200776YJ
DR   KCLB; 30026
DR   LiGeA; CCLE_752
DR   LINCS_HMS; 50058
DR   LINCS_LDP; LCL-1461
DR   Lonza; 815
DR   MetaboLights; MTBLS337
DR   MetaboLights; MTBLS387
DR   MetaboLights; MTBLS678
DR   NCBI_Iran; C578
DR   NCI-DTP; MDA-MB-231
DR   PharmacoDB; MDAMB231_900_2019
DR   PRIDE; PXD000239
DR   PRIDE; PXD000397
DR   PRIDE; PXD000691
DR   PRIDE; PXD000914
DR   PRIDE; PXD001553
DR   PRIDE; PXD002192
DR   PRIDE; PXD002649
DR   PRIDE; PXD003539
DR   PRIDE; PXD005292
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD008222
DR   PRIDE; PXD010634
DR   PRIDE; PXD028400
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0062
DR   PubChem_Cell_line; CVCL_0062
DR   SKY/M-FISH/CGH; 2815
DR   SLKBase; 3575
DR   TOKU-E; 2394
DR   Ubigene; YC-D005
DR   Wikidata; Q17577870
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=77569;
RX   PubMed=730202;
RX   PubMed=833871;
RX   PubMed=1000504;
RX   PubMed=1000505;
RX   PubMed=1000506;
RX   PubMed=1961733;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=4412247;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7000337;
RX   PubMed=7272986;
RX   PubMed=7459858;
RX   PubMed=7902062;
RX   PubMed=8824553;
RX   PubMed=9331090;
RX   PubMed=9670966;
RX   PubMed=9671407;
RX   PubMed=9815641;
RX   PubMed=10700174;
RX   PubMed=10969801;
RX   PubMed=11499871;
RX   PubMed=11687795;
RX   PubMed=11697798;
RX   PubMed=12068308;
RX   PubMed=12353263;
RX   PubMed=12661003;
RX   PubMed=12800145;
RX   PubMed=15153330;
RX   PubMed=15677628;
RX   PubMed=15748285;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=16049480;
RX   PubMed=16142302;
RX   PubMed=16397213;
RX   PubMed=16417655;
RX   PubMed=16541312;
RX   PubMed=17088437;
RX   PubMed=17157791;
RX   PubMed=17334996;
RX   PubMed=18277095;
RX   PubMed=18386134;
RX   PubMed=18516279;
RX   PubMed=18714363;
RX   PubMed=19372543;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=21378333;
RX   PubMed=21778573;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24279929;
RX   PubMed=24389870;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26055192;
RX   PubMed=26218769;
RX   PubMed=26589293;
RX   PubMed=26649326;
RX   PubMed=27331101;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31092827;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32782317;
RX   PubMed=34238275;
RX   PubMed=34320349;
RX   PubMed=35042871;
RX   PubMed=35666001;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-htb-26
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/mda-mb-231/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/MDA-MB-231_Struhl_protocol.pdf
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Nikon Small World; -; https://www.nikonsmallworld.com/galleries/2018-small-world-in-motion-competition/labeling-of-the-microtubule-cytoskeleton-in-a-human-cell-line
WW   Info; Quora; -; https://www.quora.com/What-does-231-stand-for-in-the-MDA-MB-231-cell-line
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=2
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544482
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-394.html
WW   Info; Wikipedia; -; https://de.wikipedia.org/wiki/MDA-MB-231_(Zelllinie)
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/mda-mb-231-xenograft-model/
WW   Provider; BRICS; BRICS0102; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3908
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12532.
CC   Registration: Chiron Master Culture Collection; CMCC 10583 (CMCC #10583).
CC   Population: Caucasian.
CC   Doubling time: 1.3 days (PubMed=9671407); 26.7 hours (PubMed=9815641); 24.7 hours (PubMed=24389870); 36.2 hours (PubMed=34238275); 38 hours (ATCC=HTB-26); ~25-30 hours (DSMZ=ACC-732); 41.9 hours (NCI-DTP=MDA-MB-231); ~38 hours (PBCF); 31.43 hours (JWGray panel).
CC   HLA typing: A*02/28; B*07,08; C*w02,w06 (PubMed=77569).
CC   HLA typing: A*02:01,02:17; B*40:02,41:01; C*02:02:02,17; DPB1*02:01:02,17:01; DQB1*02:02,03:01:01; DRB1*07:01,13:05 (PubMed=15748285).
CC   HLA typing: A*02:17,02:01; B*40:02,41:01; C*02:02,17:01; DQA1*02:01,02:01; DQB1*03:04,03:04; DRB1*07:01,13:05 (PubMed=25960936).
CC   HLA typing: A*02:17,02:17; B*40:02,41:01; C*02:02,17:01; DQA1*01:02,01:02; DQB1*02:02,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17334996; PubMed=19593635; ATCC=HTB-26).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=17334996).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; ATCC=HTB-26).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437; PubMed=19593635; ATCC=HTB-26).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (PubMed=1961733; PubMed=9331090; PubMed=15900046; PubMed=16541312; PubMed=17088437; PubMed=18277095; PubMed=28889351; ATCC=HTB-26).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.95%; Native American=0%; East Asian, North=2.44%; East Asian, South=0%; South Asian=7.42%; European, North=28.16%; European, South=60.03% (PubMed=30894373).
CC   Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870).
CC   Misspelling: MDA-MB-321; Note=Occasionally.
CC   Misspelling: MDA-MD-231; Cosmic=1071900; Cosmic=1176602.
CC   Misspelling: MDA-321; GEO=GSM459713.
CC   Misspelling: MDA-MG-231; PubMed=6582512.
CC   Misspelling: MD-MB-231; PRIDE=PXD010634.
CC   Misspelling: MD-MBA-231; Note=Occasionally.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006002/58; ATCC=HTB-26; CCRID; CLS=300275; Cosmic-CLP=905960; DSMZ=ACC-732; ECACC=92020424; KCLB=30026; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 14,16
ST   D12S391: 17,18
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11,16
ST   D19S433: 11,14
ST   D1S1656: 15,17
ST   D21S11: 30,33.2 (ATCC=HTB-26; CCRID; CLS=300275; DSMZ=ACC-732; PubMed=28889351; Technion Genomics Center)
ST   D21S11: 33.2 (DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)
ST   D22S1045: 16
ST   D2S1338: 20,21
ST   D2S441: 14,15
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 11,14
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18 (ATCC=HTB-26; CCRID; Cosmic-CLP=905960; DSMZ=ACC-732; ECACC=92020424; KCLB=30026; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; PubMed=28889351; Technion Genomics Center)
ST   vWA: 15,19 (AddexBio=C0006002/58; CLS=300275)
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   MDA-MB-231 25PACR
AC   CVCL_4Y38
DR   cancercelllines; CVCL_4Y38
DR   Wikidata; Q54904580
RX   PubMed=25312014;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   MDA-MB-231 50PACR
AC   CVCL_4Y39
DR   cancercelllines; CVCL_4Y39
DR   Wikidata; Q54904581
RX   PubMed=25312014;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   MDA-MB-231 CAPN2 KO
AC   CVCL_A9AZ
DR   cancercelllines; CVCL_A9AZ
DR   Wikidata; Q108820868
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   From: Greer, Peter A.; Queen's University; Kingston; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1479; CAPN2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   MDA-MB-231 Cas9
AC   CVCL_DX79
DR   Horizon_Discovery; HD+Cas9-014
DR   Wikidata; Q127382751
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-014).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   MDA-MB-231 CD44 KO
AC   CVCL_E8FU
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   From: National Research Council Canada; Ottawa; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Ayoubi, Riham.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDA-MB-231 CMV
AC   CVCL_IN16
SY   MDA Mb231 (CMV)
DR   cancercelllines; CVCL_IN16
DR   GEO; GSM246267
DR   GEO; GSM246268
DR   GEO; GSM246269
DR   GEO; GSM246270
DR   GEO; GSM246271
DR   GEO; GSM246272
DR   GEO; GSM246285
DR   GEO; GSM246286
DR   GEO; GSM246287
DR   GEO; GSM246288
DR   GEO; GSM246289
DR   GEO; GSM246290
DR   Wikidata; Q54904582
RX   PubMed=19321454;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Control cell line for the MDA-MB-231 ERalpha (Cellosaurus=CVCL_IN17), MDA-MB-231 ERalpha203/4/11 (Cellosaurus=CVCL_IN15), MDA-MB-231 ERbeta (Cellosaurus=CVCL_IN18) and MDA-MB-231 ERbetaDBD (Cellosaurus=CVCL_IN19) cell lines.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 19
//
ID   MDA-MB-231 dCas9-VPR
AC   CVCL_DX80
DR   Horizon_Discovery; HD+dCas9-VPR-014
DR   Wikidata; Q127382752
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-dCas9-VPR-WPRE, where VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA (Horizon_Discovery=HD+dCas9-VPR-014).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   MDA-MB-231 ERalpha
AC   CVCL_IN17
SY   MDA Mb231 (ERa)
DR   cancercelllines; CVCL_IN17
DR   GEO; GSM246273
DR   GEO; GSM246274
DR   GEO; GSM246275
DR   GEO; GSM246276
DR   GEO; GSM246277
DR   GEO; GSM246278
DR   Wikidata; Q54904583
RX   PubMed=19321454;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 19
//
ID   MDA-MB-231 ERalpha203/4/11
AC   CVCL_IN15
SY   MDA Mb231 (ERa3411)
DR   cancercelllines; CVCL_IN15
DR   GEO; GSM246279
DR   GEO; GSM246280
DR   GEO; GSM246281
DR   GEO; GSM246282
DR   GEO; GSM246283
DR   GEO; GSM246284
DR   Wikidata; Q54904584
RX   PubMed=19321454;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=With p.Glu203Ala, p.Gly204Ala and Arg211Glu).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 19
//
ID   MDA-MB-231 ERbeta
AC   CVCL_IN18
SY   MDA Mb231 (ERb)
DR   cancercelllines; CVCL_IN18
DR   GEO; GSM246297
DR   GEO; GSM246298
DR   GEO; GSM246299
DR   GEO; GSM246300
DR   GEO; GSM246301
DR   GEO; GSM246302
DR   Wikidata; Q54904585
RX   PubMed=19321454;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3468; ESR2.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 19
//
ID   MDA-MB-231 ERbetaDBD
AC   CVCL_IN19
SY   MDA Mb231 (ERbDBD)
DR   cancercelllines; CVCL_IN19
DR   GEO; GSM246303
DR   GEO; GSM246304
DR   GEO; GSM246305
DR   GEO; GSM246306
DR   GEO; GSM246307
DR   GEO; GSM246308
DR   Wikidata; Q54904586
RX   PubMed=19321454;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3468; ESR2 (Note=ERE-binding defective).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 19
//
ID   MDA-MB-231 HSP90AA1 KO#1
AC   CVCL_E9EA
SY   KO-alpha-#1; KO-alpha#1
RX   PubMed=27721406;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MDA-MB-231 HSP90AA1 KO#2
AC   CVCL_E9EB
SY   KO-alpha-#2; KO-alpha#2
RX   PubMed=27721406;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MDA-MB-231 met2
AC   CVCL_A5ER
SY   MDA-MB-231-Met2; MDA-MB-231met2
DR   BTO; BTO_0006470
DR   cancercelllines; CVCL_A5ER
DR   Wikidata; Q107116175
RX   PubMed=30337562;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Metastatic to lung. Established from a lung tumor after injection of the parent cell line into the tail vein of athymic nude mice (PubMed=30337562).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   MDA-MB-231 NAT1 down
AC   CVCL_A9BB
SY   NAT1 shRNA Clone 3; NAT1 Knockdown
DR   cancercelllines; CVCL_A9BB
DR   Wikidata; Q108820869
RX   PubMed=29315819;
RX   PubMed=29964355;
RX   PubMed=32555504;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pcDNA5/FRT derived construct with a NATb promoter driving the expression of NAT1 (NATb/NAT1*4).
CC   Doubling time: 27.2 hours (PubMed=29315819).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7645; NAT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   MDA-MB-231 NAT1 scrambled
AC   CVCL_A9BA
SY   NAT1 Overexpression
DR   cancercelllines; CVCL_A9BA
DR   Wikidata; Q108820871
RX   PubMed=29315819;
RX   PubMed=29964355;
RX   PubMed=32555504;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a scrambled NAT1 shRNA, control cell line for other NAT1 cell lines.
CC   Doubling time: 27.4 hours (PubMed=29315819).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   MDA-MB-231 NAT1 up
AC   CVCL_A9BC
SY   NAT1 Overexpression
DR   cancercelllines; CVCL_A9BC
DR   Wikidata; Q108820872
RX   PubMed=29315819;
RX   PubMed=29964355;
RX   PubMed=32555504;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pcDNA5/FRT derived construct with a NATb promoter driving the expression of NAT1 (NATb/NAT1*4).
CC   Doubling time: 23.4 hours (PubMed=29315819).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   MDA-MB-231 NAT1-/- 2-19
AC   CVCL_A9BE
SY   MDA-MB-231 2; CRISPR 2-19
DR   cancercelllines; CVCL_A9BE
DR   Wikidata; Q108820874
RX   PubMed=29964355;
RX   PubMed=32555504;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a scrambled NAT1 shRNA.
CC   Doubling time: 29.3 +- 1.1 hours (PubMed=29964355).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9BA ! MDA-MB-231 NAT1 scrambled
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   MDA-MB-231 NAT1-/- 5-50
AC   CVCL_A9BF
SY   MDA-MB-231 5; CRISPR 5-50
DR   cancercelllines; CVCL_A9BF
DR   Wikidata; Q108820875
RX   PubMed=29964355;
RX   PubMed=32555504;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a scrambled NAT1 shRNA.
CC   Doubling time: 29.8 +- 0.7 hours (PubMed=29964355).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9BA ! MDA-MB-231 NAT1 scrambled
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   MDA-MB-231 NAT1+/- 2-12
AC   CVCL_A9BD
SY   CRISPR 2-12
DR   cancercelllines; CVCL_A9BD
DR   Wikidata; Q108820876
RX   PubMed=32555504;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a scrambled NAT1 shRNA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9BA ! MDA-MB-231 NAT1 scrambled
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   MDA-MB-231 NucLight Green
AC   CVCL_DF47
DR   cancercelllines; CVCL_DF47
DR   Wikidata; Q54904587
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen BioSciences; Catalog number 4488.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 23
//
ID   MDA-MB-231 NucLight Red
AC   CVCL_DF48
DR   cancercelllines; CVCL_DF48
DR   Wikidata; Q54904588
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen BioSciences; Catalog number 4487.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 24
//
ID   MDA-MB-231 shPARG
AC   CVCL_RA90
SY   shPARG MDA-MB-231
DR   cancercelllines; CVCL_RA90
DR   Wikidata; Q54904589
RX   PubMed=29166620;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   MDA-MB-231 shWDR12-4
AC   CVCL_YJ26
DR   cancercelllines; CVCL_YJ26
DR   Wikidata; Q95987355
RX   CelloPub=CLPUB00550;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 20-27 hours (CelloPub=CLPUB00550).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:14098; WDR12.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Corrections of STR profile from thesis manuscript (CelloPub=CLPUB00550) from personal communication of Al-awar, Rima.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00550; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 30,33.2
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   MDA-MB-231 SimpleCell O-GalNAc
AC   CVCL_S031
SY   MDA-MB-231 SimpleCell; MDA-MB-231 SC
DR   cancercelllines; CVCL_S031
DR   Wikidata; Q54904590
RX   PubMed=23584533;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 25
//
ID   MDA-MB-231 SimpleCell O-GalNAC/O-Man
AC   CVCL_S032
DR   cancercelllines; CVCL_S032
DR   Wikidata; Q54904591
RX   PubMed=24101494;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc, NeuAc-alpha-2-6-GalNAc and Man O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:19139; POMGNT1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S031 ! MDA-MB-231 SimpleCell O-GalNAc
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 25
//
ID   MDA-MB-231 VIM RFP
AC   CVCL_VR67
DR   ATCC; HTB-26MET
DR   cancercelllines; CVCL_VR67
DR   Wikidata; Q95987359
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: A red fluorescent protein (RFP) tag was added to the C-terminal of the VIM gene by CRISPR/Cas9. Allows to monitor the epithelial-to-mesenchymal transition (EMT) status of cells in vitro by monitoring RFP expression.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-26MET
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 14
//
ID   MDA-MB-231 Vb100
AC   CVCL_ZZ22
DR   cancercelllines; CVCL_ZZ22
DR   Wikidata; Q102114519
RX   PubMed=9815641;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 33.5 hours (PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   MDA-MB-231-5a
AC   CVCL_9U30
SY   MDA-5a
DR   cancercelllines; CVCL_9U30
DR   Wikidata; Q54904592
RX   PubMed=16309168;
RX   PubMed=17129361;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 18
//
ID   MDA-MB-231-5a-D
AC   CVCL_9U31
SY   MDA-231-D
DR   cancercelllines; CVCL_9U31
DR   Wikidata; Q54904593
RX   PubMed=17129361;
RX   PubMed=18663362;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U30 ! MDA-MB-231-5a
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 18
//
ID   MDA-MB-231-5a-D-TbetaFluc/Rluc
AC   CVCL_9U32
SY   MDA-231-D-TbetaFluc/Rluc; MDA-D-TbetaFluc/Rluc; 5a-D-Luc
DR   cancercelllines; CVCL_9U32
DR   Wikidata; Q54904594
RX   PubMed=17129361;
RX   PubMed=18663362;
RX   PubMed=26691676;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U31 ! MDA-MB-231-5a-D
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 20
//
ID   MDA-MB-231-5a-D-TbetaFluc/Rluc-ZsGreen
AC   CVCL_9U33
SY   5a-D-Luc-ZsGreen
DR   cancercelllines; CVCL_9U33
DR   Wikidata; Q54904595
RX   PubMed=26691676;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 51H85; ZsGreen1 (Note=Green fluorescent protein derived from ZsGreen).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U32 ! MDA-MB-231-5a-D-TbetaFluc/Rluc
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 20
//
ID   MDA-MB-231-BAG
AC   CVCL_R956
SY   MDA-MB-231 BAG
DR   BTO; BTO_0004474
DR   cancercelllines; CVCL_R956
DR   Wikidata; Q54904596
RX   PubMed=1384607;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 24
//
ID   MDA-MB-231-Dox
AC   CVCL_UJ21
SY   MDA-231-Dox
DR   cancercelllines; CVCL_UJ21
DR   Wikidata; Q95987366
RX   PubMed=7902062;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   MDA-MB-231-EGFP
AC   CVCL_C8W8
DR   Ubigene; YC-D005-EGFP-P
DR   Wikidata; Q123033025
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MDA-MB-231-Luc [JCRB]
AC   CVCL_JG53
DR   cancercelllines; CVCL_JG53
DR   JCRB; JCRB1559
DR   Wikidata; Q54904597
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1559
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 19
//
ID   MDA-MB-231-Luc [Ubigene]
AC   CVCL_C8W9
DR   Ubigene; YC-D005-Luc-P
DR   Wikidata; Q123033026
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MDA-MB-231-luc-D3H1
AC   CVCL_1D88
SY   D3H1
DR   cancercelllines; CVCL_1D88
DR   Revvity/PerkinElmer; 119261
DR   Wikidata; Q54904598
RX   PubMed=15987449;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Expression of firefly luciferase is under the control of a SV40 promoter (Revvity/PerkinElmer=119261).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: Revvity/PerkinElmer; 119261; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 23
//
ID   MDA-MB-231-luc-D3H2LN
AC   CVCL_D257
SY   D3H2LN
DR   cancercelllines; CVCL_D257
DR   Revvity/PerkinElmer; 119369
DR   Wikidata; Q54904599
RX   PubMed=15987449;
WW   Provider; Revvity/PerkinElmer; 119369; https://web.archive.org/web/20150202002416/http://www.perkinelmer.com/catalog/product/id/119369
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Expression of firefly luciferase is under the control of a SV40 promoter (Revvity/PerkinElmer=119369).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: Revvity/PerkinElmer; 119369; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D88 ! MDA-MB-231-luc-D3H1
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 31
//
ID   MDA-MB-231-luc2
AC   CVCL_D582
SY   MDA-MB-231-Luc2
DR   BTO; BTO_0005172
DR   cancercelllines; CVCL_D582
DR   Revvity/PerkinElmer; 124319
DR   Wikidata; Q54904600
RX   DOI=10.1158/1538-7445.AM2013-3908;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124319; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 27
//
ID   MDA-MB-231-luc2-GFP
AC   CVCL_1D89
DR   cancercelllines; CVCL_1D89
DR   Revvity/PerkinElmer; 128442
DR   Wikidata; Q54904601
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 128442; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D582 ! MDA-MB-231-luc2
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 22
//
ID   MDA-MB-231-luc2-LN
AC   CVCL_1D92
DR   cancercelllines; CVCL_1D92
DR   Wikidata; Q54904602
RX   DOI=10.1158/1538-7445.AM2013-3908;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D582 ! MDA-MB-231-luc2
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 21
//
ID   MDA-MB-231-luc2-tdTomato
AC   CVCL_1D90
SY   MDA-MB231-luc2-tdTomato
DR   cancercelllines; CVCL_1D90
DR   Revvity/PerkinElmer; 125738
DR   Wikidata; Q54904603
RX   DOI=10.1158/1538-7445.AM2013-3908;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 125738; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D582 ! MDA-MB-231-luc2
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 23
//
ID   MDA-MB-231-luc2-tdTomato-LN
AC   CVCL_1E88
DR   cancercelllines; CVCL_1E88
DR   Wikidata; Q54904604
RX   DOI=10.1158/1538-7445.AM2013-3908;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D90 ! MDA-MB-231-luc2-tdTomato
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 23
//
ID   MDA-MB-231-MEK-R
AC   CVCL_V403
DR   cancercelllines; CVCL_V403
DR   Cosmic; 1927243
DR   Wikidata; Q54904605
RX   PubMed=22402123;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88249; 391210-10-9 (PD0325901).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 21
//
ID   MDA-MB-231-Red-FLuc
AC   CVCL_5J05
SY   MDA-MB231-Red-FLuc; Bioware Brite MDA-MB231-Red-FLuc
DR   cancercelllines; CVCL_5J05
DR   Revvity/PerkinElmer; BW124319
DR   Wikidata; Q54904606
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (Revvity/PerkinElmer=BW124319).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Revvity/PerkinElmer; BW124319; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 20
//
ID   MDA-MB-231-Red-FLuc-GFP
AC   CVCL_5J06
SY   MDA-MB231-Red-FLuc-GFP; Bioware Brite MDA-MB231-Red-FLuc-GFP
DR   cancercelllines; CVCL_5J06
DR   Revvity/PerkinElmer; BW128442
DR   Wikidata; Q54904607
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (Revvity/PerkinElmer=BW128442).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Discontinued: Revvity/PerkinElmer; BW128442; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 21
//
ID   MDA-MB-231-tdTomato
AC   CVCL_1D91
DR   cancercelllines; CVCL_1D91
DR   Revvity/PerkinElmer; 125737
DR   Wikidata; Q54904608
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Discontinued: Revvity/PerkinElmer; 125737; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 22
//
ID   MDA-MB-231/5-FU
AC   CVCL_S511
DR   cancercelllines; CVCL_S511
DR   Wikidata; Q54904612
RX   PubMed=24126575;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 22
//
ID   MDA-MB-231/B02
AC   CVCL_5T76
SY   MDA-MB-231-B02; MDA-B02; B02
DR   BTO; BTO_0004955
DR   cancercelllines; CVCL_5T76
DR   Wikidata; Q54904613
RX   PubMed=11697798;
RX   PubMed=18714363;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 21
//
ID   MDA-MB-231/BCRP
AC   CVCL_ZZ41
DR   cancercelllines; CVCL_ZZ41
DR   Wikidata; Q102114520
RX   PubMed=15695404;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Myc-tagged ABCG2/BCRP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:74; ABCG2.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   MDA-MB-231/Cas9-hyg
AC   CVCL_C9CE
DR   GeneCopoeia; SL515
DR   Wikidata; Q123033027
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL515).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   MDA-MB-231/GFP
AC   CVCL_JZ03
DR   cancercelllines; CVCL_JZ03
DR   Cell_Biolabs; AKR-201
DR   Wikidata; Q54904614
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Cell_Biolabs; AKR-201; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   MDA-MB-231/GFP-RFP
AC   CVCL_JZ04
DR   cancercelllines; CVCL_JZ04
DR   Cell_Biolabs; AKR-221
DR   Wikidata; Q54904615
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Cell_Biolabs; AKR-221; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   MDA-MB-231/Luc
AC   CVCL_JZ05
DR   BCRJ; 0392
DR   cancercelllines; CVCL_JZ05
DR   Cell_Biolabs; AKR-231
DR   Wikidata; Q54904616
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Cell_Biolabs; AKR-231; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 18
//
ID   MDA-MB-231/Luciferase-2A-RFP
AC   CVCL_YZ80
SY   MDA-MB-231 / Luciferase & RFP; MDA-MB-231 / Luc-RFP
DR   cancercelllines; CVCL_YZ80
DR   Wikidata; Q98127127
WW   Provider; GenTarget; SC041; https://www.gentarget.com/product/mda-mb-231-luc-rfp-stable-cell-line/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a suCMV-Luc-2A-RFP-RSV-Bsr construct (GenTarget=SC041).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 13
//
ID   MDA-MB-231/PacR
AC   CVCL_4Z64
DR   cancercelllines; CVCL_4Z64
DR   Wikidata; Q54904617
RX   CelloPub=CLPUB00286;
RX   PubMed=25275030;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 19
//
ID   MDA-MB-231/RFP
AC   CVCL_JZ06
DR   cancercelllines; CVCL_JZ06
DR   Cell_Biolabs; AKR-251
DR   Wikidata; Q54904618
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Cell_Biolabs; AKR-251; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   MDA-MB-231(Cas9)
AC   CVCL_E7JA
WW   Provider; BRICS; ECC3037; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3971
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDA-MB-231bo
AC   CVCL_A0YX
SY   MDA-231BO
DR   cancercelllines; CVCL_A0YX
DR   Wikidata; Q108820877
RX   PubMed=11499871;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Metastatic to bone. Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the bone metastatic cells and repeating this procedure 11 times.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   MDA-MB-231br
AC   CVCL_A0YY
SY   MDA-231BR
DR   cancercelllines; CVCL_A0YY
DR   Wikidata; Q108820878
RX   PubMed=11499871;
RX   PubMed=33264355;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Metastatic to brain. Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the brain metastatic cells and repeating this procedure 6 times.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   MDA-MB-231br/eGFP
AC   CVCL_B0A0
DR   cancercelllines; CVCL_B0A0
DR   Wikidata; Q108820879
RX   PubMed=33264355;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Metastatic to brain. Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the brain metastatic cells and repeating this procedure 6 times.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0YY ! MDA-MB-231br
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   MDA-MB-231cherry
AC   CVCL_E2QJ
DR   DSMZ; ACC-982
RX   PubMed=23895436;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: ~24-30 hours (DSMZ=ACC-982).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-982
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11
ST   D19S433: 12,14
ST   D21S11: 33.2
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 14
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MDA-MB-231DR
AC   CVCL_4Z65
DR   cancercelllines; CVCL_4Z65
DR   Wikidata; Q54904619
RX   PubMed=16928833;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 18
//
ID   MDA-MB-231GFP
AC   CVCL_E2QK
DR   DSMZ; ACC-981
RX   PubMed=23895436;
RX   PubMed=29569804;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: ~24-48 hours (DSMZ=ACC-981).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-981
ST   Amelogenin: X
ST   CSF1PO: 12,13,14
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11
ST   D19S433: 11,14
ST   D21S11: 33.2
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 14
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MDA-MB-231LLM
AC   CVCL_M354
DR   cancercelllines; CVCL_M354
DR   Wikidata; Q54904621
RX   PubMed=22977471;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   MDA-MB-231sci
AC   CVCL_XE60
DR   cancercelllines; CVCL_XE60
DR   CCRID; 4201PAT-CCTCC00312
DR   Wikidata; Q95987394
RX   Patent=CN102071168A;
CC   Group: Patented cell line.
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200955.
CC   Population: Caucasian.
CC   Characteristics: Highly metastatic.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   MDA-MB-231T
AC   CVCL_YA89
SY   MB231T
DR   cancercelllines; CVCL_YA89
DR   GEO; GSM1178375
DR   GEO; GSM1178376
DR   Wikidata; Q95987395
RX   PubMed=15870434;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Has metastatic potential.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   MDA-MB-253
AC   CVCL_M384
SY   MD Anderson-Metastatic Breast-253
DR   Wikidata; Q54904622
RX   PubMed=730202;
RX   PubMed=3518877;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   MDA-MB-309
AC   CVCL_M385
SY   MDA-MB-309 I; MD Anderson-Metastatic Breast-309
DR   Wikidata; Q54904623
RX   PubMed=730202;
RX   PubMed=833871;
RX   PubMed=3518877;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   MDA-MB-330
AC   CVCL_0619
SY   MDAMB330; MDA-330; MDA330; MD Anderson-Metastatic Breast-330
DR   CLO; CLO_0007635
DR   EFO; EFO_0006454
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-127
DR   BioSample; SAMN03473067
DR   cancercelllines; CVCL_0619
DR   Cell_Model_Passport; SIDM00631
DR   Cosmic; 871154
DR   Cosmic; 904378
DR   Cosmic; 934537
DR   Cosmic; 979725
DR   Cosmic; 997918
DR   Cosmic; 1046956
DR   Cosmic; 1152521
DR   Cosmic; 1287917
DR   Cosmic; 1289396
DR   Cosmic; 1603219
DR   Cosmic-CLP; 1330941
DR   DepMap; ACH-001358
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1330941
DR   GEO; GSM421874
DR   GEO; GSM783951
DR   GEO; GSM1661982
DR   GEO; GSM1670081
DR   IARC_TP53; 24350
DR   LINCS_LDP; LCL-1961
DR   PharmacoDB; MDAMB330_901_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0619
DR   Wikidata; Q54904624
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=327080;
RX   PubMed=730202;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=9671407;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19593635;
RX   PubMed=23601657;
RX   PubMed=25485619;
RX   PubMed=25757734;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28889351;
RX   PubMed=30228172;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 1.7 days (PubMed=9671407).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=16541312; PubMed=28889351).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.4%; Native American=0%; East Asian, North=2.68%; East Asian, South=0%; South Asian=0%; European, North=67.3%; European, South=29.63% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-127; Cosmic-CLP=1330941; DepMap=ACH-001358; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 21
ST   D19S433: 15,15.2
ST   D21S11: 29
ST   D2S1338: 18
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   Penta D: 9,14
ST   Penta E: 12,13,17
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   MDA-MB-331
AC   CVCL_M386
SY   MDA-MB-331 IV; MD Anderson-Metastatic Breast-331
DR   Wikidata; Q54904625
RX   PubMed=730202;
RX   PubMed=3518877;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   MDA-MB-361
AC   CVCL_0620
SY   MDA-MB 361; MDA MB 361; MDA-MB361; MDAMB361; MDA-361; MDA361; MB361; MD Anderson-Metastatic Breast-361
DR   BTO; BTO_0001569
DR   CLO; CLO_0007636
DR   EFO; EFO_0001211
DR   CLDB; cl3406
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-27
DR   BCRC; 60549
DR   BioGRID_ORCS_Cell_line; 1048
DR   BioSample; SAMN03472909
DR   BioSample; SAMN10987900
DR   cancercelllines; CVCL_0620
DR   CCRID; 1101HUM-PUMC000381
DR   Cell_Model_Passport; SIDM00528
DR   ChEMBL-Cells; CHEMBL3308405
DR   ChEMBL-Targets; CHEMBL614129
DR   CLS; 305267
DR   Cosmic; 687495
DR   Cosmic; 809235
DR   Cosmic; 871147
DR   Cosmic; 904379
DR   Cosmic; 908121
DR   Cosmic; 934527
DR   Cosmic; 979709
DR   Cosmic; 997919
DR   Cosmic; 1000124
DR   Cosmic; 1010928
DR   Cosmic; 1017160
DR   Cosmic; 1018464
DR   Cosmic; 1046933
DR   Cosmic; 1047695
DR   Cosmic; 1136355
DR   Cosmic; 1176627
DR   Cosmic; 1287895
DR   Cosmic; 1289397
DR   Cosmic; 1308994
DR   Cosmic; 1348961
DR   Cosmic; 1434953
DR   Cosmic; 1523777
DR   Cosmic; 1603220
DR   Cosmic; 1609461
DR   Cosmic; 2165011
DR   Cosmic; 2301529
DR   Cosmic-CLP; 908121
DR   DepMap; ACH-000934
DR   ECACC; 92020423
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 908121
DR   GEO; GSM73751
DR   GEO; GSM115119
DR   GEO; GSM155208
DR   GEO; GSM186437
DR   GEO; GSM186438
DR   GEO; GSM186439
DR   GEO; GSM217587
DR   GEO; GSM274655
DR   GEO; GSM344350
DR   GEO; GSM344400
DR   GEO; GSM350546
DR   GEO; GSM421875
DR   GEO; GSM481306
DR   GEO; GSM783952
DR   GEO; GSM827280
DR   GEO; GSM847402
DR   GEO; GSM847494
DR   GEO; GSM887296
DR   GEO; GSM888371
DR   GEO; GSM1008906
DR   GEO; GSM1053728
DR   GEO; GSM1172890
DR   GEO; GSM1172980
DR   GEO; GSM1238121
DR   GEO; GSM1264070
DR   GEO; GSM1264072
DR   GEO; GSM1264112
DR   GEO; GSM1264114
DR   GEO; GSM1374653
DR   GEO; GSM1374654
DR   GEO; GSM1374655
DR   GEO; GSM1401664
DR   GEO; GSM1670082
DR   GEO; GSM2258758
DR   GEO; GSM2258759
DR   GEO; GSM2258760
DR   GEO; GSM2258761
DR   GEO; GSM2258762
DR   GEO; GSM2258763
DR   GEO; GSM2258764
DR   GEO; GSM2258765
DR   GEO; GSM2258766
DR   GEO; GSM2258767
DR   GEO; GSM2258768
DR   GEO; GSM2258769
DR   GEO; GSM2258770
DR   GEO; GSM2258771
DR   GEO; GSM2258772
DR   GEO; GSM2258773
DR   GEO; GSM2258774
DR   GEO; GSM2258775
DR   GEO; GSM2258935
DR   GEO; GSM2258936
DR   GEO; GSM2258937
DR   IARC_TP53; 18373
DR   IARC_TP53; 21128
DR   LiGeA; CCLE_872
DR   LINCS_HMS; 50331
DR   LINCS_LDP; LCL-1468
DR   NCBI_Iran; C433
DR   PharmacoDB; MDAMB361_902_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0620
DR   PubChem_Cell_line; CVCL_0620
DR   SLKBase; 3600
DR   Wikidata; Q54904626
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=730202;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7272986;
RX   PubMed=9671407;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=11343771;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=17334996;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/mda-mb-361.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Population: Caucasian.
CC   Doubling time: 4.3 days (PubMed=9671407); 92.83 hours (JWGray panel).
CC   HLA typing: A*01:01,24:02; B*39:06,51:08; C*07:02,16:02; DQB1*04:01,04:01; DRB1*08:01,08:01 (PubMed=25960936).
CC   HLA typing: A*01:01,24:02; B*39:06,51:08; C*07:02,16:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=908121; DepMap=ACH-000934).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1657Ser (c.4970A>G); ClinVar=VCV000409419; Zygosity=Heterozygous (Cosmic-CLP=908121; DepMap=ACH-000934).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met52Ile (c.156G>C) (p.Asp67His, c.199G>C); ClinVar=VCV002132254; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-27; Cosmic-CLP=908121; DepMap=ACH-000934).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-27; Cosmic-CLP=908121; DepMap=ACH-000934).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=19593635; Cosmic-CLP=908121; DepMap=ACH-000934).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys567Arg (c.1700A>G); Zygosity=Heterozygous (PubMed=19593635; Cosmic-CLP=908121; DepMap=ACH-000934).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Homozygous (PubMed=16541312; Cosmic-CLP=908121; DepMap=ACH-000934).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.71%; East Asian, North=0%; East Asian, South=0%; South Asian=0.9%; European, North=62.27%; European, South=36.11% (PubMed=30894373).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=HTB-27; BCRC=60549; CCRID=1101HUM-PUMC000381; Cosmic-CLP=908121; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 12.2,14
ST   D21S11: 30,32.2 (ATCC=HTB-27; CCRID=1101HUM-PUMC000381; PubMed=25877200)
ST   D21S11: 32.2 (PubMed=28889351)
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 9 (BCRC=60549)
ST   D7S820: 9,12 (ATCC=HTB-27; CCRID=1101HUM-PUMC000381; Cosmic-CLP=908121; PubMed=25877200; PubMed=28889351)
ST   D8S1179: 15
ST   FGA: 20,24
ST   Penta D: 12,13
ST   Penta E: 8,14
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   MDA-MB-361-Luc#1
AC   CVCL_4Y09
DR   cancercelllines; CVCL_4Y09
DR   JCRB; JCRB1502
DR   JCRB; NIHS0718
DR   Wikidata; Q54904627
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1657Ser (c.4970A>G); ClinVar=VCV000409419; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met52Ile (c.156G>C) (p.Asp67His, c.199G>C); ClinVar=VCV002132254; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys567Arg (c.1700A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0718; true.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=JCRB1502
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0620 ! MDA-MB-361
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 20
//
ID   MDA-MB-390
AC   CVCL_M387
SY   MD Anderson-Metastatic Breast-390
DR   Wikidata; Q54904628
RX   PubMed=730202;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MDA-MB-411
AC   CVCL_M388
SY   MD Anderson-Metastatic Breast-411
DR   Wikidata; Q54904629
RX   PubMed=730202;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MDA-MB-415
AC   CVCL_0621
SY   MDA-MB415; MDAMB415; MDA-415; MDA415; MD Anderson-Metastatic Breast-415
DR   BTO; BTO_0006039
DR   CLO; CLO_0007637
DR   EFO; EFO_0001212
DR   CLDB; cl3407
DR   CLDB; cl7127
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-128
DR   BioGRID_ORCS_Cell_line; 555
DR   BioSample; SAMN03471279
DR   BioSample; SAMN10988336
DR   cancercelllines; CVCL_0621
DR   CCRID; 1101HUM-PUMC000350
DR   CCRID; 3101HUMTCHu175
DR   Cell_Model_Passport; SIDM00630
DR   ChEMBL-Cells; CHEMBL3308760
DR   ChEMBL-Targets; CHEMBL1075498
DR   CLS; 305129
DR   Cosmic; 871148
DR   Cosmic; 894088
DR   Cosmic; 897424
DR   Cosmic; 904380
DR   Cosmic; 924240
DR   Cosmic; 949190
DR   Cosmic; 1010917
DR   Cosmic; 1027054
DR   Cosmic; 1044225
DR   Cosmic; 1046928
DR   Cosmic; 1047697
DR   Cosmic; 1090334
DR   Cosmic; 1136348
DR   Cosmic; 1176650
DR   Cosmic; 1287896
DR   Cosmic; 1289398
DR   Cosmic; 1434954
DR   Cosmic; 1502207
DR   Cosmic; 1603221
DR   Cosmic; 1609460
DR   Cosmic; 2165026
DR   Cosmic; 2301530
DR   Cosmic; 2750527
DR   Cosmic-CLP; 924240
DR   DepMap; ACH-000876
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 924240
DR   GEO; GSM115101
DR   GEO; GSM149982
DR   GEO; GSM149990
DR   GEO; GSM149998
DR   GEO; GSM186440
DR   GEO; GSM186441
DR   GEO; GSM217588
DR   GEO; GSM344351
DR   GEO; GSM344401
DR   GEO; GSM421876
DR   GEO; GSM783953
DR   GEO; GSM844596
DR   GEO; GSM844597
DR   GEO; GSM844598
DR   GEO; GSM844599
DR   GEO; GSM847415
DR   GEO; GSM847495
DR   GEO; GSM887297
DR   GEO; GSM888372
DR   GEO; GSM1008907
DR   GEO; GSM1053714
DR   GEO; GSM1172981
DR   GEO; GSM1215266
DR   GEO; GSM1238122
DR   GEO; GSM1374656
DR   GEO; GSM1670083
DR   IARC_TP53; 24355
DR   ICLC; HTL02005
DR   LiGeA; CCLE_116
DR   LINCS_HMS; 50332
DR   LINCS_LDP; LCL-1469
DR   Lonza; 1252
DR   PharmacoDB; MDAMB415_903_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0621
DR   PubChem_Cell_line; CVCL_0621
DR   SLKBase; 3604
DR   Ubigene; YC-D007
DR   Wikidata; Q54904630
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=730202;
RX   PubMed=6935474;
RX   PubMed=7272986;
RX   PubMed=9331070;
RX   PubMed=10969801;
RX   PubMed=11343771;
RX   PubMed=12800145;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28889351;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/MDA-MB-415.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 88.87 hours (JWGray panel).
CC   HLA typing: A*30:02,33:01; B*14:02,18:01; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Ser280Ter (c.839C>A); Zygosity=Homozygous (PubMed=9331070; PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys136Tyr (c.407G>A); ClinVar=VCV000189406; Zygosity=Homozygous (PubMed=19593635; ATCC=HTB-128).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Homozygous (PubMed=16541312; ATCC=HTB-128).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.43%; Native American=12.27%; East Asian, North=1.2%; East Asian, South=1.74%; South Asian=0.34%; European, North=40.99%; European, South=42.03% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-128; CCRID; Cosmic-CLP=924240; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13,13.2
ST   D21S11: 27,28
ST   D2S1338: 19,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 8,12
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 7,16
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   MDA-MB-416
AC   CVCL_M389
SY   MD Anderson-Metastatic Breast-416
DR   Wikidata; Q54904631
RX   PubMed=730202;
RX   PubMed=7272986;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   MDA-MB-431
AC   CVCL_M390
SY   MD Anderson-Metastatic Breast-431
DR   Wikidata; Q54904632
RX   PubMed=730202;
RX   PubMed=7272986;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   MDA-MB-435
AC   CVCL_0417
SY   MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435
DR   BTO; BTO_0001567
DR   EFO; EFO_0001213
DR   MCCL; MCC:0000314
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-TABM-157
DR   BioSample; SAMN03151832
DR   BioSample; SAMN03470861
DR   cancercelllines; CVCL_0417
DR   Cell_Model_Passport; SIDM00004
DR   ChEMBL-Cells; CHEMBL3307686
DR   ChEMBL-Targets; CHEMBL614697
DR   Cosmic; 687496
DR   Cosmic; 875879
DR   Cosmic; 905988
DR   Cosmic; 974069
DR   Cosmic; 974236
DR   Cosmic; 991325
DR   Cosmic; 1000131
DR   Cosmic; 1010930
DR   Cosmic; 1044219
DR   Cosmic; 1092614
DR   Cosmic; 1175834
DR   Cosmic; 1176643
DR   Cosmic; 1219445
DR   Cosmic; 1305366
DR   Cosmic; 1312349
DR   Cosmic; 1477425
DR   Cosmic; 1524346
DR   Cosmic; 1571794
DR   Cosmic; 1945861
DR   Cosmic; 1998456
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM2095
DR   GEO; GSM50203
DR   GEO; GSM50265
DR   GEO; GSM206523
DR   GEO; GSM274648
DR   GEO; GSM274649
DR   GEO; GSM344352
DR   GEO; GSM344402
DR   GEO; GSM383801
DR   GEO; GSM383802
DR   GEO; GSM383803
DR   GEO; GSM743466
DR   GEO; GSM750814
DR   GEO; GSM783965
DR   GEO; GSM799354
DR   GEO; GSM799417
DR   GEO; GSM844589
DR   GEO; GSM844590
DR   GEO; GSM847037
DR   GEO; GSM1008908
DR   GEO; GSM1153424
DR   GEO; GSM1178391
DR   GEO; GSM1178392
DR   GEO; GSM1181294
DR   GEO; GSM1181337
DR   GEO; GSM1215267
DR   GEO; GSM1670084
DR   GEO; GSM2124670
DR   IARC_TP53; 18065
DR   NCI-DTP; MDA-MB-435
DR   PharmacoDB; MDAMB435_904_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   Progenetix; CVCL_0417
DR   PubChem_Cell_line; CVCL_0417
DR   SKY/M-FISH/CGH; 2816
DR   TOKU-E; 3544
DR   Wikidata; Q50952937
RX   DOI=10.25904/1912/1434;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=730202;
RX   PubMed=7272986;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=15153330;
RX   PubMed=15748285;
RX   PubMed=17004106;
RX   PubMed=17088437;
RX   PubMed=17157791;
RX   PubMed=18304946;
RX   PubMed=19372543;
RX   PubMed=19549886;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28721362;
RX   PubMed=28889351;
RX   PubMed=28940260;
RX   PubMed=31733513;
RX   PubMed=38861359;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/mda-mb-435.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/mda-mb-435.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=51
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=17004106; PubMed=18304946; PubMed=20143388; PubMed=28940260). Originally thought to originate from the pleural effusion of a breast carcinoma from a 31 year old patient. See also PubMed=19549886 for a dissenting but incorrect view that states that M14 is a breast cancer cell line.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00235.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12583.
CC   Population: Caucasian.
CC   Doubling time: 25.8 hours (NCI-DTP=MDA-MB-435); 38.72 hours (JWGray panel).
CC   HLA typing: A*11:01:01,24:02:01; B*15,35; C*03:03:01,04; DPB1*13:01,19:01; DQB1*03:02,06:03; DRB1*04:05:01,13:01:01 (PubMed=15748285).
CC   HLA typing: A*24:02,24:02; B*15:01,15:01; C*03:03,03:03; DQA1*01:03,01:03; DQB1*06:03,06:03; DRB1*03:17,13:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17088437; PubMed=28889351).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=9331090; PubMed=17088437; PubMed=28889351).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000351). It was one of the sources for the STR profile of this entry.
CC   Misspelling: MDA-MB-43; Note=Occasionally.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): CCRID; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13 (PubMed=25877200)
ST   D18S51: 13,17 (CCRID; DOI=10.4172/2157-7145.S2-005; PubMed=19372543)
ST   D19S433: 14 (CCRID; DOI=10.4172/2157-7145.S2-005; PubMed=25877200)
ST   D19S433: 14,15 (PubMed=19372543)
ST   D21S11: 29,31.2 (PubMed=28889351)
ST   D21S11: 30 (CCRID; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12 (CCRID; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=28889351)
ST   D5S818: 12 (PubMed=25877200)
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 45
//
ID   MDA-MB-435-BAG
AC   CVCL_R957
SY   MDA-MB-435 BAG
DR   cancercelllines; CVCL_R957
DR   Wikidata; Q54904633
RX   PubMed=1384607;
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 24
//
ID   MDA-MB-435-LCC15
AC   CVCL_B055
AS   CVCL_1U14
SY   LLC-15MB; LCC15-MB
DR   BioSample; SAMN03151830
DR   cancercelllines; CVCL_B055
DR   Wikidata; Q54904634
RX   PubMed=9637769;
RX   PubMed=10432004;
RX   PubMed=15679051;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388). Was first thought to originate from the femoral metastasis of a breast carcinoma but was later shown to be contaminated by MDA-MB-435 (PubMed=15679051).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00231.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   MDA-MB-435-Luc#1
AC   CVCL_4Y10
DR   cancercelllines; CVCL_4Y10
DR   JCRB; NIHS0719
DR   Wikidata; Q54904635
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0719; true.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 21
//
ID   MDA-MB-435E
AC   CVCL_F0XN
RX   PubMed=10545506;
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1748; CDH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MDA-MB-435HGF
AC   CVCL_6684
SY   MDA-MB-435-HGF; MDA-MB-435 HGF; MDAMB-435-HGF; MDA-MB-HGF; HGF1
DR   BTO; BTO_0004164
DR   cancercelllines; CVCL_6684
DR   Wikidata; Q54904636
RX   PubMed=9467938;
RX   PubMed=12354931;
CC   Problematic cell line: Contaminated. Ancestral cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6LJ ! MDA-MB-435S/1
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   MDA-MB-435S
AC   CVCL_0622
SY   MDA-MB-435s; MDA-MB-435 S; MDA-MB-435-S; MDAMB435S; BrCL15
DR   BTO; BTO_0003941
DR   CLO; CLO_0007638
DR   CLDB; cl7142
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-129
DR   BCRJ; 0165
DR   BioGRID_ORCS_Cell_line; 567
DR   BioSample; SAMN10987989
DR   cancercelllines; CVCL_0622
DR   CCRID; 1101HUM-PUMC000015
DR   CCRID; 3101HUMTCHu36
DR   CCTCC; GDC0053
DR   Cell_Model_Passport; SIDM01222
DR   ChEMBL-Cells; CHEMBL4483174
DR   ChEMBL-Targets; CHEMBL4483284
DR   CLS; 300277
DR   Cosmic; 809237
DR   Cosmic; 871155
DR   Cosmic; 894089
DR   Cosmic; 904381
DR   Cosmic; 1044202
DR   Cosmic; 1046951
DR   Cosmic; 1287922
DR   Cosmic; 1289399
DR   Cosmic; 1523969
DR   Cosmic; 1609477
DR   Cosmic; 2301531
DR   DepMap; ACH-000884
DR   GEO; GSM149983
DR   GEO; GSM149991
DR   GEO; GSM149999
DR   GEO; GSM421877
DR   GEO; GSM887298
DR   GEO; GSM888373
DR   GEO; GSM1374657
DR   ICLC; HTL03006
DR   KCB; KCB 200773YJ
DR   LiGeA; CCLE_408
DR   LINCS_HMS; 50030
DR   LINCS_LDP; LCL-1307
DR   PRIDE; PXD016837
DR   Progenetix; CVCL_0622
DR   PubChem_Cell_line; CVCL_0622
DR   Wikidata; Q54904637
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2007622;
RX   PubMed=10700188;
RX   PubMed=12354931;
RX   PubMed=12661003;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=26589293;
RX   PubMed=28940260;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-derivative
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-vs-mda-mb-435
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00565.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,24:02; B*15:01,15:01; C*03:03,03:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-000884).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Leu827Pro (c.2480T>C); Zygosity=Hemizygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Glu1013Gly (c.3038A>G); ClinVar=VCV000562024; Zygosity=Hemizygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=16541312; DepMap=ACH-000884).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.01%; Native American=0%; East Asian, North=2.13%; East Asian, South=0%; South Asian=0%; European, North=65.23%; European, South=32.63% (PubMed=30894373).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ATCC=HTB-129; CCRID; CLS=300277; PubMed=28940260
ST   Amelogenin: X
ST   CSF1PO: 11 (ATCC=HTB-129; CCRID; CLS=300277)
ST   CSF1PO: 11,12 (PubMed=28940260)
ST   D12S391: 18,19
ST   D13S317: 12 (ATCC=HTB-129; CCRID; PubMed=28940260)
ST   D13S317: 12,13 (CLS=300277)
ST   D16S539: 13
ST   D18S51: 13 (ATCC=HTB-129; PubMed=28940260)
ST   D18S51: 13,17 (CLS=300277)
ST   D19S433: 14 (CCRID)
ST   D19S433: 14,15 (ATCC=HTB-129; CLS=300277; PubMed=28940260)
ST   D1S1656: 12
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14 (ATCC=HTB-129; CLS=300277; PubMed=28940260)
ST   D3S1358: 14,20 (CCRID)
ST   D5S818: 11,12 (CCRID)
ST   D5S818: 12 (ATCC=HTB-129; CLS=300277; PubMed=28940260)
ST   D6S1043: 11
ST   D7S820: 8 (PubMed=28940260)
ST   D7S820: 8,10 (ATCC=HTB-129; CCRID; CLS=300277)
ST   D8S1179: 13 (ATCC=HTB-129; CCRID; CLS=300277)
ST   D8S1179: 13,14 (PubMed=28940260)
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   MDA-MB-435S/1
AC   CVCL_A6LJ
SY   MDA MB 435 S1; MDA MB 435, subline S1
DR   cancercelllines; CVCL_A6LJ
DR   Wikidata; Q107116178
RX   PubMed=2007622;
RX   PubMed=9467938;
CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0622 ! MDA-MB-435S
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDA-MB-435s-mKate2
AC   CVCL_5T70
DR   cancercelllines; CVCL_5T70
DR   Wikidata; Q54904638
RX   PubMed=25902968;
CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0622 ! MDA-MB-435S
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 20
//
ID   MDA-MB-436
AC   CVCL_0623
SY   MDA_MB_436; MDA MB 436; MDA-Mb-436; MDA-MB436; MDAMB436; MDA-436; MDA436; MB436; MD Anderson-Metastatic Breast-436
DR   BTO; BTO_0001568
DR   CLO; CLO_0007639
DR   EFO; EFO_0001214
DR   CLDB; cl7218
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-130
DR   BioGRID_ORCS_Cell_line; 553
DR   BioSample; SAMN03471588
DR   BioSample; SAMN03472712
DR   BioSample; SAMN10987901
DR   cancercelllines; CVCL_0623
DR   CCRID; 1101HUM-PUMC000352
DR   CCRID; 3101HUMTCHu184
DR   Cell_Model_Passport; SIDM00629
DR   ChEMBL-Cells; CHEMBL4295382
DR   ChEMBL-Targets; CHEMBL4296465
DR   CLS; 300278
DR   Cosmic; 809240
DR   Cosmic; 871156
DR   Cosmic; 897425
DR   Cosmic; 904382
DR   Cosmic; 934528
DR   Cosmic; 949191
DR   Cosmic; 979718
DR   Cosmic; 1010926
DR   Cosmic; 1017165
DR   Cosmic; 1027055
DR   Cosmic; 1044206
DR   Cosmic; 1044222
DR   Cosmic; 1046957
DR   Cosmic; 1071902
DR   Cosmic; 1176604
DR   Cosmic; 1287923
DR   Cosmic; 1289400
DR   Cosmic; 1309008
DR   Cosmic; 1434955
DR   Cosmic; 1609474
DR   Cosmic; 2009513
DR   Cosmic; 2164998
DR   Cosmic; 2361353
DR   Cosmic-CLP; 1240172
DR   DepMap; ACH-000573
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240172
DR   GEO; GSM115100
DR   GEO; GSM149985
DR   GEO; GSM149993
DR   GEO; GSM150001
DR   GEO; GSM217589
DR   GEO; GSM344354
DR   GEO; GSM344404
DR   GEO; GSM350541
DR   GEO; GSM421878
DR   GEO; GSM783954
DR   GEO; GSM844600
DR   GEO; GSM844601
DR   GEO; GSM845397
DR   GEO; GSM847416
DR   GEO; GSM847496
DR   GEO; GSM887299
DR   GEO; GSM888374
DR   GEO; GSM1008909
DR   GEO; GSM1053725
DR   GEO; GSM1172982
DR   GEO; GSM1214583
DR   GEO; GSM1238135
DR   GEO; GSM1374658
DR   GEO; GSM1374659
DR   GEO; GSM1401656
DR   GEO; GSM1670085
DR   GEO; GSM2258866
DR   GEO; GSM2258867
DR   GEO; GSM2258868
DR   GEO; GSM2258869
DR   GEO; GSM2258870
DR   GEO; GSM2258871
DR   GEO; GSM2258872
DR   GEO; GSM2258873
DR   GEO; GSM2258874
DR   GEO; GSM2258875
DR   GEO; GSM2258876
DR   GEO; GSM2258877
DR   GEO; GSM2258878
DR   GEO; GSM2258879
DR   GEO; GSM2258880
DR   GEO; GSM2258881
DR   GEO; GSM2258882
DR   GEO; GSM2258883
DR   GEO; GSM2258938
DR   GEO; GSM2258939
DR   GEO; GSM2258940
DR   GEO; GSM3161722
DR   GEO; GSM3161723
DR   IARC_TP53; 18371
DR   IARC_TP53; 26994
DR   ICLC; HTL11005
DR   IZSLER; BS TCL 246
DR   LiGeA; CCLE_254
DR   LINCS_HMS; 50333
DR   LINCS_LDP; LCL-1470
DR   PharmacoDB; MDAMB436_905_2019
DR   PRIDE; PXD005292
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0623
DR   PubChem_Cell_line; CVCL_0623
DR   SLKBase; 3609
DR   TOKU-E; 2399
DR   Wikidata; Q54904639
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=730202;
RX   PubMed=1961733;
RX   PubMed=3518877;
RX   PubMed=7272986;
RX   PubMed=9288768;
RX   PubMed=9823299;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11343771;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=21778573;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 89.31 hours (JWGray panel).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01; DQA1*02:01,05:02; DQB1*04:01,04:01; DRB1*03:01,11:30 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:3701; FHIT; Zygosity=Homozygous (PubMed=9288768).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.5277+1G>A; ClinVar=VCV000037654; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=16397213; PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly203fs*9 (c.607_608ins227); Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204fs*7 (c.610_612delinsGCGTGTGG); Zygosity=Unspecified (PubMed=16541312; PubMed=28889351).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.41%; Native American=0%; East Asian, North=2.21%; East Asian, South=0%; South Asian=0%; European, North=63.9%; European, South=32.49% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-130; CCRID; CLS=300278; Cosmic-CLP=1240172; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,14
ST   D12S391: 20
ST   D13S317: 10
ST   D16S539: 9 (CLS=300278; Cosmic-CLP=1240172; PubMed=25877200)
ST   D16S539: 9,11 (ATCC=HTB-130; CCRID; PubMed=28889351; Technion Genomics Center)
ST   D18S51: 12
ST   D19S433: 13
ST   D1S1656: 17.3,19.3
ST   D21S11: 30,31.2
ST   D22S1045: 17
ST   D2S1338: 23
ST   D2S441: 10
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 21,24 (CCRID)
ST   FGA: 24 (ATCC=HTB-130; CLS=300278; PubMed=25877200; Technion Genomics Center)
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,20
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   MDA-MB-436/GFP
AC   CVCL_JY98
DR   cancercelllines; CVCL_JY98
DR   Cell_Biolabs; AKR-203
DR   Wikidata; Q54904640
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.5277+1G>A; ClinVar=VCV000037654; Zygosity=Hemizygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly203fs*9 (c.607_608ins227); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204fs*7 (c.610_612delinsGCGTGTGG); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Cell_Biolabs; AKR-203; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0623 ! MDA-MB-436
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   MDA-MB-436/RFP
AC   CVCL_JY99
DR   cancercelllines; CVCL_JY99
DR   Cell_Biolabs; AKR-252
DR   Wikidata; Q54904641
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.5277+1G>A; ClinVar=VCV000037654; Zygosity=Hemizygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly203fs*9 (c.607_608ins227); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204fs*7 (c.610_612delinsGCGTGTGG); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Cell_Biolabs; AKR-252; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0623 ! MDA-MB-436
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 15
//
ID   MDA-MB-453
AC   CVCL_0418
SY   MDA-MB 453; MDA MB 453; MDA-MB453; MDAMB453; MDA-453; MDA453; MD Anderson-Metastatic Breast-453
DR   BTO; BTO_0001908
DR   CLO; CLO_0007640
DR   CLO; CLO_0050867
DR   EFO; EFO_0001215
DR   MCCL; MCC:0000315
DR   CLDB; cl3411
DR   CLDB; cl7187
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-131
DR   BCRC; 60429
DR   BioGRID_ORCS_Cell_line; 552
DR   BioSample; SAMN01821576
DR   BioSample; SAMN01821647
DR   BioSample; SAMN03472899
DR   BioSample; SAMN10988263
DR   cancercelllines; CVCL_0418
DR   CCRID; 1101HUM-PUMC000016
DR   CCRID; 3101HUMSCSP5044
DR   CCRID; 3101HUMTCHu233
DR   Cell_Model_Passport; SIDM00272
DR   ChEMBL-Cells; CHEMBL3307596
DR   ChEMBL-Targets; CHEMBL614334
DR   CLS; 305042
DR   Cosmic; 687497
DR   Cosmic; 871157
DR   Cosmic; 897426
DR   Cosmic; 904383
DR   Cosmic; 908122
DR   Cosmic; 923060
DR   Cosmic; 934529
DR   Cosmic; 979712
DR   Cosmic; 991326
DR   Cosmic; 997920
DR   Cosmic; 1010927
DR   Cosmic; 1018468
DR   Cosmic; 1027056
DR   Cosmic; 1044223
DR   Cosmic; 1046931
DR   Cosmic; 1047694
DR   Cosmic; 1129656
DR   Cosmic; 1136356
DR   Cosmic; 1152522
DR   Cosmic; 1176651
DR   Cosmic; 1287911
DR   Cosmic; 1289401
DR   Cosmic; 1308995
DR   Cosmic; 1434956
DR   Cosmic; 1524345
DR   Cosmic; 1601924
DR   Cosmic; 1603222
DR   Cosmic; 1609457
DR   Cosmic; 2165012
DR   Cosmic; 2301532
DR   Cosmic; 2318375
DR   Cosmic; 2564832
DR   Cosmic; 2820307
DR   Cosmic-CLP; 908122
DR   DepMap; ACH-000910
DR   DSMZ; ACC-65
DR   DSMZCellDive; ACC-65
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10419-106C5
DR   GDSC; 908122
DR   GEO; GSM813
DR   GEO; GSM115117
DR   GEO; GSM217590
DR   GEO; GSM219956
DR   GEO; GSM274656
DR   GEO; GSM344355
DR   GEO; GSM344405
DR   GEO; GSM350530
DR   GEO; GSM421879
DR   GEO; GSM481307
DR   GEO; GSM783928
DR   GEO; GSM844602
DR   GEO; GSM847417
DR   GEO; GSM887300
DR   GEO; GSM888375
DR   GEO; GSM1008910
DR   GEO; GSM1053710
DR   GEO; GSM1172983
DR   GEO; GSM1264071
DR   GEO; GSM1264075
DR   GEO; GSM1264113
DR   GEO; GSM1264117
DR   GEO; GSM1374660
DR   GEO; GSM1374661
DR   GEO; GSM1374662
DR   GEO; GSM1384316
DR   GEO; GSM1401667
DR   GEO; GSM1421431
DR   GEO; GSM1661983
DR   GEO; GSM1664568
DR   GEO; GSM1670086
DR   IARC_TP53; 762
DR   IARC_TP53; 21146
DR   IARC_TP53; 26995
DR   ICLC; HTL01013
DR   IGRhCellID; MDAMB453
DR   IZSLER; BS TCL 247
DR   KCLB; 30131
DR   LiGeA; CCLE_768
DR   LINCS_HMS; 50334
DR   LINCS_LDP; LCL-1485
DR   Lonza; 837
DR   NCBI_Iran; C214
DR   PharmacoDB; MDAMB453_906_2019
DR   PRIDE; PXD000309
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0418
DR   PubChem_Cell_line; CVCL_0418
DR   RCB; RCB1192
DR   SLKBase; 3613
DR   Wikidata; Q54904642
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=730202;
RX   PubMed=1961733;
RX   PubMed=3518877;
RX   PubMed=9671407;
RX   PubMed=9815641;
RX   PubMed=10969801;
RX   PubMed=11687795;
RX   PubMed=11789735;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=16142302;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21378333;
RX   PubMed=22121396;
RX   PubMed=22414580;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22719059;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25984343;
RX   PubMed=26218769;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28889351;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-htb-131
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/MDA-MB-453.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-56.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MDA-MB-453
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/mda-mb-453-xenograft-model/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Population: Caucasian.
CC   Doubling time: 38 hours (PubMed=25984343); 68.8 hours (PubMed=9815641); ~50-60 hours (DSMZ=ACC-65); 62.49 hours (JWGray panel).
CC   HLA typing: A*01:01,24:02; B*37:04,58:05; C*07:01,07:01; DQB1*06:13,06:13 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Gln868His (c.2604G>T); Zygosity=Unspecified (PubMed=22719059).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Trp638Ter (c.1913G>A); ClinVar=VCV000599651; Zygosity=Homozygous (PubMed=19593635; Cosmic-CLP=908122; DepMap=ACH-000910).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=22121396).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=19593635; PubMed=28889351; ATCC=HTB-131; Cosmic-CLP=908122; DepMap=ACH-000910).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu307Lys (c.919G>A); Zygosity=Heterozygous (PubMed=19593635; Cosmic-CLP=908122; DepMap=ACH-000910).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex10-11del; Zygosity=Homozygous (PubMed=1961733).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.43%; East Asian, South=0%; South Asian=0.43%; European, North=63.01%; European, South=34.13% (PubMed=30894373).
CC   Misspelling: MDA-MB-345; Cosmic=1129656.
CC   Discontinued: CLS; 305042; true.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
ST   Source(s): ATCC=HTB-131; CCRID; Cosmic-CLP=908122; DSMZ=ACC-65; KCLB=30131; PubMed=25877200; PubMed=28889351; RCB=RCB1192; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14,15
ST   D12S391: 18,21
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 15,20
ST   D19S433: 13,14
ST   D1S1656: 16.3,17.3
ST   D21S11: 29,31
ST   D22S1045: 15,16
ST   D2S1338: 23,24
ST   D2S441: 10
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,12
ST   FGA: 18,23
ST   Penta D: 9,10
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   MDA-MB-453 Ad15
AC   CVCL_ZZ23
DR   cancercelllines; CVCL_ZZ23
DR   Wikidata; Q102114522
RX   PubMed=9815641;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Doubling time: 120.5 hours (PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Gln868His (c.2604G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Trp638Ter (c.1913G>A); ClinVar=VCV000599651; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu307Lys (c.919G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex10-11del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0418 ! MDA-MB-453
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   MDA-MB-461
AC   CVCL_M391
SY   MD Anderson-Metastatic Breast-461
DR   Cosmic; 1129657
DR   Wikidata; Q54904643
RX   PubMed=730202;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MDA-MB-468
AC   CVCL_0419
SY   MDA-MB 468; MDA-MB468; MDAMB468; MDA-468; MDA468; MB468; MD Anderson-Metastatic Breast-468
DR   BTO; BTO_0001570
DR   CLO; CLO_0007641
DR   EFO; EFO_0001216
DR   MCCL; MCC:0000316
DR   CLDB; cl4973
DR   AddexBio; C0006003/4673
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-6647
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-132
DR   BCRJ; 0166
DR   BioGRID_ORCS_Cell_line; 551
DR   BioSample; SAMN03473056
DR   BioSample; SAMN05292454
DR   BioSample; SAMN10988340
DR   cancercelllines; CVCL_0419
DR   CCRID; 1101HUM-PUMC000249
DR   CCRID; 3101HUMTCHu136
DR   Cell_Model_Passport; SIDM00628
DR   ChEMBL-Cells; CHEMBL3308424
DR   ChEMBL-Targets; CHEMBL614335
DR   CLS; 300279
DR   Cosmic; 809241
DR   Cosmic; 850823
DR   Cosmic; 871149
DR   Cosmic; 877448
DR   Cosmic; 897427
DR   Cosmic; 904384
DR   Cosmic; 908123
DR   Cosmic; 923061
DR   Cosmic; 934530
DR   Cosmic; 949192
DR   Cosmic; 991327
DR   Cosmic; 997921
DR   Cosmic; 1000125
DR   Cosmic; 1010920
DR   Cosmic; 1017167
DR   Cosmic; 1018467
DR   Cosmic; 1044224
DR   Cosmic; 1046929
DR   Cosmic; 1047691
DR   Cosmic; 1136363
DR   Cosmic; 1152526
DR   Cosmic; 1176635
DR   Cosmic; 1287918
DR   Cosmic; 1289402
DR   Cosmic; 1305384
DR   Cosmic; 1309004
DR   Cosmic; 1477427
DR   Cosmic; 1523775
DR   Cosmic; 1524344
DR   Cosmic; 1571795
DR   Cosmic; 1603223
DR   Cosmic; 1609465
DR   Cosmic; 1998490
DR   Cosmic; 2009514
DR   Cosmic; 2036673
DR   Cosmic; 2164999
DR   Cosmic; 2301533
DR   Cosmic; 2318380
DR   Cosmic; 2361357
DR   Cosmic; 2668276
DR   Cosmic-CLP; 908123
DR   DepMap; ACH-000849
DR   DSMZ; ACC-738
DR   DSMZCellDive; ACC-738
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908123
DR   GEO; GSE184543
DR   GEO; GSM75169
DR   GEO; GSM185095
DR   GEO; GSM185096
DR   GEO; GSM217591
DR   GEO; GSM219929
DR   GEO; GSM344356
DR   GEO; GSM344406
DR   GEO; GSM350502
DR   GEO; GSM388214
DR   GEO; GSM421880
DR   GEO; GSM459714
DR   GEO; GSM459722
DR   GEO; GSM466357
DR   GEO; GSM783955
DR   GEO; GSM847418
DR   GEO; GSM847497
DR   GEO; GSM887301
DR   GEO; GSM888376
DR   GEO; GSM1008911
DR   GEO; GSM1053727
DR   GEO; GSM1172984
DR   GEO; GSM1214565
DR   GEO; GSM1238123
DR   GEO; GSM1374663
DR   GEO; GSM1374664
DR   GEO; GSM1374665
DR   GEO; GSM1401650
DR   GEO; GSM1556177
DR   GEO; GSM1556178
DR   GEO; GSM1556179
DR   GEO; GSM1556180
DR   GEO; GSM1556181
DR   GEO; GSM1661984
DR   GEO; GSM1670087
DR   GEO; GSM1833629
DR   GEO; GSM2124671
DR   GEO; GSM2258884
DR   GEO; GSM2258885
DR   GEO; GSM2258886
DR   GEO; GSM2258887
DR   GEO; GSM2258888
DR   GEO; GSM2258889
DR   GEO; GSM2258890
DR   GEO; GSM2258891
DR   GEO; GSM2258892
DR   GEO; GSM2258893
DR   GEO; GSM2258894
DR   GEO; GSM2258895
DR   GEO; GSM2258896
DR   GEO; GSM2258897
DR   GEO; GSM2258898
DR   GEO; GSM2258899
DR   GEO; GSM2258900
DR   GEO; GSM2258901
DR   GEO; GSM2258941
DR   GEO; GSM2258942
DR   GEO; GSM2258943
DR   IARC_TP53; 94
DR   IBRC; C10095
DR   ICLC; HTL99024
DR   KCB; KCB 2011114YJ
DR   LiGeA; CCLE_336
DR   LINCS_HMS; 50335
DR   LINCS_LDP; LCL-1471
DR   Lonza; 809
DR   NCBI_Iran; C208
DR   NCI-DTP; MDA-MB-468
DR   PharmacoDB; MDAMB468_907_2019
DR   PRIDE; PXD001680
DR   PRIDE; PXD005295
DR   PRIDE; PXD008222
DR   PRIDE; PXD022325
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0419
DR   PubChem_Cell_line; CVCL_0419
DR   SLKBase; 3578
DR   TOKU-E; 2401
DR   TOKU-E; 3604
DR   Ubigene; YC-D009
DR   Wikidata; Q16880225
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=730202;
RX   PubMed=1961733;
RX   PubMed=3518877;
RX   PubMed=9671407;
RX   PubMed=10969801;
RX   PubMed=11414198;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=15153330;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18262045;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=21778573;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=23856246;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24279929;
RX   PubMed=25485619;
RX   PubMed=25699542;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30613774;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32576280;
RX   PubMed=34703030;
RX   PubMed=35839778;
RX   PubMed=38861359;
RX   PubMed=40300663;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/htb-132-normal-growth-and-morphology
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/mda-mb-468.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544498
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-53.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MDA-MB-468
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/mda-mb-468-xenograft-model/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: African American.
CC   Doubling time: 40.6 hours (PubMed=32576280); ~30-40 hours (DSMZ=ACC-738); 62 hours (NCI-DTP=MDA-MB-468); ~47 hours (PBCF); 79.76 hours (JWGray panel).
CC   HLA typing: A*23:01,30:02; B*27:03,53:01; C*02:02,04:01 (PubMed=25960936).
CC   HLA typing: A*23:01,30:02; B*27:03,53:01; C*02:02,04:01; DQA1*02:01,05:02; DQB1*03:04,06:13; DRB1*04:03,13:100 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=15677628; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=1961733; PubMed=16541312; PubMed=28889351; ATCC=HTB-132).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=80.3%; Native American=0%; East Asian, North=6.19%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=13.51% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006003/4673; ATCC=HTB-132; CCRID; Cosmic-CLP=908123; DSMZ=ACC-738; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13
ST   D12S391: 18
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 12,13
ST   D1S1656: 11,14
ST   D21S11: 27 (CCRID)
ST   D21S11: 27,28 (ATCC=HTB-132; DSMZ=ACC-738; PubMed=25877200; PubMed=28889351; Technion Genomics Center)
ST   D22S1045: 10
ST   D2S1338: 17,25
ST   D2S441: 12,14
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 8,10
ST   Penta E: 5
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 52
//
ID   MDA-MB-468 shPARG
AC   CVCL_RA91
SY   shPARG MDA-MB-468
DR   cancercelllines; CVCL_RA91
DR   Wikidata; Q54904644
RX   PubMed=29166620;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   MDA-MB-468 shWDR12-4
AC   CVCL_YJ27
DR   cancercelllines; CVCL_YJ27
DR   Wikidata; Q95987445
RX   CelloPub=CLPUB00550;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Doubling time: 24-31 hours (CelloPub=CLPUB00550).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:14098; WDR12.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Corrections of STR profile from thesis manuscript (CelloPub=CLPUB00550) from personal communication of Al-awar, Rima.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00550; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 27,28
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 12
//
ID   MDA-MB-468-Luc
AC   CVCL_C8XW
DR   Ubigene; YC-D009-Luc-P
DR   Wikidata; Q123033028
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MDA-MB-468/Cas9-hyg
AC   CVCL_C9CF
DR   GeneCopoeia; SL516
DR   Wikidata; Q123033030
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL516).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   MDA-MB-468/GFP
AC   CVCL_JZ00
DR   cancercelllines; CVCL_JZ00
DR   Cell_Biolabs; AKR-204
DR   Wikidata; Q54904645
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Cell_Biolabs; AKR-204; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 17
//
ID   MDA-MB-468(Cas9)
AC   CVCL_E7JB
WW   Provider; BRICS; ECC3036; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3970
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDA-MB-468GFP
AC   CVCL_DH83
SY   468GFP
DR   cancercelllines; CVCL_DH83
DR   GEO; GSM390975
DR   GEO; GSM390978
DR   Progenetix; CVCL_DH83
DR   Wikidata; Q54904646
RX   PubMed=16170671;
RX   PubMed=20084286;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 18
//
ID   MDA-MB-468LN
AC   CVCL_M372
SY   MDA-MB-468GFP-LN; 468GFP-LN; 468LN
DR   cancercelllines; CVCL_M372
DR   GEO; GSM390976
DR   GEO; GSM390977
DR   Progenetix; CVCL_M372
DR   Wikidata; Q54904647
RX   PubMed=16170671;
RX   PubMed=18262045;
RX   PubMed=20084286;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH83 ! MDA-MB-468GFP
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   MDA-MB-468rCDDP1000
AC   CVCL_D6VQ
SY   MDA-MB-468 rCDDP1000
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   MDA-MB-468rDOX50
AC   CVCL_D6VR
SY   MDA-MB-468 rDoxorubicin50
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   MDA-MB-468rERI50
AC   CVCL_D6VS
SY   MDA-MB-468 rEribulin100
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_63587; Eribulin (Halaven).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   MDA-MB-468rPCL20
AC   CVCL_D6VT
SY   MDA-MB-468 rPaclitaxel20
RX   PubMed=40300663;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0419 ! MDA-MB-468
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   MDA-MB-469
AC   CVCL_M392
SY   MD Anderson-Metastatic Breast-469
DR   Wikidata; Q54904648
RX   PubMed=730202;
RX   PubMed=3518877;
RX   PubMed=7272986;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   MDA-N
AC   CVCL_1910
SY   MDAN
DR   BioSample; SAMN03151833
DR   cancercelllines; CVCL_1910
DR   ChEMBL-Cells; CHEMBL3307532
DR   ChEMBL-Targets; CHEMBL614078
DR   Cosmic; 875880
DR   Cosmic; 1998491
DR   GEO; GSM2096
DR   GEO; GSM750823
DR   GEO; GSM799355
DR   GEO; GSM799418
DR   GEO; GSM1153425
DR   GEO; GSM1178406
DR   GEO; GSM1178407
DR   GEO; GSM1181357
DR   GEO; GSM1181358
DR   PRIDE; PXD003539
DR   Progenetix; CVCL_1910
DR   PubChem_Cell_line; CVCL_1910
DR   Wikidata; Q54904649
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12661003;
RX   PubMed=19372543;
RX   PubMed=20143388;
RX   PubMed=22347499;
RX   PubMed=24670534;
RX   PubMed=31733513;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/mda-mb-435.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=52
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative (PubMed=20143388).
CC   Part of: NCI-60 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00236.
CC   Population: Caucasian.
CC   Doubling time: 22.5 hours (NCI-DTP).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=9331090).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 38
//
ID   MDA-Panc-28
AC   CVCL_3917
SY   MDA Panc-28; MDAPanc-28; MDAPanc28
DR   BTO; BTO_0003303
DR   EFO; EFO_0022355
DR   cancercelllines; CVCL_3917
DR   Wikidata; Q54904650
RX   PubMed=8656025;
CC   Doubling time: ~48 hours (PubMed=8656025).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=8656025).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   MDA-Panc-3
AC   CVCL_3918
SY   MDA Panc-3; MDAPanc-3; MDAPanc3
DR   BTO; BTO_0003302
DR   cancercelllines; CVCL_3918
DR   Cosmic; 710860
DR   IARC_TP53; 16742
DR   Wikidata; Q54904651
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=1688394;
RX   PubMed=11169959;
RX   PubMed=11787853;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/MDA%20Panc-3.html
CC   Doubling time: ~50 hours (PubMed=1688394).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=11169959; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=11169959; PubMed=11787853).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   MDA-PATC43
AC   CVCL_VR70
DR   cancercelllines; CVCL_VR70
DR   Wikidata; Q95987458
RX   PubMed=25336691;
RX   PubMed=25485535;
CC   Characteristics: Established from a xenograft established in NOD/SCID mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=25485535).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=25485535).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   MDA-PATC50
AC   CVCL_VR71
DR   ATCC; CRL-3430
DR   cancercelllines; CVCL_VR71
DR   Wikidata; Q95987459
RX   PubMed=25336691;
RX   PubMed=25485535;
CC   Characteristics: Established from a xenograft established in NOD/SCID mice.
CC   Doubling time: 99 hours (ATCC=CRL-3430; PubMed=25485535).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=25485535).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=25485535).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-3430
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   MDA-PATC53
AC   CVCL_VR69
DR   ATCC; CRL-3431
DR   cancercelllines; CVCL_VR69
DR   Wikidata; Q95987461
RX   PubMed=25336691;
RX   PubMed=25485535;
CC   Characteristics: Established from a xenograft established in NOD/SCID mice.
CC   Doubling time: 51 hours (ATCC=CRL-3431; PubMed=25485535).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=25485535).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-3431
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   MDA-PATC66
AC   CVCL_VR72
DR   ATCC; CRL-3432
DR   cancercelllines; CVCL_VR72
DR   Wikidata; Q95987464
RX   PubMed=25336691;
RX   PubMed=25485535;
CC   Characteristics: Established from a xenograft established in NOD/SCID mice.
CC   Doubling time: 123 hours (ATCC=CRL-3432).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=25485535).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=25485535).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-3432
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   MDA-PCa-2a
AC   CVCL_4747
SY   MDA PCa 2a; MDAPC2A; MDA2A; M.D. Anderson-Prostate Cancer-2a
DR   ATCC; CRL-2421
DR   BioSample; SAMN03471839
DR   cancercelllines; CVCL_4747
DR   Cell_Model_Passport; SIDM01666
DR   GEO; GSM91925
DR   Progenetix; CVCL_4747
DR   Wikidata; Q54904652
RX   CelloPub=CLPUB00698;
RX   PubMed=9815652;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=15486987;
CC   Population: African American.
CC   Doubling time: 82 hours (Note=In BRFF-HPC1 + 20% FBS), 87-93 hours (Note=In F12K(+) + 20% FBS) (PubMed=9815652).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ATCC; CRL-2421; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-2421; PubMed=14518029
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 16,17
ST   D21S11: 31,32,33.2
ST   D3S1358: 14,17,18
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 19,22
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4748 ! MDA-PCa-2b
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MDA-PCa-2b
AC   CVCL_4748
SY   MDA PCa 2b; MDAPCa-2b; MDAPCa2b; MDAPCA2B; MDAPC2B; MDA2B; M.D. Anderson-Prostate Cancer-2b
DR   BTO; BTO_0005050
DR   CLO; CLO_0007629
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2422
DR   BioSample; SAMN03471841
DR   BioSample; SAMN10988222
DR   cancercelllines; CVCL_4748
DR   Cell_Model_Passport; SIDM01664
DR   Cosmic; 1689712
DR   Cosmic; 2651771
DR   Cosmic; 2669171
DR   DepMap; ACH-000952
DR   GEO; GSM91928
DR   GEO; GSM648821
DR   GEO; GSM887302
DR   GEO; GSM888377
DR   IARC_TP53; 30117
DR   LiGeA; CCLE_281
DR   PharmacoDB; MDAPCa2b_896_2019
DR   Progenetix; CVCL_4748
DR   Wikidata; Q54904655
RX   CelloPub=CLPUB00698;
RX   PubMed=9815652;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=15486987;
RX   PubMed=22460905;
RX   PubMed=23671654;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: African American.
CC   Doubling time: 42-53 hours (Note=In BRFF-HPC1 + 20% FBS), 61-73 hours (Note=In F12K(+) + 20% FBS) (PubMed=9815652); 89.15 hours (JWGray panel).
CC   Microsatellite instability: Instable (MSI) (PubMed=23671654; PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=90.02%; Native American=0%; East Asian, North=2.64%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=7.34% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-2422; PubMed=14518029
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 16,17
ST   D19S433: 13.2,14.2,16
ST   D21S11: 33.2
ST   D2S1338: 22,24
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 20,21,22 (ATCC=CRL-2422)
ST   FGA: 20,22 (PubMed=14518029)
ST   Penta D: 11,13
ST   Penta E: 8,14
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4747 ! MDA-PCa-2a
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   MDA-PCa-2b-hr
AC   CVCL_4867
SY   MDA PCa 2b-hr
DR   Wikidata; Q54904656
RX   PubMed=14500404;
CC   Population: African American.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4748 ! MDA-PCa-2b
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   MDA-SDC-04
AC   CVCL_JX31
SY   MDA-SDC-04 (h-TERT)
DR   Wikidata; Q54904657
RX   PubMed=28559013;
CC   Doubling time: 62 +- 3 hours (PubMed=28559013).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Salivary gland, duct; UBERON=UBERON_0001837.
ST   Source(s): PubMed=28559013
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D16S539: 12
ST   D18S51: 18,19
ST   FGA: 21,22
ST   TH01: 8
ST   TPOX: 9,10
ST   vWA: 16
DI   NCIt; C5904; Salivary duct carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Telomerase immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   MDA-STn a
AC   CVCL_E3IV
RX   PubMed=12820722;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23614; ST6GALNAC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   MDA-STn b
AC   CVCL_E3IW
RX   PubMed=12820722;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23614; ST6GALNAC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   MDA-T120
AC   CVCL_QW85
DR   ATCC; CRL-3355
DR   cancercelllines; CVCL_QW85
DR   Cosmic; 2612757
DR   Wikidata; Q54904658
RX   PubMed=25427145;
RX   PubMed=30737244;
CC   Doubling time: ~48-72 hours (ATCC=CRL-3355).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Glu182Ter (c.544G>T); ClinVar=VCV000003289; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (PubMed=25427145; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): ATCC=CRL-3355; PubMed=25427145; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 17
//
ID   MDA-T187
AC   CVCL_A1CS
DR   cancercelllines; CVCL_A1CS
DR   Wikidata; Q102114523
RX   PubMed=34147031;
CC   Doubling time: 32.6 hours (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>C); ClinVar=VCV000376624; Zygosity=Homozygous (PubMed=34147031).
CC   Miscellaneous: Age of donor from personal communication of Henderson, Ying C.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=34147031
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 14
ST   D7S820: 12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   MDA-T22
AC   CVCL_QW80
DR   cancercelllines; CVCL_QW80
DR   Cosmic; 2612752
DR   Wikidata; Q54904659
RX   PubMed=25427145;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25427145).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=25427145).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25427145
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D7S820: 9,13
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   MDA-T248
AC   CVCL_A1CT
DR   cancercelllines; CVCL_A1CT
DR   Wikidata; Q102114524
RX   PubMed=34147031;
CC   Doubling time: 25.6 hours (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp74Asn (c.220G>A); ClinVar=VCV000483340; Zygosity=Homozygous (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.994-1G>C; ClinVar=VCV000232659; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=34147031).
CC   Miscellaneous: Age of donor from personal communication of Henderson, Ying C.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=34147031
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 9,11
ST   D7S820: 11
ST   TH01: 6,8
ST   TPOX: 9,10
ST   vWA: 14,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   MDA-T269
AC   CVCL_A1CU
DR   cancercelllines; CVCL_A1CU
DR   Wikidata; Q102114526
RX   PubMed=34147031;
CC   Doubling time: 97.4 hours (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Heterozygous (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=34147031).
CC   Miscellaneous: Age of donor from personal communication of Henderson, Ying C.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=34147031
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   MDA-T273
AC   CVCL_A1CV
DR   cancercelllines; CVCL_A1CV
DR   Wikidata; Q102114528
RX   PubMed=34147031;
CC   Doubling time: 33.9 hours (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Homozygous (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=34147031).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=34147031).
CC   Miscellaneous: Age of donor from personal communication of Henderson, Ying C.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=34147031
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   MDA-T32
AC   CVCL_W913
DR   ATCC; CRL-3351
DR   cancercelllines; CVCL_W913
DR   Cosmic; 2054087
DR   Cosmic; 2612753
DR   Wikidata; Q54904660
RX   PubMed=23833040;
RX   PubMed=25427145;
RX   PubMed=30737244;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Val (c.857A>T); ClinVar=VCV000376592; Zygosity=Heterozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): ATCC=CRL-3351; PubMed=25427145; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 20
//
ID   MDA-T41
AC   CVCL_W914
DR   ATCC; CRL-3352
DR   cancercelllines; CVCL_W914
DR   Cosmic; 2054114
DR   Cosmic; 2612755
DR   Wikidata; Q54904661
RX   PubMed=23833040;
RX   PubMed=25427145;
RX   PubMed=30737244;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ile831Phe (c.2491A>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe19fs (c.56_65delTTTCAGACCT); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Heterozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3352; PubMed=25427145; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 19
//
ID   MDA-T68
AC   CVCL_QW83
DR   ATCC; CRL-3353
DR   cancercelllines; CVCL_QW83
DR   Cosmic; 2612756
DR   Wikidata; Q54904662
RX   PubMed=25427145;
CC   Population: Caucasian.
CC   Doubling time: ~45 hours (ATCC=CRL-3353).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=25427145).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): ATCC=CRL-3353; PubMed=25427145
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   MDA-T85
AC   CVCL_QW84
DR   ATCC; CRL-3354
DR   cancercelllines; CVCL_QW84
DR   Cosmic; 2612754
DR   Wikidata; Q54904663
RX   PubMed=25427145;
RX   PubMed=30737244;
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Heterozygous (PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3354; PubMed=25427145; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,10
ST   D16S539: 10
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 18
//
ID   MDA231-BrM2-831
AC   CVCL_VR36
SY   MDA 231 BrM2 831; MDA-MB-231-BrM2 831; MDA231-BrM2
DR   cancercelllines; CVCL_VR36
DR   GEO; GSM2194109
DR   GEO; GSM2194110
DR   GEO; GSM2194111
DR   Wikidata; Q95987479
RX   PubMed=19421193;
RX   PubMed=28283064;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Brain metastasis cell lines panel.
CC   Population: Caucasian.
CC   Characteristics: Established from MDA231-TGL cell line after 2 passage in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 14,16
ST   D12S391: 17
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11,16
ST   D19S433: 11,14
ST   D1S1656: 15,17
ST   D21S11: 33.2
ST   D22S1045: 16
ST   D2S1338: 20,21
ST   D2S441: 14,15
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 14
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR35 ! MDA231-TGL
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 17
//
ID   MDA231-DOX[r]
AC   CVCL_4V67
DR   cancercelllines; CVCL_4V67
DR   Wikidata; Q54904664
WW   Provider; ChemoScreen; 10050C; https://web.archive.org/web/20160331234857/http://www.chemoscreen.com/product/mda231-doxr-cells
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10050C.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 19
//
ID   MDA231-LeptoM
AC   CVCL_XB00
SY   MDA231 LeptoM; MDA-LeptoM
DR   cancercelllines; CVCL_XB00
DR   GEO; GSM2194114
DR   GEO; GSM2194115
DR   Wikidata; Q95987482
RX   PubMed=28283064;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Brain metastasis cell lines panel.
CC   Population: Caucasian.
CC   Characteristics: Brain leptomeningeal space metastatic derivative of parental cell line. Established after 3 passages in nude mice from intracisternal injection, followed by one passage from intracardiac injection and obtained from mice bearing leptomeningeal metastases.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR35 ! MDA231-TGL
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 15
//
ID   MDA231-LM2-4142
AC   CVCL_DG21
SY   MDA 231-LM2-4142; MDA-MB-231 #4142; LM2-4142; 4142
DR   cancercelllines; CVCL_DG21
DR   GEO; GSM50017
DR   GEO; GSM587389
DR   Wikidata; Q54904665
RX   PubMed=16049480;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Established from MDA231-TGL cell line after 3 passage in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR35 ! MDA231-TGL
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 20
//
ID   MDA231-LM2-4175
AC   CVCL_5998
SY   MDA231-LM2; MDA 231-LM2-4175; MDA-MB-231 #4175; LM2-4175; 4175
DR   cancercelllines; CVCL_5998
DR   ChEMBL-Cells; CHEMBL4879540
DR   GEO; GSM49956
DR   GEO; GSM587391
DR   Wikidata; Q54904666
RX   PubMed=16049480;
RX   PubMed=18425382;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Established from MDA231-TGL cell line after 3 passage in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Proteomics; 2DE.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 16
ST   D12S391: 17,18
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11,16
ST   D19S433: 11,14
ST   D1S1656: 15,17
ST   D21S11: 33.2
ST   D22S1045: 15,16,17
ST   D2S1338: 20,21
ST   D2S441: 14,15
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 14
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR35 ! MDA231-TGL
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   MDA231-TGL
AC   CVCL_VR35
SY   MDA-231-HSV1-TK/GFP/Fluc; MDA-231-TGL; MDA 231-TGL
DR   cancercelllines; CVCL_VR35
DR   GEO; GSM2194106
DR   GEO; GSM2194107
DR   GEO; GSM2194108
DR   Wikidata; Q95987484
RX   PubMed=16049480;
RX   PubMed=28283064;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Caution: In PubMed=28283064 and the associated GEO data sets MDA234-TGL is termed MDA234 Parental.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 14,16
ST   D12S391: 17
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11,16
ST   D19S433: 11
ST   D1S1656: 15,17
ST   D21S11: 33.2
ST   D22S1045: 16
ST   D2S1338: 20,21
ST   D2S441: 14,15
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 14
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 17
//
ID   MDA435/LCC6
AC   CVCL_IN99
SY   MDA-435/LCC6
DR   BTO; BTO_0005866
DR   cancercelllines; CVCL_IN99
DR   Wikidata; Q54904667
RX   PubMed=8546900;
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 16
//
ID   MDA435/LCC6MDR1
AC   CVCL_IP00
SY   MDA435/LCC6MDR
DR   BTO; BTO_0005867
DR   cancercelllines; CVCL_IP00
DR   Wikidata; Q54904668
RX   PubMed=8546900;
CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IN99 ! MDA435/LCC6
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 16
//
ID   MDAH 2774
AC   CVCL_0420
SY   MDAH-2774; MDAH2774; MDA-H2774; 2774; #2774; OV-2774; OV-CA-2774; SK-2774
DR   BTO; BTO_0003942
DR   MCCL; MCC:0000317
DR   AddexBio; C0017001/57
DR   ATCC; CRL-10303
DR   BCRJ; 0163
DR   cancercelllines; CVCL_0420
DR   ChEMBL-Cells; CHEMBL4483147
DR   ChEMBL-Targets; CHEMBL4483256
DR   Cosmic; 724881
DR   Cosmic; 844345
DR   Cosmic; 875291
DR   Cosmic; 897431
DR   Cosmic; 923109
DR   Cosmic; 1044237
DR   Cosmic; 1113282
DR   Cosmic; 1524360
DR   Cosmic; 1708386
DR   Cosmic; 1709262
DR   Cosmic; 2186588
DR   GEO; GSE27654
DR   GEO; GSM1291124
DR   IARC_TP53; 5550
DR   IARC_TP53; 21489
DR   Lonza; 1433
DR   PubChem_Cell_line; CVCL_0420
DR   Wikidata; Q54904669
RX   PubMed=719612;
RX   PubMed=6582512;
RX   PubMed=8557231;
RX   PubMed=9698466;
RX   PubMed=11314036;
RX   PubMed=11565033;
RX   PubMed=12068308;
RX   PubMed=15153938;
RX   PubMed=19288585;
RX   PubMed=22328975;
RX   PubMed=22705003;
RX   PubMed=22710073;
RX   PubMed=25230021;
RX   PubMed=27235858;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10303.
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; c.862-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=11565033).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=12068308; PubMed=22705003).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=8557231; PubMed=25230021).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-10303; true.
CC   Discontinued: BCRJ; 0163; probable.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): AddexBio=C0017001/57; ATCC=CRL-10303; PubMed=22710073; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 10,11 (PubMed=22710073; PubMed=25230021)
ST   CSF1PO: 10,14 (AddexBio=C0017001/57; ATCC=CRL-10303)
ST   D13S317: 8,9 (PubMed=22710073; PubMed=25230021)
ST   D13S317: 8,9,12 (AddexBio=C0017001/57; ATCC=CRL-10303)
ST   D16S539: 10,11,12 (PubMed=25230021)
ST   D16S539: 10,11,12,14 (AddexBio=C0017001/57; ATCC=CRL-10303)
ST   D16S539: 11,12 (PubMed=22710073)
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19,24
ST   D3S1358: 16,17,18 (PubMed=22710073)
ST   D3S1358: 16,18 (PubMed=25230021)
ST   D5S818: 10,11,12 (PubMed=22710073; PubMed=25230021)
ST   D5S818: 10,12,13 (AddexBio=C0017001/57; ATCC=CRL-10303)
ST   D7S820: 8,9.3,10.1,11 (AddexBio=C0017001/57; ATCC=CRL-10303)
ST   D7S820: 10,11,11.1 (PubMed=22710073)
ST   D7S820: 10,11,12 (PubMed=25230021)
ST   D8S1179: 14
ST   FGA: 23,24 (PubMed=22710073)
ST   FGA: 24,25 (PubMed=25230021)
ST   Penta D: 13,14
ST   Penta E: 13,14
ST   TH01: 6,8
ST   TPOX: 8 (PubMed=22710073; PubMed=25230021)
ST   TPOX: 8,11 (AddexBio=C0017001/57; ATCC=CRL-10303)
ST   vWA: 14,16,19,21 (AddexBio=C0017001/57; ATCC=CRL-10303)
ST   vWA: 14,19 (PubMed=22710073)
ST   vWA: 15,19 (PubMed=25230021)
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   MDAH041
AC   CVCL_E212
SY   MDAH 041; 041S
DR   Wikidata; Q54904670
RX   PubMed=2000218;
RX   PubMed=2253239;
RX   PubMed=3111682;
RX   PubMed=7667317;
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   MDAH087
AC   CVCL_E213
SY   MDAH 087; 087S
DR   Wikidata; Q54904671
RX   PubMed=2000218;
RX   PubMed=2253239;
RX   PubMed=3111682;
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   MDAH172
AC   CVCL_E214
SY   172S
DR   Wikidata; Q54904672
RX   PubMed=2253239;
RX   PubMed=3111682;
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   MDAH174
AC   CVCL_E215
SY   174S
DR   Wikidata; Q54904673
RX   PubMed=2253239;
RX   PubMed=3111682;
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   MDAY-D2
AC   CVCL_S411
DR   ChEMBL-Cells; CHEMBL3308420
DR   ChEMBL-Targets; CHEMBL614337
DR   PubChem_Cell_line; CVCL_S411
DR   Wikidata; Q54904674
RX   PubMed=6591445;
RX   PubMed=6929020;
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   MDBK
AC   CVCL_0421
SY   MDBK (NBL-1); NBL-1; Madin-Darby Bovine Kidney; Madin Darby Bovine Kidney
DR   BTO; BTO_0000836
DR   CLO; CLO_0007642
DR   CLO; CLO_0007643
DR   CLO; CLO_0050865
DR   MCCL; MCC:0000318
DR   CLDB; cl3412
DR   CLDB; cl3413
DR   CLDB; cl3414
DR   CLDB; cl3415
DR   CLDB; cl3416
DR   ATCC; CCL-22
DR   ATCC; CRL-6071
DR   BCRC; 60126
DR   BCRJ; 0167
DR   CCLV; CCLV-RIE 0084
DR   CCLV; CCLV-RIE 0261
DR   CCRID; 1101BOV-PUMC000288
DR   CCRID; 1102BOV-NIFDC00076
DR   CCRID; 3101BOVGNO7
DR   CCRID; 5301BOV-KCB90031YJ
DR   CCTCC; GDC0108
DR   CCTCC; GDC0290
DR   CLS; 600396
DR   DSMZ; ACC-174
DR   DSMZCellDive; ACC-174
DR   ECACC; 90050801
DR   FCS-free; 40-4-47-1-8-6
DR   IZSLER; BS CL 63
DR   JCRB; IFO50014
DR   JCRB; JCRB9028
DR   KCB; KCB 90031YJ
DR   KCLB; 10022
DR   Lonza; 925
DR   NCBI_Iran; C500
DR   RCB; RCB0180
DR   Wikidata; Q54904675
RX   DOI=10.1007/BF02618370;
RX   PubMed=2580922;
RX   PubMed=5587551;
RX   PubMed=5988125;
RX   PubMed=13567776;
RX   PubMed=14207851;
RX   PubMed=17900332;
RX   PubMed=19941903;
RX   PubMed=24973239;
RX   PubMed=25565633;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MDBK
WW   Info; MicroscopyU; -; https://www.microscopyu.com/gallery-images/madin-darby-bovine-kidney-epithelial-cells-mdbk-line
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-133.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Not susceptible to infection by wild-type and vaccinal strains of myxoma virus (MYXV) (PubMed=17900332).
CC   Doubling time: ~35 hours (DSMZ=ACC-174); ~24 hours (Note=Lot 032699), ~31 hours (Note=Lot 07222019) (JCRB=JCRB9028).
CC   Discontinued: ATCC; CRL-6071; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   MDBK CD46 KO
AC   CVCL_E1FE
SY   CD46(-)MDBK
RX   PubMed=32781607;
CC   Virology: Much less susceptible than parent cell line to infection by bovine viral diarrhea virus (BVDV) (PubMed=32781607).
CC   Knockout cell: Method=siRNA knockdown; VGNC; VGNC:-; CD46.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MDBK clone 955-1
AC   CVCL_DD20
DR   Wikidata; Q54904676
RX   PubMed=5988125;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   MDBK clone 958-9
AC   CVCL_DD21
DR   Wikidata; Q54904677
RX   PubMed=5988125;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   MDBK DeltaGPI
AC   CVCL_VD89
DR   Wikidata; Q54904678
RX   PubMed=29618668;
CC   Characteristics: Expresses a GPI-anchorless prion protein (PubMed=29618668).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:33356; Bovine PRNP (Note=With p.Ser242_Gly264del).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   MDBK-221
AC   CVCL_RT35
DR   Wikidata; Q54904679
RX   PubMed=12033770;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q64843; Bovine adenovirus B serotype 3 E1B 157R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q64844; Bovine adenovirus B serotype 3 E1B 420R.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 7
//
ID   MDBK-Bu100
AC   CVCL_4541
SY   MDBK(BU 100); MDBK(BU100)
DR   CLO; CLO_0007644
DR   CLDB; cl5228
DR   IZSLER; BS CL 118
DR   Wikidata; Q54904680
RX   PubMed=2824831;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   MDBK-N4
AC   CVCL_A2ZW
DR   Wikidata; Q105510085
RX   PubMed=33301791;
CC   Virology: Susceptible to infection by canine parvovirus (CPV) and canine distemper virus (CDV) (PubMed=33301791).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:43719; Dog NECTIN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   MDBK-Nectin-4
AC   CVCL_A9LD
DR   Wikidata; Q108820880
RX   DOI=10.3969/j.issn.1674-7968.2018.10.020;
CC   Virology: Susceptible to infection by peste des petits ruminants virus (PPRV).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:43719; Dog NECTIN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   MDBK-NST
AC   CVCL_E073
DR   CLO; CLO_0050864
DR   RCB; RCB1859
DR   Wikidata; Q54904681
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MDBK-PES
AC   CVCL_0I74
SY   PES
DR   CCLV; CCLV-RIE 0154
DR   Wikidata; Q54904682
RX   PubMed=25565633;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   MDBK-t2
AC   CVCL_RX00
DR   CCLV; CCLV-RIE 1268
DR   Wikidata; Q54904683
RX   PubMed=11226480;
CC   Characteristics: Can be used as a reporter cell line to study interferon pathways.
CC   Characteristics: The expression of the cat reporter gene is under control of the human Mx1 gene promoter.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P62577; Escherichia coli cat.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   MDBK-TfR
AC   CVCL_A2ZX
DR   Wikidata; Q105510087
RX   PubMed=33301791;
CC   Virology: Susceptible to infection by canine parvovirus (CPV) and canine distemper virus (CDV) (PubMed=33301791).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:47305; Dog TRFC.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   MDBK.P3
AC   CVCL_3021
SY   MDBK P3
DR   JCRB; JCRB0716
DR   Wikidata; Q54904685
RX   DOI=10.1247/csf.5.315;
RX   PubMed=2993257;
RX   PubMed=3242846;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MDBK/441
AC   CVCL_IZ74
SY   MDBK 441; MDBK441
DR   ChEMBL-Cells; CHEMBL3307597
DR   ChEMBL-Targets; CHEMBL614338
DR   PubChem_Cell_line; CVCL_IZ74
DR   Wikidata; Q54904684
RX   PubMed=3774376;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   MDBK527
AC   CVCL_B7IL
DR   Wikidata; Q112930099
RX   Patent=CN111671893B;
RX   PubMed=34579242;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to growth without serum in suspension.
CC   Virology: Can be used for the production of a bovine alphaherpesvirus-1 (BoHV-1) vaccine.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_0421 ! MDBK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   MDCC-3867K
AC   CVCL_6E15
SY   3867K
DR   Wikidata; Q54904686
RX   PubMed=26612074;
CC   Group: Bird cell line.
CC   Characteristics: The lymphoma from which this cell line was produced was induced by the recombinant vRB-1B 47EGFP marker virus which expresses EGFP fused to the C terminus of pUL47, a major tegument protein (PubMed=26612074).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=vRB-1B 47EGFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   MDCC-AL1
AC   CVCL_T748
SY   AL1
DR   Wikidata; Q54904687
RX   PubMed=7390658;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Breed/subspecies: N-line.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-AL2
AC   CVCL_U116
SY   AL2
DR   Wikidata; Q54904688
RX   PubMed=7390658;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Breed/subspecies: N-line.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-AL3
AC   CVCL_U117
SY   AL3
DR   Wikidata; Q54904689
RX   PubMed=7390658;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Breed/subspecies: N-line.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-BMCL2-1C10
AC   CVCL_T649
SY   BMC-L2-1(C10)
DR   Wikidata; Q54904690
RX   CelloPub=CLPUB00078;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: BM-C.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T650 ! MDCC-BMCL2-1C2
OI   CVCL_T651 ! MDCC-BMCL2-20C1
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-BMCL2-1C2
AC   CVCL_T650
SY   BMC-L2-1(C2)
DR   Wikidata; Q54904691
RX   CelloPub=CLPUB00078;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: BM-C.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T649 ! MDCC-BMCL2-1C10
OI   CVCL_T651 ! MDCC-BMCL2-20C1
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-BMCL2-20C1
AC   CVCL_T651
SY   BMC-L2-20(C1)
DR   Wikidata; Q54904692
RX   CelloPub=CLPUB00078;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: BM-C.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T649 ! MDCC-BMCL2-1C10
OI   CVCL_T650 ! MDCC-BMCL2-1C2
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-BO1(T)
AC   CVCL_C3PL
SY   BO1(T)
DR   Wikidata; Q116049780
RX   PubMed=6254498;
RX   PubMed=6268738;
CC   Group: Bird cell line.
CC   Virology: Was established from a chicken vaccinated with herpes virus of turkey (HVT) and naturally infected with Marek's disease virus (MDV). Contains 1.6 to 1.8 HVT genome equivalents/cell and 3.4 to 3.8 MDV genome equivalents/cell (PubMed=6268738).
CC   Doubling time: 18 hours (PubMed=6254498).
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Transformant: NCBI_TaxID; 37108; Meleagrid herpesvirus 1 (Herpes virus of turkey).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   67D
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MDCC-BP1
AC   CVCL_T645
SY   JMV-YS-1
DR   Wikidata; Q54904693
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-BP2
AC   CVCL_T646
SY   JMV-YS-2
DR   Wikidata; Q54904694
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-BP3
AC   CVCL_T647
SY   JMV-YS-3
DR   Wikidata; Q54904697
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-BP4
AC   CVCL_T648
SY   JMV-YS-4
DR   Wikidata; Q54904698
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP10
AC   CVCL_T607
SY   HP10
DR   Wikidata; Q54904699
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP11
AC   CVCL_T608
SY   HP11
DR   Wikidata; Q54904701
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP12
AC   CVCL_T609
SY   HP12
DR   Wikidata; Q54904702
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP13
AC   CVCL_T610
SY   HP13
DR   Wikidata; Q54904703
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP14
AC   CVCL_T611
SY   HP14
DR   Wikidata; Q54904704
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP15
AC   CVCL_T612
SY   HP15
DR   Wikidata; Q54904705
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP16
AC   CVCL_T613
SY   HP16
DR   Wikidata; Q54904706
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: RPRL-6.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP17
AC   CVCL_T614
SY   HP17
DR   Wikidata; Q54904707
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP18
AC   CVCL_T615
SY   HP18
DR   Wikidata; Q54904708
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP19
AC   CVCL_T616
SY   HP19
DR   Wikidata; Q54904709
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP20
AC   CVCL_T617
SY   HP20
DR   Wikidata; Q54904710
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP21
AC   CVCL_T618
SY   HP21
DR   Wikidata; Q54904711
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP22
AC   CVCL_T619
SY   HP22
DR   Wikidata; Q54904712
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP23
AC   CVCL_T620
SY   HP23
DR   Wikidata; Q54904713
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: RPRL-6.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP24
AC   CVCL_T621
SY   HP24
DR   Wikidata; Q54904714
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP25
AC   CVCL_T622
SY   HP25
DR   Wikidata; Q54904715
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP26
AC   CVCL_T623
SY   HP26
DR   Wikidata; Q54904716
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP27
AC   CVCL_T624
SY   HP27
DR   Wikidata; Q54904717
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP28
AC   CVCL_T625
SY   HP28
DR   Wikidata; Q54904718
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: RPRL-6.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP29
AC   CVCL_T626
SY   HP29
DR   Wikidata; Q54904719
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP3
AC   CVCL_T600
SY   HP3
DR   Wikidata; Q54904720
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP30
AC   CVCL_T627
SY   HP30
DR   Wikidata; Q54904721
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP31
AC   CVCL_T628
SY   HP31
DR   Wikidata; Q54904722
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP4
AC   CVCL_T601
SY   HP4
DR   Wikidata; Q54904723
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP5
AC   CVCL_T602
SY   HP5
DR   Wikidata; Q54904724
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP6
AC   CVCL_T603
SY   HP6
DR   Wikidata; Q54904726
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP7
AC   CVCL_T604
SY   HP7
DR   Wikidata; Q54904727
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: HPRS-RIR.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP8
AC   CVCL_T605
SY   HP8
DR   Wikidata; Q54904728
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: RPRL-7.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-HP9
AC   CVCL_T606
SY   HP9
DR   Wikidata; Q54904729
RX   PubMed=7199514;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Breed/subspecies: RPRL-7.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   MDCC-JM-1
AC   CVCL_T448
SY   JM-1
DR   Wikidata; Q54904730
RX   PubMed=208974;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-JMV-1
AC   CVCL_T449
SY   JMV-1
DR   Wikidata; Q54904731
RX   Patent=EP0244760A2;
RX   PubMed=208974;
RX   PubMed=18670936;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9093.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   MDCC-JP1
AC   CVCL_8459
SY   JP-1; JP1; MOGA-1
DR   Wikidata; Q54904732
RX   PubMed=231432;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 19 hours (PubMed=231432).
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   MDCC-JP2
AC   CVCL_8460
SY   MDCC-JP 2; JP-2; JP2; MOGA-2
DR   Wikidata; Q54904733
RX   PubMed=231432;
RX   PubMed=3273463;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 22 hours (PubMed=231432); 13.6 hours (PubMed=3273463).
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   MDCC-LS1
AC   CVCL_H687
SY   LS1; MKT-1
DR   Wikidata; Q54904734
RX   PubMed=209622;
RX   PubMed=225531;
RX   PubMed=6251256;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   MDCC-MOB1
AC   CVCL_8456
SY   MDCC-MOB-1; MOB-1; MOB1; MOB
DR   Wikidata; Q54904735
RX   PubMed=69431;
RX   PubMed=180968;
RX   PubMed=797387;
RX   PubMed=4596339;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   MDCC-MOB2
AC   CVCL_8457
SY   MDCC-MOB-2; MOB-2; MOB2
DR   Wikidata; Q54904736
RX   PubMed=69431;
RX   PubMed=180968;
RX   PubMed=797387;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   MDCC-MOB3
AC   CVCL_8458
SY   MDCC-MOB-3; MOB-3; MOB3
DR   Wikidata; Q54904737
RX   PubMed=69431;
RX   PubMed=797387;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MDCC-MSB1
AC   CVCL_4542
SY   MDCC MSB1; MDCC-MSB-1; MDCC-MSB 1; MSB-1; MSB1
DR   CLO; CLO_0007645
DR   EFO; EFO_0002659
DR   CLDB; cl5229
DR   CLS; 601413
DR   IZSLER; BS TCL 7
DR   Wikidata; Q54904738
RX   PubMed=69431;
RX   PubMed=163334;
RX   PubMed=180968;
RX   PubMed=797387;
RX   PubMed=3273463;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 8-10 hours (PubMed=163334); 13.3 hours (PubMed=3273463); ~10 hours (CLS=601413).
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   MDCC-MSB1-33C
AC   CVCL_T660
DR   Wikidata; Q54904740
RX   PubMed=6316900;
RX   PubMed=6628902;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_4542 ! MDCC-MSB1
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   MDCC-MSB1-41C
AC   CVCL_T661
SY   MSB1-41C
DR   Wikidata; Q54904741
RX   PubMed=3273463;
RX   PubMed=6316900;
RX   PubMed=6628902;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Characteristics: Transplantable subline of MDCC-MSB1.
CC   Doubling time: 18.4 hours (PubMed=3273463).
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_4542 ! MDCC-MSB1
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   MDCC-MSB1-Clo. 18
AC   CVCL_T662
SY   MDCC-MSB1-CLO
DR   Wikidata; Q54904742
RX   PubMed=6090745;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Characteristics: Transplantable subline of MDCC-MSB1.
CC   Transformant: NCBI_TaxID; 10387; Gallid herpesvirus 2 (Marek's disease virus) (strain bc-1).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_4542 ! MDCC-MSB1
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   MDCC-PA5
AC   CVCL_T629
SY   PA5
DR   Wikidata; Q54904743
RX   PubMed=2433209;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-PA9
AC   CVCL_T630
SY   PA9
DR   Wikidata; Q54904744
RX   PubMed=2433209;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP1
AC   CVCL_T461
SY   MDCC-RP-1; MDCC-RP 1; RP-1; RP1; RPL1; RPL-1
DR   Wikidata; Q54904745
RX   PubMed=190995;
RX   PubMed=3273463;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 13.7 hours (PubMed=3273463).
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: P-line.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MDCC-RP2
AC   CVCL_T462
SY   MCL-R2; RP-2; RP2
DR   Wikidata; Q54904746
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP22
AC   CVCL_T652
DR   Wikidata; Q54904747
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MDCC-RP23
AC   CVCL_T653
DR   Wikidata; Q54904748
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP24
AC   CVCL_T654
DR   Wikidata; Q54904749
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP25
AC   CVCL_T655
DR   Wikidata; Q54904751
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP26
AC   CVCL_T656
DR   Wikidata; Q54904752
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP27
AC   CVCL_T657
DR   Wikidata; Q54904753
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP28
AC   CVCL_T658
DR   Wikidata; Q54904754
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP29
AC   CVCL_T659
DR   Wikidata; Q54904755
RX   PubMed=6314315;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-RP4
AC   CVCL_T463
SY   MDCC-RP-4; RP-4; RP4
DR   Wikidata; Q54904756
RX   PubMed=6326737;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDCC-TV1
AC   CVCL_R816
SY   TV-1; TV1
DR   Wikidata; Q54904757
RX   PubMed=226481;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   MDCC-UA01
AC   CVCL_ZB66
SY   UA01
DR   Wikidata; Q98127129
RX   PubMed=11333897;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 4
//
ID   MDCC-UA04
AC   CVCL_ZB67
SY   UA04
DR   Kerafast; EDW005
DR   Wikidata; Q98127131
RX   PubMed=10696429;
RX   PubMed=11259202;
RX   PubMed=11333897;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by insertion of a soluble modified derivative of GFP (smGFP) in the US2 locus.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US2gfpDelta-1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MDCC-UA20
AC   CVCL_ZB68
SY   UA20
DR   Wikidata; Q98127134
RX   PubMed=11333897;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by replacement of the vIL-8 gene by a soluble modified derivative of GFP (smGFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-vIL-8Delta-smGFP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MDCC-UA22
AC   CVCL_ZB69
SY   UA22
DR   Kerafast; EDW006
DR   Wikidata; Q98127136
RX   PubMed=15529969;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by insertion of a soluble modified derivative of GFP (smGFP) downstream of the pp38 protein of MDV. Thus the expression of GFP is induced during reactivation of the MDV from latency, therefore these cells are ideal for studying the early events of reactivation.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-pp38smGFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MDCC-UA23
AC   CVCL_ZB70
SY   UA23
DR   Wikidata; Q98127140
RX   PubMed=15529969;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by insertion of a soluble modified derivative of GFP (smGFP) downstream of the pp38 protein of MDV. Thus the expression of GFP is induced during reactivation of the MDV from latency, therefore these cells are ideal for studying the early events of reactivation.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-pp38smGFP).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MDCC-UA53
AC   CVCL_ZB71
SY   UA53
DR   Kerafast; EDW007
DR   Wikidata; Q98127142
RX   PubMed=16617990;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus) (Note=Strain TK).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   MDCC-UD01
AC   CVCL_ZB72
SY   UD01
DR   Wikidata; Q98127144
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by deletion of six genes from the US region of the virus genome and replaced with a lacZ expression cassette.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-Delta4.5lac).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   MDCC-UD02
AC   CVCL_ZB73
SY   UD02
DR   Wikidata; Q98127147
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by deletion of six genes from the US region of the virus genome and replaced with a lacZ expression cassette.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-Delta4.5lac).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   MDCC-UD03
AC   CVCL_ZB74
SY   UD03
DR   Wikidata; Q98127149
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by deletion of six genes from the US region of the virus genome and replaced with a lacZ expression cassette.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-Delta4.5lac).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   MDCC-UD13
AC   CVCL_ZB75
SY   UD13
DR   Wikidata; Q98127151
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Derived from site: Metastatic; Not specified.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   MDCC-UD14
AC   CVCL_ZB76
SY   UD14
DR   Kerafast; EDW008
DR   Wikidata; Q98127154
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   MDCC-UD22
AC   CVCL_ZB77
SY   UD22
DR   Wikidata; Q98127156
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_ZB78 ! MDCC-UD23
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MDCC-UD23
AC   CVCL_ZB78
SY   UD23
DR   Wikidata; Q98127158
RX   PubMed=9499123;
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_ZB77 ! MDCC-UD22
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MDCC-UD24
AC   CVCL_ZB79
SY   UD24
DR   Wikidata; Q98127162
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_ZB80 ! MDCC-UD25
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MDCC-UD25
AC   CVCL_ZB80
SY   UD25
DR   Wikidata; Q98127164
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_ZB79 ! MDCC-UD24
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MDCC-UD26
AC   CVCL_ZB81
SY   UD26
DR   Wikidata; Q98127167
RX   PubMed=9499123;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   MDCC-UD27
AC   CVCL_ZB82
SY   UD27
DR   Wikidata; Q98127169
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_ZB83 ! MDCC-UD28
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MDCC-UD28
AC   CVCL_ZB83
SY   UD28
DR   Wikidata; Q98127171
RX   PubMed=9499123;
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_ZB82 ! MDCC-UD27
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MDCC-UD29
AC   CVCL_ZB84
SY   UD29
DR   Wikidata; Q98127174
RX   PubMed=9499123;
RX   PubMed=9882341;
CC   Group: Bird cell line.
CC   Characteristics: The MDV RB-1b virus has been modified by an insertion of a lacZ-gpt cassette within the US6 gene.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b) (Note=RB-1B-US6lacgpt).
CC   Derived from site: Metastatic; Not specified.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MDCC-UD35
AC   CVCL_ZB85
SY   UD35
DR   Kerafast; EDW009
DR   Wikidata; Q98127176
RX   PubMed=22856190;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   MDCC-UD36
AC   CVCL_ZB86
SY   UD36
DR   Wikidata; Q98127179
RX   PubMed=22856190;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus) (Note=Strain rMDV-1137).
CC   Derived from site: Metastatic; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   MDCC-UD37
AC   CVCL_ZB87
SY   UD37
DR   Wikidata; Q98127181
RX   PubMed=22856190;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 33707; Gallid herpesvirus 2 (Marek's disease virus) (strain RB-1b).
CC   Derived from site: Metastatic; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   MDCC-UD38
AC   CVCL_ZB88
SY   UD38
DR   Wikidata; Q98127184
RX   PubMed=22856190;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus) (Note=Strain rMDV-1137).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   MDCi007-A
AC   CVCL_C0HD
SY   8993-A12; iPSC_A12
DR   BioSamples; SAMEA10563812
DR   hPSCreg; MDCi007-A
DR   Wikidata; Q112930100
RX   PubMed=35279592;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Homoplasmic (PubMed=35279592).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MDCi008-A
AC   CVCL_C0HE
SY   8993-B12; iPSC_B12
DR   BioSamples; SAMEA12276542
DR   hPSCreg; MDCi008-A
DR   Wikidata; Q112930101
RX   PubMed=35279592;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Pro (m.8993T>C); ClinVar=VCV000009642; Zygosity=Homoplasmic (PubMed=35279592).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MDCi009-A
AC   CVCL_C0HF
SY   8993-C11; iPSC_C11
DR   BioSamples; SAMEA12276589
DR   hPSCreg; MDCi009-A
DR   Wikidata; Q112930102
RX   PubMed=35279592;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Homoplasmic (PubMed=35279592).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MDCi010-A
AC   CVCL_C0HG
SY   8993-D7; iPSC_D7
DR   BioSamples; SAMEA12276594
DR   hPSCreg; MDCi010-A
DR   Wikidata; Q112930104
RX   PubMed=35279592;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Homoplasmic (PubMed=35279592).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MDCi011-A
AC   CVCL_ZI92
DR   BioSamples; SAMEA6673740
DR   hPSCreg; MDCi011-A
DR   Wikidata; Q98127187
RX   PubMed=32961449;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI93 ! MDCi011-B
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MDCi011-B
AC   CVCL_ZI93
DR   BioSamples; SAMEA6979631
DR   hPSCreg; MDCi011-B
DR   Wikidata; Q98127188
RX   PubMed=32961449;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI92 ! MDCi011-A
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   MDCi012-A
AC   CVCL_ZI90
DR   BioSamples; SAMEA7002449
DR   hPSCreg; MDCi012-A
DR   Wikidata; Q98127189
RX   PubMed=32961449;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI91 ! MDCi012-B
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MDCi012-B
AC   CVCL_ZI91
DR   BioSamples; SAMEA7002451
DR   hPSCreg; MDCi012-B
DR   Wikidata; Q98127190
RX   PubMed=32961449;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI90 ! MDCi012-A
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   MDCi013-A
AC   CVCL_ZI86
DR   BioSamples; SAMEA7002454
DR   hPSCreg; MDCi013-A
DR   Wikidata; Q98127191
RX   PubMed=32961449;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI87 ! MDCi013-B
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MDCi013-B
AC   CVCL_ZI87
DR   BioSamples; SAMEA7002456
DR   hPSCreg; MDCi013-B
DR   Wikidata; Q98127192
RX   PubMed=32961449;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI86 ! MDCi013-A
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   MDCi014-A
AC   CVCL_ZI88
DR   BioSamples; SAMEA7002457
DR   hPSCreg; MDCi014-A
DR   Wikidata; Q98127193
RX   PubMed=32979629;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI89 ! MDCi014-B
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MDCi014-B
AC   CVCL_ZI89
DR   BioSamples; SAMEA7002459
DR   hPSCreg; MDCi014-B
DR   Wikidata; Q98127194
RX   PubMed=32979629;
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZI88 ! MDCi014-A
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   MDCi233-A
AC   CVCL_B5J0
DR   BioSamples; SAMEA9422207
DR   hPSCreg; MDCi233-A
DR   Wikidata; Q110433024
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Leu369Pro (c.1106T>C); Zygosity=Heterozygous (hPSCreg=MDCi233-A).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1768_Pro1776del (c.5302_5328delCGGCCCCTCTACAGCCCCCTGCAGCCA); Zygosity=Heterozygous (hPSCreg=MDCi233-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5J1 ! MDCi233-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   MDCi233-B
AC   CVCL_B5J1
DR   BioSamples; SAMEA9422357
DR   hPSCreg; MDCi233-B
DR   Wikidata; Q110433025
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Leu369Pro (c.1106T>C); Zygosity=Heterozygous (hPSCreg=MDCi233-B).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1768_Pro1776del (c.5302_5328delCGGCCCCTCTACAGCCCCCTGCAGCCA); Zygosity=Heterozygous (hPSCreg=MDCi233-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5J0 ! MDCi233-A
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   MDCi234-A
AC   CVCL_C1UR
SY   #186
DR   hPSCreg; MDCi234-A
DR   Wikidata; Q114312273
CC   From: Max Delbruck Center Berlin Buch; Berlin; Germany.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   MDCK
AC   CVCL_0422
SY   MDCK (NBL-2); MDCK(NBL-2); NBL-2; Madin-Darby Canine Kidney; Madin Darby Canine Kidney
DR   BTO; BTO_0000837
DR   CLO; CLO_0007646
DR   CLO; CLO_0007647
DR   CLO; CLO_0050861
DR   EFO; EFO_0022746
DR   MCCL; MCC:0000319
DR   CLDB; cl3417
DR   CLDB; cl3418
DR   CLDB; cl3419
DR   CLDB; cl3420
DR   CLDB; cl3421
DR   CLDB; cl3422
DR   CLDB; cl3423
DR   CLDB; cl3424
DR   CLDB; cl3425
DR   ABM; T8979
DR   AddexBio; P0014003/4928
DR   ATCC; CCL-34
DR   ATCC; CRL-6253
DR   BCRC; 60004
DR   BCRJ; 0168
DR   BEI_Resources; NR-2628
DR   CCLV; CCLV-RIE 0083
DR   CCRID; 1101CAN-PUMC000078
DR   CCRID; 1102CAN-NIFDC00045
DR   CCRID; 3101CANGNO23
DR   CCRID; 4201CAN-CCTCC00012
DR   CCTCC; GDC0012
DR   CCTCC; GDC0401
DR   ChEMBL-Cells; CHEMBL3308370
DR   ChEMBL-Targets; CHEMBL614068
DR   CLS; 602280
DR   ECACC; 84121903
DR   ECACC; 85011435
DR   FCS-free; 41-14-321-2-3-3
DR   FCS-free; 41-14-427-1-4-3
DR   FCS-free; 41-14-47-1-8-9
DR   FCS-free; 41-14-585-1-18-2
DR   FCS-free; 41-14-587-1-18-2
DR   FCS-free; 41-14-588-2-18-2
DR   GEO; GSM4009056
DR   GEO; GSM4009057
DR   GEO; GSM4009058
DR   IBRC; C10556
DR   IZSLER; BS CL 64
DR   JCRB; IFO50071
DR   JCRB; JCRB9029
DR   KCB; KCB 2006105YJ
DR   KCLB; 10034
DR   Lonza; 153
DR   MeSH; D061985
DR   NCBI_Iran; C426
DR   PRIDE; PXD014768
DR   PRIDE; PXD024031
DR   PubChem_Cell_line; CVCL_0422
DR   RCB; RCB0995
DR   TOKU-E; 2403
DR   TOKU-E; 3636
DR   Ubigene; YC-C005
DR   Wikidata; Q28335011
RX   DOI=10.1007/BF02618370;
RX   PubMed=222773;
RX   PubMed=567227;
RX   PubMed=5918973;
RX   PubMed=6480288;
RX   PubMed=12667817;
RX   PubMed=13901412;
RX   PubMed=19941903;
RX   PubMed=21819694;
RX   PubMed=21982418;
RX   PubMed=24058646;
RX   PubMed=25903999;
RX   PubMed=32854295;
RX   PubMed=33122286;
RX   PubMed=33389257;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mdck/mdckcells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-ccl-34-mdck
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/mdck/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-89.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Madin-Darby_Canine_Kidney_Cells
WW   Provider; Vircell; -; https://www.vircell.com/en/products/mdck-cell-line
CC   Group: Vaccine production cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Characteristics: Used for virus production for vaccine development, toxicology and industrial biotechnology research, and high-throughput screening (ATCC=CCL-34).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C426.
CC   Discontinued: ATCC; CRL-6253; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 42
//
ID   MDCK 33016
AC   CVCL_2A36
SY   MDCK-33016
DR   Wikidata; Q54904759
RX   Patent=US6455298;
RX   PubMed=18485545;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2219.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   MDCK 33016-PF
AC   CVCL_2A37
SY   MDCK 33016 PF; MDCK 33016PF; MDCK-33016PF; MDCK subline 33016-PF
DR   Wikidata; Q54904760
RX   PubMed=20071567;
CC   Group: Vaccine production cell line.
CC   Biotechnology: Used for the production of the influenza virus vaccine Optaflu.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_2A36 ! MDCK 33016
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   MDCK 9B9-1B1
AC   CVCL_DF69
DR   Wikidata; Q54904761
RX   Patent=US8846032;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7909.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   MDCK 9B9-1E4
AC   CVCL_DF70
SY   MDCK9B9-1E4
DR   Wikidata; Q54904762
RX   Patent=US8846032;
RX   PubMed=20307595;
RX   PubMed=22902973;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7910.
CC   Characteristics: Not tumorigenic. Highly permissive to the live attenuated influenza vaccine (LAIV) components.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 11
//
ID   MDCK Actin-cpstFRET-Actin
AC   CVCL_ZV91
SY   MDCK AcpA
DR   Wikidata; Q98127195
RX   PubMed=25422450;
CC   Characteristics: Used to report forces in actin in living cells. Has one actin molecule attached on each end of cpstFRET. The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:132; ACTB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   MDCK Actinin-C-cpstFRET
AC   CVCL_ZV92
SY   MDCK C-cpstFRET
DR   Kerafast; EBU027
DR   Wikidata; Q98127197
RX   PubMed=25422450;
CC   Characteristics: Has one actinin molecule attached to the C-terminal of cpstFRET, leaving the other end of the probe dangling free and the probe devoid of tension (force-free control). The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:163; ACTN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   MDCK Actinin-M-cpstFRET
AC   CVCL_ZV93
SY   MDCK M-cpstFRET
DR   Kerafast; EBU026
DR   Wikidata; Q98127198
RX   PubMed=25422450;
CC   Characteristics: Used to report forces in actinin in living cells. Has one actinin molecule with the cpstFRET sensor incorporated between spectrin repeat domains 3 and 4 toward the middle of actinin. The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:163; ACTN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   MDCK BLVRA KO
AC   CVCL_D5IF
SY   BlvraKO MDCK
DR   JCRB; JCRB1974
DR   Wikidata; Q127382753
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:38471; BLVRA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK cMDR1-KO
AC   CVCL_A2JX
SY   MDCKcMDR1-KO; MDCK II cMdr1 KO Cl2; cMdr1 KO Cl2
DR   PRIDE; PXD020238
DR   Wikidata; Q105510090
RX   PubMed=26869442;
RX   PubMed=33007277;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:37431; ABCB1.
CC   Omics: Proteomics; Quantitative.
CC   Caution: Incorrectly indicated as originating from MDCK-II while it seems to be derived from MDCK.2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_B034 ! MDCK.2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 10
//
ID   MDCK ConAr
AC   CVCL_C8RJ
SY   ConAr
DR   Wikidata; Q123033031
RX   PubMed=7177111;
CC   Doubling time: 19 hours (PubMed=7177111).
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   MDCK cpstFRET-Actin
AC   CVCL_ZV90
SY   MDCK cpA
DR   Wikidata; Q98127199
RX   PubMed=25422450;
CC   Characteristics: Has one actin molecule attached to the C-terminal of cpstFRET, leaving the other end of the probe dangling free and the probe devoid of tension (force-free control). The cpstFRET (circularly permuted stretch sensitive FRET) sensor consists of a pair of tandemly connected circularly permutated CFP/YFPs (cpCerulean/cpVenus). Mechanical loading twists the dipole orientation from near parallel to diagonal, decreasing FRET efficiency.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:132; ACTB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   MDCK II CLDN2 KO1
AC   CVCL_E7Z3
SY   MDCK II claudin-2 knockout clone 1
RX   PubMed=25781928;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN2 KO2
AC   CVCL_E7Z4
SY   MDCK II claudin-2 knockout clone 2
RX   PubMed=25781928;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN2 KO3
AC   CVCL_E7Z5
SY   MDCK II claudin-2 knockout clone 3
RX   PubMed=25781928;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN2 KO4
AC   CVCL_E7Z6
SY   MDCK II claudin-2 knockout clone 4
RX   PubMed=25781928;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II claudin-2 knockout clone 5
AC   CVCL_E7Z7
SY   MDCK II claudin-2 KO5
RX   PubMed=25781928;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN2/CLDN4 dKO1
AC   CVCL_E7ZB
SY   MDCK II claudin-2 and claudin 4 double knockout clone 1
RX   PubMed=28777806;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39321; CLDN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_E7Z3 ! MDCK II CLDN2 KO1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN2/CLDN4 dKO2
AC   CVCL_E7ZC
SY   MDCK II claudin-2 and claudin 4 double knockout clone 2
RX   PubMed=28777806;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39321; CLDN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_E7Z3 ! MDCK II CLDN2 KO1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN2/CLDN4 dKO3
AC   CVCL_E7ZD
SY   MDCK II claudin-2 and claudin 4 double knockout clone 3
RX   PubMed=28777806;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39316; CLDN2.
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39321; CLDN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_E7Z4 ! MDCK II CLDN2 KO2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN4 KO1
AC   CVCL_E7Z8
SY   MDCK II claudin-4 knockout clone 1
RX   PubMed=28777806;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39321; CLDN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN4 KO2
AC   CVCL_E7Z9
SY   MDCK II claudin-4 knockout clone 2
RX   PubMed=28777806;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39321; CLDN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK II CLDN4 KO3
AC   CVCL_E7ZA
SY   MDCK II claudin-4 knockout clone 3
RX   PubMed=28777806;
CC   Knockout cell: Method=TALEN; VGNC; VGNC:39321; CLDN4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MDCK RCAr
AC   CVCL_C8RK
SY   RCAr
DR   Wikidata; Q123033032
RX   PubMed=7177111;
CC   Doubling time: 19 hours (PubMed=7177111).
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   MDCK siat7e-expressing clone 1
AC   CVCL_D3W3
DR   Wikidata; Q127382754
RX   PubMed=19706449;
CC   Group: Vaccine production cell line.
CC   Characteristics: Grows in suspension (PubMed=19706449).
CC   Virology: Allows efficient influenza virus growth and hemagglutinin (HA) production (PubMed=19706449).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19342; ST6GALNAC5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   MDCK siat7e-expressing clone 2
AC   CVCL_D3W4
DR   Wikidata; Q127382755
RX   PubMed=19706449;
CC   Group: Vaccine production cell line.
CC   Characteristics: Grows in suspension (PubMed=19706449).
CC   Virology: Allows efficient influenza virus growth and hemagglutinin (HA) production (PubMed=19706449).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19342; ST6GALNAC5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   MDCK Sky1023
AC   CVCL_AP67
DR   Wikidata; Q54904763
RX   Patent=US9447383;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3112.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 11
//
ID   MDCK Sky10234
AC   CVCL_AP68
DR   Wikidata; Q54904764
RX   Patent=US9447383;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3114.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 11
//
ID   MDCK Sky3851
AC   CVCL_AP69
DR   Wikidata; Q54904765
RX   Patent=US9447383;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3113.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 11
//
ID   MDCK Tet-Off
AC   CVCL_V359
SY   MDCK tet-off
DR   Wikidata; Q54904766
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630913.
CC   Discontinued: Takara/Clontech; Catalog number 631138.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   MDCK tGFP-APP
AC   CVCL_B5WN
SY   tGFP-APP MDCK; APP-tGFP / MDCK
DR   Innoprot; P30701
DR   Wikidata; Q112930105
CC   Characteristics: Allows to perform assays to evaluate the endogenous secretase proteolytic process in living cells (Innoprot=P30701).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 9
//
ID   MDCK-15D3
AC   CVCL_B0N7
DR   CCRID; 4201PAT-CCTCC01119
DR   Wikidata; Q108820881
RX   Patent=CN108277199B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017155.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   MDCK-17
AC   CVCL_WY48
DR   Wikidata; Q95987740
RX   PubMed=1468552;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6530; LCT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   MDCK-2B2
AC   CVCL_B4IA
DR   Wikidata; Q110433026
RX   Patent=CN104059873B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201323.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   MDCK-4KO-EKARrEV-NLS
AC   CVCL_D5IH
DR   JCRB; JCRB1990
DR   Wikidata; Q127382757
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I5 ! MDCK-dEGF/HBEGF/TGFalpha/EREG KO 1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-4KO-EKARrEV-NLS-EGF
AC   CVCL_D5II
DR   Wikidata; Q127382758
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:40235; Dog EGF.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IH ! MDCK-4KO-EKARrEV-NLS
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-4KO-EKARrEV-NLS-EREG
AC   CVCL_D5IJ
DR   Wikidata; Q127382759
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:111490; Dog EREG.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IH ! MDCK-4KO-EKARrEV-NLS
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-4KO-EKARrEV-NLS-HBEGF
AC   CVCL_D5IK
DR   Wikidata; Q127382760
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:41609; Dog HBEGF.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IH ! MDCK-4KO-EKARrEV-NLS
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-4KO-EKARrEV-NLS-loxP-NRG1
AC   CVCL_D5IM
DR   Wikidata; Q127382761
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:43967; Dog NRG1 (Note=With a N-terminal loxP site).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IH ! MDCK-4KO-EKARrEV-NLS
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-4KO-EKARrEV-NLS-TGFalpha
AC   CVCL_D5IL
DR   Wikidata; Q127382762
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:112755; Dog TGFA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IH ! MDCK-4KO-EKARrEV-NLS
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-5KO-EKARrEV-NLS-loxP-NRG1
AC   CVCL_D5IS
DR   Wikidata; Q127382763
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:43967; NRG1.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:43967; Dog NRG1 (Note=With a N-terminal loxP site).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IM ! MDCK-4KO-EKARrEV-NLS-loxP-NRG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-5KO-EKARrEV-NLS-loxP-NRG1-CreERT2
AC   CVCL_D5J0
DR   Wikidata; Q127382764
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal and with CreERT2 that encodes a Cre recombinase fused to a mutant estrogen ligand-binding domain (ERT2) that requires the presence of tamoxifen for activity (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:43967; NRG1.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:43967; Dog NRG1 (Note=With a N-terminal loxP site).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IS ! MDCK-5KO-EKARrEV-NLS-loxP-NRG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-6A8
AC   CVCL_WL59
DR   CCRID; 4201PAT-CCTCC01120
DR   Wikidata; Q95987742
RX   Patent=CN108277199B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017154.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   MDCK-79
AC   CVCL_B6XZ
DR   Wikidata; Q112930106
RX   PubMed=36651516;
CC   Characteristics: Obtained from the parent cell line by limited dilution method so as to obtain a cell line with low ABCB1 expression (PubMed=36651516).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   MDCK-A3-10
AC   CVCL_ZW00
SY   A3-10
DR   Wikidata; Q102114529
RX   PubMed=2127916;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1706; CD8A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   MDCK-A3-14
AC   CVCL_ZW01
SY   A3-14
DR   Wikidata; Q102114530
RX   PubMed=2127916;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1706; CD8A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   MDCK-A3-15
AC   CVCL_ZV47
SY   MDCK-A315; A3-15
DR   CLO; CLO_0007648
DR   CLDB; cl3426
DR   Wikidata; Q98127200
RX   PubMed=2127916;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1706; CD8A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   MDCK-AD
AC   CVCL_K177
DR   CLO; CLO_0050862
DR   RCB; RCB2611
DR   Wikidata; Q54904768
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   MDCK-B-702
AC   CVCL_AP66
SY   B-702
DR   Wikidata; Q54904769
RX   Patent=US6825036;
CC   Group: Serum/protein free medium cell line.
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7449.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 10
//
ID   MDCK-C09
AC   CVCL_A2JC
DR   Wikidata; Q107116181
RX   PubMed=32928630;
CC   Characteristics: Has a low tumorigenic potential (PubMed=32928630).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   MDCK-C11
AC   CVCL_AP70
SY   MDCK clone C11; Madin-Darby Canine Kidney-Clone 11
DR   Wikidata; Q54904770
RX   PubMed=7790388;
RX   PubMed=7971172;
RX   PubMed=11211115;
RX   PubMed=12457240;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 10
//
ID   MDCK-C35
AC   CVCL_A2JD
DR   Wikidata; Q107116183
RX   PubMed=32928630;
CC   Characteristics: Has a low tumorigenic potential (PubMed=32928630).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   MDCK-C7
AC   CVCL_0423
SY   MDCK clone C7; Madin-Darby Canine Kidney-Clone 7
DR   MCCL; MCC:0000320
DR   Lonza; 688
DR   Wikidata; Q54904771
RX   PubMed=7790388;
RX   PubMed=7971172;
RX   PubMed=10864013;
RX   PubMed=12457240;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   MDCK-chAbcb1
AC   CVCL_DF31
DR   Wikidata; Q54904773
RX   PubMed=27234533;
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49438; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 8
//
ID   MDCK-dADAM17
AC   CVCL_D5I6
DR   Wikidata; Q127382765
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:37576; ADAM17.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dADAM17-EKARrEV-NLS
AC   CVCL_D5IN
DR   Wikidata; Q127382766
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:37576; ADAM17.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I6 ! MDCK-dADAM17
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF-EKARrEV-NLS
AC   CVCL_D5IU
DR   Wikidata; Q127382767
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5HY ! MDCK-dEGF_#1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF_#1
AC   CVCL_D5HY
SY   MDCK-dEGF
DR   JCRB; JCRB1957
DR   Wikidata; Q127382768
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF_#2
AC   CVCL_D5I7
SY   MDCK-dEGF_2
DR   JCRB; JCRB1968
DR   Wikidata; Q127382769
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF (Note=With exon 1 deleted).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF_2-EKARrEV-NLS
AC   CVCL_D5IV
DR   Wikidata; Q127382770
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF (Note=With exon 1 deleted).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I7 ! MDCK-dEGF_#2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF/HBEGF KO
AC   CVCL_D5I2
SY   MDCK-DKO
DR   JCRB; JCRB1967
DR   Wikidata; Q127382771
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I0 ! MDCK-dHBEGF
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF/HBEGF/TGFalpha KO
AC   CVCL_D5I3
SY   MDCK-TKO
DR   JCRB; JCRB1969
DR   Wikidata; Q127382772
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I2 ! MDCK-dEGF/HBEGF KO
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF/HBEGF/TGFalpha/EREG KO 1
AC   CVCL_D5I5
SY   MDCK-4KO
DR   JCRB; JCRB1965
DR   Wikidata; Q127382773
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEGF/HBEGF/TGFalpha/EREG KO 2
AC   CVCL_D5I4
SY   MDCK-QKO
DR   JCRB; JCRB1970
DR   Wikidata; Q127382774
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I3 ! MDCK-dEGF/HBEGF/TGFalpha KO
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dEREG
AC   CVCL_D5HZ
DR   Wikidata; Q127382775
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dHBEGF
AC   CVCL_D5I0
DR   Wikidata; Q127382776
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dHBEGF-EKARrEV-NLS
AC   CVCL_D5IP
DR   JCRB; JCRB1975
DR   Wikidata; Q127382779
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I0 ! MDCK-dHBEGF
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-DKO-EKARrEV-NLS
AC   CVCL_D5IT
DR   JCRB; JCRB1985
DR   Wikidata; Q127382780
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I2 ! MDCK-dEGF/HBEGF KO
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dTGFalpha
AC   CVCL_D5I1
DR   JCRB; JCRB1961
DR   Wikidata; Q127382781
RX   PubMed=34667080;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-dTGFalpha-EKARrEV-NLS
AC   CVCL_D5IQ
DR   JCRB; JCRB1976
DR   Wikidata; Q127382783
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I1 ! MDCK-dTGFalpha
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-E [Korea]
AC   CVCL_AQ31
SY   MDCK-epithelial-like
DR   Wikidata; Q54904775
RX   CelloPub=CLPUB00313;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 8
//
ID   MDCK-E [Taiwan]
AC   CVCL_Y089
DR   BCRC; 60567
DR   Wikidata; Q54904776
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 9
//
ID   MDCK-EKAREV-NLS
AC   CVCL_D5IG
DR   Wikidata; Q127382784
RX   PubMed=27936234;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from Cdc25, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=27936234).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   MDCK-EKARrEV-NLS
AC   CVCL_D5IR
SY   MDCK-WT-EKARrEV-NLS
DR   JCRB; JCRB1973
DR   Wikidata; Q127382785
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MDCK-EKARrEV-NLS-dEGFR
AC   CVCL_D5IW
DR   JCRB; JCRB1994
DR   Wikidata; Q127382786
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:51866; EGFR.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IR ! MDCK-EKARrEV-NLS
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-EKARrEV-NLS-dEREG
AC   CVCL_D5IZ
DR   JCRB; JCRB1980
DR   Wikidata; Q127382787
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IR ! MDCK-EKARrEV-NLS
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-F
AC   CVCL_AP75
SY   MDCK-fibroblast-like
DR   Wikidata; Q54904777
RX   CelloPub=CLPUB00313;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 8
//
ID   MDCK-hBCRP cMDR1-KO
AC   CVCL_A2KC
DR   PRIDE; PXD020238
DR   Wikidata; Q105510093
RX   PubMed=33007277;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:37431; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:74; ABCG2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A2JX ! MDCK cMDR1-KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   MDCK-hMDR1 cMDR1-KO
AC   CVCL_A2KA
SY   MDCK-hMDR1cMDR1-KO
DR   PRIDE; PXD020238
DR   Wikidata; Q105510097
RX   PubMed=33007277;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:37431; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A2JZ ! MDCK2-ABCB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   MDCK-I
AC   CVCL_0592
SY   MDCK I; MDCKI; MDCK1; MDCK-1
DR   BTO; BTO_0004606
DR   CLO; CLO_0007649
DR   ECACC; 00062106
DR   Wikidata; Q54904779
RX   PubMed=21982418;
RX   PubMed=24975811;
CC   Group: Vaccine production cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   MDCK-II
AC   CVCL_0424
SY   MDCK II; MDCKII; MDCK2; MDCK-2; MDCK Type II; MDCKII-WT
DR   BTO; BTO_0004607
DR   MCCL; MCC:0000321
DR   AddexBio; P0014001/82
DR   CCLV; CCLV-RIE 1061
DR   ChEMBL-Cells; CHEMBL3308862
DR   ChEMBL-Targets; CHEMBL4296466
DR   CLS; 305233
DR   ECACC; 00062107
DR   Lonza; 811
DR   PRIDE; PXD001130
DR   PubChem_Cell_line; CVCL_0424
DR   RCB; RCB5148
DR   Wikidata; Q54904781
RX   PubMed=1468552;
RX   PubMed=19941903;
RX   PubMed=21766308;
RX   PubMed=21982418;
RX   PubMed=24975811;
RX   PubMed=34737324;
CC   Group: Vaccine production cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   MDCK-II Abcc1
AC   CVCL_B3SF
SY   rMRP1-MDCK
DR   Wikidata; Q110433027
RX   PubMed=15198509;
CC   Genetic integration: Method=Transfection; Gene=RGD; 3112; Abcc1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   MDCK-II Rab10-KO
AC   CVCL_A6UX
SY   Rab10-KO MDCK-II; Rab10-KO clone #32
DR   RCB; RCB5111
DR   Wikidata; Q107116187
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45247; RAB10.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab11-KO
AC   CVCL_A6UY
SY   Rab11-KO MDCK-II; Rab11-KO clone #7
DR   RCB; RCB5112
DR   Wikidata; Q107116190
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45248; RAB11A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45249; RAB11B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab11/25-KO
AC   CVCL_A6UZ
SY   Rab11/25-KO MDCK-II; Rab11/25-KO clone #35
DR   RCB; RCB5143
DR   Wikidata; Q107116192
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45248; RAB11A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45249; RAB11B.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45265; RAB25.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A6UY ! MDCK-II Rab11-KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab12-KO
AC   CVCL_A6VA
SY   Rab12-KO MDCK-II; Rab12-KO clone #2
DR   RCB; RCB5113
DR   Wikidata; Q107116195
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:103700; RAB12.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab13-KO
AC   CVCL_A6VB
SY   Rab13-KO MDCK-II; Rab13-KO clone #21
DR   RCB; RCB5114
DR   Wikidata; Q107116197
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45253; RAB13.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab14-KO
AC   CVCL_A6VC
SY   Rab14-KO MDCK-II; Rab14-KO clone #22
DR   RCB; RCB5115
DR   Wikidata; Q107116199
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45254; RAB14.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab15-KO
AC   CVCL_A6VD
SY   Rab15-KO MDCK-II; Rab15-KO clone #18
DR   RCB; RCB5116
DR   Wikidata; Q107116200
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45255; RAB15.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab17-KO
AC   CVCL_A6VE
SY   Rab17-KO MDCK-II; Rab17-KO clone #1
DR   RCB; RCB5117
DR   Wikidata; Q107116203
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45256; RAB17.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab18-KO
AC   CVCL_A6VF
SY   Rab18-KO MDCK-II; Rab18-KO clone #31
DR   RCB; RCB5118
DR   Wikidata; Q107116207
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45257; RAB18.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab19-KO
AC   CVCL_A6VG
SY   Rab19-KO MDCK-II; Rab19-KO clone #22
DR   RCB; RCB5119
DR   Wikidata; Q107116212
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45258; RAB19.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab19/43-KO
AC   CVCL_A6VH
SY   Rab19/43-KO MDCK-II; Rab19/43-KO clone #7
DR   RCB; RCB5144
DR   Wikidata; Q107116214
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45258; RAB19.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45289; RAB43.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A6WL ! MDCK-II Rab43-KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab1A-KO
AC   CVCL_A6VI
SY   Rab1A-KO MDCK-II; Rab1A-KO clone #19
DR   RCB; RCB5099
DR   Wikidata; Q107116217
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45259; RAB1A.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab1B-KO
AC   CVCL_A6VJ
SY   Rab1B-KO MDCK-II; Rab1B-KO clone #16
DR   RCB; RCB5100
DR   Wikidata; Q107116220
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:52037; RAB1B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab2-KO
AC   CVCL_A6VK
SY   Rab2-KO MDCK-II; Rab2-KO clone 31
DR   RCB; RCB5101
DR   Wikidata; Q107116222
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45271; RAB2A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45272; RAB2B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab20-KO
AC   CVCL_A6VL
SY   Rab20-KO MDCK-II; Rab20-KO clone #30
DR   RCB; RCB5120
DR   Wikidata; Q107116225
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45260; RAB20.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab21-KO
AC   CVCL_A6VM
SY   Rab21-KO MDCK-II; Rab21-KO clone #14
DR   RCB; RCB5121
DR   Wikidata; Q107116227
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45261; RAB21.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab22-KO
AC   CVCL_A6VN
SY   Rab22-KO MDCK-II; Rab22-KO clone #29
DR   RCB; RCB5122
DR   Wikidata; Q107116230
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45262; RAB22A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45274; RAB31.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab23-KO
AC   CVCL_A6VP
SY   Rab23-KO MDCK-II; Rab23-KO clone #3
DR   RCB; RCB5123
DR   Wikidata; Q107116233
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45263; RAB23.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab24-KO
AC   CVCL_A6VQ
SY   Rab24-KO MDCK-II; Rab24-KO clone #6
DR   RCB; RCB5124
DR   Wikidata; Q107116236
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45264; RAB24.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab25-KO
AC   CVCL_A6VR
SY   Rab25-KO MDCK-II; Rab25-KO clone #6
DR   RCB; RCB5125
DR   Wikidata; Q107116239
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45265; RAB25.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab26-KO
AC   CVCL_A6VS
SY   Rab26-KO MDCK-II; Rab26-KO clone #13
DR   RCB; RCB5126
DR   Wikidata; Q107116242
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45266; RAB26.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab26/37-KO
AC   CVCL_A6VT
SY   Rab26/37-KO MDCK-II; Rab26/37-KO clone #14
DR   RCB; RCB5145
DR   Wikidata; Q107116245
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45266; RAB26.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45279; RAB37.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A6WF ! MDCK-II Rab37-KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab27-KO
AC   CVCL_A6VU
SY   Rab27-KO MDCK-II; Rab27-KO clone #42
DR   RCB; RCB5127
DR   Wikidata; Q107116247
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45267; RAB27A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45268; RAB27B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab28-KO
AC   CVCL_A6VV
SY   Rab28-KO MDCK-II; Rab28-KO clone #26
DR   RCB; RCB5128
DR   Wikidata; Q107116251
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45269; RAB28.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab29-KO
AC   CVCL_A6VW
SY   Rab29-KO MDCK-II; Rab29-KO clone #18
DR   RCB; RCB5129
DR   Wikidata; Q107116255
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45270; RAB29.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab3-KO
AC   CVCL_A6VX
SY   Rab3-KO MDCK-II; Rab3-KO clone #8
DR   RCB; RCB5102
DR   Wikidata; Q107116259
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45282; RAB3A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45283; RAB3B.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45284; RAB3C.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45285; RAB3D.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab30-KO
AC   CVCL_A6VY
SY   Rab30-KO MDCK-II; Rab30-KO clone #5
DR   RCB; RCB5130
DR   Wikidata; Q107116262
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45273; RAB30.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab32/38-KO
AC   CVCL_A6VZ
SY   Rab32/38-KO MDCK-II; Rab32/38-KO clone #11
DR   RCB; RCB5131
DR   Wikidata; Q107116264
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:53757; RAB32.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45280; RAB38.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab33-KO
AC   CVCL_A6WA
SY   Rab33-KO MDCK-II; Rab33-KO clone #15
DR   RCB; RCB5132
DR   Wikidata; Q107116267
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45275; RAB33A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45276; RAB33B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab34-KO
AC   CVCL_A6WB
SY   Rab34-KO MDCK-II; Rab34-KO clone #20
DR   RCB; RCB5133
DR   Wikidata; Q107116271
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45277; RAB34.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab34/36-KO
AC   CVCL_A6WC
SY   Rab34/36-KO MDCK-II; Rab34/36-KO clone #3
DR   RCB; RCB5146
DR   Wikidata; Q107116275
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45277; RAB34.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:49953; RAB36.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A6WE ! MDCK-II Rab36-KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab35-KO
AC   CVCL_A6WD
SY   Rab35-KO MDCK-II; Rab35-KO clone #20
DR   RCB; RCB5134
DR   Wikidata; Q107116278
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45278; RAB35.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab36-KO
AC   CVCL_A6WE
SY   Rab36-KO MDCK-II; Rab36-KO clone #17
DR   RCB; RCB5135
DR   Wikidata; Q107116281
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:49953; RAB36.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab37-KO
AC   CVCL_A6WF
SY   Rab37-KO MDCK-II; Rab37-KO clone #32
DR   RCB; RCB5136
DR   Wikidata; Q107116283
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45279; RAB37.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab39-KO
AC   CVCL_A6WG
SY   Rab39-KO MDCK-II; Rab39-KO clone #5
DR   RCB; RCB5137
DR   Wikidata; Q107116286
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111679; RAB39A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45281; RAB39B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab39/42-KO
AC   CVCL_A6WH
SY   Rab39/42-KO MDCK-II; Rab39/42-KO clone #53
DR   RCB; RCB5147
DR   Wikidata; Q107116289
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111679; RAB39A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45281; RAB39B.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111685; RAB42.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A6WK ! MDCK-II Rab42-KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab4-KO
AC   CVCL_A6WI
SY   Rab4-KO MDCK-II; Rab4-KO clone #16
DR   RCB; RCB5103
DR   Wikidata; Q107116292
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45290; RAB4A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:53756; RAB4B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab40-KO
AC   CVCL_A6WJ
SY   Rab40-KO MDCK-II; Rab40-KO clone #9
DR   RCB; RCB5138
DR   Wikidata; Q107116294
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111680; RAB40B.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112753; RAB40C.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab42-KO
AC   CVCL_A6WK
SY   Rab42-KO MDCK-II; Rab42-KO clone #2
DR   RCB; RCB5139
DR   Wikidata; Q107116296
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111685; RAB42.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab43-KO
AC   CVCL_A6WL
SY   Rab43-KO MDCK-II; Rab43-KO clone #38
DR   RCB; RCB5140
DR   Wikidata; Q107116299
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45289; RAB43.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab5AB-KO
AC   CVCL_A6WM
SY   Rab5AB-KO MDCK-II; Rab5AB-KO clone #29
DR   RCB; RCB5104
DR   Wikidata; Q107116303
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45291; RAB5A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45292; RAB5B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab5C-KO
AC   CVCL_A6WN
SY   Rab5C-KO MDCK-II; Rab5C-KO clone #8
DR   RCB; RCB5105
DR   Wikidata; Q107116305
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:55798; RAB5C.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab6-KO
AC   CVCL_A6WP
SY   Rab6-KO MDCK-II; Rab6-KO clone #7
DR   RCB; RCB5106
DR   Wikidata; Q107116309
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:59055; RAB6A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:59057; RAB6B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab7A-KO
AC   CVCL_A6WQ
SY   Rab7A-KO MDCK-II; Rab7A-KO clone #3
DR   RCB; RCB5107
DR   Wikidata; Q107116312
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45293; RAB7A.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab7A/9-KO
AC   CVCL_A6WU
SY   Rab7A/9-KO MDCK-II; Rab7A/9-KO clone #24
DR   RCB; RCB5142
DR   Wikidata; Q107116320
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45293; RAB7A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45297; RAB9A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45298; RAB9B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_A6WT ! MDCK-II Rab9-KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab7AB-KO
AC   CVCL_A6WV
SY   Rab7AB-KO MDCK-II; Rab7AB-KO clone #11
DR   RCB; RCB5141
DR   Wikidata; Q107116323
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45293; RAB7A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45294; RAB7B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab7B-KO
AC   CVCL_A6WR
SY   Rab7B-KO MDCK-II; Rab7B-KO clone #2
DR   RCB; RCB5108
DR   Wikidata; Q107116324
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45294; RAB7B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab8-KO
AC   CVCL_A6WS
SY   Rab8-KO MDCK-II; Rab8-KO clone #8
DR   RCB; RCB5109
DR   Wikidata; Q107116327
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45295; RAB8A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45296; RAB8B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-II Rab9-KO
AC   CVCL_A6WT
SY   Rab9-KO MDCK-II; Rab9-KO clone #5
DR   RCB; RCB5110
DR   Wikidata; Q107116330
RX   PubMed=31072826;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45297; RAB9A.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45298; RAB9B.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   MDCK-MDR1
AC   CVCL_S586
SY   MDCK MDR1; MDCKII-MRP1; MDCKII-MDR1; MDCK2-MDR1; MDCKII x ABCB1-Neo
DR   BTO; BTO_0005423
DR   ChEMBL-Cells; CHEMBL4295482
DR   ChEMBL-Targets; CHEMBL4296467
DR   PubChem_Cell_line; CVCL_S586
DR   Wikidata; Q54904783
RX   PubMed=9426231;
RX   PubMed=12134945;
RX   PubMed=16749865;
RX   PubMed=21766308;
WW   Provider; Creative Cell; -; https://www.creativecell.hu/cell-line_rtu_abc.html
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: There is another MDCK-II cell line with transfected human ABCB1: MDCK2-ABCB1 (Cellosaurus=CVCL_A2JZ).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 21
//
ID   MDCK-MRP2
AC   CVCL_X022
SY   MDCKII-MRP2; MDCKII-MOAT17
DR   Wikidata; Q54904784
RX   PubMed=9525973;
RX   PubMed=12134946;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:53; ABCC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: There is another MDCK-II cell line with transfected human ABCC2: MDCK2-ABCC2 (Cellosaurus=CVCL_A2JY).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 14
//
ID   MDCK-P-gp
AC   CVCL_IZ19
DR   Wikidata; Q54904786
RX   PubMed=28093773;
CC   Characteristics: Developed to assess drugs as substrates for p-glycoprotein (ABCB1/MDR1). Expresses high level of ABCB1/MDR1.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   MDCK-Protein Free
AC   CVCL_JX35
DR   ECACC; 02050101
DR   Wikidata; Q54904788
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   MDCK-QKO-EKARrEV-NLS
AC   CVCL_D5IX
DR   Wikidata; Q127382788
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111490; EREG.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I4 ! MDCK-dEGF/HBEGF/TGFalpha/EREG KO 2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-RE7
AC   CVCL_D3UF
SY   RE7
DR   Wikidata; Q127382789
RX   PubMed=7939629;
RX   PubMed=9890710;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7381; MST1R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   MDCK-S
AC   CVCL_IQ72
DR   Wikidata; Q54904790
RX   Patent=US7670837;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6500.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   MDCK-SF101
AC   CVCL_IQ73
SY   MDCK-SF 101
DR   Wikidata; Q54904798
RX   Patent=US7670837;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6501.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 11
//
ID   MDCK-SF102
AC   CVCL_IQ74
SY   MDCK-SF 102
DR   Wikidata; Q54904799
RX   Patent=US7670837;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6502.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 11
//
ID   MDCK-SF103
AC   CVCL_IQ75
SY   MDCK-SF 103
DR   Wikidata; Q54904800
RX   Patent=US7670837;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6503.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 11
//
ID   MDCK-SFS
AC   CVCL_WL74
DR   FCS-free; 41-14-408-3-16-12
DR   Wikidata; Q95987800
RX   PubMed=20933017;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in suspension in SFM4BHK21 medium.
CC   Virology: Potentially useful for large scale influenza virus production.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   MDCK-SIAT1
AC   CVCL_Z936
DR   ABM; T6999
DR   CLS; 602281
DR   ECACC; 05071502
DR   Wikidata; Q54904801
RX   PubMed=12857911;
RX   PubMed=34737324;
WW   Provider; Vircell; -; https://www.vircell.com/en/products/mdck-siat1-cell-line
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10860; ST6GAL1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   MDCK-TKO-EKARrEV-NLS
AC   CVCL_D5IY
DR   JCRB; JCRB1983
DR   Wikidata; Q127382790
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal (PubMed=34667080).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:40235; EGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:41609; HBEGF.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112755; TGFA.
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5I3 ! MDCK-dEGF/HBEGF/TGFalpha KO
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MDCK-UT-A1
AC   CVCL_A6IW
DR   Wikidata; Q107116332
RX   PubMed=14749217;
CC   Characteristics: Transfected with the pFRT/lacZeo and pcDNA5/FRT/UT-A1 plasmids (PubMed=14749217).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10919; SLC14A2 (Note=Isoform UT-A1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 10
//
ID   MDCK-W73
AC   CVCL_A2JE
DR   Wikidata; Q107116334
RX   PubMed=32928630;
CC   Characteristics: Has a high tumorigenic potential (PubMed=32928630).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   MDCK-WT-EKARrEV-NLS-LDR
AC   CVCL_D5J1
DR   JCRB; JCRB1993
DR   Wikidata; Q127382791
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal as well a construct containing a Lyn-targeted (first 11 residues of LYN) rapamycin-binding (FRB) domain from MTOR (LDR) (PubMed=34667080).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5IR ! MDCK-EKARrEV-NLS
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-WT-EKARrEV-NLS-LDR-mRFP-FKBP-mSos1-linkercat
AC   CVCL_D5JR
DR   Wikidata; Q127382792
RX   PubMed=34667080;
CC   Characteristics: Transduced with the FRET biosensor EKARrEV-NLS FRET biosensor EKARrEV-NLS, which consists of a donor fluorescent protein CFP, an ERK substrate peptide derived from RSK1, an optimized linker, a FHA1 phosphate binding domain, an acceptor fluorescent protein YFP and a nuclear localization signal as well a construct containing a Lyn-targeted (first 11 residues of LYN) rapamycin-binding (FRB) domain from MTOR (LDR) and a third construct pT2Aneo-mRFP-FKBP-mSos1-linkercat (PubMed=34667080).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D5J1 ! MDCK-WT-EKARrEV-NLS-LDR
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   MDCK-XF02
AC   CVCL_A9IZ
DR   CCRID; 4201PAT-CCTCC01297
DR   Wikidata; Q108820882
RX   DOI=10.3969/j.issn.1002-2694.2019.00.172;
RX   Patent=CN109852580A;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018190.
CC   Doubling time: <21 hours (DOI=10.3969/j.issn.1002-2694.2019.00.172).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   MDCK-XF03
AC   CVCL_A9JA
DR   CCRID; 4201PAT-CCTCC01298
DR   Wikidata; Q108820883
RX   Patent=CN109929796A;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018191.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   MDCK-XF04
AC   CVCL_A9JB
DR   CCRID; 4201PAT-CCTCC01299
DR   Wikidata; Q108820884
RX   Patent=CN109852579A;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018192.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   MDCK.1
AC   CVCL_B033
DR   ATCC; CRL-2935
DR   BCRJ; 0169
DR   Wikidata; Q54904802
RX   PubMed=21982418;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/mdck-culture-clonal-deriviatives
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   MDCK.2
AC   CVCL_B034
DR   ATCC; CRL-2936
DR   BCRJ; 0170
DR   Wikidata; Q54904803
RX   PubMed=21982418;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/mdck-culture-clonal-deriviatives
CC   Doubling time: ~22 hours (ATCC=CRL-2936).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   MDCK.5F1
AC   CVCL_DE56
SY   BV-5F1; BV5F1
DR   Wikidata; Q54904804
RX   Patent=US20080254067;
RX   PubMed=10494965;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12042.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   MDCK.P3
AC   CVCL_2586
SY   MDCK P3
DR   JCRB; JCRB0717
DR   Wikidata; Q54904805
RX   DOI=10.1247/csf.5.315;
RX   PubMed=2993257;
RX   PubMed=3242846;
RX   PubMed=21982418;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   MDCK.STAT1 KO
AC   CVCL_YZ44
SY   MDCK.STAT1-KO; MDCK.STAT1KO
DR   ATCC; CCL-34-VHG
DR   Wikidata; Q98127201
RX   CelloPub=CLPUB00659;
CC   Group: Vaccine production cell line.
CC   Virology: Excellent cell model for virus propagation and viral vaccine production. It exhibits significant increased viral titer and enhanced virus production capability when compared to its parental cell line (ATCC=CCL-34-VHG).
CC   Doubling time: ~22 hours (ATCC=CCL-34-VHG).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112730; STAT1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   MDCK.SUS1
AC   CVCL_WL70
DR   Wikidata; Q95987809
RX   PubMed=20638458;
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to growth in suspension in SMIF8 medium.
CC   Doubling time: ~50 hours (PubMed=20638458).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MDCK.SUS2
AC   CVCL_WL71
DR   FCS-free; 41-14-330-1-16-12
DR   Wikidata; Q95987810
RX   PubMed=20638458;
RX   PubMed=25994255;
RX   PubMed=31047676;
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to growth in suspension in SMIF8 medium.
CC   Doubling time: 24 hours (Note=In wave bioreactor), 37 hours (Note=In stirred-tank reactor) (PubMed=20638458); 24-26 hours (Note=In Smif8 medium) (PubMed=31047676).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_WL70 ! MDCK.SUS1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   MDCK.Xeno
AC   CVCL_WL72
DR   Wikidata; Q95987812
RX   PubMed=31047676;
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to growth in supsension in Xeno-S001S medium (PubMed=31047676).
CC   Doubling time: ~20 hours (PubMed=31047676).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_WL71 ! MDCK.SUS2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   MDCK/60
AC   CVCL_K241
SY   MDCK 60
DR   BCRJ; 0171
DR   Wikidata; Q54904806
RX   PubMed=10738110;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   MDCK/IgR
AC   CVCL_WC98
DR   CCRID; 1101CAN-PUMC000409
DR   CCTCC; GDC0402
DR   Wikidata; Q95987828
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 9
//
ID   MDCK/wtPar6
AC   CVCL_F1BW
RX   PubMed=19617897;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15943; PARD6A (Note=With a N-terminal FLAG tag).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MDCK2-ABCB1
AC   CVCL_A2JZ
SY   ABCB1-MDCK2; MDCK-hMDR1
DR   Wikidata; Q105510100
RX   PubMed=25264565;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Caution: There is another MDCK-II cell line with transfected human ABCB1: MDCK-MDR1 (Cellosaurus=CVCL_S586).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   MDCK2-ABCC2
AC   CVCL_A2JY
SY   MDCK-MRP2; ABCC2-MDCK2
DR   Wikidata; Q105510103
RX   PubMed=24056116;
RX   PubMed=25264565;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:53; ABCC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Caution: There is another MDCK-II cell line with transfected human ABCC2: MDCK-MRP2 (Cellosaurus=CVCL_X022).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   MDCKII ABCA1 HA-KM
AC   CVCL_E6JH
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With p.Lys1952Met and a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MDCKII ABCA1 HA-MK
AC   CVCL_E6JI
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With p.Lys939Met and a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MDCKII ABCA1 HA-MM
AC   CVCL_E6JJ
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With p.Lys939Met, p.Lys1952Met and a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MDCKII ABCA1 HA-WT
AC   CVCL_E6JK
RX   PubMed=20025763;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29; ABCA1 (Note=With a HA tag inserted between p.Gly207 and p.Asp208).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MDCKII MDR1 KO
AC   CVCL_C3F0
DR   Sigma-Aldrich; MTOX1301Z
DR   Wikidata; Q114312274
CC   Knockout cell: Method=ZFN; VGNC; VGNC:37431; ABCB1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   MDCKII-LE
AC   CVCL_VR40
SY   MDCKII-Low Efflux; RRCK; Ralph Russ Canine Kidney
DR   ChEMBL-Cells; CHEMBL4295481
DR   ChEMBL-Targets; CHEMBL4296468
DR   PubChem_Cell_line; CVCL_VR40
DR   Wikidata; Q95987829
RX   PubMed=21766308;
CC   Characteristics: Compared to the parent cell line, has a lower expression of endogenous ABCB1/MDR1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0424 ! MDCK-II
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 8
//
ID   MDCKII-MRP2/UGT1A1
AC   CVCL_9U72
SY   MDCKII-UGT1A1/MRP2
DR   Wikidata; Q54904807
RX   PubMed=26833852;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:53; ABCC2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12530; UGT1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_X022 ! MDCK-MRP2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   MDCKts.src
AC   CVCL_GZ12
SY   MDCKts.src, cl2; ts-src MDCK clone ts-31-2
DR   TOKU-E; 4072
DR   Wikidata; Q54904808
RX   PubMed=8425900;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00524; Rous sarcoma virus subgroup A (strain Schmidt-Ruppin) v-Src (Note=Rendered temperature sensitive).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0592 ! MDCK-I
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
ID   mDCT15
AC   CVCL_B6H8
SY   mouse Distal Convoluted Tubule 15
DR   Wikidata; Q112930107
RX   PubMed=22718890;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Kidney, distal convoluted tubule; UBERON=UBERON_0001292.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6896 ! DKC-8
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   MDCUi001-A
AC   CVCL_XI89
SY   Th-XOI#1
DR   BioSamples; SAMEA5843916
DR   hPSCreg; MDCUi001-A
DR   SKIP; SKIP005784
DR   Wikidata; Q95987833
RX   PubMed=31326747;
CC   From: Center of Excellence for Medical Genomics, Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:15455; MBTPS2; Simple; p.Asn459Ser (c.1376A>G); ClinVar=VCV000558767; Zygosity=Hemizygous (PubMed=31326747).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164153; Osteogenesis imperfecta type XIX
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI90 ! MDCUi001-B
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   MDCUi001-B
AC   CVCL_XI90
SY   Th-XOI#2
DR   hPSCreg; MDCUi001-B
DR   SKIP; SKIP005785
DR   Wikidata; Q95987834
RX   PubMed=31326747;
CC   From: Center of Excellence for Medical Genomics, Chulalongkorn University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:15455; MBTPS2; Simple; p.Asn459Ser (c.1376A>G); ClinVar=VCV000558767; Zygosity=Hemizygous (PubMed=31326747).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C164153; Osteogenesis imperfecta type XIX
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI89 ! MDCUi001-A
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   mDD1
AC   CVCL_9T74
SY   mouse Ductus Deferens 1
DR   Wikidata; Q54904809
RX   PubMed=11850199;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Vas deferens; UBERON=UBERON_0001000.
CC   Breed/subspecies: C57BL/6 x C3H/He Hoxa11-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   mDD2
AC   CVCL_9T75
SY   mouse Ductus Deferens 2
DR   Wikidata; Q54904810
RX   PubMed=11850199;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Vas deferens; UBERON=UBERON_0001000.
CC   Breed/subspecies: C57BL/6 x C3H/He Hoxa11-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   MDEC-07114
AC   CVCL_IM31
DR   Wikidata; Q54904811
RX   CelloPub=CLPUB00364;
CC   Group: Insect cell line.
CC   Doubling time: 44 hours (CelloPub=CLPUB00364).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7370; ! Musca domestica (House fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   MDFSP-S1
AC   CVCL_D4A8
DR   Wikidata; Q127382793
RX   PubMed=37610680;
CC   Population: Chinese.
CC   Characteristics: Imatinib resistant (PubMed=37610680).
CC   Doubling time: ~5 days (PubMed=37610680).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=37610680).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=37610680).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2197; COL1A1 + HGNC; HGNC:8800; PDGFB; Name(s)=COL1A1-PDGFB (PubMed=37610680).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Right gluteal muscle; UBERON=UBERON_0002000.
ST   Source(s): PubMed=37610680
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 17,18
ST   D13S317: 10,13
ST   D16S539: 10,12
ST   D18S51: 13,17
ST   D19S433: 14,15.2
ST   D1S1656: 13,14
ST   D21S11: 27,32
ST   D22S1045: 15
ST   D2S1338: 19,24
ST   D2S441: 10,14
ST   D3S1358: 15,16
ST   D5S818: 7,10
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   Penta D: 8,10
ST   Penta E: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MDG2.1
AC   CVCL_6685
DR   Wikidata; Q54904812
RX   PubMed=8143903;
RX   PubMed=15541573;
CC   Doubling time: 24-36 hours (PubMed=8143903).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Prepubertal
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   MDGK
AC   CVCL_U237
SY   MDG.K; Madin-Darby Goat Kidney
DR   ATCC; CRL-6280
DR   Wikidata; Q54904813
RX   PubMed=5587551;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6280; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   MDM2-RNB
AC   CVCL_D272
DR   JCRB; IFO50490
DR   Wikidata; Q54904814
RX   PubMed=8895524;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6973; MDM2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D273 ! RNB
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   MDN
AC   CVCL_HX07
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_HX07
DR   Cosmic; 2809778
DR   IARC_TP53; 28508
DR   Wikidata; Q54904815
RX   PubMed=10583232;
RX   PubMed=16956823;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,02:09; B*44,51; C*04,14 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 17
//
ID   MDOK
AC   CVCL_2587
SY   Madin-Darby Ovine Kidney
DR   CLO; CLO_0007650
DR   CLDB; cl3427
DR   ATCC; CRL-1633
DR   BCRJ; 0172
DR   IZSLER; BS CL 65
DR   Wikidata; Q54904816
RX   PubMed=5587551;
RX   PubMed=13567776;
RX   PubMed=14282199;
RX   PubMed=33389257;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mdok/mdokcells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Discontinued: IZSLER; BS CL 65; probable.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   MDPC-23
AC   CVCL_0E50
SY   MDPC 23; MDPC23; Mouse Dental Papilla Cell-23
DR   ATCC; CRL-2537
DR   Wikidata; Q54904817
RX   PubMed=9541235;
RX   PubMed=9862224;
RX   PubMed=22770625;
CC   Discontinued: ATCC; CRL-2537; true.
CC   Derived from site: In situ; Embryonic tooth bud, dental papilla; UBERON=UBERON_0001763.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18-19FD
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   mDPC6T
AC   CVCL_B6Y8
DR   Wikidata; Q112129238
RX   PubMed=23299318;
CC   Characteristics: Transduced with a pHLox-CMV-TAg-IRES-TK lentiviral construct. The TK gene allows selection using ganciclovir (GCV).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18-19FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   mDPCET
AC   CVCL_B6Y9
DR   Wikidata; Q112129239
RX   PubMed=23299318;
CC   Characteristics: Reversibly immortalized; exposure to tamoxifen induces the expression of the Cre gene that effects Cre/LoxP recombination and excise the SV40 TAG gene (PubMed=23299318).
CC   Characteristics: Transduced with a pHLox-CMV-TAg-IRES-TK lentiviral construct as well as a pCAG-ERT2iCreERT2-neo construct (PubMed=23299318).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6Y8 ! mDPC6T
SX   Sex unspecified
AG   18-19FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   MDR3
AC   CVCL_Z836
DR   DGRC; 8
DR   FlyBase_Cell_line; FBtc0000008
DR   Wikidata; Q54904818
RX   PubMed=432755;
CC   Group: Insect cell line.
CC   Doubling time: 25 hours (DGRC=8).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z838 ! Kc-HP
SX   Female
AG   Dorsal closure stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   MDS
AC   CVCL_L807
DR   BioSample; SAMN03151806
DR   cancercelllines; CVCL_L807
DR   Wikidata; Q54904819
RX   PubMed=1438250;
RX   PubMed=12592342;
RX   PubMed=19344951;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (PubMed=12592342; PubMed=19344951; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00237.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 27
//
ID   MDS-2.13
AC   CVCL_VH19
DR   GEO; GSM1594193
DR   Wikidata; Q54904820
RX   PubMed=25798938;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
ST   Source(s): PubMed=25798938
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 16,23
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH20 ! MDS-2.A3
OI   CVCL_VH22 ! N-2.8
OI   CVCL_VH21 ! N-2.12
OI   CVCL_VH24 ! N-2.A2
OI   CVCL_VH23 ! N-2.A11
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   MDS-2.13C
AC   CVCL_VH25
DR   Wikidata; Q54904821
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH19 ! MDS-2.13
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   MDS-2.A3
AC   CVCL_VH20
DR   Wikidata; Q54904822
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH19 ! MDS-2.13
OI   CVCL_VH22 ! N-2.8
OI   CVCL_VH21 ! N-2.12
OI   CVCL_VH24 ! N-2.A2
OI   CVCL_VH23 ! N-2.A11
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   MDS-2.A3C
AC   CVCL_VH26
DR   GEO; GSM1594192
DR   Wikidata; Q54904823
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH20 ! MDS-2.A3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   MDS-3.1
AC   CVCL_VH15
DR   GEO; GSM1594194
DR   Wikidata; Q54904824
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
ST   Source(s): PubMed=25798938
ST   Amelogenin: X,Y
ST   D13S317: 8,12
ST   D18S51: 13,18
ST   D21S11: 28,30
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   vWA: 16,18
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH16 ! MDS-3.4
OI   CVCL_VH17 ! MDS-3.5
OI   CVCL_VH18 ! N-3.10
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   MDS-3.4
AC   CVCL_VH16
DR   Wikidata; Q54904825
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH15 ! MDS-3.1
OI   CVCL_VH17 ! MDS-3.5
OI   CVCL_VH18 ! N-3.10
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   MDS-3.5
AC   CVCL_VH17
DR   Wikidata; Q54904826
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH15 ! MDS-3.1
OI   CVCL_VH16 ! MDS-3.4
OI   CVCL_VH18 ! N-3.10
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   MDS-L
AC   CVCL_A8QV
SY   MDSL
DR   BTO; BTO_0006229
DR   cancercelllines; CVCL_A8QV
DR   Wikidata; Q108820885
RX   PubMed=11108571;
RX   PubMed=20130600;
RX   PubMed=29955132;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Where_can_I_get_MDS92_and_MDS-L_cell_lines
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:4768; H3C3; Simple; p.Lys28Met (c.83A>T); Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=29955132
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 16,18
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A647 ! MDS92
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   MDS-L-2007
AC   CVCL_A8QY
DR   cancercelllines; CVCL_A8QY
DR   Wikidata; Q108820887
RX   PubMed=29955132;
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:4768; H3C3; Simple; p.Lys28Met (c.83A>T); Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=29955132
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 16,18
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8QV ! MDS-L
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   MDS-L/GFP-N
AC   CVCL_A8QW
DR   cancercelllines; CVCL_A8QW
DR   Wikidata; Q108820888
RX   PubMed=11108571;
CC   Population: Japanese.
CC   Characteristics: Transduced with a 5'LTR-CMV-rsGFP-Neo-3'LTR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; JYYJ1; rsEGFP (Note=rsGFP, red-shifted GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8QV ! MDS-L
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   MDS-L/GR-GFP-N
AC   CVCL_A8QX
DR   cancercelllines; CVCL_A8QX
DR   Wikidata; Q108820889
RX   PubMed=11108571;
CC   Population: Japanese.
CC   Characteristics: Transduced with a 5'LTR-CSF3R-CMV-rsGFP-Neo-3'LTR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; JYYJ1; rsEGFP (Note=rsGFP, red-shifted GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2439; CSF3R.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8QV ! MDS-L
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   MDS-LGF
AC   CVCL_A8QZ
DR   cancercelllines; CVCL_A8QZ
DR   Wikidata; Q108820891
RX   PubMed=29955132;
CC   Population: Japanese.
CC   Characteristics: IL3 independent. Has lost the H3C3 p.Lys28Met mutation of the parent cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=29955132
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 16,18
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8QV ! MDS-L
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   MDS1r(17)-1 iPSC
AC   CVCL_DF95
SY   MDS1 iPSC clone 1
DR   GEO; GSM1274193
DR   Wikidata; Q54904827
RX   PubMed=24413397;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   NCIt; C3360; Supernumerary circular chromosome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U19 ! GM06047
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   MDS1r(17)-2 iPSC
AC   CVCL_DF96
SY   MDS1 iPSC clone 2
DR   GEO; GSM1274194
DR   Wikidata; Q54904828
RX   PubMed=24413397;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   NCIt; C3360; Supernumerary circular chromosome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U19 ! GM06047
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   MDS2-1 iPSC
AC   CVCL_DF97
SY   MDS2 iPSC clone 1
DR   GEO; GSM1274195
DR   Wikidata; Q54904829
RX   PubMed=24413397;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U20 ! GM06097
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 9
//
ID   MDS2-2 iPSC
AC   CVCL_DF98
DR   GEO; GSM1274196
DR   Wikidata; Q54904830
RX   PubMed=24413397;
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U20 ! GM06097
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 9
//
ID   MDS3-1 iPSC
AC   CVCL_DF99
SY   MDS3 iPSC clone 1
DR   Wikidata; Q54904831
RX   PubMed=24413397;
CC   Derived from site: In situ; Fetal diaphragm, skeletal muscle; UBERON=UBERON_0010084+UBERON_0004495.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U22 ! GM09208
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   MDS3-2 iPSC
AC   CVCL_DG00
DR   Wikidata; Q54904832
RX   PubMed=24413397;
CC   Derived from site: In situ; Fetal diaphragm, skeletal muscle; UBERON=UBERON_0010084+UBERON_0004495.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C124852; Miller-Dieker syndrome
DI   ORDO; Orphanet_531; Miller-Dieker syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5U22 ! GM09208
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   MDS92
AC   CVCL_A647
SY   MDS-92; MyeloDysplastic Syndrome 1992
DR   BTO; BTO_0006228
DR   cancercelllines; CVCL_A647
DR   Cosmic; 690409
DR   Cosmic; 1465958
DR   Wikidata; Q54904833
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7947263;
RX   PubMed=8547120;
RX   PubMed=9195772;
RX   PubMed=11108571;
RX   PubMed=19344951;
RX   PubMed=29955132;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Where_can_I_get_MDS92_and_MDS-L_cell_lines
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Doubling time: 80-90 hours (PubMed=7947263).
CC   Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (PubMed=7947263; PubMed=29955132).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=29955132
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 16,18
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   MDST8
AC   CVCL_2588
SY   T8
DR   CLO; CLO_0009970
DR   EFO; EFO_0006644
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 550
DR   BioSample; SAMN03473139
DR   BioSample; SAMN10988016
DR   cancercelllines; CVCL_2588
DR   Cell_Model_Passport; SIDM00527
DR   ColonAtlas; MDST8
DR   Cosmic; 1995502
DR   Cosmic-CLP; 1240173
DR   DepMap; ACH-000935
DR   ECACC; 99011801
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1240173
DR   GEO; GSM206524
DR   GEO; GSM827347
DR   GEO; GSM887303
DR   GEO; GSM888378
DR   GEO; GSM1448122
DR   GEO; GSM1670088
DR   IARC_TP53; 30118
DR   LiGeA; CCLE_843
DR   LINCS_LDP; LCL-1164
DR   PharmacoDB; MDST8_908_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2588
DR   Wikidata; Q54904834
RX   PubMed=9813657;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*07:02,27:05; C*01:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556fs*3 (c.4660_4661insA) (E1554fs); Zygosity=Heterozygous (Cosmic-CLP=1240173; DepMap=ACH-000935).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=1240173; DepMap=ACH-000935).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (Cosmic-CLP=1240173; DepMap=ACH-000935).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp310Gly (c.929A>G); ClinVar=VCV000566673; Zygosity=Homozygous (Cosmic-CLP=1240173; DepMap=ACH-000935).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (DepMap=ACH-000935).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.18%; Native American=0.98%; East Asian, North=1.64%; East Asian, South=0%; South Asian=1.57%; European, North=63.72%; European, South=31.91% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=1240173; ECACC=99011801; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 16,19.3
ST   D19S433: 12,14,15
ST   D21S11: 28,31
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 8,10 (Cosmic-CLP=1240173; ECACC=99011801; PubMed=25926053)
ST   D7S820: 10 (PubMed=25877200)
ST   D8S1179: 11,14
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 7,13
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 15,20
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   MDTC-CU44
AC   CVCL_T663
SY   CU44
DR   Wikidata; Q54904835
RX   PubMed=18766641;
CC   Group: Bird cell line.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MDTC-CU45
AC   CVCL_T664
SY   CU45
DR   Wikidata; Q54904836
RX   PubMed=18766641;
CC   Group: Bird cell line.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MDTC-CU46
AC   CVCL_T665
SY   CU46
DR   Wikidata; Q54904837
RX   PubMed=18766641;
CC   Group: Bird cell line.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MDTC-HP114-1
AC   CVCL_T666
SY   HP114-1
DR   Wikidata; Q54904846
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_T667 ! MDTC-HP114-2
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP114-2
AC   CVCL_T667
SY   HP114-2
DR   Wikidata; Q54904847
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_T666 ! MDTC-HP114-1
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP115
AC   CVCL_T668
SY   HP115
DR   Wikidata; Q54904848
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP116
AC   CVCL_T669
SY   HP116
DR   Wikidata; Q54904849
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP117
AC   CVCL_T670
SY   HP117
DR   Wikidata; Q54904850
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP118
AC   CVCL_T671
SY   HP118
DR   Wikidata; Q54904851
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP119
AC   CVCL_T672
SY   HP119
DR   Wikidata; Q54904852
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP121
AC   CVCL_T673
SY   HP121
DR   Wikidata; Q54904853
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP122
AC   CVCL_T674
SY   HP122
DR   Wikidata; Q54904854
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP41-1
AC   CVCL_T675
SY   HP41-1
DR   Wikidata; Q54904855
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_T676 ! MDTC-HP41-2
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP41-2
AC   CVCL_T676
SY   HP41-2
DR   Wikidata; Q54904856
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_T675 ! MDTC-HP41-1
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-HP48-3
AC   CVCL_T677
SY   HP48-3
DR   Wikidata; Q54904858
RX   PubMed=18766641;
RX   PubMed=18766837;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   MDTC-RP16
AC   CVCL_N505
SY   RP16; RP-16
DR   Wikidata; Q54904859
RX   PubMed=6277804;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 14-15 hours (PubMed=6277804).
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Nicholas; VBO=VBO_0001710.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_N506 ! MDTC-RP17
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   MDTC-RP17
AC   CVCL_N506
SY   RP17; RP-17
DR   Wikidata; Q54904860
RX   PubMed=6277804;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Nicholas; VBO=VBO_0001710.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_N505 ! MDTC-RP16
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   MDTC-RP18
AC   CVCL_N507
SY   RP18; RP-18
DR   Wikidata; Q54904861
RX   PubMed=6277804;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Doubling time: 8-11 hours (PubMed=6277804).
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Nicholas; VBO=VBO_0001710.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_2589 ! MDTC-RP19
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   MDTC-RP19
AC   CVCL_2589
SY   MDTC RP 19; RP19; RP-19
DR   CLO; CLO_0007651
DR   CLO; CLO_0007652
DR   CLDB; cl3428
DR   ATCC; CRL-8135
DR   IZSLER; BS TCL 39
DR   Wikidata; Q54904862
RX   Patent=US4388298;
RX   PubMed=6277804;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8135.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Nicholas; VBO=VBO_0001710.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
OI   CVCL_N507 ! MDTC-RP18
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   MDTC-RP30
AC   CVCL_T450
SY   RP30
DR   Wikidata; Q54904863
RX   PubMed=2848484;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP31
AC   CVCL_T451
SY   RP31
DR   Wikidata; Q54904865
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP32
AC   CVCL_T452
SY   RP32
DR   Wikidata; Q54904866
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP34
AC   CVCL_T453
SY   RP34
DR   Wikidata; Q54904867
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP35
AC   CVCL_T454
SY   RP35
DR   Wikidata; Q54904868
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP36
AC   CVCL_T455
SY   RP36
DR   Wikidata; Q54904869
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP37
AC   CVCL_T456
SY   RP37
DR   Wikidata; Q54904870
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP38
AC   CVCL_T457
SY   RP38
DR   Wikidata; Q54904871
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP39
AC   CVCL_T458
SY   RP39
DR   Wikidata; Q54904872
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP40
AC   CVCL_T459
SY   RP40
DR   Wikidata; Q54904873
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
CC   Breed/subspecies: Beltsville Small White (BSW); VBO=VBO_0016639.
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   MDTC-RP41
AC   CVCL_T460
SY   RP41
DR   Wikidata; Q54904875
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 10388; Gallid herpesvirus 2 (Marek's disease virus) (strain GA).
DI   NCIt; C84884; Marek disease
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   MDTF
AC   CVCL_J394
SY   Mus Dunni Tail Fibroblast
DR   Wikidata; Q54904876
RX   PubMed=6092693;
RX   PubMed=8510216;
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
OX   NCBI_TaxID=254704; ! Mus terricolor (Earth-colored mouse)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   MDV OU2.1
AC   CVCL_Y591
SY   OU2.1
DR   Wikidata; Q54904877
RX   Patent=US5866117;
RX   PubMed=8553556;
RX   PubMed=9126245;
CC   Group: Bird cell line.
CC   Virology: Infected with Marek's disease virus (MDV).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_Y589 ! CHCC-OU2
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   MDV OU2.2
AC   CVCL_Y590
SY   MDVOU2.2; OU2.2
DR   Wikidata; Q54904878
RX   Patent=US5866117;
RX   PubMed=8553556;
RX   PubMed=9126245;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11985.
CC   Virology: Infected with Marek's disease virus (MDV).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_Y589 ! CHCC-OU2
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   MDW1
AC   CVCL_S412
SY   Mdw1
DR   Wikidata; Q54904879
RX   PubMed=6935454;
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S411 ! MDAY-D2
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   MDW3
AC   CVCL_S413
SY   Mdw3
DR   Wikidata; Q54904880
RX   PubMed=6935454;
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S411 ! MDAY-D2
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   MDW4
AC   CVCL_S414
DR   Wikidata; Q54904881
RX   PubMed=3858579;
RX   PubMed=6935454;
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S411 ! MDAY-D2
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   MDW5
AC   CVCL_S415
DR   Wikidata; Q54904882
RX   PubMed=6935454;
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S411 ! MDAY-D2
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   ME [Human hepatocellular carcinoma]
AC   CVCL_WK60
DR   Wikidata; Q95987909
RX   PubMed=9178645;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:03; B*54,62; C*01,03 (PubMed=9178645).
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
ID   ME [Human melanoma]
AC   CVCL_C666
DR   Wikidata; Q54904883
RX   PubMed=11287286;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 27.6 hours (PubMed=11287286).
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   ME [Mouse]
AC   CVCL_4986
DR   CLO; CLO_0007653
DR   ATCC; CRL-6371
DR   Wikidata; Q54904884
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6371; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   ME [Mouse teratocarcinoma]
AC   CVCL_5T97
DR   Wikidata; Q54904885
RX   PubMed=2098280;
CC   Breed/subspecies: C3H/J.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3554 ! NE
SX   Sex unspecified
AG   7FD
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   ME 1 [Human melanoma]
AC   CVCL_JB73
DR   Wikidata; Q54904886
RX   PubMed=14287274;
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 4
//
ID   ME 1 [Mouse hybridoma]
AC   CVCL_4987
DR   CLO; CLO_0007654
DR   ATCC; HB-119
DR   Wikidata; Q54904887
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   ME 311
AC   CVCL_KS79
SY   ME-311; ME311
DR   Wikidata; Q54904890
RX   PubMed=4055789;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_61730; 9-O-acetyl-alpha-N-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide (9-O-Acetyl-GD3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 4
//
ID   Me Jon
AC   CVCL_3746
DR   CLO; CLO_0007655
DR   ATCC; CRL-1288
DR   Wikidata; Q54904892
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Me Leb
AC   CVCL_ZN88
DR   ATCC; CRL-1371
DR   Wikidata; Q98127202
CC   Discontinued: ATCC; CRL-1371; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Me Lor
AC   CVCL_U786
DR   ATCC; CRL-1368
DR   BioSample; SAMN03471359
DR   Wikidata; Q54904894
CC   Discontinued: ATCC; CRL-1368; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1368
ST   Amelogenin: X,Y
ST   CSF1PO: 7.3,11
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 10
//
ID   Me Mon
AC   CVCL_3747
DR   CLO; CLO_0007656
DR   ATCC; CRL-1342
DR   Wikidata; Q54904895
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Me Rey
AC   CVCL_U787
DR   ATCC; CRL-1346
DR   Wikidata; Q54904896
CC   Discontinued: ATCC; CRL-1346; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Me We
AC   CVCL_U677
DR   ATCC; CRL-1194
DR   Wikidata; Q54904897
CC   Discontinued: ATCC; CRL-1194; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   NCIt; C85036; Pseudoxanthoma elasticum
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   ME-1 [Human leukemia]
AC   CVCL_2110
SY   ME1
DR   CLO; CLO_0009847
DR   EFO; EFO_0006645
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03472157
DR   BioSample; SAMN10988452
DR   cancercelllines; CVCL_2110
DR   Cell_Model_Passport; SIDM00338
DR   Cosmic; 787450
DR   Cosmic; 975268
DR   Cosmic; 999732
DR   Cosmic; 1281326
DR   Cosmic; 1524833
DR   Cosmic; 2131544
DR   Cosmic; 2306217
DR   Cosmic; 2750862
DR   Cosmic-CLP; 1330942
DR   DepMap; ACH-000439
DR   DSMZ; ACC-537
DR   DSMZCellDive; ACC-537
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1330942
DR   GEO; GSM236788
DR   GEO; GSM236824
DR   GEO; GSM743412
DR   GEO; GSM887304
DR   GEO; GSM888379
DR   GEO; GSM1374666
DR   GEO; GSM1446754
DR   GEO; GSM1670089
DR   IARC_TP53; 30119
DR   LiGeA; CCLE_113
DR   LINCS_LDP; LCL-1059
DR   PharmacoDB; ME1_909_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2110
DR   Wikidata; Q54904898
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2070080;
RX   PubMed=8018932;
RX   PubMed=15843827;
RX   PubMed=16523483;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31395879;
RX   PubMed=35839778;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 4-5 days (PubMed=2070080); ~3-5 days (DSMZ=ACC-537).
CC   HLA typing: A*24:02,26:01; B*35:01,51:01; C*01:02,14:02; DQA1*01:03,01:03; DQB1*06:02,06:02; DRB1*08:02,15:01 (PubMed=26589293).
CC   HLA typing: A*24:02:01,26:01:01; B*35:01:01,51:01:01; C*01:02:01,14:02:01; DPA1*01:03:01,02:02:02; DPB1*05:01:01,02:02; DQB1*06:02:01,06:02:01; DRA*01:01:01,01:02:02; DRB1*08:02:01,15:01:01 (DSMZCellDive=ACC-537).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (PubMed=15843827).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (Cosmic-CLP=1330942; DepMap=ACH-000439).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.67%; Native American=0.61%; East Asian, North=75.25%; East Asian, South=23.47%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1330942; DSMZ=ACC-537; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 16,20 (DSMZ=ACC-537)
ST   D18S51: 16,23 (PubMed=25877200)
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   ME-1 [Human myeloma]
AC   CVCL_M535
DR   Wikidata; Q54904899
RX   CelloPub=CLPUB00079;
RX   PubMed=10936422;
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   Me-116
AC   CVCL_C598
DR   ESTDAB; ESTDAB-122
DR   Wikidata; Q54904900
RX   PubMed=15592718;
CC   HLA typing: A*02:01,01:01; B*52:01:01,18:01; DPB1*03:01,13:01; DQB1*03:03:02,02:01; DRB1*03:01:01,07:01 (PubMed=15592718).
ST   Source(s): ESTDAB=ESTDAB-122
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   FGA: 21,22
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   ME-1477
AC   CVCL_C5WH
SY   ME 1477; Me 1477; ME1477
DR   Wikidata; Q116049781
RX   PubMed=2467885;
RX   PubMed=12430630;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ME-180
AC   CVCL_1401
SY   Me-180; ME 180; ME180
DR   CLO; CLO_0007657
DR   CLO; CLO_0050924
DR   EFO; EFO_0006646
DR   CLDB; cl3429
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7932
DR   ATCC; HTB-33
DR   BioSample; SAMN03471125
DR   BioSample; SAMN03472007
DR   BioSample; SAMN03472511
DR   BioSample; SAMN03473047
DR   cancercelllines; CVCL_1401
DR   CCRID; 3101HUMTCHu177
DR   Cell_Model_Passport; SIDM00627
DR   ChEMBL-Cells; CHEMBL3308114
DR   ChEMBL-Targets; CHEMBL1075499
DR   CLS; 300196
DR   Cosmic; 687514
DR   Cosmic; 760223
DR   Cosmic; 809228
DR   Cosmic; 846185
DR   Cosmic; 877466
DR   Cosmic; 928909
DR   Cosmic; 1071909
DR   Cosmic; 1102582
DR   Cosmic; 1131524
DR   Cosmic; 1175837
DR   Cosmic; 1176609
DR   Cosmic; 1193031
DR   Cosmic; 1995503
DR   Cosmic; 2301541
DR   Cosmic; 2546868
DR   Cosmic; 2660192
DR   Cosmic; 2816215
DR   Cosmic-CLP; 687514
DR   DepMap; ACH-001359
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10553-107I4
DR   GDSC; 687514
DR   GEO; GSM113864
DR   GEO; GSM253300
DR   GEO; GSM595618
DR   GEO; GSM675736
DR   GEO; GSM685436
DR   GEO; GSM827202
DR   GEO; GSM1670090
DR   IARC_TP53; 21490
DR   ICLC; HTL96027
DR   IGRhCellID; ME180%20GEO
DR   JCRB; JCRB0810
DR   KCLB; 30033
DR   LINCS_LDP; LCL-1305
DR   PharmacoDB; ME180_910_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1401
DR   PubChem_Cell_line; CVCL_1401
DR   RCB; RCB2106
DR   TKG; TKG 0437
DR   TOKU-E; 2410
DR   Wikidata; Q54904901
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2990217;
RX   PubMed=3371749;
RX   PubMed=3518877;
RX   PubMed=4317734;
RX   PubMed=6220172;
RX   PubMed=6500159;
RX   PubMed=6582512;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=7751322;
RX   PubMed=8380785;
RX   PubMed=8931502;
RX   PubMed=9290701;
RX   PubMed=9887230;
RX   PubMed=15531914;
RX   PubMed=17325662;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22710073;
RX   PubMed=24134916;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-612.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Virology: Contains a complete HPV68 genome.
CC   Doubling time: 1.5 days (PubMed=29156801).
CC   HLA typing: A*01,11; B*05,08; C*w07 (PubMed=77569).
CC   HLA typing: A*01:01,32:03; B*08:01,44:02; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=687514; DepMap=ACH-001359).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.51%; Native American=0.16%; East Asian, North=1.49%; East Asian, South=0%; South Asian=0%; European, North=64.3%; European, South=32.53% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7932; true.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): ATCC=HTB-33; CCRID=3101HUMTCHu177; CLS=300196; Cosmic-CLP=687514; JCRB=JCRB0810; KCLB=30033; PubMed=22710073; PubMed=25877200; PubMed=29156801; RCB=RCB2106; TKG=TKG 0437
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12 (PubMed=22710073)
ST   D13S317: 11,13 (ATCC=HTB-33; CCRID=3101HUMTCHu177; CLS=300196; Cosmic-CLP=687514; JCRB=JCRB0810; KCLB=30033; PubMed=25877200; PubMed=29156801; RCB=RCB2106; TKG=TKG 0437)
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 13,15.2
ST   D21S11: 30,31
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 9,14
ST   Penta E: 12,14
ST   TH01: 8 (RCB=RCB2106)
ST   TH01: 8,9.3 (ATCC=HTB-33; CCRID=3101HUMTCHu177; CLS=300196; Cosmic-CLP=687514; JCRB=JCRB0810; KCLB=30033; PubMed=22710073; PubMed=25877200; PubMed=29156801; TKG=TKG 0437)
ST   TPOX: 8,10
ST   vWA: 15,16,17 (JCRB=JCRB0810)
ST   vWA: 15,17 (ATCC=HTB-33; CCRID=3101HUMTCHu177; CLS=300196; Cosmic-CLP=687514; KCLB=30033; PubMed=22710073; PubMed=25877200; PubMed=29156801; RCB=RCB2106; TKG=TKG 0437)
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   ME-1f2
AC   CVCL_WS58
DR   cancercelllines; CVCL_WS58
DR   Wikidata; Q95987945
RX   PubMed=14736823;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (PubMed=14736823).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Caution: It is possible that ME-F2 (Cellosaurus=CVCL_G313) and ME-1f2 are the same cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2110 ! ME-1 [Human leukemia]
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 11
//
ID   ME-2
AC   CVCL_RL95
DR   cancercelllines; CVCL_RL95
DR   Wikidata; Q54904902
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8018932;
CC   Population: Japanese.
CC   Doubling time: 2-3 days (PubMed=8018932).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2110 ! ME-1 [Human leukemia]
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   ME-3
AC   CVCL_RM25
DR   cancercelllines; CVCL_RM25
DR   Wikidata; Q54904903
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8018932;
CC   Population: Japanese.
CC   Doubling time: 9-12 days (PubMed=8018932).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2110 ! ME-1 [Human leukemia]
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   ME-F1
AC   CVCL_G312
DR   cancercelllines; CVCL_G312
DR   Wikidata; Q54904905
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8018932;
CC   Population: Japanese.
CC   Doubling time: 5-7 days (PubMed=8018932).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2110 ! ME-1 [Human leukemia]
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   ME-F2
AC   CVCL_G313
SY   Me-F2
DR   cancercelllines; CVCL_G313
DR   Wikidata; Q54904906
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8018932;
RX   PubMed=21552520;
CC   Population: Japanese.
CC   Doubling time: 2-3 days (PubMed=8018932).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Caution: It is possible that ME-F2 and ME-1f2 (Cellosaurus=CVCL_WS58) are the same cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL95 ! ME-2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   ME-F2/ADM100
AC   CVCL_G315
DR   cancercelllines; CVCL_G315
DR   Wikidata; Q54904907
RX   PubMed=9177449;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G313 ! ME-F2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   ME-F2/ADM200
AC   CVCL_G316
DR   cancercelllines; CVCL_G316
DR   Wikidata; Q54904908
RX   PubMed=9177449;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G313 ! ME-F2
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   ME-F3
AC   CVCL_G314
DR   cancercelllines; CVCL_G314
DR   Wikidata; Q54904909
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8018932;
CC   Population: Japanese.
CC   Doubling time: 9-12 days (PubMed=8018932).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM25 ! ME-3
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   ME1
AC   CVCL_L911
SY   ME-1
DR   Wikidata; Q54904910
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me1
AC   CVCL_C7RV
DR   Wikidata; Q117704691
RX   PubMed=7627973;
RX   PubMed=8205524;
CC   Derived from site: In situ; Testis, tunica vaginalis; UBERON=UBERON_0006650.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C198598; Rat tunica vaginalis sarcomatoid mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   ME10
AC   CVCL_L917
SY   ME-10
DR   Wikidata; Q54904911
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me10258
AC   CVCL_HF01
DR   Wikidata; Q54904912
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 5
//
ID   ME1042
AC   CVCL_A1SG
SY   ME 1042
DR   cancercelllines; CVCL_A1SG
DR   Wikidata; Q105510106
RX   PubMed=22383533;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533; PubMed=23455323).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   ME109
AC   CVCL_B6S1
DR   Wikidata; Q112129240
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma 92 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   Me11-TG6
AC   CVCL_G351
DR   ECACC; 11120838
DR   Wikidata; Q54904913
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: PVG/c (PVG/Arc); RS=RS_0003762.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   ME121
AC   CVCL_B6S2
DR   Wikidata; Q112129241
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma 80 kDa membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   Me1274
AC   CVCL_HF02
DR   Wikidata; Q54904914
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me1340
AC   CVCL_C669
DR   Wikidata; Q54904915
RX   PubMed=8459226;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   Me1386
AC   CVCL_VU55
SY   Me 1386
DR   Cosmic; 2759877
DR   Wikidata; Q95987967
RX   PubMed=9637706;
CC   HLA typing: A*01,31; B*08,51; C*w07 (PubMed=9637706).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Homozygous (PubMed=9637706).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   Me13923
AC   CVCL_HE94
DR   Wikidata; Q54904916
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me13924
AC   CVCL_C671
DR   Wikidata; Q54904917
RX   PubMed=8459226;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   Me14362
AC   CVCL_HF03
SY   Me#14362
DR   cancercelllines; CVCL_HF03
DR   Wikidata; Q54904918
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DOI=10.13130/grazia-giulia_phd2016-02-18).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   Me14464
AC   CVCL_HF04
SY   14464
DR   Wikidata; Q54904919
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me15
AC   CVCL_VT17
SY   ME15
DR   Wikidata; Q95987988
RX   PubMed=8181865;
RX   PubMed=11437411;
RX   PubMed=12079243;
RX   PubMed=12861389;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 6
//
ID   ME15.C2
AC   CVCL_5999
DR   Wikidata; Q54904920
RX   PubMed=1905566;
CC   Transformant: Myc.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Erythroid lineage cell; CL=CL_0000764.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Me15094
AC   CVCL_HF05
DR   Wikidata; Q54904921
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 6
//
ID   Me15392
AC   CVCL_C604
SY   Me-15392; Me 15392; 15392; 15392M
DR   cancercelllines; CVCL_C604
DR   Cosmic; 2163824
DR   ESTDAB; ESTDAB-114
DR   Wikidata; Q54904922
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
RX   PubMed=15592718;
RX   PubMed=22553342;
RX   PubMed=23851445;
RX   PubMed=25576923;
CC   HLA typing: A*11:01,03:01; B*40:01,14:01; DPB1*10:01,13:01; DQB1*05:01; DRB1*01:01,10:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-114
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D3S1358: 17
ST   D5S818: 14
ST   D7S820: 9,10
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HE34 ! LCL15392
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   Me15479
AC   CVCL_HF06
DR   Wikidata; Q54904923
RX   PubMed=22553342;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 4
//
ID   ME16
AC   CVCL_L918
SY   ME-16
DR   Wikidata; Q54904924
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   ME165
AC   CVCL_B6S3
SY   ME 165
DR   Wikidata; Q112129242
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human melanoma 200 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   ME17 [Human melanoma]
AC   CVCL_L919
SY   ME-17
DR   Wikidata; Q54904925
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 8
//
ID   ME17 [Mouse liver]
AC   CVCL_6000
DR   EFO; EFO_0022773
DR   Wikidata; Q54904926
RX   PubMed=1905566;
CC   Transformant: Myc.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Erythroid lineage cell; CL=CL_0000764.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   Me17-TG6
AC   CVCL_G352
DR   ECACC; 11120837
DR   Wikidata; Q54904927
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: PVG/c (PVG/Arc); RS=RS_0003762.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   Me17088/1
AC   CVCL_V024
DR   Wikidata; Q54904928
RX   PubMed=9743519;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 5
//
ID   Me17697
AC   CVCL_V019
DR   Wikidata; Q54904929
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9743519;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   ME18
AC   CVCL_L920
SY   ME-18
DR   Wikidata; Q54904930
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me18105
AC   CVCL_VU56
SY   ME 18105
DR   Cosmic; 2759872
DR   Wikidata; Q95988054
RX   PubMed=9637706;
CC   HLA typing: A*02; B*35,41; C*w04 (PubMed=9637706).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Arg23fs*30 (c.68-2A>G) (c.68_78del11); Zygosity=Homozygous (PubMed=9637706).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   Me1811
AC   CVCL_C675
SY   ME1811; Me 1811
DR   Wikidata; Q54904933
RX   PubMed=8459226;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C689 ! LCL1811
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   Me18656
AC   CVCL_HF07
SY   18656
DR   Wikidata; Q54904934
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me18732
AC   CVCL_C676
SY   18732
DR   Wikidata; Q54904936
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=8459226;
RX   PubMed=9743519;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   Me18816
AC   CVCL_HF08
DR   Wikidata; Q54904937
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   ME19
AC   CVCL_L921
SY   ME-19
DR   Wikidata; Q54904938
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me19-TG2
AC   CVCL_G353
DR   ECACC; 11120836
DR   Wikidata; Q54904939
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: PVG/c (PVG/Arc); RS=RS_0003762.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   Me19410
AC   CVCL_HF09
DR   Wikidata; Q54904940
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   ME195
AC   CVCL_J840
SY   ME 195
DR   CLO; CLO_0007658
DR   Wikidata; Q54904888
RX   Patent=US4666845;
RX   Patent=WO1996040295A1;
RX   PubMed=6582512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8431.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   Me1t
AC   CVCL_C7RW
DR   Wikidata; Q117704692
RX   PubMed=7627973;
RX   PubMed=8205524;
CC   Characteristics: Recovered from the tumor formed upon injection of the parent cell line into the subcutis of nude mice (PubMed=7627973).
CC   Derived from site: In situ; Testis, tunica vaginalis; UBERON=UBERON_0006650.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C198598; Rat tunica vaginalis sarcomatoid mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7RV ! Me1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   Me1Tu
AC   CVCL_D5HI
DR   JCRB; JCRB1913
DR   Wikidata; Q127382794
RX   PubMed=19876922;
CC   Population: Japanese.
CC   Characteristics: Highly tumorigenic. Established from the transplantation of the parent cell line in SCID mice (PubMed=19876922).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): JCRB=JCRB1913
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E263 ! TCC-MESO-1
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ME2
AC   CVCL_L912
SY   ME-2
DR   Wikidata; Q54904941
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   ME20
AC   CVCL_L922
DR   Wikidata; Q54904942
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me20842
AC   CVCL_V020
DR   Wikidata; Q54904943
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9743519;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HE92 ! Me20842M1
OI   CVCL_HE93 ! Me20842M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   Me20842M1
AC   CVCL_HE92
DR   Wikidata; Q54904944
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V020 ! Me20842
OI   CVCL_HE93 ! Me20842M2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me20842M2
AC   CVCL_HE93
DR   Wikidata; Q54904945
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V020 ! Me20842
OI   CVCL_HE92 ! Me20842M1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   ME21
AC   CVCL_L923
SY   ME-21
DR   Wikidata; Q54904946
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me21158
AC   CVCL_HE95
DR   Wikidata; Q54904947
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   ME22
AC   CVCL_L924
SY   ME-22
DR   Wikidata; Q54904948
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me2211
AC   CVCL_HF10
SY   Me#2211
DR   Wikidata; Q54904949
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   ME23
AC   CVCL_L925
SY   ME-23
DR   Wikidata; Q54904950
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me23526
AC   CVCL_HF11
DR   Wikidata; Q54904951
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Misspelling: Me2352; DOI=10.13130/grazia-giulia_phd2016-02-18.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   Me23682
AC   CVCL_HF12
DR   GEO; GSE34686
DR   Wikidata; Q54904952
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me2559/1
AC   CVCL_V025
SY   Me2559
DR   Wikidata; Q54904953
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9743519;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   Me26635
AC   CVCL_HF13
DR   GEO; GSM1403055
DR   GEO; GSM1403056
DR   GEO; GSM1403057
DR   GEO; GSM1403058
DR   GEO; GSM1403059
DR   GEO; GSM1403060
DR   Wikidata; Q54904954
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 5
//
ID   Me28
AC   CVCL_HE39
SY   Me 28; Melanoma 28
DR   Wikidata; Q54904955
RX   PubMed=3121738;
RX   PubMed=3158614;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 6
//
ID   Me29318
AC   CVCL_HF14
DR   Wikidata; Q54904956
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me2934
AC   CVCL_HE96
DR   Wikidata; Q54904957
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me2Tu
AC   CVCL_D5HG
DR   JCRB; JCRB1930
DR   Wikidata; Q127382795
RX   PubMed=19876922;
CC   Population: Japanese.
CC   Characteristics: Highly tumorigenic. Established from the transplantation of the parent cell line in SCID mice (PubMed=19876922).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): JCRB=JCRB1930
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E264 ! TCC-MESO-2
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   Me3
AC   CVCL_C7RX
DR   Wikidata; Q117704693
RX   PubMed=7627973;
RX   PubMed=8205524;
CC   Derived from site: In situ; Testis, tunica vaginalis; UBERON=UBERON_0006650.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C198598; Rat tunica vaginalis sarcomatoid mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   Me3044
AC   CVCL_HF15
DR   Wikidata; Q54904958
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 6
//
ID   Me3046/2
AC   CVCL_C677
DR   Wikidata; Q54904959
RX   PubMed=8459226;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HE42 ! INT-MEL-8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Me3068
AC   CVCL_C678
SY   ME3068
DR   Wikidata; Q54904960
RX   PubMed=2469723;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   ME325
AC   CVCL_B6S4
SY   ME 325
DR   Wikidata; Q112129243
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   Me32562
AC   CVCL_HF16
DR   Wikidata; Q54904961
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me32669
AC   CVCL_HF17
DR   Wikidata; Q54904962
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me32a
AC   CVCL_UT42
DR   Wikidata; Q95988211
RX   PubMed=9813047;
RX   PubMed=12385784;
RX   PubMed=20372979;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (PubMed=12385784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   Me32A-DmATP7
AC   CVCL_A8QS
DR   Wikidata; Q108820892
RX   PubMed=20372979;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0030343; ATP7 (Note=With a N-terminal Myc tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT42 ! Me32a
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   Me32a-T22/2L
AC   CVCL_UT43
SY   Me32a T22/2L; Me32aT22/2L
DR   Wikidata; Q95988213
RX   PubMed=9813047;
RX   PubMed=12385784;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (PubMed=12385784).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.His203Gln).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T22).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT42 ! Me32a
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   Me32a-T22/2L A12-H9
AC   CVCL_E3F0
SY   A12-H9
RX   PubMed=9813047;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (PubMed=12385784).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:869; ATP7A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.His203Gln).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T22).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT43 ! Me32a-T22/2L
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Me32a-T22/2L C3-C1
AC   CVCL_E3F1
SY   C3-C1
RX   PubMed=9813047;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (PubMed=12385784).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:869; ATP7A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.His203Gln).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T22).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT43 ! Me32a-T22/2L
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Me32a-T22/2L C3-C1 WND-16
AC   CVCL_E3F2
SY   WND-16
RX   PubMed=9813047;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (PubMed=12385784).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:103297; Atp7b.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.His203Gln).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T22).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT43 ! Me32a-T22/2L
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Me32a-T22/2L C3-C1 WND-2
AC   CVCL_E3F3
SY   WND-2
RX   PubMed=9813047;
CC   Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (PubMed=12385784).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:103297; Atp7b.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.His203Gln).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T22).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UT43 ! Me32a-T22/2L
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   ME361
AC   CVCL_J760
SY   ME 361; 36.1
DR   ATCC; HB-9325
DR   Wikidata; Q54904963
RX   Patent=US4849509;
RX   PubMed=2918552;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9325.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   ME361-S2a
AC   CVCL_J761
SY   ME 361-S2a; ME361S2a
DR   CLO; CLO_0007659
DR   ATCC; HB-9326
DR   Wikidata; Q54904964
RX   Patent=US4849509;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9326.
CC   Characteristics: Isotype switched derivative of ME361.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_89637; Ganglioside GD2.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J760 ! ME361
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   Me3700
AC   CVCL_HE97
DR   Wikidata; Q54904965
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me3Tu
AC   CVCL_D5HH
DR   JCRB; JCRB1937
DR   Wikidata; Q127382797
RX   PubMed=19876922;
CC   Population: Japanese.
CC   Characteristics: Highly tumorigenic. Established from the transplantation of the parent cell line in SCID mice (PubMed=19876922).
CC   Donor information: No history of asbestos exposure (PubMed=19876922).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): JCRB=JCRB1937
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E265 ! TCC-MESO-3
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Me4023
AC   CVCL_V021
SY   4023
DR   Wikidata; Q54904966
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9743519;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   Me4024/1
AC   CVCL_V022
SY   Me 4024/1
DR   Cosmic; 720623
DR   Wikidata; Q54904967
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C679 ! INT-MEL-52
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Me4024/2
AC   CVCL_V023
SY   Me 4024/2
DR   Cosmic; 720624
DR   Wikidata; Q54904968
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C679 ! INT-MEL-52
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   ME416
AC   CVCL_B6S5
DR   Wikidata; Q112129244
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Not specified ganglioside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   ME425
AC   CVCL_B6S6
DR   Wikidata; Q112129245
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   Me43
AC   CVCL_C665
SY   ME43; ME-43; Me-43; ME 43
DR   Wikidata; Q54904969
RX   PubMed=2467885;
RX   PubMed=6155995;
RX   PubMed=6746112;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   Me4473
AC   CVCL_HE98
DR   Wikidata; Q54904970
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me45
AC   CVCL_K048
SY   Me-45
DR   ArrayExpress; E-MEXP-2623
DR   ArrayExpress; E-MTAB-5197
DR   Wikidata; Q54904971
RX   PubMed=29241122;
RX   PubMed=30613987;
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=87
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   ME46
AC   CVCL_J842
SY   ME 46
DR   Wikidata; Q54904891
RX   Patent=US4666845;
RX   Patent=WO1996040295A1;
RX   PubMed=6582512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8430.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   Me4686
AC   CVCL_HE99
SY   4686
DR   Wikidata; Q54904972
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   Me4855
AC   CVCL_C681
DR   Wikidata; Q54904973
RX   PubMed=8459226;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   ME491
AC   CVCL_B6S7
DR   Wikidata; Q112129246
RX   PubMed=2579631;
RX   PubMed=4043988;
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   ME492
AC   CVCL_B6S8
DR   Wikidata; Q112129247
RX   PubMed=4043988;
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   ME493
AC   CVCL_B6S9
DR   Wikidata; Q112129248
RX   PubMed=4043988;
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   ME5
AC   CVCL_L913
SY   ME-5
DR   Wikidata; Q54904975
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me51
AC   CVCL_VT18
SY   ME51
DR   Wikidata; Q95988277
RX   PubMed=11437411;
RX   PubMed=12079243;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ME510
AC   CVCL_B6SA
DR   Wikidata; Q112129249
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   ME515
AC   CVCL_B6SB
DR   Wikidata; Q112129250
RX   PubMed=6722794;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Not specified ganglioside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   Me59
AC   CVCL_VT19
SY   ME59
DR   Wikidata; Q95988279
RX   PubMed=11437411;
RX   PubMed=12079243;
RX   PubMed=12861389;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Me59/4
AC   CVCL_VT21
SY   ME59/4; ME59/cl4
DR   Wikidata; Q95988281
RX   PubMed=12861389;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VT19 ! Me59
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Me59/7
AC   CVCL_VT22
SY   ME59/7; ME59/cl7
DR   Wikidata; Q95988283
RX   PubMed=12861389;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VT19 ! Me59
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Me665/1
AC   CVCL_C667
SY   Me 665/1; 665/1; INT-MEL-60/1
DR   Wikidata; Q54904976
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=2469723;
RX   PubMed=2776368;
RX   PubMed=8459226;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7077 ! Me665/2
OI   CVCL_HE41 ! Me665/3
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Me665/2
AC   CVCL_7077
AS   CVCL_4725
SY   ME665/2; Me 665/2; 665/2; INT-MEL-60/2
DR   BTO; BTO_0003270
DR   CLO; CLO_0001453
DR   CLDB; cl114
DR   CLDB; cl115
DR   Cosmic; 720621
DR   Cosmic; 1026920
DR   GEO; GSM1403064
DR   GEO; GSM1403065
DR   GEO; GSM1403066
DR   Wikidata; Q54904977
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=2469723;
RX   PubMed=2776368;
RX   PubMed=25576923;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C667 ! Me665/1
OI   CVCL_HE41 ! Me665/3
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Me665/2/21
AC   CVCL_7078
SY   665/2/21
DR   BTO; BTO_0005069
DR   ChEMBL-Cells; CHEMBL3307371
DR   ChEMBL-Targets; CHEMBL614339
DR   PubChem_Cell_line; CVCL_7078
DR   TOKU-E; 4285
DR   Wikidata; Q54904978
RX   PubMed=10893182;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7077 ! Me665/2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Me665/2/60
AC   CVCL_7079
DR   BTO; BTO_0005070
DR   Wikidata; Q54904979
RX   PubMed=10893182;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7077 ! Me665/2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   Me665/3
AC   CVCL_HE41
SY   INT-MEL-60/3
DR   Wikidata; Q54904980
RX   DOI=10.1007/0-306-46872-7_16;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C667 ! Me665/1
OI   CVCL_7077 ! Me665/2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   Me665/R
AC   CVCL_W187
SY   Me 665/R
DR   Wikidata; Q54904981
RX   PubMed=2469723;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7077 ! Me665/2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Me67
AC   CVCL_VT20
SY   ME67
DR   EFO; EFO_0022362
DR   Wikidata; Q95988319
RX   PubMed=11437411;
RX   PubMed=12067988;
RX   PubMed=12079243;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 6
//
ID   Me67.10
AC   CVCL_VT26
DR   Wikidata; Q95988321
RX   PubMed=12067988;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VT20 ! Me67
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Me67.3
AC   CVCL_VT23
SY   ME67.3
DR   ChEMBL-Cells; CHEMBL3307373
DR   ChEMBL-Targets; CHEMBL614341
DR   PubChem_Cell_line; CVCL_VT23
DR   Wikidata; Q95988323
RX   PubMed=12067988;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VT20 ! Me67
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Me67.5
AC   CVCL_VT24
DR   Wikidata; Q95988325
RX   PubMed=12067988;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VT20 ! Me67
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Me67.9
AC   CVCL_VT25
DR   Wikidata; Q95988327
RX   PubMed=12067988;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VT20 ! Me67
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Me6824
AC   CVCL_HF18
DR   Wikidata; Q54904983
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   ME7
AC   CVCL_L914
SY   ME-7
DR   Wikidata; Q54904984
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   ME8
AC   CVCL_L915
SY   ME-8
DR   Wikidata; Q54904985
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me8530
AC   CVCL_HE44
SY   Me 8530
DR   Wikidata; Q54904986
RX   PubMed=9973437;
RX   PubMed=22553342;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 4
//
ID   Me879
AC   CVCL_HF19
DR   Wikidata; Q54904987
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   ME9
AC   CVCL_L916
SY   ME-9
DR   Wikidata; Q54904988
RX   PubMed=19001446;
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   Me9-TG3
AC   CVCL_G354
SY   Me9/TG3
DR   ECACC; 11120841
DR   Wikidata; Q54904989
RX   PubMed=2981541;
RX   PubMed=7150478;
CC   Doubling time: 42.1 +- 1.4 hours (Note=At 3th passage), 40.0 +- 2.7 hours (Note=At 8th passage) (PubMed=2981541).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: PVG/c (PVG/Arc); RS=RS_0003762.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   Me9229/18
AC   CVCL_HE38
DR   Wikidata; Q54904990
RX   PubMed=3121738;
RX   PubMed=7607705;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F249 ! INT-MEL-58
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 6
//
ID   Me9460
AC   CVCL_C684
DR   Wikidata; Q54904991
RX   PubMed=8459226;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   MEA-1
AC   CVCL_F0S4
RX   PubMed=3053466;
CC   Doubling time: 20.4 hours (PubMed=3053466).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEA-2
AC   CVCL_F0S5
RX   PubMed=3053466;
CC   Doubling time: 19.8 hours (PubMed=3053466).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEA-3
AC   CVCL_F0S6
RX   PubMed=3053466;
CC   Doubling time: 19.8 hours (PubMed=3053466).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEA-4
AC   CVCL_F0S7
RX   PubMed=3053466;
CC   Doubling time: 17.9 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEB-1
AC   CVCL_F0S8
RX   PubMed=3053466;
CC   Doubling time: 15.6 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEB-2
AC   CVCL_F0S9
RX   PubMed=3053466;
CC   Doubling time: 21.5 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEB-3
AC   CVCL_F0SA
RX   PubMed=3053466;
CC   Doubling time: 24.0 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEB-4
AC   CVCL_4772
SY   MEB4
DR   BTO; BTO_0001219
DR   CLO; CLO_0050761
DR   RCB; RCB1027
DR   Wikidata; Q54904992
RX   PubMed=3053466;
RX   PubMed=8146177;
CC   Doubling time: 18.0 hours (PubMed=3053466); 19 hours (Note=In serum-free medium) (PubMed=8146177).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   MEB-5
AC   CVCL_F0SB
RX   PubMed=3053466;
CC   Doubling time: 24.0 hours (PubMed=3053466).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F936 ! B16
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MEB5
AC   CVCL_5221
SY   MEB 5; MEB-5
DR   ChEMBL-Cells; CHEMBL4295451
DR   ChEMBL-Targets; CHEMBL4296469
DR   JCRB; IFO50472
DR   JCRB; JCRB0145
DR   PubChem_Cell_line; CVCL_5221
DR   Wikidata; Q54904993
RX   PubMed=9719419;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MEB5
CC   Characteristics: EGF dependent. When deprived of EGF, about 50% of the cells die due to apoptosis within 24h. The remaining cells differentiated into neurons, astrncytes, or oligndendrocytes within 2 weeks.
CC   Doubling time: ~20 hours (PubMed=9719419).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Embryonic brain, forebrain; UBERON=UBERON_0006240.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   MEC
AC   CVCL_B270
DR   BioGRID_ORCS_Cell_line; 1788
DR   BioSample; SAMN03472009
DR   Cosmic; 1122351
DR   RCB; RCB2129
DR   TKG; TKG 0629
DR   Wikidata; Q54904994
RX   CelloPub=CLPUB00275;
RX   PubMed=1965684;
RX   PubMed=21451941;
RX   PubMed=35640676;
RX   PubMed=36724073;
CC   Population: Japanese.
CC   Doubling time: 40.8 hours (PubMed=1965684).
CC   Omics: Phenotyping; CRISPR screening.
CC   Discontinued: RCB; RCB2129; true.
CC   Discontinued: TKG; TKG 0629; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB2129; TKG=TKG 0629
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 8,11 (RCB=RCB2129)
ST   D13S317: 9,11 (TKG=TKG 0629)
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 9.3,11 (TKG=TKG 0629)
ST   D7S820: 11 (RCB=RCB2129)
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 22
//
ID   MEC-1
AC   CVCL_1870
SY   MEC1
DR   BTO; BTO_0005913
DR   CLO; CLO_0037181
DR   EFO; EFO_0002231
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03471015
DR   BioSample; SAMN10989555
DR   cancercelllines; CVCL_1870
DR   Cell_Model_Passport; SIDM00001
DR   ChEMBL-Cells; CHEMBL4482990
DR   ChEMBL-Targets; CHEMBL4483257
DR   Cosmic; 1762462
DR   DepMap; ACH-000405
DR   DSMZ; ACC-497
DR   DSMZCellDive; ACC-497
DR   EGA; EGAS00001000978
DR   GDSC; 1330943
DR   GEO; GSM887305
DR   GEO; GSM888381
DR   GEO; GSM1374667
DR   GEO; GSM1670091
DR   IARC_TP53; 28260
DR   IGRhCellID; MEC1
DR   LiGeA; CCLE_715
DR   LINCS_LDP; LCL-1089
DR   PharmacoDB; MEC1_911_2019
DR   Progenetix; CVCL_1870
DR   PubChem_Cell_line; CVCL_1870
DR   Wikidata; Q54904995
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10071128;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=23297799;
RX   PubMed=25162594;
RX   PubMed=25877200;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (PubMed=10071128; DSMZ=ACC-497).
CC   HLA typing: A*23:01:01,30:01:01; B*13:02:01;18:01:01; C*06:02:01;12:03:01; DPA1*01:03:01;01:03:01; DPB1*04:02:01;02:01:02; DQA1*01:02:01;05:05:01; DQB1*03:01:01;06:02:01; DRA*01:02:02;01:02:03; DRB1*12:01:01;15:01:01 (DSMZCellDive=ACC-497).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9476; HTRA1 + HGNC; HGNC:23512; R3HCC1L; Name(s)=R3HCC1L-HTRA1 (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Profs*20 (c.949dupC) (c.949_950insC); Zygosity=Homozygous (DepMap=ACH-000405).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.9%; Native American=0%; East Asian, North=2.04%; East Asian, South=0%; South Asian=5.76%; European, North=26.14%; European, South=64.15% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-497; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 17
ST   D12S391: 24
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 12,14
ST   D1S1656: 15,17
ST   D21S11: 27,29
ST   D22S1045: 15,16
ST   D2S1338: 16,19
ST   D2S441: 14
ST   D3S1358: 15,19
ST   D5S818: 10,12
ST   D7S820: 7,11
ST   D8S1179: 13,15
ST   DYS391: 10
ST   FGA: 21,25
ST   Penta D: 11,17
ST   Penta E: 10,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1871 ! MEC-2
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   MEC-2
AC   CVCL_1871
SY   MEC2
DR   BTO; BTO_0005914
DR   CLO; CLO_0037182
DR   EFO; EFO_0006285
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1871
DR   Cell_Model_Passport; SIDM00827
DR   DepMap; ACH-001121
DR   DSMZ; ACC-500
DR   DSMZCellDive; ACC-500
DR   EGA; EGAS00001000978
DR   GEO; GSM887306
DR   GEO; GSM888382
DR   GEO; GSM1374668
DR   GEO; GSM1670092
DR   IARC_TP53; 30120
DR   LINCS_LDP; LCL-1090
DR   Lonza; 1161
DR   PharmacoDB; MEC2_912_2019
DR   Progenetix; CVCL_1871
DR   Wikidata; Q54904996
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10071128;
RX   PubMed=19358282;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=23297799;
RX   PubMed=25162594;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 31 hours (PubMed=10071128); ~40-50 hours (DSMZ=ACC-500).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.35%; Native American=0%; East Asian, North=2.58%; East Asian, South=0%; South Asian=5.1%; European, North=25.37%; European, South=65.6% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-500
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 27,29
ST   D2S1338: 16,19
ST   D3S1358: 15,19
ST   D5S818: 10,12
ST   D7S820: 7,11
ST   D8S1179: 13
ST   FGA: 21,25
ST   Penta D: 11,17
ST   Penta E: 10,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1870 ! MEC-1
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   MEC-HH
AC   CVCL_X509
SY   Mammary Epithelial Cell line-High fat, High protein
DR   Wikidata; Q54904997
RX   DOI=10.3923/javaa.2012.1166.1172;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Chinese Holstein; VBO=VBO_0003142.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   MEC-LL
AC   CVCL_X510
SY   Mammary Epithelial Cell line-Low fat, Low protein
DR   Wikidata; Q54904998
RX   DOI=10.3923/javaa.2012.1166.1172;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Chinese Holstein; VBO=VBO_0003142.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   MEC1
AC   CVCL_VR92
SY   Mouse Epicardial Cells 1
DR   ChEMBL-Cells; CHEMBL4295491
DR   Millipore; SCC187
DR   PubChem_Cell_line; CVCL_VR92
DR   Wikidata; Q95988351
RX   PubMed=21429986;
CC   Characteristics: Useful model for cardiac developmental biology studies (Millipore=SCC187).
CC   Derived from site: In situ; Embryonic heart, ventricular epicardium; UBERON=UBERON_0003084+UBERON_0001082.
CC   Breed/subspecies: ICR(CD-1).
ST   Source(s): Millipore=SCC187
ST   Mouse STR 1-1: 11
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 12,13,15
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 18.3
ST   Mouse STR 6-7: 12,15
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 15,18
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 15
ST   Mouse STR 15-3: 20.3,21.3
ST   Mouse STR 17-2: 13
ST   Mouse STR 18-3: 17,20
ST   Mouse STR 19-2: 12,14
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   mEC25
AC   CVCL_C6JH
DR   Wikidata; Q116049782
RX   PubMed=32510874;
CC   Doubling time: 26.8 hours (Note=At 20th passage), 25.8 hours (Note=At 50th passage) (PubMed=32510874).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C191763; Mouse esophageal squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   30W
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MECA-32
AC   CVCL_KB76
SY   MECA 32
DR   DSHB; MECA-32
DR   Wikidata; Q54904999
RX   PubMed=2683264;
RX   PubMed=7626790;
WW   Provider; Stanford OTL; S96-104; https://stanford.resoluteinnovation.com/technologies/S96-104_meca-32
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q91VC4; Mouse Plvap.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   MECA-367
AC   CVCL_9221
DR   CLO; CLO_0007662
DR   ATCC; HB-9478
DR   Wikidata; Q54905000
RX   Patent=US5403919;
RX   PubMed=3340147;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9478.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61826; Mouse Madcam1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   MECA-79
AC   CVCL_9222
SY   MECA 79
DR   CLO; CLO_0007663
DR   ATCC; HB-9479
DR   Wikidata; Q54905001
RX   Patent=US5403919;
RX   PubMed=2460470;
RX   PubMed=9466573;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9479.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Sulfated N-acetylglucosamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   MECA-89
AC   CVCL_9223
DR   CLO; CLO_0007664
DR   ATCC; HB-292
DR   Wikidata; Q54905002
RX   Patent=US5403919;
RX   PubMed=3340147;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61826; Mouse Madcam1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 8
//
ID   MECF-1
AC   CVCL_UC84
SY   Marbled Eel Caudal Fin-1
DR   Wikidata; Q95988357
RX   PubMed=30003544;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=7939; ! Anguilla marmorata (Giant mottled eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 6
//
ID   MeCo 05
AC   CVCL_3403
SY   MECO
DR   CLDB; cl7181
DR   ICLC; HTL07001
DR   Wikidata; Q54905003
RX   PubMed=23634660;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ICLC=HTL07001
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 13
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   MED-MEB-8A
AC   CVCL_M137
SY   MEB-Med8A; MEBMED8A; MED8A; Med8A
DR   EFO; EFO_0022572
DR   cancercelllines; CVCL_M137
DR   Cosmic; 2362657
DR   GEO; GSM919363
DR   Progenetix; CVCL_M137
DR   Wikidata; Q54905004
RX   PubMed=15793295;
RX   PubMed=16946619;
RX   PubMed=22976800;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Misspelling: MHH-MED-8A; Cosmic=2362657; PubMed=16946619.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M138 ! MED-MEB-8S
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 17
//
ID   MED-MEB-8S
AC   CVCL_M138
SY   MEBMED8S
DR   Cosmic; 2362658
DR   Wikidata; Q54905005
RX   PubMed=15793295;
RX   PubMed=22976800;
CC   Misspelling: MHH-MED-8S; Cosmic=2362658.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M137 ! MED-MEB-8A
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 10
//
ID   MED1
AC   CVCL_IR47
SY   nMED1
DR   Wikidata; Q54930834
RX   PubMed=20978004;
RX   PubMed=24887326;
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C129446; Medulloblastoma, non-WNT/non-SHH, group 4
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y5M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   MED17.11
AC   CVCL_4Y33
DR   Wikidata; Q54905006
RX   PubMed=26053673;
RX   PubMed=32636736;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   MED2
AC   CVCL_IR48
SY   nMED2
DR   Wikidata; Q54930835
RX   PubMed=20978004;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   MED3
AC   CVCL_VU74
DR   Wikidata; Q95988366
RX   PubMed=24887326;
RX   PubMed=27498314;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y10M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MED4
AC   CVCL_VU75
DR   Wikidata; Q95988367
RX   PubMed=24887326;
RX   PubMed=27498314;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU76 ! MED4R
SX   Female
AG   7Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MED4R
AC   CVCL_VU76
DR   Wikidata; Q95988368
RX   PubMed=24887326;
RX   PubMed=27498314;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU75 ! MED4
SX   Female
AG   7Y10M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MED5R
AC   CVCL_VU77
DR   cancercelllines; CVCL_VU77
DR   Wikidata; Q95988369
RX   PubMed=24887326;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Unspecified (PubMed=24887326).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129440; Medulloblastoma, WNT-activated
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y9M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   MED6
AC   CVCL_VU78
DR   Wikidata; Q95988371
RX   PubMed=24887326;
RX   PubMed=27498314;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129440; Medulloblastoma, WNT-activated
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y9M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MedB-1
AC   CVCL_A649
SY   MEDB-1; MedB1; MEDB1
DR   cancercelllines; CVCL_A649
DR   Cosmic; 988832
DR   Cosmic; 1013889
DR   Cosmic; 2297036
DR   Cosmic; 2437270
DR   Cosmic; 2479247
DR   GEO; GSM119538
DR   GEO; GSM1897962
DR   Lonza; 197
DR   PRIDE; PXD000589
DR   Progenetix; CVCL_A649
DR   Wikidata; Q54905007
RX   PubMed=11291070;
RX   PubMed=16960149;
RX   PubMed=25894527;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thymus, anterior mediastinum; UBERON=UBERON_0008820.
DI   NCIt; C9280; Primary mediastinal (thymic) large B-cell lymphoma
DI   ORDO; Orphanet_98838; Primary mediastinal large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   MEDEP-BRC4-1
AC   CVCL_E139
DR   RCB; RCB2692
DR   Wikidata; Q54905008
RX   PubMed=18253492;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B981 ! BRC4
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   MEDEP-BRC4-2
AC   CVCL_E136
DR   RCB; RCB2699
DR   RCB; RCB2932
DR   Wikidata; Q54905009
RX   PubMed=18253492;
CC   Discontinued: RCB; RCB2699; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B981 ! BRC4
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MEDEP-BRC5
AC   CVCL_E137
SY   MEDEP-BRC-5
DR   RCB; RCB2609
DR   RCB; RCB2911
DR   Wikidata; Q54905010
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=18253492;
CC   Discontinued: RCB; RCB2609; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B982 ! BRC5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   MEDEP-E14
AC   CVCL_E138
DR   RCB; RCB2660
DR   Wikidata; Q54905011
RX   PubMed=18253492;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   MEDEP-E14 clone 4
AC   CVCL_E143
DR   RCB; RCB2691
DR   Wikidata; Q54905012
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E138 ! MEDEP-E14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   MEDMC-BRC6
AC   CVCL_E140
DR   RCB; RCB2694
DR   Wikidata; Q54905013
RX   PubMed=18253492;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B983 ! BRC6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   MEDMC-NT2
AC   CVCL_E141
DR   RCB; RCB2693
DR   Wikidata; Q54905014
RX   PubMed=18253492;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E142 ! NTES-2
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   mEER
AC   CVCL_B6J2
SY   mouse E6 E7 Ras; E6/E7/H-ras MTEC
DR   Wikidata; Q112129251
RX   PubMed=17515506;
RX   PubMed=19283850;
RX   PubMed=27013584;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: Age/sex of donor from personal communication of Vermeer, Paola D.
CC   Caution: Was originally said to be derived from tonsils, an anatomical structure that does not exist in mouse.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   mEERL
AC   CVCL_B6J3
SY   mouse E6 E7 Ras Luc; E6/E7/H-ras/Luc MTEC
DR   ABM; T8309
DR   GEO; GSM1687302
DR   GEO; GSM1687303
DR   GEO; GSM1687304
DR   Wikidata; Q112129252
RX   PubMed=17515506;
RX   PubMed=19283850;
RX   PubMed=27013584;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age/sex of donor from personal communication of Vermeer, Paola D.
CC   Caution: Was originally said to be derived from tonsils, an anatomical structure that does not exist in mouse.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6J2 ! mEER
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   mEERL95
AC   CVCL_B6JB
DR   Wikidata; Q112129253
RX   PubMed=29313973;
CC   Characteristics: Established from a tumor in a C57BL/6JRj mouse which was implanted with the parent cell line (PubMed=29313973).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6J3 ! mEERL
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   MEF
AC   CVCL_C1M8
DR   Wikidata; Q114312275
RX   PubMed=13954855;
CC   Population: Chinese.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   MEF (C57BL/6)
AC   CVCL_9115
SY   MEF-BL/6-1
DR   CLO; CLO_0007665
DR   ATCC; SCRC-1008
DR   Wikidata; Q54905015
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   MEF (C57BL/6) IRR
AC   CVCL_9117
DR   ATCC; SCRC-1008.1
DR   Wikidata; Q54905021
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 10000 rads.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9115 ! MEF (C57BL/6)
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   MEF (C57BL/6) MITC
AC   CVCL_9118
DR   ATCC; SCRC-1008.2
DR   Wikidata; Q54905022
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Discontinued: ATCC; SCRC-1008.2; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9115 ! MEF (C57BL/6)
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   MEF (DR4)
AC   CVCL_5277
SY   DR4 MEF; DR-4 MEF
DR   CLO; CLO_0002814
DR   ATCC; SCRC-1045
DR   CCRID; 3101MOUSCSP108
DR   Wikidata; Q54905024
RX   PubMed=9278500;
CC   Characteristics: Expresses transgenes that make this cell line resistant to three different drugs: geneticin (G418), puromycin and hygromycin. KO of Hprt1 makes the cell line resistant to 6-tioguanine (PubMed=9278500).
CC   Knockout cell: Method=KO mouse; MGI; MGI:96217; Hprt1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: DR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   MEF (DR4) IRR
AC   CVCL_VK72
SY   DR4 IRR; DR-4 IRR
DR   ATCC; SCRC-1045.1
DR   CCRID; 3101MOUSCSP108R
DR   Wikidata; Q95988434
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by irradiation with 12000 rads.
CC   Characteristics: Expresses transgenes that make this cell line resistant to three different drugs: geneticin (G418), puromycin and hygromycin. KO of Hprt1 makes the cell line resistant to 6-tioguanine (from parent cell line).
CC   Knockout cell: Method=KO mouse; MGI; MGI:96217; Hprt1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Discontinued: ATCC; SCRC-1045.1; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: DR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5277 ! MEF (DR4)
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 13
//
ID   MEF (DR4) MITC
AC   CVCL_Y468
SY   DR4 MEF MITC
DR   ATCC; SCRC-1045.2
DR   Wikidata; Q54905025
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Characteristics: Expresses transgenes that make this cell line resistant to three different drugs: geneticin (G418), puromycin and hygromycin. KO of Hprt1 makes the cell line resistant to 6-tioguanine (from parent cell line).
CC   Knockout cell: Method=KO mouse; MGI; MGI:96217; Hprt1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Discontinued: ATCC; SCRC-1045.2; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: DR4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5277 ! MEF (DR4)
SX   Mixed sex
AG   14FD
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 14
//
ID   MEF Actbf/f
AC   CVCL_ZD79
SY   Floxed Beta-Actin (Actb) KO MEF Cell Line; Actb LL-Large T
DR   Kerafast; EMN019-FP
DR   Wikidata; Q98127203
RX   PubMed=28077619;
CC   Characteristics: Actb can be knocked-out after exogenous expression of Cre recombinase via Cre-Lox recombination.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MEF Actbf/f-Actg1f/f
AC   CVCL_ZD80
SY   Floxed Beta-Actin (Actb)/Gamma-Actin (Actg1) Double KO MEF Cell Line; Actb LL Actg1 LL-Large T
DR   Kerafast; EMN020-FP
DR   Wikidata; Q98127204
RX   PubMed=28077619;
CC   Characteristics: Actb and Actg1 can be both knocked-out after exogenous expression of Cre recombinase via Cre-Lox recombination.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MEF Actg1f/f
AC   CVCL_ZD81
SY   Floxed Gamma-Actin (Actg1) KO MEF Cell Line; Actg1 LL-Large T
DR   Kerafast; EMN021-FP
DR   Wikidata; Q98127205
RX   PubMed=28077619;
CC   Characteristics: Actg1 can be knocked-out after exogenous expression of Cre recombinase via Cre-Lox recombination.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MEF Blvra-/-
AC   CVCL_D5IE
SY   Blvra-/- MEF
DR   Wikidata; Q127382798
RX   PubMed=32581154;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88170; Blvra.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6N Blvra-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-15FD
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MEF GFP-LC3-RFP-LC3deltaG
AC   CVCL_UP52
SY   GFP-LC3-RFP-LC3deltaG MEF
DR   RCB; RCB4696
DR   Wikidata; Q95988436
RX   PubMed=27818143;
CC   Characteristics: Stably expresses EGFP-LC3-mRFP-LC3delta, an autophagic flux probe. GFP-LC3 is fused to the N-terminus of RFP-LC3 whose C-terminal glycine is deleted. When expressed, the probe it is separated into EGFP-LC3 and mRFP-LC3deltaG by the action of endogenous ATG4 family proteases that cleave the peptide bond after the C-terminal glycine of LC3 in the cytosol producing equimolar amounts of EGFP-LC3 and mRFP-LC3deltaG (PubMed=27818143).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=RGD; 735183; Map1lc3a.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   MEF Lrrk2 KO
AC   CVCL_E3XC
SY   MEF Lrrk2 knock-out
CC   Knockout cell: Method=KO mouse; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line information from personal communication of Tonelli, Francesca.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.129X1(FVB)-Lrrk2tm1.1Cai/J (IMSR_JAX:012453).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   MEF Lrrk2-p.G2019S KI
AC   CVCL_C7XL
SY   Mouse Embryonic Fibroblasts Lrrk2-p.G2019S knock-in
DR   Wikidata; Q123033033
CC   Sequence variation: Mutation; MGI; MGI:1913975; Lrrk2; Simple_edited; p.Gly2019Ser (c.6055G>A); Zygosity=Homozygous; Note=By homologous recombination (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line information from personal communication of Dou, Dan.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6NTac-Lrrk2tm4.1Arte.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15-16FD
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 3
//
ID   MEF Lrrk2-p.R1441C KI
AC   CVCL_E3XD
SY   MEF Lrrk2 R1441C knock-in
CC   Sequence variation: Mutation; MGI; MGI:1913975; Lrrk2; Simple_edited; p.Arg1441Cys (c.4321C>T); Zygosity=Homozygous; Note=By targeting vector (JAX).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line information from personal communication of Tonelli, Francesca.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.Cg-Lrrk2tm1.1Shn/J (IMSR_JAX:009346).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   MEF Lrrk2-p.R1141C KI/Pink1 KO
AC   CVCL_E3Y3
CC   Knockout cell: Method=KO mouse; MGI; MGI:1916193; Pink1.
CC   Sequence variation: Mutation; MGI; MGI:1913975; Lrrk2; Simple_edited; p.Arg1441Cys (c.4321C>T); Zygosity=Homozygous; Note=By method not specified.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line information from personal communication of Bagnoli, Enrico.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.129S5-Pink1tm1Lex Lrrk2tm1.1Shn/Muqit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   MEF OGT(F/Y) GFP
AC   CVCL_E6HP
RX   PubMed=20926391;
CC   Characteristics: Control cell line for MEF OGTF/Y mER-Cre-2A-GFP (Cellosaurus=CVCL_E6HN). As this cell line does not express Cre, the loxP site flanking Ogt are not removed and the cell is not KO for Ogt (PubMed=20926391).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1339639; Ogt (Note=Flanked with two loXP sites).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MEF OGT(F/Y) mER-Cre-2A-GFP
AC   CVCL_E6HN
RX   PubMed=20926391;
WW   Provider; JHTV; C17974; https://jhu.technologypublisher.com/technology/52634
CC   Characteristics: Transduced with a CreERT2-2A-GFP construct. In the absence of 4-hydroxytamoxifen (4-OHT), the CreERT2 chimera is retained in the cytoplasm. In the presence of 4-OHT the chimera dimerizes and translocates to the nucleus recombining the loxP sites, resulting in an Ogt null cell (PubMed=20926391).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1339639; Ogt (Note=Flanked with two loXP sites).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MEF Pink1 KO
AC   CVCL_E4K2
CC   Knockout cell: Method=KO mouse; MGI; MGI:1916193; Pink1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line information from personal communication of Bagnoli, Enrico.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6.129S5-Pink1<tm1Lex>/Muqit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   MEF PKCe KO
AC   CVCL_AS81
SY   PKCepsilonKO
DR   CancerTools; 151665
DR   Wikidata; Q54905026
DR   Ximbio; 151665
RX   PubMed=12110574;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97599; Prkce.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   MEF PKCe KO KI
AC   CVCL_AS82
SY   PKCepsilonRE
DR   CancerTools; 151663
DR   Wikidata; Q54905027
DR   Ximbio; 151663
RX   PubMed=12110574;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97599; Prkce.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97599; Prkce.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AS81 ! MEF PKCe KO
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 8
//
ID   MEF Ppm1h KO
AC   CVCL_E3XE
SY   MEF Ppm1h knock-out
CC   Knockout cell: Method=KO mouse; MGI; MGI:2442087; Ppm1h.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line information from personal communication of Tonelli, Francesca.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129/SvEv-C57BL/6 Ppm1h-/- Taconic TF3142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   MEF Ppm1m KO
AC   CVCL_E7DI
SY   MEF Ppm1m knock-out
CC   Knockout cell: Method=KO mouse; MGI; MGI:1915155; Ppm1m.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Miscellaneous: Cell line information from personal communication of Tonelli, Francesca.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: C57BL/6N-Ppm1mtm2b(EUCOMM)Hmgu.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MEF-1 [Human myeloma]
AC   CVCL_M515
DR   IARC_TP53; 10417
DR   Wikidata; Q54905028
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10223569;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~36 hours (PubMed=10223569).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255_Leu257delinsSer (c.763_768del6); Zygosity=Unspecified (PubMed=10223569).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   MEF-1 [Mouse fibroblast]
AC   CVCL_4240
SY   MEF1; Mouse Embryo Fibroblast-1
DR   CLO; CLO_0007667
DR   ATCC; CRL-2214
DR   BCRJ; 0405
DR   ECACC; 98061101
DR   Wikidata; Q54905029
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MEF-N7
AC   CVCL_D5HR
DR   JCRB; JCRB1914
DR   Wikidata; Q127382799
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MEF-T7-SRp20
AC   CVCL_KU46
DR   Kerafast; ENH106-FP
DR   Wikidata; Q54905030
RX   PubMed=21179588;
WW   Provider; NIH OTT; E-229-2009/0; https://web.archive.org/web/20150920015316/https://www.ott.nih.gov/technology/e-229-2009
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10785; SRSF3 (Note=T7-tagged).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_KS91 ! MEF/3T3 Tet-Off
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   MEF/3T3 Tet-Off
AC   CVCL_KS91
SY   MEF 3T3 tet-off; MEF3T3 tet-off
DR   Wikidata; Q54905031
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630914.
CC   Discontinued: Takara/Clontech; Catalog number 631139.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   MEF_Hsp47 KO-11
AC   CVCL_A7BD
DR   RCB; RCB5292
DR   Wikidata; Q107116337
RX   PubMed=10995453;
RX   PubMed=16525016;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88283; Serpinh1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-9FD
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   MEF_Hsp47 KO-13
AC   CVCL_A7BE
DR   RCB; RCB5293
DR   Wikidata; Q107116340
RX   PubMed=10995453;
RX   PubMed=16525016;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88283; Serpinh1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-9FD
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   MEF_Hsp47 WT-1
AC   CVCL_A7BC
DR   RCB; RCB5291
DR   Wikidata; Q107116343
RX   PubMed=10995453;
RX   PubMed=16525016;
CC   Characteristics: Control cell line for MEF_Hsp47 KO-11 (Cellosaurus=CVCL_A7BD) and MEF_Hsp47 KO-13 (Cellosaurus=CVCL_A7BE).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-9FD
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   MEF3.8
AC   CVCL_R997
SY   Mef3.8
DR   Wikidata; Q54905032
RX   PubMed=10485464;
RX   PubMed=11059771;
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MEF3.8/M32
AC   CVCL_R999
SY   MEF3.8 M32; M32
DR   Wikidata; Q54905033
RX   PubMed=10485464;
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R997 ! MEF3.8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   MEF3.8/T6400
AC   CVCL_R998
SY   Mef3.8/T6400; T6400
DR   ChEMBL-Cells; CHEMBL3307255
DR   ChEMBL-Targets; CHEMBL613094
DR   PubChem_Cell_line; CVCL_R998
DR   Wikidata; Q54905034
RX   PubMed=10485464;
RX   PubMed=11956086;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b.
CC   Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R997 ! MEF3.8
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   MEG-01
AC   CVCL_0425
SY   Meg-01; MEG01; Meg01
DR   BTO; BTO_0002581
DR   CLO; CLO_0007668
DR   EFO; EFO_0002232
DR   MCCL; MCC:0000322
DR   CLDB; cl3432
DR   CLDB; cl3433
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2021
DR   BCRC; 60238
DR   BCRJ; 0262
DR   BioSample; SAMN01821577
DR   BioSample; SAMN01821648
DR   BioSample; SAMN01821734
DR   BioSample; SAMN03471278
DR   BioSample; SAMN10988184
DR   cancercelllines; CVCL_0425
DR   CCRID; 1101HUM-PUMC000521
DR   CCRID; 3101HUMTCHu197
DR   Cell_Model_Passport; SIDM00526
DR   ChEMBL-Cells; CHEMBL3308539
DR   ChEMBL-Targets; CHEMBL2366084
DR   CLS; 300482
DR   Cosmic; 787503
DR   Cosmic; 908126
DR   Cosmic; 924042
DR   Cosmic; 1026578
DR   Cosmic; 1070702
DR   Cosmic; 1078723
DR   Cosmic; 1516634
DR   Cosmic; 1523830
DR   Cosmic-CLP; 908126
DR   DepMap; ACH-000072
DR   DSMZ; ACC-364
DR   DSMZCellDive; ACC-364
DR   ECACC; 94012401
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10752-110D5
DR   GDSC; 908126
DR   GEO; GSM482498
DR   GEO; GSM887307
DR   GEO; GSM888383
DR   GEO; GSM1374669
DR   GEO; GSM1670093
DR   IARC_TP53; 21491
DR   ICLC; HTL96017
DR   IGRhCellID; MEG01
DR   JCRB; IFO50151
DR   LiGeA; CCLE_381
DR   LINCS_LDP; LCL-1110
DR   Lonza; 959
DR   PharmacoDB; MEG01_913_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0425
DR   PubChem_Cell_line; CVCL_0425
DR   Wikidata; Q54905035
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1742484;
RX   PubMed=2998511;
RX   PubMed=3332852;
RX   PubMed=9738977;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15843827;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20809971;
RX   PubMed=22460905;
RX   PubMed=26700326;
RX   PubMed=27277069;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30332548;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32180119;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; KAKEN; 60480281; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-60480281/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Can be induced to differentiate into megakaryocytes after application of 12-O-tetradecanoyl-13-phorbol acetate (TPA) or valproic acid (VPA) (PubMed=1742484; PubMed=30332548).
CC   Doubling time: 36-48 hours (PubMed=2998511); ~35 hours (DSMZ=ACC-364).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=20809971; DepMap=ACH-000072).
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Gly646Trpfs*12 (c.1934dupG); ClinVar=VCV000426927; Zygosity=Heterozygous (PubMed=26700326; DepMap=ACH-000072).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His233del (c.697_699delCAC); Zygosity=Heterozygous (Cosmic-CLP=908126; DepMap=ACH-000072).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.14%; Native American=0%; East Asian, North=79.13%; East Asian, South=17.4%; South Asian=0%; European, North=0%; European, South=2.33% (PubMed=30894373).
CC   Misspelling: Mego-1; Note=Occasionally.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2021; Cosmic-CLP=908126; DSMZ=ACC-364; ECACC=94012401; JCRB=IFO50151
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 18,22
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 26
ST   Penta D: 11,13
ST   Penta E: 15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   MEG-01s
AC   CVCL_3022
SY   MEG-01S; MEG01s
DR   BTO; BTO_0005297
DR   BioSample; SAMN03472795
DR   Cosmic; 2009519
DR   JCRB; IFO50473
DR   Wikidata; Q54905036
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Gly646Trpfs*12 (c.1934dupG); ClinVar=VCV000426927; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His233del (c.697_699delCAC); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): JCRB=IFO50473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0425 ! MEG-01
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   MEG-01SSF
AC   CVCL_3023
SY   MEG-01sSF; MEG-01s Serum Free
DR   JCRB; IFO50294
DR   Wikidata; Q54905037
RX   PubMed=1367286;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: ~20 hours (PubMed=1367286).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Gly646Trpfs*12 (c.1934dupG); ClinVar=VCV000426927; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His233del (c.697_699delCAC); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): JCRB=IFO50294
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3022 ! MEG-01s
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   MEG-A2
AC   CVCL_1832
DR   BioSample; SAMN03473398
DR   Cosmic; 1012086
DR   DSMZ; ACC-718
DR   DSMZCellDive; ACC-718
DR   FANTOM5_SSTAR; 10766-110F1
DR   JCRB; IFO50478
DR   Wikidata; Q54905038
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7869773;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Doubling time: ~30 hours (PubMed=7869773); ~40 hours (DSMZ=ACC-718).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=7869773; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-718; JCRB=IFO50478
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,14
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 13,16
ST   D21S11: 29
ST   D2S1338: 14,17
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 21,22
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   Meg-J
AC   CVCL_G311
SY   MEG-J; MegJ
DR   Cosmic; 919132
DR   Cosmic; 1012087
DR   Wikidata; Q54905039
RX   PubMed=9510473;
RX   PubMed=9722312;
RX   PubMed=10576511;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10576511).
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   MEGAL
AC   CVCL_1833
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   Cosmic; 787451
DR   Cosmic; 975269
DR   Cosmic; 1012088
DR   Cosmic; 1281327
DR   Cosmic; 2306218
DR   Cosmic; 2588711
DR   DSMZ; ACC-719
DR   DSMZCellDive; ACC-719
DR   Wikidata; Q54905040
RX   PubMed=16408098;
RX   PubMed=19166587;
RX   PubMed=31160637;
RX   PubMed=36982453;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Doubling time: ~70 hours (DSMZ=ACC-719).
CC   HLA typing: A*11:01:01,11:01:01; B*07:02:01,07:02:01; C*07:02:01,07:02:01; DPA1*02:01:02,02:01:02; DPB1*01:01:01,01:01:01; DQB1*06:02:01,06:02:01; DRA*01:02:03,01:02:03; DRB1*15:01:01,15:01:01 (DSMZCellDive=ACC-719).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8064; NUP214 + HGNC; HGNC:10760; SET; Name(s)=SET-NUP214 (PubMed=19166587).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): DSMZ=ACC-719
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 13,16
ST   D21S11: 28,30
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 20,23
ST   Penta D: 9,10
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 16
DI   NCIt; C3170; Acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   MeGo
AC   CVCL_UZ66
DR   Wikidata; Q95988461
RX   CelloPub=CLPUB00255;
RX   CelloPub=CLPUB00474;
RX   PubMed=5487065;
CC   Derived from site: Metastatic; Groin; UBERON=UBERON_0008337.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 5
//
ID   MEGR 07
AC   CVCL_F329
DR   CLDB; cl7213
DR   ICLC; HTL07005
DR   Wikidata; Q54905041
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
ST   Source(s): ICLC=HTL07005
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   MegTCC
AC   CVCL_WH30
DR   Wikidata; Q95988464
RX   PubMed=25773167;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   mEHE/CH5
AC   CVCL_Y275
SY   mEHE/CH 5
DR   Wikidata; Q54905042
RX   PubMed=7670562;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C134958; Hemangioendothelioma of the mouse thyroid gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   Mehr-80
AC   CVCL_U105
DR   NCBI_Iran; C543
DR   Wikidata; Q54905043
RX   PubMed=15619644;
RX   PubMed=23799175;
CC   Population: Iranian.
CC   Doubling time: 29 hours (PubMed=15619644).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5672; Lung large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   Mel 00.08
AC   CVCL_ZD07
SY   mel0.08; 00.08
DR   cancercelllines; CVCL_ZD07
DR   GEO; GSM1507932
DR   Wikidata; Q98127206
RX   PubMed=23685455;
RX   PubMed=25502142;
RX   PubMed=25538140;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455; PubMed=25538140).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   Mel 01.12
AC   CVCL_VU40
SY   mel1.12; 01.12
DR   cancercelllines; CVCL_VU40
DR   GEO; GSM1507937
DR   Wikidata; Q95988470
RX   PubMed=25502142;
RX   PubMed=25728708;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=25728708).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   Mel 02.02
AC   CVCL_VU41
SY   02.02
DR   cancercelllines; CVCL_VU41
DR   Wikidata; Q95988472
RX   PubMed=25728708;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=25728708).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   Mel 04.01
AC   CVCL_ZD03
SY   MEL04.01; 04.01
DR   cancercelllines; CVCL_ZD03
DR   PRIDE; PXD000497
DR   Wikidata; Q98127208
RX   PubMed=23685455;
RX   PubMed=25538140;
RX   PubMed=27350335;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455; PubMed=25538140).
CC   Sequence variation: Mutation; HGNC; HGNC:1424; CAD; Simple; p.Arg1854Gln (c.5561G>A); ClinVar=VCV001481207; Zygosity=Heterozygous (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:3330; EML1; Simple; p.Arg64Trp (c.190C>T); Zygosity=Heterozygous (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:8761; PDCD10; Simple; p.Pro28Ser (c.82C>T); Zygosity=Homozygous (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:30400; SEMA3G; Simple; p.Arg300Cys (c.898C>T); Zygosity=Heterozygous (PubMed=27350335).
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZD06 ! Mel 12.07
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   Mel 04.07
AC   CVCL_ZD08
SY   04.07
DR   cancercelllines; CVCL_ZD08
DR   Wikidata; Q98127210
RX   PubMed=23685455;
RX   PubMed=25538140;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455; PubMed=25538140).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   Mel 05.18
AC   CVCL_ZD04
SY   MEL05.18; 05.18
DR   Wikidata; Q98127212
RX   PubMed=27350335;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:29676; PUM3; Simple; p.Pro451Leu (c.1352C>T); Zygosity=Unspecified (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:10330; RPL28; Simple; p.Ser76Phe (c.227C>T); Zygosity=Heterozygous (PubMed=27350335).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZD05 ! Mel 06.07
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   Mel 06.04
AC   CVCL_ZD10
SY   06.04
DR   cancercelllines; CVCL_ZD10
DR   Wikidata; Q98127213
RX   PubMed=23685455;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   Mel 06.07
AC   CVCL_ZD05
SY   MEL06.07; 06.07
DR   Wikidata; Q98127214
RX   PubMed=27350335;
CC   Sequence variation: Mutation; HGNC; HGNC:29676; PUM3; Simple; p.Pro451Leu (c.1352C>T); Zygosity=Unspecified (PubMed=27350335).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZD04 ! Mel 05.18
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   Mel 07.16
AC   CVCL_ZD11
SY   07.16
DR   cancercelllines; CVCL_ZD11
DR   Wikidata; Q98127215
RX   PubMed=23685455;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   Mel 12
AC   CVCL_0D07
SY   Melanoma-12
DR   Wikidata; Q54905044
RX   PubMed=19147538;
RX   PubMed=19231960;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Mel 12.07
AC   CVCL_ZD06
SY   MEL12.07; 12.07
DR   cancercelllines; CVCL_ZD06
DR   Wikidata; Q98127216
RX   PubMed=27350335;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1424; CAD; Simple; p.Arg1854Gln (c.5561G>A); ClinVar=VCV001481207; Zygosity=Heterozygous (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:3330; EML1; Simple; p.Arg64Trp (c.190C>T); Zygosity=Heterozygous (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:8761; PDCD10; Simple; p.Pro28Ser (c.82C>T); Zygosity=Homozygous (PubMed=27350335).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZD03 ! Mel 04.01
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   Mel 1241
AC   CVCL_C616
SY   Mel1241; MEL1241; 1241-mel
DR   Cosmic; 876681
DR   Wikidata; Q54905045
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   Mel 13.03
AC   CVCL_ZD13
SY   MEL13.03; 13.03
DR   Wikidata; Q98127217
RX   PubMed=28903377;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   Mel 224
AC   CVCL_U915
SY   Mel224; Melanoma cell line 224; 224
DR   Cosmic; 897738
DR   Cosmic; 1054849
DR   Cosmic; 1507622
DR   Cosmic; 2233662
DR   Wikidata; Q54905046
RX   PubMed=12446472;
RX   PubMed=15688405;
RX   PubMed=17308088;
CC   From: Hansson, Johan; Karolinska Institutet; Stockholm; Sweden.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   Mel 226
AC   CVCL_B6L6
DR   Wikidata; Q112129254
RX   CelloPub=CLPUB00681;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel 23
AC   CVCL_0D08
SY   Melanoma-23
DR   Wikidata; Q54905047
RX   CelloPub=CLPUB00732;
RX   PubMed=19147538;
RX   PubMed=19231960;
RX   PubMed=25022346;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Mel 259
AC   CVCL_B6L7
DR   Wikidata; Q112129255
RX   CelloPub=CLPUB00681;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel 263
AC   CVCL_B6L0
SY   263
DR   Wikidata; Q112129256
RX   CelloPub=CLPUB00681;
RX   Patent=RU2395571;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel 26G
AC   CVCL_B6L1
SY   26G
DR   Wikidata; Q112129257
RX   Patent=RU2395571;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 701D.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6L0 ! Mel 263
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Mel 3.0
AC   CVCL_VQ12
DR   cancercelllines; CVCL_VQ12
DR   Wikidata; Q95988483
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=29492214).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   Mel 311
AC   CVCL_B6L3
SY   311
DR   Wikidata; Q112129258
RX   CelloPub=CLPUB00681;
RX   Patent=RU2395573;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   64Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel 31G
AC   CVCL_B6L4
SY   31G
DR   Wikidata; Q112129259
RX   Patent=RU2395573;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 698D.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6L3 ! Mel 311
SX   Sex unspecified
AG   64Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Mel 36
AC   CVCL_0D09
SY   Melanoma-36
DR   Wikidata; Q54905048
RX   CelloPub=CLPUB00732;
RX   PubMed=19147538;
RX   PubMed=25022346;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   Mel 364
AC   CVCL_C6VL
SY   Mel364; Melanoma 364
DR   Wikidata; Q117704694
RX   PubMed=199545;
CC   Population: Caucasian.
CC   Characteristics: Pigmented (PubMed=199545).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   Mel 50
AC   CVCL_0D10
SY   Melanoma-50
DR   Wikidata; Q54905049
RX   PubMed=19147538;
RX   PubMed=19231960;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Mel 505
AC   CVCL_U916
SY   Mel-505; MEL-505; Mel505
DR   Cosmic; 1054844
DR   Cosmic; 1102387
DR   Cosmic; 1507609
DR   Cosmic; 2233663
DR   Wikidata; Q54905050
RX   PubMed=17308088;
CC   From: Hansson, Johan; Karolinska Institutet; Stockholm; Sweden.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
ID   Mel 603
AC   CVCL_RA52
DR   Wikidata; Q54905051
RX   PubMed=9413942;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 4
//
ID   Mel 64
AC   CVCL_0D11
SY   Melanoma-64
DR   Wikidata; Q54905052
RX   PubMed=19147538;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   Mel 69
AC   CVCL_0D12
SY   Melanoma-69
DR   Wikidata; Q54905053
RX   CelloPub=CLPUB00732;
RX   PubMed=25022346;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Mel 82
AC   CVCL_B6L8
DR   Wikidata; Q112129260
RX   CelloPub=CLPUB00681;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel 83
AC   CVCL_0D13
SY   Melanoma-83
DR   Wikidata; Q54905054
RX   CelloPub=CLPUB00732;
RX   PubMed=25022346;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Mel 90.07
AC   CVCL_VU42
SY   mel90.07; 90.07
DR   cancercelllines; CVCL_VU42
DR   GEO; GSM1507942
DR   Wikidata; Q95988494
RX   PubMed=25502142;
RX   PubMed=25728708;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=25728708).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   Mel 928
AC   CVCL_C694
SY   Mel928; MEL928; 928-Mel; 928-mel; 928 MEL; 928 mel; 928mel; 928MEL
DR   EFO; EFO_0006360
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471614
DR   cancercelllines; CVCL_C694
DR   CGH-DB; 9310-4
DR   Cosmic; 876701
DR   Cosmic; 905223
DR   Cosmic; 1295545
DR   Cosmic; 1559442
DR   EGA; EGAS00001000610
DR   GEO; GSM206441
DR   GEO; GSM274693
DR   PharmacoDB; 928mel_33_2019
DR   Wikidata; Q54905055
RX   PubMed=15467732;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*11:01,24:02; B*53:01,57:01; C*04:01,06:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 14
ST   D18S51: 12
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 19
ST   Penta D: 11,13
ST   Penta E: 8,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 23
//
ID   Mel 93.03
AC   CVCL_ZD09
SY   93.03
DR   cancercelllines; CVCL_ZD09
DR   Wikidata; Q98127218
RX   PubMed=23685455;
RX   PubMed=25538140;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455; PubMed=25538140).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   Mel 93.05
AC   CVCL_ZD14
SY   MEL93.05; 93.05
DR   Wikidata; Q98127221
RX   PubMed=28903377;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   Mel 93.15.2
AC   CVCL_ZD12
SY   93.15.2
DR   cancercelllines; CVCL_ZD12
DR   Wikidata; Q98127222
RX   PubMed=23685455;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   Mel 95.23
AC   CVCL_ZD15
SY   mel95.23; 95.23
DR   GEO; GSM1507934
DR   Wikidata; Q98127223
RX   PubMed=25502142;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   Mel 99.08
AC   CVCL_VU43
SY   mel99.08; 99.08
DR   cancercelllines; CVCL_VU43
DR   GEO; GSM1507936
DR   Wikidata; Q95988496
RX   PubMed=25502142;
RX   PubMed=25728708;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=25728708).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   Mel Bgf
AC   CVCL_B6KL
SY   mel Bgf
DR   cancercelllines; CVCL_B6KL
DR   Wikidata; Q112129261
RX   CelloPub=CLPUB00680;
RX   Patent=RU2390557;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 714D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   57Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel Ch
AC   CVCL_B6KM
SY   mel Ch
DR   cancercelllines; CVCL_B6KM
DR   Wikidata; Q112129262
RX   CelloPub=CLPUB00680;
RX   Patent=RU2373279;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 706D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel Cher
AC   CVCL_B6K8
SY   mel Cher
DR   cancercelllines; CVCL_B6K8
DR   Wikidata; Q112129263
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
RX   DOI=10.17650/1726-9784-2016-15-3-90-94;
RX   DOI=10.17650/1726-9784-2018-17-4-27-35;
RX   Patent=RU2364624;
RX   Patent=RU2404243;
RX   PubMed=16107020;
RX   PubMed=27313776;
RX   PubMed=28881731;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 704D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680; DOI=10.17650/1726-9784-2018-17-4-27-35).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=28881731).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Mel Cher 5C
AC   CVCL_B6K9
SY   mel Cher 5; Cher 5C
DR   cancercelllines; CVCL_B6K9
DR   Wikidata; Q112129264
RX   DOI=10.17650/1726-9784-2016-15-3-90-94;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6K8 ! Mel Cher
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Mel E
AC   CVCL_B6L9
SY   mel E
DR   Wikidata; Q112129265
RX   CelloPub=CLPUB00681;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel Ei
AC   CVCL_3978
SY   Mel-Ei-78; Ei
DR   BTO; BTO_0001672
DR   Wikidata; Q54905056
RX   PubMed=959779;
RX   PubMed=6895502;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   Mel Gerlach
AC   CVCL_IS37
SY   Gerlach
DR   Wikidata; Q54905057
RX   PubMed=18698037;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 4
//
ID   Mel Gi
AC   CVCL_B6KN
SY   mel Gi
DR   cancercelllines; CVCL_B6KN
DR   Wikidata; Q112129266
RX   CelloPub=CLPUB00680;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Mel Gus
AC   CVCL_B6KP
SY   mel Gus
DR   cancercelllines; CVCL_B6KP
DR   Wikidata; Q112129267
RX   CelloPub=CLPUB00680;
RX   Patent=RU2373280;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 707D.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel H
AC   CVCL_B6KQ
SY   mel H
DR   cancercelllines; CVCL_B6KQ
DR   Wikidata; Q112129268
RX   CelloPub=CLPUB00680;
RX   Patent=RU2402604;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 715D.
CC   HLA typing: A*03,30; B*07,13 (Patent=RU2402604).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel Hn
AC   CVCL_B6KR
SY   mel Hn
DR   cancercelllines; CVCL_B6KR
DR   Wikidata; Q112129269
RX   CelloPub=CLPUB00680;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Mel Ho
AC   CVCL_1402
SY   MEL HO; MEL-HO; MEL-Ho; Mel-HO; MelHo; MELHO; Ho
DR   BTO; BTO_0001587
DR   CLO; CLO_0007675
DR   EFO; EFO_0006647
DR   CLDB; cl3439
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 549
DR   BioSample; SAMN03152032
DR   BioSample; SAMN03473130
DR   BioSample; SAMN03473505
DR   BioSample; SAMN10988268
DR   cancercelllines; CVCL_1402
DR   Cell_Model_Passport; SIDM00337
DR   ChEMBL-Cells; CHEMBL3308798
DR   ChEMBL-Targets; CHEMBL1075500
DR   Cosmic; 908124
DR   Cosmic; 1995504
DR   Cosmic-CLP; 908124
DR   DepMap; ACH-000450
DR   DSMZ; ACC-62
DR   DSMZCellDive; ACC-62
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 908124
DR   GEO; GSM887308
DR   GEO; GSM888384
DR   GEO; GSM1670094
DR   IARC_TP53; 21492
DR   LiGeA; CCLE_006
DR   LINCS_LDP; LCL-1251
DR   PharmacoDB; MELHO_914_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1402
DR   PubChem_Cell_line; CVCL_1402
DR   Wikidata; Q54905059
RX   PubMed=6895502;
RX   PubMed=10508494;
RX   PubMed=11668190;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=22170099;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00144.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (DSMZ=ACC-62).
CC   HLA typing: A*03:01,03:01; B*07:02,14:02; C*07:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000450).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.05%; East Asian, South=0%; South Asian=0%; European, North=64.35%; European, South=34.59% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Cosmic-CLP=908124; DSMZ=ACC-62; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10 (PubMed=25877200)
ST   D7S820: 10,11,13 (Cosmic-CLP=908124; DSMZ=ACC-62)
ST   D8S1179: 11,14 (PubMed=25877200)
ST   D8S1179: 11,16 (DSMZ=ACC-62)
ST   FGA: 22,23
ST   Penta D: 8,9
ST   Penta E: 11,16
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3981 ! Mel Wei
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   Mel Ibr
AC   CVCL_B6JK
SY   mel Ibr; Mel IBR
DR   cancercelllines; CVCL_B6JK
DR   Wikidata; Q112129270
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
RX   DOI=10.17650/1726-9784-2018-17-4-27-35;
RX   Patent=RU2287576;
RX   PubMed=16107020;
RX   PubMed=18781128;
RX   PubMed=26388567;
RX   PubMed=28726209;
RX   PubMed=28881731;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 689D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel Ibr subclone
AC   CVCL_B6KC
DR   cancercelllines; CVCL_B6KC
DR   Wikidata; Q112129271
RX   PubMed=26388567;
RX   PubMed=28726209;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6JK ! Mel Ibr
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel IG
AC   CVCL_B6L2
SY   IG
DR   cancercelllines; CVCL_B6L2
DR   Wikidata; Q112129272
RX   Patent=RU2395572;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 700D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6JK ! Mel Ibr
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   MEL III
AC   CVCL_3850
SY   Mel III; Mel-III
DR   CLO; CLO_0007669
DR   CLDB; cl5230
DR   ATCC; CRL-6308
DR   IZSLER; BS TCL 114
DR   NCBI_Iran; C456
DR   Wikidata; Q54905058
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6308; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C134784; Rhesus monkey mammary tumor
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Mel Il
AC   CVCL_B6KD
SY   mel Il; Mel IL; mel IL
DR   cancercelllines; CVCL_B6KD
DR   Wikidata; Q112129273
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
RX   Patent=RU2287577;
RX   PubMed=18781128;
RX   PubMed=28881731;
RX   PubMed=30551515;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 686D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731; PubMed=30551515).
CC   Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel IL/R
AC   CVCL_B6KF
DR   cancercelllines; CVCL_B6KF
DR   Wikidata; Q112129274
RX   PubMed=30551515;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=30551515).
CC   Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6KD ! Mel Il
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel ILG
AC   CVCL_B6LC
SY   ILG
DR   cancercelllines; CVCL_B6LC
DR   Wikidata; Q112129275
RX   Patent=RU2395574;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 697D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6KD ! Mel Il
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Mel Im
AC   CVCL_3980
SY   Mel-Im-82; Im
DR   BTO; BTO_0001674
DR   Wikidata; Q54905060
RX   PubMed=959779;
RX   PubMed=6895502;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   Mel Is
AC   CVCL_B6KS
SY   mel Is
DR   cancercelllines; CVCL_B6KS
DR   Wikidata; Q112129276
RX   CelloPub=CLPUB00680;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Mel Ju
AC   CVCL_3979
SY   Ju
DR   BTO; BTO_0001673
DR   Wikidata; Q54905061
RX   PubMed=6895502;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   Mel JuSo
AC   CVCL_1403
SY   MEL-Juso; MEL-JUSO; Mel-Juso; Mel Juso; MelJuSo; MELJUSO; JuSo
DR   BTO; BTO_0001588
DR   CLO; CLO_0007676
DR   EFO; EFO_0022434
DR   EFO; EFO_0022720
DR   CLDB; cl3440
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 548
DR   BioSample; SAMN03471884
DR   BioSample; SAMN10988249
DR   cancercelllines; CVCL_1403
DR   Cell_Model_Passport; SIDM00336
DR   ChEMBL-Cells; CHEMBL3308761
DR   ChEMBL-Targets; CHEMBL1075501
DR   CLS; 300282
DR   Cosmic; 706091
DR   Cosmic; 888060
DR   Cosmic; 888835
DR   Cosmic; 897474
DR   Cosmic; 908125
DR   Cosmic; 1020272
DR   Cosmic; 1022285
DR   Cosmic; 1459306
DR   Cosmic; 1995505
DR   Cosmic-CLP; 908125
DR   DepMap; ACH-000881
DR   DSMZ; ACC-74
DR   DSMZCellDive; ACC-74
DR   EGA; EGAS00001000978
DR   GDSC; 908125
DR   GEO; GSM887309
DR   GEO; GSM888385
DR   GEO; GSM1374670
DR   GEO; GSM1670095
DR   IARC_TP53; 21493
DR   LiGeA; CCLE_674
DR   LINCS_LDP; LCL-1252
DR   PharmacoDB; MELJUSO_915_2019
DR   PRIDE; PXD011899
DR   PRIDE; PXD019519
DR   PRIDE; PXD021877
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1403
DR   PubChem_Cell_line; CVCL_1403
DR   Wikidata; Q54905064
RX   CelloPub=CLPUB00695;
RX   PubMed=2174414;
RX   PubMed=6895502;
RX   PubMed=9598804;
RX   PubMed=10766161;
RX   PubMed=11668190;
RX   PubMed=15009714;
RX   PubMed=18698037;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~28 hours (DSMZ=ACC-74).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (Cosmic-CLP=908125; DepMap=ACH-000881).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=10766161; PubMed=15009714; Cosmic-CLP=908125; DepMap=ACH-000881).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=1.12%; South Asian=0%; European, North=63.28%; European, South=35.59% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Cosmic-CLP=908125; DSMZ=ACC-74; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D18S51: 15,18
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 20,24
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 9,14
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 5,13
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Mel JuSo ABCB5 KO clone HO1
AC   CVCL_B7EF
DR   cancercelllines; CVCL_B7EF
DR   Wikidata; Q112930108
RX   CelloPub=CLPUB00695;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1403 ! Mel JuSo
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Mel JuSo ABCB5 KO clone HO2
AC   CVCL_B7EG
DR   cancercelllines; CVCL_B7EG
DR   Wikidata; Q112930109
RX   CelloPub=CLPUB00695;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1403 ! Mel JuSo
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Mel JuSo ABCB5 KO clone HO3
AC   CVCL_B7EH
DR   cancercelllines; CVCL_B7EH
DR   Wikidata; Q112930110
RX   CelloPub=CLPUB00695;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1403 ! Mel JuSo
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Mel JuSo ABCB5 KO clone HO4
AC   CVCL_B7EI
DR   cancercelllines; CVCL_B7EI
DR   Wikidata; Q112930111
RX   CelloPub=CLPUB00695;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1403 ! Mel JuSo
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Mel KG
AC   CVCL_B6LQ
SY   KG
DR   cancercelllines; CVCL_B6LQ
DR   Wikidata; Q112129277
RX   Patent=RU2362805;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 699D.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6KB ! Mel Kor
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Mel Kis
AC   CVCL_B6LA
DR   Wikidata; Q112129278
RX   CelloPub=CLPUB00681;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel Kor
AC   CVCL_B6KB
SY   mel Kor
DR   cancercelllines; CVCL_B6KB
DR   Wikidata; Q112129279
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
RX   Patent=RU2287578;
RX   PubMed=16107020;
RX   PubMed=18781128;
RX   PubMed=27313776;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 687D.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel Kor-TurboRFP
AC   CVCL_B6KK
SY   mel Kor-TurboRFP
DR   cancercelllines; CVCL_B6KK
DR   Wikidata; Q112129280
RX   DOI=10.1134/S1070363215010429;
RX   Patent=RU2458123;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 730D.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; AHNXC; TurboRFP (Note=Orange fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6KB ! Mel Kor
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Mel Ksen
AC   CVCL_B6KT
SY   mel Ksen
DR   Wikidata; Q112129281
RX   CelloPub=CLPUB00680;
RX   Patent=RU2392316;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 713D.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   Mel Ku
AC   CVCL_B7MW
SY   Mel-Ku-77
DR   Wikidata; Q112930112
RX   PubMed=959779;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 5
//
ID   Mel Me
AC   CVCL_B6KH
SY   mel Me
DR   cancercelllines; CVCL_B6KH
DR   Wikidata; Q112129282
RX   CelloPub=CLPUB00680;
RX   Patent=RU2402603;
RX   PubMed=16107020;
RX   PubMed=27313776;
RX   PubMed=30551515;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 712D.
CC   HLA typing: A*02,31; B*56,58 (Patent=RU2402603).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=30551515).
CC   Derived from site: Metastatic; Back, skin; UBERON=UBERON_0001068.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel min-1
AC   CVCL_B6JP
DR   Wikidata; Q112129284
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-10
AC   CVCL_B6JZ
DR   Wikidata; Q112129286
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-11
AC   CVCL_B6K0
DR   Wikidata; Q112129287
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-12
AC   CVCL_B6K1
DR   Wikidata; Q112129289
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-13
AC   CVCL_B6K2
DR   Wikidata; Q112129290
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-14
AC   CVCL_B6K3
DR   Wikidata; Q112129291
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-15
AC   CVCL_B6K4
DR   Wikidata; Q112129292
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-16
AC   CVCL_B6K5
DR   Wikidata; Q112129293
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-17
AC   CVCL_B6K6
DR   Wikidata; Q112129294
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-18
AC   CVCL_B6K7
DR   Wikidata; Q112129295
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-2
AC   CVCL_B6JQ
DR   Wikidata; Q112129296
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-3
AC   CVCL_B6JR
DR   Wikidata; Q112129297
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-4
AC   CVCL_B6JS
DR   Wikidata; Q112129298
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-5
AC   CVCL_B6JT
DR   Wikidata; Q112129299
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-6
AC   CVCL_B6JU
DR   Wikidata; Q112129300
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-7
AC   CVCL_B6JV
DR   Wikidata; Q112129301
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-8
AC   CVCL_B6JW
DR   Wikidata; Q112129302
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel min-9
AC   CVCL_B6JY
DR   Wikidata; Q112129303
RX   PubMed=18781128;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel Mtp
AC   CVCL_B6KG
SY   mel Mtp; Mel MTP
DR   cancercelllines; CVCL_B6KG
DR   Wikidata; Q112129304
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
RX   Patent=RU2360963;
RX   PubMed=16107020;
RX   PubMed=30551515;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 705D.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=30551515).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel Neg
AC   CVCL_3748
DR   CLO; CLO_0007670
DR   ATCC; CRL-1193
DR   Wikidata; Q54905065
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Mel P
AC   CVCL_B6JM
SY   mel P; MelP
DR   cancercelllines; CVCL_B6JM
DR   Wikidata; Q112129305
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
RX   Patent=RU2287575;
RX   PubMed=16107020;
RX   PubMed=18781128;
RX   PubMed=27313776;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 688D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   50Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel PG
AC   CVCL_B6KZ
SY   PG
DR   cancercelllines; CVCL_B6KZ
DR   Wikidata; Q112129306
RX   Patent=RU2395570;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 702D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6JM ! Mel P
SX   Sex unspecified
AG   50Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Mel R
AC   CVCL_B6KU
SY   mel R
DR   cancercelllines; CVCL_B6KU
DR   Wikidata; Q112129307
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   Mel Rac
AC   CVCL_B6KA
SY   mel Rac
DR   cancercelllines; CVCL_B6KA
DR   Wikidata; Q112129308
RX   CelloPub=CLPUB00680;
RX   DOI=10.17650/1726-9784-2018-17-4-27-35;
RX   Patent=RU2402602;
RX   PubMed=28881731;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 710D.
CC   HLA typing: A*23,26; B*08,39 (Patent=RU2402602).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (DOI=10.17650/1726-9784-2018-17-4-27-35; PubMed=28881731).
CC   Derived from site: Metastatic; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Mel S
AC   CVCL_B6LB
DR   Wikidata; Q112129309
RX   CelloPub=CLPUB00681;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel Si
AC   CVCL_B6KV
SY   mel Si
DR   cancercelllines; CVCL_B6KV
DR   Wikidata; Q112129310
RX   CelloPub=CLPUB00680;
RX   CelloPub=CLPUB00681;
RX   Patent=RU2363734;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 708D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Gln (c.1790T>A); ClinVar=VCV000076687; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Back, skin; UBERON=UBERON_0001068.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   Mel Wei
AC   CVCL_3981
SY   MEL-WEI; Wei
DR   BTO; BTO_0001675
DR   BioSample; SAMN03152033
DR   Wikidata; Q54905066
RX   PubMed=6895502;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Shown to be identical to MEL-Ho. This cell line was reported to be isogenic with LCL-Wei (Cellosaurus=CVCL_1869) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00145.
CC   Population: Caucasian.
CC   Misspelling: ME-WEI; Note=Occasionally.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1402 ! Mel Ho
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   Mel Z
AC   CVCL_B6KE
SY   mel Z
DR   cancercelllines; CVCL_B6KE
DR   Wikidata; Q112129311
RX   CelloPub=CLPUB00680;
RX   Patent=RU2390556;
RX   PubMed=16107020;
RX   PubMed=28881731;
RX   PubMed=30551515;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 711D.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731; PubMed=30551515).
CC   Derived from site: Metastatic; Interscapular region, hypodermis; UBERON=UBERON_8480066+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MEL-1 INSGFP/w
AC   CVCL_XA16
SY   MEL1 INSGFP/w; MEL1 INS(GFP/w); Mel1-INS-GFP
DR   Wikidata; Q95988515
RX   PubMed=22120512;
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in the INS locus (PubMed=22120512).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B863 ! SCSe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 6
//
ID   MEL-1 INSGFP/w NEUROD1(-/-)
AC   CVCL_XA17
DR   Wikidata; Q95988516
RX   PubMed=31519700;
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in the INS locus (PubMed=31519700).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7762; NEUROD1.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA16 ! MEL-1 INSGFP/w
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   MEL-11
AC   CVCL_A8RI
DR   cancercelllines; CVCL_A8RI
DR   Cosmic; 888848
DR   Wikidata; Q108820894
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   MEL-14
AC   CVCL_9224
SY   MEL-14.D54
DR   CLO; CLO_0007671
DR   ATCC; HB-132
DR   Wikidata; Q54905067
RX   PubMed=2442176;
RX   PubMed=6866086;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P18337; Mouse Sell/Cd62l.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   Mel-18
AC   CVCL_H201
SY   Mel18
DR   Cosmic; 2144975
DR   Wikidata; Q54905068
RX   PubMed=19035443;
RX   PubMed=22578220;
CC   From: Institute for Advanced Medical Research, Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   Mel-2
AC   CVCL_H203
SY   Mel2
DR   Cosmic; 2144974
DR   Wikidata; Q54905069
RX   PubMed=19035443;
RX   PubMed=22578220;
CC   From: Institute for Advanced Medical Research, Keio University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   Mel-2183
AC   CVCL_L268
SY   Mel 2183; Mel_2183; Mel2183
DR   EFO; EFO_0005706
DR   ENCODE; ENCBS255AAA
DR   GEO; GSM1008599
DR   Wikidata; Q54905070
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Mel2183_Crawford_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   Mel-2a
AC   CVCL_A759
SY   Mel-2A; Mel 2a; Mel 2A; Mel2a; Mel2A
DR   Cosmic; 1181747
DR   Cosmic; 1221592
DR   Wikidata; Q54905071
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=3485457;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   MEL-31
AC   CVCL_A8RJ
DR   cancercelllines; CVCL_A8RJ
DR   Cosmic; 888856
DR   Wikidata; Q108820895
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   Mel-34
AC   CVCL_W284
SY   Mel34
DR   cancercelllines; CVCL_W284
DR   CGH-DB; 9286-4
DR   Cosmic; 905200
DR   Wikidata; Q54905072
RX   PubMed=15467732;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   Mel-57
AC   CVCL_4454
SY   Mel 57; MEL 57; Mel57
DR   BTO; BTO_0002804
DR   Wikidata; Q54905073
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=1918136;
RX   PubMed=2060184;
RX   PubMed=3485457;
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   Mel-67
AC   CVCL_WG85
SY   Mel 67
DR   Wikidata; Q95988528
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   MEL-745A cl. DR10c3
AC   CVCL_W805
SY   DR10c3; MELC DR10
DR   CLO; CLO_0007673
DR   CLDB; cl3444
DR   Wikidata; Q54905074
RX   PubMed=177980;
CC   Characteristics: Resistant to the erythropoiesis-inducing effect of DMSO (PubMed=177980).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2111 ! MEL-745A cl. DS19
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   MEL-745A cl. DS19
AC   CVCL_2111
SY   MEL-DS19; MEL DS19; MELDS19; 745/DS19; MELC DS19; DS19; MEL
DR   BTO; BTO_0003902
DR   CLO; CLO_0002823
DR   CLO; CLO_0007674
DR   EFO; EFO_0003971
DR   CLDB; cl1100
DR   CLDB; cl3445
DR   CCRID; 1101MOU-PUMC000042
DR   CLS; 305153
DR   DSMZ; ACC-501
DR   DSMZCellDive; ACC-501
DR   ENCODE; ENCBS002NUU
DR   ENCODE; ENCBS046ENC
DR   ENCODE; ENCBS047ENC
DR   ENCODE; ENCBS048ENC
DR   ENCODE; ENCBS049ENC
DR   ENCODE; ENCBS050ENC
DR   ENCODE; ENCBS217OGM
DR   ENCODE; ENCBS243ENC
DR   ENCODE; ENCBS259BOZ
DR   ENCODE; ENCBS425KAG
DR   ENCODE; ENCBS436ELB
DR   ENCODE; ENCBS437PRW
DR   ENCODE; ENCBS588DZE
DR   ENCODE; ENCBS671NUO
DR   ENCODE; ENCBS706GHU
DR   ENCODE; ENCBS802BLF
DR   ENCODE; ENCBS870FKO
DR   ENCODE; ENCBS892CGC
DR   GEO; GSM798324
DR   GEO; GSM912892
DR   GEO; GSM912893
DR   GEO; GSM912895
DR   GEO; GSM912896
DR   GEO; GSM912899
DR   GEO; GSM912903
DR   GEO; GSM912907
DR   GEO; GSM912913
DR   GEO; GSM912914
DR   GEO; GSM912915
DR   GEO; GSM912919
DR   GEO; GSM912921
DR   GEO; GSM912923
DR   GEO; GSM912927
DR   GEO; GSM912928
DR   GEO; GSM912929
DR   GEO; GSM912932
DR   GEO; GSM912934
DR   GEO; GSM912935
DR   GEO; GSM918707
DR   GEO; GSM923573
DR   GEO; GSM923577
DR   GEO; GSM923578
DR   GEO; GSM1000073
DR   GEO; GSM1000087
DR   GEO; GSM1000141
DR   GEO; GSM1000142
DR   GEO; GSM1000154
DR   GEO; GSM1000155
DR   GEO; GSM1000156
DR   GEO; GSM1003744
DR   GEO; GSM1003752
DR   GEO; GSM1003753
DR   GEO; GSM1003755
DR   GEO; GSM1003776
DR   GEO; GSM1003777
DR   GEO; GSM1003778
DR   GEO; GSM1003779
DR   GEO; GSM1003780
DR   GEO; GSM1003785
DR   GEO; GSM1003788
DR   GEO; GSM1003789
DR   GEO; GSM1003790
DR   GEO; GSM1003791
DR   GEO; GSM1003794
DR   GEO; GSM1003797
DR   GEO; GSM1003798
DR   GEO; GSM1003804
DR   GEO; GSM1003805
DR   GEO; GSM1014191
DR   GEO; GSM1113247
DR   GEO; GSM1113248
DR   KCB; KCB 200855YJ
DR   Lonza; 160
DR   Wikidata; Q54905075
RX   PubMed=177980;
RX   PubMed=4527790;
CC   Part of: ENCODE project mouse cell lines.
CC   Doubling time: ~20 hours (DSMZ=ACC-501).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Mel-Ab
AC   CVCL_B425
SY   Mel-ab
DR   BTO; BTO_0003944
DR   Wikidata; Q54905076
RX   PubMed=2856252;
RX   PubMed=8024800;
CC   Characteristics: Produces copious amounts of melanin in culture.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4624 ! Melan-a
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   MEL-AC
AC   CVCL_D549
DR   ChEMBL-Cells; CHEMBL3308636
DR   ChEMBL-Targets; CHEMBL614732
DR   PubChem_Cell_line; CVCL_D549
DR   Wikidata; Q54905077
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   mel-Alx-LP
AC   CVCL_D2PW
DR   Wikidata; Q127382800
RX   Patent=RU2796357;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 812D.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Patent=RU2796357
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14,15
ST   D12S391: 20,21
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D1S1656: 12
ST   D21S11: 30,31
ST   D22S1045: 15
ST   D2S441: 11
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   SE33: 19
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Mel-AT
AC   CVCL_S995
SY   Mel AT
DR   BTO; BTO_0005712
DR   Wikidata; Q54905079
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   Mel-BH
AC   CVCL_GR36
DR   Wikidata; Q54905080
RX   PubMed=7520026;
RX   PubMed=8980186;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-BP
AC   CVCL_GR37
DR   Wikidata; Q54905081
RX   PubMed=7520026;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   MEL-c88
AC   CVCL_C188
SY   MEL c88; MEL-C88; MEL C88; C88 MEL; MEL cell line C88
DR   Wikidata; Q54905082
RX   PubMed=279411;
RX   PubMed=10468879;
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3988 ! FLC clone 745
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 6
//
ID   MEL-CLS-1
AC   CVCL_5619
SY   FO-1; FO #1; FO 1
DR   BTO; BTO_0002943
DR   cancercelllines; CVCL_5619
DR   CLS; 300175
DR   Wikidata; Q54905083
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=1898655;
RX   PubMed=2624919;
RX   PubMed=3518877;
RX   PubMed=8537970;
RX   PubMed=15661905;
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft (CLS=300175).
CC   Doubling time: 38 hours (Note=At 49th passage) (PubMed=994214).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CLS=300175).
CC   Derived from site: Metastatic; Iliac lymph node; UBERON=UBERON_0015878.
ST   Source(s): CLS=300175
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 17
ST   D21S11: 27
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 19,23
ST   Penta D: 9
ST   Penta E: 14,17
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   MEL-CLS-2
AC   CVCL_6001
DR   cancercelllines; CVCL_6001
DR   CLS; 300283
DR   Wikidata; Q54905084
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft (CLS=300283).
CC   HLA typing: A*02:06:01,20:02:01; B*39:01:01,53:01:01; C*03:04:01,04:01:01; DPB1*02:01,04:01; DQA1*03:03:01,05:01:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,04:01:01 (CLS=300283).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CLS=300283).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): CLS=300283
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 7,11
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   MEL-CLS-3
AC   CVCL_6002
SY   MRI-H-221
DR   cancercelllines; CVCL_6002
DR   CLS; 300293
DR   Wikidata; Q54905085
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CLS=300293).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): CLS=300293
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 16,17
ST   D21S11: 28,31.2
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 12,13
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   MEL-CLS-4
AC   CVCL_6003
DR   cancercelllines; CVCL_6003
DR   CLS; 300128
DR   Wikidata; Q54905086
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft (CLS=300128).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CLS=300128).
ST   Source(s): CLS=300128
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 11,14
ST   D21S11: 30
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 19,23
ST   Penta D: 13
ST   Penta E: 7,19
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   Mel-CV
AC   CVCL_S996
SY   Mel CV
DR   BTO; BTO_0005713
DR   Wikidata; Q54905087
RX   PubMed=8980186;
RX   PubMed=9725211;
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Mel-DA
AC   CVCL_GR35
DR   Wikidata; Q54905088
RX   PubMed=7520026;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-DH
AC   CVCL_GR38
DR   Wikidata; Q54905089
RX   PubMed=7520026;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-DO
AC   CVCL_C500
DR   ESTDAB; ESTDAB-096
DR   Wikidata; Q54905090
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   Mel-DP
AC   CVCL_GR33
DR   Wikidata; Q54905091
RX   PubMed=7520026;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-FC
AC   CVCL_GR39
DR   Wikidata; Q54905092
RX   PubMed=7520026;
RX   PubMed=9725211;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 7
//
ID   Mel-FH
AC   CVCL_D547
SY   Mel FH
DR   BTO; BTO_0005714
DR   Cosmic; 889009
DR   Wikidata; Q54905093
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9725211;
RX   PubMed=10364001;
RX   PubMed=15048078;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; None_reported; -; Zygosity=- (PubMed=15048078).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   Mel-FHH
AC   CVCL_GR44
DR   Wikidata; Q54905094
RX   PubMed=8980186;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   MEL-GATA-1-ER
AC   CVCL_Y480
SY   mG/ER
DR   EFO; EFO_0005480
DR   ENCODE; ENCBS212ENC
DR   ENCODE; ENCBS533WAU
DR   Wikidata; Q54905095
RX   PubMed=14559825;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/mG-ER_Stam_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Characteristics: Transfected with a GATA-1-ER construct (GATA1 fused to the ligand-binding domains of ESR1).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4170; GATA1.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2111 ! MEL-745A cl. DS19
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   Mel-GL
AC   CVCL_S997
SY   Mel GL
DR   Wikidata; Q54905096
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Mel-JB
AC   CVCL_S998
SY   Mel JB
DR   Wikidata; Q54905097
RX   PubMed=8980186;
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   Mel-JC
AC   CVCL_S999
SY   Mel JC
DR   Wikidata; Q54905098
RX   PubMed=8980186;
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   Mel-JD
AC   CVCL_BS80
SY   MelJD
DR   BTO; BTO_0005718
DR   Wikidata; Q54905099
RX   PubMed=8980186;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   Mel-JF
AC   CVCL_T000
SY   Mel JF
DR   Wikidata; Q54905101
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   Mel-JG
AC   CVCL_T001
SY   Mel JG
DR   Wikidata; Q54905102
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Mel-JN
AC   CVCL_GR41
DR   Wikidata; Q54905103
RX   PubMed=8980186;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-JS
AC   CVCL_T002
SY   Mel JS
DR   Wikidata; Q54905104
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9725211;
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   Mel-JW
AC   CVCL_GR40
DR   Wikidata; Q54905105
RX   PubMed=7520026;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-KN
AC   CVCL_T003
SY   Mel KN
DR   Wikidata; Q54905110
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Mel-LE
AC   CVCL_C501
SY   EST94
DR   cancercelllines; CVCL_C501
DR   Cosmic; 1047658
DR   Cosmic; 2163813
DR   ESTDAB; ESTDAB-094
DR   GEO; GSM156009
DR   IARC_TP53; 26085
DR   Progenetix; CVCL_C501
DR   Wikidata; Q54905111
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   HLA typing: A*68:01:01,31:01:02; B*27:09; C*02:02:02; DPB1*04:01,03:01; DQB1*03:01:01,02:01; DRB1*04:03,03:01:02 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ESTDAB=ESTDAB-094
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   FGA: 22,25
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   Mel-LG
AC   CVCL_C502
DR   Cosmic; 2163868
DR   ESTDAB; ESTDAB-098
DR   Wikidata; Q54905112
RX   PubMed=23851445;
ST   Source(s): ESTDAB=ESTDAB-098
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,14
ST   D3S1358: 14,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   FGA: 19,20
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   Mel-LT
AC   CVCL_T004
SY   Mel LT
DR   Wikidata; Q54905113
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Mel-MC
AC   CVCL_T005
SY   Mel MC
DR   Wikidata; Q54905114
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   Mel-MI
AC   CVCL_T006
SY   Mel MI
DR   Wikidata; Q54905115
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Mel-MM
AC   CVCL_T007
SY   Mel MM
DR   Wikidata; Q54905116
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Mel-MS
AC   CVCL_T008
SY   Mel MS; MelMS
DR   Wikidata; Q54905117
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Mel-NG
AC   CVCL_GR42
DR   Wikidata; Q54905118
RX   PubMed=8980186;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-NT1-00
AC   CVCL_C530
DR   cancercelllines; CVCL_C530
DR   Cosmic; 2163825
DR   ESTDAB; ESTDAB-115
DR   Wikidata; Q54905119
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*01:01,03:01; B*35:01,57:01; DPB1*04:01; DQB1*03:01:01,05:01; DRB1*01:01,11:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Val95_His97del (c.286_294del) (p.Gly110fs, c.329_337del); Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-115
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 9,12
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 12
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   Mel-NT2-00
AC   CVCL_C531
DR   cancercelllines; CVCL_C531
DR   Cosmic; 2163815
DR   ESTDAB; ESTDAB-100
DR   Wikidata; Q54905120
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*02:01,03:01; B*14:02,44:02:01:01; C*05:01,08:02; DPB1*02:01:02,04:01; DQB1*03:01:01,04:02; DRB1*13:03,08:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-100
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   FGA: 20,23
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   Mel-NT3-00
AC   CVCL_C532
DR   cancercelllines; CVCL_C532
DR   Cosmic; 2163826
DR   ESTDAB; ESTDAB-117
DR   Wikidata; Q54905121
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*02:01,68:01:02; B*44:02:01:01,49:02; C*06:02,07:04; DPB1*04:02,04:01; DQB1*03:01:01,02:01; DRB1*11:01:01,03:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-117
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   FGA: 21,26
ST   TH01: 6
ST   TPOX: 11,12
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   Mel-NT4-00
AC   CVCL_C533
DR   ESTDAB; ESTDAB-118
DR   Wikidata; Q54905122
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   Mel-NT5-00
AC   CVCL_C534
DR   ESTDAB; ESTDAB-119
DR   Wikidata; Q54905123
RX   PubMed=15592718;
CC   HLA typing: A*68:01:02,24:02; C*06:02,02:02:02; DPB1*03:01,13:01; DQB1*06:03,02:01; DRB1*13:01,03:01:01 (PubMed=15592718).
ST   Source(s): ESTDAB=ESTDAB-119
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   FGA: 21
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   Mel-NT6-00
AC   CVCL_C535
DR   ESTDAB; ESTDAB-123
DR   Wikidata; Q54905124
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   Mel-NT7-00
AC   CVCL_UW19
DR   ESTDAB; ESTDAB-124
DR   Wikidata; Q95988642
RX   PubMed=15592718;
CC   HLA typing: A*03:02,03:02; B*51:01:01,51:01:01; C*01:02:01,01:02:01; DPB1*04:01,04:02; DQB1*03:01:01,05:01 (PubMed=15592718).
ST   Source(s): ESTDAB=ESTDAB-124
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D3S1358: 14,16
ST   D5S818: 12,14
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8,12
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   Mel-NT8-00
AC   CVCL_C536
DR   ESTDAB; ESTDAB-126
DR   Wikidata; Q54905125
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   Mel-NT9-00
AC   CVCL_C537
DR   cancercelllines; CVCL_C537
DR   Cosmic; 2163828
DR   ESTDAB; ESTDAB-125
DR   Wikidata; Q54905127
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-125
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,11
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   MEL-P
AC   CVCL_B6JG
SY   MELP
DR   Wikidata; Q112129312
RX   PubMed=8649792;
RX   PubMed=8819123;
RX   PubMed=9627116;
CC   Doubling time: 22-24 hours (Note=At 50th passage) (PubMed=8819123).
CC   Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MEL-RC08
AC   CVCL_A012
DR   cancercelllines; CVCL_A012
DR   Cosmic; 1667648
DR   Wikidata; Q54905128
RX   PubMed=22529031;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=22529031).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22529031).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=22529031).
CC   Derived from site: Metastatic; Bone, periosteum, pericranium; UBERON=UBERON_0013687.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   MEL-REO
AC   CVCL_B6L5
SY   MELREO
DR   Wikidata; Q112129313
RX   PubMed=9627116;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 4
//
ID   Mel-RM
AC   CVCL_D548
SY   Mel RM
DR   BTO; BTO_0005715
DR   EFO; EFO_0022452
DR   cancercelllines; CVCL_D548
DR   Cosmic; 889010
DR   Wikidata; Q54905129
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9725211;
RX   PubMed=10364001;
RX   PubMed=15048078;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   Mel-RMu
AC   CVCL_S994
SY   Mel-RMU; Mel RMu; MelRMu
DR   BTO; BTO_0005719
DR   cancercelllines; CVCL_S994
DR   Cosmic; 889011
DR   Cosmic; 1941942
DR   Wikidata; Q54905130
RX   PubMed=10364001;
RX   PubMed=15048078;
RX   PubMed=22383533;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15048078; PubMed=22383533; PubMed=23455323).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   Mel-RMu/DR2
AC   CVCL_T017
SY   MelRMu DR2; Mel-RMU-DR2
DR   cancercelllines; CVCL_T017
DR   Cosmic; 1941943
DR   Wikidata; Q54905131
RX   PubMed=22437314;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S994 ! Mel-RMu
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   Mel-RMu/DR4
AC   CVCL_T018
SY   MelRMu DR4; Mel-RMU-DR4
DR   cancercelllines; CVCL_T018
DR   Cosmic; 1941944
DR   Wikidata; Q54905132
RX   PubMed=22437314;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S994 ! Mel-RMu
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   Mel-RMu/DR6
AC   CVCL_T019
SY   MelRMu DR6; Mel-RMU-DR6
DR   cancercelllines; CVCL_T019
DR   Cosmic; 1941945
DR   Wikidata; Q54905133
RX   PubMed=22437314;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S994 ! Mel-RMu
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   Mel-RMu/DR8
AC   CVCL_T020
SY   MelRMu DR8; Mel-RMU-DR8
DR   cancercelllines; CVCL_T020
DR   Cosmic; 1941946
DR   Wikidata; Q54905134
RX   PubMed=22437314;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S994 ! Mel-RMu
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   Mel-RMu/DR9
AC   CVCL_T021
SY   MelRMu DR9; Mel-RMU-DR9
DR   cancercelllines; CVCL_T021
DR   Cosmic; 1941947
DR   Wikidata; Q54905135
RX   PubMed=22437314;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S994 ! Mel-RMu
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   MEL-SLM2
AC   CVCL_ZL70
SY   SLM2; SLM2-Mel; SLM-2; Storkus Lab Melanoma no. 2
DR   GEO; GSM1671961
DR   GEO; GSM1671968
DR   GEO; GSM1672005
DR   GEO; GSM1672072
DR   GEO; GSM1672079
DR   GEO; GSM1672093
DR   GEO; GSM1672108
DR   GEO; GSM1672113
DR   GEO; GSM1672133
DR   Wikidata; Q98127224
RX   PubMed=12631591;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   Mel-SOE
AC   CVCL_C503
SY   EST97
DR   cancercelllines; CVCL_C503
DR   Cosmic; 1047659
DR   Cosmic; 2163867
DR   ESTDAB; ESTDAB-097
DR   GEO; GSM156006
DR   IARC_TP53; 26086
DR   Progenetix; CVCL_C503
DR   Wikidata; Q54905136
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ESTDAB=ESTDAB-097
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   FGA: 19,25
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   Mel-SP
AC   CVCL_T009
SY   Mel SP
DR   Wikidata; Q54905137
RX   PubMed=10364001;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   MEL-STM
AC   CVCL_9U70
DR   Wikidata; Q54905138
RX   PubMed=16142232;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7029; MET (Note=Activated TPR-MET).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C854 ! MEL-STR
OI   CVCL_9U71 ! MEL-STV
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   MEL-STR
AC   CVCL_C854
DR   Cosmic; 1458969
DR   Wikidata; Q54905139
RX   PubMed=16142232;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U70 ! MEL-STM
OI   CVCL_9U71 ! MEL-STV
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   MEL-STV
AC   CVCL_9U71
DR   Cosmic; 1458968
DR   Wikidata; Q54905140
RX   PubMed=16142232;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U70 ! MEL-STM
OI   CVCL_C854 ! MEL-STR
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   Mel-Swift
AC   CVCL_A650
SY   Mel-SWIFT; Mel Swift; MEL-SWIFT
DR   cancercelllines; CVCL_A650
DR   Cosmic; 692343
DR   Cosmic; 702099
DR   Cosmic; 706087
DR   Cosmic; 888831
DR   Wikidata; Q54905141
RX   PubMed=10766161;
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=10766161; PubMed=15009714).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   MEL-TF19
AC   CVCL_B268
DR   Wikidata; Q54905142
RX   PubMed=15250154;
RX   PubMed=18763144;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1913538; Pdcd5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2111 ! MEL-745A cl. DS19
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 9
//
ID   Mel-WB
AC   CVCL_T010
SY   Mel WB
DR   Wikidata; Q54905143
RX   PubMed=7520026;
RX   PubMed=9725211;
RX   PubMed=10364001;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   Mel-WD
AC   CVCL_GR45
DR   Wikidata; Q54905144
RX   PubMed=8980186;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   Mel-WL
AC   CVCL_C504
DR   cancercelllines; CVCL_C504
DR   Cosmic; 2163814
DR   ESTDAB; ESTDAB-095
DR   Wikidata; Q54905145
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*11:01,01:01; B*35:01,51:01:01; C*04:01:01,12:03; DPB1*04:02,10:01; DQB1*03:01:01,05:01; DRB1*01:01,11:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro81Ser (c.241C>T) (p.Thr95Ile, c.284C>T); ClinVar=VCV000664812; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-095
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D3S1358: 14,15
ST   D5S818: 10,13
ST   D7S820: 9
ST   FGA: 21,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   Mel-XX4
AC   CVCL_A0GS
SY   MEL-XX4
DR   Wikidata; Q108820896
RX   Patent=US8501168;
RX   PubMed=17448240;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2829.
CC   HLA typing: A*24,33; B*18,65 (PubMed=17448240).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   Mel-XY1
AC   CVCL_A0GT
SY   MEL-XY1
DR   Wikidata; Q108820897
RX   Patent=US8501168;
RX   PubMed=17448240;
RX   PubMed=21993558;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2830.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,23; B*18,37 (PubMed=17448240).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   Mel-XY2
AC   CVCL_A0GU
SY   MEL-XY2
DR   Wikidata; Q108820898
RX   Patent=US8501168;
RX   PubMed=17448240;
RX   PubMed=21993558;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2831.
CC   Population: Caucasian.
CC   HLA typing: A*30,33; B*18,65 (PubMed=17448240).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   Mel-XY3
AC   CVCL_A0GV
SY   MEL-XY3
DR   Wikidata; Q108820899
RX   Patent=US8501168;
RX   PubMed=17448240;
RX   PubMed=21993558;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2832.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,23; B*18,18 (PubMed=17448240).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   Mel-WN
AC   CVCL_GR34
DR   Wikidata; Q54905146
RX   PubMed=7520026;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   MEL.KEL.24
AC   CVCL_E8PH
RX   PubMed=10468879;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6308; KEL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C188 ! MEL-c88
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MEL1
AC   CVCL_DG36
DR   cancercelllines; CVCL_DG36
DR   GEO; GSM202114
DR   IGRhCellID; MEL1%20GEO
DR   Progenetix; CVCL_DG36
DR   Wikidata; Q54905147
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   MEL114433
AC   CVCL_B0CE
SY   Mel114433; Melanoma model 1; M1
DR   ATCC; CRL-3473
DR   GEO; GSM4301282
DR   Wikidata; Q108820900
RX   PubMed=32284588;
CC   Doubling time: ~24 hours (ATCC=CRL-3473).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 BrafCA/+, Ptenflox/+, Cdkn2aflox/+, Tyr-CreERT2-tg.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   Mel120
AC   CVCL_D648
SY   Mel 120
DR   BTO; BTO_0005174
DR   Wikidata; Q54905148
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   MEL15765
AC   CVCL_C7UH
SY   15765 mel
DR   Wikidata; Q123033034
RX   PubMed=22207316;
RX   PubMed=23849826;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Mel1617
AC   CVCL_DG51
SY   MEL1617; Mel-1617
DR   cancercelllines; CVCL_DG51
DR   GEO; GSM1199180
DR   Progenetix; CVCL_DG51
DR   Wikidata; Q54905149
RX   PubMed=21156289;
RX   PubMed=23285177;
RX   PubMed=24055054;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21156289).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=21156289).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7928 ! WM164
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   Mel1617-BR
AC   CVCL_DG52
SY   MEL1617-BR; Mel1617BR; Mel1617-R; Mel1617 R
DR   cancercelllines; CVCL_DG52
DR   Wikidata; Q54905150
RX   PubMed=21156289;
RX   PubMed=23285177;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_131882; SB-590885.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=21156289).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DG51 ! Mel1617
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   Mel1617-MR
AC   CVCL_DG53
SY   MEL1617-MR
DR   cancercelllines; CVCL_DG53
DR   GEO; GSM1199181
DR   Progenetix; CVCL_DG53
DR   Wikidata; Q54905153
RX   PubMed=24055054;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DG51 ! Mel1617
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   MEL2
AC   CVCL_RU21
SY   MEL-2; PureStem MEL2, NCr-fac progenitor; ACTC268
DR   Wikidata; Q54905154
RX   Patent=US8685386;
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-268; https://web.archive.org/web/20141202113834/http://www.esibio.com/purestemr-mel2-ncr-fac-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11150.
CC   Characteristics: Undergoes chondrogenesis in a progenitor with markers of head and limb mesenchyme and low levels of hypertrophic marker COL10A1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   MEL2-mCherry
AC   CVCL_IR29
DR   Wikidata; Q54905155
RX   PubMed=22993664;
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B864 ! SCSe002-A
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   Mel20-06-039
AC   CVCL_8473
SY   MEL20-06-039
DR   cancercelllines; CVCL_8473
DR   Cosmic; 1665023
DR   Wikidata; Q54905156
RX   PubMed=21386926;
RX   PubMed=22515704;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Heterozygous (PubMed=21386926).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Mel20-06-045
AC   CVCL_8474
SY   MEL20-06-045
DR   cancercelllines; CVCL_8474
DR   Cosmic; 1665024
DR   Wikidata; Q54905157
RX   PubMed=21386926;
RX   PubMed=22515704;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Heterozygous (PubMed=21386926).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Mel20-07-070
AC   CVCL_8475
SY   MEL20-07-070
DR   cancercelllines; CVCL_8475
DR   Cosmic; 1665025
DR   Wikidata; Q54905158
RX   PubMed=21386926;
RX   PubMed=22515704;
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (PubMed=22515704).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Mel20-08-128
AC   CVCL_D714
DR   cancercelllines; CVCL_D714
DR   Cosmic; 1665026
DR   Wikidata; Q54905159
RX   PubMed=22515704;
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (PubMed=22515704).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   Mel20-09-196
AC   CVCL_D715
DR   cancercelllines; CVCL_D715
DR   Cosmic; 1665027
DR   Wikidata; Q54905160
RX   PubMed=22515704;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Heterozygous (PubMed=22515704).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   Mel202
AC   CVCL_C301
SY   MEL202; Mel-202; Mel 202; mel-202; EST128
DR   EFO; EFO_0022364
DR   cancercelllines; CVCL_C301
DR   Cell_Model_Passport; SIDM01357
DR   Cosmic; 848329
DR   Cosmic; 899894
DR   Cosmic; 916143
DR   Cosmic; 1047643
DR   Cosmic; 1320372
DR   Cosmic; 1628395
DR   Cosmic; 2036706
DR   Cosmic; 2163830
DR   DepMap; ACH-001554
DR   ECACC; 13012457
DR   ESTDAB; ESTDAB-128
DR   GEO; GSM156005
DR   IARC_TP53; 26116
DR   Kerafast; EEE003
DR   PRIDE; PXD051055
DR   Progenetix; CVCL_C301
DR   Wikidata; Q54905161
RX   PubMed=1748551;
RX   PubMed=17260012;
RX   PubMed=22236444;
RX   PubMed=22383533;
RX   PubMed=23851445;
RX   PubMed=24994677;
RX   PubMed=28018010;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 43 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu65Argfs*52 (c.194_201del) (p.Pro80fs, c.237_244del); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Unspecified (PubMed=22236444; PubMed=23851445; PubMed=28018010; DepMap=ACH-001554).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Arg210Lys (c.629G>A); Zygosity=Unspecified (PubMed=22236444; PubMed=23851445; PubMed=28018010; DepMap=ACH-001554).
CC   Sequence variation: Mutation; HGNC; HGNC:10768; SF3B1; Simple; p.Arg625Gly (c.1793C>T); ClinVar=VCV000376536; Zygosity=Unspecified (PubMed=24994677).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): DepMap=ACH-001554; ECACC=13012457; ESTDAB=ESTDAB-128; PubMed=22236444; PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 30.2,31.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 7,13
ST   TH01: 6 (ECACC=13012457)
ST   TH01: 6,7 (DepMap=ACH-001554; ESTDAB=ESTDAB-128; PubMed=22236444; PubMed=24994677)
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 32
//
ID   Mel249
AC   CVCL_3974
SY   MEL249
DR   BTO; BTO_0002952
DR   Wikidata; Q54905162
RX   PubMed=16740750;
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Asn62Argfs (c.184_185delAT); Zygosity=Unspecified (PubMed=16740750).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   Mel270
AC   CVCL_C302
SY   MEL270; Mel-270; Mel 270
DR   cancercelllines; CVCL_C302
DR   Cell_Model_Passport; SIDM01845
DR   Cosmic; 848330
DR   Cosmic; 899898
DR   Cosmic; 916144
DR   Cosmic; 986621
DR   Cosmic; 1628396
DR   Cosmic; 1669124
DR   Cosmic; 2036707
DR   DepMap; ACH-002014
DR   IARC_TP53; 23397
DR   ICLC; HTL13002
DR   PRIDE; PXD051055
DR   Wikidata; Q54905163
RX   PubMed=9247253;
RX   PubMed=16772116;
RX   PubMed=22236444;
RX   PubMed=22383533;
RX   PubMed=23849826;
RX   PubMed=28018010;
RX   PubMed=38601020;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ksander, Bruce R.; Schepens Eye Research Institute; Boston; USA.
CC   Characteristics: Exhibits a mesenchymal phenotype (PubMed=38601020).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Homozygous (PubMed=22236444; PubMed=22383533).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: Mel207; Cosmic=848330.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): DepMap=ACH-002014; ICLC=HTL13002; PubMed=22236444
ST   Amelogenin: X (ICLC=HTL13002)
ST   Amelogenin: X,Y (PubMed=22236444; DepMap=ACH-002014)
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 19
ST   D21S11: 28,29
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 8,13
ST   FGA: 24,26 (DepMap=ACH-002014)
ST   FGA: 26 (PubMed=22236444)
ST   Penta D: 15,16
ST   Penta E: 8,10
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C305 ! OMM2.2
OI   CVCL_C306 ! OMM2.3
OI   CVCL_C307 ! OMM2.5
OI   CVCL_C308 ! OMM2.6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 26
//
ID   Mel285
AC   CVCL_C303
SY   MEL285; Mel-285; Mel 285
DR   cancercelllines; CVCL_C303
DR   Cell_Model_Passport; SIDM01793
DR   Cosmic; 916140
DR   Cosmic; 1628405
DR   Cosmic; 2036708
DR   DepMap; ACH-002015
DR   PRIDE; PXD051055
DR   Wikidata; Q54905164
RX   PubMed=16772116;
RX   PubMed=22236444;
RX   PubMed=22383533;
RX   PubMed=23849826;
RX   PubMed=28018010;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ksander, Bruce R.; Schepens Eye Research Institute; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp11Gly (c.32A>G); Zygosity=Unspecified (PubMed=39042403).
CC   Sequence variation: Mutation; HGNC; HGNC:9284; PPP1R10; Simple; p.Met528Thr (c.1583T>C); Zygosity=Unspecified (PubMed=39042403).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): DepMap=ACH-002015; PubMed=22236444
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,14
ST   D18S51: 16,17
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 8,13
ST   D8S1179: 11,15
ST   FGA: 20,22
ST   Penta D: 5
ST   Penta E: 17
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   Mel290
AC   CVCL_C304
SY   MEL290; Mel-290; Mel 290; MEL 290
DR   CLDB; cl7222
DR   cancercelllines; CVCL_C304
DR   Cell_Model_Passport; SIDM01792
DR   Cosmic; 916141
DR   Cosmic; 1628406
DR   Cosmic; 1669125
DR   DepMap; ACH-002016
DR   ICLC; HTL12002
DR   PRIDE; PXD051055
DR   Wikidata; Q54905165
RX   PubMed=16772116;
RX   PubMed=22236444;
RX   PubMed=22383533;
RX   PubMed=23849826;
RX   PubMed=28018010;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ksander, Bruce R.; Schepens Eye Research Institute; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gln288Glu (c.862C>G); Zygosity=Unspecified (PubMed=39042403).
CC   Sequence variation: Mutation; HGNC; HGNC:9284; PPP1R10; Simple; p.Met528Thr (c.1583T>C); Zygosity=Unspecified (PubMed=39042403).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): DepMap=ACH-002016; ICLC=HTL12002; PubMed=22236444
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D21S11: 28,32.1
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 18,20
ST   Penta D: 10,11
ST   Penta E: 5,8
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   MEL4478D
AC   CVCL_C7WA
SY   4478D mel
DR   Wikidata; Q123033035
RX   PubMed=22207316;
RX   PubMed=31817719;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   Mel499
AC   CVCL_3975
DR   BTO; BTO_0002953
DR   Wikidata; Q54905166
RX   PubMed=16740750;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   Mel501A
AC   CVCL_0V14
SY   MEL501A; 501A; 501 A
DR   EFO; EFO_0006356
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473285
DR   cancercelllines; CVCL_0V14
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   PharmacoDB; 501A_18_2019
DR   Wikidata; Q54905167
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29045385;
CC   HLA typing: A*02:01,03:01; B*07:02,14:02; C*07:02,08:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Trp (c.825T>G); ClinVar=VCV000485044; Zygosity=Unspecified (PubMed=29045385).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 14
ST   D18S51: 16
ST   D21S11: 29
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8054 ! 624-mel
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   Mel505
AC   CVCL_3976
DR   BTO; BTO_0002954
DR   Wikidata; Q54905168
RX   PubMed=16740750;
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Homozygous (PubMed=16740750).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   Mel592
AC   CVCL_3977
DR   BTO; BTO_0002955
DR   Wikidata; Q54905169
RX   PubMed=16740750;
CC   Sequence variation: Gene deletion; HGNC; HGNC:914; B2M; Zygosity=Homozygous (PubMed=16740750).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Mel624-CMV-hNIS-Neo
AC   CVCL_RA30
DR   Imanis; CL001
DR   Wikidata; Q54905170
CC   Characteristics: Reporter cell line, transduced with the CMV-hNIS-IRES-Neo vector encoding for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the CMV promoter (Imanis=CL001).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Imanis; CL001; true.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8054 ! 624-mel
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   Mel624-CMV-hNIS-Neo/eGFP-Puro
AC   CVCL_RA31
DR   Imanis; CL017
DR   Wikidata; Q54905171
CC   Characteristics: Reporter cell line, transduced with both the CMV-hNIS-IRES-Neo and LV-eGFP-PGKp-Puro vectors. CMV-hNIS-IRES-Neo encodes for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the CMV promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL017).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Imanis; CL017; true.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8054 ! 624-mel
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   Mel624-hNIS-Neo
AC   CVCL_RA32
DR   Imanis; CL048
DR   Wikidata; Q54905172
CC   Characteristics: Reporter cell line, transduced with the LV-hNIS-IRES-Neo vector encoding for human SLC5A5 linked via an internal ribosomal entry site (IRES) to the Neo gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL048).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Imanis; CL048; true.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8054 ! 624-mel
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   Mela11
AC   CVCL_VP45
SY   MELA11
DR   cancercelllines; CVCL_VP45
DR   Wikidata; Q95988712
RX   DOI=10.1158/1538-7445.AM2015-2417;
CC   Doubling time: 39 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 13,17
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   Mela14
AC   CVCL_VP46
SY   MELA14
DR   cancercelllines; CVCL_VP46
DR   Wikidata; Q95988713
RX   DOI=10.1158/1538-7445.AM2015-2417;
CC   Doubling time: 30 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Small intestine, mesentery; UBERON=UBERON_0001170.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,16
ST   D18S51: 10.1,14
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 24,26
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   Mela15
AC   CVCL_VN58
SY   MELA15
DR   ABM; T8319
DR   cancercelllines; CVCL_VN58
DR   Wikidata; Q95988714
RX   DOI=10.1158/1538-7445.AM2015-2417;
RX   PubMed=29416592;
CC   Doubling time: 30 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 15
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   Mela16
AC   CVCL_VP47
SY   MELA16
DR   cancercelllines; CVCL_VP47
DR   Wikidata; Q95988716
RX   DOI=10.1158/1538-7445.AM2015-2417;
CC   Doubling time: 33 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 13,14
ST   D16S539: 12
ST   D18S51: 14
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 12,15
ST   FGA: 21,22
ST   TH01: 8,9.3
ST   TPOX: 11,12
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   Mela17
AC   CVCL_VP48
SY   MELA17
DR   cancercelllines; CVCL_VP48
DR   Wikidata; Q95988717
RX   DOI=10.1158/1538-7445.AM2015-2417;
CC   Doubling time: 38 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000045115; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Infraclavicular lymph node; UBERON=UBERON_0035162.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 12,14
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 20,25
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   Melan-a
AC   CVCL_4624
SY   melan-a
DR   BTO; BTO_0003216
DR   CancerTools; 153599
DR   ChEMBL-Cells; CHEMBL4295432
DR   ChEMBL-Targets; CHEMBL4296474
DR   Lonza; 161
DR   Millipore; SCC202
DR   PubChem_Cell_line; CVCL_4624
DR   Wikidata; Q54905173
DR   Ximbio; 153599
RX   PubMed=3102392;
RX   PubMed=16611417;
RX   PubMed=28198377;
CC   Doubling time: 22 hours (PubMed=16611417).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC202
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 19
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 30
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Melan-a 2C
AC   CVCL_ZJ82
SY   2C
DR   Wikidata; Q98127225
RX   PubMed=16611417;
CC   Doubling time: 22 hours (PubMed=16611417).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4624 ! Melan-a
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Melan-a 4C
AC   CVCL_ZJ83
SY   4C
DR   Wikidata; Q98127226
RX   PubMed=16611417;
CC   Doubling time: 20 hours (PubMed=16611417).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4624 ! Melan-a
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Melan-a 4C3
AC   CVCL_ZJ84
SY   4C3
DR   Wikidata; Q98127227
RX   PubMed=16611417;
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZJ83 ! Melan-a 4C
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Melan-a 4C11
AC   CVCL_ZJ85
SY   4C11
DR   Wikidata; Q98127228
RX   PubMed=16611417;
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZJ83 ! Melan-a 4C
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Melan-a Hm
AC   CVCL_W079
SY   melan-a Hm
DR   BTO; BTO_0005424
DR   Wikidata; Q54905174
RX   PubMed=11734563;
CC   Characteristics: Transfected with a chimeric tyrosine-protein kinase receptor composed of extracellular part of human EGFR and the intracellular part of Xmrk. Stimulation of the chimera with EGF induces activation of the xmrk kinase domain.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=Extracellular domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13388; Xiphophorus maculatus Xmrk (Note=Intracellular domain).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4624 ! Melan-a
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   Melan-a S11
AC   CVCL_ZJ86
SY   S11
DR   Wikidata; Q98127229
RX   PubMed=16611417;
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZJ83 ! Melan-a 4C
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Melan-a Tm1
AC   CVCL_ZJ87
SY   Tm1
DR   Wikidata; Q98127231
RX   PubMed=16611417;
RX   PubMed=28198377;
CC   Characteristics: Tumorigenic (PubMed=16611417).
CC   Doubling time: 18 hours (PubMed=16611417).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZJ83 ! Melan-a 4C
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Melan-a Tm5
AC   CVCL_ZJ88
SY   Tm5
DR   Wikidata; Q98127233
RX   PubMed=16611417;
RX   PubMed=28198377;
CC   Characteristics: Tumorigenic (PubMed=16611417).
CC   Doubling time: 14 hours (PubMed=16611417).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZJ83 ! Melan-a 4C
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Melan-a2
AC   CVCL_C692
SY   melan-a2; melan a2
DR   Wikidata; Q54905175
RX   PubMed=7540532;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C693 ! Melb-a
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   Melan-b
AC   CVCL_VS23
SY   melan-b
DR   Wikidata; Q95988721
RX   PubMed=1562463;
RX   PubMed=2806130;
CC   Sequence variation: Mutation; MGI; MGI:98881; Tyrp1; Simple; p.Cys110Tyr; Zygosity=Homozygous (from inference of genetic background of Brown mice).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: Q.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 7
//
ID   Melan-b-HmR
AC   CVCL_VS29
SY   melan-b-HmR; melan-bH
DR   Wikidata; Q95988722
RX   PubMed=1562463;
CC   Sequence variation: Mutation; MGI; MGI:98881; Tyrp1; Simple; p.Cys110Tyr; Zygosity=Homozygous (from inference of genetic background of Brown mice).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: Q.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VS23 ! Melan-b
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 10
//
ID   Melan-c
AC   CVCL_VS24
SY   melan-c
DR   Wikidata; Q95988723
RX   PubMed=2806130;
CC   Sequence variation: Mutation; MGI; MGI:98880; Tyr; Simple; p.Cys103Ser; Zygosity=Homozygous (from inference of genetic background of Albino mice).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: LAC-MF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 6
//
ID   melan-Usf1
AC   CVCL_VS25
DR   Wikidata; Q95988726
RX   PubMed=15358786;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99542; Usf1.
CC   Cell type: Melanocyte; CL=CL_0000148.
CC   Breed/subspecies: (129S2/SvPas x C57BL/6J)Usf1tm1Svl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   Melb-a
AC   CVCL_C693
SY   melb-a
DR   Wikidata; Q54905176
RX   PubMed=7540532;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Melanoblast; CL=CL_0000541.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   MELBA
AC   CVCL_6G44
DR   Wikidata; Q54905177
RX   PubMed=3761468;
CC   Doubling time: 28 hours (PubMed=3761468).
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   MelHOrCDDP1000
AC   CVCL_RQ53
SY   Mel-HO-rCDDP1000
DR   cancercelllines; CVCL_RQ53
DR   Wikidata; Q54905178
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1402 ! Mel Ho
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   MelHOrDACARB20
AC   CVCL_RQ54
SY   MelHOrDAC20; Mel-HOrDAC20
DR   cancercelllines; CVCL_RQ54
DR   Wikidata; Q54905179
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1402 ! Mel Ho
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   MelHOrNutlin20muM
AC   CVCL_RQ51
SY   Mel-HOrNutlin20muM
DR   cancercelllines; CVCL_RQ51
DR   Wikidata; Q54905180
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=22170099).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1402 ! Mel Ho
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   MelHOrPLX4032_10muM
AC   CVCL_RQ55
SY   Mel-HOrPLX4032_10muM; MelHOrPLX4032(10muM)
DR   cancercelllines; CVCL_RQ55
DR   Wikidata; Q54905181
RX   PubMed=22170099;
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1402 ! Mel Ho
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   MelHOrPLX4720_10muM
AC   CVCL_RS67
SY   MelHOrPLX4720(10muM)
DR   cancercelllines; CVCL_RS67
DR   Wikidata; Q54905182
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90295; PLX-4720 (PLX4720).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1402 ! Mel Ho
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   MelHOrVCR20
AC   CVCL_RQ52
SY   Mel-HOrVCR20
DR   cancercelllines; CVCL_RQ52
DR   Wikidata; Q54905183
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Problematic cell line: Misidentified/contaminated. Parent cell line (Mel-Ho) was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile.
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1402 ! Mel Ho
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   Melligen
AC   CVCL_HA63
DR   cancercelllines; CVCL_HA63
DR   Wikidata; Q54905184
RX   Patent=US10738285;
RX   PubMed=26029722;
WW   Info; -; -; https://www.diabetes.co.uk/forum/threads/potential-type-1-diabetes-treatment-receives-us-patent-approval.102547/
CC   Group: Patented cell line.
CC   Population: Japanese.
CC   Characteristics: Produces insulin in response to extracellular glucose levels that are equivalent to physiological glucose levels.
CC   Characteristics: When transplanted into diabetic immunoincompetent mice, Melligen cells restore normoglycemia.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4195; GCK.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HA62 ! HUH7-ins
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 18
//
ID   MELN
AC   CVCL_WI91
SY   MCF-7 ERE-beta-globin Luciferase Neo
DR   cancercelllines; CVCL_WI91
DR   Wikidata; Q95988749
RX   PubMed=10492897;
RX   PubMed=11312541;
CC   Population: Caucasian.
CC   Biotechnology: Used in a bioluminescent bioassay to quantitatively measure estrogenic compounds.
CC   Characteristics: The luciferase reporter gene is under the control of an estrogen-responsive element from the beta-globin promoter.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   MELS
AC   CVCL_B7H6
DR   Wikidata; Q112930113
RX   PubMed=35082206;
CC   Population: Japanese.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C4640; Rectal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   Melu
AC   CVCL_B5D6
DR   Wikidata; Q110433028
RX   PubMed=8432193;
CC   Karyotypic information: 56,X,-X,+2,+5,+7,+ 8,12q+,+15,+19,+20,+22,+3mar (PubMed=8432193).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MEM-102
AC   CVCL_KB22
DR   Wikidata; Q54905185
RX   PubMed=2534480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09326; Human CD48.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   MEM-53
AC   CVCL_KB21
DR   Wikidata; Q54905186
RX   PubMed=2534480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19397; Human CD53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   MEM-56
AC   CVCL_KB20
SY   MEM 56; MEM56
DR   Wikidata; Q54905187
RX   PubMed=2534480;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   MEM-E/02
AC   CVCL_XY37
DR   Wikidata; Q95988756
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-E/06
AC   CVCL_XY38
DR   Wikidata; Q95988757
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/01
AC   CVCL_XY28
SY   MEM-G/1
DR   Wikidata; Q95988758
RX   PubMed=10902607;
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/04
AC   CVCL_XY29
SY   MEM-G/4
DR   Wikidata; Q95988759
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/08
AC   CVCL_XY30
SY   MEM-G/8
DR   Wikidata; Q95988762
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/09
AC   CVCL_XY31
SY   MEM-G/9
DR   Wikidata; Q95988763
RX   PubMed=10902607;
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/10
AC   CVCL_XY32
DR   Wikidata; Q95988764
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/11
AC   CVCL_XY33
DR   Wikidata; Q95988765
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/12
AC   CVCL_XY34
DR   Wikidata; Q95988767
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/13
AC   CVCL_XY35
DR   Wikidata; Q95988769
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEM-G/14
AC   CVCL_XY36
DR   Wikidata; Q95988771
RX   PubMed=12590976;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P17693; Human HLA-G.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   MEMO
AC   CVCL_L300
DR   Wikidata; Q54905188
RX   PubMed=23249835;
CC   Population: Afro-Brazilian.
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   MeMo 05
AC   CVCL_F330
SY   MEMO
DR   CLDB; cl7211
DR   ICLC; HTL07002
DR   Wikidata; Q54905189
RX   PubMed=23634660;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ICLC=HTL07002
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 29,30
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   MEMOR 06
AC   CVCL_F331
DR   CLDB; cl7212
DR   ICLC; HTL07004
DR   Wikidata; Q54905190
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ICLC=HTL07004
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   mEMS88
AC   CVCL_0J51
SY   SXRA-ES
DR   Wikidata; Q54905191
RX   PubMed=12112873;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J-Sxra x 129P3/JEms.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   MEN
AC   CVCL_C1M9
DR   Wikidata; Q114312277
RX   PubMed=13954855;
CC   Population: Chinese.
CC   Doubling time: 37.6 hours (PubMed=13954855).
DI   NCIt; C3269; Schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   MEN1 Mother iPS
AC   CVCL_JL81
DR   Wikidata; Q54905192
RX   PubMed=28395808;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Chinese; Malaysian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Glu430Ter (c.1288G>T); Zygosity=Heterozygous (PubMed=28395808).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   MEN1 point mutation iPS-M22
AC   CVCL_JL82
DR   Wikidata; Q54905196
RX   PubMed=28395809;
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple_edited; p.Glu430Ter (c.1288G>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28395809).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH99 ! UiPSC-015
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 14
//
ID   MEN1 Son iPS
AC   CVCL_JL83
DR   Wikidata; Q54905197
RX   PubMed=28395810;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Population: Chinese; Malaysian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Glu430Ter (c.1288G>T); Zygosity=Heterozygous (PubMed=28395810).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   MEN1RGB
AC   CVCL_H212
DR   CLO; CLO_0051606
DR   BioSample; SAMN03472306
DR   RCB; RCB0410
DR   Wikidata; Q54905198
CC   Population: Japanese.
CC   Derived from site: In situ; Adrenal cortex; UBERON=UBERON_0001235.
ST   Source(s): RCB=RCB0410
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   MEN2RGB
AC   CVCL_H213
DR   CLO; CLO_0051607
DR   BioSample; SAMN03472307
DR   RCB; RCB0421
DR   Wikidata; Q54905199
CC   Population: Japanese.
CC   Derived from site: In situ; Adrenal cortex; UBERON=UBERON_0001235.
ST   Source(s): RCB=RCB0421
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 19,20
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   MENII-1
AC   CVCL_M431
SY   SF6717
DR   Wikidata; Q54905200
RX   PubMed=18953429;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   MEO
AC   CVCL_C1MA
DR   Wikidata; Q114312280
RX   PubMed=13954855;
CC   Population: Chinese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MEO clone 515
AC   CVCL_C1MB
SY   515
DR   Wikidata; Q114312284
RX   PubMed=13954855;
CC   Population: Chinese.
CC   Doubling time: 38.7 hours (PubMed=13954855).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1MA ! MEO
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MEP
AC   CVCL_C1MC
DR   Wikidata; Q114312288
RX   PubMed=13954855;
CC   Population: Chinese.
CC   Doubling time: 37.7 hours (PubMed=13954855).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MEP01
AC   CVCL_XI07
SY   MEP 01
DR   Wikidata; Q95988784
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEP04
AC   CVCL_XI08
SY   MEP 04
DR   Wikidata; Q95988786
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEP06
AC   CVCL_XI09
SY   MEP 06
DR   Wikidata; Q95988787
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEP08
AC   CVCL_XI10
SY   MEP 08
DR   Wikidata; Q95988788
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1941.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEP13
AC   CVCL_XI11
SY   MEP 13
DR   Wikidata; Q95988789
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEP14
AC   CVCL_XI12
SY   MEP 14
DR   Wikidata; Q95988790
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1942.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEP19
AC   CVCL_XI13
SY   MEP 19
DR   Wikidata; Q95988791
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1943.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEP21
AC   CVCL_XI14
SY   MEP 21
DR   Wikidata; Q95988792
RX   Patent=WO1999045028A1;
RX   PubMed=11025405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1944.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NQ30; Human ESM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MEQC1
AC   CVCL_J504
SY   MEQC 1; Myc Embryonic Quail Cardiomyocytes-1
DR   Wikidata; Q54905201
RX   PubMed=1846337;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   MEQC2
AC   CVCL_J505
SY   MEQC 2; Myc Embryonic Quail Cardiomyocytes-2
DR   Wikidata; Q54905202
RX   PubMed=1846337;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   MER
AC   CVCL_A5YL
SY   mer
DR   Wikidata; Q107116345
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8051085;
RX   PubMed=8427968;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   MER,P
AC   CVCL_E774
SY   MER, P
DR   dbMHC; 48969
DR   ECACC; 94082226
DR   IHW; IHW09127
DR   IPD-IMGT/HLA; 11670
DR   Wikidata; Q54905203
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02:01:01; B*08:01,37:01; C*06:02; DPB1*02:01:02,04:01:01; DQA1*01:04,05:01; DQB1*05:01:01,02:01; DRB1*03:01:01,10:01:01; DRB3*01:01 (IPD-IMGT/HLA=11670).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Mero-14
AC   CVCL_2590
SY   MERO14
DR   cancercelllines; CVCL_2590
DR   Cell_Model_Passport; SIDM01783
DR   DepMap; ACH-001555
DR   ECACC; 09100101
DR   FANTOM5_SSTAR; 10849-111F3
DR   Wikidata; Q54905204
RX   PubMed=2474517;
RX   PubMed=2790740;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~24 hours (ECACC=09100101).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001555; ECACC=09100101
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 19
ST   D21S11: 31
ST   D3S1358: 14
ST   D5S818: 9
ST   D7S820: 10,11
ST   D8S1179: 10
ST   FGA: 21,23
ST   Penta D: 12,13
ST   Penta E: 7,12
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mero-25
AC   CVCL_2591
SY   MERO25
DR   cancercelllines; CVCL_2591
DR   Cell_Model_Passport; SIDM01788
DR   DepMap; ACH-001556
DR   ECACC; 09100102
DR   FANTOM5_SSTAR; 10850-111F4
DR   Wikidata; Q54905205
RX   PubMed=2474517;
RX   PubMed=2790740;
RX   PubMed=25902174;
RX   PubMed=33567673;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~48 hours (PubMed=2474517).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): DepMap=ACH-001556; ECACC=09100102
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 18
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 7,16
ST   TH01: 8
ST   TPOX: 9
ST   vWA: 16,17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Mero-41
AC   CVCL_2592
SY   MERO41
DR   cancercelllines; CVCL_2592
DR   Cell_Model_Passport; SIDM01903
DR   DepMap; ACH-001557
DR   ECACC; 09100103
DR   FANTOM5_SSTAR; 10851-111F5
DR   Wikidata; Q54905206
RX   PubMed=2474517;
RX   PubMed=2790740;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001557; ECACC=09100103
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 7,15
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Mero-48a
AC   CVCL_2593
SY   MERO48A
DR   cancercelllines; CVCL_2593
DR   Cell_Model_Passport; SIDM01867
DR   DepMap; ACH-001558
DR   ECACC; 09100104
DR   FANTOM5_SSTAR; 10852-111F6
DR   Wikidata; Q54905207
RX   PubMed=2474517;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~24 hours (ECACC=09100104).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001558; ECACC=09100104
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 12
ST   D21S11: 27,32.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 19
ST   Penta D: 14
ST   Penta E: 16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W102 ! Mero-48b
OI   CVCL_W103 ! Mero-48c
OI   CVCL_W104 ! Mero-48d
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mero-48b
AC   CVCL_W102
DR   Cell_Model_Passport; SIDM01890
DR   Wikidata; Q54905208
RX   PubMed=2474517;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2593 ! Mero-48a
OI   CVCL_W103 ! Mero-48c
OI   CVCL_W104 ! Mero-48d
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   Mero-48c
AC   CVCL_W103
DR   Cell_Model_Passport; SIDM01892
DR   Wikidata; Q54905209
RX   PubMed=2474517;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2593 ! Mero-48a
OI   CVCL_W102 ! Mero-48b
OI   CVCL_W104 ! Mero-48d
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   Mero-48d
AC   CVCL_W104
DR   Cell_Model_Passport; SIDM01893
DR   Wikidata; Q54905210
RX   PubMed=2474517;
CC   Derived from site: Metastatic; Heart, pericardium; UBERON=UBERON_0002407.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2593 ! Mero-48a
OI   CVCL_W102 ! Mero-48b
OI   CVCL_W103 ! Mero-48c
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   Mero-72
AC   CVCL_W105
DR   Wikidata; Q54905211
RX   PubMed=2474517;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   Mero-82
AC   CVCL_2594
SY   MERO82
DR   cancercelllines; CVCL_2594
DR   Cell_Model_Passport; SIDM01894
DR   DepMap; ACH-001559
DR   ECACC; 09100105
DR   FANTOM5_SSTAR; 10853-111F7
DR   Wikidata; Q54905212
RX   PubMed=2474517;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~24 hours (PubMed=2474517).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Unspecified (DepMap=ACH-001559).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001559; ECACC=09100105
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   Mero-83
AC   CVCL_2595
SY   MERO83
DR   cancercelllines; CVCL_2595
DR   Cell_Model_Passport; SIDM01895
DR   DepMap; ACH-001560
DR   ECACC; 09100106
DR   FANTOM5_SSTAR; 10854-111F8
DR   Wikidata; Q54905213
RX   PubMed=2474517;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~40 hours (ECACC=09100106).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001560; ECACC=09100106
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D21S11: 27,30
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 12,14
ST   FGA: 25
ST   Penta D: 12,14
ST   Penta E: 9,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mero-84
AC   CVCL_2596
SY   MERO84
DR   cancercelllines; CVCL_2596
DR   Cell_Model_Passport; SIDM01905
DR   DepMap; ACH-001561
DR   ECACC; 09100107
DR   FANTOM5_SSTAR; 10855-111F9
DR   Wikidata; Q54905215
RX   PubMed=2474517;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~48 hours (ECACC=09100107).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001561; ECACC=09100107
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9
ST   D18S51: 15,16
ST   D21S11: 29,31,32
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,11 (ECACC=09100107)
ST   D7S820: 9,11,12 (DepMap=ACH-001561)
ST   D8S1179: 12
ST   FGA: 19
ST   Penta D: 10,13
ST   Penta E: 7,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mero-91
AC   CVCL_W106
DR   Wikidata; Q54905216
RX   PubMed=2474517;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Mero-95
AC   CVCL_2597
SY   MERO95
DR   cancercelllines; CVCL_2597
DR   Cell_Model_Passport; SIDM01906
DR   DepMap; ACH-001562
DR   ECACC; 09100108
DR   FANTOM5_SSTAR; 10856-111G1
DR   Wikidata; Q54905217
RX   PubMed=2474517;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~30 hours (ECACC=09100108).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001562; ECACC=09100108
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,17
ST   D21S11: 28,30
ST   D3S1358: 14,15
ST   D5S818: 11,14
ST   D7S820: 7,9
ST   D8S1179: 11,15
ST   FGA: 21,23
ST   Penta D: 12,13
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mero-96
AC   CVCL_W107
DR   Wikidata; Q54905218
RX   PubMed=2474517;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   Mes-1
AC   CVCL_H665
DR   Wikidata; Q54905219
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-10
AC   CVCL_H657
DR   Wikidata; Q54905220
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-11
AC   CVCL_H661
DR   Wikidata; Q54905221
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-15
AC   CVCL_H662
DR   Wikidata; Q54905223
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-17
AC   CVCL_H647
SY   Meso 17; Meso-17; Meso17
DR   Lonza; 325
DR   Wikidata; Q54905224
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Tyr217Ter (c.651C>A); Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-19
AC   CVCL_H656
DR   Wikidata; Q54905225
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Lys44Asn (c.132G>C); Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-2
AC   CVCL_H666
DR   Wikidata; Q54905226
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-20
AC   CVCL_H663
DR   Wikidata; Q54905227
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-29
AC   CVCL_H651
DR   Wikidata; Q54905228
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-30
AC   CVCL_H650
DR   Wikidata; Q54905229
RX   PubMed=10451704;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-35
AC   CVCL_H648
SY   Meso 35; Meso-35
DR   Wikidata; Q54905230
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Glu58Ter (c.172G>T); Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-36
AC   CVCL_H652
DR   Wikidata; Q54905231
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Unexplicit; Ex5del; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-37
AC   CVCL_H649
DR   Wikidata; Q54905232
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-45
AC   CVCL_H653
DR   Wikidata; Q54905233
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Unexplicit; Ex1-13del; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-49
AC   CVCL_H654
DR   Wikidata; Q54905234
RX   PubMed=10451704;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-5
AC   CVCL_H667
DR   Wikidata; Q54905235
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-50
AC   CVCL_H655
SY   MM 6-53; 6-53
DR   Wikidata; Q54905236
RX   PubMed=7479897;
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Pro91Glnfs*32 (c.271delC); Zygosity=Unspecified (PubMed=7479897; PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-54
AC   CVCL_H664
DR   Wikidata; Q54905237
RX   PubMed=10451704;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   Mes-7
AC   CVCL_H660
DR   Wikidata; Q54905242
RX   PubMed=10451704;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   Mes-8
AC   CVCL_H659
DR   Wikidata; Q54905243
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Cys37Trpfs*2 (c.111delC); Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   Mes-9
AC   CVCL_H658
SY   MM 1-53; 1-53
DR   Wikidata; Q54905244
RX   PubMed=7479897;
RX   PubMed=10451704;
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Unexplicit; 43-bp insertion at junction of exons 13/14; Zygosity=Unspecified (PubMed=10451704).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   mes-c-myc A1
AC   CVCL_A0WM
SY   A1 mes c-myc; A1
DR   Wikidata; Q108820901
RX   PubMed=10527628;
RX   PubMed=23246712;
RX   PubMed=33498778;
CC   Characteristics: Cease to divide and undergo morphological differentiation after serum withdrawal or addition of cAMP (PubMed=10527628).
CC   Characteristics: Established by infection with a replication-defective retrovirus bearing the MYC and neo genes under the control of MLV LTR promoter.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Myc.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Derived from site: In situ; Embryonic brain, mesencephalon; UBERON=UBERON_0009616.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   MES-OV
AC   CVCL_CZ92
SY   MESOV
DR   ATCC; CRL-3272
DR   cancercelllines; CVCL_CZ92
DR   DepMap; ACH-002486
DR   GEO; GSM95445
DR   Progenetix; CVCL_CZ92
DR   Wikidata; Q54905245
RX   PubMed=12960427;
RX   PubMed=16382445;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~22 hours (ATCC=CRL-3272).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-3272
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 8
//
ID   MES-OV/T40
AC   CVCL_CZ97
SY   MESOV T40; MESOVT40
DR   cancercelllines; CVCL_CZ97
DR   GEO; GSM95447
DR   Progenetix; CVCL_CZ97
DR   Wikidata; Q54905246
RX   PubMed=16382445;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CZ92 ! MES-OV
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   MES-OV/TxT50
AC   CVCL_CZ96
SY   MESOV TxT50; MESOVTxT50
DR   cancercelllines; CVCL_CZ96
DR   GEO; GSM95468
DR   Progenetix; CVCL_CZ96
DR   Wikidata; Q54905247
RX   PubMed=16382445;
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CZ92 ! MES-OV
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 7
//
ID   MES-SA
AC   CVCL_1404
SY   MESSA
DR   CLO; CLO_0007677
DR   EFO; EFO_0002233
DR   CLDB; cl3447
DR   CLDB; cl3448
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1976
DR   BCRC; 60333
DR   BioSample; SAMN03470984
DR   BioSample; SAMN10987906
DR   cancercelllines; CVCL_1404
DR   Cell_Model_Passport; SIDM00625
DR   ChEMBL-Cells; CHEMBL3307599
DR   ChEMBL-Targets; CHEMBL614343
DR   Cosmic; 687553
DR   Cosmic; 848889
DR   Cosmic; 908127
DR   Cosmic; 2008739
DR   Cosmic-CLP; 908127
DR   DepMap; ACH-000449
DR   ECACC; 95051030
DR   EGA; EGAS00001000978
DR   GDSC; 908127
DR   GEO; GSM827389
DR   GEO; GSM1670096
DR   GEO; GSM1676304
DR   GEO; GSM1701639
DR   IARC_TP53; 21494
DR   ICLC; HTL96008
DR   IGRhCellID; MESSA
DR   LiGeA; CCLE_298
DR   LINCS_LDP; LCL-1509
DR   PharmacoDB; MESSA_916_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1404
DR   PubChem_Cell_line; CVCL_1404
DR   Wikidata; Q54905248
RX   PubMed=6883344;
RX   PubMed=15816562;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22889595;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-490.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 22-24 hours (ATCC=CRL-1976; ECACC=95051030).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (ATCC=CRL-1976).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly1610Trpfs*38 (c.4826dupC) (p.S1609fs) (c.4825_4826insC); Zygosity=Heterozygous (Cosmic-CLP=908127; DepMap=ACH-000449).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (Cosmic-CLP=908127; DepMap=ACH-000449).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His272Thrfs*4 (c.813delT) (p.Phe271fs) (c.811delT); ClinVar=VCV000428208; Zygosity=Heterozygous (Cosmic-CLP=908127; DepMap=ACH-000449).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.13%; Native American=0%; East Asian, North=1.61%; East Asian, South=0.25%; South Asian=2.44%; European, North=50.63%; European, South=43.94% (PubMed=30894373).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): ATCC=CRL-1976; Cosmic-CLP=908127; ECACC=95051030; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14,15
ST   D12S391: 17,25
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 14.2,15
ST   D1S1656: 14,17.3
ST   D21S11: 29,30.2
ST   D22S1045: 16
ST   D2S1338: 17
ST   D2S441: 10,14
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 7,11
ST   D8S1179: 14,15
ST   FGA: 20,25
ST   Penta D: 13,15
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C6339; Uterine corpus sarcoma
DI   ORDO; Orphanet_213620; Sarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   MES-SA/Dx1
AC   CVCL_4T93
SY   Mes-SA Dx1; MESSA-DX1; Dx1
DR   cancercelllines; CVCL_4T93
DR   Wikidata; Q54905249
RX   PubMed=4028002;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly1610Trpfs*38 (c.4826dupC) (p.S1609fs) (c.4825_4826insC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His272Thrfs*4 (c.813delT) (p.Phe271fs) (c.811delT); ClinVar=VCV000428208; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C6339; Uterine corpus sarcoma
DI   ORDO; Orphanet_213620; Sarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1404 ! MES-SA
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   MES-SA/Dx5
AC   CVCL_2598
SY   MES-SA/Dx-5; MES-SA-Dx5; MES-SA Dx5; MESSA/Dx5; MESSA-DX5; MESSA Dx5; MESSADX5; Dx5
DR   CLO; CLO_0007678
DR   CLO; CLO_0037164
DR   CLDB; cl3449
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-1977
DR   BCRC; 60331
DR   BCRJ; 0403
DR   BioSample; SAMN03470985
DR   BioSample; SAMN03471267
DR   cancercelllines; CVCL_2598
DR   Cell_Model_Passport; SIDM01225
DR   ChEMBL-Cells; CHEMBL3308373
DR   ChEMBL-Targets; CHEMBL613827
DR   ECACC; 95051031
DR   GEO; GSM827348
DR   GEO; GSM1676305
DR   GEO; GSM1701640
DR   IGRhCellID; MESSADX5
DR   LINCS_LDP; LCL-1510
DR   Progenetix; CVCL_2598
DR   PubChem_Cell_line; CVCL_2598
DR   Wikidata; Q54905250
RX   PubMed=4028002;
RX   PubMed=15816562;
RX   PubMed=20215515;
RX   PubMed=22889595;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (ECACC=95051031).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly1610Trpfs*38 (c.4826dupC) (p.S1609fs) (c.4825_4826insC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His272Thrfs*4 (c.813delT) (p.Phe271fs) (c.811delT); ClinVar=VCV000428208; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: MES-AS/Dx5; BCRJ=0403.
CC   Misspelling: MES-SA/DxS; ChEMBL-Targets=CHEMBL613827; ChEMBL-Cells=CHEMBL3308373.
CC   Discontinued: ATCC; CRL-1977; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): ATCC=CRL-1977; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14,15
ST   D12S391: 17,25
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 14.2,15
ST   D1S1656: 14,17.3
ST   D21S11: 29,30.2
ST   D22S1045: 16
ST   D2S1338: 17
ST   D2S441: 10,14
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 7,11 (ATCC=CRL-1977)
ST   D7S820: 11 (PubMed=25877200; Technion Genomics Center)
ST   D8S1179: 14,15
ST   FGA: 20,25
ST   Penta D: 13,15
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C6339; Uterine corpus sarcoma
DI   ORDO; Orphanet_213620; Sarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1404 ! MES-SA
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   MES-SA/DxP5002
AC   CVCL_4T94
SY   DxP
DR   cancercelllines; CVCL_4T94
DR   Wikidata; Q54905251
RX   PubMed=9038218;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly1610Trpfs*38 (c.4826dupC) (p.S1609fs) (c.4825_4826insC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His272Thrfs*4 (c.813delT) (p.Phe271fs) (c.811delT); ClinVar=VCV000428208; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C6339; Uterine corpus sarcoma
DI   ORDO; Orphanet_213620; Sarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2598 ! MES-SA/Dx5
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 10
//
ID   MES-SA/MX2
AC   CVCL_2599
SY   MES-SA/Mx2; MES-SA-MX2; MESSA/MX2; MESSAMX2
DR   CLO; CLO_0007679
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2274
DR   BioSample; SAMN03471858
DR   cancercelllines; CVCL_2599
DR   Cell_Model_Passport; SIDM01239
DR   IGRhCellID; MESSAMX2
DR   Progenetix; CVCL_2599
DR   Wikidata; Q54905252
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly1610Trpfs*38 (c.4826dupC) (p.S1609fs) (c.4825_4826insC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Thr1690Asnfs*8 (c.5068dupA) (c.5067_5068insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His272Thrfs*4 (c.813delT) (p.Phe271fs) (c.811delT); ClinVar=VCV000428208; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): ATCC=CRL-2274
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 14.2,15
ST   D21S11: 29,30.2
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 7,11
ST   D8S1179: 14,15
ST   FGA: 20,25
ST   Penta D: 13,15
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C6339; Uterine corpus sarcoma
DI   ORDO; Orphanet_213620; Sarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1404 ! MES-SA
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Mes.Cl.-1
AC   CVCL_UW42
DR   cancercelllines; CVCL_UW42
DR   IARC_TP53; 757
DR   Wikidata; Q95988861
RX   PubMed=1913660;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Hemizygous (PubMed=1913660).
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   Mes.Cl.-2
AC   CVCL_UW43
DR   Wikidata; Q95988863
RX   PubMed=1913660;
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   Mes.Cl.-3
AC   CVCL_UW44
DR   Wikidata; Q95988864
RX   PubMed=1913660;
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   Mes.Cl.-4
AC   CVCL_UW45
DR   cancercelllines; CVCL_UW45
DR   IARC_TP53; 758
DR   Wikidata; Q95988865
RX   PubMed=1913660;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Hemizygous (PubMed=1913660).
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   MES1
AC   CVCL_Z508
SY   Mes1; Medaka ES-like line 1
DR   Wikidata; Q54905253
RX   PubMed=9025059;
RX   PubMed=9520425;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   MES11
AC   CVCL_JK79
SY   Mink Embryonic Stem cell-line 11
DR   Wikidata; Q54905254
RX   PubMed=8257564;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES12
AC   CVCL_JK80
SY   Mink Embryonic Stem cell-line 12; Mink ESC12
DR   BioSample; SAMN04123238
DR   Wikidata; Q54905255
RX   PubMed=8257564;
RX   PubMed=26694224;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   MES13
AC   CVCL_JK81
SY   Mink Embryonic Stem cell-line 13
DR   EFO; EFO_0022797
DR   Wikidata; Q54905256
RX   PubMed=8257564;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 6
//
ID   MES14
AC   CVCL_JK82
SY   Mink Embryonic Stem cell-line 14
DR   Wikidata; Q54905257
RX   PubMed=8257564;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES15
AC   CVCL_JK83
SY   Mink Embryonic Stem cell-line 15
DR   Wikidata; Q54905259
RX   PubMed=8257564;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES16
AC   CVCL_JK84
SY   Mink Embryonic Stem cell-line 16
DR   Wikidata; Q54905260
RX   PubMed=8257564;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES17
AC   CVCL_JK85
SY   Mink Embryonic Stem cell-line 17
DR   Wikidata; Q54905261
RX   PubMed=8257564;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES19
AC   CVCL_JK86
SY   Mink Embryonic Stem cell-line 19
DR   Wikidata; Q54905262
RX   PubMed=8257564;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES20
AC   CVCL_JK87
SY   Mink Embryonic Stem cell-line 20
DR   Wikidata; Q54905263
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES21
AC   CVCL_JK88
SY   Mink Embryonic Stem cell-line 21
DR   Wikidata; Q54905264
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES22
AC   CVCL_JK89
SY   Mink Embryonic Stem cell-line 22
DR   Wikidata; Q54905265
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES23
AC   CVCL_JK90
SY   Mink Embryonic Stem cell-line 23
DR   Wikidata; Q54905266
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES23.5
AC   CVCL_J351
SY   MES-23.5; MES 23.5
DR   BTO; BTO_0004476
DR   EFO; EFO_0022795
DR   Wikidata; Q54905267
RX   PubMed=1356145;
CC   Characteristics: Derived from the fusion of rat embryonic mesencephalon cells with mouse neuroblastoma cell line N18TG2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   MES24
AC   CVCL_JK91
SY   Mink Embryonic Stem cell-line 24
DR   Wikidata; Q54905268
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES25
AC   CVCL_JK92
SY   Mink Embryonic Stem cell-line 25
DR   Wikidata; Q54905269
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES26
AC   CVCL_JK93
SY   Mink Embryonic Stem cell-line 26
DR   Wikidata; Q54905270
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES27
AC   CVCL_JK94
SY   Mink Embryonic Stem cell-line 27
DR   Wikidata; Q54905272
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES28
AC   CVCL_JK95
SY   Mink Embryonic Stem cell-line 28
DR   Wikidata; Q54905273
RX   PubMed=26694224;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   MES29
AC   CVCL_JK96
SY   Mink Embryonic Stem cell-line 29; Mink ESC29
DR   BioSample; SAMN04123242
DR   Wikidata; Q54905274
RX   PubMed=26694224;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   MESC 16
AC   CVCL_M012
DR   ECACC; 11120811
DR   Wikidata; Q54905275
RX   PubMed=1483967;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Olac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   MESC 17
AC   CVCL_M013
DR   ECACC; 11120817
DR   Wikidata; Q54905276
RX   PubMed=1483967;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 6
//
ID   MESC 18
AC   CVCL_M014
DR   ECACC; 11120816
DR   Wikidata; Q54905277
RX   PubMed=1483967;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Olac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   MESC 19
AC   CVCL_M015
DR   ECACC; 11120813
DR   Wikidata; Q54905278
RX   PubMed=1483967;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Olac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   MESC 20
AC   CVCL_M016
DR   ECACC; 11120814
DR   Wikidata; Q54905279
RX   PubMed=1483967;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Olac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   MESC 21
AC   CVCL_M017
DR   ECACC; 11120815
DR   Wikidata; Q54905280
RX   PubMed=1483967;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Olac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   MESC 23
AC   CVCL_M018
DR   ECACC; 11120818
DR   Wikidata; Q54905281
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Olac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   MESC2.10
AC   CVCL_B061
DR   Wikidata; Q54905282
RX   PubMed=12145295;
RX   PubMed=17222562;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8FW
CA   Conditionally immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   Meso-10
AC   CVCL_H668
SY   Meso 10; Meso10; MESO10
DR   BioSamples; SAMEA100887
DR   cancercelllines; CVCL_H668
DR   Cosmic; 1522770
DR   Cosmic; 1541216
DR   GEO; GSM726275
DR   Progenetix; CVCL_H668
DR   Wikidata; Q54905283
RX   PubMed=16475242;
RX   PubMed=21642991;
RX   PubMed=21774103;
CC   Sequence variation: Gene deletion; HGNC; HGNC:950; BAP1; Zygosity=Heterozygous (PubMed=21642991).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   MESO-12T
AC   CVCL_RP25
DR   Wikidata; Q54905288
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 49.8 hours (Note=In 2% FCS), 37.1 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: No history of asbestos exposure (PubMed=26891694).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   MESO-14T
AC   CVCL_RP26
DR   Wikidata; Q54905289
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 69.6 hours (Note=In 2% FCS), 67.0 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=26891694
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,14
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   MESO-17T
AC   CVCL_RP27
DR   Wikidata; Q54905290
RX   PubMed=26891694;
CC   Senescence: Can only be cultured for up to 15 passages before displaying signs of senescence (PubMed=26891694).
CC   Doubling time: 53.1 hours (Note=In 2% FCS), 40.8 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   MESO-27T
AC   CVCL_RP28
DR   Wikidata; Q54905291
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 37.8 hours (Note=In 2% FCS), 31.6 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=26891694
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 13
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 8,13
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   MESO-3T
AC   CVCL_RP21
DR   Wikidata; Q54905292
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 197.8 hours (Note=In 2% FCS), 141.6 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=26891694
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D21S11: 31,33.2
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 24
ST   Penta D: 10
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   MESO-7T
AC   CVCL_RP22
DR   Wikidata; Q54905293
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 84.4 hours (Note=In 2% FCS), 62.5 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=26891694
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 24,25
ST   Penta D: 11,12
ST   Penta E: 14
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   MESO-8T
AC   CVCL_RP23
DR   Wikidata; Q54905294
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 32.4 hours (Note=In 2% FCS), 38.6 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: No history of asbestos exposure (PubMed=26891694).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=26891694
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   Meso-9
AC   CVCL_H669
SY   Meso9; Meso09; MESO09
DR   BioSamples; SAMEA100864
DR   cancercelllines; CVCL_H669
DR   Cosmic; 1522775
DR   Cosmic; 1541214
DR   GEO; GSM726274
DR   Progenetix; CVCL_H669
DR   Wikidata; Q54905295
RX   PubMed=16475242;
RX   PubMed=21642991;
RX   PubMed=21774103;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=21642991).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   MESO-9T
AC   CVCL_RP24
DR   Wikidata; Q54905296
RX   PubMed=26891694;
CC   Senescence: Can only be cultured for up to 15 passages before displaying signs of senescence (PubMed=26891694).
CC   Doubling time: 40.8 hours (Note=In 2% FCS), 41.9 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: No history of asbestos exposure (PubMed=26891694).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   Meso-CL1
AC   CVCL_IW94
DR   Wikidata; Q54905297
RX   PubMed=23285196;
CC   Group: Cancer stem cell line.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   Meso-CL2
AC   CVCL_IW95
DR   Wikidata; Q54905298
RX   PubMed=23285196;
CC   Group: Cancer stem cell line.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   Meso-CL3
AC   CVCL_IW96
DR   Wikidata; Q54905299
RX   PubMed=23285196;
CC   Group: Cancer stem cell line.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 4
//
ID   Meso11
AC   CVCL_H670
SY   Meso 11
DR   GEO; GSM433114
DR   GEO; GSM433132
DR   GEO; GSM433150
DR   GEO; GSM3943011
DR   Wikidata; Q54905300
RX   PubMed=15070823;
RX   PubMed=21356356;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso122
AC   CVCL_H671
DR   GEO; GSM433126
DR   GEO; GSM433144
DR   GEO; GSM433162
DR   GEO; GSM5342338
DR   Wikidata; Q54905301
RX   PubMed=21356356;
RX   PubMed=21540305;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso13
AC   CVCL_H672
SY   Meso 13
DR   GEO; GSM433115
DR   GEO; GSM433133
DR   GEO; GSM433151
DR   GEO; GSM3943012
DR   Wikidata; Q54905302
RX   PubMed=15070823;
RX   PubMed=21356356;
RX   PubMed=21540305;
RX   PubMed=22144115;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso144
AC   CVCL_H673
SY   Meso 144
DR   GEO; GSM5342339
DR   Wikidata; Q54905303
RX   PubMed=21540305;
RX   PubMed=22144115;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso148
AC   CVCL_H674
DR   GEO; GSM5342340
DR   Wikidata; Q54905304
RX   PubMed=21540305;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso150
AC   CVCL_D6W6
SY   Meso 150
DR   GEO; GSM5342341
RX   PubMed=26539644;
CC   Virology: Not susceptible to infection by measles virus (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso152
AC   CVCL_D6W7
SY   Meso 152
DR   GEO; GSM5342342
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death quite fast after infection (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso156
AC   CVCL_D6W8
DR   GEO; GSM5342343
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso163
AC   CVCL_D6W9
SY   Meso 163
DR   GEO; GSM3943019
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso173
AC   CVCL_D6WA
SY   Meso 173
DR   GEO; GSM3943020
RX   PubMed=26539644;
CC   Virology: Not susceptible to infection by measles virus (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso182
AC   CVCL_D6WB
DR   GEO; GSM5342344
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso225
AC   CVCL_D6WC
SY   Meso 225
DR   GEO; GSM3943021
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death quite fast after infection (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso241
AC   CVCL_D6WD
DR   GEO; GSM5342345
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso30
AC   CVCL_D6VV
DR   GEO; GSM433116
DR   GEO; GSM433134
DR   GEO; GSM433152
DR   GEO; GSM5342325
RX   PubMed=21356356;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso31
AC   CVCL_D6VW
SY   Meso 31
DR   GEO; GSM433117
DR   GEO; GSM433135
DR   GEO; GSM433153
DR   GEO; GSM3943013
RX   PubMed=21356356;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death quite fast after infection (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso34
AC   CVCL_H675
SY   Meso 34
DR   Cosmic; 1541207
DR   GEO; GSM433118
DR   GEO; GSM433136
DR   GEO; GSM433154
DR   GEO; GSM5342326
DR   Wikidata; Q54905305
RX   PubMed=21356356;
RX   PubMed=21540305;
RX   PubMed=21774103;
RX   PubMed=22144115;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso35
AC   CVCL_H676
SY   Meso 35
DR   GEO; GSM5342327
DR   Wikidata; Q54905306
RX   PubMed=21540305;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death quite fast after infection (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso36
AC   CVCL_D6VX
SY   Meso 36
DR   GEO; GSM433119
DR   GEO; GSM433137
DR   GEO; GSM433155
DR   GEO; GSM5342328
RX   PubMed=21356356;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso37
AC   CVCL_H677
SY   MESO37; Meso 37
DR   BioSamples; SAMEA100816
DR   cancercelllines; CVCL_H677
DR   Cosmic; 1522761
DR   Cosmic; 1541204
DR   GEO; GSM433120
DR   GEO; GSM433138
DR   GEO; GSM433156
DR   GEO; GSM726276
DR   GEO; GSM5342329
DR   Progenetix; CVCL_H677
DR   Wikidata; Q54905308
RX   PubMed=21356356;
RX   PubMed=21642991;
RX   PubMed=21774103;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=21642991).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Glu54Ter (c.160G>T); Zygosity=Heterozygous (PubMed=21642991).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   Meso4
AC   CVCL_H678
SY   Meso 4
DR   GEO; GSM3943010
DR   Wikidata; Q54905309
RX   PubMed=21540305;
RX   PubMed=26539644;
CC   Virology: Not susceptible to infection by measles virus (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso43
AC   CVCL_D6VY
DR   GEO; GSM5342330
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso45
AC   CVCL_H679
SY   Meso 45
DR   GEO; GSM3943014
DR   Wikidata; Q54905310
RX   PubMed=21540305;
RX   PubMed=22144115;
RX   PubMed=26539644;
CC   Virology: Not susceptible to infection by measles virus (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso47
AC   CVCL_H680
SY   Meso 47
DR   GEO; GSM433121
DR   GEO; GSM433139
DR   GEO; GSM433157
DR   GEO; GSM3943015
DR   Wikidata; Q54905311
RX   PubMed=21356356;
RX   PubMed=21540305;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso52
AC   CVCL_D6VZ
SY   Meso 52
DR   GEO; GSM433122
DR   GEO; GSM433140
DR   GEO; GSM433158
DR   GEO; GSM5342331
RX   PubMed=21356356;
RX   PubMed=26539644;
CC   Virology: Not susceptible to infection by measles virus (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso55
AC   CVCL_D6W0
DR   GEO; GSM5342332
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso56
AC   CVCL_H681
SY   MESO56; Meso 56
DR   BioSamples; SAMEA100840
DR   cancercelllines; CVCL_H681
DR   Cosmic; 1522782
DR   Cosmic; 1541206
DR   GEO; GSM433123
DR   GEO; GSM433141
DR   GEO; GSM433159
DR   GEO; GSM726277
DR   GEO; GSM5342333
DR   Progenetix; CVCL_H681
DR   Wikidata; Q54905312
RX   PubMed=21356356;
RX   PubMed=21540305;
RX   PubMed=21642991;
RX   PubMed=21774103;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   Meso61
AC   CVCL_D6W1
SY   Meso 61
DR   GEO; GSM3943016
RX   PubMed=26539644;
CC   Virology: Not susceptible to infection by measles virus (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso62
AC   CVCL_H682
DR   GEO; GSM5342334
DR   Wikidata; Q54905313
RX   PubMed=21540305;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Meso70
AC   CVCL_D6W3
DR   GEO; GSM5342335
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso75
AC   CVCL_D6W4
DR   GEO; GSM5342336
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso76
AC   CVCL_D6W5
SY   Meso 76
DR   GEO; GSM3943017
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso84
AC   CVCL_D6WF
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Meso95
AC   CVCL_D6W2
SY   Meso 95; Meso95B
DR   GEO; GSM433124
DR   GEO; GSM433142
DR   GEO; GSM433160
DR   GEO; GSM5342337
RX   PubMed=21356356;
RX   PubMed=26539644;
CC   Virology: Not susceptible to infection by measles virus (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Meso96
AC   CVCL_H683
SY   Meso 96
DR   GEO; GSM433125
DR   GEO; GSM433143
DR   GEO; GSM433161
DR   GEO; GSM3943018
DR   Wikidata; Q54905314
RX   PubMed=21356356;
RX   PubMed=21540305;
RX   PubMed=22144115;
RX   PubMed=26539644;
CC   Virology: Susceptible to infection by measles virus that leads to cell death (PubMed=26539644).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   MESV
AC   CVCL_D804
SY   Middle Ear cells derived by SV40 infection
DR   Wikidata; Q54905315
RX   PubMed=8382213;
RX   PubMed=12382283;
CC   Doubling time: 21 hours (PubMed=8382213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   MET-1
AC   CVCL_LN09
SY   MET1; SCCT
DR   cancercelllines; CVCL_LN09
DR   CancerTools; 153539
DR   Cosmic; 2688659
DR   GEO; GSM2611467
DR   GEO; GSM2611468
DR   GEO; GSM2611469
DR   Wikidata; Q54905316
DR   Ximbio; 153539
RX   PubMed=10772384;
RX   PubMed=11121147;
RX   PubMed=24662767;
RX   PubMed=29755650;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hand, skin; UBERON=UBERON_0001519.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN10 ! MET-2
OI   CVCL_LN11 ! MET-3
OI   CVCL_LN12 ! MET-4
OI   CVCL_LN13 ! PM-1 [Human oral dysplasia]
OI   CVCL_VJ50 ! SCCT9
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   Met-1
AC   CVCL_XF12
SY   Met 1; MA-CH1
DR   CCRID; 4201PAT-CCTCC00281
DR   Wikidata; Q95988936
RX   Patent=CN101597233B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200914.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_6809; Methamphetamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   Met-1(fvb2)
AC   CVCL_U373
SY   Met-1fvb2
DR   Lonza; 1227
DR   Wikidata; Q54905317
RX   PubMed=16132578;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Breed/subspecies: FVB/N-Tg(MMTV-PyVmT).
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MET-2
AC   CVCL_LN10
SY   MET2
DR   CancerTools; 153569
DR   GEO; GSM2611470
DR   GEO; GSM2611471
DR   GEO; GSM2611472
DR   Wikidata; Q54905318
DR   Ximbio; 153569
RX   PubMed=10772384;
RX   PubMed=11121147;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hand, skin; UBERON=UBERON_0001519.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN09 ! MET-1
OI   CVCL_LN11 ! MET-3
OI   CVCL_LN12 ! MET-4
OI   CVCL_LN13 ! PM-1 [Human oral dysplasia]
OI   CVCL_VJ50 ! SCCT9
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   MET-2B
AC   CVCL_VS57
SY   MET2B
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_VS57
DR   Cell_Model_Passport; SIDM00221
DR   Cosmic; 1659787
DR   DepMap; ACH-002388
DR   EGA; EGAS00001000978
DR   PharmacoDB; MET2B_917_2019
DR   Wikidata; Q95988942
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (DepMap=ACH-002388).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   MET-3
AC   CVCL_LN11
SY   MET3
DR   Wikidata; Q54905319
RX   PubMed=10772384;
RX   PubMed=11121147;
CC   Derived from site: In situ; Hand, skin; UBERON=UBERON_0001519.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN09 ! MET-1
OI   CVCL_LN10 ! MET-2
OI   CVCL_LN12 ! MET-4
OI   CVCL_LN13 ! PM-1 [Human oral dysplasia]
OI   CVCL_VJ50 ! SCCT9
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   MET-4
AC   CVCL_LN12
SY   MET4; SCCTMet
DR   CancerTools; 153570
DR   GEO; GSM2611473
DR   GEO; GSM2611474
DR   GEO; GSM2611475
DR   Wikidata; Q54905320
DR   Ximbio; 153570
RX   PubMed=10772384;
RX   PubMed=11121147;
RX   PubMed=29755650;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN09 ! MET-1
OI   CVCL_LN10 ! MET-2
OI   CVCL_LN11 ! MET-3
OI   CVCL_LN13 ! PM-1 [Human oral dysplasia]
OI   CVCL_VJ50 ! SCCT9
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   MeT-4A
AC   CVCL_H531
SY   MeT 4A; Met4A; Mesothelial cells transfected with pRSV-T 4A
DR   Wikidata; Q54905321
RX   CelloPub=CLPUB00712;
RX   PubMed=2541616;
RX   PubMed=9175740;
RX   PubMed=19935656;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   MeT-5A
AC   CVCL_3749
SY   MeT 5A; MeT5A; Met5A; MET5A; Mesothelial cells transfected with pRSV-T 5A
DR   CLO; CLO_0007680
DR   EFO; EFO_0001218
DR   ATCC; CRL-9444
DR   BCRC; 60352
DR   BioSample; SAMN03471216
DR   CLS; 305269
DR   GEO; GSM49613
DR   GEO; GSM139667
DR   GEO; GSM139668
DR   GEO; GSM139669
DR   GEO; GSM139760
DR   GEO; GSM139761
DR   GEO; GSM433109
DR   GEO; GSM433127
DR   GEO; GSM433145
DR   GEO; GSM3684948
DR   IZSLER; BS CL 214
DR   PRIDE; PXD033058
DR   Wikidata; Q54905322
RX   Patent=US4885238;
RX   PubMed=2541616;
RX   PubMed=9533946;
RX   PubMed=15920167;
RX   PubMed=17331233;
RX   PubMed=21356356;
RX   PubMed=21454801;
RX   PubMed=22576795;
RX   PubMed=24926545;
RX   PubMed=26011428;
RX   PubMed=28553954;
RX   PubMed=33567673;
RX   PubMed=34663305;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MeT-5a
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9444.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
ST   Source(s): ATCC=CRL-9444; IZSLER=BS CL 214
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 15,23
ST   D19S433: 15
ST   D21S11: 31.2
ST   D2S1338: 18,19
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 10,16
ST   TH01: 6,9.3
ST   TPOX: 8 (ATCC=CRL-9444)
ST   TPOX: 8,11 (IZSLER=BS CL 214)
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   MeT-5A/EJ-ras
AC   CVCL_LJ67
SY   MET-5A/EJ-ras; MET 5A/EJ-ras
DR   Wikidata; Q54905323
RX   Patent=US5443954;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9865.
CC   Characteristics: Tumorigenic derivative of MeT-5A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3749 ! MeT-5A
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 12
//
ID   Met10
AC   CVCL_E6MK
RX   PubMed=17415213;
CC   Doubling time: 8 days (PubMed=17415213).
CC   Karyotypic information: 45,XX,-22 (PubMed=17415213).
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Met10T
AC   CVCL_E6ML
RX   PubMed=17415213;
CC   Doubling time: 144 hours (PubMed=17415213).
CC   Karyotypic information: 45,XX,-22 (PubMed=17415213).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6MK ! Met10
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Met3
AC   CVCL_E6MM
RX   PubMed=17415213;
CC   Doubling time: 14 days (PubMed=17415213).
CC   Karyotypic information: 45,XX,t(1;5)(p36.1;q13),del(9)(p13),del(11)(p14),-22 (PubMed=17415213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Met3TSC
AC   CVCL_E6MN
RX   PubMed=17415213;
CC   Doubling time: 96 hours (PubMed=17415213).
CC   Karyotypic information: 45,XX,t(1;5)(p36.1;q13),del(9)(p13),del(11)(p14),-22 (PubMed=17415213).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C38936; Grade 1 meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6MM ! Met3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Meta 1
AC   CVCL_4559
SY   Meta-1; META-1
DR   CLO; CLO_0007684
DR   CLDB; cl3451
DR   Wikidata; Q54905324
RX   PubMed=3455746;
CC   Characteristics: The Meta series of TS/A derived cell lines are obtained from repeated subcutaneous passage of lung metastases in BALB/c female mice (PubMed=3455746).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Meta 10
AC   CVCL_3851
SY   Meta-10; META-10
DR   CLO; CLO_0007681
DR   CLO; CLO_0007685
DR   CLDB; cl3452
DR   CLDB; cl3453
DR   ECACC; 90062271
DR   Wikidata; Q54905326
RX   PubMed=3455746;
CC   Characteristics: The Meta series of TS/A derived cell lines are obtained from repeated subcutaneous passage of lung metastases in BALB/c female mice (PubMed=3455746).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3853 ! Meta 7
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Meta 15
AC   CVCL_3852
SY   Meta-15; META-15
DR   CLO; CLO_0007682
DR   CLDB; cl3450
DR   ECACC; 90062270
DR   Wikidata; Q54905327
RX   PubMed=3455746;
CC   Characteristics: The Meta series of TS/A derived cell lines are obtained from repeated subcutaneous passage of lung metastases in BALB/c female mice (PubMed=3455746).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3851 ! Meta 10
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Meta 7
AC   CVCL_3853
SY   Meta-7; META-7
DR   CLO; CLO_0007683
DR   CLO; CLO_0007686
DR   CLDB; cl3454
DR   CLDB; cl3455
DR   ECACC; 90062272
DR   Wikidata; Q54905328
RX   PubMed=3455746;
CC   Characteristics: The Meta series of TS/A derived cell lines are obtained from repeated subcutaneous passage of lung metastases in BALB/c female mice (PubMed=3455746).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4559 ! Meta 1
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Meth A MH-01
AC   CVCL_WW83
SY   MH-01; Metastatic High-01
DR   Wikidata; Q95988962
RX   DOI=10.15114/smj.56.333;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5798 ! Meth A Sarcoma
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   Meth A MH-02
AC   CVCL_WW84
SY   MH-02; Metastatic High-02
DR   Wikidata; Q95988964
RX   DOI=10.15114/smj.56.333;
RX   DOI=10.15114/smj.56.359;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5798 ! Meth A Sarcoma
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   Meth A MH-03
AC   CVCL_WW85
SY   MH-03; Metastatic High-03
DR   Wikidata; Q95988967
RX   DOI=10.15114/smj.56.333;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5798 ! Meth A Sarcoma
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   Meth A ML-01
AC   CVCL_WW86
SY   ML-01; Metastatic Low-01
DR   Wikidata; Q95988970
RX   DOI=10.15114/smj.56.333;
RX   DOI=10.15114/smj.56.359;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5798 ! Meth A Sarcoma
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   Meth A ML-02
AC   CVCL_WW87
SY   ML-02; Metastatic Low-02
DR   Wikidata; Q95988974
RX   DOI=10.15114/smj.56.333;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5798 ! Meth A Sarcoma
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 4
//
ID   Meth A Sarcoma
AC   CVCL_5798
SY   Meth A; Meth-A; Meth-A-sarkom
DR   CLS; 400284
DR   TKG; TKG 0158
DR   Wikidata; Q54905329
RX   PubMed=2529426;
RX   PubMed=11529879;
RX   PubMed=12680876;
CC   Doubling time: 24.0 hours (Note=In diploid state), 28.3 hours (Note=In tetraploid state), 30.2 hours (Note=In octaploid state) (PubMed=12680876); ~28-30 hours (CLS=400284).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   METON
AC   CVCL_T055
DR   Wikidata; Q54905335
RX   PubMed=23761224;
CC   Population: Japanese.
CC   Derived from site: In situ; Salivary gland, palatine gland; UBERON=UBERON_0002447.
DI   NCIt; C5978; Salivary gland myoepithelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   METUi001-A
AC   CVCL_A8ML
DR   hPSCreg; METUi001-A
DR   Wikidata; Q108820903
RX   PubMed=34087999;
CC   From: Middle East Technical University; Ankara; Turkey.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   METUi002-A
AC   CVCL_D0I4
DR   BioSamples; SAMEA114467819
DR   hPSCreg; METUi002-A
DR   Wikidata; Q123033036
RX   PubMed=37866220;
CC   From: Middle East Technical University; Ankara; Turkey.
CC   Sequence variation: Mutation; HGNC; HGNC:10947; SLC20A2; Simple; p.Val230Cysfs*28 (c.687dupT); ClinVar=VCV002098481; Zygosity=Heterozygous (PubMed=37866220).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MeWo
AC   CVCL_0445
SY   MEWO; Mewo; Me Wo; Me-Wo; Mevo; SK-MEL-MeWo; Mel-MeWo; BI-Mel; EST50
DR   BTO; BTO_0003301
DR   CLO; CLO_0007687
DR   CLO; CLO_0007688
DR   EFO; EFO_0006648
DR   MCCL; MCC:0000341
DR   CLDB; cl3456
DR   CLDB; cl3458
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-65
DR   BCRC; 60540
DR   BCRJ; 0358
DR   BioGRID_ORCS_Cell_line; 184
DR   BioSample; SAMN01821578
DR   BioSample; SAMN01821699
DR   BioSample; SAMN03470821
DR   BioSample; SAMN05292463
DR   BioSample; SAMN10987991
DR   cancercelllines; CVCL_0445
DR   Cell_Model_Passport; SIDM00545
DR   ChEMBL-Cells; CHEMBL3308024
DR   ChEMBL-Targets; CHEMBL613300
DR   CLS; 300285
DR   Cosmic; 721835
DR   Cosmic; 886829
DR   Cosmic; 908128
DR   Cosmic; 928689
DR   Cosmic; 932713
DR   Cosmic; 933141
DR   Cosmic; 972284
DR   Cosmic; 1047647
DR   Cosmic; 1060422
DR   Cosmic; 1132584
DR   Cosmic; 1238113
DR   Cosmic; 1303046
DR   Cosmic; 1995506
DR   Cosmic; 2036702
DR   Cosmic; 2159442
DR   Cosmic; 2163794
DR   Cosmic; 2651875
DR   Cosmic-CLP; 908128
DR   DepMap; ACH-000987
DR   ECACC; 93082609
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ESTDAB; ESTDAB-050
DR   GDSC; 908128
DR   GEO; GSM156016
DR   GEO; GSM188224
DR   GEO; GSM188254
DR   GEO; GSM188313
DR   GEO; GSM206525
DR   GEO; GSM274688
DR   GEO; GSM827470
DR   GEO; GSM887310
DR   GEO; GSM888386
DR   GEO; GSM1670097
DR   GEO; GSM3039511
DR   GEO; GSM3039514
DR   GEO; GSM3039515
DR   IARC_TP53; 26074
DR   ICLC; HTL97019
DR   JCRB; JCRB0066
DR   LiGeA; CCLE_829
DR   LINCS_LDP; LCL-1253
DR   Lonza; 437
DR   PharmacoDB; Mewo_918_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0445
DR   PubChem_Cell_line; CVCL_0445
DR   Wikidata; Q54905336
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=1383272;
RX   PubMed=2068080;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6933476;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=7459858;
RX   PubMed=7646526;
RX   PubMed=7908310;
RX   PubMed=9290701;
RX   PubMed=9598804;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23851445;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27600516;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544466
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-532.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: ~32 hours (PBCF).
CC   HLA typing: A*02:01,26:01; B*14:02,38:01; C*08:02,12:03; DPB1*04:01,04:02; DQB1*03:01:01,05:01; DRB1*11:01,01:02 (PubMed=15592718).
CC   HLA typing: A*02:01,26:01 (PubMed=25960936).
CC   HLA typing: A*02:01,26:01; B*14:02,67:02; C*12:03,12:03; DQB1*06:13,06:13; DRB1*11:30,14:17 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (PubMed=9598804; PubMed=17260012; PubMed=23851445; ATCC=HTB-65; DepMap=ACH-000987).
CC   Sequence variation: Mutation; HGNC; HGNC:3688; FGFR1; Simple; p.Pro252Ser (c.754C>T); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (ATCC=HTB-65).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.39%; Native American=1.31%; East Asian, North=0.6%; East Asian, South=0.77%; South Asian=7.24%; European, North=25.84%; European, South=61.86% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-65; CLS=300285; Cosmic-CLP=908128; ESTDAB=ESTDAB-050; JCRB=JCRB0066; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12 (ESTDAB=ESTDAB-050)
ST   CSF1PO: 12 (ATCC=HTB-65; CLS=300285; Cosmic-CLP=908128; JCRB=JCRB0066; PubMed=25877200; Technion Genomics Center)
ST   D10S1248: 13
ST   D12S391: 17
ST   D13S317: 8 (Cosmic-CLP=908128; ESTDAB=ESTDAB-050)
ST   D13S317: 8,9 (ATCC=HTB-65; CLS=300285; JCRB=JCRB0066; PubMed=25877200; Technion Genomics Center)
ST   D16S539: 10,12
ST   D18S51: 14,17
ST   D19S433: 14,16
ST   D1S1656: 15,16
ST   D21S11: 30,32.2
ST   D22S1045: 11,15
ST   D2S1338: 21,23
ST   D2S441: 10,11
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   DYS391: 10
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 5 (CLS=300285)
ST   Penta E: 5,15 (ATCC=HTB-65; PubMed=25877200; Technion Genomics Center)
ST   TH01: 7,9
ST   TPOX: 8,10 (ATCC=HTB-65; CLS=300285; Cosmic-CLP=908128; JCRB=JCRB0066; PubMed=25877200; Technion Genomics Center)
ST   TPOX: 9,11 (ESTDAB=ESTDAB-050)
ST   vWA: 15
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   MeWo CIS 0.01
AC   CVCL_AZ60
SY   MeWo-cisplatin 0.01
DR   cancercelllines; CVCL_AZ60
DR   Wikidata; Q54905337
RX   PubMed=11001322;
RX   PubMed=11058868;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   MeWo CIS 1
AC   CVCL_AZ74
SY   MeWo CIS 1.0; MeWo CIS; MeWo-cisplatin 1
DR   cancercelllines; CVCL_AZ74
DR   Wikidata; Q54905338
RX   PubMed=11001322;
RX   PubMed=11058868;
RX   PubMed=21475863;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   MeWo ETO 0.1
AC   CVCL_AZ61
SY   MeWo-etoposide 0.1
DR   cancercelllines; CVCL_AZ61
DR   Wikidata; Q54905339
RX   PubMed=11001322;
RX   PubMed=11058868;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   MeWo ETO 1
AC   CVCL_AZ62
SY   MeWo ETO 1.0; MeWo ETO; MeWo-etoposide 1
DR   cancercelllines; CVCL_AZ62
DR   Wikidata; Q54905340
RX   PubMed=11001322;
RX   PubMed=11058868;
RX   PubMed=21475863;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   MeWo FOTE 4
AC   CVCL_AZ75
SY   MeWo FOTE 4.0; MeWo-fotemustine 4
DR   cancercelllines; CVCL_AZ75
DR   Wikidata; Q54905341
RX   PubMed=11058868;
RX   PubMed=21475863;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_131848; Fotemustine (Mustophoran).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   MeWo FOTE 40
AC   CVCL_AZ76
SY   MeWo FOTE; MeWo-fotemustine 40
DR   cancercelllines; CVCL_AZ76
DR   Wikidata; Q54905343
RX   PubMed=11001322;
RX   PubMed=11058868;
RX   PubMed=21475863;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_131848; Fotemustine (Mustophoran).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   MeWo LNI 6I
AC   CVCL_Y663
DR   cancercelllines; CVCL_Y663
DR   Wikidata; Q54905344
RX   PubMed=1383272;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   MeWo VIN 0.5
AC   CVCL_AZ63
SY   MeWo-vindesine 0.5
DR   cancercelllines; CVCL_AZ63
DR   Wikidata; Q54905345
RX   PubMed=11001322;
RX   PubMed=11058868;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_36373; Vindesine.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   MeWo VIN 5
AC   CVCL_AZ77
SY   MeWo VIN 5.0; MeWo VIN; MeWo-vindesine 5
DR   cancercelllines; CVCL_AZ77
DR   Wikidata; Q54905346
RX   PubMed=11001322;
RX   PubMed=11058868;
RX   PubMed=21475863;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_36373; Vindesine.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   MeWo-LC1
AC   CVCL_U937
DR   cancercelllines; CVCL_U937
DR   Wikidata; Q54905347
RX   PubMed=3000950;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Doubling time: 42 +- 2 hours (PubMed=3000950).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   MeWo-Luc
AC   CVCL_J260
SY   Mewo-Luc
DR   cancercelllines; CVCL_J260
DR   JCRB; JCRB1396
DR   JCRB; NIHS0643
DR   Wikidata; Q54905348
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6877; MAPK3; Simple; p.Pro246Ser (c.736C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0643; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1396
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0445 ! MeWo
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 21
//
ID   MEXF 276L
AC   CVCL_D132
SY   MEXF276L; MEXF 276
DR   ChEMBL-Cells; CHEMBL3307542
DR   ChEMBL-Targets; CHEMBL614130
DR   Cosmic; 907392
DR   PubChem_Cell_line; CVCL_D132
DR   Wikidata; Q54905349
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   MEXF 462NL
AC   CVCL_D128
SY   MEXF462NL; MEXF 462; MEXF462
DR   Cosmic; 907393
DR   Wikidata; Q54905350
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   MEXF 514L
AC   CVCL_D129
SY   MEXF514L; MEXF 514; MEXF514
DR   ChEMBL-Cells; CHEMBL3307728
DR   ChEMBL-Targets; CHEMBL614873
DR   Cosmic; 907394
DR   PubChem_Cell_line; CVCL_D129
DR   Wikidata; Q54905351
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   MF
AC   CVCL_Y126
DR   ATCC; CRL-1375
DR   Wikidata; Q54905352
CC   Discontinued: ATCC; CRL-1375; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   MF 20
AC   CVCL_D3R9
SY   MF20
DR   DSHB; MF-20
DR   Wikidata; Q127382802
RX   PubMed=6185504;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P13538; Chicken MYH1E (Note=Also reacts with many other species and recognizes other myosin heavy chains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MF-1 [Human]
AC   CVCL_0C47
DR   Wikidata; Q54905355
RX   PubMed=18594539;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C42 ! BLC-1
OI   CVCL_0C52 ! HCC-1.1
OI   CVCL_0C53 ! HCC-1.2
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   MF-1 [Martes]
AC   CVCL_XZ72
DR   KCB; KCB 92037
DR   Wikidata; Q95989119
RX   PubMed=12067210;
RX   PubMed=22086079;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9659; ! Martes foina (Beech marten)
SX   Male
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   MF-2
AC   CVCL_0C48
DR   Wikidata; Q54905356
RX   PubMed=18594539;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C43 ! BLC-2
OI   CVCL_0C54 ! HCC-2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   MF-3
AC   CVCL_0C49
DR   Wikidata; Q54905357
RX   PubMed=18594539;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C57 ! HCC-3
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   MF-5
AC   CVCL_0C50
DR   Wikidata; Q54905358
RX   PubMed=18594539;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   MF-6
AC   CVCL_0C51
DR   Wikidata; Q54905359
RX   PubMed=18594539;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C45 ! BLC-6
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   MF-R 3
AC   CVCL_D3XS
DR   Wikidata; Q127382803
RX   PubMed=38057796;
CC   Doubling time: 21 +- 2.1 hours (PubMed=38057796).
CC   Derived from site: In situ; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
ST   Source(s): PubMed=38057796
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 14,20
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   MF1-PI 30
AC   CVCL_9W14
DR   NCBI_Iran; C440
DR   Wikidata; Q54905360
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   20FD
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   MF10
AC   CVCL_D5ZT
SY   UCLA-SO-MF10; UCLASO-MF10
DR   Wikidata; Q127382805
RX   PubMed=56444;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4715 ! M10
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   MF116
AC   CVCL_J762
SY   MF 116
DR   CLO; CLO_0007689
DR   Wikidata; Q54905353
RX   Patent=US4666845;
RX   Patent=WO1996040295A1;
RX   PubMed=3894261;
RX   PubMed=6582512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8411.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   MF12
AC   CVCL_D5ZU
SY   UCLA-SO-MF12; UCLASO-MF12
DR   Wikidata; Q127382806
RX   PubMed=56444;
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5T78 ! M12 [Human melanoma]
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   MF14
AC   CVCL_DI53
SY   UCLA-SO-MF14; UCLASO-MF14
DR   Wikidata; Q54905361
RX   PubMed=56444;
RX   PubMed=954005;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1395 ! M14
OI   CVCL_DI50 ! ML14 [Human LCL]
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 10
//
ID   MF15
AC   CVCL_D5ZW
SY   UCLA-SO-MF15; UCLASO-MF15
DR   Wikidata; Q127382807
RX   PubMed=56444;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ZV ! M15 [Human melanoma]
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   MF20
AC   CVCL_DI54
SY   UCLA-SO-MF20
DR   Wikidata; Q54905362
RX   PubMed=954005;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI51 ! M20 [Human melanoma]
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   MF2S
AC   CVCL_A5LJ
DR   Wikidata; Q107116348
RX   PubMed=140065;
RX   PubMed=7297559;
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4002 ! MOPC-173
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MF4
AC   CVCL_D5ZY
SY   UCLA-SO-MF4; UCLASO-MF4
DR   Wikidata; Q127382808
RX   PubMed=56444;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ZX ! M4 [Human melanoma]
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   Mf4/4
AC   CVCL_U655
SY   MF4/4
DR   Wikidata; Q54905363
RX   PubMed=9605128;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-535.html
CC   Transformant: Recombinant retrovirus 3RV/VN-11.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 8
//
ID   MF4C4
AC   CVCL_XB03
DR   CCRID; 4201PAT-CCTCC00154
DR   Wikidata; Q95989138
RX   Patent=US7303914;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200111.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51654; Human GPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   MF61
AC   CVCL_J843
SY   MF 61
DR   ATCC; HB-8410
DR   Wikidata; Q54905354
RX   Patent=US4666845;
RX   Patent=WO1996040295A1;
RX   PubMed=3894261;
RX   PubMed=6582512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8410.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   Mf9012
AC   CVCL_E5FA
RX   PubMed=18594937;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Mf9013
AC   CVCL_E5FB
RX   PubMed=18594937;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFA00335IN
AC   CVCL_E166
DR   Wikidata; Q54905364
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MFA00336IN
AC   CVCL_E167
DR   Wikidata; Q54905366
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MFA00337IN
AC   CVCL_E168
DR   Wikidata; Q54905367
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MFA00338IN
AC   CVCL_E169
DR   Wikidata; Q54905368
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MFA00340IN
AC   CVCL_E170
DR   Wikidata; Q54905369
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MFA00341IN
AC   CVCL_E171
DR   Wikidata; Q54905370
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MFA00342IN
AC   CVCL_E172
DR   Wikidata; Q54905371
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MFB-F11
AC   CVCL_5333
DR   Wikidata; Q54905372
RX   PubMed=16549026;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MFB-F11
CC   Characteristics: Can detect and quantify TGF-beta in biological samples without prior enrichment of TGF-betas, and can detect biologically activated TGF-beta in a cell co-culture system (PubMed=16549026).
CC   Characteristics: Transfected with a synthetic promoter element containing twelve CAGA boxes fused to a SEAP reporter gene (PubMed=16549026).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98725; Tgfb1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   MFBY2
AC   CVCL_M082
DR   BTO; BTO_0003526
DR   Wikidata; Q54905374
RX   PubMed=14623275;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2-3M
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   MFC
AC   CVCL_5J48
SY   Mouse Forestomach Carcinoma
DR   CCRID; 1101MOU-PUMC000143
DR   CLS; 300652
DR   KCB; KCB 92020YJ
DR   Wikidata; Q54905375
RX   PubMed=3678016;
CC   Doubling time: 24.7 hours (PubMed=3678016).
CC   Derived from site: In situ; Stomach, forestomach; UBERON=UBERON_0008827.
DI   NCIt; C24225; Mouse gastric carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   MFC-B5-GFP
AC   CVCL_WI97
DR   CCRID; 1101MOU-PUMC000410
DR   Wikidata; Q95989194
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P21115; Vaccinia virus protein B5.
CC   Derived from site: In situ; Stomach, forestomach; UBERON=UBERON_0008827.
DI   NCIt; C24225; Mouse gastric carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5J48 ! MFC
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   MFC-GFP
AC   CVCL_BT06
DR   CCRID; 1101MOU-PUMC000226
DR   Wikidata; Q54905376
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Stomach, forestomach; UBERON=UBERON_0008827.
DI   NCIt; C24225; Mouse gastric carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5J48 ! MFC
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 8
//
ID   MFC/HL-041
AC   CVCL_B6Z5
SY   Mouse Fibroblast Cell/HL-041
DR   CCRID; 4201PAT-CCTCC01012
DR   Wikidata; Q112129314
RX   Patent=CN108504625B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201714.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: NIH Swiss.
ST   Source(s): Patent=CN108504625B
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 13
ST   Mouse STR 6-4: 14.3
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 19
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 18-3: 17,21
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   16-18FD
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   MFD-1
AC   CVCL_JY36
DR   cancercelllines; CVCL_JY36
DR   Wikidata; Q54905377
RX   PubMed=27600491;
CC   Sequence variation: Mutation; HGNC; HGNC:40; ABCB1; Simple; p.Glu406Asp (c.1218T>G); Zygosity=Heterozygous (PubMed=27600491).
CC   Sequence variation: Mutation; HGNC; HGNC:40; ABCB1; Simple; p.Phe904Val (c.2710T>G); Zygosity=Heterozygous (PubMed=27600491).
CC   Sequence variation: Mutation; HGNC; HGNC:10736; SEMA5A; Simple; p.Lys378Arg; Zygosity=Homozygous (PubMed=27600491).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=27600491).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   MFE
AC   CVCL_YD03
SY   Mandarin Fish Embryo
DR   Wikidata; Q95989203
RX   DOI=10.11964/jfc.20170810942;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   MFE-280
AC   CVCL_1405
SY   MFE 280; MFE280
DR   CLO; CLO_0007692
DR   CLDB; cl5080
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 941
DR   BioSample; SAMN03473586
DR   BioSample; SAMN10987795
DR   cancercelllines; CVCL_1405
DR   Cell_Model_Passport; SIDM00335
DR   ChEMBL-Cells; CHEMBL3308455
DR   ChEMBL-Targets; CHEMBL1075502
DR   Cosmic; 908129
DR   Cosmic; 1434185
DR   Cosmic; 1576462
DR   Cosmic; 2030478
DR   Cosmic-CLP; 908129
DR   DepMap; ACH-000192
DR   DSMZ; ACC-410
DR   DSMZCellDive; ACC-410
DR   ECACC; 98050131
DR   EGA; EGAS00001000978
DR   GDSC; 908129
DR   GEO; GSM374974
DR   GEO; GSM375433
DR   GEO; GSM844603
DR   GEO; GSM887311
DR   GEO; GSM888387
DR   GEO; GSM1670098
DR   IARC_TP53; 21495
DR   LiGeA; CCLE_689
DR   LINCS_LDP; LCL-1500
DR   PharmacoDB; MFE280_919_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1405
DR   PubChem_Cell_line; CVCL_1405
DR   Ubigene; YC-C101
DR   Wikidata; Q54905380
RX   PubMed=9615781;
RX   PubMed=9620227;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/mfe280-xenofraft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~60-90 hours (DSMZ=ACC-410).
CC   HLA typing: A*02:01,31:01; B*07:02,51:01; C*07:02,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Tyr (c.3139C>T); ClinVar=VCV000039705; Zygosity=Heterozygous (Cosmic-CLP=908129; DepMap=ACH-000192).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>C (IVS8+1G>C); ClinVar=VCV000428905; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=908129; DepMap=ACH-000192).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.51%; Native American=0.41%; East Asian, North=4.71%; East Asian, South=0%; South Asian=0%; European, North=55.75%; European, South=37.62% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Cosmic-CLP=908129; DSMZ=ACC-410; ECACC=98050131
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 13,16
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 7
ST   TPOX: 9,10
ST   vWA: 17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   MFE-294
AC   CVCL_DI49
DR   Wikidata; Q54905381
RX   PubMed=9620227;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   MFE-296
AC   CVCL_1406
SY   MFE 296; MFE296
DR   CLO; CLO_0007693
DR   CLDB; cl5081
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 942
DR   BioSample; SAMN03473590
DR   BioSample; SAMN10987797
DR   cancercelllines; CVCL_1406
DR   Cell_Model_Passport; SIDM00334
DR   ChEMBL-Cells; CHEMBL3308374
DR   ChEMBL-Targets; CHEMBL1075503
DR   Cosmic; 908130
DR   Cosmic; 1105621
DR   Cosmic; 1177684
DR   Cosmic; 1434195
DR   Cosmic; 1576463
DR   Cosmic; 2030479
DR   Cosmic-CLP; 908130
DR   DepMap; ACH-000879
DR   DSMZ; ACC-419
DR   DSMZCellDive; ACC-419
DR   ECACC; 98031101
DR   EGA; EGAS00001000978
DR   GDSC; 908130
DR   GEO; GSM374975
DR   GEO; GSM375434
DR   GEO; GSM844604
DR   GEO; GSM844605
DR   GEO; GSM887312
DR   GEO; GSM888388
DR   GEO; GSM1670099
DR   IARC_TP53; 21496
DR   LiGeA; CCLE_405
DR   LINCS_LDP; LCL-1501
DR   PharmacoDB; MFE296_920_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1406
DR   PubChem_Cell_line; CVCL_1406
DR   Wikidata; Q54905382
RX   PubMed=8150529;
RX   PubMed=9620227;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-419).
CC   HLA typing: A*32:01,32:01; B*08:01,40:02; C*07:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Cys186fs*20 (c.550delC); Zygosity=Heterozygous (Cosmic-CLP=908130; DepMap=ACH-000879).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Lys860Asnfs*16 (c.2580delA); Zygosity=Heterozygous (Cosmic-CLP=908130; DepMap=ACH-000879).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gln (c.389G>A); ClinVar=VCV000007829; Zygosity=Homozygous (Cosmic-CLP=908130; DepMap=ACH-000879).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr321fs*23 (c.963delA); Zygosity=Heterozygous (Cosmic-CLP=908130; DepMap=ACH-000879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (Cosmic-CLP=908130; DepMap=ACH-000879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (Cosmic-CLP=908130; DepMap=ACH-000879).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0.72%; European, North=71.44%; European, South=27.84% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Cosmic-CLP=908130; DSMZ=ACC-419; ECACC=98031101
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,13
ST   D16S539: 11,14
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30,32
ST   D2S1338: 17,25
ST   D3S1358: 14,18
ST   D5S818: 11,12 (Cosmic-CLP=908130; DSMZ=ACC-419)
ST   D5S818: 11,13 (ECACC=98031101)
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 12,15
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   MFE-319
AC   CVCL_2112
SY   MFE319
DR   CLO; CLO_0007694
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 547
DR   BioSample; SAMN03473593
DR   BioSample; SAMN10987796
DR   cancercelllines; CVCL_2112
DR   Cell_Model_Passport; SIDM00333
DR   Cosmic; 1434187
DR   Cosmic-CLP; 1240174
DR   DepMap; ACH-000988
DR   DSMZ; ACC-423
DR   DSMZCellDive; ACC-423
DR   EGA; EGAS00001000978
DR   GDSC; 1240174
DR   GEO; GSM374976
DR   GEO; GSM375435
DR   GEO; GSM887313
DR   GEO; GSM888389
DR   GEO; GSM1670100
DR   IARC_TP53; 28233
DR   LiGeA; CCLE_240
DR   LINCS_LDP; LCL-1502
DR   PharmacoDB; MFE319_921_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2112
DR   Wikidata; Q54905383
RX   PubMed=9620227;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~100 hours (DSMZ=ACC-423).
CC   HLA typing: A*01:01,01:01; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Trp902Ter (c.2706G>A); Zygosity=Heterozygous (Cosmic-CLP=1240174; DepMap=ACH-000988).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (Cosmic-CLP=1240174; DepMap=ACH-000988).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (Cosmic-CLP=1240174; DepMap=ACH-000988).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=2.63%; European, North=66.31%; European, South=31.06% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Cosmic-CLP=1240174; DSMZ=ACC-423
ST   Amelogenin: X
ST   CSF1PO: 10,13 (Cosmic-CLP=1240174)
ST   CSF1PO: 10,14 (DSMZ=ACC-423)
ST   D13S317: 13
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 20,25
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,8.1,12 (DSMZ=ACC-423)
ST   D7S820: 8,12 (Cosmic-CLP=1240174)
ST   D8S1179: 15,16
ST   FGA: 20,21
ST   Penta D: 9,11
ST   Penta E: 18
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18,19,20 (DSMZ=ACC-423)
ST   vWA: 18,20 (Cosmic-CLP=1240174)
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   MFF-1
AC   CVCL_R912
SY   Mandarin Fish Fry-1
DR   Wikidata; Q54905384
RX   PubMed=18485510;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by infectious spleen and kidney necrosis virus (ISKNV) (PubMed=18485510).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 10
//
ID   MFF-8C1
AC   CVCL_1K31
DR   Wikidata; Q54905385
RX   PubMed=24101440;
RX   PubMed=25903999;
CC   Group: Fish cell line.
CC   Group: Vaccine production cell line.
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
HI   CVCL_R912 ! MFF-1
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   MFH-3
AC   CVCL_W489
DR   Wikidata; Q54905386
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   MFH-H
AC   CVCL_M824
DR   Wikidata; Q54905388
RX   PubMed=10470134;
CC   Doubling time: 72 hours (PubMed=10470134).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   MFH-I
AC   CVCL_M790
SY   MFH-1
DR   Wikidata; Q54905389
RX   PubMed=3025391;
CC   Doubling time: 1.1 days (PubMed=3025391).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   MFH-II
AC   CVCL_M791
SY   MFH-2
DR   Wikidata; Q54905390
RX   PubMed=3025391;
CC   Doubling time: 1.4 days (PubMed=3025391).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   MFH-ino
AC   CVCL_1407
SY   MFH-INO; MFHINO
DR   CLO; CLO_0050084
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472224
DR   cancercelllines; CVCL_1407
DR   Cell_Model_Passport; SIDM00299
DR   ChEMBL-Cells; CHEMBL3308269
DR   ChEMBL-Targets; CHEMBL2366262
DR   Cosmic; 925343
DR   Cosmic-CLP; 925343
DR   DepMap; ACH-002271
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10600-108E6
DR   GDSC; 925343
DR   GEO; GSM1670101
DR   IARC_TP53; 27563
DR   LINCS_LDP; LCL-1753
DR   PharmacoDB; MFHino_922_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1407
DR   RCB; RCB0749
DR   Wikidata; Q54905391
RX   PubMed=1653597;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 43 hours (Note=At 41th passage), 32 hours (Note=At 78th passage) (PubMed=1653597).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=925343; DepMap=ACH-002271).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=925343).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.44%; East Asian, South=24.26%; South Asian=0.29%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=925343; RCB=RCB0749
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   MFH-ToE
AC   CVCL_M825
DR   Wikidata; Q54905392
RX   PubMed=10536176;
CC   Population: Japanese.
CC   Doubling time: 37 hours (Note=At 20th passage) (PubMed=10536176).
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   Mfh-val2
AC   CVCL_LF73
SY   mfh-val2; Malignant fibrous histiocytoma-Valencia 2
DR   Wikidata; Q54905393
RX   PubMed=28676915;
CC   Doubling time: 56 hours (PubMed=28676915).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=28676915).
ST   Source(s): PubMed=28676915
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D21S11: 28,31.2
ST   D5S818: 12
ST   D7S820: 9,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   MFH1NR
AC   CVCL_M800
DR   Wikidata; Q54905394
RX   PubMed=6290021;
CC   Transformant: ChEBI; CHEBI_28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   MFHm-2
AC   CVCL_W490
DR   Wikidata; Q54905395
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   MFM-223
AC   CVCL_1408
SY   MFM223
DR   BTO; BTO_0001961
DR   CLO; CLO_0007695
DR   EFO; EFO_0006649
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 943
DR   BioSample; SAMN03473045
DR   BioSample; SAMN03473592
DR   cancercelllines; CVCL_1408
DR   Cell_Model_Passport; SIDM00332
DR   ChEMBL-Cells; CHEMBL3308115
DR   ChEMBL-Targets; CHEMBL1075504
DR   Cosmic; 910948
DR   Cosmic; 2165000
DR   Cosmic-CLP; 910948
DR   DepMap; ACH-001819
DR   DSMZ; ACC-422
DR   DSMZCellDive; ACC-422
DR   ECACC; 98050130
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910948
DR   GEO; GSM344380
DR   GEO; GSM344430
DR   GEO; GSM595616
DR   GEO; GSM783967
DR   GEO; GSM1172985
DR   GEO; GSM1670102
DR   IARC_TP53; 21497
DR   LINCS_LDP; LCL-1318
DR   PharmacoDB; MFM223_923_2019
DR   PRIDE; PXD000309
DR   PRIDE; PXD008222
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1408
DR   PubChem_Cell_line; CVCL_1408
DR   Wikidata; Q54905396
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1913690;
RX   PubMed=20164919;
RX   PubMed=22414580;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 184 hours (Note=At 12th passage), ~70 hours (Note=At 35th passage) (PubMed=1913690); ~5-7 days (DSMZ=ACC-422).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (Cosmic-CLP=910948; DepMap=ACH-001819).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (Cosmic-CLP=910948; DepMap=ACH-001819).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.51%; Native American=0%; East Asian, North=3.43%; East Asian, South=0%; South Asian=1.41%; European, North=55.91%; European, South=38.73% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=910948; DepMap=ACH-001819; DSMZ=ACC-422; ECACC=98050130; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 21
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8 (DSMZ=ACC-422)
ST   D7S820: 8,10 (Cosmic-CLP=910948; DepMap=ACH-001819; ECACC=98050130; PubMed=25877200)
ST   D8S1179: 13,14 (DepMap=ACH-001819)
ST   D8S1179: 14 (DSMZ=ACC-422; PubMed=25877200)
ST   FGA: 19,23
ST   Penta D: 8,9,12
ST   Penta E: 15,17
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   Mfn1-null MEFs
AC   CVCL_L691
DR   ATCC; CRL-2992
DR   Wikidata; Q54905397
RX   PubMed=12527753;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1914664; Mfn1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   Mfn1/Mfn2-null MEFs
AC   CVCL_L692
DR   ATCC; CRL-2994
DR   Wikidata; Q54905398
RX   PubMed=12527753;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1914664; Mfn1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:2442230; Mfn2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   Mfn2-null MEFs
AC   CVCL_L693
DR   ATCC; CRL-2993
DR   Wikidata; Q54905399
RX   PubMed=12527753;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2442230; Mfn2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   MFP-2
AC   CVCL_9V34
DR   NCBI_Iran; C605
DR   Wikidata; Q54905400
RX   Patent=US7220559;
RX   PubMed=12454369;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12482.
CC   Characteristics: Trioma generated by fusing B6B11 to human lymph node lymphocytes (PubMed=12454369).
CC   Doubling time: 20-22 hours (PubMed=12454369).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V32 ! B6B11
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   MFS5
AC   CVCL_B868
SY   MFS 5
DR   NIHhESC; NIHhESC-10-0052
DR   Wikidata; Q54905401
CC   From: Stanford University; Stanford; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0052.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   mFS6
AC   CVCL_L882
SY   FS6
DR   CLO; CLO_0007696
DR   CLDB; cl3460
DR   Wikidata; Q54905402
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 9
//
ID   mFS6 M1
AC   CVCL_E9V9
SY   M1
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M2
AC   CVCL_E9VA
SY   M2
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M3
AC   CVCL_E9VB
SY   M3
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M4
AC   CVCL_E9VC
SY   M4
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M5
AC   CVCL_E9VD
SY   M5
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M6
AC   CVCL_E9VE
SY   M6
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M7
AC   CVCL_E9VF
SY   M7
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M8
AC   CVCL_E9VG
SY   M8
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mFS6 M9
AC   CVCL_E9VH
SY   M9
RX   PubMed=7262148;
RX   PubMed=7426348;
CC   Characteristics: Obtained from lung metastases after one subcutaneous passage of the original tumor in syngeneic mice (PubMed=7262148; PubMed=7426348).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L882 ! mFS6
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MFS8
AC   CVCL_0J40
SY   MFS-8; MFS 8; MFS(8); Mouse FibroSarcoma No. 8
DR   Wikidata; Q54905403
RX   PubMed=5656887;
RX   PubMed=5954138;
RX   PubMed=9753870;
RX   PubMed=13990732;
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   MFS8 clone 1
AC   CVCL_E5EZ
SY   MFS8 Cl1
RX   PubMed=5656887;
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J40 ! MFS8
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFS8 clone 12
AC   CVCL_E5F1
SY   MFS8 Cl12
RX   PubMed=5656887;
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J40 ! MFS8
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFS8 clone 3
AC   CVCL_E5F0
SY   MFS8 Cl3
RX   PubMed=5656887;
CC   Characteristics: Tumorigenic (PubMed=5656887).
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J40 ! MFS8
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFS8 subclone 19
AC   CVCL_E5F4
SY   MFS8 SCl19
RX   PubMed=5656887;
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E5F0 ! MFS8 clone 3
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFS8 subclone 20
AC   CVCL_E5F5
SY   MFS8 SCl19
RX   PubMed=5656887;
CC   Characteristics: Tumorigenic (PubMed=5656887).
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E5F0 ! MFS8 clone 3
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFS8 subclone 5
AC   CVCL_E5F2
SY   MFS8 SCl5
RX   PubMed=5656887;
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E5EZ ! MFS8 clone 1
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFS8 subclone 7
AC   CVCL_E5F3
SY   MFS8 SCl7
RX   PubMed=5656887;
CC   Transformant: ChEBI; CHEBI_142414; 6,12-dimethyldibenzo[d,d']benzo[1,2-b:4,5-b']bisthiophene (6,12-dimethylbenzo(1,2-b:4,5-b')dithionaphthene).
CC   Breed/subspecies: Swiss.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E5EZ ! MFS8 clone 1
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MFT-16
AC   CVCL_XF95
DR   Wikidata; Q95989234
RX   PubMed=9296393;
RX   PubMed=11238446;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98932; Vim.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129S2/SvPas Vimtm1Cba.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   MFT-6
AC   CVCL_XF96
DR   Wikidata; Q95989235
RX   PubMed=9296393;
RX   PubMed=11238446;
CC   Characteristics: Control cell line for MFT-16 (Cellosaurus=CVCL_XF95) which is KO for vimentin (Vim).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   MFUM-BrTNBC-1
AC   CVCL_B5N7
SY   Medical Faculty University of Maribor-Breast Triple Negative Breast Cancer-1
DR   Wikidata; Q112129315
RX   PubMed=31749235;
RX   PubMed=35011679;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian; Slovenian.
CC   Characteristics: Shown by ICC and PCR to be ER-negative, PR-negative and ERBB2-negative (PubMed=35011679).
CC   Doubling time: 80 hours (PubMed=35011679).
CC   Sequence variation: Mutation; HGNC; HGNC:393; AKT3; Simple; p.Lys294Ter (c.880A>T); Zygosity=Heterozygous (PubMed=35011679).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Tyr2037Ter (c.6111C>G); Zygosity=Heterozygous (PubMed=35011679).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly32Arg (c.94G>C); ClinVar=VCV001690925; Zygosity=Heterozygous (PubMed=35011679).
CC   Sequence variation: Mutation; HGNC; HGNC:7993; NRBP1; Simple; p.Lys217Ter (c.649A>T); Zygosity=Heterozygous (PubMed=35011679).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=35011679).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gln829Ter (c.2485C>T); Zygosity=Heterozygous (PubMed=35011679).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=35011679
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 13,14
ST   D21S11: 28,31.2
ST   D2S1338: 22,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MFVD parental
AC   CVCL_A6RJ
SY   Mouse Fetal Vas Deferens parental
DR   Wikidata; Q107116350
RX   PubMed=12639895;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000.
CC   Breed/subspecies: B10/CBA x Tag5 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   18FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   MFVD A5
AC   CVCL_A6RK
SY   MFVD clone A5; Mouse Fetal Vas Deferens clone A5
DR   Wikidata; Q107116352
RX   PubMed=12639895;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000.
CC   Breed/subspecies: B10/CBA x Tag5 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6RJ ! MFVD parental
SX   Male
AG   18FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   MFVD A6
AC   CVCL_A6RL
SY   MFVD clone A6; Mouse Fetal Vas Deferens clone A6
DR   Wikidata; Q107116353
RX   PubMed=12639895;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000.
CC   Breed/subspecies: B10/CBA x Tag5 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   18FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   MFVD E2
AC   CVCL_A6RM
SY   MFVD clone E2; Mouse Fetal Vas Deferens clone E2
DR   Wikidata; Q107116355
RX   PubMed=12639895;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000.
CC   Breed/subspecies: B10/CBA x Tag5 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   18FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   MG-1
AC   CVCL_C8RP
DR   Wikidata; Q123033037
RX   PubMed=2766456;
CC   Characteristics: Transfected with DNA from HT-29 cell line (PubMed=2766456).
CC   Selected for resistance to: ChEBI; CHEBI_3423; Carmustine (BCNU).
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7181 ! CHO-MG
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MG-2
AC   CVCL_C8RQ
DR   Wikidata; Q123033038
RX   PubMed=2766456;
CC   Characteristics: Transfected with DNA from HT-29 cell line (PubMed=2766456).
CC   Selected for resistance to: ChEBI; CHEBI_3423; Carmustine (BCNU).
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7181 ! CHO-MG
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MG-22A
AC   CVCL_U248
SY   MG22A; MG22a
DR   ChEMBL-Cells; CHEMBL3307374
DR   ChEMBL-Targets; CHEMBL614346
DR   PubChem_Cell_line; CVCL_U248
DR   Wikidata; Q54905404
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   MG-3 [Cirrhinus]
AC   CVCL_J029
SY   Mrigal Gill-3
DR   Wikidata; Q54905405
RX   CelloPub=CLPUB00080;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=683832; ! Cirrhinus mrigala (Mrigala)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   MG-3 [Hamster]
AC   CVCL_C8RR
DR   Wikidata; Q123033039
RX   PubMed=2766456;
CC   Characteristics: Transfected with DNA from HT-29 cell line (PubMed=2766456).
CC   Selected for resistance to: ChEBI; CHEBI_3423; Carmustine (BCNU).
CC   Selected for resistance to: ChEBI; CHEBI_43996; Mitoguazone (Methylglyoxal bis-(guanylhydrazone); MGBG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7181 ! CHO-MG
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MG-34
AC   CVCL_LM96
DR   Wikidata; Q54905406
RX   PubMed=883813;
RX   PubMed=1208022;
CC   Doubling time: 39 hours (PubMed=1208022).
DI   NCIt; C6510; Leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 4
//
ID   MG-57
AC   CVCL_LM97
DR   Wikidata; Q54905407
RX   PubMed=218153;
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=218153).
CC   Derived from site: Metastatic; Bone, right humerus; UBERON=UBERON_0000976.
DI   NCIt; C121932; Giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   MG-63
AC   CVCL_0426
SY   M-G63; MG63
DR   BTO; BTO_0001596
DR   CLO; CLO_0007699
DR   CLO; CLO_0007701
DR   CLO; CLO_0050808
DR   EFO; EFO_0002234
DR   MCCL; MCC:0000323
DR   CLDB; cl3462
DR   CLDB; cl3463
DR   CLDB; cl3464
DR   CLDB; cl3465
DR   CLDB; cl4934
DR   AddexBio; C0004007/4991
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1427
DR   BCRC; 60279
DR   BCRJ; 0173
DR   BioSample; SAMN03471910
DR   BioSample; SAMN03472771
DR   BioSample; SAMN10988146
DR   cancercelllines; CVCL_0426
DR   CCRID; 1101HUM-PUMC000080
DR   CCRID; 3101HUMTCHu124
DR   CCRID; 4201HUM-CCTCC00074
DR   CCTCC; GDC0074
DR   Cell_Model_Passport; SIDM00525
DR   ChEMBL-Cells; CHEMBL3308498
DR   ChEMBL-Targets; CHEMBL614347
DR   CLS; 300441
DR   Cosmic; 755310
DR   Cosmic; 908131
DR   Cosmic; 931036
DR   Cosmic; 931913
DR   Cosmic; 1044085
DR   Cosmic; 1070844
DR   Cosmic; 1074394
DR   Cosmic; 1082504
DR   Cosmic; 1188475
DR   Cosmic; 1529903
DR   Cosmic-CLP; 908131
DR   DepMap; ACH-000359
DR   ECACC; 86051601
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS091SUW
DR   ENCODE; ENCBS462PMF
DR   GDSC; 908131
DR   GEO; GSM170251
DR   GEO; GSM320828
DR   GEO; GSM827317
DR   GEO; GSM879217
DR   GEO; GSM887314
DR   GEO; GSM888390
DR   GEO; GSM1670103
DR   GEO; GSM1915004
DR   GEO; GSM1915005
DR   GEO; GSM1915006
DR   GEO; GSM1915007
DR   GEO; GSM1915033
DR   GEO; GSM1915034
DR   GEO; GSM2635311
DR   GEO; GSM2635312
DR   IARC_TP53; 21498
DR   IARC_TP53; 21660
DR   ICLC; HTL99003
DR   IGRhCellID; MG63
DR   IZSLER; BS TCL 40
DR   JCRB; IFO50108
DR   KCB; KCB 200528YJ
DR   KCLB; 21427
DR   LiGeA; CCLE_145
DR   LINCS_LDP; LCL-1428
DR   Lonza; 872
DR   NCBI_Iran; C555
DR   PharmacoDB; MG63_924_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0426
DR   PubChem_Cell_line; CVCL_0426
DR   RCB; RCB1890
DR   TKG; TKG 0294
DR   TOKU-E; 2429
DR   Wikidata; Q54905408
RX   PubMed=218153;
RX   PubMed=883813;
RX   PubMed=1577731;
RX   PubMed=2233717;
RX   PubMed=2823272;
RX   PubMed=7873286;
RX   PubMed=8617485;
RX   PubMed=9144345;
RX   PubMed=9600771;
RX   PubMed=12645653;
RX   PubMed=15736406;
RX   PubMed=17981215;
RX   PubMed=19160414;
RX   PubMed=19363654;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21519327;
RX   PubMed=22460905;
RX   PubMed=23129384;
RX   PubMed=23144859;
RX   PubMed=24903274;
RX   PubMed=25382592;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26320182;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29334376;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=36480329;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-91.html
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Can be induced to differentiate by treating the cells with 1,25-dihydroxyvitamin D3 and TGF-beta. The cells do not differentiate into the mineralized state, but stop at the matrix maturation stage (PubMed=1577731).
CC   Doubling time: 38 hours (PubMed=218153); 28.3 hours (PubMed=19363654); ~48 hours (PubMed=21519327).
CC   HLA typing: A*01:01,01:01; B*08:01,35:08; C*07:01,07:01; DQA1*05:01,05:01; DQB1*02:02,03:04; DRB1*12:05,14:46 (PubMed=26589293).
CC   HLA typing: A*01:01:01; B*08:01:01; C*07:01:01; DPB1*01:01:01,04:02:01; DQA1*05:01:01; DQB1*02:01:01; DRB1*03:01:01 (CLS=300441).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792; ATCC=CRL-1427).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.1%; Native American=0.69%; East Asian, North=2.05%; East Asian, South=0%; South Asian=5.07%; European, North=23.83%; European, South=65.26% (PubMed=30894373).
CC   Anecdotal: Have been flown in space on Foton-10 and Foton-M3 to study if differentiation is altered in microgravity (PubMed=9144345; PubMed=9600771; PubMed=24903274).
CC   Caution: The reported STR profile from CLS of this cell line was changed in June 2019. Seven conflicts with other sources were resolved.
CC   Misspelling: MGG3; PubMed=2823272; Note=In figure 4.
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
ST   Source(s): AddexBio=C0004007/4991; ATCC=CRL-1427; CCRID; CLS=300441; Cosmic-CLP=908131; ECACC=86051601; JCRB=IFO50108; KCLB=21427; PubMed=19787792; PubMed=25877200; RCB=RCB1890; TKG=TKG 0294
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11 (AddexBio=C0004007/4991; ATCC=CRL-1427; CCRID; Cosmic-CLP=908131; ECACC=86051601; PubMed=19787792; PubMed=25877200; RCB=RCB1890; TKG=TKG 0294)
ST   D16S539: 11,12 (CLS=300441; JCRB=IFO50108)
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,25
ST   Penta D: 9,13
ST   Penta E: 11,12
ST   SE33: 20
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   MG-63-GAS-Luc2
AC   CVCL_C9CX
DR   ATCC; CRL-1427-GAS-LUC2
DR   Wikidata; Q123033040
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the gamma-activated site (GAS) promoter (ATCC=CRL-1427-GAS-LUC2).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-1427-GAS-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   MG-63/CISR8
AC   CVCL_C6UW
DR   Wikidata; Q117704695
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   MG-63/DOXR8
AC   CVCL_C6UX
DR   Wikidata; Q117704697
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   MG-63/MTXR8
AC   CVCL_C6UY
DR   Wikidata; Q117704698
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   MG-63/TRIR8
AC   CVCL_C6UZ
DR   Wikidata; Q117704699
RX   PubMed=36480329;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   MG-63.3A
AC   CVCL_IR36
SY   MG63.3A
DR   Wikidata; Q54905409
RX   PubMed=2533054;
RX   PubMed=3068006;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   MG-72
AC   CVCL_LM98
DR   Wikidata; Q54905410
RX   PubMed=218153;
CC   Population: Caucasian.
CC   Doubling time: 91 hours (PubMed=218153).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   MG-S
AC   CVCL_RM09
SY   MGS
DR   Wikidata; Q54905411
RX   CelloPub=CLPUB00414;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7647001;
RX   PubMed=8558913;
RX   PubMed=18397343;
CC   Population: Japanese.
CC   Doubling time: 36 hours (CelloPub=CLPUB00414).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Gln501His (c.1503G>T); ClinVar=VCV000376114; Zygosity=Heterozygous (PubMed=18397343).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Arg657Gln (c.1970G>A); ClinVar=VCV000376113; Zygosity=Heterozygous (PubMed=18397343).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 9
//
ID   MG0
AC   CVCL_E2UY
RX   PubMed=17121794;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97769; Prnp.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Myc.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: PrP0/0.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   MG0001
AC   CVCL_8Y19
DR   ECACC; 00080908
DR   Wikidata; Q54905412
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00080908; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   31Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MG1-ht33
AC   CVCL_UF21
DR   ICLDB; mg1-ht33
DR   Wikidata; Q95989250
RX   PubMed=21667340;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Adapted to growth at 33 Celsius.
CC   Doubling time: 20 hours (PubMed=21667340).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z093 ! BTI-Tn-MG1
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   MG1-ht35
AC   CVCL_UF22
DR   ICLDB; mg1-ht35
DR   Wikidata; Q95989251
RX   PubMed=21667340;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Adapted to growth at 35 Celsius.
CC   Doubling time: 19 hours (PubMed=21667340).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z093 ! BTI-Tn-MG1
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   MG1.19
AC   CVCL_C314
DR   BTO; BTO_0003561
DR   Wikidata; Q54905413
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C313 ! CCE
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   MG1361
AC   CVCL_3404
SY   MG-1361
DR   CLO; CLO_0007697
DR   CLDB; cl3461
DR   ICLC; ATL97003
DR   Wikidata; Q54905414
RX   PubMed=9497105;
CC   Doubling time: 23.8 hours (PubMed=9497105).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Breed/subspecies: (C57BL/6 x DBA)F1 x CD-1 MMTV-neu transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   MG20
AC   CVCL_5T82
DR   Wikidata; Q54905416
RX   PubMed=17121794;
CC   Characteristics: Overexpresses prion protein (PubMed=17121794).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Myc.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: Tga20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   MG38
AC   CVCL_J763
DR   CLO; CLO_0007698
DR   ATCC; CRL-2640
DR   Wikidata; Q54905417
RX   PubMed=10980384;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60449; Human LY75/CD205.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   MG5
AC   CVCL_5556
DR   JCRB; IFO50520
DR   Wikidata; Q54905418
RX   PubMed=9383038;
CC   Doubling time: ~3 days (Note=Lots 12222008 and 02122009), ~82 hours (Note=Lot 02232011), 20-84 hours (Note=Lot 07172017) (JCRB=IFO50520).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   MG6
AC   CVCL_8732
SY   MG6-1
DR   CLO; CLO_0050905
DR   RCB; RCB2403
DR   Wikidata; Q54905419
RX   PubMed=16122875;
RX   PubMed=17121794;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Myc.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   MG63.2
AC   CVCL_R705
DR   Wikidata; Q54905421
RX   PubMed=19363654;
RX   PubMed=26320182;
CC   Population: Caucasian.
CC   Doubling time: 36.1 hours (PubMed=19363654).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   MG63.3
AC   CVCL_WL01
DR   GEO; GSM1915000
DR   GEO; GSM1915001
DR   GEO; GSM1915002
DR   GEO; GSM1915003
DR   GEO; GSM1915030
DR   GEO; GSM1915031
DR   GEO; GSM1915032
DR   GEO; GSM2635313
DR   GEO; GSM2635314
DR   Wikidata; Q95989262
RX   PubMed=26320182;
RX   PubMed=29334376;
CC   Population: Caucasian.
CC   Characteristics: Has a high metastatic potential.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R705 ! MG63.2
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   MG63/DXR1000
AC   CVCL_9U34
DR   Wikidata; Q54905420
RX   PubMed=10854558;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   MG87
AC   CVCL_U510
SY   MG-87; NIH 3T3 subclone MG87
DR   Wikidata; Q54905423
RX   PubMed=1649703;
RX   PubMed=7657612;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-122.html
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   MG87-TrkC
AC   CVCL_C6XZ
DR   Wikidata; Q117704700
RX   PubMed=7657612;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3214; Ntrk3 (Note=Isoform TRKC).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U510 ! MG87
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   MG87-TrkC.ki14
AC   CVCL_C6Y0
DR   Wikidata; Q117704701
RX   PubMed=7657612;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3214; Ntrk3 (Note=Isoform KI14).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U510 ! MG87
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   MG87-TrkC.ki39
AC   CVCL_C6Y1
DR   Wikidata; Q117704702
RX   PubMed=7657612;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3214; Ntrk3 (Note=Isoform KI39).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U510 ! MG87
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   MG87/CD20
AC   CVCL_C6XH
DR   Wikidata; Q117704703
RX   Patent=US8329181;
RX   PubMed=26659273;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7315; MS4A1.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U510 ! MG87
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   MGAR
AC   CVCL_E775
SY   MGar; M GAR
DR   dbMHC; 48970
DR   ECACC; 88022014
DR   IHW; IHW09014
DR   IPD-IMGT/HLA; 11069
DR   Wikidata; Q54905424
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=23619976;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Hispanic.
CC   HLA typing: A*26:01:01:01; B*08:01:01:01; C*07:01:01:01; DPA1*01; DPB1*04:01:01; DQA1*01:02:01; DQB1*06:02:01; DRA*01:02; DRB1*15:01:01; DRB5*01:01:01; DRB6*02:01 (IPD-IMGT/HLA=11069).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   MGC-803
AC   CVCL_5334
SY   MGC803; MGc80-3
DR   BTO; BTO_0004953
DR   EFO; EFO_0006286
DR   ChEMBL-Cells; CHEMBL3706567
DR   ChEMBL-Targets; CHEMBL3706566
DR   Cosmic; 2267321
DR   GEO; GSM844588
DR   GEO; GSM1374671
DR   IARC_TP53; 24858
DR   PubChem_Cell_line; CVCL_5334
DR   Ubigene; YC-C081
DR   Wikidata; Q54905425
RX   CelloPub=CLPUB00751;
RX   DOI=10.1007/BF02948354;
RX   PubMed=24743803;
RX   PubMed=28107433;
RX   PubMed=28851942;
RX   PubMed=29683800;
RX   PubMed=29717028;
RX   PubMed=37543987;
RX   PubMed=38079103;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Seems to be an hybrid of HeLa and probably of a gastric cancer cell from an Asian individual. The STR profile is highly similar to that of HeLa yet shows some specific differences that suggest it is an hybrid cell line (PubMed=37543987; PubMed=38079103). Was originally thought to originate from a 53 year old male patient suffering from a poorly differentiated gastric mucinous adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00588.
CC   Doubling time: ~25 hours (CelloPub=CLPUB00751); 22.5 hours (PubMed=29683800).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3111C0001CCC000227, 3131C0001000700084). They were one of the sources for the STR profile of this entry.
CC   Misspelling: BGC-803; Note=Occasionally.
CC   Misspelling: BGC803; Note=Occasionally.
CC   Misspelling: MCG803; GEO=GSM844588.
ST   Source(s): CCRID; PubMed=28107433; PubMed=28851942; PubMed=37543987; PubMed=38079103
ST   Amelogenin: X
ST   CSF1PO: 9,10,12
ST   D10S1248: 15
ST   D12S391: 17,20,26
ST   D13S317: 7,13.3
ST   D16S539: 9,11
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 12,15,16
ST   D21S11: 27,28
ST   D22S1045: 15,17
ST   D2S1338: 17,24
ST   D2S441: 10,11
ST   D3S1358: 15,18
ST   D5S818: 10,11,12
ST   D6S1043: 18,19
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,10,16,17
ST   TH01: 7,9
ST   TPOX: 12
ST   vWA: 16,17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   MGC-803/5FU
AC   CVCL_UI41
DR   Wikidata; Q95989271
RX   PubMed=24743803;
CC   Problematic cell line: Contaminated. Parent cell line (MGC-803) seems to be a derivative of HeLa and probably of a gastric cancer cell.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5334 ! MGC-803
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   MGC-803/DDP
AC   CVCL_UI42
DR   Wikidata; Q95989272
RX   PubMed=24743803;
CC   Problematic cell line: Contaminated. Parent cell line (MGC-803) seems to be a derivative of HeLa and probably of a gastric cancer cell.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5334 ! MGC-803
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   MGC-803/PTX
AC   CVCL_VG42
SY   MGC803/PTX
DR   Wikidata; Q54905433
RX   PubMed=29683800;
CC   Problematic cell line: Contaminated. Parent cell line (MGC-803) seems to be a derivative of HeLa and probably of a gastric cancer cell.
CC   Doubling time: 24.55 hours (PubMed=29683800).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5334 ! MGC-803
CA   Hybrid cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   MGC-803/TA
AC   CVCL_UI43
DR   Wikidata; Q95989276
RX   PubMed=24743803;
CC   Problematic cell line: Contaminated. Parent cell line (MGC-803) seems to be a derivative of HeLa and probably of a gastric cancer cell.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5334 ! MGC-803
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   mGC11CEA
AC   CVCL_X065
DR   Wikidata; Q54905426
RX   PubMed=16536871;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: C57BL/6-Tg(CEACAM5-Tag)L5496Wzm x C57BL/6-Tg(CEACAM5)2682Wzm transgenic.
DI   NCIt; C24227; Mouse gastric adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   13W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   mGC2CEA
AC   CVCL_X066
DR   Wikidata; Q54905428
RX   PubMed=16536871;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: C57BL/6-Tg(CEACAM5-Tag)L5496Wzm x C57BL/6-Tg(CEACAM5)2682Wzm transgenic.
DI   NCIt; C24227; Mouse gastric adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   13W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   mGC3
AC   CVCL_X067
DR   Wikidata; Q54905429
RX   PubMed=16536871;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: C57BL/6-Tg(CEACAM5-Tag)L5496Wzm transgenic.
DI   NCIt; C24227; Mouse gastric adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   13W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   mGC4CEA
AC   CVCL_X068
DR   Wikidata; Q54905430
RX   PubMed=16536871;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: C57BL/6-Tg(CEACAM5-Tag)L5496Wzm x C57BL/6-Tg(CEACAM5)2682Wzm transgenic.
DI   NCIt; C24227; Mouse gastric adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   13W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   mGC5
AC   CVCL_X069
DR   Wikidata; Q54905431
RX   PubMed=16536871;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: C57BL/6-Tg(CEACAM5-Tag)L5496Wzm transgenic.
DI   NCIt; C24227; Mouse gastric adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   13W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   mGC8
AC   CVCL_X070
DR   Wikidata; Q54905432
RX   PubMed=16536871;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: C57BL/6-Tg(CEACAM5-Tag)L5496Wzm transgenic.
DI   NCIt; C24227; Mouse gastric adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   13W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 8
//
ID   MGE02
AC   CVCL_6B98
DR   Wikidata; Q54905434
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGE12-1
AC   CVCL_6B99
DR   Wikidata; Q54905435
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGE3-2
AC   CVCL_6C00
DR   Wikidata; Q54905436
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGE503
AC   CVCL_6C01
DR   Wikidata; Q54905437
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGE507
AC   CVCL_6C02
DR   Wikidata; Q54905438
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGE509
AC   CVCL_6C03
DR   Wikidata; Q54905439
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGE511
AC   CVCL_6C04
DR   Wikidata; Q54905440
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGE727
AC   CVCL_6C05
DR   Wikidata; Q54905441
RX   PubMed=12743444;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MGEF
AC   CVCL_YS99
SY   Matou Goat Ear Fibroblast
DR   Wikidata; Q95989290
RX   PubMed=19306575;
CC   Doubling time: ~36 hours (PubMed=19306575).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Matou; VBO=VBO_0009447.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   MGG13
AC   CVCL_D1H5
DR   Wikidata; Q127382810
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22067563).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=22067563).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MGG17
AC   CVCL_D1H6
DR   Wikidata; Q127382811
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MGG18
AC   CVCL_D1H7
DR   Wikidata; Q127382812
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4325; Giant cell glioblastoma
DI   ORDO; Orphanet_251579; Giant cell glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   MGG22
AC   CVCL_D1H8
DR   Wikidata; Q127382813
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MGG23
AC   CVCL_D1H9
DR   Wikidata; Q127382814
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22067563).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=22067563).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MGG24
AC   CVCL_D1HA
DR   Wikidata; Q127382816
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MGG27
AC   CVCL_D1HB
DR   Wikidata; Q127382817
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   MGG28
AC   CVCL_D1HC
DR   Wikidata; Q127382818
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22067563).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=22067563).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MGG29
AC   CVCL_D1HD
DR   Wikidata; Q127382819
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MGG32
AC   CVCL_D1HE
DR   Wikidata; Q127382820
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MGG34
AC   CVCL_D1HF
DR   Wikidata; Q127382821
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MGG4
AC   CVCL_D1H1
DR   GEO; GSM1306339
DR   GEO; GSM1306342
DR   GEO; GSM1306377
DR   GEO; GSM1324075
DR   GEO; GSM1324076
DR   GEO; GSM1324077
DR   GEO; GSM1324084
DR   GEO; GSM1324085
DR   GEO; GSM1324086
DR   Wikidata; Q127382822
RX   PubMed=22067563;
RX   PubMed=24726434;
CC   Group: Cancer stem cell line.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   MGG6
AC   CVCL_D1H2
DR   GEO; GSM1306340
DR   GEO; GSM1306343
DR   GEO; GSM1324078
DR   GEO; GSM1324079
DR   GEO; GSM1324080
DR   GEO; GSM1324087
DR   GEO; GSM1324088
DR   GEO; GSM1324089
DR   Wikidata; Q127382823
RX   PubMed=22067563;
RX   PubMed=24726434;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22067563).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=22067563).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MGG7
AC   CVCL_D1H3
DR   Wikidata; Q127382824
RX   PubMed=22067563;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MGG8
AC   CVCL_D1H4
SY   MGG-8
DR   BTO; BTO_0006545
DR   GEO; GSM1306341
DR   GEO; GSM1306344
DR   GEO; GSM1324081
DR   GEO; GSM1324082
DR   GEO; GSM1324083
DR   GEO; GSM1324090
DR   GEO; GSM1324091
DR   GEO; GSM1324092
DR   GEO; GSM1324093
DR   GEO; GSM1324094
DR   GEO; GSM1324095
DR   GEO; GSM1324096
DR   GEO; GSM1324097
DR   Wikidata; Q127382825
RX   PubMed=22067563;
RX   PubMed=24726434;
RX   PubMed=27564115;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22067563).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=22067563).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MGH-13
AC   CVCL_W788
SY   MGH13; Montreal General Hospital-13
DR   Wikidata; Q54905442
RX   PubMed=8097369;
RX   PubMed=8382008;
RX   PubMed=9649128;
RX   PubMed=11369051;
CC   Doubling time: 55 hours (PubMed=8382008).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   MGH-14
AC   CVCL_W789
SY   MGH14; Montreal General Hospital-14
DR   Wikidata; Q54905443
RX   PubMed=8097369;
RX   PubMed=8382008;
CC   Doubling time: 204 hours (PubMed=8382008).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MGH-24
AC   CVCL_W790
SY   MGH24; Montreal General Hospital-24
DR   Wikidata; Q54905444
RX   PubMed=8097369;
RX   PubMed=8382008;
RX   PubMed=9649128;
RX   PubMed=11369051;
CC   Doubling time: 53 hours (PubMed=8382008).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   MGH-26
AC   CVCL_W791
SY   MGH26; Montreal General Hospital-26
DR   Wikidata; Q54905445
RX   PubMed=8097369;
RX   PubMed=8382008;
CC   Doubling time: 134 hours (PubMed=8382008).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   MGH-30
AC   CVCL_W792
SY   MGH30; Montreal General Hospital-30
DR   cancercelllines; CVCL_W792
DR   Wikidata; Q54905447
RX   PubMed=8097369;
RX   PubMed=8382008;
RX   PubMed=9649128;
RX   PubMed=11369051;
CC   Doubling time: 79 hours (PubMed=8382008).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=9649128).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   MGH-4
AC   CVCL_W785
SY   MGH4; Montreal General Hospital-4
DR   Wikidata; Q54905448
RX   PubMed=8097369;
RX   PubMed=8382008;
RX   PubMed=9649128;
RX   PubMed=11369051;
CC   Doubling time: 125 hours (PubMed=8382008).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MGH-7
AC   CVCL_W786
SY   MGH7; Montreal General Hospital-7
DR   Wikidata; Q54905449
RX   PubMed=8097369;
RX   PubMed=8382008;
RX   PubMed=9649128;
RX   PubMed=11369051;
CC   Doubling time: 120 hours (PubMed=8382008).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MGH-8
AC   CVCL_W787
SY   MGH8; Montreal General Hospital-8
DR   cancercelllines; CVCL_W787
DR   Wikidata; Q54905450
RX   PubMed=8097369;
RX   PubMed=8382008;
RX   PubMed=9649128;
RX   PubMed=11369051;
CC   Doubling time: 80 hours (PubMed=8382008).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=9649128).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   MGH-BA-1
AC   CVCL_A651
SY   BA-1
DR   cancercelllines; CVCL_A651
DR   Cosmic; 706099
DR   Cosmic; 897492
DR   Wikidata; Q54905451
RX   PubMed=9692547;
RX   PubMed=10766161;
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Unspecified (PubMed=9692547).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   MGH-BO-1
AC   CVCL_A652
SY   BO-1
DR   cancercelllines; CVCL_A652
DR   Cosmic; 706100
DR   Cosmic; 888841
DR   Cosmic; 897488
DR   Wikidata; Q54905452
RX   PubMed=9692547;
RX   PubMed=10766161;
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   MGH-GO-1
AC   CVCL_W794
DR   cancercelllines; CVCL_W794
DR   Cosmic; 706094
DR   Wikidata; Q54905453
RX   PubMed=10766161;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=10766161).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   MGH-LA-1
AC   CVCL_W795
DR   Cosmic; 706109
DR   Wikidata; Q54905454
RX   PubMed=10766161;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=10766161).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 9
//
ID   MGH-MC-1
AC   CVCL_9878
DR   cancercelllines; CVCL_9878
DR   Cosmic; 888854
DR   Cosmic; 897485
DR   Wikidata; Q54905455
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   MGH-MC-2
AC   CVCL_9879
DR   cancercelllines; CVCL_9879
DR   Cosmic; 706085
DR   Cosmic; 888830
DR   Cosmic; 897470
DR   Wikidata; Q54905457
RX   PubMed=10766161;
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=10766161; PubMed=15009714).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   MGH-mcc1
AC   CVCL_D781
DR   Cosmic; 1693012
DR   Wikidata; Q54905458
RX   PubMed=22261808;
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   MGH-PO-1
AC   CVCL_A653
DR   cancercelllines; CVCL_A653
DR   Cosmic; 706088
DR   Cosmic; 888832
DR   Cosmic; 897472
DR   Wikidata; Q54905459
RX   PubMed=10766161;
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=10766161; PubMed=15009714).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   MGH-U1/OCI
AC   CVCL_LN38
DR   cancercelllines; CVCL_LN38
DR   Wikidata; Q54905460
RX   PubMed=3409229;
CC   Problematic cell line: Contaminated. Parent cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2443 ! Ej138
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   MGH-U2
AC   CVCL_9826
SY   MGHU2; MGH-U2 (HM); HM
DR   BioSample; SAMN03151950
DR   cancercelllines; CVCL_9826
DR   Cosmic; 925831
DR   Wikidata; Q54905461
RX   PubMed=3708594;
RX   PubMed=4027986;
RX   PubMed=11416159;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00081.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 19 hours (PubMed=3708594).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 16,18
ST   D21S11: 29
ST   D8S1179: 14
ST   FGA: 17,22
ST   TH01: 6
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   MGH-U3
AC   CVCL_9827
SY   MGHU3; MG-HU-3; MGH-U3 (RN); RN
DR   BTO; BTO_0006287
DR   cancercelllines; CVCL_9827
DR   Cosmic; 928825
DR   Cosmic; 1016886
DR   Cosmic; 1068090
DR   Cosmic; 1285123
DR   Cosmic; 1286013
DR   Cosmic; 1302361
DR   Cosmic; 1927290
DR   Cosmic; 1938479
DR   Cosmic; 2037951
DR   Cosmic; 2050458
DR   Cosmic; 2686110
DR   GEO; GSM136255
DR   GEO; GSM1374672
DR   GEO; GSM1374673
DR   GEO; GSM1574573
DR   Wikidata; Q54905462
RX   PubMed=4027986;
RX   PubMed=8873383;
RX   PubMed=16885334;
RX   PubMed=19802009;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=27270441;
RX   PubMed=29732388;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:391; AKT1; Simple; p.Glu17Lys (c.49G>A); ClinVar=VCV000013983; Zygosity=Unspecified (PubMed=19802009).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Arg4139Ter (c.12415C>T); ClinVar=VCV000975272; Zygosity=Homozygous (PubMed=27270441).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 8
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 14
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   MGH-U4
AC   CVCL_9828
SY   MGHU4; MG-HU-4; MGH-U4 (RB); RB
DR   BTO; BTO_0006288
DR   BioGRID_ORCS_Cell_line; 1576
DR   cancercelllines; CVCL_9828
DR   Cosmic; 928826
DR   Cosmic; 1016879
DR   Cosmic; 1927291
DR   Cosmic; 2037952
DR   GEO; GSM136256
DR   GEO; GSM1574549
DR   Wikidata; Q54905463
RX   PubMed=4027986;
RX   PubMed=8873383;
RX   PubMed=16885334;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=25336970;
RX   PubMed=25997541;
RX   PubMed=26621286;
RX   PubMed=27270441;
RX   PubMed=29732388;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=27270441).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 8,12
ST   D16S539: 12
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   MGH021-4
AC   CVCL_AY54
DR   Cosmic; 2275266
DR   Wikidata; Q54905464
RX   PubMed=24675041;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   MGH045
AC   CVCL_AY55
DR   Cosmic; 2275265
DR   Wikidata; Q54905465
RX   PubMed=24675041;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   MGH051
AC   CVCL_AY56
DR   Cosmic; 2275267
DR   Wikidata; Q54905469
RX   PubMed=24675041;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   MGH056-1
AC   CVCL_EI95
DR   Cosmic; 2245570
DR   Wikidata; Q54905470
RX   PubMed=25228534;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   MGH119
AC   CVCL_DH47
DR   GEO; GSM1568545
DR   Wikidata; Q54905471
RX   PubMed=25758528;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   MGH119-R
AC   CVCL_DH48
SY   MGH119-GR
DR   GEO; GSM1568546
DR   Wikidata; Q54905472
RX   PubMed=25758528;
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH47 ! MGH119
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   MGH121
AC   CVCL_DH49
DR   GEO; GSM1568547
DR   Wikidata; Q54905473
RX   PubMed=25758528;
RX   PubMed=25964297;
RX   PubMed=26828195;
CC   Characteristics: Erlotinib resistant (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   MGH121 Res#1
AC   CVCL_E4DN
SY   MGH121 Res # 1
RX   PubMed=25964297;
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (PubMed=25964297).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys797Ser (c.2389T>A); ClinVar=VCV000376342; Zygosity=Heterozygous; Note=Responsible for resistance to WZ4002. Located in the same allele as the p.Thr790Met mutation (PubMed=25964297).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH49 ! MGH121
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MGH125
AC   CVCL_DH50
DR   cancercelllines; CVCL_DH50
DR   GEO; GSM1568548
DR   GEO; GSM1579487
DR   Wikidata; Q54905474
RX   PubMed=25758528;
RX   PubMed=26828195;
CC   Characteristics: Erlotinib resistant (PubMed=25758528).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000013071; Zygosity=Heterozygous (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MGH126
AC   CVCL_DH51
DR   GEO; GSM1568549
DR   Wikidata; Q54905475
RX   PubMed=25758528;
CC   Characteristics: Erlotinib resistant (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   MGH131-1
AC   CVCL_DH52
DR   GEO; GSM1568553
DR   GEO; GSM1579486
DR   Wikidata; Q54905476
RX   PubMed=25758528;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH53 ! MGH131-2
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   MGH131-2
AC   CVCL_DH53
DR   GEO; GSM1568554
DR   Wikidata; Q54905477
RX   PubMed=25758528;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH52 ! MGH131-1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   MGH134
AC   CVCL_DH54
DR   cancercelllines; CVCL_DH54
DR   GEO; GSM1568550
DR   Wikidata; Q54905478
RX   PubMed=25758528;
RX   PubMed=26828195;
CC   Characteristics: Erlotinib resistant (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   MGH138
AC   CVCL_E4DQ
RX   PubMed=26828195;
CC   Characteristics: Erlotinib and gefitinib resistant (PubMed=26828195).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=26828195).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=26828195).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MGH141
AC   CVCL_DH55
DR   GEO; GSM1568551
DR   Wikidata; Q54905479
RX   PubMed=25758528;
CC   Characteristics: Erlotinib resistant (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   MGH156
AC   CVCL_DH56
DR   Wikidata; Q54905480
RX   PubMed=25758528;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   MGH157
AC   CVCL_DH57
DR   GEO; GSM1568552
DR   Wikidata; Q54905481
RX   PubMed=25758528;
RX   PubMed=26828195;
CC   Characteristics: Erlotinib resistant (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=25758528).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=25758528).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   MGH164
AC   CVCL_E4DR
RX   PubMed=26828195;
CC   Characteristics: Erlotinib resistant (PubMed=26828195).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=26828195).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=26828195).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MGH9009-1
AC   CVCL_A7PC
DR   Wikidata; Q107116356
RX   PubMed=33007380;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   MGL8
AC   CVCL_D892
SY   MGL-8
DR   BTO; BTO_0005260
DR   Wikidata; Q54905482
RX   PubMed=605378;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   MGLU-2-R
AC   CVCL_XJ75
SY   MGLU
DR   CCLV; CCLV-RIE 1304
DR   Wikidata; Q95989359
RX   PubMed=31513859;
CC   Virology: Susceptible to infection by cowpox virus, murine gammaherpesvirus 68 (MHV-68), Rift Valley fever virus (RVFV), Schmallenberg virus (SBV), Sindbis virus and vaccinia virus.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Eastern lineage.
OX   NCBI_TaxID=447135; ! Myodes glareolus (Bank vole)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   MGLVA1
AC   CVCL_RM03
DR   cancercelllines; CVCL_RM03
DR   Wikidata; Q54905483
RX   PubMed=10562577;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM02 ! MKN45G
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MGM-1
AC   CVCL_W447
SY   Miyazaki Glioblastoma Multiforme-1
DR   Wikidata; Q54905485
RX   PubMed=7556648;
RX   PubMed=9234071;
CC   Population: Japanese.
CC   Doubling time: 42.9 hours (Note=At 25th passage) (PubMed=9234071).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   MGM-2
AC   CVCL_W448
SY   Miyazaki Glioblastoma Multiforme-2
DR   Wikidata; Q54905486
RX   PubMed=7556648;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain, left fronto-parietal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   MGM-3
AC   CVCL_W449
SY   Miyazaki Glioblastoma Multiforme-3
DR   Wikidata; Q54905487
RX   PubMed=7556648;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   MGM-A
AC   CVCL_X197
DR   Wikidata; Q54905488
RX   PubMed=8513002;
RX   PubMed=8519890;
CC   Doubling time: 32 hours (Note=At 38th passage) (PubMed=8513002).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C134773; Gerbil melanoma
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
OI   CVCL_X198 ! MGM-S
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 7
//
ID   MGM-S
AC   CVCL_X198
DR   Wikidata; Q54905489
RX   PubMed=8519890;
DI   NCIt; C134773; Gerbil melanoma
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
OI   CVCL_X197 ! MGM-A
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   MGM18004E
AC   CVCL_A5DP
DR   Wikidata; Q107116358
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-fibroblasts-catalogue-isenet.pdf
CC   Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MGN-2-R
AC   CVCL_XJ76
SY   MGN
DR   CCLV; CCLV-RIE 1494
DR   Wikidata; Q95989368
RX   PubMed=31513859;
CC   Virology: Susceptible to infection by Puumala orthohantavirus (PUUV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Carpathian lineage.
OX   NCBI_TaxID=447135; ! Myodes glareolus (Bank vole)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   MGN3-1
AC   CVCL_C4PL
SY   Mouse GhreliNoma 3-1
DR   Wikidata; Q116049783
RX   PubMed=20375182;
RX   PubMed=21521750;
CC   Characteristics: Secretes substantial amount of ghrelin.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: GP-Tag transgenic.
DI   NCIt; C24219; Mouse gastric neuroendocrine neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   MGPK alphaVbeta6-C5
AC   CVCL_A0GW
SY   MGPKalphaVbeta6-C5; MGPK aVb6-C5; MGPKaVb6-C5
DR   Wikidata; Q108820904
RX   PubMed=34092457;
CC   Problematic cell line: Misidentified. Grand-parent cell line (LF-BK) was originally thought to be of bovine origin but originates from pig.
CC   Virology: Combined treatment of the parent cell line with BVDV NS5A siRNA, interferon alpha and ribavirin has cured the cell line from bovine viral diarrhea virus (BVDV) infection (PubMed=34092457).
CC   Virology: Susceptible to infection by foot-and-mouth disease virus (PubMed=34092457).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30323; Bovine ITGAV.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30331; Bovine ITGB6.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_RX27 ! LFBK-alphaVbeta6
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   MGR1
AC   CVCL_8563
SY   MGR 1; MGR-1; UWR1; UWR-1
DR   EFO; EFO_0022670
DR   cancercelllines; CVCL_8563
DR   IARC_TP53; 26931
DR   Wikidata; Q54905490
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2208164;
RX   PubMed=18505928;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Unspecified (PubMed=18505928).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   MGR2
AC   CVCL_8564
SY   MGR 2; UWR2; UWR-2
DR   EFO; EFO_0022671
DR   cancercelllines; CVCL_8564
DR   IARC_TP53; 26930
DR   Wikidata; Q54905491
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2208164;
RX   PubMed=18505928;
RX   PubMed=19706761;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=18505928).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MGR3
AC   CVCL_8565
SY   MGR 3; UWR3; UWR-3
DR   EFO; EFO_0022618
DR   IARC_TP53; 26926
DR   Wikidata; Q54905492
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=2208164;
RX   PubMed=18505928;
RX   PubMed=19706761;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18505928).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MGS
AC   CVCL_6A84
SY   Mongolian gerbil Gastric epithelial cells with SV-40
DR   Wikidata; Q54905493
RX   DOI=10.1016/S0016-5085(08)83714-6;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
OX   NCBI_TaxID=10047; ! Meriones unguiculatus (Mongolian jird)
SX   Sex unspecified
AG   5W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   mGS-DBA1
AC   CVCL_1T53
DR   RCB; AES0004
DR   RCB; RCB2003
DR   SKIP; SKIP001634
DR   Wikidata; Q54905494
RX   PubMed=15620358;
CC   Discontinued: RCB; RCB2003; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   MGSO-3
AC   CVCL_6847
DR   BTO; BTO_0005047
DR   PRIDE; PXD028400
DR   Wikidata; Q54905495
RX   PubMed=19725227;
RX   PubMed=20422346;
RX   PubMed=20664973;
RX   PubMed=23404580;
RX   PubMed=35666001;
CC   Population: Brazilian.
CC   Characteristics: Original tumor is ER-negative, PR-negative and ERBB2-positive but cell line is triple negative (PubMed=23404580).
CC   Doubling time: 25 hours (PubMed=19725227).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Age at sampling from personal communication of de Goes, Alfredo Miranda.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   MGZ5
AC   CVCL_JX50
DR   Wikidata; Q54905496
RX   PubMed=15741176;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C314 ! MG1.19
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   MGZRTcH2
AC   CVCL_JX51
DR   Wikidata; Q54905497
RX   PubMed=15741176;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JX50 ! MGZ5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   mh
AC   CVCL_6780
AS   CVCL_4242
SY   mocha; Mocha; MOCHA
DR   CLO; CLO_0007706
DR   ATCC; CRL-2709
DR   ECACC; 02111901
DR   Wikidata; Q54905498
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   MH [Human mesothelioma]
AC   CVCL_W085
DR   BioSamples; SAMEA100753
DR   cancercelllines; CVCL_W085
DR   Cosmic; 1522783
DR   GEO; GSM726278
DR   Progenetix; CVCL_W085
DR   Wikidata; Q54905499
RX   PubMed=21642991;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   MH [Human ovarian carcinoma]
AC   CVCL_F845
DR   CGH-DB; 339-2
DR   Cosmic; 931365
DR   Wikidata; Q54905500
RX   PubMed=7844449;
RX   PubMed=8217948;
RX   PubMed=8375936;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Doubling time: ~6.3 days (PubMed=8217948); 36 hours (PubMed=8375936).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   MH-1 [Human lymphoma]
AC   CVCL_H639
SY   MH1
DR   Cosmic; 1086351
DR   Wikidata; Q54905503
RX   CelloPub=CLPUB00081;
RX   PubMed=2456698;
RX   PubMed=8558920;
RX   PubMed=15356658;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   MH-1 [Mouse hybridoma against M.hyorhinis]
AC   CVCL_A0RF
DR   Wikidata; Q108820905
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mesomycoplasma hyorhinis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MH-12
AC   CVCL_AT87
DR   cancercelllines; CVCL_AT87
DR   Cosmic; 888858
DR   Wikidata; Q54905504
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 6
//
ID   MH-17
AC   CVCL_AT88
DR   cancercelllines; CVCL_AT88
DR   Cosmic; 888863
DR   Wikidata; Q54905505
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 6
//
ID   MH-2 [Human melanoma]
AC   CVCL_AT89
DR   cancercelllines; CVCL_AT89
DR   Cosmic; 888859
DR   Wikidata; Q54905506
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 6
//
ID   MH-2 [Mouse hybridoma against M.hyorhinis]
AC   CVCL_A0RG
DR   Wikidata; Q108820906
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mesomycoplasma hyorhinis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MH-22a
AC   CVCL_3854
SY   MH-22A; MH 22A; MH 22a; MH22a; MG XXIIa; Mouse hepatoma 22a
DR   CLO; CLO_0007710
DR   CLO; CLO_0007711
DR   CLDB; cl3472
DR   CLDB; cl5082
DR   ECACC; 96121721
DR   Wikidata; Q54905507
RX   DOI=10.1007/BF00803099;
RX   DOI=10.1134/S1990519X24700214;
RX   DOI=10.37421/2684-4567.2021.5.121;
RX   PubMed=6274791;
RX   PubMed=9123902;
RX   PubMed=15995628;
CC   Characteristics: Highly tumorigenic (PubMed=6274791).
CC   Karyotypic information: Hypotriploid karyotype (DOI=10.37421/2684-4567.2021.5.121).
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
ST   Source(s): DOI=10.1134/S1990519X24700214
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 15,16
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26,27
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_H613 ! H22
OI   CVCL_E7BW ! H22-F25/L
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   MH-22a clone 22/4
AC   CVCL_E7C5
RX   PubMed=15995628;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MH-22a clone 22/5
AC   CVCL_E7C6
RX   PubMed=15995628;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MH-22a clone 22/6
AC   CVCL_E7C7
RX   PubMed=15995628;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MH-22a clone 22/8
AC   CVCL_E7C8
RX   PubMed=15995628;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MH-22a clone 513
AC   CVCL_E7C9
RX   PubMed=15995628;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MH-22a clone 525
AC   CVCL_E7CA
RX   PubMed=15995628;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MH-22a clone 544
AC   CVCL_E7CB
RX   PubMed=15995628;
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3854 ! MH-22a
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MH-3
AC   CVCL_A0RH
DR   Wikidata; Q108820907
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Mesomycoplasma hyorhinis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MH-3924A
AC   CVCL_5799
SY   MH 3924A; MH3924A; MH-3924 A; MH 3924 A; 3924A; Morris hepatoma 3924A; MH-3924; MH3924; MH 3924
DR   BTO; BTO_0000577
DR   ChEMBL-Cells; CHEMBL3307989
DR   ChEMBL-Targets; CHEMBL612581
DR   CLS; 500286
DR   PubChem_Cell_line; CVCL_5799
DR   Wikidata; Q54905508
CC   Doubling time: ~25-35 hours (CLS=500286).
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1Y4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   MH-7777A
AC   CVCL_2113
SY   MH 7777A; MH7777A
DR   BTO; BTO_0000217
DR   CLO; CLO_0007713
DR   DSMZ; ACC-345
DR   DSMZCellDive; ACC-345
DR   Wikidata; Q54905509
RX   PubMed=7498532;
CC   Doubling time: ~48 hours (DSMZ=ACC-345).
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0444 ! McA-RH7777
OI   CVCL_0F78 ! 7777-14b-aza
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   MH-S
AC   CVCL_3855
DR   CLO; CLO_0007721
DR   CLDB; cl3473
DR   CLDB; cl5231
DR   ATCC; CRL-2019
DR   BCRC; 60419
DR   CLS; 300487
DR   ECACC; 95090612
DR   IZSLER; BS CL 141
DR   Wikidata; Q54905511
RX   PubMed=2787372;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: BALB/cJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   MH-SVM16
AC   CVCL_J764
SY   SVM-16
DR   Wikidata; Q54905512
RX   Patent=US4843011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8880.
CC   Monoclonal antibody isotype: IgM, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   MH-SVM23
AC   CVCL_J765
SY   SVM-23
DR   CLO; CLO_0007722
DR   ATCC; HB-8870
DR   Wikidata; Q54905513
RX   Patent=US4843011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8870.
CC   Monoclonal antibody isotype: IgG2, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   MH-SVM25
AC   CVCL_J766
SY   SVM-25
DR   CLO; CLO_0007723
DR   ATCC; HB-8871
DR   Wikidata; Q54905514
RX   Patent=US4843011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8871.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   MH-SVM26
AC   CVCL_J767
SY   SVM-26
DR   CLO; CLO_0007724
DR   ATCC; HB-8872
DR   Wikidata; Q54905515
RX   Patent=US4843011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8872.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   MH-SVM33C9
AC   CVCL_J768
SY   MH-SVM33; SVM-33
DR   CLO; CLO_0007725
DR   ABCD; ABCD_AP547
DR   ATCC; HB-8975
DR   Wikidata; Q54905516
RX   Patent=US4843011;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8975.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   MH-TC-5123
AC   CVCL_5800
DR   CLS; 500287
DR   Wikidata; Q54905517
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   MH/Nike
AC   CVCL_DN29
SY   Nike; Nike/MH; Nike / MH
DR   GEO; GSM1974795
DR   Wikidata; Q54905518
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 25 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:43761; NF1; Simple; p.Ala2176fs (c.6525delG); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235
ST   Dog FHC2054: 164
ST   Dog FHC2079: 275,291
ST   Dog PEZ1: 115
ST   Dog PEZ3: 119,139
ST   Dog PEZ5: 107,115
ST   Dog PEZ6: 167,187
ST   Dog PEZ8: 240
ST   Dog PEZ12: 270,274
ST   Dog PEZ20: 176
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   MH01
AC   CVCL_J222
DR   ECACC; 93062401
DR   Wikidata; Q54905519
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   MH1
AC   CVCL_J223
SY   F492D8
DR   CLO; CLO_0007708
DR   Wikidata; Q54905520
RX   Patent=US5091512;
RX   Patent=US5120834;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9739.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   MH1-BS
AC   CVCL_M227
DR   Wikidata; Q54905521
RX   PubMed=3030788;
CC   Population: African American.
CC   Doubling time: 44 hours (PubMed=3030788).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Asn515Lysfs*2 (c.1544dupA) (1610insA); ClinVar=VCV000042064; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Gln752Ter (c.2328C>T); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV7).
CC   Donor information: From Bloom Syndrome Registry patient 71(HaEn) (BSR71).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J657 ! GM02548
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 22
//
ID   MH11
AC   CVCL_8893
DR   Wikidata; Q54905522
RX   PubMed=1283157;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MH11
CC   Characteristics: Requires feeder cells. Maintenance of MH11 depends on the presence of cell line ST2 (Cellosaurus=CVCL_2205).
CC   Characteristics: IL7 dependent.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Factor-dependent cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   MH129
AC   CVCL_8110
SY   MH-129; MH 129
DR   Wikidata; Q54905523
CC   Breed/subspecies: C3H/He.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   MH129F-TC
AC   CVCL_8Z12
SY   MH129F
DR   TKG; TKG 0159
DR   TKG; TKG 0569
DR   Wikidata; Q54905524
CC   Breed/subspecies: C3H/He.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8110 ! MH129
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 3
//
ID   MH129P-TC
AC   CVCL_8Z13
SY   MH129P
DR   TKG; TKG 0160
DR   TKG; TKG 0570
DR   Wikidata; Q54905525
CC   Breed/subspecies: C3H/He.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8110 ! MH129
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 3
//
ID   MH134-TC
AC   CVCL_8111
SY   MH-134; MH 134; MH134
DR   BTO; BTO_0001083
DR   TKG; TKG 0161
DR   TKG; TKG 0568
DR   Wikidata; Q54905526
CC   Breed/subspecies: C3H/He.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   MH161H
AC   CVCL_C6JE
DR   Wikidata; Q116049784
RX   PubMed=1368752;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P00588; Corynephage beta diphtheria toxin.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MH1C1
AC   CVCL_2114
SY   MH1-C1; MH 1 C 1
DR   BTO; BTO_0000220
DR   CLO; CLO_0007707
DR   CLO; CLO_0007709
DR   CLDB; cl3474
DR   CLDB; cl3475
DR   CLDB; cl3476
DR   CLDB; cl3477
DR   CLDB; cl4918
DR   ATCC; CCL-144
DR   BCRC; 60143
DR   ChEMBL-Cells; CHEMBL3307375
DR   ChEMBL-Targets; CHEMBL614349
DR   DSMZ; ACC-106
DR   DSMZCellDive; ACC-106
DR   ECACC; 85112702
DR   GEO; GSM1240490
DR   GEO; GSM1240491
DR   GEO; GSM1240492
DR   GEO; GSM1240493
DR   GEO; GSM1240494
DR   GEO; GSM1240495
DR   GEO; GSM1240496
DR   GEO; GSM1240497
DR   GEO; GSM1240498
DR   GEO; GSM1240499
DR   GEO; GSM1240500
DR   GEO; GSM1240501
DR   ICLC; ATL98014
DR   IZSLER; BS TCL 41
DR   PubChem_Cell_line; CVCL_2114
DR   Wikidata; Q54905527
RX   PubMed=3431441;
RX   PubMed=4177659;
RX   PubMed=4194308;
RX   PubMed=4327442;
RX   PubMed=4399803;
RX   PubMed=24386269;
CC   Characteristics: Produces albumin and secretes it into the culture medium (PubMed=4177659).
CC   Characteristics: Derived from the transplantable Morris hepatoma 7795 (PubMed=4177659).
CC   Doubling time: 1 week (PubMed=4177659); ~33-60 hours (DSMZ=ACC-106).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 85112702; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   MH2-FA
AC   CVCL_M228
DR   Wikidata; Q54905528
RX   PubMed=3030788;
CC   Population: Arab.
CC   Doubling time: 69 hours (PubMed=3030788).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV7).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F593 ! GM02053
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   MH3-XPD
AC   CVCL_M229
DR   Wikidata; Q54905529
RX   PubMed=3030788;
CC   Doubling time: 32 hours (PubMed=3030788).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV7).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L754 ! XP3NE
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   MH55
AC   CVCL_J224
SY   MH 55
DR   CLO; CLO_0007712
DR   Wikidata; Q54905501
RX   Patent=US4666845;
RX   Patent=WO1996040295A1;
RX   PubMed=6582512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8412.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   MH60.BSF2
AC   CVCL_7201
SY   MH60.BSF-2; MH60-BSF-2; MH60
DR   ChEMBL-Cells; CHEMBL3307376
DR   ChEMBL-Targets; CHEMBL614350
DR   PubChem_Cell_line; CVCL_7201
DR   TKG; TKG 0226
DR   Wikidata; Q54905530
RX   PubMed=3260187;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MH60-BSF-2
CC   Characteristics: IL6 dependent.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P05231; Human IL6.
CC   Discontinued: TKG; TKG 0226; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   MH7A
AC   CVCL_0427
DR   BTO; BTO_0003437
DR   CLO; CLO_0050142
DR   MCCL; MCC:0000324
DR   BioSample; SAMN03472146
DR   RCB; RCB1512
DR   Wikidata; Q54905531
RX   PubMed=9832620;
RX   PubMed=20697895;
CC   Population: Japanese.
CC   Characteristics: Resveratrol induces apoptosis in MH7A cells (PubMed=20697895).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
CC   Cell type: Fibroblast-like synoviocyte; CL=CL_0002301.
ST   Source(s): RCB=RCB1512
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8
ST   D16S539: 10,11
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   MH94
AC   CVCL_J844
SY   MH 94
DR   Wikidata; Q54905502
RX   Patent=US4666845;
RX   Patent=WO1996040295A1;
RX   PubMed=3894261;
RX   PubMed=6582512;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8413.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   MH99
AC   CVCL_C5W0
DR   Wikidata; Q116049785
RX   Patent=WO1996040295A1;
RX   PubMed=3196032;
RX   PubMed=3894261;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8406.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MHCC97
AC   CVCL_4971
SY   MHCC-97; MHCC 97
DR   BTO; BTO_0004168
DR   GEO; GSM1374674
DR   Wikidata; Q54905532
RX   PubMed=10555751;
RX   PubMed=32884988;
CC   Population: Chinese.
CC   Doubling time: ~31 hours (PubMed=10555751).
CC   Karyotypic information: Has lost chromosome Y.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   MHCC97-H
AC   CVCL_4972
SY   MHCC 97-H; MHCC-97H; MHCC97H; MHCC 97-High metastatic
DR   BTO; BTO_0004169
DR   cancercelllines; CVCL_4972
DR   ChEMBL-Cells; CHEMBL4295459
DR   ChEMBL-Targets; CHEMBL4296470
DR   GEO; GSM501782
DR   GEO; GSM936771
DR   GEO; GSM1374675
DR   GEO; GSM2551579
DR   LIMORE; MHCC97H
DR   PRIDE; PXD000529
DR   PRIDE; PXD000533
DR   PRIDE; PXD000535
DR   PRIDE; PXD002453
DR   PRIDE; PXD005291
DR   PubChem_Cell_line; CVCL_4972
DR   Wikidata; Q54905533
RX   PubMed=11819844;
RX   PubMed=15048980;
RX   PubMed=15146329;
RX   PubMed=23505090;
RX   PubMed=25690035;
RX   PubMed=25886575;
RX   PubMed=31063779;
RX   PubMed=31378681;
RX   PubMed=32884988;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/MHCC97H
WW   Provider; BRICS; BRICS0079; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3893
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Chinese.
CC   Characteristics: High metastatic potential (PubMed=11819844).
CC   Doubling time: 34.2 hours (PubMed=11819844); 28.79 hours (PubMed=31378681).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11.3
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4971 ! MHCC97
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 23
//
ID   MHCC97-H c-Met shRNA
AC   CVCL_VU22
SY   MHCC97-H c-Met KD
DR   cancercelllines; CVCL_VU22
DR   GEO; GSM940343
DR   GEO; GSM940344
DR   GEO; GSM940345
DR   Wikidata; Q95989434
RX   PubMed=25886575;
RX   PubMed=26000702;
CC   Population: Chinese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   MHCC97-H CD44s shRNA
AC   CVCL_VU23
DR   cancercelllines; CVCL_VU23
DR   GEO; GSM940337
DR   GEO; GSM940338
DR   GEO; GSM940339
DR   Wikidata; Q95989435
RX   PubMed=25886575;
CC   Population: Chinese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:1681; CD44.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   MHCC97-H Scrm shRNA
AC   CVCL_VU24
SY   MHCC97-H scrambled shRNA; MHCC97-H shRNA control
DR   cancercelllines; CVCL_VU24
DR   GEO; GSM940340
DR   GEO; GSM940341
DR   GEO; GSM940342
DR   Wikidata; Q95989436
RX   PubMed=25886575;
RX   PubMed=26000702;
CC   Population: Chinese.
CC   Characteristics: Transfected with a scrambled shRNA, control cell line for MHCC97-H CD44s shRNA (Cellosaurus=CVCL_VU23) and MHCC97-H c-Met shRNA (Cellosaurus=CVCL_VU22).
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   MHCC97-L
AC   CVCL_4973
SY   MHCC 97-L; MHCC97L; MHCC 97-Low metastatic
DR   BTO; BTO_0004170
DR   Cosmic; 2773183
DR   GEO; GSM501783
DR   GEO; GSM936772
DR   GEO; GSM1374676
DR   Wikidata; Q54905534
RX   PubMed=11819844;
RX   PubMed=15048980;
RX   PubMed=15146329;
RX   PubMed=23505090;
RX   PubMed=32884988;
CC   Population: Chinese.
CC   Characteristics: Low metastatic potential (PubMed=11819844).
CC   Doubling time: 60.0 hours (PubMed=11819844).
CC   Karyotypic information: Has lost chromosome Y.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4971 ! MHCC97
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   MHCC97H-GFP-LC3
AC   CVCL_A9LY
DR   cancercelllines; CVCL_A9LY
DR   CCRID; 4201PAT-CCTCC00404
DR   Wikidata; Q108820908
RX   Patent=CN102115730A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201097.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6838; MAP1LC3A.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   MHCF1
AC   CVCL_E2YB
SY   Mouse liver tumor cells derived from HCV full-length Tg No. 1
RX   PubMed=34158541;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P26662; Hepatitis C virus genotype 1b genome polyprotein.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Donor mouse was fed a atherogenic and high-fat diet (Ath+HFD).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: HCV-Tg.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   MHCF5
AC   CVCL_E2YC
RX   PubMed=34158541;
CC   Characteristics: Established after repeatedly transplanting the parent cell line into NOD-SCID mice. The developed tumors were dissociated and passaged on culture dishes several times (PubMed=34158541).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P26662; Hepatitis C virus genotype 1b genome polyprotein.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: HCV-Tg.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E2YB ! MHCF1
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   MhCT08-E
AC   CVCL_B7GX
SY   MhCT08 epithelial
DR   Wikidata; Q112930114
RX   PubMed=35796014;
CC   Population: Indian.
CC   Doubling time: 23.61 +- 1.32 hours (PubMed=35796014).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=35796014
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 28,30
ST   D5S818: 11
ST   D7S820: 7,8
ST   TH01: 6,8
ST   TPOX: 12
ST   vWA: 15,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7GY ! MhCT08-F
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   MhCT08-F
AC   CVCL_B7GY
SY   MhCT08 fibroblast
DR   Wikidata; Q112930115
RX   PubMed=35796014;
CC   Population: Indian.
CC   Doubling time: 32.23 +- 0.91 hours (PubMed=35796014).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=35796014
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D21S11: 28,30
ST   D5S818: 11
ST   D7S820: 7,8
ST   TH01: 6,8
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7GX ! MhCT08-E
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   MhCT12-E
AC   CVCL_B7GZ
SY   MhCT12 epithelial
DR   Wikidata; Q112930116
RX   PubMed=35796014;
CC   Population: Indian.
CC   Doubling time: 25.54 +- 0.64 hours (PubMed=35796014).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=35796014
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D21S11: 31,32.2
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7H0 ! MhCT12-F
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   MhCT12-F
AC   CVCL_B7H0
SY   MhCT12 fibroblast
DR   Wikidata; Q112930117
RX   PubMed=35796014;
CC   Population: Indian.
CC   Doubling time: 39.73 +- 1.35 hours (PubMed=35796014).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=35796014
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D21S11: 31,32.2
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 3,8
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7GZ ! MhCT12-E
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   MHEC5-T
AC   CVCL_2115
SY   Mouse Heart Endothelial Cell clone 5-Transformed
DR   CLO; CLO_0007714
DR   DSMZ; ACC-336
DR   DSMZCellDive; ACC-336
DR   Wikidata; Q54905535
RX   PubMed=7655744;
CC   Doubling time: ~30 hours (DSMZ=ACC-336).
CC   Derived from site: In situ; Heart, myocardium; UBERON=UBERON_0002349.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MHFB-1
AC   CVCL_WB45
DR   IBRC; C11179
DR   Wikidata; Q95989440
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MHG-8
AC   CVCL_B0G9
SY   MHGARP8
DR   Wikidata; Q108820910
RX   Patent=US10822424;
RX   PubMed=25904740;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 10246CB.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14392; Human LRRC32.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B0G8 ! Sp2/neo
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MHH-CALL-2
AC   CVCL_1409
SY   Mhh-Call 2; MHH-CALL2; MHHCALL2
DR   CLO; CLO_0007715
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473355
DR   BioSample; SAMN10988567
DR   cancercelllines; CVCL_1409
DR   Cell_Model_Passport; SIDM00331
DR   ChEMBL-Cells; CHEMBL3308333
DR   ChEMBL-Targets; CHEMBL2366286
DR   Cosmic; 908132
DR   Cosmic; 1012089
DR   Cosmic; 1130251
DR   Cosmic; 1524803
DR   Cosmic; 1943387
DR   Cosmic; 2491071
DR   Cosmic-CLP; 908132
DR   DepMap; ACH-000020
DR   DSMZ; ACC-341
DR   DSMZCellDive; ACC-341
DR   EGA; EGAS00001000978
DR   GDSC; 908132
DR   GEO; GSM236789
DR   GEO; GSM236825
DR   GEO; GSM887315
DR   GEO; GSM888391
DR   GEO; GSM931335
DR   GEO; GSM1670104
DR   GEO; GSM5137724
DR   IARC_TP53; 21499
DR   LiGeA; CCLE_318
DR   LINCS_LDP; LCL-1009
DR   PharmacoDB; MHHCALL2_925_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_1409
DR   PubChem_Cell_line; CVCL_1409
DR   Wikidata; Q54905536
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9067587;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~100 hours (DSMZ=ACC-341).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.65%; Native American=0%; East Asian, North=2.18%; East Asian, South=0%; South Asian=0%; European, North=73.49%; European, South=22.68% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=908132; DSMZ=ACC-341
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8
ST   D16S539: 14
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   MHH-CALL-3
AC   CVCL_0089
SY   Mhh-Call 3; MHH cALL 3; MHH-CALL3; MHH-cALL3; MHHCALL3
DR   CLO; CLO_0007716
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473353
DR   BioSample; SAMN10988500
DR   cancercelllines; CVCL_0089
DR   Cell_Model_Passport; SIDM01693
DR   Cosmic; 1281374
DR   Cosmic; 1524844
DR   Cosmic; 2491072
DR   DepMap; ACH-000032
DR   DSMZ; ACC-339
DR   DSMZCellDive; ACC-339
DR   GEO; GSM236790
DR   GEO; GSM236826
DR   GEO; GSM887316
DR   GEO; GSM888392
DR   GEO; GSM5137725
DR   IARC_TP53; 30121
DR   LiGeA; CCLE_376
DR   PharmacoDB; MHHCALL3_926_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_0089
DR   Wikidata; Q54905537
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9067587;
RX   PubMed=15843827;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~120 hours (DSMZ=ACC-339).
CC   HLA typing: A*02:01,29:02; B*44:02,44:02; C*05:01,16:01 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=15843827; PubMed=35354797; DepMap=ACH-000032).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.15%; Native American=1.07%; East Asian, North=0.95%; East Asian, South=0%; South Asian=0%; European, North=66.38%; European, South=31.45% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-339
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 17,18
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 9,12
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 7
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   MHH-CALL-4
AC   CVCL_1410
SY   MHH-CALL4; MHHCALL4
DR   CLO; CLO_0007717
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473351
DR   BioSample; SAMN10988510
DR   cancercelllines; CVCL_1410
DR   Cell_Model_Passport; SIDM00376
DR   Cosmic; 908133
DR   Cosmic; 1012090
DR   Cosmic; 1278370
DR   Cosmic; 1524804
DR   Cosmic; 2759716
DR   Cosmic-CLP; 908133
DR   DepMap; ACH-000156
DR   DSMZ; ACC-337
DR   DSMZCellDive; ACC-337
DR   EGA; EGAS00001000978
DR   GEO; GSM887317
DR   GEO; GSM888393
DR   GEO; GSM1670105
DR   GEO; GSM5137726
DR   IARC_TP53; 21500
DR   LiGeA; CCLE_066
DR   PharmacoDB; MHHCALL4_927_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1410
DR   Wikidata; Q54905538
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~80-100 hours (DSMZ=ACC-337).
CC   HLA typing: A*03:01,24:02; B*07:02,37:01; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Leu23Arg (c.68T>G); ClinVar=VCV000180860; Zygosity=Heterozygous (Cosmic-CLP=908133; DepMap=ACH-000156).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=0.15%; East Asian, South=1.34%; South Asian=1.97%; European, North=65.48%; European, South=30.81% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=908133; DSMZ=ACC-337
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 13,15
ST   D19S433: 15,17
ST   D21S11: 29,31.2
ST   D2S1338: 17
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   MHH-ES-1
AC   CVCL_1411
SY   MHH-ES1; MHHES1
DR   CLO; CLO_0007718
DR   EFO; EFO_0006650
DR   CLDB; cl3478
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 185
DR   BioSample; SAMN03471911
DR   BioSample; SAMN03473362
DR   BioSample; SAMN10988548
DR   cancercelllines; CVCL_1411
DR   Cell_Model_Passport; SIDM00386
DR   ChEMBL-Cells; CHEMBL3308762
DR   ChEMBL-Targets; CHEMBL1075505
DR   CLS; 300136
DR   Cosmic; 908134
DR   Cosmic; 1718436
DR   Cosmic; 2250463
DR   Cosmic-CLP; 908134
DR   DepMap; ACH-000391
DR   DSMZ; ACC-167
DR   DSMZCellDive; ACC-167
DR   EGA; EGAS00001000610
DR   GDSC; 908134
DR   GEO; GSM887318
DR   GEO; GSM888394
DR   GEO; GSM1670106
DR   GEO; GSM5359670
DR   GEO; GSM5359671
DR   GEO; GSM5359672
DR   GEO; GSM5359673
DR   GEO; GSM5359674
DR   GEO; GSM5359675
DR   GEO; GSM5362922
DR   GEO; GSM5362923
DR   GEO; GSM5362924
DR   GEO; GSM5362925
DR   GEO; GSM5362926
DR   GEO; GSM5362927
DR   GEO; GSM5363976
DR   GEO; GSM5363977
DR   GEO; GSM5363978
DR   GEO; GSM5363979
DR   GEO; GSM5363980
DR   IARC_TP53; 21501
DR   LiGeA; CCLE_341
DR   LINCS_LDP; LCL-1454
DR   PharmacoDB; MHHES1_928_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1411
DR   PubChem_Cell_line; CVCL_1411
DR   Wikidata; Q54905539
RX   DOI=10.1016/0165-4608(89)90568-2;
RX   DOI=10.5282/edoc.27750;
RX   PubMed=20164919;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=25223734;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Population: Caucasian.
CC   Doubling time: ~28 hours (DSMZ=ACC-167).
CC   HLA typing: A*01:01,68:01; B*40:01,49:01; C*01:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=25485619; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln735fs; Zygosity=Unspecified (PubMed=25223734).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215del (c.643_645delAGT); Zygosity=Unspecified (PubMed=25223734).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.53%; Native American=0.83%; East Asian, North=4.32%; East Asian, South=3.68%; South Asian=6.47%; European, North=41.94%; European, South=41.22% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CLS=300136; Cosmic-CLP=908134; DSMZ=ACC-167; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8 (CLS=300136; PubMed=25877200)
ST   D13S317: 8,13 (Cosmic-CLP=908134; DSMZ=ACC-167)
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 11,15
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   MHH-MED-1
AC   CVCL_7988
SY   MHH-Med-1; MHH-MED1; MED1
DR   cancercelllines; CVCL_7988
DR   Cosmic; 975026
DR   Cosmic; 2362654
DR   GEO; GSM383764
DR   GEO; GSM919362
DR   Progenetix; CVCL_7988
DR   Wikidata; Q54905540
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8205550;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 72 +- 9.8 hours (PubMed=8205550).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Misspelling: mhh-1; GEO=GSM383764.
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   MHH-MED-2
AC   CVCL_7989
SY   MHH-MED2
DR   Cosmic; 2362655
DR   Wikidata; Q54905541
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8205550;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 119 +- 26.3 hours (PubMed=8205550).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C129445; Medulloblastoma, non-WNT/non-SHH, group 3
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   MHH-MED-3
AC   CVCL_7990
SY   MHH-MED3
DR   Cosmic; 2362656
DR   Wikidata; Q54905542
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8205550;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   MHH-MED-4
AC   CVCL_7991
SY   MHH-MED4
DR   Wikidata; Q54905543
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8205550;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 61 +- 15.3 hours (PubMed=8205550).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   MHH-NB-11
AC   CVCL_1412
SY   MHH-NB11; MHHNB11
DR   CLO; CLO_0007719
DR   EFO; EFO_0006651
DR   CLDB; cl3479
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 546
DR   BioSample; SAMN03473088
DR   BioSample; SAMN10988427
DR   cancercelllines; CVCL_1412
DR   Cell_Model_Passport; SIDM00387
DR   ChEMBL-Cells; CHEMBL3308310
DR   ChEMBL-Targets; CHEMBL2366185
DR   Cosmic; 908135
DR   Cosmic; 2485948
DR   Cosmic-CLP; 908135
DR   DepMap; ACH-000078
DR   DSMZ; ACC-157
DR   DSMZCellDive; ACC-157
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908135
DR   GEO; GSM887319
DR   GEO; GSM888395
DR   GEO; GSM1366409
DR   GEO; GSM1670107
DR   GEO; GSM3145573
DR   GEO; GSM3145723
DR   IARC_TP53; 21502
DR   LiGeA; CCLE_041
DR   LINCS_LDP; LCL-1975
DR   PharmacoDB; MHHNB11_929_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1412
DR   PubChem_Cell_line; CVCL_1412
DR   Wikidata; Q54905545
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=3218965;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=3218965); ~100 hours (DSMZ=ACC-157).
CC   HLA typing: A*02:01,03:01; B*40:16,40:16; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.35%; Native American=0%; East Asian, North=1.33%; East Asian, South=0%; South Asian=2.27%; European, North=69.36%; European, South=26.69% (PubMed=30894373).
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Cosmic-CLP=908135; DSMZ=ACC-157; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 16,17
ST   D19S433: 13,17
ST   D21S11: 30,31.2
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,12
ST   Penta E: 5,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   MHH-PNET-5
AC   CVCL_7992
DR   Wikidata; Q54905546
RX   PubMed=8205550;
CC   Doubling time: 96 +- 6.8 hours (PubMed=8205550).
DI   NCIt; C5406; Spinal cord embryonal tumor, not otherwise specified
DI   ORDO; Orphanet_251870; Central nervous system embryonal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   MHH-PREB-1
AC   CVCL_1413
SY   MHHPREB1
DR   CLO; CLO_0007720
DR   EFO; EFO_0002235
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471645
DR   BioSample; SAMN03473315
DR   cancercelllines; CVCL_1413
DR   Cell_Model_Passport; SIDM00388
DR   ChEMBL-Cells; CHEMBL3308334
DR   ChEMBL-Targets; CHEMBL2366127
DR   Cosmic; 908136
DR   Cosmic; 2276316
DR   Cosmic; 2491097
DR   Cosmic-CLP; 908136
DR   DepMap; ACH-002272
DR   DSMZ; ACC-354
DR   DSMZCellDive; ACC-354
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 908136
DR   GEO; GSM1670108
DR   IARC_TP53; 21503
DR   IGRhCellID; MHHPREB1
DR   LINCS_LDP; LCL-1140
DR   PharmacoDB; MHHPREB1_930_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1413
DR   PubChem_Cell_line; CVCL_1413
DR   Wikidata; Q54905548
RX   PubMed=9067587;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~20-40 hours (DSMZ=ACC-354).
CC   HLA typing: A*02:01,02:01; B*35:03,35:03; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (Cosmic-CLP=908136; DepMap=ACH-002272).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.87%; Native American=0.19%; East Asian, North=2.12%; East Asian, South=0.44%; South Asian=1.83%; European, North=34.51%; European, South=59.05% (PubMed=30894373).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=908136; DSMZ=ACC-354; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 8,13
ST   D18S51: 11,17,18 (DSMZ=ACC-354)
ST   D18S51: 11,18 (PubMed=25877200)
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 17,19
ST   D5S818: 11,13 (DSMZ=ACC-354; PubMed=25877200)
ST   D5S818: 11,13,14 (Cosmic-CLP=908136)
ST   D7S820: 11,12 (Cosmic-CLP=908136; DSMZ=ACC-354)
ST   D7S820: 11,12.3 (PubMed=25877200)
ST   D8S1179: 10,16
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 7,16
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 15,20
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   MHH-TALL-1
AC   CVCL_9824
SY   MHH-TALL1
DR   Cosmic; 1281375
DR   Cosmic; 1498421
DR   Cosmic; 2602921
DR   Wikidata; Q54905549
RX   PubMed=9697876;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   MHH-TALL-2
AC   CVCL_9825
SY   MHH-TALL2
DR   Cosmic; 1281376
DR   Cosmic; 2602922
DR   DSMZ; ACC-728
DR   DSMZCellDive; ACC-728
DR   Wikidata; Q54905550
RX   PubMed=9697876;
CC   Doubling time: ~60-72 hours (DSMZ=ACC-728).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-728
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 10,12
ST   D19S433: 13,16
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 21,26
ST   Penta D: 9,11
ST   Penta E: 14,17
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 17
//
ID   MHH225
AC   CVCL_8894
SY   MHH-225; MHH 225
DR   BioSample; SAMN03151807
DR   cancercelllines; CVCL_8894
DR   Wikidata; Q54905551
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7548328;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 60 year old male patient with acute myeloid leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00238.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 28
//
ID   MHHi001-A
AC   CVCL_QX51
SY   hHSC_Iso4_ADCF_SeV-iPS2 (Phoenix); hHSC_Iso4_ADCF_SeViPS2 (Phoenix); hHSCSeViPS2; Phoenix
DR   BioSamples; SAMEA4564584
DR   hPSCreg; MHHi001-A
DR   Wikidata; Q54905552
RX   PubMed=28677540;
RX   PubMed=29681541;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 8
//
ID   MHHi001-A-1
AC   CVCL_C4P8
SY   TT#5_K3; #5_TMEM16A_K3
DR   hPSCreg; MHHi001-A-1
DR   Wikidata; Q116049786
RX   PubMed=36162332;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MHHi001-A-10
AC   CVCL_C6TV
SY   hiPSC Arclight/Neo; Arclight hiPSC
DR   hPSCreg; MHHi001-A-10
DR   Wikidata; Q117704704
RX   PubMed=36463634;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using TALEN the voltage-sensor (GEVI) Arclight A242 and antibiotic resistance genes under the control of the cardiac-specific myosin heavy chain promoter (pCAG-Arclight-alphaMHC-Neo-PGKp-HygroR construct) were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=36463634).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=Ciona intestinalis Arclight A242 (Note=Fluorescent voltage sensor).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   MHHi001-A-12
AC   CVCL_D6KV
SY   Phx_SRCAP_g3_1200_4; UMGWi003-A-12
DR   BioSamples; SAMEA114222272
DR   hPSCreg; MHHi001-A-12
DR   Wikidata; Q127382826
RX   PubMed=38006676;
CC   From: Department of Functional Genomics - Human Molecular Genetics, University Medicine Greifswald; Greifswald; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16974; SRCAP.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C175241; Floating-Harbor syndrome
DI   ORDO; Orphanet_2044; Floating-Harbor syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MHHi001-A-13
AC   CVCL_D6KW
SY   Phx_SRCAP_g3_1200_7; UMGWi003-A-13
DR   BioSamples; SAMEA114222273
DR   hPSCreg; MHHi001-A-13
DR   Wikidata; Q127382827
RX   PubMed=38006676;
CC   From: Department of Functional Genomics - Human Molecular Genetics, University Medicine Greifswald; Greifswald; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16974; SRCAP.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C175241; Floating-Harbor syndrome
DI   ORDO; Orphanet_2044; Floating-Harbor syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MHHi001-A-2
AC   CVCL_C4P9
SY   TT#5_K21; #5_TMEM16A_K21
DR   hPSCreg; MHHi001-A-2
DR   Wikidata; Q116049787
RX   PubMed=36162332;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MHHi001-A-3
AC   CVCL_A4CX
SY   4_ISG15KO clone 3; 4_ISG15_C3
DR   hPSCreg; MHHi001-A-3
DR   Wikidata; Q105510111
RX   PubMed=33383405;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4053; ISG15.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   MHHi001-A-4
AC   CVCL_A4CY
SY   4_ISG15KO clone 4; 4_ISG15_C4
DR   hPSCreg; MHHi001-A-4
DR   Wikidata; Q105510113
RX   PubMed=33383405;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4053; ISG15.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   MHHi001-A-5
AC   CVCL_A7GA
SY   Ruby53; Ruby52_382_53; Ruby52_382_K53; LEBAOi002-A-5
DR   hPSCreg; MHHi001-A-5
DR   Wikidata; Q107116359
RX   PubMed=33571874;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using TALEN two constructs, a CAG-promoter driven GCamP6f and a CAG-prpmoter driven RedStar(nuc) were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=33571874).
CC   Genetic integration: Method=TALEN; Gene=FPbase; F5GKU; GCaMP6f (Note=Green fluorescent calcium sensor).
CC   Genetic integration: Method=TALEN; Gene=FPbase; -; RedStar(nuc) (Note=Red fluorescent protein).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   MHHi001-A-6
AC   CVCL_D0I5
SY   NRF2_A_Phoenix-iPSC clone 12; NRF2_A_Phoenix-iPSC clone12
DR   BioSamples; SAMEA112843328
DR   hPSCreg; MHHi001-A-6
DR   Wikidata; Q123033041
RX   PubMed=37104932;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MHHi001-A-7
AC   CVCL_D0I6
SY   NRF2_A_Phoenix-iPSC clone 19; NRF2_A_Phoenix-iPSC clone19
DR   BioSamples; SAMEA112847669
DR   hPSCreg; MHHi001-A-7
DR   Wikidata; Q123033042
RX   PubMed=37104932;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MHHi001-A-8
AC   CVCL_B6RK
SY   hiPSCGCaMP6f/Neo
DR   hPSCreg; MHHi001-A-8
DR   Wikidata; Q112129316
RX   PubMed=35152180;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using TALEN a CAG-promoter driven GCamP6f and a pMYH6-Neo-pPGKp-HygroR construct were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=35152180).
CC   Genetic integration: Method=TALEN; Gene=FPbase; F5GKU; GCaMP6f (Note=Green fluorescent calcium sensor).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   MHHi001-A-9
AC   CVCL_B6RL
SY   hiPSCRCaMP1h/Neo
DR   hPSCreg; MHHi001-A-9
DR   Wikidata; Q112129317
RX   PubMed=35152180;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using TALEN a CAG-promoter driven RCaMP1h and a pMYH6-Neo-pPGKp-HygroR construct were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=35152180).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=Entacmaea quadricolor RCaMP1h (Note=Red fluorescent calcium sensor).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX51 ! MHHi001-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   MHHi002-A
AC   CVCL_QX52
SY   CF[1]iPS5; CF(1)IPS5
DR   BioSamples; SAMEA103885560
DR   hPSCreg; MHHi002-A
DR   Wikidata; Q54905555
RX   PubMed=28925369;
RX   PubMed=31080112;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=28925369).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   MHHi002-A-1
AC   CVCL_QX53
SY   CF[1]iPS5-corr18b13w3C36
DR   hPSCreg; MHHi002-A-1
DR   Wikidata; Q54905556
RX   PubMed=28925369;
RX   PubMed=31080112;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=28925369).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous; Note=By TALEN (PubMed=28925369).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX52 ! MHHi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   MHHi002-A-2
AC   CVCL_XI80
SY   CFTRdTomato2; MHHi002-A-1-1; CF(1)iPS5_corr36_CFTRtomatoC2
DR   hPSCreg; MHHi002-A-2
DR   Wikidata; Q95989455
RX   PubMed=31080112;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Characteristics: Using TALEN a Neo-T2A-dTomato(nuc) construct was integrated in frame in front of the start codon of one of the two alleles of CFTR (PubMed=31080112).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous; Note=By TALEN (from parent cell line).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX53 ! MHHi002-A-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   MHHi002-A-3
AC   CVCL_XI79
SY   CFTRdTomato4; CF(1)iPS5_CFTRtomatoC4
DR   hPSCreg; MHHi002-A-3
DR   Wikidata; Q95989457
RX   PubMed=31080112;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Characteristics: Using TALEN a Neo-T2A-dTomato(nuc) construct was integrated in frame in front of the start codon of one of the two alleles of CFTR (PubMed=31080112).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX52 ! MHHi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   MHHi002-A-4
AC   CVCL_C4PA
SY   TT-CF#1_K50
DR   hPSCreg; MHHi002-A-4
DR   Wikidata; Q116049788
RX   PubMed=36162332;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX52 ! MHHi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MHHi002-A-5
AC   CVCL_C4PB
SY   TT-CF#1_K54
DR   hPSCreg; MHHi002-A-5
DR   Wikidata; Q116049789
RX   PubMed=36162332;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX52 ! MHHi002-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MHHi002-A-6
AC   CVCL_C4PC
SY   TT-corrCF#4_K17
DR   hPSCreg; MHHi002-A-6
DR   Wikidata; Q116049790
RX   PubMed=36162332;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous; Note=By TALEN (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX53 ! MHHi002-A-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MHHi002-A-7
AC   CVCL_C4PD
SY   TT-corrCF#4_K37
DR   hPSCreg; MHHi002-A-7
DR   Wikidata; Q116049791
RX   PubMed=36162332;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21625; ANO1.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous; Note=By TALEN (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX53 ! MHHi002-A-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MHHi003-A
AC   CVCL_VE58
SY   CF(15)iPS10
DR   BioSamples; SAMEA103885561
DR   hPSCreg; MHHi003-A
DR   Wikidata; Q54905557
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (hPSCreg=MHHi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   MHHi004-A
AC   CVCL_VE59
SY   CF(16)iPS1
DR   BioSamples; SAMEA103885563
DR   hPSCreg; MHHi004-A
DR   Wikidata; Q54905558
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (hPSCreg=MHHi004-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   MHHi005-A
AC   CVCL_VE60
SY   CF(17)iPS6
DR   BioSamples; SAMEA103885565
DR   hPSCreg; MHHi005-A
DR   Wikidata; Q54905559
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (hPSCreg=MHHi005-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   MHHi006-A
AC   CVCL_VN33
SY   HSC1285_T-iPS2; hHSC1285iPS2; 1285; iPSC6
DR   BioSamples; SAMEA7419418
DR   GEO; GSM4340166
DR   hPSCreg; MHHi006-A
DR   Wikidata; Q95989460
RX   PubMed=29681541;
RX   PubMed=33255686;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   MHHi006-A-1
AC   CVCL_XI78
SY   CFTRdTomato74; hHSC_F1285_T-iPS2-CFTRTomato/wt C74; HSC1285iPS2_CFTRTomatoK74
DR   hPSCreg; MHHi006-A-1
DR   Wikidata; Q95989462
RX   PubMed=31080112;
RX   PubMed=31473565;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Characteristics: Using TALEN a ZeoR-T2A-dTomato(nuc) construct was integrated in frame in front of the start codon of one of the two alleles of CFTR (PubMed=31473565).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN33 ! MHHi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   MHHi006-A-2
AC   CVCL_WX23
SY   HSC1285_T-iPS2/Nkx2.1eGFP
DR   hPSCreg; MHHi006-A-2
DR   Wikidata; Q95989463
RX   PubMed=31299562;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Characteristics: Using TALEN a P2A-eGFP-T2A-PGKp-hph construct was integrated in front of the stop codon of NXK2-1.
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN33 ! MHHi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   MHHi006-A-3
AC   CVCL_XJ45
SY   CFTRKO/CFTRdTomato89; HSC1285TiPS2_CFTRtomatoC89 (KO)
DR   hPSCreg; MHHi006-A-3
DR   Wikidata; Q95989465
RX   PubMed=31080112;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Characteristics: Using TALEN a ZeoR-T2A-dTomato(nuc) construct was integrated in one of the alleles of CFTR which has a 4 bp deletion in its Kozak sequence (PubMed=31080112).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN33 ! MHHi006-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   MHHi006-A-4
AC   CVCL_YJ73
SY   HSC1285iPS2_Nkx2.1eGFP_p63dTomato
DR   hPSCreg; MHHi006-A-4
DR   Wikidata; Q95989466
RX   PubMed=31791010;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Characteristics: Using TALEN a P2A-eGFP-T2A-PGKp-hph construct was integrated in front of the stop codon of NXK2-1 and a P2A-dTomato-nucmem-T2A-Neo_PGKPuroR construct was integrated into exon 10 of TP63.
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WX23 ! MHHi006-A-2
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   MHHi007-A
AC   CVCL_VN31
SY   HSC_F1488_SeV-iPS2
DR   hPSCreg; MHHi007-A
DR   Wikidata; Q95989468
RX   PubMed=29852468;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   MHHi007-A-1
AC   CVCL_VN32
SY   1_CDX2-C23
DR   hPSCreg; MHHi007-A-1
DR   Wikidata; Q95989469
RX   PubMed=29852468;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Characteristics: Using TALEN a P2A-Venus(nucmem)-T2A-Neo-PGKp-PuroR construct was integrated in front of the stop codon of CDX2.
CC   Genetic integration: Method=TALEN; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN31 ! MHHi007-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   MHHi008-A
AC   CVCL_VS38
SY   CD34+hPBHSC_GMPDU_SeV-iPS8
DR   hPSCreg; MHHi008-A
DR   Wikidata; Q95989471
RX   PubMed=30772682;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30772682
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D21S11: 31,32.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 12,14
ST   Penta E: 13,17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS39 ! MHHi008-B
OI   CVCL_VS40 ! MHHi008-C
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MHHi008-B
AC   CVCL_VS39
SY   CD34+hPBHSC_GMPDU_SeV-iPS16
DR   hPSCreg; MHHi008-B
DR   Wikidata; Q95989474
RX   PubMed=30772682;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30772682
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D21S11: 31,32.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 12,14
ST   Penta E: 13,17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS38 ! MHHi008-A
OI   CVCL_VS40 ! MHHi008-C
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MHHi008-C
AC   CVCL_VS40
SY   CD34+hPBSC_GMPDU_SeV-iPS18
DR   hPSCreg; MHHi008-C
DR   Wikidata; Q95989475
RX   PubMed=30772682;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30772682
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D18S51: 13,16
ST   D21S11: 31,32.2
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 12,14
ST   Penta E: 13,17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS38 ! MHHi008-A
OI   CVCL_VS39 ! MHHi008-B
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MHHi009-A
AC   CVCL_A7GM
SY   hCBiPSC2; hCBiPS2
DR   hPSCreg; MHHi009-A
DR   Wikidata; Q107116361
RX   PubMed=19796623;
RX   PubMed=33255686;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   MHHi009-A-4
AC   CVCL_A7GN
SY   hCBiPSC2_RedStar_MYH6-NeoR; Nora6
DR   hPSCreg; MHHi009-A-4
DR   Wikidata; Q107116362
RX   PubMed=33255686;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Genetic integration: Method=Transfection/transduction; Gene=RedStar(nuc) (Note=Red fluorescent protein).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7GM ! MHHi009-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   MHHi009-A-eGFP
AC   CVCL_A7GP
SY   hCBiPSC2-eGFP
DR   GEO; GSM4340172
DR   Wikidata; Q107116364
RX   PubMed=33255686;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7GM ! MHHi009-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MHHi010-A
AC   CVCL_ZE34
SY   STAT1_CMC_1
DR   hPSCreg; MHHi010-A
DR   Wikidata; Q98127234
RX   PubMed=32000109;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11362; STAT1; Simple; p.Arg274Gln (c.821G>A); ClinVar=VCV000030085; Zygosity=Heterozygous (PubMed=32000109).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172099; STAT1-associated immunodeficiency
DI   ORDO; Orphanet_391487; Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   MHHi011-A
AC   CVCL_YX87
DR   hPSCreg; MHHi011-A
DR   Wikidata; Q95989476
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   MHHi012-A
AC   CVCL_YX88
SY   LDSP1C07; LDS-P1 clone 7
DR   hPSCreg; MHHi012-A
DR   Wikidata; Q95989477
RX   PubMed=32062130;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11772; TGFBR1; Simple; p.Met253Ile (c.759G>A); ClinVar=VCV001759703; Zygosity=Heterozygous (PubMed=32062130).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75119; Loeys-Dietz syndrome type 1
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   MHHi013-A
AC   CVCL_YX89
SY   LDSP2C16; LDS-P2 clone 16
DR   hPSCreg; MHHi013-A
DR   Wikidata; Q95989478
RX   PubMed=32062130;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11772; TGFBR1; Simple; p.Met253Ile (c.759G>A); ClinVar=VCV001759703; Zygosity=Heterozygous (PubMed=32062130).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75119; Loeys-Dietz syndrome type 1
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   MHHi014-A
AC   CVCL_YX90
SY   LDSP3C03; LDS-P3 clone 3
DR   hPSCreg; MHHi014-A
DR   Wikidata; Q95989480
RX   PubMed=32062130;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11772; TGFBR1; Simple; p.Met253Ile (c.759G>A); ClinVar=VCV001759703; Zygosity=Heterozygous (PubMed=32062130).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75119; Loeys-Dietz syndrome type 1
DI   ORDO; Orphanet_60030; Loeys-Dietz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   MHHi015-A
AC   CVCL_ZX23
SY   hCD34iPSC16; hCD34-iPSC16
DR   BioSamples; SAMEA6285351
DR   hPSCreg; MHHi015-A
DR   Wikidata; Q102114531
RX   PubMed=24290698;
RX   PubMed=29249666;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX24 ! MHHi015-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   MHHi015-B
AC   CVCL_ZX24
SY   hCD34iPSC11; hCD34-iPSC11
DR   BioSamples; SAMEA6285352
DR   hPSCreg; MHHi015-B
DR   Wikidata; Q102114532
RX   PubMed=24290698;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX23 ! MHHi015-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MHHi016-A
AC   CVCL_ZJ20
SY   PCD-P1_CCNO clone 5; PCD-P1 clone 5; PCDP1C05
DR   hPSCreg; MHHi016-A
DR   Wikidata; Q98127235
RX   PubMed=32464346;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18576; CCNO; Simple; p.Gly85Cysfs*11 (c.248_252dupCAGGG); ClinVar=VCV000139599; Zygosity=Homozygous (PubMed=32464346).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172393; Primary ciliary dyskinesia 29
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ21 ! MHHi016-B
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   MHHi016-B
AC   CVCL_ZJ21
SY   PCD-P1_CCNO clone 21; PCD-P1 clone 21; PCDP1C21
DR   hPSCreg; MHHi016-B
DR   Wikidata; Q98127236
RX   PubMed=32464346;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:18576; CCNO; Simple; p.Gly85Cysfs*11 (c.248_252dupCAGGG); ClinVar=VCV000139599; Zygosity=Homozygous (PubMed=32464346).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172393; Primary ciliary dyskinesia 29
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ20 ! MHHi016-A
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MHHi017-A
AC   CVCL_ZJ18
SY   PCD-P2_DNAH5 clone 22; PCD-P2 clone 22; PCDP2C22
DR   hPSCreg; MHHi017-A
DR   Wikidata; Q98127237
RX   PubMed=32470793;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2950; DNAH5; Simple; p.Arg2639Ter (c.7915C>T); ClinVar=VCV000520775; Zygosity=Homozygous (PubMed=32470793).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172392; Primary ciliary dyskinesia 3
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ19 ! MHHi017-B
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   MHHi017-B
AC   CVCL_ZJ19
SY   PCD-P2_DNAH5 clone 24; PCD-P2 clone 24; PCDP2C24
DR   hPSCreg; MHHi017-B
DR   Wikidata; Q98127238
RX   PubMed=32470793;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2950; DNAH5; Simple; p.Arg2639Ter (c.7915C>T); ClinVar=VCV000520775; Zygosity=Homozygous (PubMed=32470793).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172392; Primary ciliary dyskinesia 3
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZJ18 ! MHHi017-A
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   MHHi018-A
AC   CVCL_YX91
SY   CF19 iPSC9; CF19_iPSCK9
DR   hPSCreg; MHHi018-A
DR   Wikidata; Q95989481
RX   PubMed=32220772;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asn1303Lys (c.3909C>G); ClinVar=VCV000007136; Zygosity=Homozygous (PubMed=32220772).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   MHHi019-A
AC   CVCL_A4WJ
SY   PCD-P3 clone 17
DR   hPSCreg; MHHi019-A
DR   Wikidata; Q107116365
RX   PubMed=32950024;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7853; NME5; Simple; p.Ile139Tyrfs*8 (c.415delA); ClinVar=VCV001705858; Zygosity=Homozygous (PubMed=32950024).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84638; Ciliary motility defect
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4WK ! MHHi019-B
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   MHHi019-B
AC   CVCL_A4WK
SY   PCD-P3 clone 23; PCD-P3_NME5 Clone 23
DR   hPSCreg; MHHi019-B
DR   Wikidata; Q107116367
RX   PubMed=32950024;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7853; NME5; Simple; p.Ile139Tyrfs*8 (c.415delA); ClinVar=VCV001705858; Zygosity=Homozygous (PubMed=32950024).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84638; Ciliary motility defect
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4WJ ! MHHi019-A
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   MHHi020-A
AC   CVCL_A4WL
DR   hPSCreg; MHHi020-A
DR   Wikidata; Q107116370
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MHHi021-A
AC   CVCL_A7GK
SY   R723G_K1_MOI10; bMHC_R723G_MOI10_K1
DR   hPSCreg; MHHi021-A
DR   Wikidata; Q107116371
RX   PubMed=33578365;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg723Gly (c.2167C>G); ClinVar=VCV000042885; Zygosity=Heterozygous (PubMed=33578365).
CC   Caution: MYH7 mutation indicated incorrectly as being at c.2169C>G in PubMed=33578365.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7GL ! MHHi021-B
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   MHHi021-B
AC   CVCL_A7GL
SY   R723G_K2_MOI1; bMHC_R723G_MOI1_K2
DR   hPSCreg; MHHi021-B
DR   Wikidata; Q107116372
RX   PubMed=33578365;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg723Gly (c.2167C>G); ClinVar=VCV000042885; Zygosity=Heterozygous (PubMed=33578365).
CC   Caution: MYH7 mutation indicated incorrectly as being at c.2169C>G in PubMed=33578365.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7GK ! MHHi021-A
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   MHHi022-A
AC   CVCL_A0YP
SY   PAH Pat. A iPS Clone11; PAH Pat.A Clone11
DR   hPSCreg; MHHi022-A
DR   Wikidata; Q108820911
RX   PubMed=34388490;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.His533Arg (c.1598A>G); ClinVar=VCV000425962; Zygosity=Heterozygous (PubMed=34388490).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   MHHi023-A
AC   CVCL_A0YQ
SY   PAH Pat. C iPS Clone18; PAH Pat.C Clone18
DR   hPSCreg; MHHi023-A
DR   Wikidata; Q108820913
RX   PubMed=34388490;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys84_Ser140del (c.248-1_418+1del171) (Ex3del); Zygosity=Heterozygous (PubMed=34388490).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   MHHi024-A
AC   CVCL_A0YR
SY   PAH Pat. D iPS Clone16; PAH Pat.D Clone16
DR   hPSCreg; MHHi024-A
DR   Wikidata; Q108820914
RX   PubMed=34388490;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Arg491Trp (c.1471C>T); ClinVar=VCV000008802; Zygosity=Heterozygous (PubMed=34388490).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   MHHi029-A
AC   CVCL_D6R2
SY   F01 clone #20; F01 #20
DR   BioSamples; SAMEA115457276
DR   hPSCreg; MHHi029-A
RX   PubMed=38552356;
CC   From: Hannover Medical School, LEBAO (MHH); Hannover; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Asn320Ile (c.959A>T); dbSNP=rs869312454; Zygosity=Hemizygous (PubMed=38552356).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MHHZ-00020533
AC   CVCL_V376
DR   IPD-IMGT/HLA; 14464
DR   Wikidata; Q54905560
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:BUVE,24:ATEA; B*15:BKVK,35:BEZX; C*03:BPSK,04:KBG; DQB1*02:MS,05:01; DRB1*01:01,03:30 (IPD-IMGT/HLA=14464).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   MHI 16
AC   CVCL_A2XD
DR   Wikidata; Q105510115
RX   PubMed=3025332;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   mHippoE-14
AC   CVCL_D375
DR   Wikidata; Q54905561
RX   PubMed=20619320;
WW   Provider; Cedarlane; CLU198; https://www.cedarlanelabs.com/Products/Detail/CLU198?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mHippoE-18
AC   CVCL_D376
DR   Wikidata; Q54905562
RX   PubMed=20619320;
WW   Provider; Cedarlane; CLU199; https://www.cedarlanelabs.com/Products/Detail/CLU199?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mHippoE-2
AC   CVCL_D377
DR   Wikidata; Q54905563
RX   PubMed=20619320;
WW   Provider; Cedarlane; CLU196; https://www.cedarlanelabs.com/Products/Detail/CLU196?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mHippoE-5
AC   CVCL_D378
DR   Wikidata; Q54905564
RX   PubMed=20619320;
WW   Provider; Cedarlane; CLU197; https://www.cedarlanelabs.com/Products/Detail/CLU197?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   MHM
AC   CVCL_B426
SY   MHMX
DR   BTO; BTO_0006420
DR   cancercelllines; CVCL_B426
DR   Cosmic; 1529904
DR   GEO; GSM879218
DR   IARC_TP53; 27031
DR   Progenetix; CVCL_B426
DR   Wikidata; Q54905565
RX   PubMed=8198963;
RX   PubMed=17354236;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   Doubling time: ~60 hours (PubMed=21519327).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone, pelvis; UBERON=UBERON_0012179.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 9,13
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 30.2,32
ST   D2S1338: 19,24
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D8S1179: 10,13
ST   FGA: 19,23
ST   SE33: 24.2
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 17,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   MHM23
AC   CVCL_B7B7
SY   MHM.23; MHM 0.23
DR   Wikidata; Q112129318
RX   PubMed=2580022;
RX   PubMed=6339253;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   MHM24
AC   CVCL_B7B8
SY   MHM.24; MHM 0.24
DR   DSHB; MHM-24
DR   Wikidata; Q112129319
RX   PubMed=2580022;
RX   PubMed=6339253;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   MHM-25
AC   CVCL_GZ63
DR   GEO; GSM1676342
DR   GEO; GSM1701673
DR   Wikidata; Q54905566
RX   PubMed=26351324;
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   MHM-8
AC   CVCL_GZ64
DR   GEO; GSM1676307
DR   GEO; GSM1701641
DR   Wikidata; Q54905568
RX   PubMed=26351324;
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   MHM6
AC   CVCL_VR95
DR   Wikidata; Q95989493
RX   PubMed=6282762;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06734; Human FCER2/CD23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   MHP36
AC   CVCL_U372
DR   Wikidata; Q54905570
RX   PubMed=9316014;
RX   PubMed=11447341;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hippocampus, neuroepithelium; UBERON=UBERON_0034705.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Conditionally immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   MHPC
AC   CVCL_C7KV
SY   Marmoset Hepatic Progenitor Cell
DR   ABM; T0719
DR   GEO; GSM2634727
DR   GEO; GSM2634728
DR   GEO; GSM2634729
DR   Wikidata; Q117704705
RX   PubMed=29796307;
CC   Group: Non-human primate cell line.
CC   Doubling time: 2.3 days (PubMed=29796307).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stem cell; CL=CL_0002195.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
AG   12-15FW
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MHR14
AC   CVCL_DE45
SY   GM11535
DR   CLO; CLO_0021002
DR   Coriell; GM11535
DR   Wikidata; Q54905571
RX   CelloPub=CLPUB00447;
RX   PubMed=1765380;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DE39 ! HHW890
CA   Hybrid cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   MHRCCGi001-A
AC   CVCL_D0I7
SY   P1SH
DR   BioSamples; SAMEA112366444
DR   hPSCreg; MHRCCGi001-A
DR   Wikidata; Q123033043
RX   DOI=10.1192/j.eurpsy.2024.1592;
CC   From: Laboratory Clinical Genetics, Mental Health Research Center; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11042; SLC6A1; Simple; p.Arg211Cys (c.631C>T); ClinVar=VCV001714623; Zygosity=Heterozygous; Note=De novo mutation (DOI=10.1192/j.eurpsy.2024.1592).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MHRCCGi004-A
AC   CVCL_D0I8
SY   A1SH
DR   BioSamples; SAMEA112845606
DR   hPSCreg; MHRCCGi004-A
DR   Wikidata; Q123033044
RX   DOI=10.1192/j.eurpsy.2024.1592;
CC   From: Laboratory Clinical Genetics, Mental Health Research Center; Moscow; Russia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MHRCCGi005-A
AC   CVCL_D0I9
SY   A2SH
DR   BioSamples; SAMEA112846471
DR   hPSCreg; MHRCCGi005-A
DR   Wikidata; Q123033045
RX   DOI=10.1192/j.eurpsy.2024.1592;
CC   From: Laboratory Clinical Genetics, Mental Health Research Center; Moscow; Russia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   mHypoA-1/1
AC   CVCL_D379
DR   Wikidata; Q54905572
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU178; https://www.cedarlanelabs.com/Products/Detail/CLU178?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-1/2
AC   CVCL_D380
DR   Wikidata; Q54905573
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU172; https://www.cedarlanelabs.com/Products/Detail/CLU172?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-1/3
AC   CVCL_D381
DR   Wikidata; Q54905574
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU173; https://www.cedarlanelabs.com/Products/Detail/CLU173?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-1/6
AC   CVCL_D382
DR   Wikidata; Q54905575
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU179; https://www.cedarlanelabs.com/Products/Detail/CLU179?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-1/9
AC   CVCL_D383
DR   Wikidata; Q54905576
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU180; https://www.cedarlanelabs.com/Products/Detail/CLU180?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/10
AC   CVCL_D384
DR   Wikidata; Q54905577
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU176; https://www.cedarlanelabs.com/Products/Detail/CLU176?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/12
AC   CVCL_D385
DR   Wikidata; Q54905578
RX   PubMed=19703933;
RX   PubMed=32575098;
RX   PubMed=32960947;
WW   Provider; Cedarlane; CLU177; https://www.cedarlanelabs.com/Products/Detail/CLU177?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/21
AC   CVCL_D386
DR   Wikidata; Q54905579
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU181; https://www.cedarlanelabs.com/Products/Detail/CLU181?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/22
AC   CVCL_D387
DR   Wikidata; Q54905580
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU182; https://www.cedarlanelabs.com/Products/Detail/CLU182?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/23
AC   CVCL_D388
DR   Wikidata; Q54905581
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU183; https://www.cedarlanelabs.com/Products/Detail/CLU183?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/24
AC   CVCL_D389
DR   Wikidata; Q54905582
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU184; https://www.cedarlanelabs.com/Products/Detail/CLU184?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/25
AC   CVCL_D390
DR   Wikidata; Q54905583
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU185; https://www.cedarlanelabs.com/Products/Detail/CLU185?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/26
AC   CVCL_D391
DR   Wikidata; Q54905584
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU186; https://www.cedarlanelabs.com/Products/Detail/CLU186?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/27
AC   CVCL_D392
DR   Wikidata; Q54905585
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU187; https://www.cedarlanelabs.com/Products/Detail/CLU187?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/28
AC   CVCL_D393
DR   Wikidata; Q54905586
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU188; https://www.cedarlanelabs.com/Products/Detail/CLU188?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/29
AC   CVCL_D394
DR   BCRJ; 0296
DR   Wikidata; Q54905587
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU189; https://www.cedarlanelabs.com/Products/Detail/CLU189?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Misspelling: CLU-189; BCRJ=0296; Note=Based on the Cellutions Biosystems catalog number.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   mHypoA-2/30
AC   CVCL_D395
DR   Wikidata; Q54905588
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU190; https://www.cedarlanelabs.com/Products/Detail/CLU190?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/31
AC   CVCL_D396
DR   Wikidata; Q54905589
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU191; https://www.cedarlanelabs.com/Products/Detail/CLU191?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/32
AC   CVCL_D397
DR   Wikidata; Q54905590
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU192; https://www.cedarlanelabs.com/Products/Detail/CLU192?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/33
AC   CVCL_D398
DR   Wikidata; Q54905591
RX   PubMed=19703933;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU193.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mHypoA-2/34
AC   CVCL_D399
DR   Wikidata; Q54905592
RX   PubMed=19703933;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU194.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mHypoA-2/4
AC   CVCL_D400
DR   Wikidata; Q54905593
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU174; https://www.cedarlanelabs.com/Products/Detail/CLU174?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-2/6
AC   CVCL_D401
DR   Wikidata; Q54905595
RX   PubMed=19703933;
WW   Provider; Cedarlane; CLU175; https://www.cedarlanelabs.com/Products/Detail/CLU175?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-41
AC   CVCL_D402
DR   Wikidata; Q54905596
WW   Provider; Cedarlane; CLU450; https://www.cedarlanelabs.com/Products/Detail/CLU450?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-42
AC   CVCL_D403
DR   Wikidata; Q54905597
WW   Provider; Cedarlane; CLU451; https://www.cedarlanelabs.com/Products/Detail/CLU451?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-43
AC   CVCL_D404
DR   Wikidata; Q54905601
WW   Provider; Cedarlane; CLU452; https://www.cedarlanelabs.com/Products/Detail/CLU452?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-44
AC   CVCL_D405
DR   Wikidata; Q54905602
WW   Provider; Cedarlane; CLU453; https://www.cedarlanelabs.com/Products/Detail/CLU453?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-45
AC   CVCL_D406
DR   Wikidata; Q54905603
WW   Provider; Cedarlane; CLU454; https://www.cedarlanelabs.com/Products/Detail/CLU454?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-46
AC   CVCL_D407
DR   Wikidata; Q54905604
WW   Provider; Cedarlane; CLU455; https://www.cedarlanelabs.com/Products/Detail/CLU455?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-47
AC   CVCL_D408
DR   Wikidata; Q54905605
WW   Provider; Cedarlane; CLU456; https://www.cedarlanelabs.com/Products/Detail/CLU456?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-48
AC   CVCL_D409
DR   Wikidata; Q54905607
WW   Provider; Cedarlane; CLU457; https://www.cedarlanelabs.com/Products/Detail/CLU457?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-49
AC   CVCL_D410
DR   Wikidata; Q54905608
WW   Provider; Cedarlane; CLU458; https://www.cedarlanelabs.com/Products/Detail/CLU458?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-50
AC   CVCL_D411
DR   Wikidata; Q54905609
WW   Provider; Cedarlane; CLU459; https://www.cedarlanelabs.com/Products/Detail/CLU459?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-51
AC   CVCL_D412
DR   Wikidata; Q54905610
WW   Provider; Cedarlane; CLU460; https://www.cedarlanelabs.com/Products/Detail/CLU460?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-52
AC   CVCL_D413
DR   Wikidata; Q54905611
WW   Provider; Cedarlane; CLU461; https://www.cedarlanelabs.com/Products/Detail/CLU461?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-53
AC   CVCL_D414
DR   Wikidata; Q54905612
WW   Provider; Cedarlane; CLU462; https://www.cedarlanelabs.com/Products/Detail/CLU462?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-54
AC   CVCL_D415
DR   Wikidata; Q54905613
WW   Provider; Cedarlane; CLU463; https://www.cedarlanelabs.com/Products/Detail/CLU463?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-55
AC   CVCL_D416
DR   Wikidata; Q54905614
WW   Provider; Cedarlane; CLU464; https://www.cedarlanelabs.com/Products/Detail/CLU464?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-56
AC   CVCL_D417
DR   Wikidata; Q54905615
WW   Provider; Cedarlane; CLU465; https://www.cedarlanelabs.com/Products/Detail/CLU465?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-57
AC   CVCL_D418
DR   Wikidata; Q54905616
WW   Provider; Cedarlane; CLU466; https://www.cedarlanelabs.com/Products/Detail/CLU466?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-58
AC   CVCL_D419
DR   Wikidata; Q54905617
WW   Provider; Cedarlane; CLU467; https://www.cedarlanelabs.com/Products/Detail/CLU467?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-59
AC   CVCL_D420
DR   Wikidata; Q54905618
RX   PubMed=21914774;
RX   PubMed=32575098;
RX   PubMed=32960947;
WW   Provider; Cedarlane; CLU468; https://www.cedarlanelabs.com/Products/Detail/CLU468?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoA-60
AC   CVCL_D421
DR   Wikidata; Q54905619
WW   Provider; Cedarlane; CLU469; https://www.cedarlanelabs.com/Products/Detail/CLU469?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-61
AC   CVCL_D422
DR   Wikidata; Q54905620
WW   Provider; Cedarlane; CLU470; https://www.cedarlanelabs.com/Products/Detail/CLU470?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-62
AC   CVCL_D423
DR   Wikidata; Q54905621
WW   Provider; Cedarlane; CLU471; https://www.cedarlanelabs.com/Products/Detail/CLU471?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-63
AC   CVCL_D424
DR   Wikidata; Q54905622
WW   Provider; Cedarlane; CLU472; https://www.cedarlanelabs.com/Products/Detail/CLU472?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-Ast1
AC   CVCL_E4K7
RX   PubMed=38788830;
CC   Characteristics: Expresses high level of GFAP (PubMed=38788830).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   mHypoA-Ast1/2
AC   CVCL_E4K8
RX   PubMed=38788830;
CC   Characteristics: Expresses high level of GFAP (PubMed=38788830).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E4K7 ! mHypoA-Ast1
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   mHypoA-BMAL1-KO/F
AC   CVCL_YI96
DR   Wikidata; Q95989563
RX   PubMed=30500912;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1096381; Arntl.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-KO/F1
AC   CVCL_YJ06
DR   Wikidata; Q95989564
RX   PubMed=30500912;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1096381; Arntl.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI96 ! mHypoA-BMAL1-KO/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-KO/F2
AC   CVCL_YJ07
DR   Wikidata; Q95989565
RX   PubMed=30500912;
RX   PubMed=32114021;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1096381; Arntl.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI96 ! mHypoA-BMAL1-KO/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-KO/F3
AC   CVCL_YJ08
DR   Wikidata; Q95989566
RX   PubMed=30500912;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1096381; Arntl.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI96 ! mHypoA-BMAL1-KO/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-KO/F4
AC   CVCL_YJ09
DR   Wikidata; Q95989567
RX   PubMed=30500912;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1096381; Arntl.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI96 ! mHypoA-BMAL1-KO/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-KO/M
AC   CVCL_YI97
DR   Wikidata; Q95989568
RX   PubMed=30500912;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1096381; Arntl.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F
AC   CVCL_YI94
DR   Wikidata; Q95989570
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F1
AC   CVCL_YI98
DR   Wikidata; Q95989572
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F2
AC   CVCL_YI99
DR   Wikidata; Q95989574
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F3
AC   CVCL_YJ00
DR   Wikidata; Q95989575
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F4
AC   CVCL_YJ01
DR   Wikidata; Q95989577
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F5
AC   CVCL_YJ02
DR   Wikidata; Q95989579
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F6
AC   CVCL_YJ03
DR   Wikidata; Q95989580
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F7
AC   CVCL_YJ04
DR   Wikidata; Q95989581
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/F8
AC   CVCL_YJ05
DR   Wikidata; Q95989582
RX   PubMed=30500912;
RX   PubMed=32114021;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YI94 ! mHypoA-BMAL1-WT/F
SX   Female
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-BMAL1-WT/M
AC   CVCL_YI95
DR   Wikidata; Q95989583
RX   PubMed=30500912;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.129-Arntltm1Bra/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8-9W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-GnRH/GFP
AC   CVCL_DP31
DR   Wikidata; Q54905623
RX   PubMed=23835445;
WW   Provider; Cedarlane; CLU498; https://www.cedarlanelabs.com/Products/Detail/CLU498?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 6HML4; rrenGFP (Note=Green fluorescent protein from Renilla reniformis).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   mHypoA-Kiss/GFP-1
AC   CVCL_A0SK
DR   Wikidata; Q108820916
RX   PubMed=26726951;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoA-Kiss/GFP-2
AC   CVCL_A0SL
DR   Wikidata; Q108820917
RX   PubMed=26726951;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   mHypoA-Kiss/GFP-3
AC   CVCL_A0SM
DR   Wikidata; Q108820918
RX   PubMed=26726951;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus, arcuate nucleus; UBERON=UBERON_0001932.
CC   Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoA-Kiss/GFP-4
AC   CVCL_A0SN
DR   Wikidata; Q108820920
RX   PubMed=26726951;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus, anteroventral periventricular nucleus; UBERON=UBERON_0002690.
CC   Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoA-NPY/GFP
AC   CVCL_Y000
DR   Wikidata; Q54905624
RX   PubMed=21914774;
WW   Provider; Cedarlane; CLU499; https://www.cedarlanelabs.com/Products/Detail/CLU499?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 6HML4; rrenGFP (Note=Green fluorescent protein from Renilla reniformis).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: B6.FVB-Tg(Npy-hrGFP)1Lowl/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   2M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 15
//
ID   mHypoA-POMC/GFP-1
AC   CVCL_EP66
DR   Wikidata; Q54905625
RX   PubMed=24134870;
WW   Provider; Cedarlane; CLU500; https://www.cedarlanelabs.com/Products/Detail/CLU500?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   mHypoA-POMC/GFP-2
AC   CVCL_EP67
DR   Wikidata; Q54905626
RX   PubMed=24134870;
WW   Provider; Cedarlane; CLU501; https://www.cedarlanelabs.com/Products/Detail/CLU501?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   mHypoA-POMC/GFP-3
AC   CVCL_EP68
DR   Wikidata; Q54905627
RX   PubMed=24134870;
WW   Provider; Cedarlane; CLU502; https://www.cedarlanelabs.com/Products/Detail/CLU502?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   mHypoA-POMC/GFP-4
AC   CVCL_EP69
DR   Wikidata; Q54905628
RX   PubMed=24134870;
WW   Provider; Cedarlane; CLU503; https://www.cedarlanelabs.com/Products/Detail/CLU503?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   mHypoA-SCN
AC   CVCL_5I56
DR   Wikidata; Q54905629
WW   Provider; Cedarlane; CLU497; https://www.cedarlanelabs.com/Products/Detail/CLU497?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   mHypoE-1
AC   CVCL_D425
SY   mHypoE-N1; N1; N-1
DR   Wikidata; Q54905630
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU101; https://www.cedarlanelabs.com/Products/Detail/CLU101?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-11
AC   CVCL_D426
SY   mHypoE-N11; N11; N-11
DR   Wikidata; Q54905631
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU107; https://www.cedarlanelabs.com/Products/Detail/CLU107?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-19
AC   CVCL_A0SD
SY   mHypoE-N19; N19; N-19
DR   Wikidata; Q108820921
RX   PubMed=14551229;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available (personal communication of Belsham, Denise D.).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-2
AC   CVCL_A0SC
SY   mHypoE-N2; N2; N-2
DR   Wikidata; Q108820922
RX   PubMed=14551229;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available (personal communication of Belsham, Denise D.).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-20
AC   CVCL_A0SF
SY   mHypoE-N20; N20; N-20
DR   Wikidata; Q108820923
RX   PubMed=14551229;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-20/1
AC   CVCL_D427
SY   mHypoE-N20/1; N20/1
DR   Wikidata; Q54905633
WW   Provider; Cedarlane; CLU108; https://www.cedarlanelabs.com/Products/Detail/CLU108?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SF ! mHypoE-20
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-20/2
AC   CVCL_D428
SY   mHypoE-N20/2; N20/2
DR   Wikidata; Q54905634
WW   Provider; Cedarlane; CLU109; https://www.cedarlanelabs.com/Products/Detail/CLU109?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SF ! mHypoE-20
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-22
AC   CVCL_A0SE
SY   mHypoE-N22; N22; N-22
DR   Wikidata; Q108820925
RX   PubMed=14551229;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available (personal communication of Belsham, Denise D.).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-25
AC   CVCL_A0SG
SY   mHypoE-N25; N25; N-25
DR   Wikidata; Q108820926
RX   PubMed=14551229;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-25/2
AC   CVCL_D429
SY   mHypoE-N25/2; N25/2
DR   Wikidata; Q54905635
WW   Provider; Cedarlane; CLU110; https://www.cedarlanelabs.com/Products/Detail/CLU110?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SG ! mHypoE-25
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-25/3
AC   CVCL_D430
SY   mHypoE-N25/3; N25/3
DR   Wikidata; Q54905636
WW   Provider; Cedarlane; CLU111; https://www.cedarlanelabs.com/Products/Detail/CLU111?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SG ! mHypoE-25
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-29
AC   CVCL_A0SH
SY   mHypoE-N29; N29; N-29
DR   Wikidata; Q108820927
RX   PubMed=14551229;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-29/1
AC   CVCL_D431
SY   mHypoE-N29/1; N29/1; N29.1
DR   Wikidata; Q54905637
RX   PubMed=29468137;
WW   Provider; Cedarlane; CLU112; https://www.cedarlanelabs.com/Products/Detail/CLU112?lob=AllProducts
CC   Virology: Low susceptibility to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SH ! mHypoE-29
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoE-29/2
AC   CVCL_D432
SY   mHypoE-N29/2; N29/2
DR   Wikidata; Q54905638
WW   Provider; Cedarlane; CLU113; https://www.cedarlanelabs.com/Products/Detail/CLU113?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SH ! mHypoE-29
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-29/3
AC   CVCL_D433
SY   mHypoE-N29/3; N29/3
DR   Wikidata; Q54905639
WW   Provider; Cedarlane; CLU114; https://www.cedarlanelabs.com/Products/Detail/CLU114?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SH ! mHypoE-29
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-29/4
AC   CVCL_D434
SY   mHypoE-N29/4; N29/4
DR   Wikidata; Q54905640
WW   Provider; Cedarlane; CLU115; https://www.cedarlanelabs.com/Products/Detail/CLU115?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SH ! mHypoE-29
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-3
AC   CVCL_D435
SY   mHypoE-N3; N3; N-3
DR   Wikidata; Q54905641
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU102; https://www.cedarlanelabs.com/Products/Detail/CLU102?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-36
AC   CVCL_A0SI
SY   mHypoE-N36; N36; N-36
DR   Wikidata; Q108820929
RX   PubMed=14551229;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-36/1
AC   CVCL_D436
AS   CVCL_0446
SY   mHypoE-N36/1; N36/1; N-36/1
DR   MCCL; MCC:0000343
DR   Wikidata; Q54905642
WW   Provider; Cedarlane; CLU116; https://www.cedarlanelabs.com/Products/Detail/CLU116?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SI ! mHypoE-36
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoE-36/2
AC   CVCL_E6I8
SY   mHypoE-N36/2; N36/2; N-36/2
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU141.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SI ! mHypoE-36
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   mHypoE-37
AC   CVCL_D437
SY   mHypoE-N37; N37; N-37
DR   Wikidata; Q54905647
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU117; https://www.cedarlanelabs.com/Products/Detail/CLU117?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-38
AC   CVCL_D438
AS   CVCL_0447
SY   mHypoE-N38; N38; N-38
DR   BTO; BTO_0003956
DR   MCCL; MCC:0000344
DR   Wikidata; Q54905648
RX   PubMed=14551229;
RX   PubMed=19605792;
WW   Provider; Cedarlane; CLU118; https://www.cedarlanelabs.com/Products/Detail/CLU118?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   mHypoE-39
AC   CVCL_D439
AS   CVCL_0448
SY   mHypoE-N39; N39; N-39
DR   MCCL; MCC:0000345
DR   Wikidata; Q54905649
WW   Provider; Cedarlane; CLU119; https://www.cedarlanelabs.com/Products/Detail/CLU119?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mHypoE-4
AC   CVCL_D440
SY   mHypoE-N4; N4; N-4
DR   Wikidata; Q54905650
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU103; https://www.cedarlanelabs.com/Products/Detail/CLU103?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-40
AC   CVCL_D441
SY   mHypoE-N40; N40
DR   Wikidata; Q54905651
WW   Provider; Cedarlane; CLU120; https://www.cedarlanelabs.com/Products/Detail/CLU120?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-41
AC   CVCL_D442
SY   mHypoE-N41; N41
DR   Wikidata; Q54905652
RX   PubMed=32575098;
RX   PubMed=32960947;
WW   Provider; Cedarlane; CLU121; https://www.cedarlanelabs.com/Products/Detail/CLU121?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-42
AC   CVCL_D443
AS   CVCL_0449
SY   mHypoE-N42; N42; N-42
DR   MCCL; MCC:0000346
DR   Wikidata; Q54905653
RX   PubMed=19605792;
RX   PubMed=32575098;
RX   PubMed=32960947;
WW   Provider; Cedarlane; CLU122; https://www.cedarlanelabs.com/Products/Detail/CLU122?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   mHypoE-43
AC   CVCL_A0SJ
SY   mHypoE-N43; N43; N-43
DR   Wikidata; Q108820930
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   mHypoE-43/1
AC   CVCL_D444
SY   mHypoE-N43/1; N43/1
DR   Wikidata; Q54905654
WW   Provider; Cedarlane; CLU123; https://www.cedarlanelabs.com/Products/Detail/CLU123?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/10
AC   CVCL_D445
SY   mHypoE-N43/10; N43/10
DR   Wikidata; Q54905655
WW   Provider; Cedarlane; CLU132; https://www.cedarlanelabs.com/Products/Detail/CLU132?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/13
AC   CVCL_D446
SY   mHypoE-N43/13; N43/13
DR   Wikidata; Q54905656
WW   Provider; Cedarlane; CLU133; https://www.cedarlanelabs.com/Products/Detail/CLU133?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/14
AC   CVCL_D447
SY   mHypoE-N43/14; N43/14
DR   Wikidata; Q54905657
WW   Provider; Cedarlane; CLU134; https://www.cedarlanelabs.com/Products/Detail/CLU134?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/15
AC   CVCL_D448
SY   mHypoE-N43/15; N43/15
DR   Wikidata; Q54905658
WW   Provider; Cedarlane; CLU135; https://www.cedarlanelabs.com/Products/Detail/CLU135?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/2
AC   CVCL_D449
SY   mHypoE-N43/2; N43/2
DR   Wikidata; Q54905659
WW   Provider; Cedarlane; CLU124; https://www.cedarlanelabs.com/Products/Detail/CLU124?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/3
AC   CVCL_D450
SY   mHypoE-N43/3; N43/3
DR   Wikidata; Q54905660
WW   Provider; Cedarlane; CLU125; https://www.cedarlanelabs.com/Products/Detail/CLU125?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/4
AC   CVCL_D451
SY   mHypoE-N43/4; N43/4
DR   Wikidata; Q54905661
WW   Provider; Cedarlane; CLU126; https://www.cedarlanelabs.com/Products/Detail/CLU126?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/5
AC   CVCL_D452
SY   mHypoE-N43/5; N43/5
DR   BTO; BTO_0006075
DR   Wikidata; Q54905662
WW   Provider; Cedarlane; CLU127; https://www.cedarlanelabs.com/Products/Detail/CLU127?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/6
AC   CVCL_D453
SY   mHypoE-N43/6; N43/6
DR   Wikidata; Q54905663
WW   Provider; Cedarlane; CLU128; https://www.cedarlanelabs.com/Products/Detail/CLU128?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/7
AC   CVCL_D454
SY   mHypoE-N43/7; N43/7
DR   Wikidata; Q54905664
WW   Provider; Cedarlane; CLU129; https://www.cedarlanelabs.com/Products/Detail/CLU129?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/8
AC   CVCL_D455
SY   mHypoE-N43/8; N43/8
DR   Wikidata; Q54905665
WW   Provider; Cedarlane; CLU130; https://www.cedarlanelabs.com/Products/Detail/CLU130?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-43/9
AC   CVCL_D456
SY   mHypoE-N43/9; N43/9
DR   Wikidata; Q54905666
WW   Provider; Cedarlane; CLU131; https://www.cedarlanelabs.com/Products/Detail/CLU131?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0SJ ! mHypoE-43
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-44
AC   CVCL_D457
SY   mHypoE-N44; N44
DR   Wikidata; Q54905667
RX   PubMed=32575098;
RX   PubMed=32960947;
WW   Provider; Cedarlane; CLU136; https://www.cedarlanelabs.com/Products/Detail/CLU136?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-45
AC   CVCL_D458
SY   mHypoE-N45; N45
DR   Wikidata; Q54905668
WW   Provider; Cedarlane; CLU137; https://www.cedarlanelabs.com/Products/Detail/CLU137?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-46
AC   CVCL_D459
SY   mHypoE-N46; N46
DR   Wikidata; Q54905669
RX   PubMed=32575098;
RX   PubMed=32960947;
WW   Provider; Cedarlane; CLU138; https://www.cedarlanelabs.com/Products/Detail/CLU138?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-47
AC   CVCL_D460
SY   mHypoE-N47; N47
DR   Wikidata; Q54905670
WW   Provider; Cedarlane; CLU139; https://www.cedarlanelabs.com/Products/Detail/CLU139?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-6
AC   CVCL_D461
SY   mHypoE-N6; N6; N-6
DR   Wikidata; Q54905671
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU104; https://www.cedarlanelabs.com/Products/Detail/CLU104?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-7
AC   CVCL_D462
SY   mHypoE-N7; N7; N-7
DR   Wikidata; Q54905672
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU105; https://www.cedarlanelabs.com/Products/Detail/CLU105?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Belsham, Denise D.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mHypoE-8
AC   CVCL_D463
SY   mHypoE-N8; N8; N-8
DR   Wikidata; Q54905673
RX   PubMed=14551229;
WW   Provider; Cedarlane; CLU106; https://www.cedarlanelabs.com/Products/Detail/CLU106?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   MI #1
AC   CVCL_1E43
SY   MI 1
DR   Wikidata; Q54905674
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=3518877;
CC   Doubling time: 48 hours (Note=At 46th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   MI 5G
AC   CVCL_UI45
SY   MI-5G
DR   Wikidata; Q95989652
RX   DOI=10.1007/BF02624448;
CC   Group: Nematode cell line.
CC   Doubling time: ~24 hours (DOI=10.1007/BF02624448).
OX   NCBI_TaxID=6306; ! Meloidogyne incognita (Southern root-knot nematode)
SX   Female
AG   Mature
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   MI 8C
AC   CVCL_UI46
SY   MI-8C
DR   Wikidata; Q95989654
RX   DOI=10.1007/BF02624448;
CC   Group: Nematode cell line.
CC   Doubling time: ~96 hours (DOI=10.1007/BF02624448).
OX   NCBI_TaxID=6306; ! Meloidogyne incognita (Southern root-knot nematode)
SX   Female
AG   Mature
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   Mi Ten
AC   CVCL_3024
AS   CVCL_V561
SY   Mi-Ten; MiTen
DR   ATCC; CRL-1113
DR   BioSample; SAMN03471061
DR   JCRB; JCRB0072
DR   Wikidata; Q54905675
RX   PubMed=7471105;
CC   Discontinued: ATCC; CRL-1113; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0072
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12,14
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   MI-31
AC   CVCL_JX98
DR   Wikidata; Q54905676
RX   PubMed=8055485;
RX   PubMed=10214354;
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MI-4 [Human glioblastoma]
AC   CVCL_N722
SY   MI4
DR   Wikidata; Q54905677
RX   PubMed=8055485;
RX   PubMed=10214354;
RX   PubMed=16102584;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, parieto-temporal lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   MI-4 [Human lung carcinoma]
AC   CVCL_6294
DR   Wikidata; Q54905678
RX   PubMed=12079515;
RX   PubMed=16820947;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MI-4
CC   Population: Japanese.
CC   Characteristics: High expression of CSF3 (PubMed=12079515).
CC   Doubling time: 96 hours (PubMed=12079515).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   MI-APY
AC   CVCL_VK39
DR   Wikidata; Q95989671
RX   CelloPub=CLPUB00435;
RX   PubMed=2095701;
CC   Karyotypic information: 46,XY,t(1;16)(q12;p13.2) (PubMed=2095701).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   MI5-4
AC   CVCL_IP24
DR   Wikidata; Q54905682
RX   PubMed=9753618;
RX   PubMed=20331963;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 7
//
ID   MI8-5
AC   CVCL_IP25
DR   BTO; BTO_0005972
DR   Wikidata; Q54905683
RX   PubMed=9753618;
RX   PubMed=9884408;
RX   PubMed=20331963;
CC   Characteristics: Lacks glucosyltransferase I (ALG6) activity.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   MIA PaCa-2
AC   CVCL_0428
SY   MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MIAPACA-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2; MiaPaCa; MIAMI Pancreatic Carcinoma-2
DR   BTO; BTO_0002137
DR   CLO; CLO_0007726
DR   CLO; CLO_0050101
DR   EFO; EFO_0002236
DR   MCCL; MCC:0000325
DR   CLDB; cl3480
DR   CLDB; cl3481
DR   CLDB; cl3482
DR   AddexBio; C0018002/59
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3263
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1420
DR   ATCC; CRM-CRL-1420
DR   BCRC; 60139
DR   BCRJ; 0174
DR   BioGRID_ORCS_Cell_line; 544
DR   BioSample; SAMN01821579
DR   BioSample; SAMN01821700
DR   BioSample; SAMN03472131
DR   BioSample; SAMN10988205
DR   cancercelllines; CVCL_0428
DR   CCRID; 3101HUMSCSP568
DR   CCRID; 4201HUM-CCTCC00255
DR   CCTCC; GDC0255
DR   Cell_Model_Passport; SIDM00505
DR   CGH-DB; 321-1
DR   CGH-DB; 9374-4
DR   ChEMBL-Cells; CHEMBL3308500
DR   ChEMBL-Targets; CHEMBL614725
DR   CLS; 300438
DR   Cosmic; 707249
DR   Cosmic; 710861
DR   Cosmic; 719677
DR   Cosmic; 724644
DR   Cosmic; 724870
DR   Cosmic; 730532
DR   Cosmic; 808172
DR   Cosmic; 868243
DR   Cosmic; 872996
DR   Cosmic; 913313
DR   Cosmic; 918056
DR   Cosmic; 922249
DR   Cosmic; 923170
DR   Cosmic; 932520
DR   Cosmic; 947399
DR   Cosmic; 948373
DR   Cosmic; 948731
DR   Cosmic; 949234
DR   Cosmic; 968107
DR   Cosmic; 1006368
DR   Cosmic; 1066202
DR   Cosmic; 1108337
DR   Cosmic; 1198208
DR   Cosmic; 1299302
DR   Cosmic; 1320461
DR   Cosmic; 1366278
DR   Cosmic; 1477431
DR   Cosmic; 1534318
DR   Cosmic; 1571779
DR   Cosmic; 1609545
DR   Cosmic; 1644314
DR   Cosmic; 1995507
DR   Cosmic; 2434084
DR   Cosmic; 2664042
DR   Cosmic; 2668287
DR   Cosmic; 2755950
DR   Cosmic-CLP; 724870
DR   DepMap; ACH-000601
DR   DSMZ; ACC-733
DR   DSMZCellDive; ACC-733
DR   ECACC; 85062806
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10488-107B2
DR   FCS-free; 216-2-440-1-3-6
DR   GDSC; 724870
DR   GEO; GSM206526
DR   GEO; GSM244425
DR   GEO; GSM621895
DR   GEO; GSM784703
DR   GEO; GSM887320
DR   GEO; GSM888396
DR   GEO; GSM1024404
DR   GEO; GSM1374677
DR   GEO; GSM1374678
DR   GEO; GSM1374679
DR   GEO; GSM1435696
DR   GEO; GSM1435697
DR   GEO; GSM1435698
DR   GEO; GSM1588612
DR   GEO; GSM1588624
DR   GEO; GSM1670109
DR   GEO; GSM5481591
DR   GEO; GSM5481592
DR   GEO; GSM5481593
DR   GEO; GSM5481594
DR   IARC_TP53; 316
DR   IGRhCellID; MIAPaCa
DR   IZSLER; BS TCL 42
DR   JCRB; JCRB0070
DR   KCLB; 21420
DR   LiGeA; CCLE_231
DR   LINCS_LDP; LCL-1738
DR   Lonza; 751
DR   MetaboLights; MTBLS812
DR   NCBI_Iran; C459
DR   PharmacoDB; MIAPaCa2_931_2019
DR   PRIDE; PXD001260
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0428
DR   PubChem_Cell_line; CVCL_0428
DR   RCB; RCB2094
DR   SKY/M-FISH/CGH; 1996
DR   TKG; TKG 0227
DR   Wikidata; Q54905679
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=832918;
RX   PubMed=1630814;
RX   PubMed=1764370;
RX   PubMed=7809022;
RX   PubMed=7961102;
RX   PubMed=8026879;
RX   PubMed=8194712;
RX   PubMed=9290701;
RX   PubMed=10027410;
RX   PubMed=11115575;
RX   PubMed=11169957;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12068308;
RX   PubMed=12692724;
RX   PubMed=14695172;
RX   PubMed=15770730;
RX   PubMed=16912165;
RX   PubMed=17254797;
RX   PubMed=18298655;
RX   PubMed=18380791;
RX   PubMed=18575732;
RX   PubMed=19077451;
RX   PubMed=19188929;
RX   PubMed=19904223;
RX   PubMed=20037478;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20418756;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23386380;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25485960;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26884312;
RX   PubMed=27067801;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31037374;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32782605;
RX   PubMed=34207840;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/MIA%20PaCA-2.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=64
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MIA_PaCa-2
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/pancreatic-xenograft-models/miapaca-2-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=832918); 26 hours (PubMed=25984343); 25.7 +- 4.3 hours (PubMed=27067801); 40 hours, 18 hours (Note=In serum-free medium) (PubMed=23386380); ~40 hours (ATCC=CRL-1420); ~30-40 hours (DSMZ=ACC-733).
CC   HLA typing: A*02,24; B*01,46; C*03 (PubMed=18575732).
CC   HLA typing: A*24:02:01; B*14:02:01; C*08:02:01; DPB1*02:01:02; DQA1*01:01:02; DQB1*05:01:01; DRB1*01:02:01 (CLS=300438).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=7961102; PubMed=8026879; PubMed=11115575; PubMed=11169959; PubMed=11787853; PubMed=12068308; PubMed=21607521; Cosmic-CLP=724870; DepMap=ACH-000601).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=1630814; PubMed=1764370; PubMed=7961102; PubMed=8026879; PubMed=8194712; PubMed=11115575; PubMed=11169959; PubMed=11787853; PubMed=21607521; Cosmic-CLP=724870; DepMap=ACH-000601).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.15%; Native American=0%; East Asian, North=3.82%; East Asian, South=0%; South Asian=8.7%; European, North=22.54%; European, South=63.79% (PubMed=30894373).
CC   Caution: Additional TP53 mutation in c.818G>A indicated incorrectly in PubMed=1630814.
CC   Misspelling: MiaPaCa-1; PubMed=15770730.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): AddexBio=C0018002/59; ATCC=CRL-1420; CCRID; Cosmic-CLP=724870; DSMZ=ACC-733; ECACC=85062806; JCRB=JCRB0070; KCLB=21420; PubMed=17254797; PubMed=25877200; RCB=RCB2094; Technion Genomics Center; TKG=TKG 0227
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 14,15
ST   D12S391: 19
ST   D13S317: 12,13
ST   D16S539: 10,13 (AddexBio=C0018002/59; ATCC=CRL-1420; CCRID; Cosmic-CLP=724870; DSMZ=ACC-733; ECACC=85062806; JCRB=JCRB0070; PubMed=25877200; RCB=RCB2094; Technion Genomics Center; TKG=TKG 0227)
ST   D16S539: 11,13 (PubMed=17254797)
ST   D18S51: 12
ST   D19S433: 15
ST   D1S1656: 15,17.3
ST   D21S11: 29,31 (PubMed=17254797)
ST   D21S11: 29,31.2 (ATCC=CRL-1420; CCRID; DSMZ=ACC-733; PubMed=25877200; Technion Genomics Center)
ST   D22S1045: 16
ST   D2S1338: 25
ST   D2S441: 14
ST   D3S1358: 16
ST   D5S818: 12,13 (AddexBio=C0018002/59; ATCC=CRL-1420; CCRID; Cosmic-CLP=724870; DSMZ=ACC-733; ECACC=85062806; JCRB=JCRB0070; PubMed=25877200; RCB=RCB2094; Technion Genomics Center; TKG=TKG 0227)
ST   D5S818: 13 (PubMed=17254797)
ST   D6S1043: 12
ST   D7S820: 12 (KCLB=21420)
ST   D7S820: 12,13 (AddexBio=C0018002/59; ATCC=CRL-1420; CCRID; Cosmic-CLP=724870; DSMZ=ACC-733; ECACC=85062806; JCRB=JCRB0070; PubMed=17254797; PubMed=25877200; RCB=RCB2094; Technion Genomics Center; TKG=TKG 0227)
ST   D8S1179: 16
ST   FGA: 22
ST   Penta D: 12,16
ST   Penta E: 13,18
ST   TH01: 9,10
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   MIA PaCa-2 GR2000
AC   CVCL_WI23
SY   MiaPaCa-2 GR2000; Gr2000
DR   cancercelllines; CVCL_WI23
DR   Wikidata; Q95989680
RX   PubMed=25485960;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   MIA PaCa-2 GR300
AC   CVCL_WI24
SY   MiaPaCa-2 GR300
DR   cancercelllines; CVCL_WI24
DR   Wikidata; Q95989682
RX   PubMed=25485960;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   MIA PaCa-2 GR800
AC   CVCL_WI25
SY   MiaPaCa-2 GR800
DR   cancercelllines; CVCL_WI25
DR   Wikidata; Q95989683
RX   PubMed=25485960;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   MIA PaCa-2/CMV-Luc
AC   CVCL_JG54
DR   cancercelllines; CVCL_JG54
DR   JCRB; JCRB1681
DR   Wikidata; Q54905680
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1681).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   TH01: 9,10
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 16
//
ID   MiaPaCa-2 F-RFP
AC   CVCL_E9C2
SY   MiaPaCa-2-RFP
RX   PubMed=26999607;
RX   PubMed=35881881;
CC   Population: Caucasian.
CC   Characteristics: Expresses farnesylated RFP (PubMed=26999607).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MiaPaCa(BCRP)
AC   CVCL_C7SQ
SY   MiaPaCaBCRP
DR   Wikidata; Q117704706
RX   PubMed=19188929;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_91367; Barasertib-HQPA (AZD1152-HQPA).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   MIB 1
AC   CVCL_C7XS
SY   MIB-1
DR   Wikidata; Q123033048
RX   PubMed=1484317;
RX   PubMed=7685843;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   MIB 2
AC   CVCL_C7XT
SY   MIB-2
DR   Wikidata; Q123033049
RX   PubMed=1484317;
RX   PubMed=7685843;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   MIB 3
AC   CVCL_C7XU
SY   MIB-3
DR   Wikidata; Q123033050
RX   PubMed=1484317;
RX   PubMed=7685843;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P46013; Human MKI67.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   MIC
AC   CVCL_EI96
DR   cancercelllines; CVCL_EI96
DR   Cosmic; 2250464
DR   GEO; GSM5359676
DR   GEO; GSM5359677
DR   GEO; GSM5359678
DR   GEO; GSM5359679
DR   GEO; GSM5359680
DR   GEO; GSM5359681
DR   GEO; GSM5362930
DR   GEO; GSM5362931
DR   GEO; GSM5362932
DR   GEO; GSM5362933
DR   GEO; GSM5362934
DR   GEO; GSM5362935
DR   GEO; GSM5363981
DR   GEO; GSM5363982
DR   GEO; GSM5363983
DR   GEO; GSM5363984
DR   GEO; GSM5363985
DR   Wikidata; Q54905684
RX   DOI=10.5282/edoc.27750;
RX   PubMed=25223734;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   From: Delattre, Olivier; Institut Curie; Paris; France.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Arg216Ter (c.646C>T); Zygosity=Unspecified (PubMed=25223734).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=25223734).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   MICCNi001-A
AC   CVCL_UM13
SY   ADHD Stem Cell Study_subject 6, hiPSC_03 family control sibling, clone C1
DR   BioSamples; SAMEA4984139
DR   hPSCreg; MICCNi001-A
DR   Wikidata; Q95989693
RX   PubMed=30622032;
CC   From: Monash Institute of Cognitive and Clinical Neurosciences, Monash University; Victoria; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM14 ! MICCNi001-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MICCNi001-B
AC   CVCL_UM14
SY   ADHD Stem Cell Study_subject 6, hiPSC_03 family control sibling, clone C2
DR   BioSamples; SAMEA4984141
DR   hPSCreg; MICCNi001-B
DR   Wikidata; Q95989694
RX   PubMed=30622032;
CC   From: Monash Institute of Cognitive and Clinical Neurosciences, Monash University; Victoria; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM13 ! MICCNi001-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MICCNi002-A
AC   CVCL_UM15
SY   ADHD Stem Cell Study_subject 5, hiPSC_03 affected sibling, clone A1
DR   BioSamples; SAMEA4984142
DR   hPSCreg; MICCNi002-A
DR   Wikidata; Q95989695
RX   PubMed=30622032;
CC   From: Monash Institute of Cognitive and Clinical Neurosciences, Monash University; Victoria; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM16 ! MICCNi002-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MICCNi002-B
AC   CVCL_UM16
SY   ADHD Stem Cell Study_subject 5, hiPSC_03 affected sibling, clone A16
DR   BioSamples; SAMEA4984143
DR   hPSCreg; MICCNi002-B
DR   Wikidata; Q95989696
RX   PubMed=30622032;
CC   From: Monash Institute of Cognitive and Clinical Neurosciences, Monash University; Victoria; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM15 ! MICCNi002-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MiCl1 (S+L-)
AC   CVCL_3405
SY   S+L- MiCl1; MiCl1; S+L-Mink; S+L-mink
DR   CLO; CLO_0007727
DR   CLO; CLO_0007728
DR   CLO; CLO_0051611
DR   CLDB; cl3483
DR   CLDB; cl3484
DR   CLDB; cl3485
DR   ATCC; CCL-64.1
DR   ECACC; 86020603
DR   ICLC; ATL97001
DR   IZSLER; BS CL 66
DR   RCB; RCB1834
DR   Wikidata; Q54905685
RX   PubMed=52940;
RX   PubMed=170737;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
HI   CVCL_0593 ! Mv1Lu
SX   Mixed sex
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Middle91
AC   CVCL_W860
SY   Middle 91
DR   Wikidata; Q54905686
RX   PubMed=8704258;
RX   PubMed=8847894;
RX   PubMed=9454894;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Doubling time: 27.5 hours (PubMed=8847894).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Indicated as originating from a 3 year old female patient in text of PubMed=8847894 and from a 4 year old in table 1 of same paper.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   Mieliki
AC   CVCL_QW69
SY   MIELIKI
DR   Wikidata; Q54905689
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630198;
RX   PubMed=7919343;
CC   Doubling time: ~5-6 days (PubMed=7630198).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   MIEU
AC   CVCL_H208
SY   Mieu
DR   Wikidata; Q54905690
RX   PubMed=15122589;
CC   From: Al Saati, Talal; Hopital de Purpan, Centre Hospitalier Universitaire de Toulouse; Toulouse; France.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   MiF-6
AC   CVCL_3750
SY   MiF-6 [Mutatect]
DR   CLO; CLO_0007729
DR   ATCC; CRL-2802
DR   Wikidata; Q54905691
RX   PubMed=14732341;
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4982 ! MC-TGS17-51
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MigA9
AC   CVCL_C5RM
DR   ChEMBL-Cells; CHEMBL4879542
DR   GEO; GSE111109
DR   Wikidata; Q116049792
RX   PubMed=30645099;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96180; Hoxa9.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   MIH5
AC   CVCL_CW88
DR   Wikidata; Q54905692
RX   PubMed=14515261;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   MIH5(GIT)
AC   CVCL_C663
DR   CLO; CLO_0050519
DR   RCB; RCB2305
DR   Wikidata; Q54905693
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_CW88 ! MIH5
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   MIH5(RPMI)
AC   CVCL_C664
DR   CLO; CLO_0050520
DR   RCB; RCB2324
DR   Wikidata; Q54905694
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_CW88 ! MIH5
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   MIH6
AC   CVCL_CW89
DR   Wikidata; Q54905695
RX   PubMed=12421930;
RX   PubMed=14515261;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   MIHA
AC   CVCL_SA11
SY   IHHA-1; IHH; Immortalized Human Hepatocytes
DR   BTO; BTO_0006471
DR   EGA; EGAD00001004475
DR   Wikidata; Q54905696
RX   Patent=US20010007153;
RX   PubMed=10613743;
RX   PubMed=23376363;
CC   Doubling time: 72 hours (PubMed=10613743).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 10
//
ID   MIHe001-A
AC   CVCL_C382
SY   Maria Biotech 01; MB01
DR   hPSCreg; MIHe001-A
DR   SKIP; SKIP002013
DR   Wikidata; Q54905697
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MIHe002-A
AC   CVCL_C383
SY   Maria Biotech 02; MB02
DR   hPSCreg; MIHe002-A
DR   SKIP; SKIP002014
DR   Wikidata; Q54905698
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MIHe003-A
AC   CVCL_C384
SY   Maria Biotech 03; MB03
DR   hPSCreg; MIHe003-A
DR   SKIP; SKIP002015
DR   Wikidata; Q54905699
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MIHe004-A
AC   CVCL_C385
SY   Maria Biotech 04; MB04
DR   hPSCreg; MIHe004-A
DR   SKIP; SKIP002055
DR   Wikidata; Q54905700
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MIHe005-A
AC   CVCL_C386
SY   Maria Biotech 05; MB05
DR   hPSCreg; MIHe005-A
DR   SKIP; SKIP002056
DR   Wikidata; Q54905701
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MIHe006-A
AC   CVCL_C387
SY   Maria Biotech 06; MB06
DR   hPSCreg; MIHe006-A
DR   SKIP; SKIP002057
DR   Wikidata; Q54905702
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MIHe007-A
AC   CVCL_C388
SY   Maria Biotech 07; MB07
DR   hPSCreg; MIHe007-A
DR   SKIP; SKIP002058
DR   Wikidata; Q54905703
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MIHe008-A
AC   CVCL_C389
SY   Maria Biotech 08; MB08
DR   hPSCreg; MIHe008-A
DR   SKIP; SKIP002059
DR   Wikidata; Q54905704
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MIHe009-A
AC   CVCL_C390
SY   Maria Biotech 09; MB09
DR   hPSCreg; MIHe009-A
DR   SKIP; SKIP002060
DR   Wikidata; Q54905705
RX   PubMed=14998970;
CC   From: Maria Infertility Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MIKA
AC   CVCL_E776
SY   5194
DR   dbMHC; 48971
DR   ECACC; 94071407
DR   IHW; IHW09274
DR   IPD-IMGT/HLA; 11075
DR   Wikidata; Q54905706
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*02:01,80:01; B*18,15:03; C*02:02; DPB1*03:01,01:01:02 (IPD-IMGT/HLA=11075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 16
//
ID   Mil Kin
AC   CVCL_0F66
DR   ATCC; CRL-1123
DR   Wikidata; Q54905707
CC   Discontinued: ATCC; CRL-1123; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   MIL-38 IF5
AC   CVCL_XI28
DR   Wikidata; Q95989720
RX   Patent=US10577418;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Cell Bank Australia; CBA20140026.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35052; Human GPC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6G47 ! BLCA-38
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   Mile Sven 1
AC   CVCL_6502
SY   MILE SVEN 1; Mile Sven-1; MILE-SVEN-1; MILE SVEN1; MS-1; MS1
DR   BTO; BTO_0006355
DR   CLO; CLO_0007875
DR   ATCC; CRL-2279
DR   BCRC; 60150
DR   BioSample; SAMN11397645
DR   CCRID; 3101MOUGNM20
DR   CLS; 305162
DR   KCB; KCB 2011117YJ
DR   Wikidata; Q54906798
RX   PubMed=9023347;
RX   PubMed=31220119;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-126.html
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 16,17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,16,17
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   Mili-KO GS
AC   CVCL_1T54
DR   RCB; AES0197
DR   SKIP; SKIP002936
DR   Wikidata; Q54905708
RX   PubMed=23611983;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   MILi001-A
AC   CVCL_A8MM
SY   K10; hFF-iPSCs
DR   BioSamples; SAMEA9086589
DR   hPSCreg; MILi001-A
DR   Wikidata; Q108820931
RX   PubMed=28943253;
CC   From: Miltenyi Biotec B.V.; Gladbach; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): hPSCreg=MILi001-A
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 5
//
ID   MILi001-B
AC   CVCL_B5IQ
SY   F5
DR   BioSamples; SAMEA9268200
DR   hPSCreg; MILi001-B
DR   Wikidata; Q110433030
CC   From: Miltenyi Biotec B.V.; Gladbach; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): hPSCreg=MILi001-B
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 5
//
ID   MILi001-C
AC   CVCL_B5IR
SY   F10
DR   BioSamples; SAMEA9268203
DR   hPSCreg; MILi001-C
DR   Wikidata; Q110433031
CC   From: Miltenyi Biotec B.V.; Gladbach; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): hPSCreg=MILi001-C
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 5
//
ID   MILOT
AC   CVCL_C8CZ
DR   Wikidata; Q123033052
RX   PubMed=8205524;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   MIM/8
AC   CVCL_Y662
DR   Wikidata; Q54905709
RX   PubMed=1383272;
CC   Characteristics: Pigmented.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   MIMA-10
AC   CVCL_E8PK
RX   PubMed=10468879;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-107
AC   CVCL_E8VL
RX   PubMed=14675417;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q16570; Human ACKR1/CD234 (Note=Recognies blood group antigen Fy6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-108
AC   CVCL_E8VM
RX   PubMed=14675417;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q16570; Human ACKR1/CD234 (Note=Recognies blood group antigen Fy6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-123
AC   CVCL_E8VG
SY   6B5
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297 (Note=Recognizes Do(b) blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-125
AC   CVCL_E8VH
SY   5A11
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-127
AC   CVCL_E8VI
SY   7C8
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-143
AC   CVCL_E8VJ
SY   Mima-143; 1G8
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297 (Note=Recognizes Do(b) blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-144
AC   CVCL_E8VN
RX   PubMed=20406026;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-149
AC   CVCL_E8VP
RX   PubMed=20406026;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-174
AC   CVCL_E8P9
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with the 36-TKSYISSQTNGETGQLVHRF-55. Recognizes specifically the "s" blood group).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-175
AC   CVCL_E8PA
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with 36-TKSYISSQTNGETGQLVHRF-55. Recognizes specifically the "s" blood group).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-176
AC   CVCL_E8PB
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with 36-TKSYISSQTNGETGQLVHRF-55. Recognizes specifically the "s" blood group).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-177
AC   CVCL_E8PC
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with 36-TKSYISSQTNGETGQLVHRF-55).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-178
AC   CVCL_E8PD
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with 36-TKSYISSQTNGETGQLVHRF-55. Recognizes specifically the "s" blood group).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-179
AC   CVCL_E8PE
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with 36-TKSYISSQTNGETGQLVHRF-55).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-180
AC   CVCL_E8PF
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with 36-TKSYISSQTNGETGQLVHRF-55. Recognizes specifically the "s" blood group).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-181
AC   CVCL_E8PG
RX   PubMed=19040495;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P06028; Human GYPB/CD235b (Note=Immunized with 36-TKSYISSQTNGETGQLVHRF-55).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   MIMA-19
AC   CVCL_E8VK
RX   PubMed=14675417;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q16570; Human ACKR1/CD234 (Note=Recognies blood group antigen Fy(a)/Fy1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-25
AC   CVCL_E8VQ
RX   PubMed=20406026;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-29
AC   CVCL_E8YG
RX   PubMed=14675417;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q16570; Human ACKR1/CD234 (Note=Recognies blood group antigen Fy(a-b-)/Fy3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-52
AC   CVCL_E8VA
SY   10B5
RX   PubMed=16168396;
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-53
AC   CVCL_E8VB
SY   8E9
RX   PubMed=16168396;
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-55
AC   CVCL_E8VC
SY   7H6/F7
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297 (Note=Recognizes Do(b) blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-64
AC   CVCL_E8VD
SY   7H6/B3
RX   PubMed=16168396;
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297 (Note=Recognizes Do(b) blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-73
AC   CVCL_E8VE
SY   15D6
RX   PubMed=16168396;
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297 (Note=Recognizes Do(b) blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-8
AC   CVCL_E8PI
DR   ABCD; ABCD_AF238
RX   PubMed=10468879;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238 (Note=Recognizes blood group Jsb/KEL7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-9
AC   CVCL_E8PJ
RX   PubMed=10468879;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MIMA-98
AC   CVCL_E8VF
SY   7D10
RX   PubMed=16168396;
RX   PubMed=23421541;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   mIMCD-3
AC   CVCL_0429
SY   mIMCD3; IMCD-3; IMCD3; mouse Inner Medullary Collecting Duct-3
DR   BTO; BTO_0003913
DR   CLO; CLO_0007730
DR   EFO; EFO_0002073
DR   MCCL; MCC:0000500
DR   ATCC; CRL-2123
DR   BioSample; SAMN11397642
DR   Lonza; 10
DR   MetaboLights; MTBLS1093
DR   Wikidata; Q28472922
RX   PubMed=8214101;
RX   PubMed=31220119;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, inner medullary collecting duct; UBERON=UBERON_0004205.
CC   Breed/subspecies: Tg(SV40E)Bri/7 transgenic.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 13,19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 14,17
ST   Mouse STR 6-4: 15,18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16.2,17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   mIMCD-K2
AC   CVCL_0430
SY   mouse Inner Medullary Collecting Duct-K2
DR   MCCL; MCC:0000501
DR   Wikidata; Q54905710
RX   PubMed=7864176;
CC   Doubling time: 20.9 +- 1.4 hours (PubMed=7864176).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, inner medullary collecting duct; UBERON=UBERON_0004205.
CC   Breed/subspecies: Tg(SV40E)Bri/7 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   MIN
AC   CVCL_E777
DR   dbMHC; 48972
DR   ECACC; 940822102
DR   IHW; IHW09198
DR   IPD-IMGT/HLA; 11739
DR   Wikidata; Q54905711
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Indonesian.
CC   HLA typing: A*02; B*15:13; C*01,03; DPA1*01:03:01; DPB1*04:01,21:01; DQA1*01:02,06:01; DQB1*03:01,05:02; DRB1*12:02; DRB3*03:01 (IPD-IMGT/HLA=11739).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   MIN01i-32517.A
AC   CVCL_AS51
SY   MIN32517 A; 32517-A; XDPi001-A
DR   hPSCreg; XDPi001-A
DR   WiCell; min01i-32517-a
DR   Wikidata; Q54905712
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS52 ! MIN02i-32517.B
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN02i-32517.B
AC   CVCL_AS52
SY   MIN32517 B; 32517-B; XDPi001-B
DR   hPSCreg; XDPi001-B
DR   WiCell; min02i-32517-b
DR   Wikidata; Q54905713
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS51 ! MIN01i-32517.A
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN03i-32642.B
AC   CVCL_AS53
SY   MIN32642 B; 32642-B; XDPi002-A
DR   hPSCreg; XDPi002-A
DR   WiCell; min03i-32642-b
DR   Wikidata; Q54905714
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN04i-33109.2B
AC   CVCL_AS54
SY   MIN33109 2B; 33109-2B; XDPi003-A
DR   hPSCreg; XDPi003-A
DR   WiCell; min04i-33109-2b
DR   Wikidata; Q54905715
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YA ! MIN30i-33109.2G
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN05i-33110.2F
AC   CVCL_AS55
SY   MIN33110 2F; 33110-2F; XDPi004-A
DR   hPSCreg; XDPi004-A
DR   WiCell; min05i-33110-2f
DR   Wikidata; Q54905716
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS56 ! MIN06i-33110.2H
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN06i-33110.2H
AC   CVCL_AS56
SY   MIN33110 2H; 33110-2H; XDPi004-B
DR   hPSCreg; XDPi004-B
DR   WiCell; min06i-33110-2h
DR   Wikidata; Q54905717
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS55 ! MIN05i-33110.2F
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN07i-33113.2D
AC   CVCL_AS57
SY   MIN33113 2D; 33113-2D
DR   WiCell; min07i-33113-2d
DR   Wikidata; Q54905718
RX   PubMed=26769797;
CC   Discontinued: WiCell; min07i-33113-2d; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS72 ! MIN22i-33113.2I
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   MIN08i-33114.B
AC   CVCL_AS58
SY   MIN33114 B; 33114-B
DR   WiCell; min08i-33114-b
DR   Wikidata; Q54905719
RX   PubMed=26769797;
CC   Discontinued: WiCell; min08i-33114-b; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS59 ! MIN09i-33114.C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   MIN09i-33114.C
AC   CVCL_AS59
SY   MIN33114 C; 33114-C; XDPi005-A
DR   hPSCreg; XDPi005-A
DR   WiCell; min09i-33114-c
DR   Wikidata; Q54905720
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS58 ! MIN08i-33114.B
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN10i-33360.A
AC   CVCL_AS60
SY   MIN33360 A; 33360-A; XDPi006-A
DR   hPSCreg; XDPi006-A
DR   WiCell; min10i-33360-a
DR   Wikidata; Q54905721
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS61 ! MIN11i-33360.B
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN11i-33360.B
AC   CVCL_AS61
SY   MIN33360 B; 33360-B; XDPi006-B
DR   hPSCreg; XDPi006-B
DR   WiCell; min11i-33360-b
DR   Wikidata; Q54905722
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS60 ! MIN10i-33360.A
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN12i-33362.C
AC   CVCL_AS62
SY   MIN33362 C; 33362-C; XDPi007-A
DR   hPSCreg; XDPi007-A
DR   WiCell; min12i-33362-c
DR   Wikidata; Q54905723
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS63 ! MIN13i-33362.D
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN13i-33362.D
AC   CVCL_AS63
SY   MIN33362 D; 33362-D; XDPi007-B
DR   hPSCreg; XDPi007-B
DR   WiCell; min13i-33362-d
DR   Wikidata; Q54905724
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS62 ! MIN12i-33362.C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN14i-33363.C
AC   CVCL_AS64
SY   MIN33363 C; 33363-C; XDPi008-A
DR   hPSCreg; XDPi008-A
DR   WiCell; min14i-33363-c
DR   Wikidata; Q54905725
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS65 ! MIN15i-33363.D
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN15i-33363.D
AC   CVCL_AS65
SY   MIN33363 D; 33363-D; XDPi008-B
DR   hPSCreg; XDPi008-B
DR   WiCell; min15i-33363-d
DR   Wikidata; Q54905726
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS64 ! MIN14i-33363.C
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN16i-33808.A
AC   CVCL_AS66
SY   MIN33808 A; 33808-A; XDPi009-A
DR   hPSCreg; XDPi009-A
DR   WiCell; min16i-33808-a
DR   Wikidata; Q54905727
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS67 ! MIN17i-33808.B
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN17i-33808.B
AC   CVCL_AS67
SY   MIN33808 B; 33808-B
DR   WiCell; min17i-33808-b
DR   Wikidata; Q54905728
RX   PubMed=26769797;
CC   Discontinued: WiCell; min17i-33808-b; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS66 ! MIN16i-33808.A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN18i-33811.A
AC   CVCL_AS68
SY   MIN33811 A; 33811-A; XDPi010-A
DR   hPSCreg; XDPi010-A
DR   WiCell; min18i-33811-a
DR   Wikidata; Q54905733
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS69 ! MIN19i-33811.D
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   Min19913
AC   CVCL_IZ79
SY   Min 19913; Pt91; PT91
DR   GEO; GSM1204866
DR   GEO; GSM1468865
DR   GEO; GSM1468873
DR   GEO; GSM1468881
DR   GEO; GSM1468889
DR   GEO; GSM1468897
DR   GEO; GSM1468905
DR   PRIDE; PXD000419
DR   Wikidata; Q54905734
RX   PubMed=21321133;
RX   PubMed=24136357;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New Iberia Research Center, University of Louisiana at Lafayette; Lafayette; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   Min19919
AC   CVCL_IZ78
SY   Min 19919; Pt30
DR   GEO; GSM1468864
DR   GEO; GSM1468872
DR   GEO; GSM1468880
DR   GEO; GSM1468888
DR   GEO; GSM1468896
DR   GEO; GSM1468904
DR   Wikidata; Q54905735
RX   PubMed=21321133;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New Iberia Research Center, University of Louisiana at Lafayette; Lafayette; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   MIN19i-33811.D
AC   CVCL_AS69
SY   MIN33811 D; 33811-D; XDPi010-B
DR   hPSCreg; XDPi010-B
DR   WiCell; min19i-33811-d
DR   Wikidata; Q54905736
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS68 ! MIN18i-33811.A
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN20i-34363.A
AC   CVCL_AS70
SY   MIN34363 A; 34363-A; XDPi011-A
DR   hPSCreg; XDPi011-A
DR   WiCell; min20i-34363-a
DR   Wikidata; Q54905737
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS71 ! MIN21i-34363.B
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN21i-34363.B
AC   CVCL_AS71
SY   MIN34363 B; 34363-B; XDPi011-B
DR   hPSCreg; XDPi011-B
DR   WiCell; min21i-34363-b
DR   Wikidata; Q54905738
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS70 ! MIN20i-34363.A
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   MIN22i-33113.2I
AC   CVCL_AS72
SY   MIN33113 2I; 33113-2I; XDPi012-A
DR   hPSCreg; XDPi012-A
DR   WiCell; min22i-33113-2i
DR   Wikidata; Q54905739
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS57 ! MIN07i-33113.2D
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   MIN24i-35613.B
AC   CVCL_A1XU
SY   35613-B; XDPi013-A
DR   hPSCreg; XDPi013-A
DR   Wikidata; Q105510119
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1XV ! MIN25i-35613.SF-1
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   MIN25i-35613.SF-1
AC   CVCL_A1XV
SY   35613-SF-1; XDPi013-B
DR   hPSCreg; XDPi013-B
DR   Wikidata; Q105510122
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1XU ! MIN24i-35613.B
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   MIN26i-35326.I
AC   CVCL_A1XW
SY   35326-I; XDPi014-A
DR   hPSCreg; XDPi014-A
DR   Wikidata; Q105510125
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1XX ! MIN27i-35326.K
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   MIN27i-35326.K
AC   CVCL_A1XX
SY   35326-K; XDPi014-B
DR   hPSCreg; XDPi014-B
DR   Wikidata; Q105510131
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1XW ! MIN26i-35326.I
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   MIN28i-35833.A
AC   CVCL_A1XY
SY   35833-A; XDPi015-A
DR   hPSCreg; XDPi015-A
DR   Wikidata; Q105510134
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1XZ ! MIN29i-35833.B
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   MIN29i-35833.B
AC   CVCL_A1XZ
SY   35833-B; XDPi015-B
DR   hPSCreg; XDPi015-B
DR   Wikidata; Q105510138
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1XY ! MIN28i-35833.A
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   MIN30i-33109.2G
AC   CVCL_A1YA
SY   33109-2G; XDPi003-B
DR   hPSCreg; XDPi003-B
DR   Wikidata; Q105510141
RX   PubMed=26769797;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS54 ! MIN04i-33109.2B
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   MIN6
AC   CVCL_0431
SY   Min6; MIN-6; Mouse INsulinoma 6
DR   BTO; BTO_0002284
DR   EFO; EFO_0002829
DR   MCCL; MCC:0000326
DR   AddexBio; C0018008/403
DR   BCRJ; 0293
DR   ChEMBL-Cells; CHEMBL4483177
DR   ChEMBL-Targets; CHEMBL4483258
DR   CLS; 302148
DR   IBRC; C10524
DR   Lonza; 163
DR   PRIDE; PXD000589
DR   PRIDE; PXD001081
DR   PubChem_Cell_line; CVCL_0431
DR   Wikidata; Q12513178
RX   PubMed=2163307;
RX   PubMed=8697299;
RX   PubMed=8824267;
RX   PubMed=18845907;
RX   PubMed=22538498;
RX   PubMed=22808281;
RX   PubMed=23560115;
RX   PubMed=25546123;
RX   PubMed=25894527;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-93.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Subcellular; Endoplasmic reticulum.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MIN6 rho0
AC   CVCL_A7QH
SY   rho0 MIN6
DR   Wikidata; Q107116373
RX   PubMed=8824267;
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Obtained by growth of parental cell line with bis-4-piperidyle-dichloride (PubMed=8824267).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0431 ! MIN6
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   MIN6-CB4
AC   CVCL_A8QI
DR   Wikidata; Q108820932
RX   PubMed=33436850;
CC   Characteristics: Retains glucose-stimulated insulin secretion even after long-term culture (PubMed=33436850).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C3/Hej x C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   9W
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   MIN6-cl4
AC   CVCL_A8QH
SY   MIN6.cl4; MIN6 clone 4
DR   Wikidata; Q108820933
RX   PubMed=23560115;
RX   PubMed=33436850;
CC   Characteristics: Retains glucose-stimulated insulin secretion even after long-term culture (PubMed=23560115).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0431 ! MIN6
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   MIN6-K20
AC   CVCL_A8QF
DR   Wikidata; Q108820934
RX   PubMed=24843422;
CC   Characteristics: Responsive to insulin, but not to glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) (PubMed=24843422).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A8QG ! MIN6-K8
SX   Male
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   MIN6-K8
AC   CVCL_A8QG
DR   Wikidata; Q108820935
RX   PubMed=24843422;
RX   PubMed=33743067;
CC   Characteristics: Responsive to insulin, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) (PubMed=24843422).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A8QF ! MIN6-K20
SX   Male
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   MIN6-m14
AC   CVCL_4372
SY   MIN6m14; m14
DR   BTO; BTO_0003538
DR   Wikidata; Q54905740
RX   PubMed=11001758;
RX   PubMed=11272172;
CC   Characteristics: Glucose-unresponsive.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0431 ! MIN6
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   MIN6-m9
AC   CVCL_4371
SY   MIN6m9; m9
DR   BTO; BTO_0003537
DR   Wikidata; Q54905741
RX   PubMed=11001758;
RX   PubMed=11272172;
CC   Characteristics: Glucose-responsive.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0431 ! MIN6
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   MIN6N8
AC   CVCL_D686
SY   MIN6-N8; Min6 N8
DR   BTO; BTO_0005320
DR   Wikidata; Q54905742
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0431 ! MIN6
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   MIN6N8a
AC   CVCL_0432
DR   MCCL; MCC:0000327
DR   Wikidata; Q54905743
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT6 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D686 ! MIN6N8
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   MIN7
AC   CVCL_J994
SY   Mouse INsulinoma 7
DR   Wikidata; Q54905744
RX   PubMed=2163307;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BL/6 IT7 transgenic.
DI   NCIt; C34053; Mouse insulinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13W
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   Minami-1
AC   CVCL_8528
DR   JCRB; JCRB1404
DR   Wikidata; Q54905745
CC   Population: Japanese.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1404
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   Minami-2
AC   CVCL_8529
DR   JCRB; JCRB1405
DR   Wikidata; Q54905746
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1405
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   Minnesota EE
AC   CVCL_8264
SY   Minnesota-EE; Minn. EE; Minn EE
DR   ATCC; CCL-4
DR   BioSample; SAMN03151744
DR   Wikidata; Q54905747
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=5668122;
RX   PubMed=13472685;
RX   PubMed=14185313;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from the esophageal epithelium of a male infant with a tracheo-esophageal fistula.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00011.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-4; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   Mino
AC   CVCL_1872
SY   MINO
DR   EFO; EFO_0022501
DR   AddexBio; C0003033/4947
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-3000
DR   BioSample; SAMN03471705
DR   BioSample; SAMN10988480
DR   cancercelllines; CVCL_1872
DR   Cell_Model_Passport; SIDM01667
DR   ChEMBL-Cells; CHEMBL4523520
DR   ChEMBL-Targets; CHEMBL4523551
DR   Cosmic; 2078181
DR   Cosmic; 2088019
DR   Cosmic; 2756236
DR   DepMap; ACH-000220
DR   DSMZ; ACC-687
DR   DSMZCellDive; ACC-687
DR   GEO; GSM629496
DR   GEO; GSM629497
DR   GEO; GSM887321
DR   GEO; GSM888397
DR   GEO; GSM907522
DR   GEO; GSM1044970
DR   GEO; GSM1044971
DR   GEO; GSM1044972
DR   GEO; GSM1044973
DR   GEO; GSM1670110
DR   GEO; GSM2322625
DR   IARC_TP53; 17152
DR   LiGeA; CCLE_916
DR   Lonza; 165
DR   PharmacoDB; Mino_932_2019
DR   Progenetix; CVCL_1872
DR   PubChem_Cell_line; CVCL_1872
DR   Wikidata; Q54905748
RX   PubMed=12127561;
RX   PubMed=12683869;
RX   PubMed=21746927;
RX   PubMed=22460905;
RX   PubMed=24362935;
RX   PubMed=25315077;
RX   PubMed=25355872;
RX   PubMed=25688540;
RX   PubMed=25960936;
RX   PubMed=26194763;
RX   PubMed=28196595;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=25315077); ~50 hours (DSMZ=ACC-687).
CC   HLA typing: A*11:01,68:01; B*35:01,39:01; C*04:01,12:03; DQA1*01:02,01:02; DQB1*05:01,06:03; DRB1*01:01,13:01 (PubMed=25960936).
CC   HLA typing: A*11,68; B*35,39; C*04,12 (PubMed=25688540).
CC   HLA typing: A*11:01:01,68:01:01; B*35:01:01,39:01:01; C*04:01:01,12:03:01; DPA1*01:03:01,02:01:01; DPB1*10:01:01,10:01:01; DQA1*01:03:01,01:01:01; DQB1*05:01:01,06:03:01; DRA*01:01:01,01:02:02; DRB1*01:01:01,13:01:01 (DSMZCellDive=ACC-687).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu88Lys (c.262G>A); ClinVar=VCV000821566; Zygosity=Homozygous (DepMap=ACH-000220).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Heterozygous (DepMap=ACH-000220).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val147Gly (c.440T>G); Zygosity=Homozygous (DepMap=ACH-000220).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.85%; Native American=0%; East Asian, North=1.5%; East Asian, South=0%; South Asian=6.1%; European, North=39.56%; European, South=51.98% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003033/4947; ATCC=CRL-3000; DSMZ=ACC-687
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23,25
ST   Penta D: 12,13
ST   Penta E: 5,17
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   MINO
AC   CVCL_UW35
DR   Wikidata; Q95989771
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MINT1
AC   CVCL_A5XK
DR   Wikidata; Q107116375
RX   PubMed=15943790;
CC   Population: Japanese.
CC   Doubling time: ~45 hours (PubMed=15943790).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C3717; Melanotic neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5XL ! MINT2
OI   CVCL_A5XM ! MINT3
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   MINT2
AC   CVCL_A5XL
DR   Wikidata; Q107116376
RX   PubMed=15943790;
CC   Population: Japanese.
CC   Doubling time: ~45 hours (PubMed=15943790).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C3717; Melanotic neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5XK ! MINT1
OI   CVCL_A5XM ! MINT3
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   MINT3
AC   CVCL_A5XM
DR   Wikidata; Q107116378
RX   PubMed=15943790;
CC   Population: Japanese.
CC   Doubling time: ~45 hours (PubMed=15943790).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
DI   NCIt; C3717; Melanotic neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5XK ! MINT1
OI   CVCL_A5XL ! MINT2
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   MIO-M1
AC   CVCL_0433
SY   Moorfields/Institute of Ophthalmology-Muller 1
DR   BTO; BTO_0003062
DR   MCCL; MCC:0000328
DR   MetaboLights; MTBLS1228
DR   PRIDE; PXD008485
DR   Wikidata; Q54905749
RX   PubMed=11867609;
RX   PubMed=17525239;
RX   PubMed=22065927;
RX   PubMed=30176221;
RX   PubMed=31254428;
RX   PubMed=32152301;
WW   Provider; UCLB; -; https://xip.uclb.com/product/MIO_M1_cells
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   MIO-M2
AC   CVCL_ZF61
SY   Moorfields/Institute of Ophthalmology-Muller 2
DR   Wikidata; Q98127239
RX   PubMed=17525239;
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   MIO-M3
AC   CVCL_ZF62
SY   Moorfields/Institute of Ophthalmology-Muller 3
DR   Wikidata; Q98127240
RX   PubMed=17525239;
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   MIO-M4
AC   CVCL_ZF63
SY   6391; Moorfields/Institute of Ophthalmology-Muller 4
DR   PRIDE; PXD008485
DR   Wikidata; Q98127241
RX   PubMed=17525239;
RX   PubMed=30176221;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   MIO-M5
AC   CVCL_ZF64
SY   6390; Moorfields/Institute of Ophthalmology-Muller 5
DR   PRIDE; PXD008485
DR   Wikidata; Q98127243
RX   PubMed=17525239;
RX   PubMed=30176221;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   MIO-M6
AC   CVCL_ZF65
SY   Moorfields/Institute of Ophthalmology-Muller 6
DR   Wikidata; Q98127244
RX   PubMed=17525239;
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   MIO-M7
AC   CVCL_ZF66
SY   6387; Moorfields/Institute of Ophthalmology-Muller 7
DR   PRIDE; PXD008485
DR   Wikidata; Q98127246
RX   PubMed=17525239;
RX   PubMed=30176221;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   MIP-101
AC   CVCL_H689
SY   MIP 101; MIP101
DR   cancercelllines; CVCL_H689
DR   ColonAtlas; MIP101
DR   Cosmic; 1374639
DR   GEO; GSM587038
DR   GEO; GSM1448116
DR   IARC_TP53; 4562
DR   Wikidata; Q54905751
RX   PubMed=2228514;
RX   PubMed=3442732;
RX   PubMed=7651727;
RX   PubMed=7757961;
RX   PubMed=10949995;
RX   PubMed=15902309;
RX   PubMed=20835245;
RX   PubMed=23671654;
RX   PubMed=25926053;
RX   PubMed=25960936;
CC   Group: Space-flown cell line (cellonaut).
CC   Doubling time: 22 hours (PubMed=3442732); 15.7 hours (PubMed=7757961).
CC   HLA typing: A*24:02,02:01; B*35:08,35:08; C*07:01,04:01 (PubMed=25960936).
CC   Microsatellite instability: Instable (MSI) (PubMed=23671654; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=7651727).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Anecdotal: Have been flown in space on shuttle flights STS-70 and STS-85 to study growth in microgravity (PubMed=10949995).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D21S11: 29,32.2
ST   D5S818: 13
ST   D7S820: 10,11.3
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   MIP-CEA clone 17
AC   CVCL_C9CQ
SY   Clone 17
DR   Wikidata; Q123033053
RX   PubMed=7757961;
CC   Characteristics: Tumorigenic when injected subcutaneously in nude mice (PubMed=7757961).
CC   Doubling time: 32.0 hours (PubMed=7757961).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MIP-CEA clone 6
AC   CVCL_C9CR
SY   Clone 6
DR   Wikidata; Q123033054
RX   PubMed=7757961;
CC   Characteristics: Tumorigenic when injected subcutaneously in nude mice (PubMed=7757961).
CC   Doubling time: 28.8 hours (PubMed=7757961).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MIP-CEA clone 8
AC   CVCL_C9CS
SY   Clone 8
DR   Wikidata; Q123033055
RX   PubMed=7757961;
CC   Characteristics: Tumorigenic when injected subcutaneously in nude mice (PubMed=7757961).
CC   Doubling time: 24.8 hours (PubMed=7757961).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1817; CEACAM5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MIP-neo
AC   CVCL_C9CT
SY   MIPneo
DR   Wikidata; Q123033056
RX   PubMed=7757961;
CC   Doubling time: 15.1 hours (PubMed=7757961).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MIP/5FU
AC   CVCL_HE61
SY   MIP/5-FU; MIP5FU
DR   cancercelllines; CVCL_HE61
DR   GEO; GSM587039
DR   Wikidata; Q54905752
RX   PubMed=15902309;
RX   PubMed=20835245;
RX   PubMed=25960936;
CC   HLA typing: A*24:02,02:01; B*35:08,35:08; C*07:01,04:01 (PubMed=25960936).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   MIP/CIS
AC   CVCL_HE62
DR   Wikidata; Q54905753
RX   PubMed=15902309;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 6
//
ID   MIP/CPT
AC   CVCL_HE63
DR   cancercelllines; CVCL_HE63
DR   Wikidata; Q54905754
RX   PubMed=15902309;
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   MIP/ETO
AC   CVCL_HE64
DR   cancercelllines; CVCL_HE64
DR   Wikidata; Q54905755
RX   PubMed=15902309;
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H689 ! MIP-101
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   MIPS-2
AC   CVCL_M826
DR   Wikidata; Q54905756
RX   PubMed=15277221;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=15277221).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MiPSC5
AC   CVCL_A4RE
DR   SKIP; SKIP002968
DR   Wikidata; Q105510144
RX   PubMed=29318513;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=In >80% of cells (PubMed=29318513).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   MiPSC5-T1
AC   CVCL_A4RF
DR   SKIP; SKIP002969
DR   Wikidata; Q105510147
RX   PubMed=29318513;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple_edited; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=By TALEN. The percentage of heteroplasmy was reduced from >80% to 27% (PubMed=29318513).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RE ! MiPSC5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MiPSC5-T3
AC   CVCL_A4RG
DR   SKIP; SKIP002970
DR   Wikidata; Q105510149
RX   PubMed=29318513;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple_corrected; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=By TALEN (PubMed=29318513).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RE ! MiPSC5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MiPSC5-T7
AC   CVCL_A4RH
DR   SKIP; SKIP002971
DR   Wikidata; Q105510152
RX   PubMed=29318513;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple_corrected; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=By TALEN (PubMed=29318513).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RE ! MiPSC5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MIPTi001-A
AC   CVCL_D4WY
SY   NAA
DR   BioSamples; SAMEA114469822
DR   hPSCreg; MIPTi001-A
DR   Wikidata; Q127382828
RX   PubMed=38176367;
CC   From: Moscow Institute of Physics and Technology; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Glu291Lys (c.871G>A); ClinVar=VCV000011292; Zygosity=Hemizygous (PubMed=38176367).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MIPTi002-A
AC   CVCL_D4WZ
SY   STCL3
DR   BioSamples; SAMEA114509542
DR   hPSCreg; MIPTi002-A
DR   Wikidata; Q127382829
RX   PubMed=38237426;
CC   From: Moscow Institute of Physics and Technology; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16783; CDC73; Simple; p.Ile26fs (c.78delC); Zygosity=Heterozygous (PubMed=38237426).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4906; Parathyroid gland carcinoma
DI   ORDO; Orphanet_143; Parathyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MIRJT6i-mND1-4
AC   CVCL_U172
SY   mND1-4; mND1; PCBC02hsi2011100704; SC12-021
DR   SKIP; SKIP003277
DR   WiCell; mirjt6i-mnd1-4
DR   Wikidata; Q54905757
RX   PubMed=21478862;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   MIRJT7i-mND2-0
AC   CVCL_U173
SY   mND2-0; MIRJT7-mND2-0-WB0119; PCBC02hsi2012082101; SC12-022
DR   SKIP; SKIP003275
DR   WiCell; mirjt7i-mnd2-0
DR   Wikidata; Q54905758
RX   PubMed=21478862;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   MISCES-01
AC   CVCL_C655
DR   Wikidata; Q54905759
RX   PubMed=20178002;
CC   From: Monash University; Melbourne; Australia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   MISK81-5
AC   CVCL_W332
DR   Wikidata; Q54905760
RX   PubMed=7531680;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=7531680).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   MIT
AC   CVCL_D526
DR   Wikidata; Q54905761
RX   PubMed=7949178;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   MITC-STO
AC   CVCL_RB17
DR   ATCC; 56-X.2
DR   Wikidata; Q54905762
CC   Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state.
CC   Characteristics: Growth-arrested by mitomycin C.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3420 ! STO
SX   Mixed sex
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   mitoLUHMES
AC   CVCL_HL95
DR   Wikidata; Q54905763
RX   PubMed=27832395;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B056 ! LUHMES
SX   Female
AG   8FW
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   Miz-1
AC   CVCL_3025
DR   JCRB; IFO50300
DR   Wikidata; Q54905764
CC   Discontinued: JCRB; IFO50300; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MIZ-2
AC   CVCL_ZS74
DR   Wikidata; Q98127247
RX   PubMed=2778352;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MIZMe001-A
AC   CVCL_9262
SY   Miz-hES1; MizhES1; MIZ1; MI01
DR   hPSCreg; MIZMe001-A
DR   SKIP; SKIP002020
DR   Wikidata; Q54905765
RX   PubMed=12930726;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   MIZMe002-A
AC   CVCL_9269
SY   Miz-hES2
DR   hPSCreg; MIZMe002-A
DR   SKIP; SKIP002061
DR   Wikidata; Q54905766
RX   PubMed=12930726;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe003-A
AC   CVCL_9270
SY   Miz-hES3
DR   hPSCreg; MIZMe003-A
DR   SKIP; SKIP002062
DR   Wikidata; Q54905767
RX   PubMed=12930726;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe004-A
AC   CVCL_9276
SY   Miz-hES9
DR   hPSCreg; MIZMe004-A
DR   SKIP; SKIP002063
DR   Wikidata; Q54905768
RX   PubMed=15317691;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe005-A
AC   CVCL_9267
SY   Miz-hES14
DR   hPSCreg; MIZMe005-A
DR   SKIP; SKIP002064
DR   Wikidata; Q54905769
RX   PubMed=15317691;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe006-A
AC   CVCL_9268
SY   Miz-hES15
DR   hPSCreg; MIZMe006-A
DR   SKIP; SKIP002065
DR   Wikidata; Q54905770
RX   PubMed=15317691;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe007-A
AC   CVCL_9271
SY   Miz-hES4; Miz-hES 4; MIZ4; Kor-hES12
DR   hPSCreg; MIZMe007-A
DR   SKIP; SKIP002259
DR   Wikidata; Q54905771
RX   PubMed=15750339;
RX   PubMed=17464211;
RX   PubMed=24159464;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010016.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   MIZMe008-A
AC   CVCL_9272
SY   Miz-hES5
DR   hPSCreg; MIZMe008-A
DR   SKIP; SKIP002260
DR   Wikidata; Q54905772
RX   PubMed=15750339;
RX   PubMed=17464211;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe009-A
AC   CVCL_9273
SY   Miz-hES6; MIZ6
DR   hPSCreg; MIZMe009-A
DR   SKIP; SKIP002261
DR   Wikidata; Q54905773
RX   PubMed=15750339;
RX   PubMed=17464211;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe010-A
AC   CVCL_9274
SY   Miz-hES7
DR   hPSCreg; MIZMe010-A
DR   SKIP; SKIP002262
DR   Wikidata; Q54905777
RX   PubMed=15750339;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe011-A
AC   CVCL_9275
SY   Miz-hES8
DR   hPSCreg; MIZMe011-A
DR   SKIP; SKIP002263
DR   Wikidata; Q54905778
RX   PubMed=15750339;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe012-A
AC   CVCL_9263
SY   Miz-hES10
DR   hPSCreg; MIZMe012-A
DR   SKIP; SKIP002264
DR   Wikidata; Q54905779
RX   PubMed=15750339;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe013-A
AC   CVCL_9264
SY   Miz-hES11
DR   hPSCreg; MIZMe013-A
DR   SKIP; SKIP002265
DR   Wikidata; Q54905781
RX   PubMed=15750339;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe014-A
AC   CVCL_9265
SY   Miz-hES12
DR   hPSCreg; MIZMe014-A
DR   SKIP; SKIP002266
DR   Wikidata; Q54905782
RX   PubMed=15750339;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MIZMe015-A
AC   CVCL_9266
SY   Miz-hES13; MIZ13
DR   hPSCreg; MIZMe015-A
DR   SKIP; SKIP002267
DR   Wikidata; Q54905783
RX   PubMed=15750339;
CC   From: MizMedi Hospital; Seoul; South Korea.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36425; Trisomy 3
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   MJ
AC   CVCL_1414
SY   G11
DR   CLO; CLO_0007731
DR   EFO; EFO_0002237
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-8294
DR   BCRC; 60543
DR   BioSample; SAMN03471200
DR   BioSample; SAMN10987950
DR   cancercelllines; CVCL_1414
DR   Cell_Model_Passport; SIDM01692
DR   Cosmic; 908137
DR   DepMap; ACH-000077
DR   GEO; GSM887322
DR   GEO; GSM888398
DR   IARC_TP53; 21504
DR   IGRhCellID; MJ
DR   LiGeA; CCLE_874
DR   LINCS_LDP; LCL-1142
DR   PharmacoDB; MJ_933_2019
DR   Progenetix; CVCL_1414
DR   Wikidata; Q54905784
RX   Patent=US4743678;
RX   PubMed=6604130;
RX   PubMed=7662981;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8294.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*08:01,27:05; C*07:01,15:02; DQA1*02:01,05:01; DQB1*02:01,02:01; DRB1*03:01,07:01 (PubMed=26589293).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0.31%; South Asian=0%; European, North=70.84%; European, South=28.85% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8294
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D19S433: 12,13
ST   D21S11: 28,31.2
ST   D2S1338: 24
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 23,25
ST   Penta D: 11,13
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   MJ-170
AC   CVCL_AQ03
SY   3A3-2A6
DR   Wikidata; Q54905785
RX   Patent=US7202346;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5286.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 6
//
ID   MJ-171
AC   CVCL_AQ04
SY   4E2-2D1-1B10
DR   Wikidata; Q54905786
RX   Patent=US7202346;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5287.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 6
//
ID   MJ-172
AC   CVCL_AQ05
SY   2F9-1F8-1C10
DR   Wikidata; Q54905787
RX   Patent=US7202346;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5288.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 6
//
ID   MJ-173
AC   CVCL_AQ06
SY   2F9-1E8-1D7
DR   Wikidata; Q54905788
RX   Patent=US7202346;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5302.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 6
//
ID   MJ7/18
AC   CVCL_B7G7
DR   DSHB; MJ7-18
DR   Wikidata; Q112930118
RX   PubMed=8125301;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q63961; Mouse Eng/Cd105.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 30-01-24; Version: 4
//
ID   MJD1-11
AC   CVCL_W570
DR   SKIP; SKIP000310
DR   Wikidata; Q54905789
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=22113611).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W571 ! MJD1-9
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   MJD1-9
AC   CVCL_W571
SY   LB-32-R9; LB-32-r9; iLB-MJD1-32m-r9; UKBi003-A
DR   BioSamples; SAMEA2614075
DR   EBiSC; UKBi003-A
DR   ECACC; 66540007
DR   hPSCreg; UKBi003-A
DR   SKIP; SKIP000309
DR   SKIP; SKIP002506
DR   Wikidata; Q54905790
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=22113611).
CC   Discontinued: ECACC; 66540007; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W570 ! MJD1-11
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 20
//
ID   MJD2-2
AC   CVCL_W572
SY   iLB-MJD2-29m-R2; UKBi001-A
DR   BioSamples; SAMEA2614016
DR   EBiSC; UKBi001-A
DR   ECACC; 66540006
DR   hPSCreg; UKBi001-A
DR   SKIP; SKIP000311
DR   SKIP; SKIP002504
DR   Wikidata; Q54905791
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous; Note=The other allele has 21 repeats (PubMed=22113611).
CC   Discontinued: EBiSC; UKBi001-A; true.
CC   Discontinued: ECACC; 66540006; true.
CC   Discontinued: hPSCreg; UKBi001-A; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W573 ! MJD2-9
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   MJD2-9
AC   CVCL_W573
SY   UKBi001-B
DR   BioSamples; SAMEA3855072
DR   EBiSC; UKBi001-B
DR   ECACC; 66540043
DR   hPSCreg; UKBi001-B
DR   SKIP; SKIP000312
DR   SKIP; SKIP002673
DR   Wikidata; Q54905792
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[74]; Zygosity=Heterozygous; Note=The other allele has 21 repeats (PubMed=22113611).
CC   Discontinued: ECACC; 66540043; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W572 ! MJD2-2
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   MJD3-5
AC   CVCL_W574
SY   LB-33-5; iLB-MJD3-33f-r5; UKBi007-A
DR   BioSamples; SAMEA2825788
DR   EBiSC; UKBi007-A
DR   ECACC; 66540011
DR   hPSCreg; UKBi007-A
DR   SKIP; SKIP000313
DR   SKIP; SKIP002510
DR   Wikidata; Q54905793
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[73]; Zygosity=Heterozygous; Note=The other allele has 27 repeats (PubMed=22113611).
CC   Discontinued: ECACC; 66540011; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   MJD4-1
AC   CVCL_W575
SY   LB-34-1; iLB-MJD4-34m-r1; UKBi008-A
DR   BioSamples; SAMEA2590882
DR   EBiSC; UKBi008-A
DR   ECACC; 66540003
DR   hPSCreg; UKBi008-A
DR   SKIP; SKIP000314
DR   SKIP; SKIP002511
DR   Wikidata; Q54905794
RX   PubMed=22113611;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[73]; Zygosity=Heterozygous; Note=The other allele has 20 repeats (PubMed=22113611).
CC   Discontinued: ECACC; 66540003; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 20
//
ID   MJM
AC   CVCL_J312
DR   Cosmic; 1132583
DR   Wikidata; Q54905795
RX   PubMed=752115;
RX   PubMed=6819484;
CC   Doubling time: ~63 hours (PubMed=752115); 102.8 hours (PubMed=6819484).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   MK 2
AC   CVCL_WH98
DR   Wikidata; Q95989897
RX   PubMed=6862145;
CC   From: Inoue, Jin; Department of Surgery, Tokyo Medical College; Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   MK-1 [Human Down syndrome]
AC   CVCL_JG76
SY   Mutant Karyotype-1
DR   JCRB; JCRB3035
DR   JCRB; KURB2765
DR   Wikidata; Q54905796
CC   Population: Japanese.
CC   Karyotypic information: 47,XY,+21 (JCRB=JCRB3035).
CC   Discontinued: JCRB; KURB2765; probable.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB3035
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5FM
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 8
//
ID   MK-1 [Human gingival squamous cell carcinoma]
AC   CVCL_W863
DR   Wikidata; Q54905797
RX   PubMed=6802943;
RX   PubMed=10359046;
RX   PubMed=23817087;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=6802943).
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   MK-19
AC   CVCL_LC38
SY   Mutant Karyotype-19
DR   JCRB; JCRB3047
DR   JCRB; KURB2782
DR   Wikidata; Q54905798
CC   Discontinued: JCRB; KURB2782; probable.
ST   Source(s): JCRB=JCRB3047
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 7
//
ID   MK-2
AC   CVCL_LC39
SY   Mutant Karyotype-2
DR   JCRB; JCRB3046
DR   JCRB; KURB2766
DR   Wikidata; Q54905799
CC   Population: Japanese.
CC   Karyotypic information: 47,XY,+21 (JCRB=JCRB3046).
CC   Discontinued: JCRB; KURB2766; probable.
ST   Source(s): JCRB=JCRB3046
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 9
//
ID   MK-3
AC   CVCL_YP55
SY   Mutant Karyotype-3
DR   JCRB; KURB2767
DR   Wikidata; Q95989904
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   MK-31
AC   CVCL_B3MH
SY   Mutant Karyotype-31
DR   JCRB; KURB2793
DR   Wikidata; Q110433033
CC   Population: Japanese.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MK-31F
AC   CVCL_B3MI
SY   Mutant Karyotype-31 Father
DR   JCRB; KURB2794
DR   Wikidata; Q110433034
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   MK-31M
AC   CVCL_B3MJ
SY   Mutant Karyotype-31 Mother
DR   JCRB; KURB2795
DR   Wikidata; Q110433035
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   MK-36
AC   CVCL_B3MG
SY   Mutant Karyotype-36
DR   JCRB; KURB2798
DR   Wikidata; Q110433037
CC   Population: Japanese.
CC   Karyotypic information: 46,XY,inv(20)mat (JCRB=KURB2798).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MK-37a
AC   CVCL_B3ME
DR   JCRB; KURB2730
DR   Wikidata; Q110433038
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3MD ! MK-37b
OI   CVCL_LC40 ! MK-37c
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MK-37b
AC   CVCL_B3MD
DR   JCRB; JCRB3069
DR   JCRB; KURB2731
DR   Wikidata; Q110433040
CC   Discontinued: JCRB; KURB2731; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3069
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3ME ! MK-37a
OI   CVCL_LC40 ! MK-37c
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 5
//
ID   MK-37c
AC   CVCL_LC40
DR   JCRB; JCRB3045
DR   JCRB; KURB2732
DR   Wikidata; Q54905800
CC   Discontinued: JCRB; KURB2732; probable.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
ST   Source(s): JCRB=JCRB3045
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3ME ! MK-37a
OI   CVCL_B3MD ! MK-37b
SX   Sex ambiguous
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 9
//
ID   MK-4
AC   CVCL_XD26
SY   Mutant Karyotype-4
DR   JCRB; JCRB3057
DR   JCRB; KURB2768
DR   Wikidata; Q95989906
CC   Discontinued: JCRB; KURB2768; probable.
ST   Source(s): JCRB=JCRB3057
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9,10
ST   D16S539: 9,10
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 7
//
ID   MK-40
AC   CVCL_B5M6
SY   Mutant Karyotype-40
DR   JCRB; KURB2800
DR   Wikidata; Q112129320
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,inv(9)(p13;q21)pat (JCRB=KURB2800).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MK-41
AC   CVCL_B5M5
SY   Mutant Karyotype-41
DR   JCRB; KURB2801
DR   Wikidata; Q112129322
CC   Population: Japanese.
CC   Karyotypic information: 48,XY,+16,+22 (JCRB=KURB2801).
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MK-42
AC   CVCL_B3MF
SY   Mutant Karyotype-42
DR   JCRB; KURB2802
DR   Wikidata; Q110433041
CC   Population: Japanese.
DI   NCIt; C3110; Hydatidiform mole
DI   ORDO; Orphanet_99927; Hydatidiform mole
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   MK-43
AC   CVCL_YP54
SY   Mutant Karyotype-43
DR   JCRB; KURB2733
DR   Wikidata; Q95989907
CC   Population: Japanese.
CC   Karyotypic information: 46,XY,t(14;18)(q11.2;p11.31)mat (JCRB=KURB2733).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   MK-44
AC   CVCL_VN90
SY   Mutant Karyotype-44
DR   JCRB; JCRB3055
DR   JCRB; KURB2734
DR   Wikidata; Q95989909
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2734; probable.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): JCRB=JCRB3055
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 10
//
ID   MK-46
AC   CVCL_VN92
SY   Mutant Karyotype-46
DR   JCRB; KURB2754
DR   Wikidata; Q95989910
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,t(14;21) (JCRB=KURB2754).
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   MK-46F
AC   CVCL_VN93
SY   Mutant Karyotype-46 Father
DR   JCRB; KURB2755
DR   Wikidata; Q95989911
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 5
//
ID   MK-46M
AC   CVCL_VN94
SY   Mutant Karyotype-46 Mother
DR   JCRB; KURB2756
DR   Wikidata; Q95989912
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 5
//
ID   MK-49
AC   CVCL_VN95
SY   Mutant Karyotype-49
DR   JCRB; KURB2858
DR   Wikidata; Q95989914
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   MK-5
AC   CVCL_YP56
SY   Mutant Karyotype-5
DR   JCRB; KURB2769
DR   Wikidata; Q95989915
CC   Population: Japanese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   MK-50
AC   CVCL_VN91
SY   Mutant Karyotype-50
DR   JCRB; KURB2744
DR   Wikidata; Q95989916
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C185241; Distal trisomy 2p
DI   ORDO; Orphanet_96070; Distal trisomy 2p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   MK-51
AC   CVCL_JG77
SY   Mutant Karyotype-51
DR   JCRB; JCRB3036
DR   JCRB; KURB2761
DR   Wikidata; Q54905801
CC   Population: Japanese.
CC   Karyotypic information: 48,XXXX (JCRB=JCRB3036).
CC   Discontinued: JCRB; KURB2761; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB3036
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 10
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 8
//
ID   MK-6
AC   CVCL_YP57
SY   Mutant Karyotype-6
DR   JCRB; KURB2770
DR   Wikidata; Q95989918
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 5
//
ID   MK-7
AC   CVCL_YP58
SY   Mutant Karyotype-7
DR   JCRB; JCRB3075
DR   JCRB; KURB2771
DR   Wikidata; Q95989919
CC   Discontinued: JCRB; KURB2771; probable.
ST   Source(s): JCRB=JCRB3075
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 8,9,13
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 02-05-24; Version: 7
//
ID   MK-8
AC   CVCL_YP59
SY   Mutant Karyotype-8
DR   JCRB; KURB2772
DR   Wikidata; Q95989920
CC   Karyotypic information: 46,XY,mar+ (JCRB=KURB2772).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   MK-D6
AC   CVCL_4543
DR   CLO; CLO_0007732
DR   CLDB; cl5232
DR   ATCC; HB-3
DR   IZSLER; BS Hy 30
DR   Wikidata; Q54905802
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MK-DIEC
AC   CVCL_ZZ31
SY   Mahesh Khatri-Duck Intestinal Embryonic Cell line
DR   Wikidata; Q102114533
RX   PubMed=25695828;
WW   Provider; OSU; TS-036842; https://web.archive.org/web/20200108060535/https://ceo.osu.edu/technologies/immortalized-duck-embryonic-intestinal-epithelial-cell-line-mk-diec
CC   Group: Bird cell line.
CC   Virology: Susceptible to infection by porcine epidemic diarrhea virus (PEDV) (PubMed=25695828).
CC   Doubling time: <24 hours (Direct_author_submission).
CC   Miscellaneous: Doubling time and sex non-determination from personal communication of Khatri, Mahesh.
CC   Derived from site: In situ; Embryonic intestine; UBERON=UBERON_0000160.
CC   Breed/subspecies: White Pekin; VBO=VBO_0000713.
OX   NCBI_TaxID=8839; ! Anas platyrhynchos (Mallard)
SX   Sex unspecified
AG   19FD
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   MK-S4
AC   CVCL_G336
DR   CLO; CLO_0007734
DR   ATCC; HB-4
DR   Wikidata; Q54905803
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4090 ! 45.6.TG1.7
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MK/T-1
AC   CVCL_9Y67
SY   MK/T1
DR   Wikidata; Q54905804
RX   PubMed=11344338;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, cornea, stroma; UBERON=UBERON_0001777.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   MK002
AC   CVCL_A8Y3
DR   GEO; GSM2055809
DR   Wikidata; Q102114535
RX   PubMed=28096185;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=28096185).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   MK024
AC   CVCL_A8Z5
SY   IDI-PD 1 fibroblasts
DR   GEO; GSM1291210
DR   Wikidata; Q102114536
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   MK071
AC   CVCL_A8Z6
SY   GBA-PD 1 fibroblasts
DR   GEO; GSM1291205
DR   Wikidata; Q102114537
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from child cell line UOXFi001-A).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   MK082
AC   CVCL_A8Y8
DR   GEO; GSM2644508
DR   Wikidata; Q102114538
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from child cell line UOXFi002-A).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   MK088
AC   CVCL_A8Y9
SY   GBA-PD 2 fibroblasts
DR   GEO; GSM1291208
DR   GEO; GSM2644506
DR   Wikidata; Q102114539
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from child cell line UOXFi003-A).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   mK1
AC   CVCL_9T76
SY   mouse Kidney 1
DR   Wikidata; Q54905805
RX   CelloPub=CLPUB00308;
RX   PubMed=11850199;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C57BL/6 x C3H/He Hoxa11-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MK1-OSU
AC   CVCL_ZZ34
SY   Mahesh Khatri 1-Ohio State University
DR   Wikidata; Q102114540
RX   PubMed=29378639;
RX   PubMed=29880757;
CC   Virology: Susceptible to infection by swine influenza viruses (PubMed=29880757).
CC   Doubling time: <24 hours (Direct_author_submission).
CC   Miscellaneous: Doubling time and sex non-determination from personal communication of Khatri, Mahesh.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   mK10
AC   CVCL_9T77
SY   mouse Kidney 10
DR   Wikidata; Q54905806
RX   CelloPub=CLPUB00308;
RX   PubMed=12060755;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   MK144
AC   CVCL_A8Y4
DR   GEO; GSM2055807
DR   Wikidata; Q102114541
RX   PubMed=28096185;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=28096185).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   mK2
AC   CVCL_9T78
SY   mouse Kidney 2
DR   Wikidata; Q54905807
RX   CelloPub=CLPUB00308;
RX   PubMed=11850199;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C57BL/6 x C3H/He Hoxa11-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   MK2
AC   CVCL_A1JM
DR   Wikidata; Q102114542
RX   CelloPub=CLPUB00584;
CC   Population: Japanese.
CC   Doubling time: 52-53 hours (CelloPub=CLPUB00584).
DI   NCIt; C5476; Gastric undifferentiated carcinoma
DI   ORDO; Orphanet_423786; Undifferentiated carcinoma of stomach
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   MK2-23
AC   CVCL_4W11
DR   Wikidata; Q54905808
RX   Patent=US5493009;
RX   PubMed=2584721;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10288.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 763.74.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   mK3
AC   CVCL_9T79
SY   MK3; mouse Kidney 3
DR   Wikidata; Q54905809
RX   CelloPub=CLPUB00308;
RX   PubMed=11850199;
RX   PubMed=23867747;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C57BL/6 x C3H/He Hoxa11-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   mk34
AC   CVCL_A8DX
DR   Wikidata; Q107116379
RX   PubMed=20920470;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9CWP4; Mouse Ly6k.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mK4
AC   CVCL_9T80
SY   MK4; mouse Kidney 4
DR   Wikidata; Q54905810
RX   CelloPub=CLPUB00308;
RX   PubMed=11850199;
RX   PubMed=23867747;
WW   Info; LifeMap Discovery; -; https://web.archive.org/web/20241222232900/https://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells/kidney-mus-musculus-mk4-childrens-hospital-medical-center-cincinnati
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C57BL/6 x C3H/He Hoxa11-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   MKB-1
AC   CVCL_8265
SY   MKB1
DR   BioSample; SAMN03151620
DR   cancercelllines; CVCL_8265
DR   Cosmic; 999729
DR   Cosmic; 1524807
DR   Cosmic; 2649238
DR   Wikidata; Q54905811
RX   PubMed=2486667;
RX   PubMed=9933131;
RX   PubMed=10508494;
RX   PubMed=10739008;
RX   PubMed=12592342;
RX   PubMed=15472075;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 17 year old female patient with acute myeloblastic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00146.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI) (PubMed=10739008).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   MKHD1
AC   CVCL_JG78
DR   JCRB; JCRB3017
DR   JCRB; KURB1993
DR   Wikidata; Q54905812
CC   Discontinued: JCRB; KURB1993; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3017
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   MKL-1
AC   CVCL_2600
SY   Mkl-1; MKL1
DR   BioGRID_ORCS_Cell_line; 732
DR   Cell_Model_Passport; SIDM01791
DR   Cosmic; 1693072
DR   Cosmic; 1699817
DR   Cosmic; 2273916
DR   DepMap; ACH-001122
DR   ECACC; 09111801
DR   FANTOM5_SSTAR; 10843-111E6
DR   PRIDE; PXD004198
DR   PRIDE; PXD008181
DR   Wikidata; Q54905813
RX   PubMed=3546933;
RX   PubMed=10732753;
RX   PubMed=20444890;
RX   PubMed=22363598;
RX   PubMed=23085629;
RX   PubMed=23563200;
RX   PubMed=27121059;
RX   PubMed=27402257;
RX   PubMed=29696010;
RX   PubMed=30873613;
RX   PubMed=31889939;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Virology: Contains 3.5 copies of the genome of MCPyV per haploid cell (PubMed=23085629).
CC   Doubling time: ~120 hours (PubMed=3546933); 3 days (PubMed=20444890).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ECACC=09111801; PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 12,18
ST   D21S11: 30
ST   D3S1358: 15.2
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 10
ST   FGA: 21,25
ST   Penta D: 12,15
ST   Penta E: 10,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ER19 ! MKL-1-FB
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   MKL-1 subclone 1
AC   CVCL_EQ70
SY   MKL-1 (subclone 1)
DR   Wikidata; Q54905814
RX   PubMed=12209990;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2600 ! MKL-1
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   MKL-1 subclone 2
AC   CVCL_EQ71
SY   MKL-1-subclone-2; MKL-1 (subclone 2)
DR   GDSC; 1333014
DR   PharmacoDB; MKL1subclone2_934_2019
DR   Wikidata; Q54905815
RX   PubMed=12209990;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2600 ! MKL-1
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   MKL-1-FB
AC   CVCL_ER19
DR   Wikidata; Q54905816
RX   PubMed=3546933;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2600 ! MKL-1
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   MKL-2
AC   CVCL_D027
SY   Mkl-2; MKL2
DR   Cell_Model_Passport; SIDM01790
DR   Cosmic; 1693073
DR   Cosmic; 2273917
DR   DepMap; ACH-001123
DR   GDSC; 1333015
DR   PharmacoDB; MKL2_935_2019
DR   PRIDE; PXD004198
DR   PRIDE; PXD008181
DR   Wikidata; Q54905817
RX   PubMed=1717086;
RX   PubMed=12209990;
RX   PubMed=20444890;
RX   PubMed=23085629;
RX   PubMed=23563200;
RX   PubMed=27121059;
RX   PubMed=27402257;
RX   PubMed=29696010;
RX   PubMed=30873613;
RX   PubMed=31889939;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Virology: Contains 1.7 copies of the genome of MCPyV per haploid cell (PubMed=23085629).
CC   Doubling time: 5 days (PubMed=20444890); 3 days (PubMed=30873613).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D18S51: 14,17
ST   D21S11: 28.2,31.2
ST   D3S1358: 17
ST   D5S818: 12,14
ST   D7S820: 10,13
ST   D8S1179: 11,13
ST   FGA: 19,26
ST   Penta D: 10,13
ST   Penta E: 11,13
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   MKM150-2
AC   CVCL_XA34
SY   MKM 150-2
DR   CCRID; 4201PAT-CCTCC00135
DR   Wikidata; Q95989935
RX   Patent=US6743611;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5086.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16881; Human TXNRD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   MKN1
AC   CVCL_1415
SY   MKN-1; MKN 1
DR   BTO; BTO_0002384
DR   CLO; CLO_0050804
DR   EFO; EFO_0002830
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473129
DR   BioSample; SAMN10987827
DR   cancercelllines; CVCL_1415
DR   Cell_Model_Passport; SIDM00271
DR   CGH-DB; 117-1
DR   CGH-DB; 9019-4
DR   ChEMBL-Cells; CHEMBL3307492
DR   ChEMBL-Targets; CHEMBL614352
DR   Cosmic; 733174
DR   Cosmic; 801337
DR   Cosmic; 848145
DR   Cosmic; 848379
DR   Cosmic; 887252
DR   Cosmic; 888824
DR   Cosmic; 897532
DR   Cosmic; 908138
DR   Cosmic; 922692
DR   Cosmic; 926111
DR   Cosmic; 1007600
DR   Cosmic; 1090459
DR   Cosmic; 1093296
DR   Cosmic; 1187282
DR   Cosmic; 1223586
DR   Cosmic; 1436023
DR   Cosmic; 1482076
DR   Cosmic; 1627263
DR   Cosmic; 1995508
DR   Cosmic; 2443801
DR   Cosmic; 2484957
DR   Cosmic; 2807632
DR   Cosmic-CLP; 908138
DR   DepMap; ACH-000351
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10614-108G2
DR   GDSC; 908138
DR   GEO; GSM552363
DR   GEO; GSM562394
DR   GEO; GSM827531
DR   GEO; GSM844606
DR   GEO; GSM887323
DR   GEO; GSM888399
DR   GEO; GSM1374680
DR   GEO; GSM1670111
DR   IARC_TP53; 998
DR   JCRB; JCRB0252
DR   KCLB; 80101
DR   LiGeA; CCLE_128
DR   LINCS_LDP; LCL-1917
DR   Lonza; 1374
DR   PharmacoDB; MKN1_936_2019
DR   Progenetix; CVCL_1415
DR   PubChem_Cell_line; CVCL_1415
DR   RCB; RCB1003
DR   Wikidata; Q54905820
RX   CelloPub=CLPUB00581;
RX   CelloPub=CLPUB00584;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=758928;
RX   PubMed=1370612;
RX   PubMed=1778766;
RX   PubMed=1933850;
RX   PubMed=6862145;
RX   PubMed=9290701;
RX   PubMed=11107048;
RX   PubMed=15723654;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22336246;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32847597;
RX   PubMed=34331011;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MKN-1
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 43-45 hours (CelloPub=CLPUB00584); 31 hours (PubMed=29435981).
CC   HLA typing: A*24:02,26:02; B*40:01,40:01; C*03:04,03:04; DQA1*04:01,04:01; DQB1*03:09,03:09; DRB1*11:01,03:17 (PubMed=25960936).
CC   HLA typing: A*24:02,26:02; B*40:01,40:01; C*03:04,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Unspecified (PubMed=1370612; PubMed=11107048; PubMed=15900046).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=0%; East Asian, North=81.4%; East Asian, South=15.4%; South Asian=0%; European, North=0.44%; European, South=2.44% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=908138; JCRB=JCRB0252; KCLB=80101; PubMed=25877200; RCB=RCB1003
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 20,23
ST   Penta D: 10
ST   Penta E: 21
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C5474; Gastric adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   MKN1 CHRNB2 KO-1
AC   CVCL_C7NI
DR   Wikidata; Q117704707
RX   PubMed=34331011;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1962; CHRNB2.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5474; Gastric adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1415 ! MKN1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   MKN1 CHRNB2 KO-2
AC   CVCL_C7NJ
DR   Wikidata; Q117704708
RX   PubMed=34331011;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1962; CHRNB2.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5474; Gastric adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1415 ! MKN1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   MKN1 NPTXR KO-1
AC   CVCL_C7NG
DR   Wikidata; Q117704709
RX   PubMed=32847597;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7954; NPTXR.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5474; Gastric adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1415 ! MKN1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   MKN1 NPTXR KO-2
AC   CVCL_C7NH
DR   Wikidata; Q117704710
RX   PubMed=32847597;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7954; NPTXR.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5474; Gastric adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1415 ! MKN1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   MKN1/CMV-Luc
AC   CVCL_J261
SY   MKN-1/CMV-Luc
DR   JCRB; JCRB1433
DR   JCRB; NIHS0720
DR   Wikidata; Q54905821
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1433).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0720; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1433
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C5474; Gastric adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1415 ! MKN1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   MKN28
AC   CVCL_1416
SY   MKN-28; MKN 28
DR   BTO; BTO_0002381
DR   CLO; CLO_0037142
DR   EFO; EFO_0002831
DR   ABM; T9192
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 944
DR   BioSample; SAMN03151847
DR   cancercelllines; CVCL_1416
DR   Cell_Model_Passport; SIDM00260
DR   CGH-DB; 119-1
DR   CGH-DB; 9021-4
DR   ChEMBL-Cells; CHEMBL3307602
DR   ChEMBL-Targets; CHEMBL614353
DR   Cosmic; 801338
DR   Cosmic; 848146
DR   Cosmic; 848371
DR   Cosmic; 873710
DR   Cosmic; 875905
DR   Cosmic; 877041
DR   Cosmic; 887249
DR   Cosmic; 888826
DR   Cosmic; 897534
DR   Cosmic; 908139
DR   Cosmic; 918496
DR   Cosmic; 922694
DR   Cosmic; 926113
DR   Cosmic; 968348
DR   Cosmic; 983726
DR   Cosmic; 1066230
DR   Cosmic; 1067208
DR   Cosmic; 1090460
DR   Cosmic; 1093298
DR   Cosmic; 1223588
DR   Cosmic; 1436025
DR   Cosmic; 1460710
DR   Cosmic; 1482081
DR   Cosmic; 1627264
DR   Cosmic; 1995509
DR   Cosmic; 2036660
DR   Cosmic; 2069778
DR   Cosmic; 2823226
DR   Cosmic-CLP; 908139
DR   DepMap; ACH-002161
DR   EGA; EGAS00001000978
DR   GDSC; 908139
DR   GEO; GSM562396
DR   GEO; GSM1670112
DR   IARC_TP53; 972
DR   IARC_TP53; 21505
DR   JCRB; FDSC0011
DR   JCRB; JCRB0253
DR   JCRB; NIHS0324
DR   JCRB; NIHS0325
DR   KCLB; 80102
DR   LINCS_LDP; LCL-1922
DR   PharmacoDB; MKN28_937_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1416
DR   PubChem_Cell_line; CVCL_1416
DR   RCB; RCB1000
DR   Wikidata; Q54905823
RX   CelloPub=CLPUB00581;
RX   CelloPub=CLPUB00584;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=758928;
RX   PubMed=1370612;
RX   PubMed=1933850;
RX   PubMed=3962675;
RX   PubMed=3986962;
RX   PubMed=6862145;
RX   PubMed=9023415;
RX   PubMed=9290701;
RX   PubMed=11107048;
RX   PubMed=11314020;
RX   PubMed=15723654;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=15901131;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=22336246;
RX   PubMed=22490663;
RX   PubMed=23671654;
RX   PubMed=25960936;
RX   PubMed=27397505;
RX   PubMed=29435981;
RX   PubMed=29717028;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a MKN74 derivative (PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00328.
CC   Population: Japanese.
CC   Doubling time: 28-32 hours (PubMed=3962675); 28 hours (PubMed=29435981); 30-34 hours (CelloPub=CLPUB00584).
CC   HLA typing: A*31:01; B*51:01; C*03:04 (PubMed=9023415).
CC   HLA typing: B*51:01; C*03:04,03:04; DRB1*15:01,15:01 (PubMed=25960936).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Leu (c.751A>C); ClinVar=VCV000182937; Zygosity=Unspecified (PubMed=1370612; PubMed=11107048; PubMed=15900046; PubMed=15901131; PubMed=22490663).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.28%; East Asian, South=16.71%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0324; true.
CC   Discontinued: JCRB; NIHS0325; true.
CC   Discontinued: JCRB; FDSC0011; true.
CC   Discontinued: RCB; RCB1000; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Cosmic-CLP=908139; JCRB=JCRB0253; KCLB=80102; RCB=RCB1000
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2791 ! MKN74
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   MKN28-EGFP
AC   CVCL_UW56
DR   cancercelllines; CVCL_UW56
DR   Wikidata; Q95989936
RX   PubMed=16077911;
CC   Problematic cell line: Contaminated. Parent cell line (MKN28) has been shown to be a MKN74 derivative.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Leu (c.751A>C); ClinVar=VCV000182937; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1416 ! MKN28
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   MKN45
AC   CVCL_0434
SY   MKN-45; MKN 45
DR   BTO; BTO_0001225
DR   CLO; CLO_0007733
DR   CLO; CLO_0050797
DR   EFO; EFO_0002832
DR   MCCL; MCC:0000329
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 404
DR   BioSample; SAMN03473237
DR   BioSample; SAMN03473585
DR   BioSample; SAMN10988555
DR   cancercelllines; CVCL_0434
DR   CCRID; 1101HUM-PUMC000229
DR   CCTCC; GDC0220
DR   Cell_Model_Passport; SIDM00247
DR   CGH-DB; 120-1
DR   CGH-DB; 9022-4
DR   ChEMBL-Cells; CHEMBL3307603
DR   ChEMBL-Targets; CHEMBL614354
DR   CLS; 300489
DR   Cosmic; 685596
DR   Cosmic; 801339
DR   Cosmic; 848147
DR   Cosmic; 848373
DR   Cosmic; 873711
DR   Cosmic; 877042
DR   Cosmic; 887256
DR   Cosmic; 888827
DR   Cosmic; 897535
DR   Cosmic; 918497
DR   Cosmic; 922696
DR   Cosmic; 925340
DR   Cosmic; 926114
DR   Cosmic; 968349
DR   Cosmic; 983727
DR   Cosmic; 1001651
DR   Cosmic; 1001655
DR   Cosmic; 1007602
DR   Cosmic; 1090461
DR   Cosmic; 1093299
DR   Cosmic; 1187283
DR   Cosmic; 1223589
DR   Cosmic; 1329185
DR   Cosmic; 1436026
DR   Cosmic; 1460707
DR   Cosmic; 1518241
DR   Cosmic; 1518255
DR   Cosmic; 1582430
DR   Cosmic; 1627265
DR   Cosmic; 1995510
DR   Cosmic; 2036663
DR   Cosmic; 2807633
DR   Cosmic; 2823225
DR   Cosmic-CLP; 925340
DR   DepMap; ACH-000356
DR   DSMZ; ACC-409
DR   DSMZCellDive; ACC-409
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10612-108F9
DR   GDSC; 925340
DR   GEO; GSM552364
DR   GEO; GSM562395
DR   GEO; GSM618013
DR   GEO; GSM618014
DR   GEO; GSM618015
DR   GEO; GSM618016
DR   GEO; GSM827532
DR   GEO; GSM828836
DR   GEO; GSM844607
DR   GEO; GSM887324
DR   GEO; GSM888400
DR   GEO; GSM1374681
DR   GEO; GSM1670113
DR   IARC_TP53; 21633
DR   IARC_TP53; 30213
DR   IBRC; C10137
DR   JCRB; JCRB0254
DR   KCLB; 80103
DR   LiGeA; CCLE_725
DR   LINCS_LDP; LCL-1535
DR   NCBI_Iran; C615
DR   PharmacoDB; MKN45_938_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0434
DR   PubChem_Cell_line; CVCL_0434
DR   RCB; RCB1001
DR   Wikidata; Q28473066
RX   CelloPub=CLPUB00581;
RX   CelloPub=CLPUB00584;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   DOI=10.1016/j.procbio.2020.01.033;
RX   PubMed=758928;
RX   PubMed=1370612;
RX   PubMed=1486568;
RX   PubMed=1778766;
RX   PubMed=1846553;
RX   PubMed=1933850;
RX   PubMed=2061947;
RX   PubMed=2105279;
RX   PubMed=3962675;
RX   PubMed=3986962;
RX   PubMed=6862145;
RX   PubMed=9023415;
RX   PubMed=9247707;
RX   PubMed=9290701;
RX   PubMed=9665481;
RX   PubMed=11107048;
RX   PubMed=11314020;
RX   PubMed=11668190;
RX   PubMed=15723654;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=15901131;
RX   PubMed=18804159;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22336246;
RX   PubMed=22460905;
RX   PubMed=22531121;
RX   PubMed=23671654;
RX   PubMed=24587255;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-496.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/gastric-xenograft-model/mkn-45-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: MET-amplified, contains 12-13 copies of the gene (PubMed=29435981).
CC   Doubling time: 30-33 hours (PubMed=3962675); 33 hours (PubMed=29435981); 30-38 hours (CelloPub=CLPUB00584); 16 hours (PubMed=2105279); ~60 hours (DSMZ=ACC-409).
CC   HLA typing: A*24:02,24:02; B*52:01; C*12:02,12:02 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*52:01,67:02; C*12:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (Cosmic-CLP=925340; DepMap=ACH-000356).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.54%; Native American=0%; East Asian, North=85.37%; East Asian, South=9.42%; South Asian=0%; European, North=0%; European, South=3.67% (PubMed=30894373).
CC   Caution: Was indicated not to have a TP53 mutation in PubMed=1370612 and PubMed=15900046.
CC   Misspelling: MKN46; Cosmic=968349.
CC   Misspelling: MNK-45; Note=Occasionally.
CC   Misspelling: MNK45; Note=Occasionally.
CC   Misspelling: NKM-45; Note=Occasionally.
CC   Misspelling: NKM45; Note=Occasionally.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000229; CLS=300489; Cosmic-CLP=925340; DSMZ=ACC-409; JCRB=JCRB0254; KCLB=80103; PubMed=25877200; RCB=RCB1001
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 26
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 14,16.2 (CCRID=1101HUM-PUMC000229; CLS=300489)
ST   D19S433: 14,17 (DSMZ=ACC-409)
ST   D21S11: 31
ST   D2S1338: 18
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D6S1043: 14
ST   D7S820: 10,11
ST   D8S1179: 13,17
ST   FGA: 19 (KCLB=80103)
ST   FGA: 19,24 (CCRID=1101HUM-PUMC000229; CLS=300489; DSMZ=ACC-409; PubMed=25877200)
ST   Penta D: 10
ST   Penta E: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   MKN45-Cas9-526
AC   CVCL_XE84
SY   MKN-45-Cas9-526
DR   cancercelllines; CVCL_XE84
DR   CCRID; 1101HUM-PUMC000526
DR   Wikidata; Q95989939
CC   Population: Japanese.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000526
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 26
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 14,16.2
ST   D21S11: 31
ST   D2S1338: 18
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D6S1043: 14
ST   D7S820: 10,11
ST   D8S1179: 13,17
ST   FGA: 19,24
ST   Penta E: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   MKN45-EGFP
AC   CVCL_UW57
DR   cancercelllines; CVCL_UW57
DR   Wikidata; Q95989940
RX   PubMed=16077911;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   MKN45-Luc
AC   CVCL_J262
SY   MKN-45-Luc; MKN-45Luc
DR   cancercelllines; CVCL_J262
DR   JCRB; JCRB1379
DR   JCRB; NIHS0634
DR   JCRB; NIHS1337
DR   Wikidata; Q54905824
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0634; true.
CC   Discontinued: JCRB; NIHS1337; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1379
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   MKN45/CDDP/R1
AC   CVCL_YX96
DR   cancercelllines; CVCL_YX96
DR   Wikidata; Q95989944
RX   PubMed=18751380;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   MKN45/CV
AC   CVCL_E2W7
SY   MKN-45/CV
RX   PubMed=18922971;
CC   Population: Japanese.
CC   Characteristics: Control cell line for MKN45/TP (Cellosaurus=CVCL_9645) (PubMed=18922971).
CC   Doubling time: 38 hours (PubMed=18922971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   MKN45/DR
AC   CVCL_A9J7
SY   MKN-45/DR
DR   cancercelllines; CVCL_A9J7
DR   Wikidata; Q102114543
RX   DOI=10.1016/j.procbio.2020.01.033;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MKN45/F2R
AC   CVCL_QY39
DR   cancercelllines; CVCL_QY39
DR   Wikidata; Q54905825
RX   PubMed=19020740;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MKN45/TP
AC   CVCL_9645
SY   MKN-45/TP
DR   cancercelllines; CVCL_9645
DR   Wikidata; Q54905826
RX   PubMed=18922971;
CC   Population: Japanese.
CC   Doubling time: 33 hours (PubMed=18922971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3148; TYMP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   MKN45cl85
AC   CVCL_D5HU
DR   GEO; GSM3097051
DR   GEO; GSM3097052
DR   GEO; GSM3097053
DR   Wikidata; Q127382830
RX   PubMed=23659450;
RX   PubMed=30410674;
CC   Population: Japanese.
CC   Characteristics: Parent cell line was injected subcutaneously in BALB/c nude mice. Cachexia-inducing tumor cells were harvested and re-injected into mice. This process was carried out 10 times (PubMed=23659450).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   MKN45G
AC   CVCL_RM02
DR   cancercelllines; CVCL_RM02
DR   Wikidata; Q54905827
RX   PubMed=2061947;
RX   PubMed=2105279;
CC   Population: Japanese.
CC   Characteristics: Gastrin-producing. Established through nine passages of the parent cell line in hypergastrinaemic nude mice.
CC   Doubling time: 16 hours (PubMed=2105279).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MKN45P
AC   CVCL_Y476
SY   MKN-45P
DR   cancercelllines; CVCL_Y476
DR   Wikidata; Q54905828
RX   PubMed=17380436;
RX   PubMed=22531121;
CC   Population: Japanese.
CC   Characteristics: High-potential peritoneal dissemination child line of MKN45.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   MKN45R0.05
AC   CVCL_Z941
DR   cancercelllines; CVCL_Z941
DR   Wikidata; Q54905829
RX   CelloPub=CLPUB00210;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   MKN45R0.08
AC   CVCL_Z942
DR   cancercelllines; CVCL_Z942
DR   Wikidata; Q54905830
RX   CelloPub=CLPUB00210;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   MKN7
AC   CVCL_1417
SY   MKN-7; MKN 7
DR   BTO; BTO_0002382
DR   CLO; CLO_0050805
DR   EFO; EFO_0002895
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472197
DR   BioSample; SAMN03473201
DR   BioSample; SAMN10988431
DR   cancercelllines; CVCL_1417
DR   Cell_Model_Passport; SIDM00560
DR   CGH-DB; 118-1
DR   CGH-DB; 9020-4
DR   ChEMBL-Cells; CHEMBL3307377
DR   ChEMBL-Targets; CHEMBL614355
DR   CLS; 305104
DR   Cosmic; 733175
DR   Cosmic; 848370
DR   Cosmic; 877040
DR   Cosmic; 888825
DR   Cosmic; 889106
DR   Cosmic; 897533
DR   Cosmic; 922693
DR   Cosmic; 924250
DR   Cosmic; 926112
DR   Cosmic; 968347
DR   Cosmic; 983725
DR   Cosmic; 1007601
DR   Cosmic; 1066229
DR   Cosmic; 1093297
DR   Cosmic; 1187284
DR   Cosmic; 1223587
DR   Cosmic; 1436024
DR   Cosmic; 1460708
DR   Cosmic; 1482077
DR   Cosmic; 1518242
DR   Cosmic; 1995511
DR   Cosmic; 2807634
DR   Cosmic-CLP; 924250
DR   DepMap; ACH-000678
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 924250
DR   GEO; GSM552365
DR   GEO; GSM562401
DR   GEO; GSM827584
DR   GEO; GSM844608
DR   GEO; GSM887326
DR   GEO; GSM888402
DR   GEO; GSM1237677
DR   GEO; GSM1237702
DR   GEO; GSM1670114
DR   IARC_TP53; 13723
DR   IARC_TP53; 21641
DR   JCRB; FDSC0010
DR   JCRB; JCRB0082
DR   JCRB; JCRB1025
DR   LiGeA; CCLE_388
DR   LINCS_LDP; LCL-1885
DR   PharmacoDB; MKN7_939_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1417
DR   PubChem_Cell_line; CVCL_1417
DR   RCB; RCB0999
DR   RCB; RCB3687
DR   TKG; TKG 0228
DR   Wikidata; Q54905831
RX   CelloPub=CLPUB00581;
RX   CelloPub=CLPUB00584;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1933850;
RX   PubMed=3962675;
RX   PubMed=6862145;
RX   PubMed=11107048;
RX   PubMed=15723654;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22336246;
RX   PubMed=22460905;
RX   PubMed=24587255;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MKN-7
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 64-66 hours (PubMed=3962675); 66 hours (PubMed=29435981); 86 hours (PubMed=25984343).
CC   HLA typing: A*24:02,24:02; B*07:02,48:01; C*04:01,08:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Homozygous (PubMed=11107048; Cosmic-CLP=924250; DepMap=ACH-000678).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.09%; East Asian, North=81.05%; East Asian, South=18.37%; South Asian=0%; European, North=0%; European, South=0.49% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at p.Ile251Leu (c.751A>C) in PubMed=15900046.
CC   Discontinued: JCRB; JCRB0082; true.
CC   Discontinued: JCRB; FDSC0010; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=924250; JCRB=JCRB1025; PubMed=25877200; RCB=RCB0999; TKG=TKG 0228
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 13,18
ST   D21S11: 29,32.2
ST   D3S1358: 17
ST   D5S818: 9,13
ST   D7S820: 9 (JCRB=JCRB1025; PubMed=25877200; TKG=TKG 0228)
ST   D7S820: 9,11 (Cosmic-CLP=924250; RCB=RCB0999)
ST   D8S1179: 15
ST   FGA: 23
ST   Penta D: 10,11
ST   Penta E: 18
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   MKN7/CMV-Luc
AC   CVCL_4Y05
SY   MKN-7/CMV-Luc
DR   cancercelllines; CVCL_4Y05
DR   JCRB; JCRB1471
DR   JCRB; NIHS0721
DR   Wikidata; Q54905832
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0721; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1471
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 9
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1417 ! MKN7
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   MKN74
AC   CVCL_2791
SY   MKN-74; MKN 74
DR   BTO; BTO_0002383
DR   CLO; CLO_0050798
DR   EFO; EFO_0002834
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN01821701
DR   BioSample; SAMN03473122
DR   BioSample; SAMN10987828
DR   cancercelllines; CVCL_2791
DR   Cell_Model_Passport; SIDM00248
DR   CGH-DB; 121-1
DR   CGH-DB; 9023-4
DR   ChEMBL-Cells; CHEMBL3307287
DR   ChEMBL-Targets; CHEMBL614048
DR   CLS; 300490
DR   Cosmic; 685597
DR   Cosmic; 801340
DR   Cosmic; 848148
DR   Cosmic; 848372
DR   Cosmic; 873712
DR   Cosmic; 877043
DR   Cosmic; 887253
DR   Cosmic; 888828
DR   Cosmic; 897536
DR   Cosmic; 918498
DR   Cosmic; 922695
DR   Cosmic; 926115
DR   Cosmic; 983728
DR   Cosmic; 1007603
DR   Cosmic; 1067209
DR   Cosmic; 1090462
DR   Cosmic; 1093300
DR   Cosmic; 1122338
DR   Cosmic; 1187285
DR   Cosmic; 1223590
DR   Cosmic; 1436027
DR   Cosmic; 1460709
DR   Cosmic; 1477424
DR   Cosmic; 1518244
DR   Cosmic; 2484974
DR   Cosmic; 2807635
DR   DepMap; ACH-000758
DR   EGA; EGAS00001000610
DR   GEO; GSM562418
DR   GEO; GSM827533
DR   GEO; GSM844609
DR   GEO; GSM887325
DR   GEO; GSM888401
DR   GEO; GSM1374682
DR   IARC_TP53; 21642
DR   IARC_TP53; 30196
DR   JCRB; JCRB0255
DR   KCLB; 80104
DR   LiGeA; CCLE_606
DR   LINCS_LDP; LCL-1536
DR   PharmacoDB; MKN74_940_2019
DR   Progenetix; CVCL_2791
DR   PubChem_Cell_line; CVCL_2791
DR   RCB; RCB1002
DR   Wikidata; Q54905833
RX   CelloPub=CLPUB00581;
RX   CelloPub=CLPUB00584;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1370612;
RX   PubMed=1933850;
RX   PubMed=3962675;
RX   PubMed=6862145;
RX   PubMed=9290701;
RX   PubMed=11107048;
RX   PubMed=11314020;
RX   PubMed=15723654;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=20215515;
RX   PubMed=22336246;
RX   PubMed=22460905;
RX   PubMed=24587255;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 42-46 hours (PubMed=3962675); 44 hours (PubMed=29435981); 46-49 hours (CelloPub=CLPUB00584).
CC   HLA typing: A*31:01,31:01; B*51:01,51:01; C*03:04,03:04; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*31:01,31:01; B*51:01,51:01; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Leu (c.751A>C); ClinVar=VCV000182937; Zygosity=Unspecified (PubMed=1370612; PubMed=15900046).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=88.48%; East Asian, South=9.79%; South Asian=0.44%; European, North=0%; European, South=1.29% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): CLS=300490; JCRB=JCRB0255; KCLB=80104; PubMed=25877200; RCB=RCB1002
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18,21
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 13,15.2
ST   D21S11: 32.2 (PubMed=25877200)
ST   D21S11: 32.2,33.2 (CLS=300490)
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 13
ST   D7S820: 9
ST   D8S1179: 11,16
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 11,14 (CLS=300490)
ST   Penta E: 11,14,15 (PubMed=25877200)
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   MKN74/CMV-Luc
AC   CVCL_4Y06
SY   MKN-74/CMV-Luc
DR   cancercelllines; CVCL_4Y06
DR   JCRB; JCRB1473
DR   JCRB; NIHS0722
DR   Wikidata; Q54905834
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1473).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Leu (c.751A>C); ClinVar=VCV000182937; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0722; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1473
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 12
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 11,16
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 11,14,15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2791 ! MKN74
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   MKO
AC   CVCL_WT60
DR   Wikidata; Q95989961
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
CC   Population: Japanese.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   MKPL-1
AC   CVCL_2116
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473446
DR   Cosmic; 787452
DR   Cosmic; 975270
DR   Cosmic; 1012091
DR   Cosmic; 1281328
DR   Cosmic; 2306219
DR   DSMZ; ACC-697
DR   DSMZCellDive; ACC-697
DR   FANTOM5_SSTAR; 10802-111A1
DR   JCRB; JCRB1325
DR   JCRB; NIHS0536
DR   Wikidata; Q54905835
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1602796;
RX   PubMed=16408098;
RX   PubMed=17360941;
RX   PubMed=31160637;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=1602796); ~50-60 hours (DSMZ=ACC-697).
CC   HLA typing: A*24:02:01,31:01:02; B*07:02:01,56:01:01; C*04:01:01,07:02:01 (DSMZCellDive=ACC-697).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2433; CSF1R + HGNC; HGNC:9903; RBM6; Name(s)=RBM6-CSF1R (PubMed=17360941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: JCRB; NIHS0536; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-697; JCRB=JCRB1325
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 29,31.2
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 19,24
ST   Penta D: 9,10
ST   Penta E: 5,17
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   mKS-A TU-5
AC   CVCL_5T88
SY   TU-5; TU5
DR   Wikidata; Q54905836
RX   PubMed=4310402;
RX   PubMed=4348218;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   mKS(tsB)
AC   CVCL_B5VR
DR   Wikidata; Q112129324
RX   PubMed=204069;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsB206).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   mKS(tsC)
AC   CVCL_B5VS
DR   Wikidata; Q112129325
RX   PubMed=204069;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsC307).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   mKS(wt)
AC   CVCL_B5VT
DR   Wikidata; Q112129326
RX   PubMed=204069;
RX   PubMed=217962;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   mKS(wt)-H
AC   CVCL_B5VU
DR   Wikidata; Q112129327
RX   PubMed=217962;
CC   Characteristics: Heat-adapted, grows at 39.8 Celsius.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VT ! mKS(wt)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   mKSA207
AC   CVCL_B5VM
SY   MKSA207; mKSA207 clone 6; mKSA207 Cl 6
DR   Wikidata; Q112129328
RX   PubMed=204069;
RX   PubMed=217962;
CC   Characteristics: At temperatures above 39.5 Celsius fails to form colonies either in soft agar or on plastic and fails to sustain growth in monolayer culture (PubMed=204069).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   mKSA207-C
AC   CVCL_B5VN
DR   Wikidata; Q112129329
RX   PubMed=217962;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VM ! mKSA207
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   mKSA207-CH
AC   CVCL_B5VP
DR   Wikidata; Q112129330
RX   PubMed=217962;
CC   Characteristics: Heat-adapted, grows at 39.8 Celsius.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VN ! mKSA207-C
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   mKSA207-H
AC   CVCL_B5VQ
DR   Wikidata; Q112129331
RX   PubMed=217962;
CC   Characteristics: Heat-adapted, grows at 39.8 Celsius.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5VM ! mKSA207
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   MKT-BR
AC   CVCL_7080
SY   MKTBR; MkTBr
DR   BTO; BTO_0002735
DR   Cosmic; 986618
DR   GEO; GSM276741
DR   Wikidata; Q54905837
RX   PubMed=9154388;
RX   PubMed=15714118;
RX   PubMed=17487557;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   ML
AC   CVCL_W799
DR   Cosmic; 706110
DR   Cosmic; 888853
DR   Wikidata; Q54905838
RX   PubMed=9692547;
RX   PubMed=10766161;
RX   PubMed=15009714;
CC   From: Byers, Hugh Randolph; Boston University Medical Center; Boston; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=10766161; PubMed=15009714).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 12
//
ID   ML-1 [Human bone marrow]
AC   CVCL_IQ95
DR   Wikidata; Q54905839
RX   Patent=US5981708;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11451.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   ML-1 [Human leukemia]
AC   CVCL_0436
SY   ML1
DR   BTO; BTO_0001884
DR   CLO; CLO_0007735
DR   EFO; EFO_0022439
DR   MCCL; MCC:0000331
DR   CLDB; cl3489
DR   Cell_Model_Passport; SIDM00440
DR   Cosmic; 787453
DR   Cosmic; 798669
DR   Cosmic; 919125
DR   Cosmic; 924048
DR   Cosmic; 947369
DR   Cosmic; 994171
DR   Cosmic; 998746
DR   Cosmic; 999727
DR   Cosmic; 1037658
DR   Cosmic; 1078735
DR   Cosmic; 1078738
DR   Cosmic; 1127255
DR   Cosmic; 2089662
DR   Cosmic; 2301563
DR   ECACC; 88113007
DR   Wikidata; Q54905840
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1571549;
RX   PubMed=3458526;
RX   PubMed=6091813;
RX   PubMed=7798274;
RX   PubMed=8814454;
RX   PubMed=9510473;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=21552520;
RX   PubMed=23955599;
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG; ECACC=88113007
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 8,13
ST   FGA: 23,25
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1418 ! ML-2
OI   CVCL_H526 ! ML-3
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   ML-1 [Human thyroid carcinoma]
AC   CVCL_H525
SY   ML1
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473557
DR   BioSample; SAMN10989572
DR   cancercelllines; CVCL_H525
DR   Cell_Model_Passport; SIDM00442
DR   Cosmic; 1239975
DR   Cosmic; 2054099
DR   Cosmic-CLP; 1240178
DR   DepMap; ACH-000058
DR   DSMZ; ACC-464
DR   DSMZCellDive; ACC-464
DR   EGA; EGAS00001000978
DR   GDSC; 1240178
DR   GEO; GSM887327
DR   GEO; GSM888403
DR   GEO; GSM1670115
DR   LiGeA; CCLE_324
DR   LINCS_LDP; LCL-1679
DR   PharmacoDB; ML1_941_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_H525
DR   Wikidata; Q54905841
RX   PubMed=10794546;
RX   PubMed=11668190;
RX   PubMed=18713817;
RX   PubMed=22460905;
RX   PubMed=23833040;
RX   PubMed=25675381;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30629668;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Virology: Infected with a murine leukemia virus-related virus (PubMed=30629668).
CC   Doubling time: ~4-7 days (DSMZ=ACC-464).
CC   HLA typing: A*68:01,68:01; B*07:02,07:02; C*07:02,07:02; DQA1*03:02,03:02; DQB1*06:02,06:02; DRB1*13:26,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.17%; Native American=0.68%; East Asian, North=3.84%; East Asian, South=0%; South Asian=0%; European, North=57.01%; European, South=38.3% (PubMed=30894373).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=1240178; DSMZ=ACC-464; PubMed=18713817; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 14,18 (PubMed=30737244)
ST   D18S51: 18 (DSMZ=ACC-464; PubMed=18713817)
ST   D19S433: 13,16
ST   D21S11: 31.2,33.2
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10 (DSMZ=ACC-464)
ST   D8S1179: 10,13 (PubMed=18713817; PubMed=30737244)
ST   FGA: 22,25
ST   Penta D: 13
ST   Penta E: 7,19
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 36
//
ID   ML-1a
AC   CVCL_0435
SY   ML1a
DR   MCCL; MCC:0000330
DR   Wikidata; Q54905842
CC   From: Takeda, Ken; Showa University; Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C7463; Acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   ML-2
AC   CVCL_1418
SY   ML2
DR   BTO; BTO_0001885
DR   CLO; CLO_0007736
DR   EFO; EFO_0002238
DR   CLDB; cl3490
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472168
DR   cancercelllines; CVCL_1418
DR   Cell_Model_Passport; SIDM00441
DR   ChEMBL-Cells; CHEMBL3307604
DR   ChEMBL-Targets; CHEMBL614356
DR   Cosmic; 787454
DR   Cosmic; 850389
DR   Cosmic; 908141
DR   Cosmic; 975271
DR   Cosmic; 999728
DR   Cosmic; 1012092
DR   Cosmic; 1078727
DR   Cosmic; 1078739
DR   Cosmic; 1151785
DR   Cosmic; 1181602
DR   Cosmic; 1281329
DR   Cosmic; 1524834
DR   Cosmic; 2131545
DR   Cosmic; 2391904
DR   Cosmic; 2750863
DR   Cosmic-CLP; 908141
DR   DepMap; ACH-002273
DR   DSMZ; ACC-15
DR   DSMZCellDive; ACC-15
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 908141
DR   GEO; GSM236791
DR   GEO; GSM236827
DR   GEO; GSM482497
DR   GEO; GSM1374683
DR   GEO; GSM1446737
DR   GEO; GSM1670116
DR   IGRhCellID; ML2
DR   LINCS_LDP; LCL-1060
DR   PharmacoDB; ML2_942_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1418
DR   PubChem_Cell_line; CVCL_1418
DR   Wikidata; Q54905843
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3458526;
RX   PubMed=3874327;
RX   PubMed=6091813;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=16969076;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-15).
CC   HLA typing: A*02:01,02:01; B*44:02,51:01; C*05:01,14:02; DRB1*14:103,14:103 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (PubMed=14671638; PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (PubMed=16969076; Cosmic-CLP=908141; DepMap=ACH-002273).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0.26%; European, North=70.54%; European, South=29.2% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=908141; DSMZ=ACC-15; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 15,18
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 8,13
ST   FGA: 23,25
ST   Penta D: 12
ST   Penta E: 5,7
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0436 ! ML-1 [Human leukemia]
OI   CVCL_H526 ! ML-3
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   ML-3
AC   CVCL_H526
SY   ML 3; ML3
DR   Cell_Model_Passport; SIDM00439
DR   Cosmic; 1070691
DR   Cosmic; 1176586
DR   Wikidata; Q54905844
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.1159/000415060;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3458526;
RX   PubMed=3874327;
RX   PubMed=6091813;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0436 ! ML-1 [Human leukemia]
OI   CVCL_1418 ! ML-2
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   ML-DmBG1
AC   CVCL_Z709
DR   DGRC; 49
DR   FlyBase_Cell_line; FBtc0000049
DR   Wikidata; Q54905846
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Doubling time: 57 hours (DGRC=49).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG1-c1
AC   CVCL_Z857
SY   BG1c1
DR   EFO; EFO_0005821
DR   DGRC; 50
DR   ENCODE; ENCBS002ZRD
DR   FlyBase_Cell_line; FBtc0000050
DR   GEO; GSM409485
DR   GEO; GSM409486
DR   GEO; GSM409487
DR   GEO; GSM609222
DR   GEO; GSM980233
DR   Wikidata; Q54905847
RX   CelloPub=CLPUB00203;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 44 hours (DGRC=50).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z709 ! ML-DmBG1
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   ML-DmBG2
AC   CVCL_Z710
DR   DGRC; 51
DR   FlyBase_Cell_line; FBtc0000051
DR   Wikidata; Q54905848
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG2-c1
AC   CVCL_Z717
DR   DGRC; 52
DR   FlyBase_Cell_line; FBtc0000052
DR   Wikidata; Q54905849
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Doubling time: 53 hours (PubMed=8069443).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG2-c10
AC   CVCL_Z718
DR   DGRC; 62
DR   FlyBase_Cell_line; FBtc0000062
DR   Wikidata; Q54905850
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
CC   Doubling time: 76 hours (DGRC=62).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG2-c11
AC   CVCL_Z797
DR   DGRC; 63
DR   FlyBase_Cell_line; FBtc0000063
DR   Wikidata; Q54905851
CC   Group: Insect cell line.
CC   Doubling time: 42 hours (DGRC=63).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG2-c12
AC   CVCL_Z798
DR   DGRC; 64
DR   FlyBase_Cell_line; FBtc0000064
DR   Wikidata; Q54905852
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG2-c2
AC   CVCL_Z719
SY   BG2-c2; BG2c2
DR   EFO; EFO_0005822
DR   DGRC; 53
DR   ENCODE; ENCBS193GRU
DR   FlyBase_Cell_line; FBtc0000053
DR   Wikidata; Q54905853
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 28 hours (PubMed=8069443); 104 hours (DGRC=53).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   ML-DmBG2-c2-attP-25C6
AC   CVCL_C7G2
SY   ML-DmBG2-c2-attP-25C6-Clone 8
DR   DGRC; 319
DR   FlyBase_Cell_line; FBtc0000319
DR   Wikidata; Q117704711
RX   PubMed=33963853;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z719 ! ML-DmBG2-c2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   ML-DmBG2-c3
AC   CVCL_Z720
DR   DGRC; 54
DR   FlyBase_Cell_line; FBtc0000054
DR   Wikidata; Q54905854
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Doubling time: 27 hours (PubMed=8069443).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG2-c4
AC   CVCL_Z721
DR   DGRC; 55
DR   FlyBase_Cell_line; FBtc0000055
DR   Wikidata; Q54905855
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Doubling time: 31 hours (PubMed=8069443); 78 hours (DGRC=55).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG2-c5
AC   CVCL_Z722
DR   DGRC; 56
DR   FlyBase_Cell_line; FBtc0000056
DR   Wikidata; Q54905856
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Doubling time: 43 hours (PubMed=8069443); 98 hours (DGRC=56).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG2-c6
AC   CVCL_Z723
SY   BG2-C6
DR   DGRC; 3
DR   FlyBase_Cell_line; FBtc0000003
DR   Wikidata; Q54905857
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
RX   PubMed=17890361;
WW   Info; -; -; https://palivec.entu.cas.cz/zurovec/eng/research/cultures.html
CC   Group: Insect cell line.
CC   Doubling time: 42 hours (PubMed=8069443); 29 hours (DGRC=3).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   ML-DmBG2-c7
AC   CVCL_Z724
DR   FlyBase_Cell_line; FBtc9000049
DR   Wikidata; Q54905858
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG2-c8
AC   CVCL_Z725
DR   DGRC; 60
DR   FlyBase_Cell_line; FBtc0000060
DR   Wikidata; Q54905859
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
CC   Doubling time: 63 hours (DGRC=60).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG2-c9
AC   CVCL_Z726
DR   FlyBase_Cell_line; FBtc9000050
DR   Wikidata; Q54905860
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z710 ! ML-DmBG2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG3
AC   CVCL_Z711
DR   DGRC; 66
DR   FlyBase_Cell_line; FBtc0000066
DR   Wikidata; Q54905862
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG3-c1
AC   CVCL_Z727
SY   BG3-c1
DR   DGRC; 67
DR   FlyBase_Cell_line; FBtc0000067
DR   Wikidata; Q54905867
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
CC   Doubling time: 56 hours (DGRC=67).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z711 ! ML-DmBG3
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmBG3-c2
AC   CVCL_Z728
SY   BG3-c2; BG3c2; BG3C2; Bm3-c2
DR   BTO; BTO_0004801
DR   BTO; BTO_0005432
DR   EFO; EFO_0005823
DR   DGRC; 68
DR   ENCODE; ENCBS005WGE
DR   ENCODE; ENCBS073JKW
DR   ENCODE; ENCBS101CUQ
DR   ENCODE; ENCBS108FTY
DR   ENCODE; ENCBS174JPC
DR   ENCODE; ENCBS216EMV
DR   ENCODE; ENCBS275KHY
DR   ENCODE; ENCBS303TQC
DR   ENCODE; ENCBS315UOB
DR   ENCODE; ENCBS329HUS
DR   ENCODE; ENCBS417TZL
DR   ENCODE; ENCBS424ESD
DR   ENCODE; ENCBS489VDG
DR   ENCODE; ENCBS494EED
DR   ENCODE; ENCBS557LTF
DR   ENCODE; ENCBS565CSY
DR   ENCODE; ENCBS637AYT
DR   ENCODE; ENCBS745OPA
DR   ENCODE; ENCBS804ZFU
DR   ENCODE; ENCBS832ABW
DR   ENCODE; ENCBS834HSY
DR   ENCODE; ENCBS843UOH
DR   ENCODE; ENCBS848TVS
DR   ENCODE; ENCBS927DOE
DR   ENCODE; ENCBS936VAG
DR   ENCODE; ENCBS946SBT
DR   ENCODE; ENCBS980BNS
DR   ENCODE; ENCBS985ADJ
DR   ENCODE; ENCBS987RFJ
DR   FlyBase_Cell_line; FBtc0000068
DR   Wikidata; Q54905868
RX   CelloPub=CLPUB00203;
RX   PubMed=18824562;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 48-127 hours (Note=Depending on growth medium) (DGRC=68).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: BG3A-C2; BTO=BTO_0004801; PubMed=18824562.
CC   Misspelling: ML-DmBG3A-C2; BTO=BTO_0004801; PubMed=18824562.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z711 ! ML-DmBG3
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   ML-DmBG3-c2-attP-25C6
AC   CVCL_C7G3
SY   ML-DmBG3-c2-attP-25C6-Clone 74
DR   DGRC; 320
DR   FlyBase_Cell_line; FBtc0000320
DR   Wikidata; Q117704712
RX   PubMed=33963853;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z728 ! ML-DmBG3-c2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   ML-DmBG3-c2 attP 99F8
AC   CVCL_C7G4
SY   ML-DmBG3-c2 attP 99F8 Clone 28
DR   DGRC; 321
DR   FlyBase_Cell_line; FBtc0000321
DR   Wikidata; Q117704713
RX   PubMed=33963853;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 99F8 locus (PubMed=33963853).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z728 ! ML-DmBG3-c2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 4
//
ID   ML-DmBG3-c2-Mt-GFP-Act5C
AC   CVCL_Z853
DR   DGRC; 174
DR   FlyBase_Cell_line; FBtc0000174
DR   Wikidata; Q54905869
RX   PubMed=24434506;
CC   Group: Insect cell line.
CC   Doubling time: 84 hours (DGRC=174).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000042; Act5C.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z728 ! ML-DmBG3-c2
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   ML-DmBG3-c3
AC   CVCL_Z729
DR   DGRC; 69
DR   FlyBase_Cell_line; FBtc0000069
DR   Wikidata; Q54905870
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
CC   Doubling time: 51 hours (DGRC=69).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z711 ! ML-DmBG3
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML-DmBG3-c4
AC   CVCL_Z730
DR   FlyBase_Cell_line; FBtc9000051
DR   Wikidata; Q54905871
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z711 ! ML-DmBG3
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG3-c5
AC   CVCL_Z731
DR   FlyBase_Cell_line; FBtc9000052
DR   Wikidata; Q54905872
RX   CelloPub=CLPUB00203;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z711 ! ML-DmBG3
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG4
AC   CVCL_Z712
DR   FlyBase_Cell_line; FBtc9000013
DR   Wikidata; Q54905873
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG5
AC   CVCL_Z713
DR   FlyBase_Cell_line; FBtc9000014
DR   Wikidata; Q54905874
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG6
AC   CVCL_Z714
DR   FlyBase_Cell_line; FBtc9000015
DR   Wikidata; Q54905875
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG7
AC   CVCL_Z715
DR   FlyBase_Cell_line; FBtc9000016
DR   Wikidata; Q54905876
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmBG8
AC   CVCL_Z716
DR   DGRC; 77
DR   FlyBase_Cell_line; FBtc0000077
DR   Wikidata; Q54905878
RX   CelloPub=CLPUB00203;
RX   PubMed=8069443;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmD1
AC   CVCL_Z736
SY   ML-DmD 1
DR   DGRC; 79
DR   FlyBase_Cell_line; FBtc0000079
DR   Wikidata; Q54905879
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
CC   Group: Insect cell line.
CC   Doubling time: 52 hours (PubMed=3117765).
CC   Discontinued: DGRC; 79; probable.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD1-c3
AC   CVCL_Z756
DR   DGRC; 81
DR   FlyBase_Cell_line; FBtc0000081
DR   Wikidata; Q54905880
CC   Group: Insect cell line.
CC   Doubling time: 58 hours (DGRC=81).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z736 ! ML-DmD1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD1-c4
AC   CVCL_Z757
DR   DGRC; 82
DR   FlyBase_Cell_line; FBtc0000082
DR   Wikidata; Q54905881
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 73-78 hours (Note=Depending on growth medium) (DGRC=82).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z736 ! ML-DmD1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   ML-DmD1-c5
AC   CVCL_Z758
DR   DGRC; 122
DR   FlyBase_Cell_line; FBtc0000122
DR   Wikidata; Q54905882
CC   Group: Insect cell line.
CC   Doubling time: 37 hours (DGRC=122).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z736 ! ML-DmD1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD1-c6
AC   CVCL_Z759
DR   FlyBase_Cell_line; FBtc9000058
DR   Wikidata; Q54905883
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z736 ! ML-DmD1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD1-c7
AC   CVCL_Z760
DR   DGRC; 83
DR   FlyBase_Cell_line; FBtc0000083
DR   Wikidata; Q54905884
CC   Group: Insect cell line.
CC   Doubling time: 55 hours (DGRC=83).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z736 ! ML-DmD1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD1-c8
AC   CVCL_Z761
DR   DGRC; 84
DR   FlyBase_Cell_line; FBtc0000084
DR   Wikidata; Q54905885
CC   Group: Insect cell line.
CC   Doubling time: 45 hours (DGRC=84).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z736 ! ML-DmD1
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD10
AC   CVCL_Z737
SY   ML-DmD 10
DR   FlyBase_Cell_line; FBtc9000043
DR   Wikidata; Q54905886
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, antenna; UBERON=UBERON_6001767.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD11
AC   CVCL_Z738
SY   D11
DR   EFO; EFO_0005824
DR   DGRC; 94
DR   ENCODE; ENCBS640WXH
DR   FlyBase_Cell_line; FBtc0000094
DR   Wikidata; Q54905887
RX   CelloPub=CLPUB00533;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: ~84 hours (DGRC=94).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, eye-antenna; UBERON=UBERON_6001766.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   ML-DmD11-c1
AC   CVCL_Z762
DR   DGRC; 208
DR   FlyBase_Cell_line; FBtc0000208
DR   Wikidata; Q54905888
CC   Group: Insect cell line.
CC   Doubling time: 66 hours (DGRC=208).
CC   Derived from site: In situ; Imaginal disc, eye-antenna; UBERON=UBERON_6001766.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z738 ! ML-DmD11
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD11-c2
AC   CVCL_Z763
DR   DGRC; 209
DR   FlyBase_Cell_line; FBtc0000209
DR   Wikidata; Q54905889
CC   Group: Insect cell line.
CC   Doubling time: 70 hours (DGRC=209).
CC   Derived from site: In situ; Imaginal disc, eye-antenna; UBERON=UBERON_6001766.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z738 ! ML-DmD11
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD11-c3
AC   CVCL_Z764
DR   DGRC; 210
DR   FlyBase_Cell_line; FBtc0000210
DR   Wikidata; Q54905890
CC   Group: Insect cell line.
CC   Doubling time: 99 hours (DGRC=210).
CC   Derived from site: In situ; Imaginal disc, eye-antenna; UBERON=UBERON_6001766.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z738 ! ML-DmD11
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD12
AC   CVCL_XA72
DR   Wikidata; Q95990024
RX   CelloPub=CLPUB00533;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   ML-DmD13
AC   CVCL_XA73
DR   Wikidata; Q95990025
RX   CelloPub=CLPUB00533;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   ML-DmD14
AC   CVCL_IY67
DR   DGRC; 95
DR   FlyBase_Cell_line; FBtc0000095
DR   Wikidata; Q54905891
RX   CelloPub=CLPUB00533;
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 95; probable.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   ML-DmD15
AC   CVCL_Z739
DR   FlyBase_Cell_line; FBtc9000059
DR   Wikidata; Q54905892
RX   CelloPub=CLPUB00533;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD16
AC   CVCL_Z740
DR   DGRC; 183
DR   FlyBase_Cell_line; FBtc0000183
DR   Wikidata; Q54905893
RX   CelloPub=CLPUB00533;
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 183; probable.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD16-c1
AC   CVCL_Z765
DR   DGRC; 96
DR   FlyBase_Cell_line; FBtc0000096
DR   Wikidata; Q54905894
CC   Group: Insect cell line.
CC   Doubling time: 130 hours (DGRC=96).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD16-c3
AC   CVCL_Z766
SY   D16-c3; D16c3
DR   EFO; EFO_0005825
DR   DGRC; 97
DR   ENCODE; ENCBS810BML
DR   FlyBase_Cell_line; FBtc0000097
DR   Wikidata; Q54905895
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: ~80 hours (DGRC=97).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   ML-DmD16-c4
AC   CVCL_Z767
DR   DGRC; 98
DR   FlyBase_Cell_line; FBtc0000098
DR   Wikidata; Q54905896
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD16-c5
AC   CVCL_IY66
DR   DGRC; 99
DR   FlyBase_Cell_line; FBtc0000099
DR   Wikidata; Q54905897
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 99; probable.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   ML-DmD16-c6
AC   CVCL_Z768
DR   DGRC; 100
DR   FlyBase_Cell_line; FBtc0000100
DR   Wikidata; Q54905898
CC   Group: Insect cell line.
CC   Doubling time: 74 hours (DGRC=100).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD16-c7
AC   CVCL_Z769
DR   DGRC; 101
DR   FlyBase_Cell_line; FBtc0000101
DR   Wikidata; Q54905899
CC   Group: Insect cell line.
CC   Doubling time: ~1 week (DGRC=101).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD16-c8
AC   CVCL_Z770
DR   DGRC; 102
DR   FlyBase_Cell_line; FBtc0000102
DR   Wikidata; Q54905900
CC   Group: Insect cell line.
CC   Doubling time: ~72 hours (DGRC=102).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD16-c9
AC   CVCL_Z771
DR   DGRC; 103
DR   FlyBase_Cell_line; FBtc0000103
DR   Wikidata; Q54905901
CC   Group: Insect cell line.
CC   Doubling time: 94 hours (DGRC=103).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z740 ! ML-DmD16
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD17
AC   CVCL_Z741
SY   D17
DR   BTO; BTO_0005223
DR   DGRC; 184
DR   FlyBase_Cell_line; FBtc0000184
DR   Wikidata; Q54905902
RX   CelloPub=CLPUB00533;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 184; probable.
CC   Derived from site: In situ; Imaginal disc, haltere; UBERON=UBERON_6001779.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   ML-DmD17-c3
AC   CVCL_Z772
SY   D17-c3; D17c3
DR   EFO; EFO_0005826
DR   DGRC; 107
DR   ENCODE; ENCBS006QKV
DR   ENCODE; ENCBS122LBB
DR   ENCODE; ENCBS141CJX
DR   ENCODE; ENCBS146SLV
DR   ENCODE; ENCBS166WDM
DR   ENCODE; ENCBS203HRH
DR   ENCODE; ENCBS248SBY
DR   ENCODE; ENCBS332YXG
DR   ENCODE; ENCBS342RHG
DR   ENCODE; ENCBS361KVW
DR   ENCODE; ENCBS397DQG
DR   ENCODE; ENCBS434TLI
DR   ENCODE; ENCBS468KEJ
DR   ENCODE; ENCBS476QMP
DR   ENCODE; ENCBS635RCT
DR   ENCODE; ENCBS787HWT
DR   ENCODE; ENCBS817KQD
DR   ENCODE; ENCBS866KNJ
DR   ENCODE; ENCBS896CUM
DR   ENCODE; ENCBS919OTC
DR   ENCODE; ENCBS999UOC
DR   FlyBase_Cell_line; FBtc0000107
DR   Wikidata; Q54905903
RX   PubMed=21177962;
RX   PubMed=21959242;
RX   PubMed=24434506;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 70-94 hours (Note=Depending on growth medium) (DGRC=107).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, haltere; UBERON=UBERON_6001779.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z741 ! ML-DmD17
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 13
//
ID   ML-DmD18
AC   CVCL_XA74
DR   Wikidata; Q95990035
RX   CelloPub=CLPUB00533;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   ML-DmD19
AC   CVCL_XA75
DR   Wikidata; Q95990036
RX   CelloPub=CLPUB00533;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   ML-DmD2
AC   CVCL_Z742
SY   ML-DmD 2
DR   FlyBase_Cell_line; FBtc9000044
DR   Wikidata; Q54905904
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
CC   Group: Insect cell line.
CC   Doubling time: 53 hours (PubMed=3117765).
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD20
AC   CVCL_Z743
DR   DGRC; 185
DR   FlyBase_Cell_line; FBtc0000185
DR   Wikidata; Q54905905
RX   CelloPub=CLPUB00533;
CC   Group: Insect cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: DGRC; 185; probable.
CC   Derived from site: In situ; Imaginal disc, antenna; UBERON=UBERON_6001767.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   ML-DmD20-c1
AC   CVCL_Z773
DR   DGRC; 108
DR   FlyBase_Cell_line; FBtc0000108
DR   Wikidata; Q54905906
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, antenna; UBERON=UBERON_6001767.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z743 ! ML-DmD20
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD20-c2
AC   CVCL_Z774
SY   D20-c2; D20c2
DR   EFO; EFO_0005827
DR   DGRC; 109
DR   ENCODE; ENCBS695UGH
DR   FlyBase_Cell_line; FBtc0000109
DR   Wikidata; Q54905907
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=25262759;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 68 hours (DGRC=109).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, antenna; UBERON=UBERON_6001767.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z743 ! ML-DmD20
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   ML-DmD20-c4
AC   CVCL_Z775
DR   DGRC; 111
DR   FlyBase_Cell_line; FBtc0000111
DR   Wikidata; Q54905910
CC   Group: Insect cell line.
CC   Doubling time: 69 hours (DGRC=111).
CC   Derived from site: In situ; Imaginal disc, antenna; UBERON=UBERON_6001767.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z743 ! ML-DmD20
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD20-c5
AC   CVCL_Z776
SY   D20-c5; D20c5
DR   EFO; EFO_0005828
DR   DGRC; 112
DR   ENCODE; ENCBS752KGT
DR   FlyBase_Cell_line; FBtc0000112
DR   GEO; GSM609217
DR   Wikidata; Q54905911
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 48 hours (DGRC=112).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, antenna; UBERON=UBERON_6001767.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z743 ! ML-DmD20
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   ML-DmD21
AC   CVCL_Z744
SY   D21
DR   EFO; EFO_0005829
DR   DGRC; 86
DR   ENCODE; ENCBS360NKZ
DR   FlyBase_Cell_line; FBtc0000086
DR   GEO; GSM609220
DR   GEO; GSM609249
DR   Wikidata; Q54905912
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 27 hours (DGRC=86).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   ML-DmD23
AC   CVCL_Z745
SY   ML DmD23; DmD23
DR   EFO; EFO_0007113
DR   DGRC; 121
DR   FlyBase_Cell_line; FBtc0000121
DR   Wikidata; Q54905913
CC   Group: Insect cell line.
CC   Doubling time: 45 hours (DGRC=121).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD23-c1
AC   CVCL_Z777
DR   DGRC; 87
DR   FlyBase_Cell_line; FBtc0000087
DR   Wikidata; Q54905914
CC   Group: Insect cell line.
CC   Doubling time: 34 hours (DGRC=87).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z745 ! ML-DmD23
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD23-c2
AC   CVCL_Z778
DR   DGRC; 116
DR   FlyBase_Cell_line; FBtc0000116
DR   Wikidata; Q54905915
CC   Group: Insect cell line.
CC   Doubling time: 130 hours (DGRC=116).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z745 ! ML-DmD23
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD23-c3
AC   CVCL_Z779
DR   DGRC; 88
DR   FlyBase_Cell_line; FBtc0000088
DR   Wikidata; Q54905916
CC   Group: Insect cell line.
CC   Doubling time: 49-117 hours (Note=Depending on growth medium) (DGRC=88).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z745 ! ML-DmD23
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD23-c4
AC   CVCL_Z780
SY   ML DmD23 c4; DmD23-c4
DR   EFO; EFO_0007114
DR   DGRC; 89
DR   FlyBase_Cell_line; FBtc0000089
DR   GEO; GSM454534
DR   GEO; GSM454535
DR   GEO; GSM454536
DR   GEO; GSM454537
DR   GEO; GSM454538
DR   GEO; GSM454539
DR   GEO; GSM454540
DR   GEO; GSM454541
DR   GEO; GSM454542
DR   Wikidata; Q54905918
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 64 hours (DGRC=89).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z745 ! ML-DmD23
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   ML-DmD23-c5
AC   CVCL_Z781
DR   DGRC; 117
DR   FlyBase_Cell_line; FBtc0000117
DR   Wikidata; Q54905919
CC   Group: Insect cell line.
CC   Doubling time: 58 hours (DGRC=117).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z745 ! ML-DmD23
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD23-c6
AC   CVCL_Z782
DR   DGRC; 118
DR   FlyBase_Cell_line; FBtc0000118
DR   Wikidata; Q54905920
CC   Group: Insect cell line.
CC   Doubling time: 68 hours (DGRC=118).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z745 ! ML-DmD23
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD25
AC   CVCL_Z746
DR   DGRC; 187
DR   FlyBase_Cell_line; FBtc0000187
DR   Wikidata; Q54905921
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 187; probable.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD25-c2
AC   CVCL_Z783
DR   DGRC; 119
DR   FlyBase_Cell_line; FBtc0000119
DR   Wikidata; Q54905922
CC   Group: Insect cell line.
CC   Doubling time: 45 hours (DGRC=119).
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z746 ! ML-DmD25
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML-DmD3
AC   CVCL_Z747
SY   ML-DmD 3
DR   FlyBase_Cell_line; FBtc9000045
DR   Wikidata; Q54905923
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
RX   PubMed=8069443;
CC   Group: Insect cell line.
CC   Doubling time: 66 hours (PubMed=3117765).
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD31
AC   CVCL_Z748
DR   DGRC; 144
DR   FlyBase_Cell_line; FBtc0000144
DR   Wikidata; Q54905924
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   ML-DmD32
AC   CVCL_Z749
SY   D32
DR   EFO; EFO_0005830
DR   DGRC; 145
DR   ENCODE; ENCBS773DNL
DR   FlyBase_Cell_line; FBtc0000145
DR   GEO; GSE16281
DR   GEO; GSE24607
DR   Wikidata; Q54905925
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   ML-DmD4
AC   CVCL_Z750
SY   ML-DmD 4
DR   DGRC; 186
DR   FlyBase_Cell_line; FBtc0000186
DR   Wikidata; Q54905926
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 186; probable.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD4-c1
AC   CVCL_Z784
SY   D4-c1; D4c1
DR   EFO; EFO_0005831
DR   DGRC; 126
DR   ENCODE; ENCBS483XFL
DR   FlyBase_Cell_line; FBtc0000126
DR   GEO; GSM278139
DR   GEO; GSM278140
DR   GEO; GSM278153
DR   GEO; GSM278154
DR   GEO; GSM278155
DR   GEO; GSM278186
DR   GEO; GSM278187
DR   GEO; GSM278229
DR   GEO; GSM278230
DR   GEO; GSM278231
DR   GEO; GSM278327
DR   GEO; GSM279695
DR   GEO; GSM279696
DR   GEO; GSM279697
DR   GEO; GSM279698
DR   Wikidata; Q54905927
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 33 hours (DGRC=126).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z750 ! ML-DmD4
SX   Male
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   ML-DmD5
AC   CVCL_Z751
SY   ML-DmD 5
DR   FlyBase_Cell_line; FBtc9000046
DR   Wikidata; Q54905928
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD6
AC   CVCL_Z752
SY   ML-DmD 6
DR   FlyBase_Cell_line; FBtc9000047
DR   Wikidata; Q54905929
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD7
AC   CVCL_Z753
SY   ML-DmD 7
DR   FlyBase_Cell_line; FBtc9000048
DR   Wikidata; Q54905930
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Imaginal disc; UBERON=UBERON_0000939.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ML-DmD8
AC   CVCL_Z754
SY   ML-DmD 8; D8
DR   EFO; EFO_0005832
DR   DGRC; 92
DR   ENCODE; ENCBS024JYY
DR   FlyBase_Cell_line; FBtc0000092
DR   GEO; GSM919264
DR   GEO; GSM919265
DR   Wikidata; Q54905931
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
RX   PubMed=8069443;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 66 hours (DGRC=92).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   ML-DmD9
AC   CVCL_Z755
SY   ML-DmD 9; D9
DR   EFO; EFO_0005833
DR   DGRC; 85
DR   ENCODE; ENCBS281VAA
DR   FlyBase_Cell_line; FBtc0000085
DR   GEO; GSM409515
DR   GEO; GSM409516
DR   GEO; GSM409517
DR   Wikidata; Q54905932
RX   CelloPub=CLPUB00533;
RX   PubMed=3117765;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 54-67 hours (Note=Depending on growth medium) (DGRC=85).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Imaginal disc, wing; UBERON=UBERON_6001778.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   ML10
AC   CVCL_Y283
DR   GEO; GSM383927
DR   Wikidata; Q54905933
RX   PubMed=9441775;
RX   PubMed=11103784;
RX   PubMed=17519898;
CC   Doubling time: 2.0 +- 0.2 days (PubMed=9441775).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7278; Ovarian papillary cystadenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 9
//
ID   ML108
AC   CVCL_F718
DR   IPD-IMGT/HLA; 11083
DR   Wikidata; Q54905934
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,26:08; B*15:18,44:02; C*05:01,07:04 (IPD-IMGT/HLA=11083).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   ML108U
AC   CVCL_F719
DR   IPD-IMGT/HLA; 11084
DR   Wikidata; Q54905935
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,26:08; B*15:18,44:02; C*05:01 (IPD-IMGT/HLA=11084).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   ML11
AC   CVCL_D7B6
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-14G6.3H3
AC   CVCL_E2YH
SY   14G6
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa .
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-17G6.3E7
AC   CVCL_E2YL
SY   17G6
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-20B10.3F4
AC   CVCL_E2YJ
SY   20B10
DR   ABCD; ABCD_BC337
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-21D4.4A11
AC   CVCL_E2YM
SY   21D4
DR   ABCD; ABCD_BC339
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-22G3.3F3
AC   CVCL_E2YP
SY   22G3
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-23F1.4G3
AC   CVCL_E2YQ
SY   23F1
DR   ABCD; ABCD_BC340
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa .
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-2B12.5G9
AC   CVCL_E2YK
SY   2B12
DR   ABCD; ABCD_BC338
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-2G11.3B1
AC   CVCL_E2YI
SY   2G11
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML129-4B6.4H3
AC   CVCL_E2YN
SY   4B6
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML13-4D10.3F3
AC   CVCL_B4HU
SY   4D10
DR   Wikidata; Q110433042
RX   Patent=US10538581;
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7405.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   ML13-7C6.1D4.4A9.5G8
AC   CVCL_B4HV
SY   7C6
DR   Wikidata; Q110433043
RX   Patent=US9540432;
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7240.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   ML130-14A9.5B12
AC   CVCL_E2YR
SY   14A9
DR   ABCD; ABCD_BC341
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML130-3F7.4A8
AC   CVCL_E2YS
SY   3F7
DR   ABCD; ABCD_BC342
RX   Patent=US10093725;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01138; Human NGF (Note=Also reacts with dog and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML14 [Human LCL]
AC   CVCL_DI50
SY   L-14
DR   BioSample; SAMN06129843
DR   Wikidata; Q54905936
RX   PubMed=204583;
RX   PubMed=3658923;
RX   PubMed=6876798;
RX   PubMed=28940260;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28940260
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D10S1248: 14,16
ST   D12S391: 18,19
ST   D13S317: 11,12,13
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D1S1656: 11,12
ST   D21S11: 30
ST   D22S1045: 15,16
ST   D2S1338: 19,24
ST   D2S441: 11,14
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   DYS391: 11
ST   FGA: 21,25,26
ST   SE33: 15,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1395 ! M14
OI   CVCL_DI53 ! MF14
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 13
//
ID   ML14 [Mouse/rat hybridoma against mouse Cd207]
AC   CVCL_D7B7
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML15-10C1.5C6.3H4
AC   CVCL_B4HW
SY   10C1
DR   Wikidata; Q110433045
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7810.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   ML15-10F11.3D9
AC   CVCL_B4HX
SY   10F11
DR   ATCC; PTA-7239
DR   Wikidata; Q110433046
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7239.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
CC   Misspelling: ML5-8F5.1F2.2A2; ATCC=PTA-7239.
CC   Discontinued: ATCC; PTA-7239; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   ML15-2F2.3E12
AC   CVCL_B4HY
SY   2F2
DR   Wikidata; Q110433049
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7408.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   ML15-3B10.2D5.3F1
AC   CVCL_B4HZ
SY   3B10
DR   Wikidata; Q110433050
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7851.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   ML15-4B7.3A6
AC   CVCL_B4I0
SY   4B7
DR   Wikidata; Q110433051
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7242.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   ML15-5F7.5B10
AC   CVCL_B4I1
SY   5F7
DR   Wikidata; Q110433053
RX   Patent=US8691224;
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7241.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   ML15-6A2-4B10
AC   CVCL_B4I2
SY   6A2
DR   Wikidata; Q110433054
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7409.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   ML15-7E5.5E12
AC   CVCL_B4I3
SY   7E5
DR   Wikidata; Q110433055
RX   Patent=WO2007062852A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7809.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 4
//
ID   ML1805
AC   CVCL_F566
SY   Ml1805; ML; TER272; TER-272; Ter 272; Extract 141; Extract 276; Extract 406
DR   IPD-IMGT/HLA; 11814
DR   Wikidata; Q54905937
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/330cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02,68:02; B*15:10,44:15; C*03:04:02,04:07; DPB1*01:01,04:01; DQA1*01:02,05:01; DQB1*06:02,02:01; DRB1*15:03,03:01; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=11814).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   ML20
AC   CVCL_D7B8
RX   PubMed=17553520;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q8VBX4; Mouse Cd207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   ML2308
AC   CVCL_M827
DR   Wikidata; Q54905938
RX   PubMed=20713527;
RX   PubMed=21335544;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   ML3
AC   CVCL_Y282
DR   Wikidata; Q54905939
RX   PubMed=9441775;
CC   Doubling time: 1.7 +- 0.3 days (PubMed=9441775).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40032; Ovarian serous cystadenofibroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   ML38
AC   CVCL_DG81
DR   Wikidata; Q54905940
RX   PubMed=17519898;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4512; Ovarian mucinous cystadenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   ML3B
AC   CVCL_A5PW
SY   ML-3B
DR   BTO; BTO_0004039
DR   Wikidata; Q107116380
RX   PubMed=9554442;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40032; Ovarian serous cystadenofibroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y282 ! ML3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   ML46
AC   CVCL_DG82
DR   Wikidata; Q54905941
RX   PubMed=17519898;
RX   PubMed=23415752;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4511; Ovarian serous cystadenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   ML5
AC   CVCL_D278
SY   ML-5
DR   BTO; BTO_0004040
DR   Wikidata; Q54905942
RX   PubMed=9441775;
RX   PubMed=9554442;
CC   Doubling time: 1.9 +- 0.2 days (PubMed=9441775).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4511; Ovarian serous cystadenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   ML68-8D1
AC   CVCL_E2YX
SY   8D1
DR   ABCD; ABCD_BE076
RX   Patent=US9605069;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96B86; Human RGMA (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   ML69-5F9
AC   CVCL_E2YY
SY   5F9; r5F9
DR   ABCD; ABCD_BE075
RX   Patent=US9605069;
RX   PubMed=25801027;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96B86; Human RGMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   ML8
AC   CVCL_Y284
DR   Wikidata; Q54905943
RX   PubMed=9441775;
CC   Doubling time: 1.7 +- 0.3 days (PubMed=9441775).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5226; Borderline ovarian serous tumor
DI   ORDO; Orphanet_398934; Malignant epithelial tumor of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 9
//
ID   ML81-18
AC   CVCL_Z801
DR   DGRC; 25
DR   FlyBase_Cell_line; FBtc0000025
DR   Wikidata; Q54905944
CC   Group: Insect cell line.
CC   Doubling time: 22-24 hours (Note=Depending on growth medium) (DGRC=25).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Early extended germ band stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML82-19a
AC   CVCL_Z802
DR   DGRC; 27
DR   FlyBase_Cell_line; FBtc0000027
DR   Wikidata; Q54905945
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7240; ! Drosophila simulans (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML82-8
AC   CVCL_Z866
SY   ML 82-08
DR   FlyBase_Cell_line; FBtc9000053
DR   Wikidata; Q54905946
RX   DOI=10.1016/0167-8817(85)90023-9;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=3141801;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: mus201D1.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML83-1b
AC   CVCL_Z803
DR   DGRC; 31
DR   FlyBase_Cell_line; FBtc0000031
DR   Wikidata; Q54905947
CC   Group: Insect cell line.
CC   Doubling time: 66-74 hours (Note=Depending on growth medium) (DGRC=31).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7243; ! Drosophila teissieri (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML83-26
AC   CVCL_Z804
DR   DGRC; 38
DR   FlyBase_Cell_line; FBtc0000038
DR   Wikidata; Q54905948
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 30-42 hours (Note=Depending on growth medium) (DGRC=38).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Extended germ band stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   ML83-33
AC   CVCL_Z805
DR   DGRC; 35
DR   FlyBase_Cell_line; FBtc0000035
DR   Wikidata; Q54905949
CC   Group: Insect cell line.
CC   Doubling time: 1 week (DGRC=35).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7220; ! Drosophila erecta (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML83-61
AC   CVCL_IY68
DR   DGRC; 46
DR   FlyBase_Cell_line; FBtc0000046
DR   Wikidata; Q54905950
CC   Group: Insect cell line.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Extended germ band stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   ML83-62
AC   CVCL_Z806
DR   DGRC; 41
DR   FlyBase_Cell_line; FBtc0000041
DR   Wikidata; Q54905954
CC   Group: Insect cell line.
CC   Doubling time: 101 hours (DGRC=41).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Extended germ band stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML83-63
AC   CVCL_Z807
DR   DGRC; 33
DR   FlyBase_Cell_line; FBtc0000033
DR   Wikidata; Q54905955
CC   Group: Insect cell line.
CC   Doubling time: 56 hours (DGRC=33).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=46245; ! Drosophila pseudoobscura pseudoobscura (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML83-68
AC   CVCL_Z808
DR   DGRC; 34
DR   FlyBase_Cell_line; FBtc0000034
DR   Wikidata; Q54905956
CC   Group: Insect cell line.
CC   Doubling time: 34-47 hours (Note=Depending on growth medium) (DGRC=34).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=47315; ! Drosophila auraria (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML84-1
AC   CVCL_Z809
DR   DGRC; 42
DR   FlyBase_Cell_line; FBtc0000042
DR   Wikidata; Q54905957
CC   Group: Insect cell line.
CC   Doubling time: 120 hours (DGRC=42).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Extended germ band stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML84-27b
AC   CVCL_Z810
DR   DGRC; 45
DR   FlyBase_Cell_line; FBtc0000045
DR   Wikidata; Q54905958
CC   Group: Insect cell line.
CC   Doubling time: 79-111 hours (Note=Depending on growth medium) (DGRC=45).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Extended germ band stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML84-29
AC   CVCL_Z811
DR   DGRC; 44
DR   FlyBase_Cell_line; FBtc0000044
DR   Wikidata; Q54905959
CC   Group: Insect cell line.
CC   Doubling time: 66 hours (DGRC=44).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Extended germ band stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ML85-5
AC   CVCL_Z812
DR   DGRC; 32
DR   FlyBase_Cell_line; FBtc0000032
DR   Wikidata; Q54905960
CC   Group: Insect cell line.
CC   Doubling time: 51 hours (DGRC=32).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7245; ! Drosophila yakuba (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ML89-1
AC   CVCL_Z813
DR   DGRC; 30
DR   FlyBase_Cell_line; FBtc0000030
DR   Wikidata; Q54905961
CC   Group: Insect cell line.
CC   Doubling time: 29-35 hours (Note=Depending on growth medium) (DGRC=30).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7238; ! Drosophila sechellia (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   MLA
AC   CVCL_C8NF
DR   Wikidata; Q123033057
RX   PubMed=2159524;
RX   PubMed=6249031;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   MLA-144 clone 15T
AC   CVCL_A0UW
DR   Wikidata; Q108820936
RX   PubMed=7047365;
CC   Group: Non-human primate cell line.
CC   Characteristics: Glucocorticoid sensitive clone.
CC   Transformant: NCBI_TaxID; 11840; Gibbon ape leukemia virus (GALV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C134774; Gibbon lymphosarcoma
OX   NCBI_TaxID=9580; ! Hylobates lar (Common gibbon)
HI   CVCL_3856 ! MLA144
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   MLA-144 clone 8T
AC   CVCL_A0UX
DR   Wikidata; Q108820937
RX   PubMed=7047365;
CC   Group: Non-human primate cell line.
CC   Characteristics: Glucocorticoid resistant clone.
CC   Transformant: NCBI_TaxID; 11840; Gibbon ape leukemia virus (GALV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C134774; Gibbon lymphosarcoma
OX   NCBI_TaxID=9580; ! Hylobates lar (Common gibbon)
HI   CVCL_3856 ! MLA144
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   MLA-144 clone E7T
AC   CVCL_A0UV
SY   MLA-E7T
DR   Wikidata; Q108820938
RX   PubMed=3129919;
RX   PubMed=8877731;
CC   Group: Non-human primate cell line.
CC   Characteristics: Glucocorticoid sensitive clone.
CC   Transformant: NCBI_TaxID; 11840; Gibbon ape leukemia virus (GALV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C134774; Gibbon lymphosarcoma
OX   NCBI_TaxID=9580; ! Hylobates lar (Common gibbon)
HI   CVCL_3856 ! MLA144
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   MLA144
AC   CVCL_3856
SY   MLA-144; MLA 144; UCD-MLA-144; UCD MLA-144
DR   CLO; CLO_0007744
DR   CLDB; cl3495
DR   CLDB; cl3496
DR   CLDB; cl3497
DR   ATCC; TIB-201
DR   ECACC; 86102901
DR   IZSLER; BS TCL 43
DR   KCB; KCB 99004YJ
DR   Wikidata; Q54905962
RX   PubMed=3129919;
RX   PubMed=4501200;
RX   PubMed=6975300;
RX   PubMed=7047365;
RX   PubMed=8877731;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MLA-144
CC   Group: Non-human primate cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8370.
CC   Doubling time: ~48 hours (PubMed=4501200).
CC   Transformant: NCBI_TaxID; 11840; Gibbon ape leukemia virus (GALV).
CC   Discontinued: ATCC; TIB-201; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C134774; Gibbon lymphosarcoma
OX   NCBI_TaxID=9580; ! Hylobates lar (Common gibbon)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   MLB13MYC clone 14
AC   CVCL_WM96
SY   MLB13MYC-clone-14; Mouse Limb Bud cells 13 dpc MYC immortalized clone 14
DR   Wikidata; Q95990095
RX   PubMed=7532346;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Limb bud; UBERON=UBERON_0004347.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_WM97 ! MLB13MYC clone 17
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   MLB13MYC clone 17
AC   CVCL_WM97
SY   MLB 13 MYC clone 17; Mouse Limb Bud cells 13 dpc MYC immortalized clone 17
DR   Wikidata; Q95990097
RX   PubMed=7532346;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Limb bud; UBERON=UBERON_0004347.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_WM96 ! MLB13MYC clone 14
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   MLC-1
AC   CVCL_C8IM
DR   Wikidata; Q123033058
RX   PubMed=4138895;
RX   PubMed=4333725;
RX   PubMed=4333772;
RX   PubMed=6988327;
CC   Group: Non-human primate cell line.
CC   Karyotypic information: Has both male and female karyotype (PubMed=4333772).
CC   Transformant: NCBI_TaxID; 10381; Saimiriine herpesvirus 2 (Herpesvirus saimiri).
CC   Donor information: While established from a monkey that was phenotypically a female, that monkey was probably a hematopoietic chimera (PubMed=4333772).
CC   Derived from site: In situ; Mesenteric lymph node; UBERON=UBERON_0002509.
DI   NCIt; C134959; Marmoset lymphoma
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Mixed sex
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MLC-1-B
AC   CVCL_2H97
DR   CLO; CLO_0051038
DR   RCB; RCB1534
DR   Wikidata; Q54905963
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MLC-2-4
AC   CVCL_2H98
DR   CLO; CLO_0051039
DR   RCB; RCB1535
DR   Wikidata; Q54905964
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MLC-6
AC   CVCL_2H99
DR   CLO; CLO_0051040
DR   RCB; RCB1536
DR   Wikidata; Q54905965
RX   PubMed=11448014;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MLC-7
AC   CVCL_2I00
DR   CLO; CLO_0051041
DR   RCB; RCB1537
DR   Wikidata; Q54905966
RX   PubMed=11448014;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MLE-12
AC   CVCL_3751
SY   MLE 12; MLE12; Murine Lung Epithelial-12
DR   BTO; BTO_0002268
DR   CLO; CLO_0007746
DR   ATCC; CRL-2110
DR   CLS; 305314
DR   Wikidata; Q54905967
RX   PubMed=8248207;
CC   Doubling time: 7-9 hours (Note=At 12th passage) (PubMed=8248207).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: FVB/N-Tg(SFTPC-TAg)5.1Jaw transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   MLE-15
AC   CVCL_D581
SY   MLE 15; MLE15; Murine Lung Epithelial-15
DR   BTO; BTO_0005242
DR   EFO; EFO_0022752
DR   ABM; T0495
DR   Wikidata; Q54905968
RX   PubMed=8248207;
RX   PubMed=19263283;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ABM; T0495; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: FVB/N-Tg(SFTPC-TAg)5.1Jaw transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5M
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   MLE-7
AC   CVCL_9Y84
SY   MLE 7; Murine Lung Epithelial-7
DR   Wikidata; Q54905969
RX   PubMed=8248207;
CC   Doubling time: 7-9 hours (Note=At 7th passage) (PubMed=8248207).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: FVB/N-Tg(SFTPC-TAg)5.1Jaw transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   MLE/BV
AC   CVCL_DC33
SY   MLE-BV
DR   Wikidata; Q54905970
RX   PubMed=8812265;
CC   From: Madhukar, Burra V.; Indiana University School of Medicine; Indianapolis; USA.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 4
//
ID   MLEC-Ext1f/f
AC   CVCL_ZC95
SY   Mouse Lung Endothelial Ext1f/f
DR   Kerafast; EGA315
DR   Wikidata; Q98127248
RX   PubMed=23649490;
RX   PubMed=30377379;
CC   Characteristics: Control cell line for MLEC-Ext1-/- (Cellosaurus=CVCL_ZC96).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ext1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MLEC-Ext1-/-
AC   CVCL_ZC96
SY   MLEC-Ext1 null; Mouse Lung Endothelial Ext1-/-
DR   Kerafast; EGA314
DR   Wikidata; Q98127249
RX   PubMed=23649490;
RX   PubMed=30377379;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:894663; Ext1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ext1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZC95 ! MLEC-Ext1f/f
SX   Sex unspecified
AG   8W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   MLEC-Glce-/-
AC   CVCL_ZD18
SY   Mouse Lung Endothelial Glce-/-
DR   Kerafast; EGA360
DR   Wikidata; Q98127250
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2136405; Glce.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD26 ! MLEC-Ndst1f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs2st1f/f
AC   CVCL_ZD16
SY   Mouse Lung Endothelial Hs2st1f/f
DR   Kerafast; EGA361
DR   Wikidata; Q98127251
RX   PubMed=30377379;
CC   Characteristics: Control cell line for MLEC-Hs2st1-/- (Cellosaurus=CVCL_ZD17).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Hs2st1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs2st1-/-
AC   CVCL_ZD17
SY   Mouse Lung Endothelial Hs2st1-/-
DR   Kerafast; EGA362
DR   Wikidata; Q98127253
RX   PubMed=30377379;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:1346049; Hs2st1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Hs2st1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD16 ! MLEC-Hs2st1f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs3st1-/-
AC   CVCL_ZD19
SY   Mouse Lung Endothelial Hs3st1-/-
DR   Kerafast; EGA367
DR   Wikidata; Q98127254
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1201606; Hs3st1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD26 ! MLEC-Ndst1f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs3st1-/-;Hs3st4-/-
AC   CVCL_ZD20
SY   Mouse Lung Endothelial Hs3st1-/-;Hs3st4-/-
DR   Kerafast; EGA369
DR   Wikidata; Q98127256
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1201606; Hs3st1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1333792; Hs3st4.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD26 ! MLEC-Ndst1f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs3st4-/-
AC   CVCL_ZD21
SY   Mouse Lung Endothelial Hs3st4-/-
DR   Kerafast; EGA368
DR   Wikidata; Q98127257
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1333792; Hs3st4.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD26 ! MLEC-Ndst1f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs6st1f/f
AC   CVCL_ZD22
SY   Mouse Lung Endothelial Hs6st1f/f
DR   Kerafast; EGA363
DR   Wikidata; Q98127258
RX   PubMed=30377379;
CC   Characteristics: Control cell line for MLEC-Hs6st1-/- (Cellosaurus=CVCL_ZD24).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Hs6st1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs6st1f/f;Hs6st2-/-
AC   CVCL_ZD23
SY   Mouse Lung Endothelial Hs6st1f/f;Hs6st2-/-
DR   Kerafast; EGA365
DR   Wikidata; Q98127259
RX   PubMed=30377379;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1354959; Hs6st2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Hs2st1f/f;Hs6st2-/- x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Hs6st1-/-
AC   CVCL_ZD24
SY   Mouse Lung Endothelial Hs6st1-/-
DR   Kerafast; EGA364
DR   Wikidata; Q98127260
RX   PubMed=30377379;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:1354958; Hs6st1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Hs6st1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD22 ! MLEC-Hs6st1f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   MLEC-Hs6st1-/-;Hs6st2-/-
AC   CVCL_ZD25
SY   Mouse Lung Endothelial Hs6st1-/-;Hs6st2-/-
DR   Kerafast; EGA366
DR   Wikidata; Q98127261
RX   PubMed=30377379;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:1354958; Hs6st1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1354959; Hs6st2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Hs2st1f/f;Hs6st2-/- x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD23 ! MLEC-Hs6st1f/f;Hs6st2-/-
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Ndst1f/f
AC   CVCL_ZD26
SY   Mouse Lung Endothelial Ndst1f/f
DR   Kerafast; EGA357
DR   Wikidata; Q98127262
RX   PubMed=30377379;
CC   Characteristics: Control cell line for MLEC-Ndst1-/- (Cellosaurus=CVCL_ZD28).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Ndst1f/f;Ndst2-/-
AC   CVCL_ZD27
SY   Mouse Lung Endothelial Ndst1f/f;Ndst2-/-
DR   Kerafast; EGA359
DR   Wikidata; Q98127263
RX   PubMed=30377379;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97040; Ndst2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f;Ndst2-/- x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Ndst1-/-
AC   CVCL_ZD28
SY   Mouse Lung Endothelial Ndst1-/-
DR   Kerafast; EGA358
DR   Wikidata; Q98127264
RX   PubMed=30377379;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:104719; Ndst1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD26 ! MLEC-Ndst1f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Ndst1-/-;Ndst2-/-
AC   CVCL_ZD29
SY   Mouse Lung Endothelial Ndst1-/-;Ndst2-/-
DR   Wikidata; Q98127266
RX   PubMed=30377379;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:104719; Ndst1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97040; Ndst2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Ndst1f/f;Ndst2-/- x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD27 ! MLEC-Ndst1f/f;Ndst2-/-
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   MLEC-Sulf1f/f;Sulf2f/f
AC   CVCL_ZD30
SY   Mouse Lung Endothelial Sulf1f/f;Sulf2f/f
DR   Kerafast; EGA370
DR   Wikidata; Q98127268
RX   PubMed=30377379;
CC   Characteristics: Control cell line for MLEC-Sulf1-/-;Sulf2-/- (Cellosaurus=CVCL_ZD31).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Sulf1f/f;Sulf2f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEC-Sulf1-/-;Sulf2-/-
AC   CVCL_ZD31
SY   Mouse Lung Endothelial Sulf1-/-;Sulf2-/-
DR   Kerafast; EGA371
DR   Wikidata; Q98127269
RX   PubMed=30377379;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:2138563; Sulf1.
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:1919293; Sulf2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
CC   Breed/subspecies: Sulf1f/f;Sulf2f/f x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD30 ! MLEC-Sulf1f/f;Sulf2f/f
SX   Sex unspecified
AG   8-10W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MLEL1.1c1
AC   CVCL_DC34
DR   Wikidata; Q54905971
RX   Patent=US5854010;
RX   PubMed=8812265;
CC   Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_DC33 ! MLE/BV
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   MLF
AC   CVCL_E778
SY   MCF
DR   dbMHC; 48973
DR   IHW; IHW09091
DR   IPD-IMGT/HLA; 11641
DR   Wikidata; Q54905972
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=18193213;
RX   PubMed=28360230;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*02:01:01:01; B*15:01:01:01; C*03:04:01:01; DPA1*01; DPB1*04:02:01; DQA1*03; DQB1*03:01:01; DRA*01:01; DRB1*04:01:01; DRB4*01:01 (IPD-IMGT/HLA=11641).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   MLg
AC   CVCL_0437
SY   Mlg 2908
DR   CLO; CLO_0007747
DR   MCCL; MCC:0000332
DR   CLDB; cl3499
DR   ATCC; CCL-206
DR   ECACC; 90112707
DR   KCLB; 10206
DR   Wikidata; Q54905973
RX   PubMed=4364904;
RX   PubMed=7065527;
RX   PubMed=25277546;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: ddY.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   MLH1
AC   CVCL_G669
DR   CLO; CLO_0007748
DR   ATCC; CRL-1766
DR   Wikidata; Q54905974
RX   PubMed=3528171;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plants light-harvesting complex II (LHC-II).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MLH2
AC   CVCL_G670
DR   CLO; CLO_0007749
DR   ATCC; CRL-1779
DR   Wikidata; Q54905975
RX   PubMed=3528171;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Plants light-harvesting complex II (LHC-II).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   MLi002-A
AC   CVCL_UJ78
SY   iEBS
DR   BioSamples; SAMEA5340004
DR   hPSCreg; MLi002-A
DR   Wikidata; Q95990117
RX   PubMed=30933721;
CC   From: Faculty of Medicine, University of Ljubljana; Ljubljana; Slovenia.
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Glu475Gly (c.1424A>G); ClinVar=VCV000014638; Zygosity=Heterozygous (PubMed=30933721).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE28 ! EB11
OI   CVCL_ZE29 ! EB12
SX   Female
AG   >38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   MLi003-A
AC   CVCL_UJ79
SY   MLi-003A; iWT; IWTK PSC
DR   BioSamples; SAMEA6877857
DR   hPSCreg; MLi003-A
DR   Wikidata; Q95990118
RX   PubMed=32361315;
CC   From: Faculty of Medicine, University of Ljubljana; Ljubljana; Slovenia.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MLi004-A
AC   CVCL_A8HI
SY   iMS
DR   BioSamples; SAMEA8868434
DR   hPSCreg; MLi004-A
DR   Wikidata; Q107116382
RX   PubMed=34284275;
CC   From: Faculty of Medicine, University of Ljubljana; Ljubljana; Slovenia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Arg682Ter (c.2044C>T); ClinVar=VCV001047976; Zygosity=Heterozygous (PubMed=34284275).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; c.6900+4A>G (IVS87+4A>G) (p.Gly2278_Gln2300del); ClinVar=VCV000374314; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34284275).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156446; Epidermolysis bullosa dystrophica, autosomal recessive
DI   ORDO; Orphanet_79408; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   MLi005-A
AC   CVCL_D4WS
SY   iDDEB
DR   BioSamples; SAMEA114469820
DR   hPSCreg; MLi005-A
DR   Wikidata; Q127382831
RX   PubMed=38271763;
CC   From: Faculty of Medicine, University of Ljubljana; Ljubljana; Slovenia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gly2043Arg (c.6127G>A); ClinVar=VCV000017438; Zygosity=Heterozygous (PubMed=38271763).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C205633; Epidermolysis bullosa dystrophica, autosomal dominant
DI   ORDO; Orphanet_231568; Autosomal dominant generalized dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MLL/AF9 Cas9
AC   CVCL_C8ZF
SY   Line#187
DR   BioGRID_ORCS_Cell_line; 814
DR   Wikidata; Q123033059
RX   PubMed=29478914;
CC   Characteristics: The MLL/AF9 oncogene was transduced into bone marrow hematopoietic stem cells and then transferred cells to sub-lethally irradiated recipients. Primary acute myeloid leukemia cells were harvested 3-6 months later, serially transplanted three times and then cultured in the presence of cytokines (PubMed=29478914).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Omics: Phenotyping; CRISPR screening.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   MLM #1
AC   CVCL_B6J4
SY   MLM#1; mEERL lung metastasis clone 1
DR   GEO; GSM1687305
DR   GEO; GSM1687306
DR   GEO; GSM1687307
DR   Wikidata; Q112129332
RX   PubMed=27013584;
CC   Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6J3 ! mEERL
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   MLM #10
AC   CVCL_B6J7
SY   MLM#10; mEERL lung metastasis clone 10
DR   GEO; GSM1687315
DR   GEO; GSM1687316
DR   GEO; GSM1687317
DR   Wikidata; Q112129333
RX   PubMed=27013584;
CC   Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6J3 ! mEERL
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   MLM #3
AC   CVCL_B6J5
SY   MLM#3; mEERL lung metastasis clone 3
DR   GEO; GSM1687308
DR   GEO; GSM1687309
DR   GEO; GSM1687310
DR   Wikidata; Q112129334
RX   PubMed=27013584;
CC   Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6J3 ! mEERL
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   MLM #5
AC   CVCL_B6J6
SY   MLM#5; mEERL lung metastasis clone 5
DR   GEO; GSM1687311
DR   GEO; GSM1687312
DR   GEO; GSM1687313
DR   GEO; GSM1687314
DR   Wikidata; Q112129335
RX   PubMed=27013584;
CC   Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6J3 ! mEERL
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   MLMA
AC   CVCL_1419
DR   CLO; CLO_0037183
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470810
DR   cancercelllines; CVCL_1419
DR   Cell_Model_Passport; SIDM00561
DR   ChEMBL-Cells; CHEMBL3308826
DR   ChEMBL-Targets; CHEMBL2366211
DR   Cosmic; 908142
DR   Cosmic; 2690010
DR   Cosmic-CLP; 908142
DR   DepMap; ACH-002274
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10775-110G1
DR   GDSC; 908142
DR   GEO; GSM827266
DR   GEO; GSM1670117
DR   IARC_TP53; 21508
DR   JCRB; JCRB0146
DR   JCRB; NIHS0175
DR   LINCS_LDP; LCL-1091
DR   PharmacoDB; MLMA_943_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1419
DR   PubChem_Cell_line; CVCL_1419
DR   Wikidata; Q54905976
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~62 hours (Note=Lot 08272014) (JCRB=JCRB0146).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Gly (c.838A>G); ClinVar=VCV000376658; Zygosity=Homozygous (Cosmic-CLP=908142; DepMap=ACH-002274).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.54%; East Asian, North=77.94%; East Asian, South=21.52%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0175; true.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
ST   Source(s): Cosmic-CLP=908142; JCRB=JCRB0146
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   MLO-A5
AC   CVCL_0P24
SY   MLOA5; Murine Long bone Osteocyte-A5
DR   Kerafast; EKC003
DR   Wikidata; Q54905977
RX   PubMed=11547831;
RX   PubMed=16738320;
RX   PubMed=22130923;
CC   Characteristics: Model for the osteoblast to osteocyte differentiation process, the mineralization process and the effects of mechanical loading on biomineralization (Kerafast=EKC003).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, long bone; UBERON=UBERON_0002495.
CC   Cell type: Osteocyte; CL=CL_0000137.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 Bgla promoter T-Ag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   MLO-Y4
AC   CVCL_M098
SY   MLOY4; Murine Long bone Osteocyte-Y4
DR   BTO; BTO_0005489
DR   EFO; EFO_0005394
DR   GEO; GSM1520095
DR   GEO; GSM1520096
DR   GEO; GSM1520097
DR   GEO; GSM1520098
DR   GEO; GSM1520099
DR   GEO; GSM1520100
DR   GEO; GSM1520101
DR   GEO; GSM1520102
DR   GEO; GSM1520103
DR   GEO; GSM1520104
DR   GEO; GSM1520105
DR   GEO; GSM1520106
DR   Kerafast; EKC002
DR   Lonza; 166
DR   Ubigene; YC-C037
DR   Wikidata; Q54905979
RX   CelloPub=CLPUB00625;
RX   Patent=US6358737;
RX   PubMed=9421234;
RX   PubMed=10084404;
RX   PubMed=12412815;
RX   PubMed=16738320;
RX   PubMed=22130923;
CC   Group: Patented cell line.
CC   Group: Space-flown cell line (cellonaut).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12161.
CC   Characteristics: Useful to study effects of fluid flow and substrate stretching on activation of osteocyte-specific signaling pathways (Kerafast=EKC002).
CC   Doubling time: 15.8 hours (CelloPub=CLPUB00625).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: STR profile from personal communication of Yi, Lan.
CC   Derived from site: In situ; Bone, long bone; UBERON=UBERON_0002495.
CC   Cell type: Osteocyte; CL=CL_0000137.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 Bgla promoter T-Ag transgenic.
ST   Source(s): Direct_author_submission; Ubigene=YC-C037
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 12,13
ST   Mouse STR 4-2: 20.3,21.3 (Ubigene=YC-C037)
ST   Mouse STR 4-2: 21.3 (Direct_author_submission)
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12 (Direct_author_submission)
ST   Mouse STR 6-7: 17 (Ubigene=YC-C037)
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 13,14
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 17,18 (Ubigene=YC-C037)
ST   Mouse STR 18-3: 18 (Direct_author_submission)
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14D
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 26
//
ID   MLO-Y4-Luc
AC   CVCL_C8UU
DR   Ubigene; YC-C037-Luc-P
DR   Wikidata; Q123033060
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, long bone; UBERON=UBERON_0002495.
CC   Cell type: Osteocyte; CL=CL_0000137.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 Bgla promoter T-Ag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M098 ! MLO-Y4
SX   Sex unspecified
AG   14D
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MLP-1
AC   CVCL_W533
DR   Wikidata; Q54905980
RX   PubMed=4280237;
CC   Doubling time: ~48 hours (PubMed=4280237).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C134776; Hamster lymphoma
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   MLP-29
AC   CVCL_VQ80
SY   MLP29; Mouse Liver Progenitor-29
DR   Lonza; 1138
DR   Wikidata; Q95990124
RX   PubMed=8730094;
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4383 ! BNL CL.2
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   Mlp3
AC   CVCL_JL51
SY   MLP3; mlp3; MLP-3
DR   Wikidata; Q54905981
RX   PubMed=9885975;
RX   PubMed=11747540;
RX   PubMed=20638124;
RX   PubMed=27250028;
CC   From: Meijne, Emmy I.M.; Nuclear Research and Consultancy Group (NRG); Petten; Netherlands.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: CBA/H.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 5
//
ID   MLS
AC   CVCL_RB32
SY   MLS/P
DR   Wikidata; Q54905982
RX   PubMed=1997098;
RX   PubMed=2715085;
RX   PubMed=2757922;
RX   PubMed=2789934;
RX   PubMed=3182331;
RX   PubMed=8194040;
CC   Doubling time: 24 hours (PubMed=3182331).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MLS-9
AC   CVCL_RW49
SY   MLS9
DR   Wikidata; Q54905983
RX   PubMed=9607936;
RX   PubMed=11561081;
CC   Derived from site: In situ; Brain, neocortex; UBERON=UBERON_0001950.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-3D
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   MLS/ADRR2
AC   CVCL_RB33
SY   MLS/ADR(R2)
DR   Wikidata; Q54905984
RX   PubMed=2715085;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB32 ! MLS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   MLTC-1
AC   CVCL_3544
SY   mLTC-1; Murine Leydig Tumor Cell line-1
DR   CLO; CLO_0007750
DR   ATCC; CRL-2065
DR   BioSample; SAMN11397640
DR   CCRID; 3101MOUTCM8
DR   CLS; 305175
DR   Wikidata; Q54905985
RX   PubMed=6288740;
RX   PubMed=15541572;
RX   PubMed=31220119;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: C57BL/6J.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 20.3,21.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 16
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D789 ! MA-10
OI   CVCL_U444 ! MA-12
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MLUi001-A
AC   CVCL_E4XB
DR   hPSCreg; MLUi001-A
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-B
AC   CVCL_E4XC
DR   hPSCreg; MLUi001-B
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-C
AC   CVCL_E4XD
DR   hPSCreg; MLUi001-c
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-D
AC   CVCL_E4XE
DR   hPSCreg; MLUi001-D
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-E
AC   CVCL_E4XF
DR   hPSCreg; MLUi001-E
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-F
AC   CVCL_E4XG
DR   hPSCreg; MLUi001-F
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-G
AC   CVCL_E4XH
DR   hPSCreg; MLUi001-G
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-H
AC   CVCL_E4XI
DR   hPSCreg; MLUi001-H
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-I
AC   CVCL_E4XJ
DR   hPSCreg; MLUi001-I
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-J
AC   CVCL_E4XK
DR   hPSCreg; MLUi001-J
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-K
AC   CVCL_E4XL
DR   hPSCreg; MLUi001-K
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XM ! MLUi001-L
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-L
AC   CVCL_E4XM
DR   hPSCreg; MLUi001-L
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi001-M).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XN ! MLUi001-M
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi001-M
AC   CVCL_E4XN
DR   BioSamples; SAMEA115054636
DR   hPSCreg; MLUi001-M
RX   PubMed=38612385;
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (PubMed=38612385).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XB ! MLUi001-A
OI   CVCL_E4XC ! MLUi001-B
OI   CVCL_E4XD ! MLUi001-C
OI   CVCL_E4XE ! MLUi001-D
OI   CVCL_E4XF ! MLUi001-E
OI   CVCL_E4XG ! MLUi001-F
OI   CVCL_E4XH ! MLUi001-G
OI   CVCL_E4XI ! MLUi001-H
OI   CVCL_E4XJ ! MLUi001-I
OI   CVCL_E4XK ! MLUi001-J
OI   CVCL_E4XL ! MLUi001-K
OI   CVCL_E4XM ! MLUi001-L
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi002-A
AC   CVCL_E4XP
DR   hPSCreg; MLUi002-A
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi002-G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XQ ! MLUi002-B
OI   CVCL_E4XR ! MLUi002-C
OI   CVCL_E4XS ! MLUi002-D
OI   CVCL_E4XT ! MLUi002-E
OI   CVCL_E4XU ! MLUi002-F
OI   CVCL_E4XV ! MLUi002-G
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi002-B
AC   CVCL_E4XQ
DR   hPSCreg; MLUi002-B
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi002-G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XP ! MLUi002-A
OI   CVCL_E4XR ! MLUi002-C
OI   CVCL_E4XS ! MLUi002-D
OI   CVCL_E4XT ! MLUi002-E
OI   CVCL_E4XU ! MLUi002-F
OI   CVCL_E4XV ! MLUi002-G
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi002-C
AC   CVCL_E4XR
DR   hPSCreg; MLUi002-C
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi002-G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XP ! MLUi002-A
OI   CVCL_E4XQ ! MLUi002-B
OI   CVCL_E4XS ! MLUi002-D
OI   CVCL_E4XT ! MLUi002-E
OI   CVCL_E4XU ! MLUi002-F
OI   CVCL_E4XV ! MLUi002-G
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi002-D
AC   CVCL_E4XS
DR   hPSCreg; MLUi002-D
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi002-G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XP ! MLUi002-A
OI   CVCL_E4XQ ! MLUi002-B
OI   CVCL_E4XR ! MLUi002-C
OI   CVCL_E4XT ! MLUi002-E
OI   CVCL_E4XU ! MLUi002-F
OI   CVCL_E4XV ! MLUi002-G
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi002-E
AC   CVCL_E4XT
DR   hPSCreg; MLUi002-E
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi002-G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XP ! MLUi002-A
OI   CVCL_E4XQ ! MLUi002-B
OI   CVCL_E4XR ! MLUi002-C
OI   CVCL_E4XS ! MLUi002-D
OI   CVCL_E4XU ! MLUi002-F
OI   CVCL_E4XV ! MLUi002-G
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi002-F
AC   CVCL_E4XU
DR   hPSCreg; MLUi002-F
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (from autologous cell line MLUi002-G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XP ! MLUi002-A
OI   CVCL_E4XQ ! MLUi002-B
OI   CVCL_E4XR ! MLUi002-C
OI   CVCL_E4XS ! MLUi002-D
OI   CVCL_E4XT ! MLUi002-E
OI   CVCL_E4XV ! MLUi002-G
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MLUi002-G
AC   CVCL_E4XV
DR   BioSamples; SAMEA115162595
DR   hPSCreg; MLUi002-G
RX   PubMed=38612385;
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:8008; NRXN1; Zygosity=Heterozygous (PubMed=38612385).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4XP ! MLUi002-A
OI   CVCL_E4XQ ! MLUi002-B
OI   CVCL_E4XR ! MLUi002-C
OI   CVCL_E4XS ! MLUi002-D
OI   CVCL_E4XT ! MLUi002-E
OI   CVCL_E4XU ! MLUi002-F
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MLUi007-A
AC   CVCL_D0IA
DR   hPSCreg; MLUi007-A
DR   Wikidata; Q123033061
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-B
AC   CVCL_D0IB
DR   hPSCreg; MLUi007-B
DR   Wikidata; Q123033062
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-C
AC   CVCL_D0IC
DR   hPSCreg; MLUi007-C
DR   Wikidata; Q123033063
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-D
AC   CVCL_D0ID
DR   hPSCreg; MLUi007-D
DR   Wikidata; Q123033064
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-E
AC   CVCL_D0IE
DR   hPSCreg; MLUi007-E
DR   Wikidata; Q123033065
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-F
AC   CVCL_D0IF
DR   hPSCreg; MLUi007-F
DR   Wikidata; Q123033066
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-G
AC   CVCL_D0IG
DR   hPSCreg; MLUi007-G
DR   Wikidata; Q123033068
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-H
AC   CVCL_D0IH
DR   hPSCreg; MLUi007-H
DR   Wikidata; Q123033069
RX   PubMed=38612385;
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0II ! MLUi007-I
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-I
AC   CVCL_D0II
DR   hPSCreg; MLUi007-I
DR   Wikidata; Q123033071
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi007-J).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0IJ ! MLUi007-J
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi007-J
AC   CVCL_D0IJ
DR   BioSamples; SAMEA112748717
DR   hPSCreg; MLUi007-J
DR   Wikidata; Q123033072
RX   PubMed=37001364;
RX   PubMed=38612385;
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=37001364).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IA ! MLUi007-A
OI   CVCL_D0IB ! MLUi007-B
OI   CVCL_D0IC ! MLUi007-C
OI   CVCL_D0ID ! MLUi007-D
OI   CVCL_D0IE ! MLUi007-E
OI   CVCL_D0IF ! MLUi007-F
OI   CVCL_D0IG ! MLUi007-G
OI   CVCL_D0IH ! MLUi007-H
OI   CVCL_D0II ! MLUi007-I
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi008-A
AC   CVCL_D0IK
DR   hPSCreg; MLUi008-A
DR   Wikidata; Q123033073
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from autologous cell line MLUi008-B).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IL ! MLUi008-B
SX   Female
AG   64-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi008-B
AC   CVCL_D0IL
DR   BioSamples; SAMEA115081049
DR   hPSCreg; MLUi008-B
DR   Wikidata; Q12303374
RX   PubMed=37001364;
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=37001364).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IK ! MLUi008-A
SX   Female
AG   64-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MLUi009-A
AC   CVCL_D0IM
DR   hPSCreg; MLUi009-A
DR   Wikidata; Q123033076
RX   PubMed=37001364;
RX   PubMed=38612385;
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=37001364).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi010-A
AC   CVCL_D0IN
DR   hPSCreg; MLUi010-A
DR   Wikidata; Q123033077
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (from autologous cell line MLUi010-B).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IP ! MLUi010-B
SX   Female
AG   64-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MLUi010-B
AC   CVCL_D0IP
DR   hPSCreg; MLUi010-B
DR   Wikidata; Q123033078
RX   PubMed=37001364;
CC   From: Medical Faculty, Martin Luther University Halle-Wittenberg; Halle; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=37001364).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IN ! MLUi010-A
SX   Female
AG   64-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Mm 150-99
AC   CVCL_IZ85
SY   Mm150-1999; 150-99
DR   ArrayExpress; E-MTAB-1511
DR   GEO; GSM945684
DR   GEO; GSM1204874
DR   GEO; GSM1468906
DR   GEO; GSM1468914
DR   GEO; GSM1468922
DR   GEO; GSM1468929
DR   GEO; GSM1468937
DR   GEO; GSM1468945
DR   PRIDE; PXD000419
DR   Wikidata; Q54905986
RX   PubMed=22797897;
RX   PubMed=24136357;
RX   PubMed=24380390;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   Mm 153-99
AC   CVCL_IZ86
DR   GEO; GSM945681
DR   GEO; GSM1468907
DR   GEO; GSM1468915
DR   GEO; GSM1468923
DR   GEO; GSM1468930
DR   GEO; GSM1468938
DR   GEO; GSM1468946
DR   Wikidata; Q54905987
RX   PubMed=22797897;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   Mm 173-02
AC   CVCL_IZ87
SY   Mm173-2002; 173-2002
DR   ArrayExpress; E-MTAB-1511
DR   GEO; GSM945685
DR   GEO; GSM1468908
DR   GEO; GSM1468916
DR   GEO; GSM1468924
DR   GEO; GSM1468931
DR   GEO; GSM1468939
DR   GEO; GSM1468947
DR   Wikidata; Q54905988
RX   PubMed=22797897;
RX   PubMed=24380390;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   Mm 181-96
AC   CVCL_IZ88
SY   R181-96
DR   GEO; GSM1204871
DR   GEO; GSM1468909
DR   GEO; GSM1468917
DR   GEO; GSM1468932
DR   GEO; GSM1468940
DR   GEO; GSM1468948
DR   PRIDE; PXD000419
DR   Wikidata; Q54905989
RX   PubMed=21321133;
RX   PubMed=24136357;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   Mm 249-97
AC   CVCL_IZ89
SY   R249-97
DR   GEO; GSM1204873
DR   GEO; GSM1468910
DR   GEO; GSM1468918
DR   GEO; GSM1468925
DR   GEO; GSM1468933
DR   GEO; GSM1468941
DR   GEO; GSM1468949
DR   PRIDE; PXD000419
DR   Wikidata; Q54905990
RX   PubMed=21321133;
RX   PubMed=24136357;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   Mm 256-95
AC   CVCL_IZ90
SY   265-95
DR   GEO; GSM945683
DR   GEO; GSM1204872
DR   GEO; GSM1468911
DR   GEO; GSM1468919
DR   GEO; GSM1468926
DR   GEO; GSM1468934
DR   GEO; GSM1468942
DR   GEO; GSM1468950
DR   PRIDE; PXD000419
DR   Wikidata; Q54905992
RX   PubMed=22797897;
RX   PubMed=24136357;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   Mm 265-95
AC   CVCL_IZ91
DR   GEO; GSM945682
DR   GEO; GSM1468912
DR   GEO; GSM1468920
DR   GEO; GSM1468927
DR   GEO; GSM1468935
DR   GEO; GSM1468943
DR   GEO; GSM1468951
DR   Wikidata; Q54905993
RX   PubMed=22797897;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   Mm 290-96
AC   CVCL_IZ92
SY   Mm290-1996; 290-96; R290-96
DR   ArrayExpress; E-MTAB-1511
DR   GEO; GSM1204875
DR   GEO; GSM1468913
DR   GEO; GSM1468921
DR   GEO; GSM1468928
DR   GEO; GSM1468936
DR   GEO; GSM1468944
DR   GEO; GSM1468952
DR   PRIDE; PXD000419
DR   Wikidata; Q54905994
RX   PubMed=21321133;
RX   PubMed=24136357;
RX   PubMed=24380390;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   Mm 303-97
AC   CVCL_IZ93
DR   GEO; GSM945686
DR   Wikidata; Q54905995
RX   PubMed=22797897;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   Mm 71-2006
AC   CVCL_A2DJ
SY   Mm71-2006; 71-2006
DR   ArrayExpress; E-MTAB-1511
DR   Wikidata; Q105510155
RX   PubMed=24380390;
CC   Group: Non-human primate cell line.
CC   From: New England Primate Research Center (NEPRC), Harvard Medical School; Boston; USA.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   MM-031
AC   CVCL_IS38
DR   Wikidata; Q54905998
RX   PubMed=11943340;
CC   Derived from site: Metastatic; Neck, skin; UBERON=UBERON_0001417.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   MM-1 [Human small cell lung carcinoma]
AC   CVCL_0C21
DR   Cosmic; 2239087
DR   Wikidata; Q54905999
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Doubling time: 66.6 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   MM-1 [Mouse spleen]
AC   CVCL_VG90
DR   Wikidata; Q54906000
RX   PubMed=6050301;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   MM-194
AC   CVCL_IS39
DR   Wikidata; Q54906001
RX   PubMed=11943340;
CC   Doubling time: 51.5 hours (PubMed=11943340).
CC   Derived from site: Metastatic; Axilla, skin; UBERON=UBERON_0015474.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   MM-195
AC   CVCL_IS40
DR   Wikidata; Q54906002
RX   PubMed=11943340;
CC   Doubling time: 86.7 hours (PubMed=11943340).
CC   Derived from site: Metastatic; Bone, scapula; UBERON=UBERON_0006849.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   MM-2
AC   CVCL_VG91
DR   Wikidata; Q54906003
RX   PubMed=6050301;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   MM-201
AC   CVCL_IS41
DR   Wikidata; Q54906005
RX   PubMed=11943340;
CC   Doubling time: 27.1 hours (PubMed=11943340).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   MM-232
AC   CVCL_IS42
DR   Wikidata; Q54906006
RX   PubMed=11943340;
CC   Doubling time: 66.2 hours (PubMed=11943340).
CC   Derived from site: Metastatic; Lower leg, skin; UBERON=UBERON_0004264.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   MM-254
AC   CVCL_IS43
DR   Wikidata; Q54906007
RX   PubMed=11943340;
CC   Doubling time: 26.3 hours (PubMed=11943340).
CC   Derived from site: Metastatic; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   Mm-2K
AC   CVCL_V316
DR   Wikidata; Q54906008
RX   PubMed=217958;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   MM-3
AC   CVCL_VG92
DR   Wikidata; Q54906009
RX   PubMed=6050301;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   MM-358
AC   CVCL_IS44
DR   Wikidata; Q54906010
RX   PubMed=11943340;
RX   PubMed=18698037;
CC   Doubling time: 35.4 hours (PubMed=11943340).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   MM-39
AC   CVCL_IN81
SY   MM39
DR   Wikidata; Q54906011
RX   PubMed=8879186;
RX   PubMed=10101000;
RX   PubMed=15463957;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trachea gland; UBERON=UBERON_0005203.
CC   Cell type: Serous cell of epithelium of trachea; CL=CL_1000330.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   MM-83
AC   CVCL_9712
DR   Wikidata; Q54906012
RX   PubMed=11004677;
CC   Derived from site: Metastatic; Bone, foot; UBERON=UBERON_0001445.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MM-A1
AC   CVCL_M536
DR   Wikidata; Q54906013
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2072743;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 48 hours (PubMed=2072743).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   MM-AN
AC   CVCL_H241
AS   CVCL_0438
SY   MMAN; AN
DR   MCCL; MCC:0000333
DR   Wikidata; Q54906014
RX   PubMed=1867326;
RX   PubMed=7680081;
RX   PubMed=8219757;
RX   PubMed=8429233;
RX   PubMed=11606052;
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   MM-B1
AC   CVCL_IW98
SY   GATES
DR   Wikidata; Q54906015
RX   PubMed=8205524;
RX   PubMed=10373640;
RX   PubMed=11485930;
RX   PubMed=16704740;
RX   PubMed=28159921;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Caution: It seems that PubMed=10373640 has renamed what was originally termed the GATES cell line (PubMed=8205524) to MM-B1 because of its phenotype (biphasic).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 6
//
ID   MM-BP
AC   CVCL_M540
SY   BP
DR   Wikidata; Q54906016
RX   PubMed=1867326;
RX   PubMed=8429233;
RX   PubMed=11606052;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MM-C1
AC   CVCL_M537
DR   Wikidata; Q54906017
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2072743;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 96 hours (PubMed=2072743).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   MM-E1
AC   CVCL_A9FJ
DR   CCRID; 5301MON-KCB15001YJ
DR   KCB; KCB 2015001YJ
DR   Wikidata; Q108820940
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-E2
AC   CVCL_A9FK
DR   CCRID; 5301MON-KCB15002YJ
DR   KCB; KCB 2015002YJ
DR   Wikidata; Q108820941
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-F1
AC   CVCL_IW99
DR   Wikidata; Q54906018
RX   PubMed=10373640;
RX   PubMed=11485930;
RX   PubMed=28159921;
CC   Caution: Could be either NCI-H2373 (Cellosaurus=CVCL_A533) or NCI-H2596 (Cellosaurus=CVCL_A546). PubMed=10373640 and subsequent papers from the same group seem to have renamed one of the cell lines described in (PubMed=7695406) to MM-F1 because of its phenotype (fibroblastic).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 6
//
ID   MM-ImJ/XS
AC   CVCL_6E56
DR   Wikidata; Q54906019
RX   PubMed=16883582;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad5-SV40 hybrid virus.
CC   Derived from site: In situ; Xiphisternum cartilage; UBERON=UBERON_0006430.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: 129S1/SvImJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3-4W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   MM-K2
AC   CVCL_A9FQ
SY   MMK2
DR   CCRID; 5301MON-KCB0002KZJ
DR   KCB; KCB 200002KZJ
DR   Wikidata; Q108820942
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A9FT ! MM-L2
OI   CVCL_A9JV ! MM-S4
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   MM-K3
AC   CVCL_A9FR
SY   MMK3
DR   CCRID; 5301MON-KCB00003ZJ
DR   KCB; KCB 200003ZJ
DR   Wikidata; Q108820943
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   MM-L1
AC   CVCL_A9FS
DR   CCRID; 5301MON-KCB85013ZJ
DR   KCB; KCB 85013ZJ
DR   Wikidata; Q108820944
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-L2
AC   CVCL_A9FT
SY   MML2
DR   CCRID; 5301MON-KCB0002LZJ
DR   KCB; KCB 200002LZJ
DR   Wikidata; Q108820946
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A9FQ ! MM-K2
OI   CVCL_A9JV ! MM-S4
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-LH
AC   CVCL_M541
SY   MMLH; LH
DR   Cosmic; 897496
DR   Wikidata; Q54906020
RX   PubMed=1867326;
RX   PubMed=8429233;
RX   PubMed=9141475;
RX   PubMed=11606052;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MM-M1
AC   CVCL_M547
SY   MM.M1; MMM1
DR   Cosmic; 2081398
DR   Cosmic; 2302407
DR   Wikidata; Q54906021
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1720489;
RX   PubMed=8695815;
RX   PubMed=8943038;
RX   PubMed=10936422;
RX   PubMed=17692805;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1582; CCND1 + HGNC; HGNC:5477; IGH; Name(s)=IGH-CCND1 (PubMed=8695815).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   MM-M7
AC   CVCL_A9FI
SY   MMm7
DR   CCRID; 5301MON-KCB0698MZJ
DR   KCB; KCB 200698MZJ
DR   Wikidata; Q108820947
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A9FH ! MM-S7
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-RU
AC   CVCL_H242
AS   CVCL_W801
SY   MMRU; RU
DR   EFO; EFO_0022547
DR   cancercelllines; CVCL_H242
DR   Cosmic; 706104
DR   Cosmic; 888844
DR   Cosmic; 2630486
DR   Wikidata; Q54906023
RX   PubMed=1867326;
RX   PubMed=7680081;
RX   PubMed=8219757;
RX   PubMed=8277038;
RX   PubMed=8429233;
RX   PubMed=9141475;
RX   PubMed=10766161;
RX   PubMed=11606052;
RX   PubMed=15009714;
RX   PubMed=18497997;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   MM-RU-Luc
AC   CVCL_J263
DR   JCRB; JCRB1378
DR   JCRB; NIHS0644
DR   Wikidata; Q54906024
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0644; true.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): JCRB=JCRB1378
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H242 ! MM-RU
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   MM-S1
AC   CVCL_M538
SY   MM_S1; MM.S1
DR   cancercelllines; CVCL_M538
DR   Cosmic; 720781
DR   Cosmic; 2367271
DR   Wikidata; Q54906025
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1720489;
RX   PubMed=2072743;
RX   PubMed=2167671;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=18647998;
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 24 hours (PubMed=2072743).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=11157491).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   MM-S10
AC   CVCL_A9FG
DR   CCRID; 5301MON-KCB18025ZJ
DR   KCB; KCB 2018025ZJ
DR   Wikidata; Q108820948
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-S4
AC   CVCL_A9JV
SY   MMS4
DR   CCRID; 5301MON-KCB00022ZJ
DR   KCB; KCB 200002SZJ
DR   Wikidata; Q108820950
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A9FQ ! MM-K2
OI   CVCL_A9FT ! MM-L2
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-S7
AC   CVCL_A9FH
SY   MMS7
DR   CCRID; 5301MON-KCB0698SZJ
DR   KCB; KCB 200698SZJ
DR   Wikidata; Q108820951
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_A9FI ! MM-M7
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MM-Sv/HP
AC   CVCL_WL45
DR   Wikidata; Q95990156
RX   PubMed=17960567;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad5-SV40 hybrid virus.
CC   Derived from site: In situ; Articular cartilage; UBERON=UBERON_0010996.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3-4W
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   MM-Sv/HP-2
AC   CVCL_W633
DR   Wikidata; Q54906026
RX   PubMed=17960567;
CC   Characteristics: Has preserved a chondrocyte phenotype.
CC   Characteristics: Useful to help understand chondrocyte biology and provide information on the underlying mechanism of osteoarthritis.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad5-SV40 hybrid virus.
CC   Derived from site: In situ; Articular cartilage; UBERON=UBERON_0010996.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WL45 ! MM-Sv/HP
SX   Sex unspecified
AG   3-4W
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   MM-Sv/XS
AC   CVCL_6E57
DR   Wikidata; Q54906027
RX   PubMed=16883582;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad5-SV40 hybrid virus.
CC   Derived from site: In situ; Xiphisternum cartilage; UBERON=UBERON_0006430.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3-4W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   MM-Sv/XS-11
AC   CVCL_6E58
DR   Wikidata; Q54906028
RX   PubMed=16883582;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad5-SV40 hybrid virus.
CC   Derived from site: In situ; Xiphisternum cartilage; UBERON=UBERON_0006430.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6E57 ! MM-Sv/XS
SX   Sex unspecified
AG   3-4W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   MM-Y1
AC   CVCL_M539
DR   Wikidata; Q54906029
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2072743;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 49 hours (PubMed=2072743).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   MM.1
AC   CVCL_5801
SY   MM-1; MM1
DR   BTO; BTO_0005490
DR   EFO; EFO_0001219
DR   cancercelllines; CVCL_5801
DR   Cell_Model_Passport; SIDM00624
DR   Cosmic; 2302411
DR   Cosmic; 2367262
DR   Wikidata; Q54906030
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2926241;
RX   PubMed=8943038;
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=12691914;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Characteristics: Produces IgA lambda.
CC   Doubling time: 72 hours (PubMed=12691914).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from child cell line MM1.S).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (from child cell line MM1.S).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   MM.1-144
AC   CVCL_EI97
SY   MM.1.144; MM1-144
DR   EFO; EFO_0022356
DR   cancercelllines; CVCL_EI97
DR   Cosmic; 720780
DR   Cosmic; 2391807
DR   Wikidata; Q54906031
RX   PubMed=11157491;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: African American.
CC   Characteristics: Produces IgA lambda.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=11157491).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5801 ! MM.1
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 15
//
ID   MM.1S-luc
AC   CVCL_B7F7
DR   cancercelllines; CVCL_B7F7
DR   Wikidata; Q112930119
RX   PubMed=32123307;
CC   Population: African American.
CC   Characteristics: Produces IgA lambda (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = effLuc).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8792 ! MM1.S
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   MM04H
AC   CVCL_B3XQ
SY   GCA-NAB 4
DR   CCRID; 4201PAT-CCTCC01945
DR   Wikidata; Q110433056
RX   Patent=CN113528456B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021182.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P28676; Human GCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   Mm1
AC   CVCL_5557
DR   CLO; CLO_0051422
DR   JCRB; IFO50008
DR   RCB; RCB0748
DR   Wikidata; Q54906035
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: SL.
DI   NCIt; C21889; Mouse myeloid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2107 ! M1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM1
AC   CVCL_D5GX
DR   Wikidata; Q127382832
RX   PubMed=12000456;
RX   PubMed=12231968;
RX   PubMed=14756764;
RX   PubMed=15358564;
RX   PubMed=16739567;
RX   PubMed=17272265;
RX   PubMed=22960909;
CC   Group: Plant cell line.
CC   Characteristics: Rapid cell proliferation (PubMed=12000456).
CC   Characteristics: Grows in continuous light (PubMed=12000456).
CC   Characteristics: The cell cycle can be synchronized by removing and re-supplying sucrose or with aphidicolin (PubMed=12000456; PubMed=16739567).
CC   Characteristics: Can be genetically transformed with Agrobacterium (PubMed=14756764).
CC   Characteristics: Used to screen for chemicals that enhance defense responses in plants (PubMed=22960909).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Unclear whether the origin of cell line described in PubMed=12231968 is MM1 cell line or PSB-L cell line. This paper reports the study of the synthesis of glutathione in response to oxidative conditions (PubMed=12231968).
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Landsberg erecta.
OX   NCBI_TaxID=3702; ! Arabidopsis thaliana (Mouse-ear cress)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   MM1.R
AC   CVCL_8794
SY   MM1.r; MM.1R; MM1-R; MM-1R; MM1R; MM1.R(L); MM1.RL
DR   BTO; BTO_0003929
DR   ABM; T8032
DR   ATCC; CRL-2975
DR   CCRID; 3101HUMSCSP5050
DR   Cell_Model_Passport; SIDM01264
DR   Cosmic; 1424219
DR   Cosmic; 2081429
DR   GEO; GSM1374684
DR   IZSLER; BS TCL 235
DR   Wikidata; Q54906036
RX   CelloPub=CLPUB00604;
RX   PubMed=12691914;
RX   PubMed=17692805;
RX   PubMed=28196595;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Characteristics: Produces IgA lambda (ATCC=CRL-2975).
CC   Characteristics: Resistant to dexamethasone.
CC   Doubling time: ~72 hours (ATCC=CRL-2975).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (PubMed=17692805).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ATCC=CRL-2975; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D10S1248: 12,15
ST   D12S391: 17,24
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11,16
ST   D19S433: 13
ST   D1S1656: 11,12
ST   D21S11: 29,30
ST   D22S1045: 10,11
ST   D2S1338: 21,22
ST   D2S441: 11
ST   D3S1358: 16,17
ST   D5S818: 8,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 20,24
ST   Penta D: 2.2,9
ST   Penta E: 13,15
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5801 ! MM.1
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 25
//
ID   MM1.R(E)
AC   CVCL_8793
SY   MM1.RE
DR   cancercelllines; CVCL_8793
DR   Wikidata; Q54906037
RX   PubMed=12691914;
CC   Population: African American.
CC   Characteristics: Produces IgA lambda (from parent cell line).
CC   Characteristics: Resistant to dexamethasone.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5801 ! MM.1
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   MM1.S
AC   CVCL_8792
SY   MM.1S; MM1-S; MM-1S; MM1S
DR   BTO; BTO_0003933
DR   CLO; CLO_0037203
DR   EFO; EFO_0005724
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-1088
DR   ATCC; CRL-2974
DR   BioGRID_ORCS_Cell_line; 801
DR   BioSample; SAMN03471684
DR   BioSample; SAMN10988254
DR   cancercelllines; CVCL_8792
DR   CCRID; 1101HUM-PUMC000680
DR   CCRID; 3101HUMSCSP5017
DR   Cell_Model_Passport; SIDM01265
DR   ChEMBL-Cells; CHEMBL4295490
DR   ChEMBL-Targets; CHEMBL4296471
DR   CLS; 305304
DR   Cosmic; 1424218
DR   Cosmic; 1483077
DR   Cosmic; 1762460
DR   Cosmic; 1889512
DR   Cosmic; 2081430
DR   Cosmic; 2391805
DR   Cosmic; 2809756
DR   Cosmic-CLP; 1659818
DR   DepMap; ACH-000763
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS205VYW
DR   ENCODE; ENCBS241TLI
DR   ENCODE; ENCBS299YQN
DR   ENCODE; ENCBS523NFL
DR   ENCODE; ENCBS981ZAE
DR   GDSC; 1659818
DR   GEO; GSM562814
DR   GEO; GSM887328
DR   GEO; GSM888404
DR   GEO; GSM1374685
DR   GEO; GSM1666388
DR   GEO; GSM1670118
DR   IARC_TP53; 28513
DR   IZSLER; BS TCL 237
DR   LiGeA; CCLE_132
DR   Lonza; 168
DR   PharmacoDB; MM1S_944_2019
DR   PRIDE; PXD021265
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_8792
DR   PubChem_Cell_line; CVCL_8792
DR   Wikidata; Q54906038
RX   CelloPub=CLPUB00604;
RX   PubMed=12691914;
RX   PubMed=14760100;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-item-mm-1s-atcc-crl-2974
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Characteristics: Produces IgA lambda (ATCC=CRL-2974).
CC   Characteristics: Sensitive to dexamethasone.
CC   Doubling time: 80 hours (PubMed=25984343); ~72 hours (ATCC=CRL-2974).
CC   HLA typing: A*23,24; B*18,42; C*12,17 (PubMed=25688540).
CC   HLA typing: A*23:01,24:02; B*18:01,42:01; C*12:03,17:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=21173094; Cosmic-CLP=1659818; DepMap=ACH-000763).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (PubMed=17692805).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=88.68%; Native American=0%; East Asian, North=4.01%; East Asian, South=0%; South Asian=0.43%; European, North=0%; European, South=6.87% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ATCC=CRL-2974; Cosmic-CLP=1659818; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D10S1248: 12,15
ST   D12S391: 17,24
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 11,16
ST   D19S433: 13
ST   D1S1656: 11,12
ST   D21S11: 29,30
ST   D22S1045: 10,11
ST   D2S1338: 21,22
ST   D2S441: 11
ST   D3S1358: 16,17
ST   D5S818: 8,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 20,24
ST   Penta D: 2.2,9
ST   Penta E: 13,15
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5801 ! MM.1
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 39
//
ID   MM102-TC
AC   CVCL_B427
SY   MM102
DR   TKG; TKG 0165
DR   TKG; TKG 0588
DR   Wikidata; Q54906039
CC   Discontinued: TKG; TKG 0588; true.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 8
//
ID   MM121224
AC   CVCL_C3FS
DR   GEO; GSM4933092
DR   Wikidata; Q114312292
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Trunk; UBERON=UBERON_0002100.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM127
AC   CVCL_2601
SY   MM-127
DR   BioSample; SAMN07624422
DR   cancercelllines; CVCL_2601
DR   CBA; CBA-1344
DR   Cell_Model_Passport; SIDM01356
DR   Cosmic; 873569
DR   Cosmic; 889012
DR   Cosmic; 928705
DR   Cosmic; 2159441
DR   DepMap; ACH-001563
DR   ECACC; 10092314
DR   GEO; GSM78852
DR   GEO; GSM78853
DR   GEO; GSM78854
DR   GEO; GSM78855
DR   GEO; GSM78856
DR   GEO; GSM78857
DR   GEO; GSM162904
DR   GEO; GSM219416
DR   Progenetix; CVCL_2601
DR   Wikidata; Q54906044
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=830403;
RX   PubMed=1697409;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=11930117;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=27087056;
CC   Problematic cell line: Possibly misclassified. It is not certain that this cell line originate from a metastatic melanoma. Lacks the expression of three protein markers: S100, HMB-45 and Melan-A commonly found in melanoma cell lines (PubMed=27087056). Has a CTNNB1 mutation not seen in other melanoma cell lines (PubMed=11930117).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Unspecified (PubMed=11930117).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): CBA=CBA-1344; PubMed=27087056
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D18S51: 15,20
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11 (CBA=CBA-1344)
ST   D7S820: 10,12 (PubMed=27087056)
ST   D8S1179: 14,15
ST   FGA: 19,20
ST   Penta D: 10
ST   Penta E: 5,10
ST   TH01: 8,9
ST   TPOX: 11,12
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MM130106
AC   CVCL_C3FM
DR   GEO; GSM4933082
DR   Wikidata; Q114312296
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Leg; UBERON=UBERON_0000978.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FN ! MM131205
OI   CVCL_C3FP ! MM131206
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM130427
AC   CVCL_C3FY
DR   GEO; GSM4933096
DR   Wikidata; Q114312298
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FV ! M130420
OI   CVCL_C3FW ! M130421
OI   CVCL_C3FX ! M130425
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM130434
AC   CVCL_C3FR
DR   GEO; GSM4933091
DR   Wikidata; Q114312299
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Back; UBERON=UBERON_0001137.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM130626
AC   CVCL_C3FL
DR   GEO; GSM4933081
DR   Wikidata; Q114312300
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   MM130820
AC   CVCL_C3FE
DR   GEO; GSM4933074
DR   Wikidata; Q114312301
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   MM130926
AC   CVCL_C3FQ
DR   GEO; GSM4933087
DR   Wikidata; Q114312302
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM131205
AC   CVCL_C3FN
DR   GEO; GSM4933083
DR   Wikidata; Q114312303
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Leg; UBERON=UBERON_0000978.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FM ! MM130106
OI   CVCL_C3FP ! MM131206
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM131206
AC   CVCL_C3FP
DR   GEO; GSM4933084
DR   Wikidata; Q114312304
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Leg; UBERON=UBERON_0000978.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FM ! MM130106
OI   CVCL_C3FN ! MM131205
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM138
AC   CVCL_2602
SY   MM 138
DR   BioSample; SAMN07624423
DR   cancercelllines; CVCL_2602
DR   CBA; CBA-1345
DR   ECACC; 10092321
DR   GEO; GSM219445
DR   Progenetix; CVCL_2602
DR   Wikidata; Q54906046
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=1697409;
RX   PubMed=3756862;
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Doubling time: ~60 hours (ECACC=10092321).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1345
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 27
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 9,10
ST   FGA: 20,22.2
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MM138-2T
AC   CVCL_UM64
DR   Wikidata; Q95990179
RX   PubMed=3756862;
CC   Selected for resistance to: ChEBI; CHEBI_72568; MTIC (5-(3-methyl-1-triazeno)imidazole-4-carboxamide).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2602 ! MM138
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   MM14
AC   CVCL_L439
DR   Wikidata; Q54906047
RX   PubMed=7286393;
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   60D
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   MM14.Lu
AC   CVCL_5802
SY   MM14Lu
DR   CLO; CLO_0007751
DR   ATCC; CRL-6382
DR   IZSLER; BS CL 235
DR   Wikidata; Q54906050
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5803 ! MM14.OT
OI   CVCL_5804 ! MM14.Ov
OI   CVCL_S355 ! MM14.Sp
OI   CVCL_S356 ! MM14.Thy
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   MM14.OT
AC   CVCL_5803
DR   CLO; CLO_0007752
DR   ATCC; CRL-6384
DR   Wikidata; Q54906051
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6384; true.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5802 ! MM14.Lu
OI   CVCL_5804 ! MM14.Ov
OI   CVCL_S355 ! MM14.Sp
OI   CVCL_S356 ! MM14.Thy
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM14.Ov
AC   CVCL_5804
SY   Mm14OV
DR   CLO; CLO_0007753
DR   ATCC; CRL-6383
DR   Wikidata; Q54906052
RX   PubMed=4366196;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5802 ! MM14.Lu
OI   CVCL_5803 ! MM14.OT
OI   CVCL_S355 ! MM14.Sp
OI   CVCL_S356 ! MM14.Thy
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MM14.Sp
AC   CVCL_S355
DR   ATCC; CRL-6385
DR   Wikidata; Q54906053
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6385; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5802 ! MM14.Lu
OI   CVCL_5803 ! MM14.OT
OI   CVCL_5804 ! MM14.Ov
OI   CVCL_S356 ! MM14.Thy
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM14.Thy
AC   CVCL_S356
DR   ATCC; CRL-6386
DR   Wikidata; Q54906054
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6386; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5802 ! MM14.Lu
OI   CVCL_5803 ! MM14.OT
OI   CVCL_5804 ! MM14.Ov
OI   CVCL_S355 ! MM14.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM140902
AC   CVCL_C3FT
DR   GEO; GSM4933089
DR   Wikidata; Q114312305
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Arm; UBERON=UBERON_0001460.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FU ! M130830
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM140905
AC   CVCL_C3FH
DR   GEO; GSM4933077
DR   Wikidata; Q114312306
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   MM14DY
AC   CVCL_IS08
SY   MM14Dy; MM14dy
DR   Wikidata; Q54906048
RX   PubMed=7286393;
CC   Doubling time: 14-18 hours (PubMed=7286393).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L439 ! MM14
SX   Male
AG   60D
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   MM14DZ
AC   CVCL_IS09
DR   Wikidata; Q54906049
RX   PubMed=7286393;
CC   Doubling time: 12-14 hours (PubMed=7286393).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L439 ! MM14
SX   Male
AG   60D
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   MM15.OT
AC   CVCL_5806
SY   MM15OT; MM140T
DR   CLO; CLO_0007755
DR   ATCC; CRL-6438
DR   Wikidata; Q54906055
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6438; true.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM15.Ov
AC   CVCL_S285
SY   Mm15OV
DR   ATCC; CRL-6387
DR   Wikidata; Q54906057
RX   PubMed=4366196;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6387; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5805 ! MM15.Sp/Thy
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM15.Sp/Thy
AC   CVCL_5805
DR   CLO; CLO_0007754
DR   ATCC; CRL-6388
DR   Wikidata; Q54906058
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6388; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S285 ! MM15.Ov
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   MM150325
AC   CVCL_C3FF
DR   GEO; GSM4933075
DR   Wikidata; Q114312307
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Trunk; UBERON=UBERON_0002100.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FG ! MM150604
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM150405
AC   CVCL_C3FZ
DR   GEO; GSM4933085
DR   Wikidata; Q114312308
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: MM130405; GEO=GSM4933085.
CC   Derived from site: Metastatic; Trunk; UBERON=UBERON_0002100.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3G0 ! M150404
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM150604
AC   CVCL_C3FG
DR   GEO; GSM4933076
DR   Wikidata; Q114312309
RX   PubMed=33445472;
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Trunk; UBERON=UBERON_0002100.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3FF ! MM150325
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   MM16
AC   CVCL_L789
SY   MM16-P
DR   GEO; GSM1275963
DR   GEO; GSM1275979
DR   Wikidata; Q54906059
RX   PubMed=21205078;
RX   PubMed=24916674;
CC   Population: Japanese.
CC   Doubling time: 12.4 +- 0.9 hours (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=21205078).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   MM160113
AC   CVCL_B4KU
SY   M160113
DR   DepMap; ACH-002512
DR   Wikidata; Q110433057
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: URPP Biobank, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000040469; Zygosity=Homozygous (DepMap=ACH-002512).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   MM16.Mg
AC   CVCL_S284
DR   ATCC; CRL-6389
DR   Wikidata; Q54906060
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6389; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S283 ! MM16.Sp
OI   CVCL_5807 ! MM16.Ov
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM16.Ov
AC   CVCL_5807
SY   Mm16OV
DR   CLO; CLO_0007756
DR   ATCC; CRL-6390
DR   Wikidata; Q54906061
RX   PubMed=4366196;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6390; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S284 ! MM16.Mg
OI   CVCL_S283 ! MM16.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM16.Sp
AC   CVCL_S283
DR   ATCC; CRL-6391
DR   Wikidata; Q54906063
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6391; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S284 ! MM16.Mg
OI   CVCL_5807 ! MM16.Ov
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM17
AC   CVCL_9482
DR   Wikidata; Q54906064
RX   PubMed=15067335;
CC   Population: Chinese.
CC   Doubling time: ~72 hours (PubMed=15067335).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=15067335).
CC   Derived from site: Metastatic; Bone, sacrum; UBERON=UBERON_0003690.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   MM17.Br
AC   CVCL_S282
DR   ATCC; CRL-6392
DR   Wikidata; Q54906065
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6392; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S281 ! MM17.Sp/Thy
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM17.Sp/Thy
AC   CVCL_S281
DR   ATCC; CRL-6393
DR   Wikidata; Q54906066
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6393; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S282 ! MM17.Br
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM170
AC   CVCL_2603
SY   MM 170
DR   BioSample; SAMN07624424
DR   cancercelllines; CVCL_2603
DR   CBA; CBA-1346
DR   Cosmic; 889013
DR   Cosmic; 928712
DR   ECACC; 10092315
DR   GEO; GSM162905
DR   Wikidata; Q54906067
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=830403;
RX   PubMed=1697409;
RX   PubMed=4059365;
RX   PubMed=6187441;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23039341;
CC   Problematic cell line: Contaminated. Presence of a second cell line in earliest stock not picked up due to low level of contamination (CBA=CBA-1346).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15048078; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: CBA; CBA-1346; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1346
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 28,31.2
ST   D2S1338: 20,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MM19.Ft
AC   CVCL_S280
DR   ATCC; CRL-6394
DR   Wikidata; Q54906068
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6394; true.
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S279 ! MM19.Ht
OI   CVCL_5808 ! MM19.Lu
OI   CVCL_S278 ! MM19.Ov
OI   CVCL_S277 ! MM19.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM19.Ht
AC   CVCL_S279
DR   ATCC; CRL-6395
DR   Wikidata; Q54906069
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6395; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S280 ! MM19.Ft
OI   CVCL_5808 ! MM19.Lu
OI   CVCL_S278 ! MM19.Ov
OI   CVCL_S277 ! MM19.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM19.Lu
AC   CVCL_5808
DR   CLO; CLO_0007757
DR   ATCC; CRL-6396
DR   Wikidata; Q54906070
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6396; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S280 ! MM19.Ft
OI   CVCL_S279 ! MM19.Ht
OI   CVCL_S278 ! MM19.Ov
OI   CVCL_S277 ! MM19.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM19.Ov
AC   CVCL_S278
DR   ATCC; CRL-6397
DR   Wikidata; Q54906071
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6397; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S280 ! MM19.Ft
OI   CVCL_S279 ! MM19.Ht
OI   CVCL_5808 ! MM19.Lu
OI   CVCL_S277 ! MM19.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM19.Sp
AC   CVCL_S277
DR   ATCC; CRL-6398
DR   Wikidata; Q54906072
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6398; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S280 ! MM19.Ft
OI   CVCL_S279 ! MM19.Ht
OI   CVCL_5808 ! MM19.Lu
OI   CVCL_S278 ! MM19.Ov
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM2
AC   CVCL_B428
DR   TKG; TKG 0162
DR   Wikidata; Q54906073
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 7
//
ID   MM2-3C6
AC   CVCL_KS22
DR   Wikidata; Q54906076
RX   PubMed=2842042;
RX   PubMed=3829045;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on melanoma cell line B16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   MM2-9B6
AC   CVCL_KS21
SY   MM2.9B6
DR   Wikidata; Q54906075
RX   PubMed=2842042;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse melanoma-associated antigen (MAA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   MM200
AC   CVCL_C836
SY   MM 200
DR   BTO; BTO_0005717
DR   EFO; EFO_0022617
DR   cancercelllines; CVCL_C836
DR   Cosmic; 889014
DR   Cosmic; 928753
DR   GEO; GSM162935
DR   GEO; GSM219446
DR   Progenetix; CVCL_C836
DR   Wikidata; Q54906077
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=830403;
RX   PubMed=1697409;
RX   PubMed=3756862;
RX   PubMed=7520026;
RX   PubMed=8980186;
RX   PubMed=9354451;
RX   PubMed=9725211;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23039341;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533; PubMed=23455323).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Phe56Ile (c.166T>A); ClinVar=VCV000811083; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   MM21
AC   CVCL_L790
SY   MM21-P
DR   GEO; GSM1275968
DR   GEO; GSM1275984
DR   Wikidata; Q54906078
RX   PubMed=21205078;
RX   PubMed=24916674;
CC   Population: Japanese.
CC   Doubling time: 13.9 +- 0.4 hours (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=21205078).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   MM21.Ut
AC   CVCL_S276
DR   ATCC; CRL-6399
DR   Wikidata; Q54906079
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6399; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM214
AC   CVCL_W453
DR   Wikidata; Q54906080
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=830403;
RX   PubMed=3756862;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   MM22.We
AC   CVCL_5809
DR   CLO; CLO_0007759
DR   ATCC; CRL-6400
DR   Wikidata; Q54906081
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6400; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM229
AC   CVCL_C837
SY   MM 229
DR   cancercelllines; CVCL_C837
DR   Cosmic; 889015
DR   Cosmic; 928699
DR   Cosmic; 1211159
DR   Cosmic; 1418461
DR   GEO; GSM170866
DR   GEO; GSM219450
DR   IARC_TP53; 10958
DR   Progenetix; CVCL_C837
DR   Wikidata; Q54906082
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=830403;
RX   PubMed=1697409;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23039341;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Ser (c.1789_1790delCTinsTC); ClinVar=VCV000375942; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=10070891).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   MM23.We
AC   CVCL_5810
DR   CLO; CLO_0007760
DR   ATCC; CRL-6401
DR   Wikidata; Q54906083
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6401; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM253
AC   CVCL_2604
SY   MM 253
DR   BioSample; SAMN07624425
DR   cancercelllines; CVCL_2604
DR   CBA; CBA-1347
DR   Cosmic; 889016
DR   Cosmic; 928706
DR   DepMap; ACH-001970
DR   ECACC; 11072804
DR   GEO; GSM78858
DR   GEO; GSM78859
DR   GEO; GSM78860
DR   GEO; GSM162940
DR   GEO; GSM219451
DR   Progenetix; CVCL_2604
DR   Wikidata; Q54906084
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=830403;
RX   PubMed=6187441;
RX   PubMed=7060019;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; PubMed=22383533).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1347; DepMap=ACH-001970
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 18,19
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 16,20
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MM253-12M
AC   CVCL_D849
DR   cancercelllines; CVCL_D849
DR   Wikidata; Q54906085
RX   PubMed=669848;
RX   PubMed=6163526;
RX   PubMed=7060019;
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2604 ! MM253
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   MM253-3D
AC   CVCL_UM65
DR   cancercelllines; CVCL_UM65
DR   Wikidata; Q95990203
RX   PubMed=3756862;
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2604 ! MM253
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   MM253c1
AC   CVCL_UM66
SY   MM253cl
DR   cancercelllines; CVCL_UM66
DR   Wikidata; Q95990205
RX   PubMed=3127479;
RX   PubMed=3756862;
RX   PubMed=4059365;
RX   PubMed=6534346;
RX   PubMed=6690060;
RX   PubMed=7060019;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2604 ! MM253
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   MM253c1-1G
AC   CVCL_UM69
DR   cancercelllines; CVCL_UM69
DR   Wikidata; Q95990206
RX   PubMed=7060019;
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UM66 ! MM253c1
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   MM253c1-1T
AC   CVCL_UM67
DR   cancercelllines; CVCL_UM67
DR   Wikidata; Q95990208
RX   PubMed=3756862;
RX   PubMed=7060019;
CC   Selected for resistance to: ChEBI; CHEBI_72568; MTIC (5-(3-methyl-1-triazeno)imidazole-4-carboxamide).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UM66 ! MM253c1
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   MM253c1-3D
AC   CVCL_UM70
DR   cancercelllines; CVCL_UM70
DR   Wikidata; Q95990209
RX   PubMed=4059365;
RX   PubMed=6534346;
RX   PubMed=6690060;
RX   PubMed=7060019;
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UM66 ! MM253c1
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   MM253c1-4CG
AC   CVCL_UM68
DR   cancercelllines; CVCL_UM68
DR   Wikidata; Q95990210
RX   PubMed=3756862;
CC   Selected for resistance to: ChEBI; CHEBI_4027; Cyclophosphamide (CP; Endoxan).
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UM66 ! MM253c1
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   MM26
AC   CVCL_L791
SY   MM26-P
DR   cancercelllines; CVCL_L791
DR   GEO; GSM1275970
DR   GEO; GSM1275986
DR   Progenetix; CVCL_L791
DR   Wikidata; Q54906087
RX   PubMed=21205078;
RX   PubMed=24916674;
CC   Population: Japanese.
CC   Doubling time: 15.7 +- 1.3 hours (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=21205078).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   MM266
AC   CVCL_DH59
DR   cancercelllines; CVCL_DH59
DR   GEO; GSM228548
DR   Progenetix; CVCL_DH59
DR   Wikidata; Q54906088
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Thr992Ile (c.2975C>T) (p.Thr1010Ile, c.3029C>T); ClinVar=VCV000041624; Zygosity=Heterozygous (PubMed=22383533).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 8
//
ID   MM27.We
AC   CVCL_5811
DR   CLO; CLO_0007761
DR   ATCC; CRL-6402
DR   Wikidata; Q54906089
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6402; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM28
AC   CVCL_4D15
DR   ATCC; CRL-3295
DR   cancercelllines; CVCL_4D15
DR   IARC_TP53; 23398
DR   PRIDE; PXD051055
DR   Wikidata; Q54906090
RX   PubMed=24994677;
RX   PubMed=39042403;
CC   Characteristics: Established from a patient-derived xenograft (PubMed=24994677).
CC   Doubling time: 109 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Tyr627Ter (c.1881C>A); Zygosity=Unspecified (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=24994677).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-3295; PubMed=24994677
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D21S11: 28,29
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 15
//
ID   MM29.We
AC   CVCL_5812
DR   CLO; CLO_0007762
DR   ATCC; CRL-6403
DR   Wikidata; Q54906091
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6403; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM2d
AC   CVCL_D5GY
DR   GEO; GSE5747
DR   GEO; GSE5750
DR   GEO; GSE108741
DR   RIKEN_BRC_EPD; rpc00103
DR   Wikidata; Q127382833
RX   PubMed=12000456;
RX   PubMed=12231968;
RX   PubMed=14756764;
RX   PubMed=16408177;
RX   PubMed=16739567;
RX   PubMed=19368694;
RX   PubMed=20130883;
RX   PubMed=21613568;
RX   PubMed=24134884;
CC   Group: Plant cell line.
CC   Characteristics: Rapid cell proliferation (PubMed=12000456).
CC   Characteristics: Grows in darkness (PubMed=12000456).
CC   Characteristics: The cell cycle can be synchronized by removing and re-supplying sucrose or with aphidicolin (PubMed=12000456; PubMed=16739567).
CC   Characteristics: Can be genetically transformed with Agrobacterium (PubMed=14756764).
CC   Characteristics: Can be used to prepare protoplasts (PubMed=24134884).
CC   Omics: Genomics; ChIP-seq; A.thaliana RBR1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Landsberg erecta.
OX   NCBI_TaxID=3702; ! Arabidopsis thaliana (Mouse-ear cress)
HI   CVCL_D5GX ! MM1
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   MM2d-LS
AC   CVCL_D5GZ
DR   RIKEN_BRC_EPD; rpc00104
DR   Wikidata; Q127382834
CC   Group: Plant cell line.
CC   Characteristics: Cell cycle synchronization, genetic transformation (RIKEN_BRC_EPD=rpc00104).
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Landsberg erecta.
OX   NCBI_TaxID=3702; ! Arabidopsis thaliana (Mouse-ear cress)
HI   CVCL_D5GY ! MM2d
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MM2MT
AC   CVCL_3545
DR   CLO; CLO_0007763
DR   ATCC; CRL-6373
DR   Wikidata; Q54906093
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6373; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   MM2MTC
AC   CVCL_3546
DR   CLO; CLO_0007764
DR   ATCC; CRL-6374
DR   Wikidata; Q54906094
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6374; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3545 ! MM2MT
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM2SCT
AC   CVCL_3547
DR   CLO; CLO_0007765
DR   ATCC; CRL-6375
DR   Wikidata; Q54906095
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6375; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Mm2T
AC   CVCL_3026
SY   Mm-2T
DR   JCRB; JCRB0609
DR   Wikidata; Q54906096
RX   CelloPub=CLPUB00082;
RX   PubMed=7586011;
CC   Doubling time: 67.5 hours (CelloPub=CLPUB00082).
CC   Discontinued: JCRB; JCRB0609; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Mm2T.P3
AC   CVCL_5481
DR   JCRB; JCRB0609.1
DR   JCRB; NIHS0358
DR   Wikidata; Q54906097
CC   Group: Serum/protein free medium cell line.
CC   Discontinued: JCRB; NIHS0358; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_3026 ! Mm2T
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Mm2T12.P3
AC   CVCL_5482
SY   CH3-B12-treated Mm2T
DR   JCRB; JCRB0650.1
DR   JCRB; NIHS0369
DR   Wikidata; Q54906098
RX   PubMed=7586011;
CC   Group: Serum/protein free medium cell line.
CC   Discontinued: JCRB; NIHS0369; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_3026 ! Mm2T
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MM30.Ut
AC   CVCL_S272
DR   ATCC; CRL-6404
DR   Wikidata; Q54906099
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6404; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM31.We
AC   CVCL_5813
DR   CLO; CLO_0007766
DR   ATCC; CRL-6405
DR   Wikidata; Q54906100
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6405; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM32.Ut
AC   CVCL_S273
DR   ATCC; CRL-6406
DR   Wikidata; Q54906101
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6406; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM329
AC   CVCL_C838
SY   MM 329
DR   cancercelllines; CVCL_C838
DR   Cosmic; 889017
DR   Cosmic; 928745
DR   GEO; GSM170841
DR   GEO; GSM220168
DR   Progenetix; CVCL_C838
DR   Wikidata; Q54906102
RX   PubMed=3756862;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=22383533;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   MM33
AC   CVCL_4D16
DR   cancercelllines; CVCL_4D16
DR   Wikidata; Q54906103
RX   PubMed=24994677;
CC   Doubling time: 91 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Unspecified (PubMed=24994677).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D21S11: 31.2,32.2
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   MM33.Ut
AC   CVCL_S274
DR   ATCC; CRL-6407
DR   Wikidata; Q54906104
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6407; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM339
AC   CVCL_GR28
DR   Wikidata; Q54906105
RX   PubMed=460945;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   MM34.We
AC   CVCL_5814
DR   CLO; CLO_0007767
DR   ATCC; CRL-6408
DR   Wikidata; Q54906106
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6408; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM344
AC   CVCL_GR29
DR   Wikidata; Q54906107
RX   PubMed=460945;
RX   PubMed=6187441;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   MM35
AC   CVCL_L792
DR   Wikidata; Q54906108
RX   PubMed=21205078;
CC   Population: Japanese.
CC   Doubling time: 32.8 +- 2.5 hours (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=21205078).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   MM35.Ut
AC   CVCL_S275
DR   ATCC; CRL-6409
DR   Wikidata; Q54906109
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6409; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM36.We
AC   CVCL_5816
SY   MM36We
DR   CLO; CLO_0007769
DR   ATCC; CRL-6413
DR   Wikidata; Q54906114
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Caution: Indicated to be from an embryo but sister cell lines are from an adult mouse.
CC   Discontinued: ATCC; CRL-6413; true.
CC   Breed/subspecies: HRS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_N495 ! MM36T(A)
OI   CVCL_N496 ! MM36T(B)
OI   CVCL_5815 ! MM36T(C)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MM369
AC   CVCL_C839
SY   MM 369
DR   cancercelllines; CVCL_C839
DR   Cosmic; 928746
DR   Cosmic; 1211157
DR   GEO; GSM224861
DR   Progenetix; CVCL_C839
DR   Wikidata; Q54906110
RX   PubMed=3756862;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=17363583;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   MM36T(A)
AC   CVCL_N495
DR   ATCC; CRL-6410
DR   Wikidata; Q54906111
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6410; true.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_N496 ! MM36T(B)
OI   CVCL_5815 ! MM36T(C)
OI   CVCL_5816 ! MM36.We
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MM36T(B)
AC   CVCL_N496
DR   ATCC; CRL-6412
DR   Wikidata; Q54906112
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6412; true.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_N495 ! MM36T(A)
OI   CVCL_5815 ! MM36T(C)
OI   CVCL_5816 ! MM36.We
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MM36T(C)
AC   CVCL_5815
DR   CLO; CLO_0007768
DR   ATCC; CRL-6411
DR   Wikidata; Q54906113
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6411; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_N495 ! MM36T(A)
OI   CVCL_N496 ! MM36T(B)
OI   CVCL_5816 ! MM36.We
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MM370
AC   CVCL_2605
SY   MM 370
DR   BioSample; SAMN07624426
DR   cancercelllines; CVCL_2605
DR   CBA; CBA-1348
DR   Cell_Model_Passport; SIDM01355
DR   Cosmic; 889018
DR   Cosmic; 928747
DR   DepMap; ACH-001566
DR   ECACC; 10092316
DR   GEO; GSM162929
DR   GEO; GSM226658
DR   Progenetix; CVCL_2605
DR   Wikidata; Q54906115
RX   PubMed=3756862;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; DepMap=ACH-001566).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1348
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 8
ST   D18S51: 14,15
ST   D19S433: 12,13
ST   D21S11: 27,32
ST   D2S1338: 17
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MM37T
AC   CVCL_5817
SY   MM37.T
DR   CLO; CLO_0007770
DR   ATCC; CRL-6414
DR   Wikidata; Q54906116
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6414; true.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM383
AC   CVCL_2606
SY   MM 383
DR   BioSample; SAMN07624427
DR   cancercelllines; CVCL_2606
DR   CBA; CBA-1350
DR   Cell_Model_Passport; SIDM01362
DR   Cosmic; 889019
DR   Cosmic; 928734
DR   DepMap; ACH-001567
DR   ECACC; 10092317
DR   GEO; GSM170843
DR   Wikidata; Q54906117
RX   PubMed=3756862;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17516929;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; DepMap=ACH-001567).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1350; DepMap=ACH-001567
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 23
ST   D19S433: 15.2
ST   D21S11: 29,31
ST   D2S1338: 16,19
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 9,14
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MM384
AC   CVCL_C840
SY   MM 384
DR   cancercelllines; CVCL_C840
DR   Cosmic; 928741
DR   GEO; GSM226659
DR   Progenetix; CVCL_C840
DR   Wikidata; Q54906118
RX   PubMed=3756862;
RX   PubMed=9354451;
RX   PubMed=17363583;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro48Leu (c.143C>T); Zygosity=Unspecified (PubMed=9354451; PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MM386
AC   CVCL_2607
SY   MM 386
DR   BioSample; SAMN07624428
DR   cancercelllines; CVCL_2607
DR   CBA; CBA-1349
DR   Cell_Model_Passport; SIDM01373
DR   Cosmic; 889020
DR   Cosmic; 928736
DR   Cosmic; 1418457
DR   DepMap; ACH-001568
DR   ECACC; 10092318
DR   GEO; GSM162932
DR   GEO; GSM226660
DR   IARC_TP53; 10957
DR   Progenetix; CVCL_2607
DR   Wikidata; Q54906119
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; DepMap=ACH-001568).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg290His (c.869G>A); ClinVar=VCV000127825; Zygosity=Unspecified (PubMed=10070891).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1349; DepMap=ACH-001568
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 30,32
ST   D2S1338: 26
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MM387
AC   CVCL_UM60
DR   Wikidata; Q95990227
RX   PubMed=3756862;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   MM392
AC   CVCL_UM61
DR   Wikidata; Q95990228
RX   PubMed=3756862;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   MM396
AC   CVCL_C841
SY   MM 396
DR   cancercelllines; CVCL_C841
DR   Cosmic; 928727
DR   GEO; GSM226661
DR   Progenetix; CVCL_C841
DR   Wikidata; Q54906120
RX   PubMed=3756862;
RX   PubMed=9354451;
RX   PubMed=17363583;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro81Leu (c.242C>T); ClinVar=VCV000833629; Zygosity=Unspecified (PubMed=9354451; PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   MM3MG
AC   CVCL_5818
DR   CLO; CLO_0007771
DR   ATCC; CRL-6376
DR   Wikidata; Q54906121
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6376; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM4
AC   CVCL_S405
SY   MM-4
DR   Wikidata; Q54906122
CC   From: Stierner, Ulrika; Gothenburg University; Gothenburg; Sweden.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   MM4.We
AC   CVCL_5819
DR   CLO; CLO_0007772
DR   ATCC; CRL-6377
DR   Wikidata; Q54906123
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6377; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM40.Ut
AC   CVCL_S286
DR   ATCC; CRL-6415
DR   Wikidata; Q54906124
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6415; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MM408
AC   CVCL_UM62
DR   Wikidata; Q95990232
RX   PubMed=3756862;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   MM409
AC   CVCL_C842
SY   MM 409
DR   cancercelllines; CVCL_C842
DR   Cosmic; 928700
DR   GEO; GSM226662
DR   Progenetix; CVCL_C842
DR   Wikidata; Q54906125
RX   PubMed=1697409;
RX   PubMed=3756862;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=17363583;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   MM41.We
AC   CVCL_5820
SY   MM41We
DR   CLO; CLO_0007773
DR   ATCC; CRL-6416
DR   Wikidata; Q54906129
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6416; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MM415
AC   CVCL_2608
SY   MM 415
DR   EFO; EFO_0022368
DR   BioSample; SAMN07624429
DR   cancercelllines; CVCL_2608
DR   CBA; CBA-1351
DR   Cell_Model_Passport; SIDM01907
DR   Cosmic; 889021
DR   Cosmic; 928751
DR   Cosmic; 2159439
DR   DepMap; ACH-001569
DR   ECACC; 10092319
DR   GEO; GSM162933
DR   GEO; GSM226671
DR   Progenetix; CVCL_2608
DR   Wikidata; Q54906126
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; DepMap=ACH-001569).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1351; DepMap=ACH-001569
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 11
ST   D18S51: 14,20
ST   D19S433: 14,15.2
ST   D21S11: 27,28
ST   D2S1338: 17,19
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 23,25
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MM418
AC   CVCL_C843
SY   MM 418; 418
DR   cancercelllines; CVCL_C843
DR   ChEMBL-Cells; CHEMBL3307300
DR   ChEMBL-Targets; CHEMBL614131
DR   Cosmic; 928707
DR   GEO; GSM226682
DR   Progenetix; CVCL_C843
DR   PubChem_Cell_line; CVCL_C843
DR   Wikidata; Q54906127
RX   PubMed=1697409;
RX   PubMed=2798324;
RX   PubMed=2798328;
RX   PubMed=3127479;
RX   PubMed=3756862;
RX   PubMed=4059365;
RX   PubMed=7520026;
RX   PubMed=9354451;
RX   PubMed=17363583;
CC   Characteristics: Highly pigmented.
CC   Doubling time: 35.8 hours (PubMed=2798324).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   MM418-1
AC   CVCL_UM71
SY   MM418-C1; MM418 Cl1; MM418 clone 1
DR   cancercelllines; CVCL_UM71
DR   Wikidata; Q95990234
RX   PubMed=8980186;
RX   PubMed=9466661;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C843 ! MM418
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   MM418-5
AC   CVCL_UM72
SY   MM418-C5; MM418 Cl5; MM418 clone 5
DR   cancercelllines; CVCL_UM72
DR   Wikidata; Q95990236
RX   PubMed=8980186;
RX   PubMed=9466661;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C843 ! MM418
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   MM42.Ut
AC   CVCL_N494
DR   ATCC; CRL-6417
DR   Wikidata; Q54906130
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6417; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   MM426
AC   CVCL_2609
SY   MM 426
DR   BioSample; SAMN07624430
DR   cancercelllines; CVCL_2609
DR   CBA; CBA-1352
DR   Cell_Model_Passport; SIDM01382
DR   Cosmic; 889022
DR   Cosmic; 928740
DR   DepMap; ACH-001570
DR   ECACC; 10092320
DR   GEO; GSM170848
DR   GEO; GSM226718
DR   Progenetix; CVCL_2609
DR   Wikidata; Q54906131
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583; DepMap=ACH-001570).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu88Ter (c.262G>T); ClinVar=VCV000376305; Zygosity=Unspecified (PubMed=9354451; PubMed=17363583; DepMap=ACH-001570).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1352; DepMap=ACH-001570
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 21
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 10,16
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 11,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MM43T
AC   CVCL_5821
SY   MM43.T
DR   CLO; CLO_0007774
DR   ATCC; CRL-6418
DR   Wikidata; Q54906132
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6418; true.
CC   Breed/subspecies: HRS/J.
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM44.Sp
AC   CVCL_5822
DR   CLO; CLO_0007775
DR   ATCC; CRL-6419
DR   Wikidata; Q54906133
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6419; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   MM446
AC   CVCL_UM73
DR   Wikidata; Q95990244
RX   PubMed=9466661;
RX   PubMed=10070891;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro316Leu (c.943_944delCCinsTT); Zygosity=Unspecified (PubMed=10070891).
CC   Caution: TP53 mutation indicated incorrectly as being in position Pro315 in PubMed=10070891.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   MM455
AC   CVCL_C835
SY   MM 455
DR   cancercelllines; CVCL_C835
DR   Cosmic; 706105
DR   Cosmic; 888845
DR   Cosmic; 889023
DR   Cosmic; 897490
DR   Cosmic; 928713
DR   GEO; GSM78861
DR   GEO; GSM78863
DR   GEO; GSM78864
DR   GEO; GSM162941
DR   Wikidata; Q54906134
RX   PubMed=1697409;
RX   PubMed=9354451;
RX   PubMed=9598804;
RX   PubMed=9692547;
RX   PubMed=10070891;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=15048078;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714; PubMed=15048078).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: M455; Cosmic=897490.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   MM45T.Bl
AC   CVCL_5823
DR   CLO; CLO_0007776
DR   ATCC; CRL-6420
DR   Wikidata; Q54906135
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6420; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5824 ! MM45T.Li
OI   CVCL_5825 ! MM45T.Sp
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM45T.Li
AC   CVCL_5824
DR   CLO; CLO_0007777
DR   ATCC; CRL-6421
DR   Wikidata; Q54906136
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6421; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5823 ! MM45T.Bl
OI   CVCL_5825 ! MM45T.Sp
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM45T.Sp
AC   CVCL_5825
DR   CLO; CLO_0007778
DR   ATCC; CRL-6422
DR   Wikidata; Q54906137
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6422; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5823 ! MM45T.Bl
OI   CVCL_5824 ! MM45T.Li
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM46 [Human mesothelioma]
AC   CVCL_L793
SY   MM46-P
DR   GEO; GSM1275978
DR   GEO; GSM1275994
DR   Wikidata; Q54906138
RX   PubMed=21205078;
RX   PubMed=24916674;
CC   Population: Japanese.
CC   Doubling time: 11.5 +- 0.5 hours (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=21205078).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   MM46 [Mouse mammary carcinoma]
AC   CVCL_B429
SY   SMCXX VI
DR   BTO; BTO_0001082
DR   ChEMBL-Cells; CHEMBL3307311
DR   ChEMBL-Targets; CHEMBL614168
DR   PubChem_Cell_line; CVCL_B429
DR   RCB; RCB2617
DR   TKG; TKG 0163
DR   Wikidata; Q54906139
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Caution: Not from strain C3H/He as originally assigned but from a NIH Swiss strain derivative (DOI=10.4051/ibc.2010.2.4.0014).
CC   Discontinued: RCB; RCB2617; true.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   MM46 CEA1-2
AC   CVCL_C515
DR   CLO; CLO_0050957
DR   RCB; RCB2633
DR   TKG; TKG 0597
DR   Wikidata; Q54906140
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1814; CEACAM1.
CC   Caution: Not from strain C3H/He as originally assigned but from a NIH Swiss strain derivative (DOI=10.4051/ibc.2010.2.4.0014).
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B429 ! MM46 [Mouse mammary carcinoma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   MM46-APR-MUC1 cl.1
AC   CVCL_C514
SY   MM46-APR-MUC1 clone 1
DR   CLO; CLO_0050958
DR   RCB; RCB2634
DR   TKG; TKG 0595
DR   Wikidata; Q54906141
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Caution: Not from strain C3H/He as originally assigned but from a NIH Swiss strain derivative (DOI=10.4051/ibc.2010.2.4.0014).
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B429 ! MM46 [Mouse mammary carcinoma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   MM466
AC   CVCL_4449
SY   MM 466
DR   BioSample; SAMN07624431
DR   cancercelllines; CVCL_4449
DR   CBA; CBA-1353
DR   Cosmic; 889024
DR   Cosmic; 928714
DR   Cosmic; 1303047
DR   DepMap; ACH-001971
DR   ECACC; 12070507
DR   GEO; GSM162936
DR   GEO; GSM226721
DR   Progenetix; CVCL_4449
DR   Wikidata; Q54906142
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1353
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 22,26
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MM46T
AC   CVCL_5826
SY   MM46.T
DR   CLO; CLO_0007779
DR   ATCC; CRL-6423
DR   Wikidata; Q54906143
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6423; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM47
AC   CVCL_B430
SY   SMCXX V
DR   Wikidata; Q54906144
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 7
//
ID   MM470
AC   CVCL_C844
SY   MM 470
DR   cancercelllines; CVCL_C844
DR   Cosmic; 889025
DR   Cosmic; 928697
DR   Wikidata; Q54906145
RX   PubMed=9354451;
RX   PubMed=15048078;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   MM472
AC   CVCL_C845
SY   MM 472
DR   cancercelllines; CVCL_C845
DR   Cosmic; 889026
DR   Cosmic; 928715
DR   GEO; GSM226722
DR   Progenetix; CVCL_C845
DR   Wikidata; Q54906146
RX   PubMed=1697409;
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro30Ile; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   MM473
AC   CVCL_4450
SY   MM 473
DR   BioSample; SAMN07624432
DR   cancercelllines; CVCL_4450
DR   CBA; CBA-1354
DR   ChEMBL-Cells; CHEMBL4295437
DR   ChEMBL-Targets; CHEMBL4296472
DR   Cosmic; 889027
DR   Cosmic; 928743
DR   ECACC; 12070508
DR   GEO; GSM170835
DR   GEO; GSM226723
DR   Progenetix; CVCL_4450
DR   PubChem_Cell_line; CVCL_4450
DR   Wikidata; Q54906147
RX   PubMed=1697409;
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (PubMed=9354451; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1354
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 12,14
ST   D21S11: 30.2,32.2
ST   D2S1338: 17
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MM47T
AC   CVCL_5827
SY   MM47.T
DR   CLO; CLO_0007780
DR   ATCC; CRL-6424
DR   Wikidata; Q54906148
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6424; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM48
AC   CVCL_B431
SY   SMCXX III
DR   TKG; TKG 0164
DR   Wikidata; Q54906149
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 9
//
ID   MM485
AC   CVCL_2610
SY   MM 485
DR   EFO; EFO_0022369
DR   BioSample; SAMN07624433
DR   cancercelllines; CVCL_2610
DR   CBA; CBA-1355
DR   Cosmic; 889028
DR   Cosmic; 928728
DR   Cosmic; 1206009
DR   Cosmic; 2159428
DR   DepMap; ACH-001973
DR   ECACC; 11072803
DR   GEO; GSM170849
DR   GEO; GSM226724
DR   Progenetix; CVCL_2610
DR   Wikidata; Q54906150
RX   PubMed=1697409;
RX   PubMed=3127479;
RX   PubMed=7780963;
RX   PubMed=9354451;
RX   PubMed=9466661;
RX   PubMed=10070891;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp100Ter; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583; DepMap=ACH-001973).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=15048078; PubMed=17363583; DepMap=ACH-001973).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1355; DepMap=ACH-001973
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 13,17
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 11,13
ST   FGA: 21,23
ST   Penta D: 10,12
ST   Penta E: 10,15
ST   TH01: 8
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MM488
AC   CVCL_C846
SY   MM 488
DR   cancercelllines; CVCL_C846
DR   Cosmic; 928701
DR   GEO; GSM226725
DR   Progenetix; CVCL_C846
DR   Wikidata; Q54906151
RX   PubMed=9354451;
RX   PubMed=10070891;
RX   PubMed=17363583;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MM48T
AC   CVCL_5828
SY   MM48.T
DR   CLO; CLO_0007781
DR   ATCC; CRL-6425
DR   Wikidata; Q54906152
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6425; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM49T
AC   CVCL_5829
SY   MM49.T
DR   CLO; CLO_0007782
DR   ATCC; CRL-6426
DR   Wikidata; Q54906153
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6426; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MM5.1 [Human myeloma]
AC   CVCL_6686
DR   Cosmic; 720766
DR   Wikidata; Q54906154
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=9009094;
RX   PubMed=10936422;
RX   PubMed=11157491;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MM5%2e1
CC   Characteristics: Produces IgA kappa.
CC   Characteristics: Requires bone marrow stromal cells for growth.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   MM5.1 [Mouse]
AC   CVCL_5830
DR   CLO; CLO_0007783
DR   ATCC; CRL-6380
DR   Wikidata; Q54906155
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6380; true.
CC   Breed/subspecies: C3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MM5.2
AC   CVCL_6687
DR   Wikidata; Q54906156
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=9009094;
RX   PubMed=10936422;
RX   PubMed=11157491;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MM5%2e2
CC   Characteristics: Produces IgA kappa and IgG kappa.
CC   Characteristics: Does not require bone marrow stromal cells for growth.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6686 ! MM5.1 [Human myeloma]
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   MM5/C1
AC   CVCL_5831
DR   CLO; CLO_0007784
DR   ATCC; CRL-6444
DR   Wikidata; Q54906157
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Discontinued: ATCC; CRL-6444; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/Crgl.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5840 ! Mm5MT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM51.Sp
AC   CVCL_5832
DR   CLO; CLO_0007785
DR   ATCC; CRL-6427
DR   Wikidata; Q54906158
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6427; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM52.Sp
AC   CVCL_5833
DR   CLO; CLO_0007786
DR   ATCC; CRL-6428
DR   Wikidata; Q54906159
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6428; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5834 ! MM52.T
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM52.T
AC   CVCL_5834
DR   CLO; CLO_0007787
DR   ATCC; CRL-6429
DR   Wikidata; Q54906160
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6429; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5833 ! MM52.Sp
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MM53.Sp
AC   CVCL_5835
DR   CLO; CLO_0007788
DR   ATCC; CRL-6430
DR   Wikidata; Q54906161
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6430; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S365 ! MM53.T
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM53.T
AC   CVCL_S365
DR   ATCC; CRL-6431
DR   Wikidata; Q54906162
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6431; true.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5835 ! MM53.Sp
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   MM537
AC   CVCL_4451
SY   MM 537
DR   BioSample; SAMN07624434
DR   cancercelllines; CVCL_4451
DR   CBA; CBA-1356
DR   Cosmic; 889029
DR   ECACC; 12070509
DR   GEO; GSM162937
DR   GEO; GSM226726
DR   Progenetix; CVCL_4451
DR   Wikidata; Q54906163
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1356
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 12,14
ST   D21S11: 28,32.2
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 20,24
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   MM54.K
AC   CVCL_5836
DR   CLO; CLO_0007789
DR   ATCC; CRL-6433
DR   Wikidata; Q54906164
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6433; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: CBA/T6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5837 ! MM54.Sp/Thy
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   MM54.Sp/Thy
AC   CVCL_5837
DR   CLO; CLO_0007790
DR   ATCC; CRL-6434
DR   Wikidata; Q54906165
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6434; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: CBA/T6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5836 ! MM54.K
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM540
AC   CVCL_C847
SY   MM 540
DR   cancercelllines; CVCL_C847
DR   Cosmic; 889030
DR   Cosmic; 928735
DR   Cosmic; 1211149
DR   GEO; GSM170867
DR   GEO; GSM226727
DR   Progenetix; CVCL_C847
DR   Wikidata; Q54906166
RX   PubMed=9354451;
RX   PubMed=9466661;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   MM548
AC   CVCL_C848
SY   MM 548
DR   cancercelllines; CVCL_C848
DR   Cosmic; 928729
DR   GEO; GSM170978
DR   GEO; GSM226728
DR   Progenetix; CVCL_C848
DR   Wikidata; Q54906167
RX   PubMed=9354451;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg99del; Zygosity=Unspecified (PubMed=9354451; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   MM55.Ht/Lu
AC   CVCL_S357
DR   ATCC; CRL-6435
DR   Wikidata; Q54906168
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6435; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: AKR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5838 ! MM55.K
OI   CVCL_5839 ! MM55.Sp/Thy
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MM55.K
AC   CVCL_5838
DR   CLO; CLO_0007791
DR   ATCC; CRL-6436
DR   Wikidata; Q54906172
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: AKR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S357 ! MM55.Ht/Lu
OI   CVCL_5839 ! MM55.Sp/Thy
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   MM55.Sp/Thy
AC   CVCL_5839
DR   CLO; CLO_0007792
DR   ATCC; CRL-6437
DR   Wikidata; Q54906173
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6437; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S357 ! MM55.Ht/Lu
OI   CVCL_5838 ! MM55.K
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MM56
AC   CVCL_L794
DR   Wikidata; Q54906174
RX   PubMed=21205078;
CC   Population: Japanese.
CC   Doubling time: 15.6 +- 1.8 hours (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21205078).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=21205078).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   MM576
AC   CVCL_2611
SY   MM 576
DR   BioSample; SAMN07624435
DR   CBA; CBA-1357
DR   Cosmic; 928737
DR   Cosmic; 929206
DR   ECACC; 11072802
DR   GEO; GSM170850
DR   Wikidata; Q54906175
RX   PubMed=9354451;
RX   PubMed=9466661;
RX   PubMed=10338330;
RX   PubMed=17516929;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CBA=CBA-1357
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 13
ST   D18S51: 16
ST   D19S433: 15,17
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 20
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   MM595
AC   CVCL_4452
SY   MM 595
DR   cancercelllines; CVCL_4452
DR   Cosmic; 889031
DR   Cosmic; 928708
DR   Cosmic; 1303048
DR   GEO; GSM170596
DR   GEO; GSM226729
DR   Progenetix; CVCL_4452
DR   Wikidata; Q54906176
RX   PubMed=9354451;
RX   PubMed=9466661;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1358 but was never distributed.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MM598
AC   CVCL_C849
SY   MM 598
DR   Cosmic; 928752
DR   Wikidata; Q54906177
RX   PubMed=9354451;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   Mm5MT
AC   CVCL_5840
AS   CVCL_3998
SY   Mm5mt; MM5MT
DR   BTO; BTO_0003299
DR   CLO; CLO_0007793
DR   CLO; CLO_0007794
DR   ATCC; CRL-1637
DR   ATCC; CRL-6590
DR   Wikidata; Q54906178
RX   PubMed=4346536;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Discontinued: ATCC; CRL-6590; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/Crgl.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   MM5MTC
AC   CVCL_3999
DR   BTO; BTO_0003300
DR   CLO; CLO_0007795
DR   ATCC; CRL-6378
DR   Wikidata; Q54906179
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/Crgl.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5840 ! Mm5MT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   MM5MTM
AC   CVCL_4000
DR   CLO; CLO_0007796
DR   ATCC; CRL-6379
DR   Wikidata; Q54906180
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Discontinued: ATCC; CRL-6379; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H/Crgl.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5840 ! Mm5MT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MM603
AC   CVCL_2612
SY   MM 603
DR   BioSample; SAMN07624436
DR   cancercelllines; CVCL_2612
DR   CBA; CBA-1359
DR   Cosmic; 889032
DR   Cosmic; 928754
DR   ECACC; 11072801
DR   GEO; GSM170597
DR   GEO; GSM226730
DR   Progenetix; CVCL_2612
DR   Wikidata; Q54906181
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): CBA=CBA-1359
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 15
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 12,17
ST   FGA: 20,23
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MM604
AC   CVCL_DG38
SY   MM 604
DR   cancercelllines; CVCL_DG38
DR   GEO; GSM226731
DR   Progenetix; CVCL_DG38
DR   Wikidata; Q54906182
RX   PubMed=17363583;
RX   PubMed=23039341;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   MM608
AC   CVCL_4453
SY   MM 608
DR   cancercelllines; CVCL_4453
DR   Cosmic; 888869
DR   Cosmic; 889033
DR   Cosmic; 928716
DR   GEO; GSM170857
DR   Wikidata; Q54906183
RX   PubMed=9354451;
RX   PubMed=15009714;
RX   PubMed=15048078;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714; PubMed=15048078).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1360 but was never distributed.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   MM612
AC   CVCL_UM74
DR   Wikidata; Q95990301
RX   PubMed=9466661;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MM622
AC   CVCL_C850
SY   MM 622
DR   cancercelllines; CVCL_C850
DR   Cosmic; 889034
DR   Cosmic; 928730
DR   GEO; GSM170858
DR   GEO; GSM226857
DR   Progenetix; CVCL_C850
DR   Wikidata; Q54906184
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly67fs*53; Zygosity=Unspecified (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu139Ter (c.416T>A); Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   MM628
AC   CVCL_C851
SY   MM 628
DR   cancercelllines; CVCL_C851
DR   Cosmic; 928756
DR   GEO; GSM226858
DR   Progenetix; CVCL_C851
DR   Wikidata; Q54906185
RX   PubMed=9354451;
RX   PubMed=17363583;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Unspecified (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MM629
AC   CVCL_W873
DR   cancercelllines; CVCL_W873
DR   Cosmic; 889035
DR   Wikidata; Q54906186
RX   PubMed=15048078;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   MM636
AC   CVCL_DH58
DR   cancercelllines; CVCL_DH58
DR   GEO; GSM226860
DR   Progenetix; CVCL_DH58
DR   Wikidata; Q54906187
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   MM647
AC   CVCL_C852
SY   MM 647
DR   cancercelllines; CVCL_C852
DR   Cosmic; 928755
DR   GEO; GSM226861
DR   Progenetix; CVCL_C852
DR   Wikidata; Q54906189
RX   PubMed=9354451;
RX   PubMed=17363583;
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MM648
AC   CVCL_A777
SY   MM 648
DR   cancercelllines; CVCL_A777
DR   Cosmic; 889036
DR   Cosmic; 928702
DR   GEO; GSM162942
DR   GEO; GSM226862
DR   Progenetix; CVCL_A777
DR   Wikidata; Q54906190
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   MM649
AC   CVCL_A776
SY   MM 649
DR   cancercelllines; CVCL_A776
DR   Cosmic; 889037
DR   Cosmic; 928742
DR   Cosmic; 1303049
DR   GEO; GSM162943
DR   GEO; GSM226863
DR   Progenetix; CVCL_A776
DR   Wikidata; Q54906191
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=17516929;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7989; NRAS; Zygosity=Homozygous (PubMed=15048078).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   MM66
AC   CVCL_4D17
DR   cancercelllines; CVCL_4D17
DR   PRIDE; PXD051055
DR   Wikidata; Q54906192
RX   PubMed=24994677;
RX   PubMed=39042403;
CC   Characteristics: Established from a patient-derived xenograft (PubMed=24994677).
CC   Doubling time: 80 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=24994677).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D21S11: 28,31
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   MM7-11.Sp
AC   CVCL_5841
DR   CLO; CLO_0007797
DR   ATCC; CRL-6381
DR   Wikidata; Q54906193
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Discontinued: ATCC; CRL-6381; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   MM96
AC   CVCL_D848
SY   MM-96; MM 96
DR   cancercelllines; CVCL_D848
DR   Cosmic; 928749
DR   Wikidata; Q54906194
RX   PubMed=294576;
RX   PubMed=460945;
RX   PubMed=830403;
RX   PubMed=1697409;
RX   PubMed=2798328;
RX   PubMed=6187441;
RX   PubMed=6277475;
RX   PubMed=7217226;
RX   PubMed=7999427;
RX   PubMed=10070891;
RX   PubMed=17363583;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   MM96 1 TgR
AC   CVCL_GR30
SY   MM961TgR
DR   cancercelllines; CVCL_GR30
DR   Wikidata; Q54906195
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D848 ! MM96
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   MM96E
AC   CVCL_D852
SY   96E; MM96 Early passage
DR   cancercelllines; CVCL_D852
DR   Wikidata; Q54906196
RX   PubMed=1422191;
RX   PubMed=2798324;
RX   PubMed=3127479;
CC   Characteristics: Lightly pigmented.
CC   Doubling time: 23.5 hours (PubMed=2798324).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D848 ! MM96
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   MM96L
AC   CVCL_D853
SY   96L; MM96 Late passage
DR   cancercelllines; CVCL_D853
DR   ChEMBL-Cells; CHEMBL3307555
DR   ChEMBL-Targets; CHEMBL614170
DR   Cosmic; 889038
DR   Cosmic; 1028798
DR   Cosmic; 2013935
DR   GEO; GSM170979
DR   GEO; GSM228385
DR   Progenetix; CVCL_D853
DR   PubChem_Cell_line; CVCL_D853
DR   Wikidata; Q54906197
RX   PubMed=1422191;
RX   PubMed=2798324;
RX   PubMed=3127479;
RX   PubMed=9466661;
RX   PubMed=15048078;
RX   PubMed=17516929;
CC   Doubling time: 22.0 hours (PubMed=2798324).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D848 ! MM96
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   MM9H-1
AC   CVCL_C6JG
DR   CCRID; 4201PAT-CCTCC01838
DR   Wikidata; Q116049793
RX   Patent=CN113201494B;
RX   PubMed=35666052;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202174.
CC   Population: Chinese.
CC   Doubling time: ~36 hours (PubMed=35666052).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   MMA
AC   CVCL_J769
DR   CLO; CLO_0007803
DR   ATCC; HB-78
DR   Wikidata; Q54906198
RX   PubMed=6179666;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 7
//
ID   MMab-1
AC   CVCL_D3E5
DR   Wikidata; Q127382835
RX   PubMed=23376717;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2 (Note=With p.Arg172Met).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   MMAc
AC   CVCL_5951
SY   MMAC
DR   CLO; CLO_0050087
DR   BioSample; SAMN03472870
DR   cancercelllines; CVCL_5951
DR   Cell_Model_Passport; SIDM00246
DR   DepMap; ACH-002084
DR   RCB; RCB0808
DR   Wikidata; Q54906200
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-002084).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=25877200; RCB=RCB0808
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12 (RCB=RCB0808)
ST   D13S317: 12 (PubMed=25877200)
ST   D16S539: 9,12 (RCB=RCB0808)
ST   D16S539: 12 (PubMed=25877200)
ST   D18S51: 14,19
ST   D19S433: 14
ST   D21S11: 31.2,32.2
ST   D2S1338: 18,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 21,22
ST   Penta D: 12
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   MMAc-SF
AC   CVCL_1420
SY   MMAC-SF; MMAc.SF; MMACSF; MMAc-Serum Free
DR   CLO; CLO_0037131
DR   CLO; CLO_0050088
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03481114
DR   cancercelllines; CVCL_1420
DR   Cell_Model_Passport; SIDM01242
DR   ChEMBL-Cells; CHEMBL3308270
DR   ChEMBL-Targets; CHEMBL2366196
DR   Cosmic; 925339
DR   Cosmic-CLP; 925339
DR   DepMap; ACH-002162
DR   EGA; EGAS00001000978
DR   GDSC; 925339
DR   GEO; GSM1670119
DR   IARC_TP53; 27564
DR   LINCS_HMS; 50999
DR   LINCS_LDP; LCL-1277
DR   PharmacoDB; MMACSF_945_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1420
DR   RCB; RCB1200
DR   Wikidata; Q54906202
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Group: Serum/protein free medium cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=925339; DepMap=ACH-002162).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.62%; Native American=0.05%; East Asian, North=77.21%; East Asian, South=20.11%; South Asian=1.76%; European, North=0%; European, South=0.25% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=925339; RCB=RCB1200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5951 ! MMAc
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   MMB-1
AC   CVCL_IW89
DR   Wikidata; Q54906203
RX   CelloPub=CLPUB00382;
RX   PubMed=6282844;
RX   PubMed=6287472;
RX   PubMed=6337052;
CC   Characteristics: Osteoblast-like cell line.
CC   Derived from site: In situ; Bone, cranium; UBERON=UBERON_0004766.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   MMC-1
AC   CVCL_U917
SY   MMC 1; Mouse Mastocytoma Cell line-1
DR   Wikidata; Q54906204
RX   PubMed=2578326;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: CXBI.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   MMC-14
AC   CVCL_U918
SY   MMC 14; Mouse Mastocytoma Cell line-14
DR   Wikidata; Q54906205
RX   PubMed=2578326;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   MMC-34
AC   CVCL_U919
SY   MMC 34; Mouse Mastocytoma Cell line-34
DR   Wikidata; Q54906206
RX   PubMed=2578326;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: CXBG.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   MMC-8
AC   CVCL_U920
SY   MMC 8; Mouse Mastocytoma Cell line-8
DR   Wikidata; Q54906207
RX   PubMed=2578326;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   MMC-E
AC   CVCL_R870
SY   MMC-E, clone 7; MMC-E clone 7
DR   ATCC; CRL-1575
DR   Wikidata; Q54906208
RX   PubMed=476648;
CC   Discontinued: ATCC; CRL-1575; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=10091; ! Mus musculus castaneus (Southeastern Asian house mouse)
OI   CVCL_R871 ! MMC-F
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MMC-F
AC   CVCL_R871
SY   MMC-F, clone B3
DR   ATCC; CRL-1577
DR   Wikidata; Q54906209
RX   PubMed=476648;
CC   Discontinued: ATCC; CRL-1577; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10091; ! Mus musculus castaneus (Southeastern Asian house mouse)
OI   CVCL_R870 ! MMC-E
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MMCi001-A
AC   CVCL_YM52
SY   MMCiPSC-001-A; MMC-iPSC-052B-02
DR   BioSamples; SAMEA6428920
DR   hPSCreg; MMCi001-A
DR   SKIP; SKIP005600
DR   Wikidata; Q95990331
RX   PubMed=31896484;
CC   From: Mackay Medical College; New Taipei City; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Val37Ile (c.109G>A); ClinVar=VCV000017023; Zygosity=Homozygous (PubMed=31896484).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   MMCi002-A
AC   CVCL_C1US
SY   MMC-iPSC-002-A
DR   BioSamples; SAMEA12546656
DR   hPSCreg; MMCi002-A
DR   Wikidata; Q114312310
CC   From: Mackay Medical College; New Taipei City; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MMD HEM#30
AC   CVCL_A4GC
DR   SKIP; SKIP002963
DR   Wikidata; Q105510160
RX   PubMed=27934594;
CC   From: CIBIO, University of Trento; Trento; Italy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   MMD ISCH#6
AC   CVCL_A4GD
DR   SKIP; SKIP002964
DR   Wikidata; Q105510165
RX   PubMed=27934593;
CC   From: CIBIO, University of Trento; Trento; Italy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84895; Moyamoya disease
DI   ORDO; Orphanet_2573; Moyamoya disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   MMDD1
AC   CVCL_8112
SY   MMDD-1; Mouse Macula Densa-Derived 1
DR   BTO; BTO_0003946
DR   Wikidata; Q54906210
RX   PubMed=10982805;
WW   Provider; NIH OTT; E-234-2009/0; https://web.archive.org/web/20150922131728/http://www.ott.nih.gov/erma/mouse-macula-densa-cell-line
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, macula densa; UBERON=UBERON_0002335.
CC   Breed/subspecies: C57BL/6J-TgN(SV)7Bri transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   MMF-1
AC   CVCL_M828
DR   Wikidata; Q54906212
RX   PubMed=7586821;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=7586821).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   MMF-2
AC   CVCL_VG64
DR   Wikidata; Q54906213
RX   PubMed=7586821;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M828 ! MMF-1
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MMF-3
AC   CVCL_VG65
DR   Wikidata; Q54906214
RX   PubMed=7586821;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M828 ! MMF-1
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MMG1
AC   CVCL_H198
SY   MMG-1
DR   CGH-DB; 9284-4
DR   Cosmic; 905198
DR   Cosmic; 1598056
DR   Cosmic; 2144977
DR   Wikidata; Q54906215
RX   PubMed=15160996;
RX   PubMed=15467732;
RX   PubMed=19035443;
RX   PubMed=22578220;
CC   From: Department of Dermatology, Gifu University; Gifu; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   MMG2
AC   CVCL_S559
DR   Wikidata; Q54906219
RX   PubMed=8097520;
CC   From: Department of Dermatology, Gifu University; Gifu; Japan.
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   MMG3
AC   CVCL_H729
SY   MMG-3
DR   cancercelllines; CVCL_H729
DR   CGH-DB; 9283-4
DR   Cosmic; 905197
DR   Wikidata; Q54906220
RX   PubMed=15160996;
RX   PubMed=15467732;
CC   From: Department of Dermatology, Gifu University; Gifu; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15467732).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   MMGT1
AC   CVCL_9U35
DR   Wikidata; Q54906221
RX   PubMed=8034755;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   MMGT12
AC   CVCL_9U36
SY   MMGT-12
DR   ChEMBL-Cells; CHEMBL3988381
DR   PubChem_Cell_line; CVCL_9U36
DR   Wikidata; Q54906222
RX   PubMed=8034755;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9U35 ! MMGT1
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   MMGT16
AC   CVCL_9U37
SY   MMGT-16
DR   Wikidata; Q54906223
RX   PubMed=8034755;
RX   PubMed=11162555;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9U35 ! MMGT1
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   MMH-D2
AC   CVCL_B5WR
SY   MMH D2; D2; Met Murine Hepatocytes-D2
DR   Wikidata; Q112129336
RX   PubMed=9034332;
RX   PubMed=9817765;
RX   PubMed=9828230;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MMH-D3
AC   CVCL_X374
SY   MMH D3; D3; Met Murine Hepatocytes-D3
DR   Wikidata; Q54906224
RX   PubMed=9034332;
RX   PubMed=9817765;
RX   PubMed=9828230;
RX   PubMed=10457350;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MMH-D3
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   MMH-D6
AC   CVCL_B5WS
SY   MMH D6; D6; Met Murine Hepatocytes-D6
DR   Wikidata; Q112129337
RX   PubMed=9034332;
RX   PubMed=9828230;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   6D
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MMH-E14
AC   CVCL_B5WT
SY   MMH E14; E14; Met Murine Hepatocytes-E14
DR   Wikidata; Q112129338
RX   PubMed=9034332;
RX   PubMed=9817765;
RX   PubMed=9828230;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MMH-E14 ep.
AC   CVCL_B5WU
SY   MMH E14 ep.; E14 ep.; Met Murine Hepatocytes-E14 epithelial clone
DR   Wikidata; Q112129340
RX   PubMed=9817765;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5WT ! MMH-E14
SX   Sex unspecified
AG   14FD
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MMH-E14 pal.
AC   CVCL_B5WV
SY   MMH E14 pal.; E14 pal.; Met Murine Hepatocytes-E14 palmitate clone
DR   Wikidata; Q112129341
RX   PubMed=9817765;
CC   Characteristics: Clone that can spread with multiple projections (PubMed=9817765).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5WT ! MMH-E14
SX   Sex unspecified
AG   14FD
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MMJ-2
AC   CVCL_W450
AS   CVCL_W45O
DR   Wikidata; Q54906225
RX   PubMed=8652447;
CC   Population: Japanese.
CC   Doubling time: 12-15 hours (Note=At 6th passage) (PubMed=8652447).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 3
//
ID   MML-1 [Human leukemia]
AC   CVCL_9Q62
SY   MML1
DR   Cosmic; 787455
DR   Cosmic; 975272
DR   Cosmic; 1281330
DR   Wikidata; Q54906226
RX   PubMed=7579353;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   MML-1 [Human melanoma]
AC   CVCL_6004
SY   MML1
DR   cancercelllines; CVCL_6004
DR   CLS; 300288
DR   Wikidata; Q54906227
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CLS=300288).
ST   Source(s): CLS=300288
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D18S51: 13,14
ST   D21S11: 31
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 14
ST   Penta E: 7,11
ST   TH01: 6,10
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   MML-6838-Cl2
AC   CVCL_JL84
SY   MML-6838-CL2
DR   Wikidata; Q54906228
RX   PubMed=28395797;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   MMLAL
AC   CVCL_U249
DR   Wikidata; Q54906229
RX   PubMed=24330858;
CC   Population: Chinese.
CC   Characteristics: Produces IgG lambda.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=24330858).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   MMM [Mouse]
AC   CVCL_S557
DR   Wikidata; Q29582815
RX   PubMed=16683986;
CC   Characteristics: Very effective in supporting the growth of human embryonic stem cells.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MMM [Mus molossinus]
AC   CVCL_Y453
DR   ATCC; CRL-6439
DR   Wikidata; Q29582694
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6439; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=57486; ! Mus musculus molossinus (Japanese house mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   MMMbz
AC   CVCL_S558
DR   ABM; T2028
DR   Kerafast; EF3004
DR   Wikidata; Q54906230
RX   PubMed=16683986;
CC   Characteristics: Very effective in supporting the growth of human embryonic stem cells (Kerafast=EF3004).
CC   Doubling time: 16 hours (PubMed=16683986).
CC   Selected for resistance to: ChEBI; CHEBI_22905; Blasticidin.
CC   Selected for resistance to: ChEBI; CHEBI_75046; Phleomycin D1 (Zeocin).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S557 ! MMM [Mouse]
SX   Sex unspecified
AG   12-13FD
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   MMNK-1
AC   CVCL_M266
SY   MMNK1
DR   JCRB; JCRB1554
DR   Wikidata; Q54906231
RX   PubMed=14966424;
RX   PubMed=21871105;
RX   PubMed=27231123;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8126.
CC   Population: Japanese.
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype.
CC   Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1554
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 11,15
ST   D7S820: 8,9
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9131 ! OUMS-21 [1993]
SX   Sex unspecified
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 23
//
ID   mMPL-32D
AC   CVCL_D6I3
DR   Wikidata; Q127382836
RX   PubMed=32417303;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97076; Mpl (Note=With a N-terminal HA tag).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6G54 ! 32Dcl23
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   MMPR-10
AC   CVCL_UV19
DR   Wikidata; Q95990347
RX   DOI=10.1002/arch.940030307;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z618 ! LT C-7
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   MMPR-11
AC   CVCL_UV20
DR   Wikidata; Q95990348
RX   DOI=10.1002/arch.940030307;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z618 ! LT C-7
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   MMPR-12
AC   CVCL_UV21
DR   Wikidata; Q95990350
RX   DOI=10.1002/arch.940030307;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z618 ! LT C-7
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   MMPR-21
AC   CVCL_UV22
DR   Wikidata; Q95990351
RX   DOI=10.1002/arch.940030307;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z618 ! LT C-7
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   MMQ
AC   CVCL_2117
DR   CLO; CLO_0007804
DR   ATCC; CRL-10609
DR   CCRID; 1101RAT-PUMC000081
DR   ChEMBL-Cells; CHEMBL3307313
DR   ChEMBL-Targets; CHEMBL614171
DR   CLS; 300498
DR   DSMZ; ACC-484
DR   DSMZCellDive; ACC-484
DR   KCB; KCB 200845YJ
DR   PubChem_Cell_line; CVCL_2117
DR   Wikidata; Q54906232
RX   Patent=US5510260;
RX   PubMed=2844508;
RX   PubMed=15541569;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10609.
CC   Doubling time: ~48 hors (DSMZ=ACC-484).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_U363 ! 235-1
SX   Sex unspecified
AG   5D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   MMR
AC   CVCL_E779
DR   IHW; 9w 0802
DR   Wikidata; Q54906233
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*03,24; B*07; C*w07 (IHW=9w 0802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   MMRU/CR1
AC   CVCL_WV59
SY   CR1
DR   Wikidata; Q95990353
RX   PubMed=18497997;
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H242 ! MM-RU
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   MMRU/CR2
AC   CVCL_WV60
SY   CR2
DR   Wikidata; Q95990354
RX   PubMed=18497997;
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H242 ! MM-RU
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   MMSr-1
AC   CVCL_5630
DR   Wikidata; Q54906235
RX   PubMed=3041621;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5634 ! Don D-6
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MMSV-1
AC   CVCL_D5KR
DR   Wikidata; Q127382837
RX   PubMed=2161799;
CC   Doubling time: 50 hours (PubMed=2161799).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Obtained from pooled samples of early lactation milks (PubMed=2161799).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MMT-060562
AC   CVCL_4241
SY   MMT 060562; MMT060562
DR   BTO; BTO_0006041
DR   CLO; CLO_0007806
DR   CLDB; cl3505
DR   ATCC; CCL-51
DR   ATCC; CRL-6337
DR   ECACC; 90111911
DR   JCRB; JCRB9077
DR   Wikidata; Q54906236
RX   DOI=10.1007/BF02618370;
RX   DOI=10.18413/2658-6533-2020-7-1-0-1;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Characteristics: Tumorigenic in BALB/c mice (ATCC=CCL-51).
CC   Discontinued: ATCC; CRL-6337; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6 x Af.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   MMT-060562/CMV-Luc #3
AC   CVCL_JG35
SY   MMT 060562 CMV-Luc #3
DR   JCRB; JCRB1688
DR   JCRB; NIHS1046
DR   Wikidata; Q54906237
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1688).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; JCRB1688; probable.
CC   Discontinued: JCRB; NIHS1046; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6 x Af.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4241 ! MMT-060562
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   mMTSV-54
AC   CVCL_JL67
DR   Wikidata; Q54906238
RX   PubMed=9185961;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMtSV-neo).
CC   Derived from site: In situ; Fetal synovial membrane; UBERON=UBERON_0002018.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_JL68 ! mMTSV-93
OI   CVCL_JL66 ! TIGEF
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   mMTSV-93
AC   CVCL_JL68
DR   Wikidata; Q54906239
RX   PubMed=9185961;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMtSV-neo).
CC   Derived from site: In situ; Fetal synovial membrane; UBERON=UBERON_0002018.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_JL67 ! mMTSV-54
OI   CVCL_JL66 ! TIGEF
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   MMTV-cmyc 116br
AC   CVCL_S720
SY   116br
DR   SKY/M-FISH/CGH; 2859
DR   Wikidata; Q54906240
RX   PubMed=10379871;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMTV-cmyc 66a7
AC   CVCL_S722
SY   66a7
DR   SKY/M-FISH/CGH; 2858
DR   Wikidata; Q54906242
RX   PubMed=10379871;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMTV-cmyc 67a5
AC   CVCL_S721
SY   67a5
DR   SKY/M-FISH/CGH; 2857
DR   Wikidata; Q54906241
RX   PubMed=10379871;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMTV-cmyc myc Tg myc3
AC   CVCL_S723
SY   MMTV-cmyc myc Tg myc 3; myc Tg myc3
DR   SKY/M-FISH/CGH; 23
DR   Wikidata; Q54906243
RX   PubMed=10379871;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMTV-cmyc myc Tg p53+/-67a3
AC   CVCL_S724
DR   SKY/M-FISH/CGH; 2856
DR   Wikidata; Q54906244
RX   PubMed=10379871;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMTV-cmyc myc6
AC   CVCL_S725
SY   myc 6
DR   SKY/M-FISH/CGH; 24
DR   Wikidata; Q54906245
RX   PubMed=10379871;
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMTV-cmyc myc7
AC   CVCL_S726
SY   myc 7
DR   SKY/M-FISH/CGH; 25
DR   Wikidata; Q54906246
RX   PubMed=10379871;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMTV-cmyc myc83
AC   CVCL_S727
SY   myc 83
DR   SKY/M-FISH/CGH; 2855
DR   Wikidata; Q54906247
RX   PubMed=10379871;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: MMTV/c-Myc.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   MMU
AC   CVCL_E780
DR   dbMHC; 48974
DR   IHW; IHW09357
DR   IPD-IMGT/HLA; 11089
DR   Wikidata; Q54906248
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*11:01:01; B*35,67; C*07,09; DPB1*03:01,13:01; DQB1*03:02,06:02; DRB1*04:07,15:01 (IPD-IMGT/HLA=11089).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   MMU00343IN
AC   CVCL_E173
DR   Wikidata; Q54906249
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MMU00344IN
AC   CVCL_E174
DR   Wikidata; Q54906250
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MMU00345IN
AC   CVCL_E175
DR   Wikidata; Q54906251
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MMU00346IN
AC   CVCL_E176
DR   Wikidata; Q54906252
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MMU00347IN
AC   CVCL_E177
DR   Wikidata; Q54906253
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MMU00348IN
AC   CVCL_E178
DR   Wikidata; Q54906254
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MMY-S2
AC   CVCL_A9HM
SY   BMS2
DR   CCRID; 5301MAM-KCB04044ZJ
DR   KCB; KCB 200444ZJ
DR   Wikidata; Q108820953
CC   Group: Bat cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=51298; ! Myotis myotis (Greater mouse-eared bat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MN-1
AC   CVCL_W126
DR   Wikidata; Q54906255
RX   DOI=10.1063/1.1291135;
RX   DOI=10.5795/jjscc.32.1;
RX   PubMed=8718548;
RX   PubMed=15677628;
RX   PubMed=19154404;
RX   PubMed=22246397;
CC   Population: Japanese.
CC   Doubling time: 29.4 hours (Note=At 47th passage) (DOI=10.5795/jjscc.32.1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   MN-11
AC   CVCL_3752
SY   MN-11 [Mutatect]
DR   CLO; CLO_0007807
DR   ATCC; CRL-2800
DR   BCRC; 60560
DR   Wikidata; Q54906256
RX   PubMed=7577474;
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4982 ! MC-TGS17-51
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   MN-1112
AC   CVCL_Z616
SY   MN1112
DR   Wikidata; Q54906257
RX   PubMed=8598320;
RX   PubMed=17374419;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=8598320).
CC   Derived from site: Metastatic; Right subclavius, hypodermis; UBERON=UBERON_0008779+UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   MN-1A
AC   CVCL_A1GU
DR   Wikidata; Q102114544
RX   DOI=10.5795/jjscc.32.1;
CC   Population: Japanese.
CC   Doubling time: 40.0 hours (Note=At 22th passage) (DOI=10.5795/jjscc.32.1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W126 ! MN-1
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MN-1B
AC   CVCL_A1GV
DR   Wikidata; Q102114545
RX   DOI=10.5795/jjscc.32.1;
CC   Population: Japanese.
CC   Doubling time: 32.0 hours (Note=At 9th passage) (DOI=10.5795/jjscc.32.1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W126 ! MN-1
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MN-2
AC   CVCL_E781
DR   dbMHC; 48975
DR   IHW; IHW09331
DR   IPD-IMGT/HLA; 11090
DR   Wikidata; Q54906258
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02; B*07; C*07; DRB1*16:01:01; DRB5*02:02 (IPD-IMGT/HLA=11090).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   MN-60
AC   CVCL_1421
SY   MN 60; MN60
DR   CLO; CLO_0007808
DR   CLDB; cl3506
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473415
DR   cancercelllines; CVCL_1421
DR   Cell_Model_Passport; SIDM00438
DR   ChEMBL-Cells; CHEMBL3308532
DR   ChEMBL-Targets; CHEMBL2366070
DR   Cosmic; 908143
DR   Cosmic; 1012093
DR   Cosmic-CLP; 908143
DR   DepMap; ACH-002275
DR   DSMZ; ACC-138
DR   DSMZCellDive; ACC-138
DR   EGA; EGAS00001000978
DR   GDSC; 908143
DR   GEO; GSM1670120
DR   GEO; GSM5137727
DR   IARC_TP53; 21509
DR   LINCS_LDP; LCL-1010
DR   PharmacoDB; MN60_946_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1421
DR   Wikidata; Q54906259
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6296550;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=24590883;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: 25 hours (PubMed=6296550); ~48-60 hours (DSMZ=ACC-138).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (DepMap=ACH-002275).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.18%; Native American=0.16%; East Asian, North=2.87%; East Asian, South=0.48%; South Asian=0.82%; European, North=78.96%; European, South=16.53% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Cosmic-CLP=908143; DSMZ=ACC-138
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17,18
ST   D19S433: 14,15
ST   D21S11: 27,28,29,30
ST   D2S1338: 17,24
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   Penta D: 13,15
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   MN-R
AC   CVCL_RW98
DR   CCLV; CCLV-RIE 0282
DR   Wikidata; Q54906263
RX   PubMed=24973239;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MN12
AC   CVCL_C0PK
SY   Mn12
DR   Wikidata; Q112930120
RX   DOI=10.1016/B978-0-7506-0421-5.50077-5;
RX   PubMed=7764662;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9R3Q6; Neisseria meningitidis serosubtype P1.16 major outer membrane protein P.IA (porA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 4
//
ID   MN14C11.6
AC   CVCL_E7DX
DR   ABCD; ABCD_AE748
RX   PubMed=3152545;
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P57041; Neisseria meningitidis serogroup A / serotype 4A (strain DSM 15465 / Z2491) porA (Note=Reacts with serosubtype 1.7. Immunized with a pool of proteins made up from three different meningococcal strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   MN14C2.3
AC   CVCL_E7Q4
RX   PubMed=3152545;
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype 1.1 porA (Note=Immunized with proteins from three different strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   MN16
AC   CVCL_AP63
SY   MN 16
DR   Wikidata; Q54906264
RX   PubMed=23974965;
CC   Characteristics: Highly expresses osteocalcin and type I collagen (PubMed=23974965).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   MN16C13F4
AC   CVCL_E7RF
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.2 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN19D6.13
AC   CVCL_E7Q5
SY   D6.13; D6-13
RX   PubMed=3152545;
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype 1.6 porA (Note=Immunized with proteins from three different strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   MN20
AC   CVCL_UF91
DR   JCRB; JCRB1722
DR   Wikidata; Q95990412
RX   PubMed=6272292;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Unexplicit; Ex16-18del (nsv1067857); ClinVar=VCV000003711; Zygosity=Homozygous (PubMed=6272292).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1722
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   MN20B9.34
AC   CVCL_E7RG
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.4 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN20F4.17
AC   CVCL_E7RJ
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.10 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN21A7.10
AC   CVCL_E7RK
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.12 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN21G3.17
AC   CVCL_E7RL
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.14 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN22A19.9
AC   CVCL_E7RH
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.5 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN3C5C
AC   CVCL_E7RM
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.15 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN4-91-6.E2
AC   CVCL_L563
DR   ECACC; 89062111
DR   Wikidata; Q54906265
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 4
//
ID   MN5A10F
AC   CVCL_E7RI
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.9 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN5C11G
AC   CVCL_E7RN
RX   PubMed=7719916;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Neisseria meningitidis serosubtype P1.16 outer membrane protein porA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MN7
AC   CVCL_WS46
DR   Wikidata; Q95990414
RX   CelloPub=CLPUB00511;
RX   PubMed=1571849;
RX   PubMed=8079665;
RX   PubMed=9813886;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Osteogenic stromal cell line. Can mineralize in vitro when cultured on a collagen type I matrix.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: N2deltaFos (Note=Derivative of Moloney murine leukemia virus (MoMuLV)).
CC   Omics: Proteomics; Subcellular; Secretome; 2DE.
CC   Anecdotal: Have been flown in space on Cosmos-2229 (Bion-10) to study growth microgravity (CelloPub=CLPUB00511; PubMed=9813886).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 10
//
ID   MN9D
AC   CVCL_M067
SY   MN-9D
DR   BTO; BTO_0003945
DR   EFO; EFO_0006455
DR   Lonza; 979
DR   Millipore; SCC281
DR   Wikidata; Q54906266
RX   PubMed=1357658;
RX   PubMed=1913182;
RX   PubMed=17028430;
CC   Characteristics: Extensively used to model dopaminergic neurons and to test mechanisms and potential therapeutics relevant to the loss of DA neurons in Parkinson's disease (Millipore=SCC281).
CC   Characteristics: Fusion of N18TG2 with rostral mesencephalic neurons from a 14-day-old C57BL/6J mouse embryo (PubMed=1913182).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
ST   Source(s): Millipore=SCC281
ST   Mouse STR 1-1: 11,17
ST   Mouse STR 1-2: 17,19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 20.3,22.3
ST   Mouse STR 5-5: 15,17
ST   Mouse STR 6-4: 18,20
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 15,16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2,17.2,18.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 16,22
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 25,28,29
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   MNB-T1
AC   CVCL_E9XF
RX   PubMed=2790751;
RX   PubMed=3339127;
CC   Characteristics: Highly malignant. Derived from the MNB transplantable tumor (PubMed=3339127).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_4343 ! C-1300
OI   CVCL_E9XG ! MNB-T2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MNB-T2
AC   CVCL_E9XG
RX   PubMed=2790751;
RX   PubMed=3339127;
CC   Characteristics: Low malignancy. Derived from the MNB transplantable tumor (PubMed=3339127).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_4343 ! C-1300
OI   CVCL_E9XF ! MNB-T1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MNB10
AC   CVCL_IQ92
SY   MNB 10
DR   Wikidata; Q54906267
RX   Patent=US7915004;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 04001.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P26022; Human PTX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   MNDINSi001-A
AC   CVCL_A9YK
SY   hiPSC-ins8
DR   Wikidata; Q102114546
RX   PubMed=32739878;
CC   From: Endocrinology Research Centre; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6081; INS; Simple; c.188-31G>A; ClinVar=VCV000211186; Zygosity=Heterozygous (PubMed=32739878).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114902; Permanent neonatal diabetes mellitus
DI   ORDO; Orphanet_99885; Permanent neonatal diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MNG-Mel
AC   CVCL_VQ10
SY   MNG
DR   Cosmic; 1295329
DR   Wikidata; Q95990417
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 6
//
ID   mNI-11
AC   CVCL_C8BS
DR   Wikidata; Q123033079
RX   PubMed=8656055;
RX   PubMed=11994479;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NPY3; Human CD93.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   mNI-58
AC   CVCL_C8BR
SY   NI-58
DR   Wikidata; Q123033080
RX   PubMed=8315809;
RX   PubMed=8544343;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   MNK-1
AC   CVCL_IZ71
DR   Wikidata; Q54906269
RX   PubMed=10229828;
RX   PubMed=25138665;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Fetal thymocyte; CL=CL_0002404.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   MNK-3
AC   CVCL_IZ72
SY   MNK3
DR   Wikidata; Q54906270
RX   PubMed=25138665;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Fetal thymocyte; CL=CL_0002404.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IZ71 ! MNK-1
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   mNKES
AC   CVCL_E8V7
RX   PubMed=9083889;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human 55 kDa adhesion-associated antigen.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MNNG/HOS Cl #5
AC   CVCL_0439
AS   CVCL_3952
SY   MNNG/HOS; MNNG-HOS; MNNG HOS; HOS-MNNG; HOS/MNNG; MNNGHOS; MNNG-HOS (Cl#5); MNNG/HOS Clone F-5; MNNG; R-1059-D; TE85; Te85; TE-85; HOS-TE85; Hos TE-85; HOS TE 85; HOS TE85; HOS (TE85); HOS(TE85); HOS (TE85, Clone F5); MNNG-HOS (TE 85, clone F-5); TE-85 clone F-5; HOS-Te85; TE 85.T; TE 85 ClF-5; HOS-TE85 clone 5; TE-85 clone 5
DR   BTO; BTO_0005416
DR   CLO; CLO_0003796
DR   CLO; CLO_0007813
DR   CLO; CLO_0007814
DR   EFO; EFO_0002866
DR   MCCL; MCC:0000334
DR   CLDB; cl1703
DR   CLDB; cl1704
DR   CLDB; cl1705
DR   CLDB; cl3510
DR   ATCC; CRL-1547
DR   ATCC; CRL-7734
DR   ATCC; CRL-7735
DR   cancercelllines; CVCL_0439
DR   CCRID; 3101HUMTCHu167
DR   CCRID; 5301HUM-KCB16037YJ
DR   ChEMBL-Cells; CHEMBL3307282
DR   ChEMBL-Targets; CHEMBL614038
DR   CLS; 300289
DR   Cosmic; 1044084
DR   Cosmic; 1074402
DR   Cosmic; 1529901
DR   Cosmic; 2301584
DR   ECACC; 87070201
DR   GEO; GSM879219
DR   GEO; GSM1915008
DR   GEO; GSM1915009
DR   GEO; GSM1915010
DR   GEO; GSM1915011
DR   GEO; GSM1915025
DR   GEO; GSM1915026
DR   GEO; GSM1915027
DR   GEO; GSM1915028
DR   GEO; GSM1915029
DR   GEO; GSM2635307
DR   GEO; GSM2635308
DR   IARC_TP53; 25022
DR   KCB; KCB 2016037YJ
DR   KCLB; 21543
DR   Progenetix; CVCL_0439
DR   PubChem_Cell_line; CVCL_0439
DR   Wikidata; Q54906271
RX   PubMed=265298;
RX   PubMed=833871;
RX   PubMed=1385192;
RX   PubMed=2823272;
RX   PubMed=2978869;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6254071;
RX   PubMed=6269117;
RX   PubMed=6575958;
RX   PubMed=6590967;
RX   PubMed=7873286;
RX   PubMed=12645653;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=22282976;
RX   PubMed=23144859;
RX   PubMed=24136885;
RX   PubMed=26320182;
RX   PubMed=28196595;
RX   PubMed=29334376;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (PubMed=21519327).
CC   HLA typing: A*02:11:01; B*52:01:01; C*12:02:02; DPB1*02:01:02; DQA1*01:02:02,01:03:01; DQB1*05:02:01,05:03:01; DRB1*15:02:01G,16:02:01 (CLS=300289).
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (PubMed=19787792).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: Cell line where the MET (MNNG-HOS transforming) oncogene was first identified (PubMed=6590967).
CC   Misspelling: MNNG/HOSC1#5; CCRID=5301HUM-KCB16037YJ.
CC   Discontinued: ATCC; CRL-7734; true.
CC   Discontinued: ATCC; CRL-7735; true.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-1547; CCRID=5301HUM-KCB16037YJ; CLS=300289; ECACC=87070201; KCLB=21543; PubMed=19787792
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31.2
ST   D2S1338: 24 (ATCC=CRL-1547)
ST   D2S1338: 24,25 (PubMed=19787792)
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 11,14 (ATCC=CRL-1547; PubMed=19787792)
ST   D8S1179: 14 (CLS=300289)
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   SE33: 20,21
ST   TH01: 6
ST   TPOX: 8,11 (ATCC=CRL-1547; CCRID=5301HUM-KCB16037YJ; CLS=300289; ECACC=87070201; KCLB=21543)
ST   TPOX: 11 (PubMed=19787792)
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 37
//
ID   MNNG/HOS/DXR1000
AC   CVCL_9U38
DR   cancercelllines; CVCL_9U38
DR   Wikidata; Q54906272
RX   PubMed=10854558;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 14
//
ID   MNR-01
AC   CVCL_WA91
SY   MeNtal Retardation-01
DR   IBRC; C10840
DR   Wikidata; Q95990421
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-02
AC   CVCL_WA92
SY   MeNtal Retardation-02
DR   IBRC; C10842
DR   Wikidata; Q95990423
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-03
AC   CVCL_WA93
SY   MeNtal Retardation-03
DR   IBRC; C10827
DR   Wikidata; Q95990424
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-04
AC   CVCL_WA94
SY   MeNtal Retardation-04
DR   IBRC; C10855
DR   Wikidata; Q95990426
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-05
AC   CVCL_WA95
SY   MeNtal Retardation-05
DR   IBRC; C10854
DR   Wikidata; Q95990427
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-06
AC   CVCL_WA96
SY   MeNtal Retardation-06
DR   IBRC; C11141
DR   Wikidata; Q95990429
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-07
AC   CVCL_WA97
SY   MeNtal Retardation-07
DR   IBRC; C11149
DR   Wikidata; Q95990430
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-08
AC   CVCL_WA98
SY   MeNtal Retardation-08
DR   IBRC; C11155
DR   Wikidata; Q95990431
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNR-09
AC   CVCL_WA99
SY   MeNtal Retardation-09
DR   IBRC; C11160
DR   Wikidata; Q95990433
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 5
//
ID   MNT-1
AC   CVCL_5624
SY   MNT1; MNT
DR   BTO; BTO_0002946
DR   EFO; EFO_0022406
DR   ATCC; CRL-3450
DR   Wikidata; Q54906273
RX   PubMed=1701342;
RX   PubMed=1706743;
RX   PubMed=11266471;
RX   PubMed=12417263;
RX   PubMed=25950383;
RX   PubMed=28940687;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-545.html
CC   Characteristics: Highly pigmented.
CC   Virology: Susceptible to infection by human metapneumovirus (MNPV) (PubMed=28940687).
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3450
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10
ST   D5S818: 13
ST   D7S820: 9
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5625 ! MNT-3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   MNT-3
AC   CVCL_5625
SY   MNT3
DR   Wikidata; Q54906274
RX   PubMed=1701342;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5624 ! MNT-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   MNUEC/HL-027
AC   CVCL_B6Z4
SY   Mouse Normal Uterine Epithelial Cell/HL-027
DR   CCRID; 4201PAT-CCTCC00810
DR   Wikidata; Q112129342
RX   Patent=CN110951672B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015108.
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MNZTASi001-A
AC   CVCL_B5IS
SY   MS_0004; MS_0004.2; MS 0004-iPSC clone 2
DR   BioSamples; SAMEA112762629
DR   hPSCreg; MNZTASi001-A
DR   Wikidata; Q110433060
RX   PubMed=34678664;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34678664
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 30,31
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   MNZTASi002-A
AC   CVCL_C0K2
SY   MS_0001; MS1
DR   BioSamples; SAMEA14387699
DR   hPSCreg; MNZTASi002-A
DR   Wikidata; Q112930121
RX   PubMed=35679759;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   MNZTASi003-A
AC   CVCL_C0K3
SY   MS_0002; MS2
DR   BioSamples; SAMEA112857421
DR   hPSCreg; MNZTASi003-A
DR   Wikidata; Q112930122
RX   PubMed=35679759;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   MNZTASi004-A
AC   CVCL_C0K4
SY   MS_0003; MS3
DR   BioSamples; SAMEA112866622
DR   hPSCreg; MNZTASi004-A
DR   Wikidata; Q112930123
RX   PubMed=35679759;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   MNZTASi005-A
AC   CVCL_C0K5
SY   MS_0006; MS6
DR   BioSamples; SAMEA112866623
DR   hPSCreg; MNZTASi005-A
DR   Wikidata; Q112930124
RX   PubMed=35679759;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   MNZTASi006-A
AC   CVCL_D0IQ
SY   MS_0005
DR   hPSCreg; MNZTASi006-A
DR   Wikidata; Q123033081
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi007-A
AC   CVCL_D0IR
SY   MS_0007
DR   BioSamples; SAMEA112937908
DR   hPSCreg; MNZTASi007-A
DR   Wikidata; Q123033082
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi008-A
AC   CVCL_D0IS
DR   hPSCreg; MNZTASi008-A
DR   Wikidata; Q123033083
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MNZTASi009-A
AC   CVCL_D0IT
SY   MS_0009.1
DR   BioSamples; SAMEA114639786
DR   hPSCreg; MNZTASi009-A
DR   Wikidata; Q123033084
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IU ! MNZTASi009-B
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi009-B
AC   CVCL_D0IU
SY   MS_0009.2
DR   BioSamples; SAMEA114639787
DR   hPSCreg; MNZTASi009-B
DR   Wikidata; Q123033085
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0IT ! MNZTASi009-A
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi010-A
AC   CVCL_D0IV
SY   MS_0010
DR   BioSamples; SAMEA112937909
DR   hPSCreg; MNZTASi010-A
DR   Wikidata; Q123033086
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi011-A
AC   CVCL_D0IW
DR   hPSCreg; MNZTASi011-A
DR   Wikidata; Q123033087
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MNZTASi012-A
AC   CVCL_D0IX
DR   hPSCreg; MNZTASi012-A
DR   Wikidata; Q123033088
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MNZTASi013-A
AC   CVCL_D0IY
DR   hPSCreg; MNZTASi013-A
DR   Wikidata; Q123033089
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MNZTASi014-A
AC   CVCL_D0IZ
SY   MS_0014
DR   BioSamples; SAMEA112937910
DR   hPSCreg; MNZTASi014-A
DR   Wikidata; Q123033090
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi015-A
AC   CVCL_D0J0
SY   MS_0015.1
DR   BioSamples; SAMEA115863643
DR   hPSCreg; MNZTASi015-A
DR   Wikidata; Q123033091
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0J1 ! MNZTASi015-B
OI   CVCL_D0J2 ! MNZTASi015-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MNZTASi015-B
AC   CVCL_D0J1
SY   MS_0015.2
DR   BioSamples; SAMEA115863644
DR   hPSCreg; MNZTASi015-B
DR   Wikidata; Q123033092
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0J0 ! MNZTASi015-A
OI   CVCL_D0J2 ! MNZTASi015-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MNZTASi015-C
AC   CVCL_D0J2
SY   MS_0015.3
DR   BioSamples; SAMEA115863645
DR   hPSCreg; MNZTASi015-C
DR   Wikidata; Q123033093
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0J0 ! MNZTASi015-A
OI   CVCL_D0J1 ! MNZTASi015-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MNZTASi016-A
AC   CVCL_D0J3
SY   MS_0016
DR   BioSamples; SAMEA112937911
DR   hPSCreg; MNZTASi016-A
DR   Wikidata; Q123033095
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi017-A
AC   CVCL_D0J4
SY   MS_0017
DR   BioSamples; SAMEA112937912
DR   hPSCreg; MNZTASi017-A
DR   Wikidata; Q123033096
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi018-A
AC   CVCL_D0J5
SY   MS_0018
DR   BioSamples; SAMEA112937913
DR   hPSCreg; MNZTASi018-A
DR   Wikidata; Q123033097
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi019-A
AC   CVCL_D0J6
SY   MS_0019
DR   BioSamples; SAMEA115160194
DR   hPSCreg; MNZTASi019-A
DR   Wikidata; Q123033098
RX   PubMed=38433209;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi020-A
AC   CVCL_D0J7
SY   MS_0020.1
DR   BioSamples; SAMEA114639788
DR   hPSCreg; MNZTASi020-A
DR   Wikidata; Q123033099
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0J8 ! MNZTASi020-B
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi020-B
AC   CVCL_D0J8
SY   MS_0020.2
DR   BioSamples; SAMEA114639789
DR   hPSCreg; MNZTASi020-B
DR   Wikidata; Q123033100
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0J7 ! MNZTASi020-A
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi021-A
AC   CVCL_D0J9
SY   MS_0021
DR   BioSamples; SAMEA115160195
DR   hPSCreg; MNZTASi021-A
DR   Wikidata; Q123033101
RX   PubMed=38433209;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi022-A
AC   CVCL_D0JA
SY   MS_0022
DR   BioSamples; SAMEA115160196
DR   hPSCreg; MNZTASi022-A
DR   Wikidata; Q123033102
RX   PubMed=38433209;
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MNZTASi023-A
AC   CVCL_E4XW
SY   MS_0023
DR   hPSCreg; MNZTASi023-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MNZTASi024-A
AC   CVCL_E4XX
SY   MS_0024
DR   hPSCreg; MNZTASi024-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MNZTASi025-A
AC   CVCL_E4XY
SY   MS_0025
DR   hPSCreg; MNZTASi025-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MNZTASi026-A
AC   CVCL_E4XZ
SY   MS_0026
DR   hPSCreg; MNZTASi026-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MNZTASi027-A
AC   CVCL_E4Y0
SY   MS_0027
DR   hPSCreg; MNZTASi027-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MNZTASi028-A
AC   CVCL_E4Y1
SY   MS_0028
DR   hPSCreg; MNZTASi028-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MNZTASi029-A
AC   CVCL_E4Y2
SY   MS_0029.1
DR   BioSamples; SAMEA115863646
DR   hPSCreg; MNZTASi029-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y3 ! MNZTASi029-B
OI   CVCL_E4Y4 ! MNZTASi029-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi029-B
AC   CVCL_E4Y3
SY   MS_0029.2
DR   BioSamples; SAMEA115863647
DR   hPSCreg; MNZTASi029-B
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y2 ! MNZTASi029-A
OI   CVCL_E4Y4 ! MNZTASi029-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi029-C
AC   CVCL_E4Y4
SY   MS_0029.3
DR   BioSamples; SAMEA115873416
DR   hPSCreg; MNZTASi029-C
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y2 ! MNZTASi029-A
OI   CVCL_E4Y3 ! MNZTASi029-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi030-A
AC   CVCL_E4Y5
SY   MS_0030.1
DR   BioSamples; SAMEA115955706
DR   hPSCreg; MNZTASi030-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y6 ! MNZTASi030-B
OI   CVCL_E4Y7 ! MNZTASi030-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi030-B
AC   CVCL_E4Y6
SY   MS_0030.2
DR   BioSamples; SAMEA115955707
DR   hPSCreg; MNZTASi030-B
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y5 ! MNZTASi030-A
OI   CVCL_E4Y7 ! MNZTASi030-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi030-C
AC   CVCL_E4Y7
SY   MS_0030.3
DR   BioSamples; SAMEA115955708
DR   hPSCreg; MNZTASi030-C
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y5 ! MNZTASi030-A
OI   CVCL_E4Y6 ! MNZTASi030-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi031-A
AC   CVCL_E4Y8
SY   MS_0031.1
DR   BioSamples; SAMEA115955718
DR   hPSCreg; MNZTASi031-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y9 ! MNZTASi031-B
OI   CVCL_E4YA ! MNZTASi031-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi031-B
AC   CVCL_E4Y9
SY   MS_0031.2
DR   BioSamples; SAMEA115955719
DR   hPSCreg; MNZTASi031-B
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y8 ! MNZTASi031-A
OI   CVCL_E4YA ! MNZTASi031-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi031-C
AC   CVCL_E4YA
SY   MS_0031.3
DR   BioSamples; SAMEA115955720
DR   hPSCreg; MNZTASi031-C
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4Y8 ! MNZTASi031-A
OI   CVCL_E4Y9 ! MNZTASi031-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi032-A
AC   CVCL_E4YB
SY   MS_0032.1
DR   BioSamples; SAMEA115955715
DR   hPSCreg; MNZTASi032-A
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YC ! MNZTASi032-B
OI   CVCL_E4YD ! MNZTASi032-C
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi032-B
AC   CVCL_E4YC
SY   MS_0032.2
DR   BioSamples; SAMEA115955716
DR   hPSCreg; MNZTASi032-B
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YB ! MNZTASi032-A
OI   CVCL_E4YD ! MNZTASi032-C
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi032-C
AC   CVCL_E4YD
SY   MS_0032.3
DR   BioSamples; SAMEA115955717
DR   hPSCreg; MNZTASi032-C
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YB ! MNZTASi032-A
OI   CVCL_E4YC ! MNZTASi032-B
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi033-A
AC   CVCL_E4YE
SY   MS_0033.1
DR   BioSamples; SAMEA115955712
DR   hPSCreg; MNZTASi033-A
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YF ! MNZTASi033-B
OI   CVCL_E4YG ! MNZTASi033-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi033-B
AC   CVCL_E4YF
SY   MS_0033.2
DR   BioSamples; SAMEA115955713
DR   hPSCreg; MNZTASi033-B
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YE ! MNZTASi033-A
OI   CVCL_E4YG ! MNZTASi033-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi033-C
AC   CVCL_E4YG
SY   MS_0033.3
DR   BioSamples; SAMEA115955714
DR   hPSCreg; MNZTASi033-C
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165675; Relapsing-remitting multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YE ! MNZTASi033-A
OI   CVCL_E4YF ! MNZTASi033-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi034-A
AC   CVCL_E4YH
SY   MS_0034.1
DR   BioSamples; SAMEA115955709
DR   hPSCreg; MNZTASi034-A
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YI ! MNZTASi034-B
OI   CVCL_E4YJ ! MNZTASi034-C
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi034-B
AC   CVCL_E4YI
SY   MS_0034.2
DR   BioSamples; SAMEA115955710
DR   hPSCreg; MNZTASi034-B
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YH ! MNZTASi034-A
OI   CVCL_E4YJ ! MNZTASi034-C
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MNZTASi034-C
AC   CVCL_E4YJ
SY   MS_0034.3
DR   BioSamples; SAMEA115955711
DR   hPSCreg; MNZTASi034-C
WW   Provider; Menzies; -; https://ms-research.neonjungle.com.au/documents/15/MS_Stem_Reference_-_iPSC_lines_Nov23.pdf
CC   From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4YH ! MNZTASi034-A
OI   CVCL_E4YI ! MNZTASi034-B
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Mo
AC   CVCL_1439
SY   MO; Mo-T; Mo T; MoT; MOT
DR   BTO; BTO_0001014
DR   CLO; CLO_0007815
DR   CLO; CLO_0037184
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-8066
DR   BioSample; SAMN03471131
DR   cancercelllines; CVCL_1439
DR   Cell_Model_Passport; SIDM00623
DR   ChEMBL-Cells; CHEMBL3308631
DR   ChEMBL-Targets; CHEMBL614722
DR   Cosmic; 683660
DR   Cosmic; 908149
DR   Cosmic; 1120712
DR   Cosmic-CLP; 908149
DR   DepMap; ACH-002339
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10712-109I1
DR   GDSC; 908149
DR   GEO; GSM1670121
DR   GEO; GSM1670131
DR   IARC_TP53; 21525
DR   LINCS_LDP; LCL-1096
DR   Lonza; 1308
DR   PharmacoDB; MoT_947_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1439
DR   Wikidata; Q54906275
RX   CelloPub=CLPUB00468;
RX   Patent=US4438032;
RX   PubMed=305224;
RX   PubMed=6600440;
RX   PubMed=6981847;
RX   PubMed=6984393;
RX   PubMed=6987658;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; -; -; http://helatermproject.blogspot.ch/2012/03/john-moore.html
WW   Info; -; -; https://scocal.stanford.edu/opinion/moore-v-regents-university-california-31115
WW   Info; -; -; https://web.archive.org/web/20240819051723/https://www.bio.davidson.edu/people/kabernd/Indep/carainbow/Cells.htm
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Moore_v._Regents_of_the_University_of_California
WW   Info; WIPO Magazine; -; https://www.wipo.int/en/web/wipo-magazine/articles/bioethics-and-patent-law-the-cases-of-moore-and-the-hagahai-people-35439
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8066.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0.37%; East Asian, North=0%; East Asian, South=1.84%; South Asian=0.34%; European, North=68.22%; European, South=29.24% (PubMed=30894373).
CC   Anecdotal: John Moore, the patient from which this cell line is derived, sued David Golde and the University of California over the patent that they deposited on the Mo cell line. Although his claims of ownership were rejected, his physician was deemed to have breached his fiduciary duty by not informing Moore of the economic and financial interests arising from the derivation of the cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-8066; Cosmic-CLP=908149
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,13
ST   D16S539: 11
ST   D18S51: 11,16
ST   D19S433: 14,15
ST   D21S11: 31,32.2
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 7,17
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2302 ! Mo-B
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   MO-011
AC   CVCL_D2X0
SY   MO011; MO011-S2
DR   Wikidata; Q127382838
RX   PubMed=32619491;
WW   Provider; CReM; 738; https://stemcellbank.bu.edu/Catalog/Item/Details/738
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   MO-1
AC   CVCL_A0RI
DR   Wikidata; Q108820954
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Metamycoplasma orale.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MO-2
AC   CVCL_A0RJ
DR   Wikidata; Q108820955
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Metamycoplasma orale.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MO-3
AC   CVCL_A0RK
DR   Wikidata; Q108820956
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Metamycoplasma orale.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MO-A
AC   CVCL_0C22
DR   Cosmic; 2239089
DR   Wikidata; Q54906276
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   Mo-B
AC   CVCL_2302
SY   Mo B; MoB
DR   BTO; BTO_0003680
DR   CLO; CLO_0007816
DR   CLDB; cl3511
DR   ATCC; CCL-245
DR   BioSample; SAMN03471482
DR   ECACC; 90021503
DR   Wikidata; Q54906277
RX   PubMed=6316341;
CC   Population: Caucasian.
CC   Virology: HTLV-2 producing cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Discontinued: ECACC; 90021503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CCL-245
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,13
ST   D16S539: 11
ST   D18S51: 11,16
ST   D19S433: 14,15
ST   D21S11: 31,32.2
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 7,17
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1439 ! Mo
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   Mo-HO
AC   CVCL_E3K7
RX   PubMed=37254642;
CC   Doubling time: ~140 hours (PubMed=37254642).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: Sex and breed of donor from personal communication of Schrock, Morgan S.
CC   Miscellaneous: STR profile carried out by CLS and provided by Schrock, Morgan S. The STR profile has 3 additional loci not in standard set: PEZ2:132, PEZ15:208 and PEZ17:206.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
ST   Source(s): Direct_author_submission
ST   Dog FHC2010: 229
ST   Dog FHC2054: 158,166
ST   Dog FHC2079: 274
ST   Dog PEZ1: 114,118
ST   Dog PEZ6: 184
ST   Dog PEZ8: 227
ST   Dog PEZ12: 270,274
DI   NCIt; C210818; Canine oligodendroglioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   MO-LAS
AC   CVCL_K236
DR   Wikidata; Q54906278
RX   PubMed=23342252;
CC   Population: Japanese.
CC   Doubling time: 91 hours (PubMed=23342252).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3205; Lymphangiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   MO-LAS-B
AC   CVCL_AS12
DR   TKG; TKG 0714
DR   Wikidata; Q54906279
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): TKG=TKG 0714
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3205; Lymphangiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K236 ! MO-LAS
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 8
//
ID   MO-N-1
AC   CVCL_HF80
DR   Wikidata; Q54906280
RX   DOI=10.5794/jjoms.43.789;
CC   Population: Japanese.
CC   Doubling time: 46.5 hours (DOI=10.5794/jjoms.43.789).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HF81 ! MO-N-2
OI   CVCL_HF82 ! MO-T
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   MO-N-2
AC   CVCL_HF81
DR   Wikidata; Q54906281
RX   DOI=10.5794/jjoms.43.789;
CC   Population: Japanese.
CC   Doubling time: 36 hours (DOI=10.5794/jjoms.43.789).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HF80 ! MO-N-1
OI   CVCL_HF82 ! MO-T
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   MO-T
AC   CVCL_HF82
DR   Wikidata; Q54906282
RX   DOI=10.5794/jjoms.43.789;
CC   Population: Japanese.
CC   Doubling time: 48 hours (DOI=10.5794/jjoms.43.789).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HF80 ! MO-N-1
OI   CVCL_HF81 ! MO-N-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   Mo03
AC   CVCL_YM56
DR   IBRC; C10070
DR   Wikidata; Q95990442
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   40D
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   Mo06
AC   CVCL_YM57
DR   IBRC; C10068
DR   Wikidata; Q95990443
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   40D
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   Mo09
AC   CVCL_YM58
DR   IBRC; C10073
DR   Wikidata; Q95990444
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   40D
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   MO1043
AC   CVCL_Y383
SY   Mo1043
DR   Wikidata; Q54906283
RX   PubMed=8412300;
RX   PubMed=19358282;
CC   Misspelling: M01043; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   MO24
AC   CVCL_SA78
DR   Wikidata; Q54906284
RX   PubMed=10741724;
CC   HLA typing: A*02:01,24:02 (PubMed=10741724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MO3.13
AC   CVCL_D357
SY   M03.13
DR   EFO; EFO_0022639
DR   PRIDE; PXD000263
DR   PRIDE; PXD004696
DR   Wikidata; Q54906285
RX   PubMed=7707048;
RX   PubMed=10074188;
RX   PubMed=14618099;
RX   PubMed=24167090;
RX   PubMed=28861932;
WW   Provider; Cedarlane; CLU301; https://www.cedarlanelabs.com/Products/Detail/CLU301?lob=AllProducts
CC   Characteristics: Produced by fusion of RD.TG6 with adult human oligodendrocytes (PubMed=7707048).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Omics: Proteomics.
ST   Source(s): Cellutions
ST   Amelogenin: X
ST   CSF1PO: 10,11,14
ST   D13S317: 12,13
ST   D16S539: 10,11,12
ST   D18S51: 13,17
ST   D19S433: 11,14
ST   D21S11: 28,29
ST   D2S1338: 22,23
ST   D3S1358: 15,17,18
ST   D5S818: 10,11,12
ST   D7S820: 8,11,12
ST   D8S1179: 11,13,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP30 ! RD.TG6
CA   Hybrid cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MO6-G3
AC   CVCL_0E51
SY   M06-G3; MO6G3
DR   Wikidata; Q54906286
RX   PubMed=7554969;
RX   PubMed=12640734;
RX   PubMed=16674740;
CC   Characteristics: High constitutive expression of dentin phosphoprotein, type I collagen and alkaline phosphatase, characteristic of an odontoblast phenotype (PubMed=7554969).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
CC   Cell type: Odontoblast; CL=CL_0000060.
CC   Breed/subspecies: Swiss Webster (CFW).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   MOA1
AC   CVCL_Y204
SY   SCLC-MOA1; ACC-LC-49D; Aichi Cancer Center-Lung Cancer-49D
DR   Wikidata; Q54906287
RX   PubMed=2540905;
RX   PubMed=2547517;
RX   PubMed=8384671;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7019 ! ACC-LC-49
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   MOA2
AC   CVCL_Y205
SY   SCLC-MOA2
DR   Wikidata; Q54906288
RX   PubMed=2540905;
RX   PubMed=2547517;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7019 ! ACC-LC-49
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   MOA2/CDDP
AC   CVCL_Y206
DR   Wikidata; Q54906289
RX   PubMed=2547517;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y205 ! MOA2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
ID   MOBS-1
AC   CVCL_8442
DR   BioSample; SAMN03151984
DR   cancercelllines; CVCL_8442
DR   Cosmic; 998752
DR   Wikidata; Q54906291
RX   DOI=10.15369/sujms1989.9.45;
RX   PubMed=10233379;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 57 year old male patient with monocytic leukemia (M5b).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00239.
CC   Population: Caucasian.
CC   Doubling time: 12 hours (DOI=10.15369/sujms1989.9.45).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   MOC-1
AC   CVCL_E1HL
RX   PubMed=2553880;
RX   PubMed=2859106;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 125/145 kDa membrane-associated antigen present in small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MOC-21
AC   CVCL_E1HM
RX   PubMed=2553880;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human 25 kDa antigen present in small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MOC-32
AC   CVCL_E1HN
RX   PubMed=2553880;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 40 kDa antigen present in small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MOC-51
AC   CVCL_E1HP
RX   PubMed=2553880;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   MOC-L1
AC   CVCL_A9X3
SY   Mouse Oral Carcinoma-Line 1
DR   ABM; T8046
DR   BCRC; 60616
DR   Wikidata; Q102114547
RX   PubMed=30922255;
CC   Characteristics: Tumorigenic in syngeneic mice and also possesses a competence for neck dissemination.
CC   Doubling time: 24.7 hours (PubMed=30922255).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Thr122Asn (c.365_366CG>AT); Zygosity=Unspecified (PubMed=30922255).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:2676887; Mir211.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6 K14-EGFP-miR-211 transgenic.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   MOC-L2
AC   CVCL_A9X4
SY   Mouse Oral Carcinoma-Line 2
DR   ABM; T8047
DR   BCRC; 60617
DR   Wikidata; Q102114548
RX   PubMed=30922255;
CC   Characteristics: Tumorigenic in syngeneic mice.
CC   Doubling time: 20.4 hours (PubMed=30922255).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Ala156Pro (c.466G>C); Zygosity=Unspecified (PubMed=30922255).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:2676887; Mir211.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6 K14-EGFP-miR-211 transgenic.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   MOC-L3
AC   CVCL_A9X5
SY   Mouse Oral Carcinoma-Line 3
DR   ABM; T8048
DR   BCRC; 60618
DR   Wikidata; Q102114549
RX   PubMed=30922255;
CC   Doubling time: 20.3 hours (PubMed=30922255).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Gly241Glu (c.722G>A); Zygosity=Unspecified (PubMed=30922255).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:2676887; Mir211.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6 K14-EGFP-miR-211 transgenic.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   MOC-L4
AC   CVCL_A9X6
SY   Mouse Oral Carcinoma-Line 4
DR   ABM; T8049
DR   BCRC; 60619
DR   Wikidata; Q102114551
RX   PubMed=30922255;
CC   Characteristics: Compared to other MOC-L cell lines, MOC-L4 is the least aggressive, has the lowest proliferation rate, invasion ability and colony formation ability. It has high migration competence and the highest tolerance to CDDP treatment (PubMed=30922255).
CC   Doubling time: 29.3 hours (PubMed=30922255).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:2676887; Mir211.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6 K14-EGFP-miR-211 transgenic.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   MOC1
AC   CVCL_ZD32
SY   Mouse Oral Cancer 1
DR   GEO; GSM1213076
DR   GEO; GSM1213077
DR   GEO; GSM1213078
DR   GEO; GSM1213079
DR   Kerafast; EWL001-FP
DR   Millipore; SCC469
DR   Wikidata; Q98127270
RX   PubMed=22086849;
RX   PubMed=22434099;
RX   PubMed=24668645;
RX   PubMed=25729643;
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/24334/
CC   Characteristics: Indolent growth phenotype.
CC   Sequence variation: Mutation; MGI; MGI:96224; Hras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Unspecified (PubMed=22086849).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Val170Glu; Zygosity=Unspecified (PubMed=24668645).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Kerafast=EWL001-FP; Millipore=SCC469
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MOC2
AC   CVCL_ZD33
SY   Mouse Oral Cancer 2
DR   GEO; GSM1213080
DR   GEO; GSM1213081
DR   GEO; GSM1213082
DR   Kerafast; EWL002-FP
DR   Millipore; SCC470
DR   Wikidata; Q98127271
RX   PubMed=22086849;
RX   PubMed=22434099;
RX   PubMed=24668645;
RX   PubMed=25729643;
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/24334/
CC   Characteristics: Agressive growth phenotype.
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>T); Zygosity=Unspecified (PubMed=22086849).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Glu225Ter; Zygosity=Unspecified (PubMed=24668645).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: C57BL/6 Cxcr3-/-.
ST   Source(s): Kerafast=EWL002-FP; Millipore=SCC470
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 18,19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15 (Kerafast=EWL002-FP)
ST   Mouse STR 6-7: 15,16 (Millipore=SCC470)
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_ZD38 ! MOC2LN
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MOC2-7
AC   CVCL_ZD34
SY   MOC7; Mouse Oral Cancer 7
DR   GEO; GSM1213083
DR   GEO; GSM1213084
DR   GEO; GSM1213085
DR   Wikidata; Q98127273
RX   PubMed=22086849;
RX   PubMed=24668645;
RX   PubMed=25729643;
CC   Problematic cell line: Contaminated. Shown to be a MOC2 derivative (PubMed=24668645). Originally (PubMed=22086849) thought to be independently derived and was named MOC7. Was renamed MOC2-7 when shown to be a derivative of MOC2.
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>T); Zygosity=Unspecified (PubMed=22086849).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Glu225Ter; Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: C57BL/6 Cxcr3-/-.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD33 ! MOC2
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   MOC2-10
AC   CVCL_ZD35
SY   MOC10; Mouse Oral Cancer 10
DR   GEO; GSM1213086
DR   GEO; GSM1213087
DR   GEO; GSM1213088
DR   Wikidata; Q98127274
RX   PubMed=22086849;
RX   PubMed=24668645;
RX   PubMed=25729643;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a MOC2 derivative (PubMed=24668645). Originally (PubMed=22086849) thought to be independently derived and was named MOC10. Was renamed MOC2-10 when shown to be a derivative of MOC2.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00594.
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>T); Zygosity=Unspecified (PubMed=22086849).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Glu225Ter; Zygosity=Unspecified (PubMed=24668645).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: C57BL/6 Cxcr3-/-.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZD33 ! MOC2
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MOC22
AC   CVCL_ZD36
SY   Mouse Oral Cancer 22
DR   GEO; GSM1213089
DR   GEO; GSM1213090
DR   GEO; GSM1213091
DR   Kerafast; EWL003-FP
DR   Millipore; SCC471
DR   Wikidata; Q98127275
RX   PubMed=22086849;
RX   PubMed=24668645;
RX   PubMed=25729643;
CC   Characteristics: Indolent growth phenotype.
CC   Sequence variation: Mutation; MGI; MGI:96224; Hras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Unspecified (PubMed=22086849).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Thr122Pro; Zygosity=Unspecified (PubMed=24668645).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Lys384Ter; Zygosity=Unspecified (PubMed=24668645).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Kerafast=EWL003-FP; Millipore=SCC471
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17 (Kerafast=EWL003-FP)
ST   Mouse STR 5-5: 17,18 (Millipore=SCC471)
ST   Mouse STR 6-4: 19
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 15,16 (Millipore=SCC471)
ST   Mouse STR 18-3: 16 (Kerafast=EWL003-FP)
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   MOC23
AC   CVCL_ZD37
SY   Mouse Oral Cancer 23
DR   GEO; GSM1213092
DR   GEO; GSM1213093
DR   GEO; GSM1213094
DR   Wikidata; Q98127276
RX   PubMed=22086849;
RX   PubMed=24668645;
RX   PubMed=25729643;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   MOC2LN
AC   CVCL_ZD38
DR   GEO; GSM1213097
DR   GEO; GSM1213098
DR   GEO; GSM1213099
DR   Wikidata; Q98127277
RX   PubMed=24668645;
RX   PubMed=25729643;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>T); Zygosity=Unspecified (from autologous cell line MOC2).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Glu225Ter; Zygosity=Unspecified (from autologous cell line MOC2).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: C57BL/6 Cxcr3-/-.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_ZD33 ! MOC2
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   MOCH-1
AC   CVCL_5H94
DR   Wikidata; Q54906292
RX   PubMed=1377283;
RX   PubMed=7745612;
CC   Doubling time: ~2 days (PubMed=1377283).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Breed/subspecies: (C57BL/6 x DBA/2) F2 MBP/c-neu transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   MOCHA
AC   CVCL_0C87
DR   cancercelllines; CVCL_0C87
DR   Wikidata; Q54906293
RX   PubMed=12791875;
CC   Population: Caucasian.
CC   Virology: Highly susceptible to infection by both CCR5-tropic and CXCR4-tropic HIV-1 strains. SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a HIV-1 long terminal repeat. This cell line secretes human placental alkaline phosphatase into the culture supernatant during HIV-1 infection.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S545 ! MOLT-4/CCR5
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 19
//
ID   Mocha
AC   CVCL_QX29
SY   Microglia of the cochlea
DR   Kerafast; EUR207
DR   Wikidata; Q54906294
RX   PubMed=29109020;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A 12S isoform).
CC   Derived from site: In situ; Ear, inner ear, cochlea; UBERON=UBERON_0001844.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   Mocha-HSA
AC   CVCL_0D00
DR   Wikidata; Q54906295
RX   PubMed=16797414;
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   MOCL1
AC   CVCL_S517
DR   Wikidata; Q54906296
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCL2
AC   CVCL_S518
DR   Wikidata; Q54906297
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCL3
AC   CVCL_S519
DR   Wikidata; Q54906298
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCL4
AC   CVCL_S520
SY   MOCL-4
DR   Wikidata; Q54906299
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCL5
AC   CVCL_S521
DR   Wikidata; Q54906300
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCL6
AC   CVCL_S522
DR   Wikidata; Q54906301
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCL7
AC   CVCL_S523
DR   Wikidata; Q54906302
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCL8
AC   CVCL_S524
DR   Wikidata; Q54906304
RX   PubMed=11587730;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   MOCP-5
AC   CVCL_F699
SY   MOCP5; Mouse OsteoClast Precursor-5
DR   Wikidata; Q54906305
RX   PubMed=9661075;
CC   Doubling time: ~2 days (Note=On tissue culture dish), ~20 hours (Note=When co-cultured with MS12) (PubMed=9661075).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoclast; CL=CL_0000092.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   MOD
AC   CVCL_5G87
DR   Wikidata; Q54906307
RX   PubMed=2423737;
RX   PubMed=24259225;
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 4
//
ID   MODE-K
AC   CVCL_B4FG
SY   Mode-K
DR   Wikidata; Q110433061
RX   PubMed=7693823;
RX   PubMed=12021345;
RX   PubMed=32304812;
CC   Doubling time: 15 hours (PubMed=7693823).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   MODE-K.CD150
AC   CVCL_B4FH
DR   Wikidata; Q110433062
RX   PubMed=12021345;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10903; SLAMF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4FG ! MODE-K
SX   Female
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   MODE-K.CD46
AC   CVCL_B4FI
DR   Wikidata; Q110433063
RX   PubMed=12021345;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6953; CD46.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4FG ! MODE-K
SX   Female
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 9
//
ID   MODY1-iPS-A-3
AC   CVCL_VM20
DR   Wikidata; Q95990466
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H970 ! GM01122
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MODY1-iPS-B-1
AC   CVCL_VM21
DR   Wikidata; Q95990467
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MODY1-iPS-B-13
AC   CVCL_VM27
DR   Wikidata; Q95990468
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MODY1-iPS-B-5
AC   CVCL_VM22
DR   Wikidata; Q95990470
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MODY1-iPS-B-6
AC   CVCL_VM23
DR   Wikidata; Q95990471
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MODY1-iPS-B-7
AC   CVCL_VM24
DR   Wikidata; Q95990472
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MODY1-iPS-B-8
AC   CVCL_VM25
DR   Wikidata; Q95990473
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MODY1-iPS-B-9
AC   CVCL_VM26
DR   Wikidata; Q95990476
RX   PubMed=29990710;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5024; HNF4A; Simple; p.Gln277Ter (c.829C>T) (Q268*); ClinVar=VCV000009210; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129744; Hepatocyte nuclear factor 4-alpha associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI26 ! GM01430
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   MOE1a
AC   CVCL_JE62
SY   Mouth Ordinary Epithelium 1a
DR   Wikidata; Q54906308
RX   DOI=10.1016/S1348-8643(11)00009-7;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With del 1-159).
CC   Derived from site: In situ; Oral cavity, epithelium; UBERON=UBERON_0002424.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE63 ! MOE1b
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   MOE1b
AC   CVCL_JE63
SY   Mouth Ordinary Epithelium 1b
DR   Wikidata; Q54906309
RX   DOI=10.1016/S1348-8643(11)00009-7;
RX   PubMed=23706918;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Oral cavity, epithelium; UBERON=UBERON_0002424.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE62 ! MOE1a
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   MOG-G-ATA
AC   CVCL_A1LA
SY   G-ATA; ATA; Medical Oncology Glascow-Glioma-ATA
DR   Wikidata; Q102114552
RX   PubMed=6200130;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MOG-G-CCM
AC   CVCL_2613
SY   MOGGCCM; GO-G-CCM; G-CCM; CCM; Medical Oncology Glascow-Glioma-CCM
DR   CLO; CLO_0007817
DR   CLDB; cl3512
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470986
DR   BioSample; SAMN10988381
DR   cancercelllines; CVCL_2613
DR   Cell_Model_Passport; SIDM00532
DR   ChEMBL-Cells; CHEMBL3308456
DR   Cosmic; 687450
DR   Cosmic; 908144
DR   Cosmic; 2367538
DR   Cosmic-CLP; 908144
DR   DepMap; ACH-001125
DR   ECACC; 86022702
DR   EGA; EGAS00001000978
DR   GDSC; 908144
DR   GEO; GSM827349
DR   GEO; GSM1374686
DR   GEO; GSM1670122
DR   IARC_TP53; 21511
DR   LINCS_LDP; LCL-1396
DR   PharmacoDB; MOGGCCM_948_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2613
DR   Wikidata; Q54906311
RX   PubMed=3254724;
RX   PubMed=6200130;
RX   PubMed=7518347;
RX   PubMed=7591247;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (Cosmic-CLP=908144; DepMap=ACH-001125).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.19%; Native American=0%; East Asian, North=0.2%; East Asian, South=0%; South Asian=0%; European, North=69.93%; European, South=29.68% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=908144; ECACC=86022702; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 17
ST   D19S433: 12,14
ST   D21S11: 31.2
ST   D2S1338: 21
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   Penta D: 9,13
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   MOG-G-IJK
AC   CVCL_S831
SY   G-IJK; IJK; Medical Oncology Glascow-Glioma-IJK
DR   Wikidata; Q54906312
RX   PubMed=3254724;
RX   PubMed=6200130;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   MOG-G-RAT
AC   CVCL_A1LB
SY   G-RAT; RAT; Medical Oncology Glascow-Glioma-RAT
DR   Wikidata; Q102114553
RX   PubMed=6200130;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MOG-G-UVW
AC   CVCL_2614
SY   MOG-GUVW; MOGGUVW; GO-G-UVW; G-UVW; UVW; Medical Oncology Glascow-Glioma-UVW
DR   CLO; CLO_0007818
DR   CLDB; cl3513
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 945
DR   BioSample; SAMN03470987
DR   BioSample; SAMN10988296
DR   cancercelllines; CVCL_2614
DR   Cell_Model_Passport; SIDM00504
DR   ChEMBL-Cells; CHEMBL3308137
DR   ChEMBL-Targets; CHEMBL1075508
DR   Cosmic; 908145
DR   Cosmic; 2367539
DR   Cosmic-CLP; 908145
DR   DepMap; ACH-001126
DR   ECACC; 86022703
DR   EGA; EGAS00001000978
DR   GDSC; 90815
DR   GEO; GSM827433
DR   GEO; GSM1374687
DR   GEO; GSM1670123
DR   IARC_TP53; 21510
DR   LINCS_LDP; LCL-1397
DR   PharmacoDB; MOGGUVW_949_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2614
DR   PubChem_Cell_line; CVCL_2614
DR   Wikidata; Q54906313
RX   PubMed=3254724;
RX   PubMed=7518347;
RX   PubMed=7591247;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Pro (c.329G>C); ClinVar=VCV000233627; Zygosity=Homozygous (Cosmic-CLP=908145; DepMap=ACH-001126).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.89%; Native American=0%; East Asian, North=2.75%; East Asian, South=0%; South Asian=0%; European, North=58.22%; European, South=37.14% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=908145; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 30,30.2
ST   D2S1338: 21,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   Penta D: 9,13
ST   Penta E: 5,7
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   MOH (TOU II-3)
AC   CVCL_2782
SY   MOH; TOU II-3
DR   CLO; CLO_0007819
DR   CLDB; cl3514
DR   ECACC; 93093002
DR   Wikidata; Q54906314
RX   PubMed=6438434;
WW   Info; IMGT; -; https://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html
CC   Population: Tunisian; Berber.
CC   Characteristics: Heterozygous for deletion of IGH G1-EP1-A1-GP-G2-G4 and of EP1-A1-GP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:5478; IGHA1; Zygosity=Homozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5523; IGHEP1; Zygosity=Homozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5525; IGHG1; Zygosity=Heterozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5526; IGHG2; Zygosity=Heterozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5528; IGHG4; Zygosity=Heterozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5529; IGHGP; Zygosity=Homozygous (PubMed=6438434).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   MOHITO
AC   CVCL_K249
SY   MOuse Hematopoietic Interleukin-dependent cell line of T-cell Origin
DR   ABM; T0131
DR   Wikidata; Q54906315
RX   PubMed=21193420;
CC   Characteristics: IL2 and IL7 dependent (PubMed=21193420).
CC   Doubling time: 16-20 hours (PubMed=21193420).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: CD4/CD8 double positive T cell; CL=CL_0000809.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   Mol/MSM-1
AC   CVCL_E5YU
RX   PubMed=19082856;
RX   PubMed=23604909;
RX   PubMed=24444128;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: MSM/Ms.
OX   NCBI_TaxID=57486; ! Mus musculus molossinus (Japanese house mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Mol/MSM-2
AC   CVCL_E5YV
RX   PubMed=19082856;
CC   Karyotypic information: 18% of cells are tetraploid (PubMed=19082856).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: MSM/Ms.
OX   NCBI_TaxID=57486; ! Mus musculus molossinus (Japanese house mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Mol/MSM-3
AC   CVCL_E5YW
RX   PubMed=19082856;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: MSM/Ms.
OX   NCBI_TaxID=57486; ! Mus musculus molossinus (Japanese house mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Molek
AC   CVCL_VL68
DR   Wikidata; Q95990483
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   MOLM-1
AC   CVCL_2118
SY   MOLM1
DR   cancercelllines; CVCL_2118
DR   CGH-DB; 9222-4
DR   Cosmic; 787504
DR   Cosmic; 798670
DR   Cosmic; 919133
DR   Cosmic; 994172
DR   Cosmic; 996324
DR   Cosmic; 998756
DR   Cosmic; 999776
DR   Cosmic; 1037676
DR   Cosmic; 2089677
DR   Cosmic; 2378087
DR   DepMap; ACH-001573
DR   DSMZ; ACC-720
DR   DSMZCellDive; ACC-720
DR   JCRB; JCRB1808
DR   Wikidata; Q54906316
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=1782185;
RX   PubMed=9510473;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10695022;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=23955599;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~43 hours (PubMed=1782185); ~60-70 hours (DSMZ=ACC-720).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=1782185; PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (DepMap=ACH-001573).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DepMap=ACH-001573; DSMZ=ACC-720; JCRB=JCRB1808
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,12 (DepMap=ACH-001573)
ST   D8S1179: 12 (DSMZ=ACC-720)
ST   FGA: 23,24
ST   Penta D: 10 (DSMZ=ACC-720)
ST   Penta D: 10,14 (DepMap=ACH-001573)
ST   Penta E: 14,19
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   MOLM-10
AC   CVCL_7920
SY   MOLM10
DR   Wikidata; Q54906317
RX   PubMed=7873501;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2122 ! MOLM-6
OI   CVCL_7917 ! MOLM-7
OI   CVCL_7918 ! MOLM-8
OI   CVCL_7919 ! MOLM-9
OI   CVCL_7921 ! MOLM-11
OI   CVCL_L075 ! MOLM-12
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   MOLM-11
AC   CVCL_7921
SY   MOLM11
DR   Cosmic; 999771
DR   Wikidata; Q54906318
RX   PubMed=7873501;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2122 ! MOLM-6
OI   CVCL_7917 ! MOLM-7
OI   CVCL_7918 ! MOLM-8
OI   CVCL_7919 ! MOLM-9
OI   CVCL_7920 ! MOLM-10
OI   CVCL_L075 ! MOLM-12
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   MOLM-12
AC   CVCL_L075
SY   MOLM12
DR   Wikidata; Q54906319
RX   PubMed=7873501;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2122 ! MOLM-6
OI   CVCL_7917 ! MOLM-7
OI   CVCL_7918 ! MOLM-8
OI   CVCL_7919 ! MOLM-9
OI   CVCL_7920 ! MOLM-10
OI   CVCL_7921 ! MOLM-11
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   MOLM-13
AC   CVCL_2119
SY   MOLM13; Molm13; Molm 13
DR   BTO; BTO_0004175
DR   CLO; CLO_0009848
DR   EFO; EFO_0022694
DR   AddexBio; C0003003/60
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 403
DR   BioSample; SAMN03473102
DR   BioSample; SAMN10988379
DR   cancercelllines; CVCL_2119
DR   Cell_Model_Passport; SIDM00437
DR   ChEMBL-Cells; CHEMBL3706573
DR   ChEMBL-Targets; CHEMBL3706572
DR   Cosmic; 787417
DR   Cosmic; 947367
DR   Cosmic; 975274
DR   Cosmic; 996319
DR   Cosmic; 998754
DR   Cosmic; 999722
DR   Cosmic; 999772
DR   Cosmic; 1012095
DR   Cosmic; 1037671
DR   Cosmic; 1078734
DR   Cosmic; 1150897
DR   Cosmic; 1152711
DR   Cosmic; 1187863
DR   Cosmic; 1197930
DR   Cosmic; 1278778
DR   Cosmic; 1281332
DR   Cosmic; 1308222
DR   Cosmic; 1465952
DR   Cosmic; 1696139
DR   Cosmic; 1741687
DR   Cosmic; 2089664
DR   Cosmic; 2131546
DR   Cosmic; 2306220
DR   Cosmic; 2750864
DR   Cosmic; 2842299
DR   Cosmic-CLP; 1330947
DR   DepMap; ACH-000362
DR   DSMZ; ACC-554
DR   DSMZCellDive; ACC-554
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1330947
DR   GEO; GSM482509
DR   GEO; GSM887329
DR   GEO; GSM888405
DR   GEO; GSM1374688
DR   GEO; GSM1374689
DR   GEO; GSM1446738
DR   GEO; GSM1670124
DR   GEO; GSM2124117
DR   GEO; GSM2716691
DR   GEO; GSM2716692
DR   GEO; GSM2716748
DR   GEO; GSM2716749
DR   GEO; GSM2716750
DR   GEO; GSM2716751
DR   IARC_TP53; 30123
DR   JCRB; JCRB1810
DR   LiGeA; CCLE_282
DR   LINCS_LDP; LCL-1061
DR   PharmacoDB; MOLM13_950_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2119
DR   PubChem_Cell_line; CVCL_2119
DR   Wikidata; Q54906320
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9305600;
RX   PubMed=10233379;
RX   PubMed=10637496;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12529668;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=15381384;
RX   PubMed=16408098;
RX   PubMed=22354205;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=27750403;
RX   PubMed=28052028;
RX   PubMed=28109323;
RX   PubMed=28196595;
RX   PubMed=29491412;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=33669837;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/leukemia-xenograft-model/molm13-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 3-4 days (PubMed=9305600); 24 hours (PubMed=25984343); 41.1 hours (PubMed=28052028); ~50 hours (DSMZ=ACC-554).
CC   HLA typing: A*26:01:01,31:01:02; B*44:03:01,51:01:01; C*14:02:01,14:03 (DSMZCellDive=ACC-554).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=9305600; PubMed=14671638; PubMed=15381384).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (PubMed=10233379; PubMed=12529668; PubMed=27750403; DepMap; ACH-000362).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.24%; East Asian, North=76.64%; East Asian, South=22.12%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003003/60; COG; Cosmic-CLP=1330947; DSMZ=ACC-554; JCRB=JCRB1810; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (AddexBio=C0003003/60)
ST   CSF1PO: 10,12 (COG; Cosmic-CLP=1330947; DSMZ=ACC-554; JCRB=JCRB1810; PubMed=25877200)
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 30,31
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 18,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7916 ! MOLM-14
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 47
//
ID   MOLM-13-RES
AC   CVCL_D779
DR   Cosmic; 1741689
DR   Cosmic; 2842301
DR   Wikidata; Q54906321
RX   PubMed=22354205;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90237; Tandutinib (MLN518; CT53518).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 18
//
ID   MOLM-13-RES-AC
AC   CVCL_D780
DR   Cosmic; 1741691
DR   Wikidata; Q54906322
RX   PubMed=22354205;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90217; Quizartinib (AC220).
CC   Selected for resistance to: ChEBI; CHEBI_90237; Tandutinib (MLN518; CT53518).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D779 ! MOLM-13-RES
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 18
//
ID   MOLM-13/AZA
AC   CVCL_C0WJ
DR   Wikidata; Q114312311
RX   PubMed=33669837;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   MOLM-13/DAC
AC   CVCL_C0WK
DR   Wikidata; Q114312312
RX   PubMed=33669837;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_50131; 5-aza-2'-deoxycytidine (Decitabine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   MOLM-14
AC   CVCL_7916
SY   Molm-14; Molm 14; Molm14; MOLM14
DR   BTO; BTO_0005720
DR   EFO; EFO_0022446
DR   Cell_Model_Passport; SIDM00436
DR   ChEMBL-Cells; CHEMBL3706571
DR   ChEMBL-Targets; CHEMBL3706570
DR   Cosmic; 787418
DR   Cosmic; 1150898
DR   Cosmic; 1281333
DR   DepMap; ACH-001574
DR   DSMZ; ACC-777
DR   DSMZCellDive; ACC-777
DR   GEO; GSM2037134
DR   GEO; GSM2037135
DR   GEO; GSM3145574
DR   GEO; GSM3145724
DR   JCRB; JCRB1812
DR   Lonza; 978
DR   PubChem_Cell_line; CVCL_7916
DR   Wikidata; Q54906323
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9305600;
RX   PubMed=12529668;
RX   PubMed=21552520;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 3-4 days (PubMed=9305600); ~50 hours (DSMZ=ACC-777).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=9305600).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=12529668).
CC   Omics: Genomics; ChIP-seq; H3K79me1.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG; DepMap=ACH-001574; DSMZ=ACC-777; JCRB=JCRB1812
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 30,31
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 18,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   MOLM-16
AC   CVCL_2120
SY   MOLM16
DR   BTO; BTO_0004176
DR   EFO; EFO_0006652
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473252
DR   BioSample; SAMN10989567
DR   cancercelllines; CVCL_2120
DR   Cell_Model_Passport; SIDM00435
DR   ChEMBL-Cells; CHEMBL4879543
DR   Cosmic; 787457
DR   Cosmic; 975275
DR   Cosmic; 1012096
DR   Cosmic; 1281334
DR   Cosmic; 2131560
DR   Cosmic; 2306221
DR   Cosmic; 2750865
DR   Cosmic-CLP; 1330948
DR   DepMap; ACH-000369
DR   DSMZ; ACC-555
DR   DSMZCellDive; ACC-555
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1330948
DR   GEO; GSM887330
DR   GEO; GSM888406
DR   GEO; GSM1374690
DR   GEO; GSM1446739
DR   IARC_TP53; 28318
DR   JCRB; JCRB1815
DR   LiGeA; CCLE_524
DR   PharmacoDB; MOLM16_951_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2120
DR   Wikidata; Q54906324
RX   PubMed=12526922;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~50-80 hours (DSMZ=ACC-555).
CC   HLA typing: A*24:02,24:02; B*52:01,67:02; C*12:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Met (c.517G>A); ClinVar=VCV000233951; Zygosity=Heterozygous (Cosmic-CLP=1330948; DepMap=ACH-000369).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Ser (c.713G>C); ClinVar=VCV000376575; Zygosity=Heterozygous (Cosmic-CLP=1330948; DepMap=ACH-000369).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.33%; Native American=0%; East Asian, North=81.24%; East Asian, South=12.89%; South Asian=0%; European, North=0%; European, South=3.54% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1330948; DSMZ=ACC-555; JCRB=JCRB1815; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 15,23
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9 (PubMed=25877200)
ST   Penta D: 9,14 (DSMZ=ACC-555)
ST   Penta E: 13,20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C8303; Adult acute myeloid leukemia with minimal differentiation
DI   ORDO; Orphanet_98832; Acute myeloid leukemia with minimal differentiation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   MOLM-17
AC   CVCL_7922
SY   MOLM17
DR   Cosmic; 975276
DR   Cosmic; 1012097
DR   Cosmic; 2306222
DR   Wikidata; Q54906325
RX   PubMed=15863212;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L076 ! B422
OI   CVCL_L077 ! B423
OI   CVCL_7923 ! MOLM-18
SX   Male
AG   60-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   MOLM-18
AC   CVCL_7923
SY   MOLM18
DR   Wikidata; Q54906327
RX   PubMed=15863212;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L076 ! B422
OI   CVCL_L077 ! B423
OI   CVCL_7922 ! MOLM-17
SX   Male
AG   60-61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MOLM-20
AC   CVCL_2121
SY   MOLM20
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473490
DR   Cosmic; 1012098
DR   DSMZ; ACC-591
DR   DSMZCellDive; ACC-591
DR   Wikidata; Q54906328
RX   PubMed=16408098;
RX   PubMed=31160637;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~70 hours (DSMZ=ACC-591).
CC   HLA typing: A*26:02:01,26:03:01; B*15:01:01,40:06:01; C*03:03:01,08:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,02:01:02; DRA*01:01:01,01:01:01; DRB1*09:01:02,09:01:02 (DSMZCellDive=ACC-591).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:25589; SEPTIN11; Name(s)=KMT2A-SEPTIN11, KMT2A-SEPT11, MLL-SEPT11 (PubMed=31160637; DSMZ=ACC-591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-591
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10
ST   FGA: 21,22
ST   Penta D: 10,12
ST   Penta E: 8,12
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3179; Chronic neutrophilic leukemia
DI   ORDO; Orphanet_86829; Chronic neutrophilic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V650 ! CNLBC1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   MOLM-6
AC   CVCL_2122
SY   MOLM6
DR   BTO; BTO_0004177
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473502
DR   BioSample; SAMN10988475
DR   cancercelllines; CVCL_2122
DR   Cell_Model_Passport; SIDM01691
DR   CGH-DB; 9210-4
DR   Cosmic; 787505
DR   Cosmic; 999769
DR   DepMap; ACH-000321
DR   DSMZ; ACC-611
DR   DSMZCellDive; ACC-611
DR   GEO; GSM887331
DR   GEO; GSM888407
DR   JCRB; JCRB1807
DR   LiGeA; CCLE_390
DR   PharmacoDB; MOLM6_952_2019
DR   Progenetix; CVCL_2122
DR   Wikidata; Q54906329
RX   PubMed=7873501;
RX   PubMed=10637496;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~48-72 hours (DSMZ=ACC-611).
CC   HLA typing: A*24:02,24:02; B*40:01,52:01; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (DepMap=ACH-000321).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.75%; East Asian, North=75.67%; East Asian, South=23.58%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-611; JCRB=JCRB1807
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12 (DSMZ=ACC-611)
ST   CSF1PO: 12 (JCRB=JCRB1807)
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30.2,33.2
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 21,26
ST   Penta D: 9
ST   Penta E: 5,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7917 ! MOLM-7
OI   CVCL_7918 ! MOLM-8
OI   CVCL_7919 ! MOLM-9
OI   CVCL_7920 ! MOLM-10
OI   CVCL_7921 ! MOLM-11
OI   CVCL_L075 ! MOLM-12
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   MOLM-7
AC   CVCL_7917
SY   MOLM7
DR   cancercelllines; CVCL_7917
DR   Cosmic; 996325
DR   Cosmic; 998757
DR   Cosmic; 999770
DR   Cosmic; 1012094
DR   Cosmic; 1037677
DR   Cosmic; 2089676
DR   Wikidata; Q54906330
RX   PubMed=7873501;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=11734303;
RX   PubMed=14504097;
RX   PubMed=16408098;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:2468; SMC3; Simple; p.Arg661Pro (c.1982G>C); ClinVar=VCV001310284; Zygosity=Unspecified (PubMed=23955599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2122 ! MOLM-6
OI   CVCL_7918 ! MOLM-8
OI   CVCL_7919 ! MOLM-9
OI   CVCL_7920 ! MOLM-10
OI   CVCL_7921 ! MOLM-11
OI   CVCL_L075 ! MOLM-12
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   MOLM-8
AC   CVCL_7918
SY   MOLM8
DR   Wikidata; Q54906331
RX   PubMed=7873501;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2122 ! MOLM-6
OI   CVCL_7917 ! MOLM-7
OI   CVCL_7919 ! MOLM-9
OI   CVCL_7920 ! MOLM-10
OI   CVCL_7921 ! MOLM-11
OI   CVCL_L075 ! MOLM-12
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   MOLM-9
AC   CVCL_7919
SY   MOLM9
DR   Wikidata; Q54906332
RX   PubMed=7873501;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2122 ! MOLM-6
OI   CVCL_7917 ! MOLM-7
OI   CVCL_7918 ! MOLM-8
OI   CVCL_7920 ! MOLM-10
OI   CVCL_7921 ! MOLM-11
OI   CVCL_L075 ! MOLM-12
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   MOLM/AZA-1
AC   CVCL_WI20
DR   Wikidata; Q95990499
RX   PubMed=28052028;
CC   Population: Japanese.
CC   Doubling time: 17 hours (PubMed=28052028).
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 12
//
ID   MOLM/DEC-5
AC   CVCL_WI21
DR   Wikidata; Q95990501
RX   PubMed=28052028;
CC   Population: Japanese.
CC   Doubling time: 17 hours (PubMed=28052028).
CC   Selected for resistance to: ChEBI; CHEBI_50131; 5-aza-2'-deoxycytidine (Decitabine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 12
//
ID   MOLM13rARA-C2mug/ML
AC   CVCL_RS50
DR   Wikidata; Q54906333
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2119 ! MOLM-13
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 14
//
ID   MOLP-2
AC   CVCL_2123
SY   MOLP2
DR   EFO; EFO_0006653
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472938
DR   BioSample; SAMN10988424
DR   cancercelllines; CVCL_2123
DR   Cell_Model_Passport; SIDM01690
DR   CGH-DB; 9146-4
DR   DepMap; ACH-000453
DR   DSMZ; ACC-607
DR   DSMZCellDive; ACC-607
DR   EGA; EGAS00001000610
DR   GEO; GSM562815
DR   GEO; GSM887332
DR   GEO; GSM888408
DR   IARC_TP53; 28365
DR   JCRB; JCRB1820
DR   LiGeA; CCLE_676
DR   PharmacoDB; MOLP2_953_2019
DR   Progenetix; CVCL_2123
DR   Wikidata; Q54906334
RX   CelloPub=CLPUB00604;
RX   PubMed=8148313;
RX   PubMed=10936422;
RX   PubMed=15215163;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Doubling time: ~72 hours (PubMed=8148313); ~4 days (DSMZ=ACC-607).
CC   HLA typing: A*02:01,31:01; B*07:02,56:01; C*04:01,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (DepMap=ACH-000453).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.42%; Native American=1.1%; East Asian, North=76.4%; East Asian, South=13.96%; South Asian=0%; European, North=0%; European, South=5.11% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-607; JCRB=JCRB1820; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 18,19
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5764 ! MOLP-3
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   MOLP-2/R
AC   CVCL_4V88
DR   cancercelllines; CVCL_4V88
DR   Wikidata; Q54906335
RX   DOI=10.1007/s10330-009-0051-5;
RX   PubMed=19756599;
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2123 ! MOLP-2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   MOLP-3
AC   CVCL_5764
SY   MOLP3
DR   Wikidata; Q54906336
RX   PubMed=8148313;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Doubling time: ~96 hours (PubMed=8148313).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2123 ! MOLP-2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   MOLP-5
AC   CVCL_5842
SY   MOLP5
DR   CGH-DB; 34-1
DR   CGH-DB; 9147-4
DR   Wikidata; Q54906337
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10848782;
RX   PubMed=10936422;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Characteristics: Produces Ig kappa.
CC   Doubling time: ~48 hours (PubMed=10848782).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L601 ! B407
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   MOLP-6
AC   CVCL_9984
DR   CGH-DB; 35-1
DR   CGH-DB; 9148-4
DR   Wikidata; Q54906338
RX   PubMed=10937346;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Characteristics: Requires bone marrow stromal cells for optimal growth.
CC   Doubling time: 48 hours (PubMed=10937346).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9985 ! MOLP-7
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   MOLP-7
AC   CVCL_9985
DR   Wikidata; Q54906339
RX   PubMed=10937346;
CC   Population: Japanese.
CC   Characteristics: Requires bone marrow stromal cells for optimal growth.
CC   Doubling time: 168 hours (PubMed=10937346).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9984 ! MOLP-6
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   MOLP-8
AC   CVCL_2124
SY   MOLP8
DR   CLO; CLO_0009849
DR   EFO; EFO_0006654
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472939
DR   BioSample; SAMN10989574
DR   cancercelllines; CVCL_2124
DR   Cell_Model_Passport; SIDM00434
DR   CLS; 304082
DR   Cosmic-CLP; 1330950
DR   DepMap; ACH-000745
DR   DSMZ; ACC-569
DR   DSMZCellDive; ACC-569
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1330950
DR   GEO; GSM562816
DR   GEO; GSM887333
DR   GEO; GSM888409
DR   GEO; GSM1374691
DR   GEO; GSM1670125
DR   IARC_TP53; 30124
DR   LiGeA; CCLE_271
DR   LINCS_LDP; LCL-2047
DR   PharmacoDB; MOLP8_954_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2124
DR   Wikidata; Q54906340
RX   CelloPub=CLPUB00604;
RX   PubMed=15203285;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Doubling time: ~40 hours (DSMZ=ACC-569).
CC   HLA typing: A*03:02,24:02; B*13:02,52:01; C*06:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (Cosmic-CLP=1330950; DepMap=ACH-000745).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.26%; East Asian, North=74.81%; East Asian, South=24.35%; South Asian=0.12%; European, North=0.46%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=1330950; DSMZ=ACC-569; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 12,15
ST   D5S818: 11
ST   D7S820: 7,8
ST   D8S1179: 11,13
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   MOLT-10
AC   CVCL_7924
SY   Molt-10; MOLT 10; MOLT10
DR   Wikidata; Q54906341
RX   PubMed=155647;
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   MOLT-11
AC   CVCL_8152
SY   Molt-11; MOLT 11
DR   Wikidata; Q54906342
CC   Miscellaneous: Cell line has been lost.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   MOLT-12
AC   CVCL_8151
SY   Molt-12; MOLT 12
DR   Wikidata; Q54906343
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2784121;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
CC   Population: Caucasian.
CC   Miscellaneous: Cell line has been lost (DOI=10.1016/B978-0-12-221970-2.50457-5).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1422 ! MOLT-13
OI   CVCL_1423 ! MOLT-14
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   MOLT-13
AC   CVCL_1422
SY   Molt-13; MOLT 13; Molt 13; MOLT13; Molt13
DR   BTO; BTO_0004171
DR   CLO; CLO_0007820
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473543
DR   BioSample; SAMN10988433
DR   cancercelllines; CVCL_1422
DR   Cell_Model_Passport; SIDM00433
DR   ChEMBL-Cells; CHEMBL3308875
DR   ChEMBL-Targets; CHEMBL2366103
DR   Cosmic; 908146
DR   Cosmic; 933538
DR   Cosmic; 1115594
DR   Cosmic; 1151786
DR   Cosmic; 1281378
DR   Cosmic; 1524805
DR   Cosmic; 2602925
DR   Cosmic; 2649239
DR   Cosmic-CLP; 908146
DR   DepMap; ACH-000795
DR   DSMZ; ACC-436
DR   DSMZCellDive; ACC-436
DR   EGA; EGAS00001000978
DR   GDSC; 908146
DR   GEO; GSM887334
DR   GEO; GSM888410
DR   GEO; GSM1670126
DR   GEO; GSM5137728
DR   IARC_TP53; 21512
DR   LiGeA; CCLE_308
DR   PharmacoDB; MOLT13_955_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1422
DR   PubChem_Cell_line; CVCL_1422
DR   Wikidata; Q54906344
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2784121;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=11021758;
RX   PubMed=15472075;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~80-120 hours (DSMZ=ACC-436).
CC   HLA typing: A*11:01,69:01; B*49:01,55:01; C*03:03,07:06 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Heterozygous (Cosmic-CLP=908146; DepMap=ACH-000795).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (Cosmic-CLP=908146; DepMap=ACH-000795).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (DepMap=ACH-000795).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (Cosmic-CLP=908146; DepMap=ACH-000795).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.68%; Native American=0.55%; East Asian, North=0%; East Asian, South=0%; South Asian=4.38%; European, North=54.27%; European, South=40.12% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=908146; DSMZ=ACC-436
ST   Amelogenin: X
ST   CSF1PO: 11,12 (DSMZ=ACC-436)
ST   CSF1PO: 11,13 (Cosmic-CLP=908146)
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 17,18
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 10,13
ST   FGA: 19,22,23
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8151 ! MOLT-12
OI   CVCL_1423 ! MOLT-14
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   MOLT-14
AC   CVCL_1423
SY   Molt-14; MOLT 14; Molt 14; MOLT14; Molt14
DR   BTO; BTO_0004172
DR   CLO; CLO_0007821
DR   BioSample; SAMN03473544
DR   cancercelllines; CVCL_1423
DR   Cell_Model_Passport; SIDM00432
DR   Cosmic; 998729
DR   Cosmic; 1037682
DR   Cosmic; 1281379
DR   Cosmic; 1330490
DR   Cosmic; 2602926
DR   DSMZ; ACC-437
DR   DSMZCellDive; ACC-437
DR   GEO; GSM5137761
DR   LINCS_LDP; LCL-2061
DR   PRIDE; PXD023662
DR   Wikidata; Q54906345
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2784121;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=35354797;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/molt-14/
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-437).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-437
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12,13
ST   D16S539: 9,11
ST   D18S51: 17,18
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 10,13
ST   FGA: 19,22,23
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8151 ! MOLT-12
OI   CVCL_1422 ! MOLT-13
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   MOLT-15
AC   CVCL_8150
SY   Molt-15; MOLT 15; BCH-5
DR   BioSample; SAMN03151632
DR   cancercelllines; CVCL_8150
DR   Cosmic; 913415
DR   Cosmic; 1524806
DR   Wikidata; Q54906346
RX   PubMed=2784121;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=9933131;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=15472075;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a CTV-1 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388). Originally thought to originate from a 33 year old male patient suffering from acute myeloid leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00147.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Gly477Ser (c.1429G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Gly831Glu (c.2492G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Ala353Val (c.1058C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Pro447Leu (c.1340C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6524; LCK; Simple; p.Ala500Thr (c.1498G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gly1532Arg (c.4594G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Ser2523Ter (c.7568C>A); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:8804; PDGFRB; Simple; p.Met772Ile (c.2316G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys656Phe (c.1967G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Arg75Met (c.224G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys175Met (c.524A>T); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1150 ! CTV-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   MOLT-16
AC   CVCL_1424
SY   Molt-16; MOLT 16; MOLT16; Molt16
DR   BTO; BTO_0004173
DR   EFO; EFO_0002239
DR   CLDB; cl3516
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473343
DR   BioSample; SAMN10988570
DR   cancercelllines; CVCL_1424
DR   Cell_Model_Passport; SIDM00431
DR   ChEMBL-Cells; CHEMBL3308271
DR   ChEMBL-Targets; CHEMBL2366362
DR   Cosmic; 908147
DR   Cosmic; 913425
DR   Cosmic; 919155
DR   Cosmic; 922678
DR   Cosmic; 998725
DR   Cosmic; 1115601
DR   Cosmic; 1151787
DR   Cosmic; 1226859
DR   Cosmic; 1281380
DR   Cosmic; 1330491
DR   Cosmic; 1641382
DR   Cosmic; 1760528
DR   Cosmic; 2458764
DR   Cosmic; 2462862
DR   Cosmic; 2602927
DR   Cosmic-CLP; 908147
DR   DepMap; ACH-000918
DR   DSMZ; ACC-29
DR   DSMZCellDive; ACC-29
DR   EGA; EGAS00001000978
DR   GDSC; 908147
DR   GEO; GSM887335
DR   GEO; GSM888411
DR   GEO; GSM1670127
DR   GEO; GSM5137729
DR   IARC_TP53; 187
DR   IARC_TP53; 21513
DR   IGRhCellID; MOLT16
DR   LiGeA; CCLE_638
DR   LINCS_LDP; LCL-1018
DR   Lonza; 2
DR   MetaboLights; MTBLS789
DR   PharmacoDB; MOLT16_956_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1424
DR   PubChem_Cell_line; CVCL_1424
DR   Wikidata; Q54906347
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2144611;
RX   PubMed=2784121;
RX   PubMed=9408752;
RX   PubMed=9510473;
RX   PubMed=9933131;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=15472075;
RX   PubMed=15843827;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/molt-16/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Doubling time: ~30 hours (DSMZ=ACC-29).
CC   HLA typing: A*23:01,30:02; B*14:02,14:02; C*08:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7553; MYC + HGNC; HGNC:12027; TRA; Name(s)=TRA@-MYC (PubMed=9408752; PubMed=15843827).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1589His (c.4766G>A); ClinVar=VCV000127298; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=908147).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg693His (c.2078G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=908147).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=908147).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg427Trp (c.1279C>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=908147).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=79.1%; Native American=0.82%; East Asian, North=2.03%; East Asian, South=0%; South Asian=1.85%; European, North=7.73%; European, South=8.47% (PubMed=30894373).
CC   Caution: TP53 mutations indicated to be at p.Met237Arg (c.710T>G) and p.Gly244Cys (c.730G>T) (PubMed=2144611).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=908147; DSMZ=ACC-29
ST   Amelogenin: X
ST   CSF1PO: 10,11,12 (DSMZ=ACC-29)
ST   CSF1PO: 11,12 (Cosmic-CLP=908147)
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 14,15,20
ST   D19S433: 10,13
ST   D21S11: 32.2,33.2
ST   D2S1338: 19,21
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 12 (Cosmic-CLP=908147)
ST   D7S820: 12,13 (DSMZ=ACC-29)
ST   D8S1179: 14
ST   FGA: 23,24
ST   Penta D: 6,10
ST   Penta E: 16
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2125 ! MOLT-17
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   MOLT-17
AC   CVCL_2125
SY   Molt-17; MOLT 17; MOLT17
DR   BTO; BTO_0004174
DR   CLO; CLO_0051012
DR   CLDB; cl3517
DR   BioSample; SAMN03472051
DR   Cell_Model_Passport; SIDM00430
DR   Cosmic; 933539
DR   Cosmic; 1118461
DR   Cosmic; 2602928
DR   DSMZ; ACC-36
DR   DSMZCellDive; ACC-36
DR   GEO; GSM5137762
DR   NCBI_Iran; C516
DR   PRIDE; PXD023662
DR   RCB; RCB1982
DR   RCB; RCB4561
DR   TKG; TKG 0385
DR   Wikidata; Q54906348
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2784121;
RX   PubMed=2961573;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=35354797;
WW   Info; RCB; -; https://cell.brc.riken.jp/en/announcement/molt-17
CC   Problematic cell line: Partially contaminated. The RCB/Riken RCB1982 stock was contaminated and was replaced by RCB4561 which originates from DSMZ ACC-36. On the basis of STR profile, the version at TKG (TKG 0385) seems to be identical or closely related to the RCB1962 contaminated stock.
CC   Population: African American.
CC   Doubling time: ~50 hours (DSMZ=ACC-36).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: RCB; RCB1982; true.
CC   Discontinued: TKG; TKG 0385; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-36; RCB=RCB1982; TKG=TKG 0385
ST   Amelogenin: X
ST   CSF1PO: 9,10,12 (RCB=RCB1982)
ST   CSF1PO: 10,12 (TKG=TKG 0385)
ST   CSF1PO: 11,12 (DSMZ=ACC-36)
ST   D13S317: 10,11,12 (RCB=RCB1982)
ST   D13S317: 10,12 (TKG=TKG 0385)
ST   D13S317: 12 (DSMZ=ACC-36)
ST   D16S539: 9,10 (DSMZ=ACC-36)
ST   D16S539: 9,14,15 (RCB=RCB1982)
ST   D16S539: 9,15 (TKG=TKG 0385)
ST   D18S51: 14,15,20
ST   D19S433: 10,13
ST   D21S11: 32.2,33.2
ST   D2S1338: 19,21
ST   D3S1358: 14,17
ST   D5S818: 11,12 (DSMZ=ACC-36)
ST   D5S818: 12 (TKG=TKG 0385)
ST   D5S818: 12,13 (RCB=RCB1982)
ST   D7S820: 11 (TKG=TKG 0385)
ST   D7S820: 11,12,13 (RCB=RCB1982)
ST   D7S820: 12 (DSMZ=ACC-36)
ST   D8S1179: 14
ST   FGA: 23,24
ST   Penta D: 6,10
ST   Penta E: 16
ST   TH01: 9 (RCB=RCB1982; TKG=TKG 0385)
ST   TH01: 9,9.3 (DSMZ=ACC-36)
ST   TPOX: 8 (RCB=RCB1982; TKG=TKG 0385)
ST   TPOX: 8,11 (DSMZ=ACC-36)
ST   vWA: 16 (DSMZ=ACC-36)
ST   vWA: 17,18,19 (RCB=RCB1982)
ST   vWA: 18,19 (TKG=TKG 0385)
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1424 ! MOLT-16
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   MOLT-3
AC   CVCL_0624
SY   Molt-3; MOLT 3; Molt 3; MOLT3; Molt3
DR   BTO; BTO_0001081
DR   CLO; CLO_0007824
DR   CLO; CLO_0051008
DR   EFO; EFO_0005265
DR   CLDB; cl3519
DR   CLDB; cl3521
DR   CLDB; cl3522
DR   CLDB; cl3523
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-1552
DR   BCRC; 60106
DR   BEI_Resources; ARP-12187
DR   BioSample; SAMN03470846
DR   BioSample; SAMN03471394
DR   BioSample; SAMN03472164
DR   BioSample; SAMN03473404
DR   BioSample; SAMN10989586
DR   cancercelllines; CVCL_0624
DR   Cell_Model_Passport; SIDM00153
DR   ChEMBL-Cells; CHEMBL3307556
DR   ChEMBL-Targets; CHEMBL614176
DR   CLS; 300116
DR   Cosmic; 724815
DR   Cosmic; 850193
DR   Cosmic; 913410
DR   Cosmic; 999756
DR   Cosmic; 1191701
DR   Cosmic; 1281377
DR   Cosmic; 1524845
DR   Cosmic; 2301561
DR   Cosmic; 2361367
DR   Cosmic; 2602923
DR   DepMap; ACH-000964
DR   DSMZ; ACC-84
DR   DSMZCellDive; ACC-84
DR   ECACC; 90021901
DR   GEO; GSM236793
DR   GEO; GSM236829
DR   GEO; GSM5137730
DR   IGRhCellID; MOLT3
DR   IZSLER; BS TCL 44
DR   JCRB; JCRB9048
DR   LiGeA; CCLE_717
DR   PharmacoDB; MOLT3_957_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_0624
DR   PubChem_Cell_line; CVCL_0624
DR   RCB; RCB1164
DR   Wikidata; Q54906351
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=327080;
RX   PubMed=1086134;
RX   PubMed=2846092;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3518877;
RX   PubMed=3856477;
RX   PubMed=3874327;
RX   PubMed=4547172;
RX   PubMed=4567231;
RX   PubMed=6220172;
RX   PubMed=6600440;
RX   PubMed=6978176;
RX   PubMed=7630190;
RX   PubMed=8547074;
RX   PubMed=8608962;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=9933131;
RX   PubMed=10739008;
RX   PubMed=11986953;
RX   PubMed=12623853;
RX   PubMed=15472075;
RX   PubMed=17170727;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/molt-3/
WW   Provider; NIBSC; 0010; http://www.nibsc.org/Default.aspx?pageid=597&id=0010&theme=default
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=6978176); 24-48 hours (CLS=300116); ~40 hours (DSMZ=ACC-84).
CC   Karyotypic information: Hypertetraploid karyotype (ATCC=CRL-1552).
CC   Microsatellite instability: Instable (MSI) (PubMed=10739008; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (PubMed=15472075; DepMap=ACH-000964).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (PubMed=15472075; DepMap=ACH-000964).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000964).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (DepMap=ACH-000964).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.91%; Native American=0%; East Asian, North=2.31%; East Asian, South=0%; South Asian=0.44%; European, North=66.02%; European, South=30.32% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-1552; CLS=300116; COG; DSMZ=ACC-84; PubMed=25877200; RCB=RCB1164
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12 (ATCC=CRL-1552; COG; DSMZ=ACC-84)
ST   CSF1PO: 11,12,13 (CLS=300116; PubMed=25877200; RCB=RCB1164)
ST   D13S317: 11,12,13 (RCB=RCB1164)
ST   D13S317: 12,13 (ATCC=CRL-1552; CLS=300116; COG; DSMZ=ACC-84; PubMed=25877200)
ST   D16S539: 10,11,13 (RCB=RCB1164)
ST   D16S539: 11,12,14 (COG)
ST   D16S539: 11,13,14 (ATCC=CRL-1552; PubMed=25877200)
ST   D16S539: 11,14 (DSMZ=ACC-84)
ST   D16S539: 11,14,15 (CLS=300116)
ST   D18S51: 12,13,16,17 (CLS=300116; DSMZ=ACC-84)
ST   D18S51: 13,17 (COG)
ST   D18S51: 13,17,18 (ATCC=CRL-1552; PubMed=25877200)
ST   D19S433: 14,15 (ATCC=CRL-1552; COG)
ST   D19S433: 14,15,16 (CLS=300116; DSMZ=ACC-84)
ST   D1S1656: 15.3,16,16.3
ST   D21S11: 28,29,30,31 (DSMZ=ACC-84)
ST   D21S11: 29,30 (ATCC=CRL-1552; PubMed=25877200)
ST   D21S11: 29,30,31,32 (CLS=300116)
ST   D2S1338: 22,23,24 (DSMZ=ACC-84)
ST   D2S1338: 23,24 (ATCC=CRL-1552; CLS=300116; COG)
ST   D3S1358: 14,15,16,17 (COG)
ST   D3S1358: 15,16,17 (ATCC=CRL-1552; CLS=300116; DSMZ=ACC-84; PubMed=25877200)
ST   D5S818: 12 (ATCC=CRL-1552; PubMed=25877200)
ST   D5S818: 12,13 (CLS=300116; DSMZ=ACC-84; RCB=RCB1164)
ST   D7S820: 7,8,9 (RCB=RCB1164)
ST   D7S820: 7,8,9,10 (CLS=300116; DSMZ=ACC-84)
ST   D7S820: 8,10 (ATCC=CRL-1552; COG; PubMed=25877200)
ST   D8S1179: 9,13,14,15 (ATCC=CRL-1552; CLS=300116; PubMed=25877200)
ST   D8S1179: 9,14 (DSMZ=ACC-84)
ST   D8S1179: 9,14,15 (COG)
ST   FGA: 19,21,25 (CLS=300116)
ST   FGA: 21,22,23,24 (PubMed=25877200)
ST   FGA: 22,23,24 (DSMZ=ACC-84)
ST   FGA: 22,24 (ATCC=CRL-1552; COG)
ST   Penta D: 8,13
ST   Penta E: 14,16
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17 (ATCC=CRL-1552; COG; PubMed=25877200)
ST   vWA: 17,18 (CLS=300116; DSMZ=ACC-84; RCB=RCB1164)
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 38
//
ID   MOLT-3/MTX.P-9
AC   CVCL_S660
DR   cancercelllines; CVCL_S660
DR   Wikidata; Q54906353
RX   PubMed=8608962;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/MTX10000
AC   CVCL_S658
SY   MOLT-3/MTX10,000
DR   cancercelllines; CVCL_S658
DR   Wikidata; Q54906354
RX   PubMed=3856477;
RX   PubMed=8608962;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/MTX200
AC   CVCL_S659
DR   cancercelllines; CVCL_S659
DR   Wikidata; Q54906355
RX   PubMed=3856477;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/MTXt
AC   CVCL_S652
DR   cancercelllines; CVCL_S652
DR   Wikidata; Q54906356
RX   PubMed=6978176;
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=6978176).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 18
//
ID   MOLT-3/TMQ200
AC   CVCL_S653
DR   cancercelllines; CVCL_S653
DR   Wikidata; Q54906357
RX   PubMed=2573416;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9737; Trimetrexate.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/TMQ200-CB371730
AC   CVCL_S654
DR   cancercelllines; CVCL_S654
DR   Wikidata; Q54906358
RX   PubMed=1683871;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9737; Trimetrexate.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S653 ! MOLT-3/TMQ200
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/TMQ200-MTX500
AC   CVCL_S657
DR   cancercelllines; CVCL_S657
DR   Wikidata; Q54906359
RX   PubMed=7850779;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Selected for resistance to: ChEBI; CHEBI_9737; Trimetrexate.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S653 ! MOLT-3/TMQ200
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/TMQ2500
AC   CVCL_S655
DR   cancercelllines; CVCL_S655
DR   Wikidata; Q54906360
RX   PubMed=2573416;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9737; Trimetrexate.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/TMQ800
AC   CVCL_S656
DR   cancercelllines; CVCL_S656
DR   Wikidata; Q54906361
RX   PubMed=2573416;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9737; Trimetrexate.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/Z29
AC   CVCL_M774
SY   Molt-3/Z29; Molt-3/Z-29; MOLT-3 / Z29
DR   BEI_Resources; ARP-12185
DR   cancercelllines; CVCL_M774
DR   Wikidata; Q54906362
RX   PubMed=1653487;
CC   Population: Caucasian.
CC   Virology: Infected by human herpesvirus 6B (HHV-6B) strain Z29.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Caution: Was discontinued from BEI_Resources because the cell line seemed to have also been infected by HIV-1 (personal communication of Rashid, Sujatha).
CC   Discontinued: BEI_Resources; ARP-12185; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   MOLT-3/ZD1694.C
AC   CVCL_S661
DR   cancercelllines; CVCL_S661
DR   Wikidata; Q54906363
RX   PubMed=8576277;
RX   PubMed=8608962;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_5847; ICI D1694 (Tomudex; ZD1694).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-3/ZD1694.P9
AC   CVCL_S662
DR   cancercelllines; CVCL_S662
DR   Wikidata; Q54906364
RX   PubMed=8608962;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_5847; ICI D1694 (Tomudex; ZD1694).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   MOLT-4
AC   CVCL_0013
SY   Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D
DR   BTO; BTO_0000873
DR   CLO; CLO_0007825
DR   CLO; CLO_0032246
DR   CLO; CLO_0050992
DR   EFO; EFO_0001220
DR   MCCL; MCC:0000335
DR   CLDB; cl3524
DR   CLDB; cl3525
DR   CLDB; cl3527
DR   CLDB; cl3528
DR   CLDB; cl3529
DR   CLDB; cl3530
DR   CLDB; cl3531
DR   CLDB; cl3532
DR   CLDB; cl4976
DR   CLDB; cl5233
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-1582
DR   BCRC; 60060
DR   BCRJ; 0176
DR   BioSample; SAMN03470847
DR   BioSample; SAMN03471400
DR   BioSample; SAMN03472410
DR   BioSample; SAMN03473319
DR   BioSample; SAMN10988202
DR   cancercelllines; CVCL_0013
DR   CCRID; 1101HUM-PUMC000043
DR   CCRID; 3101HUMTCHu224
DR   CCRID; 4201HUM-CCTCC00083
DR   CCTCC; GDC0083
DR   Cell_Model_Passport; SIDM00145
DR   ChEMBL-Cells; CHEMBL3307557
DR   ChEMBL-Targets; CHEMBL614177
DR   CLS; 300115
DR   Coriell; GM02219
DR   Cosmic; 716176
DR   Cosmic; 721716
DR   Cosmic; 801730
DR   Cosmic; 850194
DR   Cosmic; 850381
DR   Cosmic; 875865
DR   Cosmic; 897451
DR   Cosmic; 905958
DR   Cosmic; 913409
DR   Cosmic; 919154
DR   Cosmic; 922677
DR   Cosmic; 932766
DR   Cosmic; 933547
DR   Cosmic; 974249
DR   Cosmic; 991545
DR   Cosmic; 999763
DR   Cosmic; 1012099
DR   Cosmic; 1019314
DR   Cosmic; 1044254
DR   Cosmic; 1070704
DR   Cosmic; 1071877
DR   Cosmic; 1082518
DR   Cosmic; 1092615
DR   Cosmic; 1115596
DR   Cosmic; 1118467
DR   Cosmic; 1127263
DR   Cosmic; 1130237
DR   Cosmic; 1151788
DR   Cosmic; 1175131
DR   Cosmic; 1175857
DR   Cosmic; 1176596
DR   Cosmic; 1226858
DR   Cosmic; 1305339
DR   Cosmic; 1312325
DR   Cosmic; 1330500
DR   Cosmic; 1483362
DR   Cosmic; 1509200
DR   Cosmic; 1524808
DR   Cosmic; 1639636
DR   Cosmic; 1664513
DR   Cosmic; 1811158
DR   Cosmic; 1998457
DR   Cosmic; 2039521
DR   Cosmic; 2165720
DR   Cosmic; 2361368
DR   Cosmic; 2560251
DR   Cosmic; 2602924
DR   Cosmic-CLP; 905958
DR   dbMHC; 48976
DR   DepMap; ACH-001127
DR   DSMZ; ACC-362
DR   DSMZCellDive; ACC-362
DR   ECACC; 85011413
DR   ECACC; 94022544
DR   EGA; EGAS00001000978
DR   GDSC; 905958
DR   GEO; GSM2092
DR   GEO; GSM50196
DR   GEO; GSM50912
DR   GEO; GSM236794
DR   GEO; GSM236830
DR   GEO; GSM743460
DR   GEO; GSM750821
DR   GEO; GSM799348
DR   GEO; GSM799411
DR   GEO; GSM887336
DR   GEO; GSM888412
DR   GEO; GSM1178423
DR   GEO; GSM1178424
DR   GEO; GSM1178425
DR   GEO; GSM1181333
DR   GEO; GSM1181349
DR   GEO; GSM1670128
DR   GEO; GSM1696583
DR   GEO; GSM1696584
DR   GEO; GSM1696585
DR   GEO; GSM1696586
DR   GEO; GSM2124644
DR   GEO; GSM4471876
DR   GEO; GSM5137731
DR   GEO; GSM7701445
DR   GEO; GSM7701446
DR   IARC_TP53; 27042
DR   ICLC; HTL99025
DR   IGRhCellID; MOLT4
DR   IHW; IHW09226
DR   IPD-IMGT/HLA; 11094
DR   IZSLER; BS TCL 85
DR   JCRB; IFO50362
DR   JCRB; JCRB9031
DR   KCB; KCB 200940YJ
DR   KCLB; 21582
DR   LINCS_LDP; LCL-1019
DR   Lonza; 810
DR   NCBI_Iran; C149
DR   NCI-DTP; MOLT-4
DR   PharmacoDB; MOLT4_958_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD018565
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0013
DR   PubChem_Cell_line; CVCL_0013
DR   RCB; RCB0206
DR   SKY/M-FISH/CGH; 2741
DR   Ubigene; YC-C127
DR   Wikidata; Q54906365
RX   CelloPub=CLPUB00447;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=165156;
RX   PubMed=1765142;
RX   PubMed=2041050;
RX   PubMed=2140233;
RX   PubMed=2144611;
RX   PubMed=2846092;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3335022;
RX   PubMed=3874327;
RX   PubMed=4547172;
RX   PubMed=4567231;
RX   PubMed=6181032;
RX   PubMed=6198871;
RX   PubMed=6200433;
RX   PubMed=6582512;
RX   PubMed=6954533;
RX   PubMed=8127147;
RX   PubMed=8316623;
RX   PubMed=8547074;
RX   PubMed=8558913;
RX   PubMed=8641406;
RX   PubMed=8957066;
RX   PubMed=9331090;
RX   PubMed=9510473;
RX   PubMed=9685479;
RX   PubMed=9787181;
RX   PubMed=10071127;
RX   PubMed=10700174;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=11416159;
RX   PubMed=11986953;
RX   PubMed=12068308;
RX   PubMed=15472075;
RX   PubMed=15748285;
RX   PubMed=15901131;
RX   PubMed=16408098;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=17117183;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20922763;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24762992;
RX   PubMed=25877200;
RX   PubMed=26295583;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28569787;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31733513;
RX   PubMed=32449352;
RX   PubMed=35354797;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=31
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/molt-4/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-609.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/leukemia-xenograft-model/molt4-xenograft-model/
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
WW   Provider; NIBSC; 0011; http://www.nibsc.org/Default.aspx?pageid=597&id=0011&theme=default
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 31.56 +- 1.49 hours (PubMed=24762992); 33 hours (PubMed=17117183); 29 hours (PubMed=20922763); 24-48 hours (CLS=300115); ~40 hours (DSMZ=ACC-362); 27.9 hours (NCI-DTP=MOLT-4).
CC   HLA typing: A*01:01:01,25:01; B*18,57:01:01; C*06:02,12:03:01; DPB1*02:01:02; DQB1*02:02,03:01:01; DRB1*07,12 (PubMed=15748285).
CC   HLA typing: A*01:01:01:01,25:01; B*57:01:01,18:01; C*06:02,12:03; DPA1*01:03; DPB1*02:01:02; DRB1*07,12:01 (IPD-IMGT/HLA=11094).
CC   HLA typing: A*01:01:01,25:01:01; B*18:01:01,57:01:01; C*06:02:01,12:03:01 (DSMZCellDive=ACC-362).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=11226526; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (PubMed=12068308; PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (PubMed=17088437).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.38%; Native American=0%; East Asian, North=1.74%; East Asian, South=0%; South Asian=0.94%; European, North=68.08%; European, South=28.87% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-1582; CCRID; CLS=300115; COG; Cosmic-CLP=905958; DSMZ=ACC-362; JCRB=IFO50362; JCRB=JCRB9031; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543; PubMed=20922763; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12 (CLS=300115; DSMZ=ACC-362)
ST   CSF1PO: 11,12,13 (ATCC=CRL-1582; CCRID; COG; Cosmic-CLP=905958; JCRB=IFO50362; JCRB=JCRB9031; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763; PubMed=25877200)
ST   D13S317: 12,13 (ATCC=CRL-1582; CCRID; CLS=300115; COG; Cosmic-CLP=905958; JCRB=IFO50362; JCRB=JCRB9031; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763; PubMed=25877200)
ST   D13S317: 12,13,14 (DSMZ=ACC-362)
ST   D16S539: 11,14 (ATCC=CRL-1582; CCRID; CLS=300115; Cosmic-CLP=905958; DSMZ=ACC-362; JCRB=IFO50362; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763)
ST   D16S539: 11,14,15 (COG; JCRB=JCRB9031; PubMed=25877200)
ST   D18S51: 12,13,16,17,18 (DSMZ=ACC-362)
ST   D18S51: 12,13,17 (CLS=300115)
ST   D18S51: 13,16,17 (ATCC=CRL-1582; DOI=10.4172/2157-7145.S2-005)
ST   D18S51: 13,17 (CCRID; PubMed=19372543; PubMed=20922763; PubMed=25877200)
ST   D19S433: 14,15 (ATCC=CRL-1582; CCRID; DOI=10.4172/2157-7145.S2-005; DSMZ=ACC-362; PubMed=20922763; PubMed=25877200)
ST   D19S433: 14,15,16 (PubMed=19372543)
ST   D21S11: 27,28,29,30 (ATCC=CRL-1582)
ST   D21S11: 27,28,29,30,31 (COG; DOI=10.4172/2157-7145.S2-005; PubMed=25877200)
ST   D21S11: 28,29,30 (CLS=300115; DSMZ=ACC-362; PubMed=11416159)
ST   D21S11: 28,29,30,31 (CCRID; PubMed=19372543; PubMed=20922763)
ST   D2S1338: 23,24
ST   D3S1358: 14,16 (ATCC=CRL-1582; CCRID; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763; PubMed=25877200)
ST   D3S1358: 15,16 (CLS=300115; DSMZ=ACC-362)
ST   D5S818: 11,12 (DSMZ=ACC-362)
ST   D5S818: 12 (ATCC=CRL-1582; CCRID; CLS=300115; COG; Cosmic-CLP=905958; JCRB=IFO50362; JCRB=JCRB9031; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763)
ST   D5S818: 12,13 (PubMed=25877200)
ST   D7S820: 8,10 (DSMZ=ACC-362)
ST   D7S820: 8,10,11 (ATCC=CRL-1582; CCRID; CLS=300115; COG; Cosmic-CLP=905958; JCRB=IFO50362; JCRB=JCRB9031; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763; PubMed=25877200)
ST   D8S1179: 9,13,14 (ATCC=CRL-1582; CLS=300115; DSMZ=ACC-362)
ST   D8S1179: 9,13,14,15 (PubMed=25877200)
ST   D8S1179: 9,14 (CCRID; COG; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763)
ST   D8S1179: 9,14,15 (PubMed=11416159)
ST   FGA: 21,22,23,24,25 (PubMed=25877200)
ST   FGA: 21,22,24,25 (DSMZ=ACC-362)
ST   FGA: 22,23,24,25 (ATCC=CRL-1582; COG; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=20922763)
ST   FGA: 22,23,25 (CCRID)
ST   FGA: 22,24 (CLS=300115)
ST   FGA: 22,25 (PubMed=11416159)
ST   Penta D: 8,12,13 (CLS=300115; DSMZ=ACC-362)
ST   Penta D: 8,13 (ATCC=CRL-1582; PubMed=25877200)
ST   Penta E: 14,15 (DSMZ=ACC-362)
ST   Penta E: 14,15,16 (CLS=300115)
ST   Penta E: 14,16 (ATCC=CRL-1582; PubMed=25877200)
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17,18 (DSMZ=ACC-362)
ST   vWA: 17 (PubMed=11416159)
ST   vWA: 17,18 (ATCC=CRL-1582; CCRID; CLS=300115; COG; Cosmic-CLP=905958; JCRB=IFO50362; JCRB=JCRB9031; KCLB=21582; DOI=10.4172/2157-7145.S2-005; PubMed=20922763; PubMed=25877200)
ST   vWA: 17,18,19 (PubMed=19372543)
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   MOLT-4 clone 8
AC   CVCL_F827
SY   Molt-4 Clone 8; Molt-4 clone no.8; MOLT 4 clone 8; Molt 4 clone 8; Molt4 clone 8; Molt4 Clone8; MOLT-4 cl. 8; MOLT-4 cl.8; MOLT-F8; M4Cl8; M4C18; MOLT4/8
DR   BEI_Resources; ARP-175
DR   cancercelllines; CVCL_F827
DR   Wikidata; Q54906366
RX   PubMed=2419583;
WW   Provider; NIBSC; 0052; http://www.nibsc.org/Default.aspx?pageid=597&id=0052&theme=default
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 24
//
ID   MOLT-4 Ma
AC   CVCL_E8AS
SY   MOLT4 Ma; Molt4-Ma
RX   PubMed=1319062;
CC   Population: Caucasian.
CC   Virology: Infected with Moloney murine leukemia virus (MoMuLV) from MiCl1 (S+L-) (Cellosaurus=CVCL_3405) cells (PubMed=1319062).
CC   Virology: Supports replication of hepatitis C virus genome (PubMed=1319062).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MOLT-4-luc2
AC   CVCL_5J16
SY   MOLT4-luc2
DR   cancercelllines; CVCL_5J16
DR   Revvity/PerkinElmer; 125057
DR   Wikidata; Q54906367
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 125057; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 19
//
ID   MOLT-4.CCR5
AC   CVCL_WU92
DR   cancercelllines; CVCL_WU92
DR   Wikidata; Q95990573
RX   PubMed=15169555;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F827 ! MOLT-4 clone 8
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   MOLT-4/ADR
AC   CVCL_4Y72
SY   Molt-4/ADR; MAR
DR   cancercelllines; CVCL_4Y72
DR   Wikidata; Q54906368
RX   PubMed=25457413;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   MOLT-4/CCR5
AC   CVCL_S545
SY   MOLT-4 CCR5+
DR   BEI_Resources; ARP-4984
DR   cancercelllines; CVCL_S545
DR   Wikidata; Q54906369
RX   PubMed=10890354;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F827 ! MOLT-4 clone 8
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 22
//
ID   MOLT-4/R7hyg
AC   CVCL_E3D7
RX   PubMed=7523570;
CC   Population: Caucasian.
CC   Characteristics: Transfected with plasmid R7hyg containing a human immunodeficiency virus 1 (HIV-1) isolate HXB2 proviral clone containing HygR in place of the HIV-1 nef gene (PubMed=7523570).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MOLT-4(Cas9)
AC   CVCL_E7JC
WW   Provider; BRICS; ECC3044; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3978
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MOLT-4F
AC   CVCL_2792
SY   MOLT-4f; Molt-4F; MOLT 4F; Molt/4F; MOLT4F; MOLT4f; MOLT-4-F
DR   CLO; CLO_0050994
DR   BioSample; SAMN03472036
DR   cancercelllines; CVCL_2792
DR   ChEMBL-Cells; CHEMBL3307263
DR   ChEMBL-Targets; CHEMBL613515
DR   GEO; GSM827231
DR   JCRB; JCRB0021
DR   LINCS_LDP; LCL-1031
DR   Progenetix; CVCL_2792
DR   PubChem_Cell_line; CVCL_2792
DR   RCB; RCB1936
DR   TKG; TKG 0229
DR   Wikidata; Q54906370
RX   PubMed=62390;
RX   PubMed=3495441;
RX   PubMed=3518877;
RX   PubMed=6600440;
RX   PubMed=9290701;
RX   PubMed=9738977;
RX   PubMed=20215515;
RX   PubMed=20519628;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): RCB=RCB1936; TKG=TKG 0229
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,12,13
ST   D5S818: 11,12,13 (RCB=RCB1936)
ST   D5S818: 12,13 (TKG=TKG 0229)
ST   D7S820: 7,8,10 (RCB=RCB1936)
ST   D7S820: 7,8,10,11 (TKG=TKG 0229)
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17,18 (TKG=TKG 0229)
ST   vWA: 17,18,19 (RCB=RCB1936)
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   MOLT-4V
AC   CVCL_F830
DR   cancercelllines; CVCL_F830
DR   Wikidata; Q54906371
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   MOLT4/P
AC   CVCL_A1BB
DR   cancercelllines; CVCL_A1BB
DR   Wikidata; Q102114554
RX   PubMed=34332580;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_71223; Pralatrexate (Folotyn).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   MOMA-1 [Mouse mammary gland]
AC   CVCL_5G84
SY   MOuse MAmmary-1
DR   Wikidata; Q54906372
RX   PubMed=2423737;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   MOMA-1 [Mouse/rat hybridoma against mouse Siglec1]
AC   CVCL_A6ZP
SY   MOMA1
DR   Wikidata; Q107116384
RX   PubMed=3733156;
RX   PubMed=16716409;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q62230; Mouse Siglec1/Cd169.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MOMA-2 [Mouse mammary gland]
AC   CVCL_5G85
SY   MOuse MAmmary-2
DR   Wikidata; Q54906373
RX   PubMed=2423737;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   MOMA-2 [Mouse/rat hybridoma against mouse macrophages and monocytes]
AC   CVCL_A6ZQ
SY   MOMA2
DR   Wikidata; Q107116385
RX   PubMed=3321409;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse macrophages and monocytes intracellular antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MOMA-2 clone MA-4
AC   CVCL_E1IJ
SY   MA-4
RX   PubMed=3653254;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5G85 ! MOMA-2 [Mouse mammary gland]
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MON
AC   CVCL_M846
DR   BioSample; SAMN10989608
DR   cancercelllines; CVCL_M846
DR   Cell_Model_Passport; SIDM01374
DR   Cosmic; 802246
DR   DepMap; ACH-001128
DR   Wikidata; Q54906374
RX   PubMed=9671307;
RX   PubMed=10397258;
RX   PubMed=16945155;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   MON-100
AC   CVCL_D4YY
DR   Wikidata; Q127382839
RX   PubMed=1717598;
RX   PubMed=2676606;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P05408; Human SCG5 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-101
AC   CVCL_D4YZ
DR   Wikidata; Q127382840
RX   PubMed=1717598;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05408; Human SCG5 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-102
AC   CVCL_D4Z0
DR   Wikidata; Q127382841
RX   PubMed=1717598;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05408; Human SCG5 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-114
AC   CVCL_D4YM
DR   Wikidata; Q127382842
RX   PubMed=1313334;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen preferentially expressed in cells and tissues with neuroendocrine characteristics.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-138
AC   CVCL_D4YN
DR   Wikidata; Q127382844
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-139
AC   CVCL_D4YP
DR   Wikidata; Q127382845
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-140
AC   CVCL_D4YQ
DR   Wikidata; Q127382846
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-141
AC   CVCL_D4YR
DR   Wikidata; Q127382847
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-142
AC   CVCL_D4Z1
DR   Wikidata; Q127382848
RX   PubMed=1717598;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05408; Human SCG5 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-143
AC   CVCL_D4Z2
DR   Wikidata; Q127382849
RX   PubMed=1717598;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05408; Human SCG5 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-144
AC   CVCL_D4Z3
DR   Wikidata; Q127382850
RX   PubMed=1717598;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05408; Human SCG5 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-147
AC   CVCL_D4YS
DR   Wikidata; Q127382851
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-148
AC   CVCL_D4YT
DR   Wikidata; Q127382852
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG3 (PubMed=1737642); IgG2a (Enzo).
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   MON-150
AC   CVCL_D4YU
DR   Wikidata; Q127382854
RX   PubMed=1503502;
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR (Note=Also reacts with mouse).
CC   Monoclonal antibody target: UniProtKB; P07476; Human IVL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-151
AC   CVCL_D4YV
DR   Wikidata; Q127382855
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-152
AC   CVCL_D4YW
DR   Wikidata; Q127382856
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON-153
AC   CVCL_D4YX
DR   Wikidata; Q127382857
RX   PubMed=1737642;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09958; Human FUR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MON1
AC   CVCL_YE10
DR   Wikidata; Q95990583
RX   CelloPub=CLPUB00548;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   MON/4C9
AC   CVCL_XJ62
DR   CCRID; 4201PAT-CCTCC01239
DR   Wikidata; Q95990584
RX   DOI=10.1007/s12161-019-01461-3;
RX   Patent=CN109776682B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018117.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_27617; Monensin A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   Monca
AC   CVCL_0G15
DR   Wikidata; Q54906375
RX   PubMed=9738977;
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 5
//
ID   Mono-1
AC   CVCL_WN74
DR   Wikidata; Q95990588
RX   PubMed=151976;
RX   PubMed=822570;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   Mono-1-207
AC   CVCL_WN75
DR   Wikidata; Q95990589
RX   PubMed=151976;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN74 ! Mono-1
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   MONO-7
AC   CVCL_A654
SY   Mono-7; Monosomy 7
DR   cancercelllines; CVCL_A654
DR   Cosmic; 697691
DR   Cosmic; 975277
DR   Cosmic; 1281336
DR   Cosmic; 2089646
DR   Wikidata; Q54906376
RX   PubMed=11843295;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Karyotypic information: Monosomy of chromosome 7 (PubMed=11843295).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Unspecified (PubMed=11843295).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   Mono-Mac-1
AC   CVCL_1425
SY   MONO-MAC-1; Mono Mac 1; Monomac-1; MONOMAC-1; MonoMac1; MONOMAC1; MM1
DR   BTO; BTO_0003928
DR   CLO; CLO_0007827
DR   CLDB; cl3534
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 211
DR   BioSample; SAMN03473331
DR   BioSample; SAMN10988495
DR   cancercelllines; CVCL_1425
DR   Cell_Model_Passport; SIDM01022
DR   Cosmic; 787458
DR   Cosmic; 1089515
DR   DepMap; ACH-001129
DR   DSMZ; ACC-252
DR   DSMZCellDive; ACC-252
DR   EGA; EGAS00001000978
DR   GEO; GSM482510
DR   GEO; GSM887337
DR   GEO; GSM888413
DR   GEO; GSM1670129
DR   IARC_TP53; 21702
DR   LiGeA; CCLE_032
DR   LINCS_LDP; LCL-1062
DR   Lonza; 715
DR   PharmacoDB; MONOMAC1_959_2019
DR   Progenetix; CVCL_1425
DR   Wikidata; Q54906377
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3162233;
RX   PubMed=9150350;
RX   PubMed=11129653;
RX   PubMed=16142349;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=25984343); ~30-50 hours (DSMZ=ACC-252).
CC   HLA typing: A*03:01,03:01; B*07:02,51:01; C*07:02,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=16142349).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.61%; Native American=0.46%; East Asian, North=2.85%; East Asian, South=0%; South Asian=0%; European, North=54.45%; European, South=40.63% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-252
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 19,23
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1426 ! Mono-Mac-6
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   Mono-Mac-6
AC   CVCL_1426
SY   MONO-MAC-6; Mono-mac-6; MONO-MAC 6; Mono Mac 6; Mono Mac6; MonoMac 6; MonoMac6; MONOMAC6; MM6
DR   BTO; BTO_0002333
DR   CLO; CLO_0007828
DR   EFO; EFO_0006287
DR   CLDB; cl3535
DR   CLDB; cl7057
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BCRJ; 0373
DR   BioSample; SAMN03473411
DR   BioSample; SAMN10988430
DR   cancercelllines; CVCL_1426
DR   Cell_Model_Passport; SIDM01023
DR   ChEMBL-Cells; CHEMBL3308335
DR   ChEMBL-Targets; CHEMBL2366062
DR   CLS; 305440
DR   Cosmic; 787459
DR   Cosmic; 850390
DR   Cosmic; 908148
DR   Cosmic; 975278
DR   Cosmic; 1012100
DR   Cosmic; 1089514
DR   Cosmic; 1281335
DR   Cosmic; 1465950
DR   Cosmic; 1524836
DR   Cosmic; 2131547
DR   Cosmic; 2306198
DR   Cosmic; 2392975
DR   Cosmic-CLP; 908148
DR   DepMap; ACH-000006
DR   DSMZ; ACC-124
DR   DSMZCellDive; ACC-124
DR   EGA; EGAS00001000978
DR   GDSC; 908148
DR   GEO; GSM236795
DR   GEO; GSM236831
DR   GEO; GSM887338
DR   GEO; GSM888414
DR   GEO; GSM1374692
DR   GEO; GSM1670130
DR   IARC_TP53; 21514
DR   ICLC; HTL01015
DR   LiGeA; CCLE_095
DR   LINCS_LDP; LCL-1063
DR   Lonza; 4
DR   PharmacoDB; MONOMAC6_960_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1426
DR   PubChem_Cell_line; CVCL_1426
DR   Wikidata; Q54906378
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3162233;
RX   PubMed=7833491;
RX   PubMed=8225390;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Mono%20Mac%206
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-121.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=25984343); ~60 hours (DSMZ=ACC-124).
CC   HLA typing: A*03:01,03:01; B*07:02,51:01; C*07:02,15:02 (PubMed=26589293).
CC   HLA typing: A*03:01:01,03:01:01; B*07:02:01,51:01:01; C*07:02:01,15:02:01; DRA*01:01:01,01:01:01; DRB1*01:01:01,01:01:01 (DSMZCellDive=ACC-124).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13533; ATP8A2 + HGNC; HGNC:10471; RUNX1; Name(s)=RUNX1-ATP8A2 (PubMed=31160637).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=7833491; PubMed=14671638).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from autologous cell line Mono-Mac-1).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.82%; Native American=1.11%; East Asian, North=2.05%; East Asian, South=0%; South Asian=0%; European, North=54.71%; European, South=39.32% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
ST   Source(s): Cosmic-CLP=908148; DSMZ=ACC-124
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 19,23
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1425 ! Mono-Mac-1
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   MonoTCC
AC   CVCL_WH31
DR   Wikidata; Q95990594
RX   PubMed=25773167;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   MONPSYi001-A-1
AC   CVCL_F0T0
SY   MONPSYi001-A-1-BTC-KO
DR   BioSamples; SAMEA115605857
DR   hPSCreg; MONPSYi001-A-1
RX   PubMed=40848400;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1121; BTC.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MONPSYi001-A-2
AC   CVCL_F0T1
SY   MONPSYi001-A-2-BTC-KO
DR   hPSCreg; MONPSYi001-A-2
RX   PubMed=40848400;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1121; BTC.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MONUi001-A
AC   CVCL_C9IE
SY   86200001.1/001.1; 86200001.1
DR   BioSamples; SAMEA113567233
DR   hPSCreg; MONUi001-A
DR   Wikidata; Q123033103
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IF ! MONUi001-B
OI   CVCL_C9IG ! MONUi001-C
SX   Male
AG   35Y4M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi001-B
AC   CVCL_C9IF
SY   86200001.2/001.2; 86200001.2
DR   BioSamples; SAMEA114595107
DR   hPSCreg; MONUi001-B
DR   Wikidata; Q123033105
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IE ! MONUi001-A
OI   CVCL_C9IG ! MONUi001-C
SX   Male
AG   35Y4M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi001-C
AC   CVCL_C9IG
SY   86200001.4/001.4; 86200001.4
DR   BioSamples; SAMEA114595108
DR   hPSCreg; MONUi001-C
DR   Wikidata; Q123033106
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IE ! MONUi001-A
OI   CVCL_C9IF ! MONUi001-B
SX   Male
AG   35Y4M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi002-A
AC   CVCL_C9IH
SY   86202443.3/443.3; 86202443.3
DR   BioSamples; SAMEA113567234
DR   hPSCreg; MONUi002-A
DR   Wikidata; Q123033107
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9II ! MONUi002-B
OI   CVCL_C9IJ ! MONUi002-C
SX   Female
AG   10Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi002-B
AC   CVCL_C9II
SY   86202443.5/443.5; 86202443.5
DR   BioSamples; SAMEA114595109
DR   hPSCreg; MONUi002-B
DR   Wikidata; Q123033110
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IH ! MONUi002-A
OI   CVCL_C9IJ ! MONUi002-C
SX   Female
AG   10Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi002-C
AC   CVCL_C9IJ
SY   86202443.6/443.6; 86202443.6
DR   BioSamples; SAMEA114595110
DR   hPSCreg; MONUi002-C
DR   Wikidata; Q123033111
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IH ! MONUi002-A
OI   CVCL_C9II ! MONUi002-B
SX   Female
AG   10Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi003-A
AC   CVCL_C9IK
SY   86203213.1/213.1; 86203213.1
DR   BioSamples; SAMEA113567255
DR   hPSCreg; MONUi003-A
DR   Wikidata; Q123033112
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IL ! MONUi003-B
OI   CVCL_C9IM ! MONUi003-C
SX   Male
AG   13Y4M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi003-B
AC   CVCL_C9IL
SY   86203213.2/213.2; 86203213.2
DR   BioSamples; SAMEA114595111
DR   hPSCreg; MONUi003-B
DR   Wikidata; Q123033113
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IK ! MONUi003-A
OI   CVCL_C9IM ! MONUi003-C
SX   Male
AG   13Y4M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MONUi003-C
AC   CVCL_C9IM
SY   86203213.4/213.4; 86203213.4
DR   BioSamples; SAMEA114595114
DR   hPSCreg; MONUi003-C
DR   Wikidata; Q123033114
RX   PubMed=37494850;
CC   From: Monash University; Melbourne; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9IK ! MONUi003-A
OI   CVCL_C9IL ! MONUi003-B
SX   Male
AG   13Y4M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Moo2
AC   CVCL_E3SF
RX   PubMed=38087887;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9767; ! Balaenoptera acutorostrata (Common minke whale)
SX   Male
AG   Immature
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Moo2K4D
AC   CVCL_E3SG
RX   PubMed=38087887;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9767; ! Balaenoptera acutorostrata (Common minke whale)
HI   CVCL_E3SF ! Moo2
SX   Male
AG   Immature
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Moo2K4DT
AC   CVCL_E3SH
RX   PubMed=38087887;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9767; ! Balaenoptera acutorostrata (Common minke whale)
HI   CVCL_E3SF ! Moo2
SX   Male
AG   Immature
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Moo3
AC   CVCL_E3SI
RX   PubMed=38087887;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9767; ! Balaenoptera acutorostrata (Common minke whale)
SX   Female
AG   Immature
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Moo3K4D
AC   CVCL_E3SJ
RX   PubMed=38087887;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9767; ! Balaenoptera acutorostrata (Common minke whale)
HI   CVCL_E3SI ! Moo3
SX   Female
AG   Immature
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Moo3K4DT
AC   CVCL_E3SK
RX   PubMed=38087887;
CC   Group: Cetacean cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9767; ! Balaenoptera acutorostrata (Common minke whale)
HI   CVCL_E3SI ! Moo3
SX   Female
AG   Immature
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MoOV-01
AC   CVCL_VY54
DR   IBRC; C10899
DR   Wikidata; Q95990595
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-02
AC   CVCL_VY55
DR   IBRC; C10900
DR   Wikidata; Q95990596
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-03
AC   CVCL_VY56
DR   IBRC; C10901
DR   Wikidata; Q95990597
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-04
AC   CVCL_VY57
DR   IBRC; C10902
DR   Wikidata; Q95990599
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-05
AC   CVCL_VY58
DR   IBRC; C10903
DR   Wikidata; Q95990601
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-06
AC   CVCL_VY59
DR   IBRC; C10904
DR   Wikidata; Q95990602
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-07
AC   CVCL_VY60
DR   IBRC; C10905
DR   Wikidata; Q95990604
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-08
AC   CVCL_VY61
DR   IBRC; C10906
DR   Wikidata; Q95990606
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-09
AC   CVCL_VY62
DR   IBRC; C10907
DR   Wikidata; Q95990608
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-10
AC   CVCL_VY63
DR   IBRC; C10908
DR   Wikidata; Q95990609
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-11
AC   CVCL_VY64
DR   IBRC; C10909
DR   Wikidata; Q95990611
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-12
AC   CVCL_VY65
DR   IBRC; C10957
DR   Wikidata; Q95990613
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-13
AC   CVCL_VY66
DR   IBRC; C10911
DR   Wikidata; Q95990614
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-14
AC   CVCL_VY67
DR   IBRC; C10912
DR   Wikidata; Q95990615
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-15
AC   CVCL_VY68
DR   IBRC; C10913
DR   Wikidata; Q95990616
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-16
AC   CVCL_VY69
DR   IBRC; C10914
DR   Wikidata; Q95990617
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-17
AC   CVCL_VY70
DR   IBRC; C10915
DR   Wikidata; Q95990618
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-18
AC   CVCL_VY71
DR   IBRC; C10916
DR   Wikidata; Q95990619
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-19
AC   CVCL_VY72
DR   IBRC; C10917
DR   Wikidata; Q95990620
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-20
AC   CVCL_VY73
DR   IBRC; C10918
DR   Wikidata; Q95990621
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-21
AC   CVCL_VY74
DR   IBRC; C10919
DR   Wikidata; Q95990622
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-22
AC   CVCL_VY75
DR   IBRC; C10910
DR   Wikidata; Q95990623
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-23
AC   CVCL_VY76
DR   IBRC; C10921
DR   Wikidata; Q95990624
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-24
AC   CVCL_VY77
DR   IBRC; C10922
DR   Wikidata; Q95990625
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-25
AC   CVCL_VY78
DR   IBRC; C10923
DR   Wikidata; Q95990627
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-26
AC   CVCL_VY79
DR   IBRC; C10924
DR   Wikidata; Q95990630
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-27
AC   CVCL_VY80
DR   IBRC; C10925
DR   Wikidata; Q95990631
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-28
AC   CVCL_VY81
DR   IBRC; C10926
DR   Wikidata; Q95990632
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-29
AC   CVCL_VY82
DR   IBRC; C10927
DR   Wikidata; Q95990633
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-30
AC   CVCL_VY83
DR   IBRC; C10928
DR   Wikidata; Q95990634
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-31
AC   CVCL_VY84
DR   IBRC; C10929
DR   Wikidata; Q95990635
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-32
AC   CVCL_VY85
DR   IBRC; C10930
DR   Wikidata; Q95990636
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-33
AC   CVCL_VY86
DR   IBRC; C10931
DR   Wikidata; Q95990637
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-34
AC   CVCL_VY87
DR   IBRC; C10932
DR   Wikidata; Q95990638
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-35
AC   CVCL_VY88
DR   IBRC; C10933
DR   Wikidata; Q95990639
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-36
AC   CVCL_VY89
DR   IBRC; C10934
DR   Wikidata; Q95990641
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-37
AC   CVCL_VY90
DR   IBRC; C10935
DR   Wikidata; Q95990642
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-38
AC   CVCL_VY91
DR   IBRC; C10936
DR   Wikidata; Q95990643
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-39
AC   CVCL_VY92
DR   IBRC; C10937
DR   Wikidata; Q95990644
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-40
AC   CVCL_VY93
DR   IBRC; C10938
DR   Wikidata; Q95990646
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-41
AC   CVCL_VY94
DR   IBRC; C10939
DR   Wikidata; Q95990647
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-42
AC   CVCL_VY95
DR   IBRC; C10940
DR   Wikidata; Q95990649
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-43
AC   CVCL_VY96
DR   IBRC; C10941
DR   Wikidata; Q95990650
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-44
AC   CVCL_VY97
DR   IBRC; C10942
DR   Wikidata; Q95990651
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-45
AC   CVCL_VY98
DR   IBRC; C10943
DR   Wikidata; Q95990652
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-46
AC   CVCL_VY99
DR   IBRC; C10944
DR   Wikidata; Q95990653
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-47
AC   CVCL_VZ00
DR   IBRC; C10945
DR   Wikidata; Q95990654
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-48
AC   CVCL_VZ01
DR   IBRC; C10946
DR   Wikidata; Q95990656
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-49
AC   CVCL_VZ02
DR   IBRC; C10947
DR   Wikidata; Q95990657
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-50
AC   CVCL_VZ03
DR   IBRC; C10948
DR   Wikidata; Q95990658
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-51
AC   CVCL_VZ04
DR   IBRC; C10949
DR   Wikidata; Q95990660
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-52
AC   CVCL_VZ05
DR   IBRC; C10950
DR   Wikidata; Q95990662
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-53
AC   CVCL_VZ07
SY   MoOv-53
DR   IBRC; C10951
DR   Wikidata; Q95990664
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-54
AC   CVCL_VZ08
SY   MoOv-54
DR   IBRC; C10952
DR   Wikidata; Q95990666
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MoOV-55
AC   CVCL_VZ06
DR   IBRC; C10920
DR   Wikidata; Q95990667
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Moghani; VBO=VBO_0016094.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   MOP-6
AC   CVCL_Y512
SY   MOP6
DR   Wikidata; Q54906379
RX   PubMed=6096696;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 11
//
ID   MOP-8
AC   CVCL_2617
SY   MOP8
DR   CLO; CLO_0007829
DR   CLDB; cl3536
DR   ATCC; CRL-1709
DR   ECACC; 92111707
DR   Wikidata; Q54906380
RX   PubMed=6096696;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   MOPC-104E
AC   CVCL_4001
SY   MOPC 104E; MOPC104E
DR   BTO; BTO_0002102
DR   Wikidata; Q54906381
RX   PubMed=6157734;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_52071; Dextran.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   MOPC-173
AC   CVCL_4002
SY   MOPC 173
DR   BTO; BTO_0002103
DR   Wikidata; Q54906382
RX   PubMed=140065;
RX   PubMed=7297559;
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   MOPC-21
AC   CVCL_T277
SY   MOPC 21; MOPC21
DR   Wikidata; Q54906383
RX   PubMed=5439579;
RX   PubMed=9419351;
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   MOPC-315
AC   CVCL_2616
SY   MOPC 315; MOPC315
DR   BTO; BTO_0000581
DR   CLO; CLO_0007830
DR   CLDB; cl3537
DR   ATCC; TIB-23
DR   ChEMBL-Cells; CHEMBL3307316
DR   ChEMBL-Targets; CHEMBL614178
DR   ECACC; 85022106
DR   PubChem_Cell_line; CVCL_2616
DR   Wikidata; Q54906384
RX   PubMed=207531;
RX   PubMed=8098665;
RX   PubMed=9419351;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MOPC-315
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 19 hours (PubMed=207531).
CC   Monoclonal antibody isotype: IgA, lambda.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MOPC-315.4
AC   CVCL_VI67
SY   MOPC315.4
DR   Wikidata; Q95990677
RX   PubMed=8098665;
RX   PubMed=23284805;
CC   Characteristics: Derived by repeated subcutaneous injections of the parent cell line into BALB/c mice (PubMed=8098665).
CC   Monoclonal antibody isotype: IgA, lambda.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2616 ! MOPC-315
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 5
//
ID   MOPC-315.BM
AC   CVCL_VI68
SY   MOPC315.BM
DR   Wikidata; Q95990678
RX   PubMed=23284805;
CC   Characteristics: Homes to and expands in the bone marrow after intra-venous injection (PubMed=23284805).
CC   Monoclonal antibody isotype: IgA, lambda.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VI67 ! MOPC-315.4
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 5
//
ID   MOPC-315.BM.Luc+
AC   CVCL_C8RN
SY   MOPC-315.BM luciferase+; MOPC315.BM.Luc
DR   Wikidata; Q123033115
RX   PubMed=23284805;
RX   PubMed=23300660;
WW   Provider; I2B; P-77; http://inven2biologics.com/shop/cell-lines/human/mopc315bm-luciferase-multiple-myeloma
CC   Characteristics: Homes to and expands in the bone marrow after intra-venous injection (PubMed=23284805).
CC   Monoclonal antibody isotype: IgA, lambda.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VI68 ! MOPC-315.BM
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   MOPC-31C
AC   CVCL_2615
SY   MOPC 31C
DR   CLO; CLO_0007831
DR   CLO; CLO_0007832
DR   CLDB; cl3538
DR   ATCC; CCL-130
DR   ECACC; 90110707
DR   Wikidata; Q54906385
CC   Biotechnology: The monoclonal antibody (mAB) produced by this cell line is used as an isotype control for mouse IgG1 kappa light chain.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cJ.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 6
//
ID   MOPC-70A
AC   CVCL_T766
DR   RCB; RCB3007
DR   TKG; TKG 0167
DR   Wikidata; Q54906386
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MOR
AC   CVCL_2618
SY   MOR/P
DR   EFO; EFO_0006655
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472982
DR   Cell_Model_Passport; SIDM01390
DR   ECACC; 84112312
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   PharmacoDB; MOR_961_2019
DR   Wikidata; Q54906387
RX   PubMed=3034934;
RX   PubMed=7171457;
RX   PubMed=7903701;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*08:01,44:02; C*05:01,07:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ECACC=84112312; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 12,20
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mor Man
AC   CVCL_U788
DR   ATCC; CRL-1230
DR   Wikidata; Q54906388
CC   Discontinued: ATCC; CRL-1230; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75486; Menkes disease
DI   ORDO; Orphanet_565; Menkes disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   MOR/0.2R
AC   CVCL_2126
DR   CLO; CLO_0007833
DR   ECACC; 96042335
DR   Wikidata; Q54906389
RX   PubMed=7903701;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2618 ! MOR
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   MOR/0.4R
AC   CVCL_2619
DR   CLO; CLO_0007834
DR   ECACC; 96042334
DR   Wikidata; Q54906390
RX   PubMed=7903701;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ECACC=96042334
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2618 ! MOR
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   MOR/CPR
AC   CVCL_2620
SY   MOR-CPR; MORCPR
DR   CLO; CLO_0007835
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 543
DR   BioSample; SAMN10987872
DR   cancercelllines; CVCL_2620
DR   Cell_Model_Passport; SIDM01628
DR   DepMap; ACH-000851
DR   ECACC; 96042333
DR   GEO; GSM887339
DR   GEO; GSM888415
DR   IARC_TP53; 28376
DR   LiGeA; CCLE_794
DR   PharmacoDB; MOR_CPR_962_2019
DR   Progenetix; CVCL_2620
DR   Wikidata; Q54906391
RX   PubMed=1327513;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Homozygous (DepMap=ACH-000851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (DepMap=ACH-000851).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.26%; Native American=0%; East Asian, North=4.44%; East Asian, South=0%; South Asian=0%; European, North=61.77%; European, South=32.53% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ECACC=96042333
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2618 ! MOR
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   MOR115.1.13
AC   CVCL_J469
SY   MOR 115.1.13; MOR115
DR   JCRB; JCRB1342.06
DR   Wikidata; Q54906394
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR124.2.2
AC   CVCL_J470
SY   MOR 124.2.2; MOR124
DR   JCRB; JCRB1342.07
DR   Wikidata; Q54906395
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR131.5.13
AC   CVCL_J471
SY   MOR 131.5.13; MOR131
DR   ABCD; ABCD_AF046
DR   JCRB; JCRB1342.08
DR   Wikidata; Q54906396
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR158.1.3
AC   CVCL_J472
SY   MOR 158.1.3; MOR158
DR   ABCD; ABCD_AF044
DR   JCRB; JCRB1342.09
DR   Wikidata; Q54906397
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR180.2.4
AC   CVCL_J473
SY   MOR 180.2.4; MOR180
DR   ABCD; ABCD_AF043
DR   JCRB; JCRB1342.11
DR   Wikidata; Q54906398
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR33.2.9
AC   CVCL_J474
SY   MOR 33.2.9; MOR33
DR   ABCD; ABCD_AF048
DR   JCRB; JCRB1342.10
DR   Wikidata; Q54906399
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR35.4.12
AC   CVCL_J475
SY   MOR 35.4.12; MOR35
DR   ABCD; ABCD_AF047
DR   JCRB; JCRB1342.02
DR   Wikidata; Q54906400
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR39.3.9
AC   CVCL_J476
SY   MOR 39.3.9; MOR39
DR   ABCD; ABCD_AF045
DR   JCRB; JCRB1342.03
DR   Wikidata; Q54906401
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR44.4.1
AC   CVCL_J477
SY   MOR 44.4.1; MOR44
DR   ABCD; ABCD_AF052
DR   JCRB; JCRB1342.12
DR   Wikidata; Q54906402
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR76.7F.16
AC   CVCL_J478
SY   MOR 76.7F.16; MOR76
DR   ABCD; ABCD_AF049
DR   JCRB; JCRB1342.04
DR   Wikidata; Q54906403
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR8.2.1
AC   CVCL_J479
SY   MOR 8.2.1; MOR8
DR   ABCD; ABCD_AF050
DR   JCRB; JCRB1342.01
DR   Wikidata; Q54906404
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   MOR83.3.10
AC   CVCL_J480
SY   MOR 83.3.10; MOR83
DR   ABCD; ABCD_AF051
DR   JCRB; JCRB1342.05
DR   Wikidata; Q54906405
RX   PubMed=3211162;
RX   PubMed=8417377;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17303; Morphine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   Morris 5123D-TC
AC   CVCL_5335
SY   Morris 5123D
DR   CLO; CLO_0050617
DR   RCB; RCB2766
DR   TKG; TKG 0131
DR   TKG; TKG 0365
DR   Wikidata; Q54906406
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   mos-3Y1-10
AC   CVCL_H696
DR   RCB; RCB0379
DR   Wikidata; Q54906407
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   mos-3Y1-16
AC   CVCL_H697
DR   RCB; RCB0380
DR   Wikidata; Q54906408
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   MOS-J
AC   CVCL_0J56
SY   MOSJ; Mouse Osteogenic Sarcoma-Jackson laboratory
DR   Wikidata; Q54906409
RX   PubMed=12224130;
RX   PubMed=24577091;
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2Y1M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   MOSEC Trp53-/-;Pten-/- DKO clone 2
AC   CVCL_B6J9
SY   Trp53-/-;Pten-/- DKO MOSEC clone 2
DR   Wikidata; Q112129343
RX   PubMed=34944001;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct epithelium; UBERON=UBERON_0004804.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B6JA ! MOSEC Trp53-/-;Pten-/- DKO clone 4
SX   Female
AG   6W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   MOSEC Trp53-/-;Pten-/- DKO clone 4
AC   CVCL_B6JA
SY   Trp53-/-;Pten-/- DKO MOSEC clone 4
DR   Wikidata; Q112129345
RX   PubMed=34944001;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct epithelium; UBERON=UBERON_0004804.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B6J9 ! MOSEC Trp53-/-;Pten-/- DKO clone 2
SX   Female
AG   6W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   MOSER
AC   CVCL_R731
SY   Moser; MoSer; HCT-Moser
DR   cancercelllines; CVCL_R731
DR   ColonAtlas; MOSER
DR   Cosmic; 1374636
DR   IARC_TP53; 4563
DR   Wikidata; Q54906410
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=7651727;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Unspecified (PubMed=7651727).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   MOSERSF
AC   CVCL_R732
SY   MOSERsf; MOSER Serum Free
DR   cancercelllines; CVCL_R732
DR   Wikidata; Q54906411
RX   PubMed=3162826;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R731 ! MOSER
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   MOSJ-Dkk1
AC   CVCL_WN67
DR   Wikidata; Q95990705
RX   PubMed=24577091;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2891; DKK1.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J56 ! MOS-J
SX   Female
AG   2Y1M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   MOTN-1
AC   CVCL_2127
SY   MOTN1
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473538
DR   BioSample; SAMN10988469
DR   cancercelllines; CVCL_2127
DR   Cell_Model_Passport; SIDM01884
DR   DepMap; ACH-001130
DR   DSMZ; ACC-559
DR   DSMZCellDive; ACC-559
DR   GEO; GSM887340
DR   GEO; GSM888416
DR   IARC_TP53; 28296
DR   JCRB; JCRB1847
DR   PharmacoDB; MOTN1_963_2019
DR   Progenetix; CVCL_2127
DR   Wikidata; Q54906412
RX   PubMed=12127564;
RX   PubMed=14712486;
RX   PubMed=16827800;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: 24 hours (PubMed=12127564); ~30-40 hours (DSMZ=ACC-559).
CC   HLA typing: A*02:01:01,02:06:01; B*54:01:01,56:01:01; C*01:02:01,01:02:01; DPA1*02:02:02,02:02:02; DPB1*05:01:01,05:01:01; DQA1*03:01:01,03:03:01; DQB1*03:02:01,04:01:01; DRA*01:01:01,01:02:02; DRB1*04:05:01,08:02:01 (DSMZCellDive=ACC-559).
CC   Sequence variation: Gene fusion; HGNC; HGNC:29529; TBL1XR1 + HGNC; HGNC:15979; TP63; Name(s)=TBL1XR1-TP63 (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.782+1G>A; ClinVar=VCV000634684; Zygosity=Homozygous; Note=Splice donor mutation (DepMap=ACH-001130).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.84%; Native American=0.4%; East Asian, North=73.72%; East Asian, South=24.39%; South Asian=0%; European, North=0%; European, South=0.64% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-559; JCRB=JCRB1847
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12 (JCRB=JCRB1847)
ST   D13S317: 12 (DSMZ=ACC-559)
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 19
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 16,18
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4664; T-cell large granular lymphocyte leukemia
DI   ORDO; Orphanet_86872; T-cell large granular lymphocyte leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L208 ! PLT-2
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   MOU
AC   CVCL_E782
SY   MANN; Mann; MANN2; GM08605
DR   CLO; CLO_0010607
DR   Coriell; GM08605
DR   dbMHC; 48977
DR   ECACC; 88052050
DR   IHW; IHW09050
DR   IPD-IMGT/HLA; 11096
DR   PRIDE; PXD001205
DR   Wikidata; Q54906413
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=18193213;
RX   PubMed=25502872;
RX   PubMed=28360230;
RX   PubMed=29171935;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*29:02:01:01; B*44:03:01:01; C*16:01:01:01; DPA1*01:03; DPB1*02:01:02,02:01:19; DQA1*02:01; DQB1*02:02:01; DRA*01:01; DRB1*07:01:01; DRB4*01:01:01; DRB9*01:01:01:01 (IPD-IMGT/HLA=11096).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   Mouse-IMACS
AC   CVCL_C5VB
DR   Wikidata; Q116049794
CC   Characteristics: Readily divide in CSF-1 free-RPMI media and are to be passaged on non-tissue culture treated plastic ware (Direct_author_submission).
CC   Transformant: Recombinant retrovirus J2.
CC   Miscellaneous: Cell line information from personal communication of Gamage, Akshamal Mihiranga.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   MOV002AN
AC   CVCL_F567
SY   CS00055; Extract 201; Extract 274; Extract 497; EXT-0497
DR   IPD-IMGT/HLA; 11809
DR   Wikidata; Q54906414
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/353cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,02:291; B*35:03:01,44:12; C*04:01,05:01:01; DPB1*02:FZGN,04:EHKN; DQA1*01:MV,05:EF; DQB1*03:01,05:01; DRB1*01:GNCX,12EJVY; DRB3*02:02 (IPD-IMGT/HLA=11809).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   MOv16
AC   CVCL_LH59
SY   MOv-16
DR   Wikidata; Q54906415
RX   PubMed=1459581;
RX   PubMed=2434438;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   MOv18
AC   CVCL_LH60
DR   Wikidata; Q54906416
RX   PubMed=1840502;
RX   PubMed=2434438;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   MOv19
AC   CVCL_LH61
DR   Wikidata; Q54906417
RX   PubMed=1840502;
RX   PubMed=2434438;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   MOVAS-1
AC   CVCL_0F08
SY   Movas-1; MOVAS; Movas
DR   BTO; BTO_0005870
DR   ATCC; CRL-2797
DR   Wikidata; Q54906418
RX   PubMed=10722757;
RX   PubMed=12660151;
RX   PubMed=21369692;
CC   Doubling time: ~15 hours (ATCC=CRL-2797).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   MOVP-3
AC   CVCL_N031
DR   cancercelllines; CVCL_N031
DR   ChEMBL-Cells; CHEMBL3307302
DR   ChEMBL-Targets; CHEMBL614133
DR   PubChem_Cell_line; CVCL_N031
DR   Wikidata; Q54906419
RX   PubMed=12623853;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0624 ! MOLT-3
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   MovS2
AC   CVCL_U154
SY   2D2
DR   Wikidata; Q54906420
RX   PubMed=14671128;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97769; Prnp.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P23907; Sheep PRNP (Note=With p.Ala136Val and p.Arg171Gln = VRQ allele).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: tg301+/- x HuVim [830]-T/t transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   MovS6
AC   CVCL_U155
SY   6H5
DR   Wikidata; Q54906421
RX   PubMed=14671128;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97769; Prnp.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P23907; Sheep PRNP (Note=With p.Ala136Val and p.Arg171Gln = VRQ allele).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: tg301+/- x HuVim [830]-T/t transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   MovS6-4
AC   CVCL_U158
DR   Wikidata; Q54906422
RX   Patent=US20110165613;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3922.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97769; Prnp.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P23907; Sheep PRNP (Note=With p.Ala136Val and p.Arg171Gln = VRQ allele).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: tg301+/- x HuVim [830]-T/t transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U155 ! MovS6
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   MP 4109
AC   CVCL_A5IR
DR   Wikidata; Q107116387
RX   Patent=EP0368662B1;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2129.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   MP 4112
AC   CVCL_A5IS
DR   Wikidata; Q107116389
RX   Patent=EP0368662B1;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2128.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   MP 4126
AC   CVCL_A5IT
DR   Wikidata; Q107116392
RX   Patent=EP0368662B1;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2615.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   MP-1
AC   CVCL_A0RL
DR   Wikidata; Q108820957
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mycoplasmoides pneumoniae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MP-ASKIN-SA
AC   CVCL_7993
SY   Miyazaki Pediatrics-Askin-SA
DR   Wikidata; Q54906423
RX   CelloPub=CLPUB00599;
RX   PubMed=14553943;
CC   Population: Japanese.
CC   Doubling time: 19 hours (PubMed=14553943).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=14553943).
CC   Derived from site: In situ; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   MP-CCS-SY
AC   CVCL_0J33
SY   Miyazaki Pediatrics-Clear cell Sarcoma-SY
DR   EGA; EGAD00001008611
DR   Wikidata; Q28726672
RX   CelloPub=CLPUB00599;
RX   PubMed=12072203;
RX   PubMed=28745431;
RX   PubMed=36959380;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=12072203).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=12072203; PubMed=28745431).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=36959380
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,25
ST   D21S11: 30,32.2
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17-18Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   MP-MRT-AN
AC   CVCL_7049
SY   Miyazaki Pediatrics-Malignant Rhabdoid Tumor-AN
DR   Wikidata; Q54906425
RX   CelloPub=CLPUB00599;
RX   PubMed=9920784;
RX   PubMed=15355927;
RX   PubMed=18281554;
RX   PubMed=21871868;
CC   Population: Japanese.
CC   Misspelling: KP-MRT-AN; Note=In Cellosaurus releases 2 to 24 and in a few publications.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   MP-N-MS
AC   CVCL_Y139
SY   Miyazaki Pediatrics-Neuroblastoma-MS
DR   CGH-DB; 70-1
DR   CGH-DB; 9090-4
DR   Wikidata; Q54906426
RX   CelloPub=CLPUB00582;
RX   PubMed=10457905;
RX   PubMed=11129446;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   MP-N-TS
AC   CVCL_Y140
SY   Miyazaki Pediatrics-Neuroblastoma-TS
DR   CGH-DB; 68-1
DR   CGH-DB; 9087-4
DR   Wikidata; Q54906427
RX   CelloPub=CLPUB00582;
RX   PubMed=11223544;
RX   PubMed=12702577;
RX   PubMed=23268333;
CC   Population: Japanese.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   MP38
AC   CVCL_4D11
DR   ATCC; CRL-3296
DR   cancercelllines; CVCL_4D11
DR   PRIDE; PXD051055
DR   Wikidata; Q54906428
RX   PubMed=24994677;
RX   PubMed=39042403;
CC   Doubling time: 80 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; c.68-9_72del; Zygosity=Unspecified (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Unspecified (PubMed=24994677).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): ATCC=CRL-3296; PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 31,31.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   MP4-25D2.11
AC   CVCL_D1FL
SY   MP4-25D2; MP4.25D2.11; 25D2.11
DR   Wikidata; Q127382858
RX   Patent=US5041381;
RX   Patent=US5863537;
RX   PubMed=1790303;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9809.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MP41
AC   CVCL_4D12
DR   ATCC; CRL-3297
DR   cancercelllines; CVCL_4D12
DR   ChEMBL-Cells; CHEMBL4879544
DR   DepMap; ACH-002010
DR   PRIDE; PXD051055
DR   Wikidata; Q54906429
RX   PubMed=24994677;
RX   PubMed=39042403;
CC   Characteristics: Established from a patient-derived xenograft (PubMed=24994677).
CC   Doubling time: 41 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (PubMed=24994677; DepMap=ACH-002010).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Thr910Met (c.2729C>T); ClinVar=VCV000438790; Zygosity=Heterozygous (DepMap=ACH-002010).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-3297; PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 30.2,31.2
ST   D5S818: 10,13
ST   D7S820: 8.3,9,9.3,10,10.1,11 (ATCC=CRL-3297)
ST   D7S820: 9,10 (PubMed=24994677)
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 14
//
ID   MP41/GFP
AC   CVCL_E8SW
SY   MP41 / GFP
WW   Provider; GenTarget; SC089-G; https://www.gentarget.com/product/human-mp41-gfp-fluorescent-stable-cells/
CC   Characteristics: Transduced by lentivirus with a EF1a-eGFP-Rsv-PuroR construct (GenTarget=SC089-G).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Thr910Met (c.2729C>T); ClinVar=VCV000438790; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4D12 ! MP41
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MP41/Luciferase
AC   CVCL_E8SX
SY   MP41 / Luciferase
WW   Provider; GenTarget; SC089-Luc; https://www.gentarget.com/product/human-mp41-luciferase-stable-cells/
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-Rsv-PuroR construct (GenTarget=SC089-Luc).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Thr910Met (c.2729C>T); ClinVar=VCV000438790; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4D12 ! MP41
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MP41/Luciferase-2A-GFP
AC   CVCL_E8SY
SY   MP41 / Luciferase & GFP
WW   Provider; GenTarget; SC089-LG; https://www.gentarget.com/product/human-mp41-luciferase-gfp-stable-cells/
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-2A-eGFP-Rsv-PuroR construct (GenTarget=SC089-LG).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Thr910Met (c.2729C>T); ClinVar=VCV000438790; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4D12 ! MP41
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MP41/RFP
AC   CVCL_E8SZ
SY   MP41 / RFP
WW   Provider; GenTarget; SC089-R; https://www.gentarget.com/product/human-mp41-rfp-fluorescent-stable-cells/
CC   Characteristics: Transduced by lentivirus with a EF1a-RFP-Rsv-PuroR construct (GenTarget=SC089-R).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Thr910Met (c.2729C>T); ClinVar=VCV000438790; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4D12 ! MP41
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MP46
AC   CVCL_4D13
DR   ATCC; CRL-3298
DR   cancercelllines; CVCL_4D13
DR   Cell_Model_Passport; SIDM01789
DR   DepMap; ACH-002011
DR   PRIDE; PXD051055
DR   Wikidata; Q54906430
RX   PubMed=24994677;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Established from a patient-derived xenograft (PubMed=24994677).
CC   Doubling time: 110 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Unspecified (PubMed=24994677).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): ATCC=CRL-3298; DepMap=ACH-002011; PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 30,31
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,12,15
ST   FGA: 22,22.2,24
ST   Penta D: 9,12
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 14
//
ID   MP48
AC   CVCL_WY41
DR   Wikidata; Q95990771
RX   PubMed=8886757;
RX   PubMed=12740220;
CC   Doubling time: 22-24 hours (PubMed=8886757).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   MP57
AC   CVCL_VJ89
DR   Cosmic; 2663903
DR   Wikidata; Q95990774
RX   PubMed=27117832;
CC   Doubling time: ~24 hours (PubMed=27117832).
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Simple; p.Gly373Arg (c.1117G>C); Zygosity=Homozygous (PubMed=27117832).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro87Glnfs*36 (c.260delC); Zygosity=Homozygous (PubMed=27117832).
DI   NCIt; C7569; Thymic carcinoma
DI   ORDO; Orphanet_99868; Thymic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   MP65
AC   CVCL_4D14
DR   ATCC; CRL-3299
DR   cancercelllines; CVCL_4D14
DR   PRIDE; PXD051055
DR   Wikidata; Q54906431
RX   PubMed=24994677;
RX   PubMed=39042403;
CC   Doubling time: 120 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Leu573Trpfs*3 (c.1717delC); ClinVar=VCV000221278; Zygosity=Unspecified (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=24994677).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): ATCC=CRL-3299; PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8 (ATCC=CRL-3299)
ST   D13S317: 8,13 (PubMed=24994677)
ST   D16S539: 11
ST   D21S11: 30,30.2
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 14
//
ID   mPA7
AC   CVCL_B0UX
SY   Panc.5.10F3.3A11; p.5
DR   Wikidata; Q108820958
RX   Patent=US7744878;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3706.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P15529; Human CD46.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   mPAC L20
AC   CVCL_2G62
SY   mPacL20; mPAC clone L20
DR   BCGO; BCGO_0000121
DR   EFO; EFO_0006656
DR   GEO; GSM1064999
DR   GEO; GSM1065000
DR   GEO; GSM1065001
DR   Wikidata; Q54906432
RX   PubMed=15340143;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   mPAC L4S2
AC   CVCL_2G63
SY   mPAC clone L4S2
DR   Wikidata; Q54906433
RX   PubMed=15340143;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   mPAC-4
AC   CVCL_B6H1
DR   Wikidata; Q112129346
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.1
AC   CVCL_B6H2
DR   Wikidata; Q112129347
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H1 ! mPAC-4
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.1.1
AC   CVCL_B6H3
DR   Wikidata; Q112129348
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H2 ! mPAC-4.1
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.1.1.1
AC   CVCL_B6H4
DR   Wikidata; Q112129349
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H3 ! mPAC-4.1.1
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.1.2
AC   CVCL_B6H5
DR   Wikidata; Q112129350
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H2 ! mPAC-4.1
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.1.2.1
AC   CVCL_B6H6
DR   Wikidata; Q112129352
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H5 ! mPAC-4.1.2
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.1.2.2
AC   CVCL_B6H7
DR   Wikidata; Q112129353
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H5 ! mPAC-4.1.2
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.3
AC   CVCL_B6IL
DR   Wikidata; Q112129354
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H1 ! mPAC-4
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAC-4.4
AC   CVCL_B6IM
DR   Wikidata; Q112129355
RX   PubMed=7521578;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H1 ! mPAC-4
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   mPAM-CD163-GFP
AC   CVCL_ZE12
DR   Wikidata; Q98127279
RX   PubMed=32402349;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus type 2 (PRRSV-2) strains JXA1 and SD1 (PubMed=32402349).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0F14 ! IPAM 3D4/21
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 13
//
ID   MPanc-96
AC   CVCL_7165
SY   Mpanc-96; MPanc96; mPanc96; MPANC96
DR   ATCC; CRL-2380
DR   BioSample; SAMN03151612
DR   cancercelllines; CVCL_7165
DR   Cosmic; 913309
DR   Cosmic; 1299303
DR   Cosmic; 1571780
DR   GEO; GSM784704
DR   IARC_TP53; 20487
DR   Progenetix; CVCL_7165
DR   Wikidata; Q54906434
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=9185703;
RX   PubMed=15367885;
RX   PubMed=20143388;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/mpanc-96-atcc-crl-2380
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a AsPC-1 derivative (PubMed=20143388). Originally thought to originate from a 67 year old male patient with a poorly differentiated primary pancreatic adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00329.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=9185703).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu78Hisfs*41 (c.233_234delTC) (p.His93Profs*67, c.276_277delTC); ClinVar=VCV000977782; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=15367885).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg100Thr (c.299G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Alafs*35 (c.403delT); ClinVar=VCV001069265; Zygosity=Heterozygous (PubMed=15367885).
CC   Omics: Proteomics; 2DE-MS.
CC   Misspelling: Mpan96; Cosmic=1299303.
CC   Discontinued: ATCC; CRL-2380; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-2380
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0152 ! AsPC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   MPC-1
AC   CVCL_AS86
SY   Mouse Podocyte Clone-1
DR   Wikidata; Q54906438
RX   PubMed=9344605;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   MPC-11
AC   CVCL_3857
SY   MPC 11; MPC11; Merwin Plasma Cell tumor-11
DR   BTO; BTO_0001089
DR   CLO; CLO_0007854
DR   CLDB; cl3555
DR   CLDB; cl3556
DR   ATCC; CCL-167
DR   CCRID; 1101MOU-PUMC000250
DR   ChEMBL-Cells; CHEMBL3307317
DR   ChEMBL-Targets; CHEMBL614179
DR   ECACC; 91031103
DR   IBRC; C10138
DR   IZSLER; BS TCL 45
DR   Lonza; 33
DR   NCI-DTP; MPC-11
DR   PRIDE; PXD001273
DR   PubChem_Cell_line; CVCL_3857
DR   Wikidata; Q54906440
RX   PubMed=4189836;
RX   PubMed=5102530;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MPC-11
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   MPC-11/OUAr
AC   CVCL_5429
SY   MPC 11 OUAr
DR   CLO; CLO_0007853
DR   ATCC; TIB-15
DR   JCRB; JCRB9106
DR   Wikidata; Q54906441
RX   PubMed=8157994;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3857 ! MPC-11
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   MPC-3-10
AC   CVCL_4868
DR   cancercelllines; CVCL_4868
DR   Wikidata; Q54906442
RX   PubMed=7176035;
RX   PubMed=15643172;
CC   Population: Caucasian.
CC   Characteristics: Established from tumors that spontaneously metastasized to lymph nodes obtained after subcutaneous injection of the parent cell line in nude mice (PubMed=7176035).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   MPC-5
AC   CVCL_AS87
SY   MPC5; Mouse Podocyte Clone-5
DR   CLS; 305481
DR   Ubigene; YC-A104
DR   Wikidata; Q54906443
DR   Ximbio; 152136
RX   PubMed=9344605;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
ST   Source(s): Ubigene=YC-A104
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 12-1: 17
ST   Mouse STR 15-3: 22.3,26.3
ST   Mouse STR 18-3: 16
ST   Mouse STR X-1: 26,28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10W
CA   Conditionally immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   MCP-5 Alb(p.K524Q)
AC   CVCL_F0LC
SY   MCP5 Alb(p.K524Q); MPC-5-mAlb(p.K524Q(AAA>CAA))
CC   Sequence variation: Mutation; MGI; MGI:87991; Alb; Simple_edited; p.Lys524Gln (c.1570C>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: Cell line information from personal communication of Zhang, Ai-Hua.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AS87 ! MPC-5
SX   Sex unspecified
AG   10W
CA   Conditionally immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MPC-8
AC   CVCL_AS88
SY   Mouse Podocyte Clone-8
DR   Wikidata; Q54906444
RX   PubMed=9344605;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   MPC-ChlSab-C00001
AC   CVCL_D4WT
SY   76A3
DR   Wikidata; Q127382860
RX   PubMed=38277709;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MPC-ChlSab-C00002
AC   CVCL_D4WU
SY   80B1
DR   Wikidata; Q127382861
RX   PubMed=38277709;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MPC-MacMul-C00001
AC   CVCL_D4WV
SY   83Ab1.1
DR   Wikidata; Q127382862
RX   PubMed=38103336;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_D4WW ! MPC-MacMul-C00002
OI   CVCL_D4WX ! MPC-MacMul-C00003
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MPC-MacMul-C00002
AC   CVCL_D4WW
SY   83D1
DR   Wikidata; Q127382863
RX   PubMed=38103336;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_D4WV ! MPC-MacMul-C00001
OI   CVCL_D4WX ! MPC-MacMul-C00003
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MPC-MacMul-C00003
AC   CVCL_D4WX
SY   87B1
DR   Wikidata; Q127382864
RX   PubMed=38103336;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
OI   CVCL_D4WV ! MPC-MacMul-C00001
OI   CVCL_D4WW ! MPC-MacMul-C00002
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MPC-L1
AC   CVCL_XZ69
SY   MPCL1; HML-1
DR   CCRID; 5301MAM-KCB85010ZJ
DR   KCB; KCB 85010ZJ
DR   Wikidata; Q95990832
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9675; ! Paguma larvata (Masked palm civet)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   MPC-L2
AC   CVCL_XZ70
SY   MPCL2; HML-2
DR   CCRID; 5301MAM-KCB88016ZJ
DR   KCB; KCB 88016ZJ
DR   Wikidata; Q95990833
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9675; ! Paguma larvata (Masked palm civet)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   MPC-L3
AC   CVCL_A9IC
SY   MPCL3
DR   CCRID; 5301MAM-KCB0018LZJ
DR   KCB; KCB 200018LZJ
DR   Wikidata; Q108820959
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9675; ! Paguma larvata (Masked palm civet)
OI   CVCL_A9IE ! MPC-S3
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MPC-L4
AC   CVCL_A9ID
SY   MPCL4
DR   CCRID; 5301MAM-KCB00019ZJ
DR   KCB; KCB 200019LZJ
DR   Wikidata; Q108820960
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9675; ! Paguma larvata (Masked palm civet)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MPC-PapAnu-C00001
AC   CVCL_D6NI
SY   100A1
RX   PubMed=38246118;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_D6NJ ! MPC-PapAnu-C00002
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MPC-PapAnu-C00002
AC   CVCL_D6NJ
SY   100B1.3
RX   PubMed=38246118;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_D6NI ! MPC-PapAnu-C00001
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MPC-S3
AC   CVCL_A9IE
SY   MPCS3
DR   CCRID; 5301MAM-KCB0018SZJ
DR   KCB; KCB 200018SZJ
DR   Wikidata; Q108820961
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9675; ! Paguma larvata (Masked palm civet)
OI   CVCL_A9IC ! MPC-L3
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MPC2013
AC   CVCL_XH08
DR   CCRID; 4201PAT-CCTCC00817
DR   Wikidata; Q95990826
RX   Patent=CN106367393B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201601.
CC   Breed/subspecies: NOD.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   MPC298
AC   CVCL_UB98
DR   Wikidata; Q95990827
RX   CelloPub=CLPUB00793;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C36084; Invasive breast micropapillary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   MPC600
AC   CVCL_UB99
DR   Wikidata; Q95990828
RX   CelloPub=CLPUB00793;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C36084; Invasive breast micropapillary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   MPC7105
AC   CVCL_UC00
DR   Wikidata; Q95990829
RX   CelloPub=CLPUB00793;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C36084; Invasive breast micropapillary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   MPC960
AC   CVCL_UC01
DR   Wikidata; Q95990830
RX   CelloPub=CLPUB00793;
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C36084; Invasive breast micropapillary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   mPEC
AC   CVCL_6E46
SY   mouse PEC; mouse Parietal Epithelial Cells
DR   Wikidata; Q54906445
RX   PubMed=18596122;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Parietal epithelial cell; CL=CL_1000452.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   mPEC1
AC   CVCL_IN73
DR   Wikidata; Q54906446
RX   PubMed=11121394;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   mPEC1-CF
AC   CVCL_IN74
DR   Wikidata; Q54906447
RX   PubMed=11121394;
RX   PubMed=15463957;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.
CC   Sequence variation: Mutation; MGI; MGI:88388; Cftr; Simple; p.Ser489Ter (c.1466C>A); Zygosity=Homozygous (PubMed=11121394).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   MPEK-BL6
AC   CVCL_WY89
SY   Mouse Progenitor Epidermal Keratinocyte-BLack 6
DR   Wikidata; Q95990837
WW   Provider; CELLnTEC; -; https://cellntec.com/products/mpek-bl6/
CC   Doubling time: 24-30 hours (Direct_author_submission).
CC   Donor information: Culture was isolated from the skin of several neonatal mice combined.
CC   Miscellaneous: Doubling time and culture characteristics from personal communication of Girling, Peter.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18-19FD
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   MPF
AC   CVCL_YI93
SY   Mylopharyngodon Piceus Fin
DR   Wikidata; Q95990838
RX   PubMed=31755106;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 28 Celsius (PubMed=31755106).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=75356; ! Mylopharyngodon piceus (Black carp)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   Mpf
AC   CVCL_3858
SY   Mustela putorius furo
DR   CLO; CLO_0007855
DR   CLDB; cl3557
DR   ATCC; CRL-1656
DR   ECACC; 90062801
DR   Lonza; 1150
DR   Wikidata; Q54906448
RX   PubMed=6185411;
RX   PubMed=6189779;
CC   Virology: Susceptible to infection by maedi visna virus (MVV). Synthesizes and released limited amounts of visna virus into the cultures' media for 80 day after infection (PubMed=6189779).
CC   Doubling time: 12.5-17.2 hours (PubMed=6185411); 12-13 hours (ATCC=CRL-1656).
CC   Discontinued: ECACC; 90062801; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9669; ! Mustela putorius furo (European domestic ferret)
SX   Sex unspecified
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   MPfsl #1
AC   CVCL_C8IT
SY   CL-1
DR   Wikidata; Q123033116
RX   PubMed=4207874;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_C8IR ! rhfs1
SX   Male
AG   150-160FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MPfsl #2
AC   CVCL_8418
SY   CL-2; Rhfs-MPMV; Rhesus foreskin cells-MPMV
DR   CLO; CLO_0008813
DR   CLDB; cl4149
DR   Wikidata; Q54950388
RX   PubMed=4207874;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_C8IR ! rhfs1
SX   Male
AG   150-160FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   MPfsl #3
AC   CVCL_C8IU
SY   CL-3
DR   Wikidata; Q123033117
RX   PubMed=4207874;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_C8IR ! rhfs1
SX   Male
AG   150-160FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MPfsl #4
AC   CVCL_C8IV
SY   CL-4
DR   Wikidata; Q123033118
RX   PubMed=4207874;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_C8IR ! rhfs1
SX   Male
AG   150-160FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MPfsl #5
AC   CVCL_C8IW
SY   CL-5
DR   Wikidata; Q123033119
RX   PubMed=4207874;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_C8IR ! rhfs1
SX   Male
AG   150-160FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MPfsl #6
AC   CVCL_C8IX
SY   CL-6
DR   Wikidata; Q123033120
RX   PubMed=4207874;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_C8IR ! rhfs1
SX   Male
AG   150-160FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MPfsl #7
AC   CVCL_C8IY
SY   CL-7
DR   Wikidata; Q123033121
RX   PubMed=4207874;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11855; Mason-Pfizer monkey virus (MPMV).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_C8IR ! rhfs1
SX   Male
AG   150-160FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MPH1
AC   CVCL_5F96
DR   CCRID; 3101MONSCSP310
DR   Wikidata; Q54906449
RX   PubMed=23856644;
CC   Group: Non-human primate cell line.
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   MPH2
AC   CVCL_5F97
DR   Wikidata; Q54906450
RX   PubMed=23856644;
CC   Group: Non-human primate cell line.
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   MPI 65-3
AC   CVCL_Y639
DR   Wikidata; Q54906451
RX   PubMed=11084865;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   MPI-I
AC   CVCL_2H57
DR   Wikidata; Q54906452
RX   PubMed=9013705;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MPI-II
AC   CVCL_2H58
DR   Wikidata; Q54906453
RX   PubMed=9013705;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MPI-III
AC   CVCL_2H59
DR   Wikidata; Q54906454
RX   PubMed=9013705;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MPI-IV
AC   CVCL_2H60
DR   Wikidata; Q54906455
RX   PubMed=9013705;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MPI-V
AC   CVCL_2H61
DR   Wikidata; Q54906456
RX   PubMed=9013705;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MPI-VI
AC   CVCL_2H62
SY   MPI VI
DR   Wikidata; Q54906457
RX   PubMed=9013705;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   MPIi001-A
AC   CVCL_ZJ14
DR   BioSamples; SAMEA104381690
DR   hPSCreg; MPIi001-A
DR   Wikidata; Q98127280
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MPIi005-A
AC   CVCL_ZJ15
SY   SF2.1; wt1
DR   BioSamples; SAMEA104382079
DR   hPSCreg; MPIi005-A
DR   Wikidata; Q98127281
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MPIi006-A
AC   CVCL_ZJ16
DR   hPSCreg; MPIi006-A
DR   Wikidata; Q98127282
RX   PubMed=32446239;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro216Ser (c.646C>T) (P215S); ClinVar=VCV000011073; Zygosity=Hemizygous (PubMed=32446239).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32446239
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 14,16
ST   D12S391: 15,21
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 11,13
ST   D19S433: 14,15
ST   D1S1656: 11,12
ST   D21S11: 29,31.2
ST   D22S1045: 15,16
ST   D2S1338: 17
ST   D2S441: 14,15
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 21,23
ST   SE33: 18,28.2
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F209 ! GM09546
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MPIi007-A
AC   CVCL_A4WI
DR   hPSCreg; MPIi007-A
DR   Wikidata; Q107116394
RX   PubMed=32950023;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:713; ARSA; Simple; p.Thr393Ser (c.1178C>G) (p.Thr391Ser, c.1172C>G); ClinVar=VCV000021184; Zygosity=Heterozygous (PubMed=32950023).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32950023
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D18S51: 12
ST   D19S433: 15
ST   D21S11: 30.2,31.2
ST   D2S1338: 19,20
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6B33 ! GM00197
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   MPIi008-A
AC   CVCL_B5IT
SY   DDShiPS1
DR   hPSCreg; MPIi008-A
DR   Wikidata; Q110433064
RX   PubMed=35667217;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg394Leu (c.181G>T); Zygosity=Heterozygous (PubMed=35667217).
CC   Derived from site: In situ; Testis, tunica albuginea; UBERON=UBERON_0006610.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84668; Denys-Drash syndrome
DI   ORDO; Orphanet_220; Denys-Drash syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX33 ! GM13495
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   MPIMBMi011-A
AC   CVCL_QX63
SY   F1
DR   Wikidata; Q54906458
RX   PubMed=28677534;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=28677534
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D12S391: 17.3,19
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D1S1656: 12,14
ST   D21S11: 27,30
ST   D2S1338: 18,19
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D6S1043: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   MPIMBMi011-A-3
AC   CVCL_QX64
SY   F1/PITX2fs/fs-1; PITX2fs/fs-1
DR   Wikidata; Q54906459
RX   PubMed=28677534;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9005; PITX2.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=28677534
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D12S391: 17.3,19
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D1S1656: 12,14
ST   D21S11: 27,30
ST   D2S1338: 18,19
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D6S1043: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX63 ! MPIMBMi011-A
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   MPIMBMi011-A-4
AC   CVCL_QX65
SY   F1/PITX2fs/fs-2; PITX2fs/fs-2
DR   Wikidata; Q54906460
RX   PubMed=28677534;
CC   From: Max Planck Institute for Molecular Biomedicine; Munster; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9005; PITX2.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=28677534
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D12S391: 17.3,19
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D1S1656: 12,14
ST   D21S11: 27,30
ST   D2S1338: 18,19
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D6S1043: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX63 ! MPIMBMi011-A
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   mpiNSC
AC   CVCL_GP99
SY   mini-pig Neural Stem Cell line
DR   Wikidata; Q54906461
RX   PubMed=27524466;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 8
//
ID   MPIPi001-A
AC   CVCL_D4AI
DR   EBiSC; MPIPi001-A
DR   ECACC; 66770081
DR   hPSCreg; MPIPi001-A
DR   Wikidata; Q127382865
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi001-A; true.
CC   Discontinued: ECACC; 66770081; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi002-A
AC   CVCL_D4AJ
DR   EBiSC; MPIPi002-A
DR   ECACC; 66770082
DR   hPSCreg; MPIPi002-A
DR   Wikidata; Q127382866
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi002-A; true.
CC   Discontinued: ECACC; 66770082; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi003-A
AC   CVCL_D4AK
DR   EBiSC; MPIPi003-A
DR   ECACC; 66770083
DR   hPSCreg; MPIPi003-A
DR   Wikidata; Q127382867
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi003-A; true.
CC   Discontinued: ECACC; 66770083; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi004-A
AC   CVCL_D4AL
DR   EBiSC; MPIPi004-A
DR   ECACC; 66770084
DR   hPSCreg; MPIPi004-A
DR   Wikidata; Q127382868
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi004-A; true.
CC   Discontinued: ECACC; 66770084; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi005-A
AC   CVCL_D4AM
DR   EBiSC; MPIPi005-A
DR   ECACC; 66770085
DR   hPSCreg; MPIPi005-A
DR   Wikidata; Q127382869
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi005-A; true.
CC   Discontinued: ECACC; 66770085; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi006-A
AC   CVCL_D4AN
DR   EBiSC; MPIPi006-A
DR   ECACC; 66770086
DR   hPSCreg; MPIPi006-A
DR   Wikidata; Q127382870
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi006-A; true.
CC   Discontinued: ECACC; 66770086; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi007-A
AC   CVCL_D4AP
DR   EBiSC; MPIPi007-A
DR   ECACC; 66770087
DR   hPSCreg; MPIPi007-A
DR   Wikidata; Q127382871
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi007-A; true.
CC   Discontinued: ECACC; 66770087; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi008-A
AC   CVCL_D4AQ
DR   EBiSC; MPIPi008-A
DR   ECACC; 66770088
DR   hPSCreg; MPIPi008-A
DR   Wikidata; Q127382873
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi008-A; true.
CC   Discontinued: ECACC; 66770088; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi009-A
AC   CVCL_D4AR
DR   EBiSC; MPIPi009-A
DR   ECACC; 66770089
DR   hPSCreg; MPIPi009-A
DR   Wikidata; Q127382874
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi009-A; true.
CC   Discontinued: ECACC; 66770089; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi010-A
AC   CVCL_D4AS
DR   EBiSC; MPIPi010-A
DR   ECACC; 66770090
DR   hPSCreg; MPIPi010-A
DR   Wikidata; Q127382875
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi010-A; true.
CC   Discontinued: ECACC; 66770090; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi011-A
AC   CVCL_D4AT
DR   EBiSC; MPIPi011-A
DR   ECACC; 66770091
DR   hPSCreg; MPIPi011-A
DR   Wikidata; Q127382876
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi011-A; true.
CC   Discontinued: ECACC; 66770091; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi012-A
AC   CVCL_D4AU
DR   EBiSC; MPIPi012-A
DR   ECACC; 66770092
DR   hPSCreg; MPIPi012-A
DR   Wikidata; Q127382877
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi012-A; true.
CC   Discontinued: ECACC; 66770092; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi013-A
AC   CVCL_D4AV
DR   EBiSC; MPIPi013-A
DR   ECACC; 66770093
DR   hPSCreg; MPIPi013-A
DR   Wikidata; Q127382878
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi013-A; true.
CC   Discontinued: ECACC; 66770093; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi014-A
AC   CVCL_D4AW
DR   EBiSC; MPIPi014-A
DR   ECACC; 66770094
DR   hPSCreg; MPIPi014-A
DR   Wikidata; Q127382879
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi014-A; true.
CC   Discontinued: ECACC; 66770094; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi015-A
AC   CVCL_D4AX
DR   EBiSC; MPIPi015-A
DR   ECACC; 66770095
DR   hPSCreg; MPIPi015-A
DR   Wikidata; Q127382881
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi015-A; true.
CC   Discontinued: ECACC; 66770095; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi016-A
AC   CVCL_D4AY
DR   EBiSC; MPIPi016-A
DR   ECACC; 66770096
DR   hPSCreg; MPIPi016-A
DR   Wikidata; Q127382882
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi016-A; true.
CC   Discontinued: ECACC; 66770096; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi017-A
AC   CVCL_D4AZ
DR   EBiSC; MPIPi017-A
DR   ECACC; 66770097
DR   hPSCreg; MPIPi017-A
DR   Wikidata; Q127382883
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi017-A; true.
CC   Discontinued: ECACC; 66770097; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi018-A
AC   CVCL_D4B0
DR   EBiSC; MPIPi018-A
DR   ECACC; 66770098
DR   hPSCreg; MPIPi018-A
DR   Wikidata; Q127382884
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Discontinued: EBiSC; MPIPi018-A; true.
CC   Discontinued: ECACC; 66770098; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   MPIPi057-A
AC   CVCL_C1QH
SY   UL1
DR   BioSamples; SAMEA13855412
DR   hPSCreg; MPIPi057-A
DR   Wikidata; Q114312313
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179710; Myoclonic epilepsy of Unverricht and Lundborg
DI   ORDO; Orphanet_308; Unverricht-Lundborg disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MPIPi058-A
AC   CVCL_C1QI
SY   UL4
DR   BioSamples; SAMEA13846812
DR   hPSCreg; MPIPi058-A
DR   Wikidata; Q114312314
CC   From: Max Planck Institute of Psychiatry; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179710; Myoclonic epilepsy of Unverricht and Lundborg
DI   ORDO; Orphanet_308; Unverricht-Lundborg disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   mPitA-1
AC   CVCL_D464
SY   mPitA1
DR   Wikidata; Q54906462
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU401.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   mPitA-1/1
AC   CVCL_D465
DR   Wikidata; Q54906463
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU413.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D464 ! mPitA-1
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-1/3
AC   CVCL_D466
DR   Wikidata; Q54906464
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU414.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D464 ! mPitA-1
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-1/4
AC   CVCL_D467
DR   Wikidata; Q54906465
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU424.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D464 ! mPitA-1
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mPitA-1/5
AC   CVCL_D468
DR   Wikidata; Q54906466
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU415.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D464 ! mPitA-1
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-1/6
AC   CVCL_D469
DR   Wikidata; Q54906467
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU416.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D464 ! mPitA-1
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-1/8
AC   CVCL_D470
DR   Wikidata; Q54906468
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU425.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D464 ! mPitA-1
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mPitA-10
AC   CVCL_U361
SY   mPitA10
DR   Wikidata; Q54906469
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   mPitA-11
AC   CVCL_U362
SY   mPitA11
DR   Wikidata; Q54906470
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   mPitA-12
AC   CVCL_D471
SY   mPitA12
DR   Wikidata; Q54906471
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU408.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-12/3
AC   CVCL_D472
DR   Wikidata; Q54906472
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU420.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D471 ! mPitA-12
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-12/4
AC   CVCL_D473
DR   Wikidata; Q54906473
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU421.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D471 ! mPitA-12
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-12/5
AC   CVCL_D474
DR   Wikidata; Q54906474
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU422.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D471 ! mPitA-12
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mPitA-12/6
AC   CVCL_D475
DR   Wikidata; Q54906475
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU423.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D471 ! mPitA-12
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   mPitA-13
AC   CVCL_U360
SY   mPitA13
DR   Wikidata; Q54906476
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   mPitA-14
AC   CVCL_D476
SY   mPitA14
DR   Wikidata; Q54906477
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU409.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-15
AC   CVCL_D477
SY   mPitA15
DR   Wikidata; Q54906478
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU410.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-16
AC   CVCL_D478
SY   mPitA16
DR   Wikidata; Q54906483
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU411.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-17
AC   CVCL_U358
SY   mPitA17
DR   Wikidata; Q54906484
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   mPitA-18
AC   CVCL_U359
SY   mPitA18
DR   Wikidata; Q54906485
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   mPitA-19
AC   CVCL_D479
SY   mPitA19
DR   Wikidata; Q54906486
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU412.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-2
AC   CVCL_D480
SY   mPitA2
DR   Wikidata; Q54906487
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU402.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-3
AC   CVCL_D481
SY   mPitA3
DR   Wikidata; Q54906488
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU403.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-3/1
AC   CVCL_D482
DR   Wikidata; Q54906489
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU417.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D481 ! mPitA-3
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-3/2
AC   CVCL_D483
DR   Wikidata; Q54906490
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU418.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D481 ! mPitA-3
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-3/3
AC   CVCL_D484
DR   Wikidata; Q54906491
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU419.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D481 ! mPitA-3
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-4
AC   CVCL_D485
SY   mPitA4
DR   Wikidata; Q54906492
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU404.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-5
AC   CVCL_D486
SY   mPitA5
DR   Wikidata; Q54906493
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU405.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-6
AC   CVCL_D487
SY   mPitA6
DR   Wikidata; Q54906494
RX   PubMed=22132145;
WW   Provider; Cedarlane; CLU406; https://www.cedarlanelabs.com/Products/Detail/CLU406?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   mPitA-7
AC   CVCL_U357
SY   mPitA7
DR   Wikidata; Q54906495
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   mPitA-8
AC   CVCL_D488
SY   mPitA8
DR   Wikidata; Q54906496
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU407.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   mPitA-9
AC   CVCL_U356
SY   mPitA9
DR   Wikidata; Q54906497
RX   PubMed=22132145;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   mPitA-POMC/GFP-1
AC   CVCL_EP70
DR   Wikidata; Q54906498
RX   PubMed=24134870;
WW   Provider; Cedarlane; CLU504; https://www.cedarlanelabs.com/Products/Detail/CLU504?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   MPK [Mylopharyngodon]
AC   CVCL_LN40
SY   Mylopharyngodon Piceus Kidney
DR   Wikidata; Q54906499
RX   PubMed=29068065;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=75356; ! Mylopharyngodon piceus (Black carp)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   MPK [Pig]
AC   CVCL_3859
SY   MiniPig Kidney
DR   CLO; CLO_0007856
DR   CLDB; cl3558
DR   CLDB; cl3559
DR   ATCC; CCL-166
DR   CCRID; 1102SWI-NIFDC00108
DR   ECACC; 87032604
DR   IZSLER; BS CL 67
DR   Wikidata; Q54906500
RX   PubMed=3173126;
RX   PubMed=7989438;
RX   PubMed=19508353;
CC   Virology: Highly susceptible to infection by classical swine fever virus (CSFV) (PubMed=3173126).
CC   Virology: Susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   118FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 18
//
ID   mpkCCD
AC   CVCL_R771
DR   BTO; BTO_0006302
DR   Wikidata; Q54906501
RX   PubMed=9636246;
RX   PubMed=11158395;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: SV-PK/Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   mpkCCDc14
AC   CVCL_F596
SY   mpkCCD(c14)
DR   BTO; BTO_0002657
DR   Lonza; 1028
DR   Wikidata; Q54906502
RX   PubMed=10232677;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: SV-PK/Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R771 ! mpkCCD
SX   Sex unspecified
AG   1M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   mpkDCT
AC   CVCL_R773
DR   Wikidata; Q54906503
RX   PubMed=11158395;
RX   PubMed=14625201;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, distal convoluted tubule; UBERON=UBERON_0001292.
CC   Breed/subspecies: SV-PK/Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   mpkIMCD
AC   CVCL_R772
DR   Wikidata; Q54906504
RX   PubMed=11158395;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, inner medullary collecting duct; UBERON=UBERON_0004205.
CC   Breed/subspecies: SV-PK/Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   MPM1
AC   CVCL_D527
DR   Wikidata; Q54906505
RX   PubMed=18383846;
CC   Population: Japanese.
CC   Doubling time: 26 hours (PubMed=18383846).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   MPM176
AC   CVCL_A1YP
DR   Wikidata; Q105510168
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 31.5 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   MPM2
AC   CVCL_D528
DR   Wikidata; Q54906506
RX   PubMed=18383846;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=18383846).
CC   Donor information: No history of asbestos exposure (PubMed=18383846).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   MPM3
AC   CVCL_D529
DR   Wikidata; Q54906507
RX   PubMed=18383846;
CC   Population: Japanese.
CC   Doubling time: 43 hours (PubMed=18383846).
CC   Donor information: No history of asbestos exposure (PubMed=18383846).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   MPN3
AC   CVCL_Z590
DR   Wikidata; Q54906508
RX   PubMed=15950500;
RX   PubMed=30460085;
CC   Doubling time: 17.6 +- 3.8 hours (PubMed=15950500).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Minnesota miniature pig; VBO=VBO_0016874.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   MPNST-14
AC   CVCL_AU21
SY   MPNST14
DR   Wikidata; Q54906509
RX   PubMed=19890883;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 6
//
ID   MPNST-642
AC   CVCL_AU19
SY   MPNST642
DR   Wikidata; Q54906514
RX   PubMed=21084276;
RX   PubMed=25878149;
RX   PubMed=32642732;
CC   Doubling time: ~48 hours (PubMed=21084276).
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
ID   MPNST-724
AC   CVCL_AU20
SY   MPNST724
DR   DepMap; ACH-002710
DR   Wikidata; Q54906510
RX   PubMed=19890883;
RX   PubMed=21084276;
RX   PubMed=25878149;
RX   PubMed=32642732;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~24 hours (PubMed=21084276).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.280delTCA; Zygosity=Unspecified (PubMed=21084276).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   MPNST-90
AC   CVCL_J355
DR   Wikidata; Q54906511
RX   PubMed=19414372;
CC   Doubling time: 32 hours (PubMed=19414372).
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J356 ! MPNST-91
OI   CVCL_J357 ! MPNST-92
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   MPNST-91
AC   CVCL_J356
DR   Wikidata; Q54906512
RX   PubMed=19414372;
CC   Doubling time: 26 hours (PubMed=19414372).
CC   Derived from site: Metastatic; Right thigh; UBERON=UBERON_0000376.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J355 ! MPNST-90
OI   CVCL_J357 ! MPNST-92
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   MPNST-92
AC   CVCL_J357
DR   Wikidata; Q54906513
RX   PubMed=19414372;
CC   Doubling time: 24 hours (PubMed=19414372).
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J355 ! MPNST-90
OI   CVCL_J356 ! MPNST-91
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   MPP 89
AC   CVCL_1427
SY   MPP-89; MPP89
DR   CLO; CLO_0007858
DR   CLO; CLO_0037115
DR   CLDB; cl5400
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988144
DR   cancercelllines; CVCL_1427
DR   Cell_Model_Passport; SIDM00222
DR   ChEMBL-Cells; CHEMBL3308241
DR   ChEMBL-Targets; CHEMBL2366357
DR   Cosmic; 908150
DR   Cosmic; 1995512
DR   Cosmic-CLP; 908150
DR   DepMap; ACH-000319
DR   EGA; EGAS00001000978
DR   GDSC; 908150
DR   GEO; GSM887341
DR   GEO; GSM888417
DR   GEO; GSM1670132
DR   ICLC; HTL00012
DR   LiGeA; CCLE_327
DR   LINCS_LDP; LCL-1229
DR   PharmacoDB; MPP89_964_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1427
DR   PubChem_Cell_line; CVCL_1427
DR   Wikidata; Q54906515
RX   PubMed=10232421;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*51:08,57:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.06%; Native American=0%; East Asian, North=6.98%; East Asian, South=0%; South Asian=0%; European, North=33.57%; European, South=54.38% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=908150
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   MPRO clone 2.1
AC   CVCL_5430
SY   MPRO Cell Line, Clone 2.1; MPRO C2.1; MPRO
DR   CLO; CLO_0007859
DR   ATCC; CRL-3604
DR   ATCC; CRL-11422
DR   Wikidata; Q54906516
RX   Patent=US5830760;
RX   PubMed=9808058;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11422.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=With p.Gly404_Pro462del = RARalpha403).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-11422; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   MPS VII iPSC
AC   CVCL_B6LR
DR   Wikidata; Q112129356
RX   PubMed=25866157;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84903; Sly syndrome
DI   ORDO; Orphanet_584; Mucopolysaccharidosis type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z830 ! GM02784
SX   Female
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MPS-1
AC   CVCL_WB00
SY   MucoPolySaccharidosis-1
DR   IBRC; C10419
DR   Wikidata; Q95990910
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61259; Mucopolysaccharidosis
DI   ORDO; Orphanet_79213; Mucopolysaccharidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WG22 ! Hu-04
SX   Female
AG   1Y8M
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MPS-KC-iPS 1
AC   CVCL_C929
SY   MPS-KC-derived iPS 1
DR   Wikidata; Q54906517
RX   PubMed=21037085;
CC   From: University of Minnesota; Twin Cities; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Tyr167Ter (c.501C>G); ClinVar=VCV000092644; Zygosity=Heterozygous (PubMed=21037085).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (PubMed=21037085).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   MPS-KC-iPS 2
AC   CVCL_C930
SY   MPS-KC-derived iPS 2
DR   Wikidata; Q54906518
RX   PubMed=21037085;
CC   From: University of Minnesota; Twin Cities; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Homozygous (PubMed=21037085).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C931 ! MPS-MSC-iPS 2
SX   Male
AG   2Y4M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   MPS-MSC-iPS 2
AC   CVCL_C931
SY   MPS-MSC-derived iPS 2
DR   Wikidata; Q54906519
RX   PubMed=21037085;
CC   From: University of Minnesota; Twin Cities; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Homozygous (PubMed=21037085).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C930 ! MPS-KC-iPS 2
SX   Male
AG   2Y4M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   Mps1
AC   CVCL_ZU23
DR   Wikidata; Q98127283
RX   PubMed=7513056;
RX   PubMed=12655141;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Unexplicit; Ex1del; Zygosity=Homozygous (PubMed=12655141).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MPSC1
AC   CVCL_9822
SY   MPSC 1
DR   Cosmic; 906589
DR   Wikidata; Q54906520
RX   PubMed=15753399;
RX   PubMed=23415752;
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   MPSII-1.3
AC   CVCL_IJ23
DR   SKIP; SKIP001293
DR   Wikidata; Q54906521
RX   PubMed=27789399;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.Gln29Ter (c.85C>T); Zygosity=Hemizygous (PubMed=27789399).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   MPSII-2.5
AC   CVCL_IJ24
DR   SKIP; SKIP001292
DR   Wikidata; Q54906522
RX   PubMed=27789398;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.Gln29Ter (c.85C>T); Zygosity=Hemizygous (PubMed=27789398).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   MPSII-4.1
AC   CVCL_RK94
DR   SKIP; SKIP001290
DR   Wikidata; Q54906528
RX   PubMed=27789394;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.Ser61Phe (c.182C>T); ClinVar=VCV001065845; Zygosity=Hemizygous (PubMed=27789394).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   MPSII-mother.1
AC   CVCL_IJ25
DR   SKIP; SKIP001294
DR   Wikidata; Q54906529
RX   PubMed=27789401;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.Gln29Ter (c.85C>T); Zygosity=Heterozygous (PubMed=27789401).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   MPT-1
AC   CVCL_L367
DR   Wikidata; Q54906530
RX   PubMed=18086553;
CC   Doubling time: 40.3 +- 3.1 hours (PubMed=18086553).
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   MPT-S1
AC   CVCL_B7GV
DR   cancercelllines; CVCL_B7GV
DR   Wikidata; Q112930125
RX   PubMed=35365682;
CC   Population: Chinese.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: 2-3 days (PubMed=35365682).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; c.6079_6082delAATT; Zygosity=Heterozygous (PubMed=35365682).
CC   Sequence variation: Mutation; HGNC; HGNC:11957; MED12; Simple; p.Gly44Asp (c.131G>A); ClinVar=VCV000092220; Zygosity=Heterozygous (PubMed=35365682).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1530_1531delAG; Zygosity=Heterozygous (PubMed=35365682).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1588_1589delAA; Zygosity=Heterozygous (PubMed=35365682).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.750_754delinsA; Zygosity=Heterozygous (PubMed=35365682).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu252del (c.754_756delCTC); ClinVar=VCV000998484; Zygosity=Heterozygous (PubMed=35365682).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=35365682
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,14
ST   D12S391: 21
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D18S51: 18
ST   D19S433: 13.2
ST   D1S1656: 11,16
ST   D21S11: 29,30
ST   D22S1045: 14
ST   D2S1338: 23
ST   D2S441: 12
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 11,13
ST   DYS391: 9
ST   FGA: 19
ST   Penta D: 9,14
ST   Penta E: 11,19
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C4504; Malignant breast phyllodes tumor
DI   ORDO; Orphanet_180261; Phyllodes tumor of the breast
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   MPT64-A5B2
AC   CVCL_C6V9
DR   Wikidata; Q117704714
RX   Patent=CN112759644A;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P9WIN9; Mycobacterium tuberculosis MPT64 (mpt64).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   MQ-NCSU
AC   CVCL_S483
SY   Muquarrab Qureshi-North Carolina State University
DR   Wikidata; Q54906532
RX   PubMed=2176014;
RX   PubMed=16050178;
RX   PubMed=25165812;
CC   Group: Bird cell line.
CC   Characteristics: Used in the context of nitric oxide (NO) production experiments.
CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: DeKalb XL.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   MQ49
AC   CVCL_C5W1
DR   Wikidata; Q116049795
RX   Patent=US4863854;
RX   Patent=WO1996040295A1;
RX   PubMed=3932516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8874.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9750.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MR 10.2
AC   CVCL_D672
SY   MR10-2
DR   BCRJ; 0177
DR   Wikidata; Q54906533
CC   Discontinued: BCRJ; 0177; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   MR 12.4
AC   CVCL_D673
SY   MR12-4
DR   BCRJ; 0178
DR   Wikidata; Q54906534
CC   Discontinued: BCRJ; 0178; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   MR 9.4
AC   CVCL_D674
SY   MR9-4
DR   BCRJ; 0179
DR   Wikidata; Q54906535
RX   PubMed=1714479;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mouse T cell receptor (TcR) V-beta-5.1/5.2.
CC   Discontinued: BCRJ; 0179; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   MR-103
AC   CVCL_JZ43
SY   MR 103
DR   Wikidata; Q54906536
RX   PubMed=2437618;
RX   PubMed=2988594;
CC   Doubling time: 3-5 days (PubMed=2988594).
CC   Caution: According to PubMed=2988594 is from small cell lung carcinoma while according to PubMed=2437618 it is from a large cell carcinoma.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-13
AC   CVCL_JZ25
SY   MR 13
DR   Wikidata; Q54906537
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 6 days (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MR-16
AC   CVCL_JZ26
SY   MR 16
DR   Wikidata; Q54906538
RX   PubMed=2986245;
CC   Doubling time: 3 days (PubMed=2986245).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-2
AC   CVCL_JZ19
SY   MR 2
DR   Wikidata; Q54906540
RX   PubMed=2986245;
CC   Doubling time: 10 days (PubMed=2986245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-20
AC   CVCL_JZ27
SY   MR 20
DR   Wikidata; Q54906541
RX   PubMed=2986245;
CC   Doubling time: 3 days (PubMed=2986245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-21
AC   CVCL_JZ28
SY   MR 21; MR21
DR   Wikidata; Q54906543
RX   PubMed=2437618;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   MR-22
AC   CVCL_JZ29
SY   MR 22
DR   Wikidata; Q54906544
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 2 days (PubMed=2986245); 4 days (PubMed=2988594).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-25
AC   CVCL_JZ30
SY   MR 25
DR   Wikidata; Q54906545
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 1 day (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-26
AC   CVCL_JZ31
SY   MR 26
DR   Wikidata; Q54906546
RX   PubMed=2986245;
CC   Doubling time: 20 days (PubMed=2986245).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-27
AC   CVCL_JZ32
SY   MR 27
DR   Wikidata; Q54906547
RX   PubMed=2986245;
CC   Doubling time: 15 days (PubMed=2986245).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-28
AC   CVCL_JZ33
SY   MR 28
DR   Wikidata; Q54906548
RX   PubMed=2986245;
CC   Doubling time: 10 days (PubMed=2986245).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-32
AC   CVCL_JZ34
SY   MR 32
DR   Wikidata; Q54906549
RX   PubMed=2437618;
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 1.5 days (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-33
AC   CVCL_JZ35
SY   MR 33
DR   Wikidata; Q54906550
RX   PubMed=2986245;
CC   Doubling time: 0.5 day (PubMed=2986245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-4
AC   CVCL_JZ20
SY   MR 4
DR   Wikidata; Q54906551
RX   PubMed=2986245;
CC   Doubling time: 4 days (PubMed=2986245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MR-5
AC   CVCL_JZ21
SY   MR 5
DR   Wikidata; Q54906552
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 1-3 days (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MR-50
AC   CVCL_JZ36
SY   MR 50
DR   Wikidata; Q54906553
RX   PubMed=2986245;
CC   Doubling time: 2 days (PubMed=2986245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-55
AC   CVCL_JZ37
SY   MR 55
DR   Wikidata; Q54906554
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 5 days (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 8
//
ID   MR-58
AC   CVCL_JZ38
SY   MR 58
DR   Wikidata; Q54906555
RX   PubMed=2986245;
CC   Doubling time: 5 days (PubMed=2986245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-65
AC   CVCL_JZ39
SY   MR 65; MR65
DR   Wikidata; Q54906557
RX   PubMed=2437618;
RX   PubMed=2674163;
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 1 day (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 8
//
ID   MR-7
AC   CVCL_JZ22
SY   MR 7
DR   Wikidata; Q54906558
RX   PubMed=2986245;
CC   Doubling time: 2 days (PubMed=2986245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-8
AC   CVCL_JZ23
SY   MR 8
DR   Wikidata; Q54906559
RX   PubMed=2437618;
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 3 days (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-86
AC   CVCL_JZ40
SY   MR 86
DR   Wikidata; Q54906560
RX   PubMed=2437618;
RX   PubMed=2988594;
CC   Doubling time: 4 days (PubMed=2988594).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MR-87
AC   CVCL_A655
DR   Cosmic; 787460
DR   Cosmic; 975279
DR   Cosmic; 999768
DR   Wikidata; Q54906561
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1884023;
RX   PubMed=3048438;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Population: Japanese.
CC   Doubling time: 120-144 hours (PubMed=3048438).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=3048438; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QW99 ! MR-B
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   MR-9
AC   CVCL_JZ24
SY   MR 9
DR   Wikidata; Q54906562
RX   PubMed=2986245;
RX   PubMed=2988594;
CC   Doubling time: 1.5 days (PubMed=2986245; PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   MR-90
AC   CVCL_JZ41
SY   MR 90
DR   Wikidata; Q54906563
RX   PubMed=2988594;
CC   Doubling time: 1 day (PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MR-97
AC   CVCL_JZ42
SY   MR 97
DR   Wikidata; Q54906564
RX   PubMed=2988594;
CC   Doubling time: 1 day (PubMed=2988594).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   MR-B
AC   CVCL_QW99
DR   Wikidata; Q54906565
RX   PubMed=3048438;
CC   Population: Japanese.
CC   Doubling time: 24-36 hours (PubMed=3048438).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A655 ! MR-87
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   MR-Mel
AC   CVCL_7081
DR   BTO; BTO_0003790
DR   Cosmic; 1109799
DR   Wikidata; Q54906566
RX   PubMed=18384130;
CC   Sequence variation: Gene deletion; HGNC; HGNC:583; APC; Zygosity=Homozygous (PubMed=18384130).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gln939Ter (c.2815C>T); ClinVar=VCV000089318; Zygosity=Unspecified (PubMed=18384130).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Thr1008Ile (c.3023C>T); ClinVar=VCV000569009; Zygosity=Unspecified (PubMed=18384130).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   MR1
AC   CVCL_8964
DR   CLO; CLO_0007861
DR   ATCC; CRL-2580
DR   ATCC; HB-11048
DR   CCRID; 3101ETCHYB53
DR   CLS; 305000
DR   Wikidata; Q54906567
RX   Patent=US5683693;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11048.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P27548; Mouse Cd40lg/Cd154.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   MR1-3
AC   CVCL_U180
DR   CLO; CLO_0050915
DR   BioSample; SAMN03470994
DR   Cosmic; 753593
DR   RCB; RCB0504
DR   Wikidata; Q54906568
RX   PubMed=2372878;
RX   PubMed=3608093;
RX   PubMed=25877200;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=25877200; RCB=RCB0504
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,16,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U209 ! HeLa S3 mer-
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   MR10-1
AC   CVCL_U181
DR   CLO; CLO_0050917
DR   RCB; RCB0507
DR   Wikidata; Q54906569
RX   PubMed=2372878;
RX   PubMed=3163531;
RX   PubMed=3608093;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB0507
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U209 ! HeLa S3 mer-
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   MR11
AC   CVCL_U182
DR   Wikidata; Q54906570
RX   PubMed=2372878;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U209 ! HeLa S3 mer-
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   MR42D
AC   CVCL_RW50
SY   ENZR 42D; 42DENZR
DR   cancercelllines; CVCL_RW50
DR   Wikidata; Q54906571
RX   PubMed=25428917;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   MR42F
AC   CVCL_RW51
SY   ENZR 42F; 42FENZR
DR   cancercelllines; CVCL_RW51
DR   Wikidata; Q54906574
RX   PubMed=25428917;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   MR49C
AC   CVCL_RW52
SY   ENZR 49C; 49CENZR
DR   cancercelllines; CVCL_RW52
DR   Wikidata; Q54906575
RX   PubMed=25634993;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   MR49F
AC   CVCL_RW53
SY   MR49-F; ENZR 49F; 49FENZR
DR   BTO; BTO_0006265
DR   cancercelllines; CVCL_RW53
DR   ChEMBL-Cells; CHEMBL4483149
DR   ChEMBL-Targets; CHEMBL4483259
DR   PubChem_Cell_line; CVCL_RW53
DR   Wikidata; Q54906576
RX   PubMed=25428917;
RX   PubMed=25634993;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   MR6
AC   CVCL_U183
DR   CLO; CLO_0050916
DR   BioSample; SAMN03470988
DR   BioSample; SAMN03472275
DR   RCB; RCB0505
DR   Wikidata; Q54906577
RX   PubMed=2372878;
RX   PubMed=3608093;
RX   PubMed=25877200;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=25877200; RCB=RCB0505
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 8
ST   Penta E: 7,16,17
ST   TH01: 7 (PubMed=25877200)
ST   TH01: 7,9.3 (RCB=RCB0505)
ST   TPOX: 8,12
ST   vWA: 15,16,18 (RCB=RCB0505)
ST   vWA: 15,18 (PubMed=25877200)
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U209 ! HeLa S3 mer-
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   MR6F3
AC   CVCL_E8NQ
RX   PubMed=30592703;
RX   PubMed=30592704;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O94907; Human DKK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MR8
AC   CVCL_U184
DR   Wikidata; Q54906578
RX   PubMed=2372878;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U209 ! HeLa S3 mer-
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   MRC-1
AC   CVCL_VG82
SY   Medical Research Council cell strain-1
DR   Wikidata; Q54906579
RX   PubMed=5956336;
CC   Senescence: Senesces at 50 +- 10 PDL (PubMed=5956336).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MRC-5
AC   CVCL_0440
SY   MRC5; MRC 5; MRCV; MRC-V; Medical Research Council cell strain-5
DR   BTO; BTO_0001590
DR   CLO; CLO_0007865
DR   CLO; CLO_0050055
DR   EFO; EFO_0002835
DR   MCCL; MCC:0000336
DR   CLDB; cl3563
DR   CLDB; cl3564
DR   CLDB; cl3566
DR   CLDB; cl3567
DR   CLDB; cl3568
DR   CLDB; cl5168
DR   AddexBio; T0016002/4922
DR   ATCC; CCL-171
DR   BCRC; 60023
DR   BCRJ; 0180
DR   BioSample; SAMN01821580
DR   BioSample; SAMN01821702
DR   BioSample; SAMN01821735
DR   BioSample; SAMN03473183
DR   CCRID; 1101HUM-PUMC000044
DR   CCRID; 1102HUM-NIFDC00002
DR   CCRID; 3101HUMGNHu41
DR   CCRID; 3101HUMSCSP5040
DR   CCRID; 4201HUM-CCTCC00032
DR   CCRID; 5301HUM-KCB89023YJ
DR   CCTCC; GDC0032
DR   ChEMBL-Cells; CHEMBL3308499
DR   ChEMBL-Targets; CHEMBL614181
DR   CLS; 300395
DR   ECACC; 97112601
DR   FCS-free; 179-2-338-1-16-3
DR   GEO; GSM248209
DR   GEO; GSM248210
DR   GEO; GSM520665
DR   GEO; GSM520666
DR   GEO; GSM520667
DR   GEO; GSM579888
DR   GEO; GSM579889
DR   GEO; GSM607969
DR   GEO; GSM3738752
DR   GEO; GSM3738753
DR   IBRC; C10313
DR   ICLC; HL95001
DR   IZSLER; BS CL 68
DR   JCRB; IFO50073
DR   JCRB; JCRB9008
DR   KCB; KCB 200412YJ
DR   KCB; KCB 89023YJ
DR   KCLB; 10171
DR   Lonza; 52
DR   NCBI_Iran; C125
DR   PRIDE; PXD001909
DR   PRIDE; PXD013120
DR   PRIDE; PXD023286
DR   PubChem_Cell_line; CVCL_0440
DR   RCB; RCB0211
DR   RCB; RCB0218
DR   Wikidata; Q3273166
RX   CelloPub=CLPUB00391;
RX   CelloPub=CLPUB00783;
RX   PubMed=113411;
RX   PubMed=211143;
RX   PubMed=932048;
RX   PubMed=1031681;
RX   PubMed=1193162;
RX   PubMed=1756776;
RX   PubMed=1965304;
RX   PubMed=3335022;
RX   PubMed=4316953;
RX   PubMed=6538202;
RX   PubMed=6971834;
RX   PubMed=7065527;
RX   PubMed=10752125;
RX   PubMed=11416159;
RX   PubMed=17395773;
RX   PubMed=19657000;
RX   PubMed=21637780;
RX   PubMed=25877200;
RX   PubMed=25903999;
RX   PubMed=26477663;
RX   PubMed=31869419;
RX   PubMed=33389257;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mrc5/mrc5cells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/number-of-population-doublings-pdl-for-atcc-ccl-171
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=68
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-380.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/MRC-5
WW   Provider; Vircell; -; https://www.vircell.com/en/products/mrc-5-cell-line
WW   Provider; WHO; -; https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/who-reference-cell-banks
CC   Group: Vaccine production cell line.
CC   Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies).
CC   Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta.
CC   Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax).
CC   Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax).
CC   Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 45 hours (Note=Lot 08072009), ~40 hours (Note=Lot 02272015) (JCRB=IFO50073); 36 hours (Note=Lot 041392), ~5 days (Note=Lot 031098), ~2 days (Note=Lot 05192003), ~1.5 days (Note=Lot 05202005), ~34 hours (Note=Lot 06022011), ~38 hours (Note=Lot 04212016) (JCRB=JCRB9008).
CC   HLA typing: A*02:01,29:02; B*07:02,44:02; C*05:01,07:02 (PubMed=31869419).
CC   HLA typing: A*02:01:01,29:02:01; B*07:02:01,44:02:01; C*05:01:01,07:02:01; DPB1*04:01:01; DQA1*01:02:01,03:03:01; DQB1*03:01:01,06:02:01; DRB1*04:08:01,15:01:01G (CLS=300395).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Glycomics; Glycosphingolipids.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; 2DE.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: MCR-5; Note=Occasionally.
CC   Discontinued: ECACC; 97112601; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): AddexBio=T0016002/4922; ATCC=CCL-171; CCRID; CLS=300395; JCRB=IFO50073; JCRB=JCRB9008; KCLB=10171; PubMed=11416159; PubMed=21637780; PubMed=25877200; RCB=RCB0211
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 20,22
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 15,21
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 11,19
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   MRC-5 CV1
AC   CVCL_E260
SY   MRC5-CV1; MRC5CV1
DR   ChEMBL-Cells; CHEMBL3307319
DR   ChEMBL-Targets; CHEMBL614182
DR   PubChem_Cell_line; CVCL_E260
DR   Wikidata; Q54906580
RX   PubMed=2903889;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   MRC-5 pd13
AC   CVCL_2621
DR   ECACC; 05011802
DR   Wikidata; Q54906581
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MRC-5 pd19
AC   CVCL_2622
DR   ECACC; 05072101
DR   Wikidata; Q54906582
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=05072101
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   MRC-5 pd25
AC   CVCL_2623
DR   ECACC; 05081101
DR   Wikidata; Q54906583
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=05081101
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   MRC-5 pd30
AC   CVCL_2624
DR   ECACC; 05090501
DR   ECACC; 84101801
DR   Wikidata; Q54906584
CC   Discontinued: ECACC; 84101801; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=05090501
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   MRC-5 PDL12
AC   CVCL_JF54
SY   MRC-5 PDL 12; WHO MRC-5 660902-M01
DR   Wikidata; Q54906585
RX   CelloPub=CLPUB00783;
RX   CelloPub=CLPUB00784;
WW   Provider; WHO; -; https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/who-reference-cell-banks
CC   Group: Vaccine production cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   MRC-5 PDL13
AC   CVCL_E5ZR
SY   MRC-5 PDL 13; WHO MRC-5 660902-M02
RX   CelloPub=CLPUB00784;
WW   Provider; WHO; -; https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/who-reference-cell-banks
CC   Group: Vaccine production cell line.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JF54 ! MRC-5 PDL12
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MRC-5 PDL27
AC   CVCL_H749
SY   AG05965-C; AG05965C
DR   CLO; CLO_0035205
DR   Coriell; AG05965-C
DR   Wikidata; Q54906586
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   MRC-5 PDL40
AC   CVCL_H748
SY   AG05965-D; AG05965D
DR   CLO; CLO_0035211
DR   Coriell; AG05965-D
DR   Wikidata; Q54906587
RX   CelloPub=CLPUB00597;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   MRC-5 PDL5.51
AC   CVCL_8B13
SY   AG05965-G
DR   Coriell; AG05965-G
DR   Wikidata; Q54906588
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   MRC-5 SV1 TG1
AC   CVCL_2625
DR   CLO; CLO_0007866
DR   CLO; CLO_0050061
DR   CLDB; cl3569
DR   BioSample; SAMN03472345
DR   ECACC; 85042501
DR   RCB; RCB0207
DR   Wikidata; Q54906589
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=85042501; RCB=RCB0207
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   MRC-5 SV1 TG2
AC   CVCL_2626
DR   CLO; CLO_0007867
DR   CLDB; cl3570
DR   ECACC; 85042502
DR   Wikidata; Q54906590
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=85042502
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   MRC-5-30
AC   CVCL_3027
DR   JCRB; JCRB0521
DR   Wikidata; Q54906591
CC   Doubling time: ~40 hours (Note=Lot 05142008), ~26 hours (Note=Lot 09112017) (JCRB=JCRB0521).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MRC-5-40
AC   CVCL_3028
DR   JCRB; JCRB0522
DR   Wikidata; Q54906592
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MRC-5-50
AC   CVCL_3029
DR   JCRB; JCRB0523
DR   Wikidata; Q54906593
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MRC-5V1
AC   CVCL_D690
SY   MRC5-V1; MRC5V1
DR   BTO; BTO_0005066
DR   EFO; EFO_0022549
DR   Wikidata; Q54906594
RX   CelloPub=CLPUB00712;
RX   PubMed=2821020;
RX   PubMed=2903889;
RX   PubMed=3180052;
RX   PubMed=6313714;
RX   PubMed=7563073;
RX   PubMed=8055625;
RX   PubMed=8824772;
RX   PubMed=16714754;
RX   PubMed=19935656;
RX   PubMed=21528266;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   MRC-5V2
AC   CVCL_2627
SY   MRC-5 V2; MRC5-V2; MRC5V2; MRC-5 SV2; MRC-5-SV2
DR   BTO; BTO_0006540
DR   CLO; CLO_0007868
DR   CLDB; cl3571
DR   ChEMBL-Cells; CHEMBL4513119
DR   ECACC; 84100401
DR   Wikidata; Q54906595
RX   CelloPub=CLPUB00712;
RX   PubMed=1965304;
RX   PubMed=6313714;
RX   PubMed=19935656;
RX   PubMed=21528266;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ECACC=84100401
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   MRC-7
AC   CVCL_2628
SY   MRC7; Medical Research Council cell strain-7
DR   CLO; CLO_0007869
DR   CLDB; cl3572
DR   ECACC; 85020203
DR   Wikidata; Q54906596
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MRC-9
AC   CVCL_2629
SY   MRC9; Medical Research Council cell strain-9
DR   CLO; CLO_0007870
DR   CLDB; cl3573
DR   ATCC; CCL-212
DR   BioSample; SAMN01821581
DR   BioSample; SAMN01821703
DR   BioSample; SAMN01821736
DR   BioSample; SAMN03471472
DR   CLS; 300394
DR   ECACC; 85020202
DR   GEO; GSM827585
DR   GEO; GSM1887917
DR   GEO; GSM1887962
DR   JCRB; IFO50072
DR   JCRB; JCRB9060
DR   KCLB; 10212
DR   Wikidata; Q54906597
RX   PubMed=113411;
RX   PubMed=1031681;
RX   PubMed=1756776;
RX   PubMed=7065527;
RX   PubMed=20215515;
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=69
CC   Population: Caucasian.
CC   Senescence: Can undergo at least 40 PDL (PubMed=113411). Senesces at 44 PDL (JCRB=IFO50072).
CC   Virology: Susceptible to infection by a wide range of viruses (ECACC=85020202).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: KCLB; 10212; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-212; ECACC=85020202; JCRB=IFO50072; JCRB=JCRB9060
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12,19
ST   D19S433: 13.2,14
ST   D21S11: 29,30.2
ST   D2S1338: 19,23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   MRC-9-30
AC   CVCL_3030
DR   JCRB; JCRB0524
DR   Wikidata; Q54906598
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2629 ! MRC-9
SX   Female
AG   15FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 10
//
ID   MRC-iPS-1
AC   CVCL_D923
SY   Bubba; MRC-iPS-01
DR   SKIP; SKIP000414
DR   Wikidata; Q54906599
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-10
AC   CVCL_D924
SY   Snip
DR   SKIP; SKIP000423
DR   Wikidata; Q54906600
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-100
AC   CVCL_D925
SY   Flip
DR   SKIP; SKIP000512
DR   Wikidata; Q54906601
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   MRC-iPS-101
AC   CVCL_D926
SY   Cue ball
DR   SKIP; SKIP000513
DR   Wikidata; Q54906602
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-11
AC   CVCL_8343
SY   Dotcom
DR   GEO; GSM607970
DR   GEO; GSM608021
DR   JCRB; JCRB1327
DR   JCRB; NIHS0598
DR   SKIP; SKIP000009
DR   SKIP; SKIP000351
DR   Wikidata; Q54906603
RX   PubMed=21155951;
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0598; true.
CC   Discontinued: SKIP; SKIP000009; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1327; PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 15,21
ST   D21S11: 31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MRC-iPS-12
AC   CVCL_D927
SY   Marbles
DR   SKIP; SKIP000424
DR   Wikidata; Q54906604
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-13
AC   CVCL_D928
SY   Sunspot
DR   SKIP; SKIP000425
DR   Wikidata; Q54906605
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-14
AC   CVCL_D929
SY   Nickels
DR   SKIP; SKIP000426
DR   Wikidata; Q54906607
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-15
AC   CVCL_D930
SY   Hotdog
DR   SKIP; SKIP000427
DR   Wikidata; Q54906608
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-16
AC   CVCL_D931
SY   Fetch; MRC5-iPS#16; MRCiPS#16
DR   JCRB; NIHS0604
DR   SKIP; SKIP000015
DR   SKIP; SKIP000428
DR   Wikidata; Q54906609
RX   PubMed=21155951;
RX   PubMed=23631808;
RX   PubMed=26477663;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Glycomics; Glycosphingolipids.
CC   Discontinued: JCRB; NIHS0604; true.
CC   Discontinued: SKIP; SKIP000015; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   MRC-iPS-17
AC   CVCL_D932
SY   Cinders
DR   SKIP; SKIP000429
DR   Wikidata; Q54906610
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-18
AC   CVCL_8367
SY   Lollipop
DR   JCRB; JCRB1336
DR   JCRB; NIHS0605
DR   SKIP; SKIP000012
DR   SKIP; SKIP000430
DR   Wikidata; Q54906611
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: JCRB; NIHS0605; true.
CC   Discontinued: SKIP; SKIP000012; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1336
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MRC-iPS-19
AC   CVCL_D933
SY   Scout
DR   GEO; GSM607971
DR   SKIP; SKIP000168
DR   SKIP; SKIP000431
DR   Wikidata; Q54906612
RX   PubMed=21155951;
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: SKIP; SKIP000168; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 15,21
ST   D21S11: 31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MRC-iPS-2
AC   CVCL_D934
SY   Seargent; MRC-iPS-02
DR   SKIP; SKIP000161
DR   SKIP; SKIP000415
DR   Wikidata; Q54906613
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000161; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MRC-iPS-20
AC   CVCL_D935
SY   Domino
DR   SKIP; SKIP000432
DR   Wikidata; Q54906614
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-21
AC   CVCL_D936
SY   Gobstopper
DR   SKIP; SKIP000433
DR   Wikidata; Q54906618
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-22
AC   CVCL_8426
SY   Squeaky
DR   JCRB; JCRB1329
DR   JCRB; NIHS0599
DR   SKIP; SKIP000010
DR   SKIP; SKIP000434
DR   Wikidata; Q54906619
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: JCRB; NIHS0599; true.
CC   Discontinued: SKIP; SKIP000010; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1329
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MRC-iPS-23
AC   CVCL_D937
SY   Buttons
DR   SKIP; SKIP000435
DR   Wikidata; Q54906620
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-24
AC   CVCL_D938
SY   Cotton ball
DR   SKIP; SKIP000436
DR   Wikidata; Q54906621
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-25
AC   CVCL_8433
SY   Tic; MRC5-iPS#25; MRCiPS#25
DR   GEO; GSM520668
DR   GEO; GSM520669
DR   GEO; GSM520670
DR   GEO; GSM607972
DR   GEO; GSM607973
DR   GEO; GSM607974
DR   GEO; GSM608022
DR   GEO; GSM608023
DR   JCRB; JCRB1331
DR   JCRB; NIHS0606
DR   SKIP; SKIP000008
DR   SKIP; SKIP000437
DR   Wikidata; Q54906622
RX   PubMed=21155951;
RX   PubMed=21637780;
RX   PubMed=23631808;
RX   PubMed=26477663;
RX   PubMed=27638317;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Glycomics; Glycosphingolipids.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0606; true.
CC   Discontinued: SKIP; SKIP000008; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1331; PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11 (PubMed=21637780)
ST   D16S539: 11 (JCRB=JCRB1331)
ST   D18S51: 15,21
ST   D21S11: 31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   MRC-iPS-26
AC   CVCL_D939
SY   Tac
DR   SKIP; SKIP000438
DR   Wikidata; Q54906623
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-27
AC   CVCL_8434
SY   Toe
DR   JCRB; JCRB1338
DR   JCRB; NIHS0607
DR   SKIP; SKIP000011
DR   SKIP; SKIP000439
DR   Wikidata; Q54906624
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: JCRB; NIHS0607; true.
CC   Discontinued: SKIP; SKIP000011; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1338
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MRC-iPS-28
AC   CVCL_D940
SY   Junior
DR   SKIP; SKIP000440
DR   Wikidata; Q54906625
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-29
AC   CVCL_D941
SY   Jake
DR   SKIP; SKIP000441
DR   Wikidata; Q54906626
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-3
AC   CVCL_D942
SY   Chew; MRC-iPS-03
DR   SKIP; SKIP000416
DR   Wikidata; Q54906627
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-30
AC   CVCL_D943
SY   Speckles
DR   SKIP; SKIP000167
DR   SKIP; SKIP000442
DR   Wikidata; Q54906628
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000167; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MRC-iPS-31
AC   CVCL_D944
SY   Ears
DR   SKIP; SKIP000443
DR   Wikidata; Q54906629
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-32
AC   CVCL_D945
SY   Bob
DR   SKIP; SKIP000444
DR   Wikidata; Q54906631
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-33
AC   CVCL_D946
SY   Alameda
DR   SKIP; SKIP000445
DR   Wikidata; Q54906632
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-34
AC   CVCL_D947
SY   Nipper
DR   SKIP; SKIP000164
DR   SKIP; SKIP000446
DR   Wikidata; Q54906633
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000164; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MRC-iPS-35
AC   CVCL_D948
SY   Oddball
DR   SKIP; SKIP000447
DR   Wikidata; Q54906634
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-36
AC   CVCL_D949
SY   Tippy
DR   SKIP; SKIP000448
DR   Wikidata; Q54906635
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-37
AC   CVCL_D950
SY   Jersey
DR   SKIP; SKIP000449
DR   Wikidata; Q54906636
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-38
AC   CVCL_D951
SY   Twister
DR   SKIP; SKIP000450
DR   Wikidata; Q54906637
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-39
AC   CVCL_D952
SY   Badger
DR   SKIP; SKIP000451
DR   Wikidata; Q54906638
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-4
AC   CVCL_D953
SY   Bones; MRC-iPS-04
DR   SKIP; SKIP000417
DR   Wikidata; Q54906639
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-40
AC   CVCL_D954
SY   Skipper; MRC5-iPS#40; MRCiPS#40
DR   JCRB; JCRB1565
DR   JCRB; NIHS0600
DR   SKIP; SKIP000013
DR   SKIP; SKIP000452
DR   Wikidata; Q54906640
RX   PubMed=23631808;
RX   PubMed=26477663;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Glycomics; Glycosphingolipids.
CC   Discontinued: JCRB; NIHS0600; true.
CC   Discontinued: SKIP; SKIP000013; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1565
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   MRC-iPS-41
AC   CVCL_D955
SY   Snowball
DR   SKIP; SKIP000453
DR   Wikidata; Q54906641
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-42
AC   CVCL_D956
SY   Ellipses
DR   SKIP; SKIP000454
DR   Wikidata; Q54906642
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-43
AC   CVCL_D957
SY   Pepper
DR   SKIP; SKIP000166
DR   SKIP; SKIP000455
DR   Wikidata; Q54906643
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000166; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MRC-iPS-44
AC   CVCL_D958
SY   Pinwheel
DR   SKIP; SKIP000456
DR   Wikidata; Q54906644
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-45
AC   CVCL_D959
SY   Jimmies
DR   SKIP; SKIP000457
DR   Wikidata; Q54906645
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-46
AC   CVCL_D960
SY   Buddy
DR   SKIP; SKIP000458
DR   Wikidata; Q54906647
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-47
AC   CVCL_D961
SY   Stripes
DR   SKIP; SKIP000459
DR   Wikidata; Q54906648
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-48
AC   CVCL_D962
SY   Ralph
DR   SKIP; SKIP000460
DR   Wikidata; Q54906649
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-49
AC   CVCL_D963
SY   Nugget
DR   SKIP; SKIP000461
DR   Wikidata; Q54906650
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-5
AC   CVCL_D964
SY   Princess; MRC-iPS-05
DR   SKIP; SKIP000418
DR   Wikidata; Q54906651
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-50
AC   CVCL_D965
SY   Fang
DR   SKIP; SKIP000462
DR   Wikidata; Q54906652
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-51
AC   CVCL_D966
SY   Windy
DR   SKIP; SKIP000162
DR   SKIP; SKIP000463
DR   Wikidata; Q54906653
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000162; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MRC-iPS-52
AC   CVCL_D967
SY   Chester
DR   SKIP; SKIP000464
DR   Wikidata; Q54906654
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-53
AC   CVCL_D968
SY   Smoky
DR   SKIP; SKIP000465
DR   Wikidata; Q54906655
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-54
AC   CVCL_D969
SY   Chief
DR   SKIP; SKIP000466
DR   Wikidata; Q54906656
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-55
AC   CVCL_D970
SY   Soho
DR   SKIP; SKIP000467
DR   Wikidata; Q54906657
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-56
AC   CVCL_D971
SY   Drifter
DR   SKIP; SKIP000163
DR   SKIP; SKIP000468
DR   Wikidata; Q54906658
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000163; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MRC-iPS-57
AC   CVCL_D972
SY   Rufus
DR   SKIP; SKIP000469
DR   Wikidata; Q54906659
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-58
AC   CVCL_D973
SY   Peeve
DR   SKIP; SKIP000470
DR   Wikidata; Q54906662
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-59
AC   CVCL_D974
SY   Moose
DR   SKIP; SKIP000471
DR   Wikidata; Q54906663
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-6
AC   CVCL_D975
SY   Freckles; MRC-iPS-06
DR   SKIP; SKIP000419
DR   Wikidata; Q54906664
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-60
AC   CVCL_D976
SY   Cosmo
DR   SKIP; SKIP000472
DR   Wikidata; Q54906665
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-61
AC   CVCL_D977
SY   Grinder
DR   SKIP; SKIP000473
DR   Wikidata; Q54906666
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-62
AC   CVCL_D978
SY   Gideon
DR   SKIP; SKIP000474
DR   Wikidata; Q54906667
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-63
AC   CVCL_D979
SY   Snicker
DR   SKIP; SKIP000475
DR   Wikidata; Q54906668
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-64
AC   CVCL_D980
SY   Chance
DR   SKIP; SKIP000476
DR   Wikidata; Q54906670
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-65
AC   CVCL_D981
SY   Squirrel
DR   SKIP; SKIP000165
DR   SKIP; SKIP000477
DR   Wikidata; Q54906671
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000165; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MRC-iPS-66
AC   CVCL_D982
SY   Tug
DR   SKIP; SKIP000478
DR   Wikidata; Q54906672
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-67
AC   CVCL_D983
SY   Badges
DR   SKIP; SKIP000479
DR   Wikidata; Q54906673
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-68
AC   CVCL_D984
SY   Blunder
DR   SKIP; SKIP000480
DR   Wikidata; Q54906674
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-69
AC   CVCL_D985
SY   Little dipper
DR   SKIP; SKIP000481
DR   Wikidata; Q54906675
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-7
AC   CVCL_D986
SY   Eight ball; MRC-iPS-07
DR   SKIP; SKIP000420
DR   Wikidata; Q54906676
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-70
AC   CVCL_D987
SY   Zephyr
DR   SKIP; SKIP000482
DR   Wikidata; Q54906677
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-71
AC   CVCL_D988
SY   Chase
DR   SKIP; SKIP000483
DR   Wikidata; Q54906678
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-72
AC   CVCL_D989
SY   Bongo
DR   SKIP; SKIP000484
DR   Wikidata; Q54906679
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-73
AC   CVCL_D990
SY   Soccer
DR   SKIP; SKIP000485
DR   Wikidata; Q54906681
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-74
AC   CVCL_D991
SY   Sparky
DR   SKIP; SKIP000486
DR   Wikidata; Q54906682
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-75
AC   CVCL_D992
SY   Wags
DR   GEO; GSM607975
DR   JCRB; NIHS0601
DR   SKIP; SKIP000014
DR   SKIP; SKIP000487
DR   Wikidata; Q54906684
RX   PubMed=21155951;
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: JCRB; NIHS0601; true.
CC   Discontinued: SKIP; SKIP000014; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 15,21
ST   D21S11: 31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   MRC-iPS-76
AC   CVCL_D993
SY   Smudge
DR   SKIP; SKIP000488
DR   Wikidata; Q54906685
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-77
AC   CVCL_D994
SY   Bootsie
DR   SKIP; SKIP000160
DR   SKIP; SKIP000489
DR   Wikidata; Q54906686
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000160; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MRC-iPS-78
AC   CVCL_D995
SY   Bogey
DR   SKIP; SKIP000490
DR   Wikidata; Q54906688
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-79
AC   CVCL_D996
SY   Otto
DR   SKIP; SKIP000491
DR   Wikidata; Q54906689
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-8
AC   CVCL_D997
SY   Orion; MRC-iPS-08
DR   SKIP; SKIP000421
DR   Wikidata; Q54906690
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-80
AC   CVCL_D998
SY   Hydrant
DR   SKIP; SKIP000492
DR   Wikidata; Q54906691
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-81
AC   CVCL_D999
SY   Ashes
DR   SKIP; SKIP000493
DR   Wikidata; Q54906692
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-82
AC   CVCL_E000
SY   Typhoon
DR   SKIP; SKIP000496
DR   Wikidata; Q54906694
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-83
AC   CVCL_E001
SY   Snake eyes
DR   SKIP; SKIP000494
DR   Wikidata; Q54906695
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-84
AC   CVCL_E002
SY   Whirlwind
DR   SKIP; SKIP000495
DR   Wikidata; Q54906696
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-85
AC   CVCL_E003
SY   Bluster
DR   SKIP; SKIP000157
DR   SKIP; SKIP000497
DR   Wikidata; Q54906697
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000157; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   MRC-iPS-86
AC   CVCL_E004
SY   Diggity
DR   SKIP; SKIP000498
DR   Wikidata; Q54906698
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-87
AC   CVCL_E005
SY   Scamper
DR   SKIP; SKIP000499
DR   Wikidata; Q54906699
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MRC-iPS-88
AC   CVCL_E006
SY   Toffee
DR   SKIP; SKIP000158
DR   SKIP; SKIP000500
DR   Wikidata; Q54906700
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000158; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MRC-iPS-89
AC   CVCL_E007
SY   Gumball
DR   SKIP; SKIP000159
DR   SKIP; SKIP000501
DR   Wikidata; Q54906701
RX   PubMed=21155951;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Discontinued: SKIP; SKIP000159; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MRC-iPS-9
AC   CVCL_E008
SY   Full stop; MRC-iPS-09
DR   SKIP; SKIP000422
DR   Wikidata; Q54906702
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-90
AC   CVCL_E009
SY   Big dipper
DR   SKIP; SKIP000502
DR   Wikidata; Q54906703
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-91
AC   CVCL_E010
SY   Polka
DR   GEO; GSM607976
DR   JCRB; JCRB1598
DR   JCRB; NIHS0608
DR   SKIP; SKIP000016
DR   SKIP; SKIP000503
DR   Wikidata; Q54906704
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: JCRB; NIHS0608; true.
CC   Discontinued: SKIP; SKIP000016; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1598; PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 15,21
ST   D21S11: 31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 12,16
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MRC-iPS-92
AC   CVCL_E011
SY   Chocolate chip
DR   SKIP; SKIP000504
DR   Wikidata; Q54906706
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-93
AC   CVCL_E012
SY   Patches
DR   SKIP; SKIP000505
DR   Wikidata; Q54906708
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-94
AC   CVCL_E013
SY   Dab
DR   SKIP; SKIP000506
DR   Wikidata; Q54906717
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-95
AC   CVCL_E014
SY   Inky
DR   SKIP; SKIP000511
DR   Wikidata; Q54906718
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-96
AC   CVCL_E015
SY   Rorschach
DR   SKIP; SKIP000507
DR   Wikidata; Q54906719
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-97
AC   CVCL_E016
SY   Splatter
DR   SKIP; SKIP000508
DR   Wikidata; Q54906721
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-98
AC   CVCL_E017
SY   Fisher
DR   SKIP; SKIP000509
DR   Wikidata; Q54906722
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC-iPS-99
AC   CVCL_E018
SY   Spindle
DR   SKIP; SKIP000510
DR   Wikidata; Q54906723
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   MRC5-iPS12
AC   CVCL_C975
SY   MRC5-IPS12
DR   Wikidata; Q54906724
RX   PubMed=18157115;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   MRC5-iPS17
AC   CVCL_C974
DR   Wikidata; Q54906725
RX   PubMed=18157115;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   MRC5-iPS2
AC   CVCL_V234
SY   MRC5_iPS2
DR   GEO; GSM248211
DR   GEO; GSM248212
DR   GEO; GSM579896
DR   GEO; GSM579897
DR   Wikidata; Q54906726
RX   PubMed=18157115;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   MRC5-iPS7
AC   CVCL_C1XY
DR   Wikidata; Q114312315
RX   PubMed=23045682;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   MRC5-RiPS-1.11
AC   CVCL_C976
SY   MRC5_RiPS_1.11
DR   GEO; GSM579915
DR   SKIP; SKIP000680
DR   SKIP; SKIP004671
DR   Wikidata; Q54906727
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MRC5-RiPS-1.2
AC   CVCL_C977
DR   SKIP; SKIP000677
DR   SKIP; SKIP004672
DR   Wikidata; Q54906728
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   MRC5-RiPS-1.3
AC   CVCL_C978
DR   SKIP; SKIP004675
DR   Wikidata; Q54906729
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   MRC5-RiPS-1.8
AC   CVCL_C979
SY   MRC5_RiPS_1.8
DR   GEO; GSM579913
DR   SKIP; SKIP000678
DR   SKIP; SKIP004674
DR   Wikidata; Q54906730
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MRC5-RiPS-1.9
AC   CVCL_C980
SY   MRC5_RiPS_1.9
DR   GEO; GSM579914
DR   SKIP; SKIP000679
DR   SKIP; SKIP004673
DR   Wikidata; Q54906731
RX   PubMed=20888316;
CC   From: Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   MRC5/ACE2
AC   CVCL_B0XS
DR   Wikidata; Q108820962
RX   PubMed=33686154;
CC   Group: SARS-CoV-2 research cell line.
CC   Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33686154).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   MRCC
AC   CVCL_U325
SY   HiMet-ccRCC
DR   CCRID; 4201PAT-CCTCC00277
DR   Wikidata; Q54906732
RX   Patent=CN101508972A;
RX   PubMed=23442546;
RX   PubMed=27993170;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200909.
CC   Population: Chinese.
CC   Doubling time: 55.2 hours (PubMed=23442546).
CC   Derived from site: Metastatic; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 14
//
ID   mRG1
AC   CVCL_HC53
SY   mRG1-1
DR   Kerafast; EVC002
DR   Wikidata; Q54906734
RX   PubMed=9040006;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95498; Fcgr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 10
//
ID   MRHF
AC   CVCL_H691
DR   ChEMBL-Cells; CHEMBL3308589
DR   ChEMBL-Targets; CHEMBL614496
DR   PubChem_Cell_line; CVCL_H691
DR   Wikidata; Q54906735
CC   From: BioWhittaker (now part of Lonza); Walkersville; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   MRIi001-A
AC   CVCL_YT34
SY   C6
DR   BioSamples; SAMEA8944464
DR   hPSCreg; MRIi001-A
DR   Wikidata; Q95991112
RX   PubMed=25759365;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   MRIi002-A
AC   CVCL_B5FB
DR   hPSCreg; MRIi002-A
DR   Wikidata; Q110433066
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   MRIi003-A
AC   CVCL_A8MN
SY   HK
DR   BioSamples; SAMEA8976596
DR   hPSCreg; MRIi003-A
DR   Wikidata; Q108820963
RX   PubMed=34864222;
RX   PubMed=35245852;
RX   PubMed=35421847;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MRIi003-A-1
AC   CVCL_B5F9
SY   MYH10+/-
DR   BioSamples; SAMEA9438287
DR   hPSCreg; MRIi003-A-1
DR   Wikidata; Q110433067
RX   PubMed=34864222;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7568; MYH10 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8MN ! MRIi003-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   MRIi003-A-2
AC   CVCL_B5FA
SY   MYH10-/-
DR   BioSamples; SAMEA9438306
DR   hPSCreg; MRIi003-A-2
DR   Wikidata; Q110433068
RX   PubMed=34864222;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7568; MYH10.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8MN ! MRIi003-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   MRIi003-A-3
AC   CVCL_B5FC
SY   TRPM4+/-
DR   BioSamples; SAMEA9438316
DR   hPSCreg; MRIi003-A-3
DR   Wikidata; Q110433069
RX   PubMed=35245852;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17993; TRPM4 (Note=1 of 2 alleles).
CC   Misspelling: MRli003-A-3; PubMed=35245852.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8MN ! MRIi003-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   MRIi003-A-4
AC   CVCL_B5FD
SY   TRPM4-/-
DR   BioSamples; SAMEA9438320
DR   hPSCreg; MRIi003-A-4
DR   Wikidata; Q110433070
RX   PubMed=35245852;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17993; TRPM4.
CC   Misspelling: MRli003-A-4; PubMed=35245852.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8MN ! MRIi003-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   MRIi003-A-5
AC   CVCL_C0IY
SY   AAVS-CAG-VSFP heterozygous; AAVS1-CAG-VSFP-hetero
DR   BioSamples; SAMEA10056289
DR   hPSCreg; MRIi003-A-5
DR   Wikidata; Q112930126
RX   PubMed=35421847;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a CAG-promoter driven voltage-sensing fluorescent protein (VSFP) that consist of of a voltage-sensing transmembrane domain fused to a pair of fluorescent proteins: Clover and mRuby2 was integrated into one allele of the AAVS1 safe harbor locus (PubMed=35421847).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 8MJ78; mRuby2 (Note=Bright red fluorescent protein derived from eqFP61).
CC   Misspelling: MRli003-A-5; PubMed=35421847.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8MN ! MRIi003-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   MRIi003-A-6
AC   CVCL_C0IZ
SY   AAVS-CAG-VSFP homozygous; AAVS1-CAG-VSFP-homo
DR   BioSamples; SAMEA10056290
DR   hPSCreg; MRIi003-A-6
DR   Wikidata; Q112930127
RX   PubMed=35421847;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a CAG-promoter driven voltage-sensing fluorescent protein (VSFP) that consist of of a voltage-sensing transmembrane domain fused to a pair of fluorescent proteins: Clover and mRuby2 was integrated into both alleles of the AAVS1 safe harbor locus (PubMed=35421847).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 8MJ78; mRuby2 (Note=Bright red fluorescent protein derived from eqFP61).
CC   Misspelling: MRli003-A-6; PubMed=35421847.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8MN ! MRIi003-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   MRIi004-A
AC   CVCL_A8QA
DR   hPSCreg; MRIi004-A
DR   Wikidata; Q108820964
RX   PubMed=33995650;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   MRIi005-A
AC   CVCL_B938
SY   LQT1
DR   BioSamples; SAMEA8073003
DR   hPSCreg; MRIi005-A
DR   Wikidata; Q54903000
RX   PubMed=20660394;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg190Gln (c.569G>A) (p.Arg63Gln, c.188G>A); ClinVar=VCV000003117; Zygosity=Heterozygous (PubMed=20660394).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   MRIi016-A
AC   CVCL_A0TA
SY   B7; Shox2.1
DR   BioSamples; SAMEA9438084
DR   hPSCreg; MRIi016-A
DR   Wikidata; Q108820965
RX   PubMed=32976766;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10854; SHOX2; Simple; c.*28T>C; dbSNP=rs138912749; Zygosity=Heterozygous (PubMed=32976766).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   MRIi016-A-1
AC   CVCL_D0EA
SY   B7 ctrl; SHOX2 c.*28T>C_isoWT; UKHGi017-A-1
DR   BioSamples; SAMEA112450469
DR   hPSCreg; MRIi016-A-1
DR   Wikidata; Q123033122
RX   PubMed=32976766;
RX   PubMed=37028180;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10854; SHOX2; Simple_corrected; c.*28T>C; dbSNP=rs138912749; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32976766).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0TA ! MRIi016-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MRIi016-A-2
AC   CVCL_D0EB
SY   B7 ctrl SHOX2 KO; UKHGi017-A-2
DR   BioSamples; SAMEA112465910
DR   hPSCreg; MRIi016-A-2
DR   Wikidata; Q123033124
RX   PubMed=37028180;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10854; SHOX2.
CC   Sequence variation: Mutation; HGNC; HGNC:10854; SHOX2; Simple_corrected; c.*28T>C; dbSNP=rs138912749; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0EA ! MRIi016-A-1
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MRIi017-A
AC   CVCL_A0TB
SY   TRPM4
DR   BioSamples; SAMEA9468731
DR   hPSCreg; MRIi017-A
DR   Wikidata; Q108820966
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   MRIi018-A
AC   CVCL_A8MP
SY   HLHS_375
DR   BioSamples; SAMEA8944460
DR   hPSCreg; MRIi018-A
DR   Wikidata; Q108820967
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:944; ADGRB2; Simple; p.Gly267Asp (c.800G>A); Zygosity=Unspecified; Note=De novo mutation (hPSCreg=MRIi018-A).
CC   Sequence variation: Mutation; HGNC; HGNC:28338; DENND5B; Simple; p.Lys799Arg (c.2396A>G); Zygosity=Unspecified; Note=De novo mutation (hPSCreg=MRIi018-A).
CC   Sequence variation: Mutation; HGNC; HGNC:26011; SYBU; Simple; p.Pro93Leu (c.278C>A); Zygosity=Unspecified; Note=De novo mutation (hPSCreg=MRIi018-A).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   MRIi019-A
AC   CVCL_A0TG
DR   hPSCreg; MRIi019-A
DR   Wikidata; Q108820968
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MRIi020-A
AC   CVCL_A0TC
DR   hPSCreg; MRIi020-A
DR   Wikidata; Q108820969
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MRIi021-A
AC   CVCL_A0TD
DR   hPSCreg; MRIi021-A
DR   Wikidata; Q108820970
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MRIi022-A
AC   CVCL_A0TE
DR   hPSCreg; MRIi022-A
DR   Wikidata; Q108820971
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MRIi023-A
AC   CVCL_A0TF
DR   hPSCreg; MRIi023-A
DR   Wikidata; Q108820972
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MRIi024-A
AC   CVCL_A0SZ
SY   Shox2.2
DR   BioSamples; SAMEA9466941
DR   hPSCreg; MRIi024-A
DR   Wikidata; Q108820973
RX   PubMed=32976766;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10854; SHOX2; Simple; p.His259Gln (c.777C>A) (p.His283Gln, c.849C>A); Zygosity=Heterozygous (PubMed=32976766).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   MRIi025-A
AC   CVCL_A5FP
SY   Noonan 3a
DR   BioSamples; SAMEA8093241
DR   hPSCreg; MRIi025-A
DR   Wikidata; Q107116395
RX   PubMed=34988410;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Asn308Ser (c.923A>G); ClinVar=VCV000013327; Zygosity=Heterozygous (PubMed=34988410).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   MRIi026-A
AC   CVCL_A0SX
SY   Noonan 3d
DR   BioSamples; SAMEA9468451
DR   hPSCreg; MRIi026-A
DR   Wikidata; Q108820974
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   MRIi027-A
AC   CVCL_A0SY
SY   DMD 01
DR   BioSamples; SAMEA9359401
DR   hPSCreg; MRIi027-A
DR   Wikidata; Q108820975
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   MRIi027-A-1
AC   CVCL_C1UT
SY   DMD 51-3
DR   BioSamples; SAMEA10107505
DR   hPSCreg; MRIi027-A-1
DR   Wikidata; Q114312316
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0SY ! MRIi027-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MRIi028-A
AC   CVCL_A0TH
SY   PPC-4
DR   BioSamples; SAMEA9589929
DR   EBiSC; MRIi028-A
DR   ECACC; 66770027
DR   hPSCreg; MRIi028-A
DR   Wikidata; Q108820976
RX   PubMed=35397396;
CC   From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:25686; PPCS; Simple; p.Glu233Val (c.698A>T); ClinVar=VCV000590782; Zygosity=Homozygous (PubMed=35397396).
CC   Discontinued: ECACC; 66770027; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C186785; Dilated cardiomyopathy-2C
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   MRK-90
AC   CVCL_W334
SY   MRK 90; Macaca Radiata Kidney-90
DR   Wikidata; Q54906736
RX   PubMed=8641715;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9548; ! Macaca radiata (Bonnet macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   MRK-nu-1
AC   CVCL_1428
SY   MRK-NU-1; MRK-nu-I; Mrk-nu1; MRKnu-1; MRKnu1; MRKNU1
DR   BTO; BTO_0003679
DR   CLO; CLO_0009914
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471641
DR   cancercelllines; CVCL_1428
DR   Cell_Model_Passport; SIDM00562
DR   ChEMBL-Cells; CHEMBL3308550
DR   ChEMBL-Targets; CHEMBL2366325
DR   Cosmic; 908151
DR   Cosmic-CLP; 908151
DR   DepMap; ACH-002163
DR   EGA; EGAS00001000978
DR   GDSC; 908151
DR   GEO; GSM827236
DR   GEO; GSM1670133
DR   IARC_TP53; 21516
DR   JCRB; JCRB0616
DR   JCRB; JCRB0628
DR   LINCS_LDP; LCL-1487
DR   PharmacoDB; MRKnu1_965_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1428
DR   PubChem_Cell_line; CVCL_1428
DR   Wikidata; Q54906738
RX   CelloPub=CLPUB00083;
RX   PubMed=518958;
RX   PubMed=9290701;
RX   PubMed=15900046;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from the ascitic cells from BALB/c nu/nu mice injected intraperitoneal with the parent tumoral cells.
CC   Doubling time: ~47 hours (Note=Lot 02072012) (JCRB=JCRB0628).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.98%; Native American=1.19%; East Asian, North=73.82%; East Asian, South=23.21%; South Asian=0%; European, North=0.07%; European, South=0.74% (PubMed=30894373).
CC   Discontinued: JCRB; JCRB0616; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=908151; JCRB=JCRB0628
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 13
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ71 ! MRK-nu-2
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   MRK-nu-2
AC   CVCL_WZ71
SY   MRK-nu-II
DR   Wikidata; Q95991119
RX   CelloPub=CLPUB00083;
RX   PubMed=518958;
CC   Population: Japanese.
CC   Characteristics: Established from the ascitic cells from BALB/c nu/nu mice injected intraperitoneal with the parent tumoral cells.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1428 ! MRK-nu-1
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   MRK16
AC   CVCL_B0F9
SY   MRK-16
DR   Wikidata; Q108820977
RX   PubMed=2429319;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MRK17
AC   CVCL_B0FA
DR   Wikidata; Q108820979
RX   PubMed=2429319;
RX   PubMed=9205000;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   MRL/N-1
AC   CVCL_D5J6
DR   TKG; TKG 0807
DR   Wikidata; Q127382885
RX   PubMed=13130475;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MRL/Mp Tn-gld/gld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MRL/N-1/MCP-1-AT
AC   CVCL_D5J7
DR   Wikidata; Q127382886
RX   PubMed=13130475;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98259; Ccl2 (Note=With p.Met1_Ala30del and p.Pro31Met = MCP-1-Antagonist).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MRL/Mp Tn-gld/gld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5J6 ! MRL/N-1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   MRL/N-1/TARC-AT,
AC   CVCL_D5J8
DR   Wikidata; Q127382887
RX   PubMed=13130475;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1329039; Ccl17 (Note=With p.Met1_Val29del and p.Gly30Met = TARC-Antagonist).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: MRL/Mp Tn-gld/gld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5J6 ! MRL/N-1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   MRL104
AC   CVCL_B6H9
DR   Wikidata; Q112129357
RX   PubMed=2492055;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: MRL/Mp-lpr/lpr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5-7W
CA   Stromal cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   MRL104.8a
AC   CVCL_6781
DR   Wikidata; Q54906739
RX   PubMed=2492055;
RX   PubMed=2524833;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MRL104.8a
CC   Characteristics: Produces CSF1 and IL6 (PubMed=2492055).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: MRL/Mp-lpr/lpr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6H9 ! MRL104
SX   Sex unspecified
AG   5-7W
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   MRL28
AC   CVCL_B6HA
DR   Wikidata; Q112129358
RX   PubMed=2492055;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: MRL/Mp-lpr/lpr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5-7W
CA   Stromal cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   MRL28.8A
AC   CVCL_B6HB
DR   Wikidata; Q112129359
RX   PubMed=2492055;
RX   PubMed=2524833;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: MRL/Mp-lpr/lpr.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B6HA ! MRL28
SX   Sex unspecified
AG   5-7W
CA   Stromal cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   MRMT-1
AC   CVCL_5156
DR   CLO; CLO_0051603
DR   RCB; RCB2860
DR   TKG; TKG 0132
DR   Wikidata; Q54906740
RX   PubMed=1247997;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   MRN-1
AC   CVCL_5626
SY   MRN1
DR   BTO; BTO_0002945
DR   Wikidata; Q54906741
RX   PubMed=1701342;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   MRO
AC   CVCL_6310
SY   MRO-87-1; MRO 87-1; MRO-87; MRO87-1; MRO87; RO 87-M-1
DR   BioSample; SAMN03151794
DR   cancercelllines; CVCL_6310
DR   Cosmic; 886553
DR   Wikidata; Q54906742
RX   PubMed=2551628;
RX   PubMed=18713817;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817; PubMed=20143388). Originally thought to originate from a thyroid gland follicular carcinoma.
CC   From: Juillard, Guy Jean-Felix; University of California, Los Angeles; Los Angeles; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00240.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=18713817
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,22
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   mRPE
AC   CVCL_GQ00
SY   mouse Retinal Pigmented Epithelium cell line
DR   Wikidata; Q54906743
RX   PubMed=27554602;
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   MRRL-CH1
AC   CVCL_Z389
SY   MRRL-CH-1; MRRL-CH 1; MRRL-CH; CH; CH I; CM-1
DR   ChEMBL-Cells; CHEMBL3307320
DR   ChEMBL-Targets; CHEMBL614183
DR   ICLDB; mrrl-ch1
DR   PubChem_Cell_line; CVCL_Z389
DR   Wikidata; Q54906744
RX   CelloPub=CLPUB00496;
RX   PubMed=1201855;
RX   PubMed=1367489;
RX   PubMed=16346059;
RX   PubMed=16593348;
RX   PubMed=28305165;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   MRRL-CH1 clone GV1
AC   CVCL_A8Z7
SY   MRRL-CH1, clone GV1; CH1/GV1; GV1
DR   Wikidata; Q102114555
RX   DOI=10.2307/3576171;
RX   PubMed=28305165;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
HI   CVCL_Z389 ! MRRL-CH1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   MRRL-CH2
AC   CVCL_Z390
SY   CH'; CH II
DR   ICLDB; mrrl-ch2
DR   Wikidata; Q54906745
RX   CelloPub=CLPUB00496;
RX   PubMed=1201855;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   MRRL-Musdo-1
AC   CVCL_D5EH
DR   Wikidata; Q127382888
RX   PubMed=1159306;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and of the species Latin name.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7370; ! Musca domestica (House fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MRSS-1
AC   CVCL_2630
SY   D2D4
DR   CLO; CLO_0007871
DR   CLO; CLO_0007872
DR   CLDB; cl5234
DR   ATCC; HB-69
DR   IZSLER; BS Hy 11
DR   Wikidata; Q54906747
RX   PubMed=6157395;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_9160; Single-stranded DNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   MRSV2-1
AC   CVCL_8647
SY   MRSV-2.1
DR   Wikidata; Q54906748
RX   PubMed=1708884;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MRSV2-4
AC   CVCL_8646
SY   MRSV-2.4
DR   Wikidata; Q54906749
RX   PubMed=1708884;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MRT-1
AC   CVCL_W491
SY   Miyazaki Renal Tumor-1
DR   Wikidata; Q54906750
RX   PubMed=7669747;
RX   PubMed=8348978;
CC   Population: Japanese.
CC   Doubling time: 32.5 hours (Note=At 47th passage) (PubMed=7669747).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   mRTP1B
AC   CVCL_YE22
DR   Wikidata; Q95991129
RX   PubMed=20093282;
CC   Group: Fish cell line.
CC   Doubling time: 3.6 +- 0.7 days (PubMed=20093282).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   mRTP1E
AC   CVCL_YE23
DR   Wikidata; Q95991130
RX   PubMed=20093282;
CC   Group: Fish cell line.
CC   Doubling time: 2.8 +- 0.7 days (PubMed=20093282).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   mRTP1F
AC   CVCL_YE24
DR   Wikidata; Q95991132
RX   PubMed=20093282;
CC   Group: Fish cell line.
CC   Doubling time: 3.2 +- 0.8 days (PubMed=20093282).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   mRTP1K
AC   CVCL_YE25
DR   Wikidata; Q95991133
RX   PubMed=20093282;
CC   Group: Fish cell line.
CC   Doubling time: 5.5 +- 0.6 days (PubMed=20093282).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   mRTP2A
AC   CVCL_YE26
DR   Wikidata; Q95991134
RX   PubMed=20093282;
CC   Group: Fish cell line.
CC   Doubling time: 6.6 +- 0.6 days (PubMed=20093282).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   MS [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC25
DR   Wikidata; Q98127284
RX   PubMed=16099873;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   MS [Human HeLa contaminated cell line]
AC   CVCL_4243
SY   Monkey Stable
DR   CLO; CLO_0007874
DR   CLDB; cl3589
DR   CLDB; cl3590
DR   BioSample; SAMN03151745
DR   ECACC; 91070510
DR   IZSLER; BS CL 98
DR   Wikidata; Q54906751
RX   PubMed=14505435;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of Chlorocebus aethiops origin but found to be a human HeLa derivative (PubMed=14505435; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00241.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MS-1 [Human lung carcinoma]
AC   CVCL_1429
AS   CVCL_3031
SY   MS-1-L; MS1; Ms1
DR   CLO; CLO_0037031
DR   CLO; CLO_0050048
DR   EFO; EFO_0002836
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470995
DR   cancercelllines; CVCL_1429
DR   Cell_Model_Passport; SIDM00245
DR   ChEMBL-Cells; CHEMBL3308892
DR   ChEMBL-Targets; CHEMBL2366125
DR   Cosmic; 753594
DR   Cosmic; 1212198
DR   Cosmic; 1571744
DR   Cosmic; 1656910
DR   Cosmic-CLP; 753594
DR   DepMap; ACH-001958
DR   EGA; EGAS00001000978
DR   GDSC; 753594
DR   GEO; GSM17311
DR   GEO; GSM827217
DR   GEO; GSM1670134
DR   IARC_TP53; 21517
DR   JCRB; JCRB1081
DR   JCRB; NIHS0320
DR   JCRB; NIHS0353
DR   LINCS_LDP; LCL-1835
DR   PharmacoDB; MS1_966_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1429
DR   PubChem_Cell_line; CVCL_1429
DR   RCB; RCB0725
DR   Wikidata; Q54906752
RX   PubMed=9183634;
RX   PubMed=15016488;
RX   PubMed=15901131;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22313637;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=9183634).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1128-2A>G; ClinVar=VCV000428715; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=753594; DepMap=ACH-001958).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ser (c.730G>A); ClinVar=VCV000376600; Zygosity=Homozygous (PubMed=15901131; Cosmic-CLP=753594; DepMap=ACH-001958).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=9.93%; Native American=0.17%; East Asian, North=64.82%; East Asian, South=12.65%; South Asian=0%; European, North=5.2%; European, South=7.23% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0320; true.
CC   Discontinued: JCRB; NIHS0353; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=753594; JCRB=JCRB1081; PubMed=25877200; RCB=RCB0725
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 22,25
ST   Penta D: 10
ST   Penta E: 17,18
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   MS-1 [Human Merkel cell carcinoma]
AC   CVCL_E995
DR   BEI_Resources; ARP-11714
DR   cancercelllines; CVCL_E995
DR   Cell_Model_Passport; SIDM00408
DR   DepMap; ACH-001131
DR   ECACC; 09111802
DR   FANTOM5_SSTAR; 10844-111E7
DR   Wikidata; Q54906753
RX   PubMed=20444890;
RX   PubMed=23085629;
RX   PubMed=23563200;
RX   PubMed=29696010;
RX   PubMed=30873613;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Virology: Contains 2.1 copies of the genome of MCPyV per haploid cell (PubMed=23085629).
CC   Doubling time: 4 days (PubMed=20444890); 3 days (PubMed=30873613).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251_Thr253del; Zygosity=Hemizygous (PubMed=23563200).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): ECACC=09111802; PubMed=30873613
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 9
ST   D18S51: 13,14
ST   D21S11: 32
ST   D3S1358: 14,15.2
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   Penta D: 12,14
ST   Penta E: 8,19
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   MS-1 [Human mesothelioma]
AC   CVCL_E993
DR   Cosmic; 1995513
DR   Wikidata; Q54906754
RX   PubMed=2457437;
CC   Doubling time: ~46 hours (PubMed=2457437).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   MS-1 [Mouse bone marrow]
AC   CVCL_D134
SY   Mouse Stromal-1
DR   Wikidata; Q54906757
RX   PubMed=2783573;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeNSlc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   8W
CA   Stromal cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MS-1 [Mouse hybridoma against M.salivarium]
AC   CVCL_A0RM
DR   Wikidata; Q108820980
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Metamycoplasma salivarium.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ms-1
AC   CVCL_IQ55
DR   Wikidata; Q54906758
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
ID   Ms-10
AC   CVCL_ZD39
DR   Wikidata; Q98127286
RX   PubMed=8784480;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   Ms-11
AC   CVCL_IQ49
DR   Wikidata; Q54906759
RX   PubMed=8784480;
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
ID   Ms-13
AC   CVCL_IQ50
DR   Wikidata; Q54906760
RX   PubMed=8784480;
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
ID   Ms-16
AC   CVCL_IQ51
DR   Wikidata; Q54906761
RX   PubMed=8784480;
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
ID   Ms-19
AC   CVCL_ZD40
DR   Wikidata; Q98127287
RX   PubMed=8784480;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   MS-2 [Human mesothelioma]
AC   CVCL_E992
DR   Wikidata; Q54906762
RX   PubMed=2457437;
CC   Doubling time: ~72 hours (PubMed=2457437).
CC   Donor information: No history of asbestos exposure (PubMed=2457437).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   MS-2 [Mouse hybridoma against M.salivarium]
AC   CVCL_A0RN
DR   Wikidata; Q108820981
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Metamycoplasma salivarium.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ms-2
AC   CVCL_IQ54
DR   Wikidata; Q54906770
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
ID   MS-3
AC   CVCL_A0RP
DR   Wikidata; Q108820982
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Metamycoplasma salivarium.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   Ms-3
AC   CVCL_IQ53
DR   Wikidata; Q54906771
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
ID   MS-4
AC   CVCL_A0RQ
DR   Wikidata; Q108820983
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Metamycoplasma salivarium.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MS-5 [Mouse bone marrow]
AC   CVCL_2128
SY   MS5; Mouse Stromal-5
DR   CLO; CLO_0007877
DR   DSMZ; ACC-441
DR   DSMZCellDive; ACC-441
DR   RCB; RCB4680
DR   Wikidata; Q54906772
RX   PubMed=2783573;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MS-5
CC   Doubling time: ~50 hours (DSMZ=ACC-441).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeNSlc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   MS-5 [Mouse hybridoma against M.salivarium]
AC   CVCL_A0RR
DR   Wikidata; Q108820985
RX   PubMed=6811415;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Metamycoplasma salivarium.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   MS-5-Omi/HTRA2-mCherry
AC   CVCL_RG44
SY   MS-5 OMI/HTRA2-mCherry; MS-5-Omi-mCherry
DR   Wikidata; Q54906773
RX   PubMed=27257182;
WW   Provider; Inserm Transfert; RT00494; https://technology-offers.inserm-transfert.com/offer/ms-5-omi-htra2-mcherry-cells/
CC   Characteristics: The HTRA2-mCherry fusion protein is expressed in mitochondria inter-membrane space and is rapidly degraded following mitochondrial outer membrane permeabilization (MOMP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:14348; HTRA2.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeNSlc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2128 ! MS-5 [Mouse bone marrow]
SX   Male
AG   8W
CA   Stromal cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   MS-64
AC   CVCL_ZD59
DR   Wikidata; Q98127288
RX   PubMed=12920029;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1) (Note=pHTLV-X1MT).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MS-653-A
AC   CVCL_5558
SY   AS 653-HM clone A
DR   JCRB; JCRB1001.1
DR   Wikidata; Q54906774
RX   PubMed=476692;
CC   Characteristics: Highly tumorigenic.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60403; Rat fibrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   MS-653-G
AC   CVCL_5559
SY   AS 653-HM clone G
DR   JCRB; JCRB1001.2
DR   Wikidata; Q54906775
RX   PubMed=476692;
CC   Characteristics: Less tumorigenic than parent cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60403; Rat fibrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5558 ! MS-653-A
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   MS-68
AC   CVCL_ZD60
DR   Wikidata; Q98127291
RX   PubMed=12920029;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1) (Note=pHTLV-X1MT).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MS-74
AC   CVCL_ZD61
DR   Wikidata; Q98127292
RX   PubMed=12920029;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1) (Note=pHTLV-X1MT).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   Ms-8
AC   CVCL_IQ52
DR   Wikidata; Q54906776
RX   PubMed=9393586;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 7
//
ID   MS-9
AC   CVCL_ZD62
SY   PB-MS9
DR   Wikidata; Q98127363
RX   PubMed=10502522;
RX   PubMed=12920029;
RX   PubMed=25544500;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1) (Note=pHTLV-X1MT).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   MS-BP002-iPSC
AC   CVCL_JJ79
DR   Wikidata; Q54906778
RX   PubMed=28413001;
CC   From: Jilin University First Hospital; Changchun; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6557; Schwannomatosis
DI   ORDO; Orphanet_93921; Schwannomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   MS-BP003-iPSC
AC   CVCL_JL60
DR   Wikidata; Q54906779
RX   PubMed=28413006;
CC   From: Jilin University First Hospital; Changchun; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C6557; Schwannomatosis
DI   ORDO; Orphanet_93921; Schwannomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   MS-BR
AC   CVCL_X030
SY   Monk Seal-BRain
DR   Wikidata; Q54906780
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MS-D
AC   CVCL_TZ62
SY   Monk Seal-Dispersion
DR   Wikidata; Q54906781
RX   PubMed=9639098;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_TZ63 ! MS-E
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   MS-E
AC   CVCL_TZ63
SY   Monk Seal-Explantation
DR   Wikidata; Q54906782
RX   PubMed=9639098;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: 19 +- 1 hours (PubMed=9639098).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_TZ62 ! MS-D
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   MS-EwS-1
AC   CVCL_A0VK
SY   MS-PES-1; MSPES-1
DR   Wikidata; Q108820986
RX   PubMed=22374462;
RX   PubMed=24927333;
RX   PubMed=29464090;
RX   PubMed=30879952;
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   FGA: 18,22
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   MS-EwS-15
AC   CVCL_A0VP
SY   DC-ES-15
DR   Wikidata; Q108820987
RX   PubMed=30879952;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (Direct_author_submission).
CC   Miscellaneous: Gene fusion from personal communication of Rossig, Claudia.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 12,13
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   FGA: 20,22
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   MS-EwS-16
AC   CVCL_A0VQ
SY   DC-ES-6
DR   Wikidata; Q108820989
RX   PubMed=24927333;
RX   PubMed=29464090;
RX   PubMed=30879952;
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,11
ST   FGA: 20,26
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   MS-EwS-3
AC   CVCL_A0VL
SY   MS-PES-3
DR   Wikidata; Q108820990
RX   PubMed=22374462;
CC   Miscellaneous: STR profile from personal communication of Rossig, Claudia.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   FGA: 23,25
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   MS-EwS-34
AC   CVCL_A0VR
DR   Wikidata; Q108820991
RX   PubMed=30879952;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (Direct_author_submission).
CC   Miscellaneous: Gene fusion, site of sampling, sex and age of donor from personal communication of Rossig, Claudia.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 12
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   FGA: 19,23
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   MS-EwS-4
AC   CVCL_A0VM
SY   MS-PES-4; MSPES-4
DR   Wikidata; Q108820992
RX   PubMed=24927333;
RX   PubMed=29464090;
RX   PubMed=30879952;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,11
ST   FGA: 25
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   MS-EwS-5
AC   CVCL_A0VS
SY   MS-PES-5; MSPES-5
DR   Wikidata; Q108820993
RX   PubMed=24927333;
CC   Miscellaneous: STR profile and sex of donor from personal communication of Rossig, Claudia.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   FGA: 25
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   MS-EwS-6
AC   CVCL_A0VN
SY   MS-PES-6
DR   Wikidata; Q108820994
RX   PubMed=29464090;
RX   PubMed=30879952;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (Direct_author_submission).
CC   Miscellaneous: Gene fusion, site of sampling and age of donor from personal communication of Rossig, Claudia.
CC   Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 8,11
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 12,13
ST   FGA: 20,24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   MS-EY
AC   CVCL_X031
SY   Monk Seal-EYe-around soft tissue
DR   Wikidata; Q54906783
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   MS-HIPS PP9#1
AC   CVCL_A5DI
DR   Wikidata; Q107116397
RX   PubMed=28388226;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Sampling site from personal communication of BioKryo (ISENET Biobanking).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MS-HIPS RR16#5
AC   CVCL_A5DJ
DR   Wikidata; Q107116398
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Miscellaneous: Sampling site from personal communication of BioKryo (ISENET Biobanking).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   MS-HT
AC   CVCL_X032
SY   Monk Seal-HearT
DR   Wikidata; Q54906784
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Virology: Highly susceptible to infection by herpes simplex virus 1 (HHV-1), reovirus type 3, vaccinia virus and vesicular stomatitis virus (VSV) (PubMed=14960030).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   MS-K
AC   CVCL_A7AN
DR   RCB; RCB4681
DR   Wikidata; Q107116400
RX   PubMed=2043753;
CC   Doubling time: 9.4 hours (PubMed=2043753).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeNSlc.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   MS-KD
AC   CVCL_X033
SY   Monk Seal-KiDney
DR   Wikidata; Q54906785
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Virology: Highly susceptible to infection by herpes simplex virus 1 (HHV-1), vaccinia virus and vesicular stomatitis virus (VSV) (PubMed=14960030).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   MS-LG
AC   CVCL_X034
SY   Monk Seal-LunG
DR   Wikidata; Q54906786
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MS-LV
AC   CVCL_X035
SY   Monk Seal-LiVer
DR   Wikidata; Q54906787
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MS-SK
AC   CVCL_X036
SY   Monk Seal-SKin
DR   Wikidata; Q54906788
RX   PubMed=11264961;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   MS-SN
AC   CVCL_X037
SY   Monk Seal-SNout
DR   Wikidata; Q54906789
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Virology: Highly susceptible to infection by herpes simplex virus 1 (HHV-1), reovirus type 3, vaccinia virus and vesicular stomatitis virus (VSV) (PubMed=14960030).
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   MS-SP
AC   CVCL_X038
SY   Monk Seal-SPleen
DR   Wikidata; Q54906790
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X039 ! MS-TY
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MS-TY
AC   CVCL_X039
SY   Monk Seal-ThYroid
DR   Wikidata; Q54906791
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X040 ! MS-UB
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   MS-UB
AC   CVCL_X040
SY   Monk Seal-Urinary Bladder
DR   Wikidata; Q54906793
RX   PubMed=11264961;
RX   PubMed=14960030;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
OX   NCBI_TaxID=29088; ! Neomonachus schauinslandi (Hawaiian monk seal)
OI   CVCL_X030 ! MS-BR
OI   CVCL_X031 ! MS-EY
OI   CVCL_X032 ! MS-HT
OI   CVCL_X033 ! MS-KD
OI   CVCL_X034 ! MS-LG
OI   CVCL_X035 ! MS-LV
OI   CVCL_X036 ! MS-SK
OI   CVCL_X037 ! MS-SN
OI   CVCL_X038 ! MS-SP
OI   CVCL_X039 ! MS-TY
SX   Female
AG   Pup
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   MS0010
AC   CVCL_8Y20
DR   ECACC; 03080863
DR   Wikidata; Q54906795
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03080863; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   MS0011
AC   CVCL_8Y21
DR   ECACC; 03080864
DR   Wikidata; Q54906796
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03080864; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   MS0812
AC   CVCL_IK99
DR   Wikidata; Q54906797
RX   Patent=CN1904037A;
RX   PubMed=19724881;
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Doubling time: ~24 hours (PubMed=19724881).
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10FW
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 7
//
ID   MS1
AC   CVCL_C5QG
SY   mAb-MS1
DR   Wikidata; Q116252844
RX   PubMed=25069865;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_63598; Levofloxacin ((S)-ofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   MS1 GNAQ Q209L
AC   CVCL_D4Z6
DR   ATCC; CRL-3530
DR   Wikidata; Q127382889
RX   PubMed=35053574;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4390; GNAQ (Note=With p.Gln209Leu).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6502 ! Mile Sven 1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   MS1 mAKT
AC   CVCL_0F28
SY   MS1 m-Akt
DR   ATCC; CRL-2878
DR   Wikidata; Q54906799
RX   PubMed=17438183;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:87986; Akt1 (Note=With SRC myristoylation signal MGSSKSKPKDPSQR added at the N-terminus and p.Ala5_Gly130del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Discontinued: ATCC; CRL-2878; true.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6502 ! Mile Sven 1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   MS1 VEGF
AC   CVCL_6503
DR   CLO; CLO_0007876
DR   ATCC; CRL-2460
DR   BCRC; 60369
DR   JCRB; NIHS0321
DR   Wikidata; Q54906800
RX   PubMed=10751370;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12680; VEGFA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Discontinued: JCRB; NIHS0321; true.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6502 ! Mile Sven 1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   MS1-hCD276
AC   CVCL_C5QI
SY   MS1CD276; MS1-clone2 CD276
DR   Wikidata; Q116049797
RX   PubMed=24389327;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19137; CD276.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6502 ! Mile Sven 1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   MS1/19dd#7 rho-0
AC   CVCL_C0DY
DR   ABM; T0868
DR   Kerafast; ESA117
DR   Wikidata; Q112930128
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Obtained by growth of parental cell line with ethidium bromide and 2',3'dideoxycytidine (Kerafast=ESA117).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6502 ! Mile Sven 1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   MS115
AC   CVCL_N705
DR   Wikidata; Q54906801
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   MS17-57
AC   CVCL_D6DQ
DR   Wikidata; Q127382890
RX   PubMed=24143229;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09923; Human ALPI.
CC   Monoclonal antibody target: UniProtKB; P05187; Human ALPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MS18
AC   CVCL_9823
SY   Ms18; MS-18
DR   Cosmic; 801619
DR   Cosmic; 844824
DR   Cosmic; 876154
DR   Cosmic; 918018
DR   Cosmic; 1239932
DR   Cosmic; 2125279
DR   IARC_TP53; 28449
DR   Wikidata; Q54906802
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=23716474;
CC   From: Shimizu, Eiji; Tottori University; Tottori; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=10536175; PubMed=20557307).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   MS215
AC   CVCL_B3PG
DR   Wikidata; Q110433071
RX   CelloPub=CLPUB00655;
CC   Doubling time: 20.5 hours (CelloPub=CLPUB00655).
CC   Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776.
CC   Cell type: Melanocyte of choroid; CL=CL_4030000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   MS257
AC   CVCL_9834
DR   Wikidata; Q54906803
RX   PubMed=19853261;
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   MS4
AC   CVCL_IW02
DR   Wikidata; Q54906804
RX   PubMed=21272942;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: Abyssinian; VBO=VBO_0100000.
DI   NCIt; C132193; Feline lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 7
//
ID   MS428
AC   CVCL_9835
DR   EFO; EFO_0002837
DR   GEO; GSM49616
DR   Wikidata; Q54906805
RX   PubMed=15920167;
RX   PubMed=19853261;
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   MS5-hDLL1
AC   CVCL_VR88
DR   Millipore; SCC167
DR   Wikidata; Q95991188
RX   PubMed=28369043;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2908; DLL1.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeNSlc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2128 ! MS-5 [Mouse bone marrow]
SX   Male
AG   8W
CA   Stromal cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   MS5-mDLL1
AC   CVCL_VR91
DR   Millipore; SCC166
DR   Wikidata; Q95991189
CC   Genetic integration: Method=Transduction; Gene=FPbase; TN3DM; mStrawberry (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104659; Dll1.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeNSlc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2128 ! MS-5 [Mouse bone marrow]
SX   Male
AG   8W
CA   Stromal cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   MS589
AC   CVCL_9836
DR   EFO; EFO_0002838
DR   GEO; GSM49615
DR   Wikidata; Q54906806
RX   PubMed=15920167;
RX   PubMed=19853261;
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   Ms704
AC   CVCL_KA70
SY   MS704
DR   Wikidata; Q54906807
RX   PubMed=15352059;
RX   PubMed=16609957;
CC   Characteristics: Useful for the production of fucose-negative antibodies.
CC   Knockout cell: Method=Homologous recombination; UniProtKB; G3HCE4; Fut8.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   MS705
AC   CVCL_KA71
DR   Wikidata; Q54906809
RX   PubMed=15352059;
CC   Characteristics: Useful for the production of fucose-negative antibodies.
CC   Knockout cell: Method=Homologous recombination; UniProtKB; G3HCE4; Fut8.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   Ms709
AC   CVCL_KA72
DR   Wikidata; Q54906810
RX   PubMed=15352059;
CC   Characteristics: Useful for the production of fucose-negative antibodies.
CC   Knockout cell: Method=Homologous recombination; UniProtKB; G3HCE4; Fut8.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   MS751
AC   CVCL_4996
SY   MS-751; MS 751
DR   CLO; CLO_0007878
DR   EFO; EFO_0006456
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-34
DR   BioSample; SAMN03472742
DR   BioSample; SAMN03473089
DR   cancercelllines; CVCL_4996
DR   CCRID; 3101HUMSCSP537
DR   CCRID; 3101HUMTCHu178
DR   Cell_Model_Passport; SIDM00638
DR   CLS; 305115
DR   Cosmic; 928910
DR   Cosmic; 1071904
DR   Cosmic; 1131523
DR   Cosmic; 1176606
DR   Cosmic; 1193034
DR   Cosmic; 1201772
DR   Cosmic; 1995514
DR   Cosmic; 2816216
DR   Cosmic-CLP; 1240179
DR   DepMap; ACH-001360
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240179
DR   GEO; GSM113865
DR   GEO; GSM253301
DR   GEO; GSM675737
DR   GEO; GSM685439
DR   GEO; GSM1670135
DR   IARC_TP53; 27233
DR   IGRhCellID; MS751
DR   LINCS_LDP; LCL-1306
DR   PharmacoDB; MS751_967_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_4996
DR   Ubigene; YC-C123
DR   Wikidata; Q54906811
RX   PubMed=327080;
RX   PubMed=2990217;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=9049418;
RX   PubMed=15531914;
RX   PubMed=24134916;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: Contains a partial HPV45 genome.
CC   Doubling time: 2.4 days (PubMed=29156801).
CC   HLA typing: A*02:01,24:02; B*35:03,40:01; C*03:04,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.44%; East Asian, North=0%; East Asian, South=0.42%; South Asian=0.41%; European, North=67.07%; European, South=31.66% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-34; CCRID; Cosmic-CLP=1240179; DepMap=ACH-001360; PubMed=25877200; PubMed=29156801
ST   Amelogenin: X
ST   CSF1PO: 11 (CCRID; PubMed=25877200)
ST   CSF1PO: 11,12 (ATCC=HTB-34; Cosmic-CLP=1240179; DepMap=ACH-001360; PubMed=29156801)
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 16
ST   D21S11: 29,30
ST   D2S1338: 22
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   MS924
AC   CVCL_9833
SY   Meso924
DR   Wikidata; Q54906812
RX   PubMed=19853261;
CC   From: Fletcher, Jonathan A.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School; Boston; USA.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   MSA-1
AC   CVCL_E3CN
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-1 pB-rtTA(#4)-NGN2-puro-SNAP
AC   CVCL_E3CZ
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=39079530).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3CN ! MSA-1
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   MSA-10
AC   CVCL_E3CR
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-12
AC   CVCL_E3CS
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-16
AC   CVCL_E3CT
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-17
AC   CVCL_E3CU
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-20
AC   CVCL_E3CV
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-20 pB-rtTA(#4)-NGN2-puro-SNAP
AC   CVCL_E3D1
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=39079530).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3CV ! MSA-20
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   MSA-21
AC   CVCL_E3CW
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-21 pB-rtTA(#4)-NFIB-mKate2
AC   CVCL_E3D2
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NFIB-mKate2 construct (PubMed=39079530).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7785; NFIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=ZFN; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3CW ! MSA-21
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   MSA-22
AC   CVCL_E3CX
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-23
AC   CVCL_E3CY
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-23 pB-rtTA(#4)-NFIB-mKate2
AC   CVCL_E3D3
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NFIB-mKate2 construct (PubMed=39079530).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7785; NFIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=ZFN; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3CY ! MSA-23
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   MSA-5
AC   CVCL_E3CP
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   MSA-5 pB-rtTA(#4)-NGN2-puro-SNAP
AC   CVCL_E3D0
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=39079530).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3CP ! MSA-5
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   MSA-6
AC   CVCL_E3CQ
RX   PubMed=39079530;
CC   Part of: Mass General Brigham Stem Cells in Neurodegeneration [SCiN] panel.
CC   Derived from site: In situ; Ankle, skin; UBERON=UBERON_0001512.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Msb
AC   CVCL_XZ90
DR   KCB; KCB 90003
DR   Wikidata; Q95991198
RX   PubMed=14984102;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9634; ! Helarctos malayanus (Malayan sun bear)
SX   Male
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   MSBr
AC   CVCL_C0MG
SY   Micropterus Salmoides Brain
DR   CCRID; 4201PAT-CCTCC01790
DR   Wikidata; Q112930129
RX   Patent=CN113025574B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202166.
CC   Doubling time: 49.6 hours (Patent=CN113025574B).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=27706; ! Micropterus salmoides (Largemouth bass)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   MSC 80
AC   CVCL_S187
SY   MSC-80; MSC80; Mouse Schwann Cell line 80
DR   PRIDE; PXD000589
DR   Wikidata; Q54906813
RX   Patent=US7001767;
RX   PubMed=1629940;
RX   PubMed=11836421;
RX   PubMed=25894527;
CC   Characteristics: Can be infected in vitro with mouse scrapie prion (PrPSc) and will continue to produce PrPSc after 18 passages and is able to transmit the prion disease to mice.
CC   Doubling time: 17 hours (PubMed=1629940).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   MSC G-CSF#1
AC   CVCL_B6BP
SY   G-CSF#1
DR   Wikidata; Q112129360
RX   PubMed=28866844;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2438; CSF3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: C57BL/6-EGFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4-8W
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   MSC G-CSF#2
AC   CVCL_B6BQ
SY   G-CSF#2
DR   Wikidata; Q112129361
RX   PubMed=28866844;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2438; CSF3.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: C57BL/6-EGFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4-8W
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   MSC IGF-1#1
AC   CVCL_B6BR
SY   IGF-1#1
DR   Wikidata; Q112129362
RX   PubMed=28866844;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: C57BL/6-EGFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4-8W
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   MSC IGF-1#2
AC   CVCL_B6BS
SY   IGF-1#2
DR   Wikidata; Q112129363
RX   PubMed=28866844;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: C57BL/6-EGFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4-8W
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   MSC IGF-1#3
AC   CVCL_B6BT
SY   IGF-1#3
DR   Wikidata; Q112129364
RX   PubMed=28866844;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: C57BL/6-EGFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4-8W
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   MSC-1
AC   CVCL_U446
SY   Mouse Sertoli Cell line-1
DR   Wikidata; Q54906821
RX   PubMed=1331774;
RX   PubMed=7918865;
RX   PubMed=15541572;
RX   PubMed=22553484;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ts1609).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: hMIS-SV40 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   13W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   MSC-iPS(fetal)#1
AC   CVCL_9U81
DR   Wikidata; Q54906822
RX   PubMed=27345797;
CC   Derived from site: In situ; Fetal bone, femur; UBERON=UBERON_0000981.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U82 ! MSC-iPS(fetal)#2
SX   Female
AG   2FM
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MSC-iPS(fetal)#2
AC   CVCL_9U82
DR   Wikidata; Q54906824
RX   PubMed=27345797;
CC   Derived from site: In situ; Fetal bone, femur; UBERON=UBERON_0000981.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U81 ! MSC-iPS(fetal)#1
SX   Female
AG   2FM
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MSC-iPS1
AC   CVCL_C961
SY   MSC-IPS1
DR   Wikidata; Q54906825
RX   PubMed=18157115;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   MSC-iPSC 74
AC   CVCL_9S78
DR   Wikidata; Q54906826
RX   PubMed=26987921;
CC   From: Max Planck Institute for Molecular Genetics; Berlin; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MSC-P5
AC   CVCL_5843
SY   MSCP 5; MSCP-5; MSCP5
DR   CLS; 400294
DR   Wikidata; Q54906827
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C3H.
DI   NCIt; C24015; Mouse papilloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MSCB9
AC   CVCL_9T03
SY   MSC B9; B9; Mesenchymal stem cells clone B9
DR   Wikidata; Q54906828
RX   PubMed=17062733;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Rosa26-lacZ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   MSCB9-Pax3
AC   CVCL_9T04
DR   Wikidata; Q54906829
RX   PubMed=19460366;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97487; Pax3.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Rosa26-lacZ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9T03 ! MSCB9
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 6
//
ID   MSCC-1
AC   CVCL_C4YK
DR   Wikidata; Q116049798
RX   PubMed=12747977;
RX   PubMed=15328184;
RX   PubMed=22207358;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   MSCC-Inv1
AC   CVCL_C4YL
SY   Inv-1
DR   Wikidata; Q116049799
RX   PubMed=15328184;
RX   PubMed=22207358;
CC   Population: Japanese.
CC   Characteristics: Highly invasive clone. Lacks E-cadherin/CDH1 expression due to promoter hypermethylation (PubMed=15328184).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4YK ! MSCC-1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   MSCC-Inv1a
AC   CVCL_C4YN
SY   Inv-1a
DR   Wikidata; Q116049800
RX   PubMed=22207358;
CC   Population: Japanese.
CC   Characteristics: Highly invasive clone. Lacks E-cadherin/CDH1 expression due to promoter hypermethylation (PubMed=22207358).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4YL ! MSCC-Inv1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   MSCC-Inv2
AC   CVCL_C4YM
DR   Wikidata; Q116049801
RX   PubMed=15328184;
CC   Population: Japanese.
CC   Characteristics: Highly invasive clone.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4YK ! MSCC-1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   MSCEK
AC   CVCL_UW73
DR   Wikidata; Q95991214
RX   PubMed=20543532;
RX   PubMed=30502910;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   4Y
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 6
//
ID   MSCFSHR-1
AC   CVCL_U447
DR   Wikidata; Q54906830
RX   PubMed=9705082;
RX   PubMed=15541572;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2632; Fshr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ts1609).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: hMIS-SV40 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U446 ! MSC-1
SX   Male
AG   13W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   MSCPi001-A
AC   CVCL_D6KD
SY   JD001
DR   hPSCreg; MSCPi001-A
DR   Wikidata; Q127382891
RX   PubMed=37948838;
CC   From: Medical School of Chinese PLA; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Tyr559Cys (c.1676A>G); Zygosity=Hemizygous (PubMed=37948838).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MSCPi002-A
AC   CVCL_D6KE
SY   JD002
DR   hPSCreg; MSCPi002-A
DR   Wikidata; Q127382893
RX   PubMed=37948838;
CC   From: Medical School of Chinese PLA; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Glu302Asp (c.906 G>T); Zygosity=Hemizygous (PubMed=37948838).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MSD-01
AC   CVCL_VY00
DR   IBRC; C11000
DR   Wikidata; Q95991216
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-02
AC   CVCL_VY01
DR   IBRC; C11013
DR   Wikidata; Q95991217
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-03
AC   CVCL_VY02
DR   IBRC; C11014
DR   Wikidata; Q95991218
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-04
AC   CVCL_VY03
DR   IBRC; C11016
DR   Wikidata; Q95991219
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-05
AC   CVCL_VY04
DR   IBRC; C11017
DR   Wikidata; Q95991220
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-06
AC   CVCL_VY05
DR   IBRC; C11018
DR   Wikidata; Q95991221
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-07
AC   CVCL_VY06
DR   IBRC; C11019
DR   Wikidata; Q95991223
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-08
AC   CVCL_VY07
DR   IBRC; C11020
DR   Wikidata; Q95991224
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-09
AC   CVCL_VY08
DR   IBRC; C11021
DR   Wikidata; Q95991225
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-10
AC   CVCL_VY09
DR   IBRC; C11022
DR   Wikidata; Q95991226
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-11
AC   CVCL_VY10
DR   IBRC; C11023
DR   Wikidata; Q95991228
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-12
AC   CVCL_VY11
DR   IBRC; C11024
DR   Wikidata; Q95991229
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-13
AC   CVCL_VY12
DR   IBRC; C11025
DR   Wikidata; Q95991230
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-14
AC   CVCL_VY13
DR   IBRC; C11026
DR   Wikidata; Q95991231
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-15
AC   CVCL_VY14
DR   IBRC; C11027
DR   Wikidata; Q95991232
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-16
AC   CVCL_VY15
DR   IBRC; C11028
DR   Wikidata; Q95991233
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-17
AC   CVCL_VY16
DR   IBRC; C11029
DR   Wikidata; Q95991235
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-18
AC   CVCL_VY17
DR   IBRC; C11030
DR   Wikidata; Q95991236
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-19
AC   CVCL_VY18
DR   IBRC; C11033
DR   Wikidata; Q95991237
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-20
AC   CVCL_VY19
DR   IBRC; C11034
DR   Wikidata; Q95991238
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-21
AC   CVCL_VY20
DR   IBRC; C11035
DR   Wikidata; Q95991239
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-22
AC   CVCL_VY21
DR   IBRC; C11036
DR   Wikidata; Q95991240
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-23
AC   CVCL_VY22
DR   IBRC; C11037
DR   Wikidata; Q95991241
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-24
AC   CVCL_VY23
DR   IBRC; C11038
DR   Wikidata; Q95991242
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-25
AC   CVCL_VY24
DR   IBRC; C11039
DR   Wikidata; Q95991244
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-26
AC   CVCL_VY25
DR   IBRC; C11040
DR   Wikidata; Q95991245
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-27
AC   CVCL_VY26
DR   IBRC; C11041
DR   Wikidata; Q95991247
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-28
AC   CVCL_VY27
DR   IBRC; C11043
DR   Wikidata; Q95991249
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-29
AC   CVCL_VY28
DR   IBRC; C11045
DR   Wikidata; Q95991250
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-30
AC   CVCL_VY29
DR   IBRC; C11046
DR   Wikidata; Q95991251
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-31
AC   CVCL_VY30
DR   IBRC; C11047
DR   Wikidata; Q95991252
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-32
AC   CVCL_VY31
DR   IBRC; C11048
DR   Wikidata; Q95991253
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-33
AC   CVCL_VY32
DR   IBRC; C11054
DR   Wikidata; Q95991254
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-34
AC   CVCL_VY33
DR   IBRC; C11055
DR   Wikidata; Q95991256
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-35
AC   CVCL_VY34
DR   IBRC; C11062
DR   Wikidata; Q95991258
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-36
AC   CVCL_VY35
DR   IBRC; C11005
DR   Wikidata; Q95991259
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-37
AC   CVCL_VY36
DR   IBRC; C11006
DR   Wikidata; Q95991260
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-38
AC   CVCL_VY37
DR   IBRC; C11150
DR   Wikidata; Q95991261
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-39
AC   CVCL_VY38
DR   IBRC; C11181
DR   Wikidata; Q95991262
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-40
AC   CVCL_VY39
DR   IBRC; C11183
DR   Wikidata; Q95991263
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-41
AC   CVCL_VY40
DR   IBRC; C11184
DR   Wikidata; Q95991264
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-42
AC   CVCL_VY41
DR   IBRC; C11198
DR   Wikidata; Q95991265
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MSD-43
AC   CVCL_WA35
DR   IBRC; C11199
DR   Wikidata; Q95991266
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   mSDU-hES1
AC   CVCL_C818
SY   mSDU-hES 1
DR   Wikidata; Q54906831
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES2
AC   CVCL_C819
SY   mSDU-hES 2
DR   Wikidata; Q54906832
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES3
AC   CVCL_C820
SY   mSDU-hES 3
DR   Wikidata; Q54906833
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES4
AC   CVCL_C821
SY   mSDU-hES 4
DR   Wikidata; Q54906834
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES5
AC   CVCL_C822
SY   mSDU-hES 5
DR   Wikidata; Q54906835
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES6
AC   CVCL_C823
SY   mSDU-hES 6
DR   Wikidata; Q54906836
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES7
AC   CVCL_C824
SY   mSDU-hES 7
DR   Wikidata; Q54906837
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES8
AC   CVCL_C825
SY   mSDU-hES 8
DR   Wikidata; Q54906838
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   mSDU-hES9
AC   CVCL_C826
SY   mSDU-hES 9
DR   Wikidata; Q54906839
RX   PubMed=19941346;
CC   From: Provincial Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   MSE
AC   CVCL_WY65
SY   Masu Salmon Embryo
DR   Wikidata; Q95991270
RX   CelloPub=CLPUB00103;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8020; ! Oncorhynchus masou (Cherry salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 4
//
ID   mSEC1
AC   CVCL_IN75
DR   Wikidata; Q54906841
RX   PubMed=11121394;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   mSEC1-CF
AC   CVCL_IN76
DR   Wikidata; Q54906842
RX   PubMed=11121394;
RX   PubMed=15463957;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.
CC   Sequence variation: Mutation; MGI; MGI:88388; Cftr; Simple; p.Ser489Ter (c.1466C>A); Zygosity=Homozygous (PubMed=11121394).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   MSF32
AC   CVCL_6G26
SY   Mongolian Sheep Fibroblast 32
DR   Wikidata; Q54906843
RX   PubMed=21729198;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: ~28.2 hours (PubMed=21729198).
CC   Misspelling: MSF22; PubMed=21729198; Note=In one instance in the abstract.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mongolian; VBO=VBO_0001514.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   MSFIB
AC   CVCL_WJ22
SY   Michael Snyder FIBroblast
DR   ENCODE; ENCBS104LEJ
DR   ENCODE; ENCBS806MDQ
DR   GEO; GSE127042
DR   Wikidata; Q95991272
CC   Donor information: Established from Michael Snyder, a Stanford geneticist that pioneer the concept of integrative personal omics profile (iPOP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ17 ! MSLCL
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   mSG-DUC1
AC   CVCL_XY61
SY   mouse Salivary Gland-DUCtal 1
DR   Wikidata; Q95991273
RX   PubMed=31358811;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Breed/subspecies: Itga3flx/flx-Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   mSG-PAC1
AC   CVCL_XY62
SY   mouse Salivary Gland-Pro-ACinar 1
DR   Wikidata; Q95991274
RX   PubMed=31358811;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Salivary gland acinar cell; CL=CL_0002623.
CC   Breed/subspecies: Itga3flx/flx-Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   MSG1
AC   CVCL_0G10
DR   Wikidata; Q54906844
RX   PubMed=20924730;
CC   Population: Japanese.
CC   Characteristics: IL6 dependent. Also requires adhesion via fibronectin. Dependent on cell line HS-23 (Cellosaurus=CVCL_0E35) for its survival.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   MSH
AC   CVCL_B6Y3
SY   Micropterus salmoides Heart
DR   Wikidata; Q112129366
RX   DOI=10.1016/j.aquaculture.2021.737427;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=27706; ! Micropterus salmoides (Largemouth bass)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MSH-P3
AC   CVCL_A6JF
SY   Miniature Swine Hypophysis-P3
DR   Wikidata; Q107116401
RX   PubMed=29949606;
CC   Characteristics: Secretes prolactin (PubMed=29949606).
CC   Derived from site: In situ; Fetal pituitary gland; UBERON=UBERON_0034875.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   90FD
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   MSH3MAB1-1F6
AC   CVCL_A6MX
SY   MSH3MAB1(1F6); MSH3MAB1; 1F6
DR   DSHB; MSH3MAB1-1F6
DR   Wikidata; Q107116402
RX   PubMed=21344488;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MSH3MAB10-9B11
AC   CVCL_A6NG
SY   MSH3MAB10(9B11); MSH3MAB10; 9B11
DR   Wikidata; Q107116404
RX   PubMed=21344488;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MSH3MAB2-2F11
AC   CVCL_A6MY
SY   MSH3MAB2(2F11); MSH3MAB2; 2F11
DR   DSHB; MSH3MAB2-2F11
DR   Wikidata; Q107116405
RX   PubMed=21344488;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MSH3MAB3-5A5
AC   CVCL_A6MZ
SY   MSH3MAB3(5A5); MSH3MAB3; 5A5
DR   DSHB; MSH3MAB3-5A5
DR   Wikidata; Q107116408
RX   PubMed=21344488;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MSH3MAB4-8E6
AC   CVCL_A6NA
SY   MSH3MAB4(8E6); MSH3MAB4; 8E6
DR   DSHB; MSH3MAB4-8E6
DR   Wikidata; Q107116409
RX   PubMed=21344488;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Myotonic.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3 (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   MSH3MAB5-7H12
AC   CVCL_A6NB
SY   MSH3MAB5(7H12); MSH3MAB5; 7H12
DR   Wikidata; Q107116411
RX   PubMed=21344488;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MSH3MAB6-5D6
AC   CVCL_A6NC
SY   MSH3MAB6(5D6); MSH3MAB6; 5D6
DR   Wikidata; Q107116413
RX   PubMed=21344488;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MSH3MAB7-9E11
AC   CVCL_A6ND
SY   MSH3MAB7(9E11); MSH3MAB7; 9E11
DR   Wikidata; Q107116415
RX   PubMed=21344488;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MSH3MAB8-2A9
AC   CVCL_A6NE
SY   MSH3MAB8(2A9); MSH3MAB8; 2A9
DR   Wikidata; Q107116416
RX   PubMed=21344488;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MSH3MAB9-7A10
AC   CVCL_A6NF
SY   MSH3MAB9(7A10); MSH3MAB9; 7A10
DR   Wikidata; Q107116418
RX   PubMed=21344488;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MSH6-1-[ClX3.16]DT40
AC   CVCL_1R68
DR   RCB; RCB1853
DR   Wikidata; Q54906845
CC   Group: Bird cell line.
CC   Knockout cell: Method=Cre/loxP; CGNC; 6804; MSH6.
CC   Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: Hy-Line SC.
DI   NCIt; C134556; Chicken bursal lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_0249 ! DT40
SX   Female
AG   1D
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 12
//
ID   Mshi
AC   CVCL_0A02
DR   ECACC; 90070560
DR   Wikidata; Q54906846
CC   Group: Insect cell line.
CC   Discontinued: ECACC; 90070560; true.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   MSHRIe001-A
AC   CVCL_B844
SY   CA1
DR   hPSCreg; MSHRIe001-A
DR   NIHhESC; NIHhESC-11-0137
DR   SKIP; SKIP001955
DR   Wikidata; Q54906847
RX   PubMed=17572666;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0137.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-28.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   MSHRIe001-A-SOX7 control 1
AC   CVCL_C3L2
SY   CA1 NoCre Sox7H
DR   GEO; GSM272915
DR   Wikidata; Q114312317
RX   PubMed=18682240;
CC   Characteristics: Transfected with a loxP-BetaGeo(lacZ-neo)-polyA-loxP-SOX7-IRES-PuroR-polyA construct. This control cell line can be selected via neomycin resistance and does not overexpress SOX7 as this would require Cre-mediated excision of the loxP flanked betaGeo (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18196; SOX7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B844 ! MSHRIe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSHRIe001-A-SOX7 control 2
AC   CVCL_C3L3
SY   CA1 NoCre Sox7I
DR   GEO; GSM272917
DR   Wikidata; Q114312318
RX   PubMed=18682240;
CC   Characteristics: Transfected with a loxP-BetaGeo(lacZ-neo)-polyA-loxP-SOX7-IRES-PuroR-polyA construct. This control cell line can be selected via neomycin resistance and does not overexpress SOX7 as this would require Cre-mediated excision of the loxP flanked betaGeo (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18196; SOX7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B844 ! MSHRIe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSHRIe001-A-SOX7 overexpressing 1
AC   CVCL_C3L4
SY   CA1 Cre Sox7H
DR   GEO; GSM272914
DR   Wikidata; Q114312319
RX   PubMed=18682240;
CC   Characteristics: Using Cre the loxP-BetaGeo(lacZ-neo)-polyA-loxP section of the parent control cell line construct was excised leaving the SOX7-IRES-PuroR-polyA part. This cell line overexpresses SOX7 and can be selected via puromycin resistance (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18196; SOX7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3L2 ! MSHRIe001-A-SOX7 control 1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSHRIe001-A-SOX7 overexpressing 2
AC   CVCL_C3L5
SY   CA1 Cre Sox7I
DR   GEO; GSM272916
DR   Wikidata; Q114312320
RX   PubMed=18682240;
CC   Characteristics: Using Cre the loxP-BetaGeo(lacZ-neo)-polyA-loxP section of the parent control cell line construct was excised leaving the SOX7-IRES-PuroR-polyA part. This cell line overexpresses SOX7 and can be selected via puromycin resistance (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18196; SOX7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3L3 ! MSHRIe001-A-SOX7 control 2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSHRIe002-A
AC   CVCL_B845
SY   CA2
DR   hPSCreg; MSHRIe002-A
DR   NIHhESC; NIHhESC-11-0138
DR   SKIP; SKIP001956
DR   Wikidata; Q54906848
RX   PubMed=17572666;
CC   From: Samuel Lunenfeld Research Institute; Toronto; Canada.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0138.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-28.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   MSHRIe002-A-SOX17 control 1
AC   CVCL_C3L6
SY   CA2 NoCre Sox17D
DR   GEO; GSM272919
DR   Wikidata; Q114312321
RX   PubMed=18682240;
CC   Characteristics: Transfected with a loxP-BetaGeo(lacZ-neo)-polyA-loxP-SOX17-IRES-PuroR-polyA construct. This control cell line can be selected via neomycin resistance and does not overexpress SOX17 as this would require Cre-mediated excision of the loxP flanked betaGeo (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18122; SOX17.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B845 ! MSHRIe002-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSHRIe002-A-SOX17 control 2
AC   CVCL_C3L7
SY   CA2 NoCre Sox17E
DR   GEO; GSM272921
DR   Wikidata; Q114312322
RX   PubMed=18682240;
CC   Characteristics: Transfected with a loxP-BetaGeo(lacZ-neo)-polyA-loxP-SOX17-IRES-PuroR-polyA construct. This control cell line can be selected via neomycin resistance and does not overexpress SOX17 as this would require Cre-mediated excision of the loxP flanked betaGeo (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18122; SOX17.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B845 ! MSHRIe002-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSHRIe002-A-SOX17 overexpressing 1
AC   CVCL_C3L8
SY   CA2 Cre Sox17D
DR   GEO; GSM272918
DR   Wikidata; Q114312323
RX   PubMed=18682240;
CC   Characteristics: Using Cre the loxP-BetaGeo(lacZ-neo)-polyA-loxP section of the parent control cell line construct was excised leaving the SOX17-IRES-PuroR-polyA part. This cell line overexpresses SOX17 and can be selected via puromycin resistance (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18122; SOX17.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3L6 ! MSHRIe002-A-SOX17 control 1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSHRIe002-A-SOX17 overexpressing 2
AC   CVCL_C3L9
SY   CA2 Cre Sox17E
DR   GEO; GSM272920
DR   Wikidata; Q114312324
RX   PubMed=18682240;
CC   Characteristics: Using Cre the loxP-BetaGeo(lacZ-neo)-polyA-loxP section of the parent control cell line construct was excised leaving the SOX17-IRES-PuroR-polyA part. This cell line overexpresses SOX17 and can be selected via puromycin resistance (PubMed=18682240).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18122; SOX17.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3L7 ! MSHRIe002-A-SOX17 control 2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   MSIE
AC   CVCL_6E39
SY   Mouse Small Intestine Epithelium
DR   ABM; T0568
DR   Wikidata; Q54906849
RX   PubMed=7678459;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   18-21D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   MSiPS
AC   CVCL_WJ18
SY   Michael Snyder iPS
DR   EFO; EFO_0009498
DR   ENCODE; ENCBS162TUX
DR   ENCODE; ENCBS328OGH
DR   GEO; GSE127045
DR   Wikidata; Q95991277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from Michael Snyder, a Stanford geneticist that pioneer the concept of integrative personal omics profile (iPOP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ17 ! MSLCL
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MSK
AC   CVCL_8369
DR   JCRB; JCRB0259
DR   Wikidata; Q54906850
RX   DOI=10.11277/stomatology1952.38.870;
CC   Doubling time: 18 hours (DOI=10.11277/stomatology1952.38.870).
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   MSK-921
AC   CVCL_6988
SY   MSK921; MSK 921; HN 921
DR   Cosmic; 2043899
DR   Wikidata; Q54906852
RX   PubMed=7927946;
RX   PubMed=11389082;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   MSK-922
AC   CVCL_6989
SY   MSK 922; MSK922
DR   Cosmic; 2043885
DR   Cosmic; 2439756
DR   Wikidata; Q54906853
RX   PubMed=7927946;
RX   PubMed=11389082;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   MSK-C5.10C
AC   CVCL_E7XI
SY   C5.10C
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSK-C5.10H
AC   CVCL_E7XJ
SY   C5.10H
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSK-C5.4D
AC   CVCL_E7XK
SY   C5.4D
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSK-C5.4E
AC   CVCL_E7XL
SY   C5.4E
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSK-C5.4G
AC   CVCL_E7XM
SY   C5.4G
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSK-C5.6A
AC   CVCL_E7XN
SY   C5.6A
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSK-C5.8B
AC   CVCL_E7XP
SY   C5.8B
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSK-C5.8G
AC   CVCL_5336
SY   C5.8G
DR   CLO; CLO_0050829
DR   RCB; RCB2806
DR   Wikidata; Q54906854
WW   Info; KAKEN; 02670887; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-02670887/
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8369 ! MSK
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   MSK-Leuk1
AC   CVCL_D684
SY   MSK Leuk1; MSKleuk1; Leuk1
DR   BTO; BTO_0005241
DR   Lonza; 1654
DR   Wikidata; Q54906856
RX   PubMed=8842478;
RX   PubMed=9525275;
RX   PubMed=11389082;
RX   PubMed=21868764;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C3187; Oral leukoplakia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   MSK-Leuk1S
AC   CVCL_AT81
SY   MSK Leuk1S; MSKleuk1S
DR   Wikidata; Q54906858
RX   PubMed=20145189;
RX   PubMed=21868764;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C3187; Oral leukoplakia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D684 ! MSK-Leuk1
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   MSK-QLL1
AC   CVCL_6990
SY   MSK QLL1; MSKQLL1
DR   cancercelllines; CVCL_6990
DR   IARC_TP53; 3551
DR   Wikidata; Q54906859
RX   PubMed=7927946;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ser (c.730G>A); ClinVar=VCV000376600; Zygosity=Unspecified (PubMed=7927946).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MSK-QLL2
AC   CVCL_6991
SY   MSK QLL2; MSKQLL2
DR   cancercelllines; CVCL_6991
DR   IARC_TP53; 3552
DR   Wikidata; Q54906860
RX   PubMed=7927946;
RX   PubMed=11389082;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=7927946).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   MsK8
AC   CVCL_D5H4
SY   MSK8
DR   Wikidata; Q127382894
RX   DOI=10.1007/BF00206302;
RX   PubMed=17079154;
RX   PubMed=24240220;
RX   PubMed=29090012;
RX   PubMed=29982119;
CC   Group: Plant cell line.
CC   Characteristics: Used as model for the electrochemical sensing of beta-glucuronidase activity of transgenic cell lines (PubMed=29982119).
CC   Characteristics: Can be used to prepare protoplasts (DOI=10.1007/BF00206302).
CC   Derived from site: In situ; Vascular leaf; PO=PO_0009025.
CC   Breed/subspecies: Cultivar IVT741505.
OX   NCBI_TaxID=95449; ! Solanum lycopersicum x Solanum peruvianum (Hybrid tomato)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MSL-G2
AC   CVCL_M446
DR   Wikidata; Q54906861
RX   CelloPub=CLPUB00274;
RX   PubMed=2842785;
RX   PubMed=2877997;
CC   Characteristics: Established from a transplantable tumor (PubMed=2877997).
CC   Doubling time: ~4 days (PubMed=2877997).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 13
//
ID   MSL-G2-Tu6
AC   CVCL_M460
SY   Tu6; Tu-6
DR   Wikidata; Q54906862
RX   CelloPub=CLPUB00274;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M446 ! MSL-G2
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   MSLCL
AC   CVCL_WJ17
SY   Michael Snyder LCL
DR   EFO; EFO_0009497
DR   ENCODE; ENCBS885UHF
DR   ENCODE; ENCBS999WLB
DR   GEO; GSE12703
DR   Wikidata; Q95991290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from Michael Snyder, a Stanford geneticist that pioneer the concept of integrative personal omics profile (iPOP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WJ22 ! MSFIB
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   MsMab-1
AC   CVCL_D3E6
DR   ABCD; ABCD_AF673
DR   Wikidata; Q127382896
RX   PubMed=23782684;
RX   PubMed=24328750;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132Gly or p.Arg132His or p.Arg132Ser. Does not reacts with wild type IDH1).
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2 (Note=With p.Arg172Met).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   MsMab-2
AC   CVCL_D3E7
DR   Wikidata; Q127382897
RX   PubMed=24328739;
RX   PubMed=24328751;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132Leu).
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2 (Note=With p.Arg172Met).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   MSN
AC   CVCL_9882
DR   Wikidata; Q54906863
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7579408;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   MSN-1
AC   CVCL_A8Q8
DR   Wikidata; Q102114556
RX   PubMed=2478021;
RX   PubMed=3295079;
RX   PubMed=8339270;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59440; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcNAc (Lewis B).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   MSN53
AC   CVCL_LC44
DR   JCRB; JCRB1724
DR   Wikidata; Q54906886
RX   PubMed=6272292;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Unexplicit; Ex16-18del (nsv1067857); ClinVar=VCV000003711; Zygosity=Heterozygous (PubMed=6272292).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1724
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   MsNAC
AC   CVCL_E8DX
SY   Manduca sexta Non-Adherent Cell line
RX   PubMed=40050299;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 33.5 +- 6.3 hours (Note=Between passages 80 and 95) (PubMed=40050299).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MSnviPSNF1
AC   CVCL_VG10
DR   SKIP; SKIP000754
DR   Wikidata; Q54906881
RX   PubMed=21565833;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG11 ! MSnviPSNF2
OI   CVCL_VG12 ! MSnviPSNF3
OI   CVCL_VG13 ! MSnviPSNF5
OI   CVCL_VG14 ! MSnviPSNF6
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MSnviPSNF2
AC   CVCL_VG11
DR   SKIP; SKIP000755
DR   Wikidata; Q54906882
RX   PubMed=21565833;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG10 ! MSnviPSNF1
OI   CVCL_VG12 ! MSnviPSNF3
OI   CVCL_VG13 ! MSnviPSNF5
OI   CVCL_VG14 ! MSnviPSNF6
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MSnviPSNF3
AC   CVCL_VG12
DR   SKIP; SKIP000756
DR   Wikidata; Q54906883
RX   PubMed=21565833;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG10 ! MSnviPSNF1
OI   CVCL_VG11 ! MSnviPSNF2
OI   CVCL_VG13 ! MSnviPSNF5
OI   CVCL_VG14 ! MSnviPSNF6
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MSnviPSNF5
AC   CVCL_VG13
DR   SKIP; SKIP000757
DR   Wikidata; Q54906884
RX   PubMed=21565833;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG10 ! MSnviPSNF1
OI   CVCL_VG11 ! MSnviPSNF2
OI   CVCL_VG12 ! MSnviPSNF3
OI   CVCL_VG14 ! MSnviPSNF6
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MSnviPSNF6
AC   CVCL_VG14
DR   SKIP; SKIP000758
DR   Wikidata; Q54906885
RX   PubMed=21565833;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG10 ! MSnviPSNF1
OI   CVCL_VG11 ! MSnviPSNF2
OI   CVCL_VG12 ! MSnviPSNF3
OI   CVCL_VG13 ! MSnviPSNF5
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   MSOD
AC   CVCL_C6VW
SY   M-SOD; Mesenchymal Sword of Damocles; hTERT-iDS; 196hT-iDS clone 20
DR   Wikidata; Q117704716
RX   Patent=WO2013186264A1;
RX   PubMed=24561906;
RX   PubMed=34486186;
CC   Group: Patented cell line.
CC   Characteristics: Capable to efficiently differentiate toward the osteogenic lineage (PubMed=24561906).
CC   Characteristics: Transduced with a lentiviral vector containing hTERT and eGFP respectively under the control of the CMV and EF1a promoters and a retro-vector containing iCasp9-2A-CD19t under the control of a CMV promoter (PubMed=24561906).
CC   Characteristics: The suicide system of this cell line can be activated by addition of an homodimerizer that activates the apoptosis pathway through the dimerization of iCasp9 (FKBP12 linked by a linker SGGGS to Caspase-9) (PubMed=24561906).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1511; CASP9.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19 (Note=With p.Lys324_Arg556del = CD19t).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3711; FKBP1A (Note=With p.Phe37Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): PubMed=24561906
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 12
ST   D18S51: 12,17
ST   D21S11: 30,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 10,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VV ! 196hT
SX   Female
AG   51Y
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MSOD-B
AC   CVCL_C6VX
SY   MSOD-BMP2
DR   Wikidata; Q117704717
RX   PubMed=34486186;
RX   PubMed=36223446;
CC   Characteristics: Capable of chondrogenesis and deposition of a morphogen-enriched ECM (PubMed=34486186).
CC   Characteristics: Can successfully undergo chondrogenic and osteogenic differentiation in vitro, forming mature hypertrophic cartilage and osteoid tissues, respectively. Their subsequent ectopic implantation results in rapid humanized ossicles (hOss) formation and reconstitution of a cellular and molecular human mesenchymal niche (PubMed=36223446).
CC   Characteristics: Transduced with a lentiviral vector containing hTERT and eGFP respectively under the control of the CMV and EF1a promoters and a retro-vector containing iCasp9-2A-CD19t under the control of a CMV promoter (from parent cell line).
CC   Characteristics: Transduced with a lentiviral vector containing a PGK bidirectional promoter driving the expression of BMP2 and truncated LNGFR (PubMed=34486186).
CC   Characteristics: The suicide system of this cell line can be activated by addition of an homodimerizer that activates the apoptosis pathway through the dimerization of iCasp9 (FKBP12 linked by a linker SGGGS to Caspase-9) (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1069; BMP2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1511; CASP9.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19 (Note=With p.Lys324_Arg556del = CD19t).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3711; FKBP1A (Note=With p.Phe37Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7809; NGFR (Note=Truncated).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VW ! MSOD
SX   Female
AG   51Y
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   MSP-1
AC   CVCL_LB72
SY   Myeloma Stromal Puente-1
DR   Wikidata; Q54906887
RX   PubMed=27081175;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   MSP.1
AC   CVCL_A6RN
DR   ATCC; CRL-2774
DR   Wikidata; Q107116419
CC   Discontinued: ATCC; CRL-2774; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MSPF-PI 31
AC   CVCL_9W00
DR   NCBI_Iran; C441
DR   Wikidata; Q54906888
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast of spleen; CL=CL_2000051.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   MSR3-A1
AC   CVCL_VV14
DR   Wikidata; Q95991309
RX   PubMed=11668505;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*01:01).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV18 ! MSR3-mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   MSR3-B37
AC   CVCL_VV15
DR   Wikidata; Q95991310
RX   PubMed=10363990;
RX   PubMed=11668505;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*37:01).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV18 ! MSR3-mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   MSR3-B52
AC   CVCL_VV16
DR   Wikidata; Q95991311
RX   PubMed=11668505;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*52:01:01:01).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV18 ! MSR3-mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   MSR3-EBV
AC   CVCL_VV17
DR   Wikidata; Q95991312
RX   PubMed=10363990;
RX   PubMed=11668505;
CC   HLA typing: A*01:01,11:01; B*37:01,52:01:01:01; C*06:02,12:02 (PubMed=11668505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV18 ! MSR3-mel
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   MSR3-mel
AC   CVCL_VV18
SY   AUMA
DR   Wikidata; Q95991314
RX   PubMed=10363990;
RX   PubMed=11668505;
CC   HLA typing: A*01:01,11:01; B*37:01,52:01:01:01; C*06:02,12:02 (PubMed=11668505).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VV17 ! MSR3-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   MSS16
AC   CVCL_5560
DR   Wikidata; Q54906890
RX   PubMed=2804371;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MSS31
AC   CVCL_5561
SY   MSS-31; MSS 31
DR   BTO; BTO_0002863
DR   JCRB; IFO50375
DR   Wikidata; Q27671707
RX   PubMed=2032312;
RX   PubMed=2804371;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   MSS57
AC   CVCL_5562
DR   Wikidata; Q54906891
RX   PubMed=2804371;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MSS62
AC   CVCL_5563
DR   JCRB; IFO50376
DR   Wikidata; Q54906893
RX   PubMed=2804371;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MSS72
AC   CVCL_5564
DR   Wikidata; Q54906894
RX   PubMed=2804371;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MST
AC   CVCL_VT16
DR   BTO; BTO_0000492
DR   Wikidata; Q95991319
RX   PubMed=1454815;
CC   Doubling time: 14-17 hours (PubMed=1454815).
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 4
//
ID   MST-1
AC   CVCL_0J34
SY   MST1
DR   Wikidata; Q54906895
RX   PubMed=8664053;
RX   PubMed=12966428;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 69 hours (PubMed=8664053).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=12966428).
CC   Derived from site: In situ; Knee, hypodermis; UBERON=UBERON_0001465+UBERON_0002072.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 8
//
ID   MST-2
AC   CVCL_0J35
SY   MST2
DR   Wikidata; Q54906897
RX   PubMed=12966428;
RX   PubMed=15150091;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=15150091).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Knee, hypodermis; UBERON=UBERON_0001465+UBERON_0002072.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   MST-3
AC   CVCL_0J36
SY   MST3
DR   Wikidata; Q54906898
RX   PubMed=12966428;
RX   PubMed=15150091;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=15150091).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   MST1
AC   CVCL_1M73
SY   MST; GM03161; GM3161
DR   CLO; CLO_0013517
DR   Coriell; GM03161
DR   Wikidata; Q54906899
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 12
//
ID   MSTO-211H
AC   CVCL_1430
SY   MSTO-211 H; MSTO211H; MSTO-211; 211H; MeSoTheliOma-211H
DR   BTO; BTO_0002425
DR   CLO; CLO_0007880
DR   EFO; EFO_0002839
DR   CLDB; cl7174
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2081
DR   BioSample; SAMN03471440
DR   BioSample; SAMN10987652
DR   BioSamples; SAMEA100779
DR   cancercelllines; CVCL_1430
DR   CCRID; 3101HUMTCHu161
DR   Cell_Model_Passport; SIDM00640
DR   ChEMBL-Cells; CHEMBL3308116
DR   ChEMBL-Targets; CHEMBL1075509
DR   CLS; 300450
DR   Cosmic; 688057
DR   Cosmic; 877275
DR   Cosmic; 908152
DR   Cosmic; 1067228
DR   Cosmic; 1175876
DR   Cosmic; 1481542
DR   Cosmic; 1522772
DR   Cosmic; 1541211
DR   Cosmic; 1749563
DR   Cosmic; 1963324
DR   Cosmic; 1995515
DR   Cosmic; 2759001
DR   Cosmic; 2759223
DR   Cosmic-CLP; 908152
DR   DepMap; ACH-000335
DR   DSMZ; ACC-390
DR   DSMZCellDive; ACC-390
DR   EGA; EGAS00001000978
DR   GDSC; 908152
DR   GEO; GSM49614
DR   GEO; GSM726279
DR   GEO; GSM827586
DR   GEO; GSM850286
DR   GEO; GSM887342
DR   GEO; GSM888418
DR   GEO; GSM1670136
DR   IARC_TP53; 21518
DR   ICLC; HL01018
DR   LiGeA; CCLE_249
DR   LINCS_LDP; LCL-1776
DR   PharmacoDB; MSTO211H_968_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1430
DR   PubChem_Cell_line; CVCL_1430
DR   Ubigene; YC-B014
DR   Wikidata; Q54906900
RX   PubMed=2840315;
RX   PubMed=15920167;
RX   PubMed=16630136;
RX   PubMed=17270034;
RX   PubMed=20215515;
RX   PubMed=21245096;
RX   PubMed=21642991;
RX   PubMed=22460905;
RX   PubMed=24926545;
RX   PubMed=25902174;
RX   PubMed=26011428;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28553954;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/msto-211h-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Population: Caucasian.
CC   Doubling time: 20 hours (PubMed=2840315); 20 hours (CLS=300450); ~30-40 hours (DSMZ=ACC-390).
CC   HLA typing: A*01:01,03:01; B*07:02,39:01; C*07:02,07:02; DRB1*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6514; LATS1 + HGNC; HGNC:9508; PSEN1; Name(s)=LATS1-PSEN1 (PubMed=25902174).
CC   Sequence variation: Mutation; HGNC; HGNC:6515; LATS2; Simple; p.Met785_Leu798del14 (c.2355_2396del42); Zygosity=Heterozygous (PubMed=21245096; Cosmic-CLP=908152; DepMap=ACH-000335).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.17%; East Asian, North=1.28%; East Asian, South=0%; South Asian=2.13%; European, North=62.92%; European, South=33.49% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2081; CLS=300450; Cosmic-CLP=908152; DSMZ=ACC-390; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 13
ST   D18S51: 16,18 (ATCC=CRL-2081; CLS=300450; DSMZ=ACC-390)
ST   D18S51: 18,19 (Technion Genomics Center)
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 20,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 11,12
ST   Penta E: 7,13
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   MSU-1
AC   CVCL_ZS38
SY   Michigan State University-1
DR   Wikidata; Q98127366
RX   PubMed=9457909;
RX   PubMed=15009740;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MSU-1.0
AC   CVCL_9S99
SY   MSU 1.0; MSU1.0
DR   TOKU-E; 4098
DR   Wikidata; Q54906901
RX   DOI=10.1007/978-1-4612-0411-4_35;
RX   PubMed=1915659;
RX   PubMed=11888918;
RX   PubMed=18048363;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG18 ! LG1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   MSU-1.1
AC   CVCL_9S81
SY   MSU1.1
DR   Wikidata; Q54906902
RX   DOI=10.1007/978-1-4612-0411-4_35;
RX   PubMed=1915659;
RX   PubMed=2201439;
RX   PubMed=2216465;
RX   PubMed=2643097;
RX   PubMed=9419347;
RX   PubMed=11888918;
RX   PubMed=15705902;
RX   PubMed=18048363;
RX   PubMed=19008219;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S99 ! MSU-1.0
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   MSU-1.1-N-ras 2
AC   CVCL_XG19
SY   N-Ras-2T
DR   Wikidata; Q95991327
RX   PubMed=2201439;
RX   PubMed=18048363;
CC   Characteristics: Tumorigenic.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7989; NRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   MSU-1.1-N-ras 3
AC   CVCL_XG20
SY   N-Ras-3T
DR   Wikidata; Q95991328
RX   PubMed=2201439;
RX   PubMed=18048363;
CC   Characteristics: Tumorigenic.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7989; NRAS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   MSU-1.1-S41
AC   CVCL_XG21
SY   MSU1.1-S41
DR   Wikidata; Q95991329
RX   PubMed=18048363;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11270; SPRY2 (Note=With a V5 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   MSU-1.1-S62
AC   CVCL_XG22
SY   MSU1.1-S62; S62
DR   Wikidata; Q95991330
RX   PubMed=18048363;
RX   PubMed=19008219;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11270; SPRY2 (Note=With a V5 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   MSU-1.1-T24 2
AC   CVCL_XG25
SY   MSU-1.1-T24 cell strain 2; PHM2
DR   Wikidata; Q95991331
RX   PubMed=2643097;
RX   PubMed=11888918;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   MSU-1.1-T24 3
AC   CVCL_XG26
SY   MSU-1.1-T24 cell strain 3; PHM3
DR   Wikidata; Q95991332
RX   PubMed=2643097;
RX   PubMed=11888918;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   MSU-1.1-v-Ki-ras 1
AC   CVCL_XG23
SY   MSU-1.1 focus-derived cell strain #1
DR   Wikidata; Q95991334
RX   PubMed=2216465;
CC   Characteristics: Tumorigenic.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   MSU-1.1-v-Ki-ras 2
AC   CVCL_XG24
SY   MSU-1.1 focus-derived cell strain #2
DR   Wikidata; Q95991335
RX   PubMed=2216465;
CC   Characteristics: Tumorigenic.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S81 ! MSU-1.1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   MSU-2
AC   CVCL_ZS39
SY   Michigan State University-2
DR   Wikidata; Q98127368
RX   PubMed=2657812;
RX   PubMed=9457909;
CC   Misspelling: MUS-2; PubMed=2657812; Note=In figure 1 and once in text.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MSU-TnT4
AC   CVCL_9U39
SY   TnT4
DR   Wikidata; Q54906903
RX   Patent=US8383402;
RX   PubMed=18622664;
RX   PubMed=19911241;
RX   PubMed=29133148;
WW   Provider; MSUT; TEC2008-0034; http://msut.technologypublisher.com/technology/7017
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9384.
CC   Doubling time: 21 hours (PubMed=18622664).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   MSuD1
AC   CVCL_UT95
DR   JCRB; KURB1999
DR   Wikidata; Q95991336
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   MSUH-001
AC   CVCL_V155
SY   MSUH001
DR   Wikidata; Q54906904
RX   PubMed=20641038;
RX   PubMed=20736931;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_Deposito_MSUH_001.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_I_MSUH_001.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   Population: Caucasian.
CC   HLA typing: A*23:01,30:02; B*53:01,58:01; C*04:01,07:01; DQB1*05:02,06:02; DRB1*15:03,16:02 (BNLC).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   MSUMFH
AC   CVCL_M829
SY   Michigan State University Malignant Fibrous Histiocytoma
DR   Wikidata; Q54906905
RX   PubMed=21208094;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   MSV.B
AC   CVCL_4244
SY   MSV cell line
DR   CLO; CLO_0007881
DR   CLDB; cl3592
DR   ECACC; 90031901
DR   Wikidata; Q54906907
RX   PubMed=5466001;
CC   Characteristics: Control cell line for MSVIF-TK+ (Cellosaurus=CVCL_4245).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   MSV512
AC   CVCL_6E67
DR   Wikidata; Q54906908
RX   PubMed=4307755;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6E65 ! C3H2K
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   MSVIF-TK+
AC   CVCL_4245
SY   MSV-IF+; MSV-Interferon
DR   CLO; CLO_0007882
DR   CLDB; cl3593
DR   ECACC; 90031902
DR   Wikidata; Q54906909
RX   PubMed=5466001;
CC   Characteristics: Grown in the presence of interferon.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4244 ! MSV.B
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   mSXL 104
AC   CVCL_4246
SY   mSXL104
DR   CLO; CLO_0007883
DR   ATCC; CRL-1953
DR   Wikidata; Q54906910
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   mSXL 114
AC   CVCL_4247
SY   mSXL114; mSxl114
DR   CLO; CLO_0007884
DR   ATCC; CRL-1954
DR   Wikidata; Q54906911
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   mSXL 18
AC   CVCL_4248
SY   mSXL18
DR   CLO; CLO_0007885
DR   ATCC; CRL-1952
DR   Wikidata; Q54906912
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   mSXL 5
AC   CVCL_4249
SY   mSXL5
DR   CLO; CLO_0007886
DR   ATCC; CRL-1951
DR   Wikidata; Q54906913
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   MSY00349IN
AC   CVCL_E179
DR   Wikidata; Q54906914
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9546; ! Macaca sylvanus (Barbary macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MSY00350IN
AC   CVCL_E180
DR   Wikidata; Q54906915
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9546; ! Macaca sylvanus (Barbary macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MSY00351IN
AC   CVCL_E181
DR   Wikidata; Q54906916
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9546; ! Macaca sylvanus (Barbary macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MSY00352IN
AC   CVCL_E182
DR   Wikidata; Q54906917
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9546; ! Macaca sylvanus (Barbary macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MSY00353IN
AC   CVCL_E183
DR   Wikidata; Q54906918
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9546; ! Macaca sylvanus (Barbary macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MSY00354IN
AC   CVCL_E184
DR   Wikidata; Q54906925
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9546; ! Macaca sylvanus (Barbary macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MT [Human rhabdoid tumor]
AC   CVCL_B3QG
DR   Cosmic; 802243
DR   Wikidata; Q110433072
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   MT [Human ovarian carcinoma]
AC   CVCL_E6XI
RX   PubMed=9384677;
RX   PubMed=12836015;
CC   HLA typing: A*01,02; B*08,51; DQB1*02,03; DRB1*03:01:01,11:04:01 (PubMed=12836015).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MT [Muntjac]
AC   CVCL_6F14
SY   Indian Muntjac (MT)
DR   CLDB; cl2891
DR   CLDB; cl2892
DR   CLDB; cl2893
DR   CLDB; cl2894
DR   Wikidata; Q54906926
RX   PubMed=19140346;
RX   PubMed=25509114;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_9126 ! DM87
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   MT-1 [Human contaminated breast cancer]
AC   CVCL_0441
DR   MCCL; MCC:0000337
DR   BioSample; SAMN03151746
DR   Wikidata; Q54906927
RX   PubMed=1446057;
RX   PubMed=9150904;
RX   PubMed=10508494;
RX   PubMed=11044355;
RX   PubMed=12661003;
RX   PubMed=15677628;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/MT-1.html
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00148.
CC   Population: African American.
CC   Doubling time: 42.4 +- 6.0 hours (PubMed=9150904).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=15677628).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   MT-1 [Human leukemia]
AC   CVCL_M518
SY   FCCH1043
DR   BioSample; SAMN03472436
DR   cancercelllines; CVCL_M518
DR   IARC_TP53; 27001
DR   JCRB; JCRB0063
DR   JCRB; JCRB1209
DR   JCRB; NIHS0526
DR   Wikidata; Q54906928
RX   CelloPub=CLPUB00542;
RX   PubMed=1765142;
RX   PubMed=2985879;
RX   PubMed=3001699;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6275274;
RX   PubMed=6327813;
RX   PubMed=6966589;
RX   PubMed=7031654;
RX   PubMed=7662981;
RX   PubMed=8957066;
RX   PubMed=15638862;
RX   PubMed=17170727;
RX   PubMed=19220422;
RX   PubMed=19710698;
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Characteristics: Was established by co-cultivation of cells from a 69 year old male T-cell leukemia patient with cord leukocytes from a female infant (CelloPub=CLPUB00542).
CC   Virology: HTLV-1 producing cell line.
CC   Doubling time: 48-54 hours (PubMed=6966589).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Unspecified (PubMed=19220422; PubMed=19710698).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: JCRB; JCRB0063; probable.
CC   Discontinued: JCRB; NIHS0526; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB1209
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 11,13
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 27
//
ID   MT-1 [Human mesothelioma]
AC   CVCL_M519
SY   UCLA MT-1
DR   Wikidata; Q54906929
RX   CelloPub=CLPUB00383;
RX   PubMed=3597716;
CC   Doubling time: 21 hours (CelloPub=CLPUB00383).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   MT-10
AC   CVCL_M802
DR   RCB; RCB2719
DR   Wikidata; Q54906931
RX   PubMed=1850724;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M804 ! MT-P
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 8
//
ID   MT-100-TC
AC   CVCL_Y666
DR   Wikidata; Q54906932
RX   PubMed=6662551;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_Y667 ! MT-100M
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   MT-100M
AC   CVCL_Y667
DR   Wikidata; Q54906933
RX   PubMed=2096989;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_Y666 ! MT-100-TC
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   MT-10R
AC   CVCL_M803
DR   RCB; RCB2722
DR   Wikidata; Q54906934
RX   PubMed=17267196;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M802 ! MT-10
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   MT-2
AC   CVCL_2631
SY   MT2; MT-2J; MT-2Org
DR   BTO; BTO_0005492
DR   CLO; CLO_0007888
DR   EFO; EFO_0022393
DR   CLDB; cl3596
DR   CLDB; cl3597
DR   BEI_Resources; ARP-237
DR   BioSample; SAMN03472437
DR   ChEMBL-Cells; CHEMBL3307558
DR   ChEMBL-Targets; CHEMBL614184
DR   Cosmic; 919158
DR   ECACC; 08081401
DR   ECACC; 93121518
DR   IARC_TP53; 27003
DR   JCRB; JCRB1210
DR   JCRB; NIHS0527
DR   PubChem_Cell_line; CVCL_2631
DR   Wikidata; Q54906935
RX   CelloPub=CLPUB00542;
RX   PubMed=1765142;
RX   PubMed=2985879;
RX   PubMed=3001699;
RX   PubMed=3003193;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6198871;
RX   PubMed=6275274;
RX   PubMed=6281119;
RX   PubMed=7662981;
RX   PubMed=7832798;
RX   PubMed=8957066;
RX   PubMed=9510473;
RX   PubMed=12920029;
RX   PubMed=15638862;
RX   PubMed=16850164;
RX   PubMed=19220422;
RX   PubMed=22608188;
RX   PubMed=25544500;
RX   PubMed=26940204;
RX   PubMed=28357668;
RX   PubMed=29892436;
RX   PubMed=32187573;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-576.html
CC   Population: Japanese.
CC   Characteristics: Was established by co-cultivation of cells from a 45 year old female T-cell leukemia patient with cord leukocytes from a male infant (CelloPub=CLPUB00542).
CC   Virology: HTLV-1 producing cell line. Contains 11 integrated HTLV-1 proviruses: one complete proviral genome, six copies of a provirus with an internal deletion of 5.3 kb, one copy of a provirus with an internal deletion of 3.9 kb, one copy of a provirus with a 6.2 kB deletion from 5'LTR to position 6257 and two copies of a provirus composed of LTR only.
CC   Virology: Susceptible to infection by hepatitis C virus (HCV) (PubMed=7832798).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: ECACC; 93121518; true.
CC   Discontinued: JCRB; NIHS0527; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Regulatory T-cell; CL=CL_0000815.
ST   Source(s): JCRB=JCRB1210; PubMed=28357668
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 8,13
ST   D8S1179: 11,14
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 15,16
ST   TH01: 6,10
ST   TPOX: 10,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   MT-2CB1
AC   CVCL_C0YR
SY   MT-2CB; CB1; MT-2Rst
DR   Wikidata; Q114312325
RX   PubMed=16850164;
RX   PubMed=22608188;
RX   PubMed=32187573;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Regulatory T-cell; CL=CL_0000815.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2631 ! MT-2
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   MT-2CR1
AC   CVCL_C0YS
SY   MT-2CR; CR1
DR   Wikidata; Q114312327
RX   PubMed=22608188;
RX   PubMed=32187573;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Regulatory T-cell; CL=CL_0000815.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2631 ! MT-2
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   MT-213-VGH
AC   CVCL_W812
DR   BCRC; 60598
DR   Wikidata; Q54906936
RX   PubMed=11575644;
CC   Population: Chinese.
CC   Doubling time: 24.29 +- 1.81 hours (Note=At 20th passage) (PubMed=11575644).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   MT-3 [Human contaminated breast cancer]
AC   CVCL_2129
SY   MT3
DR   CLO; CLO_0007890
DR   EFO; EFO_0002241
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472975
DR   BioSample; SAMN03473582
DR   BioSample; SAMN06481118
DR   cancercelllines; CVCL_2129
DR   DSMZ; ACC-403
DR   DSMZCellDive; ACC-403
DR   EGA; EGAS00001000610
DR   GEO; GSM115102
DR   GEO; GSM217592
DR   GEO; GSM412073
DR   GEO; GSM412084
DR   GEO; GSM412093
DR   GEO; GSM412098
DR   GEO; GSM412106
DR   GEO; GSM412110
DR   GEO; GSM459700
DR   GEO; GSM474280
DR   GEO; GSM474281
DR   GEO; GSM476484
DR   GEO; GSM476485
DR   GEO; GSM478311
DR   GEO; GSM478312
DR   GEO; GSM478314
DR   GEO; GSM478315
DR   GEO; GSM478320
DR   GEO; GSM478321
DR   GEO; GSM783977
DR   GEO; GSM844610
DR   GEO; GSM847419
DR   GEO; GSM847498
DR   GEO; GSM1172986
DR   IGRhCellID; MT3
DR   LINCS_HMS; 50031
DR   LINCS_LDP; LCL-1473
DR   PharmacoDB; MT3_969_2019
DR   Progenetix; CVCL_2129
DR   Wikidata; Q54906937
RX   PubMed=1446057;
RX   PubMed=9150904;
RX   PubMed=11044355;
RX   PubMed=12661003;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=20215515;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/MT-3.html
CC   Problematic cell line: Contaminated. Shown to be a LS174T derivative (PubMed=25877200; DSMZ). Originally thought to originate from a breast carcinoma.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00506.
CC   Population: Caucasian.
CC   Doubling time: 37.1 +- 8.1 hours (PubMed=9150904); ~30 hours (DSMZ=ACC-403).
CC   HLA typing: A*02:01,02:01; B*07:17,15:50; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=12661003; PubMed=15677628).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: DSMZ; ACC-403; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): DSMZ=ACC-403; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 10,12
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 18,22
ST   D3S1358: 15,16
ST   D5S818: 12 (PubMed=25877200)
ST   D5S818: 12,17 (DSMZ=ACC-403)
ST   D7S820: 10.3,11,12
ST   D8S1179: 12,15 (PubMed=25877200)
ST   D8S1179: 13,15 (DSMZ=ACC-403)
ST   FGA: 20,21
ST   Penta D: 9,10
ST   Penta E: 13,15 (PubMed=25877200)
ST   Penta E: 13,15,17,21 (DSMZ=ACC-403)
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 13,14,16,17 (DSMZ=ACC-403)
ST   vWA: 14,17 (PubMed=25877200)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   MT-3 [Human leukocyte]
AC   CVCL_M517
DR   BioSample; SAMN03472443
DR   JCRB; JCRB1217
DR   JCRB; NIHS0528
DR   Wikidata; Q54906938
RX   CelloPub=CLPUB00542;
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Characteristics: Was established by co-cultivation of cells from a 36 year old male T-cell leukemia patient with cord leukocytes from a male infant (CelloPub=CLPUB00542).
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: JCRB; NIHS0528; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): JCRB=JCRB1217
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10.3,12
ST   D8S1179: 12,14
ST   FGA: 19,21
ST   Penta D: 9,12
ST   Penta E: 19
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 15
//
ID   MT-3 [Human mesothelioma]
AC   CVCL_M520
SY   UCLA MT-3; MT3
DR   Cosmic; 733819
DR   IARC_TP53; 23626
DR   Wikidata; Q54906939
RX   PubMed=1568228;
CC   From: Anderson, Timothy M. & Saxton, Romaine Edward; UCLA School of Medicine; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   MT-4
AC   CVCL_2632
SY   MT4
DR   BTO; BTO_0003030
DR   CLO; CLO_0007891
DR   CLDB; cl3594
DR   CLDB; cl3599
DR   BEI_Resources; ARP-120
DR   BioSample; SAMN03470803
DR   BioSample; SAMN03472442
DR   ChEMBL-Cells; CHEMBL3308375
DR   ChEMBL-Targets; CHEMBL388
DR   Cosmic; 1191697
DR   ECACC; 08081402
DR   JCRB; JCRB0135
DR   JCRB; JCRB1216
DR   JCRB; NIHS0145
DR   JCRB; NIHS0529
DR   KCB; KCB 200308YJ
DR   PubChem_Cell_line; CVCL_2632
DR   Wikidata; Q54906940
RX   CelloPub=CLPUB00542;
RX   PubMed=1364232;
RX   PubMed=1765142;
RX   PubMed=2413616;
RX   PubMed=8927062;
RX   PubMed=8957066;
RX   PubMed=9261343;
RX   PubMed=29892436;
RX   PubMed=31554688;
RX   PubMed=32938764;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-117.html
CC   Problematic cell line: Partially contaminated. Two different lots formerly distributed by NIH-ARP; 13 P7 3/9/92 and 150048; were shown not to be authentic MT-4 (PubMed=9261343; PubMed=31554688).
CC   Population: Japanese.
CC   Characteristics: Was established by co-cultivation of cells from a 50 year old male T-cell leukemia patient with cord leukocytes from a male infant (CelloPub=CLPUB00542).
CC   Virology: HTLV-1 producing cell line. Expresses Tax. Is permissive for replication of an HIV-1 gp41 mutant lacking the cytoplasmic tail.
CC   Doubling time: ~30 hours (Note=Lot 102799) (JCRB=JCRB1216).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: JCRB; JCRB0135; probable.
CC   Discontinued: JCRB; JCRB1216; probable.
CC   Discontinued: JCRB; NIHS0145; true.
CC   Discontinued: JCRB; NIHS0529; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): JCRB=JCRB0135; JCRB=JCRB1216; PubMed=31554688; PubMed=32938764
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 13
ST   D21S11: 28,30.3
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 8,9.3,10 (JCRB=JCRB1216)
ST   D7S820: 8,10 (JCRB=JCRB0135; PubMed=31554688; PubMed=32938764)
ST   D8S1179: 10,15
ST   FGA: 23
ST   Penta D: 10,13
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   MT-428
AC   CVCL_W492
SY   MT428
DR   Wikidata; Q54906942
RX   PubMed=8025019;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=8025019).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   MT-45-5-3
AC   CVCL_J275
SY   MT45-5-3; MT45
DR   JCRB; JCRB1304
DR   Wikidata; Q54906943
RX   PubMed=1500065;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04355; Rat Mt2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   MT-450TC
AC   CVCL_L173
DR   KCLB; 60006
DR   Wikidata; Q54906944
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L170 ! MT-W9A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   MT-5
AC   CVCL_U900
SY   M14T5
DR   RCB; RCB0432
DR   Wikidata; Q54906946
RX   PubMed=3026623;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   MT-6
AC   CVCL_4978
SY   MT-6 [Mutatect]
DR   CLO; CLO_0007892
DR   ATCC; CRL-2805
DR   Wikidata; Q54906947
RX   PubMed=11228549;
CC   Discontinued: ATCC; CRL-2805; true.
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4982 ! MC-TGS17-51
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MT-7
AC   CVCL_M801
DR   RCB; RCB2718
DR   Wikidata; Q54906948
RX   PubMed=1850724;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M804 ! MT-P
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 8
//
ID   MT-8
AC   CVCL_5337
DR   CLO; CLO_0050834
DR   RCB; RCB0760
DR   Wikidata; Q54906949
RX   PubMed=1850724;
RX   PubMed=7834074;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M804 ! MT-P
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   MT-8L
AC   CVCL_1Q70
DR   Wikidata; Q54906950
RX   PubMed=8916004;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5337 ! MT-8
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   MT-9
AC   CVCL_5338
DR   CLO; CLO_0050835
DR   RCB; RCB0762
DR   Wikidata; Q54906951
RX   PubMed=1850724;
RX   PubMed=7834074;
RX   PubMed=11437512;
RX   PubMed=18036812;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M804 ! MT-P
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   MT-9L
AC   CVCL_1Q71
DR   Wikidata; Q54906952
RX   PubMed=8916004;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5338 ! MT-9
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 6
//
ID   MT-ALL
AC   CVCL_RL80
DR   Wikidata; Q54906953
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2538542;
RX   PubMed=9195772;
CC   Population: Caucasian.
CC   Characteristics: CSF2 or IL2 or IL3 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   MT-ALL MN1.1
AC   CVCL_RL81
SY   MN1.1
DR   Wikidata; Q54906954
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2538542;
CC   Population: Caucasian.
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RL80 ! MT-ALL
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   MT-CHC01
AC   CVCL_4Z41
DR   cancercelllines; CVCL_4Z41
DR   GEO; GSM3209135
DR   GEO; GSM3209136
DR   Wikidata; Q54906955
RX   PubMed=26486326;
RX   PubMed=30979003;
RX   PubMed=35640676;
CC   Population: Caucasian; Italian.
CC   Characteristics: Established from a mouse xenograft (PubMed=26486326).
CC   Doubling time: ~40 hours (PubMed=26486326); 25.3 hours (PubMed=30979003).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=26486326).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   MT-CHC01R1.5
AC   CVCL_C1L3
DR   cancercelllines; CVCL_C1L3
DR   GEO; GSM3209137
DR   GEO; GSM3209138
DR   Wikidata; Q114312328
RX   PubMed=30979003;
CC   Population: Caucasian; Italian.
CC   Doubling time: 49.1 hours (PubMed=30979003).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z41 ! MT-CHC01
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MT-P
AC   CVCL_M804
DR   Wikidata; Q54906956
RX   PubMed=2558251;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 8
//
ID   MT-PR
AC   CVCL_M805
DR   RCB; RCB2723
DR   Wikidata; Q54906957
RX   PubMed=17267196;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M804 ! MT-P
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   MT-R8
AC   CVCL_1Q72
DR   RCB; RCB2720
DR   Wikidata; Q54906958
RX   PubMed=8893224;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5337 ! MT-8
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   MT-R9
AC   CVCL_1Q73
DR   RCB; RCB2721
DR   Wikidata; Q54906959
RX   PubMed=8893224;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60442; Rat malignant fibrous histiocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5338 ! MT-9
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   MT-W9/PL
AC   CVCL_L171
SY   MTW9/PL
DR   Wikidata; Q54906963
RX   PubMed=639042;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L170 ! MT-W9A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   MT-W9/PL2
AC   CVCL_L172
SY   MTW9/PL2
DR   KCLB; 60003
DR   Wikidata; Q54906964
RX   PubMed=3338970;
RX   PubMed=11039493;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L171 ! MT-W9/PL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   MT-W9A
AC   CVCL_L170
SY   MTW9A
DR   ATCC; CRL-6597
DR   Wikidata; Q54906960
RX   PubMed=639042;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: ATCC; CRL-6597; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_Y665 ! MT-W9B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 14
//
ID   MT-W9B
AC   CVCL_Y665
DR   Wikidata; Q54906961
RX   PubMed=2096989;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_L170 ! MT-W9A
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   MT1
AC   CVCL_E8BN
DR   GEO; GSM260649
DR   GEO; GSM260650
DR   GEO; GSM260651
DR   GEO; GSM260652
RX   PubMed=3745200;
RX   PubMed=8341649;
RX   PubMed=18805990;
CC   Population: Caucasian.
CC   Characteristics: Able to survive the cytotoxic effects of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Sensitive to mutagenesis by MNNG and display a mutator phenotype (PubMed=3745200).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (PubMed=33198927).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (PubMed=33198927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0561 ! TK6
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MT1.K
AC   CVCL_5844
SY   MT1K
DR   CLO; CLO_0007887
DR   ATCC; CRL-6309
DR   Wikidata; Q54906965
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6309; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=36231; ! Miopithecus talapoin (Angolan talapoin)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Mt1-1
AC   CVCL_A4RQ
DR   SKIP; SKIP002987
DR   Wikidata; Q105510172
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RI ! Mt1-fibro
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt1-2
AC   CVCL_A4RR
DR   SKIP; SKIP002988
DR   Wikidata; Q105510175
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RI ! Mt1-fibro
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt1-3
AC   CVCL_A4RS
DR   SKIP; SKIP002989
DR   Wikidata; Q105510179
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=Increased level of mutation compared to the parent skin fibroblast (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RI ! Mt1-fibro
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Mt1-4
AC   CVCL_A4RT
DR   SKIP; SKIP003000
DR   Wikidata; Q105510182
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=Increased level of mutation compared to the parent skin fibroblast (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RI ! Mt1-fibro
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Mt1-fibro
AC   CVCL_A4RI
DR   Wikidata; Q105510185
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Mt1/Mt2 DKO SV40
AC   CVCL_6E52
SY   SV40-transformed MT-/-
DR   Wikidata; Q54906966
RX   PubMed=10201648;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97171; Mt1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97172; Mt2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pcc5).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   MT14B
AC   CVCL_E783
DR   dbMHC; 48978
DR   ECACC; 88052098
DR   IHW; IHW09098
DR   IPD-IMGT/HLA; 11642
DR   Wikidata; Q54906967
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*31:01:02:01; B*40:01:02:01; C*03:04:01:01; DPB1*04:02:01; DQA1*03; DQB1*03:02:01; DRB1*04:04:01; DRB4*01:01 (IPD-IMGT/HLA=11642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   MT179
AC   CVCL_C5W9
DR   Wikidata; Q116049802
RX   Patent=US4863854;
RX   Patent=WO1996040295A1;
RX   PubMed=3677104;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Mt2-1
AC   CVCL_A4RU
DR   SKIP; SKIP003003
DR   Wikidata; Q105510188
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt2-10
AC   CVCL_A4SD
DR   SKIP; SKIP003010
DR   Wikidata; Q105510192
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=Increased level of mutation compared to the parent skin fibroblast (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Mt2-2
AC   CVCL_A4RV
DR   SKIP; SKIP003004
DR   Wikidata; Q105510194
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt2-3
AC   CVCL_A4RW
DR   SKIP; SKIP003001
DR   Wikidata; Q105510196
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt2-4
AC   CVCL_A4RX
DR   SKIP; SKIP003005
DR   Wikidata; Q105510199
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt2-5
AC   CVCL_A4RY
DR   SKIP; SKIP003006
DR   Wikidata; Q105510202
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Mt2-6
AC   CVCL_A4RZ
DR   SKIP; SKIP003002
DR   Wikidata; Q105510204
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=Increased level of mutation compared to the parent skin fibroblast (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Mt2-7
AC   CVCL_A4SA
DR   SKIP; SKIP003007
DR   Wikidata; Q105510208
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt2-8
AC   CVCL_A4SB
DR   SKIP; SKIP003008
DR   Wikidata; Q105510210
RX   PubMed=22396012;
CC   Characteristics: The MT-TL1 m.3243A>G mutation of the donor is undetectable in this cell line (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Mt2-9
AC   CVCL_A4SC
DR   SKIP; SKIP003009
DR   Wikidata; Q105510213
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic; Note=Increased level of mutation compared to the parent skin fibroblast (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4RJ ! Mt2-fibro
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Mt2-fibro
AC   CVCL_A4RJ
DR   Wikidata; Q105510215
RX   PubMed=22396012;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic (PubMed=22396012).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131859; Mitochondrial diabetes
DI   ORDO; Orphanet_225; Maternally-inherited diabetes and deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MT3
AC   CVCL_M516
DR   CLO; CLO_0007889
DR   CLDB; cl3598
DR   cancercelllines; CVCL_M516
DR   Wikidata; Q54906968
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3114153;
RX   PubMed=10936422;
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: ~40-50 hours (PubMed=3114153).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   MT334
AC   CVCL_C5W2
DR   Wikidata; Q116049803
RX   Patent=WO1996040295A1;
RX   PubMed=3932516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8876.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9751.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MT3/B4
AC   CVCL_L534
DR   ECACC; 92030607
DR   Wikidata; Q54906975
RX   PubMed=6512507;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01563; Human IFNA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   MT4/E4
AC   CVCL_L535
DR   ECACC; 92030608
DR   Wikidata; Q54906976
RX   PubMed=6512507;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01562; Human IFNA1.
CC   Monoclonal antibody target: UniProtKB; P01563; Human IFNA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   MT4/HIV-1
AC   CVCL_RW54
DR   Wikidata; Q54906977
RX   PubMed=1364232;
CC   Population: Japanese.
CC   Virology: Persistently infected with HIV-1.
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2632 ! MT-4
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   MT4C5
AC   CVCL_RW55
DR   Wikidata; Q54906978
RX   PubMed=21379343;
CC   Population: Japanese.
CC   Virology: Can be infected by both CXCR4-tropic and CCR5-tropic HIV-1 strains.
CC   Virology: HTLV-1 producing cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2632 ! MT-4
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   MT58
AC   CVCL_0442
SY   MT-58; CHO-MT58; CHO MT58; Mutant 58; Strain 58; CHO strain 58; CHO-58
DR   MCCL; MCC:0000338
DR   TOKU-E; 4018
DR   Wikidata; Q54906979
RX   PubMed=6254065;
RX   PubMed=6265447;
RX   PubMed=8185307;
RX   PubMed=26083347;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-189.html
CC   Characteristics: Displays a thermo-sensitive phenotype. At a permissive temperature (33 Celsius), the cells grow at a rate of about 80% of the parental line while maintaining 80-90% phosphatidylcholine levels. At a non-permissive temperature (40 Celsius), the endogenous Pcyt1a/CCT activity decreases dramatically, blocking membrane synthesis and ultimately leading to apoptosis.
CC   Sequence variation: Mutation; UniProtKB; P49584; Pcyt1a; Simple; p.Arg140His (c.419G>A); Zygosity=Unspecified (PubMed=8185307).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   MTA
AC   CVCL_3032
DR   BioSample; SAMN03472801
DR   cancercelllines; CVCL_3032
DR   Cell_Model_Passport; SIDM01868
DR   DepMap; ACH-001132
DR   JCRB; IFO50513
DR   Wikidata; Q54906980
RX   PubMed=10222657;
RX   PubMed=16827800;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~1.5 days (Note=Lot 03262004), ~69 hours (Note=Lot 02122015) (JCRB=IFO50513).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Unspecified (DepMap=ACH-001132).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=IFO50513
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   MTA-13
AC   CVCL_B7N4
DR   Wikidata; Q112930130
RX   PubMed=12663051;
CC   Selected for resistance to: ChEBI; CHEBI_63616; Pemetrexed (Alimta; LY231514).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MTC
AC   CVCL_E7H6
RX   PubMed=6950180;
RX   PubMed=8521618;
RX   PubMed=21104427;
CC   Characteristics: Established from a rat implanted with the DMBA-induced rat mammary adenocarcinoma 13762NF (PubMed=6950180).
CC   Doubling time: 13.5 hours (PubMed=6950180).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8133 ! MTLn2
OI   CVCL_8136 ! MTLn3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MTC-1
AC   CVCL_B366
DR   BTO; BTO_0005138
DR   Wikidata; Q54906981
RX   PubMed=2242756;
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 8
//
ID   MTC-22
AC   CVCL_E2T3
RX   PubMed=38573494;
CC   Population: Japanese.
CC   Doubling time: 18.3 +- 3.5 hours (PubMed=38573494).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gln1346Ter (c.4036C>T); Zygosity=Homozygous (PubMed=38573494).
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Glu1051Lys (c.3151G>A); Zygosity=Homozygous (PubMed=38573494).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=38573494
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 17
ST   D21S11: 29,33.2
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 14,18
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   MTC-F
AC   CVCL_8895
SY   MTC F
DR   Wikidata; Q54906982
RX   PubMed=1972348;
RX   PubMed=22538498;
CC   Population: Caucasian.
CC   Miscellaneous: Cell line has been lost (PubMed=1972348).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   MTC-M
AC   CVCL_3548
SY   Medullary Thyroid Carcinoma-Mouse
DR   CLO; CLO_0007897
DR   ATCC; CRL-1806
DR   BCRC; 60413
DR   Wikidata; Q54906983
RX   PubMed=2875121;
CC   Doubling time: ~4 days (PubMed=2875121); 96 hours (ATCC=CRL-1806).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24170; Mouse medullary thyroid carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MTC-SK
AC   CVCL_8896
SY   MTC SK
DR   CLO; CLO_0007896
DR   CLDB; cl3602
DR   ECACC; 92013101
DR   Wikidata; Q54906984
RX   CelloPub=CLPUB00412;
RX   PubMed=1972348;
RX   PubMed=12089864;
RX   PubMed=15126569;
RX   PubMed=17786610;
RX   PubMed=22538498;
CC   Population: Caucasian.
CC   Doubling time: 2.4 days (PubMed=1972348).
CC   Discontinued: ECACC; 92013101; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8895 ! MTC-F
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   MTCQ1
AC   CVCL_A9X0
SY   Mouse Tongue Carcinoma, 4NQO induced 1
DR   ABM; T8044
DR   BCRC; 60620
DR   Wikidata; Q102114557
RX   PubMed=31345390;
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Val214Leu (c.640G>T); Zygosity=Unspecified (PubMed=31345390).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Ile329_Asp390delins13; Zygosity=Unspecified (PubMed=31345390).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   MTCQ1-GFP
AC   CVCL_A9X2
DR   Wikidata; Q102114559
RX   PubMed=31345390;
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Val214Leu (c.640G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Ile329_Asp390delins13; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9X0 ! MTCQ1
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   MTCQ2
AC   CVCL_A9X1
SY   Mouse Tongue Carcinoma, 4NQO induced 2
DR   ABM; T8045
DR   BCRC; 60621
DR   Wikidata; Q102114561
RX   PubMed=31345390;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   MTD
AC   CVCL_6F15
SY   MT(D)
DR   Wikidata; Q54906985
RX   PubMed=19140346;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_6F14 ! MT [Muntjac]
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MTD-1
AC   CVCL_EG10
SY   MTD
DR   Wikidata; Q54906986
RX   DOI=10.1111/j.1440-169X.1984.00223.x;
RX   PubMed=3320048;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: SHN.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   mTD-1
AC   CVCL_C6GA
SY   mouse Temporomandibular Disk clone 1
DR   Wikidata; Q116049804
RX   PubMed=25887369;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Disk of temporomandibular joint; UBERON=UBERON_0011319.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 6
//
ID   mTD-11
AC   CVCL_C6GD
SY   mouse Temporomandibular Disk clone 11
DR   Wikidata; Q116049805
RX   PubMed=25887369;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Disk of temporomandibular joint; UBERON=UBERON_0011319.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 6
//
ID   MTD-1A
AC   CVCL_EG11
DR   EFO; EFO_0022799
DR   Wikidata; Q54906987
RX   PubMed=3320048;
RX   PubMed=7738090;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-577.html
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: SHN.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_EG10 ! MTD-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   mTD-2
AC   CVCL_C6GB
SY   mouse Temporomandibular Disk clone 2
DR   Wikidata; Q116049806
RX   PubMed=25887369;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Disk of temporomandibular joint; UBERON=UBERON_0011319.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 6
//
ID   mTD-6
AC   CVCL_C6GC
SY   mouse Temporomandibular Disk clone 6
DR   Wikidata; Q116049807
RX   PubMed=25887369;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Disk of temporomandibular joint; UBERON=UBERON_0011319.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12W
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 6
//
ID   MTE1
AC   CVCL_JZ57
SY   MTE-1; Mouse Thymic Epithelium 1
DR   Wikidata; Q54906989
RX   PubMed=2617577;
RX   PubMed=8934567;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   MTE1D
AC   CVCL_JZ58
SY   Mouse Thymic Epithelium 1D
DR   Wikidata; Q54906991
RX   PubMed=8934567;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JZ57 ! MTE1
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   MTE1P
AC   CVCL_JZ59
SY   Mouse Thymic Epithelium 1P
DR   Wikidata; Q54906992
RX   PubMed=8934567;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JZ57 ! MTE1
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   MTE2
AC   CVCL_JZ60
SY   MTE-2; Mouse Thymic Epithelium 2
DR   Wikidata; Q54906993
RX   PubMed=2617577;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   MTE3-19
AC   CVCL_JZ61
SY   MTE 3.19.11; Mouse Thymic Epithelium 3-19
DR   Wikidata; Q54906994
RX   PubMed=2150594;
RX   PubMed=7697739;
RX   PubMed=8934567;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: CBA-BR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   MTE4-14
AC   CVCL_JZ62
SY   MTE 4.14.21; Mouse Thymic Epithelium 4-14
DR   Wikidata; Q54906995
RX   PubMed=7697739;
RX   PubMed=8934567;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: C3H/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   MTEC1
AC   CVCL_0443
SY   Murine Thymic Epithelial Cell line 1
DR   MCCL; MCC:0000339
DR   Wikidata; Q54906996
RX   DOI=10.1038/cr.1992.17;
RX   PubMed=1581557;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MTEC1
CC   Doubling time: 17.1 hours (PubMed=1581557).
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   mTEC1
AC   CVCL_IN77
DR   Wikidata; Q54906997
RX   PubMed=11121394;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   mTEC1-CF
AC   CVCL_IN78
DR   Wikidata; Q54906998
RX   PubMed=11121394;
RX   PubMed=15463957;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.
CC   Sequence variation: Mutation; MGI; MGI:88388; Cftr; Simple; p.Ser489Ter (c.1466C>A); Zygosity=Homozygous (PubMed=11121394).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   mTES101-RP(N6002)
AC   CVCL_A8EE
SY   6002
DR   RCB; RCB4098
DR   Wikidata; Q107116421
RX   PubMed=18620756;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTES101-RP(N6035)
AC   CVCL_A8EF
SY   6035
DR   RCB; RCB4101
DR   Wikidata; Q107116422
RX   PubMed=18620756;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MTh
AC   CVCL_9W67
DR   Wikidata; Q54906999
RX   PubMed=11933048;
RX   PubMed=16646156;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Embryonic spinal cord; UBERON=UBERON_0006241.
CC   Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
DI   NCIt; C125660; Mouse trisomy 16
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-14D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   MTH-R
AC   CVCL_A3AX
DR   CCLV; CCLV-RIE 0281
DR   Wikidata; Q105510218
RX   PubMed=19941903;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   MTH52c
AC   CVCL_RW43
SY   MTH52C
DR   Wikidata; Q54907000
RX   PubMed=26774145;
RX   PubMed=28591165;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MTH53a
AC   CVCL_RW44
SY   MTH53A
DR   Wikidata; Q54907001
RX   PubMed=26774145;
RX   PubMed=28591165;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MTHC-1
AC   CVCL_8733
DR   CLO; CLO_0050827
DR   RCB; RCB0738
DR   Wikidata; Q54907003
RX   PubMed=1644664;
CC   Breed/subspecies: Buffalo/Mna; RS=RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   MTHC-2
AC   CVCL_8734
DR   CLO; CLO_0050161
DR   RCB; RCB0739
DR   Wikidata; Q54907004
RX   PubMed=1644664;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MTHC-3
AC   CVCL_8735
DR   CLO; CLO_0050162
DR   RCB; RCB0740
DR   Wikidata; Q54907005
RX   PubMed=1644664;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   MTKP 97-12
AC   CVCL_6504
SY   TKMp97-12
DR   CLO; CLO_0007898
DR   ATCC; CRL-8985
DR   CCRID; 4201PAT-CCTCC00012
DR   Wikidata; Q54907007
RX   Patent=US5141742;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8985.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7037; MELTF.
CC   Discontinued: ATCC; CRL-8985; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   MTLn2
AC   CVCL_8133
DR   Wikidata; Q54907008
RX   PubMed=6950180;
RX   PubMed=9397155;
RX   PubMed=21104427;
CC   Characteristics: Low metastatic potential. Established from a lung metastasis in a rat implanted with the DMBA-induced rat mammary adenocarcinoma 13762NF (PubMed=6950180).
CC   Doubling time: 13.5 hours (PubMed=6950180).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E7H6 ! MTC
OI   CVCL_8136 ! MTLn3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   MTLn2-Tf10
AC   CVCL_8134
DR   Wikidata; Q54907009
RX   PubMed=9397155;
CC   Characteristics: Tumorigenic. Obtained after 10 cycles of selection on a media containing transferrin (PubMed=9397155).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8133 ! MTLn2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   MTLn2-Tf20
AC   CVCL_8135
DR   Wikidata; Q54907010
RX   PubMed=9397155;
CC   Characteristics: Tumorigenic. Obtained after 20 cycles of selection on a media containing transferrin (PubMed=9397155).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8133 ! MTLn2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   MTLn3
AC   CVCL_8136
DR   EFO; EFO_0022807
DR   Lonza; 1113
DR   Wikidata; Q54907011
RX   PubMed=6950180;
RX   PubMed=8521618;
RX   PubMed=21104427;
RX   PubMed=21414324;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-603.html
CC   Characteristics: High metastatic potential. Established from a lung metastasis in a rat implanted with the DMBA-induced rat mammary adenocarcinoma 13762NF (PubMed=6950180).
CC   Doubling time: 13.5 hours (PubMed=6950180).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E7H6 ! MTC
OI   CVCL_8133 ! MTLn2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   MTLn3 E11
AC   CVCL_E7H7
SY   E11
RX   PubMed=11071913;
WW   Info; CIL; 35166; https://www.cellimagelibrary.org/images/35166
CC   Characteristics: Transfected with a rat Egfr-GFP fusion construct (PubMed=11071913).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2543; Egfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8136 ! MTLn3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MTO-94
AC   CVCL_W534
DR   Wikidata; Q54907012
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9284971;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   mTOP2beta-4
AC   CVCL_D632
DR   BTO; BTO_0005309
DR   Wikidata; Q54907013
RX   PubMed=10570059;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   mtop2beta-5
AC   CVCL_D633
DR   BTO; BTO_0005310
DR   Wikidata; Q54907014
RX   PubMed=10570059;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:98791; Top2b.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   mtop2beta-6
AC   CVCL_D634
DR   Wikidata; Q54907015
RX   PubMed=10570059;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:98791; Top2b.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   MTP-GFP
AC   CVCL_3406
SY   GFPneu
DR   CLDB; cl7180
DR   ICLC; ATL07002
DR   Wikidata; Q54907016
RX   PubMed=17109643;
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Breed/subspecies: CD-1 transgenic MMTV-neu x CMV-GFP.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   MTS-RC
AC   CVCL_X540
DR   Cosmic; 849374
DR   Wikidata; Q54907017
RX   PubMed=11146448;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   MTSV1-7
AC   CVCL_8645
SY   MTSV-1.7; MTSV 1.7
DR   Wikidata; Q54907018
RX   CelloPub=CLPUB00571;
RX   PubMed=1708884;
RX   PubMed=8099725;
RX   PubMed=8887648;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-107.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   MTSV1-7 ce1
AC   CVCL_3033
SY   MTSV1-7 CE1; 1-7 CE1; ce1; ce-1
DR   CancerTools; 151503
DR   ECACC; 10081202
DR   Wikidata; Q54907025
DR   Ximbio; 151503
RX   PubMed=8099725;
RX   PubMed=8887648;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 10081202; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
ST   Source(s): ECACC=10081202
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,13
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8645 ! MTSV1-7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   MTSV1-7 HB2
AC   CVCL_2261
SY   MTSV1-7HB2; 1-7HB2; 1-7 HB2; HB2
DR   CancerTools; 151445
DR   ECACC; 10081201
DR   Wikidata; Q54399840
DR   Ximbio; 151445
RX   CelloPub=CLPUB00571;
RX   PubMed=7759542;
RX   PubMed=8887648;
RX   PubMed=9443900;
RX   PubMed=23982912;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 10081201; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
ST   Source(s): ECACC=10081201
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,13
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8645 ! MTSV1-7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   MTSV1-7 HB2-Erb-B2
AC   CVCL_A8R8
SY   HB2-Erb-B2
DR   Wikidata; Q102114562
RX   PubMed=8887648;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2261 ! MTSV1-7 HB2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   MTSV1-7 HB2-neo
AC   CVCL_A8S0
SY   HB2-neo; HB2 neo
DR   Wikidata; Q102114564
RX   CelloPub=CLPUB00571;
RX   PubMed=8887648;
RX   PubMed=9443900;
CC   Characteristics: Control cell line for MTSV1-7 HB2-Erb-B2 (Cellosaurus=CVCL_A8R8) and MTSV1-7 HB2-Ras (Cellosaurus=CVCL_A8R9) (PubMed=8887648).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2261 ! MTSV1-7 HB2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   MTSV1-7 HB2-Ras
AC   CVCL_A8R9
SY   HB2-Ras; HB2-ras; HB2 Ras
DR   Wikidata; Q102114565
RX   CelloPub=CLPUB00571;
RX   PubMed=8887648;
RX   PubMed=9443900;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2261 ! MTSV1-7 HB2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   MTSV1-7 neo
AC   CVCL_A8R7
SY   MTSV1-7neo
DR   Wikidata; Q102114566
RX   PubMed=8099725;
CC   Characteristics: Control cell line for MTSV1-7 ce1 (Cellosaurus=CVCL_3033).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Luminal epithelial cell; CL=CL_0002326.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8645 ! MTSV1-7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   MTT-95
AC   CVCL_B432
DR   Cosmic; 1012101
DR   Cosmic; 2306223
DR   Wikidata; Q54907026
RX   PubMed=10358725;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   MtT/E
AC   CVCL_H712
DR   CLO; CLO_0050941
DR   RCB; RCB1278
DR   Wikidata; Q54907027
RX   PubMed=2184014;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IV56 ! F4C1
OI   CVCL_H713 ! MtT/S
OI   CVCL_H714 ! MtT/Se
OI   CVCL_H715 ! MtT/SM
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   MtT/E-2
AC   CVCL_U371
DR   Wikidata; Q54907029
RX   PubMed=10503991;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_H712 ! MtT/E
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   MtT/S
AC   CVCL_H713
DR   CLO; CLO_0050943
DR   RCB; RCB0528
DR   Wikidata; Q54907030
RX   PubMed=2184014;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IV56 ! F4C1
OI   CVCL_H712 ! MtT/E
OI   CVCL_H714 ! MtT/Se
OI   CVCL_H715 ! MtT/SM
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   MtT/Se
AC   CVCL_H714
DR   CLO; CLO_0050944
DR   RCB; RCB0529
DR   Wikidata; Q54907031
RX   PubMed=2184014;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IV56 ! F4C1
OI   CVCL_H712 ! MtT/E
OI   CVCL_H713 ! MtT/S
OI   CVCL_H715 ! MtT/SM
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   MtT/SM
AC   CVCL_H715
DR   CLO; CLO_0050942
DR   RCB; RCB0530
DR   Wikidata; Q54907032
RX   PubMed=2184014;
RX   PubMed=15541569;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IV56 ! F4C1
OI   CVCL_H712 ! MtT/E
OI   CVCL_H713 ! MtT/S
OI   CVCL_H714 ! MtT/Se
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   MTV-L/BALB
AC   CVCL_M057
DR   Wikidata; Q54907033
RX   PubMed=192465;
CC   Doubling time: 20 hours (PubMed=192465).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 8
//
ID   MTV-L/BALB Cl2
AC   CVCL_M058
SY   MTV-L/CL2
DR   KCLB; 60056
DR   Wikidata; Q54907034
RX   PubMed=192465;
CC   Doubling time: 17 hours (PubMed=192465).
CC   Discontinued: KCLB; 60056; probable.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M057 ! MTV-L/BALB
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 9
//
ID   MTV-L/BALB Cl5
AC   CVCL_F0S3
SY   MTV-L/CL5
RX   PubMed=192465;
CC   Doubling time: 17 hours (PubMed=192465).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M057 ! MTV-L/BALB
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   MTV/TM-011
AC   CVCL_M059
DR   KCLB; 60057
DR   Wikidata; Q54907035
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M058 ! MTV-L/BALB Cl2
CA   Hybrid cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 4
//
ID   MTX-HKBML
AC   CVCL_B3QK
DR   Wikidata; Q110433073
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8161 ! HKBML
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   MTX-RAJI
AC   CVCL_B3QL
DR   cancercelllines; CVCL_B3QL
DR   Wikidata; Q110433074
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   MTX-TK
AC   CVCL_B3QM
DR   Wikidata; Q110433075
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E941 ! TK [Human brain lymphoma]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   mTX1
AC   CVCL_A8DY
DR   TKG; TKG 0751
DR   Wikidata; Q107116424
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX10
AC   CVCL_A8EK
DR   TKG; TKG 0758
DR   Wikidata; Q107116426
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX11
AC   CVCL_A8ET
DR   TKG; TKG 0777
DR   Wikidata; Q107116428
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX12
AC   CVCL_A8EL
DR   TKG; TKG 0759
DR   Wikidata; Q107116430
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX3
AC   CVCL_A8DZ
DR   TKG; TKG 0752
DR   Wikidata; Q107116433
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX4
AC   CVCL_A8EA
DR   TKG; TKG 0753
DR   Wikidata; Q107116434
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX5.2
AC   CVCL_A8EB
DR   Wikidata; Q107116436
RX   PubMed=27005865;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX6
AC   CVCL_A8EC
DR   TKG; TKG 0754
DR   Wikidata; Q107116438
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX7
AC   CVCL_A8EH
DR   TKG; TKG 0755
DR   Wikidata; Q107116440
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX8
AC   CVCL_A8EI
DR   TKG; TKG 0756
DR   Wikidata; Q107116443
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   mTX9
AC   CVCL_A8EJ
DR   TKG; TKG 0757
DR   Wikidata; Q107116444
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Mu Islet (E6/E7)
AC   CVCL_B062
DR   ATCC; CRL-2999
DR   Wikidata; Q54907036
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic alpha cell; CL=CL_0002351.
CC   Breed/subspecies: C57BLKS/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8-12W
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   Mu-9
AC   CVCL_YU27
DR   Wikidata; Q95991455
RX   PubMed=2169346;
RX   PubMed=10571262;
RX   PubMed=15870874;
CC   Characteristics: The produced mAB reacts strongly with >60% of colon carcinomas.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   Mu-mpl 32D
AC   CVCL_C7PN
DR   Wikidata; Q117704718
RX   PubMed=8541543;
CC   Characteristics: IL3 dependent.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97076; Mpl.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6G54 ! 32Dcl23
SX   Male
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   MU-PH1
AC   CVCL_VF65
DR   ABM; T0373
DR   Wikidata; Q54907037
RX   Patent=WO2014096479A1;
RX   PubMed=23375594;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3187.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 8
//
ID   mU1
AC   CVCL_9T81
SY   mouse Uterus 1
DR   Wikidata; Q54907038
RX   PubMed=11850199;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Breed/subspecies: C57BL/6 x C3H/He Hoxa11-SV40Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   MU1
AC   CVCL_N681
DR   ATCC; CRL-6477
DR   Wikidata; Q54907040
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6477; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MU10
AC   CVCL_N677
DR   ATCC; CRL-6481
DR   Wikidata; Q54907041
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6481; true.
DI   NCIt; C134943; Budgerigar fibrosarcoma
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   MU11
AC   CVCL_N676
DR   ATCC; CRL-6482
DR   Wikidata; Q54907042
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6482; true.
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   MU12.T
AC   CVCL_N675
DR   ATCC; CRL-6483
DR   Wikidata; Q54907043
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6483; true.
DI   NCIt; C134943; Budgerigar fibrosarcoma
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   MU13.T
AC   CVCL_N674
SY   MU13T
DR   ATCC; CRL-6484
DR   Wikidata; Q54907044
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6484; true.
DI   NCIt; C135003; Budgerigar testicular carcinoma
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   MU14.K
AC   CVCL_5434
SY   MU14K
DR   CLO; CLO_0007899
DR   ATCC; CRL-6485
DR   Wikidata; Q54907045
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6485; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Sex unspecified
AG   Adult
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MU2
AC   CVCL_YL63
DR   Wikidata; Q95991459
RX   PubMed=16034303;
CC   Doubling time: 20 hours (PubMed=16034303).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   MU26
AC   CVCL_N672
DR   ATCC; CRL-6486
DR   Wikidata; Q54907046
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6486; true.
DI   NCIt; C134943; Budgerigar fibrosarcoma
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   MU27
AC   CVCL_N673
DR   ATCC; CRL-6487
DR   Wikidata; Q54907048
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6487; true.
DI   NCIt; C134943; Budgerigar fibrosarcoma
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   MU2F
AC   CVCL_YL05
DR   Wikidata; Q95991460
RX   PubMed=16034303;
CC   Characteristics: Established from a xenograft produced by implantation of parent cell line in BALB/cByJ nude mice.
CC   Doubling time: 18 hours (PubMed=16034303).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YL63 ! MU2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   MU3
AC   CVCL_N680
DR   ATCC; CRL-6478
DR   Wikidata; Q54907049
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6478; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MU7
AC   CVCL_YL64
DR   Wikidata; Q95991463
RX   PubMed=16034303;
CC   Population: African.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   MU78
AC   CVCL_C5W3
DR   Wikidata; Q116049808
RX   Patent=US4863854;
RX   Patent=WO1996040295A1;
RX   PubMed=3932516;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8877.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9752.
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MU8 [Human uveal melanoma]
AC   CVCL_YL65
DR   Wikidata; Q95991464
RX   PubMed=16034303;
CC   Doubling time: 20 days (PubMed=16034303).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   MU8 [Melopsittacus]
AC   CVCL_N679
DR   ATCC; CRL-6479
DR   Wikidata; Q54907050
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6479; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C135003; Budgerigar testicular carcinoma
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MU9
AC   CVCL_N678
DR   ATCC; CRL-6480
DR   Wikidata; Q54907051
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6480; true.
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
OI   CVCL_N682 ! MU9.Sp
SX   Female
AG   Adult
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   MU9.Sp
AC   CVCL_N682
DR   ATCC; CRL-6592
DR   Wikidata; Q54907052
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6592; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=13146; ! Melopsittacus undulatus (Budgerigar)
OI   CVCL_N678 ! MU9
SX   Female
AG   Adult
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MUBi002-A
AC   CVCL_D0JM
SY   CF 001; iPSC_CF_508; MUBi006-A
DR   BioSamples; SAMEA13165194
DR   BioSamples; SAMEA113425287
DR   hPSCreg; MUBi002-A
DR   hPSCreg; MUBi006-A
DR   Wikidata; Q123033126
CC   From: Medical University of Bialystok; Bialystok; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (hPSCreg=MUBi006-A).
CC   Discontinued: hPSCreg; MUBi006-A; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MUBi005-A
AC   CVCL_E4HB
SY   iPSC_COPD
DR   BioSamples; SAMEA111417888
DR   hPSCreg; MUBi005-A
CC   From: Medical University of Bialystok; Bialystok; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3199; Chronic obstructive pulmonary disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MUC 10-22
AC   CVCL_B7QM
DR   Wikidata; Q112930131
RX   PubMed=3316507;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUC 11-22
AC   CVCL_B7QN
DR   Wikidata; Q112930132
RX   PubMed=3316507;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUC 14-22
AC   CVCL_B7QP
DR   Wikidata; Q112930134
RX   PubMed=3316507;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUC 15-22
AC   CVCL_B7QQ
DR   Wikidata; Q112930135
RX   PubMed=3316507;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUC 2-63
AC   CVCL_B7QR
DR   Wikidata; Q112930136
RX   PubMed=3316507;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUC 7-22
AC   CVCL_B7QS
DR   Wikidata; Q112930137
RX   PubMed=3316507;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUC 8-22
AC   CVCL_B7QT
DR   Wikidata; Q112930138
RX   PubMed=3316507;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUC-1
AC   CVCL_C4KG
DR   Wikidata; Q116049809
RX   PubMed=27764813;
RX   PubMed=33981288;
RX   PubMed=35563746;
CC   Characteristics: Established from a patient-derived xenograft also called MUC-1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Glufs*3 (c.1024delC); ClinVar=VCV000428885; Zygosity=Unspecified (PubMed=27764813).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Neck, hypodermis; UBERON=UBERON_0000974+UBERON_0002072.
ST   Source(s): PubMed=27764813
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 19.3,22
ST   D13S317: 9
ST   D16S539: 11,14
ST   D18S51: 14,18
ST   D19S433: 13,14
ST   D1S1656: 15
ST   D21S11: 29
ST   D2S1338: 26
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 8,10
ST   D8S1179: 8
ST   FGA: 22,23.2
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   MUCC
AC   CVCL_6C56
SY   Murine Uterine Cervix Cancer
DR   Wikidata; Q54907053
RX   PubMed=3568983;
RX   PubMed=3680100;
CC   Doubling time: 27.8 hours (PubMed=3568983).
CC   Derived from site: Metastatic; Uterus, cervix; UBERON=UBERON_0000002.
CC   Breed/subspecies: Kunming.
DI   NCIt; C24068; Mouse cervical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   MUG-CC1
AC   CVCL_AV05
SY   Medical University of Graz-Clivus Chordoma 1
DR   ATCC; CRL-3327
DR   cancercelllines; CVCL_AV05
DR   DSMZ; ACC-957
DR   GEO; GSM2495970
DR   GEO; GSM2495971
DR   GEO; GSM2495972
DR   Wikidata; Q54907054
RX   PubMed=27072875;
RX   PubMed=28515451;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/mug-cc1/
CC   Doubling time: 109.16 +- 18.79 hours (PubMed=27072875); ~12 days (ATCC=CRL-3327); ~7 days (DSMZ=ACC-957); 15 days (Chordoma Foundation).
CC   HLA typing: A*24 (Chordoma Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
ST   Source(s): DSMZ=ACC-957; PubMed=27072875
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12 (DSMZ=ACC-957)
ST   D13S317: 12,13 (PubMed=27072875)
ST   D16S539: 9,14 (PubMed=27072875)
ST   D16S539: 14 (DSMZ=ACC-957)
ST   D18S51: 12
ST   D19S433: 15
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DE11 ! MUG-CC1-LCL
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 20
//
ID   MUG-CC1-LCL
AC   CVCL_DE11
DR   Wikidata; Q54907055
RX   PubMed=27072875;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): PubMed=27072875
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 9,14
ST   D18S51: 12
ST   D21S11: 28,30
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 10,13
ST   Penta E: 10,13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AV05 ! MUG-CC1
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   MUG-CCArly
AC   CVCL_D4A5
SY   MUG CCArly
DR   DSMZ; ACC-960
DR   Wikidata; Q127382899
RX   PubMed=36980644;
CC   Population: Caucasian.
CC   Characteristics: Grows as 3D co-culture tumor model (CCTM) that requires co-culture of this cell line with the cancer-associated fibroblast cell line CCArly CAF (Cellosaurus=CVCL_D4A6) (PubMed=36980644).
CC   Doubling time: ~30-40 hours (DSMZ=ACC-960).
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): DSMZ=ACC-960
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 11,14
ST   D18S51: 16
ST   D19S433: 12
ST   D21S11: 28,29
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 12,13
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D4A6 ! CCArly CAF
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   MUG-Chor1
AC   CVCL_9277
SY   MUG-CHOR1; MUGCHOR1; Medical University of Graz-Chordoma 1
DR   ATCC; CRL-3219
DR   cancercelllines; CVCL_9277
DR   Cell_Model_Passport; SIDM01427
DR   Cosmic; 2663861
DR   DepMap; ACH-001956
DR   DSMZ; ACC-755
DR   DSMZCellDive; ACC-755
DR   GEO; GSM631722
DR   GEO; GSM631723
DR   Wikidata; Q54907056
RX   PubMed=22002331;
RX   PubMed=27102572;
RX   PubMed=28515451;
RX   PubMed=28835717;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/mug-chor1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~75-100 hours (DSMZ=ACC-755); 5 days (Chordoma Foundation).
CC   HLA typing: A*11 (Chordoma Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=CRL-3219; DSMZ=ACC-755; PubMed=22002331; PubMed=27102572; PubMed=28835717
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,14
ST   D18S51: 17,22.2 (DSMZ=ACC-755)
ST   D18S51: 17,23 (PubMed=22002331; PubMed=27102572; PubMed=28835717)
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 18,20
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,12
ST   FGA: 21,26
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 28
//
ID   MUG-Lucifer-met
AC   CVCL_D4AH
SY   MUG Lucifer met
DR   DSMZ; ACC-959
DR   Wikidata; Q127382900
RX   PubMed=36710341;
CC   Doubling time: ~20 hours (DSMZ=ACC-959).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=36710341).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-959; PubMed=36710341
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13,15
ST   D16S539: 9,14
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 13
ST   TH01: 9,9.3 (PubMed=36710341)
ST   TH01: 9.3 (DSMZ=ACC-959)
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D4AG ! MUG-Lucifer-prim
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MUG-Lucifer-prim
AC   CVCL_D4AG
SY   MUG Lucifer prim
DR   DSMZ; ACC-958
DR   Wikidata; Q127382901
RX   PubMed=36710341;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-958).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=36710341).
CC   Derived from site: In situ; Knee joint, synovium; UBERON=UBERON_0001485+UBERON_0007616.
ST   Source(s): DSMZ=ACC-958; PubMed=36710341
ST   Amelogenin: X
ST   CSF1PO: 10,11 (DSMZ=ACC-958)
ST   CSF1PO: 11 (PubMed=36710341)
ST   D13S317: 13,15
ST   D16S539: 9,14
ST   D18S51: 12,19
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 13
ST   TH01: 9,9.3 (PubMed=36710341)
ST   TH01: 9.3 (DSMZ=ACC-958)
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D4AH ! MUG-Lucifer-met
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   MUG-Mel1
AC   CVCL_VV72
SY   MUG Mel1; MUGMel1; Medical University of Graz-Melanoma 1
DR   ChEMBL-Cells; CHEMBL4630709
DR   ChEMBL-Targets; CHEMBL4630715
DR   PubChem_Cell_line; CVCL_VV72
DR   Wikidata; Q95991469
RX   PubMed=29069749;
RX   PubMed=30858407;
CC   Doubling time: 32.16 +- 4.28 hours (PubMed=30858407).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys1745Glu (c.5233A>G); Zygosity=Heterozygous (PubMed=30858407).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=30858407
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 31,31.2
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   MUG-Mel1 clone C8
AC   CVCL_VV73
SY   MUG-Mel1 C8; MUG-MEL1-C8; C8; Medical University of Graz-Melanoma 1 clone C8
DR   Wikidata; Q95991471
RX   PubMed=30858407;
CC   Doubling time: 50.62 +- 8.63 hours (PubMed=30858407).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys1745Glu (c.5233A>G); Zygosity=Heterozygous (PubMed=30858407).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=30858407
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 31,31.2
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV72 ! MUG-Mel1
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   MUG-Mel1 clone D5
AC   CVCL_VV74
SY   MUG-Mel1 D5; MUG-MEL1-D5; D5; Medical University of Graz-Melanoma 1 clone D5
DR   Wikidata; Q95991472
RX   PubMed=30858407;
CC   Doubling time: 75.18 +- 20.11 hours (PubMed=30858407).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys1745Glu (c.5233A>G); Zygosity=Heterozygous (PubMed=30858407).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=30858407
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 31,31.2
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV72 ! MUG-Mel1
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   MUG-Mel2
AC   CVCL_JQ50
SY   MUG-MEL2; MUG Mel2; MUGMel2; Medical University of Graz-Melanoma 2
DR   cancercelllines; CVCL_JQ50
DR   ChEMBL-Cells; CHEMBL4630708
DR   ChEMBL-Targets; CHEMBL4630714
DR   DSMZ; ACC-855
DR   DSMZCellDive; ACC-855
DR   PubChem_Cell_line; CVCL_JQ50
DR   Wikidata; Q54907057
RX   PubMed=28522871;
CC   Characteristics: Highly pigmented. Tumorigenic in nude mice.
CC   Doubling time: 38.19 +- 4.09 hours (PubMed=28522871); ~48 hours (DSMZ=ACC-855).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=28522871).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
ST   Source(s): DSMZ=ACC-855; PubMed=28522871
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 17 (PubMed=28522871)
ST   D2S1338: 17,20 (DSMZ=ACC-855)
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   MUG-Mel3-PF
AC   CVCL_E7EH
SY   MUG Mel3 PF; Medical University of Graz-Melanoma 3-Pigmented lymph node-part cultured in FBS
RX   PubMed=34768746;
CC   Characteristics: Pigmented (PubMed=34768746).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=34768746).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=34768746
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 13
ST   D18S51: 16,18
ST   D21S11: 30,31
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7EI ! MUG-Mel3-Ph
OI   CVCL_E7EJ ! MUG-Mel3-NPF
OI   CVCL_E7EK ! MUG-Mel3-NPh
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MUG-Mel3-Ph
AC   CVCL_E7EI
SY   MUG Mel3 Ph; Medical University of Graz-Melanoma 3-Pigmented lymph node-part cultured in hPL
RX   PubMed=34768746;
CC   Characteristics: Pigmented (PubMed=34768746).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=34768746).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=34768746
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 13
ST   D18S51: 16,18
ST   D21S11: 30,31
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7EH ! MUG-Mel3-PF
OI   CVCL_E7EJ ! MUG-Mel3-NPF
OI   CVCL_E7EK ! MUG-Mel3-NPh
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MUG-Mel3-NPF
AC   CVCL_E7EJ
SY   MUG Mel3 NPF; Medical University of Graz-Melanoma 3-Non-Pigmented lymph node-part cultured in FBS
RX   PubMed=34768746;
CC   Characteristics: Non-pigmented (PubMed=34768746).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=34768746).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=34768746
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 16,18
ST   D21S11: 30,31
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7EH ! MUG-Mel3-PF
OI   CVCL_E7EI ! MUG-Mel3-Ph
OI   CVCL_E7EK ! MUG-Mel3-NPh
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MUG-Mel3-NPh
AC   CVCL_E7EK
SY   MUG Mel3 NPh; Medical University of Graz-Melanoma 3-Non-Pigmented lymph node-part cultured in hPL
RX   PubMed=34768746;
CC   Characteristics: Non-pigmented (PubMed=34768746).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=34768746).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=34768746
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 16,18
ST   D21S11: 30,31
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7EH ! MUG-Mel3-PF
OI   CVCL_E7EI ! MUG-Mel3-Ph
OI   CVCL_E7EJ ! MUG-Mel3-NPF
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MUG-Myx1
AC   CVCL_T030
SY   Medical University of Graz-Myxofibrosarcoma 1
DR   Wikidata; Q54907058
RX   PubMed=24289252;
CC   Doubling time: 24 hours (PubMed=24289252).
ST   Source(s): PubMed=24289252
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 17,24
ST   D21S11: 26,31
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 18,20
ST   Penta D: 9,12
ST   Penta E: 12,17
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   MUG-Myx2a
AC   CVCL_VJ87
SY   Medical University of Graz-Myxofibrosarcoma 2a
DR   cancercelllines; CVCL_VJ87
DR   Cosmic; 2617731
DR   Wikidata; Q95991476
RX   PubMed=28304377;
CC   Doubling time: 20 hours (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Phe386Leu (c.1158C>G); Zygosity=Unspecified (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Unspecified (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Met541Leu (c.1621A>C); ClinVar=VCV000041599; Zygosity=Unspecified (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173His (c.518G>A); ClinVar=VCV000376032; Zygosity=Unspecified (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Unspecified (PubMed=28304377).
ST   Source(s): PubMed=28304377
ST   Amelogenin: X
ST   CSF1PO: 12,14,15
ST   D13S317: 11
ST   D16S539: 13,14,15
ST   D18S51: 14
ST   D21S11: 29
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 5,9
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ88 ! MUG-Myx2b
SX   Female
AG   94Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   MUG-Myx2b
AC   CVCL_VJ88
SY   Medical University of Graz-Myxofibrosarcoma 2b
DR   cancercelllines; CVCL_VJ88
DR   Cosmic; 2617732
DR   Wikidata; Q95991478
RX   PubMed=28304377;
CC   Doubling time: 22 hours (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Phe386Leu (c.1158C>G); Zygosity=Unspecified (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Unspecified (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Met541Leu (c.1621A>C); ClinVar=VCV000041599; Zygosity=Unspecified (PubMed=28304377).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Unspecified (PubMed=28304377).
ST   Source(s): PubMed=28304377
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 13,14
ST   D18S51: 13,14
ST   D21S11: 29
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 5,9
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ87 ! MUG-Myx2a
SX   Female
AG   94Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   MuH1
AC   CVCL_C5H4
DR   Wikidata; Q116049810
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: TK-deficient. Synthesizes but does no secretes immunoglobulin mu chain (PubMed=8959651).
CC   Doubling time: 20.89 hours (PubMed=8959651).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GX ! R27H1
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   MuH4
AC   CVCL_C5H5
DR   Wikidata; Q116049811
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: TK-deficient. Synthesizes immunoglobulin mu and L chain and secretes IgM (PubMed=8959651).
CC   Doubling time: 15.72 hours (PubMed=8959651).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H0 ! R27H4
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   MUi001-A
AC   CVCL_QX54
SY   MU001.A-hiPS
DR   BioSamples; SAMEA104132914
DR   hPSCreg; MUi001-A
DR   Wikidata; Q54907059
RX   PubMed=28213976;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   MUi002-A
AC   CVCL_QX55
SY   MU002.A-hiPS
DR   hPSCreg; MUi002-A
DR   Wikidata; Q54907060
RX   PubMed=28213976;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu27Lys (c.79G>A) (E26K); ClinVar=VCV000015161; Zygosity=Heterozygous; Note=Hb E (PubMed=28213976).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-197C>T (IVS2-654C>T); ClinVar=VCV000015458; Zygosity=Heterozygous (PubMed=28213976).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   MUi009-A
AC   CVCL_QX56
DR   hPSCreg; MUi009-A
DR   Wikidata; Q54907061
RX   PubMed=28395745;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=28395745).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395745
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 15,16
ST   D19S433: 15,16.2
ST   D21S11: 31.2,32
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 15,17
ST   FGA: 19,24
ST   TH01: 9,10.3
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C34368; Alpha thalassemia
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   MUi010-A
AC   CVCL_VE99
SY   MYH9
DR   BioSamples; SAMEA104494770
DR   hPSCreg; MUi010-A
DR   Wikidata; Q54907062
RX   PubMed=30798146;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:7579; MYH9; Simple; p.Arg702Cys (c.2104C>T); ClinVar=VCV000014078; Zygosity=Heterozygous (PubMed=30798146).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C158788; Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
DI   ORDO; Orphanet_182050; MYH9-related disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   MUi011-A
AC   CVCL_9S79
SY   MU011.A-hiPS; Hb Bart-iPS
DR   BioSamples; SAMEA104235590
DR   hPSCreg; MUi011-A
DR   Wikidata; Q54907063
RX   PubMed=26432158;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   MUi015-A
AC   CVCL_VE63
SY   RB1
DR   BioSamples; SAMEA104271470
DR   hPSCreg; MUi015-A
DR   Wikidata; Q54907064
RX   PubMed=33550139;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Karyotypic information: 46,XY,del(13)(q13;q22) (PubMed=33550139).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (PubMed=33550139).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   MUi017-A
AC   CVCL_QX57
DR   hPSCreg; MUi017-A
DR   Wikidata; Q54907065
RX   PubMed=28395746;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=Hb Constant Spring (PubMed=28395746).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395746
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 15.2
ST   D21S11: 29,32.2
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 22,23
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   MUi019-A
AC   CVCL_QX58
DR   hPSCreg; MUi019-A
DR   Wikidata; Q54907066
RX   PubMed=28395748;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28395748
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 12,17
ST   D19S433: 13.2,15.2
ST   D21S11: 29,33.2
ST   D2S1338: 18,22
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   MUi020-A
AC   CVCL_B7E5
DR   hPSCreg; MUi020-A
DR   Wikidata; Q112930139
CC   From: Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUi021-A
AC   CVCL_B7E6
DR   hPSCreg; MUi021-A
DR   Wikidata; Q112930140
CC   From: Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUi022-A
AC   CVCL_A6JC
DR   hPSCreg; MUi022-A
DR   Wikidata; Q107116445
CC   From: Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MUi023-A
AC   CVCL_A8HJ
DR   hPSCreg; MUi023-A
DR   Wikidata; Q107116446
CC   From: Mahidol University; Bangkok; Thailand.
CC   Discontinued: hPSCreg; MUi023-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   MUi024-A
AC   CVCL_A6JB
DR   hPSCreg; MUi024-A
DR   Wikidata; Q107116447
CC   From: Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MUi025-A
AC   CVCL_UK92
SY   SeV-iPSC33
DR   hPSCreg; MUi025-A
DR   Wikidata; Q95991485
CC   From: Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   MUi026-A
AC   CVCL_A6IZ
SY   MU012.C4; S1C4
DR   BioSamples; SAMEA13819041
DR   hPSCreg; MUi026-A
DR   Wikidata; Q107116448
RX   PubMed=33799277;
RX   PubMed=35629189;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Gln1960Ter (c.5878C>T); ClinVar=VCV000562298; Zygosity=Heterozygous (PubMed=33799277).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   MUi027-A
AC   CVCL_A6JA
SY   MU013.C2
DR   BioSamples; SAMEA13864634
DR   hPSCreg; MUi027-A
DR   Wikidata; Q107116450
RX   PubMed=35629189;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; c.7946_7947delCT; Zygosity=Heterozygous (PubMed=35629189).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   MUi028-A
AC   CVCL_A8DE
DR   BioSamples; SAMEA8868488
DR   hPSCreg; MUi028-A
DR   Wikidata; Q107116451
RX   PubMed=35114587;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   MUi029-A
AC   CVCL_B6PP
SY   Gaucher iPSC1
DR   hPSCreg; MUi029-A
DR   Wikidata; Q112129367
CC   From: Mahidol University; Bangkok; Thailand.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   MUi030-A
AC   CVCL_B6PQ
SY   Gaucher iPSC2; GD022
DR   BioSamples; SAMEA114192171
DR   hPSCreg; MUi030-A
DR   Wikidata; Q112129368
RX   PubMed=37890332;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=37890332).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MUi031-A
AC   CVCL_B6PN
SY   Gaucher iPSC3
DR   BioSamples; SAMEA12366396
DR   hPSCreg; MUi031-A
DR   Wikidata; Q112129369
RX   PubMed=35151019;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=35151019).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MUi032-A
AC   CVCL_B7E4
DR   BioSamples; SAMEA111372278
DR   hPSCreg; MUi032-A
DR   Wikidata; Q112930141
RX   PubMed=36395688;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg293Ter (c.877C>T); ClinVar=VCV000011154; Zygosity=Hemizygous (PubMed=36395688).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   MUi033-A
AC   CVCL_B7E7
SY   020HbE
DR   BioSamples; SAMEA114240245
DR   hPSCreg; MUi033-A
DR   Wikidata; Q112930142
RX   PubMed=37890329;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu27Lys (c.79G>A) (E26K); ClinVar=VCV000015161; Zygosity=Homozygous; Note=Hb E (PubMed=37890329).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MUi034-A
AC   CVCL_B7E8
SY   homoHbCS iPSC; MU018.C11
DR   BioSamples; SAMEA111396563
DR   hPSCreg; MUi034-A
DR   Wikidata; Q112930143
RX   PubMed=36427475;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=Hb Constant Spring (PubMed=36427475).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84767; Hydrops fetalis
DI   NCIt; C61229; Severe aplastic anemia
DI   ORDO; Orphanet_1041; Hydrops fetalis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MUi035-A
AC   CVCL_C5YN
DR   BioSamples; SAMEA110693020
DR   hPSCreg; MUi035-A
DR   Wikidata; Q116049812
CC   From: Mahidol University; Bangkok; Thailand.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 3
//
ID   MUi038-A
AC   CVCL_E4E2
SY   EYS mutation
DR   BioSamples; SAMEA115419503
DR   hPSCreg; MUi038-A
RX   PubMed=38810502;
CC   From: Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:21555; EYS; Simple; p.Cys2139Tyr (c.6416G>A); ClinVar=VCV000189230; Zygosity=Heterozygous (PubMed=38810502).
CC   Sequence variation: Mutation; HGNC; HGNC:21555; EYS; Simple; p.Ala2410Aspfs*3 (c.7228+1G>A); ClinVar=VCV000658881; Zygosity=Heterozygous (PubMed=38810502).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MUi040-A
AC   CVCL_E4E3
DR   BioSamples; SAMEA115286914
DR   hPSCreg; MUi040-A
CC   From: Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Muk-BL
AC   CVCL_W775
SY   MUK-BL; MUK; Muk
DR   Wikidata; Q54907067
RX   PubMed=2824665;
RX   PubMed=2943927;
RX   PubMed=2985508;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 12
//
ID   MUL [Human B-cell IHW]
AC   CVCL_E784
SY   TER110; TER-110; Ter 110; TER251; TER-251; Ter 251; TER350; TER-350; Ter 350; TER435; TER-435; Ter 435; Terasaki B-cell 251
DR   IPD-IMGT/HLA; 11112
DR   Wikidata; Q54907071
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/348cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,03:01; B*15:03,35:03; C*04:01,12:03; DPB1*02:01:02,04:02; DQA1*03:01,05:05; DQB1*03:01:01,03:02:01; DRB1*04:03:01,11:21; DRB3*02:02:01,02:02:01; DRB4*01:03:01:01,01:03:01:01 (IPD-IMGT/HLA=11112).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   MUL
AC   CVCL_YB66
DR   Wikidata; Q95991487
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
CC   Group: Fish cell line.
CC   From: Callinan, Richard B.; Regional Veterinary Laboratory, North Coast Agricultural Institute; Wollongbar; Australia.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=48193; ! Mugil cephalus (Flathead mullet)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   Mull
AC   CVCL_A5AI
DR   BTO; BTO_0006303
DR   Wikidata; Q107116452
RX   PubMed=30674989;
CC   Miscellaneous: Age/sex of donor, exact cancer type and sampling site from personal communication of van Baren, Nicolas.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   MultiScreen HEK293T A1 receptor
AC   CVCL_E7S6
WW   Provider; Multispan; C1427B; https://multispaninc.com/resources/a1-receptor-c1427b/
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:262; ADORA1 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   MultiScreen HEK293T mGluR2
AC   CVCL_KS48
DR   Wikidata; Q54907072
WW   Provider; Multispan; MHG1189Gi; https://multispaninc.com/resources/mglur2-receptor-mhg1189gi/
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4594; GRM2 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   MultiScreen HEK293T mGluR4
AC   CVCL_KS49
DR   Wikidata; Q54907073
WW   Provider; Multispan; C1191a; https://multispaninc.com/resources/mglu4-receptor-c1191a/
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4596; GRM4 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   MuM-2B
AC   CVCL_3447
SY   MUM-2B; MUM2B; Mum2B
DR   BTO; BTO_0005298
DR   EFO; EFO_0022429
DR   GEO; GSM1082690
DR   Wikidata; Q54907074
RX   PubMed=12067204;
RX   PubMed=15299072;
RX   PubMed=18689700;
ST   Source(s): PubMed=18689700
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8471 ! C918
OI   CVCL_8472 ! M619
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   MuM-2C
AC   CVCL_3448
SY   MUM-2C; MUM2C; Mum2C
DR   BTO; BTO_0005299
DR   cancercelllines; CVCL_3448
DR   Cosmic; 1628412
DR   Wikidata; Q54907076
RX   PubMed=12067204;
RX   PubMed=15299072;
RX   PubMed=18689700;
RX   PubMed=22236444;
RX   PubMed=28940260;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with metastatic uveal melanoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00501.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22236444).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000232). It was one of the sources for the STR profile of this entry.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): CCRID; PubMed=18689700
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   MUM-4
AC   CVCL_ZZ68
DR   Wikidata; Q102114567
RX   PubMed=7535062;
CC   Monoclonal antibody isotype: IgG2c, kappa.
CC   Monoclonal antibody target: Mouse antigen on resident peritoneal macrophages.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   MUM24
AC   CVCL_M521
DR   cancercelllines; CVCL_M521
DR   Wikidata; Q54907077
RX   PubMed=23686003;
CC   Characteristics: Produces IgG kappa.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Unspecified (PubMed=23686003).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   MuMo
AC   CVCL_E9TN
RX   DOI=10.13140/2.1.5049.4087;
CC   Virology: Susceptible to infection by West Nile virus (WNV) (DOI=10.13140/2.1.5049.4087).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Monocyte; CL=CL_0000576.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4W
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MUNIe001-A
AC   CVCL_C861
SY   CCTL 6; CCTL-6; CCTL6; Center for Cell Therapy Line 6
DR   hPSCreg; MUNIe001-A
DR   SKIP; SKIP001840
DR   Wikidata; Q54907078
CC   From: Masaryk University; Brno; Czech Republic.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   MUNIe002-A
AC   CVCL_C862
SY   CCTL 8; CCTL-8; CCTL8; Center for Cell Therapy Line 8
DR   hPSCreg; MUNIe002-A
DR   SKIP; SKIP001841
DR   Wikidata; Q54907079
CC   From: Masaryk University; Brno; Czech Republic.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   MUNIe003-A
AC   CVCL_C863
SY   CCTL 9; CCTL-9; CCTL9; Center for Cell Therapy Line 9
DR   hPSCreg; MUNIe003-A
DR   SKIP; SKIP001842
DR   Wikidata; Q54907080
RX   PubMed=15955829;
RX   PubMed=17572666;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   MUNIe004-A
AC   CVCL_C857
SY   CCTL 10; CCTL-10; CCTL10; Center for Cell Therapy Line 10
DR   hPSCreg; MUNIe004-A
DR   IGRhCellID; CCTL-10%20p33
DR   SKIP; SKIP001843
DR   Wikidata; Q54907081
RX   PubMed=15955829;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   MUNIe005-A
AC   CVCL_C858
SY   CCTL 12; CCTL-12; CCTL12; CCTL-12 p143; Center for Cell Therapy Line 12
DR   hPSCreg; MUNIe005-A
DR   IGRhCellID; CCTL-12%20p143
DR   SKIP; SKIP001844
DR   Wikidata; Q54907082
RX   PubMed=15955829;
RX   PubMed=17572666;
RX   PubMed=30650618;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   MUNIe006-A
AC   CVCL_C859
SY   CCTL 13; CCTL-13; CCTL13; Center for Cell Therapy Line 13
DR   hPSCreg; MUNIe006-A
DR   SKIP; SKIP001845
DR   Wikidata; Q54907083
CC   From: Masaryk University; Brno; Czech Republic.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   MUNIe007-A
AC   CVCL_C860
SY   CCTL 14; CCTL-14; CCTL14; Center for Cell Therapy Line 14
DR   hPSCreg; MUNIe007-A
DR   IGRhCellID; CCTL-14%20p38
DR   IGRhCellID; CCTL-14%20p49
DR   SKIP; SKIP001846
DR   Wikidata; Q54907084
RX   PubMed=15955829;
RX   PubMed=17572666;
RX   PubMed=29248004;
RX   PubMed=30650618;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 16
//
ID   MUNIe008-A
AC   CVCL_A5FQ
SY   MUES 8
DR   BioSamples; SAMEA7679544
DR   hPSCreg; MUNIe008-A
DR   Wikidata; Q107116454
RX   PubMed=34715503;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Donor information: Embryo is sibling to that giving rise to MUNIe009-A (Cellosaurus=CVCL_A5FR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   MUNIe009-A
AC   CVCL_A5FR
SY   MUES 9
DR   BioSamples; SAMEA7762073
DR   hPSCreg; MUNIe009-A
DR   Wikidata; Q107116455
RX   PubMed=34715503;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Donor information: Embryo is sibling to that giving rise to MUNIe008-A (Cellosaurus=CVCL_A5FQ).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   MUNIe010-A
AC   CVCL_D0JN
SY   MUES 10
DR   BioSamples; SAMEA112699332
DR   hPSCreg; MUNIe010-A
DR   Wikidata; Q123033128
RX   PubMed=37700192;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Doubling time: 22.0 +- 1.0 hours (PubMed=37700192).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MUNIe011-A
AC   CVCL_D0JP
SY   MUES 11
DR   BioSamples; SAMEA112699336
DR   hPSCreg; MUNIe011-A
DR   Wikidata; Q123033129
RX   PubMed=37700192;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Doubling time: 28.7 +- 2.9 hours (PubMed=37700192).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MUNIe012-A
AC   CVCL_D0JQ
SY   MUES 12
DR   BioSamples; SAMEA112699337
DR   hPSCreg; MUNIe012-A
DR   Wikidata; Q123033130
RX   PubMed=37700192;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Doubling time: 21.6 +- 0.3 hours (PubMed=37700192).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MUNIi001-A
AC   CVCL_9S28
SY   DMD02
DR   BioSamples; SAMEA5466088
DR   hPSCreg; MUNIi001-A
DR   SKIP; SKIP002569
DR   Wikidata; Q54907085
RX   PubMed=30650618;
RX   PubMed=31526943;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (PubMed=30650618; PubMed=31526943).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   MUNIi002-A
AC   CVCL_9S29
SY   MDMD02
DR   BioSamples; SAMEA6145612
DR   hPSCreg; MUNIi002-A
DR   SKIP; SKIP002575
DR   Wikidata; Q54907086
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   MUNIi003-A
AC   CVCL_9S30
SY   DMD03
DR   BioSamples; SAMEA5573703
DR   hPSCreg; MUNIi003-A
DR   SKIP; SKIP002576
DR   Wikidata; Q54907087
RX   PubMed=30650618;
RX   PubMed=31526943;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex48-50del; Zygosity=Hemizygous (PubMed=30650618; PubMed=31526943).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   MUNIi004-A
AC   CVCL_RL58
SY   DMD04
DR   hPSCreg; MUNIi004-A
DR   Wikidata; Q54907088
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; c.2623-3C>G; ClinVar=VCV000217186; Zygosity=Hemizygous (hPSCreg=MUNIi004-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   MUNIi005-A
AC   CVCL_A4PD
SY   fAD1
DR   BioSamples; SAMEA7873285
DR   hPSCreg; MUNIi005-A
DR   Wikidata; Q105510220
RX   PubMed=34088008;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Heterozygous (PubMed=34088008).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H793 ! AG06840
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   MUNIi006-A
AC   CVCL_A4PE
SY   fAD2
DR   BioSamples; SAMEA7873287
DR   hPSCreg; MUNIi006-A
DR   Wikidata; Q105510223
RX   PubMed=34088008;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Heterozygous (PubMed=34088008).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D534 ! AG06848
SX   Female
AG   55Y6M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   MUNIi007-A
AC   CVCL_A4PF
SY   ADF81; fAD3
DR   BioSamples; SAMEA7873289
DR   hPSCreg; MUNIi007-A
DR   Wikidata; Q105510228
RX   PubMed=34088008;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=34088008).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T872 ! AG09908
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   MUNIi008-A
AC   CVCL_A4PG
SY   fCTRL1; fHC1; fWT1; WTM52
DR   BioSamples; SAMEA7895281
DR   hPSCreg; MUNIi008-A
DR   Wikidata; Q105510230
RX   PubMed=34088008;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW36 ! GM23967
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   MUNIi009-A
AC   CVCL_A4PH
SY   fCTRL2; fHC2; fWT2; WTF50
DR   BioSamples; SAMEA7895427
DR   hPSCreg; MUNIi009-A
DR   Wikidata; Q105510233
RX   PubMed=34088008;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F110 ! GM23251
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   MUNIi010-A
AC   CVCL_A4PI
SY   fCTRL3; fHC3; fWT3; WTF80
DR   BioSamples; SAMEA7955504
DR   hPSCreg; MUNIi010-A
DR   Wikidata; Q105510235
RX   PubMed=34088008;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7393 ! GM03525
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   MUNIi011-A
AC   CVCL_A4PJ
SY   BAD1; sAD1
DR   BioSamples; SAMEA7955506
DR   hPSCreg; MUNIi011-A
DR   Wikidata; Q105510238
RX   PubMed=34088007;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34088007).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MUNIi012-A
AC   CVCL_A4PK
SY   BAD2; sAD2
DR   BioSamples; SAMEA7955692
DR   hPSCreg; MUNIi012-A
DR   Wikidata; Q105510240
RX   PubMed=34088007;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34088007).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MUNIi013-A
AC   CVCL_A4PL
SY   BAD4; sAD3
DR   BioSamples; SAMEA7955694
DR   hPSCreg; MUNIi013-A
DR   Wikidata; Q105510242
RX   PubMed=34088007;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34088007).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MUNIi014-A
AC   CVCL_A4PM
SY   BHC2; sCTRL1; sHC1
DR   BioSamples; SAMEA7955696
DR   hPSCreg; MUNIi014-A
DR   Wikidata; Q105510246
RX   PubMed=34088007;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34088007).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MUNIi015-A
AC   CVCL_A4PN
SY   BHC1; sCTRL2; sHC2
DR   BioSamples; SAMEA7955698
DR   hPSCreg; MUNIi015-A
DR   Wikidata; Q105510250
RX   PubMed=34088007;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34088007).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MUNIi016-A
AC   CVCL_A4PP
SY   BHC3; sCTRL3; sHC3
DR   BioSamples; SAMEA7955700
DR   hPSCreg; MUNIi016-A
DR   Wikidata; Q105510253
RX   PubMed=34088007;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34088007).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   MUNIi017-A
AC   CVCL_A4PQ
SY   BWT3
DR   BioSamples; SAMEA7955702
DR   hPSCreg; MUNIi017-A
DR   Wikidata; Q105510257
CC   From: Masaryk University; Brno; Czech Republic.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   MUNIi019-A
AC   CVCL_D0JR
SY   NBS-M; NBS
DR   BioSamples; SAMEA112863139
DR   hPSCreg; MUNIi019-A
DR   Wikidata; Q123033131
CC   From: Masaryk University; Brno; Czech Republic.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MUNIi020-A
AC   CVCL_D0JS
SY   sHC5
DR   BioSamples; SAMEA114328765
DR   hPSCreg; MUNIi020-A
DR   Wikidata; Q123033132
RX   PubMed=38100913;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   MUNIi021-A
AC   CVCL_D0JT
SY   sAD5
DR   BioSamples; SAMEA114328978
DR   hPSCreg; MUNIi021-A
DR   Wikidata; Q123033133
RX   PubMed=38100913;
CC   From: Masaryk University; Brno; Czech Republic.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=38100913).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   Muntjak-T4
AC   CVCL_A4ZW
DR   ATCC; CRL-6573
DR   Wikidata; Q107116457
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6573; true.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Male
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Muntjak(Fe)
AC   CVCL_A4ZX
DR   ATCC; CRL-6572
DR   Wikidata; Q107116458
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6572; true.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   MUPS-1
AC   CVCL_B3S8
DR   Wikidata; Q110433076
RX   PubMed=32652895;
CC   Population: African American.
CC   Doubling time: 93.14 hours (PubMed=32652895).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Right mandible, hypodermis; UBERON=UBERON_0001684+UBERON_0002072.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   Muraoka
AC   CVCL_E042
SY   MURAOKA
DR   Cosmic; 1085912
DR   Wikidata; Q54907089
RX   PubMed=1357816;
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=1357816).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 4 fusion (Ex10/Ex5) (PubMed=9738976).
CC   Anecdotal: Cell line name corresponds to the name of the patient from which it was established.
CC   Derived from site: In situ; Right temporofacial region, hypodermis; UBERON=UBERON_8480069+UBERON_0002072.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 18
//
ID   Muriungi
AC   CVCL_IU23
DR   Wikidata; Q54907091
RX   PubMed=4122458;
RX   PubMed=4142009;
RX   PubMed=4347031;
RX   PubMed=4364259;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   Murphy
AC   CVCL_3549
DR   CLO; CLO_0007900
DR   ATCC; CRL-7722
DR   Wikidata; Q54907090
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7722; true.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   Murtaugh001
AC   CVCL_ZJ36
SY   Sp1
DR   ABM; T8305
DR   GEO; GSM4067477
DR   Wikidata; Q98127371
RX   PubMed=32240660;
WW   Provider; UMN; 20160314; https://license.umn.edu/product/porcine-b-lymphoma-cell-lines
CC   Doubling time: ~16 hours (PubMed=32240660).
CC   Omics: Transcriptomics; RNAseq.
CC   Anecdotal: Named in tribute to the last author of the paper PubMed=32240660, Michael P. Murtaugh, who passed away during the time when these cell lines were established.
CC   Miscellaneous: Sex assignment derived from RNAseq analysis.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C134786; Porcine lymphoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_ZJ37 ! Murtaugh002
OI   CVCL_ZJ38 ! Murtaugh003
SX   Female
AG   6-7M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   Murtaugh002
AC   CVCL_ZJ37
SY   LN2
DR   ABM; T8306
DR   GEO; GSM4067474
DR   Wikidata; Q98127373
RX   PubMed=32240660;
WW   Provider; UMN; 20160314; https://license.umn.edu/product/porcine-b-lymphoma-cell-lines
CC   Doubling time: ~16 hours (PubMed=32240660).
CC   Omics: Transcriptomics; RNAseq.
CC   Anecdotal: Named in tribute to the last author of the paper PubMed=32240660, Michael P. Murtaugh, who passed away during the time when these cell lines were established.
CC   Miscellaneous: Sex assignment derived from RNAseq analysis.
CC   Derived from site: In situ; Subiliac lymph node; UBERON=UBERON_8480045.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C134786; Porcine lymphoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_ZJ36 ! Murtaugh001
OI   CVCL_ZJ38 ! Murtaugh003
SX   Female
AG   6-7M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   Murtaugh003
AC   CVCL_ZJ38
SY   LN1
DR   ABM; T8307
DR   GEO; GSM4067473
DR   Wikidata; Q98127375
RX   PubMed=32240660;
WW   Provider; UMN; 20160314; https://license.umn.edu/product/porcine-b-lymphoma-cell-lines
CC   Doubling time: ~16 hours (PubMed=32240660).
CC   Omics: Transcriptomics; RNAseq.
CC   Anecdotal: Named in tribute to the last author of the paper PubMed=32240660, Michael P. Murtaugh, who passed away during the time when these cell lines were established.
CC   Miscellaneous: Sex assignment derived from RNAseq analysis.
CC   Derived from site: In situ; Subiliac lymph node; UBERON=UBERON_8480045.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C134786; Porcine lymphoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_ZJ36 ! Murtaugh001
OI   CVCL_ZJ37 ! Murtaugh002
SX   Female
AG   6-7M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   MuRTE15
AC   CVCL_B6AY
DR   Wikidata; Q112129370
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE21
AC   CVCL_B6AZ
DR   Wikidata; Q112129371
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE22
AC   CVCL_B6B0
DR   Wikidata; Q112129372
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE23
AC   CVCL_B6B1
DR   Wikidata; Q112129373
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE24
AC   CVCL_B6B2
DR   Wikidata; Q112129374
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE31
AC   CVCL_B6B3
DR   Wikidata; Q112129376
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE42
AC   CVCL_B6B4
DR   Wikidata; Q112129377
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE52
AC   CVCL_B6B5
DR   Wikidata; Q112129379
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE61
AC   CVCL_B6B6
DR   Wikidata; Q112129380
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE71
AC   CVCL_B6B7
DR   Wikidata; Q112129381
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE72
AC   CVCL_B6B8
DR   Wikidata; Q112129382
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE73
AC   CVCL_B6B9
DR   Wikidata; Q112129383
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MuRTE82
AC   CVCL_B6BA
DR   Wikidata; Q112129384
RX   PubMed=30603921;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MUSCSDi001-A
AC   CVCL_VJ27
SY   iPSC-K3; iPSK3
DR   BioSamples; SAMEA7023730
DR   hPSCreg; MUSCSDi001-A
DR   Wikidata; Q94323550
RX   PubMed=20682060;
RX   PubMed=26651604;
RX   PubMed=32822967;
CC   From: Medical University of South Carolina; Charleston; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=20682060
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D21S11: 29,31.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 24,26
ST   Penta D: 9,15
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   MUSCSDi001-A-1
AC   CVCL_ZX59
SY   PCCB delta14/delta29
DR   BioSamples; SAMEA7023718
DR   hPSCreg; MUSCSDi001-A-1
DR   Wikidata; Q102114568
RX   PubMed=32822967;
CC   From: Medical University of South Carolina; Charleston; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8654; PCCB.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VJ27 ! MUSCSDi001-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   MUSCSDi001-A-2
AC   CVCL_ZX60
SY   PCCB delta19/delta481
DR   BioSamples; SAMEA7023717
DR   hPSCreg; MUSCSDi001-A-2
DR   Wikidata; Q102114569
RX   PubMed=32822967;
CC   From: Medical University of South Carolina; Charleston; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8654; PCCB.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VJ27 ! MUSCSDi001-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   MUSIe001-A
AC   CVCL_VN13
SY   SiBHF1
DR   BioSamples; SAMEA5141617
DR   hPSCreg; MUSIe001-A
DR   SKIP; SKIP005812
DR   Wikidata; Q95991520
RX   PubMed=31945613;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C103920; Hemoglobin Barts
DI   ORDO; Orphanet_163596; Hb Bart's hydrops fetalis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   MUSIe002-A
AC   CVCL_B5SG
SY   Si4 hESC
DR   hPSCreg; MUSIe002-A
DR   Wikidata; Q112129385
RX   PubMed=35033856;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   MUSIe002-A-1
AC   CVCL_B5SH
SY   Si4 YAP-KD
DR   hPSCreg; MUSIe002-A-1
DR   Wikidata; Q112129386
RX   PubMed=36528979;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SG ! MUSIe002-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   MUSIi001-A
AC   CVCL_RP59
SY   SFiPSC01
DR   BioSamples; SAMEA104627072
DR   hPSCreg; MUSIi001-A
DR   SKIP; SKIP003012
DR   Wikidata; Q54907092
RX   PubMed=29367084;
RX   PubMed=34628247;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Abdomen, skin, dermis; Note=From a cesarean section scar; UBERON=UBERON_0001416+UBERON_0002067.
ST   Source(s): PubMed=29367084
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 32.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 16
ST   FGA: 20,22
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   MUSIi001-A-1
AC   CVCL_A0ZY
SY   B2M-KO-SFiPSC5
DR   BioSamples; SAMEA9652868
DR   hPSCreg; MUSIi001-A-1
DR   Wikidata; Q108820995
RX   PubMed=34628247;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Abdomen, skin, dermis; Note=From a cesarean section scar; UBERON=UBERON_0001416+UBERON_0002067.
ST   Source(s): PubMed=34628247
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 32.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 16
ST   FGA: 20,22
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RP59 ! MUSIi001-A
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   MUSIi001-A-2
AC   CVCL_D0JX
SY   HLA-I/II-null SFiPSCs
DR   BioSamples; SAMEA112466527
DR   hPSCreg; MUSIi001-A-2
DR   Wikidata; Q123033134
RX   PubMed=37343428;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Does not express HLA-I and II molecules (PubMed=37343428).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Derived from site: In situ; Abdomen, skin, dermis; Note=From a cesarean section scar; UBERON=UBERON_0001416+UBERON_0002067.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0ZY ! MUSIi001-A-1
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   MUSIi004-A
AC   CVCL_VN11
SY   EFSCA3-01.1
DR   BioSamples; SAMEA9805187
DR   hPSCreg; MUSIi004-A
DR   Wikidata; Q95991523
RX   PubMed=29852467;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 8
//
ID   MUSIi005-A
AC   CVCL_VI92
SY   SUiPSC02
DR   BioSamples; SAMEA8072998
DR   hPSCreg; MUSIi005-A
DR   Wikidata; Q95991524
RX   PubMed=29778975;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 8
//
ID   MUSIi006-A
AC   CVCL_VN12
SY   SKiPSC02
DR   BioSamples; SAMEA8073000
DR   hPSCreg; MUSIi006-A
DR   SKIP; SKIP005548
DR   Wikidata; Q95991525
RX   PubMed=30031234;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicular keratinocyte; CL=CL_2000092.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 9
//
ID   MUSIi007-A
AC   CVCL_UL51
SY   SeV-iPSC
DR   hPSCreg; MUSIi007-A
DR   Wikidata; Q95991526
RX   PubMed=30172906;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   MUSIi008-A
AC   CVCL_UL50
SY   KLF1_2-iPSC
DR   hPSCreg; MUSIi008-A
DR   Wikidata; Q95991527
RX   PubMed=30605837;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:6345; KLF1; Simple; p.Gly176Argfs*3 (c.519_525dupCGGCGCC) (c.525_526insCGGCGCC); ClinVar=VCV000100799; Zygosity=Heterozygous (PubMed=30605837).
CC   Sequence variation: Mutation; HGNC; HGNC:6345; KLF1; Simple; p.Ala298Pro (c.892G>C); ClinVar=VCV000056891; Zygosity=Heterozygous (PubMed=30605837).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157148; Congenital dyserythropoietic anemia type IV
DI   ORDO; Orphanet_293825; Congenital dyserythropoietic anemia type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   MUSIi009-A
AC   CVCL_WU23
SY   HDF-iPSC
DR   BioSamples; SAMEA6128701
DR   hPSCreg; MUSIi009-A
DR   Wikidata; Q95991528
RX   PubMed=25207966;
RX   PubMed=31677524;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   MUSIi009-A-1
AC   CVCL_YI90
SY   p.A735V-SCN5A hiPSC_4.3
DR   hPSCreg; MUSIi009-A-1
DR   SKIP; SKIP005850
DR   Wikidata; Q95991529
RX   PubMed=31677524;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple_edited; p.Ala735Val (c.2204C>T); ClinVar=VCV000009391; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31677524).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU23 ! MUSIi009-A
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   MUSIi010-A
AC   CVCL_WU22
SY   SFAGA-02.8; iPSC AGA2-08
DR   hPSCreg; MUSIi010-A
DR   SKIP; SKIP005537
DR   Wikidata; Q95991530
RX   PubMed=31228683;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Occipital scalp; UBERON=UBERON_0000403.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   MUSIi011-A
AC   CVCL_WU64
SY   STiPSC01.1
DR   BioSamples; SAMEA8072996
DR   hPSCreg; MUSIi011-A
DR   SKIP; SKIP005546
DR   Wikidata; Q95991531
RX   PubMed=31229899;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU65 ! MUSIi011-B
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   MUSIi011-B
AC   CVCL_WU65
SY   STiPSC01.8
DR   BioSamples; SAMEA8072997
DR   hPSCreg; MUSIi011-B
DR   SKIP; SKIP005547
DR   Wikidata; Q95991533
RX   PubMed=31229899;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU64 ! MUSIi011-A
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   MUSIi012-A
AC   CVCL_YE49
SY   SiPSC3.6
DR   hPSCreg; MUSIi012-A
DR   SKIP; SKIP005838
DR   Wikidata; Q95991534
RX   PubMed=31669974;
RX   PubMed=31677525;
RX   PubMed=32018207;
RX   PubMed=32791482;
RX   PubMed=37775798;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32018207; PubMed=37775798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,16
ST   FGA: 24,25.2
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 7
//
ID   MUSIi012-A-1
AC   CVCL_YE50
SY   WWTR1/TAZ-KO; WWTR1-KO
DR   hPSCreg; MUSIi012-A-1
DR   SKIP; SKIP005571
DR   SKIP; SKIP005851
DR   Wikidata; Q95991535
RX   PubMed=31677525;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE49 ! MUSIi012-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   MUSIi012-A-2
AC   CVCL_ZE20
SY   YAP-KD; YAP-KD iPSC
DR   hPSCreg; MUSIi012-A-2
DR   SKIP; SKIP005839
DR   Wikidata; Q98127377
RX   PubMed=32018207;
RX   PubMed=37775798;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32018207; PubMed=37775798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,16
ST   FGA: 24,25.2
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE49 ! MUSIi012-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   MUSIi012-A-3
AC   CVCL_ZE73
SY   LATS1-KD; LATS1-KD iPSC; LATS1-KO
DR   hPSCreg; MUSIi012-A-3
DR   SKIP; SKIP005843
DR   Wikidata; Q98127379
RX   PubMed=32791482;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32791482
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,16
ST   FGA: 24,25.2
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE49 ! MUSIi012-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   MUSIi012-A-4
AC   CVCL_D0QT
SY   SiPSC3.6-RUNX1C-5-18; SiPSC3.6-RUNX1c
DR   BioSamples; SAMEA111324110
DR   hPSCreg; MUSIi012-A-4
DR   Wikidata; Q123033135
RX   PubMed=36753833;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Using CRISPR/Cas9 eGFP was inserted at the N-terminus of one allele of RUNX1 (PubMed=36753833).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE49 ! MUSIi012-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 4
//
ID   MUSIi012-A-5
AC   CVCL_D2XS
SY   Si3-YAP-S5A; YAP-S5A iPSC
DR   hPSCreg; MUSIi012-A-5
DR   Wikidata; Q127382902
RX   PubMed=37775798;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser61Ala, p.Ser109Ala, p.Ser127Ala, p.Ser164Ala and p.Ser381Ala = YAP-S5A).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37775798
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,16
ST   FGA: 24,25.2
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YE49 ! MUSIi012-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   MUSIi013-A
AC   CVCL_A0ZV
SY   CBNK-iPSC
DR   BioSamples; SAMEA114511201
DR   hPSCreg; MUSIi013-A
DR   Wikidata; Q108820996
RX   PubMed=34311438;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Natural killer cell; CL=CL_0000623.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 5
//
ID   MUSIi014-A
AC   CVCL_A0ZW
SY   M007-III-1
DR   hPSCreg; MUSIi014-A
DR   Wikidata; Q108820998
RX   PubMed=35193007;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:32058; ZYG11A; Simple; p.Leu475Pro (c.1424T>C); Zygosity=Heterozygous (PubMed=35193007).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_183625; Rare genetic diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   MUSIi015-A
AC   CVCL_A0ZX
SY   M007-III-7
DR   hPSCreg; MUSIi015-A
DR   Wikidata; Q108820999
RX   PubMed=35853413;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:4174; GATA6; Simple; p.Glu51Lys (c.151G>T); Zygosity=Heterozygous (PubMed=35853413).
CC   Sequence variation: Mutation; HGNC; HGNC:32058; ZYG11A; Simple; p.Leu475Pro (c.1424T>C); Zygosity=Heterozygous (PubMed=35853413).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_183625; Rare genetic diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   MUSIi016-A
AC   CVCL_B5SI
SY   TyO
DR   BioSamples; SAMEA112238718
DR   hPSCreg; MUSIi016-A
DR   Wikidata; Q112129387
RX   PubMed=36603353;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Sequence variation: Mutation; HGNC; HGNC:79; ABO; Simple; p.Thr88Profs*31 (c.261delG); ClinVar=VCV000017735; Zygosity=Homozygous; Note=Allele ABO*O.01 (PubMed=36603353).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36603353
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 18,23
ST   D3S1358: 15,16
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   MUSIi017-A
AC   CVCL_B5SJ
SY   Oneg
DR   hPSCreg; MUSIi017-A
DR   Wikidata; Q112129388
RX   PubMed=37775798;
RX   PubMed=38852425;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Donor information: Established from healthy donor with Rh negative type O blood (PubMed=38852425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38852425
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 14
ST   D19S433: 14,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   FGA: 24
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   MUSIi017-A-1
AC   CVCL_C0FF
SY   Oneg-YAP-KD
DR   hPSCreg; MUSIi017-A-1
DR   Wikidata; Q112930144
RX   PubMed=37775798;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Donor information: Established from healthy donor with Rh negative type O blood (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SJ ! MUSIi017-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   MUSIi017-A-2
AC   CVCL_C0FG
SY   Oneg-S5A
DR   hPSCreg; MUSIi017-A-2
DR   Wikidata; Q112930145
RX   PubMed=37775798;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser61Ala, p.Ser109Ala, p.Ser127Ala, p.Ser164Ala and p.Ser381Ala = YAP-S5A).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from healthy donor with Rh negative type O blood (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5SJ ! MUSIi017-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   MUSIi018-A
AC   CVCL_C0FH
SY   T-iPSC
DR   hPSCreg; MUSIi018-A
DR   Wikidata; Q112930146
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Discontinued: hPSCreg; MUSIi018-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   MUSIi019-A
AC   CVCL_C0FI
SY   SLC4A1-21-C1
DR   BioSamples; SAMEA112365036
DR   hPSCreg; MUSIi019-A
DR   Wikidata; Q112930147
RX   PubMed=36791635;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:11027; SLC4A1; Simple; p.Ala400_Ala408del (c.1199_1225del); ClinVar=VCV000017753; Zygosity=Heterozygous (PubMed=36791635).
CC   Sequence variation: Mutation; HGNC; HGNC:11027; SLC4A1; Simple; p.Thr444Asn (c.1331C>A); ClinVar=VCV001691099; Zygosity=Heterozygous (PubMed=36791635).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198574; Autosomal recessive distal renal tubular acidosis-4 with hemolytic anemia
DI   ORDO; Orphanet_93610; Distal renal tubular acidosis with anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   MUSIi020-A
AC   CVCL_C1UU
SY   T-iPSC3
DR   hPSCreg; MUSIi020-A
DR   Wikidata; Q114312329
RX   PubMed=36183677;
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
CC   Population: Southeast Asian; Thai.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   MUSIi021-A
AC   CVCL_D0JU
SY   EFSCA3-02.2
DR   hPSCreg; MUSIi021-A
DR   Wikidata; Q123033136
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MUSIi022-A
AC   CVCL_D0JV
SY   iPSC AGA1-01
DR   hPSCreg; MUSIi022-A
DR   Wikidata; Q123033137
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   MUSIi023-A
AC   CVCL_E4E4
SY   hmziPSC; Homozygous HLA iPSC
DR   hPSCreg; MUSIi023-A
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MUSIi024-A
AC   CVCL_E4E5
SY   AB-; AB neg
DR   hPSCreg; MUSIi024-A
CC   From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   MuSS
AC   CVCL_8736
SY   MUSS; Murine Sarcoma Sendai
DR   CLO; CLO_0050184
DR   CLO; CLO_0050870
DR   RCB; RCB1378
DR   RCB; RCB2642
DR   TKG; TKG 0497
DR   Wikidata; Q54907093
RX   PubMed=9591335;
CC   Breed/subspecies: A/J.
DI   NCIt; C21886; Mouse histiocytic sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   MUTJ
AC   CVCL_EI98
SY   MutJ; MUT-J; Mut-J
DR   Cosmic; 2434091
DR   Wikidata; Q54907094
RX   PubMed=25167228;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Arizona Cancer Center; Tucson; USA.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   Mutu-
AC   CVCL_ZY05
DR   JCRB; JCRB1816
DR   Wikidata; Q102114570
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1816
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 13
ST   D5S818: 12,14
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7202 ! Mutu-1
SX   Male
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   Mutu-1
AC   CVCL_7202
SY   MUTU-1; Mutu 1; Mutu1; MUTU1; MUTU-BL group I; Mutu I; Mutu-I; MutuI; MUTU-BL; MUTU BL; Mutu.BL; Mutu; Mutuku
DR   Cosmic; 931129
DR   Cosmic; 1517666
DR   Cosmic; 2804853
DR   GEO; GSM1604059
DR   GEO; GSM1604060
DR   GEO; GSM1604061
DR   JCRB; JCRB1811
DR   Lonza; 1378
DR   Wikidata; Q54907095
RX   PubMed=1356511;
RX   PubMed=2165133;
RX   PubMed=2898508;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=23152513;
RX   PubMed=25787276;
RX   PubMed=28960205;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-4.html
CC   Population: African; Kenyan.
CC   Virology: Contains a complete EBV genome (strain Mutu) which has been sequenced (PubMed=23152513; PubMed=25787276).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Thr73Asn (c.218C>A); Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1811
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 13
ST   D5S818: 12,14
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU67 ! Mutu-LCL
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mutu-3
AC   CVCL_7203
SY   Mutu 3; Mutu3; MUTU-BL group III; Mutu III; Mutu-III; Mutu III-BL; MutuIII
DR   JCRB; JCRB1814
DR   Wikidata; Q54907096
RX   PubMed=2165133;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-482.html
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: MUTU 111; Note=Occasionally.
CC   Misspelling: MUTU-111; Note=Occasionally.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1814
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 13
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7202 ! Mutu-1
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Mutu-LCL
AC   CVCL_ZU67
SY   MUTU-LCL; Mutu.LCL; Mutu LCL; MutuI-LCL
DR   Wikidata; Q98127383
RX   PubMed=1356511;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7202 ! Mutu-1
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   MUTZ-1
AC   CVCL_1431
SY   Mutz-1; MUTZ1; Menschliche Und Tierische Zellkulture-1
DR   CLO; CLO_0007901
DR   CLDB; cl3603
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03151853
DR   cancercelllines; CVCL_1431
DR   Cell_Model_Passport; SIDM00656
DR   Cosmic; 908155
DR   Cosmic; 1995516
DR   Cosmic; 2491098
DR   DSMZ; ACC-13
DR   IARC_TP53; 21520
DR   Wikidata; Q54907097
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9067587;
RX   PubMed=9168445;
RX   PubMed=19344951;
RX   PubMed=20164919;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Namalwa derivative (PubMed=19344951). Originally thought to originate from a 5 year old girl with myelodysplastic disorder.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00376.
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: DSMZ; ACC-13; true.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-13
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 14
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   MUTZ-11
AC   CVCL_8288
SY   MUTZ11; Menschliche Und Tierische Zellkulture-11
DR   Cosmic; 787415
DR   Cosmic; 975283
DR   Cosmic; 1012103
DR   Cosmic; 1281341
DR   Cosmic; 1465961
DR   Wikidata; Q54907098
RX   DOI=10.1007/978-3-642-59358-1_22;
RX   PubMed=12529668;
RX   PubMed=14671638;
RX   PubMed=15068904;
RX   PubMed=16408098;
RX   PubMed=36982453;
CC   Characteristics: Cytokines dependent (PubMed=15068904).
CC   Doubling time: 64-98 hours (PubMed=15068904).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=12529668).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   MUTZ-2
AC   CVCL_1432
SY   MUTZ2; Mutz2; Menschliche Und Tierische Zellkulture-2
DR   CLO; CLO_0007902
DR   BioSample; SAMN03473338
DR   Cosmic; 787461
DR   Cosmic; 975280
DR   Cosmic; 1281337
DR   Cosmic; 2750854
DR   DSMZ; ACC-271
DR   DSMZCellDive; ACC-271
DR   Lonza; 1245
DR   Wikidata; Q54907099
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8667638;
RX   PubMed=9096695;
RX   PubMed=10637496;
RX   PubMed=21989985;
CC   Doubling time: ~47 hours (DSMZ=ACC-271); 48 hours (Note=In presence of supernatant of 5637 (Cellosaurus=CVCL_0126) cells) (PubMed=8667638).
CC   Sequence variation: Mutation; HGNC; HGNC:25657; BCORL1; Simple; p.Arg1420Ter (c.4258C>T); Zygosity=Unspecified (PubMed=21989985).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-271
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D18S51: 13,16.2
ST   D19S433: 13
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,26
ST   Penta D: 11,12
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   MUTZ-3
AC   CVCL_1433
SY   Mutz-3; MUTZ3; Mutz3; Menschliche Und Tierische Zellkulture-3
DR   CLO; CLO_0007903
DR   EFO; EFO_0005395
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473344
DR   BioSample; SAMN10989596
DR   cancercelllines; CVCL_1433
DR   Cell_Model_Passport; SIDM01873
DR   Cosmic; 787462
DR   Cosmic; 975281
DR   Cosmic; 1012102
DR   Cosmic; 1281338
DR   Cosmic; 2306224
DR   Cosmic; 2378088
DR   Cosmic; 2733530
DR   DepMap; ACH-000084
DR   DSMZ; ACC-295
DR   DSMZCellDive; ACC-295
DR   GEO; GSM305093
DR   GEO; GSM305094
DR   GEO; GSM305095
DR   GEO; GSM801964
DR   GEO; GSM1374693
DR   GEO; GSM2037138
DR   GEO; GSM2037139
DR   LiGeA; CCLE_080
DR   Lonza; 53
DR   PharmacoDB; MUTZ3_970_2019
DR   PRIDE; PXD002951
DR   Wikidata; Q54907100
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US9029143;
RX   PubMed=8667638;
RX   PubMed=9096695;
RX   PubMed=12091369;
RX   PubMed=16408098;
RX   PubMed=16423051;
RX   PubMed=17533051;
RX   PubMed=26252775;
RX   PubMed=26589293;
RX   PubMed=26764012;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Characteristics: Contains both CD34+ stem cell and CD14+ monocyte/macrophage cell populations and can thus be considered as a hematopoietic progenitor/stem cell line. Can differentiate into an osteoclast (OC)-like lineage (PubMed=17533051).
CC   Characteristics: Can be differentiated into interstitial DC-like cells by stimulation with CSF2, IL4 and TNF (PubMed=26252775).
CC   Doubling time: ~110 hours (DSMZ=ACC-295); 90-110 hours (Note=In presence of supernatant of 5637 (Cellosaurus=CVCL_0126) cells) (PubMed=8667638).
CC   HLA typing: A*02:01,03:01; B*44:02,44:02; C*04:01,04:01 (PubMed=26589293).
CC   HLA typing: A*02:01:01,03:01:01; B*44:02:01,44:03:01; C*04:01:01,07:04:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,04:01:01; DQA1*01:05:01,01:05:01; DQB1*03:01:01,05:01:01; DRA*01:01:01,01:01:01; DRB1*10:01:01,11:01:01 (DSMZCellDive=ACC-295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly10_Ala11insGly (c.31_32insGAG); Zygosity=Unspecified (DepMap=ACH-000084).
CC   Omics: Genomics; ChIP-seq; H3K79me1.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-295
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 28
ST   D2S1338: 21,23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 20,22
ST   Penta D: 9,10
ST   Penta E: 7,19
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C82426; Acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2) GATA2, MECOM
DI   ORDO; Orphanet_402020; Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   MUTZ-5
AC   CVCL_1873
SY   Mutz-5; MUTZ5; Menschliche Und Tierische Zellkulture-5
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473564
DR   BioSample; SAMN10988511
DR   cancercelllines; CVCL_1873
DR   Cell_Model_Passport; SIDM01689
DR   Cosmic; 1130257
DR   Cosmic; 1278371
DR   Cosmic; 1519165
DR   Cosmic; 1524809
DR   DepMap; ACH-000492
DR   DSMZ; ACC-490
DR   DSMZCellDive; ACC-490
DR   GEO; GSM887343
DR   GEO; GSM888419
DR   IARC_TP53; 30125
DR   LiGeA; CCLE_431
DR   PharmacoDB; MUTZ5_971_2019
DR   Progenetix; CVCL_1873
DR   Wikidata; Q54907101
RX   DOI=10.1007/978-3-642-59358-1_5;
RX   PubMed=11516110;
RX   PubMed=15843827;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~70-100 hours (DOI=10.1007/978-3-642-59358-1_5; DSMZ=ACC-490).
CC   HLA typing: A*30:01,30:01; B*13:02,13:02; C*06:02,06:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=16.18%; Native American=0.51%; East Asian, North=0%; East Asian, South=2.27%; South Asian=12.13%; European, North=13.74%; European, South=55.18% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-490
ST   Amelogenin: X
ST   CSF1PO: 8,9
ST   D13S317: 10,12
ST   D16S539: 10
ST   D18S51: 14,15
ST   D19S433: 14,17
ST   D21S11: 29,31.2
ST   D2S1338: 19,21
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,11
ST   FGA: 19,23
ST   Penta D: 10,11
ST   Penta E: 13,17
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L068 ! MUTZ-6
OI   CVCL_L069 ! MUTZ-7
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   MUTZ-6
AC   CVCL_L068
SY   MUTZ6; Menschliche Und Tierische Zellkulture-6
DR   Cell_Model_Passport; SIDM01688
DR   Wikidata; Q54907102
RX   DOI=10.1007/978-3-642-59358-1_5;
RX   PubMed=11516110;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1873 ! MUTZ-5
OI   CVCL_L069 ! MUTZ-7
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   MUTZ-7
AC   CVCL_L069
SY   MUTZ7; Menschliche Und Tierische Zellkulture-7
DR   Cell_Model_Passport; SIDM01687
DR   Wikidata; Q54907103
RX   DOI=10.1007/978-3-642-59358-1_5;
RX   PubMed=11516110;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1873 ! MUTZ-5
OI   CVCL_L068 ! MUTZ-6
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   MUTZ-8
AC   CVCL_2130
SY   MUTZ8; Menschliche Und Tierische Zellkulture-8
DR   BTO; BTO_0004768
DR   cancercelllines; CVCL_2130
DR   Cosmic; 975282
DR   Cosmic; 1012053
DR   Cosmic; 1281339
DR   Cosmic; 1465960
DR   Cosmic; 2306225
DR   DepMap; ACH-001577
DR   DSMZ; ACC-689
DR   DSMZCellDive; ACC-689
DR   Wikidata; Q54907104
RX   DOI=10.1007/978-3-642-59358-1_22;
RX   PubMed=12145698;
RX   PubMed=16408098;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MUTZ-8
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Cytokines dependent (PubMed=12145698).
CC   Doubling time: ~5 days (DOI=10.1007/978-3-642-59358-1_22); ~3-5 days (DSMZ=ACC-689).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=16408098).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DepMap=ACH-001577; DSMZ=ACC-689
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 18,20
ST   Penta D: 13,15
ST   Penta E: 12,20
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   MV-1a1b1
AC   CVCL_C6DY
DR   Wikidata; Q116049814
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1e3b
AC   CVCL_C6DZ
DR   Wikidata; Q116049815
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1e4b
AC   CVCL_C6E0
DR   Wikidata; Q116049816
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1e4f1a
AC   CVCL_C6E1
DR   Wikidata; Q116049817
RX   PubMed=12762836;
CC   Doubling time: ~24 hours (PubMed=12762836).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1e6g1a
AC   CVCL_C6E2
DR   Wikidata; Q116049818
RX   PubMed=12762836;
CC   Doubling time: ~24 hours (PubMed=12762836).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1h1b1a
AC   CVCL_C6E3
DR   Wikidata; Q116049819
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1h1b1b
AC   CVCL_C6E4
DR   Wikidata; Q116049820
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1i1b1
AC   CVCL_C6E5
DR   Wikidata; Q116049821
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1i7b1
AC   CVCL_C6E6
DR   Wikidata; Q116049822
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1i7c1a
AC   CVCL_C6E7
DR   Wikidata; Q116049823
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-1i7d2c
AC   CVCL_C6E8
DR   Wikidata; Q116049824
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-2a1b2
AC   CVCL_C6E9
DR   Wikidata; Q116049825
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-2a1b3
AC   CVCL_C6EA
DR   Wikidata; Q116049826
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-2b2a4h
AC   CVCL_C6EB
DR   Wikidata; Q116049827
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-2b2b2d
AC   CVCL_C6EC
DR   Wikidata; Q116049828
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-2b2b5b
AC   CVCL_C6ED
DR   Wikidata; Q116049829
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-2g3b2
AC   CVCL_C6EE
DR   Wikidata; Q116049830
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-2g4h
AC   CVCL_C6EF
DR   Wikidata; Q116049831
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, upper part; UBERON=UBERON_0003974.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MV-3D9
AC   CVCL_5339
SY   Mv-3D9; Mv 3D9; MV3D9; Mv3D9
DR   Wikidata; Q54907105
RX   PubMed=2384664;
CC   Characteristics: TGFB dependent.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
HI   CVCL_0593 ! Mv1Lu
SX   Mixed sex
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   MV-4-11B
AC   CVCL_C3HG
SY   MV-4-11-B; MV-4-11b
DR   cancercelllines; CVCL_C3HG
DR   GEO; GSE103068
DR   GEO; GSM2716693
DR   GEO; GSM2716694
DR   GEO; GSM2716695
DR   GEO; GSM2716696
DR   GEO; GSM2716697
DR   GEO; GSM2716698
DR   GEO; GSM2716699
DR   GEO; GSM2716700
DR   GEO; GSM2716701
DR   GEO; GSM2716702
DR   GEO; GSM2716703
DR   GEO; GSM2716704
DR   GEO; GSM2716705
DR   GEO; GSM2716706
DR   GEO; GSM2716707
DR   GEO; GSM2716713
DR   GEO; GSM2716714
DR   GEO; GSM2716715
DR   GEO; GSM2716716
DR   GEO; GSM2716717
DR   GEO; GSM2716718
DR   GEO; GSM2716719
DR   GEO; GSM2716720
DR   GEO; GSM2716721
DR   GEO; GSM2716722
DR   GEO; GSM2716723
DR   GEO; GSM2716724
DR   GEO; GSM2716725
DR   GEO; GSM2716726
DR   GEO; GSM2716727
DR   GEO; GSM2716728
DR   GEO; GSM2716729
DR   GEO; GSM2716730
DR   GEO; GSM2716731
DR   GEO; GSM2716732
DR   GEO; GSM2716733
DR   GEO; GSM2716734
DR   GEO; GSM2716735
DR   GEO; GSM2716736
DR   GEO; GSM2716737
DR   GEO; GSM2716738
DR   GEO; GSM2716739
DR   GEO; GSM2716752
DR   GEO; GSM2716753
DR   GEO; GSM2716754
DR   GEO; GSM2716755
DR   GEO; GSM2716756
DR   GEO; GSM2716757
DR   GEO; GSM2716758
DR   GEO; GSM2716759
DR   GEO; GSM2716760
DR   GEO; GSM2716761
DR   GEO; GSM2716762
DR   GEO; GSM2716763
DR   GEO; GSM2716764
DR   GEO; GSM2716765
DR   GEO; GSM2716766
DR   GEO; GSM2716767
DR   GEO; GSM2716768
DR   GEO; GSM2716769
DR   GEO; GSM2832581
DR   GEO; GSM2832582
DR   GEO; GSM2832583
DR   GEO; GSM2832584
DR   GEO; GSM2832585
DR   GEO; GSM2832586
DR   GEO; GSM2832587
DR   GEO; GSM2832588
DR   GEO; GSM2832589
DR   GEO; GSM2832590
DR   GEO; GSM2832591
DR   GEO; GSM2832592
DR   GEO; GSM2832593
DR   GEO; GSM2832594
DR   Wikidata; Q114312330
RX   PubMed=29454094;
RX   PubMed=29491412;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (PubMed=29491412; PubMed=29454094).
CC   Omics: Genomics; ChIP-seq; BRD4.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; Pol2.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0064 ! MV4-11
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   MV-522
AC   CVCL_7204
SY   MV522; Metastatic Variant-522; Metastatic Variant 522; Line 522
DR   BTO; BTO_0004952
DR   ATCC; CRL-2519
DR   BioSample; SAMN03151795
DR   cancercelllines; CVCL_7204
DR   Cosmic; 1173992
DR   Cosmic; 1945858
DR   Wikidata; Q54907106
RX   PubMed=3596831;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/mv522-atcc-crl-2519
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative. Originally thought to originate from a 53 year old male patient with a lung squamous cell carcinoma. It was thought to be a metastatic derivative of UCLA-P3 (Cellosaurus=CVCL_N513).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00409.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: MU522; Cosmic=1945858.
CC   Discontinued: ATCC; CRL-2519; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2519
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Mv1Lu
AC   CVCL_0593
SY   Mv 1 Lu (NBL-7); NBL-7; Mv 1 Lu; MV 1 LU; Mv1.Lu; Mv.1.Lu; MV-1-Lu; Mink; Mink Lung
DR   BTO; BTO_0005493
DR   CLO; CLO_0007904
DR   CLO; CLO_0007905
DR   CLO; CLO_0051612
DR   EFO; EFO_0022753
DR   MCCL; MCC:0000342
DR   CLDB; cl3604
DR   CLDB; cl3605
DR   CLDB; cl3606
DR   CLDB; cl3607
DR   CLDB; cl3608
DR   CLDB; cl3609
DR   AddexBio; T0016003/4959
DR   ATCC; CCL-64
DR   ATCC; CRL-6584
DR   ATCC; PTA-3450
DR   BCRC; 60321
DR   CCLV; CCLV-RIE 0048
DR   CCRID; 1101MAM-PUMC000195
DR   CCRID; 1102MAM-NIFDC00082
DR   CCRID; 3101MAMGNO8
DR   CCRID; 5301MAM-KCB93005YJ
DR   CLS; 305192
DR   ECACC; 88050503
DR   ICLC; AL97002
DR   IZSLER; BS CL 69
DR   JCRB; JCRB9128
DR   KCB; KCB 90027YJ
DR   KCB; KCB 93005YJ
DR   NCBI_Iran; C647
DR   RCB; RCB0996
DR   RCB; RCB1833
DR   TKG; TKG 0230
DR   Wikidata; Q54907107
RX   DOI=10.1007/BF02618370;
RX   PubMed=4366800;
RX   PubMed=7065527;
RX   PubMed=8895552;
RX   PubMed=9817906;
RX   PubMed=12067210;
RX   PubMed=15731278;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CCL-64
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-6.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3450.
CC   Virology: Susceptible to infection and replication of influenza A and B viruses (PubMed=9817906).
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15731278).
CC   Discontinued: ATCC; CRL-6584; true.
CC   Discontinued: TKG; TKG 0230; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Mixed sex
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   MV3
AC   CVCL_W280
SY   MV-3; MV 3
DR   BTO; BTO_0005033
DR   BCRJ; 0284
DR   Cosmic; 1181740
DR   Wikidata; Q54907108
RX   PubMed=1918136;
RX   PubMed=2019461;
RX   PubMed=2060184;
RX   PubMed=7646526;
RX   PubMed=8688321;
RX   PubMed=18235964;
CC   Doubling time: ~24 hours (PubMed=2019461).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   MV4-11
AC   CVCL_0064
SY   MV-4-11; MV-4:11; MV4:11; MV 4;11; MV4;11; MV411; MV(4;11); MV4II
DR   BTO; BTO_0006413
DR   CLO; CLO_0007906
DR   EFO; EFO_0002242
DR   CLDB; cl3610
DR   CLDB; cl3611
DR   AddexBio; C0003025/4955
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-9591
DR   ATCC; HTB-189
DR   BioGRID_ORCS_Cell_line; 138
DR   BioSample; SAMN01821582
DR   BioSample; SAMN01821649
DR   BioSample; SAMN03473104
DR   BioSample; SAMN10988366
DR   cancercelllines; CVCL_0064
DR   CCRID; 3101HUMSCSP5031
DR   Cell_Model_Passport; SIDM00657
DR   ChEMBL-Cells; CHEMBL3308063
DR   ChEMBL-Targets; CHEMBL613835
DR   CLS; 300295
DR   Cosmic; 787416
DR   Cosmic; 798673
DR   Cosmic; 908156
DR   Cosmic; 975284
DR   Cosmic; 994182
DR   Cosmic; 996315
DR   Cosmic; 1012104
DR   Cosmic; 1037736
DR   Cosmic; 1078732
DR   Cosmic; 1089516
DR   Cosmic; 1127256
DR   Cosmic; 1150899
DR   Cosmic; 1152712
DR   Cosmic; 1181603
DR   Cosmic; 1278781
DR   Cosmic; 1281340
DR   Cosmic; 1308221
DR   Cosmic; 1319550
DR   Cosmic; 1451846
DR   Cosmic; 1476424
DR   Cosmic; 1516631
DR   Cosmic; 1524837
DR   Cosmic; 1623635
DR   Cosmic; 1696137
DR   Cosmic; 1779133
DR   Cosmic; 2131568
DR   Cosmic; 2306226
DR   Cosmic; 2392908
DR   Cosmic; 2393011
DR   Cosmic; 2542841
DR   Cosmic; 2750867
DR   Cosmic-CLP; 908156
DR   DepMap; ACH-000045
DR   DSMZ; ACC-102
DR   DSMZCellDive; ACC-102
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10718-109I7
DR   GDSC; 908156
DR   GEO; GSM236796
DR   GEO; GSM236832
DR   GEO; GSM482560
DR   GEO; GSM887344
DR   GEO; GSM888420
DR   GEO; GSM1374694
DR   GEO; GSM1446746
DR   GEO; GSM1670137
DR   IARC_TP53; 21521
DR   IGRhCellID; MV4II
DR   LiGeA; CCLE_055
DR   LINCS_LDP; LCL-1092
DR   Lonza; 996
DR   PharmacoDB; MV411_972_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0064
DR   PubChem_Cell_line; CVCL_0064
DR   TOKU-E; 2536
DR   Ubigene; YC-C060
DR   Wikidata; Q54907109
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1423625;
RX   PubMed=2656885;
RX   PubMed=3496132;
RX   PubMed=8353274;
RX   PubMed=8358709;
RX   PubMed=9195772;
RX   PubMed=12529668;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=19608861;
RX   PubMed=20215515;
RX   PubMed=20922763;
RX   PubMed=21552520;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9591.
CC   Population: Caucasian.
CC   Characteristics: CSF2 and IL3 dependent.
CC   Doubling time: 32 hours (PubMed=25984343); ~48 hours (CLS=300295); ~50 hours (DSMZ=ACC-102).
CC   HLA typing: A*03:01,68:01; B*14:02,18:01; C*08:02,15:02; DQA1*01:02,01:02; DQB1*06:05,06:05; DRB1*01:01,13:02 (PubMed=26589293).
CC   HLA typing: A*03:01:01,20:01:02; B*14:02:01,18:01:01; C*08:02:01,15:02:01; DPB1*02:01,04:01; DQA1*01:01:01,01:02:01; DQB1*05:01:01,06:09:01; DRB1*01:01:01,13:02:01 (CLS=300295).
CC   Karyotypic information: 48,XY,t(4;11)(q21;q23),+8,+19 (ATCC=CRL-9591).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=1423625; PubMed=8358709).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=12529668).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; PTM; Acetylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.59%; Native American=0%; East Asian, North=0.34%; East Asian, South=0%; South Asian=2.57%; European, North=67.58%; European, South=28.91% (PubMed=30894373).
CC   Discontinued: ATCC; HTB-189; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003025/4955; ATCC=CRL-9591; CLS=300295; COG; Cosmic-CLP=908156; DSMZ=ACC-102; PubMed=20922763; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 11,17
ST   D19S433: 15
ST   D21S11: 32 (DSMZ=ACC-102)
ST   D21S11: 32,32.2 (ATCC=CRL-9591; CLS=300295; COG; PubMed=25877200)
ST   D21S11: 32.2 (PubMed=20922763)
ST   D2S1338: 24,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 19,21
ST   Penta D: 9,10
ST   Penta E: 7,18
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   MV522/MDR1
AC   CVCL_0E37
SY   MV522/mdr1 Q6
DR   ATCC; CRL-2520
DR   cancercelllines; CVCL_0E37
DR   Wikidata; Q54907110
RX   PubMed=9797706;
CC   Problematic cell line: Contaminated. Parent cell line (MV-522) has been shown to be a HT-29 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Discontinued: ATCC; CRL-2520; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2520
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7204 ! MV-522
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 23
//
ID   MV522/MRP
AC   CVCL_0E38
DR   ATCC; CRL-2521
DR   BioSample; SAMN03471605
DR   cancercelllines; CVCL_0E38
DR   Wikidata; Q54907111
RX   PubMed=10831281;
CC   Problematic cell line: Contaminated. Parent cell line (MV-522) has been shown to be a HT-29 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:51; ABCC1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-2521; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2521
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7204 ! MV-522
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 24
//
ID   MVA-RCC-A36
AC   CVCL_C4Z1
SY   A36
DR   Wikidata; Q116049832
RX   PubMed=3904980;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human unknown antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MVA-RCC-A6H
AC   CVCL_C4Z2
SY   A6H
DR   Wikidata; Q116049834
RX   Patent=EP0210970A2;
RX   PubMed=3904980;
RX   PubMed=11604108;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8803.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MVA-RCC-C5H
AC   CVCL_C4Z3
SY   C5H
DR   Wikidata; Q116049835
RX   Patent=EP0210970A2;
RX   PubMed=3904980;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8801.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   MVA-RCC-D5D
AC   CVCL_C4Z4
SY   D5D
DR   Wikidata; Q116049836
RX   Patent=EP0210970A2;
RX   PubMed=3904980;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8802.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on renal cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 3
//
ID   MVA28C
AC   CVCL_8Y22
DR   ECACC; 06011807
DR   Wikidata; Q54907116
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   MVh-Venns GS
AC   CVCL_1T55
DR   RCB; AES0196
DR   Wikidata; Q54907117
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Germ line stem cell; CL=CL_0000014.
CC   Breed/subspecies: C57BL/6J x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   Mvi/It
AC   CVCL_3550
SY   MVI-it
DR   CLO; CLO_0007908
DR   ATCC; CRL-6012
DR   GEO; GSM2037235
DR   Wikidata; Q28923528
RX   PubMed=27303702;
CC   Group: Bat cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Characteristics: From a skin tumor found in a bat from Frio Cave, Texas.
CC   Virology: Infected by bat gammaherpesvirus 8 (BGHV8).
CC   Discontinued: ATCC; CRL-6012; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C134955; Bat skin tumor
OX   NCBI_TaxID=9435; ! Myotis velifer (Mouse-eared bat)
OI   CVCL_S455 ! Mvi/Mu
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Mvi/Mu
AC   CVCL_S455
DR   ATCC; CRL-6011
DR   Wikidata; Q28923559
CC   Group: Bat cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6011; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=9435; ! Myotis velifer (Mouse-eared bat)
OI   CVCL_3550 ! Mvi/It
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MVL
AC   CVCL_F658
SY   GM06826; GM06826A
DR   CLO; CLO_0036524
DR   Coriell; GM06826
DR   IPD-IMGT/HLA; 11116
DR   Wikidata; Q54907118
RX   CelloPub=CLPUB00447;
RX   PubMed=6417008;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*27:05:02; C*02:02:01; DQB1*05:01:01 (IPD-IMGT/HLA=11116).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 14
//
ID   MVLN
AC   CVCL_4Y56
SY   MVLN 15-C7; MVLN-15-C7; MCF-7 Vit Luc Neo
DR   cancercelllines; CVCL_4Y56
DR   ChEMBL-Cells; CHEMBL3307321
DR   ChEMBL-Targets; CHEMBL614185
DR   PubChem_Cell_line; CVCL_4Y56
DR   Wikidata; Q54907119
RX   PubMed=2257144;
RX   PubMed=7954415;
RX   PubMed=9831484;
CC   Population: Caucasian.
CC   Biotechnology: Used in a bioluminescent bioassay to quantitatively measure estrogenic compounds.
CC   Characteristics: The luciferase reporter gene is under the control of an estrogen-responsive element from the Xenopus vitellogenin A2 gene.
CC   Doubling time: 0.8 +- 0.1 day (PubMed=7954415).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 19
//
ID   MVP1
AC   CVCL_U130
DR   CLO; CLO_0050318
DR   RCB; RCB1837
DR   Wikidata; Q54907120
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Oryzias latipes vitellogenin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   MVP25
AC   CVCL_U131
DR   CLO; CLO_0050319
DR   RCB; RCB1838
DR   Wikidata; Q54907121
RX   CelloPub=CLPUB00400;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Medaka vitellogenin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MVP47
AC   CVCL_U132
DR   CLO; CLO_0050333
DR   RCB; RCB1839
DR   Wikidata; Q54907122
RX   CelloPub=CLPUB00400;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Medaka vitellogenin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MVP49
AC   CVCL_U133
DR   CLO; CLO_0050320
DR   RCB; RCB1840
DR   Wikidata; Q54907123
RX   CelloPub=CLPUB00400;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Medaka vitellogenin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MVP51
AC   CVCL_U134
DR   CLO; CLO_0050321
DR   RCB; RCB1841
DR   Wikidata; Q54907124
RX   CelloPub=CLPUB00400;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Medaka vitellogenin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   MVPK-1
AC   CVCL_4544
SY   MVPK 1; MVPK; Mengeling-Vaughn Porcine Kidney-1
DR   CLO; CLO_0007909
DR   CLDB; cl3612
DR   IZSLER; BS CL 119
DR   Wikidata; Q54907125
RX   PubMed=185927;
RX   PubMed=192426;
CC   Virology: Susceptible to infection by foot-and-mouth disease virus. Loose its susceptibility to infection at 37 Celsius (PubMed=185927).
CC   Misspelling: Mengling-Vaughn Porcine Kidney-1; IZSLER=BS CL 119.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MVPK-1 clone 7
AC   CVCL_U234
DR   Wikidata; Q54907126
RX   PubMed=192426;
CC   Virology: Susceptible to infection by foot-and-mouth disease virus. Compared to the parent cell line, doe not loose its susceptibility to infectionat 37 Celsius (PubMed=192426).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_4544 ! MVPK-1
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Mvt1
AC   CVCL_C8Q2
SY   MVT1; Mvt-1; MVT-1
DR   BTO; BTO_0006554
DR   GEO; GSE68746
DR   Wikidata; Q123033138
RX   PubMed=15180438;
RX   PubMed=26040280;
RX   PubMed=26484297;
CC   Characteristics: Contains two distinct populations; CD24- cells (64.1%) and CD24+ cells (35.9%) (PubMed=26484297).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:103178; Vegfa.
CC   Transformant: MMTV/c-Myc.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB MMTV-c-myc/vegf double transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   MVX-1
AC   CVCL_C3M8
SY   MaxiVaX-1
DR   Wikidata; Q116049837
RX   DOI=10.1093/annonc/mdw378.12;
RX   Patent=US11013790;
CC   Group: Patented cell line.
CC   Population: Caucasian.
CC   Biotechnology: Used in clinical trial of MVX-ONCO-1 a cancer immunotherapy method using cell encapsulation technology that contains dead tumor cells from the patient itself and MVX-1 cells that produce CSF2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2434; CSF2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 6
//
ID   MVX-2
AC   CVCL_C3LY
SY   MaxiVaX-2; huGM-CSF clone 61.27; Clone #61.27
DR   Wikidata; Q116049838
RX   Patent=US20220265727;
RX   PubMed=36092361;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Culture Collection of Switzerland (CCOS); CCOS-1901.
CC   Characteristics: Expression of CSF2 is under the control of a PGK promoter (PubMed=36092361).
CC   Doubling time: 37 hours (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2434; CSF2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Miscellaneous: Cell line name and doubling time from personal communication of Lathuiliere, Aurelien.
CC   Derived from site: In situ; Muscle, semitendinosus; UBERON=UBERON_0001375.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3LX ! IHM-2
SX   Female
AG   32Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   MW [Human breast carcinoma]
AC   CVCL_WS83
DR   Wikidata; Q95991571
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=3971380;
CC   Doubling time: 31 hours (PubMed=3971380).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Ter (c.702C>A); Zygosity=Unspecified (from child cell line MW1C 6.3).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   MW [Human chondrosarcoma]
AC   CVCL_WS84
DR   Cosmic; 848243
DR   Wikidata; Q95991572
RX   PubMed=11854598;
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 5
//
ID   MW [Human melanoma]
AC   CVCL_U799
DR   cancercelllines; CVCL_U799
DR   Cosmic; 928721
DR   GEO; GSM226864
DR   Progenetix; CVCL_U799
DR   Wikidata; Q54907127
RX   PubMed=9354451;
RX   PubMed=17363583;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Unspecified (PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   MW1 [Human breast carcinoma]
AC   CVCL_M367
DR   Wikidata; Q54907128
RX   PubMed=17273757;
CC   Doubling time: 79.7 hours (Note=At 8th passage), 38.7 hours (Note=At 65th passage) (PubMed=17273757).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   MW1 [Mouse hybridoma against human HTT]
AC   CVCL_WU05
DR   DSHB; MW1
DR   Wikidata; Q95991578
RX   PubMed=11719267;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 6
//
ID   MW10
AC   CVCL_YU31
SY   MW 10
DR   Wikidata; Q95991579
RX   PubMed=1409720;
RX   PubMed=8675582;
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Ala33Val (c.98C>T) (A16V, 274T); ClinVar=VCV000013667; Zygosity=Heterozygous (PubMed=1409720).
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Tyr436His (c.1306T>C) (Y419H, 1482C); ClinVar=VCV000013668; Zygosity=Heterozygous (PubMed=1409720).
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-10Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   MW162
AC   CVCL_C5WA
DR   Wikidata; Q116049839
RX   Patent=WO1996040295A1;
RX   PubMed=3677104;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MW1C 6.3
AC   CVCL_A8VC
DR   IARC_TP53; 763
DR   Wikidata; Q108821000
RX   PubMed=1961733;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Ter (c.702C>A); Zygosity=Unspecified (PubMed=1961733).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS83 ! MW [Human breast carcinoma]
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   Mw1Ht
AC   CVCL_S347
SY   MW1H
DR   ATCC; CRL-6013
DR   Wikidata; Q54907129
CC   Group: Bat cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6013; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=124750; ! Macrotus waterhousii (Waterhouse's leaf-nosed bat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MW207
AC   CVCL_C5WB
DR   Wikidata; Q116049840
RX   Patent=WO1996040295A1;
RX   PubMed=3677104;
RX   PubMed=8194901;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15328; Human FOLR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Mw2Lu
AC   CVCL_S348
SY   MW2.Lu
DR   ATCC; CRL-6014
DR   Wikidata; Q54907130
CC   Group: Bat cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6014; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=124750; ! Macrotus waterhousii (Waterhouse's leaf-nosed bat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MW3
AC   CVCL_WU11
DR   DSHB; MW3
DR   Wikidata; Q95991582
RX   PubMed=11719267;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 7
//
ID   MW4
AC   CVCL_WU06
DR   DSHB; MW4
DR   Wikidata; Q95991583
RX   PubMed=11719267;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 7
//
ID   MW5
AC   CVCL_WU07
DR   DSHB; MW5
DR   Wikidata; Q95991584
RX   PubMed=11719267;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 6
//
ID   MW6
AC   CVCL_WU08
DR   DSHB; MW6
DR   Wikidata; Q95991585
RX   PubMed=11719267;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes poly-Gln region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 6
//
ID   MW7
AC   CVCL_WU09
DR   DSHB; MW7
DR   Wikidata; Q95991586
RX   PubMed=11719267;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes poly-Pro region).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 6
//
ID   MW8
AC   CVCL_WU10
DR   DSHB; MW8
DR   Wikidata; Q95991587
RX   PubMed=11719267;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P42858; Human HTT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D145 ! HL-1 Friendly Myeloma-653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 5
//
ID   Mwanzia
AC   CVCL_ZI20
DR   Wikidata; Q98127385
RX   PubMed=3026973;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   MWCL-1
AC   CVCL_M086
SY   MWCL.1; MWCL1
DR   CLO; CLO_0037225
DR   cancercelllines; CVCL_M086
DR   Cosmic; 1762457
DR   Cosmic; 2645644
DR   LINCS_HMS; 51098
DR   LINCS_LDP; LCL-2109
DR   Wikidata; Q28914904
RX   PubMed=21415268;
RX   PubMed=22950966;
RX   PubMed=23321251;
RX   PubMed=24189269;
RX   PubMed=25382610;
RX   PubMed=25853860;
RX   PubMed=40254718;
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (PubMed=23321251).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Hemizygous (PubMed=21415268).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 18
//
ID   MWCL-1/BR
AC   CVCL_VJ31
DR   cancercelllines; CVCL_VJ31
DR   Wikidata; Q95991589
RX   PubMed=25382610;
RX   PubMed=28548645;
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C)(p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M086 ! MWCL-1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   MWCL-1/IR
AC   CVCL_VJ32
DR   cancercelllines; CVCL_VJ32
DR   Cosmic; 2645645
DR   Wikidata; Q95991590
RX   PubMed=28548645;
CC   Selected for resistance to: ChEBI; CHEBI_76612; Ibrutinib (Imbruvica).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M086 ! MWCL-1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   MWF
AC   CVCL_1M74
SY   GM03162; GM 3162; GM3162
DR   CLO; CLO_0013519
DR   Coriell; GM03162
DR   Wikidata; Q54907131
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 12
//
ID   Mwika
AC   CVCL_7205
SY   MWIKA; Mwi-BL; MWI-BL; MWI; Mwi
DR   cancercelllines; CVCL_7205
DR   Cosmic; 2804850
DR   Wikidata; Q54907132
RX   PubMed=2470097;
RX   PubMed=2824665;
RX   PubMed=2943927;
RX   PubMed=3035497;
RX   PubMed=8108117;
RX   PubMed=9882297;
CC   Population: African; Kenyan.
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Pro72Ser (c.214C>T); ClinVar=VCV000012574; Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   MWRIi001-A-3
AC   CVCL_C0GJ
SY   Tex11_1260Ins(TT)
DR   Wikidata; Q112930148
RX   PubMed=35240466;
CC   From: Magee-Womens Research Institute, University of Pittsburgh School of Medicine; Pittsburgh; USA.
CC   Sequence variation: Mutation; MGI; MGI:1933237; Tex11; Simple_edited; p.Asp421fs (c.1260insTT); Zygosity=Hemizygous; Note=By CRISPR/Cas9. In a mouse model of human TEX11_1258Ins(TT) (PubMed=35240466).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 Tex11PM/Y.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   MX
AC   CVCL_KC00
DR   ATCC; HB-9158
DR   Wikidata; Q54907133
RX   Patent=US4820631;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9158.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01112; Human HRAS.
CC   Caution: This is a mixture of 5 different hybridoma cell lines: M8, M30, M38, M70 and M90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   MX-1
AC   CVCL_4774
SY   MX1; MXI
DR   BTO; BTO_0004179
DR   CLO; CLO_0009915
DR   EFO; EFO_0006457
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472921
DR   ChEMBL-Cells; CHEMBL3308046
DR   ChEMBL-Targets; CHEMBL613704
DR   CLS; 300296
DR   DepMap; ACH-002328
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM844611
DR   GEO; GSM844612
DR   GEO; GSM844613
DR   GEO; GSM845398
DR   GEO; GSM1172893
DR   GEO; GSM1172987
DR   LINCS_HMS; 51090
DR   LINCS_LDP; LCL-2072
DR   NCI-DTP; MX-1
DR   PharmacoDB; MX1_973_2019
DR   PubChem_Cell_line; CVCL_4774
DR   Wikidata; Q54907134
RX   PubMed=10969801;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=29045385;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Established from a tumor xenograft established in atyhmic mice.
CC   Doubling time: 30-35 hours (CLS=300296); 113.83 hours (JWGray panel).
CC   HLA typing: A*11:01,74:01; B*15:03,35:01; C*02:02,04:01; DQB1*03:09,05:01; DRB1*01:03,11:08 (PubMed=25960936).
CC   HLA typing: A*11:01,74:01; B*15:03,35:01; C*02:02,04:01; DRB1*01:03,01:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln52Valfs*3 (c.154_158delCAATG); Zygosity=Unspecified (PubMed=29045385).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): CLS=300296; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11 (PubMed=25877200)
ST   D13S317: 11,12 (CLS=300296)
ST   D16S539: 12
ST   D18S51: 12,16
ST   D19S433: 13,15.2,16.2
ST   D21S11: 29,30,31,32 (CLS=300296)
ST   D21S11: 29,32 (PubMed=25877200)
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11 (PubMed=25877200)
ST   D7S820: 11,12 (CLS=300296)
ST   D8S1179: 11 (PubMed=25877200)
ST   D8S1179: 11,12,13 (CLS=300296)
ST   FGA: 20
ST   Penta D: 6,9,11
ST   Penta E: 14
ST   TH01: 7,9
ST   TPOX: 7,8 (CLS=300296)
ST   TPOX: 8 (PubMed=25877200)
ST   vWA: 17 (PubMed=25877200)
ST   vWA: 17,18 (CLS=300296)
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   MX35
AC   CVCL_C5WC
DR   Wikidata; Q116049841
RX   Patent=WO1996040295A1;
RX   PubMed=3677104;
RX   PubMed=18251464;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95436; Human SLC34A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   MY
AC   CVCL_3034
DR   CLO; CLO_0050475
DR   BioSample; SAMN03472122
DR   cancercelllines; CVCL_3034
DR   Cell_Model_Passport; SIDM00563
DR   GEO; GSM827267
DR   JCRB; JCRB0158.0
DR   JCRB; NIHS0246
DR   LINCS_LDP; LCL-1001
DR   Progenetix; CVCL_3034
DR   RCB; RCB1701
DR   Wikidata; Q54907135
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9790503;
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=9790503).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0246; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
ST   Source(s): JCRB=JCRB0158.0; RCB=RCB1701
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4673; Acute biphenotypic leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   My 43.51
AC   CVCL_L539
SY   My 43
DR   CLO; CLO_0007910
DR   Wikidata; Q54907136
RX   Patent=US5610057;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12128.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   My-C-cC0C2-235-3H8
AC   CVCL_KS09
SY   anti-My-C-cC0C2-235-3H8
DR   Wikidata; Q54907137
RX   Patent=US9975961;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3223.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14896; Human MYBPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   My-C-cC0C2-259-1A4
AC   CVCL_KS10
SY   anti-My-C-cC0C2-259-1A4
DR   Wikidata; Q54907138
RX   Patent=US10017745;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3224.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14896; Human MYBPC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   MY-EBV-LCL
AC   CVCL_J500
DR   CLO; CLO_0050986
DR   BioSample; SAMN03472145
DR   RCB; RCB1487
DR   Wikidata; Q54907139
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1487
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,14
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 13
//
ID   My-La CD4+
AC   CVCL_2633
SY   My-La, marker chromosome
DR   ECACC; 95051032
DR   Wikidata; Q54907140
RX   PubMed=1582990;
RX   PubMed=7726642;
CC   Characteristics: IL2 and IL4 dependent.
CC   Doubling time: 50 hours (PubMed=1582990); 20-24 hours (ECACC=95051032).
ST   Source(s): ECACC=95051032
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 8,11
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2634 ! My-La CD8+
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   My-La CD8+
AC   CVCL_2634
SY   My-La 46,XY-18+i(18q); My-La 46,XY,i(18q)
DR   ECACC; 95051033
DR   Wikidata; Q54907141
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1582990;
RX   PubMed=7726642;
RX   PubMed=8045039;
CC   Characteristics: IL2 dependent.
CC   Doubling time: 20-24 hours (PubMed=1582990).
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2633 ! My-La CD4+
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   MY-M12
AC   CVCL_3035
SY   MY clone M12; MYM12
DR   CLO; CLO_0037185
DR   cancercelllines; CVCL_3035
DR   Cell_Model_Passport; SIDM01217
DR   Cosmic; 2131569
DR   Cosmic-CLP; 1330960
DR   DepMap; ACH-002276
DR   GDSC; 1330960
DR   GEO; GSM1670138
DR   JCRB; JCRB0158.1
DR   JCRB; NIHS0246.1
DR   LINCS_LDP; LCL-1002
DR   PharmacoDB; MYM12_974_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907142
RX   PubMed=9790503;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Genome ancestry: African=0.94%; Native American=0.38%; East Asian, North=81.47%; East Asian, South=16.04%; South Asian=1.17%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0246.1; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
ST   Source(s): Cosmic-CLP=1330960; JCRB=JCRB0158.1
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4673; Acute biphenotypic leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3034 ! MY
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   MY-M13
AC   CVCL_3036
SY   MY clone M13
DR   CLO; CLO_0037186
DR   JCRB; JCRB0158.2
DR   JCRB; NIHS0246.2
DR   LINCS_LDP; LCL-1003
DR   Wikidata; Q54907143
RX   PubMed=9790503;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0246.2; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
ST   Source(s): JCRB=JCRB0158.2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4673; Acute biphenotypic leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3034 ! MY
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   MY.1E12
AC   CVCL_B3R0
DR   Wikidata; Q110433077
RX   PubMed=8641986;
RX   PubMed=12379325;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227 (Note=Recognizes the sialylalpha2-3Galactosylbeta1-3N-acetylgalactosaminide trisaccharide onto the Thr within the VTS repeats).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   My.Sp
AC   CVCL_S317
DR   ATCC; CRL-6000
DR   Wikidata; Q54907144
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6000; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=181542; ! Myoprocta acouchy (Red acouchi)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   My23.1
AC   CVCL_D5DP
DR   Wikidata; Q127382904
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   My23.2
AC   CVCL_D5DQ
DR   Wikidata; Q127382905
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   My23.3
AC   CVCL_D5DR
DR   Wikidata; Q127382906
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   My23.4
AC   CVCL_D5DS
DR   Wikidata; Q127382907
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   My23.5
AC   CVCL_D5DT
DR   Wikidata; Q127382908
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   My23.6
AC   CVCL_D5DU
DR   Wikidata; Q127382910
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   My23.7
AC   CVCL_D5DV
DR   Wikidata; Q127382911
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   My23.8
AC   CVCL_D5DW
DR   Wikidata; Q127382912
RX   PubMed=2441245;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   MY3
AC   CVCL_E8W7
RX   PubMed=6945311;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on myeloid cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MY4
AC   CVCL_E8W8
SY   My4; MY-4
RX   PubMed=6945311;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08571; Human CD14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MY7
AC   CVCL_E8W9
RX   PubMed=6945311;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15144; Human ANPEP/CD13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MY8
AC   CVCL_E8WA
RX   PubMed=6945311;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human antigen on myeloid cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   MY904
AC   CVCL_C556
SY   MY-904; 904
DR   CLO; CLO_0007911
DR   ATCC; HB-9510
DR   CCRID; 4201PAT-CCTCC00027
DR   Wikidata; Q54907146
RX   Patent=US4840793;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9510.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   MYA-1
AC   CVCL_3753
SY   MYAzawa-1
DR   CLO; CLO_0007912
DR   ATCC; CRL-2417
DR   Wikidata; Q54907147
RX   PubMed=1313703;
RX   PubMed=1693845;
RX   PubMed=2391790;
RX   PubMed=2480760;
CC   Characteristics: IL2 dependent.
CC   Virology: Highly susceptible to infection by feline immunodeficiency virus (FIV) (PubMed=2391790; PubMed=2480760).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   MYB 2-3.76
AC   CVCL_B433
SY   MYB2-3.76; Myb2-3
DR   CLO; CLO_0007913
DR   ATCC; CRL-1728
DR   Wikidata; Q54907148
RX   PubMed=6084811;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb (Note=Also reacts with chicken MYB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 8
//
ID   MYB 2-32
AC   CVCL_G337
SY   Myb2-32
DR   ECACC; 84101003
DR   Wikidata; Q54907149
RX   PubMed=6084811;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb (Note=Also reacts with chicken MYB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 7
//
ID   MYB 2-37.63
AC   CVCL_B434
SY   MYB2-37.63; Myb2-37
DR   CLO; CLO_0007914
DR   ATCC; CRL-1726
DR   ECACC; 84110802
DR   Wikidata; Q54907150
RX   PubMed=6084811;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb (Note=Also reacts with chicken MYB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 8
//
ID   MYB 2-7.77
AC   CVCL_B435
SY   MYB2-7.77; Myb2-7
DR   ATCC; CRL-1724
DR   ECACC; 84110801
DR   Wikidata; Q54907151
RX   PubMed=6084811;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-myb (Note=Also reacts with chicken MYB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 8
//
ID   MYB1#4
AC   CVCL_E7AD
SY   MYB 1#4; MYB1.4
RX   PubMed=37317833;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+MYB1+4+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/MYB1%25204%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Lys600Asnfs*2 (c.1800delA); ClinVar=VCV000042568; Zygosity=Heterozygous (PubMed=37317833).
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Ile1927Phe (c.5779A>T); ClinVar=VCV000487639; Zygosity=Heterozygous (PubMed=37317833).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 29,33.2
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 20,21
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MYB1#4 corrected
AC   CVCL_E7AF
SY   IsoMYB1#4 clone 37
RX   PubMed=37317833;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_corrected; p.Lys600Asnfs*2 (c.1800delA); ClinVar=VCV000042568; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37317833).
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Ile1927Phe (c.5779A>T); ClinVar=VCV000487639; Zygosity=Heterozygous (PubMed=37317833).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7AD ! MYB1#4
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MYB#2.2
AC   CVCL_E7AE
SY   MYB 2#2; MYB2.2
RX   PubMed=37317833;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+MYB2+2+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/MYB2%25202%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Lys600Asnfs*2 (c.1800delA); ClinVar=VCV000042568; Zygosity=Heterozygous (PubMed=37317833).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 15,15.2
ST   D21S11: 28
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MYB#2.2 corrected
AC   CVCL_E7AG
SY   IsoMYB2#2 clone 2
RX   PubMed=37317833;
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_corrected; p.Lys600Asnfs*2 (c.1800delA); ClinVar=VCV000042568; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37317833).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7AE ! MYB#2.2
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MYC 1-9E10.2
AC   CVCL_G671
SY   MYC1-9E10.2; 9E10
DR   CLO; CLO_0007915
DR   ATCC; CRL-1729
DR   Wikidata; Q54907152
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L708 ! Myc1-9E10
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   MYC CT 14-G4.3
AC   CVCL_G672
SY   MYCCT 14-G4.3; CT14-G4
DR   CLO; CLO_0007916
DR   ATCC; CRL-1727
DR   Wikidata; Q54907153
RX   PubMed=3915782;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   MYC CT 9-B7.3
AC   CVCL_G673
SY   MYCCT9-B7.3; CT9-B7
DR   CLO; CLO_0007917
DR   ATCC; CRL-1725
DR   Wikidata; Q54907154
RX   PubMed=3915782;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   Myc-CaP
AC   CVCL_J703
DR   BTO; BTO_0005126
DR   ATCC; CRL-3255
DR   Wikidata; Q54907155
RX   PubMed=16357166;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/I_am_having_difficulty_growing_the_Myc-CaP_mouse_prostate_cancer_cell_line_Does_anyone_have_a_suggestion_on_how_to_care_for_this_cell_line
CC   Doubling time: ~18 hours (ATCC=CRL-3255).
CC   Transformant: Myc.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: FVB Hi-Myc transgenic.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Myc1-3C7
AC   CVCL_L706
SY   Mycl-3C7
DR   ECACC; 85102203
DR   Wikidata; Q54907156
RX   PubMed=3915782;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   Myc1-6E10
AC   CVCL_U066
DR   Wikidata; Q54907159
RX   PubMed=3915782;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   Myc1-8F9
AC   CVCL_L707
SY   Mycl-8F9
DR   ECACC; 85102204
DR   NCBI_Iran; H120
DR   Wikidata; Q54907160
RX   PubMed=3915782;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   Myc1-9E10
AC   CVCL_L708
SY   Mycl-9E10; 9E10
DR   ABCD; ABCD_AF166
DR   ABCD; ABCD_AI179
DR   ABCD; ABCD_AI831
DR   ECACC; 83133297
DR   ECACC; 85102202
DR   Wikidata; Q54907161
RX   PubMed=3915782;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01106; Human MYC.
CC   Discontinued: ECACC; 83133297; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   MYCN-2 Tet-on
AC   CVCL_VL18
SY   MYCN-2; MYCN2
DR   BTO; BTO_0006118
DR   cancercelllines; CVCL_VL18
DR   Wikidata; Q95991616
RX   PubMed=15644444;
RX   PubMed=23440295;
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   MYCN-3 Tet-on
AC   CVCL_VL19
SY   MYCN-3
DR   cancercelllines; CVCL_VL19
DR   Wikidata; Q95991617
RX   PubMed=15644444;
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   MYD88 KO (C57/129)
AC   CVCL_C0I0
SY   MYD88 KO (C57/129) Macrophage Cell Line
DR   Kerafast; ENH179-FP
DR   Wikidata; Q112930149
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   MyDauBrain/48
AC   CVCL_RX58
SY   MyDauBrain-48
DR   Wikidata; Q54907162
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=98922; ! Myotis daubentonii (Daubenton's bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MyDauBrain/48B
AC   CVCL_RX59
SY   MyDauBrain-48B
DR   Wikidata; Q54907163
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=98922; ! Myotis daubentonii (Daubenton's bat)
HI   CVCL_RX58 ! MyDauBrain/48
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MyDauDa/46
AC   CVCL_RX60
SY   MyDauDa-46
DR   Wikidata; Q54907164
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=98922; ! Myotis daubentonii (Daubenton's bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MyDauLu/47
AC   CVCL_RX49
SY   MyDauLu-47
DR   Wikidata; Q54907165
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=98922; ! Myotis daubentonii (Daubenton's bat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MyDauLu/47.1
AC   CVCL_RX18
DR   Wikidata; Q54907166
RX   PubMed=21987760;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=98922; ! Myotis daubentonii (Daubenton's bat)
HI   CVCL_RX49 ! MyDauLu/47
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MyDauNi/2
AC   CVCL_RX19
DR   Wikidata; Q54907167
RX   PubMed=23232719;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=98922; ! Myotis daubentonii (Daubenton's bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MYE 2001
AC   CVCL_E785
DR   dbMHC; 48979
DR   IHW; IHW09417
DR   IPD-IMGT/HLA; 26021
DR   Wikidata; Q54907168
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*01:04N,02:01:01:01; B*15:01:01:05,49:01:01; C*03:03:01,07:01:01; DPA1*01:03:01:05,01:03:01:04; DPB1*04:01:01,04:01:01:02; DQA1*02:01,05:05:01:01; DQB1*03:01:01:03,02:02:01:01; DRB1*07:01:01:01,11:01:01; DRB3*02:02:01:02; DRB4*01:01:01:01 (IPD-IMGT/HLA=26021).
CC   HLA typing: A*01:04N,02:01:01:01; B*15:01:01:05,49:01:01; C*03:03:01:01,07:01:01:01; DPA1*01:03:01:04,01:03:01:05; DPB1*04:01:01:01(126:01),04:02:01:02(105:01); DQA1*02:01:01,05:05:01; DQB1*02:02:01:01,03:01:01:03; DRB1*07:01:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   MYE 2002
AC   CVCL_E786
DR   dbMHC; 48980
DR   IHW; IHW09418
DR   IPD-IMGT/HLA; 26022
DR   Wikidata; Q54907169
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*03:01:01,68:11N; B*07:02:01,44:02:01:01; C*07:02; DPB1*02:01:02,05:01; DQB1*03:01:01,03:02:01; DRB1*04:05:01,11:01:01; DRB3*02:02:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=26022).
CC   HLA typing: A*03:01:01:01,68:11N; B*07:02:01,44:02:01:03; C*07:02:01:03,07:04:01:01; DPA1*01:03:01:01,02:02:02; DPB1*02:01:02,05:01:01; DQA1*03:03:01:01,05:05:01; DQB1*03:01:01:03,03:02:01; DRB1*11:01:01:01,04:05:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   MYE 2003
AC   CVCL_E787
DR   dbMHC; 48981
DR   IHW; IHW09419
DR   IPD-IMGT/HLA; 26023
DR   Wikidata; Q54907170
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24:02:01:04,68:11N; B*35:03,44:02:01:01; C*07,12:03; DPB1*02:01:02; DQB1*03:01:01,06:03; DRB1*11:01:01,13:01:01; DRB3*01:01:02:01,02:02:01 (IPD-IMGT/HLA=26023).
CC   HLA typing: A*24:02:01:04,68:11N; B*35:03:01,44:02:01:03; C*07:04:01:01,12:03:01:01; DPA1*01:03:01:01; DPB1*02:01:02; DQA1*05:05:01,01:03:01; DQB1*03:01:01:03,06:03:01; DRB1*11:01:01:01,13:01:01; DRB3*01:01:02,02:02:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   MYE 2004
AC   CVCL_E788
DR   dbMHC; 48982
DR   IHW; IHW09420
DR   IPD-IMGT/HLA; 26024
DR   Wikidata; Q54907171
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*29:02:01:01,68:18N; B*14:02:01,57:01:01; C*06:02:01:01,08:02:01:01; DPA1*01:03:01:03; DPB1*02:01:02,06:01; DQA1*02:01,05:05:01:02; DQB1*03:01:01:03,03:03:02:01; DRB1*07:01:01,13:03:01; DRB3*01:01:02:01; DRB4*01:03:01:02N (IPD-IMGT/HLA=26024).
CC   HLA typing: A*29:02:01:01,68:18N; B*14:02:01:01,57:01:01; C*06:02:01:01,08:02:01:01; DPA1*01:03:01:01,01:03:01:03; DPB1*02:01:02,06:01:01; DQA1*02:01:01,05:05:01; DQB1*03:01:01:03,03:03:02:01; DRB1*07:01:01,13:03:01; DRB3*01:01:02; DRB4*01:03:01:02N (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   MYE 2006
AC   CVCL_E789
DR   dbMHC; 48983
DR   IHW; IHW09422
DR   IPD-IMGT/HLA; 26025
DR   Wikidata; Q54907172
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24:09N,29:02; B*27:05:02,44:03:01; C*02:02:02,16:04:01; DPB1*02:01:02,04:01:01; DQB1*02:02,05:01:01; DRB1*01:01:01,07:01:01; DRB4*01:01:01 (IPD-IMGT/HLA=26025).
CC   HLA typing: A*24:09N,29:02:01:01; B*27:05:02,44:03:01:01; C*02:02:02:01,16:01:01:01; DPA1*01:03:01:01,01:03:01:04; DPB1*02:01:02,04:01:01:01; DQA1*01:01:01,02:01:01; DQB1*02:02:01:01,05:01:01:03; DRB1*01:01:01,07:01:01; DRB4*01:01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Myeloid-iPSC
AC   CVCL_E7SU
RX   PubMed=26500142;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Dep%C3%B3sito+de+iPSC+human+Myeloid+cell.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   MyEnd
AC   CVCL_2131
SY   MyEND; Myocardial Endothelial
DR   Wikidata; Q54907173
RX   PubMed=11850521;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, myocardium; UBERON=UBERON_0002349.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Myf5 Myod1 DKO MEF 2C5/7
AC   CVCL_BS98
SY   2C5/7; dblKO; MyoD-null/Myf5-null dblKO
DR   GEO; GSM73062
DR   GEO; GSM73063
DR   GEO; GSM73064
DR   Wikidata; Q54907174
RX   PubMed=16275751;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97252; Myf5.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97275; Myod1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   MyglaAEC.B
AC   CVCL_RX02
SY   Myodes glareolus Airway Epithelial Cells B
DR   Wikidata; Q54907175
RX   PubMed=24457147;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Age of donor from personal communication of Eckerle, Isabella.
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
OX   NCBI_TaxID=447135; ! Myodes glareolus (Bank vole)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   MYL
AC   CVCL_D202
DR   Cosmic; 1151880
DR   Wikidata; Q54907176
RX   PubMed=17432977;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=17432977).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   MYL-R
AC   CVCL_D203
DR   Wikidata; Q54907177
RX   PubMed=17432977;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=17432977).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D202 ! MYL
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   MyLa 1850
AC   CVCL_M415
SY   MyLa1850
DR   Wikidata; Q54907178
RX   PubMed=17179233;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MyLa 1885
AC   CVCL_8327
SY   MyLa1885; MF1885
DR   Wikidata; Q54907179
RX   PubMed=16932349;
RX   PubMed=17179233;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M416 ! MyLa 1928
OI   CVCL_8328 ! MyLa 2000
OI   CVCL_8326 ! MyLa 3675
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MyLa 1928
AC   CVCL_M416
SY   MyLa1928; MF1928
DR   Wikidata; Q54907180
RX   PubMed=16932349;
RX   PubMed=17179233;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8327 ! MyLa 1885
OI   CVCL_8328 ! MyLa 2000
OI   CVCL_8326 ! MyLa 3675
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   MyLa 1929
AC   CVCL_5340
SY   MyLa1929
DR   Wikidata; Q54907182
RX   PubMed=17179233;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5341 ! MyLa 2039
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MyLa 2000
AC   CVCL_8328
SY   MyLa2000; MF2000
DR   Wikidata; Q54907183
RX   PubMed=16932349;
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8327 ! MyLa 1885
OI   CVCL_M416 ! MyLa 1928
OI   CVCL_8326 ! MyLa 3675
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   MyLa 2039
AC   CVCL_5341
SY   MyLa2039; My-La 2039
DR   BTO; BTO_0004842
DR   Wikidata; Q54907184
RX   PubMed=17179233;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5340 ! MyLa 1929
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   MyLa 2059
AC   CVCL_5342
SY   MyLa2059; My-La 2059; MF2059
DR   BTO; BTO_0004843
DR   Wikidata; Q54907185
RX   PubMed=17179233;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5341 ! MyLa 2039
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   MyLa 2355
AC   CVCL_M417
SY   MyLa2355
DR   Wikidata; Q54907186
RX   PubMed=17179233;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MyLa 3241
AC   CVCL_M418
SY   MyLa3241
DR   Wikidata; Q54907187
RX   PubMed=17179233;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   MyLa 3675
AC   CVCL_8326
SY   MyLa3675; MF3675
DR   Wikidata; Q54907188
RX   PubMed=16932349;
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8327 ! MyLa 1885
OI   CVCL_M416 ! MyLa 1928
OI   CVCL_8328 ! MyLa 2000
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   MYN9
AC   CVCL_A2XL
DR   ICLDB; myn9
DR   Wikidata; Q105510261
RX   PubMed=21688083;
RX   PubMed=32093360;
CC   Group: Insect cell line.
CC   Virology: Seems to be infected with deformed wing virus (DWV) (PubMed=21688083).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Myc.
OX   NCBI_TaxID=7460; ! Apis mellifera (Honeybee)
SX   Sex unspecified
AG   Larva 3-5D
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   Myok9
AC   CVCL_B4I5
DR   ABM; T0826
DR   CancerTools; 160394
DR   Kerafast; EUT501
DR   Wikidata; Q110433078
DR   Ximbio; 160394
RX   PubMed=32246189;
CC   Doubling time: ~16 hours (PubMed=32246189).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor from personal communication of Nghiem, Peter P.
CC   Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Golden Retriever x Labrador Retriever; VBO=VBO_0200610+VBO_0200800.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   MYP30
AC   CVCL_Z591
SY   MYP-30
DR   BTO; BTO_0005684
DR   Wikidata; Q54907190
RX   PubMed=7524206;
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   MYP30-fDAF
AC   CVCL_CZ86
DR   Wikidata; Q54907191
RX   PubMed=25671605;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112738; Cat CD55.
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_Z591 ! MYP30
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   MZ
AC   CVCL_ZC26
DR   Wikidata; Q98127387
RX   PubMed=16099873;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   MZ-1-EBV-B
AC   CVCL_VU73
SY   MZ-PC-1-EBV-LCL; MZ1-B; MZ1B
DR   Cell_Model_Passport; SIDM01878
DR   DepMap; ACH-002360
DR   Wikidata; Q95991676
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1434 ! MZ-PC-1
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   MZ-159
AC   CVCL_M407
DR   Wikidata; Q54907192
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-172
AC   CVCL_WE94
DR   IBRC; C10239
DR   Wikidata; Q95991683
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-18
AC   CVCL_M404
DR   Wikidata; Q54907193
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-188
AC   CVCL_WE95
DR   IBRC; C10323
DR   Wikidata; Q95991690
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-201
AC   CVCL_WE96
DR   IBRC; C10365
DR   Wikidata; Q95991692
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-208
AC   CVCL_WE97
DR   IBRC; C10380
DR   Wikidata; Q95991694
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-218
AC   CVCL_WE98
DR   IBRC; C10391
DR   Wikidata; Q95991696
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-226
AC   CVCL_RX80
DR   Wikidata; Q54907194
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MZ-256
AC   CVCL_M408
DR   Wikidata; Q54907195
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-257
AC   CVCL_M409
DR   Wikidata; Q54907196
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-290
AC   CVCL_RX81
DR   Wikidata; Q54907197
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   MZ-294
AC   CVCL_M410
DR   Wikidata; Q54907198
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-304
AC   CVCL_M411
DR   Wikidata; Q54907199
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-327
AC   CVCL_M412
DR   Wikidata; Q54907200
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-348
AC   CVCL_M413
DR   Wikidata; Q54907203
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-373
AC   CVCL_M414
DR   Wikidata; Q54907205
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-375
AC   CVCL_WE99
DR   IBRC; C11164
DR   Wikidata; Q95991715
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-377
AC   CVCL_WF00
DR   IBRC; C11165
DR   Wikidata; Q95991716
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-380
AC   CVCL_WF01
DR   IBRC; C11166
DR   Wikidata; Q95991717
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-381
AC   CVCL_WF02
DR   IBRC; C11167
DR   Wikidata; Q95991718
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-383
AC   CVCL_WF03
DR   IBRC; C11193
DR   Wikidata; Q95991719
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-384
AC   CVCL_WF04
DR   IBRC; C11192
DR   Wikidata; Q95991720
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-385
AC   CVCL_WF05
DR   IBRC; C11168
DR   Wikidata; Q95991722
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-386
AC   CVCL_WF06
DR   IBRC; C11169
DR   Wikidata; Q95991724
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-387
AC   CVCL_WF07
DR   IBRC; C11194
DR   Wikidata; Q95991725
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-388
AC   CVCL_WF08
DR   IBRC; C11195
DR   Wikidata; Q95991726
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-392
AC   CVCL_WF09
DR   IBRC; C11185
DR   Wikidata; Q95991727
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-393
AC   CVCL_WF10
DR   IBRC; C11170
DR   Wikidata; Q95991728
RX   PubMed=32358742;
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-395
AC   CVCL_WF11
DR   IBRC; C11196
DR   Wikidata; Q95991730
RX   PubMed=32358742;
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-396
AC   CVCL_WF12
DR   IBRC; C11171
DR   Wikidata; Q95991731
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-397
AC   CVCL_WF13
DR   IBRC; C11197
DR   Wikidata; Q95991732
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-398
AC   CVCL_WF14
DR   IBRC; C11186
DR   Wikidata; Q95991733
RX   PubMed=32358742;
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-45
AC   CVCL_WF15
DR   IBRC; C10169
DR   Wikidata; Q95991734
RX   PubMed=32358742;
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   MZ-51
AC   CVCL_M405
DR   Wikidata; Q54907206
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-54
AC   CVCL_M406
DR   Wikidata; Q54907207
RX   PubMed=17924059;
RX   PubMed=18670645;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   MZ-7-EBV-B
AC   CVCL_VU72
SY   MZ-7-B; MZ7-B; MZ7B
DR   Cell_Model_Passport; SIDM01879
DR   DepMap; ACH-002361
DR   Wikidata; Q95991736
RX   PubMed=16247014;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1436 ! MZ-MEL-7
SX   Female
AG   25-26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   Mz-ChA-1
AC   CVCL_6932
SY   MZ CHA-1; Mz-ChA1; MzChA-1; MzChA1
DR   BTO; BTO_0003311
DR   Cosmic; 924012
DR   Cosmic; 927192
DR   Wikidata; Q54907208
RX   CelloPub=CLPUB00275;
RX   PubMed=4056357;
RX   PubMed=9824643;
RX   PubMed=21533411;
RX   PubMed=32899426;
CC   Doubling time: 3-5 days (Note=At 10th passage) (PubMed=4056357); 41 hours (PubMed=9824643).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   Mz-ChA-2
AC   CVCL_6933
SY   MZ CHA-2; Mz-ChA2; MzChA-2; MzChA2
DR   Cosmic; 924013
DR   Cosmic; 927193
DR   Cosmic; 2674058
DR   Wikidata; Q54907209
RX   CelloPub=CLPUB00275;
RX   PubMed=4056357;
RX   PubMed=9824643;
RX   PubMed=21533411;
CC   Doubling time: 48-60 hours (Note=At 10th passage) (PubMed=4056357); 34 hours (PubMed=9824643).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   Mz-ChA-3
AC   CVCL_H708
SY   MZ CHA-3; MZ-CHA-3
DR   cancercelllines; CVCL_H708
DR   Wikidata; Q54907210
RX   PubMed=28765120;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=28765120).
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   MZ-CO-1
AC   CVCL_7685
SY   MZ CO-1; MZ-Co 1; MainZ-COlon cancer-1
DR   Wikidata; Q54907211
RX   PubMed=7654439;
RX   PubMed=8375931;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   MZ-CRC-1
AC   CVCL_A656
SY   MZCRC1
DR   cancercelllines; CVCL_A656
DR   Cosmic; 796732
DR   Cosmic; 1239956
DR   Cosmic; 2036698
DR   Cosmic; 2050373
DR   Wikidata; Q54907212
RX   CelloPub=CLPUB00385;
RX   PubMed=7736432;
RX   PubMed=19897677;
RX   PubMed=30737244;
CC   Doubling time: 12-16 days (CelloPub=CLPUB00385).
CC   Sequence variation: Mutation; HGNC; HGNC:4778; H3-4; Simple; p.Arg3Ter (c.7C>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:6913; MAX; Simple; c.295+1G>A; ClinVar=VCV000186993; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:30064; PBRM1; Simple; p.Arg534Ter (c.1600C>T); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Met918Thr (c.2753T>C); ClinVar=VCV000013919; Zygosity=Heterozygous (PubMed=19897677; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 12,17
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 20
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C46099; Hereditary thyroid gland medullary carcinoma
DI   ORDO; Orphanet_99361; Familial medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   MZ-GC-1
AC   CVCL_4U28
DR   Wikidata; Q54907213
RX   PubMed=7599790;
CC   Doubling time: 7 days (PubMed=7599790).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   MZ-GC-2
AC   CVCL_4U29
SY   MzGC2
DR   Wikidata; Q54907214
RX   PubMed=7599790;
CC   Doubling time: 45 hours (PubMed=7599790).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   Mz-Hep-1
AC   CVCL_5A02
SY   MzHep1; Mainz-Hepatoma-1
DR   Wikidata; Q54907215
RX   PubMed=2415435;
RX   PubMed=2784858;
RX   PubMed=8738480;
CC   Doubling time: 60 hours (PubMed=2415435).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   MZ-LC-1
AC   CVCL_7686
SY   MainZ-Lung Cancer-1
DR   Wikidata; Q54907217
RX   PubMed=7654439;
RX   PubMed=8375931;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   MZ-MEL-11
AC   CVCL_7687
SY   MZ-Mel-11
DR   Wikidata; Q54907218
RX   PubMed=7654439;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   MZ-MEL-12
AC   CVCL_A1LG
SY   MZ-Mel-12; MZ12-MEL
DR   Wikidata; Q102114572
RX   PubMed=30626427;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   MZ-MEL-13
AC   CVCL_B286
SY   MZ-Mel-13; Mz-Mel-13; MZ MEL 13; MZ Mel 13; MZ13-MEL
DR   cancercelllines; CVCL_B286
DR   Cosmic; 972268
DR   Cosmic; 2163795
DR   ESTDAB; ESTDAB-052
DR   Wikidata; Q54907219
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*02:01; B*27:04,18:01; C*04:01:01,07:01:01; DPB1*04:01; DQB1*03:01:01; DRB1*11:03:01,04:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-052
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   FGA: 21
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   MZ-MEL-18
AC   CVCL_7688
SY   MZ-Mel-18
DR   Wikidata; Q54907220
RX   PubMed=8375931;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   MZ-MEL-19
AC   CVCL_8061
SY   MZ-Mel-19; Mz-Mel-19; MZ Mel 19; Mz-19; MZ19
DR   Wikidata; Q54907221
RX   PubMed=10910072;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DE24 ! MZ-MEL-19/B-LCL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   MZ-MEL-19/B-LCL
AC   CVCL_DE24
SY   MZ-Mel-19/B-LCL
DR   ESTDAB; ESTDAB-054
DR   Wikidata; Q54907222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ESTDAB=ESTDAB-054
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 9
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8061 ! MZ-MEL-19
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 8
//
ID   MZ-MEL-2
AC   CVCL_1435
SY   Mz-Mel-2; MZ Mel 2; MZ-2 Mel; MZ2-MEL; MZ2-Mel; MZ2-mel; MZ2MEL
DR   CLO; CLO_0037132
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1435
DR   Cell_Model_Passport; SIDM00179
DR   ChEMBL-Cells; CHEMBL3308272
DR   ChEMBL-Targets; CHEMBL2366226
DR   Cosmic; 971777
DR   Cosmic-CLP; 971777
DR   DepMap; ACH-002165
DR   EGA; EGAS00001000978
DR   GDSC; 971777
DR   GEO; GSM1507939
DR   GEO; GSM1670140
DR   IARC_TP53; 27565
DR   LINCS_LDP; LCL-1278
DR   PharmacoDB; MZ2MEL_976_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1435
DR   Wikidata; Q54907223
RX   PubMed=2529220;
RX   PubMed=3972469;
RX   PubMed=8509230;
RX   PubMed=8566071;
RX   PubMed=9637538;
RX   PubMed=20164919;
RX   PubMed=25502142;
RX   PubMed=25728708;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=25728708; Cosmic-CLP=971777; DepMap=ACH-002165).
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (Cosmic-CLP=971777; DepMap=ACH-002165).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.15%; East Asian, North=0.41%; East Asian, South=0.66%; South Asian=0.41%; European, North=64.57%; European, South=33.8% (PubMed=30894373).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): Cosmic-CLP=971777
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5U5 ! MZ2-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   MZ-MEL-3.1
AC   CVCL_7689
SY   MZ-Mel-3.1; MZ-Mel-3; MzMel3
DR   cancercelllines; CVCL_7689
DR   Cosmic; 2163796
DR   ESTDAB; ESTDAB-055
DR   Wikidata; Q54907224
RX   PubMed=8375931;
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*26:01,26:01; B*18:01,18:01; C*07:01:01,07:01:01; DPB1*04:01; DQB1*06:02,03:01:01; DRB1*11:01,15:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-055
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 9
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   MZ-MEL-4
AC   CVCL_B287
SY   Mz-Mel-4; MZ Mel 4
DR   Wikidata; Q54907225
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   MZ-MEL-5
AC   CVCL_A468
SY   MZ-Mel-5; Mz-Mel-5; MZ MEL 5; MZ5-MEL
DR   cancercelllines; CVCL_A468
DR   Cosmic; 972269
DR   Cosmic; 2163797
DR   ESTDAB; ESTDAB-056
DR   Wikidata; Q54907226
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*32:01,26:01; B*07:02,57:02; C*07:02,06:02; DPB1*04:01,04:02; DQB1*06:02,05:01; DRB1*15:01,01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg15Lys (c.44G>A); ClinVar=VCV000404147; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.782+1G>C; ClinVar=VCV003148166; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-056
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,13
ST   FGA: 21,25
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   MZ-MEL-6
AC   CVCL_7690
SY   MZ-Mel-6
DR   Wikidata; Q54907227
RX   PubMed=7654439;
RX   PubMed=8375931;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   MZ-MEL-7
AC   CVCL_1436
SY   MZ-Mel-7; MZ7-MEL; MZ7-mel; MZ7MEL; MZ7
DR   CLO; CLO_0037133
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1436
DR   Cell_Model_Passport; SIDM00516
DR   ChEMBL-Cells; CHEMBL3308546
DR   ChEMBL-Targets; CHEMBL2366138
DR   Cosmic; 753596
DR   Cosmic-CLP; 753596
DR   DepMap; ACH-002166
DR   EGA; EGAS00001000978
DR   GDSC; 753596
DR   GEO; GSM1670141
DR   GEO; GSM3039509
DR   IARC_TP53; 21523
DR   LINCS_HMS; 51006
DR   LINCS_LDP; LCL-1279
DR   PharmacoDB; MZ7mel_977_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1436
DR   Wikidata; Q54907228
RX   PubMed=16247014;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=753596; DepMap=ACH-002166).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.42%; Native American=0.24%; East Asian, North=1.19%; East Asian, South=0.69%; South Asian=0.03%; European, North=67.07%; European, South=30.35% (PubMed=30894373).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
ST   Source(s): Cosmic-CLP=753596
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU72 ! MZ-7-EBV-B
SX   Female
AG   25-26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   MZ-MEL-9
AC   CVCL_C619
SY   MZ-Mel-9; MZ9-MEL; MZ9MEL
DR   Wikidata; Q54907229
RX   PubMed=30626427;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   MZ-NKC-1790
AC   CVCL_A1LC
SY   MainZ-Normal Kidney Cell-1790
DR   Wikidata; Q102114573
RX   PubMed=7654439;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X409 ! MZ1790RC
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   MZ-NKC-1795
AC   CVCL_A1LD
SY   MainZ-Normal Kidney Cell-1795
DR   Wikidata; Q102114574
RX   PubMed=7654439;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X416 ! MZ1795RC
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   MZ-PC-1
AC   CVCL_1434
AS   CVCL_A657
SY   MZPC-1; MZ1-PC; MZ1PC; MainZ-Pancreatic Cancer-1
DR   CLO; CLO_0037111
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1434
DR   Cell_Model_Passport; SIDM00053
DR   ChEMBL-Cells; CHEMBL3308242
DR   ChEMBL-Targets; CHEMBL2366204
DR   Cosmic; 753595
DR   Cosmic; 948732
DR   Cosmic-CLP; 753595
DR   DepMap; ACH-002164
DR   EGA; EGAS00001000978
DR   GDSC; 753595
DR   GEO; GSM1670139
DR   IARC_TP53; 21522
DR   LINCS_LDP; LCL-1795
DR   PharmacoDB; MZ1PC_975_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1434
DR   Wikidata; Q54907230
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=7599790;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 45 hours (PubMed=7599790).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (Cosmic-CLP=753595; DepMap=ACH-002164).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (Cosmic-CLP=753595; DepMap=ACH-002164).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (Cosmic-CLP=753595; DepMap=ACH-002164).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.66%; Native American=0%; East Asian, North=2.92%; East Asian, South=0%; South Asian=1.85%; European, North=62.36%; European, South=32.2% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=753595
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU73 ! MZ-1-EBV-B
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   MZ-PC-2
AC   CVCL_A658
SY   MZPC-2; MainZ-Pancreatic Cancer-2
DR   cancercelllines; CVCL_A658
DR   Cosmic; 948733
DR   IARC_TP53; 3380
DR   Wikidata; Q54907231
RX   PubMed=8026879;
RX   PubMed=8514455;
RX   PubMed=9665481;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=8026879).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   MZ-PC-3
AC   CVCL_4U30
SY   MZPC-3; MainZ-Pancreatic Cancer-3
DR   Wikidata; Q54907232
RX   PubMed=9665481;
CC   From: Knuth, Alexander; Johannes Gutenberg Universitat; Mainz; Germany.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 5
//
ID   MZ-PC-4
AC   CVCL_A659
SY   MZPC-4; MainZ-Pancreatic Cancer-4
DR   cancercelllines; CVCL_A659
DR   Cosmic; 948734
DR   IARC_TP53; 3381
DR   Wikidata; Q54907233
RX   PubMed=8026879;
RX   PubMed=9665481;
CC   From: Knuth, Alexander; Johannes Gutenberg Universitat; Mainz; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Trp (c.405C>G); ClinVar=VCV000376561; Zygosity=Unspecified (PubMed=8026879).
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   Mz-Sto-1
AC   CVCL_S859
SY   MZ-Sto-1; Mainz-Stomach-1
DR   Wikidata; Q54907234
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=2784858;
RX   PubMed=2820743;
CC   Population: Caucasian.
CC   Doubling time: 28-36 hours (PubMed=2820743).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   MZ070782
AC   CVCL_E790
SY   MZO70782; MZ 070782
DR   dbMHC; 48984
DR   ECACC; 88052002
DR   IHW; IHW09002
DR   IPD-IMGT/HLA; 11120
DR   Wikidata; Q54907235
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Jewish; Ashkenazi.
CC   HLA typing: A*24:02:01:01,24:02:01:12; B*14:02:01:01; C*02:02:02:03,08:02:01:01; DPA1*01; DPB1*04:01:01; DQA1*01:01:02; DQB1*05:01:01; DRA*01:01; DRB1*01:02:01; DRB6*01:01 (IPD-IMGT/HLA=11120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   MZ1257RC
AC   CVCL_E044
SY   MZ1257-RCC; MZ-1257-RCC; MZ 1257 RC; MZ1257
DR   Wikidata; Q54907236
RX   CelloPub=CLPUB00420;
RX   PubMed=7989126;
RX   PubMed=8864171;
RX   PubMed=8900424;
RX   PubMed=9816317;
RX   PubMed=10074909;
RX   PubMed=11987130;
RX   PubMed=17200335;
RX   PubMed=21595034;
RX   PubMed=23696916;
CC   Omics: Proteomics; 2DE-MS.
CC   Misspelling: MZ1275RC; PubMed=21595034; Note=In material and methods.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   MZ1774RC
AC   CVCL_X415
SY   MZ1774-RCC; MZ 1774 RC; MZ1774
DR   Wikidata; Q54907237
RX   CelloPub=CLPUB00420;
RX   PubMed=7989126;
RX   PubMed=8864171;
RX   PubMed=9816317;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ1790RC
AC   CVCL_X409
AS   CVCL_A1LE
SY   MZ1790-RCC; MZ 1790 RC; MZ1790; MZ-RCC-1790; MainZ-Renal Cancer Cell-1790
DR   Wikidata; Q54907238
RX   CelloPub=CLPUB00420;
RX   PubMed=7654439;
RX   PubMed=8864171;
RX   PubMed=9816317;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1LC ! MZ-NKC-1790
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ1795RC
AC   CVCL_X416
AS   CVCL_A1LF
SY   MZ 1795 RC; MZ1795; MZ-RCC-1795; MainZ-Renal Cancer Cell-1795
DR   Wikidata; Q54907239
RX   CelloPub=CLPUB00420;
RX   PubMed=7654439;
RX   PubMed=9816317;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1LD ! MZ-NKC-1795
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   Mz18
AC   CVCL_M401
DR   Wikidata; Q54907240
RX   PubMed=11688964;
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MZ1846RC
AC   CVCL_X417
SY   MZ 1846 RC; MZ1846
DR   Wikidata; Q54907241
RX   CelloPub=CLPUB00420;
RX   PubMed=9816317;
RX   PubMed=12833523;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   MZ1851LN
AC   CVCL_X418
SY   MZ 1851-LN; MZ1851 LN
DR   Wikidata; Q54907242
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E045 ! MZ1851RC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   MZ1851RC
AC   CVCL_E045
SY   MZ1851-RCC; MZ 1851 RC; MZ-1851-RC; MZ1851
DR   Wikidata; Q54907243
RX   CelloPub=CLPUB00420;
RX   PubMed=7989126;
RX   PubMed=8864171;
RX   PubMed=8900424;
RX   PubMed=9816317;
RX   PubMed=10074909;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X418 ! MZ1851LN
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MZ1879RC
AC   CVCL_X406
SY   MZ1879-RCC; MZ 1879 RC; MZ1879
DR   Wikidata; Q54907244
RX   CelloPub=CLPUB00420;
RX   PubMed=7989126;
RX   PubMed=9816317;
RX   PubMed=12833523;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   MZ1940RC
AC   CVCL_X407
SY   MZ-1940-RCC; MZ1940-RCC; MZ 1940 RC; MZ1940
DR   Wikidata; Q54907247
RX   CelloPub=CLPUB00420;
RX   PubMed=7989126;
RX   PubMed=8900424;
RX   PubMed=9816317;
RX   PubMed=11987130;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   MZ1973/10-4
AC   CVCL_7684
SY   MZ1973-10-4; MZ1973-10-4-RCC; MZ1973 10-4RC
DR   Wikidata; Q54907249
RX   CelloPub=CLPUB00420;
RX   PubMed=8864171;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E046 ! MZ1973RC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   MZ1973RC
AC   CVCL_E046
SY   MZ1973-RCC; MZ 1973 RC; MZ1973
DR   Wikidata; Q54907248
RX   PubMed=8864171;
RX   PubMed=10074909;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   MZ1979RC
AC   CVCL_X408
SY   MZ1979-RCC; MZ1979
DR   Wikidata; Q54907250
RX   PubMed=7989126;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2-EBV
AC   CVCL_C5U5
DR   Wikidata; Q116049842
RX   PubMed=2529220;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1435 ! MZ-MEL-2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   MZ2-MEL.2.2
AC   CVCL_C5VC
SY   MZ2-Mel 2.2; MZ2-MEL clone 2.2
DR   Wikidata; Q116049843
RX   PubMed=2529220;
RX   PubMed=8509230;
RX   PubMed=8566071;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U7 ! MZ2-MEL.3.1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MZ2-MEL.3.0
AC   CVCL_C5U4
SY   MZ2-MEL clone 3.0
DR   Wikidata; Q116049844
RX   PubMed=2529220;
RX   PubMed=8509230;
RX   PubMed=8566071;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1435 ! MZ-MEL-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MZ2-MEL.3.1
AC   CVCL_C5U7
SY   MZ2-Mel 3.1
DR   Wikidata; Q116049845
RX   PubMed=2529220;
RX   PubMed=8566071;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U4 ! MZ2-MEL.3.0
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   MZ2-MEL.43
AC   CVCL_C5U6
DR   Wikidata; Q116049847
RX   PubMed=2529220;
RX   PubMed=8566071;
RX   PubMed=8642259;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5U4 ! MZ2-MEL.3.0
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   Mz21
AC   CVCL_M402
DR   Wikidata; Q54907251
RX   PubMed=11688964;
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MZ2175RC
AC   CVCL_RV30
SY   MZ2175
DR   Wikidata; Q54907252
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MZ2733RC
AC   CVCL_X419
SY   MZ 2733 RC; MZ2733
DR   Wikidata; Q54907254
RX   CelloPub=CLPUB00420;
RX   PubMed=11987130;
RX   PubMed=17200335;
RX   PubMed=21595034;
RX   PubMed=23696916;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RV32 ! MZ2733SVNN
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   MZ2733SVNN
AC   CVCL_RV32
SY   MZ2733NN
DR   Wikidata; Q54907253
RX   CelloPub=CLPUB00420;
RX   PubMed=11987130;
RX   PubMed=21595034;
RX   PubMed=23696916;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X419 ! MZ2733RC
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   MZ2789RC
AC   CVCL_RV36
SY   MZ2789 RC
DR   Wikidata; Q54907255
RX   CelloPub=CLPUB00420;
RX   PubMed=12833523;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   MZ2858RC
AC   CVCL_X420
SY   MZ 2858 RC; MZ2858
DR   Wikidata; Q54907256
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=21595034;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4LX ! MZ2858SVNN
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2858SVNN
AC   CVCL_C4LX
DR   Wikidata; Q116049848
RX   PubMed=21595034;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X420 ! MZ2858RC
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   MZ2861RC
AC   CVCL_X421
SY   MZ 2861 RC; MZ2861
DR   Wikidata; Q54907257
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=21595034;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4LW ! MZ2861SVNN
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2861SVNN
AC   CVCL_C4LW
DR   Wikidata; Q116049849
RX   PubMed=21595034;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X421 ! MZ2861RC
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   MZ2862RC
AC   CVCL_X422
SY   MZ 2862 RC; MZ2862
DR   Wikidata; Q54907258
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2865RC
AC   CVCL_E047
SY   MZ 2865 RC; MZ2865
DR   Wikidata; Q54907259
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   MZ2872RC
AC   CVCL_RV37
DR   Wikidata; Q54907260
RX   CelloPub=CLPUB00420;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MZ2875RC
AC   CVCL_RV38
DR   Wikidata; Q54907261
RX   CelloPub=CLPUB00420;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MZ2877RC
AC   CVCL_X423
SY   MZ 2877 RC; MZ2877
DR   Wikidata; Q54907262
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2885RC
AC   CVCL_X424
SY   MZ 2885 RC; MZ2885
DR   Wikidata; Q54907263
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2901RC
AC   CVCL_RV39
DR   Wikidata; Q54907264
RX   CelloPub=CLPUB00420;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MZ2902RC
AC   CVCL_X425
SY   MZ 2902 RC; MZ2902
DR   Wikidata; Q54907265
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2904RC
AC   CVCL_RV40
DR   Wikidata; Q54907266
RX   CelloPub=CLPUB00420;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MZ2905RC
AC   CVCL_X426
SY   MZ 2905 RC; MZ2905
DR   Wikidata; Q54907267
RX   CelloPub=CLPUB00420;
RX   PubMed=17200335;
RX   PubMed=21595034;
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   MZ2907RC
AC   CVCL_RV41
DR   Wikidata; Q54907268
RX   CelloPub=CLPUB00420;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   MZ2931RC
AC   CVCL_RV31
SY   MZ2931
DR   Wikidata; Q54907269
RX   PubMed=23696916;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   Mz35
AC   CVCL_M403
DR   Wikidata; Q54907270
RX   PubMed=11688964;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   MZ611ATRT
AC   CVCL_D4ZG
DR   Wikidata; Q127382913
RX   PubMed=38329694;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=38329694).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.541delC; Zygosity=Heterozygous (PubMed=38329694).
CC   Derived from site: In situ; Brain, quadrigeminal cistern; UBERON=UBERON_0004052.
ST   Source(s): PubMed=38329694
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 9,10
ST   D21S11: 30
ST   D5S818: 9,12
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   MZ93
AC   CVCL_F999
DR   TKG; TKG 0712
DR   Wikidata; Q54907271
RX   PubMed=11792418;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=11792418).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0712
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   N
AC   CVCL_UZ57
SY   Strain N
DR   Wikidata; Q95991822
RX   PubMed=10648628;
RX   PubMed=12077343;
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at ~52-55 PDL (PubMed=10648628; PubMed=12077343).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   N-176-15
AC   CVCL_XA76
DR   CCRID; 4201PAT-CCTCC00160
DR   Wikidata; Q95991824
RX   Patent=CN100519583C;
RX   PubMed=18986662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200507.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   N-1A-103
AC   CVCL_L428
SY   N103
DR   Wikidata; Q54907273
RX   PubMed=4400294;
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   N-2.12
AC   CVCL_VH21
DR   Wikidata; Q54907274
RX   PubMed=25798938;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
ST   Source(s): PubMed=25798938
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 16,23
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH19 ! MDS-2.13
OI   CVCL_VH20 ! MDS-2.A3
OI   CVCL_VH22 ! N-2.8
OI   CVCL_VH24 ! N-2.A2
OI   CVCL_VH23 ! N-2.A11
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   N-2.8
AC   CVCL_VH22
DR   Wikidata; Q54907275
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH19 ! MDS-2.13
OI   CVCL_VH20 ! MDS-2.A3
OI   CVCL_VH21 ! N-2.12
OI   CVCL_VH24 ! N-2.A2
OI   CVCL_VH23 ! N-2.A11
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   N-2.A11
AC   CVCL_VH23
DR   Wikidata; Q54907276
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH19 ! MDS-2.13
OI   CVCL_VH20 ! MDS-2.A3
OI   CVCL_VH22 ! N-2.8
OI   CVCL_VH21 ! N-2.12
OI   CVCL_VH24 ! N-2.A2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   N-2.A2
AC   CVCL_VH24
DR   Wikidata; Q54907277
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH19 ! MDS-2.13
OI   CVCL_VH20 ! MDS-2.A3
OI   CVCL_VH22 ! N-2.8
OI   CVCL_VH21 ! N-2.12
OI   CVCL_VH23 ! N-2.A11
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   N-3.10
AC   CVCL_VH18
DR   Wikidata; Q54907278
RX   PubMed=25798938;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell of bone marrow; CL=CL_0010004.
ST   Source(s): PubMed=25798938
ST   Amelogenin: X,Y
ST   D13S317: 8,12
ST   D18S51: 13,18
ST   D21S11: 28,30
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH15 ! MDS-3.1
OI   CVCL_VH16 ! MDS-3.4
OI   CVCL_VH17 ! MDS-3.5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   N-iPSC-1
AC   CVCL_VT51
DR   Wikidata; Q95991835
RX   PubMed=23019320;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   N-NaPi2b(15/1)
AC   CVCL_C5W7
DR   Wikidata; Q116049850
RX   PubMed=21466284;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95436; Human SLC34A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   N-NaPi2b(18/1)
AC   CVCL_C5W8
DR   Wikidata; Q116049851
RX   PubMed=21466284;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95436; Human SLC34A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   N-S.2.1
AC   CVCL_G338
DR   CLO; CLO_0008199
DR   ATCC; TIB-108
DR   Wikidata; Q54907279
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM, lambda.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   N-S.4.1
AC   CVCL_G339
DR   CLO; CLO_0008200
DR   ATCC; TIB-110
DR   Wikidata; Q54907280
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   N-S.7
AC   CVCL_G340
DR   CLO; CLO_0008201
DR   ATCC; TIB-114
DR   Wikidata; Q54907282
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   N-S.8.1
AC   CVCL_G341
DR   CLO; CLO_0008202
DR   ATCC; TIB-109
DR   Wikidata; Q54907283
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   N/61
AC   CVCL_B6UB
DR   Wikidata; Q112129389
RX   PubMed=2478103;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   N/92
AC   CVCL_B6UC
DR   Wikidata; Q112129390
RX   PubMed=2478103;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 4
//
ID   N/bmi1/TERT
AC   CVCL_UZ60
DR   Wikidata; Q95991842
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ57 ! N
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   N/E6E7
AC   CVCL_UZ61
DR   Wikidata; Q95991843
RX   PubMed=12077343;
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ57 ! N
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   N/N1003A
AC   CVCL_0450
SY   N/N 1003A; NN 1003A; NN1003A
DR   MCCL; MCC:0000347
DR   CCRID; 1101RAB-PUMC000196
DR   Wikidata; Q54907284
RX   PubMed=2920780;
RX   PubMed=3569698;
RX   PubMed=9990330;
CC   Doubling time: 24 hours (PubMed=3569698).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   4-6D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   N/N1003A-KL
AC   CVCL_B5M7
SY   N/N 1003A-KL
DR   Wikidata; Q112129391
RX   PubMed=9990330;
CC   Genetic integration: Method=Transfection; Gene=RGD; 2279; Cat.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_0450 ! N/N1003A
SX   Female
AG   4-6D
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   N/TERT-1
AC   CVCL_CW92
SY   N/Tert-1; N/TERT 1; N/TERT1; NTERT-1; NTert-1; NTert1
DR   Wikidata; Q54907285
RX   PubMed=10648628;
RX   PubMed=28928444;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Karyotypic information: 47,XY,+20 (PubMed=28928444).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ57 ! N
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   N/Tert-1 ADRB2
AC   CVCL_C3K0
SY   N/Tert MSCV-IP-N-HA-ADRB2
DR   Wikidata; Q114312331
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:286; ADRB2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 AKT1
AC   CVCL_C3K1
SY   N/Tert MSCV-IP-N-HA-AKT1
DR   Wikidata; Q114312332
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:391; AKT1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 AMPH
AC   CVCL_C3K2
SY   N/Tert MSCV-IP-N-HA-AMPH
DR   Wikidata; Q114312333
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:471; AMPH (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 BAP1
AC   CVCL_C3K3
SY   N/Tert MSCV-IP-N-FlagHA-BAP1
DR   Wikidata; Q114312335
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:950; BAP1 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 CHAF1B
AC   CVCL_C3K4
SY   N/Tert MSCV-IP-N-HA-CHAF1B
DR   Wikidata; Q114312337
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1911; CHAF1B (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 CHEK2
AC   CVCL_C3K5
SY   N/Tert MSCV-IP-N-HA-CHEK2
DR   Wikidata; Q114312339
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16627; CHEK2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 FOSL1
AC   CVCL_C3K6
SY   N/Tert MSCV-IP-N-HA-FOSL1
DR   Wikidata; Q114312340
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13718; FOSL1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 GARS
AC   CVCL_C3K7
SY   N/Tert MSCV-IP-N-HA-GARS
DR   Wikidata; Q114312341
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4162; GARS1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 GLTSCR1
AC   CVCL_C3K8
SY   N/Tert MSCV-IP-N-HA-GLTSCR1
DR   Wikidata; Q114312346
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4332; BICRA (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 GPRC5B
AC   CVCL_C3K9
SY   N/Tert MSCV-IP-N-HA-GPRC5B
DR   Wikidata; Q114312349
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13308; GPRC5B (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV16 E6 Flag-HA
AC   CVCL_C3IV
SY   N/Tert MSCV-IP-N-FlagHA-16E6
DR   Wikidata; Q114312353
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV16 E6 Flag-HA 8S9A10T
AC   CVCL_C3IW
SY   N/Tert MSCV-IP-N-FlagHA 16E6 8S9A10T
DR   Wikidata; Q114312357
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With p.Arg15Ser, p.Pro16Ala and p.Arg17Ser and a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV16 E6 Flag-HA Delta146-151
AC   CVCL_C3IX
SY   N/Tert MSCV-IP-N-FlagHA 16E6 Delta146-151
DR   Wikidata; Q114312361
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With p.Arg153_Leu158del and a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV16 E6 Flag-HA I128T
AC   CVCL_C3IY
SY   N/Tert MSCV-IP-N-FlagHA 16E6 I128T
DR   Wikidata; Q114312363
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With p.Ile135Thr and a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV16 E6 HA
AC   CVCL_C3IZ
SY   N/Tert-16E6; N/Tert-1 HA-16E6; N/Tert MSCV-IP-N-HA-16E6
DR   GEO; GSM1223702
DR   GEO; GSM1223703
DR   GEO; GSM1223704
DR   GEO; GSM1223705
DR   GEO; GSM1223706
DR   GEO; GSM1223707
DR   GEO; GSM1223708
DR   GEO; GSM1223709
DR   Wikidata; Q114312367
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV16 E6 HA + E7
AC   CVCL_C3J0
SY   N/Tert-1 HA-16E6 plus Untagged-16E7
DR   Wikidata; Q114312371
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3IZ ! N/Tert-1 HPV16 E6 HA
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV16 E7
AC   CVCL_C3J1
SY   N/Tert-16E7; N/Tert MSCV-P-C-FlagHA-16E7
DR   Wikidata; Q114312372
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV17a E6
AC   CVCL_C3J2
SY   N/Tert-17aE6; N/Tert MSCV-IP-N-HA-17aE6
DR   Wikidata; Q114312376
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P36805; Human papillomavirus type 17 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV17a E7
AC   CVCL_C3J3
SY   N/Tert-17aE7; N/Tert MSCV-P-C-FlagHA-17aE7
DR   Wikidata; Q114312378
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P36821; Human papillomavirus type 17a protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV18 E6
AC   CVCL_C3J4
SY   N/Tert-18E6; N/Tert MSCV-IP-N-HA-18E6
DR   Wikidata; Q114312379
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06463; Human papillomavirus type 18 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV18 E7
AC   CVCL_C3J5
SY   N/Tert-18E7; N/Tert MSCV-P-C-FlagHA-18E7
DR   Wikidata; Q114312380
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06788; Human papillomavirus type 18 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV20 E6
AC   CVCL_C3J6
SY   N/Tert-20E6; N/Tert MSCV-IP-N-HA-20E6
DR   Wikidata; Q114312381
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P28831; Human papillomavirus type 20 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV25 E6
AC   CVCL_C3J7
SY   N/Tert-25E6; N/Tert MSCV-IP-N-HA-25E6
DR   Wikidata; Q114312382
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P28833; Human papillomavirus type 25 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV25 E7
AC   CVCL_C3J8
SY   N/Tert-25E7; N/Tert MSCV-P-C-FlagHA-25E7
DR   Wikidata; Q114312383
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P36823; Human papillomavirus type 25 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV2a E6
AC   CVCL_C3J9
SY   N/Tert-2aE6; N/Tert-1 HA-2aE6; N/Tert MSCV-IP-N-HA-2aE6
DR   Wikidata; Q114312384
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P25484; Human papillomavirus type 2a protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P25485; Human papillomavirus type 2a protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV2a E6 HA + E7
AC   CVCL_C3JA
SY   N/Tert-1 HA-2aE6 plus Untagged-2aE7
DR   Wikidata; Q114312385
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P25484; Human papillomavirus type 2a protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3J9 ! N/Tert-1 HPV2a E6
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV2a E7
AC   CVCL_C3JB
SY   N/Tert-2aE7; N/Tert MSCV-P-C-FlagHA-2aE7
DR   Wikidata; Q114312386
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P25485; Human papillomavirus type 2a protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV31 E7
AC   CVCL_C3JC
SY   N/Tert-31E7; N/Tert MSCV-P-C-FlagHA-31E7
DR   Wikidata; Q114312387
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17387; Human papillomavirus type 31 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV33 E6
AC   CVCL_C3JD
SY   N/Tert-33E6; N/Tert-1 HA-33E6; N/Tert MSCV-IP-N-HA-33E6
DR   Wikidata; Q114312388
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06427; Human papillomavirus type 33 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV33 E6 HA + E7
AC   CVCL_C3JE
SY   N/Tert-1 HA-33E6 plus Untagged-33E7
DR   Wikidata; Q114312389
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06427; Human papillomavirus type 33 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06429; Human papillomavirus type 33 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3JD ! N/Tert-1 HPV33 E6
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV33 E7
AC   CVCL_C3JF
SY   N/Tert-33E7; N/Tert MSCV-P-C-FlagHA-33E7
DR   Wikidata; Q114312390
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06429; Human papillomavirus type 33 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV38 E6
AC   CVCL_C3JG
SY   N/Tert-38E6; N/Tert MSCV-IP-N-HA-38E6
DR   Wikidata; Q114312391
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q80907; Human papillomavirus type 38 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV38 E7
AC   CVCL_C3JH
SY   N/Tert-38E7; N/Tert MSCV-P-C-FlagHA-38E7
DR   Wikidata; Q114312392
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q80908; Human papillomavirus type 38 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV45 E6
AC   CVCL_C3JI
SY   N/Tert-45E6; N/Tert MSCV-IP-N-HA-45E6
DR   Wikidata; Q114312393
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P21735; Human papillomavirus type 45 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV45 E7
AC   CVCL_C3JJ
SY   N/Tert-45E7; N/Tert MSCV-P-C-FlagHA-45E7
DR   Wikidata; Q114312394
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P21736; Human papillomavirus type 45 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV52 E6
AC   CVCL_C3JK
SY   N/Tert-52E6; N/Tert MSCV-IP-N-HA-52E6
DR   Wikidata; Q114312395
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P36814; Human papillomavirus type 52 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV55 E7
AC   CVCL_C3JL
SY   N/Tert-55E7; N/Tert MSCV-P-C-FlagHA-55E7
DR   Wikidata; Q114312396
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q80935; Human papillomavirus type 55 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV57 E6
AC   CVCL_C3JM
SY   N/Tert-57E6; N/Tert MSCV-IP-N-HA-57E6
DR   Wikidata; Q114312397
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P22158; Human papillomavirus type 57 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV57 E7
AC   CVCL_C3JN
SY   N/Tert-57E7; N/Tert MSCV-P-C-FlagHA-57E7
DR   Wikidata; Q114312398
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P22160; Human papillomavirus type 57 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV6b E6
AC   CVCL_C3JP
SY   N/Tert-6bE6; N/Tert MSCV-IP-N-HA-6bE6
DR   GEO; GSM1223710
DR   GEO; GSM1223711
DR   GEO; GSM1223712
DR   GEO; GSM1223713
DR   GEO; GSM1223714
DR   GEO; GSM1223715
DR   Wikidata; Q114312399
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06462; Human papillomavirus type 6b protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV6b E7
AC   CVCL_C3JQ
SY   N/Tert-6bE7; N/Tert MSCV-P-C-FlagHA-6bE7
DR   Wikidata; Q114312400
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06464; Human papillomavirus type 6b protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV74 E7
AC   CVCL_C3JR
SY   N/Tert-74E7; N/Tert MSCV-P-C-FlagHA-74E7
DR   Wikidata; Q114312401
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q98005; Human papillomavirus type 74 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV76 E6
AC   CVCL_C3JS
SY   N/Tert-76E6; N/Tert MSCV-IP-N-HA-76E6
DR   Wikidata; Q114312402
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; O56940; Human papillomavirus type 76 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV76 E7
AC   CVCL_C3JT
SY   N/Tert-76E7; N/Tert MSCV-P-C-FlagHA-76E7
DR   Wikidata; Q114312403
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; O56941; Human papillomavirus type 76 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV8 E6
AC   CVCL_C3JU
SY   N/Tert-8E6; N/Tert MSCV-IP-N-HA-8E6
DR   GEO; GSM1223716
DR   GEO; GSM1223717
DR   GEO; GSM1223718
DR   GEO; GSM1223719
DR   GEO; GSM1223720
DR   GEO; GSM1223721
DR   Wikidata; Q114312404
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06428; Human papillomavirus type 8 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV8 E7
AC   CVCL_C3JV
SY   N/Tert-8E7; N/Tert MSCV-P-C-FlagHA-8E7
DR   Wikidata; Q114312405
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06430; Human papillomavirus type 8 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV92 E6
AC   CVCL_C3JW
SY   N/Tert-92E6; N/Tert MSCV-IP-N-HA-92E6
DR   GEO; GSM1223722
DR   GEO; GSM1223723
DR   GEO; GSM1223724
DR   GEO; GSM1223725
DR   GEO; GSM1223726
DR   GEO; GSM1223727
DR   Wikidata; Q114312406
RX   PubMed=23015706;
RX   PubMed=24850740;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8B5B6; Human papillomavirus type 92 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV92 E7
AC   CVCL_C3JX
SY   N/Tert-92E7; N/Tert MSCV-P-C-FlagHA-92E7
DR   Wikidata; Q114312407
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q8B5B5; Human papillomavirus type 92 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV98 E6
AC   CVCL_C3JY
SY   N/Tert-98E6; N/Tert MSCV-IP-N-HA-98E6
DR   Wikidata; Q114312408
RX   PubMed=23015706;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; C4PUC0; Human papillomavirus type 98 protein E6 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 HPV98 E7
AC   CVCL_C3JZ
SY   N/Tert-98E7; N/Tert MSCV-P-C-FlagHA-98E7
DR   Wikidata; Q114312409
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; C4PUC1; Human papillomavirus type 98 protein E7 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 JUN
AC   CVCL_C3KA
SY   N/Tert MSCV-IP-N-HA-JUN
DR   Wikidata; Q114312410
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6204; JUN (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 NIPA1
AC   CVCL_C3KB
SY   N/Tert MSCV-IP-N-HA-NIPA1
DR   Wikidata; Q114312411
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17043; NIPA1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 PP2CA
AC   CVCL_C3KC
SY   N/Tert MSCV-IP-N-HA-PP2CA
DR   Wikidata; Q114312412
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9299; PPP2CA (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 PTENP1
AC   CVCL_C3KD
SY   N/Tert MSCV-IP-N-HA-PTENP1
DR   Wikidata; Q114312413
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9589; PTENP1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 PTPN18
AC   CVCL_C3KE
SY   N/Tert MSCV-IP-N-HA-PTPN18
DR   Wikidata; Q114312414
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9649; PTPN18 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 PXMP3
AC   CVCL_C3KF
SY   N/Tert MSCV-IP-N-HA-PXMP3
DR   Wikidata; Q114312415
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9717; PEX2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 RBCK1
AC   CVCL_C3KG
SY   N/Tert MSCV-IP-N-HA-RBCK1
DR   Wikidata; Q114312416
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:15864; RBCK1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 SNCG
AC   CVCL_C3KH
SY   N/Tert MSCV-IP-N-HA-SNCG
DR   Wikidata; Q114312417
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11141; SNCG (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 SRC
AC   CVCL_C3KI
SY   N/Tert MSCV-IP-N-HA-SRC
DR   Wikidata; Q114312418
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11283; SRC (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 STAT4
AC   CVCL_C3KJ
SY   N/Tert MSCV-IP-N-HA-STAT4
DR   Wikidata; Q114312419
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11365; STAT4 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 TBPL1
AC   CVCL_C3KK
SY   N/Tert MSCV-IP-N-HA-TBPL1
DR   Wikidata; Q114312420
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11589; TBPL1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 TCTE1
AC   CVCL_C3KL
SY   N/Tert MSCV-IP-N-HA-TCTE1
DR   Wikidata; Q114312421
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11693; TCTE1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 TIMP1
AC   CVCL_C3KM
SY   N/Tert MSCV-IP-N-HA-TIMP1
DR   Wikidata; Q114312423
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11820; TIMP1 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 UBE3AI
AC   CVCL_C3KN
SY   N/Tert-1-UBE3A; N/Tert MSCV-IP-N-HA-UBE3AI
DR   Wikidata; Q114312424
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12496; UBE3A (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 UBOX5
AC   CVCL_C3KP
SY   N/Tert MSCV-IP-N-HA-UBOX5
DR   Wikidata; Q114312425
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17777; UBOX5 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 UCHL3
AC   CVCL_C3KQ
SY   N/Tert MSCV-IP-N-FlagHA UCHL3
DR   Wikidata; Q114312426
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12515; UCHL3 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 UCHL5
AC   CVCL_C3KR
SY   N/Tert-1-UCHL5; N/Tert MSCV-IP-N-FlagHA-UCHL5
DR   Wikidata; Q114312427
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:19678; UCHL5 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP10
AC   CVCL_C3KS
SY   N/Tert MSCV-P-C-FlagHA-USP10
DR   Wikidata; Q114312428
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12608; USP10 (Note=With a C-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP12
AC   CVCL_C3KT
SY   N/Tert MSCV-IP-N-FlagHA-USP12
DR   Wikidata; Q114312430
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20485; USP12 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP13
AC   CVCL_C3KU
SY   N/Tert MSCV-IP-N-FlagHA-USP13
DR   Wikidata; Q114312431
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12611; USP13 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP21
AC   CVCL_C3KV
SY   N/Tert MSCV-IP-N-FlagHA-USP21
DR   Wikidata; Q114312432
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12620; USP21 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP28
AC   CVCL_C3KW
SY   N/Tert MSCV-IP-N-FlagHA-USP28
DR   Wikidata; Q114312433
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12625; USP28 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP39
AC   CVCL_C3KX
SY   N/Tert MSCV-IP-N-FlagHA-USP39
DR   Wikidata; Q114312434
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20071; USP39 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP5
AC   CVCL_C3KY
SY   N/Tert MSCV-IP-N-FlagHA-USP5
DR   Wikidata; Q114312435
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12628; USP5 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 USP52
AC   CVCL_C3KZ
SY   N/Tert MSCV-IP-N-FlagHA-USP52
DR   Wikidata; Q114312436
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:20074; PAN2 (Note=With a N-terminal FLAG-HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 WHSC2
AC   CVCL_C3L0
SY   N/Tert MSCV-IP-N-HA-WHSC2
DR   Wikidata; Q114312437
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12768; NELFA (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   N/Tert-1 WWP2
AC   CVCL_C3L1
SY   N/Tert MSCV-IP-N-HA-WWP2
DR   Wikidata; Q114312438
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16804; WWP2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/Tert-1 ZER1
AC   CVCL_C3LA
SY   N/Tert MSCV-IP N-V5-Zer1
DR   Wikidata; Q114312439
RX   PubMed=22232672;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30960; ZER1 (Note=With a N-terminal V5 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_CW92 ! N/TERT-1
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   N/TERT-2
AC   CVCL_UZ62
SY   N/TERT-2G; N/TERT 2G; N/TERT2G
DR   Wikidata; Q95991849
RX   PubMed=10648628;
RX   PubMed=28928444;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ57 ! N
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   N_M5R1
AC   CVCL_HG07
DR   CancerTools; 152837
DR   Wikidata; Q54907286
DR   Ximbio; 152837
RX   PubMed=27323823;
CC   Selected for resistance to: ChEBI; CHEBI_134602; MI-63.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   N_N20R1
AC   CVCL_HG08
SY   N_N20R
DR   CancerTools; 152840
DR   ECACC; 17011212
DR   Wikidata; Q54907287
DR   Ximbio; 152840
RX   PubMed=27323823;
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Discontinued: ECACC; 17011212; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ECACC=17011212
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D18S51: 15,16
ST   D21S11: 32,33.1
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 19,23
ST   Penta D: 8,10
ST   Penta E: 11,15
ST   TH01: 9,9.3
ST   TPOX: 6,9
ST   vWA: 16,21
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   N0001
AC   CVCL_A7CT
DR   Wikidata; Q107116460
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   100Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   N0002
AC   CVCL_A7CU
DR   Wikidata; Q107116461
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 56 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   N0003 pre-immortalized
AC   CVCL_A6RV
SY   N0003(<50)
DR   RCB; RCB2820
DR   Wikidata; Q107116462
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
CC   Population: Japanese.
CC   Karyotypic information: 45,XX,der(13;14)(q10;q10) (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X
ST   D16S539: 9,11
ST   D18S51: 22,27
ST   D19S433: 14,14.2
ST   D21S11: 28,30
ST   D2S1338: 23,24
ST   D3S1358: 15,18
ST   D8S1179: 16
ST   FGA: 22
ST   TH01: 6,7
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6RW ! N0003 post-immortalized
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N0003 post-immortalized
AC   CVCL_A6RW
SY   N0003(>300); N0003
DR   RCB; RCB2821
DR   Wikidata; Q107116463
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
RX   PubMed=15150084;
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,add(7)(q22),+12,der(13;14)(q10;q10) (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X
ST   D16S539: 9,11
ST   D18S51: 22,27
ST   D19S433: 14,14.2
ST   D21S11: 28,30
ST   D2S1338: 23,24
ST   D3S1358: 15,18
ST   D8S1179: 16
ST   FGA: 22
ST   TH01: 6,7
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6RV ! N0003 pre-immortalized
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N0004
AC   CVCL_A7CV
DR   Wikidata; Q107116464
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 66 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0005 pre-immortalized
AC   CVCL_A6RX
SY   N0005(<50)
DR   RCB; RCB2822
DR   Wikidata; Q107116465
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
CC   Population: Japanese.
CC   Karyotypic information: 46,XY (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X,Y
ST   D16S539: 12
ST   D18S51: 13,19
ST   D19S433: 13,16.2
ST   D21S11: 31
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D8S1179: 14
ST   FGA: 20,22
ST   TH01: 6,9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6RY ! N0005 post-immortalized
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N0005 post-immortalized
AC   CVCL_A6RY
SY   N0005(>500); N0005
DR   RCB; RCB2823
DR   Wikidata; Q107116468
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
RX   PubMed=15150084;
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 46,XY,add(3)(p25),add(8)(q24.3),del(17)(p11.2) (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X,Y
ST   D16S539: 12
ST   D18S51: 13,19
ST   D19S433: 13,16.2
ST   D21S11: 31
ST   D2S1338: 17,19,20
ST   D3S1358: 16,17
ST   D8S1179: 14
ST   FGA: 20,22
ST   TH01: 6,9
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6RX ! N0005 pre-immortalized
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N0005-A1
AC   CVCL_A6RZ
DR   RCB; RCB2824
DR   Wikidata; Q107116469
RX   PubMed=12655152;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6RY ! N0005 post-immortalized
SX   Male
AG   99Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N0006
AC   CVCL_A7CW
DR   Wikidata; Q107116470
RX   PubMed=9365237;
RX   PubMed=9503605;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 150 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0007
AC   CVCL_A7CX
DR   Wikidata; Q107116471
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 111 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0008
AC   CVCL_A7CY
DR   Wikidata; Q107116472
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 149 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0009
AC   CVCL_A7CZ
DR   Wikidata; Q107116473
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 58 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0010
AC   CVCL_A7DA
DR   Wikidata; Q107116474
RX   PubMed=9365237;
RX   PubMed=9503605;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 75 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0011
AC   CVCL_A7DB
DR   Wikidata; Q107116475
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 65 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0012
AC   CVCL_A7DC
DR   Wikidata; Q107116476
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 103 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0013 pre-immortalized
AC   CVCL_A6SA
SY   N0013(<50)
DR   RCB; RCB2825
DR   Wikidata; Q107116477
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
CC   Population: Japanese.
CC   Karyotypic information: 46,XX (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 15,16
ST   D21S11: 29,31.2
ST   D2S1338: 20,24
ST   D3S1358: 16,17
ST   D8S1179: 12,13
ST   FGA: 21,26
ST   TH01: 7,9.3
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6SB ! N0013 post-immortalized
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N0013 post-immortalized
AC   CVCL_A6SB
SY   N0013(>300); N0013
DR   RCB; RCB2826
DR   Wikidata; Q107116479
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
RX   PubMed=15150084;
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,add(2)(q37),der(11)t(11;12)(p15;q13) (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 15,16
ST   D21S11: 29,31.2
ST   D2S1338: 20,24
ST   D3S1358: 16,17
ST   D8S1179: 12,13
ST   FGA: 21,26
ST   TH01: 7,9.3
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6SA ! N0013 pre-immortalized
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N0014
AC   CVCL_A7DD
DR   Wikidata; Q107116481
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 125 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N0102
AC   CVCL_A7DE
DR   Wikidata; Q107116483
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   N0103
AC   CVCL_A7DF
DR   Wikidata; Q107116485
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 30 PDL (PubMed=9365237).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   N0104
AC   CVCL_A7DG
DR   Wikidata; Q107116486
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 136 PDL (PubMed=9365237).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   N01F
AC   CVCL_A8YD
DR   GEO; GSM4616534
DR   Wikidata; Q108821001
RX   PubMed=33798453;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   1-2M
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   N01F iPSC #1
AC   CVCL_A8YE
SY   N01F iPSC no. 1; N01F_N1_iPS
DR   GEO; GSM4616535
DR   Wikidata; Q108821002
RX   PubMed=33798453;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_A8YD ! N01F
SX   Female
AG   1-2M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   N01F iPSC #2
AC   CVCL_A8YF
SY   N01F iPSC no. 2; N01F_N2_iPS
DR   GEO; GSM4616536
DR   Wikidata; Q108821003
RX   PubMed=33798453;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_A8YD ! N01F
SX   Female
AG   1-2M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   N1-1A5
AC   CVCL_A7YA
DR   BEI_Resources; MRA-473
DR   Wikidata; Q107116488
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=19 kDa fragment. Also reacts with isolate 3D7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   N1-1H10
AC   CVCL_A7XY
DR   BEI_Resources; MRA-471
DR   Wikidata; Q107116491
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O96555; Plasmodium vivax ookinete surface protein (Pvs25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   N1-2A8
AC   CVCL_A7XZ
DR   BEI_Resources; MRA-472
DR   Wikidata; Q107116492
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O96555; Plasmodium vivax ookinete surface protein (Pvs25).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   N1-iPS-1
AC   CVCL_A4FP
SY   N1-iPSC_HGPS
DR   SKIP; SKIP003114
DR   Wikidata; Q105510264
RX   PubMed=21185252;
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L604 ! AG03512
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   N1-iPS-2
AC   CVCL_A4FQ
DR   Wikidata; Q105510266
RX   PubMed=21185252;
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L604 ! AG03512
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   N1-S1
AC   CVCL_3551
DR   BTO; BTO_0000591
DR   CLO; CLO_0007923
DR   CLDB; cl3618
DR   ATCC; CRL-1604
DR   BCRC; 60267
DR   ECACC; 90011902
DR   Wikidata; Q54907288
RX   PubMed=14297488;
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_1D01 ! Novikoff-Hepatoma
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   N1-S1 Fudr
AC   CVCL_3552
SY   N1-S1/Fudr
DR   CLO; CLO_0007924
DR   ATCC; CRL-1603
DR   Wikidata; Q54907292
RX   PubMed=14297488;
CC   Selected for resistance to: ChEBI; CHEBI_60761; 5-fluoro-2'-deoxyuridine (FUdR).
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3551 ! N1-S1
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   N1/12
AC   CVCL_E9HK
DR   ABCD; ABCD_AV227
DR   DSHB; N1-12
DR   MMRRC; MMRRC:065977-UCD
RX   PubMed=26644354;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N1_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q63633; Rat Slc12a5 (Note: Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N1/66
AC   CVCL_E9HL
DR   DSHB; N1-66
DR   MMRRC; MMRRC:066083-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N1_66.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63633; Rat Slc12a5 (Note: Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N1.551
AC   CVCL_J692
DR   CLO; CLO_0007918
DR   ATCC; CRL-2040
DR   Wikidata; Q54907293
RX   PubMed=7531198;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   N10/7
AC   CVCL_E9HM
DR   ABCD; ABCD_AW908
DR   DSHB; N10-7
DR   MMRRC; MMRRC:065982-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N10_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; D4A055; Rat Cacnb4 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N100/13
AC   CVCL_E9HN
DR   ABCD; ABCD_AV228
DR   DSHB; N100-13
DR   MMRRC; MMRRC:066066-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N100_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N1000
AC   CVCL_F671
SY   GM11534
DR   CLO; CLO_0020999
DR   Coriell; GM11534
DR   Wikidata; Q54907294
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=3461479;
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   N1001
AC   CVCL_F672
DR   Wikidata; Q54907295
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=3461479;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   N1002
AC   CVCL_F673
DR   Wikidata; Q54907296
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=3461479;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   N1003
AC   CVCL_X410
DR   Wikidata; Q54907297
RX   PubMed=3004699;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   N1007
AC   CVCL_X411
DR   Wikidata; Q54907298
RX   PubMed=3004699;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   N1008
AC   CVCL_F674
DR   Wikidata; Q54907299
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=3461479;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   N1016
AC   CVCL_F675
DR   Wikidata; Q54907300
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=3461479;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   N1024
AC   CVCL_X412
DR   Wikidata; Q54907301
RX   PubMed=3004699;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   N103/31
AC   CVCL_E9HP
DR   ABCD; ABCD_AV229
DR   ABCD; ABCD_AV230
DR   DSHB; N103-31
DR   MMRRC; MMRRC:066085-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N103_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28037; Rat Aldh1l1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N103/39
AC   CVCL_E9HQ
DR   ABCD; ABCD_AV231
DR   DSHB; N103-39
DR   MMRRC; MMRRC:066061-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N103_39.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28037; Rat Aldh1l1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N104/32
AC   CVCL_E9HR
DR   ABCD; ABCD_AU889
DR   MMRRC; MMRRC:066073-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N104_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JM15; Rat Slc38a1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N104/37
AC   CVCL_E9HS
DR   ABCD; ABCD_AV232
DR   MMRRC; MMRRC:066076-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N104_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JM15; Rat Slc38a1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N1043
AC   CVCL_F676
DR   Wikidata; Q54907302
RX   PubMed=3390826;
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   N1046
AC   CVCL_X413
DR   Wikidata; Q54907303
RX   PubMed=3390826;
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 4
//
ID   N105/13
AC   CVCL_E9HT
DR   ABCD; ABCD_AV233
DR   DSHB; N105-13
DR   MMRRC; MMRRC:066067-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N105_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01484; Human ANK2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N105/17
AC   CVCL_E9HU
DR   ABCD; ABCD_AW907
DR   DSHB; N105-17
DR   MMRRC; MMRRC:066068-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N105_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01484; Human ANK2 (Note=Also reacts with mouse, rat and C.elegans).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N1050
AC   CVCL_X414
DR   Wikidata; Q54907304
RX   PubMed=3390826;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 5
//
ID   N106/20
AC   CVCL_E9HV
DR   ABCD; ABCD_AV234
DR   DSHB; N106-20
DR   MMRRC; MMRRC:066108-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N106_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q12955; Human ANK3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N106/36
AC   CVCL_E9HW
DR   ABCD; ABCD_AV235
DR   DSHB; N106-36
DR   MMRRC; MMRRC:066069-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N106_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q12955; Human ANK3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N106/43
AC   CVCL_E9HX
DR   ABCD; ABCD_AU860
DR   DSHB; N106-43
DR   MMRRC; MMRRC:066261-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N106_43.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q12955; Human ANK3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N106/65
AC   CVCL_E9HY
DR   ABCD; ABCD_AV236
DR   DSHB; N106-65
DR   MMRRC; MMRRC:066070-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N106_65.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q12955; Human ANK3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N11 [Mouse hybridoma against A.viteae tropomyosin]
AC   CVCL_C7XC
DR   Wikidata; Q123033139
RX   PubMed=20525500;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O01673; Acanthocheilonema viteae tropomyosin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   N11 [Mouse microglial]
AC   CVCL_A5PM
SY   N-11
DR   BTO; BTO_0003955
DR   Wikidata; Q107116494
RX   PubMed=2789141;
RX   PubMed=7681038;
RX   PubMed=8152810;
RX   PubMed=11860491;
RX   PubMed=12969251;
CC   Transformant: Recombinant retrovirus 3RV/VN-11.
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 9
//
ID   N11/33
AC   CVCL_E9HZ
DR   ABCD; ABCD_AK445
DR   DSHB; N11-33
DR   MMRRC; MMRRC:065978-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N11_33.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; D3Z649; Mouse Kcnt2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N110/29
AC   CVCL_E9I0
DR   ABCD; ABCD_AK460
DR   DSHB; N110-29
DR   MMRRC; MMRRC:066080-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N110_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62889; Rat Nlgn3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N111/24
AC   CVCL_E9I1
DR   ABCD; ABCD_AU861
DR   DSHB; N111-24
DR   MMRRC; MMRRC:066072-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N111_24.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q811U4; Mouse Mfn1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N112-4
AC   CVCL_B7DJ
DR   Wikidata; Q112930150
RX   PubMed=28233934;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   N112B/14
AC   CVCL_E9I2
DR   ABCD; ABCD_AV237
DR   DSHB; N112B-14
DR   MMRRC; MMRRC:066125-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N112B_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35561; Mouse Kcnj2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N114/10
AC   CVCL_E9I3
DR   ABCD; ABCD_AK452
DR   DSHB; N114-10
DR   MMRRC; MMRRC:066071-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N114_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y3Q4; Human HCN4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N115-BU-1
AC   CVCL_AR48
DR   ECACC; 08062547
DR   Wikidata; Q54907305
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 6
//
ID   N115-BU-10
AC   CVCL_4250
DR   ECACC; 08062559
DR   Wikidata; Q54907306
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   N115-BU-2
AC   CVCL_4251
DR   ECACC; 08062552
DR   Wikidata; Q54907307
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   N115-BU-7
AC   CVCL_4252
DR   ECACC; 08062554
DR   Wikidata; Q54907308
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   N115-BU-8
AC   CVCL_4253
DR   ECACC; 08062519
DR   Wikidata; Q54907310
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   N115-BU-9
AC   CVCL_4254
DR   ECACC; 08062558
DR   Wikidata; Q54907311
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   N116/14
AC   CVCL_E9I4
DR   ABCD; ABCD_AK439
DR   DSHB; N116-14
DR   MMRRC; MMRRC:066101-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N116_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B3STU3; Rat Chac1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N116213
AC   CVCL_RN73
DR   Wikidata; Q54907312
RX   PubMed=23434393;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   N117-11
AC   CVCL_B7DA
DR   Wikidata; Q112930151
RX   PubMed=28858313;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN74 ! N117322
OI   CVCL_B7DB ! N117-8
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   N117-8
AC   CVCL_B7DB
DR   Wikidata; Q112930152
RX   PubMed=28233934;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN74 ! N117322
OI   CVCL_B7DA ! N117-11
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   N117/9
AC   CVCL_E9I5
DR   ABCD; ABCD_AU888
DR   MMRRC; MMRRC:066074-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N117_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJW3; Human DNMT3L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N117322
AC   CVCL_RN74
DR   Wikidata; Q54907313
RX   PubMed=23434393;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7DB ! N117-8
OI   CVCL_B7DA ! N117-11
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   N119/44
AC   CVCL_E9I6
DR   ABCD; ABCD_AV238
DR   MMRRC; MMRRC:066075-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N119_44.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99549; Human MPHOSPH8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N120A/9
AC   CVCL_E9I7
DR   ABCD; ABCD_AU886
DR   MMRRC; MMRRC:066126-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N120A_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q02297; Human NRG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N121A/1
AC   CVCL_E9I8
DR   MMRRC; MMRRC:066127-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N121A_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P60571; Rat Panx2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N121A/31
AC   CVCL_E9I9
DR   ABCD; ABCD_AU862
DR   MMRRC; MMRRC:066128-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N121A_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P60571; Rat Panx2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N123/19
AC   CVCL_E9IA
DR   ABCD; ABCD_AV239
DR   MMRRC; MMRRC:066129-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N123_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6LED0; Rat Hist1h3b (Note=Immunized with 6-QTARKSTGGKAPRK-19 with phospho p.Thr12. Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N123/48
AC   CVCL_E9IB
DR   MMRRC; MMRRC:066130-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N123_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6LED0; Rat Hist1h3b (Note=Immunized with 6-QTARKSTGGKAPRK-19 with phospho p.Thr12. Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N124B/38
AC   CVCL_E9IC
DR   ABCD; ABCD_AU863
DR   DSHB; N124B-38
DR   MMRRC; MMRRC:066131-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N124B_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52188; Rat Kcnj12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N125/10
AC   CVCL_E9ID
DR   ABCD; ABCD_AV240
DR   DSHB; N125-10
DR   MMRRC; MMRRC:066078-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N125_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9D5T0; Mouse Atad1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N126B/31
AC   CVCL_E9IE
DR   DSHB; N126B-31
DR   MMRRC; MMRRC:066132-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N126B_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q02297; Human NRG1 (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N127/31
AC   CVCL_E9IF
DR   ABCD; ABCD_AK466
DR   DSHB; N127-31
DR   MMRRC; MMRRC:066077-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N127_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P97836; Rat Dlgap1 (Note=Also recognizes Dlgap2, Dlgap3, Dlgap4 and Dlgap5. Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N128A/2
AC   CVCL_E9IG
DR   MMRRC; MMRRC:066082-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N128A_2.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TF76; Human HASPIN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N128A/4
AC   CVCL_E9IH
DR   MMRRC; MMRRC:066086-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N128A_4.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0AEX9; Escherichia coli malE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N128MA
AC   CVCL_E7FF
SY   Normal 128 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N129/15
AC   CVCL_E9II
DR   ABCD; ABCD_AW906
DR   DSHB; N129-15
DR   MMRRC; MMRRC:066157-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N129_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BW11; Human MXD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N129A/6
AC   CVCL_E9IJ
DR   ABCD; ABCD_AU864
DR   MMRRC; MMRRC:066133-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N129A_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BW11; Human MXD3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N129MA
AC   CVCL_E7FG
SY   Normal 129 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N13
AC   CVCL_5G93
DR   Wikidata; Q54907314
RX   PubMed=2789141;
RX   PubMed=7681038;
CC   Transformant: Recombinant retrovirus 3RV/VN-11.
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 7
//
ID   N130MA
AC   CVCL_E7FH
SY   Normal 130 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N132A/12
AC   CVCL_E9IK
DR   MMRRC; MMRRC:066088-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N132A_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q10583; Megathura crenulata hemocyanin 1 (Keyhole limpet hemocyanin A) (KLH1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N133/21
AC   CVCL_E9IL
DR   ABCD; ABCD_AK461
DR   DSHB; N133-21
DR   MMRRC; MMRRC:066089-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N133_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O08773; Rat Rgs14 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N133/35
AC   CVCL_E9IM
DR   ABCD; ABCD_AV241
DR   MMRRC; MMRRC:066338-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N133_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O08773; Rat Rgs14 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N134/12
AC   CVCL_E9IN
DR   ABCD; ABCD_AV242
DR   DSHB; N134-12
DR   MMRRC; MMRRC:066087-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N134_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q62968; Rat Scn10a (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N135/37
AC   CVCL_E9IP
DR   ABCD; ABCD_AK465
DR   MMRRC; MMRRC:066084-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N135_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9ERE9; Mouse Mapk8ip2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N138/6
AC   CVCL_E9IQ
DR   DSHB; N138-6
DR   MMRRC; MMRRC:066109-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N138_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5S007; Human LRRK2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N1380
AC   CVCL_A8RU
DR   cancercelllines; CVCL_A8RU
DR   Wikidata; Q108821004
RX   PubMed=32496007;
RX   PubMed=33952773;
CC   Population: African; Shangaan.
CC   Virology: Not susceptible to infection by porcine sapelovirus. Transduced with Cas9 and then with the GeCKO v2 whole genome CRISPR/Cas9 library of guide RNAs. The resulting cells were then infected with porcine sapelovirus (PSV) (PubMed=32496007).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   N14
AC   CVCL_C5E4
DR   ABCD; ABCD_AH101
DR   Wikidata; Q116049852
RX   PubMed=23981841;
RX   PubMed=27917827;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P43652; Human AFAM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   N14.5
AC   CVCL_U465
DR   CLO; CLO_0051389
DR   RCB; RCB2863
DR   Wikidata; Q54907315
RX   PubMed=16616428;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hypothalamus, suprachiasmatic nucleus, ventrolateral part; UBERON=UBERON_0027771.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18W
CA   Conditionally immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   N140A/12
AC   CVCL_E9IR
DR   ABCD; ABCD_AV243
DR   MMRRC; MMRRC:066113-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N140A_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8BXA0; Mouse Lrfn5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N141/28
AC   CVCL_E9IS
DR   ABCD; ABCD_AV244
DR   DSHB; N141-28
DR   MMRRC; MMRRC:066096-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N141_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O88705; Mouse Hcn3 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N142/28
AC   CVCL_E9IT
DR   ABCD; ABCD_AV245
DR   MMRRC; MMRRC:066100-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N142_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O70293; Mouse Grk6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N143/36
AC   CVCL_E9IU
DR   ABCD; ABCD_AV246
DR   MMRRC; MMRRC:066119-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N143_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y6F8; Human CDY1 (Note=Also recognizes CDY2, CDYL1 and CDYL2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N143/38
AC   CVCL_E9IV
DR   ABCD; ABCD_AV247
DR   MMRRC; MMRRC:066095-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N143_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y6F8; Human CDY1 (Note=Also recognizes CDY2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N144/14
AC   CVCL_E9IW
DR   ABCD; ABCD_AV248
DR   DSHB; N144-14
DR   MMRRC; MMRRC:066091-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N144_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_232280; Hexa-His (6XHis tag).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N144/17
AC   CVCL_E9IX
DR   ABCD; ABCD_AV249
DR   MMRRC; MMRRC:066098-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N144_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q91XY5; Mouse Pcdhga3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N144/32
AC   CVCL_E9IY
DR   ABCD; ABCD_AV250
DR   DSHB; N144-32
DR   MMRRC; MMRRC:066099-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N144_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q91XY5; Mouse Pcdhga3 (Note=Also recognizes other gamma-protocadherins-A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N145/20
AC   CVCL_E9IZ
DR   ABCD; ABCD_AV251
DR   DSHB; N145-20
DR   MMRRC; MMRRC:066097-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N145_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8VEB1; Mouse Grk5 (Note=Also recognizes Grk6. Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N147/6
AC   CVCL_E9J0
DR   ABCD; ABCD_AK463
DR   MMRRC; MMRRC:066090-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N147_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96PU8; Human QKI (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N148/30
AC   CVCL_E9J1
DR   ABCD; ABCD_AV252
DR   MMRRC; MMRRC:066105-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N148_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q91XX7; Mouse Pcdhgb2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N149/25
AC   CVCL_E9J2
DR   ABCD; ABCD_AK472
DR   DSHB; N149-25
DR   MMRRC; MMRRC:066102-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N149_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JKN5; Mouse Olig1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N149MA
AC   CVCL_E7FI
SY   Normal 149 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N14A
AC   CVCL_4V86
DR   ECACC; 16110902
DR   Wikidata; Q54907316
RX   PubMed=25929336;
CC   Doubling time: ~48 hours (PubMed=25929336).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Appendix; UBERON=UBERON_0001154.
ST   Source(s): ECACC=16110902
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 8,13
ST   D18S51: 16,18
ST   D21S11: 28,30
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 5,7
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3345; Pseudomyxoma peritonei
DI   ORDO; Orphanet_26790; Pseudomyxoma peritonei
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 11
//
ID   N15/39
AC   CVCL_E9J3
DR   ABCD; ABCD_AV253
DR   MMRRC; MMRRC:065996-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N15_39.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E9PU00; Rat Trpv3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N15/4
AC   CVCL_E9J4
DR   ABCD; ABCD_AV254
DR   DSHB; N15-4
DR   MMRRC; MMRRC:066179-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N15_4.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; E9PU00; Rat Trpv3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N150/21
AC   CVCL_E9J5
DR   ABCD; ABCD_AK459
DR   MMRRC; MMRRC:066134-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N150_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P70610; Rat Doc2b (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N150MA
AC   CVCL_E7FJ
SY   Normal 150 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N151/3
AC   CVCL_E9J6
DR   ABCD; ABCD_AK458
DR   DSHB; N151-3
DR   MMRRC; MMRRC:066092-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N151_3.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18506; Rat Gabrd (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N1511
AC   CVCL_A781
SY   N-1511
DR   BTO; BTO_0005494
DR   Wikidata; Q54907317
RX   PubMed=12369787;
WW   Info; KAKEN; 13670231; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-13670231/
CC   Doubling time: 20 hours (PubMed=12369787).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Rib, cartilage; UBERON=UBERON_0006288.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6 Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   4W
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   N152B/23
AC   CVCL_E9J7
DR   ABCD; ABCD_AX011
DR   DSHB; N152B-23
DR   MMRRC; MMRRC:066135-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N152B_23.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P21796; Human VDAC1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N153/5
AC   CVCL_E9J8
DR   ABCD; ABCD_AK476
DR   DSHB; N153-5
DR   MMRRC; MMRRC:066094-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N153_5.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q80U63; Mouse Mfn2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N154/32
AC   CVCL_E9J9
DR   ABCD; ABCD_AV255
DR   DSHB; N154-32
DR   MMRRC; MMRRC:066110-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N154_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75164; Human KDM4A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N155/9
AC   CVCL_E9JA
DR   MMRRC; MMRRC:066136-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N155_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O08934; Mouse Uncx.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N158/28
AC   CVCL_E9JB
DR   MMRRC; MMRRC:066137-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N158_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P84245; Rat H3-3b (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N159/5
AC   CVCL_E9JC
DR   ABCD; ABCD_AW905
DR   DSHB; N159-5
DR   MMRRC; MMRRC:066106-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N159_5.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q91XZ0; Mouse Pcdhga1 (Note=Also recognizes all gamma-protocadherin-A, -B and -Cs).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N15A
AC   CVCL_4V87
DR   ECACC; 16110903
DR   Wikidata; Q54907318
RX   PubMed=25929336;
CC   Doubling time: ~48 hours (PubMed=25929336).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Appendix; UBERON=UBERON_0001154.
ST   Source(s): ECACC=16110903
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 29,30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3345; Pseudomyxoma peritonei
DI   ORDO; Orphanet_26790; Pseudomyxoma peritonei
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 11
//
ID   N15C6
AC   CVCL_4749
DR   Wikidata; Q54907319
RX   PubMed=15381370;
RX   PubMed=16235240;
RX   PubMed=18304946;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   N160/21
AC   CVCL_E9JD
DR   MMRRC; MMRRC:066107-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N160_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8C581; Mouse Tmem91 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N161/20
AC   CVCL_E9JE
DR   DSHB; N161-20
DR   MMRRC; MMRRC:066138-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N161_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P55011; Human SLC12A2 (Note=Immunized with 208-YYLRTFGHNTMDAVPR-223 with phospho p.Thr212 and p.Thr217. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N164/6
AC   CVCL_E9JF
DR   ABCD; ABCD_AK474
DR   DSHB; N164-6
DR   MMRRC; MMRRC:066103-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N164_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8VI56; Mouse Lrp4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N165/38
AC   CVCL_E9JG
DR   ABCD; ABCD_AW904
DR   DSHB; N165-38
DR   MMRRC; MMRRC:066114-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N165_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10586; Human PTPRF (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N165/43
AC   CVCL_E9JH
DR   ABCD; ABCD_AV256
DR   MMRRC; MMRRC:066115-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N165_43.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10586; Human PTPRF (Note=Also recognizes PTPRD and PTPRS. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N165MA
AC   CVCL_E7FK
SY   Normal 165 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N1664A
AC   CVCL_ZC52
DR   Wikidata; Q98127391
RX   PubMed=23142572;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_149489; 5,5-dimethyl-1-pyrroline N-oxide (DMPO).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 4
//
ID   N166A/26
AC   CVCL_E9JI
DR   ABCD; ABCD_AV257
DR   MMRRC; MMRRC:066139-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N166A_26.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01968; Human OCRL (Note=Also recognizes INPP5B. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N167/7
AC   CVCL_E9JJ
DR   DSHB; N167-7
DR   MMRRC; MMRRC:066117-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N167_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8R418; Mouse Dicer1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N167MA
AC   CVCL_E7FL
SY   Normal 167 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N168/6
AC   CVCL_E9JK
DR   ABCD; ABCD_AK451
DR   DSHB; N168-6
DR   MMRRC; MMRRC:066120-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N168_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7M730; Rat Scn4b (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N169MA
AC   CVCL_E7FM
SY   Normal 169 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N16B/8
AC   CVCL_E9JL
DR   ABCD; ABCD_AK455
DR   DSHB; N16B-8
DR   MMRRC; MMRRC:065992-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N16B_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25122; Rat Kcnc1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N170A/1
AC   CVCL_E9JM
DR   ABCD; ABCD_AK467
DR   DSHB; N170A-1
DR   MMRRC; MMRRC:066140-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N170A_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P58400; Human NRXN1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N170A/26
AC   CVCL_E9JN
DR   ABCD; ABCD_AV258
DR   MMRRC; MMRRC:066141-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N170A_26.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P58400; Human NRXN1 (Note=Also reacts with mpouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N171/17
AC   CVCL_E9JP
DR   ABCD; ABCD_AK479
DR   MMRRC; MMRRC:066142-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N171_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15327; Human INPP4B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N173B/13
AC   CVCL_E9JQ
DR   ABCD; ABCD_AV259
DR   MMRRC; MMRRC:066118-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N173B_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16635; Human TAZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N174B/27
AC   CVCL_E9JR
DR   ABCD; ABCD_AV260
DR   MMRRC; MMRRC:066159-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N174B_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q91XX1; Mouse Pcdhgc3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N175/9
AC   CVCL_E9JS
DR   MMRRC; MMRRC:066112-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N175_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_234281; Taurine-conjugated GM2 ganglioside (Tauro-GM2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N176A/35
AC   CVCL_E9JT
DR   ABCD; ABCD_AK480
DR   MMRRC; MMRRC:066121-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N176A_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63083; Rat S100a5 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N177MA
AC   CVCL_E7FN
SY   Normal 177 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N178A/9
AC   CVCL_E9JU
DR   ABCD; ABCD_AK462
DR   DSHB; N178A-9
DR   MMRRC; MMRRC:066151-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N178A_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9WUT2; Mouse Cacna1g (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N17A3
AC   CVCL_B0BR
DR   Wikidata; Q108821006
RX   PubMed=16235240;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   N17OS
AC   CVCL_ZS24
SY   Normal 17 OSaka
DR   Wikidata; Q98127393
RX   PubMed=2570806;
RX   PubMed=3814505;
RX   PubMed=6481688;
RX   PubMed=9536236;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   N18
AC   CVCL_4723
DR   CLO; CLO_0007919
DR   EFO; EFO_0022791
DR   CLDB; cl3619
DR   ECACC; 88112301
DR   Wikidata; Q54907321
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4724 ! C-1300 clone N18
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   N18-RE-105
AC   CVCL_J375
SY   N18-RE 105
DR   JCRB; IFO50221
DR   TOKU-E; 4029
DR   Wikidata; Q54907322
RX   PubMed=6149215;
CC   Doubling time: ~33 hours (Note=Lot 10252010) (JCRB=IFO50221).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   N18/28
AC   CVCL_E9JV
DR   ABCD; ABCD_AV261
DR   DSHB; N18-28
DR   MMRRC; MMRRC:066203-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N18_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q63622; Rat Dlg2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N18/30
AC   CVCL_E9JW
DR   ABCD; ABCD_AU890
DR   MMRRC; MMRRC:065984-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N18_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63622; Rat Dlg2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N180/41
AC   CVCL_E9JX
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N180_41.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P43005; Human SLC1A1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N182/17
AC   CVCL_E9JY
DR   ABCD; ABCD_AK481
DR   DSHB; N182-17
DR   MMRRC; MMRRC:066111-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N182_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96PU8; Human QKI (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N183/15
AC   CVCL_E9JZ
DR   ABCD; ABCD_AV262
DR   DSHB; N183-15
DR   MMRRC; MMRRC:066122-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N183_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96PU8; Human QKI (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N185/7
AC   CVCL_E9K0
DR   ABCD; ABCD_AV263
DR   DSHB; N185-7
DR   MMRRC; MMRRC:066144-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N185_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6Q760; Rat Nalcn (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N186/29
AC   CVCL_E9K1
DR   ABCD; ABCD_AW903
DR   DSHB; N186-29
DR   MMRRC; MMRRC:066145-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N186_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61169; Rat Drd2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N18TG2
AC   CVCL_2132
SY   N18Tg2; N18 tg 2
DR   BTO; BTO_0000933
DR   CLO; CLO_0007921
DR   CLDB; cl3620
DR   DSMZ; ACC-103
DR   DSMZCellDive; ACC-103
DR   ECACC; 08062523
DR   TOKU-E; 4020
DR   Wikidata; Q54907323
RX   PubMed=598387;
RX   PubMed=1150088;
CC   Doubling time: ~40 hours (DSMZ=ACC-103).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4724 ! C-1300 clone N18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   N18TG2 ChAT
AC   CVCL_E3K2
SY   N18-ChAT
RX   PubMed=10215905;
CC   Characteristics: Control cell line for the series of N18TG2 To/2 to To/9 cell lines (PubMed=10215905).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=RGD; 69313; Ache.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   N18TG2 To/0
AC   CVCL_E3K1
RX   PubMed=10215905;
CC   Characteristics: Control cell line for the series of N18TG2 To/2 to To/9 cell lines (PubMed=10215905).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q03105; Torpedo marmorata V-type proton ATPase 16 kDa proteolipid subunit c.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   N18TG2 To/2
AC   CVCL_D5JU
SY   To/2
DR   Wikidata; Q127382914
RX   PubMed=10215905;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=RGD; 69313; Ache.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q03105; Torpedo marmorata V-type proton ATPase 16 kDa proteolipid subunit c.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   N18TG2 To/3
AC   CVCL_D5JV
SY   To/3
DR   Wikidata; Q127382915
RX   PubMed=10215905;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=RGD; 69313; Ache.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q03105; Torpedo marmorata V-type proton ATPase 16 kDa proteolipid subunit c.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   N18TG2 To/4
AC   CVCL_D5JW
SY   To/4
DR   Wikidata; Q127382917
RX   PubMed=10215905;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=RGD; 69313; Ache.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q03105; Torpedo marmorata V-type proton ATPase 16 kDa proteolipid subunit c.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   N18TG2 To/5
AC   CVCL_D5JX
SY   To/5
DR   Wikidata; Q127382919
RX   PubMed=10215905;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=RGD; 69313; Ache.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q03105; Torpedo marmorata V-type proton ATPase 16 kDa proteolipid subunit c.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   N18TG2 To/9
AC   CVCL_D5JY
SY   To/9
DR   Wikidata; Q127382920
RX   PubMed=10215905;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=RGD; 69313; Ache.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q03105; Torpedo marmorata V-type proton ATPase 16 kDa proteolipid subunit c.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   N19/2
AC   CVCL_E9K2
DR   ABCD; ABCD_AW902
DR   DSHB; N19-2
DR   MMRRC; MMRRC:065983-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N19_2.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62936; Rat Dlg3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N191/7
AC   CVCL_E9K3
DR   ABCD; ABCD_AV264
DR   DSHB; N191-7
DR   MMRRC; MMRRC:066146-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N191_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16595; Human FXN (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N192/12
AC   CVCL_E9K4
DR   ABCD; ABCD_AV265
DR   DSHB; N192-12
DR   MMRRC; MMRRC:066147-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N192_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04896; Bovine GNAS (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N193A/13
AC   CVCL_E9K5
DR   ABCD; ABCD_AV266
DR   MMRRC; MMRRC:066153-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N193A_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q91XX0; Mouse Pcdhgc4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N194/11
AC   CVCL_E9K6
DR   ABCD; ABCD_AV267
DR   MMRRC; MMRRC:066193-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N194_11.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96PU8; Human QKI (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N195A/16
AC   CVCL_E9K7
DR   ABCD; ABCD_AK433
DR   DSHB; N195A-16
DR   MMRRC; MMRRC:066148-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N195A_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96PU8; Human QKI (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N196/16
AC   CVCL_E9K8
DR   ABCD; ABCD_AK428
DR   DSHB; N196-16
DR   MMRRC; MMRRC:066116-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N196_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6NUN9; Human ZNF746 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N199MA
AC   CVCL_E7FP
SY   Normal 199 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N19OS
AC   CVCL_B5LQ
SY   Normal 19 OSaka
DR   Wikidata; Q112129392
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   N1alpha2-1H2
AC   CVCL_C2F2
DR   Wikidata; Q114312440
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1 (Note=Isoform alpha-2).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   N1C12
AC   CVCL_C4BU
DR   Wikidata; Q116049853
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   N1E-115
AC   CVCL_0451
SY   N1E115; NIE-115; NIE 115
DR   BTO; BTO_0001909
DR   CLO; CLO_0007922
DR   EFO; EFO_0022740
DR   MCCL; MCC:0000348
DR   CLDB; cl3621
DR   CLDB; cl4996
DR   ATCC; CRL-2263
DR   ChEMBL-Cells; CHEMBL3307973
DR   ChEMBL-Targets; CHEMBL612553
DR   ECACC; 88112303
DR   Lonza; 54
DR   PubChem_Cell_line; CVCL_0451
DR   Wikidata; Q54907324
RX   PubMed=2759161;
RX   PubMed=3756898;
RX   PubMed=4063972;
RX   PubMed=4400294;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-95.html
CC   Characteristics: Adrenergic clone of C-1300.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   N1E-115 GFP-ADNP
AC   CVCL_C4S0
DR   Wikidata; Q116049854
RX   PubMed=36230962;
CC   Characteristics: Using CRISPR/Cas9 a GFP tag was integrated in the N-terminus of ADNP (PubMed=36230962).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   N1E-115 GFP-ADNP p.Pro403*
AC   CVCL_C4S1
DR   Wikidata; Q116049855
RX   PubMed=36230962;
CC   Characteristics: Using CRISPR/Cas9 a GFP tag was integrated in the N-terminus of ADNP (PubMed=36230962).
CC   Sequence variation: Mutation; MGI; MGI:1338758; Adnp; Simple_edited; p.Pro403Ter; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36230962).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   N1E-115 GFP-ADNP p.Tyr718*
AC   CVCL_C4S2
DR   Wikidata; Q116049856
RX   PubMed=36230962;
CC   Characteristics: Using CRISPR/Cas9 a GFP tag was integrated in the N-terminus of ADNP (PubMed=36230962).
CC   Sequence variation: Mutation; MGI; MGI:1338758; Adnp; Simple_edited; p.Tyr418Ter; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36230962).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   N1E-115-1
AC   CVCL_4033
DR   DSMZ; ACC-856
DR   DSMZCellDive; ACC-856
DR   ECACC; 08062511
DR   Wikidata; Q54907325
CC   Doubling time: ~100 hours (DSMZ=ACC-856); ~20 hours (ECACC=08062511).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0451 ! N1E-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   N1G-4C11
AC   CVCL_C2F3
DR   Wikidata; Q114312441
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-5A6
AC   CVCL_C2F4
DR   Wikidata; Q114312442
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-6C9
AC   CVCL_C2F5
DR   Wikidata; Q114312443
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-6F7
AC   CVCL_C2F6
DR   Wikidata; Q114312444
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-7C8
AC   CVCL_C2F7
DR   Wikidata; Q114312447
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-7D9
AC   CVCL_C2F8
DR   Wikidata; Q114312448
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-8C8
AC   CVCL_C2F9
DR   Wikidata; Q114312450
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-9G5
AC   CVCL_C2FA
DR   Wikidata; Q114312453
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G-ex130
AC   CVCL_C2FB
DR   Wikidata; Q114312454
RX   PubMed=27350129;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Emery-Dreifuss.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF91; Human SYNE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   N1G9
AC   CVCL_C4BV
DR   Wikidata; Q116049857
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   N1KA
AC   CVCL_ZV74
SY   Normal 1 KAnazawa
DR   Wikidata; Q98127395
RX   PubMed=3627143;
RX   PubMed=3821765;
RX   PubMed=6876478;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   N1KY
AC   CVCL_ZS75
SY   Normal 1 KYoto
DR   Wikidata; Q98127397
RX   PubMed=2778352;
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   N1MA
AC   CVCL_E7FE
SY   Normal 1 Mannheim
RX   PubMed=6862680;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N2-iPS-1
AC   CVCL_A4FR
SY   N2-iPSC_HGPS
DR   SKIP; SKIP003115
DR   Wikidata; Q105510268
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L606 ! AG06299
SX   Female
AG   34Y11M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   N2-iPS-2
AC   CVCL_A4FS
DR   Wikidata; Q105510270
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L606 ! AG06299
SX   Female
AG   34Y11M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   N2/16
AC   CVCL_E9K9
DR   ABCD; ABCD_AK473
DR   DSHB; N2-16
DR   MMRRC; MMRRC:065985-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N2_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O54982; Mouse Kcnu1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N2.261
AC   CVCL_2133
SY   N2-261
DR   CLO; CLO_0007925
DR   ATCC; CRL-2047
DR   DSMZ; ACC-322
DR   DSMZCellDive; ACC-322
DR   Wikidata; Q54907326
CC   Doubling time: ~20 hours (DSMZ=ACC-322).
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   N20.1
AC   CVCL_IZ83
DR   BTO; BTO_0000875
DR   Wikidata; Q54907327
RX   PubMed=7678286;
RX   PubMed=21472765;
CC   Doubling time: ~48-62 hours (Note=At 34 Celsius), >8 days (Note=At 39 Celsius) (PubMed=7678286).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIPSVtsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: BALB/cByJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1-2D
CA   Conditionally immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   N201/35
AC   CVCL_E9KA
DR   ABCD; ABCD_AV268
DR   DSHB; N201-35
DR   MMRRC; MMRRC:066155-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N201_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9CZW6; Mouse Rnf146 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N202/7
AC   CVCL_E9KB
DR   ABCD; ABCD_AV269
DR   DSHB; N202-7
DR   MMRRC; MMRRC:066123-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N202_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q91WF7; Mouse Fig4 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N202.1A
AC   CVCL_RW56
SY   N202/1A
DR   Wikidata; Q54907328
RX   PubMed=9714068;
WW   Provider; Metalab; -; https://web.archive.org/web/20110722041856/http://www.lollini.it/n202.htm
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB/N#202 transgenic for HER-2/neu.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   N202.1E
AC   CVCL_RW57
SY   N202/1E
DR   Wikidata; Q54907329
RX   PubMed=11696586;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: FVB N#202 transgenic for HER-2/neu.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   N205B/22
AC   CVCL_E9KC
DR   ABCD; ABCD_AU865
DR   DSHB; N205B-22
DR   MMRRC; MMRRC:066182-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N205B_22.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86VH4; Human LRRTM4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N206
AC   CVCL_C885
DR   cancercelllines; CVCL_C885
DR   Cosmic; 930068
DR   Cosmic; 1109114
DR   Cosmic; 1153807
DR   Cosmic; 1518069
DR   Cosmic; 1526631
DR   Cosmic; 1543775
DR   Cosmic; 2239463
DR   GEO; GSM692867
DR   Wikidata; Q54907330
RX   PubMed=7838528;
RX   PubMed=18923523;
RX   PubMed=20655465;
RX   PubMed=22213050;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=18923523).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   N206A/8
AC   CVCL_E9KD
DR   ABCD; ABCD_AW901
DR   DSHB; N206A-8
DR   MMRRC; MMRRC:066161-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N206A_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14136; Human GFAP (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N206B/9
AC   CVCL_E9KE
DR   ABCD; ABCD_AK469
DR   DSHB; N206B-9
DR   MMRRC; MMRRC:066199-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N206B_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14136; Human GFAP (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N207/27
AC   CVCL_E9KF
DR   ABCD; ABCD_AW900
DR   DSHB; N207-27
DR   MMRRC; MMRRC:066149-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N207_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VI56; Mouse Lrp4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N209C/35
AC   CVCL_E9KG
DR   ABCD; ABCD_AV270
DR   DSHB; N209C-35
DR   MMRRC; MMRRC:066282-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N209C_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43300; Human LRRTM2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N20OS
AC   CVCL_B5LR
SY   Normal 20 OSaka
DR   Wikidata; Q112129393
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   N210/5
AC   CVCL_E9KH
DR   ABCD; ABCD_AV271
DR   MMRRC; MMRRC:066150-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N210_5.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14832; Human PHYH (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N2102Ep Clone 2/A6
AC   CVCL_3037
DR   Cosmic; 2439939
DR   Cosmic; 2806397
DR   ECACC; 06011803
DR   Wikidata; Q54907331
CC   Characteristics: Established from a passage of 2102EP in nude mice.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C522 ! 2102EP
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   N211-1-8
AC   CVCL_DD06
DR   Wikidata; Q54907332
RX   PubMed=1986234;
RX   PubMed=6270122;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7182 ! CHO Pro-3
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 8
//
ID   N212/17
AC   CVCL_E9KI
DR   ABCD; ABCD_AU866
DR   DSHB; N212-17
DR   MMRRC; MMRRC:066165-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N212_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q925N3; Rat Pex5l (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N212/3
AC   CVCL_E9KJ
DR   ABCD; ABCD_AU867
DR   DSHB; N212-3
DR   MMRRC; MMRRC:066152-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N212_3.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q925N3; Rat Pex5l (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N212/7
AC   CVCL_E9KK
DR   ABCD; ABCD_AW194
DR   DSHB; N212-7
DR   MMRRC; MMRRC:066164-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N212_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q925N3; Rat Pex5l (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N212A/34
AC   CVCL_E9KL
DR   ABCD; ABCD_AV272
DR   DSHB; N212A-34
DR   MMRRC; MMRRC:066166-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N212A_34.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8C437; Mouse Pex5l (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N219/5
AC   CVCL_E9KM
DR   ABCD; ABCD_AV273
DR   DSHB; N219-5
DR   MMRRC; MMRRC:066156-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N219_5.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96I25; Human RBM17 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N22
AC   CVCL_8965
DR   CLO; CLO_0007926
DR   ATCC; HB-225
DR   Wikidata; Q54907336
RX   PubMed=2185332;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 6
//
ID   N22/21
AC   CVCL_E9KN
DR   ABCD; ABCD_AW899
DR   DSHB; N22-21
DR   MMRRC; MMRRC:065990-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N22_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9WV48; Rat Shank1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N221/12
AC   CVCL_E9KP
DR   ABCD; ABCD_AV274
DR   MMRRC; MMRRC:066176-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N221_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O35433; Rat Trpv1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N221/17
AC   CVCL_E9KQ
DR   ABCD; ABCD_AV275
DR   DSHB; N221-17
DR   MMRRC; MMRRC:066175-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N221_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O35433; Rat Trpv1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N222/6
AC   CVCL_E9KR
DR   ABCD; ABCD_AK427
DR   MMRRC; MMRRC:066174-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N222_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51793; Human CLCN4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N225A/10
AC   CVCL_E9KS
DR   ABCD; ABCD_AV276
DR   DSHB; N225A-10
DR   MMRRC; MMRRC:066169-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N225A_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92913; Human FGF13 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N227/21
AC   CVCL_E9KT
DR   ABCD; ABCD_AV277
DR   DSHB; N227-21
DR   MMRRC; MMRRC:066194-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N227_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51608; Human MECP2 (Note=Immunized with 157-FTVTGRGSPSRRE-169 with dimethyl p.Arg162. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N228A/16
AC   CVCL_E9KU
DR   ABCD; ABCD_AV278
DR   MMRRC; MMRRC:066162-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N228A_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9R1R0; Mouse Lhx6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N229A/32
AC   CVCL_E9KV
DR   ABCD; ABCD_AV279
DR   ABCD; ABCD_AV280
DR   MMRRC; MMRRC:066306-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N229A_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16305; Mouse Gabra6 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N230/21
AC   CVCL_E9KW
DR   ABCD; ABCD_AK482
DR   DSHB; N230-21
DR   MMRRC; MMRRC:066160-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N230_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y4U1; Human MMACHC (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N231B/34
AC   CVCL_E9KX
DR   ABCD; ABCD_AV281
DR   DSHB; N231B-34
DR   MMRRC; MMRRC:066186-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N231B_34.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5S007; Human LRRK2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N232/9
AC   CVCL_E9KY
DR   ABCD; ABCD_AV282
DR   MMRRC; MMRRC:066173-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N232_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00628; Human PEX7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N233/8
AC   CVCL_E9KZ
DR   ABCD; ABCD_AV286
DR   MMRRC; MMRRC:066205-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N233_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13608; Human PEX6 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N235/22
AC   CVCL_E9L0
DR   ABCD; ABCD_AK453
DR   DSHB; N235-22
DR   MMRRC; MMRRC:066167-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N235_22.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92913; Human FGF13 (Note=Also recognizes FGF12 and FGF14. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N238/29
AC   CVCL_E9L1
DR   ABCD; ABCD_AV287
DR   MMRRC; MMRRC:066380-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N238_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P97836; Rat Dlgap1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N238/30
AC   CVCL_E9L2
DR   ABCD; ABCD_AV288
DR   MMRRC; MMRRC:066382-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N238_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P97836; Rat Dlgap1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N238/31
AC   CVCL_E9L3
DR   DSHB; N238-31
DR   MMRRC; MMRRC:066158-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N238_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P97836; Rat Dlgap1 (Note=Also recognizes Dlgap2. Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N23B/49
AC   CVCL_E9L4
DR   ABCD; ABCD_AU868
DR   DSHB; N23B-49
DR   MMRRC; MMRRC:066012-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N23B_49.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9QX74; Rat Shank2 (Note=Also recognizes Shank1 and Shank3. Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N23B/6
AC   CVCL_E9L5
DR   ABCD; ABCD_AV289
DR   DSHB; N23B-6
DR   MMRRC; MMRRC:066011-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N23B_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9QX74; Rat Shank2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N241A/34
AC   CVCL_E9L6
DR   ABCD; ABCD_AV290
DR   DSHB; N241A-34
DR   MMRRC; MMRRC:066177-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N241A_34.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5S007; Human LRRK2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N244/5
AC   CVCL_E9L7
DR   ABCD; ABCD_AK483
DR   DSHB; N244-5
DR   MMRRC; MMRRC:066168-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N244_5.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8R464; Mouse Cadm4 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N245/1
AC   CVCL_E9L8
DR   ABCD; ABCD_AW896
DR   DSHB; N245-1
DR   MMRRC; MMRRC:066163-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N245_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q71RJ2; Rat Cacng2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N245/36
AC   CVCL_E9L9
DR   ABCD; ABCD_AV291
DR   DSHB; N245-36
DR   MMRRC; MMRRC:066172-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N245_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q71RJ2; Rat Cacng2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N245/44
AC   CVCL_E9LA
DR   MMRRC; MMRRC:066180-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N245_44.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0AA25; Escherichia coli trxA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N25/35
AC   CVCL_E9LB
DR   DSHB; N25-35
DR   MMRRC; MMRRC:066002-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N25_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P48050; Human KCNJ4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N250/21
AC   CVCL_E9LC
DR   ABCD; ABCD_AW195
DR   MMRRC; MMRRC:066209-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N250_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXX0; Human DNAH7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N251/14
AC   CVCL_E9LD
DR   MMRRC; MMRRC:066210-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N251_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P2D7; Human DNAH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N253/32
AC   CVCL_E9LE
DR   MMRRC; MMRRC:066214-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N253_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01705; Mouse Notch1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N255/38
AC   CVCL_E9LF
DR   ABCD; ABCD_AV292
DR   DSHB; N255-38
DR   MMRRC; MMRRC:066339-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N255_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15390; Rat Scn4a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N257/25
AC   CVCL_E9LG
DR   ABCD; ABCD_AV451
DR   DSHB; N257-25
DR   MMRRC; MMRRC:066211-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N257_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_234276; O-phospho-L-serine-P-ethyl ester (Phosphoserine-2-OEt).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N258/5
AC   CVCL_E9LH
DR   ABCD; ABCD_AV293
DR   DSHB; N258-5
DR   MMRRC; MMRRC:066181-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N258_5.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51790; Human CLCN3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N259/48
AC   CVCL_E9LI
DR   ABCD; ABCD_AV452
DR   DSHB; N259-48
DR   MMRRC; MMRRC:066212-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N259_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_37712; O-phosphoserine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N262/16
AC   CVCL_E9LJ
DR   ABCD; ABCD_AV453
DR   DSHB; N262-16
DR   MMRRC; MMRRC:066213-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N262_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_234278; O-phospho-L-serine-P-methyl ester (Phosphoserine-2-OMe).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N263
AC   CVCL_LF76
DR   Wikidata; Q54907337
RX   PubMed=2339117;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6018; IL6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06740; Hylobates lar IL3.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   N263/31
AC   CVCL_E9LK
DR   ABCD; ABCD_AV295
DR   DSHB; N263-31
DR   MMRRC; MMRRC:066178-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N263_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P22002; Rat Cacna1c (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N268/19
AC   CVCL_E9LL
DR   ABCD; ABCD_AK430
DR   MMRRC; MMRRC:066204-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N268_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TDD5; Human MCOLN3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N269/73
AC   CVCL_E9LM
DR   ABCD; ABCD_AK484
DR   MMRRC; MMRRC:066184-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N269_73.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9R0N4; Mouse Syt10 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N26A/23
AC   CVCL_E9LN
DR   ABCD; ABCD_AV296
DR   DSHB; N26A-23
DR   MMRRC; MMRRC:066003-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N26A_23.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43526; Human KCNQ2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N27
AC   CVCL_D584
SY   N-27; 1RB3AN27; 1RB3A-N27
DR   BTO; BTO_0002393
DR   Millipore; SCC048
DR   Wikidata; Q54907338
RX   PubMed=7820310;
RX   PubMed=22863662;
RX   PubMed=27512998;
CC   Characteristics: Used as a dopaminergic neuron model for in vitro and in vivo studies (Millipore=SCC048).
CC   Characteristics: During many passages over 20 years, the original cell line became a mixture of cell types with less than 5% TH-positive dopamine neurons (PubMed=27512998).
CC   Doubling time: 24 hours (PubMed=27512998).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Embryonic brain, mesencephalon; UBERON=UBERON_0009616.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   N27-A
AC   CVCL_ZJ56
DR   Millipore; SCC196
DR   Wikidata; Q98127400
RX   PubMed=27512998;
CC   Characteristics: Improved in vitro model of dopamine neurons for research on Parkinson's disease. Expresses TH and DAT at 4 times the level of the parent cell line. Also expresses VMAT2, dopaminergic transcription factors, dopaminergic storage protein (PubMed=27512998).
CC   Doubling time: ~36 hours (PubMed=27512998).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Embryonic brain, mesencephalon; UBERON=UBERON_0009616.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D584 ! N27
SX   Sex unspecified
AG   12FD
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   N270/47
AC   CVCL_E9LP
DR   MMRRC; MMRRC:066189-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N270_47.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9R0N8; Mouse Syt6 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N271
AC   CVCL_B6JE
SY   M271
DR   Wikidata; Q112129394
RX   Patent=US10422802;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-93.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08833; Human IGFBP1 (Note=Indicated to recognizes PAMG-1 but it is not 100% clear if PAMG-1=IGFBP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   N271/44
AC   CVCL_E9LQ
DR   ABCD; ABCD_AV297
DR   DSHB; N271-44
DR   MMRRC; MMRRC:066197-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N271_44.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6NXK8; Mouse Asic1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N274/8
AC   CVCL_E9LR
DR   ABCD; ABCD_AV298
DR   MMRRC; MMRRC:066224-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N274_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9R0N9; Mouse Syt9 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N275/14
AC   CVCL_E9LS
DR   ABCD; ABCD_AW897
DR   DSHB; N275-14
DR   MMRRC; MMRRC:066185-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N275_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9R0N7; Mouse Syt7 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N276A/15
AC   CVCL_E9LT
DR   MMRRC; MMRRC:066225-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N276A_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9R0N5; Mouse Syt5 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N277/7
AC   CVCL_E9LU
DR   ABCD; ABCD_AK434
DR   MMRRC; MMRRC:066226-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N277_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q920N7; Mouse Syt12 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N278/19
AC   CVCL_E9LV
DR   ABCD; ABCD_AK429
DR   MMRRC; MMRRC:066190-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N278_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O35681; Mouse Syt3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N279B/27
AC   CVCL_E9LW
DR   ABCD; ABCD_AU869
DR   DSHB; N279B-27
DR   MMRRC; MMRRC:066281-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N279B_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q63273; Rat Grik5 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N28/9
AC   CVCL_E9LX
DR   ABCD; ABCD_AU870
DR   DSHB; N28-9
DR   MMRRC; MMRRC:065995-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N28_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62634; Rat Slc17a7 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N283/7
AC   CVCL_E9LY
DR   ABCD; ABCD_AV299
DR   DSHB; N283-7
DR   MMRRC; MMRRC:066227-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N283_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JIA1; Mouse Lgi1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N286/74
AC   CVCL_E9LZ
DR   ABCD; ABCD_AV455
DR   DSHB; N286-74
DR   MMRRC; MMRRC:066237-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N286_74.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Danio rerio postsynaptic density fraction 90 kDa protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N289/16
AC   CVCL_E9M0
DR   ABCD; ABCD_AK485
DR   DSHB; N289-16
DR   MMRRC; MMRRC:066187-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N289_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q09429; Rat Abcc8 (Note=Also reacts with hamster and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N29/29
AC   CVCL_E9M1
DR   ABCD; ABCD_AK448
DR   DSHB; N29-29
DR   MMRRC; MMRRC:065999-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N29_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JI12; Rat Slc17a6 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N290B/25
AC   CVCL_E9M2
DR   ABCD; ABCD_AV300
DR   MMRRC; MMRRC:066215-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N290B_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8VHL8; Mouse Arhgap4 (Note=Also react with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N291C/22
AC   CVCL_E9M3
DR   ABCD; ABCD_AK486
DR   MMRRC; MMRRC:066250-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N291C_22.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8C437; Mouse Pex5l (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N293/50
AC   CVCL_E9M4
DR   DSHB; N293-50
DR   MMRRC; MMRRC:066255-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N293_50.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P68431; Human H3C1 (Note=Immunized with 5-KQTARKSTGGK-15 with dimethyl p.Arg8. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N294A/10
AC   CVCL_E9M5
DR   ABCD; ABCD_AV301
DR   DSHB; N294A-10
DR   MMRRC; MMRRC:066216-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N294A_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P55068; Rat Bcan (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N294A/6
AC   CVCL_E9M6
DR   ABCD; ABCD_AV302
DR   MMRRC; MMRRC:066200-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N294A_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55068; Rat Bcan (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N295B/66
AC   CVCL_E9M7
DR   ABCD; ABCD_AU871
DR   DSHB; N295B-66
DR   MMRRC; MMRRC:066207-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N295B_66.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q640N2; Mouse Arl13b (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N297/59
AC   CVCL_E9M8
DR   ABCD; ABCD_AV454
DR   DSHB; N297-59
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N297_59.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_139232; 5-hydroxymethylcytidine (hm5C).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N299/39
AC   CVCL_E9M9
DR   DSHB; N299-39
DR   MMRRC; MMRRC:066239-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N299_39.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C0S5; Human H2AZ1 (Note=Immunized with 2-AGGKAGKDSGKAKT-15 with acetyl p.Lys5, p.Lys8 and p.Lys12. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N2a #34
AC   CVCL_C5RF
DR   Wikidata; Q116049858
RX   PubMed=11943143;
CC   Characteristics: Prnp is tagged with an epitope recognized by the mAB 3F4 produced by hybridoma 263K 3F4 (Cellosaurus=CVCL_KR59).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97769; Prnp (Note=With a 3F4 tag).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   N2a #58
AC   CVCL_C5RG
SY   N2a#58; N2a58; N2a 58
DR   Wikidata; Q116049859
RX   PubMed=11943143;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97769; Prnp.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   N2a #58 F3
AC   CVCL_C5RH
SY   F3
DR   ChEMBL-Cells; CHEMBL3989341
DR   ChEMBL-Targets; CHEMBL3879801
DR   Wikidata; Q116049860
RX   PubMed=17850126;
CC   Characteristics: Infected with mouse Fukuoka-1 strain prions.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97769; Prnp.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C5RG ! N2a #58
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   N2a APP695-N467K
AC   CVCL_E7F3
DR   ABM; T6512
RX   PubMed=30796750;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP695 with p.Asn467Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2a APP695-N496K
AC   CVCL_E7F4
DR   ABM; T6513
RX   PubMed=30796750;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP695 with p.Asn496Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2a APP695-S206A
AC   CVCL_E7F5
DR   ABM; T6511
RX   PubMed=30796750;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP695 with p.Ser206Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2a APP695-WT
AC   CVCL_E7F6
DR   ABM; T6510
RX   PubMed=30796750;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP695).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2a APP770-N542K
AC   CVCL_E7F7
DR   ABM; T6516
CC   From: University of Leeds; Leeds; United Kingdom.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP770 with p.Asn542Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: ABM; T6516; true.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2a APP770-N571K
AC   CVCL_E7F8
DR   ABM; T6517
CC   From: University of Leeds; Leeds; United Kingdom.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP770 with p.Asn571Lys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: ABM; T6517; true.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2a APP770-S206A
AC   CVCL_E7F9
DR   ABM; T6515
CC   From: University of Leeds; Leeds; United Kingdom.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP770 with p.Ser206Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: ABM; T6515; true.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2a APP770-WT
AC   CVCL_E7FA
DR   ABM; T6514
CC   From: University of Leeds; Leeds; United Kingdom.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=Isoform APP770).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: ABM; T6514; true.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   N2A FLAG-Cdh1
AC   CVCL_ZM10
DR   PRIDE; PXD018875
DR   Wikidata; Q98127402
RX   PubMed=32434143;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1926790; Fzr1 (Note=With a N-terminal FLAG tag).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   N2A Psen1/Psen2 dKO
AC   CVCL_A0TK
SY   N2A Psen1/Psen2 double knockout; N2A-PS1/2KO-8/71
DR   Millipore; SCC297
DR   Wikidata; Q108821007
RX   PubMed=32032730;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1202717; Psen1.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109284; Psen2.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
ST   Source(s): Millipore=SCC297
ST   Mouse STR 1-1: 11
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 21.3,22.3
ST   Mouse STR 5-5: 15,17
ST   Mouse STR 6-4: 18,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 21.3,22.3,23.3,24.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 22
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26,27
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   N2a-PD88
AC   CVCL_WI09
SY   N2aPD88; PD88
DR   Wikidata; Q95991903
RX   PubMed=14504404;
CC   Biotechnology: Used in the scrapie cell (SC) assay. This susceptible cell line is exposed to mouse prion-containing samples for 3 days, grown to confluence and split 1:10 three times. The proportion of PrPSc-containing cells is determined with automated counting equipment.
CC   Characteristics: Highly susceptible to infection by prion (PrPsc).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WI08 ! N2a/Gary
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   N2a-PK1
AC   CVCL_WI10
SY   N2aPK1; PK1
DR   Wikidata; Q95991905
RX   PubMed=14504404;
RX   PubMed=18077360;
CC   Biotechnology: Used in the scrapie cell (SC) assay. This susceptible cell line is exposed to mouse prion-containing samples for 3 days, grown to confluence and split 1:10 three times. The proportion of PrPSc-containing cells is determined with automated counting equipment.
CC   Characteristics: Highly susceptible to infection by prion (PrPsc).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WI09 ! N2a-PD88
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   N2a-R33
AC   CVCL_WI11
SY   N2aR33; R33
DR   Wikidata; Q95991906
RX   PubMed=14504404;
RX   PubMed=18077360;
CC   Characteristics: Not susceptible to infection by prion (PrPsc).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 5
//
ID   N2a/Gary
AC   CVCL_WI08
DR   Wikidata; Q95991907
RX   Patent=WO2003081249A2;
RX   PubMed=14504404;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 02031337.
CC   Biotechnology: Used in the scrapie cell (SC) assay. This susceptible cell line is exposed to mouse prion-containing samples for 3 days, grown to confluence and split 1:10 three times. The proportion of PrPSc-containing cells is determined with automated counting equipment.
CC   Characteristics: Highly susceptible to infection by prion (PrPsc).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   N2a[TRb1]-274A+B Clone AB2
AC   CVCL_E1GU
SY   N2a[TRb1]-274 A+B Clone AB-2
DR   Kerafast; EMU060
RX   PubMed=27387481;
CC   Characteristics: Using CRISPR/Cas9 mutations were introduced in the thyroid hormone response element (TRE) of the Dnmt3a gene (PubMed=27387481).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1GT ! Neuro2A[TRb1]
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   N2a[TRb1]-274B Clone A1
AC   CVCL_E1GV
DR   Kerafast; EMU059
RX   PubMed=27387481;
CC   Characteristics: Using CRISPR/Cas9 mutations were introduced in the thyroid hormone response element (TRE) of the Dnmt3a gene (PubMed=27387481).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1GT ! Neuro2A[TRb1]
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   N2a[TRb1]-274B Clone B1
AC   CVCL_E1GW
DR   Kerafast; EMU058
RX   PubMed=27387481;
CC   Characteristics: Using CRISPR/Cas9 mutations were introduced in the thyroid hormone response element (TRE) of the Dnmt3a gene (PubMed=27387481).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1GT ! Neuro2A[TRb1]
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   N2a[TRb1]-Dnmt3a-Cat Domain KO Clone 2
AC   CVCL_E1GX
DR   Kerafast; EMU057
RX   PubMed=27387481;
CC   Characteristics: Using CRISPR/Cas9 mutations were introduced in the catalytic domain of the Dnmt3a gene (PubMed=27387481).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1GT ! Neuro2A[TRb1]
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   N2a[TRb1]-Dnmt3a-Cat Domain KO Clone 7
AC   CVCL_E1GY
DR   Kerafast; EMU055
RX   PubMed=27387481;
CC   Characteristics: Using CRISPR/Cas9 mutations were introduced in the catalytic domain of the Dnmt3a gene (PubMed=27387481).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1GT ! Neuro2A[TRb1]
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   N2aEGFP
AC   CVCL_D649
DR   BTO; BTO_0002653
DR   Wikidata; Q54907339
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   N2aSW
AC   CVCL_D650
SY   N2aSw; N2Asw-APP; Swe.24; N2a/APPsw; N2a-APPsw; N2a-APPswe; N2A-APPswe; N2A APPsw; N2aAPPsw
DR   BTO; BTO_0002663
DR   PRIDE; PXD032733
DR   Wikidata; Q54907340
RX   PubMed=8621605;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=With p.Lys670Asn and p.Met671Leu).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   N2H3A8
AC   CVCL_XK40
DR   Wikidata; Q95991914
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_100246; Norfloxacin (NOR) (Note=Also recognizes ciprofloxacin, enrofloxacin and ofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   N2KA
AC   CVCL_ZV75
SY   Normal 2 KAnazawa
DR   Wikidata; Q98127404
RX   PubMed=3821765;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   N2MA
AC   CVCL_E7FQ
SY   Normal 2 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N3
AC   CVCL_B6HC
DR   Wikidata; Q112129395
RX   PubMed=2789141;
CC   Transformant: Recombinant retrovirus 3RV/VN-11.
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12-13FD
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   N3-1C8
AC   CVCL_A7VU
DR   BEI_Resources; MRA-478
DR   Wikidata; Q107116495
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   N3-1D7
AC   CVCL_A7VV
DR   BEI_Resources; MRA-480
DR   Wikidata; Q107116497
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   N3-2D9
AC   CVCL_A7VW
DR   BEI_Resources; MRA-479
DR   Wikidata; Q107116498
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   N3/26
AC   CVCL_E9MA
DR   ABCD; ABCD_AU872
DR   DSHB; N3-26
DR   MMRRC; MMRRC:065981-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N3_26.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z258; Rat Kcnt1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N3.36
AC   CVCL_2134
SY   N3-36
DR   CLO; CLO_0007927
DR   CLO; CLO_0007928
DR   ATCC; CRL-2042
DR   DSHB; N3-36
DR   DSMZ; ACC-318
DR   DSMZCellDive; ACC-318
DR   Wikidata; Q54907341
RX   PubMed=1698201;
RX   PubMed=3530499;
RX   PubMed=7531198;
CC   Doubling time: ~24 hours (DSMZ=ACC-318).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P13535; Human MYH8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 9
//
ID   N302/10
AC   CVCL_E9MB
DR   ABCD; ABCD_AV303
DR   DSHB; N302-10
DR   MMRRC; MMRRC:066191-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N302_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H0F7; Human ARL6 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N304B/115
AC   CVCL_E9MC
DR   ABCD; ABCD_AV304
DR   MMRRC; MMRRC:066249-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N304B_115.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N3I7; Human BBS5 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N307/12
AC   CVCL_E9MD
DR   ABCD; ABCD_AV305
DR   DSHB; N307-12
DR   MMRRC; MMRRC:066195-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N307_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P68431; Human H3C1 (Note=Immunized with 51-EIRRYQKSTE-60 with acetyl p.Lys57. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N308/48
AC   CVCL_E9ME
DR   ABCD; ABCD_AW898
DR   DSHB; N308-48
DR   MMRRC; MMRRC:066192-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N308_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35439; Rat Grin1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N309A/21
AC   CVCL_E9MF
DR   ABCD; ABCD_AV306
DR   DSHB; N309A-21
DR   MMRRC; MMRRC:066240-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N309A_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P62805; Human H4C1 (Note=Immunized with 2-SGRGKGGKGL-11 with dimethyl p.Arg4. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N310/21
AC   CVCL_E9MG
DR   ABCD; ABCD_AV307
DR   DSHB; N310-21
DR   MMRRC; MMRRC:066196-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N310_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0C0S5; Human H2AZ1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N312/10
AC   CVCL_E9MH
DR   ABCD; ABCD_AV308
DR   DSHB; N312-10
DR   MMRRC; MMRRC:066201-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N312_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96L73; Human NSD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N319A/14
AC   CVCL_E9MI
DR   ABCD; ABCD_AV309
DR   DSHB; N319A-14
DR   MMRRC; MMRRC:066217-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N319A_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P70170; Mouse Abcc9 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N320/48
AC   CVCL_E9MJ
DR   ABCD; ABCD_AU873
DR   MMRRC; MMRRC:066202-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N320_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8BR86; Mouse Kirrel3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N321C/49
AC   CVCL_E9MK
DR   ABCD; ABCD_AK441
DR   DSHB; N321C-49
DR   MMRRC; MMRRC:066251-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N321C_49.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q09GS6; Rat Kirrel3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N323A/31
AC   CVCL_E9ML
DR   ABCD; ABCD_AV310
DR   MMRRC; MMRRC:066218-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N323A_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63563; Rat Abcc9 (Note=Also recognizes Abcc8. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N323B/20
AC   CVCL_E9MM
DR   ABCD; ABCD_AU874
DR   ABCD; ABCD_AV457
DR   ABCD; ABCD_AV458
DR   MMRRC; MMRRC:066219-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N323B_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q63563; Rat Abcc9 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N324/2
AC   CVCL_E9MN
DR   ABCD; ABCD_AV311
DR   MMRRC; MMRRC:066206-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N324_2.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9WTY2; Rat Rem2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N325B/65
AC   CVCL_E9MP
DR   ABCD; ABCD_AV312
DR   MMRRC; MMRRC:066228-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N325B_65.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q9NVV9; Human THAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N326D/13
AC   CVCL_E9MQ
DR   ABCD; ABCD_AV313
DR   MMRRC; MMRRC:066286-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N326D_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8VCD6; Mouse Reep2 (Note=Also recognizes Reep1. Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N326D/2
AC   CVCL_E9MR
DR   MMRRC; MMRRC:066287-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N326D_2.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8VCD6; Mouse Reep2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N326D/29
AC   CVCL_E9MS
DR   ABCD; ABCD_AK454
DR   MMRRC; MMRRC:066288-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N326D_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8VCD6; Mouse Reep2 (Note=Also recognizes Reep1. Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N327/95
AC   CVCL_E9MT
DR   ABCD; ABCD_AV314
DR   DSHB; N327-95
DR   MMRRC; MMRRC:066208-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N327_95.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00959; Rat Grin2a (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N327A/38
AC   CVCL_E9MU
DR   ABCD; ABCD_AV315
DR   DSHB; N327A-38
DR   MMRRC; MMRRC:066223-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N327A_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q00959; Rat Grin2a (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N328B/37
AC   CVCL_E9MV
DR   ABCD; ABCD_AU875
DR   DSHB; N328B-37
DR   MMRRC; MMRRC:066256-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N328B_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2M1K9; Human ZNF423 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N330A/51
AC   CVCL_E9MW
DR   ABCD; ABCD_AV316
DR   MMRRC; MMRRC:066220-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N330A_51.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18825; Human ADRA2C (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N330A/80
AC   CVCL_E9MX
DR   MMRRC; MMRRC:066222-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N330A_80.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18825; Human ADRA2C (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N331/19
AC   CVCL_E9MY
DR   ABCD; ABCD_AK440
DR   MMRRC; MMRRC:066221-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N331_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35462; Human DRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N332B/15
AC   CVCL_E9MZ
DR   ABCD; ABCD_AV317
DR   DSHB; N332B-15
DR   MMRRC; MMRRC:066231-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N332B_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O94805; Human ACTL6B (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N336B/83
AC   CVCL_E9N0
DR   DSHB; N336B-83
DR   MMRRC; MMRRC:066252-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N336B_83.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O96019; Human ACTL6A (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N33B2
AC   CVCL_B0BS
DR   Wikidata; Q108821008
RX   PubMed=16235240;
RX   PubMed=18304946;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   N34/34
AC   CVCL_E9N1
DR   ABCD; ABCD_AK443
DR   DSHB; N34-34
DR   MMRRC; MMRRC:066000-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N34_34.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7TSF2; Rat Slc17a8 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N341/12
AC   CVCL_E9N2
DR   ABCD; ABCD_AV318
DR   MMRRC; MMRRC:066266-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N341_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q38SD2; Human LRRK1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N341/37
AC   CVCL_E9N3
DR   ABCD; ABCD_AK450
DR   MMRRC; MMRRC:066268-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N341_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q38SD2; Human LRRK1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N343/26
AC   CVCL_E9N4
DR   ABCD; ABCD_AV319
DR   DSHB; N343-26
DR   MMRRC; MMRRC:066241-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N343_26.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q810U4; Mouse Nrcam (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N345/51
AC   CVCL_E9N5
DR   MMRRC; MMRRC:066238-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N345_51.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8BGH4; Mouse Reep1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N346/9
AC   CVCL_E9N6
DR   ABCD; ABCD_AK436
DR   MMRRC; MMRRC:066257-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N346_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WXE9; Human STON2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N347/42
AC   CVCL_E9N7
DR   ABCD; ABCD_AV320
DR   MMRRC; MMRRC:066341-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N347_42.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5SQI0; Human ATAT1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N348/82
AC   CVCL_E9N8
DR   ABCD; ABCD_AK437
DR   MMRRC; MMRRC:066242-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N348_82.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BZ95; Human NSD3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N349/96
AC   CVCL_E9N9
DR   ABCD; ABCD_AV321
DR   MMRRC; MMRRC:066243-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N349_96.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q3I5G5; Mouse Foxi2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N351/23
AC   CVCL_E9NA
DR   ABCD; ABCD_AU876
DR   MMRRC; MMRRC:066244-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N351_23.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62059; Mouse Vcan (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N351/24
AC   CVCL_E9NB
DR   ABCD; ABCD_AV322
DR   MMRRC; MMRRC:066245-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N351_24.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q62059; Mouse Vcan (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N353/13
AC   CVCL_E9NC
DR   ABCD; ABCD_AK438
DR   MMRRC; MMRRC:066246-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N353_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8BGT1; Mouse Flrt3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N355/1
AC   CVCL_E9ND
DR   ABCD; ABCD_AK435
DR   DSHB; N355-1
DR   MMRRC; MMRRC:066247-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N355_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19490; Rat Gria1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N356/23
AC   CVCL_E9NE
DR   ABCD; ABCD_AK447
DR   MMRRC; MMRRC:066271-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N356_23.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z2I7; Rat Svop (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N356/9
AC   CVCL_E9NF
DR   ABCD; ABCD_AV323
DR   MMRRC; MMRRC:066253-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N356_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Z2I7; Rat Svop (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N357/6
AC   CVCL_E9NG
DR   ABCD; ABCD_AV324
DR   MMRRC; MMRRC:066265-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N357_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BXM7; Human PINK1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N358/68
AC   CVCL_E9NH
DR   DSHB; N358-68
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N358_68.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_234279; 5-formylcytidine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N359/28
AC   CVCL_E9NI
DR   ABCD; ABCD_AK444
DR   MMRRC; MMRRC:066258-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N359_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; D3Z120; Mouse Foxi3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N360A/24
AC   CVCL_E9NJ
DR   ABCD; ABCD_AV325
DR   MMRRC; MMRRC:066262-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N360A_24.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18848; Human ATF4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N363/71
AC   CVCL_E9NK
DR   ABCD; ABCD_AV326
DR   DSHB; N363-71
DR   MMRRC; MMRRC:066312-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N363_71.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P70673; Rat Kcnj11 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N364/10
AC   CVCL_E9NL
DR   ABCD; ABCD_AV327
DR   MMRRC; MMRRC:066259-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N364_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9ESM3; Mouse Hapln2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N364/42
AC   CVCL_E9NM
DR   ABCD; ABCD_AV328
DR   MMRRC; MMRRC:066260-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N364_42.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ESM3; Mouse Hapln2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N366/60
AC   CVCL_E9NN
DR   ABCD; ABCD_AV329
DR   ABCD; ABCD_AV330
DR   DSHB; N366-60
DR   MMRRC; MMRRC:066311-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N366_60.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q63664; Rat Kcnj8 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N367/51
AC   CVCL_E9NP
DR   ABCD; ABCD_AV331
DR   MMRRC; MMRRC:066264-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N367_51.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JLU4; Rat Shank3 (Note=Also recognizes Shank3. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N367/62
AC   CVCL_E9NQ
DR   ABCD; ABCD_AV332
DR   DSHB; N367-62
DR   MMRRC; MMRRC:066263-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N367_62.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JLU4; Rat Shank3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N372B/1
AC   CVCL_E9NR
DR   ABCD; ABCD_AV333
DR   DSHB; N372B-1
DR   MMRRC; MMRRC:066285-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N372B_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63099; Rat Kcnb2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N372B/60
AC   CVCL_E9NS
DR   ABCD; ABCD_AV334
DR   MMRRC; MMRRC:066279-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N372B_60.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q63099; Rat Kcnb2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N372C/51
AC   CVCL_E9NT
DR   MMRRC; MMRRC:066276-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N372C_51.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63099; Rat Kcnb2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N374/48
AC   CVCL_E9NU
DR   ABCD; ABCD_AV335
DR   DSHB; N374-48
DR   MMRRC; MMRRC:066275-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N374_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O54912; Rat Kcnk3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N375/67
AC   CVCL_E9NV
DR   ABCD; ABCD_AV336
DR   DSHB; N375-67
DR   MMRRC; MMRRC:066272-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N375_67.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63959; Mouse Kcnc3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N377/20
AC   CVCL_E9NW
DR   ABCD; ABCD_AV337
DR   DSHB; N377-20
DR   MMRRC; MMRRC:066273-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N377_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q60700; Mouse Map3k12 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N377/83
AC   CVCL_E9NX
DR   ABCD; ABCD_AV338
DR   MMRRC; MMRRC:066274-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N377_83.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q60700; Mouse Map3k12 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N37A/10
AC   CVCL_E9NY
DR   DSHB; N37A-10
DR   MMRRC; MMRRC:066004-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N37A_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51787; Human KCNQ1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N38/8
AC   CVCL_E9NZ
DR   ABCD; ABCD_AX010
DR   DSHB; N38-8
DR   MMRRC; MMRRC:066038-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N38_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27732; Rat Cacna1d (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N380/87
AC   CVCL_E9P0
DR   ABCD; ABCD_AV339
DR   MMRRC; MMRRC:066308-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N380_87.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13286; Human CLN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N382/14
AC   CVCL_E9P1
DR   ABCD; ABCD_AV340
DR   MMRRC; MMRRC:066283-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N382_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9GZY8; Human MFF (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N382/69
AC   CVCL_E9P2
DR   ABCD; ABCD_AV341
DR   MMRRC; MMRRC:066291-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N382_69.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9GZY8; Human MFF (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N384/63
AC   CVCL_E9P3
DR   ABCD; ABCD_AV342
DR   MMRRC; MMRRC:066284-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N384_63.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IXI1; Human RHOT2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N385/21
AC   CVCL_E9P4
DR   ABCD; ABCD_AV343
DR   MMRRC; MMRRC:066292-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N385_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11277; Human SPTB (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N388A/10
AC   CVCL_E9P5
DR   ABCD; ABCD_AK432
DR   DSHB; N388A-10
DR   MMRRC; MMRRC:066298-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N388A_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16157; Human ANK1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N388A/27
AC   CVCL_E9P6
DR   ABCD; ABCD_AV344
DR   MMRRC; MMRRC:066331-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N388A_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16157; Human ANK1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N388A/60
AC   CVCL_E9P7
DR   ABCD; ABCD_AU877
DR   MMRRC; MMRRC:066299-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N388A_60.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16157; Human ANK1 (Note=Also recognizes ANK1 and ANK2. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N389/9
AC   CVCL_E9P8
DR   ABCD; ABCD_AV345
DR   MMRRC; MMRRC:066289-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N389_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UPV9; Human TRAK1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N390/43
AC   CVCL_E9P9
DR   ABCD; ABCD_AV346
DR   MMRRC; MMRRC:066293-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N390_43.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O60296; Human TRAK2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N391/68
AC   CVCL_E9PA
DR   ABCD; ABCD_AV347
DR   MMRRC; MMRRC:066296-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N391_68.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9JIH7; Rat Wnk1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N393/2
AC   CVCL_E9PB
DR   ABCD; ABCD_AV348
DR   DSHB; N393-2
DR   MMRRC; MMRRC:066294-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N393_2.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H254; Human SPTBN4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N393/76
AC   CVCL_E9PC
DR   ABCD; ABCD_AV349
DR   DSHB; N393-76
DR   MMRRC; MMRRC:066295-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N393_76.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H254; Human SPTBN4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N395/68
AC   CVCL_E9PD
DR   ABCD; ABCD_AV350
DR   DSHB; N395-68
DR   MMRRC; MMRRC:066297-UCD
RX   PubMed=26644354;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N395_68.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q56A07; Mouse Scn2b (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N396/29
AC   CVCL_E9PE
DR   DSHB; N396-29
DR   MMRRC; MMRRC:066309-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N396_29.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9JK00; Rat Scn3b (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N397/19
AC   CVCL_E9PF
DR   ABCD; ABCD_AV351
DR   ABCD; ABCD_AV352
DR   MMRRC; MMRRC:066300-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N397_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14524; Human SCN5A (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N398A/34
AC   CVCL_E9PG
DR   ABCD; ABCD_AX009
DR   DSHB; N398A-34
DR   MMRRC; MMRRC:066301-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N398A_34.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28471; Rat Gabra4 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N399/19
AC   CVCL_E9PH
DR   ABCD; ABCD_AV353
DR   ABCD; ABCD_AV354
DR   DSHB; N399-19
DR   MMRRC; MMRRC:066302-UCD
RX   PubMed=26644354;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N399_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23576; Rat Gabra2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N39B/8
AC   CVCL_E9PI
DR   ABCD; ABCD_AX008
DR   DSHB; N39B-8
DR   MMRRC; MMRRC:066023-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N39B_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z272; Rat Git1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N3G6C7
AC   CVCL_XK41
DR   Wikidata; Q95991916
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_100246; Norfloxacin (NOR) (Note=Also recognizes ciprofloxacin, enrofloxacin and ofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   N3MA
AC   CVCL_E7FR
SY   Normal 3 Mannheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N4-1F6
AC   CVCL_A7VX
DR   BEI_Resources; MRA-481
DR   Wikidata; Q107116501
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   N4-1G6
AC   CVCL_A7VY
DR   BEI_Resources; MRA-483
DR   Wikidata; Q107116503
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   N4-2E3
AC   CVCL_A7VZ
DR   BEI_Resources; MRA-482
DR   Wikidata; Q107116504
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   N4/15
AC   CVCL_E9PJ
DR   ABCD; ABCD_AV355
DR   DSHB; N4-15
DR   MMRRC; MMRRC:065987-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N4_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BXM7; Human PINK1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N4/19
AC   CVCL_E9PK
DR   ABCD; ABCD_AV356
DR   MMRRC; MMRRC:066278-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N4_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BXM7; Human PINK1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N4/49
AC   CVCL_E9PL
DR   ABCD; ABCD_AV357
DR   MMRRC; MMRRC:065988-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N4_49.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BXM7; Human PINK1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N400/24
AC   CVCL_E9PM
DR   MMRRC; MMRRC:066303-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N400_24.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NWW5; Human CLN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N402/13
AC   CVCL_E9PN
DR   ABCD; ABCD_AV358
DR   DSHB; N402-13
DR   MMRRC; MMRRC:066304-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N402_13.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10828; Human THRB (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N402/46
AC   CVCL_E9PP
DR   ABCD; ABCD_AV359
DR   DSHB; N402-46
DR   MMRRC; MMRRC:066305-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N402_46.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10828; Human THRB (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N403/63
AC   CVCL_E9PQ
DR   ABCD; ABCD_AV360
DR   DSHB; N403-63
DR   MMRRC; MMRRC:066307-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N403_63.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10827; Human THRA (Note=Also recognizes THRB. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N405/74
AC   CVCL_E9PR
DR   ABCD; ABCD_AV361
DR   DSHB; N405-74
DR   MMRRC; MMRRC:066340-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N405_74.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00954; Rat Scn1b (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N406/47
AC   CVCL_E9PS
DR   ABCD; ABCD_AV362
DR   ABCD; ABCD_AV363
DR   MMRRC; MMRRC:066171-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N406_47.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51796; Rat Clcn5 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N408/62
AC   CVCL_E9PT
DR   ABCD; ABCD_AV364
DR   DSHB; N408-62
DR   MMRRC; MMRRC:066313-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N408_62.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8CJH6; Rat Npas4 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N408/79
AC   CVCL_E9PU
DR   ABCD; ABCD_AV365
DR   ABCD; ABCD_AV366
DR   DSHB; N408-79
DR   MMRRC; MMRRC:066314-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N408_79.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8CJH6; Rat Npas4 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N40B/18
AC   CVCL_E9PV
DR   ABCD; ABCD_AV367
DR   DSHB; N40B-18
DR   MMRRC; MMRRC:066017-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N40B_18.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E9Q7U0; Mouse Kcnmb3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N410/17
AC   CVCL_E9PW
DR   ABCD; ABCD_AV368
DR   ABCD; ABCD_AV369
DR   ABCD; ABCD_AV370
DR   DSHB; N410-17
DR   MMRRC; MMRRC:066315-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N410_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22462; Rat Kcnc2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N411/51
AC   CVCL_E9PX
DR   ABCD; ABCD_AV371
DR   DSHB; N411-51
DR   MMRRC; MMRRC:066319-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N411_51.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O35085; Mouse Arx (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N413/67
AC   CVCL_E9PY
DR   ABCD; ABCD_AU878
DR   MMRRC; MMRRC:066316-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N413_67.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P78334; Human GABRE (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N414/25
AC   CVCL_E9PZ
DR   ABCD; ABCD_AV372
DR   DSHB; N414-25
DR   MMRRC; MMRRC:066320-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N414_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NFF2; Human SLC24A4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N415/24
AC   CVCL_E9Q0
DR   ABCD; ABCD_AU879
DR   DSHB; N415-24
DR   MMRRC; MMRRC:066317-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N415_24.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31644; Human GABRA5 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N416/40
AC   CVCL_E9Q1
DR   ABCD; ABCD_AV373
DR   DSHB; N416-40
DR   MMRRC; MMRRC:066332-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N416_40.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A2AIR5; Mouse Grin3a (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N418
AC   CVCL_8966
DR   CLO; CLO_0007929
DR   ATCC; HB-224
DR   Wikidata; Q54907342
RX   PubMed=2185332;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9QXH4; Mouse Itgax/Cd11c.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 6
//
ID   N419/40
AC   CVCL_E9Q2
DR   ABCD; ABCD_AK487
DR   DSHB; N419-40
DR   MMRRC; MMRRC:066321-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N419_40.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35498; Human SCN1A (Note=Also recognizes other Na+ channels. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N419/78
AC   CVCL_E9Q3
DR   ABCD; ABCD_AK488
DR   DSHB; N419-78
DR   MMRRC; MMRRC:066323-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N419_78.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35498; Human SCN1A (Note=Also recognizes other Na+ channels. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N42
AC   CVCL_B6JF
SY   M42
DR   Wikidata; Q112129396
RX   Patent=US10422802;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-94.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08833; Human IGFBP1 (Note=Indicated to recognizes PAMG-1 but it is not 100% clear if PAMG-1=IGFBP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   N420/24
AC   CVCL_E9Q4
DR   ABCD; ABCD_AV374
DR   MMRRC; MMRRC:066143-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N420_24.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P51907; Rat Slc1a1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N421A/85
AC   CVCL_E9Q5
DR   ABCD; ABCD_AV376
DR   DSHB; N421A-85
DR   MMRRC; MMRRC:066326-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N421A_85.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q75V66; Human ANO5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N422/18
AC   CVCL_E9Q6
DR   ABCD; ABCD_AV459
DR   ABCD; ABCD_AV460
DR   ABCD; ABCD_AV461
DR   DSHB; N422-18
DR   MMRRC; MMRRC:066327-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N422_18.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00961; Rat Grin2c (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N423/75
AC   CVCL_E9Q7
DR   ABCD; ABCD_AV377
DR   DSHB; N423-75
DR   MMRRC; MMRRC:066322-UCD
RX   PubMed=26644354;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N423_75.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6PIL6; Human KCNIP4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N424/45
AC   CVCL_E9Q8
DR   ABCD; ABCD_AV378
DR   DSHB; N425-45
DR   MMRRC; MMRRC:066333-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N424_45.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75311; Human GLRA3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N424/48
AC   CVCL_E9Q9
DR   ABCD; ABCD_AV379
DR   ABCD; ABCD_AV380
DR   MMRRC; MMRRC:066342-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N424_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75311; Human GLRA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N425/45
AC   CVCL_E9QA
DR   ABCD; ABCD_AV381
DR   MMRRC; MMRRC:066343-UCD
RX   PubMed=26644354;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N425_45.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62666; Rat Slc18a3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N428/12
AC   CVCL_E9QB
DR   ABCD; ABCD_AV382
DR   MMRRC; MMRRC:066183-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N428_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14191; Human WRN (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N429/19
AC   CVCL_E9QC
DR   ABCD; ABCD_AV383
DR   MMRRC; MMRRC:066334-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N429_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q4KMQ2; Human ANO6 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N43/6
AC   CVCL_E9QD
DR   ABCD; ABCD_AX007
DR   DSHB; N43-6
DR   MMRRC; MMRRC:066005-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N43_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P56696; Human KCNQ4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N431/64
AC   CVCL_E9QE
DR   ABCD; ABCD_AV384
DR   ABCD; ABCD_AV385
DR   DSHB; N431-64
DR   MMRRC; MMRRC:066335-UCD
RX   PubMed=26644354;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N431_64.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00591; Human GABRP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N432/21
AC   CVCL_E9QF
DR   ABCD; ABCD_AV386
DR   DSHB; N432-21
DR   MMRRC; MMRRC:066398-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N432_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q4V9E4; Danio rerio tpte (Note=Also reacts with chicken and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N432/63
AC   CVCL_E9QG
DR   ABCD; ABCD_AV387
DR   MMRRC; MMRRC:066399-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N432_63.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q4V9E4; Danio rerio tpte (Note=Also reacts with chicken and Xenopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N440/21
AC   CVCL_E9QH
DR   MMRRC; MMRRC:066344-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N440_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8R090; Mouse Slc18a1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N440/61
AC   CVCL_E9QI
DR   MMRRC; MMRRC:066345-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N440_61.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8R090; Mouse Slc18a1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N441/35
AC   CVCL_E9QJ
DR   ABCD; ABCD_AV388
DR   MMRRC; MMRRC:066346-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N441_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9R1V4; Mouse Adam11 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N442/28
AC   CVCL_E9QK
DR   ABCD; ABCD_AV389
DR   MMRRC; MMRRC:066355-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N442_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9D8C3; Mouse Alg13 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N444/63
AC   CVCL_E9QL
DR   MMRRC; MMRRC:066348-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N444_63.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00116; Human AGPS (Note=Recognizes processed AGPS. Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N445/27
AC   CVCL_E9QM
DR   ABCD; ABCD_AV390
DR   DSHB; N445-27
DR   MMRRC; MMRRC:066347-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N445_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O88454; Mouse Kcnk4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   N446/80
AC   CVCL_E9QN
DR   ABCD; ABCD_AV391
DR   MMRRC; MMRRC:066352-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N446_80.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BZC1; Human CELF4 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N447/24
AC   CVCL_E9QP
DR   ABCD; ABCD_AV392
DR   ABCD; ABCD_AV393
DR   MMRRC; MMRRC:066354-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N447_24.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O54852; Rat Kcnh7 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N448/50
AC   CVCL_E9QQ
DR   ABCD; ABCD_AV394
DR   DSHB; N448-50
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N448_50.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8CFS6; Mouse Kcnv2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N448/88
AC   CVCL_E9QR
DR   ABCD; ABCD_AV395
DR   MMRRC; MMRRC:066349-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N448_88.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8CFS6; Mouse Kcnv2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N449/73
AC   CVCL_E9QS
DR   ABCD; ABCD_AV396
DR   DSHB; N449-73
DR   MMRRC; MMRRC:066350-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N449_73.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8BRU6; Mouse Slc18a2 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N44SV.5
AC   CVCL_AB85
DR   Wikidata; Q54907343
RX   PubMed=27345790;
RX   PubMed=33503868;
RX   PubMed=35569737;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/SOLICITUD_DE_DEPOSITO_N44SV5_FIRMADA.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigaciones Biomedicas Alberto Sols; Madrid; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   N450/53
AC   CVCL_E9QT
DR   ABCD; ABCD_AV397
DR   ABCD; ABCD_AV398
DR   DSHB; N450-53
DR   MMRRC; MMRRC:066384-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N450_53.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P21237; Mouse Bdnf (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N451/73
AC   CVCL_E9QU
DR   ABCD; ABCD_AV399
DR   MMRRC; MMRRC:066351-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N451_73.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JKV2; Mouse Cilk1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N452/30
AC   CVCL_E9QV
DR   DSHB; N452-30
DR   MMRRC; MMRRC:066397-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N452_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P18507; Human GABRG2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N452/69
AC   CVCL_E9QW
DR   ABCD; ABCD_AV400
DR   ABCD; ABCD_AV401
DR   MMRRC; MMRRC:066356-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N452_69.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18507; Human GABRG2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N452/73
AC   CVCL_E9QX
DR   ABCD; ABCD_AX006
DR   DSHB; N452-73
DR   MMRRC; MMRRC:066353-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N452_73.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18507; Human GABRG2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N452/81
AC   CVCL_E9QY
DR   ABCD; ABCD_AX005
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N452_81.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P18507; Human GABRG2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N454/91
AC   CVCL_E9QZ
DR   DSHB; N454-91
DR   MMRRC; MMRRC:066387-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N454_91.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A2AHL1; Mouse Ano3 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N455/15
AC   CVCL_E9R0
DR   ABCD; ABCD_AV402
DR   DSHB; N455-15
DR   MMRRC; MMRRC:066359-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N455_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48543; Mouse Kcnj9 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N456/39
AC   CVCL_E9R1
DR   ABCD; ABCD_AV403
DR   MMRRC; MMRRC:066388-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N456_39.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5PRE5; Mouse Proser1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N458/10
AC   CVCL_E9R2
DR   ABCD; ABCD_AV404
DR   MMRRC; MMRRC:066372-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N458_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q80XM3; Mouse Kcng4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N459/84
AC   CVCL_E9R3
DR   ABCD; ABCD_AV405
DR   MMRRC; MMRRC:066381-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N459_84.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P97837; Rat Dlgap2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N46/30
AC   CVCL_E9R4
DR   ABCD; ABCD_AV406
DR   DSHB; N46-30
DR   MMRRC; MMRRC:066008-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N46_30.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9R1V6; Mouse Adam22 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N460/19
AC   CVCL_E9R5
DR   ABCD; ABCD_AV407
DR   MMRRC; MMRRC:066373-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N460_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O35174; Mouse Kcns2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N461/19
AC   CVCL_E9R6
DR   ABCD; ABCD_AV408
DR   MMRRC; MMRRC:066364-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N461_19.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O35173; Mouse Kcns1 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N463/52
AC   CVCL_E9R7
DR   ABCD; ABCD_AV409
DR   MMRRC; MMRRC:066360-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N463_52.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75140; Human DEPDC5 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N465/11
AC   CVCL_E9R8
DR   ABCD; ABCD_AV410
DR   MMRRC; MMRRC:066385-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N465_11.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8JZN3; Mouse Kcnj14 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N466/14
AC   CVCL_E9R9
DR   ABCD; ABCD_AV411
DR   DSHB; N466-14
DR   MMRRC; MMRRC:066375-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N466_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; G5E845; Mouse Kcnk16 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N467/1
AC   CVCL_E9RA
DR   ABCD; ABCD_AV412
DR   MMRRC; MMRRC:066389-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N467_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6VV64; Mouse Kcnk18 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N468/37
AC   CVCL_E9RB
DR   ABCD; ABCD_AV413
DR   MMRRC; MMRRC:066376-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N468_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q76M80; Mouse Kcnk12 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N469/28
AC   CVCL_E9RC
DR   ABCD; ABCD_AV414
DR   MMRRC; MMRRC:066377-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N469_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q3TBV4; Mouse Kcnk6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N470/22
AC   CVCL_E9RD
DR   ABCD; ABCD_AV415
DR   MMRRC; MMRRC:066378-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N470_22.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BX84; Human TRPM6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N4702
AC   CVCL_A7DH
DR   Wikidata; Q107116505
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   N471/27
AC   CVCL_E9RE
DR   ABCD; ABCD_AV416
DR   MMRRC; MMRRC:066391-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N471_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q17ST2; Mouse Kcna7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N472/88
AC   CVCL_E9RF
DR   ABCD; ABCD_AV417
DR   MMRRC; MMRRC:066383-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N472_88.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UJ90; Human KCNE5 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N473/36
AC   CVCL_E9RG
DR   MMRRC; MMRRC:066386-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N473_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P54284; Human CACNB3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N474/27
AC   CVCL_E9RH
DR   ABCD; ABCD_AV418
DR   MMRRC; MMRRC:066403-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N474_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A2BDX4; Mouse Kcng1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N476/9
AC   CVCL_E9RI
DR   ABCD; ABCD_AV419
DR   MMRRC; MMRRC:066400-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N476_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99K24; Mouse Slc39a3 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N479/107
AC   CVCL_E9RJ
DR   ABCD; ABCD_AV420
DR   DSHB; N479-107
DR   MMRRC; MMRRC:066409-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N479_107.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Z270; Rat Vapa (Note=Also recognizes VAPB. Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N479/12
AC   CVCL_E9RK
DR   ABCD; ABCD_AV421
DR   DSHB; N479-12
DR   MMRRC; MMRRC:066411-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N479_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z270; Rat Vapa (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N479/22
AC   CVCL_E9RL
DR   ABCD; ABCD_AV422
DR   DSHB; N479-22
DR   MMRRC; MMRRC:066408-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N479_22.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Z270; Rat Vapa (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N483/126
AC   CVCL_E9RM
DR   ABCD; ABCD_AV423
DR   MMRRC; MMRRC:066413-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N483_126.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9D394; Mouse Rufy3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N483/26
AC   CVCL_E9RN
DR   ABCD; ABCD_AV424
DR   DSHB; N483-26
DR   MMRRC; MMRRC:066416-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N483_26.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9D394; Mouse Rufy3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N483/84
AC   CVCL_E9RP
DR   ABCD; ABCD_AV425
DR   DSHB; N483-84
DR   MMRRC; MMRRC:066412-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N483_84.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9D394; Mouse Rufy3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N485/22
AC   CVCL_E9RQ
DR   MMRRC; MMRRC:066422-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N485_22.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E9PUL5; Mouse Prrt2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N486/32
AC   CVCL_E9RR
DR   ABCD; ABCD_AV462
DR   ABCD; ABCD_AV463
DR   DSHB; N486-32
DR   MMRRC; MMRRC:066419-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N486_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N486/76
AC   CVCL_E9RS
DR   ABCD; ABCD_AV426
DR   DSHB; N486-76
DR   MMRRC; MMRRC:066423-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N486_76.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N490/24
AC   CVCL_E9RT
DR   ABCD; ABCD_AV427
DR   MMRRC; MMRRC:066428-UCD
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y210; Human TRPC6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N492/39
AC   CVCL_E9RU
DR   DSHB; N492-39
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N492_39.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6PHS9; Mouse Cacna2d2 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N492/83
AC   CVCL_E9RV
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N492_83.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6PHS9; Mouse Cacna2d2 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N493/22
AC   CVCL_E9RW
DR   DSHB; N493-22
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N493_22.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q61290; Mouse Cacna1e (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N496/46
AC   CVCL_E9RX
DR   DSHB; N496-46
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N496_46.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8BYM5; Mouse Nlgn3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N497/10
AC   CVCL_E9RY
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N497_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9WTS6; Mouse Tenm3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N498/28
AC   CVCL_E9RZ
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N498_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5SV17; Human TMEM240 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N498/69
AC   CVCL_E9S0
DR   DSHB; N498-69
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N498_69.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5SV17; Human TMEM240 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N49A/21
AC   CVCL_E9S1
DR   DSHB; N49A-21
DR   MMRRC; MMRRC:066032-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N49A_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HCJ2; Human LRRC4C (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N4D5G3
AC   CVCL_XK42
DR   Wikidata; Q95991921
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_100246; Norfloxacin (NOR) (Note=Also recognizes ciprofloxacin, enrofloxacin and ofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   N4KA
AC   CVCL_ZS86
SY   Normal 4 KAnazawa
DR   Wikidata; Q98127407
RX   PubMed=3821765;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   N4TG3
AC   CVCL_2135
DR   CLO; CLO_0007930
DR   CLDB; cl3624
DR   DSMZ; ACC-101
DR   DSMZCellDive; ACC-101
DR   ECACC; 08062515
DR   Wikidata; Q54907344
RX   PubMed=4857160;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   N50/36
AC   CVCL_E9S2
DR   DSHB; N50-36
DR   MMRRC; MMRRC:066006-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N50_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99PH1; Mouse Lrrc4 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N500/4
AC   CVCL_E9S3
DR   DSHB; N500-4
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N500_4.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01815; Mouse Cacna1c (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N501/49
AC   CVCL_E9S4
DR   DSHB; N501-49
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N501_49.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; E9Q401; Mouse Ryr2 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N503/36
AC   CVCL_E9S5
DR   DSHB; N503-36
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N503_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B0V2N1; Mouse Ptprs (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N51/6
AC   CVCL_E9S6
DR   ABCD; ABCD_AX014
DR   MMRRC; MMRRC:066007-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N51_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P0CC10; Rat Lrrc4b (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N52
AC   CVCL_B6JD
SY   M52
DR   Wikidata; Q112129398
RX   Patent=US10422802;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-92.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08833; Human IGFBP1 (Note=Indicated to recognizes PAMG-1 but it is not 100% clear if PAMG-1=IGFBP1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   N52.F4
AC   CVCL_IQ89
DR   Wikidata; Q54907346
RX   Patent=US6558948;
RX   PubMed=11044912;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IQ88 ! CAP
AG   Fetus
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 12
//
ID   N521J
AC   CVCL_5343
DR   Wikidata; Q54907347
RX   PubMed=1693429;
RX   PubMed=3262925;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=N521J
CC   Characteristics: Produces significant quantity of IL6 (PubMed=1693429).
DI   NCIt; C3992; AIDS-related Kaposi sarcoma
DI   ORDO; Orphanet_33276; Kaposi sarcoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   N52A/42
AC   CVCL_E9S7
DR   ABCD; ABCD_AK477
DR   DSHB; N52A-42
DR   MMRRC; MMRRC:066048-UCD
RX   PubMed=26644354;
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N52A_42.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P38647; Mouse Hspa9 (Note=Also reacts with human, rat and C.elegans).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N52B/27
AC   CVCL_E9S8
DR   MMRRC; MMRRC:066043-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N52B_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q460M4; Mouse Lrfn1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N53/32
AC   CVCL_E9S9
DR   ABCD; ABCD_AV428
DR   DSHB; N53-32
DR   MMRRC; MMRRC:066010-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N53_32.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9CZM9; Mouse Kcnmb2 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N55/10
AC   CVCL_E9SA
DR   ABCD; ABCD_AV429
DR   DSHB; N55-10
DR   MMRRC; MMRRC:066014-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N55_10.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95180; Human CACNA1H (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N56/21
AC   CVCL_E9SB
DR   ABCD; ABCD_AV430
DR   DSHB; N56-21
DR   MMRRC; MMRRC:066015-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N56_21.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P70379; Mouse Fgf14 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N56/9
AC   CVCL_E9SC
DR   MMRRC; MMRRC:066270-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N56_9.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61823; Bovine RNASE1 (Note=Recognizes 27-KETAAAKFERQHMDS-41 = S tag).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N57/2
AC   CVCL_E9SD
DR   ABCD; ABCD_AV431
DR   DSHB; N57-2
DR   MMRRC; MMRRC:066013-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N57_2.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9R1V6; Mouse Adam22 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N59/20
AC   CVCL_E9SE
DR   ABCD; ABCD_AV432
DR   DSHB; N59-20
DR   MMRRC; MMRRC:066016-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N59_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00960; Rat Grin2b (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N59/36
AC   CVCL_E9SF
DR   ABCD; ABCD_AU887
DR   ABCD; ABCD_AV456
DR   DSHB; N59-36
DR   MMRRC; MMRRC:066022-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N59_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q00960; Rat Grin2b (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N6-1000
AC   CVCL_UJ07
DR   cancercelllines; CVCL_UJ07
DR   Wikidata; Q95991925
RX   PubMed=1370437;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   N6-500
AC   CVCL_UJ08
DR   cancercelllines; CVCL_UJ08
DR   Wikidata; Q95991926
RX   PubMed=1370437;
RX   PubMed=8099376;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   N6-KU70-2-DG
AC   CVCL_C4PE
DR   Wikidata; Q116049861
RX   PubMed=36162731;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4055; XRCC6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   N6/38
AC   CVCL_E9SG
DR   ABCD; ABCD_AV433
DR   DSHB; N6-38
DR   MMRRC; MMRRC:065986-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N6_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16572; Human SLC18A3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N6/ADR
AC   CVCL_UJ06
SY   N6/ADR clone B5
DR   ATCC; CRL-3274
DR   cancercelllines; CVCL_UJ06
DR   Wikidata; Q95991928
RX   PubMed=1370437;
RX   PubMed=8099376;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3274
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   N64A/36
AC   CVCL_E9SH
DR   DSHB; N64A-36
DR   MMRRC; MMRRC:066045-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N64A_36.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HCX4; Human TRPC7 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N65/37
AC   CVCL_E9SI
DR   MMRRC; MMRRC:066024-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N65_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54254; Mouse Atxn1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N67/15
AC   CVCL_E9SJ
DR   ABCD; ABCD_AV434
DR   DSHB; N67-15
DR   MMRRC; MMRRC:066025-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N67_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UL62; Human TRPC5 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N68/6
AC   CVCL_E9SK
DR   ABCD; ABCD_AV435
DR   DSHB; N68-6
DR   MMRRC; MMRRC:066026-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N68_6.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15858; Human SCN9A (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N6803 pre-immortalized
AC   CVCL_A6SC
SY   N6803(<50)
DR   RCB; RCB2827
DR   Wikidata; Q107116506
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
CC   Population: Japanese.
CC   Karyotypic information: 46,XY (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X,Y
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D8S1179: 15
ST   FGA: 20,24
ST   TH01: 6,7
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6SD ! N6803 post-immortalized
OI   CVCL_A6TX ! N6803-2
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N6803 post-immortalized
AC   CVCL_A6SD
SY   N6803(>500); N6803
DR   RCB; RCB2828
DR   Wikidata; Q107116507
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
RX   PubMed=15150084;
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 47,XY,dup(3)(q27;q13),+8 (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X,Y
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D8S1179: 15
ST   FGA: 20,24
ST   TH01: 6,7
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6SC ! N6803 pre-immortalized
OI   CVCL_A6TX ! N6803-2
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   N6803-2
AC   CVCL_A6TX
DR   Wikidata; Q107116508
RX   PubMed=11520562;
RX   PubMed=12655152;
RX   PubMed=14659045;
RX   PubMed=15150084;
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 47,XY,dup(1)(25q32),add(4)(q35),+12,add(18)(p11),add(20)(q13.3) (PubMed=11520562).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=14659045
ST   Amelogenin: X,Y
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D8S1179: 15
ST   FGA: 20,24
ST   TH01: 6,7
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6SC ! N6803 pre-immortalized
OI   CVCL_A6SD ! N6803 post-immortalized
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   N69/46
AC   CVCL_E9SL
DR   ABCD; ABCD_AU880
DR   DSHB; N69-46
DR   MMRRC; MMRRC:066030-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N69_46.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9JLU4; Rat Shank3 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N6HB426-20
AC   CVCL_B6XX
DR   Wikidata; Q112129399
RX   PubMed=34985994;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14973; Human SLC10A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   N6KA
AC   CVCL_ZS87
SY   Normal 6 KAnazawa
DR   Wikidata; Q98127409
RX   PubMed=3627143;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   N7/18
AC   CVCL_E9SM
DR   ABCD; ABCD_AK446
DR   DSHB; N7-18
DR   MMRRC; MMRRC:065980-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N7_18.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q02641; Human CACNB1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N70-1.5e
AC   CVCL_DC95
SY   15e
DR   Wikidata; Q54907348
RX   Patent=US6190871;
RX   PubMed=1694449;
RX   PubMed=1702163;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10464.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120. Also reacts with diverse HIV-1 isolates).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a HIV-1 infected adult.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DC96 ! N70-1.9b
OI   CVCL_DC97 ! N70-2.1H
OI   CVCL_DC98 ! N70-2.3a
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   N70-1.9b
AC   CVCL_DC96
DR   Wikidata; Q54907349
RX   Patent=US6190871;
RX   PubMed=1694449;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a HIV-1 infected adult.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DC95 ! N70-1.5e
OI   CVCL_DC97 ! N70-2.1H
OI   CVCL_DC98 ! N70-2.3a
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   N70-2.1H
AC   CVCL_DC97
DR   Wikidata; Q54907350
RX   Patent=US6190871;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10758.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: HIV-1 protein gp120.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a HIV-1 infected adult.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DC95 ! N70-1.5e
OI   CVCL_DC96 ! N70-1.9b
OI   CVCL_DC98 ! N70-2.3a
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   N70-2.3a
AC   CVCL_DC98
DR   Wikidata; Q54907351
RX   Patent=US6190871;
RX   PubMed=1694449;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a HIV-1 infected adult.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DC95 ! N70-1.5e
OI   CVCL_DC96 ! N70-1.9b
OI   CVCL_DC97 ! N70-2.1H
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 9
//
ID   N70/28
AC   CVCL_E9SN
DR   ABCD; ABCD_AK456
DR   DSHB; N70-28
DR   MMRRC; MMRRC:066033-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N70_28.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JKB0; Rat Hcn1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N71/37
AC   CVCL_E9SP
DR   ABCD; ABCD_AV436
DR   MMRRC; MMRRC:066031-UCD
RX   PubMed=26644354;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N71_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9JKA9; Rat Hcn2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N72/16
AC   CVCL_E9SQ
DR   ABCD; ABCD_AV437
DR   DSHB; N72-16
DR   MMRRC; MMRRC:066034-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N72_16.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q63734; Rat Kcnc4 (Note=Also reacts with human, mouse and C.elegans).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N74/25
AC   CVCL_E9SR
DR   ABCD; ABCD_AX004
DR   DSHB; N74-25
DR   MMRRC; MMRRC:066035-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N74_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q923J1; Mouse Trpm7 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N7401
AC   CVCL_A7DI
DR   Wikidata; Q107116510
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Senescence: Not immortalized; senesces at 75 PDL (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   N75/3
AC   CVCL_E9SS
DR   ABCD; ABCD_AV438
DR   ABCD; ABCD_AV439
DR   DSHB; N75-3
DR   MMRRC; MMRRC:066039-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N75_3.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P31424; Rat Grm5 (Note=Also recognizes human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N75/33
AC   CVCL_E9ST
DR   DSHB; N75-33
DR   MMRRC; MMRRC:066040-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N75_33.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P31424; Rat Grm5 (Note=Also recognizes human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N76/3
AC   CVCL_E9SU
DR   ABCD; ABCD_AK489
DR   DSHB; N76-3
DR   MMRRC; MMRRC:066044-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N76_3.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54254; Mouse Atxn1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N76/8
AC   CVCL_E9SV
DR   ABCD; ABCD_AU881
DR   DSHB; N76-8
DR   MMRRC; MMRRC:066036-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N76_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P54254; Mouse Atxn1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N77/15
AC   CVCL_E9SW
DR   DSHB; N77-15
DR   MMRRC; MMRRC:066041-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N77_15.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O35119; Rat Trpc4 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N7KA
AC   CVCL_ZS88
SY   Normal 7 KAnazawa
DR   Wikidata; Q98127412
RX   PubMed=3627143;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   N81/2
AC   CVCL_E9SX
DR   ABCD; ABCD_AV440
DR   DSHB; N81-2
DR   MMRRC; MMRRC:066046-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N81_2.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75899; Human GABBR2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N81/37
AC   CVCL_E9SY
DR   ABCD; ABCD_AK475
DR   DSHB; N81-37
DR   MMRRC; MMRRC:066047-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N81_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75899; Human GABBR2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N83/48
AC   CVCL_E9SZ
DR   ABCD; ABCD_AU882
DR   MMRRC; MMRRC:066049-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N83_48.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14161; Human GIT2 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N84/37
AC   CVCL_E9T0
DR   ABCD; ABCD_AK468
DR   DSHB; N84-37
DR   MMRRC; MMRRC:066124-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N84_37.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95278; Human EPM2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N85/18
AC   CVCL_E9T1
DR   ABCD; ABCD_AK457
DR   DSHB; N85-18
DR   MMRRC; MMRRC:066050-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N85_18.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6VVB1; Human NHLRC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N86/20
AC   CVCL_E9T2
DR   ABCD; ABCD_AV441
DR   MMRRC; MMRRC:066329-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N86_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein. Also reacts with CFP and YFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N86/38
AC   CVCL_E9T3
DR   ABCD; ABCD_AK442
DR   DSHB; N86-38
DR   MMRRC; MMRRC:066055-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N86_38.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein. Also reacts with CFP and YFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N86/44
AC   CVCL_E9T4
DR   ABCD; ABCD_AV442
DR   ABCD; ABCD_AV443
DR   DSHB; N86-44
DR   MMRRC; MMRRC:066330-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N86_44.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein. Also reacts with CFP and YFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N86/8
AC   CVCL_E9T5
DR   ABCD; ABCD_AV444
DR   DSHB; N86-8
DR   MMRRC; MMRRC:066054-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N86_8.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein. Also reacts with CFP and YFP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N87/25
AC   CVCL_E9T6
DR   ABCD; ABCD_AV445
DR   ABCD; ABCD_AV446
DR   DSHB; N87-25
DR   MMRRC; MMRRC:066065-UCD
RX   PubMed=30667360;
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N87_25.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P63080; Mouse Gabrb3 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N88/12
AC   CVCL_E9T7
DR   ABCD; ABCD_AK471
DR   MMRRC; MMRRC:066051-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N88_12.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9ERE7; Mouse Mesd (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N8B/1
AC   CVCL_E9T8
DR   ABCD; ABCD_AU883
DR   DSHB; N8B-1
DR   MMRRC; MMRRC:065991-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N8B_1.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8VGC3; Rat Cacnb2 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N9
AC   CVCL_0452
SY   N-9
DR   BTO; BTO_0003957
DR   MCCL; MCC:0000349
DR   ChEMBL-Cells; CHEMBL4483172
DR   ChEMBL-Targets; CHEMBL4483281
DR   Lonza; 1424
DR   PubChem_Cell_line; CVCL_0452
DR   Wikidata; Q54907352
RX   PubMed=7681038;
RX   PubMed=21961028;
RX   PubMed=22651808;
CC   Transformant: Recombinant retrovirus 3RV/VN-11.
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   13FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   N90/20
AC   CVCL_E9T9
DR   ABCD; ABCD_AV447
DR   MMRRC; MMRRC:066154-UCD
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N90_20.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8R431; Rat Mgll (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N91/27
AC   CVCL_E9TA
DR   ABCD; ABCD_AK464
DR   DSHB; N91-27
DR   MMRRC; MMRRC:066053-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N91_27.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92913; Human FGF13 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N91MA
AC   CVCL_E7FS
SY   Normal 91 Mannheim
RX   PubMed=3182904;
RX   PubMed=6862680;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N92/14
AC   CVCL_E9TB
DR   MMRRC; MMRRC:066052-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N92_14.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92914; Human FGF11 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N92MA
AC   CVCL_E7FT
SY   Normal 92 Mannheim
RX   PubMed=3182904;
RX   PubMed=6862680;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N93A/49
AC   CVCL_E9TC
DR   ABCD; ABCD_AK490
DR   DSHB; N93A-49
DR   MMRRC; MMRRC:066104-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N93A_49.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Z0U4; Rat Gabbr1 (Note=Also reacts with human and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N93MA
AC   CVCL_E7FU
SY   Normal 93 Mannheim
RX   PubMed=6862680;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N94/17
AC   CVCL_E9TD
DR   ABCD; ABCD_AK470
DR   MMRRC; MMRRC:066057-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N94_17.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61328; Human FGF12 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N95/35
AC   CVCL_E9TE
DR   ABCD; ABCD_AV448
DR   ABCD; ABCD_AV449
DR   MMRRC; MMRRC:066058-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N95_35.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14867; Human GABRA1 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N95MA
AC   CVCL_E7FV
SY   Normal 95 Mannheim
RX   PubMed=3182904;
RX   PubMed=6862680;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   N96/55
AC   CVCL_E9TF
DR   ABCD; ABCD_AK478
DR   DSHB; N96-55
DR   MMRRC; MMRRC:066059-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N96_55.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50571; Mouse Gabrb1 (Note=Also reacts with human and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N97A/31
AC   CVCL_E9TG
DR   ABCD; ABCD_AK491
DR   DSHB; N97A-31
DR   MMRRC; MMRRC:066081-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N97A_31.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q62765; Rat Nlgn1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N98/47
AC   CVCL_E9TH
DR   ABCD; ABCD_AV450
DR   MMRRC; MMRRC:066062-UCD
RX   PubMed=37758930;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N98_47.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B0F2B4; Mouse Nlgn4l.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N98/7
AC   CVCL_E9TI
DR   ABCD; ABCD_AU884
DR   MMRRC; MMRRC:066060-UCD
RX   PubMed=30667360;
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/N98_7.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; B0F2B4; Mouse Nlgn4l.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   N9OS
AC   CVCL_ZS89
SY   Normal 9 OSaka
DR   Wikidata; Q98127413
RX   PubMed=6876478;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NA
AC   CVCL_7082
DR   BTO; BTO_0004003
DR   CGH-DB; 356-2
DR   Cosmic; 930336
DR   Cosmic; 974314
DR   Cosmic; 1046035
DR   Cosmic; 1123037
DR   Cosmic; 1317412
DR   IARC_TP53; 1104
DR   Wikidata; Q54907353
RX   DOI=10.5794/jjoms.36.868;
RX   PubMed=1570156;
RX   PubMed=10069537;
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Doubling time: ~21.6 hours (DOI=10.5794/jjoms.36.868).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220His (c.658T>C); ClinVar=VCV000376687; Zygosity=Unspecified (PubMed=1570156).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Na 42/13
AC   CVCL_RW97
SY   NA 42/13; Na42/13
DR   CCLV; CCLV-RIE 0229
DR   Wikidata; Q54907354
RX   PubMed=24973239;
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 6
//
ID   NA-112-S2
AC   CVCL_2Z41
SY   NA-112-S2.4; NA-112; WC00008
DR   CLO; CLO_0013438
DR   BioSamples; SAME17781
DR   Coriell; WC00008
DR   Wikidata; Q54907355
RX   PubMed=9927581;
WW   Info; Wistar; -; https://www.wistar.org/technology-transfer/monoclonal-antibodies-influenza-research
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03466; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) nucleoprotein (NP).
CC   Discontinued: Coriell; WC00008; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 8
//
ID   NA-6
AC   CVCL_C3BP
DR   Wikidata; Q114312455
RX   PubMed=2186036;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_90151; Ganglioside GM1b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   NA-NP15
AC   CVCL_DG71
SY   NP15
DR   GEO; GSM157161
DR   GEO; GSM157162
DR   Wikidata; Q54907356
CC   Population: Chinese.
CC   Virology: In vitro infected with EBV isolate Akata.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6008 ! NPC-TW01
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   NA-NR1
AC   CVCL_DG72
SY   NR1
DR   GEO; GSM147666
DR   GEO; GSM147667
DR   Wikidata; Q54907357
CC   Population: Chinese.
CC   Virology: In vitro infected with EBV isolate Akata.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6008 ! NPC-TW01
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   NA-NR15
AC   CVCL_DG73
SY   NR15
DR   GEO; GSM147668
DR   GEO; GSM147669
DR   Wikidata; Q54907358
CC   Population: Chinese.
CC   Virology: In vitro infected with EBV isolate Akata.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DG72 ! NA-NR1
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 11
//
ID   NA1/34.HLK
AC   CVCL_G199
SY   NA1-34.HLK; NA 1/34
DR   ECACC; 85102243
DR   Wikidata; Q54907359
RX   PubMed=376318;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06126; Human CD1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NA101
AC   CVCL_L979
DR   CLO; CLO_0007933
DR   CLDB; cl3627
DR   Wikidata; Q54907360
RX   PubMed=2553220;
RX   PubMed=12763307;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Embryonic bone, tibia; UBERON=UBERON_0000979.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 11
//
ID   NA17-EBV
AC   CVCL_D7DL
RX   PubMed=8642259;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D7DK ! NA17-MEL
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NA17-MEL
AC   CVCL_D7DK
RX   PubMed=8642259;
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D7DL ! NA17-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NA74-MEL
AC   CVCL_D7CT
RX   PubMed=8642259;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NA8-MEL
AC   CVCL_S599
SY   Na8-Mel; Na-8-MEL; Na-8 MEL; NA 8-MEL; Na8Mel; Na-8; NA8; Na8
DR   EFO; EFO_0022361
DR   Wikidata; Q54907361
RX   PubMed=8642259;
RX   PubMed=10752474;
RX   PubMed=14871852;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 6
//
ID   NAB
AC   CVCL_9T72
SY   North American Burkitt
DR   Cosmic; 717424
DR   Cosmic; 923825
DR   Wikidata; Q54907362
RX   PubMed=176407;
RX   PubMed=1697668;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 8
//
ID   NAB-2
AC   CVCL_E219
SY   NAB2; Nab2; North American Burkitt-2
DR   cancercelllines; CVCL_E219
DR   Cosmic; 2297023
DR   GEO; GSM115811
DR   Progenetix; CVCL_E219
DR   Wikidata; Q54907363
RX   PubMed=1697668;
RX   PubMed=15241441;
RX   PubMed=16960149;
CC   Population: Caucasian.
CC   Virology: The single copy EBV genome is integrated on chromosome 2p13 between REL and BCL11A.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9T72 ! NAB
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   NAB9B
AC   CVCL_IU55
DR   Wikidata; Q54907364
RX   PubMed=2052620;
RX   PubMed=9359519;
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 5
//
ID   NABCA
AC   CVCL_M368
DR   Wikidata; Q54907365
RX   PubMed=17257375;
CC   Population: Japanese.
CC   Doubling time: ~66 hours (PubMed=17257375).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7362; Breast scirrhous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 13
//
ID   NAC
AC   CVCL_IX18
DR   Wikidata; Q54907366
RX   PubMed=10333454;
CC   Doubling time: 19.1 hours (PubMed=10333454).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   Nacera
AC   CVCL_B7K6
SY   NH; Na
DR   Wikidata; Q112930153
RX   PubMed=1538137;
RX   PubMed=1852002;
RX   PubMed=3133120;
RX   PubMed=7951244;
RX   PubMed=9806546;
RX   PubMed=10072068;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; c.338-25_338del (752delG26bp) (752delG-25) (26-BP DEL, NT752) (I5E6-25_I5E6+1); ClinVar=VCV001435455; Zygosity=Homozygous (PubMed=9806546; PubMed=10072068).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Nagai
AC   CVCL_6E84
SY   Nagai-cell
DR   Wikidata; Q54907367
RX   PubMed=233287;
CC   Population: Japanese.
CC   Doubling time: 130 hours (Note=At 17th passage) (PubMed=233287).
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   NAGL-1
AC   CVCL_3038
DR   BioSample; SAMN03472798
DR   JCRB; IFO50479
DR   Wikidata; Q54907368
RX   PubMed=10071461;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   HLA typing: A*02,31; B*35,55; C*w01,w03 (PubMed=10071461).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): JCRB=IFO50479
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   Nagoya-78
AC   CVCL_D116
DR   Wikidata; Q54907369
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   PubMed=5100402;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=5100402).
CC   Derived from site: In situ; Salivary gland; UBERON=UBERON_0001044.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   NAI003
AC   CVCL_E791
SY   NAI 003
DR   dbMHC; 48985
DR   ECACC; 94082270
DR   IHW; IHW09170
DR   IPD-IMGT/HLA; 11713
DR   Wikidata; Q54907370
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02,26; B*35,59; C*01,09; DPB1*03:01,04:02; DQA1*03; DQB1*04:01; DRB1*04:05; DRB4*01:01 (IPD-IMGT/HLA=11713).
CC   HLA typing: A*68:01:02:01,02:11:01; B*35:05:01,40:04; C*04:01:01:01,03:04:01:02; DPA1*02:01:01:01; DPB1*27:01; DQA1*03:01:01,03:02; DQB1*03:02:01,03:03:02; DRB1*04:11:01,09:01:02; DRB4*01:03:01,01:03:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 94082270; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   NAI006
AC   CVCL_E792
SY   NAI 006
DR   dbMHC; 48986
DR   ECACC; 94082272
DR   IHW; IHW09172
DR   IPD-IMGT/HLA; 11715
DR   Wikidata; Q54907371
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02,26:02; B*07,35; C*01:02,08; DPB1*02:01:02,04:02; DQA1*03,03:02; DQB1*03:03,04:01; DRB1*04:05,09:01; DRB4*01:01 (IPD-IMGT/HLA=11715).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   NAI026
AC   CVCL_E793
SY   NAI 026
DR   dbMHC; 48987
DR   ECACC; 94082271
DR   IHW; IHW09171
DR   IPD-IMGT/HLA; 11714
DR   Wikidata; Q54907372
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*24,26; B*35,59; C*01,03; DPB1*02:01:02,03:01; DQA1*03; DQB1*04:01; DRB1*04:05; DRB4*01:01 (IPD-IMGT/HLA=11714).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   NAI031
AC   CVCL_E794
SY   NAI 031
DR   dbMHC; 48988
DR   ECACC; 94082273
DR   IHW; IHW09173
DR   IPD-IMGT/HLA; 11716
DR   Wikidata; Q54907373
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*24; B*54,59; C*01; DPB1*02:01:02,04:02; DQA1*03,01:03; DQB1*04:01,06:01; DRB1*04:05,08:03; DRB4*01:01 (IPD-IMGT/HLA=11716).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Nak-Pc2
AC   CVCL_M587
DR   Wikidata; Q54907374
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   Nakajima
AC   CVCL_A1TQ
SY   NAKAJIMA
DR   ChEMBL-Cells; CHEMBL3307303
DR   ChEMBL-Targets; CHEMBL614134
DR   Wikidata; Q105510274
RX   CelloPub=CLPUB00594;
RX   PubMed=14766244;
RX   PubMed=18720132;
CC   Population: Japanese.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 4
//
ID   Nakajima-S1
AC   CVCL_A1TR
DR   Wikidata; Q105510276
RX   PubMed=18720132;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1TQ ! Nakajima
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   Nakajima-S2
AC   CVCL_A1TS
DR   Wikidata; Q105510279
RX   PubMed=18720132;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1TQ ! Nakajima
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   NAKT-15
AC   CVCL_L910
SY   NAKT15
DR   Wikidata; Q54907375
RX   PubMed=16186810;
RX   PubMed=16211061;
CC   Characteristics: Secretes insulin in response to glucose stimulation and nonglucose secretagogues, and expresses proteins characteristic of beta-cells.
CC   Characteristics: Because it has been transduced by two constructs containing LoxP sites, transfection with the Cre recombinase eliminates both the SV40 T gene and TERT thus reverting the cells to a non-immortal phenotype.
CC   Characteristics: Transduced with two retroviral vectors: 1) SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by two loxP sites and 2) SSR#69 (MoMLV/LTR-LoxP-HygroR-HSV/TK-IRES-SV40T-LoxP-Neo-MoMLV/LTR) expressing HygroR, HSV-1 TK and SV40 T-antigen flanked by two loxP sites.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 16
//
ID   NAL1A
AC   CVCL_R787
SY   Nal1A; NAL-1A; NAL 1A
DR   Wikidata; Q54907377
RX   PubMed=2152771;
RX   PubMed=3001399;
RX   PubMed=3409226;
RX   PubMed=4067735;
RX   PubMed=6522104;
RX   PubMed=6713549;
RX   PubMed=9347924;
CC   Doubling time: 21.5 +- 0.5 hours (PubMed=6522104).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   NAL1A clone B5
AC   CVCL_5U87
DR   Wikidata; Q54907378
RX   PubMed=3001399;
RX   PubMed=3409226;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R787 ! NAL1A
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   NAL1A clone B5D3
AC   CVCL_5U90
SY   B5D3
DR   Wikidata; Q54907379
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=3409226;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U87 ! NAL1A clone B5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   NAL1A clone B5SF11
AC   CVCL_5U91
SY   B5SF11
DR   Wikidata; Q54907380
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=3409226;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U87 ! NAL1A clone B5
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   NAL1A clone C1
AC   CVCL_5U88
DR   Wikidata; Q54907381
RX   PubMed=3409226;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R787 ! NAL1A
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   NAL1A clone C1C10
AC   CVCL_5U92
SY   Nal1a C1C10; C1C10; C-10; C10
DR   BTO; BTO_0004532
DR   Wikidata; Q54907382
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=2548715;
RX   PubMed=3409226;
RX   PubMed=9149863;
RX   PubMed=9347924;
RX   PubMed=12727792;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U88 ! NAL1A clone C1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   NAL1A clone C1SA5
AC   CVCL_5U93
SY   Nal1A C1A5; C1SA5; A-5; A5
DR   Wikidata; Q54907383
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=3409226;
RX   PubMed=9149863;
RX   PubMed=9347924;
RX   PubMed=12727792;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U88 ! NAL1A clone C1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   NAL1A clone C4
AC   CVCL_5U89
DR   Wikidata; Q54907384
RX   PubMed=3001399;
RX   PubMed=3409226;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R787 ! NAL1A
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   NAL1A clone C4E10
AC   CVCL_0251
SY   C4E10; E10
DR   MCCL; MCC:0000142
DR   Wikidata; Q54907385
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=3409226;
RX   PubMed=9347924;
RX   PubMed=12727792;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U89 ! NAL1A clone C4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   NAL1A clone C4SE9
AC   CVCL_5V04
SY   C4SE9; E9
DR   Wikidata; Q54907386
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=3409226;
RX   PubMed=9347924;
RX   PubMed=12727792;
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U89 ! NAL1A clone C4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   NAL1AM
AC   CVCL_5U85
SY   NAL1A(M); NAL1A Malignant
DR   Wikidata; Q54907387
RX   PubMed=3001399;
RX   PubMed=3409226;
CC   Characteristics: Resembles adenoma cells in morphology (PubMed=3001399).
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R787 ! NAL1A
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   NAL1AM clone B2
AC   CVCL_E9Y7
RX   PubMed=3409226;
CC   Characteristics: Malignant (PubMed=3409226).
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U85 ! NAL1AM
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NAL1AM clone D2
AC   CVCL_E9Y8
RX   PubMed=3409226;
CC   Characteristics: Malignant (PubMed=3409226).
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5U85 ! NAL1AM
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NAL1AS
AC   CVCL_5U86
DR   Wikidata; Q54907388
RX   PubMed=2152771;
RX   PubMed=3409226;
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R787 ! NAL1A
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   Naliaka
AC   CVCL_8266
SY   NALIAKA
DR   Cosmic; 931106
DR   Wikidata; Q54907389
RX   PubMed=170370;
RX   PubMed=3026973;
RX   PubMed=4122458;
RX   PubMed=4364259;
RX   PubMed=9473234;
RX   PubMed=24590883;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   NALL-1
AC   CVCL_3039
SY   Null-cell Acute Lymphoblastic Leukemia-1
DR   BTO; BTO_0004951
DR   ChEMBL-Cells; CHEMBL3307425
DR   ChEMBL-Targets; CHEMBL614769
DR   Cosmic; 801717
DR   Cosmic; 932760
DR   Cosmic; 998694
DR   Cosmic; 1037720
DR   GEO; GSM5137732
DR   GEO; GSM5137763
DR   JCRB; JCRB1332
DR   PRIDE; PXD023662
DR   PubChem_Cell_line; CVCL_3039
DR   Wikidata; Q54907390
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=155647;
RX   PubMed=197412;
RX   PubMed=200333;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6097530;
RX   PubMed=8957066;
RX   PubMed=9680106;
RX   PubMed=9738977;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=11986953;
RX   PubMed=35354797;
CC   Population: Japanese.
CC   Doubling time: 88 hours (Note=In RPMI 1640 + 20% HCS), 72 hours (Note=In RPMI 1640 + 20% FCS) (PubMed=200333).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:8619; PAX5; Name(s)=PAX5-ETV6 (PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG; JCRB=JCRB1332
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 16,19
ST   D19S433: 13,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   D8S1179: 12,13
ST   FGA: 19,23
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   NALM-1
AC   CVCL_0091
SY   Nalm-1; NALM 1; NALM1; Nalm1
DR   CLO; CLO_0007937
DR   EFO; EFO_0002244
DR   CLDB; cl3630
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-1567
DR   BioSample; SAMN01821583
DR   BioSample; SAMN01821650
DR   BioSample; SAMN03471397
DR   BioSample; SAMN10988498
DR   cancercelllines; CVCL_0091
DR   Cell_Model_Passport; SIDM01686
DR   CGH-DB; 9216-4
DR   Cosmic; 787506
DR   Cosmic; 801721
DR   Cosmic; 908157
DR   Cosmic; 999775
DR   Cosmic; 1012105
DR   Cosmic; 1026573
DR   Cosmic; 1498418
DR   Cosmic; 2491099
DR   DepMap; ACH-000462
DR   DSMZ; ACC-131
DR   DSMZCellDive; ACC-131
DR   GEO; GSM887346
DR   GEO; GSM888422
DR   IARC_TP53; 21526
DR   IGRhCellID; NALM1
DR   JCRB; JCRB0064
DR   LiGeA; CCLE_447
DR   PharmacoDB; NALM1_978_2019
DR   Progenetix; CVCL_0091
DR   Wikidata; Q54907391
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=301573;
RX   PubMed=302341;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3332852;
RX   PubMed=3874327;
RX   PubMed=6582512;
RX   PubMed=6929725;
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=12506034;
RX   PubMed=15588857;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=29786757;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35124168;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: African American.
CC   Doubling time: ~48 hours (DSMZ=ACC-131).
CC   HLA typing: A*02:01,33:03; B*52:01,53:01; C*16:01,16:01 (PubMed=26589293).
CC   HLA typing: A*02:01:01,33:03:01; B*52:01:02,53:01:01; C*04:01:01,16:01:01; DPA1*01:03:01,01:03:01; DPB1*18:01,104:01; DQA1*01:05:01,05:05:01; DQB1*03:01:01,05:01:01; DRA*01:01:01,01:02:02; DRB1*12:01:01,13:03:01 (DSMZCellDive=ACC-131).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827; DepMap=ACH-000462).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=77.03%; Native American=6.08%; East Asian, North=2.94%; East Asian, South=0%; South Asian=0%; European, North=4.83%; European, South=9.12% (PubMed=30894373).
CC   Discontinued: JCRB; JCRB0064; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-1567; DSMZ=ACC-131
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,15
ST   D18S51: 11,15
ST   D19S433: 11,15
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23,26
ST   Penta D: 3
ST   Penta E: 8,9
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NALM-10
AC   CVCL_L059
SY   NALM10
DR   Wikidata; Q54907392
RX   CelloPub=CLPUB00085;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L060 ! NALM-11
OI   CVCL_5660 ! NALM-12
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   NALM-11
AC   CVCL_L060
SY   NALM11
DR   Wikidata; Q54907393
RX   CelloPub=CLPUB00085;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_5660 ! NALM-12
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   NALM-12
AC   CVCL_5660
SY   NALM12; Nalm 12
DR   Wikidata; Q54907394
RX   CelloPub=CLPUB00085;
RX   PubMed=2939141;
CC   Population: Caucasian.
CC   HLA typing: A*01,02; B*15 (PubMed=2939141).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   NALM-13
AC   CVCL_L061
SY   NALM13
DR   Wikidata; Q54907395
RX   CelloPub=CLPUB00085;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_5660 ! NALM-12
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   NALM-14
AC   CVCL_QX00
SY   NALM14; Nalm14
DR   GEO; GSM3145585
DR   GEO; GSM3145728
DR   Wikidata; Q54907396
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   NALM-16
AC   CVCL_1834
SY   NALM16; Nalm-16
DR   BioSample; SAMN03473434
DR   cancercelllines; CVCL_1834
DR   Cosmic; 998707
DR   Cosmic; 999758
DR   Cosmic; 1037712
DR   DepMap; ACH-001993
DR   DSMZ; ACC-680
DR   DSMZCellDive; ACC-680
DR   GEO; GSM5137733
DR   PRIDE; PXD023662
DR   Wikidata; Q54907397
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=155647;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6582512;
RX   PubMed=6928235;
RX   PubMed=8847894;
RX   PubMed=9680106;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=35354797;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 36.7 hours (PubMed=8847894); ~36 hours (DSMZ=ACC-680).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DepMap=ACH-001993; DSMZ=ACC-680
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 17,18
ST   D19S433: 13
ST   D21S11: 29,30 (DSMZ=ACC-680)
ST   D21S11: 30 (DepMap=ACH-001993)
ST   D2S1338: 18
ST   D3S1358: 15,17 (DSMZ=ACC-680)
ST   D3S1358: 17 (DepMap=ACH-001993)
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 20
ST   Penta D: 9,12.4 (DSMZ=ACC-680)
ST   Penta D: 9,13 (DepMap=ACH-001993)
ST   Penta E: 8
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   NALM-17
AC   CVCL_3887
SY   NALM17
DR   BTO; BTO_0004933
DR   Cosmic; 919146
DR   Cosmic; 991552
DR   Cosmic; 996285
DR   Cosmic; 998699
DR   Cosmic; 999749
DR   Cosmic; 1037713
DR   Wikidata; Q54907398
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=9510473;
RX   PubMed=9680106;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5661 ! NALM-18
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NALM-18
AC   CVCL_5661
SY   NALM18
DR   Wikidata; Q54907399
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9680106;
RX   PubMed=9738977;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3887 ! NALM-17
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   NALM-19
AC   CVCL_1835
SY   NALM19; Nalm19
DR   CLO; CLO_0037187
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473520
DR   BioSample; SAMN10988461
DR   cancercelllines; CVCL_1835
DR   Cell_Model_Passport; SIDM01685
DR   Cosmic; 999733
DR   DepMap; ACH-000130
DR   DSMZ; ACC-522
DR   DSMZCellDive; ACC-522
DR   GEO; GSM887345
DR   GEO; GSM888421
DR   IARC_TP53; 30126
DR   JCRB; JCRB1822
DR   LiGeA; CCLE_296
DR   LINCS_LDP; LCL-1093
DR   PharmacoDB; NALM19_979_2019
DR   Progenetix; CVCL_1835
DR   Wikidata; Q54907400
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1664237;
RX   PubMed=9680106;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 29 hours (PubMed=1664237); ~50-70 hours (DSMZ=ACC-522).
CC   HLA typing: A*11:01,33:03; B*40:06,54:01; C*01:02,15:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.76%; Native American=0.1%; East Asian, North=79.97%; East Asian, South=14.34%; South Asian=0.01%; European, North=0%; European, South=3.83% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-522
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 15,17.3
ST   D19S433: 13
ST   D21S11: 30,31
ST   D2S1338: 19,25
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 10
ST   Penta E: 15,17
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L055 ! B239
OI   CVCL_L056 ! B240
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   NALM-20
AC   CVCL_1836
SY   NALM20
DR   BTO; BTO_0004934
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   BioSample; SAMN03473435
DR   Cosmic; 996290
DR   Cosmic; 998700
DR   Cosmic; 999766
DR   Cosmic; 1037714
DR   DSMZ; ACC-681
DR   DSMZCellDive; ACC-681
DR   JCRB; JCRB1823
DR   Wikidata; Q54907401
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1817649;
RX   PubMed=8139288;
RX   PubMed=9680106;
RX   PubMed=10071072;
RX   PubMed=10233379;
RX   PubMed=14504097;
RX   PubMed=34940123;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=1817649); ~60-80 hours (DSMZ=ACC-681).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=1817649; PubMed=10071072).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-681; JCRB=JCRB1823
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,16
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 9,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L054 ! B250
OI   CVCL_1837 ! NALM-21
OI   CVCL_5662 ! NALM-22
OI   CVCL_5663 ! NALM-23
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   NALM-21
AC   CVCL_1837
SY   NALM21
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   Cosmic; 999738
DR   DSMZ; ACC-682
DR   DSMZCellDive; ACC-682
DR   JCRB; JCRB1825
DR   Wikidata; Q54907402
RX   PubMed=1817649;
RX   PubMed=8139288;
RX   PubMed=9680106;
RX   PubMed=10071072;
RX   PubMed=34940123;
CC   Population: Japanese.
CC   Doubling time: ~50 hours (DSMZ=ACC-682).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-682; JCRB=JCRB1825
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,16
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 9,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L054 ! B250
OI   CVCL_1836 ! NALM-20
OI   CVCL_5662 ! NALM-22
OI   CVCL_5663 ! NALM-23
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   NALM-22
AC   CVCL_5662
SY   NALM22
DR   Wikidata; Q54907403
RX   PubMed=1817649;
RX   PubMed=9680106;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L054 ! B250
OI   CVCL_1836 ! NALM-20
OI   CVCL_1837 ! NALM-21
OI   CVCL_5663 ! NALM-23
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NALM-23
AC   CVCL_5663
SY   NALM23
DR   Wikidata; Q54907404
RX   PubMed=1817649;
RX   PubMed=9680106;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L054 ! B250
OI   CVCL_1836 ! NALM-20
OI   CVCL_1837 ! NALM-21
OI   CVCL_5662 ! NALM-22
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NALM-24
AC   CVCL_3888
SY   NALM24
DR   BTO; BTO_0004935
DR   Cosmic; 996291
DR   Cosmic; 998701
DR   Cosmic; 999745
DR   Cosmic; 1037715
DR   JCRB; JCRB1826
DR   Wikidata; Q54907405
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1667895;
RX   PubMed=8139288;
RX   PubMed=9680106;
RX   PubMed=10071072;
RX   PubMed=10233379;
RX   PubMed=10576511;
RX   PubMed=10637496;
RX   PubMed=14504097;
RX   PubMed=18599181;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=1667895; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1826
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 14
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX01 ! B262
OI   CVCL_5664 ! NALM-25
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   NALM-24 R
AC   CVCL_D3ZC
DR   Wikidata; Q127382921
RX   PubMed=18599181;
CC   Population: Japanese.
CC   Selected for resistance to: UniProtKB; P50591; Human TNFSF10/CD253.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3888 ! NALM-24
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   NALM-25
AC   CVCL_5664
SY   NALM25
DR   JCRB; JCRB1828
DR   Wikidata; Q54907407
RX   PubMed=1667895;
RX   PubMed=9680106;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=1667895; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1828
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 14
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX01 ! B262
OI   CVCL_3888 ! NALM-24
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   NALM-26
AC   CVCL_3889
SY   NALM26
DR   BTO; BTO_0004936
DR   Cosmic; 996284
DR   Cosmic; 998698
DR   Cosmic; 999734
DR   Cosmic; 1037716
DR   Cosmic; 2491083
DR   Wikidata; Q54907408
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7599111;
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
CC   Population: Japanese.
CC   Doubling time: 5 days (PubMed=7599111).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NALM-27
AC   CVCL_5665
SY   NALM27; Nalm27
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   Cosmic; 999736
DR   Cosmic; 1130247
DR   Cosmic; 2491084
DR   JCRB; JCRB1830
DR   Wikidata; Q54907409
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=9710720;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10637496;
RX   PubMed=29786757;
RX   PubMed=34940123;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 4-5 days (PubMed=9710720).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=9710720; PubMed=10071072; PubMed=10576511).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1830
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C82192; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_589534; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5666 ! NALM-28
OI   CVCL_5668 ! NALM-30
OI   CVCL_5669 ! NALM-31
OI   CVCL_5670 ! NALM-32
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   NALM-28
AC   CVCL_5666
SY   NALM28
DR   Cosmic; 999737
DR   Cosmic; 2491085
DR   Wikidata; Q54907410
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=9710720;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9710720; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82192; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_589534; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5665 ! NALM-27
OI   CVCL_5668 ! NALM-30
OI   CVCL_5669 ! NALM-31
OI   CVCL_5670 ! NALM-32
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   NALM-29
AC   CVCL_5667
SY   NALM29
DR   Cosmic; 999744
DR   Cosmic; 1037717
DR   JCRB; JCRB1854
DR   Wikidata; Q54907411
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9680106;
RX   PubMed=10456671;
RX   PubMed=10576511;
RX   PubMed=10637496;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=10456671).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1854
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX02 ! B391
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NALM-30
AC   CVCL_5668
SY   NALM30
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   Cosmic; 999735
DR   Cosmic; 2491086
DR   JCRB; JCRB1858
DR   Wikidata; Q54907412
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10363160;
RX   PubMed=10576511;
RX   PubMed=34940123;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10363160; PubMed=10576511).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1858
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C82192; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_589534; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5665 ! NALM-27
OI   CVCL_5666 ! NALM-28
OI   CVCL_5669 ! NALM-31
OI   CVCL_5670 ! NALM-32
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   NALM-31
AC   CVCL_5669
SY   NALM31
DR   Cosmic; 999739
DR   Cosmic; 2491087
DR   JCRB; JCRB1865
DR   Wikidata; Q54907413
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10363160;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10363160).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1865
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C82192; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_589534; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5665 ! NALM-27
OI   CVCL_5666 ! NALM-28
OI   CVCL_5668 ! NALM-30
OI   CVCL_5670 ! NALM-32
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   NALM-32
AC   CVCL_5670
SY   NALM32
DR   Cosmic; 999740
DR   Cosmic; 2491088
DR   JCRB; JCRB1877
DR   Wikidata; Q54907414
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10363160;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10363160).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1877
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C82192; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_589534; Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5665 ! NALM-27
OI   CVCL_5666 ! NALM-28
OI   CVCL_5668 ! NALM-30
OI   CVCL_5669 ! NALM-31
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   NALM-33
AC   CVCL_5671
SY   NALM33
DR   Cosmic; 999746
DR   DSMZ; ACC-782
DR   DSMZCellDive; ACC-782
DR   Wikidata; Q54907415
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9680106;
RX   PubMed=10609789;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=10609789); ~48 hours (DSMZ=ACC-782).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-782
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 29,31
ST   D2S1338: 18,23
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 12,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5672 ! NALM-34
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NALM-34
AC   CVCL_5672
SY   NALM34
DR   Wikidata; Q54907416
RX   PubMed=9680106;
RX   PubMed=10609789;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=10609789).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5671 ! NALM-33
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NALM-35
AC   CVCL_5673
SY   NALM35
DR   Wikidata; Q54907417
RX   PubMed=12889857;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=12889857).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NALM-36
AC   CVCL_5674
SY   NALM36
DR   JCRB; JCRB1863
DR   Wikidata; Q54907423
RX   PubMed=11734297;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=11734297).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1863
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5676 ! NALM-37
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   NALM-36KL
AC   CVCL_5675
SY   NALM36KL
DR   Wikidata; Q54907424
RX   PubMed=11734297;
CC   Population: Japanese.
CC   Characteristics: Expresses both kappa and lambda light chains.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5674 ! NALM-36
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NALM-37
AC   CVCL_5676
SY   NALM37
DR   JCRB; JCRB1856
DR   Wikidata; Q54907425
RX   PubMed=11734297;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): JCRB=JCRB1856
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5674 ! NALM-36
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   NALM-6
AC   CVCL_0092
SY   Nalm-6; NALM 6; Nalm 6; NALM6; Nalm6; NALM-6-M1
DR   BTO; BTO_0003288
DR   CLO; CLO_0007938
DR   CLO; CLO_0050970
DR   EFO; EFO_0002245
DR   CLDB; cl3631
DR   CLDB; cl3632
DR   AddexBio; C0003030/5015
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 273
DR   BioSample; SAMN03472035
DR   BioSample; SAMN03473163
DR   BioSample; SAMN03473413
DR   BioSample; SAMN10988491
DR   cancercelllines; CVCL_0092
DR   Cell_Model_Passport; SIDM00429
DR   ChEMBL-Cells; CHEMBL3307559
DR   ChEMBL-Targets; CHEMBL614187
DR   CLS; 300297
DR   Cosmic; 801722
DR   Cosmic; 850385
DR   Cosmic; 889112
DR   Cosmic; 908158
DR   Cosmic; 919147
DR   Cosmic; 991553
DR   Cosmic; 998708
DR   Cosmic; 999748
DR   Cosmic; 1012106
DR   Cosmic; 1037711
DR   Cosmic; 1070706
DR   Cosmic; 1093787
DR   Cosmic; 1130246
DR   Cosmic; 1191699
DR   Cosmic; 1483361
DR   Cosmic; 1509198
DR   Cosmic; 1524810
DR   Cosmic; 2491082
DR   Cosmic; 2649232
DR   Cosmic-CLP; 908158
DR   DepMap; ACH-000938
DR   DSMZ; ACC-128
DR   DSMZCellDive; ACC-128
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10534-107G3
DR   GDSC; 908158
DR   GEO; GSM236797
DR   GEO; GSM236833
DR   GEO; GSM887347
DR   GEO; GSM888423
DR   GEO; GSM1670142
DR   GEO; GSM5137734
DR   IARC_TP53; 21527
DR   IGRhCellID; NALM6
DR   LiGeA; CCLE_665
DR   LINCS_LDP; LCL-1007
DR   Lonza; 812
DR   NCBI_Iran; C212
DR   PharmacoDB; NALM6_980_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0092
DR   PubChem_Cell_line; CVCL_0092
DR   RCB; RCB1933
DR   TKG; TKG 0413
DR   Wikidata; Q54907426
RX   CelloPub=CLPUB00085;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=83966;
RX   PubMed=155647;
RX   PubMed=2140233;
RX   PubMed=2415623;
RX   PubMed=2783384;
RX   PubMed=2939141;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=8847894;
RX   PubMed=9067587;
RX   PubMed=9510473;
RX   PubMed=9680106;
RX   PubMed=9738977;
RX   PubMed=10490826;
RX   PubMed=10695022;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=11416159;
RX   PubMed=11986953;
RX   PubMed=15843827;
RX   PubMed=16405397;
RX   PubMed=16408098;
RX   PubMed=16969076;
RX   PubMed=20103924;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20575032;
RX   PubMed=20922763;
RX   PubMed=22460905;
RX   PubMed=23596518;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29786757;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31243274;
RX   PubMed=31305009;
RX   PubMed=31978347;
RX   PubMed=34823530;
RX   PubMed=35124168;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-607.html
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 25 hours (PubMed=25984343); 19 hours (PubMed=20922763); 40.2 hours (PubMed=8847894); ~36 hours (DSMZ=ACC-128).
CC   HLA typing: A*01,02; B*15 (PubMed=2939141).
CC   HLA typing: A*01,02; B*08,15 (PubMed=83966).
CC   HLA typing: A*01:01,02:01; B*08:01,15:01; C*04:01,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,02:01:01; B*08:01:01,15:01:01; C*04:01:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*02:01:01,02:01:01; DQB1*02:01:01,03:03:02; DRA*01:01:02,01:02:02; DRB1*03:01:01,07:01:01 (DSMZCellDive=ACC-128).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=11226526; PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (PubMed=31243274).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (Cosmic-CLP=908158; DepMap=ACH-000938).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (PubMed=16969076; Cosmic-CLP=908158; DepMap=ACH-000938).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (Cosmic-CLP=908158; DepMap=ACH-000938).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.12%; Native American=0.55%; East Asian, North=0%; East Asian, South=2.1%; South Asian=0%; European, North=75.01%; European, South=22.21% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003030/5015; COG; Cosmic-CLP=908158; DSMZ=ACC-128; PubMed=11416159; PubMed=20922763; PubMed=25877200; PubMed=34823530; RCB=RCB1933; TKG=TKG 0413
ST   Amelogenin: X,Y
ST   CSF1PO: 12 (AddexBio=C0003030/5015; COG; Cosmic-CLP=908158; DSMZ=ACC-128; PubMed=25877200)
ST   CSF1PO: 12,13 (PubMed=20922763; PubMed=34823530)
ST   CSF1PO: 13 (RCB=RCB1933; TKG=TKG 0413)
ST   D13S317: 8,9,11,12 (DSMZ=ACC-128; PubMed=34823530)
ST   D13S317: 8,9,12 (COG)
ST   D13S317: 9,11 (AddexBio=C0003030/5015)
ST   D13S317: 9,12 (Cosmic-CLP=908158; PubMed=25877200)
ST   D13S317: 9,12,13 (PubMed=20922763)
ST   D13S317: 9,13 (RCB=RCB1933; TKG=TKG 0413)
ST   D16S539: 9,10,11 (COG; DSMZ=ACC-128; PubMed=34823530)
ST   D16S539: 10,11 (Cosmic-CLP=908158; PubMed=20922763; PubMed=25877200; RCB=RCB1933; TKG=TKG 0413)
ST   D16S539: 11 (AddexBio=C0003030/5015)
ST   D18S51: 11,12,14,15 (PubMed=20922763)
ST   D18S51: 12,15 (COG; DSMZ=ACC-128; PubMed=25877200)
ST   D19S433: 12,13,15 (PubMed=20922763)
ST   D19S433: 13,15 (COG; DSMZ=ACC-128)
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D2S441: 10,14
ST   D3S1358: 15,16,17 (PubMed=20922763)
ST   D3S1358: 16,17 (COG; DSMZ=ACC-128; PubMed=25877200; PubMed=34823530)
ST   D5S818: 10,11,12 (COG; DSMZ=ACC-128; PubMed=25877200)
ST   D5S818: 11 (AddexBio=C0003030/5015)
ST   D5S818: 11,12 (Cosmic-CLP=908158; PubMed=20922763; PubMed=34823530; RCB=RCB1933; TKG=TKG 0413)
ST   D6S1043: 11
ST   D7S820: 8,9,10 (Cosmic-CLP=908158; DSMZ=ACC-128; PubMed=25877200)
ST   D7S820: 8,10 (PubMed=34823530)
ST   D7S820: 8,11 (RCB=RCB1933; TKG=TKG 0413)
ST   D7S820: 8,11,12 (PubMed=20922763)
ST   D7S820: 8,12 (AddexBio=C0003030/5015)
ST   D7S820: 10 (COG)
ST   D8S1179: 11,13,14 (COG; DSMZ=ACC-128; PubMed=25877200)
ST   D8S1179: 12,13 (PubMed=20922763)
ST   FGA: 21,22 (COG)
ST   FGA: 21,22,23 (DSMZ=ACC-128)
ST   FGA: 22 (PubMed=11416159; PubMed=25877200)
ST   FGA: 22,23 (PubMed=20922763; PubMed=34823530)
ST   Penta D: 8,14
ST   Penta E: 11
ST   TH01: 8 (PubMed=11416159; PubMed=25877200)
ST   TH01: 8,9 (AddexBio=C0003030/5015; COG; Cosmic-CLP=908158; DSMZ=ACC-128; PubMed=20922763; PubMed=34823530; RCB=RCB1933; TKG=TKG 0413)
ST   TPOX: 8,10
ST   vWA: 15,16 (COG; Cosmic-CLP=908158; DSMZ=ACC-128; PubMed=20922763; PubMed=25877200; PubMed=34823530; RCB=RCB1933; TKG=TKG 0413)
ST   vWA: 15,18 (AddexBio=C0003030/5015)
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_5660 ! NALM-12
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   NALM-6 DCLRE1C(-/-)
AC   CVCL_HE04
SY   DCLRE1C (-/-) NALM-6; ARTEMIS-/- cells
DR   cancercelllines; CVCL_HE04
DR   Horizon_Discovery; HD+115-045
DR   Wikidata; Q54907427
RX   PubMed=17941805;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17642; DCLRE1C.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 LIG4(-/-)
AC   CVCL_HE05
SY   LIG4 (-/-) NALM-6; LIG4-/- Nalm-6
DR   cancercelllines; CVCL_HE05
DR   Horizon_Discovery; HD+115-041
DR   Wikidata; Q54907428
RX   PubMed=18835848;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6601; LIG4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 MUS81(-/-)
AC   CVCL_HE06
SY   MUS81 (-/-) NALM-6
DR   cancercelllines; CVCL_HE06
DR   Horizon_Discovery; HD+115-055
DR   Wikidata; Q54907429
RX   PubMed=17903171;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:29814; MUS81.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 POLB (-/-)
AC   CVCL_A4IJ
SY   POLB (-/-) NALM-6
DR   cancercelllines; CVCL_A4IJ
DR   Horizon_Discovery; HD+115-051
DR   Wikidata; Q105510283
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9174; POLB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   NALM-6 PRKDC(+/-)
AC   CVCL_HE07
SY   PRKDC (+/-) NALM-6
DR   cancercelllines; CVCL_HE07
DR   Horizon_Discovery; HD+R08-001
DR   Wikidata; Q54907430
RX   PubMed=18710952;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9413; PRKDC (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 RAD54L(-/-)
AC   CVCL_HE08
SY   RAD54L (-/-) NALM-6
DR   cancercelllines; CVCL_HE08
DR   Horizon_Discovery; HD+115-043
DR   Wikidata; Q54907431
RX   PubMed=18835848;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9826; RAD54L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 TOP1(+/-)
AC   CVCL_HE09
SY   TOP1 (+/-) NALM-6; TOP1 +/- Nalm-6
DR   cancercelllines; CVCL_HE09
DR   Horizon_Discovery; HD+115-072
DR   Wikidata; Q54907432
RX   PubMed=19336913;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11986; TOP1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 TOP2B(-/-)
AC   CVCL_HE10
SY   TOP2B (-/-) NALM-6
DR   cancercelllines; CVCL_HE10
DR   Horizon_Discovery; HD+115-061
DR   Wikidata; Q54907433
RX   PubMed=18596031;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11990; TOP2B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 TP53(+/-)
AC   CVCL_HE11
SY   TP53 (+/-) NALM-6
DR   cancercelllines; CVCL_HE11
DR   Horizon_Discovery; HD+115-048
DR   Wikidata; Q54907434
RX   PubMed=16405397;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11998; TP53 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 TP53(-/-)
AC   CVCL_HE12
SY   TP53 (-/-) NALM-6
DR   cancercelllines; CVCL_HE12
DR   Horizon_Discovery; HD+115-049
DR   Wikidata; Q54907435
RX   PubMed=16405397;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   NALM-6 XRCC5(+/-)
AC   CVCL_HE13
SY   XRCC5 (+/-) NALM-6; Ku86+/- NALM-6
DR   cancercelllines; CVCL_HE13
DR   Horizon_Discovery; HD+115-102
DR   Wikidata; Q54907436
RX   PubMed=18387344;
RX   PubMed=18562296;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:12833; XRCC5 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   Nalm-6-MSH+
AC   CVCL_J365
DR   cancercelllines; CVCL_J365
DR   JCRB; JCRB1475
DR   Wikidata; Q54907437
RX   PubMed=23596518;
CC   Population: Caucasian.
CC   Characteristics: NALM-6 has a partial C-terminal deletion of the MSH2 gene, Nalm-6-MSH+ repairs the gene by transfection of the missing exons.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1475
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 25
//
ID   Nalm-6-MSH+/TK+/-
AC   CVCL_UD71
DR   cancercelllines; CVCL_UD71
DR   Wikidata; Q95992056
RX   PubMed=27338670;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J365 ! Nalm-6-MSH+
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 15
//
ID   Nalm-6-TK+/-
AC   CVCL_UD96
DR   cancercelllines; CVCL_UD96
DR   Wikidata; Q95992058
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   NALM-6/H
AC   CVCL_B7AM
DR   cancercelllines; CVCL_B7AM
DR   Wikidata; Q112129400
RX   PubMed=34823530;
CC   Population: Caucasian.
CC   Characteristics: Cultured under hypoxia for 5 weeks (PubMed=34823530).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34823530
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D2S441: 10,14
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,10
ST   FGA: 22,23
ST   Penta D: 8,14
ST   Penta E: 11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   NALM-6/HDR
AC   CVCL_B7AN
DR   cancercelllines; CVCL_B7AN
DR   Wikidata; Q112129401
RX   PubMed=31221196;
RX   PubMed=34823530;
CC   Population: Caucasian.
CC   Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196; PubMed=34823530).
CC   Doubling time: 19-22 hours (PubMed=34823530).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34823530
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D2S441: 10,14
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D6S1043: 11
ST   D7S820: 8,10
ST   FGA: 22,23
ST   Penta D: 8,14
ST   Penta E: 11
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   NALM-6/HDR-C5
AC   CVCL_B7AP
DR   cancercelllines; CVCL_B7AP
DR   Wikidata; Q112129402
RX   PubMed=34823530;
CC   Population: Caucasian.
CC   Characteristics: Made glucocorticoid resistant by culturing the grand-parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=34823530).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7AN ! NALM-6/HDR
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   NALM-6/SP-B
AC   CVCL_0U51
DR   cancercelllines; CVCL_0U51
DR   Wikidata; Q54907438
RX   PubMed=22684370;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90235; Spiruchostatin B (SP-B).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   NALM-7
AC   CVCL_5677
SY   NALM7
DR   Wikidata; Q54907439
RX   CelloPub=CLPUB00085;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_L057 ! NALM-8
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_5660 ! NALM-12
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   NALM-8
AC   CVCL_L057
SY   NALM8
DR   Wikidata; Q54907440
RX   CelloPub=CLPUB00085;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L058 ! NALM-9
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_5660 ! NALM-12
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   NALM-9
AC   CVCL_L058
SY   NALM9
DR   Wikidata; Q54907441
RX   CelloPub=CLPUB00085;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW76 ! B85
OI   CVCL_0092 ! NALM-6
OI   CVCL_5677 ! NALM-7
OI   CVCL_L057 ! NALM-8
OI   CVCL_L059 ! NALM-10
OI   CVCL_L060 ! NALM-11
OI   CVCL_5660 ! NALM-12
OI   CVCL_L061 ! NALM-13
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   NALM6, clone G5
AC   CVCL_UJ05
SY   NALM6 clone G5
DR   ATCC; CRL-3273
DR   cancercelllines; CVCL_UJ05
DR   Wikidata; Q95992069
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3273
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   Nalm6-eGFP-Puro
AC   CVCL_RA33
DR   cancercelllines; CVCL_RA33
DR   Imanis; CL138
DR   Wikidata; Q54907442
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-PGKp-Puro vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL138).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   Nalm6-Fluc-hNIS
AC   CVCL_RA35
DR   cancercelllines; CVCL_RA35
DR   Imanis; CL143
DR   Wikidata; Q54907444
RX   PubMed=30674994;
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Luc2-P2A-hNIS vector encoding for luciferase linked via a P2A cleavage peptide to the human SLC5A5 gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL143).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   Nalm6-Fluc-Neo/eGFP-Puro
AC   CVCL_RA34
DR   cancercelllines; CVCL_RA34
DR   Imanis; CL150
DR   Wikidata; Q54907443
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-eGFP-PGKp-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-eGFP-PGKp-Puro encodes for eGFP under control of the spleen focus-forming virus (SFFV) promoter and the PuroR gene under the control of the mouse PGK promoter (Imanis=CL150).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 17
//
ID   Nalm6-Fluc-Puro
AC   CVCL_RA36
DR   cancercelllines; CVCL_RA36
DR   Imanis; CL151
DR   Wikidata; Q54907445
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL151).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 15
//
ID   Nalm6-Fluc-Puro/CD19-KO
AC   CVCL_D5K5
DR   Imanis; CL180
DR   Wikidata; Q127382922
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RA36 ! Nalm6-Fluc-Puro
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Nalm6-Fluc-Puro/HuCD19-Puro (low)
AC   CVCL_E4BT
DR   Imanis; CL182
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (from parent cell line).
CC   Characteristics: Transduced with a human CD19 and PuroR encoding lentivirus. A low CD19 expressing population was generated by selection using a methylcellulose based semi-solid medium (Imanis=CL182).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RA36 ! Nalm6-Fluc-Puro
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   Nalm6-Fluc-Puro/HuCD19-Puro (mid)
AC   CVCL_E4BU
DR   Imanis; CL183
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-PuroR vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (from parent cell line).
CC   Characteristics: Transduced with a human CD19 and PuroR encoding lentivirus. A moderate CD19 expressing population was generated by selection using a methylcellulose based semi-solid medium (Imanis=CL183).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RA36 ! Nalm6-Fluc-Puro
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NALM6/Clo
AC   CVCL_4V57
DR   cancercelllines; CVCL_4V57
DR   Wikidata; Q54907446
RX   PubMed=25461250;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_681569; Clofarabine (CAFdA).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   Namalwa
AC   CVCL_0067
SY   NAMALWA; Namalwa IV; Namalva; NAMALVA; NWA; NK62a
DR   BTO; BTO_0003289
DR   CLO; CLO_0007939
DR   EFO; EFO_0002246
DR   CLDB; cl3633
DR   CLDB; cl3634
DR   CLDB; cl3635
DR   CLDB; cl3636
DR   CLDB; cl3637
DR   AddexBio; C0003013/4670
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1432
DR   BCRC; 60553
DR   BCRJ; 0181
DR   BioSample; SAMN01821584
DR   BioSample; SAMN01821651
DR   BioSample; SAMN03473179
DR   BioSample; SAMN10988039
DR   cancercelllines; CVCL_0067
DR   CCRID; 3101HUMTCHu75
DR   Cell_Model_Passport; SIDM00641
DR   CGH-DB; 9201-4
DR   ChEMBL-Cells; CHEMBL3307288
DR   ChEMBL-Targets; CHEMBL614049
DR   CLS; 300439
DR   Cosmic; 929814
DR   Cosmic; 931107
DR   Cosmic; 998717
DR   Cosmic; 1037702
DR   Cosmic; 1086329
DR   Cosmic; 1818345
DR   Cosmic; 2701743
DR   Cosmic; 2814540
DR   Cosmic; 2823076
DR   Cosmic-CLP; 908159
DR   DepMap; ACH-000944
DR   DSMZ; ACC-24
DR   DSMZCellDive; ACC-24
DR   ECACC; 87060801
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS040JOT
DR   ENCODE; ENCBS105ISO
DR   ENCODE; ENCBS499IUK
DR   ENCODE; ENCBS566UPJ
DR   GDSC; 908159
DR   GEO; GSM99385
DR   GEO; GSM119534
DR   GEO; GSM499728
DR   GEO; GSM499734
DR   GEO; GSM862851
DR   GEO; GSM862852
DR   GEO; GSM862853
DR   GEO; GSM862854
DR   GEO; GSM862855
DR   GEO; GSM862856
DR   GEO; GSM862857
DR   GEO; GSM862858
DR   GEO; GSM888424
DR   GEO; GSM907523
DR   GEO; GSM1374695
DR   GEO; GSM1670143
DR   IARC_TP53; 175
DR   IGRhCellID; NAMALWA
DR   IZSLER; BS TCL 47
DR   JCRB; IFO50040
DR   LiGeA; CCLE_320
DR   LINCS_LDP; LCL-2022
DR   Lonza; 73
DR   NCBI_Iran; C126
DR   PharmacoDB; NAMALWA_981_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0067
DR   PubChem_Cell_line; CVCL_0067
DR   RCB; RCB0445
DR   TOKU-E; 2556
DR   Wikidata; Q54907447
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=170370;
RX   PubMed=216485;
RX   PubMed=464569;
RX   PubMed=1325212;
RX   PubMed=1339415;
RX   PubMed=1915267;
RX   PubMed=2052620;
RX   PubMed=2415623;
RX   PubMed=2580922;
RX   PubMed=2830981;
RX   PubMed=2985879;
RX   PubMed=2995175;
RX   PubMed=2998993;
RX   PubMed=3026973;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=3997900;
RX   PubMed=4122458;
RX   PubMed=4347031;
RX   PubMed=4364259;
RX   PubMed=6231253;
RX   PubMed=6286763;
RX   PubMed=6811418;
RX   PubMed=7316467;
RX   PubMed=7849311;
RX   PubMed=8176200;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8558920;
RX   PubMed=8568269;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9973220;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12145705;
RX   PubMed=16960149;
RX   PubMed=18357372;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=21269460;
RX   PubMed=22460905;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29892436;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Namalwa
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Virology: Infected by squirrel monkey retrovirus (SMRV) (PubMed=1339415; PubMed=20454443).
CC   Doubling time: 18 hours (PubMed=8402660); ~20-30 hours (DSMZ=ACC-24).
CC   HLA typing: A*29:02,66:02; B*57:03,58:01; C*07:01,15:05; DQA1*01:02,03:02; DQB1*02:01,06:02; DRB1*07:01,15:03 (PubMed=25960936).
CC   HLA typing: A*03:01,68:02; B*07:02,49:01; C*04:01,07:01; DQA1*01:02,03:02; DQB1*03:02,06:02; DRB1*04:05,15:03 (PubMed=26589293).
CC   HLA typing: A*03:01:01,20:02:01; B*07:02:01,01:01:01; C*07:01:02,07:02:01; DPB1*01:01:01,02:01:02; DQA1*01:02:01,03:03:01; DQB1*03:02:01.06:02:01; DRB1*04:05:01,15:03:01 (CLS=300439).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493; PubMed=8402660; Cosmic-CLP=908159; DepMap=ACH-000944).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=94.65%; Native American=0%; East Asian, North=1.43%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=3.91% (PubMed=30894373).
CC   Caution: Indicated to have an additional TP53 p.Arg248Trp (c.742C>T) mutation according to PubMed=2052620, but not confirmed by other references or by CCLE and Cosmic-CLP.
CC   Misspelling: NAMALLA; Cosmic=998717.
CC   Discontinued: RCB; RCB0445; true.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): AddexBio=C0003013/4670; ATCC=CRL-1432; CLS=300439; Cosmic-CLP=908159; DSMZ=ACC-24; ECACC=87060801; JCRB=IFO50040; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,18
ST   D21S11: 27,28
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 8,13
ST   Penta E: 5,15
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 14
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   Namalwa KJM-1
AC   CVCL_4Y60
SY   Namalva KJM-1
DR   cancercelllines; CVCL_4Y60
DR   TOKU-E; 3616
DR   Wikidata; Q54907448
RX   DOI=10.1007/978-94-011-2044-9_9;
RX   PubMed=1366592;
RX   PubMed=1369278;
RX   PubMed=22358567;
CC   Group: Serum/protein free medium cell line.
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   Namalwa.CSN/70
AC   CVCL_1838
SY   NAMALWA.CSN/70; Namalwa CSN/70; NAMALWACSN70; CSN/70
DR   CLO; CLO_0007940
DR   CLDB; cl3638
DR   cancercelllines; CVCL_1838
DR   DSMZ; ACC-70
DR   DSMZCellDive; ACC-70
DR   Wikidata; Q54907452
RX   PubMed=1339415;
RX   PubMed=2298494;
RX   PubMed=3026962;
RX   PubMed=20454443;
RX   PubMed=28196595;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=CSN%2f70
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Virology: Infected by squirrel monkey retrovirus (SMRV) (PubMed=1339415; PubMed=20454443).
CC   Doubling time: ~40 hours (DSMZ=ACC-70).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-70
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,18
ST   D21S11: 27,28
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 8,13
ST   Penta E: 5,15
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 14
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Namalwa.IPN/45
AC   CVCL_1839
SY   NAMALWA.IPN/45; NAMALWA-IPN.45; Namalwa IPN/45; IPN/45
DR   CLO; CLO_0007941
DR   CLDB; cl3639
DR   BioSample; SAMN03473394
DR   cancercelllines; CVCL_1839
DR   DSMZ; ACC-71
DR   DSMZCellDive; ACC-71
DR   Wikidata; Q54907453
RX   PubMed=1339415;
RX   PubMed=2298494;
RX   PubMed=3026962;
RX   PubMed=7849311;
RX   PubMed=20454443;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=IPN%2f45
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Virology: Infected by squirrel monkey retrovirus (SMRV) (PubMed=1339415; PubMed=20454443). Contains two partial SMRV copies integrated into the MYC gene locus and 10 further copies integrated at different sites of the genome.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-71
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,18
ST   D21S11: 27,28
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 8,13
ST   Penta E: 5,15
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Namalwa.KN2
AC   CVCL_1840
SY   NAMALWA.KN2; Namalwa KN2; KN2
DR   CLO; CLO_0007942
DR   CLDB; cl3640
DR   BioSample; SAMN03473433
DR   cancercelllines; CVCL_1840
DR   DSMZ; ACC-68
DR   DSMZCellDive; ACC-68
DR   Wikidata; Q54907454
RX   PubMed=1339415;
RX   PubMed=2298494;
RX   PubMed=3026962;
RX   PubMed=20454443;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=KN2
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Virology: Infected by squirrel monkey retrovirus (SMRV) (PubMed=1339415; PubMed=20454443).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-68
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,18
ST   D21S11: 27,28
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 8,13
ST   Penta E: 5,15
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 14
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Namalwa.PNT
AC   CVCL_1841
SY   NAMALWA.PNT; NAMALWA-PNT; Namalwa PNT; PNT
DR   CLO; CLO_0007943
DR   CLDB; cl3641
DR   cancercelllines; CVCL_1841
DR   Cell_Model_Passport; SIDM01227
DR   DSMZ; ACC-69
DR   DSMZCellDive; ACC-69
DR   LINCS_LDP; LCL-2029
DR   Wikidata; Q54907455
RX   PubMed=1339415;
RX   PubMed=2298494;
RX   PubMed=3026962;
RX   PubMed=20454443;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PNT
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Virology: Infected by squirrel monkey retrovirus (SMRV) (PubMed=1339415; PubMed=20454443).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-69
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,18
ST   D21S11: 27,28
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 8,13
ST   Penta E: 5,15
ST   TH01: 7,9.3
ST   TPOX: 6,11
ST   vWA: 14
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Namalwa/21V
AC   CVCL_KU34
SY   N21V
DR   cancercelllines; CVCL_KU34
DR   Wikidata; Q54907449
RX   PubMed=18357372;
CC   Population: African; Kenyan.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   Namalwa/MDR1
AC   CVCL_KU33
SY   Namalwa/mdr-1; NMDR1
DR   cancercelllines; CVCL_KU33
DR   Wikidata; Q54907451
RX   PubMed=7492789;
RX   PubMed=10632321;
RX   PubMed=18357372;
CC   Population: African; Kenyan.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 13
//
ID   NAMEC1
AC   CVCL_IZ62
SY   NAMEC 1; Naturally Arising MEsenchymal Cells 1
DR   Wikidata; Q54907458
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ63 ! NAMEC2
OI   CVCL_IZ64 ! NAMEC3
OI   CVCL_IZ65 ! NAMEC4
OI   CVCL_IZ66 ! NAMEC5
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC10
AC   CVCL_IZ60
SY   NAMEC 10; Naturally Arising MEsenchymal Cells 10
DR   Wikidata; Q54907456
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC11
AC   CVCL_IZ61
SY   NAMEC 11; Naturally Arising MEsenchymal Cells 11
DR   Wikidata; Q54907457
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC2
AC   CVCL_IZ63
SY   NAMEC 2; Naturally Arising MEsenchymal Cells 2
DR   Wikidata; Q54907459
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ62 ! NAMEC1
OI   CVCL_IZ64 ! NAMEC3
OI   CVCL_IZ65 ! NAMEC4
OI   CVCL_IZ66 ! NAMEC5
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC3
AC   CVCL_IZ64
SY   NAMEC 3; Naturally Arising MEsenchymal Cells 3
DR   Wikidata; Q54907460
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ62 ! NAMEC1
OI   CVCL_IZ63 ! NAMEC2
OI   CVCL_IZ65 ! NAMEC4
OI   CVCL_IZ66 ! NAMEC5
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC4
AC   CVCL_IZ65
SY   NAMEC 4; Naturally Arising MEsenchymal Cells 4
DR   Wikidata; Q54907461
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ62 ! NAMEC1
OI   CVCL_IZ63 ! NAMEC2
OI   CVCL_IZ64 ! NAMEC3
OI   CVCL_IZ66 ! NAMEC5
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC5
AC   CVCL_IZ66
SY   NAMEC 5; Naturally Arising MEsenchymal Cells 5
DR   Wikidata; Q54907462
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ62 ! NAMEC1
OI   CVCL_IZ63 ! NAMEC2
OI   CVCL_IZ64 ! NAMEC3
OI   CVCL_IZ65 ! NAMEC4
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC6
AC   CVCL_IZ67
SY   NAMEC 6; Naturally Arising MEsenchymal Cells 6
DR   Wikidata; Q54907463
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC7
AC   CVCL_IZ68
SY   NAMEC 7; Naturally Arising MEsenchymal Cells 7
DR   Wikidata; Q54907467
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMEC8
AC   CVCL_IZ69
SY   NAMEC 8; N8; Naturally Arising MEsenchymal Cells 8
DR   GEO; GSE74865
DR   Wikidata; Q54907468
RX   PubMed=24029232;
RX   PubMed=26941323;
CC   Omics: Genomics; ChIP-seq; H3K9me2.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   NAMEC9
AC   CVCL_IZ70
SY   NAMEC 9; Naturally Arising MEsenchymal Cells 9
DR   Wikidata; Q54907470
RX   PubMed=24029232;
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Mesenchymal cell; CL=CL_0008019.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   NAMO-2
AC   CVCL_R913
DR   Wikidata; Q54907471
RX   PubMed=17118759;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=17118759).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=17118759).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   NAMPUT
AC   CVCL_ZI18
DR   Wikidata; Q98127415
RX   PubMed=6811418;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
HI   CVCL_ZI12 ! PUT
CA   Hybrid cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 4
//
ID   NAMRU2-CQ-01
AC   CVCL_1B68
SY   Hsu
DR   Wikidata; Q54907472
RX   PubMed=5501238;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution (Naval Medical Research Unit 2) and the species.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7176; ! Culex quinquefasciatus (Southern house mosquito)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 9
//
ID   NAMRU2-CQ-01-1.7
AC   CVCL_B3N4
SY   Hsu-1.7
DR   DGRC; 335
DR   Wikidata; Q110433079
RX   PubMed=34819517;
CC   Group: Insect cell line.
CC   Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase.
CC   Doubling time: ~24 hours (DGRC=335).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7176; ! Culex quinquefasciatus (Southern house mosquito)
HI   CVCL_1B68 ! NAMRU2-CQ-01
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   NAMRU2-CT-01
AC   CVCL_1B73
DR   Wikidata; Q54907473
RX   PubMed=5019214;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution (Naval Medical Research Unit 2) and the species.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7178; ! Culex tritaeniorhynchus (Mosquito)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   NAN-1
AC   CVCL_A775
SY   NAN1
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_A775
DR   Cosmic; 2809779
DR   IARC_TP53; 28495
DR   Wikidata; Q54907474
RX   PubMed=16638930;
RX   PubMed=16956823;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA kappa.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,02; B*44; C*16:01 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180Ter (c.538G>T); ClinVar=VCV000634687; Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   NAN-10
AC   CVCL_WR54
SY   NAN10
DR   Cosmic; 2809785
DR   Wikidata; Q95992150
RX   PubMed=30545397;
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,02; B*08,15; C*03,07 (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   NAN-11
AC   CVCL_WR55
SY   NAN11
DR   Cosmic; 2809786
DR   Wikidata; Q95992151
RX   PubMed=30545397;
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,11; B*13,27; C*02,06 (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   NAN-2
AC   CVCL_HX08
SY   NAN2
DR   Wikidata; Q54907475
RX   PubMed=16956823;
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   Miscellaneous: Cell line has been lost (personal communication of Pellat-Deceunynck, Catherine).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   NAN-3
AC   CVCL_B318
SY   NAN3
DR   ArrayExpress; E-TABM-1088
DR   Cosmic; 2809780
DR   IARC_TP53; 28516
DR   Wikidata; Q54907476
RX   PubMed=16638930;
RX   PubMed=16956823;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA kappa.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,02; B*08,40; C*03,07 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248insGln (c.744insCAG); Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   NAN-4
AC   CVCL_B319
SY   NAN4
DR   Wikidata; Q54907477
RX   PubMed=16638930;
RX   PubMed=16956823;
CC   Characteristics: Produces IgA kappa.
CC   Characteristics: IL6 dependent.
CC   Miscellaneous: Cell line has been lost (personal communication of Pellat-Deceunynck, Catherine).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   NAN-5
AC   CVCL_B324
SY   NAN5
DR   Wikidata; Q54907478
RX   PubMed=16638930;
RX   PubMed=16956823;
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Miscellaneous: Cell line has been lost (personal communication of Pellat-Deceunynck, Catherine).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   NAN-6
AC   CVCL_HX09
SY   NAN6
DR   ArrayExpress; E-TABM-1088
DR   Cosmic; 2809781
DR   IARC_TP53; 28496
DR   Wikidata; Q54907479
RX   PubMed=16956823;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA kappa.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*03,30; B*07,51; C*07,12 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex7-9del; Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   NAN-7
AC   CVCL_WR58
SY   NAN7
DR   Cosmic; 2809782
DR   Wikidata; Q95992169
RX   PubMed=30545397;
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*03; B*07; C*07 (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   NAN-8
AC   CVCL_WR56
SY   NAN8
DR   Cosmic; 2809783
DR   Wikidata; Q95992170
RX   PubMed=30545397;
CC   Characteristics: Produces IgA.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*11:01,34:01; B*40:01,55:02; C*01:02,03:04 (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   NAN-9
AC   CVCL_WR57
SY   NAN9
DR   Cosmic; 2809784
DR   Wikidata; Q95992172
RX   PubMed=30545397;
CC   Characteristics: Produces IgA.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01:01,24:02; B*08:01,15:24; C*03:03,07:01 (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   NAN2
AC   CVCL_B317
SY   NAN-2
DR   Cosmic; 932157
DR   Wikidata; Q54907480
RX   PubMed=11410884;
CC   From: Tachikawa, Tetsuhiko; Department of Oral Pathology, Showa University; Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   Nanog^(Beta geo/+)ES
AC   CVCL_T795
SY   Nanog Beta geo/+ ES
DR   RCB; AES0121
DR   RCB; RCB2662
DR   SKIP; SKIP001667
DR   Wikidata; Q54907481
RX   PubMed=12787504;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1919200; Nanog (Note=1 of 2 alleles).
CC   Discontinued: RCB; RCB2662; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T793 ! RF8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 10
//
ID   Nanog^(Beta geo/Hyg)
AC   CVCL_T796
SY   Nanog Beta geo/Hyg
DR   RCB; AES0126
DR   RCB; RCB2697
DR   SKIP; SKIP001669
DR   Wikidata; Q54907482
RX   PubMed=12787504;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1919200; Nanog.
CC   Discontinued: RCB; RCB2697; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T793 ! RF8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   NAP
AC   CVCL_HF46
DR   Wikidata; Q54907483
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 02-05-24; Version: 7
//
ID   NAP80-33-1-1
AC   CVCL_C6GS
SY   NAP80-33
DR   Wikidata; Q116049863
RX   PubMed=23600499;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A5HZZ4; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) hemagglutinin-70 (ha70).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   NAP80-5-5-3
AC   CVCL_C6GT
SY   NAP80-5
DR   Wikidata; Q116049864
RX   PubMed=23600499;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A5HZZ4; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) hemagglutinin-70 (ha70).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   NAP80-7-2-1
AC   CVCL_C6GU
SY   NAP80-7
DR   Wikidata; Q116049865
RX   PubMed=23600499;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A5HZZ4; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) hemagglutinin-70 (ha70).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   NAP83-27-7-6
AC   CVCL_C6GV
SY   NAP83-27
DR   Wikidata; Q116049866
RX   PubMed=23600499;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A5HZZ4; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) hemagglutinin-70 (ha70).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   NAP83-71-1-3
AC   CVCL_C6GW
SY   NAP83-71
DR   Wikidata; Q116049867
RX   PubMed=23600499;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A5HZZ4; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) hemagglutinin-70 (ha70).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   NAP83-97-5-2
AC   CVCL_C6GX
SY   NAP83-97
DR   Wikidata; Q116049868
RX   PubMed=23600499;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A5HZZ4; Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) hemagglutinin-70 (ha70).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   Nara-F
AC   CVCL_W997
DR   Wikidata; Q54907484
RX   PubMed=11408058;
CC   Population: Japanese.
CC   Doubling time: 33.4 hours (PubMed=11408058).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W998 ! Nara-H
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 8
//
ID   Nara-H
AC   CVCL_W998
DR   Wikidata; Q54907485
RX   PubMed=11408058;
CC   Population: Japanese.
CC   Doubling time: 38.7 hours (PubMed=11408058).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W997 ! Nara-F
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 8
//
ID   NARO-Ac-314
AC   CVCL_C3LK
SY   Ac-314
DR   Wikidata; Q116049869
RX   PubMed=35867318;
CC   Group: Insect cell line.
CC   Characteristics: Sometimes produces complex contractile structures, such as sheet-like tissues (PubMed=35867318).
CC   Doubling time: 61.4 +- 10.1 hours (PubMed=35867318).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=121601; ! Anomala cuprea (Cupreous chafer beetle)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   NARO-Cehy
AC   CVCL_ZE93
DR   ICLDB; naro-cehy
DR   Wikidata; Q98127416
RX   PubMed=32246241;
CC   Group: Insect cell line.
CC   Doubling time: 1.03 days (PubMed=32246241).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=151547; ! Cephonodes hylas (Coffee bee hawkmoth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NARO-Cyku
AC   CVCL_ZE94
DR   ICLDB; naro-cyku
DR   Wikidata; Q98127418
RX   PubMed=32246241;
CC   Group: Insect cell line.
CC   Doubling time: 1.53 days (PubMed=32246241).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=2735276; ! Cydia kurokoi (Nut fruit tortrix moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NARO-Haba
AC   CVCL_ZE95
DR   ICLDB; naro-haba
DR   Wikidata; Q98127419
RX   PubMed=32246241;
CC   Group: Insect cell line.
CC   Doubling time: 1.92 days (PubMed=32246241).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=517475; ! Haritalodes derogata (Cotton leaf roller moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NARO-Hycu
AC   CVCL_ZE96
DR   ICLDB; naro-hycu
DR   Wikidata; Q98127422
RX   PubMed=32246241;
CC   Group: Insect cell line.
CC   Doubling time: 1.61 days (PubMed=32246241).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=39466; ! Hyphantria cunea (Fall webworm moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NARO-Lydi
AC   CVCL_ZE97
DR   ICLDB; naro-lydi
DR   Wikidata; Q98127424
RX   PubMed=32246241;
CC   Group: Insect cell line.
CC   Doubling time: 2.49 days (PubMed=32246241).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NARO-Thol
AC   CVCL_ZE98
DR   ICLDB; naro-thol
DR   Wikidata; Q98127425
RX   PubMed=32246241;
CC   Group: Insect cell line.
CC   Doubling time: 1.37 days (PubMed=32246241).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=1088304; ! Theretra oldenlandiae (Impatiens hawkmoth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NASS
AC   CVCL_C8P5
DR   BTO; BTO_0006497
DR   Wikidata; Q123033140
RX   PubMed=18425327;
CC   From: Versteeg, Rogier; Department of Human Genetics, Academical Medical Centre; Amsterdam; Netherlands.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   NAT-30
AC   CVCL_U821
SY   NAT 30
DR   cancercelllines; CVCL_U821
DR   Wikidata; Q54907486
RX   PubMed=1368811;
RX   PubMed=3902783;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: African; Kenyan.
CC   Virology: Contains 2 integrated copies of EBV genome on chromosome 1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0067 ! Namalwa
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 19
//
ID   NAT1(+/-)ES(A7)
AC   CVCL_0J06
DR   RCB; AES0190
DR   SKIP; SKIP002931
DR   Wikidata; Q54907487
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   NAT1(+/-)ES(B4)
AC   CVCL_0J08
DR   RCB; AES0191
DR   SKIP; SKIP002932
DR   Wikidata; Q54907488
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   NAT1(+/-)ES(C1)
AC   CVCL_0J09
DR   RCB; AES0192
DR   SKIP; SKIP002933
DR   Wikidata; Q54907489
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   NAT1(-/-)ES(B12)
AC   CVCL_0J11
DR   RCB; AES0194
DR   Wikidata; Q54907490
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   NAT1(-/-)ES(B2)
AC   CVCL_0J10
DR   RCB; AES0193
DR   SKIP; SKIP002934
DR   Wikidata; Q54907491
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   NAT1(-/-)ES(C3)
AC   CVCL_0J12
DR   RCB; AES0195
DR   SKIP; SKIP002935
DR   Wikidata; Q54907492
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   NATO
AC   CVCL_M830
DR   Wikidata; Q54907493
RX   PubMed=7599108;
CC   Population: Japanese.
CC   Doubling time: 84 hours (PubMed=7599108).
CC   Derived from site: In situ; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   NAU-BEMC
AC   CVCL_C3N8
SY   Nanjing Agricultural University-Bovine Epithelial Mammary Cell line
DR   Wikidata; Q116049870
RX   PubMed=17577996;
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and of the cell line description.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   NaUCC-1
AC   CVCL_M680
DR   Wikidata; Q54907494
RX   PubMed=1786199;
RX   PubMed=3171272;
RX   PubMed=3819510;
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 17.3 hours (Note=In vivo), 20 hours (Note=In vitro) (PubMed=3171272).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   NaUCC-2
AC   CVCL_M681
DR   Wikidata; Q54907495
RX   PubMed=3171272;
RX   PubMed=3819510;
RX   PubMed=8397359;
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 20.6 hours (Note=In vivo) (PubMed=3171272).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   NaUCC-3
AC   CVCL_M682
DR   Wikidata; Q54907496
RX   PubMed=1786199;
RX   PubMed=3171272;
RX   PubMed=3819510;
RX   PubMed=8397359;
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 14.9 hours (Note=In vivo) (PubMed=3171272).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   NaUCC-4
AC   CVCL_M683
DR   Wikidata; Q54907498
RX   PubMed=1786199;
RX   PubMed=8397359;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   NaV 1.3 KIR 2.1
AC   CVCL_5I44
SY   Spiking HEK cells
DR   ATCC; CRL-3269
DR   Wikidata; Q54907499
RX   PubMed=24391999;
CC   Characteristics: Generate spontaneous electrical action potentials (PubMed=24391999).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104744; Kcnj2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=RGD; 3635; Scn3a.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-3269; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3269
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I43 ! HEK293-Nav 1.3
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   NB(TU)1
AC   CVCL_3041
SY   NB(Tu)-1; NBTU1; NB(TU)1-10; NB (TU) 1-10; NB-TU-1-10; NBTU110
DR   CLO; CLO_0037082
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470814
DR   BioSample; SAMN03470968
DR   cancercelllines; CVCL_3041
DR   Cell_Model_Passport; SIDM00579
DR   Cosmic; 1037354
DR   Cosmic; 2131596
DR   Cosmic-CLP; 1240181
DR   DepMap; ACH-002277
DR   EGA; EGAS00001000978
DR   GDSC; 1240181
DR   GEO; GSM827250
DR   GEO; GSM1670144
DR   JCRB; JCRB0154
DR   JCRB; NIHS0179
DR   LINCS_LDP; LCL-1976
DR   PharmacoDB; NBTU110_982_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3041
DR   Wikidata; Q54907513
RX   PubMed=9378542;
RX   PubMed=15892104;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 49 hours (PubMed=9378542).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.86%; Native American=0.24%; East Asian, North=77.99%; East Asian, South=19.62%; South Asian=1.28%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0179; true.
ST   Source(s): Cosmic-CLP=1240181; JCRB=JCRB0154; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11 (PubMed=25877200)
ST   D16S539: 9,11,12 (Cosmic-CLP=1240181)
ST   D16S539: 9,12 (JCRB=JCRB0154)
ST   D18S51: 13,15
ST   D19S433: 13.2,14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 13,16
ST   FGA: 22,24
ST   Penta D: 12,14
ST   Penta E: 14,19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   NB-1
AC   CVCL_GZ01
DR   Wikidata; Q54907500
RX   DOI=10.3353/omp.9.133;
CC   Population: Japanese.
CC   Doubling time: 25.2 hours (DOI=10.3353/omp.9.133).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   NB-1643
AC   CVCL_5627
SY   NB1643; NB 1643
DR   BTO; BTO_0002833
DR   cancercelllines; CVCL_5627
DR   Cell_Model_Passport; SIDM01388
DR   Cosmic; 1161994
DR   Cosmic; 1890114
DR   DepMap; ACH-001303
DR   GEO; GSM2371243
DR   GEO; GSM2394390
DR   GEO; GSM4104583
DR   GEO; GSM4104584
DR   GEO; GSM4104630
DR   GEO; GSM4104631
DR   GEO; GSM4105318
DR   GEO; GSM4105319
DR   GEO; GSM4105320
DR   GEO; GSM4105321
DR   GEO; GSM4105322
DR   IARC_TP53; 23603
DR   Wikidata; Q54907501
RX   PubMed=9802058;
RX   PubMed=9815701;
RX   PubMed=18724359;
RX   PubMed=20922763;
RX   PubMed=23202128;
RX   PubMed=28350380;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/NB_Cell_Lines/NB-1643%20Cell%20Line%20Data%20Sheet.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 43 hours (PubMed=20922763).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (PubMed=18724359; PubMed=28350380; DepMap=ACH-001303).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9802058).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): DepMap=ACH-001303; PubMed=20922763
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 23,24
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 10
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   NB-1691
AC   CVCL_5628
SY   NB1691; NB 1691
DR   BTO; BTO_0002834
DR   GEO; GSM2371244
DR   GEO; GSM2394384
DR   IARC_TP53; 23604
DR   Wikidata; Q54907502
RX   PubMed=9802058;
RX   PubMed=9815701;
RX   PubMed=10933967;
RX   PubMed=11306486;
RX   PubMed=28350380;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9802058).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1-3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   NB-1771
AC   CVCL_E216
SY   NB1771
DR   Cosmic; 1161995
DR   Wikidata; Q54907504
RX   PubMed=9815701;
RX   PubMed=18724359;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1-3Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   NB-39-nu
AC   CVCL_B229
SY   NB-39; NB39; NB39-nu; NB39nu
DR   BTO; BTO_0004871
DR   Cosmic; 920247
DR   Wikidata; Q54907505
RX   DOI=10.11418/jtca1981.8.2_6;
RX   PubMed=7874267;
RX   PubMed=19320641;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft produced in athymic nude mice.
CC   Doubling time: 41 hours (DOI=10.11418/jtca1981.8.2_6).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   NB-EbC1
AC   CVCL_E218
SY   NB-EBC1; NBEbC1; NBEBC1; EbC1; EBC1
DR   Cosmic; 1161996
DR   GEO; GSM2371246
DR   GEO; GSM2394378
DR   Wikidata; Q54907506
RX   PubMed=18724359;
RX   PubMed=20922763;
RX   PubMed=28350380;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/NB_Cell_Lines/NB-EBc1%20Cell%20Line%20Data%20Sheet.pdf
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Doubling time: 45 hours (PubMed=20922763).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: NB-EBcl; Note=Occasionally.
CC   Misspelling: NB-Ebcl-1; Note=Occasionally.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 15,20
ST   D19S433: 14,15
ST   D21S11: 27,32.2
ST   D2S1338: 19,20
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 12,14
ST   D8S1179: 11,13
ST   FGA: 24,25
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   NB-NR
AC   CVCL_QW53
DR   Wikidata; Q54907507
RX   PubMed=12210830;
CC   Population: Japanese.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   NB-SD
AC   CVCL_LF68
SY   NBSD
DR   cancercelllines; CVCL_LF68
DR   Cosmic; 1161998
DR   GEO; GSM2371247
DR   GEO; GSM2394380
DR   IARC_TP53; 24984
DR   Wikidata; Q54907508
RX   PubMed=9802058;
RX   PubMed=9815701;
RX   PubMed=18724359;
RX   PubMed=28350380;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (PubMed=18724359; PubMed=28350380).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Homozygous (PubMed=9802058).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1-3Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   NB-YK
AC   CVCL_M806
DR   Wikidata; Q54907509
RX   PubMed=8720061;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60478; Rat nephroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 7
//
ID   NB0001
AC   CVCL_8Y23
DR   ECACC; 01082320
DR   Wikidata; Q54907514
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: XX,dup(7)(p11.2;p13); XX (ECACC=01082320).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85068; Russell-Silver syndrome
DI   ORDO; Orphanet_813; Silver-Russell syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   NB1
AC   CVCL_1440
SY   NB-1; NB-I; NB 1
DR   BTO; BTO_0005103
DR   CLO; CLO_0051419
DR   EFO; EFO_0022502
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 402
DR   BioSample; SAMN03470966
DR   BioSample; SAMN03472043
DR   BioSample; SAMN10988531
DR   cancercelllines; CVCL_1440
DR   Cell_Model_Passport; SIDM00578
DR   CGH-DB; 74-1
DR   CGH-DB; 9097-4
DR   Cosmic; 801736
DR   Cosmic; 920243
DR   Cosmic; 947696
DR   Cosmic; 949179
DR   Cosmic; 1037339
DR   Cosmic; 1099136
DR   Cosmic; 1153784
DR   Cosmic; 1526632
DR   Cosmic; 2131573
DR   Cosmic-CLP; 949179
DR   DepMap; ACH-000804
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10539-107G8
DR   GDSC; 949179
DR   GEO; GSM333816
DR   GEO; GSM333825
DR   GEO; GSM887348
DR   GEO; GSM888425
DR   GEO; GSM1670145
DR   GEO; GSM2371241
DR   GEO; GSM2394388
DR   GEO; GSM4104581
DR   GEO; GSM4104582
DR   IARC_TP53; 27699
DR   JCRB; IFO50295
DR   JCRB; JCRB0621
DR   LiGeA; CCLE_099
DR   LINCS_LDP; LCL-1977
DR   PharmacoDB; NB1_984_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1440
DR   RCB; RCB1953
DR   TKG; TKG 0486
DR   Wikidata; Q54907515
RX   CelloPub=CLPUB00086;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=174024;
RX   PubMed=201151;
RX   PubMed=590688;
RX   PubMed=4144593;
RX   PubMed=9290701;
RX   PubMed=11129446;
RX   PubMed=12210830;
RX   PubMed=12702577;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 40-50 hours (PubMed=174024); ~1 day (Note=Lot 12092005), ~32 hours (Note=Lot 09252019) (JCRB=IFO50295); ~60 hours (Note=Lot 120898), ~2 days (Note=Lot 08152016) (JCRB=JCRB0621).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=949179; DepMap=ACH-000804).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.29%; Native American=0.21%; East Asian, North=80.53%; East Asian, South=13.17%; South Asian=0%; European, North=0%; European, South=3.8% (PubMed=30894373).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=949179; JCRB=IFO50295; JCRB=JCRB0621; PubMed=25877200; RCB=RCB1953; TKG=TKG 0486
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 9 (Cosmic-CLP=949179; JCRB=IFO50295; JCRB=JCRB0621; PubMed=25877200; TKG=TKG 0486)
ST   D16S539: 9,12 (RCB=RCB1953)
ST   D18S51: 16
ST   D19S433: 13.2,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 17,27
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 8,12 (Cosmic-CLP=949179; JCRB=IFO50295; JCRB=JCRB0621; PubMed=25877200; RCB=RCB1953)
ST   D7S820: 12 (TKG=TKG 0486)
ST   D8S1179: 12,16
ST   FGA: 19,23
ST   Penta D: 8,9
ST   Penta E: 17,18
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   NB1 [Human skin fibroblast]
AC   CVCL_ZT00
SY   Nb1
DR   Wikidata; Q98127428
RX   PubMed=15130666;
RX   PubMed=16164424;
RX   PubMed=23093295;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   NB1-C
AC   CVCL_C6WQ
DR   Wikidata; Q117704719
RX   PubMed=22028624;
CC   Characteristics: Established from the NB1 xenograft tumor in serum-free medium (PubMed=22028624).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NB1-Tert
AC   CVCL_ZT11
DR   Wikidata; Q98127431
RX   PubMed=23093295;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT00 ! NB1 [Human skin fibroblast]
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   NB1-Tert Artemis clone 1
AC   CVCL_E3FS
RX   PubMed=23093295;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17642; DCLRE1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT11 ! NB1-Tert
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NB1-Tert Artemis clone 2
AC   CVCL_E3FT
RX   PubMed=23093295;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17642; DCLRE1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT11 ! NB1-Tert
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NB1-Tert Artemis clone 3
AC   CVCL_E3FU
RX   PubMed=23093295;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17642; DCLRE1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT11 ! NB1-Tert
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NB1-Tert Artemis clone 4
AC   CVCL_E3FV
RX   PubMed=23093295;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17642; DCLRE1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT11 ! NB1-Tert
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NB1-Tert Artemis clone 5
AC   CVCL_E3FW
RX   PubMed=23093295;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17642; DCLRE1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT11 ! NB1-Tert
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NB1-Tert Artemis clone 6
AC   CVCL_E3FX
RX   PubMed=23093295;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17642; DCLRE1C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZT11 ! NB1-Tert
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NB1-G
AC   CVCL_W493
DR   Wikidata; Q54907516
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2437946;
CC   Characteristics: Established from a xenograft maintained in nude rats.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   NB16
AC   CVCL_B323
SY   NB-16; NB_16; NB 16; NB16-RIKEN
DR   CLO; CLO_0051539
DR   ArrayExpress; E-MTAB-783
DR   cancercelllines; CVCL_B323
DR   Cosmic; 688074
DR   Cosmic; 801737
DR   Cosmic; 910929
DR   Cosmic; 920245
DR   Cosmic; 947708
DR   Cosmic; 1019945
DR   Cosmic; 1037340
DR   Cosmic; 1099137
DR   Cosmic; 1153785
DR   Cosmic; 1890118
DR   Cosmic; 2131575
DR   GEO; GSM333800
DR   GEO; GSM2371242
DR   GEO; GSM2394367
DR   LINCS_LDP; LCL-1993
DR   Progenetix; CVCL_B323
DR   RCB; RCB0478
DR   Wikidata; Q54907517
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=16822308;
RX   PubMed=18082704;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=23202128;
RX   PubMed=28350380;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): RCB=RCB0478
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y11M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   NB1RGB
AC   CVCL_J377
SY   NB1-RGB
DR   CLO; CLO_0050717
DR   BioSample; SAMN03472347
DR   IARC_TP53; 25026
DR   RCB; RCB0222
DR   Wikidata; Q54907519
RX   PubMed=10385124;
RX   PubMed=17395773;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 16 PDL (PubMed=17395773).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0222
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D5S818: 7,10
ST   D7S820: 12,13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   Nb2
AC   CVCL_G705
SY   Nb 2; Nb-2; NB-2
DR   BTO; BTO_0003056
DR   Wikidata; Q54907520
RX   PubMed=1988090;
RX   PubMed=6992985;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Nb2
CC   Characteristics: Prolactin-dependent.
CC   Breed/subspecies: Nb.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 11
//
ID   Nb2-11
AC   CVCL_3860
SY   Nb2-11C
DR   CLO; CLO_0007945
DR   CLDB; cl5086
DR   ECACC; 97041101
DR   NCBI_Iran; C606
DR   Wikidata; Q54907521
RX   PubMed=1718958;
RX   PubMed=7895694;
RX   PubMed=8188682;
RX   PubMed=9639394;
RX   PubMed=9890649;
RX   PubMed=10214359;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/nb2-11/
CC   Characteristics: Prolactin-dependent; metastatic (PubMed=9639394).
CC   Characteristics: Tumorigenic (PubMed=10214359).
CC   Doubling time: 12 hours (ECACC=97041101).
CC   Breed/subspecies: Nb.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G705 ! Nb2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   Nb2-PRA
AC   CVCL_E7IB
SY   PRA
RX   PubMed=1988090;
CC   Characteristics: Prolactin-independent (PubMed=19880909).
CC   Doubling time: 17 hours (PubMed=1988090).
CC   Karyotypic information: Hypododiploid karyotype (PubMed=1988090).
CC   Breed/subspecies: Nb.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E7IA ! Nb2-U17
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   Nb2-SFJCD1
AC   CVCL_6E51
SY   SFJCD1
DR   Wikidata; Q54907522
RX   PubMed=1988090;
RX   PubMed=7895694;
RX   PubMed=9639394;
RX   PubMed=9890649;
CC   Characteristics: Prolactin-independent; metastatic (PubMed=1988090; PubMed=9639394).
CC   Doubling time: 14 hours (PubMed=1988090).
CC   Breed/subspecies: Nb.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E7IB ! Nb2-PRA
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 5
//
ID   Nb2-Sp
AC   CVCL_G706
SY   Nb2-SP; NB2-Sp
DR   BTO; BTO_0003057
DR   Wikidata; Q54907523
RX   PubMed=1718958;
RX   PubMed=3087389;
RX   PubMed=10214359;
CC   Characteristics: Prolactin-independent (PubMed=3087389).
CC   Characteristics: Tumorigenic (PubMed=10214359).
CC   Breed/subspecies: Nb.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G705 ! Nb2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 9
//
ID   Nb2-U17
AC   CVCL_E7IA
SY   U17
RX   PubMed=1988090;
RX   PubMed=9639394;
RX   PubMed=10214359;
CC   Characteristics: Prolactin-dependent; non-metastatic (PubMed=1988090; PubMed=9639394).
CC   Doubling time: 20 hours (PubMed=1988090).
CC   Karyotypic information: Pseudodiploid karyotype (PubMed=1988090).
CC   Breed/subspecies: Nb.
DI   NCIt; C60448; Rat malignant lymphoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G705 ! Nb2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   NB2a/d1
AC   CVCL_B436
DR   BTO; BTO_0003058
DR   Wikidata; Q54907524
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 9
//
ID   NB3
AC   CVCL_J050
SY   NB-3
DR   CLO; CLO_0007946
DR   AddexBio; C0033003/4949
DR   ATCC; HB-10205
DR   Wikidata; Q54907525
RX   Patent=US5604107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10205.
CC   Doubling time: 34 hours (ATCC=HB-10205).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Discontinued: ATCC; HB-10205; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   NB324K
AC   CVCL_U409
SY   NB-324 K; 324K
DR   Wikidata; Q54907526
RX   PubMed=6602222;
RX   PubMed=9015283;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-556.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1M
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   NB4
AC   CVCL_0005
SY   NB-4; NB.4
DR   BTO; BTO_0002136
DR   CLO; CLO_0007947
DR   EFO; EFO_0002798
DR   MCCL; MCC:0000350
DR   CLDB; cl3643
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 212
DR   BioSample; SAMN03470835
DR   BioSample; SAMN10988571
DR   cancercelllines; CVCL_0005
DR   Cell_Model_Passport; SIDM00428
DR   ChEMBL-Cells; CHEMBL3308423
DR   ChEMBL-Targets; CHEMBL614188
DR   CLS; 300299
DR   Cosmic; 787463
DR   Cosmic; 850391
DR   Cosmic; 922661
DR   Cosmic; 924050
DR   Cosmic; 975285
DR   Cosmic; 981582
DR   Cosmic; 996313
DR   Cosmic; 1012107
DR   Cosmic; 1037664
DR   Cosmic; 1070692
DR   Cosmic; 1078721
DR   Cosmic; 1089522
DR   Cosmic; 1127257
DR   Cosmic; 1181601
DR   Cosmic; 1523826
DR   Cosmic; 1524838
DR   Cosmic; 1601063
DR   Cosmic; 1604862
DR   Cosmic; 1779130
DR   Cosmic; 2036677
DR   Cosmic; 2089653
DR   Cosmic; 2131548
DR   Cosmic; 2306227
DR   Cosmic; 2579202
DR   Cosmic-CLP; 1323913
DR   DepMap; ACH-000294
DR   DSMZ; ACC-207
DR   DSMZCellDive; ACC-207
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS032SIL
DR   ENCODE; ENCBS259AAA
DR   ENCODE; ENCBS390ENC
DR   GDSC; 1323913
DR   GEO; GSM236798
DR   GEO; GSM236834
DR   GEO; GSM472929
DR   GEO; GSM510512
DR   GEO; GSM510513
DR   GEO; GSM749716
DR   GEO; GSM887349
DR   GEO; GSM888426
DR   GEO; GSM945252
DR   GEO; GSM945275
DR   GEO; GSM1022643
DR   GEO; GSM1374696
DR   GEO; GSM1374697
DR   GEO; GSM1446740
DR   GEO; GSM1670151
DR   GEO; GSM7701453
DR   GEO; GSM7701458
DR   IARC_TP53; 21530
DR   IARC_TP53; 21705
DR   LiGeA; CCLE_910
DR   LINCS_LDP; LCL-1084
DR   Lonza; 749
DR   NCBI_Iran; C515
DR   PharmacoDB; NB4_990_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD001610
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0005
DR   PubChem_Cell_line; CVCL_0005
DR   Ubigene; YC-C122
DR   Wikidata; Q54907527
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5589345;
RX   PubMed=1453773;
RX   PubMed=1995093;
RX   PubMed=7630193;
RX   PubMed=9737686;
RX   PubMed=11704857;
RX   PubMed=12353268;
RX   PubMed=14504097;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=16957166;
RX   PubMed=22460905;
RX   PubMed=23325432;
RX   PubMed=23955599;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/NB4_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2030.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1045.
CC   Population: Caucasian.
CC   Doubling time: 36-40 hours (PubMed=1995093); 30 hours (PubMed=25984343); ~35-45 hours (DSMZ=ACC-207).
CC   HLA typing: A*11:01,11:01; B*35:01,40:01; C*03:04,04:01 (PubMed=26589293).
CC   HLA typing: A*11:01:01; B*35:01:01,40:01:02; C*03:04:01,04:01:01; DPB1*01:01:01,04:01:01; DQA1*01:01,03:01:01; DQB1*03:02,05:01:01; DRB1*01:01:01,04:04:01 (CLS=300299).
CC   HLA typing: A*11:01:01,11:01:01; B*35:01:01,40:01:02; C*03:04:01,04:01:01 (DSMZCellDive=ACC-207).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=12353268; PubMed=15843827).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (Cosmic-CLP=1323913; DepMap=ACH-000294).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=1323913).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.99%; Native American=0%; East Asian, North=4.75%; East Asian, South=0%; South Asian=0%; European, North=49.28%; European, South=41.98% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): CLS=300299; Cosmic-CLP=1323913; DSMZ=ACC-207; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 28,33.2
ST   D2S1338: 20,25
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 10,13
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 7,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   NB4-A1
AC   CVCL_VV77
DR   cancercelllines; CVCL_VV77
DR   Wikidata; Q95992295
RX   PubMed=12353268;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=12353268).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   NB4-AsR
AC   CVCL_U080
SY   NB4-dT-AsR1
DR   cancercelllines; CVCL_U080
DR   Wikidata; Q54907528
RX   PubMed=9596679;
RX   PubMed=11704857;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_30621; Diarsenic trioxide (ATO; As2O3).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   NB4-B1
AC   CVCL_VV78
DR   cancercelllines; CVCL_VV78
DR   Wikidata; Q95992298
RX   PubMed=12353268;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=12353268).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   NB4-D5
AC   CVCL_VV79
SY   NB4D5
DR   cancercelllines; CVCL_VV79
DR   Wikidata; Q95992300
RX   PubMed=8839862;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=8839862).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   NB4-DR1
AC   CVCL_U085
SY   NB4-R1
DR   cancercelllines; CVCL_U085
DR   Wikidata; Q54907529
RX   PubMed=9342843;
RX   PubMed=9716606;
RX   PubMed=11704857;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   NB4-DR2
AC   CVCL_U087
SY   NB4-R2
DR   cancercelllines; CVCL_U087
DR   Wikidata; Q54907530
RX   PubMed=9342843;
RX   PubMed=11704857;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U086 ! NB4-S1
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   NB4-DR3
AC   CVCL_U088
SY   NB4-R3
DR   cancercelllines; CVCL_U088
DR   Wikidata; Q54907531
RX   PubMed=9342843;
RX   PubMed=11704857;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U086 ! NB4-S1
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   NB4-LR1
AC   CVCL_8811
SY   NB4-RAr; NB4-R1
DR   BTO; BTO_0006043
DR   cancercelllines; CVCL_8811
DR   Wikidata; Q54907532
RX   PubMed=1453773;
RX   PubMed=7630193;
RX   PubMed=7915840;
RX   PubMed=11704857;
RX   PubMed=36982453;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   NB4-LR2
AC   CVCL_U081
SY   NB4-R2
DR   BTO; BTO_0006044
DR   cancercelllines; CVCL_U081
DR   Wikidata; Q54907533
RX   PubMed=7915840;
RX   PubMed=10673742;
RX   PubMed=11704857;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8811 ! NB4-LR1
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   NB4-MR2
AC   CVCL_VV80
SY   NB4MR2; MR2
DR   EFO; EFO_0022532
DR   cancercelllines; CVCL_VV80
DR   Wikidata; Q95992314
RX   PubMed=8839862;
RX   PubMed=9192750;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=8839862; PubMed=9192750).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Leu398Pro (c.1193T>C); Zygosity=Unspecified; Note=Equivalent to p.Leu890Pro in the PML-RARA fusion protein responsible for retinoic acid resistance (PubMed=9192750).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV79 ! NB4-D5
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 13
//
ID   NB4-MR6
AC   CVCL_VV81
SY   NB4MR6; MR6
DR   cancercelllines; CVCL_VV81
DR   Wikidata; Q95992316
RX   PubMed=8839862;
RX   PubMed=9192750;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=9192750).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV79 ! NB4-D5
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   NB4-R4
AC   CVCL_VV82
SY   NB4R4; R4
DR   cancercelllines; CVCL_VV82
DR   Wikidata; Q95992318
RX   PubMed=8839862;
RX   PubMed=9192750;
RX   PubMed=12353268;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=8839862; PubMed=9192750; PubMed=12353268).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Leu398Pro (c.1193T>C); Zygosity=Unspecified; Note=Equivalent to p.Leu890Pro in the PML-RARA fusion protein (PubMed=9192750).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VV79 ! NB4-D5
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   NB4-S1
AC   CVCL_U086
DR   cancercelllines; CVCL_U086
DR   TOKU-E; 4157
DR   Wikidata; Q54907534
RX   PubMed=9342843;
RX   PubMed=9716606;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   NB4.007/6
AC   CVCL_U083
SY   NB4-007/6; NB4-GR007/6
DR   cancercelllines; CVCL_U083
DR   Wikidata; Q54907536
RX   PubMed=7719237;
RX   PubMed=11704857;
RX   PubMed=12353268;
RX   PubMed=36982453;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=12353268).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   NB4.306
AC   CVCL_U084
SY   NB4-306; NB4-GR306
DR   cancercelllines; CVCL_U084
DR   Wikidata; Q54907537
RX   PubMed=7719237;
RX   PubMed=8395911;
RX   PubMed=11704857;
RX   PubMed=36982453;
CC   Population: Caucasian.
CC   Characteristics: Generated by low-dose irradiation treatment (300 cGy) followed by selective ATRA pressure (PubMed=7719237; PubMed=8395911).
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   NB4.437r
AC   CVCL_U112
SY   NB4-437r; NB4-G-437R
DR   cancercelllines; CVCL_U112
DR   Wikidata; Q54907538
RX   PubMed=10753850;
RX   PubMed=11704857;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88334; AHPN (6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid; CD437).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   NB4/As
AC   CVCL_U082
SY   NB4-N-AsR1
DR   cancercelllines; CVCL_U082
DR   Wikidata; Q54907535
RX   PubMed=11021749;
RX   PubMed=11704857;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_30621; Diarsenic trioxide (ATO; As2O3).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   NB41A3
AC   CVCL_3553
SY   NB4 1A3
DR   CLO; CLO_0007948
DR   CLDB; cl3644
DR   CLDB; cl3645
DR   ATCC; CCL-147
DR   BCRC; 60295
DR   ECACC; 89121405
DR   IZSLER; BS TCL 209
DR   RCB; RCB2626
DR   TKG; TKG 0231
DR   Wikidata; Q54907539
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-and-morphology-of-nb41a3-cells-atcc-ccl-147
CC   Discontinued: RCB; RCB2626; true.
CC   Discontinued: TKG; TKG 0231; true.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   NB4R
AC   CVCL_IY15
DR   cancercelllines; CVCL_IY15
DR   Wikidata; Q54907540
RX   Patent=US5589345;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_15367; All-trans-retinoic acid (ATRA; Tretinoin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   NB5-B2
AC   CVCL_Y276
DR   Wikidata; Q54907541
RX   PubMed=1847391;
RX   PubMed=8093644;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   11M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 5
//
ID   NB56
AC   CVCL_L112
DR   Wikidata; Q54907542
RX   DOI=10.1007/0-306-46872-7_2;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   NB69
AC   CVCL_1448
SY   NB-69; NB_69; NB 69; NB69-RIKEN
DR   BTO; BTO_0005426
DR   CLO; CLO_0050263
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 951
DR   BioSample; SAMN03470996
DR   cancercelllines; CVCL_1448
DR   Cell_Model_Passport; SIDM00244
DR   ChEMBL-Cells; CHEMBL3308799
DR   ChEMBL-Targets; CHEMBL1075510
DR   Cosmic; 688081
DR   Cosmic; 801739
DR   Cosmic; 908440
DR   Cosmic; 920248
DR   Cosmic; 930069
DR   Cosmic; 947709
DR   Cosmic; 1019930
DR   Cosmic; 1037342
DR   Cosmic; 1099139
DR   Cosmic; 1109123
DR   Cosmic; 1153787
DR   Cosmic; 1890119
DR   Cosmic; 2058110
DR   Cosmic; 2131577
DR   Cosmic-CLP; 908440
DR   DepMap; ACH-002083
DR   ECACC; 99072802
DR   EGA; EGAS00001000978
DR   GDSC; 908440
DR   GEO; GSM313807
DR   GEO; GSM563353
DR   GEO; GSM827391
DR   GEO; GSM1670154
DR   GEO; GSM2371245
DR   GEO; GSM2394385
DR   GEO; GSM3145588
DR   GEO; GSM3145725
DR   GEO; GSM4104585
DR   GEO; GSM4104586
DR   GEO; GSM4104632
DR   GEO; GSM4104633
DR   GEO; GSM4104634
DR   GEO; GSM4105323
DR   GEO; GSM4105324
DR   GEO; GSM4105325
DR   GEO; GSM4105326
DR   GEO; GSM4105327
DR   IARC_TP53; 21531
DR   IARC_TP53; 27184
DR   LINCS_LDP; LCL-1999
DR   PharmacoDB; NB69_993_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1448
DR   PubChem_Cell_line; CVCL_1448
DR   RCB; RCB0480
DR   Wikidata; Q54907543
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=16822308;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=23202128;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.26%; East Asian, North=0.67%; East Asian, South=0%; South Asian=0.54%; European, North=64.54%; European, South=34% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=908440; ECACC=99072802; PubMed=25877200; RCB=RCB0480
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 30.2,31.2,32
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13.2,14,15
ST   FGA: 21,25
ST   Penta D: 7,12
ST   Penta E: 10,13
ST   TH01: 8
ST   TPOX: 8,11 (Cosmic-CLP=908440; PubMed=25877200; RCB=RCB0480)
ST   TPOX: 11 (ECACC=99072802)
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   NB76
AC   CVCL_L111
DR   Wikidata; Q54907544
RX   DOI=10.1007/0-306-46872-7_2;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   NB90-4
AC   CVCL_A5PQ
SY   NB 90-4
DR   Wikidata; Q107116512
RX   PubMed=8490657;
RX   PubMed=20655465;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   NB90-6
AC   CVCL_A5PR
SY   NB 90-6
DR   Wikidata; Q107116514
RX   PubMed=8490657;
RX   PubMed=20655465;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   NBCCS-1AW
AC   CVCL_JG79
DR   JCRB; JCRB3021
DR   JCRB; KURB2879
DR   Wikidata; Q54907545
CC   Discontinued: JCRB; KURB2879; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB3021
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 8
//
ID   NBE-3
AC   CVCL_S104
SY   Normal Beagle Embryo-3
DR   ATCC; CRL-6254
DR   Wikidata; Q54907546
RX   PubMed=700899;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6254; true.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 13
//
ID   NBE-4
AC   CVCL_TZ60
SY   NBE-IV; Normal Beagle Embryo-4
DR   ATCC; CRL-6256
DR   Wikidata; Q54907547
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6256; true.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 4
//
ID   NBE-5
AC   CVCL_Y443
SY   Normal Beagle Embryo-5
DR   ATCC; CRL-6255
DR   Wikidata; Q54907548
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6255; true.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 7
//
ID   NBFL
AC   CVCL_F013
DR   ATCC; CRL-3525
DR   Wikidata; Q54907549
RX   PubMed=7708062;
RX   PubMed=8093644;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=NBFL
CC   Characteristics: Responds to a variety of cytokines and growth factors to regulate neuropeptides. It is also easy to transfect (ATCC=CRL-3525).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): ATCC=CRL-3525
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y276 ! NB5-B2
AG   11M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 8
//
ID   NBL-3-11
AC   CVCL_0490
DR   Wikidata; Q54907550
RX   PubMed=8768552;
RX   PubMed=10591122;
RX   PubMed=14989177;
RX   PubMed=14989178;
RX   PubMed=17582998;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
HI   CVCL_0489 ! Pt K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   NBL-3-17
AC   CVCL_0491
DR   Wikidata; Q54907551
RX   PubMed=8768552;
RX   PubMed=14989177;
RX   PubMed=14989178;
RX   PubMed=17582998;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
HI   CVCL_0489 ! Pt K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   NBL-S
AC   CVCL_2136
SY   NBL_S; NBLS
DR   BioSample; SAMN03473469
DR   Cosmic; 848930
DR   Cosmic; 923829
DR   Cosmic; 930070
DR   Cosmic; 1019947
DR   Cosmic; 1109367
DR   Cosmic; 1161997
DR   Cosmic; 1167414
DR   Cosmic; 1526636
DR   DSMZ; ACC-656
DR   DSMZCellDive; ACC-656
DR   GEO; GSM2371248
DR   GEO; GSM2394377
DR   GEO; GSM4104587
DR   GEO; GSM4104588
DR   GEO; GSM4105328
DR   GEO; GSM4105329
DR   GEO; GSM4105330
DR   GEO; GSM4105331
DR   GEO; GSM4105332
DR   IARC_TP53; 23593
DR   Wikidata; Q54907552
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=11550280;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=23202128;
RX   PubMed=28350380;
CC   Doubling time: ~36 hours (DSMZ=ACC-656).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): DSMZ=ACC-656
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 14,17
ST   D19S433: 16
ST   D21S11: 30,33.2
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 21,22
ST   Penta D: 11,12
ST   Penta E: 11,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   NBL-W
AC   CVCL_9899
DR   IARC_TP53; 23830
DR   Wikidata; Q54907553
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=1933896;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   NBL-W N
AC   CVCL_9900
SY   N (W-N)
DR   Wikidata; Q54907557
RX   PubMed=1933896;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9899 ! NBL-W
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NBL-W S
AC   CVCL_9901
SY   N (W-S)
DR   Wikidata; Q54907558
RX   PubMed=1933896;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9899 ! NBL-W
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NBLW
AC   CVCL_VJ90
DR   cancercelllines; CVCL_VJ90
DR   Cosmic; 2668032
DR   Wikidata; Q95992385
RX   PubMed=27888620;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Leu (c.3824G>T); ClinVar=VCV000376365; Zygosity=Heterozygous (PubMed=27888620).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): PubMed=27888620
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 13,14
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ91 ! NBLW-R
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   NBLW-R
AC   CVCL_VJ91
DR   cancercelllines; CVCL_VJ91
DR   Cosmic; 2668033
DR   Wikidata; Q95992387
RX   PubMed=27888620;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=27888620).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=27888620
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 13
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ90 ! NBLW
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   NBN-SHIN
AC   CVCL_E4BV
RX   PubMed=39080217;
CC   Population: Japanese.
CC   Doubling time: ~56 hours (PubMed=39080217).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NBR4-RJK835
AC   CVCL_0F80
SY   NBR4; GM08011
DR   CLO; CLO_0010045
DR   Coriell; GM08011
DR   Wikidata; Q54907559
RX   CelloPub=CLPUB00447;
RX   PubMed=6947270;
RX   PubMed=7027497;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0058 ! HeLa S3
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   NBS-ILB1
AC   CVCL_XF97
SY   NBSILB1; ILB1
DR   Wikidata; Q95992392
RX   PubMed=10377945;
RX   PubMed=11238951;
RX   PubMed=16478990;
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (PubMed=10377945).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   NBsusSR
AC   CVCL_1450
SY   NBSUSSR
DR   CLO; CLO_0050117
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03472240
DR   cancercelllines; CVCL_1450
DR   Cell_Model_Passport; SIDM00002
DR   ChEMBL-Cells; CHEMBL3308847
DR   ChEMBL-Targets; CHEMBL2366150
DR   Cosmic; 925342
DR   Cosmic-CLP; 925342
DR   DepMap; ACH-002340
DR   FANTOM5_SSTAR; 10607-108F4
DR   GDSC; 925342
DR   GEO; GSM1670156
DR   IARC_TP53; 27185
DR   LINCS_LDP; LCL-1998
DR   PharmacoDB; NBsusSR_995_2019
DR   PubChem_Cell_line; CVCL_1450
DR   RCB; RCB0803
DR   Wikidata; Q54907560
RX   PubMed=20164919;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=925342; DepMap=ACH-002340).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.34%; Native American=0%; East Asian, North=75.7%; East Asian, South=20.79%; South Asian=0.62%; European, North=0.87%; European, South=0.68% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=925342; RCB=RCB0803
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NBT-2
AC   CVCL_6545
SY   NBT2
DR   Wikidata; Q54907561
RX   PubMed=439532;
RX   PubMed=3986962;
RX   PubMed=7185004;
CC   Population: Japanese.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   NBT-II
AC   CVCL_0453
SY   Nara Bladder Tumor No. 2; Nara Bladder Tumor II; NBTII
DR   BTO; BTO_0004316
DR   CLO; CLO_0007950
DR   MCCL; MCC:0000351
DR   CLDB; cl3646
DR   ATCC; CRL-1655
DR   ECACC; 93012901
DR   KCLB; 21655
DR   Wikidata; Q54907562
RX   PubMed=639055;
RX   PubMed=3567912;
RX   PubMed=4941696;
RX   PubMed=6480288;
RX   PubMed=9369930;
RX   PubMed=29732388;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-146.html
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   NBT-L1
AC   CVCL_4671
DR   CLO; CLO_0050839
DR   RCB; RCB1371
DR   Wikidata; Q54907563
RX   PubMed=9369930;
CC   Characteristics: Exhibits an elongated shape and moderate to high invasive activity in vitro (PubMed=9369930).
CC   Doubling time: 16.8 hours (PubMed=9369930).
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0453 ! NBT-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   NBT-L2a
AC   CVCL_4672
DR   CLO; CLO_0050840
DR   RCB; RCB1372
DR   Wikidata; Q54907564
RX   PubMed=9369930;
CC   Characteristics: Exhibits an elongated shape and moderate to high invasive activity in vitro (PubMed=9369930).
CC   Doubling time: 15.6 hours (PubMed=9369930).
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0453 ! NBT-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   NBT-L2b
AC   CVCL_4673
DR   CLO; CLO_0050841
DR   RCB; RCB1373
DR   Wikidata; Q54907565
RX   PubMed=9369930;
RX   PubMed=29732388;
CC   Characteristics: Exhibits an elongated shape and moderate to high invasive activity in vitro (PubMed=9369930).
CC   Doubling time: 14.2 hours (PubMed=9369930).
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0453 ! NBT-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   NBT-T1
AC   CVCL_4674
DR   CLO; CLO_0050837
DR   RCB; RCB1369
DR   Wikidata; Q54907566
RX   PubMed=9369930;
CC   Characteristics: Forms tight colonies and exhibited very low or negligible invasive activity (PubMed=9369930).
CC   Doubling time: 13.4 hours (PubMed=9369930).
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0453 ! NBT-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   NBT-T2
AC   CVCL_4675
DR   CLO; CLO_0050838
DR   RCB; RCB1370
DR   Wikidata; Q54907567
RX   PubMed=9369930;
RX   PubMed=29732388;
CC   Characteristics: Forms tight colonies and exhibited very low or negligible invasive activity (PubMed=9369930).
CC   Doubling time: 12.8 hours (PubMed=9369930).
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0453 ! NBT-II
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   NC 14.3.36
AC   CVCL_B437
DR   Wikidata; Q54907568
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 14.3.3G
AC   CVCL_B438
DR   Wikidata; Q54907569
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 14.4.6E
AC   CVCL_B439
SY   NC14.4.6E
DR   BTO; BTO_0002903
DR   Wikidata; Q54907570
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   NC 14.4.8
AC   CVCL_B440
DR   Wikidata; Q54907571
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 14.4.9D
AC   CVCL_B441
DR   Wikidata; Q54907572
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 14.9.1
AC   CVCL_B442
SY   NC14.9.1
DR   BTO; BTO_0002902
DR   Wikidata; Q54907573
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   NC 14.9.10
AC   CVCL_B443
DR   Wikidata; Q54907574
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 14.9.8
AC   CVCL_B444
DR   Wikidata; Q54907575
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 15.2.10H
AC   CVCL_B445
DR   Wikidata; Q54907577
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 15.2.56
AC   CVCL_B446
DR   Wikidata; Q54907578
RX   PubMed=1716303;
CC   Transformant: N-Myc+c-Myc.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NC 65-R
AC   CVCL_T312
SY   NC 65-Round cells
DR   Wikidata; Q54907579
RX   PubMed=291478;
RX   PubMed=711402;
CC   Doubling time: 35 hours (Note=At 36th passage) (PubMed=711402).
CC   Karyotypic information: Has lost chromosome Y (PubMed=291478).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T311 ! NC 65-Sp
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 8
//
ID   NC 65-Sp
AC   CVCL_T311
SY   NC 65-Spindle cells
DR   Wikidata; Q54907581
RX   PubMed=291478;
RX   PubMed=711402;
CC   Doubling time: 28 hours (Note=At 36th passage) (PubMed=711402).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T312 ! NC 65-R
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 8
//
ID   NC-15
AC   CVCL_Z284
DR   ICLDB; nc-15
DR   Wikidata; Q54907582
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
RX   DOI=10.2183/pjab.60.198;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=94400; ! Nephotettix cincticeps (Green rice leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NC-19
AC   CVCL_Z285
DR   ICLDB; nc-19
DR   Wikidata; Q54907583
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
RX   DOI=10.2183/pjab.60.198;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=94400; ! Nephotettix cincticeps (Green rice leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NC-20
AC   CVCL_Z286
DR   ICLDB; nc-20
DR   Wikidata; Q54907584
RX   CelloPub=CLPUB00536;
RX   DOI=10.2183/pjab.60.198;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=94400; ! Nephotettix cincticeps (Green rice leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NC-21
AC   CVCL_Z287
DR   ICLDB; nc-21
DR   Wikidata; Q54907585
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
RX   DOI=10.2183/pjab.60.198;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=94400; ! Nephotettix cincticeps (Green rice leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NC-24
AC   CVCL_Z288
DR   ICLDB; nc-24
DR   Wikidata; Q54907586
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
RX   DOI=10.2183/pjab.60.198;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=94400; ! Nephotettix cincticeps (Green rice leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NC-25
AC   CVCL_Z289
DR   ICLDB; nc-25
DR   NISES; SK0033
DR   Wikidata; Q54907587
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
RX   DOI=10.2183/pjab.60.198;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=94400; ! Nephotettix cincticeps (Green rice leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NC-37
AC   CVCL_3042
SY   NC 37; NC37; Nc37
DR   BTO; BTO_0005495
DR   CLO; CLO_0007952
DR   EFO; EFO_0002247
DR   CLDB; cl3648
DR   CLDB; cl3649
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CCL-214
DR   BEI_Resources; ARP-9936
DR   BioSample; SAMN03151899
DR   BioSample; SAMN03471475
DR   cancercelllines; CVCL_3042
DR   Cell_Model_Passport; SIDM01207
DR   ChEMBL-Cells; CHEMBL3307322
DR   ChEMBL-Targets; CHEMBL614189
DR   Cosmic; 687848
DR   ECACC; 89111414
DR   IGRhCellID; NC37
DR   JCRB; IFO50039
DR   KCLB; 10214
DR   LINCS_LDP; LCL-2057
DR   NCBI_Iran; C501
DR   NCI-DTP; NC-37
DR   Progenetix; CVCL_3042
DR   PubChem_Cell_line; CVCL_3042
DR   RCB; RCB3008
DR   TKG; TKG 0232
DR   Wikidata; Q54907589
RX   PubMed=165156;
RX   PubMed=170370;
RX   PubMed=375235;
RX   PubMed=4321017;
RX   PubMed=4366935;
RX   PubMed=6173755;
RX   PubMed=6401685;
RX   PubMed=6500159;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=29892436;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a Raji derivative (PubMed=20143388). Originally thought to originate from the peripheral blood of a human donor not suffering from a disease.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00330.
CC   Population: African; Nigerian.
CC   Doubling time: ~20 hours (BEI_Resources=ARP-9936).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 89111414; true.
CC   Discontinued: KCLB; 10214; probable.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-214; JCRB=IFO50039; TKG=TKG 0232
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13 (JCRB=IFO50039; TKG=TKG 0232)
ST   D13S317: 13,14 (ATCC=CCL-214)
ST   D16S539: 8,11
ST   D18S51: 15,17
ST   D19S433: 14,14.2
ST   D21S11: 28,31
ST   D2S1338: 22
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,27
ST   Penta D: 3.2,9
ST   Penta E: 5,13
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16 (ATCC=CCL-214)
ST   vWA: 16,19 (JCRB=IFO50039; TKG=TKG 0232)
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 37
//
ID   NC-37/DC-SIGN
AC   CVCL_S547
SY   NC-37 DC-SIGN+
DR   BEI_Resources; ARP-9937
DR   cancercelllines; CVCL_S547
DR   Wikidata; Q54907590
RX   PubMed=14972530;
CC   Problematic cell line: Contaminated. Parent cell line (NC-37) has been shown to be a Raji derivative.
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3042 ! NC-37
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 24
//
ID   NC-HIMT
AC   CVCL_W389
DR   Wikidata; Q54907591
RX   PubMed=15369138;
CC   Population: Japanese.
CC   Doubling time: 94 hours (PubMed=15369138).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8111; Immature ovarian teratoma
DI   ORDO; Orphanet_398987; Malignant teratoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   NC-NC
AC   CVCL_1874
DR   CLO; CLO_0008130
DR   EFO; EFO_0007115
DR   CLDB; cl3650
DR   ArrayExpress; E-MTAB-4527
DR   BioSample; SAMN03473410
DR   DSMZ; ACC-120
DR   DSMZCellDive; ACC-120
DR   ENCODE; ENCBS795ODE
DR   Wikidata; Q54907592
RX   PubMed=1518412;
RX   PubMed=20454443;
CC   Characteristics: Control cell line for toxicity or radiosensitivity assays.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-120).
CC   HLA typing: A*03:02:01,68:01:02; B*07:02:01,51:01:01; C*07:02:01,15:02:01; DPA1*01:03:01,02:01:01; DPB1*10:01:01,04:01:01; DQA1*01:02:01,01:04:01; DQB1*05:03:01,06:02:01; DRA*01:02:02,01:02:03; DRB1*14:54:01,15:01:01 (DSMZCellDive=ACC-120).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-120
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 12,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 18,22
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 11,12
ST   Penta E: 5,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   NC10
AC   CVCL_D3BV
SY   CJD10
DR   Wikidata; Q127382923
RX   PubMed=39332406;
WW   Provider; CReM; 699; https://stemcellbank.bu.edu/Catalog/Item/Details/699
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NC10.1
AC   CVCL_C4T9
DR   ABCD; ABCD_AE499
DR   Wikidata; Q116049871
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC10.10
AC   CVCL_C4TB
DR   ABCD; ABCD_AE501
DR   Wikidata; Q116049872
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC10.11
AC   CVCL_C4TC
DR   ABCD; ABCD_AE505
DR   Wikidata; Q116049873
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC10.12
AC   CVCL_C4TD
DR   ABCD; ABCD_AE504
DR   Wikidata; Q116049874
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC10.14
AC   CVCL_C4T8
DR   ABCD; ABCD_AD837
DR   ABCD; ABCD_AE506
DR   Wikidata; Q116049875
RX   PubMed=8232332;
RX   PubMed=10993728;
CC   Monoclonal antibody isotype: IgG2b, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC10.8
AC   CVCL_C4TA
DR   ABCD; ABCD_AE502
DR   Wikidata; Q116049876
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC11
AC   CVCL_D3BW
SY   CJD11
DR   Wikidata; Q127382924
RX   PubMed=39332406;
WW   Provider; CReM; 700; https://stemcellbank.bu.edu/Catalog/Item/Details/700
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   NC12
AC   CVCL_D3BX
SY   CJD12
DR   Wikidata; Q127382925
RX   PubMed=39332406;
WW   Provider; CReM; 701; https://stemcellbank.bu.edu/Catalog/Item/Details/701
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NC17
AC   CVCL_A0DC
DR   Wikidata; Q108821009
RX   Patent=EP0265847B1;
RX   PubMed=2440025;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04401; Mouse Il5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   NC2.3
AC   CVCL_C4TE
DR   ABCD; ABCD_AE500
DR   Wikidata; Q116049877
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC32
AC   CVCL_D3BY
SY   CJD32
DR   Wikidata; Q127382926
RX   PubMed=39332406;
WW   Provider; CReM; 703; https://stemcellbank.bu.edu/Catalog/Item/Details/703
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Jewish; Libyan.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met129Val (c.385A>G); ClinVar=VCV000013397; Zygosity=Heterozygous (PubMed=39332406).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NC6.7
AC   CVCL_C4TF
DR   ABCD; ABCD_AE498
DR   Wikidata; Q116049878
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NC6.8
AC   CVCL_C4T7
DR   ABCD; ABCD_AD838
DR   ABCD; ABCD_AE503
DR   Wikidata; Q116049879
RX   PubMed=7893280;
RX   PubMed=8232332;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_385425; [N-(4-cyanophenyl)-N'-(diphenylmethyl)guanidine]acetic acid (NC174).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NCAi001-A
AC   CVCL_YC41
DR   BioSamples; SAMEA5782239
DR   hPSCreg; NCAi001-A
DR   Wikidata; Q95992480
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 4
//
ID   NCATS-CL6481
AC   CVCL_B5V4
DR   Wikidata; Q112129403
RX   PubMed=34990619;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W661 ! GM01929
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NCATS-CL6482
AC   CVCL_B5V5
DR   Wikidata; Q112129404
RX   PubMed=34990619;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; Italian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W661 ! GM01929
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NCATS-CL6483
AC   CVCL_B5V6
DR   Wikidata; Q112129405
RX   PubMed=34990619;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W656 ! GM00615
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NCATS-CL6484
AC   CVCL_B5V7
DR   Wikidata; Q112129406
RX   PubMed=34990619;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W656 ! GM00615
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NCATS-CL7568
AC   CVCL_B5TP
DR   Wikidata; Q112129408
RX   PubMed=34411609;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Glu153Lys (c.457G>A); ClinVar=VCV001067431; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0M01 ! GM01426
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   NCATS-CL7569
AC   CVCL_B5TQ
DR   Wikidata; Q112129409
RX   PubMed=34411609;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg626Ter (c.1876C>T); ClinVar=VCV000001561; Zygosity=Homozygous (from parent cell line).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0L90 ! GM00156
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   NCATS-CL9316
AC   CVCL_B5TS
DR   Wikidata; Q112129411
RX   PubMed=33375166;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1L20 ! GM20122
SX   Male
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   NCATS-CL9318
AC   CVCL_B5TT
SY   GM28622; GM28622*B
DR   Coriell; GM28622
DR   Wikidata; Q112129412
RX   PubMed=33375166;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1K47 ! GM00338
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   NCB-20
AC   CVCL_H606
SY   NCB20
DR   TKG; TKG 0727
DR   Wikidata; Q54907593
RX   PubMed=1150088;
RX   PubMed=2537982;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-386.html
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   NCBL1.c5
AC   CVCL_C0P1
DR   Wikidata; Q112930154
RX   PubMed=36009452;
CC   From: Neuronal Circuits and Behavior Lab, Center for Neuroscience and Cell Biology; Coimbra; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   NCBL2.c11
AC   CVCL_C0P2
DR   Wikidata; Q112930155
RX   PubMed=36009452;
CC   From: Neuronal Circuits and Behavior Lab, Center for Neuroscience and Cell Biology; Coimbra; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser301Cysfs*61 (c.900_901dupGT); ClinVar=VCV003031059; Zygosity=Heterozygous (PubMed=36009452).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0P3 ! NCBL2.c46
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NCBL2.c46
AC   CVCL_C0P3
DR   Wikidata; Q112930156
RX   PubMed=36009452;
CC   From: Neuronal Circuits and Behavior Lab, Center for Neuroscience and Cell Biology; Coimbra; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser301Cysfs*61 (c.900_901dupGT); ClinVar=VCV003031059; Zygosity=Heterozygous (PubMed=36009452).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0P2 ! NCBL2.c11
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NCBL3.c2
AC   CVCL_C0P4
DR   Wikidata; Q112930157
RX   PubMed=36009452;
CC   From: Neuronal Circuits and Behavior Lab, Center for Neuroscience and Cell Biology; Coimbra; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser301Cysfs*61 (c.900_901dupGT); ClinVar=VCV003031059; Zygosity=Heterozygous (PubMed=36009452).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0P5 ! NCBL3.c6
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NCBL3.c6
AC   CVCL_C0P5
DR   Wikidata; Q112930158
RX   PubMed=36009452;
CC   From: Neuronal Circuits and Behavior Lab, Center for Neuroscience and Cell Biology; Coimbra; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser301Cysfs*61 (c.900_901dupGT); ClinVar=VCV003031059; Zygosity=Heterozygous (PubMed=36009452).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0P4 ! NCBL3.c2
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NCBL4.c27
AC   CVCL_C0P6
DR   Wikidata; Q112930159
RX   PubMed=36009452;
CC   From: Neuronal Circuits and Behavior Lab, Center for Neuroscience and Cell Biology; Coimbra; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser301Cysfs*61 (c.900_901dupGT); ClinVar=VCV003031059; Zygosity=Heterozygous (PubMed=36009452).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188214; Neuronal ceroid lipofuscinosis type 11
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0P7 ! NCBL4.c33
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   NCBL4.c33
AC   CVCL_C0P7
DR   Wikidata; Q112930160
RX   PubMed=36009452;
CC   From: Neuronal Circuits and Behavior Lab, Center for Neuroscience and Cell Biology; Coimbra; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser301Cysfs*61 (c.900_901dupGT); ClinVar=VCV003031059; Zygosity=Heterozygous (PubMed=36009452).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188214; Neuronal ceroid lipofuscinosis type 11
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0P6 ! NCBL4.c27
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   NCBSi001-A
AC   CVCL_UL57
SY   AD3
DR   hPSCreg; NCBSi001-A
DR   Wikidata; Q95992482
RX   PubMed=30605839;
CC   From: Tata Institute of Fundamental Research, National Centre for Biological Sciences; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Trp165Cys (c.495G>C); ClinVar=VCV000098036; Zygosity=Heterozygous (PubMed=30605839).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30605839
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 8,15
ST   D21S11: 29,30
ST   D5S818: 9,12
ST   D7S820: 8,12
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   NCBSi002-A
AC   CVCL_UL58
SY   AD5
DR   hPSCreg; NCBSi002-A
DR   Wikidata; Q95992483
RX   PubMed=30605839;
CC   From: Tata Institute of Fundamental Research, National Centre for Biological Sciences; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=30605839).
CC   Sequence variation: Mutation; HGNC; HGNC:4140; GAP43; Simple; p.Ser41Gly (c.121A>G) (p.Ser77Gly, c.229A>G); Zygosity=Heterozygous (PubMed=30605839).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30605839
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D21S11: 30.2,31.2
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   NCBSi003-A
AC   CVCL_C1UV
SY   Park14-R741Q-2022
DR   BioSamples; SAMEA112281646
DR   hPSCreg; NCBSi003-A
DR   Wikidata; Q114312456
RX   PubMed=36706537;
CC   From: Tata Institute of Fundamental Research, National Centre for Biological Sciences; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Arg741Gln (c.2222G>A); ClinVar=VCV000006203; Zygosity=Homozygous (PubMed=36706537).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36706537
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D21S11: 29,31.2
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C201519; Parkinson disease 14, autosomal recessive
DI   ORDO; Orphanet_199351; Adult-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   NCBSi004-A
AC   CVCL_C1UW
SY   Park14-control-2022
DR   BioSamples; SAMEA112281645
DR   hPSCreg; NCBSi004-A
DR   Wikidata; Q114312457
RX   PubMed=36706537;
CC   From: Tata Institute of Fundamental Research, National Centre for Biological Sciences; Bangalore; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Arg741Gln (c.2222G>A); ClinVar=VCV000006203; Zygosity=Heterozygous (PubMed=36706537).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36706537
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   NCC-375
AC   CVCL_WW15
DR   Wikidata; Q95992487
RX   PubMed=31228769;
CC   Population: Korean.
CC   Doubling time: 35 hours (PubMed=31228769).
CC   Sequence variation: Gene fusion; HGNC; HGNC:24943; FAM174A + HGNC; HGNC:29435; WWC1; Name(s)=FAM174A-WWC1; Note=In frame (PubMed=31228769).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=31228769
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 13,13.2
ST   D21S11: 32.2,33.2
ST   D2S1338: 17,23
ST   D3S1358: 18
ST   D5S818: 12,17
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   NCC-aRMS1-C1
AC   CVCL_A1ST
DR   Wikidata; Q105510286
RX   PubMed=32715445;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 61 hours (PubMed=32715445).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8621; PAX7; Name(s)=PAX7-FOXO1 (PubMed=32715445).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=32715445
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   NCC-ASPS1-C1
AC   CVCL_ZZ81
DR   Wikidata; Q102114578
RX   PubMed=32648033;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 6 days (PubMed=32648033).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13825; ASPSCR1 + HGNC; HGNC:11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3; Note=ASPCR1 exon 7 fused to TFE3 exon 6 (PubMed=32648033).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=32648033
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D21S11: 29
ST   D5S818: 10
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3750; Alveolar soft part sarcoma
DI   ORDO; Orphanet_163699; Alveolar soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 11
//
ID   NCC-ASPS2-C1
AC   CVCL_E2T7
RX   PubMed=38478355;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 26 hours (PubMed=38478355).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13825; ASPSCR1 + HGNC; HGNC:11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3; Note=ASPCR1 exon 7 fused to TFE3 exon 5 (PubMed=38478355).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Abdominal wall, hypodermis; UBERON=UBERON_0003697+UBERON_0002072.
ST   Source(s): PubMed=38478355
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D21S11: 29,30
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3750; Alveolar soft part sarcoma
DI   ORDO; Orphanet_163699; Alveolar soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   NCC-BD1
AC   CVCL_7883
DR   cancercelllines; CVCL_7883
DR   TKG; TKG 0737
DR   Wikidata; Q54907598
RX   CelloPub=CLPUB00275;
RX   PubMed=20088962;
RX   PubMed=26141945;
RX   PubMed=27833395;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (PubMed=20088962).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Ser (c.457C>T); ClinVar=VCV000422563; Zygosity=Unspecified (PubMed=20088962).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Pro (c.463A>C); Zygosity=Unspecified (PubMed=20088962).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Unspecified (PubMed=20088962).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): TKG=TKG 0737
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,81
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   NCC-BD2
AC   CVCL_7884
DR   TKG; TKG 0738
DR   Wikidata; Q54907599
RX   CelloPub=CLPUB00275;
RX   PubMed=20088962;
RX   PubMed=26141945;
RX   PubMed=27833395;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=20088962).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NCC-BD3
AC   CVCL_A8DN
DR   TKG; TKG 0739
DR   Wikidata; Q107116515
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   NCC-BD4-1
AC   CVCL_A8DP
DR   TKG; TKG 0741
DR   Wikidata; Q107116517
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): TKG=TKG 0741
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8DQ ! NCC-BD4-2
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   NCC-BD4-2
AC   CVCL_A8DQ
DR   Wikidata; Q107116519
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8DP ! NCC-BD4-1
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NCC-c-CX-1
AC   CVCL_IM30
SY   CX-1
DR   Wikidata; Q54907603
RX   PubMed=1721614;
CC   Population: Japanese.
CC   Characteristics: There are about 16 copies of MYC in this cell line.
CC   Virology: Contains 50-100 copies of the HPV18 genome.
CC   Doubling time: 21.8 hours (PubMed=1721614).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI   NCIt; C9039; Cervical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   NCC-CAD-299
AC   CVCL_A6WZ
DR   Wikidata; Q107116521
RX   PubMed=2702654;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22223; Human CDH3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   NCC-CC1
AC   CVCL_7885
DR   cancercelllines; CVCL_7885
DR   TKG; TKG 0742
DR   Wikidata; Q54907604
RX   CelloPub=CLPUB00275;
RX   PubMed=20088962;
RX   PubMed=26141945;
RX   PubMed=27833395;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=20088962).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=20088962).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   NCC-CC3-1
AC   CVCL_7886
DR   cancercelllines; CVCL_7886
DR   TKG; TKG 0743
DR   Wikidata; Q54907605
RX   CelloPub=CLPUB00275;
RX   PubMed=20088962;
RX   PubMed=26141945;
RX   PubMed=27833395;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20088962).
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7887 ! NCC-CC3-2
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NCC-CC3-2
AC   CVCL_7887
DR   cancercelllines; CVCL_7887
DR   TKG; TKG 0744
DR   Wikidata; Q54907606
RX   CelloPub=CLPUB00275;
RX   PubMed=20088962;
RX   PubMed=26141945;
RX   PubMed=27833395;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20088962).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7886 ! NCC-CC3-1
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   NCC-CC4-1
AC   CVCL_7888
DR   TKG; TKG 0745
DR   Wikidata; Q54907607
RX   CelloPub=CLPUB00275;
RX   PubMed=20088962;
RX   PubMed=26141945;
RX   PubMed=27833395;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): TKG=TKG 0745
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8DR ! NCC-CC4-2
OI   CVCL_A8DS ! NCC-CC4-3
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   NCC-CC4-2
AC   CVCL_A8DR
DR   TKG; TKG 0746
DR   Wikidata; Q107116523
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): TKG=TKG 0746
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7888 ! NCC-CC4-1
OI   CVCL_A8DS ! NCC-CC4-3
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   NCC-CC4-3
AC   CVCL_A8DS
SY   NCC-CC5
DR   TKG; TKG 0747
DR   Wikidata; Q107116525
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): TKG=TKG 0747
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 10,13
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7888 ! NCC-CC4-1
OI   CVCL_A8DR ! NCC-CC4-2
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   NCC-CC6-1
AC   CVCL_A8DT
DR   TKG; TKG 0748
DR   Wikidata; Q107116526
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): TKG=TKG 0748
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,13
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8DU ! NCC-CC6-2
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   NCC-CC6-2
AC   CVCL_A8DU
DR   TKG; TKG 0749
DR   Wikidata; Q107116528
RX   PubMed=26141945;
RX   PubMed=27833395;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): TKG=TKG 0749
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,13
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8DT ! NCC-CC6-1
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   NCC-CCS1-X4-C1
AC   CVCL_B3TR
SY   NCCCCS1X4C1
DR   DepMap; ACH-002793
DR   EGA; EGAD00001008611
DR   Wikidata; Q110433080
RX   PubMed=29197033;
RX   PubMed=36959380;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a fourth generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 17 hours (PubMed=29197033).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=29197033).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=29197033; PubMed=36959380
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16,19
ST   D21S11: 30,31 (PubMed=29197033)
ST   D21S11: 31 (PubMed=36959380)
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 12,19
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TS ! NCC-CCS1B-C1
OI   CVCL_B3TT ! NCC-CCS1B-X2-C1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-CCS1B-C1
AC   CVCL_B3TS
SY   NCCCCS1BC1
DR   DepMap; ACH-002792
DR   EGA; EGAD00001008611
DR   Wikidata; Q110433081
RX   PubMed=29197033;
RX   PubMed=36959380;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 20 hours (PubMed=29197033).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=29197033).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=29197033; PubMed=36959380
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16,19
ST   D21S11: 30,31
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 12,19
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TR ! NCC-CCS1-X4-C1
OI   CVCL_B3TT ! NCC-CCS1B-X2-C1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-CCS1B-X2-C1
AC   CVCL_B3TT
SY   NCCCCS1BX2C1
DR   DepMap; ACH-002791
DR   EGA; EGAD00001008611
DR   Wikidata; Q110433082
RX   PubMed=29197033;
RX   PubMed=36959380;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a second generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 20 hours (PubMed=29197033).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=29197033).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=29197033; PubMed=36959380
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16,19
ST   D21S11: 30,31
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 12,19
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TR ! NCC-CCS1-X4-C1
OI   CVCL_B3TS ! NCC-CCS1B-C1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-CDS1-X1-C1
AC   CVCL_YL54
SY   NCCCDS1X1C1
DR   DepMap; ACH-002795
DR   Wikidata; Q95992505
RX   PubMed=28680140;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a first generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~40 hours (PubMed=28680140).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14214; CIC + HGNC; HGNC:50800; DUX4; Name(s)=CIC-DUX4 (PubMed=28680140).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
ST   Source(s): PubMed=28680140
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D21S11: 30
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C165663; CIC-DUX4 sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YL55 ! NCC-CDS1-X3-C1
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 12
//
ID   NCC-CDS1-X3-C1
AC   CVCL_YL55
SY   NCCCDS1X3C1
DR   DepMap; ACH-002796
DR   Wikidata; Q95992507
RX   PubMed=28680140;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~30 hours (PubMed=28680140).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14214; CIC + HGNC; HGNC:50800; DUX4; Name(s)=CIC-DUX4 (PubMed=28680140).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
ST   Source(s): PubMed=28680140
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D21S11: 30
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C165663; CIC-DUX4 sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YL54 ! NCC-CDS1-X1-C1
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 12
//
ID   NCC-CDS2-C1
AC   CVCL_YL70
DR   Wikidata; Q95992508
RX   PubMed=31898195;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~28 hours (PubMed=31898195).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14214; CIC + HGNC; HGNC:50800; DUX4; Name(s)=CIC-DUX4 (PubMed=31898195).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=31898195
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D21S11: 29,30
ST   D5S818: 8,11
ST   D7S820: 8,9
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C165663; CIC-DUX4 sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 12
//
ID   NCC-CoC-K115B
AC   CVCL_8321
DR   JCRB; JCRB1339
DR   JCRB; NIHS0510
DR   Wikidata; Q54907608
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; NIHS0510; true.
ST   Source(s): JCRB=JCRB1339
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 10,13
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8320 ! NCC-CoC-K115L
OI   CVCL_8319 ! NCC-CoC-K115P
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   NCC-CoC-K115L
AC   CVCL_8320
DR   JCRB; JCRB1333
DR   JCRB; NIHS0509
DR   Wikidata; Q54907609
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0509; true.
CC   Derived from site: Metastatic; Peripheral lymph node; UBERON=UBERON_0003968.
ST   Source(s): JCRB=JCRB1333
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8321 ! NCC-CoC-K115B
OI   CVCL_8319 ! NCC-CoC-K115P
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   NCC-CoC-K115P
AC   CVCL_8319
DR   JCRB; JCRB1320
DR   JCRB; NIHS0508
DR   Wikidata; Q54907610
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0508; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): JCRB=JCRB1320
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8321 ! NCC-CoC-K115B
OI   CVCL_8320 ! NCC-CoC-K115L
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   NCC-cOV1-C1
AC   CVCL_A0GE
DR   Wikidata; Q108821010
RX   DOI=10.2198/jelectroph.65.23;
CC   Population: Japanese.
CC   Doubling time: 40 hours (DOI=10.2198/jelectroph.65.23).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DOI=10.2198/jelectroph.65.23
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 9
ST   D21S11: 30,32
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   NCC-CS1-C1
AC   CVCL_E6MD
RX   PubMed=39645627;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 31 hours (PubMed=39645627).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Ser (c.394C>A); ClinVar=VCV000375893; Zygosity=Unspecified (PubMed=39645627).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
ST   Source(s): PubMed=39645627
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D21S11: 29
ST   D5S818: 8
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C121871; Chondrosarcoma, grade 3
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCC-dCS1-C1
AC   CVCL_UZ21
SY   NCCDCS1C1
DR   DepMap; ACH-002781
DR   Wikidata; Q95992514
RX   PubMed=30737713;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 29 hours (PubMed=30737713).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=30737713).
CC   Sequence variation: Gene deletion; HGNC; HGNC:2348; CREBBP; Zygosity=Homozygous (PubMed=30737713).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
ST   Source(s): PubMed=30737713
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 10
ST   D21S11: 31
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 15
//
ID   NCC-DDLPS1-C1
AC   CVCL_A1BV
DR   Wikidata; Q102114579
RX   PubMed=32949334;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~50 hours (PubMed=32949334).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): PubMed=32949334
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 9,13
ST   D21S11: 32.2
ST   D5S818: 12
ST   D7S820: 9,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 9
//
ID   NCC-DDLPS2-C1
AC   CVCL_A5IJ
DR   Wikidata; Q107116529
RX   PubMed=33555519;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~54 hours (PubMed=33555519).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=33555519
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 9
ST   D21S11: 28,30
ST   D5S818: 13,14
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 8,13
ST   vWA: 17,19
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-DDLPS3-C1
AC   CVCL_A6FB
DR   Wikidata; Q107116530
RX   PubMed=33677797;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~47 hours (PubMed=33677797).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=33677797
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D21S11: 30,33.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-DDLPS4-C1
AC   CVCL_B3TQ
DR   Wikidata; Q110433083
RX   PubMed=34834427;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 72.5 hours (PubMed=34834427).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): PubMed=34834427
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 8
//
ID   NCC-DDLPS5-C1
AC   CVCL_B7EM
DR   Wikidata; Q112930161
RX   PubMed=35292923;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 47 hours (PubMed=35292923).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Inguinal fat pad; UBERON=UBERON_0010410.
ST   Source(s): PubMed=35292923
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D21S11: 32,32.2
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   NCC-DDLPS6-C1
AC   CVCL_C1GH
DR   Wikidata; Q114312458
RX   PubMed=35604485;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 47 hours (PubMed=35604485).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right leg; UBERON=UBERON_0000978.
ST   Source(s): PubMed=35604485
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D21S11: 31.2,32.2
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 8
//
ID   NCC-DFSP1-C1
AC   CVCL_UR53
SY   NCCDFSP1C1
DR   DepMap; ACH-002797
DR   Wikidata; Q95992515
RX   PubMed=30411273;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 48 hours (PubMed=30411273).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2197; COL1A1 + HGNC; HGNC:8800; PDGFB; Name(s)=COL1A1-PDGFB (PubMed=30411273).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
ST   Source(s): PubMed=30411273
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D21S11: 29,31
ST   D5S818: 8,10
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 14
//
ID   NCC-DFSP2-C1
AC   CVCL_UR54
SY   NCCDFSP2C1
DR   DepMap; ACH-002798
DR   Wikidata; Q95992516
RX   PubMed=30411273;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 44 hours (PubMed=30411273).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2197; COL1A1 + HGNC; HGNC:8800; PDGFB; Name(s)=COL1A1-PDGFB (PubMed=30411273).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=30411273
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D21S11: 30,32
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 15
//
ID   NCC-DFSP3-C1
AC   CVCL_ZE79
DR   Wikidata; Q98127433
RX   PubMed=32356243;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~28 hours (PubMed=32356243).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2197; COL1A1 + HGNC; HGNC:8800; PDGFB; Name(s)=COL1A1-PDGFB (PubMed=32356243).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=32356243
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D21S11: 29,30
ST   D5S818: 10,11
ST   D7S820: 13,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 12
//
ID   NCC-DFSP4-C1
AC   CVCL_D1GH
DR   Wikidata; Q127382927
RX   PubMed=37490236;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 39 hours (Note=At 22th passage) (PubMed=37490236).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Left ilium, hypodermis; UBERON=UBERON_0001273+UBERON_0002072.
ST   Source(s): PubMed=37490236
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   NCC-DFSP5-C1
AC   CVCL_D4ZK
DR   Wikidata; Q127382928
RX   PubMed=38372888;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 35 hours (PubMed=38372888).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2197; COL1A1 + HGNC; HGNC:8800; PDGFB; Name(s)=COL1A1-PDGFB; Note=COL1A1 exon 43 fused to PDGFB exon 2 (PubMed=38372888).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Back, hypodermis; UBERON=UBERON_0001137+UBERON_0002072.
ST   Source(s): PubMed=38372888
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D21S11: 30,31
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C4683; Dermatofibrosarcoma protuberans
DI   ORDO; Orphanet_31112; Dermatofibrosarcoma protuberans
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   NCC-DMM1-C1
AC   CVCL_B5PV
DR   GEO; GSM5606630
DR   GEO; GSM5606631
DR   GEO; GSM5618185
DR   Wikidata; Q112129413
RX   PubMed=35069873;
CC   Population: Japanese.
CC   Doubling time: 25.9 hours (PubMed=35069873).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=35069873
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 29,32.2
ST   D5S818: 9,11
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C45664; Pleural desmoplastic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   NCC-DSM1-C1
AC   CVCL_C7G0
DR   Wikidata; Q117704720
RX   PubMed=36629983;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 39 hours (PubMed=36629983).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr41Ala (c.121A>G); ClinVar=VCV000017580; Zygosity=Heterozygous (PubMed=36629983).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=36629983
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D21S11: 29,32
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C9182; Desmoid fibromatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 6
//
ID   NCC-EC-1
AC   CVCL_8316
DR   Wikidata; Q54907611
RX   PubMed=2842544;
CC   Population: Japanese.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NCC-EC-2
AC   CVCL_8317
DR   Wikidata; Q54907612
RX   PubMed=2842544;
CC   Population: Japanese.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NCC-EC-3
AC   CVCL_8318
DR   Wikidata; Q54907613
RX   PubMed=2842544;
CC   Population: Japanese.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NCC-ES1-C1
AC   CVCL_UK81
SY   NCCES1C1
DR   DepMap; ACH-002780
DR   Wikidata; Q95992526
RX   PubMed=30324244;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 33 hours (PubMed=30324244).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=EWSR1 exon 7 fused to FLI1 exon 8 (PubMed=30324244).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, left tibia; UBERON=UBERON_0000979.
ST   Source(s): PubMed=30324244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D21S11: 28,31
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 17
//
ID   NCC-ES2-C1
AC   CVCL_B7PH
DR   Wikidata; Q112930162
RX   PubMed=35441357;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~159 hours (PubMed=35441357).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=EWSR1 exon 7 fused to FLI1 exon 8 (PubMed=35441357).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=35441357
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 10
ST   D21S11: 28,30
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   NCC-ESOS1-C1
AC   CVCL_YD21
DR   cancercelllines; CVCL_YD21
DR   Wikidata; Q95992527
RX   DOI=10.2198/jelectroph.65.1;
RX   PubMed=31625124;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Exhibits invasion capability (PubMed=31625124).
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~40 hours (PubMed=31625124); ~24 hours (DOI=10.2198/jelectroph.65.1).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=31625124).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: Metastatic; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
ST   Source(s): PubMed=31625124
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 9,10
ST   D21S11: 29,32
ST   D5S818: 11,12,13
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C8810; Extraskeletal osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 14
//
ID   NCC-GCTB1-C1
AC   CVCL_A9QC
DR   Wikidata; Q102114580
RX   PubMed=32815117;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 13 hours (PubMed=32815117).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=32815117).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right distal radius; UBERON=UBERON_0004407.
ST   Source(s): PubMed=32815117
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 29,32.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 11
//
ID   NCC-GCTB10-C1
AC   CVCL_E6MF
RX   PubMed=39653987;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~41.7 hours (PubMed=39653987).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=39653987).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): PubMed=39653987
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,14
ST   D21S11: 30,31.2
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCC-GCTB14-C1
AC   CVCL_E6MP
RX   PubMed=39604602;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 29 hours (PubMed=39604602).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=39604602).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, left femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=39604602
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 9,11
ST   D21S11: 31,32.2
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCC-GCTB15-C1
AC   CVCL_E6MQ
RX   PubMed=39604602;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 38 hours (PubMed=39604602).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=39604602).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=39604602
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D21S11: 29,31.2
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCC-GCTB2-C1
AC   CVCL_A0SR
DR   Wikidata; Q108821011
RX   PubMed=34304386;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 64 hours (PubMed=34304386).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34304386).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): PubMed=34304386
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,13
ST   D21S11: 29,30
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-GCTB3-C1
AC   CVCL_A0SS
DR   Wikidata; Q108821012
RX   PubMed=34304386;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 26 hours (PubMed=34304386).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34304386).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): PubMed=34304386
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 9
ST   D21S11: 30
ST   D5S818: 10,14
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-GCTB4-C1
AC   CVCL_B3VJ
DR   Wikidata; Q110433084
RX   PubMed=34731453;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 65.78 hours (PubMed=34731453).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34731453).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, left proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): PubMed=34731453
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D21S11: 28.2,30
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-GCTB5-C1
AC   CVCL_C1GF
DR   Wikidata; Q114312459
RX   PubMed=35653034;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 32 hours (PubMed=35653034).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=35653034).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): PubMed=35653034
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 11,13
ST   D21S11: 31.2
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,16,17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   NCC-GCTB6-C1
AC   CVCL_C2WT
DR   Wikidata; Q123033141
RX   PubMed=37328637;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 21 hours (PubMed=37328637).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=37328637).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): PubMed=37328637
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10
ST   D16S539: 9,10
ST   D21S11: 30,31.2
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   NCC-GCTB7-C1
AC   CVCL_C2WX
DR   Wikidata; Q123033142
RX   PubMed=37328637;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 28 hours (PubMed=37328637).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=37328637).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: Metastatic; Bone, left distal radius; UBERON=UBERON_0004407.
ST   Source(s): PubMed=37328637
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,13
ST   D21S11: 29,31
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   NCC-GCTB8-C1
AC   CVCL_D4C0
DR   Wikidata; Q127382929
RX   PubMed=38466561;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 26 hours (PubMed=38466561).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=38466561).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, right proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): PubMed=38466561
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D21S11: 31,32.2
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   NCC-GCTB9-C1
AC   CVCL_D4C1
DR   Wikidata; Q127382930
RX   PubMed=38466561;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Can be grown as spheroids (PubMed=38466561).
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 12 hours (PubMed=38466561).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=38466561).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, distal tibia; UBERON=UBERON_0004405.
ST   Source(s): PubMed=38466561
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 32
ST   D5S818: 9,13
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   NCC-IT
AC   CVCL_1451
SY   NCCIT
DR   BTO; BTO_0004180
DR   CLO; CLO_0007955
DR   EFO; EFO_0022438
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-2073
DR   BCRC; 60314
DR   BCRJ; 0369
DR   BioSample; SAMN03471433
DR   cancercelllines; CVCL_1451
DR   CCRID; 3101HUMTCHu238
DR   Cell_Model_Passport; SIDM00655
DR   ChEMBL-Cells; CHEMBL3308379
DR   ChEMBL-Targets; CHEMBL1075511
DR   CLS; 305080
DR   Cosmic; 687051
DR   Cosmic; 908441
DR   Cosmic; 1090412
DR   Cosmic; 2077186
DR   Cosmic; 2163758
DR   Cosmic; 2807074
DR   Cosmic-CLP; 908441
DR   DepMap; ACH-001578
DR   GEO; GSM1670159
DR   IARC_TP53; 21532
DR   NCBI_Iran; C624
DR   PharmacoDB; NCCIT_999_2019
DR   PRIDE; PXD030251
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1451
DR   Wikidata; Q17578676
RX   PubMed=2842544;
RX   PubMed=9331070;
RX   PubMed=20164919;
RX   PubMed=24812411;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31500094;
RX   PubMed=35084545;
RX   PubMed=35839778;
WW   Info; Wikipedia; -; https://de.wikipedia.org/wiki/NCC-IT
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Lys309Asn (c.927G>C); Zygosity=Unspecified (PubMed=9331070).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Pro (c.518G>C); ClinVar=VCV000185195; Zygosity=Heterozygous (Cosmic-CLP=908441; DepMap=ACH-001578).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Cysfs*73 (c.814delG); Zygosity=Homozygous (Cosmic-CLP=908441; DepMap=ACH-001578).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.79%; East Asian, South=18.2%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Misspelling: NCC15; Cosmic=2163758; PubMed=24812411.
ST   Source(s): ATCC=CRL-2073; DepMap=ACH-001578; Cosmic-CLP=908441
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 29,32.2
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 10,15
ST   FGA: 22,26
ST   Penta D: 10,12
ST   Penta E: 5,14
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   NCC-IT-A3
AC   CVCL_3045
SY   NCCIT-A3
DR   CLO; CLO_0037149
DR   cancercelllines; CVCL_3045
DR   FANTOM5_SSTAR; 10790-110H7
DR   JCRB; FDSC0052
DR   JCRB; JCRB1005
DR   LINCS_LDP; LCL-1903
DR   Wikidata; Q54907614
CC   Population: Japanese.
CC   Doubling time: 27 hours (Note=Lot 01192004) (JCRB=JCRB1005).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Lys309Asn (c.927G>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Pro (c.518G>C); ClinVar=VCV000185195; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Cysfs*73 (c.814delG); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; FDSC0052; true.
ST   Source(s): JCRB=JCRB1005
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1451 ! NCC-IT
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   NCC-KT
AC   CVCL_GS47
DR   Wikidata; Q54907615
RX   PubMed=15160996;
CC   From: Hamanaka, Yuichiro; Yamaguchi University School of Medicine; Ube; Japan.
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 6
//
ID   NCC-LGFMS1-C1
AC   CVCL_B0W9
DR   Wikidata; Q108821013
RX   PubMed=34535876;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~149.9 hours (PubMed=34535876).
CC   Sequence variation: Gene fusion; HGNC; HGNC:23720; CREB3L2 + HGNC; HGNC:4010; FUS; Name(s)=FUS-CREB3L2 (PubMed=34535876).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Rectus abdominis muscle; UBERON=UBERON_0002382.
ST   Source(s): PubMed=34535876
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D21S11: 29,33.2
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C45202; Low grade fibromyxoid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-LMS1-C1
AC   CVCL_LK56
SY   NCCLMS1C1
DR   DepMap; ACH-002785
DR   Wikidata; Q54907616
RX   PubMed=28981730;
RX   PubMed=29845452;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 88 hours (PubMed=29845452).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Bone, rib; UBERON=UBERON_0002228.
ST   Source(s): PubMed=28981730
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 9
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C7154; Bone leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM07 ! NCC-LMS1-X3-C1
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 11
//
ID   NCC-LMS1-X3-C1
AC   CVCL_VM07
SY   NCCLMS1X3C1
DR   DepMap; ACH-002786
DR   Wikidata; Q95992532
RX   PubMed=29845452;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft established by subcutaneous injection in female SCID mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 57 hours (PubMed=29845452).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Bone, rib; UBERON=UBERON_0002228.
ST   Source(s): PubMed=29845452
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 9
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C7154; Bone leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LK56 ! NCC-LMS1-C1
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 10
//
ID   NCC-LMS2-C1
AC   CVCL_A4EE
DR   Wikidata; Q105510289
RX   PubMed=33001379;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 46 hours (PubMed=33001379).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: Metastatic; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=33001379
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 9
ST   D21S11: 29
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-LMS3-C1
AC   CVCL_D4A9
DR   Wikidata; Q127382931
RX   PubMed=37907774;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 19 hours (PubMed=37907774).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=37907774
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D21S11: 30
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 5,6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   NCC-MFS1-C1
AC   CVCL_VT41
SY   NCCMFS1C1
DR   DepMap; ACH-002794
DR   Wikidata; Q95992533
RX   PubMed=30737712;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 78 hours (PubMed=30737712).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
ST   Source(s): PubMed=30737712
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 11
//
ID   NCC-MFS2-C1
AC   CVCL_A2EI
DR   Wikidata; Q105510292
RX   PubMed=32870449;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 13 hours (PubMed=32870449).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=32870449
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-MFS3-C1
AC   CVCL_B3RM
DR   Wikidata; Q110433085
RX   PubMed=33990915;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~36 hours (PubMed=33990915).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=33990915).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (PubMed=33990915).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=33990915
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 12,13
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-MFS4-C1
AC   CVCL_B3RL
DR   Wikidata; Q110433086
RX   PubMed=34383271;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~64 hours (PubMed=34383271).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=34383271).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (PubMed=34383271).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lower leg, hypodermis; UBERON=UBERON_0003823+UBERON_0002072.
ST   Source(s): PubMed=34383271
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8
ST   D16S539: 10
ST   D21S11: 29,32.2
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-MFS5-C1
AC   CVCL_B5YX
DR   Wikidata; Q112129415
RX   PubMed=35053323;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 91.7 hours (PubMed=35053323).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35053323).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=35053323).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=35053323).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Right elbow, hypodermis; UBERON=UBERON_0001461+UBERON_0002072.
ST   Source(s): PubMed=35053323
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D21S11: 30,32
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 9
//
ID   NCC-MFS6-C1
AC   CVCL_D4AD
DR   Wikidata; Q127382932
RX   PubMed=35947340;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 114 hours (PubMed=35947340).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thoracic wall; UBERON=UBERON_0016403.
ST   Source(s): PubMed=35947340
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   NCC-MFS7-C1
AC   CVCL_E4BL
RX   PubMed=39214957;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 29 hours (PubMed=39214957).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=39214957).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thoracic wall; UBERON=UBERON_0016403.
ST   Source(s): PubMed=39214957
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NCC-MFS8-C1
AC   CVCL_E4BM
RX   PubMed=39214957;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 68 hours (PubMed=39214957).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=39214957).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=39214957).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Right leg; UBERON=UBERON_0000978.
ST   Source(s): PubMed=39214957
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D21S11: 29,30
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NCC-MLPS1-C1
AC   CVCL_A1VS
DR   Wikidata; Q105510296
RX   PubMed=33146842;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 98 hours (PubMed=33146842).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=33146842).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=33146842
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,14
ST   D16S539: 9,10
ST   D21S11: 30,32.2
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 10
//
ID   NCC-MLPS2-C1
AC   CVCL_C1GI
DR   Wikidata; Q114312460
RX   PubMed=35637403;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 59 hours (PubMed=35637403).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=35637403).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=35637403
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 8
ST   D16S539: 10,11
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 9
//
ID   NCC-MLPS3-C1
AC   CVCL_C1GJ
DR   Wikidata; Q114312461
RX   PubMed=35637403;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 55 hours (PubMed=35637403).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=35637403).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=35637403
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D21S11: 30,33.2
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   NCC-MPNST1-C1
AC   CVCL_YU12
SY   NCCMPNST1C1
DR   cancercelllines; CVCL_YU12
DR   DepMap; ACH-002799
DR   Wikidata; Q95992534
RX   PubMed=32099531;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 28 hours (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12362; TSC1; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1872Ter (c.5614A>T); ClinVar=VCV000037979; Zygosity=Heterozygous (PubMed=32099531).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32099531
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D21S11: 30,31
ST   D5S818: 7,13
ST   D7S820: 10.3,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 13
//
ID   NCC-MPNST2-C1
AC   CVCL_YU13
SY   NCCMPNST2C1
DR   DepMap; ACH-002800
DR   Wikidata; Q95992535
RX   PubMed=32099531;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 49 hours (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu179Tyrfs*11 (c.536_539del); Zygosity=Unspecified (PubMed=32099531).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32099531
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9,11
ST   D21S11: 31.2
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 11
//
ID   NCC-MPNST3-C1
AC   CVCL_YU14
SY   NCCMPNST3C1
DR   cancercelllines; CVCL_YU14
DR   DepMap; ACH-002801
DR   Wikidata; Q95992536
RX   PubMed=32099531;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 70 hours (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:3942; MTOR; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg816Ter (c.2446C>T); ClinVar=VCV000280055; Zygosity=Heterozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=32099531).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32099531
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YU15 ! NCC-MPNST3-X2-C1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 13
//
ID   NCC-MPNST3-X2-C1
AC   CVCL_YU15
SY   NCCMPNST3X2C1
DR   cancercelllines; CVCL_YU15
DR   DepMap; ACH-002802
DR   Wikidata; Q95992537
RX   PubMed=32099531;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a second generation xenograft established by subcutaneous grafting of tumor tissue into the bilateral hind flanks of female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 64 hours (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg816Ter (c.2446C>T); ClinVar=VCV000280055; Zygosity=Heterozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Trp (c.405C>G); ClinVar=VCV000376561; Zygosity=Heterozygous (PubMed=32099531).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32099531
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YU14 ! NCC-MPNST3-C1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 13
//
ID   NCC-MPNST4-C1
AC   CVCL_YU16
SY   NCCMPNST4C1
DR   cancercelllines; CVCL_YU16
DR   DepMap; ACH-002803
DR   Wikidata; Q95992538
RX   PubMed=32099531;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 70 hours (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:646; ARAF; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12637; KDM6A; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.5812+3delAGTA; Zygosity=Heterozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Homozygous (PubMed=32099531).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32099531
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 13
//
ID   NCC-MPNST5-C1
AC   CVCL_YU17
SY   NCCMPNST5C1
DR   cancercelllines; CVCL_YU17
DR   DepMap; ACH-002804
DR   Wikidata; Q95992539
RX   PubMed=32099531;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 33 hours (PubMed=32099531).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=32099531).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Thr586Valfs*18 (c.1756_1759delACTA) (1756delACTA); ClinVar=VCV000186215; Zygosity=Heterozygous (PubMed=32099531).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32099531
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D21S11: 31,33.2
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 13
//
ID   NCC-MPNST6-C1
AC   CVCL_B4H4
DR   Wikidata; Q110433087
RX   PubMed=34775549;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~75 hours (PubMed=34775549).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=34775549
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 12
ST   D21S11: 31
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 8
//
ID   NCC-MRT1-C1
AC   CVCL_C4MW
DR   Wikidata; Q116049880
RX   PubMed=35927606;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 30 hours (PubMed=35927606).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=35927606).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=35927606
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D21S11: 31.2,33.2
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   NCC-OS1-X2-C1
AC   CVCL_VM08
SY   NCC-OS1-C1; NCCOS1X2C1
DR   cancercelllines; CVCL_VM08
DR   DepMap; ACH-002778
DR   Wikidata; Q95992540
RX   DOI=10.2198/jelectroph.65.1;
RX   PubMed=29943355;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a second generation xenograft established by subcutaneous injection in female SCID mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 29 hours (PubMed=29943355).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His66Arg (c.197A>G) (p.Pro80Pro, c.240A>G); ClinVar=VCV000246117; Zygosity=Unspecified (DOI=10.2198/jelectroph.65.1).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
ST   Source(s): PubMed=29943355
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 14
//
ID   NCC-OvC-K119
AC   CVCL_3046
DR   BioSample; SAMN03472397
DR   JCRB; JCRB1308
DR   JCRB; NIHS0507
DR   RCB; RCB2223
DR   Wikidata; Q54907617
CC   Population: Japanese.
CC   Misspelling: NCC-OvC-K1119; RCB=RCB2223; Note=In old versions.
CC   Discontinued: JCRB; NIHS0507; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): JCRB=JCRB1308
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCC-PLPS1-C1
AC   CVCL_A2BR
DR   Wikidata; Q105510300
RX   PubMed=33205363;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 11 hours (PubMed=33205363).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
ST   Source(s): PubMed=33205363
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 10
ST   D21S11: 29,30
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3705; Pleomorphic liposarcoma
DI   ORDO; Orphanet_99969; Pleomorphic liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-PLPS2-C1
AC   CVCL_C5Z1
DR   Wikidata; Q116049881
RX   PubMed=36436139;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 24 hours (PubMed=36436139).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Unspecified (PubMed=36436139).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Glu44Gly (c.131A>G); ClinVar=VCV000041768; Zygosity=Unspecified (PubMed=36436139).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>A); ClinVar=VCV001453627; Zygosity=Unspecified (PubMed=36436139).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foot, hypodermis; UBERON=UBERON_0002387+UBERON_0002072.
ST   Source(s): PubMed=36436139
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D21S11: 29,30
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3705; Pleomorphic liposarcoma
DI   ORDO; Orphanet_99969; Pleomorphic liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   NCC-PMP1-C1
AC   CVCL_B7BM
DR   cancercelllines; CVCL_B7BM
DR   Wikidata; Q112930163
RX   PubMed=35207746;
CC   Population: Japanese.
CC   Doubling time: ~147 hours (PubMed=35207746).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=35207746).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=35207746
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D21S11: 30,32.2
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3345; Pseudomyxoma peritonei
DI   ORDO; Orphanet_26790; Pseudomyxoma peritonei
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   NCC-PMP2-C1
AC   CVCL_D3Z1
DR   Wikidata; Q127382935
RX   PubMed=38143259;
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~97 hours (PubMed=38143259).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=38143259).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11389; STK11; Zygosity=Homozygous (PubMed=38143259).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Thr122Met (c.365C>T); ClinVar=VCV000538194; Zygosity=Unspecified (PubMed=38143259).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Gln25Ter (c.73C>T); Zygosity=Unspecified (PubMed=38143259).
CC   Sequence variation: Mutation; HGNC; HGNC:10261; ROS1; Simple; p.Pro151Leu (c.452C>T); Zygosity=Unspecified (PubMed=38143259).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141Trp (c.423C>G); ClinVar=VCV000376564; Zygosity=Unspecified (PubMed=38143259).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Peritoneal cavity; UBERON=UBERON_0001179.
ST   Source(s): PubMed=38143259
ST   Amelogenin: X
ST   CSF1PO: 9,10,12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D21S11: 31,32.2
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C203949; High grade mucinous carcinoma peritonei with signet ring cells
DI   ORDO; Orphanet_26790; Pseudomyxoma peritonei
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   NCC-pRMS1-C1
AC   CVCL_B3TM
SY   NCCPRMS1C1
DR   DepMap; ACH-002787
DR   Wikidata; Q110433088
RX   DOI=10.11418/jtca.38.1;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 61 hours (DOI=10.11418/jtca.38.1).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right thigh, skeletal muscle; UBERON=UBERON_0004252.
ST   Source(s): DOI=10.11418/jtca.38.1
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 28,32.2
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C4258; Pleomorphic rhabdomyosarcoma
DI   ORDO; Orphanet_293199; Pleomorphic rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TN ! NCC-pRMS1-X4-C1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 8
//
ID   NCC-pRMS1-X4-C1
AC   CVCL_B3TN
SY   NCCPRMS1X4C1
DR   DepMap; ACH-002788
DR   Wikidata; Q110433089
RX   DOI=10.11418/jtca.38.1;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a fourth generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 40 hours (DOI=10.11418/jtca.38.1).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right thigh, skeletal muscle; UBERON=UBERON_0004252.
ST   Source(s): DOI=10.11418/jtca.38.1
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 28,32.2
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C4258; Pleomorphic rhabdomyosarcoma
DI   ORDO; Orphanet_293199; Pleomorphic rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TM ! NCC-pRMS1-C1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 8
//
ID   NCC-PS1-C1
AC   CVCL_C5Z2
DR   Wikidata; Q116049882
RX   PubMed=36103079;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 39 hours (PubMed=36103079).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Cys72Ter (c.216C>A); Zygosity=Unspecified (PubMed=36103079).
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg1873Cys (c.5617C>T); ClinVar=VCV000932356; Zygosity=Unspecified (PubMed=36103079).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=36103079).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: NCC-PS-C1; Note=In Cellosaurus releases 44 to 47.
CC   Derived from site: In situ; Popliteal fossa, hypodermis; UBERON=UBERON_0013069+UBERON_0002072.
ST   Source(s): PubMed=36103079
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 31
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18,19
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 8
//
ID   NCC-PS2-C1
AC   CVCL_E8VU
RX   PubMed=40253665;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Doubling time: 51 hours (PubMed=40253665).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Left thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=40253665
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 30,31
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NCC-RbC-30
AC   CVCL_U796
SY   NCC-RbC-R30; R30
DR   Wikidata; Q54907618
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: >100 hours (PubMed=8263010).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y10M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   NCC-RbC-39
AC   CVCL_3047
SY   NCC-RbC-R39; R39
DR   CLO; CLO_0050128
DR   BioSample; SAMN01821704
DR   BioSample; SAMN03472394
DR   JCRB; JCRB1305
DR   JCRB; NIHS0511
DR   RCB; RCB2205
DR   Wikidata; Q54907619
RX   CelloPub=CLPUB00087;
CC   Population: Japanese.
CC   Doubling time: 64 hours (CelloPub=CLPUB00087).
CC   Discontinued: JCRB; NIHS0511; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1305; RCB=RCB2205
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   NCC-RbC-51
AC   CVCL_3048
SY   NCC-RBC-51; NCC-RbC-R51; R51
DR   CLO; CLO_0050135
DR   BioSample; SAMN01821705
DR   BioSample; SAMN03472423
DR   JCRB; JCRB1182
DR   RCB; RCB2206
DR   Wikidata; Q54907620
RX   PubMed=7499444;
RX   PubMed=8263010;
RX   PubMed=12406979;
RX   PubMed=31781967;
CC   Population: Japanese.
CC   Doubling time: 85 hours (PubMed=8263010); 67 hours (PubMed=31781967).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (PubMed=31781967).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex24del; Zygosity=Heterozygous (PubMed=31781967).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): JCRB=JCRB1182; RCB=RCB2206
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 10
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   NCC-RbC-53
AC   CVCL_8309
SY   NCC-RbC-R53; R53
DR   BioSample; SAMN03472433
DR   JCRB; JCRB1200
DR   JCRB; NIHS0496
DR   Wikidata; Q54907621
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: Extremely slow growth (JCRB=JCRB1200).
CC   Discontinued: JCRB; NIHS0496; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   NCC-RbC-54
AC   CVCL_3049
SY   NCC-RbC-R54; R54
DR   CLO; CLO_0050130
DR   BioSample; SAMN03472019
DR   BioSample; SAMN03472424
DR   JCRB; JCRB1183
DR   JCRB; NIHS0497
DR   RCB; RCB2208
DR   Wikidata; Q54907622
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: 74 hours (PubMed=8263010).
CC   Discontinued: JCRB; NIHS0497; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1183; RCB=RCB2208
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 9,14
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16 (RCB=RCB2208)
ST   vWA: 16,18 (JCRB=JCRB1183)
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   NCC-RbC-56
AC   CVCL_3050
SY   NCC-RbC-R56; R56
DR   BioSample; SAMN03472438
DR   JCRB; JCRB1212
DR   JCRB; NIHS0498
DR   Wikidata; Q54907623
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=8263010).
CC   Discontinued: JCRB; NIHS0498; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1212
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   NCC-RbC-57
AC   CVCL_3051
SY   NCC-RbC-R57; R57
DR   BioSample; SAMN03472426
DR   JCRB; JCRB1190
DR   JCRB; NIHS0499
DR   Wikidata; Q54907624
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0499; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1190
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,12
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   NCC-RbC-58
AC   CVCL_U795
SY   NCC-RbC-R58; R58
DR   Wikidata; Q54907625
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   NCC-RbC-59
AC   CVCL_4072
SY   NCC-RbC-R59; R59
DR   CLO; CLO_0050134
DR   BioSample; SAMN01821706
DR   BioSample; SAMN03472425
DR   JCRB; JCRB1186
DR   JCRB; NIHS0500
DR   RCB; RCB2212
DR   Wikidata; Q54907626
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0500; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1186; RCB=RCB2212
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   NCC-RbC-60
AC   CVCL_4073
SY   NCC-RbC-R60; R60
DR   CLO; CLO_0050131
DR   BioSample; SAMN03472020
DR   JCRB; JCRB1326
DR   JCRB; NIHS0501
DR   RCB; RCB2213
DR   Wikidata; Q54907627
RX   PubMed=7499444;
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: 47 hours (PubMed=8263010).
CC   Discontinued: JCRB; NIHS0501; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1326; RCB=RCB2213
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   NCC-RbC-67
AC   CVCL_3052
SY   NCC-RbC-R67; R67
DR   CLO; CLO_0050127
DR   BioSample; SAMN01821707
DR   BioSample; SAMN03472441
DR   JCRB; JCRB1214
DR   RCB; RCB2214
DR   Wikidata; Q54907628
CC   Population: Japanese.
ST   Source(s): JCRB=JCRB1214; RCB=RCB2214
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 8,12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   NCC-RbC-70
AC   CVCL_8143
SY   NCC-RbC-R70; R70
DR   Wikidata; Q54907629
RX   PubMed=7499444;
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: 70 hours (PubMed=8263010).
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   NCC-RbC-83
AC   CVCL_4074
SY   NCC-RbC-R83; R83
DR   CLO; CLO_0050132
DR   BioSample; SAMN01821708
DR   BioSample; SAMN03472393
DR   JCRB; JCRB1303
DR   JCRB; NIHS0503
DR   RCB; RCB2217
DR   Wikidata; Q54907630
RX   PubMed=7499444;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0503; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1303; RCB=RCB2217
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   NCC-RbC-92
AC   CVCL_3053
SY   NCC-RbC-R92; R92
DR   CLO; CLO_0050133
DR   BioSample; SAMN03472446
DR   JCRB; JCRB1221
DR   JCRB; NIHS0504
DR   RCB; RCB2218
DR   Wikidata; Q54907631
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0504; true.
CC   Derived from site: In situ; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB1221; RCB=RCB2218
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,20
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   NCC-RbC-T1
AC   CVCL_3054
SY   T1
DR   CLO; CLO_0050129
DR   BioSample; SAMN03472021
DR   JCRB; JCRB1223
DR   RCB; RCB2219
DR   Wikidata; Q54907632
RX   PubMed=8263010;
CC   Population: Japanese.
CC   Doubling time: 78 hours (PubMed=8263010).
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
ST   Source(s): JCRB=JCRB1223; RCB=RCB2219
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   NCC-S4.1
AC   CVCL_C7U8
DR   Wikidata; Q123033143
RX   PubMed=11041361;
RX   PubMed=15541022;
CC   Characteristics: Scf dependent.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Cell type: Melanoblast; CL=CL_0000541.
CC   Breed/subspecies: WB-Sl/+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7U7 ! NCC-SE3
SX   Sex unspecified
AG   9-10FD
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   NCC-SE3
AC   CVCL_C7U7
SY   NCC-E3
DR   Wikidata; Q123033144
RX   PubMed=11041361;
RX   PubMed=17826037;
CC   Characteristics: Scf and Edn3 dependent.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Cell type: Melanoblast; CL=CL_0000541.
CC   Breed/subspecies: WB-Sl/+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   NCC-SFT1-C1
AC   CVCL_E6MC
RX   PubMed=39904835;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~69 hours (PubMed=39904835).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 6 fused to STAT6 exon 16 (PubMed=39904835).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Left buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=39904835
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D21S11: 30,31
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C7634; Solitary fibrous tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCC-SS1-C1
AC   CVCL_VG70
SY   NCCSS1C1
DR   DepMap; ACH-002789
DR   Wikidata; Q54907633
RX   PubMed=29450702;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 41 hours (PubMed=29450702).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=29450702).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
ST   Source(s): PubMed=29450702
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 13
ST   D21S11: 32.2,33
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 14
//
ID   NCC-SS2-C1
AC   CVCL_VE84
SY   NCCSS2C1
DR   DepMap; ACH-002790
DR   Wikidata; Q54907634
RX   PubMed=29626278;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 52 hours (PubMed=29626278).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (PubMed=29626278).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
ST   Source(s): PubMed=29626278
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,13
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 14
//
ID   NCC-SS3-C1
AC   CVCL_ZC97
DR   Wikidata; Q98127435
RX   PubMed=32274656;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 60 hours (PubMed=32274656).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=32274656).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=32274656
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,10
ST   D21S11: 31,31.2
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 11
//
ID   NCC-SS4-C1
AC   CVCL_A6FC
DR   Wikidata; Q107116531
RX   PubMed=33611700;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~245 hours (PubMed=33611700).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=33611700).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=33611700
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D21S11: 29,30
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-SS5-C1
AC   CVCL_C1GG
DR   Wikidata; Q114312462
RX   PubMed=35655041;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 218 hours (PubMed=35655041).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=35655041).
CC   Omics: Phenotyping; Drug screening.
ST   Source(s): PubMed=35655041
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D21S11: 30
ST   D5S818: 8,10
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   NCC-SS6-C1
AC   CVCL_E3AB
RX   PubMed=39174825;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 34 hours (PubMed=39174825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=39174825).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Thoracic cavity; UBERON=UBERON_0002224.
ST   Source(s): PubMed=39174825
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D21S11: 30,31
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   NCC-ssRMS1-C1
AC   CVCL_ZE13
DR   Wikidata; Q98127437
RX   PubMed=32300959;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~40 hours (PubMed=32300959).
CC   Sequence variation: Mutation; HGNC; HGNC:7611; MYOD1; Simple; p.Leu122Arg (c.365T>G); Zygosity=Unspecified (PubMed=32300959).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
ST   Source(s): PubMed=32300959
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D21S11: 29,31.2
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C121654; Spindle cell/sclerosing rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   NCC-ssRMS2-C1
AC   CVCL_A0BR
DR   Wikidata; Q108821015
RX   PubMed=34164773;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~41 hours (PubMed=34164773).
CC   Sequence variation: Mutation; HGNC; HGNC:7611; MYOD1; None_reported; -; Zygosity=- (PubMed=34164773).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: NCC-ssRMS1-C2; Note=In Cellosaurus release 39.
CC   Derived from site: In situ; Back; UBERON=UBERON_0001137.
ST   Source(s): PubMed=34164773
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 30,32.2
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C121654; Spindle cell/sclerosing rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-StC-K140
AC   CVCL_3055
SY   NCCStCK140; NCCSTCK140; K140
DR   CLO; CLO_0050803
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472022
DR   BioSample; SAMN03472448
DR   BioSample; SAMN10988058
DR   cancercelllines; CVCL_3055
DR   Cell_Model_Passport; SIDM01682
DR   DepMap; ACH-000110
DR   GEO; GSM888427
DR   IARC_TP53; 28306
DR   JCRB; JCRB1228
DR   LiGeA; CCLE_272
DR   PharmacoDB; NCCStCK140_996_2019
DR   Progenetix; CVCL_3055
DR   RCB; RCB2224
DR   Wikidata; Q54907635
RX   PubMed=8263010;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~44 hours (Note=Lot 03222018) (JCRB=JCRB1228).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DepMap=ACH-000110).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.19%; Native American=0%; East Asian, North=80.7%; East Asian, South=13.81%; South Asian=0%; European, North=0%; European, South=4.29% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): JCRB=JCRB1228; RCB=RCB2224
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 9
ST   D7S820: 11,12 (JCRB=JCRB1228)
ST   D7S820: 12 (RCB=RCB2224)
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   NCC-TGCT1-C1
AC   CVCL_A9YZ
DR   Wikidata; Q102114581
RX   PubMed=32886306;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 30 hours (PubMed=32886306).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2213; COL6A3 + HGNC; HGNC:2432; CSF1; Name(s)=COL6A3-CSF1 (PubMed=32886306).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Hip, tendon sheath; UBERON=UBERON_0001486+UBERON_0000304.
ST   Source(s): PubMed=32886306
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C6535; Malignant tenosynovial giant cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 11
//
ID   NCC-UPS1-C1
AC   CVCL_B3TP
SY   NCCUPS1C1
DR   DepMap; ACH-002782
DR   Wikidata; Q110433090
RX   DOI=10.11418/jtca.36.41;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~40.9 hours (DOI=10.11418/jtca.36.41).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Back, hypodermis; UBERON=UBERON_0001137+UBERON_0002072.
ST   Source(s): DOI=10.11418/jtca.36.41
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 28.2
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR16 ! NCC-UPS1-X3-C1
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 7
//
ID   NCC-UPS1-X3-C1
AC   CVCL_VR16
SY   NCCUPS1X3C1
DR   DepMap; ACH-002783
DR   Wikidata; Q95992631
RX   DOI=10.11418/jtca.37.133;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft established by subcutaneous injection in female SCID mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: ~40 hours (DOI=10.11418/jtca.37.133).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
ST   Source(s): DOI=10.11418/jtca.37.133
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 28.2
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TP ! NCC-UPS1-C1
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 10
//
ID   NCC-UPS2-C1
AC   CVCL_RP62
SY   NCCUPS2C1
DR   DepMap; ACH-002784
DR   Wikidata; Q54907636
RX   PubMed=29359268;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 45 hours (PubMed=29359268).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
ST   Source(s): PubMed=29359268
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 10
ST   D21S11: 33.2
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 10
ST   vWA: 14
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 10
//
ID   NCC-UPS3-C1
AC   CVCL_B3RN
DR   Wikidata; Q110433091
RX   PubMed=34665443;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 61.6 hours (PubMed=34665443).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=34665443).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (PubMed=34665443).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Left buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=34665443
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D21S11: 29,31
ST   D5S818: 11,12,13
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17,20,21,22
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 9
//
ID   NCC-UPS4-C1
AC   CVCL_B6KI
DR   cancercelllines; CVCL_B6KI
DR   Wikidata; Q112129416
RX   PubMed=35118583;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 76 hours (PubMed=35118583).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (PubMed=35118583).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Heterozygous (PubMed=35118583).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Right knee, hypodermis; UBERON=UBERON_0001465+UBERON_0002072.
ST   Source(s): PubMed=35118583
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 12
ST   D21S11: 29,32.2
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 10
//
ID   NCC010
AC   CVCL_X505
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X505
DR   Cell_Model_Passport; SIDM00231
DR   Cosmic-CLP; 1509073
DR   DepMap; ACH-002167
DR   EGA; EGAS00001000978
DR   GDSC; 1509073
DR   GEO; GSM1670157
DR   PharmacoDB; NCC010_997_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907637
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Asian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=22.3%; East Asian, South=77.7%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1509073
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 19
//
ID   NCC021
AC   CVCL_X506
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_X506
DR   Cell_Model_Passport; SIDM00232
DR   Cosmic-CLP; 1509074
DR   DepMap; ACH-002168
DR   EGA; EGAS00001000978
DR   GDSC; 1509074
DR   GEO; GSM1670158
DR   PharmacoDB; NCC021_998_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907638
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Asian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.31%; Native American=0.02%; East Asian, North=27.12%; East Asian, South=71.39%; South Asian=1.05%; European, North=0%; European, South=0.12% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1509074
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 9,13
ST   D7S820: 9
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 19
//
ID   NCC16
AC   CVCL_U219
DR   BioSample; SAMN03151898
DR   BioSample; SAMN03470809
DR   JCRB; JCRB0142
DR   JCRB; NIHS0204
DR   Wikidata; Q54907639
RX   PubMed=9310137;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PHK16-0b derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00331.
CC   Population: Caucasian.
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: Replaced by NCC16-P11.
CC   Discontinued: JCRB; JCRB0142; true.
CC   Discontinued: JCRB; NIHS0204; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB0142
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3123 ! PHK16-0b
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 18
//
ID   NCC16-P11
AC   CVCL_3044
DR   BioSample; SAMN03472368
DR   JCRB; JCRB0174.0
DR   JCRB; NIHS0259.0
DR   Wikidata; Q54907640
RX   PubMed=9310137;
CC   Population: Japanese.
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=9310137).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: Original cell line NCC16 was contaminated and retired, it was replaced by NCC16-P11.
CC   Discontinued: JCRB; NIHS0259.0; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Endothelial cell of uterus; CL=CL_0009095.
ST   Source(s): JCRB=JCRB0174.0
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   NCCDFWi001-A
AC   CVCL_YM45
DR   hPSCreg; NCCDFWi001-A
DR   SKIP; SKIP005601
DR   Wikidata; Q95992665
RX   PubMed=31901832;
RX   PubMed=34592602;
CC   From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Pro228fs (c.684_736+4del); Zygosity=Heterozygous (PubMed=31901832).
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Leu871Phe (c.2613A>C); ClinVar=VCV000667457; Zygosity=Heterozygous (PubMed=31901832).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NCCDFWi001-A-1
AC   CVCL_C0ER
DR   hPSCreg; NCCDFWi001-A-1
DR   Wikidata; Q112930164
RX   PubMed=34592602;
CC   From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Pro228fs (c.684_736+4del); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple_corrected; p.Leu871Phe (c.2613A>C); ClinVar=VCV000667457; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34592602).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YM45 ! NCCDFWi001-A
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NCCmelan5
AC   CVCL_C7UA
DR   Wikidata; Q123033145
RX   PubMed=11549110;
CC   Doubling time: 24 hours (PubMed=11549110).
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Cell type: Melanocyte; CL=CL_0000148.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   NCCmelb4
AC   CVCL_C7U9
DR   ABM; T0149
DR   Wikidata; Q123033146
RX   PubMed=15541022;
RX   PubMed=17826037;
CC   Doubling time: 32 hours (PubMed=15541022).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Cell type: Melanoblast; CL=CL_0000541.
CC   Breed/subspecies: WB-Sl/+.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C7U8 ! NCC-S4.1
SX   Sex unspecified
AG   9-10FD
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   NCCIT-R
AC   CVCL_C0QL
DR   cancercelllines; CVCL_C0QL
DR   PRIDE; PXD030251
DR   Wikidata; Q112930165
RX   PubMed=35084545;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Lys309Asn (c.927G>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Pro (c.518G>C); ClinVar=VCV000185195; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Cysfs*73 (c.814delG); Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Quantitative.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1451 ! NCC-IT
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   NCCIT_CDDP
AC   CVCL_XI44
DR   cancercelllines; CVCL_XI44
DR   Wikidata; Q95992667
RX   PubMed=31500094;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Lys309Asn (c.927G>C); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Pro (c.518G>C); ClinVar=VCV000185195; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Cysfs*73 (c.814delG); Zygosity=Homozygous (from parent cell line).
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1451 ! NCC-IT
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   NCCSEDi001-A
AC   CVCL_A4EF
DR   BioSamples; SAMEA7200924
DR   hPSCreg; NCCSEDi001-A
DR   Wikidata; Q105510304
RX   PubMed=33130469;
CC   From: National Chengdu Center for Safety Evaluation of Drugs; Chengdu; China.
CC   Population: Chinese; Han.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NCCSEDi001-A-1
AC   CVCL_A4EG
SY   NANS-2-6
DR   BioSamples; SAMEA7222556
DR   hPSCreg; NCCSEDi001-A-1
DR   Wikidata; Q105510307
RX   PubMed=33130469;
CC   From: National Chengdu Center for Safety Evaluation of Drugs; Chengdu; China.
CC   Population: Chinese; Han.
CC   Characteristics: Using CRISPR/Cas9 NANS was disrupted by insertion of a GFP-P2A-PuroR construct in exon 1 of both alleles (PubMed=33130469).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19237; NANS.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4EF ! NCCSEDi001-A
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   NCCSi001-A
AC   CVCL_VE27
SY   iP1/14
DR   hPSCreg; NCCSi001-A
DR   Wikidata; Q54907641
CC   From: National Centre for Cell Science; Pune; India.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   NCCSi002-A
AC   CVCL_VE26
SY   iP1/16
DR   hPSCreg; NCCSi002-A
DR   Wikidata; Q54907642
RX   PubMed=29268156;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   NCCSi003-A
AC   CVCL_RR92
SY   iPA1/16
DR   hPSCreg; NCCSi003-A
DR   Wikidata; Q54907645
RX   PubMed=29274886;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29274886
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D21S11: 30,32.2
ST   D5S818: 12,13
ST   D7S820: 7,8
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   NCCSi004-A
AC   CVCL_UK93
SY   iP1/15; iPA1/15
DR   hPSCreg; NCCSi004-A
DR   Wikidata; Q95992676
RX   PubMed=30711803;
RX   PubMed=30772284;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   NCCSi005-A
AC   CVCL_XI84
SY   NCCSi005A; NPC-1M1
DR   hPSCreg; NCCSi005-A
DR   Wikidata; Q95992678
RX   PubMed=31352200;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC09 ! NCCSi005-B
OI   CVCL_YC10 ! NCCSi005-C
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NCCSi005-B
AC   CVCL_YC09
DR   hPSCreg; NCCSi005-B
DR   Wikidata; Q95992680
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI84 ! NCCSi005-A
OI   CVCL_YC10 ! NCCSi005-C
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NCCSi005-C
AC   CVCL_YC10
DR   hPSCreg; NCCSi005-C
DR   Wikidata; Q95992681
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI84 ! NCCSi005-A
OI   CVCL_YC09 ! NCCSi005-B
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NCCSi006-A
AC   CVCL_XI85
SY   NCCSi006A; NPC-2A2; NCCS-NPC-2-C3P8
DR   hPSCreg; NCCSi006-A
DR   Wikidata; Q95992682
RX   PubMed=31352200;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC11 ! NCCSi006-B
OI   CVCL_YC12 ! NCCSi006-C
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NCCSi006-B
AC   CVCL_YC11
SY   NPC-2A1
DR   hPSCreg; NCCSi006-B
DR   Wikidata; Q95992683
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI85 ! NCCSi006-A
OI   CVCL_YC12 ! NCCSi006-C
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NCCSi006-C
AC   CVCL_YC12
DR   hPSCreg; NCCSi006-C
DR   Wikidata; Q95992684
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI85 ! NCCSi006-A
OI   CVCL_YC11 ! NCCSi006-B
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NCCSi007-A
AC   CVCL_YM46
SY   DYPM1-M2
DR   hPSCreg; NCCSi007-A
DR   SKIP; SKIP005602
DR   Wikidata; Q95992685
RX   PubMed=31862609;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34782; Alcoholic cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM47 ! NCCSi007-B
OI   CVCL_YM48 ! NCCSi007-C
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NCCSi007-B
AC   CVCL_YM47
SY   DYPM1-M3
DR   hPSCreg; NCCSi007-B
DR   SKIP; SKIP005603
DR   Wikidata; Q95992686
RX   PubMed=31862609;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34782; Alcoholic cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM46 ! NCCSi007-A
OI   CVCL_YM48 ! NCCSi007-C
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NCCSi007-C
AC   CVCL_YM48
SY   DYPM1-M4
DR   hPSCreg; NCCSi007-C
DR   SKIP; SKIP005604
DR   Wikidata; Q95992687
RX   PubMed=31862609;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34782; Alcoholic cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM46 ! NCCSi007-A
OI   CVCL_YM47 ! NCCSi007-B
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NCCSi008-A
AC   CVCL_YM49
SY   NPC-3A1C1
DR   hPSCreg; NCCSi008-A
DR   SKIP; SKIP005744
DR   Wikidata; Q95992688
RX   PubMed=32315960;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM50 ! NCCSi008-B
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NCCSi008-B
AC   CVCL_YM50
SY   NPC-3A2C2
DR   hPSCreg; NCCSi008-B
DR   SKIP; SKIP005743
DR   Wikidata; Q95992689
RX   PubMed=32315960;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM49 ! NCCSi008-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NCCSi009-A
AC   CVCL_YM51
SY   BT1/18
DR   hPSCreg; NCCSi009-A
DR   SKIP; SKIP005728
DR   Wikidata; Q95992690
RX   PubMed=32278313;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Ser10Valfs*14 (c.27dupG) (c.27_28insG) (cd8/9+G); ClinVar=VCV000036308; Zygosity=Homozygous (PubMed=32278313).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   NCCSi010-A
AC   CVCL_ZA75
SY   DYPM4-A1C2; DYPM-4 A1C2
DR   hPSCreg; NCCSi010-A
DR   Wikidata; Q98127438
RX   PubMed=32745713;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA76 ! NCCSi010-B
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   NCCSi010-B
AC   CVCL_ZA76
SY   DYPM4-A3C2; DYPM-4 A3C2
DR   hPSCreg; NCCSi010-B
DR   Wikidata; Q98127440
RX   PubMed=32745713;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA75 ! NCCSi010-A
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   NCCSi011-A
AC   CVCL_A2GB
SY   DYPM2-A2C2
DR   Wikidata; Q105510309
RX   PubMed=32971460;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2GC ! NCCSi011-B
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   NCCSi011-B
AC   CVCL_A2GC
SY   DYPM2-A3C1
DR   Wikidata; Q105510312
RX   PubMed=32971460;
CC   From: National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2951; Cirrhosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2GB ! NCCSi011-A
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   NCD-2
AC   CVCL_A6XA
DR   RCB; RCB5261
DR   Wikidata; Q107116532
RX   PubMed=3515198;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10288; Chicken CDH2 (Note=Also reacts with Xenopus).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NCE SVIA6
AC   CVCL_8373
SY   NCEsv-IA6.2
DR   BioSample; SAMN03472507
DR   JCRB; JCRB1092
DR   JCRB; NIHS0263
DR   Wikidata; Q54907646
RX   PubMed=12747968;
CC   Population: Japanese.
CC   Doubling time: ~3-5 days (Note=Lot 10142005) (JCRB=JCRB1092).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; NIHS0263; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB1092
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 18
//
ID   NCE SVIIA3
AC   CVCL_8374
DR   JCRB; JCRB1091
DR   JCRB; NIHS0264
DR   Wikidata; Q54907647
CC   Population: Japanese.
CC   Doubling time: ~3 days (Note=Lot 11102005) (JCRB=JCRB1091).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; NIHS0264; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB1091
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   NCE-F161
AC   CVCL_3754
DR   CLO; CLO_0007956
DR   ATCC; CRL-8727
DR   Wikidata; Q54907648
RX   Patent=US4933179;
RX   PubMed=7989438;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8727.
CC   Virology: Susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   NCE-G 102
AC   CVCL_N738
SY   G-102; G102; NeuroChirurgie Eppendorf-Glioma 102
DR   Wikidata; Q54907649
RX   PubMed=3063073;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   NCE-G 111
AC   CVCL_N739
SY   NCE-G111; G-111; G111; NeuroChirurgie Eppendorf-Glioma 111
DR   EFO; EFO_0006395
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472646
DR   EGA; EGAS00001000610
DR   PharmacoDB; G111_377_2019
DR   Wikidata; Q54907650
RX   PubMed=8154317;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*02:01,03:01; B*15:01,35:01; C*03:03,04:01 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 10,12
ST   D18S51: 15
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   NCE-G 112
AC   CVCL_N740
SY   NCE G-112; NCE G 112; NCE-G112; G-112; G112; NeuroChirurgie Eppendorf-Glioma 112
DR   EFO; EFO_0006396
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471511
DR   cancercelllines; CVCL_N740
DR   EGA; EGAS00001000610
DR   IARC_TP53; 2144
DR   IARC_TP53; 21609
DR   PharmacoDB; G112_378_2019
DR   Wikidata; Q54907651
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=10630978;
RX   PubMed=15816541;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=8253536; PubMed=15816541).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   NCE-G 118
AC   CVCL_N741
SY   NCE G-118; NCE-G118; G-118; G118; NeuroChirurgie Eppendorf-Glioma 118
DR   EFO; EFO_0006397
DR   ArrayExpress; E-MTAB-2706
DR   EGA; EGAS00001000610
DR   IARC_TP53; 23562
DR   PharmacoDB; G118_379_2019
DR   Wikidata; Q54907652
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=26589293;
CC   HLA typing: A*24:02,24:02; B*51:01,51:01; C*03:03,03:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   NCE-G 120
AC   CVCL_N742
SY   NCE G 120; NCE-G120; G-120; G120; NeuroChirurgie Eppendorf-Glioma 120
DR   EFO; EFO_0006398
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471174
DR   EGA; EGAS00001000610
DR   IARC_TP53; 21607
DR   IARC_TP53; 23566
DR   PharmacoDB; G120_380_2019
DR   Wikidata; Q54907654
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=10630978;
RX   PubMed=15816541;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*68:01,68:01; B*40:01,40:01; C*03:04,03:04; DRB1*03:01,03:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536; PubMed=15816541).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 11,17
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   NCE-G 121
AC   CVCL_N743
SY   NCE-G121; G-121; G121; NeuroChirurgie Eppendorf-Glioma 121
DR   EFO; EFO_0006399
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471076
DR   EGA; EGAS00001000610
DR   IARC_TP53; 23567
DR   PharmacoDB; G121_381_2019
DR   Wikidata; Q54907655
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,01:01; B*08:01,35:02; C*04:01,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Said to originate from a male patient according to PubMed=8289093 and PubMed=16696057, in contradiction with PubMed=8154317.
CC   Derived from site: In situ; Brain, left occipital-parietal region.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 30,32.2
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 11,17
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   NCE-G 122
AC   CVCL_N744
SY   NCE G 122; NCE-G122; G-122; G122; NeuroChirurgie Eppendorf-Glioma 122
DR   EFO; EFO_0006400
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471500
DR   EGA; EGAS00001000610
DR   IARC_TP53; 2145
DR   PharmacoDB; G122_382_2019
DR   Wikidata; Q54907656
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,02:01; B*08:01,15:01; C*03:03,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; 10bp deletion in intron4/exon5; Zygosity=Unspecified (PubMed=8253536).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 7,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   NCE-G 123
AC   CVCL_N745
SY   NCE G 123; NCE-G123; G-123; G123; NeuroChirurgie Eppendorf-Glioma 123
DR   cancercelllines; CVCL_N745
DR   IARC_TP53; 2143
DR   IARC_TP53; 21610
DR   Wikidata; Q54907658
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=15816541;
RX   PubMed=16696057;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=15816541).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=15816541).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   NCE-G 123T2
AC   CVCL_BW89
SY   G123T2
DR   cancercelllines; CVCL_BW89
DR   Wikidata; Q54907659
RX   PubMed=19519771;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N745 ! NCE-G 123
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   NCE-G 124
AC   CVCL_N746
SY   NCE G 124; NCE-G124; G-124; G124; NeuroChirurgie Eppendorf-Glioma 124
DR   EFO; EFO_0006401
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471185
DR   EGA; EGAS00001000610
DR   PharmacoDB; G124_383_2019
DR   Wikidata; Q54907660
RX   PubMed=8154317;
RX   PubMed=8289093;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*11:01,32:01; B*27:05,35:01; C*02:02,04:04 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 12,15
ST   D21S11: 28,32.2
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 11,16
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 14,16
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   NCE-G 130
AC   CVCL_N747
SY   NCE G 130; NCE-G130; G-130; G130; NeuroChirurgie Eppendorf-Glioma 130
DR   EFO; EFO_0006402
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472657
DR   EGA; EGAS00001000610
DR   IARC_TP53; 21614
DR   IARC_TP53; 23564
DR   PharmacoDB; G130_384_2019
DR   Wikidata; Q54907661
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=15816541;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*11:01,29:01; B*07:02,39:06; C*07:02,15:05 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=8253536; PubMed=15816541).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,18
ST   D21S11: 27,29
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 7,10
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 5,7
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   NCE-G 140
AC   CVCL_N748
SY   NCE-G140; G-140; G140; NeuroChirurgie Eppendorf-Glioma 140
DR   EFO; EFO_0006403
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472635
DR   cancercelllines; CVCL_N748
DR   EGA; EGAS00001000610
DR   IARC_TP53; 2146
DR   PharmacoDB; G140_385_2019
DR   Wikidata; Q54907662
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*03:01,03:01; B*35:02,35:02; C*04:01,04:01; DRB1*14:76,14:76 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr211Ile (c.632C>T); ClinVar=VCV001503185; Zygosity=Unspecified (PubMed=8253536).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 28,29
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 11,15
ST   FGA: 23,25
ST   Penta D: 9,11
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   NCE-G 141
AC   CVCL_N749
SY   NCE-G141; G-141; G141; NeuroChirurgie Eppendorf-Glioma 141
DR   EFO; EFO_0006404
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472668
DR   EGA; EGAS00001000610
DR   PharmacoDB; G141_386_2019
DR   Wikidata; Q54907663
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*24:02,24:02; B*51:01,51:01; C*03:03,03:03 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 30.2,31.2
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 19,20
ST   Penta D: 12,15
ST   Penta E: 12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   NCE-G 142
AC   CVCL_N750
SY   NCE-G142; G-142; G142; NeuroChirurgie Eppendorf-Glioma 142
DR   EFO; EFO_0006405
DR   ArrayExpress; E-MTAB-2706
DR   EGA; EGAS00001000610
DR   PharmacoDB; G142_387_2019
DR   Wikidata; Q54907664
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=26589293;
CC   HLA typing: A*11:01,24:02; B*35:03,51:01; C*03:03,12:03 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   NCE-G 151
AC   CVCL_N751
SY   G-151; G151; NeuroChirurgie Eppendorf-Glioma 151
DR   Wikidata; Q54907665
RX   PubMed=8154317;
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   NCE-G 167
AC   CVCL_N752
SY   G-167; G167; NeuroChirurgie Eppendorf-Glioma 167
DR   Wikidata; Q54907666
RX   PubMed=16696057;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   NCE-G 168
AC   CVCL_N753
SY   NCE G 168; NCE G168; NCE-G168; G-168; G168; NeuroChirurgie Eppendorf-Glioma 168
DR   IARC_TP53; 21605
DR   IARC_TP53; 23568
DR   Wikidata; Q54907667
RX   PubMed=8253536;
RX   PubMed=15816541;
RX   PubMed=16696057;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536; PubMed=15816541).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   NCE-G 169
AC   CVCL_N754
SY   G-169; G169; NeuroChirurgie Eppendorf-Glioma 169
DR   Wikidata; Q54907668
RX   PubMed=16696057;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   NCE-G 195
AC   CVCL_N755
SY   NCE G195; G-195; G195; NeuroChirurgie Eppendorf-Glioma 195
DR   Wikidata; Q54907669
RX   PubMed=16696057;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   NCE-G 22
AC   CVCL_N723
SY   NCE G-22; NCE G 22; NCE-G22; G-22; G22; NeuroChirurgie Eppendorf-Glioma 22
DR   EFO; EFO_0006406
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472679
DR   cancercelllines; CVCL_N723
DR   EGA; EGAS00001000610
DR   IARC_TP53; 2147
DR   IARC_TP53; 21608
DR   PharmacoDB; G22_388_2019
DR   Wikidata; Q54907670
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=15816541;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*02:01,30:01; B*13:02,15:01; C*03:04,06:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Heterozygous (PubMed=8253536; PubMed=15816541).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=15816541).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, occipito-medial region.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 10,11,12,13
ST   D18S51: 15,20
ST   D21S11: 31.2,34.2
ST   D3S1358: 15,19
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 18,19,23
ST   Penta D: 13
ST   Penta E: 7,13
ST   TH01: 6,7
ST   TPOX: 8,9,11
ST   vWA: 18,20,21
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   NCE-G 28
AC   CVCL_N724
SY   NCE G-28; NCE-G28; G-28; G28; NeuroChirurgie Eppendorf-Glioma 28
DR   Wikidata; Q54907671
RX   PubMed=3063073;
RX   PubMed=3275500;
RX   PubMed=8154317;
RX   PubMed=8289093;
RX   PubMed=10630978;
RX   PubMed=16696057;
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   NCE-G 28T
AC   CVCL_0V15
SY   NCE G-28T; NCE-G28T; G28T
DR   EFO; EFO_0006407
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471523
DR   EGA; EGAS00001000610
DR   PharmacoDB; G28T_389_2019
DR   Wikidata; Q54907672
RX   PubMed=3275500;
RX   PubMed=8289093;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,31:01; B*08:01,13:02; C*06:02,07:01 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 18
ST   D21S11: 29
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N724 ! NCE-G 28
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   NCE-G 30
AC   CVCL_N725
SY   G-30; G30; NeuroChirurgie Eppendorf-Glioma 30
DR   Wikidata; Q54907673
RX   PubMed=3063073;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   NCE-G 350
AC   CVCL_N756
SY   NCE-G350; G-350; G350; NeuroChirurgie Eppendorf-Glioma 350
DR   Wikidata; Q54907674
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   NCE-G 38
AC   CVCL_N726
SY   G-38; G38; NeuroChirurgie Eppendorf-Glioma 38
DR   Wikidata; Q54907675
RX   PubMed=3063073;
RX   PubMed=8154317;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C4050; Oligoastrocytoma
DI   ORDO; Orphanet_251656; Oligoastrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   NCE-G 44
AC   CVCL_N727
SY   NCE G 44; NCE-G44; G-44; G44; NeuroChirurgie Eppendorf-Glioma 44
DR   EFO; EFO_0006408
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471534
DR   EGA; EGAS00001000610
DR   IARC_TP53; 21611
DR   IARC_TP53; 23565
DR   PharmacoDB; G44_390_2019
DR   Wikidata; Q54907676
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=3063073;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=10630978;
RX   PubMed=15816541;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:06 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Ter (c.670G>T); Zygosity=Unspecified (PubMed=15816541).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D21S11: 27,29
ST   D3S1358: 14,16
ST   D5S818: 7,9
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 14,15
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   NCE-G 55
AC   CVCL_N728
SY   NCE G 55; NCE-G55; G-55; G55; NeuroChirurgie Eppendorf-Glioma 55
DR   Wikidata; Q54907677
RX   PubMed=8154317;
RX   PubMed=8289093;
RX   PubMed=16696057;
CC   Derived from site: In situ; Brain, right occipital-parietal region.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   NCE-G 55T2
AC   CVCL_BW88
SY   NCE-G55T2; G55T2; NCEG55T2
DR   BTO; BTO_0005458
DR   ChEMBL-Cells; CHEMBL4483165
DR   ChEMBL-Targets; CHEMBL4483235
DR   PubChem_Cell_line; CVCL_BW88
DR   Wikidata; Q54907678
RX   PubMed=19519771;
CC   Derived from site: In situ; Brain, right occipital-parietal region.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N728 ! NCE-G 55
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   NCE-G 59
AC   CVCL_N729
SY   NCE-G59; G-59; G59; NeuroChirurgie Eppendorf-Glioma 59
DR   EFO; EFO_0006409
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471229
DR   cancercelllines; CVCL_N729
DR   EGA; EGAS00001000610
DR   IARC_TP53; 2148
DR   PharmacoDB; G59_391_2019
DR   Wikidata; Q54907681
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=36139163;
CC   HLA typing: A*25:01,68:01; B*15:01,44:02; C*03:03,05:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:8598; PANK1; Zygosity=Homozygous (PubMed=36139163).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8253536).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left temporo-medial region.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 14,16
ST   D21S11: 29,30.2
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   NCE-G 60
AC   CVCL_N730
SY   G-60; G60; NeuroChirurgie Eppendorf-Glioma 60
DR   IARC_TP53; 23561
DR   Wikidata; Q54907683
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8253536;
RX   PubMed=10630978;
RX   PubMed=16696057;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   NCE-G 61
AC   CVCL_N731
SY   NCE-G61; G-61; G61; NeuroChirurgie Eppendorf-Glioma 61
DR   EFO; EFO_0006410
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471240
DR   EGA; EGAS00001000610
DR   IARC_TP53; 23559
DR   PharmacoDB; G61_392_2019
DR   Wikidata; Q54907684
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left temporo-occipital lobe.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D18S51: 18
ST   D21S11: 30,32.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 14
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   NCE-G 62
AC   CVCL_N732
SY   NCE G 62; NCE-G62; G-62; G62; NeuroChirurgie Eppendorf-Glioma 62
DR   IARC_TP53; 21613
DR   IARC_TP53; 23563
DR   Wikidata; Q54907686
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=10630978;
RX   PubMed=15816541;
RX   PubMed=16696057;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp49Tyr (c.145G>T); Zygosity=Unspecified (PubMed=15816541).
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   NCE-G 63
AC   CVCL_N733
SY   NCE G-63; NCE G 63; NCE-G63; G-63; G63; NeuroChirurgie Eppendorf-Glioma 63
DR   IARC_TP53; 21606
DR   IARC_TP53; 23560
DR   Wikidata; Q54907687
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=3063073;
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=15816541;
RX   PubMed=16696057;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536; PubMed=15816541).
CC   Derived from site: In situ; Brain, right temporo-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   NCE-G 80
AC   CVCL_N734
SY   G-80; G80; NeuroChirurgie Eppendorf-Glioma 80
DR   Wikidata; Q54907689
RX   PubMed=3063073;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 8
//
ID   NCE-G 84
AC   CVCL_N735
SY   NCE G 84; NCE-G84; G-84; G84; NeuroChirurgie Eppendorf-Glioma 84
DR   EFO; EFO_0006411
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471545
DR   EGA; EGAS00001000610
DR   IARC_TP53; 21612
DR   PharmacoDB; G84_393_2019
DR   Wikidata; Q54907690
RX   PubMed=8289093;
RX   PubMed=15816541;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*03:01,30:01; B*08:01,51:01; C*07:01,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala79Val (c.236C>T); Zygosity=Unspecified (PubMed=15816541).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 19
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   NCE-G 96
AC   CVCL_N736
SY   NCE-G96; G-96; G96; NeuroChirurgie Eppendorf-Glioma 96
DR   EFO; EFO_0006412
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471163
DR   EGA; EGAS00001000610
DR   IARC_TP53; 23558
DR   PharmacoDB; G96_394_2019
DR   Wikidata; Q54907691
RX   PubMed=8154317;
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8253536).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D21S11: 27,29
ST   D3S1358: 14,16
ST   D5S818: 7,9
ST   D7S820: 8
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 14,15
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 22
//
ID   NCE-G 98
AC   CVCL_N737
SY   G-98; G98; NeuroChirurgie Eppendorf-Glioma 98
DR   Wikidata; Q54907693
RX   PubMed=3063073;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   NCE16
AC   CVCL_3057
DR   BioSample; SAMN03470807
DR   JCRB; JCRB0140
DR   JCRB; NIHS0205
DR   Wikidata; Q54907694
RX   PubMed=9310137;
RX   PubMed=12747968;
CC   Population: Japanese.
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=9310137).
CC   Doubling time: ~3-5 days (Note=Lot 07242006) (JCRB=JCRB0140).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0205; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB0140
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   NCE16-IIA
AC   CVCL_3056
SY   NCE 16IIA
DR   BioSample; SAMN03472506
DR   JCRB; JCRB1090
DR   JCRB; NIHS0265
DR   Wikidata; Q54907695
RX   PubMed=12747968;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0265; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB1090
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3057 ! NCE16
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   NCE16-IIB
AC   CVCL_8304
SY   NCE 16IIB
DR   JCRB; JCRB1089
DR   JCRB; NIHS0266
DR   Wikidata; Q54907696
RX   PubMed=12747968;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; JCRB1089; probable.
CC   Discontinued: JCRB; NIHS0266; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB1089
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3057 ! NCE16
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   NCEB-1
AC   CVCL_1875
SY   Nceb-1; NCEB1; NCEB
DR   ATCC; CRL-3005
DR   BioSample; SAMN03471708
DR   cancercelllines; CVCL_1875
DR   Cosmic; 1070711
DR   Cosmic; 2296994
DR   DSMZ; ACC-721
DR   DSMZCellDive; ACC-721
DR   GEO; GSM95564
DR   GEO; GSM95569
DR   GEO; GSM104461
DR   GEO; GSM115803
DR   IARC_TP53; 25019
DR   Progenetix; CVCL_1875
DR   Wikidata; Q54907697
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2848599;
RX   PubMed=7849311;
RX   PubMed=12169673;
RX   PubMed=16183118;
RX   PubMed=16448697;
RX   PubMed=16960149;
RX   PubMed=25315077;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 72-96 hours (PubMed=2848599); 19 hours (PubMed=25315077); ~50-70 hours (DSMZ=ACC-721).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu221Lys (c.661G>A); ClinVar=VCV000184647; Zygosity=Unspecified (PubMed=16448697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Established from a 57 year old male patient but contains some intact murine chromosomes (ATCC; PubMed=16448697) so should be considered as an hybrid cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3005; DSMZ=ACC-721
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 12,15
ST   D21S11: 30,31
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20,26
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   NCF
AC   CVCL_HA35
SY   Neonatal Connective Fibroblast
DR   BCRJ; 0183
DR   Wikidata; Q54907699
CC   Discontinued: BCRJ; 0183; probable.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   NCF3
AC   CVCL_IN83
DR   Wikidata; Q54907700
RX   PubMed=2470608;
RX   PubMed=15463957;
CC   Doubling time: ~48 hours (PubMed=2470608).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=2470608).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; Note=From a nasal polyp; UBERON=UBERON_0005384.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   NCF3A
AC   CVCL_IN84
DR   Wikidata; Q54907701
RX   PubMed=2470608;
CC   Doubling time: 48 hours (PubMed=2470608).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; Note=From a nasal polyp; UBERON=UBERON_0005384.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IN83 ! NCF3
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   NCH01
AC   CVCL_E5TB
RX   PubMed=39697661;
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCH02
AC   CVCL_E5TC
RX   PubMed=39697661;
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCH03
AC   CVCL_E5TD
RX   PubMed=39697661;
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCH125
AC   CVCL_S818
SY   NCH-125
DR   Wikidata; Q54907702
RX   PubMed=16331629;
CC   Characteristics: Low-passage-number culture.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   NCH149
AC   CVCL_S819
SY   NCH-149
DR   Wikidata; Q54907703
RX   PubMed=16331629;
CC   Characteristics: Low-passage-number culture.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   NCH1681
AC   CVCL_A5HV
DR   cancercelllines; CVCL_A5HV
DR   Wikidata; Q107116533
RX   PubMed=29563135;
RX   PubMed=33504762;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33504762).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   NCH37
AC   CVCL_S820
SY   NCH-37
DR   ChEMBL-Cells; CHEMBL3307426
DR   ChEMBL-Targets; CHEMBL614770
DR   PubChem_Cell_line; CVCL_S820
DR   Wikidata; Q54907704
RX   PubMed=16331629;
CC   Characteristics: Low-passage-number culture.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   NCH4.2
AC   CVCL_E5ZV
RX   PubMed=19716222;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCH4.3
AC   CVCL_E5ZW
RX   PubMed=19716222;
RX   PubMed=28707715;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCH421k
AC   CVCL_X910
SY   NCH421K
DR   CLS; 300118
DR   Wikidata; Q54907705
RX   PubMed=20442299;
RX   PubMed=24294177;
CC   Group: Cancer stem cell line.
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CLS=300118
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,25
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 12
//
ID   NCH440
AC   CVCL_X911
DR   Wikidata; Q54907706
RX   PubMed=20442299;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   NCH441
AC   CVCL_X912
DR   Wikidata; Q54907707
RX   PubMed=20442299;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   NCH465
AC   CVCL_X944
DR   Wikidata; Q54907708
RX   PubMed=20442299;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 6
//
ID   NCH551b
AC   CVCL_A5HU
DR   Wikidata; Q107116534
RX   PubMed=29563135;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NCH57
AC   CVCL_S821
SY   NCH-57
DR   Wikidata; Q54907709
CC   Characteristics: Low-passage-number culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   NCH612
AC   CVCL_X913
DR   cancercelllines; CVCL_X913
DR   CLS; 300121
DR   Wikidata; Q54907711
RX   PubMed=29563135;
CC   Group: Cancer stem cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (CLS=300121).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CLS=300121
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,13
ST   D18S51: 13
ST   D21S11: 28,31
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 11,14
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   NCH620
AC   CVCL_A5HS
DR   Wikidata; Q107116535
RX   PubMed=29563135;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NCH644
AC   CVCL_X914
DR   CLS; 300124
DR   Wikidata; Q54907712
RX   PubMed=24294177;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CLS=300124
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 12,13
ST   D5S818: 9,10
ST   D7S820: 12,13
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 11
//
ID   NCH645
AC   CVCL_A5HT
DR   Wikidata; Q107116537
RX   PubMed=29563135;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NCH690
AC   CVCL_X915
DR   CLS; 300120
DR   Wikidata; Q54907713
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CLS=300120
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 17
ST   D21S11: 29,32
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 11,14
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 12,20
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 11
//
ID   NCH82
AC   CVCL_S822
SY   NCH-82
DR   ChEMBL-Cells; CHEMBL3307323
DR   ChEMBL-Targets; CHEMBL614191
DR   PubChem_Cell_line; CVCL_S822
DR   Wikidata; Q54907714
RX   PubMed=16331629;
CC   Characteristics: Low-passage-number culture.
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   NCH89
AC   CVCL_S823
SY   NCH-89
DR   ChEMBL-Cells; CHEMBL3307480
DR   ChEMBL-Targets; CHEMBL614192
DR   PubChem_Cell_line; CVCL_S823
DR   Wikidata; Q54907715
RX   PubMed=16331629;
CC   Characteristics: Low-passage-number culture.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   NCH93
AC   CVCL_E5ZE
RX   PubMed=30991738;
RX   PubMed=34885009;
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Lys1491Arg (c.4472A>G); ClinVar=VCV000133474; Zygosity=Unspecified (PubMed=30991738).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Asp213fs (c.639delC); Zygosity=Unspecified (PubMed=30991738).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Pro1164Leu (c.3944C>T); ClinVar=VCV000041663; Zygosity=Unspecified (PubMed=30991738).
CC   Derived from site: In situ; Brain, left parieto-occipital lobe.
DI   NCIt; C4051; Anaplastic (malignant) meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCHi001-A
AC   CVCL_C1NN
SY   LCL-iPSC4802
DR   BioSamples; SAMEA110474014
DR   hPSCreg; NCHi001-A
DR   Wikidata; Q114312466
RX   PubMed=36343514;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7775; NFATC1; Simple; chr18:g.7753998G>A; Zygosity=Homozygous; Note=Enhancer (PubMed=36343514).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50462; Aortic valve stenosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   NCHi003-A
AC   CVCL_C1LP
SY   NCH005
DR   BioSamples; SAMEA110464469
DR   hPSCreg; NCHi003-A
DR   Wikidata; Q114312470
RX   PubMed=35987120;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99032; Pulmonary valve atresia with intact ventricular septum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NCHi004-A
AC   CVCL_C1LQ
SY   NCH140
DR   BioSamples; SAMEA112964764
DR   hPSCreg; NCHi004-A
DR   Wikidata; Q114312474
RX   PubMed=37393719;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Karyotypic information: 47,XY,+21 (PubMed=37393719).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C95834; Congenital heart disease
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   NCHi005-A
AC   CVCL_C1LR
SY   NCH013
DR   hPSCreg; NCHi005-A
DR   Wikidata; Q114312475
CC   From: Nationwide Children's Hospital; Columbus; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NCHi006-A
AC   CVCL_C1LS
SY   NCH023
DR   BioSamples; SAMEA110140558
DR   hPSCreg; NCHi006-A
DR   Wikidata; Q114312476
RX   PubMed=35987121;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NCHi007-A
AC   CVCL_C1LT
SY   NCH024
DR   hPSCreg; NCHi007-A
DR   Wikidata; Q114312477
CC   From: Nationwide Children's Hospital; Columbus; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NCHi008-A
AC   CVCL_C1LU
SY   NCH025
DR   hPSCreg; NCHi008-A
DR   Wikidata; Q114312480
CC   From: Nationwide Children's Hospital; Columbus; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NCHi009-A
AC   CVCL_C6RK
SY   NCH78
DR   BioSamples; SAMEA111520029
DR   hPSCreg; NCHi009-A
DR   Wikidata; Q117704721
RX   PubMed=36599283;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly661Ser (c.1981G>A); ClinVar=VCV000264541; Zygosity=Heterozygous (PubMed=36599283).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192088; Aortic valve disease 1
DI   ORDO; Orphanet_402075; Familial bicuspid aortic valve
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   NCHi010-A
AC   CVCL_C9HZ
SY   NCH141
DR   BioSamples; SAMEA113236390
DR   hPSCreg; NCHi010-A
DR   Wikidata; Q123033147
RX   PubMed=37392705;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: African American and Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NCHi011-A
AC   CVCL_C9HY
SY   NCH092
DR   BioSamples; SAMEA114071487
DR   hPSCreg; NCHi011-A
DR   Wikidata; Q123033148
RX   PubMed=37774637;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Ser131Valfs*13 (c.390dupG); ClinVar=VCV000289187; Zygosity=Heterozygous (PubMed=37774637).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NCHi012-A
AC   CVCL_C9HX
SY   NCH089
DR   BioSamples; SAMEA114066532
DR   hPSCreg; NCHi012-A
DR   Wikidata; Q123033149
RX   PubMed=37549562;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Cys496Phefs*9 (c.1485_1486delCT); ClinVar=VCV000234321; Zygosity=Heterozygous (PubMed=37549562).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NCHi013-A
AC   CVCL_D6LA
SY   NCH017; NCH17
DR   BioSamples; SAMEA115343882
DR   hPSCreg; NCHi013-A
DR   Wikidata; Q127382936
RX   PubMed=39121650;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99032; Pulmonary valve atresia with intact ventricular septum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   NCHi014-A
AC   CVCL_D6LB
SY   NCH3-N1HET; NOTCH1+/- iPSC
DR   BioSamples; SAMEA114595741
DR   hPSCreg; NCHi014-A
DR   Wikidata; Q127382937
RX   PubMed=38118204;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Asian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   NCHi015-A
AC   CVCL_D6LC
SY   NCH178
DR   BioSamples; SAMEA115398116
DR   hPSCreg; NCHi015-A
DR   Wikidata; Q127382939
RX   PubMed=38833814;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu956Asp (c.2868G>C); ClinVar=VCV000390095; Zygosity=Heterozygous (PubMed=38833814).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; c.1099+1G>T; ClinVar=VCV002121772; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=38833814).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98880; Persistent truncus arteriosus
DI   ORDO; Orphanet_3384; Truncus arteriosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   NCHi016-A
AC   CVCL_D6LD
SY   NCH012; NCH12
DR   BioSamples; SAMEA115471289
DR   hPSCreg; NCHi016-A
DR   Wikidata; Q127382940
RX   PubMed=39126918;
CC   From: Nationwide Children's Hospital; Columbus; USA.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99032; Pulmonary valve atresia with intact ventricular septum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   NCI-ADR-RES
AC   CVCL_1452
AS   CVCL_0414; CVCL_3942
SY   NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR
DR   BTO; BTO_0004181
DR   MCCL; MCC:0000310
DR   ArrayExpress; E-MTAB-783
DR   BioGRID_ORCS_Cell_line; 390
DR   BioSample; SAMN03151880
DR   BioSample; SAMN03151881
DR   cancercelllines; CVCL_1452
DR   CancerTools; 161022
DR   Cell_Model_Passport; SIDM00089
DR   ChEMBL-Cells; CHEMBL3308057
DR   ChEMBL-Targets; CHEMBL613829
DR   Cosmic; 687498
DR   Cosmic; 897420
DR   Cosmic; 905987
DR   Cosmic; 974233
DR   Cosmic; 1044218
DR   Cosmic; 1092617
DR   Cosmic; 1312358
DR   Cosmic; 1998459
DR   GEO; GSM2099
DR   GEO; GSM50197
DR   GEO; GSM50260
DR   GEO; GSM743473
DR   GEO; GSM750832
DR   GEO; GSM799367
DR   GEO; GSM799430
DR   GEO; GSM839041
DR   GEO; GSM844614
DR   GEO; GSM844615
DR   GEO; GSM847073
DR   GEO; GSM1153433
DR   GEO; GSM1181271
DR   GEO; GSM1181300
DR   GEO; GSM2124672
DR   IARC_TP53; 21533
DR   NCI-DTP; NCI/ADRRES
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   Progenetix; CVCL_1452
DR   PubChem_Cell_line; CVCL_1452
DR   SKY/M-FISH/CGH; 2897
DR   Wikidata; Q54907717
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=9331090;
RX   PubMed=9625176;
RX   PubMed=10700174;
RX   PubMed=11416159;
RX   PubMed=15748285;
RX   PubMed=16504380;
RX   PubMed=17088437;
RX   PubMed=18304946;
RX   PubMed=19372543;
RX   PubMed=20143388;
RX   PubMed=21116879;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27807467;
RX   PubMed=31733513;
RX   PubMed=38861359;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/nci-adrres.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=28
WW   Provider; NCI TTC; TAB-4031/E-115-2021-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4031
CC   Problematic cell line: Contaminated. Shown to be a OVCAR-8 derivative (PubMed=16504380; PubMed=18304946; PubMed=20143388). Originally thought to be a derivative of MCF-7.
CC   Part of: NCI-60 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00234.
CC   Population: Caucasian.
CC   Doubling time: 34 hours (NCI-DTP=NCI/ADRRES).
CC   HLA typing: A*01:01:01,25:01; B*57:01:01; C*06:02; DPB1*02:01:02,13:01; DQB1*03:03:02,06:02; DRB1*07:01,15:01:01 (PubMed=15748285).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=9331090).
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 28
ST   D2S1338: 19,23
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 20
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1629 ! OVCAR-8
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 43
//
ID   NCI-BL1184
AC   CVCL_2635
SY   BL1184; NCI-BL5; BL5
DR   CLO; CLO_0007957
DR   ATCC; CRL-5949
DR   BioSample; SAMN03472611
DR   BioSample; SAMN03472988
DR   Cell_Model_Passport; SIDM01678
DR   DSMZ; ACC-896
DR   DSMZCellDive; ACC-896
DR   Wikidata; Q54907718
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=14762065;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Doubling time: ~44 hours (DSMZ=ACC-896).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5949; DSMZ=ACC-896; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,20
ST   D19S433: 12,14
ST   D21S11: 28,32.2
ST   D2S1338: 18,20
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,11
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 5,7
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16 (ATCC=CRL-5949)
ST   vWA: 16,17 (DSMZ=ACC-896; PubMed=25877200)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1458 ! NCI-H1184
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   NCI-BL128
AC   CVCL_2636
SY   BL128; NCI-H128BL; H128BL
DR   CLO; CLO_0007958
DR   ATCC; CRL-5947
DR   BioSample; SAMN03472609
DR   Cell_Model_Passport; SIDM01681
DR   DepMap; ACH-002362
DR   Wikidata; Q54907719
RX   PubMed=2986243;
RX   PubMed=6270685;
RX   PubMed=6713399;
RX   PubMed=8806092;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5947
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 16.3,17.3
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 17.2,20
ST   Penta D: 11,12
ST   Penta E: 7,14
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1460 ! NCI-H128
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   NCI-BL1339
AC   CVCL_2637
SY   BL1339; NCI-BL6; BL6
DR   CLO; CLO_0007959
DR   ATCC; CRL-5950
DR   BioSample; SAMN03472613
DR   Cell_Model_Passport; SIDM01386
DR   Wikidata; Q54907720
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=9559342;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5950
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A472 ! NCI-H1339
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   NCI-BL134
AC   CVCL_C2W1
SY   NCI-H134BL; H134BL
DR   Wikidata; Q114312485
RX   PubMed=6270685;
RX   PubMed=6713399;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HA42 ! NCI-H134
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   NCI-BL1395
AC   CVCL_2638
SY   BL1395
DR   CLO; CLO_0007960
DR   ATCC; CRL-5957
DR   Cell_Model_Passport; SIDM00643
DR   DepMap; ACH-002363
DR   Wikidata; Q54907721
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=11416159;
RX   PubMed=14762065;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5957; DOI=10.4172/2157-7145.S2-005; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 12,14
ST   D19S433: 13,16
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1467 ! NCI-H1395
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   NCI-BL1437
AC   CVCL_2639
SY   BL1437
DR   CLO; CLO_0007961
DR   ATCC; CRL-5958
DR   BioSample; SAMN03472619
DR   Cell_Model_Passport; SIDM01680
DR   DepMap; ACH-002364
DR   Wikidata; Q54907722
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=11416159;
RX   PubMed=14762065;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5958; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15,19
ST   D21S11: 29,30
ST   D5S818: 11,14
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   TH01: 6,8
ST   TPOX: 9,10
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1472 ! NCI-H1437
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   NCI-BL1450
AC   CVCL_2640
SY   BL1450; NCI-BL7; BL7
DR   CLO; CLO_0007962
DR   ATCC; CRL-5951
DR   BioSample; SAMN03472614
DR   Wikidata; Q54907723
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5951
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,27
ST   Penta D: 11,12
ST   Penta E: 10,14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A466 ! NCI-H1450
OI   CVCL_A495 ! NCI-H1451
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCI-BL1474
AC   CVCL_E096
SY   BL1474
DR   Wikidata; Q54907724
RX   PubMed=8806092;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   NCI-BL1514
AC   CVCL_2641
SY   BL1514; NCI-BL8; BL8
DR   CLO; CLO_0007963
DR   ATCC; CRL-5952
DR   BioSample; SAMN03472615
DR   Wikidata; Q54907725
RX   PubMed=1565469;
RX   PubMed=8806092;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5952
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 11,14
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 20,26
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 5,10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   NCI-BL1607
AC   CVCL_2642
SY   BL1607; NCI-BL9; BL9
DR   CLO; CLO_0007964
DR   ATCC; CRL-5953
DR   BioSample; SAMN03472984
DR   Wikidata; Q54907726
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5953; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 14,18
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 11,12
ST   FGA: 18,25
ST   Penta D: 10,12
ST   Penta E: 11,16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A467 ! NCI-H1607
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCI-BL1648
AC   CVCL_E097
SY   BL1648; NCI-BL10; BL10
DR   ATCC; CRL-5954
DR   BioSample; SAMN03472616
DR   Cosmic; 1887850
DR   Wikidata; Q54907727
RX   PubMed=8806092;
RX   PubMed=9559342;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-5954; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5954
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 8,11
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1482 ! NCI-H1648
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   NCI-BL1672
AC   CVCL_2643
SY   BL1672
DR   CLO; CLO_0007965
DR   ATCC; CRL-5959
DR   BioSample; SAMN03472987
DR   Wikidata; Q54907728
RX   PubMed=8183553;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5959; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D19S433: 15
ST   D21S11: 29,32.2
ST   D2S1338: 21,27
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 8,12
ST   Penta E: 8,9
ST   TH01: 6,10
ST   TPOX: 11,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1486 ! NCI-H1672
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCI-BL1688
AC   CVCL_E098
SY   BL1688
DR   Wikidata; Q54907729
RX   PubMed=8806092;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1487 ! NCI-H1688
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   NCI-BL1770
AC   CVCL_2644
SY   BL1770
DR   CLO; CLO_0007966
DR   ATCC; CRL-5960
DR   BioSample; SAMN03472620
DR   Cell_Model_Passport; SIDM00752
DR   DepMap; ACH-002365
DR   Wikidata; Q54907730
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=11416159;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5960; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1493 ! NCI-H1770
OI   CVCL_1526 ! NCI-H2106
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   NCI-BL1819
AC   CVCL_E099
SY   BL1819
DR   Cell_Model_Passport; SIDM01673
DR   Wikidata; Q54907731
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=11416159;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X
ST   D18S51: 15,17
ST   D21S11: 29
ST   D8S1179: 12,15
ST   FGA: 20,22
ST   TH01: 9,9.3
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1488 ! NCI-H1693
OI   CVCL_1497 ! NCI-H1819
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   NCI-BL1824
AC   CVCL_E100
SY   BL1824
DR   Wikidata; Q54907732
RX   PubMed=8806092;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A512 ! NCI-H1824
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 10
//
ID   NCI-BL1963
AC   CVCL_E101
SY   BL1963
DR   Wikidata; Q54907733
RX   PubMed=8806092;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1510 ! NCI-H1963
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   NCI-BL1993
AC   CVCL_E102
SY   BL1993
DR   Wikidata; Q54907734
RX   PubMed=8806092;
RX   PubMed=24297535;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1512 ! NCI-H1993
OI   CVCL_1521 ! NCI-H2073
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   NCI-BL2009
AC   CVCL_2645
SY   BL2009
DR   CLO; CLO_0007967
DR   ATCC; CRL-5961
DR   BioSample; SAMN03473257
DR   CCRID; 1101HUM-PUMC000382
DR   Cell_Model_Passport; SIDM00736
DR   DepMap; ACH-002366
DR   EGA; EGAS00001000160
DR   Wikidata; Q54907735
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=11416159;
RX   PubMed=14762065;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5961; CCRID=1101HUM-PUMC000382; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 18,21
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14,18
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 16,19
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D6S1043: 15,20
ST   D7S820: 9,11
ST   D8S1179: 10,15
ST   FGA: 22,26
ST   Penta D: 12,13
ST   Penta E: 11,18
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1514 ! NCI-H2009
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   NCI-BL2028
AC   CVCL_2646
SY   BL2028
DR   CLO; CLO_0007968
DR   ATCC; CRL-5962
DR   BioSample; SAMN03472989
DR   Wikidata; Q54907739
RX   PubMed=8806092;
RX   PubMed=25877200;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5962; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 12,18
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 14,18
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 10,12
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A522 ! NCI-H2028
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCI-BL2052
AC   CVCL_2647
SY   BL2052
DR   CLO; CLO_0007969
DR   ATCC; CRL-5963
DR   BioSample; SAMN03472621
DR   Cell_Model_Passport; SIDM00712
DR   DepMap; ACH-002367
DR   Wikidata; Q54907740
RX   PubMed=8806092;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5963
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D19S433: 12,15
ST   D21S11: 29,32.2
ST   D2S1338: 17,18
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 12,16
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1518 ! NCI-H2052
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   NCI-BL2077
AC   CVCL_E103
SY   BL2077
DR   ATCC; CRL-5964
DR   BioSample; SAMN03472622
DR   Cell_Model_Passport; SIDM01669
DR   Wikidata; Q54907741
RX   PubMed=8806092;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-5964; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5964
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5157 ! NCI-H2077
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   NCI-BL2087
AC   CVCL_2648
SY   BL2087
DR   CLO; CLO_0007970
DR   ATCC; CRL-5965
DR   BioSample; SAMN03472625
DR   BioSample; SAMN03473258
DR   BioSample; SAMN05292452
DR   Cell_Model_Passport; SIDM00707
DR   DepMap; ACH-002368
DR   EGA; EGAS00001000160
DR   Wikidata; Q54907742
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=11416159;
RX   PubMed=25877200;
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544502
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (PBCF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5965; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 11,12 (PubMed=25877200)
ST   D5S818: 11,12,13 (ATCC=CRL-5965)
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 20,26
ST   Penta D: 11,12
ST   Penta E: 7,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1524 ! NCI-H2087
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-BL209
AC   CVCL_2649
SY   BL209; NCI-H209BL; H209BL
DR   CLO; CLO_0007971
DR   ATCC; CRL-5948
DR   BioSample; SAMN03472610
DR   Cell_Model_Passport; SIDM00705
DR   DepMap; ACH-002369
DR   Wikidata; Q54907743
RX   PubMed=2986243;
RX   PubMed=6270685;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=14762065;
RX   PubMed=20016488;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5948
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 12.2,15
ST   D21S11: 32.2
ST   D2S1338: 17,20
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1525 ! NCI-H209
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-BL2107
AC   CVCL_2650
SY   BL2107
DR   CLO; CLO_0007972
DR   ATCC; CRL-5966
DR   BioSample; SAMN03472985
DR   Wikidata; Q54907744
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=25877200;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5966; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D18S51: 15,17
ST   D19S433: 12.2,15.2
ST   D21S11: 30
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 13,14
ST   D7S820: 8
ST   D8S1179: 11,14
ST   FGA: 19,22
ST   Penta D: 11
ST   Penta E: 8,13
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1527 ! NCI-H2107
OI   CVCL_1528 ! NCI-H2108
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCI-BL2122
AC   CVCL_2651
SY   BL2122
DR   CLO; CLO_0007973
DR   ATCC; CRL-5967
DR   BioSample; SAMN03472986
DR   Cell_Model_Passport; SIDM00701
DR   DepMap; ACH-002370
DR   Wikidata; Q54907745
RX   PubMed=8806092;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5967; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D18S51: 15,19
ST   D19S433: 12,14
ST   D21S11: 31.2,33.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 19,26
ST   Penta D: 10,12
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1531 ! NCI-H2122
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   NCI-BL2126
AC   CVCL_2652
SY   BL2126
DR   CLO; CLO_0007974
DR   ATCC; CCL-256.1
DR   BioSample; SAMN03471388
DR   BioSample; SAMN05292435
DR   Cell_Model_Passport; SIDM00790
DR   DepMap; ACH-002371
DR   Wikidata; Q54907746
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=11416159;
RX   PubMed=14762065;
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544581
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~66 hours (PBCF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-256.1; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12
ST   FGA: 21,26
ST   Penta D: 10,13
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1532 ! NCI-H2126
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-BL2141
AC   CVCL_2653
SY   BL2141
DR   CLO; CLO_0007975
DR   ATCC; CRL-5955
DR   BioSample; SAMN03472617
DR   Cell_Model_Passport; SIDM00714
DR   Wikidata; Q54907747
RX   PubMed=8806092;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5955
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,14
ST   D16S539: 8,12
ST   D18S51: 14,21
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 24
ST   Penta D: 10,11
ST   Penta E: 11,16
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1519 ! NCI-H2059
OI   CVCL_1534 ! NCI-H2141
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCI-BL2171
AC   CVCL_2654
SY   BL2171
DR   CLO; CLO_0007976
DR   ATCC; CRL-5969
DR   BioSample; SAMN03472626
DR   Cell_Model_Passport; SIDM00717
DR   DepMap; ACH-002372
DR   Wikidata; Q54907748
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=14762065;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5969
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 18,21
ST   D19S433: 15,16
ST   D21S11: 28,32.2
ST   D2S1338: 16,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 12
ST   Penta E: 7,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1536 ! NCI-H2171
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   NCI-BL2195
AC   CVCL_2655
SY   BL2195
DR   CLO; CLO_0007977
DR   ATCC; CRL-5956
DR   BioSample; SAMN03472618
DR   Wikidata; Q54907749
RX   PubMed=8806092;
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5956
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10,14
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 20,21
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1538 ! NCI-H2195
OI   CVCL_1539 ! NCI-H2196
OI   CVCL_1540 ! NCI-H2198
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCI-BL2347
AC   CVCL_2656
SY   BL2347
DR   CLO; CLO_0007978
DR   ATCC; CRL-5970
DR   BioSample; SAMN03472627
DR   Cell_Model_Passport; SIDM00725
DR   Wikidata; Q54907750
RX   PubMed=8806092;
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5970
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 12,19
ST   D19S433: 13,15
ST   D21S11: 31,31.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 20,25
ST   Penta D: 12
ST   Penta E: 8,19
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1550 ! NCI-H2347
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCI-BL26
AC   CVCL_C2W2
SY   NCI-H26BL; H26BL
DR   Wikidata; Q114312489
RX   PubMed=6270685;
RX   PubMed=6713399;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   NCI-BL2882
AC   CVCL_S844
SY   BL2882
DR   Wikidata; Q54907751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5158 ! NCI-H2882
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 9
//
ID   NCI-BL2887
AC   CVCL_S845
SY   BL2887
DR   Wikidata; Q54907752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5159 ! NCI-H2887
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 9
//
ID   NCI-BL289
AC   CVCL_E095
SY   BL289
DR   Wikidata; Q54907753
RX   PubMed=8806092;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A554 ! NCI-H289
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 10
//
ID   NCI-CHOdeltafurin
AC   CVCL_JA54
DR   NCI-DTP; NCI-CHOdeltafurin
DR   Wikidata; Q54907754
RX   PubMed=7806387;
CC   Characteristics: Furin deficient.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   NCI-EC1
AC   CVCL_N841
DR   Cosmic; 1622892
DR   Wikidata; Q54907755
RX   PubMed=21882256;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   NCI-EC2
AC   CVCL_N842
DR   Cosmic; 1622893
DR   Wikidata; Q54907756
RX   PubMed=21882256;
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   NCI-EWS-011
AC   CVCL_M143
SY   EWS-011
DR   Wikidata; Q54907757
RX   PubMed=12441322;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   NCI-EWS-021
AC   CVCL_M144
SY   EWS-021
DR   Wikidata; Q54907758
RX   PubMed=12441322;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   NCI-EWS-94
AC   CVCL_M145
SY   NCI-EWS 94; NCI-EWS-94(JR); EWS-94; JR
DR   Wikidata; Q54907759
RX   PubMed=9865744;
RX   PubMed=11504746;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   NCI-EWS-95
AC   CVCL_M146
SY   NCI-EWS 95; NCI-EWS-95(SB); EWS-95; SB
DR   Wikidata; Q54907760
RX   PubMed=9865744;
RX   PubMed=11504746;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   NCI-H1008
AC   CVCL_A481
SY   H1008; H-1008
DR   Wikidata; Q54907761
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 12
//
ID   NCI-H1011
AC   CVCL_A482
SY   NCI-H-1011; H1011; H-1011
DR   Wikidata; Q54907762
RX   PubMed=3478125;
RX   PubMed=8806089;
RX   PubMed=8806092;
CC   Derived from site: Metastatic; Chest; UBERON=UBERON_0001443.
DI   NCIt; C3789; Olfactory neuroblastoma
DI   ORDO; Orphanet_1957; Esthesioneuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   NCI-H1045
AC   CVCL_A469
SY   H1045; H-1045
DR   Cosmic; 850433
DR   Cosmic; 877368
DR   Cosmic; 1032408
DR   Cosmic; 1891908
DR   GEO; GSM1682801
DR   Wikidata; Q54907763
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20679594;
RX   PubMed=31803961;
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   NCI-H1048
AC   CVCL_1453
SY   H1048; H-1048; NCIH1048
DR   BTO; BTO_0005974
DR   CLO; CLO_0007979
DR   EFO; EFO_0002248
DR   AddexBio; C0016084/5027
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5853
DR   BioGRID_ORCS_Cell_line; 1618
DR   BioSample; SAMN03471878
DR   BioSample; SAMN03472573
DR   BioSample; SAMN10988119
DR   cancercelllines; CVCL_1453
DR   Cell_Model_Passport; SIDM00654
DR   ChEMBL-Cells; CHEMBL3308763
DR   ChEMBL-Targets; CHEMBL1075512
DR   Cosmic; 687995
DR   Cosmic; 844566
DR   Cosmic; 877369
DR   Cosmic; 1152481
DR   Cosmic; 1759253
DR   Cosmic; 1891919
DR   Cosmic; 2125223
DR   Cosmic-CLP; 687995
DR   DepMap; ACH-000866
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 687995
DR   GEO; GSM169449
DR   GEO; GSM827489
DR   GEO; GSM887350
DR   GEO; GSM888428
DR   GEO; GSM1670160
DR   GEO; GSM1887927
DR   GEO; GSM1888016
DR   IARC_TP53; 424
DR   IGRhCellID; NCIH1048
DR   LiGeA; CCLE_450
DR   LINCS_LDP; LCL-1810
DR   PharmacoDB; NCIH1048_1000_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1453
DR   PubChem_Cell_line; CVCL_1453
DR   Wikidata; Q54907764
RX   PubMed=1312696;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=2569043;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Small cell lung cancer p53 hotspot mutation cell panel (ATCC TCP-2040).
CC   Population: African American.
CC   HLA typing: A*23:01,68:02; B*53:01,53:01; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (Cosmic-CLP=687995; DepMap=ACH-000866).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg552Ter (c.1654C>T); ClinVar=VCV000126840; Zygosity=Homozygous (Cosmic-CLP=687995; DepMap=ACH-000866).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (PubMed=1312696; PubMed=1565469; ATCC=CRL-5853; Cosmic-CLP=687995; DepMap=ACH-000866).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=69.86%; Native American=0%; East Asian, North=6.8%; East Asian, South=0%; South Asian=0%; European, North=2.3%; European, South=21.04% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0016084/5027; ATCC=CRL-5853; Cosmic-CLP=687995; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 12
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 31.2,33.2
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 8,15
ST   FGA: 18,22
ST   Penta D: 10
ST   Penta E: 7,8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18,19 (AddexBio=C0016084/5027; ATCC=CRL-5853)
ST   vWA: 17,19 (Cosmic-CLP=687995; PubMed=20679594; PubMed=25877200)
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   NCI-H1059
AC   CVCL_A483
SY   H1059; H-1059
DR   ATCC; CRL-5854
DR   Wikidata; Q54907765
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Discontinued: ATCC; CRL-5854; true.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 13
//
ID   NCI-H1061
AC   CVCL_A484
SY   H1061; H-1061
DR   Cosmic; 844567
DR   Wikidata; Q54907766
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A470 ! NCI-H1062
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H1062
AC   CVCL_A470
SY   H1062; H-1062; HU-1062
DR   Cosmic; 687996
DR   Cosmic; 844568
DR   Cosmic; 877370
DR   Cosmic; 1152482
DR   Wikidata; Q54907767
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A484 ! NCI-H1061
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   NCI-H107
AC   CVCL_D4CB
SY   H107; H-107
DR   Wikidata; Q127382942
RX   PubMed=6272398;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   NCI-H1086
AC   CVCL_A471
SY   H1086; H-1086
DR   Cosmic; 980940
DR   Cosmic; 1032409
DR   Wikidata; Q54907768
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H1092
AC   CVCL_1454
SY   H1092; H-1092; NCIH1092
DR   CLO; CLO_0007980
DR   EFO; EFO_0002249
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5855
DR   BioSample; SAMN03473006
DR   BioSample; SAMN10987995
DR   cancercelllines; CVCL_1454
DR   Cell_Model_Passport; SIDM00653
DR   ChEMBL-Cells; CHEMBL3308311
DR   ChEMBL-Targets; CHEMBL2366351
DR   Cosmic; 687997
DR   Cosmic; 850434
DR   Cosmic; 877104
DR   Cosmic; 877371
DR   Cosmic; 980941
DR   Cosmic; 1021872
DR   Cosmic; 1032410
DR   Cosmic; 1891909
DR   Cosmic; 1995517
DR   Cosmic-CLP; 687997
DR   DepMap; ACH-000514
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687997
DR   GEO; GSM887351
DR   GEO; GSM888429
DR   GEO; GSM1670161
DR   GEO; GSM1682802
DR   GEO; GSM1887929
DR   GEO; GSM1888007
DR   IARC_TP53; 425
DR   IGRhCellID; NCIH1092
DR   KCLB; 91092
DR   LiGeA; CCLE_914
DR   LINCS_LDP; LCL-1836
DR   PharmacoDB; NCIH1092_1001_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1454
DR   PubChem_Cell_line; CVCL_1454
DR   Wikidata; Q54907769
RX   PubMed=1312696;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=11464291;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,03:01; B*08:01,35:03; C*07:01,07:01; DQB1*06:13,06:13; DRB1*15:02,15:02 (PubMed=25960936).
CC   HLA typing: A*01:01,03:01; B*07:05,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp6Gly (c.17A>G); Zygosity=Homozygous (PubMed=11464291; ATCC=CRL-5855; Cosmic-CLP=687997; DepMap=ACH-000514).
CC   Sequence variation: Mutation; HGNC; HGNC:6204; JUN; Simple; p.Glu282Ter (c.844G>T); Zygosity=Heterozygous (Cosmic-CLP=687997; DepMap=ACH-000514).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>C (IVS6-2A>C); ClinVar=VCV000635387; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1312696; PubMed=1565469; DepMap=ACH-000514).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.87%; Native American=0%; East Asian, North=4.65%; East Asian, South=0%; South Asian=0%; European, North=53.89%; European, South=39.59% (PubMed=30894373).
CC   Donor information: Established from a 120 packs per year smoker (ATCC=CRL-5855).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5855; Cosmic-CLP=687997; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 29,33.2
ST   D2S1338: 18,20
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 12,13
ST   Penta E: 13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H1105
AC   CVCL_1455
SY   H1105; H-1105; NCIH1105
DR   CLO; CLO_0007981
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5856
DR   BioSample; SAMN03473007
DR   BioSample; SAMN10987999
DR   cancercelllines; CVCL_1455
DR   Cell_Model_Passport; SIDM00652
DR   Cosmic; 687998
DR   Cosmic; 844569
DR   Cosmic; 877217
DR   Cosmic; 877372
DR   Cosmic; 908468
DR   Cosmic; 980942
DR   Cosmic; 1032411
DR   Cosmic; 1995518
DR   Cosmic-CLP; 908468
DR   DepMap; ACH-000780
DR   EGA; EGAS00001000978
DR   GDSC; 908468
DR   GEO; GSM887352
DR   GEO; GSM888430
DR   GEO; GSM1670162
DR   GEO; GSM1887914
DR   GEO; GSM1887997
DR   IARC_TP53; 27186
DR   LiGeA; CCLE_232
DR   PharmacoDB; NCIH1105_1002_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1455
DR   Wikidata; Q54907770
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Small cell lung cancer p53 hotspot mutation cell panel (ATCC TCP-2040).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,68:01; B*37:09,50:01; C*07:04,07:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (ATCC=CRL-5856; Cosmic-CLP=908468; DepMap=ACH-000780).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.28%; Native American=0%; East Asian, North=1.06%; East Asian, South=0%; South Asian=0%; European, North=62.71%; European, South=34.95% (PubMed=30894373).
CC   Donor information: Established from a 50 packs per year smoker (ATCC=CRL-5856).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5856; Cosmic-CLP=908468; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D21S11: 29,31.2
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H1112
AC   CVCL_A485
SY   H1112; H-1112
DR   Cosmic; 720787
DR   Cosmic; 760394
DR   Cosmic; 2081382
DR   Cosmic; 2302406
DR   Cosmic; 2367272
DR   Wikidata; Q54907771
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8806092;
RX   PubMed=8943038;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   NCI-H1155
AC   CVCL_1456
SY   H1155; H-1155; NCIH1155; NCI-1155
DR   BTO; BTO_0005292
DR   CLO; CLO_0007982
DR   EFO; EFO_0002250
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5818
DR   BCRJ; 0360
DR   BioGRID_ORCS_Cell_line; 953
DR   BioSample; SAMN03471357
DR   BioSample; SAMN10988300
DR   cancercelllines; CVCL_1456
DR   Cell_Model_Passport; SIDM00651
DR   ChEMBL-Cells; CHEMBL3308312
DR   ChEMBL-Targets; CHEMBL2366073
DR   Cosmic; 722065
DR   Cosmic; 724864
DR   Cosmic; 801592
DR   Cosmic; 844815
DR   Cosmic; 852005
DR   Cosmic; 876176
DR   Cosmic; 877264
DR   Cosmic; 877415
DR   Cosmic; 908467
DR   Cosmic; 918002
DR   Cosmic; 934544
DR   Cosmic; 961836
DR   Cosmic; 980970
DR   Cosmic; 1004692
DR   Cosmic; 1032442
DR   Cosmic; 1219080
DR   Cosmic; 1239924
DR   Cosmic; 1870263
DR   Cosmic; 1995519
DR   Cosmic; 2125224
DR   Cosmic; 2668266
DR   Cosmic; 2668330
DR   Cosmic-CLP; 908467
DR   DepMap; ACH-000980
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908467
DR   GEO; GSM62325
DR   GEO; GSM171838
DR   GEO; GSM171839
DR   GEO; GSM206470
DR   GEO; GSM253401
DR   GEO; GSM274799
DR   GEO; GSM274832
DR   GEO; GSM784260
DR   GEO; GSM794308
DR   GEO; GSM817079
DR   GEO; GSM827480
DR   GEO; GSM887353
DR   GEO; GSM888431
DR   GEO; GSM1670163
DR   IARC_TP53; 485
DR   IGRhCellID; NCIH1155
DR   KCLB; 91155
DR   LiGeA; CCLE_163
DR   LINCS_LDP; LCL-1628
DR   PharmacoDB; NCIH1155_1003_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1456
DR   PubChem_Cell_line; CVCL_1456
DR   Wikidata; Q54907773
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=7972006;
RX   PubMed=8806092;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=12068308;
RX   PubMed=16187286;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/h1155-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 23.2 hours (PubMed=29681454).
CC   HLA typing: A*03:01,03:01; B*47:01,47:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg232Ter (c.694C>T); ClinVar=VCV000042248; Zygosity=Heterozygous (Cosmic-CLP=908467; DepMap=ACH-000980).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (PubMed=1311061; PubMed=12068308; Cosmic-CLP=908467; DepMap=ACH-000980).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (Cosmic-CLP=908467; DepMap=ACH-000980).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=10536175; PubMed=20557307; Cosmic-CLP=908467; DepMap=ACH-000980).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.09%; Native American=1%; East Asian, North=2.22%; East Asian, South=0%; South Asian=0.79%; European, North=60.47%; European, South=34.42% (PubMed=30894373).
CC   Discontinued: KCLB; 91155; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5818; Cosmic-CLP=908467; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 16.2
ST   D21S11: 32.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 8
ST   D8S1179: 14,16
ST   FGA: 26
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   NCI-H1173
AC   CVCL_1457
SY   H1173; H-1173
DR   ATCC; CRL-5857
DR   cancercelllines; CVCL_1457
DR   Cosmic; 687999
DR   Cosmic; 1998279
DR   GEO; GSM536326
DR   Progenetix; CVCL_1457
DR   Wikidata; Q54907774
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20615970;
RX   PubMed=31803961;
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5857; true.
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   NCI-H1184
AC   CVCL_1458
SY   H1184; H-1184; NCIH1184
DR   CLO; CLO_0007983
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5858
DR   BioSample; SAMN03472574
DR   BioSample; SAMN03473568
DR   BioSample; SAMN10987606
DR   cancercelllines; CVCL_1458
DR   Cell_Model_Passport; SIDM01679
DR   Cosmic; 688000
DR   Cosmic; 852001
DR   Cosmic; 877218
DR   Cosmic; 980943
DR   Cosmic; 1032412
DR   Cosmic; 1518089
DR   Cosmic; 1891910
DR   Cosmic; 2125225
DR   Cosmic; 2560233
DR   Cosmic; 2628356
DR   DepMap; ACH-000523
DR   DSMZ; ACC-502
DR   DSMZCellDive; ACC-502
DR   GDSC; 688000
DR   GEO; GSM171840
DR   GEO; GSM171841
DR   GEO; GSM794309
DR   GEO; GSM844616
DR   GEO; GSM845539
DR   GEO; GSM887354
DR   GEO; GSM888432
DR   IARC_TP53; 426
DR   LiGeA; CCLE_745
DR   PharmacoDB; NCIH1184_1004_2019
DR   Progenetix; CVCL_1458
DR   Wikidata; Q54907775
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=23716474;
RX   PubMed=24586258;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~50-70 hours (DSMZ=ACC-502).
CC   HLA typing: A*03:01,68:02; B*07:02,07:02; C*04:01,08:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly334Val (c.1001G>T); Zygosity=Unspecified (PubMed=1312696; PubMed=1565469; PubMed=20557307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.45%; Native American=0.52%; East Asian, North=0.92%; East Asian, South=0%; South Asian=0.72%; European, North=65.61%; European, South=31.77% (PubMed=30894373).
CC   Donor information: Established from a 75 packs per year smoker (ATCC=CRL-5858).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5858; DSMZ=ACC-502; PubMed=20679594; PubMed=24586258
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11 (PubMed=24586258)
ST   D16S539: 11,12 (ATCC=CRL-5858; DSMZ=ACC-502; PubMed=20679594)
ST   D18S51: 16,20
ST   D19S433: 12,14
ST   D21S11: 32.2
ST   D2S1338: 18,20
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10,12 (ATCC=CRL-5858; DSMZ=ACC-502; PubMed=24586258)
ST   D7S820: 12 (PubMed=20679594)
ST   D8S1179: 10,11
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 5,7
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16 (ATCC=CRL-5858)
ST   vWA: 16,17 (DSMZ=ACC-502; PubMed=20679594; PubMed=24586258)
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2635 ! NCI-BL1184
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   NCI-H1185
AC   CVCL_A486
SY   H1185; H-1185
DR   Wikidata; Q54907776
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   NCI-H123
AC   CVCL_A487
SY   H123; H-123
DR   Cosmic; 1021851
DR   Wikidata; Q54907778
RX   PubMed=2985257;
RX   PubMed=6272398;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   NCI-H1238
AC   CVCL_1459
SY   H1238; H-1238
DR   CLO; CLO_0007984
DR   ATCC; CRL-5859
DR   BioSample; SAMN03472575
DR   Cosmic; 877219
DR   Cosmic; 877373
DR   Cosmic; 980944
DR   Cosmic; 1032413
DR   GEO; GSM794310
DR   Wikidata; Q54907779
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=22961666;
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a 130 packs per year smoker (ATCC=CRL-5859).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5859
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,14
ST   D16S539: 10
ST   D18S51: 10,12
ST   D19S433: 14,15
ST   D21S11: 28,32.2
ST   D2S1338: 19,26
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 7
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   NCI-H125
AC   CVCL_3968
SY   H125; H-125; NCI-Hut 125; NCI-HUT-125; NCI-HUT 125; HUT-125; HUT 125; HUT125
DR   BTO; BTO_0003010
DR   EFO; EFO_0003116
DR   ATCC; CRL-5801
DR   BioSample; SAMN03471737
DR   cancercelllines; CVCL_3968
DR   CCRID; 1102HUM-NIFDC00022
DR   Cell_Model_Passport; SIDM00106
DR   ChEMBL-Cells; CHEMBL3307888
DR   ChEMBL-Targets; CHEMBL614159
DR   Cosmic; 844593
DR   Cosmic; 877401
DR   Cosmic; 931373
DR   Cosmic; 1028943
DR   Cosmic; 1032431
DR   Cosmic; 1152496
DR   Cosmic; 2560225
DR   GEO; GSM784259
DR   GEO; GSM794271
DR   GEO; GSM817067
DR   IARC_TP53; 486
DR   KCLB; 90125
DR   Progenetix; CVCL_3968
DR   PubChem_Cell_line; CVCL_3968
DR   Wikidata; Q54907780
RX   PubMed=1311061;
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2388294;
RX   PubMed=2473086;
RX   PubMed=3335022;
RX   PubMed=3940644;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=9649128;
RX   PubMed=11030152;
RX   PubMed=11369051;
RX   PubMed=12820372;
RX   PubMed=20679594;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 39 hours (Note=In RPMI 1640 + 10% FBS), 39 hours (Note=In ACL-3), 40 hours (Note=In ACL-3 + BSA) (PubMed=3940644).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238fs (c.714_715ins1); Zygosity=Unspecified (PubMed=1311061; PubMed=12820372).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Unspecified (PubMed=1311061).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5801; true.
CC   Discontinued: KCLB; 90125; probable.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ATCC=CRL-5801; CCRID=1102HUM-NIFDC00022; PubMed=20679594
ST   Amelogenin: X (ATCC=CRL-5801; CCRID=1102HUM-NIFDC00022)
ST   Amelogenin: X,Y (PubMed=20679594)
ST   CSF1PO: 7
ST   D13S317: 11
ST   D16S539: 5,12
ST   D18S51: 20
ST   D21S11: 29,32.2
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   NCI-H1264
AC   CVCL_3970
SY   H1264; H-1264
DR   BTO; BTO_0003012
DR   ATCC; CRL-5860
DR   BioSample; SAMN03151857
DR   BioSample; SAMN03472576
DR   cancercelllines; CVCL_3970
DR   Cosmic; 724865
DR   Cosmic; 844600
DR   Cosmic; 877262
DR   Cosmic; 877416
DR   Cosmic; 903584
DR   Cosmic; 930490
DR   Cosmic; 1152508
DR   Cosmic; 2560226
DR   IARC_TP53; 487
DR   KCLB; 91264
DR   Wikidata; Q54907785
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=9649128;
RX   PubMed=11030152;
RX   PubMed=11369051;
RX   PubMed=12068308;
RX   PubMed=31803961;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/cross-contamination-of-atcc-crl-5802-and-atcc-crl-5860
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/misidentified-cell-lines-atcc-crl-5802-and-atcc-crl-5860
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h1264-atcc-crl-5860
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00410.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from autologous cell line NCI-H157).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=1311061; PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (PubMed=1311061).
CC   Discontinued: ATCC; CRL-5860; true.
CC   Discontinued: KCLB; 91264; probable.
ST   Source(s): ATCC=CRL-5860
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 6,12
ST   vWA: 15
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0463 ! NCI-H157
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   NCI-H128
AC   CVCL_1460
SY   NCI-H-128; H128; H-128; NCI-128; NCIH128
DR   BTO; BTO_0003025
DR   CLO; CLO_0007985
DR   ATCC; CCL-258
DR   ATCC; HTB-120
DR   BioSample; SAMN03471389
DR   cancercelllines; CVCL_1460
DR   Cell_Model_Passport; SIDM00650
DR   ChEMBL-Cells; CHEMBL3307427
DR   ChEMBL-Targets; CHEMBL614771
DR   CLS; 300181
DR   Cosmic; 753597
DR   Cosmic; 756013
DR   Cosmic; 844547
DR   Cosmic; 877199
DR   Cosmic; 980928
DR   Cosmic; 1021852
DR   Cosmic; 1032394
DR   Cosmic; 1219098
DR   Cosmic; 1239936
DR   Cosmic; 1518092
DR   Cosmic; 1998281
DR   Cosmic; 2125226
DR   Cosmic; 2239096
DR   Cosmic; 2699651
DR   Cosmic-CLP; 753597
DR   DepMap; ACH-002286
DR   GDSC; 753597
DR   GEO; GSM171842
DR   GEO; GSM171843
DR   GEO; GSM380508
DR   GEO; GSM536327
DR   GEO; GSM794272
DR   GEO; GSM1670164
DR   GEO; GSM1887961
DR   GEO; GSM1887964
DR   IARC_TP53; 21535
DR   IARC_TP53; 28454
DR   KCLB; 30120
DR   PharmacoDB; NCIH128_1005_2019
DR   Progenetix; CVCL_1460
DR   PubChem_Cell_line; CVCL_1460
DR   Wikidata; Q54907786
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=1563005;
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=2986243;
RX   PubMed=3335022;
RX   PubMed=6108156;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=7736387;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559344;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=20615970;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Unspecified (PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=69.81%; Native American=0%; East Asian, North=2.05%; East Asian, South=0%; South Asian=0.25%; European, North=17.44%; European, South=10.46% (PubMed=30894373).
CC   Discontinued: ATCC; CCL-258; true.
CC   Discontinued: CLS; 300181; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-120; Cosmic-CLP=753597
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 17,18
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 17.2,20
ST   TH01: 6 (Cosmic-CLP=753597)
ST   TH01: 6,9 (ATCC=HTB-120)
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2636 ! NCI-BL128
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   NCI-H1284
AC   CVCL_1461
SY   H1284; H-1284
DR   ATCC; CRL-5861
DR   BioSample; SAMN03472577
DR   Cosmic; 753598
DR   Cosmic; 844570
DR   Cosmic; 877374
DR   Cosmic; 980945
DR   Cosmic; 1021873
DR   Cosmic; 1032414
DR   NCI-DTP; NCI-H1284
DR   Wikidata; Q54907787
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20679594;
RX   PubMed=31803961;
CC   Discontinued: ATCC; CRL-5861; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5861; PubMed=20679594
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,10,11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 20
//
ID   NCI-H1299
AC   CVCL_0060
SY   H1299; H-1299; NCIH1299
DR   BTO; BTO_0002552
DR   CLO; CLO_0007986
DR   EFO; EFO_0003043
DR   MCCL; MCC:0000352
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5803
DR   BCRJ; 0185
DR   BioGRID_ORCS_Cell_line; 234
DR   BioSample; SAMN03471642
DR   BioSample; SAMN03471739
DR   BioSample; SAMN10988385
DR   cancercelllines; CVCL_0060
DR   CCRID; 1101HUM-PUMC000469
DR   CCRID; 1102HUM-NIFDC00050
DR   CCRID; 3101HUMSCSP589
DR   CCRID; 3101HUMTCHu160
DR   CCRID; 4201HUM-CCTCC00640
DR   Cell_Model_Passport; SIDM00649
DR   ChEMBL-Cells; CHEMBL3308501
DR   ChEMBL-Targets; CHEMBL612255
DR   CLS; 300485
DR   Cosmic; 722069
DR   Cosmic; 724831
DR   Cosmic; 877265
DR   Cosmic; 877418
DR   Cosmic; 903585
DR   Cosmic; 961838
DR   Cosmic; 980971
DR   Cosmic; 1004693
DR   Cosmic; 1032443
DR   Cosmic; 1047106
DR   Cosmic; 1066159
DR   Cosmic; 1146875
DR   Cosmic; 1154606
DR   Cosmic; 1175867
DR   Cosmic; 1218870
DR   Cosmic; 1239925
DR   Cosmic; 1609524
DR   Cosmic; 1870264
DR   Cosmic; 1925845
DR   Cosmic; 1995520
DR   Cosmic; 2042873
DR   Cosmic; 2125178
DR   Cosmic; 2630419
DR   Cosmic; 2664126
DR   Cosmic; 2749161
DR   Cosmic; 2772159
DR   Cosmic-CLP; 724831
DR   DepMap; ACH-000510
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 724831
DR   GEO; GSM108807
DR   GEO; GSM108808
DR   GEO; GSM185871
DR   GEO; GSM206471
DR   GEO; GSM253382
DR   GEO; GSM274743
DR   GEO; GSM274744
DR   GEO; GSM353229
DR   GEO; GSM434266
DR   GEO; GSM784253
DR   GEO; GSM794311
DR   GEO; GSM817080
DR   GEO; GSM827467
DR   GEO; GSM844617
DR   GEO; GSM887355
DR   GEO; GSM888433
DR   GEO; GSM1374698
DR   GEO; GSM1374699
DR   GEO; GSM1670165
DR   IARC_TP53; 21537
DR   IARC_TP53; 21722
DR   IGRhCellID; H1299GEO
DR   KCB; KCB2021017YJ
DR   KCLB; 25803
DR   KCLB; 91299
DR   LiGeA; CCLE_300
DR   LINCS_LDP; LCL-1609
DR   Lonza; 796
DR   MetaboLights; MTBLS873
DR   NCI-DTP; NCI-H1299
DR   PharmacoDB; NCIH1299_1006_2019
DR   PRIDE; PXD003743
DR   PRIDE; PXD005291
DR   PRIDE; PXD018581
DR   PRIDE; PXD030304
DR   PRIDE; PXD035746
DR   Progenetix; CVCL_0060
DR   PubChem_Cell_line; CVCL_0060
DR   TOKU-E; 2592
DR   TOKU-E; 3620
DR   Ubigene; YC-D010
DR   Wikidata; Q5628772
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=12068308;
RX   PubMed=17332333;
RX   PubMed=18083107;
RX   PubMed=19153074;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24335698;
RX   PubMed=25485619;
RX   PubMed=25714623;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26929325;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=34737324;
RX   PubMed=35839778;
RX   PubMed=36264037;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-15.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-173.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/H1299
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343); 22.5 hours (PubMed=29681454).
CC   HLA typing: A*24:02,32:01; B*40:02,40:02; C*02:02,02:02; DRB1*01:01,01:01 (PubMed=26589293).
CC   HLA typing: A*24:02,32:01:01; B*40:01,40:02:01; C*03:03:01,02:02:02 (PubMed=26929325).
CC   Karyotypic information: Has lost chromosome Y (PubMed=25714623).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; ATCC=CRL-5803).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=1311061; PubMed=12068308; ATCC=CRL-5803; Cosmic-CLP=724831; DepMap=ACH-000510).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=0%; East Asian, North=2.13%; East Asian, South=0%; South Asian=0%; European, North=62.86%; European, South=34.68% (PubMed=30894373).
CC   Misspelling: HI299; Note=Occasionally.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5803; CCRID; Cosmic-CLP=724831; PubMed=20679594; PubMed=24335698; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,17
ST   D12S391: 21
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 14
ST   D1S1656: 12,15
ST   D21S11: 32.2
ST   D22S1045: 15,16
ST   D2S1338: 23,24
ST   D2S441: 11,13
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20
ST   Penta D: 13
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17,18 (ATCC=CRL-5803; CCRID)
ST   vWA: 16,18 (Cosmic-CLP=724831; PubMed=20679594; PubMed=24335698; PubMed=25877200; Technion Genomics Center)
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   NCI-H1299-EGFP
AC   CVCL_XB25
DR   cancercelllines; CVCL_XB25
DR   CLS; 300272
DR   Wikidata; Q95993116
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000644). It was the sole source of information for this entry.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 21,22
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   NCI-H1299-Luc
AC   CVCL_C8W0
DR   Ubigene; YC-D010-Luc-P
DR   Wikidata; Q123033151
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   NCI-H1299-Luc2-tdT-2
AC   CVCL_XE62
DR   cancercelllines; CVCL_XE62
DR   CCRID; 1101HUM-PUMC000645
DR   Wikidata; Q95993117
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000645
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 21,22
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   NCI-H1299-mCherry
AC   CVCL_XB24
DR   cancercelllines; CVCL_XB24
DR   CCRID; 1101HUM-PUMC000643
DR   Wikidata; Q95993119
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000643
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 21,22
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   NCI-H1299-tdT
AC   CVCL_XB26
DR   cancercelllines; CVCL_XB26
DR   CCRID; 1101HUM-PUMC000642
DR   Wikidata; Q95993121
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000642
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 21,22
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 11
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 20
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   NCI-H1299/Cas9 AAVS1
AC   CVCL_C9BI
SY   NCI-H1299-Cas9 AAVS1
DR   GeneCopoeia; SL501
DR   Wikidata; Q123033152
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a CMV-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-PuroR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL501).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   NCI-H1299/Cas9-hyg
AC   CVCL_C9BJ
DR   GeneCopoeia; SL533
DR   Wikidata; Q123033153
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL533).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   NCI-H1304
AC   CVCL_1462
SY   H1304; H-1304; NCIH1304
DR   CLO; CLO_0007987
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5862
DR   BioSample; SAMN03151858
DR   BioSample; SAMN03472578
DR   cancercelllines; CVCL_1462
DR   Cell_Model_Passport; SIDM00648
DR   ChEMBL-Cells; CHEMBL3308554
DR   ChEMBL-Targets; CHEMBL2366266
DR   Cosmic; 753599
DR   Cosmic; 877220
DR   Cosmic; 877375
DR   Cosmic; 1021874
DR   Cosmic; 1032415
DR   Cosmic-CLP; 753599
DR   DepMap; ACH-002169
DR   EGA; EGAS00001000978
DR   GDSC; 753599
DR   GEO; GSM1670166
DR   IARC_TP53; 27187
DR   LINCS_LDP; LCL-2058
DR   PharmacoDB; NCIH1304_1007_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1462
DR   Wikidata; Q54907788
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20679594;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h1304-atcc-crl-5862
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00411.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Heterozygous (Cosmic-CLP=753599; DepMap=ACH-002169).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Met761Ilefs*4 (c.2283delG); Zygosity=Heterozygous (Cosmic-CLP=753599; DepMap=ACH-002169).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Homozygous (Cosmic-CLP=753599; DepMap=ACH-002169).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.09%; Native American=0.31%; East Asian, North=1.44%; East Asian, South=0.13%; South Asian=0%; European, North=72.97%; European, South=24.05% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-5862; true.
ST   Source(s): ATCC=CRL-5862; Cosmic-CLP=753599; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1502 ! NCI-H1870
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   NCI-H1315
AC   CVCL_A488
SY   H1315; H-1315
DR   Wikidata; Q54907789
RX   PubMed=8806092;
RX   PubMed=11030152;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   NCI-H1330
AC   CVCL_A489
SY   H1330; H-1330
DR   Wikidata; Q54907790
RX   PubMed=8806092;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1334
AC   CVCL_3971
SY   H1334; H-1334
DR   BTO; BTO_0003011
DR   EFO; EFO_0003117
DR   ATCC; CRL-5863
DR   cancercelllines; CVCL_3971
DR   Cosmic; 844596
DR   Cosmic; 877419
DR   Cosmic; 903586
DR   Cosmic; 980972
DR   Cosmic; 1032444
DR   Cosmic; 1152509
DR   Cosmic; 1891888
DR   IARC_TP53; 488
DR   KCLB; 91334
DR   Wikidata; Q54907791
RX   PubMed=1311061;
RX   PubMed=2386953;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=11416159;
RX   PubMed=31803961;
CC   Problematic cell line: Probably contaminated. The STR profile is identical to that of the NCI-H322 cell line. Originally thought to originate from a 56 year old male patient with a large cell lung carcinoma.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Asp (c.672G>C); ClinVar=VCV001493447; Zygosity=Unspecified (PubMed=1311061).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-5863; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
ST   Source(s): ATCC=CRL-5863; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 28
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1556 ! NCI-H322
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   NCI-H1339
AC   CVCL_A472
AS   CVCL_2052
SY   H1339; H-1339; NCIH1339
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5979
DR   BioSample; SAMN03473058
DR   BioSample; SAMN10987986
DR   cancercelllines; CVCL_A472
DR   Cell_Model_Passport; SIDM01387
DR   Cosmic; 877376
DR   Cosmic; 980946
DR   Cosmic; 1032416
DR   Cosmic; 1239942
DR   Cosmic; 1513490
DR   Cosmic; 1891911
DR   Cosmic; 2125227
DR   DSMZ; ACC-506
DR   DSMZCellDive; ACC-506
DR   GEO; GSM887356
DR   GEO; GSM888434
DR   IARC_TP53; 427
DR   LiGeA; CCLE_064
DR   PharmacoDB; NCIH1339_1008_2019
DR   Progenetix; CVCL_A472
DR   Wikidata; Q54907792
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some cultures of NCI-H1339 are contaminated with NCI-H157 or NCI-1264 (PubMed=25877200).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00534.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>T (IVS9+1G>T); ClinVar=VCV000634766; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=1312696; PubMed=1565469; PubMed=20557307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=70.93%; Native American=1.01%; East Asian, North=4.29%; East Asian, South=0%; South Asian=0%; European, North=11.76%; European, South=12.01% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-5979; true.
CC   Discontinued: DSMZ; ACC-506; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-506; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 11,13
ST   D21S11: 32
ST   D2S1338: 21,22
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 14,16
ST   FGA: 22,23 (PubMed=25877200)
ST   FGA: 22,23,28 (DSMZ=ACC-506)
ST   Penta D: 2.2 (PubMed=25877200)
ST   Penta D: 3 (DSMZ=ACC-506)
ST   Penta E: 7
ST   TH01: 7,9
ST   TPOX: 6,12
ST   vWA: 15
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2637 ! NCI-BL1339
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H134
AC   CVCL_HA42
SY   H134
DR   Wikidata; Q54907793
RX   PubMed=6108156;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C2W1 ! NCI-BL134
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   NCI-H1341
AC   CVCL_1463
SY   H1341; H-1341; NCIH1341
DR   CLO; CLO_0007988
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5864
DR   BioSample; SAMN03472580
DR   BioSample; SAMN10987643
DR   cancercelllines; CVCL_1463
DR   Cell_Model_Passport; SIDM00646
DR   Cosmic; 844571
DR   Cosmic; 877377
DR   Cosmic; 1152483
DR   Cosmic-CLP; 1330964
DR   DepMap; ACH-000129
DR   EGA; EGAS00001000978
DR   GDSC; 1330964
DR   GEO; GSM887357
DR   GEO; GSM888435
DR   GEO; GSM986178
DR   GEO; GSM1670167
DR   GEO; GSM1682803
DR   GEO; GSM1887941
DR   GEO; GSM1888017
DR   IARC_TP53; 30127
DR   LiGeA; CCLE_587
DR   PharmacoDB; NCIH1341_1009_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1463
DR   Wikidata; Q54907794
RX   PubMed=1563005;
RX   PubMed=2569043;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=38180245;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*25:01,31:01; B*18:01,44:02; C*05:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.96%; East Asian, North=2.27%; East Asian, South=0%; South Asian=0.84%; European, North=70.16%; European, South=25.77% (PubMed=30894373).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-5864; Cosmic-CLP=1330964; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 18
ST   D3S1358: 14,16
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 12,15
ST   FGA: 21,24
ST   Penta D: 9,13
ST   Penta E: 7,15
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7982; Cervical small cell carcinoma
DI   ORDO; Orphanet_213777; High-grade neuroendocrine carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   NCI-H1355
AC   CVCL_1464
SY   H1355; H-1355; NCIH1355
DR   BTO; BTO_0004823
DR   CLO; CLO_0007989
DR   EFO; EFO_0002251
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5865
DR   BioGRID_ORCS_Cell_line; 954
DR   BioSample; SAMN03471876
DR   BioSample; SAMN10987956
DR   cancercelllines; CVCL_1464
DR   Cell_Model_Passport; SIDM00645
DR   ChEMBL-Cells; CHEMBL3308876
DR   ChEMBL-Targets; CHEMBL2366227
DR   Cosmic; 722056
DR   Cosmic; 724866
DR   Cosmic; 903587
DR   Cosmic; 1146876
DR   Cosmic; 1995521
DR   Cosmic-CLP; 724866
DR   DepMap; ACH-000666
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724866
DR   GEO; GSM108809
DR   GEO; GSM108810
DR   GEO; GSM253322
DR   GEO; GSM434326
DR   GEO; GSM482107
DR   GEO; GSM794312
DR   GEO; GSM817081
DR   GEO; GSM844618
DR   GEO; GSM887358
DR   GEO; GSM888436
DR   GEO; GSM1670168
DR   IARC_TP53; 489
DR   IGRhCellID; NCIH1355
DR   KCLB; 91355
DR   LiGeA; CCLE_865
DR   LINCS_LDP; LCL-1669
DR   PharmacoDB; NCIH1355_1010_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1464
DR   PubChem_Cell_line; CVCL_1464
DR   Wikidata; Q54907795
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 48.8 hours (PubMed=29681454).
CC   HLA typing: A*02:01,02:01; B*35:08,50:01; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Gly2044Asp (c.6131G>A); ClinVar=VCV000495479; Zygosity=Homozygous (Cosmic-CLP=724866; DepMap=ACH-000666).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Heterozygous (PubMed=1311061; PubMed=12068308; Cosmic-CLP=724866; DepMap=ACH-000666).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; Cosmic-CLP=724866; DepMap=ACH-000666).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.64%; Native American=0%; East Asian, North=2.95%; East Asian, South=0.42%; South Asian=4.77%; European, North=41.22%; European, South=49.01% (PubMed=30894373).
CC   Discontinued: KCLB; 91355; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5865; Cosmic-CLP=724866; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,13
ST   D18S51: 11,17
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 21,23
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 13,15
ST   Penta E: 14 (PubMed=25877200)
ST   Penta E: 14,19 (ATCC=CRL-5865)
ST   TH01: 9
ST   TPOX: 9,12
ST   vWA: 14,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   NCI-H1373
AC   CVCL_1465
SY   H1373; H-1373; NCIH1373
DR   CLO; CLO_0007990
DR   EFO; EFO_0006657
DR   AddexBio; C0016047/5012
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-5866
DR   BioGRID_ORCS_Cell_line; 186
DR   BioSample; SAMN03470836
DR   BioSample; SAMN10988153
DR   cancercelllines; CVCL_1465
DR   Cell_Model_Passport; SIDM01677
DR   ChEMBL-Cells; CHEMBL4296202
DR   ChEMBL-Targets; CHEMBL4296389
DR   Cosmic; 722040
DR   Cosmic; 903588
DR   Cosmic; 930488
DR   Cosmic; 980973
DR   Cosmic; 1032445
DR   DepMap; ACH-000845
DR   EGA; EGAS00001000610
DR   GEO; GSM794313
DR   GEO; GSM817082
DR   GEO; GSM887359
DR   GEO; GSM888437
DR   IARC_TP53; 490
DR   KCLB; 91373
DR   PharmacoDB; NCIH1373_1011_2019
DR   Progenetix; CVCL_1465
DR   PubChem_Cell_line; CVCL_1465
DR   Wikidata; Q54907796
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: African American.
CC   Doubling time: 36.7 hours (PubMed=29681454).
CC   HLA typing: A*68:02,68:02; B*15:10,53:01; C*03:04,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=1311061; DepMap=ACH-000845).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro47Leu (c.140C>T); Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; DepMap=ACH-000845).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=71.79%; Native American=1.21%; East Asian, North=4.32%; East Asian, South=0%; South Asian=0%; European, North=11.21%; European, South=11.46% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016047/5012; ATCC=CRL-5866; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 6
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 12
ST   D21S11: 28,30.2
ST   D2S1338: 16,22
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,16
ST   FGA: 20,24
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   NCI-H1378
AC   CVCL_A490
SY   H1378; H-1378
DR   Wikidata; Q54907798
RX   PubMed=8806092;
RX   PubMed=31803961;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NCI-H1385
AC   CVCL_1466
SY   H1385; H-1385; NCIH1385
DR   CLO; CLO_0007991
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5867
DR   BioSample; SAMN03472581
DR   BioSample; SAMN10988439
DR   cancercelllines; CVCL_1466
DR   Cell_Model_Passport; SIDM01676
DR   Cosmic; 687793
DR   Cosmic; 722041
DR   Cosmic; 877420
DR   Cosmic; 903589
DR   Cosmic; 930489
DR   Cosmic; 980974
DR   Cosmic; 1032446
DR   Cosmic; 1219081
DR   Cosmic; 1891889
DR   Cosmic; 2125228
DR   DepMap; ACH-000737
DR   FANTOM5_SSTAR; 10730-110B1
DR   GDSC; 1330965
DR   GEO; GSM794314
DR   GEO; GSM887360
DR   GEO; GSM888438
DR   IARC_TP53; 30128
DR   KCLB; 91385
DR   LiGeA; CCLE_839
DR   LINCS_LDP; LCL-1624
DR   PharmacoDB; NCIH1385_1012_2019
DR   Progenetix; CVCL_1466
DR   Wikidata; Q54907799
RX   PubMed=1311061;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: African American.
CC   HLA typing: A*03:01,34:02; B*58:02,58:02; C*06:02,06:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (DepMap=ACH-000737).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=69.29%; Native American=0%; East Asian, North=3.93%; East Asian, South=0%; South Asian=0%; European, North=10.32%; European, South=16.46% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5867; KCLB=91385
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D19S433: 11.2,13
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 14,18
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 14,16
ST   FGA: 24
ST   Penta D: 8
ST   Penta E: 7,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H1387
AC   CVCL_A491
SY   H1387; H-1387
DR   Wikidata; Q54907800
RX   PubMed=8806092;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NCI-H1395
AC   CVCL_1467
SY   H1395; H-1395; NCIH1395
DR   CLO; CLO_0007992
DR   EFO; EFO_0002252
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5868
DR   BioSample; SAMN03471877
DR   BioSample; SAMN10988320
DR   cancercelllines; CVCL_1467
DR   CCRID; 3101HUMSCSP539
DR   CCRID; 3101HUMTCHu163
DR   Cell_Model_Passport; SIDM00644
DR   ChEMBL-Cells; CHEMBL3308313
DR   ChEMBL-Targets; CHEMBL2366201
DR   CLS; 305118
DR   Cosmic; 684681
DR   Cosmic; 877421
DR   Cosmic; 903590
DR   Cosmic; 917387
DR   Cosmic; 961839
DR   Cosmic; 980975
DR   Cosmic; 1006535
DR   Cosmic; 1032447
DR   Cosmic; 1146877
DR   Cosmic; 1154593
DR   Cosmic; 1209731
DR   Cosmic; 1219082
DR   Cosmic; 1239884
DR   Cosmic; 1518082
DR   Cosmic; 1802318
DR   Cosmic; 1891890
DR   Cosmic; 1995522
DR   Cosmic; 2125192
DR   Cosmic; 2630414
DR   Cosmic-CLP; 684681
DR   DepMap; ACH-000327
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 684681
DR   GEO; GSM62324
DR   GEO; GSM108811
DR   GEO; GSM108812
DR   GEO; GSM253353
DR   GEO; GSM434277
DR   GEO; GSM645857
DR   GEO; GSM721892
DR   GEO; GSM784222
DR   GEO; GSM794315
DR   GEO; GSM817083
DR   GEO; GSM844619
DR   GEO; GSM844620
DR   GEO; GSM887361
DR   GEO; GSM888439
DR   GEO; GSM1670169
DR   IARC_TP53; 27566
DR   IGRhCellID; NCIH1395
DR   LiGeA; CCLE_755
DR   LINCS_LDP; LCL-1660
DR   NCI-DTP; NCI-H1395
DR   PharmacoDB; NCIH1395_1013_2019
DR   Progenetix; CVCL_1467
DR   PubChem_Cell_line; CVCL_1467
DR   Wikidata; Q54907801
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=14762065;
RX   PubMed=16157194;
RX   PubMed=16187286;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27602502;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35117401;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H1395.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 50.5 hours (PubMed=29681454).
CC   HLA typing: A*01:01,02:01; B*15:01,40:01; C*03:03,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Thr2666Ala (c.7996A>G); ClinVar=VCV000219594; Zygosity=Homozygous (PubMed=27602502).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Ala (c.1406G>C); ClinVar=VCV000013971; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.03%; Native American=0%; East Asian, North=6.76%; East Asian, South=0%; South Asian=0%; European, North=52.83%; European, South=37.38% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5868; CCRID; Cosmic-CLP=684681; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 12,14
ST   D19S433: 13,16
ST   D21S11: 29
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   Penta D: 12
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2638 ! NCI-BL1395
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H140
AC   CVCL_JZ80
SY   H140
DR   Wikidata; Q54907802
RX   PubMed=2986243;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 8
//
ID   NCI-H1404
AC   CVCL_1468
SY   H1404; H-1404
DR   CLO; CLO_0007993
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-5819
DR   BioSample; SAMN03471744
DR   cancercelllines; CVCL_1468
DR   Cosmic; 877422
DR   Cosmic; 903591
DR   GDSC; 1330969
DR   IARC_TP53; 491
DR   IGRhCellID; NCIH1404
DR   KCLB; 91404
DR   LINCS_LDP; LCL-1912
DR   PharmacoDB; NCIH1404_1014_2019
DR   Progenetix; CVCL_1468
DR   Wikidata; Q54907803
RX   PubMed=1311061;
RX   PubMed=2386953;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20215515;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Unspecified (PubMed=1311061).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: KCLB; 91404; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5819
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,14
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 11,14
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 18
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 19
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   NCI-H1412
AC   CVCL_A492
SY   H1412; H-1412
DR   Wikidata; Q54907804
RX   PubMed=8806092;
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   NCI-H1417
AC   CVCL_1469
SY   H1417; H-1417; NCIH1417
DR   CLO; CLO_0007994
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5869
DR   BCRJ; 0186
DR   BioSample; SAMN03473062
DR   cancercelllines; CVCL_1469
DR   Cell_Model_Passport; SIDM00642
DR   ChEMBL-Cells; CHEMBL3308854
DR   ChEMBL-Targets; CHEMBL2366149
DR   Cosmic; 688001
DR   Cosmic; 877221
DR   Cosmic; 877378
DR   Cosmic; 931447
DR   Cosmic; 980947
DR   Cosmic; 1032417
DR   Cosmic; 2125170
DR   Cosmic-CLP; 688001
DR   DepMap; ACH-001591
DR   EGA; EGAS00001000978
DR   GDSC; 688001
DR   GEO; GSM169432
DR   GEO; GSM170716
DR   GEO; GSM170718
DR   GEO; GSM827504
DR   GEO; GSM1670170
DR   GEO; GSM1887930
DR   GEO; GSM1888008
DR   IARC_TP53; 21538
DR   LINCS_LDP; LCL-1837
DR   PharmacoDB; NCIH1417_1015_2019
DR   Progenetix; CVCL_1469
DR   PubChem_Cell_line; CVCL_1469
DR   Wikidata; Q54907805
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Small cell lung cancer p53 hotspot mutation cell panel (ATCC TCP-2040).
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Homozygous (ATCC=CRL-5869).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.09%; Native American=0%; East Asian, North=1.05%; East Asian, South=0.15%; South Asian=4.06%; European, North=67.94%; European, South=26.71% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5869; Cosmic-CLP=688001; DepMap=ACH-001591; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 17,18
ST   D19S433: 13.2,16
ST   D21S11: 28,29
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   NCI-H1435
AC   CVCL_1470
SY   H1435; H-1435; NCIH1435
DR   BTO; BTO_0003004
DR   CLO; CLO_0007995
DR   EFO; EFO_0006658
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5870
DR   BioSample; SAMN03471391
DR   BioSample; SAMN10988518
DR   cancercelllines; CVCL_1470
DR   Cell_Model_Passport; SIDM00658
DR   Cosmic; 903592
DR   Cosmic; 1028944
DR   Cosmic; 2630412
DR   Cosmic-CLP; 1298347
DR   DepMap; ACH-000852
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298347
DR   GEO; GSM206472
DR   GEO; GSM274800
DR   GEO; GSM274833
DR   GEO; GSM827361
DR   GEO; GSM887362
DR   GEO; GSM888440
DR   GEO; GSM1670171
DR   GEO; GSM1682804
DR   IARC_TP53; 492
DR   KCLB; 91435
DR   LiGeA; CCLE_049
DR   LINCS_LDP; LCL-1610
DR   Lonza; 1211
DR   NCI-DTP; NCI-H1435
DR   PharmacoDB; NCIH1435_1016_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1470
DR   Wikidata; Q54907806
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   HLA typing: A*01:01,01:01; B*08:01,37:04; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1158fs*7 (c.3471_3476GAGACC>AAAAA); Zygosity=Heterozygous (Cosmic-CLP=1298347).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>A (c.228C>A) (C228A); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141Trp (c.423C>G); ClinVar=VCV000376564; Zygosity=Homozygous (PubMed=1311061; DepMap=ACH-000852).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.26%; Native American=15.63%; East Asian, North=9.39%; East Asian, South=0%; South Asian=0%; European, North=41.04%; European, South=31.67% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5870; Cosmic-CLP=1298347; KCLB=91435; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 12,14
ST   D8S1179: 12,13
ST   FGA: 22 (KCLB=91435)
ST   FGA: 22,23 (ATCC=CRL-5870; PubMed=25877200)
ST   Penta D: 11,12
ST   Penta E: 5,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H1436
AC   CVCL_1471
SY   H1436; H-1436; NCIH1436
DR   CLO; CLO_0007996
DR   EFO; EFO_0002253
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5871
DR   BioSample; SAMN03473008
DR   BioSample; SAMN10988000
DR   cancercelllines; CVCL_1471
DR   Cell_Model_Passport; SIDM00697
DR   ChEMBL-Cells; CHEMBL3308893
DR   ChEMBL-Targets; CHEMBL2366205
DR   Cosmic; 688002
DR   Cosmic; 844572
DR   Cosmic; 908469
DR   Cosmic; 2125229
DR   Cosmic-CLP; 908469
DR   DepMap; ACH-000830
DR   EGA; EGAS00001000978
DR   GDSC; 908469
DR   GEO; GSM887363
DR   GEO; GSM888441
DR   GEO; GSM1670172
DR   GEO; GSM1682805
DR   GEO; GSM1887931
DR   GEO; GSM1888009
DR   IARC_TP53; 254
DR   IARC_TP53; 21539
DR   IGRhCellID; NCIH1436
DR   KCLB; 91436
DR   LiGeA; CCLE_790
DR   LINCS_LDP; LCL-1838
DR   PharmacoDB; NCIH1436_1017_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1471
DR   PubChem_Cell_line; CVCL_1471
DR   Wikidata; Q54907807
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,11:01; B*07:02,18:01; C*12:03,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Gln (c.537T>G); ClinVar=VCV000376607; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.29%; Native American=0.28%; East Asian, North=3.22%; East Asian, South=0%; South Asian=1.4%; European, North=67.17%; European, South=27.63% (PubMed=30894373).
CC   Donor information: Established from a 75 packs per year smoker (ATCC=CRL-5871).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5871; Cosmic-CLP=908469; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 30.2,32.2
ST   D2S1338: 17,21
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 8,13
ST   FGA: 19,21
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H1437
AC   CVCL_1472
SY   H1437; H-1437; NCIH1437
DR   BTO; BTO_0003244
DR   CLO; CLO_0007997
DR   EFO; EFO_0002254
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5872
DR   BioGRID_ORCS_Cell_line; 541
DR   BioSample; SAMN03471451
DR   BioSample; SAMN10987891
DR   cancercelllines; CVCL_1472
DR   CCRID; 3101HUMSCSP591
DR   Cell_Model_Passport; SIDM00734
DR   ChEMBL-Cells; CHEMBL3308764
DR   ChEMBL-Targets; CHEMBL1075513
DR   CLS; 305110
DR   Cosmic; 687794
DR   Cosmic; 877241
DR   Cosmic; 877423
DR   Cosmic; 903593
DR   Cosmic; 917388
DR   Cosmic; 980976
DR   Cosmic; 1032448
DR   Cosmic; 1146878
DR   Cosmic; 1219084
DR   Cosmic; 1239885
DR   Cosmic; 1320186
DR   Cosmic; 1518083
DR   Cosmic; 1694666
DR   Cosmic; 1889784
DR   Cosmic; 1891891
DR   Cosmic; 1995523
DR   Cosmic; 2125230
DR   Cosmic-CLP; 687794
DR   DepMap; ACH-000589
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS117IRE
DR   ENCODE; ENCBS769XMO
DR   GDSC; 687794
DR   GEO; GSM108813
DR   GEO; GSM108814
DR   GEO; GSM253308
DR   GEO; GSM434302
DR   GEO; GSM513939
DR   GEO; GSM514325
DR   GEO; GSM784208
DR   GEO; GSM794316
DR   GEO; GSM817084
DR   GEO; GSM827483
DR   GEO; GSM887364
DR   GEO; GSM888442
DR   GEO; GSM1374700
DR   GEO; GSM1374701
DR   GEO; GSM1670173
DR   IARC_TP53; 493
DR   IGRhCellID; NCIH1437
DR   KCLB; 91437
DR   LiGeA; CCLE_279
DR   LINCS_LDP; LCL-1637
DR   NCI-DTP; NCI-H1437
DR   PharmacoDB; NCIH1437_1018_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1472
DR   PubChem_Cell_line; CVCL_1472
DR   Wikidata; Q54907808
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=16157194;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H1437.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 44 hours (PubMed=25984343); 28.7 hours (PubMed=29681454).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Pro (c.800G>C); ClinVar=VCV000428867; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; ATCC=CRL-5872; Cosmic-CLP=687794; DepMap=ACH-000589).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.16%; East Asian, North=1.67%; East Asian, South=0%; South Asian=0%; European, North=68.74%; European, South=28.43% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5872; Cosmic-CLP=687794; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 19
ST   D19S433: 15.2
ST   D21S11: 29 (PubMed=25877200)
ST   D21S11: 29,30 (ATCC=CRL-5872)
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11,14
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 22
ST   Penta D: 10 (PubMed=25877200)
ST   Penta D: 10,12 (ATCC=CRL-5872)
ST   Penta E: 5,11
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2639 ! NCI-BL1437
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   NCI-H1437/Cas9-hyg
AC   CVCL_C9BM
DR   GeneCopoeia; SL536
DR   Wikidata; Q123033154
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL536).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Pro (c.800G>C); ClinVar=VCV000428867; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1472 ! NCI-H1437
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   NCI-H1440
AC   CVCL_A493
SY   H1440; H-1440
DR   Wikidata; Q54907809
RX   PubMed=8806092;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H1447
AC   CVCL_A494
SY   H1447; H-1447
DR   Wikidata; Q54907810
RX   PubMed=8806092;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   NCI-H1450
AC   CVCL_A466
SY   H1450; H-1450
DR   cancercelllines; CVCL_A466
DR   Cosmic; 844573
DR   Cosmic; 877222
DR   Cosmic; 877379
DR   Cosmic; 980948
DR   Cosmic; 1021875
DR   Cosmic; 1032418
DR   Cosmic; 1152484
DR   Cosmic; 1239943
DR   Cosmic; 1518100
DR   Cosmic; 2125231
DR   IARC_TP53; 255
DR   Wikidata; Q54907811
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469; PubMed=20557307).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2640 ! NCI-BL1450
OI   CVCL_A495 ! NCI-H1451
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   NCI-H1451
AC   CVCL_A495
SY   H1451; H-1451
DR   Wikidata; Q54907812
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2640 ! NCI-BL1450
OI   CVCL_A466 ! NCI-H1450
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
ID   NCI-H146
AC   CVCL_1473
SY   H146; H-146; NCIH146
DR   BTO; BTO_0003024
DR   CLO; CLO_0007998
DR   EFO; EFO_0006659
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-173
DR   BCRC; 60280
DR   BioSample; SAMN03473245
DR   BioSample; SAMN10988324
DR   cancercelllines; CVCL_1473
DR   Cell_Model_Passport; SIDM00698
DR   ChEMBL-Cells; CHEMBL4523541
DR   ChEMBL-Targets; CHEMBL4523572
DR   CLS; 300182
DR   Cosmic; 688003
DR   Cosmic; 755462
DR   Cosmic; 850431
DR   Cosmic; 877200
DR   Cosmic; 910899
DR   Cosmic; 980929
DR   Cosmic; 1021853
DR   Cosmic; 1032395
DR   Cosmic; 1434965
DR   Cosmic; 1995524
DR   Cosmic; 1998282
DR   Cosmic; 2668273
DR   Cosmic-CLP; 910899
DR   DepMap; ACH-000506
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910899
DR   GEO; GSM169433
DR   GEO; GSM170726
DR   GEO; GSM170727
DR   GEO; GSM171844
DR   GEO; GSM171845
DR   GEO; GSM380509
DR   GEO; GSM536328
DR   GEO; GSM784247
DR   GEO; GSM794273
DR   GEO; GSM844621
DR   GEO; GSM845540
DR   GEO; GSM887365
DR   GEO; GSM888443
DR   GEO; GSM986172
DR   GEO; GSM1670174
DR   GEO; GSM1887887
DR   GEO; GSM1887965
DR   IARC_TP53; 21540
DR   IGRhCellID; NCIH146
DR   KCLB; 30173
DR   LiGeA; CCLE_628
DR   PharmacoDB; NCIH146_1019_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1473
DR   PubChem_Cell_line; CVCL_1473
DR   Wikidata; Q54907813
RX   PubMed=1320893;
RX   PubMed=1563005;
RX   PubMed=2388294;
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=3335022;
RX   PubMed=6108156;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20615970;
RX   PubMed=20624269;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24586258;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,03:01; B*14:02,14:02; C*08:02,16:01; DQB1*04:01,04:01 (PubMed=25960936).
CC   HLA typing: A*01:01,03:01; B*14:02,14:02; C*08:02,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu2911Ter (c.8731G>T); Zygosity=Heterozygous (Cosmic-CLP=910899; DepMap=ACH-000506).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu4588Ter (c.13762G>T); Zygosity=Heterozygous (Cosmic-CLP=910899; DepMap=ACH-000506).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln850Ter (c.2548C>T); ClinVar=VCV000284733; Zygosity=Homozygous (Cosmic-CLP=910899; DepMap=ACH-000506).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro318Leufs*21 (c.953_971del19); Zygosity=Heterozygous (Cosmic-CLP=910899; DepMap=ACH-000506).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=2.05%; East Asian, South=0%; South Asian=0.45%; European, North=66.14%; European, South=30.99% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=HTB-173; CLS=300182; Cosmic-CLP=910899; KCLB=30173; PubMed=24586258; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11 (ATCC=HTB-173; CLS=300182; Cosmic-CLP=910899; KCLB=30173; PubMed=25877200)
ST   CSF1PO: 11,12 (PubMed=24586258)
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15,17
ST   D21S11: 30
ST   D3S1358: 11
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   NCI-H1466
AC   CVCL_A496
SY   H1466; H-1466
DR   cancercelllines; CVCL_A496
DR   Cosmic; 877242
DR   Cosmic; 1891892
DR   IARC_TP53; 494
DR   Wikidata; Q54907814
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Unspecified (PubMed=1311061).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   NCI-H1498
AC   CVCL_A497
SY   H1498; H-1498
DR   Cosmic; 930485
DR   Wikidata; Q54907815
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H1512
AC   CVCL_A498
SY   H1512; H-1512
DR   Wikidata; Q54907816
RX   PubMed=8806092;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   NCI-H1514
AC   CVCL_4363
SY   H1514; H-1514
DR   ATCC; CRL-5873
DR   BioSample; SAMN03152020
DR   BioSample; SAMN03472582
DR   cancercelllines; CVCL_4363
DR   Cosmic; 877223
DR   Cosmic; 877380
DR   Cosmic; 980949
DR   Cosmic; 1021876
DR   Cosmic; 1032419
DR   GEO; GSM794317
DR   IARC_TP53; 428
DR   Wikidata; Q54907817
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10949990;
RX   PubMed=11030152;
RX   PubMed=20143388;
RX   PubMed=20679594;
RX   PubMed=31803961;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388). Furthermore its STR profile is different from that of the cell line NCI-BL1514 (Cellosaurus=CVCL_2641) which is supposed to originate from the same individual, a 56 year old Caucasian woman.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00242.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu68Ter (c.202G>T); ClinVar=VCV000224551; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-5873; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5873; PubMed=20679594
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12 (PubMed=20679594)
ST   D13S317: 12 (ATCC=CRL-5873)
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,21 (PubMed=20679594)
ST   vWA: 17,21,22 (ATCC=CRL-5873)
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   NCI-H1522
AC   CVCL_1474
SY   H1522; H-1522
DR   BTO; BTO_0006524
DR   CLO; CLO_0007999
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-5874
DR   ATCC; CRL-5874_FL
DR   BioSample; SAMN03472583
DR   cancercelllines; CVCL_1474
DR   ChEMBL-Cells; CHEMBL3308877
DR   ChEMBL-Targets; CHEMBL2366178
DR   Cosmic; 688004
DR   Cosmic; 877224
DR   Cosmic; 877381
DR   Cosmic; 908464
DR   GDSC; 908464
DR   GEO; GSM827534
DR   GEO; GSM1887918
DR   GEO; GSM1887998
DR   LINCS_LDP; LCL-1839
DR   PharmacoDB; NCIH1522_1020_2019
DR   Progenetix; CVCL_1474
DR   PubChem_Cell_line; CVCL_1474
DR   Wikidata; Q54907818
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=39154123;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5874; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5874_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   NCI-H1548
AC   CVCL_A499
SY   H1548; H-1548
DR   Wikidata; Q54907819
RX   PubMed=8806092;
RX   PubMed=31803961;
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1563
AC   CVCL_1475
SY   H1563; H-1563; NCIH1563
DR   CLO; CLO_0008000
DR   EFO; EFO_0002255
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5875
DR   BioSample; SAMN03473021
DR   BioSample; SAMN10987885
DR   cancercelllines; CVCL_1475
DR   Cell_Model_Passport; SIDM00751
DR   ChEMBL-Cells; CHEMBL3308457
DR   ChEMBL-Targets; CHEMBL1075514
DR   CLS; 305131
DR   Cosmic; 753600
DR   Cosmic; 1146879
DR   Cosmic; 2664120
DR   Cosmic-CLP; 753600
DR   DepMap; ACH-000892
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 753600
DR   GEO; GSM434327
DR   GEO; GSM513940
DR   GEO; GSM514326
DR   GEO; GSM784195
DR   GEO; GSM794318
DR   GEO; GSM827536
DR   GEO; GSM887366
DR   GEO; GSM888444
DR   GEO; GSM1670175
DR   IARC_TP53; 21542
DR   IGRhCellID; H1563GEO
DR   LiGeA; CCLE_735
DR   LINCS_LDP; LCL-1661
DR   PharmacoDB; NCIH1563_1021_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1475
DR   PubChem_Cell_line; CVCL_1475
DR   Wikidata; Q54907820
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*35:02,51:01; C*04:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (DepMap=ACH-000892).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gly242Trp (c.724G>T); ClinVar=VCV000237805; Zygosity=Heterozygous (DepMap=ACH-000892).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=0%; East Asian, North=0.56%; East Asian, South=2.48%; South Asian=10.47%; European, North=24.17%; European, South=61.99% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5875; Cosmic-CLP=753600; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 9,13
ST   D18S51: 13,17
ST   D19S433: 12,16
ST   D21S11: 28,30
ST   D2S1338: 16,22
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 7,8
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 12,15
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H1568
AC   CVCL_1476
SY   H1568; H-1568; NCIH1568
DR   CLO; CLO_0008001
DR   EFO; EFO_0006660
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5876
DR   BioSample; SAMN03471252
DR   BioSample; SAMN10987877
DR   cancercelllines; CVCL_1476
DR   Cell_Model_Passport; SIDM00750
DR   CLS; 305137
DR   Cosmic; 903594
DR   Cosmic; 1146880
DR   Cosmic; 1995525
DR   Cosmic-CLP; 1298348
DR   DepMap; ACH-000869
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298348
DR   GEO; GSM206473
DR   GEO; GSM274793
DR   GEO; GSM274827
DR   GEO; GSM434278
DR   GEO; GSM513941
DR   GEO; GSM514327
DR   GEO; GSM784205
DR   GEO; GSM794319
DR   GEO; GSM827505
DR   GEO; GSM887367
DR   GEO; GSM888445
DR   GEO; GSM1670176
DR   IARC_TP53; 28352
DR   IGRhCellID; H1568GEO
DR   LiGeA; CCLE_136
DR   LINCS_LDP; LCL-1611
DR   NCI-DTP; NCI-H1568
DR   PharmacoDB; NCIH1568_1022_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1476
DR   Wikidata; Q54907821
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27602502;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 42.5 hours (PubMed=29681454).
CC   HLA typing: A*03:01,32:01; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gly506Phe (c.1516_1517GG>TT); Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=1298348; DepMap=ACH-000869).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Homozygous (Cosmic-CLP=1298348; DepMap=ACH-000869).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.1%; Native American=0%; East Asian, North=2.23%; East Asian, South=0%; South Asian=2.88%; European, North=56.39%; European, South=38.41% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5876; Cosmic-CLP=1298348; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 18,20
ST   D3S1358: 17
ST   D5S818: 9
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 12 (ATCC=CRL-5876)
ST   Penta E: 12,13 (PubMed=25877200)
ST   TH01: 7,9 (Cosmic-CLP=1298348)
ST   TH01: 9 (ATCC=CRL-5876; PubMed=25877200)
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NCI-H157
AC   CVCL_0463
SY   NCl-H157; NCI H157; H157; H-157; NCI-157; NCIH157DM; H157DM
DR   BTO; BTO_0002283
DR   CLO; CLO_0037032
DR   EFO; EFO_0003118
DR   MCCL; MCC:0000360
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-5802
DR   BioSample; SAMN03151855
DR   BioSample; SAMN03471738
DR   cancercelllines; CVCL_0463
DR   CCRID; 1101HUM-PUMC000113
DR   ChEMBL-Cells; CHEMBL3307706
DR   ChEMBL-Targets; CHEMBL614783
DR   CLS; 300387
DR   Cosmic; 722053
DR   Cosmic; 724867
DR   Cosmic; 801588
DR   Cosmic; 844816
DR   Cosmic; 852006
DR   Cosmic; 876171
DR   Cosmic; 877258
DR   Cosmic; 903569
DR   Cosmic; 911847
DR   Cosmic; 917987
DR   Cosmic; 929971
DR   Cosmic; 930486
DR   Cosmic; 932921
DR   Cosmic; 934546
DR   Cosmic; 949208
DR   Cosmic; 953987
DR   Cosmic; 980960
DR   Cosmic; 1028954
DR   Cosmic; 1032432
DR   Cosmic; 1146881
DR   Cosmic; 1219061
DR   Cosmic; 1239910
DR   Cosmic; 1320185
DR   Cosmic; 2560227
DR   Cosmic; 2648437
DR   Cosmic; 2668267
DR   Cosmic; 2668329
DR   DepMap; ACH-000921
DR   GEO; GSM62967
DR   GEO; GSM108815
DR   GEO; GSM108816
DR   GEO; GSM253365
DR   GEO; GSM434267
DR   GEO; GSM784238
DR   GEO; GSM794274
DR   GEO; GSM817068
DR   IARC_TP53; 495
DR   IARC_TP53; 28242
DR   IARC_TP53; 28453
DR   IGRhCellID; H157GEO
DR   KCB; KCB 200814YJ
DR   KCLB; 90157
DR   LINCS_LDP; LCL-1596
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_0463
DR   PubChem_Cell_line; CVCL_0463
DR   Wikidata; Q54907822
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=3940644;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=7972006;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=9649128;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11369051;
RX   PubMed=12068308;
RX   PubMed=12820372;
RX   PubMed=16187286;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20624269;
RX   PubMed=22961666;
RX   PubMed=23381221;
RX   PubMed=25120651;
RX   PubMed=26361996;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=31803961;
RX   PubMed=38180245;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/cross-contamination-of-atcc-crl-5802-and-atcc-crl-5860
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/misidentified-cell-lines-atcc-crl-5802-and-atcc-crl-5860
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00412.
CC   Doubling time: 53 hours (Note=In RPMI 1640 + 10% FBS), 90 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 20.8 hours (PubMed=29681454).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Homozygous (PubMed=30038707; DepMap=ACH-000921).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=1311061; PubMed=12068308; DepMap=ACH-000921).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Thr58Profs*36 (c.171del); Zygosity=Homozygous (DepMap=ACH-000921).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Phefs*8 (c.102_103insT) (c.103_104insT); Zygosity=Heterozygous (PubMed=10536175; PubMed=20557307; DepMap=ACH-000921).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Heterozygous (PubMed=1311061; PubMed=10536175; PubMed=20557307; DepMap=ACH-000921).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5802; true.
CC   Discontinued: KCLB; 90157; probable.
ST   Source(s): ATCC=CRL-5802; CCRID=1101HUM-PUMC000113; CLS=300387
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 11,13
ST   D21S11: 32
ST   D2S1338: 21,22
ST   D3S1358: 17,18
ST   D5S818: 10,13
ST   D6S1043: 17,24
ST   D7S820: 12
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 2.2
ST   Penta E: 7
ST   TH01: 7,9
ST   TPOX: 6,12
ST   vWA: 15
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3970 ! NCI-H1264
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   NCI-H1570
AC   CVCL_A500
SY   H1570; H-1570
DR   Cosmic; 722042
DR   GEO; GSM794320
DR   Wikidata; Q54907824
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   NCI-H1573
AC   CVCL_1478
SY   H1573; H-1573; NCIH1573
DR   CLO; CLO_0008002
DR   EFO; EFO_0002256
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5877
DR   BioSample; SAMN03472584
DR   BioSample; SAMN10987661
DR   cancercelllines; CVCL_1478
DR   Cell_Model_Passport; SIDM00749
DR   ChEMBL-Cells; CHEMBL3308117
DR   ChEMBL-Targets; CHEMBL1075515
DR   Cosmic; 687796
DR   Cosmic; 877243
DR   Cosmic; 877425
DR   Cosmic; 903595
DR   Cosmic; 908472
DR   Cosmic; 1995526
DR   Cosmic; 2125179
DR   Cosmic-CLP; 908472
DR   DepMap; ACH-000916
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 908472
DR   GEO; GSM794321
DR   GEO; GSM827530
DR   GEO; GSM887368
DR   GEO; GSM888446
DR   GEO; GSM1670177
DR   IARC_TP53; 496
DR   IGRhCellID; NCIH1573
DR   KCLB; 91573
DR   LiGeA; CCLE_321
DR   LINCS_LDP; LCL-1638
DR   PharmacoDB; NCIH1573_1023_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1478
DR   PubChem_Cell_line; CVCL_1478
DR   Wikidata; Q54907825
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*30:01,30:01; B*14:02,14:02; C*08:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (Cosmic-CLP=908472; DepMap=ACH-000916).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=908472; DepMap=ACH-000916).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Arg351Ter (c.1051C>T); ClinVar=VCV000372552; Zygosity=Heterozygous (Cosmic-CLP=908472; DepMap=ACH-000916).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=908472; DepMap=ACH-000916).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.85%; Native American=0%; East Asian, North=5.57%; East Asian, South=0%; South Asian=0%; European, North=54.36%; European, South=38.22% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5877; Cosmic-CLP=908472
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 12,15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H1581
AC   CVCL_1479
SY   H1581; H-1581; NCIH1581
DR   BTO; BTO_0006042
DR   CLO; CLO_0008003
DR   EFO; EFO_0002257
DR   AddexBio; C0016028/4987
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5878
DR   BioGRID_ORCS_Cell_line; 400
DR   BioSample; SAMN03472585
DR   BioSample; SAMN03472993
DR   BioSample; SAMN10988311
DR   cancercelllines; CVCL_1479
DR   Cell_Model_Passport; SIDM00748
DR   ChEMBL-Cells; CHEMBL3308765
DR   ChEMBL-Targets; CHEMBL1075516
DR   Cosmic; 687797
DR   Cosmic; 844597
DR   Cosmic; 877426
DR   Cosmic; 908471
DR   Cosmic; 980977
DR   Cosmic; 1032449
DR   Cosmic; 1152510
DR   Cosmic; 1995527
DR   Cosmic; 2009534
DR   Cosmic-CLP; 908471
DR   DepMap; ACH-000015
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908471
DR   GEO; GSM827484
DR   GEO; GSM844622
DR   GEO; GSM887369
DR   GEO; GSM888447
DR   GEO; GSM1670178
DR   IARC_TP53; 497
DR   IARC_TP53; 30214
DR   IGRhCellID; NCIH1581
DR   KCLB; 91581
DR   LiGeA; CCLE_180
DR   LINCS_LDP; LCL-1783
DR   PharmacoDB; NCIH1581_1024_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1479
DR   PubChem_Cell_line; CVCL_1479
DR   Wikidata; Q54907826
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,26:01; B*38:01,44:02; C*05:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ala1107fs*12 (c.3317_3318insG); Zygosity=Homozygous (ATCC=CRL-5878; Cosmic-CLP=908471; DepMap=ACH-000015).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=908471; DepMap=ACH-000015).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.94%; Native American=0%; East Asian, North=1.51%; East Asian, South=0%; South Asian=0.71%; European, North=59.07%; European, South=37.76% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016028/4987; ATCC=CRL-5878; Cosmic-CLP=908471; PubMed=25877200
ST   Amelogenin: X (ATCC=CRL-5878; Cosmic-CLP=908471; PubMed=25877200)
ST   Amelogenin: X,Y (AddexBio=C0016028/4987)
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 15 (PubMed=25877200)
ST   D18S51: 15,16 (ATCC=CRL-5878)
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 24,25
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 10,14
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 12,17
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 15,16 (AddexBio=C0016028/4987; ATCC=CRL-5878; Cosmic-CLP=908471)
ST   vWA: 16 (PubMed=25877200)
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NCI-H1592
AC   CVCL_A501
SY   H1592; H-1592
DR   Wikidata; Q54907830
RX   PubMed=8806092;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1607
AC   CVCL_A467
SY   H1607; H-1607
DR   cancercelllines; CVCL_A467
DR   Cosmic; 844576
DR   Cosmic; 877225
DR   Cosmic; 877382
DR   Cosmic; 1021877
DR   Cosmic; 1152485
DR   Cosmic; 1239944
DR   Cosmic; 1518103
DR   Cosmic; 2125232
DR   Cosmic; 2699654
DR   GEO; GSM171846
DR   GEO; GSM171847
DR   GEO; GSM794322
DR   IARC_TP53; 429
DR   Wikidata; Q54907831
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=23716474;
RX   PubMed=31803961;
RX   PubMed=34439128;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469; PubMed=20557307).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 8,10,11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2642 ! NCI-BL1607
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 28
//
ID   NCI-H1608
AC   CVCL_A502
SY   H1608; H-1608
DR   Wikidata; Q54907832
RX   PubMed=8806092;
RX   PubMed=31803961;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   NCI-H1618
AC   CVCL_1480
SY   H1618; H-1618; NCIH1618
DR   CLO; CLO_0008004
DR   EFO; EFO_0002258
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5879
DR   BioSample; SAMN03472586
DR   BioSample; SAMN10988122
DR   cancercelllines; CVCL_1480
DR   Cell_Model_Passport; SIDM01675
DR   ChEMBL-Cells; CHEMBL3308314
DR   ChEMBL-Targets; CHEMBL2366290
DR   Cosmic; 753601
DR   Cosmic; 877226
DR   Cosmic; 877383
DR   Cosmic; 980950
DR   Cosmic; 1004694
DR   Cosmic; 1032420
DR   Cosmic; 1239950
DR   Cosmic; 2125233
DR   DepMap; ACH-000179
DR   GDSC; 753601
DR   GEO; GSM380479
DR   GEO; GSM380513
DR   GEO; GSM887370
DR   GEO; GSM888448
DR   GEO; GSM1887932
DR   GEO; GSM1888010
DR   IARC_TP53; 430
DR   IGRhCellID; NCIH1618
DR   LiGeA; CCLE_539
DR   LINCS_LDP; LCL-1840
DR   Lonza; 1437
DR   PharmacoDB; NCIH1618_1025_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_1480
DR   PubChem_Cell_line; CVCL_1480
DR   Wikidata; Q54907833
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,03:01; B*07:02,58:05; C*07:01,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Pro39Argfs*26 (c.116delC); Zygosity=Homozygous (ATCC=CRL-5879; DepMap=ACH-000179).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=1312696; PubMed=1565469; PubMed=20557307; ATCC=CRL-5879; DepMap=ACH-000179).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.23%; Native American=0.54%; East Asian, North=0.24%; East Asian, South=0%; South Asian=3.51%; European, North=61.08%; European, South=34.4% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5879
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 27,31.2
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 8
ST   D8S1179: 11,14
ST   FGA: 22.2,24
ST   Penta D: 10,12
ST   Penta E: 16
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   NCI-H1622
AC   CVCL_4364
SY   H1622; H-1622
DR   ATCC; CRL-5880
DR   BioSample; SAMN03152021
DR   Wikidata; Q54907834
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=20143388;
RX   PubMed=31803961;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388). In addition according to PubMed=8806092 it is supposed to be established from the same patient as NCI-H1618 (Cellosaurus=CVCL_1480) but the STR profile is different.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00332.
CC   Discontinued: ATCC; CRL-5880; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5880
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   NCI-H1623
AC   CVCL_1481
SY   H1623; H-1623; NCIH1623
DR   CLO; CLO_0008005
DR   EFO; EFO_0002259
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5881
DR   BioSample; SAMN03472994
DR   BioSample; SAMN10988155
DR   cancercelllines; CVCL_1481
DR   Cell_Model_Passport; SIDM00747
DR   ChEMBL-Cells; CHEMBL3308766
DR   ChEMBL-Targets; CHEMBL1075517
DR   Cosmic; 687798
DR   Cosmic; 877427
DR   Cosmic; 903596
DR   Cosmic; 980978
DR   Cosmic; 1032450
DR   Cosmic; 1995528
DR   Cosmic; 2125234
DR   Cosmic-CLP; 687798
DR   DepMap; ACH-000744
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687798
DR   GEO; GSM513942
DR   GEO; GSM514328
DR   GEO; GSM784268
DR   GEO; GSM827557
DR   GEO; GSM887371
DR   GEO; GSM888449
DR   GEO; GSM1374702
DR   GEO; GSM1670179
DR   IARC_TP53; 498
DR   IGRhCellID; NCIH1623
DR   KCLB; 91623
DR   LiGeA; CCLE_888
DR   LINCS_LDP; LCL-1639
DR   PharmacoDB; NCIH1623_1026_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1481
DR   PubChem_Cell_line; CVCL_1481
DR   Wikidata; Q54907835
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,11:01; B*40:01,51:01; C*03:04,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=687798; DepMap=ACH-000744).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.52%; Native American=0.03%; East Asian, North=2.83%; East Asian, South=0%; South Asian=0%; European, North=60.22%; European, South=35.4% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5881; Cosmic-CLP=687798; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 30.2,31.2
ST   D2S1338: 19,24
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 14
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15,19,20
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H1628
AC   CVCL_A503
SY   H1628; H-1628
DR   BTO; BTO_0006564
DR   ATCC; CRL-5980
DR   Cosmic; 980951
DR   Cosmic; 1032421
DR   Wikidata; Q54907836
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Discontinued: ATCC; CRL-5980; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   NCI-H1648
AC   CVCL_1482
SY   H1648; H-1648; NCIH1648
DR   CLO; CLO_0008006
DR   EFO; EFO_0003119
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5882
DR   BioSample; SAMN03473271
DR   BioSample; SAMN10988142
DR   cancercelllines; CVCL_1482
DR   Cell_Model_Passport; SIDM00746
DR   ChEMBL-Cells; CHEMBL3308315
DR   ChEMBL-Targets; CHEMBL2366214
DR   Cosmic; 687799
DR   Cosmic; 877244
DR   Cosmic; 877428
DR   Cosmic; 903597
DR   Cosmic; 931372
DR   Cosmic; 980979
DR   Cosmic; 1028941
DR   Cosmic; 1032451
DR   Cosmic; 1146882
DR   Cosmic; 1152511
DR   Cosmic; 1154594
DR   Cosmic; 1219083
DR   Cosmic; 1239886
DR   Cosmic; 1891893
DR   Cosmic; 1995529
DR   Cosmic; 2125235
DR   Cosmic; 2628355
DR   Cosmic; 2629444
DR   Cosmic-CLP; 687799
DR   DepMap; ACH-000766
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 687799
DR   GEO; GSM62326
DR   GEO; GSM108817
DR   GEO; GSM108818
DR   GEO; GSM253366
DR   GEO; GSM434268
DR   GEO; GSM794323
DR   GEO; GSM817085
DR   GEO; GSM887372
DR   GEO; GSM888450
DR   GEO; GSM1670180
DR   IARC_TP53; 499
DR   IARC_TP53; 21403
DR   IGRhCellID; H1648GEO
DR   LiGeA; CCLE_277
DR   LINCS_HMS; 50032
DR   LINCS_LDP; LCL-1632
DR   PharmacoDB; NCIH1648_1027_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1482
DR   PubChem_Cell_line; CVCL_1482
DR   Wikidata; Q54907837
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 41.9 hours (PubMed=29681454).
CC   HLA typing: A*11:01,34:02; B*07:02,53:01; C*04:01,07:02; DQA1*01:02,04:01; DQB1*04:02,06:02; DRB1*03:02,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu35Phefs*8 (c.102_103insT) (c.103_104insT); Zygosity=Heterozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=687799; DepMap=ACH-000766).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=69.05%; Native American=0%; East Asian, North=4.46%; East Asian, South=0%; South Asian=0%; European, North=14.67%; European, South=11.82% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5882; Cosmic-CLP=687799; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 28,30
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E097 ! NCI-BL1648
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H1650
AC   CVCL_1483
SY   H1650; H-1650; H1650_CO; NCIH1650
DR   BTO; BTO_0005243
DR   CLO; CLO_0008007
DR   EFO; EFO_0002260
DR   CLDB; cl7182
DR   AddexBio; C0016015/4961
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5883
DR   BioGRID_ORCS_Cell_line; 540
DR   BioSample; SAMN03472182
DR   BioSample; SAMN10987889
DR   cancercelllines; CVCL_1483
DR   CCRID; 1101HUM-PUMC000251
DR   CCRID; 3101HUMSCSP592
DR   CCRID; 3101HUMTCHu152
DR   Cell_Model_Passport; SIDM00745
DR   ChEMBL-Cells; CHEMBL3308800
DR   ChEMBL-Targets; CHEMBL1075518
DR   CLS; 305059
DR   Cosmic; 687800
DR   Cosmic; 877429
DR   Cosmic; 903598
DR   Cosmic; 1017829
DR   Cosmic; 1028942
DR   Cosmic; 1047096
DR   Cosmic; 1128242
DR   Cosmic; 1146883
DR   Cosmic; 1212188
DR   Cosmic; 1239904
DR   Cosmic; 1571738
DR   Cosmic; 1600606
DR   Cosmic; 1741779
DR   Cosmic; 1795296
DR   Cosmic; 1802299
DR   Cosmic; 1891894
DR   Cosmic; 1995530
DR   Cosmic; 2042866
DR   Cosmic; 2125236
DR   Cosmic-CLP; 687800
DR   DepMap; ACH-000035
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 687800
DR   GEO; GSM108819
DR   GEO; GSM108820
DR   GEO; GSM206474
DR   GEO; GSM253384
DR   GEO; GSM274795
DR   GEO; GSM274828
DR   GEO; GSM434313
DR   GEO; GSM782115
DR   GEO; GSM784207
DR   GEO; GSM794324
DR   GEO; GSM817086
DR   GEO; GSM827475
DR   GEO; GSM844623
DR   GEO; GSM887373
DR   GEO; GSM888451
DR   GEO; GSM1374703
DR   GEO; GSM1670181
DR   GEO; GSM1887942
DR   GEO; GSM1888018
DR   IARC_TP53; 21543
DR   ICLC; HTL06002
DR   IGRhCellID; H1650_COGEO
DR   IGRhCellID; NCIH1650
DR   KCLB; 91650
DR   LiGeA; CCLE_526
DR   LINCS_LDP; LCL-1612
DR   Lonza; 1418
DR   PharmacoDB; NCIH1650_1028_2019
DR   PRIDE; PXD011315
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1483
DR   PubChem_Cell_line; CVCL_1483
DR   Ubigene; YC-C110
DR   Wikidata; Q54907838
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=17332333;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22433462;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=29681454;
RX   PubMed=30710758;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35117401;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=25984343); 40.4 hours (PubMed=29681454).
CC   HLA typing: A*02:01,02:01; B*15:18,15:18; C*07:04,07:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (PubMed=17332333; Cosmic-CLP=687800; DepMap=ACH-000035).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=20557307; Cosmic-CLP=687800; DepMap=ACH-000035).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.57%; Native American=0%; East Asian, North=3.27%; East Asian, South=0%; South Asian=0%; European, North=61.83%; European, South=34.34% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0016015/4961; ATCC=CRL-5883; CCRID; Cosmic-CLP=687800; KCLB=91650; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 10
ST   D19S433: 15
ST   D1S1656: 15,15.3
ST   D21S11: 30
ST   D22S1045: 11
ST   D2S1338: 19
ST   D2S441: 10
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12
ST   FGA: 20 (ATCC=CRL-5883; CCRID; PubMed=25877200; Technion Genomics Center)
ST   FGA: 20,23.2 (KCLB=91650)
ST   Penta D: 8
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   NCI-H1650-GAS-Luc2
AC   CVCL_C9CY
DR   ATCC; CRL-5883-GAS-LUC2
DR   Wikidata; Q123033156
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the gamma-activated site (GAS) promoter (ATCC=CRL-5883-GAS-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5883-GAS-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1483 ! NCI-H1650
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   NCI-H1650-Luc
AC   CVCL_4W95
DR   cancercelllines; CVCL_4W95
DR   JCRB; JCRB1478
DR   JCRB; NIHS0723
DR   Wikidata; Q54907839
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0723; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1478
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1483 ! NCI-H1650
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   NCI-H1651
AC   CVCL_1484
SY   H1651; H-1651; NCIH1651
DR   CLO; CLO_0008008
DR   EFO; EFO_0002261
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5884
DR   BioSample; SAMN03472590
DR   BioSample; SAMN10987663
DR   cancercelllines; CVCL_1484
DR   Cell_Model_Passport; SIDM00744
DR   ChEMBL-Cells; CHEMBL3308383
DR   ChEMBL-Targets; CHEMBL1075519
DR   Cosmic; 687801
DR   Cosmic; 910900
DR   Cosmic; 1609525
DR   Cosmic; 1802316
DR   Cosmic; 1995531
DR   Cosmic-CLP; 910900
DR   DepMap; ACH-000893
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910900
DR   GEO; GSM206475
DR   GEO; GSM274786
DR   GEO; GSM274823
DR   GEO; GSM513975
DR   GEO; GSM514329
DR   GEO; GSM794325
DR   GEO; GSM827529
DR   GEO; GSM844624
DR   GEO; GSM887374
DR   GEO; GSM888452
DR   GEO; GSM1374704
DR   GEO; GSM1670182
DR   IARC_TP53; 500
DR   IGRhCellID; NCIH1651
DR   LiGeA; CCLE_611
DR   LINCS_HMS; 50033
DR   LINCS_LDP; LCL-1633
DR   PharmacoDB; NCIH1651_1029_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1484
DR   PubChem_Cell_line; CVCL_1484
DR   Wikidata; Q54907840
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,24:02; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg997fs*15 (c.2990delG); Zygosity=Heterozygous (Cosmic-CLP=910900; DepMap=ACH-000893).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Homozygous (PubMed=1311061; ATCC=CRL-5884; Cosmic-CLP=910900; DepMap=ACH-000893).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.5%; Native American=0%; East Asian, North=2.72%; East Asian, South=0%; South Asian=0%; European, North=66.41%; European, South=29.37% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5884; Cosmic-CLP=910900; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 16.3 (ATCC=CRL-5884)
ST   D18S51: 17 (PubMed=25877200)
ST   D19S433: 13
ST   D21S11: 31.2
ST   D2S1338: 24
ST   D3S1358: 17
ST   D5S818: 12,14
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 12,16,17
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H1652
AC   CVCL_A504
SY   H1652; H-1652
DR   Wikidata; Q54907841
RX   PubMed=8806092;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1666
AC   CVCL_1485
SY   H1666; H-1666; H1666_DA; NCIH1666
DR   CLO; CLO_0008009
DR   EFO; EFO_0002262
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5885
DR   BioSample; SAMN03472948
DR   BioSample; SAMN10987669
DR   cancercelllines; CVCL_1485
DR   Cell_Model_Passport; SIDM00743
DR   ChEMBL-Cells; CHEMBL3308118
DR   ChEMBL-Targets; CHEMBL1075520
DR   Cosmic; 684679
DR   Cosmic; 877245
DR   Cosmic; 897729
DR   Cosmic; 908473
DR   Cosmic; 914945
DR   Cosmic; 980980
DR   Cosmic; 1032452
DR   Cosmic; 1146884
DR   Cosmic; 1209729
DR   Cosmic; 1477421
DR   Cosmic; 1600604
DR   Cosmic; 1995532
DR   Cosmic; 2042869
DR   Cosmic; 2630417
DR   Cosmic-CLP; 908473
DR   DepMap; ACH-000448
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 908473
DR   GEO; GSM108821
DR   GEO; GSM108822
DR   GEO; GSM206476
DR   GEO; GSM253346
DR   GEO; GSM274807
DR   GEO; GSM274808
DR   GEO; GSM434303
DR   GEO; GSM794326
DR   GEO; GSM817087
DR   GEO; GSM827579
DR   GEO; GSM844625
DR   GEO; GSM844626
DR   GEO; GSM844627
DR   GEO; GSM887375
DR   GEO; GSM888453
DR   GEO; GSM1374705
DR   GEO; GSM1670183
DR   IARC_TP53; 21544
DR   IGRhCellID; H1666_DAGEO
DR   IGRhCellID; NCIH1666
DR   KCLB; 25885
DR   LiGeA; CCLE_235
DR   LINCS_LDP; LCL-1673
DR   PharmacoDB; NCIH1666_1030_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1485
DR   PubChem_Cell_line; CVCL_1485
DR   Wikidata; Q54907842
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=12068308;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 45.2 hours (PubMed=29681454).
CC   HLA typing: A*01:01,02:01; B*44:02,67:02; C*07:04,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly466Val (c.1397G>T); ClinVar=VCV000013967; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1565469).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.25%; Native American=0%; East Asian, North=1.76%; East Asian, South=0%; South Asian=1.52%; European, North=63%; European, South=32.47% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5885; Cosmic-CLP=908473; KCLB=25885; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 15
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 18,24
ST   D3S1358: 16,18
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20.2,21
ST   Penta D: 10
ST   Penta E: 14
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H1670
AC   CVCL_A505
SY   H1670; H-1670
DR   Wikidata; Q54907843
RX   PubMed=8806092;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1672
AC   CVCL_1486
SY   H1672; H-1672
DR   BTO; BTO_0005975
DR   CLO; CLO_0008010
DR   ATCC; CRL-5886
DR   BioSample; SAMN03473009
DR   cancercelllines; CVCL_1486
DR   Cosmic; 688005
DR   Cosmic; 852002
DR   Cosmic; 877227
DR   Cosmic; 980952
DR   Cosmic; 1021878
DR   Cosmic; 1032422
DR   Cosmic; 1759264
DR   Cosmic; 1891912
DR   Cosmic; 2125237
DR   GEO; GSM108823
DR   GEO; GSM108824
DR   GEO; GSM794327
DR   GEO; GSM1887943
DR   GEO; GSM1888019
DR   IARC_TP53; 431
DR   Wikidata; Q54907844
RX   PubMed=1312696;
RX   PubMed=8183553;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=20624269;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His61Arg (c.182A>G); ClinVar=VCV000189402; Zygosity=Unspecified (PubMed=22961666).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Unspecified (PubMed=1312696).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly106Asp (c.317G>A); Zygosity=Unspecified (PubMed=8183553).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5886; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 15
ST   D21S11: 29,32.2
ST   D2S1338: 21,27
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 8,12
ST   Penta E: 9
ST   TH01: 10
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2643 ! NCI-BL1672
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   NCI-H1684
AC   CVCL_3972
SY   H1684; H-1684
DR   BTO; BTO_0003243
DR   Wikidata; Q54907845
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   NCI-H1688
AC   CVCL_1487
SY   H1688; H-1688; NCIH1688
DR   BTO; BTO_0005966
DR   CLO; CLO_0008011
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-257
DR   BCRC; 60497
DR   BioSample; SAMN03471387
DR   cancercelllines; CVCL_1487
DR   CCRID; 3101HUMTCHu154
DR   Cell_Model_Passport; SIDM00792
DR   Cosmic; 1995533
DR   Cosmic-CLP; 1298349
DR   DepMap; ACH-002170
DR   EGA; EGAS00001000978
DR   GDSC; 1298349
DR   GEO; GSM784264
DR   GEO; GSM986174
DR   GEO; GSM1670184
DR   GEO; GSM1887898
DR   GEO; GSM1887966
DR   KCLB; 91688
DR   LINCS_LDP; LCL-1811
DR   PharmacoDB; NCIH1688_1031_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1487
DR   Wikidata; Q54907846
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (Cosmic-CLP=1298349; DepMap=ACH-002170).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.98%; Native American=0%; East Asian, North=2.19%; East Asian, South=0%; South Asian=0%; European, North=61.82%; European, South=35% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CCL-257; Cosmic-CLP=1298349
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 13
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 18,23
ST   D3S1358: 18
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,22.2
ST   Penta D: 13
ST   Penta E: 11,12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E098 ! NCI-BL1688
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   NCI-H1693
AC   CVCL_1488
SY   H1693; H-1693; NCIH1693
DR   CLO; CLO_0008012
DR   EFO; EFO_0006661
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5887
DR   BioGRID_ORCS_Cell_line; 539
DR   BioSample; SAMN03472587
DR   BioSample; SAMN10988173
DR   cancercelllines; CVCL_1488
DR   Cell_Model_Passport; SIDM00742
DR   ChEMBL-Cells; CHEMBL3308458
DR   ChEMBL-Targets; CHEMBL1075521
DR   Cosmic; 687802
DR   Cosmic; 877430
DR   Cosmic; 903599
DR   Cosmic; 980981
DR   Cosmic; 1032453
DR   Cosmic; 1995534
DR   Cosmic-CLP; 687802
DR   DepMap; ACH-000021
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687802
DR   GEO; GSM513943
DR   GEO; GSM514330
DR   GEO; GSM784269
DR   GEO; GSM794328
DR   GEO; GSM817088
DR   GEO; GSM827560
DR   GEO; GSM887376
DR   GEO; GSM888454
DR   GEO; GSM1670185
DR   IARC_TP53; 21545
DR   LiGeA; CCLE_126
DR   LINCS_LDP; LCL-1640
DR   PharmacoDB; NCIH1693_1032_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1488
DR   PubChem_Cell_line; CVCL_1488
DR   Wikidata; Q54907847
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 51.5 hours (PubMed=29681454).
CC   HLA typing: A*03:01,03:01; B*07:02,44:02; C*07:04,07:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Leu1085Glnfs*32 (c.3254_3270del); Zygosity=Heterozygous (Cosmic-CLP=687802; DepMap=ACH-000021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>T (IVS9+1G>T); ClinVar=VCV000634766; Zygosity=Homozygous (Cosmic-CLP=687802; DepMap=ACH-000021).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.99%; Native American=0.67%; East Asian, North=3.46%; East Asian, South=0%; South Asian=0%; European, North=63.68%; European, South=31.2% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5887; Cosmic-CLP=687802; PubMed=20679594; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D10S1248: 14,15
ST   D12S391: 18,20
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 14,15
ST   D1S1656: 17.3
ST   D21S11: 29
ST   D22S1045: 15
ST   D2S1338: 20
ST   D2S441: 14
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 22
ST   Penta D: 12,14
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E099 ! NCI-BL1819
OI   CVCL_1497 ! NCI-H1819
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   NCI-H1694
AC   CVCL_1489
SY   H1694; H-1694; NCIH1694
DR   CLO; CLO_0008013
DR   EFO; EFO_0002263
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5888
DR   BioSample; SAMN03473010
DR   BioSample; SAMN10987598
DR   cancercelllines; CVCL_1489
DR   Cell_Model_Passport; SIDM00741
DR   ChEMBL-Cells; CHEMBL3308555
DR   ChEMBL-Targets; CHEMBL2366333
DR   Cosmic; 688006
DR   Cosmic; 1995535
DR   Cosmic-CLP; 688006
DR   DepMap; ACH-000431
DR   EGA; EGAS00001000978
DR   GDSC; 688006
DR   GEO; GSM887377
DR   GEO; GSM888455
DR   GEO; GSM1670186
DR   GEO; GSM1682806
DR   GEO; GSM1887944
DR   GEO; GSM1888020
DR   IARC_TP53; 21546
DR   IGRhCellID; NCIH1694
DR   LiGeA; CCLE_488
DR   LINCS_LDP; LCL-1841
DR   PharmacoDB; NCIH1694_1033_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1489
DR   PubChem_Cell_line; CVCL_1489
DR   Wikidata; Q54907848
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:05,23:01; B*50:01,50:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783-1G>T; ClinVar=VCV000634661; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=688006; DepMap=ACH-000431).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.95%; Native American=1.28%; East Asian, North=5.88%; East Asian, South=0.17%; South Asian=2.13%; European, North=23.45%; European, South=62.14% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-5888; Cosmic-CLP=688006; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 12,13
ST   D21S11: 29 (PubMed=25877200)
ST   D21S11: 29,32.2 (ATCC=CRL-5888)
ST   D2S1338: 19,20
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H1703
AC   CVCL_1490
SY   H1703; H-1703; NCIH1703
DR   BTO; BTO_0003009
DR   CLO; CLO_0008014
DR   EFO; EFO_0002264
DR   AddexBio; C0016008/4676
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5889
DR   BioGRID_ORCS_Cell_line; 538
DR   BioSample; SAMN03472937
DR   BioSample; SAMN10988304
DR   cancercelllines; CVCL_1490
DR   CCRID; 1101HUM-PUMC000353
DR   CCRID; 3101HUMSCSP593
DR   Cell_Model_Passport; SIDM00740
DR   ChEMBL-Cells; CHEMBL3308503
DR   ChEMBL-Targets; CHEMBL1075522
DR   CLS; 305090
DR   Cosmic; 687803
DR   Cosmic; 903600
DR   Cosmic; 908474
DR   Cosmic; 980982
DR   Cosmic; 1017827
DR   Cosmic; 1028952
DR   Cosmic; 1032454
DR   Cosmic; 1202065
DR   Cosmic; 1219064
DR   Cosmic; 1239887
DR   Cosmic; 1870265
DR   Cosmic; 1995536
DR   Cosmic; 2009535
DR   Cosmic; 2042871
DR   Cosmic; 2125180
DR   Cosmic; 2630421
DR   Cosmic; 2664124
DR   Cosmic-CLP; 908474
DR   DepMap; ACH-000747
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908474
DR   GEO; GSM206477
DR   GEO; GSM274733
DR   GEO; GSM274734
DR   GEO; GSM434786
DR   GEO; GSM784217
DR   GEO; GSM794329
DR   GEO; GSM827485
DR   GEO; GSM844628
DR   GEO; GSM887378
DR   GEO; GSM888456
DR   GEO; GSM1374706
DR   GEO; GSM1374707
DR   GEO; GSM1670187
DR   IARC_TP53; 501
DR   IARC_TP53; 21404
DR   IGRhCellID; NCIH1703
DR   KCLB; 91703
DR   LiGeA; CCLE_025
DR   LINCS_HMS; 50034
DR   LINCS_LDP; LCL-1582
DR   PharmacoDB; NCIH1703_1034_2019
DR   PRIDE; PXD011315
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1490
DR   PubChem_Cell_line; CVCL_1490
DR   Wikidata; Q54907849
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24805778;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30710758;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 47.9 hours (PubMed=29681454).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:06,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Val (c.251A>T); ClinVar=VCV002136746; Zygosity=Homozygous (Cosmic-CLP=908474; DepMap=ACH-000747).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>T (IVS8+1G>T); ClinVar=VCV000495326; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=20557307; Cosmic-CLP=908474; DepMap=ACH-000747).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.29%; Native American=0%; East Asian, North=5.58%; East Asian, South=0%; South Asian=0%; European, North=47.2%; European, South=43.93% (PubMed=30894373).
CC   Donor information: Established from a 50 packs per year smoker (ATCC=CRL-5889).
CC   Caution: Indicated to have a TP53 p.Glu285Lys (c.853G>A) mutation according to PubMed=1311061.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016008/4676; ATCC=CRL-5889; CCRID; Cosmic-CLP=908474; KCLB=91703; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 18
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 17,18
ST   D19S433: 13
ST   D1S1656: 15,17.3
ST   D21S11: 29
ST   D22S1045: 15,16
ST   D2S1338: 19,20
ST   D2S441: 10,14
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   DYS391: 10
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   NCI-H1710
AC   CVCL_A506
SY   H1710; H-1710
DR   cancercelllines; CVCL_A506
DR   IARC_TP53; 502
DR   Wikidata; Q54907850
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (PubMed=1311061).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>T (IVS8+1G>T); ClinVar=VCV000495326; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=1311061).
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   NCI-H1717
AC   CVCL_A507
SY   H1717; H-1717
DR   ATCC; CRL-5890
DR   BioSample; SAMN03472588
DR   Wikidata; Q54907851
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Discontinued: ATCC; CRL-5890; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5890
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
ID   NCI-H1725
AC   CVCL_A508
SY   H1725; H-1725
DR   Cosmic; 722051
DR   Wikidata; Q54907852
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   NCI-H1726
AC   CVCL_A476
SY   H1726; H-1726
DR   Cosmic; 877431
DR   Cosmic; 1152512
DR   Wikidata; Q54907853
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1734
AC   CVCL_1491
SY   H1734; H-1734; NCIH1734
DR   CLO; CLO_0008015
DR   EFO; EFO_0006662
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5891
DR   BioSample; SAMN03471721
DR   BioSample; SAMN10987672
DR   cancercelllines; CVCL_1491
DR   CCRID; 3101HUMSCSP594
DR   Cell_Model_Passport; SIDM00739
DR   ChEMBL-Cells; CHEMBL3308767
DR   ChEMBL-Targets; CHEMBL1075523
DR   Cosmic; 722058
DR   Cosmic; 897512
DR   Cosmic; 1146885
DR   Cosmic; 1609515
DR   Cosmic; 1995537
DR   Cosmic-CLP; 722058
DR   DepMap; ACH-000675
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 722058
DR   GEO; GSM434328
DR   GEO; GSM513944
DR   GEO; GSM514331
DR   GEO; GSM794330
DR   GEO; GSM827507
DR   GEO; GSM887379
DR   GEO; GSM888457
DR   GEO; GSM1374708
DR   GEO; GSM1670188
DR   IARC_TP53; 503
DR   IGRhCellID; H1734GEO
DR   LiGeA; CCLE_433
DR   LINCS_LDP; LCL-1641
DR   PharmacoDB; NCIH1734_1035_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1491
DR   PubChem_Cell_line; CVCL_1491
DR   Wikidata; Q54907854
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27602502;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-and-morphology-of-nci-h1734-atcc-crl-5891-cells
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*40:01,44:02; C*03:04,16:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln65Pro (c.194A>C); ClinVar=VCV000820386; Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=722058; DepMap=ACH-000675).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Heterozygous (PubMed=1311061; Cosmic-CLP=722058; DepMap=ACH-000675).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser127Ile (c.380G>T); ClinVar=VCV000958692; Zygosity=Homozygous (Cosmic-CLP=722058; DepMap=ACH-000675).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=722058; DepMap=ACH-000675).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.78%; East Asian, North=1.29%; East Asian, South=0%; South Asian=0%; European, North=67.8%; European, South=30.13% (PubMed=30894373).
CC   Misspelling: NCI-H734; Cosmic=897512.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5891; Cosmic-CLP=722058; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D21S11: 33.2
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 12,14
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NCI-H175
AC   CVCL_JZ17
SY   H175
DR   Wikidata; Q54907855
RX   PubMed=2986243;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   NCI-H1755
AC   CVCL_1492
SY   H1755; H-1755; NCIH1755
DR   CLO; CLO_0008016
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5892
DR   BioGRID_ORCS_Cell_line; 955
DR   BioSample; SAMN03472589
DR   BioSample; SAMN10988171
DR   cancercelllines; CVCL_1492
DR   Cell_Model_Passport; SIDM00738
DR   ChEMBL-Cells; CHEMBL3308768
DR   ChEMBL-Targets; CHEMBL1075524
DR   Cosmic; 684677
DR   Cosmic; 684678
DR   Cosmic; 903601
DR   Cosmic; 908475
DR   Cosmic; 980983
DR   Cosmic; 1032455
DR   Cosmic; 1146886
DR   Cosmic; 1209732
DR   Cosmic; 1477423
DR   Cosmic; 1995538
DR   Cosmic; 2472918
DR   Cosmic-CLP; 908475
DR   DepMap; ACH-000282
DR   EGA; EGAS00001000978
DR   GDSC; 908475
DR   GEO; GSM434279
DR   GEO; GSM513945
DR   GEO; GSM514332
DR   GEO; GSM794331
DR   GEO; GSM817089
DR   GEO; GSM827558
DR   GEO; GSM887380
DR   GEO; GSM888458
DR   GEO; GSM1374709
DR   GEO; GSM1670189
DR   IARC_TP53; 504
DR   IGRhCellID; NCIH1755
DR   KCLB; 91755
DR   LiGeA; CCLE_505
DR   LINCS_LDP; LCL-1642
DR   PharmacoDB; NCIH1755_1036_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1492
DR   PubChem_Cell_line; CVCL_1492
DR   Wikidata; Q54907856
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24805778;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*40:01,44:02; C*03:04,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Ala (c.1406G>C); ClinVar=VCV000013971; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=908475; DepMap=ACH-000282).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=908475; DepMap=ACH-000282).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.64%; Native American=0.15%; East Asian, North=2.9%; East Asian, South=0%; South Asian=0%; European, North=61.65%; European, South=34.66% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-5892; Cosmic-CLP=908475; KCLB=91755
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 12,13
ST   D21S11: 31
ST   D2S1338: 16,20
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 8,15
ST   FGA: 20,25
ST   Penta D: 8
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   NCI-H1755A
AC   CVCL_L169
SY   H1755A; H-1755A
DR   cancercelllines; CVCL_L169
DR   KCLB; 91755A
DR   Wikidata; Q54907857
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Ala (c.1406G>C); ClinVar=VCV000013971; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1492 ! NCI-H1755
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   NCI-H1769
AC   CVCL_A509
SY   H1769; H-1769
DR   Wikidata; Q54907858
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NCI-H1770
AC   CVCL_1493
SY   H1770; H-1770; NCIH1770
DR   CLO; CLO_0008017
DR   EFO; EFO_0002265
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5893
DR   BioSample; SAMN03473294
DR   cancercelllines; CVCL_1493
DR   Cell_Model_Passport; SIDM00737
DR   ChEMBL-Cells; CHEMBL3308316
DR   ChEMBL-Targets; CHEMBL2366171
DR   Cosmic; 687804
DR   Cosmic; 877269
DR   Cosmic; 980984
DR   Cosmic; 1004695
DR   Cosmic; 1032456
DR   Cosmic; 1146887
DR   Cosmic; 1239953
DR   Cosmic; 1802298
DR   Cosmic; 1891895
DR   Cosmic; 1995539
DR   Cosmic; 2125213
DR   Cosmic; 2560234
DR   Cosmic; 2699646
DR   Cosmic-CLP; 687804
DR   DepMap; ACH-001362
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10703-109H1
DR   GDSC; 687804
DR   GEO; GSM434304
DR   GEO; GSM844629
DR   GEO; GSM1670190
DR   IARC_TP53; 21547
DR   IGRhCellID; NCIH1770
DR   LINCS_LDP; LCL-1625
DR   PharmacoDB; NCIH1770_1037_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1493
DR   PubChem_Cell_line; CVCL_1493
DR   Wikidata; Q54907859
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=11416159;
RX   PubMed=16157194;
RX   PubMed=18438408;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H1770.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.741_742delinsTT) (c.741_742CC>TT); ClinVar=VCV000437017; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=687804; DepMap=ACH-001362).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.3%; Native American=0.35%; East Asian, North=4.49%; East Asian, South=0%; South Asian=0%; European, North=59.77%; European, South=33.09% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5893; Cosmic-CLP=687804; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2644 ! NCI-BL1770
OI   CVCL_1526 ! NCI-H2106
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   NCI-H1781
AC   CVCL_1494
SY   H1781; H-1781; NCIH1781
DR   CLO; CLO_0008018
DR   EFO; EFO_0006663
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5894
DR   BioSample; SAMN03471698
DR   BioSample; SAMN10988321
DR   cancercelllines; CVCL_1494
DR   Cell_Model_Passport; SIDM00754
DR   Cosmic; 877432
DR   Cosmic; 897517
DR   Cosmic; 897728
DR   Cosmic; 903568
DR   Cosmic; 914946
DR   Cosmic; 980985
DR   Cosmic; 1032457
DR   Cosmic; 1128243
DR   Cosmic; 1146888
DR   Cosmic; 1802296
DR   Cosmic; 1995540
DR   Cosmic-CLP; 1298350
DR   DepMap; ACH-000379
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298350
DR   GEO; GSM206478
DR   GEO; GSM253348
DR   GEO; GSM274797
DR   GEO; GSM274830
DR   GEO; GSM434280
DR   GEO; GSM794333
DR   GEO; GSM817091
DR   GEO; GSM827359
DR   GEO; GSM887381
DR   GEO; GSM888459
DR   GEO; GSM1374710
DR   GEO; GSM1670191
DR   IARC_TP53; 505
DR   IGRhCellID; H1781GEO
DR   LiGeA; CCLE_261
DR   LINCS_LDP; LCL-1643
DR   PharmacoDB; NCIH1781_1038_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1494
DR   Wikidata; Q54907860
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,31:01; B*07:02,55:01; C*01:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln245fs*6 (c.735_739delGCCGT); Zygosity=Heterozygous (Cosmic-CLP=1298350; DepMap=ACH-000379).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=1298350; DepMap=ACH-000379).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.69%; East Asian, South=0%; South Asian=0.46%; European, North=65.63%; European, South=32.22% (PubMed=30894373).
CC   Misspelling: NSI-H1781; Cosmic=897517.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5894; Cosmic-CLP=1298350; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 8
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 28,31
ST   D2S1338: 20,25
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 11,13
ST   Penta E: 17
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   NCI-H1781/CMV-Luc polyclone
AC   CVCL_JG93
SY   H1781/CMV-Luc polyclone
DR   cancercelllines; CVCL_JG93
DR   JCRB; JCRB1717
DR   JCRB; NIHS1069
DR   Wikidata; Q54907861
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1717).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln245fs*6 (c.735_739delGCCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; JCRB1717; probable.
CC   Discontinued: JCRB; NIHS1069; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1717
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 8
ST   D5S818: 10
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1494 ! NCI-H1781
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 15
//
ID   NCI-H1781/CMV-Luc#6
AC   CVCL_JG95
SY   H1781/CMV-Luc#6
DR   cancercelllines; CVCL_JG95
DR   JCRB; JCRB1718
DR   JCRB; NIHS1070
DR   Wikidata; Q54907862
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1718).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln245fs*6 (c.735_739delGCCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1070; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1718
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 8
ST   D5S818: 10
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1494 ! NCI-H1781
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 16
//
ID   NCI-H1788
AC   CVCL_A510
SY   H1788; H-1788
DR   ATCC; CRL-5981
DR   Cosmic; 1891913
DR   Wikidata; Q54907863
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Discontinued: ATCC; CRL-5981; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 15
//
ID   NCI-H1792
AC   CVCL_1495
SY   H1792; H-1792; NCIH1792
DR   BTO; BTO_0005836
DR   CLO; CLO_0008019
DR   EFO; EFO_0002266
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5895
DR   BioGRID_ORCS_Cell_line; 537
DR   BioSample; SAMN03470834
DR   BioSample; SAMN10987908
DR   cancercelllines; CVCL_1495
DR   Cell_Model_Passport; SIDM00771
DR   ChEMBL-Cells; CHEMBL3308816
DR   ChEMBL-Targets; CHEMBL1075525
DR   Cosmic; 722044
DR   Cosmic; 724868
DR   Cosmic; 877246
DR   Cosmic; 877433
DR   Cosmic; 903603
DR   Cosmic; 980986
DR   Cosmic; 1032458
DR   Cosmic; 1146889
DR   Cosmic; 1152513
DR   Cosmic; 1891896
DR   Cosmic; 1995541
DR   Cosmic-CLP; 724868
DR   DepMap; ACH-000496
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 724868
DR   GEO; GSM171848
DR   GEO; GSM171849
DR   GEO; GSM253305
DR   GEO; GSM434329
DR   GEO; GSM784206
DR   GEO; GSM784257
DR   GEO; GSM794334
DR   GEO; GSM817092
DR   GEO; GSM827476
DR   GEO; GSM887382
DR   GEO; GSM888460
DR   GEO; GSM1670192
DR   IARC_TP53; 506
DR   IGRhCellID; NCIH1792
DR   LiGeA; CCLE_358
DR   LINCS_LDP; LCL-1644
DR   PharmacoDB; NCIH1792_1039_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1495
DR   PubChem_Cell_line; CVCL_1495
DR   Wikidata; Q54907864
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=12068308;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31467290;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 45 hours (PubMed=25984343); 32.6 hours (PubMed=29681454).
CC   HLA typing: A*02:01,26:08; B*08:01,15:01; C*04:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Heterozygous (Cosmic-CLP=724868).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=1311061; PubMed=12068308; Cosmic-CLP=724868; DepMap=ACH-000496).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=1311061; Cosmic-CLP=724868; DepMap=ACH-000496).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.29%; Native American=0.75%; East Asian, North=2.43%; East Asian, South=0%; South Asian=0.41%; European, North=59.22%; European, South=34.89% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5895; Cosmic-CLP=724868; PubMed=25877200; PubMed=31467290; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 15
ST   D12S391: 22,23
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 15,17
ST   D19S433: 14
ST   D1S1656: 15,16
ST   D21S11: 31
ST   D22S1045: 16
ST   D2S1338: 19
ST   D2S441: 14
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 8,10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H1793
AC   CVCL_1496
SY   H1793; H-1793; NCIH1793
DR   CLO; CLO_0008020
DR   EFO; EFO_0002267
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5896
DR   BioSample; SAMN03472601
DR   BioSample; SAMN10987890
DR   cancercelllines; CVCL_1496
DR   Cell_Model_Passport; SIDM00755
DR   ChEMBL-Cells; CHEMBL3308579
DR   ChEMBL-Targets; CHEMBL1075526
DR   Cosmic; 687806
DR   Cosmic; 903604
DR   Cosmic; 908463
DR   Cosmic; 1609519
DR   Cosmic; 1995542
DR   Cosmic-CLP; 908463
DR   DepMap; ACH-000888
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908463
DR   GEO; GSM206479
DR   GEO; GSM274813
DR   GEO; GSM274814
DR   GEO; GSM513946
DR   GEO; GSM514333
DR   GEO; GSM784270
DR   GEO; GSM794335
DR   GEO; GSM827508
DR   GEO; GSM887383
DR   GEO; GSM888461
DR   GEO; GSM1374711
DR   GEO; GSM1670193
DR   IARC_TP53; 507
DR   IARC_TP53; 21405
DR   IGRhCellID; NCIH1793
DR   KCLB; 91793
DR   LiGeA; CCLE_920
DR   LINCS_LDP; LCL-1645
DR   PharmacoDB; NCIH1793_1040_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1496
DR   PubChem_Cell_line; CVCL_1496
DR   Wikidata; Q54907865
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,30:01; B*15:141,35:08; C*06:02,07:02; DQA1*02:01,02:01; DRB1*07:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Ter (c.625A>T); Zygosity=Heterozygous (PubMed=1311061; Cosmic-CLP=908463; DepMap=ACH-000888).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=1311061; Cosmic-CLP=908463; DepMap=ACH-000888).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0.91%; East Asian, North=1.4%; East Asian, South=0.39%; South Asian=6.96%; European, North=36.54%; European, South=53.57% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5896; Cosmic-CLP=908463; KCLB=91793; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 10,11,18 (ATCC=CRL-5896)
ST   D18S51: 10,18 (PubMed=25877200)
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 8,13
ST   FGA: 23,24 (KCLB=91793)
ST   FGA: 23.2,24 (ATCC=CRL-5896; PubMed=25877200)
ST   Penta D: 13,14
ST   Penta E: 14,16
ST   TH01: 9 (KCLB=91793)
ST   TH01: 9,9.3 (ATCC=CRL-5896; Cosmic-CLP=908463; PubMed=25877200)
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H1819
AC   CVCL_1497
SY   H1819; H-1819; NCIH1819
DR   CLO; CLO_0008021
DR   ATCC; CRL-5897
DR   BioSample; SAMN10989613
DR   cancercelllines; CVCL_1497
DR   Cell_Model_Passport; SIDM01674
DR   Cosmic; 877247
DR   Cosmic; 877434
DR   Cosmic; 903605
DR   Cosmic; 1146890
DR   Cosmic; 1152514
DR   Cosmic; 1219065
DR   Cosmic; 1239888
DR   Cosmic; 2125181
DR   DepMap; ACH-000033
DR   GEO; GSM62327
DR   GEO; GSM108827
DR   GEO; GSM108828
DR   GEO; GSM253312
DR   GEO; GSM434252
DR   GEO; GSM794336
DR   GEO; GSM817093
DR   IARC_TP53; 28442
DR   IGRhCellID; H1819_02%20GEO
DR   Progenetix; CVCL_1497
DR   Wikidata; Q54907866
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=11416159;
RX   PubMed=16187286;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=20624269;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 51.3 hours (PubMed=29681454).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>T (IVS9+1G>T); ClinVar=VCV000634766; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=20557307; DepMap=ACH-000033).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5897; PubMed=11416159; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 22
ST   Penta D: 12,14
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E099 ! NCI-BL1819
OI   CVCL_1488 ! NCI-H1693
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   NCI-H182
AC   CVCL_A511
SY   H182; H-182
DR   Cosmic; 844548
DR   Wikidata; Q54907867
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=6272398;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   NCI-H1824
AC   CVCL_A512
SY   H1824; H-1824
DR   Wikidata; Q54907868
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E100 ! NCI-BL1824
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   NCI-H1836
AC   CVCL_1498
SY   H1836; H-1836; NCIH1836
DR   BTO; BTO_0006525
DR   CLO; CLO_0008022
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5898
DR   BioSample; SAMN03472591
DR   BioSample; SAMN10988158
DR   cancercelllines; CVCL_1498
DR   Cell_Model_Passport; SIDM00770
DR   ChEMBL-Cells; CHEMBL4523546
DR   ChEMBL-Targets; CHEMBL4523580
DR   Cosmic; 980953
DR   Cosmic; 1032423
DR   Cosmic; 1759267
DR   Cosmic-CLP; 1240182
DR   DepMap; ACH-000559
DR   EGA; EGAS00001000978
DR   GDSC; 1240182
DR   GEO; GSM887384
DR   GEO; GSM888462
DR   GEO; GSM986175
DR   GEO; GSM1670194
DR   GEO; GSM1887933
DR   GEO; GSM1888011
DR   IARC_TP53; 28311
DR   LINCS_LDP; LCL-1842
DR   PharmacoDB; NCIH1836_1041_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1498
DR   PubChem_Cell_line; CVCL_1498
DR   Wikidata; Q54907869
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1496Glufs*27 (c.4485delC) (p.S1495fs); Zygosity=Heterozygous (Cosmic-CLP=1240182; DepMap=ACH-000559).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Cys (c.730G>T); ClinVar=VCV000376599; Zygosity=Homozygous (Cosmic-CLP=1240182; DepMap=ACH-000559).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.84%; East Asian, North=0.99%; East Asian, South=0%; South Asian=0.88%; European, North=70.01%; European, South=27.28% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5898; Cosmic-CLP=1240182
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14,16.2
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24,26
ST   Penta D: 10,12
ST   Penta E: 7
ST   TH01: 8,9.3
ST   TPOX: 9,10
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NCI-H1838
AC   CVCL_1499
SY   H1838; H-1838; NCIH1838
DR   BTO; BTO_0005779
DR   CLO; CLO_0008023
DR   EFO; EFO_0002268
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5899
DR   BioSample; SAMN03471784
DR   BioSample; SAMN10988157
DR   cancercelllines; CVCL_1499
DR   Cell_Model_Passport; SIDM00769
DR   ChEMBL-Cells; CHEMBL3308317
DR   ChEMBL-Targets; CHEMBL2366346
DR   Cosmic; 687807
DR   Cosmic; 877435
DR   Cosmic; 980987
DR   Cosmic; 1032459
DR   Cosmic; 1146891
DR   Cosmic; 1152515
DR   Cosmic; 1995543
DR   Cosmic-CLP; 687807
DR   DepMap; ACH-000733
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687807
DR   GEO; GSM206480
DR   GEO; GSM274749
DR   GEO; GSM274750
DR   GEO; GSM434330
DR   GEO; GSM513949
DR   GEO; GSM514334
DR   GEO; GSM784224
DR   GEO; GSM794337
DR   GEO; GSM887385
DR   GEO; GSM888463
DR   GEO; GSM1374712
DR   GEO; GSM1374713
DR   GEO; GSM1670195
DR   IARC_TP53; 21548
DR   IGRhCellID; NCIH1838
DR   LiGeA; CCLE_257
DR   LINCS_LDP; LCL-1662
DR   PharmacoDB; NCIH1838_1042_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1499
DR   PubChem_Cell_line; CVCL_1499
DR   Wikidata; Q54907872
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 71.8 hours (PubMed=29681454).
CC   HLA typing: A*26:01,26:01; B*40:01,45:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp1279Ter (c.3836G>A); ClinVar=VCV000127376; Zygosity=Heterozygous (Cosmic-CLP=687807; DepMap=ACH-000733).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Asn184fs*17 (c.548_549insA); Zygosity=Heterozygous (Cosmic-CLP=687807; DepMap=ACH-000733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (Cosmic-CLP=687807; DepMap=ACH-000733).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.12%; Native American=0%; East Asian, North=3.65%; East Asian, South=0%; South Asian=0%; European, North=58.09%; European, South=36.13% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5899; Cosmic-CLP=687807; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 17
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 20,23.2
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   NCI-H1869
AC   CVCL_1500
SY   H1869; H-1869; NCIH1869
DR   CLO; CLO_0008024
DR   EFO; EFO_0006664
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5900
DR   BioGRID_ORCS_Cell_line; 956
DR   BioSample; SAMN03472995
DR   BioSample; SAMN10988520
DR   cancercelllines; CVCL_1500
DR   Cell_Model_Passport; SIDM00768
DR   Cosmic; 1995544
DR   Cosmic-CLP; 1240183
DR   DepMap; ACH-000894
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240183
DR   GEO; GSM434787
DR   GEO; GSM794338
DR   GEO; GSM844630
DR   GEO; GSM844631
DR   GEO; GSM887386
DR   GEO; GSM888464
DR   GEO; GSM1374714
DR   GEO; GSM1374715
DR   GEO; GSM1670196
DR   LiGeA; CCLE_107
DR   LINCS_LDP; LCL-1613
DR   PharmacoDB; NCIH1869_1043_2019
DR   Progenetix; CVCL_1500
DR   Wikidata; Q54907873
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=18083107;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-crl-5900-nci-h1869-cell-growth-and-morphology
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 51.8 hours (PubMed=29681454).
CC   HLA typing: A*03:01,11:01; B*07:02,18:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (DepMap=ACH-000894).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.87%; Native American=0%; East Asian, North=2.87%; East Asian, South=0%; South Asian=0%; European, North=62.8%; European, South=33.45% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5900; Cosmic-CLP=1240183; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,18
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 19,23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   NCI-H187
AC   CVCL_1501
SY   H187; H-187; NCIH187
DR   BTO; BTO_0003021
DR   CLO; CLO_0008025
DR   EFO; EFO_0002269
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5804
DR   BioSample; SAMN03471879
DR   cancercelllines; CVCL_1501
DR   Cell_Model_Passport; SIDM00767
DR   ChEMBL-Cells; CHEMBL3308878
DR   ChEMBL-Targets; CHEMBL2366276
DR   Cosmic; 688007
DR   Cosmic; 844549
DR   Cosmic; 850441
DR   Cosmic; 877201
DR   Cosmic; 877353
DR   Cosmic; 1006524
DR   Cosmic; 1021854
DR   Cosmic; 1152463
DR   Cosmic; 1219099
DR   Cosmic; 1998283
DR   Cosmic; 2125193
DR   Cosmic-CLP; 688007
DR   DepMap; ACH-001136
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 688007
DR   GEO; GSM169435
DR   GEO; GSM170745
DR   GEO; GSM170746
DR   GEO; GSM170748
DR   GEO; GSM171850
DR   GEO; GSM171851
DR   GEO; GSM380510
DR   GEO; GSM380514
DR   GEO; GSM482516
DR   GEO; GSM536329
DR   GEO; GSM784232
DR   GEO; GSM794275
DR   GEO; GSM844632
DR   GEO; GSM845554
DR   GEO; GSM986173
DR   GEO; GSM1670197
DR   GEO; GSM1887888
DR   GEO; GSM1887967
DR   IARC_TP53; 17902
DR   IGRhCellID; NCIH187
DR   KCLB; 90187
DR   LINCS_LDP; LCL-1843
DR   PharmacoDB; NCIH187_1044_2019
DR   Progenetix; CVCL_1501
DR   PubChem_Cell_line; CVCL_1501
DR   Wikidata; Q54907874
RX   PubMed=1563005;
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=3335022;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20615970;
RX   PubMed=20624269;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-291.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,24:02; B*07:02,37:04; C*07:02,07:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,03:17 (PubMed=25960936).
CC   HLA typing: A*03:01,24:02; B*07:02,37:04; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Homozygous (PubMed=20557307; ATCC=CRL-5804).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.56%; Native American=0.51%; East Asian, North=0.71%; East Asian, South=0.08%; South Asian=0%; European, North=64.51%; European, South=33.62% (PubMed=30894373).
CC   Misspelling: NCIN187; GEO=GSM845554.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5804; Cosmic-CLP=688007; KCLB=90187; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 14,16
ST   D21S11: 28,29
ST   D2S1338: 19
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 25
ST   Penta D: 8,16
ST   Penta E: 12,15
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   NCI-H1870
AC   CVCL_1502
SY   H1870; H-1870
DR   CLO; CLO_0008026
DR   ATCC; CRL-5901
DR   BioSample; SAMN03151856
DR   BioSample; SAMN03472592
DR   Cell_Model_Passport; SIDM00647
DR   Cosmic; 1021879
DR   GEO; GSM168280
DR   Wikidata; Q54907875
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h1304-atcc-crl-5862
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00413.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-5901; true.
ST   Source(s): ATCC=CRL-5901
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1462 ! NCI-H1304
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   NCI-H1876
AC   CVCL_1503
SY   H1876; H-1876; NCIH1876
DR   CLO; CLO_0008027
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5902
DR   BioSample; SAMN10988001
DR   cancercelllines; CVCL_1503
DR   Cell_Model_Passport; SIDM00766
DR   Cosmic; 877384
DR   Cosmic; 1032424
DR   Cosmic; 1152486
DR   Cosmic; 1891914
DR   Cosmic-CLP; 1330972
DR   DepMap; ACH-000586
DR   EGA; EGAS00001000978
DR   GDSC; 1330972
DR   GEO; GSM887387
DR   GEO; GSM888465
DR   GEO; GSM986179
DR   GEO; GSM1670198
DR   GEO; GSM1682808
DR   GEO; GSM1887934
DR   GEO; GSM1888012
DR   IARC_TP53; 28286
DR   LiGeA; CCLE_441
DR   LINCS_LDP; LCL-1812
DR   PharmacoDB; NCIH1876_1045_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1503
DR   Wikidata; Q54907876
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-and-growth-of-crl-5902-nci-h1876-cells
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*07:02,35:01; C*04:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1330972; DepMap=ACH-000586).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (Cosmic-CLP=1330972; DepMap=ACH-000586).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.78%; Native American=0.51%; East Asian, North=1.19%; East Asian, South=0%; South Asian=0%; European, North=70.91%; European, South=26.6% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5902; Cosmic-CLP=1330972
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 25
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   Penta D: 12,13
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A513 ! NCI-H1881
OI   CVCL_1504 ! NCI-H1882
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   NCI-H1881
AC   CVCL_A513
SY   H1881; H-1881
DR   cancercelllines; CVCL_A513
DR   Cell_Model_Passport; SIDM00765
DR   IARC_TP53; 432
DR   Wikidata; Q54907877
RX   PubMed=1312696;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=1312696).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1503 ! NCI-H1876
OI   CVCL_1504 ! NCI-H1882
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   NCI-H1882
AC   CVCL_1504
SY   H1882; H-1882
DR   CLO; CLO_0008028
DR   EFO; EFO_0006665
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-5903
DR   BioSample; SAMN03473011
DR   Cell_Model_Passport; SIDM00764
DR   ChEMBL-Cells; CHEMBL3308318
DR   ChEMBL-Targets; CHEMBL2366210
DR   Cosmic; 753602
DR   Cosmic; 877228
DR   Cosmic; 980954
DR   Cosmic; 1032425
DR   EGA; EGAS00001000610
DR   GEO; GSM1887945
DR   GEO; GSM1888021
DR   IARC_TP53; 27567
DR   LINCS_LDP; LCL-1844
DR   PharmacoDB; NCIH1882_1046_2019
DR   PubChem_Cell_line; CVCL_1504
DR   Wikidata; Q54907878
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Part of: Small cell lung cancer p53 hotspot mutation cell panel (ATCC TCP-2040).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*07:02,35:01; C*04:01,07:02; DQB1*06:07,06:07 (PubMed=25960936).
CC   HLA typing: A*02:01,03:01; B*07:02,35:01; C*04:01,07:02 (PubMed=26589293).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5903; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 25
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   Penta D: 12,13
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1503 ! NCI-H1876
OI   CVCL_A513 ! NCI-H1881
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   NCI-H1904
AC   CVCL_A514
SY   H1904; H-1904
DR   IARC_TP53; 508
DR   Wikidata; Q54907879
RX   PubMed=1311061;
RX   PubMed=8806092;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Ter (c.625A>T); Zygosity=Unspecified (PubMed=1311061).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   NCI-H1915
AC   CVCL_1505
SY   H1915; H-1915; NCIH1915
DR   BTO; BTO_0004426
DR   CLO; CLO_0008029
DR   EFO; EFO_0006666
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5904
DR   BioGRID_ORCS_Cell_line; 957
DR   BioSample; SAMN03473019
DR   BioSample; SAMN10987732
DR   cancercelllines; CVCL_1505
DR   Cell_Model_Passport; SIDM00763
DR   Cosmic; 722067
DR   Cosmic; 1146892
DR   Cosmic; 1995545
DR   Cosmic-CLP; 1240184
DR   DepMap; ACH-000434
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240184
DR   GEO; GSM434314
DR   GEO; GSM827393
DR   GEO; GSM887388
DR   GEO; GSM888466
DR   GEO; GSM1670199
DR   IARC_TP53; 509
DR   IGRhCellID; H1915GEO
DR   KCLB; 91915
DR   LiGeA; CCLE_330
DR   LINCS_HMS; 50035
DR   LINCS_LDP; LCL-1598
DR   PharmacoDB; NCIH1915_1047_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1505
DR   Wikidata; Q54907880
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,24:02; B*14:02,14:02; C*02:02,02:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Phe90Leu (c.270C>G); Zygosity=Homozygous (Cosmic-CLP=1240184; DepMap=ACH-000434).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Heterozygous (PubMed=1311061; Cosmic-CLP=1240184; DepMap=ACH-000434).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys291Ter (c.871A>T); Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=1240184; DepMap=ACH-000434).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.05%; Native American=0.18%; East Asian, North=4.07%; East Asian, South=0%; South Asian=6.45%; European, North=23.9%; European, South=62.34% (PubMed=30894373).
CC   Discontinued: KCLB; 91915; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5904; Cosmic-CLP=1240184; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 11
ST   D19S433: 13,14
ST   D21S11: 27
ST   D2S1338: 17,24
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 20
ST   Penta D: 13
ST   Penta E: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NCI-H1926
AC   CVCL_1506
SY   H1926; H-1926
DR   CLO; CLO_0008030
DR   ATCC; CRL-5905
DR   BioSample; SAMN03472593
DR   cancercelllines; CVCL_1506
DR   Cosmic; 688008
DR   Cosmic; 850432
DR   Cosmic; 908477
DR   GDSC; 908477
DR   IARC_TP53; 1404
DR   IARC_TP53; 21549
DR   PharmacoDB; NCIH1926_1048_2019
DR   Wikidata; Q54907881
RX   PubMed=1312696;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20679594;
RX   PubMed=31803961;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5905; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5905; PubMed=20679594
ST   Amelogenin: X (ATCC=CRL-5905)
ST   Amelogenin: X,Y (PubMed=20679594)
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   NCI-H1930
AC   CVCL_1507
SY   H1930; H-1930; NCIH1930
DR   CLO; CLO_0008031
DR   EFO; EFO_0002270
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5906
DR   BioSample; SAMN03473063
DR   BioSample; SAMN10988154
DR   cancercelllines; CVCL_1507
DR   Cell_Model_Passport; SIDM01672
DR   ChEMBL-Cells; CHEMBL4523542
DR   ChEMBL-Targets; CHEMBL4523573
DR   Cosmic; 688009
DR   Cosmic; 844575
DR   Cosmic; 877229
DR   Cosmic; 924245
DR   Cosmic; 2125238
DR   DepMap; ACH-000870
DR   EGA; EGAS00001000610
DR   GEO; GSM380480
DR   GEO; GSM887389
DR   GEO; GSM888467
DR   GEO; GSM1887900
DR   GEO; GSM1887968
DR   IARC_TP53; 27188
DR   IGRhCellID; NCIH1930
DR   LiGeA; CCLE_459
DR   PharmacoDB; NCIH1930_1049_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_1507
DR   PubChem_Cell_line; CVCL_1507
DR   Wikidata; Q54907882
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,29:02; B*44:03,15:01; C*03:03,16:01; DQB1*05:03,05:03; DRB1*14:07,14:07 (PubMed=25960936).
CC   HLA typing: A*02:01,29:02; B*15:27,44:03; C*03:03,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Arg (c.733G>C); ClinVar=VCV000376604; Zygosity=Homozygous (ATCC=CRL-5906).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.23%; Native American=0%; East Asian, North=3.79%; East Asian, South=0%; South Asian=0%; European, North=56.29%; European, South=37.69% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5906; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 12,19
ST   D19S433: 12,16.2
ST   D21S11: 30
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 7,13
ST   TH01: 6,10
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H1934
AC   CVCL_A515
SY   H1934; H-1934
DR   Wikidata; Q54907883
RX   PubMed=8806092;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1944
AC   CVCL_1508
SY   H1944; H-1944; NCIH1944
DR   BTO; BTO_0005837
DR   CLO; CLO_0008032
DR   EFO; EFO_0006667
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5907
DR   BioGRID_ORCS_Cell_line; 536
DR   BioSample; SAMN03473281
DR   BioSample; SAMN10988538
DR   cancercelllines; CVCL_1508
DR   CCRID; 3101HUMSCSP596
DR   Cell_Model_Passport; SIDM00762
DR   ChEMBL-Cells; CHEMBL4296201
DR   ChEMBL-Targets; CHEMBL4296390
DR   CLS; 305123
DR   Cosmic; 722062
DR   Cosmic; 903606
DR   Cosmic; 1146893
DR   Cosmic; 1891897
DR   Cosmic-CLP; 1240185
DR   DepMap; ACH-000414
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1240185
DR   GEO; GSM434331
DR   GEO; GSM513950
DR   GEO; GSM514335
DR   GEO; GSM794339
DR   GEO; GSM827486
DR   GEO; GSM887390
DR   GEO; GSM888468
DR   GEO; GSM1670200
DR   IARC_TP53; 30129
DR   IGRhCellID; H1944GEO
DR   LiGeA; CCLE_517
DR   LINCS_LDP; LCL-1614
DR   NCI-DTP; NCI-H1944
DR   PharmacoDB; NCIH1944_1050_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1508
DR   PubChem_Cell_line; CVCL_1508
DR   Wikidata; Q54907884
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 37.8 hours (PubMed=29681454).
CC   HLA typing: A*03:01,24:03; B*15:18,51:01; C*07:04,07:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Arg2363Ter (c.7087C>T); Zygosity=Heterozygous (Cosmic-CLP=1240185; DepMap=ACH-000414).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (Cosmic-CLP=1240185; DepMap=ACH-000414).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.85%; Native American=0.24%; East Asian, North=2.96%; East Asian, South=0%; South Asian=0.89%; European, North=61.33%; European, South=33.73% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5907; Cosmic-CLP=1240185; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 18,19
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 16,19
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 21,25
ST   Penta D: 8,11
ST   Penta E: 5,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H1954
AC   CVCL_A516
SY   H1954; H-1954
DR   Wikidata; Q54907885
RX   PubMed=8806092;
RX   PubMed=31803961;
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H196
AC   CVCL_1509
SY   H196; H-196; NCIH196
DR   BTO; BTO_0003027
DR   CLO; CLO_0008033
DR   EFO; EFO_0006668
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5823
DR   BioSample; SAMN03471881
DR   BioSample; SAMN10988217
DR   cancercelllines; CVCL_1509
DR   Cell_Model_Passport; SIDM00761
DR   CLS; 300390
DR   Cosmic; 852003
DR   Cosmic; 953990
DR   Cosmic; 1995546
DR   Cosmic-CLP; 1240186
DR   DepMap; ACH-000752
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240186
DR   GEO; GSM169451
DR   GEO; GSM170732
DR   GEO; GSM170733
DR   GEO; GSM784210
DR   GEO; GSM827362
DR   GEO; GSM844633
DR   GEO; GSM845541
DR   GEO; GSM887392
DR   GEO; GSM888470
DR   GEO; GSM986170
DR   GEO; GSM1670201
DR   GEO; GSM1887889
DR   GEO; GSM1887969
DR   KCLB; 90196
DR   LiGeA; CCLE_482
DR   LINCS_LDP; LCL-1813
DR   PharmacoDB; NCIH196_1051_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1509
DR   Wikidata; Q54907886
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=38180245;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 64 hours (PubMed=25984343).
CC   HLA typing: A*29:01,33:03; B*07:05,50:01; C*06:02,15:05; DRB1*10:01,15:25 (PubMed=25960936).
CC   HLA typing: A*29:01,33:03; B*07:05,50:01; C*06:02,15:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln383Ter (c.1147C>T); ClinVar=VCV000428664; Zygosity=Homozygous (DepMap=ACH-000752).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (DepMap=ACH-000752).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.1%; East Asian, North=0%; East Asian, South=1.64%; South Asian=3.75%; European, North=50.92%; European, South=43.59% (PubMed=30894373).
CC   Caution: Originally classified as originating from a lung small cell carcinoma, but is reclassified as a lung sarcomatoid carcinoma based on a number of criteria (PubMed=38180245).
CC   Discontinued: KCLB; 90196; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5823; CLS=300390; Cosmic-CLP=1240186; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 19
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 17,19
ST   D19S433: 14
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 12
ST   D6S1043: 13
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 10
ST   Penta E: 8,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C45540; Lung sarcomatoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NCI-H1963
AC   CVCL_1510
SY   H1963; H-1963; NCIH1963
DR   BTO; BTO_0005976
DR   CLO; CLO_0008034
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5982
DR   BioSample; SAMN03472631
DR   BioSample; SAMN03473530
DR   BioSample; SAMN10987786
DR   cancercelllines; CVCL_1510
DR   Cell_Model_Passport; SIDM00760
DR   ChEMBL-Cells; CHEMBL3308855
DR   ChEMBL-Targets; CHEMBL2366075
DR   Cosmic; 688010
DR   Cosmic; 877230
DR   Cosmic; 1021880
DR   Cosmic; 1219106
DR   Cosmic; 1239945
DR   Cosmic; 1995547
DR   Cosmic; 2125206
DR   Cosmic-CLP; 688010
DR   DepMap; ACH-000729
DR   DSMZ; ACC-540
DR   DSMZCellDive; ACC-540
DR   EGA; EGAS00001000978
DR   GDSC; 688010
DR   GEO; GSM169429
DR   GEO; GSM170719
DR   GEO; GSM170720
DR   GEO; GSM171852
DR   GEO; GSM171853
DR   GEO; GSM844634
DR   GEO; GSM844635
DR   GEO; GSM845542
DR   GEO; GSM887391
DR   GEO; GSM888469
DR   GEO; GSM1670202
DR   GEO; GSM1682809
DR   GEO; GSM1887899
DR   GEO; GSM1887970
DR   IARC_TP53; 433
DR   IARC_TP53; 21401
DR   LiGeA; CCLE_511
DR   LINCS_LDP; LCL-1845
DR   PharmacoDB; NCIH1963_1052_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1510
DR   PubChem_Cell_line; CVCL_1510
DR   Wikidata; Q54907887
RX   PubMed=1312696;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=17426248;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=23716474;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-nci-h1963-h1963-atcc-crl-5982-cells
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Doubling time: ~3-4 days (DSMZ=ACC-540).
CC   HLA typing: A*02:01,32:01; B*07:02,44:18; C*07:01,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Cys61Ter (c.183T>A); Zygosity=Homozygous (Cosmic-CLP=688010; DepMap=ACH-000729).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val147Asp (c.440T>A); ClinVar=VCV001351017; Zygosity=Heterozygous (PubMed=1312696; PubMed=20557307; Cosmic-CLP=688010; DepMap=ACH-000729).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Heterozygous (PubMed=1312696; PubMed=20557307; Cosmic-CLP=688010; DepMap=ACH-000729).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=56.07%; Native American=0.5%; East Asian, North=4.15%; East Asian, South=0%; South Asian=0%; European, North=21.6%; European, South=17.68% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5982; Cosmic-CLP=688010; DSMZ=ACC-540
ST   Amelogenin: X (DSMZ=ACC-540)
ST   Amelogenin: X,Y (ATCC=CRL-5982; Cosmic-CLP=688010)
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 17,18,19
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 20,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,11
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 5,13
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 17,20
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E101 ! NCI-BL1963
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   NCI-H1968
AC   CVCL_A517
SY   H1968; H-1968
DR   Wikidata; Q54907888
RX   PubMed=8806092;
RX   PubMed=31803961;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1971
AC   CVCL_A518
SY   H1971; H-1971
DR   Wikidata; Q54907889
RX   PubMed=8806092;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1974
AC   CVCL_A519
SY   H1974; H-1974
DR   Wikidata; Q54907890
RX   PubMed=8806092;
RX   PubMed=31803961;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H1975
AC   CVCL_1511
SY   H1975; H-1975; NCIH1975
DR   BTO; BTO_0004824
DR   CLO; CLO_0008035
DR   EFO; EFO_0002271
DR   CLDB; cl7204
DR   AddexBio; C0016013/4946
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5908
DR   BCRJ; 0352
DR   BioGRID_ORCS_Cell_line; 958
DR   BioSample; SAMN03471753
DR   BioSample; SAMN03472594
DR   BioSample; SAMN10988259
DR   cancercelllines; CVCL_1511
DR   CCRID; 1101HUM-PUMC000252
DR   CCRID; 3101HUMSCSP597
DR   CCRID; 3101HUMTCHu193
DR   Cell_Model_Passport; SIDM00759
DR   ChEMBL-Cells; CHEMBL3307601
DR   ChEMBL-Targets; CHEMBL614348
DR   CLS; 305067
DR   Cosmic; 687808
DR   Cosmic; 903607
DR   Cosmic; 924244
DR   Cosmic; 930487
DR   Cosmic; 1028949
DR   Cosmic; 1047098
DR   Cosmic; 1128244
DR   Cosmic; 1146894
DR   Cosmic; 1154595
DR   Cosmic; 1336879
DR   Cosmic; 1513408
DR   Cosmic; 1571739
DR   Cosmic; 1609518
DR   Cosmic; 1741781
DR   Cosmic; 1795297
DR   Cosmic; 1802294
DR   Cosmic; 1995548
DR   Cosmic; 2042865
DR   Cosmic; 2125194
DR   Cosmic-CLP; 924244
DR   DepMap; ACH-000587
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 924244
DR   GEO; GSM108829
DR   GEO; GSM108830
DR   GEO; GSM206481
DR   GEO; GSM253304
DR   GEO; GSM434293
DR   GEO; GSM513951
DR   GEO; GSM514336
DR   GEO; GSM782116
DR   GEO; GSM794340
DR   GEO; GSM817094
DR   GEO; GSM887393
DR   GEO; GSM888471
DR   GEO; GSM1374716
DR   GEO; GSM1670203
DR   IARC_TP53; 27189
DR   ICLC; HTL06001
DR   IGRhCellID; NCIH1975
DR   KCB; KCB 2014034YJ
DR   LiGeA; CCLE_396
DR   LINCS_LDP; LCL-1663
DR   PharmacoDB; NCIH1975_1053_2019
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   PRIDE; PXD011315
DR   PRIDE; PXD015270
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1511
DR   PubChem_Cell_line; CVCL_1511
DR   Ubigene; YC-C106
DR   Wikidata; Q54907891
RX   PubMed=8806092;
RX   PubMed=17332333;
RX   PubMed=18083107;
RX   PubMed=19727395;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=21498706;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25008024;
RX   PubMed=25483995;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26202522;
RX   PubMed=26554430;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27835594;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30710758;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32351780;
RX   PubMed=35117401;
RX   PubMed=35839778;
RX   PubMed=39061985;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/nci-h1975-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 38.7 +- 5.92 hours (PubMed=25008024); 30.531 +- 1.823 hours (PubMed=25483995); 28 hours (PubMed=25984343); 42.2 hours (PubMed=29681454).
CC   HLA typing: A*01:01,01:01; B*41:01,41:01; C*17:01,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (PubMed=17332333; PubMed=21498706; Cosmic-CLP=924244; DepMap=ACH-000587).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (PubMed=17332333; PubMed=21498706; Cosmic-CLP=924244; DepMap=ACH-000587).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (Cosmic-CLP=924244; DepMap=ACH-000587).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=924244; DepMap=ACH-000587).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.35%; Native American=0%; East Asian, North=1.32%; East Asian, South=0%; South Asian=7.46%; European, North=30.01%; European, South=60.85% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016013/4946; ATCC=CRL-5908; CCRID; Cosmic-CLP=924244; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13
ST   D12S391: 17
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D1S1656: 14,15
ST   D21S11: 28
ST   D22S1045: 14,15
ST   D2S1338: 17
ST   D2S441: 10,11
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8 (CCRID; Cosmic-CLP=924244; PubMed=25877200)
ST   D7S820: 8,11 (AddexBio=C0016013/4946; ATCC=CRL-5908; Technion Genomics Center)
ST   D8S1179: 13 (CCRID)
ST   D8S1179: 13,16 (ATCC=CRL-5908; PubMed=25877200; Technion Genomics Center)
ST   FGA: 21,24
ST   Penta D: 12,13
ST   Penta E: 12,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   NCI-H1975 CS
AC   CVCL_A7EX
DR   cancercelllines; CVCL_A7EX
DR   Wikidata; Q107116538
RX   PubMed=32928921;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Cys797Ser (c.2389T>A); ClinVar=VCV000376342; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=32928921).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   NCI-H1975 EGFR-D770_N771insSVD
AC   CVCL_E6DD
SY   NCI-H1975 EGFR D770_N771insSVD; H1975-insSVD
RX   PubMed=29748209;
RX   PubMed=31467113;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_corrected; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous; Note=By TALEN (PubMed=29748209).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_corrected; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=By TALEN (PubMed=29748209).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insSerValAsp (c.2311_2312insGCGTGGACA)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NCI-H1975 EGFR-D770_N771insSVD_Luc
AC   CVCL_E6DE
SY   NCI-H1975 EGFR D770_N771insSVD_Luc
RX   PubMed=29748209;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_corrected; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous; Note=By TALEN (PubMed=29748209).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_corrected; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=By TALEN (PubMed=29748209).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insSerValAsp (c.2311_2312insGCGTGGACA)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6DD ! NCI-H1975 EGFR-D770_N771insSVD
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NCI-H1975 EGFR-T790M/C797S/L858R
AC   CVCL_UE30
SY   NCI-H1975 L858R/T790M/C797S
DR   cancercelllines; CVCL_UE30
DR   KYinno; KC-0128
DR   Wikidata; Q95993283
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Cys797Ser (c.2389T>A); ClinVar=VCV000376342; Zygosity=Unspecified; Note=By CRISPR/Cas9 (KYinno=KC-0128).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: KYinno; KC-0128; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 15
//
ID   NCI-H1975 KRAS (G12D/+)
AC   CVCL_LC85
SY   KRAS (G12D/+) NCI-H1975; NCI-H1975 K-RAS(G12D/+)
DR   cancercelllines; CVCL_LC85
DR   Horizon_Discovery; HD+120-001
DR   Wikidata; Q54907892
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+120-001).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   NCI-H1975-Cas9-594
AC   CVCL_XD02
DR   cancercelllines; CVCL_XD02
DR   CCRID; 1101HUM-PUMC000594
DR   Wikidata; Q95993284
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   NCI-H1975-Cas9-595
AC   CVCL_XD03
DR   cancercelllines; CVCL_XD03
DR   CCRID; 1101HUM-PUMC000595
DR   Wikidata; Q95993285
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000595
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   NCI-H1975-Cas9-596
AC   CVCL_XD04
DR   cancercelllines; CVCL_XD04
DR   CCRID; 1101HUM-PUMC000596
DR   Wikidata; Q95993286
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CCRID=1101HUM-PUMC000596
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta E: 12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   NCI-H1975-Luc [JCRB]
AC   CVCL_4W96
DR   cancercelllines; CVCL_4W96
DR   JCRB; JCRB1486
DR   JCRB; NIHS0724
DR   Wikidata; Q54907893
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0724; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1486
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   NCI-H1975-Luc [Ubigene]
AC   CVCL_C8W1
DR   Ubigene; YC-C106-Luc-P
DR   Wikidata; Q123033157
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   NCI-H1975/AR
AC   CVCL_B0JK
DR   cancercelllines; CVCL_B0JK
DR   CCRID; 4201PAT-CCTCC01379
DR   Wikidata; Q108821016
RX   Patent=AU2020103364A4;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201982.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   NCI-H1975/GR
AC   CVCL_HF59
DR   cancercelllines; CVCL_HF59
DR   Wikidata; Q54907894
RX   PubMed=25008024;
RX   PubMed=25483995;
CC   Population: Caucasian.
CC   Doubling time: 47.73 +- 3.50 hours (PubMed=25008024); 46.535 +- 0.428 hours (PubMed=25483995).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   NCI-H1975/GR/XR
AC   CVCL_HF60
DR   cancercelllines; CVCL_HF60
DR   Wikidata; Q54907895
RX   PubMed=25008024;
CC   Population: Caucasian.
CC   Doubling time: 46.68 +- 2.68 hours (PubMed=25008024).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HF59 ! NCI-H1975/GR
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   NCI-H1975/OSIR
AC   CVCL_WV99
DR   cancercelllines; CVCL_WV99
DR   Wikidata; Q95993289
RX   PubMed=27835594;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   NCI-H1977
AC   CVCL_A520
SY   H1977; H-1977
DR   Wikidata; Q54907896
RX   PubMed=8806092;
RX   PubMed=31803961;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   NCI-H1993
AC   CVCL_1512
SY   H1993; H-1993; NCIH1993
DR   CLO; CLO_0008036
DR   EFO; EFO_0002272
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5909
DR   BioGRID_ORCS_Cell_line; 959
DR   BioSample; SAMN03473255
DR   cancercelllines; CVCL_1512
DR   Cell_Model_Passport; SIDM00758
DR   ChEMBL-Cells; CHEMBL3308138
DR   ChEMBL-Targets; CHEMBL1075527
DR   Cosmic; 687809
DR   Cosmic; 877248
DR   Cosmic; 903608
DR   Cosmic; 908476
DR   Cosmic; 980988
DR   Cosmic; 1032460
DR   Cosmic; 1146895
DR   Cosmic; 1694669
DR   Cosmic; 1870266
DR   Cosmic; 1891898
DR   Cosmic; 1995549
DR   Cosmic; 2125239
DR   Cosmic; 2630415
DR   Cosmic-CLP; 908476
DR   DepMap; ACH-001137
DR   EGA; EGAS00001000978
DR   GDSC; 908476
DR   GEO; GSM62328
DR   GEO; GSM108831
DR   GEO; GSM108832
DR   GEO; GSM274706
DR   GEO; GSM434315
DR   GEO; GSM513952
DR   GEO; GSM514337
DR   GEO; GSM794341
DR   GEO; GSM817095
DR   GEO; GSM1670204
DR   IARC_TP53; 21550
DR   IGRhCellID; NCIH1993
DR   LINCS_LDP; LCL-1646
DR   NCI-DTP; NCI-H1993
DR   PharmacoDB; NCIH1993_1054_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1512
DR   PubChem_Cell_line; CVCL_1512
DR   Wikidata; Q54907897
RX   PubMed=8806092;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=24297535;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-and-growth-of-atcc-crl-5909-nci-h1993-cells
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 31.6 hours (PubMed=29681454).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Trp (c.726C>G); ClinVar=VCV000376580; Zygosity=Homozygous (Cosmic-CLP=908476; DepMap=ACH-001137).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.07%; Native American=0.66%; East Asian, North=0.47%; East Asian, South=1.32%; South Asian=0.09%; European, North=67.35%; European, South=29.05% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5909; Cosmic-CLP=908476; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X (ATCC=CRL-5909; Cosmic-CLP=908476; PubMed=25877200)
ST   Amelogenin: X,Y (PubMed=20679594)
ST   CSF1PO: 10,13
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12,14 (ATCC=CRL-5909)
ST   D8S1179: 14 (PubMed=25877200)
ST   FGA: 22,23
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E102 ! NCI-BL1993
OI   CVCL_1521 ! NCI-H2073
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H1994
AC   CVCL_1513
SY   H1994; H-1994
DR   CLO; CLO_0008037
DR   ATCC; CRL-5910
DR   BioSample; SAMN03472595
DR   Wikidata; Q54907898
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-5910; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5910
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1516 ! NCI-H2029
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 21
//
ID   NCI-H2004RT
AC   CVCL_WS70
SY   NCIH2004RT
DR   BioSample; SAMN10989609
DR   cancercelllines; CVCL_WS70
DR   Cell_Model_Passport; SIDM01671
DR   DepMap; ACH-000533
DR   Wikidata; Q95993293
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   NCI-H2007
AC   CVCL_A521
SY   H2007; H-2007
DR   Wikidata; Q54907899
RX   PubMed=8806092;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   NCI-H2009
AC   CVCL_1514
SY   H2009; H-2009; NCIH2009
DR   BTO; BTO_0003242
DR   CLO; CLO_0008038
DR   EFO; EFO_0002273
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5911
DR   BioGRID_ORCS_Cell_line; 187
DR   BioSample; SAMN03471794
DR   BioSample; SAMN10988519
DR   cancercelllines; CVCL_1514
DR   CCRID; 1101HUM-PUMC000383
DR   Cell_Model_Passport; SIDM00756
DR   ChEMBL-Cells; CHEMBL3308459
DR   ChEMBL-Targets; CHEMBL1075528
DR   Cosmic; 722054
DR   Cosmic; 724873
DR   Cosmic; 877249
DR   Cosmic; 877436
DR   Cosmic; 903609
DR   Cosmic; 980989
DR   Cosmic; 1032461
DR   Cosmic; 1146896
DR   Cosmic; 1154596
DR   Cosmic; 1188589
DR   Cosmic; 1239889
DR   Cosmic; 1518084
DR   Cosmic; 1802308
DR   Cosmic; 1870267
DR   Cosmic; 1891899
DR   Cosmic; 1995550
DR   Cosmic; 2125240
DR   Cosmic-CLP; 724873
DR   DepMap; ACH-000886
DR   EGA; EGAS00001000160
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724873
DR   GEO; GSM63697
DR   GEO; GSM108833
DR   GEO; GSM108834
DR   GEO; GSM206482
DR   GEO; GSM253369
DR   GEO; GSM274782
DR   GEO; GSM274815
DR   GEO; GSM385518
DR   GEO; GSM385529
DR   GEO; GSM434316
DR   GEO; GSM794342
DR   GEO; GSM817096
DR   GEO; GSM827528
DR   GEO; GSM887394
DR   GEO; GSM888472
DR   GEO; GSM1670205
DR   IARC_TP53; 510
DR   IGRhCellID; NCIH2009
DR   KCLB; 92009
DR   LiGeA; CCLE_730
DR   LINCS_LDP; LCL-1647
DR   PharmacoDB; NCIH2009_1055_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1514
DR   PubChem_Cell_line; CVCL_1514
DR   Wikidata; Q54907901
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=16157194;
RX   PubMed=16187286;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H2009.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 29.8 hours (PubMed=29681454).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000376369; Zygosity=Heterozygous (Cosmic-CLP=724873; DepMap=ACH-000886).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Gln28Ter (c.82C>T); Zygosity=Heterozygous (Cosmic-CLP=724873; DepMap=ACH-000886).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=1311061; PubMed=12068308; Cosmic-CLP=724873; DepMap=ACH-000886).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=724873; DepMap=ACH-000886).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.66%; Native American=0%; East Asian, North=7.51%; East Asian, South=0%; South Asian=0%; European, North=48.63%; European, South=38.19% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5911; CCRID=1101HUM-PUMC000383; Cosmic-CLP=724873; KCLB=92009; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14,16,17
ST   D21S11: 29
ST   D2S1338: 16,19
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 10,15
ST   FGA: 22 (ATCC=CRL-5911; CCRID=1101HUM-PUMC000383; KCLB=92009; PubMed=25877200)
ST   FGA: 22,26 (PubMed=11416159)
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2645 ! NCI-BL2009
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   NCI-H2009-Luc
AC   CVCL_4Y15
DR   cancercelllines; CVCL_4Y15
DR   JCRB; JCRB1529
DR   JCRB; NIHS0725
DR   Wikidata; Q54907902
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000376369; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Gln28Ter (c.82C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0725; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1529
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1514 ! NCI-H2009
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   NCI-H2023
AC   CVCL_1515
SY   H2023; H-2023; NCIH2023
DR   CLO; CLO_0008039
DR   EFO; EFO_0006669
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5912
DR   BioGRID_ORCS_Cell_line; 535
DR   BioSample; SAMN03472596
DR   BioSample; SAMN03472996
DR   BioSample; SAMN10988117
DR   cancercelllines; CVCL_1515
DR   Cell_Model_Passport; SIDM00753
DR   Cosmic; 903610
DR   Cosmic; 1995551
DR   Cosmic-CLP; 1240187
DR   DepMap; ACH-000781
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240187
DR   GEO; GSM513953
DR   GEO; GSM514338
DR   GEO; GSM784271
DR   GEO; GSM794343
DR   GEO; GSM827487
DR   GEO; GSM887395
DR   GEO; GSM888473
DR   GEO; GSM1670206
DR   IARC_TP53; 28316
DR   LiGeA; CCLE_456
DR   LINCS_HMS; 50036
DR   LINCS_LDP; LCL-1599
DR   PharmacoDB; NCIH2023_1056_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1515
DR   Wikidata; Q54907903
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=18083107;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 32.3 hours (PubMed=29681454).
CC   HLA typing: A*02:01,02:01; B*07:02,08:01; C*07:06,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Ser828Profs*3 (c.2481delC) (p.Ala826fs) (c.2477delC); Zygosity=Heterozygous (Cosmic-CLP=1240187; DepMap=ACH-000781).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser240Arg (c.720T>A); ClinVar=VCV001504304; Zygosity=Homozygous (Cosmic-CLP=1240187; DepMap=ACH-000781).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.48%; East Asian, North=0.88%; East Asian, South=0%; South Asian=0%; European, North=66.45%; European, South=32.18% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5912; Cosmic-CLP=1240187; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 17,18
ST   D19S433: 13
ST   D21S11: 29,33.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 16
ST   TH01: 7,9 (ATCC=CRL-5912; Cosmic-CLP=1240187)
ST   TH01: 7,9,9.1 (PubMed=25877200)
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NCI-H2028
AC   CVCL_A522
SY   H2028; H-2028
DR   Cosmic; 1518104
DR   Wikidata; Q54907904
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Population: Caucasian.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2646 ! NCI-BL2028
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   NCI-H2029
AC   CVCL_1516
SY   H2029; H-2029; NCIH2029
DR   BTO; BTO_0005977
DR   CLO; CLO_0008040
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5913
DR   BioSample; SAMN10987644
DR   cancercelllines; CVCL_1516
DR   Cell_Model_Passport; SIDM00735
DR   ChEMBL-Cells; CHEMBL3308473
DR   ChEMBL-Targets; CHEMBL1075529
DR   Cosmic; 688011
DR   Cosmic; 1995552
DR   Cosmic; 2125207
DR   Cosmic-CLP; 688011
DR   DepMap; ACH-000298
DR   EGA; EGAS00001000978
DR   GDSC; 688011
DR   GEO; GSM887396
DR   GEO; GSM888474
DR   GEO; GSM1670207
DR   GEO; GSM1887957
DR   GEO; GSM1888034
DR   IARC_TP53; 21551
DR   LiGeA; CCLE_738
DR   LINCS_LDP; LCL-1814
DR   PharmacoDB; NCIH2029_1057_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1516
DR   PubChem_Cell_line; CVCL_1516
DR   Wikidata; Q54907905
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,11:01; B*07:02,35:08; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.265-1G>T; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=688011; DepMap=ACH-000298).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Asp (c.658T>G); ClinVar=VCV000376689; Zygosity=Homozygous (Cosmic-CLP=688011; DepMap=ACH-000298).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.84%; Native American=0%; East Asian, North=5.65%; East Asian, South=0%; South Asian=0%; European, North=50.95%; European, South=38.55% (PubMed=30894373).
CC   Caution: The stock distributed by ATCC seems to have lost the D13S317 allele which is not detectable (ATCC=CRL-5913).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5913; Cosmic-CLP=688011; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,22
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 11,15
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1513 ! NCI-H1994
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H2030
AC   CVCL_1517
SY   H2030; H-2030; NCIH2030
DR   BTO; BTO_0006438
DR   CLO; CLO_0008041
DR   EFO; EFO_0002274
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5914
DR   BioGRID_ORCS_Cell_line; 534
DR   BioSample; SAMN03471413
DR   BioSample; SAMN10988239
DR   cancercelllines; CVCL_1517
DR   Cell_Model_Passport; SIDM00715
DR   ChEMBL-Cells; CHEMBL3308769
DR   ChEMBL-Targets; CHEMBL1075530
DR   Cosmic; 722045
DR   Cosmic; 903611
DR   Cosmic; 1146897
DR   Cosmic; 1609520
DR   Cosmic; 1995553
DR   Cosmic-CLP; 722045
DR   DepMap; ACH-000521
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 722045
DR   GEO; GSM206483
DR   GEO; GSM274747
DR   GEO; GSM274748
DR   GEO; GSM434332
DR   GEO; GSM784272
DR   GEO; GSM794344
DR   GEO; GSM817097
DR   GEO; GSM887397
DR   GEO; GSM888475
DR   GEO; GSM1374717
DR   GEO; GSM1670208
DR   IARC_TP53; 21552
DR   IGRhCellID; NCIH2030
DR   LiGeA; CCLE_404
DR   LINCS_LDP; LCL-1648
DR   PharmacoDB; NCIH2030_1058_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1517
DR   PubChem_Cell_line; CVCL_1517
DR   Wikidata; Q54907906
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*11:01,24:02; B*44:03,51:01; C*01:02,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (Cosmic-CLP=722045; DepMap=ACH-000521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262Val (c.785G>T); ClinVar=VCV000428889; Zygosity=Homozygous (Cosmic-CLP=722045; DepMap=ACH-000521).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.43%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=2.87%; European, North=64.18%; European, South=32.52% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5914; Cosmic-CLP=722045; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17,18
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,15
ST   FGA: 20,24
ST   Penta D: 9
ST   Penta E: 11,15
ST   TH01: 9.3
ST   TPOX: 9,12
ST   vWA: 15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H2052
AC   CVCL_1518
SY   H2052; H-2052; H2052_MM; NCIH2052
DR   CLO; CLO_0008042
DR   EFO; EFO_0002275
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5915
DR   BioSample; SAMN03471041
DR   BioSample; SAMN03472597
DR   BioSample; SAMN10987937
DR   BioSamples; SAMEA100851
DR   cancercelllines; CVCL_1518
DR   Cell_Model_Passport; SIDM00713
DR   ChEMBL-Cells; CHEMBL3308119
DR   ChEMBL-Targets; CHEMBL1075531
DR   Cosmic; 688058
DR   Cosmic; 877272
DR   Cosmic; 877437
DR   Cosmic; 886390
DR   Cosmic; 980998
DR   Cosmic; 1032389
DR   Cosmic; 1146898
DR   Cosmic; 1481545
DR   Cosmic; 1522774
DR   Cosmic; 1541213
DR   Cosmic; 1571797
DR   Cosmic; 1749565
DR   Cosmic; 1891920
DR   Cosmic; 1963327
DR   Cosmic; 1995554
DR   Cosmic; 2474148
DR   Cosmic; 2758842
DR   Cosmic; 2759000
DR   Cosmic; 2759220
DR   Cosmic-CLP; 688058
DR   DepMap; ACH-000153
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10847-111F1
DR   GDSC; 688058
DR   GEO; GSM171854
DR   GEO; GSM171855
DR   GEO; GSM434305
DR   GEO; GSM726264
DR   GEO; GSM794345
DR   GEO; GSM817098
DR   GEO; GSM850299
DR   GEO; GSM887398
DR   GEO; GSM888476
DR   GEO; GSM1670209
DR   IARC_TP53; 21553
DR   IGRhCellID; H2052_MMGEO
DR   IGRhCellID; NCIH2052
DR   LiGeA; CCLE_326
DR   PharmacoDB; NCIH2052_1059_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1518
DR   PubChem_Cell_line; CVCL_1518
DR   Wikidata; Q54907907
RX   PubMed=8806092;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=16630136;
RX   PubMed=17270034;
RX   PubMed=19853261;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20624269;
RX   PubMed=21245096;
RX   PubMed=21642991;
RX   PubMed=22460905;
RX   PubMed=23830731;
RX   PubMed=24926545;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25902174;
RX   PubMed=25984343;
RX   PubMed=26011428;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28553954;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=25984343); 33.4 hours (PubMed=29681454).
CC   HLA typing: A*25:01,29:02; B*18:01,44:03; C*16:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136; PubMed=21642991).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6515; LATS2; Zygosity=Homozygous (PubMed=21245096).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg341Ter (c.1021C>T); ClinVar=VCV000003292; Zygosity=Homozygous (PubMed=16630136; PubMed=25902174; Cosmic-CLP=688058; DepMap=ACH-000153).
CC   Sequence variation: Mutation; HGNC; HGNC:9883; RASSF2; Simple; p.Glu294Ter (c.880G>T); Zygosity=Heterozygous (PubMed=25902174; DepMap=ACH-000153).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=688058; DepMap=ACH-000153).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.17%; Native American=0%; East Asian, North=2.33%; East Asian, South=0%; South Asian=0.22%; European, North=64.49%; European, South=32.79% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5915; Cosmic-CLP=688058; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 16,17 (ATCC=CRL-5915)
ST   D18S51: 17 (PubMed=25877200)
ST   D19S433: 12,15
ST   D21S11: 32.2
ST   D2S1338: 17,18
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 11,12 (PubMed=25877200)
ST   D7S820: 12 (ATCC=CRL-5915; Cosmic-CLP=688058)
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 10
ST   Penta E: 12,16
ST   TH01: 7,9.3
ST   TPOX: 8 (PubMed=25877200)
ST   TPOX: 8,11 (ATCC=CRL-5915; Cosmic-CLP=688058)
ST   vWA: 17
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2647 ! NCI-BL2052
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   NCI-H2058
AC   CVCL_A523
SY   H2058; H-2058
DR   Cosmic; 877438
DR   Wikidata; Q54907908
RX   PubMed=8806092;
RX   PubMed=31803961;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   NCI-H2059
AC   CVCL_1519
SY   H2059; H-2059
DR   CLO; CLO_0008043
DR   ATCC; CRL-5916
DR   BioSample; SAMN03472598
DR   Cosmic; 753603
DR   Wikidata; Q54907909
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-5916; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5916
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 8
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1534 ! NCI-H2141
OI   CVCL_2653 ! NCI-BL2141
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 21
//
ID   NCI-H2066
AC   CVCL_1520
SY   H2066; H-2066; NCIH2066
DR   CLO; CLO_0008044
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5917
DR   BioSample; SAMN03472599
DR   BioSample; SAMN10987642
DR   cancercelllines; CVCL_1520
DR   Cell_Model_Passport; SIDM00711
DR   Cosmic; 2699647
DR   Cosmic-CLP; 1330973
DR   DepMap; ACH-000727
DR   EGA; EGAS00001000978
DR   GDSC; 1330973
DR   GEO; GSM434788
DR   GEO; GSM887399
DR   GEO; GSM888477
DR   GEO; GSM1374718
DR   GEO; GSM1670210
DR   GEO; GSM1887946
DR   GEO; GSM1888022
DR   IARC_TP53; 511
DR   KCLB; 92066
DR   LiGeA; CCLE_647
DR   PharmacoDB; NCIH2066_1060_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1520
DR   Wikidata; Q54907910
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,03:01; B*08:20,42:02; C*01:02,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=1330973; DepMap=ACH-000727).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3%; Native American=0%; East Asian, North=2.95%; East Asian, South=0%; South Asian=0%; European, North=59.43%; European, South=34.61% (PubMed=30894373).
CC   Discontinued: KCLB; 92066; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5917; Cosmic-CLP=1330973
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 14,15,16
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   NCI-H2073
AC   CVCL_1521
SY   H2073; H-2073; NCIH2073
DR   CLO; CLO_0008045
DR   EFO; EFO_0006670
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5918
DR   BioSample; SAMN03473292
DR   BioSample; SAMN10989581
DR   cancercelllines; CVCL_1521
DR   Cell_Model_Passport; SIDM00757
DR   Cosmic; 687811
DR   Cosmic; 903612
DR   Cosmic; 1146899
DR   Cosmic; 1870268
DR   DepMap; ACH-000590
DR   EGA; EGAS00001000610
DR   GEO; GSM253368
DR   GEO; GSM513954
DR   GEO; GSM514339
DR   GEO; GSM794346
DR   GEO; GSM888478
DR   GEO; GSM1374719
DR   IARC_TP53; 512
DR   LiGeA; CCLE_043
DR   LINCS_LDP; LCL-1649
DR   PharmacoDB; NCIH2073_1061_2019
DR   Progenetix; CVCL_1521
DR   Wikidata; Q54907911
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24297535;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 45.3 hours (PubMed=29681454).
CC   HLA typing: A*02:01,25:01; B*18:01,40:01; C*03:04,12:03; DQA1*01:02,01:02; DQB1*06:07,06:07; DRB1*13:02,15:01' (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Trp (c.726C>G); ClinVar=VCV000376580; Zygosity=Homozygous (PubMed=1311061; DepMap=ACH-000590).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.14%; Native American=0%; East Asian, North=2.07%; East Asian, South=0%; South Asian=0%; European, North=64.31%; European, South=32.48% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5918; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 13,17.3 (ATCC=CRL-5918)
ST   D18S51: 13,18 (PubMed=25877200)
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E102 ! NCI-BL1993
OI   CVCL_1512 ! NCI-H1993
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H2077
AC   CVCL_5157
SY   H2077; H-2077; NCIH2077
DR   ATCC; CRL-5919
DR   BioSample; SAMN10989610
DR   cancercelllines; CVCL_5157
DR   Cell_Model_Passport; SIDM01670
DR   Cosmic; 877250
DR   Cosmic; 877439
DR   Cosmic; 903613
DR   Cosmic; 980990
DR   Cosmic; 1032462
DR   DepMap; ACH-000010
DR   GEO; GSM434269
DR   GEO; GSM794347
DR   GEO; GSM817099
DR   IGRhCellID; H2077GEO
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_5157
DR   Wikidata; Q54907913
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=26361996;
RX   PubMed=28196595;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-5919; true.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E103 ! NCI-BL2077
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   NCI-H2081
AC   CVCL_1522
SY   H2081; H-2081; NCIH2081
DR   CLO; CLO_0008046
DR   EFO; EFO_0002276
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5920
DR   BioSample; SAMN03472952
DR   BioSample; SAMN10987993
DR   cancercelllines; CVCL_1522
DR   Cell_Model_Passport; SIDM00710
DR   ChEMBL-Cells; CHEMBL3308319
DR   ChEMBL-Targets; CHEMBL2366082
DR   Cosmic; 688012
DR   Cosmic; 877385
DR   Cosmic; 908480
DR   Cosmic; 980955
DR   Cosmic; 1032426
DR   Cosmic; 1891915
DR   Cosmic; 1995555
DR   Cosmic; 2125241
DR   Cosmic-CLP; 908480
DR   DepMap; ACH-000394
DR   EGA; EGAS00001000610
DR   GDSC; 908480
DR   GEO; GSM827527
DR   GEO; GSM887400
DR   GEO; GSM888479
DR   GEO; GSM1670211
DR   GEO; GSM1887935
DR   GEO; GSM1888013
DR   IGRhCellID; NCIH2081
DR   LiGeA; CCLE_762
DR   LINCS_LDP; LCL-1846
DR   PharmacoDB; NCIH2081_1062_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1522
DR   PubChem_Cell_line; CVCL_1522
DR   Wikidata; Q54907917
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,68:01; B*08:01,35:08; C*04:01,07:04 (PubMed=25960936).
CC   HLA typing: A*24:02,68:01; B*08:01,35:08; C*07:04,07:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys124Phe (c.371G>T); Zygosity=Homozygous (DepMap=ACH-000394).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.93%; Native American=0%; East Asian, North=6.2%; East Asian, South=0%; South Asian=0%; European, North=47.59%; European, South=43.27% (PubMed=30894373).
CC   Misspelling: NCI-H2018; Cosmic=877385.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5920; Cosmic-CLP=908480; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 19,21
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H2085
AC   CVCL_1523
SY   H2085; H-2085; NCIH2085
DR   CLO; CLO_0008047
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5921
DR   BioSample; SAMN03472600
DR   BioSample; SAMN10987638
DR   cancercelllines; CVCL_1523
DR   Cell_Model_Passport; SIDM00709
DR   Cosmic; 687812
DR   Cosmic; 1995556
DR   Cosmic-CLP; 687812
DR   DepMap; ACH-000451
DR   EGA; EGAS00001000978
DR   GDSC; 687812
DR   GEO; GSM513955
DR   GEO; GSM514340
DR   GEO; GSM784273
DR   GEO; GSM794348
DR   GEO; GSM827509
DR   GEO; GSM887401
DR   GEO; GSM888480
DR   GEO; GSM1374720
DR   GEO; GSM1670212
DR   IARC_TP53; 30130
DR   LiGeA; CCLE_301
DR   LINCS_LDP; LCL-1615
DR   PharmacoDB; NCIH2085_1063_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1523
DR   Wikidata; Q54907918
RX   PubMed=8806092;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 91.1 hours (PubMed=29681454).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Glu463Ter (c.1387G>T); Zygosity=Heterozygous (Cosmic-CLP=687812; DepMap=ACH-000451).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (Cosmic-CLP=687812; DepMap=ACH-000451).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.71%; Native American=0%; East Asian, North=2.54%; East Asian, South=0%; South Asian=0%; European, North=61.81%; European, South=34.93% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5921; Cosmic-CLP=687812
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 16,17
ST   D19S433: 14,16
ST   D21S11: 24.2,29
ST   D2S1338: 20
ST   D3S1358: 14,16
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,13
ST   Penta E: 10,15
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   NCI-H2086
AC   CVCL_A524
SY   H2086; H-2086
DR   cancercelllines; CVCL_A524
DR   GEO; GSM794349
DR   IARC_TP53; 484
DR   Wikidata; Q54907919
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20679594;
RX   PubMed=29681454;
RX   PubMed=31803961;
CC   Doubling time: 68.5 hours (PubMed=29681454).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=1311061).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Ser (c.659A>C); ClinVar=VCV000012383; Zygosity=Unspecified (PubMed=1565469).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 13
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,19,20
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   NCI-H2087
AC   CVCL_1524
SY   H2087; H-2087; NCIH2087
DR   BTO; BTO_0003241
DR   CLO; CLO_0008048
DR   EFO; EFO_0002277
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5922
DR   BioGRID_ORCS_Cell_line; 533
DR   BioSample; SAMN03472602
DR   BioSample; SAMN05292451
DR   BioSample; SAMN10987636
DR   cancercelllines; CVCL_1524
DR   CCRID; 1101HUM-PUMC000253
DR   Cell_Model_Passport; SIDM00708
DR   ChEMBL-Cells; CHEMBL3308770
DR   ChEMBL-Targets; CHEMBL1075532
DR   Cosmic; 724834
DR   Cosmic; 877251
DR   Cosmic; 877440
DR   Cosmic; 903614
DR   Cosmic; 917389
DR   Cosmic; 961840
DR   Cosmic; 980991
DR   Cosmic; 1006536
DR   Cosmic; 1032463
DR   Cosmic; 1146900
DR   Cosmic; 1152516
DR   Cosmic; 1209730
DR   Cosmic; 1219085
DR   Cosmic; 1239890
DR   Cosmic; 1477422
DR   Cosmic; 1518086
DR   Cosmic; 1891900
DR   Cosmic; 1925847
DR   Cosmic; 1995557
DR   Cosmic; 2125242
DR   Cosmic-CLP; 724834
DR   DepMap; ACH-000841
DR   EGA; EGAS00001000160
DR   EGA; EGAS00001000978
DR   GDSC; 724834
DR   GEO; GSM62329
DR   GEO; GSM108835
DR   GEO; GSM108836
DR   GEO; GSM253370
DR   GEO; GSM434306
DR   GEO; GSM513956
DR   GEO; GSM514341
DR   GEO; GSM794350
DR   GEO; GSM817100
DR   GEO; GSM887402
DR   GEO; GSM888481
DR   GEO; GSM1670213
DR   IARC_TP53; 513
DR   IGRhCellID; NCIH2087
DR   KCLB; 25922
DR   LiGeA; CCLE_912
DR   LINCS_LDP; LCL-1650
DR   PharmacoDB; NCIH2087_1064_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1524
DR   PubChem_Cell_line; CVCL_1524
DR   Wikidata; Q54907920
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=16157194;
RX   PubMed=16187286;
RX   PubMed=18397470;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27602502;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H2087.html
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544504
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 51 hours (PubMed=29681454); ~52 hours (PBCF).
CC   HLA typing: A*02:01,02:01; B*44:03,44:03; C*16:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu848Gln (c.2542G>C); ClinVar=VCV001686474; Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=724834; DepMap=ACH-000841).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Val (c.1789C>G); ClinVar=VCV000013969; Zygosity=Heterozygous (PubMed=12068308; PubMed=18397470; Cosmic-CLP=724834; DepMap=ACH-000841).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Glu54Lys (c.160G>A); Zygosity=Heterozygous (Cosmic-CLP=724834; DepMap=ACH-000841).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=724834; DepMap=ACH-000841).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; Cosmic-CLP=724834; DepMap=ACH-000841).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=3.19%; East Asian, South=0%; South Asian=0%; European, North=67.37%; European, South=29.44% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5922; CCRID=1101HUM-PUMC000253; Cosmic-CLP=724834; KCLB=25922; PubMed=11416159; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11 (CCRID=1101HUM-PUMC000253)
ST   D13S317: 12 (ATCC=CRL-5922; Cosmic-CLP=724834; KCLB=25922; PubMed=20679594)
ST   D16S539: 9,11
ST   D18S51: 13,15,17 (CCRID=1101HUM-PUMC000253)
ST   D18S51: 14 (ATCC=CRL-5922; PubMed=11416159)
ST   D19S433: 13,14 (CCRID=1101HUM-PUMC000253)
ST   D19S433: 14 (ATCC=CRL-5922)
ST   D21S11: 30,32.2
ST   D2S1338: 20 (ATCC=CRL-5922)
ST   D2S1338: 22,24 (CCRID=1101HUM-PUMC000253)
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 20
ST   Penta D: 11,12
ST   Penta E: 7,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2648 ! NCI-BL2087
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   NCI-H209
AC   CVCL_1525
SY   H209; H-209; NCIH209
DR   BTO; BTO_0003020
DR   CLO; CLO_0008049
DR   EFO; EFO_0006671
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-172
DR   BCRC; 60123
DR   BioSample; SAMN03473244
DR   BioSample; SAMN10988204
DR   cancercelllines; CVCL_1525
DR   CCRID; 1101HUM-PUMC000045
DR   Cell_Model_Passport; SIDM00706
DR   ChEMBL-Cells; CHEMBL3308293
DR   ChEMBL-Targets; CHEMBL2366365
DR   CLS; 300183
DR   Cosmic; 688013
DR   Cosmic; 755463
DR   Cosmic; 801617
DR   Cosmic; 808317
DR   Cosmic; 808396
DR   Cosmic; 844819
DR   Cosmic; 850429
DR   Cosmic; 876165
DR   Cosmic; 877202
DR   Cosmic; 897518
DR   Cosmic; 1004691
DR   Cosmic; 1021855
DR   Cosmic; 1219100
DR   Cosmic; 1239937
DR   Cosmic; 1518090
DR   Cosmic; 1891903
DR   Cosmic; 2125243
DR   Cosmic; 2239097
DR   Cosmic; 2301573
DR   Cosmic; 2668346
DR   Cosmic; 2699652
DR   Cosmic-CLP; 688013
DR   DepMap; ACH-000290
DR   DSMZ; ACC-499
DR   DSMZ; ACC-900
DR   DSMZCellDive; ACC-900
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 688013
DR   GEO; GSM169438
DR   GEO; GSM170735
DR   GEO; GSM170736
DR   GEO; GSM170737
DR   GEO; GSM171856
DR   GEO; GSM171857
DR   GEO; GSM380511
DR   GEO; GSM784248
DR   GEO; GSM794276
DR   GEO; GSM844636
DR   GEO; GSM845543
DR   GEO; GSM887403
DR   GEO; GSM888482
DR   GEO; GSM1374721
DR   GEO; GSM1670214
DR   GEO; GSM1887905
DR   GEO; GSM1887988
DR   IARC_TP53; 329
DR   IGRhCellID; NCIH209
DR   KCB; KCB 200816YJ
DR   KCLB; 30172
DR   LiGeA; CCLE_619
DR   LINCS_LDP; LCL-1847
DR   PharmacoDB; NCIH209_1065_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1525
DR   PubChem_Cell_line; CVCL_1525
DR   Wikidata; Q54907921
RX   PubMed=1563005;
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=7736387;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=9559344;
RX   PubMed=9815546;
RX   PubMed=10037197;
RX   PubMed=10536175;
RX   PubMed=10987304;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=14762065;
RX   PubMed=16157194;
RX   PubMed=17426248;
RX   PubMed=19472407;
RX   PubMed=20016488;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20624269;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H209.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~50-70 hours (DSMZ=ACC-900).
CC   HLA typing: A*34:02,34:02; B*07:04,14:01; C*03:07,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Cys706Phe (c.2117G>T); ClinVar=VCV000376330; Zygosity=Homozygous (ATCC=HTB-172; Cosmic-CLP=688013; DepMap=ACH-000290).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=688013; DepMap=ACH-000290).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.88%; Native American=0%; East Asian, North=1.08%; East Asian, South=0%; South Asian=0.08%; European, North=65.94%; European, South=31.02% (PubMed=30894373).
CC   Discontinued: DSMZ; ACC-499; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=HTB-172; CCRID=1101HUM-PUMC000045; CLS=300183; Cosmic-CLP=688013; DSMZ=ACC-900; KCLB=30172; PubMed=25877200
ST   Amelogenin: X (DSMZ=ACC-900)
ST   Amelogenin: X,Y (ATCC=HTB-172; CCRID=1101HUM-PUMC000045; CLS=300183; Cosmic-CLP=688013; KCLB=30172; PubMed=25877200)
ST   CSF1PO: 11 (ATCC=HTB-172; CCRID=1101HUM-PUMC000045; CLS=300183; Cosmic-CLP=688013; KCLB=30172; PubMed=25877200)
ST   CSF1PO: 11,12 (DSMZ=ACC-900)
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 14.2,15 (ATCC=HTB-172; CCRID=1101HUM-PUMC000045)
ST   D19S433: 15 (DSMZ=ACC-900)
ST   D21S11: 32.2
ST   D2S1338: 17,20
ST   D3S1358: 18 (ATCC=HTB-172; CLS=300183; DSMZ=ACC-900; KCLB=30172; PubMed=25877200)
ST   D3S1358: 18,20 (CCRID=1101HUM-PUMC000045)
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 11,12
ST   Penta E: 11,12 (ATCC=HTB-172; CLS=300183; PubMed=25877200)
ST   Penta E: 12 (DSMZ=ACC-900)
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2649 ! NCI-BL209
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   NCI-H2106
AC   CVCL_1526
SY   NCI H2106; H2106; H-2106; NCIH2106
DR   CLO; CLO_0008050
DR   EFO; EFO_0006672
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5923
DR   BioSample; SAMN03473266
DR   BioSample; SAMN10988338
DR   cancercelllines; CVCL_1526
DR   Cell_Model_Passport; SIDM01668
DR   Cosmic; 687813
DR   DepMap; ACH-000904
DR   EGA; EGAS00001000610
DR   GEO; GSM794351
DR   GEO; GSM817101
DR   GEO; GSM887404
DR   GEO; GSM888483
DR   IARC_TP53; 21555
DR   LiGeA; CCLE_570
DR   LINCS_LDP; LCL-1848
DR   PharmacoDB; NCIH2106_1066_2019
DR   Progenetix; CVCL_1526
DR   Wikidata; Q54907922
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*32:01,32:01; B*15:01,15:01; C*03:03,03:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=1565469; DepMap=ACH-000904).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.71%; East Asian, North=1.71%; East Asian, South=0%; South Asian=0%; European, North=64.26%; European, South=32.31% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5923; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2644 ! NCI-BL1770
OI   CVCL_1493 ! NCI-H1770
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   NCI-H2107
AC   CVCL_1527
SY   H2107; H-2107; NCIH2107
DR   CLO; CLO_0008051
DR   EFO; EFO_0002278
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-5983
DR   ATCC; CRL-5983_FL
DR   BioSample; SAMN03472632
DR   cancercelllines; CVCL_1527
DR   ChEMBL-Cells; CHEMBL3308879
DR   ChEMBL-Targets; CHEMBL2366122
DR   Cosmic; 877231
DR   Cosmic; 877386
DR   Cosmic; 924246
DR   Cosmic; 980956
DR   Cosmic; 1021881
DR   Cosmic; 1032427
DR   Cosmic; 1219107
DR   Cosmic; 1239946
DR   Cosmic; 1518091
DR   Cosmic; 1891916
DR   Cosmic; 2125208
DR   GDSC; 924246
DR   GEO; GSM171858
DR   GEO; GSM171859
DR   GEO; GSM794352
DR   GEO; GSM844637
DR   GEO; GSM845544
DR   GEO; GSM1887915
DR   GEO; GSM1887999
DR   IARC_TP53; 27568
DR   IARC_TP53; 28455
DR   IGRhCellID; NCIH2107
DR   PharmacoDB; NCIH2107_1067_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_1527
DR   PubChem_Cell_line; CVCL_1527
DR   Wikidata; Q54907923
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20624269;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=39154123;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys101Ter (c.301A>T); Zygosity=Unspecified (PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5983; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5983_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 14
ST   D7S820: 8
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2650 ! NCI-BL2107
OI   CVCL_1528 ! NCI-H2108
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 38
//
ID   NCI-H2108
AC   CVCL_1528
SY   H2108; H-2108
DR   CLO; CLO_0008052
DR   ATCC; CRL-5984
DR   ATCC; CRL-5984_FL
DR   Wikidata; Q54907924
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Population: African American.
CC   Discontinued: ATCC; CRL-5984; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5984_FL
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 14
ST   D7S820: 8
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2650 ! NCI-BL2107
OI   CVCL_1527 ! NCI-H2107
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   NCI-H211
AC   CVCL_1529
SY   H211; H-211; NCIH211
DR   BTO; BTO_0004427
DR   CLO; CLO_0008053
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5824
DR   BioSample; SAMN03473064
DR   BioSample; SAMN10988220
DR   cancercelllines; CVCL_1529
DR   Cell_Model_Passport; SIDM00704
DR   ChEMBL-Cells; CHEMBL4523547
DR   ChEMBL-Targets; CHEMBL4523578
DR   Cosmic; 844550
DR   Cosmic; 877203
DR   Cosmic; 980930
DR   Cosmic; 1021856
DR   Cosmic; 1032396
DR   Cosmic; 1152464
DR   Cosmic; 1995558
DR   Cosmic-CLP; 1240189
DR   DepMap; ACH-000639
DR   EGA; EGAS00001000978
DR   GDSC; 1240189
DR   GEO; GSM169440
DR   GEO; GSM170706
DR   GEO; GSM170707
DR   GEO; GSM784209
DR   GEO; GSM794277
DR   GEO; GSM887406
DR   GEO; GSM888485
DR   GEO; GSM986171
DR   GEO; GSM1670215
DR   GEO; GSM1887890
DR   GEO; GSM1887971
DR   IARC_TP53; 434
DR   KCLB; 90211
DR   LiGeA; CCLE_692
DR   LINCS_LDP; LCL-1849
DR   PharmacoDB; NCIH211_1068_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1529
DR   PubChem_Cell_line; CVCL_1529
DR   Wikidata; Q54907925
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=2986243;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26680980;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h211-h211-atcc-crl-5824-growth-and-morphology
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07:06,51:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.08%; Native American=0%; East Asian, North=5.72%; East Asian, South=0%; South Asian=0%; European, North=51.87%; European, South=39.33% (PubMed=30894373).
CC   Discontinued: KCLB; 90211; probable.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5824; Cosmic-CLP=1240189; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 12,16
ST   D21S11: 30
ST   D2S1338: 20
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 12,15
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   NCI-H2110
AC   CVCL_1530
SY   H2110; H-2110; NCIH2110
DR   BTO; BTO_0006021
DR   CLO; CLO_0008054
DR   EFO; EFO_0006673
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5924
DR   BioGRID_ORCS_Cell_line; 532
DR   BioSample; SAMN03473198
DR   BioSample; SAMN10987977
DR   cancercelllines; CVCL_1530
DR   Cell_Model_Passport; SIDM00703
DR   Cosmic; 1146901
DR   Cosmic-CLP; 1298351
DR   DepMap; ACH-000929
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298351
DR   GEO; GSM434270
DR   GEO; GSM887405
DR   GEO; GSM888484
DR   GEO; GSM1670216
DR   IGRhCellID; H2110GEO
DR   LiGeA; CCLE_265
DR   LINCS_LDP; LCL-1616
DR   PharmacoDB; NCIH2110_1069_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1530
DR   Wikidata; Q54907926
RX   PubMed=8806092;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   HLA typing: A*30:01,30:01; B*42:02,57:01; C*08:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:10023; RIT1; Simple; p.Met90Ile (c.270G>A); ClinVar=VCV000120250; Zygosity=Heterozygous (DepMap=ACH-000929).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Pro (c.473G>C); ClinVar=VCV000246118; Zygosity=Homozygous (DepMap=ACH-000929).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=82.92%; Native American=0%; East Asian, North=4.2%; East Asian, South=0%; South Asian=0%; European, North=0.75%; European, South=12.13% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5924; Cosmic-CLP=1298351; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 14,14.2
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 9,11
ST   Penta E: 8,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H2115
AC   CVCL_E104
SY   H2115; H-2115
DR   Wikidata; Q54907927
RX   PubMed=8806092;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H2122
AC   CVCL_1531
SY   H2122; H-2122; NCIH2122
DR   BTO; BTO_0003006
DR   CLO; CLO_0008055
DR   EFO; EFO_0002279
DR   AddexBio; C0016048/5013
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5985
DR   BioGRID_ORCS_Cell_line; 531
DR   BioSample; SAMN03473110
DR   BioSample; SAMN10988248
DR   cancercelllines; CVCL_1531
DR   Cell_Model_Passport; SIDM00702
DR   ChEMBL-Cells; CHEMBL3308771
DR   ChEMBL-Targets; CHEMBL1075533
DR   CLS; 305600
DR   Cosmic; 722046
DR   Cosmic; 850435
DR   Cosmic; 877252
DR   Cosmic; 877441
DR   Cosmic; 903615
DR   Cosmic; 1028947
DR   Cosmic; 1146902
DR   Cosmic; 1152517
DR   Cosmic; 1219086
DR   Cosmic; 1239891
DR   Cosmic; 1320182
DR   Cosmic; 1518085
DR   Cosmic; 1694665
DR   Cosmic; 1870269
DR   Cosmic; 1891901
DR   Cosmic; 1995559
DR   Cosmic; 2125195
DR   Cosmic; 2696405
DR   Cosmic-CLP; 722046
DR   DepMap; ACH-000311
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 722046
DR   GEO; GSM62330
DR   GEO; GSM108837
DR   GEO; GSM108838
DR   GEO; GSM206484
DR   GEO; GSM253371
DR   GEO; GSM274751
DR   GEO; GSM274752
DR   GEO; GSM434253
DR   GEO; GSM513957
DR   GEO; GSM514342
DR   GEO; GSM784219
DR   GEO; GSM794353
DR   GEO; GSM817102
DR   GEO; GSM827526
DR   GEO; GSM887407
DR   GEO; GSM888486
DR   GEO; GSM1374722
DR   GEO; GSM1374723
DR   GEO; GSM1670217
DR   GEO; GSM2807227
DR   GEO; GSM2807228
DR   IARC_TP53; 21556
DR   IGRhCellID; NCIH2122
DR   KCLB; 92122
DR   LiGeA; CCLE_056
DR   LINCS_LDP; LCL-1651
DR   PharmacoDB; NCIH2122_1070_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1531
DR   PubChem_Cell_line; CVCL_1531
DR   Wikidata; Q54907928
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=16157194;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H2122.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=25984343); 31.6 hours (PubMed=29681454).
CC   HLA typing: A*01:01,03:01; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=722046; DepMap=ACH-000311).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln16Leu (c.47A>T); Zygosity=Heterozygous (PubMed=20557307; Cosmic-CLP=722046; DepMap=ACH-000311).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Heterozygous (PubMed=20557307; Cosmic-CLP=722046; DepMap=ACH-000311).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.26%; East Asian, North=1.42%; East Asian, South=0%; South Asian=1.39%; European, North=65.92%; European, South=31.01% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0016048/5013; ATCC=CRL-5985; Cosmic-CLP=722046; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 9,12
ST   D18S51: 19
ST   D19S433: 14
ST   D21S11: 33.2
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 19,26
ST   Penta D: 10,12
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2651 ! NCI-BL2122
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H2126
AC   CVCL_1532
SY   H2126; H-2126; NCIH2126
DR   BTO; BTO_0003240
DR   CLO; CLO_0008056
DR   EFO; EFO_0002280
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-256
DR   ATCC; CRL-5925
DR   BioGRID_ORCS_Cell_line; 530
DR   BioSample; SAMN03471320
DR   BioSample; SAMN03471386
DR   BioSample; SAMN05292434
DR   BioSample; SAMN10988437
DR   cancercelllines; CVCL_1532
DR   CCRID; 3101HUMSCSP599
DR   Cell_Model_Passport; SIDM00775
DR   ChEMBL-Cells; CHEMBL3308894
DR   ChEMBL-Targets; CHEMBL2366160
DR   CLS; 300639
DR   Cosmic; 687814
DR   Cosmic; 877266
DR   Cosmic; 903616
DR   Cosmic; 961841
DR   Cosmic; 1006537
DR   Cosmic; 1146903
DR   Cosmic; 1219066
DR   Cosmic; 1239892
DR   Cosmic; 1995560
DR   Cosmic; 2125182
DR   Cosmic; 2629443
DR   Cosmic-CLP; 687814
DR   DepMap; ACH-000785
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687814
DR   GEO; GSM108839
DR   GEO; GSM108840
DR   GEO; GSM206485
DR   GEO; GSM253405
DR   GEO; GSM274811
DR   GEO; GSM274812
DR   GEO; GSM353228
DR   GEO; GSM434271
DR   GEO; GSM513958
DR   GEO; GSM514343
DR   GEO; GSM784235
DR   GEO; GSM794354
DR   GEO; GSM817103
DR   GEO; GSM887408
DR   GEO; GSM888487
DR   GEO; GSM1374724
DR   GEO; GSM1670218
DR   IARC_TP53; 21557
DR   IGRhCellID; NCIH2126
DR   LiGeA; CCLE_835
DR   LINCS_LDP; LCL-1627
DR   PharmacoDB; NCIH2126_1071_2019
DR   PRIDE; PXD002556
DR   Progenetix; CVCL_1532
DR   PubChem_Cell_line; CVCL_1532
DR   Wikidata; Q54907929
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=11416159;
RX   PubMed=14762065;
RX   PubMed=16157194;
RX   PubMed=19153074;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H2126.html
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544579
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 41.1 hours (PubMed=29681454); ~57 hours (PBCF).
CC   HLA typing: A*02:05,03:01; B*08:20,15:01; C*01:02,04:01; DQA1*03:02,05:02; DQB1*06:02,06:02; DRB1*15:01,16:08 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Trp764Arg (c.2290T>A); Zygosity=Homozygous (Cosmic-CLP=687814; DepMap=ACH-000785).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=687814; DepMap=ACH-000785).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.91%; Native American=0.65%; East Asian, North=3.65%; East Asian, South=0%; South Asian=0%; European, North=58.35%; European, South=35.45% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-5925; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CCL-256; Cosmic-CLP=687814; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9 (ATCC=CCL-256; Cosmic-CLP=687814)
ST   D7S820: 9 (PubMed=25877200)
ST   D8S1179: 12
ST   FGA: 26
ST   Penta D: 10
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2652 ! NCI-BL2126
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   NCI-H2127
AC   CVCL_A525
SY   H2127; H-2127
DR   Wikidata; Q54907930
RX   PubMed=8806092;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H2135
AC   CVCL_1533
SY   H2135; H-2135; NCIH2135
DR   CLO; CLO_0008057
DR   EFO; EFO_0006674
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5926
DR   BioSample; SAMN03472997
DR   cancercelllines; CVCL_1533
DR   Cell_Model_Passport; SIDM00700
DR   Cosmic-CLP; 1298352
DR   DepMap; ACH-001363
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298352
DR   GEO; GSM827510
DR   GEO; GSM1374725
DR   GEO; GSM1670219
DR   LINCS_LDP; LCL-1617
DR   PharmacoDB; NCIH2135_1072_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1533
DR   Wikidata; Q54907931
RX   PubMed=8806092;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,03:01; B*41:01,41:01; C*17:01,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser16Alafs*27 (c.45_48delTTCT); Zygosity=Heterozygous (Cosmic-CLP=1298352; DepMap=ACH-001363).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1298352; DepMap=ACH-001363).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg496Leu (c.1487G>T); Zygosity=Heterozygous (Cosmic-CLP=1298352; DepMap=ACH-001363).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Homozygous (Cosmic-CLP=1298352; DepMap=ACH-001363).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.4%; Native American=0%; East Asian, North=0%; East Asian, South=1.13%; South Asian=12.67%; European, North=21.96%; European, South=58.84% (PubMed=30894373).
ST   Source(s): ATCC=CRL-5926; Cosmic-CLP=1298352; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 12
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 8
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NCI-H2141
AC   CVCL_1534
SY   H2141; H-2141; NCIH2141
DR   BTO; BTO_0006526
DR   CLO; CLO_0008058
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5927
DR   BioSample; SAMN03472603
DR   BioSample; SAMN10988438
DR   cancercelllines; CVCL_1534
DR   Cell_Model_Passport; SIDM00699
DR   ChEMBL-Cells; CHEMBL3308556
DR   ChEMBL-Targets; CHEMBL2366323
DR   Cosmic; 688014
DR   Cosmic; 850436
DR   Cosmic; 877232
DR   Cosmic; 877387
DR   Cosmic; 1219108
DR   Cosmic; 1239947
DR   Cosmic; 2125209
DR   Cosmic-CLP; 688014
DR   DepMap; ACH-001138
DR   EGA; EGAS00001000978
DR   GDSC; 688014
DR   GEO; GSM171860
DR   GEO; GSM171861
DR   GEO; GSM794355
DR   GEO; GSM844638
DR   GEO; GSM887409
DR   GEO; GSM888488
DR   GEO; GSM1670220
DR   GEO; GSM1887947
DR   GEO; GSM1888023
DR   IARC_TP53; 435
DR   LINCS_LDP; LCL-1850
DR   PharmacoDB; NCIH2141_1073_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1534
DR   PubChem_Cell_line; CVCL_1534
DR   Wikidata; Q54907932
RX   PubMed=1312696;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Ter (c.625A>T); Zygosity=Homozygous (PubMed=1312696; PubMed=20557307; ATCC=CRL-5927).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.17%; Native American=0.27%; East Asian, North=1.08%; East Asian, South=0%; South Asian=1.16%; European, North=65.94%; European, South=30.38% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5927; Cosmic-CLP=688014; PubMed=20679594
ST   Amelogenin: X (Cosmic-CLP=688014)
ST   Amelogenin: X,Y (ATCC=CRL-5927; PubMed=20679594)
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 8
ST   D18S51: 14,21
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 24
ST   Penta D: 10,11
ST   Penta E: 11,16
ST   TH01: 6,8 (ATCC=CRL-5927)
ST   TH01: 8 (PubMed=20679594)
ST   TH01: 8,9.3 (Cosmic-CLP=688014)
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1519 ! NCI-H2059
OI   CVCL_2653 ! NCI-BL2141
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   NCI-H2145
AC   CVCL_A526
SY   H2145; H-2145
DR   Wikidata; Q54907933
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   NCI-H2170
AC   CVCL_1535
SY   H2170; H-2170; NCIH2170
DR   BTO; BTO_0005425
DR   CLO; CLO_0008059
DR   EFO; EFO_0002281
DR   AddexBio; C0016018/4970
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5928
DR   BCRJ; 0271
DR   BioGRID_ORCS_Cell_line; 529
DR   BioSample; SAMN03471883
DR   BioSample; SAMN10988373
DR   cancercelllines; CVCL_1535
DR   CCRID; 1101HUM-PUMC000354
DR   Cell_Model_Passport; SIDM00716
DR   ChEMBL-Cells; CHEMBL3308460
DR   ChEMBL-Targets; CHEMBL1075534
DR   CLS; 305276
DR   Cosmic; 687815
DR   Cosmic; 1802304
DR   Cosmic; 1995561
DR   Cosmic; 2042870
DR   Cosmic; 2060537
DR   Cosmic; 2125196
DR   Cosmic; 2664252
DR   Cosmic-CLP; 687815
DR   DepMap; ACH-000481
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687815
DR   GEO; GSM62966
DR   GEO; GSM434789
DR   GEO; GSM784214
DR   GEO; GSM794356
DR   GEO; GSM827511
DR   GEO; GSM844639
DR   GEO; GSM887410
DR   GEO; GSM888489
DR   GEO; GSM1670221
DR   IARC_TP53; 21558
DR   IGRhCellID; NCIH2170
DR   LiGeA; CCLE_581
DR   LINCS_LDP; LCL-1590
DR   Lonza; 949
DR   PharmacoDB; NCIH2170_1074_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1535
DR   PubChem_Cell_line; CVCL_1535
DR   Wikidata; Q54907934
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-and-growth-of-crl-5928
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,68:01; B*07:02,51:01; C*03:04,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Gly17Val (c.50G>T); Zygosity=Heterozygous (Cosmic-CLP=687815; DepMap=ACH-000481).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Gly (c.472C>G); ClinVar=VCV000856171; Zygosity=Homozygous (Cosmic-CLP=687815; DepMap=ACH-000481).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.09%; Native American=0%; East Asian, North=0.85%; East Asian, South=0.49%; South Asian=0.94%; European, North=69.01%; European, South=28.61% (PubMed=30894373).
ST   Source(s): AddexBio=C0016018/4970; ATCC=CRL-5928; CCRID=1101HUM-PUMC000354; Cosmic-CLP=687815; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 12,14
ST   D18S51: 13,14
ST   D19S433: 13.2,14
ST   D21S11: 31.2
ST   D2S1338: 17,24
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 25,26
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 15,19
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   NCI-H2171
AC   CVCL_1536
SY   H2171; H-2171; NCIH2171
DR   BTO; BTO_0005978
DR   CLO; CLO_0008060
DR   EFO; EFO_0002282
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5929
DR   BioGRID_ORCS_Cell_line; 1403
DR   BioSample; SAMN03471007
DR   BioSample; SAMN10988226
DR   cancercelllines; CVCL_1536
DR   Cell_Model_Passport; SIDM00733
DR   ChEMBL-Cells; CHEMBL3308320
DR   ChEMBL-Targets; CHEMBL2366213
DR   Cosmic; 688015
DR   Cosmic; 850437
DR   Cosmic; 877233
DR   Cosmic; 877388
DR   Cosmic; 980957
DR   Cosmic; 1021882
DR   Cosmic; 1032428
DR   Cosmic; 1219109
DR   Cosmic; 1239948
DR   Cosmic; 1518087
DR   Cosmic; 1759280
DR   Cosmic; 1891917
DR   Cosmic; 1995562
DR   Cosmic; 2125197
DR   Cosmic-CLP; 688015
DR   DepMap; ACH-000525
DR   DSMZ; ACC-544
DR   DSMZCellDive; ACC-544
DR   EGA; EGAS00001000610
DR   GDSC; 688015
DR   GEO; GSM171862
DR   GEO; GSM171863
DR   GEO; GSM794357
DR   GEO; GSM827525
DR   GEO; GSM887411
DR   GEO; GSM888490
DR   GEO; GSM1670222
DR   GEO; GSM1887901
DR   GEO; GSM1887972
DR   GEO; GSM2716708
DR   GEO; GSM2716709
DR   GEO; GSM2716710
DR   GEO; GSM2716770
DR   GEO; GSM2716771
DR   GEO; GSM2716772
DR   GEO; GSM2716773
DR   IARC_TP53; 21559
DR   IGRhCellID; NCIH2171
DR   LiGeA; CCLE_217
DR   LINCS_LDP; LCL-1851
DR   PharmacoDB; NCIH2171_1075_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1536
DR   PubChem_Cell_line; CVCL_1536
DR   Wikidata; Q54907936
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=14762065;
RX   PubMed=16157194;
RX   PubMed=18438408;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20624269;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=29491412;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H2171.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=25984343); ~35-60 hours (DSMZ=ACC-544).
CC   HLA typing: A*23:01,66:01; B*41:02,48:03; C*05:01,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:20202; CACNA2D4 + HGNC; HGNC:28945; WDR43; Name(s)=CACNA2D4-WDR43; Note=Out of frame (PubMed=18438408).
CC   Sequence variation: Gene fusion; HGNC; HGNC:19437; CCNB1IP1 + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-CCNB1IP1 (PubMed=23716474).
CC   Sequence variation: Gene fusion; HGNC; HGNC:20626; CHD7 + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-CHD7 (PubMed=18438408; PubMed=23716474).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9709; PVT1 + HGNC; HGNC:11065; SLC7A7; Name(s)=PVT1-SLC7A7 (PubMed=23716474).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser567Ter (c.1700C>A); Zygosity=Homozygous (ATCC=CRL-5929; Cosmic-CLP=688015; DepMap=ACH-000525).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Homozygous (PubMed=20557307; ATCC=CRL-5929; Cosmic-CLP=688015; DepMap=ACH-000525).
CC   Omics: Genomics; ChIP-seq; BRD4.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.06%; Native American=0%; East Asian, North=4.89%; East Asian, South=0.05%; South Asian=0%; European, North=56.36%; European, South=35.63% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5929; Cosmic-CLP=688015; DSMZ=ACC-544; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 18 (DSMZ=ACC-544)
ST   D18S51: 18,21 (ATCC=CRL-5929; PubMed=25877200)
ST   D19S433: 16
ST   D21S11: 28,32.2
ST   D2S1338: 16,20
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,13
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2654 ! NCI-BL2171
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   NCI-H2172
AC   CVCL_1537
SY   H2172; H-2172; NCIH2172
DR   BTO; BTO_0006022
DR   CLO; CLO_0008061
DR   EFO; EFO_0006675
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5930
DR   BioGRID_ORCS_Cell_line; 528
DR   BioSample; SAMN03473020
DR   BioSample; SAMN10988024
DR   cancercelllines; CVCL_1537
DR   Cell_Model_Passport; SIDM00926
DR   Cosmic; 1146904
DR   Cosmic-CLP; 1298353
DR   DepMap; ACH-000924
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298353
DR   GEO; GSM434294
DR   GEO; GSM794358
DR   GEO; GSM827524
DR   GEO; GSM887412
DR   GEO; GSM888491
DR   GEO; GSM1374726
DR   GEO; GSM1670223
DR   IGRhCellID; H2172GEO
DR   LiGeA; CCLE_599
DR   LINCS_LDP; LCL-1618
DR   PharmacoDB; NCIH2172_1076_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1537
DR   Wikidata; Q54907937
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   HLA typing: A*30:02,30:02; B*08:01,35:08; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Gly430Cys (c.1288G>T); Zygosity=Homozygous (DepMap=ACH-000924).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=81.79%; Native American=0.46%; East Asian, North=2.23%; East Asian, South=0%; South Asian=0%; European, North=5.77%; European, South=9.75% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5930; Cosmic-CLP=1298353; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D21S11: 27
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 19,22
ST   Penta D: 2.2,8
ST   Penta E: 7,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H2195
AC   CVCL_1538
SY   H2195; H-2195
DR   CLO; CLO_0008062
DR   EFO; EFO_0002283
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-5931
DR   cancercelllines; CVCL_1538
DR   Cosmic; 877389
DR   Cosmic; 1219110
DR   Cosmic; 1239949
DR   Cosmic; 1518088
DR   Cosmic; 2125244
DR   GEO; GSM171864
DR   GEO; GSM171865
DR   GEO; GSM794359
DR   IARC_TP53; 28450
DR   IGRhCellID; NCIH2195
DR   LINCS_LDP; LCL-1815
DR   Progenetix; CVCL_1538
DR   Wikidata; Q54907938
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20624269;
RX   PubMed=23716474;
RX   PubMed=28196595;
RX   PubMed=31803961;
RX   PubMed=34439128;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Unspecified (PubMed=20557307).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5931
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 20,21
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2655 ! NCI-BL2195
OI   CVCL_1539 ! NCI-H2196
OI   CVCL_1540 ! NCI-H2198
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   NCI-H2196
AC   CVCL_1539
SY   H2196; H-2196; NCIH2196
DR   CLO; CLO_0008063
DR   EFO; EFO_0006676
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5932
DR   BioSample; SAMN03473226
DR   BioSample; SAMN10988344
DR   cancercelllines; CVCL_1539
DR   Cell_Model_Passport; SIDM00731
DR   ChEMBL-Cells; CHEMBL3308772
DR   ChEMBL-Targets; CHEMBL1075535
DR   Cosmic; 688016
DR   Cosmic; 877390
DR   Cosmic; 908481
DR   Cosmic; 1995563
DR   Cosmic; 2125245
DR   Cosmic-CLP; 908481
DR   DepMap; ACH-000399
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908481
DR   GEO; GSM827562
DR   GEO; GSM887413
DR   GEO; GSM888492
DR   GEO; GSM1670224
DR   IARC_TP53; 21560
DR   LiGeA; CCLE_104
DR   LINCS_LDP; LCL-1816
DR   PharmacoDB; NCIH2196_1077_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_1539
DR   PubChem_Cell_line; CVCL_1539
DR   Wikidata; Q54907939
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:24; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (Cosmic-CLP=908481; DepMap=ACH-000399).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.17%; Native American=0%; East Asian, North=2.28%; East Asian, South=0%; South Asian=0%; European, North=66.73%; European, South=28.81% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5932; Cosmic-CLP=908481; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 20,21
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2655 ! NCI-BL2195
OI   CVCL_1538 ! NCI-H2195
OI   CVCL_1540 ! NCI-H2198
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H2198
AC   CVCL_1540
SY   H2198; H-2198
DR   CLO; CLO_0008064
DR   EFO; EFO_0006677
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-5933
DR   BioSample; SAMN03473227
DR   cancercelllines; CVCL_1540
DR   Cosmic; 688017
DR   Cosmic; 877234
DR   EGA; EGAS00001000610
DR   GEO; GSM986180
DR   GEO; GSM1887958
DR   GEO; GSM1888035
DR   LINCS_LDP; LCL-1817
DR   PharmacoDB; NCIH2198_1078_2019
DR   Progenetix; CVCL_1540
DR   Wikidata; Q54907940
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=20679594;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:24; B*07:02,08:01; C*07:01,07:01; DQA1*02:01,05:02; DQB1*02:01,02:01; DRB1*03:01,07:01 (PubMed=26589293).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5933; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 20,21
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8 (PubMed=25877200)
ST   TPOX: 8,9 (ATCC=CRL-5933; PubMed=20679594)
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2655 ! NCI-BL2195
OI   CVCL_1538 ! NCI-H2195
OI   CVCL_1539 ! NCI-H2196
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   NCI-H220
AC   CVCL_1541
SY   H220; H-220
DR   CLO; CLO_0008065
DR   ATCC; CRL-5825
DR   BioSample; SAMN03471745
DR   GDSC; 1330974
DR   GEO; GSM1887916
DR   GEO; GSM1888000
DR   LINCS_LDP; LCL-1852
DR   PharmacoDB; NCIH220_1079_2019
DR   Wikidata; Q54907942
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=6272398;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: African American.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Misspelling: NCI-N220; PubMed=6272398.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5825
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 16,18
ST   D19S433: 13.2,14
ST   D21S11: 28
ST   D2S1338: 16,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 9,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   NCI-H2227
AC   CVCL_1542
SY   H2227; H-2227; NCIH2227
DR   CLO; CLO_0008066
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5934
DR   BioSample; SAMN03473243
DR   BioSample; SAMN10987609
DR   cancercelllines; CVCL_1542
DR   CCRID; 1101HUM-PUMC000254
DR   Cell_Model_Passport; SIDM00730
DR   ChEMBL-Cells; CHEMBL3308321
DR   ChEMBL-Targets; CHEMBL2366217
DR   Cosmic; 688018
DR   Cosmic; 877279
DR   Cosmic; 877391
DR   Cosmic; 980958
DR   Cosmic; 1032429
DR   Cosmic; 2125246
DR   Cosmic-CLP; 688018
DR   DepMap; ACH-000610
DR   EGA; EGAS00001000978
DR   GDSC; 688018
DR   GEO; GSM171866
DR   GEO; GSM171867
DR   GEO; GSM794360
DR   GEO; GSM887414
DR   GEO; GSM888493
DR   GEO; GSM1670225
DR   IARC_TP53; 436
DR   KCLB; 92227
DR   LiGeA; CCLE_564
DR   LINCS_LDP; LCL-1853
DR   PharmacoDB; NCIH2227_1080_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1542
DR   PubChem_Cell_line; CVCL_1542
DR   Wikidata; Q54907943
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*08:01,51:01; C*07:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783-2A>C; ClinVar=VCV000635386; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=1312696; PubMed=1565469).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.89%; East Asian, South=0%; South Asian=1.06%; European, North=65.68%; European, South=31.37% (PubMed=30894373).
CC   Discontinued: KCLB; 92227; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5934; Cosmic-CLP=688018; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 12,13
ST   D19S433: 15
ST   D21S11: 28,32.2
ST   D2S1338: 16,22
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H2228
AC   CVCL_1543
SY   H2228; H-2228; NCIH2228
DR   BTO; BTO_0006023
DR   CLO; CLO_0008067
DR   EFO; EFO_0002284
DR   AddexBio; C0016017/4969
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5935
DR   BCRJ; 0330
DR   BioSample; SAMN03473167
DR   BioSample; SAMN10987779
DR   cancercelllines; CVCL_1543
DR   CCRID; 3101HUMSCSP5001
DR   Cell_Model_Passport; SIDM00729
DR   ChEMBL-Cells; CHEMBL3308120
DR   ChEMBL-Targets; CHEMBL1075536
DR   CLS; 305125
DR   Cosmic; 687816
DR   Cosmic; 897513
DR   Cosmic; 903617
DR   Cosmic; 930491
DR   Cosmic; 1146905
DR   Cosmic; 1609517
DR   Cosmic; 1612226
DR   Cosmic; 1995564
DR   Cosmic-CLP; 687816
DR   DepMap; ACH-000447
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687816
DR   GEO; GSM434317
DR   GEO; GSM513959
DR   GEO; GSM514344
DR   GEO; GSM794361
DR   GEO; GSM827512
DR   GEO; GSM887415
DR   GEO; GSM888494
DR   GEO; GSM1374727
DR   GEO; GSM1670226
DR   IARC_TP53; 27190
DR   IGRhCellID; NCIH2228
DR   LiGeA; CCLE_800
DR   LINCS_LDP; LCL-1652
DR   PharmacoDB; NCIH2228_1081_2019
DR   PRIDE; PXD011315
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1543
DR   PubChem_Cell_line; CVCL_1543
DR   Wikidata; Q54907944
RX   DOI=10.1101/2022.06.08.495301;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=18594010;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22334442;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23344087;
RX   PubMed=24675041;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30710758;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31900393;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 77.2 hours (PubMed=31900393).
CC   HLA typing: A*02:01,03:01; B*07:02,38:01; C*07:02,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (PubMed=18594010; DOI=10.1101/2022.06.08.495301; DepMap=ACH-000447).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:9655; PTPN3; Name(s)=ALK-PTPN3 (PubMed=22334442).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Homozygous (Cosmic-CLP=687816; DepMap=ACH-000447).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.1%; Native American=0.08%; East Asian, North=0.5%; East Asian, South=0.06%; South Asian=0.85%; European, North=65.31%; European, South=33.09% (PubMed=30894373).
CC   Misspelling: HC2228; Cosmic=1612226.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016017/4969; ATCC=CRL-5935; Cosmic-CLP=687816; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 11,13
ST   Penta E: 11,16
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   NCI-H2228-ARY
AC   CVCL_E6DB
SY   H2228-ARY
RX   PubMed=31900393;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_62268; Alectinib (CH5424802; RO5424802; AF-802).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:9655; PTPN3; Name(s)=ALK-PTPN3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1543 ! NCI-H2228
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCI-H2228-Luc
AC   CVCL_4V13
DR   cancercelllines; CVCL_4V13
DR   JCRB; JCRB1492
DR   JCRB; NIHS0726
DR   Wikidata; Q54907945
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:9655; PTPN3; Name(s)=ALK-PTPN3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0726; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1492
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1543 ! NCI-H2228
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   NCI-H2250
AC   CVCL_A527
SY   H2250; H-2250
DR   ATCC; CRL-5936
DR   cancercelllines; CVCL_A527
DR   GEO; GSM794362
DR   IARC_TP53; 514
DR   Wikidata; Q54907946
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Unspecified (PubMed=1311061).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5936; true.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   NCI-H2258
AC   CVCL_A528
SY   H2258; H-2258
DR   Cosmic; 877442
DR   Cosmic; 980959
DR   Cosmic; 1032430
DR   GEO; GSM794363
DR   Wikidata; Q54907947
RX   PubMed=8806092;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   NCI-H226
AC   CVCL_1544
SY   NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226
DR   BTO; BTO_0003008
DR   CLO; CLO_0008068
DR   EFO; EFO_0002285
DR   AddexBio; C0016011/4916
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5826
DR   BioGRID_ORCS_Cell_line; 960
DR   BioSample; SAMN03471987
DR   BioSample; SAMN10987668
DR   cancercelllines; CVCL_1544
DR   CCRID; 3101HUMTCHu235
DR   CCRID; 4201HUM-CCTCC00634
DR   Cell_Model_Passport; SIDM00139
DR   ChEMBL-Cells; CHEMBL3307697
DR   ChEMBL-Targets; CHEMBL614740
DR   CLS; 305091
DR   Cosmic; 733816
DR   Cosmic; 875850
DR   Cosmic; 877259
DR   Cosmic; 877402
DR   Cosmic; 886388
DR   Cosmic; 903570
DR   Cosmic; 905941
DR   Cosmic; 931374
DR   Cosmic; 974291
DR   Cosmic; 980961
DR   Cosmic; 1006539
DR   Cosmic; 1028953
DR   Cosmic; 1032433
DR   Cosmic; 1047100
DR   Cosmic; 1092618
DR   Cosmic; 1152497
DR   Cosmic; 1175863
DR   Cosmic; 1188585
DR   Cosmic; 1219111
DR   Cosmic; 1239951
DR   Cosmic; 1305346
DR   Cosmic; 1312331
DR   Cosmic; 1436011
DR   Cosmic; 1481544
DR   Cosmic; 1802319
DR   Cosmic; 1870270
DR   Cosmic; 1963326
DR   Cosmic; 1995565
DR   Cosmic; 1998460
DR   Cosmic; 2060522
DR   Cosmic; 2560228
DR   Cosmic; 2664122
DR   Cosmic; 2772152
DR   Cosmic-CLP; 905941
DR   DepMap; ACH-000367
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS328RVB
DR   ENCODE; ENCBS986NWY
DR   FANTOM5_SSTAR; 10846-111E9
DR   GDSC; 905941
DR   GEO; GSM2123
DR   GEO; GSM50213
DR   GEO; GSM50276
DR   GEO; GSM62965
DR   GEO; GSM206486
DR   GEO; GSM274785
DR   GEO; GSM274821
DR   GEO; GSM743452
DR   GEO; GSM750820
DR   GEO; GSM794278
DR   GEO; GSM799340
DR   GEO; GSM799403
DR   GEO; GSM844640
DR   GEO; GSM844641
DR   GEO; GSM844642
DR   GEO; GSM847074
DR   GEO; GSM887416
DR   GEO; GSM888495
DR   GEO; GSM1153411
DR   GEO; GSM1178441
DR   GEO; GSM1178442
DR   GEO; GSM1178443
DR   GEO; GSM1181351
DR   GEO; GSM1374728
DR   GEO; GSM1374729
DR   GEO; GSM1374730
DR   GEO; GSM1670227
DR   GEO; GSM2124673
DR   IARC_TP53; 515
DR   IARC_TP53; 21406
DR   IARC_TP53; 23624
DR   IGRhCellID; NCIH226
DR   KCLB; 90226
DR   LiGeA; CCLE_131
DR   LINCS_LDP; LCL-1597
DR   Lonza; 839
DR   NCI-DTP; NCI-H226
DR   PharmacoDB; NCIH226_1082_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1544
DR   PubChem_Cell_line; CVCL_1544
DR   SKY/M-FISH/CGH; 2802
DR   Wikidata; Q54907948
RX   PubMed=1311061;
RX   PubMed=1568228;
RX   PubMed=2041050;
RX   PubMed=2386953;
RX   PubMed=3335022;
RX   PubMed=6272398;
RX   PubMed=8806092;
RX   PubMed=8806101;
RX   PubMed=8956792;
RX   PubMed=9331090;
RX   PubMed=9488600;
RX   PubMed=9649128;
RX   PubMed=10700174;
RX   PubMed=11030152;
RX   PubMed=11369051;
RX   PubMed=15748285;
RX   PubMed=16187286;
RX   PubMed=17088437;
RX   PubMed=17332333;
RX   PubMed=17458138;
RX   PubMed=18083107;
RX   PubMed=19372543;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24002593;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25902174;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=29718670;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=10
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/nci-h226-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: NCI-7 clinical proteomics reference material cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 43 hours (PubMed=9488600); 52 hours (PubMed=29681454); 61 hours (NCI-DTP=NCI-H226).
CC   HLA typing: A*01:01:01,24:02:01; B*07,39; C*07:02:01,12:03:01; DPB1*02:01:02,04:01; DQB1*05:02:01,06:02; DRB1*15:01:01,16:01:01 (PubMed=15748285).
CC   HLA typing: A*01:01,24:02; B*07:02,39:01; C*07:02,12:03; DQB1*06:13,06:13; DRB1*15:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (ATCC=CRL-5826).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.16%; East Asian, South=0.88%; South Asian=1.48%; European, North=65.62%; European, South=31.86% (PubMed=30894373).
CC   Caution: Indicated to have a TP53 p.Arg158Leu (c.473G>T) mutation according to PubMed=1311061, but no TP53 mutation detected according to PubMed=20557307, CCLE and Cosmic-CLP.
CC   Discontinued: KCLB; 90226; probable.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0016011/4916; ATCC=CRL-5826; CCRID; Cosmic-CLP=905941; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 22
ST   D13S317: 13,14
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 15
ST   D21S11: 29,32.2
ST   D2S1338: 25
ST   D2S441: 14
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 13,18
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 20,23
ST   Penta D: 9,10
ST   Penta E: 12,15
ST   TH01: 8,9.3
ST   TPOX: 8 (PubMed=19372543)
ST   TPOX: 8,11 (AddexBio=C0016011/4916; ATCC=CRL-5826; CCRID; Cosmic-CLP=905941; PubMed=25877200)
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 49
//
ID   NCI-H226b
AC   CVCL_VK08
SY   H226b; H226B; H226-B
DR   Cosmic; 2645022
DR   Wikidata; Q95993364
RX   PubMed=8528963;
RX   PubMed=9498829;
RX   PubMed=28676216;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1544 ! NCI-H226
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   NCI-H226Br
AC   CVCL_AX73
SY   H226Br; H226br; 226Br
DR   BTO; BTO_0000171
DR   cancercelllines; CVCL_AX73
DR   Wikidata; Q54907949
RX   PubMed=7634243;
RX   PubMed=8089864;
RX   PubMed=8528963;
RX   PubMed=8956792;
RX   PubMed=9498829;
CC   Population: Caucasian.
CC   Characteristics: Established from brain metastasis tumor of athymic BALB/c mice after carotid artery injection of parent cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Val (c.760A>G); ClinVar=VCV000406605; Zygosity=Homozygous (PubMed=8089864).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1544 ! NCI-H226
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   NCI-H2279
AC   CVCL_9642
SY   H2279; H-2279
DR   EFO; EFO_0003120
DR   Cosmic; 1028939
DR   Wikidata; Q54907950
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   NCI-H2280
AC   CVCL_S142
SY   H2280; H-2280
DR   ATCC; CRL-5937
DR   BioSample; SAMN03472604
DR   Wikidata; Q54907951
CC   Discontinued: ATCC; CRL-5937; true.
ST   Source(s): ATCC=CRL-5937
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 15,19
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   NCI-H2282
AC   CVCL_9643
SY   H2282; H-2282
DR   EFO; EFO_0003121
DR   Wikidata; Q54907952
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   NCI-H2284
AC   CVCL_A529
SY   H2284; H-2284
DR   Wikidata; Q54907953
RX   PubMed=8806092;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NCI-H2286
AC   CVCL_1545
SY   H2286; H-2286; NCIH2286
DR   CLO; CLO_0008069
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5938
DR   BioSample; SAMN10987985
DR   cancercelllines; CVCL_1545
DR   Cell_Model_Passport; SIDM00017
DR   ChEMBL-Cells; CHEMBL4483176
DR   ChEMBL-Targets; CHEMBL4483261
DR   Cosmic; 980992
DR   Cosmic; 1032464
DR   Cosmic; 2559770
DR   DepMap; ACH-000912
DR   EGA; EGAS00001000978
DR   GDSC; 1298355
DR   GEO; GSM434790
DR   GEO; GSM827513
DR   GEO; GSM887417
DR   GEO; GSM888496
DR   GEO; GSM1374731
DR   IARC_TP53; 28267
DR   LiGeA; CCLE_205
DR   LINCS_LDP; LCL-1818
DR   PharmacoDB; NCIH2286_1083_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_1545
DR   PubChem_Cell_line; CVCL_1545
DR   Wikidata; Q54907954
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=38180245;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:21; B*51:01,51:01; C*15:02,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Arg1135Gln (c.3404G>A); Zygosity=Homozygous (DepMap=ACH-000912).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys291Ter (c.871A>T); Zygosity=Homozygous (DepMap=ACH-000912).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.79%; Native American=0%; East Asian, North=4.22%; East Asian, South=0%; South Asian=0%; European, North=60.65%; European, South=32.33% (PubMed=30894373).
CC   Caution: Originally classified as originating from a lung small cell carcinoma, but is reclassified as a lung adenocarcinoma based on a number of criteria (PubMed=38180245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5938
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 14,14.1
ST   D21S11: 27,33.2
ST   D2S1338: 19,25
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 14
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 15,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H2287
AC   CVCL_9644
SY   H2287; H-2287
DR   EFO; EFO_0003122
DR   Wikidata; Q54907955
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H2291
AC   CVCL_1546
SY   H2291; H-2291; NCIH2291
DR   CLO; CLO_0008070
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5939
DR   BioGRID_ORCS_Cell_line; 527
DR   BioSample; SAMN03472605
DR   BioSample; SAMN10987683
DR   cancercelllines; CVCL_1546
DR   Cell_Model_Passport; SIDM00728
DR   ChEMBL-Cells; CHEMBL3308880
DR   ChEMBL-Targets; CHEMBL2366197
DR   Cosmic; 724874
DR   Cosmic; 903618
DR   Cosmic; 1995566
DR   Cosmic; 2125247
DR   Cosmic-CLP; 724874
DR   DepMap; ACH-000718
DR   EGA; EGAS00001000978
DR   GDSC; 724874
DR   GEO; GSM513960
DR   GEO; GSM514345
DR   GEO; GSM794364
DR   GEO; GSM887418
DR   GEO; GSM888497
DR   GEO; GSM1374732
DR   GEO; GSM1670228
DR   IARC_TP53; 27192
DR   LiGeA; CCLE_479
DR   LINCS_LDP; LCL-1653
DR   PharmacoDB; NCIH2291_1084_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1546
DR   PubChem_Cell_line; CVCL_1546
DR   Wikidata; Q54907956
RX   PubMed=8806092;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Phe (c.34_35GG>TT) (c.34_35delinsTT); Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=724874; DepMap=ACH-000718).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (Cosmic-CLP=724874; DepMap=ACH-000718).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.1%; Native American=0%; East Asian, North=3.67%; East Asian, South=0%; South Asian=1.55%; European, North=54.53%; European, South=39.15% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5939; Cosmic-CLP=724874
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NCI-H23
AC   CVCL_1547
SY   NCI.H23; NCI H23; H-23; H23; NCIH23
DR   BTO; BTO_0003238
DR   CLO; CLO_0008071
DR   EFO; EFO_0002286
DR   AddexBio; C0016005/4861
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5800
DR   BioGRID_ORCS_Cell_line; 526
DR   BioSample; SAMN03471316
DR   BioSample; SAMN03471735
DR   BioSample; SAMN10988149
DR   cancercelllines; CVCL_1547
DR   CCRID; 3101HUMSCSP581
DR   Cell_Model_Passport; SIDM00138
DR   ChEMBL-Cells; CHEMBL3307750
DR   ChEMBL-Targets; CHEMBL614997
DR   CLS; 305044
DR   Cosmic; 687818
DR   Cosmic; 722038
DR   Cosmic; 801587
DR   Cosmic; 844829
DR   Cosmic; 852004
DR   Cosmic; 875849
DR   Cosmic; 876142
DR   Cosmic; 877237
DR   Cosmic; 905942
DR   Cosmic; 910561
DR   Cosmic; 914948
DR   Cosmic; 917993
DR   Cosmic; 953983
DR   Cosmic; 961834
DR   Cosmic; 974292
DR   Cosmic; 1004697
DR   Cosmic; 1089217
DR   Cosmic; 1092619
DR   Cosmic; 1146906
DR   Cosmic; 1154591
DR   Cosmic; 1175864
DR   Cosmic; 1188590
DR   Cosmic; 1219060
DR   Cosmic; 1239881
DR   Cosmic; 1305347
DR   Cosmic; 1312332
DR   Cosmic; 1436010
DR   Cosmic; 1802313
DR   Cosmic; 1870271
DR   Cosmic; 1995567
DR   Cosmic; 1998461
DR   Cosmic; 2058647
DR   Cosmic; 2125183
DR   Cosmic; 2433751
DR   Cosmic; 2630416
DR   Cosmic; 2647631
DR   Cosmic; 2648436
DR   Cosmic; 2668310
DR   Cosmic; 2772151
DR   Cosmic-CLP; 905942
DR   DepMap; ACH-000900
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905942
DR   GEO; GSM2106
DR   GEO; GSM50214
DR   GEO; GSM50277
DR   GEO; GSM171868
DR   GEO; GSM171869
DR   GEO; GSM206487
DR   GEO; GSM253310
DR   GEO; GSM274790
DR   GEO; GSM274820
DR   GEO; GSM353232
DR   GEO; GSM385519
DR   GEO; GSM385530
DR   GEO; GSM434335
DR   GEO; GSM482108
DR   GEO; GSM513961
DR   GEO; GSM514346
DR   GEO; GSM743453
DR   GEO; GSM750803
DR   GEO; GSM794267
DR   GEO; GSM799341
DR   GEO; GSM799404
DR   GEO; GSM817066
DR   GEO; GSM827478
DR   GEO; GSM844643
DR   GEO; GSM847075
DR   GEO; GSM887421
DR   GEO; GSM888500
DR   GEO; GSM1153412
DR   GEO; GSM1178456
DR   GEO; GSM1178457
DR   GEO; GSM1181268
DR   GEO; GSM1181312
DR   GEO; GSM1374733
DR   GEO; GSM1374734
DR   GEO; GSM1374735
DR   GEO; GSM1670229
DR   GEO; GSM2124674
DR   IARC_TP53; 256
DR   IGRhCellID; NCIH23
DR   KCLB; 90023
DR   LiGeA; CCLE_892
DR   LINCS_LDP; LCL-1619
DR   NCI-DTP; NCI-H23
DR   PharmacoDB; NCIH23_1085_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1547
DR   PubChem_Cell_line; CVCL_1547
DR   SKY/M-FISH/CGH; 2796
DR   Wikidata; Q54907958
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=1845952;
RX   PubMed=2041050;
RX   PubMed=2473086;
RX   PubMed=3335022;
RX   PubMed=3940644;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=7718330;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=9331090;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=10700174;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=12820372;
RX   PubMed=15471562;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=17088437;
RX   PubMed=19153074;
RX   PubMed=19372543;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23381221;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24135919;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25120651;
RX   PubMed=25485619;
RX   PubMed=25714623;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27602502;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=29718670;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=6
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-401.html
WW   Provider; BRICS; BRICS0118; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3922
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: NCI-7 clinical proteomics reference material cell line panel.
CC   Population: African American.
CC   Doubling time: 38 hours (Note=In RPMI 1640 + 10% FBS), 71 hours (Note=In ACL-3), 57 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 25 hours (PubMed=7718330); 35 hours (PubMed=25984343); 39.1 hours (PubMed=29681454); 38 hours (ATCC=CRL-5800); 33.4 hours (NCI-DTP=NCI-H23).
CC   HLA typing: A*80:01; B*50:01; C*06:02; DPB1*19:01; DQB1*06:03; DRB1*13:01:01 (PubMed=15748285).
CC   HLA typing: A*80:01,80:01; B*50:01,50:01; C*06:02,06:02; DQB1*06:13,06:13 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y (PubMed=25714623).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1919Pro (c.5756A>C); ClinVar=VCV000580726; Zygosity=Homozygous (PubMed=27602502).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=1311061; PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Trp332Ter (c.996G>A); ClinVar=VCV000376339; Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>C); ClinVar=VCV001758655; Zygosity=Homozygous (PubMed=1311061; PubMed=9331090; PubMed=1565469; PubMed=10536175; PubMed=12820372; PubMed=15900046; PubMed=17088437; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=67.86%; Native American=2.12%; East Asian, North=2.83%; East Asian, South=0%; South Asian=0%; European, North=10.88%; European, South=16.3% (PubMed=30894373).
CC   Misspelling: H63; PubMed=23381221; PubMed=25120651; Note=Confirmed by author personal communication.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016005/4861; ATCC=CRL-5800; Cosmic-CLP=905942; KCLB=90023; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,11 (Cosmic-CLP=905942; PubMed=19372543; PubMed=25877200)
ST   D16S539: 11 (AddexBio=C0016005/4861; ATCC=CRL-5800)
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 12 (PubMed=25877200)
ST   D5S818: 12,13 (AddexBio=C0016005/4861; ATCC=CRL-5800; Cosmic-CLP=905942; KCLB=90023; PubMed=19372543)
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 8
ST   Penta E: 7,17
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   NCI-H23-Luc
AC   CVCL_4W97
DR   cancercelllines; CVCL_4W97
DR   JCRB; JCRB1509
DR   JCRB; NIHS0727
DR   Wikidata; Q54907959
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1919Pro (c.5756A>C); ClinVar=VCV000580726; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Trp332Ter (c.996G>A); ClinVar=VCV000376339; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>C); ClinVar=VCV001758655; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0727; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1509
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1547 ! NCI-H23
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   NCI-H23/GEM-R
AC   CVCL_ZZ80
SY   H23/GEM-R
DR   cancercelllines; CVCL_ZZ80
DR   Wikidata; Q102114583
RX   PubMed=15471562;
RX   PubMed=17237272;
RX   PubMed=18445659;
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln1919Pro (c.5756A>C); ClinVar=VCV000580726; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Trp332Ter (c.996G>A); ClinVar=VCV000376339; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>C); ClinVar=VCV001758655; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1547 ! NCI-H23
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   NCI-H2330
AC   CVCL_1548
SY   H2330; H-2330
DR   CLO; CLO_0008072
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-5940
DR   BioSample; SAMN03472606
DR   cancercelllines; CVCL_1548
DR   Cosmic; 688019
DR   GEO; GSM827444
DR   GEO; GSM1887936
DR   GEO; GSM1888014
DR   Progenetix; CVCL_1548
DR   Wikidata; Q54907963
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a 65 packs per year smoker (ATCC=CRL-5940).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5940
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 17,25
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 8,9
ST   Penta E: 17
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   NCI-H2332
AC   CVCL_A530
SY   H2332; H-2332
DR   Cosmic; 1021883
DR   Wikidata; Q54907964
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   NCI-H2342
AC   CVCL_1549
SY   H2342; H-2342; NCIH2342
DR   CLO; CLO_0008073
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5941
DR   BioSample; SAMN03472998
DR   BioSample; SAMN10987673
DR   cancercelllines; CVCL_1549
DR   Cell_Model_Passport; SIDM00727
DR   ChEMBL-Cells; CHEMBL3308773
DR   ChEMBL-Targets; CHEMBL1075537
DR   Cosmic; 687819
DR   Cosmic; 903619
DR   Cosmic; 1609514
DR   Cosmic; 1995568
DR   Cosmic-CLP; 687819
DR   DepMap; ACH-000951
DR   EGA; EGAS00001000978
DR   GDSC; 687819
DR   GEO; GSM513962
DR   GEO; GSM514347
DR   GEO; GSM794365
DR   GEO; GSM827408
DR   GEO; GSM887419
DR   GEO; GSM888498
DR   GEO; GSM1374736
DR   GEO; GSM1670230
DR   IARC_TP53; 21562
DR   LiGeA; CCLE_039
DR   LINCS_LDP; LCL-1654
DR   PharmacoDB; NCIH2342_1086_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1549
DR   PubChem_Cell_line; CVCL_1549
DR   Wikidata; Q54907965
RX   PubMed=8806092;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (Cosmic-CLP=687819; DepMap=ACH-000951).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=4.52%; East Asian, South=0%; South Asian=0%; European, North=58.43%; European, South=36.81% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5941; Cosmic-CLP=687819; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 17
ST   D19S433: 13,16
ST   D21S11: 31.2,32
ST   D2S1338: 19,26
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 5
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   NCI-H2347
AC   CVCL_1550
SY   H2347; H-2347; NCIH2347
DR   BTO; BTO_0005293
DR   CLO; CLO_0008074
DR   EFO; EFO_0002287
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5942
DR   BioSample; SAMN03472999
DR   BioSample; SAMN10987629
DR   cancercelllines; CVCL_1550
DR   CCRID; 3101HUMSCSP5002
DR   Cell_Model_Passport; SIDM00726
DR   ChEMBL-Cells; CHEMBL3308386
DR   ChEMBL-Targets; CHEMBL1075538
DR   CLS; 305139
DR   Cosmic; 687820
DR   Cosmic; 877253
DR   Cosmic; 903620
DR   Cosmic; 914950
DR   Cosmic; 1146907
DR   Cosmic; 1239893
DR   Cosmic; 1925843
DR   Cosmic; 2125248
DR   Cosmic; 2776270
DR   Cosmic-CLP; 687820
DR   DepMap; ACH-000875
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687820
DR   GEO; GSM62332
DR   GEO; GSM108841
DR   GEO; GSM108842
DR   GEO; GSM253354
DR   GEO; GSM303896
DR   GEO; GSM337707
DR   GEO; GSM434254
DR   GEO; GSM513963
DR   GEO; GSM514348
DR   GEO; GSM784201
DR   GEO; GSM794366
DR   GEO; GSM817104
DR   GEO; GSM827514
DR   GEO; GSM844644
DR   GEO; GSM887420
DR   GEO; GSM888499
DR   GEO; GSM1374737
DR   GEO; GSM1670231
DR   IARC_TP53; 21563
DR   IARC_TP53; 28451
DR   IGRhCellID; NCIH2347
DR   LiGeA; CCLE_615
DR   LINCS_LDP; LCL-1620
DR   PharmacoDB; NCIH2347_1087_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1550
DR   PubChem_Cell_line; CVCL_1550
DR   Wikidata; Q54907966
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=9559342;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=12068308;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24700732;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 38.6 hours (PubMed=29681454).
CC   HLA typing: A*01:01,02:01; B*15:01,15:01; C*03:04,03:04; DQA1*02:01,02:01; DQB1*03:02,06:13 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Gln28Ter (c.82C>T); Zygosity=Homozygous (Cosmic-CLP=687820; DepMap=ACH-000875).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Leu19Phe (c.57G>T); ClinVar=VCV000376034; Zygosity=Heterozygous (Cosmic-CLP=687820; DepMap=ACH-000875).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=687820; DepMap=ACH-000875).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>A); ClinVar=VCV000177825; Zygosity=Homozygous; Note=Impairs TP53 splicing dramatically (PubMed=20557307; PubMed=24700732; Cosmic-CLP=687820; DepMap=ACH-000875).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.74%; East Asian, South=0%; South Asian=0.59%; European, North=62.76%; European, South=35.9% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5942; Cosmic-CLP=687820; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 11
ST   D18S51: 12,19
ST   D19S433: 13,15
ST   D21S11: 31,31.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 20,25
ST   Penta D: 12
ST   Penta E: 8,19
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2656 ! NCI-BL2347
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   NCI-H2365
AC   CVCL_A531
SY   H2365; H-2365
DR   Wikidata; Q54907967
RX   PubMed=8806092;
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H2369
AC   CVCL_A532
SY   H2369; H-2369
DR   EFO; EFO_0006678
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471012
DR   cancercelllines; CVCL_A532
DR   Cell_Model_Passport; SIDM00104
DR   Cosmic; 1995411
DR   Cosmic-CLP; 1290808
DR   DepMap; ACH-002123
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290808
DR   GEO; GSM1669818
DR   PharmacoDB; NCIH2369_1088_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907968
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,68:01; B*08:01,37:01; C*06:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.75%; Native American=0%; East Asian, North=0.77%; East Asian, South=0.91%; South Asian=0%; European, North=67.35%; European, South=30.22% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1290808; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,15
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 19,21
ST   Penta D: 14
ST   Penta E: 7,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   NCI-H2373
AC   CVCL_A533
SY   H2373; H-2373; NCIH2373
DR   EFO; EFO_0006679
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5943
DR   BioSample; SAMN03471008
DR   BioSample; SAMN03472607
DR   BioSamples; SAMEA100828
DR   cancercelllines; CVCL_A533
DR   Cell_Model_Passport; SIDM00103
DR   Cosmic; 886391
DR   Cosmic; 1032375
DR   Cosmic; 1522781
DR   Cosmic; 1541217
DR   Cosmic; 2759213
DR   Cosmic-CLP; 1290809
DR   DepMap; ACH-002124
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290809
DR   GEO; GSM726265
DR   GEO; GSM850300
DR   GEO; GSM1669819
DR   PharmacoDB; NCIH2373_1089_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_A533
DR   Wikidata; Q54907969
RX   PubMed=7695406;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=16630136;
RX   PubMed=21245096;
RX   PubMed=21642991;
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26011428;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28553954;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,30:01; B*41:01,55:01; C*03:03,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136; PubMed=21642991).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Homozygous (PubMed=16630136).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.63%; Native American=0%; East Asian, North=0%; East Asian, South=0.91%; South Asian=2.63%; European, North=66.33%; European, South=29.5% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-5943; true.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): ATCC=CRL-5943; Cosmic-CLP=1290809; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 17
ST   D21S11: 30
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 19,22
ST   Penta D: 12
ST   Penta E: 5,11
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 14 (Cosmic-CLP=1290809; PubMed=25877200)
ST   vWA: 14,18 (ATCC=CRL-5943)
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H2380
AC   CVCL_A534
SY   H2380; H-2380
DR   ATCC; CRL-5986
DR   BioSample; SAMN03472633
DR   Wikidata; Q54907970
RX   PubMed=8626706;
RX   PubMed=8806092;
CC   Discontinued: ATCC; CRL-5986; true.
ST   Source(s): ATCC=CRL-5986
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 13,15
ST   D7S820: 9
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 12
//
ID   NCI-H2405
AC   CVCL_1551
SY   H2405; H-2405; NCIH2405
DR   CLO; CLO_0008075
DR   EFO; EFO_0002288
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5944
DR   BioSample; SAMN03470822
DR   BioSample; SAMN10988539
DR   cancercelllines; CVCL_1551
DR   Cell_Model_Passport; SIDM00724
DR   ChEMBL-Cells; CHEMBL3308774
DR   ChEMBL-Targets; CHEMBL1075539
DR   Cosmic; 687821
DR   Cosmic; 1802309
DR   Cosmic; 1995569
DR   Cosmic-CLP; 687821
DR   DepMap; ACH-000121
DR   EGA; EGAS00001000978
DR   GDSC; 687821
DR   GEO; GSM206488
DR   GEO; GSM274803
DR   GEO; GSM274804
DR   GEO; GSM513964
DR   GEO; GSM514349
DR   GEO; GSM794367
DR   GEO; GSM844645
DR   GEO; GSM887422
DR   GEO; GSM888501
DR   GEO; GSM1670232
DR   IARC_TP53; 21564
DR   LiGeA; CCLE_440
DR   LINCS_LDP; LCL-1655
DR   PharmacoDB; NCIH2405_1090_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1551
DR   PubChem_Cell_line; CVCL_1551
DR   Wikidata; Q54907971
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,32:01; B*14:02,51:01; C*08:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu485_Pro490delinsTyr (c.1454_1469delinsA); Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (Cosmic-CLP=687821).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.18%; Native American=0%; East Asian, North=2.88%; East Asian, South=0%; South Asian=0.97%; European, North=58.28%; European, South=34.69% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5944; Cosmic-CLP=687821; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,22
ST   D3S1358: 11
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 18,21
ST   Penta D: 9,16
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   NCI-H2409
AC   CVCL_A535
SY   H2409; H-2409
DR   Wikidata; Q54907972
RX   PubMed=8806092;
RX   PubMed=11030152;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H2427
AC   CVCL_Y288
SY   H2427; H-2427
DR   Wikidata; Q54907973
RX   PubMed=11030152;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   NCI-H2444
AC   CVCL_1552
SY   H2444; H-2444; NCIH244
DR   CLO; CLO_0008076
DR   AddexBio; C0016038/5010
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5945
DR   BioSample; SAMN03472608
DR   BioSample; SAMN03473022
DR   BioSample; SAMN10988376
DR   cancercelllines; CVCL_1552
DR   Cell_Model_Passport; SIDM00723
DR   ChEMBL-Cells; CHEMBL4523548
DR   ChEMBL-Targets; CHEMBL4523579
DR   Cosmic; 1146908
DR   Cosmic; 1995570
DR   Cosmic-CLP; 1298356
DR   DepMap; ACH-000186
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1298356
DR   GEO; GSM434295
DR   GEO; GSM887423
DR   GEO; GSM888502
DR   GEO; GSM1374738
DR   GEO; GSM1670233
DR   GEO; GSM1682810
DR   IARC_TP53; 28321
DR   IGRhCellID; H2444GEO
DR   LiGeA; CCLE_239
DR   LINCS_LDP; LCL-1621
DR   PharmacoDB; NCIH2444_1091_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1552
DR   PubChem_Cell_line; CVCL_1552
DR   Wikidata; Q54907974
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31467290;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=1298356; DepMap=ACH-000186).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Homozygous (Cosmic-CLP=1298356; DepMap=ACH-000186).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.22%; East Asian, North=3%; East Asian, South=0%; South Asian=1.26%; European, North=58.66%; European, South=35.85% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016038/5010; ATCC=CRL-5945; Cosmic-CLP=1298356; PubMed=25877200; PubMed=31467290
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 16 (ATCC=CRL-5945)
ST   D19S433: 16,17 (PubMed=31467290)
ST   D21S11: 28,29
ST   D2S1338: 20 (PubMed=31467290)
ST   D2S1338: 20,25 (ATCC=CRL-5945)
ST   D3S1358: 14
ST   D5S818: 10
ST   D7S820: 8 (PubMed=25877200)
ST   D7S820: 8,10 (AddexBio=C0016038/5010; ATCC=CRL-5945; Cosmic-CLP=1298356; PubMed=31467290)
ST   D8S1179: 11,12,13 (ATCC=CRL-5945; PubMed=25877200)
ST   D8S1179: 12,13 (PubMed=31467290)
ST   FGA: 25
ST   Penta D: 9,12
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H2452
AC   CVCL_1553
SY   H2452; H-2452; NCIH2452
DR   CLO; CLO_0008077
DR   EFO; EFO_0006680
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5946
DR   BioSample; SAMN03471009
DR   BioSample; SAMN10988138
DR   BioSamples; SAMEA100910
DR   cancercelllines; CVCL_1553
DR   CCRID; 3101HUMTCHu214
DR   Cell_Model_Passport; SIDM00722
DR   ChEMBL-Cells; CHEMBL3308580
DR   ChEMBL-Targets; CHEMBL1075540
DR   CLS; 300391
DR   Cosmic; 886392
DR   Cosmic; 908462
DR   Cosmic; 1032373
DR   Cosmic; 1481546
DR   Cosmic; 1522763
DR   Cosmic; 1541212
DR   Cosmic; 1571798
DR   Cosmic; 1749557
DR   Cosmic; 1963328
DR   Cosmic; 1995571
DR   Cosmic; 2474096
DR   Cosmic; 2758999
DR   Cosmic; 2759231
DR   Cosmic-CLP; 908462
DR   DepMap; ACH-000092
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10848-111F2
DR   GDSC; 908462
DR   GEO; GSM726266
DR   GEO; GSM827515
DR   GEO; GSM850285
DR   GEO; GSM887424
DR   GEO; GSM888503
DR   GEO; GSM1670234
DR   LiGeA; CCLE_468
DR   LINCS_LDP; LCL-1230
DR   PharmacoDB; NCIH2452_1092_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1553
DR   PubChem_Cell_line; CVCL_1553
DR   Wikidata; Q54907975
RX   PubMed=7695406;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21245096;
RX   PubMed=21642991;
RX   PubMed=22460905;
RX   PubMed=24926545;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25902174;
RX   PubMed=25984343;
RX   PubMed=26011428;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28553954;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=25984343).
CC   HLA typing: A*01:01,02:01; B*35:01,57:01; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:950; BAP1; Zygosity=Heterozygous (PubMed=21642991).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Ala95Asp (c.284C>A); Zygosity=Heterozygous (PubMed=21642991; PubMed=26011428).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.27%; Native American=0%; East Asian, North=1.66%; East Asian, South=0%; South Asian=0%; European, North=63.32%; European, South=34.76% (PubMed=30894373).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): ATCC=CRL-5946; CLS=300391; Cosmic-CLP=908462; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 17.3,21
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 20
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D6S1043: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 12,15
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   NCI-H2461
AC   CVCL_A536
SY   H2461; H-2461; NCIH2461
DR   EFO; EFO_0006681
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471038
DR   cancercelllines; CVCL_A536
DR   Cell_Model_Passport; SIDM00102
DR   Cosmic; 1032371
DR   Cosmic; 1087353
DR   Cosmic; 1995412
DR   Cosmic-CLP; 1290810
DR   DepMap; ACH-002125
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290810
DR   GEO; GSM1669820
DR   PharmacoDB; NCIH2461_1093_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907976
RX   PubMed=7695406;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro34Arg (c.101C>G); Zygosity=Heterozygous (DepMap=ACH-002125).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.92%; Native American=0.07%; East Asian, North=1.1%; East Asian, South=1.25%; South Asian=0%; European, North=63.28%; European, South=33.37% (PubMed=30894373).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): Cosmic-CLP=1290810; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 11,12
ST   FGA: 20,22
ST   Penta D: 12
ST   Penta E: 10,11
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 15,17 (Cosmic-CLP=1290810)
ST   vWA: 17 (PubMed=25877200)
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   NCI-H249
AC   CVCL_A537
SY   H249; H-249; NCIH249
DR   ATCC; CRL-5827
DR   BioSample; SAMN03151645
DR   BioSample; SAMN03151860
DR   BioSample; SAMN03471746
DR   cancercelllines; CVCL_A537
DR   Cosmic; 755460
DR   Cosmic; 877204
DR   Cosmic; 980931
DR   Cosmic; 1006529
DR   Cosmic; 1021857
DR   Cosmic; 1032397
DR   Cosmic; 2125249
DR   GEO; GSM844646
DR   GEO; GSM845545
DR   GEO; GSM1887907
DR   GEO; GSM1887989
DR   IARC_TP53; 21566
DR   KCLB; 90249
DR   Wikidata; Q54907977
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2985257;
RX   PubMed=3335022;
RX   PubMed=6148444;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20143388;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h249-atcc-crl-5827
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388). Originally thought to originate from the bone marrow of a male patient with small cell lung cancer.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00334.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5827; true.
CC   Discontinued: KCLB; 90249; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5827
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H250
AC   CVCL_1554
SY   H250; H-250; NCIH250
DR   CLO; CLO_0008078
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5828
DR   BioSample; SAMN03471747
DR   cancercelllines; CVCL_1554
DR   Cell_Model_Passport; SIDM00721
DR   ChEMBL-Cells; CHEMBL3308294
DR   ChEMBL-Targets; CHEMBL2366289
DR   Cosmic; 688020
DR   Cosmic; 924241
DR   Cosmic; 1021858
DR   Cosmic-CLP; 924241
DR   DepMap; ACH-002171
DR   EGA; EGAS00001000978
DR   GDSC; 924241
DR   GEO; GSM1670235
DR   GEO; GSM1887908
DR   GEO; GSM1887990
DR   IARC_TP53; 27193
DR   PharmacoDB; NCIH250_1094_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1554
DR   Wikidata; Q54907978
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly840fs (c.2518delG); Zygosity=Heterozygous (Cosmic-CLP=924241; DepMap=ACH-002171).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Homozygous (Cosmic-CLP=924241; DepMap=ACH-002171).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=91.03%; Native American=0.09%; East Asian, North=1.17%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=7.7% (PubMed=30894373).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-5828; Cosmic-CLP=924241
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NCI-H2509
AC   CVCL_A538
SY   H2509; H-2509
DR   Wikidata; Q54907979
RX   PubMed=8806092;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H2527
AC   CVCL_A539
SY   H2527; H-2527
DR   Wikidata; Q54907980
RX   PubMed=8806092;
RX   PubMed=11030152;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   NCI-H2540
AC   CVCL_A540
SY   H2540; H-2540
DR   Wikidata; Q54907982
RX   PubMed=8806092;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   NCI-H2552
AC   CVCL_A541
SY   H2552; H-2552
DR   Wikidata; Q54907983
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   NCI-H2562
AC   CVCL_X977
SY   H2562; H-2562
DR   Wikidata; Q54907984
RX   PubMed=11030152;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   NCI-H2580
AC   CVCL_A542
SY   H2580; H-2580
DR   Wikidata; Q54907985
RX   PubMed=8806092;
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H2591
AC   CVCL_A543
SY   H2591; H-2591; NCIH2591
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471042
DR   cancercelllines; CVCL_A543
DR   Cell_Model_Passport; SIDM00101
DR   Cosmic; 1032379
DR   Cosmic-CLP; 1240131
DR   DepMap; ACH-002126
DR   EGA; EGAS00001000978
DR   GDSC; 1240131
DR   GEO; GSM1669821
DR   PharmacoDB; H2591_423_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907986
RX   PubMed=7695406;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=23830731;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0.61%; South Asian=1.63%; European, North=68.64%; European, South=29.11% (PubMed=30894373).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): Cosmic-CLP=1240131; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 12
ST   D21S11: 30,32.2
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 19,22
ST   Penta D: 12
ST   Penta E: 5,10
ST   TH01: 8
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   NCI-H2594
AC   CVCL_A544
SY   H2594; H-2594
DR   Wikidata; Q54907987
RX   PubMed=8806092;
RX   PubMed=11030152;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NCI-H2595
AC   CVCL_A545
SY   H2595; H-2595; NCIH2595
DR   EFO; EFO_0006682
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471011
DR   cancercelllines; CVCL_A545
DR   Cell_Model_Passport; SIDM00100
DR   Cosmic; 1032381
DR   Cosmic; 1087354
DR   Cosmic-CLP; 1240132
DR   DepMap; ACH-002127
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240132
DR   GEO; GSM1669822
DR   PharmacoDB; NCIH2595_1095_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907988
RX   PubMed=7695406;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,29:02; B*35:01,44:03; C*04:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.03%; Native American=0.21%; East Asian, North=0%; East Asian, South=0.22%; South Asian=2.69%; European, North=64.92%; European, South=31.93% (PubMed=30894373).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): Cosmic-CLP=1240132; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,24
ST   D21S11: 29,31.2
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 7,9
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   Penta D: 13,14
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 33
//
ID   NCI-H2596
AC   CVCL_A546
SY   H2596; H-2596
DR   EFO; EFO_0006683
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471021
DR   Cosmic; 1032390
DR   Cosmic; 1087355
DR   EGA; EGAS00001000610
DR   GDSC; 1240133
DR   PharmacoDB; NCIH2596_1096_2019
DR   Wikidata; Q54907991
RX   PubMed=7695406;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,30:02; B*27:05,49:01; C*02:02,07:06; DQA1*01:02,01:02; DQB1*06:13,06:13; DRB1*13:02,15:01 (PubMed=26589293).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 29,33.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,16
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   NCI-H2597
AC   CVCL_A547
SY   H2597; H-2597
DR   Wikidata; Q54907992
RX   PubMed=8806092;
RX   PubMed=11030152;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   NCI-H2600
AC   CVCL_A548
SY   H2600; H-2600
DR   Wikidata; Q54907993
RX   PubMed=8806092;
RX   PubMed=11030152;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   NCI-H2618
AC   CVCL_A549
SY   H2618; H-2618
DR   Cosmic; 1032391
DR   Wikidata; Q54907994
RX   PubMed=8806092;
RX   PubMed=11030152;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   NCI-H2679
AC   CVCL_A550
SY   H2679; H-2679
DR   Wikidata; Q54907995
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
RX   PubMed=34439128;
RX   PubMed=39154123;
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   NCI-H2691
AC   CVCL_A551
SY   H2691; H-2691
DR   BioSample; SAMN03471020
DR   Cosmic; 1087356
DR   Wikidata; Q54907996
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=23830731;
RX   PubMed=25877200;
CC   Omics: Variations; Array-based CGH.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 21
ST   D21S11: 30,31
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 8,9
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   NCI-H2706
AC   CVCL_A552
SY   H2706; H-2706
DR   Wikidata; Q54907997
RX   PubMed=8806092;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   NCI-H2712
AC   CVCL_Y289
SY   H2712; H-2712
DR   Wikidata; Q54907998
RX   PubMed=11030152;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 3
//
ID   NCI-H2722
AC   CVCL_U994
SY   H2722; H-2722; NCIH2722
DR   EFO; EFO_0006684
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471016
DR   cancercelllines; CVCL_U994
DR   Cell_Model_Passport; SIDM00099
DR   Cosmic; 1995413
DR   Cosmic-CLP; 1290812
DR   DepMap; ACH-002128
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290812
DR   GEO; GSM1669823
DR   PharmacoDB; NCIH2722_1097_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54907999
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,32:03; B*15:01,35:04; C*03:03,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.26%; Native American=1.83%; East Asian, North=0%; East Asian, South=0%; South Asian=2.81%; European, North=57.77%; European, South=37.33% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1290812; PubMed=25877200
ST   Amelogenin: X (PubMed=25877200)
ST   Amelogenin: X,Y (Cosmic-CLP=1290812)
ST   CSF1PO: 10,11
ST   D13S317: 7.2,11 (PubMed=25877200)
ST   D13S317: 11 (Cosmic-CLP=1290812)
ST   D16S539: 13
ST   D18S51: 11,13
ST   D21S11: 29,33.2
ST   D3S1358: 17
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 23
ST   Penta D: 10,13
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 28
//
ID   NCI-H2731
AC   CVCL_U995
SY   H2731; H-2731; NCIH2731
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471019
DR   cancercelllines; CVCL_U995
DR   Cell_Model_Passport; SIDM00098
DR   Cosmic-CLP; 1240134
DR   DepMap; ACH-002129
DR   EGA; EGAS00001000978
DR   GDSC; 1240134
DR   GEO; GSM1669824
DR   PharmacoDB; H2731_426_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908000
RX   PubMed=11030152;
RX   PubMed=23830731;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0%; Native American=0.84%; East Asian, North=1.33%; East Asian, South=0%; South Asian=1.88%; European, North=65.41%; European, South=30.53% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240134; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11 (PubMed=25877200)
ST   D13S317: 11,13 (Cosmic-CLP=1240134)
ST   D16S539: 13
ST   D18S51: 15
ST   D21S11: 30,31.2
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,14
ST   D8S1179: 8,12
ST   FGA: 21
ST   Penta D: 11,12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 25
//
ID   NCI-H2795
AC   CVCL_U996
SY   H2795; H-2795; NCIH2795
DR   EFO; EFO_0006685
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471022
DR   cancercelllines; CVCL_U996
DR   Cell_Model_Passport; SIDM00154
DR   Cosmic; 1995414
DR   Cosmic-CLP; 1290813
DR   DepMap; ACH-002130
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290813
DR   GEO; GSM1669825
DR   PharmacoDB; NCIH2795_1098_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908001
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,68:01; B*35:01,40:01; C*03:04,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.04%; Native American=1.03%; East Asian, North=1.57%; East Asian, South=0%; South Asian=0.85%; European, North=65.63%; European, South=29.89% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1290813; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 11,16
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 18,25
ST   D3S1358: 14,15
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 7,13
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 27
//
ID   NCI-H28
AC   CVCL_1555
SY   H28; H-28; NCIH28; HUT-28; HUT 28; HuT 28; HUT28; Hut28; HuT28
DR   CLO; CLO_0008079
DR   EFO; EFO_0006686
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5820
DR   BioSample; SAMN03471010
DR   BioSample; SAMN10987612
DR   BioSamples; SAMEA100874
DR   cancercelllines; CVCL_1555
DR   Cell_Model_Passport; SIDM00720
DR   ChEMBL-Cells; CHEMBL3308775
DR   ChEMBL-Targets; CHEMBL1075541
DR   Cosmic; 688059
DR   Cosmic; 733814
DR   Cosmic; 877108
DR   Cosmic; 877350
DR   Cosmic; 886387
DR   Cosmic; 908470
DR   Cosmic; 980995
DR   Cosmic; 1032386
DR   Cosmic; 1146909
DR   Cosmic; 1152495
DR   Cosmic; 1481543
DR   Cosmic; 1522766
DR   Cosmic; 1541208
DR   Cosmic; 1749556
DR   Cosmic; 1963325
DR   Cosmic; 1995572
DR   Cosmic; 2474149
DR   Cosmic; 2758840
DR   Cosmic; 2758998
DR   Cosmic; 2759230
DR   Cosmic-CLP; 908470
DR   DepMap; ACH-000648
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10845-111E8
DR   GDSC; 908470
DR   GEO; GSM171870
DR   GEO; GSM171871
DR   GEO; GSM434272
DR   GEO; GSM726267
DR   GEO; GSM794268
DR   GEO; GSM850284
DR   GEO; GSM887425
DR   GEO; GSM888504
DR   GEO; GSM1670236
DR   GEO; GSM1887939
DR   GEO; GSM1887973
DR   IARC_TP53; 21567
DR   IARC_TP53; 23623
DR   IGRhCellID; H28GEO
DR   KCLB; 90028
DR   LiGeA; CCLE_571
DR   PharmacoDB; NCIH28_1099_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1555
DR   PubChem_Cell_line; CVCL_1555
DR   Wikidata; Q54908002
RX   PubMed=1568228;
RX   PubMed=6272398;
RX   PubMed=8183553;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=11070089;
RX   PubMed=11464291;
RX   PubMed=16630136;
RX   PubMed=17270034;
RX   PubMed=20164919;
RX   PubMed=21245096;
RX   PubMed=21642991;
RX   PubMed=22460905;
RX   PubMed=23830731;
RX   PubMed=24926545;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25902174;
RX   PubMed=26011428;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28553954;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   HLA typing: A*02:02,68:01; B*35:118,53:02; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136).
CC   Sequence variation: Gene deletion; HGNC; HGNC:2514; CTNNB1; Zygosity=Homozygous (PubMed=11070089; PubMed=11464291).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Arg146Alafs*48 (c.438-24_438-2del23); Zygosity=Homozygous (PubMed=21642991; PubMed=26011428).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu89His (c.266T>A); ClinVar=VCV000376047; Zygosity=Homozygous (PubMed=8183553; DepMap=ACH-000648).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=65.11%; Native American=0.21%; East Asian, North=3.2%; East Asian, South=0%; South Asian=0%; European, North=16.44%; European, South=15.05% (PubMed=30894373).
CC   Caution: According to ATCC the ethnicity of the donor is White, but exome analysis finds it to be mostly of African lineage.
CC   Caution: It is not clear if this cell line originate from an epithelioid or sarcomatoid mesothelioma as there are contradictory reports concerning its exact nature.
CC   Discontinued: KCLB; 90028; probable.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5820; Cosmic-CLP=908470; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 19
ST   D19S433: 12,14.2
ST   D21S11: 29,30
ST   D2S1338: 18,22
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 19.2,21
ST   Penta D: 9,10
ST   Penta E: 10,16
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   NCI-H2803
AC   CVCL_U997
SY   H2803; H-2803; NCIH2803
DR   EFO; EFO_0006687
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471013
DR   cancercelllines; CVCL_U997
DR   Cell_Model_Passport; SIDM00309
DR   Cosmic; 1995415
DR   Cosmic-CLP; 1240135
DR   DepMap; ACH-002131
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240135
DR   GEO; GSM1669826
DR   PharmacoDB; NCIH2803_1100_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908003
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   HLA typing: A*68:01,68:01; B*35:01,51:01; C*04:04,15:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=59.04%; Native American=0.46%; East Asian, North=1.75%; East Asian, South=0%; South Asian=0.55%; European, North=22.93%; European, South=15.28% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240135; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 21
ST   D21S11: 30,31
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 8,9
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 26
//
ID   NCI-H2804
AC   CVCL_U998
SY   H2804; H-2804; NCIH2804
DR   EFO; EFO_0006688
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471014
DR   cancercelllines; CVCL_U998
DR   Cell_Model_Passport; SIDM00310
DR   Cosmic; 1995416
DR   Cosmic-CLP; 1240136
DR   DepMap; ACH-002132
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240136
DR   GEO; GSM1669827
DR   PharmacoDB; NCIH2804_1101_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908004
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*35:01,51:01; C*04:01,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (Cosmic-CLP=1240136; DepMap=ACH-002132).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.05%; Native American=0%; East Asian, North=2.06%; East Asian, South=0%; South Asian=0%; European, North=68.14%; European, South=28.74% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240136; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9,11
ST   D18S51: 18
ST   D21S11: 28,30
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 29
//
ID   NCI-H2810
AC   CVCL_U999
SY   H2810; H-2810; NCIH2810
DR   EFO; EFO_0006689
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471017
DR   cancercelllines; CVCL_U999
DR   Cell_Model_Passport; SIDM00311
DR   Cosmic-CLP; 1240137
DR   DepMap; ACH-002133
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240137
DR   GEO; GSM1669828
DR   PharmacoDB; NCIH2810_1102_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908005
RX   PubMed=23830731;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:05,24:02; B*35:02,50:01; C*04:01,06:02; DQB1*06:04,06:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.41%; Native American=0.47%; East Asian, North=2.44%; East Asian, South=0.76%; South Asian=5.17%; European, North=28.37%; European, South=60.38% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240137; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 7,12
ST   D8S1179: 13
ST   FGA: 20,21.2
ST   Penta D: 14
ST   Penta E: 8,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 28
//
ID   NCI-H2818
AC   CVCL_V000
SY   H2818; H-2818; NCIH2818
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_V000
DR   Cell_Model_Passport; SIDM00520
DR   Cosmic; 1995417
DR   Cosmic-CLP; 1290814
DR   DepMap; ACH-002134
DR   EGA; EGAS00001000978
DR   GDSC; 1290814
DR   GEO; GSM1669829
DR   PharmacoDB; H2818_431_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908007
RX   PubMed=23830731;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0%; Native American=1.13%; East Asian, North=0%; East Asian, South=0.17%; South Asian=3.55%; European, North=76.08%; European, South=19.07% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1290814
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 24
//
ID   NCI-H285
AC   CVCL_A553
SY   H285; H-285
DR   ATCC; CRL-5829
DR   Wikidata; Q54908008
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Discontinued: ATCC; CRL-5829; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   NCI-H2850
AC   CVCL_Y290
SY   H2850; H-2850
DR   Wikidata; Q54908009
RX   PubMed=11030152;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   NCI-H2869
AC   CVCL_V001
SY   H2869; H-2869; NCIH2869
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_V001
DR   Cell_Model_Passport; SIDM00519
DR   Cosmic; 1995418
DR   Cosmic-CLP; 1240138
DR   DepMap; ACH-002135
DR   EGA; EGAS00001000978
DR   GDSC; 1240138
DR   GEO; GSM1669830
DR   PharmacoDB; H2869_432_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908010
RX   PubMed=23830731;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0.6%; South Asian=0.96%; European, North=63.53%; European, South=34.91% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240138
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 13
ST   D5S818: 12,13
ST   D7S820: 7,8
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 24
//
ID   NCI-H2882
AC   CVCL_5158
SY   H2882; H-2882; NCIH2882
DR   BioSample; SAMN10989611
DR   cancercelllines; CVCL_5158
DR   Cell_Model_Passport; SIDM01385
DR   Cosmic; 755471
DR   Cosmic; 903621
DR   Cosmic; 1146910
DR   DepMap; ACH-000700
DR   GEO; GSM108843
DR   GEO; GSM108844
DR   GEO; GSM253402
DR   GEO; GSM434255
DR   GEO; GSM794368
DR   GEO; GSM817105
DR   IGRhCellID; H2882GEO
DR   Progenetix; CVCL_5158
DR   Wikidata; Q54908011
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=12759538;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 34.8 hours (PubMed=29681454).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S844 ! NCI-BL2882
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   NCI-H2887
AC   CVCL_5159
SY   H2887; H-2887; NCIH2887
DR   BioSample; SAMN10989612
DR   cancercelllines; CVCL_5159
DR   Cell_Model_Passport; SIDM01384
DR   Cosmic; 903622
DR   Cosmic; 1146911
DR   DepMap; ACH-000251
DR   GEO; GSM108845
DR   GEO; GSM108846
DR   GEO; GSM253355
DR   GEO; GSM434256
DR   GEO; GSM794369
DR   GEO; GSM817106
DR   IGRhCellID; H2887GEO
DR   NCI-DTP; NCI-H2887
DR   Progenetix; CVCL_5159
DR   Wikidata; Q54908012
RX   PubMed=10987304;
RX   PubMed=11314036;
RX   PubMed=12759538;
RX   PubMed=20624269;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=31803961;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 43.1 hours (PubMed=29681454).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (DepMap=ACH-000251).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Homozygous (DepMap=ACH-000251).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 6,9.3
ST   TPOX: 12
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S845 ! NCI-BL2887
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   NCI-H289
AC   CVCL_A554
SY   H289; H-289
DR   Cosmic; 877205
DR   Cosmic; 1021859
DR   Cosmic; 1320183
DR   Cosmic; 2699653
DR   GEO; GSM171872
DR   GEO; GSM171873
DR   GEO; GSM794279
DR   Wikidata; Q54908013
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10987304;
RX   PubMed=11030152;
RX   PubMed=11314036;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=31803961;
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E095 ! NCI-BL289
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-H290
AC   CVCL_A555
SY   H290; H-290; HUT-290; Hut-290; HUT 290; HUT290
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471037
DR   cancercelllines; CVCL_A555
DR   Cell_Model_Passport; SIDM00518
DR   Cosmic; 733817
DR   Cosmic; 877270
DR   Cosmic; 877403
DR   Cosmic; 886389
DR   Cosmic; 980996
DR   Cosmic; 1032387
DR   Cosmic; 1152498
DR   Cosmic; 1995419
DR   Cosmic; 2758841
DR   Cosmic; 2759212
DR   Cosmic-CLP; 1240139
DR   DepMap; ACH-002136
DR   EGA; EGAS00001000978
DR   GDSC; 1240139
DR   GEO; GSM794280
DR   GEO; GSM817069
DR   GEO; GSM850298
DR   GEO; GSM1669831
DR   IARC_TP53; 23625
DR   KCLB; 90290
DR   PharmacoDB; H290_433_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908014
RX   PubMed=1568228;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=16630136;
RX   PubMed=20679594;
RX   PubMed=21245096;
RX   PubMed=23830731;
RX   PubMed=25877200;
RX   PubMed=26011428;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28553954;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Homozygous (PubMed=16630136).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0.1%; Native American=0.64%; East Asian, North=0%; East Asian, South=0.75%; South Asian=2.62%; European, North=66.44%; European, South=29.45% (PubMed=30894373).
CC   Discontinued: KCLB; 90290; probable.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1240139; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 28,31.2
ST   D2S1338: 17,19
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   Penta D: 11,12
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 34
//
ID   NCI-H292
AC   CVCL_0455
SY   H292; H-292; NCI-HUT-292; Hut292; NCIH292
DR   BTO; BTO_0002418
DR   CLO; CLO_0008080
DR   EFO; EFO_0006690
DR   MCCL; MCC:0000353
DR   CLDB; cl3653
DR   CLDB; cl3654
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1848
DR   BCRC; 60372
DR   BCRJ; 0187
DR   BioSample; SAMN03471312
DR   BioSample; SAMN10988040
DR   cancercelllines; CVCL_0455
DR   CCRID; 1101HUM-PUMC000233
DR   CCRID; 3101HUMSCSP582
DR   CCRID; 3101HUMTCHu122
DR   CCTCC; GDC0211
DR   Cell_Model_Passport; SIDM00493
DR   ChEMBL-Cells; CHEMBL3308637
DR   ChEMBL-Targets; CHEMBL614733
DR   CLS; 305040
DR   Cosmic; 753604
DR   Cosmic; 844598
DR   Cosmic; 877404
DR   Cosmic; 1017828
DR   Cosmic; 1047099
DR   Cosmic; 1152499
DR   Cosmic; 1188584
DR   Cosmic; 1288262
DR   Cosmic; 1466803
DR   Cosmic; 1519249
DR   Cosmic; 1520933
DR   Cosmic; 1520947
DR   Cosmic; 1870272
DR   Cosmic; 1995573
DR   Cosmic; 2058648
DR   Cosmic; 2630420
DR   Cosmic; 2668261
DR   Cosmic-CLP; 753604
DR   DepMap; ACH-000474
DR   DepMap; ACH-001075
DR   ECACC; 91091815
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 753604
DR   GEO; GSM206489
DR   GEO; GSM274745
DR   GEO; GSM274746
DR   GEO; GSM784237
DR   GEO; GSM794281
DR   GEO; GSM888505
DR   GEO; GSM1670237
DR   GEO; GSM2231213
DR   IARC_TP53; 21568
DR   ICLC; HTL96009
DR   KCB; KCB 200822YJ
DR   KCLB; 21848
DR   LiGeA; CCLE_170
DR   Lonza; 1440
DR   PharmacoDB; NCIH292_1103_2019
DR   PRIDE; PXD003086
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0455
DR   PubChem_Cell_line; CVCL_0455
DR   SKY/M-FISH/CGH; 2844
DR   Ubigene; YC-B006
DR   Wikidata; Q54908015
RX   PubMed=1311061;
RX   PubMed=3335022;
RX   PubMed=8806092;
RX   PubMed=12539049;
RX   PubMed=15193437;
RX   PubMed=17332333;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   HLA typing: A*68:02,74:01; B*15:17,58:01; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (PubMed=12539049; PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Pro496Thrfs*8 (c.1484_1485insA); Zygosity=Heterozygous (Cosmic-CLP=753604; DepMap=ACH-001075).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=81.43%; Native American=0.17%; East Asian, North=2.03%; East Asian, South=0%; South Asian=0.28%; European, North=6.04%; European, South=10.06% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-000474; true.
CC   Discontinued: KCLB; 21848; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-1848; CCRID; Cosmic-CLP=753604; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 14,17
ST   D12S391: 16,20
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 16
ST   D19S433: 12,13.2
ST   D1S1656: 14,15.3
ST   D21S11: 28
ST   D22S1045: 17
ST   D2S1338: 21,24
ST   D2S441: 11,12
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 22,26
ST   Penta D: 9
ST   Penta E: 13,15
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16 (CCRID)
ST   vWA: 16,17 (ATCC=CRL-1848; Cosmic-CLP=753604; PubMed=25877200; Technion Genomics Center)
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   NCI-H292-Luc
AC   CVCL_D7FF
DR   Ubigene; YC-B006-Luc-P
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Pro496Thrfs*8 (c.1484_1485insA); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0455 ! NCI-H292
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   NCI-H2925
AC   CVCL_Y291
SY   H2925; H-2925
DR   Wikidata; Q54908016
RX   PubMed=11030152;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   NCI-H295
AC   CVCL_0456
SY   H295; H-295; NCI-H-295
DR   BTO; BTO_0002587
DR   CLO; CLO_0008081
DR   MCCL; MCC:0000502
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-10296
DR   BCRC; 60354
DR   BioSample; SAMN03471298
DR   cancercelllines; CVCL_0456
DR   Cosmic; 684682
DR   Cosmic; 908466
DR   Cosmic; 1179076
DR   Cosmic; 2239455
DR   Cosmic; 2364100
DR   TOKU-E; 2687
DR   Wikidata; Q28226675
RX   Patent=US5792657;
RX   PubMed=2386954;
RX   PubMed=8056157;
RX   PubMed=8404594;
RX   PubMed=8806089;
RX   PubMed=8806092;
RX   PubMed=15541570;
RX   PubMed=20164919;
RX   PubMed=21924324;
RX   PubMed=22266826;
RX   PubMed=35764904;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-402.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10296.
CC   Population: Caribbean; Bahamas.
CC   Characteristics: Tumorigenic in nude mice (PubMed=2386954).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (ATCC=CRL-10296).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-10296; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): ATCC=CRL-10296
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 32
//
ID   NCI-H295A
AC   CVCL_0457
SY   H295A; H-295A
DR   BTO; BTO_0005669
DR   MCCL; MCC:0000354
DR   cancercelllines; CVCL_0457
DR   Wikidata; Q54908017
RX   PubMed=9024219;
RX   PubMed=15541570;
RX   PubMed=18000308;
RX   PubMed=21924324;
RX   PubMed=22266826;
CC   Population: Caribbean; Bahamas.
CC   Characteristics: Grows as monolayer.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0456 ! NCI-H295
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   NCI-H295R
AC   CVCL_0458
SY   NCI H295R; NCIH295R; H295R; H-295R; H295R-S1
DR   BTO; BTO_0002588
DR   CLO; CLO_0008082
DR   EFO; EFO_0002289
DR   MCCL; MCC:0000355
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2128
DR   cancercelllines; CVCL_0458
DR   CCRID; 1101HUM-PUMC000256
DR   CCRID; 5301HUM-KCB15009YJ
DR   ChEMBL-Cells; CHEMBL3307998
DR   ChEMBL-Targets; CHEMBL612593
DR   CLS; 300483
DR   Cosmic; 1172633
DR   Cosmic; 1191070
DR   Cosmic; 1622873
DR   Cosmic; 2364101
DR   Cosmic; 2574494
DR   IGRhCellID; NCIH295R
DR   KCB; KCB 2015009YJ
DR   Lonza; 378
DR   Progenetix; CVCL_0458
DR   PubChem_Cell_line; CVCL_0458
DR   Wikidata; Q25323725
RX   PubMed=15541570;
RX   PubMed=18000308;
RX   PubMed=20215515;
RX   PubMed=21924324;
RX   PubMed=22266826;
RX   PubMed=23951072;
RX   PubMed=29371329;
RX   PubMed=33981288;
RX   PubMed=34572026;
RX   PubMed=35563746;
RX   PubMed=35764904;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/H295R
CC   Population: Caribbean; Bahamas.
CC   Characteristics: Grows in a medium called Nu-Serum type I.
CC   Doubling time: 25 hours (PubMed=29371329).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): ATCC=CRL-2128; CCRID; CLS=300483
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 32.2
ST   D2S1338: 25
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 19.2,24
ST   Penta D: 8
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0456 ! NCI-H295
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 31
//
ID   NCI-H295R-S2
AC   CVCL_S901
SY   H295R-S2
DR   cancercelllines; CVCL_S901
DR   Wikidata; Q54908018
RX   PubMed=21924324;
RX   PubMed=22266826;
CC   Population: Caribbean; Bahamas.
CC   Characteristics: Grows in a medium called Nu-Serum type I with a serum substitute called Ultroser-G (PubMed=22266826).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0456 ! NCI-H295
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 14
//
ID   NCI-H295R-S3
AC   CVCL_S902
SY   H295R-S3
DR   cancercelllines; CVCL_S902
DR   Wikidata; Q54908020
RX   PubMed=21924324;
RX   PubMed=22266826;
CC   Population: Caribbean; Bahamas.
CC   Characteristics: Grows in a serum called Hyclone Cosmic Calf (PubMed=22266826).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0456 ! NCI-H295
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 14
//
ID   NCI-H2973
AC   CVCL_E105
SY   H2973; H-2973
DR   Wikidata; Q54908022
RX   PubMed=11030152;
RX   PubMed=12759538;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 8
//
ID   NCI-H298
AC   CVCL_A556
SY   H298; H-298
DR   Wikidata; Q54908023
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H3026
AC   CVCL_Y292
SY   H3026; H-3026
DR   Wikidata; Q54908024
RX   PubMed=11030152;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   NCI-H3030
AC   CVCL_Y293
SY   H3030; H-3030
DR   Wikidata; Q54908025
RX   PubMed=11030152;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   NCI-H3072
AC   CVCL_Y294
SY   H3072; H-3072
DR   Wikidata; Q54908026
RX   PubMed=11030152;
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   NCI-H3118
AC   CVCL_A464
SY   H3118; H-3118
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 961
DR   cancercelllines; CVCL_A464
DR   Cell_Model_Passport; SIDM00517
DR   Cosmic; 1288269
DR   Cosmic; 1519250
DR   Cosmic-CLP; 1240140
DR   DepMap; ACH-002239
DR   EGA; EGAS00001000978
DR   GDSC; 1240140
DR   GEO; GSM1132852
DR   GEO; GSM1132853
DR   GEO; GSM1132854
DR   GEO; GSM1132855
DR   GEO; GSM1132862
DR   GEO; GSM1132863
DR   GEO; GSM1132864
DR   GEO; GSM1132865
DR   GEO; GSM1132866
DR   GEO; GSM1132867
DR   GEO; GSM1669832
DR   PharmacoDB; H3118_434_2019
DR   PRIDE; PXD030304
DR   SKY/M-FISH/CGH; 2845
DR   Wikidata; Q54908027
RX   PubMed=11030152;
RX   PubMed=12539049;
RX   PubMed=15193437;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (PubMed=12539049).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=1240140; DepMap=ACH-002239).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.85%; Native American=0.01%; East Asian, North=2.51%; East Asian, South=0%; South Asian=3.02%; European, North=59.54%; European, South=34.08% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240140
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 28
//
ID   NCI-H3122
AC   CVCL_5160
SY   H3122; H-3122; NCIH3122
DR   CLO; CLO_0037033
DR   EFO; EFO_0022675
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 962
DR   BioSample; SAMN10989614
DR   cancercelllines; CVCL_5160
DR   Cell_Model_Passport; SIDM00137
DR   ChEMBL-Cells; CHEMBL4295436
DR   ChEMBL-Targets; CHEMBL4296475
DR   CLS; 300484
DR   Cosmic; 755472
DR   Cosmic; 914951
DR   Cosmic; 1146912
DR   Cosmic; 2245571
DR   Cosmic-CLP; 1240190
DR   DepMap; ACH-000337
DR   EGA; EGAS00001000082
DR   EGA; EGAS00001000978
DR   GDSC; 1240190
DR   GEO; GSM171874
DR   GEO; GSM171875
DR   GEO; GSM253349
DR   GEO; GSM434307
DR   GEO; GSM794370
DR   GEO; GSM817107
DR   GEO; GSM1374739
DR   GEO; GSM1374740
DR   GEO; GSM1670238
DR   IGRhCellID; H3122GEO
DR   LINCS_LDP; LCL-1675
DR   NCI-DTP; NCI-H3122
DR   PharmacoDB; NCIH3122_1104_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_5160
DR   PubChem_Cell_line; CVCL_5160
DR   Wikidata; Q54908028
RX   DOI=10.1101/2022.06.08.495301;
RX   PubMed=11030152;
RX   PubMed=12759538;
RX   PubMed=18594010;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=23344087;
RX   PubMed=24675041;
RX   PubMed=26361996;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 48.5 hours (PubMed=29681454).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E13A20 v1 fusion (PubMed=18594010; DOI=10.1101/2022.06.08.495301; DepMap=ACH-000337).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.36%; East Asian, South=0%; South Asian=1.48%; European, North=65.9%; European, South=31.26% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300484; Cosmic-CLP=1240190; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 18,21
ST   Penta D: 10,13
ST   Penta E: 12
ST   TH01: 7,9.3
ST   TPOX: 10
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   NCI-H3122-CHR-A1
AC   CVCL_4Y37
SY   H3122-CHR-A1; H3122 CHR-A1
DR   Cosmic; 2245572
DR   Wikidata; Q54872052
RX   PubMed=25228534;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_62268; Alectinib (CH5424802; RO5424802; AF-802).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5160 ! NCI-H3122
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   NCI-H3122-CR1
AC   CVCL_AY53
AS   CVCL_VJ82
SY   NCI-H3122 CR1; H3122 CR1
DR   Cosmic; 1860358
DR   Wikidata; Q54872053
RX   PubMed=21502504;
RX   PubMed=23344087;
RX   PubMed=24675041;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5160 ! NCI-H3122
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 9
//
ID   NCI-H3123
AC   CVCL_Y295
SY   H3123; H-3123
DR   Wikidata; Q54908029
RX   PubMed=11030152;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 3
//
ID   NCI-H3166
AC   CVCL_X979
SY   H3166; H-3166
DR   Wikidata; Q54908030
RX   PubMed=11030152;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   NCI-H3211
AC   CVCL_X978
SY   H3211; H-3211
DR   Wikidata; Q54908032
RX   PubMed=11030152;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   NCI-H322
AC   CVCL_1556
SY   H322; H-322; H322T; NCI-H322T; NCIH322T; NCI-322; NCIH322
DR   BTO; BTO_0003007
DR   CLO; CLO_0008083
DR   EFO; EFO_0006691
DR   CLDB; cl3655
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5806
DR   BioGRID_ORCS_Cell_line; 525
DR   BioSample; SAMN03471699
DR   BioSample; SAMN03471740
DR   BioSample; SAMN03473287
DR   BioSample; SAMN10987678
DR   cancercelllines; CVCL_1556
DR   ChEMBL-Cells; CHEMBL3307405
DR   ChEMBL-Targets; CHEMBL614573
DR   Cosmic; 687822
DR   Cosmic; 801589
DR   Cosmic; 844830
DR   Cosmic; 876143
DR   Cosmic; 903571
DR   Cosmic; 917976
DR   Cosmic; 929972
DR   Cosmic; 932922
DR   Cosmic; 934547
DR   Cosmic; 980962
DR   Cosmic; 1028935
DR   Cosmic; 1032434
DR   Cosmic; 1146913
DR   Cosmic; 1152500
DR   Cosmic; 1239903
DR   Cosmic; 1802317
DR   Cosmic; 1870261
DR   Cosmic; 1891884
DR   Cosmic; 2042867
DR   Cosmic; 2125250
DR   Cosmic; 2648438
DR   Cosmic; 2668312
DR   DepMap; ACH-000837
DR   ECACC; 95111734
DR   EGA; EGAS00001000610
DR   GEO; GSM171876
DR   GEO; GSM171877
DR   GEO; GSM206490
DR   GEO; GSM253358
DR   GEO; GSM274757
DR   GEO; GSM274758
DR   GEO; GSM434333
DR   GEO; GSM784245
DR   GEO; GSM794282
DR   GEO; GSM817070
DR   GEO; GSM827434
DR   GEO; GSM887426
DR   GEO; GSM888506
DR   GEO; GSM1374741
DR   IARC_TP53; 516
DR   IGRhCellID; NCIH322
DR   KCLB; 90322
DR   LiGeA; CCLE_305
DR   LINCS_LDP; LCL-1798
DR   PharmacoDB; NCIH322_1105_2019
DR   Progenetix; CVCL_1556
DR   PubChem_Cell_line; CVCL_1556
DR   Wikidata; Q54908033
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=2386953;
RX   PubMed=2388294;
RX   PubMed=3335022;
RX   PubMed=7972006;
RX   PubMed=8806092;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=11416159;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20679594;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 50.6 hours (PubMed=29681454).
CC   HLA typing: A*29:02,29:02; B*40:01,44:03; C*16:01,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=10536175; PubMed=20557307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.01%; Native American=0%; East Asian, North=2.38%; East Asian, South=0%; South Asian=0%; European, North=68.65%; European, South=27.95% (PubMed=30894373).
CC   Caution: We are not certain that NCI-H322 and NCI-H322M are identical.
CC   Discontinued: ATCC; CRL-5806; true.
CC   Discontinued: KCLB; 90322; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
ST   Source(s): ATCC=CRL-5806; ECACC=95111734; PubMed=11416159; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X (PubMed=25877200)
ST   Amelogenin: X,Y (ATCC=CRL-5806; ECACC=95111734; PubMed=11416159; PubMed=20679594)
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   NCI-H322M
AC   CVCL_1557
SY   NCI.H322M; H322M; H-322M; H-322m
DR   BTO; BTO_0004182
DR   CLO; CLO_0037034
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 963
DR   cancercelllines; CVCL_1557
DR   Cell_Model_Passport; SIDM00117
DR   ChEMBL-Cells; CHEMBL3307710
DR   ChEMBL-Targets; CHEMBL614803
DR   Cosmic; 875851
DR   Cosmic; 905967
DR   Cosmic; 974293
DR   Cosmic; 1092620
DR   Cosmic; 1175865
DR   Cosmic; 1305348
DR   Cosmic; 1312333
DR   Cosmic; 1995574
DR   Cosmic; 1998462
DR   Cosmic; 2772153
DR   Cosmic-CLP; 905967
DR   DepMap; ACH-002172
DR   EGA; EGAS00001000978
DR   GDSC; 905967
DR   GEO; GSM2131
DR   GEO; GSM50215
DR   GEO; GSM50278
DR   GEO; GSM434296
DR   GEO; GSM743454
DR   GEO; GSM750802
DR   GEO; GSM799342
DR   GEO; GSM799405
DR   GEO; GSM1153413
DR   GEO; GSM1181269
DR   GEO; GSM1181316
DR   GEO; GSM1374742
DR   GEO; GSM1670239
DR   GEO; GSM2124675
DR   IARC_TP53; 21407
DR   IGRhCellID; H322M_03GEO
DR   LINCS_LDP; LCL-1674
DR   NCI-DTP; NCI-H322M
DR   PharmacoDB; NCIH322M_1106_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1557
DR   PubChem_Cell_line; CVCL_1557
DR   SKY/M-FISH/CGH; 2797
DR   Wikidata; Q54908034
RX   PubMed=2041050;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=11
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 35.3 hours (NCI-DTP=NCI-H322M).
CC   HLA typing: A*29:02; B*44:03:01; C*16:01; DPB1*04:01; DQB1*02:02; DRB1*07:01 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=9331090; PubMed=17088437).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.44%; Native American=0%; East Asian, North=0.73%; East Asian, South=0.88%; South Asian=0%; European, North=72.75%; European, South=25.2% (PubMed=30894373).
CC   Caution: We are not certain that NCI-H322 and NCI-H322M are identical.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
ST   Source(s): Cosmic-CLP=905967; PubMed=19372543
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 19,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1556 ! NCI-H322
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 42
//
ID   NCI-H324
AC   CVCL_3953
SY   H324; H-324
DR   BTO; BTO_0003005
DR   cancercelllines; CVCL_3953
DR   Cosmic; 844594
DR   Cosmic; 877238
DR   Cosmic; 877406
DR   Cosmic; 903572
DR   Cosmic; 1152501
DR   Cosmic; 1891885
DR   GEO; GSM794283
DR   GEO; GSM817071
DR   IARC_TP53; 517
DR   Wikidata; Q54908035
RX   PubMed=1311061;
RX   PubMed=3335022;
RX   PubMed=3940644;
RX   PubMed=6148444;
RX   PubMed=8806092;
RX   PubMed=20679594;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 47 hours (Note=In RPMI 1640 + 10% FBS), 122 hours (Note=In ACL-3 + BSA) (PubMed=3940644).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Unspecified (PubMed=1311061).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Val (c.776A>T); ClinVar=VCV000485034; Zygosity=Unspecified (PubMed=1311061).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20679594
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   NCI-H3255
AC   CVCL_6831
SY   H3255; H-3255; H3255_DA; NCIH3255
DR   BTO; BTO_0006539
DR   EFO; EFO_0003123
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2882
DR   BioSample; SAMN03471808
DR   BioSample; SAMN10988059
DR   cancercelllines; CVCL_6831
DR   Cell_Model_Passport; SIDM00046
DR   ChEMBL-Cells; CHEMBL4295484
DR   ChEMBL-Targets; CHEMBL4296476
DR   Cosmic; 897734
DR   Cosmic; 903623
DR   Cosmic; 914952
DR   Cosmic; 1028937
DR   Cosmic; 1128245
DR   Cosmic; 1146914
DR   Cosmic; 2647633
DR   Cosmic-CLP; 1247873
DR   DepMap; ACH-000109
DR   DepMap; ACH-002137
DR   EGA; EGAS00001000978
DR   GDSC; 1247873
DR   GEO; GSM63349
DR   GEO; GSM108847
DR   GEO; GSM108848
DR   GEO; GSM253411
DR   GEO; GSM434297
DR   GEO; GSM794371
DR   GEO; GSM817108
DR   GEO; GSM827356
DR   GEO; GSM1374743
DR   GEO; GSM1669833
DR   IARC_TP53; 28350
DR   IGRhCellID; H3255_DAGEO
DR   LiGeA; CCLE_545
DR   NCI-DTP; NCI-H3255
DR   PharmacoDB; NCIH3255_1108_2019
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_6831
DR   PubChem_Cell_line; CVCL_6831
DR   Wikidata; Q54908036
RX   PubMed=11030152;
RX   PubMed=12759538;
RX   PubMed=16187286;
RX   PubMed=20215515;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=26202522;
RX   PubMed=26361996;
RX   PubMed=26554430;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,03:01; B*37:01,41:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>A; ClinVar=VCV000634769; Zygosity=Unspecified; Note=Splice acceptor mutation (DepMap=ACH-000109).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.63%; Native American=0%; East Asian, North=2.06%; East Asian, South=0%; South Asian=0%; European, North=59.85%; European, South=34.46% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-2882; true.
CC   Discontinued: DepMap; ACH-002137; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2882; Cosmic-CLP=1247873; PubMed=20679594
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 11,13
ST   D16S539: 8
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   NCI-H3255DR
AC   CVCL_DI56
SY   H3255DR
DR   Wikidata; Q54908037
RX   PubMed=20118985;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DI55 ! NCI-H3255GR
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 6
//
ID   NCI-H3255GR
AC   CVCL_DI55
SY   H3255GR; H3255 GR
DR   Cosmic; 1128246
DR   Wikidata; Q54908038
RX   PubMed=16906227;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6831 ! NCI-H3255
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 6
//
ID   NCI-H3282
AC   CVCL_X980
SY   H3282; H-3282
DR   BTO; BTO_0006565
DR   Wikidata; Q54908039
RX   PubMed=11030152;
RX   PubMed=31803961;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 8
//
ID   NCI-H345
AC   CVCL_1558
SY   H345; H-345; NCI H345; NCIH345
DR   BTO; BTO_0003019
DR   CLO; CLO_0008084
DR   EFO; EFO_0006692
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-180
DR   BioSample; SAMN03471018
DR   BioSample; SAMN03472734
DR   cancercelllines; CVCL_1558
DR   Cell_Model_Passport; SIDM00719
DR   ChEMBL-Cells; CHEMBL3307324
DR   ChEMBL-Targets; CHEMBL614195
DR   Cosmic; 688021
DR   Cosmic; 755464
DR   Cosmic; 844551
DR   Cosmic; 850440
DR   Cosmic; 877206
DR   Cosmic; 877355
DR   Cosmic; 1006525
DR   Cosmic; 1021860
DR   Cosmic; 1152465
DR   Cosmic; 1219101
DR   Cosmic; 1239938
DR   Cosmic; 2125251
DR   Cosmic-CLP; 688021
DR   DepMap; ACH-001364
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 688021
DR   GEO; GSM169441
DR   GEO; GSM170742
DR   GEO; GSM170743
DR   GEO; GSM380512
DR   GEO; GSM784200
DR   GEO; GSM794284
DR   GEO; GSM844647
DR   GEO; GSM1670240
DR   GEO; GSM1887909
DR   GEO; GSM1887991
DR   IARC_TP53; 21570
DR   LINCS_LDP; LCL-1854
DR   PharmacoDB; NCIH345_1109_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1558
DR   PubChem_Cell_line; CVCL_1558
DR   Wikidata; Q54908040
RX   PubMed=1320893;
RX   PubMed=1563005;
RX   PubMed=2985257;
RX   PubMed=6148444;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,23:01; B*58:05; C*02:02,07:01 (PubMed=25960936).
CC   HLA typing: A*02:01,23:01; B*07:55,58:05; C*02:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Homozygous (PubMed=20557307; ATCC=HTB-180).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.67%; Native American=0.71%; East Asian, North=2.16%; East Asian, South=1.53%; South Asian=7.19%; European, North=25.58%; European, South=61.17% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=HTB-180; Cosmic-CLP=688021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 8
ST   D18S51: 12,13
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12 (ATCC=HTB-180; Cosmic-CLP=688021)
ST   D5S818: 12 (PubMed=25877200)
ST   D7S820: 9,13
ST   D8S1179: 14,16
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 14
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H358
AC   CVCL_1559
SY   H358; H-358; NCIH358
DR   BTO; BTO_0002835
DR   CLO; CLO_0008085
DR   EFO; EFO_0002291
DR   CLDB; cl3656
DR   AddexBio; C0016016/4968
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5807
DR   BioGRID_ORCS_Cell_line; 964
DR   BioSample; SAMN03471313
DR   BioSample; SAMN10987886
DR   cancercelllines; CVCL_1559
DR   CCRID; 1101HUM-PUMC000470
DR   CCRID; 3101HUMSCSP583
DR   CCRID; 3101HUMTCHu151
DR   Cell_Model_Passport; SIDM00718
DR   ChEMBL-Cells; CHEMBL3307543
DR   ChEMBL-Targets; CHEMBL614135
DR   CLS; 300430
DR   Cosmic; 722039
DR   Cosmic; 724875
DR   Cosmic; 877106
DR   Cosmic; 903573
DR   Cosmic; 908465
DR   Cosmic; 910563
DR   Cosmic; 914944
DR   Cosmic; 929970
DR   Cosmic; 934545
DR   Cosmic; 980963
DR   Cosmic; 1004699
DR   Cosmic; 1028934
DR   Cosmic; 1032435
DR   Cosmic; 1052333
DR   Cosmic; 1146915
DR   Cosmic; 1219075
DR   Cosmic; 1239902
DR   Cosmic; 1600603
DR   Cosmic; 1741780
DR   Cosmic; 1802307
DR   Cosmic; 1870273
DR   Cosmic; 1995575
DR   Cosmic; 2042868
DR   Cosmic; 2560229
DR   Cosmic; 2630418
DR   Cosmic; 2647632
DR   Cosmic; 2668265
DR   Cosmic-CLP; 908465
DR   DepMap; ACH-000860
DR   ECACC; 95111733
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10709-109H7
DR   GDSC; 908465
DR   GEO; GSM108849
DR   GEO; GSM108850
DR   GEO; GSM206491
DR   GEO; GSM253398
DR   GEO; GSM274731
DR   GEO; GSM274732
DR   GEO; GSM385520
DR   GEO; GSM385531
DR   GEO; GSM434257
DR   GEO; GSM513937
DR   GEO; GSM514321
DR   GEO; GSM784251
DR   GEO; GSM794285
DR   GEO; GSM817072
DR   GEO; GSM827468
DR   GEO; GSM844648
DR   GEO; GSM887427
DR   GEO; GSM888507
DR   GEO; GSM1374744
DR   GEO; GSM1670241
DR   IARC_TP53; 21571
DR   IARC_TP53; 21723
DR   IGRhCellID; NCIH358
DR   KCLB; 25807
DR   KCLB; 90358
DR   LiGeA; CCLE_423
DR   LINCS_LDP; LCL-1671
DR   Lonza; 729
DR   NCI-DTP; NCI-H358
DR   PharmacoDB; NCIH358_1110_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1559
DR   PubChem_Cell_line; CVCL_1559
DR   Wikidata; Q54908041
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=2386953;
RX   PubMed=2388294;
RX   PubMed=3335022;
RX   PubMed=3940644;
RX   PubMed=7972006;
RX   PubMed=8806092;
RX   PubMed=8806101;
RX   PubMed=9649128;
RX   PubMed=11030152;
RX   PubMed=11369051;
RX   PubMed=11464291;
RX   PubMed=12068308;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=34320349;
RX   PubMed=35117401;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-368.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 38 hours (Note=In RPMI 1640 + 10% FBS), 76 hours (Note=In ACL-3), 60 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 38 hours (PubMed=29681454); 38 hours (ECACC=95111733).
CC   HLA typing: A*03:01,03:01; B*15:01,35:01; C*03:04,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr75Ala (c.223A>G); Zygosity=Heterozygous (PubMed=11464291; DepMap=ACH-000860).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=1311061; PubMed=9649128; PubMed=12068308).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.45%; Native American=0%; East Asian, North=4.63%; East Asian, South=0%; South Asian=0%; European, North=56.1%; European, South=35.82% (PubMed=30894373).
CC   Caution: NCI-H358 and NCI-H358M (Cellosaurus=CVCL_JA53) could be identical.
CC   Misspelling: H1358; PubMed=1311061; Note=In table 1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
ST   Source(s): AddexBio=C0016016/4968; ATCC=CRL-5807; CCRID; CLS=300430; Cosmic-CLP=908465; ECACC=95111733; KCLB=25807; KCLB=90358; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 20
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 14
ST   D19S433: 13,14
ST   D1S1656: 15,15.3
ST   D21S11: 28,30
ST   D22S1045: 11,15
ST   D2S1338: 17,23
ST   D2S441: 11,15
ST   D3S1358: 14,18
ST   D5S818: 10,12
ST   D6S1043: 14
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   DYS391: 10
ST   FGA: 20,21
ST   Penta D: 10,13
ST   Penta E: 18
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 51
//
ID   NCI-H358a
AC   CVCL_VK07
SY   H358a
DR   cancercelllines; CVCL_VK07
DR   Wikidata; Q95993568
RX   PubMed=8089864;
RX   PubMed=8280799;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr75Ala (c.223A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1559 ! NCI-H358
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 13
//
ID   NCI-H358M
AC   CVCL_JA53
SY   NCIH358M; H358M
DR   cancercelllines; CVCL_JA53
DR   NCI-DTP; NCI-H358M
DR   Wikidata; Q54908042
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Thr75Ala (c.223A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Caution: NCI-H358 (Cellosaurus=CVCL_1559) and NCI-H358M could be identical.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1559 ! NCI-H358
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   NCI-H360
AC   CVCL_A557
SY   H360; H-360
DR   Cosmic; 1152466
DR   Wikidata; Q54908043
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 15
//
ID   NCI-H369
AC   CVCL_A558
SY   H369; H-369
DR   Wikidata; Q54908044
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H372
AC   CVCL_A559
SY   H372; H-372
DR   Cosmic; 844552
DR   Cosmic; 1152467
DR   Wikidata; Q54908045
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   NCI-H378
AC   CVCL_1560
SY   H378; H-378; NCIH378
DR   CLO; CLO_0008086
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5808
DR   BioSample; SAMN03471741
DR   cancercelllines; CVCL_1560
DR   Cell_Model_Passport; SIDM00915
DR   ChEMBL-Cells; CHEMBL3308295
DR   ChEMBL-Targets; CHEMBL2366088
DR   Cosmic; 688022
DR   Cosmic; 850428
DR   Cosmic; 877207
DR   Cosmic; 877356
DR   Cosmic; 980932
DR   Cosmic; 1021861
DR   Cosmic; 1032398
DR   Cosmic; 1152468
DR   Cosmic; 1995576
DR   Cosmic-CLP; 688022
DR   DepMap; ACH-002173
DR   EGA; EGAS00001000978
DR   GDSC; 688022
DR   GEO; GSM171878
DR   GEO; GSM171879
DR   GEO; GSM794286
DR   GEO; GSM844649
DR   GEO; GSM845546
DR   GEO; GSM1670242
DR   GEO; GSM1887891
DR   GEO; GSM1887974
DR   IARC_TP53; 21572
DR   IGRhCellID; NCIH378
DR   KCLB; 90378
DR   PharmacoDB; NCIH378_1111_2019
DR   Progenetix; CVCL_1560
DR   PubChem_Cell_line; CVCL_1560
DR   Wikidata; Q54908046
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22961666;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=39154123;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (ATCC=CRL-5808; Cosmic-CLP=688022).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.92%; Native American=1.24%; East Asian, North=1.45%; East Asian, South=1.89%; South Asian=8.06%; European, North=26.04%; European, South=58.4% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5808; Cosmic-CLP=688022
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 20,32.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 12,14
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A560 ! NCI-H379
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   NCI-H379
AC   CVCL_A560
SY   H379; H-379
DR   Wikidata; Q54908047
RX   PubMed=8806092;
RX   PubMed=8806103;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1560 ! NCI-H378
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 14
//
ID   NCI-H432
AC   CVCL_A563
SY   H432; H-432
DR   Wikidata; Q54908048
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A564 ! NCI-H433
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   NCI-H433
AC   CVCL_A564
SY   H433; H-433
DR   Cosmic; 1152469
DR   Wikidata; Q54908049
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A563 ! NCI-H432
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   NCI-H441
AC   CVCL_1561
SY   H441; H-441; NCI-H441-4; NCI-441; NCIH441
DR   BTO; BTO_0001910
DR   CLO; CLO_0008087
DR   EFO; EFO_0002292
DR   AddexBio; C0016019/4975
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRM-HTB-174
DR   ATCC; HTB-174
DR   BCRC; 60455
DR   BCRJ; 0359
DR   BioGRID_ORCS_Cell_line; 524
DR   BioSample; SAMN03473121
DR   BioSample; SAMN10988237
DR   cancercelllines; CVCL_1561
DR   CCRID; 4201HUM-CCTCC00308
DR   CCTCC; GDC0308
DR   Cell_Model_Passport; SIDM00925
DR   ChEMBL-Cells; CHEMBL3308121
DR   ChEMBL-Targets; CHEMBL1075542
DR   CLS; 305219
DR   Cosmic; 687824
DR   Cosmic; 722048
DR   Cosmic; 801590
DR   Cosmic; 844831
DR   Cosmic; 876144
DR   Cosmic; 897730
DR   Cosmic; 903574
DR   Cosmic; 908460
DR   Cosmic; 914949
DR   Cosmic; 917992
DR   Cosmic; 1006533
DR   Cosmic; 1028948
DR   Cosmic; 1052332
DR   Cosmic; 1146916
DR   Cosmic; 1219076
DR   Cosmic; 1239882
DR   Cosmic; 1802306
DR   Cosmic; 1870274
DR   Cosmic; 1945871
DR   Cosmic; 1995577
DR   Cosmic; 2042863
DR   Cosmic; 2125252
DR   Cosmic; 2668311
DR   Cosmic-CLP; 908460
DR   DepMap; ACH-000638
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10742-110C4
DR   GDSC; 908460
DR   GEO; GSM108851
DR   GEO; GSM108852
DR   GEO; GSM206492
DR   GEO; GSM253415
DR   GEO; GSM274741
DR   GEO; GSM274742
DR   GEO; GSM353231
DR   GEO; GSM385521
DR   GEO; GSM385532
DR   GEO; GSM434308
DR   GEO; GSM784265
DR   GEO; GSM794287
DR   GEO; GSM817073
DR   GEO; GSM827516
DR   GEO; GSM844650
DR   GEO; GSM887428
DR   GEO; GSM888508
DR   GEO; GSM1670243
DR   IARC_TP53; 518
DR   IARC_TP53; 21408
DR   IGRhCellID; NCIH441
DR   IZSLER; BS TCL 215
DR   LiGeA; CCLE_935
DR   LINCS_LDP; LCL-1911
DR   PharmacoDB; NCIH441_1112_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD005187
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1561
DR   PubChem_Cell_line; CVCL_1561
DR   Wikidata; Q54908052
RX   PubMed=1311061;
RX   PubMed=2386953;
RX   PubMed=3940644;
RX   PubMed=8806092;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=19153074;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-growth-and-morphology-of-htb-174-nci-h441-cells
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-294.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Population: Caucasian.
CC   Doubling time: 58 hours (Note=In RPMI 1640 + 10% FBS), 138 hours (Note=In ACL-3), 99 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 80 hours (PubMed=25984343); 46.5 hours (PubMed=29681454).
CC   HLA typing: A*02:01,03:01; B*38:01,44:03; C*16:02,16:02; DQB1*06:07,06:07; DRB1*13:23,14:103 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=1311061; ATCC=HTB-174; Cosmic-CLP=908460; DepMap=ACH-000638).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Homozygous (PubMed=1311061; PubMed=10536175; PubMed=20557307; Cosmic-CLP=908460; DepMap=ACH-000638).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.09%; Native American=0%; East Asian, North=3.45%; East Asian, South=0%; South Asian=1.1%; European, North=61.67%; European, South=33.69% (PubMed=30894373).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Club cell; CL=CL_0000158.
ST   Source(s): AddexBio=C0016019/4975; ATCC=HTB-174; CCRID=4201HUM-CCTCC00308; CLS=305219; Cosmic-CLP=908460; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 19.3
ST   D13S317: 9
ST   D16S539: 9,13
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 17,19
ST   D2S441: 14
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D6S1043: 17
ST   D7S820: 10
ST   D8S1179: 8,14
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   NCI-H441/CMV-Luc
AC   CVCL_M254
DR   cancercelllines; CVCL_M254
DR   JCRB; JCRB1497
DR   JCRB; NIHS0728
DR   Wikidata; Q54908053
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1497).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0728; true.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Club cell; CL=CL_0000158.
ST   Source(s): JCRB=JCRB1497
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1561 ! NCI-H441
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 21
//
ID   NCI-H446
AC   CVCL_1562
SY   H446; H-446; NCI-446; NCIH446
DR   CLO; CLO_0008088
DR   EFO; EFO_0002293
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-171
DR   BioGRID_ORCS_Cell_line; 806
DR   BioSample; SAMN03473283
DR   BioSample; SAMN10988349
DR   cancercelllines; CVCL_1562
DR   CCRID; 1101HUM-PUMC000082
DR   CCRID; 3101HUMTCHu196
DR   Cell_Model_Passport; SIDM00965
DR   ChEMBL-Cells; CHEMBL3307760
DR   ChEMBL-Targets; CHEMBL612440
DR   CLS; 305049
DR   Cosmic; 688023
DR   Cosmic; 755465
DR   Cosmic; 801352
DR   Cosmic; 844554
DR   Cosmic; 877357
DR   Cosmic; 897516
DR   Cosmic; 929976
DR   Cosmic; 932947
DR   Cosmic; 1006526
DR   Cosmic; 1021863
DR   Cosmic; 1152471
DR   Cosmic; 1219102
DR   Cosmic; 1239939
DR   Cosmic; 1434963
DR   Cosmic; 1995578
DR   Cosmic; 2125198
DR   Cosmic; 2664127
DR   Cosmic; 2668272
DR   Cosmic-CLP; 688023
DR   DepMap; ACH-000800
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 688023
DR   GEO; GSM169448
DR   GEO; GSM380477
DR   GEO; GSM784254
DR   GEO; GSM845547
DR   GEO; GSM887429
DR   GEO; GSM888509
DR   GEO; GSM1670244
DR   GEO; GSM1682798
DR   GEO; GSM1887892
DR   GEO; GSM1887975
DR   IARC_TP53; 21573
DR   IGRhCellID; NCIH446
DR   KCB; KCB 200688YJ
DR   LiGeA; CCLE_177
DR   LINCS_LDP; LCL-1855
DR   PharmacoDB; NCIH446_1113_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD015270
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1562
DR   PubChem_Cell_line; CVCL_1562
DR   Wikidata; Q54908054
RX   CelloPub=CLPUB00716;
RX   PubMed=1320893;
RX   PubMed=1563005;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=6148444;
RX   PubMed=6713399;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=16677475;
RX   PubMed=17426248;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20193106;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=21163134;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26676926;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28599409;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32351780;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Population: Caucasian.
CC   HLA typing: A*03:01,03:01; B*07:02,51:01; C*03:04,03:04 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*07:02,51:01; C*03:04,03:04 (PubMed=26589293).
CC   Karyotypic information: Hypertriploid karyotype.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6728; LY6H + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-LY6H (PubMed=23716474).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (PubMed=20557307; Cosmic-CLP=688023; DepMap=ACH-000800).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.76%; Native American=0%; East Asian, North=6.47%; East Asian, South=0%; South Asian=0%; European, North=63.72%; European, South=27.05% (PubMed=30894373).
CC   Misspelling: NCI-H4466; Cosmic=2668272; Note=Prior to 2020.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-171; Cosmic-CLP=688023; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 18,20
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 9,10
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   NCI-H449
AC   CVCL_A565
SY   H449; H-449
DR   Cosmic; 1021864
DR   Wikidata; Q54908055
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2985257;
RX   PubMed=6148444;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A566 ! NCI-H450
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 17
//
ID   NCI-H450
AC   CVCL_A566
SY   H450; H-450
DR   Wikidata; Q54908056
RX   PubMed=1320893;
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A565 ! NCI-H449
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   NCI-H460
AC   CVCL_0459
SY   NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460
DR   BTO; BTO_0002207
DR   CLO; CLO_0003601
DR   CLO; CLO_0008089
DR   EFO; EFO_0003044
DR   MCCL; MCC:0000356
DR   CLDB; cl1548
DR   4DN; 4DNSRZBU6PZA
DR   AddexBio; C0016003/39
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-177
DR   BCRC; 60373
DR   BCRJ; 0416
DR   BioGRID_ORCS_Cell_line; 523
DR   BioSample; SAMN03471184
DR   BioSample; SAMN10987808
DR   cancercelllines; CVCL_0459
DR   CCLV; CCLV-RIE 0962
DR   CCRID; 1101HUM-PUMC000355
DR   CCRID; 1102HUM-NIFDC00086
DR   CCRID; 3101HUMSCSP584
DR   CCRID; 3101HUMTCHu205
DR   CCRID; 4201HUM-CCTCC00109
DR   CCTCC; GDC0109
DR   Cell_Model_Passport; SIDM00144
DR   CGH-DB; 199-1
DR   CGH-DB; 9186-4
DR   ChEMBL-Cells; CHEMBL3307677
DR   ChEMBL-Targets; CHEMBL396
DR   CLS; 305020
DR   Cosmic; 722064
DR   Cosmic; 724876
DR   Cosmic; 755469
DR   Cosmic; 844595
DR   Cosmic; 875852
DR   Cosmic; 877263
DR   Cosmic; 877407
DR   Cosmic; 897508
DR   Cosmic; 905943
DR   Cosmic; 911996
DR   Cosmic; 931371
DR   Cosmic; 947356
DR   Cosmic; 980964
DR   Cosmic; 1006534
DR   Cosmic; 1017826
DR   Cosmic; 1028956
DR   Cosmic; 1032436
DR   Cosmic; 1044245
DR   Cosmic; 1047102
DR   Cosmic; 1089231
DR   Cosmic; 1092621
DR   Cosmic; 1146917
DR   Cosmic; 1152502
DR   Cosmic; 1154605
DR   Cosmic; 1188592
DR   Cosmic; 1219077
DR   Cosmic; 1239922
DR   Cosmic; 1305349
DR   Cosmic; 1312334
DR   Cosmic; 1434967
DR   Cosmic; 1436013
DR   Cosmic; 1477420
DR   Cosmic; 1802310
DR   Cosmic; 1870275
DR   Cosmic; 1945869
DR   Cosmic; 1995579
DR   Cosmic; 1998463
DR   Cosmic; 2042872
DR   Cosmic; 2058650
DR   Cosmic; 2125199
DR   Cosmic; 2433756
DR   Cosmic; 2560230
DR   Cosmic; 2630413
DR   Cosmic; 2664114
DR   Cosmic; 2772154
DR   Cosmic-CLP; 905943
DR   DepMap; ACH-000463
DR   DSMZ; ACC-737
DR   DSMZCellDive; ACC-737
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS279XIV
DR   ENCODE; ENCBS398KLJ
DR   ENCODE; ENCBS428IIT
DR   ENCODE; ENCBS446PPO
DR   ENCODE; ENCBS460OUE
DR   ENCODE; ENCBS514AAA
DR   ENCODE; ENCBS515AAA
DR   ENCODE; ENCBS641PGO
DR   ENCODE; ENCBS657CEJ
DR   ENCODE; ENCBS686KKP
DR   ENCODE; ENCBS798ZFS
DR   ENCODE; ENCBS814QPR
DR   FANTOM5_SSTAR; 10839-111E2
DR   GDSC; 905943
DR   GEO; GSM2152
DR   GEO; GSM50216
DR   GEO; GSM50279
DR   GEO; GSM108853
DR   GEO; GSM108854
DR   GEO; GSM206493
DR   GEO; GSM253335
DR   GEO; GSM274737
DR   GEO; GSM274738
DR   GEO; GSM385522
DR   GEO; GSM385533
DR   GEO; GSM434334
DR   GEO; GSM513936
DR   GEO; GSM514322
DR   GEO; GSM743455
DR   GEO; GSM750809
DR   GEO; GSM784193
DR   GEO; GSM794288
DR   GEO; GSM799343
DR   GEO; GSM799406
DR   GEO; GSM817074
DR   GEO; GSM827469
DR   GEO; GSM844651
DR   GEO; GSM844652
DR   GEO; GSM847076
DR   GEO; GSM887430
DR   GEO; GSM888510
DR   GEO; GSM1153414
DR   GEO; GSM1178473
DR   GEO; GSM1178474
DR   GEO; GSM1178475
DR   GEO; GSM1181352
DR   GEO; GSM1181361
DR   GEO; GSM1374746
DR   GEO; GSM1374747
DR   GEO; GSM1374748
DR   GEO; GSM1557134
DR   GEO; GSM2124676
DR   IARC_TP53; 21083
DR   IGRhCellID; NCI-H460%20GEO
DR   IZSLER; BS TCL 197
DR   KCB; KCB 2010102YJ
DR   KCLB; 30177
DR   LiGeA; CCLE_338
DR   LINCS_LDP; LCL-1784
DR   Lonza; 728
DR   NCI-DTP; NCI-H460
DR   PharmacoDB; NCIH460_1114_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0459
DR   PubChem_Cell_line; CVCL_0459
DR   SKY/M-FISH/CGH; 2798
DR   Wikidata; Q54908057
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=3335022;
RX   PubMed=3940644;
RX   PubMed=7718330;
RX   PubMed=8385084;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=9331090;
RX   PubMed=10358721;
RX   PubMed=10700174;
RX   PubMed=11030152;
RX   PubMed=11551417;
RX   PubMed=11583962;
RX   PubMed=12068308;
RX   PubMed=12794755;
RX   PubMed=15746151;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=17088437;
RX   PubMed=17332333;
RX   PubMed=18083107;
RX   PubMed=19372543;
RX   PubMed=19472407;
RX   PubMed=19941903;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20510196;
RX   PubMed=20557307;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23381221;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24135919;
RX   PubMed=24279929;
RX   PubMed=24465237;
RX   PubMed=24670534;
RX   PubMed=25120651;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28408844;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=33425914;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=12
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-613.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/h460-xenograft-model/
WW   Provider; BRICS; BRICS0123; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3926
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Expresses HPRT1 at the surface of the cell membrane (PubMed=28408844).
CC   Doubling time: 33 hours (Note=In RPMI 1640 + 10% FBS), 60 hours (Note=In ACL-3), 42 hours (Note=In ACL-3 + BSA) (PubMed=3940644); 19 hours (PubMed=7718330); 0.8 day (PubMed=11551417); 21.5 hours (PubMed=29681454); 18.39 +- 1.35 hours (PubMed=33425914); ~23 hours (DSMZ=ACC-737); 17.8 hours (NCI-DTP=NCI-H460).
CC   HLA typing: A*24,68; B*35,51; C*03,15; DQB1*03:01:01,05:01:01; DRB1*01,04 (PubMed=15748285).
CC   HLA typing: A*24:02,68:01; B*35:01,51:01; C*03:03,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (PubMed=12068308; PubMed=12794755; PubMed=17088437; DepMap=ACH-000463).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1311061; PubMed=15900046; PubMed=20557307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.96%; East Asian, South=0%; South Asian=0.15%; European, North=65.65%; European, South=32.24% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0016003/39; ATCC=HTB-177; CCRID; Cosmic-CLP=905943; DSMZ=ACC-737; KCLB=30177; PubMed=19372543; PubMed=25877200; PubMed=33425914; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13
ST   D12S391: 21
ST   D13S317: 13
ST   D16S539: 9
ST   D18S51: 13,15
ST   D19S433: 14
ST   D1S1656: 11,14.3
ST   D21S11: 30
ST   D22S1045: 17
ST   D2S1338: 17,25
ST   D2S441: 11,11.3
ST   D3S1358: 15,18
ST   D5S818: 9,10
ST   D7S820: 9,12
ST   D8S1179: 12
ST   DYS391: 11
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 53
//
ID   NCI-H460 MX10
AC   CVCL_LB67
SY   H460 MX10
DR   cancercelllines; CVCL_LB67
DR   Wikidata; Q54908058
RX   PubMed=11406094;
RX   PubMed=11559526;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 10 nM of mitoxantrone (PubMed=11559526).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   NCI-H460-LNM35
AC   CVCL_RW33
SY   LNM35
DR   cancercelllines; CVCL_RW33
DR   Wikidata; Q54908059
RX   PubMed=10811136;
RX   PubMed=11464289;
CC   Population: Caucasian.
CC   Characteristics: Has lymphogenous metastactic properties. Consistently and spontaneously metastasizes to lymph nodes when injected either subcutaneously or orthotopically.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   NCI-H460-Luc
AC   CVCL_J264
DR   cancercelllines; CVCL_J264
DR   JCRB; JCRB1407
DR   JCRB; NIHS0658
DR   Wikidata; Q54908060
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0658; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1407
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 9
ST   D5S818: 9,10
ST   D7S820: 9,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 21
//
ID   NCI-H460-luc2
AC   CVCL_5J23
DR   cancercelllines; CVCL_5J23
DR   Revvity/PerkinElmer; 124316
DR   Wikidata; Q54908061
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124316; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   NCI-H460-Red-Fluc
AC   CVCL_5J07
SY   NCI-H460 Red-Fluc; Bioware Brite NCI-H460 Red-FLuc; IVISbrite NCI-H460 Red F-luc
DR   cancercelllines; CVCL_5J07
DR   Revvity/PerkinElmer; BW124316
DR   Wikidata; Q54908062
CC   Population: Caucasian.
CC   Doubling time: 16 hours (Revvity/PerkinElmer=BW124316).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   NCI-H460/TPT10
AC   CVCL_A5XQ
SY   NCI H460/TPT10
DR   cancercelllines; CVCL_A5XQ
DR   Wikidata; Q107116539
RX   DOI=10.1158/1538-7445.AM2022-1095;
RX   PubMed=33425914;
CC   Population: Caucasian.
CC   Doubling time: 22.46 +- 0.85 hours (PubMed=33425914).
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=33425914
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 9
ST   D5S818: 9,10
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   NCI-H460/TPT10 ABCG2 KO
AC   CVCL_A5XR
DR   cancercelllines; CVCL_A5XR
DR   Wikidata; Q107116540
RX   PubMed=33425914;
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, no longer resistant to topotecan (PubMed=33425914).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:74; ABCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5XQ ! NCI-H460/TPT10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   NCI-H460(Cas9)
AC   CVCL_E7JD
WW   Provider; BRICS; ECC3003; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3937
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NCI-H460M
AC   CVCL_3969
SY   H460M; H-460M; H460-M
DR   BTO; BTO_0002836
DR   cancercelllines; CVCL_3969
DR   Wikidata; Q54908064
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   NCI-H462
AC   CVCL_A567
SY   H462; H-462
DR   Wikidata; Q54908065
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A568 ! NCI-H463
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   NCI-H463
AC   CVCL_A568
SY   H463; H-463
DR   Wikidata; Q54908066
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A567 ! NCI-H462
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H478
AC   CVCL_A569
SY   H478; H-478
DR   Wikidata; Q54908068
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H498
AC   CVCL_1563
SY   H498; H-498
DR   CLO; CLO_0008090
DR   ATCC; CCL-254
DR   BioSample; SAMN03471385
DR   cancercelllines; CVCL_1563
DR   GEO; GSM513915
DR   GEO; GSM514302
DR   GEO; GSM1448214
DR   KCLB; 10254
DR   Progenetix; CVCL_1563
DR   Wikidata; Q54908069
RX   PubMed=3479249;
RX   PubMed=8806089;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=25926053;
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): ATCC=CCL-254; KCLB=10254; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 12,15
ST   D21S11: 29,31
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   NCI-H508
AC   CVCL_1564
SY   NCI H508; NCIH508; H508; H-508
DR   CLO; CLO_0008091
DR   EFO; EFO_0002294
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-253
DR   BioSample; SAMN03471384
DR   BioSample; SAMN10987662
DR   cancercelllines; CVCL_1564
DR   CCRID; 1101HUM-PUMC000411
DR   Cell_Model_Passport; SIDM00777
DR   ChEMBL-Cells; CHEMBL4632323
DR   ChEMBL-Targets; CHEMBL4632330
DR   CLS; 305107
DR   ColonAtlas; NCIH508
DR   Cosmic; 685870
DR   Cosmic; 908442
DR   Cosmic; 1479606
DR   Cosmic; 1565529
DR   Cosmic; 1708418
DR   Cosmic; 2647533
DR   Cosmic; 2841372
DR   Cosmic-CLP; 908442
DR   DepMap; ACH-000360
DR   GDSC; 908442
DR   GEO; GSM513916
DR   GEO; GSM514303
DR   GEO; GSM741253
DR   GEO; GSM887431
DR   GEO; GSM888511
DR   GEO; GSM1448142
DR   GEO; GSM1670245
DR   GEO; GSM2550010
DR   IARC_TP53; 21574
DR   IZSLER; BS TCL 214
DR   KCLB; 10253
DR   LiGeA; CCLE_864
DR   PharmacoDB; NCIH508_1115_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1564
DR   PubChem_Cell_line; CVCL_1564
DR   SKY/M-FISH/CGH; 5012
DR   Wikidata; Q54908070
RX   PubMed=3479249;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=12068308;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=24042735;
RX   PubMed=25623215;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 32 hours (PubMed=25984343).
CC   HLA typing: A*01:01,02:01; B*08:01,51:01; C*07:01,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly596Arg (c.1786G>C); ClinVar=VCV000375943; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24042735; PubMed=28683746; ATCC=CCL-253).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=28683746; ATCC=CCL-253).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=28683746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.01%; Native American=0%; East Asian, North=3.05%; East Asian, South=0%; South Asian=0%; European, North=58.76%; European, South=38.18% (PubMed=30894373).
CC   Discontinued: CLS; 305107; true.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
ST   Source(s): ATCC=CCL-253; Cosmic-CLP=908442; KCLB=10253; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 14
ST   D21S11: 29,32.2 (PubMed=25926053)
ST   D21S11: 29,32.2,33.2 (ATCC=CCL-253)
ST   D2S1338: 18,19,27
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 24,25
ST   Penta D: 12
ST   Penta E: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   NCI-H508 R1 Cetux
AC   CVCL_A2CF
SY   NCIH508 R1 Cetux
DR   cancercelllines; CVCL_A2CF
DR   Cosmic; 2841373
DR   Wikidata; Q105510315
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly596Arg (c.1786G>C); ClinVar=VCV000375943; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1564 ! NCI-H508
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   NCI-H508 R2 Cetux
AC   CVCL_A2CG
SY   NCIH508 R2 Cetux
DR   cancercelllines; CVCL_A2CG
DR   Cosmic; 2841374
DR   Wikidata; Q105510319
RX   PubMed=25623215;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly596Arg (c.1786G>C); ClinVar=VCV000375943; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1564 ! NCI-H508
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   NCI-H510A
AC   CVCL_1565
AS   CVCL_3973
SY   H510A; H-510A; NCI-H510; NCIH510; H510; H-510
DR   BTO; BTO_0003023
DR   CLO; CLO_0008092
DR   EFO; EFO_0006693
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-184
DR   BioSample; SAMN03473048
DR   BioSample; SAMN10987639
DR   cancercelllines; CVCL_1565
DR   Cell_Model_Passport; SIDM00927
DR   ChEMBL-Cells; CHEMBL3308322
DR   ChEMBL-Targets; CHEMBL2366332
DR   Cosmic; 753605
DR   Cosmic; 755466
DR   Cosmic; 897519
DR   Cosmic; 903575
DR   Cosmic; 1006527
DR   Cosmic; 1021865
DR   Cosmic; 1219103
DR   Cosmic; 1995580
DR   Cosmic; 2125210
DR   Cosmic-CLP; 753605
DR   DepMap; ACH-000871
DR   DSMZ; ACC-568
DR   DSMZCellDive; ACC-568
DR   ECACC; 96020944
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753605
DR   GEO; GSM169437
DR   GEO; GSM170708
DR   GEO; GSM170709
DR   GEO; GSM784199
DR   GEO; GSM794289
DR   GEO; GSM887432
DR   GEO; GSM888512
DR   GEO; GSM1670246
DR   GEO; GSM1887910
DR   GEO; GSM1887992
DR   IARC_TP53; 437
DR   LiGeA; CCLE_268
DR   LINCS_LDP; LCL-1856
DR   PharmacoDB; NCIH510A_1116_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1565
DR   PubChem_Cell_line; CVCL_1565
DR   Wikidata; Q54908071
RX   PubMed=1312696;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=2569043;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 66 hours (PubMed=2985258); ~1 week (DSMZ=ACC-568).
CC   HLA typing: A*01:01,01:01; B*07:02,58:05; C*07:01,07:01; DQA1*03:02,05:02; DRB1*04:05,04:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys265Ter (c.793A>T); Zygosity=Homozygous (ATCC=HTB-184; Cosmic-CLP=753605; DepMap=ACH-000871).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly30Ter (c.88G>T); Zygosity=Homozygous (ATCC=HTB-184; Cosmic-CLP=753605; DepMap=ACH-000871).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Gly (c.844C>G); ClinVar=VCV000140821; Zygosity=Homozygous (PubMed=1312696; PubMed=1565469; PubMed=20557307; ATCC=HTB-184; Cosmic-CLP=753605; DepMap=ACH-000871).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0.3%; East Asian, North=2.01%; East Asian, South=0%; South Asian=0%; European, North=64.53%; European, South=33.11% (PubMed=30894373).
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): ATCC=HTB-184; Cosmic-CLP=753605; DSMZ=ACC-568; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 17,24
ST   D3S1358: 16,18
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 12,16
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   NCI-H513
AC   CVCL_A570
SY   H513; H-513; NCIH513; HUT513
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5830
DR   BioSample; SAMN03151854
DR   Cell_Model_Passport; SIDM00114
DR   Cosmic; 877271
DR   Cosmic; 877408
DR   Cosmic; 980997
DR   Cosmic; 1032388
DR   Cosmic; 1152503
DR   Cosmic; 1995420
DR   Cosmic-CLP; 1240141
DR   DepMap; ACH-002138
DR   DepMap; ACH-002341
DR   EGA; EGAS00001000978
DR   GDSC; 1240141
DR   GEO; GSM1669835
DR   KCLB; 90513
DR   PharmacoDB; H513_438_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908072
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=16630136;
RX   PubMed=23830731;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NCI-H125 derivative. Originally thought to originate with the pleural effusion of a mesothelioma in a 64 year old male patient.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00414.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=83.85%; Native American=0%; East Asian, North=2.18%; East Asian, South=0%; South Asian=2.16%; European, North=5.9%; European, South=5.9% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-5830; true.
CC   Discontinued: DepMap; ACH-002341; true.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ATCC=CRL-5830; Cosmic-CLP=1240141
ST   Amelogenin: X
ST   CSF1PO: 7
ST   D13S317: 11
ST   D16S539: 5,12
ST   D5S818: 10
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3968 ! NCI-H125
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   NCI-H520
AC   CVCL_1566
SY   H520; H-520; NCI-HUT-520; NCIH520
DR   BTO; BTO_0003014
DR   CLO; CLO_0008093
DR   EFO; EFO_0003124
DR   AddexBio; C0016010/4915
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-182
DR   BCRC; 60124
DR   BioGRID_ORCS_Cell_line; 521
DR   BioSample; SAMN03471318
DR   BioSample; SAMN03472735
DR   BioSample; SAMN10987782
DR   cancercelllines; CVCL_1566
DR   CCRID; 5301HUM-KCB13023YJ
DR   Cell_Model_Passport; SIDM01130
DR   ChEMBL-Cells; CHEMBL3307864
DR   ChEMBL-Targets; CHEMBL614099
DR   CLS; 305063
DR   Cosmic; 687826
DR   Cosmic; 801591
DR   Cosmic; 876172
DR   Cosmic; 908443
DR   Cosmic; 917988
DR   Cosmic; 929974
DR   Cosmic; 932932
DR   Cosmic; 933580
DR   Cosmic; 945226
DR   Cosmic; 1028955
DR   Cosmic; 1146918
DR   Cosmic; 1219078
DR   Cosmic; 1239911
DR   Cosmic; 1741782
DR   Cosmic; 1802297
DR   Cosmic; 1995581
DR   Cosmic; 2060526
DR   Cosmic; 2125253
DR   Cosmic; 2560231
DR   Cosmic; 2648439
DR   Cosmic; 2664123
DR   Cosmic; 2668328
DR   Cosmic; 2696404
DR   Cosmic; 2772157
DR   Cosmic-CLP; 908443
DR   DepMap; ACH-000395
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 908443
DR   GEO; GSM63353
DR   GEO; GSM206494
DR   GEO; GSM274798
DR   GEO; GSM274831
DR   GEO; GSM276781
DR   GEO; GSM276782
DR   GEO; GSM434281
DR   GEO; GSM784258
DR   GEO; GSM794290
DR   GEO; GSM844653
DR   GEO; GSM844654
DR   GEO; GSM887433
DR   GEO; GSM888513
DR   GEO; GSM1374750
DR   GEO; GSM1670247
DR   IARC_TP53; 519
DR   IARC_TP53; 21409
DR   IGRhCellID; NCIH520
DR   KCB; KCB 2013023YJ
DR   LiGeA; CCLE_877
DR   LINCS_LDP; LCL-1591
DR   PharmacoDB; NCIH520_1117_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1566
DR   PubChem_Cell_line; CVCL_1566
DR   Ubigene; YC-C017
DR   Wikidata; Q54908073
RX   PubMed=1311061;
RX   PubMed=2388294;
RX   PubMed=3335022;
RX   PubMed=3940644;
RX   PubMed=8806092;
RX   PubMed=9649128;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=11369051;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27602502;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 61 hours (Note=In RPMI 1640 + 10% FBS), 25 hours (Note=In ACL-3), 32 hours (Note=In ACL-3 + BSA) (PubMed=3940644).
CC   HLA typing: A*11:01,11:01; B*15:18,15:18; C*07:04,07:04; DQB1*03:02,06:02; DRB1*11:04,11:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro383Ala (c.1147C>G); ClinVar=VCV001001330; Zygosity=Heterozygous (PubMed=27602502; Cosmic-CLP=908443; DepMap=ACH-000395).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly45Valfs*8 (c.134delG); Zygosity=Homozygous (Cosmic-CLP=908443; DepMap=ACH-000395).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (PubMed=1311061; PubMed=10536175; PubMed=20557307; Cosmic-CLP=908443; DepMap=ACH-000395).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.92%; East Asian, South=0%; South Asian=0%; European, North=63.58%; European, South=35.5% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016010/4915; ATCC=HTB-182; Cosmic-CLP=908443; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13
ST   D12S391: 21
ST   D13S317: 10,11
ST   D16S539: 8,13
ST   D18S51: 17
ST   D19S433: 13,14
ST   D1S1656: 14,16.3
ST   D21S11: 30
ST   D22S1045: 16
ST   D2S1338: 18,23
ST   D2S441: 10,11
ST   D3S1358: 16
ST   D5S818: 12 (PubMed=25877200)
ST   D5S818: 12,13 (AddexBio=C0016010/4915; ATCC=HTB-182; Cosmic-CLP=908443; Technion Genomics Center)
ST   D7S820: 8,12
ST   D8S1179: 14,16,17
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 5,14
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   NCI-H520-EGFP
AC   CVCL_C8X0
DR   Ubigene; YC-C017-EGFP-P
DR   Wikidata; Q123033158
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro383Ala (c.1147C>G); ClinVar=VCV001001330; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly45Valfs*8 (c.134delG); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1566 ! NCI-H520
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   NCI-H522
AC   CVCL_1567
SY   NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522
DR   BTO; BTO_0003536
DR   CLO; CLO_0008094
DR   EFO; EFO_0002295
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5810
DR   BioSample; SAMN03471314
DR   BioSample; SAMN10988279
DR   cancercelllines; CVCL_1567
DR   Cell_Model_Passport; SIDM00116
DR   ChEMBL-Cells; CHEMBL3308392
DR   ChEMBL-Targets; CHEMBL614387
DR   Cosmic; 875853
DR   Cosmic; 877409
DR   Cosmic; 897509
DR   Cosmic; 903576
DR   Cosmic; 905944
DR   Cosmic; 974294
DR   Cosmic; 980965
DR   Cosmic; 1004696
DR   Cosmic; 1032437
DR   Cosmic; 1044246
DR   Cosmic; 1092622
DR   Cosmic; 1146919
DR   Cosmic; 1154592
DR   Cosmic; 1175866
DR   Cosmic; 1188591
DR   Cosmic; 1219062
DR   Cosmic; 1239883
DR   Cosmic; 1305350
DR   Cosmic; 1312335
DR   Cosmic; 1436012
DR   Cosmic; 1802320
DR   Cosmic; 1870276
DR   Cosmic; 1891886
DR   Cosmic; 1995582
DR   Cosmic; 1998464
DR   Cosmic; 2125185
DR   Cosmic; 2772155
DR   Cosmic-CLP; 905944
DR   DepMap; ACH-000343
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905944
DR   GEO; GSM2101
DR   GEO; GSM50217
DR   GEO; GSM50280
DR   GEO; GSM206495
DR   GEO; GSM274753
DR   GEO; GSM274754
DR   GEO; GSM353230
DR   GEO; GSM434309
DR   GEO; GSM513965
DR   GEO; GSM514350
DR   GEO; GSM743456
DR   GEO; GSM750798
DR   GEO; GSM784233
DR   GEO; GSM794291
DR   GEO; GSM799344
DR   GEO; GSM799407
DR   GEO; GSM827479
DR   GEO; GSM847077
DR   GEO; GSM887434
DR   GEO; GSM888514
DR   GEO; GSM1153415
DR   GEO; GSM1178491
DR   GEO; GSM1178492
DR   GEO; GSM1181345
DR   GEO; GSM1181346
DR   GEO; GSM1374751
DR   GEO; GSM1374752
DR   GEO; GSM1374753
DR   GEO; GSM1670248
DR   GEO; GSM2124677
DR   IARC_TP53; 520
DR   IARC_TP53; 21410
DR   IGRhCellID; NCIH522
DR   KCLB; 25810
DR   KCLB; 90522
DR   LiGeA; CCLE_084
DR   LINCS_LDP; LCL-1622
DR   NCI-DTP; NCI-H522
DR   PharmacoDB; NCIH522_1118_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD011315
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1567
DR   PubChem_Cell_line; CVCL_1567
DR   SKY/M-FISH/CGH; 2803
DR   Wikidata; Q54908074
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=2041050;
RX   PubMed=2388294;
RX   PubMed=3335022;
RX   PubMed=7718330;
RX   PubMed=8806092;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=11030152;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19153074;
RX   PubMed=19372543;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=22961666;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30710758;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=7
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lung-cancer-xenograft/nci-h522-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 20 hours (PubMed=7718330); 48.1 hours (PubMed=29681454); 38.2 hours (NCI-DTP=NCI-H522).
CC   HLA typing: A*02:01:01; B*44,55:01; C*03:03:01,05; DPB1*04:01; DQB1*03,06:02; DRB1*04:01:01,15:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,24:18; B*44:02,55:01; C*03:03,05:01; DQA1*03:02,03:02; DQB1*03:04,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191fs*56 (c.571delC); Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=15900046; PubMed=17088437; PubMed=18277095; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.94%; Native American=0%; East Asian, North=1.91%; East Asian, South=0%; South Asian=3.27%; European, North=69.74%; European, South=23.13% (PubMed=30894373).
CC   Donor information: Established from a 60 packs per year smoker (ATCC=CRL-5810).
CC   Discontinued: KCLB; 25810; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5810; Cosmic-CLP=905944; PubMed=19372543; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10 (ATCC=CRL-5810; PubMed=25877200; Technion Genomics Center)
ST   CSF1PO: 10,12 (Cosmic-CLP=905944; PubMed=19372543)
ST   D10S1248: 15,16
ST   D12S391: 17
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 14,18
ST   D19S433: 16
ST   D1S1656: 13,14
ST   D21S11: 28,31.2
ST   D22S1045: 15
ST   D2S1338: 17,20
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 10,11 (PubMed=19372543; Technion Genomics Center)
ST   D5S818: 11 (ATCC=CRL-5810; Cosmic-CLP=905944; PubMed=25877200)
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 9,10
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   NCI-H524
AC   CVCL_1568
SY   H524; H-524; NCIH524
DR   BTO; BTO_0004825
DR   CLO; CLO_0008095
DR   EFO; EFO_0002296
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5831
DR   BioSample; SAMN03472976
DR   BioSample; SAMN10988203
DR   cancercelllines; CVCL_1568
DR   CCRID; 1101HUM-PUMC000356
DR   Cell_Model_Passport; SIDM01129
DR   ChEMBL-Cells; CHEMBL3308296
DR   ChEMBL-Targets; CHEMBL2366342
DR   CLS; 305120
DR   Cosmic; 688024
DR   Cosmic; 844555
DR   Cosmic; 850442
DR   Cosmic; 877208
DR   Cosmic; 877358
DR   Cosmic; 908483
DR   Cosmic; 980933
DR   Cosmic; 1032399
DR   Cosmic; 1152472
DR   Cosmic; 1759289
DR   Cosmic; 1891904
DR   Cosmic; 2125200
DR   Cosmic-CLP; 908483
DR   DepMap; ACH-000816
DR   EGA; EGAS00001000978
DR   GDSC; 908483
DR   GEO; GSM169442
DR   GEO; GSM170710
DR   GEO; GSM170712
DR   GEO; GSM171880
DR   GEO; GSM171881
DR   GEO; GSM794292
DR   GEO; GSM845548
DR   GEO; GSM887435
DR   GEO; GSM888515
DR   GEO; GSM1670249
DR   GEO; GSM1887893
DR   GEO; GSM1887976
DR   IARC_TP53; 21575
DR   IGRhCellID; NCIH524
DR   KCB; KCB 2010137YJ
DR   KCLB; 90524
DR   LiGeA; CCLE_825
DR   LINCS_LDP; LCL-1857
DR   PharmacoDB; NCIH524_1119_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1568
DR   PubChem_Cell_line; CVCL_1568
DR   Wikidata; Q54908075
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2388294;
RX   PubMed=2473086;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=3335022;
RX   PubMed=6713399;
RX   PubMed=7720728;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 100 hours (PubMed=25984343).
CC   HLA typing: A*01:01,01:01; B*08:01,39:09; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000127327; Zygosity=Heterozygous (Cosmic-CLP=908483; DepMap=ACH-000816).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (ATCC=CRL-5831; Cosmic-CLP=908483; DepMap=ACH-000816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Homozygous (ATCC=CRL-5831; Cosmic-CLP=908483; DepMap=ACH-000816).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.55%; Native American=0%; East Asian, North=1.32%; East Asian, South=0%; South Asian=0%; European, North=66.11%; European, South=32.01% (PubMed=30894373).
CC   Discontinued: KCLB; 90524; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5831; CCRID=1101HUM-PUMC000356; Cosmic-CLP=908483; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 16
ST   D21S11: 29,30
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,22,25 (CCRID=1101HUM-PUMC000356)
ST   FGA: 21,25 (ATCC=CRL-5831)
ST   FGA: 25 (PubMed=25877200)
ST   Penta D: 12,13
ST   Penta E: 5,15
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   NCI-H524-A
AC   CVCL_WM69
SY   NCI-H524A
DR   cancercelllines; CVCL_WM69
DR   Wikidata; Q95993590
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=7720728;
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line by selection of the adherent cells.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1568 ! NCI-H524
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   NCI-H526
AC   CVCL_1569
SY   H526; H-526; NCIH526
DR   BTO; BTO_0005366
DR   CLO; CLO_0008096
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5811
DR   BioGRID_ORCS_Cell_line; 807
DR   BioSample; SAMN03473065
DR   BioSample; SAMN10988341
DR   cancercelllines; CVCL_1569
DR   Cell_Model_Passport; SIDM01128
DR   ChEMBL-Cells; CHEMBL3308881
DR   ChEMBL-Targets; CHEMBL2366102
DR   CLS; 305278
DR   Cosmic; 688025
DR   Cosmic; 755467
DR   Cosmic; 801615
DR   Cosmic; 844556
DR   Cosmic; 844820
DR   Cosmic; 850439
DR   Cosmic; 876164
DR   Cosmic; 877209
DR   Cosmic; 877359
DR   Cosmic; 918012
DR   Cosmic; 929975
DR   Cosmic; 1021866
DR   Cosmic; 1152473
DR   Cosmic; 1219104
DR   Cosmic; 1239940
DR   Cosmic; 1891905
DR   Cosmic; 1995583
DR   Cosmic; 1998284
DR   Cosmic; 2125214
DR   Cosmic; 2668275
DR   Cosmic; 2668345
DR   Cosmic-CLP; 688025
DR   DepMap; ACH-000767
DR   EGA; EGAS00001000978
DR   GDSC; 688025
DR   GEO; GSM169439
DR   GEO; GSM170738
DR   GEO; GSM170740
DR   GEO; GSM170741
DR   GEO; GSM171882
DR   GEO; GSM171883
DR   GEO; GSM380478
DR   GEO; GSM380515
DR   GEO; GSM536330
DR   GEO; GSM784231
DR   GEO; GSM794293
DR   GEO; GSM844655
DR   GEO; GSM845549
DR   GEO; GSM887436
DR   GEO; GSM888516
DR   GEO; GSM1374754
DR   GEO; GSM1670250
DR   GEO; GSM1887894
DR   GEO; GSM1887977
DR   IARC_TP53; 995
DR   IGRhCellID; NCIH526
DR   KCLB; 90526
DR   LiGeA; CCLE_134
DR   LINCS_LDP; LCL-1858
DR   PharmacoDB; NCIH526_1120_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1569
DR   PubChem_Cell_line; CVCL_1569
DR   TOKU-E; 2701
DR   Wikidata; Q54908076
RX   PubMed=1312696;
RX   PubMed=1320893;
RX   PubMed=1565469;
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=20615970;
RX   PubMed=20624269;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,24:02; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.97-1G>C (IVS3-1G>C); Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1312696; PubMed=1565469; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.13%; East Asian, South=0%; South Asian=1.94%; European, North=63.44%; European, South=33.49% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5811; Cosmic-CLP=688025; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 9
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 27,32.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 13,14
ST   Penta E: 5,13
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   NCI-H548
AC   CVCL_1570
SY   NCI H548; H548; H-548; NCIH548
DR   CLO; CLO_0008097
DR   ATCC; CCL-249
DR   BioSample; SAMN03471379
DR   GEO; GSM1374755
DR   KCLB; 10249
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54908077
RX   PubMed=3479249;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CCL-249; true.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): ATCC=CCL-249; KCLB=10249
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   FGA: 21,22
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 15,18 (KCLB=10249)
ST   vWA: 15,18,19 (ATCC=CCL-249)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   NCI-H568
AC   CVCL_A571
SY   H568; H-568
DR   Wikidata; Q54908078
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NCI-H571
AC   CVCL_A572
SY   H571; H-571
DR   Wikidata; Q54908079
RX   PubMed=8806092;
RX   PubMed=8806103;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   NCI-H578
AC   CVCL_A573
SY   H578; H-578
DR   Wikidata; Q54908080
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   NCI-H580
AC   CVCL_A574
SY   H580; H-580
DR   Wikidata; Q54908081
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H596
AC   CVCL_1571
SY   H596; H-596; NCI-HUT-596; NCIH596
DR   BTO; BTO_0002209
DR   CLO; CLO_0008098
DR   EFO; EFO_0006694
DR   AddexBio; C0016020/4974
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-178
DR   BioSample; SAMN03472805
DR   BioSample; SAMN10988026
DR   cancercelllines; CVCL_1571
DR   CCRID; 1101HUM-PUMC000257
DR   Cell_Model_Passport; SIDM01127
DR   ChEMBL-Cells; CHEMBL3307791
DR   ChEMBL-Targets; CHEMBL612256
DR   Cosmic; 687828
DR   Cosmic; 801586
DR   Cosmic; 844832
DR   Cosmic; 876226
DR   Cosmic; 897514
DR   Cosmic; 908459
DR   Cosmic; 918001
DR   Cosmic; 929973
DR   Cosmic; 934548
DR   Cosmic; 1067762
DR   Cosmic; 1146920
DR   Cosmic; 1188588
DR   Cosmic; 1219079
DR   Cosmic; 1239917
DR   Cosmic; 1694668
DR   Cosmic; 1802293
DR   Cosmic; 1995584
DR   Cosmic; 2125254
DR   Cosmic; 2647637
DR   Cosmic; 2664125
DR   Cosmic; 2668268
DR   Cosmic; 2668324
DR   Cosmic; 2772156
DR   Cosmic-CLP; 908459
DR   DepMap; ACH-000628
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908459
DR   GEO; GSM206496
DR   GEO; GSM274796
DR   GEO; GSM274829
DR   GEO; GSM434310
DR   GEO; GSM784243
DR   GEO; GSM794294
DR   GEO; GSM817075
DR   GEO; GSM844656
DR   GEO; GSM887437
DR   GEO; GSM888517
DR   GEO; GSM1374756
DR   GEO; GSM1374757
DR   GEO; GSM1670251
DR   GEO; GSM2807225
DR   GEO; GSM2807226
DR   IARC_TP53; 521
DR   IGRhCellID; NCIH596
DR   KCLB; 90596
DR   LiGeA; CCLE_201
DR   LINCS_LDP; LCL-1786
DR   PharmacoDB; NCIH596_1121_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1571
DR   PubChem_Cell_line; CVCL_1571
DR   Wikidata; Q54908082
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=7972006;
RX   PubMed=8806092;
RX   PubMed=8806101;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Population: Caucasian.
CC   Doubling time: 41.1 hours (PubMed=29681454).
CC   HLA typing: A*03:01,03:01; B*08:01,08:01; C*07:06,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=908459; DepMap=ACH-000628).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser182Ilefs*3 (c.542dupT) (c.541_542insT); ClinVar=VCV002829809; Zygosity=Heterozygous (Cosmic-CLP=908459; DepMap=ACH-000628).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Homozygous (PubMed=1311061; PubMed=10536175; PubMed=20557307; Cosmic-CLP=908459; DepMap=ACH-000628).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.07%; Native American=0%; East Asian, North=2.55%; East Asian, South=0%; South Asian=0%; European, North=62.11%; European, South=35.26% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016020/4974; ATCC=HTB-178; CCRID=1101HUM-PUMC000257; Cosmic-CLP=908459; KCLB=90596; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 10.2,18 (CCRID=1101HUM-PUMC000257)
ST   D18S51: 18 (ATCC=HTB-178; PubMed=25877200)
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 22,23
ST   D3S1358: 14
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 12,15
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   NCI-H60
AC   CVCL_A592
SY   H60; H-60
DR   BTO; BTO_0006541
DR   ATCC; CRL-5821
DR   BioSample; SAMN03151862
DR   cancercelllines; CVCL_A592
DR   Cosmic; 1021848
DR   GEO; GSM1682797
DR   Wikidata; Q54908084
RX   PubMed=1563005;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=2986243;
RX   PubMed=6108156;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h60-atcc-crl-5821
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NCI-N417 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00416.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:23139; CLVS1 + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-CLVS1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Lys (c.1636C>A); ClinVar=VCV000013657; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-5821; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5821
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1602 ! NCI-N417
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 35
//
ID   NCI-H606
AC   CVCL_A575
SY   H606; H-606
DR   Wikidata; Q54908085
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   NCI-H615
AC   CVCL_A576
SY   H615; H-615
DR   Wikidata; Q54908086
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   NCI-H618
AC   CVCL_A577
SY   H618; H-618
DR   Wikidata; Q54908087
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H620
AC   CVCL_A578
SY   H620; H-620
DR   cancercelllines; CVCL_A578
DR   Cosmic; 1021868
DR   Cosmic; 1998276
DR   GEO; GSM536332
DR   Progenetix; CVCL_A578
DR   Wikidata; Q54908088
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20615970;
RX   PubMed=31803961;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   NCI-H630
AC   CVCL_1572
SY   H630; H-630; NCIH630
DR   CLO; CLO_0008099
DR   EFO; EFO_0002297
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5833
DR   BioSample; SAMN03151846
DR   BioSample; SAMN03481113
DR   ChEMBL-Cells; CHEMBL3307966
DR   ChEMBL-Targets; CHEMBL612540
DR   Cosmic; 687535
DR   Cosmic; 908482
DR   Cosmic; 1187327
DR   Cosmic-CLP; 908482
DR   DepMap; ACH-002287
DR   EGA; EGAS00001000978
DR   GDSC; 908482
DR   GEO; GSM452725
DR   GEO; GSM452756
DR   GEO; GSM453572
DR   GEO; GSM454623
DR   GEO; GSM454643
DR   GEO; GSM454644
DR   GEO; GSM454645
DR   GEO; GSM1448143
DR   GEO; GSM1670252
DR   IARC_TP53; 21576
DR   IGRhCellID; NCIH630
DR   IZSLER; BS TCL 191
DR   KCLB; 90630
DR   LINCS_LDP; LCL-1287
DR   PharmacoDB; NCIH630_1122_2019
DR   PRIDE; PXD005235
DR   PubChem_Cell_line; CVCL_1572
DR   Wikidata; Q54908089
RX   PubMed=3479249;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h630-atcc-crl-5833
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. The contaminant is not known. Seems to be a mixture of cell lines. Originally said to originate from a 60 year old male patient with a rectal carcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00417.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (Cosmic-CLP=908482; DepMap=ACH-002287).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (Cosmic-CLP=908482; DepMap=ACH-002287).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.04%; East Asian, North=0%; East Asian, South=1.38%; South Asian=1.38%; European, North=67.59%; European, South=29.61% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-5833; true.
CC   Discontinued: KCLB; 90630; probable.
ST   Source(s): ATCC=CRL-5833; Cosmic-CLP=908482; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12,13 (Cosmic-CLP=908482)
ST   D13S317: 11,12,13,14 (ATCC=CRL-5833; PubMed=25926053)
ST   D16S539: 11,12
ST   D21S11: 30,33.2
ST   D5S818: 12
ST   D7S820: 8,11 (PubMed=25926053)
ST   D7S820: 8,11,12 (ATCC=CRL-5833; Cosmic-CLP=908482)
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,16,17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   NCI-H64
AC   CVCL_1573
SY   H64; H-64; NCIH64
DR   CLO; CLO_0037035
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5976
DR   BioSample; SAMN03472629
DR   cancercelllines; CVCL_1573
DR   Cell_Model_Passport; SIDM01126
DR   ChEMBL-Cells; CHEMBL3308273
DR   ChEMBL-Targets; CHEMBL2366319
DR   Cosmic; 688026
DR   Cosmic; 844544
DR   Cosmic; 953985
DR   Cosmic; 1995585
DR   Cosmic-CLP; 688026
DR   DepMap; ACH-001599
DR   EGA; EGAS00001000978
DR   GDSC; 688026
DR   GEO; GSM1670253
DR   IARC_TP53; 21577
DR   LINCS_LDP; LCL-1874
DR   PharmacoDB; NCIH64_1123_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1573
DR   Wikidata; Q54908090
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=6108156;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283Pro (c.848G>C); ClinVar=VCV000486555; Zygosity=Homozygous (Cosmic-CLP=688026; DepMap=ACH-001599).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=67.82%; Native American=0.62%; East Asian, North=1.03%; East Asian, South=0%; South Asian=0%; European, North=19.2%; European, South=11.33% (PubMed=30894373).
CC   Caution: Indicated as originating from a female patient in ATCC and from a male patient in PubMed=2985257 and PubMed=2986243.
CC   Caution: According to ATCC the ethnicity of the donor is White, but exome analysis finds it to be mostly of African lineage.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5976; Cosmic-CLP=688026
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 9,12
ST   D18S51: 13,23
ST   D19S433: 14,14.2
ST   D21S11: 28,31
ST   D2S1338: 22
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 13,14
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   NCI-H640
AC   CVCL_A579
SY   H640; H-640
DR   Wikidata; Q54908091
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   NCI-H647
AC   CVCL_1574
SY   H647; H-647; H647ell; NCIH647
DR   BTO; BTO_0005294
DR   CLO; CLO_0008100
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5834
DR   BioSample; SAMN03471319
DR   BioSample; SAMN10988271
DR   cancercelllines; CVCL_1574
DR   Cell_Model_Passport; SIDM01125
DR   ChEMBL-Cells; CHEMBL3308691
DR   ChEMBL-Targets; CHEMBL614999
DR   CLS; 305130
DR   Cosmic; 722060
DR   Cosmic; 903577
DR   Cosmic; 931370
DR   Cosmic; 980966
DR   Cosmic; 1032438
DR   Cosmic; 1146921
DR   Cosmic; 1891887
DR   Cosmic-CLP; 1240191
DR   DepMap; ACH-000378
DR   EGA; EGAS00001000978
DR   GDSC; 1240191
DR   GEO; GSM206497
DR   GEO; GSM274809
DR   GEO; GSM274810
DR   GEO; GSM434311
DR   GEO; GSM513970
DR   GEO; GSM514351
DR   GEO; GSM784213
DR   GEO; GSM794295
DR   GEO; GSM817076
DR   GEO; GSM827587
DR   GEO; GSM844657
DR   GEO; GSM844658
DR   GEO; GSM887438
DR   GEO; GSM888518
DR   GEO; GSM1374758
DR   GEO; GSM1670254
DR   IARC_TP53; 996
DR   IGRhCellID; H647GEO
DR   KCLB; 90647
DR   LiGeA; CCLE_620
DR   LINCS_LDP; LCL-1629
DR   PharmacoDB; NCIH647_1124_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1574
DR   PubChem_Cell_line; CVCL_1574
DR   Wikidata; Q54908092
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=3335022;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*25:01,25:01; B*27:05,58:01; C*01:03,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=1240191; DepMap=ACH-000378).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.782+1G>T; ClinVar=VCV000496048; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=1311061; PubMed=1565469; Cosmic-CLP=1240191; DepMap=ACH-000378).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.88%; East Asian, North=0%; East Asian, South=0%; South Asian=1.04%; European, North=70.95%; European, South=27.13% (PubMed=30894373).
CC   Discontinued: KCLB; 90647; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5834; Cosmic-CLP=1240191; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   NCI-H650
AC   CVCL_1575
SY   H650; H-650; NCIH650
DR   BTO; BTO_0004079
DR   CLO; CLO_0008101
DR   EFO; EFO_0002298
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5835
DR   BioGRID_ORCS_Cell_line; 965
DR   BioSample; SAMN03471315
DR   BioSample; SAMN10988027
DR   cancercelllines; CVCL_1575
DR   Cell_Model_Passport; SIDM01124
DR   ChEMBL-Cells; CHEMBL3308461
DR   ChEMBL-Targets; CHEMBL1075543
DR   Cosmic; 722066
DR   Cosmic; 1609512
DR   Cosmic; 1870277
DR   Cosmic; 1995586
DR   Cosmic-CLP; 722066
DR   DepMap; ACH-000945
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10715-109I4
DR   GDSC; 722066
DR   GEO; GSM206498
DR   GEO; GSM274787
DR   GEO; GSM274824
DR   GEO; GSM794296
DR   GEO; GSM827481
DR   GEO; GSM887439
DR   GEO; GSM888519
DR   GEO; GSM1670255
DR   IARC_TP53; 522
DR   IGRhCellID; NCIH650
DR   KCLB; 90650
DR   LiGeA; CCLE_406
DR   LINCS_LDP; LCL-1672
DR   PharmacoDB; NCIH650_1125_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1575
DR   PubChem_Cell_line; CVCL_1575
DR   Wikidata; Q54908094
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 49.4 hours (PubMed=29681454).
CC   HLA typing: A*24:02,24:02; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser871Ter (c.2612C>A); ClinVar=VCV000051315; Zygosity=Heterozygous (Cosmic-CLP=722066; DepMap=ACH-000945).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Pro41Glnfs*6 (c.121delC); Zygosity=Heterozygous (Cosmic-CLP=722066; DepMap=ACH-000945).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Glu306Ter (c.916G>T); Zygosity=Heterozygous (Cosmic-CLP=722066; DepMap=ACH-000945).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Homozygous (Cosmic-CLP=722066; DepMap=ACH-000945).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Asn (c.492G>T); Zygosity=Homozygous (PubMed=1311061; Cosmic-CLP=722066; DepMap=ACH-000945).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.27%; East Asian, South=0.48%; South Asian=0%; European, North=65.1%; European, South=33.15% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5835; Cosmic-CLP=722066; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D18S51: 14,20
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 18,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 20,22
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-H650-Luc
AC   CVCL_4Y16
DR   cancercelllines; CVCL_4Y16
DR   JCRB; JCRB1525
DR   JCRB; NIHS0729
DR   Wikidata; Q54908095
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser871Ter (c.2612C>A); ClinVar=VCV000051315; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Pro41Glnfs*6 (c.121delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Glu306Ter (c.916G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Asn (c.492G>T); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0729; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1525
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1575 ! NCI-H650
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   NCI-H660
AC   CVCL_1576
SY   H660; H-660; NCIH660; NCI660
DR   BTO; BTO_0001970
DR   CLO; CLO_0008102
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5813
DR   BioSample; SAMN03473052
DR   BioSample; SAMN10988121
DR   cancercelllines; CVCL_1576
DR   Cell_Model_Passport; SIDM01123
DR   Cosmic; 877360
DR   Cosmic; 1021869
DR   Cosmic; 1043331
DR   Cosmic; 1075272
DR   Cosmic; 1689713
DR   Cosmic; 2651769
DR   Cosmic; 2669168
DR   Cosmic-CLP; 1330975
DR   DepMap; ACH-000177
DR   EGA; EGAS00001000978
DR   GEO; GSM482672
DR   GEO; GSM648822
DR   GEO; GSM887440
DR   GEO; GSM888520
DR   GEO; GSM1670256
DR   GEO; GSM1887911
DR   GEO; GSM1887993
DR   IARC_TP53; 21084
DR   IARC_TP53; 21725
DR   IGRhCellID; NCIH660
DR   LiGeA; CCLE_659
DR   PharmacoDB; NCIH660_1126_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1576
DR   Wikidata; Q54908097
RX   CelloPub=CLPUB00698;
RX   PubMed=1563005;
RX   PubMed=2569043;
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=11304728;
RX   PubMed=14518029;
RX   PubMed=15643172;
RX   PubMed=17401460;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23671654;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 100 hours (PubMed=25984343).
CC   HLA typing: A*01:01,68:01; B*44:02,57:01; C*07:04,07:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (PubMed=17401460).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.18%; Native American=0%; East Asian, North=2.77%; East Asian, South=0%; South Asian=0%; European, North=58.05%; European, South=37% (PubMed=30894373).
CC   Caution: Was originally published as originating from a small cell lung carcinoma (PubMed=2985257), but was later shown to originate from a prostate small cell carcinoma (PubMed=2569043).
CC   Misspelling: NCI_H600; Cosmic=2669168; Note=Prior to 2020.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): ATCC=CRL-5813; Cosmic-CLP=1330975; PubMed=11304728; PubMed=14518029; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 28,31
ST   D2S1338: 18,24
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 9,10
ST   FGA: 23,24
ST   Penta D: 9,12
ST   Penta E: 12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C6766; Prostate small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   NCI-H661
AC   CVCL_1577
SY   H661; H-661; NCIH661
DR   BTO; BTO_0003013
DR   CLO; CLO_0008103
DR   EFO; EFO_0002299
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-183
DR   BCRC; 60125
DR   BioSample; SAMN03471326
DR   BioSample; SAMN10988284
DR   cancercelllines; CVCL_1577
DR   CCRID; 1101HUM-PUMC000357
DR   CCRID; 3101HUMTCHu121
DR   Cell_Model_Passport; SIDM01122
DR   ChEMBL-Cells; CHEMBL3308139
DR   ChEMBL-Targets; CHEMBL1075544
DR   CLS; 305085
DR   Cosmic; 687829
DR   Cosmic; 877410
DR   Cosmic; 903578
DR   Cosmic; 909909
DR   Cosmic; 923400
DR   Cosmic; 930610
DR   Cosmic; 933579
DR   Cosmic; 961835
DR   Cosmic; 980967
DR   Cosmic; 1006540
DR   Cosmic; 1032439
DR   Cosmic; 1146922
DR   Cosmic; 1152504
DR   Cosmic; 1219063
DR   Cosmic; 1239923
DR   Cosmic; 1995587
DR   Cosmic; 2125186
DR   Cosmic; 2560232
DR   Cosmic; 2648440
DR   Cosmic-CLP; 687829
DR   DepMap; ACH-000853
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 687829
DR   GEO; GSM171884
DR   GEO; GSM171885
DR   GEO; GSM185870
DR   GEO; GSM206499
DR   GEO; GSM253359
DR   GEO; GSM274759
DR   GEO; GSM274760
DR   GEO; GSM434273
DR   GEO; GSM784198
DR   GEO; GSM794297
DR   GEO; GSM817077
DR   GEO; GSM827517
DR   GEO; GSM887441
DR   GEO; GSM888521
DR   GEO; GSM1670257
DR   GEO; GSM2807231
DR   GEO; GSM2807232
DR   IARC_TP53; 523
DR   IARC_TP53; 21411
DR   IGRhCellID; NCIH661
DR   IZSLER; BS TCL 218
DR   KCB; KCB 200823YJ
DR   LiGeA; CCLE_830
DR   LINCS_LDP; LCL-1785
DR   Lonza; 1627
DR   PharmacoDB; NCIH661_1127_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1577
DR   PubChem_Cell_line; CVCL_1577
DR   Wikidata; Q54908098
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=9649128;
RX   PubMed=11030152;
RX   PubMed=11369051;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 61 hours (PubMed=25984343); 32.7 hours (PubMed=29681454).
CC   HLA typing: A*02:01,24:02; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.457+1G>T; ClinVar=VCV000635367; Zygosity=Homozygous; Note=Splice donor mutation (Cosmic-CLP=687829; DepMap=ACH-000853).
CC   Sequence variation: Mutation; HGNC; HGNC:6513; LASP1; Simple; p.Glu48Ter (c.142G>T); Zygosity=Heterozygous (Cosmic-CLP=687829; DepMap=ACH-000853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Heterozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=687829; DepMap=ACH-000853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Heterozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=687829; DepMap=ACH-000853).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.22%; Native American=0.51%; East Asian, North=0.62%; East Asian, South=0%; South Asian=0.92%; European, North=63.58%; European, South=34.14% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-183; CCRID; Cosmic-CLP=687829; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 11 (CCRID)
ST   D18S51: 11,14 (ATCC=HTB-183)
ST   D19S433: 13,14
ST   D21S11: 31,33.2
ST   D2S1338: 17
ST   D3S1358: 15,16 (ATCC=HTB-183; PubMed=25877200)
ST   D3S1358: 16 (CCRID)
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 10
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 12,13
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   NCI-H661/Cas9-hyg
AC   CVCL_C7U5
DR   GeneCopoeia; SL561
DR   Wikidata; Q123033159
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL561).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1577 ! NCI-H661
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   NCI-H676B
AC   CVCL_1578
SY   H676B; H-676B; NCI-H676; H676; H-676
DR   CLO; CLO_0008104
DR   ATCC; HTB-179
DR   BioSample; SAMN03472732
DR   cancercelllines; CVCL_1578
DR   IARC_TP53; 524
DR   Wikidata; Q54908099
RX   PubMed=1311061;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val217Leu (c.649G>T); ClinVar=VCV001386154; Zygosity=Unspecified (PubMed=1311061).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Unspecified (PubMed=1311061).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-179
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 16
ST   D21S11: 30,32
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 10,13
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   NCI-H678
AC   CVCL_A580
SY   H678; H-678
DR   cancercelllines; CVCL_A580
DR   Cosmic; 1998277
DR   GEO; GSM536333
DR   Progenetix; CVCL_A580
DR   Wikidata; Q54908100
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20615970;
RX   PubMed=31803961;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   NCI-H679
AC   CVCL_A581
SY   H679; H-679
DR   ATCC; CRL-5977
DR   IARC_TP53; 525
DR   Wikidata; Q54908101
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103Thrfs*20 (c.306delC) (p.Thr102fs); Zygosity=Unspecified (PubMed=1311061).
CC   Discontinued: ATCC; CRL-5977; true.
DI   NCIt; C4038; Lung carcinoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   NCI-H684
AC   CVCL_9980
SY   H684; H-684; NCIH684
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988095
DR   cancercelllines; CVCL_9980
DR   Cell_Model_Passport; SIDM01665
DR   DepMap; ACH-000089
DR   GEO; GSM1448215
DR   IARC_TP53; 28309
DR   KCLB; 90684
DR   LiGeA; CCLE_151
DR   PharmacoDB; NCIH684_1128_2019
DR   Wikidata; Q54908102
RX   PubMed=3479249;
RX   PubMed=8806092;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   HLA typing: A*03:01,03:01; B*39:01,44:02; C*05:01,12:03; DQB1*06:13,06:13; DRB1*03:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000089).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (DepMap=ACH-000089).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=90684; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12 (KCLB=90684)
ST   D13S317: 12 (PubMed=25926053)
ST   D16S539: 11,12
ST   D21S11: 31.2
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   FGA: 23
ST   TH01: 9 (PubMed=25926053)
ST   TH01: 9,9.3 (KCLB=90684)
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-H689
AC   CVCL_A582
SY   H689; H-689
DR   KCLB; 90689
DR   Wikidata; Q54908103
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Discontinued: KCLB; 90689; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-H69
AC   CVCL_1579
SY   NCI-H-69; NCI H69; H69; H-69; NCIH69; NCI-HUT-69; H69/P; NCI-H69C; H69C; H69c
DR   BTO; BTO_0003022
DR   CLO; CLO_0003609
DR   CLO; CLO_0008105
DR   EFO; EFO_0002300
DR   CLDB; cl1552
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-119
DR   BioSample; SAMN03473085
DR   BioSample; SAMN10988132
DR   cancercelllines; CVCL_1579
DR   CCRID; 1101HUM-PUMC000358
DR   Cell_Model_Passport; SIDM01121
DR   ChEMBL-Cells; CHEMBL3307712
DR   ChEMBL-Targets; CHEMBL614805
DR   CLS; 300185
DR   Cosmic; 688027
DR   Cosmic; 713879
DR   Cosmic; 755459
DR   Cosmic; 801610
DR   Cosmic; 808518
DR   Cosmic; 844545
DR   Cosmic; 844817
DR   Cosmic; 876167
DR   Cosmic; 877351
DR   Cosmic; 918010
DR   Cosmic; 929160
DR   Cosmic; 1006522
DR   Cosmic; 1021849
DR   Cosmic; 1152461
DR   Cosmic; 1175859
DR   Cosmic; 1212189
DR   Cosmic; 1219096
DR   Cosmic; 1239934
DR   Cosmic; 1434964
DR   Cosmic; 1571755
DR   Cosmic; 1609516
DR   Cosmic; 1995588
DR   Cosmic; 1998272
DR   Cosmic; 2125215
DR   Cosmic; 2239080
DR   Cosmic; 2648017
DR   Cosmic; 2668341
DR   Cosmic-CLP; 688027
DR   DepMap; ACH-000358
DR   ECACC; 91091802
DR   EGA; EGAS00001000978
DR   GDSC; 688027
DR   GEO; GSM169443
DR   GEO; GSM380498
DR   GEO; GSM536334
DR   GEO; GSM784197
DR   GEO; GSM794269
DR   GEO; GSM827305
DR   GEO; GSM844659
DR   GEO; GSM845550
DR   GEO; GSM887442
DR   GEO; GSM888522
DR   GEO; GSM1670258
DR   GEO; GSM1887950
DR   GEO; GSM1887978
DR   IARC_TP53; 328
DR   IGRhCellID; NCIH69
DR   IZSLER; BS TCL 172
DR   KCLB; 30119
DR   LiGeA; CCLE_927
DR   LINCS_LDP; LCL-1859
DR   NCI-DTP; NCI-H69
DR   PharmacoDB; NCIH69_1129_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD015270
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1579
DR   PubChem_Cell_line; CVCL_1579
DR   Wikidata; Q38568854
RX   PubMed=1662924;
RX   PubMed=1845952;
RX   PubMed=1847845;
RX   PubMed=2388294;
RX   PubMed=2473086;
RX   PubMed=2574988;
RX   PubMed=2594029;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=2986243;
RX   PubMed=3034934;
RX   PubMed=3335022;
RX   PubMed=6108156;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=7736387;
RX   PubMed=7903701;
RX   PubMed=8263009;
RX   PubMed=8626706;
RX   PubMed=8712684;
RX   PubMed=8784480;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9212023;
RX   PubMed=9413215;
RX   PubMed=9559344;
RX   PubMed=9744504;
RX   PubMed=9815546;
RX   PubMed=10037197;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=11414198;
RX   PubMed=12569360;
RX   PubMed=17426248;
RX   PubMed=19394761;
RX   PubMed=19446745;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20615970;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30038707;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32351780;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/htb-119-morphology-and-culture-conditions
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 56.0 hours (PubMed=1662924).
CC   HLA typing: A*02:01,23:01; B*42:02,58:05; C*07:01,14:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,23:01:01; B*01:01:01,51:01:01; C*07:01:01,14:02:01; DPB1*01:01:01G,03:01:01G; DQA1*03:01:01;03:03:01; DQB1*03:02:01; DRB1*04:04:01,04:05:01 (CLS=300185).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (PubMed=19394761; ATCC=HTB-119).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (PubMed=8263009; PubMed=2594029; ATCC=HTB-119).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (PubMed=8263009; PubMed=10536175; PubMed=20557307; ATCC=HTB-119).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.79%; Native American=0%; East Asian, North=1.48%; East Asian, South=0%; South Asian=0.42%; European, North=61.96%; European, South=35.34% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-119; CCRID=1101HUM-PUMC000358; CLS=300185; Cosmic-CLP=688027; ECACC=91091802; KCLB=30119; PubMed=25877200
ST   Amelogenin: X (CLS=300185)
ST   Amelogenin: X,Y (ATCC=HTB-119; CCRID=1101HUM-PUMC000358; Cosmic-CLP=688027; ECACC=91091802; KCLB=30119; PubMed=25877200)
ST   CSF1PO: 10,12 (CLS=300185; ECACC=91091802; KCLB=30119)
ST   CSF1PO: 10,12,13 (ATCC=HTB-119; CCRID=1101HUM-PUMC000358)
ST   CSF1PO: 10,13 (Cosmic-CLP=688027; PubMed=25877200)
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12 (CLS=300185)
ST   D18S51: 12,15 (ATCC=HTB-119; CCRID=1101HUM-PUMC000358; PubMed=25877200)
ST   D19S433: 15,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 12
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,17 (ATCC=HTB-119; CCRID=1101HUM-PUMC000358; CLS=300185; ECACC=91091802; KCLB=30119)
ST   vWA: 17 (Cosmic-CLP=688027; PubMed=25877200)
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   NCI-H69/CPR
AC   CVCL_2137
SY   H69/CPR
DR   cancercelllines; CVCL_2137
DR   ECACC; 96042328
DR   GEO; GSM1887948
DR   GEO; GSM1888024
DR   Wikidata; Q54908104
RX   PubMed=1327513;
RX   PubMed=27247353;
RX   PubMed=28766886;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   NCI-H69/IFN-gamma
AC   CVCL_E4CP
RX   PubMed=9415308;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NCI-H69/IL2
AC   CVCL_E4CQ
RX   PubMed=9415308;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NCI-H69/IL2/IFN-gamma
AC   CVCL_E4CR
RX   PubMed=9415308;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4CQ ! NCI-H69/IL2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   NCI-H69/LX10
AC   CVCL_2138
SY   H69/LX10
DR   cancercelllines; CVCL_2138
DR   ECACC; 96042331
DR   GEO; GSM1887949
DR   GEO; GSM1888025
DR   Wikidata; Q54908105
RX   PubMed=27247353;
RX   PubMed=28766886;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-H69/LX20
AC   CVCL_2139
SY   H69/LX20
DR   CLO; CLO_0008106
DR   cancercelllines; CVCL_2139
DR   ECACC; 96042332
DR   Wikidata; Q54908106
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   NCI-H69/LX4
AC   CVCL_2140
SY   NCI H69-LX4; H69/LX4
DR   cancercelllines; CVCL_2140
DR   ECACC; 96042329
DR   Wikidata; Q54908107
RX   PubMed=3011054;
RX   PubMed=3034934;
RX   PubMed=7903701;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=96042329
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   NCI-H69AR
AC   CVCL_3513
SY   NCI-H69 AR; NCI-H69/AR; H69AR; H-69AR
DR   BTO; BTO_0005367
DR   CLO; CLO_0003610
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-11351
DR   cancercelllines; CVCL_3513
DR   GEO; GSM169453
DR   GEO; GSM170728
DR   GEO; GSM827497
DR   GEO; GSM986176
DR   IGRhCellID; H69AR
DR   Progenetix; CVCL_3513
DR   Wikidata; Q54872205
RX   Patent=US5489519;
RX   PubMed=1314068;
RX   PubMed=2436751;
RX   PubMed=17426248;
RX   PubMed=19446745;
RX   PubMed=20215515;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Group: Patented cell line.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11351.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (ATCC=CRL-11351).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-11351
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 15,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,11
ST   Penta E: 12
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   NCI-H69VCR/R
AC   CVCL_3058
DR   cancercelllines; CVCL_3058
DR   ECACC; 96042330
DR   GEO; GSM1887951
DR   GEO; GSM1888026
DR   Wikidata; Q54908108
RX   PubMed=27247353;
RX   PubMed=28766886;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=96042330
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   NCI-H711
AC   CVCL_1580
SY   H711; H-711
DR   CLO; CLO_0008107
DR   ATCC; CRL-5836
DR   ATCC; CRL-5836_FL
DR   BioSample; SAMN03471749
DR   cancercelllines; CVCL_1580
DR   Cosmic; 844557
DR   Cosmic; 877211
DR   Cosmic; 877361
DR   Cosmic; 910709
DR   Cosmic; 1032400
DR   Cosmic; 1891906
DR   Cosmic; 2125255
DR   GEO; GSM169446
DR   GEO; GSM827535
DR   GEO; GSM1887926
DR   GEO; GSM1888015
DR   Progenetix; CVCL_1580
DR   Wikidata; Q54908109
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=17426248;
RX   PubMed=20215515;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5836; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5836_FL
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,13
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   NCI-H716
AC   CVCL_1581
SY   NCI H716; H716; H-716; NCIH716
DR   BTO; BTO_0004747
DR   CLO; CLO_0008108
DR   EFO; EFO_0002301
DR   CLDB; cl3658
DR   AddexBio; C0009022/5006
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-251
DR   BCRC; 60517
DR   BioGRID_ORCS_Cell_line; 520
DR   BioSample; SAMN03473254
DR   BioSample; SAMN10987641
DR   cancercelllines; CVCL_1581
DR   CCRID; 1101HUM-PUMC000359
DR   CCRID; 3101HUMTCHu210
DR   CCTCC; GDC0163
DR   Cell_Model_Passport; SIDM00779
DR   ChEMBL-Cells; CHEMBL3308297
DR   ChEMBL-Targets; CHEMBL2366106
DR   CLS; 305079
DR   ColonAtlas; NCIH716
DR   Cosmic; 687536
DR   Cosmic; 908458
DR   Cosmic; 1995589
DR   Cosmic; 2302001
DR   Cosmic-CLP; 908458
DR   DepMap; ACH-000491
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908458
DR   GEO; GSM513917
DR   GEO; GSM514304
DR   GEO; GSM887443
DR   GEO; GSM888523
DR   GEO; GSM1346850
DR   GEO; GSM1374759
DR   GEO; GSM1448144
DR   GEO; GSM1670259
DR   IARC_TP53; 21579
DR   IARC_TP53; 21743
DR   IGRhCellID; NCIH716
DR   KCLB; 10251
DR   LiGeA; CCLE_373
DR   LINCS_LDP; LCL-1339
DR   PharmacoDB; NCIH716_1130_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1581
DR   PubChem_Cell_line; CVCL_1581
DR   SKY/M-FISH/CGH; 5013
DR   Ubigene; YC-C112
DR   Wikidata; Q54908110
RX   PubMed=1359704;
RX   PubMed=3479249;
RX   PubMed=8806089;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=29787053;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Secretes high level of glucagon-like peptide 1 (GLP-1) (PubMed=29787053).
CC   Doubling time: 50 hours (PubMed=25984343).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:18261; NPLOC4 + HGNC; HGNC:8789; PDE6G; Name(s)=NPLOC4-PDE6G (PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Arg97Ile (c.290G>T); Zygosity=Heterozygous (Cosmic-CLP=908458; DepMap=ACH-000491).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Asp (c.672G>T); ClinVar=VCV000635390; Zygosity=Homozygous (PubMed=16418264; Cosmic-CLP=908458; DepMap=ACH-000491).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.04%; Native American=14.7%; East Asian, North=4.64%; East Asian, South=0%; South Asian=3.2%; European, North=30.38%; European, South=44.03% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): AddexBio=C0009022/5006; ATCC=CCL-251; CCRID; Cosmic-CLP=908458; KCLB=10251; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 15,18.2
ST   D21S11: 32.2
ST   D2S1338: 14,16
ST   D3S1358: 16,18
ST   D5S818: 11 (AddexBio=C0009022/5006; ATCC=CCL-251; CCRID; Cosmic-CLP=908458; PubMed=25877200; PubMed=25926053)
ST   D5S818: 12 (KCLB=10251)
ST   D7S820: 10,11
ST   D8S1179: 12.2,14,15 (CCRID)
ST   D8S1179: 15 (ATCC=CCL-251; PubMed=25877200)
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16 (CCRID)
ST   vWA: 16,17 (AddexBio=C0009022/5006; ATCC=CCL-251; Cosmic-CLP=908458; KCLB=10251; PubMed=25877200; PubMed=25926053)
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   NCI-H719
AC   CVCL_1582
SY   H719; H-719
DR   CLO; CLO_0008109
DR   ATCC; CRL-5837
DR   BioSample; SAMN03471750
DR   cancercelllines; CVCL_1582
DR   ChEMBL-Cells; CHEMBL3308551
DR   ChEMBL-Targets; CHEMBL2366184
DR   Cosmic; 688028
DR   Cosmic; 844558
DR   Cosmic; 877362
DR   Cosmic; 924242
DR   Cosmic; 980934
DR   Cosmic; 1032401
DR   Cosmic; 1152474
DR   Cosmic; 2125256
DR   GDSC; 924242
DR   GEO; GSM1887919
DR   GEO; GSM1888001
DR   IARC_TP53; 27194
DR   KCLB; 90719
DR   LINCS_LDP; LCL-1860
DR   PharmacoDB; NCIH719_1131_2019
DR   PubChem_Cell_line; CVCL_1582
DR   Wikidata; Q54908111
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Part of: Small cell lung cancer p53 hotspot mutation cell panel (ATCC TCP-2040).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (ATCC=CRL-5837).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a 100 packs per year smoker (ATCC=CRL-5837).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-5837; KCLB=90719
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 16,20
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 11
ST   FGA: 20
ST   Penta D: 13,14
ST   Penta E: 16,17
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   NCI-H720
AC   CVCL_1583
SY   H720; H-720; NCIH720
DR   CLO; CLO_0008110
DR   EFO; EFO_0001166
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5838
DR   BioSample; SAMN03471751
DR   cancercelllines; CVCL_1583
DR   Cell_Model_Passport; SIDM01120
DR   ChEMBL-Cells; CHEMBL3308851
DR   ChEMBL-Targets; CHEMBL2366105
DR   Cosmic; 687600
DR   Cosmic; 844599
DR   Cosmic; 877267
DR   Cosmic; 877411
DR   Cosmic; 980993
DR   Cosmic; 1032465
DR   Cosmic; 1152505
DR   Cosmic; 1219112
DR   Cosmic; 1891918
DR   Cosmic; 1998331
DR   Cosmic; 2125216
DR   Cosmic; 2433546
DR   Cosmic-CLP; 687600
DR   DepMap; ACH-002174
DR   EGA; EGAS00001000978
DR   GDSC; 687600
DR   GEO; GSM600371
DR   GEO; GSM794298
DR   GEO; GSM830113
DR   GEO; GSM1670260
DR   GEO; GSM1887912
DR   GEO; GSM1887994
DR   IARC_TP53; 526
DR   IGRhCellID; NCIH720
DR   KCLB; 90720
DR   LINCS_LDP; LCL-1155
DR   PharmacoDB; NCIH720_1132_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1583
DR   PubChem_Cell_line; CVCL_1583
DR   Wikidata; Q54908112
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=23119007;
RX   PubMed=26087898;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln344Ter (c.1030C>T); ClinVar=VCV001771021; Zygosity=Homozygous (PubMed=26087898; ATCC=CRL-5838; Cosmic-CLP=687600; DepMap=ACH-002174).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (PubMed=1311061; PubMed=26087898; ATCC=CRL-5838; Cosmic-CLP=687600; DepMap=ACH-002174).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.64%; Native American=1.07%; East Asian, North=3.8%; East Asian, South=0%; South Asian=6.19%; European, North=25.94%; European, South=60.36% (PubMed=30894373).
CC   Discontinued: KCLB; 90720; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5838; Cosmic-CLP=687600
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 20,25
ST   Penta D: 9,14
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4038; Lung carcinoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   NCI-H726
AC   CVCL_A465
SY   H726; H-726
DR   Cosmic; 1152506
DR   Wikidata; Q54908113
RX   PubMed=1311061;
RX   PubMed=2386953;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   NCI-H727
AC   CVCL_1584
SY   H727; H-727; NCIH727
DR   BTO; BTO_0005915
DR   CLO; CLO_0008111
DR   EFO; EFO_0006695
DR   CLDB; cl3659
DR   CLDB; cl3660
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5815
DR   BioSample; SAMN03472579
DR   BioSample; SAMN10988551
DR   cancercelllines; CVCL_1584
DR   Cell_Model_Passport; SIDM01119
DR   ChEMBL-Cells; CHEMBL3308393
DR   ChEMBL-Targets; CHEMBL1075545
DR   Cosmic; 722049
DR   Cosmic; 724855
DR   Cosmic; 877412
DR   Cosmic; 897515
DR   Cosmic; 980994
DR   Cosmic; 1006542
DR   Cosmic; 1032466
DR   Cosmic; 1152507
DR   Cosmic; 1239952
DR   Cosmic; 1802311
DR   Cosmic; 1879413
DR   Cosmic; 1998332
DR   Cosmic; 2125257
DR   Cosmic; 2433547
DR   Cosmic-CLP; 724855
DR   DepMap; ACH-000775
DR   ECACC; 94060303
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10735-110B6
DR   GDSC; 724855
DR   GEO; GSM385523
DR   GEO; GSM385534
DR   GEO; GSM600372
DR   GEO; GSM784194
DR   GEO; GSM794299
DR   GEO; GSM827523
DR   GEO; GSM830114
DR   GEO; GSM887444
DR   GEO; GSM888524
DR   GEO; GSM1374760
DR   GEO; GSM1670261
DR   IARC_TP53; 527
DR   IARC_TP53; 28250
DR   ICLC; HTL97001
DR   IGRhCellID; NCI-H727%20GEO
DR   KCLB; 90727
DR   LiGeA; CCLE_211
DR   LINCS_LDP; LCL-1153
DR   PharmacoDB; NCIH727_1133_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1584
DR   PubChem_Cell_line; CVCL_1584
DR   Ubigene; YC-C129
DR   Wikidata; Q54908114
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=12068308;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22538498;
RX   PubMed=22929519;
RX   PubMed=23119007;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26087898;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 41 hours (PubMed=29681454).
CC   HLA typing: A*32:01,32:01; B*38:01,67:02; C*12:03,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:18053; PKD1L1 + HGNC; HGNC:21616; TNS3; Name(s)=TNS3-PKD1L1 (PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=1311061; PubMed=12068308; Cosmic-CLP=724855; DepMap=ACH-000775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln165_Ser166insTyrLysGln (c.496_497insACAAGCAGT) (c.492_493ins9); Zygosity=Heterozygous (PubMed=1311061; PubMed=20557307; Cosmic-CLP=724855; DepMap=ACH-000775).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0.23%; East Asian, North=3.94%; East Asian, South=0%; South Asian=0.26%; European, North=62.32%; European, South=32.88% (PubMed=30894373).
ST   Source(s): ATCC=CRL-5815; Cosmic-CLP=724855; ECACC=94060303; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 14
ST   D12S391: 20,24
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 16
ST   D19S433: 13,14
ST   D1S1656: 14
ST   D21S11: 29,32.2
ST   D22S1045: 15
ST   D2S1338: 17,23,24 (Technion Genomics Center)
ST   D2S1338: 17,24 (ATCC=CRL-5815)
ST   D2S441: 10,11
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 20,22
ST   Penta D: 9,14
ST   Penta E: 14
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4038; Lung carcinoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   NCI-H735
AC   CVCL_1585
SY   H735; H-735
DR   CLO; CLO_0008112
DR   ATCC; CRL-5978
DR   BioSample; SAMN03472630
DR   cancercelllines; CVCL_1585
DR   Cosmic; 688029
DR   Cosmic; 844559
DR   Cosmic; 877363
DR   Cosmic; 1152475
DR   GDSC; 688029
DR   GEO; GSM986184
DR   GEO; GSM1887938
DR   GEO; GSM1888027
DR   PharmacoDB; NCIH735_1134_2019
DR   Progenetix; CVCL_1585
DR   Wikidata; Q54908115
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-5978
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11,14
ST   D16S539: 14
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 10,16
ST   Penta E: 5
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   NCI-H738
AC   CVCL_4365
SY   H738; H-738
DR   ATCC; CRL-5839
DR   BioSample; SAMN03152022
DR   BioSample; SAMN03471752
DR   Wikidata; Q54908116
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00335.
CC   Discontinued: ATCC; CRL-5839; true.
ST   Source(s): ATCC=CRL-5839
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 18,20
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   NCI-H740
AC   CVCL_1586
SY   H740; H-740; NCIH740
DR   BTO; BTO_0005979
DR   CLO; CLO_0008113
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5840
DR   BioSample; SAMN03473086
DR   cancercelllines; CVCL_1586
DR   Cell_Model_Passport; SIDM01118
DR   Cosmic; 844560
DR   Cosmic; 877212
DR   Cosmic; 980935
DR   Cosmic; 1032402
DR   Cosmic; 1152476
DR   Cosmic-CLP; 1331055
DR   DepMap; ACH-002175
DR   EGA; EGAS00001000978
DR   GEO; GSM1670262
DR   PharmacoDB; NCIH740_1135_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908117
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:16393; CARD11; Simple; p.Gly126Cys (c.376G>T); Zygosity=Heterozygous (DepMap=ACH-002175).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Pro (c.800G>C); ClinVar=VCV000428867; Zygosity=Heterozygous (DepMap=ACH-002175).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=1.71%; Native American=0%; East Asian, North=1.31%; East Asian, South=0%; South Asian=1.18%; European, North=64.24%; European, South=31.56% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5840; Cosmic-CLP=1331055; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 14,18
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 17,26
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 20,22.2
ST   Penta D: 11
ST   Penta E: 5,10
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   NCI-H742
AC   CVCL_9981
DR   Wikidata; Q54908118
RX   PubMed=3479249;
RX   PubMed=8806092;
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   NCI-H747
AC   CVCL_1587
SY   NCI H747; H747; H-747; NCI-747; NCIH747; NCI747
DR   CLO; CLO_0008114
DR   EFO; EFO_0002303
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-252
DR   BioGRID_ORCS_Cell_line; 518
DR   BioSample; SAMN03471383
DR   BioSample; SAMN10988329
DR   cancercelllines; CVCL_1587
DR   Cell_Model_Passport; SIDM00778
DR   ChEMBL-Cells; CHEMBL3308895
DR   ChEMBL-Targets; CHEMBL2366087
DR   ColonAtlas; NCIH747
DR   Cosmic; 724845
DR   Cosmic; 908457
DR   Cosmic; 1312307
DR   Cosmic; 1479598
DR   Cosmic; 1995590
DR   Cosmic; 2302002
DR   Cosmic-CLP; 908457
DR   DepMap; ACH-000403
DR   EGA; EGAS00001000978
DR   GDSC; 908457
DR   GEO; GSM513918
DR   GEO; GSM514305
DR   GEO; GSM741259
DR   GEO; GSM887445
DR   GEO; GSM888525
DR   GEO; GSM1346851
DR   GEO; GSM1448145
DR   GEO; GSM1670263
DR   IARC_TP53; 1557
DR   IGRhCellID; NCIH747
DR   IZSLER; BS TCL 176
DR   KCLB; 10252
DR   LiGeA; CCLE_889
DR   LINCS_LDP; LCL-1340
DR   PharmacoDB; NCIH747_1136_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1587
DR   PubChem_Cell_line; CVCL_1587
DR   Wikidata; Q54908119
RX   PubMed=3479249;
RX   PubMed=8806092;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*26:01,26:01; B*38:01,38:01; C*12:03,12:03; DQA1*03:02,03:02; DRB1*04:37,14:103 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln161Ter (c.481C>T); ClinVar=VCV000229997; Zygosity=Heterozygous (ATCC=CCL-252; Cosmic-CLP=908457; DepMap=ACH-000403).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1429Ter (c.4285C>T); ClinVar=VCV000376063; Zygosity=Heterozygous (ATCC=CCL-252; Cosmic-CLP=908457; DepMap=ACH-000403).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; Cosmic-CLP=908457; DepMap=ACH-000403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Homozygous (Cosmic-CLP=908457; DepMap=ACH-000403).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.58%; Native American=0.23%; East Asian, North=4.27%; East Asian, South=0%; South Asian=8.5%; European, North=24.28%; European, South=60.13% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CCL-252; Cosmic-CLP=908457; KCLB=10252; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17,21
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21.2
ST   Penta D: 12
ST   Penta E: 5,8
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   NCI-H748
AC   CVCL_1588
SY   H748; H-748; NCIH748
DR   CLO; CLO_0008115
DR   EFO; EFO_0002304
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5841
DR   BioSample; SAMN03472833
DR   cancercelllines; CVCL_1588
DR   Cell_Model_Passport; SIDM01117
DR   ChEMBL-Cells; CHEMBL3308298
DR   ChEMBL-Targets; CHEMBL2366163
DR   Cosmic; 688030
DR   Cosmic; 844561
DR   Cosmic; 877213
DR   Cosmic; 877364
DR   Cosmic; 909194
DR   Cosmic; 980936
DR   Cosmic; 1021870
DR   Cosmic; 1032403
DR   Cosmic; 1152477
DR   Cosmic; 1759296
DR   Cosmic; 1995591
DR   Cosmic-CLP; 909194
DR   DepMap; ACH-002176
DR   DepMap; ACH-003071
DR   EGA; EGAS00001000978
DR   GDSC; 909194
DR   GEO; GSM169444
DR   GEO; GSM794300
DR   GEO; GSM1670264
DR   GEO; GSM1887920
DR   GEO; GSM1888002
DR   IARC_TP53; 21580
DR   IGRhCellID; NCIH748
DR   LINCS_LDP; LCL-1861
DR   PharmacoDB; NCIH748_1137_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1588
DR   PubChem_Cell_line; CVCL_1588
DR   Wikidata; Q54908120
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asp2237Metfs*4 (c.6709del); Zygosity=Heterozygous (Cosmic-CLP=909194; DepMap=ACH-003071).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ile324fs (c.967_968insA); Zygosity=Homozygous (DepMap=ACH-003071).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (Cosmic-CLP=909194; DepMap=ACH-003071).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=86.3%; Native American=0.85%; East Asian, North=1.88%; East Asian, South=0.4%; South Asian=0.04%; European, North=3.72%; European, South=6.8% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-002176; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5841; Cosmic-CLP=909194
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 19
ST   D19S433: 12,12.2
ST   D21S11: 28
ST   D2S1338: 19
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 25,27
ST   Penta D: 10
ST   Penta E: 8
ST   TH01: 7,9
ST   TPOX: 10,12
ST   vWA: 17,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A583 ! NCI-H792
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   NCI-H768
AC   CVCL_9982
DR   Wikidata; Q54908121
RX   PubMed=3479249;
RX   PubMed=8806092;
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   NCI-H774
AC   CVCL_1589
SY   H774; H-774
DR   CLO; CLO_0008116
DR   ATCC; CRL-5842
DR   BioSample; SAMN03472967
DR   cancercelllines; CVCL_1589
DR   Cosmic; 801618
DR   Cosmic; 844562
DR   Cosmic; 844809
DR   Cosmic; 876163
DR   Cosmic; 924243
DR   Cosmic; 1006530
DR   Cosmic; 1090400
DR   Cosmic; 1152478
DR   Cosmic; 1219105
DR   Cosmic; 1759297
DR   Cosmic; 2125258
DR   GEO; GSM1887921
DR   GEO; GSM1888003
DR   IARC_TP53; 438
DR   PRIDE; PXD011896
DR   Wikidata; Q54908122
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9331070;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=25877200;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (PubMed=9331070).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469; PubMed=10536175).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
ST   Source(s): ATCC=CRL-5842; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 14
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   NCI-H792
AC   CVCL_A583
SY   H792; H-792
DR   cancercelllines; CVCL_A583
DR   Cosmic; 844563
DR   Cosmic; 877365
DR   Cosmic; 1152479
DR   Cosmic; 1998278
DR   GEO; GSM536335
DR   Progenetix; CVCL_A583
DR   Wikidata; Q54908123
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=20615970;
RX   PubMed=31803961;
CC   Population: African American.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1588 ! NCI-H748
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   NCI-H810
AC   CVCL_1590
SY   H810; H-810; NCIH810
DR   CLO; CLO_0008117
DR   EFO; EFO_0002305
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5816
DR   BioSample; SAMN03471742
DR   BioSample; SAMN03473000
DR   BioSample; SAMN10987804
DR   cancercelllines; CVCL_1590
DR   Cell_Model_Passport; SIDM01116
DR   ChEMBL-Cells; CHEMBL3308483
DR   ChEMBL-Targets; CHEMBL1075546
DR   Cosmic; 755470
DR   Cosmic; 877413
DR   Cosmic; 925341
DR   Cosmic; 1995592
DR   Cosmic-CLP; 925341
DR   DepMap; ACH-000789
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 925341
DR   GEO; GSM827518
DR   GEO; GSM887446
DR   GEO; GSM888526
DR   GEO; GSM1374762
DR   GEO; GSM1374763
DR   GEO; GSM1670265
DR   GEO; GSM1682799
DR   IARC_TP53; 27195
DR   IGRhCellID; NCIH810
DR   KCLB; 90810
DR   LiGeA; CCLE_013
DR   LINCS_HMS; 50037
DR   LINCS_LDP; LCL-1670
DR   PharmacoDB; NCIH810_1138_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1590
DR   PubChem_Cell_line; CVCL_1590
DR   Wikidata; Q54908124
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   HLA typing: A*11:01,11:01; B*49:01,58:05; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2731; DDR2; Simple; p.Asn373del (c.1117_1119del); Zygosity=Heterozygous (Cosmic-CLP=925341; DepMap=ACH-000789).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Homozygous (Cosmic-CLP=925341; DepMap=ACH-000789).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=81.52%; Native American=0.47%; East Asian, North=4.23%; East Asian, South=0%; South Asian=0%; European, North=6.51%; European, South=7.26% (PubMed=30894373).
CC   Discontinued: KCLB; 90810; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5816; Cosmic-CLP=925341; PubMed=25877200
ST   Amelogenin: X,Y (ATCC=CRL-5816; Cosmic-CLP=925341)
ST   Amelogenin: Y (PubMed=25877200)
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 9
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 22
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 25,26
ST   Penta D: 2.2,10
ST   Penta E: 11
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NCI-H82
AC   CVCL_1591
SY   NCI-H-82; H82; H-82; NCI H82; NCIH82; H82sclc
DR   BTO; BTO_0003026
DR   CLO; CLO_0008118
DR   EFO; EFO_0002306
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-175
DR   BioGRID_ORCS_Cell_line; 808
DR   BioSample; SAMN03471034
DR   BioSample; SAMN10987912
DR   cancercelllines; CVCL_1591
DR   Cell_Model_Passport; SIDM01131
DR   ChEMBL-Cells; CHEMBL3308882
DR   ChEMBL-Targets; CHEMBL2366077
DR   CLS; 300442
DR   Cosmic; 688031
DR   Cosmic; 755461
DR   Cosmic; 801351
DR   Cosmic; 801611
DR   Cosmic; 844546
DR   Cosmic; 844818
DR   Cosmic; 850430
DR   Cosmic; 876166
DR   Cosmic; 877198
DR   Cosmic; 877352
DR   Cosmic; 897520
DR   Cosmic; 918011
DR   Cosmic; 929978
DR   Cosmic; 980927
DR   Cosmic; 1006523
DR   Cosmic; 1021850
DR   Cosmic; 1032393
DR   Cosmic; 1152462
DR   Cosmic; 1219097
DR   Cosmic; 1239935
DR   Cosmic; 1891902
DR   Cosmic; 1995593
DR   Cosmic; 1998280
DR   Cosmic; 2125201
DR   Cosmic; 2668274
DR   Cosmic; 2668342
DR   Cosmic-CLP; 688031
DR   DepMap; ACH-000355
DR   DSMZ; ACC-556
DR   DSMZCellDive; ACC-556
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10842-111E5
DR   GDSC; 688031
DR   GEO; GSM169450
DR   GEO; GSM170730
DR   GEO; GSM170731
DR   GEO; GSM171886
DR   GEO; GSM171887
DR   GEO; GSM380507
DR   GEO; GSM380516
DR   GEO; GSM482517
DR   GEO; GSM536336
DR   GEO; GSM784220
DR   GEO; GSM794270
DR   GEO; GSM827490
DR   GEO; GSM844660
DR   GEO; GSM845551
DR   GEO; GSM887447
DR   GEO; GSM888527
DR   GEO; GSM1374764
DR   GEO; GSM1670266
DR   GEO; GSM1887960
DR   GEO; GSM1887979
DR   IARC_TP53; 440
DR   IARC_TP53; 21402
DR   IGRhCellID; NCIH82
DR   KCLB; 30175
DR   LiGeA; CCLE_485
DR   LINCS_LDP; LCL-1862
DR   NCI-DTP; NCI-H82
DR   PharmacoDB; NCIH82_1139_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1591
DR   PubChem_Cell_line; CVCL_1591
DR   Wikidata; Q54908125
RX   PubMed=1312696;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=1845952;
RX   PubMed=2388294;
RX   PubMed=2473086;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=2986243;
RX   PubMed=3335022;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6713399;
RX   PubMed=7720728;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=10709110;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=16157194;
RX   PubMed=17426248;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=20615970;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=24700732;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=34439128;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/LungCellLineDescriptions/NCI-H82.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=25984343); ~25 hours (CLS=300442); ~30 hours (DSMZ=ACC-556).
CC   HLA typing: A*01:01,02:01; B*58,08; C*07:01,01:02; DQA1*04:01,04:01; DQB1*04:02,02:02; DRB1*11:08,11:08 (PubMed=25960936).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7577; MYH7 + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-MYH7 (PubMed=23716474).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>T); ClinVar=VCV000237948; Zygosity=Unspecified; Note=Impairs TP53 splicing dramatically (PubMed=1312696; PubMed=1565469; PubMed=20557307; PubMed=24700732).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=1.21%; East Asian, South=0%; South Asian=0%; European, North=78.65%; European, South=19.9% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-175; CLS=300442; Cosmic-CLP=688031; DSMZ=ACC-556; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 14,18
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 11,12
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   NCI-H82-A
AC   CVCL_WM70
SY   NCI-H82A
DR   cancercelllines; CVCL_WM70
DR   Wikidata; Q95993676
RX   PubMed=2473086;
RX   PubMed=7720728;
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line by selection of the adherent cells.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7577; MYH7 + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-MYH7 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Thr (c.375G>T); ClinVar=VCV000237948; Zygosity=Unspecified; Note=Impairs TP53 splicing dramatically (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1591 ! NCI-H82
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   NCI-H820
AC   CVCL_1592
SY   H820; H-820; NCIH820
DR   BTO; BTO_0006024
DR   CLO; CLO_0008119
DR   EFO; EFO_0003125
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; HTB-181
DR   BioGRID_ORCS_Cell_line; 1442
DR   BioSample; SAMN03473295
DR   cancercelllines; CVCL_1592
DR   Cell_Model_Passport; SIDM00019
DR   Cosmic; 903579
DR   Cosmic; 1028945
DR   Cosmic; 1128247
DR   Cosmic; 1129778
DR   Cosmic; 1146923
DR   Cosmic; 1333019
DR   Cosmic; 1802301
DR   Cosmic; 2125259
DR   DepMap; ACH-001140
DR   EGA; EGAS00001000610
DR   GEO; GSM108855
DR   GEO; GSM108856
DR   GEO; GSM434282
DR   GEO; GSM784252
DR   GEO; GSM794301
DR   GEO; GSM817078
DR   IARC_TP53; 528
DR   IGRhCellID; H820GEO
DR   PharmacoDB; NCIH820_1140_2019
DR   Progenetix; CVCL_1592
DR   Wikidata; Q54908126
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=2386953;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20557307;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 65.2 hours (PubMed=29681454).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:06,07:06 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr284Pro (c.850A>C); ClinVar=VCV001763670; Zygosity=Homozygous (PubMed=1311061; PubMed=1565469; PubMed=20557307; DepMap=ACH-001140).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.6%; Native American=0%; East Asian, North=0.97%; East Asian, South=0%; South Asian=0.4%; European, North=65.84%; European, South=32.19% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-001140; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-181; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 10,13
ST   D8S1179: 10
ST   FGA: 25
ST   Penta D: 8,9
ST   Penta E: 15
ST   TH01: 8
ST   TPOX: 12
ST   vWA: 18
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 39
//
ID   NCI-H835
AC   CVCL_1593
SY   H835; H-835; NCIH835
DR   CLO; CLO_0008120
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5843
DR   BioSample; SAMN03472570
DR   cancercelllines; CVCL_1593
DR   Cell_Model_Passport; SIDM01133
DR   Cosmic; 753607
DR   Cosmic; 877268
DR   Cosmic; 1032467
DR   Cosmic; 2433548
DR   Cosmic-CLP; 753607
DR   DepMap; ACH-002177
DR   EGA; EGAS00001000978
DR   GDSC; 753607
DR   GEO; GSM1670267
DR   GEO; GSM1682800
DR   KCLB; 90835
DR   PharmacoDB; NCIH835_1141_2019
DR   Wikidata; Q54908127
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=20164919;
RX   PubMed=26087898;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31803961;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Arg1446Cys (c.4336C>T); ClinVar=VCV000095047; Zygosity=Heterozygous (DepMap=ACH-002177).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=80.01%; Native American=0%; East Asian, North=2.97%; East Asian, South=0%; South Asian=0%; European, North=9.74%; European, South=7.28% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5843; Cosmic-CLP=753607
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 17,18
ST   D19S433: 11,13
ST   D21S11: 27,30
ST   D2S1338: 19,26
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 11,12
ST   Penta E: 10,15
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4038; Lung carcinoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   NCI-H838
AC   CVCL_1594
SY   H838; H-838; NCIH838
DR   BTO; BTO_0003239
DR   CLO; CLO_0008121
DR   EFO; EFO_0002307
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5844
DR   BioGRID_ORCS_Cell_line; 517
DR   BioSample; SAMN03471317
DR   BioSample; SAMN10987750
DR   cancercelllines; CVCL_1594
DR   CCRID; 3101HUMSCSP588
DR   Cell_Model_Passport; SIDM01150
DR   ChEMBL-Cells; CHEMBL3308122
DR   ChEMBL-Targets; CHEMBL1075547
DR   CLS; 305097
DR   Cosmic; 687830
DR   Cosmic; 877239
DR   Cosmic; 877414
DR   Cosmic; 903580
DR   Cosmic; 910399
DR   Cosmic; 980968
DR   Cosmic; 1032440
DR   Cosmic; 1802315
DR   Cosmic; 1870278
DR   Cosmic; 2042864
DR   Cosmic; 2630411
DR   Cosmic-CLP; 910399
DR   DepMap; ACH-000416
DR   EGA; EGAS00001000978
DR   GDSC; 910399
DR   GEO; GSM206500
DR   GEO; GSM274794
DR   GEO; GSM274822
DR   GEO; GSM513966
DR   GEO; GSM514352
DR   GEO; GSM784196
DR   GEO; GSM794302
DR   GEO; GSM827482
DR   GEO; GSM887448
DR   GEO; GSM888528
DR   GEO; GSM1374765
DR   GEO; GSM1374766
DR   GEO; GSM1670268
DR   IARC_TP53; 25039
DR   IARC_TP53; 30215
DR   IGRhCellID; NCIH838
DR   KCB; KCB 2021016YJ
DR   LiGeA; CCLE_510
DR   LINCS_LDP; LCL-1623
DR   NCI-DTP; NCI-H838
DR   PharmacoDB; NCIH838_1142_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1594
DR   PubChem_Cell_line; CVCL_1594
DR   Wikidata; Q54908128
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=18083107;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25714623;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=29681454;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 55 hours (PubMed=25984343); 26.4 hours (PubMed=29681454).
CC   HLA typing: A*30:02,30:02; B*48:01,56:03; C*05:01,05:01 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y (PubMed=25714623).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro1876Serfs*22 (c.5625_5632del) (p.CPP1657fs) (c.5621_5628delGCCCACCA); Zygosity=Heterozygous (Cosmic-CLP=910399; DepMap=ACH-000416).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Homozygous (Cosmic-CLP=910399; DepMap=ACH-000416).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0.84%; East Asian, North=0.79%; East Asian, South=1.88%; South Asian=3.04%; European, North=50.18%; European, South=43.22% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5844; Cosmic-CLP=910399; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 15.2
ST   D21S11: 32.2
ST   D2S1338: 18
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13,16
ST   FGA: 22.2
ST   Penta D: 11
ST   Penta E: 5,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 47
//
ID   NCI-H838 EGFR (delE746-A750/+)
AC   CVCL_LE02
SY   EGFR (delE746-A750/+) NCI-H838
DR   cancercelllines; CVCL_LE02
DR   Horizon_Discovery; HD+114-004
DR   Wikidata; Q54908129
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro1876Serfs*22 (c.5625_5632del) (p.CPP1657fs) (c.5621_5628delGCCCACCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Glu746_Ala750del; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+114-004).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1594 ! NCI-H838
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   NCI-H838 EGFR (L858R/+)
AC   CVCL_LD05
SY   EGFR (L858R/+) NCI-H838
DR   cancercelllines; CVCL_LD05
DR   Horizon_Discovery; HD+114-005
DR   Wikidata; Q54908130
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro1876Serfs*22 (c.5625_5632del) (p.CPP1657fs) (c.5621_5628delGCCCACCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+114-005).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1594 ! NCI-H838
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   NCI-H838 KRAS (G12D/+9n)
AC   CVCL_A4IK
SY   KRAS (G12D/+9n) NCI-H838
DR   cancercelllines; CVCL_A4IK
DR   Horizon_Discovery; HD+114-002
DR   Wikidata; Q105510321
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation in 10 copies.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro1876Serfs*22 (c.5625_5632del) (p.CPP1657fs) (c.5621_5628delGCCCACCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+114-002).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1594 ! NCI-H838
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   NCI-H838 KRAS (G12V/+9n)
AC   CVCL_A4IL
SY   KRAS (G12V/+9n) NCI-H838
DR   cancercelllines; CVCL_A4IL
DR   Horizon_Discovery; HD+114-003
DR   Wikidata; Q105510325
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation in 10 copies.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro1876Serfs*22 (c.5625_5632del) (p.CPP1657fs) (c.5621_5628delGCCCACCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+114-003).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu62Ter (c.184G>T); ClinVar=VCV000617472; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1594 ! NCI-H838
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   NCI-H841
AC   CVCL_1595
SY   H841; H-841; NCI-841; NCIH841
DR   CLO; CLO_0008122
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5845
DR   BioSample; SAMN03471025
DR   BioSample; SAMN10988536
DR   cancercelllines; CVCL_1595
DR   Cell_Model_Passport; SIDM01134
DR   Cosmic; 801616
DR   Cosmic; 844564
DR   Cosmic; 876162
DR   Cosmic; 897511
DR   Cosmic; 918013
DR   Cosmic; 1021871
DR   Cosmic; 1032404
DR   Cosmic; 1219092
DR   Cosmic; 1239941
DR   Cosmic; 1891907
DR   Cosmic; 2125187
DR   Cosmic-CLP; 1240192
DR   DepMap; ACH-000292
DR   EGA; EGAS00001000978
DR   GDSC; 1240192
DR   GEO; GSM171888
DR   GEO; GSM171889
DR   GEO; GSM794303
DR   GEO; GSM827488
DR   GEO; GSM844661
DR   GEO; GSM845552
DR   GEO; GSM887449
DR   GEO; GSM888529
DR   GEO; GSM986177
DR   GEO; GSM1670269
DR   GEO; GSM1887922
DR   GEO; GSM1888004
DR   IARC_TP53; 11886
DR   KCLB; 90841
DR   LiGeA; CCLE_365
DR   LINCS_LDP; LCL-1819
DR   PharmacoDB; NCIH841_1143_2019
DR   Progenetix; CVCL_1595
DR   Wikidata; Q54908131
RX   PubMed=8784480;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=23716474;
RX   PubMed=25877200;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=38180245;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Lys934Ter (c.2800A>T); Zygosity=Homozygous (Cosmic-CLP=1240192; DepMap=ACH-000292).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Ser (c.725G>C); ClinVar=VCV000647334; Zygosity=Homozygous (PubMed=10536175; PubMed=20557307; Cosmic-CLP=1240192; DepMap=ACH-000292).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.52%; Native American=0%; East Asian, North=2.66%; East Asian, South=0%; South Asian=0%; European, North=55.47%; European, South=40.35% (PubMed=30894373).
CC   Caution: Originally classified as originating from a lung small cell carcinoma, but is reclassified as a thoracic SMARCA4-deficient undifferentiated tumor based on a number of criteria (PubMed=38180245).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5845; Cosmic-CLP=1240192; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 14,18
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 24
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 8,16
ST   FGA: 22
ST   Penta D: 9,16
ST   Penta E: 5,10
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C183115; Thoracic SMARCA4-deficient undifferentiated tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 38
//
ID   NCI-H847
AC   CVCL_1596
SY   H847; H-847; NCIH847
DR   CLO; CLO_0008123
DR   EFO; EFO_0006696
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5846
DR   BioSample; SAMN03473053
DR   cancercelllines; CVCL_1596
DR   Cell_Model_Passport; SIDM01149
DR   Cosmic; 877214
DR   Cosmic; 980937
DR   Cosmic; 1032405
DR   Cosmic-CLP; 1240193
DR   DepMap; ACH-001365
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240193
DR   GEO; GSM1670270
DR   GEO; GSM1887940
DR   GEO; GSM1888028
DR   LINCS_LDP; LCL-1863
DR   PharmacoDB; NCIH847_1144_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54908132
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=20679594;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,23:01; B*07:02,44:03; C*04:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Homozygous (DepMap=ACH-001365).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.07%; Native American=0.08%; East Asian, North=4.4%; East Asian, South=0%; South Asian=0%; European, North=55.14%; European, South=35.3% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5846; Cosmic-CLP=1240193; PubMed=20679594; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 24,25
ST   Penta D: 11
ST   Penta E: 12,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NCI-H854
AC   CVCL_A584
SY   H854; H-854; NCIH854
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5847
DR   BioSample; SAMN10988075
DR   cancercelllines; CVCL_A584
DR   Cosmic; 903581
DR   DepMap; ACH-000710
DR   GEO; GSM887450
DR   GEO; GSM888530
DR   IARC_TP53; 529
DR   KCLB; 90854
DR   LiGeA; CCLE_915
DR   PharmacoDB; NCIH854_1145_2019
DR   Progenetix; CVCL_A584
DR   Wikidata; Q54908133
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*29:02,29:02; B*07:17,44:03; C*16:01,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-000710).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (PubMed=1311061; DepMap=ACH-000710).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.09%; Native American=0.03%; East Asian, North=1.91%; East Asian, South=0%; South Asian=0.45%; European, North=64.74%; European, South=31.78% (PubMed=30894373).
CC   Caution: Indicated as originating from colon in PubMed=8806092 and in ATCC, from lung in PubMed=11030152 and CCLE.
CC   Discontinued: ATCC; CRL-5847; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=90854
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 11
ST   FGA: 21
ST   TH01: 8
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   NCI-H862
AC   CVCL_A585
SY   H862; H-862
DR   ATCC; CRL-5848
DR   Wikidata; Q54908134
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Discontinued: ATCC; CRL-5848; true.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   NCI-H865
AC   CVCL_1597
SY   H865; H-865
DR   CLO; CLO_0008124
DR   ATCC; CRL-5849
DR   BioSample; SAMN03473066
DR   Cosmic; 877215
DR   Cosmic; 877366
DR   Cosmic; 897521
DR   Cosmic; 980938
DR   Cosmic; 1032406
DR   Cosmic; 1152480
DR   GDSC; 1330977
DR   GEO; GSM794304
DR   GEO; GSM1887895
DR   GEO; GSM1887980
DR   KCLB; 90865
DR   PharmacoDB; NCIH865_1146_2019
DR   Wikidata; Q54908136
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=22961666;
RX   PubMed=25877200;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=31803961;
RX   PubMed=32586373;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Misspelling: H2865; PubMed=22961666; Note=In supplementary table 1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5849; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 28,29
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-H889
AC   CVCL_1598
SY   H889; H-889; NCIH889
DR   BTO; BTO_0005667
DR   CLO; CLO_0008125
DR   EFO; EFO_0006697
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-5817
DR   BioSample; SAMN03473246
DR   BioSample; SAMN10988219
DR   cancercelllines; CVCL_1598
DR   Cell_Model_Passport; SIDM01739
DR   ChEMBL-Cells; CHEMBL3308299
DR   ChEMBL-Targets; CHEMBL2366169
DR   Cosmic; 688032
DR   Cosmic; 844565
DR   Cosmic; 850438
DR   Cosmic; 877216
DR   Cosmic; 877367
DR   Cosmic; 908456
DR   Cosmic; 980939
DR   Cosmic; 1032407
DR   Cosmic; 1759300
DR   Cosmic; 2125211
DR   DepMap; ACH-000297
DR   EGA; EGAS00001000610
DR   GEO; GSM169427
DR   GEO; GSM170713
DR   GEO; GSM170715
DR   GEO; GSM171890
DR   GEO; GSM171891
DR   GEO; GSM784261
DR   GEO; GSM794305
DR   GEO; GSM827420
DR   GEO; GSM844662
DR   GEO; GSM845553
DR   GEO; GSM887451
DR   GEO; GSM888531
DR   GEO; GSM1887897
DR   GEO; GSM1887981
DR   IARC_TP53; 257
DR   KCLB; 25817
DR   LiGeA; CCLE_196
DR   LINCS_LDP; LCL-1864
DR   PharmacoDB; NCIH889_1147_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_1598
DR   PubChem_Cell_line; CVCL_1598
DR   Wikidata; Q54908137
RX   PubMed=1312696;
RX   PubMed=1565469;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=10037197;
RX   PubMed=11030152;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20624269;
RX   PubMed=22460905;
RX   PubMed=22961666;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=32586373;
RX   PubMed=39154123;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07:02,08:01; C*07:01,07:01 (PubMed=25960936).
CC   HLA typing: A*02:01,02:01; B*07:02,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Ser (c.725G>C); ClinVar=VCV000647334; Zygosity=Unspecified (PubMed=1312696; PubMed=1565469).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.19%; Native American=0%; East Asian, North=1.86%; East Asian, South=0%; South Asian=0.01%; European, North=71.51%; European, South=26.44% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-5817; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 8
ST   D18S51: 13,18
ST   D19S433: 14,16.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 18,19
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10
ST   FGA: 22
ST   Penta D: 10,15
ST   Penta E: 7
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   NCI-H890
AC   CVCL_A586
SY   H890; H-890
DR   Wikidata; Q54908140
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   NCI-H920
AC   CVCL_1599
SY   H920; H-920
DR   CLO; CLO_0008126
DR   EFO; EFO_0006698
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-5850
DR   BioSample; SAMN03472571
DR   BioSample; SAMN03473001
DR   cancercelllines; CVCL_1599
DR   Cosmic; 877240
DR   Cosmic; 903582
DR   Cosmic; 980969
DR   Cosmic; 1032441
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM513967
DR   GEO; GSM514353
DR   GEO; GSM794306
DR   IARC_TP53; 530
DR   KCLB; 90920
DR   PharmacoDB; NCIH920_1148_2019
DR   Progenetix; CVCL_1599
DR   Wikidata; Q54908141
RX   PubMed=1311061;
RX   PubMed=1565469;
RX   PubMed=2386953;
RX   PubMed=8806092;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 42.5 hours (PubMed=29681454).
CC   HLA typing: A*03:01,24:02; B*27:05,35:01; C*02:02,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>T; ClinVar=VCV003148249; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=1311061; PubMed=1565469).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a 75 packs per year smoker (ATCC=CRL-5850).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5850; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 10,13
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,22,23
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 10 (PubMed=25877200)
ST   D7S820: 10,11 (ATCC=CRL-5850)
ST   D8S1179: 12,15 (ATCC=CRL-5850)
ST   D8S1179: 15 (PubMed=25877200)
ST   FGA: 22,24
ST   Penta D: 10
ST   Penta E: 10 (PubMed=25877200)
ST   Penta E: 10,18,19 (ATCC=CRL-5850)
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   NCI-H929
AC   CVCL_1600
SY   NCI H929; NCIH929; H929; H-929
DR   BTO; BTO_0002416
DR   CLO; CLO_0008127
DR   EFO; EFO_0001221
DR   CLDB; cl3661
DR   CLDB; cl3662
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-1088
DR   ATCC; CRL-3580
DR   ATCC; CRL-9068
DR   BCRC; 60386
DR   BioSample; SAMN03473361
DR   BioSample; SAMN10988115
DR   cancercelllines; CVCL_1600
DR   CCRID; 1101HUM-PUMC000360
DR   CCRID; 4201HUM-CCTCC00300
DR   CCTCC; GDC0300
DR   Cell_Model_Passport; SIDM01148
DR   ChEMBL-Cells; CHEMBL4295412
DR   ChEMBL-Targets; CHEMBL4296391
DR   CLS; 305236
DR   Cosmic; 720769
DR   Cosmic; 724825
DR   Cosmic; 759905
DR   Cosmic; 760391
DR   Cosmic; 760392
DR   Cosmic; 886085
DR   Cosmic; 888022
DR   Cosmic; 1070716
DR   Cosmic; 1424217
DR   Cosmic; 2081399
DR   Cosmic; 2302415
DR   Cosmic; 2367293
DR   Cosmic; 2391791
DR   Cosmic; 2809759
DR   Cosmic-CLP; 724825
DR   DepMap; ACH-000050
DR   DSMZ; ACC-163
DR   DSMZCellDive; ACC-163
DR   ECACC; 95050415
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS197CBA
DR   ENCODE; ENCBS571AQH
DR   GDSC; 724825
DR   GEO; GSM143333
DR   GEO; GSM290290
DR   GEO; GSM562817
DR   GEO; GSM887452
DR   GEO; GSM888532
DR   GEO; GSM1374767
DR   GEO; GSM1670271
DR   IARC_TP53; 28520
DR   LiGeA; CCLE_061
DR   Lonza; 47
DR   PharmacoDB; NCIH929_1149_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1600
DR   PubChem_Cell_line; CVCL_1600
DR   Wikidata; Q54908142
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US4892829;
RX   PubMed=2423157;
RX   PubMed=3275865;
RX   PubMed=8806089;
RX   PubMed=8806092;
RX   PubMed=8943038;
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=12068308;
RX   PubMed=16956823;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/h929-xenograft-model/
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9068.
CC   Population: Caucasian.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: ~50 hours (Patent=US4892829; PubMed=2423157); ~70 hours (DSMZ=ACC-163).
CC   HLA typing: A*26,30; B*18,35; C*04,07 (PubMed=25688540).
CC   HLA typing: A*03:01,24:02; B*07:02,18:01; C*07:02,07:02; DQA1*01:02,03:02; DQB1*02:02,06:13; DRB1*04:05,16:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Heterozygous (PubMed=11157491; PubMed=12068308; PubMed=21173094; ATCC=CRL-3580).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.61%; East Asian, North=2.52%; East Asian, South=0%; South Asian=0.16%; European, North=68.5%; European, South=28.21% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-9068; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ATCC=CRL-3580; CCRID=1101HUM-PUMC000360; Cosmic-CLP=724825; DSMZ=ACC-163; ECACC=95050415; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,11 (ATCC=CRL-3580; DSMZ=ACC-163)
ST   CSF1PO: 11 (CCRID=1101HUM-PUMC000360; Cosmic-CLP=724825; ECACC=95050415; Technion Genomics Center)
ST   D10S1248: 13
ST   D12S391: 19.3
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 15,18
ST   D19S433: 13,14
ST   D1S1656: 17.3
ST   D21S11: 28,29
ST   D22S1045: 15
ST   D2S1338: 17,19
ST   D2S441: 10,14
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 21,24
ST   Penta D: 12,13 (DSMZ=ACC-163)
ST   Penta D: 12,14 (Technion Genomics Center)
ST   Penta E: 7,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   NCI-H929B
AC   CVCL_M400
DR   cancercelllines; CVCL_M400
DR   Wikidata; Q54908143
RX   PubMed=19830855;
CC   Population: Caucasian.
CC   Characteristics: Produces IgA kappa.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1600 ! NCI-H929
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   NCI-H930
AC   CVCL_A587
SY   H930; H-930
DR   Wikidata; Q54908145
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11030152;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   NCI-H958
AC   CVCL_9983
DR   Wikidata; Q54908146
RX   PubMed=3479249;
RX   PubMed=8806092;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   NCI-H962
AC   CVCL_A588
SY   H962; H-962
DR   Wikidata; Q54908147
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=31803961;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   NCI-H969
AC   CVCL_1601
SY   H969; H-969
DR   CLO; CLO_0008128
DR   ATCC; CRL-5852
DR   BioSample; SAMN03472572
DR   cancercelllines; CVCL_1601
DR   Cosmic; 903583
DR   GEO; GSM513968
DR   GEO; GSM514354
DR   GEO; GSM794307
DR   IARC_TP53; 21724
DR   Progenetix; CVCL_1601
DR   Wikidata; Q54908148
RX   PubMed=1311061;
RX   PubMed=8806092;
RX   PubMed=11030152;
RX   PubMed=28196595;
RX   PubMed=29681454;
RX   PubMed=31803961;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-5852; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5852
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   NCI-HPN-F1A Mam
AC   CVCL_S752
DR   CancerTools; 161023
DR   SKY/M-FISH/CGH; 5809
DR   Wikidata; Q54908149
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F1B Kid
AC   CVCL_S753
SY   F1B Kidney
DR   CancerTools; 161028
DR   SKY/M-FISH/CGH; 5666
DR   Wikidata; Q54908150
RX   PubMed=22161874;
RX   PubMed=23619298;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-F1D Kid
AC   CVCL_S754
DR   CancerTools; 161038
DR   SKY/M-FISH/CGH; 5777
DR   Wikidata; Q54908151
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-F1G Blad
AC   CVCL_S755
SY   F1G Bladder
DR   CancerTools; 161039
DR   SKY/M-FISH/CGH; 5671
DR   Wikidata; Q54908152
RX   PubMed=22161874;
RX   PubMed=23619298;
RX   PubMed=29732388;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S756 ! NCI-HPN-F1G Kid
OI   CVCL_S757 ! NCI-HPN-F1G Mam
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F1G Kid
AC   CVCL_S756
SY   F1G Kidney
DR   CancerTools; 161040
DR   SKY/M-FISH/CGH; 5675
DR   Wikidata; Q54908153
RX   PubMed=22161874;
RX   PubMed=23619298;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S755 ! NCI-HPN-F1G Blad
OI   CVCL_S757 ! NCI-HPN-F1G Mam
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-F1G Mam
AC   CVCL_S757
DR   CancerTools; 161041
DR   SKY/M-FISH/CGH; 5808
DR   Wikidata; Q54908154
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S755 ! NCI-HPN-F1G Blad
OI   CVCL_S756 ! NCI-HPN-F1G Kid
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F1I Cervix
AC   CVCL_S758
DR   CancerTools; 161049
DR   SKY/M-FISH/CGH; 5795
DR   Wikidata; Q54908155
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S759 ! NCI-HPN-F1I Mam
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F1I Mam
AC   CVCL_S759
DR   CancerTools; 161050
DR   SKY/M-FISH/CGH; 5807
DR   Wikidata; Q54908156
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S758 ! NCI-HPN-F1I Cervix
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F1K Colon
AC   CVCL_S760
DR   CancerTools; 161053
DR   GEO; GSM1818744
DR   GEO; GSM1860700
DR   GEO; GSM1860702
DR   GEO; GSM1860711
DR   GEO; GSM1860715
DR   Wikidata; Q54908157
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   NCI-HPN-F1L Cervix
AC   CVCL_S761
DR   CancerTools; 161059
DR   SKY/M-FISH/CGH; 5781
DR   Wikidata; Q54908158
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F1Q Kid
AC   CVCL_S762
DR   CancerTools; 161061
DR   SKY/M-FISH/CGH; 5778
DR   Wikidata; Q54908159
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-F23 Mam
AC   CVCL_S763
DR   CancerTools; 161064
DR   SKY/M-FISH/CGH; 5810
DR   Wikidata; Q54908161
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F24 Mam
AC   CVCL_S764
DR   CancerTools; 161065
DR   SKY/M-FISH/CGH; 5811
DR   Wikidata; Q54908162
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F2B Lung
AC   CVCL_S765
DR   CancerTools; 161029
DR   SKY/M-FISH/CGH; 5750
DR   Wikidata; Q54908164
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F2G Blad
AC   CVCL_S766
SY   F2G Bladder
DR   CancerTools; 161042
DR   SKY/M-FISH/CGH; 5672
DR   Wikidata; Q54908165
RX   PubMed=22161874;
RX   PubMed=23619298;
RX   PubMed=29732388;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S767 ! NCI-HPN-F2G Kid
OI   CVCL_S768 ! NCI-HPN-F2G Lung
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-F2G Kid
AC   CVCL_S767
SY   F2G Kidney
DR   CancerTools; 161043
DR   SKY/M-FISH/CGH; 5676
DR   Wikidata; Q54908166
RX   PubMed=22161874;
RX   PubMed=23619298;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S766 ! NCI-HPN-F2G Blad
OI   CVCL_S768 ! NCI-HPN-F2G Lung
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-F2G Lung
AC   CVCL_S768
DR   CancerTools; 161044
DR   SKY/M-FISH/CGH; 5805
DR   Wikidata; Q54908167
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S766 ! NCI-HPN-F2G Blad
OI   CVCL_S767 ! NCI-HPN-F2G Kid
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F2I Cervix
AC   CVCL_S769
DR   CancerTools; 161051
DR   SKY/M-FISH/CGH; 5796
DR   Wikidata; Q54908168
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F2K Colon
AC   CVCL_S770
DR   CancerTools; 161054
DR   GEO; GSM1818745
DR   GEO; GSM1860703
DR   GEO; GSM1860708
DR   GEO; GSM1860712
DR   Wikidata; Q54908169
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   NCI-HPN-F2L Cervix
AC   CVCL_S771
DR   Wikidata; Q54908170
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   NCI-HPN-F3A Lung
AC   CVCL_S772
DR   CancerTools; 161024
DR   SKY/M-FISH/CGH; 5798
DR   Wikidata; Q54908171
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F3K Colon
AC   CVCL_S773
DR   CancerTools; 161055
DR   GEO; GSM1818746
DR   GEO; GSM1860699
DR   GEO; GSM1860706
DR   GEO; GSM1860713
DR   Wikidata; Q54908172
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   NCI-HPN-F3L Cervix
AC   CVCL_S774
DR   CancerTools; 161060
DR   SKY/M-FISH/CGH; 5782
DR   Wikidata; Q54908173
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   NCI-HPN-F43 Mam
AC   CVCL_S775
DR   CancerTools; 161066
DR   SKY/M-FISH/CGH; 5812
DR   Wikidata; Q54908174
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F44 Mam
AC   CVCL_S776
DR   CancerTools; 161067
DR   SKY/M-FISH/CGH; 5813
DR   Wikidata; Q54908175
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-F4K Colon
AC   CVCL_S777
DR   CancerTools; 161056
DR   GEO; GSM1818747
DR   GEO; GSM1860710
DR   Wikidata; Q54908176
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   NCI-HPN-F5A Cervix
AC   CVCL_S778
DR   CancerTools; 161025
DR   SKY/M-FISH/CGH; 5783
DR   Wikidata; Q54908177
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M1A Lung
AC   CVCL_S779
DR   CancerTools; 161026
DR   SKY/M-FISH/CGH; 5799
DR   Wikidata; Q54908178
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M1C Blad
AC   CVCL_S780
SY   M1C Bladder
DR   CancerTools; 161030
DR   SKY/M-FISH/CGH; 5668
DR   Wikidata; Q54908179
RX   PubMed=22161874;
RX   PubMed=23619298;
RX   PubMed=29732388;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S781 ! NCI-HPN-M1C Colon
OI   CVCL_S782 ! NCI-HPN-M1C Kid
OI   CVCL_S783 ! NCI-HPN-M1C Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M1C Colon
AC   CVCL_S781
SY   NCI-HPN-M1C Colon p45
DR   CancerTools; 161031
DR   SKY/M-FISH/CGH; 5817
DR   Wikidata; Q54908180
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S780 ! NCI-HPN-M1C Blad
OI   CVCL_S782 ! NCI-HPN-M1C Kid
OI   CVCL_S783 ! NCI-HPN-M1C Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M1C Kid
AC   CVCL_S782
SY   M1C Kidney
DR   CancerTools; 161032
DR   SKY/M-FISH/CGH; 5673
DR   Wikidata; Q54908181
RX   PubMed=22161874;
RX   PubMed=23619298;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S780 ! NCI-HPN-M1C Blad
OI   CVCL_S781 ! NCI-HPN-M1C Colon
OI   CVCL_S783 ! NCI-HPN-M1C Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-M1C Lung
AC   CVCL_S783
DR   CancerTools; 161033
DR   SKY/M-FISH/CGH; 5801
DR   Wikidata; Q54908182
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S780 ! NCI-HPN-M1C Blad
OI   CVCL_S781 ! NCI-HPN-M1C Colon
OI   CVCL_S782 ! NCI-HPN-M1C Kid
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M1G Kid
AC   CVCL_S784
DR   CancerTools; 161045
DR   SKY/M-FISH/CGH; 5776
DR   Wikidata; Q54908189
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S785 ! NCI-HPN-M1G Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-M1G Lung
AC   CVCL_S785
DR   CancerTools; 161046
DR   SKY/M-FISH/CGH; 5803
DR   Wikidata; Q54908190
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S784 ! NCI-HPN-M1G Kid
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M1I Blad
AC   CVCL_S786
SY   M1I Bladder
DR   CancerTools; 161052
DR   SKY/M-FISH/CGH; 5670
DR   Wikidata; Q54908191
RX   PubMed=22161874;
RX   PubMed=23619298;
RX   PubMed=29732388;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M1K Colon
AC   CVCL_S787
SY   NCI-HPN-M1K Colon p28
DR   CancerTools; 161057
DR   GEO; GSM1818748
DR   GEO; GSM1860701
DR   GEO; GSM1860704
DR   GEO; GSM1860709
DR   SKY/M-FISH/CGH; 5819
DR   Wikidata; Q54908192
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   NCI-HPN-M1N Kid
AC   CVCL_S788
DR   CancerTools; 161062
DR   SKY/M-FISH/CGH; 5779
DR   Wikidata; Q54908193
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-M1P Kid
AC   CVCL_S789
DR   CancerTools; 161063
DR   SKY/M-FISH/CGH; 5780
DR   Wikidata; Q54908194
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-M2C Blad
AC   CVCL_S790
SY   M2C Bladder
DR   CancerTools; 161034
DR   SKY/M-FISH/CGH; 5669
DR   Wikidata; Q54908195
RX   PubMed=22161874;
RX   PubMed=23619298;
RX   PubMed=29732388;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S791 ! NCI-HPN-M2C Colon
OI   CVCL_S792 ! NCI-HPN-M2C Kid
OI   CVCL_S793 ! NCI-HPN-M2C Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M2C Colon
AC   CVCL_S791
SY   NCI-HPN-M2C Colon P48
DR   CancerTools; 161035
DR   GEO; GSM1818749
DR   GEO; GSM1860714
DR   SKY/M-FISH/CGH; 5186
DR   Wikidata; Q54908196
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S790 ! NCI-HPN-M2C Blad
OI   CVCL_S792 ! NCI-HPN-M2C Kid
OI   CVCL_S793 ! NCI-HPN-M2C Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   NCI-HPN-M2C Kid
AC   CVCL_S792
SY   M2C Kidney
DR   CancerTools; 161036
DR   SKY/M-FISH/CGH; 5674
DR   Wikidata; Q54908197
RX   PubMed=22161874;
RX   PubMed=23619298;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S790 ! NCI-HPN-M2C Blad
OI   CVCL_S791 ! NCI-HPN-M2C Colon
OI   CVCL_S793 ! NCI-HPN-M2C Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-M2C Lung
AC   CVCL_S793
DR   CancerTools; 161037
DR   SKY/M-FISH/CGH; 5802
DR   Wikidata; Q54908198
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S790 ! NCI-HPN-M2C Blad
OI   CVCL_S791 ! NCI-HPN-M2C Colon
OI   CVCL_S792 ! NCI-HPN-M2C Kid
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M2G Kid
AC   CVCL_S794
DR   CancerTools; 161047
DR   SKY/M-FISH/CGH; 5677
DR   Wikidata; Q54908199
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S795 ! NCI-HPN-M2G Lung
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   NCI-HPN-M2G Lung
AC   CVCL_S795
DR   CancerTools; 161048
DR   SKY/M-FISH/CGH; 5804
DR   Wikidata; Q54908200
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S794 ! NCI-HPN-M2G Kid
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-HPN-M2K Colon
AC   CVCL_S796
SY   NCI-HPN-M2K Colon p29
DR   CancerTools; 161058
DR   GEO; GSM1818750
DR   GEO; GSM1860705
DR   GEO; GSM1860707
DR   SKY/M-FISH/CGH; 5818
DR   Wikidata; Q54908201
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   NCI-HPN-M4A Lung
AC   CVCL_S797
DR   CancerTools; 161027
DR   SKY/M-FISH/CGH; 5800
DR   Wikidata; Q54908202
RX   PubMed=22161874;
CC   Part of: NCI-45 mouse cell line panel.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   5-6W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   NCI-hTERT-CL5
AC   CVCL_JY25
DR   cancercelllines; CVCL_JY25
DR   Wikidata; Q54908203
RX   PubMed=26074691;
CC   Characteristics: Overexpresses TERT; compared to the parent cell line, it has better adhesion properties, ability to be maintained in culture for longer periods after confluency and is more efficient in mucins MUC1, MUC2 and MUC13 secretion (PubMed=26074691).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   NCI-hTERT-CL6
AC   CVCL_JY26
DR   cancercelllines; CVCL_JY26
DR   Wikidata; Q54908204
RX   PubMed=26074691;
CC   Characteristics: Overexpresses TERT; compared to the parent cell line, it has better adhesion properties, ability to be maintained in culture for longer periods after confluency and is more efficient in mucins MUC1, MUC2 and MUC13 secretion (PubMed=26074691).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   NCI-N177
AC   CVCL_A589
SY   N177; N-177
DR   Wikidata; Q54908205
RX   PubMed=2985257;
RX   PubMed=6108156;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=8806103;
CC   Characteristics: Established from a mouse xenograft.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-N179
AC   CVCL_D056
SY   N179; N-179
DR   Wikidata; Q54908206
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=6108156;
RX   PubMed=8806092;
CC   Characteristics: Established from a mouse xenograft.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-N230
AC   CVCL_D057
SY   N230; N-230
DR   Cosmic; 844810
DR   Cosmic; 918014
DR   Cosmic; 1212190
DR   Cosmic; 1571753
DR   IARC_TP53; 11867
DR   Wikidata; Q54908207
RX   PubMed=2985257;
RX   PubMed=2986243;
RX   PubMed=6108156;
RX   PubMed=8806092;
RX   PubMed=10536175;
CC   Characteristics: Established from a mouse xenograft.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-N231
AC   CVCL_A788
SY   NCI-N-231; N231; N-231; NCI-H231; H231
DR   EFO; EFO_0002840
DR   cancercelllines; CVCL_A788
DR   Cosmic; 844811
DR   Cosmic; 918015
DR   Cosmic; 929979
DR   Cosmic; 953989
DR   IARC_TP53; 11868
DR   Wikidata; Q54908208
RX   PubMed=1847845;
RX   PubMed=2540905;
RX   PubMed=2985257;
RX   PubMed=6108156;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=10536175;
RX   PubMed=12569360;
CC   Characteristics: Established from a mouse xenograft.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (PubMed=10536175).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   NCI-N390
AC   CVCL_A561
SY   N390; N-390; NCI-H390
DR   Wikidata; Q54908209
RX   PubMed=2985257;
RX   PubMed=6108156;
RX   PubMed=6270685;
RX   PubMed=6272398;
RX   PubMed=6713399;
RX   PubMed=8806092;
RX   PubMed=8806103;
CC   Population: African American.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C2W3 ! NCI-N390SK3
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   NCI-N390SK3
AC   CVCL_C2W3
SY   NCI-H390SK3
DR   Wikidata; Q114312490
RX   PubMed=6270685;
RX   PubMed=6713399;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A561 ! NCI-N390
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NCI-N408
AC   CVCL_A562
SY   N408; N-408
DR   Wikidata; Q54908210
RX   PubMed=2985257;
RX   PubMed=6272398;
RX   PubMed=8806092;
RX   PubMed=8806103;
CC   Characteristics: Established from a nude mouse xenograft.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 14
//
ID   NCI-N417
AC   CVCL_1602
SY   NCI-N-417; NCI N417; N-417; N417; NCIN417; NCI417N; NCI-H417; H-417; H417; NCI-N417D; N417D; N417d
DR   BTO; BTO_0003028
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-5809
DR   BioSample; SAMN03471029
DR   cancercelllines; CVCL_1602
DR   ChEMBL-Cells; CHEMBL3307265
DR   ChEMBL-Targets; CHEMBL613287
DR   ChEMBL-Targets; CHEMBL613517
DR   Cosmic; 688033
DR   Cosmic; 801612
DR   Cosmic; 844553
DR   Cosmic; 844812
DR   Cosmic; 876161
DR   Cosmic; 918016
DR   Cosmic; 929977
DR   Cosmic; 934543
DR   Cosmic; 1006528
DR   Cosmic; 1021862
DR   Cosmic; 1212191
DR   Cosmic; 1219095
DR   Cosmic; 1239933
DR   Cosmic; 1571754
DR   Cosmic; 1656909
DR   Cosmic; 2125205
DR   Cosmic; 2648016
DR   Cosmic; 2668270
DR   Cosmic; 2668343
DR   EGA; EGAS00001000610
DR   GEO; GSM784263
DR   GEO; GSM844663
DR   GEO; GSM845555
DR   GEO; GSM986187
DR   IARC_TP53; 1407
DR   KCLB; 90417
DR   PharmacoDB; NCIN417_1150_2019
DR   Progenetix; CVCL_1602
DR   PubChem_Cell_line; CVCL_1602
DR   Wikidata; Q54908212
RX   PubMed=1320893;
RX   PubMed=1563005;
RX   PubMed=1565469;
RX   PubMed=1845952;
RX   PubMed=2473086;
RX   PubMed=2540905;
RX   PubMed=2574988;
RX   PubMed=2985257;
RX   PubMed=2985258;
RX   PubMed=3034934;
RX   PubMed=6148444;
RX   PubMed=6270685;
RX   PubMed=6713399;
RX   PubMed=7972006;
RX   PubMed=8626706;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=9744504;
RX   PubMed=10037197;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11030152;
RX   PubMed=11414198;
RX   PubMed=12712436;
RX   PubMed=19394761;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20557307;
RX   PubMed=21750403;
RX   PubMed=22313637;
RX   PubMed=23716474;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=31803961;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h60-atcc-crl-5821
CC   Characteristics: Established from a nude mouse xenograft.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (PubMed=21750403).
CC   Doubling time: 26 hours (PubMed=2985258).
CC   HLA typing: A*26:01,23:01; B*08:01,08:01; C*07:01 (PubMed=25960936).
CC   HLA typing: A*23:01,26:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:23139; CLVS1 + HGNC; HGNC:9709; PVT1; Name(s)=PVT1-CLVS1 (PubMed=23716474).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Lys (c.1636C>A); ClinVar=VCV000013657; Zygosity=Heterozygous (PubMed=19394761).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Unspecified (PubMed=1565469; PubMed=10536175; PubMed=20557307).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: NCI-417N; Cosmic=2648016.
CC   Discontinued: ATCC; CRL-5809; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-5809; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 12,13
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 5
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A788 ! NCI-N231
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NCI-N464
AC   CVCL_C2W0
SY   N464; N-464
DR   Wikidata; Q114312491
RX   PubMed=6272398;
RX   PubMed=6713399;
CC   Characteristics: Established from a nude mouse xenograft.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
ID   NCI-N592
AC   CVCL_A590
SY   N592; N-592; NCI-H592; H592; H-592; NCIN592
DR   ATCC; CRL-5832
DR   BioSample; SAMN03151861
DR   BioSample; SAMN03471748
DR   cancercelllines; CVCL_A590
DR   ChEMBL-Cells; CHEMBL3307825
DR   ChEMBL-Targets; CHEMBL613969
DR   Cosmic; 877210
DR   Cosmic; 1021867
DR   Cosmic; 1434966
DR   Cosmic; 1998273
DR   GEO; GSM536331
DR   GEO; GSM844664
DR   Progenetix; CVCL_A590
DR   PubChem_Cell_line; CVCL_A590
DR   Wikidata; Q54908213
RX   PubMed=1563005;
RX   PubMed=2574988;
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
RX   PubMed=11414198;
RX   PubMed=20615970;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/nci-h592-atcc-crl-5832
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NCI-H69 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00415.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ATCC; CRL-5832; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-5832
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1579 ! NCI-H69
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   NCI-N592/IFN-gamma
AC   CVCL_E4CS
SY   N592/IFN-gamma
RX   PubMed=9415308;
CC   Problematic cell line: Contaminated. Parent cell line (NCI-N592) shown to be a NCI-H69 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A590 ! NCI-N592
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NCI-N592/IL2
AC   CVCL_E4CT
SY   N592/IL2
RX   PubMed=9415308;
CC   Problematic cell line: Contaminated. Parent cell line (NCI-N592) shown to be a NCI-H69 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A590 ! NCI-N592
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NCI-N592/IL2/IFN-gamma
AC   CVCL_E4CU
SY   N592/IL2/IFN-gamma
RX   PubMed=9415308;
CC   Problematic cell line: Contaminated. Grand-parent cell line (NCI-N592) shown to be a NCI-H69 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly106_Arg108del (c.317_325delGGCAACCGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu748Ter (c.2242G>T); ClinVar=VCV000013078; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4CT ! NCI-N592/IL2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   NCI-N691
AC   CVCL_A591
SY   N691; N-691
DR   Wikidata; Q54908215
RX   PubMed=2985257;
RX   PubMed=8806092;
RX   PubMed=8806103;
CC   Characteristics: Established from a nude mouse xenograft.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   NCI-N857
AC   CVCL_Z438
SY   N857
DR   Wikidata; Q54908216
RX   PubMed=2540905;
RX   PubMed=12569360;
CC   Characteristics: Established from a nude mouse xenograft.
CC   Miscellaneous: The existence of a line with this name is not clear: it is not mentioned in any NCI publications, only in some papers from Japanese groups.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   NCI-N87
AC   CVCL_1603
SY   NCI N87; N87; N-87; NCI-H87; H87; H-87; NCIN87
DR   BTO; BTO_0003053
DR   CLO; CLO_0008129
DR   EFO; EFO_0002841
DR   AddexBio; C0023002/4674
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5822
DR   BCRC; 60217
DR   BCRJ; 0350
DR   BioGRID_ORCS_Cell_line; 516
DR   BioSample; SAMN01120666
DR   BioSample; SAMN03473211
DR   BioSample; SAMN10987913
DR   cancercelllines; CVCL_1603
DR   CCRID; 1101HUM-PUMC000481
DR   CCRID; 3101HUMSCSP534
DR   CCRID; 3101HUMTCHu130
DR   CCRID; 4201HUM-CCTCC00256
DR   CCTCC; GDC0256
DR   Cell_Model_Passport; SIDM01147
DR   ChEMBL-Cells; CHEMBL3307326
DR   ChEMBL-Targets; CHEMBL614197
DR   CLS; 305057
DR   Cosmic; 685598
DR   Cosmic; 687556
DR   Cosmic; 868236
DR   Cosmic; 887250
DR   Cosmic; 908461
DR   Cosmic; 1187286
DR   Cosmic; 1482074
DR   Cosmic; 1582431
DR   Cosmic; 1995594
DR   Cosmic; 2036661
DR   Cosmic; 2069775
DR   Cosmic; 2443800
DR   Cosmic; 2484955
DR   Cosmic; 2807636
DR   Cosmic; 2823228
DR   Cosmic-CLP; 908461
DR   DepMap; ACH-000427
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908461
DR   GEO; GSM267420
DR   GEO; GSM267427
DR   GEO; GSM267434
DR   GEO; GSM267441
DR   GEO; GSM552366
DR   GEO; GSM562405
DR   GEO; GSM827404
DR   GEO; GSM828827
DR   GEO; GSM844665
DR   GEO; GSM887453
DR   GEO; GSM888533
DR   GEO; GSM1237678
DR   GEO; GSM1237703
DR   GEO; GSM1374768
DR   GEO; GSM1374769
DR   GEO; GSM1374770
DR   GEO; GSM1670272
DR   IARC_TP53; 305
DR   IZSLER; BS TCL 224
DR   KCB; KCB 2010183YJ
DR   KCLB; 60113
DR   KCLB; 60187
DR   LiGeA; CCLE_561
DR   LINCS_LDP; LCL-1886
DR   PharmacoDB; NCIN87_1151_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1603
DR   PubChem_Cell_line; CVCL_1603
DR   Ubigene; YC-C068
DR   Wikidata; Q54908217
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1676761;
RX   PubMed=2158397;
RX   PubMed=8806089;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=18804159;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26919099;
RX   PubMed=27102572;
RX   PubMed=27397505;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31803961;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-and-growth-of-crl-5822-cells
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/gastric-xenograft-model/nci-n87-xenograft-model/
WW   Provider; BRICS; BRICS0122; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3925
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MET genetic alteration cell panel (ATCC TCP-1036).
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: 47 hours (PubMed=2158397); 86 hours (PubMed=25984343); 23 hours (PubMed=26919099); 47 hours (PubMed=29435981).
CC   HLA typing: A*01:01,23:01; B*07:02,37:01; C*02:02,07:02; DQB1*05:02,05:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*23:01,23:01; B*07:02,37:01; C*02:02,02:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (ATCC=CRL-5822).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (PubMed=26919099).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=1676761; ATCC=CRL-5822).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=61.23%; Native American=0%; East Asian, North=2.17%; East Asian, South=0%; South Asian=0%; European, North=20.57%; European, South=16.04% (PubMed=30894373).
CC   Caution: According to PubMed=1676761 the ethnicity of the donor is Caucasian, but exome analysis finds it to be mostly of African lineage.
CC   Misspelling: NU-N87; BioSample=SAMN01120666; PubMed=25960936; Note=Also in all the NCBI data records associated with the BioSample record.
CC   Discontinued: KCLB; 60187; probable.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): AddexBio=C0023002/4674; ATCC=CRL-5822; CCRID; Cosmic-CLP=908461; PubMed=25877200; PubMed=27102572; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D10S1248: 13
ST   D12S391: 16,21
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 14,14.2
ST   D1S1656: 16
ST   D21S11: 30
ST   D22S1045: 14,15
ST   D2S1338: 23,24
ST   D2S441: 11,12
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D6S1043: 12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   DYS391: 10
ST   FGA: 20,21
ST   Penta D: 12
ST   Penta E: 5
ST   TH01: 7,9 (PubMed=27102572)
ST   TH01: 9 (AddexBio=C0023002/4674; ATCC=CRL-5822; CCRID; Cosmic-CLP=908461; PubMed=25877200; Technion Genomics Center)
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 51
//
ID   NCI-N87 HR
AC   CVCL_WH01
SY   NCI N87 HR
DR   cancercelllines; CVCL_WH01
DR   Wikidata; Q95993868
RX   PubMed=26919099;
CC   Doubling time: 26 hours (PubMed=26919099).
CC   Selected for resistance to: DrugBank; DB00072; Trastuzumab (Herceptin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   NCI-N87 human CLDN18.2
AC   CVCL_XZ59
SY   NCI-N87-CLDN18.2
DR   cancercelllines; CVCL_XZ59
DR   KYinno; KC-1222
DR   Wikidata; Q95993869
CC   Doubling time: ~30 hours (KYinno=KC-1222).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   NCI-N87/Cas9-hyg
AC   CVCL_C9DN
DR   GeneCopoeia; SL565
DR   Wikidata; Q123033160
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL565).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   NCI-N87/TR
AC   CVCL_IL03
DR   cancercelllines; CVCL_IL03
DR   Wikidata; Q54908218
RX   PubMed=26108989;
CC   Selected for resistance to: DrugBank; DB00072; Trastuzumab (Herceptin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1603 ! NCI-N87
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   NCI-RR
AC   CVCL_D4YE
DR   Wikidata; Q127382943
RX   PubMed=5926742;
CC   Characteristics: Peristently infected with Rauscher murine leukemia virus (PubMed=5926742).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NCKA
AC   CVCL_J696
DR   CLO; CLO_0050218
DR   RCB; RCB1598
DR   Wikidata; Q54908219
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/10 H-2k.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   NCKDi001-A
AC   CVCL_A1WM
SY   NCKD-iPS-Alport-COL4A5-001; NCKD-iPS-AS-COL4A5-001
DR   hPSCreg; NCKDi001-A
DR   Wikidata; Q105510327
RX   PubMed=33128955;
CC   From: National Center of Kidney Diseases; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly896Ala (c.2687G>C); Zygosity=Hemizygous (PubMed=33128955).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   NCKDi002-A
AC   CVCL_A5FS
SY   NCKD-iPS-FSGS-WT1-002
DR   hPSCreg; NCKDi002-A
DR   Wikidata; Q107116541
RX   PubMed=33780729;
CC   From: National Center of Kidney Diseases; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg363Gly (c.1087A>G) (p.Arg219Gly, c.655A>G); Zygosity=Heterozygous (PubMed=33780729).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123106; Nephrotic syndrome - WT1 associated
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   NCKDi003-A
AC   CVCL_B3MT
DR   hPSCreg; NCKDi003-A
DR   Wikidata; Q110433092
RX   PubMed=34547705;
CC   From: National Center of Kidney Diseases; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2023; CLCN5; Simple; p.Thr347Pro (c.1042A>C) (p.Thr277Pro, c.829A>C); Zygosity=Unspecified (PubMed=34547705).
CC   Caution: Mutation indicated as hemizygous in title of PubMed=34547705 but this cell line is from a normal X,X female patient so it can't be hemizygous.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123260; Dent disease
DI   ORDO; Orphanet_93622; Dent disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   NCKDi004-A
AC   CVCL_B5IU
SY   NCKD-iPS-AS-COL4A3-004
DR   hPSCreg; NCKDi004-A
DR   Wikidata; Q110433093
RX   PubMed=34626894;
CC   From: National Center of Kidney Diseases; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Met1Ile (c.3G>A); Zygosity=Homozygous (PubMed=34626894).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   NCKDi005-A
AC   CVCL_B5IV
SY   NCKD-iPS-AS-COL4A4-005
DR   hPSCreg; NCKDi005-A
DR   Wikidata; Q110433094
RX   PubMed=34942480;
CC   From: National Center of Kidney Diseases; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2206; COL4A4; Simple; p.Gly408Cysfs*29 (c.1221_1222insTGCAGGCATGATAGGACCCCCT); Zygosity=Homozygous (PubMed=34942480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   NCKDi006-A
AC   CVCL_E4HE
SY   NCKD-iPS-FSGS-TRPC6-006
DR   BioSamples; SAMEA116072721
DR   hPSCreg; NCKDi006-A
CC   From: National Center of Kidney Diseases; Nanjing; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C205635; Focal segmental glomerulosclerosis 2
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NCKUi001-A
AC   CVCL_C9BQ
SY   hAFSC-iPSC
DR   BioSamples; SAMEA114312890
DR   hPSCreg; NCKUi001-A
DR   Wikidata; Q123033161
RX   PubMed=32235313;
CC   From: Center of Cell Therapy, National Cheng Kung University; Tainan; Taiwan.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   NCL-2
AC   CVCL_X143
DR   ABM; T0788
DR   Wikidata; Q54908220
RX   PubMed=24918047;
CC   Doubling time: ~30.1 hours (PubMed=24918047).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: NC/Kuj.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   NCL-CD10-270
AC   CVCL_C5UX
SY   NCL-L-CD10-270
DR   Wikidata; Q116049883
RX   PubMed=9916921;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   NCL-SG3
AC   CVCL_B7BV
DR   Wikidata; Q112930166
RX   PubMed=2777923;
RX   PubMed=17383636;
RX   PubMed=18070079;
CC   Doubling time: ~70 hours (Note=In serum-free medium) (PubMed=2777923).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   NCL1
AC   CVCL_RL72
SY   NCL-1
DR   Wikidata; Q54908222
RX   PubMed=29266841;
CC   From: NxCell, Inc.; Novato; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   NCL10
AC   CVCL_L188
SY   hES-NCL10
DR   Wikidata; Q54908223
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-068, Steering comm. appl. SCSC10-37.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   NCL11
AC   CVCL_L189
SY   hES-NCL11
DR   Wikidata; Q54908224
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-069, Steering comm. appl. SCSC11-01.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   NCL12
AC   CVCL_L190
SY   hES-NCL12
DR   Wikidata; Q54908225
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-070, Steering comm. appl. SCSC11-01.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   NCL14
AC   CVCL_BW71
SY   NCL-14; NCL(CLIN)14; NCL(R)14
DR   Wikidata; Q54908226
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-071, Steering comm. appl. SCSC11-01/SCSC11-25.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 9
//
ID   NCL2 [Human lung carcinoma]
AC   CVCL_A5VX
DR   Wikidata; Q107116542
RX   PubMed=1497905;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Established from a nude mouse xenograft of CL2.
CC   Doubling time: 30 hours (PubMed=1497905).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W144 ! CL2 [Human lung carcinoma]
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NCL2 [Human umbilical cord]
AC   CVCL_A9ZA
DR   Wikidata; Q103825219
RX   PubMed=29793831;
CC   From: NxCell, Inc.; Novato; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NCM356
AC   CVCL_D875
DR   Wikidata; Q54908238
RX   PubMed=7840378;
RX   PubMed=26615870;
WW   Provider; INCELL; -; http://media.wix.com/ugd/463504_2f10ba2c0321d79ff6bc7b6043303535.pdf
CC   Population: African American.
CC   Doubling time: 24 hours (PubMed=7840378); 32-35 hours (INCELL).
CC   Donor information: Established from the normal tissue of a patient suffering from a rectal adenocarcinoma.
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   NCM356D
AC   CVCL_IS46
DR   Wikidata; Q54908239
RX   PubMed=26615870;
WW   Provider; INCELL; -; https://www.incell.com/product/ncm356d-cell-line/
CC   Population: African American.
CC   Doubling time: 32-35 hours (INCELL).
CC   Donor information: Established from the normal tissue of a patient suffering from a rectal adenocarcinoma.
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D875 ! NCM356
SX   Male
AG   65Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   NCM425
AC   CVCL_D876
DR   Wikidata; Q54908240
RX   PubMed=7840378;
CC   Population: Hispanic.
CC   Doubling time: 34 hours (PubMed=7840378).
CC   Donor information: Established from the normal tissue of a patient suffering from a colone adenocarcinoma.
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   NCM460
AC   CVCL_0460
SY   NCM-460
DR   BTO; BTO_0004306
DR   EFO; EFO_0022704
DR   MCCL; MCC:0000357
DR   ChEMBL-Cells; CHEMBL4483158
DR   ChEMBL-Targets; CHEMBL4483264
DR   CLS; 305430
DR   Lonza; 75
DR   PubChem_Cell_line; CVCL_0460
DR   Wikidata; Q54908241
RX   PubMed=8842743;
RX   PubMed=26615870;
WW   Provider; INCELL; -; http://media.wix.com/ugd/463504_7934d0a2e95a933829a9239ec5610652.pdf
CC   Population: Hispanic.
CC   Doubling time: 32-38 hours (INCELL).
CC   Donor information: Established from the normal tissue of a patient suffering from gastric cancer.
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   NCM460D
AC   CVCL_IS47
DR   Wikidata; Q54908242
RX   PubMed=26615870;
WW   Provider; INCELL; -; https://www.incell.com/product/ncm460d-cell-line/
CC   Population: Hispanic.
CC   Doubling time: 32-38 hours (INCELL).
CC   Donor information: Established from the normal tissue of a patient suffering from gastric cancer.
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0460 ! NCM460
SX   Male
AG   68Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   NCMDF
AC   CVCL_LC41
SY   Normal Cynomolgus Monkey Dermal Fibroblasts
DR   JCRB; JCRB1721
DR   Wikidata; Q54908243
CC   Group: Non-human primate cell line.
CC   Doubling time: ~1.5-2 days (Note=Lot 01152019) (JCRB=JCRB1721).
CC   Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   1Y9M
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 8
//
ID   NCO2
AC   CVCL_3043
SY   NC02; NCO-2; NC-02
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472804
DR   BioSample; SAMN10987830
DR   cancercelllines; CVCL_3043
DR   Cell_Model_Passport; SIDM01756
DR   Cosmic; 2009520
DR   DepMap; ACH-000076
DR   GEO; GSM887454
DR   GEO; GSM888534
DR   IARC_TP53; 28294
DR   JCRB; IFO50525
DR   LiGeA; CCLE_337
DR   PharmacoDB; NCO2_1155_2019
DR   Progenetix; CVCL_3043
DR   Wikidata; Q54908244
RX   CelloPub=CLPUB00230;
RX   PubMed=1701357;
RX   PubMed=9738977;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 1.2 days (Note=Lot 01132005) (JCRB=IFO50525).
CC   HLA typing: A*24:02,24:02; B*15:01,52:01; C*01:21,01:21; DQA1*01:03,01:03; DQB1*06:01,06:01; DRB1*08:03,15:02 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (DepMap=ACH-000076).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.796G>C); ClinVar=VCV000376605; Zygosity=Homozygous (DepMap=ACH-000076).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=82.46%; East Asian, South=15.81%; South Asian=0%; European, North=0%; European, South=1.73% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=IFO50525
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 13
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   NCOL-1
AC   CVCL_8375
SY   Normal COLon-1
DR   BioSample; SAMN03151825
DR   cancercelllines; CVCL_8375
DR   Cell_Model_Passport; SIDM00838
DR   Wikidata; Q54908245
RX   PubMed=8812628;
RX   PubMed=15771911;
RX   PubMed=16271966;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a LoVo derivative (PubMed=15771911; PubMed=20143388). Originally thought to originate from a normal colonic mucosa sample.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00243.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): PubMed=15771911
ST   Amelogenin: X,Y
ST   D16S539: 9,12
ST   D18S51: 13,18
ST   D19S433: 13,15 (PubMed=15771911_clone_b)
ST   D19S433: 14,15 (PubMed=15771911_clone_a)
ST   D21S11: 28,29,30.2,31.2 (PubMed=15771911_clone_b)
ST   D21S11: 29,31.2 (PubMed=15771911_clone_a)
ST   D2S1338: 17,18
ST   D3S1358: 14,17
ST   D8S1179: 9,10 (PubMed=15771911_clone_b)
ST   D8S1179: 10 (PubMed=15771911_clone_a)
ST   FGA: 17,20 (PubMed=15771911_clone_a)
ST   FGA: 18,20 (PubMed=15771911_clone_b)
ST   SE33: 18.2,19.2,20.2,25.2 (PubMed=15771911_clone_b)
ST   SE33: 19.2,24.2 (PubMed=15771911_clone_a)
ST   TH01: 9.3
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   ncPNET1
AC   CVCL_IR52
DR   Wikidata; Q54908246
RX   PubMed=20978004;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   5Y1M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   NCR-EW1
AC   CVCL_F677
DR   Cosmic; 1085899
DR   Wikidata; Q54908247
RX   PubMed=1764362;
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=1764362).
CC   Derived from site: In situ; Neck; UBERON=UBERON_0000974.
DI   NCIt; C7135; Extraskeletal Ewing sarcoma
DI   ORDO; Orphanet_370334; Extraskeletal Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   NCR-EW2
AC   CVCL_F678
DR   BTO; BTO_0004872
DR   Cosmic; 1085900
DR   Wikidata; Q54908248
RX   PubMed=1764362;
RX   PubMed=9738976;
RX   PubMed=12054564;
CC   Population: Japanese.
CC   Doubling time: 34.3 hours (PubMed=1764362).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=9738976).
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C7135; Extraskeletal Ewing sarcoma
DI   ORDO; Orphanet_370334; Extraskeletal Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   NCR-EW3
AC   CVCL_F679
DR   Cosmic; 1087463
DR   Wikidata; Q54908249
RX   PubMed=1764362;
RX   PubMed=9738976;
RX   PubMed=9858836;
RX   PubMed=12054564;
CC   Population: Japanese.
CC   Doubling time: 55.4 hours (PubMed=1764362).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3493; ETV4 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ETV4, EWSR1-E1AF (PubMed=9858836; PubMed=9738976).
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C7135; Extraskeletal Ewing sarcoma
DI   ORDO; Orphanet_370334; Extraskeletal Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   NCR-EW4
AC   CVCL_F680
DR   Cosmic; 1085902
DR   Wikidata; Q54908250
RX   PubMed=1764362;
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Doubling time: 40 hours (PubMed=1764362).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7135; Extraskeletal Ewing sarcoma
DI   ORDO; Orphanet_370334; Extraskeletal Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   NCR-G1
AC   CVCL_3059
DR   CLO; CLO_0051395
DR   BioSample; SAMN03471960
DR   BioSample; SAMN03472476
DR   FANTOM5_SSTAR; 10798-110I6
DR   JCRB; JCRB1166
DR   JCRB; NIHS0442
DR   RCB; RCB2341
DR   Wikidata; Q54908251
RX   DOI=10.1267/ahc.25.563;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0442; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): JCRB=JCRB1166; RCB=RCB2341
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,13
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15 (JCRB=JCRB1166)
ST   vWA: 15,19,20 (RCB=RCB2341)
DI   NCIt; C8000; Testicular yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   NCR-G2
AC   CVCL_3060
DR   CLO; CLO_0051394
DR   BioSample; SAMN03471962
DR   BioSample; SAMN03472478
DR   JCRB; JCRB1167
DR   JCRB; NIHS0443
DR   RCB; RCB2342
DR   Wikidata; Q54908252
RX   DOI=10.1267/ahc.25.563;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0443; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): JCRB=JCRB1167; RCB=RCB2342
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 9,10
ST   vWA: 14 (JCRB=JCRB1167)
ST   vWA: 14,17 (RCB=RCB2342)
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   NCR-G3
AC   CVCL_3061
SY   NCRG3
DR   CLO; CLO_0051397
DR   BioSample; SAMN03472479
DR   JCRB; JCRB1168
DR   JCRB; NIHS0444
DR   RCB; RCB2343
DR   Wikidata; Q54908253
RX   DOI=10.1267/ahc.25.563;
RX   PubMed=21155951;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0444; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): JCRB=JCRB1168
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 13
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCR-G4
AC   CVCL_3062
DR   CLO; CLO_0051396
DR   BioSample; SAMN03472422
DR   JCRB; JCRB1175
DR   JCRB; NIHS0445
DR   RCB; RCB2344
DR   Wikidata; Q54908254
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0445; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): JCRB=JCRB1175
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 10,14
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   NCRC-11
AC   CVCL_C8BW
SY   NCRC 11
DR   Wikidata; Q123033162
RX   PubMed=6735361;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   NCRM-1
AC   CVCL_1E71
SY   NCRM1; NL-1; CRMi003-A; ND50028
DR   BioSamples; SAMEA7777168
DR   hPSCreg; CRMi003-A
DR   NHCDR; ND50028
DR   SKIP; SKIP001590
DR   SKIP; SKIP002503
DR   Wikidata; Q54908255
RX   PubMed=36459969;
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT88 ! NH50275
OI   CVCL_YT89 ! NH50285
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   NCRM-2
AC   CVCL_1E72
SY   NCRM2; ND50030; CR0000007; CRMi004-A
DR   BioSamples; SAMEA104382170
DR   hPSCreg; CRMi004-A
DR   NHCDR; ND50030
DR   SKIP; SKIP001591
DR   Wikidata; Q54908256
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   NCRM-3
AC   CVCL_1E73
SY   ND50029
DR   NHCDR; ND50029
DR   SKIP; SKIP001592
DR   Wikidata; Q54908257
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   NCRM-4
AC   CVCL_1E74
SY   ND50025
DR   NHCDR; ND50025
DR   SKIP; SKIP001593
DR   Wikidata; Q54908258
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   NCRM-5
AC   CVCL_1E75
SY   NCRM5; NL-5; CRMi001-A; ND50031
DR   BioSamples; SAMEA7775668
DR   hPSCreg; CRMi001-A
DR   NHCDR; ND50031
DR   SKIP; SKIP001594
DR   SKIP; SKIP002502
DR   Wikidata; Q54908259
RX   PubMed=36459969;
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   NCRM-6
AC   CVCL_1E76
SY   ND50018
DR   NHCDR; ND50018
DR   SKIP; SKIP001595
DR   Wikidata; Q54908260
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   NCRM5-AS1-iCAGcGFP
AC   CVCL_1E82
SY   NCRM5AS1-iCAGcGFP.c9; ND50023
DR   BioSample; SAMN17083846
DR   NHCDR; ND50023
DR   SKIP; SKIP001642
DR   Wikidata; Q54908261
RX   PubMed=33714852;
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Characteristics: Targeted with copGFP at the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E75 ! NCRM-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   NCRM5-AS1-iCLHN
AC   CVCL_1E80
SY   NCRM5AS1-iCHLN.c11; ND50024
DR   NHCDR; ND50024
DR   SKIP; SKIP001643
DR   Wikidata; Q54908262
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Characteristics: Targeted with NanoLuc-HaloTag at the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E75 ! NCRM-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   NCRM5-C13-iCLHN
AC   CVCL_1E81
SY   NCRM5C13-iCHLN.c6; ND50022
DR   NHCDR; ND50022
DR   SKIP; SKIP001641
DR   Wikidata; Q54908263
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Characteristics: Targeted with NanoLuc-HaloTag at the chromosome 13 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E75 ! NCRM-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   NCS-1
AC   CVCL_W451
DR   Wikidata; Q54908264
RX   PubMed=8060155;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   NCTC 1469
AC   CVCL_3066
SY   NCTC-1469; NCTC1469; NCTC clone 1469
DR   CLO; CLO_0008136
DR   CLDB; cl3669
DR   ATCC; CCL-9.1
DR   BCRC; 60482
DR   CCRID; 1101MOU-PUMC000290
DR   CCRID; 4201MOU-CCTCC00318
DR   CCTCC; GDC0318
DR   CLS; 400300
DR   ECACC; 88111403
DR   JCRB; IFO50080
DR   JCRB; JCRB9075
DR   KCLB; 10009.1
DR   Wikidata; Q54908265
RX   DOI=10.1007/BF02618370;
RX   PubMed=6687612;
RX   PubMed=6834359;
RX   PubMed=7265063;
RX   PubMed=13502690;
RX   PubMed=13523589;
RX   PubMed=13587550;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K271 ! NCTC 721
SX   Male
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 21
//
ID   NCTC 1469 CB
AC   CVCL_U989
DR   Wikidata; Q54908266
RX   PubMed=6834359;
CC   Characteristics: In contrat with the parent cell line, has reduced phagocytic activity.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3066 ! NCTC 1469
SX   Male
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   NCTC 1742
AC   CVCL_A0ZQ
SY   NCTC-1742; Substrain VII; Substrain 7; High sarcoma-producing line 1742
DR   Wikidata; Q108821017
RX   PubMed=13233880;
RX   PubMed=13587550;
RX   PubMed=13845891;
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V002 ! NCTC clone 1328
SX   Male
AG   82D
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   NCTC 2049
AC   CVCL_A0ZR
SY   NCTC-2049; Substrain III; Substrain 3; Low sarcoma-producing line 2049
DR   Wikidata; Q108821018
RX   PubMed=13233880;
RX   PubMed=13587550;
RX   PubMed=13845891;
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V002 ! NCTC clone 1328
SX   Male
AG   82D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   NCTC 2071
AC   CVCL_4255
SY   NCTC-2071; Strain 929 substrain series 2071; L2071
DR   CLO; CLO_0008131
DR   CLDB; cl3663
DR   ATCC; CCL-1.1
DR   ATCC; CRL-6362
DR   ECACC; 90050803
DR   KCLB; 10001.1
DR   Wikidata; Q54908267
RX   DOI=10.1007/BF02618370;
RX   PubMed=13284736;
RX   PubMed=13587550;
RX   PubMed=14242231;
RX   PubMed=16368894;
CC   Group: Serum/protein free medium cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CCL-1.1; true.
CC   Discontinued: ATCC; CRL-6362; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   NCTC 2168
AC   CVCL_A0ZP
SY   NCTC-2168
DR   Wikidata; Q108821019
RX   PubMed=13587550;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   NCTC 2472
AC   CVCL_3067
SY   NCTC clone 2472; NCTC, clone 2472; NCTC-2472; NCTC2472; High-line clone 2472
DR   CLO; CLO_0008137
DR   CLDB; cl3670
DR   ATCC; CCL-11
DR   ECACC; 90111915
DR   KCLB; 10011
DR   Wikidata; Q54908269
RX   DOI=10.1007/BF02618370;
RX   PubMed=13845891;
RX   PubMed=14185313;
CC   Discontinued: ECACC; 90111915; true.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0ZQ ! NCTC 1742
SX   Male
AG   82D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   NCTC 2544
AC   CVCL_0461
SY   NCTC-2544; NCTC2544; NCTC strain 2544
DR   BTO; BTO_0003297
DR   CLO; CLO_0008132
DR   MCCL; MCC:0000358
DR   CLDB; cl3664
DR   CLDB; cl5235
DR   ATCC; CCL-19
DR   BioSample; SAMN03151747
DR   ChEMBL-Cells; CHEMBL4295406
DR   ChEMBL-Targets; CHEMBL4296478
DR   ICLC; HL97002
DR   IZSLER; BS CL 143
DR   PubChem_Cell_line; CVCL_0461
DR   Wikidata; Q54908270
RX   DOI=10.1007/BF02618370;
RX   PubMed=565190;
RX   PubMed=566722;
RX   PubMed=990102;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=5668122;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to be a normal skin epithelium cell line.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00012.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-19; true.
CC   Discontinued: ICLC; HL97002; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   NCTC 2555
AC   CVCL_3068
SY   NCTC clone 2555; NCTC, clone 2555; NCTC-2555; Low-line clone 2555
DR   CLO; CLO_0008138
DR   CLDB; cl3671
DR   ATCC; CCL-12
DR   ECACC; 90102521
DR   KCLB; 10012
DR   Wikidata; Q54908271
RX   DOI=10.1007/BF02618370;
RX   PubMed=13845891;
RX   PubMed=14185313;
CC   Discontinued: ECACC; 90102521; true.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0ZR ! NCTC 2049
SX   Male
AG   82D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   NCTC 3075
AC   CVCL_8156
SY   NCTC-3075
DR   ATCC; CCL-19.1
DR   BioSample; SAMN03151748
DR   Wikidata; Q54908272
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=14242231;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00027.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-19.1; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   NCTC 3196
AC   CVCL_U988
SY   NCTC-3196; NCTC subline 3196; LLC-MK2(NCTC-3196); LLC-MK2-NCTC subline 3196
DR   Wikidata; Q54908273
RX   PubMed=13821019;
RX   PubMed=14449901;
RX   PubMed=14449902;
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_3009 ! LLC-MK2
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   NCTC 3526
AC   CVCL_3069
SY   NCTC clone 3526; NCTC-3526
DR   CLO; CLO_0008139
DR   CLDB; cl3672
DR   ATCC; CCL-7.2
DR   IZSLER; BS CL 70
DR   Wikidata; Q54908274
RX   DOI=10.1007/BF02618370;
RX   PubMed=14242231;
RX   PubMed=28046048;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_3009 ! LLC-MK2
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   NCTC 3749
AC   CVCL_3063
SY   NCTC-3749; NCTC3749
DR   CLO; CLO_0008133
DR   CLDB; cl3666
DR   ATCC; CCL-46.1
DR   ATCC; CRL-6441
DR   ECACC; 90111912
DR   KCLB; 10046.1
DR   Wikidata; Q54908277
RX   DOI=10.1007/BF02618370;
RX   PubMed=14242231;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: ATCC; CRL-6441; true.
CC   Discontinued: ECACC; 90111912; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   NCTC 3959
AC   CVCL_UJ48
SY   NCTC-3959
DR   ATCC; CCL-52
DR   Wikidata; Q95993923
RX   DOI=10.1007/BF02618370;
CC   Discontinued: ATCC; CCL-52; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_J817 ! S91
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 5
//
ID   NCTC 4093
AC   CVCL_3064
SY   NCTC-4093
DR   CLO; CLO_0008134
DR   CLDB; cl3667
DR   ATCC; CCL-63
DR   BCRC; 60231
DR   ECACC; 90102530
DR   KCLB; 10063
DR   Wikidata; Q54908279
CC   Breed/subspecies: C57BL/KaLw.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   NCTC 4206
AC   CVCL_3065
SY   NCTC-4206
DR   CLO; CLO_0008135
DR   CLDB; cl3668
DR   ATCC; CCL-14.2
DR   ECACC; 91010303
DR   Wikidata; Q54908280
RX   DOI=10.1007/BF02618370;
RX   PubMed=14242231;
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4584 ! B14FAF28-G3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NCTC 721
AC   CVCL_K271
SY   NCTC strain 721; NCTC-721
DR   Wikidata; Q54908281
RX   PubMed=13523589;
RX   PubMed=13587550;
RX   PubMed=14939026;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   NCTC clone 1328
AC   CVCL_V002
DR   Wikidata; Q54908282
RX   PubMed=5840079;
RX   PubMed=13233880;
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   82D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   NCTC clone 929
AC   CVCL_0462
SY   NCTC 929; NCTC-929; NCTC929; NCTC-929L; L cell; L cells; L-cell; L-cells; L cell line; L; Strain L-929; L-929; L 929; L929; L929(NCTC); Clone 929; Earles's cells; Earle's L cells
DR   BTO; BTO_0000331
DR   CLO; CLO_0007144
DR   CLO; CLO_0007219
DR   CLO; CLO_0007220
DR   CLO; CLO_0007221
DR   CLO; CLO_0008140
DR   CLO; CLO_0050233
DR   CLO; CLO_0050234
DR   CLO; CLO_0050235
DR   MCCL; MCC:0000359
DR   CLDB; cl3154
DR   CLDB; cl3156
DR   CLDB; cl3157
DR   CLDB; cl3158
DR   CLDB; cl3159
DR   CLDB; cl3160
DR   CLDB; cl3673
DR   CLDB; cl3674
DR   CLDB; cl3675
DR   CLDB; cl3676
DR   AddexBio; P0011012/5025
DR   ATCC; CCL-1
DR   ATCC; CRL-6364
DR   BCRC; 60091
DR   BCRJ; 0188
DR   BioGRID_ORCS_Cell_line; 1749
DR   BioSample; SAMN11397622
DR   CCLV; CCLV-RIE 0014
DR   CCLV; CCLV-RIE 0287
DR   CCRID; 1101MOU-PUMC000403
DR   CCRID; 1102MOU-NIFDC00019
DR   CCRID; 3101MOUGNM28
DR   CCRID; 3101MOUSCSP5039
DR   CCRID; 4201MOU-CCTCC00034
DR   CCRID; 5301MOU-KCB92012YJ
DR   CCTCC; GDC0034
DR   ChEMBL-Cells; CHEMBL3307946
DR   ChEMBL-Targets; CHEMBL612266
DR   ChEMBL-Targets; CHEMBL612267
DR   CLS; 400260
DR   DSMZ; ACC-2
DR   DSMZCellDive; ACC-2
DR   ECACC; 85011425
DR   ECACC; 85103115
DR   ECACC; 88102702
DR   FCS-free; 8-5-530-1-3-3
DR   FCS-free; 8-5-9-1-3-3
DR   IBRC; C10102
DR   ICLC; ATL95001
DR   IZSLER; BS CL 56
DR   JCRB; IFO50409
DR   JCRB; JCRB9003
DR   KCB; KCB 92012YJ
DR   KCLB; 10001
DR   Lonza; 32
DR   Lonza; 937
DR   MeSH; D007739
DR   NCBI_Iran; C161
DR   PubChem_Cell_line; CVCL_0462
DR   RCB; RCB0081
DR   RCB; RCB1422
DR   RCB; RCB1451
DR   RCB; RCB2619
DR   TKG; TKG 0217
DR   TOKU-E; 3695
DR   Ubigene; YC-C091
DR   Wikidata; Q28335098
RX   DOI=10.1007/BF02618370;
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   DOI=10.5897/IJBMBR2013.0154;
RX   PubMed=4328993;
RX   PubMed=4471172;
RX   PubMed=4560675;
RX   PubMed=6298990;
RX   PubMed=13293658;
RX   PubMed=13431913;
RX   PubMed=13587550;
RX   PubMed=14185313;
RX   PubMed=18105872;
RX   PubMed=23430347;
RX   PubMed=31220119;
RX   PubMed=32218446;
RX   PubMed=33389257;
RX   PubMed=34737324;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=L929
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Is_L929_normal_or_cancer_cell_line
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-125.html
WW   Provider; Vircell; -; https://www.vircell.com/en/products/l-929-cell-line
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 28 hours (Note=From cell counting), 32 hours (Note=From absorbance) (DOI=10.5897/IJBMBR2013.0154); ~25 hours (CLS=400260); ~21-24 hours (DSMZ=ACC-2).
CC   Omics: Proteomics; Quantitative.
CC   Anecdotal: First established continuous cell line.
CC   Miscellaneous: PubMed=23430347 has a different value for STR 6-4 (16) than that of NIST (17,18) due to a change in the marker motif (personal communication of Almeida, Jamie L.).
CC   Discontinued: ATCC; CRL-6364; true.
CC   Discontinued: RCB; RCB0081; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
ST   Source(s): DSMZ=ACC-2; PubMed=23430347; PubMed=31220119; Ubigene=YC-C091
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 16,17 (DSMZ=ACC-2)
ST   Mouse STR 6-4: 17,18 (PubMed=23430347; PubMed=31220119; Ubigene=YC-C091)
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25,26,27
ST   Mouse STR 8-1: 16
ST   Mouse STR 9-2: 15
ST   Mouse STR 11-2: 15,16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 24.3,25.3,26.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26,27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   NCU-F1
AC   CVCL_4777
DR   CLO; CLO_0050645
DR   BioSample; SAMN03472354
DR   RCB; RCB0388
DR   Wikidata; Q54908283
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0388
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCU-F10
AC   CVCL_4726
DR   CLO; CLO_0050652
DR   BioSample; SAMN03472303
DR   RCB; RCB0397
DR   Wikidata; Q54908284
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0397
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCU-F2
AC   CVCL_4727
DR   CLO; CLO_0050646
DR   BioSample; SAMN03472355
DR   RCB; RCB0389
DR   Wikidata; Q54908285
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0389
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C61263; Morquio syndrome
DI   ORDO; Orphanet_582; Mucopolysaccharidosis type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCU-F3
AC   CVCL_4728
DR   CLO; CLO_0050647
DR   BioSample; SAMN03472356
DR   RCB; RCB0390
DR   Wikidata; Q54908286
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0390
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 9,15
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCU-F4
AC   CVCL_4729
DR   CLO; CLO_0050648
DR   BioSample; SAMN03472357
DR   RCB; RCB0391
DR   Wikidata; Q54908287
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0391
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 9,15
ST   D7S820: 8
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCU-F5
AC   CVCL_E132
DR   RCB; RCB0392
DR   Wikidata; Q54908288
CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
CC   Population: Japanese.
CC   Discontinued: RCB; RCB0392; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   NCU-F6
AC   CVCL_4730
DR   CLO; CLO_0050649
DR   BioSample; SAMN03472358
DR   RCB; RCB0393
DR   Wikidata; Q54908289
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0393
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NCU-F7
AC   CVCL_4731
DR   CLO; CLO_0050650
DR   BioSample; SAMN03472301
DR   RCB; RCB0394
DR   Wikidata; Q54908290
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0394
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   NCU-F8
AC   CVCL_4732
DR   CLO; CLO_0050651
DR   BioSample; SAMN03472302
DR   RCB; RCB0395
DR   Wikidata; Q54908291
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0395
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   NCU-L-1
AC   CVCL_0G11
SY   NCU-L1; Nagoya City University-Leukemia-1
DR   Wikidata; Q54908292
RX   PubMed=19358282;
RX   PubMed=27457200;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 20-28 hours (PubMed=27457200).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 11
//
ID   NCU-L-3
AC   CVCL_0G12
SY   NCU-L3; Nagoya City University-Leukemia-3
DR   Wikidata; Q54908293
RX   CelloPub=CLPUB00229;
RX   PubMed=9738977;
RX   PubMed=19358282;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 30-46 hours (CelloPub=CLPUB00229).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   NCU-L-4
AC   CVCL_0G13
SY   NCU-L4; Nagoya City University-Leukemia-4
DR   Wikidata; Q54908294
RX   PubMed=19358282;
CC   Population: Japanese.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   NCU-MM-1
AC   CVCL_M492
SY   NCU-MM1; Nagoya City University-Multiple Myeloma-1
DR   ABM; T8055
DR   GEO; GSM143351
DR   Wikidata; Q54908295
RX   PubMed=10979215;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=17171682;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~48 hours (PubMed=10979215).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   NCU-MM-2
AC   CVCL_M507
SY   NCU-MM2; NCUMM-2; NCUMM2; Nagoya City University-Multiple Myeloma-2
DR   Wikidata; Q54908296
RX   PubMed=17229644;
CC   Population: Japanese.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   NCU-MM-3
AC   CVCL_M508
SY   NCU-MM3; NCUMM-3; Nagoya City University-Multiple Myeloma-3
DR   Wikidata; Q54908297
RX   PubMed=17229644;
CC   Population: Japanese.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   NCUFi001-A
AC   CVCL_A0MA
DR   hPSCreg; NCUFi001-A
DR   Wikidata; Q108821020
RX   PubMed=34130155;
CC   From: Niccolo Cusano University Foundation; Rome; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly314Ser (c.940G>A) (p.Gly187Ser, c.559G>A); ClinVar=VCV000003123; Zygosity=Heterozygous (PubMed=34130155).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   Nd
AC   CVCL_IU77
SY   Nd ES; Nanog dynamics
DR   ECACC; 16010601
DR   Wikidata; Q54908298
RX   PubMed=23527287;
CC   Characteristics: Provides an accurate and measurable read-out for the dynamic levels of Nanog expression.
CC   Characteristics: Contains a transgenic bacterial artificial chromosome (BAC) centered around the Nanog gene but where the Nanog coding sequence was replaced with VNP, a short-lived fluorescent reporter consisting of a Venus yellow fluorescent protein fused to a nuclear localization signal (NLS) and to a degradation signal (PEST). VNP expression is under the control of the Nanog regulatory regions.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9108 ! ES-E14TG2a
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   ND-1
AC   CVCL_4781
SY   ND1
DR   BTO; BTO_0001052
DR   BioSample; SAMN03151638
DR   cancercelllines; CVCL_4781
DR   Wikidata; Q54908299
RX   CelloPub=CLPUB00698;
RX   PubMed=1279221;
RX   PubMed=11304728;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a DU145 derivative (PubMed=11304728; PubMed=20143388; CelloPub=CLPUB00698). Originally thought to originate from a patient of unknown age with a primary prostate adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00244.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (PubMed=11304728).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (PubMed=11304728).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=11304728
ST   Amelogenin: X,Y
ST   D13S317: 11,12,14
ST   D18S51: 12
ST   D21S11: 30,33
ST   D3S1358: 15,16
ST   D5S818: 10,14
ST   D7S820: 7,10,11
ST   D8S1179: 13,14
ST   FGA: 22
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   ND-C
AC   CVCL_4261
DR   CLO; CLO_0008146
DR   ECACC; 92090913
DR   Wikidata; Q54908300
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 6
//
ID   ND-E
AC   CVCL_4262
DR   CLO; CLO_0008147
DR   CLDB; cl3677
DR   ECACC; 92090915
DR   Wikidata; Q54908301
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: ECACC; 92090915; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   ND-U1
AC   CVCL_4263
DR   CLO; CLO_0008148
DR   CLDB; cl3678
DR   ECACC; 92090916
DR   Wikidata; Q54908302
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: ECACC; 92090916; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   ND00001
AC   CVCL_CX93
DR   CLO; CLO_0030066
DR   Coriell; ND00001
DR   Wikidata; Q54908304
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00002
AC   CVCL_4E69
DR   CLO; CLO_0030063
DR   BioSample; SAMN00794697
DR   Coriell; ND00002
DR   Wikidata; Q54908305
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND00003
AC   CVCL_4E70
DR   CLO; CLO_0030070
DR   Coriell; ND00003
DR   Wikidata; Q54908306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00004
AC   CVCL_4E71
DR   CLO; CLO_0030068
DR   Coriell; ND00004
DR   Wikidata; Q54908307
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00005
AC   CVCL_CX94
DR   CLO; CLO_0030074
DR   Coriell; ND00005
DR   Wikidata; Q54908308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00006
AC   CVCL_4E72
DR   CLO; CLO_0030072
DR   Coriell; ND00006
DR   Wikidata; Q54908309
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00007
AC   CVCL_4E73
DR   CLO; CLO_0030078
DR   BioSample; SAMN00794699
DR   Coriell; ND00007
DR   Wikidata; Q54908310
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND00008
AC   CVCL_4E74
DR   CLO; CLO_0030077
DR   Coriell; ND00008
DR   Wikidata; Q54908311
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00009
AC   CVCL_CX95
DR   CLO; CLO_0030135
DR   Coriell; ND00009
DR   Wikidata; Q54908312
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00010
AC   CVCL_4E75
DR   CLO; CLO_0030131
DR   Coriell; ND00010
DR   Wikidata; Q54908313
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00011
AC   CVCL_CX96
DR   CLO; CLO_0030134
DR   Coriell; ND00011
DR   Wikidata; Q54908314
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00012
AC   CVCL_4E76
DR   CLO; CLO_0030158
DR   Coriell; ND00012
DR   Wikidata; Q54908315
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00013
AC   CVCL_4E77
DR   CLO; CLO_0030156
DR   Coriell; ND00013
DR   Wikidata; Q54908316
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00014
AC   CVCL_4E78
DR   CLO; CLO_0030154
DR   Coriell; ND00014
DR   Wikidata; Q54908317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00015
AC   CVCL_4E79
DR   CLO; CLO_0030152
DR   Coriell; ND00015
DR   Wikidata; Q54908318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00016
AC   CVCL_CX97
DR   CLO; CLO_0030148
DR   Coriell; ND00016
DR   Wikidata; Q54908320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00017
AC   CVCL_4E80
DR   CLO; CLO_0030146
DR   Coriell; ND00017
DR   Wikidata; Q54908321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00018
AC   CVCL_4E81
DR   CLO; CLO_0030142
DR   Coriell; ND00018
DR   Wikidata; Q54908322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00019
AC   CVCL_4E82
DR   CLO; CLO_0030099
DR   Coriell; ND00019
DR   Wikidata; Q54908323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00020
AC   CVCL_4E83
DR   CLO; CLO_0030101
DR   Coriell; ND00020
DR   Wikidata; Q54908324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00021
AC   CVCL_4E84
DR   CLO; CLO_0030103
DR   Coriell; ND00021
DR   Wikidata; Q54908325
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00022
AC   CVCL_CX98
SY   ND 00022
DR   CLO; CLO_0030105
DR   Coriell; ND00022
DR   GEO; GSM505297
DR   Wikidata; Q54908326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00023
AC   CVCL_4E85
DR   CLO; CLO_0030124
DR   Coriell; ND00023
DR   Wikidata; Q54908328
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00024
AC   CVCL_CX99
DR   CLO; CLO_0030122
DR   Coriell; ND00024
DR   Wikidata; Q54908329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00025
AC   CVCL_CY00
DR   CLO; CLO_0030127
DR   Coriell; ND00025
DR   Wikidata; Q54908330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00026
AC   CVCL_4E86
DR   CLO; CLO_0030125
DR   Coriell; ND00026
DR   Wikidata; Q54908331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00027
AC   CVCL_4E87
DR   CLO; CLO_0030116
DR   Coriell; ND00027
DR   Wikidata; Q54908332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00029
AC   CVCL_4E88
DR   CLO; CLO_0030114
DR   Coriell; ND00029
DR   Wikidata; Q54908333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00030
AC   CVCL_4E89
DR   CLO; CLO_0029764
DR   BioSample; SAMN00794701
DR   Coriell; ND00030
DR   Wikidata; Q54908334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00031
AC   CVCL_4E90
DR   CLO; CLO_0029766
DR   BioSample; SAMN00794703
DR   Coriell; ND00031
DR   Wikidata; Q54908335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00033
AC   CVCL_4E91
DR   CLO; CLO_0029765
DR   Coriell; ND00033
DR   Wikidata; Q54908337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00034
AC   CVCL_4E92
DR   CLO; CLO_0029768
DR   Coriell; ND00034
DR   Wikidata; Q54908338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00035
AC   CVCL_4E93
DR   CLO; CLO_0029767
DR   Coriell; ND00035
DR   Wikidata; Q54908340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00036
AC   CVCL_4E94
DR   CLO; CLO_0029749
DR   Coriell; ND00036
DR   Wikidata; Q54908341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00037
AC   CVCL_4E95
DR   CLO; CLO_0029750
DR   Coriell; ND00037
DR   Wikidata; Q54908342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00038
AC   CVCL_4E96
DR   CLO; CLO_0029751
DR   Coriell; ND00038
DR   Wikidata; Q54908343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00039
AC   CVCL_4E97
DR   CLO; CLO_0029752
DR   Coriell; ND00039
DR   Wikidata; Q54908344
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00041
AC   CVCL_AB55
DR   CLO; CLO_0029753
DR   Coriell; ND00041
DR   Wikidata; Q54908345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   ND00042
AC   CVCL_CY64
DR   CLO; CLO_0029742
DR   Coriell; ND00042
DR   Wikidata; Q54908346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00044
AC   CVCL_ER66
DR   CLO; CLO_0029748
DR   BioSample; SAMN00794707
DR   Coriell; ND00044
DR   Wikidata; Q54908347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00045
AC   CVCL_BX36
DR   CLO; CLO_0029747
DR   Coriell; ND00045
DR   Wikidata; Q54908348
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND00045).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND00046
AC   CVCL_BX37
DR   CLO; CLO_0029746
DR   Coriell; ND00046
DR   Wikidata; Q54908349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00048
AC   CVCL_BX38
DR   CLO; CLO_0029745
DR   Coriell; ND00048
DR   Wikidata; Q54908351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00049
AC   CVCL_GA24
DR   Coriell; ND00049
DR   Wikidata; Q54908352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00050
AC   CVCL_BX39
DR   CLO; CLO_0029731
DR   Coriell; ND00050
DR   Wikidata; Q54908353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00051
AC   CVCL_ER67
SY   ND 00051
DR   CLO; CLO_0029732
DR   Coriell; ND00051
DR   GEO; GSM505298
DR   Wikidata; Q54908354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND00052
AC   CVCL_ER68
DR   CLO; CLO_0029729
DR   Coriell; ND00052
DR   Wikidata; Q54908355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00053
AC   CVCL_ER69
DR   CLO; CLO_0029730
DR   Coriell; ND00053
DR   Wikidata; Q54908356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00054
AC   CVCL_BX40
DR   CLO; CLO_0029813
DR   BioSample; SAMN00794709
DR   Coriell; ND00054
DR   Wikidata; Q54908357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00055
AC   CVCL_BX41
DR   CLO; CLO_0029817
DR   BioSample; SAMN00794711
DR   Coriell; ND00055
DR   Wikidata; Q54908358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00056
AC   CVCL_ER70
DR   CLO; CLO_0029816
DR   BioSample; SAMN00794713
DR   Coriell; ND00056
DR   Wikidata; Q54908359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00057
AC   CVCL_BX42
DR   CLO; CLO_0029809
DR   Coriell; ND00057
DR   Wikidata; Q54908360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00058
AC   CVCL_BX43
DR   CLO; CLO_0029808
DR   Coriell; ND00058
DR   Wikidata; Q54908361
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00059
AC   CVCL_BX44
DR   CLO; CLO_0029811
DR   Coriell; ND00059
DR   Wikidata; Q54908362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00060
AC   CVCL_BX45
DR   CLO; CLO_0029810
DR   BioSample; SAMN00794715
DR   Coriell; ND00060
DR   Wikidata; Q54908363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00061
AC   CVCL_IG65
DR   CLO; CLO_0029799
DR   Coriell; ND00061
DR   Wikidata; Q54908367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND00061; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND00062
AC   CVCL_DB23
DR   CLO; CLO_0029800
DR   BioSample; SAMN00794717
DR   Coriell; ND00062
DR   Wikidata; Q54908368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00063
AC   CVCL_DB24
DR   CLO; CLO_0029801
DR   BioSample; SAMN00794719
DR   Coriell; ND00063
DR   Wikidata; Q54908369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00064
AC   CVCL_BX46
DR   CLO; CLO_0029798
DR   BioSample; SAMN00794721
DR   Coriell; ND00064
DR   Wikidata; Q54908370
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00065
AC   CVCL_DB25
DR   CLO; CLO_0029796
DR   BioSample; SAMN00794723
DR   Coriell; ND00065
DR   Wikidata; Q54908371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00066
AC   CVCL_DB26
DR   CLO; CLO_0029794
DR   BioSample; SAMN00794725
DR   Coriell; ND00066
DR   Wikidata; Q54908372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00067
AC   CVCL_BX47
DR   CLO; CLO_0029791
DR   Coriell; ND00067
DR   Wikidata; Q54908373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00068
AC   CVCL_DB27
DR   CLO; CLO_0029790
DR   BioSample; SAMN00794727
DR   Coriell; ND00068
DR   Wikidata; Q54908374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00069
AC   CVCL_DB28
DR   CLO; CLO_0029788
DR   BioSample; SAMN00794729
DR   Coriell; ND00069
DR   Wikidata; Q54908375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00070
AC   CVCL_BX48
DR   CLO; CLO_0029787
DR   Coriell; ND00070
DR   Wikidata; Q54908376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00071
AC   CVCL_BX49
DR   CLO; CLO_0029786
DR   Coriell; ND00071
DR   Wikidata; Q54908377
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00073
AC   CVCL_BX50
DR   CLO; CLO_0029773
DR   Coriell; ND00073
DR   Wikidata; Q54908378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00074
AC   CVCL_ER71
DR   CLO; CLO_0029774
DR   BioSample; SAMN00794731
DR   Coriell; ND00074
DR   Wikidata; Q54908379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00075
AC   CVCL_BX51
DR   CLO; CLO_0029887
DR   Coriell; ND00075
DR   Wikidata; Q54908380
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND00075).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND00076
AC   CVCL_BX52
DR   CLO; CLO_0029871
DR   Coriell; ND00076
DR   Wikidata; Q54908381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00077
AC   CVCL_ER72
DR   CLO; CLO_0029872
DR   Coriell; ND00077
DR   Wikidata; Q54908382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00078
AC   CVCL_ER73
DR   CLO; CLO_0029874
DR   BioSample; SAMN00794733
DR   Coriell; ND00078
DR   Wikidata; Q54908383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00079
AC   CVCL_BX53
DR   CLO; CLO_0029876
DR   BioSample; SAMN00794735
DR   Coriell; ND00079
DR   Wikidata; Q54908384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00080
AC   CVCL_BX54
DR   CLO; CLO_0029879
DR   Coriell; ND00080
DR   Wikidata; Q54908385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00081
AC   CVCL_BX55
DR   CLO; CLO_0029880
DR   Coriell; ND00081
DR   Wikidata; Q54908386
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00082
AC   CVCL_BX56
DR   CLO; CLO_0029882
DR   BioSample; SAMN00794737
DR   Coriell; ND00082
DR   Wikidata; Q54908387
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00083
AC   CVCL_BX57
DR   CLO; CLO_0029883
DR   Coriell; ND00083
DR   Wikidata; Q54908388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00084
AC   CVCL_CY65
DR   CLO; CLO_0029862
DR   Coriell; ND00084
DR   Wikidata; Q54908389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00085
AC   CVCL_ER74
DR   CLO; CLO_0030646
DR   BioSample; SAMN00794739
DR   Coriell; ND00085
DR   Wikidata; Q54908390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00086
AC   CVCL_ER75
DR   CLO; CLO_0030647
DR   BioSample; SAMN00794741
DR   Coriell; ND00086
DR   Wikidata; Q54908391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00087
AC   CVCL_BX58
DR   CLO; CLO_0030650
DR   BioSample; SAMN00794743
DR   Coriell; ND00087
DR   Wikidata; Q54908392
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00088
AC   CVCL_BX59
DR   CLO; CLO_0030651
DR   Coriell; ND00088
DR   Wikidata; Q54908393
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00089
AC   CVCL_ER76
DR   CLO; CLO_0030654
DR   Coriell; ND00089
DR   Wikidata; Q54908394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00090
AC   CVCL_ER77
DR   CLO; CLO_0030656
DR   Coriell; ND00090
DR   Wikidata; Q54908395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00092
AC   CVCL_ER78
DR   CLO; CLO_0030657
DR   BioSample; SAMN00794745
DR   Coriell; ND00092
DR   Wikidata; Q54908396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00093
AC   CVCL_HX82
DR   CLO; CLO_0030638
DR   Coriell; ND00093
DR   Wikidata; Q54908397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00094
AC   CVCL_BX60
DR   CLO; CLO_0030640
DR   BioSample; SAMN00794749
DR   Coriell; ND00094
DR   Wikidata; Q54908398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00095
AC   CVCL_DC37
DR   CLO; CLO_0030641
DR   Coriell; ND00095
DR   Wikidata; Q54908399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00096
AC   CVCL_DC38
DR   CLO; CLO_0030624
DR   Coriell; ND00096
DR   Wikidata; Q54908400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00097
AC   CVCL_DC39
DR   CLO; CLO_0030628
DR   Coriell; ND00097
DR   Wikidata; Q54908401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00098
AC   CVCL_DC40
DR   CLO; CLO_0030620
DR   Coriell; ND00098
DR   Wikidata; Q54908402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00099
AC   CVCL_DC41
DR   CLO; CLO_0030623
DR   Coriell; ND00099
DR   Wikidata; Q54908403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00100
AC   CVCL_BX61
DR   CLO; CLO_0030615
DR   BioSample; SAMN00794761
DR   Coriell; ND00100
DR   Wikidata; Q54908404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   101Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00101
AC   CVCL_BX62
DR   CLO; CLO_0030618
DR   BioSample; SAMN00794763
DR   Coriell; ND00101
DR   Wikidata; Q54908405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00102
AC   CVCL_IG66
DR   CLO; CLO_0030611
DR   Coriell; ND00102
DR   Wikidata; Q54908406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND00102; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND00103
AC   CVCL_DC42
DR   CLO; CLO_0030613
DR   Coriell; ND00103
DR   Wikidata; Q54908411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00104
AC   CVCL_DC43
DR   CLO; CLO_0030608
DR   Coriell; ND00104
DR   Wikidata; Q54908412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00105
AC   CVCL_DC44
DR   CLO; CLO_0030610
DR   Coriell; ND00105
DR   Wikidata; Q54908413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00106
AC   CVCL_DC45
DR   CLO; CLO_0030555
DR   Coriell; ND00106
DR   Wikidata; Q54908414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00107
AC   CVCL_DC46
DR   CLO; CLO_0030579
DR   BioSample; SAMN00794775
DR   Coriell; ND00107
DR   Wikidata; Q54908415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00108
AC   CVCL_DC47
DR   CLO; CLO_0030581
DR   Coriell; ND00108
DR   Wikidata; Q54908416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00109
AC   CVCL_DC48
DR   CLO; CLO_0030585
DR   Coriell; ND00109
DR   Wikidata; Q54908417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00110
AC   CVCL_DC49
DR   CLO; CLO_0030586
DR   Coriell; ND00110
DR   Wikidata; Q54908418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00111
AC   CVCL_DC50
DR   CLO; CLO_0030572
DR   Coriell; ND00111
DR   Wikidata; Q54908420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00112
AC   CVCL_DC51
DR   CLO; CLO_0030574
DR   BioSample; SAMN00794785
DR   Coriell; ND00112
DR   Wikidata; Q54908421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00113
AC   CVCL_DC52
DR   CLO; CLO_0030575
DR   Coriell; ND00113
DR   Wikidata; Q54908422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00114
AC   CVCL_DC53
DR   CLO; CLO_0030578
DR   Coriell; ND00114
DR   Wikidata; Q54908423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00115
AC   CVCL_DC54
DR   CLO; CLO_0030566
DR   Coriell; ND00115
DR   Wikidata; Q54908424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00116
AC   CVCL_DC55
DR   CLO; CLO_0030754
DR   Coriell; ND00116
DR   Wikidata; Q54908426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00117
AC   CVCL_DC56
DR   CLO; CLO_0030756
DR   Coriell; ND00117
DR   Wikidata; Q54908427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00118
AC   CVCL_DC57
DR   CLO; CLO_0030763
DR   Coriell; ND00118
DR   Wikidata; Q54908428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00119
AC   CVCL_DC58
DR   CLO; CLO_0030762
DR   Coriell; ND00119
DR   Wikidata; Q54908429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00120
AC   CVCL_DC59
DR   CLO; CLO_0030761
DR   Coriell; ND00120
DR   Wikidata; Q54908430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00121
AC   CVCL_DC60
DR   CLO; CLO_0030760
DR   BioSample; SAMN00794801
DR   Coriell; ND00121
DR   Wikidata; Q54908431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00122
AC   CVCL_DC61
DR   CLO; CLO_0030768
DR   Coriell; ND00122
DR   Wikidata; Q54908432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00123
AC   CVCL_BX63
DR   CLO; CLO_0030767
DR   BioSample; SAMN00794805
DR   Coriell; ND00123
DR   Wikidata; Q54908433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00124
AC   CVCL_BX64
DR   CLO; CLO_0030765
DR   Coriell; ND00124
DR   Wikidata; Q54908434
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00125
AC   CVCL_BX65
DR   CLO; CLO_0030764
DR   BioSample; SAMN00794807
DR   Coriell; ND00125
DR   Wikidata; Q54908435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00126
AC   CVCL_DC62
DR   CLO; CLO_0030736
DR   Coriell; ND00126
DR   Wikidata; Q54908436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00127
AC   CVCL_BX66
DR   CLO; CLO_0030739
DR   Coriell; ND00127
DR   Wikidata; Q54908437
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00128
AC   CVCL_BX67
DR   CLO; CLO_0030741
DR   Coriell; ND00128
DR   Wikidata; Q54908438
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00129
AC   CVCL_BX68
DR   CLO; CLO_0030743
DR   Coriell; ND00129
DR   Wikidata; Q54908439
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00130
AC   CVCL_BX69
DR   CLO; CLO_0030742
DR   Coriell; ND00130
DR   Wikidata; Q54908440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00131
AC   CVCL_ER79
DR   CLO; CLO_0030745
DR   Coriell; ND00131
DR   Wikidata; Q54908441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00132
AC   CVCL_BX70
DR   CLO; CLO_0030744
DR   Coriell; ND00132
DR   Wikidata; Q54908442
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00134
AC   CVCL_BX71
DR   CLO; CLO_0030747
DR   Coriell; ND00134
DR   Wikidata; Q54908443
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00135
AC   CVCL_HX35
DR   CLO; CLO_0030746
DR   Coriell; ND00135
DR   Wikidata; Q54908444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00136
AC   CVCL_BX72
DR   CLO; CLO_0030748
DR   BioSample; SAMN00794815
DR   Coriell; ND00136
DR   Wikidata; Q54908445
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00137
AC   CVCL_HX36
DR   CLO; CLO_0030714
DR   Coriell; ND00137
DR   Wikidata; Q54908447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00138
AC   CVCL_GA25
DR   CLO; CLO_0030715
DR   BioSample; SAMN00794819
DR   Coriell; ND00138
DR   Wikidata; Q54908448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00139
AC   CVCL_F203
DR   CLO; CLO_0030709
DR   BioSample; SAMN00794821
DR   Coriell; ND00139
DR   Wikidata; Q54908449
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (Coriell=ND00139).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L024 ! GM15844
OI   CVCL_F204 ! ND27760
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   ND00140
AC   CVCL_HX37
DR   CLO; CLO_0030711
DR   Coriell; ND00140
DR   Wikidata; Q54908450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00141
AC   CVCL_GA26
DR   CLO; CLO_0030728
DR   BioSample; SAMN00794825
DR   Coriell; ND00141
DR   Wikidata; Q54908451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00142
AC   CVCL_FC03
DR   CLO; CLO_0030727
DR   BioSample; SAMN00794827
DR   Coriell; ND00142
DR   Wikidata; Q54908452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00143
AC   CVCL_BX73
DR   CLO; CLO_0030726
DR   BioSample; SAMN00794829
DR   Coriell; ND00143
DR   Wikidata; Q54908453
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00144
AC   CVCL_HX38
DR   CLO; CLO_0030725
DR   Coriell; ND00144
DR   Wikidata; Q54908457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00145
AC   CVCL_HX39
DR   CLO; CLO_0030724
DR   Coriell; ND00145
DR   Wikidata; Q54908458
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND00146
AC   CVCL_BX74
DR   CLO; CLO_0030721
DR   BioSample; SAMN00794835
DR   Coriell; ND00146
DR   Wikidata; Q54908459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00147
AC   CVCL_EH01
DR   CLO; CLO_0030692
DR   Coriell; ND00147
DR   Wikidata; Q54908460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00148
AC   CVCL_BX75
DR   CLO; CLO_0030679
DR   BioSample; SAMN00794837
DR   Coriell; ND00148
DR   Wikidata; Q54908461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00149
AC   CVCL_BX76
DR   CLO; CLO_0030682
DR   Coriell; ND00149
DR   Wikidata; Q54908462
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00150
AC   CVCL_GA27
DR   CLO; CLO_0030684
DR   BioSample; SAMN00794839
DR   Coriell; ND00150
DR   Wikidata; Q54908463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00151
AC   CVCL_GA28
SY   ND 00151
DR   CLO; CLO_0030688
DR   BioSample; SAMN00794841
DR   Coriell; ND00151
DR   GEO; GSM505299
DR   Wikidata; Q54908464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   ND00152
AC   CVCL_GA29
DR   CLO; CLO_0030703
DR   Coriell; ND00152
DR   Wikidata; Q54908465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00153
AC   CVCL_BX77
DR   CLO; CLO_0030702
DR   Coriell; ND00153
DR   Wikidata; Q54908466
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00154
AC   CVCL_BX78
DR   CLO; CLO_0030708
DR   Coriell; ND00154
DR   Wikidata; Q54908467
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00155
AC   CVCL_BX79
DR   CLO; CLO_0030705
DR   Coriell; ND00155
DR   Wikidata; Q54908468
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00156
AC   CVCL_FB44
DR   CLO; CLO_0030698
DR   Coriell; ND00156
DR   Wikidata; Q54908470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00157
AC   CVCL_FB50
DR   CLO; CLO_0030433
DR   Coriell; ND00157
DR   Wikidata; Q54908471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00164
AC   CVCL_BX80
DR   CLO; CLO_0030432
DR   Coriell; ND00164
DR   Wikidata; Q54908472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00165
AC   CVCL_BX81
DR   CLO; CLO_0030435
DR   Coriell; ND00165
DR   Wikidata; Q54908473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00166
AC   CVCL_FB51
DR   CLO; CLO_0030434
DR   BioSample; SAMN00794847
DR   Coriell; ND00166
DR   Wikidata; Q54908474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00167
AC   CVCL_BX82
DR   CLO; CLO_0030437
DR   BioSample; SAMN00794849
DR   Coriell; ND00167
DR   Wikidata; Q54908475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00168
AC   CVCL_BX83
DR   CLO; CLO_0030436
DR   Coriell; ND00168
DR   Wikidata; Q54908476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00169
AC   CVCL_FB65
DR   CLO; CLO_0030427
DR   Coriell; ND00169
DR   Wikidata; Q54908477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00170
AC   CVCL_BX84
DR   CLO; CLO_0030428
DR   Coriell; ND00170
DR   Wikidata; Q54908478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00171
AC   CVCL_BX85
DR   CLO; CLO_0030429
DR   BioSample; SAMN00794853
DR   Coriell; ND00171
DR   Wikidata; Q54908479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00172
AC   CVCL_FB68
DR   CLO; CLO_0030430
DR   Coriell; ND00172
DR   Wikidata; Q54908480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00173
AC   CVCL_BX86
DR   CLO; CLO_0030414
DR   BioSample; SAMN00794857
DR   Coriell; ND00173
DR   Wikidata; Q54908481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00174
AC   CVCL_FB69
DR   CLO; CLO_0030413
DR   Coriell; ND00174
DR   Wikidata; Q54908482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00175
AC   CVCL_BX87
DR   CLO; CLO_0030412
DR   Coriell; ND00175
DR   Wikidata; Q54908483
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00176
AC   CVCL_BX88
DR   CLO; CLO_0030418
DR   Coriell; ND00176
DR   Wikidata; Q54908484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00177
AC   CVCL_BX89
DR   CLO; CLO_0030417
DR   Coriell; ND00177
DR   Wikidata; Q54908485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00179
AC   CVCL_BX90
DR   CLO; CLO_0030416
DR   Coriell; ND00179
DR   Wikidata; Q54908486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00180
AC   CVCL_BX91
DR   CLO; CLO_0030415
DR   Coriell; ND00180
DR   Wikidata; Q54908487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00181
AC   CVCL_FB71
DR   CLO; CLO_0030410
DR   BioSample; SAMN00794861
DR   Coriell; ND00181
DR   Wikidata; Q54908488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00182
AC   CVCL_BX92
DR   CLO; CLO_0030411
DR   Coriell; ND00182
DR   Wikidata; Q54908489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00183
AC   CVCL_BX93
DR   CLO; CLO_0030409
DR   BioSample; SAMN00794863
DR   Coriell; ND00183
DR   Wikidata; Q54908490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00184
AC   CVCL_FB72
DR   CLO; CLO_0030398
DR   BioSample; SAMN00794865
DR   Coriell; ND00184
DR   Wikidata; Q54908491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00185
AC   CVCL_BX94
DR   CLO; CLO_0030395
DR   Coriell; ND00185
DR   Wikidata; Q54908492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00186
AC   CVCL_BX95
DR   CLO; CLO_0030400
DR   Coriell; ND00186
DR   Wikidata; Q54908493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00187
AC   CVCL_BX96
DR   CLO; CLO_0030399
DR   BioSample; SAMN00794867
DR   Coriell; ND00187
DR   Wikidata; Q54908495
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00188
AC   CVCL_FB73
DR   CLO; CLO_0030392
DR   BioSample; SAMN00794869
DR   Coriell; ND00188
DR   Wikidata; Q54908496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00189
AC   CVCL_BX97
DR   CLO; CLO_0030391
DR   Coriell; ND00189
DR   Wikidata; Q54908497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00190
AC   CVCL_BX98
DR   CLO; CLO_0030394
DR   BioSample; SAMN00794871
DR   Coriell; ND00190
DR   Wikidata; Q54908498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00191
AC   CVCL_GA30
DR   CLO; CLO_0030393
DR   BioSample; SAMN00794873
DR   Coriell; ND00191
DR   Wikidata; Q54908501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00192
AC   CVCL_BX99
DR   CLO; CLO_0030389
DR   Coriell; ND00192
DR   Wikidata; Q54908502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00193
AC   CVCL_GA31
DR   CLO; CLO_0030390
DR   BioSample; SAMN00794875
DR   Coriell; ND00193
DR   Wikidata; Q54908503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00194
AC   CVCL_BY00
DR   CLO; CLO_0030850
DR   BioSample; SAMN00794877
DR   Coriell; ND00194
DR   Wikidata; Q54908504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00195
AC   CVCL_HE89
DR   CLO; CLO_0030849
DR   Coriell; ND00195
DR   Wikidata; Q54908505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00196
AC   CVCL_HE88
DR   CLO; CLO_0030854
DR   BioSample; SAMN00794881
DR   Coriell; ND00196
DR   Wikidata; Q54908506
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (Coriell=ND00196).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HE86 ! GM15009
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   ND00197
AC   CVCL_BY01
DR   CLO; CLO_0030853
DR   BioSample; SAMN00794883
DR   Coriell; ND00197
DR   Wikidata; Q54908507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00198
AC   CVCL_BY02
DR   CLO; CLO_0030852
DR   BioSample; SAMN00794885
DR   Coriell; ND00198
DR   Wikidata; Q54908508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00199
AC   CVCL_BY03
DR   CLO; CLO_0030851
DR   Coriell; ND00199
DR   Wikidata; Q54908509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00200
AC   CVCL_BY04
DR   CLO; CLO_0030858
DR   Coriell; ND00200
DR   Wikidata; Q54908510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00201
AC   CVCL_BY05
DR   CLO; CLO_0030857
DR   BioSample; SAMN00794887
DR   Coriell; ND00201
DR   Wikidata; Q54908511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00202
AC   CVCL_HX40
DR   CLO; CLO_0030856
DR   Coriell; ND00202
DR   Wikidata; Q54908512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00203
AC   CVCL_GA32
DR   CLO; CLO_0030855
DR   Coriell; ND00203
DR   Wikidata; Q54908513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00204
AC   CVCL_DS99
DR   CLO; CLO_0026451
DR   Coriell; ND00204
DR   Wikidata; Q54908514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00205
AC   CVCL_9W58
DR   CLO; CLO_0026450
DR   Coriell; ND00205
DR   Wikidata; Q54908516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125662; Carotid artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND00206
AC   CVCL_DT00
DR   CLO; CLO_0026449
DR   Coriell; ND00206
DR   Wikidata; Q54908517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00208
AC   CVCL_DT01
DR   CLO; CLO_0026456
DR   Coriell; ND00208
DR   Wikidata; Q54908518
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00209
AC   CVCL_DT02
DR   CLO; CLO_0026455
DR   Coriell; ND00209
DR   Wikidata; Q54908519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00210
AC   CVCL_DT03
DR   CLO; CLO_0026453
DR   Coriell; ND00210
DR   Wikidata; Q54908520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00211
AC   CVCL_DT04
DR   CLO; CLO_0026452
DR   Coriell; ND00211
DR   Wikidata; Q54908521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00212
AC   CVCL_BY06
DR   CLO; CLO_0026459
DR   Coriell; ND00212
DR   Wikidata; Q54908522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00213
AC   CVCL_DT05
DR   CLO; CLO_0026458
DR   Coriell; ND00213
DR   Wikidata; Q54908523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00214
AC   CVCL_FB38
DR   CLO; CLO_0026457
DR   Coriell; ND00214
DR   Wikidata; Q54908524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00215
AC   CVCL_FB39
DR   CLO; CLO_0026483
DR   Coriell; ND00215
DR   Wikidata; Q54908525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00216
AC   CVCL_BY07
DR   CLO; CLO_0026480
DR   Coriell; ND00216
DR   Wikidata; Q54908526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00217
AC   CVCL_HX41
DR   CLO; CLO_0026488
DR   Coriell; ND00217
DR   Wikidata; Q54908527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00218
AC   CVCL_HX42
DR   CLO; CLO_0026485
DR   Coriell; ND00218
DR   Wikidata; Q54908528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00219
AC   CVCL_HX43
DR   CLO; CLO_0026492
DR   Coriell; ND00219
DR   Wikidata; Q54908529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00220
AC   CVCL_HX44
DR   CLO; CLO_0026490
DR   Coriell; ND00220
DR   Wikidata; Q54908530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00221
AC   CVCL_BY08
DR   CLO; CLO_0026498
DR   BioSample; SAMN00794899
DR   Coriell; ND00221
DR   Wikidata; Q54908531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00223
AC   CVCL_BY09
DR   CLO; CLO_0026493
DR   BioSample; SAMN00794901
DR   Coriell; ND00223
DR   Wikidata; Q54908533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00224
AC   CVCL_HX45
DR   CLO; CLO_0026501
DR   Coriell; ND00224
DR   Wikidata; Q54908534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00225
AC   CVCL_GA33
DR   CLO; CLO_0026500
DR   BioSample; SAMN00794905
DR   Coriell; ND00225
DR   Wikidata; Q54908535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00226
AC   CVCL_HX46
DR   CLO; CLO_0026550
DR   Coriell; ND00226
DR   Wikidata; Q54908536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00227
AC   CVCL_BY10
DR   CLO; CLO_0026537
DR   Coriell; ND00227
DR   Wikidata; Q54908537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00228
AC   CVCL_DT06
DR   CLO; CLO_0026534
DR   Coriell; ND00228
DR   Wikidata; Q54908538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00229
AC   CVCL_DT07
DR   CLO; CLO_0026532
DR   Coriell; ND00229
DR   Wikidata; Q54908539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00230
AC   CVCL_DT08
DR   CLO; CLO_0026530
DR   Coriell; ND00230
DR   Wikidata; Q54908540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00231
AC   CVCL_BY11
DR   CLO; CLO_0026527
DR   Coriell; ND00231
DR   Wikidata; Q54908541
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00232
AC   CVCL_HX48
DR   CLO; CLO_0026526
DR   Coriell; ND00232
DR   Wikidata; Q54908542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00233
AC   CVCL_GA34
DR   CLO; CLO_0026524
DR   BioSample; SAMN00794911
DR   Coriell; ND00233
DR   Wikidata; Q54908544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00234
AC   CVCL_DT09
DR   CLO; CLO_0026521
DR   Coriell; ND00234
DR   Wikidata; Q54908545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00235
AC   CVCL_DT10
DR   CLO; CLO_0026540
DR   Coriell; ND00235
DR   Wikidata; Q54908546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00236
AC   CVCL_BY12
DR   CLO; CLO_0026589
DR   Coriell; ND00236
DR   Wikidata; Q54908547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00237
AC   CVCL_GA35
DR   CLO; CLO_0026593
DR   Coriell; ND00237
DR   Wikidata; Q54908548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00238
AC   CVCL_GA36
DR   CLO; CLO_0026572
DR   BioSample; SAMN00794913
DR   Coriell; ND00238
DR   Wikidata; Q54908549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00241
AC   CVCL_BY13
DR   CLO; CLO_0026569
DR   Coriell; ND00241
DR   Wikidata; Q54908551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00248
AC   CVCL_BY14
DR   CLO; CLO_0026577
DR   Coriell; ND00248
DR   Wikidata; Q54908552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00249
AC   CVCL_DT11
DR   CLO; CLO_0026575
DR   Coriell; ND00249
DR   Wikidata; Q54908553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00250
AC   CVCL_DT12
DR   CLO; CLO_0026563
DR   Coriell; ND00250
DR   Wikidata; Q54908554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00251
AC   CVCL_DT13
DR   CLO; CLO_0026561
DR   Coriell; ND00251
DR   Wikidata; Q54908555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00252
AC   CVCL_HX31
DR   CLO; CLO_0026568
DR   Coriell; ND00252
DR   Wikidata; Q54908556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   ND00253
AC   CVCL_GA37
DR   CLO; CLO_0026565
DR   BioSample; SAMN00794917
DR   Coriell; ND00253
DR   Wikidata; Q54908557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00254
AC   CVCL_FB40
DR   CLO; CLO_0026368
DR   Coriell; ND00254
DR   Wikidata; Q54908558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00255
AC   CVCL_DT14
DR   CLO; CLO_0026365
DR   Coriell; ND00255
DR   Wikidata; Q54908559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00256
AC   CVCL_DT15
DR   CLO; CLO_0026363
DR   Coriell; ND00256
DR   Wikidata; Q54908560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00257
AC   CVCL_BY15
DR   CLO; CLO_0026354
DR   Coriell; ND00257
DR   Wikidata; Q54908561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00258
AC   CVCL_BY16
DR   CLO; CLO_0026355
DR   Coriell; ND00258
DR   Wikidata; Q54908562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00259
AC   CVCL_GA38
SY   ND 00259
DR   CLO; CLO_0026349
DR   Coriell; ND00259
DR   GEO; GSM505300
DR   Wikidata; Q54908563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND00260
AC   CVCL_BY17
DR   CLO; CLO_0026352
DR   Coriell; ND00260
DR   Wikidata; Q54908564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00261
AC   CVCL_DT16
DR   CLO; CLO_0026358
DR   Coriell; ND00261
DR   Wikidata; Q54908565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00262
AC   CVCL_DT17
DR   CLO; CLO_0026359
DR   Coriell; ND00262
DR   Wikidata; Q54908566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00264
AC   CVCL_BY18
DR   CLO; CLO_0026357
DR   Coriell; ND00264
DR   Wikidata; Q54908567
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND00264).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND00265
AC   CVCL_BY19
DR   CLO; CLO_0026397
DR   Coriell; ND00265
DR   Wikidata; Q54908568
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00266
AC   CVCL_BY20
DR   CLO; CLO_0026394
DR   Coriell; ND00266
DR   Wikidata; Q54908569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00267
AC   CVCL_BY21
DR   CLO; CLO_0026401
DR   BioSample; SAMN00794919
DR   Coriell; ND00267
DR   Wikidata; Q54908570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00268
AC   CVCL_GA39
SY   ND 00268
DR   CLO; CLO_0026399
DR   Coriell; ND00268
DR   GEO; GSM505301
DR   Wikidata; Q54908572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND00269
AC   CVCL_GA40
DR   CLO; CLO_0026380
DR   Coriell; ND00269
DR   Wikidata; Q54908573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00270
AC   CVCL_GA41
DR   CLO; CLO_0026381
DR   BioSample; SAMN00794921
DR   Coriell; ND00270
DR   Wikidata; Q54908574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00271
AC   CVCL_GA42
DR   CLO; CLO_0026384
DR   Coriell; ND00271
DR   Wikidata; Q54908575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00273
AC   CVCL_BY22
DR   CLO; CLO_0026385
DR   BioSample; SAMN00794923
DR   Coriell; ND00273
DR   Wikidata; Q54908576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00274
AC   CVCL_GA43
DR   CLO; CLO_0026387
DR   BioSample; SAMN00794925
DR   Coriell; ND00274
DR   Wikidata; Q54908577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00275
AC   CVCL_BY23
DR   CLO; CLO_0026389
DR   BioSample; SAMN00794927
DR   Coriell; ND00275
DR   Wikidata; Q54908578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00276
AC   CVCL_GA44
DR   CLO; CLO_0026418
DR   BioSample; SAMN00794929
DR   Coriell; ND00276
DR   Wikidata; Q54908579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00277
AC   CVCL_BY24
DR   CLO; CLO_0026417
DR   BioSample; SAMN00794931
DR   Coriell; ND00277
DR   Wikidata; Q54908580
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00278
AC   CVCL_HX47
DR   CLO; CLO_0026416
DR   Coriell; ND00278
DR   Wikidata; Q54908581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00279
AC   CVCL_GA45
DR   CLO; CLO_0026415
DR   BioSample; SAMN00794935
DR   Coriell; ND00279
DR   Wikidata; Q54908582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00280
AC   CVCL_BY25
DR   CLO; CLO_0026414
DR   BioSample; SAMN00794937
DR   Coriell; ND00280
DR   Wikidata; Q54908583
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00281
AC   CVCL_HX49
DR   CLO; CLO_0026412
DR   Coriell; ND00281
DR   Wikidata; Q54908584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00282
AC   CVCL_DT18
DR   CLO; CLO_0026413
DR   Coriell; ND00282
DR   Wikidata; Q54908585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00283
AC   CVCL_BY26
DR   CLO; CLO_0026410
DR   BioSample; SAMN00794941
DR   Coriell; ND00283
DR   Wikidata; Q54908589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00284
AC   CVCL_GA46
DR   CLO; CLO_0026411
DR   BioSample; SAMN00794943
DR   Coriell; ND00284
DR   Wikidata; Q54908590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00285
AC   CVCL_BY27
DR   CLO; CLO_0026409
DR   Coriell; ND00285
DR   Wikidata; Q54908591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00286
AC   CVCL_BY28
DR   CLO; CLO_0026441
DR   Coriell; ND00286
DR   Wikidata; Q54908592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00287
AC   CVCL_BY29
DR   CLO; CLO_0026440
DR   Coriell; ND00287
DR   Wikidata; Q54908593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00288
AC   CVCL_DT19
DR   CLO; CLO_0026434
DR   Coriell; ND00288
DR   Wikidata; Q54908595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00289
AC   CVCL_BY30
DR   CLO; CLO_0026433
DR   BioSample; SAMN00794945
DR   Coriell; ND00289
DR   Wikidata; Q54908596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00290
AC   CVCL_DT20
DR   CLO; CLO_0026439
DR   Coriell; ND00290
DR   Wikidata; Q54908597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00291
AC   CVCL_DT21
DR   CLO; CLO_0026437
DR   Coriell; ND00291
DR   Wikidata; Q54908598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00292
AC   CVCL_BY31
DR   CLO; CLO_0026427
DR   Coriell; ND00292
DR   Wikidata; Q54908599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00293
AC   CVCL_BY32
DR   CLO; CLO_0026429
DR   BioSample; SAMN00794947
DR   Coriell; ND00293
DR   Wikidata; Q54908601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00294
AC   CVCL_GA47
DR   CLO; CLO_0026431
DR   BioSample; SAMN00794949
DR   Coriell; ND00294
DR   Wikidata; Q54908603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00295
AC   CVCL_BY33
DR   CLO; CLO_0026432
DR   BioSample; SAMN00794951
DR   Coriell; ND00295
DR   Wikidata; Q54908605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00296
AC   CVCL_GA48
DR   CLO; CLO_0026762
DR   BioSample; SAMN00794953
DR   Coriell; ND00296
DR   Wikidata; Q54908608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00297
AC   CVCL_FB41
DR   CLO; CLO_0026763
DR   Coriell; ND00297
DR   Wikidata; Q54908611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00298
AC   CVCL_DT22
DR   CLO; CLO_0026764
DR   Coriell; ND00298
DR   Wikidata; Q54908614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00299
AC   CVCL_DT23
DR   CLO; CLO_0026765
DR   Coriell; ND00299
DR   Wikidata; Q54908617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00301
AC   CVCL_DT24
DR   CLO; CLO_0026766
DR   Coriell; ND00301
DR   Wikidata; Q54908618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00302
AC   CVCL_DT25
DR   CLO; CLO_0026767
DR   Coriell; ND00302
DR   Wikidata; Q54908619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00303
AC   CVCL_DT26
DR   CLO; CLO_0026768
DR   Coriell; ND00303
DR   Wikidata; Q54908620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00304
AC   CVCL_DT27
DR   CLO; CLO_0026770
DR   Coriell; ND00304
DR   Wikidata; Q54908621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00305
AC   CVCL_BY34
DR   CLO; CLO_0026769
DR   Coriell; ND00305
DR   Wikidata; Q54908622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00307
AC   CVCL_GA49
DR   CLO; CLO_0026772
DR   Coriell; ND00307
DR   Wikidata; Q54908623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00308
AC   CVCL_BY35
DR   CLO; CLO_0026988
DR   BioSample; SAMN00794955
DR   Coriell; ND00308
DR   Wikidata; Q54908624
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00309
AC   CVCL_GA50
DR   CLO; CLO_0026986
DR   BioSample; SAMN00794957
DR   Coriell; ND00309
DR   Wikidata; Q54908625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00310
AC   CVCL_BY36
DR   CLO; CLO_0026987
DR   BioSample; SAMN00794959
DR   Coriell; ND00310
DR   Wikidata; Q54908626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00311
AC   CVCL_GA51
DR   CLO; CLO_0026984
DR   BioSample; SAMN00794961
DR   Coriell; ND00311
DR   Wikidata; Q54908627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00312
AC   CVCL_GA52
DR   CLO; CLO_0026985
DR   Coriell; ND00312
DR   Wikidata; Q54908628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00313
AC   CVCL_BY37
DR   CLO; CLO_0026982
DR   Coriell; ND00313
DR   Wikidata; Q54908629
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00314
AC   CVCL_DT28
DR   CLO; CLO_0026983
DR   Coriell; ND00314
DR   Wikidata; Q54908630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00315
AC   CVCL_DT29
DR   CLO; CLO_0026980
DR   Coriell; ND00315
DR   Wikidata; Q54908631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00316
AC   CVCL_DT30
DR   CLO; CLO_0026981
DR   Coriell; ND00316
DR   Wikidata; Q54908632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00317
AC   CVCL_DT31
DR   CLO; CLO_0026979
DR   Coriell; ND00317
DR   Wikidata; Q54908634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00318
AC   CVCL_BY38
DR   CLO; CLO_0027003
DR   Coriell; ND00318
DR   Wikidata; Q54908635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00319
AC   CVCL_BY39
DR   CLO; CLO_0027004
DR   Coriell; ND00319
DR   Wikidata; Q54908636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00320
AC   CVCL_BY40
DR   CLO; CLO_0027005
DR   Coriell; ND00320
DR   Wikidata; Q54908637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00321
AC   CVCL_DT32
DR   CLO; CLO_0027006
DR   Coriell; ND00321
DR   Wikidata; Q54908638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00322
AC   CVCL_DT33
DR   CLO; CLO_0027007
DR   Coriell; ND00322
DR   Wikidata; Q54908639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00323
AC   CVCL_BY41
DR   CLO; CLO_0027008
DR   Coriell; ND00323
DR   Wikidata; Q54908640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00324
AC   CVCL_BY42
DR   CLO; CLO_0026999
DR   Coriell; ND00324
DR   Wikidata; Q54908641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00325
AC   CVCL_BY43
DR   CLO; CLO_0027000
DR   BioSample; SAMN00794963
DR   Coriell; ND00325
DR   Wikidata; Q54908644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00326
AC   CVCL_HX50
DR   CLO; CLO_0027001
DR   Coriell; ND00326
DR   Wikidata; Q54908645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00327
AC   CVCL_DT34
DR   CLO; CLO_0027002
DR   Coriell; ND00327
DR   Wikidata; Q54908646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00328
AC   CVCL_DT35
DR   CLO; CLO_0026994
DR   Coriell; ND00328
DR   Wikidata; Q54908647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00329
AC   CVCL_BY44
DR   CLO; CLO_0026992
DR   Coriell; ND00329
DR   Wikidata; Q54908648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00330
AC   CVCL_FB42
DR   CLO; CLO_0026993
DR   Coriell; ND00330
DR   Wikidata; Q54908649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00331
AC   CVCL_BY45
DR   CLO; CLO_0026997
DR   BioSample; SAMN00794967
DR   Coriell; ND00331
DR   Wikidata; Q54908650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00332
AC   CVCL_GA53
DR   CLO; CLO_0026998
DR   BioSample; SAMN00794969
DR   Coriell; ND00332
DR   Wikidata; Q54908651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00333
AC   CVCL_BY46
DR   CLO; CLO_0026995
DR   Coriell; ND00333
DR   Wikidata; Q54908652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00334
AC   CVCL_BY47
DR   CLO; CLO_0026996
DR   Coriell; ND00334
DR   Wikidata; Q54908653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00335
AC   CVCL_DT36
DR   CLO; CLO_0026990
DR   Coriell; ND00335
DR   Wikidata; Q54908654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00336
AC   CVCL_DT37
DR   CLO; CLO_0026991
DR   Coriell; ND00336
DR   Wikidata; Q54908655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00337
AC   CVCL_DT38
DR   CLO; CLO_0026989
DR   Coriell; ND00337
DR   Wikidata; Q54908656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00338
AC   CVCL_DT39
DR   CLO; CLO_0027104
DR   Coriell; ND00338
DR   Wikidata; Q54908657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00339
AC   CVCL_DT40
DR   CLO; CLO_0027103
DR   Coriell; ND00339
DR   Wikidata; Q54908658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00340
AC   CVCL_DT41
DR   CLO; CLO_0027102
DR   Coriell; ND00340
DR   Wikidata; Q54908659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00341
AC   CVCL_DT42
DR   CLO; CLO_0027101
DR   Coriell; ND00341
DR   Wikidata; Q54908660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00342
AC   CVCL_DT43
DR   CLO; CLO_0027108
DR   Coriell; ND00342
DR   Wikidata; Q54908661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00343
AC   CVCL_DT44
DR   CLO; CLO_0027107
DR   Coriell; ND00343
DR   Wikidata; Q54908662
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00345
AC   CVCL_HX51
DR   CLO; CLO_0027106
DR   Coriell; ND00345
DR   Wikidata; Q54908663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00346
AC   CVCL_DT45
DR   CLO; CLO_0027105
DR   Coriell; ND00346
DR   Wikidata; Q54908664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00347
AC   CVCL_DT46
DR   CLO; CLO_0027100
DR   Coriell; ND00347
DR   Wikidata; Q54908665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00348
AC   CVCL_BY48
DR   CLO; CLO_0027099
DR   BioSample; SAMN00794971
DR   Coriell; ND00348
DR   Wikidata; Q54908666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00349
AC   CVCL_BY49
DR   CLO; CLO_0027136
DR   Coriell; ND00349
DR   Wikidata; Q54908667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00350
AC   CVCL_GA54
DR   CLO; CLO_0027121
DR   BioSample; SAMN00794973
DR   Coriell; ND00350
DR   Wikidata; Q54908668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00351
AC   CVCL_BY50
DR   CLO; CLO_0027120
DR   Coriell; ND00351
DR   Wikidata; Q54908669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00352
AC   CVCL_GA55
DR   CLO; CLO_0027123
DR   Coriell; ND00352
DR   Wikidata; Q54908670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00353
AC   CVCL_BY51
DR   CLO; CLO_0027122
DR   Coriell; ND00353
DR   Wikidata; Q54908671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00355
AC   CVCL_BY52
DR   CLO; CLO_0027125
DR   BioSample; SAMN00794975
DR   Coriell; ND00355
DR   Wikidata; Q54908672
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00356
AC   CVCL_GA56
DR   CLO; CLO_0027124
DR   BioSample; SAMN00794977
DR   Coriell; ND00356
DR   Wikidata; Q54908673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00357
AC   CVCL_BY53
DR   CLO; CLO_0027128
DR   BioSample; SAMN00794979
DR   Coriell; ND00357
DR   Wikidata; Q54908676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00358
AC   CVCL_GA57
DR   CLO; CLO_0027126
DR   BioSample; SAMN00794981
DR   Coriell; ND00358
DR   Wikidata; Q54908677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00359
AC   CVCL_BY54
DR   CLO; CLO_0027119
DR   BioSample; SAMN00794983
DR   Coriell; ND00359
DR   Wikidata; Q54908678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00361
AC   CVCL_GA58
DR   CLO; CLO_0027057
DR   BioSample; SAMN00794985
DR   Coriell; ND00361
DR   Wikidata; Q54908679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00362
AC   CVCL_GA59
DR   CLO; CLO_0027060
DR   Coriell; ND00362
DR   Wikidata; Q54908680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00363
AC   CVCL_BY55
DR   CLO; CLO_0027056
DR   BioSample; SAMN00794987
DR   Coriell; ND00363
DR   Wikidata; Q54908681
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00364
AC   CVCL_HX52
DR   CLO; CLO_0027055
DR   Coriell; ND00364
DR   Wikidata; Q54908682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00365
AC   CVCL_BY56
DR   CLO; CLO_0027054
DR   BioSample; SAMN00794991
DR   Coriell; ND00365
DR   Wikidata; Q54908683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00366
AC   CVCL_GA60
DR   CLO; CLO_0027053
DR   BioSample; SAMN00794993
DR   Coriell; ND00366
DR   Wikidata; Q54908684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00367
AC   CVCL_FB43
DR   CLO; CLO_0027052
DR   Coriell; ND00367
DR   Wikidata; Q54908685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00369
AC   CVCL_II04
DR   CLO; CLO_0027051
DR   Coriell; ND00369
DR   Wikidata; Q54908697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00370
AC   CVCL_BY57
DR   CLO; CLO_0027050
DR   Coriell; ND00370
DR   Wikidata; Q54908698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00371
AC   CVCL_HX53
DR   CLO; CLO_0027049
DR   Coriell; ND00371
DR   Wikidata; Q54908699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00372
AC   CVCL_HX54
DR   CLO; CLO_0027088
DR   Coriell; ND00372
DR   Wikidata; Q54908700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00374
AC   CVCL_HX55
DR   CLO; CLO_0027089
DR   Coriell; ND00374
DR   Wikidata; Q54908701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00375
AC   CVCL_HX56
DR   CLO; CLO_0027091
DR   Coriell; ND00375
DR   Wikidata; Q54908702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00376
AC   CVCL_CY66
DR   CLO; CLO_0027081
DR   Coriell; ND00376
DR   Wikidata; Q54908703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00377
AC   CVCL_GA61
DR   CLO; CLO_0027078
DR   BioSample; SAMN00795007
DR   Coriell; ND00377
DR   Wikidata; Q54908704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00379
AC   CVCL_BY58
DR   CLO; CLO_0027085
DR   BioSample; SAMN00795009
DR   Coriell; ND00379
DR   Wikidata; Q54908705
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00380
AC   CVCL_FG78
DR   CLO; CLO_0027082
DR   Coriell; ND00380
DR   Wikidata; Q54908706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00381
AC   CVCL_DT47
DR   CLO; CLO_0027074
DR   Coriell; ND00381
DR   Wikidata; Q54908707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00382
AC   CVCL_DT48
DR   CLO; CLO_0027071
DR   Coriell; ND00382
DR   Wikidata; Q54908708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00383
AC   CVCL_DT49
DR   CLO; CLO_0027077
DR   Coriell; ND00383
DR   Wikidata; Q54908709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00384
AC   CVCL_BY59
DR   CLO; CLO_0027028
DR   BioSample; SAMN00795011
DR   Coriell; ND00384
DR   Wikidata; Q54908710
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00385
AC   CVCL_HX57
DR   CLO; CLO_0027027
DR   Coriell; ND00385
DR   Wikidata; Q54908713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00386
AC   CVCL_BY60
DR   CLO; CLO_0027026
DR   BioSample; SAMN00795015
DR   Coriell; ND00386
DR   Wikidata; Q54908716
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00387
AC   CVCL_GA62
DR   CLO; CLO_0027025
DR   BioSample; SAMN00795017
DR   Coriell; ND00387
DR   Wikidata; Q54908719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00388
AC   CVCL_BY61
DR   CLO; CLO_0027021
DR   BioSample; SAMN00795019
DR   Coriell; ND00388
DR   Wikidata; Q54908722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00389
AC   CVCL_BY62
DR   CLO; CLO_0027022
DR   BioSample; SAMN00795021
DR   Coriell; ND00389
DR   Wikidata; Q54908725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00390
AC   CVCL_BY63
DR   CLO; CLO_0027019
DR   Coriell; ND00390
DR   Wikidata; Q54908728
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00391
AC   CVCL_HX58
DR   CLO; CLO_0027020
DR   Coriell; ND00391
DR   Wikidata; Q54908731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00392
AC   CVCL_GA63
DR   CLO; CLO_0027023
DR   BioSample; SAMN00795025
DR   Coriell; ND00392
DR   Wikidata; Q54908734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00393
AC   CVCL_BY64
DR   CLO; CLO_0027024
DR   Coriell; ND00393
DR   Wikidata; Q54908736
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00394
AC   CVCL_DT50
DR   CLO; CLO_0027040
DR   Coriell; ND00394
DR   Wikidata; Q54908739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00395
AC   CVCL_DT51
DR   CLO; CLO_0027043
DR   Coriell; ND00395
DR   Wikidata; Q54908741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00396
AC   CVCL_DT52
DR   CLO; CLO_0027042
DR   Coriell; ND00396
DR   Wikidata; Q54908744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00397
AC   CVCL_DT53
DR   CLO; CLO_0027048
DR   Coriell; ND00397
DR   Wikidata; Q54908747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00398
AC   CVCL_DT54
DR   CLO; CLO_0027046
DR   Coriell; ND00398
DR   Wikidata; Q54908750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00399
AC   CVCL_FG79
DR   CLO; CLO_0027029
DR   Coriell; ND00399
DR   Wikidata; Q54908752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00400
AC   CVCL_HX59
DR   CLO; CLO_0027030
DR   Coriell; ND00400
DR   Wikidata; Q54908755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00401
AC   CVCL_BY65
DR   CLO; CLO_0027031
DR   BioSample; SAMN00795031
DR   Coriell; ND00401
DR   Wikidata; Q54908758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00402
AC   CVCL_GA64
DR   CLO; CLO_0027032
DR   BioSample; SAMN00795033
DR   Coriell; ND00402
DR   Wikidata; Q54908760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00403
AC   CVCL_DT55
DR   CLO; CLO_0027033
DR   Coriell; ND00403
DR   Wikidata; Q54908763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00404
AC   CVCL_DT56
DR   CLO; CLO_0027018
DR   Coriell; ND00404
DR   Wikidata; Q54908765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00405
AC   CVCL_DT57
DR   CLO; CLO_0027017
DR   Coriell; ND00405
DR   Wikidata; Q54908768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00406
AC   CVCL_BY66
DR   CLO; CLO_0027016
DR   Coriell; ND00406
DR   Wikidata; Q54908771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00407
AC   CVCL_DT58
DR   CLO; CLO_0027015
DR   Coriell; ND00407
DR   Wikidata; Q54908774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00408
AC   CVCL_DT59
DR   CLO; CLO_0027014
DR   Coriell; ND00408
DR   Wikidata; Q54908778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00409
AC   CVCL_BY67
DR   CLO; CLO_0027013
DR   Coriell; ND00409
DR   Wikidata; Q54908781
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00410
AC   CVCL_BY68
DR   CLO; CLO_0027011
DR   BioSample; SAMN00795035
DR   Coriell; ND00410
DR   Wikidata; Q54908785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00411
AC   CVCL_HX60
DR   CLO; CLO_0027012
DR   Coriell; ND00411
DR   Wikidata; Q54908884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00412
AC   CVCL_1V29
SY   ND-412
DR   CLO; CLO_0027009
DR   BioSample; SAMN00795039
DR   Coriell; ND00412
DR   Wikidata; Q54908885
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND00413
AC   CVCL_BY69
DR   CLO; CLO_0027010
DR   BioSample; SAMN00795041
DR   Coriell; ND00413
DR   Wikidata; Q54908886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00414
AC   CVCL_ER80
DR   CLO; CLO_0027568
DR   BioSample; SAMN00795043
DR   Coriell; ND00414
DR   Wikidata; Q54908887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00415
AC   CVCL_BY70
DR   CLO; CLO_0027567
DR   BioSample; SAMN00795045
DR   Coriell; ND00415
DR   Wikidata; Q54908888
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00416
AC   CVCL_BY71
DR   CLO; CLO_0027566
DR   BioSample; SAMN00795047
DR   Coriell; ND00416
DR   Wikidata; Q54908889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00417
AC   CVCL_BY72
DR   CLO; CLO_0027565
DR   Coriell; ND00417
DR   Wikidata; Q54908890
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00418
AC   CVCL_DT60
DR   CLO; CLO_0027562
DR   Coriell; ND00418
DR   Wikidata; Q54908891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00419
AC   CVCL_DT61
DR   CLO; CLO_0027561
DR   Coriell; ND00419
DR   Wikidata; Q54908892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00420
AC   CVCL_DT62
DR   CLO; CLO_0027560
DR   Coriell; ND00420
DR   Wikidata; Q54908893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00422
AC   CVCL_BY73
DR   CLO; CLO_0027559
DR   Coriell; ND00422
DR   Wikidata; Q54908894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00423
AC   CVCL_DT63
DR   CLO; CLO_0027564
DR   Coriell; ND00423
DR   Wikidata; Q54908895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00424
AC   CVCL_BY74
DR   CLO; CLO_0027563
DR   Coriell; ND00424
DR   Wikidata; Q54908896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00425
AC   CVCL_DT64
DR   CLO; CLO_0027553
DR   Coriell; ND00425
DR   Wikidata; Q54908897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00426
AC   CVCL_DT65
DR   CLO; CLO_0027549
DR   Coriell; ND00426
DR   Wikidata; Q54908898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00427
AC   CVCL_DT66
DR   CLO; CLO_0027550
DR   Coriell; ND00427
DR   Wikidata; Q54908899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00428
AC   CVCL_BY75
DR   CLO; CLO_0027551
DR   Coriell; ND00428
DR   Wikidata; Q54908900
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00429
AC   CVCL_BY76
DR   CLO; CLO_0027552
DR   BioSample; SAMN00795049
DR   Coriell; ND00429
DR   Wikidata; Q54908901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00430
AC   CVCL_DT67
DR   CLO; CLO_0027555
DR   Coriell; ND00430
DR   Wikidata; Q54908902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00447
AC   CVCL_BY77
DR   CLO; CLO_0027556
DR   BioSample; SAMN00795051
DR   Coriell; ND00447
DR   Wikidata; Q54908903
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00448
AC   CVCL_HX61
DR   CLO; CLO_0027557
DR   Coriell; ND00448
DR   Wikidata; Q54908905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00449
AC   CVCL_BY78
DR   CLO; CLO_0027558
DR   BioSample; SAMN00795055
DR   Coriell; ND00449
DR   Wikidata; Q54908906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00450
AC   CVCL_GA65
DR   CLO; CLO_0027554
DR   BioSample; SAMN00795057
DR   Coriell; ND00450
DR   Wikidata; Q54908907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00451
AC   CVCL_BY79
DR   CLO; CLO_0027543
DR   BioSample; SAMN00795059
DR   Coriell; ND00451
DR   Wikidata; Q54908908
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00452
AC   CVCL_FC04
DR   CLO; CLO_0027544
DR   BioSample; SAMN00795061
DR   Coriell; ND00452
DR   Wikidata; Q54908909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00453
AC   CVCL_BY80
DR   CLO; CLO_0027541
DR   Coriell; ND00453
DR   Wikidata; Q54908910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00454
AC   CVCL_DT68
DR   CLO; CLO_0027542
DR   Coriell; ND00454
DR   Wikidata; Q54908911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00455
AC   CVCL_DT69
DR   CLO; CLO_0027539
DR   Coriell; ND00455
DR   Wikidata; Q54908912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00456
AC   CVCL_DT70
DR   CLO; CLO_0027540
DR   Coriell; ND00456
DR   Wikidata; Q54908913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00457
AC   CVCL_BY81
DR   CLO; CLO_0027547
DR   Coriell; ND00457
DR   Wikidata; Q54908914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00468
AC   CVCL_DT71
DR   CLO; CLO_0027548
DR   Coriell; ND00468
DR   Wikidata; Q54908915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00469
AC   CVCL_DT72
DR   CLO; CLO_0027545
DR   Coriell; ND00469
DR   Wikidata; Q54908916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00470
AC   CVCL_DT73
DR   CLO; CLO_0027546
DR   Coriell; ND00470
DR   Wikidata; Q54908918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00471
AC   CVCL_DT74
DR   CLO; CLO_0027529
DR   Coriell; ND00471
DR   Wikidata; Q54908919
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00473
AC   CVCL_DT75
DR   CLO; CLO_0027530
DR   Coriell; ND00473
DR   Wikidata; Q54908920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00474
AC   CVCL_HX62
DR   CLO; CLO_0027531
DR   Coriell; ND00474
DR   Wikidata; Q54908921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00476
AC   CVCL_DT76
DR   CLO; CLO_0027532
DR   Coriell; ND00476
DR   Wikidata; Q54908922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00477
AC   CVCL_DT77
DR   CLO; CLO_0027533
DR   Coriell; ND00477
DR   Wikidata; Q54908923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00483
AC   CVCL_BY82
DR   CLO; CLO_0027534
DR   Coriell; ND00483
DR   Wikidata; Q54908924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00484
AC   CVCL_ER81
DR   CLO; CLO_0027535
DR   Coriell; ND00484
DR   Wikidata; Q54908925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00485
AC   CVCL_GA66
DR   CLO; CLO_0027536
DR   Coriell; ND00485
DR   Wikidata; Q54908933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00486
AC   CVCL_BY83
DR   CLO; CLO_0027537
DR   Coriell; ND00486
DR   Wikidata; Q54908934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00488
AC   CVCL_DT78
DR   CLO; CLO_0027538
DR   Coriell; ND00488
DR   Wikidata; Q54908935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00489
AC   CVCL_DT79
DR   CLO; CLO_0027521
DR   Coriell; ND00489
DR   Wikidata; Q54908936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00497
AC   CVCL_BY84
DR   CLO; CLO_0027522
DR   Coriell; ND00497
DR   Wikidata; Q54908937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00498
AC   CVCL_BY85
DR   CLO; CLO_0027519
DR   Coriell; ND00498
DR   Wikidata; Q54908938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00499
AC   CVCL_BY86
DR   CLO; CLO_0027520
DR   BioSample; SAMN00795065
DR   Coriell; ND00499
DR   Wikidata; Q54908939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00500
AC   CVCL_GA67
DR   CLO; CLO_0027525
DR   BioSample; SAMN00795067
DR   Coriell; ND00500
DR   Wikidata; Q54908941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00501
AC   CVCL_CY67
DR   CLO; CLO_0027526
DR   Coriell; ND00501
DR   Wikidata; Q54908943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00502
AC   CVCL_V147
DR   CLO; CLO_0027523
DR   Coriell; ND00502
DR   Wikidata; Q54908944
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   ND00503
AC   CVCL_IG67
DR   CLO; CLO_0027524
DR   Coriell; ND00503
DR   Wikidata; Q54908945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND00503; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND00504
AC   CVCL_BY87
DR   CLO; CLO_0027527
DR   Coriell; ND00504
DR   Wikidata; Q54908946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00505
AC   CVCL_DT80
DR   CLO; CLO_0027528
DR   Coriell; ND00505
DR   Wikidata; Q54908947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00506
AC   CVCL_DT81
DR   CLO; CLO_0027576
DR   Coriell; ND00506
DR   Wikidata; Q54908948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00507
AC   CVCL_DT82
DR   CLO; CLO_0027583
DR   Coriell; ND00507
DR   Wikidata; Q54908949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00528
AC   CVCL_1V30
SY   ND-528
DR   CLO; CLO_0027582
DR   BioSample; SAMN00795073
DR   Coriell; ND00528
DR   Wikidata; Q54908950
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND00542
AC   CVCL_BY88
DR   CLO; CLO_0027581
DR   BioSample; SAMN00795075
DR   Coriell; ND00542
DR   Wikidata; Q54908951
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00543
AC   CVCL_BY89
DR   CLO; CLO_0027580
DR   Coriell; ND00543
DR   Wikidata; Q54908952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00544
AC   CVCL_BY90
DR   CLO; CLO_0027587
DR   Coriell; ND00544
DR   Wikidata; Q54908953
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00545
AC   CVCL_BY91
DR   CLO; CLO_0027586
DR   BioSample; SAMN00795077
DR   Coriell; ND00545
DR   Wikidata; Q54908954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00546
AC   CVCL_FF35
DR   CLO; CLO_0027585
DR   BioSample; SAMN00795079
DR   Coriell; ND00546
DR   Wikidata; Q54908955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00547
AC   CVCL_BY92
DR   CLO; CLO_0027584
DR   Coriell; ND00547
DR   Wikidata; Q54908956
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00548
AC   CVCL_BY93
DR   CLO; CLO_0027588
DR   Coriell; ND00548
DR   Wikidata; Q54908957
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00549
AC   CVCL_BY94
DR   CLO; CLO_0027598
DR   Coriell; ND00549
DR   Wikidata; Q54908958
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00554
AC   CVCL_DT83
DR   CLO; CLO_0027599
DR   Coriell; ND00554
DR   Wikidata; Q54908959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00556
AC   CVCL_BY95
DR   CLO; CLO_0027602
DR   Coriell; ND00556
DR   Wikidata; Q54908960
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00589
AC   CVCL_BY96
DR   CLO; CLO_0027601
DR   Coriell; ND00589
DR   Wikidata; Q54908961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00590
AC   CVCL_BY97
DR   CLO; CLO_0027604
DR   Coriell; ND00590
DR   Wikidata; Q54908962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00591
AC   CVCL_BY98
DR   CLO; CLO_0027603
DR   BioSample; SAMN00795081
DR   Coriell; ND00591
DR   Wikidata; Q54908963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00592
AC   CVCL_1V31
SY   ND-592
DR   CLO; CLO_0027606
DR   BioSample; SAMN00795083
DR   Coriell; ND00592
DR   Wikidata; Q54908964
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00593
AC   CVCL_HS16
DR   Coriell; ND00593
DR   Wikidata; Q54908965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00594
AC   CVCL_HS17
DR   Coriell; ND00594
DR   Wikidata; Q54908966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00603
AC   CVCL_BY99
DR   CLO; CLO_0027605
DR   Coriell; ND00603
DR   Wikidata; Q54908967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00604
AC   CVCL_II05
DR   Coriell; ND00604
DR   Wikidata; Q54908968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00605
AC   CVCL_FW10
DR   Coriell; ND00605
DR   Wikidata; Q54908969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00606
AC   CVCL_II06
DR   Coriell; ND00606
DR   Wikidata; Q54908970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00607
AC   CVCL_II07
DR   Coriell; ND00607
DR   Wikidata; Q54908971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00608
AC   CVCL_II08
DR   Coriell; ND00608
DR   Wikidata; Q54908972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00609
AC   CVCL_II09
DR   Coriell; ND00609
DR   Wikidata; Q54908973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00610
AC   CVCL_FW11
DR   Coriell; ND00610
DR   Wikidata; Q54908974
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00611
AC   CVCL_HS18
DR   Coriell; ND00611
DR   Wikidata; Q54908977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00612
AC   CVCL_FG80
DR   CLO; CLO_0027608
DR   Coriell; ND00612
DR   Wikidata; Q54908978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00613
AC   CVCL_HX63
DR   CLO; CLO_0027607
DR   Coriell; ND00613
DR   Wikidata; Q54908979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00614
AC   CVCL_HX64
DR   CLO; CLO_0027611
DR   Coriell; ND00614
DR   Wikidata; Q54908980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00615
AC   CVCL_HX65
DR   CLO; CLO_0027609
DR   Coriell; ND00615
DR   Wikidata; Q54908981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00616
AC   CVCL_II10
DR   Coriell; ND00616
DR   Wikidata; Q54908982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00617
AC   CVCL_HS19
DR   Coriell; ND00617
DR   Wikidata; Q54908983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00619
AC   CVCL_HS20
DR   Coriell; ND00619
DR   Wikidata; Q54908984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00620
AC   CVCL_II11
DR   Coriell; ND00620
DR   Wikidata; Q54908985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00631
AC   CVCL_HX66
DR   CLO; CLO_0027610
DR   Coriell; ND00631
DR   Wikidata; Q54908986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00634
AC   CVCL_DT84
DR   Coriell; ND00634
DR   Wikidata; Q54908987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00637
AC   CVCL_BZ00
DR   CLO; CLO_0027618
DR   Coriell; ND00637
DR   Wikidata; Q54908988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00638
AC   CVCL_II12
DR   Coriell; ND00638
DR   Wikidata; Q54908989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00639
AC   CVCL_II13
DR   Coriell; ND00639
DR   Wikidata; Q54908990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00640
AC   CVCL_HS21
DR   Coriell; ND00640
DR   Wikidata; Q54908991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00641
AC   CVCL_IL16
DR   Coriell; ND00641
DR   Wikidata; Q54908992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00642
AC   CVCL_II14
DR   Coriell; ND00642
DR   Wikidata; Q54908993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00643
AC   CVCL_HS22
DR   Coriell; ND00643
DR   Wikidata; Q54908994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00644
AC   CVCL_HS23
DR   Coriell; ND00644
DR   Wikidata; Q54908995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00645
AC   CVCL_HS24
DR   Coriell; ND00645
DR   Wikidata; Q54908996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00646
AC   CVCL_II15
DR   Coriell; ND00646
DR   Wikidata; Q54908997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00647
AC   CVCL_BZ01
DR   CLO; CLO_0027617
DR   Coriell; ND00647
DR   Wikidata; Q54908998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00648
AC   CVCL_II16
DR   Coriell; ND00648
DR   Wikidata; Q54908999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00649
AC   CVCL_II17
DR   Coriell; ND00649
DR   Wikidata; Q54909000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00650
AC   CVCL_HS25
DR   Coriell; ND00650
DR   Wikidata; Q54909001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00651
AC   CVCL_HS26
DR   Coriell; ND00651
DR   Wikidata; Q54909002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00652
AC   CVCL_II18
DR   Coriell; ND00652
DR   Wikidata; Q54909003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00653
AC   CVCL_FW12
DR   Coriell; ND00653
DR   Wikidata; Q54909004
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00654
AC   CVCL_II19
DR   Coriell; ND00654
DR   Wikidata; Q54909005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00655
AC   CVCL_II20
DR   Coriell; ND00655
DR   Wikidata; Q54909006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00656
AC   CVCL_HY00
DR   Coriell; ND00656
DR   Wikidata; Q54909007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00657
AC   CVCL_HS27
DR   Coriell; ND00657
DR   Wikidata; Q54909008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00658
AC   CVCL_HY01
DR   Coriell; ND00658
DR   Wikidata; Q54909009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00659
AC   CVCL_GA68
DR   CLO; CLO_0027616
DR   Coriell; ND00659
DR   Wikidata; Q54909010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00660
AC   CVCL_FC05
DR   CLO; CLO_0027615
DR   Coriell; ND00660
DR   Wikidata; Q54909011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00662
AC   CVCL_GA69
DR   CLO; CLO_0027614
DR   Coriell; ND00662
DR   Wikidata; Q54909012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00663
AC   CVCL_GA70
DR   CLO; CLO_0027613
DR   Coriell; ND00663
DR   Wikidata; Q54909013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00664
AC   CVCL_BZ02
DR   CLO; CLO_0027612
DR   BioSample; SAMN00799155
DR   Coriell; ND00664
DR   Wikidata; Q54909014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00665
AC   CVCL_1V32
SY   ND-665
DR   CLO; CLO_0027625
DR   BioSample; SAMN00799157
DR   Coriell; ND00665
DR   Wikidata; Q54909015
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00666
AC   CVCL_BZ03
DR   CLO; CLO_0027626
DR   BioSample; SAMN00799159
DR   Coriell; ND00666
DR   Wikidata; Q54909016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00668
AC   CVCL_BZ04
DR   CLO; CLO_0027628
DR   BioSample; SAMN00799161
DR   Coriell; ND00668
DR   Wikidata; Q54909023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00670
AC   CVCL_HX67
DR   CLO; CLO_0027630
DR   Coriell; ND00670
DR   Wikidata; Q54909024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00671
AC   CVCL_BZ05
DR   CLO; CLO_0027642
DR   BioSample; SAMN00799165
DR   Coriell; ND00671
DR   Wikidata; Q54909025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00672
AC   CVCL_1V33
SY   ND-672
DR   CLO; CLO_0027639
DR   BioSample; SAMN00799167
DR   Coriell; ND00672
DR   Wikidata; Q54909026
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00673
AC   CVCL_BZ06
DR   CLO; CLO_0027646
DR   BioSample; SAMN00799169
DR   Coriell; ND00673
DR   Wikidata; Q54909027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00674
AC   CVCL_1V34
SY   ND-674
DR   CLO; CLO_0027643
DR   BioSample; SAMN00799171
DR   Coriell; ND00674
DR   Wikidata; Q54909028
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00675
AC   CVCL_BZ07
DR   CLO; CLO_0027636
DR   BioSample; SAMN00799173
DR   Coriell; ND00675
DR   Wikidata; Q54909029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00676
AC   CVCL_HX68
DR   CLO; CLO_0027634
DR   Coriell; ND00676
DR   Wikidata; Q54909030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00677
AC   CVCL_1V35
SY   ND-677
DR   CLO; CLO_0027649
DR   BioSample; SAMN00799177
DR   Coriell; ND00677
DR   Wikidata; Q54909031
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00678
AC   CVCL_BZ08
DR   CLO; CLO_0027653
DR   BioSample; SAMN00799179
DR   Coriell; ND00678
DR   Wikidata; Q54909032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00679
AC   CVCL_1V36
SY   ND-679
DR   CLO; CLO_0027652
DR   Coriell; ND00679
DR   Wikidata; Q54909033
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00680
AC   CVCL_BZ09
DR   CLO; CLO_0027651
DR   BioSample; SAMN00799183
DR   Coriell; ND00680
DR   Wikidata; Q54909034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00681
AC   CVCL_HX69
DR   CLO; CLO_0027650
DR   Coriell; ND00681
DR   Wikidata; Q54909035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00682
AC   CVCL_HX70
DR   CLO; CLO_0027661
DR   Coriell; ND00682
DR   Wikidata; Q54909036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00683
AC   CVCL_BZ10
DR   CLO; CLO_0027662
DR   BioSample; SAMN00799189
DR   Coriell; ND00683
DR   Wikidata; Q54909037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00684
AC   CVCL_HX71
DR   CLO; CLO_0027657
DR   Coriell; ND00684
DR   Wikidata; Q54909038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00685
AC   CVCL_GA71
DR   CLO; CLO_0027659
DR   Coriell; ND00685
DR   Wikidata; Q54909039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00686
AC   CVCL_BZ11
DR   CLO; CLO_0027667
DR   BioSample; SAMN00799193
DR   Coriell; ND00686
DR   Wikidata; Q54909040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00687
AC   CVCL_BZ12
DR   CLO; CLO_0027904
DR   Coriell; ND00687
DR   Wikidata; Q54909041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00688
AC   CVCL_BZ13
DR   CLO; CLO_0027903
DR   BioSample; SAMN00799195
DR   Coriell; ND00688
DR   Wikidata; Q54909042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00689
AC   CVCL_1V37
SY   ND-689
DR   CLO; CLO_0027902
DR   BioSample; SAMN00799197
DR   Coriell; ND00689
DR   Wikidata; Q54909043
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00690
AC   CVCL_BZ14
DR   CLO; CLO_0027911
DR   BioSample; SAMN00799199
DR   Coriell; ND00690
DR   Wikidata; Q54909044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00691
AC   CVCL_BZ15
DR   CLO; CLO_0027910
DR   BioSample; SAMN00799201
DR   Coriell; ND00691
DR   Wikidata; Q54909045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00692
AC   CVCL_GA72
DR   CLO; CLO_0027909
DR   Coriell; ND00692
DR   Wikidata; Q54909046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00693
AC   CVCL_BZ16
DR   CLO; CLO_0027908
DR   BioSample; SAMN00799203
DR   Coriell; ND00693
DR   Wikidata; Q54909047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00694
AC   CVCL_1V38
SY   ND-694
DR   CLO; CLO_0027907
DR   BioSample; SAMN00799205
DR   Coriell; ND00694
DR   Wikidata; Q54909048
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00695
AC   CVCL_BZ17
DR   CLO; CLO_0027906
DR   BioSample; SAMN00799207
DR   Coriell; ND00695
DR   Wikidata; Q54909049
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00696
AC   CVCL_HX72
DR   CLO; CLO_0027905
DR   Coriell; ND00696
DR   Wikidata; Q54909050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00697
AC   CVCL_HX73
DR   CLO; CLO_0027923
DR   Coriell; ND00697
DR   Wikidata; Q54909051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00698
AC   CVCL_HY02
DR   Coriell; ND00698
DR   Wikidata; Q54909052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00699
AC   CVCL_BZ18
DR   CLO; CLO_0027922
DR   BioSample; SAMN00799215
DR   Coriell; ND00699
DR   Wikidata; Q54909053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00700
AC   CVCL_1V39
SY   ND-700
DR   CLO; CLO_0027925
DR   BioSample; SAMN00799217
DR   Coriell; ND00700
DR   Wikidata; Q54909054
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND00701
AC   CVCL_BZ19
DR   CLO; CLO_0027924
DR   BioSample; SAMN00799219
DR   Coriell; ND00701
DR   Wikidata; Q54909055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00702
AC   CVCL_1V40
SY   ND-702
DR   CLO; CLO_0027927
DR   BioSample; SAMN00799221
DR   Coriell; ND00702
DR   Wikidata; Q54909056
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00703
AC   CVCL_BZ20
DR   CLO; CLO_0027926
DR   BioSample; SAMN00799223
DR   Coriell; ND00703
DR   Wikidata; Q54909057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00704
AC   CVCL_HY03
DR   Coriell; ND00704
DR   Wikidata; Q54909058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00705
AC   CVCL_BZ21
DR   CLO; CLO_0027929
DR   BioSample; SAMN00799227
DR   Coriell; ND00705
DR   Wikidata; Q54909059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00706
AC   CVCL_1V41
SY   ND-706
DR   CLO; CLO_0027928
DR   BioSample; SAMN00799229
DR   Coriell; ND00706
DR   Wikidata; Q54909060
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00707
AC   CVCL_1V42
SY   ND-707
DR   CLO; CLO_0027931
DR   Coriell; ND00707
DR   Wikidata; Q54909061
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00708
AC   CVCL_BZ22
DR   CLO; CLO_0027930
DR   BioSample; SAMN00799231
DR   Coriell; ND00708
DR   Wikidata; Q54909062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00709
AC   CVCL_1V43
SY   ND-709
DR   CLO; CLO_0027912
DR   BioSample; SAMN00799233
DR   Coriell; ND00709
DR   Wikidata; Q54909064
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00712
AC   CVCL_BZ23
DR   CLO; CLO_0027916
DR   Coriell; ND00712
DR   Wikidata; Q54909065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00713
AC   CVCL_BZ24
DR   CLO; CLO_0027915
DR   BioSample; SAMN00799235
DR   Coriell; ND00713
DR   Wikidata; Q54909066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00714
AC   CVCL_1V44
SY   ND-714
DR   CLO; CLO_0027914
DR   BioSample; SAMN00799237
DR   Coriell; ND00714
DR   Wikidata; Q54909067
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00715
AC   CVCL_BZ25
DR   CLO; CLO_0027913
DR   BioSample; SAMN00799239
DR   Coriell; ND00715
DR   Wikidata; Q54909068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00716
AC   CVCL_FA31
DR   CLO; CLO_0027920
DR   Coriell; ND00716
DR   Wikidata; Q54909069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00717
AC   CVCL_GA73
DR   CLO; CLO_0027919
DR   Coriell; ND00717
DR   Wikidata; Q54909070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00718
AC   CVCL_HX32
DR   CLO; CLO_0027918
DR   Coriell; ND00718
DR   Wikidata; Q54909071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   ND00719
AC   CVCL_HX74
DR   CLO; CLO_0027917
DR   Coriell; ND00719
DR   Wikidata; Q54909072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00720
AC   CVCL_BZ26
DR   CLO; CLO_0027921
DR   BioSample; SAMN00799247
DR   Coriell; ND00720
DR   Wikidata; Q54909073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00721
AC   CVCL_HY04
DR   Coriell; ND00721
DR   Wikidata; Q54909074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00722
AC   CVCL_HX75
DR   CLO; CLO_0027960
DR   Coriell; ND00722
DR   Wikidata; Q54909075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00723
AC   CVCL_1V45
SY   ND-723
DR   CLO; CLO_0027961
DR   BioSample; SAMN00799253
DR   Coriell; ND00723
DR   Wikidata; Q54909076
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00724
AC   CVCL_BZ27
DR   CLO; CLO_0027956
DR   BioSample; SAMN00799255
DR   Coriell; ND00724
DR   Wikidata; Q54909077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00725
AC   CVCL_HX76
DR   CLO; CLO_0027957
DR   Coriell; ND00725
DR   Wikidata; Q54909078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00726
AC   CVCL_BZ28
DR   CLO; CLO_0027958
DR   BioSample; SAMN00799259
DR   Coriell; ND00726
DR   Wikidata; Q54909079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00727
AC   CVCL_1V46
SY   ND-727
DR   CLO; CLO_0027959
DR   Coriell; ND00727
DR   Wikidata; Q54909080
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00728
AC   CVCL_1V47
SY   ND-728
DR   CLO; CLO_0027952
DR   Coriell; ND00728
DR   Wikidata; Q54909081
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND00729
AC   CVCL_CY68
DR   CLO; CLO_0027953
DR   Coriell; ND00729
DR   Wikidata; Q54909082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00730
AC   CVCL_CY69
DR   CLO; CLO_0027954
DR   Coriell; ND00730
DR   Wikidata; Q54909083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00731
AC   CVCL_CY70
DR   CLO; CLO_0027955
DR   Coriell; ND00731
DR   Wikidata; Q54909084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00732
AC   CVCL_BZ29
DR   CLO; CLO_0027951
DR   BioSample; SAMN00799267
DR   Coriell; ND00732
DR   Wikidata; Q54909085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00733
AC   CVCL_HX77
DR   CLO; CLO_0027946
DR   Coriell; ND00733
DR   Wikidata; Q54909086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00734
AC   CVCL_BZ30
DR   CLO; CLO_0027947
DR   Coriell; ND00734
DR   Wikidata; Q54909087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00736
AC   CVCL_GA74
DR   CLO; CLO_0027942
DR   Coriell; ND00736
DR   Wikidata; Q54909088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00737
AC   CVCL_BZ31
DR   CLO; CLO_0027943
DR   Coriell; ND00737
DR   Wikidata; Q54909089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00739
AC   CVCL_HX78
DR   CLO; CLO_0027937
DR   Coriell; ND00739
DR   Wikidata; Q54909090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00740
AC   CVCL_BZ32
DR   CLO; CLO_0027939
DR   Coriell; ND00740
DR   Wikidata; Q54909091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00742
AC   CVCL_HX79
DR   CLO; CLO_0027935
DR   Coriell; ND00742
DR   Wikidata; Q54909092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00744
AC   CVCL_BZ33
DR   CLO; CLO_0027936
DR   BioSample; SAMN00799273
DR   Coriell; ND00744
DR   Wikidata; Q54909093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00745
AC   CVCL_1V48
SY   ND-745
DR   CLO; CLO_0027934
DR   BioSample; SAMN00799275
DR   Coriell; ND00745
DR   Wikidata; Q54909094
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND00746
AC   CVCL_BZ34
DR   CLO; CLO_0027988
DR   Coriell; ND00746
DR   Wikidata; Q54909095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00747
AC   CVCL_HY05
DR   Coriell; ND00747
DR   Wikidata; Q54909096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00773
AC   CVCL_FW13
DR   Coriell; ND00773
DR   Wikidata; Q54909097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00774
AC   CVCL_IL17
DR   Coriell; ND00774
DR   Wikidata; Q54909098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00775
AC   CVCL_FW14
DR   Coriell; ND00775
DR   Wikidata; Q54909099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00776
AC   CVCL_FW15
DR   Coriell; ND00776
DR   Wikidata; Q54909100
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00777
AC   CVCL_HY06
DR   Coriell; ND00777
DR   Wikidata; Q54909101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00778
AC   CVCL_HY07
DR   Coriell; ND00778
DR   Wikidata; Q54909102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00789
AC   CVCL_HY08
DR   Coriell; ND00789
DR   Wikidata; Q54909103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00790
AC   CVCL_HY09
DR   Coriell; ND00790
DR   Wikidata; Q54909106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00791
AC   CVCL_HS28
DR   Coriell; ND00791
DR   Wikidata; Q54909107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00792
AC   CVCL_BZ35
DR   CLO; CLO_0027989
DR   Coriell; ND00792
DR   Wikidata; Q54909108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00793
AC   CVCL_BZ36
DR   CLO; CLO_0027991
DR   BioSample; SAMN00799297
DR   Coriell; ND00793
DR   Wikidata; Q54909109
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00812
AC   CVCL_HS29
DR   Coriell; ND00812
DR   Wikidata; Q54909110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00813
AC   CVCL_II21
DR   Coriell; ND00813
DR   Wikidata; Q54909111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00814
AC   CVCL_IL18
DR   Coriell; ND00814
DR   Wikidata; Q54909113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00816
AC   CVCL_BZ37
DR   CLO; CLO_0027993
DR   BioSample; SAMN00799305
DR   Coriell; ND00816
DR   Wikidata; Q54909114
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND00817
AC   CVCL_II22
DR   BioSample; SAMN00799307
DR   Coriell; ND00817
DR   Wikidata; Q54909115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND00818
AC   CVCL_BZ38
DR   CLO; CLO_0027995
DR   Coriell; ND00818
DR   Wikidata; Q54909116
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00819
AC   CVCL_BZ39
DR   CLO; CLO_0027997
DR   Coriell; ND00819
DR   Wikidata; Q54909117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00820
AC   CVCL_II23
DR   Coriell; ND00820
DR   Wikidata; Q54909118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00821
AC   CVCL_II24
DR   Coriell; ND00821
DR   Wikidata; Q54909119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00824
AC   CVCL_BZ40
DR   CLO; CLO_0027998
DR   Coriell; ND00824
DR   Wikidata; Q54909120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00825
AC   CVCL_BZ41
DR   CLO; CLO_0028001
DR   Coriell; ND00825
DR   Wikidata; Q54909121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00826
AC   CVCL_FG81
DR   Coriell; ND00826
DR   Wikidata; Q54909122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00827
AC   CVCL_II25
DR   Coriell; ND00827
DR   Wikidata; Q54909123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00828
AC   CVCL_DT85
DR   CLO; CLO_0027982
DR   Coriell; ND00828
DR   Wikidata; Q54909124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00829
AC   CVCL_DT86
DR   CLO; CLO_0027983
DR   Coriell; ND00829
DR   Wikidata; Q54909125
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00830
AC   CVCL_DT87
DR   CLO; CLO_0027981
DR   Coriell; ND00830
DR   Wikidata; Q54909126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00831
AC   CVCL_BZ42
DR   CLO; CLO_0027971
DR   Coriell; ND00831
DR   Wikidata; Q54909127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00832
AC   CVCL_BZ43
DR   CLO; CLO_0027973
DR   BioSample; SAMN00799317
DR   Coriell; ND00832
DR   Wikidata; Q54909128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00834
AC   CVCL_HX80
DR   CLO; CLO_0027967
DR   Coriell; ND00834
DR   Wikidata; Q54909129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00835
AC   CVCL_HS30
DR   Coriell; ND00835
DR   Wikidata; Q54909130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00850
AC   CVCL_IL19
DR   Coriell; ND00850
DR   Wikidata; Q54909131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00851
AC   CVCL_FW16
DR   Coriell; ND00851
DR   Wikidata; Q54909132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00853
AC   CVCL_II26
DR   Coriell; ND00853
DR   Wikidata; Q54909133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00854
AC   CVCL_IL20
DR   Coriell; ND00854
DR   Wikidata; Q54909134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00855
AC   CVCL_II27
DR   Coriell; ND00855
DR   Wikidata; Q54909135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00857
AC   CVCL_II28
DR   Coriell; ND00857
DR   Wikidata; Q54909136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00858
AC   CVCL_II29
DR   Coriell; ND00858
DR   Wikidata; Q54909137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00859
AC   CVCL_II30
DR   Coriell; ND00859
DR   Wikidata; Q54909138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00860
AC   CVCL_II31
DR   Coriell; ND00860
DR   Wikidata; Q54909139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00861
AC   CVCL_II32
DR   Coriell; ND00861
DR   Wikidata; Q54909140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00862
AC   CVCL_FW17
DR   Coriell; ND00862
DR   Wikidata; Q54909141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00863
AC   CVCL_II33
DR   Coriell; ND00863
DR   Wikidata; Q54909142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00864
AC   CVCL_II34
DR   Coriell; ND00864
DR   Wikidata; Q54909143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00868
AC   CVCL_DT88
DR   CLO; CLO_0027970
DR   Coriell; ND00868
DR   Wikidata; Q54909144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00873
AC   CVCL_FW18
DR   Coriell; ND00873
DR   Wikidata; Q54909145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00877
AC   CVCL_II35
DR   Coriell; ND00877
DR   Wikidata; Q54909146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00878
AC   CVCL_HS31
DR   Coriell; ND00878
DR   Wikidata; Q54909156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00880
AC   CVCL_II36
DR   Coriell; ND00880
DR   Wikidata; Q54909157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00881
AC   CVCL_II37
DR   Coriell; ND00881
DR   Wikidata; Q54909159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00882
AC   CVCL_II38
DR   Coriell; ND00882
DR   Wikidata; Q54909160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00883
AC   CVCL_II39
DR   Coriell; ND00883
DR   Wikidata; Q54909161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00884
AC   CVCL_II40
DR   Coriell; ND00884
DR   Wikidata; Q54909162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00885
AC   CVCL_II41
DR   Coriell; ND00885
DR   Wikidata; Q54909163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00886
AC   CVCL_II42
DR   Coriell; ND00886
DR   Wikidata; Q54909164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00888
AC   CVCL_FG82
DR   CLO; CLO_0027979
DR   Coriell; ND00888
DR   Wikidata; Q54909165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00891
AC   CVCL_DT89
DR   Coriell; ND00891
DR   Wikidata; Q54909166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00892
AC   CVCL_HS32
DR   Coriell; ND00892
DR   Wikidata; Q54909167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00896
AC   CVCL_BZ44
DR   CLO; CLO_0027980
DR   Coriell; ND00896
DR   Wikidata; Q54909168
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00898
AC   CVCL_II43
DR   Coriell; ND00898
DR   Wikidata; Q54909169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00899
AC   CVCL_FW19
DR   Coriell; ND00899
DR   Wikidata; Q54909170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00900
AC   CVCL_II44
DR   Coriell; ND00900
DR   Wikidata; Q54909171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00902
AC   CVCL_II45
DR   Coriell; ND00902
DR   Wikidata; Q54909172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00921
AC   CVCL_FG83
DR   CLO; CLO_0027976
DR   Coriell; ND00921
DR   Wikidata; Q54909173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00925
AC   CVCL_II46
DR   Coriell; ND00925
DR   Wikidata; Q54909174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00926
AC   CVCL_II47
DR   Coriell; ND00926
DR   Wikidata; Q54909175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00927
AC   CVCL_BZ45
DR   CLO; CLO_0027977
DR   Coriell; ND00927
DR   Wikidata; Q54909176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00928
AC   CVCL_FG84
DR   CLO; CLO_0027962
DR   Coriell; ND00928
DR   Wikidata; Q54909177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND00929
AC   CVCL_BZ46
DR   CLO; CLO_0028012
DR   Coriell; ND00929
DR   Wikidata; Q54909178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00930
AC   CVCL_BZ47
DR   CLO; CLO_0028013
DR   Coriell; ND00930
DR   Wikidata; Q54909179
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00931
AC   CVCL_BZ48
DR   CLO; CLO_0028017
DR   Coriell; ND00931
DR   Wikidata; Q54909180
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00936
AC   CVCL_II48
DR   Coriell; ND00936
DR   Wikidata; Q54909181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00937
AC   CVCL_BZ49
DR   CLO; CLO_0028016
DR   Coriell; ND00937
DR   Wikidata; Q54909182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00938
AC   CVCL_FW00
DR   CLO; CLO_0028015
DR   Coriell; ND00938
DR   Wikidata; Q54909183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00939
AC   CVCL_BZ50
DR   CLO; CLO_0028014
DR   BioSample; SAMN00799381
DR   Coriell; ND00939
DR   Wikidata; Q54909184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00940
AC   CVCL_1V49
SY   ND-940
DR   CLO; CLO_0028021
DR   BioSample; SAMN00799383
DR   Coriell; ND00940
DR   Wikidata; Q54909185
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND00941
AC   CVCL_BZ51
DR   CLO; CLO_0028020
DR   Coriell; ND00941
DR   Wikidata; Q54909186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00942
AC   CVCL_BZ52
DR   CLO; CLO_0028019
DR   BioSample; SAMN00799385
DR   Coriell; ND00942
DR   Wikidata; Q54909187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00944
AC   CVCL_BZ53
DR   CLO; CLO_0028018
DR   Coriell; ND00944
DR   Wikidata; Q54909188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00946
AC   CVCL_II49
DR   Coriell; ND00946
DR   Wikidata; Q54909189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00947
AC   CVCL_HS33
DR   Coriell; ND00947
DR   Wikidata; Q54909190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00948
AC   CVCL_HS34
DR   Coriell; ND00948
DR   Wikidata; Q54909191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00949
AC   CVCL_HS35
DR   Coriell; ND00949
DR   Wikidata; Q54909192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00968
AC   CVCL_BZ54
DR   CLO; CLO_0028025
DR   BioSample; SAMN00799395
DR   Coriell; ND00968
DR   Wikidata; Q54909193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00970
AC   CVCL_FW20
DR   Coriell; ND00970
DR   Wikidata; Q54909194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00972
AC   CVCL_II50
DR   Coriell; ND00972
DR   Wikidata; Q54909196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00973
AC   CVCL_IL21
DR   Coriell; ND00973
DR   Wikidata; Q54909197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00974
AC   CVCL_HY40
DR   Coriell; ND00974
DR   Wikidata; Q54909204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00975
AC   CVCL_FG85
DR   CLO; CLO_0028027
DR   Coriell; ND00975
DR   Wikidata; Q54909205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00976
AC   CVCL_FG86
DR   CLO; CLO_0028030
DR   Coriell; ND00976
DR   Wikidata; Q54909206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND00977
AC   CVCL_BZ55
DR   CLO; CLO_0028036
DR   BioSample; SAMN00799403
DR   Coriell; ND00977
DR   Wikidata; Q54909207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND00978
AC   CVCL_BZ56
DR   CLO; CLO_0028035
DR   Coriell; ND00978
DR   Wikidata; Q54909208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00979
AC   CVCL_HS36
DR   Coriell; ND00979
DR   Wikidata; Q54909209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND00982
AC   CVCL_BZ57
DR   CLO; CLO_0028038
DR   Coriell; ND00982
DR   Wikidata; Q54909210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00986
AC   CVCL_BZ58
DR   CLO; CLO_0028037
DR   Coriell; ND00986
DR   Wikidata; Q54909211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND00997
AC   CVCL_DT90
DR   Coriell; ND00997
DR   Wikidata; Q54909212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND00998
AC   CVCL_DT91
DR   Coriell; ND00998
DR   Wikidata; Q54909213
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND00999
AC   CVCL_FW21
DR   Coriell; ND00999
DR   Wikidata; Q54909214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01000
AC   CVCL_HY41
DR   Coriell; ND01000
DR   Wikidata; Q54909215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01001
AC   CVCL_HY42
DR   Coriell; ND01001
DR   Wikidata; Q54909216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01002
AC   CVCL_HS37
DR   Coriell; ND01002
DR   Wikidata; Q54909217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01003
AC   CVCL_FW22
DR   Coriell; ND01003
DR   Wikidata; Q54909218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01004
AC   CVCL_HY43
DR   Coriell; ND01004
DR   Wikidata; Q54909219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01005
AC   CVCL_BZ59
DR   CLO; CLO_0028040
DR   Coriell; ND01005
DR   Wikidata; Q54909220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01023
AC   CVCL_DT92
DR   Coriell; ND01023
DR   Wikidata; Q54909221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01024
AC   CVCL_ER82
DR   CLO; CLO_0028039
DR   Coriell; ND01024
DR   Wikidata; Q54909222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01025
AC   CVCL_DT93
DR   Coriell; ND01025
DR   Wikidata; Q54909224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01027
AC   CVCL_HY44
DR   Coriell; ND01027
DR   Wikidata; Q54909225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01028
AC   CVCL_HY45
DR   Coriell; ND01028
DR   Wikidata; Q54909226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01034
AC   CVCL_HY46
DR   Coriell; ND01034
DR   Wikidata; Q54909227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01035
AC   CVCL_FW23
DR   Coriell; ND01035
DR   Wikidata; Q54909228
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01036
AC   CVCL_FG87
DR   CLO; CLO_0028041
DR   Coriell; ND01036
DR   Wikidata; Q54909229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01037
AC   CVCL_HX33
DR   CLO; CLO_0028004
DR   BioSample; SAMN00799429
DR   Coriell; ND01037
DR   Wikidata; Q54909230
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4del; Zygosity=Homozygous (Coriell=ND01037).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   ND01038
AC   CVCL_HY47
DR   Coriell; ND01038
DR   Wikidata; Q54909231
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4del; Zygosity=Unspecified (Coriell=ND01038).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   ND01039
AC   CVCL_IK48
DR   Coriell; ND01039
DR   Wikidata; Q54909232
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4del; Zygosity=Heterozygous (Coriell=ND01039).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ND01040
AC   CVCL_HY48
DR   Coriell; ND01040
DR   Wikidata; Q54909233
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4del; Zygosity=Unspecified (Coriell=ND01040).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   ND01041
AC   CVCL_BZ60
DR   CLO; CLO_0028005
DR   BioSample; SAMN00799437
DR   Coriell; ND01041
DR   Wikidata; Q54909234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01042
AC   CVCL_1V50
SY   ND-1042
DR   CLO; CLO_0028002
DR   BioSample; SAMN00799439
DR   Coriell; ND01042
DR   Wikidata; Q54909235
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND01043
AC   CVCL_HX81
DR   CLO; CLO_0028003
DR   Coriell; ND01043
DR   Wikidata; Q54909236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01044
AC   CVCL_BZ61
DR   CLO; CLO_0028011
DR   Coriell; ND01044
DR   Wikidata; Q54909237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01045
AC   CVCL_DT94
DR   Coriell; ND01045
DR   Wikidata; Q54909238
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01046
AC   CVCL_HS38
DR   Coriell; ND01046
DR   Wikidata; Q54909239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01048
AC   CVCL_HY49
DR   Coriell; ND01048
DR   Wikidata; Q54909240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01049
AC   CVCL_HS39
DR   Coriell; ND01049
DR   Wikidata; Q54909242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01050
AC   CVCL_HS40
DR   Coriell; ND01050
DR   Wikidata; Q54909243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01051
AC   CVCL_II53
DR   Coriell; ND01051
DR   Wikidata; Q54909244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01052
AC   CVCL_HS41
DR   Coriell; ND01052
DR   Wikidata; Q54909245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01053
AC   CVCL_II54
DR   Coriell; ND01053
DR   Wikidata; Q54909250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01054
AC   CVCL_FG88
DR   CLO; CLO_0028010
DR   Coriell; ND01054
DR   Wikidata; Q54909251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01056
AC   CVCL_FG89
DR   CLO; CLO_0028009
DR   Coriell; ND01056
DR   Wikidata; Q54909252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01057
AC   CVCL_ER83
DR   CLO; CLO_0028008
DR   Coriell; ND01057
DR   Wikidata; Q54909253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01058
AC   CVCL_BZ62
DR   CLO; CLO_0028007
DR   BioSample; SAMN00799459
DR   Coriell; ND01058
DR   Wikidata; Q54909254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01059
AC   CVCL_II51
DR   CLO; CLO_0028006
DR   Coriell; ND01059
DR   Wikidata; Q54909255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01060
AC   CVCL_BZ63
DR   CLO; CLO_0028322
DR   BioSample; SAMN00799463
DR   Coriell; ND01060
DR   Wikidata; Q54909256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01061
AC   CVCL_HX83
DR   CLO; CLO_0028324
DR   Coriell; ND01061
DR   Wikidata; Q54909257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01073
AC   CVCL_IG68
DR   CLO; CLO_0028326
DR   Coriell; ND01073
DR   Wikidata; Q54909258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND01073; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND01074
AC   CVCL_BZ64
DR   CLO; CLO_0028327
DR   Coriell; ND01074
DR   Wikidata; Q54909259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01075
AC   CVCL_BZ65
DR   CLO; CLO_0028330
DR   Coriell; ND01075
DR   Wikidata; Q54909260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01076
AC   CVCL_BZ66
DR   CLO; CLO_0028331
DR   Coriell; ND01076
DR   Wikidata; Q54909261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01077
AC   CVCL_BZ67
DR   CLO; CLO_0028334
DR   Coriell; ND01077
DR   Wikidata; Q54909262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01078
AC   CVCL_BZ68
DR   CLO; CLO_0028335
DR   Coriell; ND01078
DR   Wikidata; Q54909263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01079
AC   CVCL_BZ69
DR   CLO; CLO_0028336
DR   Coriell; ND01079
DR   Wikidata; Q54909264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01080
AC   CVCL_FG90
DR   Coriell; ND01080
DR   Wikidata; Q54909265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01081
AC   CVCL_DT95
DR   Coriell; ND01081
DR   Wikidata; Q54909266
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01082
AC   CVCL_IL22
DR   Coriell; ND01082
DR   Wikidata; Q54909267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01085
AC   CVCL_BZ70
DR   CLO; CLO_0028339
DR   Coriell; ND01085
DR   Wikidata; Q54909268
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01086
AC   CVCL_BZ71
DR   CLO; CLO_0028420
DR   Coriell; ND01086
DR   Wikidata; Q54909269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01087
AC   CVCL_GA75
DR   CLO; CLO_0028422
DR   Coriell; ND01087
DR   Wikidata; Q54909270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01088
AC   CVCL_BZ72
DR   CLO; CLO_0028421
DR   Coriell; ND01088
DR   Wikidata; Q54909271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01089
AC   CVCL_BZ73
DR   CLO; CLO_0028417
DR   Coriell; ND01089
DR   Wikidata; Q54909272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01091
AC   CVCL_BZ74
DR   CLO; CLO_0028416
DR   Coriell; ND01091
DR   Wikidata; Q54909273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01096
AC   CVCL_1V51
SY   ND-1096
DR   CLO; CLO_0028419
DR   Coriell; ND01096
DR   Wikidata; Q54909274
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01097
AC   CVCL_IZ56
DR   Coriell; ND01097
DR   Wikidata; Q54909275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   ND01098
AC   CVCL_HX84
DR   CLO; CLO_0028418
DR   Coriell; ND01098
DR   Wikidata; Q54909276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01099
AC   CVCL_1V52
SY   ND-1099
DR   CLO; CLO_0028414
DR   BioSample; SAMN00799471
DR   Coriell; ND01099
DR   Wikidata; Q54909277
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01100
AC   CVCL_DT96
DR   Coriell; ND01100
DR   Wikidata; Q54909278
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01101
AC   CVCL_BZ75
DR   CLO; CLO_0028413
DR   Coriell; ND01101
DR   Wikidata; Q54909279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01104
AC   CVCL_II55
DR   Coriell; ND01104
DR   Wikidata; Q54909280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01105
AC   CVCL_II56
DR   Coriell; ND01105
DR   Wikidata; Q54909281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01114
AC   CVCL_FG91
DR   CLO; CLO_0028415
DR   Coriell; ND01114
DR   Wikidata; Q54909282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01116
AC   CVCL_BZ76
DR   CLO; CLO_0028412
DR   Coriell; ND01116
DR   Wikidata; Q54909283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01117
AC   CVCL_FG92
DR   CLO; CLO_0028411
DR   Coriell; ND01117
DR   Wikidata; Q54909284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01118
AC   CVCL_FG93
DR   CLO; CLO_0028410
DR   Coriell; ND01118
DR   Wikidata; Q54909285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01119
AC   CVCL_BZ77
DR   CLO; CLO_0028409
DR   Coriell; ND01119
DR   Wikidata; Q54909286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01120
AC   CVCL_BZ78
DR   CLO; CLO_0028408
DR   Coriell; ND01120
DR   Wikidata; Q54909287
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01121
AC   CVCL_BZ79
DR   CLO; CLO_0028407
DR   Coriell; ND01121
DR   Wikidata; Q54909288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01122
AC   CVCL_BZ80
DR   CLO; CLO_0028406
DR   Coriell; ND01122
DR   Wikidata; Q54909289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01123
AC   CVCL_II57
DR   Coriell; ND01123
DR   Wikidata; Q54909300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01124
AC   CVCL_FW24
DR   Coriell; ND01124
DR   Wikidata; Q54909301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01125
AC   CVCL_II58
DR   Coriell; ND01125
DR   Wikidata; Q54909302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01126
AC   CVCL_HS42
DR   Coriell; ND01126
DR   Wikidata; Q54909303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01127
AC   CVCL_IL23
DR   Coriell; ND01127
DR   Wikidata; Q54909304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01128
AC   CVCL_II59
DR   Coriell; ND01128
DR   Wikidata; Q54909305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01129
AC   CVCL_BZ81
DR   CLO; CLO_0028405
DR   Coriell; ND01129
DR   Wikidata; Q54909306
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01130
AC   CVCL_DT97
DR   Coriell; ND01130
DR   Wikidata; Q54909307
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01131
AC   CVCL_BZ82
DR   CLO; CLO_0028404
DR   Coriell; ND01131
DR   Wikidata; Q54909308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01132
AC   CVCL_BZ83
DR   CLO; CLO_0028403
DR   Coriell; ND01132
DR   Wikidata; Q54909309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01133
AC   CVCL_BZ84
DR   CLO; CLO_0028398
DR   Coriell; ND01133
DR   Wikidata; Q54909310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01134
AC   CVCL_BZ85
DR   CLO; CLO_0028400
DR   Coriell; ND01134
DR   Wikidata; Q54909311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01135
AC   CVCL_BZ86
DR   CLO; CLO_0028399
DR   Coriell; ND01135
DR   Wikidata; Q54909312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01137
AC   CVCL_BZ87
DR   CLO; CLO_0028402
DR   BioSample; SAMN00799491
DR   Coriell; ND01137
DR   Wikidata; Q54909313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01138
AC   CVCL_HX85
DR   CLO; CLO_0028401
DR   Coriell; ND01138
DR   Wikidata; Q54909314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01139
AC   CVCL_HX86
DR   CLO; CLO_0028394
DR   Coriell; ND01139
DR   Wikidata; Q54909315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01140
AC   CVCL_DT98
DR   Coriell; ND01140
DR   Wikidata; Q54909316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01142
AC   CVCL_HX87
DR   CLO; CLO_0028393
DR   Coriell; ND01142
DR   Wikidata; Q54909317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01143
AC   CVCL_DT99
DR   Coriell; ND01143
DR   Wikidata; Q54909318
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01144
AC   CVCL_II60
DR   Coriell; ND01144
DR   Wikidata; Q54909319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01145
AC   CVCL_II61
DR   Coriell; ND01145
DR   Wikidata; Q54909320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01146
AC   CVCL_IL24
DR   Coriell; ND01146
DR   Wikidata; Q54909321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01147
AC   CVCL_II62
DR   Coriell; ND01147
DR   Wikidata; Q54909323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01148
AC   CVCL_II64
DR   Coriell; ND01148
DR   Wikidata; Q54909325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01164
AC   CVCL_HS43
DR   Coriell; ND01164
DR   Wikidata; Q54909326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01167
AC   CVCL_IL25
DR   Coriell; ND01167
DR   Wikidata; Q54909327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01168
AC   CVCL_II65
DR   Coriell; ND01168
DR   Wikidata; Q54909328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01169
AC   CVCL_HS44
DR   Coriell; ND01169
DR   Wikidata; Q54909329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01170
AC   CVCL_IL26
DR   Coriell; ND01170
DR   Wikidata; Q54909330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01171
AC   CVCL_BZ88
DR   CLO; CLO_0028396
DR   BioSample; SAMN00803601
DR   Coriell; ND01171
DR   Wikidata; Q54909331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01172
AC   CVCL_HX88
DR   CLO; CLO_0028395
DR   Coriell; ND01172
DR   Wikidata; Q54909332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01173
AC   CVCL_BZ89
SY   ND 01173
DR   CLO; CLO_0028397
DR   BioSample; SAMN00803605
DR   Coriell; ND01173
DR   GEO; GSM505308
DR   Wikidata; Q54909333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ND01174
AC   CVCL_HX89
DR   CLO; CLO_0028388
DR   Coriell; ND01174
DR   Wikidata; Q54909334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01175
AC   CVCL_BZ90
DR   CLO; CLO_0028387
DR   BioSample; SAMN00803609
DR   Coriell; ND01175
DR   Wikidata; Q54909335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01176
AC   CVCL_HX90
DR   CLO; CLO_0028392
DR   Coriell; ND01176
DR   Wikidata; Q54909336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01177
AC   CVCL_BZ91
DR   CLO; CLO_0028391
DR   BioSample; SAMN00803613
DR   Coriell; ND01177
DR   Wikidata; Q54909337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01178
AC   CVCL_HX91
DR   CLO; CLO_0028390
DR   Coriell; ND01178
DR   Wikidata; Q54909338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01179
AC   CVCL_BZ92
DR   CLO; CLO_0028389
DR   Coriell; ND01179
DR   Wikidata; Q54909339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01180
AC   CVCL_BZ93
DR   CLO; CLO_0028386
DR   Coriell; ND01180
DR   Wikidata; Q54909340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01181
AC   CVCL_BZ94
DR   CLO; CLO_0028385
DR   Coriell; ND01181
DR   Wikidata; Q54909341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01182
AC   CVCL_IL27
DR   Coriell; ND01182
DR   Wikidata; Q54909347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01183
AC   CVCL_BZ95
DR   CLO; CLO_0028384
DR   BioSample; SAMN00803619
DR   Coriell; ND01183
DR   Wikidata; Q54909348
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND01184
AC   CVCL_FC06
DR   CLO; CLO_0028383
DR   BioSample; SAMN00803621
DR   Coriell; ND01184
DR   Wikidata; Q54909349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01185
AC   CVCL_HX92
DR   CLO; CLO_0028467
DR   Coriell; ND01185
DR   Wikidata; Q54909350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01187
AC   CVCL_DU00
DR   Coriell; ND01187
DR   Wikidata; Q54909351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01188
AC   CVCL_IG69
DR   CLO; CLO_0028468
DR   Coriell; ND01188
DR   Wikidata; Q54909352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   101Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01191
AC   CVCL_FW25
DR   Coriell; ND01191
DR   Wikidata; Q54909353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01192
AC   CVCL_HS45
DR   Coriell; ND01192
DR   Wikidata; Q54909354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01193
AC   CVCL_IL28
DR   Coriell; ND01193
DR   Wikidata; Q54909355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01198
AC   CVCL_II66
DR   Coriell; ND01198
DR   Wikidata; Q54909356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01199
AC   CVCL_FG94
DR   CLO; CLO_0028469
DR   Coriell; ND01199
DR   Wikidata; Q54909357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01200
AC   CVCL_HX93
DR   CLO; CLO_0028463
DR   Coriell; ND01200
DR   Wikidata; Q54909358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01201
AC   CVCL_FW26
DR   Coriell; ND01201
DR   Wikidata; Q54909359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01203
AC   CVCL_II67
DR   Coriell; ND01203
DR   Wikidata; Q54909360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01204
AC   CVCL_BZ96
DR   CLO; CLO_0028464
DR   Coriell; ND01204
DR   Wikidata; Q54909361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01205
AC   CVCL_1V53
SY   ND-1205
DR   CLO; CLO_0028465
DR   BioSample; SAMN00803641
DR   Coriell; ND01205
DR   Wikidata; Q54909362
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01207
AC   CVCL_1V54
SY   ND-1207
DR   CLO; CLO_0028466
DR   Coriell; ND01207
DR   Wikidata; Q54909363
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01208
AC   CVCL_BZ97
DR   CLO; CLO_0028470
DR   Coriell; ND01208
DR   Wikidata; Q54909364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01209
AC   CVCL_BZ98
DR   CLO; CLO_0028471
DR   BioSample; SAMN00803643
DR   Coriell; ND01209
DR   Wikidata; Q54909365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01210
AC   CVCL_HX94
DR   CLO; CLO_0028472
DR   Coriell; ND01210
DR   Wikidata; Q54909366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01211
AC   CVCL_BZ99
DR   CLO; CLO_0028459
DR   BioSample; SAMN00803647
DR   Coriell; ND01211
DR   Wikidata; Q54909367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01212
AC   CVCL_1V55
SY   ND-1212
DR   CLO; CLO_0028460
DR   BioSample; SAMN00803649
DR   Coriell; ND01212
DR   Wikidata; Q54909368
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01213
AC   CVCL_CA00
DR   CLO; CLO_0028457
DR   BioSample; SAMN00803651
DR   Coriell; ND01213
DR   Wikidata; Q54909369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01214
AC   CVCL_HX95
DR   CLO; CLO_0028458
DR   Coriell; ND01214
DR   Wikidata; Q54909371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01215
AC   CVCL_CA01
DR   CLO; CLO_0028455
DR   Coriell; ND01215
DR   Wikidata; Q54909372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01216
AC   CVCL_CA02
DR   CLO; CLO_0028456
DR   BioSample; SAMN00803655
DR   Coriell; ND01216
DR   Wikidata; Q54909373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01217
AC   CVCL_1V56
SY   ND-1217
DR   CLO; CLO_0028453
DR   BioSample; SAMN00803657
DR   Coriell; ND01217
DR   Wikidata; Q54909374
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01218
AC   CVCL_CA03
DR   CLO; CLO_0028454
DR   Coriell; ND01218
DR   Wikidata; Q54909375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01220
AC   CVCL_1V57
SY   ND-1220
DR   CLO; CLO_0028461
DR   BioSample; SAMN00803659
DR   Coriell; ND01220
DR   Wikidata; Q54909376
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01221
AC   CVCL_II68
DR   Coriell; ND01221
DR   Wikidata; Q54909377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01236
AC   CVCL_CA04
DR   BioSample; SAMN00803663
DR   Coriell; ND01236
DR   Wikidata; Q54909378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND01237
AC   CVCL_DU01
DR   Coriell; ND01237
DR   Wikidata; Q54909379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01238
AC   CVCL_II69
DR   Coriell; ND01238
DR   Wikidata; Q54909380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01239
AC   CVCL_IL29
DR   Coriell; ND01239
DR   Wikidata; Q54909381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01240
AC   CVCL_II70
DR   Coriell; ND01240
DR   Wikidata; Q54909382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01242
AC   CVCL_GA76
DR   CLO; CLO_0028462
DR   Coriell; ND01242
DR   Wikidata; Q54909383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01243
AC   CVCL_CA05
DR   CLO; CLO_0028452
DR   Coriell; ND01243
DR   Wikidata; Q54909384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01244
AC   CVCL_IZ57
DR   CLO; CLO_0028443
DR   Coriell; ND01244
DR   Wikidata; Q54909385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   ND01245
AC   CVCL_CA06
DR   CLO; CLO_0028444
DR   Coriell; ND01245
DR   Wikidata; Q54909386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01246
AC   CVCL_CA07
DR   CLO; CLO_0028445
DR   Coriell; ND01246
DR   Wikidata; Q54909387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01247
AC   CVCL_CA08
DR   CLO; CLO_0028446
DR   Coriell; ND01247
DR   Wikidata; Q54909393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01248
AC   CVCL_CA09
DR   CLO; CLO_0028447
DR   Coriell; ND01248
DR   Wikidata; Q54909394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01249
AC   CVCL_CA10
DR   Coriell; ND01249
DR   Wikidata; Q54909395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01250
AC   CVCL_FG95
DR   CLO; CLO_0028449
DR   Coriell; ND01250
DR   Wikidata; Q54909396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01254
AC   CVCL_GA77
DR   CLO; CLO_0028450
DR   Coriell; ND01254
DR   Wikidata; Q54909397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01255
AC   CVCL_HS46
DR   Coriell; ND01255
DR   Wikidata; Q54909398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01256
AC   CVCL_FW27
DR   Coriell; ND01256
DR   Wikidata; Q54909399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01257
AC   CVCL_II71
DR   Coriell; ND01257
DR   Wikidata; Q54909400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01259
AC   CVCL_DU02
DR   Coriell; ND01259
DR   Wikidata; Q54909401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01260
AC   CVCL_DU03
DR   Coriell; ND01260
DR   Wikidata; Q54909402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01261
AC   CVCL_DU04
DR   Coriell; ND01261
DR   Wikidata; Q54909403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01262
AC   CVCL_II72
DR   Coriell; ND01262
DR   Wikidata; Q54909404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01263
AC   CVCL_IL30
DR   Coriell; ND01263
DR   Wikidata; Q54909405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01264
AC   CVCL_FW28
DR   Coriell; ND01264
DR   Wikidata; Q54909406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01265
AC   CVCL_HS47
DR   Coriell; ND01265
DR   Wikidata; Q54909407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01266
AC   CVCL_II73
DR   Coriell; ND01266
DR   Wikidata; Q54909408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01268
AC   CVCL_DU05
DR   Coriell; ND01268
DR   Wikidata; Q54909409
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01269
AC   CVCL_DU06
DR   Coriell; ND01269
DR   Wikidata; Q54909410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01270
AC   CVCL_DU07
DR   Coriell; ND01270
DR   Wikidata; Q54909411
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01271
AC   CVCL_CA11
DR   Coriell; ND01271
DR   Wikidata; Q54909412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01272
AC   CVCL_CA12
DR   Coriell; ND01272
DR   Wikidata; Q54909413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01273
AC   CVCL_CA13
DR   Coriell; ND01273
DR   Wikidata; Q54909414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01274
AC   CVCL_GA78
DR   CLO; CLO_0028451
DR   Coriell; ND01274
DR   Wikidata; Q54909415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01275
AC   CVCL_CA14
DR   CLO; CLO_0028442
DR   Coriell; ND01275
DR   Wikidata; Q54909416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01276
AC   CVCL_CA15
DR   CLO; CLO_0028441
DR   BioSample; SAMN00803685
DR   Coriell; ND01276
DR   Wikidata; Q54909417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01277
AC   CVCL_1V58
SY   ND-1277
DR   CLO; CLO_0028427
DR   BioSample; SAMN00803687
DR   Coriell; ND01277
DR   Wikidata; Q54909418
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01279
AC   CVCL_II52
DR   Coriell; ND01279
DR   Wikidata; Q54909419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01280
AC   CVCL_DU08
DR   Coriell; ND01280
DR   Wikidata; Q54909420
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01281
AC   CVCL_DU09
DR   Coriell; ND01281
DR   Wikidata; Q54909421
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01282
AC   CVCL_EH34
DR   CLO; CLO_0028429
DR   Coriell; ND01282
DR   Wikidata; Q54909422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01283
AC   CVCL_GA79
DR   CLO; CLO_0028424
DR   Coriell; ND01283
DR   Wikidata; Q54909423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01284
AC   CVCL_FG96
DR   CLO; CLO_0028426
DR   Coriell; ND01284
DR   Wikidata; Q54909424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01285
AC   CVCL_HX96
DR   CLO; CLO_0028435
DR   Coriell; ND01285
DR   Wikidata; Q54909425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01286
AC   CVCL_FG97
DR   CLO; CLO_0028437
DR   Coriell; ND01286
DR   Wikidata; Q54909426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01287
AC   CVCL_HX97
DR   CLO; CLO_0028431
DR   Coriell; ND01287
DR   Wikidata; Q54909427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01288
AC   CVCL_HX98
DR   CLO; CLO_0028433
DR   Coriell; ND01288
DR   Wikidata; Q54909428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01289
AC   CVCL_HX99
DR   CLO; CLO_0025146
DR   Coriell; ND01289
DR   Wikidata; Q54909429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01290
AC   CVCL_FG98
DR   CLO; CLO_0025148
DR   Coriell; ND01290
DR   Wikidata; Q54909430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01291
AC   CVCL_HY71
DR   CLO; CLO_0025147
DR   Coriell; ND01291
DR   Wikidata; Q54909431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01312
AC   CVCL_DU10
DR   Coriell; ND01312
DR   Wikidata; Q54909432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01314
AC   CVCL_CA16
DR   CLO; CLO_0025119
DR   Coriell; ND01314
DR   Wikidata; Q54909436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01315
AC   CVCL_CA17
DR   CLO; CLO_0025121
DR   BioSample; SAMN00803707
DR   Coriell; ND01315
DR   Wikidata; Q54909437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01316
AC   CVCL_HY72
DR   CLO; CLO_0025122
DR   Coriell; ND01316
DR   Wikidata; Q54909438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01317
AC   CVCL_1V59
SY   ND-1317
DR   CLO; CLO_0025124
DR   Coriell; ND01317
DR   Wikidata; Q54909439
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01318
AC   CVCL_CA18
DR   CLO; CLO_0025127
DR   BioSample; SAMN00803711
DR   Coriell; ND01318
DR   Wikidata; Q54909440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01319
AC   CVCL_HY73
DR   CLO; CLO_0025128
DR   Coriell; ND01319
DR   Wikidata; Q54909441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01320
AC   CVCL_CA19
DR   CLO; CLO_0025131
DR   Coriell; ND01320
DR   Wikidata; Q54909442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01321
AC   CVCL_HY74
DR   CLO; CLO_0017562
DR   Coriell; ND01321
DR   Wikidata; Q54909443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01322
AC   CVCL_CA20
DR   CLO; CLO_0017575
DR   BioSample; SAMN00803717
DR   Coriell; ND01322
DR   Wikidata; Q54909444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01323
AC   CVCL_1V60
SY   ND-1323
DR   CLO; CLO_0017576
DR   BioSample; SAMN00803719
DR   Coriell; ND01323
DR   Wikidata; Q54909445
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01324
AC   CVCL_FG99
DR   CLO; CLO_0017577
DR   Coriell; ND01324
DR   Wikidata; Q54909446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01325
AC   CVCL_IH94
DR   CLO; CLO_0017578
DR   Coriell; ND01325
DR   Wikidata; Q54909447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01326
AC   CVCL_IH95
DR   CLO; CLO_0017569
DR   Coriell; ND01326
DR   Wikidata; Q54909448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01330
AC   CVCL_HY75
DR   Coriell; ND01330
DR   Wikidata; Q54909449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01331
AC   CVCL_HY76
DR   Coriell; ND01331
DR   Wikidata; Q54909450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01332
AC   CVCL_CA21
DR   Coriell; ND01332
DR   Wikidata; Q54909451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01333
AC   CVCL_GA80
DR   CLO; CLO_0017570
DR   Coriell; ND01333
DR   Wikidata; Q54909452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01334
AC   CVCL_CA22
DR   CLO; CLO_0017572
DR   Coriell; ND01334
DR   Wikidata; Q54909453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01336
AC   CVCL_ER84
DR   CLO; CLO_0017573
DR   Coriell; ND01336
DR   Wikidata; Q54909454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01337
AC   CVCL_HS48
DR   Coriell; ND01337
DR   Wikidata; Q54909455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01345
AC   CVCL_CA23
DR   CLO; CLO_0017585
DR   Coriell; ND01345
DR   Wikidata; Q54909456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01346
AC   CVCL_HY77
DR   CLO; CLO_0017591
DR   Coriell; ND01346
DR   Wikidata; Q54909457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01347
AC   CVCL_CA24
DR   CLO; CLO_0017592
DR   Coriell; ND01347
DR   Wikidata; Q54909458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01348
AC   CVCL_IH96
DR   CLO; CLO_0017608
DR   Coriell; ND01348
DR   Wikidata; Q54909459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01349
AC   CVCL_IH97
DR   CLO; CLO_0017609
DR   Coriell; ND01349
DR   Wikidata; Q54909460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01350
AC   CVCL_GA81
DR   CLO; CLO_0017606
DR   Coriell; ND01350
DR   Wikidata; Q54909461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01351
AC   CVCL_DU11
DR   Coriell; ND01351
DR   Wikidata; Q54909462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01353
AC   CVCL_CA25
DR   CLO; CLO_0017607
DR   BioSample; SAMN00803733
DR   Coriell; ND01353
DR   Wikidata; Q54909463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01354
AC   CVCL_1V61
SY   ND-1354
DR   CLO; CLO_0017604
DR   BioSample; SAMN00803735
DR   Coriell; ND01354
DR   Wikidata; Q54909464
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01355
AC   CVCL_CA26
DR   CLO; CLO_0017605
DR   BioSample; SAMN00803737
DR   Coriell; ND01355
DR   Wikidata; Q54909465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01357
AC   CVCL_FW29
DR   Coriell; ND01357
DR   Wikidata; Q54909466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01358
AC   CVCL_CA27
DR   Coriell; ND01358
DR   Wikidata; Q54909467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01359
AC   CVCL_CA28
DR   BioSample; SAMN00803739
DR   Coriell; ND01359
DR   Wikidata; Q54909468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01360
AC   CVCL_HY78
DR   BioSample; SAMN00803741
DR   Coriell; ND01360
DR   Wikidata; Q54909470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01361
AC   CVCL_FH00
DR   CLO; CLO_0017600
DR   Coriell; ND01361
DR   Wikidata; Q54909471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01362
AC   CVCL_IH98
DR   CLO; CLO_0017603
DR   Coriell; ND01362
DR   Wikidata; Q54909473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01363
AC   CVCL_DU12
DR   Coriell; ND01363
DR   Wikidata; Q54909474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01364
AC   CVCL_DU13
DR   Coriell; ND01364
DR   Wikidata; Q54909475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01365
AC   CVCL_FW30
DR   Coriell; ND01365
DR   Wikidata; Q54909476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01366
AC   CVCL_HS49
DR   Coriell; ND01366
DR   Wikidata; Q54909478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01367
AC   CVCL_FH01
DR   CLO; CLO_0017383
DR   Coriell; ND01367
DR   Wikidata; Q54909505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01369
AC   CVCL_CA29
DR   BioSample; SAMN00803751
DR   Coriell; ND01369
DR   Wikidata; Q54909506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EY62 ! ND30116
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND01370
AC   CVCL_CA30
DR   CLO; CLO_0017389
DR   BioSample; SAMN00803753
DR   Coriell; ND01370
DR   Wikidata; Q54909507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01372
AC   CVCL_ER85
DR   CLO; CLO_0017387
DR   BioSample; SAMN00803755
DR   Coriell; ND01372
DR   Wikidata; Q54909508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01373
AC   CVCL_CA31
DR   CLO; CLO_0017370
DR   Coriell; ND01373
DR   Wikidata; Q54909509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01374
AC   CVCL_EH35
DR   CLO; CLO_0017369
DR   Coriell; ND01374
DR   Wikidata; Q54909510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01375
AC   CVCL_DU14
DR   Coriell; ND01375
DR   Wikidata; Q54909511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01376
AC   CVCL_DU15
DR   Coriell; ND01376
DR   Wikidata; Q54909512
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01377
AC   CVCL_HY79
DR   Coriell; ND01377
DR   Wikidata; Q54909513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01379
AC   CVCL_HS50
DR   Coriell; ND01379
DR   Wikidata; Q54909514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01380
AC   CVCL_HS51
DR   Coriell; ND01380
DR   Wikidata; Q54909515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01381
AC   CVCL_HS52
DR   Coriell; ND01381
DR   Wikidata; Q54909516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01382
AC   CVCL_IL31
DR   Coriell; ND01382
DR   Wikidata; Q54909517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01396
AC   CVCL_CA32
DR   CLO; CLO_0017372
DR   Coriell; ND01396
DR   Wikidata; Q54909518
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01397
AC   CVCL_CA33
DR   CLO; CLO_0017371
DR   Coriell; ND01397
DR   Wikidata; Q54909519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01398
AC   CVCL_CA34
DR   CLO; CLO_0017375
DR   BioSample; SAMN00803767
DR   Coriell; ND01398
DR   Wikidata; Q54909520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01399
AC   CVCL_ER86
DR   CLO; CLO_0017373
DR   BioSample; SAMN00803769
DR   Coriell; ND01399
DR   Wikidata; Q54909521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01400
AC   CVCL_CA35
DR   CLO; CLO_0017377
DR   Coriell; ND01400
DR   Wikidata; Q54909523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01401
AC   CVCL_CA36
DR   CLO; CLO_0017429
DR   Coriell; ND01401
DR   Wikidata; Q54909525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01402
AC   CVCL_CA37
DR   CLO; CLO_0017427
DR   Coriell; ND01402
DR   Wikidata; Q54909527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01403
AC   CVCL_CA38
DR   CLO; CLO_0017426
DR   Coriell; ND01403
DR   Wikidata; Q54909529
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01404
AC   CVCL_CA39
DR   CLO; CLO_0017423
DR   BioSample; SAMN00803771
DR   Coriell; ND01404
DR   Wikidata; Q54909531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01405
AC   CVCL_GA82
DR   CLO; CLO_0017413
DR   BioSample; SAMN00803773
DR   Coriell; ND01405
DR   Wikidata; Q54909533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01406
AC   CVCL_DU16
DR   Coriell; ND01406
DR   Wikidata; Q54909535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01407
AC   CVCL_DU17
DR   Coriell; ND01407
DR   Wikidata; Q54909536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01408
AC   CVCL_CA40
DR   Coriell; ND01408
DR   Wikidata; Q54909538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01409
AC   CVCL_CA41
DR   Coriell; ND01409
DR   Wikidata; Q54909540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01410
AC   CVCL_HY80
DR   Coriell; ND01410
DR   Wikidata; Q54909541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01411
AC   CVCL_FW31
DR   Coriell; ND01411
DR   Wikidata; Q54909542
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01413
AC   CVCL_CA42
DR   CLO; CLO_0017412
DR   Coriell; ND01413
DR   Wikidata; Q54909543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01414
AC   CVCL_HX34
DR   CLO; CLO_0017411
DR   Coriell; ND01414
DR   Wikidata; Q54909544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   ND01415
AC   CVCL_HY81
DR   Coriell; ND01415
DR   Wikidata; Q54909545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01416
AC   CVCL_HY82
DR   Coriell; ND01416
DR   Wikidata; Q54909546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01417
AC   CVCL_HY83
DR   Coriell; ND01417
DR   Wikidata; Q54909547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01418
AC   CVCL_IL32
DR   Coriell; ND01418
DR   Wikidata; Q54909548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01419
AC   CVCL_HY84
DR   Coriell; ND01419
DR   Wikidata; Q54909549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01423
AC   CVCL_CA43
DR   CLO; CLO_0017410
DR   BioSample; SAMN00803789
DR   Coriell; ND01423
DR   Wikidata; Q54909550
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND01424
AC   CVCL_1V62
SY   ND-1424
DR   CLO; CLO_0017417
DR   BioSample; SAMN00803791
DR   Coriell; ND01424
DR   Wikidata; Q54909551
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01425
AC   CVCL_CA44
DR   CLO; CLO_0017415
DR   Coriell; ND01425
DR   Wikidata; Q54909552
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01426
AC   CVCL_CA45
DR   CLO; CLO_0017450
DR   BioSample; SAMN00803793
DR   Coriell; ND01426
DR   Wikidata; Q54909553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01427
AC   CVCL_GA83
DR   CLO; CLO_0017447
DR   BioSample; SAMN00803795
DR   Coriell; ND01427
DR   Wikidata; Q54909583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01428
AC   CVCL_IH99
DR   CLO; CLO_0017446
DR   Coriell; ND01428
DR   Wikidata; Q54909584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01429
AC   CVCL_II00
DR   CLO; CLO_0017449
DR   Coriell; ND01429
DR   Wikidata; Q54909585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01430
AC   CVCL_CA46
DR   CLO; CLO_0017448
DR   BioSample; SAMN00803801
DR   Coriell; ND01430
DR   Wikidata; Q54909586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01431
AC   CVCL_II01
DR   CLO; CLO_0017443
DR   Coriell; ND01431
DR   Wikidata; Q54909587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01432
AC   CVCL_DU18
DR   Coriell; ND01432
DR   Wikidata; Q54909588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01433
AC   CVCL_DU19
DR   Coriell; ND01433
DR   Wikidata; Q54909589
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01434
AC   CVCL_CA47
DR   Coriell; ND01434
DR   Wikidata; Q54909590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01435
AC   CVCL_CA48
DR   Coriell; ND01435
DR   Wikidata; Q54909592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01437
AC   CVCL_HY85
DR   Coriell; ND01437
DR   Wikidata; Q54909594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01438
AC   CVCL_FH02
DR   CLO; CLO_0017442
DR   Coriell; ND01438
DR   Wikidata; Q54909596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01439
AC   CVCL_HY86
DR   CLO; CLO_0017445
DR   Coriell; ND01439
DR   Wikidata; Q54909598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01440
AC   CVCL_FH03
DR   CLO; CLO_0017444
DR   Coriell; ND01440
DR   Wikidata; Q54909599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01441
AC   CVCL_FH04
DR   CLO; CLO_0017441
DR   Coriell; ND01441
DR   Wikidata; Q54909601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01442
AC   CVCL_HY87
DR   Coriell; ND01442
DR   Wikidata; Q54909602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01443
AC   CVCL_HY88
DR   Coriell; ND01443
DR   Wikidata; Q54909603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01453
AC   CVCL_GQ10
DR   CLO; CLO_0017481
DR   Coriell; ND01453
DR   Wikidata; Q54909604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01454
AC   CVCL_DU20
DR   Coriell; ND01454
DR   Wikidata; Q54909605
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01455
AC   CVCL_DU21
DR   Coriell; ND01455
DR   Wikidata; Q54909606
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01456
AC   CVCL_HY89
DR   Coriell; ND01456
DR   Wikidata; Q54909607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01457
AC   CVCL_HY90
DR   Coriell; ND01457
DR   Wikidata; Q54909608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01458
AC   CVCL_HY91
DR   Coriell; ND01458
DR   Wikidata; Q54909609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01460
AC   CVCL_HS53
DR   Coriell; ND01460
DR   Wikidata; Q54909610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01461
AC   CVCL_HY92
DR   Coriell; ND01461
DR   Wikidata; Q54909611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01462
AC   CVCL_HS54
DR   Coriell; ND01462
DR   Wikidata; Q54909612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01463
AC   CVCL_FW32
DR   Coriell; ND01463
DR   Wikidata; Q54909613
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01466
AC   CVCL_DU22
DR   Coriell; ND01466
DR   Wikidata; Q54909614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01467
AC   CVCL_DU23
DR   Coriell; ND01467
DR   Wikidata; Q54909615
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01470
AC   CVCL_CA49
DR   Coriell; ND01470
DR   Wikidata; Q54909616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01472
AC   CVCL_HS55
DR   Coriell; ND01472
DR   Wikidata; Q54909617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01491
AC   CVCL_1V63
SY   ND-1491
DR   CLO; CLO_0017480
DR   BioSample; SAMN00803837
DR   Coriell; ND01491
DR   Wikidata; Q54909618
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01492
AC   CVCL_CA50
DR   CLO; CLO_0017479
DR   BioSample; SAMN00803839
DR   Coriell; ND01492
DR   Wikidata; Q54909619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01493
AC   CVCL_1V64
SY   ND-1493
DR   CLO; CLO_0017478
DR   Coriell; ND01493
DR   Wikidata; Q54909620
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01494
AC   CVCL_CA51
DR   CLO; CLO_0017477
DR   Coriell; ND01494
DR   Wikidata; Q54909621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01495
AC   CVCL_CA52
DR   CLO; CLO_0017476
DR   Coriell; ND01495
DR   Wikidata; Q54909622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01496
AC   CVCL_1V65
SY   ND-1496
DR   CLO; CLO_0017475
DR   BioSample; SAMN00803841
DR   Coriell; ND01496
DR   Wikidata; Q54909623
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01497
AC   CVCL_CA53
DR   CLO; CLO_0017474
DR   BioSample; SAMN00803843
DR   Coriell; ND01497
DR   Wikidata; Q54909624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01498
AC   CVCL_CA54
DR   CLO; CLO_0017473
DR   BioSample; SAMN00803845
DR   Coriell; ND01498
DR   Wikidata; Q54909625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01499
AC   CVCL_GQ11
DR   CLO; CLO_0017472
DR   Coriell; ND01499
DR   Wikidata; Q54909626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01500
AC   CVCL_CA55
DR   CLO; CLO_0017867
DR   Coriell; ND01500
DR   Wikidata; Q54909627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01501
AC   CVCL_CA56
DR   CLO; CLO_0017864
DR   Coriell; ND01501
DR   Wikidata; Q54909631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01502
AC   CVCL_CA57
DR   CLO; CLO_0017866
DR   Coriell; ND01502
DR   Wikidata; Q54909632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01504
AC   CVCL_1V66
SY   ND-1504
DR   CLO; CLO_0017861
DR   BioSample; SAMN00803849
DR   Coriell; ND01504
DR   Wikidata; Q54909633
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01505
AC   CVCL_FC07
DR   CLO; CLO_0017862
DR   BioSample; SAMN00803851
DR   Coriell; ND01505
DR   Wikidata; Q54909634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01506
AC   CVCL_CA58
DR   CLO; CLO_0017859
DR   BioSample; SAMN00803853
DR   Coriell; ND01506
DR   Wikidata; Q54909635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01509
AC   CVCL_GQ12
DR   CLO; CLO_0017860
DR   Coriell; ND01509
DR   Wikidata; Q54909636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01510
AC   CVCL_CA59
DR   CLO; CLO_0017876
DR   Coriell; ND01510
DR   Wikidata; Q54909637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01511
AC   CVCL_CA60
DR   CLO; CLO_0017877
DR   BioSample; SAMN00803857
DR   Coriell; ND01511
DR   Wikidata; Q54909638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01512
AC   CVCL_GQ13
DR   CLO; CLO_0017873
DR   Coriell; ND01512
DR   Wikidata; Q54909639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01513
AC   CVCL_CA61
DR   CLO; CLO_0017833
DR   Coriell; ND01513
DR   Wikidata; Q54909640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01514
AC   CVCL_CA62
DR   CLO; CLO_0017834
DR   Coriell; ND01514
DR   Wikidata; Q54909641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01515
AC   CVCL_CA63
DR   CLO; CLO_0017835
DR   BioSample; SAMN00803861
DR   Coriell; ND01515
DR   Wikidata; Q54909642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01516
AC   CVCL_CA64
DR   CLO; CLO_0017837
DR   Coriell; ND01516
DR   Wikidata; Q54909643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01517
AC   CVCL_CA65
DR   CLO; CLO_0017829
DR   Coriell; ND01517
DR   Wikidata; Q54909644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01518
AC   CVCL_CA66
DR   CLO; CLO_0017830
DR   Coriell; ND01518
DR   Wikidata; Q54909645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01519
AC   CVCL_1V67
SY   ND-1519
DR   CLO; CLO_0017831
DR   BioSample; SAMN00803863
DR   Coriell; ND01519
DR   Wikidata; Q54909646
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND01520
AC   CVCL_CA67
DR   CLO; CLO_0017832
DR   Coriell; ND01520
DR   Wikidata; Q54909647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01521
AC   CVCL_CA68
DR   CLO; CLO_0017843
DR   Coriell; ND01521
DR   Wikidata; Q54909648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01522
AC   CVCL_CA69
DR   CLO; CLO_0017844
DR   BioSample; SAMN00803865
DR   Coriell; ND01522
DR   Wikidata; Q54909649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01523
AC   CVCL_1V68
SY   ND-1523
DR   CLO; CLO_0017946
DR   BioSample; SAMN00803867
DR   Coriell; ND01523
DR   Wikidata; Q54909650
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01524
AC   CVCL_CA70
DR   CLO; CLO_0017921
DR   BioSample; SAMN00803869
DR   Coriell; ND01524
DR   Wikidata; Q54909651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01525
AC   CVCL_1V69
SY   ND-1525
DR   CLO; CLO_0017922
DR   BioSample; SAMN00803871
DR   Coriell; ND01525
DR   Wikidata; Q54909652
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01526
AC   CVCL_CA71
DR   CLO; CLO_0017919
DR   BioSample; SAMN00803873
DR   Coriell; ND01526
DR   Wikidata; Q54909653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01527
AC   CVCL_1V70
SY   ND-1527
DR   CLO; CLO_0017920
DR   BioSample; SAMN00803875
DR   Coriell; ND01527
DR   Wikidata; Q54909654
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01528
AC   CVCL_1V71
SY   ND-1528
DR   CLO; CLO_0017925
DR   BioSample; SAMN00803877
DR   Coriell; ND01528
DR   Wikidata; Q54909655
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01529
AC   CVCL_CA72
DR   CLO; CLO_0017926
DR   Coriell; ND01529
DR   Wikidata; Q54909656
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01530
AC   CVCL_CA73
DR   CLO; CLO_0017923
DR   Coriell; ND01530
DR   Wikidata; Q54909657
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01531
AC   CVCL_CA74
DR   CLO; CLO_0017924
DR   Coriell; ND01531
DR   Wikidata; Q54909658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01532
AC   CVCL_CA75
DR   CLO; CLO_0017930
DR   Coriell; ND01532
DR   Wikidata; Q54909659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01533
AC   CVCL_CA76
DR   CLO; CLO_0017918
DR   Coriell; ND01533
DR   Wikidata; Q54909660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01534
AC   CVCL_CA77
DR   CLO; CLO_0017916
DR   BioSample; SAMN00803879
DR   Coriell; ND01534
DR   Wikidata; Q54909661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01535
AC   CVCL_CA78
DR   CLO; CLO_0017889
DR   Coriell; ND01535
DR   Wikidata; Q54909662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01536
AC   CVCL_DU24
DR   Coriell; ND01536
DR   Wikidata; Q54909663
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01537
AC   CVCL_HS56
DR   Coriell; ND01537
DR   Wikidata; Q54909664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01538
AC   CVCL_HY93
DR   Coriell; ND01538
DR   Wikidata; Q54909665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01539
AC   CVCL_HY94
DR   Coriell; ND01539
DR   Wikidata; Q54909666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01540
AC   CVCL_HY95
DR   Coriell; ND01540
DR   Wikidata; Q54909667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01545
AC   CVCL_CA79
DR   CLO; CLO_0017890
DR   Coriell; ND01545
DR   Wikidata; Q54909668
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01547
AC   CVCL_GQ14
DR   CLO; CLO_0017891
DR   Coriell; ND01547
DR   Wikidata; Q54909669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01548
AC   CVCL_1V72
SY   ND-1548
DR   CLO; CLO_0017892
DR   Coriell; ND01548
DR   Wikidata; Q54909670
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01549
AC   CVCL_HY96
DR   Coriell; ND01549
DR   Wikidata; Q54909672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01550
AC   CVCL_IG70
DR   CLO; CLO_0017893
DR   Coriell; ND01550
DR   Wikidata; Q54909673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01551
AC   CVCL_II02
DR   CLO; CLO_0017894
DR   Coriell; ND01551
DR   Wikidata; Q54909674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01552
AC   CVCL_1V73
SY   ND-1552
DR   CLO; CLO_0017895
DR   Coriell; ND01552
DR   Wikidata; Q54909675
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01553
AC   CVCL_DU25
DR   CLO; CLO_0017896
DR   Coriell; ND01553
DR   Wikidata; Q54909676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01555
AC   CVCL_CA80
DR   CLO; CLO_0016731
DR   BioSample; SAMN00803885
DR   Coriell; ND01555
DR   Wikidata; Q54909677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01556
AC   CVCL_GA84
DR   CLO; CLO_0016729
DR   BioSample; SAMN00803887
DR   Coriell; ND01556
DR   Wikidata; Q54909678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01557
AC   CVCL_CA81
DR   CLO; CLO_0016728
DR   Coriell; ND01557
DR   Wikidata; Q54909679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01559
AC   CVCL_ER87
DR   CLO; CLO_0016727
DR   Coriell; ND01559
DR   Wikidata; Q54909680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01560
AC   CVCL_DU26
DR   CLO; CLO_0016726
DR   Coriell; ND01560
DR   Wikidata; Q54909681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01562
AC   CVCL_1V74
SY   ND-1562
DR   CLO; CLO_0016724
DR   Coriell; ND01562
DR   Wikidata; Q54909682
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01563
AC   CVCL_1V75
SY   ND-1563
DR   CLO; CLO_0016722
DR   Coriell; ND01563
DR   Wikidata; Q54909683
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01564
AC   CVCL_GQ15
DR   CLO; CLO_0016721
DR   Coriell; ND01564
DR   Wikidata; Q54909684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01565
AC   CVCL_1V76
SY   ND-1565
DR   CLO; CLO_0016712
DR   Coriell; ND01565
DR   Wikidata; Q54909686
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01566
AC   CVCL_1V77
SY   ND-1566
DR   CLO; CLO_0016715
DR   Coriell; ND01566
DR   Wikidata; Q54909687
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01567
AC   CVCL_1V78
SY   ND-1567
DR   CLO; CLO_0016704
DR   Coriell; ND01567
DR   Wikidata; Q54909688
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01568
AC   CVCL_1V79
SY   ND-1568
DR   Coriell; ND01568
DR   Wikidata; Q54909689
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01569
AC   CVCL_1V80
SY   ND-1569
DR   CLO; CLO_0016700
DR   BioSample; SAMN00803889
DR   Coriell; ND01569
DR   Wikidata; Q54909690
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01570
AC   CVCL_1V81
SY   ND-1570
DR   CLO; CLO_0016697
DR   BioSample; SAMN00803891
DR   Coriell; ND01570
DR   Wikidata; Q54909691
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01571
AC   CVCL_HY97
DR   CLO; CLO_0016703
DR   Coriell; ND01571
DR   Wikidata; Q54909692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01572
AC   CVCL_DU27
DR   CLO; CLO_0016702
DR   Coriell; ND01572
DR   Wikidata; Q54909693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01573
AC   CVCL_CA82
DR   CLO; CLO_0016692
DR   Coriell; ND01573
DR   Wikidata; Q54909694
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01574
AC   CVCL_1V82
SY   ND-1574
DR   CLO; CLO_0016689
DR   Coriell; ND01574
DR   Wikidata; Q54909695
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01575
AC   CVCL_GA85
DR   CLO; CLO_0016695
DR   Coriell; ND01575
DR   Wikidata; Q54909696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01576
AC   CVCL_IG71
DR   CLO; CLO_0016693
DR   Coriell; ND01576
DR   Wikidata; Q54909697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01577
AC   CVCL_1V83
SY   ND-1577
DR   CLO; CLO_0016799
DR   Coriell; ND01577
DR   Wikidata; Q54909698
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01579
AC   CVCL_HY98
DR   Coriell; ND01579
DR   Wikidata; Q54909699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01580
AC   CVCL_1V84
SY   ND-1580
DR   CLO; CLO_0016792
DR   Coriell; ND01580
DR   Wikidata; Q54909700
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01581
AC   CVCL_FB45
DR   CLO; CLO_0016791
DR   Coriell; ND01581
DR   Wikidata; Q54909701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01582
AC   CVCL_1V85
SY   ND-1582
DR   CLO; CLO_0016784
DR   Coriell; ND01582
DR   Wikidata; Q54909702
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01583
AC   CVCL_1V86
SY   ND-1583
DR   CLO; CLO_0016783
DR   Coriell; ND01583
DR   Wikidata; Q54909703
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01584
AC   CVCL_IG72
DR   CLO; CLO_0016780
DR   BioSample; SAMN00803895
DR   Coriell; ND01584
DR   Wikidata; Q54909704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND01585
AC   CVCL_IG73
DR   CLO; CLO_0016778
DR   BioSample; SAMN00803897
DR   Coriell; ND01585
DR   Wikidata; Q54909705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND01586
AC   CVCL_HY99
DR   Coriell; ND01586
DR   Wikidata; Q54909706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01587
AC   CVCL_HZ00
DR   Coriell; ND01587
DR   Wikidata; Q54909707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01588
AC   CVCL_1V87
SY   ND-1588
DR   CLO; CLO_0016790
DR   Coriell; ND01588
DR   Wikidata; Q54909708
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01589
AC   CVCL_II03
DR   CLO; CLO_0016789
DR   Coriell; ND01589
DR   Wikidata; Q54909709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01590
AC   CVCL_HY10
DR   CLO; CLO_0016787
DR   Coriell; ND01590
DR   Wikidata; Q54909711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01591
AC   CVCL_DU28
DR   Coriell; ND01591
DR   Wikidata; Q54909712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01592
AC   CVCL_CA83
DR   CLO; CLO_0016786
DR   Coriell; ND01592
DR   Wikidata; Q54909713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01593
AC   CVCL_CA84
DR   CLO; CLO_0016762
DR   Coriell; ND01593
DR   Wikidata; Q54909715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01594
AC   CVCL_HS57
DR   Coriell; ND01594
DR   Wikidata; Q54909716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01596
AC   CVCL_HS58
DR   Coriell; ND01596
DR   Wikidata; Q54909717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01597
AC   CVCL_HS59
DR   Coriell; ND01597
DR   Wikidata; Q54909718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01599
AC   CVCL_FH05
DR   CLO; CLO_0016764
DR   Coriell; ND01599
DR   Wikidata; Q54909719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01600
AC   CVCL_DU29
DR   Coriell; ND01600
DR   Wikidata; Q54909720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01601
AC   CVCL_DU30
DR   Coriell; ND01601
DR   Wikidata; Q54909721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01603
AC   CVCL_HZ01
DR   Coriell; ND01603
DR   Wikidata; Q54909722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01604
AC   CVCL_ER88
DR   CLO; CLO_0016763
DR   Coriell; ND01604
DR   Wikidata; Q54909723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01605
AC   CVCL_ER89
DR   CLO; CLO_0016751
DR   Coriell; ND01605
DR   Wikidata; Q54909724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01606
AC   CVCL_GA86
DR   CLO; CLO_0016749
DR   Coriell; ND01606
DR   Wikidata; Q54909725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01607
AC   CVCL_CA85
DR   CLO; CLO_0016754
DR   BioSample; SAMN00803907
DR   Coriell; ND01607
DR   Wikidata; Q54909726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND01607; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01608
AC   CVCL_HZ02
DR   CLO; CLO_0016752
DR   Coriell; ND01608
DR   Wikidata; Q54909727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01609
AC   CVCL_CA86
DR   CLO; CLO_0016758
DR   Coriell; ND01609
DR   Wikidata; Q54909728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01610
AC   CVCL_CA87
DR   CLO; CLO_0016756
DR   BioSample; SAMN00803911
DR   Coriell; ND01610
DR   Wikidata; Q54909729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01611
AC   CVCL_1V88
SY   ND-1611
DR   CLO; CLO_0016761
DR   BioSample; SAMN00803913
DR   Coriell; ND01611
DR   Wikidata; Q54909730
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01612
AC   CVCL_CA88
DR   CLO; CLO_0016571
DR   BioSample; SAMN00803915
DR   Coriell; ND01612
DR   Wikidata; Q54909731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01613
AC   CVCL_1V89
SY   ND-1613
DR   CLO; CLO_0016572
DR   BioSample; SAMN00803916
DR   Coriell; ND01613
DR   Wikidata; Q54909732
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01616
AC   CVCL_FW33
DR   Coriell; ND01616
DR   Wikidata; Q54909733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01618
AC   CVCL_CA89
DR   BioSample; SAMN00803918
DR   Coriell; ND01618
DR   Wikidata; Q54909734
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND01618).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   ND01623
AC   CVCL_DU31
DR   Coriell; ND01623
DR   Wikidata; Q54909735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01624
AC   CVCL_DU32
DR   Coriell; ND01624
DR   Wikidata; Q54909736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01625
AC   CVCL_DU33
DR   Coriell; ND01625
DR   Wikidata; Q54909737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01626
AC   CVCL_DU34
DR   Coriell; ND01626
DR   Wikidata; Q54909738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01627
AC   CVCL_DU35
DR   Coriell; ND01627
DR   Wikidata; Q54909739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01628
AC   CVCL_CA90
DR   CLO; CLO_0016569
DR   Coriell; ND01628
DR   Wikidata; Q54909740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01629
AC   CVCL_CA91
DR   CLO; CLO_0016570
DR   BioSample; SAMN00803920
DR   Coriell; ND01629
DR   Wikidata; Q54909741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01630
AC   CVCL_1V90
SY   ND-1630
DR   CLO; CLO_0016589
DR   BioSample; SAMN00803922
DR   Coriell; ND01630
DR   Wikidata; Q54909742
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ND01631
AC   CVCL_HZ03
DR   Coriell; ND01631
DR   Wikidata; Q54909743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01645
AC   CVCL_IL33
DR   Coriell; ND01645
DR   Wikidata; Q54909744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01647
AC   CVCL_FH06
DR   CLO; CLO_0016590
DR   Coriell; ND01647
DR   Wikidata; Q54909745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01648
AC   CVCL_HZ04
DR   CLO; CLO_0016583
DR   Coriell; ND01648
DR   Wikidata; Q54909746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01649
AC   CVCL_DU36
DR   Coriell; ND01649
DR   Wikidata; Q54909747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01650
AC   CVCL_CA92
DR   Coriell; ND01650
DR   Wikidata; Q54909748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01651
AC   CVCL_CA93
DR   CLO; CLO_0016586
DR   Coriell; ND01651
DR   Wikidata; Q54909749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01652
AC   CVCL_FW34
DR   Coriell; ND01652
DR   Wikidata; Q54909750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01653
AC   CVCL_HZ05
DR   Coriell; ND01653
DR   Wikidata; Q54909751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01654
AC   CVCL_HZ06
DR   Coriell; ND01654
DR   Wikidata; Q54909752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01657
AC   CVCL_1V91
SY   ND-1657
DR   CLO; CLO_0016576
DR   Coriell; ND01657
DR   Wikidata; Q54909753
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01658
AC   CVCL_ER90
DR   CLO; CLO_0016578
DR   Coriell; ND01658
DR   Wikidata; Q54909754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01659
AC   CVCL_1V92
SY   ND-1659
DR   CLO; CLO_0016533
DR   Coriell; ND01659
DR   Wikidata; Q54909757
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01660
AC   CVCL_1V93
SY   ND-1660
DR   CLO; CLO_0016529
DR   Coriell; ND01660
DR   Wikidata; Q54909758
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01661
AC   CVCL_HZ07
DR   CLO; CLO_0016530
DR   Coriell; ND01661
DR   Wikidata; Q54909759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01662
AC   CVCL_HZ08
DR   Coriell; ND01662
DR   Wikidata; Q54909760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01663
AC   CVCL_ER91
DR   CLO; CLO_0016531
DR   Coriell; ND01663
DR   Wikidata; Q54909761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01664
AC   CVCL_HZ09
DR   Coriell; ND01664
DR   Wikidata; Q54909762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01665
AC   CVCL_IG74
DR   CLO; CLO_0016532
DR   Coriell; ND01665
DR   Wikidata; Q54909763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01666
AC   CVCL_1V94
SY   ND-1666
DR   CLO; CLO_0016542
DR   Coriell; ND01666
DR   Wikidata; Q54909764
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   ND01667
AC   CVCL_ER92
DR   CLO; CLO_0016546
DR   BioSample; SAMN00803936
DR   Coriell; ND01667
DR   Wikidata; Q54909765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01668
AC   CVCL_FC08
DR   CLO; CLO_0016549
DR   Coriell; ND01668
DR   Wikidata; Q54909766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01669
AC   CVCL_ER93
DR   CLO; CLO_0016553
DR   Coriell; ND01669
DR   Wikidata; Q54909767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01670
AC   CVCL_1V95
SY   ND-1670
DR   CLO; CLO_0016535
DR   Coriell; ND01670
DR   Wikidata; Q54909768
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01671
AC   CVCL_1V96
SY   ND-1671
DR   CLO; CLO_0016649
DR   Coriell; ND01671
DR   Wikidata; Q54909769
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01672
AC   CVCL_1V97
SY   ND-1672
DR   CLO; CLO_0016650
DR   Coriell; ND01672
DR   Wikidata; Q54909770
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01673
AC   CVCL_HZ10
DR   Coriell; ND01673
DR   Wikidata; Q54909771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01674
AC   CVCL_1V98
SY   ND-1674
DR   CLO; CLO_0016653
DR   Coriell; ND01674
DR   Wikidata; Q54909772
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01675
AC   CVCL_1V99
SY   ND-1675
DR   CLO; CLO_0016654
DR   Coriell; ND01675
DR   Wikidata; Q54909773
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01676
AC   CVCL_1W00
SY   ND-1676
DR   CLO; CLO_0016651
DR   Coriell; ND01676
DR   Wikidata; Q54909774
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01678
AC   CVCL_1W01
SY   ND-1678
DR   CLO; CLO_0016652
DR   Coriell; ND01678
DR   Wikidata; Q54909775
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01679
AC   CVCL_1W02
SY   ND-1679
DR   CLO; CLO_0016661
DR   Coriell; ND01679
DR   Wikidata; Q54909776
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01680
AC   CVCL_IG75
DR   CLO; CLO_0016663
DR   Coriell; ND01680
DR   Wikidata; Q54909777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01682
AC   CVCL_1W03
SY   ND-1682
DR   CLO; CLO_0016655
DR   Coriell; ND01682
DR   Wikidata; Q54909778
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01683
AC   CVCL_CA94
DR   CLO; CLO_0016659
DR   BioSample; SAMN00803938
DR   Coriell; ND01683
DR   Wikidata; Q54909779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01684
AC   CVCL_1W04
SY   ND-1684
DR   CLO; CLO_0016609
DR   Coriell; ND01684
DR   Wikidata; Q54909780
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01685
AC   CVCL_HZ11
DR   CLO; CLO_0016611
DR   Coriell; ND01685
DR   Wikidata; Q54909781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01686
AC   CVCL_1W05
SY   ND-1686
DR   CLO; CLO_0016612
DR   Coriell; ND01686
DR   Wikidata; Q54909782
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01688
AC   CVCL_1W06
SY   ND-1688
DR   CLO; CLO_0016613
DR   Coriell; ND01688
DR   Wikidata; Q54909783
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01689
AC   CVCL_IG76
DR   CLO; CLO_0016614
DR   Coriell; ND01689
DR   Wikidata; Q54909784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01690
AC   CVCL_1W07
SY   ND-1690
DR   CLO; CLO_0016615
DR   Coriell; ND01690
DR   Wikidata; Q54909785
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01691
AC   CVCL_1W08
SY   ND-1691
DR   CLO; CLO_0016616
DR   BioSample; SAMN00803942
DR   Coriell; ND01691
DR   Wikidata; Q54909786
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01692
AC   CVCL_1W09
SY   ND-1692
DR   CLO; CLO_0016618
DR   BioSample; SAMN00803944
DR   Coriell; ND01692
DR   Wikidata; Q54909787
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01693
AC   CVCL_1W10
SY   ND-1693
DR   CLO; CLO_0016619
DR   Coriell; ND01693
DR   Wikidata; Q54909788
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01695
AC   CVCL_1W11
SY   ND-1695
DR   CLO; CLO_0016622
DR   Coriell; ND01695
DR   Wikidata; Q54909789
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01696
AC   CVCL_ER94
DR   CLO; CLO_0016341
DR   Coriell; ND01696
DR   Wikidata; Q54909790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01697
AC   CVCL_GA87
DR   CLO; CLO_0016339
DR   Coriell; ND01697
DR   Wikidata; Q54909791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01698
AC   CVCL_ER95
DR   CLO; CLO_0016344
DR   Coriell; ND01698
DR   Wikidata; Q54909792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01699
AC   CVCL_1W12
SY   ND-1699
DR   CLO; CLO_0016343
DR   Coriell; ND01699
DR   Wikidata; Q54909793
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01700
AC   CVCL_1W13
SY   ND-1700
DR   CLO; CLO_0016346
DR   Coriell; ND01700
DR   Wikidata; Q54909794
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01701
AC   CVCL_1W14
SY   ND-1701
DR   CLO; CLO_0016345
DR   Coriell; ND01701
DR   Wikidata; Q54909795
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01702
AC   CVCL_1W15
SY   ND-1702
DR   CLO; CLO_0016348
DR   Coriell; ND01702
DR   Wikidata; Q54909796
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01703
AC   CVCL_1W16
SY   ND-1703
DR   CLO; CLO_0016347
DR   BioSample; SAMN00803946
DR   Coriell; ND01703
DR   Wikidata; Q54909798
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01704
AC   CVCL_CA95
DR   CLO; CLO_0016331
DR   BioSample; SAMN00803948
DR   Coriell; ND01704
DR   Wikidata; Q54909799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01705
AC   CVCL_1W17
SY   ND-1705
DR   CLO; CLO_0016330
DR   BioSample; SAMN00803950
DR   Coriell; ND01705
DR   Wikidata; Q54909800
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01707
AC   CVCL_CA96
DR   CLO; CLO_0016349
DR   BioSample; SAMN00803952
DR   Coriell; ND01707
DR   Wikidata; Q54909801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01708
AC   CVCL_1W18
SY   ND-1708
DR   Coriell; ND01708
DR   Wikidata; Q54909802
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01712
AC   CVCL_HS60
DR   Coriell; ND01712
DR   Wikidata; Q54909803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01734
AC   CVCL_DU37
DR   Coriell; ND01734
DR   Wikidata; Q54909804
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01735
AC   CVCL_CA97
DR   CLO; CLO_0016364
DR   BioSample; SAMN00803958
DR   Coriell; ND01735
DR   Wikidata; Q54909805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01736
AC   CVCL_GA88
DR   CLO; CLO_0016363
DR   BioSample; SAMN00803960
DR   Coriell; ND01736
DR   Wikidata; Q54909806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01737
AC   CVCL_CA98
SY   ND 01737
DR   CLO; CLO_0016362
DR   Coriell; ND01737
DR   GEO; GSM505312
DR   Wikidata; Q54909807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND01738
AC   CVCL_CA99
DR   CLO; CLO_0016361
DR   Coriell; ND01738
DR   Wikidata; Q54909808
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01739
AC   CVCL_GA89
DR   CLO; CLO_0016368
DR   BioSample; SAMN00803962
DR   Coriell; ND01739
DR   Wikidata; Q54909809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01740
AC   CVCL_GA90
DR   CLO; CLO_0016367
DR   Coriell; ND01740
DR   Wikidata; Q54909810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01741
AC   CVCL_HZ12
DR   Coriell; ND01741
DR   Wikidata; Q54909811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01742
AC   CVCL_HS61
DR   Coriell; ND01742
DR   Wikidata; Q54909812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01743
AC   CVCL_HZ13
DR   Coriell; ND01743
DR   Wikidata; Q54909813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01744
AC   CVCL_FW35
DR   Coriell; ND01744
DR   Wikidata; Q54909814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01745
AC   CVCL_HZ14
DR   Coriell; ND01745
DR   Wikidata; Q54909815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01746
AC   CVCL_HZ15
DR   Coriell; ND01746
DR   Wikidata; Q54909816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01747
AC   CVCL_HZ16
DR   Coriell; ND01747
DR   Wikidata; Q54909817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01748
AC   CVCL_DU38
DR   Coriell; ND01748
DR   Wikidata; Q54909818
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01749
AC   CVCL_CB00
DR   CLO; CLO_0016366
DR   Coriell; ND01749
DR   Wikidata; Q54909819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01750
AC   CVCL_CB01
DR   CLO; CLO_0016365
DR   BioSample; SAMN00803978
DR   Coriell; ND01750
DR   Wikidata; Q54909820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01751
AC   CVCL_1W19
SY   ND-1751
DR   CLO; CLO_0016356
DR   BioSample; SAMN00803980
DR   Coriell; ND01751
DR   Wikidata; Q54909821
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND01752
AC   CVCL_CB02
DR   CLO; CLO_0017036
DR   Coriell; ND01752
DR   Wikidata; Q54909822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01753
AC   CVCL_CB03
DR   CLO; CLO_0017037
DR   BioSample; SAMN00805725
DR   Coriell; ND01753
DR   Wikidata; Q54909823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01754
AC   CVCL_1W20
SY   ND-1754
DR   CLO; CLO_0017038
DR   BioSample; SAMN00805727
DR   Coriell; ND01754
DR   Wikidata; Q54909824
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND01755
AC   CVCL_CB04
DR   CLO; CLO_0017039
DR   Coriell; ND01755
DR   Wikidata; Q54909825
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01756
AC   CVCL_GA91
DR   CLO; CLO_0017040
DR   Coriell; ND01756
DR   Wikidata; Q54909826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01757
AC   CVCL_1W21
SY   ND-1757
DR   CLO; CLO_0017041
DR   Coriell; ND01757
DR   Wikidata; Q54909827
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01758
AC   CVCL_CB05
DR   CLO; CLO_0017042
DR   Coriell; ND01758
DR   Wikidata; Q54909828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01759
AC   CVCL_CB06
DR   CLO; CLO_0017001
DR   BioSample; SAMN00805729
DR   Coriell; ND01759
DR   Wikidata; Q54909829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01760
AC   CVCL_ER96
DR   CLO; CLO_0016999
DR   BioSample; SAMN00805731
DR   Coriell; ND01760
DR   Wikidata; Q54909830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01761
AC   CVCL_CB07
DR   CLO; CLO_0016998
DR   Coriell; ND01761
DR   Wikidata; Q54909831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01762
AC   CVCL_DU39
DR   Coriell; ND01762
DR   Wikidata; Q54909832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01763
AC   CVCL_HS62
DR   Coriell; ND01763
DR   Wikidata; Q54909833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01764
AC   CVCL_HS63
DR   Coriell; ND01764
DR   Wikidata; Q54909834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01765
AC   CVCL_HZ17
DR   Coriell; ND01765
DR   Wikidata; Q54909835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01767
AC   CVCL_CB08
DR   CLO; CLO_0017009
DR   Coriell; ND01767
DR   Wikidata; Q54909836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01768
AC   CVCL_DU40
DR   Coriell; ND01768
DR   Wikidata; Q54909837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01769
AC   CVCL_HS64
DR   Coriell; ND01769
DR   Wikidata; Q54909840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01771
AC   CVCL_HS65
DR   Coriell; ND01771
DR   Wikidata; Q54909841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01772
AC   CVCL_DU41
DR   Coriell; ND01772
DR   Wikidata; Q54909842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01773
AC   CVCL_HS66
DR   Coriell; ND01773
DR   Wikidata; Q54909843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01774
AC   CVCL_HZ18
DR   Coriell; ND01774
DR   Wikidata; Q54909844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01775
AC   CVCL_HZ19
DR   Coriell; ND01775
DR   Wikidata; Q54909845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01776
AC   CVCL_HZ20
DR   Coriell; ND01776
DR   Wikidata; Q54909846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01777
AC   CVCL_CB09
DR   CLO; CLO_0017011
DR   Coriell; ND01777
DR   Wikidata; Q54909847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01778
AC   CVCL_CB10
DR   CLO; CLO_0017007
DR   Coriell; ND01778
DR   Wikidata; Q54909848
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01779
AC   CVCL_CB11
DR   CLO; CLO_0017008
DR   Coriell; ND01779
DR   Wikidata; Q54909849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01780
AC   CVCL_CB12
DR   CLO; CLO_0017015
DR   Coriell; ND01780
DR   Wikidata; Q54909850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01781
AC   CVCL_CB13
DR   CLO; CLO_0017016
DR   Coriell; ND01781
DR   Wikidata; Q54909851
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01782
AC   CVCL_ER97
DR   CLO; CLO_0017013
DR   Coriell; ND01782
DR   Wikidata; Q54909852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01783
AC   CVCL_CB14
DR   CLO; CLO_0017014
DR   Coriell; ND01783
DR   Wikidata; Q54909853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01784
AC   CVCL_CB15
DR   CLO; CLO_0017346
DR   Coriell; ND01784
DR   Wikidata; Q54909854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01785
AC   CVCL_CB16
DR   CLO; CLO_0017348
DR   Coriell; ND01785
DR   Wikidata; Q54909855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01786
AC   CVCL_CB17
DR   CLO; CLO_0017318
DR   BioSample; SAMN00805744
DR   Coriell; ND01786
DR   Wikidata; Q54909857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01787
AC   CVCL_HZ21
DR   CLO; CLO_0017333
DR   Coriell; ND01787
DR   Wikidata; Q54909858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01788
AC   CVCL_CB18
DR   CLO; CLO_0017331
DR   BioSample; SAMN00805747
DR   Coriell; ND01788
DR   Wikidata; Q54909859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01789
AC   CVCL_ER98
DR   CLO; CLO_0017329
DR   BioSample; SAMN00805748
DR   Coriell; ND01789
DR   Wikidata; Q54909860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01790
AC   CVCL_CB19
DR   CLO; CLO_0017328
DR   BioSample; SAMN00805750
DR   Coriell; ND01790
DR   Wikidata; Q54909861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01791
AC   CVCL_HZ22
DR   CLO; CLO_0017326
DR   Coriell; ND01791
DR   Wikidata; Q54909862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01792
AC   CVCL_DU42
DR   Coriell; ND01792
DR   Wikidata; Q54909863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01793
AC   CVCL_DU43
DR   Coriell; ND01793
DR   Wikidata; Q54909864
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01794
AC   CVCL_HZ23
DR   Coriell; ND01794
DR   Wikidata; Q54909865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01795
AC   CVCL_HS67
DR   Coriell; ND01795
DR   Wikidata; Q54909866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01798
AC   CVCL_HZ24
DR   Coriell; ND01798
DR   Wikidata; Q54909867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01799
AC   CVCL_CB20
DR   CLO; CLO_0017323
DR   BioSample; SAMN00805757
DR   Coriell; ND01799
DR   Wikidata; Q54909868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01800
AC   CVCL_HZ25
DR   Coriell; ND01800
DR   Wikidata; Q54909869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01801
AC   CVCL_1W22
SY   ND-1801
DR   CLO; CLO_0017321
DR   BioSample; SAMN00805761
DR   Coriell; ND01801
DR   Wikidata; Q54909870
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01802
AC   CVCL_HZ26
DR   CLO; CLO_0017319
DR   Coriell; ND01802
DR   Wikidata; Q54909871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01804
AC   CVCL_DU44
DR   Coriell; ND01804
DR   Wikidata; Q54909872
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01805
AC   CVCL_HY11
DR   CLO; CLO_0017311
DR   Coriell; ND01805
DR   Wikidata; Q54909873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01806
AC   CVCL_HY12
DR   CLO; CLO_0017288
DR   Coriell; ND01806
DR   Wikidata; Q54909874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01807
AC   CVCL_HY13
DR   CLO; CLO_0017287
DR   Coriell; ND01807
DR   Wikidata; Q54909875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01808
AC   CVCL_DU45
DR   Coriell; ND01808
DR   Wikidata; Q54909876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01809
AC   CVCL_HS68
DR   Coriell; ND01809
DR   Wikidata; Q54909877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01810
AC   CVCL_HZ27
DR   Coriell; ND01810
DR   Wikidata; Q54909878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01811
AC   CVCL_FH07
DR   CLO; CLO_0017299
DR   Coriell; ND01811
DR   Wikidata; Q54909879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01812
AC   CVCL_HZ28
DR   CLO; CLO_0017297
DR   Coriell; ND01812
DR   Wikidata; Q54909880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01813
AC   CVCL_HS69
DR   Coriell; ND01813
DR   Wikidata; Q54909884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01814
AC   CVCL_HZ29
DR   Coriell; ND01814
DR   Wikidata; Q54909885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01815
AC   CVCL_HS70
DR   Coriell; ND01815
DR   Wikidata; Q54909886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01816
AC   CVCL_FW36
DR   Coriell; ND01816
DR   Wikidata; Q54909887
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01819
AC   CVCL_FW37
DR   Coriell; ND01819
DR   Wikidata; Q54909888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01820
AC   CVCL_HS71
DR   Coriell; ND01820
DR   Wikidata; Q54909889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01821
AC   CVCL_HS72
DR   Coriell; ND01821
DR   Wikidata; Q54909890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01840
AC   CVCL_1W23
SY   ND-1840
DR   CLO; CLO_0017303
DR   BioSample; SAMN00805793
DR   Coriell; ND01840
DR   Wikidata; Q54909891
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01841
AC   CVCL_FH08
DR   CLO; CLO_0017302
DR   Coriell; ND01841
DR   Wikidata; Q54909892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01842
AC   CVCL_GQ16
DR   CLO; CLO_0017291
DR   Coriell; ND01842
DR   Wikidata; Q54909893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01843
AC   CVCL_ER99
DR   CLO; CLO_0017290
DR   Coriell; ND01843
DR   Wikidata; Q54909894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01846
AC   CVCL_HZ30
DR   Coriell; ND01846
DR   Wikidata; Q54909895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01848
AC   CVCL_HZ31
DR   Coriell; ND01848
DR   Wikidata; Q54909896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01849
AC   CVCL_HS73
DR   Coriell; ND01849
DR   Wikidata; Q54909897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01850
AC   CVCL_HS74
DR   Coriell; ND01850
DR   Wikidata; Q54909898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01853
AC   CVCL_FH09
DR   CLO; CLO_0017296
DR   Coriell; ND01853
DR   Wikidata; Q54909899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01854
AC   CVCL_HZ32
DR   CLO; CLO_0017293
DR   Coriell; ND01854
DR   Wikidata; Q54909900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01855
AC   CVCL_DU46
DR   Coriell; ND01855
DR   Wikidata; Q54909901
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01856
AC   CVCL_DU47
DR   Coriell; ND01856
DR   Wikidata; Q54909902
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01857
AC   CVCL_FH10
DR   CLO; CLO_0017259
DR   Coriell; ND01857
DR   Wikidata; Q54909903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01858
AC   CVCL_HY14
DR   CLO; CLO_0017258
DR   Coriell; ND01858
DR   Wikidata; Q54909904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01859
AC   CVCL_HY15
DR   CLO; CLO_0017257
DR   Coriell; ND01859
DR   Wikidata; Q54909905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01865
AC   CVCL_FH11
DR   CLO; CLO_0017267
DR   Coriell; ND01865
DR   Wikidata; Q54909906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01866
AC   CVCL_FH12
DR   CLO; CLO_0017264
DR   Coriell; ND01866
DR   Wikidata; Q54909907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01867
AC   CVCL_FH13
DR   CLO; CLO_0017262
DR   Coriell; ND01867
DR   Wikidata; Q54909909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01868
AC   CVCL_FH14
DR   CLO; CLO_0017260
DR   Coriell; ND01868
DR   Wikidata; Q54909910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01872
AC   CVCL_HY16
DR   CLO; CLO_0017273
DR   Coriell; ND01872
DR   Wikidata; Q54909911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01873
AC   CVCL_HY17
DR   CLO; CLO_0017272
DR   Coriell; ND01873
DR   Wikidata; Q54909912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01874
AC   CVCL_DU48
DR   Coriell; ND01874
DR   Wikidata; Q54909913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01875
AC   CVCL_HZ33
DR   Coriell; ND01875
DR   Wikidata; Q54909914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01877
AC   CVCL_CB21
DR   CLO; CLO_0017270
DR   Coriell; ND01877
DR   Wikidata; Q54909915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01878
AC   CVCL_CB22
DR   CLO; CLO_0017228
DR   BioSample; SAMN00805827
DR   Coriell; ND01878
DR   Wikidata; Q54909916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01879
AC   CVCL_HZ34
DR   CLO; CLO_0017227
DR   Coriell; ND01879
DR   Wikidata; Q54909917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01880
AC   CVCL_1W24
SY   ND-1880
DR   CLO; CLO_0017230
DR   BioSample; SAMN00805831
DR   Coriell; ND01880
DR   Wikidata; Q54909918
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01881
AC   CVCL_CB23
DR   CLO; CLO_0017229
DR   BioSample; SAMN00805833
DR   Coriell; ND01881
DR   Wikidata; Q54909919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01882
AC   CVCL_HZ35
DR   CLO; CLO_0017233
DR   BioSample; SAMN00805835
DR   Coriell; ND01882
DR   Wikidata; Q54909920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND01883
AC   CVCL_CB24
DR   CLO; CLO_0017231
DR   BioSample; SAMN00805837
DR   Coriell; ND01883
DR   Wikidata; Q54909921
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND01884
AC   CVCL_GA92
DR   CLO; CLO_0017238
DR   BioSample; SAMN00805839
DR   Coriell; ND01884
DR   Wikidata; Q54909922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01885
AC   CVCL_1W25
SY   ND-1885
DR   CLO; CLO_0017236
DR   BioSample; SAMN00805841
DR   Coriell; ND01885
DR   Wikidata; Q54909923
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01886
AC   CVCL_CB25
DR   CLO; CLO_0017242
DR   BioSample; SAMN00805843
DR   Coriell; ND01886
DR   Wikidata; Q54909924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01887
AC   CVCL_1W26
SY   ND-1887
DR   CLO; CLO_0017239
DR   BioSample; SAMN00805845
DR   Coriell; ND01887
DR   Wikidata; Q54909928
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01888
AC   CVCL_HZ36
DR   CLO; CLO_0017223
DR   Coriell; ND01888
DR   Wikidata; Q54909929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01890
AC   CVCL_FW38
DR   Coriell; ND01890
DR   Wikidata; Q54909930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01892
AC   CVCL_HZ37
DR   Coriell; ND01892
DR   Wikidata; Q54909931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01893
AC   CVCL_DU49
DR   Coriell; ND01893
DR   Wikidata; Q54909932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01914
AC   CVCL_FW39
DR   Coriell; ND01914
DR   Wikidata; Q54909933
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01915
AC   CVCL_DU50
DR   Coriell; ND01915
DR   Wikidata; Q54909934
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01916
AC   CVCL_DU51
DR   Coriell; ND01916
DR   Wikidata; Q54909935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01917
AC   CVCL_DU52
DR   Coriell; ND01917
DR   Wikidata; Q54909936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01918
AC   CVCL_DU53
DR   Coriell; ND01918
DR   Wikidata; Q54909937
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01919
AC   CVCL_HZ38
DR   Coriell; ND01919
DR   Wikidata; Q54909938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01920
AC   CVCL_HS75
DR   Coriell; ND01920
DR   Wikidata; Q54909939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01921
AC   CVCL_HS76
DR   Coriell; ND01921
DR   Wikidata; Q54909940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01922
AC   CVCL_HZ39
DR   Coriell; ND01922
DR   Wikidata; Q54909941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01923
AC   CVCL_DU54
DR   Coriell; ND01923
DR   Wikidata; Q54909942
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01924
AC   CVCL_FH15
DR   CLO; CLO_0017221
DR   Coriell; ND01924
DR   Wikidata; Q54909943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01925
AC   CVCL_HY18
DR   CLO; CLO_0017222
DR   Coriell; ND01925
DR   Wikidata; Q54909944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01926
AC   CVCL_HY19
DR   CLO; CLO_0017219
DR   Coriell; ND01926
DR   Wikidata; Q54909945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01927
AC   CVCL_CB26
DR   CLO; CLO_0017220
DR   Coriell; ND01927
DR   Wikidata; Q54909946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01928
AC   CVCL_BX34
DR   CLO; CLO_0017215
DR   BioSample; SAMN00805869
DR   Coriell; ND01928
DR   Wikidata; Q54909947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01929
AC   CVCL_1W27
SY   ND-1929
DR   CLO; CLO_0017217
DR   BioSample; SAMN00805871
DR   Coriell; ND01929
DR   Wikidata; Q54909949
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01930
AC   CVCL_BX35
DR   CLO; CLO_0017212
DR   Coriell; ND01930
DR   Wikidata; Q54909950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01931
AC   CVCL_CB27
DR   CLO; CLO_0017213
DR   BioSample; SAMN00805873
DR   Coriell; ND01931
DR   Wikidata; Q54909951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01932
AC   CVCL_GQ17
DR   CLO; CLO_0017208
DR   Coriell; ND01932
DR   Wikidata; Q54909953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01933
AC   CVCL_CB28
DR   CLO; CLO_0017203
DR   Coriell; ND01933
DR   Wikidata; Q54909954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND01934
AC   CVCL_1W28
SY   ND-1934
DR   CLO; CLO_0017204
DR   Coriell; ND01934
DR   Wikidata; Q54909955
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01935
AC   CVCL_CB29
DR   CLO; CLO_0017199
DR   BioSample; SAMN00805877
DR   Coriell; ND01935
DR   Wikidata; Q54909956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01936
AC   CVCL_1W29
SY   ND-1936
DR   CLO; CLO_0017200
DR   BioSample; SAMN00805879
DR   Coriell; ND01936
DR   Wikidata; Q54909957
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01937
AC   CVCL_CB30
DR   CLO; CLO_0017201
DR   BioSample; SAMN00805881
DR   Coriell; ND01937
DR   Wikidata; Q54909958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01938
AC   CVCL_1W30
SY   ND-1938
DR   CLO; CLO_0017202
DR   Coriell; ND01938
DR   Wikidata; Q54909959
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND01939
AC   CVCL_CB31
DR   CLO; CLO_0017191
DR   BioSample; SAMN00805885
DR   Coriell; ND01939
DR   Wikidata; Q54909960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01940
AC   CVCL_1W31
SY   ND-1940
DR   CLO; CLO_0017194
DR   BioSample; SAMN00805887
DR   Coriell; ND01940
DR   Wikidata; Q54909961
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01941
AC   CVCL_CB32
DR   CLO; CLO_0017195
DR   BioSample; SAMN00805889
DR   Coriell; ND01941
DR   Wikidata; Q54909962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01942
AC   CVCL_1W32
SY   ND-1942
DR   CLO; CLO_0017197
DR   BioSample; SAMN00805891
DR   Coriell; ND01942
DR   Wikidata; Q54909964
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01943
AC   CVCL_CB33
DR   CLO; CLO_0017167
DR   BioSample; SAMN00805893
DR   Coriell; ND01943
DR   Wikidata; Q54909965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01944
AC   CVCL_1W33
SY   ND-1944
DR   CLO; CLO_0017164
DR   BioSample; SAMN00805895
DR   Coriell; ND01944
DR   Wikidata; Q54909966
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01945
AC   CVCL_DU55
DR   Coriell; ND01945
DR   Wikidata; Q54909967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01946
AC   CVCL_DU56
DR   Coriell; ND01946
DR   Wikidata; Q54909968
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND01949
AC   CVCL_HS77
DR   Coriell; ND01949
DR   Wikidata; Q54909969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01950
AC   CVCL_HS78
DR   Coriell; ND01950
DR   Wikidata; Q54909970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01969
AC   CVCL_HZ40
DR   Coriell; ND01969
DR   Wikidata; Q54909976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01970
AC   CVCL_FW40
DR   Coriell; ND01970
DR   Wikidata; Q54909977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01971
AC   CVCL_FW41
DR   Coriell; ND01971
DR   Wikidata; Q54909978
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01972
AC   CVCL_FW42
DR   Coriell; ND01972
DR   Wikidata; Q54909979
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01973
AC   CVCL_FW43
DR   Coriell; ND01973
DR   Wikidata; Q54909980
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01974
AC   CVCL_FH16
DR   CLO; CLO_0017165
DR   Coriell; ND01974
DR   Wikidata; Q54909981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND01975
AC   CVCL_HY20
DR   CLO; CLO_0017170
DR   Coriell; ND01975
DR   Wikidata; Q54909982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01976
AC   CVCL_HY21
DR   CLO; CLO_0017171
DR   Coriell; ND01976
DR   Wikidata; Q54909983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01977
AC   CVCL_HY22
DR   CLO; CLO_0017168
DR   Coriell; ND01977
DR   Wikidata; Q54909984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01978
AC   CVCL_HY23
DR   CLO; CLO_0017169
DR   Coriell; ND01978
DR   Wikidata; Q54909985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01979
AC   CVCL_CB34
DR   CLO; CLO_0017153
DR   BioSample; SAMN00805917
DR   Coriell; ND01979
DR   Wikidata; Q54909986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01980
AC   CVCL_GA93
DR   CLO; CLO_0017155
DR   BioSample; SAMN00805919
DR   Coriell; ND01980
DR   Wikidata; Q54909987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND01981
AC   CVCL_CB35
DR   CLO; CLO_0017148
DR   BioSample; SAMN00805921
DR   Coriell; ND01981
DR   Wikidata; Q54909988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01982
AC   CVCL_CB36
DR   CLO; CLO_0017126
DR   BioSample; SAMN00805923
DR   Coriell; ND01982
DR   Wikidata; Q54909989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01983
AC   CVCL_1W34
SY   ND-1983
DR   CLO; CLO_0017127
DR   BioSample; SAMN00805925
DR   Coriell; ND01983
DR   Wikidata; Q54909990
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND01984
AC   CVCL_DU57
DR   Coriell; ND01984
DR   Wikidata; Q54909991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01985
AC   CVCL_CB37
DR   CLO; CLO_0017128
DR   BioSample; SAMN00805927
DR   Coriell; ND01985
DR   Wikidata; Q54909992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND01986
AC   CVCL_HZ41
DR   Coriell; ND01986
DR   Wikidata; Q54909993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01987
AC   CVCL_DU58
DR   Coriell; ND01987
DR   Wikidata; Q54909994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01988
AC   CVCL_DU59
DR   Coriell; ND01988
DR   Wikidata; Q54909995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND01989
AC   CVCL_HZ42
DR   Coriell; ND01989
DR   Wikidata; Q54909996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01990
AC   CVCL_HS79
DR   Coriell; ND01990
DR   Wikidata; Q54909997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01991
AC   CVCL_HS80
DR   Coriell; ND01991
DR   Wikidata; Q54909998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01992
AC   CVCL_HZ43
DR   Coriell; ND01992
DR   Wikidata; Q54909999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01994
AC   CVCL_HZ44
DR   Coriell; ND01994
DR   Wikidata; Q54910000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01996
AC   CVCL_HS81
DR   Coriell; ND01996
DR   Wikidata; Q54910001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01997
AC   CVCL_HZ45
DR   Coriell; ND01997
DR   Wikidata; Q54910002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01998
AC   CVCL_HS82
DR   Coriell; ND01998
DR   Wikidata; Q54910003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND01999
AC   CVCL_HZ46
DR   Coriell; ND01999
DR   Wikidata; Q54910004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02000
AC   CVCL_HZ47
DR   Coriell; ND02000
DR   Wikidata; Q54910005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02001
AC   CVCL_HZ48
DR   Coriell; ND02001
DR   Wikidata; Q54910006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02002
AC   CVCL_HZ49
DR   Coriell; ND02002
DR   Wikidata; Q54910007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02003
AC   CVCL_FH17
DR   CLO; CLO_0017129
DR   Coriell; ND02003
DR   Wikidata; Q54910008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02004
AC   CVCL_FH18
DR   CLO; CLO_0017130
DR   Coriell; ND02004
DR   Wikidata; Q54910009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02005
AC   CVCL_HZ50
DR   CLO; CLO_0017131
DR   Coriell; ND02005
DR   Wikidata; Q54910010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02006
AC   CVCL_FH19
DR   CLO; CLO_0017132
DR   Coriell; ND02006
DR   Wikidata; Q54910011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02007
AC   CVCL_HY24
DR   CLO; CLO_0017133
DR   Coriell; ND02007
DR   Wikidata; Q54910012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02008
AC   CVCL_HY25
DR   CLO; CLO_0017118
DR   Coriell; ND02008
DR   Wikidata; Q54910013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02009
AC   CVCL_FH20
DR   CLO; CLO_0017119
DR   Coriell; ND02009
DR   Wikidata; Q54910014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02010
AC   CVCL_FH21
DR   CLO; CLO_0015474
DR   Coriell; ND02010
DR   Wikidata; Q54910015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02011
AC   CVCL_GT05
DR   CLO; CLO_0015475
DR   Coriell; ND02011
DR   Wikidata; Q54910018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02013
AC   CVCL_DU60
DR   CLO; CLO_0015470
DR   Coriell; ND02013
DR   Wikidata; Q54910019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02014
AC   CVCL_DU61
DR   CLO; CLO_0015471
DR   Coriell; ND02014
DR   Wikidata; Q54910020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02016
AC   CVCL_DU62
DR   Coriell; ND02016
DR   Wikidata; Q54910021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02017
AC   CVCL_HZ51
DR   Coriell; ND02017
DR   Wikidata; Q54910022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02019
AC   CVCL_CB38
DR   Coriell; ND02019
DR   Wikidata; Q54910023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02020
AC   CVCL_CB39
DR   Coriell; ND02020
DR   Wikidata; Q54910024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02021
AC   CVCL_DU63
DR   Coriell; ND02021
DR   Wikidata; Q54910025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02022
AC   CVCL_HZ52
DR   Coriell; ND02022
DR   Wikidata; Q54910026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02023
AC   CVCL_HS83
DR   Coriell; ND02023
DR   Wikidata; Q54910027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02034
AC   CVCL_FH22
DR   Coriell; ND02034
DR   Wikidata; Q54910028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02035
AC   CVCL_HZ53
DR   Coriell; ND02035
DR   Wikidata; Q54910029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02036
AC   CVCL_HZ54
DR   Coriell; ND02036
DR   Wikidata; Q54910030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02037
AC   CVCL_FH23
DR   CLO; CLO_0015472
DR   Coriell; ND02037
DR   Wikidata; Q54910031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02038
AC   CVCL_GT06
DR   CLO; CLO_0015473
DR   Coriell; ND02038
DR   Wikidata; Q54910033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02039
AC   CVCL_GT07
DR   CLO; CLO_0015468
DR   Coriell; ND02039
DR   Wikidata; Q54910034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02040
AC   CVCL_HZ55
DR   Coriell; ND02040
DR   Wikidata; Q54910035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02041
AC   CVCL_HS84
DR   Coriell; ND02041
DR   Wikidata; Q54910036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02042
AC   CVCL_HS85
DR   Coriell; ND02042
DR   Wikidata; Q54910037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02043
AC   CVCL_DU64
DR   Coriell; ND02043
DR   Wikidata; Q54910038
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02045
AC   CVCL_HS86
DR   Coriell; ND02045
DR   Wikidata; Q54910039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02046
AC   CVCL_HS87
DR   Coriell; ND02046
DR   Wikidata; Q54910040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02049
AC   CVCL_HZ56
DR   Coriell; ND02049
DR   Wikidata; Q54910041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02050
AC   CVCL_HZ57
DR   Coriell; ND02050
DR   Wikidata; Q54910042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02051
AC   CVCL_DU65
DR   CLO; CLO_0015466
DR   Coriell; ND02051
DR   Wikidata; Q54910043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02052
AC   CVCL_DU66
DR   CLO; CLO_0015464
DR   Coriell; ND02052
DR   Wikidata; Q54910044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02053
AC   CVCL_HZ58
DR   Coriell; ND02053
DR   Wikidata; Q54910045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02055
AC   CVCL_FW44
DR   Coriell; ND02055
DR   Wikidata; Q54910046
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02059
AC   CVCL_GA94
DR   CLO; CLO_0015461
DR   Coriell; ND02059
DR   Wikidata; Q54910047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02060
AC   CVCL_IG77
DR   CLO; CLO_0015455
DR   Coriell; ND02060
DR   Wikidata; Q54910048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND02060; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND02062
AC   CVCL_GA95
DR   CLO; CLO_0015453
DR   Coriell; ND02062
DR   Wikidata; Q54910049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02063
AC   CVCL_FE90
DR   CLO; CLO_0015454
DR   Coriell; ND02063
DR   Wikidata; Q54910050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02064
AC   CVCL_DU67
DR   CLO; CLO_0015451
DR   Coriell; ND02064
DR   Wikidata; Q54910051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02065
AC   CVCL_FC09
DR   CLO; CLO_0015452
DR   Coriell; ND02065
DR   Wikidata; Q54910052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02066
AC   CVCL_DU68
DR   CLO; CLO_0015449
DR   Coriell; ND02066
DR   Wikidata; Q54910053
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02067
AC   CVCL_FC10
DR   CLO; CLO_0015450
DR   Coriell; ND02067
DR   Wikidata; Q54910054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02069
AC   CVCL_FW45
DR   Coriell; ND02069
DR   Wikidata; Q54910055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02070
AC   CVCL_HZ59
DR   Coriell; ND02070
DR   Wikidata; Q54910056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02071
AC   CVCL_HZ60
DR   Coriell; ND02071
DR   Wikidata; Q54910057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02074
AC   CVCL_FC11
DR   CLO; CLO_0015520
DR   Coriell; ND02074
DR   Wikidata; Q54910058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02075
AC   CVCL_GT08
DR   CLO; CLO_0015518
DR   Coriell; ND02075
DR   Wikidata; Q54910062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02076
AC   CVCL_HZ61
DR   Coriell; ND02076
DR   Wikidata; Q54910063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02077
AC   CVCL_CB40
DR   CLO; CLO_0015523
DR   Coriell; ND02077
DR   Wikidata; Q54910064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02078
AC   CVCL_HZ62
DR   Coriell; ND02078
DR   Wikidata; Q54910065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02079
AC   CVCL_DU69
DR   Coriell; ND02079
DR   Wikidata; Q54910066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02081
AC   CVCL_DU70
DR   Coriell; ND02081
DR   Wikidata; Q54910067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02082
AC   CVCL_FH24
DR   CLO; CLO_0015507
DR   Coriell; ND02082
DR   Wikidata; Q54910068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02083
AC   CVCL_GT09
DR   CLO; CLO_0015509
DR   Coriell; ND02083
DR   Wikidata; Q54910069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02085
AC   CVCL_HZ63
DR   Coriell; ND02085
DR   Wikidata; Q54910070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02086
AC   CVCL_FW46
DR   Coriell; ND02086
DR   Wikidata; Q54910071
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02087
AC   CVCL_FW47
DR   Coriell; ND02087
DR   Wikidata; Q54910072
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02088
AC   CVCL_HS88
DR   Coriell; ND02088
DR   Wikidata; Q54910073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02110
AC   CVCL_FH25
DR   CLO; CLO_0015511
DR   Coriell; ND02110
DR   Wikidata; Q54910074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02111
AC   CVCL_HY26
DR   CLO; CLO_0015512
DR   Coriell; ND02111
DR   Wikidata; Q54910075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02112
AC   CVCL_HY27
DR   CLO; CLO_0015513
DR   Coriell; ND02112
DR   Wikidata; Q54910076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02113
AC   CVCL_HZ64
DR   Coriell; ND02113
DR   Wikidata; Q54910077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02114
AC   CVCL_FC12
DR   CLO; CLO_0015514
DR   Coriell; ND02114
DR   Wikidata; Q54910078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02116
AC   CVCL_HZ65
DR   Coriell; ND02116
DR   Wikidata; Q54910079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02117
AC   CVCL_HS89
DR   Coriell; ND02117
DR   Wikidata; Q54910080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02120
AC   CVCL_CB41
DR   CLO; CLO_0015515
DR   Coriell; ND02120
DR   Wikidata; Q54910081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02121
AC   CVCL_CB42
DR   CLO; CLO_0015516
DR   Coriell; ND02121
DR   Wikidata; Q54910082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02122
AC   CVCL_DU71
DR   Coriell; ND02122
DR   Wikidata; Q54910083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02126
AC   CVCL_DU72
DR   CLO; CLO_0015502
DR   Coriell; ND02126
DR   Wikidata; Q54910084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02127
AC   CVCL_DU73
DR   CLO; CLO_0015500
DR   Coriell; ND02127
DR   Wikidata; Q54910085
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02128
AC   CVCL_GA96
DR   CLO; CLO_0015486
DR   Coriell; ND02128
DR   Wikidata; Q54910086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02129
AC   CVCL_HZ66
DR   Coriell; ND02129
DR   Wikidata; Q54910087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02131
AC   CVCL_FW48
DR   Coriell; ND02131
DR   Wikidata; Q54910088
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02134
AC   CVCL_GA97
DR   CLO; CLO_0015490
DR   Coriell; ND02134
DR   Wikidata; Q54910089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02135
AC   CVCL_FE91
DR   CLO; CLO_0015493
DR   Coriell; ND02135
DR   Wikidata; Q54910090
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02136
AC   CVCL_GA98
DR   CLO; CLO_0015487
DR   Coriell; ND02136
DR   Wikidata; Q54910091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02137
AC   CVCL_GA99
DR   CLO; CLO_0015489
DR   Coriell; ND02137
DR   Wikidata; Q54910092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02138
AC   CVCL_DU74
DR   CLO; CLO_0015496
DR   Coriell; ND02138
DR   Wikidata; Q54910093
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02140
AC   CVCL_CB43
DR   CLO; CLO_0015497
DR   BioSample; SAMN00806029
DR   Coriell; ND02140
DR   Wikidata; Q54910094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02141
AC   CVCL_FC13
DR   CLO; CLO_0015494
DR   BioSample; SAMN00806031
DR   Coriell; ND02141
DR   Wikidata; Q54910095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02142
AC   CVCL_CB44
DR   CLO; CLO_0015495
DR   BioSample; SAMN00806033
DR   Coriell; ND02142
DR   Wikidata; Q54910096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02143
AC   CVCL_FC14
DR   CLO; CLO_0015584
DR   BioSample; SAMN00806035
DR   Coriell; ND02143
DR   Wikidata; Q54910097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02144
AC   CVCL_CB45
DR   CLO; CLO_0015607
DR   Coriell; ND02144
DR   Wikidata; Q54910098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02145
AC   CVCL_CB46
DR   CLO; CLO_0015606
DR   BioSample; SAMN00806037
DR   Coriell; ND02145
DR   Wikidata; Q54910099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02146
AC   CVCL_CB47
DR   CLO; CLO_0015605
DR   Coriell; ND02146
DR   Wikidata; Q54910100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02147
AC   CVCL_DU75
DR   Coriell; ND02147
DR   Wikidata; Q54910101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02148
AC   CVCL_DU76
DR   CLO; CLO_0015603
DR   Coriell; ND02148
DR   Wikidata; Q54910104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02149
AC   CVCL_HZ67
DR   Coriell; ND02149
DR   Wikidata; Q54910105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02150
AC   CVCL_DU77
DR   Coriell; ND02150
DR   Wikidata; Q54910106
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02151
AC   CVCL_DU78
DR   Coriell; ND02151
DR   Wikidata; Q54910107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02152
AC   CVCL_HZ68
DR   Coriell; ND02152
DR   Wikidata; Q54910108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02153
AC   CVCL_DU79
DR   Coriell; ND02153
DR   Wikidata; Q54910109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02154
AC   CVCL_DU80
DR   Coriell; ND02154
DR   Wikidata; Q54910110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02155
AC   CVCL_ES00
DR   CLO; CLO_0015600
DR   Coriell; ND02155
DR   Wikidata; Q54910111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02156
AC   CVCL_HS90
DR   Coriell; ND02156
DR   Wikidata; Q54910112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02158
AC   CVCL_HZ69
DR   Coriell; ND02158
DR   Wikidata; Q54910113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02159
AC   CVCL_HS91
DR   Coriell; ND02159
DR   Wikidata; Q54910114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02160
AC   CVCL_FB46
DR   CLO; CLO_0015597
DR   Coriell; ND02160
DR   Wikidata; Q54910115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02161
AC   CVCL_DU81
DR   CLO; CLO_0015593
DR   Coriell; ND02161
DR   Wikidata; Q54910116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02162
AC   CVCL_DU82
DR   Coriell; ND02162
DR   Wikidata; Q54910117
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02163
AC   CVCL_FH26
DR   CLO; CLO_0015592
DR   Coriell; ND02163
DR   Wikidata; Q54910118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02164
AC   CVCL_HZ70
DR   CLO; CLO_0015589
DR   Coriell; ND02164
DR   Wikidata; Q54910119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02165
AC   CVCL_FW49
DR   Coriell; ND02165
DR   Wikidata; Q54910120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02168
AC   CVCL_FW50
DR   Coriell; ND02168
DR   Wikidata; Q54910121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02169
AC   CVCL_IL34
DR   Coriell; ND02169
DR   Wikidata; Q54910122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02170
AC   CVCL_HZ71
DR   Coriell; ND02170
DR   Wikidata; Q54910123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02171
AC   CVCL_DU83
DR   CLO; CLO_0015587
DR   Coriell; ND02171
DR   Wikidata; Q54910124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02172
AC   CVCL_GB00
DR   CLO; CLO_0015563
DR   Coriell; ND02172
DR   Wikidata; Q54910125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02173
AC   CVCL_DU84
DR   CLO; CLO_0015565
DR   Coriell; ND02173
DR   Wikidata; Q54910126
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02174
AC   CVCL_HS92
DR   Coriell; ND02174
DR   Wikidata; Q54910127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02175
AC   CVCL_HS93
DR   Coriell; ND02175
DR   Wikidata; Q54910128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02176
AC   CVCL_HZ72
DR   Coriell; ND02176
DR   Wikidata; Q54910129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02178
AC   CVCL_HZ73
DR   Coriell; ND02178
DR   Wikidata; Q54910130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02180
AC   CVCL_FH27
DR   CLO; CLO_0015564
DR   Coriell; ND02180
DR   Wikidata; Q54910131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02181
AC   CVCL_HY28
DR   CLO; CLO_0015555
DR   Coriell; ND02181
DR   Wikidata; Q54910132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02182
AC   CVCL_HY29
DR   CLO; CLO_0015554
DR   Coriell; ND02182
DR   Wikidata; Q54910133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02183
AC   CVCL_GB01
DR   CLO; CLO_0015561
DR   Coriell; ND02183
DR   Wikidata; Q54910134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02184
AC   CVCL_GB02
DR   CLO; CLO_0015558
DR   Coriell; ND02184
DR   Wikidata; Q54910135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02185
AC   CVCL_FE92
DR   CLO; CLO_0015549
DR   Coriell; ND02185
DR   Wikidata; Q54910136
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02186
AC   CVCL_FE93
DR   CLO; CLO_0015546
DR   Coriell; ND02186
DR   Wikidata; Q54910137
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02187
AC   CVCL_FE94
DR   CLO; CLO_0015552
DR   Coriell; ND02187
DR   Wikidata; Q54910138
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02188
AC   CVCL_GB03
DR   CLO; CLO_0015688
DR   Coriell; ND02188
DR   Wikidata; Q54910139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02189
AC   CVCL_GB04
DR   CLO; CLO_0015687
DR   Coriell; ND02189
DR   Wikidata; Q54910140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02190
AC   CVCL_DU85
DR   CLO; CLO_0015686
DR   Coriell; ND02190
DR   Wikidata; Q54910141
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02192
AC   CVCL_HZ74
DR   Coriell; ND02192
DR   Wikidata; Q54910142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02193
AC   CVCL_HZ75
DR   Coriell; ND02193
DR   Wikidata; Q54910143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02194
AC   CVCL_HZ76
DR   Coriell; ND02194
DR   Wikidata; Q54910148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02195
AC   CVCL_HZ77
DR   Coriell; ND02195
DR   Wikidata; Q54910149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02197
AC   CVCL_HZ78
DR   Coriell; ND02197
DR   Wikidata; Q54910150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02199
AC   CVCL_DU86
DR   CLO; CLO_0015685
DR   Coriell; ND02199
DR   Wikidata; Q54910151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02200
AC   CVCL_ES01
DR   CLO; CLO_0015677
DR   Coriell; ND02200
DR   Wikidata; Q54910152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02201
AC   CVCL_AB56
DR   CLO; CLO_0015675
DR   Coriell; ND02201
DR   Wikidata; Q54910153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND02202
AC   CVCL_HZ79
DR   Coriell; ND02202
DR   Wikidata; Q54910154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02203
AC   CVCL_GT10
DR   CLO; CLO_0015672
DR   Coriell; ND02203
DR   Wikidata; Q54910155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02204
AC   CVCL_CY71
DR   CLO; CLO_0015671
DR   Coriell; ND02204
DR   Wikidata; Q54910156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02205
AC   CVCL_CB48
DR   CLO; CLO_0015684
DR   BioSample; SAMN00806087
DR   Coriell; ND02205
DR   Wikidata; Q54910157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02206
AC   CVCL_ES02
DR   CLO; CLO_0015680
DR   BioSample; SAMN00806089
DR   Coriell; ND02206
DR   Wikidata; Q54910158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02207
AC   CVCL_AB57
DR   CLO; CLO_0015644
DR   Coriell; ND02207
DR   Wikidata; Q54910159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND02208
AC   CVCL_ES03
DR   CLO; CLO_0015646
DR   Coriell; ND02208
DR   Wikidata; Q54910160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02210
AC   CVCL_CB49
DR   CLO; CLO_0015645
DR   Coriell; ND02210
DR   Wikidata; Q54910161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02211
AC   CVCL_CY72
DR   CLO; CLO_0015648
DR   Coriell; ND02211
DR   Wikidata; Q54910162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02212
AC   CVCL_1W35
SY   ND-2212
DR   CLO; CLO_0015647
DR   BioSample; SAMN00806093
DR   Coriell; ND02212
DR   Wikidata; Q54910163
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND02213
AC   CVCL_CB50
DR   CLO; CLO_0015630
DR   BioSample; SAMN00806095
DR   Coriell; ND02213
DR   Wikidata; Q54910164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02214
AC   CVCL_1W36
SY   ND-2214
DR   CLO; CLO_0015627
DR   BioSample; SAMN00806097
DR   Coriell; ND02214
DR   Wikidata; Q54910165
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02215
AC   CVCL_CB51
DR   CLO; CLO_0015634
DR   Coriell; ND02215
DR   Wikidata; Q54910166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02216
AC   CVCL_HM24
DR   CLO; CLO_0015632
DR   Coriell; ND02216
DR   Wikidata; Q54910167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02217
AC   CVCL_CB52
DR   CLO; CLO_0015640
DR   BioSample; SAMN00806103
DR   Coriell; ND02217
DR   Wikidata; Q54910168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02218
AC   CVCL_HM25
DR   CLO; CLO_0015725
DR   Coriell; ND02218
DR   Wikidata; Q54910169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02219
AC   CVCL_GB05
DR   CLO; CLO_0015726
DR   Coriell; ND02219
DR   Wikidata; Q54910170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02220
AC   CVCL_GB06
DR   CLO; CLO_0015723
DR   Coriell; ND02220
DR   Wikidata; Q54910171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02221
AC   CVCL_IG78
DR   CLO; CLO_0015724
DR   Coriell; ND02221
DR   Wikidata; Q54910172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND02222
AC   CVCL_GB07
DR   CLO; CLO_0015721
DR   Coriell; ND02222
DR   Wikidata; Q54910173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02224
AC   CVCL_FE95
DR   CLO; CLO_0015722
DR   Coriell; ND02224
DR   Wikidata; Q54910174
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02225
AC   CVCL_FE96
DR   CLO; CLO_0015736
DR   Coriell; ND02225
DR   Wikidata; Q54910175
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02227
AC   CVCL_CB53
DR   CLO; CLO_0015738
DR   BioSample; SAMN00806107
DR   Coriell; ND02227
DR   Wikidata; Q54910176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02228
AC   CVCL_HZ80
DR   Coriell; ND02228
DR   Wikidata; Q54910177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02231
AC   CVCL_HZ81
DR   Coriell; ND02231
DR   Wikidata; Q54910178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02249
AC   CVCL_FB47
DR   CLO; CLO_0015732
DR   Coriell; ND02249
DR   Wikidata; Q54910179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02250
AC   CVCL_DU87
DR   Coriell; ND02250
DR   Wikidata; Q54910180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02251
AC   CVCL_DU88
DR   CLO; CLO_0015733
DR   Coriell; ND02251
DR   Wikidata; Q54910181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02252
AC   CVCL_DU89
DR   Coriell; ND02252
DR   Wikidata; Q54910182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02253
AC   CVCL_CB54
DR   CLO; CLO_0015703
DR   Coriell; ND02253
DR   Wikidata; Q54910183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02254
AC   CVCL_CB55
DR   CLO; CLO_0015704
DR   BioSample; SAMN00806109
DR   Coriell; ND02254
DR   Wikidata; Q54910184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02255
AC   CVCL_GT11
DR   CLO; CLO_0015705
DR   Coriell; ND02255
DR   Wikidata; Q54910185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02256
AC   CVCL_1W37
SY   ND-2256
DR   CLO; CLO_0015699
DR   BioSample; SAMN00806113
DR   Coriell; ND02256
DR   Wikidata; Q54910186
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02257
AC   CVCL_GY36
DR   CLO; CLO_0015700
DR   Coriell; ND02257
DR   Wikidata; Q54910187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02258
AC   CVCL_1W38
SY   ND-2258
DR   CLO; CLO_0015701
DR   BioSample; SAMN00806117
DR   Coriell; ND02258
DR   Wikidata; Q54910190
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02259
AC   CVCL_DU90
DR   Coriell; ND02259
DR   Wikidata; Q54910191
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02261
AC   CVCL_EH36
DR   CLO; CLO_0015702
DR   Coriell; ND02261
DR   Wikidata; Q54910192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02262
AC   CVCL_GY37
DR   CLO; CLO_0015706
DR   Coriell; ND02262
DR   Wikidata; Q54910193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02263
AC   CVCL_CB56
DR   CLO; CLO_0015707
DR   BioSample; SAMN00806123
DR   Coriell; ND02263
DR   Wikidata; Q54910194
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02264
AC   CVCL_GY38
DR   CLO; CLO_0015708
DR   Coriell; ND02264
DR   Wikidata; Q54910195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02265
AC   CVCL_GY39
DR   CLO; CLO_0016002
DR   Coriell; ND02265
DR   Wikidata; Q54910196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02266
AC   CVCL_CB57
DR   CLO; CLO_0016004
DR   Coriell; ND02266
DR   Wikidata; Q54910197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02268
AC   CVCL_GY40
DR   CLO; CLO_0016003
DR   Coriell; ND02268
DR   Wikidata; Q54910198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02269
AC   CVCL_DU91
DR   CLO; CLO_0016006
DR   Coriell; ND02269
DR   Wikidata; Q54910199
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02270
AC   CVCL_AB58
DR   CLO; CLO_0016005
DR   Coriell; ND02270
DR   Wikidata; Q54910200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND02271
AC   CVCL_DU92
DR   Coriell; ND02271
DR   Wikidata; Q54910201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02272
AC   CVCL_CB58
DR   CLO; CLO_0015982
DR   Coriell; ND02272
DR   Wikidata; Q54910202
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02274
AC   CVCL_FW51
DR   Coriell; ND02274
DR   Wikidata; Q54910203
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02275
AC   CVCL_HZ82
DR   Coriell; ND02275
DR   Wikidata; Q54910204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02276
AC   CVCL_HS94
DR   Coriell; ND02276
DR   Wikidata; Q54910205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02279
AC   CVCL_HZ83
DR   Coriell; ND02279
DR   Wikidata; Q54910206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02280
AC   CVCL_FH28
DR   CLO; CLO_0015984
DR   Coriell; ND02280
DR   Wikidata; Q54910207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02281
AC   CVCL_FH29
DR   CLO; CLO_0015977
DR   Coriell; ND02281
DR   Wikidata; Q54910208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02282
AC   CVCL_HZ84
DR   Coriell; ND02282
DR   Wikidata; Q54910209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02283
AC   CVCL_FW52
DR   Coriell; ND02283
DR   Wikidata; Q54910210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02284
AC   CVCL_HZ85
DR   Coriell; ND02284
DR   Wikidata; Q54910211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02285
AC   CVCL_HZ86
DR   Coriell; ND02285
DR   Wikidata; Q54910212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02286
AC   CVCL_DU93
DR   Coriell; ND02286
DR   Wikidata; Q54910213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02287
AC   CVCL_GY41
DR   CLO; CLO_0015980
DR   Coriell; ND02287
DR   Wikidata; Q54910214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02288
AC   CVCL_FH30
DR   CLO; CLO_0015988
DR   Coriell; ND02288
DR   Wikidata; Q54910215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02289
AC   CVCL_FH31
DR   CLO; CLO_0015971
DR   Coriell; ND02289
DR   Wikidata; Q54910216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02290
AC   CVCL_FH32
DR   CLO; CLO_0015970
DR   Coriell; ND02290
DR   Wikidata; Q54910217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02291
AC   CVCL_GY42
DR   CLO; CLO_0015975
DR   Coriell; ND02291
DR   Wikidata; Q54910218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02292
AC   CVCL_FH33
DR   CLO; CLO_0015974
DR   Coriell; ND02292
DR   Wikidata; Q54910219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02293
AC   CVCL_GY43
DR   CLO; CLO_0015973
DR   Coriell; ND02293
DR   Wikidata; Q54910220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02294
AC   CVCL_GY44
DR   CLO; CLO_0015972
DR   Coriell; ND02294
DR   Wikidata; Q54910221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02295
AC   CVCL_CB59
DR   CLO; CLO_0016133
DR   Coriell; ND02295
DR   Wikidata; Q54910222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02296
AC   CVCL_1W39
SY   ND-2296
DR   CLO; CLO_0016131
DR   BioSample; SAMN00806153
DR   Coriell; ND02296
DR   Wikidata; Q54910223
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND02297
AC   CVCL_CB60
DR   CLO; CLO_0016137
DR   BioSample; SAMN00806155
DR   Coriell; ND02297
DR   Wikidata; Q54910224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02298
AC   CVCL_CB61
DR   CLO; CLO_0016135
DR   BioSample; SAMN00806157
DR   Coriell; ND02298
DR   Wikidata; Q54910225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02299
AC   CVCL_ES04
DR   CLO; CLO_0016122
DR   BioSample; SAMN00806159
DR   Coriell; ND02299
DR   Wikidata; Q54910226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02300
AC   CVCL_HS95
DR   Coriell; ND02300
DR   Wikidata; Q54910227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02306
AC   CVCL_HS96
DR   Coriell; ND02306
DR   Wikidata; Q54910228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02309
AC   CVCL_CB62
DR   CLO; CLO_0016124
DR   Coriell; ND02309
DR   Wikidata; Q54910229
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02310
AC   CVCL_CB63
DR   CLO; CLO_0016125
DR   Coriell; ND02310
DR   Wikidata; Q54910232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02311
AC   CVCL_CB64
DR   CLO; CLO_0016118
DR   Coriell; ND02311
DR   Wikidata; Q54910233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02312
AC   CVCL_CB65
DR   CLO; CLO_0016119
DR   Coriell; ND02312
DR   Wikidata; Q54910234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02313
AC   CVCL_CY73
DR   CLO; CLO_0016120
DR   Coriell; ND02313
DR   Wikidata; Q54910235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02314
AC   CVCL_GB08
DR   CLO; CLO_0016121
DR   Coriell; ND02314
DR   Wikidata; Q54910236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02315
AC   CVCL_DU94
DR   CLO; CLO_0016116
DR   Coriell; ND02315
DR   Wikidata; Q54910237
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02316
AC   CVCL_DU95
DR   CLO; CLO_0016114
DR   Coriell; ND02316
DR   Wikidata; Q54910238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02317
AC   CVCL_DU96
DR   Coriell; ND02317
DR   Wikidata; Q54910239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02318
AC   CVCL_CB66
DR   CLO; CLO_0016112
DR   BioSample; SAMN00806165
DR   Coriell; ND02318
DR   Wikidata; Q54910240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02319
AC   CVCL_GY45
DR   CLO; CLO_0016103
DR   Coriell; ND02319
DR   Wikidata; Q54910241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02320
AC   CVCL_CB67
DR   CLO; CLO_0016106
DR   BioSample; SAMN00806169
DR   Coriell; ND02320
DR   Wikidata; Q54910243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02321
AC   CVCL_GY46
DR   CLO; CLO_0016101
DR   Coriell; ND02321
DR   Wikidata; Q54910244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02322
AC   CVCL_CB68
DR   CLO; CLO_0016102
DR   BioSample; SAMN00806173
DR   Coriell; ND02322
DR   Wikidata; Q54910245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02323
AC   CVCL_IL35
DR   CLO; CLO_0016099
DR   Coriell; ND02323
DR   Wikidata; Q54910246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND02323; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND02324
AC   CVCL_GY47
DR   CLO; CLO_0016100
DR   Coriell; ND02324
DR   Wikidata; Q54910247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02325
AC   CVCL_GY48
DR   CLO; CLO_0016097
DR   Coriell; ND02325
DR   Wikidata; Q54910248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02326
AC   CVCL_CB69
DR   CLO; CLO_0016098
DR   Coriell; ND02326
DR   Wikidata; Q54910249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02327
AC   CVCL_CB70
DR   CLO; CLO_0016089
DR   Coriell; ND02327
DR   Wikidata; Q54910250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02329
AC   CVCL_HS97
DR   Coriell; ND02329
DR   Wikidata; Q54910251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02331
AC   CVCL_IL36
DR   CLO; CLO_0016088
DR   Coriell; ND02331
DR   Wikidata; Q54910252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND02331; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND02332
AC   CVCL_DU97
DR   CLO; CLO_0016087
DR   Coriell; ND02332
DR   Wikidata; Q54910253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02333
AC   CVCL_DU98
DR   CLO; CLO_0016076
DR   Coriell; ND02333
DR   Wikidata; Q54910254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02334
AC   CVCL_HZ87
DR   Coriell; ND02334
DR   Wikidata; Q54910255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02336
AC   CVCL_DU99
DR   CLO; CLO_0016079
DR   Coriell; ND02336
DR   Wikidata; Q54910256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02337
AC   CVCL_DV00
DR   CLO; CLO_0016080
DR   Coriell; ND02337
DR   Wikidata; Q54910257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02338
AC   CVCL_HZ88
DR   Coriell; ND02338
DR   Wikidata; Q54910258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02339
AC   CVCL_HS98
DR   Coriell; ND02339
DR   Wikidata; Q54910259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02340
AC   CVCL_GB09
DR   CLO; CLO_0016081
DR   Coriell; ND02340
DR   Wikidata; Q54910260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02341
AC   CVCL_DV01
DR   CLO; CLO_0016083
DR   Coriell; ND02341
DR   Wikidata; Q54910261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02353
AC   CVCL_DV02
DR   Coriell; ND02353
DR   Wikidata; Q54910262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02354
AC   CVCL_CB71
DR   CLO; CLO_0016084
DR   Coriell; ND02354
DR   Wikidata; Q54910263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02355
AC   CVCL_CB72
DR   CLO; CLO_0016085
DR   Coriell; ND02355
DR   Wikidata; Q54910264
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02356
AC   CVCL_CB73
DR   CLO; CLO_0016086
DR   Coriell; ND02356
DR   Wikidata; Q54910265
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02357
AC   CVCL_CB74
DR   CLO; CLO_0016071
DR   Coriell; ND02357
DR   Wikidata; Q54910266
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02359
AC   CVCL_CB75
DR   CLO; CLO_0016067
DR   Coriell; ND02359
DR   Wikidata; Q54910267
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02360
AC   CVCL_DV03
DR   CLO; CLO_0016068
DR   Coriell; ND02360
DR   Wikidata; Q54910268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02361
AC   CVCL_GB10
DR   CLO; CLO_0016060
DR   Coriell; ND02361
DR   Wikidata; Q54910269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02362
AC   CVCL_DV04
DR   CLO; CLO_0016061
DR   Coriell; ND02362
DR   Wikidata; Q54910270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02363
AC   CVCL_DV05
DR   CLO; CLO_0016055
DR   Coriell; ND02363
DR   Wikidata; Q54910271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02364
AC   CVCL_DV06
DR   CLO; CLO_0016058
DR   Coriell; ND02364
DR   Wikidata; Q54910272
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02365
AC   CVCL_GB11
DR   CLO; CLO_0016065
DR   Coriell; ND02365
DR   Wikidata; Q54910275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02370
AC   CVCL_HZ89
DR   Coriell; ND02370
DR   Wikidata; Q54910276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02371
AC   CVCL_FE97
DR   CLO; CLO_0016066
DR   Coriell; ND02371
DR   Wikidata; Q54910277
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02372
AC   CVCL_GB12
DR   CLO; CLO_0016063
DR   Coriell; ND02372
DR   Wikidata; Q54910278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02373
AC   CVCL_GB13
DR   CLO; CLO_0016064
DR   Coriell; ND02373
DR   Wikidata; Q54910279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02374
AC   CVCL_HZ90
DR   Coriell; ND02374
DR   Wikidata; Q54910280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02376
AC   CVCL_HS99
DR   Coriell; ND02376
DR   Wikidata; Q54910281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02377
AC   CVCL_GB14
DR   CLO; CLO_0016236
DR   Coriell; ND02377
DR   Wikidata; Q54910282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02378
AC   CVCL_GB15
DR   CLO; CLO_0016235
DR   Coriell; ND02378
DR   Wikidata; Q54910283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02379
AC   CVCL_GB16
DR   CLO; CLO_0016234
DR   Coriell; ND02379
DR   Wikidata; Q54910284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02380
AC   CVCL_IZ55
DR   Coriell; ND02380
DR   Wikidata; Q54910285
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (Coriell=ND02380).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 14
//
ID   ND02381
AC   CVCL_GB17
DR   CLO; CLO_0016246
DR   BioSample; SAMN00806185
DR   Coriell; ND02381
DR   Wikidata; Q54910286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02382
AC   CVCL_FH34
DR   CLO; CLO_0016244
DR   Coriell; ND02382
DR   Wikidata; Q54910287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02383
AC   CVCL_FH35
DR   CLO; CLO_0016241
DR   Coriell; ND02383
DR   Wikidata; Q54910288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02384
AC   CVCL_GY49
DR   CLO; CLO_0016240
DR   Coriell; ND02384
DR   Wikidata; Q54910289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02385
AC   CVCL_CB76
DR   Coriell; ND02385
DR   Wikidata; Q54910290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02387
AC   CVCL_CB77
DR   CLO; CLO_0016238
DR   Coriell; ND02387
DR   Wikidata; Q54910291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02388
AC   CVCL_DV07
DR   CLO; CLO_0016237
DR   Coriell; ND02388
DR   Wikidata; Q54910292
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02389
AC   CVCL_DV08
DR   CLO; CLO_0016214
DR   Coriell; ND02389
DR   Wikidata; Q54910293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02390
AC   CVCL_HZ91
DR   Coriell; ND02390
DR   Wikidata; Q54910294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02391
AC   CVCL_HZ92
DR   Coriell; ND02391
DR   Wikidata; Q54910295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02392
AC   CVCL_HZ93
DR   Coriell; ND02392
DR   Wikidata; Q54910296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02393
AC   CVCL_HZ94
DR   Coriell; ND02393
DR   Wikidata; Q54910297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02394
AC   CVCL_HZ95
DR   Coriell; ND02394
DR   Wikidata; Q54910298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02395
AC   CVCL_CB78
DR   CLO; CLO_0016213
DR   Coriell; ND02395
DR   Wikidata; Q54910299
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02396
AC   CVCL_FH36
DR   CLO; CLO_0016216
DR   Coriell; ND02396
DR   Wikidata; Q54910300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02397
AC   CVCL_GY50
DR   CLO; CLO_0016215
DR   Coriell; ND02397
DR   Wikidata; Q54910301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02398
AC   CVCL_GY51
DR   CLO; CLO_0016223
DR   Coriell; ND02398
DR   Wikidata; Q54910302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02399
AC   CVCL_FC15
DR   CLO; CLO_0016222
DR   Coriell; ND02399
DR   Wikidata; Q54910303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02400
AC   CVCL_FC16
DR   CLO; CLO_0016227
DR   Coriell; ND02400
DR   Wikidata; Q54910304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02401
AC   CVCL_GB18
DR   CLO; CLO_0016226
DR   Coriell; ND02401
DR   Wikidata; Q54910305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02402
AC   CVCL_DV09
DR   CLO; CLO_0016219
DR   Coriell; ND02402
DR   Wikidata; Q54910306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02403
AC   CVCL_DV10
DR   CLO; CLO_0016218
DR   Coriell; ND02403
DR   Wikidata; Q54910307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02404
AC   CVCL_CB79
DR   CLO; CLO_0016187
DR   Coriell; ND02404
DR   Wikidata; Q54910308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02405
AC   CVCL_1W40
SY   ND-2405
DR   CLO; CLO_0016191
DR   Coriell; ND02405
DR   Wikidata; Q54910309
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND02406
AC   CVCL_DV11
DR   CLO; CLO_0016190
DR   Coriell; ND02406
DR   Wikidata; Q54910310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02407
AC   CVCL_DV12
DR   CLO; CLO_0016189
DR   Coriell; ND02407
DR   Wikidata; Q54910311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02408
AC   CVCL_DV13
DR   CLO; CLO_0016188
DR   Coriell; ND02408
DR   Wikidata; Q54910312
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02409
AC   CVCL_IL37
DR   Coriell; ND02409
DR   Wikidata; Q54910313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02410
AC   CVCL_HZ96
DR   Coriell; ND02410
DR   Wikidata; Q54910314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02411
AC   CVCL_FW53
DR   Coriell; ND02411
DR   Wikidata; Q54910319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02412
AC   CVCL_HZ97
DR   Coriell; ND02412
DR   Wikidata; Q54910320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02413
AC   CVCL_DV14
DR   Coriell; ND02413
DR   Wikidata; Q54910321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02414
AC   CVCL_DV15
DR   Coriell; ND02414
DR   Wikidata; Q54910322
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02415
AC   CVCL_FH37
DR   CLO; CLO_0016200
DR   Coriell; ND02415
DR   Wikidata; Q54910323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02416
AC   CVCL_FH38
DR   CLO; CLO_0016197
DR   Coriell; ND02416
DR   Wikidata; Q54910324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02417
AC   CVCL_GY52
DR   CLO; CLO_0016196
DR   Coriell; ND02417
DR   Wikidata; Q54910325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02418
AC   CVCL_FH39
DR   CLO; CLO_0016193
DR   Coriell; ND02418
DR   Wikidata; Q54910326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02419
AC   CVCL_GY53
DR   CLO; CLO_0016206
DR   Coriell; ND02419
DR   Wikidata; Q54910327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02420
AC   CVCL_GY54
DR   CLO; CLO_0016154
DR   Coriell; ND02420
DR   Wikidata; Q54910328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02421
AC   CVCL_CB80
DR   CLO; CLO_0016153
DR   BioSample; SAMN00806217
DR   Coriell; ND02421
DR   Wikidata; Q54910329
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02422
AC   CVCL_1W41
SY   ND-2422
DR   CLO; CLO_0016156
DR   BioSample; SAMN00806219
DR   Coriell; ND02422
DR   Wikidata; Q54910330
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02423
AC   CVCL_BA20
DR   Coriell; ND02423
DR   Wikidata; Q54910331
CC   Population: Caucasian; Welsh.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND02424
AC   CVCL_GY55
DR   CLO; CLO_0016155
DR   Coriell; ND02424
DR   Wikidata; Q54910332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02425
AC   CVCL_CB81
DR   CLO; CLO_0016158
DR   Coriell; ND02425
DR   Wikidata; Q54910333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02426
AC   CVCL_CB82
DR   CLO; CLO_0016157
DR   Coriell; ND02426
DR   Wikidata; Q54910334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02430
AC   CVCL_HZ98
DR   Coriell; ND02430
DR   Wikidata; Q54910335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02432
AC   CVCL_ES05
DR   CLO; CLO_0016160
DR   Coriell; ND02432
DR   Wikidata; Q54910336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02433
AC   CVCL_GY56
DR   CLO; CLO_0016159
DR   Coriell; ND02433
DR   Wikidata; Q54910337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02434
AC   CVCL_DV16
DR   Coriell; ND02434
DR   Wikidata; Q54910338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02435
AC   CVCL_DV17
DR   CLO; CLO_0016163
DR   Coriell; ND02435
DR   Wikidata; Q54910339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02436
AC   CVCL_HT00
DR   Coriell; ND02436
DR   Wikidata; Q54910340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02437
AC   CVCL_HZ99
DR   Coriell; ND02437
DR   Wikidata; Q54910341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02438
AC   CVCL_FW54
DR   Coriell; ND02438
DR   Wikidata; Q54910342
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02440
AC   CVCL_IA00
DR   Coriell; ND02440
DR   Wikidata; Q54910343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02441
AC   CVCL_GB19
DR   CLO; CLO_0016161
DR   Coriell; ND02441
DR   Wikidata; Q54910344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02442
AC   CVCL_FH40
DR   CLO; CLO_0014428
DR   Coriell; ND02442
DR   Wikidata; Q54910345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02443
AC   CVCL_IA01
DR   Coriell; ND02443
DR   Wikidata; Q54910346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02444
AC   CVCL_DV18
DR   Coriell; ND02444
DR   Wikidata; Q54910347
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02446
AC   CVCL_DV19
DR   CLO; CLO_0014429
DR   Coriell; ND02446
DR   Wikidata; Q54910348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02447
AC   CVCL_DV20
DR   Coriell; ND02447
DR   Wikidata; Q54910349
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02448
AC   CVCL_DV21
DR   Coriell; ND02448
DR   Wikidata; Q54910350
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02449
AC   CVCL_FW55
DR   Coriell; ND02449
DR   Wikidata; Q54910351
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02450
AC   CVCL_HT01
DR   Coriell; ND02450
DR   Wikidata; Q54910352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02451
AC   CVCL_DV22
DR   Coriell; ND02451
DR   Wikidata; Q54910353
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02452
AC   CVCL_DV23
DR   CLO; CLO_0014430
DR   Coriell; ND02452
DR   Wikidata; Q54910354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02453
AC   CVCL_CB83
DR   CLO; CLO_0014431
DR   BioSample; SAMN00806235
DR   Coriell; ND02453
DR   Wikidata; Q54910355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02454
AC   CVCL_CB84
DR   CLO; CLO_0014437
DR   Coriell; ND02454
DR   Wikidata; Q54910356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02455
AC   CVCL_GB20
DR   CLO; CLO_0014436
DR   Coriell; ND02455
DR   Wikidata; Q54910357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02456
AC   CVCL_GB21
DR   CLO; CLO_0014435
DR   Coriell; ND02456
DR   Wikidata; Q54910358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02457
AC   CVCL_DV24
DR   Coriell; ND02457
DR   Wikidata; Q54910362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02458
AC   CVCL_IA02
DR   Coriell; ND02458
DR   Wikidata; Q54910363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02459
AC   CVCL_FW56
DR   Coriell; ND02459
DR   Wikidata; Q54910364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02460
AC   CVCL_FW57
DR   Coriell; ND02460
DR   Wikidata; Q54910365
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02461
AC   CVCL_IA03
DR   Coriell; ND02461
DR   Wikidata; Q54910366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02462
AC   CVCL_IA04
DR   Coriell; ND02462
DR   Wikidata; Q54910367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02463
AC   CVCL_IA05
DR   Coriell; ND02463
DR   Wikidata; Q54910368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02464
AC   CVCL_IA06
DR   Coriell; ND02464
DR   Wikidata; Q54910369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02465
AC   CVCL_IA07
DR   Coriell; ND02465
DR   Wikidata; Q54910370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02466
AC   CVCL_DV25
DR   CLO; CLO_0014434
DR   Coriell; ND02466
DR   Wikidata; Q54910371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02467
AC   CVCL_GB22
DR   CLO; CLO_0014433
DR   Coriell; ND02467
DR   Wikidata; Q54910372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02468
AC   CVCL_IL38
DR   CLO; CLO_0014432
DR   Coriell; ND02468
DR   Wikidata; Q54910373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND02469
AC   CVCL_GB23
DR   CLO; CLO_0014442
DR   Coriell; ND02469
DR   Wikidata; Q54910374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02470
AC   CVCL_GB24
DR   CLO; CLO_0014440
DR   Coriell; ND02470
DR   Wikidata; Q54910375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02471
AC   CVCL_CB85
DR   CLO; CLO_0014441
DR   BioSample; SAMN00806253
DR   Coriell; ND02471
DR   Wikidata; Q54910376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02472
AC   CVCL_GB25
DR   CLO; CLO_0014438
DR   BioSample; SAMN00806255
DR   Coriell; ND02472
DR   Wikidata; Q54910377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02473
AC   CVCL_GY57
DR   CLO; CLO_0014439
DR   Coriell; ND02473
DR   Wikidata; Q54910378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02474
AC   CVCL_GY58
DR   CLO; CLO_0014444
DR   Coriell; ND02474
DR   Wikidata; Q54910379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02475
AC   CVCL_DV26
DR   Coriell; ND02475
DR   Wikidata; Q54910380
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02476
AC   CVCL_DV27
DR   Coriell; ND02476
DR   Wikidata; Q54910381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02477
AC   CVCL_HT02
DR   Coriell; ND02477
DR   Wikidata; Q54910382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02480
AC   CVCL_HT03
DR   Coriell; ND02480
DR   Wikidata; Q54910383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02481
AC   CVCL_IA08
DR   Coriell; ND02481
DR   Wikidata; Q54910384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02482
AC   CVCL_GB26
DR   CLO; CLO_0014443
DR   Coriell; ND02482
DR   Wikidata; Q54910385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02483
AC   CVCL_DV28
DR   CLO; CLO_0014446
DR   Coriell; ND02483
DR   Wikidata; Q54910386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02484
AC   CVCL_DV29
DR   CLO; CLO_0014445
DR   Coriell; ND02484
DR   Wikidata; Q54910387
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02485
AC   CVCL_DV30
DR   CLO; CLO_0014447
DR   Coriell; ND02485
DR   Wikidata; Q54910388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02486
AC   CVCL_FH41
DR   Coriell; ND02486
DR   Wikidata; Q54910389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02487
AC   CVCL_IA09
DR   Coriell; ND02487
DR   Wikidata; Q54910390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02488
AC   CVCL_IA10
DR   Coriell; ND02488
DR   Wikidata; Q54910391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02489
AC   CVCL_IA11
DR   Coriell; ND02489
DR   Wikidata; Q54910392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02490
AC   CVCL_DV31
DR   Coriell; ND02490
DR   Wikidata; Q54910393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02491
AC   CVCL_FH42
DR   CLO; CLO_0014448
DR   Coriell; ND02491
DR   Wikidata; Q54910394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02492
AC   CVCL_DV32
DR   CLO; CLO_0014449
DR   Coriell; ND02492
DR   Wikidata; Q54910395
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02493
AC   CVCL_IA12
DR   Coriell; ND02493
DR   Wikidata; Q54910396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02495
AC   CVCL_IA13
DR   Coriell; ND02495
DR   Wikidata; Q54910397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02496
AC   CVCL_HT04
DR   Coriell; ND02496
DR   Wikidata; Q54910398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02497
AC   CVCL_FW58
DR   Coriell; ND02497
DR   Wikidata; Q54910399
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02498
AC   CVCL_FW59
DR   Coriell; ND02498
DR   Wikidata; Q54910400
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02499
AC   CVCL_IA14
DR   Coriell; ND02499
DR   Wikidata; Q54910401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02500
AC   CVCL_HT05
DR   Coriell; ND02500
DR   Wikidata; Q54910405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02503
AC   CVCL_CB86
DR   CLO; CLO_0014450
DR   Coriell; ND02503
DR   Wikidata; Q54910406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02504
AC   CVCL_CB87
DR   CLO; CLO_0014451
DR   BioSample; SAMN00806289
DR   Coriell; ND02504
DR   Wikidata; Q54910407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02505
AC   CVCL_GY59
DR   CLO; CLO_0014452
DR   Coriell; ND02505
DR   Wikidata; Q54910408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02506
AC   CVCL_CB88
DR   CLO; CLO_0014453
DR   Coriell; ND02506
DR   Wikidata; Q54910409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02507
AC   CVCL_IA15
DR   Coriell; ND02507
DR   Wikidata; Q54910410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02509
AC   CVCL_CB89
DR   CLO; CLO_0014457
DR   Coriell; ND02509
DR   Wikidata; Q54910411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02511
AC   CVCL_CY74
DR   CLO; CLO_0014456
DR   Coriell; ND02511
DR   Wikidata; Q54910412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02512
AC   CVCL_CB90
DR   CLO; CLO_0014455
DR   Coriell; ND02512
DR   Wikidata; Q54910413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02513
AC   CVCL_GB27
DR   CLO; CLO_0014454
DR   Coriell; ND02513
DR   Wikidata; Q54910414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02514
AC   CVCL_DV33
DR   CLO; CLO_0014460
DR   Coriell; ND02514
DR   Wikidata; Q54910415
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02517
AC   CVCL_IA16
DR   Coriell; ND02517
DR   Wikidata; Q54910416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02518
AC   CVCL_IA17
DR   Coriell; ND02518
DR   Wikidata; Q54910417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02519
AC   CVCL_IA18
DR   Coriell; ND02519
DR   Wikidata; Q54910418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02521
AC   CVCL_DV34
DR   CLO; CLO_0014458
DR   Coriell; ND02521
DR   Wikidata; Q54910419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02522
AC   CVCL_FH43
DR   Coriell; ND02522
DR   Wikidata; Q54910420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02523
AC   CVCL_GY60
DR   CLO; CLO_0014459
DR   Coriell; ND02523
DR   Wikidata; Q54910421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02524
AC   CVCL_FH44
DR   CLO; CLO_0014463
DR   Coriell; ND02524
DR   Wikidata; Q54910422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02525
AC   CVCL_HT06
DR   Coriell; ND02525
DR   Wikidata; Q54910423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02526
AC   CVCL_DV35
DR   CLO; CLO_0014464
DR   Coriell; ND02526
DR   Wikidata; Q54910424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02527
AC   CVCL_CB91
DR   CLO; CLO_0014461
DR   BioSample; SAMN00806300
DR   Coriell; ND02527
DR   Wikidata; Q54910425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02528
AC   CVCL_ES06
DR   CLO; CLO_0014462
DR   BioSample; SAMN00806301
DR   Coriell; ND02528
DR   Wikidata; Q54910426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02529
AC   CVCL_IA19
DR   Coriell; ND02529
DR   Wikidata; Q54910427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02530
AC   CVCL_CB92
DR   CLO; CLO_0014326
DR   BioSample; SAMN00806302
DR   Coriell; ND02530
DR   Wikidata; Q54910428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02531
AC   CVCL_GB28
DR   CLO; CLO_0014329
DR   BioSample; SAMN00806304
DR   Coriell; ND02531
DR   Wikidata; Q54910429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02532
AC   CVCL_GB29
DR   CLO; CLO_0014331
DR   Coriell; ND02532
DR   Wikidata; Q54910430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02533
AC   CVCL_CB93
DR   CLO; CLO_0014353
DR   BioSample; SAMN00806306
DR   Coriell; ND02533
DR   Wikidata; Q54910431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02534
AC   CVCL_ES07
DR   CLO; CLO_0014352
DR   BioSample; SAMN00806308
DR   Coriell; ND02534
DR   Wikidata; Q54910432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02535
AC   CVCL_HT07
DR   Coriell; ND02535
DR   Wikidata; Q54910433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02537
AC   CVCL_FH45
DR   CLO; CLO_0014355
DR   Coriell; ND02537
DR   Wikidata; Q54910434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02538
AC   CVCL_GY61
DR   CLO; CLO_0014354
DR   Coriell; ND02538
DR   Wikidata; Q54910435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02539
AC   CVCL_GY62
DR   CLO; CLO_0014349
DR   Coriell; ND02539
DR   Wikidata; Q54910436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02540
AC   CVCL_GY63
DR   CLO; CLO_0014348
DR   Coriell; ND02540
DR   Wikidata; Q54910437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02541
AC   CVCL_GB30
DR   CLO; CLO_0014351
DR   Coriell; ND02541
DR   Wikidata; Q54910438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02542
AC   CVCL_DV36
DR   CLO; CLO_0014350
DR   Coriell; ND02542
DR   Wikidata; Q54910439
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02543
AC   CVCL_DV37
DR   CLO; CLO_0014360
DR   Coriell; ND02543
DR   Wikidata; Q54910440
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02544
AC   CVCL_DV38
DR   Coriell; ND02544
DR   Wikidata; Q54910441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02545
AC   CVCL_IA20
DR   Coriell; ND02545
DR   Wikidata; Q54910442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02546
AC   CVCL_IA21
DR   Coriell; ND02546
DR   Wikidata; Q54910443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02548
AC   CVCL_CY75
DR   CLO; CLO_0014364
DR   Coriell; ND02548
DR   Wikidata; Q54910444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02549
AC   CVCL_CY76
DR   CLO; CLO_0014378
DR   Coriell; ND02549
DR   Wikidata; Q54910447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02550
AC   CVCL_FC17
DR   CLO; CLO_0014386
DR   BioSample; SAMN00806328
DR   Coriell; ND02550
DR   Wikidata; Q54910448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02551
AC   CVCL_ES08
DR   CLO; CLO_0014385
DR   BioSample; SAMN00806330
DR   Coriell; ND02551
DR   Wikidata; Q54910449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02552
AC   CVCL_CB94
DR   CLO; CLO_0014384
DR   Coriell; ND02552
DR   Wikidata; Q54910451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02553
AC   CVCL_1W42
SY   ND-2553
DR   CLO; CLO_0014383
DR   BioSample; SAMN00806332
DR   Coriell; ND02553
DR   Wikidata; Q54910452
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02554
AC   CVCL_CB95
DR   CLO; CLO_0014382
DR   Coriell; ND02554
DR   Wikidata; Q54910453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02556
AC   CVCL_CB96
DR   CLO; CLO_0014381
DR   BioSample; SAMN00806334
DR   Coriell; ND02556
DR   Wikidata; Q54910454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02557
AC   CVCL_GT12
DR   CLO; CLO_0014380
DR   Coriell; ND02557
DR   Wikidata; Q54910455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02558
AC   CVCL_FH46
DR   CLO; CLO_0014379
DR   Coriell; ND02558
DR   Wikidata; Q54910456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02559
AC   CVCL_GB31
DR   CLO; CLO_0014387
DR   Coriell; ND02559
DR   Wikidata; Q54910457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02560
AC   CVCL_FC18
DR   CLO; CLO_0014399
DR   Coriell; ND02560
DR   Wikidata; Q54910458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02563
AC   CVCL_DV39
DR   Coriell; ND02563
DR   Wikidata; Q54910459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02570
AC   CVCL_FH47
DR   CLO; CLO_0014398
DR   Coriell; ND02570
DR   Wikidata; Q54910460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02571
AC   CVCL_GY64
DR   CLO; CLO_0014401
DR   Coriell; ND02571
DR   Wikidata; Q54910461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02572
AC   CVCL_GY65
DR   CLO; CLO_0014400
DR   Coriell; ND02572
DR   Wikidata; Q54910462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02573
AC   CVCL_HT08
DR   Coriell; ND02573
DR   Wikidata; Q54910463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02575
AC   CVCL_CB97
DR   CLO; CLO_0014403
DR   BioSample; SAMN00806346
DR   Coriell; ND02575
DR   Wikidata; Q54910464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02577
AC   CVCL_CB98
DR   CLO; CLO_0014402
DR   Coriell; ND02577
DR   Wikidata; Q54910465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02578
AC   CVCL_CB99
DR   CLO; CLO_0014405
DR   Coriell; ND02578
DR   Wikidata; Q54910466
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02579
AC   CVCL_CC00
SY   ND 02579
DR   CLO; CLO_0014404
DR   BioSample; SAMN00806348
DR   Coriell; ND02579
DR   GEO; GSM505313
DR   Wikidata; Q54910467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ND02580
AC   CVCL_FC19
DR   CLO; CLO_0014407
DR   BioSample; SAMN00806350
DR   Coriell; ND02580
DR   Wikidata; Q54910468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02581
AC   CVCL_FH48
DR   Coriell; ND02581
DR   Wikidata; Q54910470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02582
AC   CVCL_CC01
SY   ND 02852
DR   Coriell; ND02582
DR   GEO; GSM505314
DR   Wikidata; Q54910471
CC   Population: Caucasian; Lithuanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ND02583
AC   CVCL_DV40
DR   Coriell; ND02583
DR   Wikidata; Q54910472
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02587
AC   CVCL_CC02
DR   CLO; CLO_0014406
DR   Coriell; ND02587
DR   Wikidata; Q54910473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02589
AC   CVCL_DV41
DR   Coriell; ND02589
DR   Wikidata; Q54910474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02591
AC   CVCL_HT09
DR   Coriell; ND02591
DR   Wikidata; Q54910475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02593
AC   CVCL_CC03
DR   CLO; CLO_0014420
DR   Coriell; ND02593
DR   Wikidata; Q54910476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02594
AC   CVCL_CC04
DR   CLO; CLO_0014419
DR   Coriell; ND02594
DR   Wikidata; Q54910477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02595
AC   CVCL_CC05
DR   CLO; CLO_0014418
DR   BioSample; SAMN00806354
DR   Coriell; ND02595
DR   Wikidata; Q54910478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02596
AC   CVCL_ES09
DR   CLO; CLO_0014424
DR   BioSample; SAMN00806356
DR   Coriell; ND02596
DR   Wikidata; Q54910479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02597
AC   CVCL_DV42
DR   Coriell; ND02597
DR   Wikidata; Q54910480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02598
AC   CVCL_DV43
DR   CLO; CLO_0014423
DR   Coriell; ND02598
DR   Wikidata; Q54910481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02599
AC   CVCL_FW60
DR   Coriell; ND02599
DR   Wikidata; Q54910482
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02603
AC   CVCL_FW61
DR   Coriell; ND02603
DR   Wikidata; Q54910483
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02604
AC   CVCL_FW62
DR   Coriell; ND02604
DR   Wikidata; Q54910484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02605
AC   CVCL_FH49
DR   Coriell; ND02605
DR   Wikidata; Q54910485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02606
AC   CVCL_IA22
DR   Coriell; ND02606
DR   Wikidata; Q54910486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02609
AC   CVCL_DV44
DR   Coriell; ND02609
DR   Wikidata; Q54910487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02617
AC   CVCL_IA23
DR   Coriell; ND02617
DR   Wikidata; Q54910488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02618
AC   CVCL_FH50
DR   Coriell; ND02618
DR   Wikidata; Q54910492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02621
AC   CVCL_HT10
DR   Coriell; ND02621
DR   Wikidata; Q54910493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02624
AC   CVCL_CC06
DR   CLO; CLO_0014422
DR   Coriell; ND02624
DR   Wikidata; Q54910494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02625
AC   CVCL_CC07
DR   CLO; CLO_0014421
DR   Coriell; ND02625
DR   Wikidata; Q54910495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02627
AC   CVCL_GY66
DR   CLO; CLO_0014427
DR   Coriell; ND02627
DR   Wikidata; Q54910496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02628
AC   CVCL_GY67
DR   CLO; CLO_0014426
DR   Coriell; ND02628
DR   Wikidata; Q54910497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02629
AC   CVCL_CC08
DR   CLO; CLO_0014425
DR   BioSample; SAMN00806374
DR   Coriell; ND02629
DR   Wikidata; Q54910498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02630
AC   CVCL_CC09
DR   CLO; CLO_0014273
DR   Coriell; ND02630
DR   Wikidata; Q54910499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02631
AC   CVCL_CC10
DR   CLO; CLO_0014274
DR   Coriell; ND02631
DR   Wikidata; Q54910500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02632
AC   CVCL_CC11
DR   CLO; CLO_0014271
DR   BioSample; SAMN00806376
DR   Coriell; ND02632
DR   Wikidata; Q54910501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02633
AC   CVCL_1W43
SY   ND-2633
DR   CLO; CLO_0014272
DR   BioSample; SAMN00806378
DR   Coriell; ND02633
DR   Wikidata; Q54910502
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND02634
AC   CVCL_DV45
DR   Coriell; ND02634
DR   Wikidata; Q54910503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02637
AC   CVCL_DV46
DR   Coriell; ND02637
DR   Wikidata; Q54910504
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02638
AC   CVCL_DV47
DR   Coriell; ND02638
DR   Wikidata; Q54910505
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02639
AC   CVCL_CC12
DR   CLO; CLO_0014269
DR   BioSample; SAMN00806380
DR   Coriell; ND02639
DR   Wikidata; Q54910506
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02641
AC   CVCL_CC13
DR   CLO; CLO_0014270
DR   BioSample; SAMN00806382
DR   Coriell; ND02641
DR   Wikidata; Q54910507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02644
AC   CVCL_CC14
DR   CLO; CLO_0014267
DR   BioSample; SAMN00806384
DR   Coriell; ND02644
DR   Wikidata; Q54910508
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02645
AC   CVCL_1W44
SY   ND-2645
DR   CLO; CLO_0014268
DR   BioSample; SAMN00806386
DR   Coriell; ND02645
DR   Wikidata; Q54910509
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02652
AC   CVCL_1W45
SY   ND-2652
DR   CLO; CLO_0014265
DR   Coriell; ND02652
DR   Wikidata; Q54910510
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND02657
AC   CVCL_FH51
DR   CLO; CLO_0014266
DR   Coriell; ND02657
DR   Wikidata; Q54910511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02658
AC   CVCL_FC20
DR   CLO; CLO_0014294
DR   BioSample; SAMN00806388
DR   Coriell; ND02658
DR   Wikidata; Q54910512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02660
AC   CVCL_CC15
DR   CLO; CLO_0014290
DR   BioSample; SAMN00806390
DR   Coriell; ND02660
DR   Wikidata; Q54910513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02661
AC   CVCL_CC16
DR   CLO; CLO_0014291
DR   BioSample; SAMN00806392
DR   Coriell; ND02661
DR   Wikidata; Q54910514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02662
AC   CVCL_FC21
DR   CLO; CLO_0014292
DR   BioSample; SAMN00806394
DR   Coriell; ND02662
DR   Wikidata; Q54910515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02669
AC   CVCL_DV48
DR   Coriell; ND02669
DR   Wikidata; Q54910516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02672
AC   CVCL_IA24
DR   Coriell; ND02672
DR   Wikidata; Q54910517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02674
AC   CVCL_DV49
DR   Coriell; ND02674
DR   Wikidata; Q54910518
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02687
AC   CVCL_FH52
DR   CLO; CLO_0014293
DR   Coriell; ND02687
DR   Wikidata; Q54910519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02688
AC   CVCL_GY68
DR   CLO; CLO_0014286
DR   Coriell; ND02688
DR   Wikidata; Q54910520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02689
AC   CVCL_CC17
DR   CLO; CLO_0014287
DR   BioSample; SAMN00806400
DR   Coriell; ND02689
DR   Wikidata; Q54910521
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02690
AC   CVCL_1W46
SY   ND-2690
DR   CLO; CLO_0014288
DR   BioSample; SAMN00806402
DR   Coriell; ND02690
DR   Wikidata; Q54910522
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND02691
AC   CVCL_CC18
DR   CLO; CLO_0014289
DR   BioSample; SAMN00806404
DR   Coriell; ND02691
DR   Wikidata; Q54910523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02692
AC   CVCL_IL39
DR   CLO; CLO_0014285
DR   Coriell; ND02692
DR   Wikidata; Q54910524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND02692; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND02693
AC   CVCL_CC19
DR   CLO; CLO_0013900
DR   Coriell; ND02693
DR   Wikidata; Q54910525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02698
AC   CVCL_DV50
DR   Coriell; ND02698
DR   Wikidata; Q54910526
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02701
AC   CVCL_FW63
DR   Coriell; ND02701
DR   Wikidata; Q54910527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02703
AC   CVCL_HT11
DR   Coriell; ND02703
DR   Wikidata; Q54910528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02704
AC   CVCL_HT12
DR   Coriell; ND02704
DR   Wikidata; Q54910529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02706
AC   CVCL_HT13
DR   Coriell; ND02706
DR   Wikidata; Q54910530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02707
AC   CVCL_HT14
DR   Coriell; ND02707
DR   Wikidata; Q54910531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02708
AC   CVCL_CC20
DR   CLO; CLO_0013899
DR   BioSample; SAMN00806414
DR   Coriell; ND02708
DR   Wikidata; Q54910535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02710
AC   CVCL_CC21
DR   CLO; CLO_0013896
DR   BioSample; SAMN00806416
DR   Coriell; ND02710
DR   Wikidata; Q54910536
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02712
AC   CVCL_CC22
DR   CLO; CLO_0013863
DR   BioSample; SAMN00806418
DR   Coriell; ND02712
DR   Wikidata; Q54910537
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02713
AC   CVCL_GT13
DR   CLO; CLO_0013864
DR   Coriell; ND02713
DR   Wikidata; Q54910538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02714
AC   CVCL_CC23
DR   CLO; CLO_0013865
DR   BioSample; SAMN00806422
DR   Coriell; ND02714
DR   Wikidata; Q54910539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02715
AC   CVCL_ES10
DR   CLO; CLO_0013866
DR   BioSample; SAMN00806424
DR   Coriell; ND02715
DR   Wikidata; Q54910540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02716
AC   CVCL_DV51
DR   CLO; CLO_0013856
DR   Coriell; ND02716
DR   Wikidata; Q54910541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02719
AC   CVCL_FH53
DR   Coriell; ND02719
DR   Wikidata; Q54910542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02722
AC   CVCL_DV52
DR   Coriell; ND02722
DR   Wikidata; Q54910543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02729
AC   CVCL_HT15
DR   Coriell; ND02729
DR   Wikidata; Q54910544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02730
AC   CVCL_FW64
DR   Coriell; ND02730
DR   Wikidata; Q54910545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02742
AC   CVCL_FH54
DR   CLO; CLO_0013857
DR   Coriell; ND02742
DR   Wikidata; Q54910546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02743
AC   CVCL_GY69
DR   CLO; CLO_0013858
DR   Coriell; ND02743
DR   Wikidata; Q54910547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02744
AC   CVCL_CC24
DR   CLO; CLO_0013846
DR   BioSample; SAMN00806436
DR   Coriell; ND02744
DR   Wikidata; Q54910548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02746
AC   CVCL_CY77
DR   CLO; CLO_0013844
DR   Coriell; ND02746
DR   Wikidata; Q54910549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02747
AC   CVCL_CY78
DR   CLO; CLO_0013849
DR   BioSample; SAMN00806440
DR   Coriell; ND02747
DR   Wikidata; Q54910550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02748
AC   CVCL_IA25
DR   Coriell; ND02748
DR   Wikidata; Q54910551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02749
AC   CVCL_IA26
DR   Coriell; ND02749
DR   Wikidata; Q54910552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02750
AC   CVCL_CC25
DR   CLO; CLO_0013848
DR   BioSample; SAMN00806442
DR   Coriell; ND02750
DR   Wikidata; Q54910553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02751
AC   CVCL_1W47
SY   ND-2751
DR   CLO; CLO_0015220
DR   BioSample; SAMN00806444
DR   Coriell; ND02751
DR   Wikidata; Q54910554
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND02752
AC   CVCL_CC26
DR   CLO; CLO_0015219
DR   Coriell; ND02752
DR   Wikidata; Q54910555
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND02752).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND02753
AC   CVCL_CC27
DR   CLO; CLO_0015222
DR   Coriell; ND02753
DR   Wikidata; Q54910556
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02754
AC   CVCL_CC28
DR   CLO; CLO_0015221
DR   Coriell; ND02754
DR   Wikidata; Q54910557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02755
AC   CVCL_CC29
DR   CLO; CLO_0015218
DR   BioSample; SAMN00806446
DR   Coriell; ND02755
DR   Wikidata; Q54910558
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02756
AC   CVCL_GB32
DR   CLO; CLO_0015217
DR   BioSample; SAMN00806448
DR   Coriell; ND02756
DR   Wikidata; Q54910559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02757
AC   CVCL_CC30
DR   CLO; CLO_0015227
DR   Coriell; ND02757
DR   Wikidata; Q54910560
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02759
AC   CVCL_CC31
DR   CLO; CLO_0015223
DR   BioSample; SAMN00806450
DR   Coriell; ND02759
DR   Wikidata; Q54910561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02760
AC   CVCL_1W48
SY   ND-2760
DR   CLO; CLO_0015224
DR   BioSample; SAMN00806452
DR   Coriell; ND02760
DR   Wikidata; Q54910562
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND02761
AC   CVCL_CC32
DR   CLO; CLO_0015225
DR   Coriell; ND02761
DR   Wikidata; Q54910563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02762
AC   CVCL_CC33
DR   CLO; CLO_0015226
DR   Coriell; ND02762
DR   Wikidata; Q54910564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02765
AC   CVCL_HT16
DR   Coriell; ND02765
DR   Wikidata; Q54910565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02767
AC   CVCL_HT17
DR   Coriell; ND02767
DR   Wikidata; Q54910566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02768
AC   CVCL_FH55
DR   CLO; CLO_0015232
DR   Coriell; ND02768
DR   Wikidata; Q54910567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02771
AC   CVCL_CC34
DR   BioSample; SAMN00806458
DR   Coriell; ND02771
DR   Wikidata; Q54910568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02773
AC   CVCL_IA27
DR   Coriell; ND02773
DR   Wikidata; Q54910569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02774
AC   CVCL_IA28
DR   Coriell; ND02774
DR   Wikidata; Q54910570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02778
AC   CVCL_IA29
DR   Coriell; ND02778
DR   Wikidata; Q54910571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02782
AC   CVCL_DV53
DR   CLO; CLO_0015231
DR   Coriell; ND02782
DR   Wikidata; Q54910572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02783
AC   CVCL_DV54
DR   Coriell; ND02783
DR   Wikidata; Q54910573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02784
AC   CVCL_IA30
DR   Coriell; ND02784
DR   Wikidata; Q54910574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02787
AC   CVCL_IA31
DR   Coriell; ND02787
DR   Wikidata; Q54910578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02788
AC   CVCL_IA32
DR   Coriell; ND02788
DR   Wikidata; Q54910579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02791
AC   CVCL_DV55
DR   Coriell; ND02791
DR   Wikidata; Q54910580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02792
AC   CVCL_DV56
DR   Coriell; ND02792
DR   Wikidata; Q54910581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02794
AC   CVCL_HT18
DR   Coriell; ND02794
DR   Wikidata; Q54910582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02795
AC   CVCL_FH56
DR   CLO; CLO_0015230
DR   Coriell; ND02795
DR   Wikidata; Q54910583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02796
AC   CVCL_GT14
DR   CLO; CLO_0015229
DR   Coriell; ND02796
DR   Wikidata; Q54910584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02797
AC   CVCL_CC35
DR   CLO; CLO_0015228
DR   Coriell; ND02797
DR   Wikidata; Q54910585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02798
AC   CVCL_CC36
DR   CLO; CLO_0015237
DR   BioSample; SAMN00806466
DR   Coriell; ND02798
DR   Wikidata; Q54910586
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02799
AC   CVCL_IA33
DR   BioSample; SAMN00806468
DR   Coriell; ND02799
DR   Wikidata; Q54910587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND02801
AC   CVCL_GB33
DR   CLO; CLO_0015238
DR   BioSample; SAMN00806470
DR   Coriell; ND02801
DR   Wikidata; Q54910588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02803
AC   CVCL_IA34
DR   Coriell; ND02803
DR   Wikidata; Q54910589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02804
AC   CVCL_IA35
DR   Coriell; ND02804
DR   Wikidata; Q54910590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02805
AC   CVCL_IA36
DR   Coriell; ND02805
DR   Wikidata; Q54910591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02807
AC   CVCL_GB34
DR   CLO; CLO_0015235
DR   Coriell; ND02807
DR   Wikidata; Q54910592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02808
AC   CVCL_GB35
DR   CLO; CLO_0015236
DR   Coriell; ND02808
DR   Wikidata; Q54910593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02809
AC   CVCL_CC37
DR   CLO; CLO_0015233
DR   BioSample; SAMN00806472
DR   Coriell; ND02809
DR   Wikidata; Q54910594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02810
AC   CVCL_ES11
DR   CLO; CLO_0015234
DR   BioSample; SAMN00806474
DR   Coriell; ND02810
DR   Wikidata; Q54910595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02811
AC   CVCL_CC38
DR   CLO; CLO_0015196
DR   BioSample; SAMN00806476
DR   Coriell; ND02811
DR   Wikidata; Q54910596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02812
AC   CVCL_GY70
DR   CLO; CLO_0015195
DR   Coriell; ND02812
DR   Wikidata; Q54910597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02813
AC   CVCL_AB59
DR   CLO; CLO_0015198
DR   Coriell; ND02813
DR   Wikidata; Q54910598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   NCIt; C125695; Striatonigral degeneration
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   ND02814
AC   CVCL_IA37
DR   Coriell; ND02814
DR   Wikidata; Q54910599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02815
AC   CVCL_CY79
DR   CLO; CLO_0015197
DR   Coriell; ND02815
DR   Wikidata; Q54910600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02817
AC   CVCL_EH37
DR   CLO; CLO_0015199
DR   Coriell; ND02817
DR   Wikidata; Q54910601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02818
AC   CVCL_IA38
DR   Coriell; ND02818
DR   Wikidata; Q54910602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02819
AC   CVCL_CC39
DR   CLO; CLO_0015200
DR   BioSample; SAMN00806489
DR   Coriell; ND02819
DR   Wikidata; Q54910603
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND02820
AC   CVCL_ES12
DR   CLO; CLO_0015201
DR   BioSample; SAMN00806491
DR   Coriell; ND02820
DR   Wikidata; Q54910604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02822
AC   CVCL_IA39
DR   Coriell; ND02822
DR   Wikidata; Q54910605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02823
AC   CVCL_IA40
DR   Coriell; ND02823
DR   Wikidata; Q54910606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02833
AC   CVCL_DV57
DR   CLO; CLO_0015202
DR   Coriell; ND02833
DR   Wikidata; Q54910607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02835
AC   CVCL_FH57
DR   CLO; CLO_0015203
DR   Coriell; ND02835
DR   Wikidata; Q54910608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02836
AC   CVCL_GY71
DR   CLO; CLO_0015204
DR   Coriell; ND02836
DR   Wikidata; Q54910609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02837
AC   CVCL_GY72
DR   CLO; CLO_0015205
DR   Coriell; ND02837
DR   Wikidata; Q54910610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02838
AC   CVCL_GY73
DR   CLO; CLO_0015208
DR   Coriell; ND02838
DR   Wikidata; Q54910611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02839
AC   CVCL_FH58
DR   CLO; CLO_0015207
DR   Coriell; ND02839
DR   Wikidata; Q54910612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02840
AC   CVCL_GY74
DR   CLO; CLO_0015206
DR   Coriell; ND02840
DR   Wikidata; Q54910613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02842
AC   CVCL_IA41
DR   Coriell; ND02842
DR   Wikidata; Q54910614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02845
AC   CVCL_CC40
DR   CLO; CLO_0015211
DR   BioSample; SAMN00806505
DR   Coriell; ND02845
DR   Wikidata; Q54910616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02849
AC   CVCL_CC41
DR   CLO; CLO_0015212
DR   Coriell; ND02849
DR   Wikidata; Q54910617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02851
AC   CVCL_IA42
DR   Coriell; ND02851
DR   Wikidata; Q54910618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02852
AC   CVCL_CC42
DR   CLO; CLO_0015209
DR   BioSample; SAMN00806507
DR   Coriell; ND02852
DR   Wikidata; Q54910621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02853
AC   CVCL_GB36
DR   CLO; CLO_0015210
DR   BioSample; SAMN00806509
DR   Coriell; ND02853
DR   Wikidata; Q54910623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02854
AC   CVCL_CC43
DR   CLO; CLO_0015215
DR   BioSample; SAMN00806511
DR   Coriell; ND02854
DR   Wikidata; Q54910624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02855
AC   CVCL_GB37
DR   CLO; CLO_0015216
DR   BioSample; SAMN00806513
DR   Coriell; ND02855
DR   Wikidata; Q54910625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02856
AC   CVCL_CC44
DR   CLO; CLO_0015213
DR   BioSample; SAMN00806515
DR   Coriell; ND02856
DR   Wikidata; Q54910626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02857
AC   CVCL_GY75
DR   CLO; CLO_0015214
DR   Coriell; ND02857
DR   Wikidata; Q54910627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02858
AC   CVCL_CC45
DR   CLO; CLO_0015160
DR   BioSample; SAMN00806519
DR   Coriell; ND02858
DR   Wikidata; Q54910628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02859
AC   CVCL_GY76
DR   CLO; CLO_0015162
DR   Coriell; ND02859
DR   Wikidata; Q54910629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02860
AC   CVCL_GY77
DR   CLO; CLO_0015173
DR   Coriell; ND02860
DR   Wikidata; Q54910630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02861
AC   CVCL_CC46
DR   CLO; CLO_0015170
DR   BioSample; SAMN00806525
DR   Coriell; ND02861
DR   Wikidata; Q54910631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02862
AC   CVCL_1W49
SY   ND-2862
DR   CLO; CLO_0015169
DR   BioSample; SAMN00806527
DR   Coriell; ND02862
DR   Wikidata; Q54910632
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02863
AC   CVCL_CC47
DR   CLO; CLO_0015172
DR   BioSample; SAMN00806529
DR   Coriell; ND02863
DR   Wikidata; Q54910633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02864
AC   CVCL_1W50
SY   ND-2864
DR   CLO; CLO_0015171
DR   BioSample; SAMN00806531
DR   Coriell; ND02864
DR   Wikidata; Q54910634
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND02866
AC   CVCL_FW65
DR   Coriell; ND02866
DR   Wikidata; Q54910635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02867
AC   CVCL_FH59
DR   CLO; CLO_0015166
DR   Coriell; ND02867
DR   Wikidata; Q54910636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02868
AC   CVCL_GY78
DR   CLO; CLO_0015165
DR   Coriell; ND02868
DR   Wikidata; Q54910637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02869
AC   CVCL_GY79
DR   CLO; CLO_0015168
DR   Coriell; ND02869
DR   Wikidata; Q54910638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02871
AC   CVCL_IA43
DR   Coriell; ND02871
DR   Wikidata; Q54910639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02872
AC   CVCL_IA44
DR   Coriell; ND02872
DR   Wikidata; Q54910640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02873
AC   CVCL_IA45
DR   Coriell; ND02873
DR   Wikidata; Q54910641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02874
AC   CVCL_IA46
DR   Coriell; ND02874
DR   Wikidata; Q54910642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02892
AC   CVCL_CC48
DR   CLO; CLO_0015167
DR   Coriell; ND02892
DR   Wikidata; Q54910643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02893
AC   CVCL_CC49
DR   CLO; CLO_0015182
DR   BioSample; SAMN00806541
DR   Coriell; ND02893
DR   Wikidata; Q54910644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02895
AC   CVCL_IA47
DR   Coriell; ND02895
DR   Wikidata; Q54910645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02896
AC   CVCL_IA48
DR   Coriell; ND02896
DR   Wikidata; Q54910646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02897
AC   CVCL_IA49
DR   Coriell; ND02897
DR   Wikidata; Q54910647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02899
AC   CVCL_FE98
DR   Coriell; ND02899
DR   Wikidata; Q54910648
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02901
AC   CVCL_HT19
DR   Coriell; ND02901
DR   Wikidata; Q54910649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02907
AC   CVCL_HT20
DR   Coriell; ND02907
DR   Wikidata; Q54910650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02908
AC   CVCL_HT21
DR   Coriell; ND02908
DR   Wikidata; Q54910651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02911
AC   CVCL_DV58
DR   Coriell; ND02911
DR   Wikidata; Q54910652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02912
AC   CVCL_DV59
DR   Coriell; ND02912
DR   Wikidata; Q54910653
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02915
AC   CVCL_HT22
DR   Coriell; ND02915
DR   Wikidata; Q54910654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02916
AC   CVCL_CC50
DR   CLO; CLO_0015194
DR   Coriell; ND02916
DR   Wikidata; Q54910655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02917
AC   CVCL_IA50
DR   Coriell; ND02917
DR   Wikidata; Q54910656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02918
AC   CVCL_CC51
DR   CLO; CLO_0015193
DR   Coriell; ND02918
DR   Wikidata; Q54910657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02919
AC   CVCL_FH60
DR   CLO; CLO_0015192
DR   Coriell; ND02919
DR   Wikidata; Q54910658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02920
AC   CVCL_FH61
DR   CLO; CLO_0015191
DR   Coriell; ND02920
DR   Wikidata; Q54910659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02921
AC   CVCL_GY80
DR   CLO; CLO_0015190
DR   Coriell; ND02921
DR   Wikidata; Q54910660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02923
AC   CVCL_HT23
DR   Coriell; ND02923
DR   Wikidata; Q54910661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02924
AC   CVCL_GY81
DR   CLO; CLO_0015189
DR   Coriell; ND02924
DR   Wikidata; Q54910667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02925
AC   CVCL_CY80
DR   CLO; CLO_0015188
DR   Coriell; ND02925
DR   Wikidata; Q54910668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02926
AC   CVCL_CY81
DR   CLO; CLO_0015187
DR   Coriell; ND02926
DR   Wikidata; Q54910669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02927
AC   CVCL_GB38
DR   CLO; CLO_0015186
DR   Coriell; ND02927
DR   Wikidata; Q54910670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02928
AC   CVCL_IK49
DR   Coriell; ND02928
DR   Wikidata; Q54910671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   ND02930
AC   CVCL_DV60
DR   CLO; CLO_0015185
DR   Coriell; ND02930
DR   Wikidata; Q54910672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02931
AC   CVCL_DV61
DR   CLO; CLO_0015108
DR   Coriell; ND02931
DR   Wikidata; Q54910673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02938
AC   CVCL_DV62
DR   Coriell; ND02938
DR   Wikidata; Q54910674
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02939
AC   CVCL_IA51
DR   Coriell; ND02939
DR   Wikidata; Q54910675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02958
AC   CVCL_CC52
DR   CLO; CLO_0015110
DR   BioSample; SAMN00806561
DR   Coriell; ND02958
DR   Wikidata; Q54910676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02959
AC   CVCL_GY82
DR   CLO; CLO_0015109
DR   Coriell; ND02959
DR   Wikidata; Q54910677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02960
AC   CVCL_CC53
DR   CLO; CLO_0015101
DR   BioSample; SAMN00806565
DR   Coriell; ND02960
DR   Wikidata; Q54910678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02961
AC   CVCL_ES13
DR   CLO; CLO_0015100
DR   BioSample; SAMN00806567
DR   Coriell; ND02961
DR   Wikidata; Q54910679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02962
AC   CVCL_CC54
DR   CLO; CLO_0015104
DR   BioSample; SAMN00806569
DR   Coriell; ND02962
DR   Wikidata; Q54910680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND02964
AC   CVCL_CC55
DR   CLO; CLO_0015103
DR   Coriell; ND02964
DR   Wikidata; Q54910681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02965
AC   CVCL_FH62
DR   CLO; CLO_0015106
DR   Coriell; ND02965
DR   Wikidata; Q54910682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02966
AC   CVCL_IG93
DR   CLO; CLO_0015105
DR   Coriell; ND02966
DR   Wikidata; Q54910683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02967
AC   CVCL_FH63
DR   Coriell; ND02967
DR   Wikidata; Q54910684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02972
AC   CVCL_DV63
DR   Coriell; ND02972
DR   Wikidata; Q54910685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02976
AC   CVCL_FW66
DR   Coriell; ND02976
DR   Wikidata; Q54910686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02978
AC   CVCL_CC56
DR   CLO; CLO_0015107
DR   Coriell; ND02978
DR   Wikidata; Q54910687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02979
AC   CVCL_CC57
DR   CLO; CLO_0015152
DR   Coriell; ND02979
DR   Wikidata; Q54910688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND02980
AC   CVCL_FH64
DR   Coriell; ND02980
DR   Wikidata; Q54910689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02983
AC   CVCL_IA52
DR   Coriell; ND02983
DR   Wikidata; Q54910690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02984
AC   CVCL_DV64
DR   Coriell; ND02984
DR   Wikidata; Q54910691
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02985
AC   CVCL_DV65
DR   Coriell; ND02985
DR   Wikidata; Q54910692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02987
AC   CVCL_FW67
DR   Coriell; ND02987
DR   Wikidata; Q54910693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02988
AC   CVCL_DV66
DR   CLO; CLO_0015151
DR   Coriell; ND02988
DR   Wikidata; Q54910694
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND02989
AC   CVCL_DV67
DR   CLO; CLO_0015150
DR   Coriell; ND02989
DR   Wikidata; Q54910695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND02993
AC   CVCL_HT24
DR   Coriell; ND02993
DR   Wikidata; Q54910696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02994
AC   CVCL_FW68
DR   Coriell; ND02994
DR   Wikidata; Q54910697
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND02995
AC   CVCL_FH65
DR   CLO; CLO_0015149
DR   Coriell; ND02995
DR   Wikidata; Q54910698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02996
AC   CVCL_FH66
DR   CLO; CLO_0015144
DR   Coriell; ND02996
DR   Wikidata; Q54910699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02997
AC   CVCL_HY30
DR   CLO; CLO_0015142
DR   Coriell; ND02997
DR   Wikidata; Q54910700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND02998
AC   CVCL_FH67
DR   CLO; CLO_0015141
DR   Coriell; ND02998
DR   Wikidata; Q54910701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND02999
AC   CVCL_FH68
DR   CLO; CLO_0015139
DR   Coriell; ND02999
DR   Wikidata; Q54910703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03000
AC   CVCL_CC58
DR   CLO; CLO_0015147
DR   Coriell; ND03000
DR   Wikidata; Q54910704
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND03000).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND03001
AC   CVCL_CC59
DR   CLO; CLO_0015146
DR   BioSample; SAMN00806591
DR   Coriell; ND03001
DR   Wikidata; Q54910705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03002
AC   CVCL_HM26
DR   CLO; CLO_0014597
DR   Coriell; ND03002
DR   Wikidata; Q54910706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03003
AC   CVCL_CC60
DR   CLO; CLO_0014595
DR   Coriell; ND03003
DR   Wikidata; Q54910707
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03004
AC   CVCL_CC61
DR   CLO; CLO_0014574
DR   BioSample; SAMN00806595
DR   Coriell; ND03004
DR   Wikidata; Q54910715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03012
AC   CVCL_DV68
DR   Coriell; ND03012
DR   Wikidata; Q54910716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03015
AC   CVCL_FW69
DR   Coriell; ND03015
DR   Wikidata; Q54910717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03016
AC   CVCL_HT25
DR   Coriell; ND03016
DR   Wikidata; Q54910718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03017
AC   CVCL_HT26
DR   Coriell; ND03017
DR   Wikidata; Q54910719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03021
AC   CVCL_HT27
DR   Coriell; ND03021
DR   Wikidata; Q54910720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03043
AC   CVCL_FH69
DR   CLO; CLO_0014575
DR   Coriell; ND03043
DR   Wikidata; Q54910721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03044
AC   CVCL_FR82
DR   CLO; CLO_0014576
DR   Coriell; ND03044
DR   Wikidata; Q54910722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03045
AC   CVCL_FR83
DR   CLO; CLO_0014578
DR   Coriell; ND03045
DR   Wikidata; Q54910723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03047
AC   CVCL_1W51
SY   ND-3047
DR   CLO; CLO_0014581
DR   BioSample; SAMN00806611
DR   Coriell; ND03047
DR   Wikidata; Q54910724
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03048
AC   CVCL_IA53
DR   Coriell; ND03048
DR   Wikidata; Q54910725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03049
AC   CVCL_DV69
DR   CLO; CLO_0014584
DR   Coriell; ND03049
DR   Wikidata; Q54910726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03050
AC   CVCL_IA54
DR   Coriell; ND03050
DR   Wikidata; Q54910727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03051
AC   CVCL_FW70
DR   Coriell; ND03051
DR   Wikidata; Q54910728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03052
AC   CVCL_IA55
DR   CLO; CLO_0014587
DR   Coriell; ND03052
DR   Wikidata; Q54910729
CC   Population: Caucasian; Welsh.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03053
AC   CVCL_HM27
DR   CLO; CLO_0014588
DR   Coriell; ND03053
DR   Wikidata; Q54910730
CC   Population: Caucasian; Welsh.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03054
AC   CVCL_IA56
DR   Coriell; ND03054
DR   Wikidata; Q54910731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03055
AC   CVCL_CC62
DR   CLO; CLO_0014553
DR   Coriell; ND03055
DR   Wikidata; Q54910732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03058
AC   CVCL_HT28
DR   Coriell; ND03058
DR   Wikidata; Q54910733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03061
AC   CVCL_HT29
DR   Coriell; ND03061
DR   Wikidata; Q54910734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03063
AC   CVCL_HT30
DR   Coriell; ND03063
DR   Wikidata; Q54910735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03071
AC   CVCL_1W52
SY   ND-3071
DR   CLO; CLO_0014558
DR   BioSample; SAMN00806623
DR   Coriell; ND03071
DR   Wikidata; Q54910736
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND03072
AC   CVCL_CC63
DR   CLO; CLO_0014556
DR   BioSample; SAMN00806625
DR   Coriell; ND03072
DR   Wikidata; Q54910737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03073
AC   CVCL_IA57
DR   CLO; CLO_0014547
DR   Coriell; ND03073
DR   Wikidata; Q54910738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03074
AC   CVCL_FH70
DR   CLO; CLO_0014548
DR   Coriell; ND03074
DR   Wikidata; Q54910739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03075
AC   CVCL_FH71
DR   CLO; CLO_0014545
DR   Coriell; ND03075
DR   Wikidata; Q54910740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03076
AC   CVCL_FH72
DR   CLO; CLO_0014546
DR   Coriell; ND03076
DR   Wikidata; Q54910742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03077
AC   CVCL_DV70
DR   Coriell; ND03077
DR   Wikidata; Q54910743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03084
AC   CVCL_DV71
DR   Coriell; ND03084
DR   Wikidata; Q54910744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03085
AC   CVCL_HQ67
DR   CLO; CLO_0014543
DR   Coriell; ND03085
DR   Wikidata; Q54910745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03086
AC   CVCL_IA58
DR   Coriell; ND03086
DR   Wikidata; Q54910746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03087
AC   CVCL_IA59
DR   Coriell; ND03087
DR   Wikidata; Q54910747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03088
AC   CVCL_DV72
DR   CLO; CLO_0014544
DR   Coriell; ND03088
DR   Wikidata; Q54910748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03089
AC   CVCL_DV73
DR   CLO; CLO_0014537
DR   Coriell; ND03089
DR   Wikidata; Q54910749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03090
AC   CVCL_CC64
DR   CLO; CLO_0014513
DR   BioSample; SAMN00806635
DR   Coriell; ND03090
DR   Wikidata; Q54910750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03091
AC   CVCL_HM28
DR   CLO; CLO_0014512
DR   Coriell; ND03091
DR   Wikidata; Q54910751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03092
AC   CVCL_CC65
DR   CLO; CLO_0014509
DR   Coriell; ND03092
DR   Wikidata; Q54910752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03093
AC   CVCL_CC66
DR   CLO; CLO_0014508
DR   Coriell; ND03093
DR   Wikidata; Q54910753
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03094
AC   CVCL_1W53
SY   ND-3094
DR   CLO; CLO_0014503
DR   Coriell; ND03094
DR   Wikidata; Q54910754
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03095
AC   CVCL_CC67
DR   CLO; CLO_0014504
DR   BioSample; SAMN00806639
DR   Coriell; ND03095
DR   Wikidata; Q54910755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03096
AC   CVCL_1W54
SY   ND-3096
DR   CLO; CLO_0014505
DR   BioSample; SAMN00806641
DR   Coriell; ND03096
DR   Wikidata; Q54910759
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03098
AC   CVCL_HT31
DR   Coriell; ND03098
DR   Wikidata; Q54910760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03099
AC   CVCL_HT32
DR   Coriell; ND03099
DR   Wikidata; Q54910761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03101
AC   CVCL_CC68
DR   CLO; CLO_0014506
DR   BioSample; SAMN00806646
DR   Coriell; ND03101
DR   Wikidata; Q54910762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03102
AC   CVCL_1W55
SY   ND-3102
DR   CLO; CLO_0014497
DR   BioSample; SAMN00806648
DR   Coriell; ND03102
DR   Wikidata; Q54910763
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03103
AC   CVCL_CC69
DR   CLO; CLO_0014498
DR   Coriell; ND03103
DR   Wikidata; Q54910764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03104
AC   CVCL_GB39
DR   CLO; CLO_0014476
DR   Coriell; ND03104
DR   Wikidata; Q54910765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03105
AC   CVCL_DV74
DR   Coriell; ND03105
DR   Wikidata; Q54910766
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03106
AC   CVCL_DV75
DR   CLO; CLO_0014468
DR   Coriell; ND03106
DR   Wikidata; Q54910767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03107
AC   CVCL_ES14
DR   CLO; CLO_0014466
DR   Coriell; ND03107
DR   Wikidata; Q54910768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03110
AC   CVCL_1W56
SY   ND-3110
DR   CLO; CLO_0014472
DR   Coriell; ND03110
DR   Wikidata; Q54910769
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03118
AC   CVCL_FC22
DR   CLO; CLO_0014470
DR   Coriell; ND03118
DR   Wikidata; Q54910770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03123
AC   CVCL_1W57
SY   ND-3123
DR   CLO; CLO_0012869
DR   Coriell; ND03123
DR   Wikidata; Q54910771
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03125
AC   CVCL_1W58
SY   ND-3125
DR   CLO; CLO_0012867
DR   Coriell; ND03125
DR   Wikidata; Q54910772
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03126
AC   CVCL_ES15
DR   CLO; CLO_0012873
DR   Coriell; ND03126
DR   Wikidata; Q54910773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03128
AC   CVCL_ES16
DR   CLO; CLO_0012871
DR   Coriell; ND03128
DR   Wikidata; Q54910774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03134
AC   CVCL_FC23
DR   CLO; CLO_0012864
DR   Coriell; ND03134
DR   Wikidata; Q54910775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03136
AC   CVCL_GB40
DR   CLO; CLO_0012839
DR   Coriell; ND03136
DR   Wikidata; Q54910776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03137
AC   CVCL_GB41
DR   CLO; CLO_0012840
DR   Coriell; ND03137
DR   Wikidata; Q54910777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03138
AC   CVCL_IA60
DR   Coriell; ND03138
DR   Wikidata; Q54910778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03140
AC   CVCL_DV76
DR   Coriell; ND03140
DR   Wikidata; Q54910779
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03142
AC   CVCL_DV77
DR   CLO; CLO_0012835
DR   Coriell; ND03142
DR   Wikidata; Q54910780
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03143
AC   CVCL_HT33
DR   Coriell; ND03143
DR   Wikidata; Q54910781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03144
AC   CVCL_FH73
DR   CLO; CLO_0012836
DR   Coriell; ND03144
DR   Wikidata; Q54910782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03145
AC   CVCL_FH74
DR   CLO; CLO_0012837
DR   Coriell; ND03145
DR   Wikidata; Q54910783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03146
AC   CVCL_HM29
DR   CLO; CLO_0012838
DR   Coriell; ND03146
DR   Wikidata; Q54910784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03147
AC   CVCL_FH75
DR   CLO; CLO_0012915
DR   Coriell; ND03147
DR   Wikidata; Q54910785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03148
AC   CVCL_HM30
DR   CLO; CLO_0012911
DR   Coriell; ND03148
DR   Wikidata; Q54910786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03149
AC   CVCL_IA61
DR   Coriell; ND03149
DR   Wikidata; Q54910787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03151
AC   CVCL_FH76
DR   Coriell; ND03151
DR   Wikidata; Q54910788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03154
AC   CVCL_IA62
DR   Coriell; ND03154
DR   Wikidata; Q54910789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03157
AC   CVCL_HT34
DR   Coriell; ND03157
DR   Wikidata; Q54910790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03158
AC   CVCL_FW71
DR   Coriell; ND03158
DR   Wikidata; Q54910791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03159
AC   CVCL_IG94
DR   CLO; CLO_0012910
DR   Coriell; ND03159
DR   Wikidata; Q54910792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03167
AC   CVCL_DV78
DR   Coriell; ND03167
DR   Wikidata; Q54910793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03168
AC   CVCL_IA63
DR   Coriell; ND03168
DR   Wikidata; Q54910794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03169
AC   CVCL_HT35
DR   Coriell; ND03169
DR   Wikidata; Q54910795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03172
AC   CVCL_DV79
DR   CLO; CLO_0012908
DR   Coriell; ND03172
DR   Wikidata; Q54910796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03173
AC   CVCL_DV80
DR   CLO; CLO_0012880
DR   Coriell; ND03173
DR   Wikidata; Q54910797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03174
AC   CVCL_IA64
DR   Coriell; ND03174
DR   Wikidata; Q54910798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03178
AC   CVCL_HQ68
DR   CLO; CLO_0012878
DR   Coriell; ND03178
DR   Wikidata; Q54910803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03179
AC   CVCL_IG95
DR   CLO; CLO_0012879
DR   Coriell; ND03179
DR   Wikidata; Q54910804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03180
AC   CVCL_DV81
DR   Coriell; ND03180
DR   Wikidata; Q54910805
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03182
AC   CVCL_HT36
DR   Coriell; ND03182
DR   Wikidata; Q54910806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03194
AC   CVCL_HT37
DR   Coriell; ND03194
DR   Wikidata; Q54910807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03195
AC   CVCL_HQ69
DR   CLO; CLO_0012876
DR   Coriell; ND03195
DR   Wikidata; Q54910808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03196
AC   CVCL_DV82
DR   CLO; CLO_0012877
DR   Coriell; ND03196
DR   Wikidata; Q54910809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03197
AC   CVCL_DV83
DR   CLO; CLO_0012874
DR   Coriell; ND03197
DR   Wikidata; Q54910810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03203
AC   CVCL_FC24
DR   CLO; CLO_0012875
DR   Coriell; ND03203
DR   Wikidata; Q54910811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03209
AC   CVCL_FW72
DR   Coriell; ND03209
DR   Wikidata; Q54910812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03210
AC   CVCL_FW73
DR   Coriell; ND03210
DR   Wikidata; Q54910813
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03211
AC   CVCL_FW74
DR   Coriell; ND03211
DR   Wikidata; Q54910814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03212
AC   CVCL_FH77
DR   CLO; CLO_0012933
DR   Coriell; ND03212
DR   Wikidata; Q54910815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03213
AC   CVCL_GT67
DR   CLO; CLO_0012931
DR   Coriell; ND03213
DR   Wikidata; Q54910816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03214
AC   CVCL_GT68
DR   CLO; CLO_0012936
DR   Coriell; ND03214
DR   Wikidata; Q54910817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03215
AC   CVCL_GB42
DR   CLO; CLO_0012916
DR   Coriell; ND03215
DR   Wikidata; Q54910818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03217
AC   CVCL_HT38
DR   Coriell; ND03217
DR   Wikidata; Q54910819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03227
AC   CVCL_1W59
SY   ND-3227
DR   CLO; CLO_0012917
DR   Coriell; ND03227
DR   Wikidata; Q54910820
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03228
AC   CVCL_GB43
DR   CLO; CLO_0012918
DR   Coriell; ND03228
DR   Wikidata; Q54910821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03229
AC   CVCL_1W60
SY   ND-3229
DR   CLO; CLO_0012919
DR   Coriell; ND03229
DR   Wikidata; Q54910822
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03230
AC   CVCL_DV84
DR   CLO; CLO_0012920
DR   Coriell; ND03230
DR   Wikidata; Q54910823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03231
AC   CVCL_1W61
SY   ND-3231
DR   CLO; CLO_0012921
DR   Coriell; ND03231
DR   Wikidata; Q54910824
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03236
AC   CVCL_HT39
DR   Coriell; ND03236
DR   Wikidata; Q54910825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03237
AC   CVCL_IL40
DR   Coriell; ND03237
DR   Wikidata; Q54910826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03241
AC   CVCL_FH78
DR   CLO; CLO_0012922
DR   Coriell; ND03241
DR   Wikidata; Q54910827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03242
AC   CVCL_HY31
DR   CLO; CLO_0012923
DR   Coriell; ND03242
DR   Wikidata; Q54910828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03243
AC   CVCL_HY32
DR   CLO; CLO_0012957
DR   Coriell; ND03243
DR   Wikidata; Q54910829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03244
AC   CVCL_FH79
DR   CLO; CLO_0012954
DR   Coriell; ND03244
DR   Wikidata; Q54910830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03245
AC   CVCL_IA65
DR   CLO; CLO_0012945
DR   Coriell; ND03245
DR   Wikidata; Q54910831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03247
AC   CVCL_IA66
DR   Coriell; ND03247
DR   Wikidata; Q54910832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03248
AC   CVCL_IA67
DR   Coriell; ND03248
DR   Wikidata; Q54910833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03250
AC   CVCL_IA68
DR   Coriell; ND03250
DR   Wikidata; Q54910834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03251
AC   CVCL_DV85
DR   Coriell; ND03251
DR   Wikidata; Q54910835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03252
AC   CVCL_DV86
DR   CLO; CLO_0012939
DR   Coriell; ND03252
DR   Wikidata; Q54910836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03256
AC   CVCL_1W62
SY   ND-3256
DR   CLO; CLO_0012940
DR   Coriell; ND03256
DR   Wikidata; Q54910837
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03257
AC   CVCL_DV87
DR   CLO; CLO_0012937
DR   Coriell; ND03257
DR   Wikidata; Q54910838
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03258
AC   CVCL_DV88
DR   CLO; CLO_0012938
DR   Coriell; ND03258
DR   Wikidata; Q54910839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03259
AC   CVCL_DV89
DR   CLO; CLO_0012943
DR   Coriell; ND03259
DR   Wikidata; Q54910840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03260
AC   CVCL_DV90
DR   CLO; CLO_0012944
DR   Coriell; ND03260
DR   Wikidata; Q54910841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03261
AC   CVCL_1W63
SY   ND-3261
DR   CLO; CLO_0012941
DR   Coriell; ND03261
DR   Wikidata; Q54910842
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03262
AC   CVCL_IA69
DR   Coriell; ND03262
DR   Wikidata; Q54910845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03263
AC   CVCL_IG96
DR   CLO; CLO_0012942
DR   Coriell; ND03263
DR   Wikidata; Q54910846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03266
AC   CVCL_FW75
DR   Coriell; ND03266
DR   Wikidata; Q54910847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03269
AC   CVCL_DV91
DR   Coriell; ND03269
DR   Wikidata; Q54910848
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03273
AC   CVCL_FH80
DR   CLO; CLO_0012970
DR   Coriell; ND03273
DR   Wikidata; Q54910849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03274
AC   CVCL_GT69
DR   CLO; CLO_0012960
DR   Coriell; ND03274
DR   Wikidata; Q54910850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03275
AC   CVCL_GT70
DR   CLO; CLO_0012959
DR   Coriell; ND03275
DR   Wikidata; Q54910851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03276
AC   CVCL_FH81
DR   CLO; CLO_0012966
DR   Coriell; ND03276
DR   Wikidata; Q54910852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03277
AC   CVCL_GT71
DR   CLO; CLO_0012965
DR   Coriell; ND03277
DR   Wikidata; Q54910853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03278
AC   CVCL_GT72
DR   CLO; CLO_0012968
DR   Coriell; ND03278
DR   Wikidata; Q54910854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03279
AC   CVCL_IL41
DR   CLO; CLO_0012967
DR   Coriell; ND03279
DR   Wikidata; Q54910855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND03279; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND03280
AC   CVCL_DV92
DR   CLO; CLO_0012962
DR   Coriell; ND03280
DR   Wikidata; Q54910856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03281
AC   CVCL_CC70
DR   CLO; CLO_0012961
DR   Coriell; ND03281
DR   Wikidata; Q54910857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03282
AC   CVCL_CC71
DR   CLO; CLO_0012964
DR   Coriell; ND03282
DR   Wikidata; Q54910858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03283
AC   CVCL_FW76
DR   CLO; CLO_0012963
DR   Coriell; ND03283
DR   Wikidata; Q54910859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03285
AC   CVCL_FH82
DR   Coriell; ND03285
DR   Wikidata; Q54910862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03287
AC   CVCL_DV93
DR   Coriell; ND03287
DR   Wikidata; Q54910863
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03288
AC   CVCL_DV94
DR   Coriell; ND03288
DR   Wikidata; Q54910864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03289
AC   CVCL_DV95
DR   Coriell; ND03289
DR   Wikidata; Q54910865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03292
AC   CVCL_FW77
DR   Coriell; ND03292
DR   Wikidata; Q54910866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03293
AC   CVCL_IL42
DR   CLO; CLO_0012991
DR   Coriell; ND03293
DR   Wikidata; Q54910867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND03293; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND03294
AC   CVCL_FH83
DR   CLO; CLO_0012990
DR   Coriell; ND03294
DR   Wikidata; Q54910868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03295
AC   CVCL_FH84
DR   CLO; CLO_0012989
DR   Coriell; ND03295
DR   Wikidata; Q54910869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03296
AC   CVCL_IA70
DR   CLO; CLO_0012998
DR   Coriell; ND03296
DR   Wikidata; Q54910870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03297
AC   CVCL_DV96
DR   CLO; CLO_0012997
DR   Coriell; ND03297
DR   Wikidata; Q54910871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03298
AC   CVCL_IA71
DR   Coriell; ND03298
DR   Wikidata; Q54910872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03300
AC   CVCL_DV97
DR   Coriell; ND03300
DR   Wikidata; Q54910873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03303
AC   CVCL_FH85
DR   CLO; CLO_0012996
DR   Coriell; ND03303
DR   Wikidata; Q54910874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03304
AC   CVCL_IA72
DR   Coriell; ND03304
DR   Wikidata; Q54910875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03306
AC   CVCL_HT40
DR   Coriell; ND03306
DR   Wikidata; Q54910876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03307
AC   CVCL_FW78
DR   Coriell; ND03307
DR   Wikidata; Q54910877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03310
AC   CVCL_FW79
DR   CLO; CLO_0012995
DR   Coriell; ND03310
DR   Wikidata; Q54910878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03311
AC   CVCL_FW80
DR   CLO; CLO_0012994
DR   Coriell; ND03311
DR   Wikidata; Q54910879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03312
AC   CVCL_IA73
DR   Coriell; ND03312
DR   Wikidata; Q54910880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03313
AC   CVCL_DV98
DR   CLO; CLO_0012993
DR   Coriell; ND03313
DR   Wikidata; Q54910881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03314
AC   CVCL_DV99
DR   CLO; CLO_0012992
DR   Coriell; ND03314
DR   Wikidata; Q54910882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03315
AC   CVCL_IA74
DR   Coriell; ND03315
DR   Wikidata; Q54910883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03316
AC   CVCL_IA75
DR   Coriell; ND03316
DR   Wikidata; Q54910884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03317
AC   CVCL_IA76
DR   Coriell; ND03317
DR   Wikidata; Q54910885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03318
AC   CVCL_DW00
DR   CLO; CLO_0012326
DR   Coriell; ND03318
DR   Wikidata; Q54910886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03321
AC   CVCL_IA77
DR   Coriell; ND03321
DR   Wikidata; Q54910890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03323
AC   CVCL_IL43
DR   Coriell; ND03323
DR   Wikidata; Q54910891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03324
AC   CVCL_FW81
DR   Coriell; ND03324
DR   Wikidata; Q54910892
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03325
AC   CVCL_HT41
DR   Coriell; ND03325
DR   Wikidata; Q54910893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03326
AC   CVCL_HT42
DR   Coriell; ND03326
DR   Wikidata; Q54910894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03327
AC   CVCL_FW82
DR   Coriell; ND03327
DR   Wikidata; Q54910895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03333
AC   CVCL_CC72
DR   CLO; CLO_0012281
DR   BioSample; SAMN00806740
DR   Coriell; ND03333
DR   Wikidata; Q54910896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03334
AC   CVCL_CC73
DR   CLO; CLO_0012280
DR   BioSample; SAMN00806742
DR   Coriell; ND03334
DR   Wikidata; Q54910897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03335
AC   CVCL_GT73
DR   CLO; CLO_0012283
DR   Coriell; ND03335
DR   Wikidata; Q54910898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03336
AC   CVCL_GT74
DR   CLO; CLO_0012282
DR   Coriell; ND03336
DR   Wikidata; Q54910899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03337
AC   CVCL_GT75
DR   CLO; CLO_0012272
DR   Coriell; ND03337
DR   Wikidata; Q54910900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03338
AC   CVCL_GB44
DR   CLO; CLO_0012270
DR   Coriell; ND03338
DR   Wikidata; Q54910902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03341
AC   CVCL_IA78
DR   Coriell; ND03341
DR   Wikidata; Q54910903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03347
AC   CVCL_CC74
DR   CLO; CLO_0012278
DR   Coriell; ND03347
DR   Wikidata; Q54910904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03351
AC   CVCL_FC25
DR   CLO; CLO_0012275
DR   Coriell; ND03351
DR   Wikidata; Q54910905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03353
AC   CVCL_DW01
DR   CLO; CLO_0012260
DR   Coriell; ND03353
DR   Wikidata; Q54910906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03354
AC   CVCL_DW02
DR   CLO; CLO_0012286
DR   Coriell; ND03354
DR   Wikidata; Q54910907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03355
AC   CVCL_1W64
SY   ND-3355
DR   CLO; CLO_0012288
DR   Coriell; ND03355
DR   Wikidata; Q54910908
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03356
AC   CVCL_1W65
SY   ND-3356
DR   CLO; CLO_0012386
DR   Coriell; ND03356
DR   Wikidata; Q54910909
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03357
AC   CVCL_1W66
SY   ND-3357
DR   CLO; CLO_0012387
DR   Coriell; ND03357
DR   Wikidata; Q54910910
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03359
AC   CVCL_IA79
DR   Coriell; ND03359
DR   Wikidata; Q54910911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03360
AC   CVCL_DW03
DR   Coriell; ND03360
DR   Wikidata; Q54910912
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03363
AC   CVCL_ES17
DR   CLO; CLO_0012382
DR   Coriell; ND03363
DR   Wikidata; Q54910913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03364
AC   CVCL_FH86
DR   CLO; CLO_0012385
DR   Coriell; ND03364
DR   Wikidata; Q54910914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03366
AC   CVCL_DR40
DR   Coriell; ND03366
DR   Wikidata; Q54910915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03367
AC   CVCL_DR41
DR   Coriell; ND03367
DR   Wikidata; Q54910916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03368
AC   CVCL_DR39
DR   Coriell; ND03368
DR   Wikidata; Q54910917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03369
AC   CVCL_CC75
DR   CLO; CLO_0012395
DR   Coriell; ND03369
DR   Wikidata; Q54910918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03370
AC   CVCL_CC76
DR   CLO; CLO_0012398
DR   Coriell; ND03370
DR   Wikidata; Q54910919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03371
AC   CVCL_CC77
DR   CLO; CLO_0012388
DR   Coriell; ND03371
DR   Wikidata; Q54910920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03372
AC   CVCL_CC78
DR   CLO; CLO_0012392
DR   Coriell; ND03372
DR   Wikidata; Q54910921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03373
AC   CVCL_FW83
DR   CLO; CLO_0012421
DR   Coriell; ND03373
DR   Wikidata; Q54910922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03374
AC   CVCL_CC79
DR   CLO; CLO_0012420
DR   Coriell; ND03374
DR   Wikidata; Q54910923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03375
AC   CVCL_CC80
DR   CLO; CLO_0012417
DR   BioSample; SAMN00806756
DR   Coriell; ND03375
DR   Wikidata; Q54910924
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND03376
AC   CVCL_GB45
DR   CLO; CLO_0012340
DR   BioSample; SAMN00806758
DR   Coriell; ND03376
DR   Wikidata; Q54910925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03377
AC   CVCL_CC81
DR   CLO; CLO_0012342
DR   BioSample; SAMN00806760
DR   Coriell; ND03377
DR   Wikidata; Q54910926
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   ND03379
AC   CVCL_CC82
DR   CLO; CLO_0012344
DR   Coriell; ND03379
DR   Wikidata; Q54910927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03380
AC   CVCL_FH89
DR   CLO; CLO_0012346
DR   Coriell; ND03380
DR   Wikidata; Q54910928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03381
AC   CVCL_IA80
DR   CLO; CLO_0012347
DR   Coriell; ND03381
DR   Wikidata; Q54910929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03382
AC   CVCL_IA81
DR   Coriell; ND03382
DR   Wikidata; Q54910930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03383
AC   CVCL_FH90
DR   CLO; CLO_0012349
DR   Coriell; ND03383
DR   Wikidata; Q54910934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03384
AC   CVCL_GT76
DR   CLO; CLO_0012353
DR   Coriell; ND03384
DR   Wikidata; Q54910935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03385
AC   CVCL_GT77
DR   CLO; CLO_0012376
DR   Coriell; ND03385
DR   Wikidata; Q54910936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03397
AC   CVCL_CC83
DR   CLO; CLO_0012374
DR   Coriell; ND03397
DR   Wikidata; Q54910937
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03400
AC   CVCL_FW84
DR   CLO; CLO_0012380
DR   Coriell; ND03400
DR   Wikidata; Q54910938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03401
AC   CVCL_1W67
SY   ND-3401
DR   CLO; CLO_0012379
DR   Coriell; ND03401
DR   Wikidata; Q54910939
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03403
AC   CVCL_1W68
SY   ND-3403
DR   CLO; CLO_0012474
DR   Coriell; ND03403
DR   Wikidata; Q54910940
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03405
AC   CVCL_DW04
DR   CLO; CLO_0012475
DR   Coriell; ND03405
DR   Wikidata; Q54910941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03406
AC   CVCL_1W69
SY   ND-3406
DR   CLO; CLO_0012472
DR   Coriell; ND03406
DR   Wikidata; Q54910942
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03407
AC   CVCL_DW05
DR   CLO; CLO_0012473
DR   Coriell; ND03407
DR   Wikidata; Q54910943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03408
AC   CVCL_DW06
DR   CLO; CLO_0012468
DR   Coriell; ND03408
DR   Wikidata; Q54910944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03412
AC   CVCL_FW85
DR   Coriell; ND03412
DR   Wikidata; Q54910945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03413
AC   CVCL_FW86
DR   Coriell; ND03413
DR   Wikidata; Q54910946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03417
AC   CVCL_FW87
DR   Coriell; ND03417
DR   Wikidata; Q54910947
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03421
AC   CVCL_IA82
DR   Coriell; ND03421
DR   Wikidata; Q54910948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03422
AC   CVCL_IA83
DR   Coriell; ND03422
DR   Wikidata; Q54910949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03423
AC   CVCL_FH87
DR   CLO; CLO_0012470
DR   Coriell; ND03423
DR   Wikidata; Q54910950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03424
AC   CVCL_FH88
DR   CLO; CLO_0012502
DR   Coriell; ND03424
DR   Wikidata; Q54910951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03425
AC   CVCL_FI75
DR   CLO; CLO_0012501
DR   Coriell; ND03425
DR   Wikidata; Q54910952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03427
AC   CVCL_DW07
DR   Coriell; ND03427
DR   Wikidata; Q54910953
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03431
AC   CVCL_CC84
DR   CLO; CLO_0012499
DR   Coriell; ND03431
DR   Wikidata; Q54910954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03432
AC   CVCL_CC85
SY   ND 03432
DR   CLO; CLO_0012496
DR   Coriell; ND03432
DR   GEO; GSM505606
DR   Wikidata; Q54910955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND03433
AC   CVCL_CC86
DR   CLO; CLO_0012495
DR   Coriell; ND03433
DR   Wikidata; Q54910956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03434
AC   CVCL_CC87
DR   CLO; CLO_0012429
DR   Coriell; ND03434
DR   Wikidata; Q54910957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03435
AC   CVCL_CC88
DR   CLO; CLO_0012430
DR   Coriell; ND03435
DR   Wikidata; Q54910958
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03437
AC   CVCL_CC89
DR   CLO; CLO_0012432
DR   Coriell; ND03437
DR   Wikidata; Q54910959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03438
AC   CVCL_CC90
DR   CLO; CLO_0012433
DR   BioSample; SAMN00806782
DR   Coriell; ND03438
DR   Wikidata; Q54910960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03440
AC   CVCL_CC91
DR   CLO; CLO_0012425
DR   Coriell; ND03440
DR   Wikidata; Q54910961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03441
AC   CVCL_FH91
DR   CLO; CLO_0012463
DR   Coriell; ND03441
DR   Wikidata; Q54910962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03442
AC   CVCL_IL44
DR   CLO; CLO_0012462
DR   Coriell; ND03442
DR   Wikidata; Q54910963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND03442; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND03446
AC   CVCL_IA84
DR   Coriell; ND03446
DR   Wikidata; Q54910964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03447
AC   CVCL_1W70
SY   ND-3447
DR   CLO; CLO_0012455
DR   Coriell; ND03447
DR   Wikidata; Q54910965
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ND03448
AC   CVCL_DW08
DR   CLO; CLO_0012453
DR   Coriell; ND03448
DR   Wikidata; Q54910966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03449
AC   CVCL_DW09
DR   CLO; CLO_0012459
DR   Coriell; ND03449
DR   Wikidata; Q54910967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03450
AC   CVCL_DW10
DR   CLO; CLO_0012456
DR   Coriell; ND03450
DR   Wikidata; Q54910968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03451
AC   CVCL_DW11
DR   CLO; CLO_0013664
DR   Coriell; ND03451
DR   Wikidata; Q54910969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03452
AC   CVCL_IG97
DR   CLO; CLO_0013663
DR   Coriell; ND03452
DR   Wikidata; Q54910970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03453
AC   CVCL_HQ70
DR   CLO; CLO_0013666
DR   Coriell; ND03453
DR   Wikidata; Q54910971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03456
AC   CVCL_CC92
DR   CLO; CLO_0013665
DR   Coriell; ND03456
DR   Wikidata; Q54910972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03458
AC   CVCL_FW88
DR   CLO; CLO_0013660
DR   Coriell; ND03458
DR   Wikidata; Q54910973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03459
AC   CVCL_FH92
DR   CLO; CLO_0013661
DR   Coriell; ND03459
DR   Wikidata; Q54910975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03460
AC   CVCL_FH93
DR   CLO; CLO_0013662
DR   Coriell; ND03460
DR   Wikidata; Q54910977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03461
AC   CVCL_FW89
DR   Coriell; ND03461
DR   Wikidata; Q54910978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03462
AC   CVCL_IK50
DR   CLO; CLO_0013656
DR   Coriell; ND03462
DR   Wikidata; Q54910979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   ND03463
AC   CVCL_1W71
SY   ND-3463
DR   CLO; CLO_0013657
DR   BioSample; SAMN00806794
DR   Coriell; ND03463
DR   Wikidata; Q54910980
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03464
AC   CVCL_IG98
DR   CLO; CLO_0013658
DR   Coriell; ND03464
DR   Wikidata; Q54910981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03465
AC   CVCL_1W72
SY   ND-3465
DR   CLO; CLO_0013659
DR   Coriell; ND03465
DR   Wikidata; Q54910982
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03468
AC   CVCL_DW12
DR   CLO; CLO_0013686
DR   Coriell; ND03468
DR   Wikidata; Q54910983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03469
AC   CVCL_DW13
DR   CLO; CLO_0013685
DR   Coriell; ND03469
DR   Wikidata; Q54910984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03471
AC   CVCL_GB46
DR   CLO; CLO_0013684
DR   Coriell; ND03471
DR   Wikidata; Q54910985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03472
AC   CVCL_FC26
DR   CLO; CLO_0013682
DR   Coriell; ND03472
DR   Wikidata; Q54910986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03473
AC   CVCL_DW14
DR   Coriell; ND03473
DR   Wikidata; Q54910987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03480
AC   CVCL_FH94
DR   CLO; CLO_0013683
DR   Coriell; ND03480
DR   Wikidata; Q54910988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03481
AC   CVCL_FH95
DR   CLO; CLO_0013680
DR   Coriell; ND03481
DR   Wikidata; Q54910989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03482
AC   CVCL_GT78
DR   CLO; CLO_0013681
DR   Coriell; ND03482
DR   Wikidata; Q54910990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03483
AC   CVCL_GT79
DR   CLO; CLO_0013678
DR   Coriell; ND03483
DR   Wikidata; Q54910991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03485
AC   CVCL_FH96
DR   CLO; CLO_0013679
DR   Coriell; ND03485
DR   Wikidata; Q54910992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03486
AC   CVCL_GT80
DR   CLO; CLO_0013676
DR   Coriell; ND03486
DR   Wikidata; Q54910993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03487
AC   CVCL_GT81
DR   CLO; CLO_0013677
DR   Coriell; ND03487
DR   Wikidata; Q54910994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03488
AC   CVCL_GT82
DR   CLO; CLO_0013608
DR   Coriell; ND03488
DR   Wikidata; Q54910995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03489
AC   CVCL_CC93
DR   CLO; CLO_0013606
DR   Coriell; ND03489
DR   Wikidata; Q54910996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03490
AC   CVCL_CC94
DR   CLO; CLO_0013595
DR   Coriell; ND03490
DR   Wikidata; Q54910997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03491
AC   CVCL_DW15
DR   Coriell; ND03491
DR   Wikidata; Q54910998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03493
AC   CVCL_GB47
DR   CLO; CLO_0013597
DR   Coriell; ND03493
DR   Wikidata; Q54910999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03494
AC   CVCL_GB48
DR   CLO; CLO_0013598
DR   Coriell; ND03494
DR   Wikidata; Q54911000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03495
AC   CVCL_GB49
DR   CLO; CLO_0013599
DR   Coriell; ND03495
DR   Wikidata; Q54911001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03497
AC   CVCL_GB50
DR   CLO; CLO_0013600
DR   Coriell; ND03497
DR   Wikidata; Q54911002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03499
AC   CVCL_HT43
DR   Coriell; ND03499
DR   Wikidata; Q54911003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03503
AC   CVCL_GB51
DR   CLO; CLO_0013601
DR   Coriell; ND03503
DR   Wikidata; Q54911004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03506
AC   CVCL_IA85
DR   Coriell; ND03506
DR   Wikidata; Q54911005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03508
AC   CVCL_DW16
DR   CLO; CLO_0013602
DR   Coriell; ND03508
DR   Wikidata; Q54911006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03509
AC   CVCL_DW17
DR   CLO; CLO_0013603
DR   Coriell; ND03509
DR   Wikidata; Q54911007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03510
AC   CVCL_1W73
SY   ND-3510
DR   CLO; CLO_0013604
DR   Coriell; ND03510
DR   Wikidata; Q54911008
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03511
AC   CVCL_DW18
DR   CLO; CLO_0013640
DR   Coriell; ND03511
DR   Wikidata; Q54911009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03514
AC   CVCL_FW90
DR   Coriell; ND03514
DR   Wikidata; Q54911010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03515
AC   CVCL_HT44
DR   Coriell; ND03515
DR   Wikidata; Q54911011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03516
AC   CVCL_HT45
DR   Coriell; ND03516
DR   Wikidata; Q54911012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03522
AC   CVCL_1W74
SY   ND-3522
DR   Coriell; ND03522
DR   Wikidata; Q54911013
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Coriell; ND03522; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   ND03527
AC   CVCL_1W75
SY   ND-3527
DR   Coriell; ND03527
DR   Wikidata; Q54911014
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Coriell; ND03527; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   ND03528
AC   CVCL_FH97
DR   CLO; CLO_0013624
DR   Coriell; ND03528
DR   Wikidata; Q54911015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03529
AC   CVCL_IA86
DR   CLO; CLO_0013626
DR   Coriell; ND03529
DR   Wikidata; Q54911018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03530
AC   CVCL_FH98
DR   CLO; CLO_0013630
DR   Coriell; ND03530
DR   Wikidata; Q54911019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03531
AC   CVCL_IA87
DR   CLO; CLO_0013631
DR   Coriell; ND03531
DR   Wikidata; Q54911020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03532
AC   CVCL_1W76
SY   ND-3532
DR   CLO; CLO_0013628
DR   Coriell; ND03532
DR   Wikidata; Q54911021
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03533
AC   CVCL_CC95
DR   CLO; CLO_0013629
DR   Coriell; ND03533
DR   Wikidata; Q54911022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03534
AC   CVCL_CC96
DR   CLO; CLO_0013634
DR   Coriell; ND03534
DR   Wikidata; Q54911023
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03535
AC   CVCL_CC97
DR   CLO; CLO_0013635
DR   Coriell; ND03535
DR   Wikidata; Q54911024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03536
AC   CVCL_IA88
DR   Coriell; ND03536
DR   Wikidata; Q54911025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03538
AC   CVCL_FW91
DR   Coriell; ND03538
DR   Wikidata; Q54911026
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03544
AC   CVCL_HT46
DR   Coriell; ND03544
DR   Wikidata; Q54911027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03545
AC   CVCL_HT47
DR   Coriell; ND03545
DR   Wikidata; Q54911028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03547
AC   CVCL_FW92
DR   CLO; CLO_0013632
DR   Coriell; ND03547
DR   Wikidata; Q54911029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03548
AC   CVCL_DW19
DR   CLO; CLO_0013633
DR   Coriell; ND03548
DR   Wikidata; Q54911030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03549
AC   CVCL_1W77
SY   ND-3549
DR   CLO; CLO_0013146
DR   Coriell; ND03549
DR   Wikidata; Q54911031
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03550
AC   CVCL_DW20
DR   CLO; CLO_0013144
DR   Coriell; ND03550
DR   Wikidata; Q54911032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03551
AC   CVCL_FH99
DR   CLO; CLO_0013148
DR   Coriell; ND03551
DR   Wikidata; Q54911033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03552
AC   CVCL_FI00
DR   CLO; CLO_0013147
DR   Coriell; ND03552
DR   Wikidata; Q54911034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03553
AC   CVCL_HY33
DR   CLO; CLO_0013152
DR   Coriell; ND03553
DR   Wikidata; Q54911036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03554
AC   CVCL_HY34
DR   CLO; CLO_0013149
DR   Coriell; ND03554
DR   Wikidata; Q54911037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03555
AC   CVCL_GB52
DR   CLO; CLO_0013158
DR   Coriell; ND03555
DR   Wikidata; Q54911038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03556
AC   CVCL_IA89
DR   Coriell; ND03556
DR   Wikidata; Q54911039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03557
AC   CVCL_DW21
DR   Coriell; ND03557
DR   Wikidata; Q54911040
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03578
AC   CVCL_FI01
DR   CLO; CLO_0013157
DR   Coriell; ND03578
DR   Wikidata; Q54911041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03579
AC   CVCL_IA90
DR   CLO; CLO_0013166
DR   Coriell; ND03579
DR   Wikidata; Q54911042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03580
AC   CVCL_IA91
DR   CLO; CLO_0013164
DR   Coriell; ND03580
DR   Wikidata; Q54911043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03581
AC   CVCL_CC98
DR   CLO; CLO_0013184
DR   Coriell; ND03581
DR   Wikidata; Q54911044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03582
AC   CVCL_CC99
DR   CLO; CLO_0013112
DR   Coriell; ND03582
DR   Wikidata; Q54911045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03583
AC   CVCL_CD00
DR   CLO; CLO_0013111
DR   Coriell; ND03583
DR   Wikidata; Q54911046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03584
AC   CVCL_FW93
DR   Coriell; ND03584
DR   Wikidata; Q54911047
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03586
AC   CVCL_GY83
DR   CLO; CLO_0013110
DR   Coriell; ND03586
DR   Wikidata; Q54911048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03587
AC   CVCL_1W78
SY   ND-3587
DR   CLO; CLO_0013109
DR   BioSample; SAMN00806848
DR   Coriell; ND03587
DR   Wikidata; Q54911049
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03588
AC   CVCL_IA92
DR   CLO; CLO_0013107
DR   Coriell; ND03588
DR   Wikidata; Q54911050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03589
AC   CVCL_IA93
DR   Coriell; ND03589
DR   Wikidata; Q54911051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03590
AC   CVCL_IA94
DR   Coriell; ND03590
DR   Wikidata; Q54911052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03593
AC   CVCL_CD01
DR   CLO; CLO_0013106
DR   Coriell; ND03593
DR   Wikidata; Q54911053
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03594
AC   CVCL_IG81
DR   CLO; CLO_0013103
DR   Coriell; ND03594
DR   Wikidata; Q54911054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   ND03595
AC   CVCL_FI02
DR   CLO; CLO_0013102
DR   Coriell; ND03595
DR   Wikidata; Q54911055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03596
AC   CVCL_IA95
DR   CLO; CLO_0013131
DR   Coriell; ND03596
DR   Wikidata; Q54911056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03597
AC   CVCL_FI04
DR   CLO; CLO_0013142
DR   Coriell; ND03597
DR   Wikidata; Q54911057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03598
AC   CVCL_FI03
DR   CLO; CLO_0013143
DR   Coriell; ND03598
DR   Wikidata; Q54911058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03603
AC   CVCL_HT48
DR   Coriell; ND03603
DR   Wikidata; Q54911062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03604
AC   CVCL_HT49
DR   Coriell; ND03604
DR   Wikidata; Q54911063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03607
AC   CVCL_CD02
DR   CLO; CLO_0013070
DR   Coriell; ND03607
DR   Wikidata; Q54911064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03608
AC   CVCL_CD03
DR   CLO; CLO_0013069
DR   Coriell; ND03608
DR   Wikidata; Q54911065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03609
AC   CVCL_ES18
DR   CLO; CLO_0013072
DR   BioSample; SAMN00806861
DR   Coriell; ND03609
DR   Wikidata; Q54911066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03610
AC   CVCL_CD04
DR   CLO; CLO_0013071
DR   BioSample; SAMN00806863
DR   Coriell; ND03610
DR   Wikidata; Q54911067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND03611
AC   CVCL_CD05
DR   CLO; CLO_0013062
DR   Coriell; ND03611
DR   Wikidata; Q54911068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03612
AC   CVCL_FW94
DR   Coriell; ND03612
DR   Wikidata; Q54911069
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03614
AC   CVCL_FW95
DR   Coriell; ND03614
DR   Wikidata; Q54911070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03616
AC   CVCL_HT50
DR   Coriell; ND03616
DR   Wikidata; Q54911071
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03622
AC   CVCL_IA96
DR   Coriell; ND03622
DR   Wikidata; Q54911072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03625
AC   CVCL_HT51
DR   Coriell; ND03625
DR   Wikidata; Q54911073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03627
AC   CVCL_1W79
SY   ND-3627
DR   CLO; CLO_0013061
DR   Coriell; ND03627
DR   Wikidata; Q54911074
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03628
AC   CVCL_1W80
SY   ND-3628
DR   CLO; CLO_0013067
DR   Coriell; ND03628
DR   Wikidata; Q54911075
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03629
AC   CVCL_DW22
DR   CLO; CLO_0013065
DR   Coriell; ND03629
DR   Wikidata; Q54911076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03630
AC   CVCL_DW23
DR   CLO; CLO_0013099
DR   Coriell; ND03630
DR   Wikidata; Q54911077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03631
AC   CVCL_DW24
DR   CLO; CLO_0013100
DR   Coriell; ND03631
DR   Wikidata; Q54911078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03632
AC   CVCL_ES19
DR   CLO; CLO_0013101
DR   Coriell; ND03632
DR   Wikidata; Q54911079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03633
AC   CVCL_1W81
SY   ND-3633
DR   CLO; CLO_0013336
DR   Coriell; ND03633
DR   Wikidata; Q54911080
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03635
AC   CVCL_ES20
DR   CLO; CLO_0013338
DR   Coriell; ND03635
DR   Wikidata; Q54911081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03636
AC   CVCL_GB53
DR   CLO; CLO_0013333
DR   Coriell; ND03636
DR   Wikidata; Q54911082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03637
AC   CVCL_GB54
DR   CLO; CLO_0013335
DR   Coriell; ND03637
DR   Wikidata; Q54911083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03638
AC   CVCL_GB55
DR   CLO; CLO_0013342
DR   Coriell; ND03638
DR   Wikidata; Q54911084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03639
AC   CVCL_FW96
DR   CLO; CLO_0013344
DR   Coriell; ND03639
DR   Wikidata; Q54911085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03642
AC   CVCL_HT52
DR   Coriell; ND03642
DR   Wikidata; Q54911086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03644
AC   CVCL_HT53
DR   Coriell; ND03644
DR   Wikidata; Q54911087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03645
AC   CVCL_FW97
DR   Coriell; ND03645
DR   Wikidata; Q54911088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03648
AC   CVCL_FE99
DR   Coriell; ND03648
DR   Wikidata; Q54911089
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03649
AC   CVCL_HT54
DR   Coriell; ND03649
DR   Wikidata; Q54911090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03651
AC   CVCL_FF00
DR   Coriell; ND03651
DR   Wikidata; Q54911091
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03654
AC   CVCL_ES21
DR   CLO; CLO_0013339
DR   Coriell; ND03654
DR   Wikidata; Q54911092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03658
AC   CVCL_CD06
DR   CLO; CLO_0013349
DR   Coriell; ND03658
DR   Wikidata; Q54911093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03659
AC   CVCL_ES22
DR   CLO; CLO_0013348
DR   Coriell; ND03659
DR   Wikidata; Q54911094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03660
AC   CVCL_1W82
SY   ND-3660
DR   CLO; CLO_0013347
DR   Coriell; ND03660
DR   Wikidata; Q54911095
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03661
AC   CVCL_1W83
SY   ND-3661
DR   CLO; CLO_0013346
DR   Coriell; ND03661
DR   Wikidata; Q54911096
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03662
AC   CVCL_1W84
SY   ND-3662
DR   CLO; CLO_0013292
DR   Coriell; ND03662
DR   Wikidata; Q54911097
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03663
AC   CVCL_1W85
SY   ND-3663
DR   CLO; CLO_0013294
DR   Coriell; ND03663
DR   Wikidata; Q54911098
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03664
AC   CVCL_1W86
SY   ND-3664
DR   CLO; CLO_0013296
DR   Coriell; ND03664
DR   Wikidata; Q54911099
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03665
AC   CVCL_1W87
SY   ND-3665
DR   CLO; CLO_0013298
DR   Coriell; ND03665
DR   Wikidata; Q54911100
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03668
AC   CVCL_FW98
DR   Coriell; ND03668
DR   Wikidata; Q54911101
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03669
AC   CVCL_FW99
DR   Coriell; ND03669
DR   Wikidata; Q54911106
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03670
AC   CVCL_FX00
DR   Coriell; ND03670
DR   Wikidata; Q54911107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03671
AC   CVCL_FX01
DR   Coriell; ND03671
DR   Wikidata; Q54911108
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03672
AC   CVCL_CD07
DR   Coriell; ND03672
DR   Wikidata; Q54911109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03674
AC   CVCL_IG99
DR   CLO; CLO_0013299
DR   Coriell; ND03674
DR   Wikidata; Q54911110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03675
AC   CVCL_FX02
DR   CLO; CLO_0013302
DR   Coriell; ND03675
DR   Wikidata; Q54911111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03676
AC   CVCL_CD08
DR   Coriell; ND03676
DR   Wikidata; Q54911112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03677
AC   CVCL_CD09
DR   CLO; CLO_0013308
DR   Coriell; ND03677
DR   Wikidata; Q54911113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03678
AC   CVCL_CD10
DR   CLO; CLO_0013307
DR   Coriell; ND03678
DR   Wikidata; Q54911114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03679
AC   CVCL_AB60
DR   CLO; CLO_0013310
DR   Coriell; ND03679
DR   Wikidata; Q54911115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND03680
AC   CVCL_FC27
DR   CLO; CLO_0013309
DR   BioSample; SAMN00806891
DR   Coriell; ND03680
DR   Wikidata; Q54911116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03681
AC   CVCL_CY82
DR   CLO; CLO_0013265
DR   Coriell; ND03681
DR   Wikidata; Q54911117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03682
AC   CVCL_CD11
DR   CLO; CLO_0013266
DR   Coriell; ND03682
DR   Wikidata; Q54911118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03683
AC   CVCL_CD12
DR   CLO; CLO_0013263
DR   Coriell; ND03683
DR   Wikidata; Q54911119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03684
AC   CVCL_CD13
DR   CLO; CLO_0013264
DR   Coriell; ND03684
DR   Wikidata; Q54911120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03685
AC   CVCL_AB61
DR   CLO; CLO_0013260
DR   Coriell; ND03685
DR   Wikidata; Q54911121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND03690
AC   CVCL_HT55
DR   Coriell; ND03690
DR   Wikidata; Q54911122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03691
AC   CVCL_FF01
DR   Coriell; ND03691
DR   Wikidata; Q54911123
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03693
AC   CVCL_DW25
DR   Coriell; ND03693
DR   Wikidata; Q54911124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03698
AC   CVCL_DW26
DR   Coriell; ND03698
DR   Wikidata; Q54911125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03699
AC   CVCL_FX03
DR   CLO; CLO_0013272
DR   Coriell; ND03699
DR   Wikidata; Q54911126
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03700
AC   CVCL_HY35
DR   CLO; CLO_0013271
DR   Coriell; ND03700
DR   Wikidata; Q54911127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03701
AC   CVCL_HY36
DR   CLO; CLO_0013270
DR   Coriell; ND03701
DR   Wikidata; Q54911128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03702
AC   CVCL_FI05
DR   CLO; CLO_0013269
DR   Coriell; ND03702
DR   Wikidata; Q54911129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03703
AC   CVCL_CY83
DR   CLO; CLO_0013268
DR   Coriell; ND03703
DR   Wikidata; Q54911130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03704
AC   CVCL_1W88
SY   ND-3704
DR   CLO; CLO_0013267
DR   BioSample; SAMN00806903
DR   Coriell; ND03704
DR   Wikidata; Q54911131
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   ND03705
AC   CVCL_CD14
DR   CLO; CLO_0013230
DR   BioSample; SAMN00806905
DR   Coriell; ND03705
DR   Wikidata; Q54911132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03707
AC   CVCL_GY84
DR   CLO; CLO_0013231
DR   Coriell; ND03707
DR   Wikidata; Q54911133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03708
AC   CVCL_CY84
DR   CLO; CLO_0013232
DR   Coriell; ND03708
DR   Wikidata; Q54911134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03709
AC   CVCL_CY85
DR   CLO; CLO_0013234
DR   BioSample; SAMN00806909
DR   Coriell; ND03709
DR   Wikidata; Q54911135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03710
AC   CVCL_1W89
SY   ND-3710
DR   CLO; CLO_0013240
DR   Coriell; ND03710
DR   Wikidata; Q54911136
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03711
AC   CVCL_1W90
SY   ND-3711
DR   CLO; CLO_0013242
DR   Coriell; ND03711
DR   Wikidata; Q54911137
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03712
AC   CVCL_1W91
SY   ND-3712
DR   CLO; CLO_0013241
DR   Coriell; ND03712
DR   Wikidata; Q54911138
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03713
AC   CVCL_1W92
SY   ND-3713
DR   CLO; CLO_0013237
DR   Coriell; ND03713
DR   Wikidata; Q54911139
RX   PubMed=17116639;
RX   PubMed=34468209;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03714
AC   CVCL_DW27
DR   CLO; CLO_0013236
DR   Coriell; ND03714
DR   Wikidata; Q54911140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03715
AC   CVCL_1W93
SY   ND-3715
DR   CLO; CLO_0013239
DR   Coriell; ND03715
DR   Wikidata; Q54911141
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03719
AC   CVCL_IA97
DR   Coriell; ND03719
DR   Wikidata; Q54911142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03720
AC   CVCL_FX04
DR   CLO; CLO_0013238
DR   Coriell; ND03720
DR   Wikidata; Q54911143
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03721
AC   CVCL_FX05
DR   CLO; CLO_0011404
DR   Coriell; ND03721
DR   Wikidata; Q54911144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03722
AC   CVCL_CD15
DR   CLO; CLO_0011405
DR   Coriell; ND03722
DR   Wikidata; Q54911145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03723
AC   CVCL_HT56
DR   Coriell; ND03723
DR   Wikidata; Q54911147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03737
AC   CVCL_HT57
DR   Coriell; ND03737
DR   Wikidata; Q54911148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03739
AC   CVCL_HT58
DR   Coriell; ND03739
DR   Wikidata; Q54911149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03742
AC   CVCL_GB56
DR   CLO; CLO_0011403
DR   Coriell; ND03742
DR   Wikidata; Q54911150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03745
AC   CVCL_DW28
DR   CLO; CLO_0011413
DR   Coriell; ND03745
DR   Wikidata; Q54911151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03746
AC   CVCL_1W94
SY   ND-3746
DR   CLO; CLO_0011412
DR   Coriell; ND03746
DR   Wikidata; Q54911152
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03747
AC   CVCL_FX06
DR   CLO; CLO_0011411
DR   Coriell; ND03747
DR   Wikidata; Q54911153
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03748
AC   CVCL_FX07
DR   CLO; CLO_0011410
DR   Coriell; ND03748
DR   Wikidata; Q54911154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03749
AC   CVCL_FX08
DR   CLO; CLO_0011409
DR   Coriell; ND03749
DR   Wikidata; Q54911155
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03750
AC   CVCL_HT59
DR   Coriell; ND03750
DR   Wikidata; Q54911156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03751
AC   CVCL_HT60
DR   Coriell; ND03751
DR   Wikidata; Q54911157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03755
AC   CVCL_IA98
DR   Coriell; ND03755
DR   Wikidata; Q54911158
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03760
AC   CVCL_HT61
DR   Coriell; ND03760
DR   Wikidata; Q54911159
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03762
AC   CVCL_HQ71
DR   CLO; CLO_0011408
DR   Coriell; ND03762
DR   Wikidata; Q54911160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03763
AC   CVCL_FX09
DR   CLO; CLO_0011407
DR   Coriell; ND03763
DR   Wikidata; Q54911161
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03764
AC   CVCL_AB62
DR   CLO; CLO_0011406
DR   Coriell; ND03764
DR   Wikidata; Q54911162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND03765
AC   CVCL_CD16
DR   CLO; CLO_0011382
DR   BioSample; SAMN00806920
DR   Coriell; ND03765
DR   Wikidata; Q54911163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03766
AC   CVCL_CD17
DR   CLO; CLO_0011383
DR   Coriell; ND03766
DR   Wikidata; Q54911164
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03767
AC   CVCL_EH38
DR   CLO; CLO_0011397
DR   Coriell; ND03767
DR   Wikidata; Q54911165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03768
AC   CVCL_EH39
DR   CLO; CLO_0011390
DR   Coriell; ND03768
DR   Wikidata; Q54911166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03769
AC   CVCL_CD18
DR   CLO; CLO_0011389
DR   Coriell; ND03769
DR   Wikidata; Q54911167
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03770
AC   CVCL_1W95
SY   ND-3770
DR   CLO; CLO_0011393
DR   Coriell; ND03770
DR   Wikidata; Q54911168
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03771
AC   CVCL_FI06
DR   CLO; CLO_0011392
DR   Coriell; ND03771
DR   Wikidata; Q54911169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03785
AC   CVCL_IH00
DR   CLO; CLO_0011385
DR   Coriell; ND03785
DR   Wikidata; Q54911170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03786
AC   CVCL_FI07
DR   CLO; CLO_0011384
DR   Coriell; ND03786
DR   Wikidata; Q54911171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03788
AC   CVCL_DW29
DR   CLO; CLO_0011387
DR   Coriell; ND03788
DR   Wikidata; Q54911172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03790
AC   CVCL_1W96
SY   ND-3790
DR   CLO; CLO_0011386
DR   Coriell; ND03790
DR   Wikidata; Q54911173
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03791
AC   CVCL_DW30
DR   CLO; CLO_0011381
DR   Coriell; ND03791
DR   Wikidata; Q54911174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03792
AC   CVCL_1W97
SY   ND-3792
DR   CLO; CLO_0033637
DR   Coriell; ND03792
DR   Wikidata; Q54911175
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03795
AC   CVCL_CD19
DR   CLO; CLO_0033638
DR   Coriell; ND03795
DR   Wikidata; Q54911176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03796
AC   CVCL_CD20
DR   CLO; CLO_0033631
DR   Coriell; ND03796
DR   Wikidata; Q54911177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03797
AC   CVCL_CD21
DR   CLO; CLO_0033632
DR   Coriell; ND03797
DR   Wikidata; Q54911178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03798
AC   CVCL_CD22
DR   CLO; CLO_0033629
DR   Coriell; ND03798
DR   Wikidata; Q54911180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03799
AC   CVCL_CD23
DR   CLO; CLO_0033630
DR   Coriell; ND03799
DR   Wikidata; Q54911181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03800
AC   CVCL_HT62
DR   Coriell; ND03800
DR   Wikidata; Q54911182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03809
AC   CVCL_HT63
DR   Coriell; ND03809
DR   Wikidata; Q54911183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03810
AC   CVCL_IL45
DR   Coriell; ND03810
DR   Wikidata; Q54911184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03811
AC   CVCL_HT64
DR   Coriell; ND03811
DR   Wikidata; Q54911185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03812
AC   CVCL_FX10
DR   Coriell; ND03812
DR   Wikidata; Q54911186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03815
AC   CVCL_HT65
DR   Coriell; ND03815
DR   Wikidata; Q54911187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03816
AC   CVCL_HT66
DR   Coriell; ND03816
DR   Wikidata; Q54915361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03818
AC   CVCL_FX11
DR   Coriell; ND03818
DR   Wikidata; Q54915362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03819
AC   CVCL_HT67
DR   Coriell; ND03819
DR   Wikidata; Q54915363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03823
AC   CVCL_FX12
DR   CLO; CLO_0033635
DR   Coriell; ND03823
DR   Wikidata; Q54915364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03824
AC   CVCL_IH01
DR   CLO; CLO_0033636
DR   Coriell; ND03824
DR   Wikidata; Q54915365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03825
AC   CVCL_FI08
DR   CLO; CLO_0033633
DR   Coriell; ND03825
DR   Wikidata; Q54915366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03826
AC   CVCL_HY37
DR   CLO; CLO_0033634
DR   Coriell; ND03826
DR   Wikidata; Q54915367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03827
AC   CVCL_HY38
DR   CLO; CLO_0033556
DR   Coriell; ND03827
DR   Wikidata; Q54915368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03828
AC   CVCL_GY85
DR   CLO; CLO_0033557
DR   Coriell; ND03828
DR   Wikidata; Q54915369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03829
AC   CVCL_AB63
DR   CLO; CLO_0033558
DR   Coriell; ND03829
DR   Wikidata; Q54915370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND03830
AC   CVCL_1W98
SY   ND-3830
DR   CLO; CLO_0033552
DR   BioSample; SAMN00806948
DR   Coriell; ND03830
DR   Wikidata; Q54915371
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND03831
AC   CVCL_CD24
DR   CLO; CLO_0033553
DR   Coriell; ND03831
DR   Wikidata; Q54915372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03832
AC   CVCL_AB64
DR   CLO; CLO_0033554
DR   Coriell; ND03832
DR   Wikidata; Q54915373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND03833
AC   CVCL_1W99
SY   ND-3833
DR   CLO; CLO_0033555
DR   BioSample; SAMN00806952
DR   Coriell; ND03833
DR   Wikidata; Q54915374
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03834
AC   CVCL_1X00
SY   ND-3834
DR   CLO; CLO_0033549
DR   Coriell; ND03834
DR   Wikidata; Q54915375
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03835
AC   CVCL_1X01
SY   ND-3835
DR   CLO; CLO_0033550
DR   Coriell; ND03835
DR   Wikidata; Q54915376
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03836
AC   CVCL_1X02
SY   ND-3836
DR   CLO; CLO_0033551
DR   Coriell; ND03836
DR   Wikidata; Q54915377
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03837
AC   CVCL_FI09
DR   CLO; CLO_0033587
DR   Coriell; ND03837
DR   Wikidata; Q54915378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03838
AC   CVCL_GA14
DR   CLO; CLO_0033588
DR   Coriell; ND03838
DR   Wikidata; Q54915379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03844
AC   CVCL_GA15
DR   CLO; CLO_0033585
DR   Coriell; ND03844
DR   Wikidata; Q54915381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03845
AC   CVCL_GA16
DR   CLO; CLO_0033586
DR   Coriell; ND03845
DR   Wikidata; Q54915382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03846
AC   CVCL_HQ72
DR   CLO; CLO_0033583
DR   Coriell; ND03846
DR   Wikidata; Q54915383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03849
AC   CVCL_HT68
DR   Coriell; ND03849
DR   Wikidata; Q54915384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03858
AC   CVCL_DW31
DR   Coriell; ND03858
DR   Wikidata; Q54915385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03862
AC   CVCL_CY86
DR   CLO; CLO_0033584
DR   Coriell; ND03862
DR   Wikidata; Q54915386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03863
AC   CVCL_CD25
DR   CLO; CLO_0033581
DR   Coriell; ND03863
DR   Wikidata; Q54915387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03864
AC   CVCL_CD26
DR   CLO; CLO_0033582
DR   BioSample; SAMN00806960
DR   Coriell; ND03864
DR   Wikidata; Q54915388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03865
AC   CVCL_CD27
DR   CLO; CLO_0033579
DR   Coriell; ND03865
DR   Wikidata; Q54915389
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03866
AC   CVCL_CD28
DR   CLO; CLO_0033580
DR   Coriell; ND03866
DR   Wikidata; Q54915390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03867
AC   CVCL_ES23
DR   CLO; CLO_0033053
DR   Coriell; ND03867
DR   Wikidata; Q54915391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03868
AC   CVCL_DW32
DR   CLO; CLO_0033052
DR   Coriell; ND03868
DR   Wikidata; Q54915392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03869
AC   CVCL_DW33
DR   CLO; CLO_0033051
DR   Coriell; ND03869
DR   Wikidata; Q54915393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03870
AC   CVCL_1X03
SY   ND-3870
DR   CLO; CLO_0033050
DR   Coriell; ND03870
DR   Wikidata; Q54915394
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03871
AC   CVCL_CD29
DR   CLO; CLO_0033049
DR   Coriell; ND03871
DR   Wikidata; Q54915395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03872
AC   CVCL_CD30
DR   CLO; CLO_0033058
DR   BioSample; SAMN00806962
DR   Coriell; ND03872
DR   Wikidata; Q54915396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03873
AC   CVCL_GB57
DR   CLO; CLO_0033057
DR   BioSample; SAMN00806964
DR   Coriell; ND03873
DR   Wikidata; Q54915397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03874
AC   CVCL_CD31
DR   CLO; CLO_0033056
DR   Coriell; ND03874
DR   Wikidata; Q54915398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03875
AC   CVCL_CD32
DR   CLO; CLO_0033055
DR   BioSample; SAMN00806966
DR   Coriell; ND03875
DR   Wikidata; Q54915399
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND03876
AC   CVCL_GB58
DR   CLO; CLO_0033054
DR   BioSample; SAMN00806968
DR   Coriell; ND03876
DR   Wikidata; Q54915401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03877
AC   CVCL_IA99
DR   Coriell; ND03877
DR   Wikidata; Q54915402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03878
AC   CVCL_IB00
DR   BioSample; SAMN00806970
DR   Coriell; ND03878
DR   Wikidata; Q54915407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03879
AC   CVCL_GA17
DR   Coriell; ND03879
DR   Wikidata; Q54915408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03881
AC   CVCL_IB01
DR   Coriell; ND03881
DR   Wikidata; Q54915409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03883
AC   CVCL_IL46
DR   Coriell; ND03883
DR   Wikidata; Q54915410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03884
AC   CVCL_CD33
DR   CLO; CLO_0033044
DR   BioSample; SAMN00806976
DR   Coriell; ND03884
DR   Wikidata; Q54915411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03885
AC   CVCL_1X04
SY   ND-3885
DR   CLO; CLO_0033043
DR   BioSample; SAMN00806978
DR   Coriell; ND03885
DR   Wikidata; Q54915413
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03896
AC   CVCL_CD34
DR   Coriell; ND03896
DR   Wikidata; Q54915414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03899
AC   CVCL_CD35
DR   CLO; CLO_0033040
DR   Coriell; ND03899
DR   Wikidata; Q54915415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03900
AC   CVCL_CD36
DR   CLO; CLO_0033039
DR   Coriell; ND03900
DR   Wikidata; Q54915416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03901
AC   CVCL_CD37
DR   CLO; CLO_0033042
DR   Coriell; ND03901
DR   Wikidata; Q54915417
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03902
AC   CVCL_CD38
DR   CLO; CLO_0033041
DR   BioSample; SAMN00806980
DR   Coriell; ND03902
DR   Wikidata; Q54915418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03903
AC   CVCL_1X05
SY   ND-3903
DR   CLO; CLO_0033046
DR   BioSample; SAMN00806982
DR   Coriell; ND03903
DR   Wikidata; Q54915419
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND03904
AC   CVCL_CD39
DR   CLO; CLO_0033045
DR   Coriell; ND03904
DR   Wikidata; Q54915420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03915
AC   CVCL_HT69
DR   Coriell; ND03915
DR   Wikidata; Q54915421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03916
AC   CVCL_FX13
DR   Coriell; ND03916
DR   Wikidata; Q54915422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03917
AC   CVCL_IB02
DR   Coriell; ND03917
DR   Wikidata; Q54915423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03918
AC   CVCL_DW34
DR   CLO; CLO_0033048
DR   Coriell; ND03918
DR   Wikidata; Q54915424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03919
AC   CVCL_DW35
DR   CLO; CLO_0033047
DR   Coriell; ND03919
DR   Wikidata; Q54915425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03920
AC   CVCL_DW36
DR   CLO; CLO_0033031
DR   Coriell; ND03920
DR   Wikidata; Q54915426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03926
AC   CVCL_CD40
DR   CLO; CLO_0033030
DR   BioSample; SAMN00806988
DR   Coriell; ND03926
DR   Wikidata; Q54915427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND03927
AC   CVCL_ES24
DR   CLO; CLO_0033029
DR   BioSample; SAMN00806990
DR   Coriell; ND03927
DR   Wikidata; Q54915428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03937
AC   CVCL_ES25
DR   CLO; CLO_0033035
DR   Coriell; ND03937
DR   Wikidata; Q54915429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03938
AC   CVCL_1X06
SY   ND-3938
DR   CLO; CLO_0033034
DR   Coriell; ND03938
DR   Wikidata; Q54915430
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03939
AC   CVCL_CD41
DR   CLO; CLO_0033033
DR   Coriell; ND03939
DR   Wikidata; Q54915432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03940
AC   CVCL_FX14
DR   CLO; CLO_0033032
DR   Coriell; ND03940
DR   Wikidata; Q54915433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03941
AC   CVCL_GA18
DR   Coriell; ND03941
DR   Wikidata; Q54915434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03944
AC   CVCL_CD42
DR   Coriell; ND03944
DR   Wikidata; Q54915436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03948
AC   CVCL_FX15
DR   CLO; CLO_0033038
DR   Coriell; ND03948
DR   Wikidata; Q54915437
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03949
AC   CVCL_CD43
DR   CLO; CLO_0033037
DR   Coriell; ND03949
DR   Wikidata; Q54915438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03950
AC   CVCL_1X07
SY   ND-3950
DR   CLO; CLO_0033036
DR   Coriell; ND03950
DR   Wikidata; Q54915439
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03951
AC   CVCL_CD44
DR   CLO; CLO_0033020
DR   Coriell; ND03951
DR   Wikidata; Q54915440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03952
AC   CVCL_FC28
DR   CLO; CLO_0033019
DR   Coriell; ND03952
DR   Wikidata; Q54915441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03953
AC   CVCL_IB03
DR   Coriell; ND03953
DR   Wikidata; Q54915442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03955
AC   CVCL_CD45
DR   CLO; CLO_0033022
DR   Coriell; ND03955
DR   Wikidata; Q54915443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03956
AC   CVCL_IB04
DR   Coriell; ND03956
DR   Wikidata; Q54915444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03957
AC   CVCL_GA19
DR   CLO; CLO_0033021
DR   Coriell; ND03957
DR   Wikidata; Q54915445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03958
AC   CVCL_GA20
DR   CLO; CLO_0033024
DR   BioSample; SAMN00807000
DR   Coriell; ND03958
DR   Wikidata; Q54915446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03959
AC   CVCL_IB05
DR   CLO; CLO_0033023
DR   BioSample; SAMN00807002
DR   Coriell; ND03959
DR   Wikidata; Q54915447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03963
AC   CVCL_HT70
DR   BioSample; SAMN00807004
DR   Coriell; ND03963
DR   Wikidata; Q54915448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03964
AC   CVCL_CD46
DR   Coriell; ND03964
DR   Wikidata; Q54915449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03965
AC   CVCL_FX16
DR   BioSample; SAMN00807006
DR   Coriell; ND03965
DR   Wikidata; Q54915454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03966
AC   CVCL_HT71
DR   BioSample; SAMN00807008
DR   Coriell; ND03966
DR   Wikidata; Q54915455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03967
AC   CVCL_GB59
DR   CLO; CLO_0033026
DR   Coriell; ND03967
DR   Wikidata; Q54915457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03968
AC   CVCL_GB60
DR   CLO; CLO_0033025
DR   Coriell; ND03968
DR   Wikidata; Q54915458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03969
AC   CVCL_ES26
DR   CLO; CLO_0033028
DR   Coriell; ND03969
DR   Wikidata; Q54915460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03970
AC   CVCL_1X08
SY   ND-3970
DR   CLO; CLO_0033027
DR   Coriell; ND03970
DR   Wikidata; Q54915461
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03971
AC   CVCL_1X09
SY   ND-3971
DR   CLO; CLO_0033088
DR   Coriell; ND03971
DR   Wikidata; Q54915462
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03972
AC   CVCL_1X10
SY   ND-3972
DR   CLO; CLO_0033086
DR   Coriell; ND03972
DR   Wikidata; Q54915463
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03973
AC   CVCL_GB61
DR   CLO; CLO_0033087
DR   Coriell; ND03973
DR   Wikidata; Q54915464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND03974
AC   CVCL_1X11
SY   ND-3974
DR   CLO; CLO_0033084
DR   Coriell; ND03974
DR   Wikidata; Q54915465
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND03975
AC   CVCL_1X12
SY   ND-3975
DR   CLO; CLO_0033085
DR   Coriell; ND03975
DR   Wikidata; Q54915466
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03976
AC   CVCL_1X13
SY   ND-3976
DR   CLO; CLO_0033082
DR   Coriell; ND03976
DR   Wikidata; Q54915467
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND03977
AC   CVCL_DW37
DR   CLO; CLO_0033083
DR   Coriell; ND03977
DR   Wikidata; Q54915468
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND03978
AC   CVCL_DW38
DR   CLO; CLO_0033080
DR   Coriell; ND03978
DR   Wikidata; Q54915469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03979
AC   CVCL_DW39
DR   CLO; CLO_0033081
DR   Coriell; ND03979
DR   Wikidata; Q54915471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND03980
AC   CVCL_CD47
DR   CLO; CLO_0033079
DR   Coriell; ND03980
DR   Wikidata; Q54915472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03982
AC   CVCL_CD48
DR   CLO; CLO_0033078
DR   Coriell; ND03982
DR   Wikidata; Q54915473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND03983
AC   CVCL_AB65
DR   CLO; CLO_0033077
DR   Coriell; ND03983
DR   Wikidata; Q54915474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND03984
AC   CVCL_GA21
DR   CLO; CLO_0033073
DR   BioSample; SAMN00807010
DR   Coriell; ND03984
DR   Wikidata; Q54915475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03985
AC   CVCL_GA22
DR   CLO; CLO_0033074
DR   BioSample; SAMN00807012
DR   Coriell; ND03985
DR   Wikidata; Q54915476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03986
AC   CVCL_GA23
DR   CLO; CLO_0033075
DR   BioSample; SAMN00807014
DR   Coriell; ND03986
DR   Wikidata; Q54915478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND03987
AC   CVCL_IB06
DR   CLO; CLO_0033076
DR   BioSample; SAMN00807016
DR   Coriell; ND03987
DR   Wikidata; Q54915479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03988
AC   CVCL_HM31
DR   CLO; CLO_0033069
DR   BioSample; SAMN00807018
DR   Coriell; ND03988
DR   Wikidata; Q54915480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND03996
AC   CVCL_HT72
DR   Coriell; ND03996
DR   Wikidata; Q54915481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND03999
AC   CVCL_CD49
DR   CLO; CLO_0033070
DR   BioSample; SAMN00807020
DR   Coriell; ND03999
DR   Wikidata; Q54915482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04000
AC   CVCL_GB62
DR   CLO; CLO_0033071
DR   BioSample; SAMN00807022
DR   Coriell; ND04000
DR   Wikidata; Q54915483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04001
AC   CVCL_CD50
DR   CLO; CLO_0033072
DR   Coriell; ND04001
DR   Wikidata; Q54915484
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04005
AC   CVCL_CD51
DR   BioSample; SAMN00807024
DR   Coriell; ND04005
DR   Wikidata; Q54915485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04006
AC   CVCL_CD52
DR   Coriell; ND04006
DR   Wikidata; Q54915487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04007
AC   CVCL_CD53
DR   Coriell; ND04007
DR   Wikidata; Q54915488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04009
AC   CVCL_GB63
DR   CLO; CLO_0033068
DR   Coriell; ND04009
DR   Wikidata; Q54915489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04010
AC   CVCL_GB64
DR   CLO; CLO_0033067
DR   Coriell; ND04010
DR   Wikidata; Q54915490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04011
AC   CVCL_GB65
DR   CLO; CLO_0033066
DR   Coriell; ND04011
DR   Wikidata; Q54915491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04012
AC   CVCL_GB66
DR   CLO; CLO_0033061
DR   Coriell; ND04012
DR   Wikidata; Q54915492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04013
AC   CVCL_GB67
DR   CLO; CLO_0033062
DR   Coriell; ND04013
DR   Wikidata; Q54915493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04014
AC   CVCL_ES27
DR   CLO; CLO_0033059
DR   Coriell; ND04014
DR   Wikidata; Q54915494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04015
AC   CVCL_DW40
DR   CLO; CLO_0033060
DR   Coriell; ND04015
DR   Wikidata; Q54915495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04016
AC   CVCL_1X14
SY   ND-4016
DR   CLO; CLO_0033064
DR   Coriell; ND04016
DR   Wikidata; Q54915496
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04017
AC   CVCL_1X15
SY   ND-4017
DR   CLO; CLO_0033065
DR   Coriell; ND04017
DR   Wikidata; Q54915497
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04018
AC   CVCL_CD54
DR   CLO; CLO_0033063
DR   BioSample; SAMN00807026
DR   Coriell; ND04018
DR   Wikidata; Q54915498
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND04019
AC   CVCL_1X16
SY   ND-4019
DR   CLO; CLO_0032896
DR   BioSample; SAMN00807028
DR   Coriell; ND04019
DR   Wikidata; Q54915514
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND04020
AC   CVCL_GB68
DR   CLO; CLO_0032895
DR   Coriell; ND04020
DR   Wikidata; Q54915515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04021
AC   CVCL_FI10
DR   CLO; CLO_0032892
DR   BioSample; SAMN00807030
DR   Coriell; ND04021
DR   Wikidata; Q54915516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04022
AC   CVCL_HM32
DR   CLO; CLO_0032890
DR   BioSample; SAMN00807032
DR   Coriell; ND04022
DR   Wikidata; Q54915517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04023
AC   CVCL_HM33
DR   CLO; CLO_0032888
DR   BioSample; SAMN00807034
DR   Coriell; ND04023
DR   Wikidata; Q54915518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04024
AC   CVCL_CD55
DR   CLO; CLO_0032887
DR   Coriell; ND04024
DR   Wikidata; Q54915519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04025
AC   CVCL_HQ73
DR   CLO; CLO_0032886
DR   Coriell; ND04025
DR   Wikidata; Q54915520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04026
AC   CVCL_CD56
DR   CLO; CLO_0032885
DR   Coriell; ND04026
DR   Wikidata; Q54915521
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04027
AC   CVCL_CD57
DR   CLO; CLO_0032884
DR   Coriell; ND04027
DR   Wikidata; Q54915522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04028
AC   CVCL_AB66
DR   CLO; CLO_0032901
DR   Coriell; ND04028
DR   Wikidata; Q54915523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND04029
AC   CVCL_FF02
DR   CLO; CLO_0032918
DR   Coriell; ND04029
DR   Wikidata; Q54915524
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04030
AC   CVCL_GB69
DR   CLO; CLO_0032919
DR   Coriell; ND04030
DR   Wikidata; Q54915525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04034
AC   CVCL_HT73
DR   BioSample; SAMN00807036
DR   Coriell; ND04034
DR   Wikidata; Q54915526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04035
AC   CVCL_FX17
DR   BioSample; SAMN00807038
DR   Coriell; ND04035
DR   Wikidata; Q54915527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04038
AC   CVCL_CD58
DR   Coriell; ND04038
DR   Wikidata; Q54915528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04045
AC   CVCL_1X17
SY   ND-4045
DR   CLO; CLO_0032920
DR   Coriell; ND04045
DR   Wikidata; Q54915529
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04046
AC   CVCL_DW41
DR   CLO; CLO_0032921
DR   Coriell; ND04046
DR   Wikidata; Q54915530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04047
AC   CVCL_DW42
DR   CLO; CLO_0032922
DR   Coriell; ND04047
DR   Wikidata; Q54915531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04051
AC   CVCL_BA21
DR   CLO; CLO_0032923
DR   BioSample; SAMN00807044
DR   Coriell; ND04051
DR   Wikidata; Q54915532
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND04052
AC   CVCL_BA22
DR   CLO; CLO_0032924
DR   BioSample; SAMN00807046
DR   Coriell; ND04052
DR   Wikidata; Q54915533
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND04054
AC   CVCL_BA23
DR   CLO; CLO_0032925
DR   BioSample; SAMN00807048
DR   Coriell; ND04054
DR   Wikidata; Q54915534
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND04055
AC   CVCL_BA24
DR   CLO; CLO_0032926
DR   Coriell; ND04055
DR   Wikidata; Q54915535
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND04056
AC   CVCL_BA25
DR   CLO; CLO_0032927
DR   BioSample; SAMN00807050
DR   Coriell; ND04056
DR   Wikidata; Q54915536
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND04058
AC   CVCL_BA26
DR   CLO; CLO_0032950
DR   Coriell; ND04058
DR   Wikidata; Q54915537
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND04059
AC   CVCL_BA27
DR   CLO; CLO_0032948
DR   Coriell; ND04059
DR   Wikidata; Q54915538
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND04060
AC   CVCL_BA28
DR   CLO; CLO_0032949
DR   BioSample; SAMN00807052
DR   Coriell; ND04060
DR   Wikidata; Q54915539
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND04061
AC   CVCL_HY39
DR   CLO; CLO_0032953
DR   BioSample; SAMN00807054
DR   Coriell; ND04061
DR   Wikidata; Q54915540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04062
AC   CVCL_IH84
DR   CLO; CLO_0032954
DR   BioSample; SAMN00807056
DR   Coriell; ND04062
DR   Wikidata; Q54915541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04063
AC   CVCL_IH85
DR   CLO; CLO_0032951
DR   BioSample; SAMN00807058
DR   Coriell; ND04063
DR   Wikidata; Q54915542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04064
AC   CVCL_BA29
DR   CLO; CLO_0032952
DR   Coriell; ND04064
DR   Wikidata; Q54915543
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND04066
AC   CVCL_FB35
DR   CLO; CLO_0032956
DR   Coriell; ND04066
DR   Wikidata; Q54915544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04067
AC   CVCL_FB36
DR   CLO; CLO_0032957
DR   BioSample; SAMN00807060
DR   Coriell; ND04067
DR   Wikidata; Q54915545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04068
AC   CVCL_ES28
DR   CLO; CLO_0032955
DR   Coriell; ND04068
DR   Wikidata; Q54915546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04069
AC   CVCL_1X18
SY   ND-4069
DR   CLO; CLO_0032978
DR   BioSample; SAMN00807062
DR   Coriell; ND04069
DR   Wikidata; Q54915547
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND04071
AC   CVCL_ES29
DR   CLO; CLO_0032979
DR   BioSample; SAMN00807064
DR   Coriell; ND04071
DR   Wikidata; Q54915548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04077
AC   CVCL_FI11
DR   CLO; CLO_0032980
DR   Coriell; ND04077
DR   Wikidata; Q54915549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04078
AC   CVCL_FI12
DR   CLO; CLO_0032981
DR   Coriell; ND04078
DR   Wikidata; Q54915550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04079
AC   CVCL_FI13
DR   CLO; CLO_0032984
DR   Coriell; ND04079
DR   Wikidata; Q54915551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04080
AC   CVCL_FI14
DR   CLO; CLO_0032985
DR   Coriell; ND04080
DR   Wikidata; Q54915552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04081
AC   CVCL_FI15
DR   CLO; CLO_0032986
DR   Coriell; ND04081
DR   Wikidata; Q54915553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04082
AC   CVCL_FI16
DR   CLO; CLO_0032987
DR   Coriell; ND04082
DR   Wikidata; Q54915562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04083
AC   CVCL_FI17
DR   CLO; CLO_0032982
DR   Coriell; ND04083
DR   Wikidata; Q54915563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04084
AC   CVCL_FI18
DR   CLO; CLO_0032983
DR   BioSample; SAMN00807066
DR   Coriell; ND04084
DR   Wikidata; Q54915564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04085
AC   CVCL_IB07
DR   CLO; CLO_0033013
DR   BioSample; SAMN00807068
DR   Coriell; ND04085
DR   Wikidata; Q54915565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04086
AC   CVCL_FF03
DR   CLO; CLO_0033011
DR   Coriell; ND04086
DR   Wikidata; Q54915566
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04089
AC   CVCL_HT74
DR   BioSample; SAMN00807070
DR   Coriell; ND04089
DR   Wikidata; Q54915567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04090
AC   CVCL_EH40
DR   CLO; CLO_0033012
DR   Coriell; ND04090
DR   Wikidata; Q54915568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04091
AC   CVCL_CD59
DR   CLO; CLO_0033009
DR   Coriell; ND04091
DR   Wikidata; Q54915569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04093
AC   CVCL_CD60
DR   CLO; CLO_0033010
DR   Coriell; ND04093
DR   Wikidata; Q54915571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04094
AC   CVCL_HQ74
DR   CLO; CLO_0033017
DR   Coriell; ND04094
DR   Wikidata; Q54915572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04097
AC   CVCL_FF04
DR   CLO; CLO_0033018
DR   Coriell; ND04097
DR   Wikidata; Q54915573
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04098
AC   CVCL_FF05
DR   Coriell; ND04098
DR   Wikidata; Q54915574
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04099
AC   CVCL_FX18
DR   BioSample; SAMN00807072
DR   Coriell; ND04099
DR   Wikidata; Q54915575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04100
AC   CVCL_HT75
DR   BioSample; SAMN00807074
DR   Coriell; ND04100
DR   Wikidata; Q54915576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04102
AC   CVCL_FI19
DR   BioSample; SAMN00807076
DR   Coriell; ND04102
DR   Wikidata; Q54915577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04103
AC   CVCL_1X19
SY   ND-4103
DR   Coriell; ND04103
DR   Wikidata; Q54915578
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Coriell; ND04103; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   ND04104
AC   CVCL_1X20
SY   ND-4104
DR   CLO; CLO_0033015
DR   Coriell; ND04104
DR   Wikidata; Q54915579
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04105
AC   CVCL_DW43
DR   CLO; CLO_0033016
DR   Coriell; ND04105
DR   Wikidata; Q54915580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04107
AC   CVCL_FC29
DR   CLO; CLO_0033014
DR   BioSample; SAMN00807078
DR   Coriell; ND04107
DR   Wikidata; Q54915581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04108
AC   CVCL_ES30
DR   CLO; CLO_0032618
DR   BioSample; SAMN00807080
DR   Coriell; ND04108
DR   Wikidata; Q54915582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04113
AC   CVCL_GB70
DR   CLO; CLO_0032617
DR   Coriell; ND04113
DR   Wikidata; Q54915583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04114
AC   CVCL_ES31
DR   CLO; CLO_0032616
DR   Coriell; ND04114
DR   Wikidata; Q54915585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04117
AC   CVCL_GB71
DR   CLO; CLO_0032615
DR   Coriell; ND04117
DR   Wikidata; Q54915586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04119
AC   CVCL_FI20
DR   CLO; CLO_0032614
DR   Coriell; ND04119
DR   Wikidata; Q54915587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04120
AC   CVCL_FX19
DR   CLO; CLO_0032613
DR   Coriell; ND04120
DR   Wikidata; Q54915588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04121
AC   CVCL_FX20
DR   CLO; CLO_0032612
DR   Coriell; ND04121
DR   Wikidata; Q54915589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04122
AC   CVCL_FX21
DR   CLO; CLO_0032611
DR   Coriell; ND04122
DR   Wikidata; Q54915591
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04123
AC   CVCL_FI21
DR   CLO; CLO_0032610
DR   BioSample; SAMN00807082
DR   Coriell; ND04123
DR   Wikidata; Q54915593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04124
AC   CVCL_IB08
DR   CLO; CLO_0032609
DR   BioSample; SAMN00807084
DR   Coriell; ND04124
DR   Wikidata; Q54915594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04125
AC   CVCL_IB09
DR   BioSample; SAMN00807086
DR   Coriell; ND04125
DR   Wikidata; Q54915595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04135
AC   CVCL_FX22
DR   BioSample; SAMN00807092
DR   Coriell; ND04135
DR   Wikidata; Q54915596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04136
AC   CVCL_HT76
DR   BioSample; SAMN00807094
DR   Coriell; ND04136
DR   Wikidata; Q54915597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04140
AC   CVCL_FX23
DR   BioSample; SAMN00807096
DR   Coriell; ND04140
DR   Wikidata; Q54915598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04145
AC   CVCL_CD61
DR   Coriell; ND04145
DR   Wikidata; Q54915599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04147
AC   CVCL_CD62
DR   CLO; CLO_0032606
DR   Coriell; ND04147
DR   Wikidata; Q54915600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04149
AC   CVCL_CD63
DR   CLO; CLO_0032608
DR   Coriell; ND04149
DR   Wikidata; Q54915601
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04151
AC   CVCL_CD64
DR   CLO; CLO_0032607
DR   BioSample; SAMN00807098
DR   Coriell; ND04151
DR   Wikidata; Q54915602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04152
AC   CVCL_1X21
SY   ND-4152
DR   CLO; CLO_0032603
DR   BioSample; SAMN00807100
DR   Coriell; ND04152
DR   Wikidata; Q54915603
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04153
AC   CVCL_FI22
DR   CLO; CLO_0032602
DR   BioSample; SAMN00807102
DR   Coriell; ND04153
DR   Wikidata; Q54915604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04154
AC   CVCL_IH86
DR   CLO; CLO_0032605
DR   BioSample; SAMN00807104
DR   Coriell; ND04154
DR   Wikidata; Q54915605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04155
AC   CVCL_IH87
DR   CLO; CLO_0032604
DR   BioSample; SAMN00807106
DR   Coriell; ND04155
DR   Wikidata; Q54915609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04156
AC   CVCL_CD65
DR   CLO; CLO_0032600
DR   Coriell; ND04156
DR   Wikidata; Q54915610
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04157
AC   CVCL_CD66
DR   CLO; CLO_0032599
DR   Coriell; ND04157
DR   Wikidata; Q54915611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04158
AC   CVCL_CD67
SY   ND 04158
DR   CLO; CLO_0032601
DR   Coriell; ND04158
DR   GEO; GSM505607
DR   Wikidata; Q54915613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND04159
AC   CVCL_CD68
DR   CLO; CLO_0032644
DR   BioSample; SAMN00807108
DR   Coriell; ND04159
DR   Wikidata; Q54915614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04160
AC   CVCL_CD69
DR   CLO; CLO_0032643
DR   Coriell; ND04160
DR   Wikidata; Q54915615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04162
AC   CVCL_CD70
DR   CLO; CLO_0032642
DR   Coriell; ND04162
DR   Wikidata; Q54915616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04164
AC   CVCL_CD71
DR   CLO; CLO_0032641
DR   Coriell; ND04164
DR   Wikidata; Q54915617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04167
AC   CVCL_HT77
DR   BioSample; SAMN00807110
DR   Coriell; ND04167
DR   Wikidata; Q54915618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04175
AC   CVCL_HT78
DR   BioSample; SAMN00807112
DR   Coriell; ND04175
DR   Wikidata; Q54915619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04176
AC   CVCL_CD72
DR   CLO; CLO_0032648
DR   Coriell; ND04176
DR   Wikidata; Q54915620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04177
AC   CVCL_CD73
DR   CLO; CLO_0032647
DR   BioSample; SAMN00807114
DR   Coriell; ND04177
DR   Wikidata; Q54915621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04178
AC   CVCL_1X22
SY   ND-4178
DR   CLO; CLO_0032646
DR   BioSample; SAMN00807116
DR   Coriell; ND04178
DR   Wikidata; Q54915622
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND04179
AC   CVCL_CD74
DR   CLO; CLO_0032645
DR   Coriell; ND04179
DR   Wikidata; Q54915623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04180
AC   CVCL_CD75
DR   CLO; CLO_0032640
DR   Coriell; ND04180
DR   Wikidata; Q54915624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04181
AC   CVCL_CD76
DR   CLO; CLO_0032639
DR   Coriell; ND04181
DR   Wikidata; Q54915625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04182
AC   CVCL_FX24
DR   CLO; CLO_0032634
DR   Coriell; ND04182
DR   Wikidata; Q54915626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04183
AC   CVCL_FI23
DR   CLO; CLO_0032621
DR   Coriell; ND04183
DR   Wikidata; Q54915627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04184
AC   CVCL_CD77
DR   CLO; CLO_0032620
DR   Coriell; ND04184
DR   Wikidata; Q54915628
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04187
AC   CVCL_IB10
DR   Coriell; ND04187
DR   Wikidata; Q54915629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04188
AC   CVCL_ES32
DR   CLO; CLO_0032623
DR   Coriell; ND04188
DR   Wikidata; Q54915630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04190
AC   CVCL_ES33
DR   CLO; CLO_0032622
DR   Coriell; ND04190
DR   Wikidata; Q54915631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04191
AC   CVCL_FI24
DR   CLO; CLO_0032625
DR   Coriell; ND04191
DR   Wikidata; Q54915632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04192
AC   CVCL_FI25
DR   CLO; CLO_0032624
DR   Coriell; ND04192
DR   Wikidata; Q54915633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04193
AC   CVCL_FI26
DR   CLO; CLO_0032627
DR   Coriell; ND04193
DR   Wikidata; Q54915634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04194
AC   CVCL_FI27
DR   CLO; CLO_0032626
DR   Coriell; ND04194
DR   Wikidata; Q54915635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04195
AC   CVCL_FI28
DR   CLO; CLO_0032619
DR   Coriell; ND04195
DR   Wikidata; Q54915636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04196
AC   CVCL_FI29
DR   CLO; CLO_0032668
DR   BioSample; SAMN00807118
DR   Coriell; ND04196
DR   Wikidata; Q54915637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04197
AC   CVCL_FI30
DR   CLO; CLO_0032667
DR   BioSample; SAMN00807120
DR   Coriell; ND04197
DR   Wikidata; Q54915639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04200
AC   CVCL_DW44
DR   CLO; CLO_0032665
DR   Coriell; ND04200
DR   Wikidata; Q54915640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04201
AC   CVCL_DW45
DR   CLO; CLO_0032666
DR   Coriell; ND04201
DR   Wikidata; Q54915641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04202
AC   CVCL_IB11
DR   Coriell; ND04202
DR   Wikidata; Q54915642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04203
AC   CVCL_ES34
DR   CLO; CLO_0032663
DR   Coriell; ND04203
DR   Wikidata; Q54915643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04204
AC   CVCL_DW46
DR   CLO; CLO_0032664
DR   Coriell; ND04204
DR   Wikidata; Q54915644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04205
AC   CVCL_HT79
DR   BioSample; SAMN00807122
DR   Coriell; ND04205
DR   Wikidata; Q54915645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04206
AC   CVCL_CD78
DR   Coriell; ND04206
DR   Wikidata; Q54915646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04207
AC   CVCL_CD79
DR   Coriell; ND04207
DR   Wikidata; Q54915647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04212
AC   CVCL_CY87
DR   CLO; CLO_0032661
DR   Coriell; ND04212
DR   Wikidata; Q54915648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04213
AC   CVCL_CD80
DR   CLO; CLO_0032662
DR   BioSample; SAMN00807124
DR   Coriell; ND04213
DR   Wikidata; Q54915649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04214
AC   CVCL_1X23
SY   ND-4214
DR   CLO; CLO_0032659
DR   BioSample; SAMN00807126
DR   Coriell; ND04214
DR   Wikidata; Q54915650
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND04215
AC   CVCL_IL47
DR   CLO; CLO_0032660
DR   Coriell; ND04215
DR   Wikidata; Q54915655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND04215; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND04216
AC   CVCL_FX25
DR   CLO; CLO_0034414
DR   Coriell; ND04216
DR   Wikidata; Q54915656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04217
AC   CVCL_FX26
DR   CLO; CLO_0034413
DR   Coriell; ND04217
DR   Wikidata; Q54915657
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04222
AC   CVCL_IB12
DR   Coriell; ND04222
DR   Wikidata; Q54915658
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04223
AC   CVCL_HT80
DR   BioSample; SAMN00807128
DR   Coriell; ND04223
DR   Wikidata; Q54915659
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND04224
AC   CVCL_FI31
DR   CLO; CLO_0034411
DR   Coriell; ND04224
DR   Wikidata; Q54915660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04225
AC   CVCL_GB72
DR   CLO; CLO_0034410
DR   Coriell; ND04225
DR   Wikidata; Q54915661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04226
AC   CVCL_FI32
DR   Coriell; ND04226
DR   Wikidata; Q54915662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04227
AC   CVCL_FX27
DR   CLO; CLO_0034418
DR   Coriell; ND04227
DR   Wikidata; Q54915663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04228
AC   CVCL_CD81
DR   CLO; CLO_0034417
DR   Coriell; ND04228
DR   Wikidata; Q54915664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04231
AC   CVCL_IB13
DR   Coriell; ND04231
DR   Wikidata; Q54915665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04233
AC   CVCL_ES35
DR   CLO; CLO_0034416
DR   BioSample; SAMN00807130
DR   Coriell; ND04233
DR   Wikidata; Q54915666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04234
AC   CVCL_CD82
DR   CLO; CLO_0034415
DR   Coriell; ND04234
DR   Wikidata; Q54915667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04235
AC   CVCL_CD83
DR   CLO; CLO_0034343
DR   BioSample; SAMN00807132
DR   Coriell; ND04235
DR   Wikidata; Q54915668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04236
AC   CVCL_EH41
DR   CLO; CLO_0034346
DR   BioSample; SAMN00807134
DR   Coriell; ND04236
DR   Wikidata; Q54915669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04237
AC   CVCL_ES36
DR   CLO; CLO_0034326
DR   BioSample; SAMN00807136
DR   Coriell; ND04237
DR   Wikidata; Q54915670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04238
AC   CVCL_ES37
DR   CLO; CLO_0034332
DR   Coriell; ND04238
DR   Wikidata; Q54915671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04239
AC   CVCL_ES38
DR   CLO; CLO_0034331
DR   Coriell; ND04239
DR   Wikidata; Q54915672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04240
AC   CVCL_1X24
SY   ND-4240
DR   CLO; CLO_0034336
DR   Coriell; ND04240
DR   Wikidata; Q54915673
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04241
AC   CVCL_FI33
DR   CLO; CLO_0034333
DR   Coriell; ND04241
DR   Wikidata; Q54915674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04242
AC   CVCL_FI34
DR   CLO; CLO_0034328
DR   Coriell; ND04242
DR   Wikidata; Q54915675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04243
AC   CVCL_FI35
DR   CLO; CLO_0034327
DR   Coriell; ND04243
DR   Wikidata; Q54915676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04244
AC   CVCL_FI36
DR   CLO; CLO_0034330
DR   Coriell; ND04244
DR   Wikidata; Q54915677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04248
AC   CVCL_CD84
DR   Coriell; ND04248
DR   Wikidata; Q54915678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04249
AC   CVCL_CD85
DR   Coriell; ND04249
DR   Wikidata; Q54915679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04251
AC   CVCL_IB14
DR   Coriell; ND04251
DR   Wikidata; Q54915680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04260
AC   CVCL_FI37
DR   CLO; CLO_0034329
DR   BioSample; SAMN00807138
DR   Coriell; ND04260
DR   Wikidata; Q54915681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04261
AC   CVCL_IH88
DR   CLO; CLO_0034381
DR   BioSample; SAMN00807140
DR   Coriell; ND04261
DR   Wikidata; Q54915682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04262
AC   CVCL_IH89
DR   CLO; CLO_0034359
DR   BioSample; SAMN00807142
DR   Coriell; ND04262
DR   Wikidata; Q54915683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04263
AC   CVCL_CD86
DR   CLO; CLO_0034358
DR   Coriell; ND04263
DR   Wikidata; Q54915684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04264
AC   CVCL_CD87
DR   CLO; CLO_0034368
DR   Coriell; ND04264
DR   Wikidata; Q54915685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04265
AC   CVCL_CD88
DR   CLO; CLO_0034367
DR   Coriell; ND04265
DR   Wikidata; Q54915686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04266
AC   CVCL_CD89
DR   CLO; CLO_0034366
DR   Coriell; ND04266
DR   Wikidata; Q54915687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04267
AC   CVCL_GB73
DR   CLO; CLO_0034365
DR   Coriell; ND04267
DR   Wikidata; Q54915688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04268
AC   CVCL_FX28
DR   CLO; CLO_0034363
DR   Coriell; ND04268
DR   Wikidata; Q54915689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04269
AC   CVCL_FX29
DR   CLO; CLO_0034362
DR   Coriell; ND04269
DR   Wikidata; Q54915690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04274
AC   CVCL_1X25
SY   ND-4274
DR   CLO; CLO_0034361
DR   Coriell; ND04274
DR   Wikidata; Q54915691
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04275
AC   CVCL_1X26
SY   ND-4275
DR   CLO; CLO_0034360
DR   Coriell; ND04275
DR   Wikidata; Q54915693
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04276
AC   CVCL_1X27
SY   ND-4276
DR   CLO; CLO_0034293
DR   Coriell; ND04276
DR   Wikidata; Q54915694
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04278
AC   CVCL_FI38
DR   CLO; CLO_0034294
DR   Coriell; ND04278
DR   Wikidata; Q54915695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04279
AC   CVCL_ES39
DR   CLO; CLO_0034295
DR   Coriell; ND04279
DR   Wikidata; Q54915704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04280
AC   CVCL_ES40
DR   CLO; CLO_0034286
DR   Coriell; ND04280
DR   Wikidata; Q54915705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04281
AC   CVCL_IB15
DR   Coriell; ND04281
DR   Wikidata; Q54915706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04282
AC   CVCL_FI39
DR   CLO; CLO_0034287
DR   Coriell; ND04282
DR   Wikidata; Q54915707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04283
AC   CVCL_FI40
DR   Coriell; ND04283
DR   Wikidata; Q54915708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04284
AC   CVCL_ES41
DR   CLO; CLO_0034288
DR   Coriell; ND04284
DR   Wikidata; Q54915709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04285
AC   CVCL_FI41
DR   CLO; CLO_0034289
DR   Coriell; ND04285
DR   Wikidata; Q54915710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04286
AC   CVCL_FI42
DR   CLO; CLO_0034290
DR   Coriell; ND04286
DR   Wikidata; Q54915711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04287
AC   CVCL_FI43
DR   CLO; CLO_0034291
DR   Coriell; ND04287
DR   Wikidata; Q54915712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04288
AC   CVCL_FI44
DR   CLO; CLO_0034292
DR   Coriell; ND04288
DR   Wikidata; Q54915713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04289
AC   CVCL_FI45
DR   CLO; CLO_0034314
DR   Coriell; ND04289
DR   Wikidata; Q54915714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04290
AC   CVCL_FI46
DR   CLO; CLO_0034315
DR   Coriell; ND04290
DR   Wikidata; Q54915715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04291
AC   CVCL_1X28
SY   ND-4291
DR   CLO; CLO_0034312
DR   BioSample; SAMN00807144
DR   Coriell; ND04291
DR   Wikidata; Q54915716
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04292
AC   CVCL_IB16
DR   Coriell; ND04292
DR   Wikidata; Q54915718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04293
AC   CVCL_CD90
DR   CLO; CLO_0034313
DR   BioSample; SAMN00807146
DR   Coriell; ND04293
DR   Wikidata; Q54915719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04294
AC   CVCL_CD91
DR   CLO; CLO_0034308
DR   Coriell; ND04294
DR   Wikidata; Q54915720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04295
AC   CVCL_DW47
DR   CLO; CLO_0034309
DR   Coriell; ND04295
DR   Wikidata; Q54915721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04296
AC   CVCL_1X29
SY   ND-4296
DR   CLO; CLO_0034306
DR   Coriell; ND04296
DR   Wikidata; Q54915722
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04297
AC   CVCL_DW48
DR   CLO; CLO_0034307
DR   Coriell; ND04297
DR   Wikidata; Q54915723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04298
AC   CVCL_DW49
DR   CLO; CLO_0034310
DR   Coriell; ND04298
DR   Wikidata; Q54915724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04299
AC   CVCL_DW50
DR   CLO; CLO_0034311
DR   Coriell; ND04299
DR   Wikidata; Q54915725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04300
AC   CVCL_EH42
DR   CLO; CLO_0034256
DR   Coriell; ND04300
DR   Wikidata; Q54915726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04301
AC   CVCL_CD92
DR   CLO; CLO_0034251
DR   Coriell; ND04301
DR   Wikidata; Q54915727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04302
AC   CVCL_1X30
SY   ND-4302
DR   CLO; CLO_0034253
DR   BioSample; SAMN00807148
DR   Coriell; ND04302
DR   Wikidata; Q54915728
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04303
AC   CVCL_CD93
DR   CLO; CLO_0034254
DR   BioSample; SAMN00807150
DR   Coriell; ND04303
DR   Wikidata; Q54915729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04304
AC   CVCL_IB17
DR   Coriell; ND04304
DR   Wikidata; Q54915730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04305
AC   CVCL_1X31
SY   ND-4305
DR   CLO; CLO_0034255
DR   Coriell; ND04305
DR   Wikidata; Q54915731
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04306
AC   CVCL_HT81
DR   BioSample; SAMN00807152
DR   Coriell; ND04306
DR   Wikidata; Q54915732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04309
AC   CVCL_HT82
DR   BioSample; SAMN00807154
DR   Coriell; ND04309
DR   Wikidata; Q54915733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04310
AC   CVCL_ES42
DR   Coriell; ND04310
DR   Wikidata; Q54915734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04311
AC   CVCL_GB74
DR   CLO; CLO_0034247
DR   Coriell; ND04311
DR   Wikidata; Q54915735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04312
AC   CVCL_1X32
SY   ND-4312
DR   CLO; CLO_0034248
DR   Coriell; ND04312
DR   Wikidata; Q54915736
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04313
AC   CVCL_GB75
DR   CLO; CLO_0034249
DR   Coriell; ND04313
DR   Wikidata; Q54915737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04314
AC   CVCL_ES43
DR   CLO; CLO_0034250
DR   Coriell; ND04314
DR   Wikidata; Q54915738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04315
AC   CVCL_IH02
DR   CLO; CLO_0034246
DR   Coriell; ND04315
DR   Wikidata; Q54915739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04325
AC   CVCL_CD94
DR   Coriell; ND04325
DR   Wikidata; Q54915740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04329
AC   CVCL_DW51
DR   Coriell; ND04329
DR   Wikidata; Q54915741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04332
AC   CVCL_FX30
DR   BioSample; SAMN00807156
DR   Coriell; ND04332
DR   Wikidata; Q54915742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04334
AC   CVCL_CD95
DR   Coriell; ND04334
DR   Wikidata; Q54915743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04336
AC   CVCL_ES44
DR   Coriell; ND04336
DR   Wikidata; Q54915744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04337
AC   CVCL_GB76
DR   CLO; CLO_0034274
DR   Coriell; ND04337
DR   Wikidata; Q54915758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04338
AC   CVCL_ES45
DR   CLO; CLO_0034275
DR   Coriell; ND04338
DR   Wikidata; Q54915759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04339
AC   CVCL_ES46
DR   CLO; CLO_0034272
DR   Coriell; ND04339
DR   Wikidata; Q54915760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04340
AC   CVCL_CD96
DR   CLO; CLO_0034273
DR   Coriell; ND04340
DR   Wikidata; Q54915761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04341
AC   CVCL_CD97
DR   CLO; CLO_0034270
DR   Coriell; ND04341
DR   Wikidata; Q54915763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04342
AC   CVCL_CD98
DR   CLO; CLO_0034271
DR   BioSample; SAMN00807158
DR   Coriell; ND04342
DR   Wikidata; Q54915764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04343
AC   CVCL_1X33
SY   ND-4343
DR   CLO; CLO_0034268
DR   BioSample; SAMN00807160
DR   Coriell; ND04343
DR   Wikidata; Q54915765
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04344
AC   CVCL_CD99
DR   CLO; CLO_0034269
DR   Coriell; ND04344
DR   Wikidata; Q54915766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04347
AC   CVCL_IB18
DR   Coriell; ND04347
DR   Wikidata; Q54915767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04349
AC   CVCL_DW52
DR   CLO; CLO_0034266
DR   Coriell; ND04349
DR   Wikidata; Q54915768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04350
AC   CVCL_1X34
SY   ND-4350
DR   CLO; CLO_0034267
DR   Coriell; ND04350
DR   Wikidata; Q54915769
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04353
AC   CVCL_FI47
DR   CLO; CLO_0034084
DR   BioSample; SAMN00807162
DR   Coriell; ND04353
DR   Wikidata; Q54915770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04354
AC   CVCL_HP93
DR   CLO; CLO_0034083
DR   BioSample; SAMN00807164
DR   Coriell; ND04354
DR   Wikidata; Q54915771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04355
AC   CVCL_ES47
DR   CLO; CLO_0034082
DR   Coriell; ND04355
DR   Wikidata; Q54915772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04356
AC   CVCL_ES48
DR   CLO; CLO_0034081
DR   Coriell; ND04356
DR   Wikidata; Q54915773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04357
AC   CVCL_1X35
SY   ND-4357
DR   Coriell; ND04357
DR   Wikidata; Q54915774
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Coriell; ND04357; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   ND04361
AC   CVCL_1X36
SY   ND-4361
DR   CLO; CLO_0034080
DR   Coriell; ND04361
DR   Wikidata; Q54915775
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04362
AC   CVCL_DW53
DR   CLO; CLO_0034079
DR   Coriell; ND04362
DR   Wikidata; Q54915776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04363
AC   CVCL_DW54
DR   CLO; CLO_0034078
DR   Coriell; ND04363
DR   Wikidata; Q54915777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04364
AC   CVCL_DW55
DR   CLO; CLO_0034087
DR   Coriell; ND04364
DR   Wikidata; Q54915778
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04365
AC   CVCL_IB19
DR   BioSample; SAMN00807166
DR   Coriell; ND04365
DR   Wikidata; Q54915779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04367
AC   CVCL_HT83
DR   BioSample; SAMN00807168
DR   Coriell; ND04367
DR   Wikidata; Q54915780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04368
AC   CVCL_HT84
DR   BioSample; SAMN00807170
DR   Coriell; ND04368
DR   Wikidata; Q54915782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04369
AC   CVCL_HT85
DR   BioSample; SAMN00807172
DR   Coriell; ND04369
DR   Wikidata; Q54915784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04375
AC   CVCL_CE00
DR   CLO; CLO_0034086
DR   BioSample; SAMN00807174
DR   Coriell; ND04375
DR   Wikidata; Q54915785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04376
AC   CVCL_ES49
DR   CLO; CLO_0034085
DR   BioSample; SAMN00807176
DR   Coriell; ND04376
DR   Wikidata; Q54915787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04377
AC   CVCL_GB77
DR   CLO; CLO_0034073
DR   Coriell; ND04377
DR   Wikidata; Q54915788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04380
AC   CVCL_DW56
DR   CLO; CLO_0034072
DR   Coriell; ND04380
DR   Wikidata; Q54915789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04381
AC   CVCL_CE01
DR   CLO; CLO_0034075
DR   Coriell; ND04381
DR   Wikidata; Q54915790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04382
AC   CVCL_ES50
DR   CLO; CLO_0034074
DR   Coriell; ND04382
DR   Wikidata; Q54915791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04383
AC   CVCL_CE02
DR   CLO; CLO_0034069
DR   Coriell; ND04383
DR   Wikidata; Q54915792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04384
AC   CVCL_GB78
DR   CLO; CLO_0034068
DR   Coriell; ND04384
DR   Wikidata; Q54915794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04385
AC   CVCL_GB79
DR   CLO; CLO_0034071
DR   Coriell; ND04385
DR   Wikidata; Q54915795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04386
AC   CVCL_FX31
DR   CLO; CLO_0034070
DR   Coriell; ND04386
DR   Wikidata; Q54915796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04387
AC   CVCL_FX32
DR   CLO; CLO_0034077
DR   Coriell; ND04387
DR   Wikidata; Q54915797
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04388
AC   CVCL_FI48
DR   BioSample; SAMN00807178
DR   Coriell; ND04388
DR   Wikidata; Q54915798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04389
AC   CVCL_IB20
DR   Coriell; ND04389
DR   Wikidata; Q54915799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04392
AC   CVCL_HT86
DR   BioSample; SAMN00807180
DR   Coriell; ND04392
DR   Wikidata; Q54915800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04393
AC   CVCL_HT87
DR   BioSample; SAMN00807182
DR   Coriell; ND04393
DR   Wikidata; Q54915801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04396
AC   CVCL_CE03
DR   CLO; CLO_0034076
DR   Coriell; ND04396
DR   Wikidata; Q54915802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04397
AC   CVCL_CE04
DR   CLO; CLO_0034058
DR   BioSample; SAMN00807184
DR   Coriell; ND04397
DR   Wikidata; Q54915810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04398
AC   CVCL_GB80
DR   CLO; CLO_0034062
DR   BioSample; SAMN00807186
DR   Coriell; ND04398
DR   Wikidata; Q54915811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04399
AC   CVCL_CE05
DR   CLO; CLO_0034061
DR   Coriell; ND04399
DR   Wikidata; Q54915812
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04400
AC   CVCL_CE06
DR   CLO; CLO_0034060
DR   Coriell; ND04400
DR   Wikidata; Q54915814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04401
AC   CVCL_CE07
DR   CLO; CLO_0034059
DR   Coriell; ND04401
DR   Wikidata; Q54915815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04402
AC   CVCL_GB81
DR   CLO; CLO_0034066
DR   Coriell; ND04402
DR   Wikidata; Q54915816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04403
AC   CVCL_CY88
DR   CLO; CLO_0034065
DR   BioSample; SAMN00807188
DR   Coriell; ND04403
DR   Wikidata; Q54915817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04404
AC   CVCL_1X37
SY   ND-4404
DR   CLO; CLO_0034064
DR   BioSample; SAMN00807190
DR   Coriell; ND04404
DR   Wikidata; Q54915818
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04405
AC   CVCL_FX33
DR   CLO; CLO_0034063
DR   Coriell; ND04405
DR   Wikidata; Q54915819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04406
AC   CVCL_CE08
DR   BioSample; SAMN00807192
DR   Coriell; ND04406
DR   Wikidata; Q54915820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04407
AC   CVCL_CE09
DR   Coriell; ND04407
DR   Wikidata; Q54915821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04408
AC   CVCL_FI49
DR   BioSample; SAMN00807194
DR   Coriell; ND04408
DR   Wikidata; Q54915822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04411
AC   CVCL_IB21
DR   Coriell; ND04411
DR   Wikidata; Q54915823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04412
AC   CVCL_IB22
DR   Coriell; ND04412
DR   Wikidata; Q54915824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04423
AC   CVCL_DW57
DR   CLO; CLO_0034067
DR   Coriell; ND04423
DR   Wikidata; Q54915825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04424
AC   CVCL_CE10
SY   ND 04424
DR   CLO; CLO_0033747
DR   Coriell; ND04424
DR   GEO; GSM505617
DR   Wikidata; Q54915826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND04425
AC   CVCL_CE11
DR   CLO; CLO_0033750
DR   Coriell; ND04425
DR   Wikidata; Q54915827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04429
AC   CVCL_FF06
DR   Coriell; ND04429
DR   Wikidata; Q54915828
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04431
AC   CVCL_1X38
SY   ND-4431
DR   CLO; CLO_0033752
DR   Coriell; ND04431
DR   Wikidata; Q54915829
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04432
AC   CVCL_FX34
DR   BioSample; SAMN00807196
DR   Coriell; ND04432
DR   Wikidata; Q54915830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04433
AC   CVCL_HT88
DR   BioSample; SAMN00807198
DR   Coriell; ND04433
DR   Wikidata; Q54915831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04436
AC   CVCL_HQ75
DR   CLO; CLO_0033740
DR   Coriell; ND04436
DR   Wikidata; Q54915833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04437
AC   CVCL_IH03
DR   CLO; CLO_0033741
DR   Coriell; ND04437
DR   Wikidata; Q54915835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04438
AC   CVCL_FX35
DR   CLO; CLO_0033742
DR   Coriell; ND04438
DR   Wikidata; Q54915836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04439
AC   CVCL_FX36
DR   CLO; CLO_0033744
DR   Coriell; ND04439
DR   Wikidata; Q54915837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04440
AC   CVCL_CE12
DR   CLO; CLO_0033927
DR   BioSample; SAMN00807200
DR   Coriell; ND04440
DR   Wikidata; Q54915838
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND04441
AC   CVCL_HP94
DR   CLO; CLO_0033930
DR   BioSample; SAMN00807202
DR   Coriell; ND04441
DR   Wikidata; Q54915839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04444
AC   CVCL_HT89
DR   BioSample; SAMN00807204
DR   Coriell; ND04444
DR   Wikidata; Q54915841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04450
AC   CVCL_CE13
DR   BioSample; SAMN00807206
DR   Coriell; ND04450
DR   Wikidata; Q54915842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04451
AC   CVCL_CE14
DR   BioSample; SAMN00807208
DR   Coriell; ND04451
DR   Wikidata; Q54915844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04453
AC   CVCL_DW58
DR   Coriell; ND04453
DR   Wikidata; Q54915845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04454
AC   CVCL_DW59
DR   Coriell; ND04454
DR   Wikidata; Q54915846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04456
AC   CVCL_CE15
DR   Coriell; ND04456
DR   Wikidata; Q54915847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04457
AC   CVCL_CE16
DR   Coriell; ND04457
DR   Wikidata; Q54915848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04460
AC   CVCL_DW60
DR   CLO; CLO_0033933
DR   Coriell; ND04460
DR   Wikidata; Q54915849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04470
AC   CVCL_IB23
DR   Coriell; ND04470
DR   Wikidata; Q54915850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04478
AC   CVCL_GB82
DR   CLO; CLO_0033914
DR   Coriell; ND04478
DR   Wikidata; Q54915851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04479
AC   CVCL_GB83
DR   CLO; CLO_0033913
DR   Coriell; ND04479
DR   Wikidata; Q54915852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04480
AC   CVCL_GB84
DR   CLO; CLO_0033918
DR   Coriell; ND04480
DR   Wikidata; Q54915853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04481
AC   CVCL_CE17
DR   CLO; CLO_0033916
DR   Coriell; ND04481
DR   Wikidata; Q54915854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04482
AC   CVCL_CE18
DR   CLO; CLO_0033920
DR   Coriell; ND04482
DR   Wikidata; Q54915866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04483
AC   CVCL_DW61
DR   CLO; CLO_0033919
DR   Coriell; ND04483
DR   Wikidata; Q54915867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04484
AC   CVCL_1X39
SY   ND-4484
DR   CLO; CLO_0033922
DR   Coriell; ND04484
DR   Wikidata; Q54915868
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04488
AC   CVCL_IB24
DR   Coriell; ND04488
DR   Wikidata; Q54915869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04492
AC   CVCL_HT90
DR   BioSample; SAMN00807214
DR   Coriell; ND04492
DR   Wikidata; Q54915870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04494
AC   CVCL_FX37
DR   BioSample; SAMN00807216
DR   Coriell; ND04494
DR   Wikidata; Q54915871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04496
AC   CVCL_FI50
DR   BioSample; SAMN00807218
DR   Coriell; ND04496
DR   Wikidata; Q54915872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04497
AC   CVCL_CE19
DR   CLO; CLO_0033921
DR   BioSample; SAMN00807220
DR   Coriell; ND04497
DR   Wikidata; Q54915873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04498
AC   CVCL_1X40
SY   ND-4498
DR   CLO; CLO_0033965
DR   BioSample; SAMN00807222
DR   Coriell; ND04498
DR   Wikidata; Q54915874
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04502
AC   CVCL_1X41
SY   ND-4502
DR   CLO; CLO_0033968
DR   Coriell; ND04502
DR   Wikidata; Q54915875
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04503
AC   CVCL_CE20
DR   Coriell; ND04503
DR   Wikidata; Q54915876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04504
AC   CVCL_CE21
DR   Coriell; ND04504
DR   Wikidata; Q54915877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04505
AC   CVCL_FI51
DR   Coriell; ND04505
DR   Wikidata; Q54915878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04506
AC   CVCL_DW62
DR   CLO; CLO_0033954
DR   Coriell; ND04506
DR   Wikidata; Q54915879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04507
AC   CVCL_DW63
DR   CLO; CLO_0033949
DR   Coriell; ND04507
DR   Wikidata; Q54915880
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04508
AC   CVCL_DW64
DR   CLO; CLO_0033948
DR   Coriell; ND04508
DR   Wikidata; Q54915881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04509
AC   CVCL_DW65
DR   CLO; CLO_0033947
DR   Coriell; ND04509
DR   Wikidata; Q54915882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04510
AC   CVCL_IL48
DR   CLO; CLO_0033946
DR   Coriell; ND04510
DR   Wikidata; Q54915883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND04510; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND04511
AC   CVCL_FX38
DR   CLO; CLO_0033953
DR   Coriell; ND04511
DR   Wikidata; Q54915884
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04512
AC   CVCL_CE22
DR   CLO; CLO_0033952
DR   Coriell; ND04512
DR   Wikidata; Q54915885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04513
AC   CVCL_CE23
DR   CLO; CLO_0033951
DR   Coriell; ND04513
DR   Wikidata; Q54915886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04514
AC   CVCL_CE24
DR   CLO; CLO_0033950
DR   Coriell; ND04514
DR   Wikidata; Q54915887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04515
AC   CVCL_GB85
DR   CLO; CLO_0033999
DR   BioSample; SAMN00807224
DR   Coriell; ND04515
DR   Wikidata; Q54915888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04516
AC   CVCL_CE25
DR   CLO; CLO_0033988
DR   Coriell; ND04516
DR   Wikidata; Q54915889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04517
AC   CVCL_CE26
DR   CLO; CLO_0033987
DR   Coriell; ND04517
DR   Wikidata; Q54915890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04518
AC   CVCL_CE27
DR   CLO; CLO_0033982
DR   BioSample; SAMN00807226
DR   Coriell; ND04518
DR   Wikidata; Q54915891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04519
AC   CVCL_FC30
DR   CLO; CLO_0033980
DR   BioSample; SAMN00807228
DR   Coriell; ND04519
DR   Wikidata; Q54915892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04520
AC   CVCL_FI52
DR   CLO; CLO_0033985
DR   BioSample; SAMN00807230
DR   Coriell; ND04520
DR   Wikidata; Q54915893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04521
AC   CVCL_HP95
DR   CLO; CLO_0033983
DR   BioSample; SAMN00807232
DR   Coriell; ND04521
DR   Wikidata; Q54915895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04522
AC   CVCL_HP96
DR   CLO; CLO_0033977
DR   BioSample; SAMN00807234
DR   Coriell; ND04522
DR   Wikidata; Q54915896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04523
AC   CVCL_FI53
DR   CLO; CLO_0033976
DR   BioSample; SAMN00807235
DR   Coriell; ND04523
DR   Wikidata; Q54915897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04524
AC   CVCL_FI54
DR   CLO; CLO_0033979
DR   BioSample; SAMN00807237
DR   Coriell; ND04524
DR   Wikidata; Q54915898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04526
AC   CVCL_IB25
DR   Coriell; ND04526
DR   Wikidata; Q54915899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04527
AC   CVCL_FF07
DR   Coriell; ND04527
DR   Wikidata; Q54915900
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04530
AC   CVCL_FI55
DR   Coriell; ND04530
DR   Wikidata; Q54915901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04531
AC   CVCL_1X42
SY   ND-4531
DR   CLO; CLO_0033978
DR   Coriell; ND04531
DR   Wikidata; Q54915903
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04532
AC   CVCL_1X43
SY   ND-4532
DR   CLO; CLO_0034019
DR   Coriell; ND04532
DR   Wikidata; Q54915904
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04533
AC   CVCL_1X44
SY   ND-4533
DR   CLO; CLO_0034018
DR   Coriell; ND04533
DR   Wikidata; Q54915905
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04534
AC   CVCL_1X45
SY   ND-4534
DR   CLO; CLO_0034017
DR   Coriell; ND04534
DR   Wikidata; Q54915906
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04535
AC   CVCL_FB48
DR   CLO; CLO_0034016
DR   Coriell; ND04535
DR   Wikidata; Q54915907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04536
AC   CVCL_1X46
SY   ND-4536
DR   CLO; CLO_0034015
DR   Coriell; ND04536
DR   Wikidata; Q54915912
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04537
AC   CVCL_DW66
DR   CLO; CLO_0034013
DR   Coriell; ND04537
DR   Wikidata; Q54915913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04538
AC   CVCL_FI56
DR   BioSample; SAMN00807239
DR   Coriell; ND04538
DR   Wikidata; Q54915914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04539
AC   CVCL_IH04
DR   CLO; CLO_0034012
DR   Coriell; ND04539
DR   Wikidata; Q54915915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04540
AC   CVCL_FX39
DR   CLO; CLO_0034010
DR   Coriell; ND04540
DR   Wikidata; Q54915916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04541
AC   CVCL_GB86
DR   CLO; CLO_0034009
DR   Coriell; ND04541
DR   Wikidata; Q54915917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04542
AC   CVCL_ES51
DR   CLO; CLO_0034008
DR   Coriell; ND04542
DR   Wikidata; Q54915919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04543
AC   CVCL_CE28
DR   CLO; CLO_0033813
DR   Coriell; ND04543
DR   Wikidata; Q54915920
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04544
AC   CVCL_CE29
DR   Coriell; ND04544
DR   Wikidata; Q54915921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04548
AC   CVCL_CE30
DR   BioSample; SAMN00807241
DR   Coriell; ND04548
DR   Wikidata; Q54915922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04549
AC   CVCL_CE31
DR   Coriell; ND04549
DR   Wikidata; Q54915923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04550
AC   CVCL_CE32
DR   Coriell; ND04550
DR   Wikidata; Q54915925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04551
AC   CVCL_CE33
DR   Coriell; ND04551
DR   Wikidata; Q54915926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04552
AC   CVCL_CE34
DR   Coriell; ND04552
DR   Wikidata; Q54915927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04553
AC   CVCL_CE35
DR   BioSample; SAMN00807243
DR   Coriell; ND04553
DR   Wikidata; Q54915928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04554
AC   CVCL_CE36
DR   Coriell; ND04554
DR   Wikidata; Q54915929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04555
AC   CVCL_CE37
DR   Coriell; ND04555
DR   Wikidata; Q54915930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04556
AC   CVCL_DW67
DR   Coriell; ND04556
DR   Wikidata; Q54915932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04559
AC   CVCL_DW68
DR   Coriell; ND04559
DR   Wikidata; Q54915933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04561
AC   CVCL_DW69
DR   CLO; CLO_0033814
DR   Coriell; ND04561
DR   Wikidata; Q54915934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04562
AC   CVCL_DW70
DR   Coriell; ND04562
DR   Wikidata; Q54915935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04564
AC   CVCL_CE38
DR   Coriell; ND04564
DR   Wikidata; Q54915936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04566
AC   CVCL_CE39
DR   BioSample; SAMN00807245
DR   Coriell; ND04566
DR   Wikidata; Q54915937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04568
AC   CVCL_1X47
SY   ND-4568
DR   CLO; CLO_0033815
DR   BioSample; SAMN00807249
DR   Coriell; ND04568
DR   Wikidata; Q54915938
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04569
AC   CVCL_CE40
DR   BioSample; SAMN00807251
DR   Coriell; ND04569
DR   Wikidata; Q54915939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04570
AC   CVCL_FX40
DR   BioSample; SAMN00807253
DR   Coriell; ND04570
DR   Wikidata; Q54915940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04571
AC   CVCL_HT91
DR   BioSample; SAMN00807255
DR   Coriell; ND04571
DR   Wikidata; Q54915942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04572
AC   CVCL_HT92
DR   BioSample; SAMN00807257
DR   Coriell; ND04572
DR   Wikidata; Q54915943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04573
AC   CVCL_IB26
DR   BioSample; SAMN00807259
DR   Coriell; ND04573
DR   Wikidata; Q54915944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04574
AC   CVCL_CE41
DR   CLO; CLO_0033816
DR   BioSample; SAMN00807261
DR   Coriell; ND04574
DR   Wikidata; Q54915945
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND04575
AC   CVCL_1X48
SY   ND-4575
DR   CLO; CLO_0033817
DR   BioSample; SAMN00807262
DR   Coriell; ND04575
DR   Wikidata; Q54915946
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04579
AC   CVCL_IB27
DR   Coriell; ND04579
DR   Wikidata; Q54915947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04580
AC   CVCL_HQ76
DR   CLO; CLO_0033818
DR   Coriell; ND04580
DR   Wikidata; Q54915948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04581
AC   CVCL_CE42
DR   CLO; CLO_0033819
DR   Coriell; ND04581
DR   Wikidata; Q54915949
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04582
AC   CVCL_CE43
DR   CLO; CLO_0033820
DR   Coriell; ND04582
DR   Wikidata; Q54915950
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04583
AC   CVCL_ES52
DR   CLO; CLO_0033821
DR   Coriell; ND04583
DR   Wikidata; Q54915951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04584
AC   CVCL_1X49
SY   ND-4584
DR   CLO; CLO_0033822
DR   BioSample; SAMN00807263
DR   Coriell; ND04584
DR   Wikidata; Q54915952
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND04585
AC   CVCL_CE44
DR   CLO; CLO_0033833
DR   BioSample; SAMN00807265
DR   Coriell; ND04585
DR   Wikidata; Q54915953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04586
AC   CVCL_1X50
SY   ND-4586
DR   CLO; CLO_0033836
DR   BioSample; SAMN00807267
DR   Coriell; ND04586
DR   Wikidata; Q54915954
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND04587
AC   CVCL_CE45
DR   CLO; CLO_0033837
DR   BioSample; SAMN00807269
DR   Coriell; ND04587
DR   Wikidata; Q54915955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04588
AC   CVCL_FX41
DR   BioSample; SAMN00807271
DR   Coriell; ND04588
DR   Wikidata; Q54915973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04589
AC   CVCL_HT93
DR   BioSample; SAMN00807273
DR   Coriell; ND04589
DR   Wikidata; Q54915974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04591
AC   CVCL_FF08
DR   Coriell; ND04591
DR   Wikidata; Q54915975
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04594
AC   CVCL_CE46
DR   CLO; CLO_0033834
DR   Coriell; ND04594
DR   Wikidata; Q54915976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04595
AC   CVCL_DW71
DR   CLO; CLO_0033835
DR   Coriell; ND04595
DR   Wikidata; Q54915978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04596
AC   CVCL_ES53
DR   CLO; CLO_0033840
DR   Coriell; ND04596
DR   Wikidata; Q54915979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04597
AC   CVCL_CE47
DR   CLO; CLO_0033841
DR   Coriell; ND04597
DR   Wikidata; Q54915980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04598
AC   CVCL_CE48
DR   CLO; CLO_0033838
DR   Coriell; ND04598
DR   Wikidata; Q54915981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04599
AC   CVCL_AB67
DR   CLO; CLO_0033839
DR   Coriell; ND04599
DR   Wikidata; Q54915982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND04600
AC   CVCL_1X51
SY   ND-4600
DR   CLO; CLO_0033842
DR   Coriell; ND04600
DR   Wikidata; Q54915983
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04604
AC   CVCL_DW72
DR   Coriell; ND04604
DR   Wikidata; Q54915984
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04605
AC   CVCL_DW73
DR   Coriell; ND04605
DR   Wikidata; Q54915985
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04606
AC   CVCL_DW74
DR   Coriell; ND04606
DR   Wikidata; Q54915986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04608
AC   CVCL_DW75
DR   Coriell; ND04608
DR   Wikidata; Q54915987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04613
AC   CVCL_FI57
DR   BioSample; SAMN00807275
DR   Coriell; ND04613
DR   Wikidata; Q54915988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04614
AC   CVCL_FI58
DR   BioSample; SAMN00807277
DR   Coriell; ND04614
DR   Wikidata; Q54915989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y10M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04615
AC   CVCL_FI59
DR   CLO; CLO_0033857
DR   BioSample; SAMN00807279
DR   Coriell; ND04615
DR   Wikidata; Q54915990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04616
AC   CVCL_HP97
DR   CLO; CLO_0033858
DR   BioSample; SAMN00807281
DR   Coriell; ND04616
DR   Wikidata; Q54915991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04617
AC   CVCL_FX42
DR   CLO; CLO_0033853
DR   Coriell; ND04617
DR   Wikidata; Q54915992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04618
AC   CVCL_DW76
DR   CLO; CLO_0033854
DR   Coriell; ND04618
DR   Wikidata; Q54915993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04619
AC   CVCL_DW77
DR   Coriell; ND04619
DR   Wikidata; Q54915994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04620
AC   CVCL_DW78
DR   CLO; CLO_0033855
DR   Coriell; ND04620
DR   Wikidata; Q54915995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04622
AC   CVCL_DW79
DR   Coriell; ND04622
DR   Wikidata; Q54915996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04623
AC   CVCL_DW80
DR   Coriell; ND04623
DR   Wikidata; Q54915997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04624
AC   CVCL_DW81
DR   Coriell; ND04624
DR   Wikidata; Q54915998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04625
AC   CVCL_DW82
DR   Coriell; ND04625
DR   Wikidata; Q54915999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04626
AC   CVCL_DW83
DR   Coriell; ND04626
DR   Wikidata; Q54916000
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04632
AC   CVCL_GB87
DR   CLO; CLO_0033856
DR   Coriell; ND04632
DR   Wikidata; Q54916002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04633
AC   CVCL_FI60
DR   CLO; CLO_0033859
DR   BioSample; SAMN00807283
DR   Coriell; ND04633
DR   Wikidata; Q54916003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04634
AC   CVCL_HP98
DR   CLO; CLO_0033860
DR   BioSample; SAMN00807285
DR   Coriell; ND04634
DR   Wikidata; Q54916004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04635
AC   CVCL_HP99
DR   CLO; CLO_0033861
DR   BioSample; SAMN00807287
DR   Coriell; ND04635
DR   Wikidata; Q54916005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04636
AC   CVCL_CE49
DR   CLO; CLO_0033862
DR   BioSample; SAMN00807289
DR   Coriell; ND04636
DR   Wikidata; Q54916006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04637
AC   CVCL_1X52
SY   ND-4637
DR   CLO; CLO_0033889
DR   BioSample; SAMN00807291
DR   Coriell; ND04637
DR   Wikidata; Q54916007
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04639
AC   CVCL_1X53
SY   ND-4639
DR   CLO; CLO_0033887
DR   Coriell; ND04639
DR   Wikidata; Q54916008
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04647
AC   CVCL_FX43
DR   BioSample; SAMN00807293
DR   Coriell; ND04647
DR   Wikidata; Q54916009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04648
AC   CVCL_CE50
DR   Coriell; ND04648
DR   Wikidata; Q54916010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04649
AC   CVCL_CE51
DR   Coriell; ND04649
DR   Wikidata; Q54916011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04650
AC   CVCL_CE52
DR   Coriell; ND04650
DR   Wikidata; Q54916012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04651
AC   CVCL_CE53
DR   Coriell; ND04651
DR   Wikidata; Q54916013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04652
AC   CVCL_CE54
DR   BioSample; SAMN00807295
DR   Coriell; ND04652
DR   Wikidata; Q54916014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04653
AC   CVCL_CE55
DR   Coriell; ND04653
DR   Wikidata; Q54916023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04655
AC   CVCL_CE56
DR   Coriell; ND04655
DR   Wikidata; Q54916024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04658
AC   CVCL_FI61
DR   BioSample; SAMN00807299
DR   Coriell; ND04658
DR   Wikidata; Q54916025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04660
AC   CVCL_IB28
DR   Coriell; ND04660
DR   Wikidata; Q54916026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04661
AC   CVCL_FX44
DR   CLO; CLO_0033888
DR   Coriell; ND04661
DR   Wikidata; Q54916027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04663
AC   CVCL_HT94
DR   BioSample; SAMN00807303
DR   Coriell; ND04663
DR   Wikidata; Q54916028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04665
AC   CVCL_FX45
DR   BioSample; SAMN00807305
DR   Coriell; ND04665
DR   Wikidata; Q54916029
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND04666
AC   CVCL_FF09
DR   Coriell; ND04666
DR   Wikidata; Q54916031
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04669
AC   CVCL_DW84
DR   Coriell; ND04669
DR   Wikidata; Q54916032
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04670
AC   CVCL_CE57
DR   CLO; CLO_0033885
DR   Coriell; ND04670
DR   Wikidata; Q54916033
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04671
AC   CVCL_FI62
DR   CLO; CLO_0033886
DR   Coriell; ND04671
DR   Wikidata; Q54916035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04672
AC   CVCL_CE58
DR   CLO; CLO_0033883
DR   Coriell; ND04672
DR   Wikidata; Q54916036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04673
AC   CVCL_ES54
DR   CLO; CLO_0033884
DR   Coriell; ND04673
DR   Wikidata; Q54916037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04674
AC   CVCL_CE59
DR   CLO; CLO_0033891
DR   BioSample; SAMN00807307
DR   Coriell; ND04674
DR   Wikidata; Q54916038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04675
AC   CVCL_1X54
SY   ND-4675
DR   CLO; CLO_0033892
DR   BioSample; SAMN00807309
DR   Coriell; ND04675
DR   Wikidata; Q54916039
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04676
AC   CVCL_CE60
DR   Coriell; ND04676
DR   Wikidata; Q54916040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04677
AC   CVCL_CE61
DR   BioSample; SAMN00807311
DR   Coriell; ND04677
DR   Wikidata; Q54916041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04678
AC   CVCL_GB88
DR   CLO; CLO_0033890
DR   Coriell; ND04678
DR   Wikidata; Q54916042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04679
AC   CVCL_GB89
DR   CLO; CLO_0033648
DR   Coriell; ND04679
DR   Wikidata; Q54916043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04681
AC   CVCL_DW85
DR   Coriell; ND04681
DR   Wikidata; Q54916044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04684
AC   CVCL_FF10
DR   Coriell; ND04684
DR   Wikidata; Q54916045
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04685
AC   CVCL_DW86
DR   Coriell; ND04685
DR   Wikidata; Q54916046
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04686
AC   CVCL_IB29
DR   Coriell; ND04686
DR   Wikidata; Q54916047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04687
AC   CVCL_CE62
DR   Coriell; ND04687
DR   Wikidata; Q54916048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04690
AC   CVCL_FX46
DR   Coriell; ND04690
DR   Wikidata; Q54916049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04691
AC   CVCL_GB90
DR   CLO; CLO_0033647
DR   Coriell; ND04691
DR   Wikidata; Q54916050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04692
AC   CVCL_FI63
DR   CLO; CLO_0033646
DR   BioSample; SAMN00807313
DR   Coriell; ND04692
DR   Wikidata; Q54916051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04693
AC   CVCL_HQ00
DR   CLO; CLO_0033645
DR   BioSample; SAMN00807315
DR   Coriell; ND04693
DR   Wikidata; Q54916052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04694
AC   CVCL_CE63
DR   CLO; CLO_0033644
DR   Coriell; ND04694
DR   Wikidata; Q54916053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04695
AC   CVCL_CE64
DR   CLO; CLO_0033643
DR   Coriell; ND04695
DR   Wikidata; Q54916054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04696
AC   CVCL_CE65
DR   CLO; CLO_0033642
DR   Coriell; ND04696
DR   Wikidata; Q54916055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04697
AC   CVCL_CE66
DR   CLO; CLO_0033641
DR   Coriell; ND04697
DR   Wikidata; Q54916056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04698
AC   CVCL_CE67
DR   CLO; CLO_0033640
DR   Coriell; ND04698
DR   Wikidata; Q54916057
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04701
AC   CVCL_CE68
DR   CLO; CLO_0033639
DR   Coriell; ND04701
DR   Wikidata; Q54916059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04702
AC   CVCL_DW87
DR   CLO; CLO_0026610
DR   Coriell; ND04702
DR   Wikidata; Q54916060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04703
AC   CVCL_DW88
DR   CLO; CLO_0026609
DR   Coriell; ND04703
DR   Wikidata; Q54916061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04704
AC   CVCL_DW89
DR   CLO; CLO_0026608
DR   Coriell; ND04704
DR   Wikidata; Q54916063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04705
AC   CVCL_DW90
DR   CLO; CLO_0026606
DR   Coriell; ND04705
DR   Wikidata; Q54916064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04706
AC   CVCL_DW91
DR   CLO; CLO_0026604
DR   Coriell; ND04706
DR   Wikidata; Q54916066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04707
AC   CVCL_DW92
DR   CLO; CLO_0026602
DR   Coriell; ND04707
DR   Wikidata; Q54916067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04708
AC   CVCL_FI64
DR   CLO; CLO_0026752
DR   Coriell; ND04708
DR   Wikidata; Q54916078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04709
AC   CVCL_FX47
DR   CLO; CLO_0026755
DR   Coriell; ND04709
DR   Wikidata; Q54916079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04710
AC   CVCL_IH05
DR   CLO; CLO_0026757
DR   Coriell; ND04710
DR   Wikidata; Q54916080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04713
AC   CVCL_CE69
DR   Coriell; ND04713
DR   Wikidata; Q54916081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04714
AC   CVCL_CE70
DR   Coriell; ND04714
DR   Wikidata; Q54916082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04715
AC   CVCL_HT95
DR   BioSample; SAMN00807317
DR   Coriell; ND04715
DR   Wikidata; Q54916083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04718
AC   CVCL_IB30
DR   BioSample; SAMN00807321
DR   Coriell; ND04718
DR   Wikidata; Q54916084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04720
AC   CVCL_HT96
DR   BioSample; SAMN00807323
DR   Coriell; ND04720
DR   Wikidata; Q54916087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04722
AC   CVCL_DW93
DR   Coriell; ND04722
DR   Wikidata; Q54916088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04723
AC   CVCL_DW94
DR   Coriell; ND04723
DR   Wikidata; Q54916089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04724
AC   CVCL_CE71
DR   Coriell; ND04724
DR   Wikidata; Q54916090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04725
AC   CVCL_CE72
DR   Coriell; ND04725
DR   Wikidata; Q54916091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04726
AC   CVCL_CE73
DR   Coriell; ND04726
DR   Wikidata; Q54916092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04727
AC   CVCL_CE74
DR   Coriell; ND04727
DR   Wikidata; Q54916093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04728
AC   CVCL_CE75
DR   Coriell; ND04728
DR   Wikidata; Q54916094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04729
AC   CVCL_CE76
DR   Coriell; ND04729
DR   Wikidata; Q54916095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04730
AC   CVCL_CE77
DR   Coriell; ND04730
DR   Wikidata; Q54916096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04732
AC   CVCL_DW95
DR   CLO; CLO_0026758
DR   Coriell; ND04732
DR   Wikidata; Q54916097
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04733
AC   CVCL_DW96
DR   Coriell; ND04733
DR   Wikidata; Q54916098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04739
AC   CVCL_FC31
DR   CLO; CLO_0026718
DR   Coriell; ND04739
DR   Wikidata; Q54916099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04740
AC   CVCL_1X55
SY   ND-4740
DR   CLO; CLO_0026722
DR   Coriell; ND04740
DR   Wikidata; Q54916100
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04741
AC   CVCL_CE78
DR   CLO; CLO_0026720
DR   Coriell; ND04741
DR   Wikidata; Q54916101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04742
AC   CVCL_CE79
DR   CLO; CLO_0026727
DR   Coriell; ND04742
DR   Wikidata; Q54916102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04743
AC   CVCL_CE80
DR   CLO; CLO_0026724
DR   Coriell; ND04743
DR   Wikidata; Q54916103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04744
AC   CVCL_CE81
DR   CLO; CLO_0026730
DR   Coriell; ND04744
DR   Wikidata; Q54916104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04745
AC   CVCL_HQ77
DR   CLO; CLO_0026729
DR   Coriell; ND04745
DR   Wikidata; Q54916105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04746
AC   CVCL_FX48
DR   CLO; CLO_0026715
DR   Coriell; ND04746
DR   Wikidata; Q54916106
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04747
AC   CVCL_FX49
DR   CLO; CLO_0026716
DR   Coriell; ND04747
DR   Wikidata; Q54916107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04748
AC   CVCL_HQ78
DR   CLO; CLO_0026712
DR   Coriell; ND04748
DR   Wikidata; Q54916108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04749
AC   CVCL_IB31
DR   Coriell; ND04749
DR   Wikidata; Q54916109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04750
AC   CVCL_FI65
DR   Coriell; ND04750
DR   Wikidata; Q54916110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04754
AC   CVCL_CE82
DR   BioSample; SAMN00807333
DR   Coriell; ND04754
DR   Wikidata; Q54916111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04755
AC   CVCL_CE83
DR   Coriell; ND04755
DR   Wikidata; Q54916112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04756
AC   CVCL_CE84
DR   BioSample; SAMN00807335
DR   Coriell; ND04756
DR   Wikidata; Q54916114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04757
AC   CVCL_FX50
DR   BioSample; SAMN00807337
DR   Coriell; ND04757
DR   Wikidata; Q54916115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04758
AC   CVCL_HT97
DR   BioSample; SAMN00807339
DR   Coriell; ND04758
DR   Wikidata; Q54916116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04759
AC   CVCL_CE85
DR   CLO; CLO_0026682
DR   Coriell; ND04759
DR   Wikidata; Q54916117
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04760
AC   CVCL_CE86
DR   BioSample; SAMN00807341
DR   Coriell; ND04760
DR   Wikidata; Q54916118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04761
AC   CVCL_CE87
DR   Coriell; ND04761
DR   Wikidata; Q54916119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04767
AC   CVCL_HT98
DR   BioSample; SAMN00807343
DR   Coriell; ND04767
DR   Wikidata; Q54916120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04769
AC   CVCL_AB68
DR   CLO; CLO_0026681
DR   Coriell; ND04769
DR   Wikidata; Q54916130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND04770
AC   CVCL_CE88
DR   CLO; CLO_0026680
DR   BioSample; SAMN00807345
DR   Coriell; ND04770
DR   Wikidata; Q54916131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04771
AC   CVCL_1X56
SY   ND-4771
DR   CLO; CLO_0026678
DR   BioSample; SAMN00807347
DR   Coriell; ND04771
DR   Wikidata; Q54916132
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04772
AC   CVCL_CE89
DR   CLO; CLO_0026689
DR   Coriell; ND04772
DR   Wikidata; Q54916134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04773
AC   CVCL_CE90
DR   CLO; CLO_0026688
DR   Coriell; ND04773
DR   Wikidata; Q54916135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04774
AC   CVCL_FI66
DR   CLO; CLO_0026685
DR   BioSample; SAMN00807349
DR   Coriell; ND04774
DR   Wikidata; Q54916136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04775
AC   CVCL_IH90
DR   CLO; CLO_0026683
DR   BioSample; SAMN00807351
DR   Coriell; ND04775
DR   Wikidata; Q54916137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04776
AC   CVCL_IH91
DR   CLO; CLO_0026497
DR   BioSample; SAMN00807353
DR   Coriell; ND04776
DR   Wikidata; Q54916138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04777
AC   CVCL_FI67
DR   CLO; CLO_0026495
DR   BioSample; SAMN00807355
DR   Coriell; ND04777
DR   Wikidata; Q54916139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04778
AC   CVCL_HU61
DR   CLO; CLO_0026502
DR   BioSample; SAMN00807357
DR   Coriell; ND04778
DR   Wikidata; Q54916140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04779
AC   CVCL_HU70
DR   CLO; CLO_0026518
DR   BioSample; SAMN00807359
DR   Coriell; ND04779
DR   Wikidata; Q54916141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04780
AC   CVCL_CE91
DR   BioSample; SAMN00807361
DR   Coriell; ND04780
DR   Wikidata; Q54916142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04785
AC   CVCL_HT99
DR   BioSample; SAMN00807363
DR   Coriell; ND04785
DR   Wikidata; Q54916143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04786
AC   CVCL_FI68
DR   BioSample; SAMN00807365
DR   Coriell; ND04786
DR   Wikidata; Q54916144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04787
AC   CVCL_FI69
DR   CLO; CLO_0026520
DR   BioSample; SAMN00807367
DR   Coriell; ND04787
DR   Wikidata; Q54916145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04788
AC   CVCL_1X57
SY   ND-4788
DR   CLO; CLO_0026513
DR   Coriell; ND04788
DR   Wikidata; Q54916146
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04789
AC   CVCL_1X58
SY   ND-4789
DR   CLO; CLO_0026514
DR   Coriell; ND04789
DR   Wikidata; Q54916147
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04790
AC   CVCL_DW97
DR   CLO; CLO_0026508
DR   Coriell; ND04790
DR   Wikidata; Q54916148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04791
AC   CVCL_DW98
DR   CLO; CLO_0026510
DR   Coriell; ND04791
DR   Wikidata; Q54916149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04792
AC   CVCL_ES55
DR   CLO; CLO_0026505
DR   Coriell; ND04792
DR   Wikidata; Q54916150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04793
AC   CVCL_HQ79
DR   CLO; CLO_0026506
DR   Coriell; ND04793
DR   Wikidata; Q54916151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04794
AC   CVCL_IH06
DR   CLO; CLO_0026454
DR   Coriell; ND04794
DR   Wikidata; Q54916152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04795
AC   CVCL_FX51
DR   CLO; CLO_0026460
DR   Coriell; ND04795
DR   Wikidata; Q54916153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04796
AC   CVCL_FX52
DR   CLO; CLO_0026461
DR   Coriell; ND04796
DR   Wikidata; Q54916154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04797
AC   CVCL_FI70
DR   Coriell; ND04797
DR   Wikidata; Q54916155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04832
AC   CVCL_CE92
DR   BioSample; SAMN00807369
DR   Coriell; ND04832
DR   Wikidata; Q54916156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04835
AC   CVCL_FX53
DR   BioSample; SAMN00807371
DR   Coriell; ND04835
DR   Wikidata; Q54916157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04836
AC   CVCL_HU00
DR   BioSample; SAMN00807373
DR   Coriell; ND04836
DR   Wikidata; Q54916158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04837
AC   CVCL_CE93
DR   CLO; CLO_0026472
DR   Coriell; ND04837
DR   Wikidata; Q54916159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04838
AC   CVCL_CE94
DR   CLO; CLO_0026474
DR   Coriell; ND04838
DR   Wikidata; Q54916160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04839
AC   CVCL_IB32
DR   Coriell; ND04839
DR   Wikidata; Q54916162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04841
AC   CVCL_CE95
DR   BioSample; SAMN00807375
DR   Coriell; ND04841
DR   Wikidata; Q54916163
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Gln34Arg (c.101A>G); ClinVar=VCV000468584; Zygosity=Unspecified (Coriell=ND04841).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EY55 ! ND29968
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND04842
AC   CVCL_IB33
DR   Coriell; ND04842
DR   Wikidata; Q54916164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04845
AC   CVCL_1X59
SY   ND-4845
DR   CLO; CLO_0026477
DR   Coriell; ND04845
DR   Wikidata; Q54916165
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04846
AC   CVCL_CE96
DR   Coriell; ND04846
DR   Wikidata; Q54916166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04847
AC   CVCL_CE97
DR   Coriell; ND04847
DR   Wikidata; Q54916167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04849
AC   CVCL_IL49
DR   BioSample; SAMN00807377
DR   Coriell; ND04849
DR   Wikidata; Q54916168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04850
AC   CVCL_FI71
DR   CLO; CLO_0026478
DR   BioSample; SAMN00807379
DR   Coriell; ND04850
DR   Wikidata; Q54916169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04851
AC   CVCL_IH92
DR   CLO; CLO_0026465
DR   BioSample; SAMN00807381
DR   Coriell; ND04851
DR   Wikidata; Q54916170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04852
AC   CVCL_IH93
DR   CLO; CLO_0026467
DR   BioSample; SAMN00807383
DR   Coriell; ND04852
DR   Wikidata; Q54916171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04853
AC   CVCL_1X60
SY   ND-4853
DR   CLO; CLO_0026469
DR   BioSample; SAMN00807385
DR   Coriell; ND04853
DR   Wikidata; Q54916178
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04854
AC   CVCL_CE98
DR   CLO; CLO_0026471
DR   BioSample; SAMN00807387
DR   Coriell; ND04854
DR   Wikidata; Q54916179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04858
AC   CVCL_CE99
DR   Coriell; ND04858
DR   Wikidata; Q54916180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04859
AC   CVCL_CF00
DR   Coriell; ND04859
DR   Wikidata; Q54916181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04863
AC   CVCL_HU01
DR   BioSample; SAMN00807389
DR   Coriell; ND04863
DR   Wikidata; Q54916182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04865
AC   CVCL_CF01
DR   CLO; CLO_0026584
DR   Coriell; ND04865
DR   Wikidata; Q54916183
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04866
AC   CVCL_DW99
DR   CLO; CLO_0026582
DR   Coriell; ND04866
DR   Wikidata; Q54916184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04867
AC   CVCL_DY00
DR   CLO; CLO_0026583
DR   Coriell; ND04867
DR   Wikidata; Q54916186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04868
AC   CVCL_FB49
DR   CLO; CLO_0026590
DR   Coriell; ND04868
DR   Wikidata; Q54916187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04869
AC   CVCL_DY01
DR   Coriell; ND04869
DR   Wikidata; Q54916188
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04871
AC   CVCL_DY02
DR   Coriell; ND04871
DR   Wikidata; Q54916189
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04873
AC   CVCL_DY03
DR   Coriell; ND04873
DR   Wikidata; Q54916190
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04874
AC   CVCL_FF11
DR   Coriell; ND04874
DR   Wikidata; Q54916191
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04875
AC   CVCL_CF02
DR   Coriell; ND04875
DR   Wikidata; Q54916192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04876
AC   CVCL_FI72
DR   BioSample; SAMN00807391
DR   Coriell; ND04876
DR   Wikidata; Q54916193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04880
AC   CVCL_1X61
SY   ND-4880
DR   CLO; CLO_0026592
DR   Coriell; ND04880
DR   Wikidata; Q54916194
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04881
AC   CVCL_CF03
DR   CLO; CLO_0026585
DR   Coriell; ND04881
DR   Wikidata; Q54916196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04884
AC   CVCL_CF04
DR   CLO; CLO_0026588
DR   Coriell; ND04884
DR   Wikidata; Q54916197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04885
AC   CVCL_CF05
DR   CLO; CLO_0026598
DR   Coriell; ND04885
DR   Wikidata; Q54916198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04886
AC   CVCL_CF06
DR   CLO; CLO_0026599
DR   Coriell; ND04886
DR   Wikidata; Q54916199
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04887
AC   CVCL_1X62
SY   ND-4887
DR   CLO; CLO_0026595
DR   Coriell; ND04887
DR   Wikidata; Q54916200
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04888
AC   CVCL_GY86
DR   CLO; CLO_0026542
DR   Coriell; ND04888
DR   Wikidata; Q54916201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04889
AC   CVCL_CF07
DR   CLO; CLO_0026543
DR   Coriell; ND04889
DR   Wikidata; Q54916203
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04890
AC   CVCL_HU02
DR   BioSample; SAMN00807393
DR   Coriell; ND04890
DR   Wikidata; Q54916204
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND04891
AC   CVCL_IB34
DR   Coriell; ND04891
DR   Wikidata; Q54916205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04893
AC   CVCL_CF08
DR   Coriell; ND04893
DR   Wikidata; Q54916207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04894
AC   CVCL_CF09
DR   Coriell; ND04894
DR   Wikidata; Q54916208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04896
AC   CVCL_FX54
DR   BioSample; SAMN00807395
DR   Coriell; ND04896
DR   Wikidata; Q54916209
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND04897
AC   CVCL_HE91
DR   CLO; CLO_0026544
DR   BioSample; SAMN00807397
DR   Coriell; ND04897
DR   Wikidata; Q54916210
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND04898
AC   CVCL_CF10
DR   CLO; CLO_0026545
DR   Coriell; ND04898
DR   Wikidata; Q54916211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04900
AC   CVCL_1X63
SY   ND-4900
DR   CLO; CLO_0026547
DR   Coriell; ND04900
DR   Wikidata; Q54916212
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04901
AC   CVCL_DY04
DR   CLO; CLO_0026548
DR   Coriell; ND04901
DR   Wikidata; Q54916213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04902
AC   CVCL_DY05
DR   CLO; CLO_0026552
DR   Coriell; ND04902
DR   Wikidata; Q54916214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04903
AC   CVCL_1X64
SY   ND-4903
DR   CLO; CLO_0026554
DR   Coriell; ND04903
DR   Wikidata; Q54916215
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04904
AC   CVCL_DY06
DR   CLO; CLO_0026555
DR   Coriell; ND04904
DR   Wikidata; Q54916217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04905
AC   CVCL_DY07
DR   CLO; CLO_0026557
DR   Coriell; ND04905
DR   Wikidata; Q54916218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04906
AC   CVCL_DY08
DR   Coriell; ND04906
DR   Wikidata; Q54916221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04907
AC   CVCL_DY09
DR   Coriell; ND04907
DR   Wikidata; Q54916222
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04913
AC   CVCL_FX55
DR   BioSample; SAMN00807399
DR   Coriell; ND04913
DR   Wikidata; Q54916223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04914
AC   CVCL_FX56
DR   CLO; CLO_0026408
DR   Coriell; ND04914
DR   Wikidata; Q54916224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04916
AC   CVCL_CF11
DR   CLO; CLO_0026407
DR   BioSample; SAMN00807401
DR   Coriell; ND04916
DR   Wikidata; Q54916232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04917
AC   CVCL_IB35
DR   BioSample; SAMN00807403
DR   Coriell; ND04917
DR   Wikidata; Q54916233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04918
AC   CVCL_FI73
DR   CLO; CLO_0026406
DR   BioSample; SAMN00807405
DR   Coriell; ND04918
DR   Wikidata; Q54916234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04919
AC   CVCL_IB36
DR   CLO; CLO_0026405
DR   BioSample; SAMN00807407
DR   Coriell; ND04919
DR   Wikidata; Q54916235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04920
AC   CVCL_FI74
DR   CLO; CLO_0026404
DR   Coriell; ND04920
DR   Wikidata; Q54916236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04921
AC   CVCL_DY10
DR   CLO; CLO_0026402
DR   Coriell; ND04921
DR   Wikidata; Q54916237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04922
AC   CVCL_DY11
DR   CLO; CLO_0026398
DR   Coriell; ND04922
DR   Wikidata; Q54916238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04925
AC   CVCL_EH02
DR   CLO; CLO_0026395
DR   Coriell; ND04925
DR   Wikidata; Q54916239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04928
AC   CVCL_FF12
DR   Coriell; ND04928
DR   Wikidata; Q54916240
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04930
AC   CVCL_IB37
DR   Coriell; ND04930
DR   Wikidata; Q54916241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04932
AC   CVCL_CF12
DR   Coriell; ND04932
DR   Wikidata; Q54916242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04933
AC   CVCL_CF13
DR   Coriell; ND04933
DR   Wikidata; Q54916243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04940
AC   CVCL_FX57
DR   BioSample; SAMN00807413
DR   Coriell; ND04940
DR   Wikidata; Q54916244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04941
AC   CVCL_HU03
DR   BioSample; SAMN00807415
DR   Coriell; ND04941
DR   Wikidata; Q54916245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04944
AC   CVCL_DY12
DR   CLO; CLO_0026392
DR   Coriell; ND04944
DR   Wikidata; Q54916246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04945
AC   CVCL_DY13
DR   CLO; CLO_0026391
DR   Coriell; ND04945
DR   Wikidata; Q54916247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04946
AC   CVCL_1X65
SY   ND-4946
DR   CLO; CLO_0026378
DR   Coriell; ND04946
DR   Wikidata; Q54916248
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND04947
AC   CVCL_CF14
DR   CLO; CLO_0026377
DR   Coriell; ND04947
DR   Wikidata; Q54916249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04948
AC   CVCL_IB38
DR   Coriell; ND04948
DR   Wikidata; Q54916250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04949
AC   CVCL_IB39
DR   Coriell; ND04949
DR   Wikidata; Q54916251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04951
AC   CVCL_DY14
DR   Coriell; ND04951
DR   Wikidata; Q54916252
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND04952
AC   CVCL_HU04
DR   BioSample; SAMN00807417
DR   Coriell; ND04952
DR   Wikidata; Q54916253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04953
AC   CVCL_FX58
DR   BioSample; SAMN00807419
DR   Coriell; ND04953
DR   Wikidata; Q54916254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04954
AC   CVCL_FX59
DR   BioSample; SAMN00807421
DR   Coriell; ND04954
DR   Wikidata; Q54916255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04955
AC   CVCL_FI76
DR   CLO; CLO_0026374
DR   Coriell; ND04955
DR   Wikidata; Q54916256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04956
AC   CVCL_CF15
DR   Coriell; ND04956
DR   Wikidata; Q54916257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04957
AC   CVCL_CF16
DR   Coriell; ND04957
DR   Wikidata; Q54916259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04958
AC   CVCL_CF17
DR   CLO; CLO_0026373
DR   Coriell; ND04958
DR   Wikidata; Q54916260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04959
AC   CVCL_CF18
DR   Coriell; ND04959
DR   Wikidata; Q54916261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04962
AC   CVCL_DY15
DR   Coriell; ND04962
DR   Wikidata; Q54916262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04964
AC   CVCL_IB40
DR   Coriell; ND04964
DR   Wikidata; Q54916263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04965
AC   CVCL_FX60
DR   BioSample; SAMN00807423
DR   Coriell; ND04965
DR   Wikidata; Q54916264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04968
AC   CVCL_FX61
DR   CLO; CLO_0026376
DR   Coriell; ND04968
DR   Wikidata; Q54916265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04969
AC   CVCL_FI77
DR   CLO; CLO_0026375
DR   BioSample; SAMN00807425
DR   Coriell; ND04969
DR   Wikidata; Q54916266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04970
AC   CVCL_IB41
DR   CLO; CLO_0026367
DR   Coriell; ND04970
DR   Wikidata; Q54916267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04971
AC   CVCL_GB91
DR   CLO; CLO_0026362
DR   Coriell; ND04971
DR   Wikidata; Q54916268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04972
AC   CVCL_CF19
DR   CLO; CLO_0026371
DR   BioSample; SAMN00807429
DR   Coriell; ND04972
DR   Wikidata; Q54916269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04975
AC   CVCL_CF20
DR   BioSample; SAMN00807431
DR   Coriell; ND04975
DR   Wikidata; Q54916270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04976
AC   CVCL_DY16
DR   Coriell; ND04976
DR   Wikidata; Q54916271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04978
AC   CVCL_GB92
DR   CLO; CLO_0026370
DR   Coriell; ND04978
DR   Wikidata; Q54916272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04979
AC   CVCL_IB42
DR   Coriell; ND04979
DR   Wikidata; Q54916286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04980
AC   CVCL_1X66
SY   ND-4980
DR   CLO; CLO_0026444
DR   BioSample; SAMN00807433
DR   Coriell; ND04980
DR   Wikidata; Q54916287
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND04981
AC   CVCL_GB93
DR   CLO; CLO_0026443
DR   Coriell; ND04981
DR   Wikidata; Q54916288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04982
AC   CVCL_CF21
DR   CLO; CLO_0026442
DR   Coriell; ND04982
DR   Wikidata; Q54916289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND04983
AC   CVCL_CF22
DR   CLO; CLO_0026448
DR   BioSample; SAMN00807435
DR   Coriell; ND04983
DR   Wikidata; Q54916290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04984
AC   CVCL_GB94
DR   CLO; CLO_0026447
DR   BioSample; SAMN00807437
DR   Coriell; ND04984
DR   Wikidata; Q54916291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04985
AC   CVCL_CF23
DR   CLO; CLO_0026446
DR   Coriell; ND04985
DR   Wikidata; Q54916292
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND04986
AC   CVCL_DY17
DR   CLO; CLO_0026445
DR   Coriell; ND04986
DR   Wikidata; Q54916293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04987
AC   CVCL_DY18
DR   CLO; CLO_0026438
DR   Coriell; ND04987
DR   Wikidata; Q54916294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04988
AC   CVCL_DY19
DR   CLO; CLO_0026436
DR   Coriell; ND04988
DR   Wikidata; Q54916295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04989
AC   CVCL_DY20
DR   CLO; CLO_0026435
DR   Coriell; ND04989
DR   Wikidata; Q54916296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND04990
AC   CVCL_GB95
DR   CLO; CLO_0027294
DR   Coriell; ND04990
DR   Wikidata; Q54916297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND04991
AC   CVCL_1X67
SY   ND-4991
DR   CLO; CLO_0027297
DR   Coriell; ND04991
DR   Wikidata; Q54916298
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04992
AC   CVCL_1X68
SY   ND-4992
DR   CLO; CLO_0027298
DR   Coriell; ND04992
DR   Wikidata; Q54916299
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND04993
AC   CVCL_FI78
DR   CLO; CLO_0027295
DR   BioSample; SAMN00807439
DR   Coriell; ND04993
DR   Wikidata; Q54916300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04994
AC   CVCL_HY50
DR   CLO; CLO_0027296
DR   BioSample; SAMN00807441
DR   Coriell; ND04994
DR   Wikidata; Q54916301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04995
AC   CVCL_HY51
DR   CLO; CLO_0027270
DR   BioSample; SAMN00807443
DR   Coriell; ND04995
DR   Wikidata; Q54916302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04996
AC   CVCL_FI79
DR   CLO; CLO_0027271
DR   BioSample; SAMN00807445
DR   Coriell; ND04996
DR   Wikidata; Q54916303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND04997
AC   CVCL_HY52
DR   CLO; CLO_0027275
DR   BioSample; SAMN00807447
DR   Coriell; ND04997
DR   Wikidata; Q54916304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND04998
AC   CVCL_IB43
DR   Coriell; ND04998
DR   Wikidata; Q54916305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND04999
AC   CVCL_IB44
DR   Coriell; ND04999
DR   Wikidata; Q54916306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05000
AC   CVCL_IB45
DR   Coriell; ND05000
DR   Wikidata; Q54916307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05004
AC   CVCL_FX62
DR   BioSample; SAMN00807449
DR   Coriell; ND05004
DR   Wikidata; Q54916308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05005
AC   CVCL_HU05
DR   CLO; CLO_0027277
DR   Coriell; ND05005
DR   Wikidata; Q54916309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05006
AC   CVCL_HU06
DR   CLO; CLO_0027267
DR   Coriell; ND05006
DR   Wikidata; Q54916310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05007
AC   CVCL_FX63
DR   CLO; CLO_0027265
DR   Coriell; ND05007
DR   Wikidata; Q54916311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05008
AC   CVCL_ES56
DR   CLO; CLO_0027264
DR   Coriell; ND05008
DR   Wikidata; Q54916312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05009
AC   CVCL_CF24
DR   CLO; CLO_0027261
DR   Coriell; ND05009
DR   Wikidata; Q54916313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05011
AC   CVCL_CF25
DR   BioSample; SAMN00807451
DR   Coriell; ND05011
DR   Wikidata; Q54916314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05012
AC   CVCL_CF26
DR   Coriell; ND05012
DR   Wikidata; Q54916315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05014
AC   CVCL_FI80
DR   BioSample; SAMN00807453
DR   Coriell; ND05014
DR   Wikidata; Q54916316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05015
AC   CVCL_CF27
DR   CLO; CLO_0027260
DR   Coriell; ND05015
DR   Wikidata; Q54916317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05016
AC   CVCL_1X69
SY   ND-5016
DR   CLO; CLO_0027263
DR   Coriell; ND05016
DR   Wikidata; Q54916318
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05017
AC   CVCL_CF28
DR   CLO; CLO_0027262
DR   Coriell; ND05017
DR   Wikidata; Q54916319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05018
AC   CVCL_CF29
DR   CLO; CLO_0027234
DR   Coriell; ND05018
DR   Wikidata; Q54916320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05019
AC   CVCL_CF30
DR   CLO; CLO_0027235
DR   Coriell; ND05019
DR   Wikidata; Q54916321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05020
AC   CVCL_FI81
DR   CLO; CLO_0027228
DR   BioSample; SAMN00807455
DR   Coriell; ND05020
DR   Wikidata; Q54916322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05021
AC   CVCL_HV50
DR   CLO; CLO_0027231
DR   BioSample; SAMN00807457
DR   Coriell; ND05021
DR   Wikidata; Q54916323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05022
AC   CVCL_HW88
DR   CLO; CLO_0027223
DR   BioSample; SAMN00807459
DR   Coriell; ND05022
DR   Wikidata; Q54916324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05023
AC   CVCL_FI82
DR   CLO; CLO_0027222
DR   Coriell; ND05023
DR   Wikidata; Q54916325
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05024
AC   CVCL_HW89
DR   CLO; CLO_0027221
DR   Coriell; ND05024
DR   Wikidata; Q54916336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05026
AC   CVCL_DY21
DR   CLO; CLO_0027220
DR   Coriell; ND05026
DR   Wikidata; Q54916337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05027
AC   CVCL_1X70
SY   ND-5027
DR   CLO; CLO_0027219
DR   Coriell; ND05027
DR   Wikidata; Q54916338
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05028
AC   CVCL_ES57
DR   CLO; CLO_0027218
DR   Coriell; ND05028
DR   Wikidata; Q54916339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05029
AC   CVCL_1X71
SY   ND-5029
DR   CLO; CLO_0027217
DR   Coriell; ND05029
DR   Wikidata; Q54916340
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05030
AC   CVCL_CF31
DR   BioSample; SAMN00807461
DR   Coriell; ND05030
DR   Wikidata; Q54916341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05032
AC   CVCL_DY22
DR   Coriell; ND05032
DR   Wikidata; Q54916343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05033
AC   CVCL_DY23
DR   Coriell; ND05033
DR   Wikidata; Q54916344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05038
AC   CVCL_IB46
DR   Coriell; ND05038
DR   Wikidata; Q54916345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05039
AC   CVCL_FI83
DR   Coriell; ND05039
DR   Wikidata; Q54916347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05043
AC   CVCL_HU07
DR   BioSample; SAMN00807463
DR   Coriell; ND05043
DR   Wikidata; Q54916348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05049
AC   CVCL_FI84
DR   BioSample; SAMN00807465
DR   Coriell; ND05049
DR   Wikidata; Q54916349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05050
AC   CVCL_IH07
DR   CLO; CLO_0027193
DR   Coriell; ND05050
DR   Wikidata; Q54916350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05051
AC   CVCL_CF32
DR   CLO; CLO_0027194
DR   BioSample; SAMN00807467
DR   Coriell; ND05051
DR   Wikidata; Q54916352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05052
AC   CVCL_1X72
SY   ND-5052
DR   CLO; CLO_0027196
DR   BioSample; SAMN00807469
DR   Coriell; ND05052
DR   Wikidata; Q54916353
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND05053
AC   CVCL_CF33
DR   CLO; CLO_0027185
DR   Coriell; ND05053
DR   Wikidata; Q54916354
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05054
AC   CVCL_CF34
DR   CLO; CLO_0027184
DR   Coriell; ND05054
DR   Wikidata; Q54916355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05055
AC   CVCL_CF35
DR   CLO; CLO_0027187
DR   Coriell; ND05055
DR   Wikidata; Q54916356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05056
AC   CVCL_CF36
DR   Coriell; ND05056
DR   Wikidata; Q54916357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05057
AC   CVCL_FF13
DR   Coriell; ND05057
DR   Wikidata; Q54916358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05059
AC   CVCL_HU08
DR   BioSample; SAMN00807471
DR   Coriell; ND05059
DR   Wikidata; Q54916360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05064
AC   CVCL_CF37
DR   CLO; CLO_0027186
DR   Coriell; ND05064
DR   Wikidata; Q54916361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05065
AC   CVCL_1X73
SY   ND-5065
DR   CLO; CLO_0027189
DR   Coriell; ND05065
DR   Wikidata; Q54916362
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05066
AC   CVCL_ES58
DR   CLO; CLO_0027188
DR   Coriell; ND05066
DR   Wikidata; Q54916363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05067
AC   CVCL_1X74
SY   ND-5067
DR   CLO; CLO_0027191
DR   Coriell; ND05067
DR   Wikidata; Q54916364
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05068
AC   CVCL_DY24
DR   CLO; CLO_0027190
DR   Coriell; ND05068
DR   Wikidata; Q54916365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05069
AC   CVCL_CF38
DR   CLO; CLO_0027161
DR   Coriell; ND05069
DR   Wikidata; Q54916366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05070
AC   CVCL_CY89
DR   CLO; CLO_0027162
DR   BioSample; SAMN00807473
DR   Coriell; ND05070
DR   Wikidata; Q54916367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05071
AC   CVCL_1X75
SY   ND-5071
DR   CLO; CLO_0027145
DR   BioSample; SAMN00807475
DR   Coriell; ND05071
DR   Wikidata; Q54916368
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05072
AC   CVCL_CF39
DR   CLO; CLO_0027153
DR   Coriell; ND05072
DR   Wikidata; Q54916369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05073
AC   CVCL_FI85
DR   CLO; CLO_0027152
DR   BioSample; SAMN00807477
DR   Coriell; ND05073
DR   Wikidata; Q54916370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05074
AC   CVCL_HW90
DR   CLO; CLO_0027151
DR   BioSample; SAMN00807479
DR   Coriell; ND05074
DR   Wikidata; Q54916371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05075
AC   CVCL_HW91
DR   CLO; CLO_0027150
DR   BioSample; SAMN00807481
DR   Coriell; ND05075
DR   Wikidata; Q54916372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05076
AC   CVCL_CF40
DR   BioSample; SAMN00807483
DR   Coriell; ND05076
DR   Wikidata; Q54916374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05077
AC   CVCL_IB47
DR   BioSample; SAMN00807485
DR   Coriell; ND05077
DR   Wikidata; Q54916375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05078
AC   CVCL_CF41
DR   Coriell; ND05078
DR   Wikidata; Q54916376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05079
AC   CVCL_CF42
DR   Coriell; ND05079
DR   Wikidata; Q54916377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05080
AC   CVCL_CF43
DR   Coriell; ND05080
DR   Wikidata; Q54916378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05081
AC   CVCL_CF44
DR   BioSample; SAMN00807487
DR   Coriell; ND05081
DR   Wikidata; Q54916379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05082
AC   CVCL_DY25
DR   Coriell; ND05082
DR   Wikidata; Q54916380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05083
AC   CVCL_DY26
DR   Coriell; ND05083
DR   Wikidata; Q54916398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05086
AC   CVCL_FX64
DR   BioSample; SAMN00807489
DR   Coriell; ND05086
DR   Wikidata; Q54916399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05087
AC   CVCL_FX65
DR   BioSample; SAMN00807491
DR   Coriell; ND05087
DR   Wikidata; Q54916401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05089
AC   CVCL_IB48
DR   Coriell; ND05089
DR   Wikidata; Q54916402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05090
AC   CVCL_HU09
DR   CLO; CLO_0027157
DR   Coriell; ND05090
DR   Wikidata; Q54916403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05091
AC   CVCL_HQ80
DR   CLO; CLO_0027156
DR   Coriell; ND05091
DR   Wikidata; Q54916404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05092
AC   CVCL_CF45
DR   CLO; CLO_0027155
DR   BioSample; SAMN00807493
DR   Coriell; ND05092
DR   Wikidata; Q54916405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05093
AC   CVCL_1X76
SY   ND-5093
DR   CLO; CLO_0027154
DR   BioSample; SAMN00807495
DR   Coriell; ND05093
DR   Wikidata; Q54916406
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05099
AC   CVCL_FI86
DR   Coriell; ND05099
DR   Wikidata; Q54916407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05101
AC   CVCL_CF46
DR   BioSample; SAMN00807497
DR   Coriell; ND05101
DR   Wikidata; Q54916408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05102
AC   CVCL_IB49
DR   Coriell; ND05102
DR   Wikidata; Q54916409
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05104
AC   CVCL_HU10
DR   BioSample; SAMN00807499
DR   Coriell; ND05104
DR   Wikidata; Q54916410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05105
AC   CVCL_CF47
DR   CLO; CLO_0027127
DR   Coriell; ND05105
DR   Wikidata; Q54916411
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05106
AC   CVCL_CF48
DR   CLO; CLO_0027138
DR   Coriell; ND05106
DR   Wikidata; Q54916414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05107
AC   CVCL_CF49
DR   Coriell; ND05107
DR   Wikidata; Q54916416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05110
AC   CVCL_DY27
DR   Coriell; ND05110
DR   Wikidata; Q54916417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05111
AC   CVCL_DY28
DR   Coriell; ND05111
DR   Wikidata; Q54916418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05112
AC   CVCL_CF50
DR   Coriell; ND05112
DR   Wikidata; Q54916419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05113
AC   CVCL_CF51
DR   Coriell; ND05113
DR   Wikidata; Q54916420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05116
AC   CVCL_FX66
DR   BioSample; SAMN00807501
DR   Coriell; ND05116
DR   Wikidata; Q54916421
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND05119
AC   CVCL_CF52
DR   CLO; CLO_0027139
DR   Coriell; ND05119
DR   Wikidata; Q54916422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05120
AC   CVCL_FI87
DR   CLO; CLO_0027135
DR   Coriell; ND05120
DR   Wikidata; Q54916423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05121
AC   CVCL_CF53
DR   CLO; CLO_0027137
DR   Coriell; ND05121
DR   Wikidata; Q54916424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05122
AC   CVCL_CF54
DR   CLO; CLO_0027133
DR   BioSample; SAMN00807503
DR   Coriell; ND05122
DR   Wikidata; Q54916425
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05123
AC   CVCL_GB96
DR   CLO; CLO_0027134
DR   BioSample; SAMN00807505
DR   Coriell; ND05123
DR   Wikidata; Q54916427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05124
AC   CVCL_1X77
SY   ND-5124
DR   CLO; CLO_0027131
DR   Coriell; ND05124
DR   Wikidata; Q54916428
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05125
AC   CVCL_1X78
SY   ND-5125
DR   CLO; CLO_0027132
DR   Coriell; ND05125
DR   Wikidata; Q54916430
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05128
AC   CVCL_DY29
DR   CLO; CLO_0027129
DR   Coriell; ND05128
DR   Wikidata; Q54916431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05132
AC   CVCL_IB50
DR   Coriell; ND05132
DR   Wikidata; Q54916432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05134
AC   CVCL_HU11
DR   BioSample; SAMN00807507
DR   Coriell; ND05134
DR   Wikidata; Q54916433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05135
AC   CVCL_FI88
DR   CLO; CLO_0027130
DR   BioSample; SAMN00807509
DR   Coriell; ND05135
DR   Wikidata; Q54916435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05136
AC   CVCL_HW92
DR   CLO; CLO_0027116
DR   BioSample; SAMN00807511
DR   Coriell; ND05136
DR   Wikidata; Q54916436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05137
AC   CVCL_HW93
DR   CLO; CLO_0027117
DR   BioSample; SAMN00807513
DR   Coriell; ND05137
DR   Wikidata; Q54916437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05138
AC   CVCL_FI89
DR   CLO; CLO_0027118
DR   Coriell; ND05138
DR   Wikidata; Q54916438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05139
AC   CVCL_FI90
DR   CLO; CLO_0027112
DR   Coriell; ND05139
DR   Wikidata; Q54916439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05140
AC   CVCL_DY30
DR   Coriell; ND05140
DR   Wikidata; Q54916440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05142
AC   CVCL_DY31
DR   Coriell; ND05142
DR   Wikidata; Q54916441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05144
AC   CVCL_DY32
DR   Coriell; ND05144
DR   Wikidata; Q54916442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05150
AC   CVCL_CF55
DR   Coriell; ND05150
DR   Wikidata; Q54916443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05153
AC   CVCL_HU12
DR   BioSample; SAMN00807515
DR   Coriell; ND05153
DR   Wikidata; Q54916444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05154
AC   CVCL_1X79
SY   ND-5154
DR   CLO; CLO_0027113
DR   Coriell; ND05154
DR   Wikidata; Q54916449
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05155
AC   CVCL_1X80
SY   ND-5155
DR   CLO; CLO_0027114
DR   Coriell; ND05155
DR   Wikidata; Q54916450
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05156
AC   CVCL_1X81
SY   ND-5156
DR   CLO; CLO_0027115
DR   Coriell; ND05156
DR   Wikidata; Q54916451
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05158
AC   CVCL_DY33
DR   Coriell; ND05158
DR   Wikidata; Q54916452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05161
AC   CVCL_1X82
SY   ND-5161
DR   CLO; CLO_0027109
DR   Coriell; ND05161
DR   Wikidata; Q54916453
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05162
AC   CVCL_DY34
DR   CLO; CLO_0027110
DR   Coriell; ND05162
DR   Wikidata; Q54916455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05163
AC   CVCL_CF56
DR   CLO; CLO_0027111
DR   Coriell; ND05163
DR   Wikidata; Q54916456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05164
AC   CVCL_CF57
DR   CLO; CLO_0027097
DR   BioSample; SAMN00807517
DR   Coriell; ND05164
DR   Wikidata; Q54916457
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05165
AC   CVCL_1X83
SY   ND-5165
DR   CLO; CLO_0027098
DR   BioSample; SAMN00807519
DR   Coriell; ND05165
DR   Wikidata; Q54916458
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND05166
AC   CVCL_ES59
DR   CLO; CLO_0027095
DR   Coriell; ND05166
DR   Wikidata; Q54916459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05167
AC   CVCL_CF58
DR   CLO; CLO_0027096
DR   Coriell; ND05167
DR   Wikidata; Q54916460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05168
AC   CVCL_ES60
DR   CLO; CLO_0027090
DR   Coriell; ND05168
DR   Wikidata; Q54916461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05169
AC   CVCL_ES61
DR   CLO; CLO_0027092
DR   Coriell; ND05169
DR   Wikidata; Q54916462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05170
AC   CVCL_CF59
DR   CLO; CLO_0027086
DR   Coriell; ND05170
DR   Wikidata; Q54916463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05171
AC   CVCL_CF60
DR   CLO; CLO_0027087
DR   Coriell; ND05171
DR   Wikidata; Q54916464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05172
AC   CVCL_FX67
DR   CLO; CLO_0027093
DR   Coriell; ND05172
DR   Wikidata; Q54916465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05173
AC   CVCL_FX68
DR   CLO; CLO_0027094
DR   Coriell; ND05173
DR   Wikidata; Q54916467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05176
AC   CVCL_DY35
DR   CLO; CLO_0027064
DR   Coriell; ND05176
DR   Wikidata; Q54916468
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05178
AC   CVCL_CF61
DR   BioSample; SAMN00807521
DR   Coriell; ND05178
DR   Wikidata; Q54916469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05179
AC   CVCL_IB51
DR   BioSample; SAMN00807523
DR   Coriell; ND05179
DR   Wikidata; Q54916470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05180
AC   CVCL_IB52
DR   BioSample; SAMN00807525
DR   Coriell; ND05180
DR   Wikidata; Q54916471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05181
AC   CVCL_CF62
DR   BioSample; SAMN00807527
DR   Coriell; ND05181
DR   Wikidata; Q54916472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05182
AC   CVCL_CF63
DR   Coriell; ND05182
DR   Wikidata; Q54916473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05184
AC   CVCL_DY36
DR   Coriell; ND05184
DR   Wikidata; Q54916474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05187
AC   CVCL_IB53
DR   BioSample; SAMN00807531
DR   Coriell; ND05187
DR   Wikidata; Q54916475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05188
AC   CVCL_FX69
DR   BioSample; SAMN00807533
DR   Coriell; ND05188
DR   Wikidata; Q54916476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05189
AC   CVCL_CF64
DR   CLO; CLO_0027065
DR   Coriell; ND05189
DR   Wikidata; Q54916477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05190
AC   CVCL_CF65
DR   CLO; CLO_0027066
DR   Coriell; ND05190
DR   Wikidata; Q54916478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05191
AC   CVCL_CF66
DR   CLO; CLO_0027067
DR   Coriell; ND05191
DR   Wikidata; Q54916479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05192
AC   CVCL_CF67
DR   CLO; CLO_0027068
DR   Coriell; ND05192
DR   Wikidata; Q54916480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05193
AC   CVCL_CF68
DR   CLO; CLO_0027058
DR   Coriell; ND05193
DR   Wikidata; Q54916481
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05194
AC   CVCL_FI91
DR   CLO; CLO_0027059
DR   BioSample; SAMN00807535
DR   Coriell; ND05194
DR   Wikidata; Q54916482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05195
AC   CVCL_GT15
DR   CLO; CLO_0027061
DR   BioSample; SAMN00807537
DR   Coriell; ND05195
DR   Wikidata; Q54916483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05196
AC   CVCL_FX70
DR   CLO; CLO_0027062
DR   Coriell; ND05196
DR   Wikidata; Q54916484
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05197
AC   CVCL_FX71
DR   CLO; CLO_0027063
DR   Coriell; ND05197
DR   Wikidata; Q54916485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05198
AC   CVCL_FX72
DR   CLO; CLO_0027039
DR   Coriell; ND05198
DR   Wikidata; Q54916486
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05200
AC   CVCL_CF69
DR   Coriell; ND05200
DR   Wikidata; Q54916487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05203
AC   CVCL_HU13
DR   BioSample; SAMN00807539
DR   Coriell; ND05203
DR   Wikidata; Q54916488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05204
AC   CVCL_HU14
DR   BioSample; SAMN00807541
DR   Coriell; ND05204
DR   Wikidata; Q54916489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05207
AC   CVCL_ES62
DR   CLO; CLO_0027038
DR   Coriell; ND05207
DR   Wikidata; Q54916490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05208
AC   CVCL_ES63
DR   CLO; CLO_0027037
DR   Coriell; ND05208
DR   Wikidata; Q54916500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05209
AC   CVCL_DY37
DR   CLO; CLO_0027036
DR   Coriell; ND05209
DR   Wikidata; Q54916501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05210
AC   CVCL_DY38
DR   CLO; CLO_0027035
DR   Coriell; ND05210
DR   Wikidata; Q54916502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05211
AC   CVCL_GB97
DR   CLO; CLO_0027034
DR   Coriell; ND05211
DR   Wikidata; Q54916503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05212
AC   CVCL_ES64
DR   CLO; CLO_0027047
DR   Coriell; ND05212
DR   Wikidata; Q54916504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05214
AC   CVCL_CF70
DR   Coriell; ND05214
DR   Wikidata; Q54916505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05215
AC   CVCL_CF71
DR   Coriell; ND05215
DR   Wikidata; Q54916506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05216
AC   CVCL_DY39
DR   Coriell; ND05216
DR   Wikidata; Q54916507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05219
AC   CVCL_FI92
DR   CLO; CLO_0027045
DR   Coriell; ND05219
DR   Wikidata; Q54916508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05220
AC   CVCL_CF72
DR   Coriell; ND05220
DR   Wikidata; Q54916509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05221
AC   CVCL_CF73
DR   Coriell; ND05221
DR   Wikidata; Q54916510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05222
AC   CVCL_CF74
DR   Coriell; ND05222
DR   Wikidata; Q54916511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05223
AC   CVCL_CF75
DR   Coriell; ND05223
DR   Wikidata; Q54916512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05224
AC   CVCL_CF76
DR   Coriell; ND05224
DR   Wikidata; Q54916513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05228
AC   CVCL_FF14
DR   Coriell; ND05228
DR   Wikidata; Q54916514
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05229
AC   CVCL_FF15
DR   Coriell; ND05229
DR   Wikidata; Q54916515
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05232
AC   CVCL_ES65
DR   CLO; CLO_0027044
DR   Coriell; ND05232
DR   Wikidata; Q54916516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05233
AC   CVCL_GB98
DR   CLO; CLO_0027041
DR   Coriell; ND05233
DR   Wikidata; Q54916517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05234
AC   CVCL_FI93
DR   CLO; CLO_0027721
DR   BioSample; SAMN00807543
DR   Coriell; ND05234
DR   Wikidata; Q54916518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05235
AC   CVCL_IB54
DR   CLO; CLO_0027722
DR   BioSample; SAMN00807545
DR   Coriell; ND05235
DR   Wikidata; Q54916519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05236
AC   CVCL_FI94
DR   CLO; CLO_0027719
DR   BioSample; SAMN00807547
DR   Coriell; ND05236
DR   Wikidata; Q54916520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05240
AC   CVCL_DY40
DR   Coriell; ND05240
DR   Wikidata; Q54916521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05249
AC   CVCL_HU15
DR   BioSample; SAMN00807549
DR   Coriell; ND05249
DR   Wikidata; Q54916522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05253
AC   CVCL_ES66
DR   CLO; CLO_0027720
DR   BioSample; SAMN00807551
DR   Coriell; ND05253
DR   Wikidata; Q54916523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05254
AC   CVCL_CF77
DR   CLO; CLO_0027755
DR   BioSample; SAMN00807553
DR   Coriell; ND05254
DR   Wikidata; Q54916524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05255
AC   CVCL_CF78
DR   CLO; CLO_0027754
DR   BioSample; SAMN00807555
DR   Coriell; ND05255
DR   Wikidata; Q54916525
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05256
AC   CVCL_1X84
SY   ND-5256
DR   CLO; CLO_0027757
DR   BioSample; SAMN00807557
DR   Coriell; ND05256
DR   Wikidata; Q54916526
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND05257
AC   CVCL_CF79
DR   CLO; CLO_0027756
DR   Coriell; ND05257
DR   Wikidata; Q54916527
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05258
AC   CVCL_IH08
DR   CLO; CLO_0027759
DR   Coriell; ND05258
DR   Wikidata; Q54916528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05259
AC   CVCL_CF80
DR   CLO; CLO_0027758
DR   Coriell; ND05259
DR   Wikidata; Q54916529
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05260
AC   CVCL_FI95
DR   CLO; CLO_0027770
DR   BioSample; SAMN00807559
DR   Coriell; ND05260
DR   Wikidata; Q54916530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05261
AC   CVCL_HW94
DR   CLO; CLO_0027771
DR   BioSample; SAMN00807561
DR   Coriell; ND05261
DR   Wikidata; Q54916531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05262
AC   CVCL_HW95
DR   CLO; CLO_0027772
DR   BioSample; SAMN00807563
DR   Coriell; ND05262
DR   Wikidata; Q54916533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05263
AC   CVCL_IB55
DR   Coriell; ND05263
DR   Wikidata; Q54916534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05265
AC   CVCL_HU16
DR   BioSample; SAMN00807565
DR   Coriell; ND05265
DR   Wikidata; Q54916536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05266
AC   CVCL_FX73
DR   BioSample; SAMN00807567
DR   Coriell; ND05266
DR   Wikidata; Q54916537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05267
AC   CVCL_GB99
DR   CLO; CLO_0027773
DR   Coriell; ND05267
DR   Wikidata; Q54916538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05269
AC   CVCL_IB56
DR   Coriell; ND05269
DR   Wikidata; Q54916539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05270
AC   CVCL_CF81
DR   BioSample; SAMN00807569
DR   Coriell; ND05270
DR   Wikidata; Q54916540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05271
AC   CVCL_CF82
DR   Coriell; ND05271
DR   Wikidata; Q54916541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05272
AC   CVCL_CF83
DR   Coriell; ND05272
DR   Wikidata; Q54916548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05275
AC   CVCL_DY41
DR   Coriell; ND05275
DR   Wikidata; Q54916549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05276
AC   CVCL_HU17
DR   CLO; CLO_0027774
DR   Coriell; ND05276
DR   Wikidata; Q54916550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05277
AC   CVCL_FX74
DR   CLO; CLO_0027737
DR   Coriell; ND05277
DR   Wikidata; Q54916551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05278
AC   CVCL_GC00
DR   CLO; CLO_0027736
DR   Coriell; ND05278
DR   Wikidata; Q54916552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05279
AC   CVCL_ES67
DR   CLO; CLO_0027735
DR   Coriell; ND05279
DR   Wikidata; Q54916553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05280
AC   CVCL_ES68
DR   CLO; CLO_0027733
DR   Coriell; ND05280
DR   Wikidata; Q54916554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05281
AC   CVCL_ES69
DR   CLO; CLO_0027738
DR   Coriell; ND05281
DR   Wikidata; Q54916555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05283
AC   CVCL_1X85
SY   ND-5283
DR   CLO; CLO_0027748
DR   Coriell; ND05283
DR   Wikidata; Q54916556
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05284
AC   CVCL_FI96
DR   CLO; CLO_0027749
DR   BioSample; SAMN00807571
DR   Coriell; ND05284
DR   Wikidata; Q54916557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05285
AC   CVCL_FI97
DR   CLO; CLO_0027752
DR   Coriell; ND05285
DR   Wikidata; Q54916559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05286
AC   CVCL_FI98
DR   CLO; CLO_0027753
DR   Coriell; ND05286
DR   Wikidata; Q54916560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05287
AC   CVCL_CF84
DR   Coriell; ND05287
DR   Wikidata; Q54916561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05291
AC   CVCL_HU18
DR   BioSample; SAMN00807573
DR   Coriell; ND05291
DR   Wikidata; Q54916562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05292
AC   CVCL_ES70
DR   CLO; CLO_0027750
DR   BioSample; SAMN00807575
DR   Coriell; ND05292
DR   Wikidata; Q54916563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05293
AC   CVCL_CF85
DR   CLO; CLO_0027751
DR   BioSample; SAMN00807577
DR   Coriell; ND05293
DR   Wikidata; Q54916564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05294
AC   CVCL_DY42
DR   CLO; CLO_0027796
DR   Coriell; ND05294
DR   Wikidata; Q54916565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05295
AC   CVCL_ES71
DR   CLO; CLO_0027797
DR   Coriell; ND05295
DR   Wikidata; Q54916566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05296
AC   CVCL_1X86
SY   ND-5296
DR   CLO; CLO_0027798
DR   Coriell; ND05296
DR   Wikidata; Q54916567
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05297
AC   CVCL_1X87
SY   ND-5297
DR   CLO; CLO_0027799
DR   Coriell; ND05297
DR   Wikidata; Q54916568
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05298
AC   CVCL_DY43
DR   CLO; CLO_0027804
DR   Coriell; ND05298
DR   Wikidata; Q54916569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05299
AC   CVCL_1X88
SY   ND-5299
DR   CLO; CLO_0027806
DR   Coriell; ND05299
DR   Wikidata; Q54916570
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05300
AC   CVCL_CF86
DR   Coriell; ND05300
DR   Wikidata; Q54916572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05301
AC   CVCL_CF87
DR   BioSample; SAMN00807579
DR   Coriell; ND05301
DR   Wikidata; Q54916573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05302
AC   CVCL_CF88
DR   Coriell; ND05302
DR   Wikidata; Q54916575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05303
AC   CVCL_CF89
DR   Coriell; ND05303
DR   Wikidata; Q54916576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05304
AC   CVCL_CF90
DR   BioSample; SAMN00807581
DR   Coriell; ND05304
DR   Wikidata; Q54916577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05305
AC   CVCL_IB57
DR   BioSample; SAMN00807583
DR   Coriell; ND05305
DR   Wikidata; Q54916578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05310
AC   CVCL_DY44
DR   CLO; CLO_0027805
DR   Coriell; ND05310
DR   Wikidata; Q54916579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05314
AC   CVCL_IL50
DR   BioSample; SAMN00807585
DR   Coriell; ND05314
DR   Wikidata; Q54916580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05318
AC   CVCL_HU19
DR   BioSample; SAMN00807587
DR   Coriell; ND05318
DR   Wikidata; Q54916581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05319
AC   CVCL_HU20
DR   BioSample; SAMN00807589
DR   Coriell; ND05319
DR   Wikidata; Q54916583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05320
AC   CVCL_FI99
DR   CLO; CLO_0027801
DR   Coriell; ND05320
DR   Wikidata; Q54916584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05321
AC   CVCL_FJ00
DR   CLO; CLO_0027800
DR   BioSample; SAMN00807591
DR   Coriell; ND05321
DR   Wikidata; Q54916586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05322
AC   CVCL_CF91
DR   CLO; CLO_0027803
DR   Coriell; ND05322
DR   Wikidata; Q54916587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05326
AC   CVCL_IB58
DR   Coriell; ND05326
DR   Wikidata; Q54916588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05330
AC   CVCL_FJ01
DR   BioSample; SAMN00807593
DR   Coriell; ND05330
DR   Wikidata; Q54916590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05331
AC   CVCL_CF92
DR   BioSample; SAMN00807595
DR   Coriell; ND05331
DR   Wikidata; Q54916591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05332
AC   CVCL_CF93
DR   Coriell; ND05332
DR   Wikidata; Q54916592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05333
AC   CVCL_CF94
DR   BioSample; SAMN00807597
DR   Coriell; ND05333
DR   Wikidata; Q54916593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05336
AC   CVCL_CF95
DR   Coriell; ND05336
DR   Wikidata; Q54916600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05337
AC   CVCL_CF96
DR   Coriell; ND05337
DR   Wikidata; Q54916601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05338
AC   CVCL_ES72
DR   CLO; CLO_0027802
DR   Coriell; ND05338
DR   Wikidata; Q54916602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05339
AC   CVCL_FJ02
DR   CLO; CLO_0027783
DR   Coriell; ND05339
DR   Wikidata; Q54916603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05341
AC   CVCL_HQ81
DR   CLO; CLO_0027784
DR   Coriell; ND05341
DR   Wikidata; Q54916604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05342
AC   CVCL_FX75
DR   CLO; CLO_0027782
DR   Coriell; ND05342
DR   Wikidata; Q54916605
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05348
AC   CVCL_DY45
DR   Coriell; ND05348
DR   Wikidata; Q54916606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05349
AC   CVCL_DY46
DR   Coriell; ND05349
DR   Wikidata; Q54916607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05351
AC   CVCL_DY47
DR   Coriell; ND05351
DR   Wikidata; Q54916608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05352
AC   CVCL_DY48
DR   CLO; CLO_0027792
DR   Coriell; ND05352
DR   Wikidata; Q54916610
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05353
AC   CVCL_IB59
DR   Coriell; ND05353
DR   Wikidata; Q54916611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05354
AC   CVCL_IB60
DR   Coriell; ND05354
DR   Wikidata; Q54916612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05357
AC   CVCL_FX76
DR   BioSample; SAMN00807599
DR   Coriell; ND05357
DR   Wikidata; Q54916613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05364
AC   CVCL_CF97
DR   CLO; CLO_0027791
DR   BioSample; SAMN00807601
DR   Coriell; ND05364
DR   Wikidata; Q54916614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05366
AC   CVCL_CF98
DR   CLO; CLO_0027790
DR   Coriell; ND05366
DR   Wikidata; Q54916615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05367
AC   CVCL_IL51
DR   CLO; CLO_0027789
DR   Coriell; ND05367
DR   Wikidata; Q54916616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND05367; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND05368
AC   CVCL_1X89
SY   ND-5368
DR   CLO; CLO_0027788
DR   Coriell; ND05368
DR   Wikidata; Q54916617
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05369
AC   CVCL_1X90
SY   ND-5369
DR   CLO; CLO_0027787
DR   Coriell; ND05369
DR   Wikidata; Q54916618
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05370
AC   CVCL_1X91
SY   ND-5370
DR   CLO; CLO_0027786
DR   Coriell; ND05370
DR   Wikidata; Q54916619
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05371
AC   CVCL_DY49
DR   CLO; CLO_0027785
DR   Coriell; ND05371
DR   Wikidata; Q54916620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05372
AC   CVCL_1X92
SY   ND-5372
DR   CLO; CLO_0027818
DR   Coriell; ND05372
DR   Wikidata; Q54916621
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05373
AC   CVCL_CF99
DR   BioSample; SAMN00807603
DR   Coriell; ND05373
DR   Wikidata; Q54916622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05374
AC   CVCL_IB61
DR   BioSample; SAMN00807605
DR   Coriell; ND05374
DR   Wikidata; Q54916623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05375
AC   CVCL_CG00
DR   BioSample; SAMN00807607
DR   Coriell; ND05375
DR   Wikidata; Q54916624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05376
AC   CVCL_IB62
DR   BioSample; SAMN00807609
DR   Coriell; ND05376
DR   Wikidata; Q54916625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05377
AC   CVCL_IB63
DR   BioSample; SAMN00807611
DR   Coriell; ND05377
DR   Wikidata; Q54916626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05378
AC   CVCL_IB64
DR   BioSample; SAMN00807613
DR   Coriell; ND05378
DR   Wikidata; Q54916627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05379
AC   CVCL_IB65
DR   BioSample; SAMN00807615
DR   Coriell; ND05379
DR   Wikidata; Q54916628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05380
AC   CVCL_IB66
DR   BioSample; SAMN00807617
DR   Coriell; ND05380
DR   Wikidata; Q54916629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05381
AC   CVCL_IB67
DR   BioSample; SAMN00807619
DR   Coriell; ND05381
DR   Wikidata; Q54916631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05382
AC   CVCL_IB68
DR   BioSample; SAMN00807621
DR   Coriell; ND05382
DR   Wikidata; Q54916632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05383
AC   CVCL_IB69
DR   BioSample; SAMN00807623
DR   Coriell; ND05383
DR   Wikidata; Q54916633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05384
AC   CVCL_IB70
DR   BioSample; SAMN00807625
DR   Coriell; ND05384
DR   Wikidata; Q54916634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05385
AC   CVCL_CG01
DR   BioSample; SAMN00807627
DR   Coriell; ND05385
DR   Wikidata; Q54916635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05386
AC   CVCL_CG02
DR   Coriell; ND05386
DR   Wikidata; Q54916636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05387
AC   CVCL_CG03
DR   Coriell; ND05387
DR   Wikidata; Q54916637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05388
AC   CVCL_DY50
DR   CLO; CLO_0027819
DR   Coriell; ND05388
DR   Wikidata; Q54916638
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05389
AC   CVCL_DY51
DR   Coriell; ND05389
DR   Wikidata; Q54916639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05390
AC   CVCL_DY52
DR   Coriell; ND05390
DR   Wikidata; Q54916640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05391
AC   CVCL_DY53
DR   CLO; CLO_0027828
DR   Coriell; ND05391
DR   Wikidata; Q54916641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05393
AC   CVCL_CG04
DR   Coriell; ND05393
DR   Wikidata; Q54916651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05394
AC   CVCL_CG05
DR   Coriell; ND05394
DR   Wikidata; Q54916652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05398
AC   CVCL_IB71
DR   Coriell; ND05398
DR   Wikidata; Q54916653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05400
AC   CVCL_FJ03
DR   BioSample; SAMN00807631
DR   Coriell; ND05400
DR   Wikidata; Q54916654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05401
AC   CVCL_CG06
DR   CLO; CLO_0027821
DR   Coriell; ND05401
DR   Wikidata; Q54916655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05402
AC   CVCL_FX77
DR   CLO; CLO_0027820
DR   Coriell; ND05402
DR   Wikidata; Q54916656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05403
AC   CVCL_HQ82
DR   CLO; CLO_0027823
DR   Coriell; ND05403
DR   Wikidata; Q54916657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05404
AC   CVCL_CG07
DR   CLO; CLO_0027822
DR   Coriell; ND05404
DR   Wikidata; Q54916659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05405
AC   CVCL_ES73
DR   CLO; CLO_0027825
DR   Coriell; ND05405
DR   Wikidata; Q54916660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05406
AC   CVCL_FJ04
DR   CLO; CLO_0027824
DR   BioSample; SAMN00807633
DR   Coriell; ND05406
DR   Wikidata; Q54916661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05407
AC   CVCL_HW96
DR   CLO; CLO_0027827
DR   BioSample; SAMN00807635
DR   Coriell; ND05407
DR   Wikidata; Q54916663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05408
AC   CVCL_HW97
DR   CLO; CLO_0027826
DR   BioSample; SAMN00807637
DR   Coriell; ND05408
DR   Wikidata; Q54916664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05413
AC   CVCL_DY54
DR   Coriell; ND05413
DR   Wikidata; Q54916665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05414
AC   CVCL_ES74
DR   CLO; CLO_0027807
DR   Coriell; ND05414
DR   Wikidata; Q54916666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05415
AC   CVCL_CG08
DR   CLO; CLO_0027817
DR   Coriell; ND05415
DR   Wikidata; Q54916667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05416
AC   CVCL_CG09
DR   CLO; CLO_0027816
DR   BioSample; SAMN00807639
DR   Coriell; ND05416
DR   Wikidata; Q54916668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05418
AC   CVCL_FJ05
DR   CLO; CLO_0027811
DR   BioSample; SAMN00807641
DR   Coriell; ND05418
DR   Wikidata; Q54916669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05419
AC   CVCL_HW98
DR   CLO; CLO_0027810
DR   BioSample; SAMN00807643
DR   Coriell; ND05419
DR   Wikidata; Q54916670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05420
AC   CVCL_HW99
DR   CLO; CLO_0027809
DR   BioSample; SAMN00807645
DR   Coriell; ND05420
DR   Wikidata; Q54916671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05421
AC   CVCL_1X93
SY   ND-5421
DR   CLO; CLO_0027808
DR   Coriell; ND05421
DR   Wikidata; Q54916672
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05422
AC   CVCL_1X94
SY   ND-5422
DR   CLO; CLO_0027815
DR   Coriell; ND05422
DR   Wikidata; Q54916673
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05423
AC   CVCL_DY55
DR   CLO; CLO_0027814
DR   Coriell; ND05423
DR   Wikidata; Q54916675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05424
AC   CVCL_1X95
SY   ND-5424
DR   CLO; CLO_0027813
DR   Coriell; ND05424
DR   Wikidata; Q54916676
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05425
AC   CVCL_CG10
DR   Coriell; ND05425
DR   Wikidata; Q54916677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05426
AC   CVCL_CG11
DR   Coriell; ND05426
DR   Wikidata; Q54916678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05432
AC   CVCL_HU21
DR   BioSample; SAMN00807647
DR   Coriell; ND05432
DR   Wikidata; Q54916679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05434
AC   CVCL_FJ06
DR   BioSample; SAMN00807649
DR   Coriell; ND05434
DR   Wikidata; Q54916680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05437
AC   CVCL_GT29
DR   CLO; CLO_0027812
DR   BioSample; SAMN00807651
DR   Coriell; ND05437
DR   Wikidata; Q54916681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05438
AC   CVCL_GC01
DR   CLO; CLO_0027591
DR   Coriell; ND05438
DR   Wikidata; Q54916682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05439
AC   CVCL_GC02
DR   CLO; CLO_0027589
DR   Coriell; ND05439
DR   Wikidata; Q54916683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05445
AC   CVCL_DY56
DR   CLO; CLO_0027590
DR   Coriell; ND05445
DR   Wikidata; Q54916684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05446
AC   CVCL_DY57
DR   Coriell; ND05446
DR   Wikidata; Q54916685
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05447
AC   CVCL_DY58
DR   Coriell; ND05447
DR   Wikidata; Q54916686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05450
AC   CVCL_DY59
DR   Coriell; ND05450
DR   Wikidata; Q54916687
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05452
AC   CVCL_IB72
DR   BioSample; SAMN00807653
DR   Coriell; ND05452
DR   Wikidata; Q54916688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05453
AC   CVCL_IB73
DR   BioSample; SAMN00807655
DR   Coriell; ND05453
DR   Wikidata; Q54916689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05454
AC   CVCL_IB74
DR   BioSample; SAMN00807657
DR   Coriell; ND05454
DR   Wikidata; Q54916690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05456
AC   CVCL_FX78
DR   Coriell; ND05456
DR   Wikidata; Q54916691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05460
AC   CVCL_CG12
DR   CLO; CLO_0027597
DR   Coriell; ND05460
DR   Wikidata; Q54916692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05461
AC   CVCL_1X96
SY   ND-5461
DR   CLO; CLO_0027600
DR   BioSample; SAMN00807659
DR   Coriell; ND05461
DR   Wikidata; Q54916693
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND05462
AC   CVCL_CG13
DR   CLO; CLO_0027595
DR   BioSample; SAMN00807661
DR   Coriell; ND05462
DR   Wikidata; Q54916707
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05463
AC   CVCL_FJ07
DR   CLO; CLO_0027596
DR   Coriell; ND05463
DR   Wikidata; Q54916708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05466
AC   CVCL_HU22
DR   BioSample; SAMN00807663
DR   Coriell; ND05466
DR   Wikidata; Q54916709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05474
AC   CVCL_IB75
DR   Coriell; ND05474
DR   Wikidata; Q54916710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05479
AC   CVCL_DY60
DR   Coriell; ND05479
DR   Wikidata; Q54916711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05480
AC   CVCL_FJ08
DR   CLO; CLO_0027593
DR   Coriell; ND05480
DR   Wikidata; Q54916712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05481
AC   CVCL_IH09
DR   CLO; CLO_0027594
DR   Coriell; ND05481
DR   Wikidata; Q54916713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05482
AC   CVCL_CG14
DR   CLO; CLO_0027592
DR   Coriell; ND05482
DR   Wikidata; Q54916714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05483
AC   CVCL_DY61
DR   CLO; CLO_0027569
DR   Coriell; ND05483
DR   Wikidata; Q54916715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05484
AC   CVCL_1X97
SY   ND-5484
DR   CLO; CLO_0027570
DR   Coriell; ND05484
DR   Wikidata; Q54916716
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05485
AC   CVCL_DY62
DR   CLO; CLO_0027571
DR   Coriell; ND05485
DR   Wikidata; Q54916717
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05486
AC   CVCL_IB76
DR   Coriell; ND05486
DR   Wikidata; Q54916718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05487
AC   CVCL_IB77
DR   Coriell; ND05487
DR   Wikidata; Q54916719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05495
AC   CVCL_DY63
DR   Coriell; ND05495
DR   Wikidata; Q54916720
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05498
AC   CVCL_CG15
DR   CLO; CLO_0027572
DR   Coriell; ND05498
DR   Wikidata; Q54916721
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05499
AC   CVCL_CG16
DR   CLO; CLO_0027575
DR   BioSample; SAMN00807664
DR   Coriell; ND05499
DR   Wikidata; Q54916722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05500
AC   CVCL_1X98
SY   ND-5500
DR   CLO; CLO_0027577
DR   BioSample; SAMN00807666
DR   Coriell; ND05500
DR   Wikidata; Q54916723
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05501
AC   CVCL_ES75
DR   CLO; CLO_0027578
DR   BioSample; SAMN00807668
DR   Coriell; ND05501
DR   Wikidata; Q54916724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05502
AC   CVCL_CG17
DR   CLO; CLO_0027579
DR   BioSample; SAMN00807670
DR   Coriell; ND05502
DR   Wikidata; Q54916725
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05503
AC   CVCL_IB78
DR   CLO; CLO_0027573
DR   BioSample; SAMN00807672
DR   Coriell; ND05503
DR   Wikidata; Q54916726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05506
AC   CVCL_IB79
DR   Coriell; ND05506
DR   Wikidata; Q54916727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05508
AC   CVCL_FJ09
DR   BioSample; SAMN00807674
DR   Coriell; ND05508
DR   Wikidata; Q54916729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05510
AC   CVCL_FX79
DR   BioSample; SAMN00807676
DR   Coriell; ND05510
DR   Wikidata; Q54916730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05511
AC   CVCL_HU23
DR   BioSample; SAMN00807678
DR   Coriell; ND05511
DR   Wikidata; Q54916731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05514
AC   CVCL_FX80
DR   Coriell; ND05514
DR   Wikidata; Q54916732
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05515
AC   CVCL_HU24
DR   BioSample; SAMN00807680
DR   Coriell; ND05515
DR   Wikidata; Q54916733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05517
AC   CVCL_HU25
DR   Coriell; ND05517
DR   Wikidata; Q54916734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05520
AC   CVCL_CG18
DR   CLO; CLO_0027574
DR   Coriell; ND05520
DR   Wikidata; Q54916735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05521
AC   CVCL_ES76
DR   CLO; CLO_0027619
DR   Coriell; ND05521
DR   Wikidata; Q54916736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05522
AC   CVCL_DY64
DR   CLO; CLO_0027622
DR   Coriell; ND05522
DR   Wikidata; Q54916737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05523
AC   CVCL_1X99
SY   ND-5523
DR   CLO; CLO_0027623
DR   Coriell; ND05523
DR   Wikidata; Q54916739
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05524
AC   CVCL_DY65
DR   CLO; CLO_0027620
DR   Coriell; ND05524
DR   Wikidata; Q54916740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05525
AC   CVCL_DY66
DR   CLO; CLO_0027621
DR   Coriell; ND05525
DR   Wikidata; Q54916741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05530
AC   CVCL_IB80
DR   Coriell; ND05530
DR   Wikidata; Q54916742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05535
AC   CVCL_CG19
DR   CLO; CLO_0027629
DR   BioSample; SAMN00807682
DR   Coriell; ND05535
DR   Wikidata; Q54916743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05536
AC   CVCL_1Y00
SY   ND-5536
DR   CLO; CLO_0027631
DR   BioSample; SAMN00807684
DR   Coriell; ND05536
DR   Wikidata; Q54916745
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ND05545
AC   CVCL_CG20
DR   Coriell; ND05545
DR   Wikidata; Q54916746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05548
AC   CVCL_HU26
DR   BioSample; SAMN00807686
DR   Coriell; ND05548
DR   Wikidata; Q54916747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05550
AC   CVCL_HU27
DR   BioSample; SAMN00807688
DR   Coriell; ND05550
DR   Wikidata; Q54916748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05554
AC   CVCL_HU28
DR   BioSample; SAMN00807690
DR   Coriell; ND05554
DR   Wikidata; Q54916749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05555
AC   CVCL_FX81
DR   BioSample; SAMN00807692
DR   Coriell; ND05555
DR   Wikidata; Q54916757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05556
AC   CVCL_CG21
DR   CLO; CLO_0027624
DR   Coriell; ND05556
DR   Wikidata; Q54916758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05558
AC   CVCL_CG22
DR   Coriell; ND05558
DR   Wikidata; Q54916759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05560
AC   CVCL_CG23
DR   Coriell; ND05560
DR   Wikidata; Q54916760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05561
AC   CVCL_IB81
DR   Coriell; ND05561
DR   Wikidata; Q54916761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05563
AC   CVCL_DY67
DR   Coriell; ND05563
DR   Wikidata; Q54916762
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05567
AC   CVCL_HU29
DR   BioSample; SAMN00807694
DR   Coriell; ND05567
DR   Wikidata; Q54916763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05573
AC   CVCL_GC03
DR   CLO; CLO_0027627
DR   Coriell; ND05573
DR   Wikidata; Q54916764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05574
AC   CVCL_DY68
DR   CLO; CLO_0027632
DR   Coriell; ND05574
DR   Wikidata; Q54916765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05575
AC   CVCL_1Y01
SY   ND-5575
DR   CLO; CLO_0027889
DR   Coriell; ND05575
DR   Wikidata; Q54916766
RX   PubMed=17116639;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05577
AC   CVCL_DY69
DR   CLO; CLO_0027891
DR   Coriell; ND05577
DR   Wikidata; Q54916767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05578
AC   CVCL_DY70
DR   CLO; CLO_0027890
DR   Coriell; ND05578
DR   Wikidata; Q54916768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05579
AC   CVCL_DY71
DR   CLO; CLO_0028173
DR   Coriell; ND05579
DR   Wikidata; Q54916769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05583
AC   CVCL_CG24
DR   CLO; CLO_0028171
DR   Coriell; ND05583
DR   Wikidata; Q54916770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05585
AC   CVCL_CG25
DR   CLO; CLO_0028176
DR   Coriell; ND05585
DR   Wikidata; Q54916771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05586
AC   CVCL_FJ10
DR   CLO; CLO_0028175
DR   BioSample; SAMN00807696
DR   Coriell; ND05586
DR   Wikidata; Q54916772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05587
AC   CVCL_HX00
DR   CLO; CLO_0028169
DR   BioSample; SAMN00807698
DR   Coriell; ND05587
DR   Wikidata; Q54916774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05588
AC   CVCL_HX01
DR   CLO; CLO_0028168
DR   BioSample; SAMN00807700
DR   Coriell; ND05588
DR   Wikidata; Q54916775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05592
AC   CVCL_DY72
DR   Coriell; ND05592
DR   Wikidata; Q54916776
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05593
AC   CVCL_DY73
DR   Coriell; ND05593
DR   Wikidata; Q54916777
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05594
AC   CVCL_FJ11
DR   BioSample; SAMN00807702
DR   Coriell; ND05594
DR   Wikidata; Q54916778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05595
AC   CVCL_FJ12
DR   Coriell; ND05595
DR   Wikidata; Q54916779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05596
AC   CVCL_FJ13
DR   Coriell; ND05596
DR   Wikidata; Q54916781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05597
AC   CVCL_FJ14
DR   BioSample; SAMN00807704
DR   Coriell; ND05597
DR   Wikidata; Q54916782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05598
AC   CVCL_CG26
DR   Coriell; ND05598
DR   Wikidata; Q54916783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05600
AC   CVCL_FX82
DR   CLO; CLO_0028170
DR   Coriell; ND05600
DR   Wikidata; Q54916784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05601
AC   CVCL_GC04
DR   CLO; CLO_0028178
DR   BioSample; SAMN00807706
DR   Coriell; ND05601
DR   Wikidata; Q54916785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05602
AC   CVCL_CG27
DR   CLO; CLO_0028179
DR   BioSample; SAMN00807708
DR   Coriell; ND05602
DR   Wikidata; Q54916786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05603
AC   CVCL_CG28
DR   CLO; CLO_0028180
DR   BioSample; SAMN00807710
DR   Coriell; ND05603
DR   Wikidata; Q54916787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05604
AC   CVCL_AB69
DR   CLO; CLO_0028181
DR   Coriell; ND05604
DR   Wikidata; Q54916788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND05606
AC   CVCL_DY74
DR   Coriell; ND05606
DR   Wikidata; Q54916789
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05607
AC   CVCL_CG29
DR   Coriell; ND05607
DR   Wikidata; Q54916790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05610
AC   CVCL_FX83
DR   BioSample; SAMN00807712
DR   Coriell; ND05610
DR   Wikidata; Q54916791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05611
AC   CVCL_HU30
DR   BioSample; SAMN00807714
DR   Coriell; ND05611
DR   Wikidata; Q54916792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05612
AC   CVCL_HU31
DR   BioSample; SAMN00807716
DR   Coriell; ND05612
DR   Wikidata; Q54916793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05613
AC   CVCL_FJ15
DR   CLO; CLO_0028146
DR   BioSample; SAMN00807718
DR   Coriell; ND05613
DR   Wikidata; Q54916794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05614
AC   CVCL_IB82
DR   CLO; CLO_0028143
DR   BioSample; SAMN00807720
DR   Coriell; ND05614
DR   Wikidata; Q54916795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05615
AC   CVCL_CG30
DR   CLO; CLO_0028141
DR   BioSample; SAMN00807724
DR   Coriell; ND05615
DR   Wikidata; Q54916796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05616
AC   CVCL_ES77
DR   CLO; CLO_0028140
DR   BioSample; SAMN00807726
DR   Coriell; ND05616
DR   Wikidata; Q54916797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05617
AC   CVCL_ES78
DR   CLO; CLO_0028138
DR   Coriell; ND05617
DR   Wikidata; Q54916798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05618
AC   CVCL_ES79
DR   CLO; CLO_0028137
DR   Coriell; ND05618
DR   Wikidata; Q54916805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05619
AC   CVCL_FF16
DR   Coriell; ND05619
DR   Wikidata; Q54916807
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05622
AC   CVCL_CG31
DR   Coriell; ND05622
DR   Wikidata; Q54916808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05623
AC   CVCL_CG32
DR   CLO; CLO_0028151
DR   Coriell; ND05623
DR   Wikidata; Q54916809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05624
AC   CVCL_CG33
DR   CLO; CLO_0028149
DR   Coriell; ND05624
DR   Wikidata; Q54916810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05625
AC   CVCL_CY90
DR   CLO; CLO_0028150
DR   Coriell; ND05625
DR   Wikidata; Q54916811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05626
AC   CVCL_IL52
DR   CLO; CLO_0028147
DR   Coriell; ND05626
DR   Wikidata; Q54916812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND05626; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND05627
AC   CVCL_FX84
DR   BioSample; SAMN00807728
DR   Coriell; ND05627
DR   Wikidata; Q54916813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05629
AC   CVCL_HU32
DR   BioSample; SAMN00807730
DR   Coriell; ND05629
DR   Wikidata; Q54916814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05635
AC   CVCL_FX85
DR   BioSample; SAMN00807732
DR   Coriell; ND05635
DR   Wikidata; Q54916815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05637
AC   CVCL_FX86
DR   BioSample; SAMN00807734
DR   Coriell; ND05637
DR   Wikidata; Q54916816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05638
AC   CVCL_FX87
DR   Coriell; ND05638
DR   Wikidata; Q54916817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05641
AC   CVCL_CG34
DR   BioSample; SAMN00807736
DR   Coriell; ND05641
DR   Wikidata; Q54916818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05642
AC   CVCL_CG35
DR   Coriell; ND05642
DR   Wikidata; Q54916819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05643
AC   CVCL_CG36
DR   Coriell; ND05643
DR   Wikidata; Q54916820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05646
AC   CVCL_IH10
DR   CLO; CLO_0028148
DR   Coriell; ND05646
DR   Wikidata; Q54916821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05647
AC   CVCL_IH11
DR   CLO; CLO_0028112
DR   Coriell; ND05647
DR   Wikidata; Q54916822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05648
AC   CVCL_IH12
DR   CLO; CLO_0028111
DR   Coriell; ND05648
DR   Wikidata; Q54916823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05649
AC   CVCL_DY75
DR   Coriell; ND05649
DR   Wikidata; Q54916825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05650
AC   CVCL_DY76
DR   Coriell; ND05650
DR   Wikidata; Q54916826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05651
AC   CVCL_DY77
DR   Coriell; ND05651
DR   Wikidata; Q54916827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05652
AC   CVCL_CG37
DR   CLO; CLO_0028115
DR   Coriell; ND05652
DR   Wikidata; Q54916828
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05653
AC   CVCL_ES80
DR   CLO; CLO_0028113
DR   BioSample; SAMN00807738
DR   Coriell; ND05653
DR   Wikidata; Q54916829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05654
AC   CVCL_CG38
DR   CLO; CLO_0028116
DR   Coriell; ND05654
DR   Wikidata; Q54916830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05655
AC   CVCL_CG39
DR   CLO; CLO_0028117
DR   Coriell; ND05655
DR   Wikidata; Q54916831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05659
AC   CVCL_IB83
DR   Coriell; ND05659
DR   Wikidata; Q54916832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05660
AC   CVCL_CG40
DR   Coriell; ND05660
DR   Wikidata; Q54916833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05661
AC   CVCL_CG41
DR   Coriell; ND05661
DR   Wikidata; Q54916834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05662
AC   CVCL_CG42
DR   Coriell; ND05662
DR   Wikidata; Q54916835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05669
AC   CVCL_FJ16
DR   Coriell; ND05669
DR   Wikidata; Q54916836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05670
AC   CVCL_FJ17
DR   BioSample; SAMN00807740
DR   Coriell; ND05670
DR   Wikidata; Q54916837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y1M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05671
AC   CVCL_FJ18
DR   BioSample; SAMN00807742
DR   Coriell; ND05671
DR   Wikidata; Q54916838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05672
AC   CVCL_ES81
DR   CLO; CLO_0028118
DR   Coriell; ND05672
DR   Wikidata; Q54916839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05673
AC   CVCL_CG43
DR   CLO; CLO_0028119
DR   Coriell; ND05673
DR   Wikidata; Q54916840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05674
AC   CVCL_CG44
DR   CLO; CLO_0028120
DR   Coriell; ND05674
DR   Wikidata; Q54916841
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05675
AC   CVCL_CG45
DR   CLO; CLO_0028121
DR   Coriell; ND05675
DR   Wikidata; Q54916842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05676
AC   CVCL_CG46
DR   CLO; CLO_0028122
DR   Coriell; ND05676
DR   Wikidata; Q54916843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05677
AC   CVCL_CG47
DR   CLO; CLO_0028090
DR   Coriell; ND05677
DR   Wikidata; Q54916844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05678
AC   CVCL_FJ19
DR   CLO; CLO_0028089
DR   Coriell; ND05678
DR   Wikidata; Q54916845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05679
AC   CVCL_ES82
DR   CLO; CLO_0028087
DR   Coriell; ND05679
DR   Wikidata; Q54916846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05680
AC   CVCL_DY78
DR   CLO; CLO_0028085
DR   Coriell; ND05680
DR   Wikidata; Q54916855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05681
AC   CVCL_ES83
DR   CLO; CLO_0028093
DR   Coriell; ND05681
DR   Wikidata; Q54916856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05682
AC   CVCL_ES84
DR   CLO; CLO_0028091
DR   Coriell; ND05682
DR   Wikidata; Q54916857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05683
AC   CVCL_IB84
DR   Coriell; ND05683
DR   Wikidata; Q54916858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05684
AC   CVCL_ES85
DR   CLO; CLO_0028092
DR   Coriell; ND05684
DR   Wikidata; Q54916859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05685
AC   CVCL_ES86
DR   CLO; CLO_0028096
DR   Coriell; ND05685
DR   Wikidata; Q54916860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05686
AC   CVCL_CG48
DR   Coriell; ND05686
DR   Wikidata; Q54916861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05687
AC   CVCL_CG49
DR   Coriell; ND05687
DR   Wikidata; Q54916862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05689
AC   CVCL_CG50
DR   Coriell; ND05689
DR   Wikidata; Q54916863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05690
AC   CVCL_CG51
DR   BioSample; SAMN00807744
DR   Coriell; ND05690
DR   Wikidata; Q54916864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05691
AC   CVCL_1Y02
SY   ND-5691
DR   BioSample; SAMN00807746
DR   Coriell; ND05691
DR   Wikidata; Q54916866
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ND05692
AC   CVCL_CG52
DR   BioSample; SAMN00807748
DR   Coriell; ND05692
DR   Wikidata; Q54916867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05705
AC   CVCL_CG53
DR   CLO; CLO_0028097
DR   BioSample; SAMN00807756
DR   Coriell; ND05705
DR   Wikidata; Q54916868
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05706
AC   CVCL_GC05
DR   CLO; CLO_0028094
DR   BioSample; SAMN00807758
DR   Coriell; ND05706
DR   Wikidata; Q54916869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05708
AC   CVCL_HU33
DR   CLO; CLO_0028095
DR   Coriell; ND05708
DR   Wikidata; Q54916870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05709
AC   CVCL_IH13
DR   CLO; CLO_0028238
DR   Coriell; ND05709
DR   Wikidata; Q54916871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05718
AC   CVCL_FJ20
DR   CLO; CLO_0028239
DR   BioSample; SAMN00807760
DR   Coriell; ND05718
DR   Wikidata; Q54916873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05719
AC   CVCL_FJ21
DR   CLO; CLO_0028240
DR   BioSample; SAMN00807762
DR   Coriell; ND05719
DR   Wikidata; Q54916874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05720
AC   CVCL_CG54
DR   CLO; CLO_0028256
DR   Coriell; ND05720
DR   Wikidata; Q54916875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05721
AC   CVCL_CG55
DR   CLO; CLO_0028255
DR   BioSample; SAMN00807764
DR   Coriell; ND05721
DR   Wikidata; Q54916876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05722
AC   CVCL_HN41
DR   CLO; CLO_0028258
DR   BioSample; SAMN00807766
DR   Coriell; ND05722
DR   Wikidata; Q54916877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05723
AC   CVCL_HN42
DR   CLO; CLO_0028257
DR   BioSample; SAMN00807768
DR   Coriell; ND05723
DR   Wikidata; Q54916878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05732
AC   CVCL_CG56
DR   Coriell; ND05732
DR   Wikidata; Q54916880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05733
AC   CVCL_CG57
DR   Coriell; ND05733
DR   Wikidata; Q54916881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05734
AC   CVCL_CG58
DR   Coriell; ND05734
DR   Wikidata; Q54916882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05736
AC   CVCL_FJ22
DR   Coriell; ND05736
DR   Wikidata; Q54916883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05742
AC   CVCL_DY79
DR   Coriell; ND05742
DR   Wikidata; Q54916884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05743
AC   CVCL_IB85
DR   Coriell; ND05743
DR   Wikidata; Q54916885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05745
AC   CVCL_CG59
DR   Coriell; ND05745
DR   Wikidata; Q54916886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05748
AC   CVCL_FX88
DR   BioSample; SAMN00807772
DR   Coriell; ND05748
DR   Wikidata; Q54916887
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND05751
AC   CVCL_HU34
DR   BioSample; SAMN00807774
DR   Coriell; ND05751
DR   Wikidata; Q54916888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05752
AC   CVCL_FX89
DR   BioSample; SAMN00807776
DR   Coriell; ND05752
DR   Wikidata; Q54916889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05753
AC   CVCL_CG60
DR   CLO; CLO_0028252
DR   Coriell; ND05753
DR   Wikidata; Q54916890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05757
AC   CVCL_DY80
DR   Coriell; ND05757
DR   Wikidata; Q54916892
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND05759
AC   CVCL_FJ23
DR   Coriell; ND05759
DR   Wikidata; Q54916893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05760
AC   CVCL_FX90
DR   BioSample; SAMN00807778
DR   Coriell; ND05760
DR   Wikidata; Q54916894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05764
AC   CVCL_ES87
DR   CLO; CLO_0028251
DR   Coriell; ND05764
DR   Wikidata; Q54916895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05765
AC   CVCL_ES88
DR   CLO; CLO_0028254
DR   Coriell; ND05765
DR   Wikidata; Q54916896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05766
AC   CVCL_1Y03
SY   ND-5766
DR   CLO; CLO_0028253
DR   Coriell; ND05766
DR   Wikidata; Q54916897
RX   PubMed=17116639;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ND05767
AC   CVCL_ES89
DR   CLO; CLO_0028217
DR   Coriell; ND05767
DR   Wikidata; Q54916898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05768
AC   CVCL_IB86
DR   Coriell; ND05768
DR   Wikidata; Q54916907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05769
AC   CVCL_ES90
DR   CLO; CLO_0028218
DR   Coriell; ND05769
DR   Wikidata; Q54916908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05770
AC   CVCL_ES91
DR   CLO; CLO_0028227
DR   Coriell; ND05770
DR   Wikidata; Q54916909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05771
AC   CVCL_ES92
DR   CLO; CLO_0028237
DR   Coriell; ND05771
DR   Wikidata; Q54916910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05772
AC   CVCL_DY81
DR   CLO; CLO_0028236
DR   Coriell; ND05772
DR   Wikidata; Q54916911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05773
AC   CVCL_ES93
DR   CLO; CLO_0028235
DR   Coriell; ND05773
DR   Wikidata; Q54916913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05774
AC   CVCL_CG61
DR   BioSample; SAMN00807780
DR   Coriell; ND05774
DR   Wikidata; Q54916914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05776
AC   CVCL_CG62
DR   Coriell; ND05776
DR   Wikidata; Q54916915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05778
AC   CVCL_CG63
DR   Coriell; ND05778
DR   Wikidata; Q54916917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05782
AC   CVCL_CG64
DR   Coriell; ND05782
DR   Wikidata; Q54916918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05783
AC   CVCL_CG65
DR   Coriell; ND05783
DR   Wikidata; Q54916919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05784
AC   CVCL_CG66
DR   Coriell; ND05784
DR   Wikidata; Q54916920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05785
AC   CVCL_CG67
DR   Coriell; ND05785
DR   Wikidata; Q54916922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05786
AC   CVCL_CG68
DR   Coriell; ND05786
DR   Wikidata; Q54916924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05790
AC   CVCL_CG69
DR   Coriell; ND05790
DR   Wikidata; Q54916925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05791
AC   CVCL_IH14
DR   CLO; CLO_0028234
DR   Coriell; ND05791
DR   Wikidata; Q54916928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05792
AC   CVCL_FX91
DR   CLO; CLO_0028233
DR   Coriell; ND05792
DR   Wikidata; Q54916929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05793
AC   CVCL_GQ18
DR   CLO; CLO_0028232
DR   Coriell; ND05793
DR   Wikidata; Q54916930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36192; Arteriovenous fistula
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05794
AC   CVCL_FJ24
DR   Coriell; ND05794
DR   Wikidata; Q54916931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05798
AC   CVCL_HU35
DR   BioSample; SAMN00807782
DR   Coriell; ND05798
DR   Wikidata; Q54916932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05799
AC   CVCL_FX92
DR   BioSample; SAMN00807784
DR   Coriell; ND05799
DR   Wikidata; Q54916933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05801
AC   CVCL_HU36
DR   BioSample; SAMN00807786
DR   Coriell; ND05801
DR   Wikidata; Q54916934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05802
AC   CVCL_ES94
DR   CLO; CLO_0028231
DR   BioSample; SAMN00807788
DR   Coriell; ND05802
DR   Wikidata; Q54916935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05803
AC   CVCL_CG70
DR   CLO; CLO_0028230
DR   BioSample; SAMN00807790
DR   Coriell; ND05803
DR   Wikidata; Q54916936
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05804
AC   CVCL_CG71
DR   Coriell; ND05804
DR   Wikidata; Q54916937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05805
AC   CVCL_ES95
DR   CLO; CLO_0028206
DR   Coriell; ND05805
DR   Wikidata; Q54916938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05806
AC   CVCL_DY82
DR   CLO; CLO_0028208
DR   Coriell; ND05806
DR   Wikidata; Q54916939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05807
AC   CVCL_ES96
DR   CLO; CLO_0028207
DR   Coriell; ND05807
DR   Wikidata; Q54916940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05808
AC   CVCL_ES97
DR   CLO; CLO_0028210
DR   Coriell; ND05808
DR   Wikidata; Q54916941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05809
AC   CVCL_ES98
DR   CLO; CLO_0028209
DR   Coriell; ND05809
DR   Wikidata; Q54916942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05815
AC   CVCL_IB87
DR   Coriell; ND05815
DR   Wikidata; Q54916943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05816
AC   CVCL_FX93
DR   BioSample; SAMN00807792
DR   Coriell; ND05816
DR   Wikidata; Q54916944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05819
AC   CVCL_FJ25
DR   BioSample; SAMN00807793
DR   Coriell; ND05819
DR   Wikidata; Q54916945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y6M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05820
AC   CVCL_CG72
DR   Coriell; ND05820
DR   Wikidata; Q54916946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05821
AC   CVCL_CG73
DR   Coriell; ND05821
DR   Wikidata; Q54916947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05822
AC   CVCL_CG74
DR   Coriell; ND05822
DR   Wikidata; Q54916948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05823
AC   CVCL_CG75
DR   Coriell; ND05823
DR   Wikidata; Q54916949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05824
AC   CVCL_CG76
DR   Coriell; ND05824
DR   Wikidata; Q54916950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05825
AC   CVCL_IL53
DR   Coriell; ND05825
DR   Wikidata; Q54916951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05826
AC   CVCL_HU37
DR   BioSample; SAMN00807795
DR   Coriell; ND05826
DR   Wikidata; Q54916952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05827
AC   CVCL_HU38
DR   BioSample; SAMN00807797
DR   Coriell; ND05827
DR   Wikidata; Q54916965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND05828
AC   CVCL_FX94
DR   BioSample; SAMN00807799
DR   Coriell; ND05828
DR   Wikidata; Q54916966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05831
AC   CVCL_FX95
DR   Coriell; ND05831
DR   Wikidata; Q54916967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05833
AC   CVCL_HU39
DR   Coriell; ND05833
DR   Wikidata; Q54916968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05834
AC   CVCL_IL54
DR   Coriell; ND05834
DR   Wikidata; Q54916969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05835
AC   CVCL_HU40
DR   Coriell; ND05835
DR   Wikidata; Q54916970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05837
AC   CVCL_FX96
DR   CLO; CLO_0028212
DR   Coriell; ND05837
DR   Wikidata; Q54916971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05839
AC   CVCL_CG77
DR   CLO; CLO_0028211
DR   Coriell; ND05839
DR   Wikidata; Q54916972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05840
AC   CVCL_CY91
DR   CLO; CLO_0028214
DR   Coriell; ND05840
DR   Wikidata; Q54916973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05841
AC   CVCL_CG78
DR   CLO; CLO_0028213
DR   Coriell; ND05841
DR   Wikidata; Q54916974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05842
AC   CVCL_CG79
DR   CLO; CLO_0028216
DR   Coriell; ND05842
DR   Wikidata; Q54916977
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05843
AC   CVCL_CG80
DR   CLO; CLO_0028215
DR   Coriell; ND05843
DR   Wikidata; Q54916978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05844
AC   CVCL_FJ26
DR   CLO; CLO_0028197
DR   Coriell; ND05844
DR   Wikidata; Q54916979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05845
AC   CVCL_HN44
DR   CLO; CLO_0028195
DR   Coriell; ND05845
DR   Wikidata; Q54916980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05849
AC   CVCL_CG81
DR   Coriell; ND05849
DR   Wikidata; Q54916981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05850
AC   CVCL_CG82
DR   Coriell; ND05850
DR   Wikidata; Q54916982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05859
AC   CVCL_FX97
DR   Coriell; ND05859
DR   Wikidata; Q54916983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05863
AC   CVCL_FX98
DR   Coriell; ND05863
DR   Wikidata; Q54916984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05864
AC   CVCL_FX99
DR   Coriell; ND05864
DR   Wikidata; Q54916986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05865
AC   CVCL_CG83
DR   CLO; CLO_0028192
DR   Coriell; ND05865
DR   Wikidata; Q54916988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05866
AC   CVCL_DY83
DR   Coriell; ND05866
DR   Wikidata; Q54916989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05867
AC   CVCL_DY84
DR   CLO; CLO_0028202
DR   Coriell; ND05867
DR   Wikidata; Q54916990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05868
AC   CVCL_ES99
DR   CLO; CLO_0028201
DR   Coriell; ND05868
DR   Wikidata; Q54916991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05869
AC   CVCL_ET00
DR   CLO; CLO_0028200
DR   Coriell; ND05869
DR   Wikidata; Q54916992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05871
AC   CVCL_DY85
DR   Coriell; ND05871
DR   Wikidata; Q54916993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05872
AC   CVCL_CG84
DR   CLO; CLO_0028199
DR   Coriell; ND05872
DR   Wikidata; Q54916994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05873
AC   CVCL_GC06
DR   CLO; CLO_0028205
DR   Coriell; ND05873
DR   Wikidata; Q54916995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05877
AC   CVCL_IB88
DR   Coriell; ND05877
DR   Wikidata; Q54916997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05878
AC   CVCL_CG85
DR   Coriell; ND05878
DR   Wikidata; Q54916998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05879
AC   CVCL_CG86
DR   Coriell; ND05879
DR   Wikidata; Q54916999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05885
AC   CVCL_IH15
DR   CLO; CLO_0028204
DR   Coriell; ND05885
DR   Wikidata; Q54917000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05886
AC   CVCL_FY00
DR   CLO; CLO_0028203
DR   Coriell; ND05886
DR   Wikidata; Q54917001
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05887
AC   CVCL_FY01
DR   CLO; CLO_0028033
DR   Coriell; ND05887
DR   Wikidata; Q54917002
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05888
AC   CVCL_CG87
DR   CLO; CLO_0028034
DR   Coriell; ND05888
DR   Wikidata; Q54917003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05895
AC   CVCL_CG88
DR   CLO; CLO_0028031
DR   Coriell; ND05895
DR   Wikidata; Q54917004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05896
AC   CVCL_CG89
DR   Coriell; ND05896
DR   Wikidata; Q54917005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05897
AC   CVCL_ET01
DR   CLO; CLO_0028032
DR   Coriell; ND05897
DR   Wikidata; Q54917006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05898
AC   CVCL_DY86
DR   CLO; CLO_0028028
DR   Coriell; ND05898
DR   Wikidata; Q54917007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05899
AC   CVCL_ET02
DR   CLO; CLO_0028029
DR   Coriell; ND05899
DR   Wikidata; Q54917009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05900
AC   CVCL_ET03
DR   CLO; CLO_0028024
DR   Coriell; ND05900
DR   Wikidata; Q54917010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05901
AC   CVCL_CG90
DR   Coriell; ND05901
DR   Wikidata; Q54917016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05902
AC   CVCL_FY02
DR   Coriell; ND05902
DR   Wikidata; Q54917018
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05903
AC   CVCL_IB89
DR   Coriell; ND05903
DR   Wikidata; Q54917019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05904
AC   CVCL_CG91
DR   CLO; CLO_0028026
DR   Coriell; ND05904
DR   Wikidata; Q54917020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05905
AC   CVCL_IL55
DR   CLO; CLO_0028022
DR   Coriell; ND05905
DR   Wikidata; Q54917021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND05905; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND05906
AC   CVCL_CG92
DR   CLO; CLO_0028023
DR   Coriell; ND05906
DR   Wikidata; Q54917022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05910
AC   CVCL_CG93
DR   Coriell; ND05910
DR   Wikidata; Q54917023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05916
AC   CVCL_FY03
DR   Coriell; ND05916
DR   Wikidata; Q54917024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05918
AC   CVCL_FY04
DR   Coriell; ND05918
DR   Wikidata; Q54917025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05919
AC   CVCL_FY05
DR   Coriell; ND05919
DR   Wikidata; Q54917026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05921
AC   CVCL_CG94
DR   CLO; CLO_0028372
DR   Coriell; ND05921
DR   Wikidata; Q54917027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05922
AC   CVCL_CG95
DR   CLO; CLO_0028371
DR   Coriell; ND05922
DR   Wikidata; Q54917029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05923
AC   CVCL_CG96
DR   CLO; CLO_0028321
DR   Coriell; ND05923
DR   Wikidata; Q54917030
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05924
AC   CVCL_CG97
DR   CLO; CLO_0028323
DR   Coriell; ND05924
DR   Wikidata; Q54917031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05925
AC   CVCL_FJ27
DR   CLO; CLO_0028319
DR   Coriell; ND05925
DR   Wikidata; Q54917032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05926
AC   CVCL_HN45
DR   CLO; CLO_0028320
DR   Coriell; ND05926
DR   Wikidata; Q54917033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05927
AC   CVCL_HP48
DR   CLO; CLO_0028317
DR   Coriell; ND05927
DR   Wikidata; Q54917034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05928
AC   CVCL_CG98
DR   Coriell; ND05928
DR   Wikidata; Q54917035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05929
AC   CVCL_CG99
DR   Coriell; ND05929
DR   Wikidata; Q54917037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05930
AC   CVCL_CH00
DR   Coriell; ND05930
DR   Wikidata; Q54917038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05931
AC   CVCL_CH01
DR   BioSample; SAMN00807841
DR   Coriell; ND05931
DR   Wikidata; Q54917039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05935
AC   CVCL_FY06
DR   Coriell; ND05935
DR   Wikidata; Q54917040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05938
AC   CVCL_FY07
DR   CLO; CLO_0028318
DR   Coriell; ND05938
DR   Wikidata; Q54917041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05939
AC   CVCL_FY08
DR   CLO; CLO_0028315
DR   Coriell; ND05939
DR   Wikidata; Q54917042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05940
AC   CVCL_FY09
DR   CLO; CLO_0028316
DR   Coriell; ND05940
DR   Wikidata; Q54917043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05941
AC   CVCL_IH16
DR   CLO; CLO_0028314
DR   Coriell; ND05941
DR   Wikidata; Q54917044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05942
AC   CVCL_FJ28
DR   Coriell; ND05942
DR   Wikidata; Q54917045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05943
AC   CVCL_FJ29
DR   CLO; CLO_0028313
DR   Coriell; ND05943
DR   Wikidata; Q54917046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05944
AC   CVCL_FJ30
DR   CLO; CLO_0028312
DR   Coriell; ND05944
DR   Wikidata; Q54917048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05945
AC   CVCL_FJ31
DR   CLO; CLO_0028349
DR   Coriell; ND05945
DR   Wikidata; Q54917049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05946
AC   CVCL_FJ32
DR   CLO; CLO_0028350
DR   Coriell; ND05946
DR   Wikidata; Q54917050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05947
AC   CVCL_FJ33
DR   CLO; CLO_0028351
DR   Coriell; ND05947
DR   Wikidata; Q54917051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05948
AC   CVCL_CH02
DR   CLO; CLO_0028352
DR   BioSample; SAMN00807845
DR   Coriell; ND05948
DR   Wikidata; Q54917052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05950
AC   CVCL_CH03
DR   CLO; CLO_0028346
DR   BioSample; SAMN00807847
DR   Coriell; ND05950
DR   Wikidata; Q54917053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05951
AC   CVCL_ET04
DR   CLO; CLO_0028347
DR   BioSample; SAMN00807849
DR   Coriell; ND05951
DR   Wikidata; Q54917055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05952
AC   CVCL_CH04
DR   CLO; CLO_0028348
DR   Coriell; ND05952
DR   Wikidata; Q54917056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05954
AC   CVCL_IB90
DR   Coriell; ND05954
DR   Wikidata; Q54917057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05955
AC   CVCL_IB91
DR   Coriell; ND05955
DR   Wikidata; Q54917058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05956
AC   CVCL_CH05
DR   Coriell; ND05956
DR   Wikidata; Q54917059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05957
AC   CVCL_CH06
DR   Coriell; ND05957
DR   Wikidata; Q54917060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05958
AC   CVCL_CH07
DR   BioSample; SAMN00807851
DR   Coriell; ND05958
DR   Wikidata; Q54917073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05959
AC   CVCL_CH08
DR   Coriell; ND05959
DR   Wikidata; Q54917074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05967
AC   CVCL_FJ34
DR   Coriell; ND05967
DR   Wikidata; Q54917075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05970
AC   CVCL_FJ35
DR   Coriell; ND05970
DR   Wikidata; Q54917076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05971
AC   CVCL_CH09
DR   CLO; CLO_0028343
DR   Coriell; ND05971
DR   Wikidata; Q54917077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05972
AC   CVCL_CH10
DR   CLO; CLO_0028342
DR   Coriell; ND05972
DR   Wikidata; Q54917078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05973
AC   CVCL_CH11
DR   CLO; CLO_0028345
DR   Coriell; ND05973
DR   Wikidata; Q54917079
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05974
AC   CVCL_CH12
DR   CLO; CLO_0028344
DR   Coriell; ND05974
DR   Wikidata; Q54917080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05975
AC   CVCL_CH13
DR   CLO; CLO_0028590
DR   Coriell; ND05975
DR   Wikidata; Q54917081
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05976
AC   CVCL_CH14
DR   CLO; CLO_0028591
DR   BioSample; SAMN00807859
DR   Coriell; ND05976
DR   Wikidata; Q54917082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05977
AC   CVCL_ET05
DR   CLO; CLO_0028593
DR   BioSample; SAMN00807861
DR   Coriell; ND05977
DR   Wikidata; Q54917083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05978
AC   CVCL_DY87
DR   CLO; CLO_0028594
DR   Coriell; ND05978
DR   Wikidata; Q54917084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05979
AC   CVCL_DY88
DR   CLO; CLO_0028585
DR   Coriell; ND05979
DR   Wikidata; Q54917085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05980
AC   CVCL_DY89
DR   CLO; CLO_0028586
DR   Coriell; ND05980
DR   Wikidata; Q54917086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05981
AC   CVCL_ET06
DR   CLO; CLO_0028581
DR   Coriell; ND05981
DR   Wikidata; Q54917087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05982
AC   CVCL_DY90
DR   CLO; CLO_0028572
DR   Coriell; ND05982
DR   Wikidata; Q54917088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05983
AC   CVCL_DY91
DR   CLO; CLO_0028571
DR   Coriell; ND05983
DR   Wikidata; Q54917089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND05984
AC   CVCL_HU41
DR   CLO; CLO_0028576
DR   Coriell; ND05984
DR   Wikidata; Q54917090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND05985
AC   CVCL_FY10
DR   CLO; CLO_0028574
DR   Coriell; ND05985
DR   Wikidata; Q54917091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05986
AC   CVCL_FY11
DR   CLO; CLO_0028625
DR   Coriell; ND05986
DR   Wikidata; Q54917092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND05994
AC   CVCL_CH15
DR   CLO; CLO_0028626
DR   BioSample; SAMN00807863
DR   Coriell; ND05994
DR   Wikidata; Q54917093
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND05995
AC   CVCL_ET07
DR   CLO; CLO_0028621
DR   BioSample; SAMN00807865
DR   Coriell; ND05995
DR   Wikidata; Q54917094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05996
AC   CVCL_CH16
DR   CLO; CLO_0028623
DR   Coriell; ND05996
DR   Wikidata; Q54917095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND05997
AC   CVCL_ET08
DR   CLO; CLO_0028617
DR   BioSample; SAMN00807867
DR   Coriell; ND05997
DR   Wikidata; Q54917097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND05998
AC   CVCL_CH17
DR   CLO; CLO_0028612
DR   BioSample; SAMN00807869
DR   Coriell; ND05998
DR   Wikidata; Q54917099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND05999
AC   CVCL_IL56
DR   Coriell; ND05999
DR   Wikidata; Q54917100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06002
AC   CVCL_FJ36
DR   Coriell; ND06002
DR   Wikidata; Q54917101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06003
AC   CVCL_FJ37
DR   Coriell; ND06003
DR   Wikidata; Q54917102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06006
AC   CVCL_FY12
DR   Coriell; ND06006
DR   Wikidata; Q54917104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06008
AC   CVCL_ET09
DR   CLO; CLO_0028610
DR   BioSample; SAMN00807875
DR   Coriell; ND06008
DR   Wikidata; Q54917105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06009
AC   CVCL_CH18
DR   CLO; CLO_0028608
DR   BioSample; SAMN00807877
DR   Coriell; ND06009
DR   Wikidata; Q54917106
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06010
AC   CVCL_ET10
DR   CLO; CLO_0028607
DR   BioSample; SAMN00807879
DR   Coriell; ND06010
DR   Wikidata; Q54917108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06012
AC   CVCL_CH19
DR   CLO; CLO_0028605
DR   Coriell; ND06012
DR   Wikidata; Q54917109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06013
AC   CVCL_CH20
DR   Coriell; ND06013
DR   Wikidata; Q54917110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06014
AC   CVCL_CH21
DR   Coriell; ND06014
DR   Wikidata; Q54917111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06015
AC   CVCL_CH22
DR   Coriell; ND06015
DR   Wikidata; Q54917113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06020
AC   CVCL_CH23
DR   CLO; CLO_0028603
DR   Coriell; ND06020
DR   Wikidata; Q54917114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06021
AC   CVCL_ET11
DR   CLO; CLO_0028650
DR   Coriell; ND06021
DR   Wikidata; Q54917115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06022
AC   CVCL_ET12
DR   CLO; CLO_0028651
DR   Coriell; ND06022
DR   Wikidata; Q54917117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06023
AC   CVCL_DY92
DR   CLO; CLO_0028652
DR   Coriell; ND06023
DR   Wikidata; Q54917118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06024
AC   CVCL_DY93
DR   CLO; CLO_0028653
DR   Coriell; ND06024
DR   Wikidata; Q54917121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06025
AC   CVCL_CH24
DR   CLO; CLO_0028631
DR   BioSample; SAMN00807881
DR   Coriell; ND06025
DR   Wikidata; Q54917122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06026
AC   CVCL_ET13
DR   CLO; CLO_0028637
DR   BioSample; SAMN00807883
DR   Coriell; ND06026
DR   Wikidata; Q54917124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06028
AC   CVCL_CH25
DR   Coriell; ND06028
DR   Wikidata; Q54917125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06029
AC   CVCL_CH26
DR   Coriell; ND06029
DR   Wikidata; Q54917126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06030
AC   CVCL_CH27
DR   Coriell; ND06030
DR   Wikidata; Q54917127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06033
AC   CVCL_FJ38
DR   Coriell; ND06033
DR   Wikidata; Q54917128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06041
AC   CVCL_IL57
DR   Coriell; ND06041
DR   Wikidata; Q54917129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06044
AC   CVCL_FY13
DR   Coriell; ND06044
DR   Wikidata; Q54917130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06046
AC   CVCL_HU42
DR   Coriell; ND06046
DR   Wikidata; Q54917131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06047
AC   CVCL_FJ39
DR   CLO; CLO_0028635
DR   Coriell; ND06047
DR   Wikidata; Q54917132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06048
AC   CVCL_IB92
DR   CLO; CLO_0028643
DR   Coriell; ND06048
DR   Wikidata; Q54917133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06049
AC   CVCL_FJ40
DR   CLO; CLO_0028642
DR   Coriell; ND06049
DR   Wikidata; Q54917134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06050
AC   CVCL_HY53
DR   CLO; CLO_0028649
DR   Coriell; ND06050
DR   Wikidata; Q54917135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06051
AC   CVCL_HY54
DR   CLO; CLO_0028647
DR   Coriell; ND06051
DR   Wikidata; Q54917136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06052
AC   CVCL_FJ41
DR   CLO; CLO_0028683
DR   Coriell; ND06052
DR   Wikidata; Q54917137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06053
AC   CVCL_IB93
DR   CLO; CLO_0028684
DR   Coriell; ND06053
DR   Wikidata; Q54917138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06054
AC   CVCL_FJ42
DR   CLO; CLO_0028682
DR   Coriell; ND06054
DR   Wikidata; Q54917139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06055
AC   CVCL_IB94
DR   Coriell; ND06055
DR   Wikidata; Q54917141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06056
AC   CVCL_IB95
DR   CLO; CLO_0028670
DR   Coriell; ND06056
DR   Wikidata; Q54917142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06057
AC   CVCL_CH28
DR   CLO; CLO_0028668
DR   Coriell; ND06057
DR   Wikidata; Q54917143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06058
AC   CVCL_EH43
DR   CLO; CLO_0028666
DR   Coriell; ND06058
DR   Wikidata; Q54917144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06059
AC   CVCL_EH44
DR   CLO; CLO_0028662
DR   Coriell; ND06059
DR   Wikidata; Q54917145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06060
AC   CVCL_FY14
DR   CLO; CLO_0028680
DR   Coriell; ND06060
DR   Wikidata; Q54917147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06070
AC   CVCL_CH29
DR   Coriell; ND06070
DR   Wikidata; Q54917148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06071
AC   CVCL_CH30
DR   Coriell; ND06071
DR   Wikidata; Q54917149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06072
AC   CVCL_CH31
DR   Coriell; ND06072
DR   Wikidata; Q54917150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06076
AC   CVCL_AB70
DR   CLO; CLO_0028677
DR   Coriell; ND06076
DR   Wikidata; Q54917151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND06077
AC   CVCL_FC32
DR   CLO; CLO_0028674
DR   BioSample; SAMN00807913
DR   Coriell; ND06077
DR   Wikidata; Q54917152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06078
AC   CVCL_CH32
DR   CLO; CLO_0028673
DR   Coriell; ND06078
DR   Wikidata; Q54917153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06079
AC   CVCL_DY94
DR   CLO; CLO_0028503
DR   Coriell; ND06079
DR   Wikidata; Q54917154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06080
AC   CVCL_ET14
DR   CLO; CLO_0028502
DR   Coriell; ND06080
DR   Wikidata; Q54917155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06081
AC   CVCL_FC33
DR   CLO; CLO_0028497
DR   Coriell; ND06081
DR   Wikidata; Q54917156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06082
AC   CVCL_DY95
DR   CLO; CLO_0028485
DR   Coriell; ND06082
DR   Wikidata; Q54917157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06083
AC   CVCL_CH33
DR   CLO; CLO_0028490
DR   Coriell; ND06083
DR   Wikidata; Q54917159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06084
AC   CVCL_CH34
DR   CLO; CLO_0028491
DR   Coriell; ND06084
DR   Wikidata; Q54917160
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06085
AC   CVCL_CH35
DR   CLO; CLO_0028494
DR   BioSample; SAMN00807915
DR   Coriell; ND06085
DR   Wikidata; Q54917161
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06086
AC   CVCL_CH36
DR   CLO; CLO_0028474
DR   Coriell; ND06086
DR   Wikidata; Q54917162
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06087
AC   CVCL_FJ43
DR   CLO; CLO_0028477
DR   Coriell; ND06087
DR   Wikidata; Q54917163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06088
AC   CVCL_HP81
DR   CLO; CLO_0028479
DR   Coriell; ND06088
DR   Wikidata; Q54917164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06092
AC   CVCL_CH37
DR   Coriell; ND06092
DR   Wikidata; Q54917170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06093
AC   CVCL_CH38
DR   Coriell; ND06093
DR   Wikidata; Q54917171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06094
AC   CVCL_CH39
DR   Coriell; ND06094
DR   Wikidata; Q54917172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06095
AC   CVCL_CH40
DR   Coriell; ND06095
DR   Wikidata; Q54917173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06096
AC   CVCL_CH41
DR   Coriell; ND06096
DR   Wikidata; Q54917174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06097
AC   CVCL_CH42
DR   Coriell; ND06097
DR   Wikidata; Q54917175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06100
AC   CVCL_HU43
DR   Coriell; ND06100
DR   Wikidata; Q54917176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06103
AC   CVCL_IB96
DR   Coriell; ND06103
DR   Wikidata; Q54917177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06104
AC   CVCL_IB97
DR   Coriell; ND06104
DR   Wikidata; Q54917178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06105
AC   CVCL_CH43
DR   CLO; CLO_0028482
DR   Coriell; ND06105
DR   Wikidata; Q54917180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06106
AC   CVCL_CH44
DR   CLO; CLO_0028534
DR   Coriell; ND06106
DR   Wikidata; Q54917181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06107
AC   CVCL_FY15
DR   CLO; CLO_0028527
DR   Coriell; ND06107
DR   Wikidata; Q54917182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06108
AC   CVCL_CH45
DR   CLO; CLO_0028528
DR   Coriell; ND06108
DR   Wikidata; Q54917184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06135
AC   CVCL_IL58
DR   Coriell; ND06135
DR   Wikidata; Q54917185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06136
AC   CVCL_HU44
DR   Coriell; ND06136
DR   Wikidata; Q54917186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06140
AC   CVCL_GC07
DR   CLO; CLO_0028521
DR   Coriell; ND06140
DR   Wikidata; Q54917187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06141
AC   CVCL_GC08
DR   CLO; CLO_0028525
DR   Coriell; ND06141
DR   Wikidata; Q54917188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06142
AC   CVCL_CH46
DR   CLO; CLO_0028516
DR   Coriell; ND06142
DR   Wikidata; Q54917189
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06143
AC   CVCL_ET15
DR   CLO; CLO_0028520
DR   Coriell; ND06143
DR   Wikidata; Q54917190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06144
AC   CVCL_DY96
DR   CLO; CLO_0028510
DR   Coriell; ND06144
DR   Wikidata; Q54917191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06148
AC   CVCL_CH47
DR   Coriell; ND06148
DR   Wikidata; Q54917192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06149
AC   CVCL_CH48
DR   Coriell; ND06149
DR   Wikidata; Q54917193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06150
AC   CVCL_CH49
DR   Coriell; ND06150
DR   Wikidata; Q54917194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06151
AC   CVCL_CH50
DR   Coriell; ND06151
DR   Wikidata; Q54917196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06152
AC   CVCL_CH51
DR   Coriell; ND06152
DR   Wikidata; Q54917197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06153
AC   CVCL_CH52
DR   Coriell; ND06153
DR   Wikidata; Q54917198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06154
AC   CVCL_CH53
DR   BioSample; SAMN00807931
DR   Coriell; ND06154
DR   Wikidata; Q54917199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06157
AC   CVCL_HU45
DR   Coriell; ND06157
DR   Wikidata; Q54917200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06159
AC   CVCL_FY16
DR   Coriell; ND06159
DR   Wikidata; Q54917201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06160
AC   CVCL_HU46
DR   Coriell; ND06160
DR   Wikidata; Q54917202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06161
AC   CVCL_FY17
DR   Coriell; ND06161
DR   Wikidata; Q54917203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06163
AC   CVCL_FY18
DR   Coriell; ND06163
DR   Wikidata; Q54917204
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06164
AC   CVCL_CH54
DR   CLO; CLO_0028513
DR   Coriell; ND06164
DR   Wikidata; Q54917205
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06165
AC   CVCL_CH55
DR   CLO; CLO_0028505
DR   BioSample; SAMN00807943
DR   Coriell; ND06165
DR   Wikidata; Q54917206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06166
AC   CVCL_GC09
DR   CLO; CLO_0028508
DR   BioSample; SAMN00807945
DR   Coriell; ND06166
DR   Wikidata; Q54917207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06167
AC   CVCL_FJ44
DR   CLO; CLO_0028552
DR   Coriell; ND06167
DR   Wikidata; Q54917209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06168
AC   CVCL_HY55
DR   CLO; CLO_0028553
DR   Coriell; ND06168
DR   Wikidata; Q54917210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06169
AC   CVCL_HY56
DR   CLO; CLO_0028554
DR   Coriell; ND06169
DR   Wikidata; Q54917211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06170
AC   CVCL_BA30
DR   CLO; CLO_0028535
DR   Coriell; ND06170
DR   Wikidata; Q54917212
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06171
AC   CVCL_BA31
DR   CLO; CLO_0028537
DR   Coriell; ND06171
DR   Wikidata; Q54917213
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06173
AC   CVCL_BA32
DR   CLO; CLO_0028540
DR   Coriell; ND06173
DR   Wikidata; Q54917222
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06174
AC   CVCL_BA33
DR   CLO; CLO_0028542
DR   Coriell; ND06174
DR   Wikidata; Q54917223
CC   Population: Pacific; Hawaiian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06175
AC   CVCL_BA34
DR   CLO; CLO_0028543
DR   Coriell; ND06175
DR   Wikidata; Q54917224
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06176
AC   CVCL_BA35
DR   CLO; CLO_0028545
DR   Coriell; ND06176
DR   Wikidata; Q54917225
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06177
AC   CVCL_BA36
DR   CLO; CLO_0028548
DR   Coriell; ND06177
DR   Wikidata; Q54917226
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06178
AC   CVCL_BA37
DR   CLO; CLO_0029153
DR   Coriell; ND06178
DR   Wikidata; Q54917227
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06179
AC   CVCL_BA38
DR   CLO; CLO_0029054
DR   Coriell; ND06179
DR   Wikidata; Q54917228
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BL06 ! ND12547
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06180
AC   CVCL_BA39
DR   CLO; CLO_0029053
DR   Coriell; ND06180
DR   Wikidata; Q54917229
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06181
AC   CVCL_BA40
DR   CLO; CLO_0029052
DR   Coriell; ND06181
DR   Wikidata; Q54917230
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06182
AC   CVCL_BA41
DR   CLO; CLO_0029051
DR   Coriell; ND06182
DR   Wikidata; Q54917231
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06183
AC   CVCL_BA42
DR   CLO; CLO_0029058
DR   Coriell; ND06183
DR   Wikidata; Q54917232
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06184
AC   CVCL_BA43
DR   CLO; CLO_0029057
DR   Coriell; ND06184
DR   Wikidata; Q54917233
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06185
AC   CVCL_BA44
DR   CLO; CLO_0029056
DR   Coriell; ND06185
DR   Wikidata; Q54917234
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06186
AC   CVCL_BA45
DR   CLO; CLO_0029055
DR   Coriell; ND06186
DR   Wikidata; Q54917235
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06187
AC   CVCL_BA46
DR   CLO; CLO_0029049
DR   Coriell; ND06187
DR   Wikidata; Q54917236
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06189
AC   CVCL_BA47
DR   CLO; CLO_0029060
DR   Coriell; ND06189
DR   Wikidata; Q54917237
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06190
AC   CVCL_BA48
DR   CLO; CLO_0029061
DR   Coriell; ND06190
DR   Wikidata; Q54917238
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06191
AC   CVCL_BA49
DR   CLO; CLO_0029030
DR   Coriell; ND06191
DR   Wikidata; Q54917239
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06192
AC   CVCL_BA50
DR   CLO; CLO_0029029
DR   Coriell; ND06192
DR   Wikidata; Q54917240
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06199
AC   CVCL_CH56
DR   Coriell; ND06199
DR   Wikidata; Q54917241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06200
AC   CVCL_CH57
DR   Coriell; ND06200
DR   Wikidata; Q54917242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06209
AC   CVCL_HU47
DR   Coriell; ND06209
DR   Wikidata; Q54917243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06211
AC   CVCL_FJ45
DR   CLO; CLO_0029032
DR   Coriell; ND06211
DR   Wikidata; Q54917244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06212
AC   CVCL_IB98
DR   CLO; CLO_0029031
DR   Coriell; ND06212
DR   Wikidata; Q54917246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06217
AC   CVCL_CH58
DR   Coriell; ND06217
DR   Wikidata; Q54917247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06220
AC   CVCL_HU48
DR   Coriell; ND06220
DR   Wikidata; Q54917248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06227
AC   CVCL_DY97
DR   CLO; CLO_0029034
DR   Coriell; ND06227
DR   Wikidata; Q54917249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06228
AC   CVCL_ET16
DR   CLO; CLO_0029033
DR   Coriell; ND06228
DR   Wikidata; Q54917250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06229
AC   CVCL_ET17
SY   ND 06229
DR   CLO; CLO_0029036
DR   Coriell; ND06229
DR   GEO; GSM505618
DR   Wikidata; Q54917251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND06230
AC   CVCL_DY98
DR   CLO; CLO_0029035
DR   Coriell; ND06230
DR   Wikidata; Q54917252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06231
AC   CVCL_DY99
DR   CLO; CLO_0029037
DR   Coriell; ND06231
DR   Wikidata; Q54917253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06232
AC   CVCL_ET18
DR   CLO; CLO_0029038
DR   Coriell; ND06232
DR   Wikidata; Q54917254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06233
AC   CVCL_ET19
DR   CLO; CLO_0029039
DR   Coriell; ND06233
DR   Wikidata; Q54917255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06234
AC   CVCL_ET20
DR   CLO; CLO_0029098
DR   Coriell; ND06234
DR   Wikidata; Q54917256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06235
AC   CVCL_ET21
DR   CLO; CLO_0029097
DR   Coriell; ND06235
DR   Wikidata; Q54917257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06240
AC   CVCL_IB99
DR   Coriell; ND06240
DR   Wikidata; Q54917258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06241
AC   CVCL_FY19
DR   CLO; CLO_0029096
DR   Coriell; ND06241
DR   Wikidata; Q54917259
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06242
AC   CVCL_ET22
DR   CLO; CLO_0029095
DR   Coriell; ND06242
DR   Wikidata; Q54917260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06243
AC   CVCL_CH59
DR   CLO; CLO_0029094
DR   BioSample; SAMN00807961
DR   Coriell; ND06243
DR   Wikidata; Q54917261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06244
AC   CVCL_ET23
DR   CLO; CLO_0029093
DR   BioSample; SAMN00807963
DR   Coriell; ND06244
DR   Wikidata; Q54917262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06245
AC   CVCL_CH60
DR   CLO; CLO_0029092
DR   Coriell; ND06245
DR   Wikidata; Q54917271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06246
AC   CVCL_CH61
DR   CLO; CLO_0029103
DR   BioSample; SAMN00807965
DR   Coriell; ND06246
DR   Wikidata; Q54917272
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06247
AC   CVCL_GC10
DR   CLO; CLO_0029105
DR   BioSample; SAMN00807967
DR   Coriell; ND06247
DR   Wikidata; Q54917273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06255
AC   CVCL_CH62
DR   CLO; CLO_0029099
DR   Coriell; ND06255
DR   Wikidata; Q54917274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06256
AC   CVCL_ET24
DR   CLO; CLO_0029101
DR   Coriell; ND06256
DR   Wikidata; Q54917275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06257
AC   CVCL_DZ00
DR   CLO; CLO_0029074
DR   Coriell; ND06257
DR   Wikidata; Q54917276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06258
AC   CVCL_ET25
DR   CLO; CLO_0029073
DR   Coriell; ND06258
DR   Wikidata; Q54917277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06259
AC   CVCL_ET26
DR   CLO; CLO_0029076
DR   Coriell; ND06259
DR   Wikidata; Q54917279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06260
AC   CVCL_ET27
DR   CLO; CLO_0029075
DR   Coriell; ND06260
DR   Wikidata; Q54917280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06261
AC   CVCL_ET28
DR   CLO; CLO_0029072
DR   Coriell; ND06261
DR   Wikidata; Q54917281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06263
AC   CVCL_DZ01
DR   Coriell; ND06263
DR   Wikidata; Q54917282
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06265
AC   CVCL_DZ02
DR   Coriell; ND06265
DR   Wikidata; Q54917283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06266
AC   CVCL_LL45
DR   Coriell; ND06266
DR   Wikidata; Q54917284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90-94Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND06269
AC   CVCL_FJ46
DR   Coriell; ND06269
DR   Wikidata; Q54917285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06274
AC   CVCL_DZ04
DR   CLO; CLO_0029071
DR   Coriell; ND06274
DR   Wikidata; Q54917286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06275
AC   CVCL_CH63
DR   CLO; CLO_0029083
DR   Coriell; ND06275
DR   Wikidata; Q54917287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06276
AC   CVCL_CH64
DR   CLO; CLO_0029077
DR   Coriell; ND06276
DR   Wikidata; Q54917288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06277
AC   CVCL_CH65
DR   CLO; CLO_0029078
DR   Coriell; ND06277
DR   Wikidata; Q54917290
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06278
AC   CVCL_CH66
DR   CLO; CLO_0029079
DR   Coriell; ND06278
DR   Wikidata; Q54917291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06284
AC   CVCL_CH67
DR   BioSample; SAMN00807969
DR   Coriell; ND06284
DR   Wikidata; Q54917292
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (from autologous cell line ND30171).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Heterozygous (from autologous cell line ND30171).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD47 ! ND30171
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   ND06285
AC   CVCL_CH68
DR   Coriell; ND06285
DR   Wikidata; Q54917293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06288
AC   CVCL_HU49
DR   Coriell; ND06288
DR   Wikidata; Q54917294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06289
AC   CVCL_HU50
DR   Coriell; ND06289
DR   Wikidata; Q54917295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06290
AC   CVCL_HU51
DR   Coriell; ND06290
DR   Wikidata; Q54917296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06291
AC   CVCL_CH69
DR   CLO; CLO_0029082
DR   Coriell; ND06291
DR   Wikidata; Q54917297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06292
AC   CVCL_CH70
DR   CLO; CLO_0029333
DR   Coriell; ND06292
DR   Wikidata; Q54917298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06293
AC   CVCL_CH71
DR   CLO; CLO_0029334
DR   BioSample; SAMN00807977
DR   Coriell; ND06293
DR   Wikidata; Q54917299
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06294
AC   CVCL_ET29
DR   CLO; CLO_0029335
DR   BioSample; SAMN00807979
DR   Coriell; ND06294
DR   Wikidata; Q54917300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06295
AC   CVCL_CH72
DR   CLO; CLO_0029337
DR   Coriell; ND06295
DR   Wikidata; Q54917302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06296
AC   CVCL_CH73
DR   CLO; CLO_0029329
DR   Coriell; ND06296
DR   Wikidata; Q54917304
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06297
AC   CVCL_IH17
DR   CLO; CLO_0029321
DR   Coriell; ND06297
DR   Wikidata; Q54917305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06298
AC   CVCL_HQ83
DR   CLO; CLO_0029318
DR   Coriell; ND06298
DR   Wikidata; Q54917306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06299
AC   CVCL_HQ84
DR   CLO; CLO_0029310
DR   Coriell; ND06299
DR   Wikidata; Q54917307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06300
AC   CVCL_IH18
DR   CLO; CLO_0029307
DR   Coriell; ND06300
DR   Wikidata; Q54917308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06301
AC   CVCL_CH74
DR   CLO; CLO_0029314
DR   BioSample; SAMN00807981
DR   Coriell; ND06301
DR   Wikidata; Q54917309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06302
AC   CVCL_GC11
DR   CLO; CLO_0029312
DR   BioSample; SAMN00807983
DR   Coriell; ND06302
DR   Wikidata; Q54917310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06303
AC   CVCL_FJ47
DR   CLO; CLO_0029367
DR   Coriell; ND06303
DR   Wikidata; Q54917311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06310
AC   CVCL_CH75
DR   Coriell; ND06310
DR   Wikidata; Q54917312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06311
AC   CVCL_CH76
DR   Coriell; ND06311
DR   Wikidata; Q54917313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06328
AC   CVCL_CH77
DR   CLO; CLO_0029368
DR   Coriell; ND06328
DR   Wikidata; Q54917314
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06329
AC   CVCL_ET30
DR   CLO; CLO_0029363
DR   Coriell; ND06329
DR   Wikidata; Q54917318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06330
AC   CVCL_CH78
DR   CLO; CLO_0029365
DR   Coriell; ND06330
DR   Wikidata; Q54917319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06332
AC   CVCL_CH79
DR   Coriell; ND06332
DR   Wikidata; Q54917320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06339
AC   CVCL_HQ85
DR   CLO; CLO_0029350
DR   Coriell; ND06339
DR   Wikidata; Q54917321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06340
AC   CVCL_HQ86
DR   CLO; CLO_0029348
DR   Coriell; ND06340
DR   Wikidata; Q54917322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06341
AC   CVCL_HU52
DR   CLO; CLO_0029345
DR   Coriell; ND06341
DR   Wikidata; Q54917323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06342
AC   CVCL_CH80
DR   CLO; CLO_0029344
DR   Coriell; ND06342
DR   Wikidata; Q54917324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06343
AC   CVCL_EH45
DR   CLO; CLO_0029342
DR   Coriell; ND06343
DR   Wikidata; Q54917325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06344
AC   CVCL_CH81
DR   CLO; CLO_0029341
DR   Coriell; ND06344
DR   Wikidata; Q54917326
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06345
AC   CVCL_IC00
DR   Coriell; ND06345
DR   Wikidata; Q54917327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06346
AC   CVCL_ET31
DR   CLO; CLO_0029339
DR   Coriell; ND06346
DR   Wikidata; Q54917328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06347
AC   CVCL_ET32
DR   CLO; CLO_0029270
DR   Coriell; ND06347
DR   Wikidata; Q54917329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06348
AC   CVCL_ET33
DR   CLO; CLO_0029271
DR   Coriell; ND06348
DR   Wikidata; Q54917330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06349
AC   CVCL_ET34
DR   CLO; CLO_0029272
DR   Coriell; ND06349
DR   Wikidata; Q54917332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06350
AC   CVCL_ET35
DR   CLO; CLO_0029247
DR   Coriell; ND06350
DR   Wikidata; Q54917333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06351
AC   CVCL_ET36
DR   CLO; CLO_0029245
DR   Coriell; ND06351
DR   Wikidata; Q54917334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06352
AC   CVCL_DZ05
DR   CLO; CLO_0029254
DR   Coriell; ND06352
DR   Wikidata; Q54917335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06354
AC   CVCL_IC01
DR   Coriell; ND06354
DR   Wikidata; Q54917336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06355
AC   CVCL_EH46
DR   CLO; CLO_0029251
DR   Coriell; ND06355
DR   Wikidata; Q54917338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06356
AC   CVCL_ET37
DR   CLO; CLO_0029260
DR   BioSample; SAMN00807993
DR   Coriell; ND06356
DR   Wikidata; Q54917339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06357
AC   CVCL_AB71
DR   CLO; CLO_0029257
DR   Coriell; ND06357
DR   Wikidata; Q54917340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND06358
AC   CVCL_ET38
DR   CLO; CLO_0029265
DR   Coriell; ND06358
DR   Wikidata; Q54917341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06359
AC   CVCL_CH82
DR   CLO; CLO_0029262
DR   Coriell; ND06359
DR   Wikidata; Q54917342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06360
AC   CVCL_CH83
DR   CLO; CLO_0029301
DR   Coriell; ND06360
DR   Wikidata; Q54917343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06361
AC   CVCL_CH84
DR   CLO; CLO_0029302
DR   BioSample; SAMN00807995
DR   Coriell; ND06361
DR   Wikidata; Q54917344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06362
AC   CVCL_ET39
DR   CLO; CLO_0029299
DR   BioSample; SAMN00807997
DR   Coriell; ND06362
DR   Wikidata; Q54917345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06363
AC   CVCL_CH85
DR   BioSample; SAMN00807999
DR   Coriell; ND06363
DR   Wikidata; Q54917346
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (Coriell=ND06363).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD49 ! ND31618
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   ND06364
AC   CVCL_IC02
DR   BioSample; SAMN00808001
DR   Coriell; ND06364
DR   Wikidata; Q54917347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06365
AC   CVCL_IC03
DR   BioSample; SAMN00808003
DR   Coriell; ND06365
DR   Wikidata; Q54917348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06366
AC   CVCL_IC04
DR   BioSample; SAMN00808005
DR   Coriell; ND06366
DR   Wikidata; Q54917349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06370
AC   CVCL_DZ06
DR   Coriell; ND06370
DR   Wikidata; Q54917350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06371
AC   CVCL_CH86
DR   CLO; CLO_0029283
DR   Coriell; ND06371
DR   Wikidata; Q54917351
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06374
AC   CVCL_ET40
DR   CLO; CLO_0029281
DR   Coriell; ND06374
DR   Wikidata; Q54917352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06375
AC   CVCL_IC05
DR   Coriell; ND06375
DR   Wikidata; Q54917353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06376
AC   CVCL_FC34
DR   CLO; CLO_0029278
DR   Coriell; ND06376
DR   Wikidata; Q54917354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06377
AC   CVCL_ET41
DR   CLO; CLO_0029277
DR   Coriell; ND06377
DR   Wikidata; Q54917356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06378
AC   CVCL_ET42
DR   CLO; CLO_0029293
DR   Coriell; ND06378
DR   Wikidata; Q54917357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06379
AC   CVCL_FC35
DR   CLO; CLO_0029290
DR   Coriell; ND06379
DR   Wikidata; Q54917358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06380
AC   CVCL_ET43
DR   CLO; CLO_0029287
DR   Coriell; ND06380
DR   Wikidata; Q54917359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06381
AC   CVCL_ET44
DR   CLO; CLO_0029286
DR   Coriell; ND06381
DR   Wikidata; Q54917360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06382
AC   CVCL_ET45
DR   CLO; CLO_0029214
DR   Coriell; ND06382
DR   Wikidata; Q54917372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06383
AC   CVCL_CH87
DR   BioSample; SAMN00808007
DR   Coriell; ND06383
DR   Wikidata; Q54917373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06384
AC   CVCL_IC06
DR   BioSample; SAMN00808009
DR   Coriell; ND06384
DR   Wikidata; Q54917374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06385
AC   CVCL_DZ07
DR   Coriell; ND06385
DR   Wikidata; Q54917375
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06389
AC   CVCL_HU53
DR   BioSample; SAMN00808011
DR   Coriell; ND06389
DR   Wikidata; Q54917376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06391
AC   CVCL_CH88
DR   CLO; CLO_0029184
DR   Coriell; ND06391
DR   Wikidata; Q54917377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06392
AC   CVCL_CH89
DR   CLO; CLO_0029185
DR   BioSample; SAMN00808013
DR   Coriell; ND06392
DR   Wikidata; Q54917379
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06393
AC   CVCL_ET46
DR   CLO; CLO_0029203
DR   BioSample; SAMN00808015
DR   Coriell; ND06393
DR   Wikidata; Q54917380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06394
AC   CVCL_CH90
DR   CLO; CLO_0029205
DR   BioSample; SAMN00808017
DR   Coriell; ND06394
DR   Wikidata; Q54917381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06395
AC   CVCL_ET47
DR   CLO; CLO_0029208
DR   BioSample; SAMN00808019
DR   Coriell; ND06395
DR   Wikidata; Q54917382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06397
AC   CVCL_IL59
DR   CLO; CLO_0029212
DR   Coriell; ND06397
DR   Wikidata; Q54917383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND06397; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND06399
AC   CVCL_CH91
DR   Coriell; ND06399
DR   Wikidata; Q54917385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06405
AC   CVCL_FY20
DR   BioSample; SAMN00808021
DR   Coriell; ND06405
DR   Wikidata; Q54917386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06407
AC   CVCL_FY21
DR   CLO; CLO_0029189
DR   Coriell; ND06407
DR   Wikidata; Q54917387
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06408
AC   CVCL_CH92
DR   CLO; CLO_0029194
DR   Coriell; ND06408
DR   Wikidata; Q54917388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06415
AC   CVCL_CH93
DR   Coriell; ND06415
DR   Wikidata; Q54917389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06416
AC   CVCL_CH94
DR   Coriell; ND06416
DR   Wikidata; Q54917390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06419
AC   CVCL_DZ08
DR   Coriell; ND06419
DR   Wikidata; Q54917391
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06427
AC   CVCL_HU54
DR   Coriell; ND06427
DR   Wikidata; Q54917392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06429
AC   CVCL_FJ48
DR   CLO; CLO_0029195
DR   Coriell; ND06429
DR   Wikidata; Q54917393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06430
AC   CVCL_FJ49
DR   CLO; CLO_0029200
DR   Coriell; ND06430
DR   Wikidata; Q54917394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06431
AC   CVCL_GC12
DR   CLO; CLO_0018501
DR   Coriell; ND06431
DR   Wikidata; Q54917395
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06432
AC   CVCL_ET48
DR   CLO; CLO_0018499
DR   Coriell; ND06432
DR   Wikidata; Q54917396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06433
AC   CVCL_GC13
DR   CLO; CLO_0018500
DR   Coriell; ND06433
DR   Wikidata; Q54917398
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06434
AC   CVCL_ET49
DR   CLO; CLO_0018521
DR   Coriell; ND06434
DR   Wikidata; Q54917399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06435
AC   CVCL_DZ09
DR   CLO; CLO_0018525
DR   Coriell; ND06435
DR   Wikidata; Q54917400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06436
AC   CVCL_FC36
DR   CLO; CLO_0018518
DR   Coriell; ND06436
DR   Wikidata; Q54917401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06437
AC   CVCL_DZ10
DR   CLO; CLO_0018519
DR   Coriell; ND06437
DR   Wikidata; Q54917402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06438
AC   CVCL_DZ11
DR   CLO; CLO_0018510
DR   Coriell; ND06438
DR   Wikidata; Q54917403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06443
AC   CVCL_HQ87
DR   CLO; CLO_0018513
DR   Coriell; ND06443
DR   Wikidata; Q54917404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06444
AC   CVCL_IH19
DR   CLO; CLO_0018506
DR   Coriell; ND06444
DR   Wikidata; Q54917406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06445
AC   CVCL_HQ88
DR   CLO; CLO_0018549
DR   Coriell; ND06445
DR   Wikidata; Q54917407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06446
AC   CVCL_CH95
DR   CLO; CLO_0018550
DR   Coriell; ND06446
DR   Wikidata; Q54917408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06447
AC   CVCL_CH96
DR   CLO; CLO_0018551
DR   Coriell; ND06447
DR   Wikidata; Q54917409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06448
AC   CVCL_CH97
DR   CLO; CLO_0018552
DR   Coriell; ND06448
DR   Wikidata; Q54917410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06449
AC   CVCL_CH98
SY   ND 06449
DR   CLO; CLO_0018566
DR   BioSample; SAMN00808023
DR   Coriell; ND06449
DR   GEO; GSM505623
DR   Wikidata; Q54917411
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   ND06450
AC   CVCL_ET50
DR   CLO; CLO_0018568
DR   BioSample; SAMN00808025
DR   Coriell; ND06450
DR   Wikidata; Q54917412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06456
AC   CVCL_IC07
DR   Coriell; ND06456
DR   Wikidata; Q54917413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06458
AC   CVCL_FY22
DR   BioSample; SAMN00808027
DR   Coriell; ND06458
DR   Wikidata; Q54917414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06462
AC   CVCL_DZ12
DR   CLO; CLO_0018570
DR   Coriell; ND06462
DR   Wikidata; Q54917415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06464
AC   CVCL_DZ13
DR   Coriell; ND06464
DR   Wikidata; Q54917423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06466
AC   CVCL_CH99
DR   Coriell; ND06466
DR   Wikidata; Q54917424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06470
AC   CVCL_HU55
DR   BioSample; SAMN00808029
DR   Coriell; ND06470
DR   Wikidata; Q54917425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06471
AC   CVCL_HU56
DR   BioSample; SAMN00808031
DR   Coriell; ND06471
DR   Wikidata; Q54917426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06472
AC   CVCL_HU57
DR   BioSample; SAMN00808033
DR   Coriell; ND06472
DR   Wikidata; Q54917427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06474
AC   CVCL_CI00
DR   CLO; CLO_0018571
DR   BioSample; SAMN00808035
DR   Coriell; ND06474
DR   Wikidata; Q54917428
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06475
AC   CVCL_FC37
DR   CLO; CLO_0018556
DR   BioSample; SAMN00808037
DR   Coriell; ND06475
DR   Wikidata; Q54917429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06476
AC   CVCL_CI01
DR   CLO; CLO_0018558
DR   Coriell; ND06476
DR   Wikidata; Q54917430
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06477
AC   CVCL_CI02
DR   Coriell; ND06477
DR   Wikidata; Q54917431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06479
AC   CVCL_DZ14
DR   Coriell; ND06479
DR   Wikidata; Q54917432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06485
AC   CVCL_DZ15
DR   CLO; CLO_0018590
DR   Coriell; ND06485
DR   Wikidata; Q54917433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06486
AC   CVCL_FJ50
DR   CLO; CLO_0018593
DR   Coriell; ND06486
DR   Wikidata; Q54917434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06487
AC   CVCL_CI03
DR   CLO; CLO_0018594
DR   Coriell; ND06487
DR   Wikidata; Q54917435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06488
AC   CVCL_CI04
DR   CLO; CLO_0018591
DR   Coriell; ND06488
DR   Wikidata; Q54917436
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06491
AC   CVCL_CI05
DR   Coriell; ND06491
DR   Wikidata; Q54917437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06492
AC   CVCL_IC08
DR   BioSample; SAMN00808039
DR   Coriell; ND06492
DR   Wikidata; Q54917438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06493
AC   CVCL_DZ16
DR   Coriell; ND06493
DR   Wikidata; Q54917439
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06495
AC   CVCL_DZ17
DR   Coriell; ND06495
DR   Wikidata; Q54917440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06498
AC   CVCL_FJ51
DR   BioSample; SAMN00808041
DR   Coriell; ND06498
DR   Wikidata; Q54917441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06499
AC   CVCL_IC09
DR   BioSample; SAMN00808043
DR   Coriell; ND06499
DR   Wikidata; Q54917443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06501
AC   CVCL_GC14
DR   CLO; CLO_0018592
DR   BioSample; SAMN00808045
DR   Coriell; ND06501
DR   Wikidata; Q54917444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06502
AC   CVCL_CI06
DR   CLO; CLO_0018599
DR   BioSample; SAMN00808047
DR   Coriell; ND06502
DR   Wikidata; Q54917445
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06503
AC   CVCL_CI07
DR   CLO; CLO_0018601
DR   Coriell; ND06503
DR   Wikidata; Q54917446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06504
AC   CVCL_IH20
DR   CLO; CLO_0018596
DR   Coriell; ND06504
DR   Wikidata; Q54917448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06505
AC   CVCL_FY23
DR   CLO; CLO_0018598
DR   Coriell; ND06505
DR   Wikidata; Q54917449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06507
AC   CVCL_IC10
DR   Coriell; ND06507
DR   Wikidata; Q54917450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06512
AC   CVCL_CI08
DR   CLO; CLO_0018609
DR   Coriell; ND06512
DR   Wikidata; Q54917451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06514
AC   CVCL_CI09
DR   BioSample; SAMN00808049
DR   Coriell; ND06514
DR   Wikidata; Q54917452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06515
AC   CVCL_IC11
DR   BioSample; SAMN00808051
DR   Coriell; ND06515
DR   Wikidata; Q54917453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06523
AC   CVCL_HU58
DR   BioSample; SAMN00808053
DR   Coriell; ND06523
DR   Wikidata; Q54917454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06524
AC   CVCL_FY24
DR   Coriell; ND06524
DR   Wikidata; Q54917455
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06529
AC   CVCL_IC12
DR   BioSample; SAMN00808055
DR   Coriell; ND06529
DR   Wikidata; Q54917456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06530
AC   CVCL_FJ52
DR   BioSample; SAMN00808057
DR   Coriell; ND06530
DR   Wikidata; Q54917457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06536
AC   CVCL_IC13
DR   Coriell; ND06536
DR   Wikidata; Q54917458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06537
AC   CVCL_IC14
DR   Coriell; ND06537
DR   Wikidata; Q54917460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06538
AC   CVCL_CI10
DR   Coriell; ND06538
DR   Wikidata; Q54917461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06539
AC   CVCL_DZ18
DR   Coriell; ND06539
DR   Wikidata; Q54917462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06546
AC   CVCL_HU59
DR   BioSample; SAMN00808059
DR   Coriell; ND06546
DR   Wikidata; Q54917464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06549
AC   CVCL_CI11
DR   CLO; CLO_0018631
DR   Coriell; ND06549
DR   Wikidata; Q54917465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06550
AC   CVCL_CI12
DR   CLO; CLO_0018632
DR   Coriell; ND06550
DR   Wikidata; Q54917466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06552
AC   CVCL_FJ53
DR   Coriell; ND06552
DR   Wikidata; Q54917470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06554
AC   CVCL_HU60
DR   BioSample; SAMN00808061
DR   Coriell; ND06554
DR   Wikidata; Q54917471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06556
AC   CVCL_FJ54
DR   CLO; CLO_0018633
DR   BioSample; SAMN00808063
DR   Coriell; ND06556
DR   Wikidata; Q54917472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06557
AC   CVCL_IC15
DR   CLO; CLO_0018634
DR   BioSample; SAMN00808065
DR   Coriell; ND06557
DR   Wikidata; Q54917473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06559
AC   CVCL_DZ19
DR   CLO; CLO_0018635
DR   Coriell; ND06559
DR   Wikidata; Q54917474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06560
AC   CVCL_CI13
DR   Coriell; ND06560
DR   Wikidata; Q54917475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06565
AC   CVCL_DZ20
DR   Coriell; ND06565
DR   Wikidata; Q54917476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06568
AC   CVCL_CI14
DR   BioSample; SAMN00808066
DR   Coriell; ND06568
DR   Wikidata; Q54917477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06571
AC   CVCL_IL60
DR   BioSample; SAMN00808067
DR   Coriell; ND06571
DR   Wikidata; Q54917478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06572
AC   CVCL_CI15
DR   CLO; CLO_0018636
DR   Coriell; ND06572
DR   Wikidata; Q54917479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06573
AC   CVCL_AB72
DR   CLO; CLO_0018638
DR   Coriell; ND06573
DR   Wikidata; Q54917480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND06574
AC   CVCL_AB73
DR   CLO; CLO_0018640
DR   Coriell; ND06574
DR   Wikidata; Q54917481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND06575
AC   CVCL_FY25
DR   CLO; CLO_0018641
DR   Coriell; ND06575
DR   Wikidata; Q54917482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06576
AC   CVCL_IH47
DR   CLO; CLO_0018643
DR   Coriell; ND06576
DR   Wikidata; Q54917483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06577
AC   CVCL_FY26
DR   CLO; CLO_0018688
DR   Coriell; ND06577
DR   Wikidata; Q54917484
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06578
AC   CVCL_IC16
DR   Coriell; ND06578
DR   Wikidata; Q54917485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06579
AC   CVCL_IC17
DR   Coriell; ND06579
DR   Wikidata; Q54917486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06580
AC   CVCL_IC18
DR   Coriell; ND06580
DR   Wikidata; Q54917487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06581
AC   CVCL_IC19
DR   BioSample; SAMN00808068
DR   Coriell; ND06581
DR   Wikidata; Q54917488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06584
AC   CVCL_IC20
DR   Coriell; ND06584
DR   Wikidata; Q54917489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06587
AC   CVCL_CI16
DR   CLO; CLO_0018687
DR   Coriell; ND06587
DR   Wikidata; Q54917490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06588
AC   CVCL_CI17
DR   CLO; CLO_0018686
DR   Coriell; ND06588
DR   Wikidata; Q54917491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06589
AC   CVCL_CI18
DR   CLO; CLO_0018685
DR   Coriell; ND06589
DR   Wikidata; Q54917493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06590
AC   CVCL_CI19
DR   CLO; CLO_0018684
DR   Coriell; ND06590
DR   Wikidata; Q54917494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06593
AC   CVCL_BA51
DR   CLO; CLO_0018683
DR   Coriell; ND06593
DR   Wikidata; Q54917495
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06594
AC   CVCL_BA52
DR   CLO; CLO_0018682
DR   Coriell; ND06594
DR   Wikidata; Q54917496
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06595
AC   CVCL_BA53
DR   CLO; CLO_0018680
DR   Coriell; ND06595
DR   Wikidata; Q54917497
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06596
AC   CVCL_CI20
DR   CLO; CLO_0018678
DR   BioSample; SAMN00808069
DR   Coriell; ND06596
DR   Wikidata; Q54917498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06597
AC   CVCL_ET51
DR   CLO; CLO_0018677
DR   BioSample; SAMN00808070
DR   Coriell; ND06597
DR   Wikidata; Q54917499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06598
AC   CVCL_FJ55
DR   CLO; CLO_0018725
DR   BioSample; SAMN00808071
DR   Coriell; ND06598
DR   Wikidata; Q54917500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06599
AC   CVCL_IC21
DR   CLO; CLO_0018724
DR   BioSample; SAMN00808073
DR   Coriell; ND06599
DR   Wikidata; Q54917501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06600
AC   CVCL_FJ56
DR   CLO; CLO_0018727
DR   BioSample; SAMN00808075
DR   Coriell; ND06600
DR   Wikidata; Q54917503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06601
AC   CVCL_HP83
DR   CLO; CLO_0018726
DR   BioSample; SAMN00808077
DR   Coriell; ND06601
DR   Wikidata; Q54917504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06615
AC   CVCL_CI21
DR   Coriell; ND06615
DR   Wikidata; Q54917505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06616
AC   CVCL_CI22
DR   Coriell; ND06616
DR   Wikidata; Q54917506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06617
AC   CVCL_CI23
DR   Coriell; ND06617
DR   Wikidata; Q54917507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06618
AC   CVCL_CI24
DR   Coriell; ND06618
DR   Wikidata; Q54917509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06619
AC   CVCL_CI25
DR   BioSample; SAMN00808079
DR   Coriell; ND06619
DR   Wikidata; Q54917510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06620
AC   CVCL_HU62
DR   BioSample; SAMN00808081
DR   Coriell; ND06620
DR   Wikidata; Q54917511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06621
AC   CVCL_FY27
DR   BioSample; SAMN00808083
DR   Coriell; ND06621
DR   Wikidata; Q54917512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06622
AC   CVCL_HU63
DR   BioSample; SAMN00808085
DR   Coriell; ND06622
DR   Wikidata; Q54917518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06623
AC   CVCL_FY28
DR   BioSample; SAMN00808087
DR   Coriell; ND06623
DR   Wikidata; Q54917519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06627
AC   CVCL_FY29
DR   CLO; CLO_0018721
DR   Coriell; ND06627
DR   Wikidata; Q54917520
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06628
AC   CVCL_FY30
DR   CLO; CLO_0018720
DR   Coriell; ND06628
DR   Wikidata; Q54917521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06629
AC   CVCL_FJ57
DR   CLO; CLO_0018723
DR   BioSample; SAMN00808089
DR   Coriell; ND06629
DR   Wikidata; Q54917522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06630
AC   CVCL_IC22
DR   CLO; CLO_0018722
DR   BioSample; SAMN00808091
DR   Coriell; ND06630
DR   Wikidata; Q54917523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06631
AC   CVCL_FJ58
DR   CLO; CLO_0018716
DR   BioSample; SAMN00808093
DR   Coriell; ND06631
DR   Wikidata; Q54917524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06632
AC   CVCL_IC23
DR   CLO; CLO_0018715
DR   BioSample; SAMN00808095
DR   Coriell; ND06632
DR   Wikidata; Q54917525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06633
AC   CVCL_FJ59
DR   CLO; CLO_0018761
DR   BioSample; SAMN00808097
DR   Coriell; ND06633
DR   Wikidata; Q54917527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06634
AC   CVCL_CI26
DR   CLO; CLO_0018747
DR   Coriell; ND06634
DR   Wikidata; Q54917528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06635
AC   CVCL_CI27
DR   CLO; CLO_0018746
DR   Coriell; ND06635
DR   Wikidata; Q54917529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06636
AC   CVCL_CI28
DR   CLO; CLO_0018745
DR   Coriell; ND06636
DR   Wikidata; Q54917530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06637
AC   CVCL_CI29
DR   CLO; CLO_0018744
DR   BioSample; SAMN00808099
DR   Coriell; ND06637
DR   Wikidata; Q54917531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06639
AC   CVCL_CI30
DR   CLO; CLO_0018751
DR   Coriell; ND06639
DR   Wikidata; Q54917533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06640
AC   CVCL_CI31
DR   CLO; CLO_0018750
DR   Coriell; ND06640
DR   Wikidata; Q54917534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06642
AC   CVCL_CI32
DR   BioSample; SAMN00808101
DR   Coriell; ND06642
DR   Wikidata; Q54917535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06643
AC   CVCL_CI33
DR   Coriell; ND06643
DR   Wikidata; Q54917536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06644
AC   CVCL_CI34
DR   Coriell; ND06644
DR   Wikidata; Q54917537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06645
AC   CVCL_IC24
DR   Coriell; ND06645
DR   Wikidata; Q54917538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06646
AC   CVCL_CI35
DR   BioSample; SAMN00808103
DR   Coriell; ND06646
DR   Wikidata; Q54917539
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (Coriell=ND06646).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EY56 ! ND29969
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND06647
AC   CVCL_IC25
DR   Coriell; ND06647
DR   Wikidata; Q54917540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06648
AC   CVCL_ER63
DR   BioSample; SAMN00808105
DR   Coriell; ND06648
DR   Wikidata; Q54917541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06657
AC   CVCL_FY31
DR   BioSample; SAMN00808107
DR   Coriell; ND06657
DR   Wikidata; Q54917542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06658
AC   CVCL_IL61
DR   BioSample; SAMN00808109
DR   Coriell; ND06658
DR   Wikidata; Q54917543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06663
AC   CVCL_FJ60
DR   CLO; CLO_0018749
DR   Coriell; ND06663
DR   Wikidata; Q54917544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06664
AC   CVCL_IC26
DR   CLO; CLO_0018748
DR   BioSample; SAMN00808111
DR   Coriell; ND06664
DR   Wikidata; Q54917545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06665
AC   CVCL_FJ61
DR   CLO; CLO_0018743
DR   BioSample; SAMN00808113
DR   Coriell; ND06665
DR   Wikidata; Q54917546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06666
AC   CVCL_HY57
DR   CLO; CLO_0018798
DR   BioSample; SAMN00808115
DR   Coriell; ND06666
DR   Wikidata; Q54917548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06667
AC   CVCL_HY58
DR   CLO; CLO_0018800
DR   BioSample; SAMN00808116
DR   Coriell; ND06667
DR   Wikidata; Q54917549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06668
AC   CVCL_GC15
DR   CLO; CLO_0018783
DR   Coriell; ND06668
DR   Wikidata; Q54917550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06670
AC   CVCL_CI36
DR   Coriell; ND06670
DR   Wikidata; Q54917551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06679
AC   CVCL_CI37
DR   CLO; CLO_0018782
DR   BioSample; SAMN00795100
DR   Coriell; ND06679
DR   Wikidata; Q54917552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06680
AC   CVCL_ET52
DR   CLO; CLO_0018785
DR   BioSample; SAMN00795102
DR   Coriell; ND06680
DR   Wikidata; Q54917553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06681
AC   CVCL_HU64
DR   CLO; CLO_0018784
DR   Coriell; ND06681
DR   Wikidata; Q54917554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06682
AC   CVCL_FY32
DR   CLO; CLO_0018787
DR   Coriell; ND06682
DR   Wikidata; Q54917555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06685
AC   CVCL_IC27
DR   Coriell; ND06685
DR   Wikidata; Q54917556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06691
AC   CVCL_FJ62
DR   Coriell; ND06691
DR   Wikidata; Q54917557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06694
AC   CVCL_IC28
DR   Coriell; ND06694
DR   Wikidata; Q54917558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06700
AC   CVCL_HU65
DR   Coriell; ND06700
DR   Wikidata; Q54917559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06705
AC   CVCL_HU66
DR   Coriell; ND06705
DR   Wikidata; Q54917560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06707
AC   CVCL_FJ63
DR   Coriell; ND06707
DR   Wikidata; Q54917563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06709
AC   CVCL_FJ64
DR   Coriell; ND06709
DR   Wikidata; Q54917564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06710
AC   CVCL_CI38
DR   Coriell; ND06710
DR   Wikidata; Q54917565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06711
AC   CVCL_CI39
DR   Coriell; ND06711
DR   Wikidata; Q54917566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06712
AC   CVCL_CI40
DR   Coriell; ND06712
DR   Wikidata; Q54917567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06713
AC   CVCL_CI41
DR   Coriell; ND06713
DR   Wikidata; Q54917568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06724
AC   CVCL_HU67
DR   Coriell; ND06724
DR   Wikidata; Q54917569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06726
AC   CVCL_CI42
DR   CLO; CLO_0018786
DR   Coriell; ND06726
DR   Wikidata; Q54917570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06727
AC   CVCL_CI43
DR   CLO; CLO_0018789
DR   Coriell; ND06727
DR   Wikidata; Q54917571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06728
AC   CVCL_CI44
DR   CLO; CLO_0018788
DR   Coriell; ND06728
DR   Wikidata; Q54917572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06729
AC   CVCL_CI45
DR   CLO; CLO_0018820
DR   Coriell; ND06729
DR   Wikidata; Q54917573
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06730
AC   CVCL_CI46
DR   CLO; CLO_0018826
DR   Coriell; ND06730
DR   Wikidata; Q54917574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06731
AC   CVCL_CI47
DR   CLO; CLO_0018823
DR   Coriell; ND06731
DR   Wikidata; Q54917575
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06732
AC   CVCL_CI48
DR   CLO; CLO_0018837
DR   Coriell; ND06732
DR   Wikidata; Q54917577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06733
AC   CVCL_CI49
DR   Coriell; ND06733
DR   Wikidata; Q54917578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06740
AC   CVCL_CI50
DR   Coriell; ND06740
DR   Wikidata; Q54917579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06744
AC   CVCL_DZ21
DR   Coriell; ND06744
DR   Wikidata; Q54917580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06751
AC   CVCL_BA54
DR   CLO; CLO_0018838
DR   Coriell; ND06751
DR   Wikidata; Q54917581
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND06753
AC   CVCL_FJ65
DR   CLO; CLO_0018839
DR   Coriell; ND06753
DR   Wikidata; Q54917582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06754
AC   CVCL_FJ66
DR   CLO; CLO_0018840
DR   Coriell; ND06754
DR   Wikidata; Q54917583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06755
AC   CVCL_FJ67
DR   CLO; CLO_0018834
DR   Coriell; ND06755
DR   Wikidata; Q54917584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06756
AC   CVCL_ET53
DR   CLO; CLO_0018835
DR   Coriell; ND06756
DR   Wikidata; Q54917585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06757
AC   CVCL_DZ22
DR   CLO; CLO_0018836
DR   Coriell; ND06757
DR   Wikidata; Q54917586
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06758
AC   CVCL_ET54
DR   CLO; CLO_0018858
DR   Coriell; ND06758
DR   Wikidata; Q54917587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06759
AC   CVCL_FB52
DR   CLO; CLO_0018857
DR   Coriell; ND06759
DR   Wikidata; Q54917589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06760
AC   CVCL_DZ23
DR   CLO; CLO_0018855
DR   Coriell; ND06760
DR   Wikidata; Q54917590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06761
AC   CVCL_DZ24
DR   CLO; CLO_0018852
DR   Coriell; ND06761
DR   Wikidata; Q54917591
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06762
AC   CVCL_ET55
DR   CLO; CLO_0018870
DR   Coriell; ND06762
DR   Wikidata; Q54917592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06764
AC   CVCL_CI51
DR   Coriell; ND06764
DR   Wikidata; Q54917593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06769
AC   CVCL_BA55
DR   Coriell; ND06769
DR   Wikidata; Q54917594
RX   PubMed=22815561;
CC   Population: Caucasian; Welsh.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND06769; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND06771
AC   CVCL_CI52
DR   CLO; CLO_0018871
DR   Coriell; ND06771
DR   Wikidata; Q54917595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06772
AC   CVCL_CI53
DR   CLO; CLO_0018868
DR   Coriell; ND06772
DR   Wikidata; Q54917596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06773
AC   CVCL_CI54
DR   CLO; CLO_0018869
DR   Coriell; ND06773
DR   Wikidata; Q54917597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06778
AC   CVCL_IC29
DR   Coriell; ND06778
DR   Wikidata; Q54917598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06779
AC   CVCL_IC30
DR   BioSample; SAMN00795120
DR   Coriell; ND06779
DR   Wikidata; Q54917599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06782
AC   CVCL_HU68
DR   Coriell; ND06782
DR   Wikidata; Q54917600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06784
AC   CVCL_HU69
DR   Coriell; ND06784
DR   Wikidata; Q54917601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06785
AC   CVCL_CI55
DR   CLO; CLO_0018866
DR   BioSample; SAMN00795126
DR   Coriell; ND06785
DR   Wikidata; Q54917602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06786
AC   CVCL_FC38
DR   CLO; CLO_0018867
DR   BioSample; SAMN00795128
DR   Coriell; ND06786
DR   Wikidata; Q54917603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06787
AC   CVCL_ET56
DR   CLO; CLO_0018401
DR   Coriell; ND06787
DR   Wikidata; Q54917604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06788
AC   CVCL_DZ25
DR   CLO; CLO_0018400
DR   Coriell; ND06788
DR   Wikidata; Q54917608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06789
AC   CVCL_FC39
DR   CLO; CLO_0018408
DR   Coriell; ND06789
DR   Wikidata; Q54917609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06790
AC   CVCL_DZ26
DR   CLO; CLO_0018407
DR   Coriell; ND06790
DR   Wikidata; Q54917610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06791
AC   CVCL_DZ27
DR   CLO; CLO_0018410
DR   Coriell; ND06791
DR   Wikidata; Q54917611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06792
AC   CVCL_ER65
DR   CLO; CLO_0018409
DR   Coriell; ND06792
DR   Wikidata; Q54917612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06793
AC   CVCL_DZ28
DR   CLO; CLO_0018403
DR   Coriell; ND06793
DR   Wikidata; Q54917613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06794
AC   CVCL_DZ29
DR   CLO; CLO_0018402
DR   Coriell; ND06794
DR   Wikidata; Q54917614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06795
AC   CVCL_DZ30
DR   CLO; CLO_0018406
DR   Coriell; ND06795
DR   Wikidata; Q54917615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06796
AC   CVCL_CI56
DR   CLO; CLO_0018405
DR   Coriell; ND06796
DR   Wikidata; Q54917616
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06801
AC   CVCL_IC31
DR   Coriell; ND06801
DR   Wikidata; Q54917617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06802
AC   CVCL_CI57
DR   Coriell; ND06802
DR   Wikidata; Q54920436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06803
AC   CVCL_ER64
DR   Coriell; ND06803
DR   Wikidata; Q54920437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06804
AC   CVCL_CI58
DR   Coriell; ND06804
DR   Wikidata; Q54920438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06806
AC   CVCL_CI59
DR   CLO; CLO_0018381
DR   Coriell; ND06806
DR   Wikidata; Q54920439
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06807
AC   CVCL_FJ68
DR   CLO; CLO_0018380
DR   Coriell; ND06807
DR   Wikidata; Q54920440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06808
AC   CVCL_GT16
DR   CLO; CLO_0018379
DR   Coriell; ND06808
DR   Wikidata; Q54920441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06809
AC   CVCL_FJ69
DR   CLO; CLO_0018390
DR   Coriell; ND06809
DR   Wikidata; Q54920442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06811
AC   CVCL_CI60
DR   Coriell; ND06811
DR   Wikidata; Q54920444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06812
AC   CVCL_CI61
DR   Coriell; ND06812
DR   Wikidata; Q54920445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06813
AC   CVCL_CI62
DR   Coriell; ND06813
DR   Wikidata; Q54920446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06819
AC   CVCL_FY33
DR   Coriell; ND06819
DR   Wikidata; Q54920447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06824
AC   CVCL_FJ70
DR   Coriell; ND06824
DR   Wikidata; Q54920448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06825
AC   CVCL_FJ71
DR   CLO; CLO_0018389
DR   Coriell; ND06825
DR   Wikidata; Q54920449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06826
AC   CVCL_GT17
DR   CLO; CLO_0018388
DR   Coriell; ND06826
DR   Wikidata; Q54920450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06827
AC   CVCL_CI63
DR   CLO; CLO_0018387
DR   BioSample; SAMN00795148
DR   Coriell; ND06827
DR   Wikidata; Q54920451
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06828
AC   CVCL_ET57
DR   CLO; CLO_0018386
DR   BioSample; SAMN00795150
DR   Coriell; ND06828
DR   Wikidata; Q54920452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06829
AC   CVCL_FY34
DR   CLO; CLO_0018384
DR   Coriell; ND06829
DR   Wikidata; Q54920453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06832
AC   CVCL_LL58
DR   Coriell; ND06832
DR   Wikidata; Q54920454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND06840
AC   CVCL_FJ72
DR   CLO; CLO_0018382
DR   Coriell; ND06840
DR   Wikidata; Q54920455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06841
AC   CVCL_DZ32
DR   CLO; CLO_0018127
DR   Coriell; ND06841
DR   Wikidata; Q54920456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06842
AC   CVCL_FC40
DR   CLO; CLO_0018128
DR   Coriell; ND06842
DR   Wikidata; Q54920457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06843
AC   CVCL_BA56
DR   CLO; CLO_0018125
DR   Coriell; ND06843
DR   Wikidata; Q54920458
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06844
AC   CVCL_CI64
DR   Coriell; ND06844
DR   Wikidata; Q54920459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06849
AC   CVCL_EH47
DR   Coriell; ND06849
DR   Wikidata; Q54920460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06850
AC   CVCL_CI65
DR   Coriell; ND06850
DR   Wikidata; Q54920461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06852
AC   CVCL_CI66
DR   CLO; CLO_0018126
DR   Coriell; ND06852
DR   Wikidata; Q54920462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06853
AC   CVCL_CI67
DR   CLO; CLO_0018123
DR   Coriell; ND06853
DR   Wikidata; Q54920463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06854
AC   CVCL_CI68
DR   CLO; CLO_0018124
DR   Coriell; ND06854
DR   Wikidata; Q54920464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06855
AC   CVCL_ET58
DR   CLO; CLO_0018121
DR   Coriell; ND06855
DR   Wikidata; Q54920465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06856
AC   CVCL_CI69
DR   CLO; CLO_0018122
DR   Coriell; ND06856
DR   Wikidata; Q54920466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06857
AC   CVCL_CI70
DR   CLO; CLO_0018119
DR   Coriell; ND06857
DR   Wikidata; Q54920467
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06858
AC   CVCL_CI71
DR   CLO; CLO_0018120
DR   BioSample; SAMN00795152
DR   Coriell; ND06858
DR   Wikidata; Q54920468
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND06859
AC   CVCL_ET59
DR   CLO; CLO_0018148
DR   BioSample; SAMN00795154
DR   Coriell; ND06859
DR   Wikidata; Q54920469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06860
AC   CVCL_CI72
DR   CLO; CLO_0018144
DR   Coriell; ND06860
DR   Wikidata; Q54920471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06861
AC   CVCL_CI73
DR   CLO; CLO_0018145
DR   Coriell; ND06861
DR   Wikidata; Q54920472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06862
AC   CVCL_HY59
DR   CLO; CLO_0018146
DR   Coriell; ND06862
DR   Wikidata; Q54920473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06863
AC   CVCL_IH21
DR   CLO; CLO_0018147
DR   Coriell; ND06863
DR   Wikidata; Q54920474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06864
AC   CVCL_HX02
DR   CLO; CLO_0018140
DR   Coriell; ND06864
DR   Wikidata; Q54920475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND06864; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND06865
AC   CVCL_HQ89
DR   CLO; CLO_0018141
DR   Coriell; ND06865
DR   Wikidata; Q54920476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06866
AC   CVCL_HQ90
DR   Coriell; ND06866
DR   Wikidata; Q54920477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06868
AC   CVCL_ET60
DR   CLO; CLO_0018142
DR   Coriell; ND06868
DR   Wikidata; Q54920487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06869
AC   CVCL_IC32
DR   BioSample; SAMN00795158
DR   Coriell; ND06869
DR   Wikidata; Q54920488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06870
AC   CVCL_IC33
DR   BioSample; SAMN00795160
DR   Coriell; ND06870
DR   Wikidata; Q54920489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND06871
AC   CVCL_FB53
DR   Coriell; ND06871
DR   Wikidata; Q54920490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06875
AC   CVCL_CI74
DR   CLO; CLO_0018143
DR   Coriell; ND06875
DR   Wikidata; Q54920491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06876
AC   CVCL_CI75
DR   CLO; CLO_0018139
DR   Coriell; ND06876
DR   Wikidata; Q54920492
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06877
AC   CVCL_CI76
DR   CLO; CLO_0018066
DR   BioSample; SAMN00795162
DR   Coriell; ND06877
DR   Wikidata; Q54920493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06878
AC   CVCL_ET61
DR   CLO; CLO_0018067
DR   Coriell; ND06878
DR   Wikidata; Q54920494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06879
AC   CVCL_CI77
DR   CLO; CLO_0018070
DR   Coriell; ND06879
DR   Wikidata; Q54920495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06880
AC   CVCL_BA57
DR   CLO; CLO_0018071
DR   Coriell; ND06880
DR   Wikidata; Q54920496
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06881
AC   CVCL_GC16
DR   CLO; CLO_0018068
DR   Coriell; ND06881
DR   Wikidata; Q54920497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06882
AC   CVCL_DZ33
DR   CLO; CLO_0018069
DR   Coriell; ND06882
DR   Wikidata; Q54920498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06883
AC   CVCL_DZ34
DR   CLO; CLO_0018063
DR   Coriell; ND06883
DR   Wikidata; Q54920499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06903
AC   CVCL_CI78
DR   Coriell; ND06903
DR   Wikidata; Q54920500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06905
AC   CVCL_IL62
DR   Coriell; ND06905
DR   Wikidata; Q54920501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06906
AC   CVCL_FY35
DR   Coriell; ND06906
DR   Wikidata; Q54920502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06907
AC   CVCL_HU71
DR   Coriell; ND06907
DR   Wikidata; Q54920503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06910
AC   CVCL_CI79
DR   Coriell; ND06910
DR   Wikidata; Q54920504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06912
AC   CVCL_FJ73
DR   Coriell; ND06912
DR   Wikidata; Q54920505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06917
AC   CVCL_FJ74
DR   CLO; CLO_0018065
DR   Coriell; ND06917
DR   Wikidata; Q54920507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06918
AC   CVCL_CI80
DR   CLO; CLO_0018060
DR   BioSample; SAMN00795172
DR   Coriell; ND06918
DR   Wikidata; Q54920508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06919
AC   CVCL_DZ35
DR   CLO; CLO_0018062
DR   Coriell; ND06919
DR   Wikidata; Q54920509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06920
AC   CVCL_FB54
DR   CLO; CLO_0018096
DR   Coriell; ND06920
DR   Wikidata; Q54920510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06921
AC   CVCL_DZ36
DR   CLO; CLO_0018097
DR   Coriell; ND06921
DR   Wikidata; Q54920511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06922
AC   CVCL_FB55
DR   CLO; CLO_0018098
DR   Coriell; ND06922
DR   Wikidata; Q54920512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06923
AC   CVCL_FB56
DR   Coriell; ND06923
DR   Wikidata; Q54920513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06924
AC   CVCL_DZ37
DR   CLO; CLO_0018099
DR   Coriell; ND06924
DR   Wikidata; Q54920514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06925
AC   CVCL_DZ38
DR   CLO; CLO_0018100
DR   Coriell; ND06925
DR   Wikidata; Q54920516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06926
AC   CVCL_CI81
DR   CLO; CLO_0018101
DR   Coriell; ND06926
DR   Wikidata; Q54920517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06930
AC   CVCL_CI82
DR   Coriell; ND06930
DR   Wikidata; Q54920518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06936
AC   CVCL_HU72
DR   Coriell; ND06936
DR   Wikidata; Q54920519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06938
AC   CVCL_IL63
DR   Coriell; ND06938
DR   Wikidata; Q54920520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06939
AC   CVCL_CI83
DR   CLO; CLO_0018102
DR   Coriell; ND06939
DR   Wikidata; Q54920521
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06940
AC   CVCL_CI84
DR   CLO; CLO_0018089
DR   Coriell; ND06940
DR   Wikidata; Q54920522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06941
AC   CVCL_CI85
DR   CLO; CLO_0018091
DR   BioSample; SAMN00795178
DR   Coriell; ND06941
DR   Wikidata; Q54920523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06942
AC   CVCL_GC17
DR   CLO; CLO_0018093
DR   BioSample; SAMN00795180
DR   Coriell; ND06942
DR   Wikidata; Q54920524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND06943
AC   CVCL_CI86
DR   CLO; CLO_0018006
DR   Coriell; ND06943
DR   Wikidata; Q54920525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06944
AC   CVCL_CI87
DR   CLO; CLO_0018005
DR   Coriell; ND06944
DR   Wikidata; Q54920526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06945
AC   CVCL_CI88
DR   CLO; CLO_0018004
DR   Coriell; ND06945
DR   Wikidata; Q54920527
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06946
AC   CVCL_CY92
DR   CLO; CLO_0018003
DR   Coriell; ND06946
DR   Wikidata; Q54920528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06947
AC   CVCL_CY93
DR   CLO; CLO_0018002
DR   BioSample; SAMN00795184
DR   Coriell; ND06947
DR   Wikidata; Q54920538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06948
AC   CVCL_FY36
DR   CLO; CLO_0018001
DR   Coriell; ND06948
DR   Wikidata; Q54920540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06949
AC   CVCL_FY37
DR   CLO; CLO_0018000
DR   Coriell; ND06949
DR   Wikidata; Q54920541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06950
AC   CVCL_FJ75
DR   CLO; CLO_0017999
DR   Coriell; ND06950
DR   Wikidata; Q54920542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06951
AC   CVCL_FY38
DR   CLO; CLO_0018009
DR   Coriell; ND06951
DR   Wikidata; Q54920543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06957
AC   CVCL_IC34
DR   Coriell; ND06957
DR   Wikidata; Q54920544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06958
AC   CVCL_IC35
DR   Coriell; ND06958
DR   Wikidata; Q54920546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06959
AC   CVCL_IC36
DR   Coriell; ND06959
DR   Wikidata; Q54920547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06960
AC   CVCL_IC37
DR   Coriell; ND06960
DR   Wikidata; Q54920548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06961
AC   CVCL_CI89
DR   Coriell; ND06961
DR   Wikidata; Q54920550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06965
AC   CVCL_CI90
DR   CLO; CLO_0018008
DR   Coriell; ND06965
DR   Wikidata; Q54920551
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06966
AC   CVCL_CI91
DR   CLO; CLO_0018024
DR   Coriell; ND06966
DR   Wikidata; Q54920552
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06967
AC   CVCL_CI92
DR   CLO; CLO_0018035
DR   Coriell; ND06967
DR   Wikidata; Q54920553
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND06968
AC   CVCL_DZ39
DR   CLO; CLO_0018034
DR   Coriell; ND06968
DR   Wikidata; Q54920554
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06969
AC   CVCL_DZ40
DR   CLO; CLO_0018037
DR   Coriell; ND06969
DR   Wikidata; Q54920555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06970
AC   CVCL_DZ41
DR   CLO; CLO_0018036
DR   Coriell; ND06970
DR   Wikidata; Q54920556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06971
AC   CVCL_ET62
DR   CLO; CLO_0018031
DR   Coriell; ND06971
DR   Wikidata; Q54920557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06972
AC   CVCL_FJ76
DR   CLO; CLO_0018030
DR   Coriell; ND06972
DR   Wikidata; Q54920558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06973
AC   CVCL_HY60
DR   CLO; CLO_0018033
DR   Coriell; ND06973
DR   Wikidata; Q54920559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06974
AC   CVCL_HY61
DR   CLO; CLO_0018032
DR   Coriell; ND06974
DR   Wikidata; Q54920560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06980
AC   CVCL_IC38
DR   Coriell; ND06980
DR   Wikidata; Q54920561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06981
AC   CVCL_IC39
DR   Coriell; ND06981
DR   Wikidata; Q54920562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06982
AC   CVCL_IC40
DR   Coriell; ND06982
DR   Wikidata; Q54920563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06985
AC   CVCL_FY39
DR   Coriell; ND06985
DR   Wikidata; Q54920564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND06986
AC   CVCL_HU73
DR   Coriell; ND06986
DR   Wikidata; Q54920565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND06987
AC   CVCL_BA58
DR   CLO; CLO_0018038
DR   Coriell; ND06987
DR   Wikidata; Q54920566
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06988
AC   CVCL_BA59
DR   CLO; CLO_0017956
DR   Coriell; ND06988
DR   Wikidata; Q54920567
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND06994
AC   CVCL_DZ42
DR   Coriell; ND06994
DR   Wikidata; Q54920568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND06995
AC   CVCL_DZ43
DR   Coriell; ND06995
DR   Wikidata; Q54920569
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND06996
AC   CVCL_CI93
DR   Coriell; ND06996
DR   Wikidata; Q54920570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06997
AC   CVCL_CI94
DR   Coriell; ND06997
DR   Wikidata; Q54920571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND06999
AC   CVCL_IL64
DR   Coriell; ND06999
DR   Wikidata; Q54920572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07001
AC   CVCL_IC41
DR   Coriell; ND07001
DR   Wikidata; Q54920573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07005
AC   CVCL_DZ44
DR   Coriell; ND07005
DR   Wikidata; Q54920574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07010
AC   CVCL_HU74
DR   Coriell; ND07010
DR   Wikidata; Q54920575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07012
AC   CVCL_DZ45
DR   CLO; CLO_0017958
DR   Coriell; ND07012
DR   Wikidata; Q54920576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07013
AC   CVCL_FB57
DR   CLO; CLO_0017964
DR   Coriell; ND07013
DR   Wikidata; Q54920578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07014
AC   CVCL_DZ46
DR   CLO; CLO_0017963
DR   Coriell; ND07014
DR   Wikidata; Q54920579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07015
AC   CVCL_ET63
DR   CLO; CLO_0017962
DR   Coriell; ND07015
DR   Wikidata; Q54920580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07016
AC   CVCL_DZ47
DR   Coriell; ND07016
DR   Wikidata; Q54920581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07017
AC   CVCL_FB58
DR   Coriell; ND07017
DR   Wikidata; Q54920587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07024
AC   CVCL_HU75
DR   Coriell; ND07024
DR   Wikidata; Q54920588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07026
AC   CVCL_HU76
DR   Coriell; ND07026
DR   Wikidata; Q54920590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07027
AC   CVCL_FY40
DR   CLO; CLO_0017961
DR   Coriell; ND07027
DR   Wikidata; Q54920591
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07029
AC   CVCL_CI95
DR   CLO; CLO_0017968
DR   Coriell; ND07029
DR   Wikidata; Q54920592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07030
AC   CVCL_CI96
DR   CLO; CLO_0017967
DR   Coriell; ND07030
DR   Wikidata; Q54920594
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07031
AC   CVCL_ET64
DR   CLO; CLO_0017966
DR   Coriell; ND07031
DR   Wikidata; Q54920595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07034
AC   CVCL_IC42
DR   Coriell; ND07034
DR   Wikidata; Q54920596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07035
AC   CVCL_DZ48
DR   Coriell; ND07035
DR   Wikidata; Q54920597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07038
AC   CVCL_FJ77
DR   CLO; CLO_0017965
DR   Coriell; ND07038
DR   Wikidata; Q54920598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07039
AC   CVCL_HY62
DR   CLO; CLO_0017978
DR   Coriell; ND07039
DR   Wikidata; Q54920599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07040
AC   CVCL_HY63
DR   CLO; CLO_0017979
DR   Coriell; ND07040
DR   Wikidata; Q54920600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07041
AC   CVCL_FJ78
DR   CLO; CLO_0017980
DR   Coriell; ND07041
DR   Wikidata; Q54920601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07042
AC   CVCL_IC43
DR   CLO; CLO_0017983
DR   Coriell; ND07042
DR   Wikidata; Q54920602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07043
AC   CVCL_FJ79
DR   CLO; CLO_0017982
DR   Coriell; ND07043
DR   Wikidata; Q54920603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07044
AC   CVCL_IC44
DR   CLO; CLO_0017985
DR   Coriell; ND07044
DR   Wikidata; Q54920604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07045
AC   CVCL_FB59
DR   CLO; CLO_0017984
DR   Coriell; ND07045
DR   Wikidata; Q54920605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07046
AC   CVCL_DZ49
DR   CLO; CLO_0017987
DR   Coriell; ND07046
DR   Wikidata; Q54920606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07047
AC   CVCL_DZ50
DR   CLO; CLO_0017986
DR   Coriell; ND07047
DR   Wikidata; Q54920607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07048
AC   CVCL_ET65
DR   CLO; CLO_0017988
DR   Coriell; ND07048
DR   Wikidata; Q54920608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07053
AC   CVCL_IC45
DR   Coriell; ND07053
DR   Wikidata; Q54920609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07055
AC   CVCL_IC46
DR   BioSample; SAMN00795236
DR   Coriell; ND07055
DR   Wikidata; Q54920610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND07059
AC   CVCL_FJ80
DR   Coriell; ND07059
DR   Wikidata; Q54920611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07060
AC   CVCL_HU77
DR   Coriell; ND07060
DR   Wikidata; Q54920612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07063
AC   CVCL_HU78
DR   Coriell; ND07063
DR   Wikidata; Q54920613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07064
AC   CVCL_FJ81
DR   CLO; CLO_0017779
DR   Coriell; ND07064
DR   Wikidata; Q54920614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07065
AC   CVCL_BA60
DR   CLO; CLO_0017772
DR   Coriell; ND07065
DR   Wikidata; Q54920615
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07066
AC   CVCL_BA61
DR   CLO; CLO_0017771
DR   Coriell; ND07066
DR   Wikidata; Q54920616
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07067
AC   CVCL_DZ51
DR   Coriell; ND07067
DR   Wikidata; Q54920618
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07082
AC   CVCL_FJ82
DR   Coriell; ND07082
DR   Wikidata; Q54920619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07083
AC   CVCL_CI97
DR   Coriell; ND07083
DR   Wikidata; Q54920620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07084
AC   CVCL_CI98
DR   Coriell; ND07084
DR   Wikidata; Q54920621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07085
AC   CVCL_HU79
DR   Coriell; ND07085
DR   Wikidata; Q54920622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07087
AC   CVCL_CI99
DR   Coriell; ND07087
DR   Wikidata; Q54920623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07088
AC   CVCL_CJ00
DR   Coriell; ND07088
DR   Wikidata; Q54920624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07089
AC   CVCL_CJ01
DR   Coriell; ND07089
DR   Wikidata; Q54920625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07090
AC   CVCL_CJ02
DR   Coriell; ND07090
DR   Wikidata; Q54920626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07098
AC   CVCL_HU80
DR   Coriell; ND07098
DR   Wikidata; Q54920627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07101
AC   CVCL_FJ83
DR   CLO; CLO_0017774
DR   Coriell; ND07101
DR   Wikidata; Q54920628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07102
AC   CVCL_FJ84
DR   CLO; CLO_0017773
DR   Coriell; ND07102
DR   Wikidata; Q54920630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07103
AC   CVCL_GC18
DR   CLO; CLO_0017776
DR   Coriell; ND07103
DR   Wikidata; Q54920634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07104
AC   CVCL_CJ03
DR   CLO; CLO_0017775
DR   Coriell; ND07104
DR   Wikidata; Q54920635
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07105
AC   CVCL_ET66
DR   CLO; CLO_0017778
DR   Coriell; ND07105
DR   Wikidata; Q54920636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07106
AC   CVCL_BA62
DR   CLO; CLO_0017777
DR   Coriell; ND07106
DR   Wikidata; Q54920637
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07107
AC   CVCL_GC19
DR   CLO; CLO_0017770
DR   BioSample; SAMN00795248
DR   Coriell; ND07107
DR   Wikidata; Q54920638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07108
AC   CVCL_DZ52
DR   CLO; CLO_0017759
DR   Coriell; ND07108
DR   Wikidata; Q54920639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07109
AC   CVCL_DZ53
DR   CLO; CLO_0017758
DR   Coriell; ND07109
DR   Wikidata; Q54920640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07110
AC   CVCL_DZ54
DR   CLO; CLO_0017753
DR   Coriell; ND07110
DR   Wikidata; Q54920641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07111
AC   CVCL_DZ55
DR   CLO; CLO_0017752
DR   Coriell; ND07111
DR   Wikidata; Q54920642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07112
AC   CVCL_ET67
DR   CLO; CLO_0017751
DR   Coriell; ND07112
DR   Wikidata; Q54920643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07113
AC   CVCL_ET68
DR   CLO; CLO_0017750
DR   Coriell; ND07113
DR   Wikidata; Q54920644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07114
AC   CVCL_GC20
DR   CLO; CLO_0017757
DR   Coriell; ND07114
DR   Wikidata; Q54920645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07115
AC   CVCL_DZ56
DR   CLO; CLO_0017756
DR   Coriell; ND07115
DR   Wikidata; Q54920647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07116
AC   CVCL_DZ57
DR   CLO; CLO_0017755
DR   Coriell; ND07116
DR   Wikidata; Q54920650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07117
AC   CVCL_HQ91
DR   CLO; CLO_0017754
DR   Coriell; ND07117
DR   Wikidata; Q54920651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07121
AC   CVCL_CJ04
DR   BioSample; SAMN00795250
DR   Coriell; ND07121
DR   Wikidata; Q54920652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07122
AC   CVCL_CJ05
DR   Coriell; ND07122
DR   Wikidata; Q54920653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07123
AC   CVCL_EH48
DR   Coriell; ND07123
DR   Wikidata; Q54920654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07124
AC   CVCL_AB74
DR   Coriell; ND07124
DR   Wikidata; Q54920655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND07125
AC   CVCL_HU81
DR   Coriell; ND07125
DR   Wikidata; Q54920656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07126
AC   CVCL_HU82
DR   Coriell; ND07126
DR   Wikidata; Q54920657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07127
AC   CVCL_IC47
DR   Coriell; ND07127
DR   Wikidata; Q54920658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07131
AC   CVCL_CJ06
DR   CLO; CLO_0017817
DR   Coriell; ND07131
DR   Wikidata; Q54920659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07132
AC   CVCL_CJ07
DR   BioSample; SAMN00795256
DR   Coriell; ND07132
DR   Wikidata; Q54920660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07133
AC   CVCL_IC48
DR   BioSample; SAMN00795258
DR   Coriell; ND07133
DR   Wikidata; Q54920661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND07134
AC   CVCL_IC49
DR   Coriell; ND07134
DR   Wikidata; Q54920662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07135
AC   CVCL_IC50
DR   Coriell; ND07135
DR   Wikidata; Q54920663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07136
AC   CVCL_IC51
DR   Coriell; ND07136
DR   Wikidata; Q54920664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07137
AC   CVCL_FB60
DR   CLO; CLO_0017819
DR   Coriell; ND07137
DR   Wikidata; Q54920666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07138
AC   CVCL_DZ58
DR   CLO; CLO_0017818
DR   Coriell; ND07138
DR   Wikidata; Q54920667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07139
AC   CVCL_DZ59
DR   CLO; CLO_0017814
DR   Coriell; ND07139
DR   Wikidata; Q54920668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07140
AC   CVCL_DZ60
DR   CLO; CLO_0017813
DR   Coriell; ND07140
DR   Wikidata; Q54920669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07141
AC   CVCL_DZ61
DR   CLO; CLO_0017816
DR   Coriell; ND07141
DR   Wikidata; Q54920670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07142
AC   CVCL_ET69
DR   CLO; CLO_0017815
DR   Coriell; ND07142
DR   Wikidata; Q54920671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07143
AC   CVCL_DZ62
DR   CLO; CLO_0017810
DR   Coriell; ND07143
DR   Wikidata; Q54920672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07144
AC   CVCL_DZ63
DR   Coriell; ND07144
DR   Wikidata; Q54920673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07152
AC   CVCL_FY41
DR   Coriell; ND07152
DR   Wikidata; Q54920674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07153
AC   CVCL_FJ85
DR   CLO; CLO_0017809
DR   Coriell; ND07153
DR   Wikidata; Q54920675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07154
AC   CVCL_BA63
DR   CLO; CLO_0017812
DR   Coriell; ND07154
DR   Wikidata; Q54920676
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07155
AC   CVCL_BA64
DR   CLO; CLO_0017799
DR   Coriell; ND07155
DR   Wikidata; Q54920677
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07156
AC   CVCL_BA65
DR   CLO; CLO_0017798
DR   Coriell; ND07156
DR   Wikidata; Q54920683
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07157
AC   CVCL_BA66
DR   CLO; CLO_0017797
DR   Coriell; ND07157
DR   Wikidata; Q54920684
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07165
AC   CVCL_FY42
DR   Coriell; ND07165
DR   Wikidata; Q54920685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07166
AC   CVCL_HU83
DR   Coriell; ND07166
DR   Wikidata; Q54920686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07170
AC   CVCL_CJ08
DR   CLO; CLO_0017796
DR   Coriell; ND07170
DR   Wikidata; Q54920687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07171
AC   CVCL_CJ09
DR   CLO; CLO_0017795
DR   Coriell; ND07171
DR   Wikidata; Q54920688
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07172
AC   CVCL_GY87
DR   CLO; CLO_0017794
DR   Coriell; ND07172
DR   Wikidata; Q54920689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07175
AC   CVCL_CJ10
DR   Coriell; ND07175
DR   Wikidata; Q54920690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07180
AC   CVCL_CJ11
DR   Coriell; ND07180
DR   Wikidata; Q54920691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07183
AC   CVCL_FC41
DR   CLO; CLO_0017793
DR   Coriell; ND07183
DR   Wikidata; Q54920692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07184
AC   CVCL_DZ64
DR   CLO; CLO_0017792
DR   Coriell; ND07184
DR   Wikidata; Q54920693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07185
AC   CVCL_FB61
DR   CLO; CLO_0017790
DR   Coriell; ND07185
DR   Wikidata; Q54920694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07186
AC   CVCL_ET70
DR   CLO; CLO_0017789
DR   Coriell; ND07186
DR   Wikidata; Q54920695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07187
AC   CVCL_FB62
DR   CLO; CLO_0017498
DR   Coriell; ND07187
DR   Wikidata; Q54920696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07188
AC   CVCL_DZ65
DR   CLO; CLO_0017496
DR   Coriell; ND07188
DR   Wikidata; Q54920697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07189
AC   CVCL_HQ92
DR   CLO; CLO_0017497
DR   Coriell; ND07189
DR   Wikidata; Q54920698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07190
AC   CVCL_IL65
DR   CLO; CLO_0017494
DR   Coriell; ND07190
DR   Wikidata; Q54920700
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND07191
AC   CVCL_HQ93
DR   CLO; CLO_0017495
DR   Coriell; ND07191
DR   Wikidata; Q54920701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07193
AC   CVCL_CJ12
DR   Coriell; ND07193
DR   Wikidata; Q54920702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07195
AC   CVCL_IC52
DR   Coriell; ND07195
DR   Wikidata; Q54920703
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND07197
AC   CVCL_CJ13
DR   Coriell; ND07197
DR   Wikidata; Q54920704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07201
AC   CVCL_IH22
DR   CLO; CLO_0017509
DR   Coriell; ND07201
DR   Wikidata; Q54920705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07202
AC   CVCL_CJ14
DR   CLO; CLO_0017511
DR   Coriell; ND07202
DR   Wikidata; Q54920706
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07204
AC   CVCL_CJ15
DR   BioSample; SAMN00795270
DR   Coriell; ND07204
DR   Wikidata; Q54920707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07205
AC   CVCL_IC53
DR   Coriell; ND07205
DR   Wikidata; Q54920708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07206
AC   CVCL_IC54
DR   Coriell; ND07206
DR   Wikidata; Q54920709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07207
AC   CVCL_IC55
DR   Coriell; ND07207
DR   Wikidata; Q54920710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07208
AC   CVCL_IC56
DR   BioSample; SAMN00795274
DR   Coriell; ND07208
DR   Wikidata; Q54920711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND07209
AC   CVCL_IC57
DR   Coriell; ND07209
DR   Wikidata; Q54920712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07210
AC   CVCL_IC58
DR   Coriell; ND07210
DR   Wikidata; Q54920714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07212
AC   CVCL_FJ86
DR   Coriell; ND07212
DR   Wikidata; Q54920715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07221
AC   CVCL_FB63
DR   CLO; CLO_0017505
DR   Coriell; ND07221
DR   Wikidata; Q54920716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07222
AC   CVCL_DZ66
DR   CLO; CLO_0017506
DR   Coriell; ND07222
DR   Wikidata; Q54920717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07223
AC   CVCL_DZ67
DR   CLO; CLO_0017502
DR   Coriell; ND07223
DR   Wikidata; Q54920718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07224
AC   CVCL_CJ16
DR   Coriell; ND07224
DR   Wikidata; Q54920719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07240
AC   CVCL_CJ17
DR   BioSample; SAMN00795276
DR   Coriell; ND07240
DR   Wikidata; Q54920720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07241
AC   CVCL_CJ18
DR   Coriell; ND07241
DR   Wikidata; Q54920721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07246
AC   CVCL_FY43
DR   Coriell; ND07246
DR   Wikidata; Q54920722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07247
AC   CVCL_FJ87
DR   CLO; CLO_0017529
DR   Coriell; ND07247
DR   Wikidata; Q54920723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07248
AC   CVCL_IC59
DR   CLO; CLO_0017530
DR   Coriell; ND07248
DR   Wikidata; Q54920724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07249
AC   CVCL_IC60
DR   Coriell; ND07249
DR   Wikidata; Q54920734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07250
AC   CVCL_FJ88
DR   CLO; CLO_0017525
DR   Coriell; ND07250
DR   Wikidata; Q54920735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07251
AC   CVCL_IC61
DR   CLO; CLO_0017526
DR   Coriell; ND07251
DR   Wikidata; Q54920736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07252
AC   CVCL_FJ89
DR   CLO; CLO_0017527
DR   Coriell; ND07252
DR   Wikidata; Q54920737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07253
AC   CVCL_IC62
DR   CLO; CLO_0017528
DR   Coriell; ND07253
DR   Wikidata; Q54920738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07254
AC   CVCL_CJ19
DR   CLO; CLO_0017536
DR   Coriell; ND07254
DR   Wikidata; Q54920739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07255
AC   CVCL_AB75
DR   CLO; CLO_0017537
DR   Coriell; ND07255
DR   Wikidata; Q54920740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND07256
AC   CVCL_GY88
DR   CLO; CLO_0017539
DR   Coriell; ND07256
DR   Wikidata; Q54920741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129069; Corticobasal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07257
AC   CVCL_CJ20
DR   CLO; CLO_0017541
DR   Coriell; ND07257
DR   Wikidata; Q54920742
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07258
AC   CVCL_FJ90
DR   Coriell; ND07258
DR   Wikidata; Q54920743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07260
AC   CVCL_FJ91
DR   Coriell; ND07260
DR   Wikidata; Q54920744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07261
AC   CVCL_FJ92
DR   Coriell; ND07261
DR   Wikidata; Q54920745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07262
AC   CVCL_CJ21
DR   Coriell; ND07262
DR   Wikidata; Q54920746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07265
AC   CVCL_HU84
DR   Coriell; ND07265
DR   Wikidata; Q54920747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07266
AC   CVCL_HQ94
DR   CLO; CLO_0017563
DR   Coriell; ND07266
DR   Wikidata; Q54920748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07267
AC   CVCL_HQ95
DR   CLO; CLO_0017560
DR   Coriell; ND07267
DR   Wikidata; Q54920749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07268
AC   CVCL_HQ96
DR   CLO; CLO_0017561
DR   Coriell; ND07268
DR   Wikidata; Q54920750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07269
AC   CVCL_HQ97
DR   CLO; CLO_0017566
DR   Coriell; ND07269
DR   Wikidata; Q54920752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07270
AC   CVCL_ET71
DR   CLO; CLO_0017567
DR   Coriell; ND07270
DR   Wikidata; Q54920753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07271
AC   CVCL_DZ68
DR   CLO; CLO_0017564
DR   Coriell; ND07271
DR   Wikidata; Q54920754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07272
AC   CVCL_FJ93
DR   CLO; CLO_0017565
DR   Coriell; ND07272
DR   Wikidata; Q54920755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07273
AC   CVCL_HQ98
DR   CLO; CLO_0017571
DR   Coriell; ND07273
DR   Wikidata; Q54920756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07274
AC   CVCL_HQ99
DR   CLO; CLO_0017574
DR   Coriell; ND07274
DR   Wikidata; Q54920758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07275
AC   CVCL_DZ69
DR   Coriell; ND07275
DR   Wikidata; Q54920759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07276
AC   CVCL_DZ70
DR   Coriell; ND07276
DR   Wikidata; Q54920760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07278
AC   CVCL_Y810
DR   BioSample; SAMN00795318
DR   Coriell; ND07278
DR   Wikidata; Q54920761
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Asn52Metfs*29 (c.155delA) (255delA); ClinVar=VCV000536457; Zygosity=Heterozygous (Coriell=ND07278).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3-4del; Zygosity=Heterozygous (Coriell=ND07278).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y811 ! ND29543
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   ND07279
AC   CVCL_IC63
DR   Coriell; ND07279
DR   Wikidata; Q54920762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07280
AC   CVCL_IC64
DR   Coriell; ND07280
DR   Wikidata; Q54920763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07281
AC   CVCL_IH23
DR   CLO; CLO_0017568
DR   Coriell; ND07281
DR   Wikidata; Q54920764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07282
AC   CVCL_FY44
DR   CLO; CLO_0017590
DR   Coriell; ND07282
DR   Wikidata; Q54920765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07283
AC   CVCL_FY45
DR   CLO; CLO_0017593
DR   Coriell; ND07283
DR   Wikidata; Q54920766
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07284
AC   CVCL_CJ22
DR   Coriell; ND07284
DR   Wikidata; Q54920767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07285
AC   CVCL_CJ23
DR   CLO; CLO_0017594
DR   Coriell; ND07285
DR   Wikidata; Q54920768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07286
AC   CVCL_CJ24
DR   CLO; CLO_0017595
DR   Coriell; ND07286
DR   Wikidata; Q54920769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07287
AC   CVCL_CJ25
DR   CLO; CLO_0017596
DR   Coriell; ND07287
DR   Wikidata; Q54920770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07288
AC   CVCL_CJ26
DR   CLO; CLO_0017597
DR   BioSample; SAMN00795324
DR   Coriell; ND07288
DR   Wikidata; Q54920772
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND07293
AC   CVCL_CJ27
DR   Coriell; ND07293
DR   Wikidata; Q54920773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07294
AC   CVCL_IC65
DR   Coriell; ND07294
DR   Wikidata; Q54920774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07295
AC   CVCL_IC66
DR   Coriell; ND07295
DR   Wikidata; Q54920775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07298
AC   CVCL_FB64
DR   CLO; CLO_0017598
DR   Coriell; ND07298
DR   Wikidata; Q54920776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07299
AC   CVCL_DZ71
DR   CLO; CLO_0017599
DR   Coriell; ND07299
DR   Wikidata; Q54920786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07300
AC   CVCL_ET72
DR   CLO; CLO_0017601
DR   Coriell; ND07300
DR   Wikidata; Q54920787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07301
AC   CVCL_DZ72
DR   CLO; CLO_0017602
DR   Coriell; ND07301
DR   Wikidata; Q54920788
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07302
AC   CVCL_GC21
DR   CLO; CLO_0017350
DR   Coriell; ND07302
DR   Wikidata; Q54920789
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07303
AC   CVCL_CJ28
DR   Coriell; ND07303
DR   Wikidata; Q54920790
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07310
AC   CVCL_DZ73
DR   Coriell; ND07310
DR   Wikidata; Q54920791
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07311
AC   CVCL_DZ74
DR   Coriell; ND07311
DR   Wikidata; Q54920792
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07312
AC   CVCL_CJ29
DR   CLO; CLO_0017388
DR   Coriell; ND07312
DR   Wikidata; Q54920793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07313
AC   CVCL_CJ30
DR   CLO; CLO_0017386
DR   Coriell; ND07313
DR   Wikidata; Q54920794
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07314
AC   CVCL_BA67
DR   CLO; CLO_0017385
DR   Coriell; ND07314
DR   Wikidata; Q54920795
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07316
AC   CVCL_FY46
DR   Coriell; ND07316
DR   Wikidata; Q54920796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07320
AC   CVCL_CJ31
DR   BioSample; SAMN00795332
DR   Coriell; ND07320
DR   Wikidata; Q54920797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07328
AC   CVCL_FJ94
DR   Coriell; ND07328
DR   Wikidata; Q54920798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07329
AC   CVCL_FJ95
DR   CLO; CLO_0017384
DR   Coriell; ND07329
DR   Wikidata; Q54920799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07330
AC   CVCL_IC67
DR   CLO; CLO_0017382
DR   Coriell; ND07330
DR   Wikidata; Q54920800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07332
AC   CVCL_IC68
DR   CLO; CLO_0017381
DR   Coriell; ND07332
DR   Wikidata; Q54920801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07333
AC   CVCL_BA68
DR   CLO; CLO_0017380
DR   Coriell; ND07333
DR   Wikidata; Q54920802
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07334
AC   CVCL_ET73
DR   CLO; CLO_0017379
DR   Coriell; ND07334
DR   Wikidata; Q54920805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07406
AC   CVCL_CJ32
DR   Coriell; ND07406
DR   Wikidata; Q54920806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07407
AC   CVCL_IC69
DR   Coriell; ND07407
DR   Wikidata; Q54920807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07415
AC   CVCL_FY47
DR   Coriell; ND07415
DR   Wikidata; Q54920808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07416
AC   CVCL_HU85
DR   Coriell; ND07416
DR   Wikidata; Q54920809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07417
AC   CVCL_HU86
DR   Coriell; ND07417
DR   Wikidata; Q54920810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07419
AC   CVCL_CJ33
DR   CLO; CLO_0017378
DR   Coriell; ND07419
DR   Wikidata; Q54920811
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07420
AC   CVCL_CJ34
DR   CLO; CLO_0017391
DR   Coriell; ND07420
DR   Wikidata; Q54920812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07421
AC   CVCL_DZ75
DR   CLO; CLO_0017392
DR   Coriell; ND07421
DR   Wikidata; Q54920813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07422
AC   CVCL_DZ76
DR   CLO; CLO_0017425
DR   Coriell; ND07422
DR   Wikidata; Q54920814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07423
AC   CVCL_ET74
DR   CLO; CLO_0017424
DR   Coriell; ND07423
DR   Wikidata; Q54920815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07424
AC   CVCL_ET75
DR   CLO; CLO_0017430
DR   Coriell; ND07424
DR   Wikidata; Q54920816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07425
AC   CVCL_DZ77
DR   CLO; CLO_0017428
DR   Coriell; ND07425
DR   Wikidata; Q54920817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07426
AC   CVCL_DZ78
DR   CLO; CLO_0017420
DR   Coriell; ND07426
DR   Wikidata; Q54920818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07427
AC   CVCL_ET76
DR   CLO; CLO_0017419
DR   Coriell; ND07427
DR   Wikidata; Q54920819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07428
AC   CVCL_ET77
DR   CLO; CLO_0017422
DR   Coriell; ND07428
DR   Wikidata; Q54920820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07435
AC   CVCL_DZ79
DR   Coriell; ND07435
DR   Wikidata; Q54920821
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07438
AC   CVCL_CJ35
DR   Coriell; ND07438
DR   Wikidata; Q54920822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07443
AC   CVCL_IC70
DR   Coriell; ND07443
DR   Wikidata; Q54920823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07447
AC   CVCL_HR00
DR   CLO; CLO_0017421
DR   Coriell; ND07447
DR   Wikidata; Q54920824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07448
AC   CVCL_FJ96
DR   CLO; CLO_0021161
DR   Coriell; ND07448
DR   Wikidata; Q54920825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07449
AC   CVCL_CJ36
DR   CLO; CLO_0021160
DR   Coriell; ND07449
DR   Wikidata; Q54920826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07457
AC   CVCL_FC42
DR   CLO; CLO_0021164
DR   Coriell; ND07457
DR   Wikidata; Q54920827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07461
AC   CVCL_DZ80
DR   Coriell; ND07461
DR   Wikidata; Q54920834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07463
AC   CVCL_CJ37
DR   Coriell; ND07463
DR   Wikidata; Q54920835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07464
AC   CVCL_CJ38
DR   Coriell; ND07464
DR   Wikidata; Q54920836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07465
AC   CVCL_CJ39
DR   Coriell; ND07465
DR   Wikidata; Q54920837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07466
AC   CVCL_FJ97
DR   Coriell; ND07466
DR   Wikidata; Q54920838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07470
AC   CVCL_HU87
DR   Coriell; ND07470
DR   Wikidata; Q54920839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07471
AC   CVCL_IH24
DR   CLO; CLO_0021163
DR   Coriell; ND07471
DR   Wikidata; Q54920840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07472
AC   CVCL_FY48
DR   CLO; CLO_0021157
DR   Coriell; ND07472
DR   Wikidata; Q54920841
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07473
AC   CVCL_FY49
DR   CLO; CLO_0021156
DR   Coriell; ND07473
DR   Wikidata; Q54920842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07474
AC   CVCL_BA69
DR   CLO; CLO_0021159
DR   Coriell; ND07474
DR   Wikidata; Q54920843
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07475
AC   CVCL_BA70
DR   CLO; CLO_0021158
DR   Coriell; ND07475
DR   Wikidata; Q54920844
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07476
AC   CVCL_IC71
DR   CLO; CLO_0021165
DR   Coriell; ND07476
DR   Wikidata; Q54920845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07477
AC   CVCL_FJ98
DR   CLO; CLO_0021166
DR   Coriell; ND07477
DR   Wikidata; Q54920846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07478
AC   CVCL_IC72
DR   CLO; CLO_0021175
DR   Coriell; ND07478
DR   Wikidata; Q54920847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07486
AC   CVCL_CJ40
DR   Coriell; ND07486
DR   Wikidata; Q54920848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07489
AC   CVCL_BA71
DR   CLO; CLO_0021174
DR   Coriell; ND07489
DR   Wikidata; Q54920849
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND07495
AC   CVCL_CJ41
DR   Coriell; ND07495
DR   Wikidata; Q54920850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07496
AC   CVCL_DZ81
DR   Coriell; ND07496
DR   Wikidata; Q54920851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07499
AC   CVCL_HU88
DR   Coriell; ND07499
DR   Wikidata; Q54920852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07500
AC   CVCL_HU89
DR   Coriell; ND07500
DR   Wikidata; Q54920853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07501
AC   CVCL_IL66
DR   Coriell; ND07501
DR   Wikidata; Q54920854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07504
AC   CVCL_FY50
DR   Coriell; ND07504
DR   Wikidata; Q54920855
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07505
AC   CVCL_HU90
DR   Coriell; ND07505
DR   Wikidata; Q54920856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07506
AC   CVCL_FY51
DR   Coriell; ND07506
DR   Wikidata; Q54920857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07508
AC   CVCL_BA72
DR   CLO; CLO_0021173
DR   Coriell; ND07508
DR   Wikidata; Q54920858
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07509
AC   CVCL_DZ82
DR   CLO; CLO_0021172
DR   Coriell; ND07509
DR   Wikidata; Q54920860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07510
AC   CVCL_DZ83
DR   CLO; CLO_0021171
DR   Coriell; ND07510
DR   Wikidata; Q54920861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07511
AC   CVCL_ET78
DR   CLO; CLO_0021170
DR   Coriell; ND07511
DR   Wikidata; Q54920862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07512
AC   CVCL_ET79
DR   CLO; CLO_0021169
DR   Coriell; ND07512
DR   Wikidata; Q54920863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07514
AC   CVCL_CJ42
DR   Coriell; ND07514
DR   Wikidata; Q54920864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07515
AC   CVCL_CJ43
DR   Coriell; ND07515
DR   Wikidata; Q54920865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07518
AC   CVCL_IC73
DR   Coriell; ND07518
DR   Wikidata; Q54920866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07520
AC   CVCL_CJ44
DR   BioSample; SAMN00795364
DR   Coriell; ND07520
DR   Wikidata; Q54920867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07521
AC   CVCL_FY52
DR   CLO; CLO_0021168
DR   Coriell; ND07521
DR   Wikidata; Q54920868
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07530
AC   CVCL_CJ45
DR   Coriell; ND07530
DR   Wikidata; Q54920869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07532
AC   CVCL_HU91
DR   Coriell; ND07532
DR   Wikidata; Q54920870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07533
AC   CVCL_HU92
DR   Coriell; ND07533
DR   Wikidata; Q54920871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07535
AC   CVCL_ET80
DR   CLO; CLO_0021167
DR   Coriell; ND07535
DR   Wikidata; Q54920872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07536
AC   CVCL_ET81
DR   CLO; CLO_0021218
DR   Coriell; ND07536
DR   Wikidata; Q54920873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07537
AC   CVCL_ET82
DR   CLO; CLO_0021227
DR   Coriell; ND07537
DR   Wikidata; Q54920874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07538
AC   CVCL_IC74
DR   Coriell; ND07538
DR   Wikidata; Q54920879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07539
AC   CVCL_IC75
DR   Coriell; ND07539
DR   Wikidata; Q54920880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07540
AC   CVCL_GC22
DR   CLO; CLO_0021228
DR   Coriell; ND07540
DR   Wikidata; Q54920881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07541
AC   CVCL_ET83
DR   CLO; CLO_0021229
DR   Coriell; ND07541
DR   Wikidata; Q54920883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07542
AC   CVCL_ET84
DR   CLO; CLO_0021230
DR   Coriell; ND07542
DR   Wikidata; Q54920884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07543
AC   CVCL_ET85
DR   CLO; CLO_0021231
DR   Coriell; ND07543
DR   Wikidata; Q54920885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07545
AC   CVCL_ET86
DR   CLO; CLO_0021232
DR   Coriell; ND07545
DR   Wikidata; Q54920886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07547
AC   CVCL_GC23
DR   CLO; CLO_0021233
DR   Coriell; ND07547
DR   Wikidata; Q54920887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07548
AC   CVCL_ET87
DR   CLO; CLO_0021234
DR   Coriell; ND07548
DR   Wikidata; Q54920888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07549
AC   CVCL_ET88
DR   CLO; CLO_0021235
DR   Coriell; ND07549
DR   Wikidata; Q54920889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07550
AC   CVCL_ET89
DR   CLO; CLO_0021236
DR   Coriell; ND07550
DR   Wikidata; Q54920890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07551
AC   CVCL_ET90
DR   CLO; CLO_0021239
DR   Coriell; ND07551
DR   Wikidata; Q54920892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07552
AC   CVCL_ET91
DR   CLO; CLO_0021237
DR   Coriell; ND07552
DR   Wikidata; Q54920893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07553
AC   CVCL_ET92
DR   CLO; CLO_0021238
DR   Coriell; ND07553
DR   Wikidata; Q54920895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07554
AC   CVCL_ET93
DR   CLO; CLO_0021242
DR   Coriell; ND07554
DR   Wikidata; Q54920896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07576
AC   CVCL_FJ99
DR   CLO; CLO_0021243
DR   Coriell; ND07576
DR   Wikidata; Q54920897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07577
AC   CVCL_FK00
DR   CLO; CLO_0021240
DR   Coriell; ND07577
DR   Wikidata; Q54920898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07578
AC   CVCL_FK01
DR   CLO; CLO_0021241
DR   Coriell; ND07578
DR   Wikidata; Q54920899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07579
AC   CVCL_FK02
DR   CLO; CLO_0021245
DR   Coriell; ND07579
DR   Wikidata; Q54920900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07580
AC   CVCL_HR01
DR   CLO; CLO_0021246
DR   Coriell; ND07580
DR   Wikidata; Q54920901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07581
AC   CVCL_HR02
DR   CLO; CLO_0021244
DR   Coriell; ND07581
DR   Wikidata; Q54920902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07582
AC   CVCL_DZ84
DR   CLO; CLO_0021186
DR   Coriell; ND07582
DR   Wikidata; Q54920903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07583
AC   CVCL_FB66
DR   CLO; CLO_0021187
DR   Coriell; ND07583
DR   Wikidata; Q54920904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07586
AC   CVCL_HU93
DR   Coriell; ND07586
DR   Wikidata; Q54920905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07595
AC   CVCL_FY53
DR   Coriell; ND07595
DR   Wikidata; Q54920906
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07599
AC   CVCL_FK03
DR   CLO; CLO_0021188
DR   Coriell; ND07599
DR   Wikidata; Q54920907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07600
AC   CVCL_GQ19
DR   CLO; CLO_0021189
DR   Coriell; ND07600
DR   Wikidata; Q54920908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07601
AC   CVCL_GC24
DR   CLO; CLO_0021192
DR   Coriell; ND07601
DR   Wikidata; Q54920909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07602
AC   CVCL_DZ85
DR   Coriell; ND07602
DR   Wikidata; Q54920910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07603
AC   CVCL_CJ46
DR   Coriell; ND07603
DR   Wikidata; Q54920911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07604
AC   CVCL_FK04
DR   Coriell; ND07604
DR   Wikidata; Q54920912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07608
AC   CVCL_DZ86
DR   Coriell; ND07608
DR   Wikidata; Q54920913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07610
AC   CVCL_HU94
DR   Coriell; ND07610
DR   Wikidata; Q54920914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07611
AC   CVCL_CJ47
DR   CLO; CLO_0021193
DR   BioSample; SAMN00795395
DR   Coriell; ND07611
DR   Wikidata; Q54920915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07612
AC   CVCL_HR03
DR   CLO; CLO_0021194
DR   Coriell; ND07612
DR   Wikidata; Q54920916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07613
AC   CVCL_HR04
DR   CLO; CLO_0021195
DR   Coriell; ND07613
DR   Wikidata; Q54920918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07614
AC   CVCL_DZ87
DR   CLO; CLO_0021190
DR   Coriell; ND07614
DR   Wikidata; Q54920919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07615
AC   CVCL_ET94
DR   CLO; CLO_0021191
DR   Coriell; ND07615
DR   Wikidata; Q54920920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07616
AC   CVCL_FB67
DR   CLO; CLO_0021210
DR   Coriell; ND07616
DR   Wikidata; Q54920921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07617
AC   CVCL_ET95
DR   CLO; CLO_0021208
DR   Coriell; ND07617
DR   Wikidata; Q54920922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07618
AC   CVCL_DZ88
DR   CLO; CLO_0021209
DR   Coriell; ND07618
DR   Wikidata; Q54920935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07619
AC   CVCL_DZ89
DR   CLO; CLO_0021206
DR   Coriell; ND07619
DR   Wikidata; Q54920936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07624
AC   CVCL_DZ90
DR   Coriell; ND07624
DR   Wikidata; Q54920937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07625
AC   CVCL_DZ91
DR   Coriell; ND07625
DR   Wikidata; Q54920938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07626
AC   CVCL_DZ92
DR   Coriell; ND07626
DR   Wikidata; Q54920939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07628
AC   CVCL_DZ93
DR   Coriell; ND07628
DR   Wikidata; Q54920940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07629
AC   CVCL_HR05
DR   CLO; CLO_0021207
DR   Coriell; ND07629
DR   Wikidata; Q54920941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07630
AC   CVCL_FY54
DR   CLO; CLO_0021214
DR   Coriell; ND07630
DR   Wikidata; Q54920942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07631
AC   CVCL_IC76
DR   Coriell; ND07631
DR   Wikidata; Q54920943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07632
AC   CVCL_IC77
DR   BioSample; SAMN00795403
DR   Coriell; ND07632
DR   Wikidata; Q54920944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND07633
AC   CVCL_IC78
DR   Coriell; ND07633
DR   Wikidata; Q54920945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07634
AC   CVCL_IC79
DR   Coriell; ND07634
DR   Wikidata; Q54920946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07638
AC   CVCL_FY55
DR   Coriell; ND07638
DR   Wikidata; Q54920947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07643
AC   CVCL_HU95
DR   Coriell; ND07643
DR   Wikidata; Q54920948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07646
AC   CVCL_FY56
DR   Coriell; ND07646
DR   Wikidata; Q54920950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07653
AC   CVCL_DZ94
DR   CLO; CLO_0021215
DR   Coriell; ND07653
DR   Wikidata; Q54920951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07654
AC   CVCL_DZ95
DR   CLO; CLO_0021212
DR   Coriell; ND07654
DR   Wikidata; Q54920952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07655
AC   CVCL_ET96
DR   CLO; CLO_0021213
DR   Coriell; ND07655
DR   Wikidata; Q54920953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07658
AC   CVCL_IC80
DR   Coriell; ND07658
DR   Wikidata; Q54920954
CC   Population: Latino or Hispanic; Dominican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   ND07659
AC   CVCL_IC81
DR   Coriell; ND07659
DR   Wikidata; Q54920955
CC   Population: Latino or Hispanic; Dominican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   ND07663
AC   CVCL_CJ48
DR   CLO; CLO_0021211
DR   Coriell; ND07663
DR   Wikidata; Q54920956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07668
AC   CVCL_FY57
DR   Coriell; ND07668
DR   Wikidata; Q54920957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07669
AC   CVCL_BA73
DR   CLO; CLO_0021146
DR   Coriell; ND07669
DR   Wikidata; Q54920958
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND07670
AC   CVCL_DZ96
DR   Coriell; ND07670
DR   Wikidata; Q54920959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07674
AC   CVCL_FK05
DR   CLO; CLO_0021145
DR   Coriell; ND07674
DR   Wikidata; Q54920960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07675
AC   CVCL_HP84
DR   CLO; CLO_0021144
DR   Coriell; ND07675
DR   Wikidata; Q54920961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07685
AC   CVCL_IL67
DR   CLO; CLO_0021143
DR   Coriell; ND07685
DR   Wikidata; Q54920962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND07685; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND07690
AC   CVCL_CJ49
DR   BioSample; SAMN00795425
DR   Coriell; ND07690
DR   Wikidata; Q54920963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07691
AC   CVCL_CJ50
DR   Coriell; ND07691
DR   Wikidata; Q54920964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07693
AC   CVCL_HR06
DR   CLO; CLO_0021142
DR   Coriell; ND07693
DR   Wikidata; Q54920966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07694
AC   CVCL_BA74
DR   CLO; CLO_0021141
DR   Coriell; ND07694
DR   Wikidata; Q54920967
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07695
AC   CVCL_DZ97
DR   CLO; CLO_0021140
DR   Coriell; ND07695
DR   Wikidata; Q54920968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07696
AC   CVCL_ET97
DR   CLO; CLO_0021139
DR   Coriell; ND07696
DR   Wikidata; Q54920969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07697
AC   CVCL_DZ98
DR   CLO; CLO_0021138
DR   Coriell; ND07697
DR   Wikidata; Q54920970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07698
AC   CVCL_ET98
DR   CLO; CLO_0021137
DR   Coriell; ND07698
DR   Wikidata; Q54920971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07699
AC   CVCL_DZ99
DR   CLO; CLO_0021134
DR   Coriell; ND07699
DR   Wikidata; Q54920972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07700
AC   CVCL_EA00
DR   CLO; CLO_0021136
DR   Coriell; ND07700
DR   Wikidata; Q54920973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07701
AC   CVCL_EA01
DR   CLO; CLO_0021135
DR   Coriell; ND07701
DR   Wikidata; Q54920974
CC   Population: Asian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07702
AC   CVCL_EA02
DR   CLO; CLO_0021131
DR   Coriell; ND07702
DR   Wikidata; Q54920975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND07702; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07703
AC   CVCL_EA03
DR   CLO; CLO_0021130
DR   Coriell; ND07703
DR   Wikidata; Q54920976
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07704
AC   CVCL_FB70
DR   CLO; CLO_0021133
DR   Coriell; ND07704
DR   Wikidata; Q54920988
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07705
AC   CVCL_EA04
DR   Coriell; ND07705
DR   Wikidata; Q54920989
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07707
AC   CVCL_FY58
DR   Coriell; ND07707
DR   Wikidata; Q54920990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07708
AC   CVCL_HU96
DR   Coriell; ND07708
DR   Wikidata; Q54920991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07709
AC   CVCL_IH25
DR   Coriell; ND07709
DR   Wikidata; Q54920992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07710
AC   CVCL_FK06
DR   CLO; CLO_0021132
DR   Coriell; ND07710
DR   Wikidata; Q54920993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07712
AC   CVCL_EA05
DR   Coriell; ND07712
DR   Wikidata; Q54920994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07714
AC   CVCL_HU97
DR   Coriell; ND07714
DR   Wikidata; Q54920995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07715
AC   CVCL_IC82
DR   Coriell; ND07715
DR   Wikidata; Q54920996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07716
AC   CVCL_HU98
DR   Coriell; ND07716
DR   Wikidata; Q54920997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07717
AC   CVCL_HU99
DR   Coriell; ND07717
DR   Wikidata; Q54920998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07719
AC   CVCL_FY59
DR   Coriell; ND07719
DR   Wikidata; Q54921000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07720
AC   CVCL_HV00
DR   Coriell; ND07720
DR   Wikidata; Q54921001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07721
AC   CVCL_HR07
DR   CLO; CLO_0021128
DR   Coriell; ND07721
DR   Wikidata; Q54921002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07722
AC   CVCL_HR08
DR   CLO; CLO_0021127
DR   Coriell; ND07722
DR   Wikidata; Q54921003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07723
AC   CVCL_ET99
DR   CLO; CLO_0021129
DR   BioSample; SAMN00795445
DR   Coriell; ND07723
DR   Wikidata; Q54921004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07724
AC   CVCL_HR09
DR   CLO; CLO_0021122
DR   Coriell; ND07724
DR   Wikidata; Q54921005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07725
AC   CVCL_HR10
DR   CLO; CLO_0021121
DR   Coriell; ND07725
DR   Wikidata; Q54921006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07726
AC   CVCL_HR11
DR   CLO; CLO_0021120
DR   Coriell; ND07726
DR   Wikidata; Q54921007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07727
AC   CVCL_HR12
DR   CLO; CLO_0021119
DR   Coriell; ND07727
DR   Wikidata; Q54921008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07728
AC   CVCL_EU00
DR   CLO; CLO_0021126
DR   BioSample; SAMN00795455
DR   Coriell; ND07728
DR   Wikidata; Q54921009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07729
AC   CVCL_IC83
DR   CLO; CLO_0021125
DR   Coriell; ND07729
DR   Wikidata; Q54921010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07730
AC   CVCL_EU01
DR   CLO; CLO_0021124
DR   BioSample; SAMN00795459
DR   Coriell; ND07730
DR   Wikidata; Q54921012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07731
AC   CVCL_HR13
DR   CLO; CLO_0021123
DR   Coriell; ND07731
DR   Wikidata; Q54921013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07732
AC   CVCL_HR14
DR   CLO; CLO_0021118
DR   Coriell; ND07732
DR   Wikidata; Q54921014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07733
AC   CVCL_HR15
DR   CLO; CLO_0021117
DR   Coriell; ND07733
DR   Wikidata; Q54921015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07734
AC   CVCL_GC25
DR   CLO; CLO_0021116
DR   BioSample; SAMN00795467
DR   Coriell; ND07734
DR   Wikidata; Q54921016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07735
AC   CVCL_BA75
DR   CLO; CLO_0021109
DR   Coriell; ND07735
DR   Wikidata; Q54921017
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07736
AC   CVCL_HR16
DR   CLO; CLO_0021108
DR   Coriell; ND07736
DR   Wikidata; Q54921018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07737
AC   CVCL_HR17
DR   CLO; CLO_0021111
DR   Coriell; ND07737
DR   Wikidata; Q54921019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07738
AC   CVCL_BA76
DR   CLO; CLO_0021110
DR   Coriell; ND07738
DR   Wikidata; Q54921020
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07739
AC   CVCL_BA77
DR   CLO; CLO_0021113
DR   Coriell; ND07739
DR   Wikidata; Q54921021
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07740
AC   CVCL_EA06
DR   CLO; CLO_0021112
DR   Coriell; ND07740
DR   Wikidata; Q54921022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07741
AC   CVCL_EA07
DR   CLO; CLO_0021115
DR   Coriell; ND07741
DR   Wikidata; Q54921024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07742
AC   CVCL_EA08
DR   CLO; CLO_0021114
DR   Coriell; ND07742
DR   Wikidata; Q54921025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07743
AC   CVCL_EA09
DR   CLO; CLO_0021107
DR   Coriell; ND07743
DR   Wikidata; Q54921026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07749
AC   CVCL_IC84
DR   Coriell; ND07749
DR   Wikidata; Q54921027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07750
AC   CVCL_IC85
DR   Coriell; ND07750
DR   Wikidata; Q54921028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07751
AC   CVCL_CJ51
DR   Coriell; ND07751
DR   Wikidata; Q54921029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07752
AC   CVCL_CJ52
DR   Coriell; ND07752
DR   Wikidata; Q54921030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07756
AC   CVCL_EA10
DR   Coriell; ND07756
DR   Wikidata; Q54921038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07761
AC   CVCL_IC86
DR   Coriell; ND07761
DR   Wikidata; Q54921039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07763
AC   CVCL_HV01
DR   Coriell; ND07763
DR   Wikidata; Q54921040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07770
AC   CVCL_IC87
DR   Coriell; ND07770
DR   Wikidata; Q54921041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07771
AC   CVCL_IC88
DR   Coriell; ND07771
DR   Wikidata; Q54921042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07781
AC   CVCL_IC89
DR   Coriell; ND07781
DR   Wikidata; Q54921043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07784
AC   CVCL_IC90
DR   Coriell; ND07784
DR   Wikidata; Q54921044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07803
AC   CVCL_IC91
DR   Coriell; ND07803
DR   Wikidata; Q54921045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07823
AC   CVCL_IC92
DR   Coriell; ND07823
DR   Wikidata; Q54921046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07826
AC   CVCL_FY60
DR   Coriell; ND07826
DR   Wikidata; Q54921047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07827
AC   CVCL_CJ53
DR   CLO; CLO_0020727
DR   Coriell; ND07827
DR   Wikidata; Q54921048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07828
AC   CVCL_FC43
DR   CLO; CLO_0020729
DR   Coriell; ND07828
DR   Wikidata; Q54921049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07830
AC   CVCL_GQ20
DR   CLO; CLO_0020728
DR   Coriell; ND07830
DR   Wikidata; Q54921050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36192; Arteriovenous fistula
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07831
AC   CVCL_FY61
DR   CLO; CLO_0020731
DR   Coriell; ND07831
DR   Wikidata; Q54921051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07832
AC   CVCL_FY62
DR   CLO; CLO_0020730
DR   Coriell; ND07832
DR   Wikidata; Q54921052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07839
AC   CVCL_IC93
DR   Coriell; ND07839
DR   Wikidata; Q54921053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07849
AC   CVCL_IC94
DR   Coriell; ND07849
DR   Wikidata; Q54921055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07873
AC   CVCL_IC95
DR   Coriell; ND07873
DR   Wikidata; Q54921056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07876
AC   CVCL_IC96
DR   Coriell; ND07876
DR   Wikidata; Q54921057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07879
AC   CVCL_IC97
DR   Coriell; ND07879
DR   Wikidata; Q54921058
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND07880
AC   CVCL_IC98
DR   Coriell; ND07880
DR   Wikidata; Q54921059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07881
AC   CVCL_IC99
DR   Coriell; ND07881
DR   Wikidata; Q54921060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07882
AC   CVCL_ID00
DR   Coriell; ND07882
DR   Wikidata; Q54921061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07883
AC   CVCL_ID01
DR   Coriell; ND07883
DR   Wikidata; Q54921062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07884
AC   CVCL_ID02
DR   Coriell; ND07884
DR   Wikidata; Q54921063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07886
AC   CVCL_ID03
DR   Coriell; ND07886
DR   Wikidata; Q54921064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07887
AC   CVCL_ID04
DR   Coriell; ND07887
DR   Wikidata; Q54921065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07894
AC   CVCL_HV02
DR   Coriell; ND07894
DR   Wikidata; Q54921066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07896
AC   CVCL_FY63
DR   Coriell; ND07896
DR   Wikidata; Q54921067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07899
AC   CVCL_EU02
DR   CLO; CLO_0020733
DR   Coriell; ND07899
DR   Wikidata; Q54921068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07900
AC   CVCL_EA11
DR   CLO; CLO_0020732
DR   Coriell; ND07900
DR   Wikidata; Q54921069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07901
AC   CVCL_FK07
DR   CLO; CLO_0020735
DR   Coriell; ND07901
DR   Wikidata; Q54921070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07902
AC   CVCL_CJ54
DR   Coriell; ND07902
DR   Wikidata; Q54921071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07903
AC   CVCL_CJ55
DR   Coriell; ND07903
DR   Wikidata; Q54921072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07918
AC   CVCL_FK08
DR   CLO; CLO_0020736
DR   Coriell; ND07918
DR   Wikidata; Q54921073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07919
AC   CVCL_GT18
DR   CLO; CLO_0020734
DR   Coriell; ND07919
DR   Wikidata; Q54921074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07920
AC   CVCL_BA78
DR   Coriell; ND07920
DR   Wikidata; Q54921075
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07921
AC   CVCL_BA79
DR   CLO; CLO_0020740
DR   Coriell; ND07921
DR   Wikidata; Q54921076
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07925
AC   CVCL_FK09
DR   CLO; CLO_0020739
DR   Coriell; ND07925
DR   Wikidata; Q54921077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07926
AC   CVCL_ID05
DR   CLO; CLO_0020738
DR   Coriell; ND07926
DR   Wikidata; Q54921078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07927
AC   CVCL_FK10
DR   CLO; CLO_0020737
DR   Coriell; ND07927
DR   Wikidata; Q54921086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07928
AC   CVCL_ID06
DR   CLO; CLO_0020744
DR   Coriell; ND07928
DR   Wikidata; Q54921087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07929
AC   CVCL_FK11
DR   CLO; CLO_0020743
DR   Coriell; ND07929
DR   Wikidata; Q54921088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07930
AC   CVCL_ID07
DR   CLO; CLO_0020742
DR   Coriell; ND07930
DR   Wikidata; Q54921089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07931
AC   CVCL_CJ56
DR   CLO; CLO_0020741
DR   Coriell; ND07931
DR   Wikidata; Q54921090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07932
AC   CVCL_CJ57
DR   CLO; CLO_0020745
DR   Coriell; ND07932
DR   Wikidata; Q54921091
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07933
AC   CVCL_FY64
DR   CLO; CLO_0020746
DR   Coriell; ND07933
DR   Wikidata; Q54921092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07934
AC   CVCL_FY65
DR   CLO; CLO_0020747
DR   Coriell; ND07934
DR   Wikidata; Q54921093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07935
AC   CVCL_GC26
DR   CLO; CLO_0020753
DR   Coriell; ND07935
DR   Wikidata; Q54921094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07941
AC   CVCL_CJ58
DR   Coriell; ND07941
DR   Wikidata; Q54921095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07942
AC   CVCL_CJ59
DR   CLO; CLO_0020752
DR   Coriell; ND07942
DR   Wikidata; Q54921096
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07943
AC   CVCL_CJ60
DR   CLO; CLO_0020755
DR   BioSample; SAMN00795509
DR   Coriell; ND07943
DR   Wikidata; Q54921097
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND07944
AC   CVCL_GC27
DR   CLO; CLO_0020754
DR   BioSample; SAMN00795510
DR   Coriell; ND07944
DR   Wikidata; Q54921098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND07945
AC   CVCL_CJ61
DR   CLO; CLO_0020749
DR   Coriell; ND07945
DR   Wikidata; Q54921099
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND07946
AC   CVCL_CJ62
DR   CLO; CLO_0020748
DR   BioSample; SAMN00795512
DR   Coriell; ND07946
DR   Wikidata; Q54921100
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND07947
AC   CVCL_EA12
DR   CLO; CLO_0020751
DR   Coriell; ND07947
DR   Wikidata; Q54921101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07948
AC   CVCL_EA13
DR   CLO; CLO_0020750
DR   Coriell; ND07948
DR   Wikidata; Q54921102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07949
AC   CVCL_EU03
DR   CLO; CLO_0020756
DR   Coriell; ND07949
DR   Wikidata; Q54921103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07950
AC   CVCL_EU04
DR   CLO; CLO_0020758
DR   Coriell; ND07950
DR   Wikidata; Q54921104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07951
AC   CVCL_EU05
DR   CLO; CLO_0020757
DR   Coriell; ND07951
DR   Wikidata; Q54921105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07952
AC   CVCL_EA14
DR   CLO; CLO_0020766
DR   Coriell; ND07952
DR   Wikidata; Q54921106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07953
AC   CVCL_EA15
DR   CLO; CLO_0020765
DR   Coriell; ND07953
DR   Wikidata; Q54921107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07954
AC   CVCL_EA16
DR   CLO; CLO_0020764
DR   Coriell; ND07954
DR   Wikidata; Q54921108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07955
AC   CVCL_GC28
DR   CLO; CLO_0020763
DR   Coriell; ND07955
DR   Wikidata; Q54921109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07956
AC   CVCL_GC29
DR   CLO; CLO_0020762
DR   Coriell; ND07956
DR   Wikidata; Q54921110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07957
AC   CVCL_EA17
DR   CLO; CLO_0020761
DR   Coriell; ND07957
DR   Wikidata; Q54921111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07958
AC   CVCL_EA18
DR   CLO; CLO_0020760
DR   Coriell; ND07958
DR   Wikidata; Q54921112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07959
AC   CVCL_EA19
DR   CLO; CLO_0020759
DR   Coriell; ND07959
DR   Wikidata; Q54921113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND07964
AC   CVCL_EA20
DR   Coriell; ND07964
DR   Wikidata; Q54921114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07966
AC   CVCL_CJ63
DR   Coriell; ND07966
DR   Wikidata; Q54921115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07967
AC   CVCL_HV03
DR   CLO; CLO_0020774
DR   Coriell; ND07967
DR   Wikidata; Q54921116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07968
AC   CVCL_FK12
DR   CLO; CLO_0020775
DR   Coriell; ND07968
DR   Wikidata; Q54921117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07969
AC   CVCL_HR18
DR   CLO; CLO_0020776
DR   Coriell; ND07969
DR   Wikidata; Q54921118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07970
AC   CVCL_FY66
DR   CLO; CLO_0020767
DR   Coriell; ND07970
DR   Wikidata; Q54921119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07971
AC   CVCL_IH26
DR   CLO; CLO_0020768
DR   Coriell; ND07971
DR   Wikidata; Q54921120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND07975
AC   CVCL_CJ64
DR   Coriell; ND07975
DR   Wikidata; Q54921121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND07979
AC   CVCL_EA21
DR   CLO; CLO_0020769
DR   Coriell; ND07979
DR   Wikidata; Q54921122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07980
AC   CVCL_EU06
DR   CLO; CLO_0020770
DR   Coriell; ND07980
DR   Wikidata; Q54921124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07981
AC   CVCL_EA22
DR   CLO; CLO_0020771
DR   Coriell; ND07981
DR   Wikidata; Q54921125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07982
AC   CVCL_FC44
DR   CLO; CLO_0020772
DR   Coriell; ND07982
DR   Wikidata; Q54921126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07984
AC   CVCL_EA23
DR   Coriell; ND07984
DR   Wikidata; Q54921138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07985
AC   CVCL_EA24
DR   CLO; CLO_0020773
DR   Coriell; ND07985
DR   Wikidata; Q54921139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND07986
AC   CVCL_FK13
DR   Coriell; ND07986
DR   Wikidata; Q54921140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07987
AC   CVCL_FK14
DR   Coriell; ND07987
DR   Wikidata; Q54921141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND07994
AC   CVCL_BA80
DR   CLO; CLO_0020785
DR   Coriell; ND07994
DR   Wikidata; Q54921142
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07995
AC   CVCL_BA81
DR   CLO; CLO_0020786
DR   Coriell; ND07995
DR   Wikidata; Q54921143
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND07996
AC   CVCL_FK15
DR   CLO; CLO_0020783
DR   Coriell; ND07996
DR   Wikidata; Q54921144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08001
AC   CVCL_CJ65
DR   CLO; CLO_0020784
DR   BioSample; SAMN00795530
DR   Coriell; ND08001
DR   Wikidata; Q54921145
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND08002
AC   CVCL_EU07
DR   CLO; CLO_0020779
DR   BioSample; SAMN00795532
DR   Coriell; ND08002
DR   Wikidata; Q54921146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08004
AC   CVCL_FK16
DR   CLO; CLO_0020780
DR   Coriell; ND08004
DR   Wikidata; Q54921147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08005
AC   CVCL_EU08
DR   CLO; CLO_0020777
DR   Coriell; ND08005
DR   Wikidata; Q54921148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08007
AC   CVCL_CJ66
DR   CLO; CLO_0020778
DR   Coriell; ND08007
DR   Wikidata; Q54921149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08009
AC   CVCL_FK17
DR   Coriell; ND08009
DR   Wikidata; Q54921150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08010
AC   CVCL_ID08
DR   Coriell; ND08010
DR   Wikidata; Q54921151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08011
AC   CVCL_CJ67
DR   Coriell; ND08011
DR   Wikidata; Q54921152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08012
AC   CVCL_CJ68
DR   Coriell; ND08012
DR   Wikidata; Q54921154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08013
AC   CVCL_CJ69
DR   Coriell; ND08013
DR   Wikidata; Q54921155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08014
AC   CVCL_HV04
DR   Coriell; ND08014
DR   Wikidata; Q54921156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08018
AC   CVCL_FK18
DR   CLO; CLO_0020781
DR   Coriell; ND08018
DR   Wikidata; Q54921157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08019
AC   CVCL_ID09
DR   CLO; CLO_0020782
DR   Coriell; ND08019
DR   Wikidata; Q54921158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08020
AC   CVCL_EU09
DR   CLO; CLO_0020806
DR   Coriell; ND08020
DR   Wikidata; Q54921159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08021
AC   CVCL_FK19
DR   CLO; CLO_0020802
DR   Coriell; ND08021
DR   Wikidata; Q54921160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08022
AC   CVCL_HR19
DR   CLO; CLO_0020803
DR   Coriell; ND08022
DR   Wikidata; Q54921161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08023
AC   CVCL_HR20
DR   CLO; CLO_0020804
DR   Coriell; ND08023
DR   Wikidata; Q54921162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08024
AC   CVCL_EA25
DR   CLO; CLO_0020805
DR   Coriell; ND08024
DR   Wikidata; Q54921163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08025
AC   CVCL_EU10
DR   CLO; CLO_0020798
DR   Coriell; ND08025
DR   Wikidata; Q54921164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08026
AC   CVCL_EA26
DR   CLO; CLO_0020799
DR   Coriell; ND08026
DR   Wikidata; Q54921165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08027
AC   CVCL_EU11
DR   CLO; CLO_0020800
DR   Coriell; ND08027
DR   Wikidata; Q54921166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08028
AC   CVCL_EA27
DR   CLO; CLO_0020801
DR   Coriell; ND08028
DR   Wikidata; Q54921167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08029
AC   CVCL_EU12
DR   CLO; CLO_0020797
DR   Coriell; ND08029
DR   Wikidata; Q54921169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08030
AC   CVCL_EU13
DR   CLO; CLO_0020815
DR   Coriell; ND08030
DR   Wikidata; Q54921170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08035
AC   CVCL_EA28
DR   Coriell; ND08035
DR   Wikidata; Q54921171
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08038
AC   CVCL_CJ70
DR   CLO; CLO_0020816
DR   Coriell; ND08038
DR   Wikidata; Q54921172
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08039
AC   CVCL_CJ71
DR   CLO; CLO_0020813
DR   Coriell; ND08039
DR   Wikidata; Q54921173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08040
AC   CVCL_CJ72
DR   CLO; CLO_0020814
DR   Coriell; ND08040
DR   Wikidata; Q54921174
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08044
AC   CVCL_EA29
DR   Coriell; ND08044
DR   Wikidata; Q54921175
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08045
AC   CVCL_FF17
DR   Coriell; ND08045
DR   Wikidata; Q54921176
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08047
AC   CVCL_ID10
DR   Coriell; ND08047
DR   Wikidata; Q54921177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08048
AC   CVCL_ID11
DR   Coriell; ND08048
DR   Wikidata; Q54921178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08049
AC   CVCL_ID12
DR   Coriell; ND08049
DR   Wikidata; Q54921179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08050
AC   CVCL_ID13
DR   BioSample; SAMN00795558
DR   Coriell; ND08050
DR   Wikidata; Q54921192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08053
AC   CVCL_ID14
DR   Coriell; ND08053
DR   Wikidata; Q54921193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08055
AC   CVCL_FY67
DR   Coriell; ND08055
DR   Wikidata; Q54921194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08056
AC   CVCL_EU14
DR   CLO; CLO_0020811
DR   Coriell; ND08056
DR   Wikidata; Q54921195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08057
AC   CVCL_HR21
DR   CLO; CLO_0020812
DR   Coriell; ND08057
DR   Wikidata; Q54921196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08058
AC   CVCL_EU15
DR   CLO; CLO_0020809
DR   Coriell; ND08058
DR   Wikidata; Q54921197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08059
AC   CVCL_EU16
DR   CLO; CLO_0020810
DR   Coriell; ND08059
DR   Wikidata; Q54921198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08060
AC   CVCL_EU17
DR   CLO; CLO_0020807
DR   Coriell; ND08060
DR   Wikidata; Q54921199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08061
AC   CVCL_EU18
DR   CLO; CLO_0020808
DR   Coriell; ND08061
DR   Wikidata; Q54921200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08062
AC   CVCL_EA30
DR   CLO; CLO_0020723
DR   Coriell; ND08062
DR   Wikidata; Q54921201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08066
AC   CVCL_HV05
DR   Coriell; ND08066
DR   Wikidata; Q54921202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08067
AC   CVCL_FK20
DR   CLO; CLO_0020722
DR   Coriell; ND08067
DR   Wikidata; Q54921204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08071
AC   CVCL_ID15
DR   Coriell; ND08071
DR   Wikidata; Q54921205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08074
AC   CVCL_CY94
DR   CLO; CLO_0020721
DR   Coriell; ND08074
DR   Wikidata; Q54921206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND08075 (Cellosaurus=CVCL_CY95).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08075
AC   CVCL_CY95
DR   CLO; CLO_0020720
DR   Coriell; ND08075
DR   Wikidata; Q54921207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND08074 (Cellosaurus=CVCL_CY94).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08076
AC   CVCL_BA82
DR   CLO; CLO_0020719
DR   Coriell; ND08076
DR   Wikidata; Q54921208
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08077
AC   CVCL_GC30
DR   CLO; CLO_0020718
DR   BioSample; SAMN00795580
DR   Coriell; ND08077
DR   Wikidata; Q54921209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08078
AC   CVCL_BA83
DR   CLO; CLO_0020717
DR   Coriell; ND08078
DR   Wikidata; Q54921210
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND08079
AC   CVCL_EU19
DR   CLO; CLO_0020726
DR   Coriell; ND08079
DR   Wikidata; Q54921211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08080
AC   CVCL_FY68
DR   CLO; CLO_0020725
DR   Coriell; ND08080
DR   Wikidata; Q54921212
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08081
AC   CVCL_CJ73
DR   CLO; CLO_0020724
DR   Coriell; ND08081
DR   Wikidata; Q54921213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08082
AC   CVCL_CJ74
DR   CLO; CLO_0020712
DR   BioSample; SAMN00795582
DR   Coriell; ND08082
DR   Wikidata; Q54921214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08083
AC   CVCL_EU20
DR   CLO; CLO_0020711
DR   BioSample; SAMN00795584
DR   Coriell; ND08083
DR   Wikidata; Q54921215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08085
AC   CVCL_CJ75
DR   BioSample; SAMN00795586
DR   Coriell; ND08085
DR   Wikidata; Q54921217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08092
AC   CVCL_ID16
DR   CLO; CLO_0020714
DR   Coriell; ND08092
DR   Wikidata; Q54921218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08094
AC   CVCL_EA31
DR   CLO; CLO_0020713
DR   Coriell; ND08094
DR   Wikidata; Q54921219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08095
AC   CVCL_EA32
DR   CLO; CLO_0020708
DR   Coriell; ND08095
DR   Wikidata; Q54921220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08096
AC   CVCL_EA33
DR   Coriell; ND08096
DR   Wikidata; Q54921221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08097
AC   CVCL_EA34
DR   CLO; CLO_0020707
DR   Coriell; ND08097
DR   Wikidata; Q54921222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08107
AC   CVCL_CJ76
DR   CLO; CLO_0020710
DR   Coriell; ND08107
DR   Wikidata; Q54921223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08108
AC   CVCL_FY69
DR   CLO; CLO_0020709
DR   Coriell; ND08108
DR   Wikidata; Q54921224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08109
AC   CVCL_FK21
DR   CLO; CLO_0020716
DR   Coriell; ND08109
DR   Wikidata; Q54921225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08117
AC   CVCL_EA35
DR   CLO; CLO_0020715
DR   Coriell; ND08117
DR   Wikidata; Q54921226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08119
AC   CVCL_EA36
DR   CLO; CLO_0020576
DR   Coriell; ND08119
DR   Wikidata; Q54921228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08120
AC   CVCL_EA37
DR   CLO; CLO_0020577
DR   Coriell; ND08120
DR   Wikidata; Q54921229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08121
AC   CVCL_EA38
DR   CLO; CLO_0020574
DR   Coriell; ND08121
DR   Wikidata; Q54921230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08122
AC   CVCL_EA39
DR   CLO; CLO_0020575
DR   Coriell; ND08122
DR   Wikidata; Q54921231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08127
AC   CVCL_BA84
DR   CLO; CLO_0020572
DR   Coriell; ND08127
DR   Wikidata; Q54921232
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08128
AC   CVCL_FC45
DR   CLO; CLO_0020573
DR   Coriell; ND08128
DR   Wikidata; Q54921233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08129
AC   CVCL_FK22
DR   Coriell; ND08129
DR   Wikidata; Q54921234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08130
AC   CVCL_HV06
DR   Coriell; ND08130
DR   Wikidata; Q54921245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08131
AC   CVCL_HV07
DR   Coriell; ND08131
DR   Wikidata; Q54921247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08137
AC   CVCL_HV08
DR   Coriell; ND08137
DR   Wikidata; Q54921248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08141
AC   CVCL_CJ77
DR   CLO; CLO_0020579
DR   Coriell; ND08141
DR   Wikidata; Q54921249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08142
AC   CVCL_CJ78
DR   CLO; CLO_0020578
DR   Coriell; ND08142
DR   Wikidata; Q54921250
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08143
AC   CVCL_FY70
DR   CLO; CLO_0020581
DR   Coriell; ND08143
DR   Wikidata; Q54921251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08151
AC   CVCL_CJ79
DR   CLO; CLO_0020580
DR   BioSample; SAMN00795604
DR   Coriell; ND08151
DR   Wikidata; Q54921252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08152
AC   CVCL_GC31
DR   CLO; CLO_0020586
DR   BioSample; SAMN00795606
DR   Coriell; ND08152
DR   Wikidata; Q54921253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08153
AC   CVCL_CJ80
DR   CLO; CLO_0020587
DR   Coriell; ND08153
DR   Wikidata; Q54921254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08154
AC   CVCL_CJ81
DR   CLO; CLO_0020588
DR   Coriell; ND08154
DR   Wikidata; Q54921255
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08160
AC   CVCL_CJ82
DR   Coriell; ND08160
DR   Wikidata; Q54921256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08161
AC   CVCL_CJ83
DR   CLO; CLO_0020582
DR   Coriell; ND08161
DR   Wikidata; Q54921257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08162
AC   CVCL_CJ84
DR   CLO; CLO_0020583
DR   Coriell; ND08162
DR   Wikidata; Q54921258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08163
AC   CVCL_CJ85
DR   CLO; CLO_0020584
DR   Coriell; ND08163
DR   Wikidata; Q54921259
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08164
AC   CVCL_CJ86
DR   CLO; CLO_0020585
DR   Coriell; ND08164
DR   Wikidata; Q54921260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08165
AC   CVCL_HV09
DR   CLO; CLO_0020541
DR   Coriell; ND08165
DR   Wikidata; Q54921261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08166
AC   CVCL_GQ21
DR   CLO; CLO_0020542
DR   Coriell; ND08166
DR   Wikidata; Q54921262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36192; Arteriovenous fistula
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08181
AC   CVCL_CJ87
DR   Coriell; ND08181
DR   Wikidata; Q54921263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08186
AC   CVCL_FC46
DR   CLO; CLO_0020545
DR   BioSample; SAMN00795608
DR   Coriell; ND08186
DR   Wikidata; Q54921264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08187
AC   CVCL_CJ88
DR   CLO; CLO_0020531
DR   Coriell; ND08187
DR   Wikidata; Q54921265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08188
AC   CVCL_EU21
DR   CLO; CLO_0020530
DR   BioSample; SAMN00795610
DR   Coriell; ND08188
DR   Wikidata; Q54921266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08189
AC   CVCL_CJ89
DR   CLO; CLO_0020533
DR   BioSample; SAMN00795612
DR   Coriell; ND08189
DR   Wikidata; Q54921267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08190
AC   CVCL_CJ90
DR   CLO; CLO_0020532
DR   BioSample; SAMN00795614
DR   Coriell; ND08190
DR   Wikidata; Q54921268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08191
AC   CVCL_CJ91
DR   CLO; CLO_0020535
DR   Coriell; ND08191
DR   Wikidata; Q54921269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08192
AC   CVCL_CJ92
DR   CLO; CLO_0020534
DR   Coriell; ND08192
DR   Wikidata; Q54921270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08193
AC   CVCL_CJ93
DR   CLO; CLO_0020537
DR   Coriell; ND08193
DR   Wikidata; Q54921271
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08196
AC   CVCL_EA40
DR   Coriell; ND08196
DR   Wikidata; Q54921273
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08203
AC   CVCL_HV10
DR   Coriell; ND08203
DR   Wikidata; Q54921274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08204
AC   CVCL_HV11
DR   Coriell; ND08204
DR   Wikidata; Q54921275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08207
AC   CVCL_EA41
DR   CLO; CLO_0020536
DR   Coriell; ND08207
DR   Wikidata; Q54921276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08208
AC   CVCL_EA42
DR   CLO; CLO_0020560
DR   Coriell; ND08208
DR   Wikidata; Q54921277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08209
AC   CVCL_CJ94
DR   CLO; CLO_0020561
DR   Coriell; ND08209
DR   Wikidata; Q54921278
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08210
AC   CVCL_CJ95
DR   CLO; CLO_0020559
DR   BioSample; SAMN00795622
DR   Coriell; ND08210
DR   Wikidata; Q54921279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08212
AC   CVCL_CJ96
DR   CLO; CLO_0020554
DR   Coriell; ND08212
DR   Wikidata; Q54921280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08213
AC   CVCL_CJ97
DR   CLO; CLO_0020553
DR   Coriell; ND08213
DR   Wikidata; Q54921281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08216
AC   CVCL_FK23
DR   Coriell; ND08216
DR   Wikidata; Q54921282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08217
AC   CVCL_FK24
DR   Coriell; ND08217
DR   Wikidata; Q54921283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08218
AC   CVCL_CJ98
DR   Coriell; ND08218
DR   Wikidata; Q54921285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08219
AC   CVCL_CJ99
DR   Coriell; ND08219
DR   Wikidata; Q54921286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08228
AC   CVCL_FY71
DR   CLO; CLO_0020552
DR   Coriell; ND08228
DR   Wikidata; Q54921287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08230
AC   CVCL_EU22
DR   CLO; CLO_0020551
DR   Coriell; ND08230
DR   Wikidata; Q54921292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08231
AC   CVCL_IL68
DR   CLO; CLO_0020558
DR   Coriell; ND08231
DR   Wikidata; Q54921293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND08231; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND08237
AC   CVCL_CK00
DR   Coriell; ND08237
DR   Wikidata; Q54921294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08239
AC   CVCL_GC32
DR   CLO; CLO_0020557
DR   Coriell; ND08239
DR   Wikidata; Q54921295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08240
AC   CVCL_EU23
DR   CLO; CLO_0020556
DR   Coriell; ND08240
DR   Wikidata; Q54921296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08241
AC   CVCL_EA43
DR   CLO; CLO_0020555
DR   Coriell; ND08241
DR   Wikidata; Q54921297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08242
AC   CVCL_BA85
DR   CLO; CLO_0020505
DR   Coriell; ND08242
DR   Wikidata; Q54921298
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND08243 (Cellosaurus=CVCL_DR38).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   ND08243
AC   CVCL_DR38
DR   CLO; CLO_0020498
DR   Coriell; ND08243
DR   Wikidata; Q54921299
CC   Population: Caucasian; Italian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND08242 (Cellosaurus=CVCL_BA85). At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   ND08244
AC   CVCL_GC33
DR   CLO; CLO_0020497
DR   Coriell; ND08244
DR   Wikidata; Q54921300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08245
AC   CVCL_CK01
DR   CLO; CLO_0020494
DR   Coriell; ND08245
DR   Wikidata; Q54921301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08246
AC   CVCL_CK02
DR   CLO; CLO_0020493
DR   Coriell; ND08246
DR   Wikidata; Q54921302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08253
AC   CVCL_GC34
DR   CLO; CLO_0020496
DR   Coriell; ND08253
DR   Wikidata; Q54921303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08254
AC   CVCL_CK03
DR   CLO; CLO_0020495
DR   Coriell; ND08254
DR   Wikidata; Q54921304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08255
AC   CVCL_IH27
DR   CLO; CLO_0020490
DR   Coriell; ND08255
DR   Wikidata; Q54921305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08257
AC   CVCL_FY72
DR   CLO; CLO_0020489
DR   Coriell; ND08257
DR   Wikidata; Q54921306
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08258
AC   CVCL_FY73
DR   CLO; CLO_0020492
DR   Coriell; ND08258
DR   Wikidata; Q54921307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08268
AC   CVCL_CK04
DR   Coriell; ND08268
DR   Wikidata; Q54921308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08273
AC   CVCL_FK25
DR   CLO; CLO_0020491
DR   Coriell; ND08273
DR   Wikidata; Q54921309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08274
AC   CVCL_HR22
DR   CLO; CLO_0020519
DR   Coriell; ND08274
DR   Wikidata; Q54921310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08275
AC   CVCL_HR23
DR   CLO; CLO_0020518
DR   Coriell; ND08275
DR   Wikidata; Q54921311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08276
AC   CVCL_EA44
DR   CLO; CLO_0020517
DR   Coriell; ND08276
DR   Wikidata; Q54921312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08277
AC   CVCL_EU24
DR   CLO; CLO_0020516
DR   Coriell; ND08277
DR   Wikidata; Q54921313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08278
AC   CVCL_GC35
DR   CLO; CLO_0020515
DR   Coriell; ND08278
DR   Wikidata; Q54921314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08280
AC   CVCL_EA45
DR   Coriell; ND08280
DR   Wikidata; Q54921315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08286
AC   CVCL_EU25
DR   CLO; CLO_0020514
DR   Coriell; ND08286
DR   Wikidata; Q54921316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08287
AC   CVCL_EU26
DR   CLO; CLO_0020513
DR   Coriell; ND08287
DR   Wikidata; Q54921318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08288
AC   CVCL_CK05
DR   CLO; CLO_0020512
DR   Coriell; ND08288
DR   Wikidata; Q54921319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08295
AC   CVCL_CK06
DR   Coriell; ND08295
DR   Wikidata; Q54921320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08296
AC   CVCL_CK07
DR   Coriell; ND08296
DR   Wikidata; Q54921322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08297
AC   CVCL_CK08
DR   Coriell; ND08297
DR   Wikidata; Q54921323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08298
AC   CVCL_CK09
DR   Coriell; ND08298
DR   Wikidata; Q54921324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08299
AC   CVCL_CK10
DR   BioSample; SAMN00795634
DR   Coriell; ND08299
DR   Wikidata; Q54921325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08300
AC   CVCL_CK11
DR   Coriell; ND08300
DR   Wikidata; Q54921326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08301
AC   CVCL_CK12
DR   BioSample; SAMN00795636
DR   Coriell; ND08301
DR   Wikidata; Q54921327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08306
AC   CVCL_CK13
DR   CLO; CLO_0020511
DR   Coriell; ND08306
DR   Wikidata; Q54921328
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08307
AC   CVCL_IL69
DR   CLO; CLO_0020510
DR   Coriell; ND08307
DR   Wikidata; Q54921329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND08307; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND08308
AC   CVCL_BA86
DR   CLO; CLO_0020449
DR   Coriell; ND08308
DR   Wikidata; Q54921330
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08312
AC   CVCL_CK14
DR   Coriell; ND08312
DR   Wikidata; Q54921331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08313
AC   CVCL_FY74
DR   Coriell; ND08313
DR   Wikidata; Q54921332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08314
AC   CVCL_HV12
DR   Coriell; ND08314
DR   Wikidata; Q54921333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08316
AC   CVCL_FY75
DR   Coriell; ND08316
DR   Wikidata; Q54921341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08317
AC   CVCL_ID17
DR   Coriell; ND08317
DR   Wikidata; Q54921342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08318
AC   CVCL_EU27
DR   CLO; CLO_0020450
DR   Coriell; ND08318
DR   Wikidata; Q54921343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08319
AC   CVCL_EU28
DR   CLO; CLO_0020451
DR   Coriell; ND08319
DR   Wikidata; Q54921344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08320
AC   CVCL_FY76
DR   CLO; CLO_0020452
DR   Coriell; ND08320
DR   Wikidata; Q54921345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08321
AC   CVCL_FK26
DR   CLO; CLO_0020453
DR   Coriell; ND08321
DR   Wikidata; Q54921346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08322
AC   CVCL_HR24
DR   CLO; CLO_0020454
DR   Coriell; ND08322
DR   Wikidata; Q54921347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08323
AC   CVCL_HR25
DR   CLO; CLO_0020455
DR   Coriell; ND08323
DR   Wikidata; Q54921348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08324
AC   CVCL_FK27
DR   CLO; CLO_0020456
DR   Coriell; ND08324
DR   Wikidata; Q54921349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08325
AC   CVCL_ID18
DR   CLO; CLO_0020457
DR   Coriell; ND08325
DR   Wikidata; Q54921350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08329
AC   CVCL_CK15
DR   Coriell; ND08329
DR   Wikidata; Q54921351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08334
AC   CVCL_ID19
DR   CLO; CLO_0020458
DR   Coriell; ND08334
DR   Wikidata; Q54921352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08335
AC   CVCL_FK28
DR   CLO; CLO_0020469
DR   Coriell; ND08335
DR   Wikidata; Q54921353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08343
AC   CVCL_EA46
DR   Coriell; ND08343
DR   Wikidata; Q54921354
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08346
AC   CVCL_CK16
DR   Coriell; ND08346
DR   Wikidata; Q54921355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08347
AC   CVCL_CK17
DR   Coriell; ND08347
DR   Wikidata; Q54921356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08349
AC   CVCL_HV13
DR   Coriell; ND08349
DR   Wikidata; Q54921357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08350
AC   CVCL_EU29
DR   CLO; CLO_0020472
DR   Coriell; ND08350
DR   Wikidata; Q54921359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08351
AC   CVCL_GC36
DR   CLO; CLO_0020473
DR   Coriell; ND08351
DR   Wikidata; Q54921360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08352
AC   CVCL_FC47
DR   CLO; CLO_0020470
DR   Coriell; ND08352
DR   Wikidata; Q54921361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08359
AC   CVCL_HV14
DR   Coriell; ND08359
DR   Wikidata; Q54921362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08360
AC   CVCL_BA87
DR   CLO; CLO_0020471
DR   Coriell; ND08360
DR   Wikidata; Q54921363
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08368
AC   CVCL_EU30
DR   CLO; CLO_0020476
DR   Coriell; ND08368
DR   Wikidata; Q54921364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08369
AC   CVCL_FK29
DR   CLO; CLO_0020477
DR   Coriell; ND08369
DR   Wikidata; Q54921366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08370
AC   CVCL_FK30
DR   CLO; CLO_0020474
DR   Coriell; ND08370
DR   Wikidata; Q54921367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08371
AC   CVCL_ID20
DR   CLO; CLO_0020475
DR   Coriell; ND08371
DR   Wikidata; Q54921369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08377
AC   CVCL_FK31
DR   Coriell; ND08377
DR   Wikidata; Q54921370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08378
AC   CVCL_ID21
DR   Coriell; ND08378
DR   Wikidata; Q54921371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08380
AC   CVCL_EA47
DR   Coriell; ND08380
DR   Wikidata; Q54921372
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   ND08381
AC   CVCL_CK18
DR   Coriell; ND08381
DR   Wikidata; Q54921373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08382
AC   CVCL_CK19
DR   Coriell; ND08382
DR   Wikidata; Q54921374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08383
AC   CVCL_HV15
DR   Coriell; ND08383
DR   Wikidata; Q54921375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08384
AC   CVCL_ID22
DR   Coriell; ND08384
DR   Wikidata; Q54921376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08386
AC   CVCL_FK32
DR   CLO; CLO_0020478
DR   Coriell; ND08386
DR   Wikidata; Q54921377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08387
AC   CVCL_ID23
DR   CLO; CLO_0020413
DR   Coriell; ND08387
DR   Wikidata; Q54921378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08388
AC   CVCL_CK20
DR   CLO; CLO_0020414
DR   Coriell; ND08388
DR   Wikidata; Q54921379
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08389
AC   CVCL_FK33
DR   CLO; CLO_0020409
DR   Coriell; ND08389
DR   Wikidata; Q54921380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08390
AC   CVCL_GC37
DR   CLO; CLO_0020410
DR   Coriell; ND08390
DR   Wikidata; Q54921381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08391
AC   CVCL_EU31
DR   CLO; CLO_0020411
DR   Coriell; ND08391
DR   Wikidata; Q54921382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08392
AC   CVCL_EU32
DR   CLO; CLO_0020412
DR   Coriell; ND08392
DR   Wikidata; Q54921383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08393
AC   CVCL_EU33
DR   CLO; CLO_0020415
DR   Coriell; ND08393
DR   Wikidata; Q54921389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08394
AC   CVCL_EU34
DR   CLO; CLO_0020416
DR   Coriell; ND08394
DR   Wikidata; Q54921390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08395
AC   CVCL_IH28
DR   CLO; CLO_0020417
DR   Coriell; ND08395
DR   Wikidata; Q54921391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08396
AC   CVCL_IH29
DR   CLO; CLO_0020418
DR   Coriell; ND08396
DR   Wikidata; Q54921392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08397
AC   CVCL_IH30
DR   CLO; CLO_0020435
DR   Coriell; ND08397
DR   Wikidata; Q54921393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08398
AC   CVCL_IH48
DR   CLO; CLO_0020433
DR   Coriell; ND08398
DR   Wikidata; Q54921394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08399
AC   CVCL_FY77
DR   CLO; CLO_0020434
DR   Coriell; ND08399
DR   Wikidata; Q54921395
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08400
AC   CVCL_FY78
DR   CLO; CLO_0020431
DR   Coriell; ND08400
DR   Wikidata; Q54921396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08403
AC   CVCL_EA48
DR   Coriell; ND08403
DR   Wikidata; Q54921397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08405
AC   CVCL_CK21
DR   Coriell; ND08405
DR   Wikidata; Q54921398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08406
AC   CVCL_IL70
DR   CLO; CLO_0020432
DR   Coriell; ND08406
DR   Wikidata; Q54921399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND08406; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND08407
AC   CVCL_HR26
DR   CLO; CLO_0020429
DR   Coriell; ND08407
DR   Wikidata; Q54921401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08408
AC   CVCL_ID24
DR   Coriell; ND08408
DR   Wikidata; Q54921402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08418
AC   CVCL_ID25
DR   Coriell; ND08418
DR   Wikidata; Q54921403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08423
AC   CVCL_ID26
DR   Coriell; ND08423
DR   Wikidata; Q54921404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08441
AC   CVCL_ID27
DR   Coriell; ND08441
DR   Wikidata; Q54921406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08445
AC   CVCL_FY79
DR   Coriell; ND08445
DR   Wikidata; Q54921407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08446
AC   CVCL_EA49
DR   CLO; CLO_0020430
DR   Coriell; ND08446
DR   Wikidata; Q54921408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08447
AC   CVCL_EU35
DR   CLO; CLO_0020437
DR   Coriell; ND08447
DR   Wikidata; Q54921409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08455
AC   CVCL_BA88
DR   CLO; CLO_0020438
DR   Coriell; ND08455
DR   Wikidata; Q54921410
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08461
AC   CVCL_CK22
DR   Coriell; ND08461
DR   Wikidata; Q54921411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08466
AC   CVCL_BA89
DR   CLO; CLO_0020436
DR   Coriell; ND08466
DR   Wikidata; Q54921412
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08467
AC   CVCL_EU36
DR   CLO; CLO_0020101
DR   BioSample; SAMN00795688
DR   Coriell; ND08467
DR   Wikidata; Q54921414
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND08468
AC   CVCL_GC38
DR   CLO; CLO_0020104
DR   BioSample; SAMN00795690
DR   Coriell; ND08468
DR   Wikidata; Q54921415
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND08469
AC   CVCL_BA90
DR   CLO; CLO_0020105
DR   Coriell; ND08469
DR   Wikidata; Q54921416
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08470
AC   CVCL_BA91
DR   CLO; CLO_0020102
DR   Coriell; ND08470
DR   Wikidata; Q54921417
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08471
AC   CVCL_CK23
DR   CLO; CLO_0020103
DR   Coriell; ND08471
DR   Wikidata; Q54921418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08472
AC   CVCL_CK24
DR   BioSample; SAMN00795692
DR   Coriell; ND08472
DR   Wikidata; Q54921419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08473
AC   CVCL_FK34
DR   CLO; CLO_0020113
DR   Coriell; ND08473
DR   Wikidata; Q54921420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08474
AC   CVCL_FK35
DR   CLO; CLO_0020112
DR   Coriell; ND08474
DR   Wikidata; Q54921421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08475
AC   CVCL_IH31
DR   CLO; CLO_0020115
DR   Coriell; ND08475
DR   Wikidata; Q54921422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08476
AC   CVCL_FY80
DR   CLO; CLO_0020114
DR   Coriell; ND08476
DR   Wikidata; Q54921424
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08477
AC   CVCL_HR27
DR   CLO; CLO_0020116
DR   Coriell; ND08477
DR   Wikidata; Q54921425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08478
AC   CVCL_EA50
DR   Coriell; ND08478
DR   Wikidata; Q54921426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08486
AC   CVCL_CK25
DR   CLO; CLO_0020117
DR   Coriell; ND08486
DR   Wikidata; Q54921427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08487
AC   CVCL_EA51
DR   CLO; CLO_0020118
DR   Coriell; ND08487
DR   Wikidata; Q54921428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08488
AC   CVCL_EA52
DR   CLO; CLO_0020119
DR   Coriell; ND08488
DR   Wikidata; Q54921429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08489
AC   CVCL_EU37
DR   CLO; CLO_0020120
DR   Coriell; ND08489
DR   Wikidata; Q54921430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08490
AC   CVCL_EA53
DR   CLO; CLO_0020121
DR   Coriell; ND08490
DR   Wikidata; Q54921431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08491
AC   CVCL_EA54
DR   CLO; CLO_0020122
DR   Coriell; ND08491
DR   Wikidata; Q54921432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   93Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08492
AC   CVCL_EU38
DR   CLO; CLO_0020130
DR   Coriell; ND08492
DR   Wikidata; Q54921443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08500
AC   CVCL_IL71
DR   CLO; CLO_0020129
DR   Coriell; ND08500
DR   Wikidata; Q54921445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND08500; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND08501
AC   CVCL_IL72
DR   CLO; CLO_0020128
DR   Coriell; ND08501
DR   Wikidata; Q54921446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND08501; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND08502
AC   CVCL_GC39
DR   CLO; CLO_0020127
DR   Coriell; ND08502
DR   Wikidata; Q54921447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08503
AC   CVCL_FK36
DR   CLO; CLO_0020137
DR   Coriell; ND08503
DR   Wikidata; Q54921448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08504
AC   CVCL_HY64
DR   CLO; CLO_0020135
DR   Coriell; ND08504
DR   Wikidata; Q54921449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08505
AC   CVCL_FK37
DR   CLO; CLO_0020136
DR   Coriell; ND08505
DR   Wikidata; Q54921450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08506
AC   CVCL_HY65
DR   CLO; CLO_0020133
DR   Coriell; ND08506
DR   Wikidata; Q54921451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08507
AC   CVCL_HR28
DR   CLO; CLO_0020134
DR   Coriell; ND08507
DR   Wikidata; Q54921452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08508
AC   CVCL_FY81
DR   CLO; CLO_0020131
DR   Coriell; ND08508
DR   Wikidata; Q54921453
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08509
AC   CVCL_FK38
DR   CLO; CLO_0020132
DR   Coriell; ND08509
DR   Wikidata; Q54921454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08517
AC   CVCL_HV16
DR   Coriell; ND08517
DR   Wikidata; Q54921455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08518
AC   CVCL_HV17
DR   Coriell; ND08518
DR   Wikidata; Q54921456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08520
AC   CVCL_EA55
DR   CLO; CLO_0020139
DR   Coriell; ND08520
DR   Wikidata; Q54921457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08521
AC   CVCL_EA56
DR   CLO; CLO_0020138
DR   Coriell; ND08521
DR   Wikidata; Q54921458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08528
AC   CVCL_CK26
DR   Coriell; ND08528
DR   Wikidata; Q54921460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08531
AC   CVCL_BA92
DR   CLO; CLO_0020140
DR   Coriell; ND08531
DR   Wikidata; Q54921461
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08532
AC   CVCL_FC48
DR   CLO; CLO_0020145
DR   BioSample; SAMN00795712
DR   Coriell; ND08532
DR   Wikidata; Q54921462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08533
AC   CVCL_GC40
DR   CLO; CLO_0020146
DR   Coriell; ND08533
DR   Wikidata; Q54921463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08534
AC   CVCL_FK39
DR   Coriell; ND08534
DR   Wikidata; Q54921464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08536
AC   CVCL_HR29
DR   CLO; CLO_0020147
DR   Coriell; ND08536
DR   Wikidata; Q54921465
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08537
AC   CVCL_HR30
DR   CLO; CLO_0020148
DR   Coriell; ND08537
DR   Wikidata; Q54921466
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08538
AC   CVCL_EU39
DR   CLO; CLO_0020141
DR   BioSample; SAMN00795720
DR   Coriell; ND08538
DR   Wikidata; Q54921467
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND08539
AC   CVCL_EU40
DR   CLO; CLO_0020142
DR   Coriell; ND08539
DR   Wikidata; Q54921468
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08540
AC   CVCL_HR31
DR   CLO; CLO_0020143
DR   Coriell; ND08540
DR   Wikidata; Q54921469
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08541
AC   CVCL_HR32
DR   CLO; CLO_0020144
DR   Coriell; ND08541
DR   Wikidata; Q54921470
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08542
AC   CVCL_HR33
DR   CLO; CLO_0020058
DR   Coriell; ND08542
DR   Wikidata; Q54921472
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08543
AC   CVCL_EU41
DR   CLO; CLO_0020059
DR   BioSample; SAMN00795730
DR   Coriell; ND08543
DR   Wikidata; Q54921473
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND08544
AC   CVCL_HR34
DR   CLO; CLO_0020049
DR   Coriell; ND08544
DR   Wikidata; Q54921474
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08545
AC   CVCL_HR35
DR   CLO; CLO_0020051
DR   Coriell; ND08545
DR   Wikidata; Q54921475
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08546
AC   CVCL_HR36
DR   CLO; CLO_0020050
DR   Coriell; ND08546
DR   Wikidata; Q54921476
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08547
AC   CVCL_HR37
DR   CLO; CLO_0020053
DR   Coriell; ND08547
DR   Wikidata; Q54921478
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08548
AC   CVCL_HR38
DR   CLO; CLO_0020052
DR   Coriell; ND08548
DR   Wikidata; Q54921479
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08549
AC   CVCL_HR39
DR   CLO; CLO_0020055
DR   Coriell; ND08549
DR   Wikidata; Q54921480
RX   PubMed=34468209;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND08550
AC   CVCL_HR40
DR   CLO; CLO_0020054
DR   Coriell; ND08550
DR   Wikidata; Q54921481
RX   PubMed=34468209;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND08551
AC   CVCL_GN70
DR   CLO; CLO_0020057
DR   Coriell; ND08551
DR   Wikidata; Q54921482
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08552
AC   CVCL_GM92
DR   CLO; CLO_0020056
DR   Coriell; ND08552
DR   Wikidata; Q54921483
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08553
AC   CVCL_GK97
DR   CLO; CLO_0020070
DR   Coriell; ND08553
DR   Wikidata; Q54921484
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08554
AC   CVCL_BA93
DR   CLO; CLO_0020061
DR   Coriell; ND08554
DR   Wikidata; Q54921485
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND08555
AC   CVCL_ID28
DR   CLO; CLO_0020060
DR   Coriell; ND08555
DR   Wikidata; Q54921486
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08556
AC   CVCL_GC41
DR   CLO; CLO_0020065
DR   BioSample; SAMN00795756
DR   Coriell; ND08556
DR   Wikidata; Q54921499
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND08557
AC   CVCL_HR41
DR   CLO; CLO_0020064
DR   Coriell; ND08557
DR   Wikidata; Q54921500
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08558
AC   CVCL_HR42
DR   CLO; CLO_0020063
DR   Coriell; ND08558
DR   Wikidata; Q54921501
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08559
AC   CVCL_IL73
DR   CLO; CLO_0020062
DR   Coriell; ND08559
DR   Wikidata; Q54921502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND08559; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND08560
AC   CVCL_GC42
DR   CLO; CLO_0020069
DR   BioSample; SAMN00795764
DR   Coriell; ND08560
DR   Wikidata; Q54921503
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND08561
AC   CVCL_HR43
DR   CLO; CLO_0020068
DR   Coriell; ND08561
DR   Wikidata; Q54921504
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08562
AC   CVCL_HR44
DR   CLO; CLO_0020067
DR   Coriell; ND08562
DR   Wikidata; Q54921505
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08563
AC   CVCL_HR45
DR   CLO; CLO_0020066
DR   Coriell; ND08563
DR   Wikidata; Q54921507
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND08568
AC   CVCL_CK27
DR   Coriell; ND08568
DR   Wikidata; Q54921508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08569
AC   CVCL_CK28
DR   CLO; CLO_0020071
DR   Coriell; ND08569
DR   Wikidata; Q54921509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08570
AC   CVCL_UT66
DR   CLO; CLO_0020073
DR   Coriell; ND08570
DR   Wikidata; Q96035790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125695; Striatonigral degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND08571
AC   CVCL_CK29
DR   CLO; CLO_0020072
DR   Coriell; ND08571
DR   Wikidata; Q54921510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08572
AC   CVCL_GC43
DR   CLO; CLO_0020078
DR   Coriell; ND08572
DR   Wikidata; Q54921511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08573
AC   CVCL_GC44
DR   CLO; CLO_0020077
DR   BioSample; SAMN00795772
DR   Coriell; ND08573
DR   Wikidata; Q54921512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08580
AC   CVCL_FK40
DR   CLO; CLO_0020080
DR   Coriell; ND08580
DR   Wikidata; Q54921513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08582
AC   CVCL_EA57
DR   CLO; CLO_0020079
DR   Coriell; ND08582
DR   Wikidata; Q54921514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08583
AC   CVCL_EA58
DR   CLO; CLO_0020075
DR   Coriell; ND08583
DR   Wikidata; Q54921515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08584
AC   CVCL_HR46
DR   CLO; CLO_0020074
DR   Coriell; ND08584
DR   Wikidata; Q54921516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08585
AC   CVCL_BA94
DR   CLO; CLO_0020076
DR   Coriell; ND08585
DR   Wikidata; Q54921517
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08586
AC   CVCL_HR47
DR   CLO; CLO_0020094
DR   Coriell; ND08586
DR   Wikidata; Q54921518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08587
AC   CVCL_HR48
DR   CLO; CLO_0020093
DR   Coriell; ND08587
DR   Wikidata; Q54921519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08588
AC   CVCL_FC49
DR   CLO; CLO_0020092
DR   Coriell; ND08588
DR   Wikidata; Q54921520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08589
AC   CVCL_GC45
DR   CLO; CLO_0020091
DR   BioSample; SAMN00795782
DR   Coriell; ND08589
DR   Wikidata; Q54921521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08590
AC   CVCL_ID29
DR   Coriell; ND08590
DR   Wikidata; Q54921522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08593
AC   CVCL_EA59
DR   Coriell; ND08593
DR   Wikidata; Q54921523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08603
AC   CVCL_EA60
DR   CLO; CLO_0020100
DR   Coriell; ND08603
DR   Wikidata; Q54921524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08608
AC   CVCL_EA61
DR   Coriell; ND08608
DR   Wikidata; Q54921525
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08610
AC   CVCL_EA62
DR   Coriell; ND08610
DR   Wikidata; Q54921526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND08613
AC   CVCL_FK41
DR   Coriell; ND08613
DR   Wikidata; Q54921527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08616
AC   CVCL_ID30
DR   CLO; CLO_0020099
DR   Coriell; ND08616
DR   Wikidata; Q54921528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08617
AC   CVCL_BA95
DR   CLO; CLO_0020098
DR   Coriell; ND08617
DR   Wikidata; Q54921530
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08618
AC   CVCL_BA96
DR   CLO; CLO_0020097
DR   Coriell; ND08618
DR   Wikidata; Q54921531
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08619
AC   CVCL_BA97
DR   CLO; CLO_0020096
DR   Coriell; ND08619
DR   Wikidata; Q54921532
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08628
AC   CVCL_FY82
DR   CLO; CLO_0020095
DR   Coriell; ND08628
DR   Wikidata; Q54921533
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08630
AC   CVCL_BA98
DR   CLO; CLO_0019994
DR   Coriell; ND08630
DR   Wikidata; Q54921534
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08631
AC   CVCL_BA99
DR   CLO; CLO_0019995
DR   Coriell; ND08631
DR   Wikidata; Q54921535
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08632
AC   CVCL_FK42
DR   CLO; CLO_0019996
DR   Coriell; ND08632
DR   Wikidata; Q54921536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08633
AC   CVCL_ID31
DR   CLO; CLO_0019997
DR   Coriell; ND08633
DR   Wikidata; Q54921537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08639
AC   CVCL_EA63
DR   CLO; CLO_0019998
DR   Coriell; ND08639
DR   Wikidata; Q54921538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08640
AC   CVCL_EA64
DR   CLO; CLO_0019989
DR   Coriell; ND08640
DR   Wikidata; Q54921539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08641
AC   CVCL_FK43
DR   CLO; CLO_0019990
DR   Coriell; ND08641
DR   Wikidata; Q54921540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08648
AC   CVCL_CK30
DR   BioSample; SAMN00795794
DR   Coriell; ND08648
DR   Wikidata; Q54921549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08649
AC   CVCL_ID32
DR   Coriell; ND08649
DR   Wikidata; Q54921550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08653
AC   CVCL_HV18
DR   Coriell; ND08653
DR   Wikidata; Q54921551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08655
AC   CVCL_EA65
DR   CLO; CLO_0019991
DR   Coriell; ND08655
DR   Wikidata; Q54921553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08656
AC   CVCL_EA66
DR   CLO; CLO_0019992
DR   Coriell; ND08656
DR   Wikidata; Q54921554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08657
AC   CVCL_BB00
DR   CLO; CLO_0019993
DR   Coriell; ND08657
DR   Wikidata; Q54921555
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08658
AC   CVCL_BB01
DR   CLO; CLO_0020013
DR   Coriell; ND08658
DR   Wikidata; Q54921556
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08659
AC   CVCL_BB02
DR   CLO; CLO_0020014
DR   Coriell; ND08659
DR   Wikidata; Q54921557
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08660
AC   CVCL_BB03
DR   CLO; CLO_0020017
DR   Coriell; ND08660
DR   Wikidata; Q54921558
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08661
AC   CVCL_BB04
DR   Coriell; ND08661
DR   Wikidata; Q54921559
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08662
AC   CVCL_EH49
DR   CLO; CLO_0020018
DR   Coriell; ND08662
DR   Wikidata; Q54921560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08663
AC   CVCL_AB76
DR   CLO; CLO_0020015
DR   Coriell; ND08663
DR   Wikidata; Q54921561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND08665
AC   CVCL_CK31
DR   Coriell; ND08665
DR   Wikidata; Q54921562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08666
AC   CVCL_FY83
DR   Coriell; ND08666
DR   Wikidata; Q54921563
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08667
AC   CVCL_HV19
DR   Coriell; ND08667
DR   Wikidata; Q54921564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08669
AC   CVCL_FK44
DR   CLO; CLO_0020016
DR   Coriell; ND08669
DR   Wikidata; Q54921565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08670
AC   CVCL_BB05
DR   CLO; CLO_0020011
DR   Coriell; ND08670
DR   Wikidata; Q54921566
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08671
AC   CVCL_CK32
DR   CLO; CLO_0020012
DR   Coriell; ND08671
DR   Wikidata; Q54921567
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08672
AC   CVCL_FK45
DR   CLO; CLO_0020009
DR   Coriell; ND08672
DR   Wikidata; Q54921568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08673
AC   CVCL_GC46
DR   CLO; CLO_0020010
DR   BioSample; SAMN00795806
DR   Coriell; ND08673
DR   Wikidata; Q54921569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08674
AC   CVCL_EU42
DR   CLO; CLO_0014015
DR   Coriell; ND08674
DR   Wikidata; Q54921571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08675
AC   CVCL_EA67
DR   CLO; CLO_0014016
DR   Coriell; ND08675
DR   Wikidata; Q54921572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08676
AC   CVCL_FY84
DR   CLO; CLO_0014019
DR   Coriell; ND08676
DR   Wikidata; Q54921573
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08677
AC   CVCL_FK46
DR   CLO; CLO_0014020
DR   Coriell; ND08677
DR   Wikidata; Q54921574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08678
AC   CVCL_FK47
DR   Coriell; ND08678
DR   Wikidata; Q54921575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08680
AC   CVCL_CK33
DR   CLO; CLO_0014005
DR   Coriell; ND08680
DR   Wikidata; Q54921576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08681
AC   CVCL_ID33
DR   Coriell; ND08681
DR   Wikidata; Q54921577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08683
AC   CVCL_ID34
DR   Coriell; ND08683
DR   Wikidata; Q54921578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08684
AC   CVCL_CK34
DR   Coriell; ND08684
DR   Wikidata; Q54921579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08692
AC   CVCL_EA68
DR   CLO; CLO_0014003
DR   Coriell; ND08692
DR   Wikidata; Q54921580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08693
AC   CVCL_CK35
DR   Coriell; ND08693
DR   Wikidata; Q54921581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08701
AC   CVCL_EA69
DR   Coriell; ND08701
DR   Wikidata; Q54921582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08703
AC   CVCL_FK48
DR   CLO; CLO_0014001
DR   Coriell; ND08703
DR   Wikidata; Q54921583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08704
AC   CVCL_FK49
DR   CLO; CLO_0013999
DR   Coriell; ND08704
DR   Wikidata; Q54921584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08705
AC   CVCL_BB06
DR   CLO; CLO_0014009
DR   Coriell; ND08705
DR   Wikidata; Q54921585
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08706
AC   CVCL_ID35
DR   CLO; CLO_0014008
DR   Coriell; ND08706
DR   Wikidata; Q54921586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08707
AC   CVCL_BB07
DR   CLO; CLO_0013971
DR   Coriell; ND08707
DR   Wikidata; Q54921587
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08708
AC   CVCL_FK50
DR   CLO; CLO_0013978
DR   Coriell; ND08708
DR   Wikidata; Q54921588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08709
AC   CVCL_ID36
DR   CLO; CLO_0013980
DR   Coriell; ND08709
DR   Wikidata; Q54921589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08710
AC   CVCL_FK51
DR   CLO; CLO_0013974
DR   Coriell; ND08710
DR   Wikidata; Q54921590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08715
AC   CVCL_HV20
DR   Coriell; ND08715
DR   Wikidata; Q54921601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08717
AC   CVCL_FY85
DR   Coriell; ND08717
DR   Wikidata; Q54921602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08720
AC   CVCL_EH50
DR   CLO; CLO_0013976
DR   Coriell; ND08720
DR   Wikidata; Q54921603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08721
AC   CVCL_EU43
DR   CLO; CLO_0013806
DR   BioSample; SAMN00795824
DR   Coriell; ND08721
DR   Wikidata; Q54921604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08722
AC   CVCL_CK36
DR   CLO; CLO_0013808
DR   Coriell; ND08722
DR   Wikidata; Q54921605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08723
AC   CVCL_CK37
DR   CLO; CLO_0013812
DR   Coriell; ND08723
DR   Wikidata; Q54921606
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08724
AC   CVCL_EU44
DR   CLO; CLO_0013814
DR   BioSample; SAMN00795826
DR   Coriell; ND08724
DR   Wikidata; Q54921607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08725
AC   CVCL_FK52
DR   CLO; CLO_0013805
DR   Coriell; ND08725
DR   Wikidata; Q54921609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08726
AC   CVCL_HR49
DR   CLO; CLO_0013804
DR   Coriell; ND08726
DR   Wikidata; Q54921610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08727
AC   CVCL_GQ22
DR   CLO; CLO_0013803
DR   Coriell; ND08727
DR   Wikidata; Q54921611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36192; Arteriovenous fistula
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08728
AC   CVCL_CK38
DR   CLO; CLO_0013800
DR   Coriell; ND08728
DR   Wikidata; Q54921612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08729
AC   CVCL_CK39
DR   CLO; CLO_0013799
DR   Coriell; ND08729
DR   Wikidata; Q54921613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08734
AC   CVCL_FK53
DR   CLO; CLO_0013802
DR   Coriell; ND08734
DR   Wikidata; Q54921614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08735
AC   CVCL_HR50
DR   CLO; CLO_0013801
DR   Coriell; ND08735
DR   Wikidata; Q54921615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08736
AC   CVCL_HR51
DR   CLO; CLO_0013771
DR   Coriell; ND08736
DR   Wikidata; Q54921616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08737
AC   CVCL_EA70
DR   CLO; CLO_0013772
DR   Coriell; ND08737
DR   Wikidata; Q54921617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08747
AC   CVCL_HV21
DR   Coriell; ND08747
DR   Wikidata; Q54921618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08748
AC   CVCL_HV22
DR   Coriell; ND08748
DR   Wikidata; Q54921620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08749
AC   CVCL_LL46
DR   Coriell; ND08749
DR   Wikidata; Q54921621
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   ND08750
AC   CVCL_FK54
DR   CLO; CLO_0013766
DR   Coriell; ND08750
DR   Wikidata; Q54921622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08751
AC   CVCL_FY86
DR   CLO; CLO_0013769
DR   Coriell; ND08751
DR   Wikidata; Q54921623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08752
AC   CVCL_FY87
DR   CLO; CLO_0013762
DR   Coriell; ND08752
DR   Wikidata; Q54921624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08753
AC   CVCL_FY88
DR   CLO; CLO_0013761
DR   Coriell; ND08753
DR   Wikidata; Q54921625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08754
AC   CVCL_CK40
DR   Coriell; ND08754
DR   Wikidata; Q54921626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08762
AC   CVCL_HV23
DR   Coriell; ND08762
DR   Wikidata; Q54921627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08763
AC   CVCL_EA71
DR   CLO; CLO_0013760
DR   Coriell; ND08763
DR   Wikidata; Q54921628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08764
AC   CVCL_EA72
DR   CLO; CLO_0013759
DR   Coriell; ND08764
DR   Wikidata; Q54921629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08766
AC   CVCL_FK55
DR   CLO; CLO_0013758
DR   Coriell; ND08766
DR   Wikidata; Q54921630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08767
AC   CVCL_EU45
DR   CLO; CLO_0013757
DR   Coriell; ND08767
DR   Wikidata; Q54921631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08768
AC   CVCL_FK56
DR   CLO; CLO_0013756
DR   Coriell; ND08768
DR   Wikidata; Q54921632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08769
AC   CVCL_HR52
DR   CLO; CLO_0013908
DR   Coriell; ND08769
DR   Wikidata; Q54921633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08770
AC   CVCL_HR53
DR   CLO; CLO_0013910
DR   Coriell; ND08770
DR   Wikidata; Q54921634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08771
AC   CVCL_FK57
DR   CLO; CLO_0013911
DR   Coriell; ND08771
DR   Wikidata; Q54921636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08772
AC   CVCL_ID37
DR   CLO; CLO_0013898
DR   Coriell; ND08772
DR   Wikidata; Q54921637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08774
AC   CVCL_EA73
DR   Coriell; ND08774
DR   Wikidata; Q54921638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08777
AC   CVCL_ID38
DR   Coriell; ND08777
DR   Wikidata; Q54921639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08780
AC   CVCL_CK41
DR   CLO; CLO_0013897
DR   Coriell; ND08780
DR   Wikidata; Q54921640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08781
AC   CVCL_CK42
DR   CLO; CLO_0013902
DR   Coriell; ND08781
DR   Wikidata; Q54921641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08782
AC   CVCL_CK43
DR   Coriell; ND08782
DR   Wikidata; Q54921642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08783
AC   CVCL_CK44
DR   BioSample; SAMN00795852
DR   Coriell; ND08783
DR   Wikidata; Q54921643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08788
AC   CVCL_FK58
DR   CLO; CLO_0013901
DR   Coriell; ND08788
DR   Wikidata; Q54921651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08789
AC   CVCL_BB08
DR   CLO; CLO_0013904
DR   Coriell; ND08789
DR   Wikidata; Q54921652
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08791
AC   CVCL_BB09
DR   CLO; CLO_0013903
DR   Coriell; ND08791
DR   Wikidata; Q54921653
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08792
AC   CVCL_CK45
DR   Coriell; ND08792
DR   Wikidata; Q54921654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08794
AC   CVCL_FY89
DR   Coriell; ND08794
DR   Wikidata; Q54921656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08797
AC   CVCL_HV24
DR   Coriell; ND08797
DR   Wikidata; Q54921657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08798
AC   CVCL_FK59
DR   CLO; CLO_0013906
DR   Coriell; ND08798
DR   Wikidata; Q54921658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08800
AC   CVCL_FK60
DR   CLO; CLO_0013905
DR   Coriell; ND08800
DR   Wikidata; Q54921659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08801
AC   CVCL_FK61
DR   CLO; CLO_0013859
DR   Coriell; ND08801
DR   Wikidata; Q54921660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08802
AC   CVCL_EA74
DR   CLO; CLO_0013862
DR   Coriell; ND08802
DR   Wikidata; Q54921661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08803
AC   CVCL_EA75
DR   CLO; CLO_0013838
DR   Coriell; ND08803
DR   Wikidata; Q54921663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08804
AC   CVCL_EA76
DR   CLO; CLO_0013850
DR   Coriell; ND08804
DR   Wikidata; Q54921664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08805
AC   CVCL_EA77
DR   CLO; CLO_0013847
DR   Coriell; ND08805
DR   Wikidata; Q54921665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08811
AC   CVCL_FK62
DR   Coriell; ND08811
DR   Wikidata; Q54921666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08812
AC   CVCL_FK63
DR   Coriell; ND08812
DR   Wikidata; Q54921667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08822
AC   CVCL_CK46
DR   Coriell; ND08822
DR   Wikidata; Q54921668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08824
AC   CVCL_CK47
DR   BioSample; SAMN00795860
DR   Coriell; ND08824
DR   Wikidata; Q54921669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08825
AC   CVCL_HV25
DR   Coriell; ND08825
DR   Wikidata; Q54921670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08826
AC   CVCL_HV26
DR   Coriell; ND08826
DR   Wikidata; Q54921671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08827
AC   CVCL_HV27
DR   Coriell; ND08827
DR   Wikidata; Q54921672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08828
AC   CVCL_FY90
DR   CLO; CLO_0013845
DR   Coriell; ND08828
DR   Wikidata; Q54921673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08829
AC   CVCL_HR54
DR   CLO; CLO_0013843
DR   Coriell; ND08829
DR   Wikidata; Q54921675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08835
AC   CVCL_FY91
DR   Coriell; ND08835
DR   Wikidata; Q54921676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08836
AC   CVCL_FK64
DR   CLO; CLO_0013854
DR   Coriell; ND08836
DR   Wikidata; Q54921677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08837
AC   CVCL_EA78
DR   CLO; CLO_0013853
DR   Coriell; ND08837
DR   Wikidata; Q54921678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08840
AC   CVCL_EA79
DR   Coriell; ND08840
DR   Wikidata; Q54921679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08847
AC   CVCL_FK65
DR   Coriell; ND08847
DR   Wikidata; Q54921680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08848
AC   CVCL_HV28
DR   Coriell; ND08848
DR   Wikidata; Q54921681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08849
AC   CVCL_HV29
DR   Coriell; ND08849
DR   Wikidata; Q54921682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08850
AC   CVCL_BB10
DR   CLO; CLO_0013852
DR   Coriell; ND08850
DR   Wikidata; Q54921683
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08851
AC   CVCL_EU46
DR   CLO; CLO_0013851
DR   BioSample; SAMN00795878
DR   Coriell; ND08851
DR   Wikidata; Q54921684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08852
AC   CVCL_BB11
DR   CLO; CLO_0014134
DR   Coriell; ND08852
DR   Wikidata; Q54921685
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08853
AC   CVCL_FK66
DR   CLO; CLO_0014143
DR   Coriell; ND08853
DR   Wikidata; Q54921686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08854
AC   CVCL_FK67
DR   CLO; CLO_0014144
DR   Coriell; ND08854
DR   Wikidata; Q54921687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08855
AC   CVCL_FK68
DR   CLO; CLO_0014141
DR   Coriell; ND08855
DR   Wikidata; Q54921688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08856
AC   CVCL_FK69
DR   CLO; CLO_0014142
DR   Coriell; ND08856
DR   Wikidata; Q54921689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08857
AC   CVCL_FK70
DR   CLO; CLO_0014139
DR   Coriell; ND08857
DR   Wikidata; Q54921691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08870
AC   CVCL_FK71
DR   CLO; CLO_0014140
DR   Coriell; ND08870
DR   Wikidata; Q54921693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08871
AC   CVCL_FK72
DR   CLO; CLO_0014137
DR   Coriell; ND08871
DR   Wikidata; Q54921694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08872
AC   CVCL_HR55
DR   CLO; CLO_0014138
DR   Coriell; ND08872
DR   Wikidata; Q54921695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08873
AC   CVCL_HR56
DR   CLO; CLO_0014135
DR   Coriell; ND08873
DR   Wikidata; Q54921706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08875
AC   CVCL_CK48
DR   CLO; CLO_0014136
DR   Coriell; ND08875
DR   Wikidata; Q54921707
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08876
AC   CVCL_CK49
DR   CLO; CLO_0014121
DR   Coriell; ND08876
DR   Wikidata; Q54921708
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08877
AC   CVCL_FK73
DR   Coriell; ND08877
DR   Wikidata; Q54921709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08878
AC   CVCL_BB12
DR   Coriell; ND08878
DR   Wikidata; Q54921710
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08880
AC   CVCL_CK50
DR   Coriell; ND08880
DR   Wikidata; Q54921712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08881
AC   CVCL_CK51
DR   Coriell; ND08881
DR   Wikidata; Q54921713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08882
AC   CVCL_CK52
DR   Coriell; ND08882
DR   Wikidata; Q54921714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08883
AC   CVCL_CK53
DR   BioSample; SAMN00795886
DR   Coriell; ND08883
DR   Wikidata; Q54921715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08884
AC   CVCL_CK54
DR   BioSample; SAMN00795888
DR   Coriell; ND08884
DR   Wikidata; Q54921716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08891
AC   CVCL_FY92
DR   Coriell; ND08891
DR   Wikidata; Q54921717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08895
AC   CVCL_FY93
DR   CLO; CLO_0014122
DR   Coriell; ND08895
DR   Wikidata; Q54921718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08896
AC   CVCL_IH32
DR   CLO; CLO_0014123
DR   Coriell; ND08896
DR   Wikidata; Q54921719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08897
AC   CVCL_FK74
DR   CLO; CLO_0014116
DR   Coriell; ND08897
DR   Wikidata; Q54921720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08898
AC   CVCL_GC55
DR   CLO; CLO_0014118
DR   Coriell; ND08898
DR   Wikidata; Q54921721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08899
AC   CVCL_EA80
DR   CLO; CLO_0014119
DR   Coriell; ND08899
DR   Wikidata; Q54921723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08900
AC   CVCL_EU47
DR   CLO; CLO_0014120
DR   Coriell; ND08900
DR   Wikidata; Q54921724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08901
AC   CVCL_EA81
DR   CLO; CLO_0014113
DR   Coriell; ND08901
DR   Wikidata; Q54921725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08902
AC   CVCL_EA82
DR   CLO; CLO_0014114
DR   Coriell; ND08902
DR   Wikidata; Q54921726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08903
AC   CVCL_EA83
DR   CLO; CLO_0014115
DR   Coriell; ND08903
DR   Wikidata; Q54921727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08904
AC   CVCL_EA84
DR   CLO; CLO_0014223
DR   Coriell; ND08904
DR   Wikidata; Q54921728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08905
AC   CVCL_EA85
DR   CLO; CLO_0014224
DR   Coriell; ND08905
DR   Wikidata; Q54921730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08906
AC   CVCL_CK55
DR   Coriell; ND08906
DR   Wikidata; Q54921731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08917
AC   CVCL_CK56
DR   BioSample; SAMN00795896
DR   Coriell; ND08917
DR   Wikidata; Q54921732
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND08917).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Ala82Glu (c.245C>A); ClinVar=VCV000007038; Zygosity=Heterozygous (Coriell=ND08917).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex5-6del; Zygosity=Heterozygous (Coriell=ND08917).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   ND08918
AC   CVCL_FY94
DR   CLO; CLO_0014221
DR   Coriell; ND08918
DR   Wikidata; Q54921733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08919
AC   CVCL_CK57
DR   BioSample; SAMN00795898
DR   Coriell; ND08919
DR   Wikidata; Q54921735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND08925
AC   CVCL_EA86
DR   CLO; CLO_0014222
DR   Coriell; ND08925
DR   Wikidata; Q54921736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08926
AC   CVCL_EA87
DR   CLO; CLO_0014213
DR   Coriell; ND08926
DR   Wikidata; Q54921737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08927
AC   CVCL_EU48
DR   CLO; CLO_0014215
DR   Coriell; ND08927
DR   Wikidata; Q54921738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08933
AC   CVCL_BB13
DR   CLO; CLO_0014211
DR   Coriell; ND08933
DR   Wikidata; Q54921739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND08934
AC   CVCL_GC47
DR   CLO; CLO_0014212
DR   Coriell; ND08934
DR   Wikidata; Q54921740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08935
AC   CVCL_FK75
DR   CLO; CLO_0014218
DR   Coriell; ND08935
DR   Wikidata; Q54921741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08936
AC   CVCL_FK76
DR   CLO; CLO_0014220
DR   Coriell; ND08936
DR   Wikidata; Q54921742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08938
AC   CVCL_FK77
DR   CLO; CLO_0014180
DR   Coriell; ND08938
DR   Wikidata; Q54921743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08939
AC   CVCL_FK78
DR   CLO; CLO_0014181
DR   Coriell; ND08939
DR   Wikidata; Q54921744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08945
AC   CVCL_CK58
DR   Coriell; ND08945
DR   Wikidata; Q54921745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08951
AC   CVCL_ID39
DR   Coriell; ND08951
DR   Wikidata; Q54921746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08953
AC   CVCL_HV30
DR   Coriell; ND08953
DR   Wikidata; Q54921748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08954
AC   CVCL_HV31
DR   Coriell; ND08954
DR   Wikidata; Q54921749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND08955
AC   CVCL_EU49
DR   CLO; CLO_0014182
DR   Coriell; ND08955
DR   Wikidata; Q54921750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08956
AC   CVCL_EU50
DR   CLO; CLO_0014183
DR   Coriell; ND08956
DR   Wikidata; Q54921757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08957
AC   CVCL_BB14
DR   CLO; CLO_0014184
DR   Coriell; ND08957
DR   Wikidata; Q54921758
RX   PubMed=22815561;
CC   Population: Caucasian; Irish/Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND08958
AC   CVCL_EU51
DR   CLO; CLO_0014171
DR   Coriell; ND08958
DR   Wikidata; Q54921760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08959
AC   CVCL_FK79
DR   CLO; CLO_0014172
DR   Coriell; ND08959
DR   Wikidata; Q54921761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08960
AC   CVCL_FK80
DR   CLO; CLO_0014173
DR   Coriell; ND08960
DR   Wikidata; Q54921762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08963
AC   CVCL_IL74
DR   CLO; CLO_0014174
DR   Coriell; ND08963
DR   Wikidata; Q54921763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND08963; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND08964
AC   CVCL_GC48
DR   CLO; CLO_0014175
DR   Coriell; ND08964
DR   Wikidata; Q54921764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08965
AC   CVCL_GC49
DR   CLO; CLO_0014711
DR   Coriell; ND08965
DR   Wikidata; Q54921765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08966
AC   CVCL_GC50
DR   CLO; CLO_0014712
DR   Coriell; ND08966
DR   Wikidata; Q54921766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08968
AC   CVCL_FY95
DR   CLO; CLO_0014714
DR   Coriell; ND08968
DR   Wikidata; Q54921767
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08969
AC   CVCL_CK59
DR   Coriell; ND08969
DR   Wikidata; Q54921768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08971
AC   CVCL_GC51
DR   CLO; CLO_0014691
DR   Coriell; ND08971
DR   Wikidata; Q54921769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08972
AC   CVCL_CK60
DR   Coriell; ND08972
DR   Wikidata; Q54921771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08973
AC   CVCL_CK61
DR   Coriell; ND08973
DR   Wikidata; Q54921772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08977
AC   CVCL_EU52
DR   CLO; CLO_0014688
DR   Coriell; ND08977
DR   Wikidata; Q54921773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08978
AC   CVCL_EU53
DR   CLO; CLO_0014687
DR   Coriell; ND08978
DR   Wikidata; Q54921774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08980
AC   CVCL_BB15
DR   CLO; CLO_0014686
DR   Coriell; ND08980
DR   Wikidata; Q54921775
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND08981
AC   CVCL_EU54
DR   CLO; CLO_0014685
DR   BioSample; SAMN00795908
DR   Coriell; ND08981
DR   Wikidata; Q54921776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND08984
AC   CVCL_GC52
DR   CLO; CLO_0014682
DR   Coriell; ND08984
DR   Wikidata; Q54921777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08985
AC   CVCL_EU55
DR   CLO; CLO_0014680
DR   Coriell; ND08985
DR   Wikidata; Q54921778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08986
AC   CVCL_GC53
DR   CLO; CLO_0014671
DR   Coriell; ND08986
DR   Wikidata; Q54921780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08987
AC   CVCL_BB16
DR   CLO; CLO_0014673
DR   Coriell; ND08987
DR   Wikidata; Q54921781
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND08995
AC   CVCL_GC54
DR   CLO; CLO_0014667
DR   Coriell; ND08995
DR   Wikidata; Q54921782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08996
AC   CVCL_CK62
DR   CLO; CLO_0014668
DR   Coriell; ND08996
DR   Wikidata; Q54921783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND08997
AC   CVCL_EA88
DR   Coriell; ND08997
DR   Wikidata; Q54921784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND08998
AC   CVCL_EU56
DR   CLO; CLO_0014654
DR   Coriell; ND08998
DR   Wikidata; Q54921785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND08999
AC   CVCL_EU57
DR   CLO; CLO_0014653
DR   Coriell; ND08999
DR   Wikidata; Q54921786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09000
AC   CVCL_FK81
DR   Coriell; ND09000
DR   Wikidata; Q54921787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09002
AC   CVCL_EA89
DR   Coriell; ND09002
DR   Wikidata; Q54921788
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND09014
AC   CVCL_BB17
DR   CLO; CLO_0014656
DR   Coriell; ND09014
DR   Wikidata; Q54921789
CC   Population: Caucasian; Russian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09015
AC   CVCL_EU58
DR   CLO; CLO_0014655
DR   BioSample; SAMN00795911
DR   Coriell; ND09015
DR   Wikidata; Q54921790
CC   Population: Caucasian; English.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09016
AC   CVCL_IH33
DR   CLO; CLO_0014658
DR   Coriell; ND09016
DR   Wikidata; Q54921791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09017
AC   CVCL_FY96
DR   CLO; CLO_0014657
DR   Coriell; ND09017
DR   Wikidata; Q54921792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09018
AC   CVCL_CK63
DR   Coriell; ND09018
DR   Wikidata; Q54921794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09019
AC   CVCL_CK64
DR   Coriell; ND09019
DR   Wikidata; Q54921795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09021
AC   CVCL_CK65
DR   Coriell; ND09021
DR   Wikidata; Q54921796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09025
AC   CVCL_FK82
DR   CLO; CLO_0014648
DR   Coriell; ND09025
DR   Wikidata; Q54921797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09026
AC   CVCL_EU59
DR   CLO; CLO_0014649
DR   Coriell; ND09026
DR   Wikidata; Q54921798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09027
AC   CVCL_FK83
DR   CLO; CLO_0014650
DR   Coriell; ND09027
DR   Wikidata; Q54921799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09028
AC   CVCL_FK84
DR   CLO; CLO_0014651
DR   Coriell; ND09028
DR   Wikidata; Q54921800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09029
AC   CVCL_FK85
DR   CLO; CLO_0014652
DR   Coriell; ND09029
DR   Wikidata; Q54921804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09030
AC   CVCL_FK86
DR   CLO; CLO_0014635
DR   Coriell; ND09030
DR   Wikidata; Q54921805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09042
AC   CVCL_CK66
DR   Coriell; ND09042
DR   Wikidata; Q54921806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09044
AC   CVCL_FK87
DR   Coriell; ND09044
DR   Wikidata; Q54921807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09045
AC   CVCL_FK88
DR   CLO; CLO_0014634
DR   Coriell; ND09045
DR   Wikidata; Q54921808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09046
AC   CVCL_ID40
DR   Coriell; ND09046
DR   Wikidata; Q54921809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09048
AC   CVCL_IH34
DR   CLO; CLO_0014633
DR   Coriell; ND09048
DR   Wikidata; Q54921810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09049
AC   CVCL_FY97
DR   CLO; CLO_0014632
DR   Coriell; ND09049
DR   Wikidata; Q54921812
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09050
AC   CVCL_FY98
DR   CLO; CLO_0014636
DR   Coriell; ND09050
DR   Wikidata; Q54921813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09056
AC   CVCL_EA90
DR   Coriell; ND09056
DR   Wikidata; Q54921814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09057
AC   CVCL_FK89
DR   CLO; CLO_0014626
DR   Coriell; ND09057
DR   Wikidata; Q54921815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09058
AC   CVCL_FK90
DR   CLO; CLO_0014627
DR   Coriell; ND09058
DR   Wikidata; Q54921816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09059
AC   CVCL_HY66
DR   CLO; CLO_0014630
DR   Coriell; ND09059
DR   Wikidata; Q54921817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09060
AC   CVCL_HY67
DR   CLO; CLO_0014631
DR   Coriell; ND09060
DR   Wikidata; Q54921818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09064
AC   CVCL_CK67
DR   Coriell; ND09064
DR   Wikidata; Q54921819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09065
AC   CVCL_CK68
DR   Coriell; ND09065
DR   Wikidata; Q54921820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09066
AC   CVCL_EA91
DR   Coriell; ND09066
DR   Wikidata; Q54921821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09069
AC   CVCL_FY99
DR   Coriell; ND09069
DR   Wikidata; Q54921822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09070
AC   CVCL_BB18
DR   CLO; CLO_0014628
DR   Coriell; ND09070
DR   Wikidata; Q54921823
CC   Population: Caucasian; Irish/Scottish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09071
AC   CVCL_FK91
DR   CLO; CLO_0014629
DR   Coriell; ND09071
DR   Wikidata; Q54921825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09072
AC   CVCL_FK92
DR   CLO; CLO_0014617
DR   Coriell; ND09072
DR   Wikidata; Q54921826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09082
AC   CVCL_FZ00
DR   Coriell; ND09082
DR   Wikidata; Q54921827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09083
AC   CVCL_FK93
DR   CLO; CLO_0014618
DR   Coriell; ND09083
DR   Wikidata; Q54921828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09085
AC   CVCL_CK69
DR   Coriell; ND09085
DR   Wikidata; Q54921829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09086
AC   CVCL_ID41
DR   Coriell; ND09086
DR   Wikidata; Q54921830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09099
AC   CVCL_FK94
DR   CLO; CLO_0014621
DR   Coriell; ND09099
DR   Wikidata; Q54921831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09104
AC   CVCL_IH35
DR   CLO; CLO_0014622
DR   Coriell; ND09104
DR   Wikidata; Q54921832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09105
AC   CVCL_HV32
DR   CLO; CLO_0014596
DR   Coriell; ND09105
DR   Wikidata; Q54921833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09109
AC   CVCL_FZ01
DR   Coriell; ND09109
DR   Wikidata; Q54921834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09110
AC   CVCL_CK70
DR   CLO; CLO_0014599
DR   Coriell; ND09110
DR   Wikidata; Q54921835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09111
AC   CVCL_CK71
DR   Coriell; ND09111
DR   Wikidata; Q54921836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09112
AC   CVCL_BB19
DR   CLO; CLO_0014598
DR   Coriell; ND09112
DR   Wikidata; Q54921837
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09113
AC   CVCL_EU60
DR   CLO; CLO_0014592
DR   BioSample; SAMN00795926
DR   Coriell; ND09113
DR   Wikidata; Q54921838
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09114
AC   CVCL_FC50
DR   CLO; CLO_0014591
DR   Coriell; ND09114
DR   Wikidata; Q54921839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09115
AC   CVCL_BB20
DR   CLO; CLO_0014594
DR   Coriell; ND09115
DR   Wikidata; Q54921840
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09118
AC   CVCL_CK72
DR   Coriell; ND09118
DR   Wikidata; Q54921841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09124
AC   CVCL_EA92
DR   Coriell; ND09124
DR   Wikidata; Q54921842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09127
AC   CVCL_FK95
DR   Coriell; ND09127
DR   Wikidata; Q54921843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09128
AC   CVCL_FK96
DR   Coriell; ND09128
DR   Wikidata; Q54921844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09129
AC   CVCL_FZ02
DR   Coriell; ND09129
DR   Wikidata; Q54921845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09130
AC   CVCL_HV33
DR   Coriell; ND09130
DR   Wikidata; Q54921857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09131
AC   CVCL_HV34
DR   Coriell; ND09131
DR   Wikidata; Q54921858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09132
AC   CVCL_HV35
DR   Coriell; ND09132
DR   Wikidata; Q54921860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09133
AC   CVCL_FZ03
DR   Coriell; ND09133
DR   Wikidata; Q54921861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09134
AC   CVCL_BB21
DR   CLO; CLO_0014593
DR   Coriell; ND09134
DR   Wikidata; Q54921862
CC   Population: Caucasian; German/Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09135
AC   CVCL_EU61
DR   CLO; CLO_0014586
DR   BioSample; SAMN00795942
DR   Coriell; ND09135
DR   Wikidata; Q54921863
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09136
AC   CVCL_BB22
DR   CLO; CLO_0014590
DR   Coriell; ND09136
DR   Wikidata; Q54921864
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09137
AC   CVCL_BB23
DR   CLO; CLO_0014582
DR   Coriell; ND09137
DR   Wikidata; Q54921865
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09146
AC   CVCL_CK73
DR   Coriell; ND09146
DR   Wikidata; Q54921866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09148
AC   CVCL_ID42
DR   Coriell; ND09148
DR   Wikidata; Q54921867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09149
AC   CVCL_BB24
DR   CLO; CLO_0014559
DR   Coriell; ND09149
DR   Wikidata; Q54921868
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09150
AC   CVCL_EU62
DR   CLO; CLO_0014557
DR   Coriell; ND09150
DR   Wikidata; Q54921870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09151
AC   CVCL_EU63
DR   CLO; CLO_0014555
DR   Coriell; ND09151
DR   Wikidata; Q54921871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09152
AC   CVCL_EU64
DR   CLO; CLO_0014554
DR   Coriell; ND09152
DR   Wikidata; Q54921872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09153
AC   CVCL_FK97
DR   CLO; CLO_0014552
DR   Coriell; ND09153
DR   Wikidata; Q54921873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09154
AC   CVCL_FK98
DR   CLO; CLO_0014551
DR   Coriell; ND09154
DR   Wikidata; Q54921874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09155
AC   CVCL_GT83
DR   CLO; CLO_0014550
DR   Coriell; ND09155
DR   Wikidata; Q54921875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09156
AC   CVCL_GT84
DR   CLO; CLO_0014549
DR   Coriell; ND09156
DR   Wikidata; Q54921876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09163
AC   CVCL_HV36
DR   Coriell; ND09163
DR   Wikidata; Q54921878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09164
AC   CVCL_FZ04
DR   CLO; CLO_0014538
DR   Coriell; ND09164
DR   Wikidata; Q54921879
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09165
AC   CVCL_GQ23
DR   Coriell; ND09165
DR   Wikidata; Q54921880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36192; Arteriovenous fistula
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09166
AC   CVCL_FZ05
DR   CLO; CLO_0014541
DR   Coriell; ND09166
DR   Wikidata; Q54921881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09167
AC   CVCL_FZ06
DR   CLO; CLO_0014525
DR   Coriell; ND09167
DR   Wikidata; Q54921882
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09168
AC   CVCL_CK74
DR   BioSample; SAMN00795954
DR   Coriell; ND09168
DR   Wikidata; Q54921883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09169
AC   CVCL_ID43
DR   BioSample; SAMN00795956
DR   Coriell; ND09169
DR   Wikidata; Q54921884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09170
AC   CVCL_ID44
DR   Coriell; ND09170
DR   Wikidata; Q54921885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09171
AC   CVCL_CK75
DR   Coriell; ND09171
DR   Wikidata; Q54921886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09180
AC   CVCL_BB25
DR   CLO; CLO_0014510
DR   Coriell; ND09180
DR   Wikidata; Q54921888
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09181
AC   CVCL_CK76
DR   CLO; CLO_0014507
DR   Coriell; ND09181
DR   Wikidata; Q54921889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09182
AC   CVCL_GC56
DR   CLO; CLO_0014514
DR   BioSample; SAMN00795960
DR   Coriell; ND09182
DR   Wikidata; Q54921890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09183
AC   CVCL_CK77
DR   CLO; CLO_0014511
DR   BioSample; SAMN00795962
DR   Coriell; ND09183
DR   Wikidata; Q54921891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09184
AC   CVCL_GT85
DR   CLO; CLO_0014516
DR   Coriell; ND09184
DR   Wikidata; Q54921892
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09185
AC   CVCL_BB26
DR   CLO; CLO_0014515
DR   Coriell; ND09185
DR   Wikidata; Q54921893
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09186
AC   CVCL_GT86
DR   CLO; CLO_0014518
DR   Coriell; ND09186
DR   Wikidata; Q54921894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09187
AC   CVCL_GT87
DR   CLO; CLO_0014517
DR   Coriell; ND09187
DR   Wikidata; Q54921895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09188
AC   CVCL_BB27
DR   CLO; CLO_0014500
DR   Coriell; ND09188
DR   Wikidata; Q54921896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09189
AC   CVCL_BB28
DR   CLO; CLO_0014485
DR   Coriell; ND09189
DR   Wikidata; Q54921897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09190
AC   CVCL_BB29
DR   CLO; CLO_0014482
DR   Coriell; ND09190
DR   Wikidata; Q54921898
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09191
AC   CVCL_BB30
DR   CLO; CLO_0014471
DR   Coriell; ND09191
DR   Wikidata; Q54921899
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09192
AC   CVCL_BB31
DR   CLO; CLO_0014469
DR   Coriell; ND09192
DR   Wikidata; Q54921900
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09193
AC   CVCL_ID45
DR   CLO; CLO_0014467
DR   Coriell; ND09193
DR   Wikidata; Q54921903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09194
AC   CVCL_GC57
DR   CLO; CLO_0014465
DR   BioSample; SAMN00795972
DR   Coriell; ND09194
DR   Wikidata; Q54921904
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09195
AC   CVCL_BB32
DR   CLO; CLO_0014477
DR   Coriell; ND09195
DR   Wikidata; Q54921906
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09197
AC   CVCL_BB33
DR   CLO; CLO_0014475
DR   Coriell; ND09197
DR   Wikidata; Q54921908
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09198
AC   CVCL_ID46
DR   Coriell; ND09198
DR   Wikidata; Q54921909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09199
AC   CVCL_BB34
DR   CLO; CLO_0014474
DR   Coriell; ND09199
DR   Wikidata; Q54921910
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09204
AC   CVCL_BB35
DR   CLO; CLO_0014473
DR   Coriell; ND09204
DR   Wikidata; Q54921911
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND09207
AC   CVCL_HV37
DR   Coriell; ND09207
DR   Wikidata; Q54921912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09210
AC   CVCL_BB36
DR   CLO; CLO_0014949
DR   Coriell; ND09210
DR   Wikidata; Q54921913
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09211
AC   CVCL_GC58
DR   CLO; CLO_0014944
DR   BioSample; SAMN00795980
DR   Coriell; ND09211
DR   Wikidata; Q54921914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09212
AC   CVCL_BB37
DR   CLO; CLO_0014946
DR   Coriell; ND09212
DR   Wikidata; Q54921915
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09213
AC   CVCL_GT88
DR   CLO; CLO_0014967
DR   Coriell; ND09213
DR   Wikidata; Q54921917
CC   Population: Caucasian; Norwegian/Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09214
AC   CVCL_GT89
DR   CLO; CLO_0014969
DR   Coriell; ND09214
DR   Wikidata; Q54921918
CC   Population: Caucasian; Belgian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09215
AC   CVCL_HR57
DR   CLO; CLO_0014962
DR   Coriell; ND09215
DR   Wikidata; Q54921919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09216
AC   CVCL_CK78
DR   CLO; CLO_0014963
DR   Coriell; ND09216
DR   Wikidata; Q54921920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09217
AC   CVCL_FK99
DR   CLO; CLO_0014958
DR   Coriell; ND09217
DR   Wikidata; Q54921921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09218
AC   CVCL_FL00
DR   CLO; CLO_0014960
DR   Coriell; ND09218
DR   Wikidata; Q54921922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09219
AC   CVCL_GC59
DR   CLO; CLO_0014954
DR   BioSample; SAMN00795990
DR   Coriell; ND09219
DR   Wikidata; Q54921923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09220
AC   CVCL_FL01
DR   CLO; CLO_0014892
DR   Coriell; ND09220
DR   Wikidata; Q54921924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09221
AC   CVCL_GC60
DR   CLO; CLO_0014895
DR   Coriell; ND09221
DR   Wikidata; Q54921925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09222
AC   CVCL_ID47
DR   CLO; CLO_0014897
DR   Coriell; ND09222
DR   Wikidata; Q54921926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09223
AC   CVCL_CK79
DR   CLO; CLO_0014899
DR   BioSample; SAMN00795994
DR   Coriell; ND09223
DR   Wikidata; Q54921927
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND09224
AC   CVCL_CK80
DR   CLO; CLO_0014910
DR   BioSample; SAMN00795996
DR   Coriell; ND09224
DR   Wikidata; Q54921929
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND09225
AC   CVCL_ID48
DR   CLO; CLO_0014915
DR   Coriell; ND09225
DR   Wikidata; Q54921930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09226
AC   CVCL_EU65
DR   CLO; CLO_0014917
DR   Coriell; ND09226
DR   Wikidata; Q54921931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09227
AC   CVCL_CK81
DR   CLO; CLO_0014918
DR   Coriell; ND09227
DR   Wikidata; Q54921932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09228
AC   CVCL_CK82
DR   CLO; CLO_0014904
DR   BioSample; SAMN00796000
DR   Coriell; ND09228
DR   Wikidata; Q54921933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09230
AC   CVCL_EU66
DR   CLO; CLO_0014907
DR   BioSample; SAMN00796002
DR   Coriell; ND09230
DR   Wikidata; Q54921935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09231
AC   CVCL_CK83
DR   CLO; CLO_0015102
DR   BioSample; SAMN00796004
DR   Coriell; ND09231
DR   Wikidata; Q54921936
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND09232
AC   CVCL_ID49
DR   CLO; CLO_0015099
DR   Coriell; ND09232
DR   Wikidata; Q54921937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09233
AC   CVCL_EU67
DR   CLO; CLO_0015135
DR   BioSample; SAMN00796008
DR   Coriell; ND09233
DR   Wikidata; Q54921938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09234
AC   CVCL_CK84
DR   CLO; CLO_0015136
DR   BioSample; SAMN00796010
DR   Coriell; ND09234
DR   Wikidata; Q54921939
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND09235
AC   CVCL_CK85
DR   CLO; CLO_0015137
DR   Coriell; ND09235
DR   Wikidata; Q54921940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09236
AC   CVCL_CK86
DR   CLO; CLO_0015138
DR   BioSample; SAMN00796012
DR   Coriell; ND09236
DR   Wikidata; Q54921941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09242
AC   CVCL_CK87
DR   Coriell; ND09242
DR   Wikidata; Q54921942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09243
AC   CVCL_FL02
DR   Coriell; ND09243
DR   Wikidata; Q54921943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09244
AC   CVCL_CK88
DR   Coriell; ND09244
DR   Wikidata; Q54921945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09248
AC   CVCL_FZ07
DR   Coriell; ND09248
DR   Wikidata; Q54921946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09249
AC   CVCL_CK89
DR   Coriell; ND09249
DR   Wikidata; Q54921947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09255
AC   CVCL_ID50
DR   Coriell; ND09255
DR   Wikidata; Q54921948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09256
AC   CVCL_HV38
DR   Coriell; ND09256
DR   Wikidata; Q54921953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09257
AC   CVCL_FZ08
DR   CLO; CLO_0015127
DR   Coriell; ND09257
DR   Wikidata; Q54921954
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09258
AC   CVCL_CY96
DR   CLO; CLO_0015129
DR   Coriell; ND09258
DR   Wikidata; Q54921956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09259
AC   CVCL_FL03
DR   CLO; CLO_0015131
DR   Coriell; ND09259
DR   Wikidata; Q54921957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09261
AC   CVCL_FZ09
DR   Coriell; ND09261
DR   Wikidata; Q54921958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09266
AC   CVCL_CK90
DR   Coriell; ND09266
DR   Wikidata; Q54921960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09269
AC   CVCL_ID51
DR   Coriell; ND09269
DR   Wikidata; Q54921961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09270
AC   CVCL_ID52
DR   BioSample; SAMN00796026
DR   Coriell; ND09270
DR   Wikidata; Q54921962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09271
AC   CVCL_ID53
DR   Coriell; ND09271
DR   Wikidata; Q54921963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09272
AC   CVCL_ID54
DR   Coriell; ND09272
DR   Wikidata; Q54921964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09273
AC   CVCL_ID55
DR   BioSample; SAMN00796032
DR   Coriell; ND09273
DR   Wikidata; Q54921965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09274
AC   CVCL_HV39
DR   Coriell; ND09274
DR   Wikidata; Q54921966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09275
AC   CVCL_FL04
DR   CLO; CLO_0015134
DR   Coriell; ND09275
DR   Wikidata; Q54921967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09276
AC   CVCL_FL05
DR   CLO; CLO_0015140
DR   Coriell; ND09276
DR   Wikidata; Q54921968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09277
AC   CVCL_FL06
DR   CLO; CLO_0015145
DR   Coriell; ND09277
DR   Wikidata; Q54921969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09278
AC   CVCL_EA93
DR   Coriell; ND09278
DR   Wikidata; Q54921970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09282
AC   CVCL_FL07
DR   Coriell; ND09282
DR   Wikidata; Q54921972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09285
AC   CVCL_BB38
DR   CLO; CLO_0015143
DR   Coriell; ND09285
DR   Wikidata; Q54921973
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09286
AC   CVCL_BB39
DR   CLO; CLO_0012231
DR   Coriell; ND09286
DR   Wikidata; Q54921974
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09287
AC   CVCL_EU68
DR   CLO; CLO_0012230
DR   BioSample; SAMN00796038
DR   Coriell; ND09287
DR   Wikidata; Q54921975
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09288
AC   CVCL_BB40
DR   CLO; CLO_0012236
DR   Coriell; ND09288
DR   Wikidata; Q54921976
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09289
AC   CVCL_EU69
DR   CLO; CLO_0012234
DR   Coriell; ND09289
DR   Wikidata; Q54921978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09290
AC   CVCL_BB41
DR   CLO; CLO_0012227
DR   Coriell; ND09290
DR   Wikidata; Q54921979
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09291
AC   CVCL_ID56
DR   CLO; CLO_0012226
DR   Coriell; ND09291
DR   Wikidata; Q54921980
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09292
AC   CVCL_BB42
DR   CLO; CLO_0012228
DR   Coriell; ND09292
DR   Wikidata; Q54921981
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09293
AC   CVCL_ID57
DR   CLO; CLO_0012238
DR   Coriell; ND09293
DR   Wikidata; Q54921982
CC   Population: Caucasian; English/Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09294
AC   CVCL_BB43
DR   CLO; CLO_0012239
DR   Coriell; ND09294
DR   Wikidata; Q54921983
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09301
AC   CVCL_EA94
DR   Coriell; ND09301
DR   Wikidata; Q54921984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09303
AC   CVCL_FZ10
DR   Coriell; ND09303
DR   Wikidata; Q54921985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09305
AC   CVCL_GC61
DR   CLO; CLO_0012240
DR   Coriell; ND09305
DR   Wikidata; Q54921986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09306
AC   CVCL_FL08
DR   CLO; CLO_0012241
DR   Coriell; ND09306
DR   Wikidata; Q54921987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09307
AC   CVCL_GT90
DR   CLO; CLO_0012196
DR   Coriell; ND09307
DR   Wikidata; Q54921988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09308
AC   CVCL_GT91
DR   CLO; CLO_0012192
DR   Coriell; ND09308
DR   Wikidata; Q54921989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09310
AC   CVCL_IH36
DR   CLO; CLO_0012188
DR   Coriell; ND09310
DR   Wikidata; Q54921990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09311
AC   CVCL_FZ11
DR   CLO; CLO_0012186
DR   Coriell; ND09311
DR   Wikidata; Q54921991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09312
AC   CVCL_FZ12
DR   CLO; CLO_0012185
DR   Coriell; ND09312
DR   Wikidata; Q54921992
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09313
AC   CVCL_HR58
DR   CLO; CLO_0012184
DR   Coriell; ND09313
DR   Wikidata; Q54921993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09314
AC   CVCL_BB44
DR   CLO; CLO_0012201
DR   Coriell; ND09314
DR   Wikidata; Q54921994
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09321
AC   CVCL_HV40
DR   Coriell; ND09321
DR   Wikidata; Q54921995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09322
AC   CVCL_FL09
DR   Coriell; ND09322
DR   Wikidata; Q54921996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09323
AC   CVCL_GC62
DR   CLO; CLO_0012199
DR   Coriell; ND09323
DR   Wikidata; Q54922004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09324
AC   CVCL_EU70
DR   CLO; CLO_0012200
DR   Coriell; ND09324
DR   Wikidata; Q54922005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09325
AC   CVCL_GC63
DR   CLO; CLO_0012197
DR   Coriell; ND09325
DR   Wikidata; Q54922006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09326
AC   CVCL_FL10
DR   CLO; CLO_0012198
DR   Coriell; ND09326
DR   Wikidata; Q54922007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09328
AC   CVCL_FL11
DR   CLO; CLO_0012321
DR   Coriell; ND09328
DR   Wikidata; Q54922008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09329
AC   CVCL_BB45
DR   CLO; CLO_0012320
DR   Coriell; ND09329
DR   Wikidata; Q54922009
CC   Population: Caucasian; Norwegian/Swedish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND09330
AC   CVCL_EU71
DR   CLO; CLO_0012323
DR   Coriell; ND09330
DR   Wikidata; Q54922011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09331
AC   CVCL_GC64
DR   CLO; CLO_0012322
DR   BioSample; SAMN00796064
DR   Coriell; ND09331
DR   Wikidata; Q54922012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09332
AC   CVCL_FL12
DR   CLO; CLO_0012325
DR   Coriell; ND09332
DR   Wikidata; Q54922013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09336
AC   CVCL_CK91
DR   Coriell; ND09336
DR   Wikidata; Q54922014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09338
AC   CVCL_CK92
DR   Coriell; ND09338
DR   Wikidata; Q54922015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09346
AC   CVCL_BB46
DR   CLO; CLO_0012327
DR   Coriell; ND09346
DR   Wikidata; Q54922016
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09347
AC   CVCL_GC65
DR   CLO; CLO_0012328
DR   BioSample; SAMN00796070
DR   Coriell; ND09347
DR   Wikidata; Q54922017
CC   Population: Indian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09348
AC   CVCL_BB47
DR   CLO; CLO_0012329
DR   Coriell; ND09348
DR   Wikidata; Q54922018
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09349
AC   CVCL_GC66
DR   CLO; CLO_0012330
DR   BioSample; SAMN00796074
DR   Coriell; ND09349
DR   Wikidata; Q54922019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09350
AC   CVCL_BB48
DR   CLO; CLO_0012331
DR   Coriell; ND09350
DR   Wikidata; Q54922020
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09351
AC   CVCL_EU72
DR   CLO; CLO_0012332
DR   BioSample; SAMN00796078
DR   Coriell; ND09351
DR   Wikidata; Q54922021
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09352
AC   CVCL_CK93
DR   CLO; CLO_0012277
DR   BioSample; SAMN00796080
DR   Coriell; ND09352
DR   Wikidata; Q54922022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09353
AC   CVCL_GC67
DR   CLO; CLO_0012276
DR   BioSample; SAMN00796082
DR   Coriell; ND09353
DR   Wikidata; Q54922023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09358
AC   CVCL_HV41
DR   Coriell; ND09358
DR   Wikidata; Q54922025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09360
AC   CVCL_BB49
DR   CLO; CLO_0012273
DR   Coriell; ND09360
DR   Wikidata; Q54922026
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09361
AC   CVCL_BB50
DR   CLO; CLO_0012269
DR   Coriell; ND09361
DR   Wikidata; Q54922027
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09362
AC   CVCL_BB51
DR   CLO; CLO_0012287
DR   Coriell; ND09362
DR   Wikidata; Q54922028
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09363
AC   CVCL_GC68
DR   CLO; CLO_0012284
DR   BioSample; SAMN00796088
DR   Coriell; ND09363
DR   Wikidata; Q54922029
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09364
AC   CVCL_BB52
DR   CLO; CLO_0012285
DR   Coriell; ND09364
DR   Wikidata; Q54922030
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09365
AC   CVCL_HY68
DR   CLO; CLO_0012291
DR   Coriell; ND09365
DR   Wikidata; Q54922031
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09367
AC   CVCL_IL75
DR   CLO; CLO_0012292
DR   Coriell; ND09367
DR   Wikidata; Q54922033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND09367; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND09368
AC   CVCL_BB53
DR   Coriell; ND09368
DR   Wikidata; Q54922034
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09369
AC   CVCL_BB54
DR   CLO; CLO_0012289
DR   Coriell; ND09369
DR   Wikidata; Q54922035
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09370
AC   CVCL_GT92
DR   CLO; CLO_0012290
DR   Coriell; ND09370
DR   Wikidata; Q54922036
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09371
AC   CVCL_GT93
DR   CLO; CLO_0012390
DR   Coriell; ND09371
DR   Wikidata; Q54922037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09372
AC   CVCL_GT94
DR   CLO; CLO_0012393
DR   Coriell; ND09372
DR   Wikidata; Q54922039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09373
AC   CVCL_BB55
DR   CLO; CLO_0012396
DR   Coriell; ND09373
DR   Wikidata; Q54922040
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND09374
AC   CVCL_EU73
DR   CLO; CLO_0012419
DR   BioSample; SAMN00796104
DR   Coriell; ND09374
DR   Wikidata; Q54922041
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09375
AC   CVCL_BB56
DR   CLO; CLO_0012418
DR   Coriell; ND09375
DR   Wikidata; Q54922042
RX   PubMed=22815561;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND09376
AC   CVCL_GC69
DR   CLO; CLO_0012423
DR   BioSample; SAMN00796108
DR   Coriell; ND09376
DR   Wikidata; Q54922043
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09377
AC   CVCL_BB57
DR   CLO; CLO_0012422
DR   Coriell; ND09377
DR   Wikidata; Q54922044
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09378
AC   CVCL_CK94
DR   Coriell; ND09378
DR   Wikidata; Q54922045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09379
AC   CVCL_ID58
DR   Coriell; ND09379
DR   Wikidata; Q54922046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09380
AC   CVCL_ID59
DR   Coriell; ND09380
DR   Wikidata; Q54922047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09381
AC   CVCL_CK95
DR   BioSample; SAMN00796114
DR   Coriell; ND09381
DR   Wikidata; Q54922058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09385
AC   CVCL_FL13
DR   CLO; CLO_0012414
DR   Coriell; ND09385
DR   Wikidata; Q54922059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09387
AC   CVCL_FZ13
DR   Coriell; ND09387
DR   Wikidata; Q54922060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09391
AC   CVCL_IL76
DR   Coriell; ND09391
DR   Wikidata; Q54922061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09392
AC   CVCL_BB58
DR   CLO; CLO_0012413
DR   Coriell; ND09392
DR   Wikidata; Q54922062
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09393
AC   CVCL_BB59
DR   CLO; CLO_0012416
DR   Coriell; ND09393
DR   Wikidata; Q54922063
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09394
AC   CVCL_IL77
DR   CLO; CLO_0012415
DR   BioSample; SAMN00796122
DR   Coriell; ND09394
DR   Wikidata; Q54922064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND09394; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09395
AC   CVCL_BB60
DR   CLO; CLO_0012352
DR   Coriell; ND09395
DR   Wikidata; Q54922065
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09397
AC   CVCL_EU74
DR   CLO; CLO_0012355
DR   BioSample; SAMN00796124
DR   Coriell; ND09397
DR   Wikidata; Q54922066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09399
AC   CVCL_GC70
DR   CLO; CLO_0012367
DR   Coriell; ND09399
DR   Wikidata; Q54922067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09400
AC   CVCL_GC71
DR   CLO; CLO_0012381
DR   Coriell; ND09400
DR   Wikidata; Q54922068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09401
AC   CVCL_GC72
DR   CLO; CLO_0012378
DR   Coriell; ND09401
DR   Wikidata; Q54922069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09402
AC   CVCL_GC73
DR   CLO; CLO_0012377
DR   Coriell; ND09402
DR   Wikidata; Q54922070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09403
AC   CVCL_BB61
DR   CLO; CLO_0012375
DR   Coriell; ND09403
DR   Wikidata; Q54922071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND09403; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09404
AC   CVCL_BB62
DR   CLO; CLO_0012373
DR   Coriell; ND09404
DR   Wikidata; Q54922072
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND09405
AC   CVCL_BB63
DR   CLO; CLO_0012372
DR   Coriell; ND09405
DR   Wikidata; Q54922073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09406
AC   CVCL_BB64
DR   CLO; CLO_0012371
DR   Coriell; ND09406
DR   Wikidata; Q54922075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09407
AC   CVCL_BB65
DR   CLO; CLO_0012370
DR   Coriell; ND09407
DR   Wikidata; Q54922076
RX   PubMed=22815561;
CC   Population: Caucasian; English/Greek/Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   ND09408
AC   CVCL_EU75
DR   CLO; CLO_0012465
DR   BioSample; SAMN00796130
DR   Coriell; ND09408
DR   Wikidata; Q54922077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09409
AC   CVCL_EU76
DR   CLO; CLO_0012492
DR   BioSample; SAMN00796132
DR   Coriell; ND09409
DR   Wikidata; Q54922078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09419
AC   CVCL_GC74
DR   CLO; CLO_0012491
DR   Coriell; ND09419
DR   Wikidata; Q54922079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09420
AC   CVCL_BB66
DR   CLO; CLO_0012497
DR   Coriell; ND09420
DR   Wikidata; Q54922080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09421
AC   CVCL_BB67
DR   CLO; CLO_0012494
DR   Coriell; ND09421
DR   Wikidata; Q54922081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09422
AC   CVCL_EU77
DR   CLO; CLO_0012500
DR   Coriell; ND09422
DR   Wikidata; Q54922082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09423
AC   CVCL_EU78
DR   CLO; CLO_0012498
DR   Coriell; ND09423
DR   Wikidata; Q54922083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09424
AC   CVCL_GC75
DR   CLO; CLO_0012504
DR   Coriell; ND09424
DR   Wikidata; Q54922084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09425
AC   CVCL_EU79
DR   CLO; CLO_0012503
DR   Coriell; ND09425
DR   Wikidata; Q54922085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09431
AC   CVCL_FZ14
DR   Coriell; ND09431
DR   Wikidata; Q54922087
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09432
AC   CVCL_BB68
DR   CLO; CLO_0012506
DR   Coriell; ND09432
DR   Wikidata; Q54922088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09433
AC   CVCL_EU80
DR   CLO; CLO_0012505
DR   Coriell; ND09433
DR   Wikidata; Q54922089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09434
AC   CVCL_FC51
DR   CLO; CLO_0012449
DR   BioSample; SAMN00796140
DR   Coriell; ND09434
DR   Wikidata; Q54922090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09435
AC   CVCL_BB69
DR   CLO; CLO_0012447
DR   Coriell; ND09435
DR   Wikidata; Q54922091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09436
AC   CVCL_BB70
DR   CLO; CLO_0012446
DR   Coriell; ND09436
DR   Wikidata; Q54922092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09437
AC   CVCL_BB71
DR   CLO; CLO_0012458
DR   Coriell; ND09437
DR   Wikidata; Q54922093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09438
AC   CVCL_BB72
DR   CLO; CLO_0012457
DR   Coriell; ND09438
DR   Wikidata; Q54922094
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND09439
AC   CVCL_BB73
DR   CLO; CLO_0012454
DR   Coriell; ND09439
DR   Wikidata; Q54922095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09440
AC   CVCL_CK96
DR   CLO; CLO_0012452
DR   Coriell; ND09440
DR   Wikidata; Q54922096
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09441
AC   CVCL_IH37
DR   CLO; CLO_0012464
DR   Coriell; ND09441
DR   Wikidata; Q54922097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09442
AC   CVCL_IH38
DR   CLO; CLO_0012461
DR   Coriell; ND09442
DR   Wikidata; Q54922098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09443
AC   CVCL_ID60
DR   CLO; CLO_0012460
DR   Coriell; ND09443
DR   Wikidata; Q54922099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09444
AC   CVCL_FL14
DR   CLO; CLO_0031862
DR   Coriell; ND09444
DR   Wikidata; Q54922106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09448
AC   CVCL_CK97
DR   Coriell; ND09448
DR   Wikidata; Q54922107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09456
AC   CVCL_GC76
DR   CLO; CLO_0031864
DR   Coriell; ND09456
DR   Wikidata; Q54922109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09457
AC   CVCL_EU81
DR   CLO; CLO_0031868
DR   Coriell; ND09457
DR   Wikidata; Q54922111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09458
AC   CVCL_GC77
DR   CLO; CLO_0031871
DR   Coriell; ND09458
DR   Wikidata; Q54922112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09460
AC   CVCL_CK98
DR   CLO; CLO_0031873
DR   Coriell; ND09460
DR   Wikidata; Q54922113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09461
AC   CVCL_GC78
DR   CLO; CLO_0031875
DR   Coriell; ND09461
DR   Wikidata; Q54922114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09462
AC   CVCL_GC79
DR   CLO; CLO_0031877
DR   Coriell; ND09462
DR   Wikidata; Q54922115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09463
AC   CVCL_FC52
DR   CLO; CLO_0031878
DR   Coriell; ND09463
DR   Wikidata; Q54922116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09464
AC   CVCL_BB74
DR   Coriell; ND09464
DR   Wikidata; Q54922117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09465
AC   CVCL_EU82
DR   CLO; CLO_0031880
DR   Coriell; ND09465
DR   Wikidata; Q54922118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09466
AC   CVCL_BB75
DR   CLO; CLO_0031881
DR   Coriell; ND09466
DR   Wikidata; Q54922119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09467
AC   CVCL_EU83
DR   CLO; CLO_0031762
DR   BioSample; SAMN00796150
DR   Coriell; ND09467
DR   Wikidata; Q54922120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09470
AC   CVCL_CK99
DR   Coriell; ND09470
DR   Wikidata; Q54922121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09471
AC   CVCL_CL00
DR   BioSample; SAMN00796152
DR   Coriell; ND09471
DR   Wikidata; Q54922122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09472
AC   CVCL_ID61
DR   Coriell; ND09472
DR   Wikidata; Q54922123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09473
AC   CVCL_ID62
DR   Coriell; ND09473
DR   Wikidata; Q54922124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09474
AC   CVCL_ID63
DR   Coriell; ND09474
DR   Wikidata; Q54922125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09475
AC   CVCL_FL15
DR   CLO; CLO_0031760
DR   Coriell; ND09475
DR   Wikidata; Q54922126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09477
AC   CVCL_CL01
DR   Coriell; ND09477
DR   Wikidata; Q54922127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09478
AC   CVCL_CL02
DR   Coriell; ND09478
DR   Wikidata; Q54922128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09480
AC   CVCL_FL16
DR   Coriell; ND09480
DR   Wikidata; Q54922129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09482
AC   CVCL_HV42
DR   Coriell; ND09482
DR   Wikidata; Q54922131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09483
AC   CVCL_FZ15
DR   Coriell; ND09483
DR   Wikidata; Q54922132
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09484
AC   CVCL_FL17
DR   CLO; CLO_0031759
DR   Coriell; ND09484
DR   Wikidata; Q54922133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09485
AC   CVCL_GC80
DR   CLO; CLO_0031756
DR   Coriell; ND09485
DR   Wikidata; Q54922134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09486
AC   CVCL_BB76
DR   CLO; CLO_0031754
DR   Coriell; ND09486
DR   Wikidata; Q54922135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09487
AC   CVCL_BB77
DR   CLO; CLO_0031753
DR   Coriell; ND09487
DR   Wikidata; Q54922137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09488
AC   CVCL_EU84
DR   CLO; CLO_0031752
DR   BioSample; SAMN00796168
DR   Coriell; ND09488
DR   Wikidata; Q54922138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09489
AC   CVCL_BB78
DR   CLO; CLO_0031751
DR   Coriell; ND09489
DR   Wikidata; Q54922139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09490
AC   CVCL_BB79
DR   CLO; CLO_0031750
DR   Coriell; ND09490
DR   Wikidata; Q54922140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09491
AC   CVCL_BB80
DR   CLO; CLO_0031749
DR   Coriell; ND09491
DR   Wikidata; Q54922141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09492
AC   CVCL_BB81
DR   CLO; CLO_0031783
DR   Coriell; ND09492
DR   Wikidata; Q54922142
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND09493
AC   CVCL_BB82
DR   CLO; CLO_0031782
DR   Coriell; ND09493
DR   Wikidata; Q54922143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09494
AC   CVCL_BB83
DR   CLO; CLO_0031776
DR   Coriell; ND09494
DR   Wikidata; Q54922145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09495
AC   CVCL_BB84
DR   CLO; CLO_0031773
DR   Coriell; ND09495
DR   Wikidata; Q54922146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09496
AC   CVCL_BB85
DR   CLO; CLO_0031779
DR   Coriell; ND09496
DR   Wikidata; Q54922147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09497
AC   CVCL_EU85
DR   CLO; CLO_0031778
DR   Coriell; ND09497
DR   Wikidata; Q54922148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09498
AC   CVCL_BB86
DR   CLO; CLO_0031770
DR   Coriell; ND09498
DR   Wikidata; Q54922149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09499
AC   CVCL_EU86
DR   CLO; CLO_0031769
DR   BioSample; SAMN00796172
DR   Coriell; ND09499
DR   Wikidata; Q54922150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09500
AC   CVCL_BB87
DR   CLO; CLO_0031772
DR   Coriell; ND09500
DR   Wikidata; Q54922260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09501
AC   CVCL_FL18
DR   CLO; CLO_0031771
DR   Coriell; ND09501
DR   Wikidata; Q54922263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09502
AC   CVCL_CL03
DR   Coriell; ND09502
DR   Wikidata; Q54922267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09505
AC   CVCL_FZ16
DR   Coriell; ND09505
DR   Wikidata; Q54922271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09507
AC   CVCL_CY97
DR   CLO; CLO_0031794
DR   Coriell; ND09507
DR   Wikidata; Q54922274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09508
AC   CVCL_BB88
DR   CLO; CLO_0031793
DR   Coriell; ND09508
DR   Wikidata; Q54922278
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND09509
AC   CVCL_FL19
DR   CLO; CLO_0031792
DR   Coriell; ND09509
DR   Wikidata; Q54922282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09510
AC   CVCL_HR59
DR   CLO; CLO_0031798
DR   Coriell; ND09510
DR   Wikidata; Q54922285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09511
AC   CVCL_HR60
DR   CLO; CLO_0031797
DR   Coriell; ND09511
DR   Wikidata; Q54922286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09513
AC   CVCL_EA95
DR   Coriell; ND09513
DR   Wikidata; Q54922287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09514
AC   CVCL_EA96
DR   Coriell; ND09514
DR   Wikidata; Q54922288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09516
AC   CVCL_HV43
DR   Coriell; ND09516
DR   Wikidata; Q54922289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09520
AC   CVCL_FL20
DR   CLO; CLO_0031796
DR   Coriell; ND09520
DR   Wikidata; Q54922290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09521
AC   CVCL_GC81
DR   CLO; CLO_0031795
DR   Coriell; ND09521
DR   Wikidata; Q54922291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09522
AC   CVCL_EU87
DR   CLO; CLO_0031791
DR   Coriell; ND09522
DR   Wikidata; Q54922292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09523
AC   CVCL_GC82
DR   CLO; CLO_0031790
DR   Coriell; ND09523
DR   Wikidata; Q54922293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09524
AC   CVCL_IL78
DR   CLO; CLO_0031789
DR   Coriell; ND09524
DR   Wikidata; Q54922294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND09524; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND09528
AC   CVCL_CL04
DR   BioSample; SAMN00796184
DR   Coriell; ND09528
DR   Wikidata; Q54922295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09529
AC   CVCL_CL05
DR   Coriell; ND09529
DR   Wikidata; Q54922296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09530
AC   CVCL_CL06
DR   Coriell; ND09530
DR   Wikidata; Q54922297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09534
AC   CVCL_HV44
DR   Coriell; ND09534
DR   Wikidata; Q54922298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09541
AC   CVCL_CL07
DR   Coriell; ND09541
DR   Wikidata; Q54922299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09542
AC   CVCL_HV45
DR   CLO; CLO_0031802
DR   Coriell; ND09542
DR   Wikidata; Q54922300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09543
AC   CVCL_FL21
DR   CLO; CLO_0031801
DR   Coriell; ND09543
DR   Wikidata; Q54922301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09544
AC   CVCL_ID64
DR   CLO; CLO_0031804
DR   Coriell; ND09544
DR   Wikidata; Q54922302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09545
AC   CVCL_EU88
DR   CLO; CLO_0031803
DR   Coriell; ND09545
DR   Wikidata; Q54922303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09546
AC   CVCL_BB89
DR   CLO; CLO_0031806
DR   Coriell; ND09546
DR   Wikidata; Q54922304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09547
AC   CVCL_BB90
DR   CLO; CLO_0031805
DR   Coriell; ND09547
DR   Wikidata; Q54922305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09548
AC   CVCL_BB91
DR   CLO; CLO_0031808
DR   Coriell; ND09548
DR   Wikidata; Q54922307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09549
AC   CVCL_BB92
DR   CLO; CLO_0031807
DR   Coriell; ND09549
DR   Wikidata; Q54922308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09550
AC   CVCL_BB93
DR   CLO; CLO_0031800
DR   Coriell; ND09550
DR   Wikidata; Q54922309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09551
AC   CVCL_BB94
DR   CLO; CLO_0031799
DR   Coriell; ND09551
DR   Wikidata; Q54922310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09552
AC   CVCL_FA49
DR   CLO; CLO_0031946
DR   Coriell; ND09552
DR   Wikidata; Q54922311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09553
AC   CVCL_BB95
DR   CLO; CLO_0031964
DR   Coriell; ND09553
DR   Wikidata; Q54922312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09554
AC   CVCL_GC83
DR   CLO; CLO_0031966
DR   Coriell; ND09554
DR   Wikidata; Q54922313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09555
AC   CVCL_GC84
DR   CLO; CLO_0031967
DR   Coriell; ND09555
DR   Wikidata; Q54922314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09556
AC   CVCL_EU89
DR   CLO; CLO_0031970
DR   BioSample; SAMN00796198
DR   Coriell; ND09556
DR   Wikidata; Q54922315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09557
AC   CVCL_EU90
DR   CLO; CLO_0031954
DR   BioSample; SAMN00796200
DR   Coriell; ND09557
DR   Wikidata; Q54922317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09560
AC   CVCL_CL08
DR   CLO; CLO_0031958
DR   Coriell; ND09560
DR   Wikidata; Q54922318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09561
AC   CVCL_EU91
DR   CLO; CLO_0031959
DR   Coriell; ND09561
DR   Wikidata; Q54922319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09563
AC   CVCL_EU92
DR   CLO; CLO_0031961
DR   Coriell; ND09563
DR   Wikidata; Q54922328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09564
AC   CVCL_CL09
DR   CLO; CLO_0031971
DR   BioSample; SAMN00796202
DR   Coriell; ND09564
DR   Wikidata; Q54922329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09565
AC   CVCL_GT95
DR   CLO; CLO_0031975
DR   Coriell; ND09565
DR   Wikidata; Q54922330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09566
AC   CVCL_IL79
DR   CLO; CLO_0031973
DR   Coriell; ND09566
DR   Wikidata; Q54922331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND09566; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND09568
AC   CVCL_GC85
DR   CLO; CLO_0031985
DR   Coriell; ND09568
DR   Wikidata; Q54922332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09569
AC   CVCL_IL80
DR   CLO; CLO_0031986
DR   Coriell; ND09569
DR   Wikidata; Q54922334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND09569; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND09573
AC   CVCL_ID65
DR   Coriell; ND09573
DR   Wikidata; Q54922335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09574
AC   CVCL_BB96
DR   CLO; CLO_0031983
DR   Coriell; ND09574
DR   Wikidata; Q54922336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09575
AC   CVCL_BB97
DR   CLO; CLO_0031984
DR   Coriell; ND09575
DR   Wikidata; Q54922337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09576
AC   CVCL_BB98
DR   CLO; CLO_0031981
DR   Coriell; ND09576
DR   Wikidata; Q54922339
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND09577
AC   CVCL_EU93
DR   CLO; CLO_0031982
DR   BioSample; SAMN00796208
DR   Coriell; ND09577
DR   Wikidata; Q54922340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09578
AC   CVCL_BB99
DR   CLO; CLO_0031979
DR   Coriell; ND09578
DR   Wikidata; Q54922341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09579
AC   CVCL_EU94
DR   CLO; CLO_0031980
DR   BioSample; SAMN00796212
DR   Coriell; ND09579
DR   Wikidata; Q54922342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09580
AC   CVCL_BC00
DR   CLO; CLO_0031992
DR   Coriell; ND09580
DR   Wikidata; Q54922343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09581
AC   CVCL_BC01
DR   CLO; CLO_0031997
DR   Coriell; ND09581
DR   Wikidata; Q54922344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09582
AC   CVCL_BC02
DR   CLO; CLO_0031995
DR   Coriell; ND09582
DR   Wikidata; Q54922345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09583
AC   CVCL_FL22
DR   CLO; CLO_0031998
DR   Coriell; ND09583
DR   Wikidata; Q54922347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09586
AC   CVCL_EA97
DR   Coriell; ND09586
DR   Wikidata; Q54922349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09587
AC   CVCL_CL10
DR   Coriell; ND09587
DR   Wikidata; Q54922350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09588
AC   CVCL_HV46
DR   Coriell; ND09588
DR   Wikidata; Q54922351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09589
AC   CVCL_EU95
DR   CLO; CLO_0032000
DR   Coriell; ND09589
DR   Wikidata; Q54922352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09590
AC   CVCL_FL23
DR   CLO; CLO_0032002
DR   Coriell; ND09590
DR   Wikidata; Q54922353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09591
AC   CVCL_CL11
DR   Coriell; ND09591
DR   Wikidata; Q54922354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09593
AC   CVCL_FZ17
DR   Coriell; ND09593
DR   Wikidata; Q54922355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09594
AC   CVCL_EU96
DR   CLO; CLO_0032004
DR   Coriell; ND09594
DR   Wikidata; Q54922356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09595
AC   CVCL_BC03
DR   CLO; CLO_0032005
DR   Coriell; ND09595
DR   Wikidata; Q54922358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09597
AC   CVCL_BC04
DR   CLO; CLO_0032006
DR   Coriell; ND09597
DR   Wikidata; Q54922359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09598
AC   CVCL_EU97
DR   CLO; CLO_0032007
DR   BioSample; SAMN00796220
DR   Coriell; ND09598
DR   Wikidata; Q54922360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09599
AC   CVCL_BC05
DR   CLO; CLO_0032017
DR   Coriell; ND09599
DR   Wikidata; Q54922361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09601
AC   CVCL_BC06
DR   CLO; CLO_0032015
DR   Coriell; ND09601
DR   Wikidata; Q54922362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09602
AC   CVCL_EU98
DR   CLO; CLO_0032013
DR   BioSample; SAMN00796224
DR   Coriell; ND09602
DR   Wikidata; Q54922364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09603
AC   CVCL_BC07
DR   CLO; CLO_0032011
DR   Coriell; ND09603
DR   Wikidata; Q54922365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09604
AC   CVCL_GC86
DR   CLO; CLO_0032023
DR   BioSample; SAMN00796228
DR   Coriell; ND09604
DR   Wikidata; Q54922366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09605
AC   CVCL_BC08
DR   Coriell; ND09605
DR   Wikidata; Q54922367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09607
AC   CVCL_BC09
DR   CLO; CLO_0032025
DR   Coriell; ND09607
DR   Wikidata; Q54922368
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND09608
AC   CVCL_EU99
DR   CLO; CLO_0032019
DR   BioSample; SAMN00796232
DR   Coriell; ND09608
DR   Wikidata; Q54922369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09609
AC   CVCL_GC87
DR   CLO; CLO_0032022
DR   Coriell; ND09609
DR   Wikidata; Q54922370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09611
AC   CVCL_GC88
DR   CLO; CLO_0032027
DR   Coriell; ND09611
DR   Wikidata; Q54922371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09612
AC   CVCL_EV00
DR   CLO; CLO_0032028
DR   Coriell; ND09612
DR   Wikidata; Q54922372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09613
AC   CVCL_EV01
DR   CLO; CLO_0031901
DR   Coriell; ND09613
DR   Wikidata; Q54922374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09614
AC   CVCL_BC10
DR   CLO; CLO_0031889
DR   Coriell; ND09614
DR   Wikidata; Q54922384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09615
AC   CVCL_BC11
DR   CLO; CLO_0031891
DR   Coriell; ND09615
DR   Wikidata; Q54922385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09616
AC   CVCL_EV02
DR   CLO; CLO_0031894
DR   BioSample; SAMN00796236
DR   Coriell; ND09616
DR   Wikidata; Q54922386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09617
AC   CVCL_FL24
DR   CLO; CLO_0031896
DR   Coriell; ND09617
DR   Wikidata; Q54922387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09618
AC   CVCL_FL25
DR   CLO; CLO_0031906
DR   Coriell; ND09618
DR   Wikidata; Q54922388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09619
AC   CVCL_FL26
DR   CLO; CLO_0031905
DR   Coriell; ND09619
DR   Wikidata; Q54922389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09620
AC   CVCL_GC89
DR   CLO; CLO_0031909
DR   Coriell; ND09620
DR   Wikidata; Q54922390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09634
AC   CVCL_BC12
DR   Coriell; ND09634
DR   Wikidata; Q54922391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09638
AC   CVCL_BC13
DR   Coriell; ND09638
DR   Wikidata; Q54922392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09641
AC   CVCL_ID66
DR   Coriell; ND09641
DR   Wikidata; Q54922393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09642
AC   CVCL_HV47
DR   CLO; CLO_0031908
DR   Coriell; ND09642
DR   Wikidata; Q54922394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09644
AC   CVCL_BC14
DR   CLO; CLO_0031904
DR   Coriell; ND09644
DR   Wikidata; Q54922395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09645
AC   CVCL_BC15
DR   CLO; CLO_0032416
DR   Coriell; ND09645
DR   Wikidata; Q54922396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09646
AC   CVCL_BC16
DR   CLO; CLO_0032417
DR   Coriell; ND09646
DR   Wikidata; Q54922397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09647
AC   CVCL_BC17
DR   CLO; CLO_0032418
DR   Coriell; ND09647
DR   Wikidata; Q54922398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09648
AC   CVCL_BC18
DR   CLO; CLO_0032412
DR   Coriell; ND09648
DR   Wikidata; Q54922400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09649
AC   CVCL_EV03
DR   CLO; CLO_0032413
DR   Coriell; ND09649
DR   Wikidata; Q54922401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09650
AC   CVCL_EV04
DR   CLO; CLO_0032414
DR   Coriell; ND09650
DR   Wikidata; Q54922402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09651
AC   CVCL_ID67
DR   Coriell; ND09651
DR   Wikidata; Q54922403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09652
AC   CVCL_ID68
DR   Coriell; ND09652
DR   Wikidata; Q54922404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09653
AC   CVCL_ID69
DR   Coriell; ND09653
DR   Wikidata; Q54922405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09654
AC   CVCL_ID70
DR   Coriell; ND09654
DR   Wikidata; Q54922406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09656
AC   CVCL_CL12
DR   Coriell; ND09656
DR   Wikidata; Q54922407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09657
AC   CVCL_EA98
DR   Coriell; ND09657
DR   Wikidata; Q54922408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09658
AC   CVCL_GC90
DR   CLO; CLO_0032415
DR   Coriell; ND09658
DR   Wikidata; Q54922410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09659
AC   CVCL_EV05
DR   CLO; CLO_0032409
DR   Coriell; ND09659
DR   Wikidata; Q54922411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09660
AC   CVCL_EV06
DR   CLO; CLO_0032410
DR   Coriell; ND09660
DR   Wikidata; Q54922413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09661
AC   CVCL_FL27
DR   Coriell; ND09661
DR   Wikidata; Q54922414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09662
AC   CVCL_ID71
DR   Coriell; ND09662
DR   Wikidata; Q54922415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09664
AC   CVCL_IL81
DR   Coriell; ND09664
DR   Wikidata; Q54922416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09665
AC   CVCL_FZ18
DR   Coriell; ND09665
DR   Wikidata; Q54922417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09668
AC   CVCL_GC91
DR   CLO; CLO_0032411
DR   Coriell; ND09668
DR   Wikidata; Q54922418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09669
AC   CVCL_BC19
DR   CLO; CLO_0032367
DR   Coriell; ND09669
DR   Wikidata; Q54922419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09670
AC   CVCL_BC20
DR   CLO; CLO_0032368
DR   Coriell; ND09670
DR   Wikidata; Q54922420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09671
AC   CVCL_EV07
DR   CLO; CLO_0032365
DR   Coriell; ND09671
DR   Wikidata; Q54922422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09672
AC   CVCL_EV08
DR   CLO; CLO_0032366
DR   Coriell; ND09672
DR   Wikidata; Q54922423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09673
AC   CVCL_BC21
DR   CLO; CLO_0032361
DR   Coriell; ND09673
DR   Wikidata; Q54922424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09674
AC   CVCL_IJ46
DR   CLO; CLO_0032362
DR   Coriell; ND09674
DR   Wikidata; Q54922425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09675
AC   CVCL_BC22
DR   CLO; CLO_0032359
DR   Coriell; ND09675
DR   Wikidata; Q54922426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09676
AC   CVCL_EV09
DR   CLO; CLO_0032360
DR   BioSample; SAMN00796254
DR   Coriell; ND09676
DR   Wikidata; Q54922427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09677
AC   CVCL_BC23
DR   CLO; CLO_0032363
DR   Coriell; ND09677
DR   Wikidata; Q54922439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09678
AC   CVCL_BC24
DR   Coriell; ND09678
DR   Wikidata; Q54922440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09679
AC   CVCL_BC25
DR   CLO; CLO_0032364
DR   Coriell; ND09679
DR   Wikidata; Q54922442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09680
AC   CVCL_BC26
DR   CLO; CLO_0032384
DR   Coriell; ND09680
DR   Wikidata; Q54922443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09681
AC   CVCL_FC53
DR   CLO; CLO_0032385
DR   BioSample; SAMN00796258
DR   Coriell; ND09681
DR   Wikidata; Q54922444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09682
AC   CVCL_BC27
DR   CLO; CLO_0032387
DR   Coriell; ND09682
DR   Wikidata; Q54922446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09683
AC   CVCL_BC28
DR   CLO; CLO_0032389
DR   Coriell; ND09683
DR   Wikidata; Q54922447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09684
AC   CVCL_BC29
DR   CLO; CLO_0032390
DR   Coriell; ND09684
DR   Wikidata; Q54922448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09685
AC   CVCL_BC30
DR   CLO; CLO_0032379
DR   Coriell; ND09685
DR   Wikidata; Q54922449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09686
AC   CVCL_GC92
DR   CLO; CLO_0032380
DR   Coriell; ND09686
DR   Wikidata; Q54922451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09687
AC   CVCL_EV10
DR   CLO; CLO_0032381
DR   BioSample; SAMN00796262
DR   Coriell; ND09687
DR   Wikidata; Q54922452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09688
AC   CVCL_GC93
DR   CLO; CLO_0032382
DR   Coriell; ND09688
DR   Wikidata; Q54922453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09691
AC   CVCL_EV11
DR   CLO; CLO_0032383
DR   Coriell; ND09691
DR   Wikidata; Q54922454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09692
AC   CVCL_FC54
DR   CLO; CLO_0032327
DR   Coriell; ND09692
DR   Wikidata; Q54922455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09694
AC   CVCL_BC31
DR   CLO; CLO_0032326
DR   Coriell; ND09694
DR   Wikidata; Q54922456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09696
AC   CVCL_BC32
DR   CLO; CLO_0032324
DR   Coriell; ND09696
DR   Wikidata; Q54922458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09698
AC   CVCL_BC33
DR   CLO; CLO_0032322
DR   Coriell; ND09698
DR   Wikidata; Q54922459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09699
AC   CVCL_EA99
DR   Coriell; ND09699
DR   Wikidata; Q54922460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09707
AC   CVCL_FL28
DR   CLO; CLO_0032321
DR   Coriell; ND09707
DR   Wikidata; Q54922461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09708
AC   CVCL_FL29
DR   CLO; CLO_0032319
DR   Coriell; ND09708
DR   Wikidata; Q54922462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09709
AC   CVCL_FL30
DR   CLO; CLO_0032331
DR   Coriell; ND09709
DR   Wikidata; Q54922463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09710
AC   CVCL_BC34
DR   CLO; CLO_0032330
DR   Coriell; ND09710
DR   Wikidata; Q54922464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09711
AC   CVCL_BC35
DR   CLO; CLO_0032329
DR   Coriell; ND09711
DR   Wikidata; Q54922465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09712
AC   CVCL_BC36
DR   CLO; CLO_0032328
DR   Coriell; ND09712
DR   Wikidata; Q54922466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09713
AC   CVCL_BC37
DR   CLO; CLO_0032347
DR   Coriell; ND09713
DR   Wikidata; Q54922467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09714
AC   CVCL_IJ47
DR   CLO; CLO_0032349
DR   Coriell; ND09714
DR   Wikidata; Q54922468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09715
AC   CVCL_BC38
DR   CLO; CLO_0032348
DR   Coriell; ND09715
DR   Wikidata; Q54922469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09716
AC   CVCL_EV12
DR   CLO; CLO_0032342
DR   BioSample; SAMN00796268
DR   Coriell; ND09716
DR   Wikidata; Q54922470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09717
AC   CVCL_EV13
DR   CLO; CLO_0032340
DR   BioSample; SAMN00796270
DR   Coriell; ND09717
DR   Wikidata; Q54922471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09718
AC   CVCL_BC39
DR   CLO; CLO_0032345
DR   Coriell; ND09718
DR   Wikidata; Q54922472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09720
AC   CVCL_FL31
DR   Coriell; ND09720
DR   Wikidata; Q54922473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09721
AC   CVCL_HV48
DR   Coriell; ND09721
DR   Wikidata; Q54922474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09723
AC   CVCL_GC94
DR   CLO; CLO_0032343
DR   Coriell; ND09723
DR   Wikidata; Q54922475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09724
AC   CVCL_GC95
DR   CLO; CLO_0032351
DR   Coriell; ND09724
DR   Wikidata; Q54922476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09725
AC   CVCL_GC96
DR   CLO; CLO_0032350
DR   Coriell; ND09725
DR   Wikidata; Q54922477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09726
AC   CVCL_GC97
DR   CLO; CLO_0032352
DR   Coriell; ND09726
DR   Wikidata; Q54922478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09727
AC   CVCL_GC98
DR   CLO; CLO_0032283
DR   Coriell; ND09727
DR   Wikidata; Q54922479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09728
AC   CVCL_GC99
DR   CLO; CLO_0032282
DR   Coriell; ND09728
DR   Wikidata; Q54922480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09729
AC   CVCL_EV14
DR   CLO; CLO_0032280
DR   Coriell; ND09729
DR   Wikidata; Q54922481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09730
AC   CVCL_EV15
DR   CLO; CLO_0032279
DR   Coriell; ND09730
DR   Wikidata; Q54922482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09731
AC   CVCL_FF18
DR   CLO; CLO_0032290
DR   Coriell; ND09731
DR   Wikidata; Q54922495
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09732
AC   CVCL_GD00
DR   CLO; CLO_0032289
DR   Coriell; ND09732
DR   Wikidata; Q54922497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09733
AC   CVCL_GD01
DR   CLO; CLO_0032287
DR   Coriell; ND09733
DR   Wikidata; Q54922498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND09733; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09734
AC   CVCL_BC40
DR   CLO; CLO_0032284
DR   Coriell; ND09734
DR   Wikidata; Q54922499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09735
AC   CVCL_BC41
DR   CLO; CLO_0032293
DR   Coriell; ND09735
DR   Wikidata; Q54922502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09736
AC   CVCL_BC42
DR   CLO; CLO_0032292
DR   Coriell; ND09736
DR   Wikidata; Q54922503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09737
AC   CVCL_EV16
DR   CLO; CLO_0032318
DR   BioSample; SAMN00796278
DR   Coriell; ND09737
DR   Wikidata; Q54922504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09738
AC   CVCL_FL32
DR   CLO; CLO_0032302
DR   Coriell; ND09738
DR   Wikidata; Q54922505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09739
AC   CVCL_EV17
DR   CLO; CLO_0032299
DR   Coriell; ND09739
DR   Wikidata; Q54922507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09741
AC   CVCL_FL33
DR   CLO; CLO_0032304
DR   Coriell; ND09741
DR   Wikidata; Q54922508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09742
AC   CVCL_HY69
DR   CLO; CLO_0032303
DR   Coriell; ND09742
DR   Wikidata; Q54922509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09747
AC   CVCL_FL34
DR   CLO; CLO_0032308
DR   Coriell; ND09747
DR   Wikidata; Q54922510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09748
AC   CVCL_FZ19
DR   CLO; CLO_0032305
DR   Coriell; ND09748
DR   Wikidata; Q54922511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09749
AC   CVCL_HV49
DR   CLO; CLO_0032311
DR   Coriell; ND09749
DR   Wikidata; Q54922512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09750
AC   CVCL_FZ20
DR   CLO; CLO_0032310
DR   Coriell; ND09750
DR   Wikidata; Q54922513
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09751
AC   CVCL_FZ21
DR   CLO; CLO_0032313
DR   Coriell; ND09751
DR   Wikidata; Q54922514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09752
AC   CVCL_FZ22
DR   CLO; CLO_0032440
DR   Coriell; ND09752
DR   Wikidata; Q54922515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09753
AC   CVCL_FZ23
DR   CLO; CLO_0032439
DR   Coriell; ND09753
DR   Wikidata; Q54922516
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09768
AC   CVCL_EV18
DR   CLO; CLO_0032445
DR   Coriell; ND09768
DR   Wikidata; Q54922517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09769
AC   CVCL_GD02
DR   CLO; CLO_0032446
DR   Coriell; ND09769
DR   Wikidata; Q54922518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09771
AC   CVCL_GD03
DR   CLO; CLO_0032447
DR   Coriell; ND09771
DR   Wikidata; Q54922519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09772
AC   CVCL_ID72
DR   Coriell; ND09772
DR   Wikidata; Q54922520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09773
AC   CVCL_EV19
DR   CLO; CLO_0032448
DR   Coriell; ND09773
DR   Wikidata; Q54922521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09774
AC   CVCL_BC43
DR   CLO; CLO_0032441
DR   Coriell; ND09774
DR   Wikidata; Q54922522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09775
AC   CVCL_BC44
DR   CLO; CLO_0032442
DR   Coriell; ND09775
DR   Wikidata; Q54922523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09777
AC   CVCL_EV20
DR   CLO; CLO_0032443
DR   Coriell; ND09777
DR   Wikidata; Q54922524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09778
AC   CVCL_EV21
DR   CLO; CLO_0032444
DR   Coriell; ND09778
DR   Wikidata; Q54922525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09779
AC   CVCL_EV22
DR   CLO; CLO_0032451
DR   Coriell; ND09779
DR   Wikidata; Q54922526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09780
AC   CVCL_GD04
DR   CLO; CLO_0032450
DR   Coriell; ND09780
DR   Wikidata; Q54922527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09781
AC   CVCL_BC45
DR   CLO; CLO_0032449
DR   Coriell; ND09781
DR   Wikidata; Q54922528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09782
AC   CVCL_BC46
DR   CLO; CLO_0032457
DR   Coriell; ND09782
DR   Wikidata; Q54922529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09783
AC   CVCL_BC47
DR   CLO; CLO_0032458
DR   Coriell; ND09783
DR   Wikidata; Q54922530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09784
AC   CVCL_EV23
DR   CLO; CLO_0032455
DR   BioSample; SAMN00796286
DR   Coriell; ND09784
DR   Wikidata; Q54922531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09785
AC   CVCL_BC48
DR   CLO; CLO_0032456
DR   Coriell; ND09785
DR   Wikidata; Q54922532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09786
AC   CVCL_BC49
DR   CLO; CLO_0032453
DR   Coriell; ND09786
DR   Wikidata; Q54922533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09787
AC   CVCL_BC50
DR   CLO; CLO_0032454
DR   Coriell; ND09787
DR   Wikidata; Q54922534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09788
AC   CVCL_BC51
DR   CLO; CLO_0032452
DR   Coriell; ND09788
DR   Wikidata; Q54922535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09789
AC   CVCL_EV24
DR   CLO; CLO_0032430
DR   BioSample; SAMN00796290
DR   Coriell; ND09789
DR   Wikidata; Q54922536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09790
AC   CVCL_GD05
DR   CLO; CLO_0032429
DR   Coriell; ND09790
DR   Wikidata; Q54922537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09791
AC   CVCL_EV25
DR   CLO; CLO_0032432
DR   Coriell; ND09791
DR   Wikidata; Q54922538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09793
AC   CVCL_CL13
DR   BioSample; SAMN00796292
DR   Coriell; ND09793
DR   Wikidata; Q54922540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09799
AC   CVCL_HV51
DR   Coriell; ND09799
DR   Wikidata; Q54922541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09800
AC   CVCL_BC52
DR   CLO; CLO_0032431
DR   Coriell; ND09800
DR   Wikidata; Q54922542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09801
AC   CVCL_BC53
DR   CLO; CLO_0032433
DR   Coriell; ND09801
DR   Wikidata; Q54922543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09803
AC   CVCL_BC54
DR   CLO; CLO_0032434
DR   Coriell; ND09803
DR   Wikidata; Q54922544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09804
AC   CVCL_BC55
DR   CLO; CLO_0032435
DR   Coriell; ND09804
DR   Wikidata; Q54922545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09805
AC   CVCL_BC56
DR   CLO; CLO_0032436
DR   Coriell; ND09805
DR   Wikidata; Q54922546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09806
AC   CVCL_EV26
DR   CLO; CLO_0032437
DR   BioSample; SAMN00796298
DR   Coriell; ND09806
DR   Wikidata; Q54922547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09807
AC   CVCL_GD06
DR   CLO; CLO_0032438
DR   Coriell; ND09807
DR   Wikidata; Q54922548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09810
AC   CVCL_CL14
DR   Coriell; ND09810
DR   Wikidata; Q54922549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09811
AC   CVCL_CL15
DR   Coriell; ND09811
DR   Wikidata; Q54922550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09812
AC   CVCL_ID73
DR   Coriell; ND09812
DR   Wikidata; Q54922551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09815
AC   CVCL_BC57
DR   CLO; CLO_0035847
DR   Coriell; ND09815
DR   Wikidata; Q54922552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09816
AC   CVCL_CL16
DR   CLO; CLO_0035848
DR   Coriell; ND09816
DR   Wikidata; Q54922553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09817
AC   CVCL_CL17
DR   CLO; CLO_0035843
DR   Coriell; ND09817
DR   Wikidata; Q54922554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09818
AC   CVCL_CL18
DR   CLO; CLO_0035844
DR   Coriell; ND09818
DR   Wikidata; Q54922555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09819
AC   CVCL_GD07
DR   CLO; CLO_0035845
DR   BioSample; SAMN00796300
DR   Coriell; ND09819
DR   Wikidata; Q54922556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09820
AC   CVCL_FA50
DR   CLO; CLO_0035846
DR   Coriell; ND09820
DR   Wikidata; Q54922557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09821
AC   CVCL_BC58
DR   CLO; CLO_0035839
DR   Coriell; ND09821
DR   Wikidata; Q54922558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09822
AC   CVCL_FL35
DR   CLO; CLO_0035840
DR   Coriell; ND09822
DR   Wikidata; Q54922559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09823
AC   CVCL_GD08
DR   CLO; CLO_0035841
DR   Coriell; ND09823
DR   Wikidata; Q54922560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09824
AC   CVCL_GD09
DR   CLO; CLO_0035842
DR   Coriell; ND09824
DR   Wikidata; Q54922561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09825
AC   CVCL_GD10
DR   CLO; CLO_0036055
DR   Coriell; ND09825
DR   Wikidata; Q54922562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09826
AC   CVCL_ID74
DR   Coriell; ND09826
DR   Wikidata; Q54922563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09827
AC   CVCL_FC55
DR   CLO; CLO_0036057
DR   Coriell; ND09827
DR   Wikidata; Q54922564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09828
AC   CVCL_HY70
DR   CLO; CLO_0036056
DR   Coriell; ND09828
DR   Wikidata; Q54922565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09829
AC   CVCL_BC59
DR   CLO; CLO_0036062
DR   Coriell; ND09829
DR   Wikidata; Q54922566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09830
AC   CVCL_EV27
DR   CLO; CLO_0036061
DR   BioSample; SAMN00796306
DR   Coriell; ND09830
DR   Wikidata; Q54922567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09831
AC   CVCL_BC60
DR   CLO; CLO_0036064
DR   Coriell; ND09831
DR   Wikidata; Q54922568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09832
AC   CVCL_BC61
DR   CLO; CLO_0036063
DR   Coriell; ND09832
DR   Wikidata; Q54922569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09833
AC   CVCL_BC62
DR   CLO; CLO_0036059
DR   Coriell; ND09833
DR   Wikidata; Q54922570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09834
AC   CVCL_BC63
DR   CLO; CLO_0036058
DR   Coriell; ND09834
DR   Wikidata; Q54922571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09837
AC   CVCL_CL19
DR   Coriell; ND09837
DR   Wikidata; Q54922572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09838
AC   CVCL_CL20
DR   Coriell; ND09838
DR   Wikidata; Q54922573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09840
AC   CVCL_CL21
DR   Coriell; ND09840
DR   Wikidata; Q54922574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09841
AC   CVCL_CL22
DR   Coriell; ND09841
DR   Wikidata; Q54922575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09842
AC   CVCL_BC64
DR   CLO; CLO_0036060
DR   Coriell; ND09842
DR   Wikidata; Q54922576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09843
AC   CVCL_GD11
DR   CLO; CLO_0036048
DR   Coriell; ND09843
DR   Wikidata; Q54922577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09844
AC   CVCL_BC65
DR   CLO; CLO_0036047
DR   Coriell; ND09844
DR   Wikidata; Q54922579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09845
AC   CVCL_BC66
DR   CLO; CLO_0036046
DR   Coriell; ND09845
DR   Wikidata; Q54922580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09846
AC   CVCL_BC67
DR   CLO; CLO_0036045
DR   Coriell; ND09846
DR   Wikidata; Q54922586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09850
AC   CVCL_ID75
DR   Coriell; ND09850
DR   Wikidata; Q54922587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09855
AC   CVCL_FL36
DR   Coriell; ND09855
DR   Wikidata; Q54922589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09856
AC   CVCL_CL23
DR   CLO; CLO_0036054
DR   Coriell; ND09856
DR   Wikidata; Q54922590
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09857
AC   CVCL_EV28
DR   CLO; CLO_0036053
DR   Coriell; ND09857
DR   Wikidata; Q54922591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09858
AC   CVCL_BC68
DR   CLO; CLO_0036052
DR   Coriell; ND09858
DR   Wikidata; Q54922592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09859
AC   CVCL_BC69
DR   CLO; CLO_0036051
DR   Coriell; ND09859
DR   Wikidata; Q54922593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09860
AC   CVCL_FA51
DR   CLO; CLO_0036050
DR   Coriell; ND09860
DR   Wikidata; Q54922594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09861
AC   CVCL_EV29
DR   CLO; CLO_0036049
DR   Coriell; ND09861
DR   Wikidata; Q54922595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09862
AC   CVCL_ID76
DR   Coriell; ND09862
DR   Wikidata; Q54922596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09870
AC   CVCL_FL37
DR   CLO; CLO_0036035
DR   Coriell; ND09870
DR   Wikidata; Q54922597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09871
AC   CVCL_FL38
DR   CLO; CLO_0036037
DR   Coriell; ND09871
DR   Wikidata; Q54922598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09872
AC   CVCL_FL39
DR   CLO; CLO_0036036
DR   Coriell; ND09872
DR   Wikidata; Q54922599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09873
AC   CVCL_BC70
DR   CLO; CLO_0036039
DR   Coriell; ND09873
DR   Wikidata; Q54922600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09874
AC   CVCL_IJ48
DR   CLO; CLO_0036038
DR   Coriell; ND09874
DR   Wikidata; Q54922601
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND09875
AC   CVCL_FC56
DR   CLO; CLO_0036041
DR   Coriell; ND09875
DR   Wikidata; Q54922602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09876
AC   CVCL_BC71
DR   CLO; CLO_0036040
DR   Coriell; ND09876
DR   Wikidata; Q54922604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09877
AC   CVCL_EV30
DR   CLO; CLO_0036043
DR   Coriell; ND09877
DR   Wikidata; Q54922605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09878
AC   CVCL_BC72
DR   CLO; CLO_0036042
DR   Coriell; ND09878
DR   Wikidata; Q54922606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09879
AC   CVCL_EV31
DR   CLO; CLO_0036044
DR   BioSample; SAMN00796314
DR   Coriell; ND09879
DR   Wikidata; Q54922607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09880
AC   CVCL_EV32
DR   CLO; CLO_0036026
DR   Coriell; ND09880
DR   Wikidata; Q54922608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09881
AC   CVCL_BC73
DR   CLO; CLO_0036025
DR   Coriell; ND09881
DR   Wikidata; Q54922610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09882
AC   CVCL_GD12
DR   CLO; CLO_0036030
DR   Coriell; ND09882
DR   Wikidata; Q54922611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09883
AC   CVCL_EV33
DR   CLO; CLO_0036029
DR   Coriell; ND09883
DR   Wikidata; Q54922612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09884
AC   CVCL_BC74
DR   CLO; CLO_0036028
DR   Coriell; ND09884
DR   Wikidata; Q54922613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09885
AC   CVCL_BC75
DR   CLO; CLO_0036027
DR   Coriell; ND09885
DR   Wikidata; Q54922614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09887
AC   CVCL_EV34
DR   CLO; CLO_0036034
DR   BioSample; SAMN00796315
DR   Coriell; ND09887
DR   Wikidata; Q54922615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09888
AC   CVCL_EV35
DR   CLO; CLO_0036033
DR   Coriell; ND09888
DR   Wikidata; Q54922616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09889
AC   CVCL_BC76
DR   CLO; CLO_0036032
DR   Coriell; ND09889
DR   Wikidata; Q54922617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09890
AC   CVCL_BC77
DR   CLO; CLO_0036031
DR   Coriell; ND09890
DR   Wikidata; Q54922618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09891
AC   CVCL_EV36
DR   CLO; CLO_0036102
DR   Coriell; ND09891
DR   Wikidata; Q54922619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09892
AC   CVCL_GD13
DR   CLO; CLO_0036103
DR   Coriell; ND09892
DR   Wikidata; Q54922620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09893
AC   CVCL_GD14
DR   CLO; CLO_0036104
DR   Coriell; ND09893
DR   Wikidata; Q54922621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09894
AC   CVCL_GD15
DR   CLO; CLO_0036098
DR   Coriell; ND09894
DR   Wikidata; Q54922622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09895
AC   CVCL_GD16
DR   CLO; CLO_0036099
DR   Coriell; ND09895
DR   Wikidata; Q54922623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09896
AC   CVCL_GD17
DR   CLO; CLO_0036100
DR   Coriell; ND09896
DR   Wikidata; Q54922624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09900
AC   CVCL_CL24
DR   Coriell; ND09900
DR   Wikidata; Q54922625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09901
AC   CVCL_CL25
DR   BioSample; SAMN00796317
DR   Coriell; ND09901
DR   Wikidata; Q54922626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND09902
AC   CVCL_CL26
DR   Coriell; ND09902
DR   Wikidata; Q54922627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09905
AC   CVCL_FL40
DR   Coriell; ND09905
DR   Wikidata; Q54922628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09906
AC   CVCL_FL41
DR   CLO; CLO_0036101
DR   Coriell; ND09906
DR   Wikidata; Q54922634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09907
AC   CVCL_BC78
DR   CLO; CLO_0036095
DR   Coriell; ND09907
DR   Wikidata; Q54922635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09908
AC   CVCL_GD18
DR   CLO; CLO_0036096
DR   Coriell; ND09908
DR   Wikidata; Q54922636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09909
AC   CVCL_BC79
DR   CLO; CLO_0036097
DR   Coriell; ND09909
DR   Wikidata; Q54922637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09911
AC   CVCL_BC80
DR   CLO; CLO_0036093
DR   Coriell; ND09911
DR   Wikidata; Q54922638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09912
AC   CVCL_GD19
DR   CLO; CLO_0036094
DR   Coriell; ND09912
DR   Wikidata; Q54922639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09913
AC   CVCL_BC81
DR   Coriell; ND09913
DR   Wikidata; Q54922640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09914
AC   CVCL_BC82
DR   CLO; CLO_0036091
DR   Coriell; ND09914
DR   Wikidata; Q54922641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09915
AC   CVCL_BC83
DR   CLO; CLO_0036092
DR   Coriell; ND09915
DR   Wikidata; Q54922642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09920
AC   CVCL_FF19
DR   Coriell; ND09920
DR   Wikidata; Q54922643
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09924
AC   CVCL_CL27
DR   Coriell; ND09924
DR   Wikidata; Q54922644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09931
AC   CVCL_IL82
DR   Coriell; ND09931
DR   Wikidata; Q54922645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09937
AC   CVCL_EB00
DR   Coriell; ND09937
DR   Wikidata; Q54922646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND09938
AC   CVCL_GD20
DR   CLO; CLO_0036089
DR   Coriell; ND09938
DR   Wikidata; Q54922647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09939
AC   CVCL_EV37
DR   CLO; CLO_0036090
DR   Coriell; ND09939
DR   Wikidata; Q54922648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09941
AC   CVCL_GD21
DR   CLO; CLO_0036087
DR   Coriell; ND09941
DR   Wikidata; Q54922649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09942
AC   CVCL_GD22
DR   CLO; CLO_0036088
DR   Coriell; ND09942
DR   Wikidata; Q54922650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09943
AC   CVCL_BC84
DR   CLO; CLO_0036085
DR   Coriell; ND09943
DR   Wikidata; Q54922651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09944
AC   CVCL_EV38
DR   CLO; CLO_0036086
DR   Coriell; ND09944
DR   Wikidata; Q54922652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09945
AC   CVCL_BC85
DR   CLO; CLO_0036075
DR   Coriell; ND09945
DR   Wikidata; Q54922653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09947
AC   CVCL_GD23
DR   CLO; CLO_0036077
DR   Coriell; ND09947
DR   Wikidata; Q54922654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09949
AC   CVCL_GD24
DR   CLO; CLO_0036078
DR   Coriell; ND09949
DR   Wikidata; Q54922655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09950
AC   CVCL_EV39
DR   CLO; CLO_0036079
DR   Coriell; ND09950
DR   Wikidata; Q54922656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09951
AC   CVCL_GD25
DR   CLO; CLO_0036080
DR   Coriell; ND09951
DR   Wikidata; Q54922657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09952
AC   CVCL_GD26
DR   CLO; CLO_0036081
DR   Coriell; ND09952
DR   Wikidata; Q54922658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09953
AC   CVCL_BC86
DR   CLO; CLO_0036082
DR   Coriell; ND09953
DR   Wikidata; Q54922659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09954
AC   CVCL_BC87
DR   CLO; CLO_0036083
DR   Coriell; ND09954
DR   Wikidata; Q54922660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09955
AC   CVCL_BC88
DR   CLO; CLO_0036084
DR   Coriell; ND09955
DR   Wikidata; Q54922661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09956
AC   CVCL_BC89
DR   CLO; CLO_0036076
DR   Coriell; ND09956
DR   Wikidata; Q54922662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09957
AC   CVCL_EV40
DR   CLO; CLO_0036066
DR   BioSample; SAMN00796325
DR   Coriell; ND09957
DR   Wikidata; Q54922663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09958
AC   CVCL_GD27
DR   CLO; CLO_0036065
DR   BioSample; SAMN00796326
DR   Coriell; ND09958
DR   Wikidata; Q54922664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09959
AC   CVCL_BC90
DR   CLO; CLO_0036069
DR   Coriell; ND09959
DR   Wikidata; Q54922665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09960
AC   CVCL_BC91
DR   CLO; CLO_0036070
DR   Coriell; ND09960
DR   Wikidata; Q54922666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09961
AC   CVCL_EV41
DR   CLO; CLO_0036067
DR   Coriell; ND09961
DR   Wikidata; Q54922667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09962
AC   CVCL_EV42
DR   CLO; CLO_0036068
DR   Coriell; ND09962
DR   Wikidata; Q54922668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09963
AC   CVCL_EV43
DR   CLO; CLO_0036073
DR   Coriell; ND09963
DR   Wikidata; Q54922669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09964
AC   CVCL_GD28
DR   CLO; CLO_0036074
DR   Coriell; ND09964
DR   Wikidata; Q54922670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09965
AC   CVCL_EV44
DR   CLO; CLO_0036071
DR   Coriell; ND09965
DR   Wikidata; Q54922671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09966
AC   CVCL_FF20
DR   CLO; CLO_0036072
DR   Coriell; ND09966
DR   Wikidata; Q54922672
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09967
AC   CVCL_GD29
DR   CLO; CLO_0035976
DR   Coriell; ND09967
DR   Wikidata; Q54922674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09976
AC   CVCL_BC92
DR   CLO; CLO_0035973
DR   Coriell; ND09976
DR   Wikidata; Q54922699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09977
AC   CVCL_BC93
DR   CLO; CLO_0035974
DR   Coriell; ND09977
DR   Wikidata; Q54922700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09979
AC   CVCL_CL28
DR   Coriell; ND09979
DR   Wikidata; Q54922701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09983
AC   CVCL_ID77
DR   CLO; CLO_0035972
DR   Coriell; ND09983
DR   Wikidata; Q54922702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09984
AC   CVCL_CL29
DR   CLO; CLO_0035971
DR   Coriell; ND09984
DR   Wikidata; Q54922703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND09985
AC   CVCL_EV45
DR   CLO; CLO_0035970
DR   Coriell; ND09985
DR   Wikidata; Q54922704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09986
AC   CVCL_BC94
DR   CLO; CLO_0035969
DR   Coriell; ND09986
DR   Wikidata; Q54922705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09987
AC   CVCL_ID78
DR   CLO; CLO_0035968
DR   Coriell; ND09987
DR   Wikidata; Q54922706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND09988
AC   CVCL_BC95
DR   CLO; CLO_0035967
DR   Coriell; ND09988
DR   Wikidata; Q54922707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09989
AC   CVCL_EV46
DR   CLO; CLO_0035966
DR   BioSample; SAMN00796334
DR   Coriell; ND09989
DR   Wikidata; Q54922708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND09990
AC   CVCL_GT96
DR   CLO; CLO_0036105
DR   Coriell; ND09990
DR   Wikidata; Q54922709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09991
AC   CVCL_GD30
DR   CLO; CLO_0036106
DR   Coriell; ND09991
DR   Wikidata; Q54922710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09992
AC   CVCL_GT97
DR   CLO; CLO_0036107
DR   Coriell; ND09992
DR   Wikidata; Q54922711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09993
AC   CVCL_GT98
DR   CLO; CLO_0036108
DR   Coriell; ND09993
DR   Wikidata; Q54922712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09994
AC   CVCL_GT99
DR   CLO; CLO_0036109
DR   Coriell; ND09994
DR   Wikidata; Q54922713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09995
AC   CVCL_BC96
DR   CLO; CLO_0036110
DR   Coriell; ND09995
DR   Wikidata; Q54922714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND09996
AC   CVCL_BC97
DR   CLO; CLO_0036111
DR   Coriell; ND09996
DR   Wikidata; Q54922715
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND09997
AC   CVCL_GU00
DR   CLO; CLO_0036112
DR   Coriell; ND09997
DR   Wikidata; Q54922716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND09998
AC   CVCL_FF21
DR   CLO; CLO_0036113
DR   BioSample; SAMN00796339
DR   Coriell; ND09998
DR   Wikidata; Q54922717
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND09999
AC   CVCL_GD31
DR   CLO; CLO_0036124
DR   Coriell; ND09999
DR   Wikidata; Q54922718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND1.4
AC   CVCL_1E77
SY   ND50021; CR0000011; CRMi005-A
DR   BioSamples; SAMEA5070572
DR   hPSCreg; CRMi005-A
DR   NHCDR; ND50021
DR   SKIP; SKIP003116
DR   Wikidata; Q54922719
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   ND10
AC   CVCL_VK88
SY   Neuroblastoma X DRG neurons hybrid 10
DR   Wikidata; Q98127442
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND10000
AC   CVCL_BC98
DR   CLO; CLO_0036114
DR   Coriell; ND10000
DR   Wikidata; Q54922720
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10001
AC   CVCL_BC99
DR   CLO; CLO_0036115
DR   Coriell; ND10001
DR   Wikidata; Q54922721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND10002
AC   CVCL_BD00
DR   CLO; CLO_0036122
DR   Coriell; ND10002
DR   Wikidata; Q54922722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10003
AC   CVCL_BD01
DR   CLO; CLO_0036123
DR   Coriell; ND10003
DR   Wikidata; Q54922724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10008
AC   CVCL_GD32
DR   CLO; CLO_0036120
DR   Coriell; ND10008
DR   Wikidata; Q54922725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10009
AC   CVCL_EV47
DR   CLO; CLO_0036121
DR   Coriell; ND10009
DR   Wikidata; Q54922726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10010
AC   CVCL_FL42
DR   CLO; CLO_0036118
DR   Coriell; ND10010
DR   Wikidata; Q54922727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10011
AC   CVCL_BD02
DR   CLO; CLO_0036119
DR   Coriell; ND10011
DR   Wikidata; Q54922728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10012
AC   CVCL_EV48
DR   CLO; CLO_0036116
DR   Coriell; ND10012
DR   Wikidata; Q54922729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10014
AC   CVCL_BD03
DR   CLO; CLO_0036117
DR   Coriell; ND10014
DR   Wikidata; Q54922730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10015
AC   CVCL_EV49
DR   CLO; CLO_0036125
DR   BioSample; SAMN00796342
DR   Coriell; ND10015
DR   Wikidata; Q54922731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10016
AC   CVCL_BD04
DR   CLO; CLO_0036126
DR   Coriell; ND10016
DR   Wikidata; Q54922732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10017
AC   CVCL_GD33
DR   CLO; CLO_0036127
DR   BioSample; SAMN00796345
DR   Coriell; ND10017
DR   Wikidata; Q54922733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10019
AC   CVCL_GD34
DR   CLO; CLO_0036131
DR   Coriell; ND10019
DR   Wikidata; Q54922734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10020
AC   CVCL_EV50
DR   CLO; CLO_0036132
DR   Coriell; ND10020
DR   Wikidata; Q54922735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10021
AC   CVCL_EV51
DR   CLO; CLO_0036133
DR   Coriell; ND10021
DR   Wikidata; Q54922736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10022
AC   CVCL_BD05
DR   CLO; CLO_0036134
DR   Coriell; ND10022
DR   Wikidata; Q54922737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10023
AC   CVCL_BD06
DR   CLO; CLO_0036128
DR   Coriell; ND10023
DR   Wikidata; Q54922738
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10026
AC   CVCL_HV52
DR   Coriell; ND10026
DR   Wikidata; Q54922739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10027
AC   CVCL_HV53
DR   Coriell; ND10027
DR   Wikidata; Q54922746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10029
AC   CVCL_FL43
DR   Coriell; ND10029
DR   Wikidata; Q54922747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10030
AC   CVCL_CL30
DR   CLO; CLO_0036129
DR   Coriell; ND10030
DR   Wikidata; Q54922749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10031
AC   CVCL_FL44
DR   CLO; CLO_0036130
DR   Coriell; ND10031
DR   Wikidata; Q54922750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10032
AC   CVCL_HR61
DR   CLO; CLO_0036252
DR   Coriell; ND10032
DR   Wikidata; Q54922751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10034
AC   CVCL_FZ24
DR   CLO; CLO_0036251
DR   Coriell; ND10034
DR   Wikidata; Q54922752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10035
AC   CVCL_BD07
DR   CLO; CLO_0036254
DR   Coriell; ND10035
DR   Wikidata; Q54922753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10036
AC   CVCL_BD08
DR   Coriell; ND10036
DR   Wikidata; Q54922754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10037
AC   CVCL_EB01
DR   Coriell; ND10037
DR   Wikidata; Q54922755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10038
AC   CVCL_EB02
DR   Coriell; ND10038
DR   Wikidata; Q54922756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10039
AC   CVCL_GD35
DR   CLO; CLO_0036253
DR   BioSample; SAMN00796350
DR   Coriell; ND10039
DR   Wikidata; Q54922757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10040
AC   CVCL_EV52
DR   CLO; CLO_0036248
DR   Coriell; ND10040
DR   Wikidata; Q54922758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10041
AC   CVCL_BD09
DR   CLO; CLO_0036247
DR   Coriell; ND10041
DR   Wikidata; Q54922759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10042
AC   CVCL_BD10
DR   CLO; CLO_0036250
DR   Coriell; ND10042
DR   Wikidata; Q54922760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10055
AC   CVCL_HV54
DR   Coriell; ND10055
DR   Wikidata; Q54922761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10057
AC   CVCL_EV53
DR   CLO; CLO_0036249
DR   Coriell; ND10057
DR   Wikidata; Q54922762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10058
AC   CVCL_GD36
DR   CLO; CLO_0036246
DR   Coriell; ND10058
DR   Wikidata; Q54922763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10059
AC   CVCL_BD11
DR   CLO; CLO_0036245
DR   Coriell; ND10059
DR   Wikidata; Q54922764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10061
AC   CVCL_CL31
DR   Coriell; ND10061
DR   Wikidata; Q54922765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10064
AC   CVCL_FZ25
DR   CLO; CLO_0036244
DR   Coriell; ND10064
DR   Wikidata; Q54922766
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10065
AC   CVCL_FZ26
DR   CLO; CLO_0036243
DR   Coriell; ND10065
DR   Wikidata; Q54922767
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10066
AC   CVCL_IH39
DR   CLO; CLO_0036242
DR   Coriell; ND10066
DR   Wikidata; Q54922768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10067
AC   CVCL_BD12
DR   CLO; CLO_0036241
DR   Coriell; ND10067
DR   Wikidata; Q54922769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10068
AC   CVCL_BD13
DR   CLO; CLO_0036240
DR   Coriell; ND10068
DR   Wikidata; Q54922770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10069
AC   CVCL_BD14
DR   CLO; CLO_0036239
DR   Coriell; ND10069
DR   Wikidata; Q54922771
RX   PubMed=22572540;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg662Cys (c.1984C>T) (c.2373C>T); ClinVar=VCV000572697; Zygosity=Heterozygous (PubMed=22572540).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10071
AC   CVCL_HV55
DR   Coriell; ND10071
DR   Wikidata; Q54922772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10076
AC   CVCL_BD15
DR   CLO; CLO_0036238
DR   Coriell; ND10076
DR   Wikidata; Q54922773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10077
AC   CVCL_IJ49
DR   CLO; CLO_0036237
DR   Coriell; ND10077
DR   Wikidata; Q54922775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10078
AC   CVCL_BD16
DR   CLO; CLO_0036236
DR   Coriell; ND10078
DR   Wikidata; Q54922776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10079
AC   CVCL_FA52
DR   CLO; CLO_0036235
DR   Coriell; ND10079
DR   Wikidata; Q54922777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10080
AC   CVCL_BD17
DR   CLO; CLO_0036270
DR   Coriell; ND10080
DR   Wikidata; Q54922778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10081
AC   CVCL_BD18
DR   CLO; CLO_0036269
DR   Coriell; ND10081
DR   Wikidata; Q54922779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10082
AC   CVCL_CL32
DR   CLO; CLO_0036272
DR   Coriell; ND10082
DR   Wikidata; Q54922780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10089
AC   CVCL_CL33
DR   CLO; CLO_0036271
DR   Coriell; ND10089
DR   Wikidata; Q54922781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10090
AC   CVCL_GD37
DR   CLO; CLO_0036274
DR   Coriell; ND10090
DR   Wikidata; Q54922782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10091
AC   CVCL_GD38
DR   CLO; CLO_0036273
DR   Coriell; ND10091
DR   Wikidata; Q54922783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10093
AC   CVCL_FA53
DR   CLO; CLO_0036266
DR   Coriell; ND10093
DR   Wikidata; Q54922784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10094
AC   CVCL_BD19
DR   CLO; CLO_0036265
DR   Coriell; ND10094
DR   Wikidata; Q54922786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10095
AC   CVCL_BD20
DR   CLO; CLO_0036268
DR   Coriell; ND10095
DR   Wikidata; Q54922787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10096
AC   CVCL_BD21
DR   CLO; CLO_0036267
DR   Coriell; ND10096
DR   Wikidata; Q54922788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10098
AC   CVCL_BD22
DR   CLO; CLO_0036260
DR   Coriell; ND10098
DR   Wikidata; Q54922799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10099
AC   CVCL_EV54
DR   CLO; CLO_0036259
DR   Coriell; ND10099
DR   Wikidata; Q54922800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10100
AC   CVCL_FA54
DR   CLO; CLO_0036258
DR   Coriell; ND10100
DR   Wikidata; Q54922801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10101
AC   CVCL_BD23
DR   CLO; CLO_0036264
DR   Coriell; ND10101
DR   Wikidata; Q54922802
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10102
AC   CVCL_GD39
DR   CLO; CLO_0036263
DR   BioSample; SAMN00796361
DR   Coriell; ND10102
DR   Wikidata; Q54922804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10103
AC   CVCL_BD24
DR   CLO; CLO_0036262
DR   Coriell; ND10103
DR   Wikidata; Q54922805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10104
AC   CVCL_BD25
DR   CLO; CLO_0036261
DR   Coriell; ND10104
DR   Wikidata; Q54922807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10105
AC   CVCL_BD26
DR   CLO; CLO_0036257
DR   Coriell; ND10105
DR   Wikidata; Q54922808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10106
AC   CVCL_BD27
DR   CLO; CLO_0036256
DR   Coriell; ND10106
DR   Wikidata; Q54922809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10107
AC   CVCL_EV55
DR   CLO; CLO_0036255
DR   Coriell; ND10107
DR   Wikidata; Q54922810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10115
AC   CVCL_FZ27
DR   Coriell; ND10115
DR   Wikidata; Q54922811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10116
AC   CVCL_CL34
DR   CLO; CLO_0036289
DR   Coriell; ND10116
DR   Wikidata; Q54922812
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND10117
AC   CVCL_BD28
DR   CLO; CLO_0036290
DR   Coriell; ND10117
DR   Wikidata; Q54922813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10118
AC   CVCL_BD29
DR   CLO; CLO_0036291
DR   Coriell; ND10118
DR   Wikidata; Q54922814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10119
AC   CVCL_EV56
DR   CLO; CLO_0036292
DR   BioSample; SAMN00796368
DR   Coriell; ND10119
DR   Wikidata; Q54922815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10120
AC   CVCL_GD40
DR   CLO; CLO_0036285
DR   Coriell; ND10120
DR   Wikidata; Q54922816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10121
AC   CVCL_BD30
DR   CLO; CLO_0036286
DR   Coriell; ND10121
DR   Wikidata; Q54922817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10122
AC   CVCL_BD31
DR   CLO; CLO_0036287
DR   Coriell; ND10122
DR   Wikidata; Q54922818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10123
AC   CVCL_BD32
DR   CLO; CLO_0036288
DR   Coriell; ND10123
DR   Wikidata; Q54922819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10124
AC   CVCL_BD33
DR   CLO; CLO_0036293
DR   Coriell; ND10124
DR   Wikidata; Q54922820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10125
AC   CVCL_BD34
DR   CLO; CLO_0036294
DR   Coriell; ND10125
DR   Wikidata; Q54922821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10126
AC   CVCL_FC57
DR   CLO; CLO_0036275
DR   BioSample; SAMN00796375
DR   Coriell; ND10126
DR   Wikidata; Q54922822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10127
AC   CVCL_FC58
DR   CLO; CLO_0036282
DR   BioSample; SAMN00796377
DR   Coriell; ND10127
DR   Wikidata; Q54922823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10128
AC   CVCL_GD41
DR   CLO; CLO_0036283
DR   BioSample; SAMN00796379
DR   Coriell; ND10128
DR   Wikidata; Q54922824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10129
AC   CVCL_FL45
DR   Coriell; ND10129
DR   Wikidata; Q54922825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10132
AC   CVCL_EB03
DR   Coriell; ND10132
DR   Wikidata; Q54922826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10136
AC   CVCL_CL35
DR   Coriell; ND10136
DR   Wikidata; Q54922827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10137
AC   CVCL_FL46
DR   CLO; CLO_0036280
DR   Coriell; ND10137
DR   Wikidata; Q54922828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10138
AC   CVCL_EV57
DR   CLO; CLO_0036281
DR   Coriell; ND10138
DR   Wikidata; Q54922829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10139
AC   CVCL_ID79
DR   Coriell; ND10139
DR   Wikidata; Q54922830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10140
AC   CVCL_ID80
DR   Coriell; ND10140
DR   Wikidata; Q54922831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10141
AC   CVCL_BD35
DR   CLO; CLO_0036278
DR   Coriell; ND10141
DR   Wikidata; Q54922832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10142
AC   CVCL_BD36
DR   Coriell; ND10142
DR   Wikidata; Q54922833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10143
AC   CVCL_BD37
DR   CLO; CLO_0036279
DR   Coriell; ND10143
DR   Wikidata; Q54922835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10144
AC   CVCL_BD38
DR   CLO; CLO_0036276
DR   Coriell; ND10144
DR   Wikidata; Q54922836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10145
AC   CVCL_BD39
DR   CLO; CLO_0036277
DR   Coriell; ND10145
DR   Wikidata; Q54922837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10146
AC   CVCL_BD40
DR   CLO; CLO_0036284
DR   Coriell; ND10146
DR   Wikidata; Q54922839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10147
AC   CVCL_GD42
DR   CLO; CLO_0036296
DR   BioSample; SAMN00796389
DR   Coriell; ND10147
DR   Wikidata; Q54922840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10152
AC   CVCL_CL36
DR   Coriell; ND10152
DR   Wikidata; Q54922841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10154
AC   CVCL_HV56
DR   Coriell; ND10154
DR   Wikidata; Q54922842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10155
AC   CVCL_BD41
DR   CLO; CLO_0036295
DR   Coriell; ND10155
DR   Wikidata; Q54922848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10156
AC   CVCL_IJ50
DR   CLO; CLO_0036297
DR   Coriell; ND10156
DR   Wikidata; Q54922849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10157
AC   CVCL_BD42
DR   CLO; CLO_0036298
DR   Coriell; ND10157
DR   Wikidata; Q54922850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10158
AC   CVCL_FA55
DR   CLO; CLO_0036299
DR   Coriell; ND10158
DR   Wikidata; Q54922852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10159
AC   CVCL_FC59
DR   CLO; CLO_0036300
DR   Coriell; ND10159
DR   Wikidata; Q54922853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10160
AC   CVCL_FL47
DR   CLO; CLO_0036301
DR   Coriell; ND10160
DR   Wikidata; Q54922854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10161
AC   CVCL_BD43
DR   CLO; CLO_0036302
DR   Coriell; ND10161
DR   Wikidata; Q54922855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10162
AC   CVCL_IH40
DR   CLO; CLO_0036303
DR   Coriell; ND10162
DR   Wikidata; Q54922856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10163
AC   CVCL_HR62
DR   CLO; CLO_0036304
DR   Coriell; ND10163
DR   Wikidata; Q54922857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10164
AC   CVCL_HR63
DR   CLO; CLO_0036412
DR   Coriell; ND10164
DR   Wikidata; Q54922859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10165
AC   CVCL_HV57
DR   CLO; CLO_0036411
DR   Coriell; ND10165
DR   Wikidata; Q54922860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10166
AC   CVCL_HR64
DR   CLO; CLO_0036414
DR   Coriell; ND10166
DR   Wikidata; Q54922861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10167
AC   CVCL_GQ24
DR   CLO; CLO_0036413
DR   Coriell; ND10167
DR   Wikidata; Q54922862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36192; Arteriovenous fistula
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10169
AC   CVCL_HV58
DR   Coriell; ND10169
DR   Wikidata; Q54922863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10170
AC   CVCL_FZ28
DR   Coriell; ND10170
DR   Wikidata; Q54922864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10176
AC   CVCL_CL37
DR   Coriell; ND10176
DR   Wikidata; Q54922865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10179
AC   CVCL_BD44
DR   CLO; CLO_0036408
DR   Coriell; ND10179
DR   Wikidata; Q54922866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10180
AC   CVCL_GD43
DR   CLO; CLO_0036407
DR   BioSample; SAMN00796395
DR   Coriell; ND10180
DR   Wikidata; Q54922867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10181
AC   CVCL_BD45
DR   CLO; CLO_0036410
DR   Coriell; ND10181
DR   Wikidata; Q54922868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10182
AC   CVCL_BD46
DR   CLO; CLO_0036409
DR   Coriell; ND10182
DR   Wikidata; Q54922870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10187
AC   CVCL_GD44
DR   CLO; CLO_0036347
DR   Coriell; ND10187
DR   Wikidata; Q54922871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10188
AC   CVCL_ID81
DR   Coriell; ND10188
DR   Wikidata; Q54922872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10189
AC   CVCL_EV58
DR   CLO; CLO_0036346
DR   Coriell; ND10189
DR   Wikidata; Q54922873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10190
AC   CVCL_ID82
DR   Coriell; ND10190
DR   Wikidata; Q54922874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10192
AC   CVCL_CL38
DR   Coriell; ND10192
DR   Wikidata; Q54922875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10193
AC   CVCL_FZ29
DR   Coriell; ND10193
DR   Wikidata; Q54922876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10194
AC   CVCL_CL39
DR   Coriell; ND10194
DR   Wikidata; Q54922877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10197
AC   CVCL_EB04
DR   Coriell; ND10197
DR   Wikidata; Q54922878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10199
AC   CVCL_FL48
DR   CLO; CLO_0036363
DR   Coriell; ND10199
DR   Wikidata; Q54922879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10200
AC   CVCL_FZ30
DR   CLO; CLO_0036350
DR   Coriell; ND10200
DR   Wikidata; Q54922880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10201
AC   CVCL_HV59
DR   CLO; CLO_0036351
DR   Coriell; ND10201
DR   Wikidata; Q54922881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10202
AC   CVCL_IH41
DR   CLO; CLO_0036348
DR   Coriell; ND10202
DR   Wikidata; Q54922882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10203
AC   CVCL_HV60
DR   CLO; CLO_0036349
DR   Coriell; ND10203
DR   Wikidata; Q54922883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10205
AC   CVCL_BD47
DR   CLO; CLO_0036355
DR   Coriell; ND10205
DR   Wikidata; Q54922884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10206
AC   CVCL_BD48
DR   CLO; CLO_0036356
DR   Coriell; ND10206
DR   Wikidata; Q54922885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10207
AC   CVCL_BD49
DR   CLO; CLO_0036352
DR   Coriell; ND10207
DR   Wikidata; Q54922886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10208
AC   CVCL_BD50
DR   Coriell; ND10208
DR   Wikidata; Q54922887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10209
AC   CVCL_BD51
DR   CLO; CLO_0036353
DR   Coriell; ND10209
DR   Wikidata; Q54922888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10215
AC   CVCL_EB05
DR   Coriell; ND10215
DR   Wikidata; Q54922889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10219
AC   CVCL_FL49
DR   Coriell; ND10219
DR   Wikidata; Q54922890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10220
AC   CVCL_BD52
DR   CLO; CLO_0036366
DR   Coriell; ND10220
DR   Wikidata; Q54922895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10221
AC   CVCL_BD53
DR   CLO; CLO_0036384
DR   Coriell; ND10221
DR   Wikidata; Q54922896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10222
AC   CVCL_IL83
DR   CLO; CLO_0036385
DR   Coriell; ND10222
DR   Wikidata; Q54922897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND10222; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND10223
AC   CVCL_BD54
DR   CLO; CLO_0036367
DR   Coriell; ND10223
DR   Wikidata; Q54922898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10224
AC   CVCL_BD55
DR   CLO; CLO_0036368
DR   Coriell; ND10224
DR   Wikidata; Q54922899
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND10225
AC   CVCL_GD45
DR   CLO; CLO_0036369
DR   BioSample; SAMN00796406
DR   Coriell; ND10225
DR   Wikidata; Q54922900
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND10226
AC   CVCL_BD56
DR   CLO; CLO_0036370
DR   Coriell; ND10226
DR   Wikidata; Q54922901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10227
AC   CVCL_EV59
DR   CLO; CLO_0036372
DR   Coriell; ND10227
DR   Wikidata; Q54922902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10228
AC   CVCL_FA56
DR   Coriell; ND10228
DR   Wikidata; Q54922903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10229
AC   CVCL_GD46
DR   CLO; CLO_0036374
DR   Coriell; ND10229
DR   Wikidata; Q54922904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10230
AC   CVCL_BD57
DR   CLO; CLO_0036375
DR   Coriell; ND10230
DR   Wikidata; Q54922905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10231
AC   CVCL_EV60
DR   CLO; CLO_0036376
DR   Coriell; ND10231
DR   Wikidata; Q54922906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10232
AC   CVCL_EV61
DR   CLO; CLO_0036320
DR   Coriell; ND10232
DR   Wikidata; Q54922907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10233
AC   CVCL_EV62
DR   CLO; CLO_0036315
DR   Coriell; ND10233
DR   Wikidata; Q54922908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10234
AC   CVCL_GD47
DR   CLO; CLO_0036317
DR   Coriell; ND10234
DR   Wikidata; Q54922909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10235
AC   CVCL_BD58
DR   Coriell; ND10235
DR   Wikidata; Q54922910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10236
AC   CVCL_BD59
DR   CLO; CLO_0036313
DR   Coriell; ND10236
DR   Wikidata; Q54922911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10239
AC   CVCL_EB06
DR   Coriell; ND10239
DR   Wikidata; Q54922912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10240
AC   CVCL_EV63
DR   CLO; CLO_0036314
DR   Coriell; ND10240
DR   Wikidata; Q54922913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10241
AC   CVCL_FC60
DR   CLO; CLO_0036311
DR   Coriell; ND10241
DR   Wikidata; Q54922914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10242
AC   CVCL_FC61
DR   CLO; CLO_0036312
DR   Coriell; ND10242
DR   Wikidata; Q54922915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10243
AC   CVCL_FC62
DR   CLO; CLO_0036309
DR   Coriell; ND10243
DR   Wikidata; Q54922916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10244
AC   CVCL_BD60
DR   CLO; CLO_0036310
DR   Coriell; ND10244
DR   Wikidata; Q54922919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10245
AC   CVCL_BD61
DR   CLO; CLO_0036308
DR   Coriell; ND10245
DR   Wikidata; Q54922920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10246
AC   CVCL_BD62
DR   CLO; CLO_0036333
DR   Coriell; ND10246
DR   Wikidata; Q54922921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10247
AC   CVCL_BD63
DR   CLO; CLO_0036335
DR   Coriell; ND10247
DR   Wikidata; Q54922922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10248
AC   CVCL_BD64
DR   CLO; CLO_0036338
DR   Coriell; ND10248
DR   Wikidata; Q54922923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10249
AC   CVCL_EV64
DR   CLO; CLO_0036339
DR   Coriell; ND10249
DR   Wikidata; Q54922924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10250
AC   CVCL_HR65
DR   CLO; CLO_0036329
DR   Coriell; ND10250
DR   Wikidata; Q54922925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10251
AC   CVCL_GQ25
DR   CLO; CLO_0036330
DR   Coriell; ND10251
DR   Wikidata; Q54922926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36192; Arteriovenous fistula
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10252
AC   CVCL_BD65
DR   CLO; CLO_0036331
DR   Coriell; ND10252
DR   Wikidata; Q54922927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10253
AC   CVCL_GD48
DR   CLO; CLO_0036332
DR   BioSample; SAMN00796410
DR   Coriell; ND10253
DR   Wikidata; Q54922928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10254
AC   CVCL_BD66
DR   CLO; CLO_0036327
DR   Coriell; ND10254
DR   Wikidata; Q54922929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10255
AC   CVCL_BD67
DR   CLO; CLO_0036328
DR   Coriell; ND10255
DR   Wikidata; Q54922930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10256
AC   CVCL_ID83
DR   CLO; CLO_0036712
DR   Coriell; ND10256
DR   Wikidata; Q54922931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10257
AC   CVCL_BD68
DR   CLO; CLO_0036709
DR   Coriell; ND10257
DR   Wikidata; Q54922932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10258
AC   CVCL_BD69
DR   CLO; CLO_0036708
DR   Coriell; ND10258
DR   Wikidata; Q54922933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10259
AC   CVCL_EV65
DR   CLO; CLO_0036711
DR   BioSample; SAMN00796419
DR   Coriell; ND10259
DR   Wikidata; Q54922934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10261
AC   CVCL_BD70
DR   CLO; CLO_0036710
DR   Coriell; ND10261
DR   Wikidata; Q54922935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10262
AC   CVCL_CL40
DR   Coriell; ND10262
DR   Wikidata; Q54922936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10264
AC   CVCL_BD71
DR   CLO; CLO_0036715
DR   Coriell; ND10264
DR   Wikidata; Q54922940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10265
AC   CVCL_EV66
DR   CLO; CLO_0036714
DR   Coriell; ND10265
DR   Wikidata; Q54922941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10266
AC   CVCL_EV67
DR   CLO; CLO_0036717
DR   Coriell; ND10266
DR   Wikidata; Q54922942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10267
AC   CVCL_GD49
DR   CLO; CLO_0036716
DR   Coriell; ND10267
DR   Wikidata; Q54922944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10268
AC   CVCL_EV68
DR   CLO; CLO_0036713
DR   Coriell; ND10268
DR   Wikidata; Q54922945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10269
AC   CVCL_FC63
DR   CLO; CLO_0036703
DR   Coriell; ND10269
DR   Wikidata; Q54922946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10270
AC   CVCL_BD72
DR   Coriell; ND10270
DR   Wikidata; Q54922947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10271
AC   CVCL_GD50
DR   CLO; CLO_0036702
DR   Coriell; ND10271
DR   Wikidata; Q54922948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10272
AC   CVCL_EV69
DR   CLO; CLO_0036701
DR   Coriell; ND10272
DR   Wikidata; Q54922949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10273
AC   CVCL_EV70
DR   CLO; CLO_0036700
DR   Coriell; ND10273
DR   Wikidata; Q54922950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10274
AC   CVCL_EV71
DR   CLO; CLO_0036699
DR   Coriell; ND10274
DR   Wikidata; Q54922951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10275
AC   CVCL_EV72
DR   CLO; CLO_0036698
DR   Coriell; ND10275
DR   Wikidata; Q54922952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10276
AC   CVCL_EV73
DR   CLO; CLO_0036707
DR   Coriell; ND10276
DR   Wikidata; Q54922953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10277
AC   CVCL_EV74
DR   CLO; CLO_0036706
DR   Coriell; ND10277
DR   Wikidata; Q54922954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10278
AC   CVCL_GD51
DR   CLO; CLO_0036705
DR   Coriell; ND10278
DR   Wikidata; Q54922955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10279
AC   CVCL_GD52
DR   CLO; CLO_0036704
DR   Coriell; ND10279
DR   Wikidata; Q54922956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10280
AC   CVCL_GD53
DR   CLO; CLO_0036678
DR   Coriell; ND10280
DR   Wikidata; Q54922957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10281
AC   CVCL_BD73
DR   CLO; CLO_0036683
DR   Coriell; ND10281
DR   Wikidata; Q54922958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10282
AC   CVCL_BD74
DR   CLO; CLO_0036682
DR   Coriell; ND10282
DR   Wikidata; Q54922959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10283
AC   CVCL_BD75
DR   CLO; CLO_0036687
DR   Coriell; ND10283
DR   Wikidata; Q54922960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10284
AC   CVCL_BD76
DR   CLO; CLO_0036686
DR   Coriell; ND10284
DR   Wikidata; Q54922961
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10290
AC   CVCL_HR66
DR   CLO; CLO_0036691
DR   Coriell; ND10290
DR   Wikidata; Q54922962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10291
AC   CVCL_HR67
DR   CLO; CLO_0036688
DR   Coriell; ND10291
DR   Wikidata; Q54922963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10292
AC   CVCL_BD77
DR   CLO; CLO_0036693
DR   Coriell; ND10292
DR   Wikidata; Q54922964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10293
AC   CVCL_GD54
DR   CLO; CLO_0036692
DR   BioSample; SAMN00796424
DR   Coriell; ND10293
DR   Wikidata; Q54922965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10294
AC   CVCL_BD78
DR   CLO; CLO_0036694
DR   Coriell; ND10294
DR   Wikidata; Q54922966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10295
AC   CVCL_BD79
DR   CLO; CLO_0036671
DR   Coriell; ND10295
DR   Wikidata; Q54922967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10296
AC   CVCL_BD80
DR   CLO; CLO_0036670
DR   Coriell; ND10296
DR   Wikidata; Q54922968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10297
AC   CVCL_EV75
DR   CLO; CLO_0036669
DR   BioSample; SAMN00796427
DR   Coriell; ND10297
DR   Wikidata; Q54922969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10298
AC   CVCL_EV76
DR   CLO; CLO_0036668
DR   Coriell; ND10298
DR   Wikidata; Q54922970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10299
AC   CVCL_GD55
DR   CLO; CLO_0036675
DR   Coriell; ND10299
DR   Wikidata; Q54922971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10300
AC   CVCL_GD56
DR   CLO; CLO_0036674
DR   BioSample; SAMN00796429
DR   Coriell; ND10300
DR   Wikidata; Q54922972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10301
AC   CVCL_GD57
DR   CLO; CLO_0036673
DR   Coriell; ND10301
DR   Wikidata; Q54922974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10302
AC   CVCL_BD81
DR   CLO; CLO_0036672
DR   Coriell; ND10302
DR   Wikidata; Q54922975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10303
AC   CVCL_GD58
DR   CLO; CLO_0036677
DR   Coriell; ND10303
DR   Wikidata; Q54922976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10304
AC   CVCL_GD59
DR   CLO; CLO_0036676
DR   Coriell; ND10304
DR   Wikidata; Q54922977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10305
AC   CVCL_GD60
DR   CLO; CLO_0036663
DR   Coriell; ND10305
DR   Wikidata; Q54922978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10306
AC   CVCL_GD61
DR   CLO; CLO_0036659
DR   Coriell; ND10306
DR   Wikidata; Q54922980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10307
AC   CVCL_GD62
DR   CLO; CLO_0036660
DR   Coriell; ND10307
DR   Wikidata; Q54922981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10311
AC   CVCL_IJ51
DR   CLO; CLO_0036661
DR   Coriell; ND10311
DR   Wikidata; Q54922982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10312
AC   CVCL_BD82
DR   CLO; CLO_0036662
DR   Coriell; ND10312
DR   Wikidata; Q54922989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10313
AC   CVCL_BD83
DR   CLO; CLO_0036655
DR   Coriell; ND10313
DR   Wikidata; Q54922990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10314
AC   CVCL_BD84
DR   CLO; CLO_0036656
DR   Coriell; ND10314
DR   Wikidata; Q54922991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10319
AC   CVCL_FZ31
DR   Coriell; ND10319
DR   Wikidata; Q54922992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10320
AC   CVCL_FZ32
DR   Coriell; ND10320
DR   Wikidata; Q54922993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10321
AC   CVCL_HV61
DR   Coriell; ND10321
DR   Wikidata; Q54922994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10322
AC   CVCL_CL41
DR   CLO; CLO_0036657
DR   Coriell; ND10322
DR   Wikidata; Q54922995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10323
AC   CVCL_FL50
DR   CLO; CLO_0036658
DR   Coriell; ND10323
DR   Wikidata; Q54922996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10324
AC   CVCL_BD85
DR   CLO; CLO_0036654
DR   Coriell; ND10324
DR   Wikidata; Q54922997
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND10325
AC   CVCL_GD63
DR   CLO; CLO_0036759
DR   Coriell; ND10325
DR   Wikidata; Q54922998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10326
AC   CVCL_BD86
DR   CLO; CLO_0036761
DR   Coriell; ND10326
DR   Wikidata; Q54922999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10327
AC   CVCL_IJ52
DR   CLO; CLO_0036760
DR   Coriell; ND10327
DR   Wikidata; Q54923000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10328
AC   CVCL_BD87
DR   CLO; CLO_0036763
DR   Coriell; ND10328
DR   Wikidata; Q54923001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10329
AC   CVCL_BD88
DR   CLO; CLO_0036762
DR   Coriell; ND10329
DR   Wikidata; Q54923002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10330
AC   CVCL_BD89
DR   CLO; CLO_0036765
DR   Coriell; ND10330
DR   Wikidata; Q54923003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10331
AC   CVCL_GD64
DR   CLO; CLO_0036764
DR   Coriell; ND10331
DR   Wikidata; Q54923004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10332
AC   CVCL_EV77
DR   CLO; CLO_0036767
DR   Coriell; ND10332
DR   Wikidata; Q54923006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10333
AC   CVCL_GD65
DR   CLO; CLO_0036768
DR   Coriell; ND10333
DR   Wikidata; Q54923007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10334
AC   CVCL_EV78
DR   CLO; CLO_0036766
DR   Coriell; ND10334
DR   Wikidata; Q54923008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10335
AC   CVCL_BD90
DR   CLO; CLO_0036776
DR   Coriell; ND10335
DR   Wikidata; Q54923009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10336
AC   CVCL_GD66
DR   CLO; CLO_0036775
DR   Coriell; ND10336
DR   Wikidata; Q54923010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10337
AC   CVCL_GD67
DR   CLO; CLO_0036774
DR   Coriell; ND10337
DR   Wikidata; Q54923011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10340
AC   CVCL_HV62
DR   Coriell; ND10340
DR   Wikidata; Q54923012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10341
AC   CVCL_EV79
DR   CLO; CLO_0036773
DR   Coriell; ND10341
DR   Wikidata; Q54923013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10342
AC   CVCL_GD68
DR   CLO; CLO_0036772
DR   Coriell; ND10342
DR   Wikidata; Q54923014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10343
AC   CVCL_GD69
DR   CLO; CLO_0036771
DR   Coriell; ND10343
DR   Wikidata; Q54923015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10344
AC   CVCL_GD70
DR   CLO; CLO_0036770
DR   Coriell; ND10344
DR   Wikidata; Q54923016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10345
AC   CVCL_EV80
DR   CLO; CLO_0036769
DR   Coriell; ND10345
DR   Wikidata; Q54923017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10346
AC   CVCL_BD91
DR   CLO; CLO_0036777
DR   Coriell; ND10346
DR   Wikidata; Q54923018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10347
AC   CVCL_BD92
DR   Coriell; ND10347
DR   Wikidata; Q54923019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10348
AC   CVCL_GD71
DR   CLO; CLO_0036778
DR   Coriell; ND10348
DR   Wikidata; Q54923020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10349
AC   CVCL_EV81
DR   CLO; CLO_0036787
DR   Coriell; ND10349
DR   Wikidata; Q54923021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10356
AC   CVCL_BD93
DR   Coriell; ND10356
DR   Wikidata; Q54923022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10357
AC   CVCL_BD94
DR   CLO; CLO_0036784
DR   Coriell; ND10357
DR   Wikidata; Q54923023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10358
AC   CVCL_GD72
DR   CLO; CLO_0036783
DR   Coriell; ND10358
DR   Wikidata; Q54923025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10359
AC   CVCL_GD73
DR   CLO; CLO_0036786
DR   Coriell; ND10359
DR   Wikidata; Q54923026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10360
AC   CVCL_GD74
DR   CLO; CLO_0036785
DR   Coriell; ND10360
DR   Wikidata; Q54923027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10361
AC   CVCL_GD75
DR   CLO; CLO_0036780
DR   Coriell; ND10361
DR   Wikidata; Q54923028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10362
AC   CVCL_FC64
DR   CLO; CLO_0036779
DR   Coriell; ND10362
DR   Wikidata; Q54923029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10363
AC   CVCL_GD76
DR   CLO; CLO_0036782
DR   Coriell; ND10363
DR   Wikidata; Q54923030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10364
AC   CVCL_GD77
DR   CLO; CLO_0036781
DR   Coriell; ND10364
DR   Wikidata; Q54923037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10365
AC   CVCL_EV82
DR   CLO; CLO_0036718
DR   Coriell; ND10365
DR   Wikidata; Q54923038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10366
AC   CVCL_T857
DR   CLO; CLO_0036719
DR   Coriell; ND10366
DR   Wikidata; Q54923039
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND10366).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T856 ! ND29774
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   ND10371
AC   CVCL_EB07
DR   Coriell; ND10371
DR   Wikidata; Q54923040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10375
AC   CVCL_FL51
DR   CLO; CLO_0036720
DR   Coriell; ND10375
DR   Wikidata; Q54923041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10376
AC   CVCL_HR68
DR   CLO; CLO_0036723
DR   Coriell; ND10376
DR   Wikidata; Q54923042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10377
AC   CVCL_BD96
DR   CLO; CLO_0036724
DR   Coriell; ND10377
DR   Wikidata; Q54923043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10378
AC   CVCL_EV83
DR   CLO; CLO_0036721
DR   Coriell; ND10378
DR   Wikidata; Q54923044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10379
AC   CVCL_BD97
DR   CLO; CLO_0036722
DR   Coriell; ND10379
DR   Wikidata; Q54923045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10380
AC   CVCL_EV84
DR   CLO; CLO_0036727
DR   BioSample; SAMN00796443
DR   Coriell; ND10380
DR   Wikidata; Q54923046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10381
AC   CVCL_GD78
DR   CLO; CLO_0036728
DR   Coriell; ND10381
DR   Wikidata; Q54923047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10383
AC   CVCL_GD79
DR   CLO; CLO_0036725
DR   BioSample; SAMN00796445
DR   Coriell; ND10383
DR   Wikidata; Q54923048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10385
AC   CVCL_EB08
DR   Coriell; ND10385
DR   Wikidata; Q54923049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10389
AC   CVCL_GD80
DR   CLO; CLO_0036726
DR   Coriell; ND10389
DR   Wikidata; Q54923050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10390
AC   CVCL_IL84
DR   CLO; CLO_0036729
DR   Coriell; ND10390
DR   Wikidata; Q54923051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND10390; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND10391
AC   CVCL_GD81
DR   CLO; CLO_0036730
DR   Coriell; ND10391
DR   Wikidata; Q54923053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10392
AC   CVCL_GD82
DR   CLO; CLO_0036731
DR   Coriell; ND10392
DR   Wikidata; Q54923054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10393
AC   CVCL_EV85
DR   CLO; CLO_0036732
DR   Coriell; ND10393
DR   Wikidata; Q54923055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10394
AC   CVCL_BD98
DR   CLO; CLO_0036733
DR   Coriell; ND10394
DR   Wikidata; Q54923056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10395
AC   CVCL_BD99
DR   CLO; CLO_0036734
DR   Coriell; ND10395
DR   Wikidata; Q54923057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10396
AC   CVCL_BE00
DR   CLO; CLO_0036735
DR   Coriell; ND10396
DR   Wikidata; Q54923058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10397
AC   CVCL_IJ53
DR   CLO; CLO_0036736
DR   Coriell; ND10397
DR   Wikidata; Q54923059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10398
AC   CVCL_BE01
DR   CLO; CLO_0036737
DR   Coriell; ND10398
DR   Wikidata; Q54923060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10399
AC   CVCL_EV86
DR   BioSample; SAMN00796448
DR   Coriell; ND10399
DR   Wikidata; Q54923061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10400
AC   CVCL_HV63
DR   Coriell; ND10400
DR   Wikidata; Q54923062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10402
AC   CVCL_FL52
DR   CLO; CLO_0036738
DR   Coriell; ND10402
DR   Wikidata; Q54923063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10403
AC   CVCL_BE02
DR   CLO; CLO_0036741
DR   Coriell; ND10403
DR   Wikidata; Q54923064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10404
AC   CVCL_BE03
DR   Coriell; ND10404
DR   Wikidata; Q54923065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10405
AC   CVCL_BE04
DR   CLO; CLO_0036742
DR   Coriell; ND10405
DR   Wikidata; Q54923066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10406
AC   CVCL_BE05
DR   CLO; CLO_0036739
DR   Coriell; ND10406
DR   Wikidata; Q54923067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10408
AC   CVCL_EV87
DR   CLO; CLO_0036740
DR   Coriell; ND10408
DR   Wikidata; Q54923069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10409
AC   CVCL_EV88
DR   CLO; CLO_0036747
DR   Coriell; ND10409
DR   Wikidata; Q54923070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10410
AC   CVCL_GD83
DR   CLO; CLO_0036748
DR   Coriell; ND10410
DR   Wikidata; Q54923071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10411
AC   CVCL_BE06
DR   CLO; CLO_0036745
DR   Coriell; ND10411
DR   Wikidata; Q54923072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10412
AC   CVCL_BE07
DR   CLO; CLO_0036746
DR   Coriell; ND10412
DR   Wikidata; Q54923073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10413
AC   CVCL_BE08
DR   CLO; CLO_0036743
DR   Coriell; ND10413
DR   Wikidata; Q54923074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10417
AC   CVCL_EV89
DR   CLO; CLO_0036744
DR   Coriell; ND10417
DR   Wikidata; Q54923075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10418
AC   CVCL_BE09
DR   CLO; CLO_0036753
DR   Coriell; ND10418
DR   Wikidata; Q54923076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10419
AC   CVCL_BE10
DR   CLO; CLO_0036749
DR   Coriell; ND10419
DR   Wikidata; Q54923077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10420
AC   CVCL_EV90
DR   CLO; CLO_0036750
DR   BioSample; SAMN00796452
DR   Coriell; ND10420
DR   Wikidata; Q54923078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10421
AC   CVCL_GD84
DR   CLO; CLO_0036751
DR   Coriell; ND10421
DR   Wikidata; Q54923086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10422
AC   CVCL_BE11
DR   CLO; CLO_0036752
DR   Coriell; ND10422
DR   Wikidata; Q54923087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10423
AC   CVCL_GD85
DR   CLO; CLO_0036755
DR   BioSample; SAMN00796455
DR   Coriell; ND10423
DR   Wikidata; Q54923088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10424
AC   CVCL_BE12
DR   CLO; CLO_0036756
DR   Coriell; ND10424
DR   Wikidata; Q54923090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10425
AC   CVCL_GD86
DR   CLO; CLO_0036757
DR   Coriell; ND10425
DR   Wikidata; Q54923091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10426
AC   CVCL_GD87
DR   CLO; CLO_0036758
DR   Coriell; ND10426
DR   Wikidata; Q54923092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10427
AC   CVCL_EV91
DR   CLO; CLO_0036754
DR   Coriell; ND10427
DR   Wikidata; Q54923093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10428
AC   CVCL_GD88
DR   CLO; CLO_0036973
DR   Coriell; ND10428
DR   Wikidata; Q54923094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10429
AC   CVCL_GD89
DR   CLO; CLO_0036972
DR   Coriell; ND10429
DR   Wikidata; Q54923095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10430
AC   CVCL_BE13
DR   CLO; CLO_0036969
DR   Coriell; ND10430
DR   Wikidata; Q54923096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10431
AC   CVCL_GD90
DR   CLO; CLO_0036968
DR   Coriell; ND10431
DR   Wikidata; Q54923097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10432
AC   CVCL_CL42
DR   Coriell; ND10432
DR   Wikidata; Q54923098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10433
AC   CVCL_CL43
DR   Coriell; ND10433
DR   Wikidata; Q54923099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10434
AC   CVCL_CL44
DR   Coriell; ND10434
DR   Wikidata; Q54923100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10435
AC   CVCL_CL45
DR   Coriell; ND10435
DR   Wikidata; Q54923101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10436
AC   CVCL_HV64
DR   Coriell; ND10436
DR   Wikidata; Q54923102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10439
AC   CVCL_HV65
DR   Coriell; ND10439
DR   Wikidata; Q54923103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10441
AC   CVCL_BE14
DR   CLO; CLO_0036971
DR   Coriell; ND10441
DR   Wikidata; Q54923104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10442
AC   CVCL_BE15
DR   CLO; CLO_0036970
DR   Coriell; ND10442
DR   Wikidata; Q54923105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10443
AC   CVCL_BE16
DR   CLO; CLO_0036965
DR   Coriell; ND10443
DR   Wikidata; Q54923106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10444
AC   CVCL_EV92
DR   CLO; CLO_0036964
DR   Coriell; ND10444
DR   Wikidata; Q54923107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10445
AC   CVCL_BE17
DR   CLO; CLO_0036967
DR   Coriell; ND10445
DR   Wikidata; Q54923108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10446
AC   CVCL_EV93
DR   CLO; CLO_0036966
DR   Coriell; ND10446
DR   Wikidata; Q54923109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10447
AC   CVCL_EV94
DR   CLO; CLO_0036954
DR   Coriell; ND10447
DR   Wikidata; Q54923110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10448
AC   CVCL_BE18
DR   CLO; CLO_0036953
DR   Coriell; ND10448
DR   Wikidata; Q54923111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10449
AC   CVCL_FA57
DR   Coriell; ND10449
DR   Wikidata; Q54923112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10450
AC   CVCL_BE19
DR   CLO; CLO_0036952
DR   Coriell; ND10450
DR   Wikidata; Q54923113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10451
AC   CVCL_BE20
DR   CLO; CLO_0036951
DR   Coriell; ND10451
DR   Wikidata; Q54923114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10452
AC   CVCL_IJ54
DR   CLO; CLO_0036950
DR   Coriell; ND10452
DR   Wikidata; Q54923115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10453
AC   CVCL_CL46
DR   Coriell; ND10453
DR   Wikidata; Q54923116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10458
AC   CVCL_HV66
DR   Coriell; ND10458
DR   Wikidata; Q54923117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10459
AC   CVCL_FZ33
DR   CLO; CLO_0036949
DR   Coriell; ND10459
DR   Wikidata; Q54923118
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10460
AC   CVCL_HR69
DR   CLO; CLO_0036948
DR   Coriell; ND10460
DR   Wikidata; Q54923119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10461
AC   CVCL_BE21
DR   CLO; CLO_0036947
DR   Coriell; ND10461
DR   Wikidata; Q54923120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10462
AC   CVCL_EV95
DR   CLO; CLO_0036946
DR   Coriell; ND10462
DR   Wikidata; Q54923121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10463
AC   CVCL_EV96
DR   CLO; CLO_0036945
DR   Coriell; ND10463
DR   Wikidata; Q54923122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10464
AC   CVCL_BE22
DR   CLO; CLO_0036995
DR   Coriell; ND10464
DR   Wikidata; Q54923123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10465
AC   CVCL_ID84
DR   Coriell; ND10465
DR   Wikidata; Q54923124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10466
AC   CVCL_GD91
DR   CLO; CLO_0036994
DR   BioSample; SAMN00796462
DR   Coriell; ND10466
DR   Wikidata; Q54923125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10467
AC   CVCL_ID85
DR   Coriell; ND10467
DR   Wikidata; Q54923126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10468
AC   CVCL_EV97
DR   CLO; CLO_0036997
DR   Coriell; ND10468
DR   Wikidata; Q54923129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10469
AC   CVCL_EV98
DR   CLO; CLO_0036996
DR   Coriell; ND10469
DR   Wikidata; Q54923130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10470
AC   CVCL_EV99
DR   CLO; CLO_0036999
DR   Coriell; ND10470
DR   Wikidata; Q54923131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10471
AC   CVCL_GD92
DR   CLO; CLO_0036998
DR   Coriell; ND10471
DR   Wikidata; Q54923132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10472
AC   CVCL_GD93
DR   CLO; CLO_0037001
DR   Coriell; ND10472
DR   Wikidata; Q54923133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10473
AC   CVCL_BE23
DR   CLO; CLO_0037000
DR   Coriell; ND10473
DR   Wikidata; Q54923134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10474
AC   CVCL_GD94
DR   CLO; CLO_0036992
DR   Coriell; ND10474
DR   Wikidata; Q54923135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10475
AC   CVCL_EW00
DR   CLO; CLO_0036991
DR   Coriell; ND10475
DR   Wikidata; Q54923136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10476
AC   CVCL_BE24
DR   CLO; CLO_0034474
DR   Coriell; ND10476
DR   Wikidata; Q54923137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10477
AC   CVCL_BE25
DR   CLO; CLO_0034473
DR   Coriell; ND10477
DR   Wikidata; Q54923138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10478
AC   CVCL_GD95
DR   CLO; CLO_0034472
DR   Coriell; ND10478
DR   Wikidata; Q54923139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10479
AC   CVCL_FC65
DR   CLO; CLO_0034471
DR   BioSample; SAMN00796466
DR   Coriell; ND10479
DR   Wikidata; Q54923140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10480
AC   CVCL_GD96
DR   CLO; CLO_0034470
DR   BioSample; SAMN00796468
DR   Coriell; ND10480
DR   Wikidata; Q54923141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10481
AC   CVCL_ID86
DR   BioSample; SAMN00796470
DR   Coriell; ND10481
DR   Wikidata; Q54923142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10482
AC   CVCL_FA58
DR   CLO; CLO_0034469
DR   Coriell; ND10482
DR   Wikidata; Q54923143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10483
AC   CVCL_BE26
DR   CLO; CLO_0034613
DR   Coriell; ND10483
DR   Wikidata; Q54923144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10484
AC   CVCL_FA59
DR   CLO; CLO_0034612
DR   Coriell; ND10484
DR   Wikidata; Q54923145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10485
AC   CVCL_BE27
DR   CLO; CLO_0034610
DR   Coriell; ND10485
DR   Wikidata; Q54923146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10486
AC   CVCL_ID87
DR   BioSample; SAMN00796475
DR   Coriell; ND10486
DR   Wikidata; Q54923149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10487
AC   CVCL_EW01
DR   CLO; CLO_0034607
DR   BioSample; SAMN00796476
DR   Coriell; ND10487
DR   Wikidata; Q54923150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10488
AC   CVCL_FA60
DR   Coriell; ND10488
DR   Wikidata; Q54923151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10489
AC   CVCL_FA61
DR   CLO; CLO_0034597
DR   Coriell; ND10489
DR   Wikidata; Q54923152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10490
AC   CVCL_FA62
DR   CLO; CLO_0034593
DR   Coriell; ND10490
DR   Wikidata; Q54923153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10491
AC   CVCL_BE28
DR   CLO; CLO_0034595
DR   Coriell; ND10491
DR   Wikidata; Q54923154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10492
AC   CVCL_BE29
DR   CLO; CLO_0034604
DR   Coriell; ND10492
DR   Wikidata; Q54923155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10493
AC   CVCL_FA63
DR   CLO; CLO_0034605
DR   Coriell; ND10493
DR   Wikidata; Q54923156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10494
AC   CVCL_FA64
DR   CLO; CLO_0034599
DR   Coriell; ND10494
DR   Wikidata; Q54923157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10495
AC   CVCL_ID88
DR   Coriell; ND10495
DR   Wikidata; Q54923158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10496
AC   CVCL_EW02
DR   CLO; CLO_0034602
DR   BioSample; SAMN00796481
DR   Coriell; ND10496
DR   Wikidata; Q54923159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10497
AC   CVCL_EW03
DR   CLO; CLO_0034580
DR   Coriell; ND10497
DR   Wikidata; Q54923160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10498
AC   CVCL_FC66
DR   CLO; CLO_0034578
DR   Coriell; ND10498
DR   Wikidata; Q54923161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10499
AC   CVCL_GD97
DR   CLO; CLO_0034582
DR   BioSample; SAMN00796483
DR   Coriell; ND10499
DR   Wikidata; Q54923162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10502
AC   CVCL_CL47
DR   Coriell; ND10502
DR   Wikidata; Q54923163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10503
AC   CVCL_ID89
DR   Coriell; ND10503
DR   Wikidata; Q54923164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10504
AC   CVCL_CL48
DR   BioSample; SAMN00796487
DR   Coriell; ND10504
DR   Wikidata; Q54923165
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (Coriell=ND10504).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD48 ! ND29369
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 17
//
ID   ND10505
AC   CVCL_ID90
DR   Coriell; ND10505
DR   Wikidata; Q54923166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10506
AC   CVCL_ID91
DR   Coriell; ND10506
DR   Wikidata; Q54923167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10507
AC   CVCL_ID92
DR   Coriell; ND10507
DR   Wikidata; Q54923168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10513
AC   CVCL_EW04
DR   CLO; CLO_0034563
DR   Coriell; ND10513
DR   Wikidata; Q54923169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10514
AC   CVCL_BE30
DR   CLO; CLO_0034565
DR   Coriell; ND10514
DR   Wikidata; Q54923171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10515
AC   CVCL_BE31
DR   CLO; CLO_0034568
DR   Coriell; ND10515
DR   Wikidata; Q54923176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10516
AC   CVCL_IJ55
DR   CLO; CLO_0034569
DR   Coriell; ND10516
DR   Wikidata; Q54923177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10517
AC   CVCL_BE32
DR   CLO; CLO_0034570
DR   Coriell; ND10517
DR   Wikidata; Q54923178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10518
AC   CVCL_BE33
DR   CLO; CLO_0034573
DR   Coriell; ND10518
DR   Wikidata; Q54923179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10519
AC   CVCL_CL49
DR   CLO; CLO_0034575
DR   Coriell; ND10519
DR   Wikidata; Q54923180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10520
AC   CVCL_CL50
DR   CLO; CLO_0034577
DR   Coriell; ND10520
DR   Wikidata; Q54923181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10522
AC   CVCL_FZ34
DR   Coriell; ND10522
DR   Wikidata; Q54923182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10523
AC   CVCL_GD98
DR   CLO; CLO_0034553
DR   Coriell; ND10523
DR   Wikidata; Q54923183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10524
AC   CVCL_BE34
DR   Coriell; ND10524
DR   Wikidata; Q54923184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10525
AC   CVCL_GD99
DR   CLO; CLO_0034552
DR   BioSample; SAMN00796496
DR   Coriell; ND10525
DR   Wikidata; Q54923185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10526
AC   CVCL_GE00
DR   CLO; CLO_0034527
DR   Coriell; ND10526
DR   Wikidata; Q54923186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10527
AC   CVCL_BE35
DR   CLO; CLO_0034543
DR   Coriell; ND10527
DR   Wikidata; Q54923187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10528
AC   CVCL_IJ56
DR   CLO; CLO_0034544
DR   Coriell; ND10528
DR   Wikidata; Q54923188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10529
AC   CVCL_EW05
DR   CLO; CLO_0034541
DR   Coriell; ND10529
DR   Wikidata; Q54923189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10530
AC   CVCL_EW06
DR   CLO; CLO_0034542
DR   Coriell; ND10530
DR   Wikidata; Q54923190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10531
AC   CVCL_ID93
DR   Coriell; ND10531
DR   Wikidata; Q54923191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10532
AC   CVCL_BE36
DR   CLO; CLO_0034538
DR   Coriell; ND10532
DR   Wikidata; Q54923192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10533
AC   CVCL_BE37
DR   CLO; CLO_0034540
DR   Coriell; ND10533
DR   Wikidata; Q54923193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10534
AC   CVCL_BE38
DR   CLO; CLO_0034534
DR   Coriell; ND10534
DR   Wikidata; Q54923194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10535
AC   CVCL_BE39
DR   Coriell; ND10535
DR   Wikidata; Q54923195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10536
AC   CVCL_BE40
DR   CLO; CLO_0034536
DR   Coriell; ND10536
DR   Wikidata; Q54923196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10537
AC   CVCL_BE41
DR   CLO; CLO_0034521
DR   Coriell; ND10537
DR   Wikidata; Q54923197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10538
AC   CVCL_BE42
DR   CLO; CLO_0034505
DR   Coriell; ND10538
DR   Wikidata; Q54923198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10539
AC   CVCL_BE43
DR   CLO; CLO_0034506
DR   Coriell; ND10539
DR   Wikidata; Q54923199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10540
AC   CVCL_GE01
DR   CLO; CLO_0034511
DR   BioSample; SAMN00796503
DR   Coriell; ND10540
DR   Wikidata; Q54923200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10541
AC   CVCL_EW07
DR   CLO; CLO_0034513
DR   Coriell; ND10541
DR   Wikidata; Q54923201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10542
AC   CVCL_EW08
DR   CLO; CLO_0034514
DR   Coriell; ND10542
DR   Wikidata; Q54923202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10543
AC   CVCL_BE44
DR   CLO; CLO_0034515
DR   Coriell; ND10543
DR   Wikidata; Q54923203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10544
AC   CVCL_CL51
DR   Coriell; ND10544
DR   Wikidata; Q54923204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10545
AC   CVCL_CL52
DR   Coriell; ND10545
DR   Wikidata; Q54923206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10546
AC   CVCL_EW09
DR   CLO; CLO_0034507
DR   Coriell; ND10546
DR   Wikidata; Q54923207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10547
AC   CVCL_BE45
DR   CLO; CLO_0034508
DR   Coriell; ND10547
DR   Wikidata; Q54923208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10548
AC   CVCL_FL53
DR   Coriell; ND10548
DR   Wikidata; Q54923209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10549
AC   CVCL_BE46
DR   Coriell; ND10549
DR   Wikidata; Q54923210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10550
AC   CVCL_BE47
DR   CLO; CLO_0034509
DR   Coriell; ND10550
DR   Wikidata; Q54923212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10551
AC   CVCL_FA65
DR   Coriell; ND10551
DR   Wikidata; Q54923213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10552
AC   CVCL_IJ57
DR   CLO; CLO_0034510
DR   Coriell; ND10552
DR   Wikidata; Q54923214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10553
AC   CVCL_FA66
DR   CLO; CLO_0034658
DR   Coriell; ND10553
DR   Wikidata; Q54923215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10554
AC   CVCL_BE48
DR   CLO; CLO_0034657
DR   Coriell; ND10554
DR   Wikidata; Q54923216
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10556
AC   CVCL_BE49
DR   CLO; CLO_0034656
DR   Coriell; ND10556
DR   Wikidata; Q54923217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10557
AC   CVCL_BE50
DR   CLO; CLO_0034652
DR   Coriell; ND10557
DR   Wikidata; Q54923221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10558
AC   CVCL_GE02
DR   CLO; CLO_0034651
DR   Coriell; ND10558
DR   Wikidata; Q54923222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10560
AC   CVCL_GE03
DR   CLO; CLO_0034650
DR   BioSample; SAMN00796509
DR   Coriell; ND10560
DR   Wikidata; Q54923224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10561
AC   CVCL_BE51
DR   CLO; CLO_0034649
DR   Coriell; ND10561
DR   Wikidata; Q54923225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10562
AC   CVCL_GE04
DR   CLO; CLO_0034655
DR   BioSample; SAMN00796513
DR   Coriell; ND10562
DR   Wikidata; Q54923226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10565
AC   CVCL_CL53
DR   Coriell; ND10565
DR   Wikidata; Q54923227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10566
AC   CVCL_CL54
DR   Coriell; ND10566
DR   Wikidata; Q54923229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10567
AC   CVCL_CL55
DR   Coriell; ND10567
DR   Wikidata; Q54923230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10572
AC   CVCL_CL56
DR   CLO; CLO_0034654
DR   Coriell; ND10572
DR   Wikidata; Q54923231
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND10573
AC   CVCL_FL54
DR   CLO; CLO_0034653
DR   Coriell; ND10573
DR   Wikidata; Q54923232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3021; Generalized epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10574
AC   CVCL_GE05
DR   CLO; CLO_0034646
DR   Coriell; ND10574
DR   Wikidata; Q54923233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10575
AC   CVCL_BE52
DR   CLO; CLO_0034645
DR   Coriell; ND10575
DR   Wikidata; Q54923234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10577
AC   CVCL_EW10
DR   CLO; CLO_0034648
DR   Coriell; ND10577
DR   Wikidata; Q54923236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10578
AC   CVCL_BE53
DR   CLO; CLO_0034647
DR   Coriell; ND10578
DR   Wikidata; Q54923237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10579
AC   CVCL_BE54
DR   CLO; CLO_0034640
DR   Coriell; ND10579
DR   Wikidata; Q54923238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10580
AC   CVCL_EW11
DR   CLO; CLO_0034639
DR   Coriell; ND10580
DR   Wikidata; Q54923239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10581
AC   CVCL_EW12
DR   CLO; CLO_0034642
DR   BioSample; SAMN00796516
DR   Coriell; ND10581
DR   Wikidata; Q54923240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10582
AC   CVCL_FC67
DR   CLO; CLO_0034641
DR   Coriell; ND10582
DR   Wikidata; Q54923241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10583
AC   CVCL_EW13
DR   CLO; CLO_0034644
DR   Coriell; ND10583
DR   Wikidata; Q54923242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10584
AC   CVCL_BE55
DR   CLO; CLO_0034643
DR   Coriell; ND10584
DR   Wikidata; Q54923243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10585
AC   CVCL_BE56
DR   CLO; CLO_0034638
DR   Coriell; ND10585
DR   Wikidata; Q54923244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10586
AC   CVCL_BE57
DR   CLO; CLO_0034637
DR   Coriell; ND10586
DR   Wikidata; Q54923245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10587
AC   CVCL_EW14
DR   CLO; CLO_0034636
DR   Coriell; ND10587
DR   Wikidata; Q54923246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10588
AC   CVCL_BE58
DR   CLO; CLO_0034635
DR   Coriell; ND10588
DR   Wikidata; Q54923247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10589
AC   CVCL_IJ58
DR   CLO; CLO_0034634
DR   Coriell; ND10589
DR   Wikidata; Q54923248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10590
AC   CVCL_IJ59
DR   CLO; CLO_0034633
DR   Coriell; ND10590
DR   Wikidata; Q54923249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10591
AC   CVCL_BE59
DR   CLO; CLO_0034632
DR   Coriell; ND10591
DR   Wikidata; Q54923250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10592
AC   CVCL_EW15
DR   CLO; CLO_0034631
DR   BioSample; SAMN00796519
DR   Coriell; ND10592
DR   Wikidata; Q54923251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10593
AC   CVCL_EW16
DR   CLO; CLO_0034630
DR   BioSample; SAMN00796521
DR   Coriell; ND10593
DR   Wikidata; Q54923252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10594
AC   CVCL_EW17
DR   CLO; CLO_0034629
DR   BioSample; SAMN00796523
DR   Coriell; ND10594
DR   Wikidata; Q54923253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10595
AC   CVCL_GE06
DR   CLO; CLO_0034628
DR   BioSample; SAMN00796525
DR   Coriell; ND10595
DR   Wikidata; Q54923254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10596
AC   CVCL_EW18
DR   CLO; CLO_0034627
DR   BioSample; SAMN00796527
DR   Coriell; ND10596
DR   Wikidata; Q54923255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10597
AC   CVCL_GE07
DR   CLO; CLO_0034624
DR   Coriell; ND10597
DR   Wikidata; Q54923256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10598
AC   CVCL_GE08
DR   CLO; CLO_0034623
DR   Coriell; ND10598
DR   Wikidata; Q54923257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10600
AC   CVCL_ID94
DR   CLO; CLO_0034626
DR   Coriell; ND10600
DR   Wikidata; Q54923258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10601
AC   CVCL_EW19
DR   CLO; CLO_0034625
DR   Coriell; ND10601
DR   Wikidata; Q54923259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10602
AC   CVCL_EW20
DR   CLO; CLO_0034620
DR   BioSample; SAMN00796532
DR   Coriell; ND10602
DR   Wikidata; Q54923260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10603
AC   CVCL_EW21
DR   CLO; CLO_0034619
DR   Coriell; ND10603
DR   Wikidata; Q54923261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10604
AC   CVCL_EW22
DR   CLO; CLO_0034622
DR   Coriell; ND10604
DR   Wikidata; Q54923262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10605
AC   CVCL_GE09
DR   CLO; CLO_0034621
DR   Coriell; ND10605
DR   Wikidata; Q54923263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10606
AC   CVCL_GE10
DR   CLO; CLO_0034705
DR   BioSample; SAMN00796534
DR   Coriell; ND10606
DR   Wikidata; Q54923268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10607
AC   CVCL_GE11
DR   CLO; CLO_0034706
DR   Coriell; ND10607
DR   Wikidata; Q54923269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10608
AC   CVCL_ID95
DR   Coriell; ND10608
DR   Wikidata; Q54923270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10609
AC   CVCL_GE12
DR   CLO; CLO_0034707
DR   Coriell; ND10609
DR   Wikidata; Q54923271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10610
AC   CVCL_ID96
DR   Coriell; ND10610
DR   Wikidata; Q54923272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10611
AC   CVCL_EW23
DR   CLO; CLO_0034701
DR   BioSample; SAMN00796536
DR   Coriell; ND10611
DR   Wikidata; Q54923273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10612
AC   CVCL_GE13
DR   CLO; CLO_0034702
DR   Coriell; ND10612
DR   Wikidata; Q54923274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10613
AC   CVCL_FC68
DR   CLO; CLO_0034703
DR   Coriell; ND10613
DR   Wikidata; Q54923276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10614
AC   CVCL_GE14
DR   CLO; CLO_0034704
DR   Coriell; ND10614
DR   Wikidata; Q54923277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10615
AC   CVCL_GE15
DR   CLO; CLO_0034708
DR   Coriell; ND10615
DR   Wikidata; Q54923278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10616
AC   CVCL_GE16
DR   CLO; CLO_0034709
DR   Coriell; ND10616
DR   Wikidata; Q54923279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10617
AC   CVCL_BE60
DR   CLO; CLO_0034710
DR   Coriell; ND10617
DR   Wikidata; Q54923280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10618
AC   CVCL_BE61
DR   CLO; CLO_0034900
DR   Coriell; ND10618
DR   Wikidata; Q54923282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10620
AC   CVCL_BE62
DR   Coriell; ND10620
DR   Wikidata; Q54923283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10621
AC   CVCL_BE63
DR   Coriell; ND10621
DR   Wikidata; Q54923284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10622
AC   CVCL_BE64
DR   CLO; CLO_0034904
DR   Coriell; ND10622
DR   Wikidata; Q54923286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10623
AC   CVCL_BE65
DR   CLO; CLO_0034903
DR   Coriell; ND10623
DR   Wikidata; Q54923287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10624
AC   CVCL_BE66
DR   CLO; CLO_0034902
DR   Coriell; ND10624
DR   Wikidata; Q54923288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10625
AC   CVCL_BE67
DR   CLO; CLO_0034901
DR   Coriell; ND10625
DR   Wikidata; Q54923289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10626
AC   CVCL_BE68
DR   Coriell; ND10626
DR   Wikidata; Q54923290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10627
AC   CVCL_IJ60
DR   Coriell; ND10627
DR   Wikidata; Q54923291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10632
AC   CVCL_FL55
DR   CLO; CLO_0034950
DR   Coriell; ND10632
DR   Wikidata; Q54923292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10633
AC   CVCL_GE17
DR   CLO; CLO_0034951
DR   Coriell; ND10633
DR   Wikidata; Q54923293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10634
AC   CVCL_GE18
DR   CLO; CLO_0034953
DR   Coriell; ND10634
DR   Wikidata; Q54923294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10635
AC   CVCL_EW24
DR   CLO; CLO_0034945
DR   Coriell; ND10635
DR   Wikidata; Q54923295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10636
AC   CVCL_EW25
DR   CLO; CLO_0034965
DR   Coriell; ND10636
DR   Wikidata; Q54923296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10637
AC   CVCL_GE19
DR   CLO; CLO_0034964
DR   Coriell; ND10637
DR   Wikidata; Q54923298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10638
AC   CVCL_FZ35
DR   CLO; CLO_0034961
DR   Coriell; ND10638
DR   Wikidata; Q54923299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10639
AC   CVCL_FZ36
DR   CLO; CLO_0034960
DR   Coriell; ND10639
DR   Wikidata; Q54923300
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10640
AC   CVCL_FZ37
DR   CLO; CLO_0034963
DR   Coriell; ND10640
DR   Wikidata; Q54923301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10641
AC   CVCL_BE69
DR   CLO; CLO_0034962
DR   Coriell; ND10641
DR   Wikidata; Q54923302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10642
AC   CVCL_FA67
DR   CLO; CLO_0034930
DR   Coriell; ND10642
DR   Wikidata; Q54923303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10643
AC   CVCL_IJ61
DR   CLO; CLO_0034932
DR   Coriell; ND10643
DR   Wikidata; Q54923304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10644
AC   CVCL_FA68
DR   CLO; CLO_0034927
DR   Coriell; ND10644
DR   Wikidata; Q54923305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10645
AC   CVCL_IG79
DR   CLO; CLO_0034929
DR   Coriell; ND10645
DR   Wikidata; Q54923306
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)41 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (Coriell=ND10645).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ND10646
AC   CVCL_BE70
DR   CLO; CLO_0034944
DR   Coriell; ND10646
DR   Wikidata; Q54923307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10647
AC   CVCL_FA69
DR   CLO; CLO_0034943
DR   Coriell; ND10647
DR   Wikidata; Q54923309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10648
AC   CVCL_FA70
DR   CLO; CLO_0034942
DR   Coriell; ND10648
DR   Wikidata; Q54923310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10649
AC   CVCL_BE71
DR   CLO; CLO_0034941
DR   Coriell; ND10649
DR   Wikidata; Q54923311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10650
AC   CVCL_BE72
DR   CLO; CLO_0034940
DR   Coriell; ND10650
DR   Wikidata; Q54923312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10651
AC   CVCL_IJ62
DR   CLO; CLO_0034939
DR   Coriell; ND10651
DR   Wikidata; Q54923316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10652
AC   CVCL_GE20
DR   CLO; CLO_0034938
DR   Coriell; ND10652
DR   Wikidata; Q54923317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10653
AC   CVCL_EW26
DR   CLO; CLO_0034997
DR   BioSample; SAMN00796558
DR   Coriell; ND10653
DR   Wikidata; Q54923318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10654
AC   CVCL_GE21
DR   CLO; CLO_0034996
DR   BioSample; SAMN00796560
DR   Coriell; ND10654
DR   Wikidata; Q54923319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10655
AC   CVCL_EW27
DR   CLO; CLO_0034995
DR   Coriell; ND10655
DR   Wikidata; Q54923320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10656
AC   CVCL_EW28
DR   CLO; CLO_0034979
DR   Coriell; ND10656
DR   Wikidata; Q54923321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10657
AC   CVCL_ID97
DR   BioSample; SAMN00796562
DR   Coriell; ND10657
DR   Wikidata; Q54923322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10658
AC   CVCL_ID98
DR   Coriell; ND10658
DR   Wikidata; Q54923323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10660
AC   CVCL_GE22
DR   CLO; CLO_0034980
DR   Coriell; ND10660
DR   Wikidata; Q54923324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10661
AC   CVCL_ID99
DR   BioSample; SAMN00796563
DR   Coriell; ND10661
DR   Wikidata; Q54923325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10662
AC   CVCL_IJ63
DR   CLO; CLO_0034977
DR   Coriell; ND10662
DR   Wikidata; Q54923327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10663
AC   CVCL_BE73
DR   CLO; CLO_0034978
DR   Coriell; ND10663
DR   Wikidata; Q54923328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10664
AC   CVCL_BE74
DR   CLO; CLO_0034985
DR   Coriell; ND10664
DR   Wikidata; Q54923329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10665
AC   CVCL_FC69
DR   CLO; CLO_0034987
DR   Coriell; ND10665
DR   Wikidata; Q54923330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10666
AC   CVCL_BE75
DR   CLO; CLO_0034982
DR   Coriell; ND10666
DR   Wikidata; Q54923331
RX   PubMed=22572540;
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Unexplicit; 3'UTR*12C>T; Zygosity=Heterozygous; Note=VUS (PubMed=22572540).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   ND10667
AC   CVCL_BE76
DR   CLO; CLO_0034984
DR   Coriell; ND10667
DR   Wikidata; Q54923333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10668
AC   CVCL_EW29
DR   CLO; CLO_0034976
DR   BioSample; SAMN00796568
DR   Coriell; ND10668
DR   Wikidata; Q54923334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10669
AC   CVCL_FF22
DR   Coriell; ND10669
DR   Wikidata; Q54923335
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10673
AC   CVCL_FZ38
DR   Coriell; ND10673
DR   Wikidata; Q54923336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10677
AC   CVCL_GE23
DR   CLO; CLO_0034975
DR   Coriell; ND10677
DR   Wikidata; Q54923338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10678
AC   CVCL_GE24
DR   CLO; CLO_0034974
DR   BioSample; SAMN00796572
DR   Coriell; ND10678
DR   Wikidata; Q54923339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10679
AC   CVCL_EW30
DR   CLO; CLO_0034966
DR   Coriell; ND10679
DR   Wikidata; Q54923340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10680
AC   CVCL_GE25
DR   CLO; CLO_0034967
DR   BioSample; SAMN00796573
DR   Coriell; ND10680
DR   Wikidata; Q54923341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10681
AC   CVCL_GE26
DR   CLO; CLO_0034968
DR   Coriell; ND10681
DR   Wikidata; Q54923342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10682
AC   CVCL_GE27
DR   CLO; CLO_0034969
DR   Coriell; ND10682
DR   Wikidata; Q54923343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10683
AC   CVCL_EW31
DR   CLO; CLO_0034970
DR   Coriell; ND10683
DR   Wikidata; Q54923344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10684
AC   CVCL_IE00
DR   BioSample; SAMN00796575
DR   Coriell; ND10684
DR   Wikidata; Q54923345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10685
AC   CVCL_BE77
DR   CLO; CLO_0034971
DR   Coriell; ND10685
DR   Wikidata; Q54923346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10686
AC   CVCL_BE78
DR   Coriell; ND10686
DR   Wikidata; Q54923347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10687
AC   CVCL_BE79
DR   CLO; CLO_0034972
DR   Coriell; ND10687
DR   Wikidata; Q54923348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10688
AC   CVCL_BE80
DR   CLO; CLO_0034973
DR   Coriell; ND10688
DR   Wikidata; Q54923349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10689
AC   CVCL_BE81
DR   CLO; CLO_0035038
DR   Coriell; ND10689
DR   Wikidata; Q54923350
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10690
AC   CVCL_BE82
DR   CLO; CLO_0035027
DR   Coriell; ND10690
DR   Wikidata; Q54923351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10694
AC   CVCL_EW32
DR   CLO; CLO_0035028
DR   Coriell; ND10694
DR   Wikidata; Q54923352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10695
AC   CVCL_BE83
DR   CLO; CLO_0035025
DR   Coriell; ND10695
DR   Wikidata; Q54923353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10696
AC   CVCL_BE84
DR   CLO; CLO_0035026
DR   Coriell; ND10696
DR   Wikidata; Q54923355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10697
AC   CVCL_BE85
DR   CLO; CLO_0035022
DR   Coriell; ND10697
DR   Wikidata; Q54923356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10698
AC   CVCL_BE86
DR   CLO; CLO_0035023
DR   Coriell; ND10698
DR   Wikidata; Q54923357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10699
AC   CVCL_EW33
DR   CLO; CLO_0035020
DR   BioSample; SAMN00796583
DR   Coriell; ND10699
DR   Wikidata; Q54923358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10700
AC   CVCL_BE87
DR   CLO; CLO_0035021
DR   Coriell; ND10700
DR   Wikidata; Q54923359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10701
AC   CVCL_BE88
DR   CLO; CLO_0035018
DR   Coriell; ND10701
DR   Wikidata; Q54923364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10702
AC   CVCL_BE89
DR   CLO; CLO_0035019
DR   Coriell; ND10702
DR   Wikidata; Q54923365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10705
AC   CVCL_EB09
DR   Coriell; ND10705
DR   Wikidata; Q54923366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10707
AC   CVCL_BE90
DR   CLO; CLO_0035007
DR   Coriell; ND10707
DR   Wikidata; Q54923367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10708
AC   CVCL_BE91
DR   CLO; CLO_0035008
DR   Coriell; ND10708
DR   Wikidata; Q54923368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10709
AC   CVCL_CL57
DR   CLO; CLO_0035009
DR   Coriell; ND10709
DR   Wikidata; Q54923370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10710
AC   CVCL_BE92
DR   CLO; CLO_0035001
DR   Coriell; ND10710
DR   Wikidata; Q54923371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10711
AC   CVCL_BE93
DR   CLO; CLO_0035004
DR   Coriell; ND10711
DR   Wikidata; Q54923372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10712
AC   CVCL_GE28
DR   CLO; CLO_0035005
DR   Coriell; ND10712
DR   Wikidata; Q54923373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10713
AC   CVCL_GE29
DR   CLO; CLO_0035006
DR   Coriell; ND10713
DR   Wikidata; Q54923374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10714
AC   CVCL_GE30
DR   CLO; CLO_0034998
DR   Coriell; ND10714
DR   Wikidata; Q54923375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10715
AC   CVCL_IE01
DR   Coriell; ND10715
DR   Wikidata; Q54923376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10716
AC   CVCL_FZ39
DR   Coriell; ND10716
DR   Wikidata; Q54923377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10718
AC   CVCL_IJ64
DR   CLO; CLO_0034999
DR   Coriell; ND10718
DR   Wikidata; Q54923378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10719
AC   CVCL_BE94
DR   CLO; CLO_0035000
DR   Coriell; ND10719
DR   Wikidata; Q54923380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10720
AC   CVCL_IJ65
DR   CLO; CLO_0035052
DR   Coriell; ND10720
DR   Wikidata; Q54923381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10721
AC   CVCL_IJ66
DR   CLO; CLO_0035051
DR   Coriell; ND10721
DR   Wikidata; Q54923382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10722
AC   CVCL_EW34
DR   CLO; CLO_0035050
DR   BioSample; SAMN00796590
DR   Coriell; ND10722
DR   Wikidata; Q54923383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10725
AC   CVCL_FC70
DR   CLO; CLO_0035049
DR   Coriell; ND10725
DR   Wikidata; Q54923384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10726
AC   CVCL_IE02
DR   BioSample; SAMN00796594
DR   Coriell; ND10726
DR   Wikidata; Q54923385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10727
AC   CVCL_EW35
DR   CLO; CLO_0035056
DR   BioSample; SAMN00796595
DR   Coriell; ND10727
DR   Wikidata; Q54923386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10728
AC   CVCL_EW36
DR   CLO; CLO_0035055
DR   Coriell; ND10728
DR   Wikidata; Q54923387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10729
AC   CVCL_BE95
DR   CLO; CLO_0035054
DR   Coriell; ND10729
DR   Wikidata; Q54923388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10730
AC   CVCL_BE96
DR   CLO; CLO_0035053
DR   Coriell; ND10730
DR   Wikidata; Q54923389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10731
AC   CVCL_FA71
DR   CLO; CLO_0035058
DR   Coriell; ND10731
DR   Wikidata; Q54923390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10732
AC   CVCL_BE97
DR   CLO; CLO_0035057
DR   Coriell; ND10732
DR   Wikidata; Q54923391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10733
AC   CVCL_FA72
DR   CLO; CLO_0035039
DR   Coriell; ND10733
DR   Wikidata; Q54923392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10734
AC   CVCL_U113
DR   CLO; CLO_0035041
DR   Coriell; ND10734
DR   Wikidata; Q54923393
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (from autologous cell line ND39027).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T855 ! ND39027
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   ND10735
AC   CVCL_V338
DR   CLO; CLO_0035040
DR   Coriell; ND10735
DR   Wikidata; Q54923394
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (from familial inference of ND10734).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   ND10736
AC   CVCL_EW37
DR   CLO; CLO_0035043
DR   Coriell; ND10736
DR   Wikidata; Q54923396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10737
AC   CVCL_FC71
DR   CLO; CLO_0035042
DR   Coriell; ND10737
DR   Wikidata; Q54923397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10739
AC   CVCL_BF00
DR   CLO; CLO_0035045
DR   Coriell; ND10739
DR   Wikidata; Q54923398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10740
AC   CVCL_BF01
DR   CLO; CLO_0035044
DR   Coriell; ND10740
DR   Wikidata; Q54923399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10741
AC   CVCL_BF02
DR   CLO; CLO_0035047
DR   Coriell; ND10741
DR   Wikidata; Q54923400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10742
AC   CVCL_CL58
DR   CLO; CLO_0035046
DR   Coriell; ND10742
DR   Wikidata; Q54923401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10743
AC   CVCL_EW38
DR   CLO; CLO_0035048
DR   Coriell; ND10743
DR   Wikidata; Q54923402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10744
AC   CVCL_CL59
DR   CLO; CLO_0035064
DR   Coriell; ND10744
DR   Wikidata; Q54923403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10745
AC   CVCL_EW39
DR   CLO; CLO_0035063
DR   BioSample; SAMN00796605
DR   Coriell; ND10745
DR   Wikidata; Q54923405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10746
AC   CVCL_CL60
DR   CLO; CLO_0035062
DR   BioSample; SAMN00796607
DR   Coriell; ND10746
DR   Wikidata; Q54923407
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND10747
AC   CVCL_CL61
DR   CLO; CLO_0035061
DR   Coriell; ND10747
DR   Wikidata; Q54923408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10748
AC   CVCL_CL62
DR   CLO; CLO_0035060
DR   Coriell; ND10748
DR   Wikidata; Q54923415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10749
AC   CVCL_CL63
DR   CLO; CLO_0035059
DR   Coriell; ND10749
DR   Wikidata; Q54923416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10750
AC   CVCL_EW40
DR   CLO; CLO_0035068
DR   BioSample; SAMN00796609
DR   Coriell; ND10750
DR   Wikidata; Q54923417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10752
AC   CVCL_CL64
DR   CLO; CLO_0035067
DR   BioSample; SAMN00796610
DR   Coriell; ND10752
DR   Wikidata; Q54923418
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND10753
AC   CVCL_IE03
DR   CLO; CLO_0035066
DR   Coriell; ND10753
DR   Wikidata; Q54923419
RX   PubMed=34468209;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10754
AC   CVCL_EB10
DR   Coriell; ND10754
DR   Wikidata; Q54923420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10762
AC   CVCL_HR70
DR   CLO; CLO_0035065
DR   Coriell; ND10762
DR   Wikidata; Q54923421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10763
AC   CVCL_BF03
DR   Coriell; ND10763
DR   Wikidata; Q54923422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10764
AC   CVCL_BF04
DR   CLO; CLO_0035365
DR   Coriell; ND10764
DR   Wikidata; Q54923423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10765
AC   CVCL_EW41
DR   CLO; CLO_0035366
DR   Coriell; ND10765
DR   Wikidata; Q54923424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10766
AC   CVCL_EW42
DR   CLO; CLO_0035363
DR   Coriell; ND10766
DR   Wikidata; Q54923426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10767
AC   CVCL_BF05
DR   CLO; CLO_0035364
DR   Coriell; ND10767
DR   Wikidata; Q54923427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10768
AC   CVCL_BF06
DR   CLO; CLO_0035348
DR   Coriell; ND10768
DR   Wikidata; Q54923429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10769
AC   CVCL_EW43
DR   CLO; CLO_0035350
DR   BioSample; SAMN00796615
DR   Coriell; ND10769
DR   Wikidata; Q54923430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10770
AC   CVCL_GE31
DR   CLO; CLO_0035351
DR   Coriell; ND10770
DR   Wikidata; Q54923431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10771
AC   CVCL_GE32
DR   CLO; CLO_0035353
DR   Coriell; ND10771
DR   Wikidata; Q54923432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10772
AC   CVCL_BF07
DR   CLO; CLO_0035355
DR   Coriell; ND10772
DR   Wikidata; Q54923433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10773
AC   CVCL_BF08
DR   CLO; CLO_0035358
DR   Coriell; ND10773
DR   Wikidata; Q54923434
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10774
AC   CVCL_BF09
DR   Coriell; ND10774
DR   Wikidata; Q54923435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10775
AC   CVCL_EW44
DR   CLO; CLO_0035331
DR   BioSample; SAMN00796619
DR   Coriell; ND10775
DR   Wikidata; Q54923436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10776
AC   CVCL_BF10
DR   Coriell; ND10776
DR   Wikidata; Q54923437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10777
AC   CVCL_EW45
DR   CLO; CLO_0035333
DR   Coriell; ND10777
DR   Wikidata; Q54923438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10778
AC   CVCL_BF11
DR   Coriell; ND10778
DR   Wikidata; Q54923440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10780
AC   CVCL_BF12
DR   Coriell; ND10780
DR   Wikidata; Q54923441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10781
AC   CVCL_IJ67
DR   CLO; CLO_0035332
DR   Coriell; ND10781
DR   Wikidata; Q54923442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10782
AC   CVCL_BF13
DR   CLO; CLO_0035335
DR   Coriell; ND10782
DR   Wikidata; Q54923443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10783
AC   CVCL_IJ68
DR   CLO; CLO_0035334
DR   Coriell; ND10783
DR   Wikidata; Q54923445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10784
AC   CVCL_GE33
DR   CLO; CLO_0035319
DR   BioSample; SAMN00796626
DR   Coriell; ND10784
DR   Wikidata; Q54923446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10785
AC   CVCL_FC72
DR   CLO; CLO_0035322
DR   Coriell; ND10785
DR   Wikidata; Q54923447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10786
AC   CVCL_IE04
DR   BioSample; SAMN00796628
DR   Coriell; ND10786
DR   Wikidata; Q54923448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10787
AC   CVCL_IE05
DR   BioSample; SAMN00796629
DR   Coriell; ND10787
DR   Wikidata; Q54923449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND10788
AC   CVCL_IE06
DR   Coriell; ND10788
DR   Wikidata; Q54923450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10795
AC   CVCL_CL65
DR   Coriell; ND10795
DR   Wikidata; Q54923451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10796
AC   CVCL_IE07
DR   Coriell; ND10796
DR   Wikidata; Q54923452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10800
AC   CVCL_IJ69
DR   CLO; CLO_0035316
DR   Coriell; ND10800
DR   Wikidata; Q54923453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10801
AC   CVCL_BF14
DR   CLO; CLO_0035318
DR   Coriell; ND10801
DR   Wikidata; Q54923454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10802
AC   CVCL_BF15
DR   CLO; CLO_0035327
DR   Coriell; ND10802
DR   Wikidata; Q54923455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10803
AC   CVCL_BF16
DR   CLO; CLO_0035301
DR   Coriell; ND10803
DR   Wikidata; Q54923456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10805
AC   CVCL_BF17
DR   CLO; CLO_0035300
DR   Coriell; ND10805
DR   Wikidata; Q54923457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10806
AC   CVCL_FA73
DR   CLO; CLO_0035306
DR   Coriell; ND10806
DR   Wikidata; Q54923458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10807
AC   CVCL_BF18
DR   CLO; CLO_0035305
DR   Coriell; ND10807
DR   Wikidata; Q54923473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10808
AC   CVCL_BF19
DR   CLO; CLO_0035304
DR   Coriell; ND10808
DR   Wikidata; Q54923474
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10809
AC   CVCL_BF20
DR   CLO; CLO_0035303
DR   Coriell; ND10809
DR   Wikidata; Q54923475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10810
AC   CVCL_IJ70
DR   CLO; CLO_0035293
DR   Coriell; ND10810
DR   Wikidata; Q54923476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10811
AC   CVCL_EW46
DR   CLO; CLO_0035294
DR   BioSample; SAMN00796636
DR   Coriell; ND10811
DR   Wikidata; Q54923477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10812
AC   CVCL_BF21
DR   Coriell; ND10812
DR   Wikidata; Q54923478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10813
AC   CVCL_BF22
DR   CLO; CLO_0035296
DR   Coriell; ND10813
DR   Wikidata; Q54923479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10814
AC   CVCL_IE08
DR   Coriell; ND10814
DR   Wikidata; Q54923480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10815
AC   CVCL_EW47
DR   CLO; CLO_0035298
DR   Coriell; ND10815
DR   Wikidata; Q54923481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10816
AC   CVCL_FC73
DR   CLO; CLO_0035275
DR   BioSample; SAMN00796638
DR   Coriell; ND10816
DR   Wikidata; Q54923482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10817
AC   CVCL_EW48
DR   CLO; CLO_0035277
DR   BioSample; SAMN00796639
DR   Coriell; ND10817
DR   Wikidata; Q54923483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10826
AC   CVCL_BF23
DR   CLO; CLO_0035276
DR   Coriell; ND10826
DR   Wikidata; Q54923484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10827
AC   CVCL_EW49
DR   CLO; CLO_0035272
DR   BioSample; SAMN00796641
DR   Coriell; ND10827
DR   Wikidata; Q54923485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10828
AC   CVCL_BF24
DR   CLO; CLO_0035271
DR   Coriell; ND10828
DR   Wikidata; Q54923486
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10829
AC   CVCL_BF25
DR   CLO; CLO_0035274
DR   Coriell; ND10829
DR   Wikidata; Q54923487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10831
AC   CVCL_BF26
DR   CLO; CLO_0035273
DR   Coriell; ND10831
DR   Wikidata; Q54923490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10833
AC   CVCL_BF27
DR   CLO; CLO_0035268
DR   Coriell; ND10833
DR   Wikidata; Q54923491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10834
AC   CVCL_EW50
DR   CLO; CLO_0035269
DR   BioSample; SAMN00796646
DR   Coriell; ND10834
DR   Wikidata; Q54923492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10835
AC   CVCL_BF28
DR   CLO; CLO_0035264
DR   Coriell; ND10835
DR   Wikidata; Q54923493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10836
AC   CVCL_GE34
DR   CLO; CLO_0035246
DR   BioSample; SAMN00796648
DR   Coriell; ND10836
DR   Wikidata; Q54923494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10837
AC   CVCL_EW51
DR   CLO; CLO_0035245
DR   Coriell; ND10837
DR   Wikidata; Q54923495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10838
AC   CVCL_EW52
DR   CLO; CLO_0035244
DR   Coriell; ND10838
DR   Wikidata; Q54923496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10839
AC   CVCL_BF29
DR   CLO; CLO_0035243
DR   Coriell; ND10839
DR   Wikidata; Q54923497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10840
AC   CVCL_GE35
DR   CLO; CLO_0035242
DR   Coriell; ND10840
DR   Wikidata; Q54923498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10841
AC   CVCL_BF30
DR   CLO; CLO_0035241
DR   Coriell; ND10841
DR   Wikidata; Q54923499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10842
AC   CVCL_FA74
DR   CLO; CLO_0035240
DR   Coriell; ND10842
DR   Wikidata; Q54923500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10843
AC   CVCL_EW53
DR   CLO; CLO_0035239
DR   BioSample; SAMN00796651
DR   Coriell; ND10843
DR   Wikidata; Q54923502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10844
AC   CVCL_BF31
DR   CLO; CLO_0035450
DR   Coriell; ND10844
DR   Wikidata; Q54923503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10847
AC   CVCL_BF32
DR   CLO; CLO_0035449
DR   Coriell; ND10847
DR   Wikidata; Q54923504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10848
AC   CVCL_BF33
DR   CLO; CLO_0035451
DR   Coriell; ND10848
DR   Wikidata; Q54923505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10849
AC   CVCL_BF34
DR   CLO; CLO_0035454
DR   Coriell; ND10849
DR   Wikidata; Q54923506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10850
AC   CVCL_GE36
DR   CLO; CLO_0035455
DR   Coriell; ND10850
DR   Wikidata; Q54923507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10852
AC   CVCL_EW54
DR   CLO; CLO_0035452
DR   BioSample; SAMN00796655
DR   Coriell; ND10852
DR   Wikidata; Q54923508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10853
AC   CVCL_BF35
DR   CLO; CLO_0035453
DR   Coriell; ND10853
DR   Wikidata; Q54923510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10854
AC   CVCL_BF36
DR   CLO; CLO_0035458
DR   Coriell; ND10854
DR   Wikidata; Q54923511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10855
AC   CVCL_BF37
DR   CLO; CLO_0035459
DR   Coriell; ND10855
DR   Wikidata; Q54923512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10856
AC   CVCL_GE37
DR   CLO; CLO_0035456
DR   Coriell; ND10856
DR   Wikidata; Q54923514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10857
AC   CVCL_EW55
DR   CLO; CLO_0035457
DR   Coriell; ND10857
DR   Wikidata; Q54923515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10858
AC   CVCL_EW56
DR   CLO; CLO_0035438
DR   Coriell; ND10858
DR   Wikidata; Q54923516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10860
AC   CVCL_EW57
DR   CLO; CLO_0035439
DR   Coriell; ND10860
DR   Wikidata; Q54923517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10861
AC   CVCL_EW58
DR   CLO; CLO_0035440
DR   Coriell; ND10861
DR   Wikidata; Q54923522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10862
AC   CVCL_EW59
DR   CLO; CLO_0035441
DR   Coriell; ND10862
DR   Wikidata; Q54923523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10863
AC   CVCL_GE38
DR   CLO; CLO_0035442
DR   Coriell; ND10863
DR   Wikidata; Q54923524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10864
AC   CVCL_EW60
DR   CLO; CLO_0035443
DR   Coriell; ND10864
DR   Wikidata; Q54923525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10865
AC   CVCL_IE09
DR   Coriell; ND10865
DR   Wikidata; Q54923526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10866
AC   CVCL_GE39
DR   CLO; CLO_0035444
DR   Coriell; ND10866
DR   Wikidata; Q54923527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10867
AC   CVCL_GE40
DR   CLO; CLO_0035445
DR   Coriell; ND10867
DR   Wikidata; Q54923528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10868
AC   CVCL_EW61
DR   CLO; CLO_0035446
DR   Coriell; ND10868
DR   Wikidata; Q54923529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10869
AC   CVCL_EW62
DR   CLO; CLO_0035447
DR   Coriell; ND10869
DR   Wikidata; Q54923530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10870
AC   CVCL_GE41
DR   CLO; CLO_0035448
DR   Coriell; ND10870
DR   Wikidata; Q54923531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10871
AC   CVCL_EW63
DR   CLO; CLO_0035430
DR   Coriell; ND10871
DR   Wikidata; Q54923533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10872
AC   CVCL_EW64
DR   CLO; CLO_0035428
DR   Coriell; ND10872
DR   Wikidata; Q54923534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10873
AC   CVCL_GE42
DR   CLO; CLO_0035429
DR   Coriell; ND10873
DR   Wikidata; Q54923535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10875
AC   CVCL_EW65
DR   CLO; CLO_0035436
DR   Coriell; ND10875
DR   Wikidata; Q54923536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10876
AC   CVCL_EW66
DR   CLO; CLO_0035437
DR   Coriell; ND10876
DR   Wikidata; Q54923537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10877
AC   CVCL_BF38
DR   CLO; CLO_0035434
DR   Coriell; ND10877
DR   Wikidata; Q54923538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10878
AC   CVCL_GE43
DR   CLO; CLO_0035435
DR   Coriell; ND10878
DR   Wikidata; Q54923539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10879
AC   CVCL_EW67
DR   CLO; CLO_0035432
DR   Coriell; ND10879
DR   Wikidata; Q54923540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10880
AC   CVCL_EW68
DR   CLO; CLO_0035433
DR   Coriell; ND10880
DR   Wikidata; Q54923541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10881
AC   CVCL_GE44
DR   CLO; CLO_0035431
DR   Coriell; ND10881
DR   Wikidata; Q54923542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10882
AC   CVCL_EW69
DR   CLO; CLO_0035418
DR   Coriell; ND10882
DR   Wikidata; Q54923543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10883
AC   CVCL_GE45
DR   CLO; CLO_0035419
DR   Coriell; ND10883
DR   Wikidata; Q54923544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10884
AC   CVCL_GE46
DR   CLO; CLO_0035420
DR   Coriell; ND10884
DR   Wikidata; Q54923545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10885
AC   CVCL_EW70
DR   CLO; CLO_0035421
DR   Coriell; ND10885
DR   Wikidata; Q54923546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10886
AC   CVCL_GE47
DR   CLO; CLO_0035424
DR   Coriell; ND10886
DR   Wikidata; Q54923548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10887
AC   CVCL_GE48
DR   CLO; CLO_0035425
DR   Coriell; ND10887
DR   Wikidata; Q54923549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10888
AC   CVCL_GE49
DR   CLO; CLO_0035426
DR   Coriell; ND10888
DR   Wikidata; Q54923550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10889
AC   CVCL_IJ71
DR   CLO; CLO_0035427
DR   Coriell; ND10889
DR   Wikidata; Q54923552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10890
AC   CVCL_BF39
DR   CLO; CLO_0035422
DR   Coriell; ND10890
DR   Wikidata; Q54923553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10891
AC   CVCL_GE50
DR   CLO; CLO_0035423
DR   Coriell; ND10891
DR   Wikidata; Q54923554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10892
AC   CVCL_IE10
DR   CLO; CLO_0035413
DR   Coriell; ND10892
DR   Wikidata; Q54923555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10893
AC   CVCL_BF40
DR   CLO; CLO_0035417
DR   Coriell; ND10893
DR   Wikidata; Q54923556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10894
AC   CVCL_IE11
DR   CLO; CLO_0035416
DR   Coriell; ND10894
DR   Wikidata; Q54923557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10895
AC   CVCL_BF41
DR   CLO; CLO_0035415
DR   Coriell; ND10895
DR   Wikidata; Q54923558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10896
AC   CVCL_EW71
DR   CLO; CLO_0035414
DR   Coriell; ND10896
DR   Wikidata; Q54923559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10897
AC   CVCL_EW72
DR   CLO; CLO_0035411
DR   Coriell; ND10897
DR   Wikidata; Q54923560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10898
AC   CVCL_BF42
DR   CLO; CLO_0035410
DR   Coriell; ND10898
DR   Wikidata; Q54923561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10899
AC   CVCL_BF43
DR   CLO; CLO_0035409
DR   Coriell; ND10899
DR   Wikidata; Q54923563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10900
AC   CVCL_BF44
DR   Coriell; ND10900
DR   Wikidata; Q54923564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10901
AC   CVCL_BF45
DR   CLO; CLO_0035408
DR   Coriell; ND10901
DR   Wikidata; Q54923565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10902
AC   CVCL_IL85
DR   CLO; CLO_0035412
DR   Coriell; ND10902
DR   Wikidata; Q54923571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND10902; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND10903
AC   CVCL_BF46
DR   CLO; CLO_0035647
DR   Coriell; ND10903
DR   Wikidata; Q54923572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10904
AC   CVCL_BF47
DR   CLO; CLO_0035645
DR   Coriell; ND10904
DR   Wikidata; Q54923573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10905
AC   CVCL_BF48
DR   CLO; CLO_0035646
DR   Coriell; ND10905
DR   Wikidata; Q54923574
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10906
AC   CVCL_EW73
DR   CLO; CLO_0035724
DR   BioSample; SAMN00796667
DR   Coriell; ND10906
DR   Wikidata; Q54923575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10907
AC   CVCL_BF49
DR   Coriell; ND10907
DR   Wikidata; Q54923576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10908
AC   CVCL_IL86
DR   CLO; CLO_0035722
DR   Coriell; ND10908
DR   Wikidata; Q54923577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND10908; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND10909
AC   CVCL_EW74
DR   CLO; CLO_0035727
DR   Coriell; ND10909
DR   Wikidata; Q54923578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10910
AC   CVCL_EW75
DR   CLO; CLO_0035725
DR   Coriell; ND10910
DR   Wikidata; Q54923579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10911
AC   CVCL_BF50
DR   CLO; CLO_0035719
DR   Coriell; ND10911
DR   Wikidata; Q54923580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10912
AC   CVCL_BF51
DR   CLO; CLO_0035718
DR   Coriell; ND10912
DR   Wikidata; Q54923581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10913
AC   CVCL_BF52
DR   CLO; CLO_0035720
DR   Coriell; ND10913
DR   Wikidata; Q54923582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10914
AC   CVCL_BF53
DR   CLO; CLO_0035707
DR   Coriell; ND10914
DR   Wikidata; Q54923583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10915
AC   CVCL_BF54
DR   Coriell; ND10915
DR   Wikidata; Q54923584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10917
AC   CVCL_IE12
DR   Coriell; ND10917
DR   Wikidata; Q54923585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10918
AC   CVCL_FL56
DR   Coriell; ND10918
DR   Wikidata; Q54923586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10920
AC   CVCL_IE13
DR   Coriell; ND10920
DR   Wikidata; Q54923587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10924
AC   CVCL_HV67
DR   Coriell; ND10924
DR   Wikidata; Q54923588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10926
AC   CVCL_BF55
DR   CLO; CLO_0035708
DR   Coriell; ND10926
DR   Wikidata; Q54923589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10927
AC   CVCL_GE51
DR   CLO; CLO_0035709
DR   BioSample; SAMN00796674
DR   Coriell; ND10927
DR   Wikidata; Q54923590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10928
AC   CVCL_BF56
DR   CLO; CLO_0035710
DR   Coriell; ND10928
DR   Wikidata; Q54923591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10929
AC   CVCL_GE52
DR   CLO; CLO_0035705
DR   BioSample; SAMN00796677
DR   Coriell; ND10929
DR   Wikidata; Q54923592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10930
AC   CVCL_BF57
DR   CLO; CLO_0035704
DR   Coriell; ND10930
DR   Wikidata; Q54923593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10931
AC   CVCL_GE53
DR   CLO; CLO_0035702
DR   Coriell; ND10931
DR   Wikidata; Q54923594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10932
AC   CVCL_GE54
DR   CLO; CLO_0035699
DR   Coriell; ND10932
DR   Wikidata; Q54923595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10933
AC   CVCL_EW76
DR   CLO; CLO_0035698
DR   Coriell; ND10933
DR   Wikidata; Q54923596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10934
AC   CVCL_FA75
DR   CLO; CLO_0035697
DR   Coriell; ND10934
DR   Wikidata; Q54923597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10935
AC   CVCL_BF58
DR   CLO; CLO_0035690
DR   Coriell; ND10935
DR   Wikidata; Q54923598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10936
AC   CVCL_FA76
DR   CLO; CLO_0035688
DR   Coriell; ND10936
DR   Wikidata; Q54923599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10937
AC   CVCL_BF59
DR   CLO; CLO_0035689
DR   Coriell; ND10937
DR   Wikidata; Q54923600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10938
AC   CVCL_BF60
DR   CLO; CLO_0035686
DR   Coriell; ND10938
DR   Wikidata; Q54923601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10939
AC   CVCL_BF61
DR   CLO; CLO_0035687
DR   Coriell; ND10939
DR   Wikidata; Q54923602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10940
AC   CVCL_BF62
DR   CLO; CLO_0035566
DR   Coriell; ND10940
DR   Wikidata; Q54923603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10941
AC   CVCL_BF63
DR   CLO; CLO_0035567
DR   Coriell; ND10941
DR   Wikidata; Q54923606
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (Coriell=ND10941).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 16
//
ID   ND10942
AC   CVCL_EB11
DR   Coriell; ND10942
DR   Wikidata; Q54923607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10944
AC   CVCL_EB12
DR   Coriell; ND10944
DR   Wikidata; Q54923608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND10951
AC   CVCL_EW77
DR   Coriell; ND10951
DR   Wikidata; Q54923609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10952
AC   CVCL_EW78
DR   CLO; CLO_0035568
DR   Coriell; ND10952
DR   Wikidata; Q54923610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10953
AC   CVCL_GE55
DR   CLO; CLO_0035569
DR   Coriell; ND10953
DR   Wikidata; Q54923611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10954
AC   CVCL_EW79
DR   CLO; CLO_0035570
DR   Coriell; ND10954
DR   Wikidata; Q54923612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10955
AC   CVCL_EW80
DR   CLO; CLO_0035561
DR   Coriell; ND10955
DR   Wikidata; Q54923617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10956
AC   CVCL_GE56
DR   CLO; CLO_0035560
DR   Coriell; ND10956
DR   Wikidata; Q54923618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10957
AC   CVCL_EW81
DR   CLO; CLO_0035563
DR   Coriell; ND10957
DR   Wikidata; Q54923619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10958
AC   CVCL_FC74
DR   CLO; CLO_0035562
DR   Coriell; ND10958
DR   Wikidata; Q54923620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10959
AC   CVCL_GE57
DR   CLO; CLO_0035565
DR   Coriell; ND10959
DR   Wikidata; Q54923621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10960
AC   CVCL_EW82
DR   CLO; CLO_0035564
DR   Coriell; ND10960
DR   Wikidata; Q54923622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10961
AC   CVCL_IE14
DR   Coriell; ND10961
DR   Wikidata; Q54923623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10962
AC   CVCL_GE58
DR   CLO; CLO_0035548
DR   Coriell; ND10962
DR   Wikidata; Q54923624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10963
AC   CVCL_BF64
DR   Coriell; ND10963
DR   Wikidata; Q54923625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10964
AC   CVCL_BF65
DR   CLO; CLO_0035549
DR   Coriell; ND10964
DR   Wikidata; Q54923626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10965
AC   CVCL_BF66
DR   CLO; CLO_0035546
DR   Coriell; ND10965
DR   Wikidata; Q54923627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10966
AC   CVCL_BF67
DR   CLO; CLO_0035547
DR   Coriell; ND10966
DR   Wikidata; Q54923628
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10967
AC   CVCL_BF68
DR   CLO; CLO_0035541
DR   Coriell; ND10967
DR   Wikidata; Q54923629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10968
AC   CVCL_BF69
DR   CLO; CLO_0035540
DR   Coriell; ND10968
DR   Wikidata; Q54923630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10969
AC   CVCL_BF70
DR   Coriell; ND10969
DR   Wikidata; Q54923631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10970
AC   CVCL_GE59
DR   CLO; CLO_0035539
DR   BioSample; SAMN00796685
DR   Coriell; ND10970
DR   Wikidata; Q54923632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10971
AC   CVCL_BF71
DR   CLO; CLO_0035545
DR   Coriell; ND10971
DR   Wikidata; Q54923633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10972
AC   CVCL_BF72
DR   Coriell; ND10972
DR   Wikidata; Q54923634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10973
AC   CVCL_BF73
DR   CLO; CLO_0035544
DR   Coriell; ND10973
DR   Wikidata; Q54923635
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND10974
AC   CVCL_BF74
DR   CLO; CLO_0035543
DR   Coriell; ND10974
DR   Wikidata; Q54923636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10975
AC   CVCL_FC75
DR   CLO; CLO_0035542
DR   BioSample; SAMN00796689
DR   Coriell; ND10975
DR   Wikidata; Q54923637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND10976
AC   CVCL_IL87
DR   CLO; CLO_0035627
DR   Coriell; ND10976
DR   Wikidata; Q54923638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND10976; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND10977
AC   CVCL_EW83
DR   CLO; CLO_0035629
DR   Coriell; ND10977
DR   Wikidata; Q54923639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10978
AC   CVCL_EW84
DR   CLO; CLO_0035632
DR   Coriell; ND10978
DR   Wikidata; Q54923640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10979
AC   CVCL_BF75
DR   CLO; CLO_0035620
DR   Coriell; ND10979
DR   Wikidata; Q54923641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10980
AC   CVCL_GE60
DR   CLO; CLO_0035619
DR   Coriell; ND10980
DR   Wikidata; Q54923642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10981
AC   CVCL_EW85
DR   CLO; CLO_0035622
DR   Coriell; ND10981
DR   Wikidata; Q54923643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10982
AC   CVCL_BF76
DR   CLO; CLO_0035621
DR   Coriell; ND10982
DR   Wikidata; Q54923644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10983
AC   CVCL_BF77
DR   CLO; CLO_0035616
DR   Coriell; ND10983
DR   Wikidata; Q54923645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10984
AC   CVCL_BF78
DR   CLO; CLO_0035615
DR   Coriell; ND10984
DR   Wikidata; Q54923646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10985
AC   CVCL_BF79
DR   CLO; CLO_0035618
DR   Coriell; ND10985
DR   Wikidata; Q54923647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND10992
AC   CVCL_FL57
DR   Coriell; ND10992
DR   Wikidata; Q54923648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y2M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10994
AC   CVCL_CL66
DR   Coriell; ND10994
DR   Wikidata; Q54923650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND10997
AC   CVCL_HV68
DR   CLO; CLO_0035617
DR   Coriell; ND10997
DR   Wikidata; Q54923651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND10998
AC   CVCL_FZ40
DR   CLO; CLO_0035599
DR   Coriell; ND10998
DR   Wikidata; Q54923653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND10999
AC   CVCL_HR71
DR   CLO; CLO_0035601
DR   Coriell; ND10999
DR   Wikidata; Q54923654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11
AC   CVCL_VK89
SY   Neuroblastoma X DRG neurons hybrid 11
DR   Wikidata; Q98127444
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND11000
AC   CVCL_IH42
DR   CLO; CLO_0035581
DR   Coriell; ND11000
DR   Wikidata; Q54923655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11001
AC   CVCL_FZ41
DR   CLO; CLO_0035590
DR   Coriell; ND11001
DR   Wikidata; Q54923656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11002
AC   CVCL_GE61
DR   CLO; CLO_0035589
DR   Coriell; ND11002
DR   Wikidata; Q54923657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11003
AC   CVCL_GE62
DR   CLO; CLO_0035588
DR   Coriell; ND11003
DR   Wikidata; Q54923658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11004
AC   CVCL_GE63
DR   CLO; CLO_0035587
DR   Coriell; ND11004
DR   Wikidata; Q54923666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11005
AC   CVCL_GE64
DR   CLO; CLO_0035586
DR   Coriell; ND11005
DR   Wikidata; Q54923667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11006
AC   CVCL_FA77
DR   CLO; CLO_0035585
DR   Coriell; ND11006
DR   Wikidata; Q54923668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11007
AC   CVCL_FA78
DR   CLO; CLO_0035584
DR   Coriell; ND11007
DR   Wikidata; Q54923669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11008
AC   CVCL_BF80
DR   CLO; CLO_0035583
DR   Coriell; ND11008
DR   Wikidata; Q54923670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11009
AC   CVCL_BF81
DR   CLO; CLO_0035738
DR   Coriell; ND11009
DR   Wikidata; Q54923673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11010
AC   CVCL_GE65
DR   CLO; CLO_0035747
DR   Coriell; ND11010
DR   Wikidata; Q54923674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11011
AC   CVCL_BF82
DR   CLO; CLO_0035748
DR   Coriell; ND11011
DR   Wikidata; Q54923675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11012
AC   CVCL_IE15
DR   Coriell; ND11012
DR   Wikidata; Q54923676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11014
AC   CVCL_IE16
DR   Coriell; ND11014
DR   Wikidata; Q54923677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11015
AC   CVCL_IE17
DR   Coriell; ND11015
DR   Wikidata; Q54923678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11021
AC   CVCL_FL58
DR   Coriell; ND11021
DR   Wikidata; Q54923679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11022
AC   CVCL_IE18
DR   Coriell; ND11022
DR   Wikidata; Q54923680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11024
AC   CVCL_IE19
DR   Coriell; ND11024
DR   Wikidata; Q54923681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11025
AC   CVCL_BF83
DR   CLO; CLO_0035741
DR   Coriell; ND11025
DR   Wikidata; Q54923683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11026
AC   CVCL_BF84
DR   CLO; CLO_0035742
DR   Coriell; ND11026
DR   Wikidata; Q54923684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11027
AC   CVCL_BF85
DR   CLO; CLO_0035739
DR   Coriell; ND11027
DR   Wikidata; Q54923685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11029
AC   CVCL_IE20
DR   BioSample; SAMN00796700
DR   Coriell; ND11029
DR   Wikidata; Q54923686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND11030
AC   CVCL_BF86
DR   CLO; CLO_0035740
DR   Coriell; ND11030
DR   Wikidata; Q54923687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11031
AC   CVCL_BF87
DR   Coriell; ND11031
DR   Wikidata; Q54923688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11033
AC   CVCL_GE66
DR   CLO; CLO_0035745
DR   Coriell; ND11033
DR   Wikidata; Q54923689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11034
AC   CVCL_GE67
DR   CLO; CLO_0035746
DR   Coriell; ND11034
DR   Wikidata; Q54923690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11035
AC   CVCL_GE68
DR   CLO; CLO_0035743
DR   Coriell; ND11035
DR   Wikidata; Q54923691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11036
AC   CVCL_BF88
DR   CLO; CLO_0035744
DR   Coriell; ND11036
DR   Wikidata; Q54923692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11037
AC   CVCL_BF89
DR   CLO; CLO_0035735
DR   Coriell; ND11037
DR   Wikidata; Q54923693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11038
AC   CVCL_GE69
DR   CLO; CLO_0035736
DR   BioSample; SAMN00796707
DR   Coriell; ND11038
DR   Wikidata; Q54923694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11039
AC   CVCL_GE70
DR   CLO; CLO_0035737
DR   BioSample; SAMN00796709
DR   Coriell; ND11039
DR   Wikidata; Q54923695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11040
AC   CVCL_BF90
DR   CLO; CLO_0035728
DR   Coriell; ND11040
DR   Wikidata; Q54923696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11041
AC   CVCL_BF91
DR   CLO; CLO_0035729
DR   Coriell; ND11041
DR   Wikidata; Q54923697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11042
AC   CVCL_FC76
DR   CLO; CLO_0035730
DR   Coriell; ND11042
DR   Wikidata; Q54923698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11043
AC   CVCL_GE71
DR   CLO; CLO_0035731
DR   Coriell; ND11043
DR   Wikidata; Q54923699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11044
AC   CVCL_FC77
DR   CLO; CLO_0035732
DR   Coriell; ND11044
DR   Wikidata; Q54923700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11045
AC   CVCL_FC78
DR   CLO; CLO_0035733
DR   Coriell; ND11045
DR   Wikidata; Q54923701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11047
AC   CVCL_GE72
DR   CLO; CLO_0035734
DR   Coriell; ND11047
DR   Wikidata; Q54923702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11048
AC   CVCL_GE73
DR   CLO; CLO_0035757
DR   Coriell; ND11048
DR   Wikidata; Q54923703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11049
AC   CVCL_IE21
DR   Coriell; ND11049
DR   Wikidata; Q54923704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11050
AC   CVCL_GE74
DR   CLO; CLO_0035758
DR   Coriell; ND11050
DR   Wikidata; Q54923706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11051
AC   CVCL_GE75
DR   CLO; CLO_0035755
DR   Coriell; ND11051
DR   Wikidata; Q54923707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11052
AC   CVCL_EW86
DR   CLO; CLO_0035756
DR   Coriell; ND11052
DR   Wikidata; Q54923708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11053
AC   CVCL_GE76
DR   CLO; CLO_0035753
DR   Coriell; ND11053
DR   Wikidata; Q54923709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11054
AC   CVCL_GE77
DR   CLO; CLO_0035754
DR   Coriell; ND11054
DR   Wikidata; Q54923712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11055
AC   CVCL_GE78
DR   CLO; CLO_0035751
DR   Coriell; ND11055
DR   Wikidata; Q54923713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11056
AC   CVCL_GE79
DR   CLO; CLO_0035752
DR   Coriell; ND11056
DR   Wikidata; Q54923714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11057
AC   CVCL_GE80
DR   CLO; CLO_0035749
DR   Coriell; ND11057
DR   Wikidata; Q54923715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11058
AC   CVCL_EW87
DR   CLO; CLO_0035750
DR   Coriell; ND11058
DR   Wikidata; Q54923716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11059
AC   CVCL_GE81
DR   CLO; CLO_0020289
DR   Coriell; ND11059
DR   Wikidata; Q54923717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11060
AC   CVCL_FC79
DR   CLO; CLO_0020292
DR   Coriell; ND11060
DR   Wikidata; Q54923718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11061
AC   CVCL_EW88
DR   CLO; CLO_0020293
DR   Coriell; ND11061
DR   Wikidata; Q54923719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11062
AC   CVCL_FC80
DR   CLO; CLO_0020290
DR   Coriell; ND11062
DR   Wikidata; Q54923720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11063
AC   CVCL_IL88
DR   CLO; CLO_0020291
DR   Coriell; ND11063
DR   Wikidata; Q54923722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND11063; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND11064
AC   CVCL_FC81
DR   CLO; CLO_0020282
DR   Coriell; ND11064
DR   Wikidata; Q54923723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11065
AC   CVCL_GE82
DR   CLO; CLO_0020283
DR   Coriell; ND11065
DR   Wikidata; Q54923724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11066
AC   CVCL_GE83
DR   CLO; CLO_0020280
DR   Coriell; ND11066
DR   Wikidata; Q54923725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11067
AC   CVCL_EW89
DR   CLO; CLO_0020281
DR   Coriell; ND11067
DR   Wikidata; Q54923726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11074
AC   CVCL_BF92
DR   CLO; CLO_0020286
DR   Coriell; ND11074
DR   Wikidata; Q54923727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11075
AC   CVCL_BF93
DR   CLO; CLO_0020266
DR   Coriell; ND11075
DR   Wikidata; Q54923728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11076
AC   CVCL_BF94
DR   CLO; CLO_0020267
DR   Coriell; ND11076
DR   Wikidata; Q54923729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11077
AC   CVCL_BF95
DR   CLO; CLO_0020268
DR   Coriell; ND11077
DR   Wikidata; Q54923730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11078
AC   CVCL_BF96
DR   CLO; CLO_0020269
DR   Coriell; ND11078
DR   Wikidata; Q54923731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11079
AC   CVCL_IL89
DR   CLO; CLO_0020270
DR   Coriell; ND11079
DR   Wikidata; Q54923732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND11079; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND11080
AC   CVCL_GE84
DR   CLO; CLO_0020271
DR   BioSample; SAMN00796710
DR   Coriell; ND11080
DR   Wikidata; Q54923733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11081
AC   CVCL_BF97
DR   CLO; CLO_0020259
DR   Coriell; ND11081
DR   Wikidata; Q54923735
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11082
AC   CVCL_GE85
DR   CLO; CLO_0020260
DR   Coriell; ND11082
DR   Wikidata; Q54923736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11083
AC   CVCL_GE86
DR   CLO; CLO_0020261
DR   BioSample; SAMN00796712
DR   Coriell; ND11083
DR   Wikidata; Q54923737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11084
AC   CVCL_BF98
DR   Coriell; ND11084
DR   Wikidata; Q54923738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11086
AC   CVCL_GE87
DR   CLO; CLO_0020262
DR   Coriell; ND11086
DR   Wikidata; Q54923739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11087
AC   CVCL_BF99
DR   Coriell; ND11087
DR   Wikidata; Q54923740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11088
AC   CVCL_GE88
DR   CLO; CLO_0020403
DR   BioSample; SAMN00796716
DR   Coriell; ND11088
DR   Wikidata; Q54923742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11089
AC   CVCL_FC82
DR   CLO; CLO_0020405
DR   BioSample; SAMN00796718
DR   Coriell; ND11089
DR   Wikidata; Q54923743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11090
AC   CVCL_FA79
DR   CLO; CLO_0020404
DR   Coriell; ND11090
DR   Wikidata; Q54923745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11091
AC   CVCL_FA80
DR   CLO; CLO_0020400
DR   Coriell; ND11091
DR   Wikidata; Q54923746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11092
AC   CVCL_BG00
DR   CLO; CLO_0020399
DR   Coriell; ND11092
DR   Wikidata; Q54923747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11093
AC   CVCL_IL90
DR   CLO; CLO_0020402
DR   Coriell; ND11093
DR   Wikidata; Q54923748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND11093; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND11094
AC   CVCL_BG01
DR   CLO; CLO_0020401
DR   Coriell; ND11094
DR   Wikidata; Q54923750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11095
AC   CVCL_IJ72
DR   CLO; CLO_0020407
DR   Coriell; ND11095
DR   Wikidata; Q54923751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11096
AC   CVCL_GE89
DR   CLO; CLO_0020406
DR   Coriell; ND11096
DR   Wikidata; Q54923752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11098
AC   CVCL_EB13
DR   Coriell; ND11098
DR   Wikidata; Q54923753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11099
AC   CVCL_CL67
DR   Coriell; ND11099
DR   Wikidata; Q54923754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11100
AC   CVCL_FZ42
DR   Coriell; ND11100
DR   Wikidata; Q54923755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11101
AC   CVCL_HR72
DR   CLO; CLO_0020408
DR   Coriell; ND11101
DR   Wikidata; Q54923756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11104
AC   CVCL_CL68
DR   CLO; CLO_0020396
DR   BioSample; SAMN00796724
DR   Coriell; ND11104
DR   Wikidata; Q54923762
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND11105
AC   CVCL_EW90
DR   CLO; CLO_0020395
DR   BioSample; SAMN00796726
DR   Coriell; ND11105
DR   Wikidata; Q54923763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11106
AC   CVCL_FB74
DR   CLO; CLO_0020394
DR   Coriell; ND11106
DR   Wikidata; Q54923764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11107
AC   CVCL_EW91
DR   CLO; CLO_0020393
DR   Coriell; ND11107
DR   Wikidata; Q54923765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11108
AC   CVCL_GE90
DR   CLO; CLO_0020392
DR   Coriell; ND11108
DR   Wikidata; Q54923766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11110
AC   CVCL_BG02
DR   Coriell; ND11110
DR   Wikidata; Q54923767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11111
AC   CVCL_BG03
DR   Coriell; ND11111
DR   Wikidata; Q54923768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11112
AC   CVCL_IE22
DR   Coriell; ND11112
DR   Wikidata; Q54923769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11113
AC   CVCL_FC83
DR   CLO; CLO_0020391
DR   Coriell; ND11113
DR   Wikidata; Q54923770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11114
AC   CVCL_GE91
DR   CLO; CLO_0020390
DR   Coriell; ND11114
DR   Wikidata; Q54923771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11123
AC   CVCL_FL59
DR   Coriell; ND11123
DR   Wikidata; Q54923772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y7M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11124
AC   CVCL_CL69
DR   Coriell; ND11124
DR   Wikidata; Q54923773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11125
AC   CVCL_CL70
DR   Coriell; ND11125
DR   Wikidata; Q54923774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11126
AC   CVCL_GE92
DR   CLO; CLO_0020389
DR   Coriell; ND11126
DR   Wikidata; Q54923775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11127
AC   CVCL_GE93
DR   CLO; CLO_0020398
DR   Coriell; ND11127
DR   Wikidata; Q54923776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11128
AC   CVCL_GE94
DR   CLO; CLO_0020397
DR   Coriell; ND11128
DR   Wikidata; Q54923777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11130
AC   CVCL_IE23
DR   CLO; CLO_0020379
DR   Coriell; ND11130
DR   Wikidata; Q54923778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11131
AC   CVCL_CL71
DR   CLO; CLO_0020381
DR   Coriell; ND11131
DR   Wikidata; Q54923779
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND11132
AC   CVCL_CL72
DR   CLO; CLO_0020380
DR   Coriell; ND11132
DR   Wikidata; Q54923780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11133
AC   CVCL_CL73
DR   CLO; CLO_0020383
DR   Coriell; ND11133
DR   Wikidata; Q54923781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11134
AC   CVCL_BG04
DR   CLO; CLO_0020382
DR   Coriell; ND11134
DR   Wikidata; Q54923782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11135
AC   CVCL_GE95
DR   CLO; CLO_0020385
DR   Coriell; ND11135
DR   Wikidata; Q54923784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11136
AC   CVCL_GE96
DR   CLO; CLO_0020384
DR   Coriell; ND11136
DR   Wikidata; Q54923785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11137
AC   CVCL_GE97
DR   CLO; CLO_0020387
DR   Coriell; ND11137
DR   Wikidata; Q54923787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11138
AC   CVCL_GE98
DR   CLO; CLO_0020386
DR   Coriell; ND11138
DR   Wikidata; Q54923788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11139
AC   CVCL_BG05
DR   CLO; CLO_0020388
DR   Coriell; ND11139
DR   Wikidata; Q54923789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11140
AC   CVCL_BG06
DR   CLO; CLO_0020369
DR   Coriell; ND11140
DR   Wikidata; Q54923790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11141
AC   CVCL_IE24
DR   Coriell; ND11141
DR   Wikidata; Q54923791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11142
AC   CVCL_BG07
DR   CLO; CLO_0020370
DR   Coriell; ND11142
DR   Wikidata; Q54923793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11143
AC   CVCL_GE99
DR   CLO; CLO_0020374
DR   BioSample; SAMN00796734
DR   Coriell; ND11143
DR   Wikidata; Q54923794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11144
AC   CVCL_EW92
DR   CLO; CLO_0020373
DR   BioSample; SAMN00796736
DR   Coriell; ND11144
DR   Wikidata; Q54923795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11145
AC   CVCL_IE25
DR   BioSample; SAMN00796737
DR   Coriell; ND11145
DR   Wikidata; Q54923796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND11146
AC   CVCL_IE26
DR   BioSample; SAMN00796739
DR   Coriell; ND11146
DR   Wikidata; Q54923797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND11147
AC   CVCL_BG08
DR   CLO; CLO_0020372
DR   Coriell; ND11147
DR   Wikidata; Q54923798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11148
AC   CVCL_BG09
DR   CLO; CLO_0020371
DR   Coriell; ND11148
DR   Wikidata; Q54923799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11149
AC   CVCL_BG10
DR   CLO; CLO_0020378
DR   Coriell; ND11149
DR   Wikidata; Q54923800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11150
AC   CVCL_BG11
DR   Coriell; ND11150
DR   Wikidata; Q54923801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11151
AC   CVCL_EW93
DR   CLO; CLO_0020377
DR   BioSample; SAMN00796744
DR   Coriell; ND11151
DR   Wikidata; Q54923802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11152
AC   CVCL_GF00
DR   CLO; CLO_0020376
DR   Coriell; ND11152
DR   Wikidata; Q54923803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11153
AC   CVCL_GF01
DR   CLO; CLO_0020375
DR   Coriell; ND11153
DR   Wikidata; Q54923804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11154
AC   CVCL_BG12
DR   CLO; CLO_0020359
DR   Coriell; ND11154
DR   Wikidata; Q54923820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11155
AC   CVCL_BG13
DR   CLO; CLO_0020361
DR   Coriell; ND11155
DR   Wikidata; Q54923821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11156
AC   CVCL_IJ73
DR   Coriell; ND11156
DR   Wikidata; Q54923822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11157
AC   CVCL_BG14
DR   CLO; CLO_0020360
DR   Coriell; ND11157
DR   Wikidata; Q54923824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11158
AC   CVCL_IJ74
DR   CLO; CLO_0020365
DR   Coriell; ND11158
DR   Wikidata; Q54923825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11159
AC   CVCL_FC84
DR   CLO; CLO_0020366
DR   Coriell; ND11159
DR   Wikidata; Q54923826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11160
AC   CVCL_BG15
DR   CLO; CLO_0020367
DR   Coriell; ND11160
DR   Wikidata; Q54923827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11162
AC   CVCL_IE27
DR   Coriell; ND11162
DR   Wikidata; Q54923828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11163
AC   CVCL_IE28
DR   Coriell; ND11163
DR   Wikidata; Q54923829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11164
AC   CVCL_GF02
DR   CLO; CLO_0020368
DR   Coriell; ND11164
DR   Wikidata; Q54923830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11165
AC   CVCL_IE29
DR   Coriell; ND11165
DR   Wikidata; Q54923831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11167
AC   CVCL_FC85
DR   CLO; CLO_0020362
DR   Coriell; ND11167
DR   Wikidata; Q54923832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11168
AC   CVCL_BG16
DR   CLO; CLO_0020363
DR   Coriell; ND11168
DR   Wikidata; Q54923833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11169
AC   CVCL_BG17
DR   CLO; CLO_0020364
DR   Coriell; ND11169
DR   Wikidata; Q54923835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11170
AC   CVCL_BG18
DR   Coriell; ND11170
DR   Wikidata; Q54923836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11171
AC   CVCL_FC86
DR   CLO; CLO_0020352
DR   BioSample; SAMN00796748
DR   Coriell; ND11171
DR   Wikidata; Q54923837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11172
AC   CVCL_GF03
DR   CLO; CLO_0020351
DR   Coriell; ND11172
DR   Wikidata; Q54923839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11173
AC   CVCL_GF04
DR   CLO; CLO_0020350
DR   Coriell; ND11173
DR   Wikidata; Q54923841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11174
AC   CVCL_GF05
DR   CLO; CLO_0020349
DR   Coriell; ND11174
DR   Wikidata; Q54923842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11175
AC   CVCL_GF06
DR   CLO; CLO_0020357
DR   Coriell; ND11175
DR   Wikidata; Q54923843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11176
AC   CVCL_FC87
DR   CLO; CLO_0020358
DR   Coriell; ND11176
DR   Wikidata; Q54923845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11177
AC   CVCL_GF07
DR   CLO; CLO_0020355
DR   Coriell; ND11177
DR   Wikidata; Q54923846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11178
AC   CVCL_GF08
DR   CLO; CLO_0020356
DR   Coriell; ND11178
DR   Wikidata; Q54923847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11179
AC   CVCL_GF09
DR   CLO; CLO_0020353
DR   Coriell; ND11179
DR   Wikidata; Q54923848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11181
AC   CVCL_GF10
DR   CLO; CLO_0020354
DR   Coriell; ND11181
DR   Wikidata; Q54923849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11182
AC   CVCL_GF11
DR   CLO; CLO_0020339
DR   Coriell; ND11182
DR   Wikidata; Q54923850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11183
AC   CVCL_GF12
DR   CLO; CLO_0020341
DR   Coriell; ND11183
DR   Wikidata; Q54923851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11184
AC   CVCL_GF13
DR   CLO; CLO_0020340
DR   Coriell; ND11184
DR   Wikidata; Q54923852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11185
AC   CVCL_GF14
DR   CLO; CLO_0020343
DR   Coriell; ND11185
DR   Wikidata; Q54923853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11186
AC   CVCL_GF15
DR   CLO; CLO_0020342
DR   Coriell; ND11186
DR   Wikidata; Q54923854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11187
AC   CVCL_GF16
DR   CLO; CLO_0020344
DR   Coriell; ND11187
DR   Wikidata; Q54923855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11189
AC   CVCL_GF17
DR   CLO; CLO_0020345
DR   Coriell; ND11189
DR   Wikidata; Q54923856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11190
AC   CVCL_GF18
DR   CLO; CLO_0020346
DR   Coriell; ND11190
DR   Wikidata; Q54923857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11191
AC   CVCL_EW94
DR   CLO; CLO_0020347
DR   Coriell; ND11191
DR   Wikidata; Q54923858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11192
AC   CVCL_GF19
DR   CLO; CLO_0020348
DR   Coriell; ND11192
DR   Wikidata; Q54923859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11193
AC   CVCL_GF20
DR   CLO; CLO_0020330
DR   Coriell; ND11193
DR   Wikidata; Q54923860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11194
AC   CVCL_GF21
DR   CLO; CLO_0020329
DR   Coriell; ND11194
DR   Wikidata; Q54923861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11195
AC   CVCL_GF22
DR   CLO; CLO_0020334
DR   Coriell; ND11195
DR   Wikidata; Q54923863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11196
AC   CVCL_EW95
DR   CLO; CLO_0020333
DR   Coriell; ND11196
DR   Wikidata; Q54923864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11197
AC   CVCL_FC88
DR   CLO; CLO_0020332
DR   Coriell; ND11197
DR   Wikidata; Q54923865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11198
AC   CVCL_IE30
DR   Coriell; ND11198
DR   Wikidata; Q54923872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11199
AC   CVCL_GF23
DR   CLO; CLO_0020331
DR   Coriell; ND11199
DR   Wikidata; Q54923873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11200
AC   CVCL_GF24
DR   CLO; CLO_0020337
DR   BioSample; SAMN00796749
DR   Coriell; ND11200
DR   Wikidata; Q54923874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11201
AC   CVCL_GF25
DR   CLO; CLO_0020338
DR   Coriell; ND11201
DR   Wikidata; Q54923875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11202
AC   CVCL_GF26
DR   CLO; CLO_0020335
DR   Coriell; ND11202
DR   Wikidata; Q54923876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11203
AC   CVCL_GF27
DR   CLO; CLO_0020336
DR   Coriell; ND11203
DR   Wikidata; Q54923877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11204
AC   CVCL_IE31
DR   Coriell; ND11204
DR   Wikidata; Q54923878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11205
AC   CVCL_IE32
DR   Coriell; ND11205
DR   Wikidata; Q54923879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11206
AC   CVCL_GF28
DR   CLO; CLO_0018922
DR   Coriell; ND11206
DR   Wikidata; Q54923880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11207
AC   CVCL_GF29
DR   CLO; CLO_0018921
DR   Coriell; ND11207
DR   Wikidata; Q54923882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11208
AC   CVCL_GF30
DR   CLO; CLO_0018918
DR   Coriell; ND11208
DR   Wikidata; Q54923883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11209
AC   CVCL_GF31
DR   CLO; CLO_0018916
DR   Coriell; ND11209
DR   Wikidata; Q54923884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11210
AC   CVCL_GF32
DR   CLO; CLO_0018932
DR   Coriell; ND11210
DR   Wikidata; Q54923885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11211
AC   CVCL_GF33
DR   CLO; CLO_0018931
DR   Coriell; ND11211
DR   Wikidata; Q54923886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11212
AC   CVCL_GF34
DR   CLO; CLO_0018930
DR   Coriell; ND11212
DR   Wikidata; Q54923887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11213
AC   CVCL_GF35
DR   CLO; CLO_0018929
DR   Coriell; ND11213
DR   Wikidata; Q54923888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11214
AC   CVCL_GF36
DR   CLO; CLO_0018928
DR   Coriell; ND11214
DR   Wikidata; Q54923889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11215
AC   CVCL_GF37
DR   CLO; CLO_0018927
DR   Coriell; ND11215
DR   Wikidata; Q54923890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11216
AC   CVCL_GF38
DR   CLO; CLO_0018958
DR   Coriell; ND11216
DR   Wikidata; Q54923891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11217
AC   CVCL_GF39
DR   CLO; CLO_0018949
DR   Coriell; ND11217
DR   Wikidata; Q54923892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11218
AC   CVCL_GF40
DR   CLO; CLO_0018947
DR   Coriell; ND11218
DR   Wikidata; Q54923893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11219
AC   CVCL_GF41
DR   CLO; CLO_0018956
DR   Coriell; ND11219
DR   Wikidata; Q54923894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11221
AC   CVCL_GF42
DR   CLO; CLO_0018952
DR   Coriell; ND11221
DR   Wikidata; Q54923896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11222
AC   CVCL_GF43
DR   CLO; CLO_0018961
DR   Coriell; ND11222
DR   Wikidata; Q54923897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11223
AC   CVCL_GF44
DR   CLO; CLO_0018960
DR   Coriell; ND11223
DR   Wikidata; Q54923898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11224
AC   CVCL_GF45
DR   CLO; CLO_0018963
DR   Coriell; ND11224
DR   Wikidata; Q54923899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11226
AC   CVCL_GF46
DR   CLO; CLO_0018962
DR   Coriell; ND11226
DR   Wikidata; Q54923900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11227
AC   CVCL_GF47
DR   CLO; CLO_0018959
DR   Coriell; ND11227
DR   Wikidata; Q54923901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11228
AC   CVCL_IE33
DR   Coriell; ND11228
DR   Wikidata; Q54923902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11229
AC   CVCL_GF48
DR   CLO; CLO_0018970
DR   Coriell; ND11229
DR   Wikidata; Q54923903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11230
AC   CVCL_IE34
DR   Coriell; ND11230
DR   Wikidata; Q54923904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11231
AC   CVCL_GF49
DR   CLO; CLO_0018969
DR   Coriell; ND11231
DR   Wikidata; Q54923905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11232
AC   CVCL_IE35
DR   Coriell; ND11232
DR   Wikidata; Q54923906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11233
AC   CVCL_GF50
DR   CLO; CLO_0018978
DR   Coriell; ND11233
DR   Wikidata; Q54923907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11234
AC   CVCL_FC89
DR   CLO; CLO_0018976
DR   Coriell; ND11234
DR   Wikidata; Q54923908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11235
AC   CVCL_GF51
DR   CLO; CLO_0018974
DR   Coriell; ND11235
DR   Wikidata; Q54923909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11236
AC   CVCL_FC90
DR   CLO; CLO_0018973
DR   Coriell; ND11236
DR   Wikidata; Q54923910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11237
AC   CVCL_GF52
DR   CLO; CLO_0018983
DR   Coriell; ND11237
DR   Wikidata; Q54923911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11238
AC   CVCL_GF53
DR   CLO; CLO_0018982
DR   Coriell; ND11238
DR   Wikidata; Q54923912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11239
AC   CVCL_GF54
DR   CLO; CLO_0018981
DR   Coriell; ND11239
DR   Wikidata; Q54923913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11240
AC   CVCL_GF55
DR   CLO; CLO_0018980
DR   Coriell; ND11240
DR   Wikidata; Q54923917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11241
AC   CVCL_GF56
DR   CLO; CLO_0018988
DR   Coriell; ND11241
DR   Wikidata; Q54923918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11242
AC   CVCL_GF57
DR   CLO; CLO_0018990
DR   Coriell; ND11242
DR   Wikidata; Q54923919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11245
AC   CVCL_GF58
DR   CLO; CLO_0018989
DR   Coriell; ND11245
DR   Wikidata; Q54923920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11246
AC   CVCL_GF59
DR   CLO; CLO_0018992
DR   Coriell; ND11246
DR   Wikidata; Q54923921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11247
AC   CVCL_IE36
DR   Coriell; ND11247
DR   Wikidata; Q54923922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11248
AC   CVCL_GF60
DR   CLO; CLO_0018991
DR   Coriell; ND11248
DR   Wikidata; Q54923923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11249
AC   CVCL_FC91
DR   CLO; CLO_0018994
DR   Coriell; ND11249
DR   Wikidata; Q54923924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11250
AC   CVCL_GF61
DR   CLO; CLO_0018993
DR   Coriell; ND11250
DR   Wikidata; Q54923925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11251
AC   CVCL_BG19
DR   CLO; CLO_0018996
DR   Coriell; ND11251
DR   Wikidata; Q54923926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11252
AC   CVCL_BG20
DR   CLO; CLO_0018995
DR   Coriell; ND11252
DR   Wikidata; Q54923927
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11253
AC   CVCL_BG21
DR   CLO; CLO_0018997
DR   Coriell; ND11253
DR   Wikidata; Q54923928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11254
AC   CVCL_BG22
DR   CLO; CLO_0018517
DR   Coriell; ND11254
DR   Wikidata; Q54923929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11255
AC   CVCL_GF62
DR   CLO; CLO_0018520
DR   BioSample; SAMN00796753
DR   Coriell; ND11255
DR   Wikidata; Q54923930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11256
AC   CVCL_EB14
DR   Coriell; ND11256
DR   Wikidata; Q54923931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11257
AC   CVCL_CL74
DR   Coriell; ND11257
DR   Wikidata; Q54923932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11258
AC   CVCL_BG23
DR   CLO; CLO_0018523
DR   Coriell; ND11258
DR   Wikidata; Q54923933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11259
AC   CVCL_GF63
DR   CLO; CLO_0018524
DR   Coriell; ND11259
DR   Wikidata; Q54923935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11260
AC   CVCL_FA81
DR   CLO; CLO_0018505
DR   Coriell; ND11260
DR   Wikidata; Q54923936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11261
AC   CVCL_BG24
DR   CLO; CLO_0018507
DR   Coriell; ND11261
DR   Wikidata; Q54923937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11262
AC   CVCL_GF64
DR   CLO; CLO_0018509
DR   Coriell; ND11262
DR   Wikidata; Q54923938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11263
AC   CVCL_EW96
DR   CLO; CLO_0018516
DR   Coriell; ND11263
DR   Wikidata; Q54923940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11264
AC   CVCL_EW97
DR   CLO; CLO_0018502
DR   Coriell; ND11264
DR   Wikidata; Q54923941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11265
AC   CVCL_DE92
DR   CLO; CLO_0018503
DR   Coriell; ND11265
DR   Wikidata; Q54923942
RX   PubMed=17622782;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Unexplicit; IVS20+4delGTAA; Zygosity=Heterozygous; Note=Splicing mutation (PubMed=17622782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   ND11266
AC   CVCL_FC92
DR   CLO; CLO_0018574
DR   Coriell; ND11266
DR   Wikidata; Q54923943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11267
AC   CVCL_GU01
DR   CLO; CLO_0018569
DR   Coriell; ND11267
DR   Wikidata; Q54923944
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (Coriell=ND11267).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND11268
AC   CVCL_HR73
DR   CLO; CLO_0018572
DR   Coriell; ND11268
DR   Wikidata; Q54923945
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (Coriell=ND11268).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   ND11269
AC   CVCL_HR74
DR   CLO; CLO_0018565
DR   Coriell; ND11269
DR   Wikidata; Q54923946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11277
AC   CVCL_CL75
DR   BioSample; SAMN00796764
DR   Coriell; ND11277
DR   Wikidata; Q54923947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND11278
AC   CVCL_FL60
DR   Coriell; ND11278
DR   Wikidata; Q54923948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11281
AC   CVCL_BG25
DR   CLO; CLO_0018567
DR   Coriell; ND11281
DR   Wikidata; Q54923949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11282
AC   CVCL_GF65
DR   CLO; CLO_0018561
DR   Coriell; ND11282
DR   Wikidata; Q54923950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11283
AC   CVCL_BG26
DR   CLO; CLO_0018564
DR   Coriell; ND11283
DR   Wikidata; Q54923951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11284
AC   CVCL_IJ75
DR   CLO; CLO_0018554
DR   Coriell; ND11284
DR   Wikidata; Q54923952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11285
AC   CVCL_BG27
DR   CLO; CLO_0018560
DR   Coriell; ND11285
DR   Wikidata; Q54923953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11286
AC   CVCL_BG28
DR   CLO; CLO_0018553
DR   Coriell; ND11286
DR   Wikidata; Q54923954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11287
AC   CVCL_BG29
DR   CLO; CLO_0018625
DR   Coriell; ND11287
DR   Wikidata; Q54923955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11289
AC   CVCL_EW98
DR   CLO; CLO_0018624
DR   BioSample; SAMN00796770
DR   Coriell; ND11289
DR   Wikidata; Q54923957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11290
AC   CVCL_GF66
DR   CLO; CLO_0018595
DR   Coriell; ND11290
DR   Wikidata; Q54923958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11291
AC   CVCL_FC93
DR   CLO; CLO_0018597
DR   Coriell; ND11291
DR   Wikidata; Q54923959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11292
AC   CVCL_GF67
DR   CLO; CLO_0018600
DR   Coriell; ND11292
DR   Wikidata; Q54923964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11293
AC   CVCL_FC94
DR   CLO; CLO_0018602
DR   Coriell; ND11293
DR   Wikidata; Q54923965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11294
AC   CVCL_BG30
DR   CLO; CLO_0018604
DR   Coriell; ND11294
DR   Wikidata; Q54923966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11295
AC   CVCL_BG31
DR   CLO; CLO_0018606
DR   Coriell; ND11295
DR   Wikidata; Q54923967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11296
AC   CVCL_IJ76
DR   CLO; CLO_0018608
DR   Coriell; ND11296
DR   Wikidata; Q54923968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11297
AC   CVCL_BG32
DR   CLO; CLO_0018611
DR   Coriell; ND11297
DR   Wikidata; Q54923970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11298
AC   CVCL_EW99
DR   CLO; CLO_0018666
DR   Coriell; ND11298
DR   Wikidata; Q54923971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11300
AC   CVCL_GF68
DR   CLO; CLO_0018665
DR   BioSample; SAMN00796772
DR   Coriell; ND11300
DR   Wikidata; Q54923972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11303
AC   CVCL_EB15
DR   Coriell; ND11303
DR   Wikidata; Q54923974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11312
AC   CVCL_HV69
DR   Coriell; ND11312
DR   Wikidata; Q54923975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11315
AC   CVCL_HV70
DR   Coriell; ND11315
DR   Wikidata; Q54923977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11316
AC   CVCL_GF69
DR   CLO; CLO_0018661
DR   Coriell; ND11316
DR   Wikidata; Q54923978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11317
AC   CVCL_FC95
DR   CLO; CLO_0018642
DR   Coriell; ND11317
DR   Wikidata; Q54923979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11318
AC   CVCL_BG33
DR   CLO; CLO_0018644
DR   Coriell; ND11318
DR   Wikidata; Q54923980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11319
AC   CVCL_BG34
DR   CLO; CLO_0018637
DR   Coriell; ND11319
DR   Wikidata; Q54923981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11320
AC   CVCL_BG35
DR   CLO; CLO_0018639
DR   Coriell; ND11320
DR   Wikidata; Q54923982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11321
AC   CVCL_BG36
DR   Coriell; ND11321
DR   Wikidata; Q54923983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11322
AC   CVCL_EX00
DR   CLO; CLO_0018649
DR   BioSample; SAMN00796778
DR   Coriell; ND11322
DR   Wikidata; Q54923984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11323
AC   CVCL_IJ77
DR   CLO; CLO_0018651
DR   Coriell; ND11323
DR   Wikidata; Q54923985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11324
AC   CVCL_BG37
DR   CLO; CLO_0018647
DR   Coriell; ND11324
DR   Wikidata; Q54923986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11325
AC   CVCL_GF70
DR   CLO; CLO_0018700
DR   BioSample; SAMN00796780
DR   Coriell; ND11325
DR   Wikidata; Q54923987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11326
AC   CVCL_FC96
DR   CLO; CLO_0018702
DR   BioSample; SAMN00796782
DR   Coriell; ND11326
DR   Wikidata; Q54923988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11327
AC   CVCL_GF71
DR   CLO; CLO_0018707
DR   Coriell; ND11327
DR   Wikidata; Q54923989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11328
AC   CVCL_GF72
DR   CLO; CLO_0018710
DR   Coriell; ND11328
DR   Wikidata; Q54923990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11329
AC   CVCL_GF73
DR   CLO; CLO_0018676
DR   Coriell; ND11329
DR   Wikidata; Q54923991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11330
AC   CVCL_GF74
DR   CLO; CLO_0018675
DR   Coriell; ND11330
DR   Wikidata; Q54923992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11331
AC   CVCL_GF75
DR   CLO; CLO_0018681
DR   Coriell; ND11331
DR   Wikidata; Q54923993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11332
AC   CVCL_GF76
DR   CLO; CLO_0018679
DR   Coriell; ND11332
DR   Wikidata; Q54923994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11333
AC   CVCL_GF77
DR   CLO; CLO_0018674
DR   Coriell; ND11333
DR   Wikidata; Q54923995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11334
AC   CVCL_GF78
DR   CLO; CLO_0018673
DR   Coriell; ND11334
DR   Wikidata; Q54923996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11335
AC   CVCL_GF79
DR   CLO; CLO_0018742
DR   Coriell; ND11335
DR   Wikidata; Q54923997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11337
AC   CVCL_IJ78
DR   CLO; CLO_0018737
DR   Coriell; ND11337
DR   Wikidata; Q54923998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11338
AC   CVCL_GF80
DR   CLO; CLO_0018738
DR   Coriell; ND11338
DR   Wikidata; Q54923999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11340
AC   CVCL_GF81
DR   CLO; CLO_0018732
DR   BioSample; SAMN00796784
DR   Coriell; ND11340
DR   Wikidata; Q54924000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11342
AC   CVCL_EB16
DR   Coriell; ND11342
DR   Wikidata; Q54924001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11343
AC   CVCL_BG38
DR   CLO; CLO_0018734
DR   Coriell; ND11343
DR   Wikidata; Q54924002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11344
AC   CVCL_GF82
DR   CLO; CLO_0018719
DR   Coriell; ND11344
DR   Wikidata; Q54924003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11345
AC   CVCL_EB17
DR   Coriell; ND11345
DR   Wikidata; Q54924004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11346
AC   CVCL_CL76
DR   Coriell; ND11346
DR   Wikidata; Q54924005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11347
AC   CVCL_CL77
DR   Coriell; ND11347
DR   Wikidata; Q54924006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11348
AC   CVCL_CL78
DR   Coriell; ND11348
DR   Wikidata; Q54924011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11350
AC   CVCL_EB18
DR   Coriell; ND11350
DR   Wikidata; Q54924012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11351
AC   CVCL_EB19
DR   Coriell; ND11351
DR   Wikidata; Q54924013
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND11355
AC   CVCL_FC97
DR   CLO; CLO_0018718
DR   Coriell; ND11355
DR   Wikidata; Q54924014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11356
AC   CVCL_BG39
DR   CLO; CLO_0018717
DR   Coriell; ND11356
DR   Wikidata; Q54924015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11357
AC   CVCL_GF83
DR   CLO; CLO_0018714
DR   BioSample; SAMN00796788
DR   Coriell; ND11357
DR   Wikidata; Q54924016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11358
AC   CVCL_GF84
DR   CLO; CLO_0018713
DR   Coriell; ND11358
DR   Wikidata; Q54924017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11369
AC   CVCL_BG40
DR   CLO; CLO_0019466
DR   Coriell; ND11369
DR   Wikidata; Q54924018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11370
AC   CVCL_BG41
DR   CLO; CLO_0019464
DR   Coriell; ND11370
DR   Wikidata; Q54924019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11371
AC   CVCL_BG42
DR   CLO; CLO_0019465
DR   Coriell; ND11371
DR   Wikidata; Q54924020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11372
AC   CVCL_FC98
DR   CLO; CLO_0019469
DR   BioSample; SAMN00796792
DR   Coriell; ND11372
DR   Wikidata; Q54924021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11373
AC   CVCL_EX01
DR   CLO; CLO_0019470
DR   BioSample; SAMN00796794
DR   Coriell; ND11373
DR   Wikidata; Q54924022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11374
AC   CVCL_BG43
DR   CLO; CLO_0019467
DR   Coriell; ND11374
DR   Wikidata; Q54924023
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11375
AC   CVCL_BG44
DR   CLO; CLO_0019468
DR   Coriell; ND11375
DR   Wikidata; Q54924024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11377
AC   CVCL_BG45
DR   CLO; CLO_0019472
DR   Coriell; ND11377
DR   Wikidata; Q54924025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11378
AC   CVCL_BG46
DR   CLO; CLO_0019473
DR   Coriell; ND11378
DR   Wikidata; Q54924026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11379
AC   CVCL_FC99
DR   CLO; CLO_0019471
DR   BioSample; SAMN00796796
DR   Coriell; ND11379
DR   Wikidata; Q54924027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11380
AC   CVCL_BG47
DR   CLO; CLO_0019483
DR   Coriell; ND11380
DR   Wikidata; Q54924028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11381
AC   CVCL_GF85
DR   CLO; CLO_0019485
DR   Coriell; ND11381
DR   Wikidata; Q54924029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11382
AC   CVCL_BG48
DR   CLO; CLO_0019486
DR   Coriell; ND11382
DR   Wikidata; Q54924030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11383
AC   CVCL_EX02
DR   CLO; CLO_0019487
DR   Coriell; ND11383
DR   Wikidata; Q54924031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11385
AC   CVCL_BG49
DR   CLO; CLO_0019488
DR   Coriell; ND11385
DR   Wikidata; Q54924033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11386
AC   CVCL_BG50
DR   CLO; CLO_0019489
DR   Coriell; ND11386
DR   Wikidata; Q54924034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11388
AC   CVCL_GF86
DR   CLO; CLO_0019490
DR   BioSample; SAMN00796800
DR   Coriell; ND11388
DR   Wikidata; Q54924035
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND11389
AC   CVCL_BG51
DR   CLO; CLO_0019491
DR   Coriell; ND11389
DR   Wikidata; Q54924036
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11390
AC   CVCL_GF87
DR   CLO; CLO_0019492
DR   BioSample; SAMN00796804
DR   Coriell; ND11390
DR   Wikidata; Q54924037
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND11391
AC   CVCL_CL79
DR   Coriell; ND11391
DR   Wikidata; Q54924038
CC   Population: Caucasian; Greek.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND11392
AC   CVCL_CL80
DR   Coriell; ND11392
DR   Wikidata; Q54924039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11393
AC   CVCL_CL81
DR   Coriell; ND11393
DR   Wikidata; Q54924040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11394
AC   CVCL_CL82
DR   Coriell; ND11394
DR   Wikidata; Q54924041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11402
AC   CVCL_HV71
DR   Coriell; ND11402
DR   Wikidata; Q54924042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11404
AC   CVCL_HV72
DR   Coriell; ND11404
DR   Wikidata; Q54924043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11405
AC   CVCL_HV73
DR   Coriell; ND11405
DR   Wikidata; Q54924044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11407
AC   CVCL_BG52
DR   CLO; CLO_0019493
DR   Coriell; ND11407
DR   Wikidata; Q54924045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11409
AC   CVCL_EX03
DR   CLO; CLO_0019619
DR   BioSample; SAMN00796810
DR   Coriell; ND11409
DR   Wikidata; Q54924046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11410
AC   CVCL_BG53
DR   CLO; CLO_0019616
DR   Coriell; ND11410
DR   Wikidata; Q54924047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11411
AC   CVCL_BG54
DR   CLO; CLO_0019614
DR   Coriell; ND11411
DR   Wikidata; Q54924048
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11412
AC   CVCL_GF88
DR   CLO; CLO_0019611
DR   BioSample; SAMN00796814
DR   Coriell; ND11412
DR   Wikidata; Q54924050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11413
AC   CVCL_GF89
DR   CLO; CLO_0019609
DR   Coriell; ND11413
DR   Wikidata; Q54924051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11414
AC   CVCL_GF90
DR   CLO; CLO_0019607
DR   Coriell; ND11414
DR   Wikidata; Q54924052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11415
AC   CVCL_EX04
DR   CLO; CLO_0019606
DR   Coriell; ND11415
DR   Wikidata; Q54924059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11416
AC   CVCL_EX05
DR   CLO; CLO_0019605
DR   Coriell; ND11416
DR   Wikidata; Q54924061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11417
AC   CVCL_FD00
DR   CLO; CLO_0019604
DR   Coriell; ND11417
DR   Wikidata; Q54924062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11418
AC   CVCL_GF91
DR   CLO; CLO_0019603
DR   Coriell; ND11418
DR   Wikidata; Q54924063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11419
AC   CVCL_GF92
DR   CLO; CLO_0019650
DR   Coriell; ND11419
DR   Wikidata; Q54924064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11420
AC   CVCL_GF93
DR   CLO; CLO_0019649
DR   Coriell; ND11420
DR   Wikidata; Q54924065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11422
AC   CVCL_FA82
DR   CLO; CLO_0019642
DR   Coriell; ND11422
DR   Wikidata; Q54924066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11423
AC   CVCL_FA83
DR   CLO; CLO_0019639
DR   Coriell; ND11423
DR   Wikidata; Q54924067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11424
AC   CVCL_GF94
DR   CLO; CLO_0019647
DR   Coriell; ND11424
DR   Wikidata; Q54924068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11425
AC   CVCL_IE37
DR   Coriell; ND11425
DR   Wikidata; Q54924069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11426
AC   CVCL_GF95
DR   CLO; CLO_0019646
DR   Coriell; ND11426
DR   Wikidata; Q54924070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11427
AC   CVCL_FD01
DR   CLO; CLO_0019635
DR   Coriell; ND11427
DR   Wikidata; Q54924071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11428
AC   CVCL_GF96
DR   CLO; CLO_0019634
DR   Coriell; ND11428
DR   Wikidata; Q54924072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11429
AC   CVCL_BG55
DR   CLO; CLO_0019637
DR   Coriell; ND11429
DR   Wikidata; Q54924073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11430
AC   CVCL_GF97
DR   CLO; CLO_0019636
DR   BioSample; SAMN00796818
DR   Coriell; ND11430
DR   Wikidata; Q54924074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11431
AC   CVCL_GF98
DR   CLO; CLO_0019544
DR   Coriell; ND11431
DR   Wikidata; Q54924075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11432
AC   CVCL_GF99
DR   CLO; CLO_0019542
DR   Coriell; ND11432
DR   Wikidata; Q54924076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11433
AC   CVCL_BG56
DR   CLO; CLO_0019541
DR   Coriell; ND11433
DR   Wikidata; Q54924077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11434
AC   CVCL_IJ79
DR   CLO; CLO_0019555
DR   Coriell; ND11434
DR   Wikidata; Q54924078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11435
AC   CVCL_BG57
DR   CLO; CLO_0019553
DR   Coriell; ND11435
DR   Wikidata; Q54924079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11436
AC   CVCL_BG58
DR   CLO; CLO_0019550
DR   Coriell; ND11436
DR   Wikidata; Q54924081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11437
AC   CVCL_BG59
DR   CLO; CLO_0019548
DR   Coriell; ND11437
DR   Wikidata; Q54924082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11438
AC   CVCL_BG60
DR   CLO; CLO_0019539
DR   Coriell; ND11438
DR   Wikidata; Q54924083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11439
AC   CVCL_BG61
DR   CLO; CLO_0019538
DR   Coriell; ND11439
DR   Wikidata; Q54924084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11440
AC   CVCL_BG62
DR   CLO; CLO_0019537
DR   Coriell; ND11440
DR   Wikidata; Q54924085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11442
AC   CVCL_EX06
DR   CLO; CLO_0019572
DR   BioSample; SAMN00796820
DR   Coriell; ND11442
DR   Wikidata; Q54924086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11443
AC   CVCL_GG00
DR   CLO; CLO_0019570
DR   Coriell; ND11443
DR   Wikidata; Q54924087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11444
AC   CVCL_BG63
DR   CLO; CLO_0019576
DR   Coriell; ND11444
DR   Wikidata; Q54924088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11445
AC   CVCL_BG64
DR   CLO; CLO_0019574
DR   Coriell; ND11445
DR   Wikidata; Q54924089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11446
AC   CVCL_FA84
DR   CLO; CLO_0019582
DR   Coriell; ND11446
DR   Wikidata; Q54924090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11447
AC   CVCL_BG65
DR   CLO; CLO_0019577
DR   Coriell; ND11447
DR   Wikidata; Q54924091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11448
AC   CVCL_BG66
DR   CLO; CLO_0019586
DR   Coriell; ND11448
DR   Wikidata; Q54924092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11449
AC   CVCL_BG67
DR   Coriell; ND11449
DR   Wikidata; Q54924093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11450
AC   CVCL_GG01
DR   CLO; CLO_0019584
DR   Coriell; ND11450
DR   Wikidata; Q54924094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11451
AC   CVCL_BG68
DR   CLO; CLO_0019569
DR   Coriell; ND11451
DR   Wikidata; Q54924095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11452
AC   CVCL_GG02
DR   CLO; CLO_0019568
DR   BioSample; SAMN00796826
DR   Coriell; ND11452
DR   Wikidata; Q54924096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11453
AC   CVCL_BG69
DR   CLO; CLO_0019327
DR   Coriell; ND11453
DR   Wikidata; Q54924097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11455
AC   CVCL_GG03
DR   CLO; CLO_0019312
DR   Coriell; ND11455
DR   Wikidata; Q54924098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11456
AC   CVCL_GG04
DR   CLO; CLO_0019313
DR   Coriell; ND11456
DR   Wikidata; Q54924099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11457
AC   CVCL_BG70
DR   CLO; CLO_0019315
DR   Coriell; ND11457
DR   Wikidata; Q54924100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11458
AC   CVCL_GG05
DR   CLO; CLO_0019316
DR   Coriell; ND11458
DR   Wikidata; Q54924105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11459
AC   CVCL_BG71
DR   CLO; CLO_0019301
DR   Coriell; ND11459
DR   Wikidata; Q54924106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11460
AC   CVCL_BG72
DR   CLO; CLO_0019304
DR   Coriell; ND11460
DR   Wikidata; Q54924108
RX   PubMed=22572540;
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Unexplicit; IVS12+9T>C; Zygosity=Heterozygous; Note=VUS (PubMed=22572540).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   ND11461
AC   CVCL_BG73
DR   CLO; CLO_0019305
DR   Coriell; ND11461
DR   Wikidata; Q54924109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11462
AC   CVCL_GG06
DR   CLO; CLO_0019309
DR   Coriell; ND11462
DR   Wikidata; Q54924110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11463
AC   CVCL_FD02
DR   CLO; CLO_0019317
DR   Coriell; ND11463
DR   Wikidata; Q54924111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11464
AC   CVCL_BG74
DR   CLO; CLO_0019361
DR   Coriell; ND11464
DR   Wikidata; Q54924112
RX   PubMed=34468209;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11465
AC   CVCL_BG75
DR   CLO; CLO_0019357
DR   Coriell; ND11465
DR   Wikidata; Q54924114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11466
AC   CVCL_EB20
DR   Coriell; ND11466
DR   Wikidata; Q54924115
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND11467
AC   CVCL_CL83
DR   Coriell; ND11467
DR   Wikidata; Q54924116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11468
AC   CVCL_CL84
DR   Coriell; ND11468
DR   Wikidata; Q54924117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11469
AC   CVCL_CL85
DR   Coriell; ND11469
DR   Wikidata; Q54924118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11474
AC   CVCL_IH43
DR   CLO; CLO_0019351
DR   Coriell; ND11474
DR   Wikidata; Q54924119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11475
AC   CVCL_HV74
DR   CLO; CLO_0019352
DR   Coriell; ND11475
DR   Wikidata; Q54924120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11476
AC   CVCL_FZ43
DR   CLO; CLO_0019349
DR   Coriell; ND11476
DR   Wikidata; Q54924121
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11477
AC   CVCL_IH44
DR   CLO; CLO_0019350
DR   Coriell; ND11477
DR   Wikidata; Q54924122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11478
AC   CVCL_FZ44
DR   CLO; CLO_0019347
DR   Coriell; ND11478
DR   Wikidata; Q54924123
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11479
AC   CVCL_BG76
DR   CLO; CLO_0019348
DR   Coriell; ND11479
DR   Wikidata; Q54924124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11480
AC   CVCL_BG77
DR   CLO; CLO_0019344
DR   Coriell; ND11480
DR   Wikidata; Q54924125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11481
AC   CVCL_BG78
DR   CLO; CLO_0019345
DR   Coriell; ND11481
DR   Wikidata; Q54924126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11482
AC   CVCL_FD03
DR   CLO; CLO_0019260
DR   BioSample; SAMN00796830
DR   Coriell; ND11482
DR   Wikidata; Q54924127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11483
AC   CVCL_FD04
DR   CLO; CLO_0019267
DR   BioSample; SAMN00796832
DR   Coriell; ND11483
DR   Wikidata; Q54924128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11484
AC   CVCL_BG79
DR   CLO; CLO_0019264
DR   Coriell; ND11484
DR   Wikidata; Q54924129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11485
AC   CVCL_FA85
DR   CLO; CLO_0019239
DR   Coriell; ND11485
DR   Wikidata; Q54924130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11487
AC   CVCL_EB21
DR   CLO; CLO_0019240
DR   Coriell; ND11487
DR   Wikidata; Q54924131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11488
AC   CVCL_FB75
DR   CLO; CLO_0019241
DR   Coriell; ND11488
DR   Wikidata; Q54924132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11492
AC   CVCL_CL86
DR   Coriell; ND11492
DR   Wikidata; Q54924133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11494
AC   CVCL_BG80
DR   CLO; CLO_0019242
DR   Coriell; ND11494
DR   Wikidata; Q54924134
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11495
AC   CVCL_FA86
DR   CLO; CLO_0019243
DR   Coriell; ND11495
DR   Wikidata; Q54924135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11496
AC   CVCL_BG81
DR   CLO; CLO_0019245
DR   Coriell; ND11496
DR   Wikidata; Q54924136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11497
AC   CVCL_BG82
DR   CLO; CLO_0019246
DR   Coriell; ND11497
DR   Wikidata; Q54924137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11498
AC   CVCL_BG83
DR   CLO; CLO_0019299
DR   Coriell; ND11498
DR   Wikidata; Q54924138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11499
AC   CVCL_BG84
DR   CLO; CLO_0019296
DR   Coriell; ND11499
DR   Wikidata; Q54924139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11500
AC   CVCL_EX07
DR   CLO; CLO_0019294
DR   Coriell; ND11500
DR   Wikidata; Q54924140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11501
AC   CVCL_GG07
DR   CLO; CLO_0019290
DR   Coriell; ND11501
DR   Wikidata; Q54924141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11502
AC   CVCL_EX08
DR   CLO; CLO_0019272
DR   Coriell; ND11502
DR   Wikidata; Q54924142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11503
AC   CVCL_FD05
DR   CLO; CLO_0019273
DR   Coriell; ND11503
DR   Wikidata; Q54924144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11504
AC   CVCL_GG08
DR   CLO; CLO_0019270
DR   Coriell; ND11504
DR   Wikidata; Q54924145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11505
AC   CVCL_BG85
DR   CLO; CLO_0019271
DR   Coriell; ND11505
DR   Wikidata; Q54924146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11506
AC   CVCL_BG86
DR   CLO; CLO_0019276
DR   Coriell; ND11506
DR   Wikidata; Q54924147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11507
AC   CVCL_BG87
DR   CLO; CLO_0019277
DR   Coriell; ND11507
DR   Wikidata; Q54924150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11508
AC   CVCL_GG09
DR   CLO; CLO_0017658
DR   BioSample; SAMN00796836
DR   Coriell; ND11508
DR   Wikidata; Q54924151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11509
AC   CVCL_EX09
DR   CLO; CLO_0017659
DR   Coriell; ND11509
DR   Wikidata; Q54924152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11510
AC   CVCL_BG88
DR   CLO; CLO_0017656
DR   Coriell; ND11510
DR   Wikidata; Q54924153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11511
AC   CVCL_BG89
DR   CLO; CLO_0017657
DR   Coriell; ND11511
DR   Wikidata; Q54924154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11512
AC   CVCL_BG90
DR   CLO; CLO_0017654
DR   Coriell; ND11512
DR   Wikidata; Q54924155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11513
AC   CVCL_BG91
DR   CLO; CLO_0017655
DR   Coriell; ND11513
DR   Wikidata; Q54924156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11514
AC   CVCL_BG92
DR   CLO; CLO_0017652
DR   Coriell; ND11514
DR   Wikidata; Q54924157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11515
AC   CVCL_EX10
DR   CLO; CLO_0017653
DR   BioSample; SAMN00796840
DR   Coriell; ND11515
DR   Wikidata; Q54924158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11516
AC   CVCL_FA87
DR   CLO; CLO_0017650
DR   Coriell; ND11516
DR   Wikidata; Q54924159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11517
AC   CVCL_BG93
DR   CLO; CLO_0017651
DR   Coriell; ND11517
DR   Wikidata; Q54924160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11518
AC   CVCL_EX11
DR   CLO; CLO_0017667
DR   BioSample; SAMN00796846
DR   Coriell; ND11518
DR   Wikidata; Q54924161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11519
AC   CVCL_EX12
DR   CLO; CLO_0017668
DR   BioSample; SAMN00796848
DR   Coriell; ND11519
DR   Wikidata; Q54924162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11521
AC   CVCL_CL87
DR   Coriell; ND11521
DR   Wikidata; Q54924163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11522
AC   CVCL_HV75
DR   Coriell; ND11522
DR   Wikidata; Q54924164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11523
AC   CVCL_HV76
DR   Coriell; ND11523
DR   Wikidata; Q54924165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11524
AC   CVCL_BG94
DR   CLO; CLO_0017669
DR   Coriell; ND11524
DR   Wikidata; Q54924166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11525
AC   CVCL_GG10
DR   CLO; CLO_0017663
DR   BioSample; SAMN00796856
DR   Coriell; ND11525
DR   Wikidata; Q54924167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11526
AC   CVCL_BG95
DR   Coriell; ND11526
DR   Wikidata; Q54924168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11527
AC   CVCL_IE38
DR   BioSample; SAMN00796860
DR   Coriell; ND11527
DR   Wikidata; Q54924169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND11528
AC   CVCL_BG96
DR   Coriell; ND11528
DR   Wikidata; Q54924170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11529
AC   CVCL_IE39
DR   BioSample; SAMN00796864
DR   Coriell; ND11529
DR   Wikidata; Q54924171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND11530
AC   CVCL_BG97
DR   CLO; CLO_0017664
DR   Coriell; ND11530
DR   Wikidata; Q54924172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11531
AC   CVCL_EX13
DR   CLO; CLO_0017665
DR   BioSample; SAMN00796868
DR   Coriell; ND11531
DR   Wikidata; Q54924173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11533
AC   CVCL_BG98
DR   CLO; CLO_0017666
DR   Coriell; ND11533
DR   Wikidata; Q54924174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11534
AC   CVCL_EX14
DR   CLO; CLO_0017660
DR   Coriell; ND11534
DR   Wikidata; Q54924175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11535
AC   CVCL_GG11
DR   CLO; CLO_0017661
DR   Coriell; ND11535
DR   Wikidata; Q54924176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11536
AC   CVCL_BG99
DR   CLO; CLO_0017662
DR   Coriell; ND11536
DR   Wikidata; Q54924177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11537
AC   CVCL_GG12
DR   CLO; CLO_0017678
DR   BioSample; SAMN00796874
DR   Coriell; ND11537
DR   Wikidata; Q54924178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11538
AC   CVCL_EX15
DR   CLO; CLO_0017679
DR   Coriell; ND11538
DR   Wikidata; Q54924179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11539
AC   CVCL_BH00
DR   CLO; CLO_0017676
DR   Coriell; ND11539
DR   Wikidata; Q54924180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11540
AC   CVCL_EX16
DR   CLO; CLO_0017677
DR   BioSample; SAMN00796878
DR   Coriell; ND11540
DR   Wikidata; Q54924181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11541
AC   CVCL_BH01
DR   CLO; CLO_0017672
DR   Coriell; ND11541
DR   Wikidata; Q54924182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11542
AC   CVCL_BH02
DR   CLO; CLO_0017673
DR   Coriell; ND11542
DR   Wikidata; Q54924183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11543
AC   CVCL_BH03
DR   CLO; CLO_0017670
DR   Coriell; ND11543
DR   Wikidata; Q54924184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11546
AC   CVCL_GG13
DR   CLO; CLO_0017671
DR   Coriell; ND11546
DR   Wikidata; Q54924185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11547
AC   CVCL_GG14
DR   CLO; CLO_0017674
DR   Coriell; ND11547
DR   Wikidata; Q54924186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11548
AC   CVCL_BH04
DR   CLO; CLO_0017675
DR   Coriell; ND11548
DR   Wikidata; Q54924187
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11549
AC   CVCL_EX17
DR   CLO; CLO_0017685
DR   BioSample; SAMN00796884
DR   Coriell; ND11549
DR   Wikidata; Q54924189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11550
AC   CVCL_GG15
DR   CLO; CLO_0017686
DR   Coriell; ND11550
DR   Wikidata; Q54924190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11551
AC   CVCL_GG16
DR   CLO; CLO_0017687
DR   BioSample; SAMN00796886
DR   Coriell; ND11551
DR   Wikidata; Q54924194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11552
AC   CVCL_EX18
DR   CLO; CLO_0017688
DR   BioSample; SAMN00796888
DR   Coriell; ND11552
DR   Wikidata; Q54924195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11553
AC   CVCL_BH05
DR   CLO; CLO_0017689
DR   Coriell; ND11553
DR   Wikidata; Q54924196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11554
AC   CVCL_BH06
DR   CLO; CLO_0017680
DR   Coriell; ND11554
DR   Wikidata; Q54924197
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11555
AC   CVCL_IJ80
DR   Coriell; ND11555
DR   Wikidata; Q54924198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11556
AC   CVCL_BH07
DR   CLO; CLO_0017681
DR   Coriell; ND11556
DR   Wikidata; Q54924199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11557
AC   CVCL_FA88
DR   CLO; CLO_0017682
DR   Coriell; ND11557
DR   Wikidata; Q54924200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11558
AC   CVCL_BH08
DR   CLO; CLO_0017683
DR   Coriell; ND11558
DR   Wikidata; Q54924201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11559
AC   CVCL_GG17
DR   CLO; CLO_0017684
DR   Coriell; ND11559
DR   Wikidata; Q54924202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11560
AC   CVCL_FD06
DR   CLO; CLO_0017615
DR   BioSample; SAMN00796892
DR   Coriell; ND11560
DR   Wikidata; Q54924203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11561
AC   CVCL_BH09
DR   CLO; CLO_0017614
DR   Coriell; ND11561
DR   Wikidata; Q54924204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11562
AC   CVCL_BH10
DR   CLO; CLO_0017613
DR   Coriell; ND11562
DR   Wikidata; Q54924205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11563
AC   CVCL_BH11
DR   CLO; CLO_0017612
DR   Coriell; ND11563
DR   Wikidata; Q54924206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11564
AC   CVCL_BH12
DR   CLO; CLO_0017611
DR   Coriell; ND11564
DR   Wikidata; Q54924207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11567
AC   CVCL_IE40
DR   Coriell; ND11567
DR   Wikidata; Q54924208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11569
AC   CVCL_FZ45
DR   Coriell; ND11569
DR   Wikidata; Q54924209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11570
AC   CVCL_BH13
DR   CLO; CLO_0017610
DR   Coriell; ND11570
DR   Wikidata; Q54924210
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Caucasian and Native North American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11571
AC   CVCL_BH14
DR   CLO; CLO_0017619
DR   Coriell; ND11571
DR   Wikidata; Q54924211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11572
AC   CVCL_GG18
DR   CLO; CLO_0017618
DR   Coriell; ND11572
DR   Wikidata; Q54924212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11573
AC   CVCL_BH15
DR   CLO; CLO_0017617
DR   Coriell; ND11573
DR   Wikidata; Q54924213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11574
AC   CVCL_FA89
DR   CLO; CLO_0017616
DR   Coriell; ND11574
DR   Wikidata; Q54924214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11575
AC   CVCL_EX19
DR   Coriell; ND11575
DR   Wikidata; Q54924215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11576
AC   CVCL_GG19
DR   CLO; CLO_0017624
DR   Coriell; ND11576
DR   Wikidata; Q54924216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11577
AC   CVCL_GG20
DR   CLO; CLO_0017626
DR   Coriell; ND11577
DR   Wikidata; Q54924217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11578
AC   CVCL_BH16
DR   CLO; CLO_0017625
DR   Coriell; ND11578
DR   Wikidata; Q54924218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11579
AC   CVCL_FA90
DR   CLO; CLO_0017621
DR   Coriell; ND11579
DR   Wikidata; Q54924219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11580
AC   CVCL_BH17
DR   CLO; CLO_0017620
DR   Coriell; ND11580
DR   Wikidata; Q54924220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11581
AC   CVCL_BH18
DR   CLO; CLO_0017623
DR   Coriell; ND11581
DR   Wikidata; Q54924221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11582
AC   CVCL_BH19
DR   CLO; CLO_0017622
DR   Coriell; ND11582
DR   Wikidata; Q54924222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11583
AC   CVCL_BH20
DR   CLO; CLO_0017628
DR   Coriell; ND11583
DR   Wikidata; Q54924223
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11584
AC   CVCL_GG21
DR   CLO; CLO_0017627
DR   BioSample; SAMN00796900
DR   Coriell; ND11584
DR   Wikidata; Q54924224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11585
AC   CVCL_BH21
DR   CLO; CLO_0017629
DR   Coriell; ND11585
DR   Wikidata; Q54924225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11586
AC   CVCL_IJ81
DR   CLO; CLO_0017633
DR   Coriell; ND11586
DR   Wikidata; Q54924226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11587
AC   CVCL_BH22
DR   CLO; CLO_0017632
DR   Coriell; ND11587
DR   Wikidata; Q54924227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11588
AC   CVCL_GG22
DR   CLO; CLO_0017631
DR   BioSample; SAMN00796904
DR   Coriell; ND11588
DR   Wikidata; Q54924228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11589
AC   CVCL_BH23
DR   CLO; CLO_0017630
DR   Coriell; ND11589
DR   Wikidata; Q54924229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11590
AC   CVCL_BH24
DR   CLO; CLO_0017637
DR   Coriell; ND11590
DR   Wikidata; Q54924231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11591
AC   CVCL_BH25
DR   CLO; CLO_0017636
DR   Coriell; ND11591
DR   Wikidata; Q54924232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11592
AC   CVCL_BH26
DR   CLO; CLO_0017635
DR   Coriell; ND11592
DR   Wikidata; Q54924233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11593
AC   CVCL_IE41
DR   CLO; CLO_0017634
DR   Coriell; ND11593
DR   Wikidata; Q54924234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11595
AC   CVCL_CL88
DR   CLO; CLO_0017639
DR   Coriell; ND11595
DR   Wikidata; Q54924236
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND11596
AC   CVCL_BH27
DR   Coriell; ND11596
DR   Wikidata; Q54924237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11597
AC   CVCL_CL89
DR   Coriell; ND11597
DR   Wikidata; Q54924238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11598
AC   CVCL_BH28
DR   CLO; CLO_0017638
DR   Coriell; ND11598
DR   Wikidata; Q54924239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11599
AC   CVCL_BH29
DR   CLO; CLO_0017649
DR   Coriell; ND11599
DR   Wikidata; Q54924240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11600
AC   CVCL_BH30
DR   CLO; CLO_0017641
DR   Coriell; ND11600
DR   Wikidata; Q54924241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11601
AC   CVCL_BH31
DR   CLO; CLO_0017640
DR   Coriell; ND11601
DR   Wikidata; Q54924242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11602
AC   CVCL_GG23
DR   CLO; CLO_0017643
DR   Coriell; ND11602
DR   Wikidata; Q54924244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11603
AC   CVCL_EX20
DR   CLO; CLO_0017642
DR   Coriell; ND11603
DR   Wikidata; Q54924245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11604
AC   CVCL_EX21
DR   CLO; CLO_0017645
DR   Coriell; ND11604
DR   Wikidata; Q54924246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11605
AC   CVCL_GG24
DR   CLO; CLO_0017644
DR   Coriell; ND11605
DR   Wikidata; Q54924247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11606
AC   CVCL_BH32
DR   CLO; CLO_0017647
DR   Coriell; ND11606
DR   Wikidata; Q54924248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11607
AC   CVCL_GG25
DR   CLO; CLO_0017646
DR   BioSample; SAMN00796910
DR   Coriell; ND11607
DR   Wikidata; Q54924249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11608
AC   CVCL_BH33
DR   CLO; CLO_0017648
DR   Coriell; ND11608
DR   Wikidata; Q54924250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11609
AC   CVCL_EX22
DR   CLO; CLO_0017486
DR   BioSample; SAMN00796914
DR   Coriell; ND11609
DR   Wikidata; Q54924251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11610
AC   CVCL_BH34
DR   CLO; CLO_0017484
DR   Coriell; ND11610
DR   Wikidata; Q54924252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11611
AC   CVCL_BH35
DR   CLO; CLO_0017504
DR   Coriell; ND11611
DR   Wikidata; Q54924253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11612
AC   CVCL_BH36
DR   CLO; CLO_0017507
DR   Coriell; ND11612
DR   Wikidata; Q54924254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11613
AC   CVCL_EX23
DR   CLO; CLO_0017508
DR   Coriell; ND11613
DR   Wikidata; Q54924256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11614
AC   CVCL_GG26
DR   CLO; CLO_0017510
DR   Coriell; ND11614
DR   Wikidata; Q54924257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11615
AC   CVCL_GG27
DR   CLO; CLO_0017499
DR   Coriell; ND11615
DR   Wikidata; Q54924258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11616
AC   CVCL_BH37
DR   CLO; CLO_0017500
DR   Coriell; ND11616
DR   Wikidata; Q54924259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11617
AC   CVCL_BH38
DR   CLO; CLO_0017501
DR   Coriell; ND11617
DR   Wikidata; Q54924260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11618
AC   CVCL_IJ82
DR   CLO; CLO_0017503
DR   Coriell; ND11618
DR   Wikidata; Q54924261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11619
AC   CVCL_BH39
DR   CLO; CLO_0017516
DR   Coriell; ND11619
DR   Wikidata; Q54924262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11620
AC   CVCL_BH40
DR   CLO; CLO_0017514
DR   Coriell; ND11620
DR   Wikidata; Q54924263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11621
AC   CVCL_BH41
DR   CLO; CLO_0017512
DR   Coriell; ND11621
DR   Wikidata; Q54924264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11622
AC   CVCL_EX24
DR   CLO; CLO_0017540
DR   BioSample; SAMN00796920
DR   Coriell; ND11622
DR   Wikidata; Q54924265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11623
AC   CVCL_GG28
DR   CLO; CLO_0017542
DR   Coriell; ND11623
DR   Wikidata; Q54924266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11624
AC   CVCL_BH42
DR   CLO; CLO_0017535
DR   Coriell; ND11624
DR   Wikidata; Q54924267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11626
AC   CVCL_BH43
DR   CLO; CLO_0017538
DR   Coriell; ND11626
DR   Wikidata; Q54924268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11627
AC   CVCL_BH44
DR   CLO; CLO_0017533
DR   Coriell; ND11627
DR   Wikidata; Q54924269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11628
AC   CVCL_BH45
DR   CLO; CLO_0017534
DR   Coriell; ND11628
DR   Wikidata; Q54924270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11629
AC   CVCL_BH46
DR   CLO; CLO_0017532
DR   Coriell; ND11629
DR   Wikidata; Q54924271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11630
AC   CVCL_BH47
DR   CLO; CLO_0018313
DR   Coriell; ND11630
DR   Wikidata; Q54924272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11631
AC   CVCL_IJ83
DR   CLO; CLO_0018308
DR   Coriell; ND11631
DR   Wikidata; Q54924273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11632
AC   CVCL_FA91
DR   CLO; CLO_0018307
DR   Coriell; ND11632
DR   Wikidata; Q54924274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11633
AC   CVCL_BH48
DR   CLO; CLO_0018310
DR   Coriell; ND11633
DR   Wikidata; Q54924276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11634
AC   CVCL_BH49
DR   CLO; CLO_0018309
DR   Coriell; ND11634
DR   Wikidata; Q54924277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11635
AC   CVCL_GG29
DR   CLO; CLO_0018302
DR   Coriell; ND11635
DR   Wikidata; Q54924279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11636
AC   CVCL_BH50
DR   CLO; CLO_0018300
DR   Coriell; ND11636
DR   Wikidata; Q54924285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11637
AC   CVCL_BH51
DR   CLO; CLO_0018305
DR   Coriell; ND11637
DR   Wikidata; Q54924286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11638
AC   CVCL_BH52
DR   CLO; CLO_0018303
DR   Coriell; ND11638
DR   Wikidata; Q54924287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11639
AC   CVCL_EX25
DR   CLO; CLO_0018279
DR   BioSample; SAMN00796922
DR   Coriell; ND11639
DR   Wikidata; Q54924288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11640
AC   CVCL_EX26
DR   CLO; CLO_0018293
DR   Coriell; ND11640
DR   Wikidata; Q54924289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11641
AC   CVCL_CL90
DR   CLO; CLO_0018290
DR   BioSample; SAMN00796924
DR   Coriell; ND11641
DR   Wikidata; Q54924290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND11642
AC   CVCL_CL91
DR   CLO; CLO_0018289
DR   BioSample; SAMN00796926
DR   Coriell; ND11642
DR   Wikidata; Q54924291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND11643
AC   CVCL_IE42
DR   BioSample; SAMN00796928
DR   Coriell; ND11643
DR   Wikidata; Q54924292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND11644
AC   CVCL_EB22
DR   Coriell; ND11644
DR   Wikidata; Q54924293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11646
AC   CVCL_CL92
DR   Coriell; ND11646
DR   Wikidata; Q54924294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11649
AC   CVCL_CL93
DR   Coriell; ND11649
DR   Wikidata; Q54924295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11650
AC   CVCL_CL94
DR   Coriell; ND11650
DR   Wikidata; Q54924296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11653
AC   CVCL_EB23
DR   CLO; CLO_0018288
DR   Coriell; ND11653
DR   Wikidata; Q54924297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11654
AC   CVCL_BH53
DR   CLO; CLO_0018287
DR   Coriell; ND11654
DR   Wikidata; Q54924298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11655
AC   CVCL_GG30
DR   CLO; CLO_0018286
DR   Coriell; ND11655
DR   Wikidata; Q54924299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11656
AC   CVCL_GG31
DR   CLO; CLO_0018285
DR   Coriell; ND11656
DR   Wikidata; Q54924300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11657
AC   CVCL_FD07
DR   CLO; CLO_0018284
DR   Coriell; ND11657
DR   Wikidata; Q54924301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11658
AC   CVCL_BH54
DR   CLO; CLO_0018282
DR   Coriell; ND11658
DR   Wikidata; Q54924302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11659
AC   CVCL_BH55
DR   CLO; CLO_0018280
DR   Coriell; ND11659
DR   Wikidata; Q54924303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11660
AC   CVCL_GG32
DR   CLO; CLO_0018241
DR   BioSample; SAMN00796930
DR   Coriell; ND11660
DR   Wikidata; Q54924304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11661
AC   CVCL_GG33
DR   CLO; CLO_0018239
DR   Coriell; ND11661
DR   Wikidata; Q54924305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11662
AC   CVCL_BH56
DR   CLO; CLO_0018240
DR   Coriell; ND11662
DR   Wikidata; Q54924306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11664
AC   CVCL_BH57
DR   CLO; CLO_0018247
DR   Coriell; ND11664
DR   Wikidata; Q54924309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11665
AC   CVCL_BH58
DR   CLO; CLO_0018248
DR   Coriell; ND11665
DR   Wikidata; Q54924310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11666
AC   CVCL_GG34
DR   CLO; CLO_0018245
DR   Coriell; ND11666
DR   Wikidata; Q54924311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11668
AC   CVCL_BH59
DR   CLO; CLO_0018246
DR   Coriell; ND11668
DR   Wikidata; Q54924312
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11677
AC   CVCL_BH60
DR   CLO; CLO_0018243
DR   Coriell; ND11677
DR   Wikidata; Q54924313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11678
AC   CVCL_FD08
DR   CLO; CLO_0018244
DR   Coriell; ND11678
DR   Wikidata; Q54924314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11679
AC   CVCL_BH61
DR   CLO; CLO_0018242
DR   Coriell; ND11679
DR   Wikidata; Q54924315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11680
AC   CVCL_BH62
DR   CLO; CLO_0018259
DR   Coriell; ND11680
DR   Wikidata; Q54924317
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11681
AC   CVCL_BH63
DR   CLO; CLO_0018260
DR   Coriell; ND11681
DR   Wikidata; Q54924318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11682
AC   CVCL_BH64
DR   CLO; CLO_0018262
DR   Coriell; ND11682
DR   Wikidata; Q54924319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11683
AC   CVCL_BH65
DR   CLO; CLO_0018263
DR   Coriell; ND11683
DR   Wikidata; Q54924320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11684
AC   CVCL_FA92
DR   CLO; CLO_0018266
DR   Coriell; ND11684
DR   Wikidata; Q54924321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11685
AC   CVCL_BH66
DR   CLO; CLO_0018267
DR   Coriell; ND11685
DR   Wikidata; Q54924322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11686
AC   CVCL_BH67
DR   CLO; CLO_0018268
DR   Coriell; ND11686
DR   Wikidata; Q54924323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11687
AC   CVCL_BH68
DR   CLO; CLO_0018269
DR   Coriell; ND11687
DR   Wikidata; Q54924325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11688
AC   CVCL_BH69
DR   CLO; CLO_0018264
DR   Coriell; ND11688
DR   Wikidata; Q54924326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11689
AC   CVCL_EX27
DR   CLO; CLO_0018265
DR   Coriell; ND11689
DR   Wikidata; Q54924327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11690
AC   CVCL_IJ84
DR   CLO; CLO_0018199
DR   Coriell; ND11690
DR   Wikidata; Q54924328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11691
AC   CVCL_GG35
DR   CLO; CLO_0018203
DR   Coriell; ND11691
DR   Wikidata; Q54924334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11692
AC   CVCL_FA93
DR   CLO; CLO_0018205
DR   Coriell; ND11692
DR   Wikidata; Q54924336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11693
AC   CVCL_GG36
DR   CLO; CLO_0018200
DR   BioSample; SAMN00796936
DR   Coriell; ND11693
DR   Wikidata; Q54924337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11694
AC   CVCL_BH70
DR   CLO; CLO_0018201
DR   Coriell; ND11694
DR   Wikidata; Q54924338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11695
AC   CVCL_EX28
DR   CLO; CLO_0018208
DR   Coriell; ND11695
DR   Wikidata; Q54924339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11696
AC   CVCL_GG37
DR   CLO; CLO_0018209
DR   Coriell; ND11696
DR   Wikidata; Q54924340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11697
AC   CVCL_BH71
DR   CLO; CLO_0018206
DR   Coriell; ND11697
DR   Wikidata; Q54924341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11698
AC   CVCL_BH72
DR   CLO; CLO_0018207
DR   Coriell; ND11698
DR   Wikidata; Q54924342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11699
AC   CVCL_EB24
DR   Coriell; ND11699
DR   Wikidata; Q54924343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11701
AC   CVCL_EB25
DR   Coriell; ND11701
DR   Wikidata; Q54924344
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND11702
AC   CVCL_EB26
DR   CLO; CLO_0018210
DR   Coriell; ND11702
DR   Wikidata; Q54924345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11711
AC   CVCL_BH73
DR   CLO; CLO_0018219
DR   Coriell; ND11711
DR   Wikidata; Q54924346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11712
AC   CVCL_FD09
DR   CLO; CLO_0018220
DR   BioSample; SAMN00796942
DR   Coriell; ND11712
DR   Wikidata; Q54924347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11713
AC   CVCL_EX29
DR   CLO; CLO_0018222
DR   BioSample; SAMN00796944
DR   Coriell; ND11713
DR   Wikidata; Q54924348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11714
AC   CVCL_BH74
DR   CLO; CLO_0018224
DR   Coriell; ND11714
DR   Wikidata; Q54924349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11715
AC   CVCL_BH75
DR   Coriell; ND11715
DR   Wikidata; Q54924350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11716
AC   CVCL_EX30
DR   CLO; CLO_0018225
DR   BioSample; SAMN00796950
DR   Coriell; ND11716
DR   Wikidata; Q54924351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11717
AC   CVCL_FA94
DR   CLO; CLO_0018227
DR   Coriell; ND11717
DR   Wikidata; Q54924352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11718
AC   CVCL_BH76
DR   CLO; CLO_0018228
DR   Coriell; ND11718
DR   Wikidata; Q54924353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11719
AC   CVCL_BH77
DR   CLO; CLO_0018229
DR   Coriell; ND11719
DR   Wikidata; Q54924355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11720
AC   CVCL_BH78
DR   CLO; CLO_0018230
DR   Coriell; ND11720
DR   Wikidata; Q54924356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11721
AC   CVCL_GG38
DR   CLO; CLO_0018231
DR   Coriell; ND11721
DR   Wikidata; Q54924357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11722
AC   CVCL_GG39
DR   CLO; CLO_0018182
DR   Coriell; ND11722
DR   Wikidata; Q54924358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11723
AC   CVCL_GG40
DR   CLO; CLO_0018181
DR   Coriell; ND11723
DR   Wikidata; Q54924359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11724
AC   CVCL_BH79
DR   CLO; CLO_0018180
DR   Coriell; ND11724
DR   Wikidata; Q54924360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11725
AC   CVCL_GG41
DR   CLO; CLO_0018178
DR   Coriell; ND11725
DR   Wikidata; Q54924361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11726
AC   CVCL_GG42
DR   CLO; CLO_0018177
DR   Coriell; ND11726
DR   Wikidata; Q54924362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11727
AC   CVCL_BH80
DR   CLO; CLO_0018175
DR   Coriell; ND11727
DR   Wikidata; Q54924363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11728
AC   CVCL_BH81
DR   CLO; CLO_0018172
DR   Coriell; ND11728
DR   Wikidata; Q54924364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11729
AC   CVCL_IJ85
DR   CLO; CLO_0018171
DR   Coriell; ND11729
DR   Wikidata; Q54924365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11730
AC   CVCL_BH82
DR   CLO; CLO_0018170
DR   Coriell; ND11730
DR   Wikidata; Q54924366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11731
AC   CVCL_GG43
DR   CLO; CLO_0018169
DR   BioSample; SAMN00796956
DR   Coriell; ND11731
DR   Wikidata; Q54924367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11732
AC   CVCL_FD10
DR   CLO; CLO_0018196
DR   Coriell; ND11732
DR   Wikidata; Q54924368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11733
AC   CVCL_GG44
DR   CLO; CLO_0018195
DR   Coriell; ND11733
DR   Wikidata; Q54924369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11734
AC   CVCL_FD11
DR   CLO; CLO_0018198
DR   BioSample; SAMN00796958
DR   Coriell; ND11734
DR   Wikidata; Q54924370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11735
AC   CVCL_BH83
DR   CLO; CLO_0018197
DR   Coriell; ND11735
DR   Wikidata; Q54924371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11736
AC   CVCL_BH84
DR   CLO; CLO_0018192
DR   Coriell; ND11736
DR   Wikidata; Q54924372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11737
AC   CVCL_BH85
DR   CLO; CLO_0018191
DR   Coriell; ND11737
DR   Wikidata; Q54924373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11738
AC   CVCL_BH86
DR   CLO; CLO_0018194
DR   Coriell; ND11738
DR   Wikidata; Q54924374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11739
AC   CVCL_BH87
DR   CLO; CLO_0018193
DR   Coriell; ND11739
DR   Wikidata; Q54924375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11741
AC   CVCL_BH88
DR   CLO; CLO_0018190
DR   Coriell; ND11741
DR   Wikidata; Q54924380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11742
AC   CVCL_BH89
DR   CLO; CLO_0018189
DR   Coriell; ND11742
DR   Wikidata; Q54924381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11743
AC   CVCL_BH90
DR   CLO; CLO_0018158
DR   Coriell; ND11743
DR   Wikidata; Q54924382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11744
AC   CVCL_BH91
DR   Coriell; ND11744
DR   Wikidata; Q54924383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11748
AC   CVCL_IE43
DR   Coriell; ND11748
DR   Wikidata; Q54924384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11749
AC   CVCL_BH92
DR   CLO; CLO_0018153
DR   Coriell; ND11749
DR   Wikidata; Q54924385
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11750
AC   CVCL_BH93
DR   Coriell; ND11750
DR   Wikidata; Q54924386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11751
AC   CVCL_EX31
DR   CLO; CLO_0018152
DR   BioSample; SAMN00796962
DR   Coriell; ND11751
DR   Wikidata; Q54924388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11752
AC   CVCL_GG45
DR   CLO; CLO_0018151
DR   Coriell; ND11752
DR   Wikidata; Q54924389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11753
AC   CVCL_FA95
DR   CLO; CLO_0018150
DR   Coriell; ND11753
DR   Wikidata; Q54924390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11754
AC   CVCL_BH94
DR   CLO; CLO_0018157
DR   Coriell; ND11754
DR   Wikidata; Q54924391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11755
AC   CVCL_BH95
DR   CLO; CLO_0018156
DR   Coriell; ND11755
DR   Wikidata; Q54924392
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11756
AC   CVCL_BH96
DR   CLO; CLO_0018155
DR   Coriell; ND11756
DR   Wikidata; Q54924393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11757
AC   CVCL_BH97
DR   CLO; CLO_0018154
DR   Coriell; ND11757
DR   Wikidata; Q54924394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11758
AC   CVCL_BH98
DR   Coriell; ND11758
DR   Wikidata; Q54924395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11759
AC   CVCL_IL91
DR   CLO; CLO_0018149
DR   Coriell; ND11759
DR   Wikidata; Q54924396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND11759; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND11760
AC   CVCL_BH99
DR   CLO; CLO_0018167
DR   Coriell; ND11760
DR   Wikidata; Q54924397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND11760; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   ND11761
AC   CVCL_FA96
DR   CLO; CLO_0018168
DR   Coriell; ND11761
DR   Wikidata; Q54924398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11762
AC   CVCL_BI00
DR   CLO; CLO_0018160
DR   Coriell; ND11762
DR   Wikidata; Q54924399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11763
AC   CVCL_IE44
DR   BioSample; SAMN00796970
DR   Coriell; ND11763
DR   Wikidata; Q54924400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND11764
AC   CVCL_BI01
DR   CLO; CLO_0018159
DR   Coriell; ND11764
DR   Wikidata; Q54924401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11765
AC   CVCL_BI02
DR   CLO; CLO_0018162
DR   Coriell; ND11765
DR   Wikidata; Q54924402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11766
AC   CVCL_FD12
DR   CLO; CLO_0018161
DR   Coriell; ND11766
DR   Wikidata; Q54924403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11767
AC   CVCL_BI03
DR   CLO; CLO_0018164
DR   Coriell; ND11767
DR   Wikidata; Q54924405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11768
AC   CVCL_BI04
DR   CLO; CLO_0018163
DR   Coriell; ND11768
DR   Wikidata; Q54924406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11769
AC   CVCL_GG46
DR   CLO; CLO_0018166
DR   Coriell; ND11769
DR   Wikidata; Q54924407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11770
AC   CVCL_GG47
DR   CLO; CLO_0018165
DR   Coriell; ND11770
DR   Wikidata; Q54924408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11771
AC   CVCL_GG48
DR   CLO; CLO_0022462
DR   Coriell; ND11771
DR   Wikidata; Q54924409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11772
AC   CVCL_FD13
DR   CLO; CLO_0022463
DR   Coriell; ND11772
DR   Wikidata; Q54924410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11773
AC   CVCL_BI05
DR   CLO; CLO_0022460
DR   Coriell; ND11773
DR   Wikidata; Q54924412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11774
AC   CVCL_BI06
DR   CLO; CLO_0022461
DR   Coriell; ND11774
DR   Wikidata; Q54924413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11775
AC   CVCL_BI07
DR   CLO; CLO_0022466
DR   Coriell; ND11775
DR   Wikidata; Q54924414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11776
AC   CVCL_BI08
DR   CLO; CLO_0022467
DR   Coriell; ND11776
DR   Wikidata; Q54924415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11777
AC   CVCL_BI09
DR   CLO; CLO_0022464
DR   Coriell; ND11777
DR   Wikidata; Q54924416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11778
AC   CVCL_BI10
DR   CLO; CLO_0022465
DR   Coriell; ND11778
DR   Wikidata; Q54924417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11779
AC   CVCL_BI11
DR   CLO; CLO_0022478
DR   Coriell; ND11779
DR   Wikidata; Q54924418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11780
AC   CVCL_BI12
DR   Coriell; ND11780
DR   Wikidata; Q54924419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11781
AC   CVCL_BI13
DR   CLO; CLO_0022477
DR   Coriell; ND11781
DR   Wikidata; Q54924420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11782
AC   CVCL_BI14
DR   CLO; CLO_0022468
DR   Coriell; ND11782
DR   Wikidata; Q54924421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11783
AC   CVCL_BI15
DR   CLO; CLO_0022469
DR   Coriell; ND11783
DR   Wikidata; Q54924422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11784
AC   CVCL_IJ86
DR   CLO; CLO_0022470
DR   Coriell; ND11784
DR   Wikidata; Q54924427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11785
AC   CVCL_BI16
DR   CLO; CLO_0022471
DR   Coriell; ND11785
DR   Wikidata; Q54924429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11786
AC   CVCL_GG49
DR   CLO; CLO_0022472
DR   Coriell; ND11786
DR   Wikidata; Q54924430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11787
AC   CVCL_GG50
DR   CLO; CLO_0022473
DR   BioSample; SAMN00796974
DR   Coriell; ND11787
DR   Wikidata; Q54924431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11788
AC   CVCL_GG51
DR   CLO; CLO_0022474
DR   Coriell; ND11788
DR   Wikidata; Q54924433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11789
AC   CVCL_FD14
DR   CLO; CLO_0022475
DR   Coriell; ND11789
DR   Wikidata; Q54924434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11790
AC   CVCL_CL95
DR   Coriell; ND11790
DR   Wikidata; Q54924435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11791
AC   CVCL_CL96
DR   Coriell; ND11791
DR   Wikidata; Q54924436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11798
AC   CVCL_HV77
DR   Coriell; ND11798
DR   Wikidata; Q54924437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11799
AC   CVCL_HV78
DR   Coriell; ND11799
DR   Wikidata; Q54924438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11800
AC   CVCL_GG52
DR   CLO; CLO_0022476
DR   Coriell; ND11800
DR   Wikidata; Q54924439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11801
AC   CVCL_GG53
DR   CLO; CLO_0022449
DR   Coriell; ND11801
DR   Wikidata; Q54924440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11802
AC   CVCL_GG54
DR   CLO; CLO_0022439
DR   Coriell; ND11802
DR   Wikidata; Q54924441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11803
AC   CVCL_GG55
DR   CLO; CLO_0022440
DR   Coriell; ND11803
DR   Wikidata; Q54924442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11804
AC   CVCL_GG56
DR   CLO; CLO_0022447
DR   Coriell; ND11804
DR   Wikidata; Q54924443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11806
AC   CVCL_EB27
DR   CLO; CLO_0022448
DR   Coriell; ND11806
DR   Wikidata; Q54924444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11807
AC   CVCL_BI17
DR   CLO; CLO_0022445
DR   Coriell; ND11807
DR   Wikidata; Q54924445
RX   PubMed=22572540;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg159Cys (c.475C>T) (c.864C>T); ClinVar=VCV000280123; Zygosity=Heterozygous (PubMed=22572540).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   ND11808
AC   CVCL_BI18
DR   CLO; CLO_0022446
DR   Coriell; ND11808
DR   Wikidata; Q54924446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11809
AC   CVCL_BI19
DR   CLO; CLO_0022443
DR   Coriell; ND11809
DR   Wikidata; Q54924447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11810
AC   CVCL_FD15
DR   CLO; CLO_0022444
DR   BioSample; SAMN00796984
DR   Coriell; ND11810
DR   Wikidata; Q54924448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11811
AC   CVCL_EX32
DR   CLO; CLO_0022441
DR   BioSample; SAMN00796986
DR   Coriell; ND11811
DR   Wikidata; Q54924449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11812
AC   CVCL_GG57
DR   CLO; CLO_0022442
DR   Coriell; ND11812
DR   Wikidata; Q54924450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11813
AC   CVCL_BI20
DR   CLO; CLO_0022450
DR   Coriell; ND11813
DR   Wikidata; Q54924451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11815
AC   CVCL_FD16
DR   CLO; CLO_0022451
DR   Coriell; ND11815
DR   Wikidata; Q54924452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11816
AC   CVCL_GG58
DR   CLO; CLO_0022452
DR   Coriell; ND11816
DR   Wikidata; Q54924454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11817
AC   CVCL_BI21
DR   CLO; CLO_0022456
DR   Coriell; ND11817
DR   Wikidata; Q54924455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11818
AC   CVCL_BI22
DR   CLO; CLO_0022457
DR   Coriell; ND11818
DR   Wikidata; Q54924456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11819
AC   CVCL_EX33
DR   CLO; CLO_0022458
DR   BioSample; SAMN00796994
DR   Coriell; ND11819
DR   Wikidata; Q54924457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11821
AC   CVCL_BI23
DR   CLO; CLO_0022459
DR   Coriell; ND11821
DR   Wikidata; Q54924458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11822
AC   CVCL_FD17
DR   CLO; CLO_0022453
DR   BioSample; SAMN00796998
DR   Coriell; ND11822
DR   Wikidata; Q54924459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11823
AC   CVCL_BI24
DR   CLO; CLO_0022454
DR   Coriell; ND11823
DR   Wikidata; Q54924460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11824
AC   CVCL_BI25
DR   CLO; CLO_0022455
DR   Coriell; ND11824
DR   Wikidata; Q54924462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11825
AC   CVCL_EX34
DR   CLO; CLO_0022516
DR   BioSample; SAMN00797002
DR   Coriell; ND11825
DR   Wikidata; Q54924464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11828
AC   CVCL_EB28
DR   CLO; CLO_0022515
DR   Coriell; ND11828
DR   Wikidata; Q54924465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND11831
AC   CVCL_HR75
DR   CLO; CLO_0022518
DR   Coriell; ND11831
DR   Wikidata; Q54924466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11832
AC   CVCL_FZ46
DR   CLO; CLO_0022517
DR   Coriell; ND11832
DR   Wikidata; Q54924467
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11833
AC   CVCL_BI26
DR   Coriell; ND11833
DR   Wikidata; Q54924468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11834
AC   CVCL_CL97
DR   CLO; CLO_0022512
DR   Coriell; ND11834
DR   Wikidata; Q54924470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11835
AC   CVCL_IJ87
DR   CLO; CLO_0022511
DR   Coriell; ND11835
DR   Wikidata; Q54924471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11836
AC   CVCL_BI27
DR   CLO; CLO_0022514
DR   Coriell; ND11836
DR   Wikidata; Q54924472
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11837
AC   CVCL_BI28
DR   CLO; CLO_0022513
DR   Coriell; ND11837
DR   Wikidata; Q54924484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11838
AC   CVCL_BI29
DR   CLO; CLO_0022510
DR   Coriell; ND11838
DR   Wikidata; Q54924485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11839
AC   CVCL_GG59
DR   CLO; CLO_0022509
DR   BioSample; SAMN00797008
DR   Coriell; ND11839
DR   Wikidata; Q54924486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11840
AC   CVCL_GG60
DR   CLO; CLO_0022508
DR   Coriell; ND11840
DR   Wikidata; Q54924487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11841
AC   CVCL_GG61
DR   CLO; CLO_0022507
DR   Coriell; ND11841
DR   Wikidata; Q54924488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11842
AC   CVCL_GG62
DR   CLO; CLO_0022506
DR   Coriell; ND11842
DR   Wikidata; Q54924489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11843
AC   CVCL_GG63
DR   CLO; CLO_0022505
DR   Coriell; ND11843
DR   Wikidata; Q54924490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11854
AC   CVCL_IJ88
DR   CLO; CLO_0022504
DR   Coriell; ND11854
DR   Wikidata; Q54924491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11855
AC   CVCL_FA97
DR   CLO; CLO_0022503
DR   Coriell; ND11855
DR   Wikidata; Q54924492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11856
AC   CVCL_BI30
DR   CLO; CLO_0022502
DR   Coriell; ND11856
DR   Wikidata; Q54924493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11857
AC   CVCL_GG64
DR   CLO; CLO_0022501
DR   BioSample; SAMN00797010
DR   Coriell; ND11857
DR   Wikidata; Q54924494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11858
AC   CVCL_BI31
DR   CLO; CLO_0022500
DR   Coriell; ND11858
DR   Wikidata; Q54924495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11859
AC   CVCL_BI32
DR   CLO; CLO_0022499
DR   Coriell; ND11859
DR   Wikidata; Q54924496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11860
AC   CVCL_GG65
DR   CLO; CLO_0022494
DR   Coriell; ND11860
DR   Wikidata; Q54924497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11861
AC   CVCL_GG66
DR   CLO; CLO_0022493
DR   Coriell; ND11861
DR   Wikidata; Q54924498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11862
AC   CVCL_IJ89
DR   CLO; CLO_0022496
DR   Coriell; ND11862
DR   Wikidata; Q54924499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11863
AC   CVCL_BI33
DR   CLO; CLO_0022495
DR   Coriell; ND11863
DR   Wikidata; Q54924500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11864
AC   CVCL_GG67
DR   CLO; CLO_0022498
DR   BioSample; SAMN00797016
DR   Coriell; ND11864
DR   Wikidata; Q54924501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11865
AC   CVCL_EX35
DR   CLO; CLO_0022497
DR   BioSample; SAMN00797018
DR   Coriell; ND11865
DR   Wikidata; Q54924502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11866
AC   CVCL_BI34
DR   CLO; CLO_0022490
DR   Coriell; ND11866
DR   Wikidata; Q54924503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11867
AC   CVCL_BI35
DR   CLO; CLO_0022489
DR   Coriell; ND11867
DR   Wikidata; Q54924504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11868
AC   CVCL_GG68
DR   CLO; CLO_0022492
DR   Coriell; ND11868
DR   Wikidata; Q54924505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11869
AC   CVCL_BI36
DR   CLO; CLO_0022491
DR   Coriell; ND11869
DR   Wikidata; Q54924506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11870
AC   CVCL_FA98
DR   CLO; CLO_0022484
DR   Coriell; ND11870
DR   Wikidata; Q54924507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11871
AC   CVCL_BI37
DR   CLO; CLO_0022483
DR   Coriell; ND11871
DR   Wikidata; Q54924508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11872
AC   CVCL_FA99
DR   CLO; CLO_0022482
DR   Coriell; ND11872
DR   Wikidata; Q54924509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11873
AC   CVCL_GG69
DR   CLO; CLO_0022488
DR   BioSample; SAMN00797022
DR   Coriell; ND11873
DR   Wikidata; Q54924510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11874
AC   CVCL_GG70
DR   CLO; CLO_0022487
DR   BioSample; SAMN00797024
DR   Coriell; ND11874
DR   Wikidata; Q54924511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11875
AC   CVCL_BI38
DR   CLO; CLO_0022486
DR   Coriell; ND11875
DR   Wikidata; Q54924512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11876
AC   CVCL_GG71
DR   CLO; CLO_0022485
DR   Coriell; ND11876
DR   Wikidata; Q54924513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11878
AC   CVCL_BI39
DR   CLO; CLO_0022481
DR   Coriell; ND11878
DR   Wikidata; Q54924514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11879
AC   CVCL_BI40
DR   CLO; CLO_0022480
DR   Coriell; ND11879
DR   Wikidata; Q54924515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11880
AC   CVCL_BI41
DR   CLO; CLO_0022479
DR   Coriell; ND11880
DR   Wikidata; Q54924516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11881
AC   CVCL_BI42
DR   CLO; CLO_0022538
DR   Coriell; ND11881
DR   Wikidata; Q54924517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11883
AC   CVCL_BI43
DR   CLO; CLO_0022539
DR   Coriell; ND11883
DR   Wikidata; Q54924518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11884
AC   CVCL_IE45
DR   BioSample; SAMN00797030
DR   Coriell; ND11884
DR   Wikidata; Q54924519
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ND11885
AC   CVCL_FD18
DR   CLO; CLO_0022540
DR   BioSample; SAMN00797032
DR   Coriell; ND11885
DR   Wikidata; Q54924520
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND11886
AC   CVCL_BI44
DR   CLO; CLO_0022541
DR   Coriell; ND11886
DR   Wikidata; Q54924521
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11887
AC   CVCL_BI45
DR   CLO; CLO_0022534
DR   Coriell; ND11887
DR   Wikidata; Q54924523
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND11888
AC   CVCL_EX36
DR   CLO; CLO_0022535
DR   BioSample; SAMN00797036
DR   Coriell; ND11888
DR   Wikidata; Q54924524
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND11889
AC   CVCL_BI46
DR   CLO; CLO_0022536
DR   Coriell; ND11889
DR   Wikidata; Q54924528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11890
AC   CVCL_GG72
DR   CLO; CLO_0022537
DR   Coriell; ND11890
DR   Wikidata; Q54924529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11891
AC   CVCL_EX37
DR   CLO; CLO_0022542
DR   BioSample; SAMN00797038
DR   Coriell; ND11891
DR   Wikidata; Q54924530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11892
AC   CVCL_GG73
DR   CLO; CLO_0022543
DR   Coriell; ND11892
DR   Wikidata; Q54924531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11893
AC   CVCL_GG74
DR   CLO; CLO_0022524
DR   Coriell; ND11893
DR   Wikidata; Q54924532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11894
AC   CVCL_BI47
DR   CLO; CLO_0022531
DR   Coriell; ND11894
DR   Wikidata; Q54924533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11895
AC   CVCL_BI48
DR   CLO; CLO_0022532
DR   Coriell; ND11895
DR   Wikidata; Q54924534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11896
AC   CVCL_BI49
DR   CLO; CLO_0022529
DR   Coriell; ND11896
DR   Wikidata; Q54924535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11897
AC   CVCL_BI50
DR   CLO; CLO_0022530
DR   Coriell; ND11897
DR   Wikidata; Q54924536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11898
AC   CVCL_BI51
DR   CLO; CLO_0022527
DR   Coriell; ND11898
DR   Wikidata; Q54924537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11899
AC   CVCL_GG75
DR   CLO; CLO_0022528
DR   BioSample; SAMN00797041
DR   Coriell; ND11899
DR   Wikidata; Q54924538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11900
AC   CVCL_BI52
DR   CLO; CLO_0022525
DR   Coriell; ND11900
DR   Wikidata; Q54924539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11901
AC   CVCL_BI53
DR   CLO; CLO_0022526
DR   Coriell; ND11901
DR   Wikidata; Q54924540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11902
AC   CVCL_EX38
DR   CLO; CLO_0022533
DR   BioSample; SAMN00797045
DR   Coriell; ND11902
DR   Wikidata; Q54924541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11904
AC   CVCL_GG76
DR   CLO; CLO_0022715
DR   Coriell; ND11904
DR   Wikidata; Q54924542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11905
AC   CVCL_GG77
DR   CLO; CLO_0022714
DR   Coriell; ND11905
DR   Wikidata; Q54924543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11906
AC   CVCL_GG78
DR   CLO; CLO_0022713
DR   Coriell; ND11906
DR   Wikidata; Q54924544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11908
AC   CVCL_GG79
DR   CLO; CLO_0022712
DR   Coriell; ND11908
DR   Wikidata; Q54924545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11909
AC   CVCL_GG80
DR   CLO; CLO_0022711
DR   Coriell; ND11909
DR   Wikidata; Q54924546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11910
AC   CVCL_FF23
DR   CLO; CLO_0022710
DR   Coriell; ND11910
DR   Wikidata; Q54924547
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11911
AC   CVCL_BI54
DR   CLO; CLO_0022709
DR   Coriell; ND11911
DR   Wikidata; Q54924548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11912
AC   CVCL_BI55
DR   CLO; CLO_0022724
DR   Coriell; ND11912
DR   Wikidata; Q54924549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11913
AC   CVCL_BI56
DR   CLO; CLO_0022725
DR   Coriell; ND11913
DR   Wikidata; Q54924550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11914
AC   CVCL_BI57
DR   CLO; CLO_0022726
DR   Coriell; ND11914
DR   Wikidata; Q54924551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11915
AC   CVCL_BI58
DR   CLO; CLO_0022721
DR   Coriell; ND11915
DR   Wikidata; Q54924552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11916
AC   CVCL_BI59
DR   CLO; CLO_0022720
DR   Coriell; ND11916
DR   Wikidata; Q54924553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11917
AC   CVCL_BI60
DR   CLO; CLO_0022723
DR   Coriell; ND11917
DR   Wikidata; Q54924554
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11918
AC   CVCL_GG81
DR   CLO; CLO_0022722
DR   Coriell; ND11918
DR   Wikidata; Q54924555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11919
AC   CVCL_GG82
DR   CLO; CLO_0022717
DR   Coriell; ND11919
DR   Wikidata; Q54924556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11920
AC   CVCL_GG83
DR   CLO; CLO_0022716
DR   BioSample; SAMN00797051
DR   Coriell; ND11920
DR   Wikidata; Q54924557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11921
AC   CVCL_FD19
DR   CLO; CLO_0022719
DR   BioSample; SAMN00797053
DR   Coriell; ND11921
DR   Wikidata; Q54924558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11922
AC   CVCL_BI61
DR   CLO; CLO_0022718
DR   Coriell; ND11922
DR   Wikidata; Q54924559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11923
AC   CVCL_BI62
DR   CLO; CLO_0022737
DR   Coriell; ND11923
DR   Wikidata; Q54924560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11924
AC   CVCL_GG84
DR   CLO; CLO_0022736
DR   BioSample; SAMN00797059
DR   Coriell; ND11924
DR   Wikidata; Q54924561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11925
AC   CVCL_EX39
DR   CLO; CLO_0022735
DR   Coriell; ND11925
DR   Wikidata; Q54924562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11926
AC   CVCL_BI63
DR   CLO; CLO_0022729
DR   Coriell; ND11926
DR   Wikidata; Q54924563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11927
AC   CVCL_EX40
DR   CLO; CLO_0022730
DR   BioSample; SAMN00797061
DR   Coriell; ND11927
DR   Wikidata; Q54924564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11928
AC   CVCL_GG85
DR   CLO; CLO_0022727
DR   Coriell; ND11928
DR   Wikidata; Q54924565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11929
AC   CVCL_GG86
DR   CLO; CLO_0022728
DR   Coriell; ND11929
DR   Wikidata; Q54924566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11930
AC   CVCL_BI64
DR   CLO; CLO_0022733
DR   Coriell; ND11930
DR   Wikidata; Q54924567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11931
AC   CVCL_BI65
DR   CLO; CLO_0022734
DR   Coriell; ND11931
DR   Wikidata; Q54924569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11932
AC   CVCL_BI66
DR   CLO; CLO_0022731
DR   Coriell; ND11932
DR   Wikidata; Q54924570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11933
AC   CVCL_BI67
DR   CLO; CLO_0022732
DR   Coriell; ND11933
DR   Wikidata; Q54924571
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND11934
AC   CVCL_BI68
DR   CLO; CLO_0022748
DR   Coriell; ND11934
DR   Wikidata; Q54924572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11935
AC   CVCL_BI69
DR   CLO; CLO_0022746
DR   Coriell; ND11935
DR   Wikidata; Q54924574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11936
AC   CVCL_BI70
DR   CLO; CLO_0022747
DR   Coriell; ND11936
DR   Wikidata; Q54924575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11937
AC   CVCL_BI71
DR   Coriell; ND11937
DR   Wikidata; Q54924576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11938
AC   CVCL_BI72
DR   CLO; CLO_0022738
DR   Coriell; ND11938
DR   Wikidata; Q54924577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11939
AC   CVCL_BI73
DR   Coriell; ND11939
DR   Wikidata; Q54924578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11940
AC   CVCL_FD20
DR   CLO; CLO_0022739
DR   BioSample; SAMN00797067
DR   Coriell; ND11940
DR   Wikidata; Q54924579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11941
AC   CVCL_BI74
DR   CLO; CLO_0022740
DR   Coriell; ND11941
DR   Wikidata; Q54924580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11942
AC   CVCL_IJ90
DR   CLO; CLO_0022741
DR   Coriell; ND11942
DR   Wikidata; Q54924581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11943
AC   CVCL_BI75
DR   CLO; CLO_0022742
DR   Coriell; ND11943
DR   Wikidata; Q54924582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11944
AC   CVCL_GG87
DR   CLO; CLO_0022743
DR   Coriell; ND11944
DR   Wikidata; Q54924583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11945
AC   CVCL_GG88
DR   CLO; CLO_0022744
DR   Coriell; ND11945
DR   Wikidata; Q54924584
CC   Population: Lebanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11946
AC   CVCL_GG89
DR   CLO; CLO_0022745
DR   Coriell; ND11946
DR   Wikidata; Q54924585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11957
AC   CVCL_HV79
DR   Coriell; ND11957
DR   Wikidata; Q54924586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11960
AC   CVCL_HV80
DR   Coriell; ND11960
DR   Wikidata; Q54924587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11961
AC   CVCL_FZ47
DR   Coriell; ND11961
DR   Wikidata; Q54924588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11962
AC   CVCL_CL98
DR   Coriell; ND11962
DR   Wikidata; Q54924589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11966
AC   CVCL_HV81
DR   Coriell; ND11966
DR   Wikidata; Q54924590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11968
AC   CVCL_HV82
DR   CLO; CLO_0022758
DR   Coriell; ND11968
DR   Wikidata; Q54924591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND11970
AC   CVCL_BI76
DR   CLO; CLO_0022756
DR   Coriell; ND11970
DR   Wikidata; Q54924592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11971
AC   CVCL_BI77
DR   CLO; CLO_0022757
DR   Coriell; ND11971
DR   Wikidata; Q54924593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11972
AC   CVCL_BI78
DR   CLO; CLO_0022754
DR   Coriell; ND11972
DR   Wikidata; Q54924594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11973
AC   CVCL_GG90
DR   CLO; CLO_0022755
DR   Coriell; ND11973
DR   Wikidata; Q54924595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11974
AC   CVCL_BI79
DR   CLO; CLO_0022752
DR   Coriell; ND11974
DR   Wikidata; Q54924596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND11975
AC   CVCL_GG91
DR   CLO; CLO_0022753
DR   Coriell; ND11975
DR   Wikidata; Q54924597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11976
AC   CVCL_GG92
DR   CLO; CLO_0022750
DR   BioSample; SAMN00797079
DR   Coriell; ND11976
DR   Wikidata; Q54924598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND11977
AC   CVCL_FD21
DR   CLO; CLO_0022751
DR   Coriell; ND11977
DR   Wikidata; Q54924599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11978
AC   CVCL_GG93
DR   CLO; CLO_0022749
DR   Coriell; ND11978
DR   Wikidata; Q54924600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11979
AC   CVCL_GG94
DR   CLO; CLO_0022765
DR   Coriell; ND11979
DR   Wikidata; Q54924601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11980
AC   CVCL_GG95
DR   CLO; CLO_0022766
DR   Coriell; ND11980
DR   Wikidata; Q54924602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11981
AC   CVCL_GG96
DR   CLO; CLO_0022767
DR   Coriell; ND11981
DR   Wikidata; Q54924603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11982
AC   CVCL_GG97
DR   CLO; CLO_0022768
DR   Coriell; ND11982
DR   Wikidata; Q54924604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11983
AC   CVCL_GG98
DR   CLO; CLO_0022761
DR   Coriell; ND11983
DR   Wikidata; Q54924605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11984
AC   CVCL_GG99
DR   CLO; CLO_0022762
DR   Coriell; ND11984
DR   Wikidata; Q54924606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11985
AC   CVCL_GH00
DR   CLO; CLO_0022763
DR   Coriell; ND11985
DR   Wikidata; Q54924607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND11991
AC   CVCL_EB29
DR   Coriell; ND11991
DR   Wikidata; Q54924608
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND11994
AC   CVCL_CL99
DR   BioSample; SAMN00797081
DR   Coriell; ND11994
DR   Wikidata; Q54924609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND11995
AC   CVCL_CM00
DR   Coriell; ND11995
DR   Wikidata; Q54924611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11996
AC   CVCL_CM01
DR   Coriell; ND11996
DR   Wikidata; Q54924612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11997
AC   CVCL_CM02
DR   Coriell; ND11997
DR   Wikidata; Q54924613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11998
AC   CVCL_CM03
DR   Coriell; ND11998
DR   Wikidata; Q54924614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND11999
AC   CVCL_CM04
DR   Coriell; ND11999
DR   Wikidata; Q54924615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12
AC   CVCL_VK90
SY   Neuroblastoma X DRG neurons hybrid 12
DR   Wikidata; Q98127446
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND12001
AC   CVCL_HV83
DR   Coriell; ND12001
DR   Wikidata; Q54924616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12008
AC   CVCL_BI80
DR   CLO; CLO_0022764
DR   Coriell; ND12008
DR   Wikidata; Q54924617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12009
AC   CVCL_GH01
DR   CLO; CLO_0022759
DR   Coriell; ND12009
DR   Wikidata; Q54924618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12010
AC   CVCL_GH02
DR   CLO; CLO_0022760
DR   Coriell; ND12010
DR   Wikidata; Q54924619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12011
AC   CVCL_BI81
DR   CLO; CLO_0022783
DR   Coriell; ND12011
DR   Wikidata; Q54924620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12012
AC   CVCL_BI82
DR   CLO; CLO_0022780
DR   Coriell; ND12012
DR   Wikidata; Q54924621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12013
AC   CVCL_GH03
DR   CLO; CLO_0022779
DR   BioSample; SAMN00797091
DR   Coriell; ND12013
DR   Wikidata; Q54924622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12014
AC   CVCL_FD22
DR   CLO; CLO_0022782
DR   BioSample; SAMN00797093
DR   Coriell; ND12014
DR   Wikidata; Q54924623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12015
AC   CVCL_BI83
DR   CLO; CLO_0022781
DR   Coriell; ND12015
DR   Wikidata; Q54924624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12016
AC   CVCL_GH04
DR   CLO; CLO_0022786
DR   BioSample; SAMN00797097
DR   Coriell; ND12016
DR   Wikidata; Q54924625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12017
AC   CVCL_BI84
DR   CLO; CLO_0022785
DR   Coriell; ND12017
DR   Wikidata; Q54924626
CC   Population: Caucasian; Lithuanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND12018
AC   CVCL_FB76
DR   CLO; CLO_0022788
DR   Coriell; ND12018
DR   Wikidata; Q54924627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12022
AC   CVCL_CM05
DR   Coriell; ND12022
DR   Wikidata; Q54924628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12023
AC   CVCL_CM06
DR   Coriell; ND12023
DR   Wikidata; Q54924629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12024
AC   CVCL_CM07
DR   Coriell; ND12024
DR   Wikidata; Q54924630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12025
AC   CVCL_BI85
DR   CLO; CLO_0022787
DR   Coriell; ND12025
DR   Wikidata; Q54924631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12026
AC   CVCL_EX41
DR   CLO; CLO_0022784
DR   BioSample; SAMN00797101
DR   Coriell; ND12026
DR   Wikidata; Q54924632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12027
AC   CVCL_BI86
DR   CLO; CLO_0022774
DR   Coriell; ND12027
DR   Wikidata; Q54924633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12028
AC   CVCL_BI87
DR   CLO; CLO_0022773
DR   Coriell; ND12028
DR   Wikidata; Q54924634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12029
AC   CVCL_EB30
DR   Coriell; ND12029
DR   Wikidata; Q54924635
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND12032
AC   CVCL_CM08
DR   Coriell; ND12032
DR   Wikidata; Q54924636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12033
AC   CVCL_CM09
DR   Coriell; ND12033
DR   Wikidata; Q54924637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12034
AC   CVCL_BI88
DR   CLO; CLO_0022772
DR   Coriell; ND12034
DR   Wikidata; Q54924638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12035
AC   CVCL_BI89
DR   CLO; CLO_0022771
DR   Coriell; ND12035
DR   Wikidata; Q54924639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12036
AC   CVCL_BI90
DR   CLO; CLO_0022770
DR   Coriell; ND12036
DR   Wikidata; Q54924640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12037
AC   CVCL_EB31
DR   Coriell; ND12037
DR   Wikidata; Q54924641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12038
AC   CVCL_BI91
DR   CLO; CLO_0022769
DR   Coriell; ND12038
DR   Wikidata; Q54924642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12039
AC   CVCL_GH05
DR   CLO; CLO_0022778
DR   Coriell; ND12039
DR   Wikidata; Q54924643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12040
AC   CVCL_GH06
DR   CLO; CLO_0022777
DR   Coriell; ND12040
DR   Wikidata; Q54924644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12042
AC   CVCL_EB32
DR   Coriell; ND12042
DR   Wikidata; Q54924645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12045
AC   CVCL_EB33
DR   CLO; CLO_0022776
DR   Coriell; ND12045
DR   Wikidata; Q54924646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12046
AC   CVCL_BI92
DR   CLO; CLO_0022775
DR   Coriell; ND12046
DR   Wikidata; Q54924647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12047
AC   CVCL_BI93
DR   CLO; CLO_0022799
DR   Coriell; ND12047
DR   Wikidata; Q54924648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12048
AC   CVCL_BI94
DR   CLO; CLO_0022801
DR   Coriell; ND12048
DR   Wikidata; Q54924649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12049
AC   CVCL_BI95
DR   CLO; CLO_0022800
DR   Coriell; ND12049
DR   Wikidata; Q54924650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12050
AC   CVCL_BI96
DR   CLO; CLO_0022803
DR   Coriell; ND12050
DR   Wikidata; Q54924653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12051
AC   CVCL_BI97
DR   CLO; CLO_0022802
DR   Coriell; ND12051
DR   Wikidata; Q54924654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12052
AC   CVCL_BI98
DR   CLO; CLO_0022805
DR   Coriell; ND12052
DR   Wikidata; Q54924655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12053
AC   CVCL_BI99
DR   CLO; CLO_0022804
DR   Coriell; ND12053
DR   Wikidata; Q54924656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12054
AC   CVCL_BJ00
DR   CLO; CLO_0022807
DR   Coriell; ND12054
DR   Wikidata; Q54924657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12055
AC   CVCL_EX42
DR   CLO; CLO_0022806
DR   BioSample; SAMN00797109
DR   Coriell; ND12055
DR   Wikidata; Q54924658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12056
AC   CVCL_EX43
DR   CLO; CLO_0022808
DR   BioSample; SAMN00797111
DR   Coriell; ND12056
DR   Wikidata; Q54924659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12057
AC   CVCL_GH07
DR   CLO; CLO_0022792
DR   BioSample; SAMN00797113
DR   Coriell; ND12057
DR   Wikidata; Q54924660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12061
AC   CVCL_CM10
DR   Coriell; ND12061
DR   Wikidata; Q54924661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12063
AC   CVCL_EB34
DR   Coriell; ND12063
DR   Wikidata; Q54924662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12067
AC   CVCL_GH08
DR   CLO; CLO_0022791
DR   Coriell; ND12067
DR   Wikidata; Q54924663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12068
AC   CVCL_BJ01
DR   CLO; CLO_0022790
DR   Coriell; ND12068
DR   Wikidata; Q54924664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12069
AC   CVCL_BJ02
DR   CLO; CLO_0022789
DR   Coriell; ND12069
DR   Wikidata; Q54924665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12070
AC   CVCL_BJ03
DR   CLO; CLO_0022796
DR   Coriell; ND12070
DR   Wikidata; Q54924666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12071
AC   CVCL_IL92
DR   CLO; CLO_0022795
DR   Coriell; ND12071
DR   Wikidata; Q54924667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND12071; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND12072
AC   CVCL_BJ04
DR   CLO; CLO_0022794
DR   Coriell; ND12072
DR   Wikidata; Q54924668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12073
AC   CVCL_FB00
DR   CLO; CLO_0022793
DR   Coriell; ND12073
DR   Wikidata; Q54924669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12078
AC   CVCL_BJ05
DR   CLO; CLO_0022798
DR   Coriell; ND12078
DR   Wikidata; Q54924670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12079
AC   CVCL_BJ06
DR   CLO; CLO_0022797
DR   Coriell; ND12079
DR   Wikidata; Q54924671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12080
AC   CVCL_JB55
DR   CLO; CLO_0022053
DR   Coriell; ND12080
DR   Wikidata; Q54924672
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133085; Brachial amyotrophic diplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   ND12081
AC   CVCL_BJ07
DR   CLO; CLO_0022052
DR   Coriell; ND12081
DR   Wikidata; Q54924673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12082
AC   CVCL_FD23
DR   CLO; CLO_0022057
DR   BioSample; SAMN00797117
DR   Coriell; ND12082
DR   Wikidata; Q54924674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12083
AC   CVCL_FB01
DR   CLO; CLO_0022056
DR   Coriell; ND12083
DR   Wikidata; Q54924675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12084
AC   CVCL_BJ08
DR   CLO; CLO_0022055
DR   Coriell; ND12084
DR   Wikidata; Q54924676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12085
AC   CVCL_GH09
DR   CLO; CLO_0022054
DR   Coriell; ND12085
DR   Wikidata; Q54924677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12087
AC   CVCL_GH10
DR   CLO; CLO_0022058
DR   Coriell; ND12087
DR   Wikidata; Q54924678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12088
AC   CVCL_BJ09
DR   CLO; CLO_0022059
DR   Coriell; ND12088
DR   Wikidata; Q54924679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12089
AC   CVCL_BJ10
DR   CLO; CLO_0022060
DR   Coriell; ND12089
DR   Wikidata; Q54924680
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12090
AC   CVCL_BJ11
DR   CLO; CLO_0022061
DR   Coriell; ND12090
DR   Wikidata; Q54924681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12091
AC   CVCL_GH11
DR   CLO; CLO_0022062
DR   Coriell; ND12091
DR   Wikidata; Q54924682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12092
AC   CVCL_FD24
DR   CLO; CLO_0022064
DR   BioSample; SAMN00797121
DR   Coriell; ND12092
DR   Wikidata; Q54924683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12093
AC   CVCL_BJ12
DR   CLO; CLO_0022063
DR   Coriell; ND12093
DR   Wikidata; Q54924684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12094
AC   CVCL_BJ13
DR   CLO; CLO_0022066
DR   Coriell; ND12094
DR   Wikidata; Q54924685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12095
AC   CVCL_BJ14
DR   CLO; CLO_0022065
DR   Coriell; ND12095
DR   Wikidata; Q54924686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12096
AC   CVCL_BJ15
DR   CLO; CLO_0022068
DR   Coriell; ND12096
DR   Wikidata; Q54924687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12097
AC   CVCL_BJ16
DR   CLO; CLO_0022067
DR   Coriell; ND12097
DR   Wikidata; Q54924688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12098
AC   CVCL_BJ17
DR   Coriell; ND12098
DR   Wikidata; Q54924689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12099
AC   CVCL_BJ18
DR   CLO; CLO_0022031
DR   Coriell; ND12099
DR   Wikidata; Q54924690
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12100
AC   CVCL_BJ19
DR   CLO; CLO_0022032
DR   Coriell; ND12100
DR   Wikidata; Q54924691
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12101
AC   CVCL_BJ20
DR   CLO; CLO_0022030
DR   Coriell; ND12101
DR   Wikidata; Q54924692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12102
AC   CVCL_BJ21
DR   CLO; CLO_0022040
DR   Coriell; ND12102
DR   Wikidata; Q54924695
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12103
AC   CVCL_BJ22
DR   CLO; CLO_0022039
DR   Coriell; ND12103
DR   Wikidata; Q54924696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12104
AC   CVCL_BJ23
DR   CLO; CLO_0022038
DR   Coriell; ND12104
DR   Wikidata; Q54924697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12105
AC   CVCL_BJ24
DR   CLO; CLO_0022037
DR   Coriell; ND12105
DR   Wikidata; Q54924698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12106
AC   CVCL_FD25
DR   CLO; CLO_0022036
DR   BioSample; SAMN00797125
DR   Coriell; ND12106
DR   Wikidata; Q54924699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12108
AC   CVCL_EX44
DR   CLO; CLO_0022035
DR   Coriell; ND12108
DR   Wikidata; Q54924700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12109
AC   CVCL_GH12
DR   CLO; CLO_0022034
DR   Coriell; ND12109
DR   Wikidata; Q54924701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12110
AC   CVCL_FD26
DR   CLO; CLO_0022033
DR   BioSample; SAMN00797127
DR   Coriell; ND12110
DR   Wikidata; Q54924702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12112
AC   CVCL_BJ25
DR   CLO; CLO_0022041
DR   Coriell; ND12112
DR   Wikidata; Q54924703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12113
AC   CVCL_BJ26
DR   CLO; CLO_0022042
DR   Coriell; ND12113
DR   Wikidata; Q54924704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12114
AC   CVCL_BJ27
DR   CLO; CLO_0022051
DR   Coriell; ND12114
DR   Wikidata; Q54924705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12115
AC   CVCL_BJ28
DR   CLO; CLO_0022048
DR   Coriell; ND12115
DR   Wikidata; Q54924706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12117
AC   CVCL_BJ29
DR   CLO; CLO_0022047
DR   Coriell; ND12117
DR   Wikidata; Q54924707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12118
AC   CVCL_GH13
DR   CLO; CLO_0022050
DR   Coriell; ND12118
DR   Wikidata; Q54924708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12119
AC   CVCL_BJ30
DR   CLO; CLO_0022049
DR   Coriell; ND12119
DR   Wikidata; Q54924709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12120
AC   CVCL_BJ31
DR   CLO; CLO_0022044
DR   Coriell; ND12120
DR   Wikidata; Q54924710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12121
AC   CVCL_BJ32
DR   CLO; CLO_0022043
DR   Coriell; ND12121
DR   Wikidata; Q54924711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12122
AC   CVCL_BJ33
DR   CLO; CLO_0022046
DR   Coriell; ND12122
DR   Wikidata; Q54924712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12123
AC   CVCL_EX45
DR   CLO; CLO_0022045
DR   Coriell; ND12123
DR   Wikidata; Q54924713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12124
AC   CVCL_BJ34
DR   CLO; CLO_0022009
DR   Coriell; ND12124
DR   Wikidata; Q54924714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12125
AC   CVCL_GH14
DR   CLO; CLO_0022010
DR   Coriell; ND12125
DR   Wikidata; Q54924715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12126
AC   CVCL_BJ35
DR   CLO; CLO_0022011
DR   Coriell; ND12126
DR   Wikidata; Q54924716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12127
AC   CVCL_EX46
DR   CLO; CLO_0022014
DR   BioSample; SAMN00797133
DR   Coriell; ND12127
DR   Wikidata; Q54924717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12128
AC   CVCL_BJ36
DR   CLO; CLO_0022015
DR   Coriell; ND12128
DR   Wikidata; Q54924718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12129
AC   CVCL_GH15
DR   CLO; CLO_0022012
DR   BioSample; SAMN00797137
DR   Coriell; ND12129
DR   Wikidata; Q54924719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12130
AC   CVCL_BJ37
DR   Coriell; ND12130
DR   Wikidata; Q54924720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12131
AC   CVCL_BJ38
DR   CLO; CLO_0022013
DR   Coriell; ND12131
DR   Wikidata; Q54924721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12132
AC   CVCL_BJ39
DR   CLO; CLO_0022018
DR   Coriell; ND12132
DR   Wikidata; Q54924722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12133
AC   CVCL_GH16
DR   CLO; CLO_0022019
DR   BioSample; SAMN00797143
DR   Coriell; ND12133
DR   Wikidata; Q54924723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12135
AC   CVCL_BJ40
DR   CLO; CLO_0022016
DR   Coriell; ND12135
DR   Wikidata; Q54924724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12136
AC   CVCL_BJ41
DR   CLO; CLO_0022017
DR   Coriell; ND12136
DR   Wikidata; Q54924725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12137
AC   CVCL_GH17
DR   CLO; CLO_0022020
DR   BioSample; SAMN00797145
DR   Coriell; ND12137
DR   Wikidata; Q54924726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12139
AC   CVCL_BJ42
DR   CLO; CLO_0022021
DR   Coriell; ND12139
DR   Wikidata; Q54924727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12140
AC   CVCL_BJ43
DR   CLO; CLO_0022022
DR   Coriell; ND12140
DR   Wikidata; Q54924729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12141
AC   CVCL_GH18
DR   CLO; CLO_0022023
DR   Coriell; ND12141
DR   Wikidata; Q54924730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12142
AC   CVCL_FF24
DR   CLO; CLO_0022024
DR   Coriell; ND12142
DR   Wikidata; Q54924731
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12143
AC   CVCL_GH19
DR   CLO; CLO_0022025
DR   Coriell; ND12143
DR   Wikidata; Q54924732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12144
AC   CVCL_FF25
DR   CLO; CLO_0022026
DR   Coriell; ND12144
DR   Wikidata; Q54924733
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12145
AC   CVCL_GH20
DR   CLO; CLO_0022027
DR   Coriell; ND12145
DR   Wikidata; Q54924734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12146
AC   CVCL_EX47
DR   CLO; CLO_0022028
DR   Coriell; ND12146
DR   Wikidata; Q54924735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12147
AC   CVCL_GH21
DR   CLO; CLO_0022029
DR   Coriell; ND12147
DR   Wikidata; Q54924738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12148
AC   CVCL_GH22
DR   CLO; CLO_0021991
DR   Coriell; ND12148
DR   Wikidata; Q54924739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12149
AC   CVCL_GH23
DR   CLO; CLO_0021992
DR   Coriell; ND12149
DR   Wikidata; Q54924740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12150
AC   CVCL_BJ44
DR   CLO; CLO_0021989
DR   Coriell; ND12150
DR   Wikidata; Q54924741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12151
AC   CVCL_GH24
DR   CLO; CLO_0021990
DR   Coriell; ND12151
DR   Wikidata; Q54924742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12153
AC   CVCL_FZ48
DR   Coriell; ND12153
DR   Wikidata; Q54924743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12154
AC   CVCL_FB02
DR   CLO; CLO_0021997
DR   Coriell; ND12154
DR   Wikidata; Q54924744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12155
AC   CVCL_BJ45
DR   CLO; CLO_0021998
DR   Coriell; ND12155
DR   Wikidata; Q54924745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12156
AC   CVCL_GH25
DR   CLO; CLO_0021995
DR   Coriell; ND12156
DR   Wikidata; Q54924746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12157
AC   CVCL_GH26
DR   CLO; CLO_0021996
DR   Coriell; ND12157
DR   Wikidata; Q54924747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12158
AC   CVCL_BJ46
DR   Coriell; ND12158
DR   Wikidata; Q54924748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12159
AC   CVCL_BJ47
DR   CLO; CLO_0021993
DR   Coriell; ND12159
DR   Wikidata; Q54924749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12160
AC   CVCL_GH27
DR   CLO; CLO_0021994
DR   BioSample; SAMN00797155
DR   Coriell; ND12160
DR   Wikidata; Q54924750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12161
AC   CVCL_BJ48
DR   CLO; CLO_0022003
DR   Coriell; ND12161
DR   Wikidata; Q54924751
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12163
AC   CVCL_BJ49
DR   CLO; CLO_0021999
DR   Coriell; ND12163
DR   Wikidata; Q54924752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12164
AC   CVCL_BJ50
DR   CLO; CLO_0022000
DR   Coriell; ND12164
DR   Wikidata; Q54924753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12165
AC   CVCL_BJ51
DR   CLO; CLO_0022001
DR   Coriell; ND12165
DR   Wikidata; Q54924754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12166
AC   CVCL_BJ52
DR   CLO; CLO_0022002
DR   Coriell; ND12166
DR   Wikidata; Q54924755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12167
AC   CVCL_BJ53
DR   CLO; CLO_0022005
DR   Coriell; ND12167
DR   Wikidata; Q54924756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12168
AC   CVCL_BJ54
DR   CLO; CLO_0022006
DR   Coriell; ND12168
DR   Wikidata; Q54924757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12169
AC   CVCL_FB03
DR   CLO; CLO_0022007
DR   Coriell; ND12169
DR   Wikidata; Q54924758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12170
AC   CVCL_EX48
DR   CLO; CLO_0022008
DR   BioSample; SAMN00797161
DR   Coriell; ND12170
DR   Wikidata; Q54924759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12171
AC   CVCL_BJ55
DR   CLO; CLO_0022004
DR   Coriell; ND12171
DR   Wikidata; Q54924760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12172
AC   CVCL_BJ56
DR   CLO; CLO_0022088
DR   Coriell; ND12172
DR   Wikidata; Q54924761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12173
AC   CVCL_GH28
DR   CLO; CLO_0022087
DR   BioSample; SAMN00797165
DR   Coriell; ND12173
DR   Wikidata; Q54924762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12174
AC   CVCL_IL93
DR   CLO; CLO_0022084
DR   Coriell; ND12174
DR   Wikidata; Q54924763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND12174; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND12175
AC   CVCL_BJ57
DR   CLO; CLO_0022083
DR   Coriell; ND12175
DR   Wikidata; Q54924764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12176
AC   CVCL_BJ58
DR   CLO; CLO_0022086
DR   Coriell; ND12176
DR   Wikidata; Q54924765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12177
AC   CVCL_EX49
DR   CLO; CLO_0022085
DR   BioSample; SAMN00797171
DR   Coriell; ND12177
DR   Wikidata; Q54924766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12178
AC   CVCL_BJ59
DR   CLO; CLO_0022080
DR   Coriell; ND12178
DR   Wikidata; Q54924767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12179
AC   CVCL_FF26
DR   BioSample; SAMN00797175
DR   Coriell; ND12179
DR   Wikidata; Q54924768
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND12180
AC   CVCL_BJ60
DR   CLO; CLO_0022079
DR   Coriell; ND12180
DR   Wikidata; Q54924769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12181
AC   CVCL_GH29
DR   CLO; CLO_0022082
DR   BioSample; SAMN00797179
DR   Coriell; ND12181
DR   Wikidata; Q54924770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12182
AC   CVCL_BJ61
DR   CLO; CLO_0022081
DR   Coriell; ND12182
DR   Wikidata; Q54924771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12183
AC   CVCL_GH30
DR   CLO; CLO_0022078
DR   Coriell; ND12183
DR   Wikidata; Q54924772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12185
AC   CVCL_CM11
DR   Coriell; ND12185
DR   Wikidata; Q54924773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12187
AC   CVCL_CM12
DR   BioSample; SAMN00797181
DR   Coriell; ND12187
DR   Wikidata; Q54924774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND12190
AC   CVCL_BJ62
DR   CLO; CLO_0022077
DR   Coriell; ND12190
DR   Wikidata; Q54924775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12191
AC   CVCL_FD27
DR   CLO; CLO_0022076
DR   Coriell; ND12191
DR   Wikidata; Q54924776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12192
AC   CVCL_GH31
DR   CLO; CLO_0022075
DR   Coriell; ND12192
DR   Wikidata; Q54924777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12193
AC   CVCL_GH32
DR   CLO; CLO_0022074
DR   Coriell; ND12193
DR   Wikidata; Q54924779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12194
AC   CVCL_BJ63
DR   CLO; CLO_0022073
DR   Coriell; ND12194
DR   Wikidata; Q54924780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12195
AC   CVCL_BJ64
DR   CLO; CLO_0022072
DR   Coriell; ND12195
DR   Wikidata; Q54924781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12196
AC   CVCL_BJ65
DR   CLO; CLO_0022071
DR   Coriell; ND12196
DR   Wikidata; Q54924782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12197
AC   CVCL_EB35
DR   CLO; CLO_0022070
DR   Coriell; ND12197
DR   Wikidata; Q54924783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12198
AC   CVCL_FB04
DR   CLO; CLO_0022069
DR   Coriell; ND12198
DR   Wikidata; Q54924784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12199
AC   CVCL_BJ66
DR   CLO; CLO_0022163
DR   Coriell; ND12199
DR   Wikidata; Q54924785
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12200
AC   CVCL_BJ67
DR   CLO; CLO_0022159
DR   Coriell; ND12200
DR   Wikidata; Q54924786
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12201
AC   CVCL_GH33
DR   CLO; CLO_0022160
DR   Coriell; ND12201
DR   Wikidata; Q54924787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12202
AC   CVCL_BJ68
DR   CLO; CLO_0022161
DR   Coriell; ND12202
DR   Wikidata; Q54924788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12203
AC   CVCL_BJ69
DR   CLO; CLO_0022162
DR   Coriell; ND12203
DR   Wikidata; Q54924789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12204
AC   CVCL_IJ91
DR   CLO; CLO_0022174
DR   Coriell; ND12204
DR   Wikidata; Q54924790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12205
AC   CVCL_BJ70
DR   CLO; CLO_0022173
DR   Coriell; ND12205
DR   Wikidata; Q54924791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12206
AC   CVCL_BJ71
DR   CLO; CLO_0022172
DR   Coriell; ND12206
DR   Wikidata; Q54924792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12207
AC   CVCL_EB36
DR   CLO; CLO_0022171
DR   Coriell; ND12207
DR   Wikidata; Q54924793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12208
AC   CVCL_EB37
DR   CLO; CLO_0022170
DR   Coriell; ND12208
DR   Wikidata; Q54924794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12209
AC   CVCL_BJ72
DR   CLO; CLO_0022168
DR   Coriell; ND12209
DR   Wikidata; Q54924795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12210
AC   CVCL_BJ73
DR   CLO; CLO_0022169
DR   Coriell; ND12210
DR   Wikidata; Q54924796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12212
AC   CVCL_FD28
DR   CLO; CLO_0022166
DR   BioSample; SAMN00797184
DR   Coriell; ND12212
DR   Wikidata; Q54924797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12213
AC   CVCL_BJ74
DR   CLO; CLO_0022167
DR   Coriell; ND12213
DR   Wikidata; Q54924798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12214
AC   CVCL_BJ75
DR   CLO; CLO_0022164
DR   Coriell; ND12214
DR   Wikidata; Q54924799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12215
AC   CVCL_BJ76
DR   CLO; CLO_0022165
DR   Coriell; ND12215
DR   Wikidata; Q54924800
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Puerto Rican.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND12216
AC   CVCL_BJ77
DR   CLO; CLO_0022227
DR   Coriell; ND12216
DR   Wikidata; Q54924801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12217
AC   CVCL_BJ78
DR   CLO; CLO_0022228
DR   Coriell; ND12217
DR   Wikidata; Q54924802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12218
AC   CVCL_BJ79
DR   CLO; CLO_0022225
DR   Coriell; ND12218
DR   Wikidata; Q54924803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND14318 (Cellosaurus=CVCL_DR43).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   ND12219
AC   CVCL_FD29
DR   CLO; CLO_0022226
DR   Coriell; ND12219
DR   Wikidata; Q54924804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12220
AC   CVCL_FD30
DR   CLO; CLO_0022231
DR   Coriell; ND12220
DR   Wikidata; Q54924805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12221
AC   CVCL_FD31
DR   CLO; CLO_0022230
DR   Coriell; ND12221
DR   Wikidata; Q54924806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12222
AC   CVCL_GH34
DR   CLO; CLO_0022229
DR   Coriell; ND12222
DR   Wikidata; Q54924807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12223
AC   CVCL_IE46
DR   Coriell; ND12223
DR   Wikidata; Q54924808
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12224
AC   CVCL_GH35
DR   CLO; CLO_0022235
DR   Coriell; ND12224
DR   Wikidata; Q54924809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12225
AC   CVCL_GH36
DR   CLO; CLO_0022234
DR   Coriell; ND12225
DR   Wikidata; Q54924810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12226
AC   CVCL_BJ80
DR   CLO; CLO_0022233
DR   Coriell; ND12226
DR   Wikidata; Q54924811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12227
AC   CVCL_IL94
DR   CLO; CLO_0022232
DR   Coriell; ND12227
DR   Wikidata; Q54924812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND12227; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND12228
AC   CVCL_CM13
DR   CLO; CLO_0022236
DR   Coriell; ND12228
DR   Wikidata; Q54924813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12229
AC   CVCL_CM14
DR   CLO; CLO_0022237
DR   Coriell; ND12229
DR   Wikidata; Q54924814
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND12230
AC   CVCL_EX50
DR   CLO; CLO_0022238
DR   Coriell; ND12230
DR   Wikidata; Q54924815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12231
AC   CVCL_BJ81
DR   CLO; CLO_0022240
DR   Coriell; ND12231
DR   Wikidata; Q54924816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12232
AC   CVCL_EB38
DR   CLO; CLO_0022239
DR   Coriell; ND12232
DR   Wikidata; Q54924817
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND12235
AC   CVCL_GH37
DR   CLO; CLO_0022242
DR   BioSample; SAMN00797186
DR   Coriell; ND12235
DR   Wikidata; Q54924818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12236
AC   CVCL_BJ82
DR   CLO; CLO_0022241
DR   Coriell; ND12236
DR   Wikidata; Q54924820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12237
AC   CVCL_BJ83
DR   CLO; CLO_0022244
DR   Coriell; ND12237
DR   Wikidata; Q54924821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12238
AC   CVCL_BJ84
DR   CLO; CLO_0022243
DR   Coriell; ND12238
DR   Wikidata; Q54924822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12239
AC   CVCL_BJ85
DR   CLO; CLO_0022246
DR   Coriell; ND12239
DR   Wikidata; Q54924823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12240
AC   CVCL_GH38
DR   CLO; CLO_0022245
DR   Coriell; ND12240
DR   Wikidata; Q54924824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12241
AC   CVCL_GH39
DR   CLO; CLO_0022247
DR   Coriell; ND12241
DR   Wikidata; Q54924825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12242
AC   CVCL_GH40
DR   CLO; CLO_0022248
DR   Coriell; ND12242
DR   Wikidata; Q54924826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12249
AC   CVCL_BJ86
DR   CLO; CLO_0022249
DR   Coriell; ND12249
DR   Wikidata; Q54924827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12250
AC   CVCL_GH41
DR   CLO; CLO_0022257
DR   Coriell; ND12250
DR   Wikidata; Q54924828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12251
AC   CVCL_GH42
DR   CLO; CLO_0022256
DR   Coriell; ND12251
DR   Wikidata; Q54924829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12252
AC   CVCL_BJ87
DR   CLO; CLO_0022255
DR   Coriell; ND12252
DR   Wikidata; Q54924830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12253
AC   CVCL_GH43
DR   CLO; CLO_0022254
DR   BioSample; SAMN00797192
DR   Coriell; ND12253
DR   Wikidata; Q54924831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12254
AC   CVCL_EY23
DR   CLO; CLO_0022253
DR   Coriell; ND12254
DR   Wikidata; Q54924832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12256
AC   CVCL_HV84
DR   Coriell; ND12256
DR   Wikidata; Q54924833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12257
AC   CVCL_CM15
DR   Coriell; ND12257
DR   Wikidata; Q54924834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12259
AC   CVCL_EX51
DR   CLO; CLO_0022252
DR   BioSample; SAMN00797196
DR   Coriell; ND12259
DR   Wikidata; Q54924835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12260
AC   CVCL_GH44
DR   CLO; CLO_0022251
DR   Coriell; ND12260
DR   Wikidata; Q54924836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12261
AC   CVCL_GH45
DR   CLO; CLO_0022250
DR   Coriell; ND12261
DR   Wikidata; Q54924837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12263
AC   CVCL_FB05
DR   CLO; CLO_0022258
DR   Coriell; ND12263
DR   Wikidata; Q54924838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12264
AC   CVCL_BJ88
DR   CLO; CLO_0022260
DR   Coriell; ND12264
DR   Wikidata; Q54924839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12265
AC   CVCL_GH46
DR   CLO; CLO_0022259
DR   BioSample; SAMN00797202
DR   Coriell; ND12265
DR   Wikidata; Q54924840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12266
AC   CVCL_BJ89
DR   CLO; CLO_0022266
DR   Coriell; ND12266
DR   Wikidata; Q54924841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12267
AC   CVCL_BJ90
DR   CLO; CLO_0022265
DR   Coriell; ND12267
DR   Wikidata; Q54924842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12268
AC   CVCL_BJ91
DR   CLO; CLO_0022268
DR   Coriell; ND12268
DR   Wikidata; Q54924843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12269
AC   CVCL_BJ92
DR   CLO; CLO_0022267
DR   Coriell; ND12269
DR   Wikidata; Q54924844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12270
AC   CVCL_BJ93
DR   Coriell; ND12270
DR   Wikidata; Q54924845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12271
AC   CVCL_GH47
DR   CLO; CLO_0022262
DR   Coriell; ND12271
DR   Wikidata; Q54924846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12272
AC   CVCL_BJ94
DR   CLO; CLO_0022261
DR   Coriell; ND12272
DR   Wikidata; Q54924847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12273
AC   CVCL_GH48
DR   CLO; CLO_0022264
DR   Coriell; ND12273
DR   Wikidata; Q54924848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12274
AC   CVCL_BJ95
DR   CLO; CLO_0022263
DR   Coriell; ND12274
DR   Wikidata; Q54924849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12275
AC   CVCL_FF27
DR   CLO; CLO_0022194
DR   Coriell; ND12275
DR   Wikidata; Q54924850
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12276
AC   CVCL_BJ96
DR   CLO; CLO_0022192
DR   Coriell; ND12276
DR   Wikidata; Q54924851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12277
AC   CVCL_BJ97
DR   CLO; CLO_0022193
DR   Coriell; ND12277
DR   Wikidata; Q54924852
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12278
AC   CVCL_BJ98
DR   CLO; CLO_0022187
DR   Coriell; ND12278
DR   Wikidata; Q54924853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12279
AC   CVCL_FD32
DR   CLO; CLO_0022188
DR   Coriell; ND12279
DR   Wikidata; Q54924854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12280
AC   CVCL_GH49
DR   CLO; CLO_0022185
DR   Coriell; ND12280
DR   Wikidata; Q54924855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12281
AC   CVCL_BJ99
DR   CLO; CLO_0022186
DR   Coriell; ND12281
DR   Wikidata; Q54924856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12282
AC   CVCL_BK00
DR   CLO; CLO_0022190
DR   Coriell; ND12282
DR   Wikidata; Q54924857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12283
AC   CVCL_BK01
DR   CLO; CLO_0022191
DR   Coriell; ND12283
DR   Wikidata; Q54924858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12284
AC   CVCL_BK02
DR   CLO; CLO_0022189
DR   Coriell; ND12284
DR   Wikidata; Q54924859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12285
AC   CVCL_GH50
DR   CLO; CLO_0022201
DR   BioSample; SAMN00797206
DR   Coriell; ND12285
DR   Wikidata; Q54924861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12286
AC   CVCL_BK03
DR   CLO; CLO_0022202
DR   Coriell; ND12286
DR   Wikidata; Q54924862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12287
AC   CVCL_BK04
DR   CLO; CLO_0022203
DR   Coriell; ND12287
DR   Wikidata; Q54924863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12288
AC   CVCL_BK05
DR   CLO; CLO_0022204
DR   Coriell; ND12288
DR   Wikidata; Q54924864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12289
AC   CVCL_BK06
DR   CLO; CLO_0022195
DR   Coriell; ND12289
DR   Wikidata; Q54924865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12290
AC   CVCL_BK07
DR   CLO; CLO_0022196
DR   Coriell; ND12290
DR   Wikidata; Q54924866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12291
AC   CVCL_FD33
DR   CLO; CLO_0022197
DR   Coriell; ND12291
DR   Wikidata; Q54924867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12292
AC   CVCL_BK08
DR   CLO; CLO_0022198
DR   Coriell; ND12292
DR   Wikidata; Q54924868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12293
AC   CVCL_FB06
DR   CLO; CLO_0022199
DR   Coriell; ND12293
DR   Wikidata; Q54924869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12294
AC   CVCL_BK09
DR   CLO; CLO_0022200
DR   Coriell; ND12294
DR   Wikidata; Q54924870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12295
AC   CVCL_BK10
DR   CLO; CLO_0022214
DR   Coriell; ND12295
DR   Wikidata; Q54924871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12296
AC   CVCL_BK11
DR   CLO; CLO_0022212
DR   Coriell; ND12296
DR   Wikidata; Q54924872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12297
AC   CVCL_GH51
DR   CLO; CLO_0022213
DR   BioSample; SAMN00797208
DR   Coriell; ND12297
DR   Wikidata; Q54924873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12298
AC   CVCL_BK12
DR   CLO; CLO_0022210
DR   Coriell; ND12298
DR   Wikidata; Q54924874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12302
AC   CVCL_CM16
DR   BioSample; SAMN00797212
DR   Coriell; ND12302
DR   Wikidata; Q54924875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND12303
AC   CVCL_CM17
DR   Coriell; ND12303
DR   Wikidata; Q54924876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12304
AC   CVCL_CM18
DR   Coriell; ND12304
DR   Wikidata; Q54924877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12305
AC   CVCL_HV85
DR   Coriell; ND12305
DR   Wikidata; Q54924878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12307
AC   CVCL_BK13
DR   CLO; CLO_0022211
DR   Coriell; ND12307
DR   Wikidata; Q54924879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12308
AC   CVCL_FD34
DR   CLO; CLO_0022208
DR   BioSample; SAMN00797218
DR   Coriell; ND12308
DR   Wikidata; Q54924880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12309
AC   CVCL_BK14
DR   CLO; CLO_0022209
DR   Coriell; ND12309
DR   Wikidata; Q54924881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12310
AC   CVCL_BK15
DR   CLO; CLO_0022206
DR   Coriell; ND12310
DR   Wikidata; Q54924882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12311
AC   CVCL_EX52
DR   CLO; CLO_0022207
DR   Coriell; ND12311
DR   Wikidata; Q54924883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12312
AC   CVCL_FB07
DR   CLO; CLO_0022205
DR   Coriell; ND12312
DR   Wikidata; Q54924884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12313
AC   CVCL_GH52
DR   CLO; CLO_0022223
DR   BioSample; SAMN00797222
DR   Coriell; ND12313
DR   Wikidata; Q54924885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12314
AC   CVCL_BK16
DR   CLO; CLO_0022224
DR   Coriell; ND12314
DR   Wikidata; Q54924886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12315
AC   CVCL_CW87
DR   CLO; CLO_0022219
DR   BioSample; SAMN00797226
DR   Coriell; ND12315
DR   Wikidata; Q54924887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND12316
AC   CVCL_BK17
DR   CLO; CLO_0022220
DR   Coriell; ND12316
DR   Wikidata; Q54924888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12317
AC   CVCL_BK18
DR   CLO; CLO_0022221
DR   Coriell; ND12317
DR   Wikidata; Q54924889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12318
AC   CVCL_BK19
DR   CLO; CLO_0022222
DR   Coriell; ND12318
DR   Wikidata; Q54924890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12319
AC   CVCL_BK20
DR   CLO; CLO_0022215
DR   Coriell; ND12319
DR   Wikidata; Q54924891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12320
AC   CVCL_GH53
DR   CLO; CLO_0022216
DR   BioSample; SAMN00797230
DR   Coriell; ND12320
DR   Wikidata; Q54924892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12321
AC   CVCL_BK21
DR   CLO; CLO_0022217
DR   Coriell; ND12321
DR   Wikidata; Q54924893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12322
AC   CVCL_FB08
DR   CLO; CLO_0022218
DR   Coriell; ND12322
DR   Wikidata; Q54924894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12323
AC   CVCL_GH54
DR   CLO; CLO_0021856
DR   Coriell; ND12323
DR   Wikidata; Q54924895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12324
AC   CVCL_GH55
DR   CLO; CLO_0021855
DR   Coriell; ND12324
DR   Wikidata; Q54924896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12325
AC   CVCL_BK22
DR   CLO; CLO_0021858
DR   Coriell; ND12325
DR   Wikidata; Q54924897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12326
AC   CVCL_FD35
DR   CLO; CLO_0021857
DR   BioSample; SAMN00797234
DR   Coriell; ND12326
DR   Wikidata; Q54924898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12327
AC   CVCL_BK23
DR   CLO; CLO_0021829
DR   Coriell; ND12327
DR   Wikidata; Q54924899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12328
AC   CVCL_EX53
DR   CLO; CLO_0021830
DR   BioSample; SAMN00797236
DR   Coriell; ND12328
DR   Wikidata; Q54924900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12329
AC   CVCL_BK24
DR   CLO; CLO_0021824
DR   Coriell; ND12329
DR   Wikidata; Q54924903
RX   PubMed=22572540;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Asn387Thr (c.1160A>C) (c.1549A>C); ClinVar=VCV000448854; Zygosity=Heterozygous (PubMed=22572540).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   ND12330
AC   CVCL_EX54
DR   CLO; CLO_0021826
DR   BioSample; SAMN00797240
DR   Coriell; ND12330
DR   Wikidata; Q54924904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12331
AC   CVCL_BK25
DR   CLO; CLO_0021833
DR   Coriell; ND12331
DR   Wikidata; Q54924905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12332
AC   CVCL_BK26
DR   CLO; CLO_0021835
DR   Coriell; ND12332
DR   Wikidata; Q54924906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12334
AC   CVCL_BK27
DR   CLO; CLO_0021840
DR   Coriell; ND12334
DR   Wikidata; Q54924907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12335
AC   CVCL_EX55
DR   CLO; CLO_0021844
DR   BioSample; SAMN00797248
DR   Coriell; ND12335
DR   Wikidata; Q54924908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12341
AC   CVCL_HV86
DR   Coriell; ND12341
DR   Wikidata; Q54924909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12342
AC   CVCL_CM19
DR   Coriell; ND12342
DR   Wikidata; Q54924910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12345
AC   CVCL_BK28
DR   CLO; CLO_0021843
DR   Coriell; ND12345
DR   Wikidata; Q54924911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12346
AC   CVCL_GH56
DR   CLO; CLO_0021842
DR   BioSample; SAMN00797252
DR   Coriell; ND12346
DR   Wikidata; Q54924912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12347
AC   CVCL_BK29
DR   CLO; CLO_0021841
DR   Coriell; ND12347
DR   Wikidata; Q54924913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12348
AC   CVCL_HR76
DR   CLO; CLO_0021814
DR   Coriell; ND12348
DR   Wikidata; Q54924914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12349
AC   CVCL_HR77
DR   CLO; CLO_0021815
DR   Coriell; ND12349
DR   Wikidata; Q54924915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12351
AC   CVCL_BK30
DR   CLO; CLO_0021816
DR   Coriell; ND12351
DR   Wikidata; Q54924916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12352
AC   CVCL_BK31
DR   CLO; CLO_0021817
DR   Coriell; ND12352
DR   Wikidata; Q54924917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12353
AC   CVCL_FB09
DR   CLO; CLO_0021813
DR   Coriell; ND12353
DR   Wikidata; Q54924918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12354
AC   CVCL_FB10
DR   CLO; CLO_0021823
DR   Coriell; ND12354
DR   Wikidata; Q54924919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12355
AC   CVCL_BK32
DR   CLO; CLO_0021822
DR   Coriell; ND12355
DR   Wikidata; Q54924920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12356
AC   CVCL_GH57
DR   CLO; CLO_0021819
DR   BioSample; SAMN00797262
DR   Coriell; ND12356
DR   Wikidata; Q54924921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12357
AC   CVCL_BK33
DR   CLO; CLO_0021818
DR   Coriell; ND12357
DR   Wikidata; Q54924922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12358
AC   CVCL_BK34
DR   CLO; CLO_0021821
DR   Coriell; ND12358
DR   Wikidata; Q54924923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12359
AC   CVCL_GH58
DR   CLO; CLO_0021820
DR   BioSample; SAMN00797264
DR   Coriell; ND12359
DR   Wikidata; Q54924924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12360
AC   CVCL_FB11
DR   Coriell; ND12360
DR   Wikidata; Q54924925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12361
AC   CVCL_GH59
DR   CLO; CLO_0021797
DR   Coriell; ND12361
DR   Wikidata; Q54924926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12362
AC   CVCL_GH60
DR   CLO; CLO_0021798
DR   Coriell; ND12362
DR   Wikidata; Q54924927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12363
AC   CVCL_BK35
DR   CLO; CLO_0021792
DR   Coriell; ND12363
DR   Wikidata; Q54924928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12364
AC   CVCL_BK36
DR   CLO; CLO_0021795
DR   Coriell; ND12364
DR   Wikidata; Q54924929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12366
AC   CVCL_FD36
DR   CLO; CLO_0021812
DR   Coriell; ND12366
DR   Wikidata; Q54924930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12367
AC   CVCL_FD37
DR   CLO; CLO_0021811
DR   Coriell; ND12367
DR   Wikidata; Q54924931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12368
AC   CVCL_BK37
DR   CLO; CLO_0021810
DR   Coriell; ND12368
DR   Wikidata; Q54924932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12369
AC   CVCL_BK38
DR   CLO; CLO_0021809
DR   Coriell; ND12369
DR   Wikidata; Q54924933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12371
AC   CVCL_GH61
DR   CLO; CLO_0021808
DR   BioSample; SAMN00797268
DR   Coriell; ND12371
DR   Wikidata; Q54924934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12372
AC   CVCL_GH62
DR   CLO; CLO_0021807
DR   Coriell; ND12372
DR   Wikidata; Q54924935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12373
AC   CVCL_FD38
DR   CLO; CLO_0021806
DR   Coriell; ND12373
DR   Wikidata; Q54924936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12374
AC   CVCL_BK39
DR   CLO; CLO_0021736
DR   Coriell; ND12374
DR   Wikidata; Q54924937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12375
AC   CVCL_BK40
DR   CLO; CLO_0021734
DR   Coriell; ND12375
DR   Wikidata; Q54924938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12376
AC   CVCL_BK41
DR   CLO; CLO_0021732
DR   Coriell; ND12376
DR   Wikidata; Q54924939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12377
AC   CVCL_GH63
DR   CLO; CLO_0021723
DR   BioSample; SAMN00797272
DR   Coriell; ND12377
DR   Wikidata; Q54924940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12379
AC   CVCL_EX56
DR   CLO; CLO_0021725
DR   BioSample; SAMN00797274
DR   Coriell; ND12379
DR   Wikidata; Q54924941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12380
AC   CVCL_BK42
DR   CLO; CLO_0021721
DR   Coriell; ND12380
DR   Wikidata; Q54924942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12381
AC   CVCL_BK43
DR   CLO; CLO_0021722
DR   Coriell; ND12381
DR   Wikidata; Q54924945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12382
AC   CVCL_BK44
DR   CLO; CLO_0021728
DR   Coriell; ND12382
DR   Wikidata; Q54924946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12383
AC   CVCL_GH64
DR   CLO; CLO_0021729
DR   Coriell; ND12383
DR   Wikidata; Q54924947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12384
AC   CVCL_GH65
DR   CLO; CLO_0021726
DR   Coriell; ND12384
DR   Wikidata; Q54924948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12385
AC   CVCL_GH66
DR   CLO; CLO_0021727
DR   Coriell; ND12385
DR   Wikidata; Q54924949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12386
AC   CVCL_GH67
DR   CLO; CLO_0021714
DR   Coriell; ND12386
DR   Wikidata; Q54924950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12387
AC   CVCL_BK45
DR   CLO; CLO_0021712
DR   Coriell; ND12387
DR   Wikidata; Q54924951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12388
AC   CVCL_BK46
DR   CLO; CLO_0021710
DR   Coriell; ND12388
DR   Wikidata; Q54924952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12389
AC   CVCL_BK47
DR   CLO; CLO_0021700
DR   Coriell; ND12389
DR   Wikidata; Q54924953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12390
AC   CVCL_BK48
DR   CLO; CLO_0021702
DR   Coriell; ND12390
DR   Wikidata; Q54924954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12391
AC   CVCL_BK49
DR   Coriell; ND12391
DR   Wikidata; Q54924955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12392
AC   CVCL_BK50
DR   CLO; CLO_0021704
DR   Coriell; ND12392
DR   Wikidata; Q54924956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12393
AC   CVCL_BK51
DR   CLO; CLO_0021705
DR   Coriell; ND12393
DR   Wikidata; Q54924957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12394
AC   CVCL_FD39
DR   CLO; CLO_0021706
DR   Coriell; ND12394
DR   Wikidata; Q54924958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12395
AC   CVCL_GH68
DR   CLO; CLO_0021707
DR   Coriell; ND12395
DR   Wikidata; Q54924959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12398
AC   CVCL_EB39
DR   Coriell; ND12398
DR   Wikidata; Q54924960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12400
AC   CVCL_BK52
DR   CLO; CLO_0021708
DR   Coriell; ND12400
DR   Wikidata; Q54924961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12402
AC   CVCL_BK53
DR   CLO; CLO_0021709
DR   Coriell; ND12402
DR   Wikidata; Q54924962
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12403
AC   CVCL_BK54
DR   CLO; CLO_0021698
DR   Coriell; ND12403
DR   Wikidata; Q54924964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12414
AC   CVCL_EB40
DR   CLO; CLO_0021687
DR   Coriell; ND12414
DR   Wikidata; Q54924965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12415
AC   CVCL_EB41
DR   CLO; CLO_0021688
DR   Coriell; ND12415
DR   Wikidata; Q54924966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12416
AC   CVCL_BK55
DR   CLO; CLO_0021685
DR   Coriell; ND12416
DR   Wikidata; Q54924967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12417
AC   CVCL_BK56
DR   CLO; CLO_0021686
DR   Coriell; ND12417
DR   Wikidata; Q54924968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12418
AC   CVCL_EX57
DR   CLO; CLO_0021683
DR   BioSample; SAMN00797280
DR   Coriell; ND12418
DR   Wikidata; Q54924969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12419
AC   CVCL_BK57
DR   CLO; CLO_0021684
DR   Coriell; ND12419
DR   Wikidata; Q54924970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12420
AC   CVCL_BK58
DR   CLO; CLO_0021681
DR   Coriell; ND12420
DR   Wikidata; Q54924971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12421
AC   CVCL_BK59
DR   CLO; CLO_0021682
DR   Coriell; ND12421
DR   Wikidata; Q54924972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND12422 (Cellosaurus=CVCL_DR42).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   ND12422
AC   CVCL_DR42
DR   CLO; CLO_0021679
DR   Coriell; ND12422
DR   Wikidata; Q54924973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND12421 (Cellosaurus=CVCL_BK59).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   ND12423
AC   CVCL_BK60
DR   CLO; CLO_0021680
DR   Coriell; ND12423
DR   Wikidata; Q54924974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12424
AC   CVCL_GH69
DR   CLO; CLO_0021666
DR   BioSample; SAMN00797286
DR   Coriell; ND12424
DR   Wikidata; Q54924975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12425
AC   CVCL_BK61
DR   CLO; CLO_0021667
DR   Coriell; ND12425
DR   Wikidata; Q54924976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12426
AC   CVCL_BK62
DR   CLO; CLO_0021668
DR   Coriell; ND12426
DR   Wikidata; Q54924977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12427
AC   CVCL_BK63
DR   CLO; CLO_0021662
DR   Coriell; ND12427
DR   Wikidata; Q54924978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12428
AC   CVCL_BK64
DR   CLO; CLO_0021663
DR   Coriell; ND12428
DR   Wikidata; Q54924979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12429
AC   CVCL_BK65
DR   CLO; CLO_0021664
DR   Coriell; ND12429
DR   Wikidata; Q54924980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12430
AC   CVCL_BK66
DR   CLO; CLO_0021665
DR   Coriell; ND12430
DR   Wikidata; Q54924981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12431
AC   CVCL_EX58
DR   CLO; CLO_0021659
DR   Coriell; ND12431
DR   Wikidata; Q54924982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12432
AC   CVCL_BK67
DR   CLO; CLO_0021660
DR   Coriell; ND12432
DR   Wikidata; Q54924983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12434
AC   CVCL_BK68
DR   CLO; CLO_0021661
DR   Coriell; ND12434
DR   Wikidata; Q54924984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12435
AC   CVCL_BK69
DR   CLO; CLO_0021775
DR   Coriell; ND12435
DR   Wikidata; Q54924985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12438
AC   CVCL_BK70
DR   CLO; CLO_0021774
DR   Coriell; ND12438
DR   Wikidata; Q54924987
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12439
AC   CVCL_IE47
DR   CLO; CLO_0021773
DR   Coriell; ND12439
DR   Wikidata; Q54924988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12445
AC   CVCL_FL61
DR   Coriell; ND12445
DR   Wikidata; Q54924989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12446
AC   CVCL_IJ92
DR   CLO; CLO_0021772
DR   Coriell; ND12446
DR   Wikidata; Q54924990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12447
AC   CVCL_BK71
DR   CLO; CLO_0021783
DR   Coriell; ND12447
DR   Wikidata; Q54924991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12448
AC   CVCL_BK72
DR   CLO; CLO_0021781
DR   Coriell; ND12448
DR   Wikidata; Q54924992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12449
AC   CVCL_BK73
DR   CLO; CLO_0021779
DR   Coriell; ND12449
DR   Wikidata; Q54924993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12450
AC   CVCL_BK74
DR   CLO; CLO_0021776
DR   Coriell; ND12450
DR   Wikidata; Q54924994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12451
AC   CVCL_FB12
DR   CLO; CLO_0021785
DR   Coriell; ND12451
DR   Wikidata; Q54924995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12452
AC   CVCL_BK75
DR   CLO; CLO_0021784
DR   Coriell; ND12452
DR   Wikidata; Q54924996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12453
AC   CVCL_FD40
DR   CLO; CLO_0021762
DR   Coriell; ND12453
DR   Wikidata; Q54924997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12454
AC   CVCL_GH70
DR   CLO; CLO_0021764
DR   Coriell; ND12454
DR   Wikidata; Q54924998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12455
AC   CVCL_BK76
DR   CLO; CLO_0021763
DR   Coriell; ND12455
DR   Wikidata; Q54924999
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12456
AC   CVCL_IE48
DR   CLO; CLO_0021766
DR   Coriell; ND12456
DR   Wikidata; Q54925000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12457
AC   CVCL_IE49
DR   CLO; CLO_0021765
DR   Coriell; ND12457
DR   Wikidata; Q54925001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12458
AC   CVCL_GH71
DR   CLO; CLO_0021768
DR   BioSample; SAMN00797307
DR   Coriell; ND12458
DR   Wikidata; Q54925002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12459
AC   CVCL_IE50
DR   CLO; CLO_0021767
DR   Coriell; ND12459
DR   Wikidata; Q54925003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12460
AC   CVCL_BK77
DR   CLO; CLO_0021770
DR   Coriell; ND12460
DR   Wikidata; Q54925004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12461
AC   CVCL_BK78
DR   CLO; CLO_0021769
DR   Coriell; ND12461
DR   Wikidata; Q54925005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12462
AC   CVCL_BK79
DR   CLO; CLO_0021771
DR   Coriell; ND12462
DR   Wikidata; Q54925006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12463
AC   CVCL_BK80
DR   CLO; CLO_0031175
DR   Coriell; ND12463
DR   Wikidata; Q54925007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12464
AC   CVCL_BK81
DR   CLO; CLO_0031176
DR   Coriell; ND12464
DR   Wikidata; Q54925008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12465
AC   CVCL_BK82
DR   CLO; CLO_0031173
DR   Coriell; ND12465
DR   Wikidata; Q54925009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12466
AC   CVCL_FZ49
DR   Coriell; ND12466
DR   Wikidata; Q54925010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12470
AC   CVCL_EB42
DR   Coriell; ND12470
DR   Wikidata; Q54925011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12473
AC   CVCL_CM20
DR   Coriell; ND12473
DR   Wikidata; Q54925012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12475
AC   CVCL_HV87
DR   Coriell; ND12475
DR   Wikidata; Q54925013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12478
AC   CVCL_FB13
DR   CLO; CLO_0031174
DR   Coriell; ND12478
DR   Wikidata; Q54925014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12479
AC   CVCL_BK83
DR   CLO; CLO_0031171
DR   Coriell; ND12479
DR   Wikidata; Q54925015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12480
AC   CVCL_BK84
DR   CLO; CLO_0031172
DR   Coriell; ND12480
DR   Wikidata; Q54925016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12481
AC   CVCL_BK85
DR   CLO; CLO_0031179
DR   Coriell; ND12481
DR   Wikidata; Q54925017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12482
AC   CVCL_EX59
DR   CLO; CLO_0031180
DR   Coriell; ND12482
DR   Wikidata; Q54925018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12483
AC   CVCL_GH72
DR   CLO; CLO_0031177
DR   Coriell; ND12483
DR   Wikidata; Q54925019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12484
AC   CVCL_BK86
DR   CLO; CLO_0031178
DR   Coriell; ND12484
DR   Wikidata; Q54925021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12485
AC   CVCL_FB14
DR   CLO; CLO_0031241
DR   Coriell; ND12485
DR   Wikidata; Q54925022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12486
AC   CVCL_EX60
DR   CLO; CLO_0031242
DR   BioSample; SAMN00797317
DR   Coriell; ND12486
DR   Wikidata; Q54925023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12487
AC   CVCL_BK87
DR   CLO; CLO_0031243
DR   Coriell; ND12487
DR   Wikidata; Q54925024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12488
AC   CVCL_BK88
DR   CLO; CLO_0031244
DR   Coriell; ND12488
DR   Wikidata; Q54925025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12489
AC   CVCL_GH73
DR   CLO; CLO_0031245
DR   Coriell; ND12489
DR   Wikidata; Q54925026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12490
AC   CVCL_GH74
DR   CLO; CLO_0031246
DR   BioSample; SAMN00797319
DR   Coriell; ND12490
DR   Wikidata; Q54925027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12491
AC   CVCL_BK89
DR   CLO; CLO_0031247
DR   Coriell; ND12491
DR   Wikidata; Q54925029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12492
AC   CVCL_BK90
DR   CLO; CLO_0031249
DR   Coriell; ND12492
DR   Wikidata; Q54925030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12493
AC   CVCL_GH75
DR   CLO; CLO_0031250
DR   Coriell; ND12493
DR   Wikidata; Q54925031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12494
AC   CVCL_GH76
DR   CLO; CLO_0031251
DR   Coriell; ND12494
DR   Wikidata; Q54925032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12495
AC   CVCL_GH77
DR   CLO; CLO_0031213
DR   Coriell; ND12495
DR   Wikidata; Q54925033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12496
AC   CVCL_GH78
DR   CLO; CLO_0031214
DR   Coriell; ND12496
DR   Wikidata; Q54925034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12497
AC   CVCL_EX61
DR   CLO; CLO_0031211
DR   Coriell; ND12497
DR   Wikidata; Q54925035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12498
AC   CVCL_GH79
DR   CLO; CLO_0031212
DR   Coriell; ND12498
DR   Wikidata; Q54925036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12499
AC   CVCL_EB43
DR   CLO; CLO_0031217
DR   Coriell; ND12499
DR   Wikidata; Q54925037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12501
AC   CVCL_EB44
DR   Coriell; ND12501
DR   Wikidata; Q54925038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12502
AC   CVCL_EB45
DR   CLO; CLO_0031218
DR   Coriell; ND12502
DR   Wikidata; Q54925039
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND12503
AC   CVCL_FF28
DR   BioSample; SAMN00797329
DR   Coriell; ND12503
DR   Wikidata; Q54925040
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND12506
AC   CVCL_FL62
DR   Coriell; ND12506
DR   Wikidata; Q54925041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12507
AC   CVCL_IE51
DR   Coriell; ND12507
DR   Wikidata; Q54925042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12510
AC   CVCL_EB46
DR   CLO; CLO_0031215
DR   Coriell; ND12510
DR   Wikidata; Q54925043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12511
AC   CVCL_BK91
DR   CLO; CLO_0031216
DR   Coriell; ND12511
DR   Wikidata; Q54925044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12512
AC   CVCL_GH80
DR   CLO; CLO_0031219
DR   Coriell; ND12512
DR   Wikidata; Q54925045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12513
AC   CVCL_GH81
DR   CLO; CLO_0031220
DR   Coriell; ND12513
DR   Wikidata; Q54925046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12514
AC   CVCL_GH82
DR   CLO; CLO_0031273
DR   Coriell; ND12514
DR   Wikidata; Q54925047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12515
AC   CVCL_GH83
DR   CLO; CLO_0031289
DR   Coriell; ND12515
DR   Wikidata; Q54925048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12516
AC   CVCL_GH84
DR   CLO; CLO_0031288
DR   BioSample; SAMN00797337
DR   Coriell; ND12516
DR   Wikidata; Q54925050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12517
AC   CVCL_BK92
DR   CLO; CLO_0031291
DR   Coriell; ND12517
DR   Wikidata; Q54925051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12519
AC   CVCL_GH85
DR   CLO; CLO_0031290
DR   Coriell; ND12519
DR   Wikidata; Q54925052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12520
AC   CVCL_BK93
DR   CLO; CLO_0031285
DR   Coriell; ND12520
DR   Wikidata; Q54925053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12521
AC   CVCL_BK94
DR   CLO; CLO_0031284
DR   Coriell; ND12521
DR   Wikidata; Q54925055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12522
AC   CVCL_GH86
DR   CLO; CLO_0031287
DR   BioSample; SAMN00797342
DR   Coriell; ND12522
DR   Wikidata; Q54925056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12525
AC   CVCL_BK95
DR   CLO; CLO_0031286
DR   Coriell; ND12525
DR   Wikidata; Q54925057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12526
AC   CVCL_BK96
DR   CLO; CLO_0031283
DR   Coriell; ND12526
DR   Wikidata; Q54925058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12527
AC   CVCL_EB47
DR   Coriell; ND12527
DR   Wikidata; Q54925059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12529
AC   CVCL_EX62
DR   CLO; CLO_0031252
DR   BioSample; SAMN00797344
DR   Coriell; ND12529
DR   Wikidata; Q54925060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12530
AC   CVCL_BK97
DR   Coriell; ND12530
DR   Wikidata; Q54925061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12531
AC   CVCL_BK98
DR   CLO; CLO_0031255
DR   Coriell; ND12531
DR   Wikidata; Q54925062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12532
AC   CVCL_GH87
DR   CLO; CLO_0031271
DR   BioSample; SAMN00797353
DR   Coriell; ND12532
DR   Wikidata; Q54925063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12533
AC   CVCL_BK99
DR   CLO; CLO_0031270
DR   Coriell; ND12533
DR   Wikidata; Q54925064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12534
AC   CVCL_EX63
DR   CLO; CLO_0031269
DR   BioSample; SAMN00797357
DR   Coriell; ND12534
DR   Wikidata; Q54925065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12535
AC   CVCL_FB77
DR   CLO; CLO_0031268
DR   Coriell; ND12535
DR   Wikidata; Q54925066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12536
AC   CVCL_EB48
DR   CLO; CLO_0031267
DR   Coriell; ND12536
DR   Wikidata; Q54925067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12537
AC   CVCL_EB49
DR   CLO; CLO_0031266
DR   Coriell; ND12537
DR   Wikidata; Q54925068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12538
AC   CVCL_FB78
DR   CLO; CLO_0031265
DR   Coriell; ND12538
DR   Wikidata; Q54925069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12539
AC   CVCL_EB50
DR   CLO; CLO_0031264
DR   Coriell; ND12539
DR   Wikidata; Q54925070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12541
AC   CVCL_BL00
DR   CLO; CLO_0031315
DR   Coriell; ND12541
DR   Wikidata; Q54925073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12542
AC   CVCL_BL01
DR   CLO; CLO_0031316
DR   Coriell; ND12542
DR   Wikidata; Q54925074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12543
AC   CVCL_BL02
DR   CLO; CLO_0031318
DR   Coriell; ND12543
DR   Wikidata; Q54925075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12544
AC   CVCL_BL03
DR   CLO; CLO_0031323
DR   Coriell; ND12544
DR   Wikidata; Q54925076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12545
AC   CVCL_BL04
DR   CLO; CLO_0031320
DR   Coriell; ND12545
DR   Wikidata; Q54925077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12546
AC   CVCL_BL05
DR   CLO; CLO_0031326
DR   Coriell; ND12546
DR   Wikidata; Q54925078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12547
AC   CVCL_BL06
DR   Coriell; ND12547
DR   Wikidata; Q54925079
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BA38 ! ND06179
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND12548
AC   CVCL_BL07
DR   CLO; CLO_0031324
DR   Coriell; ND12548
DR   Wikidata; Q54925080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12550
AC   CVCL_BL08
DR   CLO; CLO_0031328
DR   Coriell; ND12550
DR   Wikidata; Q54925081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12551
AC   CVCL_BL09
DR   CLO; CLO_0031327
DR   Coriell; ND12551
DR   Wikidata; Q54925082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12552
AC   CVCL_BL10
DR   CLO; CLO_0031329
DR   Coriell; ND12552
DR   Wikidata; Q54925083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12553
AC   CVCL_BL11
DR   CLO; CLO_0031299
DR   Coriell; ND12553
DR   Wikidata; Q54925084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12554
AC   CVCL_BL12
DR   CLO; CLO_0031301
DR   Coriell; ND12554
DR   Wikidata; Q54925085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12556
AC   CVCL_HV88
DR   Coriell; ND12556
DR   Wikidata; Q54925086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12557
AC   CVCL_IL95
DR   Coriell; ND12557
DR   Wikidata; Q54925087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12558
AC   CVCL_BL13
DR   CLO; CLO_0031296
DR   Coriell; ND12558
DR   Wikidata; Q54925088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12559
AC   CVCL_GH88
DR   CLO; CLO_0031297
DR   Coriell; ND12559
DR   Wikidata; Q54925089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12560
AC   CVCL_IJ93
DR   CLO; CLO_0031306
DR   Coriell; ND12560
DR   Wikidata; Q54925090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12561
AC   CVCL_BL14
DR   CLO; CLO_0031305
DR   Coriell; ND12561
DR   Wikidata; Q54925091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12562
AC   CVCL_IJ94
DR   CLO; CLO_0031304
DR   Coriell; ND12562
DR   Wikidata; Q54925092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12563
AC   CVCL_IJ95
DR   CLO; CLO_0031303
DR   Coriell; ND12563
DR   Wikidata; Q54925093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12564
AC   CVCL_BL15
DR   CLO; CLO_0031308
DR   Coriell; ND12564
DR   Wikidata; Q54925095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12565
AC   CVCL_GH89
DR   CLO; CLO_0031307
DR   BioSample; SAMN00797368
DR   Coriell; ND12565
DR   Wikidata; Q54925096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12566
AC   CVCL_BL16
DR   CLO; CLO_0031546
DR   Coriell; ND12566
DR   Wikidata; Q54925097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12567
AC   CVCL_GH90
DR   CLO; CLO_0031555
DR   Coriell; ND12567
DR   Wikidata; Q54925098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12568
AC   CVCL_GH91
DR   CLO; CLO_0031552
DR   Coriell; ND12568
DR   Wikidata; Q54925099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12569
AC   CVCL_BL17
DR   CLO; CLO_0031550
DR   Coriell; ND12569
DR   Wikidata; Q54925100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12570
AC   CVCL_BL18
DR   CLO; CLO_0031548
DR   Coriell; ND12570
DR   Wikidata; Q54925101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12571
AC   CVCL_GH92
DR   CLO; CLO_0031541
DR   Coriell; ND12571
DR   Wikidata; Q54925102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12572
AC   CVCL_BL19
DR   CLO; CLO_0031542
DR   Coriell; ND12572
DR   Wikidata; Q54925103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12573
AC   CVCL_FD41
DR   CLO; CLO_0031536
DR   Coriell; ND12573
DR   Wikidata; Q54925104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12574
AC   CVCL_GH93
DR   CLO; CLO_0031539
DR   Coriell; ND12574
DR   Wikidata; Q54925105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12575
AC   CVCL_FD42
DR   CLO; CLO_0031545
DR   BioSample; SAMN00797372
DR   Coriell; ND12575
DR   Wikidata; Q54925106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12576
AC   CVCL_BL20
DR   CLO; CLO_0031567
DR   Coriell; ND12576
DR   Wikidata; Q54925107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12577
AC   CVCL_BL21
DR   CLO; CLO_0031566
DR   Coriell; ND12577
DR   Wikidata; Q54925109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12578
AC   CVCL_BL22
DR   CLO; CLO_0031571
DR   Coriell; ND12578
DR   Wikidata; Q54925110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12581
AC   CVCL_HV89
DR   Coriell; ND12581
DR   Wikidata; Q54925111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12582
AC   CVCL_FZ50
DR   Coriell; ND12582
DR   Wikidata; Q54925112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12584
AC   CVCL_FB15
DR   CLO; CLO_0031568
DR   Coriell; ND12584
DR   Wikidata; Q54925113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12585
AC   CVCL_GH94
DR   CLO; CLO_0031574
DR   BioSample; SAMN00797384
DR   Coriell; ND12585
DR   Wikidata; Q54925114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12586
AC   CVCL_BL23
DR   CLO; CLO_0031573
DR   Coriell; ND12586
DR   Wikidata; Q54925117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12587
AC   CVCL_BL24
DR   CLO; CLO_0031556
DR   Coriell; ND12587
DR   Wikidata; Q54925118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12588
AC   CVCL_BL25
DR   CLO; CLO_0031559
DR   Coriell; ND12588
DR   Wikidata; Q54925119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12589
AC   CVCL_BL26
DR   Coriell; ND12589
DR   Wikidata; Q54925120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12590
AC   CVCL_EB51
DR   Coriell; ND12590
DR   Wikidata; Q54925121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12591
AC   CVCL_BL27
DR   CLO; CLO_0031560
DR   Coriell; ND12591
DR   Wikidata; Q54925122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12592
AC   CVCL_BL28
DR   CLO; CLO_0031562
DR   Coriell; ND12592
DR   Wikidata; Q54925123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12593
AC   CVCL_GH95
DR   CLO; CLO_0031518
DR   BioSample; SAMN00797393
DR   Coriell; ND12593
DR   Wikidata; Q54925124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12594
AC   CVCL_BL29
DR   CLO; CLO_0031515
DR   Coriell; ND12594
DR   Wikidata; Q54925125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12595
AC   CVCL_EX64
DR   CLO; CLO_0031513
DR   Coriell; ND12595
DR   Wikidata; Q54925126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12596
AC   CVCL_BL30
DR   Coriell; ND12596
DR   Wikidata; Q54925128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12598
AC   CVCL_BL31
DR   CLO; CLO_0031511
DR   Coriell; ND12598
DR   Wikidata; Q54925129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12600
AC   CVCL_BL32
DR   CLO; CLO_0031507
DR   Coriell; ND12600
DR   Wikidata; Q54925130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12601
AC   CVCL_GH96
DR   CLO; CLO_0031505
DR   BioSample; SAMN00797401
DR   Coriell; ND12601
DR   Wikidata; Q54925131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12602
AC   CVCL_BL33
DR   Coriell; ND12602
DR   Wikidata; Q54925132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12603
AC   CVCL_GH97
DR   CLO; CLO_0031503
DR   BioSample; SAMN00797409
DR   Coriell; ND12603
DR   Wikidata; Q54925133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12604
AC   CVCL_GH98
DR   CLO; CLO_0031499
DR   Coriell; ND12604
DR   Wikidata; Q54925134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12605
AC   CVCL_EB52
DR   CLO; CLO_0031502
DR   Coriell; ND12605
DR   Wikidata; Q54925135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12612
AC   CVCL_GH99
DR   CLO; CLO_0031497
DR   Coriell; ND12612
DR   Wikidata; Q54925136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12614
AC   CVCL_IL96
DR   Coriell; ND12614
DR   Wikidata; Q54925137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12615
AC   CVCL_HV90
DR   Coriell; ND12615
DR   Wikidata; Q54925138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12617
AC   CVCL_GI00
DR   CLO; CLO_0031739
DR   Coriell; ND12617
DR   Wikidata; Q54925139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12618
AC   CVCL_BL34
DR   CLO; CLO_0031741
DR   Coriell; ND12618
DR   Wikidata; Q54925140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12619
AC   CVCL_BL35
DR   CLO; CLO_0031740
DR   Coriell; ND12619
DR   Wikidata; Q54925141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12620
AC   CVCL_BL36
DR   CLO; CLO_0031743
DR   Coriell; ND12620
DR   Wikidata; Q54925142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12621
AC   CVCL_BL37
DR   CLO; CLO_0031742
DR   Coriell; ND12621
DR   Wikidata; Q54925143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12622
AC   CVCL_FD43
DR   CLO; CLO_0031745
DR   BioSample; SAMN00797424
DR   Coriell; ND12622
DR   Wikidata; Q54925144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12623
AC   CVCL_EX65
DR   CLO; CLO_0031744
DR   BioSample; SAMN00797426
DR   Coriell; ND12623
DR   Wikidata; Q54925145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12624
AC   CVCL_EB53
DR   CLO; CLO_0031747
DR   Coriell; ND12624
DR   Wikidata; Q54925146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12625
AC   CVCL_BL38
DR   Coriell; ND12625
DR   Wikidata; Q54925147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12626
AC   CVCL_BL39
DR   CLO; CLO_0031746
DR   Coriell; ND12626
DR   Wikidata; Q54925148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12627
AC   CVCL_GI01
DR   CLO; CLO_0031748
DR   BioSample; SAMN00797430
DR   Coriell; ND12627
DR   Wikidata; Q54925149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12628
AC   CVCL_BL40
DR   CLO; CLO_0031697
DR   Coriell; ND12628
DR   Wikidata; Q54925150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12629
AC   CVCL_BL41
DR   CLO; CLO_0031698
DR   Coriell; ND12629
DR   Wikidata; Q54925151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12630
AC   CVCL_BL42
DR   CLO; CLO_0031693
DR   Coriell; ND12630
DR   Wikidata; Q54925152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12631
AC   CVCL_FB16
DR   CLO; CLO_0031694
DR   Coriell; ND12631
DR   Wikidata; Q54925153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12632
AC   CVCL_IJ96
DR   CLO; CLO_0031695
DR   Coriell; ND12632
DR   Wikidata; Q54925154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12633
AC   CVCL_GI02
DR   CLO; CLO_0031696
DR   BioSample; SAMN00797436
DR   Coriell; ND12633
DR   Wikidata; Q54925155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12634
AC   CVCL_GI03
DR   CLO; CLO_0031689
DR   Coriell; ND12634
DR   Wikidata; Q54925156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12635
AC   CVCL_GI04
DR   CLO; CLO_0031690
DR   Coriell; ND12635
DR   Wikidata; Q54925157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12636
AC   CVCL_GI05
DR   CLO; CLO_0031691
DR   Coriell; ND12636
DR   Wikidata; Q54925159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12637
AC   CVCL_IE52
DR   Coriell; ND12637
DR   Wikidata; Q54925160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12638
AC   CVCL_GI06
DR   CLO; CLO_0031692
DR   Coriell; ND12638
DR   Wikidata; Q54925161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12639
AC   CVCL_GI07
DR   CLO; CLO_0031678
DR   Coriell; ND12639
DR   Wikidata; Q54925162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12640
AC   CVCL_FB17
DR   CLO; CLO_0031676
DR   Coriell; ND12640
DR   Wikidata; Q54925163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12642
AC   CVCL_BL43
DR   CLO; CLO_0031677
DR   Coriell; ND12642
DR   Wikidata; Q54925164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12643
AC   CVCL_BL44
DR   CLO; CLO_0031674
DR   Coriell; ND12643
DR   Wikidata; Q54925165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12644
AC   CVCL_BL45
DR   CLO; CLO_0031675
DR   Coriell; ND12644
DR   Wikidata; Q54925166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12645
AC   CVCL_BL46
DR   CLO; CLO_0031672
DR   Coriell; ND12645
DR   Wikidata; Q54925167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12646
AC   CVCL_CM21
DR   CLO; CLO_0031673
DR   Coriell; ND12646
DR   Wikidata; Q54925168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12647
AC   CVCL_GI08
DR   CLO; CLO_0031670
DR   Coriell; ND12647
DR   Wikidata; Q54925169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12648
AC   CVCL_CM22
DR   CLO; CLO_0031671
DR   Coriell; ND12648
DR   Wikidata; Q54925170
RX   PubMed=17622782;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Thr2356Ile (c.7067C>T); ClinVar=VCV000039232; Zygosity=Heterozygous (PubMed=17622782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   ND12656
AC   CVCL_CM23
DR   Coriell; ND12656
DR   Wikidata; Q54925171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12657
AC   CVCL_HV91
DR   Coriell; ND12657
DR   Wikidata; Q54925172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12658
AC   CVCL_HV92
DR   Coriell; ND12658
DR   Wikidata; Q54925173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12659
AC   CVCL_BL47
DR   CLO; CLO_0031669
DR   Coriell; ND12659
DR   Wikidata; Q54925174
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND12660
AC   CVCL_GI09
DR   CLO; CLO_0031651
DR   Coriell; ND12660
DR   Wikidata; Q54925175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12663
AC   CVCL_BL48
DR   CLO; CLO_0031652
DR   Coriell; ND12663
DR   Wikidata; Q54925176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12664
AC   CVCL_BL49
DR   CLO; CLO_0031653
DR   Coriell; ND12664
DR   Wikidata; Q54925177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12665
AC   CVCL_FB18
DR   CLO; CLO_0031654
DR   Coriell; ND12665
DR   Wikidata; Q54925178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12666
AC   CVCL_BL50
DR   CLO; CLO_0031655
DR   Coriell; ND12666
DR   Wikidata; Q54925179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12667
AC   CVCL_BL51
DR   CLO; CLO_0031656
DR   Coriell; ND12667
DR   Wikidata; Q54925180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12668
AC   CVCL_BL52
DR   CLO; CLO_0031657
DR   Coriell; ND12668
DR   Wikidata; Q54925181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12669
AC   CVCL_BL53
DR   CLO; CLO_0031658
DR   Coriell; ND12669
DR   Wikidata; Q54925182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12670
AC   CVCL_BL54
DR   CLO; CLO_0031649
DR   Coriell; ND12670
DR   Wikidata; Q54925183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12671
AC   CVCL_BL55
DR   CLO; CLO_0031650
DR   Coriell; ND12671
DR   Wikidata; Q54925184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12672
AC   CVCL_BL56
DR   CLO; CLO_0031619
DR   Coriell; ND12672
DR   Wikidata; Q54925185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12673
AC   CVCL_BL57
DR   CLO; CLO_0031633
DR   Coriell; ND12673
DR   Wikidata; Q54925186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12674
AC   CVCL_EB54
DR   Coriell; ND12674
DR   Wikidata; Q54925187
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND12675
AC   CVCL_GI10
DR   CLO; CLO_0031634
DR   Coriell; ND12675
DR   Wikidata; Q54925188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12676
AC   CVCL_GI11
DR   CLO; CLO_0031631
DR   Coriell; ND12676
DR   Wikidata; Q54925189
CC   Population: Uzbekistani.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12677
AC   CVCL_GI12
DR   CLO; CLO_0031632
DR   Coriell; ND12677
DR   Wikidata; Q54925191
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12678
AC   CVCL_EX66
DR   CLO; CLO_0031637
DR   Coriell; ND12678
DR   Wikidata; Q54925192
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12679
AC   CVCL_GI13
DR   CLO; CLO_0031638
DR   BioSample; SAMN00797448
DR   Coriell; ND12679
DR   Wikidata; Q54925193
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND12680
AC   CVCL_BL58
DR   CLO; CLO_0031635
DR   Coriell; ND12680
DR   Wikidata; Q54925194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12681
AC   CVCL_BL59
DR   CLO; CLO_0031636
DR   Coriell; ND12681
DR   Wikidata; Q54925195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12682
AC   CVCL_BL60
DR   CLO; CLO_0031630
DR   Coriell; ND12682
DR   Wikidata; Q54925196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12683
AC   CVCL_BL61
DR   CLO; CLO_0031729
DR   Coriell; ND12683
DR   Wikidata; Q54925197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12684
AC   CVCL_BL62
DR   CLO; CLO_0031730
DR   Coriell; ND12684
DR   Wikidata; Q54925198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12686
AC   CVCL_BL63
DR   CLO; CLO_0031736
DR   Coriell; ND12686
DR   Wikidata; Q54925199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12688
AC   CVCL_FZ51
DR   Coriell; ND12688
DR   Wikidata; Q54925202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12690
AC   CVCL_FZ52
DR   Coriell; ND12690
DR   Wikidata; Q54925203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12692
AC   CVCL_BL64
DR   CLO; CLO_0031735
DR   Coriell; ND12692
DR   Wikidata; Q54925204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12693
AC   CVCL_BL65
DR   CLO; CLO_0031738
DR   Coriell; ND12693
DR   Wikidata; Q54925205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12694
AC   CVCL_BL66
DR   CLO; CLO_0031737
DR   Coriell; ND12694
DR   Wikidata; Q54925206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12695
AC   CVCL_BL67
DR   CLO; CLO_0031732
DR   Coriell; ND12695
DR   Wikidata; Q54925207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12696
AC   CVCL_GI14
DR   CLO; CLO_0031731
DR   Coriell; ND12696
DR   Wikidata; Q54925208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12697
AC   CVCL_BL68
DR   CLO; CLO_0031734
DR   Coriell; ND12697
DR   Wikidata; Q54925209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12698
AC   CVCL_EB55
DR   Coriell; ND12698
DR   Wikidata; Q54925210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12700
AC   CVCL_BL69
DR   CLO; CLO_0031733
DR   Coriell; ND12700
DR   Wikidata; Q54925211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12701
AC   CVCL_GI15
DR   CLO; CLO_0031721
DR   Coriell; ND12701
DR   Wikidata; Q54925212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12702
AC   CVCL_IJ44
DR   CLO; CLO_0031719
DR   Coriell; ND12702
DR   Wikidata; Q54925213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129934; Pseudobulbar palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12703
AC   CVCL_BL70
DR   CLO; CLO_0031720
DR   Coriell; ND12703
DR   Wikidata; Q54925214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12705
AC   CVCL_IJ97
DR   CLO; CLO_0031728
DR   Coriell; ND12705
DR   Wikidata; Q54925215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12706
AC   CVCL_FB19
DR   CLO; CLO_0031727
DR   Coriell; ND12706
DR   Wikidata; Q54925216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12707
AC   CVCL_GI16
DR   CLO; CLO_0031726
DR   Coriell; ND12707
DR   Wikidata; Q54925217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12708
AC   CVCL_EX67
DR   CLO; CLO_0031725
DR   BioSample; SAMN00797457
DR   Coriell; ND12708
DR   Wikidata; Q54925218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12709
AC   CVCL_BL71
DR   CLO; CLO_0031724
DR   Coriell; ND12709
DR   Wikidata; Q54925219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12710
AC   CVCL_EX68
DR   CLO; CLO_0031723
DR   BioSample; SAMN00797461
DR   Coriell; ND12710
DR   Wikidata; Q54925220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12711
AC   CVCL_BL72
DR   CLO; CLO_0031722
DR   Coriell; ND12711
DR   Wikidata; Q54925221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12712
AC   CVCL_GI17
DR   CLO; CLO_0031709
DR   BioSample; SAMN00797465
DR   Coriell; ND12712
DR   Wikidata; Q54925222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12713
AC   CVCL_BL73
DR   CLO; CLO_0031710
DR   Coriell; ND12713
DR   Wikidata; Q54925223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12714
AC   CVCL_BL74
DR   CLO; CLO_0031711
DR   Coriell; ND12714
DR   Wikidata; Q54925224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12715
AC   CVCL_EB56
DR   CLO; CLO_0031712
DR   Coriell; ND12715
DR   Wikidata; Q54925225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12716
AC   CVCL_FB79
DR   CLO; CLO_0031714
DR   Coriell; ND12716
DR   Wikidata; Q54925226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12717
AC   CVCL_FB80
DR   CLO; CLO_0031713
DR   Coriell; ND12717
DR   Wikidata; Q54925227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12718
AC   CVCL_EB57
DR   CLO; CLO_0031716
DR   Coriell; ND12718
DR   Wikidata; Q54925228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12719
AC   CVCL_IJ98
DR   CLO; CLO_0031715
DR   Coriell; ND12719
DR   Wikidata; Q54925229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12720
AC   CVCL_BL75
DR   CLO; CLO_0031718
DR   Coriell; ND12720
DR   Wikidata; Q54925230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12721
AC   CVCL_IJ99
DR   CLO; CLO_0031717
DR   Coriell; ND12721
DR   Wikidata; Q54925231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12722
AC   CVCL_BL76
DR   CLO; CLO_0031699
DR   Coriell; ND12722
DR   Wikidata; Q54925232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12723
AC   CVCL_EX69
DR   CLO; CLO_0031702
DR   BioSample; SAMN00797469
DR   Coriell; ND12723
DR   Wikidata; Q54925233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12724
AC   CVCL_GI18
DR   CLO; CLO_0031703
DR   Coriell; ND12724
DR   Wikidata; Q54925235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12725
AC   CVCL_CM24
DR   CLO; CLO_0031700
DR   Coriell; ND12725
DR   Wikidata; Q54925236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12728
AC   CVCL_FL63
DR   Coriell; ND12728
DR   Wikidata; Q54925237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12736
AC   CVCL_BL77
DR   CLO; CLO_0031701
DR   Coriell; ND12736
DR   Wikidata; Q54925238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12737
AC   CVCL_BL78
DR   CLO; CLO_0031707
DR   Coriell; ND12737
DR   Wikidata; Q54925239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12738
AC   CVCL_BL79
DR   CLO; CLO_0031706
DR   Coriell; ND12738
DR   Wikidata; Q54925240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12739
AC   CVCL_BL80
DR   CLO; CLO_0031705
DR   Coriell; ND12739
DR   Wikidata; Q54925241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12740
AC   CVCL_FD44
DR   CLO; CLO_0031704
DR   Coriell; ND12740
DR   Wikidata; Q54925242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12741
AC   CVCL_BL81
DR   CLO; CLO_0031708
DR   Coriell; ND12741
DR   Wikidata; Q54925244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12742
AC   CVCL_GI19
DR   CLO; CLO_0031944
DR   Coriell; ND12742
DR   Wikidata; Q54925245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12745
AC   CVCL_BL82
DR   CLO; CLO_0031942
DR   Coriell; ND12745
DR   Wikidata; Q54925246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12747
AC   CVCL_BL83
DR   CLO; CLO_0031952
DR   Coriell; ND12747
DR   Wikidata; Q54925247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12748
AC   CVCL_BL84
DR   CLO; CLO_0031950
DR   Coriell; ND12748
DR   Wikidata; Q54925248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12749
AC   CVCL_GI20
DR   CLO; CLO_0031949
DR   BioSample; SAMN00797473
DR   Coriell; ND12749
DR   Wikidata; Q54925249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12750
AC   CVCL_BL85
DR   CLO; CLO_0031948
DR   Coriell; ND12750
DR   Wikidata; Q54925250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12751
AC   CVCL_FD45
DR   CLO; CLO_0031960
DR   Coriell; ND12751
DR   Wikidata; Q54925251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12752
AC   CVCL_BL86
DR   CLO; CLO_0031962
DR   Coriell; ND12752
DR   Wikidata; Q54925252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12753
AC   CVCL_BL87
DR   CLO; CLO_0031955
DR   Coriell; ND12753
DR   Wikidata; Q54925253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12754
AC   CVCL_BL88
DR   CLO; CLO_0031957
DR   Coriell; ND12754
DR   Wikidata; Q54925254
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12755
AC   CVCL_CM25
DR   Coriell; ND12755
DR   Wikidata; Q54925255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12756
AC   CVCL_CM26
DR   Coriell; ND12756
DR   Wikidata; Q54925256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12762
AC   CVCL_FZ53
DR   Coriell; ND12762
DR   Wikidata; Q54925257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12765
AC   CVCL_BL89
DR   CLO; CLO_0032141
DR   Coriell; ND12765
DR   Wikidata; Q54925258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12766
AC   CVCL_GI21
DR   CLO; CLO_0032139
DR   Coriell; ND12766
DR   Wikidata; Q54925259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12767
AC   CVCL_BL90
DR   CLO; CLO_0032145
DR   Coriell; ND12767
DR   Wikidata; Q54925260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12768
AC   CVCL_GI22
DR   CLO; CLO_0032144
DR   BioSample; SAMN00797482
DR   Coriell; ND12768
DR   Wikidata; Q54925261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12769
AC   CVCL_FD46
DR   CLO; CLO_0032136
DR   BioSample; SAMN00797485
DR   Coriell; ND12769
DR   Wikidata; Q54925262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12770
AC   CVCL_BL91
DR   CLO; CLO_0032135
DR   Coriell; ND12770
DR   Wikidata; Q54925263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12771
AC   CVCL_EX70
DR   CLO; CLO_0032138
DR   BioSample; SAMN00797491
DR   Coriell; ND12771
DR   Wikidata; Q54925264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12772
AC   CVCL_BL92
DR   CLO; CLO_0032137
DR   Coriell; ND12772
DR   Wikidata; Q54925265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12773
AC   CVCL_BL93
DR   CLO; CLO_0032134
DR   Coriell; ND12773
DR   Wikidata; Q54925266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12774
AC   CVCL_BL94
DR   CLO; CLO_0032133
DR   Coriell; ND12774
DR   Wikidata; Q54925267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12775
AC   CVCL_GI23
DR   CLO; CLO_0032216
DR   Coriell; ND12775
DR   Wikidata; Q54925268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12776
AC   CVCL_BL95
DR   CLO; CLO_0032228
DR   Coriell; ND12776
DR   Wikidata; Q54925269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12777
AC   CVCL_FD47
DR   CLO; CLO_0032226
DR   Coriell; ND12777
DR   Wikidata; Q54925270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12778
AC   CVCL_BL96
DR   CLO; CLO_0032223
DR   Coriell; ND12778
DR   Wikidata; Q54925271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12779
AC   CVCL_BL97
DR   CLO; CLO_0032222
DR   Coriell; ND12779
DR   Wikidata; Q54925272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12780
AC   CVCL_BL98
DR   CLO; CLO_0032213
DR   Coriell; ND12780
DR   Wikidata; Q54925273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12781
AC   CVCL_BL99
DR   CLO; CLO_0032212
DR   Coriell; ND12781
DR   Wikidata; Q54925274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12782
AC   CVCL_BM00
DR   CLO; CLO_0032211
DR   Coriell; ND12782
DR   Wikidata; Q54925275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12783
AC   CVCL_BM01
DR   CLO; CLO_0032210
DR   Coriell; ND12783
DR   Wikidata; Q54925276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12784
AC   CVCL_EB58
DR   CLO; CLO_0032215
DR   Coriell; ND12784
DR   Wikidata; Q54925277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12785
AC   CVCL_BM02
DR   CLO; CLO_0032189
DR   Coriell; ND12785
DR   Wikidata; Q54925278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12786
AC   CVCL_GI24
DR   CLO; CLO_0032188
DR   Coriell; ND12786
DR   Wikidata; Q54925279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12795
AC   CVCL_BM03
DR   CLO; CLO_0032194
DR   Coriell; ND12795
DR   Wikidata; Q54925280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12797
AC   CVCL_BM04
DR   CLO; CLO_0032192
DR   Coriell; ND12797
DR   Wikidata; Q54925281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12798
AC   CVCL_GI25
DR   CLO; CLO_0032197
DR   Coriell; ND12798
DR   Wikidata; Q54925282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12799
AC   CVCL_IL97
DR   CLO; CLO_0032195
DR   Coriell; ND12799
DR   Wikidata; Q54925283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND12799; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND12800
AC   CVCL_EB59
DR   Coriell; ND12800
DR   Wikidata; Q54925285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12803
AC   CVCL_FA47
DR   CLO; CLO_0032182
DR   Coriell; ND12803
DR   Wikidata; Q54925286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12805
AC   CVCL_FA45
DR   CLO; CLO_0032181
DR   Coriell; ND12805
DR   Wikidata; Q54925287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12806
AC   CVCL_FA46
DR   CLO; CLO_0032184
DR   BioSample; SAMN00797495
DR   Coriell; ND12806
DR   Wikidata; Q54925288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12807
AC   CVCL_BM05
DR   CLO; CLO_0032183
DR   Coriell; ND12807
DR   Wikidata; Q54925289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12808
AC   CVCL_BM06
DR   CLO; CLO_0032083
DR   Coriell; ND12808
DR   Wikidata; Q54925290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12809
AC   CVCL_EX71
DR   CLO; CLO_0032084
DR   BioSample; SAMN00797499
DR   Coriell; ND12809
DR   Wikidata; Q54925291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12810
AC   CVCL_EB60
DR   CLO; CLO_0032085
DR   Coriell; ND12810
DR   Wikidata; Q54925292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12811
AC   CVCL_GI26
DR   CLO; CLO_0032079
DR   BioSample; SAMN00797501
DR   Coriell; ND12811
DR   Wikidata; Q54925293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12813
AC   CVCL_GI27
DR   CLO; CLO_0032080
DR   BioSample; SAMN00797503
DR   Coriell; ND12813
DR   Wikidata; Q54925294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12814
AC   CVCL_BM07
DR   CLO; CLO_0032081
DR   Coriell; ND12814
DR   Wikidata; Q54925295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12815
AC   CVCL_BM08
DR   CLO; CLO_0032082
DR   Coriell; ND12815
DR   Wikidata; Q54925296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12816
AC   CVCL_BM09
DR   CLO; CLO_0032086
DR   Coriell; ND12816
DR   Wikidata; Q54925297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12817
AC   CVCL_BM10
DR   CLO; CLO_0032087
DR   Coriell; ND12817
DR   Wikidata; Q54925298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12818
AC   CVCL_BM11
DR   CLO; CLO_0032088
DR   Coriell; ND12818
DR   Wikidata; Q54925299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12819
AC   CVCL_HR78
DR   CLO; CLO_0032065
DR   Coriell; ND12819
DR   Wikidata; Q54925300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND12820
AC   CVCL_EX72
DR   CLO; CLO_0032066
DR   BioSample; SAMN00797513
DR   Coriell; ND12820
DR   Wikidata; Q54925301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12824
AC   CVCL_HV93
DR   Coriell; ND12824
DR   Wikidata; Q54925302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12825
AC   CVCL_HV94
DR   Coriell; ND12825
DR   Wikidata; Q54925303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12827
AC   CVCL_BM12
DR   CLO; CLO_0032063
DR   Coriell; ND12827
DR   Wikidata; Q54925305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12828
AC   CVCL_BM13
DR   CLO; CLO_0032064
DR   Coriell; ND12828
DR   Wikidata; Q54925306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12829
AC   CVCL_GI28
DR   CLO; CLO_0032061
DR   BioSample; SAMN00797519
DR   Coriell; ND12829
DR   Wikidata; Q54925307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12830
AC   CVCL_BM14
DR   CLO; CLO_0032062
DR   Coriell; ND12830
DR   Wikidata; Q54925308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12833
AC   CVCL_BM15
DR   CLO; CLO_0032059
DR   Coriell; ND12833
DR   Wikidata; Q54925309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12834
AC   CVCL_BM16
DR   CLO; CLO_0032060
DR   Coriell; ND12834
DR   Wikidata; Q54925310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12835
AC   CVCL_BM17
DR   CLO; CLO_0032067
DR   Coriell; ND12835
DR   Wikidata; Q54925311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12836
AC   CVCL_IK00
DR   CLO; CLO_0032068
DR   Coriell; ND12836
DR   Wikidata; Q54925312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12837
AC   CVCL_GI29
DR   CLO; CLO_0032118
DR   BioSample; SAMN00797523
DR   Coriell; ND12837
DR   Wikidata; Q54925313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12838
AC   CVCL_BM18
DR   CLO; CLO_0032109
DR   Coriell; ND12838
DR   Wikidata; Q54925314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12839
AC   CVCL_GI30
DR   CLO; CLO_0032110
DR   Coriell; ND12839
DR   Wikidata; Q54925315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12840
AC   CVCL_BM19
DR   CLO; CLO_0032111
DR   Coriell; ND12840
DR   Wikidata; Q54925316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12841
AC   CVCL_BM20
DR   CLO; CLO_0032112
DR   Coriell; ND12841
DR   Wikidata; Q54925317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12842
AC   CVCL_BM21
DR   CLO; CLO_0032113
DR   Coriell; ND12842
DR   Wikidata; Q54925318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12843
AC   CVCL_BM22
DR   CLO; CLO_0032114
DR   Coriell; ND12843
DR   Wikidata; Q54925319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12844
AC   CVCL_GI31
DR   CLO; CLO_0032115
DR   Coriell; ND12844
DR   Wikidata; Q54925320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12845
AC   CVCL_BM23
DR   CLO; CLO_0032116
DR   Coriell; ND12845
DR   Wikidata; Q54925321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12846
AC   CVCL_BM24
DR   CLO; CLO_0032117
DR   Coriell; ND12846
DR   Wikidata; Q54925322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12847
AC   CVCL_EB61
DR   CLO; CLO_0032108
DR   Coriell; ND12847
DR   Wikidata; Q54925323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12848
AC   CVCL_FB81
DR   CLO; CLO_0032107
DR   Coriell; ND12848
DR   Wikidata; Q54925324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12849
AC   CVCL_BM25
DR   Coriell; ND12849
DR   Wikidata; Q54925325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12850
AC   CVCL_GI32
DR   CLO; CLO_0032101
DR   Coriell; ND12850
DR   Wikidata; Q54925327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12851
AC   CVCL_CM27
DR   CLO; CLO_0032102
DR   Coriell; ND12851
DR   Wikidata; Q54925328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12852
AC   CVCL_EB62
DR   Coriell; ND12852
DR   Wikidata; Q54925329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12854
AC   CVCL_CM28
DR   Coriell; ND12854
DR   Wikidata; Q54925330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12855
AC   CVCL_CM29
DR   Coriell; ND12855
DR   Wikidata; Q54925331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12859
AC   CVCL_GI33
DR   CLO; CLO_0032099
DR   Coriell; ND12859
DR   Wikidata; Q54925332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12860
AC   CVCL_GI34
DR   CLO; CLO_0032100
DR   Coriell; ND12860
DR   Wikidata; Q54925333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12861
AC   CVCL_BM26
DR   CLO; CLO_0032105
DR   Coriell; ND12861
DR   Wikidata; Q54925334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12862
AC   CVCL_BM27
DR   CLO; CLO_0032106
DR   Coriell; ND12862
DR   Wikidata; Q54925335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12863
AC   CVCL_BM28
DR   CLO; CLO_0032103
DR   Coriell; ND12863
DR   Wikidata; Q54925336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12864
AC   CVCL_BM29
DR   CLO; CLO_0032104
DR   Coriell; ND12864
DR   Wikidata; Q54925337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12865
AC   CVCL_FB20
DR   CLO; CLO_0032046
DR   Coriell; ND12865
DR   Wikidata; Q54925338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12866
AC   CVCL_GI35
DR   CLO; CLO_0032047
DR   Coriell; ND12866
DR   Wikidata; Q54925339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12867
AC   CVCL_GI36
DR   CLO; CLO_0032048
DR   Coriell; ND12867
DR   Wikidata; Q54925341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12868
AC   CVCL_BM30
DR   CLO; CLO_0032043
DR   Coriell; ND12868
DR   Wikidata; Q54925342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12869
AC   CVCL_BM31
DR   CLO; CLO_0032042
DR   Coriell; ND12869
DR   Wikidata; Q54925343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12870
AC   CVCL_GI37
DR   CLO; CLO_0032045
DR   Coriell; ND12870
DR   Wikidata; Q54925344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12872
AC   CVCL_GI38
DR   CLO; CLO_0032044
DR   Coriell; ND12872
DR   Wikidata; Q54925345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12873
AC   CVCL_IK01
DR   CLO; CLO_0032040
DR   Coriell; ND12873
DR   Wikidata; Q54925346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12874
AC   CVCL_BM32
DR   CLO; CLO_0032039
DR   Coriell; ND12874
DR   Wikidata; Q54925347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12875
AC   CVCL_BM33
DR   CLO; CLO_0032041
DR   Coriell; ND12875
DR   Wikidata; Q54925348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12876
AC   CVCL_BM34
DR   CLO; CLO_0032037
DR   Coriell; ND12876
DR   Wikidata; Q54925349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12878
AC   CVCL_IE53
DR   Coriell; ND12878
DR   Wikidata; Q54925350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12884
AC   CVCL_GI39
DR   CLO; CLO_0032038
DR   Coriell; ND12884
DR   Wikidata; Q54925351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12885
AC   CVCL_IE54
DR   CLO; CLO_0032035
DR   Coriell; ND12885
DR   Wikidata; Q54925352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12886
AC   CVCL_IE55
DR   CLO; CLO_0032036
DR   Coriell; ND12886
DR   Wikidata; Q54925353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12887
AC   CVCL_GI40
DR   CLO; CLO_0032034
DR   Coriell; ND12887
DR   Wikidata; Q54925354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12888
AC   CVCL_BM35
DR   CLO; CLO_0032033
DR   Coriell; ND12888
DR   Wikidata; Q54925355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12889
AC   CVCL_GI41
DR   CLO; CLO_0032032
DR   Coriell; ND12889
DR   Wikidata; Q54925356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12892
AC   CVCL_BM36
DR   CLO; CLO_0032031
DR   Coriell; ND12892
DR   Wikidata; Q54925357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12893
AC   CVCL_BM37
DR   CLO; CLO_0032030
DR   Coriell; ND12893
DR   Wikidata; Q54925358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12894
AC   CVCL_BM38
DR   CLO; CLO_0032029
DR   Coriell; ND12894
DR   Wikidata; Q54925359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12895
AC   CVCL_EB63
DR   Coriell; ND12895
DR   Wikidata; Q54925360
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND12896
AC   CVCL_EB64
DR   Coriell; ND12896
DR   Wikidata; Q54925361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12901
AC   CVCL_CM30
DR   Coriell; ND12901
DR   Wikidata; Q54925362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12902
AC   CVCL_CM31
DR   Coriell; ND12902
DR   Wikidata; Q54925363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12903
AC   CVCL_BM39
DR   CLO; CLO_0032054
DR   Coriell; ND12903
DR   Wikidata; Q54925364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12904
AC   CVCL_BM40
DR   CLO; CLO_0032055
DR   Coriell; ND12904
DR   Wikidata; Q54925365
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12905
AC   CVCL_BM41
DR   CLO; CLO_0032056
DR   Coriell; ND12905
DR   Wikidata; Q54925366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12906
AC   CVCL_GI42
DR   CLO; CLO_0032057
DR   BioSample; SAMN00797535
DR   Coriell; ND12906
DR   Wikidata; Q54925367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12907
AC   CVCL_GI43
DR   CLO; CLO_0032058
DR   Coriell; ND12907
DR   Wikidata; Q54925370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12908
AC   CVCL_GI44
DR   CLO; CLO_0032050
DR   Coriell; ND12908
DR   Wikidata; Q54925371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12909
AC   CVCL_BM42
DR   CLO; CLO_0032049
DR   Coriell; ND12909
DR   Wikidata; Q54925372
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND12910
AC   CVCL_BM43
DR   CLO; CLO_0032052
DR   Coriell; ND12910
DR   Wikidata; Q54925373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12911
AC   CVCL_BM44
DR   CLO; CLO_0032051
DR   Coriell; ND12911
DR   Wikidata; Q54925374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12912
AC   CVCL_FD48
DR   CLO; CLO_0032053
DR   BioSample; SAMN00797539
DR   Coriell; ND12912
DR   Wikidata; Q54925375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12913
AC   CVCL_BM45
DR   CLO; CLO_0032596
DR   Coriell; ND12913
DR   Wikidata; Q54925376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12914
AC   CVCL_BM46
DR   CLO; CLO_0032597
DR   Coriell; ND12914
DR   Wikidata; Q54925377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12919
AC   CVCL_BM47
DR   CLO; CLO_0032598
DR   Coriell; ND12919
DR   Wikidata; Q54925378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12920
AC   CVCL_GI45
DR   CLO; CLO_0032589
DR   Coriell; ND12920
DR   Wikidata; Q54925380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12921
AC   CVCL_IE56
DR   Coriell; ND12921
DR   Wikidata; Q54925381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12923
AC   CVCL_BM48
DR   CLO; CLO_0032590
DR   Coriell; ND12923
DR   Wikidata; Q54925382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12924
AC   CVCL_BM49
DR   CLO; CLO_0032591
DR   Coriell; ND12924
DR   Wikidata; Q54925383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12925
AC   CVCL_IE57
DR   Coriell; ND12925
DR   Wikidata; Q54925384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12926
AC   CVCL_IE58
DR   Coriell; ND12926
DR   Wikidata; Q54925385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12928
AC   CVCL_HV95
DR   Coriell; ND12928
DR   Wikidata; Q54925386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12931
AC   CVCL_HR79
DR   CLO; CLO_0032592
DR   Coriell; ND12931
DR   Wikidata; Q54925387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND12932
AC   CVCL_BM50
DR   CLO; CLO_0032593
DR   Coriell; ND12932
DR   Wikidata; Q54925388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12933
AC   CVCL_BM51
DR   CLO; CLO_0032594
DR   Coriell; ND12933
DR   Wikidata; Q54925389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12934
AC   CVCL_BM52
DR   CLO; CLO_0032595
DR   Coriell; ND12934
DR   Wikidata; Q54925390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12935
AC   CVCL_BM53
DR   CLO; CLO_0032582
DR   Coriell; ND12935
DR   Wikidata; Q54925391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12937
AC   CVCL_BM54
DR   CLO; CLO_0032581
DR   Coriell; ND12937
DR   Wikidata; Q54925392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12938
AC   CVCL_BM55
DR   CLO; CLO_0032580
DR   Coriell; ND12938
DR   Wikidata; Q54925393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12939
AC   CVCL_BM56
DR   CLO; CLO_0032579
DR   Coriell; ND12939
DR   Wikidata; Q54925394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12942
AC   CVCL_GI46
DR   CLO; CLO_0032588
DR   Coriell; ND12942
DR   Wikidata; Q54925395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12943
AC   CVCL_GI47
DR   CLO; CLO_0032587
DR   Coriell; ND12943
DR   Wikidata; Q54925396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12944
AC   CVCL_GI48
DR   CLO; CLO_0032586
DR   Coriell; ND12944
DR   Wikidata; Q54925397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12945
AC   CVCL_BM57
DR   CLO; CLO_0032585
DR   Coriell; ND12945
DR   Wikidata; Q54925398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12946
AC   CVCL_FD49
DR   CLO; CLO_0032584
DR   BioSample; SAMN00797550
DR   Coriell; ND12946
DR   Wikidata; Q54925399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12947
AC   CVCL_BM58
DR   CLO; CLO_0032583
DR   Coriell; ND12947
DR   Wikidata; Q54925400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12948
AC   CVCL_FL64
DR   Coriell; ND12948
DR   Wikidata; Q54925401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12951
AC   CVCL_GI49
DR   CLO; CLO_0032563
DR   Coriell; ND12951
DR   Wikidata; Q54925402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12952
AC   CVCL_GI50
DR   CLO; CLO_0032560
DR   Coriell; ND12952
DR   Wikidata; Q54925404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12953
AC   CVCL_EX73
DR   CLO; CLO_0032559
DR   Coriell; ND12953
DR   Wikidata; Q54925405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12954
AC   CVCL_GI51
DR   CLO; CLO_0032562
DR   Coriell; ND12954
DR   Wikidata; Q54925406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12955
AC   CVCL_GI52
DR   CLO; CLO_0032561
DR   Coriell; ND12955
DR   Wikidata; Q54925407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12956
AC   CVCL_GI53
DR   CLO; CLO_0032566
DR   Coriell; ND12956
DR   Wikidata; Q54925408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12960
AC   CVCL_CM32
DR   Coriell; ND12960
DR   Wikidata; Q54925409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12961
AC   CVCL_CM33
DR   Coriell; ND12961
DR   Wikidata; Q54925410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12967
AC   CVCL_HV96
DR   Coriell; ND12967
DR   Wikidata; Q54925411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12969
AC   CVCL_GI54
DR   CLO; CLO_0032565
DR   BioSample; SAMN00797556
DR   Coriell; ND12969
DR   Wikidata; Q54925413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12970
AC   CVCL_BM59
DR   CLO; CLO_0032568
DR   Coriell; ND12970
DR   Wikidata; Q54925414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12971
AC   CVCL_GI55
DR   CLO; CLO_0032567
DR   Coriell; ND12971
DR   Wikidata; Q54925415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12972
AC   CVCL_BM60
DR   CLO; CLO_0032564
DR   Coriell; ND12972
DR   Wikidata; Q54925416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12973
AC   CVCL_GI56
DR   CLO; CLO_0032540
DR   Coriell; ND12973
DR   Wikidata; Q54925417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12974
AC   CVCL_IK02
DR   CLO; CLO_0032539
DR   Coriell; ND12974
DR   Wikidata; Q54925418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND12975
AC   CVCL_BM61
DR   CLO; CLO_0032544
DR   Coriell; ND12975
DR   Wikidata; Q54925419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12976
AC   CVCL_BM62
DR   CLO; CLO_0032543
DR   Coriell; ND12976
DR   Wikidata; Q54925420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12977
AC   CVCL_BM63
DR   CLO; CLO_0032542
DR   Coriell; ND12977
DR   Wikidata; Q54925421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12978
AC   CVCL_EB65
DR   CLO; CLO_0032541
DR   Coriell; ND12978
DR   Wikidata; Q54925422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND12979
AC   CVCL_IL98
DR   CLO; CLO_0032548
DR   Coriell; ND12979
DR   Wikidata; Q54925423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND12979; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND12980
AC   CVCL_FB82
DR   CLO; CLO_0032547
DR   Coriell; ND12980
DR   Wikidata; Q54925424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12981
AC   CVCL_GI57
DR   CLO; CLO_0032546
DR   Coriell; ND12981
DR   Wikidata; Q54925425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12982
AC   CVCL_EX74
DR   CLO; CLO_0032545
DR   Coriell; ND12982
DR   Wikidata; Q54925426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12983
AC   CVCL_EX75
DR   CLO; CLO_0032519
DR   Coriell; ND12983
DR   Wikidata; Q54925427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND12984
AC   CVCL_GI58
DR   CLO; CLO_0032521
DR   BioSample; SAMN00797562
DR   Coriell; ND12984
DR   Wikidata; Q54925428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND12993
AC   CVCL_CM34
DR   Coriell; ND12993
DR   Wikidata; Q54925429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND12994
AC   CVCL_BM64
DR   CLO; CLO_0032520
DR   Coriell; ND12994
DR   Wikidata; Q54925430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12995
AC   CVCL_BM65
DR   CLO; CLO_0032523
DR   Coriell; ND12995
DR   Wikidata; Q54925431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12996
AC   CVCL_BM66
DR   CLO; CLO_0032522
DR   Coriell; ND12996
DR   Wikidata; Q54925432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12997
AC   CVCL_BM67
DR   CLO; CLO_0032525
DR   Coriell; ND12997
DR   Wikidata; Q54925433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND12998
AC   CVCL_BM68
DR   CLO; CLO_0032524
DR   Coriell; ND12998
DR   Wikidata; Q54925434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13001
AC   CVCL_HV97
DR   Coriell; ND13001
DR   Wikidata; Q54925435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13002
AC   CVCL_BM69
DR   CLO; CLO_0032527
DR   Coriell; ND13002
DR   Wikidata; Q54925436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13003
AC   CVCL_BM70
DR   CLO; CLO_0032526
DR   Coriell; ND13003
DR   Wikidata; Q54925437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13004
AC   CVCL_FA48
DR   CLO; CLO_0032528
DR   BioSample; SAMN00797568
DR   Coriell; ND13004
DR   Wikidata; Q54925438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13005
AC   CVCL_FB21
DR   CLO; CLO_0032505
DR   Coriell; ND13005
DR   Wikidata; Q54925439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13006
AC   CVCL_BM71
DR   CLO; CLO_0032506
DR   Coriell; ND13006
DR   Wikidata; Q54925440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13007
AC   CVCL_FD50
DR   CLO; CLO_0032507
DR   Coriell; ND13007
DR   Wikidata; Q54925441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13008
AC   CVCL_IE59
DR   Coriell; ND13008
DR   Wikidata; Q54925442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13009
AC   CVCL_GI59
DR   CLO; CLO_0032508
DR   Coriell; ND13009
DR   Wikidata; Q54925443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13010
AC   CVCL_GI60
DR   CLO; CLO_0032501
DR   Coriell; ND13010
DR   Wikidata; Q54925444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13011
AC   CVCL_BM72
DR   CLO; CLO_0032502
DR   Coriell; ND13011
DR   Wikidata; Q54925445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13012
AC   CVCL_BM73
DR   CLO; CLO_0032503
DR   Coriell; ND13012
DR   Wikidata; Q54925446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13013
AC   CVCL_IG80
DR   CLO; CLO_0032504
DR   Coriell; ND13013
DR   Wikidata; Q54925447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND13014
AC   CVCL_CM35
DR   Coriell; ND13014
DR   Wikidata; Q54925448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13015
AC   CVCL_CM36
DR   CLO; CLO_0032499
DR   BioSample; SAMN00797570
DR   Coriell; ND13015
DR   Wikidata; Q54925449
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND13016
AC   CVCL_CM37
DR   CLO; CLO_0032500
DR   BioSample; SAMN00797572
DR   Coriell; ND13016
DR   Wikidata; Q54925450
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND13017
AC   CVCL_CM38
DR   Coriell; ND13017
DR   Wikidata; Q54925451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13020
AC   CVCL_CM39
DR   Coriell; ND13020
DR   Wikidata; Q54925452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13021
AC   CVCL_BM74
DR   CLO; CLO_0032498
DR   Coriell; ND13021
DR   Wikidata; Q54925455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13022
AC   CVCL_IE60
DR   Coriell; ND13022
DR   Wikidata; Q54925456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13023
AC   CVCL_BM75
DR   CLO; CLO_0032496
DR   Coriell; ND13023
DR   Wikidata; Q54925457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13024
AC   CVCL_IK03
DR   Coriell; ND13024
DR   Wikidata; Q54925458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13026
AC   CVCL_GI61
DR   CLO; CLO_0032497
DR   Coriell; ND13026
DR   Wikidata; Q54925459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13029
AC   CVCL_IE61
DR   Coriell; ND13029
DR   Wikidata; Q54925460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13030
AC   CVCL_EB66
DR   Coriell; ND13030
DR   Wikidata; Q54925461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13034
AC   CVCL_BM76
DR   CLO; CLO_0032494
DR   Coriell; ND13034
DR   Wikidata; Q54925462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13039
AC   CVCL_BM77
DR   CLO; CLO_0032495
DR   Coriell; ND13039
DR   Wikidata; Q54925464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13040
AC   CVCL_BM78
DR   CLO; CLO_0032492
DR   Coriell; ND13040
DR   Wikidata; Q54925465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13042
AC   CVCL_EX76
DR   CLO; CLO_0032493
DR   Coriell; ND13042
DR   Wikidata; Q54925466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13043
AC   CVCL_BM79
DR   CLO; CLO_0032490
DR   Coriell; ND13043
DR   Wikidata; Q54925467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13045
AC   CVCL_EX77
DR   CLO; CLO_0032491
DR   BioSample; SAMN00797576
DR   Coriell; ND13045
DR   Wikidata; Q54925468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13046
AC   CVCL_FD51
DR   CLO; CLO_0032489
DR   BioSample; SAMN00797578
DR   Coriell; ND13046
DR   Wikidata; Q54925470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13047
AC   CVCL_BM80
DR   CLO; CLO_0032488
DR   Coriell; ND13047
DR   Wikidata; Q54925471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13048
AC   CVCL_BM81
DR   CLO; CLO_0032487
DR   Coriell; ND13048
DR   Wikidata; Q54925472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13049
AC   CVCL_BM82
DR   CLO; CLO_0032479
DR   Coriell; ND13049
DR   Wikidata; Q54925473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13053
AC   CVCL_BM83
DR   CLO; CLO_0032480
DR   Coriell; ND13053
DR   Wikidata; Q54925474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13054
AC   CVCL_BM84
DR   CLO; CLO_0032481
DR   Coriell; ND13054
DR   Wikidata; Q54925475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13055
AC   CVCL_BM85
DR   CLO; CLO_0032482
DR   Coriell; ND13055
DR   Wikidata; Q54925476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13056
AC   CVCL_BM86
DR   CLO; CLO_0032483
DR   Coriell; ND13056
DR   Wikidata; Q54925477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13057
AC   CVCL_BM87
DR   CLO; CLO_0032484
DR   Coriell; ND13057
DR   Wikidata; Q54925478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13058
AC   CVCL_BM88
DR   CLO; CLO_0032485
DR   Coriell; ND13058
DR   Wikidata; Q54925479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13059
AC   CVCL_GI62
DR   CLO; CLO_0032486
DR   BioSample; SAMN00797586
DR   Coriell; ND13059
DR   Wikidata; Q54925480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13060
AC   CVCL_EX78
DR   CLO; CLO_0032478
DR   Coriell; ND13060
DR   Wikidata; Q54925481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13067
AC   CVCL_GI63
DR   CLO; CLO_0032477
DR   Coriell; ND13067
DR   Wikidata; Q54925482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13068
AC   CVCL_FD52
DR   CLO; CLO_0032476
DR   Coriell; ND13068
DR   Wikidata; Q54925483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13069
AC   CVCL_BM89
DR   CLO; CLO_0032471
DR   Coriell; ND13069
DR   Wikidata; Q54925484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13070
AC   CVCL_BM90
DR   CLO; CLO_0032472
DR   Coriell; ND13070
DR   Wikidata; Q54925485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13071
AC   CVCL_BM91
DR   CLO; CLO_0032469
DR   Coriell; ND13071
DR   Wikidata; Q54925486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13072
AC   CVCL_FD53
DR   CLO; CLO_0032470
DR   Coriell; ND13072
DR   Wikidata; Q54925487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13073
AC   CVCL_BM92
DR   CLO; CLO_0032474
DR   Coriell; ND13073
DR   Wikidata; Q54925488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13074
AC   CVCL_BM93
DR   CLO; CLO_0032475
DR   Coriell; ND13074
DR   Wikidata; Q54925489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13075
AC   CVCL_BM94
DR   CLO; CLO_0032473
DR   Coriell; ND13075
DR   Wikidata; Q54925490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13076
AC   CVCL_IL99
DR   CLO; CLO_0032465
DR   Coriell; ND13076
DR   Wikidata; Q54925491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND13076; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND13077
AC   CVCL_GI64
DR   CLO; CLO_0032466
DR   BioSample; SAMN00797588
DR   Coriell; ND13077
DR   Wikidata; Q54925492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13078
AC   CVCL_BM95
DR   CLO; CLO_0032467
DR   Coriell; ND13078
DR   Wikidata; Q54925493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13079
AC   CVCL_BM96
DR   Coriell; ND13079
DR   Wikidata; Q54925494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13080
AC   CVCL_FD54
DR   CLO; CLO_0032468
DR   BioSample; SAMN00797594
DR   Coriell; ND13080
DR   Wikidata; Q54925495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13081
AC   CVCL_GI65
DR   CLO; CLO_0032462
DR   Coriell; ND13081
DR   Wikidata; Q54925496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13082
AC   CVCL_GI66
DR   CLO; CLO_0032461
DR   Coriell; ND13082
DR   Wikidata; Q54925500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13083
AC   CVCL_GI67
DR   CLO; CLO_0032464
DR   Coriell; ND13083
DR   Wikidata; Q54925501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13084
AC   CVCL_GI68
DR   CLO; CLO_0032463
DR   Coriell; ND13084
DR   Wikidata; Q54925502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13085
AC   CVCL_GI69
DR   CLO; CLO_0032460
DR   Coriell; ND13085
DR   Wikidata; Q54925503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13086
AC   CVCL_GI70
DR   CLO; CLO_0032459
DR   Coriell; ND13086
DR   Wikidata; Q54925504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13091
AC   CVCL_IE62
DR   Coriell; ND13091
DR   Wikidata; Q54925505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13092
AC   CVCL_IM00
DR   Coriell; ND13092
DR   Wikidata; Q54925506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13093
AC   CVCL_CM40
DR   CLO; CLO_0032700
DR   Coriell; ND13093
DR   Wikidata; Q54925507
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13094
AC   CVCL_GI71
DR   CLO; CLO_0032699
DR   Coriell; ND13094
DR   Wikidata; Q54925508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13095
AC   CVCL_BM97
DR   CLO; CLO_0032706
DR   Coriell; ND13095
DR   Wikidata; Q54925509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13096
AC   CVCL_BM98
DR   CLO; CLO_0032705
DR   Coriell; ND13096
DR   Wikidata; Q54925510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13098
AC   CVCL_BM99
DR   CLO; CLO_0032708
DR   Coriell; ND13098
DR   Wikidata; Q54925511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13099
AC   CVCL_GI72
DR   CLO; CLO_0032707
DR   BioSample; SAMN00797598
DR   Coriell; ND13099
DR   Wikidata; Q54925512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13100
AC   CVCL_GI73
DR   CLO; CLO_0032702
DR   Coriell; ND13100
DR   Wikidata; Q54925513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13101
AC   CVCL_BN00
DR   Coriell; ND13101
DR   Wikidata; Q54925514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13102
AC   CVCL_BN01
DR   CLO; CLO_0032701
DR   Coriell; ND13102
DR   Wikidata; Q54925515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13103
AC   CVCL_GI74
DR   CLO; CLO_0032704
DR   Coriell; ND13103
DR   Wikidata; Q54925516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13105
AC   CVCL_IM01
DR   CLO; CLO_0032703
DR   Coriell; ND13105
DR   Wikidata; Q54925517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND13105; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND13106
AC   CVCL_HR80
DR   CLO; CLO_0032721
DR   Coriell; ND13106
DR   Wikidata; Q54925518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND13107
AC   CVCL_BN02
DR   CLO; CLO_0032720
DR   Coriell; ND13107
DR   Wikidata; Q54925519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13108
AC   CVCL_EB67
DR   CLO; CLO_0032719
DR   Coriell; ND13108
DR   Wikidata; Q54925520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13110
AC   CVCL_FB83
DR   CLO; CLO_0032727
DR   Coriell; ND13110
DR   Wikidata; Q54925521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13111
AC   CVCL_EB68
DR   CLO; CLO_0032725
DR   Coriell; ND13111
DR   Wikidata; Q54925522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13112
AC   CVCL_BN03
DR   CLO; CLO_0032723
DR   Coriell; ND13112
DR   Wikidata; Q54925523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13114
AC   CVCL_BN04
DR   CLO; CLO_0032722
DR   Coriell; ND13114
DR   Wikidata; Q54925524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13115
AC   CVCL_GI75
DR   CLO; CLO_0032730
DR   Coriell; ND13115
DR   Wikidata; Q54925525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13116
AC   CVCL_GI76
DR   CLO; CLO_0032729
DR   Coriell; ND13116
DR   Wikidata; Q54925526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13117
AC   CVCL_GI77
DR   CLO; CLO_0032728
DR   Coriell; ND13117
DR   Wikidata; Q54925527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13118
AC   CVCL_CM41
DR   Coriell; ND13118
DR   Wikidata; Q54925528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13127
AC   CVCL_CM42
DR   CLO; CLO_0032740
DR   Coriell; ND13127
DR   Wikidata; Q54925529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13128
AC   CVCL_IH49
DR   CLO; CLO_0032739
DR   Coriell; ND13128
DR   Wikidata; Q54925530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13129
AC   CVCL_GI78
DR   CLO; CLO_0032742
DR   Coriell; ND13129
DR   Wikidata; Q54925531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13130
AC   CVCL_GI79
DR   CLO; CLO_0032741
DR   Coriell; ND13130
DR   Wikidata; Q54925532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13131
AC   CVCL_IE63
DR   Coriell; ND13131
DR   Wikidata; Q54925533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13132
AC   CVCL_IE64
DR   Coriell; ND13132
DR   Wikidata; Q54925534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13133
AC   CVCL_IE65
DR   Coriell; ND13133
DR   Wikidata; Q54925535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13135
AC   CVCL_BN05
DR   CLO; CLO_0032745
DR   Coriell; ND13135
DR   Wikidata; Q54925536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13136
AC   CVCL_BN06
DR   CLO; CLO_0032744
DR   Coriell; ND13136
DR   Wikidata; Q54925537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13137
AC   CVCL_IK04
DR   CLO; CLO_0032747
DR   Coriell; ND13137
DR   Wikidata; Q54925538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13138
AC   CVCL_BN07
DR   CLO; CLO_0032746
DR   Coriell; ND13138
DR   Wikidata; Q54925539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13139
AC   CVCL_BN08
DR   CLO; CLO_0032749
DR   Coriell; ND13139
DR   Wikidata; Q54925541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13140
AC   CVCL_BN09
DR   CLO; CLO_0032748
DR   Coriell; ND13140
DR   Wikidata; Q54925542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13145
AC   CVCL_BN10
DR   CLO; CLO_0032772
DR   Coriell; ND13145
DR   Wikidata; Q54925543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13146
AC   CVCL_BN11
DR   CLO; CLO_0032770
DR   Coriell; ND13146
DR   Wikidata; Q54925544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13147
AC   CVCL_BN12
DR   CLO; CLO_0032771
DR   Coriell; ND13147
DR   Wikidata; Q54925545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13148
AC   CVCL_BN13
DR   CLO; CLO_0032768
DR   Coriell; ND13148
DR   Wikidata; Q54925546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13149
AC   CVCL_BN14
DR   CLO; CLO_0032769
DR   Coriell; ND13149
DR   Wikidata; Q54925547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13150
AC   CVCL_BN15
DR   CLO; CLO_0032765
DR   Coriell; ND13150
DR   Wikidata; Q54925548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13151
AC   CVCL_BN16
DR   CLO; CLO_0032766
DR   Coriell; ND13151
DR   Wikidata; Q54925549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13152
AC   CVCL_BN17
DR   CLO; CLO_0032760
DR   Coriell; ND13152
DR   Wikidata; Q54925550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13153
AC   CVCL_BN18
DR   CLO; CLO_0032763
DR   Coriell; ND13153
DR   Wikidata; Q54925551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13154
AC   CVCL_BN19
DR   CLO; CLO_0032759
DR   Coriell; ND13154
DR   Wikidata; Q54925552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13155
AC   CVCL_BN20
DR   CLO; CLO_0032790
DR   Coriell; ND13155
DR   Wikidata; Q54925553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13156
AC   CVCL_BN21
DR   CLO; CLO_0032791
DR   Coriell; ND13156
DR   Wikidata; Q54925554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13157
AC   CVCL_BN22
DR   CLO; CLO_0032786
DR   Coriell; ND13157
DR   Wikidata; Q54925555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13158
AC   CVCL_BN23
DR   CLO; CLO_0032787
DR   Coriell; ND13158
DR   Wikidata; Q54925556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13159
AC   CVCL_BN24
DR   CLO; CLO_0032788
DR   Coriell; ND13159
DR   Wikidata; Q54925557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13160
AC   CVCL_BN25
DR   CLO; CLO_0032789
DR   Coriell; ND13160
DR   Wikidata; Q54925558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13161
AC   CVCL_BN26
DR   CLO; CLO_0032779
DR   Coriell; ND13161
DR   Wikidata; Q54925559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13162
AC   CVCL_BN27
DR   CLO; CLO_0032781
DR   Coriell; ND13162
DR   Wikidata; Q54925560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13163
AC   CVCL_BN28
DR   CLO; CLO_0032783
DR   Coriell; ND13163
DR   Wikidata; Q54925561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13164
AC   CVCL_BN29
DR   CLO; CLO_0032785
DR   Coriell; ND13164
DR   Wikidata; Q54925562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13165
AC   CVCL_BN30
DR   CLO; CLO_0032804
DR   Coriell; ND13165
DR   Wikidata; Q54925563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13166
AC   CVCL_BN31
DR   CLO; CLO_0032802
DR   Coriell; ND13166
DR   Wikidata; Q54925564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13167
AC   CVCL_BN32
DR   CLO; CLO_0032803
DR   Coriell; ND13167
DR   Wikidata; Q54925565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13168
AC   CVCL_BN33
DR   CLO; CLO_0032807
DR   Coriell; ND13168
DR   Wikidata; Q54925567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13169
AC   CVCL_CM43
DR   Coriell; ND13169
DR   Wikidata; Q54925568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13170
AC   CVCL_CM44
DR   Coriell; ND13170
DR   Wikidata; Q54925569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13178
AC   CVCL_CM45
DR   Coriell; ND13178
DR   Wikidata; Q54925570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13180
AC   CVCL_HV98
DR   Coriell; ND13180
DR   Wikidata; Q54925571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13181
AC   CVCL_GI80
DR   CLO; CLO_0032808
DR   BioSample; SAMN00797610
DR   Coriell; ND13181
DR   Wikidata; Q54925572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13182
AC   CVCL_BN34
DR   CLO; CLO_0032805
DR   Coriell; ND13182
DR   Wikidata; Q54925573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13183
AC   CVCL_BN35
DR   CLO; CLO_0032806
DR   Coriell; ND13183
DR   Wikidata; Q54925574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13184
AC   CVCL_BN36
DR   CLO; CLO_0032800
DR   Coriell; ND13184
DR   Wikidata; Q54925575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13185
AC   CVCL_EX79
DR   CLO; CLO_0032801
DR   Coriell; ND13185
DR   Wikidata; Q54925576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13186
AC   CVCL_GI81
DR   CLO; CLO_0032799
DR   BioSample; SAMN00797616
DR   Coriell; ND13186
DR   Wikidata; Q54925577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13187
AC   CVCL_BN37
DR   CLO; CLO_0032811
DR   Coriell; ND13187
DR   Wikidata; Q54925578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13188
AC   CVCL_BN38
DR   CLO; CLO_0032812
DR   Coriell; ND13188
DR   Wikidata; Q54925579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13189
AC   CVCL_IE66
DR   CLO; CLO_0032813
DR   Coriell; ND13189
DR   Wikidata; Q54925580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13190
AC   CVCL_GI82
DR   CLO; CLO_0032814
DR   Coriell; ND13190
DR   Wikidata; Q54925581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13191
AC   CVCL_GI83
DR   CLO; CLO_0032815
DR   Coriell; ND13191
DR   Wikidata; Q54925584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13192
AC   CVCL_BN39
DR   CLO; CLO_0032816
DR   Coriell; ND13192
DR   Wikidata; Q54925585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13193
AC   CVCL_BN40
DR   CLO; CLO_0032817
DR   Coriell; ND13193
DR   Wikidata; Q54925586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13194
AC   CVCL_BN41
DR   CLO; CLO_0032818
DR   Coriell; ND13194
DR   Wikidata; Q54925587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13195
AC   CVCL_BN42
DR   CLO; CLO_0032809
DR   Coriell; ND13195
DR   Wikidata; Q54925588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13196
AC   CVCL_FB22
DR   CLO; CLO_0032810
DR   Coriell; ND13196
DR   Wikidata; Q54925589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13197
AC   CVCL_BN43
DR   CLO; CLO_0032822
DR   Coriell; ND13197
DR   Wikidata; Q54925590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13198
AC   CVCL_GI84
DR   CLO; CLO_0032836
DR   Coriell; ND13198
DR   Wikidata; Q54925591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13199
AC   CVCL_BN44
DR   CLO; CLO_0032835
DR   Coriell; ND13199
DR   Wikidata; Q54925592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13205
AC   CVCL_FZ54
DR   Coriell; ND13205
DR   Wikidata; Q54925593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13206
AC   CVCL_IM02
DR   Coriell; ND13206
DR   Wikidata; Q54925594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13208
AC   CVCL_EB69
DR   CLO; CLO_0032838
DR   Coriell; ND13208
DR   Wikidata; Q54925595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13209
AC   CVCL_EB70
DR   CLO; CLO_0032837
DR   Coriell; ND13209
DR   Wikidata; Q54925596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13210
AC   CVCL_GI85
DR   CLO; CLO_0032830
DR   Coriell; ND13210
DR   Wikidata; Q54925597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13211
AC   CVCL_EX80
DR   CLO; CLO_0032829
DR   Coriell; ND13211
DR   Wikidata; Q54925598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13212
AC   CVCL_BN45
DR   CLO; CLO_0032834
DR   Coriell; ND13212
DR   Wikidata; Q54925599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13213
AC   CVCL_GI86
DR   CLO; CLO_0032832
DR   Coriell; ND13213
DR   Wikidata; Q54925600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13214
AC   CVCL_GI87
DR   CLO; CLO_0032839
DR   Coriell; ND13214
DR   Wikidata; Q54925601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13215
AC   CVCL_BN46
DR   CLO; CLO_0032841
DR   Coriell; ND13215
DR   Wikidata; Q54925603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13216
AC   CVCL_BN47
DR   CLO; CLO_0032843
DR   Coriell; ND13216
DR   Wikidata; Q54925604
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND13221
AC   CVCL_CM46
DR   Coriell; ND13221
DR   Wikidata; Q54925605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13225
AC   CVCL_IE67
DR   Coriell; ND13225
DR   Wikidata; Q54925606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13246
AC   CVCL_IE68
DR   BioSample; SAMN00797628
DR   Coriell; ND13246
DR   Wikidata; Q54925607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND13258
AC   CVCL_BN48
DR   CLO; CLO_0032860
DR   Coriell; ND13258
DR   Wikidata; Q54925608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13259
AC   CVCL_EX81
DR   CLO; CLO_0032859
DR   BioSample; SAMN00797632
DR   Coriell; ND13259
DR   Wikidata; Q54925609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13260
AC   CVCL_BN49
DR   CLO; CLO_0032858
DR   Coriell; ND13260
DR   Wikidata; Q54925610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13261
AC   CVCL_BN50
DR   CLO; CLO_0032857
DR   Coriell; ND13261
DR   Wikidata; Q54925611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13262
AC   CVCL_GI88
DR   CLO; CLO_0032856
DR   Coriell; ND13262
DR   Wikidata; Q54925612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13263
AC   CVCL_GI89
DR   CLO; CLO_0032855
DR   BioSample; SAMN00797634
DR   Coriell; ND13263
DR   Wikidata; Q54925613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13264
AC   CVCL_GI90
DR   CLO; CLO_0032854
DR   Coriell; ND13264
DR   Wikidata; Q54925614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13269
AC   CVCL_FZ55
DR   Coriell; ND13269
DR   Wikidata; Q54925615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13270
AC   CVCL_FZ56
DR   Coriell; ND13270
DR   Wikidata; Q54925616
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13271
AC   CVCL_CM47
DR   CLO; CLO_0032851
DR   Coriell; ND13271
DR   Wikidata; Q54925617
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13272
AC   CVCL_CM48
DR   Coriell; ND13272
DR   Wikidata; Q54925618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13273
AC   CVCL_BN51
DR   CLO; CLO_0032867
DR   Coriell; ND13273
DR   Wikidata; Q54925619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13274
AC   CVCL_BN52
DR   Coriell; ND13274
DR   Wikidata; Q54925621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13275
AC   CVCL_BN53
DR   CLO; CLO_0032868
DR   Coriell; ND13275
DR   Wikidata; Q54925622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13276
AC   CVCL_IE69
DR   Coriell; ND13276
DR   Wikidata; Q54925623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13279
AC   CVCL_FL65
DR   Coriell; ND13279
DR   Wikidata; Q54925624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13280
AC   CVCL_IE70
DR   Coriell; ND13280
DR   Wikidata; Q54925625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13285
AC   CVCL_FD55
DR   CLO; CLO_0032869
DR   Coriell; ND13285
DR   Wikidata; Q54925627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13286
AC   CVCL_GI91
DR   CLO; CLO_0032871
DR   Coriell; ND13286
DR   Wikidata; Q54925628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13287
AC   CVCL_GI92
DR   CLO; CLO_0032870
DR   Coriell; ND13287
DR   Wikidata; Q54925629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13288
AC   CVCL_GI93
DR   CLO; CLO_0032873
DR   Coriell; ND13288
DR   Wikidata; Q54925630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13289
AC   CVCL_GI94
DR   CLO; CLO_0032872
DR   Coriell; ND13289
DR   Wikidata; Q54925631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13290
AC   CVCL_FD56
DR   CLO; CLO_0032875
DR   Coriell; ND13290
DR   Wikidata; Q54925632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13292
AC   CVCL_GI95
DR   CLO; CLO_0032874
DR   BioSample; SAMN00797644
DR   Coriell; ND13292
DR   Wikidata; Q54925633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13293
AC   CVCL_BN54
DR   CLO; CLO_0032876
DR   Coriell; ND13293
DR   Wikidata; Q54925634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13294
AC   CVCL_GI96
DR   CLO; CLO_0033136
DR   BioSample; SAMN00797646
DR   Coriell; ND13294
DR   Wikidata; Q54925635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13295
AC   CVCL_BN55
DR   CLO; CLO_0033146
DR   Coriell; ND13295
DR   Wikidata; Q54925636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13296
AC   CVCL_IE71
DR   CLO; CLO_0033148
DR   Coriell; ND13296
DR   Wikidata; Q54925637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13297
AC   CVCL_BN56
DR   CLO; CLO_0033141
DR   Coriell; ND13297
DR   Wikidata; Q54925638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13299
AC   CVCL_GI97
DR   CLO; CLO_0033144
DR   Coriell; ND13299
DR   Wikidata; Q54925639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13300
AC   CVCL_GI98
DR   CLO; CLO_0033139
DR   Coriell; ND13300
DR   Wikidata; Q54925640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13301
AC   CVCL_GI99
DR   CLO; CLO_0033140
DR   Coriell; ND13301
DR   Wikidata; Q54925641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13302
AC   CVCL_GJ00
DR   CLO; CLO_0033137
DR   Coriell; ND13302
DR   Wikidata; Q54925642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13303
AC   CVCL_GJ01
DR   CLO; CLO_0033138
DR   Coriell; ND13303
DR   Wikidata; Q54925643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13304
AC   CVCL_FD57
DR   CLO; CLO_0033292
DR   Coriell; ND13304
DR   Wikidata; Q54925644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13305
AC   CVCL_EX82
DR   CLO; CLO_0033268
DR   Coriell; ND13305
DR   Wikidata; Q54925645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13306
AC   CVCL_EX83
DR   CLO; CLO_0033267
DR   Coriell; ND13306
DR   Wikidata; Q54925646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13307
AC   CVCL_EX84
DR   CLO; CLO_0033266
DR   Coriell; ND13307
DR   Wikidata; Q54925647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13308
AC   CVCL_GJ02
DR   CLO; CLO_0033264
DR   Coriell; ND13308
DR   Wikidata; Q54925648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13309
AC   CVCL_GJ03
DR   CLO; CLO_0033263
DR   Coriell; ND13309
DR   Wikidata; Q54925649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13310
AC   CVCL_EX85
DR   CLO; CLO_0033262
DR   Coriell; ND13310
DR   Wikidata; Q54925650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13311
AC   CVCL_GJ04
DR   CLO; CLO_0033261
DR   Coriell; ND13311
DR   Wikidata; Q54925651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13312
AC   CVCL_GJ05
DR   CLO; CLO_0033260
DR   Coriell; ND13312
DR   Wikidata; Q54925652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13313
AC   CVCL_EX86
DR   CLO; CLO_0033259
DR   Coriell; ND13313
DR   Wikidata; Q54925653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13314
AC   CVCL_GJ06
DR   CLO; CLO_0033258
DR   Coriell; ND13314
DR   Wikidata; Q54925654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13315
AC   CVCL_GJ07
DR   CLO; CLO_0033306
DR   Coriell; ND13315
DR   Wikidata; Q54925655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13316
AC   CVCL_IE72
DR   Coriell; ND13316
DR   Wikidata; Q54925656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13317
AC   CVCL_IE73
DR   Coriell; ND13317
DR   Wikidata; Q54925657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13318
AC   CVCL_GJ08
DR   CLO; CLO_0033308
DR   Coriell; ND13318
DR   Wikidata; Q54925658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13319
AC   CVCL_GJ09
DR   CLO; CLO_0033307
DR   Coriell; ND13319
DR   Wikidata; Q54925659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13320
AC   CVCL_GJ10
DR   CLO; CLO_0033303
DR   Coriell; ND13320
DR   Wikidata; Q54925660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13321
AC   CVCL_GJ11
DR   CLO; CLO_0033302
DR   Coriell; ND13321
DR   Wikidata; Q54925661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13322
AC   CVCL_FD58
DR   CLO; CLO_0033305
DR   Coriell; ND13322
DR   Wikidata; Q54925662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13323
AC   CVCL_GJ12
DR   CLO; CLO_0033304
DR   Coriell; ND13323
DR   Wikidata; Q54925663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13324
AC   CVCL_GJ13
DR   CLO; CLO_0033300
DR   Coriell; ND13324
DR   Wikidata; Q54925664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13325
AC   CVCL_GJ14
DR   CLO; CLO_0033299
DR   Coriell; ND13325
DR   Wikidata; Q54925665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13326
AC   CVCL_GJ15
DR   CLO; CLO_0033301
DR   Coriell; ND13326
DR   Wikidata; Q54925666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13327
AC   CVCL_GJ16
DR   CLO; CLO_0033190
DR   Coriell; ND13327
DR   Wikidata; Q54925668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13328
AC   CVCL_GJ17
DR   CLO; CLO_0033189
DR   Coriell; ND13328
DR   Wikidata; Q54925670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13329
AC   CVCL_FD59
DR   CLO; CLO_0033188
DR   Coriell; ND13329
DR   Wikidata; Q54925671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13330
AC   CVCL_GJ18
DR   CLO; CLO_0033187
DR   Coriell; ND13330
DR   Wikidata; Q54925672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13331
AC   CVCL_BN57
DR   CLO; CLO_0033183
DR   Coriell; ND13331
DR   Wikidata; Q54925673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13332
AC   CVCL_FD60
DR   CLO; CLO_0033181
DR   BioSample; SAMN00797652
DR   Coriell; ND13332
DR   Wikidata; Q54925674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13333
AC   CVCL_EX87
DR   CLO; CLO_0033180
DR   Coriell; ND13333
DR   Wikidata; Q54925675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13334
AC   CVCL_GJ19
DR   CLO; CLO_0033178
DR   Coriell; ND13334
DR   Wikidata; Q54925676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13335
AC   CVCL_GJ20
DR   CLO; CLO_0033186
DR   Coriell; ND13335
DR   Wikidata; Q54925677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13336
AC   CVCL_EX88
DR   CLO; CLO_0033185
DR   Coriell; ND13336
DR   Wikidata; Q54925678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13337
AC   CVCL_GJ21
DR   CLO; CLO_0033225
DR   Coriell; ND13337
DR   Wikidata; Q54925679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13338
AC   CVCL_FB23
DR   CLO; CLO_0033227
DR   Coriell; ND13338
DR   Wikidata; Q54925680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13339
AC   CVCL_BN58
DR   Coriell; ND13339
DR   Wikidata; Q54925681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13340
AC   CVCL_BN59
DR   CLO; CLO_0033226
DR   Coriell; ND13340
DR   Wikidata; Q54925682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13341
AC   CVCL_FB24
DR   CLO; CLO_0033229
DR   Coriell; ND13341
DR   Wikidata; Q54925683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13342
AC   CVCL_GJ22
DR   CLO; CLO_0033228
DR   Coriell; ND13342
DR   Wikidata; Q54925685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13343
AC   CVCL_GJ23
DR   CLO; CLO_0033221
DR   Coriell; ND13343
DR   Wikidata; Q54925686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13344
AC   CVCL_GJ24
DR   CLO; CLO_0033218
DR   Coriell; ND13344
DR   Wikidata; Q54925688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13345
AC   CVCL_GJ25
DR   CLO; CLO_0033223
DR   Coriell; ND13345
DR   Wikidata; Q54925689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13346
AC   CVCL_GJ26
DR   CLO; CLO_0033222
DR   Coriell; ND13346
DR   Wikidata; Q54925690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13347
AC   CVCL_BN60
DR   CLO; CLO_0033224
DR   Coriell; ND13347
DR   Wikidata; Q54925691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13348
AC   CVCL_GJ27
DR   CLO; CLO_0033403
DR   BioSample; SAMN00797656
DR   Coriell; ND13348
DR   Wikidata; Q54925692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13349
AC   CVCL_BN61
DR   CLO; CLO_0033404
DR   Coriell; ND13349
DR   Wikidata; Q54925693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13350
AC   CVCL_CM49
DR   Coriell; ND13350
DR   Wikidata; Q54925694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13351
AC   CVCL_CM50
DR   Coriell; ND13351
DR   Wikidata; Q54925695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13356
AC   CVCL_EB71
DR   Coriell; ND13356
DR   Wikidata; Q54925696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13357
AC   CVCL_HV99
DR   Coriell; ND13357
DR   Wikidata; Q54925697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13358
AC   CVCL_BN62
DR   CLO; CLO_0033401
DR   Coriell; ND13358
DR   Wikidata; Q54925698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13359
AC   CVCL_BN63
DR   CLO; CLO_0033402
DR   Coriell; ND13359
DR   Wikidata; Q54925699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13360
AC   CVCL_BN64
DR   CLO; CLO_0033399
DR   Coriell; ND13360
DR   Wikidata; Q54925700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13361
AC   CVCL_BN65
DR   CLO; CLO_0033400
DR   Coriell; ND13361
DR   Wikidata; Q54925701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13362
AC   CVCL_CM51
DR   CLO; CLO_0033407
DR   Coriell; ND13362
DR   Wikidata; Q54925702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13363
AC   CVCL_BN66
DR   CLO; CLO_0033408
DR   Coriell; ND13363
DR   Wikidata; Q54925703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13364
AC   CVCL_BN67
DR   CLO; CLO_0033405
DR   Coriell; ND13364
DR   Wikidata; Q54925704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13365
AC   CVCL_BN68
DR   CLO; CLO_0033406
DR   Coriell; ND13365
DR   Wikidata; Q54925705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13366
AC   CVCL_BN69
DR   CLO; CLO_0033432
DR   Coriell; ND13366
DR   Wikidata; Q54925706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13368
AC   CVCL_CM52
DR   Coriell; ND13368
DR   Wikidata; Q54925707
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13369
AC   CVCL_CM53
DR   CLO; CLO_0033433
DR   Coriell; ND13369
DR   Wikidata; Q54925708
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13370
AC   CVCL_CM54
DR   CLO; CLO_0033435
DR   Coriell; ND13370
DR   Wikidata; Q54925709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13371
AC   CVCL_IE74
DR   Coriell; ND13371
DR   Wikidata; Q54925710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13372
AC   CVCL_BN70
DR   CLO; CLO_0033424
DR   Coriell; ND13372
DR   Wikidata; Q54925713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13373
AC   CVCL_BN71
DR   CLO; CLO_0033427
DR   Coriell; ND13373
DR   Wikidata; Q54925714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13374
AC   CVCL_BN72
DR   CLO; CLO_0033428
DR   Coriell; ND13374
DR   Wikidata; Q54925715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13375
AC   CVCL_GJ28
DR   CLO; CLO_0033431
DR   Coriell; ND13375
DR   Wikidata; Q54925716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13376
AC   CVCL_GJ29
DR   CLO; CLO_0033436
DR   Coriell; ND13376
DR   Wikidata; Q54925717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13377
AC   CVCL_BN73
DR   CLO; CLO_0033437
DR   Coriell; ND13377
DR   Wikidata; Q54925718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13378
AC   CVCL_BN74
DR   CLO; CLO_0033438
DR   Coriell; ND13378
DR   Wikidata; Q54925719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13379
AC   CVCL_FD61
DR   CLO; CLO_0033341
DR   BioSample; SAMN00797666
DR   Coriell; ND13379
DR   Wikidata; Q54925720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13380
AC   CVCL_CM55
DR   CLO; CLO_0033342
DR   Coriell; ND13380
DR   Wikidata; Q54925721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13381
AC   CVCL_BN75
DR   CLO; CLO_0033339
DR   Coriell; ND13381
DR   Wikidata; Q54925722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13387
AC   CVCL_BN76
DR   CLO; CLO_0033340
DR   Coriell; ND13387
DR   Wikidata; Q54925723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13388
AC   CVCL_EB72
DR   CLO; CLO_0033345
DR   Coriell; ND13388
DR   Wikidata; Q54925724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13389
AC   CVCL_FB84
DR   CLO; CLO_0033346
DR   Coriell; ND13389
DR   Wikidata; Q54925725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13390
AC   CVCL_EB73
DR   CLO; CLO_0033343
DR   Coriell; ND13390
DR   Wikidata; Q54925726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13391
AC   CVCL_BN77
DR   CLO; CLO_0033344
DR   Coriell; ND13391
DR   Wikidata; Q54925728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13392
AC   CVCL_GJ30
DR   CLO; CLO_0033347
DR   BioSample; SAMN00797670
DR   Coriell; ND13392
DR   Wikidata; Q54925729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13393
AC   CVCL_GJ31
DR   CLO; CLO_0033348
DR   Coriell; ND13393
DR   Wikidata; Q54925730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13394
AC   CVCL_CM56
DR   CLO; CLO_0033394
DR   Coriell; ND13394
DR   Wikidata; Q54925731
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13395
AC   CVCL_GJ32
DR   CLO; CLO_0033369
DR   Coriell; ND13395
DR   Wikidata; Q54925732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13398
AC   CVCL_IE75
DR   Coriell; ND13398
DR   Wikidata; Q54925733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13401
AC   CVCL_EB74
DR   Coriell; ND13401
DR   Wikidata; Q54925734
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND13402
AC   CVCL_EB75
DR   Coriell; ND13402
DR   Wikidata; Q54925735
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND13407
AC   CVCL_FZ57
DR   Coriell; ND13407
DR   Wikidata; Q54925736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13408
AC   CVCL_BN78
DR   CLO; CLO_0033370
DR   Coriell; ND13408
DR   Wikidata; Q54925737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13409
AC   CVCL_BN79
DR   CLO; CLO_0033371
DR   Coriell; ND13409
DR   Wikidata; Q54925738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13410
AC   CVCL_BN80
DR   CLO; CLO_0033373
DR   Coriell; ND13410
DR   Wikidata; Q54925739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13411
AC   CVCL_BN81
DR   CLO; CLO_0033374
DR   Coriell; ND13411
DR   Wikidata; Q54925740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13412
AC   CVCL_CM57
DR   CLO; CLO_0033375
DR   Coriell; ND13412
DR   Wikidata; Q54925741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13413
AC   CVCL_CM58
DR   CLO; CLO_0033376
DR   Coriell; ND13413
DR   Wikidata; Q54925742
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13414
AC   CVCL_CM59
DR   CLO; CLO_0033377
DR   Coriell; ND13414
DR   Wikidata; Q54925743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13415
AC   CVCL_FD62
DR   CLO; CLO_0033378
DR   Coriell; ND13415
DR   Wikidata; Q54925744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13416
AC   CVCL_GJ33
DR   CLO; CLO_0033500
DR   Coriell; ND13416
DR   Wikidata; Q54925745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13417
AC   CVCL_BN82
DR   CLO; CLO_0033502
DR   Coriell; ND13417
DR   Wikidata; Q54925746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13425
AC   CVCL_IE76
DR   Coriell; ND13425
DR   Wikidata; Q54925747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13426
AC   CVCL_IE77
DR   Coriell; ND13426
DR   Wikidata; Q54925748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13427
AC   CVCL_CM60
DR   Coriell; ND13427
DR   Wikidata; Q54925749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13428
AC   CVCL_HW00
DR   Coriell; ND13428
DR   Wikidata; Q54925750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13429
AC   CVCL_CM61
DR   CLO; CLO_0033515
DR   Coriell; ND13429
DR   Wikidata; Q54925751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13430
AC   CVCL_EB76
DR   CLO; CLO_0033514
DR   Coriell; ND13430
DR   Wikidata; Q54925752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13431
AC   CVCL_FB85
DR   CLO; CLO_0033517
DR   Coriell; ND13431
DR   Wikidata; Q54925753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13432
AC   CVCL_BN83
DR   CLO; CLO_0033516
DR   Coriell; ND13432
DR   Wikidata; Q54925758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13433
AC   CVCL_BN84
DR   CLO; CLO_0033509
DR   Coriell; ND13433
DR   Wikidata; Q54925759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13434
AC   CVCL_GJ34
DR   CLO; CLO_0033508
DR   Coriell; ND13434
DR   Wikidata; Q54925760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13435
AC   CVCL_EX89
DR   CLO; CLO_0033513
DR   BioSample; SAMN00797682
DR   Coriell; ND13435
DR   Wikidata; Q54925761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13436
AC   CVCL_EX90
DR   CLO; CLO_0033511
DR   BioSample; SAMN00797684
DR   Coriell; ND13436
DR   Wikidata; Q54925762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13437
AC   CVCL_BN85
DR   CLO; CLO_0033651
DR   Coriell; ND13437
DR   Wikidata; Q54925763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13438
AC   CVCL_BN86
DR   CLO; CLO_0033652
DR   Coriell; ND13438
DR   Wikidata; Q54925764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13439
AC   CVCL_BN87
DR   CLO; CLO_0033649
DR   Coriell; ND13439
DR   Wikidata; Q54925766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13440
AC   CVCL_BN88
DR   CLO; CLO_0033650
DR   Coriell; ND13440
DR   Wikidata; Q54925767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13441
AC   CVCL_BN89
DR   CLO; CLO_0033655
DR   Coriell; ND13441
DR   Wikidata; Q54925768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13442
AC   CVCL_BN90
DR   CLO; CLO_0033656
DR   Coriell; ND13442
DR   Wikidata; Q54925769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13443
AC   CVCL_BN91
DR   CLO; CLO_0033653
DR   Coriell; ND13443
DR   Wikidata; Q54925770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13444
AC   CVCL_BN92
DR   CLO; CLO_0033654
DR   Coriell; ND13444
DR   Wikidata; Q54925771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13446
AC   CVCL_EB77
DR   Coriell; ND13446
DR   Wikidata; Q54925772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13448
AC   CVCL_CM62
DR   CLO; CLO_0033678
DR   Coriell; ND13448
DR   Wikidata; Q54925773
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13450
AC   CVCL_BN93
DR   CLO; CLO_0033677
DR   Coriell; ND13450
DR   Wikidata; Q54925774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13451
AC   CVCL_BN94
DR   CLO; CLO_0033676
DR   Coriell; ND13451
DR   Wikidata; Q54925775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13452
AC   CVCL_IK05
DR   CLO; CLO_0033672
DR   Coriell; ND13452
DR   Wikidata; Q54925776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13453
AC   CVCL_IK06
DR   CLO; CLO_0033673
DR   Coriell; ND13453
DR   Wikidata; Q54925777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13454
AC   CVCL_BN95
DR   CLO; CLO_0033674
DR   Coriell; ND13454
DR   Wikidata; Q54925778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13455
AC   CVCL_IE78
DR   CLO; CLO_0033675
DR   Coriell; ND13455
DR   Wikidata; Q54925779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13456
AC   CVCL_GJ35
DR   CLO; CLO_0033668
DR   Coriell; ND13456
DR   Wikidata; Q54925780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13457
AC   CVCL_BN96
DR   CLO; CLO_0033669
DR   Coriell; ND13457
DR   Wikidata; Q54925781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13458
AC   CVCL_BN97
DR   CLO; CLO_0033670
DR   Coriell; ND13458
DR   Wikidata; Q54925782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13459
AC   CVCL_BN98
DR   CLO; CLO_0033671
DR   Coriell; ND13459
DR   Wikidata; Q54925783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13460
AC   CVCL_CM63
DR   CLO; CLO_0033667
DR   Coriell; ND13460
DR   Wikidata; Q54925784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13461
AC   CVCL_GJ36
DR   CLO; CLO_0033665
DR   BioSample; SAMN00797693
DR   Coriell; ND13461
DR   Wikidata; Q54925785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13462
AC   CVCL_BN99
DR   CLO; CLO_0033666
DR   Coriell; ND13462
DR   Wikidata; Q54925786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13463
AC   CVCL_EB78
DR   CLO; CLO_0033663
DR   Coriell; ND13463
DR   Wikidata; Q54925787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13465
AC   CVCL_FB86
DR   CLO; CLO_0033664
DR   Coriell; ND13465
DR   Wikidata; Q54925788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13471
AC   CVCL_FF29
DR   Coriell; ND13471
DR   Wikidata; Q54925789
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13476
AC   CVCL_CM64
DR   CLO; CLO_0033661
DR   Coriell; ND13476
DR   Wikidata; Q54925790
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13478
AC   CVCL_BP00
DR   CLO; CLO_0033662
DR   Coriell; ND13478
DR   Wikidata; Q54925791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13479
AC   CVCL_BP01
DR   CLO; CLO_0033659
DR   Coriell; ND13479
DR   Wikidata; Q54925792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13480
AC   CVCL_BP02
DR   CLO; CLO_0033660
DR   Coriell; ND13480
DR   Wikidata; Q54925793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13481
AC   CVCL_FB25
DR   CLO; CLO_0033657
DR   Coriell; ND13481
DR   Wikidata; Q54925794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13482
AC   CVCL_BP03
DR   CLO; CLO_0033658
DR   Coriell; ND13482
DR   Wikidata; Q54925795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13483
AC   CVCL_BP04
DR   CLO; CLO_0033763
DR   Coriell; ND13483
DR   Wikidata; Q54925796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13484
AC   CVCL_BP05
DR   CLO; CLO_0033762
DR   Coriell; ND13484
DR   Wikidata; Q54925797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13485
AC   CVCL_BP06
DR   CLO; CLO_0033761
DR   Coriell; ND13485
DR   Wikidata; Q54925798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13486
AC   CVCL_IK07
DR   CLO; CLO_0033771
DR   Coriell; ND13486
DR   Wikidata; Q54925800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13487
AC   CVCL_IK08
DR   CLO; CLO_0033769
DR   Coriell; ND13487
DR   Wikidata; Q54925801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13488
AC   CVCL_BP07
DR   CLO; CLO_0033768
DR   Coriell; ND13488
DR   Wikidata; Q54925802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13489
AC   CVCL_BP08
DR   CLO; CLO_0033767
DR   Coriell; ND13489
DR   Wikidata; Q54925803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13490
AC   CVCL_BP09
DR   CLO; CLO_0033766
DR   Coriell; ND13490
DR   Wikidata; Q54925804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13491
AC   CVCL_IE79
DR   Coriell; ND13491
DR   Wikidata; Q54925805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13492
AC   CVCL_IE80
DR   BioSample; SAMN00797699
DR   Coriell; ND13492
DR   Wikidata; Q54925806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND13493
AC   CVCL_IE81
DR   Coriell; ND13493
DR   Wikidata; Q54925807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13495
AC   CVCL_EB79
DR   Coriell; ND13495
DR   Wikidata; Q54925808
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND13497
AC   CVCL_EB80
DR   CLO; CLO_0033765
DR   Coriell; ND13497
DR   Wikidata; Q54925809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13499
AC   CVCL_CM65
DR   Coriell; ND13499
DR   Wikidata; Q54925810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13500
AC   CVCL_CM66
DR   Coriell; ND13500
DR   Wikidata; Q54925811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13501
AC   CVCL_CM67
DR   Coriell; ND13501
DR   Wikidata; Q54925812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13502
AC   CVCL_BP10
DR   CLO; CLO_0033764
DR   Coriell; ND13502
DR   Wikidata; Q54925813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13503
AC   CVCL_BP11
DR   CLO; CLO_0033783
DR   Coriell; ND13503
DR   Wikidata; Q54925814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13504
AC   CVCL_GJ37
DR   CLO; CLO_0033782
DR   BioSample; SAMN00797707
DR   Coriell; ND13504
DR   Wikidata; Q54925815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13505
AC   CVCL_BP12
DR   CLO; CLO_0033785
DR   Coriell; ND13505
DR   Wikidata; Q54925816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13506
AC   CVCL_BP13
DR   CLO; CLO_0033784
DR   Coriell; ND13506
DR   Wikidata; Q54925817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13507
AC   CVCL_GJ38
DR   CLO; CLO_0033790
DR   BioSample; SAMN00797709
DR   Coriell; ND13507
DR   Wikidata; Q54925818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13510
AC   CVCL_BP14
DR   CLO; CLO_0033789
DR   Coriell; ND13510
DR   Wikidata; Q54925819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13511
AC   CVCL_BP15
DR   CLO; CLO_0033792
DR   Coriell; ND13511
DR   Wikidata; Q54925820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13512
AC   CVCL_BP16
DR   CLO; CLO_0033791
DR   Coriell; ND13512
DR   Wikidata; Q54925821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13513
AC   CVCL_BP17
DR   CLO; CLO_0033787
DR   Coriell; ND13513
DR   Wikidata; Q54925822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13514
AC   CVCL_BP18
DR   CLO; CLO_0033786
DR   Coriell; ND13514
DR   Wikidata; Q54925823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13515
AC   CVCL_FD63
DR   CLO; CLO_0033793
DR   Coriell; ND13515
DR   Wikidata; Q54925824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13516
AC   CVCL_EX91
DR   CLO; CLO_0033797
DR   BioSample; SAMN00797715
DR   Coriell; ND13516
DR   Wikidata; Q54925825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13517
AC   CVCL_BP19
DR   CLO; CLO_0033796
DR   Coriell; ND13517
DR   Wikidata; Q54925826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13518
AC   CVCL_FB87
DR   CLO; CLO_0033795
DR   Coriell; ND13518
DR   Wikidata; Q54925827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13519
AC   CVCL_BP20
DR   CLO; CLO_0033794
DR   Coriell; ND13519
DR   Wikidata; Q54925828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13520
AC   CVCL_BP21
DR   CLO; CLO_0033801
DR   Coriell; ND13520
DR   Wikidata; Q54925829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13521
AC   CVCL_GJ39
DR   CLO; CLO_0033800
DR   BioSample; SAMN00797719
DR   Coriell; ND13521
DR   Wikidata; Q54925830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13522
AC   CVCL_BP22
DR   CLO; CLO_0033799
DR   Coriell; ND13522
DR   Wikidata; Q54925831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13523
AC   CVCL_GJ40
DR   CLO; CLO_0033798
DR   BioSample; SAMN00797723
DR   Coriell; ND13523
DR   Wikidata; Q54925832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13524
AC   CVCL_GJ41
DR   CLO; CLO_0033802
DR   Coriell; ND13524
DR   Wikidata; Q54925833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13525
AC   CVCL_IK09
DR   CLO; CLO_0033804
DR   Coriell; ND13525
DR   Wikidata; Q54925834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13526
AC   CVCL_IK10
DR   CLO; CLO_0033803
DR   Coriell; ND13526
DR   Wikidata; Q54925835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13527
AC   CVCL_EX92
DR   CLO; CLO_0033806
DR   BioSample; SAMN00797727
DR   Coriell; ND13527
DR   Wikidata; Q54925836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13530
AC   CVCL_CM68
DR   Coriell; ND13530
DR   Wikidata; Q54925837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13539
AC   CVCL_BP23
DR   CLO; CLO_0033805
DR   Coriell; ND13539
DR   Wikidata; Q54925838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13540
AC   CVCL_EX93
DR   CLO; CLO_0033808
DR   BioSample; SAMN00797731
DR   Coriell; ND13540
DR   Wikidata; Q54925839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13541
AC   CVCL_EX94
DR   CLO; CLO_0033807
DR   BioSample; SAMN00797733
DR   Coriell; ND13541
DR   Wikidata; Q54925841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13542
AC   CVCL_BP24
DR   CLO; CLO_0033810
DR   Coriell; ND13542
DR   Wikidata; Q54925842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13543
AC   CVCL_BP25
DR   Coriell; ND13543
DR   Wikidata; Q54925844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13544
AC   CVCL_BP26
DR   CLO; CLO_0033809
DR   Coriell; ND13544
DR   Wikidata; Q54925845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13545
AC   CVCL_EX95
DR   CLO; CLO_0033812
DR   Coriell; ND13545
DR   Wikidata; Q54925846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13546
AC   CVCL_GJ42
DR   CLO; CLO_0033811
DR   Coriell; ND13546
DR   Wikidata; Q54925847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13549
AC   CVCL_BP27
DR   CLO; CLO_0033699
DR   Coriell; ND13549
DR   Wikidata; Q54925848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13550
AC   CVCL_BP28
DR   CLO; CLO_0033696
DR   Coriell; ND13550
DR   Wikidata; Q54925849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13551
AC   CVCL_GJ43
DR   CLO; CLO_0033698
DR   BioSample; SAMN00797741
DR   Coriell; ND13551
DR   Wikidata; Q54925850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13552
AC   CVCL_BP29
DR   CLO; CLO_0033692
DR   Coriell; ND13552
DR   Wikidata; Q54925851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13553
AC   CVCL_GJ44
DR   CLO; CLO_0033695
DR   Coriell; ND13553
DR   Wikidata; Q54925852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13554
AC   CVCL_GJ45
DR   CLO; CLO_0033688
DR   Coriell; ND13554
DR   Wikidata; Q54925853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13561
AC   CVCL_IE82
DR   Coriell; ND13561
DR   Wikidata; Q54925854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13562
AC   CVCL_IE83
DR   Coriell; ND13562
DR   Wikidata; Q54925856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13563
AC   CVCL_IE84
DR   Coriell; ND13563
DR   Wikidata; Q54925857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13564
AC   CVCL_IE85
DR   Coriell; ND13564
DR   Wikidata; Q54925858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13565
AC   CVCL_IE86
DR   BioSample; SAMN00797751
DR   Coriell; ND13565
DR   Wikidata; Q54925859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND13569
AC   CVCL_GJ46
DR   CLO; CLO_0033690
DR   BioSample; SAMN00797753
DR   Coriell; ND13569
DR   Wikidata; Q54925860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13570
AC   CVCL_FD64
DR   CLO; CLO_0033686
DR   BioSample; SAMN00797755
DR   Coriell; ND13570
DR   Wikidata; Q54925861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13571
AC   CVCL_FD65
DR   CLO; CLO_0033687
DR   Coriell; ND13571
DR   Wikidata; Q54925862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13572
AC   CVCL_GJ47
DR   CLO; CLO_0033685
DR   Coriell; ND13572
DR   Wikidata; Q54925863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13573
AC   CVCL_GJ48
DR   CLO; CLO_0033717
DR   Coriell; ND13573
DR   Wikidata; Q54925864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13574
AC   CVCL_GJ49
DR   CLO; CLO_0033718
DR   Coriell; ND13574
DR   Wikidata; Q54925866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13575
AC   CVCL_GJ50
DR   CLO; CLO_0033719
DR   Coriell; ND13575
DR   Wikidata; Q54925867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13576
AC   CVCL_GJ51
DR   CLO; CLO_0033720
DR   Coriell; ND13576
DR   Wikidata; Q54925868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13577
AC   CVCL_FF30
DR   CLO; CLO_0033709
DR   Coriell; ND13577
DR   Wikidata; Q54925869
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13578
AC   CVCL_IE87
DR   Coriell; ND13578
DR   Wikidata; Q54925870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13579
AC   CVCL_GJ52
DR   CLO; CLO_0033711
DR   Coriell; ND13579
DR   Wikidata; Q54925871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13580
AC   CVCL_FD66
DR   CLO; CLO_0033713
DR   Coriell; ND13580
DR   Wikidata; Q54925872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13581
AC   CVCL_FD67
DR   CLO; CLO_0033716
DR   Coriell; ND13581
DR   Wikidata; Q54925874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13582
AC   CVCL_GJ53
DR   CLO; CLO_0033707
DR   Coriell; ND13582
DR   Wikidata; Q54925875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13583
AC   CVCL_GJ54
DR   CLO; CLO_0033708
DR   Coriell; ND13583
DR   Wikidata; Q54925876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13584
AC   CVCL_GJ55
DR   CLO; CLO_0033725
DR   Coriell; ND13584
DR   Wikidata; Q54925877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13585
AC   CVCL_GJ56
DR   CLO; CLO_0033729
DR   BioSample; SAMN00797757
DR   Coriell; ND13585
DR   Wikidata; Q54925878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13586
AC   CVCL_FD68
DR   CLO; CLO_0033730
DR   Coriell; ND13586
DR   Wikidata; Q54925879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13587
AC   CVCL_IM03
DR   CLO; CLO_0033727
DR   Coriell; ND13587
DR   Wikidata; Q54925880
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND13587; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 10
//
ID   ND13588
AC   CVCL_FD69
DR   CLO; CLO_0033728
DR   BioSample; SAMN00797761
DR   Coriell; ND13588
DR   Wikidata; Q54925882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13589
AC   CVCL_BP30
DR   CLO; CLO_0033733
DR   Coriell; ND13589
DR   Wikidata; Q54925883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13590
AC   CVCL_EX96
DR   CLO; CLO_0033734
DR   Coriell; ND13590
DR   Wikidata; Q54925884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13591
AC   CVCL_BP31
DR   CLO; CLO_0033731
DR   Coriell; ND13591
DR   Wikidata; Q54925886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13592
AC   CVCL_GJ57
DR   CLO; CLO_0033732
DR   Coriell; ND13592
DR   Wikidata; Q54925900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13593
AC   CVCL_BP32
DR   CLO; CLO_0033726
DR   Coriell; ND13593
DR   Wikidata; Q54925902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13594
AC   CVCL_GJ58
DR   CLO; CLO_0034137
DR   Coriell; ND13594
DR   Wikidata; Q54925903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13595
AC   CVCL_BP33
DR   CLO; CLO_0034136
DR   Coriell; ND13595
DR   Wikidata; Q54925904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13596
AC   CVCL_FD70
DR   CLO; CLO_0034135
DR   BioSample; SAMN00797765
DR   Coriell; ND13596
DR   Wikidata; Q54925905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13597
AC   CVCL_BP34
DR   CLO; CLO_0034134
DR   Coriell; ND13597
DR   Wikidata; Q54925906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13598
AC   CVCL_BP35
DR   CLO; CLO_0034133
DR   Coriell; ND13598
DR   Wikidata; Q54925907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13599
AC   CVCL_FB88
DR   CLO; CLO_0034132
DR   Coriell; ND13599
DR   Wikidata; Q54925908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13600
AC   CVCL_IM04
DR   CLO; CLO_0034131
DR   Coriell; ND13600
DR   Wikidata; Q54925910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND13601
AC   CVCL_CM69
DR   CLO; CLO_0034129
DR   Coriell; ND13601
DR   Wikidata; Q54925911
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13602
AC   CVCL_CM70
DR   CLO; CLO_0034128
DR   Coriell; ND13602
DR   Wikidata; Q54925912
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13603
AC   CVCL_CM71
DR   CLO; CLO_0034130
DR   Coriell; ND13603
DR   Wikidata; Q54925913
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13604
AC   CVCL_BP36
DR   CLO; CLO_0034120
DR   Coriell; ND13604
DR   Wikidata; Q54925914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13605
AC   CVCL_IM05
DR   CLO; CLO_0034121
DR   Coriell; ND13605
DR   Wikidata; Q54925915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND13605; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND13606
AC   CVCL_BP37
DR   CLO; CLO_0034122
DR   Coriell; ND13606
DR   Wikidata; Q54925916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13607
AC   CVCL_EX97
DR   CLO; CLO_0034123
DR   BioSample; SAMN00797769
DR   Coriell; ND13607
DR   Wikidata; Q54925918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13608
AC   CVCL_BP38
DR   CLO; CLO_0034124
DR   Coriell; ND13608
DR   Wikidata; Q54925919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13609
AC   CVCL_GJ59
DR   CLO; CLO_0034125
DR   Coriell; ND13609
DR   Wikidata; Q54925920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13610
AC   CVCL_BP39
DR   CLO; CLO_0034126
DR   Coriell; ND13610
DR   Wikidata; Q54925921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13611
AC   CVCL_IE88
DR   CLO; CLO_0034127
DR   Coriell; ND13611
DR   Wikidata; Q54925922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13612
AC   CVCL_BP40
DR   CLO; CLO_0034119
DR   Coriell; ND13612
DR   Wikidata; Q54925923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13613
AC   CVCL_IE89
DR   CLO; CLO_0034118
DR   Coriell; ND13613
DR   Wikidata; Q54925924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13614
AC   CVCL_GJ60
DR   CLO; CLO_0034109
DR   Coriell; ND13614
DR   Wikidata; Q54925925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13615
AC   CVCL_BP41
DR   CLO; CLO_0034112
DR   Coriell; ND13615
DR   Wikidata; Q54925927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13616
AC   CVCL_FD71
DR   CLO; CLO_0034113
DR   Coriell; ND13616
DR   Wikidata; Q54925928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13618
AC   CVCL_EB81
DR   Coriell; ND13618
DR   Wikidata; Q54925929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13621
AC   CVCL_FL66
DR   Coriell; ND13621
DR   Wikidata; Q54925930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13623
AC   CVCL_GJ61
DR   CLO; CLO_0034110
DR   BioSample; SAMN00797785
DR   Coriell; ND13623
DR   Wikidata; Q54925931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13624
AC   CVCL_BP42
DR   Coriell; ND13624
DR   Wikidata; Q54925932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13625
AC   CVCL_BP43
DR   CLO; CLO_0034111
DR   Coriell; ND13625
DR   Wikidata; Q54925933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13626
AC   CVCL_BP44
DR   CLO; CLO_0034116
DR   Coriell; ND13626
DR   Wikidata; Q54925934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13627
AC   CVCL_GJ62
DR   CLO; CLO_0034117
DR   Coriell; ND13627
DR   Wikidata; Q54925935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13628
AC   CVCL_BP45
DR   CLO; CLO_0034114
DR   Coriell; ND13628
DR   Wikidata; Q54925937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13629
AC   CVCL_BP46
DR   CLO; CLO_0034115
DR   Coriell; ND13629
DR   Wikidata; Q54925938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13630
AC   CVCL_GJ63
DR   CLO; CLO_0034108
DR   BioSample; SAMN00797791
DR   Coriell; ND13630
DR   Wikidata; Q54925939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13631
AC   CVCL_BP47
DR   CLO; CLO_0034098
DR   Coriell; ND13631
DR   Wikidata; Q54925940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13632
AC   CVCL_BP48
DR   CLO; CLO_0034099
DR   Coriell; ND13632
DR   Wikidata; Q54925941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13633
AC   CVCL_BP49
DR   CLO; CLO_0034104
DR   Coriell; ND13633
DR   Wikidata; Q54925942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13634
AC   CVCL_IK11
DR   CLO; CLO_0034105
DR   Coriell; ND13634
DR   Wikidata; Q54925943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13635
AC   CVCL_BP50
DR   CLO; CLO_0034106
DR   Coriell; ND13635
DR   Wikidata; Q54925944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13636
AC   CVCL_IK12
DR   CLO; CLO_0034107
DR   Coriell; ND13636
DR   Wikidata; Q54925948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13637
AC   CVCL_IK13
DR   CLO; CLO_0034100
DR   Coriell; ND13637
DR   Wikidata; Q54925949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13638
AC   CVCL_BP51
DR   CLO; CLO_0034101
DR   Coriell; ND13638
DR   Wikidata; Q54925950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13639
AC   CVCL_BP52
DR   CLO; CLO_0034102
DR   Coriell; ND13639
DR   Wikidata; Q54925951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13640
AC   CVCL_IK14
DR   CLO; CLO_0034103
DR   Coriell; ND13640
DR   Wikidata; Q54925952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13641
AC   CVCL_BP53
DR   CLO; CLO_0034090
DR   Coriell; ND13641
DR   Wikidata; Q54925953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13642
AC   CVCL_BP54
DR   CLO; CLO_0034088
DR   Coriell; ND13642
DR   Wikidata; Q54925954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13643
AC   CVCL_EX98
DR   CLO; CLO_0034089
DR   Coriell; ND13643
DR   Wikidata; Q54925955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13644
AC   CVCL_EX99
DR   CLO; CLO_0034096
DR   Coriell; ND13644
DR   Wikidata; Q54925956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13645
AC   CVCL_CM72
DR   BioSample; SAMN00797793
DR   Coriell; ND13645
DR   Wikidata; Q54925957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13646
AC   CVCL_CM73
DR   CLO; CLO_0034097
DR   BioSample; SAMN00797795
DR   Coriell; ND13646
DR   Wikidata; Q54925958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13651
AC   CVCL_IE90
DR   Coriell; ND13651
DR   Wikidata; Q54925959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13652
AC   CVCL_IE91
DR   Coriell; ND13652
DR   Wikidata; Q54925960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13653
AC   CVCL_EB82
DR   Coriell; ND13653
DR   Wikidata; Q54925961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13654
AC   CVCL_CM74
DR   Coriell; ND13654
DR   Wikidata; Q54925962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13655
AC   CVCL_CM75
DR   BioSample; SAMN00797797
DR   Coriell; ND13655
DR   Wikidata; Q54925963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13656
AC   CVCL_CM76
DR   BioSample; SAMN00797799
DR   Coriell; ND13656
DR   Wikidata; Q54925964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13658
AC   CVCL_FZ58
DR   Coriell; ND13658
DR   Wikidata; Q54925965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13660
AC   CVCL_GJ64
DR   CLO; CLO_0034094
DR   Coriell; ND13660
DR   Wikidata; Q54925966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13661
AC   CVCL_IK15
DR   CLO; CLO_0034095
DR   Coriell; ND13661
DR   Wikidata; Q54925967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13662
AC   CVCL_BP55
DR   CLO; CLO_0034092
DR   Coriell; ND13662
DR   Wikidata; Q54925968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13664
AC   CVCL_BP56
DR   CLO; CLO_0034093
DR   Coriell; ND13664
DR   Wikidata; Q54925969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13665
AC   CVCL_IK16
DR   CLO; CLO_0034091
DR   Coriell; ND13665
DR   Wikidata; Q54925970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13666
AC   CVCL_GJ65
DR   CLO; CLO_0034224
DR   BioSample; SAMN00797805
DR   Coriell; ND13666
DR   Wikidata; Q54925971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13667
AC   CVCL_BP57
DR   CLO; CLO_0034223
DR   Coriell; ND13667
DR   Wikidata; Q54925972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13668
AC   CVCL_BP58
DR   CLO; CLO_0034222
DR   Coriell; ND13668
DR   Wikidata; Q54925973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13669
AC   CVCL_GJ66
DR   CLO; CLO_0034221
DR   Coriell; ND13669
DR   Wikidata; Q54925974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13670
AC   CVCL_GJ67
DR   CLO; CLO_0034220
DR   Coriell; ND13670
DR   Wikidata; Q54925975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13671
AC   CVCL_GJ68
DR   CLO; CLO_0034219
DR   Coriell; ND13671
DR   Wikidata; Q54925976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13672
AC   CVCL_EY00
DR   CLO; CLO_0034218
DR   Coriell; ND13672
DR   Wikidata; Q54925977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13673
AC   CVCL_BP59
DR   CLO; CLO_0034217
DR   Coriell; ND13673
DR   Wikidata; Q54925978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13674
AC   CVCL_GJ69
DR   CLO; CLO_0034216
DR   Coriell; ND13674
DR   Wikidata; Q54925979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13675
AC   CVCL_EB83
DR   Coriell; ND13675
DR   Wikidata; Q54925980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13676
AC   CVCL_GJ70
DR   CLO; CLO_0034215
DR   BioSample; SAMN00797809
DR   Coriell; ND13676
DR   Wikidata; Q54925981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13677
AC   CVCL_IV97
DR   CLO; CLO_0034243
DR   Coriell; ND13677
DR   Wikidata; Q54925982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   ND13678
AC   CVCL_GJ71
DR   CLO; CLO_0034236
DR   Coriell; ND13678
DR   Wikidata; Q54925983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13679
AC   CVCL_IK17
DR   CLO; CLO_0034235
DR   Coriell; ND13679
DR   Wikidata; Q54925984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13680
AC   CVCL_IK18
DR   CLO; CLO_0034241
DR   Coriell; ND13680
DR   Wikidata; Q54925985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13681
AC   CVCL_BP60
DR   CLO; CLO_0034239
DR   Coriell; ND13681
DR   Wikidata; Q54925986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13682
AC   CVCL_BP61
DR   CLO; CLO_0034231
DR   Coriell; ND13682
DR   Wikidata; Q54925987
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND13683
AC   CVCL_BP62
DR   CLO; CLO_0034230
DR   Coriell; ND13683
DR   Wikidata; Q54925989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13684
AC   CVCL_BP63
DR   CLO; CLO_0034233
DR   Coriell; ND13684
DR   Wikidata; Q54925990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13685
AC   CVCL_BP64
DR   CLO; CLO_0034232
DR   Coriell; ND13685
DR   Wikidata; Q54925991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13686
AC   CVCL_BP65
DR   CLO; CLO_0034229
DR   Coriell; ND13686
DR   Wikidata; Q54925992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13688
AC   CVCL_CM77
DR   Coriell; ND13688
DR   Wikidata; Q54925993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13689
AC   CVCL_CM78
DR   Coriell; ND13689
DR   Wikidata; Q54925994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13690
AC   CVCL_CM79
DR   Coriell; ND13690
DR   Wikidata; Q54925995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13691
AC   CVCL_CM80
DR   Coriell; ND13691
DR   Wikidata; Q54925996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13698
AC   CVCL_IM06
DR   Coriell; ND13698
DR   Wikidata; Q54925997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13701
AC   CVCL_EY01
DR   CLO; CLO_0034197
DR   BioSample; SAMN00797815
DR   Coriell; ND13701
DR   Wikidata; Q54925998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13702
AC   CVCL_GJ72
DR   CLO; CLO_0034196
DR   Coriell; ND13702
DR   Wikidata; Q54925999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13703
AC   CVCL_IK19
DR   CLO; CLO_0034201
DR   Coriell; ND13703
DR   Wikidata; Q54926000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13705
AC   CVCL_CM81
DR   CLO; CLO_0034200
DR   Coriell; ND13705
DR   Wikidata; Q54926001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13706
AC   CVCL_CM82
DR   CLO; CLO_0034199
DR   Coriell; ND13706
DR   Wikidata; Q54926002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13707
AC   CVCL_CM83
DR   Coriell; ND13707
DR   Wikidata; Q54926003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13708
AC   CVCL_BP66
DR   CLO; CLO_0034198
DR   Coriell; ND13708
DR   Wikidata; Q54926004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13709
AC   CVCL_EY02
DR   CLO; CLO_0034195
DR   BioSample; SAMN00797819
DR   Coriell; ND13709
DR   Wikidata; Q54926005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13710
AC   CVCL_EY03
DR   CLO; CLO_0034194
DR   Coriell; ND13710
DR   Wikidata; Q54926006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13711
AC   CVCL_GJ73
DR   CLO; CLO_0034193
DR   Coriell; ND13711
DR   Wikidata; Q54926007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13712
AC   CVCL_BP67
DR   CLO; CLO_0034192
DR   Coriell; ND13712
DR   Wikidata; Q54926008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13713
AC   CVCL_GJ74
DR   CLO; CLO_0034205
DR   Coriell; ND13713
DR   Wikidata; Q54926009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13714
AC   CVCL_CM84
DR   CLO; CLO_0034207
DR   Coriell; ND13714
DR   Wikidata; Q54926010
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13715
AC   CVCL_CM85
DR   CLO; CLO_0034206
DR   Coriell; ND13715
DR   Wikidata; Q54926011
CC   Population: Caucasian; French/Irish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13716
AC   CVCL_CM86
DR   Coriell; ND13716
DR   Wikidata; Q54926012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13718
AC   CVCL_CM87
DR   CLO; CLO_0034209
DR   Coriell; ND13718
DR   Wikidata; Q54926013
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13722
AC   CVCL_IE92
DR   Coriell; ND13722
DR   Wikidata; Q54926014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13724
AC   CVCL_IE93
DR   Coriell; ND13724
DR   Wikidata; Q54926015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13726
AC   CVCL_BP68
DR   CLO; CLO_0034208
DR   Coriell; ND13726
DR   Wikidata; Q54926016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13727
AC   CVCL_FD72
DR   CLO; CLO_0034211
DR   Coriell; ND13727
DR   Wikidata; Q54926017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13728
AC   CVCL_GJ75
DR   CLO; CLO_0034210
DR   Coriell; ND13728
DR   Wikidata; Q54926018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13729
AC   CVCL_GJ76
DR   CLO; CLO_0034203
DR   Coriell; ND13729
DR   Wikidata; Q54926019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13730
AC   CVCL_GJ77
DR   CLO; CLO_0034202
DR   Coriell; ND13730
DR   Wikidata; Q54926020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13731
AC   CVCL_GJ78
DR   CLO; CLO_0034204
DR   Coriell; ND13731
DR   Wikidata; Q54926021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13733
AC   CVCL_GJ79
DR   CLO; CLO_0034177
DR   Coriell; ND13733
DR   Wikidata; Q54926022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13734
AC   CVCL_GJ80
DR   CLO; CLO_0034178
DR   Coriell; ND13734
DR   Wikidata; Q54926023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13735
AC   CVCL_GJ81
DR   CLO; CLO_0034175
DR   Coriell; ND13735
DR   Wikidata; Q54926024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13739
AC   CVCL_GJ82
DR   CLO; CLO_0034176
DR   Coriell; ND13739
DR   Wikidata; Q54926025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13740
AC   CVCL_GJ83
DR   CLO; CLO_0034171
DR   Coriell; ND13740
DR   Wikidata; Q54926026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13741
AC   CVCL_IG82
DR   Coriell; ND13741
DR   Wikidata; Q54926027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   ND13742
AC   CVCL_IE94
DR   Coriell; ND13742
DR   Wikidata; Q54926028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13744
AC   CVCL_HW01
DR   Coriell; ND13744
DR   Wikidata; Q54926031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13745
AC   CVCL_HW02
DR   Coriell; ND13745
DR   Wikidata; Q54926032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13746
AC   CVCL_FL67
DR   Coriell; ND13746
DR   Wikidata; Q54926033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13747
AC   CVCL_BP69
DR   CLO; CLO_0034173
DR   Coriell; ND13747
DR   Wikidata; Q54926034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13748
AC   CVCL_BP70
DR   CLO; CLO_0034167
DR   Coriell; ND13748
DR   Wikidata; Q54926035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13749
AC   CVCL_FB26
DR   CLO; CLO_0034170
DR   Coriell; ND13749
DR   Wikidata; Q54926036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13750
AC   CVCL_BP71
DR   CLO; CLO_0034179
DR   Coriell; ND13750
DR   Wikidata; Q54926037
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (Coriell=ND13750).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   ND13751
AC   CVCL_IM07
DR   CLO; CLO_0034180
DR   Coriell; ND13751
DR   Wikidata; Q54926038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND13751; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND13752
AC   CVCL_CM88
DR   CLO; CLO_0034711
DR   Coriell; ND13752
DR   Wikidata; Q54926039
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13753
AC   CVCL_BP72
DR   CLO; CLO_0034712
DR   Coriell; ND13753
DR   Wikidata; Q54926040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13754
AC   CVCL_BP73
DR   CLO; CLO_0034713
DR   Coriell; ND13754
DR   Wikidata; Q54926041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13755
AC   CVCL_BP74
DR   CLO; CLO_0034714
DR   Coriell; ND13755
DR   Wikidata; Q54926042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13756
AC   CVCL_BP75
DR   CLO; CLO_0034715
DR   Coriell; ND13756
DR   Wikidata; Q54926043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13757
AC   CVCL_GJ84
DR   CLO; CLO_0034716
DR   BioSample; SAMN00797833
DR   Coriell; ND13757
DR   Wikidata; Q54926044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13758
AC   CVCL_FD73
DR   CLO; CLO_0034670
DR   BioSample; SAMN00797835
DR   Coriell; ND13758
DR   Wikidata; Q54926045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13759
AC   CVCL_FD74
DR   CLO; CLO_0034667
DR   Coriell; ND13759
DR   Wikidata; Q54926046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13760
AC   CVCL_GJ85
DR   CLO; CLO_0034665
DR   Coriell; ND13760
DR   Wikidata; Q54926047
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13763
AC   CVCL_BP76
DR   CLO; CLO_0034663
DR   Coriell; ND13763
DR   Wikidata; Q54926048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13764
AC   CVCL_GJ86
DR   CLO; CLO_0034678
DR   BioSample; SAMN00797837
DR   Coriell; ND13764
DR   Wikidata; Q54926049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13766
AC   CVCL_EB84
DR   CLO; CLO_0034675
DR   Coriell; ND13766
DR   Wikidata; Q54926050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13767
AC   CVCL_GJ87
DR   CLO; CLO_0034676
DR   Coriell; ND13767
DR   Wikidata; Q54926051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13768
AC   CVCL_BP77
DR   CLO; CLO_0034673
DR   Coriell; ND13768
DR   Wikidata; Q54926052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13769
AC   CVCL_EY04
DR   CLO; CLO_0034674
DR   BioSample; SAMN00797841
DR   Coriell; ND13769
DR   Wikidata; Q54926053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13770
AC   CVCL_BP78
DR   CLO; CLO_0034671
DR   Coriell; ND13770
DR   Wikidata; Q54926054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13775
AC   CVCL_CM89
DR   CLO; CLO_0034672
DR   Coriell; ND13775
DR   Wikidata; Q54926055
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13777
AC   CVCL_CM90
DR   Coriell; ND13777
DR   Wikidata; Q54926056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13778
AC   CVCL_CM91
DR   Coriell; ND13778
DR   Wikidata; Q54926057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13779
AC   CVCL_FF31
DR   Coriell; ND13779
DR   Wikidata; Q54926058
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13782
AC   CVCL_BP79
DR   CLO; CLO_0034686
DR   Coriell; ND13782
DR   Wikidata; Q54926059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13784
AC   CVCL_GJ88
DR   CLO; CLO_0034684
DR   Coriell; ND13784
DR   Wikidata; Q54926060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13785
AC   CVCL_BP80
DR   CLO; CLO_0034689
DR   Coriell; ND13785
DR   Wikidata; Q54926061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13786
AC   CVCL_BP81
DR   CLO; CLO_0034695
DR   Coriell; ND13786
DR   Wikidata; Q54926062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13787
AC   CVCL_BP82
DR   CLO; CLO_0034696
DR   Coriell; ND13787
DR   Wikidata; Q54926063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13792
AC   CVCL_CM92
DR   BioSample; SAMN00797843
DR   Coriell; ND13792
DR   Wikidata; Q54926064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13793
AC   CVCL_CM93
DR   Coriell; ND13793
DR   Wikidata; Q54926065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13795
AC   CVCL_CM94
DR   Coriell; ND13795
DR   Wikidata; Q54926066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13796
AC   CVCL_CM95
DR   Coriell; ND13796
DR   Wikidata; Q54926067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13797
AC   CVCL_EB85
DR   Coriell; ND13797
DR   Wikidata; Q54926068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13800
AC   CVCL_EY05
DR   CLO; CLO_0034699
DR   Coriell; ND13800
DR   Wikidata; Q54926069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13801
AC   CVCL_CM96
DR   CLO; CLO_0034700
DR   Coriell; ND13801
DR   Wikidata; Q54926070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13802
AC   CVCL_CM97
DR   CLO; CLO_0034690
DR   Coriell; ND13802
DR   Wikidata; Q54926073
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13803
AC   CVCL_BP83
DR   CLO; CLO_0034691
DR   Coriell; ND13803
DR   Wikidata; Q54926075
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND13804
AC   CVCL_FD75
DR   CLO; CLO_0034692
DR   BioSample; SAMN00797847
DR   Coriell; ND13804
DR   Wikidata; Q54926076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13805
AC   CVCL_CM98
DR   CLO; CLO_0034693
DR   Coriell; ND13805
DR   Wikidata; Q54926077
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13806
AC   CVCL_CM99
DR   CLO; CLO_0034737
DR   Coriell; ND13806
DR   Wikidata; Q54926078
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13807
AC   CVCL_EY06
DR   CLO; CLO_0034738
DR   Coriell; ND13807
DR   Wikidata; Q54926079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13808
AC   CVCL_BP84
DR   CLO; CLO_0034747
DR   Coriell; ND13808
DR   Wikidata; Q54926080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13809
AC   CVCL_BP85
DR   CLO; CLO_0034742
DR   Coriell; ND13809
DR   Wikidata; Q54926081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13810
AC   CVCL_EY07
DR   CLO; CLO_0034741
DR   BioSample; SAMN00797853
DR   Coriell; ND13810
DR   Wikidata; Q54926082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13811
AC   CVCL_FD76
DR   CLO; CLO_0034740
DR   BioSample; SAMN00797855
DR   Coriell; ND13811
DR   Wikidata; Q54926083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13812
AC   CVCL_GJ89
DR   CLO; CLO_0034739
DR   Coriell; ND13812
DR   Wikidata; Q54926084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13813
AC   CVCL_EY08
DR   CLO; CLO_0034746
DR   Coriell; ND13813
DR   Wikidata; Q54926085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13814
AC   CVCL_GJ90
DR   CLO; CLO_0034745
DR   Coriell; ND13814
DR   Wikidata; Q54926086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13815
AC   CVCL_BP86
DR   CLO; CLO_0034744
DR   Coriell; ND13815
DR   Wikidata; Q54926087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13816
AC   CVCL_FD77
DR   CLO; CLO_0034743
DR   Coriell; ND13816
DR   Wikidata; Q54926088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13817
AC   CVCL_FD78
DR   CLO; CLO_0034748
DR   Coriell; ND13817
DR   Wikidata; Q54926089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13818
AC   CVCL_CN00
DR   CLO; CLO_0034758
DR   Coriell; ND13818
DR   Wikidata; Q54926090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13819
AC   CVCL_CN01
DR   CLO; CLO_0034757
DR   Coriell; ND13819
DR   Wikidata; Q54926091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13820
AC   CVCL_CN02
DR   CLO; CLO_0034750
DR   Coriell; ND13820
DR   Wikidata; Q54926092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13821
AC   CVCL_HR81
DR   CLO; CLO_0034749
DR   Coriell; ND13821
DR   Wikidata; Q54926093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND13822
AC   CVCL_BP87
DR   CLO; CLO_0034752
DR   Coriell; ND13822
DR   Wikidata; Q54926094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13823
AC   CVCL_FB27
DR   CLO; CLO_0034751
DR   Coriell; ND13823
DR   Wikidata; Q54926095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13824
AC   CVCL_IE95
DR   Coriell; ND13824
DR   Wikidata; Q54926096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13825
AC   CVCL_BP88
DR   CLO; CLO_0034754
DR   Coriell; ND13825
DR   Wikidata; Q54926097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13826
AC   CVCL_BP89
DR   CLO; CLO_0034753
DR   Coriell; ND13826
DR   Wikidata; Q54926098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13827
AC   CVCL_BP90
DR   CLO; CLO_0034756
DR   Coriell; ND13827
DR   Wikidata; Q54926099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13828
AC   CVCL_BP91
DR   CLO; CLO_0034755
DR   Coriell; ND13828
DR   Wikidata; Q54926100
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND13829
AC   CVCL_BP92
DR   CLO; CLO_0034726
DR   Coriell; ND13829
DR   Wikidata; Q54926102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13830
AC   CVCL_FD79
DR   CLO; CLO_0034725
DR   BioSample; SAMN00797859
DR   Coriell; ND13830
DR   Wikidata; Q54926103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13831
AC   CVCL_BP93
DR   CLO; CLO_0034724
DR   Coriell; ND13831
DR   Wikidata; Q54926104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13833
AC   CVCL_BP94
DR   CLO; CLO_0034723
DR   Coriell; ND13833
DR   Wikidata; Q54926105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13834
AC   CVCL_BP95
DR   CLO; CLO_0034722
DR   Coriell; ND13834
DR   Wikidata; Q54926106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13835
AC   CVCL_BP96
DR   CLO; CLO_0034721
DR   Coriell; ND13835
DR   Wikidata; Q54926107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13836
AC   CVCL_EY09
DR   CLO; CLO_0034720
DR   BioSample; SAMN00797863
DR   Coriell; ND13836
DR   Wikidata; Q54926108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13837
AC   CVCL_BP97
DR   CLO; CLO_0034719
DR   Coriell; ND13837
DR   Wikidata; Q54926109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13838
AC   CVCL_GJ91
DR   CLO; CLO_0034718
DR   Coriell; ND13838
DR   Wikidata; Q54926110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13839
AC   CVCL_GJ92
DR   CLO; CLO_0034717
DR   Coriell; ND13839
DR   Wikidata; Q54926111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13840
AC   CVCL_GJ93
DR   CLO; CLO_0034734
DR   Coriell; ND13840
DR   Wikidata; Q54926112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13841
AC   CVCL_GJ94
DR   CLO; CLO_0034733
DR   Coriell; ND13841
DR   Wikidata; Q54926113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13842
AC   CVCL_EY10
DR   CLO; CLO_0034736
DR   Coriell; ND13842
DR   Wikidata; Q54926114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13843
AC   CVCL_GJ95
DR   CLO; CLO_0034735
DR   Coriell; ND13843
DR   Wikidata; Q54926117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13844
AC   CVCL_EY11
DR   CLO; CLO_0034730
DR   Coriell; ND13844
DR   Wikidata; Q54926118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13850
AC   CVCL_EB86
DR   Coriell; ND13850
DR   Wikidata; Q54926120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13852
AC   CVCL_EB87
DR   CLO; CLO_0034729
DR   Coriell; ND13852
DR   Wikidata; Q54926121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13853
AC   CVCL_CN03
DR   CLO; CLO_0034732
DR   Coriell; ND13853
DR   Wikidata; Q54926122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13854
AC   CVCL_CN04
DR   CLO; CLO_0034731
DR   Coriell; ND13854
DR   Wikidata; Q54926123
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13855
AC   CVCL_CN05
DR   CLO; CLO_0034728
DR   Coriell; ND13855
DR   Wikidata; Q54926124
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13857
AC   CVCL_IE96
DR   Coriell; ND13857
DR   Wikidata; Q54926125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13858
AC   CVCL_EB88
DR   CLO; CLO_0034727
DR   Coriell; ND13858
DR   Wikidata; Q54926126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13859
AC   CVCL_EB89
DR   CLO; CLO_0034592
DR   Coriell; ND13859
DR   Wikidata; Q54926127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13860
AC   CVCL_GJ96
DR   CLO; CLO_0034588
DR   Coriell; ND13860
DR   Wikidata; Q54926128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13861
AC   CVCL_GJ97
DR   CLO; CLO_0034589
DR   Coriell; ND13861
DR   Wikidata; Q54926129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13862
AC   CVCL_GJ98
DR   CLO; CLO_0034590
DR   Coriell; ND13862
DR   Wikidata; Q54926130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13863
AC   CVCL_BP98
DR   CLO; CLO_0034591
DR   Coriell; ND13863
DR   Wikidata; Q54926131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13864
AC   CVCL_BP99
DR   CLO; CLO_0034600
DR   Coriell; ND13864
DR   Wikidata; Q54926132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13865
AC   CVCL_BQ00
DR   CLO; CLO_0034601
DR   Coriell; ND13865
DR   Wikidata; Q54926133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13866
AC   CVCL_BQ01
DR   CLO; CLO_0034603
DR   Coriell; ND13866
DR   Wikidata; Q54926134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13867
AC   CVCL_BQ02
DR   CLO; CLO_0034606
DR   Coriell; ND13867
DR   Wikidata; Q54926135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13868
AC   CVCL_FB28
DR   CLO; CLO_0034594
DR   Coriell; ND13868
DR   Wikidata; Q54926136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13872
AC   CVCL_IE97
DR   Coriell; ND13872
DR   Wikidata; Q54926137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13878
AC   CVCL_FZ59
DR   Coriell; ND13878
DR   Wikidata; Q54926138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13879
AC   CVCL_CN06
DR   CLO; CLO_0034561
DR   Coriell; ND13879
DR   Wikidata; Q54926139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13880
AC   CVCL_CN07
DR   CLO; CLO_0034562
DR   Coriell; ND13880
DR   Wikidata; Q54926140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13881
AC   CVCL_CN08
DR   CLO; CLO_0034559
DR   Coriell; ND13881
DR   Wikidata; Q54926141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13882
AC   CVCL_BQ03
DR   Coriell; ND13882
DR   Wikidata; Q54926142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13885
AC   CVCL_EB90
DR   CLO; CLO_0034560
DR   Coriell; ND13885
DR   Wikidata; Q54926143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13886
AC   CVCL_FB89
DR   CLO; CLO_0034557
DR   Coriell; ND13886
DR   Wikidata; Q54926144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13887
AC   CVCL_EB91
DR   CLO; CLO_0034558
DR   Coriell; ND13887
DR   Wikidata; Q54926145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13889
AC   CVCL_BQ04
DR   CLO; CLO_0034574
DR   Coriell; ND13889
DR   Wikidata; Q54926146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13890
AC   CVCL_BQ05
DR   CLO; CLO_0034576
DR   Coriell; ND13890
DR   Wikidata; Q54926147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13891
AC   CVCL_EY12
DR   CLO; CLO_0034571
DR   BioSample; SAMN00797873
DR   Coriell; ND13891
DR   Wikidata; Q54926148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13905
AC   CVCL_CN09
DR   Coriell; ND13905
DR   Wikidata; Q54926149
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (Coriell=ND13905).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EY33 ! ND33995
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   ND13906
AC   CVCL_CN10
DR   Coriell; ND13906
DR   Wikidata; Q54926150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13907
AC   CVCL_EB92
DR   Coriell; ND13907
DR   Wikidata; Q54926151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13909
AC   CVCL_EB93
DR   Coriell; ND13909
DR   Wikidata; Q54926152
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND13910
AC   CVCL_CN11
DR   CLO; CLO_0034572
DR   Coriell; ND13910
DR   Wikidata; Q54926153
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13911
AC   CVCL_CN12
DR   CLO; CLO_0034526
DR   Coriell; ND13911
DR   Wikidata; Q54926154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13912
AC   CVCL_FD80
DR   CLO; CLO_0034528
DR   BioSample; SAMN00797875
DR   Coriell; ND13912
DR   Wikidata; Q54926155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13913
AC   CVCL_BQ06
DR   CLO; CLO_0034529
DR   Coriell; ND13913
DR   Wikidata; Q54926156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13914
AC   CVCL_GJ99
DR   CLO; CLO_0034530
DR   Coriell; ND13914
DR   Wikidata; Q54926157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13915
AC   CVCL_GK00
DR   CLO; CLO_0034531
DR   Coriell; ND13915
DR   Wikidata; Q54926160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13916
AC   CVCL_BQ07
DR   CLO; CLO_0034532
DR   Coriell; ND13916
DR   Wikidata; Q54926161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13917
AC   CVCL_GK01
DR   CLO; CLO_0034533
DR   Coriell; ND13917
DR   Wikidata; Q54926162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13918
AC   CVCL_GK02
DR   CLO; CLO_0034535
DR   Coriell; ND13918
DR   Wikidata; Q54926163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13919
AC   CVCL_GK03
DR   CLO; CLO_0034537
DR   Coriell; ND13919
DR   Wikidata; Q54926164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13920
AC   CVCL_GK04
DR   CLO; CLO_0034539
DR   Coriell; ND13920
DR   Wikidata; Q54926165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13921
AC   CVCL_GK05
DR   CLO; CLO_0035228
DR   Coriell; ND13921
DR   Wikidata; Q54926166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13922
AC   CVCL_GK06
DR   CLO; CLO_0035227
DR   Coriell; ND13922
DR   Wikidata; Q54926167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13923
AC   CVCL_GK07
DR   CLO; CLO_0035226
DR   Coriell; ND13923
DR   Wikidata; Q54926168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13924
AC   CVCL_GK08
DR   CLO; CLO_0035225
DR   Coriell; ND13924
DR   Wikidata; Q54926169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13925
AC   CVCL_GK09
DR   CLO; CLO_0035224
DR   Coriell; ND13925
DR   Wikidata; Q54926170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13926
AC   CVCL_FD81
DR   CLO; CLO_0035072
DR   Coriell; ND13926
DR   Wikidata; Q54926171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13927
AC   CVCL_GK10
DR   CLO; CLO_0035071
DR   Coriell; ND13927
DR   Wikidata; Q54926172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13932
AC   CVCL_BQ08
DR   CLO; CLO_0035070
DR   Coriell; ND13932
DR   Wikidata; Q54926173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13933
AC   CVCL_BQ09
DR   CLO; CLO_0035069
DR   Coriell; ND13933
DR   Wikidata; Q54926174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13934
AC   CVCL_FD82
DR   CLO; CLO_0035073
DR   Coriell; ND13934
DR   Wikidata; Q54926175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13935
AC   CVCL_GK11
DR   CLO; CLO_0035074
DR   Coriell; ND13935
DR   Wikidata; Q54926176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13936
AC   CVCL_GK12
DR   CLO; CLO_0035075
DR   Coriell; ND13936
DR   Wikidata; Q54926177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13938
AC   CVCL_BQ10
DR   CLO; CLO_0035078
DR   Coriell; ND13938
DR   Wikidata; Q54926178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13939
AC   CVCL_BQ11
DR   CLO; CLO_0035079
DR   Coriell; ND13939
DR   Wikidata; Q54926179
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND13940
AC   CVCL_GK13
DR   CLO; CLO_0035076
DR   BioSample; SAMN00797879
DR   Coriell; ND13940
DR   Wikidata; Q54926180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13941
AC   CVCL_GK14
DR   CLO; CLO_0035077
DR   Coriell; ND13941
DR   Wikidata; Q54926181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13942
AC   CVCL_GK15
DR   CLO; CLO_0035081
DR   Coriell; ND13942
DR   Wikidata; Q54926182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13943
AC   CVCL_FD83
DR   CLO; CLO_0035080
DR   Coriell; ND13943
DR   Wikidata; Q54926183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13944
AC   CVCL_BQ12
DR   CLO; CLO_0035083
DR   Coriell; ND13944
DR   Wikidata; Q54926184
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND13945
AC   CVCL_BQ13
DR   CLO; CLO_0035082
DR   Coriell; ND13945
DR   Wikidata; Q54926185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13946
AC   CVCL_CN13
DR   CLO; CLO_0035084
DR   Coriell; ND13946
DR   Wikidata; Q54926186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13947
AC   CVCL_CN14
DR   CLO; CLO_0035085
DR   Coriell; ND13947
DR   Wikidata; Q54926187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13948
AC   CVCL_CN15
DR   CLO; CLO_0035086
DR   Coriell; ND13948
DR   Wikidata; Q54926188
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13949
AC   CVCL_CN16
DR   CLO; CLO_0035087
DR   Coriell; ND13949
DR   Wikidata; Q54926189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13950
AC   CVCL_CN17
DR   Coriell; ND13950
DR   Wikidata; Q54926190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13951
AC   CVCL_EB94
DR   Coriell; ND13951
DR   Wikidata; Q54926191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13955
AC   CVCL_JM23
DR   CLO; CLO_0035088
DR   Coriell; ND13955
DR   Wikidata; Q54926193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   ND13956
AC   CVCL_IK20
DR   CLO; CLO_0035089
DR   Coriell; ND13956
DR   Wikidata; Q54926194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND13957
AC   CVCL_BQ14
DR   CLO; CLO_0035090
DR   Coriell; ND13957
DR   Wikidata; Q54926195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13958
AC   CVCL_GK16
DR   CLO; CLO_0035093
DR   BioSample; SAMN00797885
DR   Coriell; ND13958
DR   Wikidata; Q54926196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13959
AC   CVCL_BQ15
DR   CLO; CLO_0035092
DR   Coriell; ND13959
DR   Wikidata; Q54926197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13960
AC   CVCL_BQ16
DR   CLO; CLO_0035091
DR   Coriell; ND13960
DR   Wikidata; Q54926198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13962
AC   CVCL_FB29
DR   CLO; CLO_0035100
DR   Coriell; ND13962
DR   Wikidata; Q54926199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13964
AC   CVCL_BQ17
DR   CLO; CLO_0035101
DR   Coriell; ND13964
DR   Wikidata; Q54926200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13965
AC   CVCL_GK17
DR   CLO; CLO_0035098
DR   BioSample; SAMN00797889
DR   Coriell; ND13965
DR   Wikidata; Q54926203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13966
AC   CVCL_BQ18
DR   CLO; CLO_0035099
DR   Coriell; ND13966
DR   Wikidata; Q54926204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13967
AC   CVCL_FD84
DR   CLO; CLO_0035096
DR   BioSample; SAMN00797894
DR   Coriell; ND13967
DR   Wikidata; Q54926205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13968
AC   CVCL_BQ19
DR   CLO; CLO_0035097
DR   Coriell; ND13968
DR   Wikidata; Q54926206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13969
AC   CVCL_GK18
DR   CLO; CLO_0035094
DR   BioSample; SAMN00797898
DR   Coriell; ND13969
DR   Wikidata; Q54926207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13970
AC   CVCL_BQ20
DR   CLO; CLO_0035095
DR   Coriell; ND13970
DR   Wikidata; Q54926208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13971
AC   CVCL_FD85
DR   CLO; CLO_0035103
DR   BioSample; SAMN00797902
DR   Coriell; ND13971
DR   Wikidata; Q54926209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13972
AC   CVCL_BQ21
DR   CLO; CLO_0035102
DR   Coriell; ND13972
DR   Wikidata; Q54926210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13974
AC   CVCL_BQ22
DR   CLO; CLO_0035112
DR   Coriell; ND13974
DR   Wikidata; Q54926211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13975
AC   CVCL_BQ23
DR   CLO; CLO_0035108
DR   Coriell; ND13975
DR   Wikidata; Q54926212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13976
AC   CVCL_BQ24
DR   CLO; CLO_0035109
DR   Coriell; ND13976
DR   Wikidata; Q54926213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13983
AC   CVCL_CN18
DR   CLO; CLO_0035110
DR   Coriell; ND13983
DR   Wikidata; Q54926214
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13984
AC   CVCL_BQ25
DR   CLO; CLO_0035111
DR   Coriell; ND13984
DR   Wikidata; Q54926215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13985
AC   CVCL_FD86
DR   CLO; CLO_0035104
DR   BioSample; SAMN00797908
DR   Coriell; ND13985
DR   Wikidata; Q54926216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND13986
AC   CVCL_BQ26
DR   CLO; CLO_0035105
DR   Coriell; ND13986
DR   Wikidata; Q54926217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13987
AC   CVCL_BQ27
DR   CLO; CLO_0035106
DR   Coriell; ND13987
DR   Wikidata; Q54926218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13988
AC   CVCL_BQ28
DR   CLO; CLO_0035107
DR   Coriell; ND13988
DR   Wikidata; Q54926219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13989
AC   CVCL_CN19
DR   CLO; CLO_0035113
DR   Coriell; ND13989
DR   Wikidata; Q54926220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13990
AC   CVCL_BQ29
DR   CLO; CLO_0035115
DR   Coriell; ND13990
DR   Wikidata; Q54926221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND13991
AC   CVCL_CN20
DR   Coriell; ND13991
DR   Wikidata; Q54926222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND13992
AC   CVCL_EB95
DR   CLO; CLO_0035114
DR   Coriell; ND13992
DR   Wikidata; Q54926223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND13994
AC   CVCL_FB90
DR   CLO; CLO_0035119
DR   Coriell; ND13994
DR   Wikidata; Q54926224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13995
AC   CVCL_FB91
DR   CLO; CLO_0035118
DR   Coriell; ND13995
DR   Wikidata; Q54926225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13996
AC   CVCL_FB92
DR   CLO; CLO_0035117
DR   Coriell; ND13996
DR   Wikidata; Q54926226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND13997
AC   CVCL_CN21
DR   CLO; CLO_0035116
DR   Coriell; ND13997
DR   Wikidata; Q54926227
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13998
AC   CVCL_CN22
DR   CLO; CLO_0035123
DR   Coriell; ND13998
DR   Wikidata; Q54926228
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND13999
AC   CVCL_CN23
DR   CLO; CLO_0035122
DR   Coriell; ND13999
DR   Wikidata; Q54926229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14000
AC   CVCL_GK19
DR   CLO; CLO_0035121
DR   Coriell; ND14000
DR   Wikidata; Q54926230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14001
AC   CVCL_GK20
DR   CLO; CLO_0035120
DR   Coriell; ND14001
DR   Wikidata; Q54926231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14002
AC   CVCL_FD87
DR   CLO; CLO_0035124
DR   Coriell; ND14002
DR   Wikidata; Q54926232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14003
AC   CVCL_EY13
DR   CLO; CLO_0035126
DR   Coriell; ND14003
DR   Wikidata; Q54926233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14004
AC   CVCL_FD88
DR   CLO; CLO_0035125
DR   Coriell; ND14004
DR   Wikidata; Q54926234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14005
AC   CVCL_GK21
DR   CLO; CLO_0035128
DR   Coriell; ND14005
DR   Wikidata; Q54926235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14006
AC   CVCL_GK22
DR   CLO; CLO_0035127
DR   Coriell; ND14006
DR   Wikidata; Q54926236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14009
AC   CVCL_FL68
DR   Coriell; ND14009
DR   Wikidata; Q54926237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14016
AC   CVCL_FL69
DR   Coriell; ND14016
DR   Wikidata; Q54926238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14017
AC   CVCL_GK23
DR   CLO; CLO_0035130
DR   Coriell; ND14017
DR   Wikidata; Q54926239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14018
AC   CVCL_GK24
DR   CLO; CLO_0035129
DR   Coriell; ND14018
DR   Wikidata; Q54926240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14019
AC   CVCL_GK25
DR   CLO; CLO_0035132
DR   Coriell; ND14019
DR   Wikidata; Q54926241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14020
AC   CVCL_GK26
DR   CLO; CLO_0035131
DR   Coriell; ND14020
DR   Wikidata; Q54926242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14021
AC   CVCL_FD89
DR   CLO; CLO_0035133
DR   Coriell; ND14021
DR   Wikidata; Q54926248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14022
AC   CVCL_GK27
DR   CLO; CLO_0035137
DR   Coriell; ND14022
DR   Wikidata; Q54926249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14023
AC   CVCL_FD90
DR   CLO; CLO_0035136
DR   Coriell; ND14023
DR   Wikidata; Q54926250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14024
AC   CVCL_GK28
DR   CLO; CLO_0035135
DR   Coriell; ND14024
DR   Wikidata; Q54926251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14025
AC   CVCL_GK29
DR   CLO; CLO_0035134
DR   Coriell; ND14025
DR   Wikidata; Q54926252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14026
AC   CVCL_BQ30
DR   CLO; CLO_0035143
DR   Coriell; ND14026
DR   Wikidata; Q54926254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14027
AC   CVCL_GK30
DR   CLO; CLO_0035142
DR   Coriell; ND14027
DR   Wikidata; Q54926255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14028
AC   CVCL_FD91
DR   CLO; CLO_0035141
DR   Coriell; ND14028
DR   Wikidata; Q54926256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14029
AC   CVCL_GK31
DR   CLO; CLO_0035140
DR   BioSample; SAMN00797912
DR   Coriell; ND14029
DR   Wikidata; Q54926257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14030
AC   CVCL_BQ31
DR   CLO; CLO_0035139
DR   Coriell; ND14030
DR   Wikidata; Q54926258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14031
AC   CVCL_BQ32
DR   CLO; CLO_0035138
DR   Coriell; ND14031
DR   Wikidata; Q54926259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14032
AC   CVCL_EY14
DR   CLO; CLO_0035148
DR   Coriell; ND14032
DR   Wikidata; Q54926260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14033
AC   CVCL_EB96
DR   CLO; CLO_0035145
DR   Coriell; ND14033
DR   Wikidata; Q54926261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14034
AC   CVCL_BQ33
DR   CLO; CLO_0035144
DR   Coriell; ND14034
DR   Wikidata; Q54926262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14035
AC   CVCL_GK32
DR   CLO; CLO_0035147
DR   Coriell; ND14035
DR   Wikidata; Q54926263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14036
AC   CVCL_GK33
DR   CLO; CLO_0035146
DR   Coriell; ND14036
DR   Wikidata; Q54926264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14037
AC   CVCL_GK34
DR   CLO; CLO_0035151
DR   Coriell; ND14037
DR   Wikidata; Q54926266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14038
AC   CVCL_CN24
DR   Coriell; ND14038
DR   Wikidata; Q54926267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14043
AC   CVCL_CN25
DR   Coriell; ND14043
DR   Wikidata; Q54926268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14044
AC   CVCL_CN26
DR   CLO; CLO_0035150
DR   Coriell; ND14044
DR   Wikidata; Q54926269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14045
AC   CVCL_BQ34
DR   CLO; CLO_0035153
DR   Coriell; ND14045
DR   Wikidata; Q54926270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14046
AC   CVCL_BQ35
DR   CLO; CLO_0035152
DR   Coriell; ND14046
DR   Wikidata; Q54926271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14047
AC   CVCL_BQ36
DR   CLO; CLO_0035149
DR   Coriell; ND14047
DR   Wikidata; Q54926272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14048
AC   CVCL_IK21
DR   CLO; CLO_0034993
DR   Coriell; ND14048
DR   Wikidata; Q54926273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14049
AC   CVCL_GK35
DR   CLO; CLO_0034994
DR   BioSample; SAMN00797916
DR   Coriell; ND14049
DR   Wikidata; Q54926274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14050
AC   CVCL_CN27
DR   CLO; CLO_0034989
DR   Coriell; ND14050
DR   Wikidata; Q54926275
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14051
AC   CVCL_GK36
DR   CLO; CLO_0034990
DR   Coriell; ND14051
DR   Wikidata; Q54926276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14052
AC   CVCL_GK37
DR   CLO; CLO_0034991
DR   Coriell; ND14052
DR   Wikidata; Q54926277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14053
AC   CVCL_GK38
DR   CLO; CLO_0034992
DR   Coriell; ND14053
DR   Wikidata; Q54926278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14054
AC   CVCL_GK39
DR   CLO; CLO_0034981
DR   Coriell; ND14054
DR   Wikidata; Q54926279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14055
AC   CVCL_HR82
DR   CLO; CLO_0034983
DR   Coriell; ND14055
DR   Wikidata; Q54926280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14056
AC   CVCL_FB30
DR   CLO; CLO_0034986
DR   Coriell; ND14056
DR   Wikidata; Q54926281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14057
AC   CVCL_GK40
DR   CLO; CLO_0034988
DR   Coriell; ND14057
DR   Wikidata; Q54926282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14058
AC   CVCL_BQ37
DR   CLO; CLO_0028700
DR   Coriell; ND14058
DR   Wikidata; Q54926283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14059
AC   CVCL_BQ38
DR   CLO; CLO_0028698
DR   Coriell; ND14059
DR   Wikidata; Q54926284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14060
AC   CVCL_CN28
DR   CLO; CLO_0028699
DR   Coriell; ND14060
DR   Wikidata; Q54926285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14061
AC   CVCL_IK22
DR   CLO; CLO_0028703
DR   Coriell; ND14061
DR   Wikidata; Q54926286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14062
AC   CVCL_FD92
DR   CLO; CLO_0028705
DR   BioSample; SAMN00797923
DR   Coriell; ND14062
DR   Wikidata; Q54926287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14066
AC   CVCL_CN29
DR   Coriell; ND14066
DR   Wikidata; Q54926288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14070
AC   CVCL_BQ39
DR   Coriell; ND14070
DR   Wikidata; Q54926289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14071
AC   CVCL_EY15
DR   CLO; CLO_0028701
DR   BioSample; SAMN00797925
DR   Coriell; ND14071
DR   Wikidata; Q54926293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14074
AC   CVCL_CN30
DR   CLO; CLO_0028702
DR   Coriell; ND14074
DR   Wikidata; Q54926294
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14075
AC   CVCL_EB97
DR   CLO; CLO_0028707
DR   Coriell; ND14075
DR   Wikidata; Q54926295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14076
AC   CVCL_BQ40
DR   CLO; CLO_0028708
DR   Coriell; ND14076
DR   Wikidata; Q54926296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14077
AC   CVCL_BQ41
DR   CLO; CLO_0028706
DR   Coriell; ND14077
DR   Wikidata; Q54926297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14078
AC   CVCL_GK41
DR   CLO; CLO_0028717
DR   BioSample; SAMN00797932
DR   Coriell; ND14078
DR   Wikidata; Q54926298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14079
AC   CVCL_GK42
DR   CLO; CLO_0028718
DR   BioSample; SAMN00797934
DR   Coriell; ND14079
DR   Wikidata; Q54926299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14080
AC   CVCL_BQ42
DR   CLO; CLO_0028719
DR   Coriell; ND14080
DR   Wikidata; Q54926300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14081
AC   CVCL_BQ43
DR   CLO; CLO_0028720
DR   Coriell; ND14081
DR   Wikidata; Q54926301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14082
AC   CVCL_BQ44
DR   CLO; CLO_0028721
DR   Coriell; ND14082
DR   Wikidata; Q54926302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14083
AC   CVCL_BQ45
DR   CLO; CLO_0028724
DR   Coriell; ND14083
DR   Wikidata; Q54926303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14084
AC   CVCL_BQ46
DR   CLO; CLO_0028725
DR   Coriell; ND14084
DR   Wikidata; Q54926304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14085
AC   CVCL_FD93
DR   CLO; CLO_0028726
DR   BioSample; SAMN00797938
DR   Coriell; ND14085
DR   Wikidata; Q54926305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14086
AC   CVCL_BQ47
DR   CLO; CLO_0028727
DR   Coriell; ND14086
DR   Wikidata; Q54926306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14087
AC   CVCL_GK43
DR   CLO; CLO_0028728
DR   BioSample; SAMN00797942
DR   Coriell; ND14087
DR   Wikidata; Q54926307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14088
AC   CVCL_BQ48
DR   CLO; CLO_0028733
DR   Coriell; ND14088
DR   Wikidata; Q54926308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14089
AC   CVCL_GK44
DR   CLO; CLO_0028756
DR   Coriell; ND14089
DR   Wikidata; Q54926309
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14090
AC   CVCL_GK45
DR   CLO; CLO_0028757
DR   Coriell; ND14090
DR   Wikidata; Q54926310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14091
AC   CVCL_BQ49
DR   CLO; CLO_0028754
DR   Coriell; ND14091
DR   Wikidata; Q54926311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14092
AC   CVCL_CN31
DR   Coriell; ND14092
DR   Wikidata; Q54926312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14093
AC   CVCL_IK23
DR   CLO; CLO_0028755
DR   Coriell; ND14093
DR   Wikidata; Q54926313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14094
AC   CVCL_GK46
DR   CLO; CLO_0028751
DR   Coriell; ND14094
DR   Wikidata; Q54926314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14095
AC   CVCL_GK47
DR   CLO; CLO_0028753
DR   Coriell; ND14095
DR   Wikidata; Q54926315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14096
AC   CVCL_GK48
DR   CLO; CLO_0028748
DR   Coriell; ND14096
DR   Wikidata; Q54926316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14097
AC   CVCL_GK49
DR   CLO; CLO_0028749
DR   Coriell; ND14097
DR   Wikidata; Q54926317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14098
AC   CVCL_GK50
DR   CLO; CLO_0028758
DR   Coriell; ND14098
DR   Wikidata; Q54926318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14099
AC   CVCL_FD94
DR   CLO; CLO_0028766
DR   Coriell; ND14099
DR   Wikidata; Q54926319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14109
AC   CVCL_EB98
DR   Coriell; ND14109
DR   Wikidata; Q54926320
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14113
AC   CVCL_CN32
DR   CLO; CLO_0028764
DR   Coriell; ND14113
DR   Wikidata; Q54926321
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14114
AC   CVCL_CN33
DR   CLO; CLO_0028775
DR   Coriell; ND14114
DR   Wikidata; Q54926322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14115
AC   CVCL_CN34
DR   CLO; CLO_0028776
DR   Coriell; ND14115
DR   Wikidata; Q54926323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14116
AC   CVCL_GK51
DR   CLO; CLO_0028777
DR   BioSample; SAMN00797944
DR   Coriell; ND14116
DR   Wikidata; Q54926324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14117
AC   CVCL_BQ50
DR   CLO; CLO_0028778
DR   Coriell; ND14117
DR   Wikidata; Q54926325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14118
AC   CVCL_GK52
DR   CLO; CLO_0028771
DR   Coriell; ND14118
DR   Wikidata; Q54926326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14119
AC   CVCL_FD95
DR   CLO; CLO_0028772
DR   Coriell; ND14119
DR   Wikidata; Q54926327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14120
AC   CVCL_GK53
DR   CLO; CLO_0028773
DR   Coriell; ND14120
DR   Wikidata; Q54926328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14121
AC   CVCL_BQ51
DR   CLO; CLO_0028774
DR   Coriell; ND14121
DR   Wikidata; Q54926329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14122
AC   CVCL_BQ52
DR   CLO; CLO_0030830
DR   Coriell; ND14122
DR   Wikidata; Q54926330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14123
AC   CVCL_BQ53
DR   CLO; CLO_0030832
DR   Coriell; ND14123
DR   Wikidata; Q54926331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14124
AC   CVCL_FD96
DR   CLO; CLO_0030834
DR   Coriell; ND14124
DR   Wikidata; Q54926332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14125
AC   CVCL_GK54
DR   CLO; CLO_0030844
DR   BioSample; SAMN00797947
DR   Coriell; ND14125
DR   Wikidata; Q54926335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14126
AC   CVCL_BQ54
DR   CLO; CLO_0030841
DR   Coriell; ND14126
DR   Wikidata; Q54926336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14127
AC   CVCL_GK55
DR   CLO; CLO_0030848
DR   BioSample; SAMN00797951
DR   Coriell; ND14127
DR   Wikidata; Q54926337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14128
AC   CVCL_EY16
DR   CLO; CLO_0030846
DR   Coriell; ND14128
DR   Wikidata; Q54926338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14129
AC   CVCL_GK56
DR   CLO; CLO_0030839
DR   Coriell; ND14129
DR   Wikidata; Q54926339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14130
AC   CVCL_GK57
DR   CLO; CLO_0030838
DR   Coriell; ND14130
DR   Wikidata; Q54926340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14131
AC   CVCL_GK58
DR   CLO; CLO_0030840
DR   Coriell; ND14131
DR   Wikidata; Q54926341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14133
AC   CVCL_IE98
DR   BioSample; SAMN00797953
DR   Coriell; ND14133
DR   Wikidata; Q54926342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14135
AC   CVCL_BQ55
DR   CLO; CLO_0030814
DR   Coriell; ND14135
DR   Wikidata; Q54926343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14136
AC   CVCL_BQ56
DR   CLO; CLO_0030815
DR   Coriell; ND14136
DR   Wikidata; Q54926344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14137
AC   CVCL_BQ57
DR   Coriell; ND14137
DR   Wikidata; Q54926345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14138
AC   CVCL_GK59
DR   CLO; CLO_0030809
DR   BioSample; SAMN00797957
DR   Coriell; ND14138
DR   Wikidata; Q54926346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14139
AC   CVCL_BQ58
DR   CLO; CLO_0030811
DR   Coriell; ND14139
DR   Wikidata; Q54926347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14140
AC   CVCL_GK60
DR   CLO; CLO_0030827
DR   Coriell; ND14140
DR   Wikidata; Q54926348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14141
AC   CVCL_BQ59
DR   CLO; CLO_0030826
DR   Coriell; ND14141
DR   Wikidata; Q54926349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14143
AC   CVCL_CN35
DR   BioSample; SAMN00797959
DR   Coriell; ND14143
DR   Wikidata; Q54926350
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (Coriell=ND14143).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD54 ! ND29756
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   ND14145
AC   CVCL_IM08
DR   CLO; CLO_0030824
DR   Coriell; ND14145
DR   Wikidata; Q54926351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14146
AC   CVCL_EB99
DR   CLO; CLO_0030822
DR   Coriell; ND14146
DR   Wikidata; Q54926353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14147
AC   CVCL_EC00
DR   CLO; CLO_0030820
DR   Coriell; ND14147
DR   Wikidata; Q54926354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14148
AC   CVCL_CN36
DR   CLO; CLO_0030819
DR   Coriell; ND14148
DR   Wikidata; Q54926355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14149
AC   CVCL_BQ60
DR   CLO; CLO_0030789
DR   Coriell; ND14149
DR   Wikidata; Q54926356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14150
AC   CVCL_GK61
DR   CLO; CLO_0030791
DR   BioSample; SAMN00797963
DR   Coriell; ND14150
DR   Wikidata; Q54926357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14151
AC   CVCL_BQ61
DR   CLO; CLO_0030793
DR   Coriell; ND14151
DR   Wikidata; Q54926358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14152
AC   CVCL_CN37
DR   Coriell; ND14152
DR   Wikidata; Q54926359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14153
AC   CVCL_CN38
DR   CLO; CLO_0030795
DR   Coriell; ND14153
DR   Wikidata; Q54926360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14154
AC   CVCL_BQ62
DR   CLO; CLO_0030797
DR   Coriell; ND14154
DR   Wikidata; Q54926361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14155
AC   CVCL_CN39
DR   CLO; CLO_0030800
DR   Coriell; ND14155
DR   Wikidata; Q54926362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14157
AC   CVCL_IG86
DR   Coriell; ND14157
DR   Wikidata; Q54926363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14158
AC   CVCL_IE99
DR   Coriell; ND14158
DR   Wikidata; Q54926364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14160
AC   CVCL_EC01
DR   Coriell; ND14160
DR   Wikidata; Q54926365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14161
AC   CVCL_EC02
DR   Coriell; ND14161
DR   Wikidata; Q54926366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14162
AC   CVCL_CN40
DR   Coriell; ND14162
DR   Wikidata; Q54926367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14163
AC   CVCL_CN41
DR   Coriell; ND14163
DR   Wikidata; Q54926368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14165
AC   CVCL_HW03
DR   Coriell; ND14165
DR   Wikidata; Q54926369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14166
AC   CVCL_CN42
DR   CLO; CLO_0030798
DR   Coriell; ND14166
DR   Wikidata; Q54926370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14167
AC   CVCL_CN43
DR   CLO; CLO_0030804
DR   Coriell; ND14167
DR   Wikidata; Q54926371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14168
AC   CVCL_CN44
DR   CLO; CLO_0030802
DR   Coriell; ND14168
DR   Wikidata; Q54926372
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14169
AC   CVCL_CN45
DR   CLO; CLO_0030806
DR   Coriell; ND14169
DR   Wikidata; Q54926373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14170
AC   CVCL_CN46
DR   Coriell; ND14170
DR   Wikidata; Q54926374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14171
AC   CVCL_BQ63
DR   CLO; CLO_0030769
DR   Coriell; ND14171
DR   Wikidata; Q54926375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14172
AC   CVCL_BQ64
DR   CLO; CLO_0030770
DR   Coriell; ND14172
DR   Wikidata; Q54926378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14173
AC   CVCL_GK62
DR   CLO; CLO_0030775
DR   BioSample; SAMN00797971
DR   Coriell; ND14173
DR   Wikidata; Q54926379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14174
AC   CVCL_HR83
DR   CLO; CLO_0030776
DR   Coriell; ND14174
DR   Wikidata; Q54926380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14175
AC   CVCL_GK63
DR   CLO; CLO_0030771
DR   Coriell; ND14175
DR   Wikidata; Q54926381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14176
AC   CVCL_FB31
DR   CLO; CLO_0030773
DR   Coriell; ND14176
DR   Wikidata; Q54926382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14177
AC   CVCL_BQ65
DR   CLO; CLO_0030785
DR   Coriell; ND14177
DR   Wikidata; Q54926383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14178
AC   CVCL_FB32
DR   CLO; CLO_0030783
DR   Coriell; ND14178
DR   Wikidata; Q54926384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14179
AC   CVCL_BQ66
DR   CLO; CLO_0030781
DR   Coriell; ND14179
DR   Wikidata; Q54926385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14180
AC   CVCL_HR84
DR   CLO; CLO_0030779
DR   Coriell; ND14180
DR   Wikidata; Q54926386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14181
AC   CVCL_HR85
DR   CLO; CLO_0030885
DR   Coriell; ND14181
DR   Wikidata; Q54926387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14182
AC   CVCL_BQ67
DR   CLO; CLO_0030887
DR   Coriell; ND14182
DR   Wikidata; Q54926388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14183
AC   CVCL_BQ68
DR   CLO; CLO_0030886
DR   Coriell; ND14183
DR   Wikidata; Q54926389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14184
AC   CVCL_GK64
DR   CLO; CLO_0030882
DR   BioSample; SAMN00797977
DR   Coriell; ND14184
DR   Wikidata; Q54926391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14185
AC   CVCL_BQ69
DR   CLO; CLO_0030880
DR   Coriell; ND14185
DR   Wikidata; Q54926392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14186
AC   CVCL_BQ70
DR   CLO; CLO_0030884
DR   Coriell; ND14186
DR   Wikidata; Q54926393
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND14187
AC   CVCL_BQ71
DR   CLO; CLO_0030883
DR   Coriell; ND14187
DR   Wikidata; Q54926394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14188
AC   CVCL_BQ72
DR   CLO; CLO_0030893
DR   Coriell; ND14188
DR   Wikidata; Q54926395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14189
AC   CVCL_GK65
DR   CLO; CLO_0030895
DR   BioSample; SAMN00797983
DR   Coriell; ND14189
DR   Wikidata; Q54926396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14192
AC   CVCL_CN47
DR   Coriell; ND14192
DR   Wikidata; Q54926397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14203
AC   CVCL_HW04
DR   Coriell; ND14203
DR   Wikidata; Q54926398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14205
AC   CVCL_BQ73
DR   CLO; CLO_0030896
DR   Coriell; ND14205
DR   Wikidata; Q54926399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14206
AC   CVCL_CN48
DR   CLO; CLO_0030867
DR   Coriell; ND14206
DR   Wikidata; Q54926400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14207
AC   CVCL_CN49
DR   CLO; CLO_0030866
DR   Coriell; ND14207
DR   Wikidata; Q54926401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14208
AC   CVCL_BQ74
DR   CLO; CLO_0030865
DR   Coriell; ND14208
DR   Wikidata; Q54926402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14209
AC   CVCL_BQ75
DR   CLO; CLO_0030864
DR   Coriell; ND14209
DR   Wikidata; Q54926403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14210
AC   CVCL_BQ76
DR   CLO; CLO_0030863
DR   Coriell; ND14210
DR   Wikidata; Q54926404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14211
AC   CVCL_CN50
DR   CLO; CLO_0030861
DR   Coriell; ND14211
DR   Wikidata; Q54926405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14212
AC   CVCL_CN51
DR   CLO; CLO_0030860
DR   Coriell; ND14212
DR   Wikidata; Q54926406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14213
AC   CVCL_GK66
DR   CLO; CLO_0030859
DR   Coriell; ND14213
DR   Wikidata; Q54926407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14214
AC   CVCL_GK67
DR   CLO; CLO_0030875
DR   Coriell; ND14214
DR   Wikidata; Q54926408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14215
AC   CVCL_GK68
DR   CLO; CLO_0030877
DR   Coriell; ND14215
DR   Wikidata; Q54926409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14216
AC   CVCL_GK69
DR   CLO; CLO_0030559
DR   Coriell; ND14216
DR   Wikidata; Q54926410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14217
AC   CVCL_GK70
DR   CLO; CLO_0030558
DR   Coriell; ND14217
DR   Wikidata; Q54926411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14218
AC   CVCL_GK71
DR   CLO; CLO_0030557
DR   Coriell; ND14218
DR   Wikidata; Q54926412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14219
AC   CVCL_IK24
DR   CLO; CLO_0030554
DR   Coriell; ND14219
DR   Wikidata; Q54926413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14221
AC   CVCL_EC03
DR   Coriell; ND14221
DR   Wikidata; Q54926414
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14226
AC   CVCL_BQ77
DR   Coriell; ND14226
DR   Wikidata; Q54926415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14227
AC   CVCL_CN52
DR   CLO; CLO_0030551
DR   Coriell; ND14227
DR   Wikidata; Q54926416
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14228
AC   CVCL_FF32
DR   CLO; CLO_0030549
DR   Coriell; ND14228
DR   Wikidata; Q54926417
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14229
AC   CVCL_EC04
DR   CLO; CLO_0030565
DR   Coriell; ND14229
DR   Wikidata; Q54926418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14230
AC   CVCL_GK72
DR   CLO; CLO_0030564
DR   Coriell; ND14230
DR   Wikidata; Q54926425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14231
AC   CVCL_GK73
DR   CLO; CLO_0030563
DR   Coriell; ND14231
DR   Wikidata; Q54926426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14232
AC   CVCL_GK74
DR   CLO; CLO_0030562
DR   Coriell; ND14232
DR   Wikidata; Q54926427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14233
AC   CVCL_GK75
DR   CLO; CLO_0030598
DR   Coriell; ND14233
DR   Wikidata; Q54926428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14234
AC   CVCL_CN53
DR   CLO; CLO_0030602
DR   Coriell; ND14234
DR   Wikidata; Q54926429
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14235
AC   CVCL_BQ78
DR   Coriell; ND14235
DR   Wikidata; Q54926430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14236
AC   CVCL_GK76
DR   CLO; CLO_0030600
DR   Coriell; ND14236
DR   Wikidata; Q54926431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14237
AC   CVCL_GK77
DR   CLO; CLO_0030591
DR   Coriell; ND14237
DR   Wikidata; Q54926432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14238
AC   CVCL_GK78
DR   CLO; CLO_0030590
DR   Coriell; ND14238
DR   Wikidata; Q54926433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14239
AC   CVCL_GK79
DR   CLO; CLO_0030595
DR   Coriell; ND14239
DR   Wikidata; Q54926434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14240
AC   CVCL_GK80
DR   CLO; CLO_0030593
DR   Coriell; ND14240
DR   Wikidata; Q54926435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14241
AC   CVCL_BQ79
DR   CLO; CLO_0030604
DR   Coriell; ND14241
DR   Wikidata; Q54926436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14242
AC   CVCL_FD97
DR   CLO; CLO_0030603
DR   Coriell; ND14242
DR   Wikidata; Q54926437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14243
AC   CVCL_GK81
DR   CLO; CLO_0030605
DR   Coriell; ND14243
DR   Wikidata; Q54926438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14244
AC   CVCL_GK82
DR   CLO; CLO_0030733
DR   Coriell; ND14244
DR   Wikidata; Q54926439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14245
AC   CVCL_GK83
DR   CLO; CLO_0030734
DR   Coriell; ND14245
DR   Wikidata; Q54926440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14248
AC   CVCL_FD98
DR   CLO; CLO_0030731
DR   Coriell; ND14248
DR   Wikidata; Q54926441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14250
AC   CVCL_BQ80
DR   CLO; CLO_0030732
DR   Coriell; ND14250
DR   Wikidata; Q54926442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14251
AC   CVCL_FD99
DR   CLO; CLO_0030738
DR   BioSample; SAMN00797989
DR   Coriell; ND14251
DR   Wikidata; Q54926443
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14252
AC   CVCL_BQ81
DR   CLO; CLO_0030740
DR   Coriell; ND14252
DR   Wikidata; Q54926444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14253
AC   CVCL_BQ82
DR   CLO; CLO_0030735
DR   Coriell; ND14253
DR   Wikidata; Q54926445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14254
AC   CVCL_FE00
DR   CLO; CLO_0030737
DR   BioSample; SAMN00797993
DR   Coriell; ND14254
DR   Wikidata; Q54926446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14259
AC   CVCL_GK84
DR   CLO; CLO_0030729
DR   BioSample; SAMN00797995
DR   Coriell; ND14259
DR   Wikidata; Q54926447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14260
AC   CVCL_BQ83
DR   CLO; CLO_0030730
DR   Coriell; ND14260
DR   Wikidata; Q54926448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14261
AC   CVCL_BQ84
DR   CLO; CLO_0030766
DR   Coriell; ND14261
DR   Wikidata; Q54926450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14262
AC   CVCL_BQ85
DR   CLO; CLO_0030750
DR   BioSample; SAMN00798001
DR   Coriell; ND14262
DR   Wikidata; Q54926451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14263
AC   CVCL_BQ86
DR   CLO; CLO_0030751
DR   Coriell; ND14263
DR   Wikidata; Q54926452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14264
AC   CVCL_FE01
DR   CLO; CLO_0030752
DR   BioSample; SAMN00798003
DR   Coriell; ND14264
DR   Wikidata; Q54926453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14265
AC   CVCL_FE02
DR   CLO; CLO_0030753
DR   BioSample; SAMN00798005
DR   Coriell; ND14265
DR   Wikidata; Q54926454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14266
AC   CVCL_GK85
DR   CLO; CLO_0030755
DR   BioSample; SAMN00798007
DR   Coriell; ND14266
DR   Wikidata; Q54926455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14268
AC   CVCL_BQ87
DR   CLO; CLO_0030757
DR   Coriell; ND14268
DR   Wikidata; Q54926456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14269
AC   CVCL_GK86
DR   CLO; CLO_0030758
DR   Coriell; ND14269
DR   Wikidata; Q54926457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14273
AC   CVCL_GK87
DR   CLO; CLO_0030759
DR   Coriell; ND14273
DR   Wikidata; Q54926458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14274
AC   CVCL_GK88
DR   CLO; CLO_0030749
DR   Coriell; ND14274
DR   Wikidata; Q54926459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14275
AC   CVCL_GK89
DR   CLO; CLO_0030696
DR   Coriell; ND14275
DR   Wikidata; Q54926460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14277
AC   CVCL_BQ88
DR   CLO; CLO_0030695
DR   BioSample; SAMN00798009
DR   Coriell; ND14277
DR   Wikidata; Q54926461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14278
AC   CVCL_FE03
DR   CLO; CLO_0030691
DR   Coriell; ND14278
DR   Wikidata; Q54926462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14279
AC   CVCL_EC05
DR   CLO; CLO_0030693
DR   Coriell; ND14279
DR   Wikidata; Q54926463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14280
AC   CVCL_FE04
DR   CLO; CLO_0030689
DR   Coriell; ND14280
DR   Wikidata; Q54926464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14281
AC   CVCL_GK90
DR   CLO; CLO_0030690
DR   Coriell; ND14281
DR   Wikidata; Q54926465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14282
AC   CVCL_GK91
DR   CLO; CLO_0030685
DR   Coriell; ND14282
DR   Wikidata; Q54926470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14283
AC   CVCL_IF00
DR   Coriell; ND14283
DR   Wikidata; Q54926471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14284
AC   CVCL_GK92
DR   CLO; CLO_0030687
DR   Coriell; ND14284
DR   Wikidata; Q54926472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14285
AC   CVCL_GK93
DR   CLO; CLO_0030680
DR   Coriell; ND14285
DR   Wikidata; Q54926473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14286
AC   CVCL_CN54
DR   CLO; CLO_0030681
DR   Coriell; ND14286
DR   Wikidata; Q54926474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14287
AC   CVCL_CN55
DR   CLO; CLO_0030720
DR   Coriell; ND14287
DR   Wikidata; Q54926475
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14288
AC   CVCL_IK25
DR   CLO; CLO_0030723
DR   Coriell; ND14288
DR   Wikidata; Q54926476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14289
AC   CVCL_BQ89
DR   CLO; CLO_0030722
DR   Coriell; ND14289
DR   Wikidata; Q54926477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14290
AC   CVCL_GK94
DR   CLO; CLO_0030716
DR   Coriell; ND14290
DR   Wikidata; Q54926478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14291
AC   CVCL_GK95
DR   CLO; CLO_0030717
DR   Coriell; ND14291
DR   Wikidata; Q54926479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14292
AC   CVCL_GK96
DR   CLO; CLO_0030718
DR   BioSample; SAMN00798011
DR   Coriell; ND14292
DR   Wikidata; Q54926480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14293
AC   CVCL_BQ90
DR   CLO; CLO_0030719
DR   Coriell; ND14293
DR   Wikidata; Q54926481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14294
AC   CVCL_BQ91
DR   CLO; CLO_0030710
DR   Coriell; ND14294
DR   Wikidata; Q54926482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14295
AC   CVCL_BQ92
DR   CLO; CLO_0030712
DR   BioSample; SAMN00798013
DR   Coriell; ND14295
DR   Wikidata; Q54926483
RX   PubMed=34468209;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND14296
AC   CVCL_FE05
DR   CLO; CLO_0030713
DR   Coriell; ND14296
DR   Wikidata; Q54926484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14297
AC   CVCL_1V06
DR   CLO; CLO_0030179
DR   Coriell; ND14297
DR   Wikidata; Q54926485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   ND14298
AC   CVCL_1V07
DR   CLO; CLO_0030182
DR   Coriell; ND14298
DR   Wikidata; Q54926486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   ND14299
AC   CVCL_GK98
DR   CLO; CLO_0030183
DR   Coriell; ND14299
DR   Wikidata; Q54926487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14300
AC   CVCL_IK26
DR   CLO; CLO_0030185
DR   BioSample; SAMN00798015
DR   Coriell; ND14300
DR   Wikidata; Q54926488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14301
AC   CVCL_BQ93
DR   CLO; CLO_0030194
DR   Coriell; ND14301
DR   Wikidata; Q54926489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14302
AC   CVCL_GK99
DR   CLO; CLO_0030192
DR   Coriell; ND14302
DR   Wikidata; Q54926490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14303
AC   CVCL_FE06
DR   CLO; CLO_0030197
DR   BioSample; SAMN00798017
DR   Coriell; ND14303
DR   Wikidata; Q54926491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14304
AC   CVCL_FE07
DR   CLO; CLO_0030196
DR   Coriell; ND14304
DR   Wikidata; Q54926492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14305
AC   CVCL_BQ94
DR   CLO; CLO_0030191
DR   Coriell; ND14305
DR   Wikidata; Q54926493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14306
AC   CVCL_BQ95
DR   CLO; CLO_0030190
DR   Coriell; ND14306
DR   Wikidata; Q54926494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14307
AC   CVCL_GL00
DR   CLO; CLO_0030167
DR   BioSample; SAMN00798019
DR   Coriell; ND14307
DR   Wikidata; Q54926495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14308
AC   CVCL_BQ96
DR   CLO; CLO_0030164
DR   BioSample; SAMN00798021
DR   Coriell; ND14308
DR   Wikidata; Q54926496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14309
AC   CVCL_EY17
DR   CLO; CLO_0030165
DR   BioSample; SAMN00798023
DR   Coriell; ND14309
DR   Wikidata; Q54926497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14310
AC   CVCL_BQ97
DR   BioSample; SAMN00798025
DR   Coriell; ND14310
DR   Wikidata; Q54926498
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   ND14311
AC   CVCL_BQ98
DR   CLO; CLO_0030159
DR   Coriell; ND14311
DR   Wikidata; Q54926499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14312
AC   CVCL_CN56
DR   CLO; CLO_0030161
DR   Coriell; ND14312
DR   Wikidata; Q54926500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14317
AC   CVCL_CN57
DR   BioSample; SAMN00798027
DR   Coriell; ND14317
DR   Wikidata; Q54926501
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND14317).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DD52 ! ND29542
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   ND14318
AC   CVCL_DR43
DR   Coriell; ND14318
DR   Wikidata; Q54926502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND12218 (Cellosaurus=CVCL_BJ79).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   ND14320
AC   CVCL_IF01
DR   Coriell; ND14320
DR   Wikidata; Q54926503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14322
AC   CVCL_CN58
DR   Coriell; ND14322
DR   Wikidata; Q54926504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14323
AC   CVCL_CN59
DR   Coriell; ND14323
DR   Wikidata; Q54926505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14324
AC   CVCL_CN60
DR   Coriell; ND14324
DR   Wikidata; Q54926506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14328
AC   CVCL_EC06
DR   Coriell; ND14328
DR   Wikidata; Q54926507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14329
AC   CVCL_CN61
DR   CLO; CLO_0030178
DR   Coriell; ND14329
DR   Wikidata; Q54926508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14330
AC   CVCL_CN62
DR   Coriell; ND14330
DR   Wikidata; Q54926509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14331
AC   CVCL_IK27
DR   CLO; CLO_0030176
DR   Coriell; ND14331
DR   Wikidata; Q54926514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14332
AC   CVCL_BQ99
DR   CLO; CLO_0030173
DR   Coriell; ND14332
DR   Wikidata; Q54926516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14333
AC   CVCL_BR00
DR   CLO; CLO_0030171
DR   Coriell; ND14333
DR   Wikidata; Q54926517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14334
AC   CVCL_BR01
DR   CLO; CLO_0030170
DR   Coriell; ND14334
DR   Wikidata; Q54926518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14335
AC   CVCL_BR02
DR   CLO; CLO_0030222
DR   BioSample; SAMN00798029
DR   Coriell; ND14335
DR   Wikidata; Q54926519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14336
AC   CVCL_GL01
DR   CLO; CLO_0030224
DR   BioSample; SAMN00798031
DR   Coriell; ND14336
DR   Wikidata; Q54926520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14337
AC   CVCL_BR03
DR   CLO; CLO_0030227
DR   Coriell; ND14337
DR   Wikidata; Q54926521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14338
AC   CVCL_BR04
DR   CLO; CLO_0030229
DR   Coriell; ND14338
DR   Wikidata; Q54926522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14339
AC   CVCL_BR05
DR   CLO; CLO_0030231
DR   Coriell; ND14339
DR   Wikidata; Q54926523
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND14340
AC   CVCL_IK28
DR   CLO; CLO_0030233
DR   Coriell; ND14340
DR   Wikidata; Q54926524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14341
AC   CVCL_IF02
DR   Coriell; ND14341
DR   Wikidata; Q54926525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14358
AC   CVCL_IF03
DR   Coriell; ND14358
DR   Wikidata; Q54926526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14360
AC   CVCL_IM10
DR   Coriell; ND14360
DR   Wikidata; Q54926527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14362
AC   CVCL_CN63
DR   CLO; CLO_0030238
DR   Coriell; ND14362
DR   Wikidata; Q54926528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14363
AC   CVCL_CN64
DR   CLO; CLO_0030237
DR   Coriell; ND14363
DR   Wikidata; Q54926529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14364
AC   CVCL_BR06
DR   CLO; CLO_0030242
DR   Coriell; ND14364
DR   Wikidata; Q54926530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14365
AC   CVCL_BR07
DR   CLO; CLO_0030241
DR   Coriell; ND14365
DR   Wikidata; Q54926531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14369
AC   CVCL_HW05
DR   BioSample; SAMN00798033
DR   Coriell; ND14369
DR   Wikidata; Q54926532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14373
AC   CVCL_FL70
DR   BioSample; SAMN00798035
DR   Coriell; ND14373
DR   Wikidata; Q54926533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14374
AC   CVCL_CN65
DR   Coriell; ND14374
DR   Wikidata; Q54926534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14375
AC   CVCL_CN66
DR   CLO; CLO_0030201
DR   Coriell; ND14375
DR   Wikidata; Q54926535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14376
AC   CVCL_FB93
DR   CLO; CLO_0030199
DR   Coriell; ND14376
DR   Wikidata; Q54926536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14377
AC   CVCL_IH50
DR   CLO; CLO_0030200
DR   Coriell; ND14377
DR   Wikidata; Q54926537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14378
AC   CVCL_FB94
DR   CLO; CLO_0030207
DR   Coriell; ND14378
DR   Wikidata; Q54926538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14379
AC   CVCL_BR08
DR   CLO; CLO_0030208
DR   BioSample; SAMN00798037
DR   Coriell; ND14379
DR   Wikidata; Q54926539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14380
AC   CVCL_GL02
DR   CLO; CLO_0030202
DR   Coriell; ND14380
DR   Wikidata; Q54926540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14381
AC   CVCL_GL03
DR   CLO; CLO_0030205
DR   BioSample; SAMN00798039
DR   Coriell; ND14381
DR   Wikidata; Q54926541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14382
AC   CVCL_BR09
DR   CLO; CLO_0030216
DR   Coriell; ND14382
DR   Wikidata; Q54926542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14383
AC   CVCL_IK29
DR   BioSample; SAMN00798041
DR   Coriell; ND14383
DR   Wikidata; Q54926543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14384
AC   CVCL_EY18
DR   CLO; CLO_0030214
DR   BioSample; SAMN00798043
DR   Coriell; ND14384
DR   Wikidata; Q54926544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14385
AC   CVCL_FE08
DR   CLO; CLO_0030212
DR   Coriell; ND14385
DR   Wikidata; Q54926545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14386
AC   CVCL_BR10
DR   BioSample; SAMN00798045
DR   Coriell; ND14386
DR   Wikidata; Q54926546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14387
AC   CVCL_BR11
DR   CLO; CLO_0029945
DR   Coriell; ND14387
DR   Wikidata; Q54926547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14388
AC   CVCL_BR12
DR   CLO; CLO_0029954
DR   Coriell; ND14388
DR   Wikidata; Q54926548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14389
AC   CVCL_BR13
DR   CLO; CLO_0029952
DR   Coriell; ND14389
DR   Wikidata; Q54926549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14390
AC   CVCL_BR14
DR   CLO; CLO_0029951
DR   Coriell; ND14390
DR   Wikidata; Q54926550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14391
AC   CVCL_BR15
DR   CLO; CLO_0029948
DR   Coriell; ND14391
DR   Wikidata; Q54926551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14392
AC   CVCL_BR16
DR   CLO; CLO_0029942
DR   Coriell; ND14392
DR   Wikidata; Q54926552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14397
AC   CVCL_GL04
DR   CLO; CLO_0029941
DR   BioSample; SAMN00798047
DR   Coriell; ND14397
DR   Wikidata; Q54926553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14398
AC   CVCL_BR17
DR   CLO; CLO_0029940
DR   BioSample; SAMN00798049
DR   Coriell; ND14398
DR   Wikidata; Q54926554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14399
AC   CVCL_BR18
DR   CLO; CLO_0029939
DR   BioSample; SAMN00798051
DR   Coriell; ND14399
DR   Wikidata; Q54926556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14400
AC   CVCL_GL05
DR   CLO; CLO_0029943
DR   BioSample; SAMN00798053
DR   Coriell; ND14400
DR   Wikidata; Q54926557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14401
AC   CVCL_GL06
DR   CLO; CLO_0029978
DR   Coriell; ND14401
DR   Wikidata; Q54926558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14402
AC   CVCL_BR19
DR   CLO; CLO_0029976
DR   BioSample; SAMN00798055
DR   Coriell; ND14402
DR   Wikidata; Q54926559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14403
AC   CVCL_GL07
DR   CLO; CLO_0029981
DR   Coriell; ND14403
DR   Wikidata; Q54926560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14404
AC   CVCL_GL08
DR   CLO; CLO_0029980
DR   BioSample; SAMN00798057
DR   Coriell; ND14404
DR   Wikidata; Q54926561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14405
AC   CVCL_GL09
DR   CLO; CLO_0029986
DR   Coriell; ND14405
DR   Wikidata; Q54926562
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14406
AC   CVCL_GL10
DR   CLO; CLO_0029983
DR   Coriell; ND14406
DR   Wikidata; Q54926563
RX   PubMed=34468209;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14407
AC   CVCL_IF04
DR   BioSample; SAMN00798059
DR   Coriell; ND14407
DR   Wikidata; Q54926564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14408
AC   CVCL_BR20
DR   CLO; CLO_0029970
DR   BioSample; SAMN00798061
DR   Coriell; ND14408
DR   Wikidata; Q54926565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14409
AC   CVCL_BR21
DR   CLO; CLO_0029969
DR   Coriell; ND14409
DR   Wikidata; Q54926566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14410
AC   CVCL_BR22
DR   CLO; CLO_0029972
DR   Coriell; ND14410
DR   Wikidata; Q54926567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14411
AC   CVCL_GL11
DR   CLO; CLO_0029971
DR   BioSample; SAMN00798063
DR   Coriell; ND14411
DR   Wikidata; Q54926568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14412
AC   CVCL_BR23
DR   BioSample; SAMN00798065
DR   Coriell; ND14412
DR   Wikidata; Q54926569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14413
AC   CVCL_BR24
DR   CLO; CLO_0030008
DR   Coriell; ND14413
DR   Wikidata; Q54926571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14414
AC   CVCL_BR25
DR   CLO; CLO_0030007
DR   Coriell; ND14414
DR   Wikidata; Q54926572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14415
AC   CVCL_BR26
DR   CLO; CLO_0030006
DR   Coriell; ND14415
DR   Wikidata; Q54926573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14416
AC   CVCL_BR27
DR   CLO; CLO_0030005
DR   Coriell; ND14416
DR   Wikidata; Q54926574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14417
AC   CVCL_BR28
DR   CLO; CLO_0030004
DR   BioSample; SAMN00798067
DR   Coriell; ND14417
DR   Wikidata; Q54926575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14421
AC   CVCL_CN67
DR   Coriell; ND14421
DR   Wikidata; Q54926576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14424
AC   CVCL_EC07
DR   CLO; CLO_0030003
DR   Coriell; ND14424
DR   Wikidata; Q54926577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14425
AC   CVCL_EC08
DR   CLO; CLO_0030002
DR   Coriell; ND14425
DR   Wikidata; Q54926578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14426
AC   CVCL_EC09
DR   Coriell; ND14426
DR   Wikidata; Q54926579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14428
AC   CVCL_IK30
DR   CLO; CLO_0030001
DR   Coriell; ND14428
DR   Wikidata; Q54926580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14429
AC   CVCL_BR29
DR   CLO; CLO_0030000
DR   Coriell; ND14429
DR   Wikidata; Q54926581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14430
AC   CVCL_GL12
DR   CLO; CLO_0029999
DR   Coriell; ND14430
DR   Wikidata; Q54926582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14431
AC   CVCL_GL13
DR   CLO; CLO_0030036
DR   Coriell; ND14431
DR   Wikidata; Q54926583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14432
AC   CVCL_GL14
DR   CLO; CLO_0030035
DR   Coriell; ND14432
DR   Wikidata; Q54926584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14433
AC   CVCL_GL15
DR   CLO; CLO_0030038
DR   Coriell; ND14433
DR   Wikidata; Q54926585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14434
AC   CVCL_BR30
DR   CLO; CLO_0030037
DR   Coriell; ND14434
DR   Wikidata; Q54926586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14435
AC   CVCL_IF05
DR   Coriell; ND14435
DR   Wikidata; Q54926587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14436
AC   CVCL_GL16
DR   CLO; CLO_0030032
DR   Coriell; ND14436
DR   Wikidata; Q54926588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14437
AC   CVCL_GL17
DR   CLO; CLO_0030031
DR   BioSample; SAMN00798069
DR   Coriell; ND14437
DR   Wikidata; Q54926589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14438
AC   CVCL_FE09
DR   CLO; CLO_0030034
DR   BioSample; SAMN00798071
DR   Coriell; ND14438
DR   Wikidata; Q54926590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14439
AC   CVCL_GL18
DR   CLO; CLO_0030033
DR   Coriell; ND14439
DR   Wikidata; Q54926591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14440
AC   CVCL_IK31
DR   CLO; CLO_0030030
DR   BioSample; SAMN00798073
DR   Coriell; ND14440
DR   Wikidata; Q54926592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14441
AC   CVCL_BR31
DR   CLO; CLO_0030029
DR   Coriell; ND14441
DR   Wikidata; Q54926593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14442
AC   CVCL_BR32
DR   CLO; CLO_0030073
DR   BioSample; SAMN00798075
DR   Coriell; ND14442
DR   Wikidata; Q54926594
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND14453
AC   CVCL_BR33
DR   CLO; CLO_0030051
DR   Coriell; ND14453
DR   Wikidata; Q54926595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14457
AC   CVCL_CN68
DR   CLO; CLO_0030052
DR   Coriell; ND14457
DR   Wikidata; Q54926596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14458
AC   CVCL_CN69
DR   BioSample; SAMN00798077
DR   Coriell; ND14458
DR   Wikidata; Q54926601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14459
AC   CVCL_IF06
DR   BioSample; SAMN00798079
DR   Coriell; ND14459
DR   Wikidata; Q54926602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14461
AC   CVCL_CN70
DR   Coriell; ND14461
DR   Wikidata; Q54926603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14464
AC   CVCL_EC10
DR   Coriell; ND14464
DR   Wikidata; Q54926604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14466
AC   CVCL_CN71
DR   Coriell; ND14466
DR   Wikidata; Q54926605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14467
AC   CVCL_HW06
DR   Coriell; ND14467
DR   Wikidata; Q54926606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14468
AC   CVCL_CN72
DR   Coriell; ND14468
DR   Wikidata; Q54926607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14469
AC   CVCL_CN73
DR   CLO; CLO_0030049
DR   Coriell; ND14469
DR   Wikidata; Q54926608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14470
AC   CVCL_CN74
DR   CLO; CLO_0030050
DR   Coriell; ND14470
DR   Wikidata; Q54926609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14471
AC   CVCL_CN75
DR   CLO; CLO_0030058
DR   Coriell; ND14471
DR   Wikidata; Q54926610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14472
AC   CVCL_BR34
DR   CLO; CLO_0030060
DR   Coriell; ND14472
DR   Wikidata; Q54926611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14473
AC   CVCL_BR35
DR   CLO; CLO_0030053
DR   Coriell; ND14473
DR   Wikidata; Q54926612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14474
AC   CVCL_BR36
DR   CLO; CLO_0030055
DR   BioSample; SAMN00798081
DR   Coriell; ND14474
DR   Wikidata; Q54926613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14475
AC   CVCL_FE10
DR   CLO; CLO_0030062
DR   BioSample; SAMN00798083
DR   Coriell; ND14475
DR   Wikidata; Q54926614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14476
AC   CVCL_BR37
DR   CLO; CLO_0030098
DR   Coriell; ND14476
DR   Wikidata; Q54926615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14477
AC   CVCL_FE11
DR   CLO; CLO_0030096
DR   Coriell; ND14477
DR   Wikidata; Q54926616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14479
AC   CVCL_BR38
DR   CLO; CLO_0030079
DR   Coriell; ND14479
DR   Wikidata; Q54926617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14489
AC   CVCL_BR39
DR   CLO; CLO_0030080
DR   BioSample; SAMN00798085
DR   Coriell; ND14489
DR   Wikidata; Q54926618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14490
AC   CVCL_IF07
DR   CLO; CLO_0030081
DR   BioSample; SAMN00798087
DR   Coriell; ND14490
DR   Wikidata; Q54926619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14491
AC   CVCL_FE12
DR   CLO; CLO_0030082
DR   BioSample; SAMN00798089
DR   Coriell; ND14491
DR   Wikidata; Q54926620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14492
AC   CVCL_IK32
DR   BioSample; SAMN00798091
DR   Coriell; ND14492
DR   Wikidata; Q54926621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14493
AC   CVCL_CN76
DR   CLO; CLO_0030083
DR   Coriell; ND14493
DR   Wikidata; Q54926622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14494
AC   CVCL_GL19
DR   CLO; CLO_0030085
DR   Coriell; ND14494
DR   Wikidata; Q54926623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14495
AC   CVCL_BR40
DR   CLO; CLO_0030086
DR   Coriell; ND14495
DR   Wikidata; Q54926624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14496
AC   CVCL_BR41
DR   CLO; CLO_0030087
DR   Coriell; ND14496
DR   Wikidata; Q54926625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14497
AC   CVCL_BR42
DR   CLO; CLO_0030118
DR   Coriell; ND14497
DR   Wikidata; Q54926626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14498
AC   CVCL_BR43
DR   CLO; CLO_0030117
DR   BioSample; SAMN00798093
DR   Coriell; ND14498
DR   Wikidata; Q54926627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14499
AC   CVCL_FE13
DR   CLO; CLO_0030112
DR   BioSample; SAMN00798095
DR   Coriell; ND14499
DR   Wikidata; Q54926628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14500
AC   CVCL_IF08
DR   BioSample; SAMN00798097
DR   Coriell; ND14500
DR   Wikidata; Q54926629
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14501
AC   CVCL_FB95
DR   Coriell; ND14501
DR   Wikidata; Q54926630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14502
AC   CVCL_BR44
DR   CLO; CLO_0030109
DR   BioSample; SAMN00798099
DR   Coriell; ND14502
DR   Wikidata; Q54926631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14503
AC   CVCL_BR45
DR   CLO; CLO_0030110
DR   Coriell; ND14503
DR   Wikidata; Q54926632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14504
AC   CVCL_BR46
DR   CLO; CLO_0030107
DR   Coriell; ND14504
DR   Wikidata; Q54926633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14505
AC   CVCL_CN77
DR   CLO; CLO_0030108
DR   Coriell; ND14505
DR   Wikidata; Q54926634
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14506
AC   CVCL_CN78
DR   CLO; CLO_0030102
DR   Coriell; ND14506
DR   Wikidata; Q54926635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14507
AC   CVCL_BR47
DR   CLO; CLO_0030106
DR   Coriell; ND14507
DR   Wikidata; Q54926636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14508
AC   CVCL_HX03
DR   CLO; CLO_0030100
DR   BioSample; SAMN00798101
DR   Coriell; ND14508
DR   Wikidata; Q54926637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14509
AC   CVCL_HX04
DR   CLO; CLO_0030143
DR   BioSample; SAMN00798103
DR   Coriell; ND14509
DR   Wikidata; Q54926638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14510
AC   CVCL_HX05
DR   CLO; CLO_0030140
DR   BioSample; SAMN00798105
DR   Coriell; ND14510
DR   Wikidata; Q54926639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14514
AC   CVCL_CN79
DR   CLO; CLO_0030149
DR   Coriell; ND14514
DR   Wikidata; Q54926640
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14515
AC   CVCL_CN80
DR   Coriell; ND14515
DR   Wikidata; Q54926643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14516
AC   CVCL_IM09
DR   CLO; CLO_0030147
DR   Coriell; ND14516
DR   Wikidata; Q54926644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14516; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 6
//
ID   ND14518
AC   CVCL_BR48
DR   CLO; CLO_0030136
DR   Coriell; ND14518
DR   Wikidata; Q54926645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14519
AC   CVCL_EY19
DR   CLO; CLO_0030137
DR   Coriell; ND14519
DR   Wikidata; Q54926646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14520
AC   CVCL_CN81
DR   CLO; CLO_0030138
DR   Coriell; ND14520
DR   Wikidata; Q54926647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14521
AC   CVCL_CN82
DR   CLO; CLO_0030139
DR   Coriell; ND14521
DR   Wikidata; Q54926648
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14522
AC   CVCL_GL20
DR   CLO; CLO_0030129
DR   Coriell; ND14522
DR   Wikidata; Q54926649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14523
AC   CVCL_FE14
DR   CLO; CLO_0030132
DR   Coriell; ND14523
DR   Wikidata; Q54926650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14524
AC   CVCL_GL21
DR   CLO; CLO_0018528
DR   Coriell; ND14524
DR   Wikidata; Q54926651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14525
AC   CVCL_FE15
DR   CLO; CLO_0018544
DR   Coriell; ND14525
DR   Wikidata; Q54926652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14526
AC   CVCL_GL22
DR   CLO; CLO_0018541
DR   BioSample; SAMN00798107
DR   Coriell; ND14526
DR   Wikidata; Q54926653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14527
AC   CVCL_FE16
DR   CLO; CLO_0018540
DR   BioSample; SAMN00798109
DR   Coriell; ND14527
DR   Wikidata; Q54926654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14528
AC   CVCL_BR49
DR   CLO; CLO_0018537
DR   Coriell; ND14528
DR   Wikidata; Q54926655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14529
AC   CVCL_BR50
DR   CLO; CLO_0018511
DR   BioSample; SAMN00798111
DR   Coriell; ND14529
DR   Wikidata; Q54926656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14530
AC   CVCL_BR51
DR   CLO; CLO_0018514
DR   Coriell; ND14530
DR   Wikidata; Q54926657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14531
AC   CVCL_BR52
DR   CLO; CLO_0018504
DR   BioSample; SAMN00798113
DR   Coriell; ND14531
DR   Wikidata; Q54926658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14532
AC   CVCL_CN83
DR   CLO; CLO_0018508
DR   Coriell; ND14532
DR   Wikidata; Q54926659
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14533
AC   CVCL_GL23
DR   CLO; CLO_0018522
DR   Coriell; ND14533
DR   Wikidata; Q54926660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14534
AC   CVCL_AB77
DR   CLO; CLO_0018579
DR   Coriell; ND14534
DR   Wikidata; Q54926661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND14535
AC   CVCL_CN84
DR   CLO; CLO_0018577
DR   Coriell; ND14535
DR   Wikidata; Q54926662
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14536
AC   CVCL_CN85
DR   CLO; CLO_0018582
DR   BioSample; SAMN00798115
DR   Coriell; ND14536
DR   Wikidata; Q54926663
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND14537
AC   CVCL_FB37
DR   CLO; CLO_0018581
DR   BioSample; SAMN00798117
DR   Coriell; ND14537
DR   Wikidata; Q54926664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14538
AC   CVCL_CN86
DR   CLO; CLO_0018587
DR   Coriell; ND14538
DR   Wikidata; Q54926665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14539
AC   CVCL_EC11
DR   Coriell; ND14539
DR   Wikidata; Q54926666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14551
AC   CVCL_CN87
DR   Coriell; ND14551
DR   Wikidata; Q54926667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14552
AC   CVCL_CN88
DR   Coriell; ND14552
DR   Wikidata; Q54926668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14553
AC   CVCL_CN89
DR   Coriell; ND14553
DR   Wikidata; Q54926669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14554
AC   CVCL_BR53
DR   CLO; CLO_0018585
DR   BioSample; SAMN00798119
DR   Coriell; ND14554
DR   Wikidata; Q54926670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14556
AC   CVCL_BR54
DR   CLO; CLO_0018555
DR   Coriell; ND14556
DR   Wikidata; Q54926671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14557
AC   CVCL_FE17
DR   CLO; CLO_0018557
DR   Coriell; ND14557
DR   Wikidata; Q54926672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14558
AC   CVCL_BR55
DR   CLO; CLO_0018562
DR   Coriell; ND14558
DR   Wikidata; Q54926673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14559
AC   CVCL_BR56
DR   CLO; CLO_0018563
DR   BioSample; SAMN00798121
DR   Coriell; ND14559
DR   Wikidata; Q54926674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14562
AC   CVCL_EH51
DR   BioSample; SAMN00798123
DR   Coriell; ND14562
DR   Wikidata; Q54926675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14563
AC   CVCL_IF09
DR   BioSample; SAMN00798125
DR   Coriell; ND14563
DR   Wikidata; Q54926676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14564
AC   CVCL_IF10
DR   Coriell; ND14564
DR   Wikidata; Q54926677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14566
AC   CVCL_EC12
DR   Coriell; ND14566
DR   Wikidata; Q54926678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14568
AC   CVCL_FE18
DR   CLO; CLO_0019061
DR   Coriell; ND14568
DR   Wikidata; Q54926679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14569
AC   CVCL_BR57
DR   CLO; CLO_0019060
DR   Coriell; ND14569
DR   Wikidata; Q54926680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14570
AC   CVCL_HR86
DR   CLO; CLO_0019059
DR   Coriell; ND14570
DR   Wikidata; Q54926681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14571
AC   CVCL_BR58
DR   CLO; CLO_0019058
DR   Coriell; ND14571
DR   Wikidata; Q54926682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14572
AC   CVCL_BR59
DR   CLO; CLO_0019065
DR   Coriell; ND14572
DR   Wikidata; Q54926686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14573
AC   CVCL_IK33
DR   CLO; CLO_0019064
DR   Coriell; ND14573
DR   Wikidata; Q54926687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14578
AC   CVCL_CN90
DR   CLO; CLO_0019063
DR   Coriell; ND14578
DR   Wikidata; Q54926688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14579
AC   CVCL_CN91
DR   CLO; CLO_0019062
DR   Coriell; ND14579
DR   Wikidata; Q54926689
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14580
AC   CVCL_CN92
DR   CLO; CLO_0019067
DR   Coriell; ND14580
DR   Wikidata; Q54926690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14581
AC   CVCL_CN93
DR   CLO; CLO_0019066
DR   Coriell; ND14581
DR   Wikidata; Q54926691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14582
AC   CVCL_CN94
DR   CLO; CLO_0019038
DR   Coriell; ND14582
DR   Wikidata; Q54926692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14583
AC   CVCL_CN95
DR   CLO; CLO_0019040
DR   Coriell; ND14583
DR   Wikidata; Q54926693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14584
AC   CVCL_CN96
DR   CLO; CLO_0019039
DR   Coriell; ND14584
DR   Wikidata; Q54926694
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14585
AC   CVCL_CN97
DR   CLO; CLO_0019042
DR   Coriell; ND14585
DR   Wikidata; Q54926695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14586
AC   CVCL_CN98
DR   CLO; CLO_0019041
DR   Coriell; ND14586
DR   Wikidata; Q54926696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14587
AC   CVCL_BR60
DR   CLO; CLO_0019044
DR   Coriell; ND14587
DR   Wikidata; Q54926697
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (Coriell=ND14587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   ND14588
AC   CVCL_BR61
DR   CLO; CLO_0019043
DR   BioSample; SAMN00798127
DR   Coriell; ND14588
DR   Wikidata; Q54926698
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (Coriell=ND14588).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 14
//
ID   ND14589
AC   CVCL_GL24
DR   CLO; CLO_0019046
DR   BioSample; SAMN00798129
DR   Coriell; ND14589
DR   Wikidata; Q54926699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14590
AC   CVCL_GL25
DR   CLO; CLO_0019045
DR   Coriell; ND14590
DR   Wikidata; Q54926700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14591
AC   CVCL_GL26
DR   CLO; CLO_0019047
DR   Coriell; ND14591
DR   Wikidata; Q54926701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14592
AC   CVCL_GL27
DR   CLO; CLO_0019117
DR   Coriell; ND14592
DR   Wikidata; Q54926702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14593
AC   CVCL_GL28
DR   CLO; CLO_0019118
DR   Coriell; ND14593
DR   Wikidata; Q54926703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14594
AC   CVCL_BR62
DR   CLO; CLO_0019113
DR   Coriell; ND14594
DR   Wikidata; Q54926705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14595
AC   CVCL_IK34
DR   CLO; CLO_0019114
DR   Coriell; ND14595
DR   Wikidata; Q54926706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14596
AC   CVCL_BR63
DR   CLO; CLO_0019115
DR   Coriell; ND14596
DR   Wikidata; Q54926707
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND14597
AC   CVCL_BR64
DR   CLO; CLO_0019116
DR   Coriell; ND14597
DR   Wikidata; Q54926708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14598
AC   CVCL_CN99
DR   Coriell; ND14598
DR   Wikidata; Q54926709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14599
AC   CVCL_CP00
DR   Coriell; ND14599
DR   Wikidata; Q54926710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14602
AC   CVCL_CP01
DR   Coriell; ND14602
DR   Wikidata; Q54926711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14604
AC   CVCL_IF11
DR   BioSample; SAMN00798131
DR   Coriell; ND14604
DR   Wikidata; Q54926712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14605
AC   CVCL_IF12
DR   BioSample; SAMN00798133
DR   Coriell; ND14605
DR   Wikidata; Q54926713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14606
AC   CVCL_IF13
DR   BioSample; SAMN00798135
DR   Coriell; ND14606
DR   Wikidata; Q54926714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14609
AC   CVCL_BR65
DR   Coriell; ND14609
DR   Wikidata; Q54926715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14610
AC   CVCL_BR66
DR   CLO; CLO_0019109
DR   Coriell; ND14610
DR   Wikidata; Q54926716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14611
AC   CVCL_BR67
DR   CLO; CLO_0019110
DR   Coriell; ND14611
DR   Wikidata; Q54926717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14612
AC   CVCL_BR68
DR   CLO; CLO_0019111
DR   Coriell; ND14612
DR   Wikidata; Q54926718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14613
AC   CVCL_CP02
DR   CLO; CLO_0019112
DR   Coriell; ND14613
DR   Wikidata; Q54926719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14614
AC   CVCL_CP03
DR   CLO; CLO_0019098
DR   Coriell; ND14614
DR   Wikidata; Q54926720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14615
AC   CVCL_CP04
DR   CLO; CLO_0019096
DR   Coriell; ND14615
DR   Wikidata; Q54926721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14616
AC   CVCL_CP05
DR   CLO; CLO_0019097
DR   Coriell; ND14616
DR   Wikidata; Q54926722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14617
AC   CVCL_BR69
DR   CLO; CLO_0019094
DR   Coriell; ND14617
DR   Wikidata; Q54926723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14618
AC   CVCL_BR70
DR   CLO; CLO_0019095
DR   Coriell; ND14618
DR   Wikidata; Q54926724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14619
AC   CVCL_BR71
DR   CLO; CLO_0019091
DR   Coriell; ND14619
DR   Wikidata; Q54926725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14621
AC   CVCL_IK35
DR   CLO; CLO_0019093
DR   Coriell; ND14621
DR   Wikidata; Q54926726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14622
AC   CVCL_BR72
DR   CLO; CLO_0019089
DR   Coriell; ND14622
DR   Wikidata; Q54926729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14623
AC   CVCL_BR73
DR   CLO; CLO_0019090
DR   Coriell; ND14623
DR   Wikidata; Q54926730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14626
AC   CVCL_CP06
DR   Coriell; ND14626
DR   Wikidata; Q54926731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14630
AC   CVCL_CP07
DR   CLO; CLO_0019088
DR   Coriell; ND14630
DR   Wikidata; Q54926732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14631
AC   CVCL_CP08
DR   CLO; CLO_0019151
DR   Coriell; ND14631
DR   Wikidata; Q54926733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14632
AC   CVCL_EC13
DR   CLO; CLO_0019152
DR   Coriell; ND14632
DR   Wikidata; Q54926734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14633
AC   CVCL_EC14
DR   CLO; CLO_0019153
DR   Coriell; ND14633
DR   Wikidata; Q54926735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14634
AC   CVCL_CP09
DR   CLO; CLO_0019154
DR   Coriell; ND14634
DR   Wikidata; Q54926736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14635
AC   CVCL_CP10
DR   CLO; CLO_0019155
DR   Coriell; ND14635
DR   Wikidata; Q54926737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14636
AC   CVCL_CP11
DR   CLO; CLO_0019156
DR   Coriell; ND14636
DR   Wikidata; Q54926738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14637
AC   CVCL_CP12
DR   CLO; CLO_0019157
DR   Coriell; ND14637
DR   Wikidata; Q54926739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14638
AC   CVCL_CP13
DR   CLO; CLO_0019158
DR   Coriell; ND14638
DR   Wikidata; Q54926740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14639
AC   CVCL_FE19
DR   CLO; CLO_0019149
DR   Coriell; ND14639
DR   Wikidata; Q54926741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14640
AC   CVCL_CP14
DR   CLO; CLO_0019150
DR   Coriell; ND14640
DR   Wikidata; Q54926742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14641
AC   CVCL_CP15
DR   CLO; CLO_0019122
DR   Coriell; ND14641
DR   Wikidata; Q54926743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14642
AC   CVCL_FE20
DR   CLO; CLO_0019133
DR   Coriell; ND14642
DR   Wikidata; Q54926744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14643
AC   CVCL_BR74
DR   CLO; CLO_0019134
DR   Coriell; ND14643
DR   Wikidata; Q54926745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14644
AC   CVCL_BR75
DR   CLO; CLO_0019131
DR   BioSample; SAMN00798137
DR   Coriell; ND14644
DR   Wikidata; Q54926746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14645
AC   CVCL_FE21
DR   CLO; CLO_0019132
DR   BioSample; SAMN00798139
DR   Coriell; ND14645
DR   Wikidata; Q54926747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14646
AC   CVCL_BR76
DR   CLO; CLO_0019137
DR   Coriell; ND14646
DR   Wikidata; Q54926748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14647
AC   CVCL_GL29
DR   CLO; CLO_0019138
DR   Coriell; ND14647
DR   Wikidata; Q54926749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14648
AC   CVCL_EC15
DR   Coriell; ND14648
DR   Wikidata; Q54926750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14649
AC   CVCL_BR77
DR   CLO; CLO_0019135
DR   Coriell; ND14649
DR   Wikidata; Q54926751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14650
AC   CVCL_GL30
DR   CLO; CLO_0019136
DR   Coriell; ND14650
DR   Wikidata; Q54926752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14651
AC   CVCL_GL31
DR   CLO; CLO_0019130
DR   Coriell; ND14651
DR   Wikidata; Q54926753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14652
AC   CVCL_BR78
DR   CLO; CLO_0019188
DR   Coriell; ND14652
DR   Wikidata; Q54926754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14653
AC   CVCL_BR79
DR   CLO; CLO_0019190
DR   Coriell; ND14653
DR   Wikidata; Q54926755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14654
AC   CVCL_CP16
DR   Coriell; ND14654
DR   Wikidata; Q54926756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14658
AC   CVCL_HW07
DR   BioSample; SAMN00798141
DR   Coriell; ND14658
DR   Wikidata; Q54926757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14660
AC   CVCL_CP17
DR   CLO; CLO_0019196
DR   Coriell; ND14660
DR   Wikidata; Q54926758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14661
AC   CVCL_CP18
DR   CLO; CLO_0019195
DR   Coriell; ND14661
DR   Wikidata; Q54926759
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14662
AC   CVCL_BR80
DR   CLO; CLO_0019198
DR   Coriell; ND14662
DR   Wikidata; Q54926760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14663
AC   CVCL_BR81
DR   CLO; CLO_0019197
DR   Coriell; ND14663
DR   Wikidata; Q54926761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14664
AC   CVCL_BR82
DR   CLO; CLO_0019192
DR   Coriell; ND14664
DR   Wikidata; Q54926762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14666
AC   CVCL_GL32
DR   CLO; CLO_0019191
DR   Coriell; ND14666
DR   Wikidata; Q54926763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14667
AC   CVCL_BR83
DR   CLO; CLO_0019194
DR   Coriell; ND14667
DR   Wikidata; Q54926764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14668
AC   CVCL_FE22
DR   CLO; CLO_0019193
DR   Coriell; ND14668
DR   Wikidata; Q54926765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14669
AC   CVCL_FE23
DR   CLO; CLO_0019171
DR   BioSample; SAMN00798143
DR   Coriell; ND14669
DR   Wikidata; Q54926766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14670
AC   CVCL_GL33
DR   CLO; CLO_0019165
DR   Coriell; ND14670
DR   Wikidata; Q54926767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14671
AC   CVCL_GL34
DR   CLO; CLO_0019167
DR   Coriell; ND14671
DR   Wikidata; Q54926768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14672
AC   CVCL_BR84
DR   CLO; CLO_0019178
DR   Coriell; ND14672
DR   Wikidata; Q54926774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14673
AC   CVCL_BR85
DR   CLO; CLO_0019177
DR   Coriell; ND14673
DR   Wikidata; Q54926775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14674
AC   CVCL_IK36
DR   CLO; CLO_0019176
DR   Coriell; ND14674
DR   Wikidata; Q54926776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14675
AC   CVCL_BR86
DR   CLO; CLO_0019175
DR   Coriell; ND14675
DR   Wikidata; Q54926777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14676
AC   CVCL_BR87
DR   CLO; CLO_0019174
DR   Coriell; ND14676
DR   Wikidata; Q54926778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14677
AC   CVCL_GL35
DR   CLO; CLO_0019173
DR   BioSample; SAMN00798145
DR   Coriell; ND14677
DR   Wikidata; Q54926779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14678
AC   CVCL_GL36
DR   CLO; CLO_0019172
DR   BioSample; SAMN00798147
DR   Coriell; ND14678
DR   Wikidata; Q54926780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14681
AC   CVCL_BR88
DR   CLO; CLO_0019227
DR   BioSample; SAMN00798149
DR   Coriell; ND14681
DR   Wikidata; Q54926781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14682
AC   CVCL_BR89
DR   CLO; CLO_0019228
DR   BioSample; SAMN00798151
DR   Coriell; ND14682
DR   Wikidata; Q54926782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14683
AC   CVCL_BR90
DR   CLO; CLO_0019230
DR   BioSample; SAMN00798153
DR   Coriell; ND14683
DR   Wikidata; Q54926783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14684
AC   CVCL_BR91
DR   CLO; CLO_0019231
DR   Coriell; ND14684
DR   Wikidata; Q54926784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14685
AC   CVCL_BR92
DR   CLO; CLO_0019233
DR   Coriell; ND14685
DR   Wikidata; Q54926785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14686
AC   CVCL_BR93
DR   CLO; CLO_0019232
DR   Coriell; ND14686
DR   Wikidata; Q54926786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14687
AC   CVCL_EC16
DR   CLO; CLO_0019235
DR   Coriell; ND14687
DR   Wikidata; Q54926787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14688
AC   CVCL_FB96
DR   CLO; CLO_0019234
DR   Coriell; ND14688
DR   Wikidata; Q54926788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14689
AC   CVCL_FB97
DR   CLO; CLO_0019237
DR   Coriell; ND14689
DR   Wikidata; Q54926789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14700
AC   CVCL_IF14
DR   Coriell; ND14700
DR   Wikidata; Q54926790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14705
AC   CVCL_CP19
DR   CLO; CLO_0019236
DR   Coriell; ND14705
DR   Wikidata; Q54926791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14706
AC   CVCL_BR94
DR   CLO; CLO_0019207
DR   Coriell; ND14706
DR   Wikidata; Q54926792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14707
AC   CVCL_BR95
DR   CLO; CLO_0019212
DR   Coriell; ND14707
DR   Wikidata; Q54926793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14708
AC   CVCL_BR96
DR   Coriell; ND14708
DR   Wikidata; Q54926794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14709
AC   CVCL_BR97
DR   CLO; CLO_0019213
DR   Coriell; ND14709
DR   Wikidata; Q54926795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14710
AC   CVCL_BR98
DR   Coriell; ND14710
DR   Wikidata; Q54926796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14711
AC   CVCL_GL37
DR   CLO; CLO_0019209
DR   Coriell; ND14711
DR   Wikidata; Q54926797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14712
AC   CVCL_BR99
DR   CLO; CLO_0019211
DR   Coriell; ND14712
DR   Wikidata; Q54926798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14713
AC   CVCL_BS00
DR   CLO; CLO_0019217
DR   Coriell; ND14713
DR   Wikidata; Q54926799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14714
AC   CVCL_BS01
DR   CLO; CLO_0019216
DR   Coriell; ND14714
DR   Wikidata; Q54926800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14715
AC   CVCL_BS02
DR   CLO; CLO_0019215
DR   Coriell; ND14715
DR   Wikidata; Q54926801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14716
AC   CVCL_CP20
DR   CLO; CLO_0019214
DR   Coriell; ND14716
DR   Wikidata; Q54926802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14720
AC   CVCL_A5IZ
DR   BioSample; SAMN00798155
DR   Coriell; ND14720
DR   Wikidata; Q107116543
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14720; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   ND14722
AC   CVCL_FL71
DR   BioSample; SAMN00798157
DR   Coriell; ND14722
DR   Wikidata; Q54926803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14725
AC   CVCL_GL38
DR   CLO; CLO_0019218
DR   Coriell; ND14725
DR   Wikidata; Q54926804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14726
AC   CVCL_GL39
DR   CLO; CLO_0019720
DR   BioSample; SAMN00798159
DR   Coriell; ND14726
DR   Wikidata; Q54926805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14727
AC   CVCL_BS03
DR   CLO; CLO_0019719
DR   Coriell; ND14727
DR   Wikidata; Q54926806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14728
AC   CVCL_IF15
DR   Coriell; ND14728
DR   Wikidata; Q54926807
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14729
AC   CVCL_BS04
DR   CLO; CLO_0019718
DR   Coriell; ND14729
DR   Wikidata; Q54926809
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14730
AC   CVCL_BS05
DR   CLO; CLO_0019717
DR   BioSample; SAMN00798161
DR   Coriell; ND14730
DR   Wikidata; Q54926810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14731
AC   CVCL_BS06
DR   CLO; CLO_0019716
DR   Coriell; ND14731
DR   Wikidata; Q54926811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14732
AC   CVCL_BS07
DR   CLO; CLO_0019715
DR   Coriell; ND14732
DR   Wikidata; Q54926812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14733
AC   CVCL_FB33
DR   CLO; CLO_0019714
DR   Coriell; ND14733
DR   Wikidata; Q54926813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14734
AC   CVCL_BS08
DR   CLO; CLO_0019713
DR   Coriell; ND14734
DR   Wikidata; Q54926814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14735
AC   CVCL_BS09
DR   CLO; CLO_0019712
DR   Coriell; ND14735
DR   Wikidata; Q54926817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14736
AC   CVCL_BS10
DR   CLO; CLO_0019711
DR   Coriell; ND14736
DR   Wikidata; Q54926818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14737
AC   CVCL_BS11
DR   CLO; CLO_0019698
DR   Coriell; ND14737
DR   Wikidata; Q54926819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14738
AC   CVCL_BS12
DR   CLO; CLO_0019697
DR   Coriell; ND14738
DR   Wikidata; Q54926820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14739
AC   CVCL_BS13
DR   CLO; CLO_0019700
DR   Coriell; ND14739
DR   Wikidata; Q54926821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14740
AC   CVCL_GL40
DR   CLO; CLO_0019699
DR   BioSample; SAMN00798163
DR   Coriell; ND14740
DR   Wikidata; Q54926823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14741
AC   CVCL_BS14
DR   CLO; CLO_0019694
DR   BioSample; SAMN00798165
DR   Coriell; ND14741
DR   Wikidata; Q54926824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14742
AC   CVCL_GL41
DR   CLO; CLO_0019693
DR   BioSample; SAMN00798167
DR   Coriell; ND14742
DR   Wikidata; Q54926825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14743
AC   CVCL_BS15
DR   CLO; CLO_0019696
DR   BioSample; SAMN00798169
DR   Coriell; ND14743
DR   Wikidata; Q54926827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14744
AC   CVCL_GL42
DR   CLO; CLO_0019695
DR   Coriell; ND14744
DR   Wikidata; Q54926828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14745
AC   CVCL_GL43
DR   CLO; CLO_0019692
DR   BioSample; SAMN00798171
DR   Coriell; ND14745
DR   Wikidata; Q54926829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14746
AC   CVCL_EC17
DR   Coriell; ND14746
DR   Wikidata; Q54926830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14748
AC   CVCL_BS16
DR   CLO; CLO_0019691
DR   BioSample; SAMN00798173
DR   Coriell; ND14748
DR   Wikidata; Q54926831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14749
AC   CVCL_FE24
DR   CLO; CLO_0019676
DR   Coriell; ND14749
DR   Wikidata; Q54926832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14750
AC   CVCL_FE25
DR   CLO; CLO_0019680
DR   Coriell; ND14750
DR   Wikidata; Q54926833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14751
AC   CVCL_GL44
DR   CLO; CLO_0019679
DR   Coriell; ND14751
DR   Wikidata; Q54926834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14752
AC   CVCL_GL45
DR   CLO; CLO_0019678
DR   Coriell; ND14752
DR   Wikidata; Q54926835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14753
AC   CVCL_BS17
DR   Coriell; ND14753
DR   Wikidata; Q54926836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14754
AC   CVCL_FF33
DR   Coriell; ND14754
DR   Wikidata; Q54926837
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14756
AC   CVCL_CP21
DR   Coriell; ND14756
DR   Wikidata; Q54926838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14758
AC   CVCL_CP22
DR   Coriell; ND14758
DR   Wikidata; Q54926839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14759
AC   CVCL_GL46
DR   CLO; CLO_0019677
DR   Coriell; ND14759
DR   Wikidata; Q54926840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14760
AC   CVCL_IF16
DR   Coriell; ND14760
DR   Wikidata; Q54926841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14761
AC   CVCL_A5JA
DR   BioSample; SAMN00798175
DR   Coriell; ND14761
DR   Wikidata; Q107116544
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14761; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND14762
AC   CVCL_GL47
DR   CLO; CLO_0019674
DR   Coriell; ND14762
DR   Wikidata; Q54926842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14763
AC   CVCL_GL48
DR   CLO; CLO_0019673
DR   BioSample; SAMN00798177
DR   Coriell; ND14763
DR   Wikidata; Q54926843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14764
AC   CVCL_BS18
DR   CLO; CLO_0019672
DR   BioSample; SAMN00798179
DR   Coriell; ND14764
DR   Wikidata; Q54926844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14765
AC   CVCL_GL49
DR   CLO; CLO_0019671
DR   Coriell; ND14765
DR   Wikidata; Q54926845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14766
AC   CVCL_BS19
DR   CLO; CLO_0019675
DR   Coriell; ND14766
DR   Wikidata; Q54926846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14767
AC   CVCL_BS20
DR   CLO; CLO_0019656
DR   Coriell; ND14767
DR   Wikidata; Q54926847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14768
AC   CVCL_BS21
DR   CLO; CLO_0019655
DR   Coriell; ND14768
DR   Wikidata; Q54926848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14771
AC   CVCL_CP23
DR   Coriell; ND14771
DR   Wikidata; Q54926849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14775
AC   CVCL_HW08
DR   BioSample; SAMN00798181
DR   Coriell; ND14775
DR   Wikidata; Q54926850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14777
AC   CVCL_CP24
DR   Coriell; ND14777
DR   Wikidata; Q54926851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14787
AC   CVCL_HW09
DR   BioSample; SAMN00798183
DR   Coriell; ND14787
DR   Wikidata; Q54926852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14788
AC   CVCL_FZ60
DR   BioSample; SAMN00798185
DR   Coriell; ND14788
DR   Wikidata; Q54926853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14790
AC   CVCL_BS22
DR   CLO; CLO_0019658
DR   Coriell; ND14790
DR   Wikidata; Q54926854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14791
AC   CVCL_BS23
DR   CLO; CLO_0019657
DR   Coriell; ND14791
DR   Wikidata; Q54926855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14792
AC   CVCL_FE26
DR   CLO; CLO_0019660
DR   Coriell; ND14792
DR   Wikidata; Q54926856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14793
AC   CVCL_BS24
DR   CLO; CLO_0019659
DR   Coriell; ND14793
DR   Wikidata; Q54926857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14794
AC   CVCL_BS25
DR   CLO; CLO_0019652
DR   Coriell; ND14794
DR   Wikidata; Q54926858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14795
AC   CVCL_BS26
DR   CLO; CLO_0019651
DR   BioSample; SAMN00798187
DR   Coriell; ND14795
DR   Wikidata; Q54926861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14796
AC   CVCL_HR87
DR   CLO; CLO_0019654
DR   BioSample; SAMN00798189
DR   Coriell; ND14796
DR   Wikidata; Q54926862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14797
AC   CVCL_GL50
DR   CLO; CLO_0019653
DR   Coriell; ND14797
DR   Wikidata; Q54926863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14798
AC   CVCL_GL51
DR   CLO; CLO_0019795
DR   Coriell; ND14798
DR   Wikidata; Q54926864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14799
AC   CVCL_GL52
DR   CLO; CLO_0019796
DR   Coriell; ND14799
DR   Wikidata; Q54926865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14800
AC   CVCL_GL53
DR   CLO; CLO_0019797
DR   Coriell; ND14800
DR   Wikidata; Q54926866
RX   PubMed=34468209;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14803
AC   CVCL_HW10
DR   BioSample; SAMN00798191
DR   Coriell; ND14803
DR   Wikidata; Q54926867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14805
AC   CVCL_FZ61
DR   BioSample; SAMN00798193
DR   Coriell; ND14805
DR   Wikidata; Q54926868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14807
AC   CVCL_FB98
DR   CLO; CLO_0019791
DR   Coriell; ND14807
DR   Wikidata; Q54926869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14808
AC   CVCL_EC18
DR   CLO; CLO_0019792
DR   Coriell; ND14808
DR   Wikidata; Q54926870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14809
AC   CVCL_IH51
DR   CLO; CLO_0019793
DR   Coriell; ND14809
DR   Wikidata; Q54926871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14810
AC   CVCL_EC19
DR   CLO; CLO_0019794
DR   Coriell; ND14810
DR   Wikidata; Q54926872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14811
AC   CVCL_EC20
DR   CLO; CLO_0019798
DR   Coriell; ND14811
DR   Wikidata; Q54926873
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14812
AC   CVCL_IH52
DR   CLO; CLO_0019799
DR   Coriell; ND14812
DR   Wikidata; Q54926874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14813
AC   CVCL_EC21
DR   Coriell; ND14813
DR   Wikidata; Q54926875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14814
AC   CVCL_EC22
DR   Coriell; ND14814
DR   Wikidata; Q54926876
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14815
AC   CVCL_CP25
DR   CLO; CLO_0019800
DR   Coriell; ND14815
DR   Wikidata; Q54926878
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14816
AC   CVCL_BS27
DR   CLO; CLO_0019777
DR   BioSample; SAMN00798195
DR   Coriell; ND14816
DR   Wikidata; Q54926879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14817
AC   CVCL_GL54
DR   CLO; CLO_0019778
DR   Coriell; ND14817
DR   Wikidata; Q54926880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14818
AC   CVCL_BS28
DR   CLO; CLO_0019775
DR   Coriell; ND14818
DR   Wikidata; Q54926881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14823
AC   CVCL_CP26
DR   Coriell; ND14823
DR   Wikidata; Q54926882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14825
AC   CVCL_EC23
DR   Coriell; ND14825
DR   Wikidata; Q54926883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14829
AC   CVCL_IF17
DR   Coriell; ND14829
DR   Wikidata; Q54926884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14830
AC   CVCL_FZ62
DR   BioSample; SAMN00798197
DR   Coriell; ND14830
DR   Wikidata; Q54926885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14831
AC   CVCL_BS29
DR   CLO; CLO_0019776
DR   Coriell; ND14831
DR   Wikidata; Q54926886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14832
AC   CVCL_BS30
DR   CLO; CLO_0019773
DR   BioSample; SAMN00798199
DR   Coriell; ND14832
DR   Wikidata; Q54926887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14833
AC   CVCL_BS31
DR   CLO; CLO_0019774
DR   Coriell; ND14833
DR   Wikidata; Q54926888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14834
AC   CVCL_BS32
DR   CLO; CLO_0019771
DR   Coriell; ND14834
DR   Wikidata; Q54926889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14835
AC   CVCL_GL55
DR   CLO; CLO_0019772
DR   BioSample; SAMN00798201
DR   Coriell; ND14835
DR   Wikidata; Q54926890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14836
AC   CVCL_FE27
DR   CLO; CLO_0019779
DR   Coriell; ND14836
DR   Wikidata; Q54926891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14837
AC   CVCL_CP27
DR   Coriell; ND14837
DR   Wikidata; Q54926892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14840
AC   CVCL_BS33
DR   CLO; CLO_0019780
DR   Coriell; ND14840
DR   Wikidata; Q54926893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14841
AC   CVCL_BS34
DR   CLO; CLO_0019749
DR   Coriell; ND14841
DR   Wikidata; Q54926895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14842
AC   CVCL_IK37
DR   Coriell; ND14842
DR   Wikidata; Q54926896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14843
AC   CVCL_BS35
DR   CLO; CLO_0019752
DR   BioSample; SAMN00798203
DR   Coriell; ND14843
DR   Wikidata; Q54926897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14844
AC   CVCL_IK38
DR   CLO; CLO_0019753
DR   Coriell; ND14844
DR   Wikidata; Q54926898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14845
AC   CVCL_FE28
DR   CLO; CLO_0019754
DR   BioSample; SAMN00798205
DR   Coriell; ND14845
DR   Wikidata; Q54926900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14846
AC   CVCL_EC24
DR   Coriell; ND14846
DR   Wikidata; Q54926901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14848
AC   CVCL_EC25
DR   Coriell; ND14848
DR   Wikidata; Q54926902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14849
AC   CVCL_EC26
DR   CLO; CLO_0019755
DR   Coriell; ND14849
DR   Wikidata; Q54926903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14852
AC   CVCL_CP28
DR   Coriell; ND14852
DR   Wikidata; Q54926908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14853
AC   CVCL_CP29
DR   Coriell; ND14853
DR   Wikidata; Q54926909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14854
AC   CVCL_CP30
DR   Coriell; ND14854
DR   Wikidata; Q54926910
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14857
AC   CVCL_IF18
DR   Coriell; ND14857
DR   Wikidata; Q54926911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14860
AC   CVCL_BS36
DR   CLO; CLO_0019756
DR   Coriell; ND14860
DR   Wikidata; Q54926912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14861
AC   CVCL_GL56
DR   CLO; CLO_0019757
DR   Coriell; ND14861
DR   Wikidata; Q54926913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14862
AC   CVCL_BS37
DR   CLO; CLO_0019758
DR   Coriell; ND14862
DR   Wikidata; Q54926914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14863
AC   CVCL_BS38
DR   CLO; CLO_0019759
DR   Coriell; ND14863
DR   Wikidata; Q54926915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14864
AC   CVCL_BS39
DR   CLO; CLO_0019760
DR   Coriell; ND14864
DR   Wikidata; Q54926916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14865
AC   CVCL_BS40
DR   CLO; CLO_0019730
DR   Coriell; ND14865
DR   Wikidata; Q54926917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14866
AC   CVCL_BS41
DR   CLO; CLO_0019727
DR   Coriell; ND14866
DR   Wikidata; Q54926918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14870
AC   CVCL_CP31
DR   Coriell; ND14870
DR   Wikidata; Q54926919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14871
AC   CVCL_HM34
DR   CLO; CLO_0019735
DR   BioSample; SAMN00798207
DR   Coriell; ND14871
DR   Wikidata; Q54926920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND14872
AC   CVCL_GL57
DR   CLO; CLO_0019736
DR   Coriell; ND14872
DR   Wikidata; Q54926921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14873
AC   CVCL_GL58
DR   CLO; CLO_0019733
DR   Coriell; ND14873
DR   Wikidata; Q54926922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14874
AC   CVCL_BS42
DR   CLO; CLO_0019734
DR   Coriell; ND14874
DR   Wikidata; Q54926923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14875
AC   CVCL_IK39
DR   CLO; CLO_0019739
DR   Coriell; ND14875
DR   Wikidata; Q54926924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14878
AC   CVCL_EC27
DR   Coriell; ND14878
DR   Wikidata; Q54926925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14879
AC   CVCL_CP32
DR   BioSample; SAMN00798209
DR   Coriell; ND14879
DR   Wikidata; Q54926926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14881
AC   CVCL_CP33
DR   BioSample; SAMN00798211
DR   Coriell; ND14881
DR   Wikidata; Q54926927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14883
AC   CVCL_A5JB
DR   BioSample; SAMN00798213
DR   Coriell; ND14883
DR   Wikidata; Q107116545
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14883; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   ND14887
AC   CVCL_EC28
DR   Coriell; ND14887
DR   Wikidata; Q54926928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14889
AC   CVCL_BS43
DR   Coriell; ND14889
DR   Wikidata; Q54926929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14894
AC   CVCL_EC29
DR   CLO; CLO_0019740
DR   Coriell; ND14894
DR   Wikidata; Q54926930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14895
AC   CVCL_IH53
DR   CLO; CLO_0019737
DR   Coriell; ND14895
DR   Wikidata; Q54926931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND14896
AC   CVCL_EC30
DR   CLO; CLO_0019738
DR   Coriell; ND14896
DR   Wikidata; Q54926932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND14897
AC   CVCL_FB99
DR   CLO; CLO_0019839
DR   Coriell; ND14897
DR   Wikidata; Q54926933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14898
AC   CVCL_FC00
DR   CLO; CLO_0019840
DR   Coriell; ND14898
DR   Wikidata; Q54926934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14899
AC   CVCL_GL59
DR   CLO; CLO_0019843
DR   Coriell; ND14899
DR   Wikidata; Q54926935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14900
AC   CVCL_GL60
DR   CLO; CLO_0019856
DR   Coriell; ND14900
DR   Wikidata; Q54926936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14901
AC   CVCL_GL61
DR   CLO; CLO_0019855
DR   Coriell; ND14901
DR   Wikidata; Q54926937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14902
AC   CVCL_GL62
DR   CLO; CLO_0019858
DR   Coriell; ND14902
DR   Wikidata; Q54926938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14904
AC   CVCL_FE29
DR   CLO; CLO_0019857
DR   Coriell; ND14904
DR   Wikidata; Q54926939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14907
AC   CVCL_CP34
DR   CLO; CLO_0019853
DR   Coriell; ND14907
DR   Wikidata; Q54926940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14911
AC   CVCL_BS44
DR   CLO; CLO_0019852
DR   Coriell; ND14911
DR   Wikidata; Q54926941
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND14912
AC   CVCL_BS45
DR   CLO; CLO_0019854
DR   Coriell; ND14912
DR   Wikidata; Q54926942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14913
AC   CVCL_BS46
DR   CLO; CLO_0019823
DR   Coriell; ND14913
DR   Wikidata; Q54926943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14914
AC   CVCL_GL63
DR   CLO; CLO_0019825
DR   Coriell; ND14914
DR   Wikidata; Q54926944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14915
AC   CVCL_FE30
DR   CLO; CLO_0019820
DR   Coriell; ND14915
DR   Wikidata; Q54926945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14916
AC   CVCL_GL64
DR   CLO; CLO_0019821
DR   Coriell; ND14916
DR   Wikidata; Q54926946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14917
AC   CVCL_GL65
DR   CLO; CLO_0019838
DR   Coriell; ND14917
DR   Wikidata; Q54926947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14918
AC   CVCL_GL66
DR   CLO; CLO_0019837
DR   Coriell; ND14918
DR   Wikidata; Q54926950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14919
AC   CVCL_GL67
DR   CLO; CLO_0019836
DR   Coriell; ND14919
DR   Wikidata; Q54926951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14920
AC   CVCL_GL68
DR   CLO; CLO_0019835
DR   Coriell; ND14920
DR   Wikidata; Q54926952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14921
AC   CVCL_GL69
DR   CLO; CLO_0019834
DR   Coriell; ND14921
DR   Wikidata; Q54926953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14922
AC   CVCL_GL70
DR   CLO; CLO_0019833
DR   Coriell; ND14922
DR   Wikidata; Q54926954
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14925
AC   CVCL_CP35
DR   Coriell; ND14925
DR   Wikidata; Q54926955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14926
AC   CVCL_CP36
DR   Coriell; ND14926
DR   Wikidata; Q54926956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14927
AC   CVCL_BS47
DR   CLO; CLO_0017748
DR   Coriell; ND14927
DR   Wikidata; Q54926957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14928
AC   CVCL_BS48
DR   CLO; CLO_0017749
DR   BioSample; SAMN00798215
DR   Coriell; ND14928
DR   Wikidata; Q54926958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14929
AC   CVCL_FE31
DR   CLO; CLO_0017742
DR   BioSample; SAMN00798217
DR   Coriell; ND14929
DR   Wikidata; Q54926959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14930
AC   CVCL_EC31
DR   CLO; CLO_0017743
DR   Coriell; ND14930
DR   Wikidata; Q54926960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND14933
AC   CVCL_CP37
DR   BioSample; SAMN00798219
DR   Coriell; ND14933
DR   Wikidata; Q54926961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND14936
AC   CVCL_FL72
DR   BioSample; SAMN00798221
DR   Coriell; ND14936
DR   Wikidata; Q54926962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14939
AC   CVCL_GL71
DR   CLO; CLO_0017740
DR   BioSample; SAMN00798223
DR   Coriell; ND14939
DR   Wikidata; Q54926963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14940
AC   CVCL_GL72
DR   CLO; CLO_0017741
DR   Coriell; ND14940
DR   Wikidata; Q54926964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14941
AC   CVCL_BS49
DR   CLO; CLO_0017746
DR   BioSample; SAMN00798225
DR   Coriell; ND14941
DR   Wikidata; Q54926965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14942
AC   CVCL_BS50
DR   CLO; CLO_0017747
DR   Coriell; ND14942
DR   Wikidata; Q54926966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14943
AC   CVCL_BS51
DR   CLO; CLO_0017744
DR   Coriell; ND14943
DR   Wikidata; Q54926967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14944
AC   CVCL_BS52
DR   CLO; CLO_0017745
DR   Coriell; ND14944
DR   Wikidata; Q54926968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14945
AC   CVCL_BS53
DR   CLO; CLO_0017737
DR   BioSample; SAMN00798227
DR   Coriell; ND14945
DR   Wikidata; Q54926969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14946
AC   CVCL_BS54
DR   CLO; CLO_0017738
DR   Coriell; ND14946
DR   Wikidata; Q54926970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14947
AC   CVCL_BS55
DR   CLO; CLO_0017739
DR   Coriell; ND14947
DR   Wikidata; Q54926971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14949
AC   CVCL_FE32
DR   CLO; CLO_0017730
DR   Coriell; ND14949
DR   Wikidata; Q54926972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14950
AC   CVCL_GL73
DR   CLO; CLO_0017731
DR   BioSample; SAMN00798229
DR   Coriell; ND14950
DR   Wikidata; Q54926973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14951
AC   CVCL_GL74
DR   CLO; CLO_0017732
DR   Coriell; ND14951
DR   Wikidata; Q54926974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14952
AC   CVCL_GL75
DR   CLO; CLO_0017733
DR   Coriell; ND14952
DR   Wikidata; Q54926975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14953
AC   CVCL_GL76
DR   CLO; CLO_0017734
DR   Coriell; ND14953
DR   Wikidata; Q54926976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14954
AC   CVCL_BS56
DR   CLO; CLO_0017735
DR   BioSample; SAMN00798231
DR   Coriell; ND14954
DR   Wikidata; Q54926977
RX   PubMed=22815561;
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (PubMed=22815561).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   ND14955
AC   CVCL_BS57
DR   CLO; CLO_0017736
DR   Coriell; ND14955
DR   Wikidata; Q54926978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14956
AC   CVCL_FE33
DR   CLO; CLO_0017703
DR   BioSample; SAMN00798233
DR   Coriell; ND14956
DR   Wikidata; Q54926979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14957
AC   CVCL_FE34
DR   CLO; CLO_0017702
DR   Coriell; ND14957
DR   Wikidata; Q54926980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14958
AC   CVCL_GL77
DR   CLO; CLO_0017701
DR   Coriell; ND14958
DR   Wikidata; Q54926981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14959
AC   CVCL_GL78
DR   CLO; CLO_0017700
DR   Coriell; ND14959
DR   Wikidata; Q54926982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14960
AC   CVCL_FE35
DR   CLO; CLO_0017709
DR   BioSample; SAMN00798235
DR   Coriell; ND14960
DR   Wikidata; Q54926983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14961
AC   CVCL_FE36
DR   CLO; CLO_0017708
DR   BioSample; SAMN00798237
DR   Coriell; ND14961
DR   Wikidata; Q54926984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14962
AC   CVCL_BS58
DR   CLO; CLO_0017707
DR   BioSample; SAMN00798239
DR   Coriell; ND14962
DR   Wikidata; Q54926985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14963
AC   CVCL_GL79
DR   CLO; CLO_0017706
DR   BioSample; SAMN00798241
DR   Coriell; ND14963
DR   Wikidata; Q54926986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND14964
AC   CVCL_BS59
DR   CLO; CLO_0017705
DR   Coriell; ND14964
DR   Wikidata; Q54926987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND14965
AC   CVCL_FB34
DR   CLO; CLO_0017704
DR   Coriell; ND14965
DR   Wikidata; Q54926988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND14967
AC   CVCL_CP38
DR   Coriell; ND14967
DR   Wikidata; Q54926989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND14970
AC   CVCL_A5JC
DR   BioSample; SAMN00798243
DR   Coriell; ND14970
DR   Wikidata; Q107116546
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14970; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND14972
AC   CVCL_A5JD
DR   BioSample; SAMN00798245
DR   Coriell; ND14972
DR   Wikidata; Q107116547
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14972; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND14973
AC   CVCL_A5JE
DR   BioSample; SAMN00798247
DR   Coriell; ND14973
DR   Wikidata; Q107116548
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14973; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   ND14974
AC   CVCL_A5JF
DR   BioSample; SAMN00798249
DR   Coriell; ND14974
DR   Wikidata; Q107116549
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND14974; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   ND14975
AC   CVCL_BS60
DR   CLO; CLO_0017694
DR   Coriell; ND14975
DR   Wikidata; Q54926992
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND14982
AC   CVCL_CP39
DR   BioSample; SAMN00798251
DR   Coriell; ND14982
DR   Wikidata; Q54926993
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND14998
AC   CVCL_IF19
DR   BioSample; SAMN00798253
DR   Coriell; ND14998
DR   Wikidata; Q54926994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15
AC   CVCL_4256
SY   Neuroblastoma X DRG neurons hybrid 15
DR   CLO; CLO_0008141
DR   ECACC; 92090907
DR   Wikidata; Q54926995
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 7
//
ID   ND15000
AC   CVCL_GL80
DR   BioSample; SAMN00798255
DR   Coriell; ND15000
DR   Wikidata; Q54926996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15001
AC   CVCL_A5JG
DR   BioSample; SAMN00798257
DR   Coriell; ND15001
DR   Wikidata; Q107116550
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15001; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15007
AC   CVCL_CP40
DR   Coriell; ND15007
DR   Wikidata; Q54926997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15009
AC   CVCL_EY20
DR   CLO; CLO_0017691
DR   Coriell; ND15009
DR   Wikidata; Q54926998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15018
AC   CVCL_FE37
DR   Coriell; ND15018
DR   Wikidata; Q54926999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15019
AC   CVCL_FE38
DR   Coriell; ND15019
DR   Wikidata; Q54927000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15022
AC   CVCL_IK55
DR   Coriell; ND15022
DR   Wikidata; Q54927001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15025
AC   CVCL_EC32
DR   Coriell; ND15025
DR   Wikidata; Q54927002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15026
AC   CVCL_EC33
DR   Coriell; ND15026
DR   Wikidata; Q54927003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15028
AC   CVCL_FF34
DR   Coriell; ND15028
DR   Wikidata; Q54927004
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15032
AC   CVCL_EC34
DR   CLO; CLO_0017690
DR   Coriell; ND15032
DR   Wikidata; Q54927005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15036
AC   CVCL_CP41
DR   BioSample; SAMN00798259
DR   Coriell; ND15036
DR   Wikidata; Q54927006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15039
AC   CVCL_CP42
DR   Coriell; ND15039
DR   Wikidata; Q54927007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15043
AC   CVCL_FL73
DR   Coriell; ND15043
DR   Wikidata; Q54927008
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15047
AC   CVCL_HW11
DR   BioSample; SAMN00798261
DR   Coriell; ND15047
DR   Wikidata; Q54927009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15056
AC   CVCL_A5JH
DR   BioSample; SAMN00798263
DR   Coriell; ND15056
DR   Wikidata; Q107116551
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15056; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15057
AC   CVCL_FE39
DR   BioSample; SAMN00798265
DR   Coriell; ND15057
DR   Wikidata; Q54927010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15058
AC   CVCL_A5JI
DR   BioSample; SAMN00798267
DR   Coriell; ND15058
DR   Wikidata; Q107116553
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15058; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15062
AC   CVCL_CP43
DR   Coriell; ND15062
DR   Wikidata; Q54927011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15074
AC   CVCL_FE40
DR   Coriell; ND15074
DR   Wikidata; Q54927012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15079
AC   CVCL_A5KZ
DR   BioSample; SAMN00798269
DR   Coriell; ND15079
DR   Wikidata; Q107116554
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15079; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15080
AC   CVCL_GL81
DR   BioSample; SAMN00798271
DR   Coriell; ND15080
DR   Wikidata; Q54927013
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND15085
AC   CVCL_FZ63
DR   BioSample; SAMN00798273
DR   Coriell; ND15085
DR   Wikidata; Q54927014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15090
AC   CVCL_IK56
DR   BioSample; SAMN00798275
DR   Coriell; ND15090
DR   Wikidata; Q54927015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15091
AC   CVCL_IK57
DR   BioSample; SAMN00798277
DR   Coriell; ND15091
DR   Wikidata; Q54927016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15092
AC   CVCL_IK58
DR   BioSample; SAMN00798279
DR   Coriell; ND15092
DR   Wikidata; Q54927017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15093
AC   CVCL_GL82
DR   BioSample; SAMN00798281
DR   Coriell; ND15093
DR   Wikidata; Q54927018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15094
AC   CVCL_IK59
DR   BioSample; SAMN00798283
DR   Coriell; ND15094
DR   Wikidata; Q54927019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15095
AC   CVCL_IK60
DR   BioSample; SAMN00798285
DR   Coriell; ND15095
DR   Wikidata; Q54927020
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15096
AC   CVCL_A5JJ
DR   BioSample; SAMN00798287
DR   Coriell; ND15096
DR   Wikidata; Q107116555
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15096; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15097
AC   CVCL_IK61
DR   BioSample; SAMN00798289
DR   Coriell; ND15097
DR   Wikidata; Q54927021
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15098
AC   CVCL_IK62
DR   BioSample; SAMN00798291
DR   Coriell; ND15098
DR   Wikidata; Q54927022
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15099
AC   CVCL_A5JK
DR   BioSample; SAMN00798295
DR   Coriell; ND15099
DR   Wikidata; Q107116556
CC   Population: Caucasian; British.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15099; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15104
AC   CVCL_IK63
DR   Coriell; ND15104
DR   Wikidata; Q54927023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15114
AC   CVCL_A5JL
DR   BioSample; SAMN00798297
DR   Coriell; ND15114
DR   Wikidata; Q107116557
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15114; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15116
AC   CVCL_EY21
DR   CLO; CLO_0017693
DR   Coriell; ND15116
DR   Wikidata; Q54927024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15117
AC   CVCL_IK64
DR   Coriell; ND15117
DR   Wikidata; Q54927025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15118
AC   CVCL_A5JM
DR   BioSample; SAMN00798299
DR   Coriell; ND15118
DR   Wikidata; Q107116558
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15118; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15121
AC   CVCL_CP44
DR   Coriell; ND15121
DR   Wikidata; Q54927026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15125
AC   CVCL_GL83
DR   Coriell; ND15125
DR   Wikidata; Q54927027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15127
AC   CVCL_GL84
DR   Coriell; ND15127
DR   Wikidata; Q54927028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15129
AC   CVCL_CP45
DR   Coriell; ND15129
DR   Wikidata; Q54927029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15130
AC   CVCL_IK65
DR   Coriell; ND15130
DR   Wikidata; Q54927030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15133
AC   CVCL_EC35
DR   Coriell; ND15133
DR   Wikidata; Q54927031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15137
AC   CVCL_FE41
DR   BioSample; SAMN00798301
DR   Coriell; ND15137
DR   Wikidata; Q54927036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15139
AC   CVCL_A5JN
DR   BioSample; SAMN00798303
DR   Coriell; ND15139
DR   Wikidata; Q107116559
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15139; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15147
AC   CVCL_A5JP
DR   BioSample; SAMN00798305
DR   Coriell; ND15147
DR   Wikidata; Q107116560
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15147; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15148
AC   CVCL_A5JQ
DR   BioSample; SAMN00798307
DR   Coriell; ND15148
DR   Wikidata; Q107116561
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15148; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15149
AC   CVCL_A5JR
DR   BioSample; SAMN00798309
DR   Coriell; ND15149
DR   Wikidata; Q107116562
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15149; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15150
AC   CVCL_A5JS
DR   BioSample; SAMN00798311
DR   Coriell; ND15150
DR   Wikidata; Q107116563
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15150; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15151
AC   CVCL_CP46
DR   Coriell; ND15151
DR   Wikidata; Q54927037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15160
AC   CVCL_IK66
DR   Coriell; ND15160
DR   Wikidata; Q54927038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15161
AC   CVCL_CP47
DR   Coriell; ND15161
DR   Wikidata; Q54927039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15163
AC   CVCL_FL74
DR   Coriell; ND15163
DR   Wikidata; Q54927040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15164
AC   CVCL_FZ64
DR   BioSample; SAMN00798313
DR   Coriell; ND15164
DR   Wikidata; Q54927041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15167
AC   CVCL_A5JT
DR   BioSample; SAMN00798315
DR   Coriell; ND15167
DR   Wikidata; Q107116565
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15167; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   ND15171
AC   CVCL_A5JU
DR   BioSample; SAMN00798317
DR   Coriell; ND15171
DR   Wikidata; Q107116566
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND15171; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ND15173
AC   CVCL_FE42
DR   BioSample; SAMN00798319
DR   Coriell; ND15173
DR   Wikidata; Q54927042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15174
AC   CVCL_CP48
DR   Coriell; ND15174
DR   Wikidata; Q54927044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15182
AC   CVCL_BS61
DR   CLO; CLO_0017692
DR   Coriell; ND15182
DR   Wikidata; Q54927045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND15185
AC   CVCL_EC36
DR   Coriell; ND15185
DR   Wikidata; Q54927046
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15186
AC   CVCL_EC37
DR   Coriell; ND15186
DR   Wikidata; Q54927047
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15189
AC   CVCL_CP49
DR   Coriell; ND15189
DR   Wikidata; Q54927048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15190
AC   CVCL_EC38
DR   Coriell; ND15190
DR   Wikidata; Q54927049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15191
AC   CVCL_GL85
DR   Coriell; ND15191
DR   Wikidata; Q54927050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15195
AC   CVCL_HW12
DR   BioSample; SAMN00798329
DR   Coriell; ND15195
DR   Wikidata; Q54927051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15205
AC   CVCL_CP50
DR   Coriell; ND15205
DR   Wikidata; Q54927052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15210
AC   CVCL_EY22
DR   CLO; CLO_0017697
DR   Coriell; ND15210
DR   Wikidata; Q54927053
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15211
AC   CVCL_IK67
DR   Coriell; ND15211
DR   Wikidata; Q54927054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15218
AC   CVCL_IK68
DR   BioSample; SAMN00798331
DR   Coriell; ND15218
DR   Wikidata; Q54927055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15219
AC   CVCL_IK69
DR   BioSample; SAMN00798333
DR   Coriell; ND15219
DR   Wikidata; Q54927056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15222
AC   CVCL_EC39
DR   Coriell; ND15222
DR   Wikidata; Q54927057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15223
AC   CVCL_EC40
DR   Coriell; ND15223
DR   Wikidata; Q54927058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15229
AC   CVCL_CP51
DR   BioSample; SAMN00798335
DR   Coriell; ND15229
DR   Wikidata; Q54927059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15232
AC   CVCL_FE43
DR   Coriell; ND15232
DR   Wikidata; Q54927060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15237
AC   CVCL_EC41
DR   Coriell; ND15237
DR   Wikidata; Q54927061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15241
AC   CVCL_FE44
DR   Coriell; ND15241
DR   Wikidata; Q54927062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15246
AC   CVCL_FZ65
DR   BioSample; SAMN00798337
DR   Coriell; ND15246
DR   Wikidata; Q54927063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15247
AC   CVCL_GL86
DR   Coriell; ND15247
DR   Wikidata; Q54927064
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15249
AC   CVCL_FE45
DR   Coriell; ND15249
DR   Wikidata; Q54927065
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15259
AC   CVCL_IK70
DR   BioSample; SAMN00798345
DR   Coriell; ND15259
DR   Wikidata; Q54927066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15260
AC   CVCL_GL87
DR   Coriell; ND15260
DR   Wikidata; Q54927067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15265
AC   CVCL_CP52
DR   Coriell; ND15265
DR   Wikidata; Q54927068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15267
AC   CVCL_GL88
DR   Coriell; ND15267
DR   Wikidata; Q54927069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15269
AC   CVCL_GL89
DR   Coriell; ND15269
DR   Wikidata; Q54927070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15270
AC   CVCL_IK71
DR   Coriell; ND15270
DR   Wikidata; Q54927071
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15271
AC   CVCL_FE46
DR   BioSample; SAMN00798347
DR   Coriell; ND15271
DR   Wikidata; Q54927072
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15272
AC   CVCL_FE47
DR   BioSample; SAMN00798348
DR   Coriell; ND15272
DR   Wikidata; Q54927073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15287
AC   CVCL_FF36
DR   Coriell; ND15287
DR   Wikidata; Q54927074
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15288
AC   CVCL_IK72
DR   BioSample; SAMN00798358
DR   Coriell; ND15288
DR   Wikidata; Q54927075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15291
AC   CVCL_GL90
DR   Coriell; ND15291
DR   Wikidata; Q54927076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15294
AC   CVCL_FE48
DR   Coriell; ND15294
DR   Wikidata; Q54927080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15296
AC   CVCL_FF37
DR   BioSample; SAMN00798360
DR   Coriell; ND15296
DR   Wikidata; Q54927081
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND15314
AC   CVCL_CP53
DR   Coriell; ND15314
DR   Wikidata; Q54927082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15329
AC   CVCL_CP54
DR   BioSample; SAMN00798376
DR   Coriell; ND15329
DR   Wikidata; Q54927083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15334
AC   CVCL_FF38
DR   Coriell; ND15334
DR   Wikidata; Q54927084
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15335
AC   CVCL_EC42
DR   Coriell; ND15335
DR   Wikidata; Q54927085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15343
AC   CVCL_FE49
DR   Coriell; ND15343
DR   Wikidata; Q54927086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15346
AC   CVCL_GL91
DR   Coriell; ND15346
DR   Wikidata; Q54927087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15348
AC   CVCL_FE50
DR   Coriell; ND15348
DR   Wikidata; Q54927088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15357
AC   CVCL_GL92
DR   Coriell; ND15357
DR   Wikidata; Q54927089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15369
AC   CVCL_FF39
DR   Coriell; ND15369
DR   Wikidata; Q54927090
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15371
AC   CVCL_FF40
DR   Coriell; ND15371
DR   Wikidata; Q54927091
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15373
AC   CVCL_FE51
DR   Coriell; ND15373
DR   Wikidata; Q54927092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15381
AC   CVCL_FF41
DR   Coriell; ND15381
DR   Wikidata; Q54927093
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15388
AC   CVCL_IK73
DR   Coriell; ND15388
DR   Wikidata; Q54927095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15392
AC   CVCL_CP55
DR   Coriell; ND15392
DR   Wikidata; Q54927096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15393
AC   CVCL_CP56
DR   Coriell; ND15393
DR   Wikidata; Q54927097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15403
AC   CVCL_FE52
DR   Coriell; ND15403
DR   Wikidata; Q54927098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15406
AC   CVCL_FF42
DR   Coriell; ND15406
DR   Wikidata; Q54927099
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15411
AC   CVCL_FE53
DR   Coriell; ND15411
DR   Wikidata; Q54927101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15415
AC   CVCL_GL93
DR   Coriell; ND15415
DR   Wikidata; Q54927102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15426
AC   CVCL_CP57
DR   Coriell; ND15426
DR   Wikidata; Q54927103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15427
AC   CVCL_CP58
DR   Coriell; ND15427
DR   Wikidata; Q54927104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15444
AC   CVCL_CP59
DR   Coriell; ND15444
DR   Wikidata; Q54927105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15445
AC   CVCL_CP60
DR   Coriell; ND15445
DR   Wikidata; Q54927106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15458
AC   CVCL_HW13
DR   BioSample; SAMN00798386
DR   Coriell; ND15458
DR   Wikidata; Q54927107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15465
AC   CVCL_GL94
DR   Coriell; ND15465
DR   Wikidata; Q54927108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15474
AC   CVCL_GL95
DR   BioSample; SAMN00798390
DR   Coriell; ND15474
DR   Wikidata; Q54927109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15485
AC   CVCL_CP61
DR   Coriell; ND15485
DR   Wikidata; Q54927110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15487
AC   CVCL_FE54
DR   Coriell; ND15487
DR   Wikidata; Q54927111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15489
AC   CVCL_GL96
DR   Coriell; ND15489
DR   Wikidata; Q54927112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15493
AC   CVCL_GL97
DR   Coriell; ND15493
DR   Wikidata; Q54927113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15494
AC   CVCL_FE55
DR   Coriell; ND15494
DR   Wikidata; Q54927114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15495
AC   CVCL_CP62
DR   Coriell; ND15495
DR   Wikidata; Q54927115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15510
AC   CVCL_FF43
DR   Coriell; ND15510
DR   Wikidata; Q54927116
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15514
AC   CVCL_GL98
DR   Coriell; ND15514
DR   Wikidata; Q54927117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15520
AC   CVCL_FF44
DR   Coriell; ND15520
DR   Wikidata; Q54927118
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15522
AC   CVCL_EC43
DR   Coriell; ND15522
DR   Wikidata; Q54927119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15523
AC   CVCL_EC44
DR   Coriell; ND15523
DR   Wikidata; Q54927120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15525
AC   CVCL_EC45
DR   Coriell; ND15525
DR   Wikidata; Q54927121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15527
AC   CVCL_CP63
DR   Coriell; ND15527
DR   Wikidata; Q54927129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15533
AC   CVCL_GL99
DR   Coriell; ND15533
DR   Wikidata; Q54927130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15535
AC   CVCL_GM00
DR   Coriell; ND15535
DR   Wikidata; Q54927131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15536
AC   CVCL_GM01
DR   Coriell; ND15536
DR   Wikidata; Q54927132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15537
AC   CVCL_GM02
DR   Coriell; ND15537
DR   Wikidata; Q54927133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15538
AC   CVCL_GM03
DR   Coriell; ND15538
DR   Wikidata; Q54927134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15540
AC   CVCL_GM04
DR   Coriell; ND15540
DR   Wikidata; Q54927135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15545
AC   CVCL_GM05
DR   Coriell; ND15545
DR   Wikidata; Q54927136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15550
AC   CVCL_FF45
DR   Coriell; ND15550
DR   Wikidata; Q54927137
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15551
AC   CVCL_GM06
DR   Coriell; ND15551
DR   Wikidata; Q54927138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15553
AC   CVCL_GM07
DR   Coriell; ND15553
DR   Wikidata; Q54927139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15554
AC   CVCL_GM08
DR   Coriell; ND15554
DR   Wikidata; Q54927140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15561
AC   CVCL_CP64
DR   Coriell; ND15561
DR   Wikidata; Q54927141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15562
AC   CVCL_CP65
DR   BioSample; SAMN00798398
DR   Coriell; ND15562
DR   Wikidata; Q54927142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15566
AC   CVCL_FE56
DR   Coriell; ND15566
DR   Wikidata; Q54927143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15569
AC   CVCL_GM09
DR   Coriell; ND15569
DR   Wikidata; Q54927144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15570
AC   CVCL_FF46
DR   Coriell; ND15570
DR   Wikidata; Q54927145
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15571
AC   CVCL_GM10
DR   Coriell; ND15571
DR   Wikidata; Q54927146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15572
AC   CVCL_GM11
DR   Coriell; ND15572
DR   Wikidata; Q54927147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15573
AC   CVCL_GM12
DR   Coriell; ND15573
DR   Wikidata; Q54927148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15577
AC   CVCL_FF47
DR   Coriell; ND15577
DR   Wikidata; Q54927149
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15580
AC   CVCL_EC46
DR   Coriell; ND15580
DR   Wikidata; Q54927150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15581
AC   CVCL_EC47
DR   Coriell; ND15581
DR   Wikidata; Q54927151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15588
AC   CVCL_CP66
DR   Coriell; ND15588
DR   Wikidata; Q54927152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15593
AC   CVCL_EC48
DR   Coriell; ND15593
DR   Wikidata; Q54927153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15596
AC   CVCL_FZ66
DR   BioSample; SAMN00798404
DR   Coriell; ND15596
DR   Wikidata; Q54927154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15597
AC   CVCL_HW14
DR   BioSample; SAMN00798406
DR   Coriell; ND15597
DR   Wikidata; Q54927155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15605
AC   CVCL_CP67
DR   Coriell; ND15605
DR   Wikidata; Q54927156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15618
AC   CVCL_CP68
DR   Coriell; ND15618
DR   Wikidata; Q54927157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15619
AC   CVCL_IK74
DR   BioSample; SAMN00798414
DR   Coriell; ND15619
DR   Wikidata; Q54927158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15620
AC   CVCL_IK75
DR   BioSample; SAMN00798416
DR   Coriell; ND15620
DR   Wikidata; Q54927159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15621
AC   CVCL_IK76
DR   BioSample; SAMN00798418
DR   Coriell; ND15621
DR   Wikidata; Q54927160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15626
AC   CVCL_IK77
DR   BioSample; SAMN00798422
DR   Coriell; ND15626
DR   Wikidata; Q54927161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15627
AC   CVCL_GM13
DR   BioSample; SAMN00798424
DR   Coriell; ND15627
DR   Wikidata; Q54927162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15632
AC   CVCL_GM14
DR   Coriell; ND15632
DR   Wikidata; Q54927163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15634
AC   CVCL_CP69
DR   Coriell; ND15634
DR   Wikidata; Q54927164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15638
AC   CVCL_FL75
DR   BioSample; SAMN00798428
DR   Coriell; ND15638
DR   Wikidata; Q54927165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15640
AC   CVCL_CP70
DR   Coriell; ND15640
DR   Wikidata; Q54927167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15649
AC   CVCL_EC49
DR   Coriell; ND15649
DR   Wikidata; Q54927168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15655
AC   CVCL_CP71
DR   Coriell; ND15655
DR   Wikidata; Q54927169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15656
AC   CVCL_HW15
DR   BioSample; SAMN00798430
DR   Coriell; ND15656
DR   Wikidata; Q54927174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15662
AC   CVCL_EC50
DR   Coriell; ND15662
DR   Wikidata; Q54927175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15665
AC   CVCL_CP72
DR   Coriell; ND15665
DR   Wikidata; Q54927176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15666
AC   CVCL_CP73
DR   BioSample; SAMN00798434
DR   Coriell; ND15666
DR   Wikidata; Q54927177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15679
AC   CVCL_CP74
DR   BioSample; SAMN00798436
DR   Coriell; ND15679
DR   Wikidata; Q54927178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15685
AC   CVCL_CP75
DR   Coriell; ND15685
DR   Wikidata; Q54927179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15690
AC   CVCL_CP76
DR   Coriell; ND15690
DR   Wikidata; Q54927180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15699
AC   CVCL_EC51
DR   Coriell; ND15699
DR   Wikidata; Q54927181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15708
AC   CVCL_CP77
DR   Coriell; ND15708
DR   Wikidata; Q54927182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15710
AC   CVCL_CP78
DR   Coriell; ND15710
DR   Wikidata; Q54927183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15713
AC   CVCL_CP79
DR   Coriell; ND15713
DR   Wikidata; Q54927184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15718
AC   CVCL_CP80
DR   Coriell; ND15718
DR   Wikidata; Q54927185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15719
AC   CVCL_EC52
DR   Coriell; ND15719
DR   Wikidata; Q54927186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15721
AC   CVCL_FZ67
DR   BioSample; SAMN00798440
DR   Coriell; ND15721
DR   Wikidata; Q54927187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15722
AC   CVCL_FZ68
DR   Coriell; ND15722
DR   Wikidata; Q54927188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15728
AC   CVCL_EC53
DR   Coriell; ND15728
DR   Wikidata; Q54927189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15729
AC   CVCL_EH52
DR   BioSample; SAMN00798444
DR   Coriell; ND15729
DR   Wikidata; Q54927190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15730
AC   CVCL_GM15
DR   BioSample; SAMN00798446
DR   Coriell; ND15730
DR   Wikidata; Q54927191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15731
AC   CVCL_HW16
DR   BioSample; SAMN00798448
DR   Coriell; ND15731
DR   Wikidata; Q54927192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15735
AC   CVCL_CP81
DR   BioSample; SAMN00798450
DR   Coriell; ND15735
DR   Wikidata; Q54927193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15736
AC   CVCL_IK78
DR   BioSample; SAMN00798452
DR   Coriell; ND15736
DR   Wikidata; Q54927194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15737
AC   CVCL_GM16
DR   BioSample; SAMN00798454
DR   Coriell; ND15737
DR   Wikidata; Q54927195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15738
AC   CVCL_IK79
DR   BioSample; SAMN00798456
DR   Coriell; ND15738
DR   Wikidata; Q54927196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15739
AC   CVCL_IK80
DR   BioSample; SAMN00798458
DR   Coriell; ND15739
DR   Wikidata; Q54927197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15740
AC   CVCL_IK81
DR   BioSample; SAMN00798460
DR   Coriell; ND15740
DR   Wikidata; Q54927198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15741
AC   CVCL_IK82
DR   BioSample; SAMN00798462
DR   Coriell; ND15741
DR   Wikidata; Q54927199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15742
AC   CVCL_IK83
DR   BioSample; SAMN00798464
DR   Coriell; ND15742
DR   Wikidata; Q54927200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15744
AC   CVCL_GM17
DR   Coriell; ND15744
DR   Wikidata; Q54927201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15745
AC   CVCL_CP82
DR   Coriell; ND15745
DR   Wikidata; Q54927202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15746
AC   CVCL_GM18
DR   BioSample; SAMN00798466
DR   Coriell; ND15746
DR   Wikidata; Q54927203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15752
AC   CVCL_CP83
DR   Coriell; ND15752
DR   Wikidata; Q54927204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15753
AC   CVCL_GM19
DR   Coriell; ND15753
DR   Wikidata; Q54927205
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15755
AC   CVCL_CP84
DR   Coriell; ND15755
DR   Wikidata; Q54927206
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15756
AC   CVCL_EC54
DR   Coriell; ND15756
DR   Wikidata; Q54927207
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15757
AC   CVCL_EC55
DR   Coriell; ND15757
DR   Wikidata; Q54927208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15760
AC   CVCL_HW17
DR   BioSample; SAMN00798468
DR   Coriell; ND15760
DR   Wikidata; Q54927209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15769
AC   CVCL_FL76
DR   Coriell; ND15769
DR   Wikidata; Q54927210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15770
AC   CVCL_FZ69
DR   BioSample; SAMN00798470
DR   Coriell; ND15770
DR   Wikidata; Q54927211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15774
AC   CVCL_EH53
DR   Coriell; ND15774
DR   Wikidata; Q54927212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15775
AC   CVCL_GM20
DR   Coriell; ND15775
DR   Wikidata; Q54927213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15780
AC   CVCL_CP85
DR   BioSample; SAMN00798476
DR   Coriell; ND15780
DR   Wikidata; Q54927217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15785
AC   CVCL_EC56
DR   Coriell; ND15785
DR   Wikidata; Q54927218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15786
AC   CVCL_EC57
DR   Coriell; ND15786
DR   Wikidata; Q54927219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15787
AC   CVCL_EC58
DR   Coriell; ND15787
DR   Wikidata; Q54927220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15798
AC   CVCL_CP86
DR   Coriell; ND15798
DR   Wikidata; Q54927221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15799
AC   CVCL_CP87
DR   BioSample; SAMN00798480
DR   Coriell; ND15799
DR   Wikidata; Q54927222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15801
AC   CVCL_CP88
DR   Coriell; ND15801
DR   Wikidata; Q54927223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15802
AC   CVCL_CP89
DR   Coriell; ND15802
DR   Wikidata; Q54927224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15807
AC   CVCL_CP90
DR   Coriell; ND15807
DR   Wikidata; Q54927225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15808
AC   CVCL_CP91
DR   Coriell; ND15808
DR   Wikidata; Q54927226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15809
AC   CVCL_FF48
DR   Coriell; ND15809
DR   Wikidata; Q54927227
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15810
AC   CVCL_EC59
DR   Coriell; ND15810
DR   Wikidata; Q54927229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15811
AC   CVCL_CP92
DR   Coriell; ND15811
DR   Wikidata; Q54927230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15812
AC   CVCL_CP93
DR   BioSample; SAMN00798482
DR   Coriell; ND15812
DR   Wikidata; Q54927231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15813
AC   CVCL_CP94
DR   Coriell; ND15813
DR   Wikidata; Q54927232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15818
AC   CVCL_EH54
DR   BioSample; SAMN00798486
DR   Coriell; ND15818
DR   Wikidata; Q54927233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15819
AC   CVCL_IK84
DR   BioSample; SAMN00798488
DR   Coriell; ND15819
DR   Wikidata; Q54927235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15820
AC   CVCL_GM21
DR   Coriell; ND15820
DR   Wikidata; Q54927236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15821
AC   CVCL_CP95
DR   Coriell; ND15821
DR   Wikidata; Q54927237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15822
AC   CVCL_CP96
DR   Coriell; ND15822
DR   Wikidata; Q54927238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15833
AC   CVCL_CY98
DR   BioSample; SAMN00798494
DR   Coriell; ND15833
DR   Wikidata; Q54927239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15835
AC   CVCL_CP97
DR   BioSample; SAMN00798498
DR   Coriell; ND15835
DR   Wikidata; Q54927240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15836
AC   CVCL_FE57
DR   BioSample; SAMN00798500
DR   Coriell; ND15836
DR   Wikidata; Q54927241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15838
AC   CVCL_CP98
DR   Coriell; ND15838
DR   Wikidata; Q54927242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15839
AC   CVCL_BS62
DR   Coriell; ND15839
DR   Wikidata; Q54927243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND15842
AC   CVCL_EH55
DR   BioSample; SAMN00798502
DR   Coriell; ND15842
DR   Wikidata; Q54927245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15843
AC   CVCL_GM22
DR   BioSample; SAMN00798504
DR   Coriell; ND15843
DR   Wikidata; Q54927246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15845
AC   CVCL_CP99
DR   Coriell; ND15845
DR   Wikidata; Q54927247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15849
AC   CVCL_EC60
DR   Coriell; ND15849
DR   Wikidata; Q54927248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15850
AC   CVCL_EC61
DR   Coriell; ND15850
DR   Wikidata; Q54927249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15851
AC   CVCL_EC62
DR   Coriell; ND15851
DR   Wikidata; Q54927250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15854
AC   CVCL_HW18
DR   BioSample; SAMN00798506
DR   Coriell; ND15854
DR   Wikidata; Q54927251
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15855
AC   CVCL_EH56
DR   Coriell; ND15855
DR   Wikidata; Q54927252
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15856
AC   CVCL_IK85
DR   Coriell; ND15856
DR   Wikidata; Q54927253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15857
AC   CVCL_IK86
DR   Coriell; ND15857
DR   Wikidata; Q54927254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15863
AC   CVCL_CQ00
DR   Coriell; ND15863
DR   Wikidata; Q54927255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15864
AC   CVCL_EC63
DR   Coriell; ND15864
DR   Wikidata; Q54927256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15865
AC   CVCL_GM23
DR   BioSample; SAMN00798508
DR   Coriell; ND15865
DR   Wikidata; Q54927257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15868
AC   CVCL_IK87
DR   BioSample; SAMN00798510
DR   Coriell; ND15868
DR   Wikidata; Q54927258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15871
AC   CVCL_CQ01
DR   Coriell; ND15871
DR   Wikidata; Q54927259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15872
AC   CVCL_EH57
DR   Coriell; ND15872
DR   Wikidata; Q54927263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15874
AC   CVCL_GM24
DR   BioSample; SAMN00798512
DR   Coriell; ND15874
DR   Wikidata; Q54927265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15885
AC   CVCL_IK88
DR   BioSample; SAMN00798514
DR   Coriell; ND15885
DR   Wikidata; Q54927266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15886
AC   CVCL_AB78
DR   Coriell; ND15886
DR   Wikidata; Q54927267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   ND15887
AC   CVCL_EC64
DR   Coriell; ND15887
DR   Wikidata; Q54927268
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15888
AC   CVCL_EC65
DR   Coriell; ND15888
DR   Wikidata; Q54927269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15890
AC   CVCL_CQ02
DR   Coriell; ND15890
DR   Wikidata; Q54927270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15892
AC   CVCL_HW19
DR   BioSample; SAMN00798516
DR   Coriell; ND15892
DR   Wikidata; Q54927271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15893
AC   CVCL_HW20
DR   BioSample; SAMN00798518
DR   Coriell; ND15893
DR   Wikidata; Q54927272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15896
AC   CVCL_GM25
DR   Coriell; ND15896
DR   Wikidata; Q54927273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15897
AC   CVCL_FE58
DR   Coriell; ND15897
DR   Wikidata; Q54927274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15901
AC   CVCL_CQ03
DR   Coriell; ND15901
DR   Wikidata; Q54927275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15903
AC   CVCL_FE59
DR   BioSample; SAMN00798522
DR   Coriell; ND15903
DR   Wikidata; Q54927276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15904
AC   CVCL_BS63
DR   Coriell; ND15904
DR   Wikidata; Q54927277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND15905
AC   CVCL_CQ04
DR   Coriell; ND15905
DR   Wikidata; Q54927278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15906
AC   CVCL_CQ05
DR   CLO; CLO_0017696
DR   Coriell; ND15906
DR   Wikidata; Q54927279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15907
AC   CVCL_CQ06
DR   Coriell; ND15907
DR   Wikidata; Q54927280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15908
AC   CVCL_CQ07
DR   Coriell; ND15908
DR   Wikidata; Q54927281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15909
AC   CVCL_CQ08
DR   BioSample; SAMN00798524
DR   Coriell; ND15909
DR   Wikidata; Q54927282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15913
AC   CVCL_IK89
DR   Coriell; ND15913
DR   Wikidata; Q54927283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND15914
AC   CVCL_CQ09
DR   Coriell; ND15914
DR   Wikidata; Q54927284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15915
AC   CVCL_GM26
DR   Coriell; ND15915
DR   Wikidata; Q54927285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15917
AC   CVCL_FF49
DR   Coriell; ND15917
DR   Wikidata; Q54927286
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15918
AC   CVCL_EH58
DR   BioSample; SAMN00798526
DR   Coriell; ND15918
DR   Wikidata; Q54927287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15919
AC   CVCL_GM27
DR   BioSample; SAMN00798528
DR   Coriell; ND15919
DR   Wikidata; Q54927288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15920
AC   CVCL_GM28
DR   Coriell; ND15920
DR   Wikidata; Q54927289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15926
AC   CVCL_EC66
DR   Coriell; ND15926
DR   Wikidata; Q54927290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15927
AC   CVCL_EC67
DR   Coriell; ND15927
DR   Wikidata; Q54927291
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15929
AC   CVCL_EC68
DR   Coriell; ND15929
DR   Wikidata; Q54927293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND15936
AC   CVCL_CQ10
DR   Coriell; ND15936
DR   Wikidata; Q54927294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15941
AC   CVCL_CQ11
DR   Coriell; ND15941
DR   Wikidata; Q54927295
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15944
AC   CVCL_CQ12
DR   Coriell; ND15944
DR   Wikidata; Q54927296
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15948
AC   CVCL_GM29
DR   Coriell; ND15948
DR   Wikidata; Q54927297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND15950
AC   CVCL_CQ13
DR   Coriell; ND15950
DR   Wikidata; Q54927298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15951
AC   CVCL_CQ14
DR   Coriell; ND15951
DR   Wikidata; Q54927299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15952
AC   CVCL_IK90
DR   BioSample; SAMN00798532
DR   Coriell; ND15952
DR   Wikidata; Q54927300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15953
AC   CVCL_IK91
DR   BioSample; SAMN00798534
DR   Coriell; ND15953
DR   Wikidata; Q54927301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15954
AC   CVCL_IK92
DR   BioSample; SAMN00798536
DR   Coriell; ND15954
DR   Wikidata; Q54927302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND15955
AC   CVCL_GM30
DR   BioSample; SAMN00798538
DR   Coriell; ND15955
DR   Wikidata; Q54927303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND15957
AC   CVCL_CQ15
DR   Coriell; ND15957
DR   Wikidata; Q54927304
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15958
AC   CVCL_CQ16
DR   Coriell; ND15958
DR   Wikidata; Q54927313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15971
AC   CVCL_BS64
DR   CLO; CLO_0017699
DR   Coriell; ND15971
DR   Wikidata; Q54927314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND15972
AC   CVCL_CQ17
DR   CLO; CLO_0017698
DR   Coriell; ND15972
DR   Wikidata; Q54927315
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND15973
AC   CVCL_CQ18
DR   Coriell; ND15973
DR   Wikidata; Q54927316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15977
AC   CVCL_CQ19
DR   Coriell; ND15977
DR   Wikidata; Q54927317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15978
AC   CVCL_EC69
DR   Coriell; ND15978
DR   Wikidata; Q54927318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15979
AC   CVCL_EC70
DR   Coriell; ND15979
DR   Wikidata; Q54927319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND15983
AC   CVCL_CQ20
DR   Coriell; ND15983
DR   Wikidata; Q54927320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15985
AC   CVCL_CQ21
DR   Coriell; ND15985
DR   Wikidata; Q54927321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15989
AC   CVCL_CQ22
DR   Coriell; ND15989
DR   Wikidata; Q54927322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND15999
AC   CVCL_EC71
DR   Coriell; ND15999
DR   Wikidata; Q54927323
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND16004
AC   CVCL_CQ23
DR   BioSample; SAMN00798544
DR   Coriell; ND16004
DR   Wikidata; Q54927324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16014
AC   CVCL_CQ24
DR   Coriell; ND16014
DR   Wikidata; Q54927325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16015
AC   CVCL_IF20
DR   BioSample; SAMN00798546
DR   Coriell; ND16015
DR   Wikidata; Q54927326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16016
AC   CVCL_IF21
DR   BioSample; SAMN00798548
DR   Coriell; ND16016
DR   Wikidata; Q54927327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16017
AC   CVCL_IF22
DR   BioSample; SAMN00798550
DR   Coriell; ND16017
DR   Wikidata; Q54927328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16019
AC   CVCL_CQ25
DR   Coriell; ND16019
DR   Wikidata; Q54927329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16022
AC   CVCL_CQ26
DR   Coriell; ND16022
DR   Wikidata; Q54927330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16024
AC   CVCL_HW21
DR   BioSample; SAMN00798552
DR   Coriell; ND16024
DR   Wikidata; Q54927331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16027
AC   CVCL_CQ27
DR   Coriell; ND16027
DR   Wikidata; Q54927332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16028
AC   CVCL_FF50
DR   Coriell; ND16028
DR   Wikidata; Q54927333
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16029
AC   CVCL_EC72
DR   Coriell; ND16029
DR   Wikidata; Q54927334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16030
AC   CVCL_EC73
DR   Coriell; ND16030
DR   Wikidata; Q54927335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16032
AC   CVCL_EC74
DR   Coriell; ND16032
DR   Wikidata; Q54927336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16035
AC   CVCL_CQ28
DR   Coriell; ND16035
DR   Wikidata; Q54927337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16036
AC   CVCL_CQ29
DR   Coriell; ND16036
DR   Wikidata; Q54927338
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND16037
AC   CVCL_CQ30
DR   Coriell; ND16037
DR   Wikidata; Q54927339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16044
AC   CVCL_CQ31
DR   Coriell; ND16044
DR   Wikidata; Q54927340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16045
AC   CVCL_CQ32
DR   BioSample; SAMN00798556
DR   Coriell; ND16045
DR   Wikidata; Q54927341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16050
AC   CVCL_IF23
DR   BioSample; SAMN00798558
DR   Coriell; ND16050
DR   Wikidata; Q54927342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16051
AC   CVCL_IF24
DR   BioSample; SAMN00798560
DR   Coriell; ND16051
DR   Wikidata; Q54927343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16052
AC   CVCL_CQ33
DR   BioSample; SAMN00798562
DR   Coriell; ND16052
DR   Wikidata; Q54927344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16053
AC   CVCL_EH59
DR   BioSample; SAMN00798564
DR   Coriell; ND16053
DR   Wikidata; Q54927345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND16054
AC   CVCL_GM31
DR   BioSample; SAMN00798566
DR   Coriell; ND16054
DR   Wikidata; Q54927346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16058
AC   CVCL_FC01
DR   Coriell; ND16058
DR   Wikidata; Q54927347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16061
AC   CVCL_BS65
DR   Coriell; ND16061
DR   Wikidata; Q54927348
RX   PubMed=35467758;
RX   PubMed=35933467;
CC   Population: Caucasian; German.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND16062
AC   CVCL_CQ34
DR   Coriell; ND16062
DR   Wikidata; Q54927349
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16063
AC   CVCL_CQ35
DR   Coriell; ND16063
DR   Wikidata; Q54927350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16064
AC   CVCL_CQ36
DR   Coriell; ND16064
DR   Wikidata; Q54927351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16066
AC   CVCL_GM32
DR   BioSample; SAMN00798568
DR   Coriell; ND16066
DR   Wikidata; Q54927352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16068
AC   CVCL_CQ37
DR   Coriell; ND16068
DR   Wikidata; Q54927357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16072
AC   CVCL_CQ38
DR   Coriell; ND16072
DR   Wikidata; Q54927358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16075
AC   CVCL_CQ39
DR   Coriell; ND16075
DR   Wikidata; Q54927360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16076
AC   CVCL_EC75
DR   Coriell; ND16076
DR   Wikidata; Q54927361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16077
AC   CVCL_EC76
DR   Coriell; ND16077
DR   Wikidata; Q54927362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16078
AC   CVCL_EC77
DR   Coriell; ND16078
DR   Wikidata; Q54927363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16081
AC   CVCL_EC78
DR   Coriell; ND16081
DR   Wikidata; Q54927364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16083
AC   CVCL_GM33
DR   Coriell; ND16083
DR   Wikidata; Q54927365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16086
AC   CVCL_IK40
DR   Coriell; ND16086
DR   Wikidata; Q54927366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16087
AC   CVCL_FL77
DR   Coriell; ND16087
DR   Wikidata; Q54927367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16088
AC   CVCL_BS66
DR   CLO; CLO_0017695
DR   BioSample; SAMN00798572
DR   Coriell; ND16088
DR   Wikidata; Q54927368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND16097
AC   CVCL_FZ70
DR   BioSample; SAMN00798574
DR   Coriell; ND16097
DR   Wikidata; Q54927369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16099
AC   CVCL_CQ40
DR   Coriell; ND16099
DR   Wikidata; Q54927370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16100
AC   CVCL_CQ41
DR   Coriell; ND16100
DR   Wikidata; Q54927371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16102
AC   CVCL_IF25
DR   BioSample; SAMN00798576
DR   Coriell; ND16102
DR   Wikidata; Q54927372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16103
AC   CVCL_IF26
DR   BioSample; SAMN00798578
DR   Coriell; ND16103
DR   Wikidata; Q54927373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16104
AC   CVCL_IF27
DR   BioSample; SAMN00798580
DR   Coriell; ND16104
DR   Wikidata; Q54927374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16105
AC   CVCL_IF28
DR   BioSample; SAMN00798582
DR   Coriell; ND16105
DR   Wikidata; Q54927375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16106
AC   CVCL_IF29
DR   BioSample; SAMN00798584
DR   Coriell; ND16106
DR   Wikidata; Q54927376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16107
AC   CVCL_EH60
DR   BioSample; SAMN00798586
DR   Coriell; ND16107
DR   Wikidata; Q54927377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND16108
AC   CVCL_IF30
DR   BioSample; SAMN00798588
DR   Coriell; ND16108
DR   Wikidata; Q54927378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   ND16109
AC   CVCL_EC79
DR   Coriell; ND16109
DR   Wikidata; Q54927379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16110
AC   CVCL_EH61
DR   BioSample; SAMN00798590
DR   Coriell; ND16110
DR   Wikidata; Q54927380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND16111
AC   CVCL_EH62
DR   Coriell; ND16111
DR   Wikidata; Q54927381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16112
AC   CVCL_GM34
DR   BioSample; SAMN00798592
DR   Coriell; ND16112
DR   Wikidata; Q54927382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16114
AC   CVCL_GM35
DR   Coriell; ND16114
DR   Wikidata; Q54927383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16176
AC   CVCL_GM36
DR   Coriell; ND16176
DR   Wikidata; Q54927384
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16181
AC   CVCL_CQ42
DR   Coriell; ND16181
DR   Wikidata; Q54927385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16183
AC   CVCL_BS67
DR   CLO; CLO_0017721
DR   BioSample; SAMN00798594
DR   Coriell; ND16183
DR   Wikidata; Q54927386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   ND16186
AC   CVCL_EC80
DR   Coriell; ND16186
DR   Wikidata; Q54927387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16188
AC   CVCL_FE60
DR   BioSample; SAMN00798598
DR   Coriell; ND16188
DR   Wikidata; Q54927388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16189
AC   CVCL_EC81
DR   Coriell; ND16189
DR   Wikidata; Q54927389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16197
AC   CVCL_CQ43
DR   Coriell; ND16197
DR   Wikidata; Q54927390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16198
AC   CVCL_CQ44
DR   Coriell; ND16198
DR   Wikidata; Q54927391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16203
AC   CVCL_CQ45
DR   Coriell; ND16203
DR   Wikidata; Q54927392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16205
AC   CVCL_EH63
DR   Coriell; ND16205
DR   Wikidata; Q54927393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16207
AC   CVCL_CQ46
DR   Coriell; ND16207
DR   Wikidata; Q54927394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16211
AC   CVCL_EH64
DR   Coriell; ND16211
DR   Wikidata; Q54927395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16212
AC   CVCL_GM37
DR   BioSample; SAMN00798604
DR   Coriell; ND16212
DR   Wikidata; Q54927396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16217
AC   CVCL_FE61
DR   BioSample; SAMN00798612
DR   Coriell; ND16217
DR   Wikidata; Q54927397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16218
AC   CVCL_IF31
DR   Coriell; ND16218
DR   Wikidata; Q54927401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16233
AC   CVCL_CQ47
DR   Coriell; ND16233
DR   Wikidata; Q54927402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16235
AC   CVCL_EC82
DR   Coriell; ND16235
DR   Wikidata; Q54927403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16237
AC   CVCL_EC83
DR   Coriell; ND16237
DR   Wikidata; Q54927404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16238
AC   CVCL_EC84
DR   Coriell; ND16238
DR   Wikidata; Q54927405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16241
AC   CVCL_EC85
DR   Coriell; ND16241
DR   Wikidata; Q54927406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16244
AC   CVCL_EC86
DR   Coriell; ND16244
DR   Wikidata; Q54927407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16245
AC   CVCL_EC87
DR   Coriell; ND16245
DR   Wikidata; Q54927408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16246
AC   CVCL_CQ48
DR   Coriell; ND16246
DR   Wikidata; Q54927409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16249
AC   CVCL_CQ49
DR   Coriell; ND16249
DR   Wikidata; Q54927410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16250
AC   CVCL_CQ50
DR   Coriell; ND16250
DR   Wikidata; Q54927411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16261
AC   CVCL_HW22
DR   Coriell; ND16261
DR   Wikidata; Q54927412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16262
AC   CVCL_CQ51
DR   Coriell; ND16262
DR   Wikidata; Q54927413
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND16263
AC   CVCL_CQ52
DR   Coriell; ND16263
DR   Wikidata; Q54927414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16264
AC   CVCL_CQ53
DR   Coriell; ND16264
DR   Wikidata; Q54927415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16266
AC   CVCL_GM38
DR   BioSample; SAMN00798620
DR   Coriell; ND16266
DR   Wikidata; Q54927416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16268
AC   CVCL_FZ71
DR   Coriell; ND16268
DR   Wikidata; Q54927417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16272
AC   CVCL_CQ54
DR   BioSample; SAMN00798624
DR   Coriell; ND16272
DR   Wikidata; Q54927418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16274
AC   CVCL_CQ55
DR   BioSample; SAMN00798626
DR   Coriell; ND16274
DR   Wikidata; Q54927419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16275
AC   CVCL_FE62
DR   BioSample; SAMN00798628
DR   Coriell; ND16275
DR   Wikidata; Q54927420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16278
AC   CVCL_GM39
DR   Coriell; ND16278
DR   Wikidata; Q54927421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16280
AC   CVCL_GM40
DR   BioSample; SAMN00798632
DR   Coriell; ND16280
DR   Wikidata; Q54927422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16285
AC   CVCL_CQ56
DR   Coriell; ND16285
DR   Wikidata; Q54927423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16290
AC   CVCL_BS68
DR   Coriell; ND16290
DR   Wikidata; Q54927424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND16293
AC   CVCL_FL78
DR   Coriell; ND16293
DR   Wikidata; Q54927425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16296
AC   CVCL_CQ57
DR   Coriell; ND16296
DR   Wikidata; Q54927426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16297
AC   CVCL_CQ58
DR   Coriell; ND16297
DR   Wikidata; Q54927427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16309
AC   CVCL_EC88
DR   Coriell; ND16309
DR   Wikidata; Q54927428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16311
AC   CVCL_EC89
DR   Coriell; ND16311
DR   Wikidata; Q54927429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16316
AC   CVCL_CQ59
DR   Coriell; ND16316
DR   Wikidata; Q54927430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16317
AC   CVCL_CQ60
DR   Coriell; ND16317
DR   Wikidata; Q54927431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16321
AC   CVCL_CQ61
DR   BioSample; SAMN00798634
DR   Coriell; ND16321
DR   Wikidata; Q54927432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16326
AC   CVCL_EH65
DR   Coriell; ND16326
DR   Wikidata; Q54927433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16327
AC   CVCL_GM41
DR   BioSample; SAMN00798638
DR   Coriell; ND16327
DR   Wikidata; Q54927434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16329
AC   CVCL_EC90
DR   Coriell; ND16329
DR   Wikidata; Q54927435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16332
AC   CVCL_FL79
DR   Coriell; ND16332
DR   Wikidata; Q54927436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16334
AC   CVCL_CQ62
DR   Coriell; ND16334
DR   Wikidata; Q54927437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16336
AC   CVCL_EC91
DR   Coriell; ND16336
DR   Wikidata; Q54927438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16347
AC   CVCL_CQ63
DR   Coriell; ND16347
DR   Wikidata; Q54927439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16348
AC   CVCL_CQ64
DR   Coriell; ND16348
DR   Wikidata; Q54927440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16350
AC   CVCL_EC92
DR   Coriell; ND16350
DR   Wikidata; Q54927448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16351
AC   CVCL_EC93
DR   Coriell; ND16351
DR   Wikidata; Q54927449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16357
AC   CVCL_IF32
DR   Coriell; ND16357
DR   Wikidata; Q54927450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16358
AC   CVCL_IF33
DR   Coriell; ND16358
DR   Wikidata; Q54927451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16359
AC   CVCL_CQ65
DR   Coriell; ND16359
DR   Wikidata; Q54927452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16371
AC   CVCL_CQ66
DR   Coriell; ND16371
DR   Wikidata; Q54927453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16372
AC   CVCL_CQ67
DR   Coriell; ND16372
DR   Wikidata; Q54927454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16373
AC   CVCL_CQ68
DR   Coriell; ND16373
DR   Wikidata; Q54927455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16375
AC   CVCL_EH66
DR   Coriell; ND16375
DR   Wikidata; Q54927457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16376
AC   CVCL_GM42
DR   BioSample; SAMN00798658
DR   Coriell; ND16376
DR   Wikidata; Q54927458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16377
AC   CVCL_CQ69
DR   Coriell; ND16377
DR   Wikidata; Q54927459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16378
AC   CVCL_GM43
DR   Coriell; ND16378
DR   Wikidata; Q54927460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16381
AC   CVCL_IF34
DR   Coriell; ND16381
DR   Wikidata; Q54927461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16383
AC   CVCL_CQ70
DR   Coriell; ND16383
DR   Wikidata; Q54927462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16384
AC   CVCL_CQ71
DR   Coriell; ND16384
DR   Wikidata; Q54927463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16385
AC   CVCL_GM44
DR   BioSample; SAMN00798664
DR   Coriell; ND16385
DR   Wikidata; Q54927464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16388
AC   CVCL_IF35
DR   Coriell; ND16388
DR   Wikidata; Q54927465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16389
AC   CVCL_CQ72
DR   Coriell; ND16389
DR   Wikidata; Q54927466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16390
AC   CVCL_CQ73
DR   Coriell; ND16390
DR   Wikidata; Q54927467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16392
AC   CVCL_CQ74
DR   Coriell; ND16392
DR   Wikidata; Q54927468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16393
AC   CVCL_CQ75
DR   Coriell; ND16393
DR   Wikidata; Q54927469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16394
AC   CVCL_CQ76
DR   Coriell; ND16394
DR   Wikidata; Q54927470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16395
AC   CVCL_CQ77
DR   Coriell; ND16395
DR   Wikidata; Q54927471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16399
AC   CVCL_CQ78
DR   Coriell; ND16399
DR   Wikidata; Q54927472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16401
AC   CVCL_CQ79
DR   Coriell; ND16401
DR   Wikidata; Q54927473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16403
AC   CVCL_EC94
DR   Coriell; ND16403
DR   Wikidata; Q54927474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16406
AC   CVCL_CQ80
DR   Coriell; ND16406
DR   Wikidata; Q54927475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16409
AC   CVCL_CQ81
DR   BioSample; SAMN00798674
DR   Coriell; ND16409
DR   Wikidata; Q54927476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16410
AC   CVCL_CQ82
DR   Coriell; ND16410
DR   Wikidata; Q54927477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16411
AC   CVCL_CQ83
DR   Coriell; ND16411
DR   Wikidata; Q54927478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16413
AC   CVCL_CQ84
DR   Coriell; ND16413
DR   Wikidata; Q54927479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16426
AC   CVCL_CQ85
DR   Coriell; ND16426
DR   Wikidata; Q54927480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16429
AC   CVCL_CQ86
DR   Coriell; ND16429
DR   Wikidata; Q54927481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16437
AC   CVCL_FE63
DR   BioSample; SAMN00798678
DR   Coriell; ND16437
DR   Wikidata; Q54927482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16439
AC   CVCL_CQ87
DR   Coriell; ND16439
DR   Wikidata; Q54927483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16441
AC   CVCL_CQ88
DR   Coriell; ND16441
DR   Wikidata; Q54927484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16449
AC   CVCL_GM45
DR   Coriell; ND16449
DR   Wikidata; Q54927485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16455
AC   CVCL_CQ89
DR   Coriell; ND16455
DR   Wikidata; Q54927486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16457
AC   CVCL_GM46
DR   Coriell; ND16457
DR   Wikidata; Q54927487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16459
AC   CVCL_EC95
DR   Coriell; ND16459
DR   Wikidata; Q54927488
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND16462
AC   CVCL_IF36
DR   Coriell; ND16462
DR   Wikidata; Q54927490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16463
AC   CVCL_IF37
DR   Coriell; ND16463
DR   Wikidata; Q54927491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16464
AC   CVCL_CQ90
DR   Coriell; ND16464
DR   Wikidata; Q54927492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16465
AC   CVCL_CQ91
DR   CLO; CLO_0017720
DR   Coriell; ND16465
DR   Wikidata; Q54927493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16467
AC   CVCL_GM47
DR   Coriell; ND16467
DR   Wikidata; Q54927494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16470
AC   CVCL_EH67
DR   Coriell; ND16470
DR   Wikidata; Q54927495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16471
AC   CVCL_IF38
DR   Coriell; ND16471
DR   Wikidata; Q54927496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16477
AC   CVCL_GM48
DR   Coriell; ND16477
DR   Wikidata; Q54927497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16479
AC   CVCL_EH68
DR   Coriell; ND16479
DR   Wikidata; Q54927498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16480
AC   CVCL_IF39
DR   Coriell; ND16480
DR   Wikidata; Q54927499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16481
AC   CVCL_GM49
DR   Coriell; ND16481
DR   Wikidata; Q54927500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16483
AC   CVCL_CQ92
DR   Coriell; ND16483
DR   Wikidata; Q54927501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16488
AC   CVCL_EH69
DR   Coriell; ND16488
DR   Wikidata; Q54927502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16489
AC   CVCL_GM50
DR   BioSample; SAMN00798699
DR   Coriell; ND16489
DR   Wikidata; Q54927503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16490
AC   CVCL_CQ93
DR   Coriell; ND16490
DR   Wikidata; Q54927504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16491
AC   CVCL_EC96
DR   Coriell; ND16491
DR   Wikidata; Q54927505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16492
AC   CVCL_CQ94
DR   Coriell; ND16492
DR   Wikidata; Q54927506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16493
AC   CVCL_CQ95
DR   Coriell; ND16493
DR   Wikidata; Q54927507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16497
AC   CVCL_EH70
DR   Coriell; ND16497
DR   Wikidata; Q54927508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16498
AC   CVCL_IG83
DR   Coriell; ND16498
DR   Wikidata; Q54927509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3390; Cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16499
AC   CVCL_CQ96
DR   BioSample; SAMN00798709
DR   Coriell; ND16499
DR   Wikidata; Q54927510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16502
AC   CVCL_CQ97
DR   Coriell; ND16502
DR   Wikidata; Q54927511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16503
AC   CVCL_CQ98
DR   Coriell; ND16503
DR   Wikidata; Q54927512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16504
AC   CVCL_EC97
DR   CLO; CLO_0017725
DR   Coriell; ND16504
DR   Wikidata; Q54927513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16505
AC   CVCL_GM51
DR   BioSample; SAMN00798715
DR   Coriell; ND16505
DR   Wikidata; Q54927514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16506
AC   CVCL_CQ99
DR   Coriell; ND16506
DR   Wikidata; Q54927515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16512
AC   CVCL_FF51
DR   Coriell; ND16512
DR   Wikidata; Q54927516
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16535
AC   CVCL_EC98
DR   Coriell; ND16535
DR   Wikidata; Q54927517
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16536
AC   CVCL_EC99
DR   Coriell; ND16536
DR   Wikidata; Q54927518
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16546
AC   CVCL_CR00
DR   Coriell; ND16546
DR   Wikidata; Q54927519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16547
AC   CVCL_CR01
DR   Coriell; ND16547
DR   Wikidata; Q54927520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16553
AC   CVCL_IF40
DR   Coriell; ND16553
DR   Wikidata; Q54927521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16555
AC   CVCL_FF52
DR   Coriell; ND16555
DR   Wikidata; Q54927522
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16556
AC   CVCL_FE64
DR   Coriell; ND16556
DR   Wikidata; Q54927523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16557
AC   CVCL_GM52
DR   Coriell; ND16557
DR   Wikidata; Q54927524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16558
AC   CVCL_CR02
DR   Coriell; ND16558
DR   Wikidata; Q54927525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16561
AC   CVCL_IM11
DR   CLO; CLO_0017724
DR   Coriell; ND16561
DR   Wikidata; Q54927526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND16561; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND16563
AC   CVCL_CR03
DR   Coriell; ND16563
DR   Wikidata; Q54927527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16564
AC   CVCL_ED00
DR   Coriell; ND16564
DR   Wikidata; Q54927528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16565
AC   CVCL_ED01
DR   Coriell; ND16565
DR   Wikidata; Q54927529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16567
AC   CVCL_CR04
DR   Coriell; ND16567
DR   Wikidata; Q54927533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16569
AC   CVCL_CR05
DR   Coriell; ND16569
DR   Wikidata; Q54927534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16577
AC   CVCL_IF41
DR   Coriell; ND16577
DR   Wikidata; Q54927535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16578
AC   CVCL_EH71
DR   Coriell; ND16578
DR   Wikidata; Q54927536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16579
AC   CVCL_GM53
DR   Coriell; ND16579
DR   Wikidata; Q54927537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16584
AC   CVCL_GM54
DR   Coriell; ND16584
DR   Wikidata; Q54927538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16585
AC   CVCL_GM55
DR   BioSample; SAMN00798741
DR   Coriell; ND16585
DR   Wikidata; Q54927539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16594
AC   CVCL_CR06
DR   Coriell; ND16594
DR   Wikidata; Q54927540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16595
AC   CVCL_BS69
DR   Coriell; ND16595
DR   Wikidata; Q54927541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND16597
AC   CVCL_FE65
DR   BioSample; SAMN00798747
DR   Coriell; ND16597
DR   Wikidata; Q54927542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16599
AC   CVCL_ED02
DR   Coriell; ND16599
DR   Wikidata; Q54927543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16602
AC   CVCL_ED03
DR   Coriell; ND16602
DR   Wikidata; Q54927544
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16608
AC   CVCL_GM56
DR   Coriell; ND16608
DR   Wikidata; Q54927545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16612
AC   CVCL_CR07
DR   Coriell; ND16612
DR   Wikidata; Q54927546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16613
AC   CVCL_CR08
DR   Coriell; ND16613
DR   Wikidata; Q54927547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16614
AC   CVCL_GM57
DR   Coriell; ND16614
DR   Wikidata; Q54927548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16616
AC   CVCL_CR09
DR   Coriell; ND16616
DR   Wikidata; Q54927549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16620
AC   CVCL_GM58
DR   BioSample; SAMN00798749
DR   Coriell; ND16620
DR   Wikidata; Q54927550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16621
AC   CVCL_IF42
DR   Coriell; ND16621
DR   Wikidata; Q54927551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16622
AC   CVCL_IF43
DR   Coriell; ND16622
DR   Wikidata; Q54927552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16623
AC   CVCL_IF44
DR   Coriell; ND16623
DR   Wikidata; Q54927553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16624
AC   CVCL_IF45
DR   Coriell; ND16624
DR   Wikidata; Q54927554
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16625
AC   CVCL_IF46
DR   Coriell; ND16625
DR   Wikidata; Q54927555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16626
AC   CVCL_IF47
DR   Coriell; ND16626
DR   Wikidata; Q54927556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16634
AC   CVCL_CR10
DR   Coriell; ND16634
DR   Wikidata; Q54927557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16636
AC   CVCL_ED04
DR   Coriell; ND16636
DR   Wikidata; Q54927558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16644
AC   CVCL_GM59
DR   Coriell; ND16644
DR   Wikidata; Q54927559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16647
AC   CVCL_ED05
DR   Coriell; ND16647
DR   Wikidata; Q54927560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16650
AC   CVCL_EH72
DR   Coriell; ND16650
DR   Wikidata; Q54927561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16651
AC   CVCL_GM60
DR   BioSample; SAMN00798766
DR   Coriell; ND16651
DR   Wikidata; Q54927562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16653
AC   CVCL_CR11
DR   Coriell; ND16653
DR   Wikidata; Q54927563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16654
AC   CVCL_CR12
DR   Coriell; ND16654
DR   Wikidata; Q54927564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16656
AC   CVCL_GM61
DR   Coriell; ND16656
DR   Wikidata; Q54927565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16667
AC   CVCL_ED06
DR   Coriell; ND16667
DR   Wikidata; Q54927566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16669
AC   CVCL_ED07
DR   Coriell; ND16669
DR   Wikidata; Q54927567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16674
AC   CVCL_CR13
DR   Coriell; ND16674
DR   Wikidata; Q54927568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16678
AC   CVCL_CR14
DR   Coriell; ND16678
DR   Wikidata; Q54927569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16679
AC   CVCL_CR15
DR   BioSample; SAMN00798776
DR   Coriell; ND16679
DR   Wikidata; Q54927570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND16680
AC   CVCL_CR16
DR   BioSample; SAMN00798778
DR   Coriell; ND16680
DR   Wikidata; Q54927571
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line ND31960).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EY32 ! ND31960
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   ND16682
AC   CVCL_CR17
DR   Coriell; ND16682
DR   Wikidata; Q54927572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16689
AC   CVCL_CR18
DR   Coriell; ND16689
DR   Wikidata; Q54927578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16691
AC   CVCL_IF48
DR   Coriell; ND16691
DR   Wikidata; Q54927579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16705
AC   CVCL_GM62
DR   BioSample; SAMN00798782
DR   Coriell; ND16705
DR   Wikidata; Q54927580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND16706
AC   CVCL_ED08
DR   Coriell; ND16706
DR   Wikidata; Q54927581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND16707
AC   CVCL_GM63
DR   Coriell; ND16707
DR   Wikidata; Q54927582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16710
AC   CVCL_FZ72
DR   Coriell; ND16710
DR   Wikidata; Q54927583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND16712
AC   CVCL_IK41
DR   CLO; CLO_0017723
DR   Coriell; ND16712
DR   Wikidata; Q54927584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16713
AC   CVCL_IK42
DR   CLO; CLO_0017722
DR   Coriell; ND16713
DR   Wikidata; Q54927585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16714
AC   CVCL_CR19
DR   Coriell; ND16714
DR   Wikidata; Q54927586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16716
AC   CVCL_IK43
DR   Coriell; ND16716
DR   Wikidata; Q54927587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16719
AC   CVCL_CR20
DR   Coriell; ND16719
DR   Wikidata; Q54927588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16721
AC   CVCL_IH54
DR   Coriell; ND16721
DR   Wikidata; Q54927589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND16722
AC   CVCL_CR21
DR   Coriell; ND16722
DR   Wikidata; Q54927590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16725
AC   CVCL_CR22
DR   Coriell; ND16725
DR   Wikidata; Q54927591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND16726
AC   CVCL_CR23
DR   Coriell; ND16726
DR   Wikidata; Q54927592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19179
AC   CVCL_ED09
DR   Coriell; ND19179
DR   Wikidata; Q54927593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19180
AC   CVCL_FC02
DR   Coriell; ND19180
DR   Wikidata; Q54927594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50781; Transient ischemic attack
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19183
AC   CVCL_IF49
DR   Coriell; ND19183
DR   Wikidata; Q54927595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19184
AC   CVCL_CR24
DR   Coriell; ND19184
DR   Wikidata; Q54927596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19186
AC   CVCL_CR25
DR   Coriell; ND19186
DR   Wikidata; Q54927597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19187
AC   CVCL_HW23
DR   Coriell; ND19187
DR   Wikidata; Q54927598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19188
AC   CVCL_FZ73
DR   Coriell; ND19188
DR   Wikidata; Q54927599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19190
AC   CVCL_CR26
DR   BioSample; SAMN00798790
DR   Coriell; ND19190
DR   Wikidata; Q54927600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19191
AC   CVCL_GM64
DR   BioSample; SAMN00798792
DR   Coriell; ND19191
DR   Wikidata; Q54927601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19195
AC   CVCL_GM65
DR   BioSample; SAMN00798794
DR   Coriell; ND19195
DR   Wikidata; Q54927602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19196
AC   CVCL_IF50
DR   Coriell; ND19196
DR   Wikidata; Q54927603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19197
AC   CVCL_IF51
DR   Coriell; ND19197
DR   Wikidata; Q54927604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19198
AC   CVCL_EH73
DR   Coriell; ND19198
DR   Wikidata; Q54927605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19199
AC   CVCL_GM66
DR   BioSample; SAMN00798802
DR   Coriell; ND19199
DR   Wikidata; Q54927606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19200
AC   CVCL_GM67
DR   Coriell; ND19200
DR   Wikidata; Q54927607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19202
AC   CVCL_CR27
DR   Coriell; ND19202
DR   Wikidata; Q54927608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19207
AC   CVCL_ED10
DR   Coriell; ND19207
DR   Wikidata; Q54927609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19214
AC   CVCL_CR28
DR   BioSample; SAMN00798808
DR   Coriell; ND19214
DR   Wikidata; Q54927610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19217
AC   CVCL_GM68
DR   BioSample; SAMN00798810
DR   Coriell; ND19217
DR   Wikidata; Q54927611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19218
AC   CVCL_EH74
DR   Coriell; ND19218
DR   Wikidata; Q54927612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19226
AC   CVCL_CR29
DR   Coriell; ND19226
DR   Wikidata; Q54927613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19237
AC   CVCL_ED11
DR   Coriell; ND19237
DR   Wikidata; Q54927614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19238
AC   CVCL_ED12
DR   Coriell; ND19238
DR   Wikidata; Q54927615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19240
AC   CVCL_ED13
DR   Coriell; ND19240
DR   Wikidata; Q54927616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19248
AC   CVCL_CR30
DR   BioSample; SAMN00798822
DR   Coriell; ND19248
DR   Wikidata; Q54927617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19249
AC   CVCL_CR31
DR   Coriell; ND19249
DR   Wikidata; Q54927622
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND19251
AC   CVCL_ED14
DR   Coriell; ND19251
DR   Wikidata; Q54927623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19254
AC   CVCL_CR32
DR   Coriell; ND19254
DR   Wikidata; Q54927624
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19256
AC   CVCL_FE66
DR   Coriell; ND19256
DR   Wikidata; Q54927625
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19259
AC   CVCL_GM69
DR   Coriell; ND19259
DR   Wikidata; Q54927626
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19260
AC   CVCL_EH03
DR   Coriell; ND19260
DR   Wikidata; Q54927627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19261
AC   CVCL_CR33
DR   Coriell; ND19261
DR   Wikidata; Q54927628
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19263
AC   CVCL_FE67
DR   BioSample; SAMN00798826
DR   Coriell; ND19263
DR   Wikidata; Q54927630
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19266
AC   CVCL_HW24
DR   Coriell; ND19266
DR   Wikidata; Q54927631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19269
AC   CVCL_CR34
DR   Coriell; ND19269
DR   Wikidata; Q54927632
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19270
AC   CVCL_CR35
DR   Coriell; ND19270
DR   Wikidata; Q54927633
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19271
AC   CVCL_CR36
DR   Coriell; ND19271
DR   Wikidata; Q54927634
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19273
AC   CVCL_CR37
DR   Coriell; ND19273
DR   Wikidata; Q54927635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19276
AC   CVCL_IK44
DR   CLO; CLO_0017729
DR   Coriell; ND19276
DR   Wikidata; Q54927636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19277
AC   CVCL_CR38
DR   Coriell; ND19277
DR   Wikidata; Q54927637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19278
AC   CVCL_CR39
DR   Coriell; ND19278
DR   Wikidata; Q54927638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19283
AC   CVCL_ED15
DR   Coriell; ND19283
DR   Wikidata; Q54927639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19285
AC   CVCL_ED16
DR   Coriell; ND19285
DR   Wikidata; Q54927640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19303
AC   CVCL_FL80
DR   Coriell; ND19303
DR   Wikidata; Q54927641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19304
AC   CVCL_CR40
DR   Coriell; ND19304
DR   Wikidata; Q54927642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19309
AC   CVCL_GM70
DR   Coriell; ND19309
DR   Wikidata; Q54927643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19325
AC   CVCL_CR41
DR   Coriell; ND19325
DR   Wikidata; Q54927644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19326
AC   CVCL_CR42
DR   Coriell; ND19326
DR   Wikidata; Q54927645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19327
AC   CVCL_CR43
DR   Coriell; ND19327
DR   Wikidata; Q54927646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19330
AC   CVCL_ED17
DR   Coriell; ND19330
DR   Wikidata; Q54927647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19331
AC   CVCL_ED18
DR   Coriell; ND19331
DR   Wikidata; Q54927648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19335
AC   CVCL_CR44
DR   Coriell; ND19335
DR   Wikidata; Q54927649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19336
AC   CVCL_CR45
DR   Coriell; ND19336
DR   Wikidata; Q54927650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19342
AC   CVCL_EH75
DR   Coriell; ND19342
DR   Wikidata; Q54927651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19347
AC   CVCL_EH76
DR   Coriell; ND19347
DR   Wikidata; Q54927652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19348
AC   CVCL_IF52
DR   Coriell; ND19348
DR   Wikidata; Q54927653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19351
AC   CVCL_CR46
DR   BioSample; SAMN00798842
DR   Coriell; ND19351
DR   Wikidata; Q54927654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19354
AC   CVCL_EH77
DR   Coriell; ND19354
DR   Wikidata; Q54927655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19355
AC   CVCL_GM71
DR   BioSample; SAMN00798846
DR   Coriell; ND19355
DR   Wikidata; Q54927656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19356
AC   CVCL_GM72
DR   Coriell; ND19356
DR   Wikidata; Q54927657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19368
AC   CVCL_CR47
DR   Coriell; ND19368
DR   Wikidata; Q54927658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19369
AC   CVCL_CR48
DR   Coriell; ND19369
DR   Wikidata; Q54927659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19371
AC   CVCL_CR49
DR   Coriell; ND19371
DR   Wikidata; Q54927660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19372
AC   CVCL_CR50
DR   Coriell; ND19372
DR   Wikidata; Q54927661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19373
AC   CVCL_IF53
DR   Coriell; ND19373
DR   Wikidata; Q54927662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19388
AC   CVCL_EH78
DR   Coriell; ND19388
DR   Wikidata; Q54927665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19389
AC   CVCL_GM73
DR   BioSample; SAMN00798864
DR   Coriell; ND19389
DR   Wikidata; Q54927666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19392
AC   CVCL_CR51
DR   Coriell; ND19392
DR   Wikidata; Q54927667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19393
AC   CVCL_EH79
DR   Coriell; ND19393
DR   Wikidata; Q54927668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19394
AC   CVCL_GM74
DR   BioSample; SAMN00798868
DR   Coriell; ND19394
DR   Wikidata; Q54927669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19403
AC   CVCL_CR52
DR   Coriell; ND19403
DR   Wikidata; Q54927670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19404
AC   CVCL_IF54
DR   Coriell; ND19404
DR   Wikidata; Q54927671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19409
AC   CVCL_ED19
DR   Coriell; ND19409
DR   Wikidata; Q54927672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19424
AC   CVCL_ED20
DR   Coriell; ND19424
DR   Wikidata; Q54927673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19426
AC   CVCL_CR53
DR   Coriell; ND19426
DR   Wikidata; Q54927674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19438
AC   CVCL_CR54
DR   Coriell; ND19438
DR   Wikidata; Q54927675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19439
AC   CVCL_CR55
DR   Coriell; ND19439
DR   Wikidata; Q54927676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19440
AC   CVCL_CR56
DR   Coriell; ND19440
DR   Wikidata; Q54927677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19446
AC   CVCL_IF55
DR   Coriell; ND19446
DR   Wikidata; Q54927678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19449
AC   CVCL_EH80
DR   Coriell; ND19449
DR   Wikidata; Q54927679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19454
AC   CVCL_BS70
DR   Coriell; ND19454
DR   Wikidata; Q54927680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND19465
AC   CVCL_CR57
DR   Coriell; ND19465
DR   Wikidata; Q54927681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19471
AC   CVCL_CR58
DR   BioSample; SAMN00798910
DR   Coriell; ND19471
DR   Wikidata; Q54927682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19472
AC   CVCL_IF56
DR   Coriell; ND19472
DR   Wikidata; Q54927683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19473
AC   CVCL_IF57
DR   Coriell; ND19473
DR   Wikidata; Q54927684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19474
AC   CVCL_IF58
DR   Coriell; ND19474
DR   Wikidata; Q54927685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19475
AC   CVCL_IF59
DR   Coriell; ND19475
DR   Wikidata; Q54927686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19476
AC   CVCL_CR59
DR   BioSample; SAMN00798920
DR   Coriell; ND19476
DR   Wikidata; Q54927687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19477
AC   CVCL_IF60
DR   Coriell; ND19477
DR   Wikidata; Q54927689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19488
AC   CVCL_ED21
DR   Coriell; ND19488
DR   Wikidata; Q54927690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19489
AC   CVCL_ED22
DR   Coriell; ND19489
DR   Wikidata; Q54927692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19491
AC   CVCL_ED23
DR   Coriell; ND19491
DR   Wikidata; Q54927693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19493
AC   CVCL_GM75
DR   Coriell; ND19493
DR   Wikidata; Q54927694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19509
AC   CVCL_CR60
DR   Coriell; ND19509
DR   Wikidata; Q54927695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19510
AC   CVCL_EH81
DR   Coriell; ND19510
DR   Wikidata; Q54927696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19512
AC   CVCL_CR61
DR   Coriell; ND19512
DR   Wikidata; Q54927697
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19523
AC   CVCL_CR62
DR   Coriell; ND19523
DR   Wikidata; Q54927698
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19525
AC   CVCL_CR63
DR   Coriell; ND19525
DR   Wikidata; Q54927699
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19530
AC   CVCL_CR64
DR   BioSample; SAMN00798938
DR   Coriell; ND19530
DR   Wikidata; Q54927700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19531
AC   CVCL_ED24
DR   Coriell; ND19531
DR   Wikidata; Q54927702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19534
AC   CVCL_CR65
DR   Coriell; ND19534
DR   Wikidata; Q54927703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19535
AC   CVCL_ED25
DR   Coriell; ND19535
DR   Wikidata; Q54927704
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND19547
AC   CVCL_CR66
DR   Coriell; ND19547
DR   Wikidata; Q54927705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19548
AC   CVCL_CR67
DR   Coriell; ND19548
DR   Wikidata; Q54927706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19556
AC   CVCL_CR68
DR   Coriell; ND19556
DR   Wikidata; Q54927707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19558
AC   CVCL_CR69
DR   Coriell; ND19558
DR   Wikidata; Q54927713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19566
AC   CVCL_CR70
DR   Coriell; ND19566
DR   Wikidata; Q54927714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19574
AC   CVCL_CR71
DR   Coriell; ND19574
DR   Wikidata; Q54927715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19576
AC   CVCL_GM76
DR   Coriell; ND19576
DR   Wikidata; Q54927716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19577
AC   CVCL_GM77
DR   Coriell; ND19577
DR   Wikidata; Q54927717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19584
AC   CVCL_GM78
DR   BioSample; SAMN00798954
DR   Coriell; ND19584
DR   Wikidata; Q54927718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19586
AC   CVCL_CR72
DR   Coriell; ND19586
DR   Wikidata; Q54927719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19594
AC   CVCL_CR73
DR   Coriell; ND19594
DR   Wikidata; Q54927720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19596
AC   CVCL_CR74
DR   BioSample; SAMN00798966
DR   Coriell; ND19596
DR   Wikidata; Q54927721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19602
AC   CVCL_ED26
DR   Coriell; ND19602
DR   Wikidata; Q54927722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19618
AC   CVCL_CR75
DR   Coriell; ND19618
DR   Wikidata; Q54927723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19619
AC   CVCL_CR76
DR   Coriell; ND19619
DR   Wikidata; Q54927724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19620
AC   CVCL_CR77
DR   Coriell; ND19620
DR   Wikidata; Q54927725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19625
AC   CVCL_CR78
DR   Coriell; ND19625
DR   Wikidata; Q54927726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19633
AC   CVCL_CR79
DR   BioSample; SAMN00798982
DR   Coriell; ND19633
DR   Wikidata; Q54927727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19705
AC   CVCL_CR80
DR   BioSample; SAMN00798990
DR   Coriell; ND19705
DR   Wikidata; Q54927728
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19707
AC   CVCL_CR81
DR   BioSample; SAMN00798992
DR   Coriell; ND19707
DR   Wikidata; Q54927729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19715
AC   CVCL_CR82
DR   BioSample; SAMN00798994
DR   Coriell; ND19715
DR   Wikidata; Q54927730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19719
AC   CVCL_CR83
DR   BioSample; SAMN00798996
DR   Coriell; ND19719
DR   Wikidata; Q54927731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19731
AC   CVCL_FF53
DR   Coriell; ND19731
DR   Wikidata; Q54927732
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19734
AC   CVCL_GM79
DR   Coriell; ND19734
DR   Wikidata; Q54927733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19735
AC   CVCL_GM80
DR   Coriell; ND19735
DR   Wikidata; Q54927734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19738
AC   CVCL_ED27
DR   Coriell; ND19738
DR   Wikidata; Q54927735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19739
AC   CVCL_IG84
DR   Coriell; ND19739
DR   Wikidata; Q54927736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3390; Cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19740
AC   CVCL_ED28
DR   Coriell; ND19740
DR   Wikidata; Q54927737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19742
AC   CVCL_ED29
DR   Coriell; ND19742
DR   Wikidata; Q54927738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19746
AC   CVCL_CR84
DR   Coriell; ND19746
DR   Wikidata; Q54927739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19755
AC   CVCL_GM81
DR   Coriell; ND19755
DR   Wikidata; Q54927740
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND19761
AC   CVCL_GM82
DR   Coriell; ND19761
DR   Wikidata; Q54927741
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19762
AC   CVCL_CR85
DR   Coriell; ND19762
DR   Wikidata; Q54927742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19766
AC   CVCL_IF61
DR   Coriell; ND19766
DR   Wikidata; Q54927743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19767
AC   CVCL_EH82
DR   Coriell; ND19767
DR   Wikidata; Q54927744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19777
AC   CVCL_CR86
DR   Coriell; ND19777
DR   Wikidata; Q54927745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19784
AC   CVCL_IK45
DR   Coriell; ND19784
DR   Wikidata; Q54927746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19792
AC   CVCL_ED30
DR   Coriell; ND19792
DR   Wikidata; Q54927747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19794
AC   CVCL_ED31
DR   Coriell; ND19794
DR   Wikidata; Q54927748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19797
AC   CVCL_ED32
DR   Coriell; ND19797
DR   Wikidata; Q54927749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19802
AC   CVCL_CR87
DR   Coriell; ND19802
DR   Wikidata; Q54927750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19805
AC   CVCL_CR88
DR   Coriell; ND19805
DR   Wikidata; Q54927751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19819
AC   CVCL_CR89
DR   Coriell; ND19819
DR   Wikidata; Q54927753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19823
AC   CVCL_CR90
DR   Coriell; ND19823
DR   Wikidata; Q54927762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19825
AC   CVCL_CR91
DR   Coriell; ND19825
DR   Wikidata; Q54927763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19834
AC   CVCL_CR92
DR   Coriell; ND19834
DR   Wikidata; Q54927764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19846
AC   CVCL_GM83
DR   Coriell; ND19846
DR   Wikidata; Q54927766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19847
AC   CVCL_CR93
DR   Coriell; ND19847
DR   Wikidata; Q54927767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19848
AC   CVCL_ED33
DR   Coriell; ND19848
DR   Wikidata; Q54927768
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND19850
AC   CVCL_EH83
DR   Coriell; ND19850
DR   Wikidata; Q54927769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19851
AC   CVCL_GM84
DR   BioSample; SAMN00799044
DR   Coriell; ND19851
DR   Wikidata; Q54927770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19852
AC   CVCL_GM85
DR   Coriell; ND19852
DR   Wikidata; Q54927771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19860
AC   CVCL_CR94
DR   BioSample; SAMN00799046
DR   Coriell; ND19860
DR   Wikidata; Q54927772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19861
AC   CVCL_IH55
DR   Coriell; ND19861
DR   Wikidata; Q54927773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19868
AC   CVCL_GM86
DR   Coriell; ND19868
DR   Wikidata; Q54927774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19871
AC   CVCL_CR95
DR   Coriell; ND19871
DR   Wikidata; Q54927775
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19873
AC   CVCL_CR96
DR   Coriell; ND19873
DR   Wikidata; Q54927776
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19899
AC   CVCL_CR97
DR   Coriell; ND19899
DR   Wikidata; Q54927777
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19908
AC   CVCL_FE68
DR   Coriell; ND19908
DR   Wikidata; Q54927778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19909
AC   CVCL_FE69
DR   Coriell; ND19909
DR   Wikidata; Q54927779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19913
AC   CVCL_EH84
DR   Coriell; ND19913
DR   Wikidata; Q54927780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19919
AC   CVCL_ED34
DR   Coriell; ND19919
DR   Wikidata; Q54927781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19922
AC   CVCL_ED35
DR   Coriell; ND19922
DR   Wikidata; Q54927782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19924
AC   CVCL_EH85
DR   Coriell; ND19924
DR   Wikidata; Q54927784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19925
AC   CVCL_GM87
DR   BioSample; SAMN00799070
DR   Coriell; ND19925
DR   Wikidata; Q54927785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19926
AC   CVCL_IF62
DR   Coriell; ND19926
DR   Wikidata; Q54927786
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19927
AC   CVCL_CR98
DR   BioSample; SAMN00799072
DR   Coriell; ND19927
DR   Wikidata; Q54927787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND19934
AC   CVCL_CR99
DR   Coriell; ND19934
DR   Wikidata; Q54927788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19935
AC   CVCL_GM88
DR   Coriell; ND19935
DR   Wikidata; Q54927790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19937
AC   CVCL_CS00
DR   Coriell; ND19937
DR   Wikidata; Q54927791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19940
AC   CVCL_CS01
DR   Coriell; ND19940
DR   Wikidata; Q54927792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19944
AC   CVCL_CS02
DR   Coriell; ND19944
DR   Wikidata; Q54927793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19945
AC   CVCL_IF63
DR   Coriell; ND19945
DR   Wikidata; Q54927794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND19946
AC   CVCL_FL81
DR   Coriell; ND19946
DR   Wikidata; Q54927795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19957
AC   CVCL_CS03
DR   Coriell; ND19957
DR   Wikidata; Q54927796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19958
AC   CVCL_CS04
DR   Coriell; ND19958
DR   Wikidata; Q54927797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19961
AC   CVCL_CS05
DR   Coriell; ND19961
DR   Wikidata; Q54927798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19966
AC   CVCL_CS06
DR   Coriell; ND19966
DR   Wikidata; Q54927799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND19972
AC   CVCL_FL82
DR   Coriell; ND19972
DR   Wikidata; Q54927800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND19978
AC   CVCL_EH86
DR   Coriell; ND19978
DR   Wikidata; Q54927801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19979
AC   CVCL_GM89
DR   BioSample; SAMN00799088
DR   Coriell; ND19979
DR   Wikidata; Q54927803
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND19981
AC   CVCL_ED36
DR   Coriell; ND19981
DR   Wikidata; Q54927804
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19982
AC   CVCL_ED37
DR   Coriell; ND19982
DR   Wikidata; Q54927805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19985
AC   CVCL_ED38
DR   Coriell; ND19985
DR   Wikidata; Q54927811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19987
AC   CVCL_ED39
DR   Coriell; ND19987
DR   Wikidata; Q54927812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND19993
AC   CVCL_CS07
DR   BioSample; SAMN00799090
DR   Coriell; ND19993
DR   Wikidata; Q54927813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND2.0
AC   CVCL_1E78
SY   mND2-0; ND50019; NHLBIi003-A
DR   BioSamples; SAMEA8230932
DR   hPSCreg; NHLBIi003-A
DR   NHCDR; ND50019
DR   SKIP; SKIP003117
DR   Wikidata; Q54927814
RX   PubMed=31869686;
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2337 ! CCD-1079Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   ND20
AC   CVCL_VK91
SY   Neuroblastoma X DRG neurons hybrid 20
DR   Wikidata; Q98127449
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND20003
AC   CVCL_GM90
DR   Coriell; ND20003
DR   Wikidata; Q54927815
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20013
AC   CVCL_CS08
DR   BioSample; SAMN00799497
DR   Coriell; ND20013
DR   Wikidata; Q54927816
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND20014
AC   CVCL_CS09
DR   BioSample; SAMN00799499
DR   Coriell; ND20014
DR   Wikidata; Q54927817
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND20018
AC   CVCL_CS10
DR   Coriell; ND20018
DR   Wikidata; Q54927818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20022
AC   CVCL_CS11
DR   BioSample; SAMN00799501
DR   Coriell; ND20022
DR   Wikidata; Q54927819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20030
AC   CVCL_ED40
DR   Coriell; ND20030
DR   Wikidata; Q54927820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20031
AC   CVCL_ED41
DR   Coriell; ND20031
DR   Wikidata; Q54927821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20032
AC   CVCL_ED42
DR   Coriell; ND20032
DR   Wikidata; Q54927822
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND20033
AC   CVCL_ED43
DR   Coriell; ND20033
DR   Wikidata; Q54927823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20034
AC   CVCL_CS12
DR   Coriell; ND20034
DR   Wikidata; Q54927824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20037
AC   CVCL_IH56
DR   Coriell; ND20037
DR   Wikidata; Q54927825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20041
AC   CVCL_IF64
DR   Coriell; ND20041
DR   Wikidata; Q54927826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20043
AC   CVCL_FF54
DR   Coriell; ND20043
DR   Wikidata; Q54927827
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20044
AC   CVCL_CS13
DR   Coriell; ND20044
DR   Wikidata; Q54927828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20045
AC   CVCL_FU23
DR   Coriell; ND20045
DR   Wikidata; Q54927829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20049
AC   CVCL_CS14
DR   BioSample; SAMN00799507
DR   Coriell; ND20049
DR   Wikidata; Q54927830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20055
AC   CVCL_LL47
DR   Coriell; ND20055
DR   Wikidata; Q54927831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND20061
AC   CVCL_CS15
DR   Coriell; ND20061
DR   Wikidata; Q54927832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20069
AC   CVCL_EH87
DR   Coriell; ND20069
DR   Wikidata; Q54927833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20070
AC   CVCL_IF65
DR   Coriell; ND20070
DR   Wikidata; Q54927834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20071
AC   CVCL_IG85
DR   Coriell; ND20071
DR   Wikidata; Q54927835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3390; Cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20080
AC   CVCL_FF55
DR   BioSample; SAMN00799529
DR   Coriell; ND20080
DR   Wikidata; Q54927836
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND20082
AC   CVCL_EH88
DR   Coriell; ND20082
DR   Wikidata; Q54927837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20088
AC   CVCL_CS16
DR   BioSample; SAMN00799535
DR   Coriell; ND20088
DR   Wikidata; Q54927838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20089
AC   CVCL_IF66
DR   Coriell; ND20089
DR   Wikidata; Q54927839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20090
AC   CVCL_IF67
DR   Coriell; ND20090
DR   Wikidata; Q54927840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20091
AC   CVCL_GM91
DR   BioSample; SAMN00799541
DR   Coriell; ND20091
DR   Wikidata; Q54927841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20093
AC   CVCL_CS17
DR   Coriell; ND20093
DR   Wikidata; Q54927842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20119
AC   CVCL_FE70
DR   BioSample; SAMN00799558
DR   Coriell; ND20119
DR   Wikidata; Q54927843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20120
AC   CVCL_LL48
DR   Coriell; ND20120
DR   Wikidata; Q54927844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND20121
AC   CVCL_CY01
DR   CLO; CLO_0017728
DR   Coriell; ND20121
DR   Wikidata; Q54927845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20122
AC   CVCL_CS18
DR   Coriell; ND20122
DR   Wikidata; Q54927846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20125
AC   CVCL_CS19
DR   Coriell; ND20125
DR   Wikidata; Q54927848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20127
AC   CVCL_CS20
DR   Coriell; ND20127
DR   Wikidata; Q54927849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20132
AC   CVCL_CS21
DR   BioSample; SAMN00799570
DR   Coriell; ND20132
DR   Wikidata; Q54927850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20133
AC   CVCL_IF68
DR   Coriell; ND20133
DR   Wikidata; Q54927851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20135
AC   CVCL_IF69
DR   Coriell; ND20135
DR   Wikidata; Q54927860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20136
AC   CVCL_GM93
DR   BioSample; SAMN00799578
DR   Coriell; ND20136
DR   Wikidata; Q54927861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20144
AC   CVCL_CS22
DR   Coriell; ND20144
DR   Wikidata; Q54927862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20145
AC   CVCL_ED44
DR   Coriell; ND20145
DR   Wikidata; Q54927864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20146
AC   CVCL_ED45
DR   Coriell; ND20146
DR   Wikidata; Q54927865
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND20155
AC   CVCL_CS23
DR   BioSample; SAMN00799580
DR   Coriell; ND20155
DR   Wikidata; Q54927866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20156
AC   CVCL_GM94
DR   Coriell; ND20156
DR   Wikidata; Q54927867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20157
AC   CVCL_IF70
DR   Coriell; ND20157
DR   Wikidata; Q54927868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20159
AC   CVCL_CS24
DR   Coriell; ND20159
DR   Wikidata; Q54927869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20161
AC   CVCL_GM95
DR   BioSample; SAMN00799584
DR   Coriell; ND20161
DR   Wikidata; Q54927870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20180
AC   CVCL_CS25
DR   Coriell; ND20180
DR   Wikidata; Q54927871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20182
AC   CVCL_CS26
DR   Coriell; ND20182
DR   Wikidata; Q54927872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20194
AC   CVCL_ED46
DR   Coriell; ND20194
DR   Wikidata; Q54927873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20197
AC   CVCL_ED47
DR   Coriell; ND20197
DR   Wikidata; Q54927874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20199
AC   CVCL_ED48
DR   Coriell; ND20199
DR   Wikidata; Q54927875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20200
AC   CVCL_CS27
DR   BioSample; SAMN00799602
DR   Coriell; ND20200
DR   Wikidata; Q54927876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20205
AC   CVCL_CS28
DR   Coriell; ND20205
DR   Wikidata; Q54927878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20210
AC   CVCL_CS29
DR   Coriell; ND20210
DR   Wikidata; Q54927879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20211
AC   CVCL_CS30
DR   BioSample; SAMN00799610
DR   Coriell; ND20211
DR   Wikidata; Q54927880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20219
AC   CVCL_GM96
DR   Coriell; ND20219
DR   Wikidata; Q54927881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20227
AC   CVCL_CS31
DR   Coriell; ND20227
DR   Wikidata; Q54927882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20237
AC   CVCL_EH89
DR   Coriell; ND20237
DR   Wikidata; Q54927883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20238
AC   CVCL_GM97
DR   BioSample; SAMN00799630
DR   Coriell; ND20238
DR   Wikidata; Q54927884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20245
AC   CVCL_ED49
DR   Coriell; ND20245
DR   Wikidata; Q54927885
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20248
AC   CVCL_CS32
DR   Coriell; ND20248
DR   Wikidata; Q54927886
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20256
AC   CVCL_IF71
DR   Coriell; ND20256
DR   Wikidata; Q54927887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20257
AC   CVCL_IF72
DR   Coriell; ND20257
DR   Wikidata; Q54927888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20258
AC   CVCL_IF73
DR   Coriell; ND20258
DR   Wikidata; Q54927889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20259
AC   CVCL_ED50
DR   Coriell; ND20259
DR   Wikidata; Q54927890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20271
AC   CVCL_CS33
DR   Coriell; ND20271
DR   Wikidata; Q54927891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20272
AC   CVCL_IG87
DR   Coriell; ND20272
DR   Wikidata; Q54927893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20274
AC   CVCL_GM98
DR   Coriell; ND20274
DR   Wikidata; Q54927895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20275
AC   CVCL_GM99
DR   Coriell; ND20275
DR   Wikidata; Q54927896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20277
AC   CVCL_IM12
DR   CLO; CLO_0017727
DR   Coriell; ND20277
DR   Wikidata; Q54927897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND20277; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129933; Primary lateral sclerosis
DI   ORDO; Orphanet_35689; Primary lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   ND20279
AC   CVCL_ED51
DR   Coriell; ND20279
DR   Wikidata; Q54927898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20288
AC   CVCL_FF56
DR   Coriell; ND20288
DR   Wikidata; Q54927899
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20293
AC   CVCL_GN00
DR   Coriell; ND20293
DR   Wikidata; Q54927900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20296
AC   CVCL_ED52
DR   Coriell; ND20296
DR   Wikidata; Q54927901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20297
AC   CVCL_CS34
DR   Coriell; ND20297
DR   Wikidata; Q54927902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20298
AC   CVCL_CS35
DR   Coriell; ND20298
DR   Wikidata; Q54927903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20304
AC   CVCL_GN01
DR   BioSample; SAMN00799652
DR   Coriell; ND20304
DR   Wikidata; Q54927911
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20305
AC   CVCL_CS36
DR   Coriell; ND20305
DR   Wikidata; Q54927912
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20306
AC   CVCL_CS37
DR   Coriell; ND20306
DR   Wikidata; Q54927913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20307
AC   CVCL_CS38
DR   Coriell; ND20307
DR   Wikidata; Q54927914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20315
AC   CVCL_CS39
DR   Coriell; ND20315
DR   Wikidata; Q54927915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20321
AC   CVCL_CS40
DR   Coriell; ND20321
DR   Wikidata; Q54927916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20322
AC   CVCL_CS41
DR   Coriell; ND20322
DR   Wikidata; Q54927917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20323
AC   CVCL_CS42
DR   Coriell; ND20323
DR   Wikidata; Q54927918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20325
AC   CVCL_IH57
DR   Coriell; ND20325
DR   Wikidata; Q54927919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20331
AC   CVCL_CS43
DR   BioSample; SAMN00799666
DR   Coriell; ND20331
DR   Wikidata; Q54927920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20332
AC   CVCL_GN02
DR   BioSample; SAMN00799668
DR   Coriell; ND20332
DR   Wikidata; Q54927921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20333
AC   CVCL_CS44
DR   Coriell; ND20333
DR   Wikidata; Q54927922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20334
AC   CVCL_GN03
DR   Coriell; ND20334
DR   Wikidata; Q54927923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20335
AC   CVCL_CS45
DR   BioSample; SAMN00799670
DR   Coriell; ND20335
DR   Wikidata; Q54927924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20336
AC   CVCL_CS46
DR   Coriell; ND20336
DR   Wikidata; Q54927925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20339
AC   CVCL_CS47
DR   Coriell; ND20339
DR   Wikidata; Q54927926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20344
AC   CVCL_ED53
DR   Coriell; ND20344
DR   Wikidata; Q54927927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20349
AC   CVCL_GN04
DR   BioSample; SAMN00799678
DR   Coriell; ND20349
DR   Wikidata; Q54927928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20355
AC   CVCL_CS48
SY   ND00043
DR   CLO; CLO_0029740
DR   Coriell; ND00043
DR   Coriell; ND20355
DR   Wikidata; Q54927929
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND00043; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   ND20358
AC   CVCL_GN05
DR   Coriell; ND20358
DR   Wikidata; Q54927930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20364
AC   CVCL_CS49
DR   Coriell; ND20364
DR   Wikidata; Q54927931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20365
AC   CVCL_CS50
DR   Coriell; ND20365
DR   Wikidata; Q54927932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20366
AC   CVCL_CS51
DR   Coriell; ND20366
DR   Wikidata; Q54927933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20368
AC   CVCL_CS52
DR   Coriell; ND20368
DR   Wikidata; Q54927934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20369
AC   CVCL_CS53
DR   Coriell; ND20369
DR   Wikidata; Q54927935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20374
AC   CVCL_CS54
DR   Coriell; ND20374
DR   Wikidata; Q54927936
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20381
AC   CVCL_IF74
DR   Coriell; ND20381
DR   Wikidata; Q54927937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20393
AC   CVCL_CS55
DR   Coriell; ND20393
DR   Wikidata; Q54927938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20394
AC   CVCL_ED54
DR   Coriell; ND20394
DR   Wikidata; Q54927939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20395
AC   CVCL_ED55
DR   Coriell; ND20395
DR   Wikidata; Q54927940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20397
AC   CVCL_ED56
DR   Coriell; ND20397
DR   Wikidata; Q54927941
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20398
AC   CVCL_ED57
DR   Coriell; ND20398
DR   Wikidata; Q54927942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20399
AC   CVCL_ED58
DR   Coriell; ND20399
DR   Wikidata; Q54927943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20412
AC   CVCL_CS56
DR   Coriell; ND20412
DR   Wikidata; Q54927944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20417
AC   CVCL_ED59
DR   Coriell; ND20417
DR   Wikidata; Q54927945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20419
AC   CVCL_FE71
DR   Coriell; ND20419
DR   Wikidata; Q54927946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20420
AC   CVCL_GN06
DR   Coriell; ND20420
DR   Wikidata; Q54927947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20423
AC   CVCL_FE72
DR   Coriell; ND20423
DR   Wikidata; Q54927948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20425
AC   CVCL_ED60
DR   Coriell; ND20425
DR   Wikidata; Q54927949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20431
AC   CVCL_FE73
DR   Coriell; ND20431
DR   Wikidata; Q54927950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20433
AC   CVCL_GN07
DR   Coriell; ND20433
DR   Wikidata; Q54927956
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20434
AC   CVCL_FE74
DR   Coriell; ND20434
DR   Wikidata; Q54927957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20437
AC   CVCL_LL49
DR   Coriell; ND20437
DR   Wikidata; Q54927958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND20440
AC   CVCL_ED61
DR   Coriell; ND20440
DR   Wikidata; Q54927960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20442
AC   CVCL_CS57
DR   Coriell; ND20442
DR   Wikidata; Q54927962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20443
AC   CVCL_CS58
DR   Coriell; ND20443
DR   Wikidata; Q54927963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20444
AC   CVCL_CS59
DR   Coriell; ND20444
DR   Wikidata; Q54927964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20465
AC   CVCL_CS60
DR   Coriell; ND20465
DR   Wikidata; Q54927965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20470
AC   CVCL_CS61
DR   Coriell; ND20470
DR   Wikidata; Q54927966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20473
AC   CVCL_FE75
DR   Coriell; ND20473
DR   Wikidata; Q54927968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20474
AC   CVCL_FE76
DR   Coriell; ND20474
DR   Wikidata; Q54927969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20475
AC   CVCL_CS62
DR   Coriell; ND20475
DR   Wikidata; Q54927970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND20475; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20477
AC   CVCL_CS63
DR   Coriell; ND20477
DR   Wikidata; Q54927971
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20478
AC   CVCL_CS64
DR   Coriell; ND20478
DR   Wikidata; Q54927972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20483
AC   CVCL_ED62
DR   Coriell; ND20483
DR   Wikidata; Q54927973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20485
AC   CVCL_GN08
DR   Coriell; ND20485
DR   Wikidata; Q54927974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20493
AC   CVCL_CS65
DR   Coriell; ND20493
DR   Wikidata; Q54927976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20496
AC   CVCL_CS66
DR   BioSample; SAMN00799714
DR   Coriell; ND20496
DR   Wikidata; Q54927977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20497
AC   CVCL_IF75
DR   Coriell; ND20497
DR   Wikidata; Q54927978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20499
AC   CVCL_FU24
DR   Coriell; ND20499
DR   Wikidata; Q54927979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20505
AC   CVCL_CS67
DR   Coriell; ND20505
DR   Wikidata; Q54927980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20511
AC   CVCL_CS68
DR   BioSample; SAMN00799724
DR   Coriell; ND20511
DR   Wikidata; Q54927981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20515
AC   CVCL_ED63
DR   Coriell; ND20515
DR   Wikidata; Q54927983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20516
AC   CVCL_ED64
DR   Coriell; ND20516
DR   Wikidata; Q54927984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20518
AC   CVCL_GN09
DR   BioSample; SAMN00799728
DR   Coriell; ND20518
DR   Wikidata; Q54927985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20519
AC   CVCL_CS69
DR   Coriell; ND20519
DR   Wikidata; Q54927986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20522
AC   CVCL_IJ45
DR   Coriell; ND20522
DR   Wikidata; Q54927987
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND20522).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T860 ! ND29509
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   ND20523
AC   CVCL_IF76
DR   Coriell; ND20523
DR   Wikidata; Q54927988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20527
AC   CVCL_FE77
DR   Coriell; ND20527
DR   Wikidata; Q54927989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20528
AC   CVCL_ED65
DR   Coriell; ND20528
DR   Wikidata; Q54927991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20531
AC   CVCL_FE78
DR   Coriell; ND20531
DR   Wikidata; Q54927992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20552
AC   CVCL_CS70
DR   BioSample; SAMN00799767
DR   Coriell; ND20552
DR   Wikidata; Q54927993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20553
AC   CVCL_IF77
DR   Coriell; ND20553
DR   Wikidata; Q54927994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20554
AC   CVCL_IF78
DR   Coriell; ND20554
DR   Wikidata; Q54927995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20556
AC   CVCL_IF79
DR   Coriell; ND20556
DR   Wikidata; Q54927996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20559
AC   CVCL_IF80
DR   Coriell; ND20559
DR   Wikidata; Q54927998
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20560
AC   CVCL_IF81
DR   Coriell; ND20560
DR   Wikidata; Q54927999
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20561
AC   CVCL_IF82
DR   Coriell; ND20561
DR   Wikidata; Q54928000
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20563
AC   CVCL_CS71
DR   Coriell; ND20563
DR   Wikidata; Q54928001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20570
AC   CVCL_CS72
DR   BioSample; SAMN00799787
DR   Coriell; ND20570
DR   Wikidata; Q54928002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20576
AC   CVCL_FU25
DR   Coriell; ND20576
DR   Wikidata; Q54928013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20577
AC   CVCL_CS73
DR   Coriell; ND20577
DR   Wikidata; Q54928014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20578
AC   CVCL_FL83
DR   Coriell; ND20578
DR   Wikidata; Q54928015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20579
AC   CVCL_CS74
DR   BioSample; SAMN00799796
DR   Coriell; ND20579
DR   Wikidata; Q54928017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20582
AC   CVCL_CS75
DR   Coriell; ND20582
DR   Wikidata; Q54928018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20583
AC   CVCL_CS76
DR   BioSample; SAMN00799799
DR   Coriell; ND20583
DR   Wikidata; Q54928019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20584
AC   CVCL_GN10
DR   BioSample; SAMN00799801
DR   Coriell; ND20584
DR   Wikidata; Q54928020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20585
AC   CVCL_GN11
DR   Coriell; ND20585
DR   Wikidata; Q54928021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20586
AC   CVCL_CS77
DR   Coriell; ND20586
DR   Wikidata; Q54928022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20593
AC   CVCL_IF83
DR   Coriell; ND20593
DR   Wikidata; Q54928023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20594
AC   CVCL_IF84
DR   Coriell; ND20594
DR   Wikidata; Q54928024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20598
AC   CVCL_CS78
DR   Coriell; ND20598
DR   Wikidata; Q54928025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20600
AC   CVCL_CS79
DR   Coriell; ND20600
DR   Wikidata; Q54928026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20627
AC   CVCL_ED66
DR   Coriell; ND20627
DR   Wikidata; Q54928027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20628
AC   CVCL_ED67
DR   Coriell; ND20628
DR   Wikidata; Q54928028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20635
AC   CVCL_CS80
DR   Coriell; ND20635
DR   Wikidata; Q54928029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20646
AC   CVCL_CS81
DR   Coriell; ND20646
DR   Wikidata; Q54928030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20647
AC   CVCL_CS82
DR   Coriell; ND20647
DR   Wikidata; Q54928031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20648
AC   CVCL_CS83
DR   Coriell; ND20648
DR   Wikidata; Q54928032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20650
AC   CVCL_CS84
DR   Coriell; ND20650
DR   Wikidata; Q54928034
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20659
AC   CVCL_CS85
DR   Coriell; ND20659
DR   Wikidata; Q54928035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20660
AC   CVCL_CS86
DR   Coriell; ND20660
DR   Wikidata; Q54928036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20665
AC   CVCL_ED68
DR   Coriell; ND20665
DR   Wikidata; Q54928037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20673
AC   CVCL_GN12
DR   Coriell; ND20673
DR   Wikidata; Q54928038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20677
AC   CVCL_GN13
DR   BioSample; SAMN00799873
DR   Coriell; ND20677
DR   Wikidata; Q54928039
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20683
AC   CVCL_ED69
DR   Coriell; ND20683
DR   Wikidata; Q54928040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20684
AC   CVCL_CS87
DR   Coriell; ND20684
DR   Wikidata; Q54928042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20688
AC   CVCL_FL84
DR   Coriell; ND20688
DR   Wikidata; Q54928043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20689
AC   CVCL_FL85
DR   Coriell; ND20689
DR   Wikidata; Q54928044
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20696
AC   CVCL_CS88
DR   Coriell; ND20696
DR   Wikidata; Q54928045
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20697
AC   CVCL_FE79
DR   Coriell; ND20697
DR   Wikidata; Q54928046
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20698
AC   CVCL_CS89
DR   Coriell; ND20698
DR   Wikidata; Q54928048
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20699
AC   CVCL_CS90
DR   Coriell; ND20699
DR   Wikidata; Q54928050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20709
AC   CVCL_CS91
DR   Coriell; ND20709
DR   Wikidata; Q54928051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20727
AC   CVCL_GN14
DR   BioSample; SAMN00799921
DR   Coriell; ND20727
DR   Wikidata; Q54928052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20729
AC   CVCL_CS92
DR   BioSample; SAMN00799923
DR   Coriell; ND20729
DR   Wikidata; Q54928053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20730
AC   CVCL_CS93
DR   Coriell; ND20730
DR   Wikidata; Q54928054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20731
AC   CVCL_ED70
DR   Coriell; ND20731
DR   Wikidata; Q54928055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20737
AC   CVCL_CS94
DR   Coriell; ND20737
DR   Wikidata; Q54928057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20738
AC   CVCL_CS95
DR   Coriell; ND20738
DR   Wikidata; Q54928058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20740
AC   CVCL_FL86
DR   Coriell; ND20740
DR   Wikidata; Q54928073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20749
AC   CVCL_ED71
DR   Coriell; ND20749
DR   Wikidata; Q54928074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20751
AC   CVCL_FE80
DR   Coriell; ND20751
DR   Wikidata; Q54928076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20752
AC   CVCL_CS96
DR   Coriell; ND20752
DR   Wikidata; Q54928077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20754
AC   CVCL_ED72
DR   Coriell; ND20754
DR   Wikidata; Q54928078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20756
AC   CVCL_GN15
DR   BioSample; SAMN00799931
DR   Coriell; ND20756
DR   Wikidata; Q54928079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20764
AC   CVCL_CS97
DR   Coriell; ND20764
DR   Wikidata; Q54928080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20765
AC   CVCL_CS98
DR   Coriell; ND20765
DR   Wikidata; Q54928081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20766
AC   CVCL_CS99
DR   Coriell; ND20766
DR   Wikidata; Q54928082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20769
AC   CVCL_ED73
DR   Coriell; ND20769
DR   Wikidata; Q54928083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20770
AC   CVCL_ED74
DR   Coriell; ND20770
DR   Wikidata; Q54928084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20775
AC   CVCL_CT00
DR   Coriell; ND20775
DR   Wikidata; Q54928085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20776
AC   CVCL_CT01
DR   Coriell; ND20776
DR   Wikidata; Q54928086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20778
AC   CVCL_ED75
DR   Coriell; ND20778
DR   Wikidata; Q54928087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20779
AC   CVCL_FL87
DR   Coriell; ND20779
DR   Wikidata; Q54928088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20784
AC   CVCL_CT02
DR   Coriell; ND20784
DR   Wikidata; Q54928089
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20786
AC   CVCL_EH90
DR   Coriell; ND20786
DR   Wikidata; Q54928090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20794
AC   CVCL_FL88
DR   Coriell; ND20794
DR   Wikidata; Q54928091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20795
AC   CVCL_CT03
DR   Coriell; ND20795
DR   Wikidata; Q54928092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20796
AC   CVCL_CT04
DR   Coriell; ND20796
DR   Wikidata; Q54928093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20801
AC   CVCL_CT05
DR   Coriell; ND20801
DR   Wikidata; Q54928094
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20802
AC   CVCL_CT06
DR   Coriell; ND20802
DR   Wikidata; Q54928095
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20803
AC   CVCL_CT07
DR   Coriell; ND20803
DR   Wikidata; Q54928096
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20805
AC   CVCL_CT08
DR   BioSample; SAMN00799970
DR   Coriell; ND20805
DR   Wikidata; Q54928097
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20811
AC   CVCL_CT09
DR   Coriell; ND20811
DR   Wikidata; Q54928098
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20812
AC   CVCL_ED76
DR   Coriell; ND20812
DR   Wikidata; Q54928099
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20813
AC   CVCL_ED77
DR   Coriell; ND20813
DR   Wikidata; Q54928100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20816
AC   CVCL_CT10
DR   Coriell; ND20816
DR   Wikidata; Q54928101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20818
AC   CVCL_FE81
DR   Coriell; ND20818
DR   Wikidata; Q54928102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20819
AC   CVCL_IH58
DR   Coriell; ND20819
DR   Wikidata; Q54928103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20821
AC   CVCL_IH59
DR   Coriell; ND20821
DR   Wikidata; Q54928104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20827
AC   CVCL_FU26
DR   Coriell; ND20827
DR   Wikidata; Q54928105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20830
AC   CVCL_CT11
DR   Coriell; ND20830
DR   Wikidata; Q54928106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20832
AC   CVCL_CT12
DR   Coriell; ND20832
DR   Wikidata; Q54928107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20851
AC   CVCL_CT13
DR   Coriell; ND20851
DR   Wikidata; Q54928108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20852
AC   CVCL_CT14
DR   Coriell; ND20852
DR   Wikidata; Q54928109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20862
AC   CVCL_ED78
DR   Coriell; ND20862
DR   Wikidata; Q54928110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20863
AC   CVCL_CT15
DR   Coriell; ND20863
DR   Wikidata; Q54928111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20865
AC   CVCL_CT16
DR   Coriell; ND20865
DR   Wikidata; Q54928112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20873
AC   CVCL_CT17
DR   Coriell; ND20873
DR   Wikidata; Q54928113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20880
AC   CVCL_CT18
DR   Coriell; ND20880
DR   Wikidata; Q54928117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20883
AC   CVCL_CT19
DR   Coriell; ND20883
DR   Wikidata; Q54928118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20886
AC   CVCL_CT20
DR   Coriell; ND20886
DR   Wikidata; Q54928119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20890
AC   CVCL_CT21
DR   Coriell; ND20890
DR   Wikidata; Q54928120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20892
AC   CVCL_CT22
DR   Coriell; ND20892
DR   Wikidata; Q54928121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20894
AC   CVCL_ED79
DR   Coriell; ND20894
DR   Wikidata; Q54928122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20895
AC   CVCL_CT23
DR   Coriell; ND20895
DR   Wikidata; Q54928123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20900
AC   CVCL_CT24
DR   BioSample; SAMN00800014
DR   Coriell; ND20900
DR   Wikidata; Q54928124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND20905
AC   CVCL_FE82
DR   BioSample; SAMN00800018
DR   Coriell; ND20905
DR   Wikidata; Q54928125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20908
AC   CVCL_CT25
DR   Coriell; ND20908
DR   Wikidata; Q54928126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20911
AC   CVCL_CT26
DR   Coriell; ND20911
DR   Wikidata; Q54928127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20919
AC   CVCL_EH91
DR   Coriell; ND20919
DR   Wikidata; Q54928128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20920
AC   CVCL_GN16
DR   BioSample; SAMN00800022
DR   Coriell; ND20920
DR   Wikidata; Q54928129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND20921
AC   CVCL_CT27
DR   Coriell; ND20921
DR   Wikidata; Q54928130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20922
AC   CVCL_CT28
DR   Coriell; ND20922
DR   Wikidata; Q54928131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20950
AC   CVCL_CT29
DR   Coriell; ND20950
DR   Wikidata; Q54928132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20951
AC   CVCL_CT30
DR   Coriell; ND20951
DR   Wikidata; Q54928133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20952
AC   CVCL_CT31
DR   Coriell; ND20952
DR   Wikidata; Q54928134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20955
AC   CVCL_CT32
DR   Coriell; ND20955
DR   Wikidata; Q54928135
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20956
AC   CVCL_ED80
DR   Coriell; ND20956
DR   Wikidata; Q54928136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND20957
AC   CVCL_CT33
DR   Coriell; ND20957
DR   Wikidata; Q54928137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20963
AC   CVCL_FU27
DR   Coriell; ND20963
DR   Wikidata; Q54928138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND20965
AC   CVCL_IF85
DR   Coriell; ND20965
DR   Wikidata; Q54928139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20972
AC   CVCL_CT34
DR   Coriell; ND20972
DR   Wikidata; Q54928140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20975
AC   CVCL_CT35
DR   Coriell; ND20975
DR   Wikidata; Q54928141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20988
AC   CVCL_CT36
DR   Coriell; ND20988
DR   Wikidata; Q54928142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20989
AC   CVCL_CT37
DR   Coriell; ND20989
DR   Wikidata; Q54928143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20990
AC   CVCL_IF86
DR   Coriell; ND20990
DR   Wikidata; Q54928144
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND20991
AC   CVCL_CT38
DR   Coriell; ND20991
DR   Wikidata; Q54928145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20997
AC   CVCL_CT39
DR   Coriell; ND20997
DR   Wikidata; Q54928146
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND20998
AC   CVCL_CT40
DR   Coriell; ND20998
DR   Wikidata; Q54928147
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21
AC   CVCL_VK92
SY   Neuroblastoma X DRG neurons hybrid 21
DR   Wikidata; Q98127452
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND21000
AC   CVCL_CT41
DR   BioSample; SAMN00800090
DR   Coriell; ND21000
DR   Wikidata; Q54928148
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND21002
AC   CVCL_CT42
DR   BioSample; SAMN00800094
DR   Coriell; ND21002
DR   Wikidata; Q54928149
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND21003
AC   CVCL_GN17
DR   BioSample; SAMN00800096
DR   Coriell; ND21003
DR   Wikidata; Q54928150
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21010
AC   CVCL_FL89
DR   Coriell; ND21010
DR   Wikidata; Q54928151
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21013
AC   CVCL_FL90
DR   Coriell; ND21013
DR   Wikidata; Q54928152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21015
AC   CVCL_FL91
DR   Coriell; ND21015
DR   Wikidata; Q54928153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21016
AC   CVCL_FL92
DR   Coriell; ND21016
DR   Wikidata; Q54928154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21017
AC   CVCL_FL93
DR   Coriell; ND21017
DR   Wikidata; Q54928155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21020
AC   CVCL_FL94
DR   Coriell; ND21020
DR   Wikidata; Q54928156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21022
AC   CVCL_CT43
DR   Coriell; ND21022
DR   Wikidata; Q54928165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21023
AC   CVCL_ED81
DR   Coriell; ND21023
DR   Wikidata; Q54928166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21024
AC   CVCL_FL95
DR   Coriell; ND21024
DR   Wikidata; Q54928167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21025
AC   CVCL_CT44
DR   Coriell; ND21025
DR   Wikidata; Q54928168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21026
AC   CVCL_FL96
DR   Coriell; ND21026
DR   Wikidata; Q54928169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21029
AC   CVCL_IH60
DR   Coriell; ND21029
DR   Wikidata; Q54928170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21035
AC   CVCL_FU28
DR   Coriell; ND21035
DR   Wikidata; Q54928171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21039
AC   CVCL_FL97
DR   Coriell; ND21039
DR   Wikidata; Q54928172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21044
AC   CVCL_CT45
DR   Coriell; ND21044
DR   Wikidata; Q54928173
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21045
AC   CVCL_FL98
DR   Coriell; ND21045
DR   Wikidata; Q54928174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21046
AC   CVCL_CT46
DR   Coriell; ND21046
DR   Wikidata; Q54928175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21048
AC   CVCL_ED82
DR   Coriell; ND21048
DR   Wikidata; Q54928176
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND21051
AC   CVCL_CT47
DR   BioSample; SAMN00800137
DR   Coriell; ND21051
DR   Wikidata; Q54928177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND21059
AC   CVCL_FL99
DR   Coriell; ND21059
DR   Wikidata; Q54928178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21060
AC   CVCL_CT48
DR   Coriell; ND21060
DR   Wikidata; Q54928179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21061
AC   CVCL_CT49
DR   Coriell; ND21061
DR   Wikidata; Q54928180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21063
AC   CVCL_FM00
DR   Coriell; ND21063
DR   Wikidata; Q54928181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21069
AC   CVCL_FM01
DR   Coriell; ND21069
DR   Wikidata; Q54928182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21089
AC   CVCL_CT50
DR   Coriell; ND21089
DR   Wikidata; Q54928183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21102
AC   CVCL_FM02
DR   Coriell; ND21102
DR   Wikidata; Q54928184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21109
AC   CVCL_CT51
DR   Coriell; ND21109
DR   Wikidata; Q54928185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21111
AC   CVCL_FE83
DR   BioSample; SAMN00800185
DR   Coriell; ND21111
DR   Wikidata; Q54928186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21113
AC   CVCL_ED83
DR   Coriell; ND21113
DR   Wikidata; Q54928187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21120
AC   CVCL_FM03
DR   Coriell; ND21120
DR   Wikidata; Q54928188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21121
AC   CVCL_FM04
DR   Coriell; ND21121
DR   Wikidata; Q54928189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21131
AC   CVCL_FU29
DR   Coriell; ND21131
DR   Wikidata; Q54928190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21140
AC   CVCL_CT52
DR   Coriell; ND21140
DR   Wikidata; Q54928191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21146
AC   CVCL_FM05
DR   Coriell; ND21146
DR   Wikidata; Q54928192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y6M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21147
AC   CVCL_FM06
DR   Coriell; ND21147
DR   Wikidata; Q54928193
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21148
AC   CVCL_FM07
DR   Coriell; ND21148
DR   Wikidata; Q54928194
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21150
AC   CVCL_CT53
DR   Coriell; ND21150
DR   Wikidata; Q54928195
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21152
AC   CVCL_CT54
DR   Coriell; ND21152
DR   Wikidata; Q54928196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21154
AC   CVCL_ED84
DR   Coriell; ND21154
DR   Wikidata; Q54928197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21165
AC   CVCL_CT55
DR   Coriell; ND21165
DR   Wikidata; Q54928198
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21168
AC   CVCL_CT56
DR   Coriell; ND21168
DR   Wikidata; Q54928199
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21170
AC   CVCL_CT57
DR   Coriell; ND21170
DR   Wikidata; Q54928200
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21171
AC   CVCL_FM08
DR   Coriell; ND21171
DR   Wikidata; Q54928201
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21176
AC   CVCL_CT58
DR   Coriell; ND21176
DR   Wikidata; Q54928202
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21177
AC   CVCL_ED85
DR   Coriell; ND21177
DR   Wikidata; Q54928203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21178
AC   CVCL_CT59
DR   Coriell; ND21178
DR   Wikidata; Q54928204
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21196
AC   CVCL_CT60
DR   Coriell; ND21196
DR   Wikidata; Q54928211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21197
AC   CVCL_ED86
DR   Coriell; ND21197
DR   Wikidata; Q54928212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21202
AC   CVCL_FM09
DR   Coriell; ND21202
DR   Wikidata; Q54928213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21207
AC   CVCL_GN18
DR   BioSample; SAMN00800251
DR   Coriell; ND21207
DR   Wikidata; Q54928214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21211
AC   CVCL_CT61
DR   Coriell; ND21211
DR   Wikidata; Q54928215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21215
AC   CVCL_CT62
DR   Coriell; ND21215
DR   Wikidata; Q54928216
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21222
AC   CVCL_CT63
DR   Coriell; ND21222
DR   Wikidata; Q54928217
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21232
AC   CVCL_CT64
DR   BioSample; SAMN00800269
DR   Coriell; ND21232
DR   Wikidata; Q54928218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND21233
AC   CVCL_GN19
DR   BioSample; SAMN00800271
DR   Coriell; ND21233
DR   Wikidata; Q54928219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21237
AC   CVCL_BS71
DR   Coriell; ND21237
DR   Wikidata; Q54928220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND21239
AC   CVCL_FE84
DR   BioSample; SAMN00800275
DR   Coriell; ND21239
DR   Wikidata; Q54928221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21254
AC   CVCL_CT65
DR   Coriell; ND21254
DR   Wikidata; Q54928222
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21256
AC   CVCL_CT66
DR   Coriell; ND21256
DR   Wikidata; Q54928223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21258
AC   CVCL_FM10
DR   Coriell; ND21258
DR   Wikidata; Q54928224
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21269
AC   CVCL_FM11
DR   Coriell; ND21269
DR   Wikidata; Q54928225
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21277
AC   CVCL_CT67
DR   Coriell; ND21277
DR   Wikidata; Q54928226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21279
AC   CVCL_CT68
DR   Coriell; ND21279
DR   Wikidata; Q54928227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21280
AC   CVCL_FM12
DR   Coriell; ND21280
DR   Wikidata; Q54928228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21286
AC   CVCL_FM13
DR   Coriell; ND21286
DR   Wikidata; Q54928229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21287
AC   CVCL_GN20
DR   BioSample; SAMN00800313
DR   Coriell; ND21287
DR   Wikidata; Q54928230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21288
AC   CVCL_ED87
DR   Coriell; ND21288
DR   Wikidata; Q54928231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21289
AC   CVCL_CT69
DR   Coriell; ND21289
DR   Wikidata; Q54928232
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21298
AC   CVCL_FM14
DR   Coriell; ND21298
DR   Wikidata; Q54928233
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21306
AC   CVCL_IF87
DR   Coriell; ND21306
DR   Wikidata; Q54928234
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21307
AC   CVCL_IF88
DR   Coriell; ND21307
DR   Wikidata; Q54928235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21309
AC   CVCL_FU30
DR   Coriell; ND21309
DR   Wikidata; Q54928236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21313
AC   CVCL_FU31
DR   Coriell; ND21313
DR   Wikidata; Q54928237
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21328
AC   CVCL_FM15
DR   Coriell; ND21328
DR   Wikidata; Q54928238
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21330
AC   CVCL_FU32
DR   Coriell; ND21330
DR   Wikidata; Q54928239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21345
AC   CVCL_FM16
DR   Coriell; ND21345
DR   Wikidata; Q54928240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21350
AC   CVCL_CT70
DR   Coriell; ND21350
DR   Wikidata; Q54928241
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21351
AC   CVCL_CT71
DR   Coriell; ND21351
DR   Wikidata; Q54928242
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21353
AC   CVCL_FM17
DR   Coriell; ND21353
DR   Wikidata; Q54928243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21356
AC   CVCL_FM18
DR   Coriell; ND21356
DR   Wikidata; Q54928244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21367
AC   CVCL_CT72
DR   Coriell; ND21367
DR   Wikidata; Q54928245
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21369
AC   CVCL_ED88
DR   Coriell; ND21369
DR   Wikidata; Q54928246
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21370
AC   CVCL_FE85
DR   BioSample; SAMN00800396
DR   Coriell; ND21370
DR   Wikidata; Q54928247
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21371
AC   CVCL_ED89
DR   Coriell; ND21371
DR   Wikidata; Q54928248
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21376
AC   CVCL_IF89
DR   Coriell; ND21376
DR   Wikidata; Q54928249
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21388
AC   CVCL_IF90
DR   Coriell; ND21388
DR   Wikidata; Q54928250
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21393
AC   CVCL_IH61
DR   Coriell; ND21393
DR   Wikidata; Q54928253
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21425
AC   CVCL_CT73
DR   Coriell; ND21425
DR   Wikidata; Q54928254
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21426
AC   CVCL_CT74
DR   BioSample; SAMN00800486
DR   Coriell; ND21426
DR   Wikidata; Q54928255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND21428
AC   CVCL_CT75
DR   Coriell; ND21428
DR   Wikidata; Q54928256
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21429
AC   CVCL_CT76
DR   Coriell; ND21429
DR   Wikidata; Q54928257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21440
AC   CVCL_CT77
DR   Coriell; ND21440
DR   Wikidata; Q54928258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21442
AC   CVCL_CT78
DR   Coriell; ND21442
DR   Wikidata; Q54928259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21450
AC   CVCL_FM19
DR   Coriell; ND21450
DR   Wikidata; Q54928260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21451
AC   CVCL_FM20
DR   Coriell; ND21451
DR   Wikidata; Q54928261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21454
AC   CVCL_FM21
DR   Coriell; ND21454
DR   Wikidata; Q54928262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21455
AC   CVCL_ED90
DR   Coriell; ND21455
DR   Wikidata; Q54928263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21457
AC   CVCL_ED91
DR   Coriell; ND21457
DR   Wikidata; Q54928264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21458
AC   CVCL_CT79
DR   Coriell; ND21458
DR   Wikidata; Q54928265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21462
AC   CVCL_FM22
DR   Coriell; ND21462
DR   Wikidata; Q54928266
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21469
AC   CVCL_IF91
DR   Coriell; ND21469
DR   Wikidata; Q54928267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21475
AC   CVCL_FM23
DR   Coriell; ND21475
DR   Wikidata; Q54928268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21479
AC   CVCL_CT80
DR   Coriell; ND21479
DR   Wikidata; Q54928269
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21480
AC   CVCL_CT81
DR   Coriell; ND21480
DR   Wikidata; Q54928270
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21488
AC   CVCL_FU33
DR   Coriell; ND21488
DR   Wikidata; Q54928271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21496
AC   CVCL_CT82
DR   Coriell; ND21496
DR   Wikidata; Q54928272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21515
AC   CVCL_CT83
DR   Coriell; ND21515
DR   Wikidata; Q54928273
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21517
AC   CVCL_CT84
DR   Coriell; ND21517
DR   Wikidata; Q54928274
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21520
AC   CVCL_GN21
DR   Coriell; ND21520
DR   Wikidata; Q54928275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21521
AC   CVCL_CT85
DR   Coriell; ND21521
DR   Wikidata; Q54928276
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21522
AC   CVCL_CT86
DR   Coriell; ND21522
DR   Wikidata; Q54928277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21524
AC   CVCL_CT87
DR   Coriell; ND21524
DR   Wikidata; Q54928278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21531
AC   CVCL_CT88
DR   Coriell; ND21531
DR   Wikidata; Q54928279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21533
AC   CVCL_FM24
DR   Coriell; ND21533
DR   Wikidata; Q54928280
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21538
AC   CVCL_CT89
DR   Coriell; ND21538
DR   Wikidata; Q54928281
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21543
AC   CVCL_ED92
DR   Coriell; ND21543
DR   Wikidata; Q54928282
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21545
AC   CVCL_CT90
DR   Coriell; ND21545
DR   Wikidata; Q54928283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21548
AC   CVCL_FM25
DR   Coriell; ND21548
DR   Wikidata; Q54928284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21562
AC   CVCL_FM26
DR   Coriell; ND21562
DR   Wikidata; Q54928285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21566
AC   CVCL_CT91
DR   Coriell; ND21566
DR   Wikidata; Q54928286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21569
AC   CVCL_CT92
DR   Coriell; ND21569
DR   Wikidata; Q54928287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21574
AC   CVCL_ED93
DR   Coriell; ND21574
DR   Wikidata; Q54928288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21576
AC   CVCL_GN22
DR   BioSample; SAMN00800616
DR   Coriell; ND21576
DR   Wikidata; Q54928289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21579
AC   CVCL_CT93
DR   Coriell; ND21579
DR   Wikidata; Q54928290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21584
AC   CVCL_FM27
DR   Coriell; ND21584
DR   Wikidata; Q54928291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21585
AC   CVCL_FM28
DR   Coriell; ND21585
DR   Wikidata; Q54928292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21586
AC   CVCL_FM29
DR   Coriell; ND21586
DR   Wikidata; Q54928297
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21587
AC   CVCL_FM30
DR   Coriell; ND21587
DR   Wikidata; Q54928298
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21589
AC   CVCL_CT94
DR   Coriell; ND21589
DR   Wikidata; Q54928299
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21592
AC   CVCL_CT95
DR   Coriell; ND21592
DR   Wikidata; Q54928300
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21595
AC   CVCL_CT96
DR   Coriell; ND21595
DR   Wikidata; Q54928301
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21601
AC   CVCL_FM31
DR   Coriell; ND21601
DR   Wikidata; Q54928302
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21609
AC   CVCL_CT97
DR   Coriell; ND21609
DR   Wikidata; Q54928303
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21611
AC   CVCL_CT98
DR   Coriell; ND21611
DR   Wikidata; Q54928304
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21618
AC   CVCL_GN23
DR   Coriell; ND21618
DR   Wikidata; Q54928305
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21619
AC   CVCL_FE86
DR   Coriell; ND21619
DR   Wikidata; Q54928306
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21623
AC   CVCL_CT99
DR   Coriell; ND21623
DR   Wikidata; Q54928307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21624
AC   CVCL_CU00
DR   Coriell; ND21624
DR   Wikidata; Q54928308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21629
AC   CVCL_ED94
DR   Coriell; ND21629
DR   Wikidata; Q54928309
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND21631
AC   CVCL_FM32
DR   Coriell; ND21631
DR   Wikidata; Q54928310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21672
AC   CVCL_CU01
DR   Coriell; ND21672
DR   Wikidata; Q54928311
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21676
AC   CVCL_FM33
DR   Coriell; ND21676
DR   Wikidata; Q54928312
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21680
AC   CVCL_CU02
DR   Coriell; ND21680
DR   Wikidata; Q54928313
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21687
AC   CVCL_CU03
DR   Coriell; ND21687
DR   Wikidata; Q54928314
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21688
AC   CVCL_CU04
DR   Coriell; ND21688
DR   Wikidata; Q54928315
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21689
AC   CVCL_FM34
DR   Coriell; ND21689
DR   Wikidata; Q54928316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21690
AC   CVCL_IF92
DR   Coriell; ND21690
DR   Wikidata; Q54928317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21693
AC   CVCL_FM35
DR   Coriell; ND21693
DR   Wikidata; Q54928318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21694
AC   CVCL_IF93
DR   Coriell; ND21694
DR   Wikidata; Q54928319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21695
AC   CVCL_IF94
DR   Coriell; ND21695
DR   Wikidata; Q54928320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21698
AC   CVCL_GN24
DR   Coriell; ND21698
DR   Wikidata; Q54928321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21704
AC   CVCL_FM36
DR   Coriell; ND21704
DR   Wikidata; Q54928322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21706
AC   CVCL_AB79
DR   Coriell; ND21706
DR   Wikidata; Q54928323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ND21709
AC   CVCL_CU05
DR   Coriell; ND21709
DR   Wikidata; Q54928324
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21718
AC   CVCL_CU06
DR   Coriell; ND21718
DR   Wikidata; Q54928325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21739
AC   CVCL_FM37
DR   Coriell; ND21739
DR   Wikidata; Q54928326
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21741
AC   CVCL_FG77
DR   Coriell; ND21741
DR   Wikidata; Q54928328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21747
AC   CVCL_CU07
DR   Coriell; ND21747
DR   Wikidata; Q54928329
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21751
AC   CVCL_FM38
DR   Coriell; ND21751
DR   Wikidata; Q54928330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21754
AC   CVCL_CU08
DR   Coriell; ND21754
DR   Wikidata; Q54928331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21758
AC   CVCL_ED95
DR   Coriell; ND21758
DR   Wikidata; Q54928332
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND21773
AC   CVCL_CU09
DR   Coriell; ND21773
DR   Wikidata; Q54928333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21780
AC   CVCL_FU34
DR   Coriell; ND21780
DR   Wikidata; Q54928334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21783
AC   CVCL_FU35
DR   Coriell; ND21783
DR   Wikidata; Q54928335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21787
AC   CVCL_FU36
DR   Coriell; ND21787
DR   Wikidata; Q54928336
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21788
AC   CVCL_IF95
DR   Coriell; ND21788
DR   Wikidata; Q54928337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21789
AC   CVCL_FU37
DR   Coriell; ND21789
DR   Wikidata; Q54928341
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21792
AC   CVCL_FU38
DR   Coriell; ND21792
DR   Wikidata; Q54928342
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21797
AC   CVCL_FU39
DR   Coriell; ND21797
DR   Wikidata; Q54928343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21798
AC   CVCL_FU40
DR   Coriell; ND21798
DR   Wikidata; Q54928344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21803
AC   CVCL_CU10
DR   Coriell; ND21803
DR   Wikidata; Q54928345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21805
AC   CVCL_CU11
DR   Coriell; ND21805
DR   Wikidata; Q54928346
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21806
AC   CVCL_IH62
DR   Coriell; ND21806
DR   Wikidata; Q54928347
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21845
AC   CVCL_CU12
DR   Coriell; ND21845
DR   Wikidata; Q54928348
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21846
AC   CVCL_CU13
DR   Coriell; ND21846
DR   Wikidata; Q54928350
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21856
AC   CVCL_CU14
DR   Coriell; ND21856
DR   Wikidata; Q54928351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21871
AC   CVCL_CU15
DR   Coriell; ND21871
DR   Wikidata; Q54928352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21872
AC   CVCL_CU16
DR   Coriell; ND21872
DR   Wikidata; Q54928353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21873
AC   CVCL_FM39
DR   Coriell; ND21873
DR   Wikidata; Q54928354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21890
AC   CVCL_CU17
DR   Coriell; ND21890
DR   Wikidata; Q54928355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21891
AC   CVCL_CU18
DR   Coriell; ND21891
DR   Wikidata; Q54928356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21892
AC   CVCL_CU19
DR   Coriell; ND21892
DR   Wikidata; Q54928357
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21898
AC   CVCL_CU20
DR   Coriell; ND21898
DR   Wikidata; Q54928358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21902
AC   CVCL_GN25
DR   BioSample; SAMN00800880
DR   Coriell; ND21902
DR   Wikidata; Q54928359
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND21914
AC   CVCL_CU21
DR   Coriell; ND21914
DR   Wikidata; Q54928360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21915
AC   CVCL_CU22
DR   Coriell; ND21915
DR   Wikidata; Q54928361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21917
AC   CVCL_ED96
DR   Coriell; ND21917
DR   Wikidata; Q54928362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21920
AC   CVCL_ED97
DR   Coriell; ND21920
DR   Wikidata; Q54928363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21922
AC   CVCL_ED98
DR   Coriell; ND21922
DR   Wikidata; Q54928364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21925
AC   CVCL_ED99
DR   Coriell; ND21925
DR   Wikidata; Q54928365
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND21937
AC   CVCL_FM40
DR   Coriell; ND21937
DR   Wikidata; Q54928366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21938
AC   CVCL_FM41
DR   Coriell; ND21938
DR   Wikidata; Q54928367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21942
AC   CVCL_FU41
DR   Coriell; ND21942
DR   Wikidata; Q54928368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND21954
AC   CVCL_CU23
DR   Coriell; ND21954
DR   Wikidata; Q54928369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21955
AC   CVCL_CU24
DR   Coriell; ND21955
DR   Wikidata; Q54928370
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21957
AC   CVCL_CU25
DR   Coriell; ND21957
DR   Wikidata; Q54928371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21975
AC   CVCL_IF96
DR   Coriell; ND21975
DR   Wikidata; Q54928372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND21982
AC   CVCL_CU26
DR   Coriell; ND21982
DR   Wikidata; Q54928373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND21986
AC   CVCL_FM42
DR   Coriell; ND21986
DR   Wikidata; Q54928374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22
AC   CVCL_VK93
SY   Neuroblastoma X DRG neurons hybrid 22
DR   Wikidata; Q98127454
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND22006
AC   CVCL_EE00
DR   Coriell; ND22006
DR   Wikidata; Q54928375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22007
AC   CVCL_EE01
DR   Coriell; ND22007
DR   Wikidata; Q54928376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22008
AC   CVCL_EE02
DR   Coriell; ND22008
DR   Wikidata; Q54928377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22026
AC   CVCL_EE03
DR   Coriell; ND22026
DR   Wikidata; Q54928378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22035
AC   CVCL_CU27
DR   Coriell; ND22035
DR   Wikidata; Q54928379
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22037
AC   CVCL_CU28
DR   Coriell; ND22037
DR   Wikidata; Q54928380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22040
AC   CVCL_GN26
DR   Coriell; ND22040
DR   Wikidata; Q54928381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22051
AC   CVCL_CU29
DR   Coriell; ND22051
DR   Wikidata; Q54928388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22055
AC   CVCL_CU30
DR   Coriell; ND22055
DR   Wikidata; Q54928389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22063
AC   CVCL_FU42
DR   Coriell; ND22063
DR   Wikidata; Q54928390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22067
AC   CVCL_CU31
DR   Coriell; ND22067
DR   Wikidata; Q54928391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22070
AC   CVCL_FM43
DR   Coriell; ND22070
DR   Wikidata; Q54928392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C122812; Partial epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22086
AC   CVCL_CU32
DR   Coriell; ND22086
DR   Wikidata; Q54928394
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22094
AC   CVCL_CU33
DR   Coriell; ND22094
DR   Wikidata; Q54928395
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22099
AC   CVCL_CU34
DR   Coriell; ND22099
DR   Wikidata; Q54928396
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22100
AC   CVCL_CU35
DR   Coriell; ND22100
DR   Wikidata; Q54928397
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22102
AC   CVCL_CU36
DR   Coriell; ND22102
DR   Wikidata; Q54928398
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22105
AC   CVCL_CU37
DR   Coriell; ND22105
DR   Wikidata; Q54928399
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22106
AC   CVCL_GN27
DR   BioSample; SAMN00801012
DR   Coriell; ND22106
DR   Wikidata; Q54928400
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22107
AC   CVCL_CU38
DR   Coriell; ND22107
DR   Wikidata; Q54928401
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22108
AC   CVCL_CU39
DR   Coriell; ND22108
DR   Wikidata; Q54928402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22126
AC   CVCL_CU40
DR   Coriell; ND22126
DR   Wikidata; Q54928403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22136
AC   CVCL_CU41
DR   Coriell; ND22136
DR   Wikidata; Q54928404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22138
AC   CVCL_CU42
DR   Coriell; ND22138
DR   Wikidata; Q54928405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22142
AC   CVCL_EE04
DR   Coriell; ND22142
DR   Wikidata; Q54928406
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22143
AC   CVCL_EE05
DR   Coriell; ND22143
DR   Wikidata; Q54928407
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22162
AC   CVCL_CU43
DR   Coriell; ND22162
DR   Wikidata; Q54928408
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22172
AC   CVCL_CU44
DR   Coriell; ND22172
DR   Wikidata; Q54928409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22176
AC   CVCL_FM44
DR   Coriell; ND22176
DR   Wikidata; Q54928410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22181
AC   CVCL_CU45
DR   Coriell; ND22181
DR   Wikidata; Q54928411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22224
AC   CVCL_CU46
DR   Coriell; ND22224
DR   Wikidata; Q54928412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22247
AC   CVCL_CU47
DR   Coriell; ND22247
DR   Wikidata; Q54928413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22262
AC   CVCL_HW25
DR   Coriell; ND22262
DR   Wikidata; Q54928414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22263
AC   CVCL_FZ74
DR   Coriell; ND22263
DR   Wikidata; Q54928415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22265
AC   CVCL_HW26
DR   Coriell; ND22265
DR   Wikidata; Q54928416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22274
AC   CVCL_IM13
DR   Coriell; ND22274
DR   Wikidata; Q54928417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22276
AC   CVCL_FZ75
DR   Coriell; ND22276
DR   Wikidata; Q54928418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22281
AC   CVCL_FZ76
DR   Coriell; ND22281
DR   Wikidata; Q54928419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22283
AC   CVCL_HW27
DR   Coriell; ND22283
DR   Wikidata; Q54928420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22285
AC   CVCL_HW28
DR   Coriell; ND22285
DR   Wikidata; Q54928421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22286
AC   CVCL_HW29
DR   Coriell; ND22286
DR   Wikidata; Q54928422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22287
AC   CVCL_FZ77
DR   Coriell; ND22287
DR   Wikidata; Q54928423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22288
AC   CVCL_FZ78
DR   Coriell; ND22288
DR   Wikidata; Q54928424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22289
AC   CVCL_HW30
DR   Coriell; ND22289
DR   Wikidata; Q54928425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22290
AC   CVCL_FZ79
DR   Coriell; ND22290
DR   Wikidata; Q54928426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22292
AC   CVCL_IM14
DR   Coriell; ND22292
DR   Wikidata; Q54928427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22297
AC   CVCL_HW31
DR   Coriell; ND22297
DR   Wikidata; Q54928428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22298
AC   CVCL_HW32
DR   Coriell; ND22298
DR   Wikidata; Q54928433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22299
AC   CVCL_HW33
DR   Coriell; ND22299
DR   Wikidata; Q54928434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22307
AC   CVCL_FZ80
DR   Coriell; ND22307
DR   Wikidata; Q54928435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22308
AC   CVCL_FZ81
DR   Coriell; ND22308
DR   Wikidata; Q54928436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22316
AC   CVCL_HW34
DR   Coriell; ND22316
DR   Wikidata; Q54928437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22318
AC   CVCL_IM15
DR   Coriell; ND22318
DR   Wikidata; Q54928438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22322
AC   CVCL_FZ82
DR   Coriell; ND22322
DR   Wikidata; Q54928439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22325
AC   CVCL_HW35
DR   Coriell; ND22325
DR   Wikidata; Q54928440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22327
AC   CVCL_LL50
DR   Coriell; ND22327
DR   Wikidata; Q54928441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND22328
AC   CVCL_HW36
DR   Coriell; ND22328
DR   Wikidata; Q54928442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22331
AC   CVCL_HW37
DR   Coriell; ND22331
DR   Wikidata; Q54928444
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22336
AC   CVCL_HW38
DR   Coriell; ND22336
DR   Wikidata; Q54928445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22337
AC   CVCL_HW39
DR   Coriell; ND22337
DR   Wikidata; Q54928446
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22339
AC   CVCL_HW40
DR   Coriell; ND22339
DR   Wikidata; Q54928447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22347
AC   CVCL_HW41
DR   Coriell; ND22347
DR   Wikidata; Q54928448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22349
AC   CVCL_HW42
DR   Coriell; ND22349
DR   Wikidata; Q54928449
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22359
AC   CVCL_HW43
DR   Coriell; ND22359
DR   Wikidata; Q54928450
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22360
AC   CVCL_HW44
DR   Coriell; ND22360
DR   Wikidata; Q54928451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22362
AC   CVCL_FZ83
DR   Coriell; ND22362
DR   Wikidata; Q54928452
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22366
AC   CVCL_FZ84
DR   Coriell; ND22366
DR   Wikidata; Q54928453
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22367
AC   CVCL_HW45
DR   Coriell; ND22367
DR   Wikidata; Q54928454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22369
AC   CVCL_HW46
DR   Coriell; ND22369
DR   Wikidata; Q54928455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22371
AC   CVCL_FZ85
DR   Coriell; ND22371
DR   Wikidata; Q54928456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22374
AC   CVCL_IM16
DR   Coriell; ND22374
DR   Wikidata; Q54928457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22376
AC   CVCL_HW47
DR   Coriell; ND22376
DR   Wikidata; Q54928458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22378
AC   CVCL_FZ86
DR   Coriell; ND22378
DR   Wikidata; Q54928459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22379
AC   CVCL_HW48
DR   Coriell; ND22379
DR   Wikidata; Q54928460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22382
AC   CVCL_HW49
DR   Coriell; ND22382
DR   Wikidata; Q54928461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22383
AC   CVCL_HW50
DR   Coriell; ND22383
DR   Wikidata; Q54928462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22386
AC   CVCL_HW51
DR   Coriell; ND22386
DR   Wikidata; Q54928463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22388
AC   CVCL_HW52
DR   Coriell; ND22388
DR   Wikidata; Q54928464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22389
AC   CVCL_HW53
DR   Coriell; ND22389
DR   Wikidata; Q54928465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22390
AC   CVCL_FZ87
DR   Coriell; ND22390
DR   Wikidata; Q54928466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22391
AC   CVCL_IM17
DR   Coriell; ND22391
DR   Wikidata; Q54928467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22392
AC   CVCL_HW54
DR   Coriell; ND22392
DR   Wikidata; Q54928468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22395
AC   CVCL_HW55
DR   Coriell; ND22395
DR   Wikidata; Q54928469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22396
AC   CVCL_FZ88
DR   Coriell; ND22396
DR   Wikidata; Q54928470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22399
AC   CVCL_FZ89
DR   Coriell; ND22399
DR   Wikidata; Q54928471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22402
AC   CVCL_HW56
DR   Coriell; ND22402
DR   Wikidata; Q54928472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22404
AC   CVCL_FZ90
DR   Coriell; ND22404
DR   Wikidata; Q54928473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22405
AC   CVCL_HW57
DR   Coriell; ND22405
DR   Wikidata; Q54928477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22414
AC   CVCL_HW58
DR   Coriell; ND22414
DR   Wikidata; Q54928478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22418
AC   CVCL_FZ91
DR   Coriell; ND22418
DR   Wikidata; Q54928479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22420
AC   CVCL_FZ92
DR   Coriell; ND22420
DR   Wikidata; Q54928480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22427
AC   CVCL_IM18
DR   Coriell; ND22427
DR   Wikidata; Q54928481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22433
AC   CVCL_IF97
DR   Coriell; ND22433
DR   Wikidata; Q54928482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22434
AC   CVCL_HW59
DR   Coriell; ND22434
DR   Wikidata; Q54928483
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22446
AC   CVCL_IF98
DR   Coriell; ND22446
DR   Wikidata; Q54928484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22448
AC   CVCL_HW60
DR   Coriell; ND22448
DR   Wikidata; Q54928485
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22451
AC   CVCL_HW61
DR   Coriell; ND22451
DR   Wikidata; Q54928486
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22456
AC   CVCL_IM19
DR   Coriell; ND22456
DR   Wikidata; Q54928487
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22458
AC   CVCL_HW62
DR   Coriell; ND22458
DR   Wikidata; Q54928488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22460
AC   CVCL_FZ93
DR   Coriell; ND22460
DR   Wikidata; Q54928489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22462
AC   CVCL_FZ94
DR   Coriell; ND22462
DR   Wikidata; Q54928490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22465
AC   CVCL_HW63
DR   Coriell; ND22465
DR   Wikidata; Q54928491
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22473
AC   CVCL_IF99
DR   Coriell; ND22473
DR   Wikidata; Q54928492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22484
AC   CVCL_FM45
DR   Coriell; ND22484
DR   Wikidata; Q54928493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22487
AC   CVCL_FM46
DR   Coriell; ND22487
DR   Wikidata; Q54928494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22488
AC   CVCL_FM47
DR   Coriell; ND22488
DR   Wikidata; Q54928495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22499
AC   CVCL_CU48
DR   Coriell; ND22499
DR   Wikidata; Q54928496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22519
AC   CVCL_EE06
DR   Coriell; ND22519
DR   Wikidata; Q54928497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22520
AC   CVCL_EE07
DR   Coriell; ND22520
DR   Wikidata; Q54928498
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22532
AC   CVCL_CU49
DR   Coriell; ND22532
DR   Wikidata; Q54928499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22533
AC   CVCL_IG00
DR   Coriell; ND22533
DR   Wikidata; Q54928500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22544
AC   CVCL_GN28
DR   Coriell; ND22544
DR   Wikidata; Q54928501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22545
AC   CVCL_GN29
DR   BioSample; SAMN00801305
DR   Coriell; ND22545
DR   Wikidata; Q54928502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22547
AC   CVCL_GN30
DR   BioSample; SAMN00801307
DR   Coriell; ND22547
DR   Wikidata; Q54928503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22548
AC   CVCL_GN31
DR   Coriell; ND22548
DR   Wikidata; Q54928504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22553
AC   CVCL_EE08
DR   Coriell; ND22553
DR   Wikidata; Q54928505
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22570
AC   CVCL_CU50
DR   Coriell; ND22570
DR   Wikidata; Q54928506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22576
AC   CVCL_GN32
DR   Coriell; ND22576
DR   Wikidata; Q54928507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22584
AC   CVCL_CU51
DR   Coriell; ND22584
DR   Wikidata; Q54928508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22596
AC   CVCL_EH92
DR   Coriell; ND22596
DR   Wikidata; Q54928509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22624
AC   CVCL_CU52
DR   Coriell; ND22624
DR   Wikidata; Q54928510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22625
AC   CVCL_CU53
DR   Coriell; ND22625
DR   Wikidata; Q54928511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22635
AC   CVCL_CU54
DR   Coriell; ND22635
DR   Wikidata; Q54928512
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22647
AC   CVCL_CU55
DR   Coriell; ND22647
DR   Wikidata; Q54928513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22663
AC   CVCL_GN33
DR   Coriell; ND22663
DR   Wikidata; Q54928514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22672
AC   CVCL_FM48
DR   Coriell; ND22672
DR   Wikidata; Q54928515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22674
AC   CVCL_FM49
DR   Coriell; ND22674
DR   Wikidata; Q54928516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22677
AC   CVCL_FM50
DR   Coriell; ND22677
DR   Wikidata; Q54928521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22680
AC   CVCL_FM51
DR   Coriell; ND22680
DR   Wikidata; Q54928522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22681
AC   CVCL_FM52
DR   Coriell; ND22681
DR   Wikidata; Q54928523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22686
AC   CVCL_EE09
DR   Coriell; ND22686
DR   Wikidata; Q54928524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22687
AC   CVCL_EE10
DR   Coriell; ND22687
DR   Wikidata; Q54928525
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22701
AC   CVCL_CU56
DR   Coriell; ND22701
DR   Wikidata; Q54928526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22729
AC   CVCL_GN34
DR   Coriell; ND22729
DR   Wikidata; Q54928527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22732
AC   CVCL_EE11
DR   Coriell; ND22732
DR   Wikidata; Q54928528
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22734
AC   CVCL_EE12
DR   Coriell; ND22734
DR   Wikidata; Q54928529
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22740
AC   CVCL_GN35
DR   Coriell; ND22740
DR   Wikidata; Q54928530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22749
AC   CVCL_CU57
DR   Coriell; ND22749
DR   Wikidata; Q54928531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22750
AC   CVCL_FM53
DR   Coriell; ND22750
DR   Wikidata; Q54928532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22751
AC   CVCL_IG01
DR   Coriell; ND22751
DR   Wikidata; Q54928533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND22772
AC   CVCL_CU58
DR   Coriell; ND22772
DR   Wikidata; Q54928534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22773
AC   CVCL_CU59
DR   Coriell; ND22773
DR   Wikidata; Q54928535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22775
AC   CVCL_GN36
DR   BioSample; SAMN00801483
DR   Coriell; ND22775
DR   Wikidata; Q54928536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22777
AC   CVCL_CU60
DR   Coriell; ND22777
DR   Wikidata; Q54928537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22785
AC   CVCL_FF57
DR   Coriell; ND22785
DR   Wikidata; Q54928538
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22786
AC   CVCL_FF58
DR   Coriell; ND22786
DR   Wikidata; Q54928539
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22787
AC   CVCL_FF59
DR   Coriell; ND22787
DR   Wikidata; Q54928540
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22789
AC   CVCL_FF60
DR   Coriell; ND22789
DR   Wikidata; Q54928541
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22790
AC   CVCL_FF61
DR   Coriell; ND22790
DR   Wikidata; Q54928542
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22793
AC   CVCL_FF62
DR   Coriell; ND22793
DR   Wikidata; Q54928543
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22797
AC   CVCL_FF63
DR   Coriell; ND22797
DR   Wikidata; Q54928544
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22798
AC   CVCL_FF64
DR   Coriell; ND22798
DR   Wikidata; Q54928545
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22800
AC   CVCL_FM54
DR   Coriell; ND22800
DR   Wikidata; Q54928546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22801
AC   CVCL_FM55
DR   Coriell; ND22801
DR   Wikidata; Q54928548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22819
AC   CVCL_FM56
DR   Coriell; ND22819
DR   Wikidata; Q54928549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22833
AC   CVCL_CU61
DR   Coriell; ND22833
DR   Wikidata; Q54928550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22835
AC   CVCL_FM57
DR   Coriell; ND22835
DR   Wikidata; Q54928551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22841
AC   CVCL_CU62
DR   Coriell; ND22841
DR   Wikidata; Q54928552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22843
AC   CVCL_CU63
DR   Coriell; ND22843
DR   Wikidata; Q54928553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22856
AC   CVCL_FF65
DR   Coriell; ND22856
DR   Wikidata; Q54928554
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22858
AC   CVCL_GN37
DR   Coriell; ND22858
DR   Wikidata; Q54928555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22864
AC   CVCL_GN38
DR   Coriell; ND22864
DR   Wikidata; Q54928556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22865
AC   CVCL_GN39
DR   Coriell; ND22865
DR   Wikidata; Q54928557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22867
AC   CVCL_GN40
DR   Coriell; ND22867
DR   Wikidata; Q54928558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22868
AC   CVCL_FF66
DR   Coriell; ND22868
DR   Wikidata; Q54928559
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22879
AC   CVCL_FF67
DR   Coriell; ND22879
DR   Wikidata; Q54928560
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22882
AC   CVCL_GN41
DR   Coriell; ND22882
DR   Wikidata; Q54928561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22884
AC   CVCL_GN42
DR   Coriell; ND22884
DR   Wikidata; Q54928565
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22891
AC   CVCL_GN43
DR   Coriell; ND22891
DR   Wikidata; Q54928566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22892
AC   CVCL_FF68
DR   Coriell; ND22892
DR   Wikidata; Q54928567
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22897
AC   CVCL_GN44
DR   BioSample; SAMN00801516
DR   Coriell; ND22897
DR   Wikidata; Q54928568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22898
AC   CVCL_GN45
DR   BioSample; SAMN00801518
DR   Coriell; ND22898
DR   Wikidata; Q54928569
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22901
AC   CVCL_GN46
DR   Coriell; ND22901
DR   Wikidata; Q54928570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22905
AC   CVCL_GN47
DR   Coriell; ND22905
DR   Wikidata; Q54928571
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22911
AC   CVCL_GN48
DR   Coriell; ND22911
DR   Wikidata; Q54928572
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22913
AC   CVCL_GN49
DR   Coriell; ND22913
DR   Wikidata; Q54928573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22914
AC   CVCL_FF69
DR   Coriell; ND22914
DR   Wikidata; Q54928574
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22915
AC   CVCL_GN50
DR   Coriell; ND22915
DR   Wikidata; Q54928575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22919
AC   CVCL_GN51
DR   Coriell; ND22919
DR   Wikidata; Q54928576
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22921
AC   CVCL_GN52
DR   BioSample; SAMN00801522
DR   Coriell; ND22921
DR   Wikidata; Q54928577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22926
AC   CVCL_FF70
DR   Coriell; ND22926
DR   Wikidata; Q54928578
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22927
AC   CVCL_FF71
DR   Coriell; ND22927
DR   Wikidata; Q54928579
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22929
AC   CVCL_GN53
DR   Coriell; ND22929
DR   Wikidata; Q54928580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22930
AC   CVCL_GN54
DR   Coriell; ND22930
DR   Wikidata; Q54928581
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22932
AC   CVCL_GN55
DR   Coriell; ND22932
DR   Wikidata; Q54928582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22934
AC   CVCL_GN56
DR   Coriell; ND22934
DR   Wikidata; Q54928583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22942
AC   CVCL_FF72
DR   Coriell; ND22942
DR   Wikidata; Q54928584
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22954
AC   CVCL_FF73
DR   Coriell; ND22954
DR   Wikidata; Q54928585
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND22963
AC   CVCL_FM58
DR   Coriell; ND22963
DR   Wikidata; Q54928586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22967
AC   CVCL_FU43
DR   Coriell; ND22967
DR   Wikidata; Q54928587
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22976
AC   CVCL_CU64
DR   Coriell; ND22976
DR   Wikidata; Q54928588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22987
AC   CVCL_CU65
DR   Coriell; ND22987
DR   Wikidata; Q54928589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22991
AC   CVCL_CU66
DR   Coriell; ND22991
DR   Wikidata; Q54928590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND22992
AC   CVCL_EH93
DR   Coriell; ND22992
DR   Wikidata; Q54928591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND22993
AC   CVCL_FM59
DR   Coriell; ND22993
DR   Wikidata; Q54928592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND22998
AC   CVCL_FF74
DR   Coriell; ND22998
DR   Wikidata; Q54928593
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23
AC   CVCL_VK94
SY   Neuroblastoma X DRG neurons hybrid 23
DR   Wikidata; Q98127456
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND23002
AC   CVCL_FF75
DR   Coriell; ND23002
DR   Wikidata; Q54928594
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23009
AC   CVCL_FF76
DR   Coriell; ND23009
DR   Wikidata; Q54928595
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23011
AC   CVCL_FF77
DR   Coriell; ND23011
DR   Wikidata; Q54928596
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23012
AC   CVCL_FF78
DR   Coriell; ND23012
DR   Wikidata; Q54928597
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23013
AC   CVCL_FF79
DR   Coriell; ND23013
DR   Wikidata; Q54928598
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23014
AC   CVCL_FF80
DR   Coriell; ND23014
DR   Wikidata; Q54928599
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23017
AC   CVCL_FF81
DR   Coriell; ND23017
DR   Wikidata; Q54928600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND23017; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   ND23019
AC   CVCL_FF82
DR   Coriell; ND23019
DR   Wikidata; Q54928601
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23020
AC   CVCL_FF83
DR   Coriell; ND23020
DR   Wikidata; Q54928602
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23021
AC   CVCL_GN57
DR   Coriell; ND23021
DR   Wikidata; Q54928603
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23022
AC   CVCL_FF84
DR   Coriell; ND23022
DR   Wikidata; Q54928604
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23023
AC   CVCL_FF85
DR   Coriell; ND23023
DR   Wikidata; Q54928608
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23024
AC   CVCL_FF86
DR   Coriell; ND23024
DR   Wikidata; Q54928609
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23025
AC   CVCL_FF87
DR   Coriell; ND23025
DR   Wikidata; Q54928611
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23049
AC   CVCL_GN58
DR   Coriell; ND23049
DR   Wikidata; Q54928612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23051
AC   CVCL_GN59
DR   Coriell; ND23051
DR   Wikidata; Q54928613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23063
AC   CVCL_GN60
DR   Coriell; ND23063
DR   Wikidata; Q54928614
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23069
AC   CVCL_FF88
DR   Coriell; ND23069
DR   Wikidata; Q54928615
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23074
AC   CVCL_IG02
DR   Coriell; ND23074
DR   Wikidata; Q54928616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND23076
AC   CVCL_FF89
DR   Coriell; ND23076
DR   Wikidata; Q54928617
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23078
AC   CVCL_GN61
DR   Coriell; ND23078
DR   Wikidata; Q54928618
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23082
AC   CVCL_GN62
DR   Coriell; ND23082
DR   Wikidata; Q54928619
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23084
AC   CVCL_GN63
DR   Coriell; ND23084
DR   Wikidata; Q54928620
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23090
AC   CVCL_GN64
DR   Coriell; ND23090
DR   Wikidata; Q54928621
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23092
AC   CVCL_GN65
DR   Coriell; ND23092
DR   Wikidata; Q54928622
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23103
AC   CVCL_GN66
DR   Coriell; ND23103
DR   Wikidata; Q54928623
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23104
AC   CVCL_FF90
DR   Coriell; ND23104
DR   Wikidata; Q54928624
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23105
AC   CVCL_FF91
DR   Coriell; ND23105
DR   Wikidata; Q54928625
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23106
AC   CVCL_FF92
DR   Coriell; ND23106
DR   Wikidata; Q54928626
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23109
AC   CVCL_GN67
DR   Coriell; ND23109
DR   Wikidata; Q54928627
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23110
AC   CVCL_FF93
DR   Coriell; ND23110
DR   Wikidata; Q54928628
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23114
AC   CVCL_FF94
DR   Coriell; ND23114
DR   Wikidata; Q54928629
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23118
AC   CVCL_FF95
DR   Coriell; ND23118
DR   Wikidata; Q54928630
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23121
AC   CVCL_GN68
DR   Coriell; ND23121
DR   Wikidata; Q54928631
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23122
AC   CVCL_FF96
DR   Coriell; ND23122
DR   Wikidata; Q54928632
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23123
AC   CVCL_FF97
DR   Coriell; ND23123
DR   Wikidata; Q54928633
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23125
AC   CVCL_FF98
DR   Coriell; ND23125
DR   Wikidata; Q54928634
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23129
AC   CVCL_FF99
DR   Coriell; ND23129
DR   Wikidata; Q54928635
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23132
AC   CVCL_FU44
DR   Coriell; ND23132
DR   Wikidata; Q54928636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23153
AC   CVCL_CU67
DR   Coriell; ND23153
DR   Wikidata; Q54928637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23159
AC   CVCL_CU68
DR   Coriell; ND23159
DR   Wikidata; Q54928638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23164
AC   CVCL_IG03
DR   Coriell; ND23164
DR   Wikidata; Q54928639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND23169
AC   CVCL_CU69
DR   Coriell; ND23169
DR   Wikidata; Q54928640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23174
AC   CVCL_CU70
DR   Coriell; ND23174
DR   Wikidata; Q54928641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23175
AC   CVCL_CU71
DR   Coriell; ND23175
DR   Wikidata; Q54928642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23179
AC   CVCL_GN69
DR   BioSample; SAMN00801629
DR   Coriell; ND23179
DR   Wikidata; Q54928643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23187
AC   CVCL_IG04
DR   Coriell; ND23187
DR   Wikidata; Q54928644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND23204
AC   CVCL_FE87
DR   Coriell; ND23204
DR   Wikidata; Q54928645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23205
AC   CVCL_FE88
DR   Coriell; ND23205
DR   Wikidata; Q54928646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23206
AC   CVCL_FE89
DR   Coriell; ND23206
DR   Wikidata; Q54928647
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23209
AC   CVCL_GN71
DR   Coriell; ND23209
DR   Wikidata; Q54928648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23225
AC   CVCL_EH94
DR   Coriell; ND23225
DR   Wikidata; Q54928651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND23230
AC   CVCL_FM60
DR   Coriell; ND23230
DR   Wikidata; Q54928652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23231
AC   CVCL_FM61
DR   Coriell; ND23231
DR   Wikidata; Q54928653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23244
AC   CVCL_FM62
DR   Coriell; ND23244
DR   Wikidata; Q54928654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23245
AC   CVCL_FM63
DR   Coriell; ND23245
DR   Wikidata; Q54928655
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23246
AC   CVCL_CU72
DR   Coriell; ND23246
DR   Wikidata; Q54928656
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23248
AC   CVCL_FG00
DR   Coriell; ND23248
DR   Wikidata; Q54928657
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23252
AC   CVCL_FU45
DR   Coriell; ND23252
DR   Wikidata; Q54928658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23271
AC   CVCL_GN72
DR   Coriell; ND23271
DR   Wikidata; Q54928659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23275
AC   CVCL_CU73
DR   Coriell; ND23275
DR   Wikidata; Q54928660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23278
AC   CVCL_IH63
DR   Coriell; ND23278
DR   Wikidata; Q54928661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND23294
AC   CVCL_GN73
DR   Coriell; ND23294
DR   Wikidata; Q54928662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23312
AC   CVCL_CU74
DR   Coriell; ND23312
DR   Wikidata; Q54928663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23313
AC   CVCL_CU75
DR   BioSample; SAMN00801735
DR   Coriell; ND23313
DR   Wikidata; Q54928664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND23316
AC   CVCL_GN74
DR   Coriell; ND23316
DR   Wikidata; Q54928665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23348
AC   CVCL_CU76
DR   Coriell; ND23348
DR   Wikidata; Q54928666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23350
AC   CVCL_GN75
DR   Coriell; ND23350
DR   Wikidata; Q54928667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23359
AC   CVCL_IG05
DR   Coriell; ND23359
DR   Wikidata; Q54928668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND23363
AC   CVCL_CU77
DR   Coriell; ND23363
DR   Wikidata; Q54928670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23373
AC   CVCL_CU78
DR   Coriell; ND23373
DR   Wikidata; Q54928671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23401
AC   CVCL_CU79
DR   Coriell; ND23401
DR   Wikidata; Q54928672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23419
AC   CVCL_FG01
DR   Coriell; ND23419
DR   Wikidata; Q54928673
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23420
AC   CVCL_GN76
DR   Coriell; ND23420
DR   Wikidata; Q54928674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23427
AC   CVCL_GN77
DR   Coriell; ND23427
DR   Wikidata; Q54928675
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23439
AC   CVCL_FU46
DR   Coriell; ND23439
DR   Wikidata; Q54928676
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23448
AC   CVCL_CU80
DR   Coriell; ND23448
DR   Wikidata; Q54928677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23452
AC   CVCL_CU81
DR   Coriell; ND23452
DR   Wikidata; Q54928678
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23453
AC   CVCL_CU82
DR   Coriell; ND23453
DR   Wikidata; Q54928679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23456
AC   CVCL_CU83
DR   Coriell; ND23456
DR   Wikidata; Q54928680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23465
AC   CVCL_FM64
DR   Coriell; ND23465
DR   Wikidata; Q54928681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23466
AC   CVCL_CU84
DR   Coriell; ND23466
DR   Wikidata; Q54928682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23468
AC   CVCL_CU85
DR   Coriell; ND23468
DR   Wikidata; Q54928683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23488
AC   CVCL_FM65
DR   Coriell; ND23488
DR   Wikidata; Q54928684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23490
AC   CVCL_CU86
DR   Coriell; ND23490
DR   Wikidata; Q54928685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23501
AC   CVCL_CU87
DR   Coriell; ND23501
DR   Wikidata; Q54928686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23514
AC   CVCL_FG02
DR   Coriell; ND23514
DR   Wikidata; Q54928687
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23524
AC   CVCL_CU88
DR   Coriell; ND23524
DR   Wikidata; Q54928688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23526
AC   CVCL_CU89
DR   Coriell; ND23526
DR   Wikidata; Q54928689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23527
AC   CVCL_CU90
DR   Coriell; ND23527
DR   Wikidata; Q54928690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23528
AC   CVCL_CU91
DR   Coriell; ND23528
DR   Wikidata; Q54928691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23531
AC   CVCL_FM66
DR   Coriell; ND23531
DR   Wikidata; Q54928693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23532
AC   CVCL_GN78
DR   Coriell; ND23532
DR   Wikidata; Q54928694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23534
AC   CVCL_FG03
DR   Coriell; ND23534
DR   Wikidata; Q54928695
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23535
AC   CVCL_FG04
DR   Coriell; ND23535
DR   Wikidata; Q54928696
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23536
AC   CVCL_FG05
DR   Coriell; ND23536
DR   Wikidata; Q54928697
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23537
AC   CVCL_FG06
DR   Coriell; ND23537
DR   Wikidata; Q54928699
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23538
AC   CVCL_FG07
DR   Coriell; ND23538
DR   Wikidata; Q54928700
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23539
AC   CVCL_FG08
DR   Coriell; ND23539
DR   Wikidata; Q54928701
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23540
AC   CVCL_FG09
DR   Coriell; ND23540
DR   Wikidata; Q54928702
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23578
AC   CVCL_FM67
DR   Coriell; ND23578
DR   Wikidata; Q54928703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23579
AC   CVCL_FM68
DR   Coriell; ND23579
DR   Wikidata; Q54928704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23580
AC   CVCL_CU92
DR   Coriell; ND23580
DR   Wikidata; Q54928705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23594
AC   CVCL_GN79
DR   Coriell; ND23594
DR   Wikidata; Q54928706
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23606
AC   CVCL_IG06
DR   Coriell; ND23606
DR   Wikidata; Q54928707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND23608
AC   CVCL_GN80
DR   Coriell; ND23608
DR   Wikidata; Q54928708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23613
AC   CVCL_GN81
DR   Coriell; ND23613
DR   Wikidata; Q54928709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23624
AC   CVCL_FU47
DR   Coriell; ND23624
DR   Wikidata; Q54928710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23626
AC   CVCL_FU48
DR   Coriell; ND23626
DR   Wikidata; Q54928711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23637
AC   CVCL_FM69
DR   Coriell; ND23637
DR   Wikidata; Q54928712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23639
AC   CVCL_GN82
DR   Coriell; ND23639
DR   Wikidata; Q54928713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23640
AC   CVCL_GN83
DR   Coriell; ND23640
DR   Wikidata; Q54928714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23648
AC   CVCL_GN84
DR   Coriell; ND23648
DR   Wikidata; Q54928715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23649
AC   CVCL_GN85
DR   Coriell; ND23649
DR   Wikidata; Q54928716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23650
AC   CVCL_CU93
DR   Coriell; ND23650
DR   Wikidata; Q54928717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23651
AC   CVCL_CU94
DR   Coriell; ND23651
DR   Wikidata; Q54928718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23666
AC   CVCL_CU95
DR   Coriell; ND23666
DR   Wikidata; Q54928719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23667
AC   CVCL_CU96
DR   Coriell; ND23667
DR   Wikidata; Q54928720
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23682
AC   CVCL_CU97
DR   Coriell; ND23682
DR   Wikidata; Q54928721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23687
AC   CVCL_GN86
DR   Coriell; ND23687
DR   Wikidata; Q54928722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23688
AC   CVCL_GN87
DR   Coriell; ND23688
DR   Wikidata; Q54928723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23717
AC   CVCL_GN88
DR   Coriell; ND23717
DR   Wikidata; Q54928724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23718
AC   CVCL_GN89
DR   Coriell; ND23718
DR   Wikidata; Q54928725
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23719
AC   CVCL_FM70
DR   Coriell; ND23719
DR   Wikidata; Q54928726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23743
AC   CVCL_FM71
DR   Coriell; ND23743
DR   Wikidata; Q54928727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23756
AC   CVCL_FG10
DR   Coriell; ND23756
DR   Wikidata; Q54928728
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23758
AC   CVCL_CU98
DR   Coriell; ND23758
DR   Wikidata; Q54928729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23766
AC   CVCL_CU99
DR   Coriell; ND23766
DR   Wikidata; Q54928730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23777
AC   CVCL_CV00
DR   Coriell; ND23777
DR   Wikidata; Q54928731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23778
AC   CVCL_FU49
DR   Coriell; ND23778
DR   Wikidata; Q54928732
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23780
AC   CVCL_FU50
DR   Coriell; ND23780
DR   Wikidata; Q54928733
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23785
AC   CVCL_GN90
DR   Coriell; ND23785
DR   Wikidata; Q54928735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23786
AC   CVCL_FG11
DR   Coriell; ND23786
DR   Wikidata; Q54928736
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23787
AC   CVCL_GN91
DR   Coriell; ND23787
DR   Wikidata; Q54928737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23788
AC   CVCL_GN92
DR   Coriell; ND23788
DR   Wikidata; Q54928738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23795
AC   CVCL_CV01
DR   Coriell; ND23795
DR   Wikidata; Q54928739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23799
AC   CVCL_CV02
DR   Coriell; ND23799
DR   Wikidata; Q54928740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND238
AC   CVCL_0B85
DR   Wikidata; Q54928741
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 17,24
ST   D3S1358: 13,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 20,26
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   ND23802
AC   CVCL_CV03
DR   Coriell; ND23802
DR   Wikidata; Q54928742
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23813
AC   CVCL_FM72
DR   Coriell; ND23813
DR   Wikidata; Q54928743
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23823
AC   CVCL_CV04
DR   Coriell; ND23823
DR   Wikidata; Q54928744
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23824
AC   CVCL_FM73
DR   Coriell; ND23824
DR   Wikidata; Q54928745
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23828
AC   CVCL_FM74
DR   Coriell; ND23828
DR   Wikidata; Q54928746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23829
AC   CVCL_CV05
DR   Coriell; ND23829
DR   Wikidata; Q54928747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23835
AC   CVCL_CV06
DR   Coriell; ND23835
DR   Wikidata; Q54928748
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23848
AC   CVCL_FG12
DR   Coriell; ND23848
DR   Wikidata; Q54928749
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23851
AC   CVCL_GN93
DR   Coriell; ND23851
DR   Wikidata; Q54928750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23852
AC   CVCL_FM75
DR   Coriell; ND23852
DR   Wikidata; Q54928751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23873
AC   CVCL_CV07
DR   Coriell; ND23873
DR   Wikidata; Q54928752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23887
AC   CVCL_GN94
DR   Coriell; ND23887
DR   Wikidata; Q54928753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23888
AC   CVCL_GN95
DR   Coriell; ND23888
DR   Wikidata; Q54928754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23889
AC   CVCL_FG13
DR   Coriell; ND23889
DR   Wikidata; Q54928755
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23890
AC   CVCL_FG14
DR   Coriell; ND23890
DR   Wikidata; Q54928756
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND23892
AC   CVCL_GN96
DR   Coriell; ND23892
DR   Wikidata; Q54928757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23909
AC   CVCL_GN97
DR   Coriell; ND23909
DR   Wikidata; Q54928758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23910
AC   CVCL_GN98
DR   Coriell; ND23910
DR   Wikidata; Q54928759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23920
AC   CVCL_GN99
DR   Coriell; ND23920
DR   Wikidata; Q54928760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23922
AC   CVCL_GP00
DR   Coriell; ND23922
DR   Wikidata; Q54928761
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23926
AC   CVCL_CV08
DR   Coriell; ND23926
DR   Wikidata; Q54928762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND23960
AC   CVCL_GP01
DR   Coriell; ND23960
DR   Wikidata; Q54928763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23969
AC   CVCL_GP02
DR   Coriell; ND23969
DR   Wikidata; Q54928764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23970
AC   CVCL_GP03
DR   Coriell; ND23970
DR   Wikidata; Q54928765
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23989
AC   CVCL_FM76
DR   Coriell; ND23989
DR   Wikidata; Q54928766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23990
AC   CVCL_GP04
DR   Coriell; ND23990
DR   Wikidata; Q54928767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND23993
AC   CVCL_GP05
DR   Coriell; ND23993
DR   Wikidata; Q54928768
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24001
AC   CVCL_IG07
DR   Coriell; ND24001
DR   Wikidata; Q54928769
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND24005
AC   CVCL_FM77
DR   Coriell; ND24005
DR   Wikidata; Q54928770
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24006
AC   CVCL_GP06
DR   Coriell; ND24006
DR   Wikidata; Q54928771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24010
AC   CVCL_FG15
DR   Coriell; ND24010
DR   Wikidata; Q54928772
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24012
AC   CVCL_FG16
DR   Coriell; ND24012
DR   Wikidata; Q54928773
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24015
AC   CVCL_FG17
DR   Coriell; ND24015
DR   Wikidata; Q54928774
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24017
AC   CVCL_FG18
DR   Coriell; ND24017
DR   Wikidata; Q54928780
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24018
AC   CVCL_FG19
DR   Coriell; ND24018
DR   Wikidata; Q54928781
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24019
AC   CVCL_FG20
DR   Coriell; ND24019
DR   Wikidata; Q54928782
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24020
AC   CVCL_FG21
DR   Coriell; ND24020
DR   Wikidata; Q54928783
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24022
AC   CVCL_GP07
DR   Coriell; ND24022
DR   Wikidata; Q54928784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24023
AC   CVCL_FG22
DR   Coriell; ND24023
DR   Wikidata; Q54928785
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24024
AC   CVCL_FG23
DR   Coriell; ND24024
DR   Wikidata; Q54928786
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24029
AC   CVCL_FG24
DR   Coriell; ND24029
DR   Wikidata; Q54928787
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24030
AC   CVCL_FG25
DR   Coriell; ND24030
DR   Wikidata; Q54928788
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24031
AC   CVCL_FG26
DR   Coriell; ND24031
DR   Wikidata; Q54928789
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24041
AC   CVCL_IH64
DR   Coriell; ND24041
DR   Wikidata; Q54928790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND24057
AC   CVCL_CV09
DR   Coriell; ND24057
DR   Wikidata; Q54928791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24060
AC   CVCL_GP08
DR   Coriell; ND24060
DR   Wikidata; Q54928792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24061
AC   CVCL_GP09
DR   Coriell; ND24061
DR   Wikidata; Q54928793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24062
AC   CVCL_FG27
DR   Coriell; ND24062
DR   Wikidata; Q54928794
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24065
AC   CVCL_FM78
DR   Coriell; ND24065
DR   Wikidata; Q54928795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24081
AC   CVCL_GP10
DR   Coriell; ND24081
DR   Wikidata; Q54928796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24096
AC   CVCL_FM79
DR   Coriell; ND24096
DR   Wikidata; Q54928797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24098
AC   CVCL_IH65
DR   Coriell; ND24098
DR   Wikidata; Q54928798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND24104
AC   CVCL_FM80
DR   Coriell; ND24104
DR   Wikidata; Q54928799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24105
AC   CVCL_FM81
DR   Coriell; ND24105
DR   Wikidata; Q54928801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24108
AC   CVCL_EH95
DR   Coriell; ND24108
DR   Wikidata; Q54928802
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND24111
AC   CVCL_FG28
DR   Coriell; ND24111
DR   Wikidata; Q54928803
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24112
AC   CVCL_FG29
DR   Coriell; ND24112
DR   Wikidata; Q54928804
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24113
AC   CVCL_FG30
DR   Coriell; ND24113
DR   Wikidata; Q54928805
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24118
AC   CVCL_FG31
DR   Coriell; ND24118
DR   Wikidata; Q54928806
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24135
AC   CVCL_FG32
DR   Coriell; ND24135
DR   Wikidata; Q54928807
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24136
AC   CVCL_FG33
DR   Coriell; ND24136
DR   Wikidata; Q54928808
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24138
AC   CVCL_FG34
DR   Coriell; ND24138
DR   Wikidata; Q54928809
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24141
AC   CVCL_GP11
DR   Coriell; ND24141
DR   Wikidata; Q54928810
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24142
AC   CVCL_GP12
DR   Coriell; ND24142
DR   Wikidata; Q54928811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24145
AC   CVCL_GP13
DR   Coriell; ND24145
DR   Wikidata; Q54928812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24146
AC   CVCL_FG35
DR   Coriell; ND24146
DR   Wikidata; Q54928813
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24148
AC   CVCL_GP14
DR   Coriell; ND24148
DR   Wikidata; Q54928814
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24149
AC   CVCL_FG36
DR   Coriell; ND24149
DR   Wikidata; Q54928815
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24151
AC   CVCL_FG37
DR   Coriell; ND24151
DR   Wikidata; Q54928816
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24174
AC   CVCL_FM82
DR   Coriell; ND24174
DR   Wikidata; Q54928817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y11M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24188
AC   CVCL_FM83
DR   Coriell; ND24188
DR   Wikidata; Q54928818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24191
AC   CVCL_FM84
DR   Coriell; ND24191
DR   Wikidata; Q54928819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24199
AC   CVCL_FU51
DR   Coriell; ND24199
DR   Wikidata; Q54928820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24202
AC   CVCL_IG08
DR   Coriell; ND24202
DR   Wikidata; Q54928824
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND24217
AC   CVCL_FM85
DR   Coriell; ND24217
DR   Wikidata; Q54928825
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24218
AC   CVCL_FM86
DR   Coriell; ND24218
DR   Wikidata; Q54928826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24220
AC   CVCL_GP15
DR   Coriell; ND24220
DR   Wikidata; Q54928827
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24221
AC   CVCL_GP16
DR   Coriell; ND24221
DR   Wikidata; Q54928828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24275
AC   CVCL_CV10
DR   Coriell; ND24275
DR   Wikidata; Q54928829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24284
AC   CVCL_GP17
DR   Coriell; ND24284
DR   Wikidata; Q54928830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24290
AC   CVCL_FM87
DR   Coriell; ND24290
DR   Wikidata; Q54928831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24291
AC   CVCL_FM88
DR   Coriell; ND24291
DR   Wikidata; Q54928832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24310
AC   CVCL_GP18
DR   Coriell; ND24310
DR   Wikidata; Q54928833
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24311
AC   CVCL_FG38
DR   Coriell; ND24311
DR   Wikidata; Q54928834
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24312
AC   CVCL_GP19
DR   Coriell; ND24312
DR   Wikidata; Q54928835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24317
AC   CVCL_GP20
DR   Coriell; ND24317
DR   Wikidata; Q54928837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24343
AC   CVCL_FM89
DR   Coriell; ND24343
DR   Wikidata; Q54928838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24346
AC   CVCL_FM90
DR   Coriell; ND24346
DR   Wikidata; Q54928839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24360
AC   CVCL_FM91
DR   Coriell; ND24360
DR   Wikidata; Q54928840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24366
AC   CVCL_GP21
DR   Coriell; ND24366
DR   Wikidata; Q54928841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24370
AC   CVCL_GP22
DR   Coriell; ND24370
DR   Wikidata; Q54928842
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24389
AC   CVCL_FM92
DR   Coriell; ND24389
DR   Wikidata; Q54928843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24396
AC   CVCL_GP23
DR   Coriell; ND24396
DR   Wikidata; Q54928844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24401
AC   CVCL_GP24
DR   Coriell; ND24401
DR   Wikidata; Q54928845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24433
AC   CVCL_FU52
DR   Coriell; ND24433
DR   Wikidata; Q54928846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24444
AC   CVCL_FM93
DR   Coriell; ND24444
DR   Wikidata; Q54928847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24453
AC   CVCL_FM94
DR   Coriell; ND24453
DR   Wikidata; Q54928848
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24498
AC   CVCL_FU53
DR   Coriell; ND24498
DR   Wikidata; Q54928849
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24514
AC   CVCL_FM95
DR   Coriell; ND24514
DR   Wikidata; Q54928850
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24539
AC   CVCL_FM96
DR   Coriell; ND24539
DR   Wikidata; Q54928851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24549
AC   CVCL_FM97
DR   Coriell; ND24549
DR   Wikidata; Q54928852
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24550
AC   CVCL_FM98
DR   Coriell; ND24550
DR   Wikidata; Q54928853
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24563
AC   CVCL_IG09
DR   Coriell; ND24563
DR   Wikidata; Q54928854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND24568
AC   CVCL_CV11
DR   Coriell; ND24568
DR   Wikidata; Q54928855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24573
AC   CVCL_CV12
DR   Coriell; ND24573
DR   Wikidata; Q54928856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24581
AC   CVCL_FU54
DR   Coriell; ND24581
DR   Wikidata; Q54928857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24589
AC   CVCL_FM99
DR   Coriell; ND24589
DR   Wikidata; Q54928858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24606
AC   CVCL_CV13
DR   BioSample; SAMN00802645
DR   Coriell; ND24606
DR   Wikidata; Q54928859
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   ND24612
AC   CVCL_FN00
DR   Coriell; ND24612
DR   Wikidata; Q54928860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24613
AC   CVCL_FN01
DR   Coriell; ND24613
DR   Wikidata; Q54928861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24627
AC   CVCL_CV14
DR   Coriell; ND24627
DR   Wikidata; Q54928862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24630
AC   CVCL_FG39
DR   Coriell; ND24630
DR   Wikidata; Q54928863
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24631
AC   CVCL_FG40
DR   Coriell; ND24631
DR   Wikidata; Q54928864
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24634
AC   CVCL_CV15
DR   Coriell; ND24634
DR   Wikidata; Q54928867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24643
AC   CVCL_FN02
DR   Coriell; ND24643
DR   Wikidata; Q54928868
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24646
AC   CVCL_FN03
DR   Coriell; ND24646
DR   Wikidata; Q54928869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24647
AC   CVCL_FN04
DR   Coriell; ND24647
DR   Wikidata; Q54928870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24657
AC   CVCL_FN05
DR   Coriell; ND24657
DR   Wikidata; Q54928871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24670
AC   CVCL_FG41
DR   Coriell; ND24670
DR   Wikidata; Q54928872
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24687
AC   CVCL_FN06
DR   Coriell; ND24687
DR   Wikidata; Q54928874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24688
AC   CVCL_IG10
DR   Coriell; ND24688
DR   Wikidata; Q54928875
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND24710
AC   CVCL_FN07
DR   Coriell; ND24710
DR   Wikidata; Q54928876
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24748
AC   CVCL_CV16
DR   Coriell; ND24748
DR   Wikidata; Q54928877
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24753
AC   CVCL_GP25
DR   Coriell; ND24753
DR   Wikidata; Q54928878
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24782
AC   CVCL_FN08
DR   Coriell; ND24782
DR   Wikidata; Q54928879
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24785
AC   CVCL_FN09
DR   Coriell; ND24785
DR   Wikidata; Q54928880
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24788
AC   CVCL_FU55
DR   Coriell; ND24788
DR   Wikidata; Q54928881
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24791
AC   CVCL_FU56
DR   Coriell; ND24791
DR   Wikidata; Q54928882
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24792
AC   CVCL_FU57
DR   Coriell; ND24792
DR   Wikidata; Q54928883
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24821
AC   CVCL_CV17
DR   Coriell; ND24821
DR   Wikidata; Q54928884
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24826
AC   CVCL_FG42
DR   Coriell; ND24826
DR   Wikidata; Q54928886
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24838
AC   CVCL_FN10
DR   Coriell; ND24838
DR   Wikidata; Q54928887
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24839
AC   CVCL_FN11
DR   Coriell; ND24839
DR   Wikidata; Q54928888
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24891
AC   CVCL_FN12
DR   Coriell; ND24891
DR   Wikidata; Q54928889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24901
AC   CVCL_GP26
DR   Coriell; ND24901
DR   Wikidata; Q54928890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24922
AC   CVCL_FN13
DR   Coriell; ND24922
DR   Wikidata; Q54928891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24925
AC   CVCL_CV18
DR   Coriell; ND24925
DR   Wikidata; Q54928892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24927
AC   CVCL_CV19
DR   Coriell; ND24927
DR   Wikidata; Q54928893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24930
AC   CVCL_CV20
DR   Coriell; ND24930
DR   Wikidata; Q54928894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24933
AC   CVCL_FN14
DR   Coriell; ND24933
DR   Wikidata; Q54928895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24936
AC   CVCL_CV21
DR   Coriell; ND24936
DR   Wikidata; Q54928896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND24948
AC   CVCL_FN15
DR   Coriell; ND24948
DR   Wikidata; Q54928897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24955
AC   CVCL_IH66
DR   Coriell; ND24955
DR   Wikidata; Q54928898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND24979
AC   CVCL_FN16
DR   Coriell; ND24979
DR   Wikidata; Q54928899
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24980
AC   CVCL_FN17
DR   Coriell; ND24980
DR   Wikidata; Q54928900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND24985
AC   CVCL_FG43
DR   Coriell; ND24985
DR   Wikidata; Q54928901
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND24996
AC   CVCL_FN18
DR   Coriell; ND24996
DR   Wikidata; Q54928903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25008
AC   CVCL_FN19
DR   Coriell; ND25008
DR   Wikidata; Q54928904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25010
AC   CVCL_IH67
DR   Coriell; ND25010
DR   Wikidata; Q54928905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND25026
AC   CVCL_FN20
DR   Coriell; ND25026
DR   Wikidata; Q54928906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25031
AC   CVCL_IH68
DR   Coriell; ND25031
DR   Wikidata; Q54928907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND25037
AC   CVCL_CV22
DR   Coriell; ND25037
DR   Wikidata; Q54928908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND25049
AC   CVCL_IH69
DR   Coriell; ND25049
DR   Wikidata; Q54928909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND25055
AC   CVCL_CV23
DR   Coriell; ND25055
DR   Wikidata; Q54928913
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND25070
AC   CVCL_FN21
DR   Coriell; ND25070
DR   Wikidata; Q54928914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25071
AC   CVCL_FN22
DR   Coriell; ND25071
DR   Wikidata; Q54928915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25126
AC   CVCL_GP27
DR   BioSample; SAMN00803047
DR   Coriell; ND25126
DR   Wikidata; Q54928916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25128
AC   CVCL_IH70
DR   Coriell; ND25128
DR   Wikidata; Q54928917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND25181
AC   CVCL_FN23
DR   Coriell; ND25181
DR   Wikidata; Q54928918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25193
AC   CVCL_FN24
DR   Coriell; ND25193
DR   Wikidata; Q54928919
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25206
AC   CVCL_FN25
DR   Coriell; ND25206
DR   Wikidata; Q54928920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25207
AC   CVCL_FN26
DR   Coriell; ND25207
DR   Wikidata; Q54928921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25209
AC   CVCL_GP28
DR   Coriell; ND25209
DR   Wikidata; Q54928922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25216
AC   CVCL_GP29
DR   Coriell; ND25216
DR   Wikidata; Q54928923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25220
AC   CVCL_FG44
DR   Coriell; ND25220
DR   Wikidata; Q54928925
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25221
AC   CVCL_FG45
DR   Coriell; ND25221
DR   Wikidata; Q54928926
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25222
AC   CVCL_FG46
DR   Coriell; ND25222
DR   Wikidata; Q54928927
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25223
AC   CVCL_FG47
DR   Coriell; ND25223
DR   Wikidata; Q54928928
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25228
AC   CVCL_FG48
DR   Coriell; ND25228
DR   Wikidata; Q54928929
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25250
AC   CVCL_FN27
DR   Coriell; ND25250
DR   Wikidata; Q54928930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25260
AC   CVCL_FN28
DR   Coriell; ND25260
DR   Wikidata; Q54928931
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25261
AC   CVCL_FN29
DR   Coriell; ND25261
DR   Wikidata; Q54928932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25283
AC   CVCL_FU58
DR   Coriell; ND25283
DR   Wikidata; Q54928933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25300
AC   CVCL_FN30
DR   Coriell; ND25300
DR   Wikidata; Q54928934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25301
AC   CVCL_FN31
DR   Coriell; ND25301
DR   Wikidata; Q54928935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25311
AC   CVCL_FG49
DR   Coriell; ND25311
DR   Wikidata; Q54928936
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25318
AC   CVCL_FG50
DR   Coriell; ND25318
DR   Wikidata; Q54928937
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25386
AC   CVCL_FN32
DR   Coriell; ND25386
DR   Wikidata; Q54928938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25400
AC   CVCL_FG51
DR   Coriell; ND25400
DR   Wikidata; Q54928939
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25412
AC   CVCL_FN33
DR   Coriell; ND25412
DR   Wikidata; Q54928940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25433
AC   CVCL_FG52
DR   Coriell; ND25433
DR   Wikidata; Q54928941
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25465
AC   CVCL_FN34
DR   Coriell; ND25465
DR   Wikidata; Q54928942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25480
AC   CVCL_GP30
DR   Coriell; ND25480
DR   Wikidata; Q54928943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25485
AC   CVCL_FN35
DR   Coriell; ND25485
DR   Wikidata; Q54928944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25486
AC   CVCL_FN36
DR   Coriell; ND25486
DR   Wikidata; Q54928945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25525
AC   CVCL_EE13
DR   Coriell; ND25525
DR   Wikidata; Q54928946
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND25540
AC   CVCL_FN37
DR   Coriell; ND25540
DR   Wikidata; Q54928947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25544
AC   CVCL_FN38
DR   Coriell; ND25544
DR   Wikidata; Q54928948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25545
AC   CVCL_FN39
DR   Coriell; ND25545
DR   Wikidata; Q54928949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25582
AC   CVCL_FN40
DR   Coriell; ND25582
DR   Wikidata; Q54928950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25632
AC   CVCL_FG53
DR   Coriell; ND25632
DR   Wikidata; Q54928951
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25682
AC   CVCL_FN41
DR   Coriell; ND25682
DR   Wikidata; Q54928952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25683
AC   CVCL_FN42
DR   Coriell; ND25683
DR   Wikidata; Q54928953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25686
AC   CVCL_FN43
DR   Coriell; ND25686
DR   Wikidata; Q54928957
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25720
AC   CVCL_FU59
DR   Coriell; ND25720
DR   Wikidata; Q54928958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25722
AC   CVCL_IG11
DR   Coriell; ND25722
DR   Wikidata; Q54928959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND25739
AC   CVCL_FN44
DR   Coriell; ND25739
DR   Wikidata; Q54928960
CC   Population: Bolivian and Caucasian; Lithuanian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y6M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND25754
AC   CVCL_GP31
DR   Coriell; ND25754
DR   Wikidata; Q54928961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25755
AC   CVCL_EE14
DR   Coriell; ND25755
DR   Wikidata; Q54928962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND25774
AC   CVCL_CV24
DR   Coriell; ND25774
DR   Wikidata; Q54928963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND25795
AC   CVCL_CV25
DR   Coriell; ND25795
DR   Wikidata; Q54928964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND25818
AC   CVCL_FN45
DR   Coriell; ND25818
DR   Wikidata; Q54928965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25819
AC   CVCL_FN46
DR   Coriell; ND25819
DR   Wikidata; Q54928966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25839
AC   CVCL_FN47
DR   Coriell; ND25839
DR   Wikidata; Q54928967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25874
AC   CVCL_FN48
DR   Coriell; ND25874
DR   Wikidata; Q54928968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25904
AC   CVCL_FN49
DR   Coriell; ND25904
DR   Wikidata; Q54928969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25930
AC   CVCL_CV26
DR   Coriell; ND25930
DR   Wikidata; Q54928970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND25948
AC   CVCL_FU60
DR   Coriell; ND25948
DR   Wikidata; Q54928971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND25988
AC   CVCL_IG12
DR   Coriell; ND25988
DR   Wikidata; Q54928972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26
AC   CVCL_VK95
SY   Neuroblastoma X DRG neurons hybrid 26
DR   Wikidata; Q98127458
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND26014
AC   CVCL_IG13
DR   Coriell; ND26014
DR   Wikidata; Q54928973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26020
AC   CVCL_GP32
DR   Coriell; ND26020
DR   Wikidata; Q54928974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26028
AC   CVCL_FU61
DR   Coriell; ND26028
DR   Wikidata; Q54928975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26031
AC   CVCL_FU62
DR   Coriell; ND26031
DR   Wikidata; Q54928976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26043
AC   CVCL_FG54
DR   Coriell; ND26043
DR   Wikidata; Q54928977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND26043; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   ND26072
AC   CVCL_IG14
DR   Coriell; ND26072
DR   Wikidata; Q54928978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26087
AC   CVCL_FN50
DR   Coriell; ND26087
DR   Wikidata; Q54928979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26121
AC   CVCL_FN51
DR   Coriell; ND26121
DR   Wikidata; Q54928980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26122
AC   CVCL_FN52
DR   Coriell; ND26122
DR   Wikidata; Q54928981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26123
AC   CVCL_FN53
DR   Coriell; ND26123
DR   Wikidata; Q54928982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26128
AC   CVCL_FG55
DR   BioSample; SAMN00804143
DR   Coriell; ND26128
DR   Wikidata; Q54928983
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND26129
AC   CVCL_FG56
DR   BioSample; SAMN00804145
DR   Coriell; ND26129
DR   Wikidata; Q54928985
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND26130
AC   CVCL_FG57
DR   Coriell; ND26130
DR   Wikidata; Q54928986
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26163
AC   CVCL_FN54
DR   Coriell; ND26163
DR   Wikidata; Q54928987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26164
AC   CVCL_FN55
DR   Coriell; ND26164
DR   Wikidata; Q54928988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26184
AC   CVCL_FG58
DR   Coriell; ND26184
DR   Wikidata; Q54928989
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26186
AC   CVCL_FG59
DR   Coriell; ND26186
DR   Wikidata; Q54928990
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26189
AC   CVCL_FG60
DR   Coriell; ND26189
DR   Wikidata; Q54928991
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26190
AC   CVCL_FG61
DR   Coriell; ND26190
DR   Wikidata; Q54928992
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26210
AC   CVCL_BS72
DR   Coriell; ND26210
DR   Wikidata; Q54928993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND26221
AC   CVCL_FG62
DR   Coriell; ND26221
DR   Wikidata; Q54928994
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26238
AC   CVCL_GP33
DR   Coriell; ND26238
DR   Wikidata; Q54928995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26243
AC   CVCL_GP34
DR   Coriell; ND26243
DR   Wikidata; Q54928996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26248
AC   CVCL_BS73
DR   Coriell; ND26248
DR   Wikidata; Q54928997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND26250
AC   CVCL_FN56
DR   Coriell; ND26250
DR   Wikidata; Q54929001
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26252
AC   CVCL_FN57
DR   Coriell; ND26252
DR   Wikidata; Q54929002
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26261
AC   CVCL_FG63
DR   Coriell; ND26261
DR   Wikidata; Q54929003
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26262
AC   CVCL_FG64
DR   Coriell; ND26262
DR   Wikidata; Q54929004
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26336
AC   CVCL_IG15
DR   Coriell; ND26336
DR   Wikidata; Q54929005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26355
AC   CVCL_FU63
DR   Coriell; ND26355
DR   Wikidata; Q54929006
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26413
AC   CVCL_EE15
DR   Coriell; ND26413
DR   Wikidata; Q54929007
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND26433
AC   CVCL_FG65
DR   Coriell; ND26433
DR   Wikidata; Q54929008
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26512
AC   CVCL_FG66
DR   Coriell; ND26512
DR   Wikidata; Q54929009
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; ND26512; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   ND26513
AC   CVCL_FG67
DR   Coriell; ND26513
DR   Wikidata; Q54929010
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26524
AC   CVCL_FN58
DR   Coriell; ND26524
DR   Wikidata; Q54929011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26531
AC   CVCL_FG68
DR   Coriell; ND26531
DR   Wikidata; Q54929012
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26557
AC   CVCL_FN59
DR   Coriell; ND26557
DR   Wikidata; Q54929013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26558
AC   CVCL_FN60
DR   Coriell; ND26558
DR   Wikidata; Q54929014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26601
AC   CVCL_GP35
DR   Coriell; ND26601
DR   Wikidata; Q54929015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26656
AC   CVCL_GP36
DR   Coriell; ND26656
DR   Wikidata; Q54929016
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26772
AC   CVCL_IG16
DR   Coriell; ND26772
DR   Wikidata; Q54929017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26773
AC   CVCL_HW64
DR   Coriell; ND26773
DR   Wikidata; Q54929018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26786
AC   CVCL_CV27
DR   Coriell; ND26786
DR   Wikidata; Q54929019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND26805
AC   CVCL_GP37
DR   Coriell; ND26805
DR   Wikidata; Q54929020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26816
AC   CVCL_GP38
DR   Coriell; ND26816
DR   Wikidata; Q54929021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26818
AC   CVCL_GP39
DR   Coriell; ND26818
DR   Wikidata; Q54929022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26867
AC   CVCL_IH71
DR   Coriell; ND26867
DR   Wikidata; Q54929023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26894
AC   CVCL_FG69
DR   Coriell; ND26894
DR   Wikidata; Q54929024
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26941
AC   CVCL_FG70
DR   Coriell; ND26941
DR   Wikidata; Q54929025
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND26974
AC   CVCL_FN61
DR   Coriell; ND26974
DR   Wikidata; Q54929026
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26976
AC   CVCL_GP40
DR   Coriell; ND26976
DR   Wikidata; Q54929027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26978
AC   CVCL_IG17
DR   Coriell; ND26978
DR   Wikidata; Q54929028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND26984
AC   CVCL_GP41
DR   Coriell; ND26984
DR   Wikidata; Q54929029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26987
AC   CVCL_GP42
DR   Coriell; ND26987
DR   Wikidata; Q54929030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26988
AC   CVCL_GP43
DR   Coriell; ND26988
DR   Wikidata; Q54929031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26993
AC   CVCL_GP44
DR   Coriell; ND26993
DR   Wikidata; Q54929032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND26995
AC   CVCL_GP45
DR   Coriell; ND26995
DR   Wikidata; Q54929033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27
AC   CVCL_4257
SY   Neuroblastoma X DRG neurons hybrid 27
DR   CLO; CLO_0008142
DR   CLDB; cl3679
DR   ECACC; 92090912
DR   Wikidata; Q54929034
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 7
//
ID   ND27062
AC   CVCL_FN62
DR   Coriell; ND27062
DR   Wikidata; Q54929035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27103
AC   CVCL_CV28
DR   Coriell; ND27103
DR   Wikidata; Q54929036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND27104
AC   CVCL_HW65
DR   Coriell; ND27104
DR   Wikidata; Q54929037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND27110
AC   CVCL_FN63
DR   Coriell; ND27110
DR   Wikidata; Q54929038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27117
AC   CVCL_GP46
DR   Coriell; ND27117
DR   Wikidata; Q54929040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27124
AC   CVCL_FN64
DR   Coriell; ND27124
DR   Wikidata; Q54929041
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27174
AC   CVCL_FU64
DR   Coriell; ND27174
DR   Wikidata; Q54929049
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27188
AC   CVCL_BS74
DR   Coriell; ND27188
DR   Wikidata; Q54929050
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND27253
AC   CVCL_FN65
DR   Coriell; ND27253
DR   Wikidata; Q54929051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27254
AC   CVCL_IH72
DR   Coriell; ND27254
DR   Wikidata; Q54929052
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND27325
AC   CVCL_HW66
DR   Coriell; ND27325
DR   Wikidata; Q54929053
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND27348
AC   CVCL_FN66
DR   Coriell; ND27348
DR   Wikidata; Q54929054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27371
AC   CVCL_FN67
DR   Coriell; ND27371
DR   Wikidata; Q54929055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27378
AC   CVCL_FU65
DR   Coriell; ND27378
DR   Wikidata; Q54929056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27390
AC   CVCL_IH73
DR   Coriell; ND27390
DR   Wikidata; Q54929057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND27404
AC   CVCL_FU66
DR   Coriell; ND27404
DR   Wikidata; Q54929059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27408
AC   CVCL_FN68
DR   Coriell; ND27408
DR   Wikidata; Q54929060
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27461
AC   CVCL_GP47
DR   Coriell; ND27461
DR   Wikidata; Q54929061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27464
AC   CVCL_FZ95
DR   Coriell; ND27464
DR   Wikidata; Q54929062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27474
AC   CVCL_FN69
DR   Coriell; ND27474
DR   Wikidata; Q54929063
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27522
AC   CVCL_FG71
DR   Coriell; ND27522
DR   Wikidata; Q54929065
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND27547
AC   CVCL_FU67
DR   Coriell; ND27547
DR   Wikidata; Q54929066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27654
AC   CVCL_FN70
DR   Coriell; ND27654
DR   Wikidata; Q54929067
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27733
AC   CVCL_FN71
DR   Coriell; ND27733
DR   Wikidata; Q54929068
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27734
AC   CVCL_FN72
DR   Coriell; ND27734
DR   Wikidata; Q54929069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27755
AC   CVCL_FN73
DR   Coriell; ND27755
DR   Wikidata; Q54929070
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27760
AC   CVCL_F204
DR   Coriell; ND27760
DR   NHCDR; ND27760
DR   Wikidata; Q54929071
RX   PubMed=22952635;
RX   PubMed=27191603;
RX   PubMed=34826737;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND27760; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L024 ! GM15844
OI   CVCL_F203 ! ND00139
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   ND27790
AC   CVCL_FG72
DR   Coriell; ND27790
DR   Wikidata; Q54929072
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND27841
AC   CVCL_FN74
DR   Coriell; ND27841
DR   Wikidata; Q54929073
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27880
AC   CVCL_FN75
DR   Coriell; ND27880
DR   Wikidata; Q54929074
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27885
AC   CVCL_IH74
DR   Coriell; ND27885
DR   Wikidata; Q54929075
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND27895
AC   CVCL_HW67
DR   Coriell; ND27895
DR   Wikidata; Q54929076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND27897
AC   CVCL_FZ96
DR   Coriell; ND27897
DR   Wikidata; Q54929078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27935
AC   CVCL_FN76
DR   Coriell; ND27935
DR   Wikidata; Q54929079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27945
AC   CVCL_GP48
DR   Coriell; ND27945
DR   Wikidata; Q54929080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27947
AC   CVCL_FN77
DR   Coriell; ND27947
DR   Wikidata; Q54929081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27948
AC   CVCL_FN78
DR   Coriell; ND27948
DR   Wikidata; Q54929082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27949
AC   CVCL_FN79
DR   Coriell; ND27949
DR   Wikidata; Q54929083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND27970
AC   CVCL_FN80
DR   Coriell; ND27970
DR   Wikidata; Q54929084
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28008
AC   CVCL_IG18
DR   Coriell; ND28008
DR   Wikidata; Q54929085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28046
AC   CVCL_IG19
DR   Coriell; ND28046
DR   Wikidata; Q54929086
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28051
AC   CVCL_FN81
DR   Coriell; ND28051
DR   Wikidata; Q54929087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28052
AC   CVCL_FN82
DR   Coriell; ND28052
DR   Wikidata; Q54929088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28079
AC   CVCL_FN83
DR   Coriell; ND28079
DR   Wikidata; Q54929090
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28086
AC   CVCL_FU68
DR   Coriell; ND28086
DR   Wikidata; Q54929092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28088
AC   CVCL_FU69
DR   Coriell; ND28088
DR   Wikidata; Q54929093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28099
AC   CVCL_GP49
DR   Coriell; ND28099
DR   Wikidata; Q54929100
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28114
AC   CVCL_FN84
DR   Coriell; ND28114
DR   Wikidata; Q54929101
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28130
AC   CVCL_CV29
DR   Coriell; ND28130
DR   Wikidata; Q54929102
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND28244
AC   CVCL_FU70
DR   Coriell; ND28244
DR   Wikidata; Q54929103
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28255
AC   CVCL_FN85
DR   Coriell; ND28255
DR   Wikidata; Q54929104
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28267
AC   CVCL_FU71
DR   Coriell; ND28267
DR   Wikidata; Q54929105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28294
AC   CVCL_FN86
DR   Coriell; ND28294
DR   Wikidata; Q54929106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28295
AC   CVCL_FN87
DR   Coriell; ND28295
DR   Wikidata; Q54929107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28304
AC   CVCL_GP50
DR   Coriell; ND28304
DR   Wikidata; Q54929108
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28350
AC   CVCL_BS75
DR   Coriell; ND28350
DR   Wikidata; Q54929109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   ND28383
AC   CVCL_IH75
DR   Coriell; ND28383
DR   Wikidata; Q54929110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28404
AC   CVCL_FN88
DR   Coriell; ND28404
DR   Wikidata; Q54929111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28405
AC   CVCL_FN89
DR   Coriell; ND28405
DR   Wikidata; Q54929112
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28426
AC   CVCL_FN90
DR   Coriell; ND28426
DR   Wikidata; Q54929113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28470
AC   CVCL_IG20
DR   Coriell; ND28470
DR   Wikidata; Q54929114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28472
AC   CVCL_FN91
DR   Coriell; ND28472
DR   Wikidata; Q54929115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28478
AC   CVCL_FN92
DR   Coriell; ND28478
DR   Wikidata; Q54929116
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28543
AC   CVCL_FU72
DR   Coriell; ND28543
DR   Wikidata; Q54929117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28559
AC   CVCL_IG21
DR   Coriell; ND28559
DR   Wikidata; Q54929118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28560
AC   CVCL_FN93
DR   Coriell; ND28560
DR   Wikidata; Q54929119
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28570
AC   CVCL_FN94
DR   Coriell; ND28570
DR   Wikidata; Q54929120
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28584
AC   CVCL_FU73
DR   Coriell; ND28584
DR   Wikidata; Q54929122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28597
AC   CVCL_FU74
DR   Coriell; ND28597
DR   Wikidata; Q54929123
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   ND28600
AC   CVCL_FU75
DR   Coriell; ND28600
DR   Wikidata; Q54929124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28634
AC   CVCL_FN95
DR   Coriell; ND28634
DR   Wikidata; Q54929125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28645
AC   CVCL_FN96
DR   Coriell; ND28645
DR   Wikidata; Q54929127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28646
AC   CVCL_IG22
DR   Coriell; ND28646
DR   Wikidata; Q54929128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28647
AC   CVCL_IG23
DR   Coriell; ND28647
DR   Wikidata; Q54929130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28659
AC   CVCL_FN97
DR   Coriell; ND28659
DR   Wikidata; Q54929131
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28661
AC   CVCL_FN98
DR   Coriell; ND28661
DR   Wikidata; Q54929132
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28682
AC   CVCL_FN99
DR   Coriell; ND28682
DR   Wikidata; Q54929133
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28696
AC   CVCL_FP00
DR   Coriell; ND28696
DR   Wikidata; Q54929134
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28697
AC   CVCL_FP01
DR   Coriell; ND28697
DR   Wikidata; Q54929137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28699
AC   CVCL_FP02
DR   Coriell; ND28699
DR   Wikidata; Q54929138
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28707
AC   CVCL_FP03
DR   Coriell; ND28707
DR   Wikidata; Q54929139
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28731
AC   CVCL_FP04
DR   Coriell; ND28731
DR   Wikidata; Q54929140
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28737
AC   CVCL_FU76
DR   Coriell; ND28737
DR   Wikidata; Q54929141
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28745
AC   CVCL_FU77
DR   Coriell; ND28745
DR   Wikidata; Q54929142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28747
AC   CVCL_FP05
DR   Coriell; ND28747
DR   Wikidata; Q54929143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28749
AC   CVCL_FP06
DR   Coriell; ND28749
DR   Wikidata; Q54929145
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28752
AC   CVCL_FP07
DR   Coriell; ND28752
DR   Wikidata; Q54929152
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28810
AC   CVCL_FP08
DR   Coriell; ND28810
DR   Wikidata; Q54929153
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28829
AC   CVCL_HW68
DR   Coriell; ND28829
DR   Wikidata; Q54929154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28840
AC   CVCL_FP09
DR   Coriell; ND28840
DR   Wikidata; Q54929155
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28841
AC   CVCL_FP10
DR   Coriell; ND28841
DR   Wikidata; Q54929156
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28872
AC   CVCL_FP11
DR   Coriell; ND28872
DR   Wikidata; Q54929157
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28886
AC   CVCL_HW69
DR   Coriell; ND28886
DR   Wikidata; Q54929158
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28899
AC   CVCL_FP12
DR   Coriell; ND28899
DR   Wikidata; Q54929159
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28902
AC   CVCL_FP13
DR   Coriell; ND28902
DR   Wikidata; Q54929160
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28921
AC   CVCL_FP14
DR   Coriell; ND28921
DR   Wikidata; Q54929161
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28925
AC   CVCL_FU78
DR   Coriell; ND28925
DR   Wikidata; Q54929162
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28926
AC   CVCL_FP15
DR   Coriell; ND28926
DR   Wikidata; Q54929163
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28940
AC   CVCL_FP16
DR   Coriell; ND28940
DR   Wikidata; Q54929164
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28946
AC   CVCL_FP17
DR   Coriell; ND28946
DR   Wikidata; Q54929165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28968
AC   CVCL_FP18
DR   Coriell; ND28968
DR   Wikidata; Q54929166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28972
AC   CVCL_IG24
DR   Coriell; ND28972
DR   Wikidata; Q54929167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND28982
AC   CVCL_FP19
DR   Coriell; ND28982
DR   Wikidata; Q54929168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND28987
AC   CVCL_FZ97
DR   Coriell; ND28987
DR   Wikidata; Q54929169
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29001
AC   CVCL_FP20
DR   Coriell; ND29001
DR   Wikidata; Q54929170
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29002
AC   CVCL_FP21
DR   Coriell; ND29002
DR   Wikidata; Q54929171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29006
AC   CVCL_FP22
DR   Coriell; ND29006
DR   Wikidata; Q54929172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29009
AC   CVCL_FP23
DR   Coriell; ND29009
DR   Wikidata; Q54929174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29010
AC   CVCL_FP24
DR   Coriell; ND29010
DR   Wikidata; Q54929175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29034
AC   CVCL_FP25
DR   Coriell; ND29034
DR   Wikidata; Q54929176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y7M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29047
AC   CVCL_FP26
DR   Coriell; ND29047
DR   Wikidata; Q54929177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29050
AC   CVCL_FP27
DR   Coriell; ND29050
DR   Wikidata; Q54929178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29051
AC   CVCL_FP28
DR   Coriell; ND29051
DR   Wikidata; Q54929179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29055
AC   CVCL_FP29
DR   Coriell; ND29055
DR   Wikidata; Q54929180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29057
AC   CVCL_FP30
DR   Coriell; ND29057
DR   Wikidata; Q54929181
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29058
AC   CVCL_FP31
DR   Coriell; ND29058
DR   Wikidata; Q54929182
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29065
AC   CVCL_FP32
DR   Coriell; ND29065
DR   Wikidata; Q54929183
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29068
AC   CVCL_FP33
DR   Coriell; ND29068
DR   Wikidata; Q54929184
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29069
AC   CVCL_FP34
DR   Coriell; ND29069
DR   Wikidata; Q54929185
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29084
AC   CVCL_IG25
DR   Coriell; ND29084
DR   Wikidata; Q54929186
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29089
AC   CVCL_FZ98
DR   Coriell; ND29089
DR   Wikidata; Q54929187
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29108
AC   CVCL_IG26
DR   Coriell; ND29108
DR   Wikidata; Q54929188
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29115
AC   CVCL_FP35
DR   Coriell; ND29115
DR   Wikidata; Q54929189
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29117
AC   CVCL_IG27
DR   Coriell; ND29117
DR   Wikidata; Q54929190
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29125
AC   CVCL_FP36
DR   Coriell; ND29125
DR   Wikidata; Q54929191
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29133
AC   CVCL_IH76
DR   Coriell; ND29133
DR   Wikidata; Q54929192
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29145
AC   CVCL_IH77
DR   Coriell; ND29145
DR   Wikidata; Q54929203
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29149
AC   CVCL_T849
DR   Coriell; ND29149
DR   NHCDR; ND29149
DR   Wikidata; Q54929204
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29149; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   ND29178
AC   CVCL_EY47
DR   Coriell; ND29178
DR   NHCDR; ND29178
DR   Wikidata; Q54929205
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND29178; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29179
AC   CVCL_EY48
DR   Coriell; ND29179
DR   NHCDR; ND29179
DR   Wikidata; Q54929206
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND29179; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29194
AC   CVCL_EY34
DR   Coriell; ND29194
DR   NHCDR; ND29194
DR   Wikidata; Q54929207
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND29194; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND29199
AC   CVCL_FP37
DR   Coriell; ND29199
DR   Wikidata; Q54929208
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29257
AC   CVCL_FP38
DR   Coriell; ND29257
DR   Wikidata; Q54929209
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29267
AC   CVCL_FP39
DR   Coriell; ND29267
DR   Wikidata; Q54929210
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29292
AC   CVCL_FP40
DR   Coriell; ND29292
DR   Wikidata; Q54929211
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29304
AC   CVCL_FP41
DR   Coriell; ND29304
DR   Wikidata; Q54929212
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29305
AC   CVCL_FP42
DR   Coriell; ND29305
DR   Wikidata; Q54929213
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29309
AC   CVCL_GP51
DR   Coriell; ND29309
DR   Wikidata; Q54929214
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29319
AC   CVCL_FP43
DR   Coriell; ND29319
DR   Wikidata; Q54929215
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29369
AC   CVCL_DD48
DR   BioSample; SAMN00805445
DR   Coriell; ND29369
DR   NHCDR; ND29369
DR   Wikidata; Q54929216
RX   PubMed=22952635;
RX   PubMed=25843045;
RX   PubMed=27191603;
RX   PubMed=35378365;
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND29369; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CL48 ! ND10504
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   ND29370
AC   CVCL_EY49
DR   BioSample; SAMN00805447
DR   Coriell; ND29370
DR   NHCDR; ND29370
DR   Wikidata; Q54929217
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND29370; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND29377
AC   CVCL_FP44
DR   Coriell; ND29377
DR   Wikidata; Q54929218
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29378
AC   CVCL_FP45
DR   Coriell; ND29378
DR   Wikidata; Q54929219
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29383
AC   CVCL_FP46
DR   Coriell; ND29383
DR   Wikidata; Q54929220
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29414
AC   CVCL_FP47
DR   Coriell; ND29414
DR   Wikidata; Q54929221
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29415
AC   CVCL_EY26
DR   Coriell; ND29415
DR   NHCDR; ND29415
DR   Wikidata; Q54929222
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (PubMed=22952635).
CC   Caution: SOD1 mutation wrongly indicated as L144P in PubMed=22952635.
CC   Discontinued: Coriell; ND29415; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND29418
AC   CVCL_FP48
DR   Coriell; ND29418
DR   Wikidata; Q54929223
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29422
AC   CVCL_T851
DR   Coriell; ND29422
DR   NHCDR; ND29422
DR   Wikidata; Q54929224
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29422; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   ND29423
AC   CVCL_EY35
DR   BioSample; SAMN00805455
DR   Coriell; ND29423
DR   Wikidata; Q54929225
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND29423; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND29429
AC   CVCL_FP49
DR   Coriell; ND29429
DR   Wikidata; Q54929226
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29430
AC   CVCL_FP50
DR   Coriell; ND29430
DR   Wikidata; Q54929227
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29431
AC   CVCL_FP51
DR   Coriell; ND29431
DR   Wikidata; Q54929228
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29432
AC   CVCL_FP52
DR   Coriell; ND29432
DR   Wikidata; Q54929229
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29479
AC   CVCL_FP53
DR   Coriell; ND29479
DR   Wikidata; Q54929230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29481
AC   CVCL_FU79
DR   Coriell; ND29481
DR   Wikidata; Q54929231
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29492
AC   CVCL_DD51
DR   Coriell; ND29492
DR   NHCDR; ND29492
DR   Wikidata; Q54929232
RX   PubMed=22952635;
RX   PubMed=27191603;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635; PubMed=27191603).
CC   Discontinued: Coriell; ND29492; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   ND29494
AC   CVCL_EY50
DR   BioSample; SAMN00805461
DR   Coriell; ND29494
DR   NHCDR; ND29494
DR   Wikidata; Q54929233
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND29494; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND29509
AC   CVCL_T860
DR   Coriell; ND29509
DR   NHCDR; ND29509
DR   Wikidata; Q54929234
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29509; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IJ45 ! ND20522
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   ND29510
AC   CVCL_Y813
DR   Coriell; ND29510
DR   NHCDR; ND29510
DR   Wikidata; Q54929235
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND29510; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ND29516
AC   CVCL_FP54
DR   Coriell; ND29516
DR   Wikidata; Q54929236
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29523
AC   CVCL_EY51
DR   Coriell; ND29523
DR   NHCDR; ND29523
DR   Wikidata; Q54929237
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu39Val (c.115C>G) (L38V); ClinVar=VCV000014753; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29523; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND29530
AC   CVCL_FP55
DR   Coriell; ND29530
DR   Wikidata; Q54929239
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29535
AC   CVCL_HW70
DR   Coriell; ND29535
DR   Wikidata; Q54929240
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29541
AC   CVCL_EY52
DR   BioSample; SAMN00805463
DR   Coriell; ND29541
DR   NHCDR; ND29541
DR   Wikidata; Q54929241
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND29541; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND29542
AC   CVCL_DD52
DR   BioSample; SAMN00805465
DR   Coriell; ND29542
DR   Wikidata; Q54929242
RX   PubMed=22952635;
RX   PubMed=27191603;
RX   PubMed=34736041;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635; PubMed=27191603).
CC   Discontinued: Coriell; ND29542; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CN57 ! ND14317
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   ND29543
AC   CVCL_Y811
DR   BioSample; SAMN00805467
DR   Coriell; ND29543
DR   NHCDR; ND29543
DR   Wikidata; Q54929243
RX   PubMed=22952635;
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Asn52Metfs*29 (c.155delA) (255delA); ClinVar=VCV000536457; Zygosity=Heterozygous (PubMed=22952635).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3-4del; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND29543; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y810 ! ND07278
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   ND29549
AC   CVCL_FP56
DR   Coriell; ND29549
DR   Wikidata; Q54929255
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29563
AC   CVCL_Y894
DR   Coriell; ND29563
DR   NHCDR; ND29563
DR   Wikidata; Q54929256
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg522Arg (c.1566G>A); ClinVar=VCV000540280; Zygosity=Unspecified; Note=Mislocalized protein (NHCDR=ND29563).
CC   Discontinued: Coriell; ND29563; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   ND29564
AC   CVCL_FU80
DR   Coriell; ND29564
DR   Wikidata; Q54929257
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29567
AC   CVCL_FU81
DR   Coriell; ND29567
DR   Wikidata; Q54929258
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29572
AC   CVCL_FU82
DR   Coriell; ND29572
DR   Wikidata; Q54929259
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29578
AC   CVCL_IG28
DR   Coriell; ND29578
DR   Wikidata; Q54929260
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29579
AC   CVCL_IG29
DR   Coriell; ND29579
DR   Wikidata; Q54929261
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29582
AC   CVCL_FP57
DR   Coriell; ND29582
DR   Wikidata; Q54929262
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29588
AC   CVCL_FP58
DR   Coriell; ND29588
DR   Wikidata; Q54929263
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29598
AC   CVCL_FP59
DR   Coriell; ND29598
DR   Wikidata; Q54929264
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29599
AC   CVCL_FP60
DR   Coriell; ND29599
DR   Wikidata; Q54929265
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29645
AC   CVCL_FP61
DR   Coriell; ND29645
DR   Wikidata; Q54929267
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29646
AC   CVCL_FP62
DR   Coriell; ND29646
DR   Wikidata; Q54929268
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29688
AC   CVCL_EY31
DR   Coriell; ND29688
DR   Wikidata; Q54929269
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu101Gly (c.302A>G) (E100G); ClinVar=VCV000014761; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29688; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND29689
AC   CVCL_EY53
DR   Coriell; ND29689
DR   NHCDR; ND29689
DR   Wikidata; Q54929270
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND29689; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND29711
AC   CVCL_FP63
DR   Coriell; ND29711
DR   Wikidata; Q54929271
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29727
AC   CVCL_FP64
DR   Coriell; ND29727
DR   Wikidata; Q54929272
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29756
AC   CVCL_DD54
DR   BioSample; SAMN00805489
DR   Coriell; ND29756
DR   Wikidata; Q54929274
RX   PubMed=22952635;
RX   PubMed=27191603;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29756; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CN35 ! ND14143
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 19
//
ID   ND29761
AC   CVCL_FP65
DR   Coriell; ND29761
DR   Wikidata; Q54929275
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29774
AC   CVCL_T856
DR   Coriell; ND29774
DR   NHCDR; ND29774
DR   Wikidata; Q54929276
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29774; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T857 ! ND10366
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   ND29785
AC   CVCL_FP66
DR   Coriell; ND29785
DR   Wikidata; Q54929277
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29796
AC   CVCL_FU83
DR   Coriell; ND29796
DR   Wikidata; Q54929278
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29797
AC   CVCL_FU84
DR   Coriell; ND29797
DR   Wikidata; Q54929279
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29801
AC   CVCL_EY54
DR   Coriell; ND29801
DR   NHCDR; ND29801
DR   Wikidata; Q54929280
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: Coriell; ND29801; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND29802
AC   CVCL_DD50
DR   BioSample; SAMN00805493
DR   Coriell; ND29802
DR   NHCDR; ND29802
DR   Wikidata; Q54929281
RX   PubMed=22952635;
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635; PubMed=27191603).
CC   Discontinued: Coriell; ND29802; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 8,13
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   ND29810
AC   CVCL_FP67
DR   Coriell; ND29810
DR   Wikidata; Q54929283
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29825
AC   CVCL_FP68
DR   Coriell; ND29825
DR   Wikidata; Q54929284
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29830
AC   CVCL_FZ99
DR   Coriell; ND29830
DR   Wikidata; Q54929285
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29838
AC   CVCL_FP69
DR   Coriell; ND29838
DR   Wikidata; Q54929286
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29844
AC   CVCL_FP70
DR   Coriell; ND29844
DR   Wikidata; Q54929287
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29868
AC   CVCL_FP71
DR   Coriell; ND29868
DR   Wikidata; Q54929288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29874
AC   CVCL_HW71
DR   Coriell; ND29874
DR   Wikidata; Q54929289
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND29877
AC   CVCL_FP72
DR   Coriell; ND29877
DR   Wikidata; Q54929290
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29885
AC   CVCL_FP73
DR   Coriell; ND29885
DR   Wikidata; Q54929291
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29897
AC   CVCL_FP74
DR   Coriell; ND29897
DR   Wikidata; Q54929292
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29900
AC   CVCL_FP75
DR   Coriell; ND29900
DR   Wikidata; Q54929293
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29937
AC   CVCL_FU85
DR   Coriell; ND29937
DR   Wikidata; Q54929294
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29968
AC   CVCL_EY55
DR   BioSample; SAMN00805499
DR   Coriell; ND29968
DR   NHCDR; ND29968
DR   Wikidata; Q54929295
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Gln34Arg (c.101A>G); ClinVar=VCV000468584; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND29968; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CE95 ! ND04841
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND29969
AC   CVCL_EY56
DR   BioSample; SAMN00805501
DR   Coriell; ND29969
DR   NHCDR; ND29969
DR   Wikidata; Q54929296
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND29969; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CI35 ! ND06646
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND29970
AC   CVCL_EY57
DR   Coriell; ND29970
DR   NHCDR; ND29970
DR   Wikidata; Q54929298
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND29970; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND29971
AC   CVCL_EY58
DR   Coriell; ND29971
DR   NHCDR; ND29971
DR   Wikidata; Q54929306
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND29971; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29975
AC   CVCL_FP76
DR   Coriell; ND29975
DR   Wikidata; Q54929307
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND29985
AC   CVCL_HR88
DR   Coriell; ND29985
DR   Wikidata; Q54929308
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND3
AC   CVCL_4258
SY   Neuroblastoma X DRG neurons hybrid 3
DR   CLO; CLO_0008143
DR   ECACC; 92090901
DR   Wikidata; Q54929309
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 7
//
ID   ND30005
AC   CVCL_FP77
DR   Coriell; ND30005
DR   Wikidata; Q54929310
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30013
AC   CVCL_Y899
DR   Coriell; ND30013
DR   NHCDR; ND30013
DR   Wikidata; Q54929311
RX   PubMed=22952635;
RX   PubMed=30256717;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Caution: Patient indicated as not affected with HD in HQ01808, but as affected in ND30013.
CC   Discontinued: Coriell; ND30013; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3S77 ! HQ01808
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   ND30014
AC   CVCL_Y898
DR   Coriell; ND30014
DR   NHCDR; ND30014
DR   Wikidata; Q54929312
RX   PubMed=22952635;
RX   PubMed=30256717;
CC   Discontinued: Coriell; ND30014; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ND30015
AC   CVCL_EY59
DR   Coriell; ND30015
DR   NHCDR; ND30015
DR   Wikidata; Q54929313
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: Coriell; ND30015; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND30016
AC   CVCL_EY60
DR   Coriell; ND30016
DR   NHCDR; ND30016
DR   Wikidata; Q54929314
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: Coriell; ND30016; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND30047
AC   CVCL_EY61
DR   Coriell; ND30047
DR   NHCDR; ND30047
DR   Wikidata; Q54929315
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: Coriell; ND30047; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND30067
AC   CVCL_HW72
DR   Coriell; ND30067
DR   Wikidata; Q54929316
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30071
AC   CVCL_FP78
DR   Coriell; ND30071
DR   Wikidata; Q54929317
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30075
AC   CVCL_FP79
DR   Coriell; ND30075
DR   Wikidata; Q54929318
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30086
AC   CVCL_FP80
DR   Coriell; ND30086
DR   Wikidata; Q54929319
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30092
AC   CVCL_FP81
DR   Coriell; ND30092
DR   Wikidata; Q54929320
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30099
AC   CVCL_FP82
DR   Coriell; ND30099
DR   Wikidata; Q54929321
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30102
AC   CVCL_FP83
DR   Coriell; ND30102
DR   Wikidata; Q54929322
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30109
AC   CVCL_FP84
DR   Coriell; ND30109
DR   Wikidata; Q54929323
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30116
AC   CVCL_EY62
DR   BioSample; SAMN00805535
DR   Coriell; ND30116
DR   NHCDR; ND30116
DR   Wikidata; Q54929324
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND30116; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CA29 ! ND01369
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND30125
AC   CVCL_FP85
DR   Coriell; ND30125
DR   Wikidata; Q54929325
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30159
AC   CVCL_EY63
DR   BioSample; SAMN00805543
DR   Coriell; ND30159
DR   NHCDR; ND30159
DR   Wikidata; Q54929326
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND30159; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND30160
AC   CVCL_FP86
DR   Coriell; ND30160
DR   Wikidata; Q54929327
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30166
AC   CVCL_FU86
DR   Coriell; ND30166
DR   Wikidata; Q54929328
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30171
AC   CVCL_DD47
DR   BioSample; SAMN00805545
DR   Coriell; ND30171
DR   NHCDR; ND30171
DR   Wikidata; Q54929329
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (PubMed=25843045).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Heterozygous (PubMed=25843045).
CC   Discontinued: Coriell; ND30171; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D21S11: 28,32.2
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CH67 ! ND06284
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   ND30172
AC   CVCL_FP87
DR   Coriell; ND30172
DR   Wikidata; Q54929330
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30188
AC   CVCL_HW73
DR   Coriell; ND30188
DR   Wikidata; Q54929331
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30200
AC   CVCL_FU87
DR   Coriell; ND30200
DR   Wikidata; Q54929332
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30201
AC   CVCL_FP88
DR   Coriell; ND30201
DR   Wikidata; Q54929333
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30221
AC   CVCL_FP89
DR   Coriell; ND30221
DR   Wikidata; Q54929334
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30239
AC   CVCL_FP90
DR   Coriell; ND30239
DR   Wikidata; Q54929335
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30244
AC   CVCL_EY64
DR   BioSample; SAMN00805547
DR   Coriell; ND30244
DR   NHCDR; ND30244
DR   Wikidata; Q54929336
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND30244).
CC   Discontinued: Coriell; ND30244; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND30246
AC   CVCL_FU88
DR   Coriell; ND30246
DR   Wikidata; Q54929337
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30247
AC   CVCL_FU89
DR   Coriell; ND30247
DR   Wikidata; Q54929338
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30251
AC   CVCL_FP91
DR   BioSample; SAMN00805549
DR   Coriell; ND30251
DR   Wikidata; Q54929339
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND30253
AC   CVCL_FP92
DR   BioSample; SAMN00805553
DR   Coriell; ND30253
DR   Wikidata; Q54929340
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND30259
AC   CVCL_EY65
DR   Coriell; ND30259
DR   NHCDR; ND30259
DR   Wikidata; Q54929341
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[38] (c.52CAG(38)) (c.52CAG[(36_39)]); ClinVar=VCV000031916; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND30259; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND30260
AC   CVCL_EY66
DR   Coriell; ND30260
DR   NHCDR; ND30260
DR   Wikidata; Q54929342
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[38] (c.52CAG(38)) (c.52CAG[(36_39)]); ClinVar=VCV000031916; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND30260; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND30272
AC   CVCL_FP93
DR   Coriell; ND30272
DR   Wikidata; Q54929343
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30279
AC   CVCL_FP94
DR   Coriell; ND30279
DR   Wikidata; Q54929344
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30280
AC   CVCL_FP95
DR   Coriell; ND30280
DR   Wikidata; Q54929345
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30282
AC   CVCL_FP96
DR   Coriell; ND30282
DR   Wikidata; Q54929351
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30294
AC   CVCL_FP97
DR   Coriell; ND30294
DR   Wikidata; Q54929352
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30299
AC   CVCL_FP98
DR   Coriell; ND30299
DR   Wikidata; Q54929353
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30313
AC   CVCL_FP99
DR   Coriell; ND30313
DR   Wikidata; Q54929354
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30314
AC   CVCL_FQ00
DR   Coriell; ND30314
DR   Wikidata; Q54929355
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30316
AC   CVCL_IG30
DR   Coriell; ND30316
DR   Wikidata; Q54929356
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30327
AC   CVCL_EY36
DR   Coriell; ND30327
DR   Wikidata; Q54929357
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND30327; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   ND30330
AC   CVCL_FQ01
DR   Coriell; ND30330
DR   Wikidata; Q54929358
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30364
AC   CVCL_EY67
DR   Coriell; ND30364
DR   NHCDR; ND30364
DR   Wikidata; Q54929359
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (NHCDR=ND30364).
CC   Discontinued: Coriell; ND30364; true.
CC   Discontinued: NHCDR; ND30364; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   ND30372
AC   CVCL_FQ02
DR   Coriell; ND30372
DR   Wikidata; Q54929360
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30373
AC   CVCL_FQ03
DR   Coriell; ND30373
DR   Wikidata; Q54929361
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30377
AC   CVCL_FQ04
DR   Coriell; ND30377
DR   Wikidata; Q54929362
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30378
AC   CVCL_FQ05
DR   Coriell; ND30378
DR   Wikidata; Q54929363
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30384
AC   CVCL_FQ06
DR   Coriell; ND30384
DR   Wikidata; Q54929364
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30386
AC   CVCL_IG31
DR   Coriell; ND30386
DR   Wikidata; Q54929366
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30387
AC   CVCL_FU90
DR   Coriell; ND30387
DR   Wikidata; Q54929367
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30400
AC   CVCL_FQ07
DR   Coriell; ND30400
DR   Wikidata; Q54929368
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30411
AC   CVCL_FU91
DR   Coriell; ND30411
DR   Wikidata; Q54929369
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30422
AC   CVCL_EY68
DR   Coriell; ND30422
DR   NHCDR; ND30422
DR   Wikidata; Q54929370
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: Coriell; ND30422; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND30430
AC   CVCL_FQ08
DR   Coriell; ND30430
DR   Wikidata; Q54929371
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30431
AC   CVCL_FQ09
DR   Coriell; ND30431
DR   Wikidata; Q54929372
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30439
AC   CVCL_FQ10
DR   Coriell; ND30439
DR   Wikidata; Q54929373
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30440
AC   CVCL_IG32
DR   Coriell; ND30440
DR   Wikidata; Q54929374
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30441
AC   CVCL_FQ11
DR   Coriell; ND30441
DR   Wikidata; Q54929375
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30474
AC   CVCL_FQ12
DR   Coriell; ND30474
DR   Wikidata; Q54929376
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30479
AC   CVCL_FQ13
DR   Coriell; ND30479
DR   Wikidata; Q54929377
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30480
AC   CVCL_FQ14
DR   Coriell; ND30480
DR   Wikidata; Q54929378
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30482
AC   CVCL_FQ15
DR   Coriell; ND30482
DR   Wikidata; Q54929380
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30494
AC   CVCL_FQ16
DR   Coriell; ND30494
DR   Wikidata; Q54929381
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30514
AC   CVCL_FQ17
DR   Coriell; ND30514
DR   Wikidata; Q54929382
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30523
AC   CVCL_FQ18
DR   Coriell; ND30523
DR   Wikidata; Q54929383
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30527
AC   CVCL_FQ19
DR   Coriell; ND30527
DR   Wikidata; Q54929385
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30552
AC   CVCL_FQ20
DR   Coriell; ND30552
DR   Wikidata; Q54929386
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30554
AC   CVCL_FQ21
DR   Coriell; ND30554
DR   Wikidata; Q54929387
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30556
AC   CVCL_FQ22
DR   Coriell; ND30556
DR   Wikidata; Q54929388
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30561
AC   CVCL_FQ23
DR   Coriell; ND30561
DR   Wikidata; Q54929389
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30562
AC   CVCL_FQ24
DR   Coriell; ND30562
DR   Wikidata; Q54929390
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30563
AC   CVCL_FQ25
DR   Coriell; ND30563
DR   Wikidata; Q54929391
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30573
AC   CVCL_FQ26
DR   Coriell; ND30573
DR   Wikidata; Q54929392
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30574
AC   CVCL_FQ27
DR   Coriell; ND30574
DR   Wikidata; Q54929393
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30595
AC   CVCL_FQ28
DR   Coriell; ND30595
DR   Wikidata; Q54929402
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30602
AC   CVCL_HW74
DR   Coriell; ND30602
DR   Wikidata; Q54929403
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30610
AC   CVCL_FQ29
DR   Coriell; ND30610
DR   Wikidata; Q54929404
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30616
AC   CVCL_FQ30
DR   Coriell; ND30616
DR   Wikidata; Q54929405
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30625
AC   CVCL_Y895
DR   CLO; CLO_0037415
DR   Coriell; ND30625
DR   LINCS_LDP; LPC-1016
DR   NHCDR; ND30625
DR   Wikidata; Q54929407
RX   PubMed=22952635;
RX   PubMed=34746695;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND30625; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34746695
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   ND30626
AC   CVCL_Y896
DR   Coriell; ND30626
DR   NHCDR; ND30626
DR   Wikidata; Q54929408
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[41] (c.52CAG(41)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Caution: Patient indicated as not affected with HD in HQ01462, but as affected in ND30626.
CC   Discontinued: Coriell; ND30626; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3P45 ! HQ01462
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   ND30632
AC   CVCL_FQ31
DR   Coriell; ND30632
DR   Wikidata; Q54929409
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30642
AC   CVCL_FQ32
DR   Coriell; ND30642
DR   Wikidata; Q54929410
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30679
AC   CVCL_FQ33
DR   Coriell; ND30679
DR   Wikidata; Q54929411
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30681
AC   CVCL_FQ34
DR   Coriell; ND30681
DR   Wikidata; Q54929412
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30683
AC   CVCL_IG33
DR   Coriell; ND30683
DR   Wikidata; Q54929413
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30687
AC   CVCL_FU92
DR   Coriell; ND30687
DR   Wikidata; Q54929414
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30690
AC   CVCL_IG34
DR   Coriell; ND30690
DR   Wikidata; Q54929415
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30692
AC   CVCL_FU93
DR   Coriell; ND30692
DR   Wikidata; Q54929416
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30700
AC   CVCL_FU94
DR   Coriell; ND30700
DR   Wikidata; Q54929417
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30703
AC   CVCL_FQ35
DR   Coriell; ND30703
DR   Wikidata; Q54929418
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30709
AC   CVCL_FQ36
DR   Coriell; ND30709
DR   Wikidata; Q54929419
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30710
AC   CVCL_FQ37
DR   Coriell; ND30710
DR   Wikidata; Q54929420
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30714
AC   CVCL_GA00
DR   Coriell; ND30714
DR   Wikidata; Q54929421
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30731
AC   CVCL_FQ38
DR   Coriell; ND30731
DR   Wikidata; Q54929422
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30753
AC   CVCL_FQ39
DR   Coriell; ND30753
DR   Wikidata; Q54929423
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30756
AC   CVCL_FQ40
DR   Coriell; ND30756
DR   Wikidata; Q54929424
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30795
AC   CVCL_FQ41
DR   Coriell; ND30795
DR   Wikidata; Q54929425
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30796
AC   CVCL_FQ42
DR   Coriell; ND30796
DR   Wikidata; Q54929426
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30798
AC   CVCL_FQ43
DR   Coriell; ND30798
DR   Wikidata; Q54929427
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30801
AC   CVCL_GA01
DR   Coriell; ND30801
DR   Wikidata; Q54929428
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30835
AC   CVCL_FQ44
DR   Coriell; ND30835
DR   Wikidata; Q54929429
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30836
AC   CVCL_FQ45
DR   Coriell; ND30836
DR   Wikidata; Q54929430
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30839
AC   CVCL_IG35
DR   Coriell; ND30839
DR   Wikidata; Q54929431
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30840
AC   CVCL_IG36
DR   Coriell; ND30840
DR   Wikidata; Q54929432
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30842
AC   CVCL_IG37
DR   Coriell; ND30842
DR   Wikidata; Q54929433
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30846
AC   CVCL_HR89
DR   Coriell; ND30846
DR   Wikidata; Q54929434
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30857
AC   CVCL_FQ46
DR   Coriell; ND30857
DR   Wikidata; Q54929435
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30880
AC   CVCL_FQ47
DR   Coriell; ND30880
DR   Wikidata; Q54929436
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30908
AC   CVCL_FQ48
DR   Coriell; ND30908
DR   Wikidata; Q54929437
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30915
AC   CVCL_FQ49
DR   Coriell; ND30915
DR   Wikidata; Q54929438
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30922
AC   CVCL_HR90
DR   Coriell; ND30922
DR   Wikidata; Q54929439
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND30925
AC   CVCL_FU95
DR   Coriell; ND30925
DR   Wikidata; Q54929440
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30929
AC   CVCL_FQ50
DR   Coriell; ND30929
DR   Wikidata; Q54929441
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30965
AC   CVCL_FQ51
DR   Coriell; ND30965
DR   Wikidata; Q54929442
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30966
AC   CVCL_FQ52
DR   Coriell; ND30966
DR   Wikidata; Q54929445
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30967
AC   CVCL_EY69
DR   Coriell; ND30967
DR   NHCDR; ND30967
DR   Wikidata; Q54929446
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: Coriell; ND30967; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND30970
AC   CVCL_FQ53
DR   Coriell; ND30970
DR   Wikidata; Q54929447
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND30971
AC   CVCL_FQ54
DR   Coriell; ND30971
DR   Wikidata; Q54929448
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31008
AC   CVCL_2Y36
DR   Coriell; ND31008
DR   NHCDR; ND31008
DR   Wikidata; Q54929449
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND31008; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3Z56 ! HQ02584
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   ND31009
AC   CVCL_2Y35
DR   Coriell; ND31009
DR   NHCDR; ND31009
DR   Wikidata; Q54929450
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40-49] (c.52CAG(40-49)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND31009; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3Z57 ! HQ02585
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   ND31016
AC   CVCL_GP52
DR   Coriell; ND31016
DR   Wikidata; Q54929451
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31037
AC   CVCL_EY70
DR   Coriell; ND31037
DR   NHCDR; ND31037
DR   Wikidata; Q54929452
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND31037; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31038
AC   CVCL_EY71
DR   Coriell; ND31038
DR   NHCDR; ND31038
DR   Wikidata; Q54929453
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND31038; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND31058
AC   CVCL_GP53
DR   BioSample; SAMN00805607
DR   Coriell; ND31058
DR   Wikidata; Q54929454
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND31098
AC   CVCL_GP54
DR   Coriell; ND31098
DR   Wikidata; Q54929455
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31115
AC   CVCL_FQ55
DR   Coriell; ND31115
DR   Wikidata; Q54929456
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31120
AC   CVCL_FQ56
DR   Coriell; ND31120
DR   Wikidata; Q54929457
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31124
AC   CVCL_FQ57
DR   Coriell; ND31124
DR   Wikidata; Q54929458
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31134
AC   CVCL_FQ58
DR   Coriell; ND31134
DR   Wikidata; Q54929459
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31136
AC   CVCL_FQ59
DR   Coriell; ND31136
DR   Wikidata; Q54929460
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31156
AC   CVCL_GA02
DR   Coriell; ND31156
DR   Wikidata; Q54929461
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31179
AC   CVCL_FQ60
DR   Coriell; ND31179
DR   Wikidata; Q54929462
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31190
AC   CVCL_FQ61
DR   Coriell; ND31190
DR   Wikidata; Q54929463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31208
AC   CVCL_IG38
DR   Coriell; ND31208
DR   Wikidata; Q54929464
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31212
AC   CVCL_IH45
DR   Coriell; ND31212
DR   Wikidata; Q54929465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31222
AC   CVCL_FQ62
DR   Coriell; ND31222
DR   Wikidata; Q54929466
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31228
AC   CVCL_FQ63
DR   Coriell; ND31228
DR   Wikidata; Q54929467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31243
AC   CVCL_FQ64
DR   Coriell; ND31243
DR   Wikidata; Q54929468
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31244
AC   CVCL_FQ65
DR   Coriell; ND31244
DR   Wikidata; Q54929469
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31267
AC   CVCL_FQ66
DR   Coriell; ND31267
DR   Wikidata; Q54929470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31269
AC   CVCL_FQ67
DR   Coriell; ND31269
DR   Wikidata; Q54929471
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31300
AC   CVCL_FQ68
DR   Coriell; ND31300
DR   Wikidata; Q54929472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31305
AC   CVCL_FQ69
DR   Coriell; ND31305
DR   Wikidata; Q54929473
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31308
AC   CVCL_FQ70
DR   Coriell; ND31308
DR   Wikidata; Q54929474
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31315
AC   CVCL_IH78
DR   Coriell; ND31315
DR   Wikidata; Q54929475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31364
AC   CVCL_FQ71
DR   Coriell; ND31364
DR   Wikidata; Q54929476
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31400
AC   CVCL_HW75
DR   Coriell; ND31400
DR   Wikidata; Q54929477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31467
AC   CVCL_FQ72
DR   Coriell; ND31467
DR   Wikidata; Q54929478
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31477
AC   CVCL_IG39
DR   Coriell; ND31477
DR   Wikidata; Q54929479
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31480
AC   CVCL_IG40
DR   Coriell; ND31480
DR   Wikidata; Q54929480
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31498
AC   CVCL_FQ73
DR   Coriell; ND31498
DR   Wikidata; Q54929481
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31501
AC   CVCL_FQ74
DR   Coriell; ND31501
DR   Wikidata; Q54929482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31508
AC   CVCL_EY72
DR   BioSample; SAMN00805617
DR   Coriell; ND31508
DR   NHCDR; ND31508
DR   Wikidata; Q54929483
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND31508; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND31514
AC   CVCL_FU96
DR   Coriell; ND31514
DR   Wikidata; Q54929484
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31530
AC   CVCL_FQ75
DR   Coriell; ND31530
DR   Wikidata; Q54929488
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31531
AC   CVCL_FQ76
DR   Coriell; ND31531
DR   Wikidata; Q54929489
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31533
AC   CVCL_FQ77
DR   Coriell; ND31533
DR   Wikidata; Q54929490
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31551
AC   CVCL_EY73
DR   Coriell; ND31551
DR   NHCDR; ND31551
DR   Wikidata; Q54929491
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[38] (c.52CAG(38)) (c.52CAG[(36_39)]); ClinVar=VCV000031916; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND31551; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND31552
AC   CVCL_FQ78
DR   Coriell; ND31552
DR   Wikidata; Q54929492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31553
AC   CVCL_IG41
DR   Coriell; ND31553
DR   Wikidata; Q54929493
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31574
AC   CVCL_FQ79
DR   Coriell; ND31574
DR   Wikidata; Q54929494
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31600
AC   CVCL_FQ80
DR   Coriell; ND31600
DR   Wikidata; Q54929495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31602
AC   CVCL_FQ81
DR   Coriell; ND31602
DR   Wikidata; Q54929496
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31607
AC   CVCL_FQ82
DR   Coriell; ND31607
DR   Wikidata; Q54929497
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31618
AC   CVCL_DD49
DR   BioSample; SAMN00805619
DR   Coriell; ND31618
DR   NHCDR; ND31618
DR   Wikidata; Q54929498
RX   PubMed=22952635;
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND31618; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 10
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CH85 ! ND06363
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 16
//
ID   ND31630
AC   CVCL_DD53
DR   BioSample; SAMN00805625
DR   Coriell; ND31630
DR   NHCDR; ND31630
DR   Wikidata; Q54929499
RX   PubMed=22952635;
RX   PubMed=27191603;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND31630; probable.
CC   Discontinued: NHCDR; ND31630; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 9,11
ST   D16S539: 12
ST   D21S11: 28,31
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 18
//
ID   ND31633
AC   CVCL_FQ83
DR   Coriell; ND31633
DR   Wikidata; Q54929500
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31635
AC   CVCL_FQ84
DR   Coriell; ND31635
DR   Wikidata; Q54929501
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31646
AC   CVCL_HW76
DR   Coriell; ND31646
DR   Wikidata; Q54929502
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31652
AC   CVCL_FQ85
DR   Coriell; ND31652
DR   Wikidata; Q54929503
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31656
AC   CVCL_FQ86
DR   Coriell; ND31656
DR   Wikidata; Q54929504
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31660
AC   CVCL_FU97
DR   Coriell; ND31660
DR   Wikidata; Q54929505
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND31666
AC   CVCL_IG42
DR   Coriell; ND31666
DR   Wikidata; Q54929506
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31691
AC   CVCL_GA03
DR   Coriell; ND31691
DR   Wikidata; Q54929507
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31694
AC   CVCL_FQ87
DR   Coriell; ND31694
DR   Wikidata; Q54929508
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31696
AC   CVCL_FQ88
DR   Coriell; ND31696
DR   Wikidata; Q54929509
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31700
AC   CVCL_FQ89
DR   Coriell; ND31700
DR   Wikidata; Q54929510
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31702
AC   CVCL_FQ90
DR   Coriell; ND31702
DR   Wikidata; Q54929511
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31717
AC   CVCL_EY74
DR   BioSample; SAMN00805627
DR   Coriell; ND31717
DR   NHCDR; ND31717
DR   Wikidata; Q54929512
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND31717; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND31740
AC   CVCL_FU98
DR   Coriell; ND31740
DR   Wikidata; Q54929513
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31770
AC   CVCL_FQ91
DR   Coriell; ND31770
DR   Wikidata; Q54929514
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31789
AC   CVCL_FU99
DR   Coriell; ND31789
DR   Wikidata; Q54929515
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31821
AC   CVCL_FQ92
DR   Coriell; ND31821
DR   Wikidata; Q54929516
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31845
AC   CVCL_EY75
DR   Coriell; ND31845
DR   NHCDR; ND31845
DR   Wikidata; Q54929517
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND31845; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31846
AC   CVCL_EY76
DR   Coriell; ND31846
DR   NHCDR; ND31846
DR   Wikidata; Q54929518
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: Coriell; ND31846; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND31853
AC   CVCL_FQ93
DR   Coriell; ND31853
DR   Wikidata; Q54929519
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31855
AC   CVCL_FQ94
DR   Coriell; ND31855
DR   Wikidata; Q54929520
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31878
AC   CVCL_FQ95
DR   Coriell; ND31878
DR   Wikidata; Q54929521
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31898
AC   CVCL_FQ96
DR   Coriell; ND31898
DR   Wikidata; Q54929522
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31899
AC   CVCL_FQ97
DR   Coriell; ND31899
DR   Wikidata; Q54929523
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31912
AC   CVCL_IG43
DR   Coriell; ND31912
DR   Wikidata; Q54929524
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND31960
AC   CVCL_EY32
DR   BioSample; SAMN00805645
DR   Coriell; ND31960
DR   Wikidata; Q54929525
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND31960; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CR16 ! ND16680
SX   Female
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND31961
AC   CVCL_FQ98
DR   Coriell; ND31961
DR   Wikidata; Q54929526
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31963
AC   CVCL_FQ99
DR   Coriell; ND31963
DR   Wikidata; Q54929527
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND31964
AC   CVCL_FR00
DR   Coriell; ND31964
DR   Wikidata; Q54929530
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32002
AC   CVCL_FR01
DR   Coriell; ND32002
DR   Wikidata; Q54929531
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32012
AC   CVCL_FV00
DR   Coriell; ND32012
DR   Wikidata; Q54929532
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32014
AC   CVCL_IG44
DR   Coriell; ND32014
DR   Wikidata; Q54929533
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND32023
AC   CVCL_EE16
DR   Coriell; ND32023
DR   Wikidata; Q54929534
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND32066
AC   CVCL_FR02
DR   Coriell; ND32066
DR   Wikidata; Q54929535
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32119
AC   CVCL_IG45
DR   Coriell; ND32119
DR   Wikidata; Q54929536
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND32121
AC   CVCL_FR03
DR   Coriell; ND32121
DR   Wikidata; Q54929537
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32122
AC   CVCL_FR04
DR   Coriell; ND32122
DR   Wikidata; Q54929538
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32123
AC   CVCL_FV01
DR   Coriell; ND32123
DR   Wikidata; Q54929539
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32131
AC   CVCL_FR05
DR   Coriell; ND32131
DR   Wikidata; Q54929540
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32132
AC   CVCL_FR06
DR   Coriell; ND32132
DR   Wikidata; Q54929541
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32136
AC   CVCL_FV02
DR   Coriell; ND32136
DR   Wikidata; Q54929542
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32137
AC   CVCL_FV03
DR   Coriell; ND32137
DR   Wikidata; Q54929543
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32157
AC   CVCL_EY77
DR   BioSample; SAMN00805647
DR   Coriell; ND32157
DR   NHCDR; ND32157
DR   Wikidata; Q54929544
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND32157; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND32165
AC   CVCL_FR07
DR   Coriell; ND32165
DR   Wikidata; Q54929545
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32224
AC   CVCL_FR08
DR   Coriell; ND32224
DR   Wikidata; Q54929546
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32244
AC   CVCL_FR09
DR   Coriell; ND32244
DR   Wikidata; Q54929547
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32281
AC   CVCL_FV04
DR   Coriell; ND32281
DR   Wikidata; Q54929548
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32340
AC   CVCL_FR10
DR   Coriell; ND32340
DR   Wikidata; Q54929549
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32382
AC   CVCL_FR11
DR   Coriell; ND32382
DR   Wikidata; Q54929550
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32400
AC   CVCL_FV05
DR   Coriell; ND32400
DR   Wikidata; Q54929551
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32411
AC   CVCL_FR12
DR   Coriell; ND32411
DR   Wikidata; Q54929552
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32454
AC   CVCL_FR13
DR   Coriell; ND32454
DR   Wikidata; Q54929553
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32462
AC   CVCL_EY78
DR   BioSample; SAMN00805655
DR   Coriell; ND32462
DR   NHCDR; ND32462
DR   Wikidata; Q54929554
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND32462; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND32466
AC   CVCL_FR14
DR   Coriell; ND32466
DR   Wikidata; Q54929555
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32483
AC   CVCL_FV06
DR   Coriell; ND32483
DR   Wikidata; Q54929556
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32486
AC   CVCL_FV07
DR   Coriell; ND32486
DR   Wikidata; Q54929557
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32487
AC   CVCL_FV08
DR   Coriell; ND32487
DR   Wikidata; Q54929558
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32497
AC   CVCL_FR15
DR   Coriell; ND32497
DR   Wikidata; Q54929559
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32511
AC   CVCL_FR16
DR   Coriell; ND32511
DR   Wikidata; Q54929560
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32523
AC   CVCL_FR17
DR   Coriell; ND32523
DR   Wikidata; Q54929561
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32524
AC   CVCL_FR18
DR   Coriell; ND32524
DR   Wikidata; Q54929562
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32547
AC   CVCL_FR19
DR   Coriell; ND32547
DR   Wikidata; Q54929563
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32550
AC   CVCL_FR20
DR   Coriell; ND32550
DR   Wikidata; Q54929564
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32556
AC   CVCL_FR21
DR   Coriell; ND32556
DR   Wikidata; Q54929566
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32557
AC   CVCL_FR22
DR   Coriell; ND32557
DR   Wikidata; Q54929567
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32560
AC   CVCL_FR23
DR   Coriell; ND32560
DR   Wikidata; Q54929568
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32574
AC   CVCL_FV09
DR   Coriell; ND32574
DR   Wikidata; Q54929569
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND32582
AC   CVCL_FR24
DR   Coriell; ND32582
DR   Wikidata; Q54929570
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32603
AC   CVCL_EY79
DR   Coriell; ND32603
DR   NHCDR; ND32603
DR   Wikidata; Q54929572
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND32603; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32623
AC   CVCL_GA04
DR   Coriell; ND32623
DR   Wikidata; Q54929573
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32644
AC   CVCL_FR25
DR   Coriell; ND32644
DR   Wikidata; Q54929574
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32645
AC   CVCL_FR26
DR   Coriell; ND32645
DR   Wikidata; Q54929575
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32646
AC   CVCL_FR27
DR   Coriell; ND32646
DR   Wikidata; Q54929577
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32648
AC   CVCL_FR28
DR   Coriell; ND32648
DR   Wikidata; Q54929578
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32650
AC   CVCL_FR29
DR   Coriell; ND32650
DR   Wikidata; Q54929579
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32651
AC   CVCL_FR30
DR   Coriell; ND32651
DR   Wikidata; Q54929580
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32652
AC   CVCL_FR31
DR   Coriell; ND32652
DR   Wikidata; Q54929582
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32670
AC   CVCL_FR32
DR   Coriell; ND32670
DR   Wikidata; Q54929583
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32671
AC   CVCL_FR33
DR   Coriell; ND32671
DR   Wikidata; Q54929584
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32676
AC   CVCL_FR34
DR   Coriell; ND32676
DR   Wikidata; Q54929585
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32681
AC   CVCL_FR35
DR   Coriell; ND32681
DR   Wikidata; Q54929586
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32697
AC   CVCL_EY80
DR   BioSample; SAMN00805659
DR   Coriell; ND32697
DR   NHCDR; ND32697
DR   Wikidata; Q54929587
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND32697; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND32702
AC   CVCL_FR36
DR   Coriell; ND32702
DR   Wikidata; Q54929588
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32703
AC   CVCL_FR37
DR   Coriell; ND32703
DR   Wikidata; Q54929589
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32706
AC   CVCL_FR38
DR   Coriell; ND32706
DR   Wikidata; Q54929590
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32721
AC   CVCL_FR39
DR   Coriell; ND32721
DR   Wikidata; Q54929591
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32722
AC   CVCL_FR40
DR   Coriell; ND32722
DR   Wikidata; Q54929592
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32723
AC   CVCL_FR41
DR   Coriell; ND32723
DR   Wikidata; Q54929593
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32753
AC   CVCL_FR42
DR   Coriell; ND32753
DR   Wikidata; Q54929594
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32754
AC   CVCL_FR43
DR   Coriell; ND32754
DR   Wikidata; Q54929595
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32757
AC   CVCL_FR44
DR   Coriell; ND32757
DR   Wikidata; Q54929596
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32758
AC   CVCL_IG46
DR   Coriell; ND32758
DR   Wikidata; Q54929597
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND32759
AC   CVCL_IG47
DR   Coriell; ND32759
DR   Wikidata; Q54929598
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND32760
AC   CVCL_FR45
DR   Coriell; ND32760
DR   Wikidata; Q54929599
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32763
AC   CVCL_FR46
DR   Coriell; ND32763
DR   Wikidata; Q54929600
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32766
AC   CVCL_FR47
DR   Coriell; ND32766
DR   Wikidata; Q54929601
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32767
AC   CVCL_FR48
DR   Coriell; ND32767
DR   Wikidata; Q54929602
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32771
AC   CVCL_IG48
DR   Coriell; ND32771
DR   Wikidata; Q54929603
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND32772
AC   CVCL_FV10
DR   Coriell; ND32772
DR   Wikidata; Q54929604
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32773
AC   CVCL_FV11
DR   Coriell; ND32773
DR   Wikidata; Q54929605
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32786
AC   CVCL_FV12
DR   Coriell; ND32786
DR   Wikidata; Q54929606
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32787
AC   CVCL_FV13
DR   Coriell; ND32787
DR   Wikidata; Q54929607
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32802
AC   CVCL_FR49
DR   Coriell; ND32802
DR   Wikidata; Q54929608
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32805
AC   CVCL_FR50
DR   Coriell; ND32805
DR   Wikidata; Q54929609
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32823
AC   CVCL_FR51
DR   Coriell; ND32823
DR   Wikidata; Q54929610
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32847
AC   CVCL_FR52
DR   Coriell; ND32847
DR   Wikidata; Q54929611
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32848
AC   CVCL_FR53
DR   Coriell; ND32848
DR   Wikidata; Q54929612
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32880
AC   CVCL_FR54
DR   Coriell; ND32880
DR   Wikidata; Q54929613
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32891
AC   CVCL_EH96
DR   Coriell; ND32891
DR   Wikidata; Q54929615
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND32892
AC   CVCL_FV14
DR   Coriell; ND32892
DR   Wikidata; Q54929616
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND32904
AC   CVCL_IH79
DR   Coriell; ND32904
DR   Wikidata; Q54929617
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND32943
AC   CVCL_EY27
DR   Coriell; ND32943
DR   NHCDR; ND32943
DR   Wikidata; Q54929618
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (NHCDR=ND32943).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND32943; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND32944
AC   CVCL_EY28
DR   Coriell; ND32944
DR   NHCDR; ND32944
DR   Wikidata; Q54929619
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (NHCDR=ND32944).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND32944; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND32945
AC   CVCL_EY37
SY   FTDP-17-1
DR   Coriell; ND32945
DR   NHCDR; ND32945
DR   Wikidata; Q54929620
RX   PubMed=22952635;
RX   PubMed=26143746;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Discontinued: Coriell; ND32945; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 16
//
ID   ND32946
AC   CVCL_EY81
DR   Coriell; ND32946
DR   NHCDR; ND32946
DR   Wikidata; Q54929621
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2711; DCTN1; Simple; p.Thr72Pro (c.214A>C); ClinVar=VCV000021392; Zygosity=Unspecified (NHCDR=ND32946).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND32946; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND32947
AC   CVCL_EY82
DR   Coriell; ND32947
DR   NHCDR; ND32947
DR   Wikidata; Q54929622
RX   PubMed=22855461;
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly298Ser (c.892G>A); ClinVar=VCV000005232; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND32947; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND32948
AC   CVCL_A9R0
DR   Coriell; ND32948
DR   Wikidata; Q102114585
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (Coriell=ND32948).
CC   Discontinued: Coriell; ND32948; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   ND32949
AC   CVCL_EY38
DR   Coriell; ND32949
DR   Wikidata; Q54929623
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND32949; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND32951
AC   CVCL_EY39
SY   FTDP-17-2
DR   Coriell; ND32951
DR   Wikidata; Q54929624
RX   PubMed=22952635;
RX   PubMed=26143746;
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND32951; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   ND32953
AC   CVCL_EY40
DR   Coriell; ND32953
DR   Wikidata; Q54929625
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ala9Asp (c.26C>A); ClinVar=VCV000016013; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND32953; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND32954
AC   CVCL_EY83
DR   BioSample; SAMN00805667
DR   Coriell; ND32954
DR   NHCDR; ND32954
DR   Wikidata; Q54929626
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND32954; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND32955
AC   CVCL_EY84
DR   Coriell; ND32955
DR   NHCDR; ND32955
DR   Wikidata; Q54929627
RX   PubMed=22952635;
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Unspecified (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Discontinued: Coriell; ND32955; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND32956
AC   CVCL_EY85
DR   Coriell; ND32956
DR   NHCDR; ND32956
DR   Wikidata; Q54929628
RX   PubMed=22952635;
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Unspecified (PubMed=22952635).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Discontinued: Coriell; ND32956; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND32969
AC   CVCL_EY86
DR   Coriell; ND32969
DR   NHCDR; ND32969
DR   Wikidata; Q54929629
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND32969; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND32970
AC   CVCL_EY41
DR   Coriell; ND32970
DR   Wikidata; Q54929630
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND32970; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND32973
AC   CVCL_EY87
DR   Coriell; ND32973
DR   NHCDR; ND32973
DR   Wikidata; Q54929631
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND32973; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND32974
AC   CVCL_EY88
DR   Coriell; ND32974
DR   NHCDR; ND32974
DR   Wikidata; Q54929632
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Arg747Trp (c.2239C>T); ClinVar=VCV000006204; Zygosity=Homozygous (NHCDR=ND32974).
CC   Discontinued: Coriell; ND32974; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C201519; Parkinson disease 14, autosomal recessive
DI   ORDO; Orphanet_199351; Adult-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND32975
AC   CVCL_EY89
DR   BioSample; SAMN00805673
DR   Coriell; ND32975
DR   NHCDR; ND32975
DR   Wikidata; Q54929633
RX   PubMed=22952635;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND32975; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND32976
AC   CVCL_EY90
DR   BioSample; SAMN00805675
DR   Coriell; ND32976
DR   NHCDR; ND32976
DR   Wikidata; Q54929634
RX   PubMed=22952635;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND32976; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND32979
AC   CVCL_FR55
DR   Coriell; ND32979
DR   Wikidata; Q54929635
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33000
AC   CVCL_CV30
DR   Coriell; ND33000
DR   Wikidata; Q54929636
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   ND33012
AC   CVCL_FR56
DR   Coriell; ND33012
DR   Wikidata; Q54929637
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33021
AC   CVCL_FV15
DR   Coriell; ND33021
DR   Wikidata; Q54929638
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33030
AC   CVCL_FR57
DR   Coriell; ND33030
DR   Wikidata; Q54929639
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33031
AC   CVCL_FR58
DR   Coriell; ND33031
DR   Wikidata; Q54929640
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33035
AC   CVCL_FR59
DR   Coriell; ND33035
DR   Wikidata; Q54929641
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33113
AC   CVCL_HW77
DR   Coriell; ND33113
DR   Wikidata; Q54929642
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33117
AC   CVCL_FR60
DR   Coriell; ND33117
DR   Wikidata; Q54929643
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33125
AC   CVCL_FR61
DR   Coriell; ND33125
DR   Wikidata; Q54929644
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33126
AC   CVCL_FR62
DR   Coriell; ND33126
DR   Wikidata; Q54929645
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33144
AC   CVCL_IG49
DR   Coriell; ND33144
DR   Wikidata; Q54929646
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33145
AC   CVCL_FV16
DR   Coriell; ND33145
DR   Wikidata; Q54929647
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33150
AC   CVCL_FR63
DR   Coriell; ND33150
DR   Wikidata; Q54929648
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33171
AC   CVCL_FR64
DR   Coriell; ND33171
DR   Wikidata; Q54929649
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33174
AC   CVCL_FR65
DR   Coriell; ND33174
DR   Wikidata; Q54929650
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33175
AC   CVCL_FR66
DR   Coriell; ND33175
DR   Wikidata; Q54929651
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33177
AC   CVCL_FR67
DR   Coriell; ND33177
DR   Wikidata; Q54929652
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33197
AC   CVCL_FR68
DR   Coriell; ND33197
DR   Wikidata; Q54929653
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33202
AC   CVCL_FR69
DR   Coriell; ND33202
DR   Wikidata; Q54929654
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33203
AC   CVCL_FR70
DR   Coriell; ND33203
DR   Wikidata; Q54929657
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33225
AC   CVCL_FR71
DR   Coriell; ND33225
DR   Wikidata; Q54929658
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33226
AC   CVCL_IG50
DR   Coriell; ND33226
DR   Wikidata; Q54929659
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33227
AC   CVCL_FV17
DR   Coriell; ND33227
DR   Wikidata; Q54929660
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33228
AC   CVCL_FV18
DR   Coriell; ND33228
DR   Wikidata; Q54929661
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33229
AC   CVCL_FV19
DR   Coriell; ND33229
DR   Wikidata; Q54929662
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33259
AC   CVCL_FR72
DR   Coriell; ND33259
DR   Wikidata; Q54929663
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33262
AC   CVCL_FR73
DR   Coriell; ND33262
DR   Wikidata; Q54929664
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33264
AC   CVCL_FR74
DR   Coriell; ND33264
DR   Wikidata; Q54929665
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33266
AC   CVCL_FR75
DR   Coriell; ND33266
DR   Wikidata; Q54929666
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33271
AC   CVCL_IH80
DR   Coriell; ND33271
DR   Wikidata; Q54929667
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33283
AC   CVCL_FR76
DR   Coriell; ND33283
DR   Wikidata; Q54929668
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33286
AC   CVCL_FV20
DR   Coriell; ND33286
DR   Wikidata; Q54929669
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33296
AC   CVCL_FR77
DR   Coriell; ND33296
DR   Wikidata; Q54929670
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33322
AC   CVCL_FR78
DR   Coriell; ND33322
DR   Wikidata; Q54929671
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33323
AC   CVCL_FR79
DR   Coriell; ND33323
DR   Wikidata; Q54929672
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33352
AC   CVCL_FR80
DR   Coriell; ND33352
DR   Wikidata; Q54929673
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33390
AC   CVCL_IG51
DR   Coriell; ND33390
DR   Wikidata; Q54929674
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33391
AC   CVCL_EY91
DR   Coriell; ND33391
DR   NHCDR; ND33391
DR   Wikidata; Q54929675
RX   PubMed=22952635;
CC   Discontinued: Coriell; ND33391; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33392
AC   CVCL_Y897
DR   Coriell; ND33392
DR   NHCDR; ND33392
DR   Wikidata; Q54929676
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[57] (c.52CAG(57)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND33392; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   ND33408
AC   CVCL_FR81
DR   Coriell; ND33408
DR   Wikidata; Q54929677
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33424
AC   CVCL_EY92
DR   Coriell; ND33424
DR   NHCDR; ND33424
DR   Wikidata; Q54929678
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND33424; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND33438
AC   CVCL_DR50
DR   Coriell; ND33438
DR   Wikidata; Q54929679
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND33439 (Cellosaurus=CVCL_DR51).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   ND33439
AC   CVCL_DR51
DR   Coriell; ND33439
DR   Wikidata; Q54929680
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from monozygotic twin of ND33438 (Cellosaurus=CVCL_DR50).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   ND33447
AC   CVCL_IG88
DR   Coriell; ND33447
DR   Wikidata; Q54929681
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84626; Cerebral cavernous malformation
DI   ORDO; Orphanet_221061; Familial cerebral cavernous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33456
AC   CVCL_FR84
DR   Coriell; ND33456
DR   Wikidata; Q54929682
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33465
AC   CVCL_FR85
DR   Coriell; ND33465
DR   Wikidata; Q54929683
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33498
AC   CVCL_FR86
DR   Coriell; ND33498
DR   Wikidata; Q54929684
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33515
AC   CVCL_FR87
DR   Coriell; ND33515
DR   Wikidata; Q54929685
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33516
AC   CVCL_FR88
DR   Coriell; ND33516
DR   Wikidata; Q54929686
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33518
AC   CVCL_FR89
DR   Coriell; ND33518
DR   Wikidata; Q54929687
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33519
AC   CVCL_FR90
DR   Coriell; ND33519
DR   Wikidata; Q54929688
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33520
AC   CVCL_FR91
DR   Coriell; ND33520
DR   Wikidata; Q54929689
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33563
AC   CVCL_FR92
DR   Coriell; ND33563
DR   Wikidata; Q54929690
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33581
AC   CVCL_FR93
DR   Coriell; ND33581
DR   Wikidata; Q54929691
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33592
AC   CVCL_FV21
DR   Coriell; ND33592
DR   Wikidata; Q54929692
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33594
AC   CVCL_FV22
DR   Coriell; ND33594
DR   Wikidata; Q54929693
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33613
AC   CVCL_FR94
DR   Coriell; ND33613
DR   Wikidata; Q54929694
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33620
AC   CVCL_FR95
DR   Coriell; ND33620
DR   Wikidata; Q54929695
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33641
AC   CVCL_HW78
DR   Coriell; ND33641
DR   Wikidata; Q54929696
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33651
AC   CVCL_FR96
DR   Coriell; ND33651
DR   Wikidata; Q54929700
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33660
AC   CVCL_FR97
DR   Coriell; ND33660
DR   Wikidata; Q54929701
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33706
AC   CVCL_FR98
DR   Coriell; ND33706
DR   Wikidata; Q54929702
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33744
AC   CVCL_FR99
DR   Coriell; ND33744
DR   Wikidata; Q54929703
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33778
AC   CVCL_FV23
DR   Coriell; ND33778
DR   Wikidata; Q54929704
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33780
AC   CVCL_HR91
DR   Coriell; ND33780
DR   Wikidata; Q54929705
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33789
AC   CVCL_FS00
DR   Coriell; ND33789
DR   Wikidata; Q54929707
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33791
AC   CVCL_FS01
DR   Coriell; ND33791
DR   Wikidata; Q54929708
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33793
AC   CVCL_FS02
DR   Coriell; ND33793
DR   Wikidata; Q54929709
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33794
AC   CVCL_FS03
DR   Coriell; ND33794
DR   Wikidata; Q54929710
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33795
AC   CVCL_FS04
DR   Coriell; ND33795
DR   Wikidata; Q54929711
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33797
AC   CVCL_HR92
DR   Coriell; ND33797
DR   Wikidata; Q54929712
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33798
AC   CVCL_FV24
DR   Coriell; ND33798
DR   Wikidata; Q54929713
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33799
AC   CVCL_IG52
DR   Coriell; ND33799
DR   Wikidata; Q54929714
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33800
AC   CVCL_IG53
DR   Coriell; ND33800
DR   Wikidata; Q54929715
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND33801
AC   CVCL_FV25
DR   Coriell; ND33801
DR   Wikidata; Q54929716
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33807
AC   CVCL_FS05
DR   Coriell; ND33807
DR   Wikidata; Q54929717
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33834
AC   CVCL_FS06
DR   Coriell; ND33834
DR   Wikidata; Q54929718
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33835
AC   CVCL_FS07
DR   Coriell; ND33835
DR   Wikidata; Q54929719
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33847
AC   CVCL_EY93
DR   Coriell; ND33847
DR   NHCDR; ND33847
DR   Wikidata; Q54929720
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND33847; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND33854
AC   CVCL_FS08
DR   Coriell; ND33854
DR   Wikidata; Q54929721
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33856
AC   CVCL_FS09
DR   Coriell; ND33856
DR   Wikidata; Q54929722
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33860
AC   CVCL_FS10
DR   Coriell; ND33860
DR   Wikidata; Q54929723
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33861
AC   CVCL_FS11
DR   Coriell; ND33861
DR   Wikidata; Q54929724
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33879
AC   CVCL_EY94
DR   Coriell; ND33879
DR   NHCDR; ND33879
DR   Wikidata; Q54929725
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND33879; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND33884
AC   CVCL_FS12
DR   Coriell; ND33884
DR   Wikidata; Q54929726
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33916
AC   CVCL_GA05
DR   Coriell; ND33916
DR   Wikidata; Q54929727
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33947
AC   CVCL_EY95
DR   Coriell; ND33947
DR   NHCDR; ND33947
DR   Wikidata; Q54929728
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND33947; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND33948
AC   CVCL_FS13
DR   Coriell; ND33948
DR   Wikidata; Q54929729
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33950
AC   CVCL_FS14
DR   Coriell; ND33950
DR   Wikidata; Q54929730
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33951
AC   CVCL_FS15
DR   Coriell; ND33951
DR   Wikidata; Q54929731
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND33965
AC   CVCL_EY96
DR   Coriell; ND33965
DR   NHCDR; ND33965
DR   Wikidata; Q54929732
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND33965; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND33995
AC   CVCL_EY33
DR   Coriell; ND33995
DR   Wikidata; Q54929733
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND33995; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CN09 ! ND13905
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34056
AC   CVCL_FS16
DR   Coriell; ND34056
DR   Wikidata; Q54929734
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34058
AC   CVCL_FS17
DR   Coriell; ND34058
DR   Wikidata; Q54929735
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34059
AC   CVCL_FS18
DR   Coriell; ND34059
DR   Wikidata; Q54929736
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34064
AC   CVCL_IH81
DR   Coriell; ND34064
DR   Wikidata; Q54929737
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34077
AC   CVCL_FS19
DR   Coriell; ND34077
DR   Wikidata; Q54929738
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34078
AC   CVCL_FS20
DR   Coriell; ND34078
DR   Wikidata; Q54929739
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34088
AC   CVCL_HR93
DR   Coriell; ND34088
DR   Wikidata; Q54929740
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34095
AC   CVCL_FS21
DR   Coriell; ND34095
DR   Wikidata; Q54929746
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34097
AC   CVCL_FS22
DR   Coriell; ND34097
DR   Wikidata; Q54929747
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34106
AC   CVCL_EY97
DR   Coriell; ND34106
DR   NHCDR; ND34106
DR   Wikidata; Q54929748
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND34106; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND34110
AC   CVCL_FS23
DR   Coriell; ND34110
DR   Wikidata; Q54929749
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34116
AC   CVCL_FS24
DR   Coriell; ND34116
DR   Wikidata; Q54929750
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34126
AC   CVCL_FS25
DR   Coriell; ND34126
DR   Wikidata; Q54929751
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34128
AC   CVCL_FS26
DR   Coriell; ND34128
DR   Wikidata; Q54929752
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34158
AC   CVCL_FV26
DR   Coriell; ND34158
DR   Wikidata; Q54929753
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34169
AC   CVCL_FS27
DR   Coriell; ND34169
DR   Wikidata; Q54929754
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34170
AC   CVCL_FS28
DR   Coriell; ND34170
DR   Wikidata; Q54929755
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34171
AC   CVCL_HR94
DR   Coriell; ND34171
DR   Wikidata; Q54929756
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34172
AC   CVCL_HR95
DR   Coriell; ND34172
DR   Wikidata; Q54929757
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34178
AC   CVCL_EH97
DR   Coriell; ND34178
DR   Wikidata; Q54929758
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND34184
AC   CVCL_HW79
DR   Coriell; ND34184
DR   Wikidata; Q54929759
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34187
AC   CVCL_FS29
DR   Coriell; ND34187
DR   Wikidata; Q54929760
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34198
AC   CVCL_EY42
DR   Coriell; ND34198
DR   Wikidata; Q54929761
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND34198; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34200
AC   CVCL_FS30
DR   Coriell; ND34200
DR   Wikidata; Q54929762
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34212
AC   CVCL_IG54
DR   Coriell; ND34212
DR   Wikidata; Q54929763
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34215
AC   CVCL_GA06
DR   Coriell; ND34215
DR   Wikidata; Q54929764
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34235
AC   CVCL_EY98
DR   Coriell; ND34235
DR   NHCDR; ND34235
DR   Wikidata; Q54929765
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND34235; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34239
AC   CVCL_FS31
DR   Coriell; ND34239
DR   Wikidata; Q54929766
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34242
AC   CVCL_FS32
DR   Coriell; ND34242
DR   Wikidata; Q54929767
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34263
AC   CVCL_EY99
DR   Coriell; ND34263
DR   NHCDR; ND34263
DR   Wikidata; Q54929768
RX   PubMed=22952635;
RX   PubMed=30497978;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=22952635; PubMed=30497978).
CC   Discontinued: Coriell; ND34263; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   ND34265
AC   CVCL_EZ00
DR   BioSample; SAMN00805685
DR   Coriell; ND34265
DR   NHCDR; ND34265
DR   Wikidata; Q54929769
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND34265; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND34267
AC   CVCL_EZ01
DR   Coriell; ND34267
DR   NHCDR; ND34267
DR   Wikidata; Q54929770
RX   PubMed=22952635;
RX   PubMed=34736041;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND34267; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34274
AC   CVCL_FS33
DR   Coriell; ND34274
DR   Wikidata; Q54929771
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34304
AC   CVCL_FS34
DR   Coriell; ND34304
DR   Wikidata; Q54929772
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34321
AC   CVCL_FS35
DR   Coriell; ND34321
DR   Wikidata; Q54929773
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34338
AC   CVCL_FS36
DR   Coriell; ND34338
DR   Wikidata; Q54929774
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34391
AC   CVCL_F202
SY   ND34391*E; ND34391*H
DR   Coriell; ND34391
DR   NHCDR; ND34391
DR   SKIP; SKIP001366
DR   SKIP; SKIP004681
DR   Wikidata; Q54929775
RX   PubMed=26651604;
RX   PubMed=27264186;
RX   PubMed=35688132;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (NHCDR=ND34391).
CC   Discontinued: Coriell; ND34391; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   ND34391 clone C34139
AC   CVCL_E3CB
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F202 ! ND34391
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   ND34391 clone C6
AC   CVCL_E3CC
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=2 of the 4 copies).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3CB ! ND34391 clone C34139
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   ND34391 clone E2
AC   CVCL_E3CD
RX   PubMed=35688132;
RX   PubMed=39079530;
CC   Population: Caucasian.
CC   Characteristics: Transposed with a piggyBac-rtTA(TRE4G)-NGN2-T2A-PuroR-IRES-SNAP-tag construct (PubMed=35688132).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=4 of the 4 copies).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3CC ! ND34391 clone C6
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   ND34392
AC   CVCL_A9R1
DR   Coriell; ND34392
DR   Wikidata; Q102114586
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (Coriell=ND34392).
CC   Discontinued: Coriell; ND34392; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9R0 ! ND32948
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   ND34393
AC   CVCL_T843
SY   ND34393*C
DR   Coriell; ND34393
DR   NHCDR; ND34393
DR   SKIP; SKIP001367
DR   SKIP; SKIP004683
DR   Wikidata; Q54929776
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (from parent cell line).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND34393; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY28 ! ND32944
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   ND34394
AC   CVCL_T844
SY   ND34394*C
DR   Coriell; ND34394
DR   NHCDR; ND34394
DR   SKIP; SKIP001368
DR   SKIP; SKIP004682
DR   Wikidata; Q54929777
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Coriell; ND34394; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY28 ! ND32944
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   ND34400
AC   CVCL_FS37
DR   Coriell; ND34400
DR   Wikidata; Q54929778
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34401
AC   CVCL_FS38
DR   Coriell; ND34401
DR   Wikidata; Q54929779
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34404
AC   CVCL_FS39
DR   Coriell; ND34404
DR   Wikidata; Q54929780
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34405
AC   CVCL_FS40
DR   Coriell; ND34405
DR   Wikidata; Q54929781
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34406
AC   CVCL_FS41
DR   Coriell; ND34406
DR   Wikidata; Q54929782
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34430
AC   CVCL_FS42
DR   Coriell; ND34430
DR   Wikidata; Q54929783
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34437
AC   CVCL_IH82
DR   Coriell; ND34437
DR   Wikidata; Q54929784
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34448
AC   CVCL_IG55
DR   Coriell; ND34448
DR   Wikidata; Q54929785
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34449
AC   CVCL_FV27
DR   Coriell; ND34449
DR   Wikidata; Q54929787
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34462
AC   CVCL_FS43
DR   Coriell; ND34462
DR   Wikidata; Q54929788
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34463
AC   CVCL_FS44
DR   Coriell; ND34463
DR   Wikidata; Q54929789
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34510
AC   CVCL_UT54
DR   Coriell; ND34510
DR   Wikidata; Q98127460
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Ile149Thr (c.446T>C); Zygosity=Heterozygous (Coriell=ND34510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EZ51 ! ND40075
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   ND34529
AC   CVCL_FS45
DR   Coriell; ND34529
DR   Wikidata; Q54929790
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34530
AC   CVCL_FS46
DR   Coriell; ND34530
DR   Wikidata; Q54929791
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34545
AC   CVCL_FS47
DR   Coriell; ND34545
DR   Wikidata; Q54929792
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34548
AC   CVCL_FS48
DR   Coriell; ND34548
DR   Wikidata; Q54929793
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34611
AC   CVCL_FS49
DR   Coriell; ND34611
DR   Wikidata; Q54929794
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34616
AC   CVCL_FS50
DR   Coriell; ND34616
DR   Wikidata; Q54929795
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34617
AC   CVCL_FS51
DR   Coriell; ND34617
DR   Wikidata; Q54929796
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34618
AC   CVCL_FS52
DR   Coriell; ND34618
DR   Wikidata; Q54929797
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34639
AC   CVCL_FS53
DR   Coriell; ND34639
DR   Wikidata; Q54929798
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34691
AC   CVCL_HR96
DR   Coriell; ND34691
DR   Wikidata; Q54929799
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34693
AC   CVCL_HR97
DR   Coriell; ND34693
DR   Wikidata; Q54929800
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34709
AC   CVCL_FS54
DR   Coriell; ND34709
DR   Wikidata; Q54929801
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34730
AC   CVCL_EZ02
DR   Coriell; ND34730
DR   NHCDR; ND34730
DR   Wikidata; Q54929802
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Glu184Asp (c.552A>C); ClinVar=VCV000098049; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND34730; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34732
AC   CVCL_EZ03
DR   Coriell; ND34732
DR   NHCDR; ND34732
DR   Wikidata; Q54929803
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Ile (c.438G>A); ClinVar=VCV000018137; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND34732; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34733
AC   CVCL_EY43
DR   Coriell; ND34733
DR   NHCDR; ND34733
DR   Wikidata; Q54929804
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Pro264Leu (c.791C>T); ClinVar=VCV000098080; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND34733; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34750
AC   CVCL_FS55
DR   Coriell; ND34750
DR   Wikidata; Q54929805
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34761
AC   CVCL_HR98
DR   Coriell; ND34761
DR   Wikidata; Q54929806
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34769
AC   CVCL_EZ04
DR   Coriell; ND34769
DR   NHCDR; ND34769
DR   Wikidata; Q54929807
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND34769; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34770
AC   CVCL_EY44
DR   Coriell; ND34770
DR   NHCDR; ND34770
DR   Wikidata; Q54929808
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND34770; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34791
AC   CVCL_DD55
DR   Coriell; ND34791
DR   Wikidata; Q54929809
RX   PubMed=22952635;
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Discontinued: Coriell; ND34791; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 28
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   ND34810
AC   CVCL_EY45
DR   Coriell; ND34810
DR   Wikidata; Q54929810
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND34810; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND34815
AC   CVCL_FS56
DR   Coriell; ND34815
DR   Wikidata; Q54929811
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34816
AC   CVCL_FS57
DR   Coriell; ND34816
DR   Wikidata; Q54929812
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34817
AC   CVCL_FS58
DR   Coriell; ND34817
DR   Wikidata; Q54929813
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34854
AC   CVCL_EZ05
DR   Coriell; ND34854
DR   NHCDR; ND34854
DR   Wikidata; Q54929814
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND34854; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND34885
AC   CVCL_FS59
DR   Coriell; ND34885
DR   Wikidata; Q54929815
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34896
AC   CVCL_HW80
DR   Coriell; ND34896
DR   Wikidata; Q54929816
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND34930
AC   CVCL_FS60
DR   Coriell; ND34930
DR   Wikidata; Q54929817
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34948
AC   CVCL_FS61
DR   Coriell; ND34948
DR   Wikidata; Q54929818
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34949
AC   CVCL_FS62
DR   Coriell; ND34949
DR   Wikidata; Q54929819
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34950
AC   CVCL_FS63
DR   Coriell; ND34950
DR   Wikidata; Q54929820
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34951
AC   CVCL_FS64
DR   Coriell; ND34951
DR   Wikidata; Q54929821
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34952
AC   CVCL_FS65
DR   Coriell; ND34952
DR   Wikidata; Q54929822
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34968
AC   CVCL_FS66
DR   Coriell; ND34968
DR   Wikidata; Q54929823
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34980
AC   CVCL_EZ06
DR   Coriell; ND34980
DR   NHCDR; ND34980
DR   Wikidata; Q54929824
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (NHCDR=ND34980).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22952635).
CC   Discontinued: Coriell; ND34980; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   ND34982
AC   CVCL_EZ07
DR   Coriell; ND34982
DR   NHCDR; ND34982
DR   Wikidata; Q54929825
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND34982; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   ND34983
AC   CVCL_FS67
DR   Coriell; ND34983
DR   Wikidata; Q54929826
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34991
AC   CVCL_FS68
DR   Coriell; ND34991
DR   Wikidata; Q54929828
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34994
AC   CVCL_FS69
DR   Coriell; ND34994
DR   Wikidata; Q54929829
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND34995
AC   CVCL_FS70
DR   Coriell; ND34995
DR   Wikidata; Q54929830
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35026
AC   CVCL_FV28
DR   Coriell; ND35026
DR   Wikidata; Q54929831
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35029
AC   CVCL_IG56
DR   Coriell; ND35029
DR   Wikidata; Q54929832
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35044
AC   CVCL_EZ08
DR   Coriell; ND35044
DR   NHCDR; ND35044
DR   Wikidata; Q54929833
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35044; true.
CC   Discontinued: NHCDR; ND35044; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35055
AC   CVCL_FS71
DR   Coriell; ND35055
DR   Wikidata; Q54929834
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35056
AC   CVCL_FS72
DR   Coriell; ND35056
DR   Wikidata; Q54929835
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35068
AC   CVCL_FS73
DR   Coriell; ND35068
DR   Wikidata; Q54929836
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35081
AC   CVCL_FS74
DR   Coriell; ND35081
DR   Wikidata; Q54929837
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35111
AC   CVCL_EE17
DR   Coriell; ND35111
DR   Wikidata; Q54929838
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND35150
AC   CVCL_FS75
DR   Coriell; ND35150
DR   Wikidata; Q54929839
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35151
AC   CVCL_FS76
DR   Coriell; ND35151
DR   Wikidata; Q54929840
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35188
AC   CVCL_GA07
DR   Coriell; ND35188
DR   Wikidata; Q54929841
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35200
AC   CVCL_EY46
DR   Coriell; ND35200
DR   Wikidata; Q54929842
RX   PubMed=22952635;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Unspecified (PubMed=22952635).
CC   Discontinued: Coriell; ND35200; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND35217
AC   CVCL_FV29
DR   Coriell; ND35217
DR   Wikidata; Q54929843
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35226
AC   CVCL_FS77
DR   Coriell; ND35226
DR   Wikidata; Q54929844
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35227
AC   CVCL_FS78
DR   Coriell; ND35227
DR   Wikidata; Q54929845
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35259
AC   CVCL_FS79
DR   Coriell; ND35259
DR   Wikidata; Q54929846
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35278
AC   CVCL_FS80
DR   Coriell; ND35278
DR   Wikidata; Q54929847
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35302
AC   CVCL_EZ09
DR   Coriell; ND35302
DR   NHCDR; ND35302
DR   Wikidata; Q54929848
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35302; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND35320
AC   CVCL_EZ10
DR   Coriell; ND35320
DR   NHCDR; ND35320
DR   Wikidata; Q54929849
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35320; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND35322
AC   CVCL_EZ11
DR   Coriell; ND35322
DR   NHCDR; ND35322
DR   Wikidata; Q54929850
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35322; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND35324
AC   CVCL_FS81
DR   Coriell; ND35324
DR   Wikidata; Q54929851
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35342
AC   CVCL_UT55
DR   Coriell; ND35342
DR   Wikidata; Q98127463
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND35367
AC   CVCL_T845
SY   ND35367*C; ND35367*F
DR   BioSample; SAMN00805709
DR   Coriell; ND35367
DR   NHCDR; ND35367
DR   SKIP; SKIP001369
DR   SKIP; SKIP004684
DR   Wikidata; Q54929852
RX   PubMed=26651604;
RX   PubMed=27264186;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (NHCDR=ND35367).
CC   Discontinued: Coriell; ND35367; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9R0 ! ND32948
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   ND35371
AC   CVCL_T846
SY   ND35371*D
DR   Coriell; ND35371
DR   NHCDR; ND35371
DR   SKIP; SKIP001370
DR   SKIP; SKIP004685
DR   Wikidata; Q54929853
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Unspecified (from parent cell line).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND35371; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY27 ! ND32943
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   ND35376
AC   CVCL_FS82
DR   Coriell; ND35376
DR   Wikidata; Q54929854
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35377
AC   CVCL_FS83
DR   Coriell; ND35377
DR   Wikidata; Q54929855
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35393
AC   CVCL_GA08
DR   Coriell; ND35393
DR   Wikidata; Q54929856
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35409
AC   CVCL_FS84
DR   Coriell; ND35409
DR   Wikidata; Q54929857
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35413
AC   CVCL_FS85
DR   Coriell; ND35413
DR   Wikidata; Q54929858
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35425
AC   CVCL_EZ12
DR   Coriell; ND35425
DR   NHCDR; ND35425
DR   Wikidata; Q54929859
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35425; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND35427
AC   CVCL_FS86
DR   Coriell; ND35427
DR   Wikidata; Q54929860
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35451
AC   CVCL_FS87
DR   Coriell; ND35451
DR   Wikidata; Q54929861
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35453
AC   CVCL_FS88
DR   Coriell; ND35453
DR   Wikidata; Q54929862
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35454
AC   CVCL_FS89
DR   Coriell; ND35454
DR   Wikidata; Q54929863
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35498
AC   CVCL_FS90
DR   Coriell; ND35498
DR   Wikidata; Q54929864
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35499
AC   CVCL_FS91
DR   Coriell; ND35499
DR   Wikidata; Q54929865
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35503
AC   CVCL_FS92
DR   Coriell; ND35503
DR   Wikidata; Q54929866
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35564
AC   CVCL_FS93
DR   Coriell; ND35564
DR   Wikidata; Q54929867
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35574
AC   CVCL_FS94
DR   Coriell; ND35574
DR   Wikidata; Q54929869
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35575
AC   CVCL_FS95
DR   Coriell; ND35575
DR   Wikidata; Q54929870
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35604
AC   CVCL_IG57
DR   Coriell; ND35604
DR   Wikidata; Q54929871
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35618
AC   CVCL_FS96
DR   Coriell; ND35618
DR   Wikidata; Q54929872
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35636
AC   CVCL_FS97
DR   Coriell; ND35636
DR   Wikidata; Q54929873
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35639
AC   CVCL_FS98
DR   Coriell; ND35639
DR   Wikidata; Q54929874
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35658
AC   CVCL_T847
SY   ND35658*C
DR   Coriell; ND35658
DR   NHCDR; ND35658
DR   SKIP; SKIP001069
DR   SKIP; SKIP004686
DR   Wikidata; Q54929875
RX   PubMed=25760436;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asn140Lys (c.420C>A) (N139K); ClinVar=VCV000586635; Zygosity=Unspecified (NHCDR=ND35658).
CC   Discontinued: Coriell; ND35658; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   ND35659
AC   CVCL_T848
SY   ND35659*C
DR   Coriell; ND35659
DR   NHCDR; ND35659
DR   SKIP; SKIP001070
DR   SKIP; SKIP004687
DR   Wikidata; Q54929876
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND35659).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Discontinued: Coriell; ND35659; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   ND35660
AC   CVCL_T850
SY   ND35660*C
DR   Coriell; ND35660
DR   NHCDR; ND35660
DR   SKIP; SKIP001071
DR   SKIP; SKIP004688
DR   Wikidata; Q54929877
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND35660).
CC   Discontinued: Coriell; ND35660; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T849 ! ND29149
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   ND35661
AC   CVCL_T852
SY   ND35661*E
DR   Coriell; ND35661
DR   NHCDR; ND35661
DR   SKIP; SKIP001072
DR   SKIP; SKIP004689
DR   Wikidata; Q54929878
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (Coriell=ND35661).
CC   Discontinued: Coriell; ND35661; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T851 ! ND29422
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   ND35662
AC   CVCL_T853
SY   ND35662*C
DR   Coriell; ND35662
DR   NHCDR; ND35662
DR   SKIP; SKIP001073
DR   SKIP; SKIP004690
DR   Wikidata; Q54929879
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu101Gly (c.302A>G) (E100G); ClinVar=VCV000014761; Zygosity=Unspecified (NHCDR=ND35662).
CC   Discontinued: Coriell; ND35662; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY31 ! ND29688
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   ND35663
AC   CVCL_T854
SY   ND35663*C
DR   Coriell; ND35663
DR   NHCDR; ND35663
DR   SKIP; SKIP001074
DR   SKIP; SKIP004691
DR   Wikidata; Q54929881
RX   PubMed=25760436;
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (NHCDR=ND35663).
CC   Discontinued: Coriell; ND35663; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T855 ! ND39027
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 21
//
ID   ND35664
AC   CVCL_T858
SY   ND35664*C
DR   Coriell; ND35664
DR   NHCDR; ND35664
DR   SKIP; SKIP001075
DR   SKIP; SKIP004692
DR   Wikidata; Q54929882
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND35664).
CC   Discontinued: Coriell; ND35664; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T856 ! ND29774
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 22
//
ID   ND35665
AC   CVCL_A9PM
DR   Coriell; ND35665
DR   Wikidata; Q102114587
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35665; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY53 ! ND29689
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   ND35666
AC   CVCL_T859
SY   ND35666*C
DR   Coriell; ND35666
DR   NHCDR; ND35666
DR   SKIP; SKIP001076
DR   SKIP; SKIP004693
DR   Wikidata; Q54929883
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND35666).
CC   Discontinued: Coriell; ND35666; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T860 ! ND29509
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 22
//
ID   ND35668
AC   CVCL_T861
SY   ND35668*C
DR   Coriell; ND35668
DR   NHCDR; ND35668
DR   SKIP; SKIP001077
DR   SKIP; SKIP004694
DR   Wikidata; Q54929884
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu50Lys (c.148G>A) (E49K); ClinVar=VCV000658902; Zygosity=Unspecified (NHCDR=ND35668).
CC   Discontinued: Coriell; ND35668; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T862 ! ND39026
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 21
//
ID   ND35669
AC   CVCL_T863
SY   ND35669*C
DR   Coriell; ND35669
DR   NHCDR; ND35669
DR   SKIP; SKIP001078
DR   SKIP; SKIP004695
DR   Wikidata; Q54929885
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16873; FIG4; Simple; p.Ile9Ile (c.27C>T); ClinVar=VCV000137376; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: Coriell; ND35669; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168753; Amyotrophic lateral sclerosis 11
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T864 ! ND39025
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   ND35670
AC   CVCL_Y804
SY   ND35670*D
DR   Coriell; ND35670
DR   NHCDR; ND35670
DR   SKIP; SKIP001079
DR   SKIP; SKIP004696
DR   Wikidata; Q54929886
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Val149Gly (c.446T>G) (V148G); ClinVar=VCV000873204; Zygosity=Unspecified (NHCDR=ND35670).
CC   Discontinued: Coriell; ND35670; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   ND35671
AC   CVCL_T865
SY   ND35671*C
DR   Coriell; ND35671
DR   NHCDR; ND35671
DR   SKIP; SKIP001080
DR   SKIP; SKIP004697
DR   Wikidata; Q54929887
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND35671).
CC   Discontinued: Coriell; ND35671; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   ND35673
AC   CVCL_Y805
SY   ND35673*C
DR   Coriell; ND35673
DR   NHCDR; ND35673
DR   SKIP; SKIP001081
DR   SKIP; SKIP004698
DR   Wikidata; Q54929888
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND35673).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Discontinued: Coriell; ND35673; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y806 ! ND39023
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 19
//
ID   ND35702
AC   CVCL_FS99
DR   Coriell; ND35702
DR   Wikidata; Q54929889
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35703
AC   CVCL_FT00
DR   Coriell; ND35703
DR   Wikidata; Q54929890
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35739
AC   CVCL_FT01
DR   Coriell; ND35739
DR   Wikidata; Q54929891
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35743
AC   CVCL_FT02
DR   Coriell; ND35743
DR   Wikidata; Q54929892
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35787
AC   CVCL_FT03
DR   Coriell; ND35787
DR   Wikidata; Q54929893
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35815
AC   CVCL_FT04
DR   Coriell; ND35815
DR   Wikidata; Q54929894
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35820
AC   CVCL_FT05
DR   Coriell; ND35820
DR   Wikidata; Q54929895
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35821
AC   CVCL_HR99
DR   Coriell; ND35821
DR   Wikidata; Q54929896
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35822
AC   CVCL_IH46
DR   Coriell; ND35822
DR   Wikidata; Q54929897
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35825
AC   CVCL_UT57
DR   Coriell; ND35825
DR   Wikidata; Q98127465
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND35838
AC   CVCL_HW81
DR   Coriell; ND35838
DR   Wikidata; Q54929898
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35843
AC   CVCL_EZ13
DR   Coriell; ND35843
DR   NHCDR; ND35843
DR   Wikidata; Q54929899
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35843; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   ND35845
AC   CVCL_FT06
DR   Coriell; ND35845
DR   Wikidata; Q54929900
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35865
AC   CVCL_FT07
DR   Coriell; ND35865
DR   Wikidata; Q54929901
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35866
AC   CVCL_FT08
DR   Coriell; ND35866
DR   Wikidata; Q54929902
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35868
AC   CVCL_FT09
DR   Coriell; ND35868
DR   Wikidata; Q54929903
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35888
AC   CVCL_FT10
DR   Coriell; ND35888
DR   Wikidata; Q54929904
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35894
AC   CVCL_HS00
DR   Coriell; ND35894
DR   Wikidata; Q54929905
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35907
AC   CVCL_FT11
DR   Coriell; ND35907
DR   Wikidata; Q54929906
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35910
AC   CVCL_FT12
DR   Coriell; ND35910
DR   Wikidata; Q54929907
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35929
AC   CVCL_FT13
DR   Coriell; ND35929
DR   Wikidata; Q54929908
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35931
AC   CVCL_UT58
DR   Coriell; ND35931
DR   Wikidata; Q98127467
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND35934
AC   CVCL_HW82
DR   Coriell; ND35934
DR   Wikidata; Q54929909
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35935
AC   CVCL_HW83
DR   Coriell; ND35935
DR   Wikidata; Q54929914
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35939
AC   CVCL_GA09
DR   Coriell; ND35939
DR   Wikidata; Q54929915
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35945
AC   CVCL_HS01
DR   Coriell; ND35945
DR   Wikidata; Q54929916
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35947
AC   CVCL_GA10
DR   Coriell; ND35947
DR   Wikidata; Q54929917
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50757; Subarachnoid hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35951
AC   CVCL_FT14
DR   Coriell; ND35951
DR   Wikidata; Q54929918
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND35976
AC   CVCL_EZ14
DR   Coriell; ND35976
DR   NHCDR; ND35976
DR   Wikidata; Q54929919
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND35976; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND35991
AC   CVCL_HS02
DR   Coriell; ND35991
DR   Wikidata; Q54929920
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35992
AC   CVCL_HS03
DR   Coriell; ND35992
DR   Wikidata; Q54929921
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND35993
AC   CVCL_HS04
DR   Coriell; ND35993
DR   Wikidata; Q54929922
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36015
AC   CVCL_FT15
DR   Coriell; ND36015
DR   Wikidata; Q54929923
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36022
AC   CVCL_FT16
DR   Coriell; ND36022
DR   Wikidata; Q54929924
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36039
AC   CVCL_EH98
DR   Coriell; ND36039
DR   Wikidata; Q54929925
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND36040
AC   CVCL_GP55
DR   Coriell; ND36040
DR   Wikidata; Q54929926
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36041
AC   CVCL_FT17
DR   Coriell; ND36041
DR   Wikidata; Q54929927
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36055
AC   CVCL_FT18
DR   Coriell; ND36055
DR   Wikidata; Q54929928
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36066
AC   CVCL_FT19
DR   Coriell; ND36066
DR   Wikidata; Q54929929
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36080
AC   CVCL_FV30
DR   Coriell; ND36080
DR   Wikidata; Q54929930
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36091
AC   CVCL_EZ15
DR   Coriell; ND36091
DR   NHCDR; ND36091
DR   Wikidata; Q54929931
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND36091; true.
CC   Discontinued: NHCDR; ND36091; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36093
AC   CVCL_FT20
DR   Coriell; ND36093
DR   Wikidata; Q54929932
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36094
AC   CVCL_FT21
DR   Coriell; ND36094
DR   Wikidata; Q54929933
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36106
AC   CVCL_FT22
DR   Coriell; ND36106
DR   Wikidata; Q54929934
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36107
AC   CVCL_FT23
DR   Coriell; ND36107
DR   Wikidata; Q54929935
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36127
AC   CVCL_HW84
DR   Coriell; ND36127
DR   Wikidata; Q54929936
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36128
AC   CVCL_IG58
DR   Coriell; ND36128
DR   Wikidata; Q54929937
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36133
AC   CVCL_FT24
DR   Coriell; ND36133
DR   Wikidata; Q54929938
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36152
AC   CVCL_HW85
DR   Coriell; ND36152
DR   Wikidata; Q54929939
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36158
AC   CVCL_FT25
DR   Coriell; ND36158
DR   Wikidata; Q54929940
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36159
AC   CVCL_FT26
DR   Coriell; ND36159
DR   Wikidata; Q54929942
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36160
AC   CVCL_FT27
DR   Coriell; ND36160
DR   Wikidata; Q54929943
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36161
AC   CVCL_FT28
DR   Coriell; ND36161
DR   Wikidata; Q54929944
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36167
AC   CVCL_EE18
DR   Coriell; ND36167
DR   Wikidata; Q54929945
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND36206
AC   CVCL_FT29
DR   Coriell; ND36206
DR   Wikidata; Q54929947
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36210
AC   CVCL_FT30
DR   Coriell; ND36210
DR   Wikidata; Q54929948
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36211
AC   CVCL_FT31
DR   Coriell; ND36211
DR   Wikidata; Q54929949
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36223
AC   CVCL_FT32
DR   Coriell; ND36223
DR   Wikidata; Q54929950
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36265
AC   CVCL_FV31
DR   Coriell; ND36265
DR   Wikidata; Q54929951
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36281
AC   CVCL_FT33
DR   Coriell; ND36281
DR   Wikidata; Q54929952
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36301
AC   CVCL_FV32
DR   Coriell; ND36301
DR   Wikidata; Q54929953
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36320
AC   CVCL_EZ16
DR   Coriell; ND36320
DR   NHCDR; ND36320
DR   Wikidata; Q54929954
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND36320; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36326
AC   CVCL_FT34
DR   Coriell; ND36326
DR   Wikidata; Q54929955
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36353
AC   CVCL_HS05
DR   Coriell; ND36353
DR   Wikidata; Q54929958
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36369
AC   CVCL_IG59
DR   Coriell; ND36369
DR   Wikidata; Q54929959
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36375
AC   CVCL_FT35
DR   Coriell; ND36375
DR   Wikidata; Q54929960
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36394
AC   CVCL_FT36
DR   Coriell; ND36394
DR   Wikidata; Q54929961
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36396
AC   CVCL_FT37
DR   Coriell; ND36396
DR   Wikidata; Q54929962
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36439
AC   CVCL_FT38
DR   Coriell; ND36439
DR   Wikidata; Q54929963
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36440
AC   CVCL_FT39
DR   Coriell; ND36440
DR   Wikidata; Q54929964
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36495
AC   CVCL_FT40
DR   Coriell; ND36495
DR   Wikidata; Q54929965
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36496
AC   CVCL_FT41
DR   Coriell; ND36496
DR   Wikidata; Q54929966
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36505
AC   CVCL_HW86
DR   Coriell; ND36505
DR   Wikidata; Q54929967
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36530
AC   CVCL_FT42
DR   Coriell; ND36530
DR   Wikidata; Q54929968
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36531
AC   CVCL_HS06
DR   Coriell; ND36531
DR   Wikidata; Q54929969
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36561
AC   CVCL_FT43
DR   Coriell; ND36561
DR   Wikidata; Q54929970
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36578
AC   CVCL_FT44
DR   Coriell; ND36578
DR   Wikidata; Q54929971
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36580
AC   CVCL_FT45
DR   Coriell; ND36580
DR   Wikidata; Q54929972
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36610
AC   CVCL_FT46
DR   Coriell; ND36610
DR   Wikidata; Q54929973
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36629
AC   CVCL_FT47
DR   Coriell; ND36629
DR   Wikidata; Q54929974
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36638
AC   CVCL_UT59
DR   Coriell; ND36638
DR   Wikidata; Q98127470
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND36642
AC   CVCL_HS07
DR   Coriell; ND36642
DR   Wikidata; Q54929975
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36646
AC   CVCL_FT48
DR   Coriell; ND36646
DR   Wikidata; Q54929976
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36712
AC   CVCL_FT49
DR   Coriell; ND36712
DR   Wikidata; Q54929977
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36735
AC   CVCL_FT50
DR   Coriell; ND36735
DR   Wikidata; Q54929978
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36750
AC   CVCL_HW87
DR   Coriell; ND36750
DR   Wikidata; Q54929979
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34458; Intracranial aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36775
AC   CVCL_FT51
DR   Coriell; ND36775
DR   Wikidata; Q54929980
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36798
AC   CVCL_FT52
DR   Coriell; ND36798
DR   Wikidata; Q54929981
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36817
AC   CVCL_FT53
DR   Coriell; ND36817
DR   Wikidata; Q54929982
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36836
AC   CVCL_FT54
DR   Coriell; ND36836
DR   Wikidata; Q54929983
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36839
AC   CVCL_FT55
DR   Coriell; ND36839
DR   Wikidata; Q54929984
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36860
AC   CVCL_FT56
DR   Coriell; ND36860
DR   Wikidata; Q54929985
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36861
AC   CVCL_FT57
DR   Coriell; ND36861
DR   Wikidata; Q54929986
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36865
AC   CVCL_FT58
DR   Coriell; ND36865
DR   Wikidata; Q54929987
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36867
AC   CVCL_FT59
DR   Coriell; ND36867
DR   Wikidata; Q54929988
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36872
AC   CVCL_IG89
DR   Coriell; ND36872
DR   Wikidata; Q54929989
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84626; Cerebral cavernous malformation
DI   ORDO; Orphanet_221061; Familial cerebral cavernous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND36883
AC   CVCL_FT60
DR   Coriell; ND36883
DR   Wikidata; Q54929990
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36921
AC   CVCL_FT61
DR   Coriell; ND36921
DR   Wikidata; Q54929991
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36939
AC   CVCL_FT62
DR   Coriell; ND36939
DR   Wikidata; Q54929992
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36940
AC   CVCL_FT63
DR   Coriell; ND36940
DR   Wikidata; Q54929993
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36942
AC   CVCL_FT64
DR   Coriell; ND36942
DR   Wikidata; Q54929994
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36943
AC   CVCL_FT65
DR   Coriell; ND36943
DR   Wikidata; Q54929995
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36965
AC   CVCL_FT66
DR   Coriell; ND36965
DR   Wikidata; Q54929996
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36966
AC   CVCL_FT67
DR   Coriell; ND36966
DR   Wikidata; Q54929997
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36967
AC   CVCL_FT68
DR   Coriell; ND36967
DR   Wikidata; Q54930003
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36976
AC   CVCL_FT69
DR   Coriell; ND36976
DR   Wikidata; Q54930004
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36980
AC   CVCL_FT70
DR   Coriell; ND36980
DR   Wikidata; Q54930005
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND36997
AC   CVCL_Y808
SY   ND36997*C; HD 21
DR   Coriell; ND36997
DR   NHCDR; ND36997
DR   SKIP; SKIP001087
DR   SKIP; SKIP004699
DR   Wikidata; Q54930006
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (NHCDR=ND36997).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: Coriell; ND36997; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   ND36998
AC   CVCL_Y807
SY   ND36998*G; HD 29
DR   Coriell; ND36998
DR   NHCDR; ND36998
DR   SKIP; SKIP001088
DR   SKIP; SKIP004700
DR   Wikidata; Q54930007
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[60] (c.52CAG(60)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND36998).
CC   Discontinued: Coriell; ND36998; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F063 ! GM03621
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   ND36999
AC   CVCL_W577
SY   ND36999*F; HD 6
DR   Coriell; ND36999
DR   NHCDR; ND36999
DR   SKIP; SKIP001089
DR   SKIP; SKIP004701
DR   Wikidata; Q54930008
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND36999).
CC   Discontinued: Coriell; ND36999; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W576 ! GM09197
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   ND37002
AC   CVCL_FT71
DR   Coriell; ND37002
DR   Wikidata; Q54930010
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37057
AC   CVCL_FT72
DR   Coriell; ND37057
DR   Wikidata; Q54930011
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37066
AC   CVCL_FT73
DR   Coriell; ND37066
DR   Wikidata; Q54930012
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37083
AC   CVCL_FT74
DR   Coriell; ND37083
DR   Wikidata; Q54930013
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37114
AC   CVCL_FT75
DR   Coriell; ND37114
DR   Wikidata; Q54930014
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37127
AC   CVCL_IG90
DR   Coriell; ND37127
DR   Wikidata; Q54930015
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84626; Cerebral cavernous malformation
DI   ORDO; Orphanet_221061; Familial cerebral cavernous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND37132
AC   CVCL_EZ17
DR   Coriell; ND37132
DR   NHCDR; ND37132
DR   Wikidata; Q54930016
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND37132; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND37136
AC   CVCL_FT76
DR   Coriell; ND37136
DR   Wikidata; Q54930017
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37145
AC   CVCL_IG60
DR   Coriell; ND37145
DR   Wikidata; Q54930018
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND37147
AC   CVCL_FT77
DR   Coriell; ND37147
DR   Wikidata; Q54930019
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37149
AC   CVCL_FT78
DR   Coriell; ND37149
DR   Wikidata; Q54930020
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37151
AC   CVCL_FT79
DR   Coriell; ND37151
DR   Wikidata; Q54930021
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37176
AC   CVCL_FT80
DR   Coriell; ND37176
DR   Wikidata; Q54930022
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37177
AC   CVCL_IG61
DR   Coriell; ND37177
DR   Wikidata; Q54930023
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND37178
AC   CVCL_FT81
DR   Coriell; ND37178
DR   Wikidata; Q54930024
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37179
AC   CVCL_HS08
DR   Coriell; ND37179
DR   Wikidata; Q54930025
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND37180
AC   CVCL_EZ18
DR   Coriell; ND37180
DR   NHCDR; ND37180
DR   Wikidata; Q54930026
RX   PubMed=22952635;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (NHCDR=ND37180).
CC   Discontinued: Coriell; ND37180; true.
CC   Discontinued: NHCDR; ND37180; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   ND37183
AC   CVCL_FT82
DR   Coriell; ND37183
DR   Wikidata; Q54930027
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37199
AC   CVCL_FT83
DR   Coriell; ND37199
DR   Wikidata; Q54930028
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37306
AC   CVCL_FT84
DR   Coriell; ND37306
DR   Wikidata; Q54930029
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37321
AC   CVCL_FT85
DR   Coriell; ND37321
DR   Wikidata; Q54930030
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37346
AC   CVCL_FT86
DR   Coriell; ND37346
DR   Wikidata; Q54930031
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37356
AC   CVCL_FT87
DR   Coriell; ND37356
DR   Wikidata; Q54930032
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37357
AC   CVCL_FT88
DR   Coriell; ND37357
DR   Wikidata; Q54930033
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37377
AC   CVCL_FT89
DR   Coriell; ND37377
DR   Wikidata; Q54930035
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37378
AC   CVCL_FT90
DR   Coriell; ND37378
DR   Wikidata; Q54930036
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37428
AC   CVCL_FT91
DR   Coriell; ND37428
DR   Wikidata; Q54930037
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37503
AC   CVCL_FT92
DR   Coriell; ND37503
DR   Wikidata; Q54930038
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37517
AC   CVCL_EZ19
DR   Coriell; ND37517
DR   NHCDR; ND37517
DR   Wikidata; Q54930039
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (NHCDR=ND37517).
CC   Discontinued: Coriell; ND37517; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND37601
AC   CVCL_FT93
DR   Coriell; ND37601
DR   Wikidata; Q54930040
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND37609
AC   CVCL_EZ20
DR   Coriell; ND37609
DR   NHCDR; ND37609
DR   Wikidata; Q54930041
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND37609; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND37624
AC   CVCL_EE19
DR   Coriell; ND37624
DR   Wikidata; Q54930042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND37626
AC   CVCL_UT60
DR   Coriell; ND37626
DR   Wikidata; Q98127472
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND37710
AC   CVCL_HS09
DR   Coriell; ND37710
DR   Wikidata; Q54930043
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND37731
AC   CVCL_EZ21
DR   Coriell; ND37731
DR   NHCDR; ND37731
DR   Wikidata; Q54930044
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3 40bp del; Zygosity=Heterozygous (NHCDR=ND37731).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3-4del; Zygosity=Heterozygous (NHCDR=ND37731).
CC   Discontinued: Coriell; ND37731; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND37732
AC   CVCL_EZ22
DR   Coriell; ND37732
DR   NHCDR; ND37732
DR   Wikidata; Q54930049
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3 40bp del; Zygosity=Heterozygous (NHCDR=ND37732).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3-4del; Zygosity=Heterozygous (NHCDR=ND37732).
CC   Discontinued: Coriell; ND37732; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND37757
AC   CVCL_EZ23
DR   Coriell; ND37757
DR   NHCDR; ND37757
DR   Wikidata; Q54930050
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (NHCDR=ND37757).
CC   Discontinued: Coriell; ND37757; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND37766
AC   CVCL_FT94
DR   Coriell; ND37766
DR   Wikidata; Q54930051
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38020
AC   CVCL_EZ24
DR   Coriell; ND38020
DR   NHCDR; ND38020
DR   Wikidata; Q54930052
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND38020; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND38136
AC   CVCL_EZ25
DR   Coriell; ND38136
DR   NHCDR; ND38136
DR   Wikidata; Q54930053
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (NHCDR=ND38136).
CC   Discontinued: Coriell; ND38136; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND38155
AC   CVCL_HS10
DR   Coriell; ND38155
DR   Wikidata; Q54930054
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND38170
AC   CVCL_HS11
DR   Coriell; ND38170
DR   Wikidata; Q54930055
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2882; Arteriovenous hemangioma/malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND38181
AC   CVCL_HS12
DR   Coriell; ND38181
DR   Wikidata; Q54930056
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND38208
AC   CVCL_IH83
DR   Coriell; ND38208
DR   Wikidata; Q54930057
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50485; Cerebral hemorrhage
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND38209
AC   CVCL_FT95
DR   Coriell; ND38209
DR   Wikidata; Q54930058
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38258
AC   CVCL_FT96
DR   Coriell; ND38258
DR   Wikidata; Q54930059
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38262
AC   CVCL_EZ26
DR   Coriell; ND38262
DR   NHCDR; ND38262
DR   Wikidata; Q54930060
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (NHCDR=ND38262).
CC   Discontinued: Coriell; ND38262; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND38409
AC   CVCL_FT97
DR   Coriell; ND38409
DR   Wikidata; Q54930061
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38473
AC   CVCL_IG62
DR   Coriell; ND38473
DR   Wikidata; Q54930062
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND38477
AC   CVCL_Y812
DR   Coriell; ND38477
DR   NHCDR; ND38477
DR   SKIP; SKIP001371
DR   SKIP; SKIP004702
DR   Wikidata; Q54930063
RX   PubMed=27264186;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Asn52Metfs*29 (c.155delA) (255delA); ClinVar=VCV000536457; Zygosity=Heterozygous (Coriell=ND38477).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3-4del; Zygosity=Heterozygous (Coriell=ND38477).
CC   Discontinued: Coriell; ND38477; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y811 ! ND29543
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   ND38528
AC   CVCL_EZ27
DR   Coriell; ND38528
DR   NHCDR; ND38528
DR   Wikidata; Q54930064
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND38528; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND38530
AC   CVCL_EZ28
DR   Coriell; ND38530
DR   NHCDR; ND38530
DR   Wikidata; Q54930065
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND38530; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38534
AC   CVCL_FT98
DR   Coriell; ND38534
DR   Wikidata; Q54930066
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38545
AC   CVCL_Y814
SY   ND38545*C
DR   Coriell; ND38545
DR   NHCDR; ND38545
DR   SKIP; SKIP001090
DR   SKIP; SKIP004703
DR   Wikidata; Q54930067
CC   Population: South American (Brazil, Guyana, Venezuela).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38545).
CC   Discontinued: Coriell; ND38545; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M952 ! GM04689
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND38546
AC   CVCL_Y815
DR   Coriell; ND38546
DR   NHCDR; ND38546
DR   SKIP; SKIP001375
DR   SKIP; SKIP004704
DR   Wikidata; Q54930068
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[45] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38546).
CC   Discontinued: Coriell; ND38546; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V574 ! GM04887
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND38547
AC   CVCL_Y816
SY   ND38547*H
DR   Coriell; ND38547
DR   NHCDR; ND38547
DR   SKIP; SKIP001376
DR   SKIP; SKIP004705
DR   Wikidata; Q54930069
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38547).
CC   Discontinued: Coriell; ND38547; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y854 ! GM04777
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   ND38548
AC   CVCL_Y817
DR   Coriell; ND38548
DR   NHCDR; ND38548
DR   SKIP; SKIP001091
DR   SKIP; SKIP004706
DR   Wikidata; Q54930070
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38548).
CC   Discontinued: Coriell; ND38548; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V568 ! GM04717
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND38549
AC   CVCL_Y818
DR   Coriell; ND38549
DR   NHCDR; ND38549
DR   SKIP; SKIP001092
DR   SKIP; SKIP004707
DR   Wikidata; Q54930071
CC   Discontinued: Coriell; ND38549; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y964 ! GM04805
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   ND38551
AC   CVCL_Y819
DR   Coriell; ND38551
DR   NHCDR; ND38551
DR   SKIP; SKIP001093
DR   SKIP; SKIP004708
DR   Wikidata; Q54930072
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38551).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y859 ! GM04287
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND38552
AC   CVCL_Y820
DR   Coriell; ND38552
DR   NHCDR; ND38552
DR   SKIP; SKIP001094
DR   SKIP; SKIP004709
DR   Wikidata; Q54930073
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[49-50] (c.52CAG(49-50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND38552).
CC   Discontinued: Coriell; ND38552; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y861 ! GM04687
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND38554
AC   CVCL_Y821
DR   Coriell; ND38554
DR   NHCDR; ND38554
DR   SKIP; SKIP001364
DR   SKIP; SKIP004710
DR   Wikidata; Q54930074
CC   Discontinued: Coriell; ND38554; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y882 ! GM04729
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   ND38555
AC   CVCL_Y822
DR   Coriell; ND38555
DR   NHCDR; ND38555
DR   SKIP; SKIP001365
DR   SKIP; SKIP004711
DR   Wikidata; Q54930075
CC   Discontinued: Coriell; ND38555; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y885 ! GM04797
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   ND38558
AC   CVCL_FT99
DR   Coriell; ND38558
DR   Wikidata; Q54930076
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38582
AC   CVCL_FU00
DR   Coriell; ND38582
DR   Wikidata; Q54930077
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38594
AC   CVCL_IG92
DR   Coriell; ND38594
DR   Wikidata; Q54930078
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84626; Cerebral cavernous malformation
DI   ORDO; Orphanet_221061; Familial cerebral cavernous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND38630
AC   CVCL_FU01
DR   Coriell; ND38630
DR   Wikidata; Q54930079
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38635
AC   CVCL_UT61
DR   Coriell; ND38635
DR   Wikidata; Q98127475
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND38689
AC   CVCL_HS13
DR   Coriell; ND38689
DR   Wikidata; Q54930080
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND38709
AC   CVCL_UT62
DR   Coriell; ND38709
DR   Wikidata; Q98127477
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND38724
AC   CVCL_FV33
DR   Coriell; ND38724
DR   Wikidata; Q54930081
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38771
AC   CVCL_FU02
DR   Coriell; ND38771
DR   Wikidata; Q54930082
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38782
AC   CVCL_GP56
DR   Coriell; ND38782
DR   Wikidata; Q54930083
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38791
AC   CVCL_EZ29
DR   Coriell; ND38791
DR   NHCDR; ND38791
DR   Wikidata; Q54930084
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND38791; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND38836
AC   CVCL_FU03
DR   Coriell; ND38836
DR   Wikidata; Q54930085
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38865
AC   CVCL_EZ30
DR   Coriell; ND38865
DR   NHCDR; ND38865
DR   Wikidata; Q54930086
CC   Population: Pacific.
CC   Discontinued: Coriell; ND38865; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND38894
AC   CVCL_LL51
DR   Coriell; ND38894
DR   Wikidata; Q54930087
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >90Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   ND38912
AC   CVCL_FU04
DR   Coriell; ND38912
DR   Wikidata; Q54930088
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38947
AC   CVCL_FU05
DR   Coriell; ND38947
DR   Wikidata; Q54930091
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38960
AC   CVCL_FV34
DR   Coriell; ND38960
DR   Wikidata; Q54930092
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND38965
AC   CVCL_FU06
DR   Coriell; ND38965
DR   Wikidata; Q54930093
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39021
AC   CVCL_EZ31
DR   Coriell; ND39021
DR   NHCDR; ND39021
DR   Wikidata; Q54930094
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile113Thr (c.338T>C) (I112T); ClinVar=VCV000014762; Zygosity=Unspecified (NHCDR=ND39021).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Discontinued: Coriell; ND39021; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND39022
AC   CVCL_EZ32
DR   Coriell; ND39022
DR   NHCDR; ND39022
DR   Wikidata; Q54930095
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND39022).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Discontinued: Coriell; ND39022; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   ND39023
AC   CVCL_Y806
DR   Coriell; ND39023
DR   NHCDR; ND39023
DR   Wikidata; Q54930096
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND39023).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Discontinued: Coriell; ND39023; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   ND39025
AC   CVCL_T864
DR   Coriell; ND39025
DR   NHCDR; ND39025
DR   Wikidata; Q54930097
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16873; FIG4; Simple; p.Ile9Ile (c.27C>T); ClinVar=VCV000137376; Zygosity=Unspecified (NHCDR=ND39025).
CC   Discontinued: Coriell; ND39025; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168753; Amyotrophic lateral sclerosis 11
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   ND39026
AC   CVCL_T862
DR   Coriell; ND39026
DR   NHCDR; ND39026
DR   Wikidata; Q54930098
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu50Lys (c.148G>A) (E49K); ClinVar=VCV000658902; Zygosity=Unspecified (NHCDR=ND39026).
CC   Discontinued: Coriell; ND39026; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   ND39027
AC   CVCL_T855
DR   Coriell; ND39027
DR   NHCDR; ND39027
DR   Wikidata; Q54930099
RX   PubMed=25760436;
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (NHCDR=ND39027).
CC   Discontinued: Coriell; ND39027; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U113 ! ND10734
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   ND39028
AC   CVCL_A9P9
DR   Coriell; ND39028
DR   Wikidata; Q102114588
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Gly86Arg (c.256G>C) (G85R); ClinVar=VCV000014758; Zygosity=Unspecified (Coriell=ND39028).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Discontinued: Coriell; ND39028; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   ND39030
AC   CVCL_Y823
SY   ND39030*C
DR   Coriell; ND39030
DR   NHCDR; ND39030
DR   SKIP; SKIP001082
DR   Wikidata; Q54930100
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Unspecified (Coriell=ND39030).
CC   Discontinued: Coriell; ND39030; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T849 ! ND29149
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND39032
AC   CVCL_Y824
SY   ND39032*C
DR   Coriell; ND39032
DR   NHCDR; ND39032
DR   SKIP; SKIP001083
DR   SKIP; SKIP004712
DR   Wikidata; Q54930101
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Leu145Phe (c.435G>C) (L144F); ClinVar=VCV000586637; Zygosity=Unspecified (NHCDR=ND39032).
CC   Caution: SOD1 mutation wrongly indicated as L144P in NHCDR.
CC   Discontinued: Coriell; ND39032; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY26 ! ND29415
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   ND39034
AC   CVCL_Y825
SY   ND39034*C
DR   Coriell; ND39034
DR   NHCDR; ND39034
DR   SKIP; SKIP001084
DR   SKIP; SKIP004713
DR   Wikidata; Q54930102
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg522Arg (c.1566G>A); ClinVar=VCV000540280; Zygosity=Unspecified; Note=Mislocalized protein (from parent cell line).
CC   Discontinued: Coriell; ND39034; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y894 ! ND29563
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   ND39036
AC   CVCL_Y826
DR   Coriell; ND39036
DR   NHCDR; ND39036
DR   SKIP; SKIP001085
DR   SKIP; SKIP004714
DR   Wikidata; Q54930103
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Gly86Arg (c.256G>C) (G85R); ClinVar=VCV000014758; Zygosity=Unspecified (NHCDR=ND39036).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Discontinued: Coriell; ND39036; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9P9 ! ND39028
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   ND39037
AC   CVCL_Y827
SY   ND39037*C
DR   Coriell; ND39037
DR   NHCDR; ND39037
DR   SKIP; SKIP001086
DR   SKIP; SKIP004715
DR   Wikidata; Q54930104
RX   PubMed=25760436;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39037; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   ND39064
AC   CVCL_FV35
DR   Coriell; ND39064
DR   Wikidata; Q54930105
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39131
AC   CVCL_FU07
DR   Coriell; ND39131
DR   Wikidata; Q54930106
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39132
AC   CVCL_FU08
DR   Coriell; ND39132
DR   Wikidata; Q54930107
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39183
AC   CVCL_EZ33
DR   Coriell; ND39183
DR   NHCDR; ND39183
DR   Wikidata; Q54930108
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39183; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND39258
AC   CVCL_ZC78
DR   Coriell; ND39258
DR   Wikidata; Q98127479
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=ND39258).
CC   Discontinued: Coriell; ND39258; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   ND39276
AC   CVCL_FV36
DR   Coriell; ND39276
DR   Wikidata; Q54930109
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39277
AC   CVCL_EE20
DR   Coriell; ND39277
DR   Wikidata; Q54930110
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND39326
AC   CVCL_FV37
DR   Coriell; ND39326
DR   Wikidata; Q54930111
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39450
AC   CVCL_EZ34
DR   Coriell; ND39450
DR   NHCDR; ND39450
DR   Wikidata; Q54930112
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39450; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND39461
AC   CVCL_LM04
DR   Coriell; ND39461
DR   Wikidata; Q54930113
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND39472
AC   CVCL_FU09
DR   Coriell; ND39472
DR   Wikidata; Q54930114
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39508
AC   CVCL_EE21
DR   Coriell; ND39508
DR   Wikidata; Q54930115
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND39510
AC   CVCL_EZ35
DR   Coriell; ND39510
DR   NHCDR; ND39510
DR   Wikidata; Q54930116
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39510; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND39515
AC   CVCL_FU10
DR   Coriell; ND39515
DR   Wikidata; Q54930117
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39518
AC   CVCL_FU11
DR   Coriell; ND39518
DR   Wikidata; Q54930118
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39528
AC   CVCL_EZ36
DR   Coriell; ND39528
DR   NHCDR; ND39528
DR   Wikidata; Q54930119
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39528; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND39538
AC   CVCL_EZ37
DR   Coriell; ND39538
DR   NHCDR; ND39538
DR   Wikidata; Q54930120
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39538; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND39575
AC   CVCL_UT63
DR   Coriell; ND39575
DR   Wikidata; Q98127482
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND39588
AC   CVCL_LM05
DR   Coriell; ND39588
DR   Wikidata; Q54930121
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84626; Cerebral cavernous malformation
DI   ORDO; Orphanet_221061; Familial cerebral cavernous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND39589
AC   CVCL_LL53
DR   Coriell; ND39589
DR   Wikidata; Q54930122
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84626; Cerebral cavernous malformation
DI   ORDO; Orphanet_221061; Familial cerebral cavernous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND39621
AC   CVCL_LL54
DR   Coriell; ND39621
DR   Wikidata; Q54930123
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND39701
AC   CVCL_EE22
DR   Coriell; ND39701
DR   Wikidata; Q54930124
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND39708
AC   CVCL_FU12
DR   Coriell; ND39708
DR   Wikidata; Q54930125
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39734
AC   CVCL_LL55
DR   Coriell; ND39734
DR   Wikidata; Q54930126
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND39757
AC   CVCL_FU13
DR   Coriell; ND39757
DR   Wikidata; Q54930127
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39793
AC   CVCL_FU14
DR   Coriell; ND39793
DR   Wikidata; Q54930128
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39826
AC   CVCL_EH99
DR   Coriell; ND39826
DR   Wikidata; Q54930129
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND39876
AC   CVCL_IG63
DR   Coriell; ND39876
DR   Wikidata; Q54930130
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND39896
AC   CVCL_Y828
SY   ND39896*C
DR   Coriell; ND39896
DR   NHCDR; ND39896
DR   SKIP; SKIP001377
DR   SKIP; SKIP004716
DR   Wikidata; Q54930133
RX   PubMed=27264186;
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39896; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   ND39955
AC   CVCL_EZ38
DR   Coriell; ND39955
DR   NHCDR; ND39955
DR   Wikidata; Q54930134
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39955; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND39957
AC   CVCL_EZ39
DR   Coriell; ND39957
DR   NHCDR; ND39957
DR   Wikidata; Q54930135
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39957; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND39985
AC   CVCL_FU15
DR   Coriell; ND39985
DR   Wikidata; Q54930136
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39997
AC   CVCL_FV38
DR   Coriell; ND39997
DR   Wikidata; Q54930137
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND39999
AC   CVCL_EZ40
DR   Coriell; ND39999
DR   NHCDR; ND39999
DR   Wikidata; Q54930138
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND39999; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND40018
AC   CVCL_Y829
SY   ND40018*C
DR   Coriell; ND40018
DR   NHCDR; ND40018
DR   SKIP; SKIP001372
DR   SKIP; SKIP004717
DR   Wikidata; Q54930139
RX   PubMed=26651604;
RX   PubMed=27264186;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous (Coriell=ND40018).
CC   Discontinued: Coriell; ND40018; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 18
//
ID   ND40019
AC   CVCL_Y830
SY   ND40019*C
DR   Coriell; ND40019
DR   NHCDR; ND40019
DR   SKIP; SKIP001373
DR   SKIP; SKIP004718
DR   Wikidata; Q54930140
RX   PubMed=26651604;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND40019).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND40019; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y831 ! ND40020
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   ND40020
AC   CVCL_Y831
SY   ND40020*C
DR   Coriell; ND40020
DR   NHCDR; ND40020
DR   SKIP; SKIP001374
DR   SKIP; SKIP004719
DR   Wikidata; Q54930141
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND40020).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND40020; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y830 ! ND40019
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 17
//
ID   ND40021
AC   CVCL_FU16
DR   Coriell; ND40021
DR   Wikidata; Q54930142
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40026
AC   CVCL_FU17
DR   Coriell; ND40026
DR   Wikidata; Q54930143
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40061
AC   CVCL_EZ41
DR   Coriell; ND40061
DR   NHCDR; ND40061
DR   Wikidata; Q54930144
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[71]; Zygosity=Heterozygous; Note=The other allele has 23 repeats (NHCDR=ND40061).
CC   Discontinued: Coriell; ND40061; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   ND40064
AC   CVCL_EZ42
DR   Coriell; ND40064
DR   NHCDR; ND40064
DR   Wikidata; Q54930145
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[366]; ClinVar=VCV000561195; Zygosity=Heterozygous (NHCDR=ND40064).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1066]; ClinVar=VCV000561195; Zygosity=Heterozygous (NHCDR=ND40064).
CC   Discontinued: Coriell; ND40064; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND40065
AC   CVCL_EZ43
DR   Coriell; ND40065
DR   NHCDR; ND40065
DR   Wikidata; Q54930146
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND40065; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40066
AC   CVCL_EZ44
DR   Coriell; ND40066
DR   NHCDR; ND40066
DR   Wikidata; Q54930147
RX   PubMed=35378365;
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (NHCDR=ND40066).
CC   Discontinued: Coriell; ND40066; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND40067
AC   CVCL_EZ45
DR   Coriell; ND40067
DR   NHCDR; ND40067
DR   Wikidata; Q54930148
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; c.203_204delAG; Zygosity=Heterozygous (NHCDR=ND40067).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4-7del; Zygosity=Heterozygous (NHCDR=ND40067).
CC   Discontinued: Coriell; ND40067; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND40068
AC   CVCL_EY29
DR   Coriell; ND40068
DR   NHCDR; ND40068
DR   Wikidata; Q54930149
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (NHCDR=ND40068).
CC   Discontinued: Coriell; ND40068; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND40069
AC   CVCL_EZ46
DR   Coriell; ND40069
DR   NHCDR; ND40069
DR   Wikidata; Q54930150
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND40069).
CC   Discontinued: Coriell; ND40069; true.
CC   Discontinued: NHCDR; ND40069; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   ND40070
AC   CVCL_EZ47
DR   Coriell; ND40070
DR   NHCDR; ND40070
DR   Wikidata; Q54930151
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=ND40070).
CC   Discontinued: Coriell; ND40070; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 14
//
ID   ND40071
AC   CVCL_EZ48
DR   Coriell; ND40071
DR   NHCDR; ND40071
DR   Wikidata; Q54930152
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Unspecified (NHCDR=ND40071).
CC   Discontinued: Coriell; ND40071; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 27-11-25; Version: 14
//
ID   ND40071E11
AC   CVCL_RH64
SY   FTLD-Tau2
DR   SKIP; SKIP001267
DR   Wikidata; Q54930153
RX   PubMed=27721502;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Unspecified (PubMed=27721502).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ48 ! ND40071
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 12
//
ID   ND40072
AC   CVCL_EZ49
DR   Coriell; ND40072
DR   NHCDR; ND40072
DR   Wikidata; Q54930154
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Unspecified (NHCDR=ND40072).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Discontinued: Coriell; ND40072; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 27-11-25; Version: 16
//
ID   ND40074
AC   CVCL_EZ50
DR   Coriell; ND40074
DR   NHCDR; ND40074
DR   Wikidata; Q54930155
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=ND40074).
CC   Discontinued: Coriell; ND40074; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 14
//
ID   ND40075
AC   CVCL_EZ51
DR   Coriell; ND40075
DR   NHCDR; ND40075
DR   Wikidata; Q54930156
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20856; THAP1; Simple; p.Ile149Thr (c.446T>C); Zygosity=Heterozygous (NHCDR=ND40075).
CC   Discontinued: Coriell; ND40075; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UT54 ! ND34510
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND40076
AC   CVCL_EZ52
DR   Coriell; ND40076
DR   NHCDR; ND40076
DR   Wikidata; Q54930157
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=ND40076).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Discontinued: Coriell; ND40076; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 17
//
ID   ND40077
AC   CVCL_EZ53
DR   Coriell; ND40077
DR   NHCDR; ND40077
DR   Wikidata; Q54930158
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Heterozygous (NHCDR=ND40077).
CC   Discontinued: Coriell; ND40077; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND40078
AC   CVCL_EZ54
DR   Coriell; ND40078
DR   NHCDR; ND40078
DR   Wikidata; Q54930159
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (NHCDR=ND40078).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Gln (c.824G>A); ClinVar=VCV000931482; Zygosity=Heterozygous (NHCDR=ND40078).
CC   Discontinued: Coriell; ND40078; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   ND40079
AC   CVCL_EZ55
DR   Coriell; ND40079
DR   NHCDR; ND40079
DR   Wikidata; Q54930160
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2711; DCTN1; Simple; p.Gly71Arg (c.211G>A); ClinVar=VCV000008406; Zygosity=Unspecified (NHCDR=ND40079).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Discontinued: Coriell; ND40079; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   ND40080
AC   CVCL_EZ56
DR   Coriell; ND40080
DR   NHCDR; ND40080
DR   Wikidata; Q54930161
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2711; DCTN1; Simple; p.Gly71Arg (c.211G>A); ClinVar=VCV000008406; Zygosity=Unspecified (NHCDR=ND40080).
CC   Discontinued: Coriell; ND40080; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   ND40081
AC   CVCL_EZ57
DR   Coriell; ND40081
DR   NHCDR; ND40081
DR   Wikidata; Q54930162
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Arg1345Ter (c.4033C>T) (p.Arg1346Ter, c.4036C>T) (R1346*); ClinVar=VCV000585570; Zygosity=Unspecified (NHCDR=ND40081).
CC   Discontinued: Coriell; ND40081; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   ND40082
AC   CVCL_EZ58
DR   Coriell; ND40082
DR   NHCDR; ND40082
DR   Wikidata; Q54930163
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ala9Asp (c.26C>A); ClinVar=VCV000016013; Zygosity=Unspecified (NHCDR=ND40082).
CC   Discontinued: Coriell; ND40082; true.
CC   Discontinued: NHCDR; ND40082; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND40260
AC   CVCL_EZ59
DR   Coriell; ND40260
DR   NHCDR; ND40260
DR   Wikidata; Q54930164
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND40260; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND40268
AC   CVCL_GP57
DR   Coriell; ND40268
DR   Wikidata; Q54930165
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40346
AC   CVCL_FV39
DR   Coriell; ND40346
DR   Wikidata; Q54930166
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40365
AC   CVCL_IG64
DR   Coriell; ND40365
DR   Wikidata; Q54930167
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND40459
AC   CVCL_FU18
DR   Coriell; ND40459
DR   Wikidata; Q54930168
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40534
AC   CVCL_EZ60
DR   NHCDR; ND40534
DR   Wikidata; Q54930169
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[46] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND40534).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND40536
AC   CVCL_EZ61
DR   NHCDR; ND40536
DR   Wikidata; Q54930170
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[66] (c.52CAG(66)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND40536).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND40597
AC   CVCL_UF61
DR   Coriell; ND40597
DR   Wikidata; Q98127484
RX   PubMed=27264186;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND40597).
CC   Discontinued: Coriell; ND40597; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY94 ! ND33879
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   ND40599
AC   CVCL_UF62
DR   Coriell; ND40599
DR   Wikidata; Q98127487
RX   PubMed=27264186;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND40599).
CC   Discontinued: Coriell; ND40599; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   ND40600
AC   CVCL_UF63
DR   Coriell; ND40600
DR   Wikidata; Q98127489
RX   PubMed=27264186;
CC   Discontinued: Coriell; ND40600; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   ND40608
AC   CVCL_EI00
DR   Coriell; ND40608
DR   Wikidata; Q54930171
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND40629
AC   CVCL_FU19
DR   Coriell; ND40629
DR   Wikidata; Q54930172
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40636
AC   CVCL_EE23
DR   Coriell; ND40636
DR   Wikidata; Q54930174
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND40653
AC   CVCL_FU20
DR   Coriell; ND40653
DR   Wikidata; Q54930175
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40783
AC   CVCL_UT64
DR   Coriell; ND40783
DR   Wikidata; Q98127492
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND40795
AC   CVCL_LL56
DR   Coriell; ND40795
DR   Wikidata; Q54930176
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND40809
AC   CVCL_EI01
DR   Coriell; ND40809
DR   Wikidata; Q54930177
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85028; Progressive supranuclear palsy
DI   ORDO; Orphanet_683; Progressive supranuclear palsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND40874
AC   CVCL_FU21
DR   Coriell; ND40874
DR   Wikidata; Q54930178
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40877
AC   CVCL_FU22
DR   Coriell; ND40877
DR   Wikidata; Q54930179
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND40985
AC   CVCL_HS14
DR   Coriell; ND40985
DR   Wikidata; Q54930180
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND40992
AC   CVCL_EZ62
DR   NHCDR; ND40992
DR   Wikidata; Q54930181
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Unspecified (NHCDR=ND40992).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 27-11-25; Version: 13
//
ID   ND40996
AC   CVCL_RY33
DR   NHCDR; ND40996
DR   Wikidata; Q54930183
RX   PubMed=34826737;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (NHCDR=ND40996).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND41001
AC   CVCL_EZ63
DR   NHCDR; ND41001
DR   Wikidata; Q54930184
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; c.338+1delG (p.Leu113_Ile114insThr) (int4del); ClinVar=VCV000098013; Zygosity=Unspecified (NHCDR=ND41001).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND41003
AC   CVCL_EZ64
DR   Coriell; ND41003
DR   NHCDR; ND41003
DR   Wikidata; Q54930185
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous (NHCDR=ND41003).
CC   Discontinued: Coriell; ND41003; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND41004
AC   CVCL_EZ65
DR   NHCDR; ND41004
DR   Wikidata; Q54930186
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp110Tyr (c.328G>T) (D109Y); ClinVar=VCV000899185; Zygosity=Unspecified (NHCDR=ND41004).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND41006
AC   CVCL_EZ66
DR   NHCDR; ND41006
DR   Wikidata; Q54930187
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Unspecified (NHCDR=ND41006).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND41007
AC   CVCL_EZ67
DR   NHCDR; ND41007
DR   Wikidata; Q54930188
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:16812; COQ8A; Simple; p.Ser616Leufs*114 (c.1844dupG) (p.Gly615fs) (c.1844_1845insG); ClinVar=VCV000214046; Zygosity=Unspecified (NHCDR=ND41007).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   ND41010
AC   CVCL_EZ68
DR   Coriell; ND41010
DR   NHCDR; ND41010
DR   Wikidata; Q54930189
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Arg246Ter (c.736C>T); ClinVar=VCV000002407; Zygosity=Homozygous (NHCDR=ND41010).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex4-6del; Zygosity=Heterozygous (NHCDR=ND41010).
CC   Discontinued: Coriell; ND41010; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND41014
AC   CVCL_EZ69
DR   NHCDR; ND41014
DR   Wikidata; Q54930190
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Homozygous (NHCDR=ND41014).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   ND41015
AC   CVCL_EZ70
DR   NHCDR; ND41015
DR   Wikidata; Q54930191
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=ND41015).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   ND41016
AC   CVCL_EZ71
DR   NHCDR; ND41016
DR   Wikidata; Q54930192
RX   PubMed=36130205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Homozygous (NHCDR=ND41016).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   ND41113
AC   CVCL_Y809
SY   ND41113*D
DR   Coriell; ND41113
DR   NHCDR; ND41113
DR   SKIP; SKIP001555
DR   SKIP; SKIP004720
DR   Wikidata; Q54930193
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (NHCDR=ND41113).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Discontinued: Coriell; ND41113; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   ND41114
AC   CVCL_Y832
SY   ND41114*C
DR   Coriell; ND41114
DR   NHCDR; ND41114
DR   SKIP; SKIP001556
DR   SKIP; SKIP004721
DR   Wikidata; Q54930194
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Coriell; ND41114; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   ND41125
AC   CVCL_EZ72
DR   NHCDR; ND41125
DR   Wikidata; Q54930195
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   ND41130
AC   CVCL_UT65
DR   Coriell; ND41130
DR   Wikidata; Q98127495
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND41180
AC   CVCL_UF69
DR   Coriell; ND41180
DR   Wikidata; Q98127497
RX   PubMed=27264186;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND41180).
CC   Discontinued: Coriell; ND41180; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   ND41181
AC   CVCL_UF70
DR   Coriell; ND41181
DR   Wikidata; Q98127498
RX   PubMed=27264186;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (Coriell=ND41181).
CC   Discontinued: Coriell; ND41181; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY94 ! ND33879
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   ND41330
AC   CVCL_LL57
DR   Coriell; ND41330
DR   Wikidata; Q54930196
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND41375
AC   CVCL_HS15
DR   Coriell; ND41375
DR   Wikidata; Q54930197
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   ND41654
AC   CVCL_Y833
SY   ND41654*D
DR   Coriell; ND41654
DR   NHCDR; ND41654
DR   SKIP; SKIP001559
DR   Wikidata; Q54930198
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND41654; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y895 ! ND30625
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ND41656
AC   CVCL_Y834
DR   Coriell; ND41656
DR   NHCDR; ND41656
DR   SKIP; SKIP001561
DR   SKIP; SKIP004723
DR   Wikidata; Q54930199
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[57] (c.52CAG(57)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND41656).
CC   Discontinued: Coriell; ND41656; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y897 ! ND33392
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND41657
AC   CVCL_Y835
DR   Coriell; ND41657
DR   NHCDR; ND41657
DR   SKIP; SKIP001562
DR   SKIP; SKIP004722
DR   Wikidata; Q54930200
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[57] (c.52CAG(57)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=ND41657).
CC   Discontinued: Coriell; ND41657; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y897 ! ND33392
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   ND41658
AC   CVCL_Y836
SY   ND41658*H
DR   Coriell; ND41658
DR   NHCDR; ND41658
DR   SKIP; SKIP001560
DR   Wikidata; Q54930201
CC   Population: Caucasian.
CC   Discontinued: Coriell; ND41658; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y895 ! ND30625
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ND41864
AC   CVCL_1N97
AS   CVCL_RX95
SY   2L16; Control #16
DR   Coriell; ND41864
DR   NHCDR; ND41864
DR   Wikidata; Q54584597
RX   PubMed=23063362;
CC   Discontinued: Coriell; ND41864; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y837 ! ND41865
OI   CVCL_Y838 ! ND41866
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   ND41865
AC   CVCL_Y837
AS   CVCL_RX96
SY   ND41865*C; 2L17; Control #17
DR   Coriell; ND41865
DR   NHCDR; ND41865
DR   SKIP; SKIP004725
DR   Wikidata; Q54584599
RX   PubMed=23063362;
RX   PubMed=27594586;
CC   Discontinued: Coriell; ND41865; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N97 ! ND41864
OI   CVCL_Y838 ! ND41866
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 14
//
ID   ND41866
AC   CVCL_Y838
AS   CVCL_RX97
SY   ND41866*C; 2L20; Control #20; CTRL 2
DR   Coriell; ND41866
DR   NHCDR; ND41866
DR   SKIP; SKIP004724
DR   Wikidata; Q54584600
RX   PubMed=23063362;
RX   PubMed=27594586;
RX   PubMed=28564594;
CC   Discontinued: Coriell; ND41866; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N97 ! ND41864
OI   CVCL_Y837 ! ND41865
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 13
//
ID   ND41867
AC   CVCL_Y839
SY   ND41867*J
DR   Coriell; ND41867
DR   NHCDR; ND41867
DR   SKIP; SKIP001563
DR   Wikidata; Q54930205
CC   Discontinued: Coriell; ND41867; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   ND41869
AC   CVCL_Y840
SY   ND41869*C
DR   Coriell; ND41869
DR   NHCDR; ND41869
DR   SKIP; SKIP001564
DR   SKIP; SKIP004726
DR   Wikidata; Q54930206
CC   Discontinued: Coriell; ND41869; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   ND41870
AC   CVCL_RY02
AS   CVCL_Y841
SY   ND41870*C; 2L1; PGRN S116X iPSC #1
DR   Coriell; ND41870
DR   NHCDR; ND41870
DR   SKIP; SKIP001565
DR   SKIP; SKIP004727
DR   Wikidata; Q54584591
RX   PubMed=23063362;
RX   PubMed=27594586;
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser116Ter (c.347C>A); Zygosity=Unspecified (PubMed=23063362).
CC   Discontinued: Coriell; ND41870; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY03 ! ND41871
OI   CVCL_RY04 ! ND41872
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   ND41871
AC   CVCL_RY03
AS   CVCL_Y842
SY   ND41871*F; 2L14; PGRN S116X iPSC #14
DR   Coriell; ND41871
DR   NHCDR; ND41871
DR   SKIP; SKIP001566
DR   Wikidata; Q54584594
RX   PubMed=23063362;
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser116Ter (c.347C>A); ClinVar=VCV002633502; Zygosity=Unspecified (PubMed=23063362).
CC   Discontinued: Coriell; ND41871; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY02 ! ND41870
OI   CVCL_RY04 ! ND41872
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ND41872
AC   CVCL_RY04
AS   CVCL_Y843
SY   ND41872*C; 2L26; PGRN S116X iPSC #26
DR   Coriell; ND41872
DR   NHCDR; ND41872
DR   SKIP; SKIP001567
DR   SKIP; SKIP004728
DR   Wikidata; Q54584601
RX   PubMed=23063362;
RX   PubMed=27594586;
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ser116Ter (c.347C>A); ClinVar=VCV002633502; Zygosity=Unspecified (PubMed=23063362).
CC   Discontinued: Coriell; ND41872; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RY02 ! ND41870
OI   CVCL_RY03 ! ND41871
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   ND42222
AC   CVCL_Y844
SY   ND42222*D
DR   Coriell; ND42222
DR   NHCDR; ND42222
DR   SKIP; SKIP001568
DR   Wikidata; Q54930210
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=ND42222).
CC   Discontinued: Coriell; ND42222; true.
CC   Discontinued: NHCDR; ND42222; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N95 ! ND42223
OI   CVCL_Y845 ! ND42224
OI   CVCL_GP60 ! ND50034
OI   CVCL_RH33 ! ND50036
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   ND42223
AC   CVCL_1N95
SY   ND42223*E
DR   Coriell; ND42223
DR   NHCDR; ND42223
DR   Wikidata; Q54930211
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=ND42223).
CC   Discontinued: Coriell; ND42223; true.
CC   Discontinued: NHCDR; ND42223; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y844 ! ND42222
OI   CVCL_Y845 ! ND42224
OI   CVCL_GP60 ! ND50034
OI   CVCL_RH33 ! ND50036
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   ND42224
AC   CVCL_Y845
SY   ND42224*B
DR   Coriell; ND42224
DR   NHCDR; ND42224
DR   Wikidata; Q54930212
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Coriell=ND42224).
CC   Discontinued: Coriell; ND42224; true.
CC   Discontinued: NHCDR; ND42224; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y844 ! ND42222
OI   CVCL_1N95 ! ND42223
OI   CVCL_GP60 ! ND50034
OI   CVCL_RH33 ! ND50036
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   ND42228
AC   CVCL_1N96
SY   ND42228*E
DR   Coriell; ND42228
DR   NHCDR; ND42228
DR   Wikidata; Q54930213
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Coriell; ND42228; true.
CC   Discontinued: NHCDR; ND42228; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   ND42229
AC   CVCL_Y846
DR   Coriell; ND42229
DR   NHCDR; ND42229
DR   Wikidata; Q54930214
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Coriell; ND42229; true.
CC   Discontinued: NHCDR; ND42229; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   ND42230
AC   CVCL_Y847
DR   Coriell; ND42230
DR   NHCDR; ND42230
DR   SKIP; SKIP001571
DR   Wikidata; Q54930216
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Coriell; ND42230; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   ND42235
AC   CVCL_Y848
DR   Coriell; ND42235
DR   NHCDR; ND42235
DR   SKIP; SKIP001574
DR   Wikidata; Q54930217
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[49-50] (c.52CAG(49-50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Coriell; ND42235; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y861 ! GM04687
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   ND42240
AC   CVCL_Y849
SY   ND42240*E
DR   Coriell; ND42240
DR   NHCDR; ND42240
DR   SKIP; SKIP001557
DR   Wikidata; Q54930218
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Coriell; ND42240; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   ND42241
AC   CVCL_Y850
SY   ND42241*E
DR   Coriell; ND42241
DR   NHCDR; ND42241
DR   SKIP; SKIP001558
DR   Wikidata; Q54930219
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Coriell; ND42241; true.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   ND42242
AC   CVCL_Y851
SY   ND42242*C
DR   Coriell; ND42242
DR   NHCDR; ND42242
DR   SKIP; SKIP001575
DR   Wikidata; Q54930220
CC   Discontinued: Coriell; ND42242; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y898 ! ND30014
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   ND42245
AC   CVCL_Y852
SY   ND42245*F
DR   Coriell; ND42245
DR   NHCDR; ND42245
DR   SKIP; SKIP001576
DR   Wikidata; Q54930221
CC   Population: African American.
CC   Discontinued: Coriell; ND42245; true.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7426 ! GM05400
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   ND42485
AC   CVCL_EZ73
DR   NHCDR; ND42485
DR   Wikidata; Q54930222
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Unspecified (NHCDR=ND42485).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   ND42487
AC   CVCL_EZ74
DR   NHCDR; ND42487
DR   Wikidata; Q54930223
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND42490
AC   CVCL_EZ75
DR   NHCDR; ND42490
DR   Wikidata; Q54930224
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND42491
AC   CVCL_EZ76
DR   NHCDR; ND42491
DR   Wikidata; Q54930225
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND42492
AC   CVCL_EZ77
DR   NHCDR; ND42492
DR   Wikidata; Q54930226
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND42493
AC   CVCL_EY30
DR   NHCDR; ND42493
DR   Wikidata; Q54930227
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000016009; Zygosity=Unspecified (NHCDR=ND42493).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND42494
AC   CVCL_EZ78
DR   NHCDR; ND42494
DR   Wikidata; Q54930228
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND42496
AC   CVCL_EZ79
DR   NHCDR; ND42496
DR   Wikidata; Q54930229
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND42496).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND42497
AC   CVCL_EZ80
DR   NHCDR; ND42497
DR   Wikidata; Q54930230
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Unspecified (NHCDR=ND42497).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 14
//
ID   ND42498
AC   CVCL_EZ81
DR   NHCDR; ND42498
DR   Wikidata; Q54930231
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   ND42499
AC   CVCL_A9T4
DR   Coriell; ND42499
DR   Wikidata; Q102114589
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (Coriell=ND42499).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Discontinued: Coriell; ND42499; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   ND42503
AC   CVCL_EZ82
DR   NHCDR; ND42503
DR   Wikidata; Q54930232
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND42504
AC   CVCL_EZ83
DR   NHCDR; ND42504
DR   Wikidata; Q54930233
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND42504).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND42506
AC   CVCL_EZ84
DR   NHCDR; ND42506
DR   Wikidata; Q54930234
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND42506).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   ND42514
AC   CVCL_UT56
DR   Coriell; ND42514
DR   Wikidata; Q98127499
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ND42619
AC   CVCL_EE24
DR   Coriell; ND42619
DR   Wikidata; Q54930235
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95802; Ischemic cerebrovascular accident
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   ND42716
AC   CVCL_EZ85
DR   NHCDR; ND42716
DR   Wikidata; Q54930236
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND42717
AC   CVCL_EZ86
DR   NHCDR; ND42717
DR   Wikidata; Q54930237
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   ND42765
AC   CVCL_1N98
SY   ND42765*C
DR   Coriell; ND42765
DR   NHCDR; ND42765
DR   Wikidata; Q54930238
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND42765).
CC   Discontinued: Coriell; ND42765; true.
CC   Discontinued: NHCDR; ND42765; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N99 ! ND43208
OI   CVCL_GP61 ! ND50035
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   ND42767
AC   CVCL_EZ87
SY   ND42767*C
DR   Coriell; ND42767
DR   NHCDR; ND42767
DR   Wikidata; Q54930239
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND42767).
CC   Discontinued: Coriell; ND42767; true.
CC   Discontinued: NHCDR; ND42767; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH34 ! ND50037
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND43208
AC   CVCL_1N99
DR   Coriell; ND43208
DR   NHCDR; ND43208
DR   Wikidata; Q54930240
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND43208).
CC   Discontinued: Coriell; ND43208; true.
CC   Discontinued: NHCDR; ND43208; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N98 ! ND42765
OI   CVCL_GP61 ! ND50035
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   ND43209
AC   CVCL_EZ88
SY   ND43209*C
DR   Coriell; ND43209
DR   NHCDR; ND43209
DR   SKIP; SKIP001577
DR   Wikidata; Q54930242
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (NHCDR=ND43209).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Discontinued: Coriell; ND43209; true.
CC   Discontinued: NHCDR; ND43209; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9T4 ! ND42499
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   ND43343
AC   CVCL_LL43
DR   Coriell; ND43343
DR   Wikidata; Q54930243
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND43344
AC   CVCL_LL44
DR   Coriell; ND43344
DR   Wikidata; Q54930244
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   ND50012
AC   CVCL_EZ89
DR   NHCDR; ND50012
DR   SKIP; SKIP001614
DR   Wikidata; Q54930245
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY29 ! ND40068
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND50013
AC   CVCL_EZ90
DR   NHCDR; ND50013
DR   SKIP; SKIP001615
DR   Wikidata; Q54930246
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY29 ! ND40068
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND50014
AC   CVCL_EZ91
DR   NHCDR; ND50014
DR   Wikidata; Q54930247
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: NHCDR; ND50014; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY29 ! ND40068
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND50015
AC   CVCL_EZ92
DR   NHCDR; ND50015
DR   SKIP; SKIP001616
DR   Wikidata; Q54930248
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000016009; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY30 ! ND42493
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND50016
AC   CVCL_EZ93
DR   NHCDR; ND50016
DR   SKIP; SKIP001617
DR   Wikidata; Q54930249
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000016009; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY30 ! ND42493
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND50017
AC   CVCL_EZ94
DR   NHCDR; ND50017
DR   SKIP; SKIP001618
DR   Wikidata; Q54930250
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Met1Ile (c.3G>A); ClinVar=VCV000016009; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY30 ! ND42493
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND50032
AC   CVCL_GP58
DR   NHCDR; ND50032
DR   SKIP; SKIP001572
DR   Wikidata; Q54930251
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND50033
AC   CVCL_GP59
DR   NHCDR; ND50033
DR   SKIP; SKIP001573
DR   Wikidata; Q54930252
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[71] (c.52CAG(71)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8519 ! GM04281
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   ND50034
AC   CVCL_GP60
DR   NHCDR; ND50034
DR   SKIP; SKIP001569
DR   Wikidata; Q54930253
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell lines ND42222; ND42223; ND42224).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y844 ! ND42222
OI   CVCL_1N95 ! ND42223
OI   CVCL_Y845 ! ND42224
OI   CVCL_RH33 ! ND50036
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   ND50035
AC   CVCL_GP61
DR   NHCDR; ND50035
DR   SKIP; SKIP001646
DR   Wikidata; Q54930254
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50035).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N98 ! ND42765
OI   CVCL_1N99 ! ND43208
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   ND50036
AC   CVCL_RH33
DR   NHCDR; ND50036
DR   SKIP; SKIP001570
DR   Wikidata; Q54930255
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[109] (c.52CAG(109)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (from autologous cell lines ND42222; ND42223; ND42224).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y844 ! ND42222
OI   CVCL_1N95 ! ND42223
OI   CVCL_Y845 ! ND42224
OI   CVCL_GP60 ! ND50034
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   ND50037
AC   CVCL_RH34
DR   NHCDR; ND50037
DR   SKIP; SKIP001647
DR   Wikidata; Q54930256
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50037).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EZ87 ! ND42767
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   ND50038
AC   CVCL_RH35
AS   CVCL_WU26
SY   50-001-21.P20_10; TC-1133; RUCDRi002-A
DR   BioSamples; SAMEA4933040
DR   hPSCreg; RUCDRi002-A
DR   NHCDR; ND50038
DR   SKIP; SKIP001648
DR   Wikidata; Q54930260
RX   PubMed=33038615;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Hispanic.
CC   Discontinued: NHCDR; ND50038; true.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL65 ! LiPSC-GR1.1
OI   CVCL_RL66 ! LiPSC-GR1.2
OI   CVCL_RH36 ! ND50039
OI   CVCL_UX45 ! NH50191
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   ND50039
AC   CVCL_RH36
SY   50-001-21.P14_186; TC-1133
DR   NHCDR; ND50039
DR   SKIP; SKIP001649
DR   Wikidata; Q54930261
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL65 ! LiPSC-GR1.1
OI   CVCL_RL66 ! LiPSC-GR1.2
OI   CVCL_RH35 ! ND50038
OI   CVCL_UX45 ! NH50191
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   ND50040
AC   CVCL_RN26
DR   NHCDR; ND50040
DR   Wikidata; Q54930262
RX   PubMed=34831478;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (NHCDR=ND50040).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 15
//
ID   ND50041
AC   CVCL_RN27
DR   NHCDR; ND50041
DR   Wikidata; Q54930263
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (NHCDR=ND50041).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   ND50042
AC   CVCL_RN28
DR   NHCDR; ND50042
DR   Wikidata; Q54930264
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (NHCDR=ND50042).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   ND50043
AC   CVCL_RH37
DR   NHCDR; ND50043
DR   SKIP; SKIP001650
DR   Wikidata; Q54930265
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ70 ! ND41015
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   ND50044
AC   CVCL_RH38
DR   NHCDR; ND50044
DR   SKIP; SKIP001651
DR   Wikidata; Q54930266
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ70 ! ND41015
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   ND50045
AC   CVCL_RH39
DR   NHCDR; ND50045
DR   SKIP; SKIP001652
DR   Wikidata; Q54930267
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ70 ! ND41015
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   ND50046
AC   CVCL_RH40
DR   NHCDR; ND50046
DR   SKIP; SKIP001653
DR   Wikidata; Q54930268
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Heterozygous (from parent cell line).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY84 ! ND32955
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   ND50047
AC   CVCL_RH41
DR   NHCDR; ND50047
DR   SKIP; SKIP001654
DR   Wikidata; Q54930269
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Unspecified (from parent cell line).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY84 ! ND32955
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   ND50048
AC   CVCL_RH42
DR   NHCDR; ND50048
DR   SKIP; SKIP001655
DR   Wikidata; Q54930270
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Unspecified (from parent cell line).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY84 ! ND32955
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   ND50049
AC   CVCL_RY34
DR   NHCDR; ND50049
DR   Wikidata; Q54930271
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY33 ! ND40996
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50050
AC   CVCL_RY35
DR   NHCDR; ND50050
DR   Wikidata; Q54930272
RX   PubMed=34831478;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY33 ! ND40996
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50051
AC   CVCL_QX26
DR   NHCDR; ND50051
DR   Wikidata; Q54930273
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND50051).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD50 ! ND29802
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   ND50052
AC   CVCL_QX27
DR   NHCDR; ND50052
DR   Wikidata; Q54930274
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND50052).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD50 ! ND29802
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   ND50053
AC   CVCL_QX28
DR   NHCDR; ND50053
DR   Wikidata; Q54930275
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=ND50053).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD50 ! ND29802
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   ND50054
AC   CVCL_RY44
DR   NHCDR; ND50054
DR   Wikidata; Q54930276
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY89 ! ND32975
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50055
AC   CVCL_RY45
DR   NHCDR; ND50055
DR   Wikidata; Q54930277
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY89 ! ND32975
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50056
AC   CVCL_RY46
DR   NHCDR; ND50056
DR   Wikidata; Q54930278
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY89 ! ND32975
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50057
AC   CVCL_RY52
DR   NHCDR; ND50057
DR   Wikidata; Q54930279
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: NHCDR; ND50057; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD49 ! ND31618
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50058
AC   CVCL_RY53
DR   NHCDR; ND50058
DR   Wikidata; Q54930280
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: NHCDR; ND50058; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD49 ! ND31618
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50059
AC   CVCL_SA16
DR   NHCDR; ND50059
DR   Wikidata; Q54930281
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: NHCDR; ND50059; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ66 ! ND41006
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   ND50060
AC   CVCL_SA14
DR   NHCDR; ND50060
DR   Wikidata; Q54930282
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (NHCDR=ND50060).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9T4 ! ND42499
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   ND50061
AC   CVCL_SA17
DR   NHCDR; ND50061
DR   Wikidata; Q54930283
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ66 ! ND41006
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   ND50062
AC   CVCL_SA18
DR   NHCDR; ND50062
DR   Wikidata; Q54930284
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: NHCDR; ND50062; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ66 ! ND41006
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   ND50063
AC   CVCL_RY54
DR   NHCDR; ND50063
DR   Wikidata; Q54930285
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD49 ! ND31618
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50064
AC   CVCL_RY55
DR   NHCDR; ND50064
DR   Wikidata; Q54930286
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD49 ! ND31618
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50065
AC   CVCL_RY56
DR   NHCDR; ND50065
DR   Wikidata; Q54930287
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD49 ! ND31618
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50066
AC   CVCL_TZ58
DR   NHCDR; ND50066
DR   Wikidata; Q54930288
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ66 ! ND41006
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   ND50067
AC   CVCL_SA19
DR   NHCDR; ND50067
DR   Wikidata; Q54930289
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ66 ! ND41006
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   ND50068
AC   CVCL_RY49
DR   NHCDR; ND50068
DR   Wikidata; Q54930290
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His44Arg (c.131A>G) (H43R); ClinVar=VCV000014756; Zygosity=Heterozygous (NHCDR=ND50068).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK09 ! CS04iALS-SOD1H44Rn3
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   ND50069
AC   CVCL_RY48
DR   NHCDR; ND50069
DR   Wikidata; Q54930291
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50070
AC   CVCL_RY47
DR   NHCDR; ND50070
DR   Wikidata; Q54930292
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (NHCDR=ND50070).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50071
AC   CVCL_RY50
DR   NHCDR; ND50071
DR   Wikidata; Q54930293
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (NHCDR=ND50071).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK10 ! CS11iALS-SOD1I114Tn10
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   ND50072
AC   CVCL_RY51
DR   NHCDR; ND50072
DR   Wikidata; Q54930294
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (NHCDR=ND50072).
CC   Derived from site: In situ; Eye, ocular lens; UBERON=UBERON_0000965.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W562 ! GM09677
SX   Male
AG   1Y11M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   ND50073
AC   CVCL_SA20
DR   NHCDR; ND50073
DR   Wikidata; Q54930295
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK11 ! CS14isALS-Tn16
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   ND50074
AC   CVCL_SA21
DR   NHCDR; ND50074
DR   Wikidata; Q54930296
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50074).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W560 ! CS30iALS-C9n1
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ND50075
AC   CVCL_TZ59
DR   NHCDR; ND50075
DR   Wikidata; Q54930297
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50075).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZD02 ! F09152
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ND50076
AC   CVCL_SA22
DR   NHCDR; ND50076
DR   Wikidata; Q54930298
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50076).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9SR ! F09229
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ND50077
AC   CVCL_SA23
DR   NHCDR; ND50077
DR   Wikidata; Q54930299
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK13 ! CS138isALS-Tn1
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   ND50078
AC   CVCL_SA24
DR   NHCDR; ND50078
DR   Wikidata; Q54930306
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y895 ! ND30625
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   ND50079
AC   CVCL_SA25
DR   NHCDR; ND50079
DR   Wikidata; Q54930307
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu50Lys (c.148G>A) (E49K); ClinVar=VCV000658902; Zygosity=Unspecified (NHCDR=ND50079).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T862 ! ND39026
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   ND50080
AC   CVCL_SA26
DR   NHCDR; ND50080
DR   Wikidata; Q54930308
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50080).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9T5 ! F09128
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 12
//
ID   ND50081
AC   CVCL_SA27
DR   NHCDR; ND50081
DR   Wikidata; Q54930309
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (NHCDR=ND50081).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y965 ! GM00232
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50082
AC   CVCL_SA28
DR   NHCDR; ND50082
DR   Wikidata; Q54930310
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK15 ! CS166isALS-Tn2
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   ND50083
AC   CVCL_SA29
DR   NHCDR; ND50083
DR   Wikidata; Q54930311
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (NHCDR=ND50083).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W564 ! GM10684
SX   Female
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50084
AC   CVCL_SA30
DR   NHCDR; ND50084
DR   Wikidata; Q54930312
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK14 ! CS152isALS-Tn2
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   ND50085
AC   CVCL_RY36
DR   NHCDR; ND50085
DR   Wikidata; Q54930313
RX   PubMed=34434090;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=ND50085).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY35 ! ND50050
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   ND50086
AC   CVCL_RY37
DR   NHCDR; ND50086
DR   Wikidata; Q54930314
CC   Population: Caucasian; Greek.
CC   Characteristics: Non-edited control for NH50085 (Cellosaurus=CVCL_RY36).
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (NHCDR=ND50086).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY35 ! ND50050
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   ND50087
AC   CVCL_SA31
DR   NHCDR; ND50087
DR   Wikidata; Q54930315
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   ND50088
AC   CVCL_SA32
DR   NHCDR; ND50088
DR   Wikidata; Q54930316
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)51 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (NHCDR=ND50088).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50089
AC   CVCL_SA33
DR   NHCDR; ND50089
DR   Wikidata; Q54930317
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)51 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (NHCDR=ND50089).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50090
AC   CVCL_SA34
DR   NHCDR; ND50090
DR   Wikidata; Q54930318
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)62 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (NHCDR=ND50090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50091
AC   CVCL_SA35
DR   NHCDR; ND50091
DR   Wikidata; Q54930319
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)53 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (NHCDR=ND50091).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50092
AC   CVCL_SA36
DR   NHCDR; ND50092
DR   Wikidata; Q54930320
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)68 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (NHCDR=ND50092).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50093
AC   CVCL_RY38
DR   NHCDR; ND50093
DR   Wikidata; Q54930321
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY29 ! ND40068
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50094
AC   CVCL_RY39
DR   NHCDR; ND50094
DR   Wikidata; Q54930322
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (NHCDR=ND50094).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY33 ! ND40996
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50095
AC   CVCL_SA37
DR   NHCDR; ND50095
DR   Wikidata; Q54930323
CC   Population: Latino or Hispanic; Dominican.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD48 ! ND29369
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ND50096
AC   CVCL_SA38
DR   NHCDR; ND50096
DR   Wikidata; Q54930324
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Unspecified (NHCDR=ND50096).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UK12 ! CS22iALS-SOD1I114Tn2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ND50097
AC   CVCL_RY58
DR   NHCDR; ND50097
DR   Wikidata; Q54930325
CC   Population: African American.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7426 ! GM05400
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
ID   ND50098
AC   CVCL_RY40
DR   NHCDR; ND50098
DR   Wikidata; Q54930326
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=ND50098).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH40 ! ND50046
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   ND50099
AC   CVCL_RY41
DR   NHCDR; ND50099
DR   Wikidata; Q54930327
CC   Population: Caucasian; Polish.
CC   Characteristics: Non-edited control for NH50098 (Cellosaurus=CVCL_RY40).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Heterozygous (NHCDR=ND50099).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH40 ! ND50046
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   ND50100
AC   CVCL_RY42
DR   NHCDR; ND50100
DR   Wikidata; Q54930328
CC   Population: Caucasian; Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_corrected; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous; Note=By CRISPR/Cas9 (NHCDR=ND50100).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ89 ! ND50012
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   ND50101
AC   CVCL_RY43
DR   NHCDR; ND50101
DR   Wikidata; Q54930329
CC   Population: Caucasian; Polish.
CC   Characteristics: Non-edited control for NH50100 (Cellosaurus=CVCL_RY42).
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (NHCDR=ND50101).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ89 ! ND50012
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   ND50102
AC   CVCL_SA39
DR   NHCDR; ND50102
DR   Wikidata; Q54930330
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
ID   ND50103
AC   CVCL_SA40
DR   NHCDR; ND50103
DR   Wikidata; Q54930331
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
ID   ND50104
AC   CVCL_SA41
DR   NHCDR; ND50104
DR   Wikidata; Q54930332
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
ID   ND50105
AC   CVCL_SA42
DR   NHCDR; ND50105
DR   Wikidata; Q54930333
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=ND50105).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=ND50105).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   ND50106
AC   CVCL_SA43
DR   NHCDR; ND50106
DR   Wikidata; Q54930334
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
ID   ND50107
AC   CVCL_SA44
DR   NHCDR; ND50107
DR   Wikidata; Q54930335
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=ND50107).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=ND50107).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   ND50108
AC   CVCL_SA45
DR   NHCDR; ND50108
DR   Wikidata; Q54930336
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 9
//
ID   ND7
AC   CVCL_VK87
SY   Neuroblastoma X DRG neurons hybrid 7
DR   Wikidata; Q98127500
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   ND7/23
AC   CVCL_4259
SY   ND7-23
DR   CLO; CLO_0008144
DR   CLDB; cl3680
DR   CCRID; 3101ETCSCSP5026
DR   ECACC; 92090903
DR   Wikidata; Q54930337
RX   PubMed=1979443;
RX   PubMed=17928298;
RX   PubMed=32636736;
CC   Characteristics: Clone of ND7 which is derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_VK87 ! ND7
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   ND8
AC   CVCL_G216
SY   Neuroblastoma X DRG neurons hybrid 8
DR   Wikidata; Q54930338
RX   PubMed=1979443;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   ND8/34
AC   CVCL_4260
DR   CLO; CLO_0008145
DR   ECACC; 92090904
DR   Wikidata; Q54930339
RX   PubMed=1979443;
CC   Characteristics: Clone of ND8 which is derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_G216 ! ND8
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   NDC
AC   CVCL_B7D8
SY   ND-C; ND C
DR   Wikidata; Q112930167
RX   PubMed=1979443;
RX   PubMed=17928298;
RX   PubMed=32636736;
CC   Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 4
//
ID   NDCS-1
AC   CVCL_EJ23
SY   NDCS1
DR   cancercelllines; CVCL_EJ23
DR   Cosmic; 1602482
DR   IARC_TP53; 25032
DR   Wikidata; Q54930340
RX   PubMed=17653762;
RX   PubMed=22057234;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=17653762).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Ser (c.724T>A); ClinVar=VCV000376579; Zygosity=Unspecified (PubMed=17653762).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   NDDLS-1
AC   CVCL_M831
DR   Wikidata; Q54930341
RX   PubMed=21790860;
CC   Population: Japanese.
CC   Characteristics: Produces CSF3 and IL6.
CC   Doubling time: 53.5 hours (Note=At 20th passage), 37.9 hours (Note=At 60th passage) (PubMed=21790860).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   NDi001-A
AC   CVCL_YN03
SY   HL-60-iPSC c25; HL-60 iPSC c25
DR   hPSCreg; NDi001-A
DR   Wikidata; Q98127502
RX   PubMed=33370871;
CC   From: University of Notre Dame; Notre Dame; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   NDi002-A
AC   CVCL_YN04
SY   AML-iPSC c33
DR   hPSCreg; NDi002-A
DR   Wikidata; Q98127503
RX   PubMed=31739201;
CC   From: University of Notre Dame; Notre Dame; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN05 ! NDi002-B
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   NDi002-B
AC   CVCL_YN05
SY   AML-iPSC c43
DR   hPSCreg; NDi002-B
DR   Wikidata; Q98127504
RX   PubMed=31739201;
CC   From: University of Notre Dame; Notre Dame; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN04 ! NDi002-A
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   NDi003-A
AC   CVCL_YN06
DR   hPSCreg; NDi003-A
DR   Wikidata; Q98127505
CC   From: University of Notre Dame; Notre Dame; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN07 ! NDi003-B
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   NDi003-B
AC   CVCL_YN07
DR   hPSCreg; NDi003-B
DR   Wikidata; Q98127506
CC   From: University of Notre Dame; Notre Dame; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN06 ! NDi003-A
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   NDi004-A
AC   CVCL_B5IW
SY   KB-1-ND-iPSC c5
DR   hPSCreg; NDi004-A
DR   Wikidata; Q110433095
RX   PubMed=35550987;
CC   From: University of Notre Dame; Notre Dame; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg4198Ter (c.12592C>T); ClinVar=VCV000158722; Zygosity=Heterozygous (PubMed=35550987).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5IX ! NDi004-B
OI   CVCL_B5IY ! NDi004-C
SX   Male
AG   7Y11M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   NDi004-B
AC   CVCL_B5IX
SY   KB-1-ND-iPSC c7
DR   hPSCreg; NDi004-B
DR   Wikidata; Q110433096
RX   PubMed=35550987;
CC   From: University of Notre Dame; Notre Dame; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg4198Ter (c.12592C>T); ClinVar=VCV000158722; Zygosity=Heterozygous (PubMed=35550987).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5IW ! NDi004-A
OI   CVCL_B5IY ! NDi004-C
SX   Male
AG   7Y11M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   NDi004-C
AC   CVCL_B5IY
SY   KB-1-ND-iPSC c8
DR   hPSCreg; NDi004-C
DR   Wikidata; Q110433097
RX   PubMed=35550987;
CC   From: University of Notre Dame; Notre Dame; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg4198Ter (c.12592C>T); ClinVar=VCV000158722; Zygosity=Heterozygous (PubMed=35550987).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5IW ! NDi004-A
OI   CVCL_B5IX ! NDi004-B
SX   Male
AG   7Y11M
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   NDPEM 2/2
AC   CVCL_UY57
SY   DPEM 2/2
DR   Wikidata; Q98127507
RX   DOI=10.5713/ajas.2004.1338;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Debao pony; VBO=VBO_0017512.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 8
//
ID   NDS-758
AC   CVCL_F569
SY   758; TER125; TER214
DR   IPD-IMGT/HLA; 12014
DR   Wikidata; Q54930342
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,29:02; B*44:03,15:57; C*04:01,16:01; DQB1*02,05; DRB1*01:01,07:01; DRB4*01 (IPD-IMGT/HLA=12014).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   NDS-AN
AC   CVCL_F570
DR   IPD-IMGT/HLA; 11787
DR   Wikidata; Q54930343
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:32N,03:01; B*51:01; C*14; DRB1*08,13:01; DRB3*01:01 (IPD-IMGT/HLA=11787).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   NDS-DG
AC   CVCL_F571
SY   TER93
DR   IPD-IMGT/HLA; 11131
DR   Wikidata; Q54930344
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01; B*18:01,51:08; C*07:01,16:02; DQB1*03:AD,03:02; DRB1*04,11; DRB3*02:BC; DRB4*01:03:01:02N (IPD-IMGT/HLA=11131).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   NDS-HM
AC   CVCL_F572
SY   TER153; TER223
DR   IPD-IMGT/HLA; 12739
DR   Wikidata; Q54930345
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*68:01:01,68:01:02; B*35:03,44:02; C*04:01:01,07:04:02; DQB1*04:02,05:01; DRB1*01:01,08:01/08:05/08:05/08:07/08:08/08:11/08:16 (IPD-IMGT/HLA=12739).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   NDS-IH
AC   CVCL_F573
DR   IPD-IMGT/HLA; 12173
DR   Wikidata; Q54930354
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,30:01; B*39:24,51:01:01; C*07:AG,16:02; DPB1*04:01,17:01; DQB1*02:02,03:02; DRB1*04:03,04:05; DRB4*01 (IPD-IMGT/HLA=12173).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   NDS-JD
AC   CVCL_F574
SY   TER86; TER242; Extract 177; Extract 218; Extract 266
DR   IPD-IMGT/HLA; 11132
DR   Wikidata; Q54930355
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:33,68:01:02; B*07:02:01,51:06; C*07:02,12:04:02; DPB1*04:02,26:01; DQA1*01:03; DQB1*06:01; DRB1*15:02; DRB5*01:02 (IPD-IMGT/HLA=11132).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   NDS-MA
AC   CVCL_F575
DR   IPD-IMGT/HLA; 11133
DR   Wikidata; Q54930356
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:01,31:03; B*07:02,27:03; C*02:02,07:02; DQB1*02,04; DRB1*03:01,08; DRB3*02:02 (IPD-IMGT/HLA=11133).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   NDS-NH
AC   CVCL_F576
SY   TER122; TER254; TER256; Extract 334
DR   IPD-IMGT/HLA; 11134
DR   Wikidata; Q54930357
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:17,33:03; B*07:02,15:02; C*07:02,08:01; DPB1*04:01,13:01; DQA1*02:01,06:01; DQB1*03:01,03:03; DRB1*07:01,12:02; DRB3*03:01; DRB4*01:03:01:02N (IPD-IMGT/HLA=11134).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   NDUSD-1
AC   CVCL_JE65
SY   NDUSD1; Nippon Dental University School of Dentistry-1
DR   Wikidata; Q54930358
RX   PubMed=12221015;
RX   PubMed=19184294;
CC   Characteristics: Has the capability to deposit calcium in vitro.
CC   Doubling time: 31.7 +- 2.8 hours (PubMed=19184294).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JE64 ! Ori-
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   NDUSD-2
AC   CVCL_JE66
SY   Nippon Dental University School of Dentistry-2
DR   Wikidata; Q54930359
RX   PubMed=19184294;
CC   Doubling time: 25.3 +- 3.0 hours (PubMed=19184294).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JE64 ! Ori-
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   NDUSD-4
AC   CVCL_JE67
SY   Nippon Dental University School of Dentistry-4
DR   Wikidata; Q54930360
RX   PubMed=19184294;
CC   Doubling time: 32.1 +- 3.2 hours (PubMed=19184294).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JE64 ! Ori-
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   NE
AC   CVCL_3554
DR   CLO; CLO_0008149
DR   ATCC; CRL-2070
DR   Wikidata; Q54930361
RX   PubMed=2098280;
CC   Breed/subspecies: C3H/J.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5T97 ! ME [Mouse teratocarcinoma]
SX   Sex unspecified
AG   7FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Ne Col
AC   CVCL_U789
DR   ATCC; CRL-1345
DR   Wikidata; Q54930362
CC   Discontinued: ATCC; CRL-1345; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Ne Loc
AC   CVCL_3555
DR   CLO; CLO_0008150
DR   ATCC; CRL-1205
DR   Wikidata; Q54930363
CC   Discontinued: ATCC; CRL-1205; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118636; Stiff skin syndrome
DI   ORDO; Orphanet_2833; Stiff skin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NE-18
AC   CVCL_7083
SY   NE18
DR   BTO; BTO_0003018
DR   Cosmic; 844590
DR   Cosmic; 877396
DR   Cosmic; 1028951
DR   Cosmic; 1152491
DR   Wikidata; Q54930365
RX   PubMed=3422461;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7114 ! RH-SLC-L11
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   NE-4C
AC   CVCL_B063
DR   BTO; BTO_0005624
DR   ATCC; CRL-2925
DR   CCRID; 3101MOUSCSP1501
DR   CLS; 305182
DR   Wikidata; Q54930366
RX   PubMed=9057134;
RX   PubMed=16183159;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Discontinued: CLS; 305182; true.
CC   Breed/subspecies: C57BL/6 x 129/Sv-Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   NE-GFP-4C
AC   CVCL_L103
SY   GFP-4C
DR   BTO; BTO_0005625
DR   ATCC; CRL-2926
DR   Wikidata; Q54930367
RX   PubMed=15246825;
RX   PubMed=16183159;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-2926; true.
CC   Breed/subspecies: C57BL/6 x 129/Sv-Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B063 ! NE-4C
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 12
//
ID   NE-MD
AC   CVCL_6C06
SY   nNOS-EGFP Expressing Macula Densa
DR   Wikidata; Q54930368
RX   PubMed=16412259;
RX   PubMed=17233813;
RX   PubMed=19340543;
CC   Characteristics: Expresses GFP under the control of the Nos1 promoter (PubMed=16412259).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, macula densa; UBERON=UBERON_0002335.
CC   Cell type: Epithelial cell of distal tubule; CL=CL_0002305.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   NE-PLAP-4C
AC   CVCL_E9TL
SY   PLAP-4C
RX   PubMed=15246825;
RX   PubMed=16183159;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: C57BL/6 x 129/Sv-Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B063 ! NE-4C
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NE-R
AC   CVCL_XH39
DR   CCLV; CCLV-RIE 0055
DR   Wikidata; Q98127509
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   NE1-E6E7
AC   CVCL_E306
SY   NE-1; NE1
DR   AddexBio; T0013001/75
DR   Wikidata; Q54930364
RX   PubMed=15489894;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   Ne2/1b4.14
AC   CVCL_0E04
SY   NE2/1B4-14; NE2-1B4.14; NE2-1B4
DR   ATCC; CRL-2356
DR   Wikidata; Q54930369
RX   PubMed=1911397;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on seam cells.
CC   Discontinued: ATCC; CRL-2356; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   NE6-E6E7
AC   CVCL_B0BT
SY   NE6
DR   Wikidata; Q108821021
RX   PubMed=15489894;
RX   PubMed=18717758;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   NE6-E6E7/hTERT
AC   CVCL_B0BU
DR   Wikidata; Q108821022
RX   PubMed=18717758;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0BT ! NE6-E6E7
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   Ne8/4c6.3
AC   CVCL_0E05
SY   NE8/4C6.3; NE8-4C6.3; NE8 4C6.3
DR   ATCC; CRL-2355
DR   Wikidata; Q54930370
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Caenorhabditis elegans antigen on muscle cells.
CC   Discontinued: ATCC; CRL-2355; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   NEAmp-48.2
AC   CVCL_L101
SY   NEAMP 48.2
DR   Wikidata; Q54930371
RX   Patent=US7101980;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5295.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_132237; rac-3,4-methylenedioxy-N-ethylamphetamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   NEAmp-62.1
AC   CVCL_L102
SY   NEAMP 62.1
DR   Wikidata; Q54930372
RX   Patent=US7101980;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5294.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_132237; rac-3,4-methylenedioxy-N-ethylamphetamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   NEAU-Ds-950821
AC   CVCL_A8XK
SY   Ds-950821
DR   Wikidata; Q108821023
RX   DOI=10.1007/BF02855536;
CC   Group: Insect cell line.
CC   Doubling time: 52.6 hours (DOI=10.1007/BF02855536).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=420590; ! Dendrolimus superans (Siberian silkmoth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   NEAU-Ms-921015
AC   CVCL_IM40
SY   NEAU-Ms-941015; Ms-921015
DR   ICLDB; neau-ms-941015
DR   Wikidata; Q54930373
RX   DOI=10.1111/j.1744-7917.1998.tb00302.x;
RX   DOI=10.3969/j.issn.1005-9369.2000.04.006;
CC   Group: Insect cell line.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   NEAU-Ms-927311
AC   CVCL_IM41
SY   NEAU-Ms-947311; Ms-927311; Ms7311
DR   ICLDB; neau-ms-947311
DR   Wikidata; Q54930374
RX   DOI=10.1007/BF02855536;
RX   DOI=10.1007/BF02899643;
RX   DOI=10.1111/j.1744-7917.1998.tb00302.x;
RX   DOI=10.3969/j.issn.1005-9369.2000.04.006;
CC   Group: Insect cell line.
CC   Doubling time: 58.8 hours (DOI=10.1111/j.1744-7917.1998.tb00302.x).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   NEAU-Ms-980312
AC   CVCL_AV36
SY   NEAU-MS-980312
DR   ICLDB; neau-ms-980312
DR   Wikidata; Q54930375
RX   CelloPub=CLPUB00314;
CC   Group: Insect cell line.
CC   Doubling time: 47.82 hours (CelloPub=CLPUB00314).
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   NEAU-Xc-730E
AC   CVCL_0A25
SY   Xc730E
DR   Wikidata; Q54930376
RX   DOI=10.16380/j.kcxb.2002.02.022;
RX   DOI=10.3969/j.issn.1005-9369.2000.04.006;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=987431; ! Xestia c-nigrum (Lesser black-letter dart moth)
HI   CVCL_A8XL ! NEAU-Xc-920730
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   NEAU-Xc-920730
AC   CVCL_A8XL
SY   Xc-920730
DR   Wikidata; Q108821025
RX   DOI=10.1007/BF02855536;
RX   DOI=10.1111/j.1744-7917.1998.tb00302.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=987431; ! Xestia c-nigrum (Lesser black-letter dart moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   NEAU-Xc-960716H
AC   CVCL_0A13
DR   Wikidata; Q54930377
RX   DOI=10.16380/j.kcxb.2002.02.022;
CC   Group: Insect cell line.
CC   Doubling time: ~63 hours (DOI=10.16380/j.kcxb.2002.02.022).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=987431; ! Xestia c-nigrum (Lesser black-letter dart moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   NEC-DUE1
AC   CVCL_AS96
DR   Wikidata; Q54930378
RX   PubMed=24551139;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=24551139
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 16,17
ST   D12S391: 18
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 13,20
ST   D19S433: 13,16
ST   D1S1656: 14,15
ST   D21S11: 32.2
ST   D22S1045: 15,16
ST   D2S1338: 19,20
ST   D2S441: 11
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 20,25
ST   SE33: 25.2
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C126323; Gastroesophageal junction large cell neuroendocrine carcinoma
DI   ORDO; Orphanet_506136; Neuroendocrine neoplasm of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 8
//
ID   NEC-DUE2
AC   CVCL_AS97
DR   Wikidata; Q54930379
RX   PubMed=24551139;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=24551139
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D10S1248: 14
ST   D12S391: 17,23
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 12,15
ST   D19S433: 15,16
ST   D1S1656: 12,14
ST   D21S11: 29
ST   D22S1045: 11,16
ST   D2S1338: 17
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 21
ST   SE33: 22.2,24.2
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C96157; Colorectal large cell neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   NEC-DUE3
AC   CVCL_UD77
DR   Wikidata; Q98127510
RX   PubMed=30025411;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): PubMed=30025411
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 15,15.2
ST   D1S1656: 12,14
ST   D21S11: 27,29
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D6S1043: 11,18
ST   D7S820: 9,11
ST   D8S1179: 10,11
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C96549; Anal canal neuroendocrine carcinoma
DI   ORDO; Orphanet_100082; Neuroendocrine tumor of anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   NEC14
AC   CVCL_3070
DR   CLO; CLO_0051392
DR   BioSample; SAMN03470816
DR   BioSample; SAMN03472271
DR   FANTOM5_SSTAR; 10591-108D6
DR   JCRB; FDSC0006
DR   JCRB; JCRB0162
DR   RCB; RCB0490
DR   Wikidata; Q54930380
RX   PubMed=2445169;
RX   PubMed=3618218;
CC   Population: Japanese.
CC   Discontinued: JCRB; FDSC0006; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): JCRB=JCRB0162; RCB=RCB0490
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 12,13 (RCB=RCB0490)
ST   D5S818: 13 (JCRB=JCRB0162)
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   NEC15
AC   CVCL_3929
DR   CLO; CLO_0051393
DR   BioSample; SAMN03472273
DR   FANTOM5_SSTAR; 10593-108D8
DR   JCRB; FDSC0007
DR   RCB; RCB0494
DR   Wikidata; Q54930381
RX   PubMed=2445169;
RX   PubMed=3618218;
RX   PubMed=24812411;
CC   Population: Japanese.
CC   Discontinued: JCRB; FDSC0007; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): RCB=RCB0494
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   NEC8
AC   CVCL_1604
SY   NEC-8
DR   BTO; BTO_0006542
DR   CLO; CLO_0051391
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471665
DR   cancercelllines; CVCL_1604
DR   Cell_Model_Passport; SIDM00243
DR   ChEMBL-Cells; CHEMBL3308176
DR   ChEMBL-Targets; CHEMBL2366340
DR   Cosmic; 910942
DR   Cosmic-CLP; 910942
DR   DepMap; ACH-002288
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10590-108D5
DR   GDSC; 910942
DR   GEO; GSM827251
DR   GEO; GSM1670276
DR   IARC_TP53; 21583
DR   JCRB; FDSC0005
DR   JCRB; JCRB0250
DR   LINCS_LDP; LCL-1900
DR   PharmacoDB; NEC8_1156_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1604
DR   PubChem_Cell_line; CVCL_1604
DR   RCB; RCB0489
DR   Wikidata; Q54930382
RX   PubMed=520758;
RX   PubMed=2445169;
RX   PubMed=3518877;
RX   PubMed=3618218;
RX   PubMed=9290701;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.09%; Native American=0.61%; East Asian, North=79.76%; East Asian, South=13.39%; South Asian=0%; European, North=0%; European, South=4.15% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0005; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): Cosmic-CLP=910942; JCRB=JCRB0250; RCB=RCB0489
ST   Amelogenin: X
ST   CSF1PO: 13,15
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 10,14
ST   D7S820: 8
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   NEC8 cl-1
AC   CVCL_IW43
SY   NEC8 clone-1
DR   Wikidata; Q54930384
RX   PubMed=2445169;
CC   Population: Japanese.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C6341; Testicular embryonal carcinoma
DI   ORDO; Orphanet_289362; Non-central nervous system-localized embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1604 ! NEC8
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   NECS-L
AC   CVCL_L212
DR   Wikidata; Q54930385
RX   PubMed=11070410;
CC   Population: Japanese.
CC   Doubling time: 28.9 +- 4.2 hours (PubMed=11070410).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C60639; Rectal small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L213 ! NECS-P
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   NECS-P
AC   CVCL_L213
DR   Wikidata; Q54930386
RX   PubMed=11070410;
CC   Population: Japanese.
CC   Doubling time: 32.8 +- 2.1 hours (PubMed=11070410).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C60639; Rectal small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L212 ! NECS-L
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   NEDCASB FiPS319-Ep6F-7
AC   CVCL_E7A8
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+NEDCASB+FiPS319-Ep6F-7+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/NEDCASB%2520FiPS319-Ep6F-7%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C215054; Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NEF
AC   CVCL_D900
DR   BTO; BTO_0005262
DR   Wikidata; Q54930387
RX   PubMed=1417788;
RX   PubMed=2246335;
RX   PubMed=2543678;
CC   Characteristics: Expresses ~300000 EGFR (PubMed=1417788).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   NEF26.Ov
AC   CVCL_6422
SY   NFF26.Ov
DR   CLO; CLO_0008151
DR   ATCC; CRL-6175
DR   Wikidata; Q54930389
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6175; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   NEF36.Sg
AC   CVCL_6423
SY   NFF36.Sg
DR   CLO; CLO_0008152
DR   ATCC; CRL-6176
DR   Wikidata; Q54930390
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6176; true.
CC   Derived from site: In situ; Fetal salivary gland, sublingual gland; UBERON=UBERON_0006297.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Fetus
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NeHepBaHT
AC   CVCL_0F42
DR   ATCC; CRL-4022
DR   Wikidata; Q54930391
RX   Patent=US20090155232;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: ATCC; CRL-4022; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): ATCC=CRL-4022
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C465 ! NeHepLxHT
OI   CVCL_0F41 ! NeHepMsHT
SX   Male
AG   2D
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   NeHepLxHT
AC   CVCL_C465
DR   ATCC; CRL-4020
DR   BioSample; SAMN03471727
DR   Wikidata; Q54930392
RX   Patent=US20090155232;
RX   PubMed=19565302;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-4020; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): ATCC=CRL-4020; PubMed=19565302
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0F42 ! NeHepBaHT
OI   CVCL_0F41 ! NeHepMsHT
SX   Male
AG   2D
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   NeHepMsHT
AC   CVCL_0F41
DR   ATCC; CRL-4021
DR   Wikidata; Q54930393
RX   Patent=US20090155232;
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ATCC; CRL-4021; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
ST   Source(s): ATCC=CRL-4021
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0F42 ! NeHepBaHT
OI   CVCL_C465 ! NeHepLxHT
SX   Male
AG   2D
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   NEIi001-A
AC   CVCL_C1UX
SY   iPSC-F34
DR   BioSamples; SAMEA14215627
DR   hPSCreg; NEIi001-A
DR   Wikidata; Q114312492
CC   From: National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NEIi002-A
AC   CVCL_C1UY
SY   iPSC-F35
DR   BioSamples; SAMEA12816317
DR   hPSCreg; NEIi002-A
DR   Wikidata; Q114312496
CC   From: National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NEIi003-A
AC   CVCL_C1UZ
SY   iPSC-F36
DR   BioSamples; SAMEA12816318
DR   hPSCreg; NEIi003-A
DR   Wikidata; Q114312500
CC   From: National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NEIi004-A
AC   CVCL_C1V0
SY   iPSC-F41
DR   BioSamples; SAMEA12816322
DR   hPSCreg; NEIi004-A
DR   Wikidata; Q114312504
CC   From: National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Nelson
AC   CVCL_ZU75
SY   NK53; NK 53
DR   Wikidata; Q98127511
RX   PubMed=5021706;
CC   Population: African; Kenyan.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 6
//
ID   NEM157
AC   CVCL_IT35
DR   cancercelllines; CVCL_IT35
DR   Wikidata; Q54930394
RX   PubMed=25534822;
RX   PubMed=25939062;
CC   Doubling time: 30 hours (PubMed=25534822).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   NEM163
AC   CVCL_IT36
DR   cancercelllines; CVCL_IT36
DR   Wikidata; Q54930396
RX   PubMed=25534822;
RX   PubMed=25939062;
CC   Doubling time: 36 hours (PubMed=25534822).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062
ST   Amelogenin: X,Y
ST   CSF1PO: 8,10
ST   D13S317: 10,11
ST   D16S539: 11
ST   D21S11: 28,30
ST   D5S818: 12,13
ST   D7S820: 9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   NEM165
AC   CVCL_IT37
DR   cancercelllines; CVCL_IT37
DR   Wikidata; Q54930397
RX   PubMed=25534822;
RX   PubMed=25939062;
CC   Doubling time: 32 hours (PubMed=25534822).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11
ST   D21S11: 29,33.2
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 15
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   NEM168
AC   CVCL_IT38
DR   cancercelllines; CVCL_IT38
DR   Wikidata; Q54930398
RX   PubMed=25534822;
RX   PubMed=25939062;
CC   Doubling time: 34 hours (PubMed=25534822).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 11
ST   D21S11: 29,29.2
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   Nemo-1
AC   CVCL_1E49
DR   Wikidata; Q54930400
RX   PubMed=833871;
DI   NCIt; C3269; Schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 4
//
ID   NENCKIi001-A
AC   CVCL_E4HF
SY   MPAN-3.1
DR   BioSamples; SAMEA115772287
DR   hPSCreg; NENCKIi001-A
RX   PubMed=39489009;
CC   From: Nencki Institute of Experimental Biology PAS; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25443; C19orf12; Simple; p.Gly58Argfs*10 (c.171_181del11) (p.Gly69Argfs*10, c.204_214del11); ClinVar=VCV000031155; Zygosity=Homozygous (PubMed=39489009).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175707; Neurodegeneration with brain iron accumulation 4
DI   ORDO; Orphanet_289560; Mitochondrial membrane protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NENCKIi002-A
AC   CVCL_E4HG
SY   MPAN-9.3
DR   BioSamples; SAMEA115779458
DR   hPSCreg; NENCKIi002-A
RX   PubMed=39489009;
CC   From: Nencki Institute of Experimental Biology PAS; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25443; C19orf12; Simple; p.Gly58Argfs*10 (c.171_181del11) (p.Gly69Argfs*10, c.204_214del11); ClinVar=VCV000031155; Zygosity=Homozygous (PubMed=39489009).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175707; Neurodegeneration with brain iron accumulation 4
DI   ORDO; Orphanet_289560; Mitochondrial membrane protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NENCKIi003-A
AC   CVCL_E4HH
SY   MPAN-18.1
DR   BioSamples; SAMEA115779459
DR   hPSCreg; NENCKIi003-A
RX   PubMed=39489009;
CC   From: Nencki Institute of Experimental Biology PAS; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25443; C19orf12; Simple; p.Gly58Argfs*10 (c.171_181del11) (p.Gly69Argfs*10, c.204_214del11); ClinVar=VCV000031155; Zygosity=Homozygous (PubMed=39489009).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175707; Neurodegeneration with brain iron accumulation 4
DI   ORDO; Orphanet_289560; Mitochondrial membrane protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NENCKIi004-A
AC   CVCL_E4HI
SY   MPAN-22.3
DR   BioSamples; SAMEA115779529
DR   hPSCreg; NENCKIi004-A
RX   PubMed=39489009;
CC   From: Nencki Institute of Experimental Biology PAS; Warsaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25443; C19orf12; Simple; p.Gly58Argfs*10 (c.171_181del11) (p.Gly69Argfs*10, c.204_214del11); ClinVar=VCV000031155; Zygosity=Homozygous (PubMed=39489009).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175707; Neurodegeneration with brain iron accumulation 4
DI   ORDO; Orphanet_289560; Mitochondrial membrane protein-associated neurodegeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Neo Jurkat
AC   CVCL_U621
DR   ATCC; CRL-2898
DR   cancercelllines; CVCL_U621
DR   Wikidata; Q54930401
RX   PubMed=10567572;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2898
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,21
ST   D19S433: 14,15.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 20
//
ID   NEO217
AC   CVCL_JX49
DR   Wikidata; Q54930402
RX   PubMed=28551767;
CC   Population: Chinese.
CC   Doubling time: 26 hours (PubMed=28551767).
CC   Derived from site: In situ; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   NEO217-luc
AC   CVCL_XU15
DR   CCRID; 4201PAT-CCTCC01290
DR   Wikidata; Q98127513
RX   Patent=CN109750001A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018179.
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JX49 ! NEO217
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   neo6/C8161.1
AC   CVCL_6815
DR   Wikidata; Q54930403
RX   PubMed=8302587;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6813 ! C8161
HI   CVCL_6C50 ! MCH262A1.D6
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   neo6/C8161.2
AC   CVCL_6816
DR   Wikidata; Q54930404
RX   PubMed=8302587;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6813 ! C8161
HI   CVCL_6C50 ! MCH262A1.D6
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   neo6/C8161.3
AC   CVCL_6817
DR   Wikidata; Q54930405
RX   PubMed=8302587;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6813 ! C8161
HI   CVCL_6C50 ! MCH262A1.D6
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   Neopu
AC   CVCL_Z995
DR   CLO; CLO_0008153
DR   CLDB; cl3681
DR   ECACC; 90070561
DR   FlyBase_Cell_line; FBtc9000054
DR   Wikidata; Q54930406
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   nEPN1
AC   CVCL_IR49
DR   Wikidata; Q54930407
RX   PubMed=20978004;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   22Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   nEPN2
AC   CVCL_IR50
DR   Wikidata; Q54930408
RX   PubMed=20978004;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, fourth ventricle; UBERON=UBERON_0002422.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3Y5M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   NEPS
AC   CVCL_IS66
DR   Wikidata; Q54930409
RX   PubMed=19756736;
CC   Population: Japanese.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   NERCe002-A-1
AC   CVCL_RV24
SY   chHES-90-PLEX-ZsGreen
DR   BioSamples; SAMEA104132873
DR   hPSCreg; NERCe002-A-1
DR   SKIP; SKIP003165
DR   Wikidata; Q54930410
RX   PubMed=29414419;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29414419
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 20,21
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 13,17
ST   D19S433: 12.2,14
ST   D1S1656: 16,17
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D6S1043: 11,18
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 17,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B008 ! chHES-90
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   NERCe002-A-2
AC   CVCL_RV25
SY   chHES-90-PLEX-Luciferase
DR   BioSamples; SAMEA104132872
DR   hPSCreg; NERCe002-A-2
DR   SKIP; SKIP003163
DR   Wikidata; Q54930411
RX   PubMed=29501955;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29501955
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 20,21
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 13,17
ST   D19S433: 12.2,14
ST   D1S1656: 16,17
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D6S1043: 11,18
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 17,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B008 ! chHES-90
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   NERCe002-A-3
AC   CVCL_VF81
SY   chHES-90-pINDUCER20-tet-14-3-3zeta
DR   BioSamples; SAMEA104132874
DR   hPSCreg; NERCe002-A-3
DR   SKIP; SKIP003164
DR   Wikidata; Q54930412
RX   PubMed=29414411;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Characteristics: Upon doxycycline-induction expresses YWHAZ (14-3-3 zeta).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12855; YWHAZ.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29414411
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D12S391: 20,21
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 13,17
ST   D19S433: 12.2,14
ST   D1S1656: 16,17
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D6S1043: 11,18
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 22,24
ST   Penta D: 9,10
ST   Penta E: 17,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B008 ! chHES-90
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   NERCe003-A-1
AC   CVCL_VF83
SY   chHES-8-pINDUCER10-tet-CTNNB1
DR   BioSamples; SAMEA104132952
DR   hPSCreg; NERCe003-A-1
DR   SKIP; SKIP003166
DR   Wikidata; Q54930413
RX   PubMed=29428849;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Characteristics: Upon doxycycline-induction expresses CTNNB1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A996 ! chHES-8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   NERCe003-A-3
AC   CVCL_VF84
SY   chHES-8-KO-p53; chHES-8-KO-P53
DR   BioSamples; SAMEA994658
DR   hPSCreg; NERCe003-A-3
DR   SKIP; SKIP005557
DR   Wikidata; Q54930414
RX   PubMed=30658254;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A996 ! chHES-8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   NERCe003-A-5
AC   CVCL_D0JW
SY   chHES-8-KO-HES1
DR   BioSamples; SAMEA6602308
DR   hPSCreg; NERCe003-A-5
DR   Wikidata; Q123033163
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A996 ! chHES-8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NERCi001-A
AC   CVCL_A0YM
DR   BioSamples; SAMEA7851605
DR   hPSCreg; NERCi001-A
DR   Wikidata; Q108821026
CC   From: National Engineering and Research Center of Human Stem Cell; Changsha; China.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Arg599Gln (c.1796G>A); ClinVar=VCV000635412; Zygosity=Heterozygous (hPSCreg=NERCi001-A).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Ser947Pro (c.2839T>C); ClinVar=VCV000635413; Zygosity=Heterozygous (hPSCreg=NERCi001-A).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Glu1116Gln (c.3346G>C); ClinVar=VCV000635414; Zygosity=Heterozygous (hPSCreg=NERCi001-A).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   NES-4G10G8
AC   CVCL_C6MR
SY   4G10G8
DR   Wikidata; Q116049884
RX   PubMed=23407796;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48681; Human NES (Note=Also reacts with bovine and mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   NES2Y
AC   CVCL_LB86
SY   NES 2Y
DR   Wikidata; Q54930415
RX   Patent=US6372501;
RX   PubMed=9280302;
RX   PubMed=10567373;
RX   PubMed=10866047;
RX   PubMed=21099259;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 98081006.
CC   Characteristics: Insulin secreting.
CC   Characteristics: Has a loss of function of ATP-regulated potassium channels.
DI   NCIt; C122923; Persistent hyperinsulinemic hypoglycemia of infancy
DI   ORDO; Orphanet_276575; Autosomal dominant hyperinsulinism due to SUR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 6
//
ID   Neu7
AC   CVCL_AZ70
SY   Neu-7; Neu 7
DR   BTO; BTO_0005800
DR   Wikidata; Q54930416
RX   PubMed=7583324;
RX   PubMed=10516297;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Activated Erbb2/neu.
CC   Caution: Erroneously indicated as originating from mouse in BTO=BTO_0005800.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   NeuCHO
AC   CVCL_IR07
SY   NeuCho
DR   Wikidata; Q54930417
RX   Patent=US20170233695;
WW   Provider; NeuClone; -; http://www.neuclone.com/technology/
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Cell Bank Australia; CBA20130024.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4261; GH1.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 13
//
ID   Neuro-2a
AC   CVCL_0470
SY   NEURO-2A; Neuro 2a; Neuro2a; Neuro2A; N-2a; N2a; N2A; Nb2a; NB2a
DR   BTO; BTO_0001976
DR   CLO; CLO_0008154
DR   CLO; CLO_0050180
DR   EFO; EFO_0022756
DR   MCCL; MCC:0000368
DR   CLDB; cl3682
DR   CLDB; cl3683
DR   CLDB; cl3684
DR   CLDB; cl3685
DR   CLDB; cl4956
DR   CLDB; cl5236
DR   Abcam; ab279975
DR   ATCC; CCL-131
DR   BCRC; 60026
DR   BCRJ; 0189
DR   BioGRID_ORCS_Cell_line; 1373
DR   CCLV; CCLV-RIE 0132
DR   CCRID; 1101MOU-PUMC000291
DR   CCRID; 3101MOUSCSP5035
DR   CCRID; 3101MOUTCM29
DR   CCRID; 4201MOU-CCTCC00162
DR   CCTCC; GDC0162
DR   ChEMBL-Cells; CHEMBL3307521
DR   ChEMBL-Targets; CHEMBL614062
DR   CLS; 400394
DR   DSMZ; ACC-148
DR   DSMZCellDive; ACC-148
DR   ECACC; 89121404
DR   ICLC; ATL99007
DR   IZSLER; BS TCL 128
DR   JCRB; IFO50081
DR   KCB; KCB 2014025YJ
DR   Lonza; 451
DR   PRIDE; PXD000065
DR   PRIDE; PXD000666
DR   PRIDE; PXD002290
DR   PRIDE; PXD018875
DR   PubChem_Cell_line; CVCL_0470
DR   RCB; RCB2639
DR   TKG; TKG 0509
DR   TOKU-E; 2746
DR   TOKU-E; 3552
DR   TOKU-E; 3563
DR   Wikidata; Q18391478
RX   DOI=10.5352/JLS.2009.19.4.449;
RX   PubMed=11470893;
RX   PubMed=14504404;
RX   PubMed=19903493;
RX   PubMed=25193168;
RX   PubMed=25277546;
RX   PubMed=25565633;
RX   PubMed=35339896;
RX   PubMed=37333171;
RX   PubMed=39594637;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/What_are_the_details_of_N2A_cell_differentiation_methods
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-213.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-384.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/N2a_cell
CC   Characteristics: Capable of differentiating into various types of neurons.
CC   Doubling time: ~70 hours (DSMZ=ACC-148).
CC   Karyotypic information: Has a hyper-tetraploid karyotype. Has lost chromosome Y (PubMed=39594637).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
ST   Source(s): Direct_author_submission; PubMed=35339896
ST   Mouse STR 1-1: 11
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 12,13,14
ST   Mouse STR 4-2: 21.3,22.3
ST   Mouse STR 5-5: 15,17
ST   Mouse STR 6-4: 18,19 (Direct_author_submission)
ST   Mouse STR 6-4: 18,20 (PubMed=35339896)
ST   Mouse STR 6-7: 12 (Direct_author_submission)
ST   Mouse STR 6-7: 15 (PubMed=35339896)
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 21.3,22.3,23.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 22 (Direct_author_submission)
ST   Mouse STR 18-3: 22,23 (PubMed=35339896)
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26,27
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 37
//
ID   Neuro-2a NucLight Green
AC   CVCL_DF49
DR   Wikidata; Q54930418
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4511.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   Neuro-2a NucLight Red
AC   CVCL_DF50
DR   Wikidata; Q54930419
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Biosciences; Catalog number 4512.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   Neuro-2a-Luc
AC   CVCL_K046
SY   Neuro2A-Luc
DR   BTO; BTO_0003958
DR   Wikidata; Q54930420
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   Neuro-2a/Cas9-Rosa26-Hyg
AC   CVCL_C9FD
DR   GeneCopoeia; SL509
DR   Wikidata; Q123033164
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the Rosa26 safe locus (GeneCopoeia=SL509).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Neuro-2a/Cas9-Rosa26-Neo
AC   CVCL_C9FE
DR   GeneCopoeia; SL511
DR   Wikidata; Q123033165
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-Neo construct from the Rosa26 safe locus (GeneCopoeia=SL511).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Neuro-2a/Cas9-Rosa26-Puro
AC   CVCL_C9FC
DR   GeneCopoeia; SL510
DR   Wikidata; Q123033166
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-PuroR-SV40pa construct from the Rosa26 safe locus (GeneCopoeia=SL510).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Neuro-2a/CMV-Luc
AC   CVCL_A9J5
SY   Neuro-2a CMV-Luc
DR   JCRB; JCRB1837
DR   JCRB; NIHS1295
DR   Wikidata; Q102114591
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1837).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1295; true.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   Neuro-2a/HF-Cas9-Rosa26
AC   CVCL_C9FB
SY   Neuro 2a/HF-Cas9-ROSA26
DR   GeneCopoeia; SL571
DR   Wikidata; Q123033167
CC   Characteristics: Stably expresses a CMV-3xFLAG-HFCas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the Rosa26 safe locus (GeneCopoeia=SL571).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asn497Ala, p.Arg661Ala, p.Gln695Ala and p.Gln926Ala = High-fidelity Cas9).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Neuro-2a/LoxP-Cas9-hyg-Rosa26
AC   CVCL_C9FF
SY   Neuro 2a/LoxP-Cas9-hyg-Rosa26
DR   GeneCopoeia; SL559
DR   Wikidata; Q123033168
CC   Characteristics: Stably expresses a loxP-CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa-loxP construct from the Rosa26 safe locus (GeneCopoeia=SL559).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Neuro-2aTG
AC   CVCL_F275
DR   JCRB; IFO50495
DR   Wikidata; Q54930421
RX   PubMed=7763725;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   Neuro2a (HSE:EGFP)
AC   CVCL_E6II
RX   PubMed=32661089;
CC   Characteristics: Constitutively expresses mCherry and expresses EGFP upon induction by stress. Transfected with two constructs, pCMV-mCherry and pminHsp70p-EGFP where EGFP is under the control of a minimal Hsp70 promoter (PubMed=32661089).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Neuro2a-RXR
AC   CVCL_D3XR
SY   N2a-pVgRXR
DR   RCB; RCB5511
DR   Wikidata; Q127382946
RX   PubMed=10574348;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (PubMed=10574348).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   Neuro2a-tNhtt-EGFP-16Q
AC   CVCL_D3YR
DR   RCB; RCB5512
DR   Wikidata; Q127382947
RX   PubMed=10574348;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (from parent cell line).
CC   Characteristics: Transfected with a ecdysone inducible pIND-HDexon1-EGFP construct containing the first exon of HTT with a 16 Gln repeat followed by EGFP (PubMed=10574348).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=1st exon with 16-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3XR ! Neuro2a-RXR
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   Neuro2a-tNhtt-EGFP-150Q
AC   CVCL_D3YT
DR   RCB; RCB5514
DR   Wikidata; Q127382949
RX   PubMed=10574348;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (from parent cell line).
CC   Characteristics: Transfected with a ecdysone inducible pIND-HDexon1-EGFP construct containing the first exon of HTT with a 150 Gln repeat followed by EGFP (PubMed=10574348).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=1st exon with 150-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3XR ! Neuro2a-RXR
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   Neuro2a-tNhtt-EGFP-60Q
AC   CVCL_D3YS
DR   RCB; RCB5513
DR   Wikidata; Q127382950
RX   PubMed=10574348;
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (from parent cell line).
CC   Characteristics: Transfected with a ecdysone inducible pIND-HDexon1-EGFP construct containing the first exon of HTT with a 60 Gln repeat followed by EGFP (PubMed=10574348).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=1st exon with 60-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3XR ! Neuro2a-RXR
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   Neuro2A[TRa1]
AC   CVCL_E7G2
SY   Neuro2A[TRalpha1]; N2a-alpha; Neuro-2a TR-alpha
RX   PubMed=8146169;
RX   PubMed=39594637;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11796; THRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Neuro2A[TRb1]
AC   CVCL_E1GT
SY   Neuro2A[TRbeta1]; N2a-beta; Neuro-2a TR-beta
DR   Kerafast; EMU050
RX   PubMed=8146169;
RX   PubMed=20506002;
RX   PubMed=27387481;
RX   PubMed=39594637;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Neuroscreen-1
AC   CVCL_JY59
SY   NeuroScreen-1; Neuroscreen 1; NS-1; NS1
DR   Wikidata; Q54930422
WW   Provider; Thermo Fisher; R04-0001; https://static.thermoscientific.com/images/D21372~.pdf
CC   Characteristics: Compared to the parent cell line, possesses rapid growth and enhanced sensitivity to NGF (Thermo Fisher=R04-0001).
CC   Discontinued: Thermo Fisher/Cellomics; Catalog number R04-0001.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   Newton
AC   CVCL_U800
DR   Cosmic; 928703
DR   Wikidata; Q54930423
RX   PubMed=9354451;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 5
//
ID   Nex2B
AC   CVCL_C3PY
DR   Wikidata; Q116049885
RX   PubMed=15457088;
CC   Characteristics: Low metastatic potential.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F942 ! B16-F10-Nex2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   Nex2D
AC   CVCL_C3PZ
DR   Wikidata; Q116049886
RX   PubMed=15457088;
CC   Characteristics: High metastatic potential.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F942 ! B16-F10-Nex2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   NEYS
AC   CVCL_M893
DR   Wikidata; Q54930424
RX   PubMed=19624308;
CC   Population: Japanese.
CC   Doubling time: 59 hours (Note=At 10th passage), 56 hours (Note=At 30th passage) (PubMed=19624308).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   NF
AC   CVCL_W770
DR   Wikidata; Q54930425
RX   PubMed=2156601;
CC   Doubling time: 46 hours (PubMed=2156601).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   NF-1
AC   CVCL_3556
DR   CLO; CLO_0008155
DR   ATCC; CRL-2075
DR   Wikidata; Q54930426
RX   PubMed=6137898;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   NF-hTERT patient 2
AC   CVCL_E6I9
SY   NIh; Normal Fibroblast-hTERT immortalized from patient 2
DR   ABM; T0387
RX   PubMed=29584680;
CC   Characteristics: Control cell line for CWF-hTERT patient 2 (Cellosaurus=CVCL_E6IA) (PubMed=29584680).
CC   Doubling time: 48-72 hours (ABM=T0387).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6IA ! CWF-hTERT patient 2
SX   Female
AG   75Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NF-HFO-1
AC   CVCL_UJ50
SY   CF-1; Noble Foundation-Human FOreskin-1
DR   Wikidata; Q98127514
RX   DOI=10.1016/B978-0-12-427150-0.50063-2;
RX   PubMed=4570356;
CC   Senescence: Senesces at 35 +- 5 PDL (DOI=10.1016/B978-0-12-427150-0.50063-2; PubMed=4570356).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   NF-HFO-2
AC   CVCL_B7RW
SY   CF-3; Noble Foundation-Human FOreskin-2
DR   Wikidata; Q112930168
RX   PubMed=6785281;
CC   Senescence: Senesces at 65 +- 10 PDL (PubMed=6785281).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   NF-HFO-3
AC   CVCL_UJ51
SY   WLW; Noble Foundation-Human FOreskin-3
DR   Wikidata; Q98127515
RX   DOI=10.1016/B978-0-12-427150-0.50063-2;
RX   PubMed=4817727;
CC   Senescence: Senesces at 15-20 PDL (DOI=10.1016/B978-0-12-427150-0.50063-2; PubMed=4817727).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   NF1
AC   CVCL_JG80
DR   JCRB; JCRB3015
DR   JCRB; KURB2807
DR   Wikidata; Q54930427
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2807; probable.
ST   Source(s): JCRB=JCRB3015
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 6
//
ID   NF1-08-CL
AC   CVCL_E5GK
SY   MPNST-NF1-08-CL
RX   PubMed=37798904;
CC   Population: Caucasian; Spanish.
CC   Doubling time: 2.90 days (PubMed=37798904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=37798904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (PubMed=37798904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:17101; SUZ12; Zygosity=Heterozygous (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.701_730+10del; Zygosity=Heterozygous; Note=Germline (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:17101; SUZ12; Simple; p.Glu415Glyfs*5 (c.1236_1240del); Zygosity=Heterozygous (PubMed=37798904).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Dorsal nerve of penis; UBERON=UBERON_0019197.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NF1-09-CL
AC   CVCL_E5GL
SY   MPNST-NF1-09-CL
RX   PubMed=37798904;
CC   Population: Caucasian; Spanish.
CC   Characteristics: Tumorigenic (PubMed=37798904).
CC   Doubling time: 0.44 day (PubMed=37798904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=37798904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.1186-5_1186-1del; Zygosity=Heterozygous; Note=Somatic (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Tyr2285Ter (c.6855C>A) (p.Tyr2264Ter, c.6792C>A); ClinVar=VCV000185082; Zygosity=Heterozygous; Note=Germline (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=37798904).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NF2C
AC   CVCL_HE74
DR   Wikidata; Q54930428
RX   Patent=US6825394;
RX   PubMed=10417352;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 96092754.
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Dies at the restrictive temperature (39 Celsius).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Sprague Dawley SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   NF2S-1
AC   CVCL_7691
SY   Nf2S-1
DR   Wikidata; Q54930429
RX   PubMed=17304235;
CC   Doubling time: 24 hours (PubMed=17304235).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: NIH Swiss.
DI   NCIt; C21997; Mouse schwannoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   NF90-8
AC   CVCL_1B47
SY   MPNST 90-8TL; 90-8TL; NF190-8; 90-8
DR   EFO; EFO_0006288
DR   cancercelllines; CVCL_1B47
DR   Wikidata; Q54605631
RX   PubMed=1568246;
RX   PubMed=7522538;
RX   PubMed=10534774;
RX   PubMed=10791998;
RX   PubMed=16239399;
RX   PubMed=16510576;
RX   PubMed=21481793;
RX   PubMed=28469964;
RX   PubMed=32076030;
RX   PubMed=32642732;
RX   PubMed=34059954;
RX   PubMed=36818284;
CC   Karyotypic information: Average ploidy of 3.56 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous; Note=Germline (PubMed=10534774).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Asp1302Tyrfs*5 (c.3904_3910del); Zygosity=Heterozygous; Note=Somatic (PubMed=36818284).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.96+1G>A (IVS3+1G>A); ClinVar=VCV000860797; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=7522538).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Left forearm; UBERON=UBERON_0002386.
ST   Source(s): PubMed=32076030; PubMed=36818284
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 14,18
ST   D19S433: 13,16
ST   D21S11: 30
ST   D2S1338: 16,24
ST   D3S1358: 15 (PubMed=36818284)
ST   D3S1358: 15,21 (PubMed=32076030)
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 25
ST   Penta D: 14
ST   Penta E: 5,10
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   NFH-46
AC   CVCL_A9ST
DR   Wikidata; Q102114598
RX   PubMed=25765079;
CC   HLA typing: A*01:01,03:01; B*08,35; C*04:01,07:01; DRB1*03:01,11:01 (PubMed=25765079).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NFHHMUi001-A
AC   CVCL_C1V1
DR   BioSamples; SAMEA13602499
DR   hPSCreg; NFHHMUi001-A
DR   Wikidata; Q114312505
RX   PubMed=35716468;
CC   From: Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University; Harbin; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1573; KRIT1; Simple; p.Thr545fs*6 (c.1635delA); Zygosity=Heterozygous (PubMed=35716468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84626; Cerebral cavernous malformation
DI   ORDO; Orphanet_221061; Familial cerebral cavernous malformation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   NFkappaB-TIME
AC   CVCL_Z064
DR   ATCC; CRL-4049
DR   Wikidata; Q54930430
CC   Characteristics: The NanoLuc reporter gene is under the control of multiple copies of the NF-kappaB response element (ATCC=CRL-4049).
CC   Characteristics: When cells are exposed to inflammatory cytokines such as TNFalpha, activation of the NF-kappaB signaling pathway occurs resulting in increased luciferase activity (ATCC=CRL-4049).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Foreskin, skin, dermis, microvascular endothelium; UBERON=UBERON_0001471+UBERON_0008339.
ST   Source(s): ATCC=CRL-4049
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0047 ! TIME
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 17
//
ID   NFKB p50 KO (C57/129)
AC   CVCL_C0MB
SY   NFKB p50 KO (C57/129) Macrophage Cell Line
DR   Kerafast; ENH180-FP
DR   Wikidata; Q112930169
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97312; Nfkb1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   NFL/T
AC   CVCL_D888
SY   Normal Fetal Liver/Transformed
DR   Wikidata; Q54930432
RX   PubMed=7777587;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16-SV40(ori-)).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 14
//
ID   NFPE
AC   CVCL_3557
DR   CLO; CLO_0008158
DR   ATCC; CRL-2069
DR   Wikidata; Q54930434
CC   Breed/subspecies: BALB/c.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3556 ! NF-1
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   NFS-1
AC   CVCL_1Y69
DR   Cosmic; 1132065
DR   Cosmic; 1801807
DR   Wikidata; Q54930435
RX   PubMed=18650488;
RX   PubMed=23437333;
CC   Misspelling: NSF-1; Cosmic=1801807.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   NFS-1.0 C-1
AC   CVCL_0E46
SY   NFS-1.0 C1; NFS-1.0
DR   ATCC; CRL-1705
DR   Wikidata; Q54930436
RX   PubMed=6330201;
RX   PubMed=25277546;
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: NFS.C58v1.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 6
//
ID   NFS-107
AC   CVCL_5230
SY   NFS107
DR   Wikidata; Q54930437
RX   PubMed=3014527;
CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC   Breed/subspecies: NFS.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   NFS-124
AC   CVCL_5231
SY   NFS124
DR   Wikidata; Q54930438
RX   PubMed=3014527;
CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC   Breed/subspecies: NFS.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   NFS-2
AC   CVCL_W494
DR   Wikidata; Q54930441
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   NFS-22
AC   CVCL_5211
SY   NFS22
DR   Wikidata; Q54930442
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   NFS-25 C-3
AC   CVCL_3558
SY   NFS-25 C3
DR   CLO; CLO_0008159
DR   CLDB; cl3688
DR   ATCC; CRL-1695
DR   ECACC; 93090713
DR   Wikidata; Q54930443
RX   PubMed=6330201;
CC   Breed/subspecies: NFS.C58v1.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   NFS-5 C-1
AC   CVCL_3559
SY   NFS-5 C1
DR   CLO; CLO_0008160
DR   CLDB; cl3689
DR   ATCC; CRL-1693
DR   ECACC; 88041904
DR   Wikidata; Q54930444
RX   PubMed=6330201;
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   NFS-58
AC   CVCL_5232
SY   NFS 58; NFS58
DR   Wikidata; Q54930445
RX   PubMed=2656885;
RX   PubMed=3014527;
CC   Breed/subspecies: NFS x DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   NFS-60
AC   CVCL_3543
SY   M-NFS-60; NFS 60; NFS60
DR   CLO; CLO_0007812
DR   AddexBio; C0003022/4945
DR   ATCC; CRL-1838
DR   BCRJ; 0175
DR   BioSample; SAMN11397637
DR   CCRID; 1102MOU-NIFDC00100
DR   ChEMBL-Cells; CHEMBL3307327
DR   ChEMBL-Targets; CHEMBL614199
DR   CLS; 400301
DR   NCBI_Iran; C482
DR   NCBI_Iran; C603
DR   PubChem_Cell_line; CVCL_3543
DR   Wikidata; Q54930446
RX   PubMed=2497280;
RX   PubMed=2656885;
RX   PubMed=3014527;
RX   PubMed=31220119;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/m-nfs-60-atcc-crl-1338
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=NFS-60
CC   Characteristics: IL3 dependent.
CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC   Breed/subspecies: NFS x DBA/2.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 10,16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 15.3,18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 28,29
ST   Mouse STR 8-1: 15,16
ST   Mouse STR 11-2: 17,19
ST   Mouse STR 12-1: 16,20
ST   Mouse STR 13-1: 13,15.2
ST   Mouse STR 15-3: 20.3,21.3
ST   Mouse STR 17-2: 13,15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 11,12
ST   Mouse STR X-1: 25,27
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   NFS-61
AC   CVCL_5233
SY   NFS61
DR   Wikidata; Q54930447
RX   PubMed=3014527;
CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: NFS.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NFS-70 C-10
AC   CVCL_3560
SY   NFS-70 C10; NFS70
DR   CLO; CLO_0008161
DR   CLDB; cl3690
DR   ATCC; CRL-1694
DR   ECACC; 88041905
DR   Wikidata; Q54930448
RX   PubMed=6330201;
RX   PubMed=19363217;
CC   Characteristics: Contains DJ rearrangements on both IgH alleles (PubMed=19363217).
CC   Transformant: NCBI_TaxID; 11786; Murine leukemia virus (Note=Isolate CAS-NS-7).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   NFS-78
AC   CVCL_5234
SY   NFS78
DR   Wikidata; Q54930449
RX   PubMed=3014527;
CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC   Breed/subspecies: NFS.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   NFS70.226
AC   CVCL_ZS81
DR   Wikidata; Q98127516
RX   PubMed=19363217;
CC   Characteristics: Subclone of NFS-70 that does not produce IgMu chains.
CC   Transformant: NCBI_TaxID; 11786; Murine leukemia virus (Note=Isolate CAS-NS-7).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3560 ! NFS-70 C-10
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   NFS70.255
AC   CVCL_ZS82
DR   Wikidata; Q98127517
RX   PubMed=19363217;
CC   Transformant: NCBI_TaxID; 11786; Murine leukemia virus (Note=Isolate CAS-NS-7).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3560 ! NFS-70 C-10
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   NFS70.255.23
AC   CVCL_ZS83
DR   Wikidata; Q98127518
RX   PubMed=19363217;
CC   Characteristics: Subclone of NFS-70 that produce IgMu chains. Contains one productively rearranged allele and one nonproductively rearranged allele.
CC   Transformant: NCBI_TaxID; 11786; Murine leukemia virus (Note=Isolate CAS-NS-7).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: NFS/N.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZS82 ! NFS70.255
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   NFS812
AC   CVCL_ZS80
SY   NF812
DR   Wikidata; Q98127519
RX   PubMed=3136916;
RX   PubMed=6422469;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NFSa Y83
AC   CVCL_H735
SY   NFSaY83
DR   CLO; CLO_0050201
DR   RCB; RCB0282
DR   Wikidata; Q54930450
CC   Breed/subspecies: C3Hf/Bu.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NFSC
AC   CVCL_M103
SY   Normal Fat Storing Cells
DR   BTO; BTO_0003521
DR   Wikidata; Q54930451
RX   PubMed=1753710;
RX   PubMed=17760834;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   NFSL66
AC   CVCL_ZS77
DR   Wikidata; Q98127521
RX   PubMed=3136916;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NFSL68
AC   CVCL_ZS78
DR   Wikidata; Q98127522
RX   PubMed=3136916;
RX   PubMed=3932847;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NFSL70
AC   CVCL_ZS79
DR   Wikidata; Q98127523
RX   PubMed=3136916;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NG-3Y1-D303
AC   CVCL_H236
DR   RCB; RCB0359
DR   Wikidata; Q54930452
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   NG-3Y1-T15L
AC   CVCL_H227
DR   JCRB; JCRB0739
DR   Wikidata; Q54930453
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   NG-3Y1-T18D
AC   CVCL_H237
DR   RCB; RCB0371
DR   Wikidata; Q54930454
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   NG-3Y1-T308
AC   CVCL_H228
DR   JCRB; JCRB0740
DR   Wikidata; Q54930455
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   NG-3Y1-T6R
AC   CVCL_H229
DR   JCRB; JCRB0741
DR   Wikidata; Q54930456
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   NG115-401L
AC   CVCL_3938
DR   CLO; CLO_0008163
DR   CLDB; cl3692
DR   ECACC; 87032003
DR   Wikidata; Q54930457
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   NG125
AC   CVCL_U379
SY   NG 125; NG-125
DR   Wikidata; Q54930458
RX   PubMed=2547146;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-451.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18-20FW
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   NG2-2.16
AC   CVCL_4Y73
DR   Wikidata; Q54930459
RX   PubMed=3428508;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Breed/subspecies: 129/Sv-SlJ-CP.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7221 ! PSA1-NG2
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 5
//
ID   NG97
AC   CVCL_A660
SY   NG-97
DR   Wikidata; Q54930460
RX   PubMed=11775071;
RX   PubMed=15885136;
CC   Population: Brazilian.
CC   Doubling time: ~72 hours (PubMed=11775071); ~24 hours (PubMed=15885136).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 12
//
ID   NG97ht
AC   CVCL_A661
DR   Wikidata; Q54930461
RX   PubMed=19009596;
CC   Population: Brazilian.
CC   Characteristics: Established from a nude mice xenotransplanted with NG97 (PubMed=19009596).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A660 ! NG97
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 12
//
ID   NGAL-2D8
AC   CVCL_XV52
DR   CCRID; 4201PAT-CCTCC00988
DR   Wikidata; Q98127524
RX   Patent=CN106645762B;
RX   Patent=WO2018119626A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016215.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P80188; Human LCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   NGAL-3B5
AC   CVCL_XV53
DR   CCRID; 4201PAT-CCTCC00987
DR   Wikidata; Q98127525
RX   Patent=CN106645762B;
RX   Patent=WO2018119626A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016214.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P80188; Human LCN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   NGAL-4F6
AC   CVCL_XV54
DR   CCRID; 4201PAT-CCTCC00989
DR   Wikidata; Q98127526
RX   Patent=CN106645762B;
RX   Patent=WO2018119626A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016216.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P80188; Human LCN2.
CC   Misspelling: NGAL-4F7; Note=In Cellosaurus releases 33 to 38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   NGC-0295
AC   CVCL_DF66
SY   NGC0295
DR   Wikidata; Q54930462
RX   PubMed=20664524;
RX   PubMed=22113314;
RX   PubMed=22655593;
CC   Biotechnology: Used in NsG0202, an encapsulated cell biodelivery device capable of local delivery of NGF to the brain so at to treat the cognitive decline in Alzheimer disease patients.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7808; NGF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   NGC-0301
AC   CVCL_DF67
SY   C101
DR   Wikidata; Q54930463
RX   Patent=US20080286250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2732.
CC   Biotechnology: Used in NsG0301, an encapsulated cell biodelivery device capable of local delivery of GDNF to the brain so at to treat Parkinson disease patients.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4232; GDNF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   NGC-0363
AC   CVCL_DF68
SY   C63
DR   Wikidata; Q54930464
RX   Patent=US20080286250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2733.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4232; GDNF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   NGC-407
AC   CVCL_DF59
DR   Wikidata; Q54930465
RX   Patent=US8088567;
RX   PubMed=17555745;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2718.
CC   Characteristics: Neural progenitor cell line that can differentiate into neurons, astrocytes and dopaminergic neurons depending on the differentiation conditions.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7FW
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   NGC0211
AC   CVCL_DF65
DR   Wikidata; Q54930466
RX   DOI=10.2174/1875043501205010035;
RX   PubMed=22113314;
CC   Biotechnology: Used in NsG0202.1, an encapsulated cell biodelivery device capable of local delivery of NGF to the brain so at to treat the cognitive decline in Alzheimer disease patients.
CC   Characteristics: Contains 4 integrated copies of the NGF gene.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7808; NGF.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   NGF-2
AC   CVCL_W098
DR   Wikidata; Q54930467
RX   PubMed=18034678;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 8
//
ID   NGF-3
AC   CVCL_W099
DR   Wikidata; Q54930468
RX   PubMed=18034678;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7962; ! Cyprinus carpio (Common carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 8
//
ID   NGFR5
AC   CVCL_KB83
SY   NGFR 5
DR   Wikidata; Q54930469
RX   PubMed=2552791;
RX   PubMed=3025363;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08138; Human NGFR/CD271 (Note=Also reacts with many other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   NGM
AC   CVCL_0R16
DR   BCRJ; 0190
DR   Wikidata; Q54930470
CC   Derived from site: In situ; Skin, dermis, nevus; UBERON=UBERON_1000010.
ST   Source(s): BCRJ=0190
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 6
//
ID   NGP
AC   CVCL_2141
DR   CLO; CLO_0037091
DR   BioSample; SAMN03473431
DR   cancercelllines; CVCL_2141
DR   Cell_Model_Passport; SIDM01785
DR   Cosmic; 717421
DR   Cosmic; 923823
DR   Cosmic; 930071
DR   Cosmic; 1019937
DR   Cosmic; 1109120
DR   Cosmic; 1161999
DR   Cosmic; 1167422
DR   Cosmic; 1167988
DR   Cosmic; 1526637
DR   Cosmic; 2058106
DR   Cosmic; 2393638
DR   DepMap; ACH-001366
DR   DSMZ; ACC-676
DR   DSMZCellDive; ACC-676
DR   GEO; GSM453633
DR   GEO; GSM692865
DR   GEO; GSM2371249
DR   GEO; GSM2394382
DR   GEO; GSM3145577
DR   GEO; GSM3145726
DR   GEO; GSM4104589
DR   GEO; GSM4104590
DR   GEO; GSM4105333
DR   GEO; GSM4105334
DR   GEO; GSM4105335
DR   GEO; GSM4105336
DR   GEO; GSM4105337
DR   IARC_TP53; 23601
DR   LINCS_HMS; 51099
DR   LINCS_LDP; LCL-2103
DR   Progenetix; CVCL_2141
DR   Wikidata; Q54930471
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=922665;
RX   PubMed=6888561;
RX   PubMed=8490657;
RX   PubMed=9283597;
RX   PubMed=11550280;
RX   PubMed=15150091;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=23202128;
RX   PubMed=24466371;
RX   PubMed=28350380;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~50-70 hours (DSMZ=ACC-676).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141Trp (c.423C>G); ClinVar=VCV000376564; Zygosity=Unspecified (DepMap=ACH-001366).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): DepMap=ACH-001366; DSMZ=ACC-676
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 32,33 (DSMZ=ACC-676)
ST   D21S11: 32,33.1 (DepMap=ACH-001366)
ST   D2S1338: 24,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 11 (DSMZ=ACC-676)
ST   D8S1179: 11,12 (DepMap=ACH-001366)
ST   FGA: 19,23
ST   Penta D: 8,10 (DepMap=ACH-001366)
ST   Penta D: 10 (DSMZ=ACC-676)
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 6,9
ST   vWA: 16,21
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   NGP-127
AC   CVCL_UF75
SY   NGP127
DR   Wikidata; Q98127527
RX   PubMed=9823299;
CC   From: Brodeur, Garrett M.; Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   NGP-C4
AC   CVCL_0B58
SY   NGP-c4
DR   Cosmic; 1518071
DR   Cosmic; 2239464
DR   Wikidata; Q54930472
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NGP.1A.TR1
AC   CVCL_AX38
DR   Wikidata; Q54930473
RX   PubMed=1679663;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 8
//
ID   NGPrBORTE20
AC   CVCL_RS68
DR   Wikidata; Q54930474
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrCARBO5000
AC   CVCL_RS30
DR   Wikidata; Q54930475
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrCDDP1000
AC   CVCL_RS31
DR   Wikidata; Q54930476
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrDACARB18
AC   CVCL_RT19
DR   Wikidata; Q54930477
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   NGPrDOCE20
AC   CVCL_RS32
DR   Wikidata; Q54930478
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrDOX20
AC   CVCL_RS33
DR   Wikidata; Q54930479
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrETO200
AC   CVCL_RS69
DR   Wikidata; Q54930480
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrETO400
AC   CVCL_RS34
DR   Wikidata; Q54930484
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrGEMCI20
AC   CVCL_RR55
DR   Wikidata; Q54930485
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrIRINO1000
AC   CVCL_RS70
DR   Wikidata; Q54930486
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrMEL2000
AC   CVCL_RS71
DR   Wikidata; Q54930487
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrMEL3000
AC   CVCL_RS35
DR   Wikidata; Q54930488
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrMEL4000
AC   CVCL_RS72
DR   Wikidata; Q54930489
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrOXALI4000
AC   CVCL_RS36
DR   Wikidata; Q54930490
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrPCL20
AC   CVCL_RS73
DR   Wikidata; Q54930491
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrTOPO20
AC   CVCL_RS37
DR   Wikidata; Q54930492
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrVCR10
AC   CVCL_RR40
DR   Wikidata; Q54930493
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrVCR100
AC   CVCL_RR41
DR   Wikidata; Q54930494
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrVCR20
AC   CVCL_RS74
DR   Wikidata; Q54930495
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrVINB20
AC   CVCL_RS75
DR   Wikidata; Q54930496
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGPrVINOR20
AC   CVCL_RS76
DR   Wikidata; Q54930497
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2141 ! NGP
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NGR50
AC   CVCL_J705
DR   CLO; CLO_0050340
DR   RCB; RCB2040
DR   Wikidata; Q54930498
RX   PubMed=8794950;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   NGR53
AC   CVCL_U838
DR   Wikidata; Q54930499
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: IV6-NeuAcalpha-nLc4Cer gangliosides.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   NGR54
AC   CVCL_J706
DR   CLO; CLO_0050338
DR   RCB; RCB2037
DR   Wikidata; Q54930500
RX   PubMed=7734848;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: IV3-NeuAcalpha-nLc4Cer gangliosides.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   NGUK-1
AC   CVCL_7692
DR   CLO; CLO_0008168
DR   CLDB; cl3697
DR   Wikidata; Q54930501
RX   PubMed=2718262;
RX   PubMed=21116501;
CC   Derived from site: In situ; Peripheral nervous system, gasserian ganglion; UBERON=UBERON_0001675.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   NH
AC   CVCL_A5ZJ
DR   Wikidata; Q107116567
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=21394097;
CC   From: Suzukawa, Kazumi; University of Tsukuba; Tsukuba; Japan.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 4
//
ID   NH-12
AC   CVCL_1605
SY   NH12; Neuroblastoma-12
DR   CLO; CLO_0050267
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 966
DR   BioSample; SAMN01821709
DR   BioSample; SAMN03472526
DR   cancercelllines; CVCL_1605
DR   Cell_Model_Passport; SIDM00577
DR   ChEMBL-Cells; CHEMBL3308211
DR   ChEMBL-Targets; CHEMBL2366263
DR   Cosmic; 801745
DR   Cosmic; 908447
DR   Cosmic; 947719
DR   Cosmic; 1037350
DR   Cosmic; 1099147
DR   Cosmic; 1153788
DR   Cosmic; 2131593
DR   Cosmic-CLP; 908447
DR   DepMap; ACH-001603
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10555-107I6
DR   GDSC; 908447
DR   GEO; GSM313808
DR   GEO; GSM333802
DR   GEO; GSM1670277
DR   IARC_TP53; 21584
DR   JCRB; JCRB0833
DR   LINCS_LDP; LCL-1978
DR   PharmacoDB; NH12_1157_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1605
DR   PubChem_Cell_line; CVCL_1605
DR   RCB; RCB2108
DR   TKG; TKG 0448
DR   Wikidata; Q54930502
RX   PubMed=9290701;
RX   PubMed=12210830;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=74.87%; East Asian, South=25.12%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Cosmic-CLP=908447; DepMap=ACH-001603; JCRB=JCRB0833; RCB=RCB2108; TKG=TKG 0448
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 29,31
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 11,13
ST   D8S1179: 10,15
ST   FGA: 23,26
ST   Penta D: 11,12
ST   Penta E: 19,20
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   NH-6
AC   CVCL_1606
SY   NH6; Neuroblastoma-6
DR   CLO; CLO_0050089
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN01821710
DR   BioSample; SAMN03472525
DR   BioSample; SAMN10987623
DR   cancercelllines; CVCL_1606
DR   Cell_Model_Passport; SIDM01391
DR   ChEMBL-Cells; CHEMBL3308801
DR   ChEMBL-Targets; CHEMBL1075551
DR   Cosmic; 925344
DR   DepMap; ACH-000203
DR   GEO; GSM887455
DR   GEO; GSM888535
DR   IARC_TP53; 27701
DR   JCRB; JCRB0832
DR   LiGeA; CCLE_072
DR   PharmacoDB; NH6_1158_2019
DR   Progenetix; CVCL_1606
DR   PubChem_Cell_line; CVCL_1606
DR   RCB; RCB2109
DR   TKG; TKG 0468
DR   Wikidata; Q54930503
RX   PubMed=2004381;
RX   PubMed=9290701;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: >3 days (Note=Lot 06262000) (JCRB=JCRB0832).
CC   HLA typing: A*02:06,24:02; B*07:02,35:08; C*03:03,07:02; DQB1*06:04,06:04 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.3%; Native American=0%; East Asian, North=79.85%; East Asian, South=14.99%; South Asian=0%; European, North=0%; European, South=2.86% (PubMed=30894373).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): JCRB=JCRB0832; RCB=RCB2109; TKG=TKG 0468
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   NH-AR
AC   CVCL_LK79
DR   Wikidata; Q54930504
RX   PubMed=7002281;
CC   Population: Japanese.
CC   Doubling time: 38.4 hours (PubMed=7002281).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from 'nodular histiocytic lymphoma'.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   NH-GEN1
AC   CVCL_W169
DR   Wikidata; Q54930505
RX   PubMed=7933662;
RX   PubMed=8007420;
CC   Doubling time: 32 hours (Note=At 20th passage) (PubMed=7933662).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Glomerular endothelial cell; CL=CL_0002188.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   1Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   NH1-1
AC   CVCL_RM54
DR   GEO; GSM627801
DR   Wikidata; Q54930506
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   NH15-CA2
AC   CVCL_4545
DR   ECACC; 08062525
DR   Wikidata; Q54930507
RX   PubMed=41246;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0464 ! 108CC15
HI   CVCL_4253 ! N115-BU-8
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   NH17
AC   CVCL_2657
DR   CLO; CLO_0008169
DR   CLDB; cl3698
DR   cancercelllines; CVCL_2657
DR   ECACC; 92111101
DR   Wikidata; Q54930508
RX   PubMed=11892817;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0013 ! MOLT-4
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   NH2-6
AC   CVCL_RM55
DR   GEO; GSM627808
DR   Wikidata; Q54930509
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   NH32
AC   CVCL_A1RF
DR   Wikidata; Q105510331
RX   PubMed=10397247;
RX   PubMed=22042714;
RX   PubMed=26774668;
CC   Population: Caucasian.
CC   Knockout cell: Method=Promoterless gene targeting; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (PubMed=26774668).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0561 ! TK6
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   NH50109
AC   CVCL_UX46
DR   NHCDR; NH50109
DR   Wikidata; Q98127528
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Unspecified (NHCDR=NH50109).
CC   Discontinued: NHCDR; NH50109; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50110
AC   CVCL_UX17
DR   NHCDR; NH50110
DR   Wikidata; Q98127529
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Gly389Arg (c.1165G>A) (G706R, c.2116G>A); ClinVar=VCV000014255; Zygosity=Unspecified (NHCDR=NH50110).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX18 ! NH50111
OI   CVCL_UX19 ! NH50165
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50111
AC   CVCL_UX18
DR   NHCDR; NH50111
DR   Wikidata; Q98127530
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Gly389Arg (c.1165G>A) (G706R, c.2116G>A); ClinVar=VCV000014255; Zygosity=Unspecified (NHCDR=NH50111).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX17 ! NH50110
OI   CVCL_UX19 ! NH50165
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50112
AC   CVCL_UX20
DR   NHCDR; NH50112
DR   Wikidata; Q98127532
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (NHCDR=NH50112).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX21 ! NH50113
OI   CVCL_UX22 ! NH50114
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50113
AC   CVCL_UX21
DR   NHCDR; NH50113
DR   Wikidata; Q98127533
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (NHCDR=NH50113).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX20 ! NH50112
OI   CVCL_UX22 ! NH50114
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50114
AC   CVCL_UX22
DR   NHCDR; NH50114
DR   Wikidata; Q98127534
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (NHCDR=NH50114).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX20 ! NH50112
OI   CVCL_UX21 ! NH50113
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50115
AC   CVCL_UX14
DR   NHCDR; NH50115
DR   Wikidata; Q98127535
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ser305Ile (c.914G>T) (S622I, c.1865G>T or S640I, c.1919G>T); ClinVar=VCV001256161; Zygosity=Unspecified (NHCDR=NH50115).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX15 ! NH50166
OI   CVCL_UX16 ! NH50167
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50116
AC   CVCL_UX23
DR   NHCDR; NH50116
DR   Wikidata; Q98127536
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (NHCDR=NH50116).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX24 ! NH50117
OI   CVCL_UX25 ! NH50118
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50117
AC   CVCL_UX24
DR   NHCDR; NH50117
DR   Wikidata; Q98127537
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (NHCDR=NH50117).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX23 ! NH50116
OI   CVCL_UX25 ! NH50118
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50118
AC   CVCL_UX25
DR   NHCDR; NH50118
DR   Wikidata; Q98127538
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (NHCDR=NH50118).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX23 ! NH50116
OI   CVCL_UX24 ! NH50117
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50119
AC   CVCL_UX02
DR   NHCDR; NH50119
DR   Wikidata; Q98127539
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous (NHCDR=NH50119).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX03 ! NH50120
OI   CVCL_UX04 ! NH50177
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50120
AC   CVCL_UX03
DR   NHCDR; NH50120
DR   Wikidata; Q98127540
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous (NHCDR=NH50120).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX02 ! NH50119
OI   CVCL_UX04 ! NH50177
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50122
AC   CVCL_UY39
DR   NHCDR; NH50122
DR   Wikidata; Q98127541
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50123
AC   CVCL_UY40
DR   NHCDR; NH50123
DR   Wikidata; Q98127542
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with torsion dystonia 6 but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50124
AC   CVCL_UY41
DR   NHCDR; NH50124
DR   Wikidata; Q98127544
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Unspecified (NHCDR=NH50124).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50125
AC   CVCL_UY42
DR   NHCDR; NH50125
DR   Wikidata; Q98127545
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:801; ATP1A3; Simple; p.Glu277Lys (c.829G>A); ClinVar=VCV000012911; Zygosity=Heterozygous; Note=De novo mutation (NHCDR=NH50125).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157577; Dystonia 12
DI   ORDO; Orphanet_71517; Rapid-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50126
AC   CVCL_UY43
DR   NHCDR; NH50126
DR   Wikidata; Q98127546
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50127
AC   CVCL_UY44
DR   NHCDR; NH50127
DR   Wikidata; Q98127547
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50128
AC   CVCL_UY45
DR   NHCDR; NH50128
DR   Wikidata; Q98127548
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50128).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50129
AC   CVCL_UY46
DR   NHCDR; NH50129
DR   Wikidata; Q98127549
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=NH50129).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=NH50129).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50130
AC   CVCL_UY47
DR   NHCDR; NH50130
DR   Wikidata; Q98127550
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50131
AC   CVCL_UY48
DR   NHCDR; NH50131
DR   Wikidata; Q98127553
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50132
AC   CVCL_UY49
DR   NHCDR; NH50132
DR   Wikidata; Q98127554
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50133
AC   CVCL_UY50
DR   NHCDR; NH50133
DR   Wikidata; Q98127556
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50134
AC   CVCL_UY51
DR   NHCDR; NH50134
DR   Wikidata; Q98127558
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   NH50135
AC   CVCL_UY52
DR   NHCDR; NH50135
DR   Wikidata; Q98127559
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50136
AC   CVCL_UY53
DR   NHCDR; NH50136
DR   Wikidata; Q98127560
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Unspecified (NHCDR=NH50136).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Unspecified (NHCDR=NH50136).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50137
AC   CVCL_UY54
DR   NHCDR; NH50137
DR   Wikidata; Q98127561
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50138
AC   CVCL_UY55
DR   NHCDR; NH50138
DR   Wikidata; Q98127562
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   NH50139
AC   CVCL_UY56
DR   NHCDR; NH50139
DR   Wikidata; Q98127563
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with autosomal dominant torsion dystonia 1 but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50140
AC   CVCL_UW84
DR   NHCDR; NH50140
DR   Wikidata; Q98127564
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_corrected; p.His44Arg (c.131A>G) (H43R); ClinVar=VCV000014756; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50140).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY49 ! ND50068
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50141
AC   CVCL_UW85
DR   NHCDR; NH50141
DR   Wikidata; Q98127565
CC   Population: Hispanic.
CC   Characteristics: Non-edited control for NH50140 (Cellosaurus=CVCL_UW84).
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.His44Arg (c.131A>G) (H43R); ClinVar=VCV000014756; Zygosity=Heterozygous (NHCDR=NH50141).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RY49 ! ND50068
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50142
AC   CVCL_UW93
DR   NHCDR; NH50142
DR   Wikidata; Q98127566
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50142).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH37 ! ND50043
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   NH50143
AC   CVCL_UW94
DR   NHCDR; NH50143
DR   Wikidata; Q98127567
CC   Population: Caucasian.
CC   Characteristics: Non-edited control for NH50142 (Cellosaurus=CVCL_UW93).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=NH50143).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH37 ! ND50043
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   NH50144
AC   CVCL_UW97
DR   NHCDR; NH50144
DR   Wikidata; Q98127569
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50145
AC   CVCL_UW98
DR   NHCDR; NH50145
DR   Wikidata; Q98127570
CC   Population: Pacific.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50147
AC   CVCL_UW99
DR   NHCDR; NH50147
DR   Wikidata; Q98127571
CC   Population: Pacific.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50148
AC   CVCL_UX26
DR   NHCDR; NH50148
DR   Wikidata; Q98127572
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50149
AC   CVCL_UX27
DR   NHCDR; NH50149
DR   Wikidata; Q98127573
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=NH50149).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=NH50149).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50150
AC   CVCL_UX28
DR   NHCDR; NH50150
DR   Wikidata; Q98127575
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50151
AC   CVCL_UX29
DR   NHCDR; NH50151
DR   Wikidata; Q98127577
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   NH50152
AC   CVCL_UX30
DR   NHCDR; NH50152
DR   Wikidata; Q98127578
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50153
AC   CVCL_UX31
DR   NHCDR; NH50153
DR   Wikidata; Q98127579
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[238] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50153).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX32 ! NH50154
OI   CVCL_UX33 ! NH50155
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50154
AC   CVCL_UX32
DR   NHCDR; NH50154
DR   Wikidata; Q98127580
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[238] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50154).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX31 ! NH50153
OI   CVCL_UX33 ! NH50155
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50155
AC   CVCL_UX33
DR   NHCDR; NH50155
DR   Wikidata; Q98127582
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[238] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50155).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX31 ! NH50153
OI   CVCL_UX32 ! NH50154
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50156
AC   CVCL_UX34
DR   NHCDR; NH50156
DR   Wikidata; Q98127583
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[150] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50156).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX35 ! NH50157
OI   CVCL_UX36 ! NH50158
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50157
AC   CVCL_UX35
DR   NHCDR; NH50157
DR   Wikidata; Q98127584
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[150] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50157).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX34 ! NH50156
OI   CVCL_UX36 ! NH50158
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50158
AC   CVCL_UX36
DR   NHCDR; NH50158
DR   Wikidata; Q98127585
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[150] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50158).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX34 ! NH50156
OI   CVCL_UX35 ! NH50157
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50159
AC   CVCL_UX37
DR   NHCDR; NH50159
DR   Wikidata; Q98127586
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX38 ! NH50160
OI   CVCL_UX39 ! NH50161
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50160
AC   CVCL_UX38
DR   NHCDR; NH50160
DR   Wikidata; Q98127587
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX37 ! NH50159
OI   CVCL_UX39 ! NH50161
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50161
AC   CVCL_UX39
DR   NHCDR; NH50161
DR   Wikidata; Q98127588
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX37 ! NH50159
OI   CVCL_UX38 ! NH50160
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50162
AC   CVCL_UX40
DR   NHCDR; NH50162
DR   Wikidata; Q98127589
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FA00 ! TALSCTRL15.12
OI   CVCL_UX41 ! NH50163
OI   CVCL_YP76 ! NH50286
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   NH50163
AC   CVCL_UX41
DR   NHCDR; NH50163
DR   Wikidata; Q98127590
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FA00 ! TALSCTRL15.12
OI   CVCL_UX40 ! NH50162
OI   CVCL_YP76 ! NH50286
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   NH50164
AC   CVCL_UX42
DR   NHCDR; NH50164
DR   Wikidata; Q98127591
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=NH50164).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50165
AC   CVCL_UX19
DR   NHCDR; NH50165
DR   Wikidata; Q98127593
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Gly389Arg (c.1165G>A) (G706R, c.2116G>A); ClinVar=VCV000014255; Zygosity=Unspecified (NHCDR=NH50165).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX17 ! NH50110
OI   CVCL_UX18 ! NH50111
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50166
AC   CVCL_UX15
DR   NHCDR; NH50166
DR   Wikidata; Q98127594
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ser305Ile (c.914G>T) (S622I, c.1865G>T or S640I, c.1919G>T); ClinVar=VCV001256161; Zygosity=Unspecified (NHCDR=NH50166).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX14 ! NH50115
OI   CVCL_UX16 ! NH50167
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50167
AC   CVCL_UX16
DR   NHCDR; NH50167
DR   Wikidata; Q98127596
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ser305Ile (c.914G>T) (S622I, c.1865G>T or S640I, c.1919G>T); ClinVar=VCV001256161; Zygosity=Unspecified (NHCDR=NH50167).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX14 ! NH50115
OI   CVCL_UX15 ! NH50166
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   NH50168
AC   CVCL_UX11
DR   NHCDR; NH50168
DR   Wikidata; Q98127598
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ser305Asn (c.914G>A) (S622N, c.1865G>A or S640N, c.1919G>A); ClinVar=VCV000014254; Zygosity=Unspecified (NHCDR=NH50168).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX12 ! NH50169
OI   CVCL_UX13 ! NH50170
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   NH50169
AC   CVCL_UX12
DR   NHCDR; NH50169
DR   Wikidata; Q98127600
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ser305Asn (c.914G>A) (S622N, c.1865G>A or S640N, c.1919G>A); ClinVar=VCV000014254; Zygosity=Unspecified (NHCDR=NH50169).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX11 ! NH50168
OI   CVCL_UX13 ! NH50170
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   NH50170
AC   CVCL_UX13
DR   NHCDR; NH50170
DR   Wikidata; Q98127602
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Ser305Asn (c.914G>A) (S622N, c.1865G>A or S640N, c.1919G>A); ClinVar=VCV000014254; Zygosity=Unspecified (NHCDR=NH50170).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX11 ! NH50168
OI   CVCL_UX12 ! NH50169
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   NH50171
AC   CVCL_UX08
DR   NHCDR; NH50171
DR   Wikidata; Q98127605
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=NH50171).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX09 ! NH50172
OI   CVCL_UX10 ! NH50173
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   NH50172
AC   CVCL_UX09
DR   NHCDR; NH50172
DR   Wikidata; Q98127607
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=NH50172).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX08 ! NH50171
OI   CVCL_UX10 ! NH50173
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50173
AC   CVCL_UX10
DR   NHCDR; NH50173
DR   Wikidata; Q98127610
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=NH50173).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX08 ! NH50171
OI   CVCL_UX09 ! NH50172
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50174
AC   CVCL_UX05
DR   NHCDR; NH50174
DR   Wikidata; Q98127612
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Unspecified (NHCDR=NH50174).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX06 ! NH50175
OI   CVCL_UX07 ! NH50176
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 12
//
ID   NH50175
AC   CVCL_UX06
DR   NHCDR; NH50175
DR   Wikidata; Q98127613
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Unspecified (NHCDR=NH50175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX05 ! NH50174
OI   CVCL_UX07 ! NH50176
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 12
//
ID   NH50176
AC   CVCL_UX07
DR   NHCDR; NH50176
DR   Wikidata; Q98127615
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Arg798Trp (c.2392C>T) (p.Arg406Trp, c.1216C>T or p.Arg723Trp, c.2167C>T); ClinVar=VCV000014247; Zygosity=Unspecified (NHCDR=NH50176).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX05 ! NH50174
OI   CVCL_UX06 ! NH50175
SX   Male
AG   70-79Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 12
//
ID   NH50177
AC   CVCL_UX04
DR   NHCDR; NH50177
DR   Wikidata; Q98127616
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous (NHCDR=NH50177).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX02 ! NH50119
OI   CVCL_UX03 ! NH50120
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   NH50178
AC   CVCL_UX00
DR   NHCDR; NH50178
DR   Wikidata; Q98127617
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=NH50178).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX01 ! NH50179
OI   CVCL_YP75 ! NH50210
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   NH50179
AC   CVCL_UX01
DR   NHCDR; NH50179
DR   Wikidata; Q98127618
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=NH50179).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX00 ! NH50178
OI   CVCL_YP75 ! NH50210
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   NH50180
AC   CVCL_UW95
DR   NHCDR; NH50180
DR   Wikidata; Q98127619
CC   Population: Pacific.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NH50181
AC   CVCL_UW96
DR   NHCDR; NH50181
DR   Wikidata; Q98127620
CC   Population: Southeast Asian; Filipino and Hispanic.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   NH50182
AC   CVCL_UW86
DR   NHCDR; NH50182
DR   Wikidata; Q98127621
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (NHCDR=NH50182).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY99 ! ND34263
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50183
AC   CVCL_UW87
DR   NHCDR; NH50183
DR   Wikidata; Q98127622
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (NHCDR=NH50183).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY99 ! ND34263
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50184
AC   CVCL_UX43
DR   NHCDR; NH50184
DR   Wikidata; Q98127624
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (NHCDR=NH50184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T855 ! ND39027
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   NH50185
AC   CVCL_UX44
DR   NHCDR; NH50185
DR   Wikidata; Q98127626
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (NHCDR=NH50185).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T855 ! ND39027
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   NH50186
AC   CVCL_UW88
DR   NHCDR; NH50186
DR   Wikidata; Q98127627
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous; Note=By CRISPR/Cas9 (NHCDR=NH50186).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UW86 ! NH50182
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50187
AC   CVCL_UW89
DR   NHCDR; NH50187
DR   Wikidata; Q98127628
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (NHCDR=NH50187).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50187).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UW86 ! NH50182
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50188
AC   CVCL_UW90
DR   NHCDR; NH50188
DR   Wikidata; Q98127629
CC   Population: Caucasian.
CC   Characteristics: Non-edited control for NH50186 (Cellosaurus=CVCL_UW88) and NH50187 (Cellosaurus=CVCL_UW89).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (NHCDR=NH50188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UW86 ! NH50182
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   NH50189
AC   CVCL_UW91
DR   NHCDR; NH50189
DR   Wikidata; Q98127630
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50189).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX26 ! ND50051
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50190
AC   CVCL_UW92
DR   NHCDR; NH50190
DR   Wikidata; Q98127631
CC   Population: Caucasian.
CC   Characteristics: Non-edited control for NH50189 (Cellosaurus=CVCL_UW91).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=NH50190).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QX26 ! ND50051
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   NH50191
AC   CVCL_UX45
DR   NHCDR; NH50191
DR   Wikidata; Q98127632
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL65 ! LiPSC-GR1.1
OI   CVCL_RL66 ! LiPSC-GR1.2
OI   CVCL_RH35 ! ND50038
OI   CVCL_RH36 ! ND50039
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   NH50192
AC   CVCL_YP42
DR   NHCDR; NH50192
DR   Wikidata; Q98127633
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (NHCDR=NH50192).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T855 ! ND39027
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   NH50193
AC   CVCL_YP41
DR   NHCDR; NH50193
DR   Wikidata; Q98127634
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50194
AC   CVCL_YP40
DR   NHCDR; NH50194
DR   Wikidata; Q98127635
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=NH50194).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=NH50194).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50195
AC   CVCL_YP39
DR   NHCDR; NH50195
DR   Wikidata; Q98127637
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50196
AC   CVCL_YP38
DR   NHCDR; NH50196
DR   Wikidata; Q98127639
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50196).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50197
AC   CVCL_YP37
DR   NHCDR; NH50197
DR   Wikidata; Q98127640
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with autosomal dominant torsion dystonia 1 but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50198
AC   CVCL_YP36
DR   NHCDR; NH50198
DR   Wikidata; Q98127642
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9438; PRKRA; Simple; p.Cys213Arg (c.637T>C); ClinVar=VCV000689778; Zygosity=Heterozygous (NHCDR=NH50198).
CC   Sequence variation: Mutation; HGNC; HGNC:9438; PRKRA; Simple; p.Pro222Leu (c.665C>T); ClinVar=VCV000006346; Zygosity=Heterozygous (NHCDR=NH50198).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168729; Dystonia 16
DI   ORDO; Orphanet_210571; Dystonia 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50199
AC   CVCL_YP35
DR   NHCDR; NH50199
DR   Wikidata; Q98127643
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50199).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50200
AC   CVCL_YP77
DR   NHCDR; NH50200
DR   Wikidata; Q98127644
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=NH50200).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=NH50200).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50201
AC   CVCL_YP78
DR   NHCDR; NH50201
DR   Wikidata; Q98127646
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50202
AC   CVCL_YP79
DR   NHCDR; NH50202
DR   Wikidata; Q98127647
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50203
AC   CVCL_YP80
DR   NHCDR; NH50203
DR   Wikidata; Q98127648
CC   Population: African American.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50204
AC   CVCL_YP81
DR   NHCDR; NH50204
DR   Wikidata; Q98127650
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50204).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50205
AC   CVCL_YP82
DR   NHCDR; NH50205
DR   Wikidata; Q98127652
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50206
AC   CVCL_YP83
DR   NHCDR; NH50206
DR   Wikidata; Q98127653
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50206).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50207
AC   CVCL_YP84
DR   NHCDR; NH50207
DR   Wikidata; Q98127654
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50208
AC   CVCL_YP85
DR   NHCDR; NH50208
DR   Wikidata; Q98127655
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50209
AC   CVCL_YP86
DR   NHCDR; NH50209
DR   Wikidata; Q98127656
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50210
AC   CVCL_YP75
DR   NHCDR; NH50210
DR   Wikidata; Q98127657
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Unspecified (NHCDR=NH50210).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX00 ! NH50178
OI   CVCL_UX01 ! NH50179
SX   Female
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   NH50211
AC   CVCL_YP87
DR   NHCDR; NH50211
DR   Wikidata; Q98127658
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Heterozygous (NHCDR=NH50211).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ53 ! ND40077
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50212
AC   CVCL_YP88
DR   NHCDR; NH50212
DR   Wikidata; Q98127659
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Heterozygous (NHCDR=NH50212).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ53 ! ND40077
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50213
AC   CVCL_YP89
DR   NHCDR; NH50213
DR   Wikidata; Q98127660
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Heterozygous (NHCDR=NH50213).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ53 ! ND40077
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50214
AC   CVCL_YP94
DR   NHCDR; NH50214
DR   Wikidata; Q98127661
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly298Ser (c.892G>A); ClinVar=VCV000005232; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY82 ! ND32947
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50215
AC   CVCL_YP95
DR   NHCDR; NH50215
DR   Wikidata; Q98127663
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly298Ser (c.892G>A); ClinVar=VCV000005232; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY82 ! ND32947
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50216
AC   CVCL_YP96
DR   NHCDR; NH50216
DR   Wikidata; Q98127665
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly298Ser (c.892G>A); ClinVar=VCV000005232; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY82 ! ND32947
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50217
AC   CVCL_YP97
DR   NHCDR; NH50217
DR   Wikidata; Q98127666
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous (NHCDR=NH50217).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ64 ! ND41003
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50218
AC   CVCL_YP98
DR   NHCDR; NH50218
DR   Wikidata; Q98127667
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous (NHCDR=NH50218).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ64 ! ND41003
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50219
AC   CVCL_YP99
DR   NHCDR; NH50219
DR   Wikidata; Q98127668
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous (NHCDR=NH50219).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ64 ! ND41003
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50220
AC   CVCL_YQ00
DR   NHCDR; NH50220
DR   Wikidata; Q98127669
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (NHCDR=NH50220).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ01 ! NH50221
OI   CVCL_YQ02 ! NH50222
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50221
AC   CVCL_YQ01
DR   NHCDR; NH50221
DR   Wikidata; Q98127670
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (NHCDR=NH50221).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ00 ! NH50220
OI   CVCL_YQ02 ! NH50222
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50222
AC   CVCL_YQ02
DR   NHCDR; NH50222
DR   Wikidata; Q98127671
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg493Ter (c.1477C>T); ClinVar=VCV000016014; Zygosity=Unspecified (NHCDR=NH50222).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ00 ! NH50220
OI   CVCL_YQ01 ! NH50221
SX   Male
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50223
AC   CVCL_YQ15
DR   NHCDR; NH50223
DR   Wikidata; Q98127672
CC   Population: Pacific.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50224
AC   CVCL_YQ16
DR   NHCDR; NH50224
DR   Wikidata; Q98127673
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50225
AC   CVCL_YQ17
DR   NHCDR; NH50225
DR   Wikidata; Q98127675
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50226
AC   CVCL_A9SF
DR   NHCDR; NH50226
DR   Wikidata; Q102114600
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NH50227
AC   CVCL_YQ18
DR   NHCDR; NH50227
DR   Wikidata; Q98127677
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50228
AC   CVCL_YQ19
DR   NHCDR; NH50228
DR   Wikidata; Q98127678
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50229
AC   CVCL_YQ20
DR   NHCDR; NH50229
DR   Wikidata; Q98127679
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg418Ter (c.1252C>T); ClinVar=VCV000098177; Zygosity=Unspecified (NHCDR=NH50229).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ21 ! NH50230
OI   CVCL_YQ22 ! NH50231
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50230
AC   CVCL_YQ21
DR   NHCDR; NH50230
DR   Wikidata; Q98127680
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg418Ter (c.1252C>T); ClinVar=VCV000098177; Zygosity=Unspecified (NHCDR=NH50230).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ20 ! NH50229
OI   CVCL_YQ22 ! NH50231
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50231
AC   CVCL_YQ22
DR   NHCDR; NH50231
DR   Wikidata; Q98127681
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg418Ter (c.1252C>T); ClinVar=VCV000098177; Zygosity=Unspecified (NHCDR=NH50231).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ20 ! NH50229
OI   CVCL_YQ21 ! NH50230
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50232
AC   CVCL_YQ23
DR   NHCDR; NH50232
DR   Wikidata; Q98127683
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (NHCDR=NH50232).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Heterozygous (NHCDR=NH50232).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD47 ! ND30171
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50233
AC   CVCL_YQ24
DR   NHCDR; NH50233
DR   Wikidata; Q98127684
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (NHCDR=NH50233).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Heterozygous (NHCDR=NH50233).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD47 ! ND30171
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50234
AC   CVCL_YQ25
DR   NHCDR; NH50234
DR   Wikidata; Q98127685
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (NHCDR=NH50234).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Heterozygous (NHCDR=NH50234).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD47 ! ND30171
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   NH50235
AC   CVCL_YQ26
DR   NHCDR; NH50235
DR   Wikidata; Q98127687
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50236
AC   CVCL_YQ27
DR   NHCDR; NH50236
DR   Wikidata; Q98127688
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50236).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50237
AC   CVCL_YQ28
DR   NHCDR; NH50237
DR   Wikidata; Q98127689
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50238
AC   CVCL_YQ29
DR   NHCDR; NH50238
DR   Wikidata; Q98127690
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50239
AC   CVCL_YQ30
DR   NHCDR; NH50239
DR   Wikidata; Q98127691
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50239).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50240
AC   CVCL_YQ31
DR   NHCDR; NH50240
DR   Wikidata; Q98127693
CC   Population: Southeast Asian; Filipino and Hispanic.
CC   Donor information: At sampling donor was not affected with X-linked dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   NH50241
AC   CVCL_YQ32
DR   NHCDR; NH50241
DR   Wikidata; Q98127694
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=NH50241).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=NH50241).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50242
AC   CVCL_YQ33
DR   NHCDR; NH50242
DR   Wikidata; Q98127695
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50242).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50243
AC   CVCL_YQ34
DR   NHCDR; NH50243
DR   Wikidata; Q98127696
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with autosomal dominant torsion dystonia 1 but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50244
AC   CVCL_YQ35
DR   NHCDR; NH50244
DR   Wikidata; Q98127697
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50245
AC   CVCL_YQ36
DR   NHCDR; NH50245
DR   Wikidata; Q98127699
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50246
AC   CVCL_YQ37
DR   NHCDR; NH50246
DR   Wikidata; Q98127700
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50247
AC   CVCL_YQ38
DR   NHCDR; NH50247
DR   Wikidata; Q98127702
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50248
AC   CVCL_YQ39
DR   NHCDR; NH50248
DR   Wikidata; Q98127703
CC   Population: Caucasian; Scottish and Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50249
AC   CVCL_YQ40
DR   NHCDR; NH50249
DR   Wikidata; Q98127704
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50250
AC   CVCL_YQ41
DR   NHCDR; NH50250
DR   Wikidata; Q98127706
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50250).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50251
AC   CVCL_YQ42
DR   NHCDR; NH50251
DR   Wikidata; Q98127707
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; 48-bp intronic deletion; Zygosity=Hemizygous (NHCDR=NH50251).
CC   Sequence variation: Mutation; HGNC; HGNC:11535; TAF1; Unexplicit; SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 32; ClinVar=VCV000009862; Zygosity=Hemizygous (NHCDR=NH50251).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50252
AC   CVCL_YQ43
DR   NHCDR; NH50252
DR   Wikidata; Q98127708
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with X-linked dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50253
AC   CVCL_YQ44
DR   NHCDR; NH50253
DR   Wikidata; Q98127709
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (NHCDR=NH50253).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50254
AC   CVCL_YQ45
DR   NHCDR; NH50254
DR   Wikidata; Q98127710
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with autosomal dominant torsion dystonia 1 but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50255
AC   CVCL_YQ46
DR   NHCDR; NH50255
DR   Wikidata; Q98127711
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with X-linked dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50256
AC   CVCL_YP43
DR   NHCDR; NH50256
DR   Wikidata; Q98127713
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[1150] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50256).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP44 ! NH50257
OI   CVCL_YP45 ! NH50259
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50257
AC   CVCL_YP44
DR   NHCDR; NH50257
DR   Wikidata; Q98127714
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[1150] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50257).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP43 ! NH50256
OI   CVCL_YP45 ! NH50259
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50258
AC   CVCL_YT72
DR   NHCDR; NH50258
DR   Wikidata; Q98127716
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)54 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Hemizygous (NHCDR=NH50258).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   NH50259
AC   CVCL_YP45
DR   NHCDR; NH50259
DR   Wikidata; Q98127717
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[1150] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (NHCDR=NH50259).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YP43 ! NH50256
OI   CVCL_YP44 ! NH50257
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50260
AC   CVCL_YT73
DR   NHCDR; NH50260
DR   Wikidata; Q98127718
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT74 ! NH50261
OI   CVCL_YT75 ! NH50262
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50261
AC   CVCL_YT74
DR   NHCDR; NH50261
DR   Wikidata; Q98127719
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT73 ! NH50260
OI   CVCL_YT75 ! NH50262
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50262
AC   CVCL_YT75
DR   NHCDR; NH50262
DR   Wikidata; Q98127721
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT73 ! NH50260
OI   CVCL_YT74 ! NH50261
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50263
AC   CVCL_YT76
DR   NHCDR; NH50263
DR   Wikidata; Q98127722
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT77 ! NH50264
OI   CVCL_YT78 ! NH50265
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50264
AC   CVCL_YT77
DR   NHCDR; NH50264
DR   Wikidata; Q98127723
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT76 ! NH50263
OI   CVCL_YT78 ! NH50265
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50265
AC   CVCL_YT78
DR   NHCDR; NH50265
DR   Wikidata; Q98127726
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT76 ! NH50263
OI   CVCL_YT77 ! NH50264
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50266
AC   CVCL_YT79
DR   NHCDR; NH50266
DR   Wikidata; Q98127727
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT80 ! NH50267
OI   CVCL_YT81 ! NH50268
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50267
AC   CVCL_YT80
DR   NHCDR; NH50267
DR   Wikidata; Q98127728
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT79 ! NH50266
OI   CVCL_YT81 ! NH50268
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50268
AC   CVCL_YT81
DR   NHCDR; NH50268
DR   Wikidata; Q98127729
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT79 ! NH50266
OI   CVCL_YT80 ! NH50267
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50269
AC   CVCL_YT82
DR   NHCDR; NH50269
DR   Wikidata; Q98127730
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT83 ! NH50270
OI   CVCL_YT84 ! NH50271
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50270
AC   CVCL_YT83
DR   NHCDR; NH50270
DR   Wikidata; Q98127731
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT82 ! NH50269
OI   CVCL_YT84 ! NH50271
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50271
AC   CVCL_YT84
DR   NHCDR; NH50271
DR   Wikidata; Q98127732
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT82 ! NH50269
OI   CVCL_YT83 ! NH50270
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50272
AC   CVCL_YT85
DR   NHCDR; NH50272
DR   Wikidata; Q98127733
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT86 ! NH50273
OI   CVCL_YT87 ! NH50274
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50273
AC   CVCL_YT86
DR   NHCDR; NH50273
DR   Wikidata; Q98127734
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT85 ! NH50272
OI   CVCL_YT87 ! NH50274
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50274
AC   CVCL_YT87
DR   NHCDR; NH50274
DR   Wikidata; Q98127735
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT85 ! NH50272
OI   CVCL_YT86 ! NH50273
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50275
AC   CVCL_YT88
DR   NHCDR; NH50275
DR   Wikidata; Q98127736
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E71 ! NCRM-1
OI   CVCL_YT89 ! NH50285
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   NH50276
AC   CVCL_YT90
DR   NHCDR; NH50276
DR   Wikidata; Q98127738
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EZ99 ! TALSCTRL11.5
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50277
AC   CVCL_YT91
DR   NHCDR; NH50277
DR   Wikidata; Q98127739
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with torsion dystonia 6 but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156361; Torsion dystonia 6
DI   ORDO; Orphanet_98806; Primary dystonia, DYT6 type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50278
AC   CVCL_YT92
DR   NHCDR; NH50278
DR   Wikidata; Q98127740
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50279
AC   CVCL_YT93
DR   NHCDR; NH50279
DR   Wikidata; Q98127741
CC   Population: Caucasian; Scottish and Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50280
AC   CVCL_YT94
DR   NHCDR; NH50280
DR   Wikidata; Q98127743
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50281
AC   CVCL_YT95
SY   CAR3
DR   NHCDR; NH50281
DR   Wikidata; Q98127744
RX   PubMed=26677768;
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu73Metfs*26 (c.217_218delGA); ClinVar=VCV000569567; Zygosity=Heterozygous (PubMed=26677768).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   NH50282
AC   CVCL_YT96
SY   Q1SA
DR   GEO; GSM1847138
DR   GEO; GSM1847139
DR   NHCDR; NH50282
DR   Wikidata; Q98127745
RX   PubMed=26677768;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu522Ilefs (c.1564_1565delGA) (1563_1564delAG); ClinVar=VCV000127340; Zygosity=Heterozygous (PubMed=26677768).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser2394Leu (c.7181C>T); ClinVar=VCV000127437; Zygosity=Heterozygous (PubMed=26677768).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   NH50283
AC   CVCL_YT97
SY   Q3SA
DR   GEO; GSM1847140
DR   GEO; GSM1847141
DR   NHCDR; NH50283
DR   Wikidata; Q98127746
RX   PubMed=26677768;
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Glu73Metfs*26 (c.217_218delGA); ClinVar=VCV000569567; Zygosity=Heterozygous (PubMed=26677768).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2598Ter (c.7792C>T); ClinVar=VCV000265383; Zygosity=Heterozygous (PubMed=26677768).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT98 ! NH50284
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   NH50284
AC   CVCL_YT98
SY   Q3SC
DR   GEO; GSM1847142
DR   GEO; GSM1847143
DR   NHCDR; NH50284
DR   Wikidata; Q98127747
RX   PubMed=26677768;
CC   Population: Asian.
CC   Characteristics: The ATM p.Glu73Metfs*26 (c.217_218delGA) present in the patient and in another iPSC from the same individual has been lost during the reprogramming process.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Arg2598Ter (c.7792C>T); ClinVar=VCV000265383; Zygosity=Heterozygous (PubMed=26677768).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT97 ! NH50283
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   NH50285
AC   CVCL_YT89
DR   NHCDR; NH50285
DR   Wikidata; Q98127749
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E71 ! NCRM-1
OI   CVCL_YT88 ! NH50275
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   NH50286
AC   CVCL_YP76
DR   NHCDR; NH50286
DR   Wikidata; Q98127750
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_FA00 ! TALSCTRL15.12
OI   CVCL_UX40 ! NH50162
OI   CVCL_UX41 ! NH50163
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   NH50287
AC   CVCL_YT99
DR   NHCDR; NH50287
DR   Wikidata; Q98127751
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50288
AC   CVCL_YU00
DR   NHCDR; NH50288
DR   Wikidata; Q98127752
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NH50289
AC   CVCL_YU01
DR   NHCDR; NH50289
DR   Wikidata; Q98127753
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg245Lys (c.734G>A); Zygosity=Heterozygous (NHCDR=NH50289).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Gly430Asp (c.1289G>A); ClinVar=VCV000356016; Zygosity=Heterozygous (NHCDR=NH50289).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NH50290
AC   CVCL_YU02
DR   NHCDR; NH50290
DR   Wikidata; Q98127754
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Heterozygous (NHCDR=NH50290).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_corrected; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50290).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP42 ! NH50192
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50291
AC   CVCL_YU03
DR   NHCDR; NH50291
DR   Wikidata; Q98127755
CC   Population: Cape Verdian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_corrected; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous; Note=By CRISPR/Cas9 (NHCDR=NH50291).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP42 ! NH50192
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50292
AC   CVCL_YU04
DR   NHCDR; NH50292
DR   Wikidata; Q98127756
CC   Population: Cape Verdian.
CC   Characteristics: Non-edited control for NH50290 (Cellosaurus=CVCL_YU02) and NH50291 (Cellosaurus=CVCL_YU03).
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.His517Gln (c.1551C>G); ClinVar=VCV000016221; Zygosity=Homozygous (NHCDR=NH50292).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP42 ! NH50192
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   NH50293
AC   CVCL_A9RN
DR   NHCDR; NH50293
DR   Wikidata; Q102114602
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ala9Asp (c.26C>A); ClinVar=VCV000016013; Zygosity=Heterozygous (NHCDR=NH50293).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   NH50294
AC   CVCL_A9RP
DR   NHCDR; NH50294
DR   Wikidata; Q102114604
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NH50295
AC   CVCL_A9RQ
DR   NHCDR; NH50295
DR   Wikidata; Q102114605
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NH50296
AC   CVCL_A9RR
DR   NHCDR; NH50296
DR   Wikidata; Q102114607
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NH50297
AC   CVCL_A9RS
DR   NHCDR; NH50297
DR   Wikidata; Q102114608
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RT ! NH50298
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NH50298
AC   CVCL_A9RT
DR   NHCDR; NH50298
DR   Wikidata; Q102114610
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RS ! NH50297
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NH50299
AC   CVCL_A9RU
DR   NHCDR; NH50299
DR   Wikidata; Q102114612
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RV ! NH50300
OI   CVCL_A9RW ! NH50301
SX   Female
AG   69Y3M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   NH50300
AC   CVCL_A9RV
DR   NHCDR; NH50300
DR   Wikidata; Q102114613
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RU ! NH50299
OI   CVCL_A9RW ! NH50301
SX   Female
AG   69Y3M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   NH50301
AC   CVCL_A9RW
DR   NHCDR; NH50301
DR   Wikidata; Q102114615
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RU ! NH50299
OI   CVCL_A9RV ! NH50300
SX   Female
AG   69Y3M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   NH50302
AC   CVCL_A9RX
DR   NHCDR; NH50302
DR   Wikidata; Q102114617
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RY ! NH50303
OI   CVCL_A9RZ ! NH50304
SX   Male
AG   58Y9M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   NH50303
AC   CVCL_A9RY
DR   NHCDR; NH50303
DR   Wikidata; Q102114618
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RX ! NH50302
OI   CVCL_A9RZ ! NH50304
SX   Male
AG   58Y9M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   NH50304
AC   CVCL_A9RZ
DR   NHCDR; NH50304
DR   Wikidata; Q102114619
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9RX ! NH50302
OI   CVCL_A9RY ! NH50303
SX   Male
AG   58Y9M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   NH50305
AC   CVCL_A9S0
DR   NHCDR; NH50305
DR   Wikidata; Q102114620
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_corrected; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50305).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP97 ! NH50217
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   NH50306
AC   CVCL_A9S1
DR   NHCDR; NH50306
DR   Wikidata; Q102114622
CC   Population: Caucasian; Italian.
CC   Characteristics: Non-edited control for NH50305 (Cellosaurus=CVCL_A9S0).
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous (NHCDR=NH50306).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YP97 ! NH50217
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   NH50307
AC   CVCL_A9S2
DR   NHCDR; NH50307
DR   Wikidata; Q102114623
CC   Population: Asian.
CC   Donor information: At sampling donor was not affected with dystonia but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34563; Dystonia
DI   ORDO; Orphanet_68363; Rare dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NH50308
AC   CVCL_A4NB
DR   NHCDR; NH50308
DR   Wikidata; Q105510334
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NC ! NH50309
OI   CVCL_A4ND ! NH50310
SX   Female
AG   71Y6M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50309
AC   CVCL_A4NC
DR   NHCDR; NH50309
DR   Wikidata; Q105510337
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NB ! NH50308
OI   CVCL_A4ND ! NH50310
SX   Female
AG   71Y6M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50310
AC   CVCL_A4ND
DR   NHCDR; NH50310
DR   Wikidata; Q105510340
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NB ! NH50308
OI   CVCL_A4NC ! NH50309
SX   Female
AG   71Y6M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50311
AC   CVCL_A4NE
DR   NHCDR; NH50311
DR   Wikidata; Q105510343
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NF ! NH50312
OI   CVCL_A4NG ! NH50313
SX   Male
AG   72Y9M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50312
AC   CVCL_A4NF
DR   NHCDR; NH50312
DR   Wikidata; Q105510347
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NE ! NH50311
OI   CVCL_A4NG ! NH50313
SX   Male
AG   72Y9M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50313
AC   CVCL_A4NG
DR   NHCDR; NH50313
DR   Wikidata; Q105510350
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NE ! NH50311
OI   CVCL_A4NF ! NH50312
SX   Male
AG   72Y9M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50314
AC   CVCL_A4NH
DR   NHCDR; NH50314
DR   Wikidata; Q105510355
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NI ! NH50315
OI   CVCL_A4NJ ! NH50316
SX   Male
AG   82Y1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50315
AC   CVCL_A4NI
DR   NHCDR; NH50315
DR   Wikidata; Q105510359
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NH ! NH50314
OI   CVCL_A4NJ ! NH50316
SX   Male
AG   82Y1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50316
AC   CVCL_A4NJ
DR   NHCDR; NH50316
DR   Wikidata; Q105510362
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NH ! NH50314
OI   CVCL_A4NI ! NH50315
SX   Male
AG   82Y1M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50317
AC   CVCL_A4NK
DR   NHCDR; NH50317
DR   Wikidata; Q105510366
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y8M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   NH50318
AC   CVCL_A4NL
DR   NHCDR; NH50318
DR   Wikidata; Q105510368
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y6M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   NH50319
AC   CVCL_A4NM
DR   NHCDR; NH50319
DR   Wikidata; Q105510371
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y8M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   NH50320
AC   CVCL_A4NN
DR   NHCDR; NH50320
DR   Wikidata; Q105510373
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NP ! NH50321
SX   Female
AG   63Y3M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50321
AC   CVCL_A4NP
DR   NHCDR; NH50321
DR   Wikidata; Q105510375
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NN ! NH50320
SX   Female
AG   63Y3M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NH50322
AC   CVCL_B6HF
DR   NHCDR; NH50322
DR   Wikidata; Q112129417
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y4M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   NH50323
AC   CVCL_B6HG
DR   NHCDR; NH50323
DR   Wikidata; Q112129418
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   NH50324
AC   CVCL_B6HH
DR   NHCDR; NH50324
DR   Wikidata; Q112129419
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y5M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   NH50325
AC   CVCL_B6HI
DR   NHCDR; NH50325
DR   Wikidata; Q112129420
CC   Population: Caucasian.
CC   Characteristics: Non-edited control for NH50326 (Cellosaurus=CVCL_B6HJ).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous (NHCDR=NH50325).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UX04 ! NH50177
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   NH50326
AC   CVCL_B6HJ
DR   NHCDR; NH50326
DR   Wikidata; Q112129421
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50326).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UX04 ! NH50177
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   NH50327
AC   CVCL_B6HK
DR   NHCDR; NH50327
DR   Wikidata; Q112129422
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple_corrected; p.Ala9Asp (c.26C>A); ClinVar=VCV000016013; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50327).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9RN ! NH50293
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   NH50328
AC   CVCL_B6HL
DR   NHCDR; NH50328
DR   Wikidata; Q112129423
CC   Population: Caucasian.
CC   Characteristics: Non-edited control for NH50327 (Cellosaurus=CVCL_B6HK).
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ala9Asp (c.26C>A); ClinVar=VCV000016013; Zygosity=Heterozygous (NHCDR=NH50328).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9RN ! NH50293
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   NH50329
AC   CVCL_B6HM
DR   NHCDR; NH50329
DR   Wikidata; Q112129424
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion_corrected; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50329).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W577 ! ND36999
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   NH50330
AC   CVCL_B6HP
DR   NHCDR; NH50330
DR   Wikidata; Q112129425
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6HQ ! NH50331
OI   CVCL_B6HR ! NH50332
SX   Female
AG   82Y3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50331
AC   CVCL_B6HQ
DR   NHCDR; NH50331
DR   Wikidata; Q112129426
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6HP ! NH50330
OI   CVCL_B6HR ! NH50332
SX   Female
AG   82Y3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50332
AC   CVCL_B6HR
DR   NHCDR; NH50332
DR   Wikidata; Q112129427
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6HP ! NH50330
OI   CVCL_B6HQ ! NH50331
SX   Female
AG   82Y3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50333
AC   CVCL_B6HS
DR   NHCDR; NH50333
DR   Wikidata; Q112129428
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6HT ! NH50334
OI   CVCL_B6HU ! NH50335
SX   Female
AG   73Y6M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50334
AC   CVCL_B6HT
DR   NHCDR; NH50334
DR   Wikidata; Q112129429
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6HS ! NH50333
OI   CVCL_B6HU ! NH50335
SX   Female
AG   73Y6M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50335
AC   CVCL_B6HU
DR   NHCDR; NH50335
DR   Wikidata; Q112129430
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84826; Lewy body dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6HS ! NH50333
OI   CVCL_B6HT ! NH50334
SX   Female
AG   73Y6M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50336
AC   CVCL_B6HV
DR   NHCDR; NH50336
DR   Wikidata; Q112129431
CC   Population: Caucasian.
CC   Characteristics: Non-edited control for NH50337 (Cellosaurus=CVCL_B6HW).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (NHCDR=NH50336).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UX23 ! NH50116
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   NH50337
AC   CVCL_B6HW
DR   NHCDR; NH50337
DR   Wikidata; Q112129432
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50337).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C217087; Frontotemporal dementia-1
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UX23 ! NH50116
SX   Male
AG   40-49Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   NH50338
AC   CVCL_B6HX
DR   NHCDR; NH50338
DR   Wikidata; Q112129433
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EZ43 ! ND40065
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50339
AC   CVCL_B6HY
DR   NHCDR; NH50339
DR   Wikidata; Q112129434
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NH50340
AC   CVCL_B6HZ
DR   NHCDR; NH50340
DR   Wikidata; Q112129435
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   NH50341
AC   CVCL_B6I0
DR   NHCDR; NH50341
DR   Wikidata; Q112129436
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   NH50342
AC   CVCL_B6I1
DR   NHCDR; NH50342
DR   Wikidata; Q112129437
CC   Population: Southeast Asian; Filipino.
CC   Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126330; X-linked dystonia parkinsonism
DI   ORDO; Orphanet_53351; X-linked dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   NH50343
AC   CVCL_B6I2
DR   NHCDR; NH50343
DR   Wikidata; Q112129438
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y9M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   NH50344
AC   CVCL_B6I3
DR   NHCDR; NH50344
DR   Wikidata; Q112129439
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   NH50345
AC   CVCL_B6I4
DR   NHCDR; NH50345
DR   Wikidata; Q112129440
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=NH50345).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6I5 ! NH50346
OI   CVCL_B6I6 ! NH50347
SX   Male
AG   55Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50346
AC   CVCL_B6I5
DR   NHCDR; NH50346
DR   Wikidata; Q112129441
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=NH50346).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6I4 ! NH50345
OI   CVCL_B6I6 ! NH50347
SX   Male
AG   55Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50347
AC   CVCL_B6I6
DR   NHCDR; NH50347
DR   Wikidata; Q112129442
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=NH50347).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6I4 ! NH50345
OI   CVCL_B6I5 ! NH50346
SX   Male
AG   55Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50348
AC   CVCL_B6I7
DR   NHCDR; NH50348
DR   Wikidata; Q112129443
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (NHCDR=NH50348).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6I8 ! NH50349
OI   CVCL_B6I9 ! NH50350
SX   Female
AG   67Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50349
AC   CVCL_B6I8
DR   NHCDR; NH50349
DR   Wikidata; Q112129444
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (NHCDR=NH50349).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6I7 ! NH50348
OI   CVCL_B6I9 ! NH50350
SX   Female
AG   67Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50350
AC   CVCL_B6I9
DR   NHCDR; NH50350
DR   Wikidata; Q112129445
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (NHCDR=NH50350).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6I7 ! NH50348
OI   CVCL_B6I8 ! NH50349
SX   Female
AG   67Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50351
AC   CVCL_B6IA
DR   NHCDR; NH50351
DR   Wikidata; Q112129446
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6IB ! NH50352
OI   CVCL_B6IC ! NH50353
SX   Female
AG   62Y3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   NH50352
AC   CVCL_B6IB
DR   NHCDR; NH50352
DR   Wikidata; Q112129447
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6IA ! NH50351
OI   CVCL_B6IC ! NH50353
SX   Female
AG   62Y3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   NH50353
AC   CVCL_B6IC
DR   NHCDR; NH50353
DR   Wikidata; Q112129448
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6IA ! NH50351
OI   CVCL_B6IB ! NH50352
SX   Female
AG   62Y3M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   NH50354
AC   CVCL_B6ID
DR   NHCDR; NH50354
DR   Wikidata; Q112129449
CC   Population: Asian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6IE ! NH50355
OI   CVCL_B6IF ! NH50356
SX   Male
AG   67Y9M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   NH50355
AC   CVCL_B6IE
DR   NHCDR; NH50355
DR   Wikidata; Q112129450
CC   Population: Asian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6ID ! NH50354
OI   CVCL_B6IF ! NH50356
SX   Male
AG   67Y9M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   NH50356
AC   CVCL_B6IF
DR   NHCDR; NH50356
DR   Wikidata; Q112129452
CC   Population: Asian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6ID ! NH50354
OI   CVCL_B6IE ! NH50355
SX   Male
AG   67Y9M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   NH50357
AC   CVCL_B6IG
DR   NHCDR; NH50357
DR   Wikidata; Q112129453
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=NH50357).
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6IH ! NH50358
SX   Male
AG   81Y5M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   NH50358
AC   CVCL_B6IH
DR   NHCDR; NH50358
DR   Wikidata; Q112129454
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=NH50358).
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6IG ! NH50357
SX   Male
AG   81Y5M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   NH50359
AC   CVCL_B6HN
DR   NHCDR; NH50359
DR   Wikidata; Q112129455
CC   Population: Caucasian.
CC   Characteristics: Non-edited control for NH50329 (Cellosaurus=CVCL_B6HM).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=NH50359).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W577 ! ND36999
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   NH50360
AC   CVCL_B6II
DR   NHCDR; NH50360
DR   Wikidata; Q112129456
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (NHCDR=NH50360).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6IJ ! NH50361
OI   CVCL_B6IK ! NH50362
SX   Male
AG   71Y8M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50361
AC   CVCL_B6IJ
DR   NHCDR; NH50361
DR   Wikidata; Q112129457
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (NHCDR=NH50361).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6II ! NH50360
OI   CVCL_B6IK ! NH50362
SX   Male
AG   71Y8M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50362
AC   CVCL_B6IK
DR   NHCDR; NH50362
DR   Wikidata; Q112129458
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (NHCDR=NH50362).
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6II ! NH50360
OI   CVCL_B6IJ ! NH50361
SX   Male
AG   71Y8M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   NH50374
AC   CVCL_C0ME
DR   NHCDR; NH50374
DR   Wikidata; Q114312506
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Unspecified (NHCDR=NH50374).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NH50375
AC   CVCL_C0MF
DR   NHCDR; NH50375
DR   Wikidata; Q114312507
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion_corrected; p.Gln18[44] (c.52CAG(45)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50375).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y816 ! ND38547
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NHA E6/E7/hTERT/Ras
AC   CVCL_E3G4
RX   PubMed=11431323;
RX   PubMed=11559533;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NHA E6/E7/hTERT/Ras/Akt
AC   CVCL_E3G5
RX   PubMed=11559533;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:87986; Akt1 (Note=With SRC myristoylation signal MGSSKSKPKDPSQR added at the N-terminus and p.Ala5_Gly130del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3G4 ! NHA E6/E7/hTERT/Ras
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   NHAd-60
AC   CVCL_JF58
SY   Normal Human Adenoid-60
DR   Wikidata; Q54930510
RX   PubMed=196968;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Adenoid; UBERON=UBERON_0001732.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   NHAHTDD
AC   CVCL_WS73
DR   BioSample; SAMN10989615
DR   DepMap; ACH-001142
DR   Wikidata; Q98127757
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Caution: No information is available about this cell line except that it is an immortalized epithelial central nervous system cell line.
CC   Derived from site: In situ; Central nervous system; UBERON=UBERON_0001017.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   NHBE-BMI-1
AC   CVCL_E6IM
SY   Normal Human Bronchial Epithelial cells-BMI-1 transduced
RX   PubMed=27979861;
WW   Provider; UCLB; -; https://xip.uclb.com/product/bmi-1-transduced-basal-epithelial-cells
CC   Senescence: Senesces at 25 PDL (PubMed=27979861).
CC   Doubling time: 1.25 days (Note=At 12th passage), 1.21 days (Note=At 15th passage), 1.49 days (Note=At 23th passage) (PubMed=27979861).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NHBE-T
AC   CVCL_S124
DR   Wikidata; Q54930511
RX   PubMed=19608870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0112 ! 16HBE14o-
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   NHBEC BMI-1 1
AC   CVCL_VP20
SY   BMI-1 1
DR   CancerTools; 153532
DR   Wikidata; Q98127758
DR   Ximbio; 153532
RX   PubMed=27558999;
CC   Characteristics: Has an extended lifespan compared to primary bronchial epithelial cells. Retains both viability and differentiation potential of wild-type human bronchial epithelium.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   NHBEC BMI-1 2
AC   CVCL_VP21
SY   BMI-1 2
DR   CancerTools; 153582
DR   Wikidata; Q98127760
DR   Ximbio; 153582
CC   Characteristics: Has an extended lifespan compared to primary bronchial epithelial cells. Retains both viability and differentiation potential of wild-type human bronchial epithelium.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   NHBEC BMI-1 3
AC   CVCL_VP22
SY   BMI-1 3
DR   CancerTools; 153583
DR   Wikidata; Q98127763
DR   Ximbio; 153583
CC   Characteristics: Has an extended lifespan compared to primary bronchial epithelial cells. Retains both viability and differentiation potential of wild-type human bronchial epithelium.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   NHBEC BMI-1 4
AC   CVCL_VP23
SY   BMI-1 4
DR   CancerTools; 153584
DR   Wikidata; Q98127766
DR   Ximbio; 153584
RX   PubMed=27558999;
CC   Characteristics: Has an extended lifespan compared to primary bronchial epithelial cells. Retains both viability and differentiation potential of wild-type human bronchial epithelium.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   NHBEC BMI-1 5
AC   CVCL_VP24
SY   BMI-1 5
DR   CancerTools; 153585
DR   Wikidata; Q98127768
DR   Ximbio; 153585
CC   Characteristics: Has an extended lifespan compared to primary bronchial epithelial cells. Retains both viability and differentiation potential of wild-type human bronchial epithelium.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   NHBEC BMI-1 6
AC   CVCL_VP25
SY   BMI-1 6
DR   CancerTools; 153586
DR   Wikidata; Q98127770
DR   Ximbio; 153586
CC   Characteristics: Has an extended lifespan compared to primary bronchial epithelial cells. Retains both viability and differentiation potential of wild-type human bronchial epithelium.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   NHBL2
AC   CVCL_VG80
DR   Wikidata; Q54930512
RX   PubMed=29435697;
CC   Population: Chinese.
CC   Doubling time: 27 hours (PubMed=29435697).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   NHEK-iPSCs #1
AC   CVCL_A4HY
DR   SKIP; SKIP003123
DR   Wikidata; Q105510382
RX   PubMed=29229433;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HZ ! NHEK-iPSCs #2
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NHEK-iPSCs #2
AC   CVCL_A4HZ
DR   SKIP; SKIP003124
DR   Wikidata; Q105510385
RX   PubMed=29229433;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HY ! NHEK-iPSCs #1
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NHEK/SV3
AC   CVCL_9Q50
DR   Evercyte; CLT-011-0026
DR   Wikidata; Q54930513
RX   PubMed=28776197;
WW   Provider; Evercyte; CLT-011-0026; https://web.archive.org/web/20150302212441/http://www.evercyte.com:80/medizin/cell-lines/immortalized-human-somatic-cells/nhek-sv3.html
CC   Senescence: SV40-transformed but with a finite life span (maximum PDL is 30) (Evercyte=CLT-011-0026).
CC   Doubling time: ~48 hours (Evercyte=CLT-011-0026).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Evercyte; CLT-011-0026; true.
CC   Derived from site: In situ; Abdomen, skin, epidermis; UBERON=UBERON_0001416+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   NHEK/SVTERT3-5
AC   CVCL_9Q51
DR   Evercyte; CLHT-011-0026-5
DR   Wikidata; Q54930514
RX   PubMed=28776197;
CC   Doubling time: 48-60 hours (Evercyte=CLHT-011-0026-5).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Abdomen, skin, epidermis; UBERON=UBERON_0001416+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): Evercyte=CLHT-011-0026-5
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D5S818: 7,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9Q50 ! NHEK/SV3
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   NHEM2493
AC   CVCL_B447
SY   NHEM 2493
DR   BTO; BTO_0004821
DR   Wikidata; Q54930515
RX   PubMed=19620624;
CC   From: BioWhittaker (now part of Lonza); Walkersville; USA.
CC   Cell type: Melanocyte; CL=CL_0000148.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   NHEM680
AC   CVCL_A1DU
DR   Wikidata; Q102114624
RX   PubMed=9759882;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NHEM693
AC   CVCL_B448
SY   NHEM 693
DR   BTO; BTO_0004820
DR   Wikidata; Q54930516
RX   PubMed=19620624;
CC   From: BioWhittaker (now part of Lonza); Walkersville; USA.
CC   Cell type: Melanocyte; CL=CL_0000148.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   NHF-23
AC   CVCL_WN76
SY   Normal Human Fibroblast-23
DR   Wikidata; Q98127773
RX   PubMed=1351906;
RX   PubMed=9052686;
CC   Group: Space-flown cell line (cellonaut).
CC   Anecdotal: Have been flown in space on shuttle flight STS-65 (Spacelab IML-2) to study DNA repair in microgravity (PubMed=9052686).
CC   Misspelling: HNF-23; Note=In some European Space Agency documents.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   NHI-5B
AC   CVCL_M461
DR   Wikidata; Q54930517
RX   PubMed=2842785;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M446 ! MSL-G2
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   NHI-6F
AC   CVCL_M462
SY   NHI-6F-INS; NHI-Ins; NHI-ins
DR   Wikidata; Q54930518
RX   PubMed=2842785;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M446 ! MSL-G2
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   NHI-6F-28
AC   CVCL_M463
SY   NHI-6F-Tu28; NHI 6F Tu28; NHI-Glu; NHI-glu
DR   Wikidata; Q54930519
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M462 ! NHI-6F
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   NHIK 3016
AC   CVCL_Z877
SY   Norsk Hydro's Institute for Kreftforskning 3016
DR   Wikidata; Q54930520
RX   CelloPub=CLPUB00088;
RX   CelloPub=CLPUB00205;
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   NHIK 3017
AC   CVCL_Z878
SY   Norsk Hydro's Institute for Kreftforskning 3017
DR   Wikidata; Q54930521
RX   CelloPub=CLPUB00088;
RX   CelloPub=CLPUB00205;
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   NHIK 3025
AC   CVCL_U089
SY   NHIK-3025; NHIK3025; Norsk Hydro's Institute for Kreftforskning 3025
DR   ChEMBL-Cells; CHEMBL3307328
DR   ChEMBL-Targets; CHEMBL614201
DR   PubChem_Cell_line; CVCL_U089
DR   Wikidata; Q54930522
RX   CelloPub=CLPUB00088;
RX   CelloPub=CLPUB00205;
RX   DOI=10.1177/026119299602400;
RX   PubMed=369700;
RX   PubMed=976591;
RX   PubMed=4066771;
RX   PubMed=6879111;
RX   PubMed=7270009;
CC   Doubling time: 18.9 hours (Note=For exponentially growing cells), 20.3 hours (Note=For synchronized cells) (PubMed=6879111).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   NHIK 3043
AC   CVCL_Z879
SY   Norsk Hydro's Institute for Kreftforskning 3043
DR   Wikidata; Q54930523
RX   CelloPub=CLPUB00088;
RX   CelloPub=CLPUB00205;
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   NHKT
AC   CVCL_B7EE
DR   Wikidata; Q114312511
RX   PubMed=4083156;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NHLBIi001-A
AC   CVCL_YD90
SY   MS19-ES-D
DR   BioSamples; SAMEA6348715
DR   hPSCreg; NHLBIi001-A
DR   Wikidata; Q98127776
RX   PubMed=31733441;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD91 ! NHLBIi001-B
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NHLBIi001-B
AC   CVCL_YD91
SY   MS19-ES-H
DR   BioSamples; SAMEA6348716
DR   hPSCreg; NHLBIi001-B
DR   Wikidata; Q98127778
RX   PubMed=31733441;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YD90 ! NHLBIi001-A
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NHLBIi002-A
AC   CVCL_YN02
SY   HT24-JB-D
DR   hPSCreg; NHLBIi002-A
DR   Wikidata; Q98127780
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   NHLBIi003-A-1
AC   CVCL_YM53
SY   ND2-tdTom1
DR   BioSamples; SAMEA6348717
DR   hPSCreg; NHLBIi003-A-1
DR   Wikidata; Q98127782
RX   PubMed=31869686;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Characteristics: Using CRISPR/Cas9 tdTomato under the control of a CAG promoter was integrated into one allele of the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E78 ! ND2.0
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 8
//
ID   NHLBIi003-A-2
AC   CVCL_YM54
SY   ND2-tdTom4
DR   BioSamples; SAMEA6348719
DR   hPSCreg; NHLBIi003-A-2
DR   Wikidata; Q98127784
RX   PubMed=31869686;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Characteristics: Using CRISPR/Cas9 tdTomato under the control of a CAG promoter was integrated into one allele of the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E78 ! ND2.0
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 8
//
ID   NHOS
AC   CVCL_6688
SY   Nishi-Hirosaki OSteosarcoma
DR   CLO; CLO_0050198
DR   RCB; RCB1741
DR   Wikidata; Q54930525
RX   PubMed=11429054;
RX   PubMed=18630519;
CC   Derived from site: In situ; Soft tissue; UBERON=UBERON_0034929.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   NHRI-HN1
AC   CVCL_YL71
DR   Wikidata; Q98127786
RX   PubMed=31878324;
CC   Characteristics: Capable of generating orthotopic tumors in syngeneic mice.
CC   Transformant: ChEBI; CHEBI_2814; Arecoline.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C168554; Squamous cell carcinoma of the mouse tongue
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 5
//
ID   NHRI-HN2
AC   CVCL_YL72
DR   Wikidata; Q98127790
RX   PubMed=31878324;
CC   Transformant: ChEBI; CHEBI_2814; Arecoline.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C168554; Squamous cell carcinoma of the mouse tongue
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 5
//
ID   NHRI-iPSC-001-01
AC   CVCL_QY25
SY   NHRI-iPSC-01-01
DR   BCRC; SC81041
DR   BCRC; SC81113
DR   SKIP; SKIP005628
DR   SKIP; SKIP005717
DR   Wikidata; Q54930526
CC   From: National Health Research Institutes (NHRI); Zhunan; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   NHRI-iPSC-003-04
AC   CVCL_RP81
DR   BCRC; SC81062
DR   SKIP; SKIP005658
DR   Wikidata; Q54930527
CC   From: National Health Research Institutes (NHRI); Zhunan; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   NHRI-iPSC-004-03
AC   CVCL_VL30
DR   BCRC; SC81089
DR   SKIP; SKIP005685
DR   Wikidata; Q98127792
CC   From: National Health Research Institutes (NHRI); Zhunan; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   NHRI-iPSC-005-01
AC   CVCL_QY26
DR   BCRC; SC81063
DR   SKIP; SKIP005659
DR   Wikidata; Q54930528
CC   From: National Health Research Institutes (NHRI); Zhunan; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   NHRI-iPSC-006-01
AC   CVCL_RP82
DR   BCRC; SC81078
DR   SKIP; SKIP005674
DR   Wikidata; Q54930529
CC   From: National Health Research Institutes (NHRI); Zhunan; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   NHRI-iPSC-007-01
AC   CVCL_VL31
DR   BCRC; SC81090
DR   SKIP; SKIP005686
DR   Wikidata; Q98127796
CC   From: National Health Research Institutes (NHRI); Zhunan; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   NHRI-iPSC-008-01
AC   CVCL_RP83
DR   BCRC; SC81079
DR   SKIP; SKIP005675
DR   Wikidata; Q54930530
CC   From: National Health Research Institutes (NHRI); Zhunan; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   NHSF3
AC   CVCL_ZM45
SY   NHSF-3; NHF3; Normal Human Skin Fibroblast 3 year old
DR   Wikidata; Q98127798
RX   PubMed=967189;
RX   PubMed=6876478;
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NHSF40
AC   CVCL_ZM47
SY   NHSF-40; Normal Human Skin Fibroblast 40 year old
DR   Wikidata; Q98127801
RX   PubMed=967189;
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   40Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NHSF41
AC   CVCL_A7PV
SY   Normal Human Skin Fibroblast 41 year old
DR   Wikidata; Q107116568
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 50 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   NHSF46
AC   CVCL_G283
SY   NHSF-46; Normal Human Skin Fibroblast 46 year old
DR   CLO; CLO_0050707
DR   BioSample; SAMN03472341
DR   RCB; RCB0162
DR   Wikidata; Q54930531
RX   PubMed=4011712;
RX   PubMed=4031543;
RX   PubMed=4083160;
RX   PubMed=7300843;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 37 PDL (PubMed=4083160); 45 PDL (RCB=RCB0162).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0162
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 10,14
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   NHSF5
AC   CVCL_A7PW
SY   Normal Human Skin Fibroblast 5 year old
DR   Wikidata; Q107116569
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 53 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   NHSF6
AC   CVCL_ZM46
SY   NHSF-6; Normal Human Skin Fibroblast 6 year old
DR   Wikidata; Q98127803
RX   PubMed=967189;
RX   PubMed=1986275;
RX   PubMed=3922833;
RX   PubMed=4011712;
RX   PubMed=4031543;
RX   PubMed=4083160;
RX   PubMed=7240788;
RX   PubMed=7259973;
RX   PubMed=7264357;
CC   Population: Japanese.
CC   Senescence: Senesces at 56 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   NHSF63
AC   CVCL_A7PX
SY   Normal Human Skin Fibroblast 63 year old
DR   Wikidata; Q107116570
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 42 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   NHSF64
AC   CVCL_A7PY
SY   Normal Human Skin Fibroblast 64 year old
DR   Wikidata; Q107116571
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 37 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   NI 1 alpha 364/3B3-14
AC   CVCL_K161
DR   ECACC; 92030611
DR   Wikidata; Q54930532
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01583; Human IL1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NI 1 alpha 364/8C4-8
AC   CVCL_K162
DR   ECACC; 92030612
DR   Wikidata; Q54930533
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01583; Human IL1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NI 3 416/6C6-6
AC   CVCL_J845
DR   ECACC; 92030615
DR   Wikidata; Q54930534
RX   PubMed=1790303;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08700; Human IL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NI 3 416/7B5-5
AC   CVCL_J846
DR   ECACC; 92030616
DR   Wikidata; Q54930535
RX   PubMed=1790303;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08700; Human IL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NI 4 426/1A6-10
AC   CVCL_J847
DR   ECACC; 92030617
DR   Wikidata; Q54930536
RX   PubMed=1790303;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NI 4 426/7A3-3
AC   CVCL_J848
DR   ECACC; 92030618
DR   NCBI_Iran; H123
DR   Wikidata; Q54930537
RX   PubMed=1790303;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   NI 4 426/8B1-7
AC   CVCL_J849
DR   ECACC; 92030619
DR   Wikidata; Q54930538
RX   PubMed=1790303;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   NI 8
AC   CVCL_XC29
SY   NI8; HB NI8
DR   CCRID; 4201PAT-CCTCC00051
DR   Wikidata; Q98127805
RX   Patent=US5147783;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1606.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04179; Human SOD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   NI G 386/3B6-12
AC   CVCL_J850
SY   3B6
DR   ECACC; 92030614
DR   Wikidata; Q54930539
RX   PubMed=1691238;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   NI G 386/3D1-16
AC   CVCL_J851
SY   3D1
DR   ECACC; 92030613
DR   Wikidata; Q54930540
RX   PubMed=1691238;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   NI GM 465/7A6-37
AC   CVCL_J852
SY   NI GM465/7A6-37
DR   ECACC; 92030620
DR   NCBI_Iran; H124
DR   Wikidata; Q54930541
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   NI-1 [Dog mastocytoma]
AC   CVCL_GT45
DR   ABM; T8336
DR   Wikidata; Q54930542
RX   PubMed=22583069;
CC   Sequence variation: Mutation; VGNC; VGNC:42422; KIT; Simple; p.Pro36Leu (c.107C>T); Zygosity=Unspecified (PubMed=22583069).
CC   Sequence variation: Mutation; VGNC; VGNC:42422; KIT; Simple; p.Gln396Arg (c.1187A>G); Zygosity=Unspecified (PubMed=22583069).
CC   Sequence variation: Mutation; VGNC; VGNC:42422; KIT; Simple; p.Glu417_Thr420dup (c.1249_1263dup); Zygosity=Unspecified (PubMed=22583069).
CC   Sequence variation: Mutation; VGNC; VGNC:42422; KIT; Simple; p.Gly513_Lys516del (c.1537_1548delGGTAACAGCAAG); Zygosity=Unspecified (PubMed=22583069).
CC   Miscellaneous: Sex of donor from personal communication of Willmann, Michael.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   3-4Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   NI-1 [Mouse T-cell]
AC   CVCL_C8YM
SY   NOD derived Islet-specific 1
DR   Wikidata; Q123033169
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NI-1.17
AC   CVCL_C8YT
DR   Wikidata; Q123033170
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8YM ! NI-1 [Mouse T-cell]
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NI-1.23
AC   CVCL_C8YU
DR   Wikidata; Q123033171
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8YM ! NI-1 [Mouse T-cell]
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NI-1.9
AC   CVCL_C8YS
DR   Wikidata; Q123033172
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8YM ! NI-1 [Mouse T-cell]
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NI-2
AC   CVCL_C8YN
SY   NOD derived Islet-specific 2
DR   Wikidata; Q123033173
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NI-3
AC   CVCL_C8YP
SY   NOD derived Islet-specific 3
DR   Wikidata; Q123033174
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NI-4
AC   CVCL_C8YQ
SY   NOD derived Islet-specific 4
DR   Wikidata; Q123033175
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NI-5
AC   CVCL_C8YR
SY   NOD derived Islet-specific 5
DR   Wikidata; Q123033176
RX   PubMed=7902094;
CC   Characteristics: Obtained from islets transplanted under the kidney capsule of syngenic mice (PubMed=7902094).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: NOD/Bdc.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NiAC
AC   CVCL_E5VH
SY   Non-OA iAC; Non-OA immortalized Articular Chondrocytes
DR   ABM; T0384
RX   PubMed=36647698;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a patient that had a hip fracture (PubMed=36647698).
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIAi001-A
AC   CVCL_A8ZH
SY   A18945 LRRK2 I2020T PL2F4; I2020T PL2F4
DR   hPSCreg; NIAi001-A
DR   Wikidata; Q108821027
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-B
AC   CVCL_A8ZI
SY   A18945 LRRK2 I2020T PL2D7; I2020T PL2D7
DR   hPSCreg; NIAi001-B
DR   Wikidata; Q108821029
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-C
AC   CVCL_A8ZJ
SY   A18945 LRRK2 G2019S PL2A9; G2019S PL2A9
DR   hPSCreg; NIAi001-C
DR   Wikidata; Q108821030
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-D
AC   CVCL_A8ZK
SY   A18945 LRRK2 G2019S PL2H7; G2019S PL2H7
DR   hPSCreg; NIAi001-D
DR   Wikidata; Q108821032
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-E
AC   CVCL_A8ZL
SY   A18945 LRRK2 Y1699C PL3H2; Y1699C PL3H2
DR   hPSCreg; NIAi001-E
DR   Wikidata; Q108821033
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Tyr1699Cys (c.5096A>G); ClinVar=VCV000001937; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-F
AC   CVCL_A8ZM
SY   A18945 LRRK2 Y1699C PL2H7; Y1699C PL2H7
DR   hPSCreg; NIAi001-F
DR   Wikidata; Q108821034
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Tyr1699Cys (c.5096A>G); ClinVar=VCV000001937; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-G
AC   CVCL_A8ZN
SY   A18945 LRRK2 R1441C PL2F5; R1441C PL2F5
DR   hPSCreg; NIAi001-G
DR   Wikidata; Q108821035
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-H
AC   CVCL_A8ZP
SY   A18945 LRRK2 R1441C PL3C2; R1441C PL3C2
DR   hPSCreg; NIAi001-H
DR   Wikidata; Q108821036
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-I
AC   CVCL_A8ZQ
SY   A18945 LRRK2 N1437H PL3D7; N1437H PL3D7
DR   hPSCreg; NIAi001-I
DR   Wikidata; Q108821037
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Asn1437His (c.4309A>C); ClinVar=VCV000039183; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-J
AC   CVCL_A8ZR
SY   A18945 LRRK2 N1437H PL3F5; N1437H PL3F5
DR   hPSCreg; NIAi001-J
DR   Wikidata; Q108821038
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Asn1437His (c.4309A>C); ClinVar=VCV000039183; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-K
AC   CVCL_A8ZS
SY   A18945 LRRK2 K1906M PL2H7; K1906M PL2H7
DR   hPSCreg; NIAi001-K
DR   Wikidata; Q108821040
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Lys1906Met (c.5717A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-L
AC   CVCL_A8ZT
SY   A18945 LRRK2 T1348N PL1B6; T1348N PL1B6
DR   hPSCreg; NIAi001-L
DR   Wikidata; Q108821041
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Thr1348Asn (c.4043A>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-M
AC   CVCL_A8ZU
SY   A18945 LRRK2 KO PL1C4; KO PL1C4
DR   hPSCreg; NIAi001-M
DR   Wikidata; Q108821042
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi001-N
AC   CVCL_A8ZV
SY   A18945 LRRK2 KO PL1C6; KO PL1C6
DR   hPSCreg; NIAi001-N
DR   Wikidata; Q108821043
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   NIAi002-A
AC   CVCL_D0JY
SY   A53T SNCA 40760
DR   hPSCreg; NIAi002-A
DR   Wikidata; Q123033177
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIAi002-A-1
AC   CVCL_D0K0
SY   Iso-WT SNCA 40760 PL1E11
DR   hPSCreg; NIAi002-A-1
DR   Wikidata; Q123033179
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0JY ! NIAi002-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIAi002-A-2
AC   CVCL_D0K1
SY   Iso-WT SNCA 40760 PL3B3
DR   hPSCreg; NIAi002-A-2
DR   Wikidata; Q123033180
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0JY ! NIAi002-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIAi002-A-3
AC   CVCL_D0K2
SY   Iso-WT SNCA 40760 PL3B7
DR   hPSCreg; NIAi002-A-3
DR   Wikidata; Q123033181
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0JY ! NIAi002-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIAi003-A
AC   CVCL_D0JZ
SY   A53T SNCA 42720
DR   hPSCreg; NIAi003-A
DR   Wikidata; Q123033182
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIAi003-A-1
AC   CVCL_D0K3
SY   Iso-WT SNCA 42720 PL2B9
DR   hPSCreg; NIAi003-A-1
DR   Wikidata; Q123033183
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0JZ ! NIAi003-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIAi003-A-2
AC   CVCL_D0K4
SY   Iso-WT SNCA 42072 PL2C11
DR   hPSCreg; NIAi003-A-2
DR   Wikidata; Q123033184
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0JZ ! NIAi003-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIAi003-A-3
AC   CVCL_D0K5
SY   Iso-WT SNCA 42072 PL3G1
DR   hPSCreg; NIAi003-A-3
DR   Wikidata; Q123033185
RX   PubMed=37229975;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37229975).
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0JZ ! NIAi003-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Nialym
AC   CVCL_0D20
DR   Wikidata; Q54931211
RX   PubMed=25711304;
CC   Population: Japanese.
CC   Doubling time: ~46 hours (PubMed=25711304).
CC   Misspelling: Nyalim; Note=In Cellosaurus releases 12 to 35.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   Nialymx
AC   CVCL_0D21
DR   Wikidata; Q54931212
RX   PubMed=25711304;
CC   Population: Japanese.
CC   Doubling time: ~42 hours (PubMed=25711304).
CC   Misspelling: Nyalimx; Note=In Cellosaurus releases 12 to 35.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0D20 ! Nialym
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   NIAS-AeAl-2
AC   CVCL_Z549
SY   NIAS-AeAl 2; AeAl2
DR   NISES; SK0013
DR   RCB; RCB0277
DR   Wikidata; Q54930543
RX   CelloPub=CLPUB00492;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1303/aez.32.227;
RX   DOI=10.2220/biomedres.2.599;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Characteristics: Has a very high acetylcholinesterase activity (AchE) (DOI=10.1303/aez.32.227).
CC   Doubling time: ~30 hours (DOI=10.2220/biomedres.2.599).
CC   Misspelling: NIAS-AeA1-2; Note=Occasionally.
CC   Misspelling: NIAS-AeA-2; Note=Occasionally.
CC   Discontinued: NGRC Genebank; Catalog number 275011.
CC   Discontinued: RCB; RCB0277; true.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 13
//
ID   NIAS-Bm-aff3
AC   CVCL_Z559
SY   Bm-aff3
DR   ICLDB; nias-bm-aff3
DR   Wikidata; Q54930544
RX   PubMed=15827172;
RX   PubMed=19734648;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIAS-Bm-ao1
AC   CVCL_Z560
DR   ICLDB; nias-bm-ao1
DR   Wikidata; Q54930545
RX   PubMed=15827172;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIAS-Bm-F1
AC   CVCL_ZF33
DR   Wikidata; Q98127807
RX   PubMed=17967886;
RX   PubMed=20956562;
CC   Group: Insect cell line.
CC   Doubling time: ~3 days (PubMed=17967886).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Sex limited black egg.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   NIAS-Bm-Ke1
AC   CVCL_Z561
SY   Ke1
DR   ICLDB; nias-bm-ke1
DR   Wikidata; Q54930546
RX   DOI=10.11416/konchubiotec.75.45;
RX   PubMed=22302376;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIAS-Bm-Ke17
AC   CVCL_Z562
DR   ICLDB; nias-bm-ke17
DR   Wikidata; Q54930547
RX   Patent=JP5765699;
RX   PubMed=22302376;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-21809.
CC   Doubling time: 83.67 +- 5.22 hours (PubMed=22302376).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z561 ! NIAS-Bm-Ke1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   NIAS-Bm-M1
AC   CVCL_ZF34
DR   ICLDB; nias-bm-m1
DR   Wikidata; Q98127810
RX   PubMed=17967886;
RX   PubMed=20956562;
CC   Group: Insect cell line.
CC   Doubling time: ~3 days (PubMed=17967886).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Sex limited black egg.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NIAS-Bm-Oyanagi 1
AC   CVCL_Z563
SY   NIAS-Bm-oyanagi1; NBO1
DR   ICLDB; nias-bm-oyanagi-1
DR   Wikidata; Q54930548
RX   DOI=10.11416/jibs.74.117;
RX   PubMed=15827172;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: N137 x C146.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIAS-Bm-Oyanagi 2
AC   CVCL_Z564
SY   NIAS-Bm-oyanagi2; NBO2
DR   ICLDB; nias-bm-oyanagi-2
DR   Wikidata; Q54930549
RX   DOI=10.11416/jibs.74.117;
RX   PubMed=19734648;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: N137 x C146.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIAS-Bm-SLBEM-1228
AC   CVCL_Z565
SY   NBS1228
DR   ICLDB; nias-bm-slbem-1228
DR   Wikidata; Q54930550
RX   DOI=10.11416/jibs.74.117;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Sex limited black egg.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIAS-Bm-SLBEM-1230
AC   CVCL_Z566
SY   NBS1230
DR   ICLDB; nias-bm-slbem-1230
DR   Wikidata; Q54930551
RX   DOI=10.11416/jibs.74.117;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Sex limited black egg.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIAS-Boma-529b
AC   CVCL_Z092
SY   Boma-529b
DR   ICLDB; nias-boma-529b
DR   Wikidata; Q54930552
RX   PubMed=19460387;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7092; ! Bombyx mandarina (Wild silk moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NIAS-LeSe-11
AC   CVCL_Z368
SY   LeSe-11
DR   CLO; CLO_0050505
DR   ICLDB; nias-lese-11
DR   NISES; SK0008
DR   RCB; RCB0405
DR   Wikidata; Q54930553
RX   DOI=10.1303/aez.18.533;
RX   PubMed=10358729;
CC   Group: Insect cell line.
CC   Doubling time: ~48 hours (DOI=10.1303/aez.18.533).
CC   Discontinued: NGRC Genebank; Catalog number 275012.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   NIAS-MaBr-85
AC   CVCL_Z126
SY   MaBr-85
DR   ICLDB; nias-mabr-85
DR   Wikidata; Q54930554
RX   CelloPub=CLPUB00492;
RX   DOI=10.1111/j.1440-169X.1981.00063.x;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275010.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   NIAS-MaBr-92
AC   CVCL_Z124
DR   CLO; CLO_0050228
DR   ICLDB; nias-mabr-92
DR   NISES; SK0006
DR   RCB; RCB0279
DR   Wikidata; Q54930555
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00532;
RX   DOI=10.1111/j.1440-169X.1985.00599.x;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=1367489;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275019.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 12
//
ID   NIAS-MaBr-93
AC   CVCL_Z125
DR   CLO; CLO_0050229
DR   ICLDB; nias-mabr-93
DR   NISES; SK0009
DR   RCB; RCB0414
DR   Wikidata; Q54930556
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00532;
RX   DOI=10.1111/j.1440-169X.1985.00599.x;
RX   PubMed=9282311;
WW   Provider; NGRC Genebank; 275020; https://web.archive.org/web/20230326062857/https://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275020
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275020.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   NIAS-Mb-19
AC   CVCL_Z121
SY   NIAS-MB-19; MB-19
DR   ICLDB; nias-mb-19
DR   Wikidata; Q54930557
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1440-169X.1977.00337.x;
RX   DOI=10.1303/aez.13.170;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275006.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   NIAS-Mb-25
AC   CVCL_Z122
SY   NIAS-MB-25; MB-25
DR   CLO; CLO_0050504
DR   ICLDB; nias-mb-25
DR   NISES; SK0005
DR   RCB; RCB0278
DR   Wikidata; Q54930558
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00496;
RX   DOI=10.1111/j.1440-169X.1977.00337.x;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=1367489;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275007.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 12
//
ID   NIAS-Mb-32
AC   CVCL_Z123
SY   NIAS-MB-32; NIAS-MaBr-32; MB-32
DR   CLO; CLO_0050503
DR   ICLDB; nias-mb-32
DR   NISES; SK0001
DR   RCB; RCB0413
DR   Wikidata; Q54930560
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00496;
RX   CelloPub=CLPUB00532;
RX   DOI=10.1111/j.1440-169X.1977.00337.x;
RX   DOI=10.1303/aez.32.227;
WW   Provider; NGRC Genebank; 275008; https://web.archive.org/web/20231206205607/https://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275008
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275008.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 13
//
ID   NIAS-PRC-819A
AC   CVCL_Z118
SY   NIAS-PRC819A
DR   ICLDB; nias-prc-819a
DR   Wikidata; Q54930561
RX   PubMed=14505438;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275054.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
OI   CVCL_Z119 ! NIAS-PRC-819B
OI   CVCL_Z120 ! NIAS-PRC-819C
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   NIAS-PRC-819B
AC   CVCL_Z119
SY   NIAS-PRC819B
DR   ICLDB; nias-prc-819b
DR   Wikidata; Q54930562
RX   PubMed=14505438;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275055.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
OI   CVCL_Z118 ! NIAS-PRC-819A
OI   CVCL_Z120 ! NIAS-PRC-819C
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   NIAS-PRC-819C
AC   CVCL_Z120
SY   NIAS-PRC819C
DR   ICLDB; nias-prc-819c
DR   Wikidata; Q54930563
RX   PubMed=14505438;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275056.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
OI   CVCL_Z118 ! NIAS-PRC-819A
OI   CVCL_Z119 ! NIAS-PRC-819B
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   NIAS-Pv-11
AC   CVCL_WH44
SY   Pv11
DR   Wikidata; Q98127812
RX   PubMed=19850023;
RX   PubMed=27207249;
RX   PubMed=27757696;
RX   PubMed=28747745;
RX   PubMed=32191739;
RX   PubMed=34071490;
CC   Group: Insect cell line.
CC   Characteristics: Dessication tolerant. Cells can be preserved in the dry state for 251 days and retain their proliferation potential (PubMed=27207249).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=319348; ! Polypedilum vanderplanki (Sleeping chironomid midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   NIAS-Pv-210
AC   CVCL_WH45
SY   Pv210
DR   Wikidata; Q98127814
RX   PubMed=19850023;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=319348; ! Polypedilum vanderplanki (Sleeping chironomid midge)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   NIAS-Px-58
AC   CVCL_Z132
SY   NIAS-PX-58; NIAS-Px 58; PX-58; Px 58; Px58
DR   CLO; CLO_0050002
DR   ICLDB; nias-px-58
DR   NISES; SK0012
DR   RCB; RCB0556
DR   Wikidata; Q54930564
RX   CelloPub=CLPUB00492;
RX   DOI=10.1016/B978-0-12-470270-7.50007-0;
RX   DOI=10.1303/aez.8.64;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275004.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=66420; ! Papilio xuthus (Asian swallowtail butterfly)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   NIAS-Px-64
AC   CVCL_Z134
SY   NIAS-PX-64; PX-64; Px 64
DR   CLO; CLO_0050001
DR   ICLDB; nias-px-64
DR   NISES; SK0017
DR   RCB; RCB0412
DR   Wikidata; Q54930565
RX   DOI=10.1016/B978-0-12-470270-7.50007-0;
RX   DOI=10.1303/aez.32.227;
RX   DOI=10.1303/aez.8.64;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275005.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=66420; ! Papilio xuthus (Asian swallowtail butterfly)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 11
//
ID   NIAS-SL64
AC   CVCL_HF61
DR   ICLDB; nias-sl64
DR   Wikidata; Q54930569
RX   PubMed=25172011;
CC   Group: Insect cell line.
CC   Doubling time: 24 hours (PubMed=25172011).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   NIAS-SpSe-1
AC   CVCL_Z545
DR   ICLDB; nias-spse-1
DR   Wikidata; Q54930570
RX   CelloPub=CLPUB00195;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Doubling time: ~3 days (CelloPub=CLPUB00195).
CC   Discontinued: NGRC Genebank; Catalog number 275013.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=1426856; ! Spilarctia seriatopunctata (Moth)
SX   Male
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   NIBSC8-Cl83
AC   CVCL_D3FH
SY   NIBSC8 clone 83
DR   Wikidata; Q127382952
RX   PubMed=36744062;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a Superfolder GFP (sfGFP) construct was inserted at the C-terminal end of PLP1 (PubMed=36744062).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=36744062
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12,19
ST   D19S433: 13.2,14
ST   D21S11: 29,30.2
ST   D2S1338: 23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VF51 ! USCBi001-A
SX   Female
AG   15FW
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   NIC
AC   CVCL_F577
SY   TER73; TER160
DR   IPD-IMGT/HLA; 11140
DR   Wikidata; Q54930571
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02; B*38:01,57:01; C*07:01,12:03; DPB1*02:01,14:01; DQA1*01:03,03:01; DQB1*06:03,03:02; DRB1*04:15,13:01; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=11140).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   NID-1
AC   CVCL_WG26
SY   Neuro Immune Disease-1
DR   IBRC; C10608
DR   Wikidata; Q98127819
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   NID-2
AC   CVCL_WG34
SY   Neuro Immune Disease-2
DR   IBRC; C10609
DR   Wikidata; Q98127821
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   NIDCRi001-A
AC   CVCL_YC42
SY   MS-iPSC-1a
DR   BioSamples; SAMEA6185506
DR   hPSCreg; NIDCRi001-A
DR   Wikidata; Q98127823
RX   PubMed=32505898;
CC   From: National Institute of Dental and Craniofacial Research; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Pro250Arg (c.749C>G); ClinVar=VCV000016340; Zygosity=Heterozygous (PubMed=32505898).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84904; Muenke syndrome
DI   ORDO; Orphanet_53271; Muenke syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   NIDCRi002-A
AC   CVCL_YC43
DR   hPSCreg; NIDCRi002-A
DR   Wikidata; Q98127825
CC   From: National Institute of Dental and Craniofacial Research; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   NIDCRi003-A
AC   CVCL_YC44
DR   hPSCreg; NIDCRi003-A
DR   Wikidata; Q98127826
CC   From: National Institute of Dental and Craniofacial Research; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   NIDCRi004-A
AC   CVCL_YC45
DR   hPSCreg; NIDCRi004-A
DR   Wikidata; Q98127828
CC   From: National Institute of Dental and Craniofacial Research; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   NIE
AC   CVCL_F578
SY   TER265; TER-265; Ter 265; TER348; TER-348; Ter 348; TER475; TER-475; Ter 475; Extract 146
DR   IPD-IMGT/HLA; 11141
DR   Wikidata; Q54930572
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/367cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01; B*07:02,15:01; C*03:03,07:02; DPB1*01:01,04:01; DQA1*03:01,05:01; DQB1*02:01,03:02; DRB1*03:01,04:32; DRB3*01:01; DRB4*01:03 (IPD-IMGT/HLA=11141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   NIH 2/4
AC   CVCL_5I45
SY   NIH2/4
DR   Kerafast; ENH101-FP
DR   Wikidata; Q54930573
RX   PubMed=17486118;
RX   PubMed=18483401;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   NIH 3T3
AC   CVCL_0594
SY   NIH/3T3; NIH-3T3; NIH3T3; 3T3; 3T3NIH; 3T3-Swiss; Swiss-3T3; Swiss/3T3; Swiss 3T3; Swiss3T3
DR   BTO; BTO_0000944
DR   BTO; BTO_0005065
DR   CLO; CLO_0008172
DR   CLO; CLO_0009227
DR   CLO; CLO_0050548
DR   EFO; EFO_0001222
DR   MCCL; MCC:0000362
DR   CLDB; cl3702
DR   CLDB; cl3704
DR   CLDB; cl3705
DR   CLDB; cl3706
DR   CLDB; cl3707
DR   CLDB; cl3708
DR   CLDB; cl3709
DR   CLDB; cl3710
DR   CLDB; cl3711
DR   CLDB; cl4451
DR   CLDB; cl7203
DR   ABM; T8981
DR   AddexBio; P0011001/83
DR   ATCC; CRL-1658
DR   ATCC; CRL-6442
DR   BCRC; 60008
DR   BCRJ; 0191
DR   BEI_Resources; ARP-9946
DR   BioGRID_ORCS_Cell_line; 301
DR   BioSample; SAMN11397633
DR   CCLV; CCLV-RIE 0058
DR   CCRID; 1101MOU-PUMC000018
DR   CCRID; 1102MOU-NIFDC00034
DR   CCRID; 3101MOUGNM6
DR   CCRID; 3101MOUSCSP515
DR   CCRID; 4201MOU-CCTCC00030
DR   CCTCC; GDC0030
DR   ChEMBL-Cells; CHEMBL3307716
DR   ChEMBL-Targets; CHEMBL614822
DR   CLS; 400101
DR   DSMZ; ACC-59
DR   DSMZCellDive; ACC-59
DR   ECACC; 93061524
DR   ENCODE; ENCBS117ENC
DR   ENCODE; ENCBS990YBC
DR   GEO; GSE5810
DR   GEO; GSM1014177
DR   IBRC; C10100
DR   ICLC; AL07001
DR   IZSLER; BS CL 165
DR   KCB; KCB 200645YJ
DR   KCLB; 21658
DR   Lonza; 115
DR   MeSH; D041681
DR   NCBI_Iran; C156
DR   PRIDE; PXD001241
DR   PRIDE; PXD004929
DR   PubChem_Cell_line; CVCL_0594
DR   RCB; RCB2767
DR   TKG; TKG 0299
DR   TOKU-E; 2753
DR   TOKU-E; 3547
DR   Ubigene; YC-A013
DR   Wikidata; Q4636420
RX   DOI=10.3917/bhesv.191.0045;
RX   PubMed=2463382;
RX   PubMed=4087463;
RX   PubMed=4311790;
RX   PubMed=9753870;
RX   PubMed=17284666;
RX   PubMed=22619183;
RX   PubMed=23321776;
RX   PubMed=23430347;
RX   PubMed=25277546;
RX   PubMed=31220119;
RX   PubMed=36078083;
WW   Info; -; -; https://nih3t3.com/
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-ccl-92-vs-atcc-crl-1658
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/confluence-for-atcc-crl-1658
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-rate-for-atcc-crl-1658
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=3T3
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/NIH-3T3_Stam_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/3T3_cells
CC   Part of: ENCODE project mouse cell lines.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: 21.3 +- 0.5 hours (PubMed=22619183); ~20 hours (DSMZ=ACC-59).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: PubMed=23430347 has a different value for STR 4-2 (19.3) than that of NIST (19.3,20.3) due to a change in the stutter rules (personal communication of Almeida, Jamie L.).
CC   Miscellaneous: PubMed=23430347 has a different value for STR 6-4 (14.3) than that of NIST (15.3) due to a change in the marker motif (personal communication of Almeida, Jamie L.).
CC   Discontinued: ATCC; CRL-6442; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
ST   Source(s): PubMed=23430347; PubMed=31220119; Ubigene=YC-A013
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 13,17
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 15
ST   Mouse STR 9-2: 15,16
ST   Mouse STR 11-2: 15,17
ST   Mouse STR 12-1: 20
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 13,14
ST   Mouse STR 18-3: 17,19
ST   Mouse STR 19-2: 11,12
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   NIH 3T3 Atg5 KO
AC   CVCL_QY95
SY   ATG5 KO NIH 3T3; ATG5 KO (#4)
DR   Wikidata; Q54930574
RX   PubMed=28294316;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1277186; Atg5.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   NIH 3T3 Beta6
AC   CVCL_A0MM
SY   Beta6-NIH 3T3; Beta6NIH3T3
DR   Wikidata; Q108821044
RX   Patent=US9745376;
RX   PubMed=14960589;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96615; Itgb6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   NIH 3T3 Duo
AC   CVCL_HC51
SY   NIH3T3duo
DR   Kerafast; ENH102-FP
DR   Wikidata; Q54930575
RX   PubMed=23929981;
RX   PubMed=25255091;
CC   Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.
CC   Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO), two copies of a TetO-ISceI-TetO construct (96 copies of TetO) as well as a LacR-GFP and a TetR-mCherry constructs.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03023; Escherichia coli lacI.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HC50 ! NIH 3T3 Duo Parental
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 13
//
ID   NIH 3T3 Duo Parental
AC   CVCL_HC50
DR   Kerafast; ENH103-FP
DR   Wikidata; Q54930576
RX   PubMed=23929981;
RX   PubMed=25255091;
CC   Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.
CC   Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO) and two copies of a TetO-ISceI-TetO construct (96 copies of TetO).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03023; Escherichia coli lacI.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 11
//
ID   NIH 3T3 Duo-BFP53BP1
AC   CVCL_HC52
DR   Kerafast; ENH104-FP
DR   Wikidata; Q54930577
RX   PubMed=23929981;
CC   Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.
CC   Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO), two copies of a TetO-ISceI-TetO construct (96 copies of TetO) as well as a LacR-GFP and a TetR-mCherry constructs.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1351320; Trp53bp1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03023; Escherichia coli lacI.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HC51 ! NIH 3T3 Duo
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   NIH 3T3 EGFR
AC   CVCL_E6DP
SY   NIH/3T3 EGFR
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-A763_Y764insFQEA
AC   CVCL_E6DQ
SY   NIH/3T3 EGFR-A763_Y764insFQEA
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ala763insPheGlnGluAla (c.2290_2291insTCCAGGAAGCCT)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-D770_N771insG
AC   CVCL_E6DR
SY   NIH/3T3 EGFR-D770_N771insG
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insGly (c.2310_2311insGGT)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-D770_N771insSVD
AC   CVCL_E6DS
SY   NIH/3T3 EGFR-D770_N771insSVD
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Asp770_Asn771insSerValAsp (c.2311_2312insGCGTGGACA)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-Ex19del
AC   CVCL_E6DT
SY   NIH/3T3 EGFR-delE746_A750
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-Ex19del/T790M
AC   CVCL_E6DU
SY   NIH/3T3 EGFR-delE746_A750 + T790M
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Glu746_Ala750del and p.Thr790Met (c.2369C>T)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-H773_V774insNPH
AC   CVCL_E6DV
SY   NIH/3T3 EGFR-H773_V774insNPH
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insAsnProHis (p.Asn771_His773dup) (c.2311_2319dup)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-H773_V774insPH
AC   CVCL_E6DW
SY   NIH/3T3 EGFR-H773_V774insPH
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.His773_Val774insProHis (p.Pro772_His773dup) (c.2314_2319dup)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 EGFR-V769_D770insASV
AC   CVCL_E6DX
SY   NIH/3T3 EGFR-V769_D770insASV
RX   PubMed=29748209;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val769insAlaSerVal (c.2308_2309insCCAGCGTGG)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 A158V
AC   CVCL_E5L8
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Ala158Val and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 A167T
AC   CVCL_E5L9
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Ala167Thr and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 A70T
AC   CVCL_E5LA
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Ala70Thr and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 D42Y
AC   CVCL_E5LB
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Asp42Tyr and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 D44E
AC   CVCL_E5LC
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Asp44Glu and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 D49Y
AC   CVCL_E5LD
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Asp49Tyr and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 D8N
AC   CVCL_E5LE
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Asp8Asn and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 E48D
AC   CVCL_E5LF
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Glu48Asp and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 F204L
AC   CVCL_E5LG
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Phe204Leu and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 G23A
AC   CVCL_E5LH
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gly23Ala and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 G23C
AC   CVCL_E5LI
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gly23Cys and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 G23S
AC   CVCL_E5LJ
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gly23Ser and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 G24C
AC   CVCL_E5LK
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gly24Cys and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 G24D
AC   CVCL_E5LL
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gly24Asp and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 G24V
AC   CVCL_E5LM
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gly24Val and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 K14T
AC   CVCL_E5LN
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Lys14Thr and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 K159Q
AC   CVCL_E5LP
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Lys159Gln and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 K177T
AC   CVCL_E5LQ
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Lys177Thr and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 K53M
AC   CVCL_E5LR
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Lys53Met and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 L112I
AC   CVCL_E5LS
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Leu112Ile and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 M162V
AC   CVCL_E5LT
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Met162Val and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 P45R
AC   CVCL_E5LU
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Pro45Arg and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 Q72H
AC   CVCL_E5LV
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gln72His and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 Q72L
AC   CVCL_E5LW
RX   PubMed=36476833;
CC   Characteristics: Displays transforming activity in focus formation assays (PubMed=36476833).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Gln72Leu and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 R117C
AC   CVCL_E5LX
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Arg117Cys and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 R135S
AC   CVCL_E5LY
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Arg135Ser and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 R147Q
AC   CVCL_E5LZ
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Arg147Gln and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 R173W
AC   CVCL_E5M0
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Arg173Trp and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 R63Q
AC   CVCL_E5M1
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Arg63Gln and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 WT
AC   CVCL_E5M2
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 hRRAS2 Y105C
AC   CVCL_E5M3
RX   PubMed=36476833;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17271; RRAS2 (Note=With p.Tyr105Cys and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH 3T3 IFT20-GFP
AC   CVCL_A9G7
DR   Wikidata; Q102114625
RX   PubMed=29150645;
CC   Characteristics: Transfected with mouse Ift20 C-terminally tagged with GFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1915585; Ift20.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   NIH 3T3 MCT-1
AC   CVCL_F0S0
RX   PubMed=17016429;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23357; MCTS1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH 3T3 MCT-1-S118A
AC   CVCL_F0S1
RX   PubMed=17016429;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23357; MCTS1 (Note=With p.Ser118Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH 3T3 MCT-1-T81A
AC   CVCL_F0S2
RX   PubMed=17016429;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23357; MCTS1 (Note=With p.Thr81Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH 3T3 Met-H1092L
AC   CVCL_ZD68
SY   Murine MET (H1112L) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH026-FP
DR   Wikidata; Q98127831
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.His1092Leu).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-H1092Y
AC   CVCL_ZD69
SY   Murine MET (H1112Y) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH025-FP
DR   Wikidata; Q98127833
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.His1092Tyr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-H1104D
AC   CVCL_ZD70
SY   Murine MET (H1124D) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH027-FP
DR   Wikidata; Q98127835
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.His1104Asp).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-L1193V
AC   CVCL_ZD71
SY   Murine MET (L1213V) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH030-FP
DR   Wikidata; Q98127838
RX   PubMed=9326629;
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Leu1193Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-M1129T
AC   CVCL_ZD72
SY   Murine MET (M1149T) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH028-FP
DR   Wikidata; Q98127841
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Met1129Thr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-M1248T
AC   CVCL_ZD73
SY   Murine MET (M1268T) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH034-FP
DR   Wikidata; Q98127843
RX   PubMed=9326629;
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Met1248Thr).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-V1090I
AC   CVCL_ZD74
SY   Murine MET (V1110I) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH024-FP
DR   Wikidata; Q98127847
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Val1090Ile).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-V1186L
AC   CVCL_ZD75
SY   Murine MET (V1206L) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH029-FP
DR   Wikidata; Q98127849
RX   PubMed=9326629;
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Val1186Leu).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-V1218I
AC   CVCL_ZD76
SY   Murine MET (V1238I) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH031-FP
DR   Wikidata; Q98127852
RX   PubMed=9326629;
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Val1218Ile).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-WT
AC   CVCL_ZD67
SY   Murine MET (Wild-Type) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH023-FP
DR   Wikidata; Q98127854
RX   PubMed=9326629;
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-Y1228D
AC   CVCL_ZD77
SY   Murine MET (Y1248D) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH033-FP
DR   Wikidata; Q98127856
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Tyr1228Asp).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 Met-Y1228H
AC   CVCL_ZD78
SY   Murine MET (Y1248H) Expressing NIH3T3 Cell Line
DR   Kerafast; ENH032-FP
DR   Wikidata; Q98127858
RX   PubMed=9326629;
RX   PubMed=10327054;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96969; Met (Note=With p.Tyr1228His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   NIH 3T3 p-7 cl-3
AC   CVCL_L994
DR   JCRB; IFO50019
DR   Wikidata; Q54930578
CC   Doubling time: ~1 day (Note=Lot 01252011) (JCRB=IFO50019).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   NIH 3T3-IL-7
AC   CVCL_D675
SY   3T3 IL-7
DR   BCRJ; 0018
DR   Wikidata; Q54930579
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   NIH 3T3-ras
AC   CVCL_5845
SY   NIH-3T3-ras; NIH3T3-ras; A51; EJ-NIH/3T3; EJ-NIH-3T3
DR   BTO; BTO_0005549
DR   CLS; 400100
DR   Wikidata; Q54930580
RX   PubMed=2153549;
RX   PubMed=3858844;
RX   PubMed=11173916;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   NIH 3T3-TK-
AC   CVCL_9116
SY   NIH 3T3 TK-; 3T3 NIH TK-; TK- NIH/3T3
DR   CLO; CLO_0001349
DR   CLDB; cl68
DR   Wikidata; Q54930581
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   NIH 3T3/DC-SIGN
AC   CVCL_0R23
SY   NIH 3T3/MX-DC-SIGN
DR   BEI_Resources; ARP-9947
DR   Wikidata; Q54930582
RX   PubMed=12021323;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   NIH 3T3/HER2-3(400)
AC   CVCL_LG16
SY   NIH 3T3/HER2-3 400; NIH 3T3/HER2-3400
DR   Wikidata; Q54930583
RX   PubMed=1689212;
RX   PubMed=2566907;
RX   PubMed=2890160;
CC   Characteristics: Transfected with at least 55 copies of ERBB2 under the control of a SV40 promoter (PubMed=2890160).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   NIH 3T3/HNP
AC   CVCL_C6XF
DR   Wikidata; Q117704722
RX   PubMed=8329717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2761; DEFA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   NIH 3T3/L-SIGN
AC   CVCL_0R24
SY   NIH 3T3/MX-L-SIGN (L6)
DR   BEI_Resources; ARP-9948
DR   Wikidata; Q54930584
RX   PubMed=12021323;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13523; CLEC4M.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   NIH 3T3/pL2neoSRalphaIIISFA-1
AC   CVCL_C4BD
DR   Wikidata; Q116049888
RX   PubMed=8627808;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1630; CD151.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   NIH-3T3 4-2
AC   CVCL_7219
DR   CLO; CLO_0008173
DR   CLDB; cl3700
DR   ECACC; 86041101
DR   Wikidata; Q54930585
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   NIH-3T3 clone 5611
AC   CVCL_7220
SY   NIH/3T3 clone 5611
DR   JCRB; JCRB0615
DR   Wikidata; Q54930586
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   NIH-3T3 Tsc2 KO
AC   CVCL_C4RN
SY   TSC2 KO NIH-3T3; TSC2-KO NIH-3T3
DR   Wikidata; Q116049889
RX   PubMed=36181622;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:102548; Tsc2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   NIH-3T3-A14
AC   CVCL_L990
SY   NIH 3T3-A14; NIH3T3-A14; A14
DR   BTO; BTO_0004245
DR   EFO; EFO_0022729
DR   Wikidata; Q54930587
RX   PubMed=2022184;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6091; INSR.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 14
//
ID   NIH-3T3-eGFP-Smo
AC   CVCL_E7X7
RX   PubMed=18497258;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11119; SMO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH-3T3-Flag-Smo 1.1
AC   CVCL_E7X5
RX   PubMed=18497258;
WW   Provider; Duke ORI; T-003617; https://otc.duke.edu/technologies/cell-lines-for-the-overexpression-of-gpcrs/
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11119; SMO (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH-3T3-Flag-Smo 1.7
AC   CVCL_E7X6
RX   PubMed=18497258;
WW   Provider; Duke ORI; T-003617; https://otc.duke.edu/technologies/cell-lines-for-the-overexpression-of-gpcrs/
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11119; SMO (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH-3T3-G185
AC   CVCL_L991
SY   NIH 3T3-G185; NIH 3T3 G185; NIH3T3-G185; NIH MDR1-G185; NIH-MDR-G185; G185
DR   BTO; BTO_0002396
DR   ChEMBL-Cells; CHEMBL3988465
DR   PubChem_Cell_line; CVCL_L991
DR   Wikidata; Q54930588
RX   PubMed=1356986;
RX   PubMed=7866993;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   NIH-3T3-V185
AC   CVCL_E9X9
SY   NIH 3T3-V185; NIH 3T3 V185; NIH3T3-V185; NIH MDR1-V185; NIH-MDR-V185; V185
RX   PubMed=1356986;
RX   PubMed=7866993;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1 (Note=With p.Val185).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NIH-3T3D4
AC   CVCL_7218
SY   NIH 3T3 D4; NIH-3T3 D4; NIH3T3-D4; NIH 3T3 clone D4; NIH3T3 clone D4
DR   CLO; CLO_0008174
DR   CLDB; cl3701
DR   ECACC; 85111801
DR   IZSLER; BS CL 213
DR   NCBI_Iran; C155
DR   Wikidata; Q54930589
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NIH-AP16
AC   CVCL_F0XS
RX   PubMed=9743536;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11928; TNFSF13 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH-AP18
AC   CVCL_F0XT
RX   PubMed=9743536;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11928; TNFSF13 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH-AP2
AC   CVCL_F0XQ
RX   PubMed=9743536;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11928; TNFSF13 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH-AP4
AC   CVCL_F0XR
RX   PubMed=9743536;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11928; TNFSF13 (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH-SaPe-4
AC   CVCL_Z550
SY   NIH-Sape-4; NIH SaPe4
DR   ICLDB; nih-sape-4
DR   NISES; SK0014
DR   RCB; RCB0280
DR   Wikidata; Q54930590
RX   CelloPub=CLPUB00492;
RX   DOI=10.1111/j.1440-169X.1980.00011.x;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275009.
CC   Discontinued: RCB; RCB0280; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7386; ! Sarcophaga peregrina (Flesh fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 12
//
ID   NIH/3T3 Cas9
AC   CVCL_DX81
DR   Horizon_Discovery; HD+Cas9-010
DR   Wikidata; Q127382953
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-010).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NIH/3T3 MMCV-transformed clone MC315
AC   CVCL_E5TR
SY   MC315
RX   PubMed=6526015;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P12523; Avian retrovirus OK10 v-Myc.
CC   Transformant: Recombinant Murine myc-containing virus (MMCV OK-10 v-myc).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NIH/3T3 Tet-On 3G
AC   CVCL_V360
DR   Wikidata; Q54930591
WW   Provider; Takara Bio; 631197; https://www.takarabio.com/products/gene-function/tet-inducible-expression-systems/tet-on-3g-systems/tet-on-3g-cell-lines
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   NIH/3T3-174
AC   CVCL_B6J0
DR   Wikidata; Q112129459
RX   Patent=RU2396343;
RX   PubMed=28873013;
CC   Group: Patented cell line.
CC   Characteristics: Overexpresses SURF6 in the presence of doxycycline.
CC   Characteristics: Transfected with two constructs: 1) pcDNA3.1(-)rtTA which contains a rtTA and a neo gene. The reverse tetracycline-controlled transactivator (rtTA) is a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16. 2) pBI-mSURF6 that contains a bidirectorial tetracycline-responsible element (Tre) flanked by two minimal bi-directorial CMV promoters which govern co-expression of SURF6 and EGFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98447; Surf6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   NIH/3T3-Luc
AC   CVCL_C8Y9
DR   Ubigene; YC-A013-Luc-P
DR   Wikidata; Q123033186
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   NIH/3T3/Cas9-hyg
AC   CVCL_C9FL
SY   NIH/3T3-Cas9-hyg
DR   GeneCopoeia; SL569
DR   Wikidata; Q123033187
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL569).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   NIH3T3 Halo-GLI2
AC   CVCL_E7UG
RX   PubMed=40073114;
CC   Characteristics: Transfected with both a pEF5-FRT-DEST-3XHA-Halo-mGLI2 and a pOG44 constructs (PubMed=40073114).
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95728; Gli2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U422 ! Flp-In-3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NIH3T3 Halo-GLI2+KIF7-Snap
AC   CVCL_E7UJ
SY   NIH3T3 Halo-GLI2 and KIF7-Snap
RX   PubMed=40073114;
CC   Characteristics: Transduced with a Kif7-SNAP tag construct (PubMed=40073114).
CC   Characteristics: Transfected with both a pEF5-FRT-DEST-3XHA-Halo-mGLI2 and a pOG44 constructs (from parent cell line).
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1098239; Kif7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95728; Gli2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E7UG ! NIH3T3 Halo-GLI2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   NIH3T3 Kif7 KO
AC   CVCL_E7UI
SY   NIH3T3 KIF7-/-
RX   PubMed=40073114;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1098239; Kif7.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NIH3T3 KIF7-Halo
AC   CVCL_E7UH
RX   PubMed=40073114;
CC   Characteristics: Transfected with both a pEF5/FRT/DEST/mKIF7-Halo and a pOG44 constructs (PubMed=40073114).
CC   Characteristics: Transfected with a pFRT/lacZeo construct that contains a FRT site for subsequent targeted integration of a Flp-In expression vector (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1098239; Kif7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U422 ! Flp-In-3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NIH3T3-3
AC   CVCL_L992
DR   RCB; RCB0150
DR   Wikidata; Q54930592
CC   Discontinued: RCB; RCB0150; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   NIH3T3-3-4
AC   CVCL_L993
DR   CLO; CLO_0050553
DR   RCB; RCB1862
DR   Wikidata; Q54930593
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L992 ! NIH3T3-3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   NIH3T3-47
AC   CVCL_VA35
DR   Wikidata; Q54930594
CC   Discontinued: New England Biolabs; Catalog number C2001.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   NIH3T3-C11
AC   CVCL_F1XB
SY   C11
RX   PubMed=36078083;
CC   Doubling time: 14.63 hours (PubMed=36078083).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH3T3-F2
AC   CVCL_F1XC
SY   F2
RX   PubMed=36078083;
CC   Doubling time: 16.34 hours (PubMed=36078083).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NIH3T3/13C7
AC   CVCL_M025
DR   CLO; CLO_0050550
DR   RCB; RCB0057
DR   Wikidata; Q54930595
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   NIH3T3/14-1
AC   CVCL_L995
DR   CLO; CLO_0050549
DR   RCB; RCB0056
DR   Wikidata; Q54930596
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   NIH3T3/ATCC/CMV-Luc
AC   CVCL_4Y01
DR   JCRB; JCRB1503
DR   JCRB; NIHS0730
DR   Wikidata; Q54930597
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1503).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0730; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   NIH3T3/fPD1
AC   CVCL_D2QR
DR   Wikidata; Q127382954
RX   PubMed=37095139;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:68742; Cat PDCD1 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NIH3T3/fPDL1
AC   CVCL_D2QS
DR   Wikidata; Q127382956
RX   PubMed=37095139;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:60602; Cat CD274 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NIH3T3/GFP
AC   CVCL_JY97
DR   Cell_Biolabs; AKR-214
DR   Wikidata; Q54930598
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   NIH3T3/NFkB-luc
AC   CVCL_KS45
DR   Wikidata; Q54930599
CC   Characteristics: The luciferase reporter gene is under the control of multiple copies of the NF-kappaB response element.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Thermo Fisher/Panomics; Catalog number RC0015.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   NIHi003-A
AC   CVCL_C1V2
DR   BioSamples; SAMEA13793753
DR   hPSCreg; NIHi003-A
DR   Wikidata; Q114312515
CC   From: National Institutes of Health; Bethesda; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NIHi004-A
AC   CVCL_C1V3
DR   BioSamples; SAMEA13793776
DR   hPSCreg; NIHi004-A
DR   Wikidata; Q114312519
CC   From: National Institutes of Health; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NIHTVBi001-A
AC   CVCL_WU70
SY   iPSCp117
DR   hPSCreg; NIHTVBi001-A
DR   Wikidata; Q98127860
RX   PubMed=31234109;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1606; CCR5; Simple; p.Ser185Ilefs*32 (c.554_585del32) (CCR5del32); ClinVar=VCV000008184; Zygosity=Homozygous (PubMed=31234109).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31234109
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 13,19
ST   D21S11: 30
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 7,11
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   Penta D: 10,13
ST   Penta E: 7,20
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NIHTVBi002-A
AC   CVCL_WU71
SY   iPSCp118
DR   hPSCreg; NIHTVBi002-A
DR   Wikidata; Q98127863
RX   PubMed=31234109;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1606; CCR5; Simple; p.Ser185Ilefs*32 (c.554_585del32) (CCR5del32); ClinVar=VCV000008184; Zygosity=Homozygous (PubMed=31234109).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31234109
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D21S11: 31.2,33.2
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,22
ST   Penta D: 12,13
ST   Penta E: 5,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NIHTVBi003-A
AC   CVCL_WU72
SY   iPSCp120
DR   hPSCreg; NIHTVBi003-A
DR   Wikidata; Q98127865
RX   PubMed=31234109;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1606; CCR5; Simple; p.Ser185Ilefs*32 (c.554_585del32) (CCR5del32); ClinVar=VCV000008184; Zygosity=Homozygous (PubMed=31234109).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31234109
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D21S11: 29,30
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,14
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NIHTVBi004-A
AC   CVCL_ZE05
SY   HT405A
DR   hPSCreg; NIHTVBi004-A
DR   Wikidata; Q98127867
RX   PubMed=32344328;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg332Cys (c.994C>T); ClinVar=VCV000009224; Zygosity=Heterozygous (PubMed=32344328).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32344328
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,14
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 31
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   NIHTVBi005-A
AC   CVCL_ZE06
SY   HT406D
DR   hPSCreg; NIHTVBi005-A
DR   Wikidata; Q98127869
RX   PubMed=32344328;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Arg169Cys (c.505C>T); ClinVar=VCV000009219; Zygosity=Heterozygous (PubMed=32344328).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32344328
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D18S51: 12,15
ST   D21S11: 29,34.2
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 19,22
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   NIHTVBi006-A
AC   CVCL_YM86
SY   HT407D
DR   hPSCreg; NIHTVBi006-A
DR   Wikidata; Q98127872
RX   PubMed=32344328;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Cys233Gly (c.697T>G); Zygosity=Heterozygous (PubMed=32344328).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32344328
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 15,16
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 12,19
ST   TH01: 8,9
ST   TPOX: 11,12
ST   vWA: 16
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   NIHTVBi007-A
AC   CVCL_ZE07
SY   HT409A
DR   hPSCreg; NIHTVBi007-A
DR   Wikidata; Q98127875
RX   PubMed=32344328;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Cys222Tyr (c.665G>A); ClinVar=VCV000447867; Zygosity=Heterozygous (PubMed=32344328).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32344328
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 12,14
ST   D18S51: 12,15
ST   D21S11: 28,29
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 20,21
ST   Penta D: 12,13
ST   Penta E: 10,20
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   NIHTVBi008-A
AC   CVCL_ZE08
SY   HT454D
DR   hPSCreg; NIHTVBi008-A
DR   Wikidata; Q98127877
RX   PubMed=32344328;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Cys455Tyr (c.1364G>A); ClinVar=VCV000447784; Zygosity=Heterozygous (PubMed=32344328).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32344328
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,19
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 10,12
ST   Penta E: 11
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C84606; CADASIL syndrome
DI   ORDO; Orphanet_136; CADASIL
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   NIHTVBi009-A
AC   CVCL_YM87
DR   hPSCreg; NIHTVBi009-A
DR   Wikidata; Q98127879
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   NIHTVBi010-A
AC   CVCL_YM88
DR   hPSCreg; NIHTVBi010-A
DR   Wikidata; Q98127882
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   NIHTVBi011-A
AC   CVCL_YM83
SY   AD-HIES3
DR   hPSCreg; NIHTVBi011-A
DR   SKIP; SKIP005573
DR   Wikidata; Q98127885
RX   PubMed=31707214;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Pro639Ala (c.1915C>G); ClinVar=VCV001429145; Zygosity=Heterozygous (PubMed=31707214).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31707214
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,13
ST   D16S539: 9,10
ST   D18S51: 13,17
ST   D21S11: 29,31
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D7S820: 9,11
ST   D8S1179: 8,15
ST   FGA: 19,25
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3144; Hyperimmunoglobulin E syndrome
DI   ORDO; Orphanet_2314; Autosomal dominant hyper-IgE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NIHTVBi012-A
AC   CVCL_YM84
SY   AD-HIES4
DR   hPSCreg; NIHTVBi012-A
DR   SKIP; SKIP005574
DR   Wikidata; Q98127888
RX   PubMed=31707214;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Glu652Lys (c.1954G>A); Zygosity=Heterozygous (PubMed=31707214).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31707214
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D21S11: 24.2,28
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,16
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 13,15
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3144; Hyperimmunoglobulin E syndrome
DI   ORDO; Orphanet_2314; Autosomal dominant hyper-IgE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   NIHTVBi013-A
AC   CVCL_YM85
SY   AD-HIES5
DR   hPSCreg; NIHTVBi013-A
DR   SKIP; SKIP005575
DR   Wikidata; Q98127890
RX   PubMed=31707214;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Val463del (c.1384_1386GTG[1]) (c.1387_1389delGTG); ClinVar=VCV000018303; Zygosity=Heterozygous (PubMed=31707214).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31707214
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 17
ST   D21S11: 27,31.2
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 16
ST   FGA: 21,24
ST   Penta D: 9,11
ST   Penta E: 11,17
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3144; Hyperimmunoglobulin E syndrome
DI   ORDO; Orphanet_2314; Autosomal dominant hyper-IgE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   NIHTVBi014-A
AC   CVCL_YM89
SY   p342
DR   hPSCreg; NIHTVBi014-A
DR   Wikidata; Q98127892
RX   PubMed=32721894;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:25118; OTULIN; Simple; p.Leu272Pro (c.815T>C); ClinVar=VCV000254124; Zygosity=Homozygous (PubMed=32721894).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32721894
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 12,16
ST   D21S11: 31.2
ST   D3S1358: 14
ST   D5S818: 9,11
ST   D7S820: 11,13
ST   D8S1179: 13,16
ST   FGA: 21,24
ST   Penta D: 12,14
ST   Penta E: 7,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C174441; Autoinflammation, panniculitis, and dermatosis syndrome
DI   ORDO; Orphanet_500062; Infantile-onset periodic fever-panniculitis-dermatosis syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   NIHTVBi015-A
AC   CVCL_ZE09
SY   HT188
DR   BioSample; SAMN14510998
DR   hPSCreg; NIHTVBi015-A
DR   Wikidata; Q98127895
RX   PubMed=34419745;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple; p.Ala111Leufs*7 (c.331delG); Zygosity=Homozygous (PubMed=34419745).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   NIHTVBi016-A
AC   CVCL_B7SS
SY   HT876D
DR   BioSamples; SAMEA14269913
DR   hPSCreg; NIHTVBi016-A
DR   Wikidata; Q114312520
RX   PubMed=35660921;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:9545; PSMB8; Simple; p.Thr75Met (c.224C>T); ClinVar=VCV000659832; Zygosity=Homozygous (PubMed=35660921).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176619; Proteasome-associated autoinflammatory syndrome 1
DI   ORDO; Orphanet_324977; Proteasome-associated autoinflammatory syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi017-A
AC   CVCL_B7ST
SY   HT939A
DR   BioSamples; SAMEA14305983
DR   hPSCreg; NIHTVBi017-A
DR   Wikidata; Q114312521
RX   PubMed=35660921;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:9545; PSMB8; Simple; p.Thr75Met (c.224C>T); ClinVar=VCV000659832; Zygosity=Homozygous (PubMed=35660921).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176619; Proteasome-associated autoinflammatory syndrome 1
DI   ORDO; Orphanet_324977; Proteasome-associated autoinflammatory syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi018-A
AC   CVCL_B7SU
SY   HT940B
DR   BioSamples; SAMEA14305984
DR   hPSCreg; NIHTVBi018-A
DR   Wikidata; Q114312522
RX   PubMed=35660921;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:9545; PSMB8; Simple; p.Thr75Met (c.224C>T); ClinVar=VCV000659832; Zygosity=Homozygous (PubMed=35660921).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176619; Proteasome-associated autoinflammatory syndrome 1
DI   ORDO; Orphanet_324977; Proteasome-associated autoinflammatory syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi019-A
AC   CVCL_B7SV
SY   HT852
DR   BioSamples; SAMEA14026991
DR   hPSCreg; NIHTVBi019-A
DR   Wikidata; Q114312526
RX   PubMed=36070637;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.His69Pro (c.206A>C); Zygosity=Heterozygous (PubMed=36070637).
CC   Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.Gly120Glu (c.359G>A); Zygosity=Heterozygous (PubMed=36070637).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61253; Leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi019-A-1
AC   CVCL_B7SW
SY   HT852-DC; HT852-Double Corrected
DR   BioSamples; SAMEA14027204
DR   hPSCreg; NIHTVBi019-A-1
DR   Wikidata; Q114312530
RX   PubMed=36070637;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple_corrected; p.His69Pro (c.206A>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36070637).
CC   Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple_corrected; p.Gly120Glu (c.359G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36070637).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61253; Leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7SV ! NIHTVBi019-A
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi020-A
AC   CVCL_B7SX
SY   HT853
DR   BioSamples; SAMEA14027189
DR   hPSCreg; NIHTVBi020-A
DR   Wikidata; Q114312534
RX   PubMed=36070637;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.His69Pro (c.206A>C); Zygosity=Heterozygous (PubMed=36070637).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi021-A
AC   CVCL_B7SY
SY   HT854
DR   BioSamples; SAMEA14027200
DR   hPSCreg; NIHTVBi021-A
DR   Wikidata; Q114312535
RX   PubMed=36070637;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.Gly120Glu (c.359G>A); Zygosity=Heterozygous (PubMed=36070637).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi022-A
AC   CVCL_B7SZ
SY   HT964
DR   BioSamples; SAMEA14027202
DR   hPSCreg; NIHTVBi022-A
DR   Wikidata; Q114312536
RX   PubMed=36070637;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.Leu62Pro (c.185T>C); Zygosity=Homozygous (PubMed=36070637).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61253; Leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi023-A
AC   CVCL_B7T0
DR   hPSCreg; NIHTVBi023-A
DR   Wikidata; Q114312537
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   NIHTVBi024-A
AC   CVCL_C1QD
SY   182-5
DR   BioSamples; SAMEA110414316
DR   hPSCreg; NIHTVBi024-A
DR   Wikidata; Q114312542
RX   PubMed=36399927;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27962; STING1; Simple; p.Asn154Ser (c.461A>G); ClinVar=VCV000143861; Zygosity=Heterozygous (PubMed=36399927).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177547; STING-associated vasculopathy, infantile-onset
DI   ORDO; Orphanet_425120; STING-associated vasculopathy with onset in infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi025-A
AC   CVCL_C1QE
SY   198-2
DR   BioSamples; SAMEA110420003
DR   hPSCreg; NIHTVBi025-A
DR   Wikidata; Q114312544
RX   PubMed=36399927;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:27962; STING1; Simple; p.Val147Leu (c.439G>C); ClinVar=VCV000143863; Zygosity=Heterozygous (PubMed=36399927).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177547; STING-associated vasculopathy, infantile-onset
DI   ORDO; Orphanet_425120; STING-associated vasculopathy with onset in infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi026-A
AC   CVCL_C1QF
SY   199-2
DR   BioSamples; SAMEA110421569
DR   hPSCreg; NIHTVBi026-A
DR   Wikidata; Q114312545
RX   PubMed=36399927;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27962; STING1; Simple; p.Asn154Ser (c.461A>G); ClinVar=VCV000143861; Zygosity=Heterozygous (PubMed=36399927).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177547; STING-associated vasculopathy, infantile-onset
DI   ORDO; Orphanet_425120; STING-associated vasculopathy with onset in infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi027-A
AC   CVCL_C1QG
SY   1131
DR   BioSamples; SAMEA110411658
DR   hPSCreg; NIHTVBi027-A
DR   Wikidata; Q114312546
RX   PubMed=36399927;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27962; STING1; Simple; p.Asn154Ser (c.461A>G); ClinVar=VCV000143861; Zygosity=Heterozygous (PubMed=36399927).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177547; STING-associated vasculopathy, infantile-onset
DI   ORDO; Orphanet_425120; STING-associated vasculopathy with onset in infancy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   NIHTVBi028-A
AC   CVCL_C4RU
SY   HT605B
DR   BioSamples; SAMEA111353028
DR   hPSCreg; NIHTVBi028-A
DR   Wikidata; Q116049890
RX   PubMed=36215934;
CC   From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6735; LYN; Simple; p.Tyr508Ter (c.1524C>G); ClinVar=VCV001895417; Zygosity=Homozygous (PubMed=36215934).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   NIID-CTR
AC   CVCL_Z827
DR   Wikidata; Q54930600
RX   PubMed=22706601;
CC   Group: Insect cell line.
CC   Doubling time: 20 hours (Note=At 30th passage in the presence of 12% FBS), 46 hours (Note=At 60th passage in 5% FBS), 76 hours (Note=At 60th passage in the absence of FBS) (PubMed=22706601).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7178; ! Culex tritaeniorhynchus (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIKS
AC   CVCL_A1LW
SY   BC1-Ep/SL; BC-1-Ep/SL; Normal Immortal KeratinocyteS
DR   GEO; GSM2197772
DR   GEO; GSM2197773
DR   GEO; GSM2197774
DR   GEO; GSM3763043
DR   Wikidata; Q102114626
RX   Patent=US6884595;
RX   PubMed=10502513;
RX   PubMed=10692102;
RX   PubMed=20688150;
RX   PubMed=23899513;
RX   PubMed=24527287;
RX   PubMed=28623356;
RX   PubMed=29021401;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12191.
CC   Biotechnology: Can be used to construct a living bioengineered skin substitute (StrataGraft) intended to provide immediate wound coverage and promote wound healaling through sustained expression by living cells of wound healing factors (PubMed=24527287).
CC   Biotechnology: Can be used to construct a human skin model (Stratatest) that can be used to assess tissue damage caused by chemical or physical agents and for the identification and characterization of agents formulated to mitigate this damage (PubMed=20688150).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Lee, Denis L.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D21S11: 31,31.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 20,24
ST   Penta D: 12,17
ST   Penta E: 7,17
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   NIKS-16
AC   CVCL_B0UM
SY   NIKS16; BC-1-Ep/SL/HPV-16
DR   GEO; GSM2197775
DR   GEO; GSM2197776
DR   GEO; GSM2197777
DR   Wikidata; Q108821045
RX   PubMed=10864676;
RX   PubMed=28623356;
RX   PubMed=29021401;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1LW ! NIKS
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   NIKS-16deltaE7
AC   CVCL_B0UN
SY   BC-1-Ep/SL/HPV-16/E7TTL; 13-9
DR   GEO; GSM2197781
DR   GEO; GSM2197782
DR   GEO; GSM2197783
DR   Wikidata; Q108821046
RX   PubMed=10864676;
RX   PubMed=28623356;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) (Note=With defective E7).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1LW ! NIKS
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   NIKS-18
AC   CVCL_B0UP
DR   GEO; GSM2197778
DR   GEO; GSM2197779
DR   GEO; GSM2197780
DR   Wikidata; Q108821047
RX   PubMed=28623356;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1LW ! NIKS
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   NIL 1c1
AC   CVCL_8737
SY   Nil1C1
DR   CLO; CLO_0050253
DR   RCB; RCB0245
DR   Wikidata; Q54930601
RX   PubMed=4337244;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8743 ! NIL B1
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   NIL 2c1
AC   CVCL_8739
SY   Nil 2C1; Nil2C1
DR   CLO; CLO_0050254
DR   RCB; RCB0244
DR   Wikidata; Q54930602
RX   PubMed=1169114;
RX   PubMed=4337244;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8742 ! Nil-2E
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   NIL 2c2
AC   CVCL_8740
SY   Nil 2C2; Nil2C2
DR   CLO; CLO_0050255
DR   RCB; RCB0243
DR   Wikidata; Q54930603
RX   PubMed=1169114;
RX   PubMed=4337244;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8742 ! Nil-2E
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   NIL 2c3
AC   CVCL_8741
SY   Nil 2C3; Nil2C3
DR   Wikidata; Q54930604
RX   PubMed=4337244;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8742 ! Nil-2E
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   NIL B1
AC   CVCL_8743
DR   Wikidata; Q54930605
RX   PubMed=4337244;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8738 ! Nil-2
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 6
//
ID   Nil-1
AC   CVCL_W454
DR   Wikidata; Q54930606
RX   PubMed=6039764;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_8738 ! Nil-2
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   Nil-2
AC   CVCL_8738
AS   CVCL_3071
SY   NIL-2; NIL 2; Nil 2; NIL2; Nil2; NIL
DR   ATCC; CRL-6443
DR   JCRB; IFO50018
DR   Wikidata; Q54930607
RX   PubMed=6039764;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6443; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_W454 ! Nil-1
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Nil-2E
AC   CVCL_8742
SY   NIL 2e; NIL 2E; Nil2e; Nil-2 clone E
DR   Wikidata; Q54930608
RX   PubMed=4337244;
RX   PubMed=5650922;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8738 ! Nil-2
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 6
//
ID   NIL-SF2
AC   CVCL_3072
DR   JCRB; IFO50426
DR   Wikidata; Q54930610
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in serum-free culture conditions.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8738 ! Nil-2
SX   Male
AG   13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   NIM-1
AC   CVCL_5344
SY   NIM
DR   Cosmic; 849974
DR   Cosmic; 931240
DR   Wikidata; Q54930611
RX   PubMed=1372885;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=NIM-1
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Derived from site: Metastatic; Bone, sacrum; UBERON=UBERON_0003690.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   NIMHi001-A
AC   CVCL_YT35
SY   BPPD01
DR   BioSamples; SAMEA6675820
DR   hPSCreg; NIMHi001-A
DR   SKIP; SKIP005731
DR   Wikidata; Q98127897
RX   PubMed=32244201;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ile1371Val (c.4111A>G); ClinVar=VCV000039176; Zygosity=Heterozygous (PubMed=32244201).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   NIMHi002-A
AC   CVCL_A1DJ
SY   BPPD02
DR   BioSamples; SAMEA7267294
DR   hPSCreg; NIMHi002-A
DR   Wikidata; Q102114627
RX   PubMed=33010678;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33010678
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15,19
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   NIMHi003-A
AC   CVCL_A1DK
SY   BPPD03
DR   BioSamples; SAMEA7267296
DR   hPSCreg; NIMHi003-A
DR   Wikidata; Q102114628
RX   PubMed=33010678;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33010678
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D3S1358: 24
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 14,15
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   NIMHi004-A
AC   CVCL_C0CH
SY   BPHC-01
DR   BioSamples; SAMEA12097271
DR   hPSCreg; NIMHi004-A
DR   Wikidata; Q114312547
RX   PubMed=35220026;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NIMHi005-A
AC   CVCL_C0CI
SY   BPHC-02
DR   BioSamples; SAMEA12097272
DR   hPSCreg; NIMHi005-A
DR   Wikidata; Q114312548
RX   PubMed=35220026;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NIMHi006-A
AC   CVCL_C0CJ
SY   BPHC-03
DR   BioSamples; SAMEA12097273
DR   hPSCreg; NIMHi006-A
DR   Wikidata; Q114312549
RX   PubMed=35220026;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NIMHi007-A
AC   CVCL_D0K6
DR   BioSamples; SAMEA112358184
DR   hPSCreg; NIMHi007-A
DR   Wikidata; Q123033188
RX   PubMed=37269666;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NIMHi008-A
AC   CVCL_D0K7
SY   NphyiALS1
DR   BioSamples; SAMEA114007117
DR   hPSCreg; NIMHi008-A
DR   Wikidata; Q123033189
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:15710; LDB3; Simple; p.Ala485Ser (c.1453G>T); ClinVar=VCV000045519; Zygosity=Heterozygous (hPSCreg=NIMHi008-A).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   NIMHi009-A
AC   CVCL_D0K8
DR   BioSamples; SAMEA114323040
DR   hPSCreg; NIMHi009-A
DR   Wikidata; Q123033190
RX   PubMed=38368738;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   NIMHi010-A
AC   CVCL_D6J0
DR   BioSamples; SAMEA115038796
DR   hPSCreg; NIMHi010-A
DR   Wikidata; Q127382957
RX   PubMed=38412659;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   NIMHi011-A
AC   CVCL_D6J1
DR   hPSCreg; NIMHi011-A
DR   Wikidata; Q127382958
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   NIMHi012-A
AC   CVCL_D6J2
DR   BioSamples; SAMEA117610314
DR   hPSCreg; NIMHi012-A
DR   Wikidata; Q127382959
RX   PubMed=40848398;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Ile227Thr (c.680T>C); ClinVar=VCV000930374; Zygosity=Heterozygous; Note=De novo mutation (PubMed=40848398).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176016; Febrile seizures, familial, 3A
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 4
//
ID   NIMHi013-A
AC   CVCL_D6J3
DR   BioSamples; SAMEA115577279
DR   hPSCreg; NIMHi013-A
DR   Wikidata; Q127382961
RX   PubMed=39383605;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Glu1032Lys (c.3094G>A); ClinVar=VCV003242014; Zygosity=Heterozygous (PubMed=39383605).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NIMHi014-A
AC   CVCL_D6J4
DR   BioSamples; SAMEA115598640
DR   hPSCreg; NIMHi014-A
DR   Wikidata; Q127382962
RX   PubMed=39923287;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Tyr1374Ter (c.4122C>G); ClinVar=VCV002664188; Zygosity=Heterozygous (PubMed=39923287).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NIMHi015-A
AC   CVCL_D6J5
SY   PD06
DR   BioSamples; SAMEA115344211
DR   hPSCreg; NIMHi015-A
DR   Wikidata; Q127382963
RX   PubMed=38739971;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; c.(171+1_172-1)_(412+1_413-1)del (Ex2i-3i del); Zygosity=Homozygous (PubMed=38739971).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   NIMHi016-A
AC   CVCL_E6X2
DR   BioSamples; SAMEA116131285
DR   hPSCreg; NIMHi016-A
RX   PubMed=39787833;
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:8896; PGK1; Simple; p.Asn5Lys (c.15C>G); Zygosity=Hemizygous (PubMed=39787833).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126738; Phosphoglycerate kinase 1 deficiency
DI   ORDO; Orphanet_713; Glycogen storage disease due to phosphoglycerate kinase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NIMHi017-A
AC   CVCL_E6X3
DR   hPSCreg; NIMHi017-A
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   NIMHi018-A
AC   CVCL_E7SQ
SY   PD07
DR   BioSamples; SAMEA116324150
DR   hPSCreg; NIMHi018-A
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Trp403Ter (c.1208G>A); Zygosity=Homozygous (hPSCreg=NIMHi018-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NIMHi019-A
AC   CVCL_E7SR
DR   BioSamples; SAMEA117661315
DR   hPSCreg; NIMHi019-A
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   NIMHi020-A
AC   CVCL_F0T2
DR   BioSamples; SAMEA118088681
DR   hPSCreg; NIMHi020-A
CC   From: National Institute of Mental Health and Neurosciences; Bengaluru; India.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NimoAb101
AC   CVCL_B0GA
DR   Wikidata; Q108821048
RX   Patent=US11008405;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 03050904.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O00187; Human MASP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   NIMP-R10
AC   CVCL_A8N2
DR   Wikidata; Q102114629
RX   PubMed=1640170;
RX   PubMed=6204196;
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   NIMP-R11
AC   CVCL_A8N3
DR   Wikidata; Q102114630
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: Mouse antigen on eosinophils.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R12
AC   CVCL_A8N4
DR   Wikidata; Q102114632
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   NIMP-R13
AC   CVCL_A8N5
DR   Wikidata; Q102114634
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on eosinophils.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R14
AC   CVCL_A8N6
DR   ECACC; 18071701
DR   Wikidata; Q102114635
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse antigen on neutrophils.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R16
AC   CVCL_A8N7
DR   Wikidata; Q102114637
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on granulocyte-macrophages.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R3
AC   CVCL_A8M7
DR   Wikidata; Q102114638
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: Mouse antigen on eosinophils.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R4
AC   CVCL_A8M8
DR   Wikidata; Q102114640
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: Mouse antigen on eosinophils.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R5
AC   CVCL_A8M9
DR   Wikidata; Q102114641
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: Mouse antigen on granulocyte-macrophages.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R6
AC   CVCL_A8N0
DR   Wikidata; Q102114642
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse antigen on eosinophils.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIMP-R9
AC   CVCL_A8N1
DR   Wikidata; Q102114643
RX   PubMed=6743568;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse antigen on granulocyte-macrophages.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   NIP
AC   CVCL_WH37
DR   Wikidata; Q98127899
RX   PubMed=27292541;
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   NIPBC-1
AC   CVCL_U921
SY   NIPBC1; National Institute of Pathology Breast Cancer-1
DR   Wikidata; Q54930612
RX   PubMed=24502646;
WW   Provider; NICHDR; -; http://instpath.gov.in/3.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Indian.
CC   Doubling time: 33.25 hours (PubMed=24502646).
CC   Karyotypic information: Near tetraploid karyotype with a modal number of 58 to 62 chromosomes.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=24502646).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=24502646
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TPOX: 8,13
ST   vWA: 12
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   NIPBC-2
AC   CVCL_U922
SY   NIPBC2; National Institute of Pathology Breast Cancer-2
DR   Wikidata; Q54930613
RX   PubMed=24502646;
WW   Provider; NICHDR; -; http://instpath.gov.in/3A.pdf
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Indian.
CC   Doubling time: 31.56 hours (PubMed=24502646).
CC   Karyotypic information: Near tetraploid/pentaploid karyotype with a modal number of 107 to 110 chromosomes.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=24502646).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
ST   Source(s): PubMed=24502646
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,12
ST   TPOX: 8
ST   vWA: 12
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   NiPCK-1
AC   CVCL_WB01
SY   Nipck-1
DR   IBRC; C10607
DR   Wikidata; Q98127903
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61269; Niemann-Pick disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   Nips-B2
AC   CVCL_T775
SY   iPS-B2; HPS0223
DR   RCB; HPS0223
DR   SKIP; SKIP000266
DR   Wikidata; Q54930614
RX   PubMed=22912751;
RX   PubMed=26199952;
RX   PubMed=32996421;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   Nips-B2 GNAS R201H/+ clone 1
AC   CVCL_A2GL
SY   GNASR201H/+1
DR   Wikidata; Q105510389
RX   PubMed=32996421;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4392; GNAS; Simple_edited; p.Arg201His (c.602G>A); ClinVar=VCV000015934; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32996421).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T775 ! Nips-B2
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   Nips-B2 GNAS R201H/+ clone 2
AC   CVCL_A2GM
SY   GNASR201H/+2
DR   Wikidata; Q105510393
RX   PubMed=32996421;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4392; GNAS; Simple_edited; p.Arg201His (c.602G>A); ClinVar=VCV000015934; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32996421).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T775 ! Nips-B2
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   NIRRHe001-A
AC   CVCL_B234
SY   KIND-1; KIND1
DR   hPSCreg; NIRRHe001-A
DR   SKIP; SKIP002257
DR   Wikidata; Q54930615
RX   PubMed=18699724;
RX   PubMed=21614653;
CC   From: National Institute for Research in Reproductive Health; Mumbai; India.
CC   HLA typing: A*11,29; B*07,35; C*04,15; DQB1*:03; DRB1*:10:01,07 (PubMed=18699724).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=18699724
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 11,14
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   NIRRHe002-A
AC   CVCL_B235
SY   KIND-2; KIND2
DR   hPSCreg; NIRRHe002-A
DR   SKIP; SKIP002258
DR   Wikidata; Q54930616
RX   PubMed=18699724;
RX   PubMed=21614653;
CC   From: National Institute for Research in Reproductive Health; Mumbai; India.
CC   HLA typing: A*01,30; B*35,40; C*12,15; DQB1*05,06; DRB1*15:02,05 (PubMed=18699724).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=18699724
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   NIS-G
AC   CVCL_6005
DR   CLS; 300303
DR   Wikidata; Q54930617
CC   Population: Caucasian.
ST   Source(s): CLS=300303
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 21
ST   D21S11: 31,31.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   NISES-AnPe-426
AC   CVCL_Z103
SY   AnPe-426
DR   NISES; SK0024
DR   Wikidata; Q54930618
RX   DOI=10.11416/kontyushigen1930.64.79;
RX   PubMed=1748622;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7119; ! Antheraea pernyi (Chinese oak silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NISES-AnPe-428
AC   CVCL_AV48
SY   AnPe-428
DR   Wikidata; Q54930619
RX   CelloPub=CLPUB00320;
RX   DOI=10.11416/jibs.72.79;
RX   DOI=10.11416/kontyushigen1930.64.79;
RX   PubMed=34349353;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Virology: Supports productive replication of Autographa californica multiple nucleopolyhedrovirus (AcMNPV), Antheraea pernyi nucleopolyhedrovirus (AnpeNPV), Bombyx mori nucleopolyhedrovirus (BmNPV) and Hyphantria cunea multiple nucleopolyhedrovirus (HycuMNPV). Upon infection with Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV), a subset of the cells population undergoes apoptosis. Refractory to infection by Lymantria dispar multiple nucleopolyhedrovirus (LdMNPV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7119; ! Antheraea pernyi (Chinese oak silk moth)
HI   CVCL_Z103 ! NISES-AnPe-426
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   NISES-Anya-0611
AC   CVCL_Z107
SY   Anya-0611
DR   ICLDB; nises-anya-0611
DR   Wikidata; Q54930620
RX   PubMed=12892519;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275035.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7121; ! Antheraea yamamai (Japanese oak silkmoth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   NISES-BoMo-15AIIc
AC   CVCL_Z420
SY   NISES-BoMo-15 AIIc; BoMo-15 AIIc
DR   ICLDB; nises-bomo-15aiic
DR   NISES; SK0018
DR   Wikidata; Q54930621
RX   CelloPub=CLPUB00184;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kuroko.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z419 ! SES-BoMo-15AII
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   NISES-BoMo-Cam1
AC   CVCL_Z844
SY   NIAS-BoMo-Cam1
DR   ICLDB; nises-bomo-cam1
DR   NISES; SK0026
DR   Wikidata; Q54930622
RX   CelloPub=CLPUB00197;
RX   PubMed=15827172;
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Cambodge.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NISES-BoMo-DZ
AC   CVCL_Z552
DR   ICLDB; nises-bomo-dz
DR   Wikidata; Q54930623
RX   DOI=10.1303/aez.34.259;
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17389.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Daizo.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   NISES-BoMo-E2
AC   CVCL_Z556
DR   ICLDB; nises-bomo-e2
DR   Wikidata; Q54930624
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J147 x C145.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NISES-BoMo-E3
AC   CVCL_Z557
SY   NIAS-BoMo-E3
DR   ICLDB; nises-bomo-e3
DR   Wikidata; Q54930625
RX   DOI=10.11416/jibs.74.117;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: N137 x C146.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NISES-BoMo-E4
AC   CVCL_Z558
SY   NIAS-BoMo-E4
DR   ICLDB; nises-bomo-e4
DR   Wikidata; Q54930626
RX   DOI=10.11416/jibs.74.117;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: N137 x C146.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NISES-BoMo-KG
AC   CVCL_Z553
DR   ICLDB; nises-bomo-kg
DR   Wikidata; Q54930627
RX   DOI=10.1303/aez.34.259;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17390.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kokuga.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   NISES-BoMo-MK
AC   CVCL_Z554
DR   ICLDB; nises-bomo-mk
DR   Wikidata; Q54930628
RX   DOI=10.1303/aez.34.259;
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17391.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Murasaki kaiko.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   NISES-BoMo-OH
AC   CVCL_Z555
DR   ICLDB; nises-bomo-oh
DR   Wikidata; Q54930629
RX   DOI=10.1303/aez.34.259;
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17392.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Ohha.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   NISES-SaCy-12
AC   CVCL_Z104
DR   ICLDB; nises-sacy-12
DR   NISES; SK0025
DR   Wikidata; Q54930630
RX   DOI=10.11416/kontyushigen1930.64.270;
CC   Group: Insect cell line.
CC   Doubling time: 4 days (Note=At 41th passage), 2.3 days (Note=At 307th passage) (DOI=10.11416/kontyushigen1930.64.270).
CC   Misspelling: NISE-Sacy-12; Note=Occasionally.
CC   Discontinued: NGRC Genebank; Catalog number 275033.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=7127; ! Samia cynthia (Ailanthus silkmoth)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   NISH
AC   CVCL_U225
DR   Wikidata; Q54930631
RX   PubMed=9590506;
CC   Doubling time: 20-24 hours (PubMed=9590506).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Assaf x Booroola; VBO=VBO_0001304+VBO_0001345.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   NISK9
AC   CVCL_LB87
SY   NISK 9
DR   Wikidata; Q54930632
RX   Patent=US6372501;
RX   PubMed=10567373;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 09709106.
CC   Characteristics: Insulin secreting.
CC   Characteristics: Compared to the parent cell line, it has a repaired ATP-regulated potassium channel activity.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:59; ABCC8.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6257; KCNJ11.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6107; PDX1.
DI   NCIt; C122923; Persistent hyperinsulinemic hypoglycemia of infancy
DI   ORDO; Orphanet_276575; Autosomal dominant hyperinsulinism due to SUR1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LB86 ! NES2Y
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   NIT-1
AC   CVCL_3561
SY   NIT1
DR   CLO; CLO_0008175
DR   ATCC; CRL-2055
DR   BCRC; 60452
DR   IZSLER; BS TCL 192
DR   Wikidata; Q54930633
RX   PubMed=1647994;
RX   PubMed=8697299;
CC   Characteristics: Secretes insulin.
CC   Doubling time: 49.1 hours (Note=At 18th passage) (PubMed=1647994).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NOD/Lt-Tg(RIPTag)1Lt transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   NIT-2
AC   CVCL_3562
DR   CLO; CLO_0008176
DR   ATCC; CRL-2364
DR   Wikidata; Q54930634
RX   PubMed=9348219;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BLKS/J-Cpefat/1 x NOD/Lt-Tg(RIPTag)1Lt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   NIT-3
AC   CVCL_U269
DR   Wikidata; Q54930635
RX   PubMed=9348219;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: C57BLKS/J-Cpefat/1 x NOD/Lt-Tg(RIPTag)1Lt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   NIV-AA-706
AC   CVCL_Z268
DR   Wikidata; Q54930636
RX   PubMed=19533252;
CC   Group: Insect cell line.
CC   Doubling time: 102 hours (Note=At 23th passage), 23 hours (Note=At 52th passage) (PubMed=19533252).
OX   NCBI_TaxID=7159; ! Aedes aegypti (Yellowfever mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NIV-AK-453
AC   CVCL_Z347
SY   NIVI-AK-453
DR   Wikidata; Q28470898
RX   PubMed=1335966;
RX   PubMed=1429352;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Chikungunya virus, Sindbis virus, Japanese encephalitis virus (JEV), West Nile virus (WNV), dengue virus types 1 to 4, vesicular stomatitis virus (VSV), Chandipura virus and African horse sickness virus (PubMed=1335966; PubMed=1429352).
CC   Virology: Not susceptible to infection by Kaisodi virus and sandfly fever virus (SFV) (PubMed=1335966).
CC   Doubling time: 19 hours (Note=At 83th passage) (PubMed=1429352).
OX   NCBI_TaxID=1579483; ! Aedes krombeini (Mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 10
//
ID   NIV-BM-1296
AC   CVCL_Z309
DR   ICLDB; niv-bm-1296
DR   Wikidata; Q54930637
RX   PubMed=12362558;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Doubling time: ~60 hours (PubMed=12362558).
CC   Misspelling: NIV-HA-1296; PubMed=16037617.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NIV-BM-197
AC   CVCL_Z310
DR   ICLDB; niv-bm-197
DR   Wikidata; Q54930638
RX   PubMed=12362558;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Doubling time: ~60 hours (PubMed=12362558).
CC   Misspelling: NIV-HA-197; PubMed=16037617.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NIV-BtEPC
AC   CVCL_T049
DR   Wikidata; Q54930639
RX   PubMed=24056599;
CC   Group: Bat cell line.
CC   Virology: Susceptible to infection by Chandipura virus and bat adenovirus 1050597 (BtAdv-RLM 1050497).
OX   NCBI_TaxID=1081694; ! Pipistrellus ceylonicus (Kelaart's pipistrelle)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   NIV-CT-894
AC   CVCL_Z348
DR   Wikidata; Q54930640
RX   PubMed=12693860;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7178; ! Culex tritaeniorhynchus (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NIV-HA-1195
AC   CVCL_Z308
DR   ICLDB; niv-ha-1195
DR   Wikidata; Q54930641
RX   PubMed=12561972;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Doubling time: 96 hours (Note=At 8th passage), 60 hours (Note=At 43th passage) (PubMed=12561972).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   NIV-HA-197
AC   CVCL_Z307
DR   ICLDB; niv-ha-197
DR   Wikidata; Q54930642
RX   PubMed=12418922;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Doubling time: ~60 hours (PubMed=12418922).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIV-PTM-1095
AC   CVCL_Z349
DR   Wikidata; Q54930643
RX   PubMed=15802757;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NIV-SU-1095
AC   CVCL_Z306
DR   ICLDB; niv-su-1095
DR   Wikidata; Q54930644
RX   PubMed=11411040;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NIV-SU-893
AC   CVCL_Z350
DR   ICLDB; niv-su-893
DR   Wikidata; Q54930645
RX   PubMed=9112123;
RX   PubMed=10475268;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NIV-SU-992
AC   CVCL_Z351
DR   ICLDB; niv-su-992
DR   Wikidata; Q54930646
RX   CelloPub=CLPUB00176;
RX   PubMed=10475268;
RX   PubMed=16037617;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Female
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NIVI-CH-440
AC   CVCL_Z885
DR   ICLDB; nivi-ch-440
DR   Wikidata; Q54930647
RX   DOI=10.1007/BF02624190;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=757355; ! Cimex hemipterus (Tropical bed bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NIVI-CH-442
AC   CVCL_Z886
DR   ICLDB; nivi-ch-442
DR   Wikidata; Q54930648
RX   DOI=10.1007/BF02624190;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=757355; ! Cimex hemipterus (Tropical bed bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NIVI-CH-445
AC   CVCL_Z887
DR   ICLDB; nivi-ch-445
DR   Wikidata; Q54930649
RX   DOI=10.1007/BF02624190;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=757355; ! Cimex hemipterus (Tropical bed bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NIZEDSM1iD21-C3
AC   CVCL_B4ZQ
SY   D21C3
DR   Wikidata; Q110433098
RX   PubMed=25694335;
CC   Karyotypic information: Disomic Chr21 cell line that originate from a mosaic Down syndrome individual.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4ZP ! CM05287
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   NIZEDSM1iD21-C7
AC   CVCL_B4ZR
SY   D21C7
DR   Wikidata; Q110433099
RX   PubMed=25694335;
CC   Karyotypic information: Disomic Chr21 cell line that originate from a mosaic Down syndrome individual.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4ZP ! CM05287
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   NIZEDSM1iD21-C9
AC   CVCL_B4ZS
SY   D21C9
DR   Wikidata; Q110433100
RX   PubMed=25694335;
CC   Karyotypic information: Disomic Chr21 cell line that originate from a mosaic Down syndrome individual.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4ZP ! CM05287
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   NIZEDSM1iT21-C13
AC   CVCL_B4ZV
SY   T21C13
DR   Wikidata; Q110433101
RX   PubMed=25694335;
CC   Karyotypic information: Trisomic Chr21 cell line that originate from a mosaic Down syndrome individual.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4ZP ! CM05287
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   NIZEDSM1iT21-C5
AC   CVCL_B4ZT
SY   T21C5
DR   Wikidata; Q110433102
RX   PubMed=25694335;
CC   Karyotypic information: Trisomic Chr21 cell line that originate from a mosaic Down syndrome individual.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4ZP ! CM05287
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   NIZEDSM1iT21-C6
AC   CVCL_B4ZU
SY   T21C6
DR   Wikidata; Q110433103
RX   PubMed=25694335;
CC   Karyotypic information: Trisomic Chr21 cell line that originate from a mosaic Down syndrome individual.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4ZP ! CM05287
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   NJB
AC   CVCL_L113
DR   Wikidata; Q54930651
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=4530294;
RX   PubMed=14114966;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y9M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   NJDTHi001-A
AC   CVCL_A1NE
DR   BioSamples; SAMEA7346334
DR   hPSCreg; NJDTHi001-A
DR   Wikidata; Q102114644
RX   PubMed=33038746;
CC   From: Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6501; LAMP2; Simple; p.Leu156Ter (c.467T>G); ClinVar=VCV001323203; Zygosity=Hemizygous (PubMed=33038746).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84735; Glycogen storage disease type IIb
DI   ORDO; Orphanet_34587; Glycogen storage disease due to LAMP-2 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   NJG
AC   CVCL_3073
DR   BioSample; SAMN03470970
DR   JCRB; IFO50322
DR   Wikidata; Q54930652
RX   CelloPub=CLPUB00481;
RX   PubMed=3611867;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Doubling time: 80 hours (PubMed=3611867); 34 hours (Note=Lot 06132007) (JCRB=IFO50322).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): JCRB=IFO50322; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 23
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   NJMUi001-A
AC   CVCL_VE08
SY   iPKU-C10
DR   hPSCreg; NJMUi001-A
DR   Wikidata; Q54930653
RX   PubMed=29154227;
CC   From: Obstetrics and Gynecology Hospital, Nanjing Medical University; Nanjing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000000581; Zygosity=Heterozygous (PubMed=29154227).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Tyr325Ter (c.975C>G); ClinVar=VCV000102921; Zygosity=Heterozygous (PubMed=29154227).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   NJUCMi001-A
AC   CVCL_C6RL
SY   LAMA2c.3367delA iPSCs
DR   BioSamples; SAMEA111265573
DR   hPSCreg; NJUCMi001-A
DR   Wikidata; Q117704723
RX   PubMed=36334577;
CC   From: Nanjing University of Chinese Medicine; Nanjing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Lys1124Asnfs (c.3372delA) (c.3367delA); dbSNP=rs1361925574; Zygosity=Heterozygous (PubMed=36334577).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118783; Merosin-deficient congenital muscular dystrophy type 1A
DI   ORDO; Orphanet_258; Laminin subunit alpha 2-related congenital muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   NK 62
AC   CVCL_8267
SY   NK62; NK line 62
DR   Wikidata; Q54930654
RX   PubMed=10318937;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 6
//
ID   NK 70
AC   CVCL_8268
SY   NK70; NK line 70
DR   Wikidata; Q54930655
RX   PubMed=10318937;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 6
//
ID   NK m-1
AC   CVCL_8269
SY   NK line m-1
DR   Wikidata; Q54930656
RX   PubMed=10318937;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 6
//
ID   NK-6B10-E6
AC   CVCL_C8I4
DR   Wikidata; Q123033191
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NK-6G8-B5
AC   CVCL_C8I5
DR   Wikidata; Q123033192
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NK-8H5-E3
AC   CVCL_C8I6
DR   Wikidata; Q123033193
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NK-92
AC   CVCL_2142
SY   NK92; Natural Killer-92; NK-92.05; Neukoplast; aNK
DR   BTO; BTO_0003287
DR   CLO; CLO_0008177
DR   EFO; EFO_0022517
DR   AddexBio; C0003026/NA
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2407
DR   BCRC; 60414
DR   BioSample; SAMN03471836
DR   CCRID; 4201HUM-CCTCC00052
DR   CCTCC; GDC0052
DR   Cell_Model_Passport; SIDM01143
DR   Cosmic; 1534874
DR   Cosmic; 1542071
DR   Cosmic; 2025326
DR   Cosmic; 2390215
DR   Cosmic; 2785204
DR   DSMZ; ACC-488
DR   DSMZCellDive; ACC-488
DR   GEO; GSM472001
DR   IPD-IMGT/HLA; 13674
DR   Lonza; 1093
DR   Wikidata; Q17149636
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8152260;
RX   PubMed=9118301;
RX   PubMed=9573023;
RX   PubMed=10365666;
RX   PubMed=10803505;
RX   PubMed=11454312;
RX   PubMed=12850795;
RX   PubMed=16827800;
RX   PubMed=18424763;
RX   PubMed=19194464;
RX   PubMed=20454443;
RX   PubMed=21052088;
RX   PubMed=21570725;
RX   PubMed=25586472;
RX   PubMed=26559813;
RX   PubMed=30054012;
RX   PubMed=31126350;
RX   PubMed=31160637;
RX   PubMed=34349345;
RX   PubMed=36610812;
WW   Info; -; -; https://web.archive.org/web/20211125114549/http://www2.kumc.edu/soalab/LabLinks/cell%20lines/nk92.htm
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-and-morphology-of-nk-92-cells
WW   Info; ClinicalTrials.gov; NCT00900809; https://clinicaltrials.gov/study/NCT00900809
WW   Info; ClinicalTrials.gov; NCT00990717; https://clinicaltrials.gov/study/NCT00990717
WW   Info; ClinicalTrials.gov; NCT02465957; https://clinicaltrials.gov/study/NCT02465957
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/NK-92
WW   Provider; Brink Biologics; -; https://brinkbiologics.com/platform/
CC   Group: Patented cell line.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6670.
CC   Population: Caucasian.
CC   Characteristics: Laboratory use as a standard cell line for antibody-dependent cell-mediated cytotoxicity (ADCC) testing. Also being developed for cellular adoptive immunotherapy for cancers and viral infections.
CC   Characteristics: IL2 dependent.
CC   Characteristics: Does not express FCGR3A/CD16.
CC   Doubling time: 35.6 +- 6.1 hours (PubMed=31126350); ~40-50 hours (DSMZ=ACC-488).
CC   HLA typing: A*03:01:01,11:01:01; B*07:02:01,44:03:01; C*07:02:01,16:01:01; DPA1*01:03:01,01:03:01; DQB1*06:02:01,06:02:01 (DSMZCellDive=ACC-488).
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Unexplicit; Ex29-34del; Zygosity=Heterozygous (PubMed=16827800).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Neukoplast is used as a trademark to refer to NK-92 cells that are available for non-human research applications while aNK is used as a trademark to refer to cells from the cGMP-grade NK-92 cell-line that is in use for therapeutic human testing.
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and noncommercial suppliers of NK-92 cells. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Discontinued: AddexBio; C0003026/NA; true.
CC   Discontinued: BCRC; 60414; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
ST   Source(s): ATCC=CRL-2407; DSMZ=ACC-488; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 14,15
ST   D12S391: 19,22
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D1S1656: 12,14
ST   D21S11: 31.2,32
ST   D22S1045: 12,17
ST   D2S1338: 19,20
ST   D2S441: 19,20
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   DYS391: 12
ST   FGA: 20,22
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18 (DSMZ=ACC-488; Technion Genomics Center)
ST   vWA: 18 (ATCC=CRL-2407)
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   NK-92 clone 1
AC   CVCL_C7GQ
DR   Wikidata; Q117704724
RX   PubMed=36039429;
CC   Population: Caucasian.
CC   Characteristics: High cytotoxic activity (PubMed=36039429).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NK-92 clone 2
AC   CVCL_C7GR
DR   Wikidata; Q117704725
RX   PubMed=36039429;
CC   Population: Caucasian.
CC   Characteristics: Low cytotoxic activity (PubMed=36039429).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NK-92 GFP
AC   CVCL_VN56
SY   GFP+NK-92.05; GFP aNK control
DR   Wikidata; Q98127905
WW   Provider; Brink Biologics; -; https://brinkbiologics.com/platform/
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers for this cell line. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   NK-92.26.5
AC   CVCL_VN57
SY   NK-92fc
DR   Wikidata; Q98127909
RX   PubMed=18424763;
RX   PubMed=22023526;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   NK-92CI
AC   CVCL_U271
SY   NK-92 ci; NK92CI; NK-92 transfected with pCEP4-LTR-hIL2
DR   ATCC; CRL-2409
DR   BioSample; SAMN03471837
DR   Wikidata; Q54930657
RX   Patent=US8034332;
RX   PubMed=10365666;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6672.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Caution: NantKwest exclusively owns, controls and distributes this cell line.
CC   Discontinued: ATCC; CRL-2409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
ST   Source(s): ATCC=CRL-2409
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   NK-92MI
AC   CVCL_3755
SY   NK-92 MI; NK-92 mi; NK92-MI; NK92MI; NK-92 transfected with MFG-hIL2
DR   CLO; CLO_0008178
DR   ATCC; CRL-2408
DR   BCRC; 60438
DR   cancercelllines; CVCL_3755
DR   CCRID; 1102HUM-NIFDC00065
DR   Cell_Model_Passport; SIDM01201
DR   Cosmic-CLP; 1330981
DR   DepMap; ACH-002289
DR   GDSC; 1330981
DR   GEO; GSM1670278
DR   KCB; KCB 200677YJ
DR   LINCS_LDP; LCL-1127
DR   PharmacoDB; NK92MI_1160_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54930658
RX   Patent=US8034332;
RX   PubMed=10365666;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6671.
CC   Population: Caucasian.
CC   Characteristics: No longer dependent on IL2.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Genome ancestry: African=1.91%; Native American=0.5%; East Asian, North=2.04%; East Asian, South=0%; South Asian=0%; European, North=62.71%; European, South=32.85% (PubMed=30894373).
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers of NK-92MI. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Discontinued: BCRC; 60438; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
ST   Source(s): ATCC=CRL-2408; CCRID=1102HUM-NIFDC00065; Cosmic-CLP=1330981
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D21S11: 31.2,32
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 20,22
ST   Penta D: 10,12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NK-92MI human CD16a-V158
AC   CVCL_XZ60
SY   NK-92MI CD16a-V158
DR   KYinno; KC-1233
DR   Wikidata; Q98127911
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: KYinno; KC-1233; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3755 ! NK-92MI
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   NK-92MIhCD16
AC   CVCL_JX95
DR   Wikidata; Q54930659
RX   PubMed=28415754;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the CD16-BB-zeta construct that consist of a signal peptide, the FCGR3/CD16A extracellular domain, the CD8A extracellular domain, the CD28 TM and co-activation domains, the 4-1BB co-activation domain and finally the CD247/CD3Z signaling domain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=Extracellular domain).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Caution: NantKwest exclusively owns, controls and distributes NK-92MI. This CD16-modified variant of NK-92MI was created by a research group and is governed by a Material Transfer Agreement that prevents them from legally distributing the cells to any third party.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3755 ! NK-92MI
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   NK-92MIhCD64
AC   CVCL_JX96
DR   Wikidata; Q54930661
RX   PubMed=28415754;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the CD64-BB-zeta construct that consist of a signal peptide, the FCGR1A/CD64 extracellular domain, the CD8A extracellular domain, the CD28 TM and co-activation domains, the 4-1BB co-activation domain and finally the CD247/CD3Z signaling domain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3613; FCGR1A (Note=Extracellular domain).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Caution: NantKwest exclusively owns, controls and distributes NK-92MI. This CD64-modified variant of NK-92MI was created by a research group and is governed by a Material Transfer Agreement that prevents them from legally distributing the cells to any third party.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3755 ! NK-92MI
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   NK-NJ
AC   CVCL_C3ES
DR   Wikidata; Q123033194
RX   PubMed=36520345;
CC   Population: Chinese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: 48 hours (PubMed=36520345).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple; p.Met228Ile (c.684G>A); ClinVar=VCV001686397; Zygosity=Heterozygous (PubMed=36520345).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ile11Glufs*2 (c.30_54del); Zygosity=Heterozygous (PubMed=36520345).
CC   Sequence variation: Mutation; HGNC; HGNC:11367; STAT5B; Simple; p.Asn642His (c.1924A>C); ClinVar=VCV000657518; Zygosity=Heterozygous (PubMed=36520345).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=36520345).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: NK T-cell; CL=CL_0000814.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   NK-TY2
AC   CVCL_F0XV
RX   Patent=US7781210;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7865.
CC   Population: Japanese.
CC   Characteristics: IL2 dependent (Patent=US7781210).
CC   Doubling time: 72 hours (Patent=US7781210).
CC   Donor information: Although the patient was Epstein-Barr virus positive, the cell line is not.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: NK T-cell; CL=CL_0000814.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NK-YS
AC   CVCL_8461
AS   CVCL_AX40
SY   NKYS
DR   cancercelllines; CVCL_8461
DR   Cosmic; 1534872
DR   Cosmic; 1542075
DR   Cosmic; 2025325
DR   Cosmic; 2390119
DR   Cosmic; 2785205
DR   GEO; GSM472002
DR   GEO; GSM3021082
DR   Progenetix; CVCL_8461
DR   Wikidata; Q54930662
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9694726;
RX   PubMed=10803505;
RX   PubMed=19194464;
RX   PubMed=21052088;
RX   PubMed=25586472;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: ~48 hours (PubMed=9694726).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: NK T-cell; CL=CL_0000814.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   NK0504
AC   CVCL_LB91
DR   Wikidata; Q54930663
RX   PubMed=25723285;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_138017; 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 4
//
ID   NK101
AC   CVCL_WN95
DR   Wikidata; Q98127913
RX   PubMed=31126350;
CC   Population: Korean.
CC   Characteristics: Possesses fundamental characteristics of natural killer NK (cells). Potential to simultaneously act as a cytokine producer and a cytotoxic effector.
CC   Doubling time: 21.9 +- 2.4 hours (PubMed=31126350).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Kim, Sae Won.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 31.2,32.2
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   D8S1179: 11,15
ST   FGA: 21,24
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   NK2/13
AC   CVCL_F1I3
RX   Patent=US4423147;
RX   PubMed=6157091;
RX   PubMed=6167666;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NK2/13.35
AC   CVCL_F1I4
RX   Patent=US4423147;
RX   PubMed=6157091;
RX   PubMed=6167666;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1I3 ! NK2/13
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NK2/13.35.6
AC   CVCL_F1I5
SY   NK2
RX   Patent=US4423147;
RX   PubMed=6157091;
RX   PubMed=6167666;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Human alpha-interferons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F1I4 ! NK2/13.35
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NK3.3
AC   CVCL_7994
SY   NK 3.3
DR   EFO; EFO_0022365
DR   Lonza; 78
DR   PRIDE; PXD027051
DR   Wikidata; Q54930664
RX   PubMed=6982944;
RX   PubMed=30054012;
RX   PubMed=34368150;
WW   Info; -; -; https://web.archive.org/web/20141104150747/http://www2.kumc.edu/soalab/LabLinks/cell%20lines/nk33.htm
WW   Provider; SLU; 98-013; https://www.slu.edu/research/faculty-resources/research-innovation-group/browse-ip/research-tools/98-013-human-natural-killer-3-3-cell-line.php
CC   Characteristics: IL2 dependent.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   NK7801
AC   CVCL_F976
SY   NK-7801; Nara Kidney Tumor 7801
DR   TKG; TKG 0133
DR   Wikidata; Q54930665
RX   CelloPub=CLPUB00283;
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   NK92-41BB
AC   CVCL_B5ZF
DR   Wikidata; Q112129460
RX   PubMed=34349345;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the CD16-CAR construct that consist of the signal peptide, the FCGR3/CD16A extracellular domain, the CD8A extracellular domain, the CD28 TM and co-activation domains, the 4-1BB co-activation domain and finally the CD247/CD3Z signaling domain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=Extracellular domain).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   NK92-CD16
AC   CVCL_B5ZE
DR   Wikidata; Q112129461
RX   PubMed=34349345;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   NK92.39
AC   CVCL_A0AP
DR   Wikidata; Q108821049
RX   PubMed=15034010;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P40200; Human CD96.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   NKB-1
AC   CVCL_3919
SY   NKB1
DR   BTO; BTO_0003481
DR   TKG; TKG 0699
DR   Wikidata; Q54930666
RX   PubMed=9183630;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=9183630).
CC   Misspelling: NKK1; PubMed=9183630; Note=In two instances in the abstract.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): TKG=TKG 0699
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   NKc11
AC   CVCL_ZE26
DR   Wikidata; Q98127914
RX   PubMed=19157792;
RX   PubMed=21490615;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE27 ! NKc12
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   NKc12
AC   CVCL_ZE27
DR   Wikidata; Q98127916
RX   PubMed=19157792;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE26 ! NKc11
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   NKc21
AC   CVCL_ZE33
DR   Wikidata; Q98127919
RX   PubMed=20977447;
RX   PubMed=28765827;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   NKC3
AC   CVCL_6006
DR   Wikidata; Q54930667
RX   PubMed=6600260;
RX   PubMed=6983881;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=NKC3
CC   Characteristics: IL2 dependent.
CC   Caution: It is unclear which of the clones described in PubMed=6600260 has been later renamed as NKC3.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6-8W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   NKI-1
AC   CVCL_LI44
SY   NKI1; Nederlands Kanker Instituut-1
DR   Wikidata; Q54930668
RX   PubMed=1101782;
RX   PubMed=1104492;
RX   PubMed=7399746;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 6
//
ID   NKI-10
AC   CVCL_LI43
SY   NKI10; Nederlands Kanker Instituut-10
DR   Wikidata; Q54930669
RX   PubMed=1079770;
RX   PubMed=7399746;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 4
//
ID   NKI-2
AC   CVCL_LI41
SY   NKI2; Nederlands Kanker Instituut-2
DR   Wikidata; Q54930670
RX   PubMed=1079770;
RX   PubMed=1104492;
RX   PubMed=4549213;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 4
//
ID   NKI-3
AC   CVCL_LI47
SY   NKI3; Nederlands Kanker Instituut-3
DR   Wikidata; Q54930671
RX   PubMed=1101782;
RX   PubMed=1104492;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 5
//
ID   NKI-4
AC   CVCL_DG47
SY   NKI4; NK1-4; NK14; Nederlands Kanker Instituut-4
DR   cancercelllines; CVCL_DG47
DR   Cosmic; 928726
DR   Wikidata; Q54930672
RX   PubMed=1079770;
RX   PubMed=1101782;
RX   PubMed=1104492;
RX   PubMed=1697409;
RX   PubMed=4549213;
RX   PubMed=6090953;
RX   PubMed=9354451;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=9354451).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   NKI-6
AC   CVCL_LI48
SY   NKI6; Nederlands Kanker Instituut-6
DR   Wikidata; Q54930673
RX   PubMed=1101782;
RX   PubMed=1104492;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 6
//
ID   NKI-7
AC   CVCL_LI45
SY   NKI7; Nederlands Kanker Instituut-7
DR   Wikidata; Q54930674
RX   PubMed=1104492;
RX   PubMed=7399746;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 4
//
ID   NKI-8
AC   CVCL_LI42
SY   NKI8; Nederlands Kanker Instituut-8
DR   Wikidata; Q54930675
RX   PubMed=1079770;
RX   PubMed=1101782;
RX   PubMed=1104492;
RX   PubMed=4549213;
RX   PubMed=7399746;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 5
//
ID   NKI-B20/2a
AC   CVCL_E3YS
RX   PubMed=9064283;
CC   Characteristics: Isotype switched derivative of NKI-B20/2b.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3YR ! NKI-B20/2b
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NKI-B20/2b
AC   CVCL_E3YR
RX   PubMed=9064283;
CC   Characteristics: Isotype switched derivative of D2-1H4.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P11836; Human MS4A1/CD20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3YQ ! D2-1H4
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NKI-SC173
AC   CVCL_LI49
SY   SC173; Nederlands Kanker Instituut-Squamous cell Carcinoma 173
DR   cancercelllines; CVCL_LI49
DR   Wikidata; Q54930676
RX   PubMed=25184754;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25184754).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   NKI-SC179
AC   CVCL_LI50
SY   SC179; Nederlands Kanker Instituut-Squamous cell Carcinoma 179
DR   Wikidata; Q54930677
RX   PubMed=12175565;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   NKI-SC263
AC   CVCL_LI51
SY   SC263; Nederlands Kanker Instituut-Squamous cell Carcinoma 263
DR   cancercelllines; CVCL_LI51
DR   Wikidata; Q54930678
RX   PubMed=12175565;
RX   PubMed=25184754;
RX   PubMed=26032726;
RX   PubMed=26269754;
CC   Doubling time: 35-40 hours (Direct_author_submission).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous; Note=Possible (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.704_735del32; Zygosity=Unspecified (PubMed=25184754).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=25184754).
CC   Miscellaneous: Doubling time and CDKN2A status from personal communication of Dok, Ruveyda.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 13
//
ID   NKI/beteb
AC   CVCL_C1CV
DR   Wikidata; Q114312551
RX   PubMed=3276209;
RX   PubMed=8624261;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P40967; Human PMEL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NKI/black-13
AC   CVCL_C1CW
DR   Wikidata; Q114312552
RX   PubMed=2430706;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NKI/C-3
AC   CVCL_C1CX
SY   NKI/C3
DR   Wikidata; Q114312553
RX   PubMed=2430706;
RX   PubMed=3882581;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08962; Human CD63.
CC   Misspelling: NK-1-C-3; Note=Occasionally.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NKK1
AC   CVCL_G365
DR   Wikidata; Q54930679
RX   PubMed=9183637;
CC   Population: Japanese.
CC   Doubling time: 45 hours (Note=At 20th passage) (PubMed=9183637).
CC   Caution: The age/sex of donor of this cell line and that of SKR1 (Cellosaurus=CVCL_G366), both described in PubMed=9183637 are inverted in the abstract of that paper. We believe that the information in the material and methods section is the correct one as it is corroborated by the karyotype information in the same paper.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   NKL
AC   CVCL_0466
DR   EFO; EFO_0022550
DR   MCCL; MCC:0000364
DR   cancercelllines; CVCL_0466
DR   Cell_Model_Passport; SIDM01880
DR   Cosmic; 1534875
DR   Cosmic; 2025324
DR   Cosmic; 2785207
DR   DepMap; ACH-001143
DR   Lonza; 145
DR   Wikidata; Q54930680
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8599969;
RX   PubMed=10803505;
RX   PubMed=30054012;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: IL2 dependent.
CC   Doubling time: 24-48 hours (PubMed=8599969).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   NKM-1
AC   CVCL_1607
SY   NKM1
DR   CLO; CLO_0009850
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472796
DR   cancercelllines; CVCL_1607
DR   Cell_Model_Passport; SIDM00576
DR   ChEMBL-Cells; CHEMBL3308212
DR   ChEMBL-Targets; CHEMBL2366133
DR   Cosmic; 908448
DR   Cosmic; 1523824
DR   Cosmic; 2131549
DR   Cosmic; 2306228
DR   Cosmic-CLP; 908448
DR   DepMap; ACH-002290
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10765-110E9
DR   GDSC; 908448
DR   GEO; GSM1670279
DR   IARC_TP53; 21586
DR   JCRB; IFO50476
DR   LINCS_LDP; LCL-1073
DR   PharmacoDB; NKM1_1161_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1607
DR   Wikidata; Q54930681
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1699657;
RX   PubMed=1701353;
RX   PubMed=1701357;
RX   PubMed=9737686;
RX   PubMed=9738977;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=1701353).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=76.96%; East Asian, South=21.17%; South Asian=0.96%; European, North=0.9%; European, South=0.01% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=908448; JCRB=IFO50476
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NKNT-3
AC   CVCL_S905
DR   Wikidata; Q54930683
RX   PubMed=10678831;
RX   PubMed=10937342;
RX   PubMed=16970284;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: The SV40 T antigen is flanked by LoxP recombination targets so that it can be excised by Cre/Lox site-specific recombination.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 14
//
ID   NKY113
AC   CVCL_J276
SY   MSW113; MSW 113
DR   JCRB; IFO50279
DR   Wikidata; Q54930684
RX   PubMed=2466827;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61793; Alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc (Sialyl Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   NL-AC1
AC   CVCL_WM65
DR   Wikidata; Q98127921
RX   PubMed=1845952;
RX   PubMed=2473086;
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   NL-Ch
AC   CVCL_ZS90
SY   EB-NL-Ch
DR   Wikidata; Q98127924
RX   PubMed=1900268;
RX   PubMed=2805228;
RX   PubMed=6099120;
CC   Doubling time: 48 hours (PubMed=1900268).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NL-Ha
AC   CVCL_ZS91
SY   EB-NL-Ha
DR   Wikidata; Q98127927
RX   PubMed=1900268;
RX   PubMed=2805228;
RX   PubMed=6099120;
RX   PubMed=6299928;
CC   Doubling time: 36 hours (PubMed=1900268).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NL-HESC1
AC   CVCL_C8CG
DR   Wikidata; Q123033195
RX   PubMed=16274613;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   NL-Mu
AC   CVCL_ZS92
SY   EB-NL-Mu
DR   Wikidata; Q98127929
RX   PubMed=6099120;
RX   PubMed=6299928;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NL-SCLC2
AC   CVCL_WM63
DR   Wikidata; Q98127931
RX   PubMed=1845952;
RX   PubMed=2473086;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   NL-SCLC3
AC   CVCL_WM64
DR   Wikidata; Q98127934
RX   PubMed=1845952;
RX   PubMed=2473086;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   NL-Sh
AC   CVCL_ZS93
SY   EB-NL-Sh
DR   Wikidata; Q98127936
RX   PubMed=6099120;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NL/T4
AC   CVCL_HA80
DR   Wikidata; Q54930685
RX   PubMed=2472008;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIPneoSV(X)1/SV40T).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   NL11SV
AC   CVCL_C5B0
DR   Wikidata; Q116049891
RX   PubMed=21566947;
CC   Senescence: SV40 transformed but with a finite life span. Senesces after 22 passages (PubMed=21566947).
CC   Doubling time: 44 hours (PubMed=21566947).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL20
AC   CVCL_3756
SY   NL-20
DR   CLO; CLO_0008179
DR   ATCC; CRL-2503
DR   BCRC; 60361
DR   BioSample; SAMN03471599
DR   BioSample; SAMN05292446
DR   GEO; GSM185872
DR   Wikidata; Q54930686
RX   PubMed=1522038;
RX   PubMed=9216860;
RX   PubMed=21566947;
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544547
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (PubMed=1522038); ~24 hours (PBCF).
CC   Karyotypic information: 43,X,-X,-5,-7,-15,del(4)(p14),del(6)(q21-q25),i(14q),18p+,21p+,+i(5q),+der(15)t(7p;15q) (PubMed=1522038).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-2503
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 21,24
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9,11
ST   Penta E: 6,16
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5AZ ! NL20SV
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   NL20SV
AC   CVCL_C5AZ
DR   Wikidata; Q116049892
RX   PubMed=21566947;
CC   Population: Caucasian.
CC   Senescence: SV40 transformed but with a finite life span. Senesces after 22 passages (PubMed=21566947).
CC   Doubling time: 36 hours (PubMed=21566947).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3756 ! NL20
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL20T
AC   CVCL_C5B5
DR   Wikidata; Q116049893
RX   PubMed=8521416;
RX   PubMed=9216860;
CC   Population: Caucasian.
CC   Characteristics: Forms very slowly growing tumors in nude mice. Established from a spontaneously occurring subcutaneous tumor in an athymic nude mouse inoculated with the parent cell line (PubMed=9216860).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3756 ! NL20
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL20T-A
AC   CVCL_3757
SY   NL20-TA; NL20TA
DR   CLO; CLO_0008180
DR   ATCC; CRL-2504
DR   cancercelllines; CVCL_3757
DR   GEO; GSM827477
DR   Progenetix; CVCL_3757
DR   Wikidata; Q54930687
RX   PubMed=8521416;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Characteristics: Tumorigenic. Established from a subcutaneous tumor in an athymic nude mouse inoculated with the parent cell line (PubMed=8521416).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-2504
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 21,24
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 6,15,16
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5B5 ! NL20T
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   NL20T-B
AC   CVCL_C5B6
DR   Wikidata; Q116049894
RX   PubMed=8521416;
CC   Population: Caucasian.
CC   Characteristics: Tumorigenic. Established from a subcutaneous tumor in an athymic nude mouse inoculated with the parent cell line (PubMed=8521416).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5B5 ! NL20T
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL25
AC   CVCL_C5B2
DR   Wikidata; Q116049895
RX   PubMed=21566947;
CC   Senescence: SV40 transformed but with a finite life span. Senesces after 21 passages (PubMed=21566947).
CC   Doubling time: 32 hours (PubMed=21566947).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL30-N
AC   CVCL_C5B3
DR   Wikidata; Q116049896
RX   PubMed=21566947;
CC   Senescence: SV40 transformed but with a finite life span. Senesces after 19 passages (PubMed=21566947).
CC   Doubling time: 28 hours (PubMed=21566947).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5B4 ! NL30-O
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL30-O
AC   CVCL_C5B4
DR   Wikidata; Q116049897
RX   PubMed=21566947;
CC   Senescence: SV40 transformed but with a finite life span. Senesces after 19 passages (PubMed=21566947).
CC   Doubling time: 28 hours (PubMed=21566947).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5B3 ! NL30-N
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL4SV
AC   CVCL_C5B1
DR   Wikidata; Q116049898
RX   PubMed=21566947;
CC   Senescence: SV40 transformed but with a finite life span. Senesces after 28 passages (PubMed=21566947).
CC   Doubling time: 28 hours (PubMed=21566947).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   NL9980
AC   CVCL_X187
SY   NL-9980
DR   Wikidata; Q54930688
RX   PubMed=21310132;
RX   PubMed=28920308;
RX   PubMed=30950202;
CC   Population: Chinese.
CC   Characteristics: Has a low tumorigenic potential and lung metastatic ability in nude mice (PubMed=21310132).
CC   Omics: Proteomics; Subcellular; Mitochondrion; 2DE-MS.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X186 ! WCQH-9801
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 7
//
ID   NLF
AC   CVCL_E217
SY   NLF-Trk-NULL
DR   Cosmic; 697276
DR   Cosmic; 717423
DR   Cosmic; 848928
DR   Cosmic; 923824
DR   Cosmic; 930072
DR   Cosmic; 1019953
DR   Cosmic; 1162000
DR   Cosmic; 1526638
DR   Cosmic; 2393639
DR   GEO; GSM2371250
DR   GEO; GSM2394370
DR   GEO; GSM3145565
DR   GEO; GSM3145727
DR   Kerafast; ECP008
DR   Wikidata; Q54930689
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=6888561;
RX   PubMed=11550280;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=23202128;
RX   PubMed=24466371;
RX   PubMed=25730103;
RX   PubMed=28350380;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (PubMed=16822308).
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 24
//
ID   NLF-TrkA, clone #2
AC   CVCL_UJ92
SY   NLF-TrkA, NTA#2
DR   Kerafast; ECP009
DR   Wikidata; Q98127938
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8031; NTRK1.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   NLF-TrkB, clone #6
AC   CVCL_UJ93
SY   NLF-TrkB, NTA#6
DR   Kerafast; ECP010
DR   Wikidata; Q98127940
RX   PubMed=26797418;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8032; NTRK2.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   NLFK
AC   CVCL_C0Z5
SY   NLFK-1; Norden Laboratory Feline Kidney
DR   Wikidata; Q114312554
RX   PubMed=2558634;
RX   PubMed=6316627;
RX   PubMed=17494075;
RX   PubMed=24398227;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 5
//
ID   NLFrCARBO5000
AC   CVCL_RR42
DR   Wikidata; Q54930690
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrCDDP1000
AC   CVCL_RR43
DR   Wikidata; Q54930691
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrCDDP500
AC   CVCL_RS77
DR   Wikidata; Q54930692
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrDACARB20
AC   CVCL_RR44
SY   NLFrDAC20
DR   Wikidata; Q54930694
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   NLFrDOCE20
AC   CVCL_RR45
DR   Wikidata; Q54930695
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrDOX40
AC   CVCL_RR46
DR   Wikidata; Q54930696
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrETO100
AC   CVCL_RR47
DR   Wikidata; Q54930698
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrGEMCI20
AC   CVCL_RR48
DR   Wikidata; Q54930699
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrIRINO1000
AC   CVCL_RS78
DR   Wikidata; Q54930700
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrMEL3000
AC   CVCL_RR49
DR   Wikidata; Q54930701
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrOXALI4000
AC   CVCL_RR50
DR   Wikidata; Q54930702
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrPCL20
AC   CVCL_RR76
DR   Wikidata; Q54930703
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrTOPO10
AC   CVCL_RR74
DR   Wikidata; Q54930704
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrVCR10
AC   CVCL_RR51
DR   Wikidata; Q54930705
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrVCR5
AC   CVCL_RR52
DR   Wikidata; Q54930706
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrVINB10
AC   CVCL_RR77
DR   Wikidata; Q54930707
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLFrVINOR10
AC   CVCL_RS79
DR   Wikidata; Q54930708
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   NLGIP-1103
AC   CVCL_JA68
DR   Wikidata; Q54930709
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Lybian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1105
AC   CVCL_JA69
DR   Wikidata; Q54930710
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1112
AC   CVCL_JA70
DR   GEO; GSM1517019
DR   Wikidata; Q54930711
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=25542143;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1116
AC   CVCL_JA71
DR   Wikidata; Q54930712
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1122
AC   CVCL_JA72
DR   Wikidata; Q54930713
RX   PubMed=25542143;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1126
AC   CVCL_JA73
DR   Wikidata; Q54930714
RX   CelloPub=CLPUB00389;
RX   PubMed=24129413;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1149
AC   CVCL_JA74
DR   Wikidata; Q54930715
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1156
AC   CVCL_JA75
DR   Wikidata; Q54930716
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Yemenite.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1235
AC   CVCL_JA76
DR   Wikidata; Q54930717
RX   PubMed=24129413;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 11
//
ID   NLGIP-1236
AC   CVCL_JA77
DR   Wikidata; Q54930718
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1354
AC   CVCL_JA78
DR   Wikidata; Q54930719
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ethiopian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1363
AC   CVCL_JA79
DR   GEO; GSM1517021
DR   Wikidata; Q54930720
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1369
AC   CVCL_JA80
DR   GEO; GSM1517018
DR   Wikidata; Q54930721
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1371
AC   CVCL_JA81
DR   Wikidata; Q54930722
RX   CelloPub=CLPUB00389;
RX   PubMed=24129413;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1427
AC   CVCL_JA82
DR   Wikidata; Q54930723
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ethiopian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1515
AC   CVCL_JA83
DR   Wikidata; Q54930724
RX   CelloPub=CLPUB00389;
RX   PubMed=25542143;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1516
AC   CVCL_JA84
DR   Wikidata; Q54930725
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1562
AC   CVCL_JA85
DR   Wikidata; Q54930726
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1564
AC   CVCL_JA86
DR   Wikidata; Q54930727
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1567
AC   CVCL_JA87
DR   Wikidata; Q54930728
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1570
AC   CVCL_JA88
DR   Wikidata; Q54930729
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ethiopian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1585
AC   CVCL_JA89
DR   GEO; GSM1517016
DR   Wikidata; Q54930730
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1590
AC   CVCL_JA90
DR   Wikidata; Q54930731
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1728
AC   CVCL_JA91
DR   Wikidata; Q54930732
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1730
AC   CVCL_JA92
DR   Wikidata; Q54930733
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1740
AC   CVCL_JA93
DR   Wikidata; Q54930734
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1747
AC   CVCL_JA94
DR   GEO; GSM1517017
DR   Wikidata; Q54930736
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1751
AC   CVCL_JA95
DR   Wikidata; Q54930737
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1754
AC   CVCL_JA96
DR   Wikidata; Q54930738
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1801
AC   CVCL_JA97
DR   GEO; GSM1517012
DR   Wikidata; Q54930739
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1807
AC   CVCL_JA98
DR   Wikidata; Q54930740
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1810
AC   CVCL_JA99
DR   Wikidata; Q54930741
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1816
AC   CVCL_JB00
DR   Wikidata; Q54930742
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1820
AC   CVCL_JB01
DR   Wikidata; Q54930743
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1823
AC   CVCL_JB02
DR   GEO; GSM1517013
DR   Wikidata; Q54930745
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1830
AC   CVCL_JB03
DR   Wikidata; Q54930746
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-1976
AC   CVCL_JB04
DR   GEO; GSM1517014
DR   Wikidata; Q54930747
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4297
AC   CVCL_JB05
DR   Wikidata; Q54930748
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Iraqi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4921
AC   CVCL_JB12
DR   Wikidata; Q54930755
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4941
AC   CVCL_JB13
DR   Wikidata; Q54930756
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4942
AC   CVCL_JB14
DR   Wikidata; Q54930757
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4943
AC   CVCL_JB15
DR   Wikidata; Q54930758
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4945
AC   CVCL_JB16
DR   Wikidata; Q54930759
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4973
AC   CVCL_JB17
DR   GEO; GSM1517022
DR   Wikidata; Q54930760
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4983
AC   CVCL_JB18
DR   Wikidata; Q54930761
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4987
AC   CVCL_JB19
DR   Wikidata; Q54930762
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4991
AC   CVCL_JB20
DR   Wikidata; Q54930763
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4995
AC   CVCL_JB21
DR   Wikidata; Q54930764
RX   PubMed=20235789;
RX   PubMed=25542143;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-4996
AC   CVCL_JB22
DR   Wikidata; Q54930765
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5000
AC   CVCL_JB23
DR   Wikidata; Q54930766
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5036
AC   CVCL_JB24
DR   Wikidata; Q54930767
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5040
AC   CVCL_JB25
DR   Wikidata; Q54930768
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5047
AC   CVCL_JB26
DR   Wikidata; Q54930769
RX   CelloPub=CLPUB00388;
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5048
AC   CVCL_JB27
DR   Wikidata; Q54930770
RX   CelloPub=CLPUB00388;
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5225
AC   CVCL_JB28
DR   Wikidata; Q54930771
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 11
//
ID   NLGIP-5232
AC   CVCL_JB29
DR   Wikidata; Q54930772
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5257
AC   CVCL_JB30
DR   Wikidata; Q54930773
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5341
AC   CVCL_JB31
DR   Wikidata; Q54930774
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5365
AC   CVCL_JB32
DR   Wikidata; Q54930775
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5366
AC   CVCL_JB33
DR   Wikidata; Q54930776
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5370
AC   CVCL_JB34
DR   Wikidata; Q54930779
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5420
AC   CVCL_JB35
DR   Wikidata; Q54930780
RX   CelloPub=CLPUB00388;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Palestinian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5452
AC   CVCL_JB36
DR   GEO; GSM1517020
DR   Wikidata; Q54930781
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Lybian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5519
AC   CVCL_JB37
DR   GEO; GSM1517015
DR   Wikidata; Q54930782
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Lybian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5534
AC   CVCL_JB38
DR   Wikidata; Q54930783
RX   CelloPub=CLPUB00389;
RX   PubMed=20235789;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Lybian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-5876
AC   CVCL_JB39
DR   Wikidata; Q54930784
RX   PubMed=25542143;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6037
AC   CVCL_JB40
DR   Wikidata; Q54930785
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6153
AC   CVCL_JB41
DR   Wikidata; Q54930786
RX   PubMed=25542143;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6203
AC   CVCL_JB42
DR   Wikidata; Q54930787
RX   PubMed=25542143;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6333
AC   CVCL_JB43
DR   Wikidata; Q54930788
RX   CelloPub=CLPUB00389;
RX   PubMed=25542143;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6343
AC   CVCL_JB44
DR   Wikidata; Q54930789
RX   PubMed=20235789;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6398
AC   CVCL_JB45
DR   Wikidata; Q54930790
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6417
AC   CVCL_JB46
DR   Wikidata; Q54930791
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6421
AC   CVCL_JB47
DR   Wikidata; Q54930792
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6423
AC   CVCL_JB48
DR   Wikidata; Q54930793
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6425
AC   CVCL_JB49
DR   Wikidata; Q54930794
RX   CelloPub=CLPUB00389;
RX   PubMed=25542143;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6429
AC   CVCL_JB50
DR   Wikidata; Q54930795
RX   PubMed=25542143;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Sephardic (Bulgarian).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6445
AC   CVCL_JB51
DR   Wikidata; Q54930796
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6472
AC   CVCL_JB52
DR   Wikidata; Q54930797
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLGIP-6478
AC   CVCL_JB53
DR   Wikidata; Q54930798
RX   CelloPub=CLPUB00389;
RX   PubMed=26015807;
WW   Provider; NLGIP; -; https://www.nlgip-yoran.sites.tau.ac.il
CC   Part of: National Laboratory for the Genetics of Israeli Populations (NLGIP) collection.
CC   Population: Jewish; Ashkenazi.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 12
//
ID   NLS-6-5
AC   CVCL_U863
DR   CLO; CLO_0050416
DR   RCB; RCB0733
DR   Wikidata; Q54930799
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 7
//
ID   NLT
AC   CVCL_ZL27
DR   Wikidata; Q98127943
RX   PubMed=9139717;
RX   PubMed=18406727;
CC   Characteristics: Secretes more GnRH1 than the autologous cell line GN11 (Cellosaurus=CVCL_ZL25).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: Transgenic with human GNRH1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZL19 ! GN
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   NM-1
AC   CVCL_3074
DR   JCRB; JCRB0155
DR   JCRB; NIHS0232
DR   Wikidata; Q54930800
CC   Senescence: Estimated life-span is 110 PDL (JCRB=JCRB0155).
CC   Doubling time: 30 hours (Note=Lot 02142008) (JCRB=JCRB0155).
CC   Discontinued: JCRB; NIHS0232; true.
CC   Derived from site: In situ; Fetal artery, endothelium; UBERON=UBERON_0001917.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   NM-1/E
AC   CVCL_8302
DR   JCRB; JCRB0155.1
DR   Wikidata; Q54930801
CC   Discontinued: JCRB; JCRB0155.1; probable.
CC   Derived from site: In situ; Fetal artery, endothelium; UBERON=UBERON_0001917.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_3074 ! NM-1
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NM-1/F
AC   CVCL_8303
DR   JCRB; JCRB0155.2
DR   Wikidata; Q54930802
CC   Discontinued: JCRB; JCRB0155.2; probable.
CC   Derived from site: In situ; Fetal artery, endothelium; UBERON=UBERON_0001917.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_3074 ! NM-1
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NM-D4
AC   CVCL_IQ44
SY   K562-D4
DR   Wikidata; Q54930803
RX   Patent=US8283161;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2605.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 17
//
ID   NM-F9
AC   CVCL_IQ45
SY   K562-F9
DR   Wikidata; Q54930804
RX   Patent=US8283161;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2606.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 17
//
ID   NM-iPS
AC   CVCL_A8XV
SY   NMiPS
DR   GEO; GSE164497
DR   Wikidata; Q108821050
RX   PubMed=34088009;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   NM-M2
AC   CVCL_L772
DR   KCLB; 60024
DR   Wikidata; Q54930805
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L175 ! TMT-081NM
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 10
//
ID   NM-M2/TC
AC   CVCL_M053
DR   KCLB; 60026
DR   Wikidata; Q54930806
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L772 ! NM-M2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 10
//
ID   NM002-1
AC   CVCL_KS11
SY   NJ002-1
DR   Wikidata; Q54930807
RX   Patent=US10444237;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201173.
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: Human antigen on pancreatic cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   NM008
AC   CVCL_W755
DR   Cosmic; 929203
DR   Wikidata; Q54930808
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM1007
AC   CVCL_W756
DR   Cosmic; 929207
DR   Wikidata; Q54930809
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM11
AC   CVCL_X014
DR   Wikidata; Q54930810
RX   PubMed=8609053;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0240 ! MC-26
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
ID   NM112
AC   CVCL_W757
DR   cancercelllines; CVCL_W757
DR   Cosmic; 929198
DR   Wikidata; Q54930811
RX   PubMed=10338330;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23455323).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   NM123
AC   CVCL_W758
SY   Nm123
DR   Cosmic; 929199
DR   Wikidata; Q54930812
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM16
AC   CVCL_W759
DR   Cosmic; 929194
DR   Wikidata; Q54930813
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM176
AC   CVCL_W760
DR   Cosmic; 929200
DR   Wikidata; Q54930814
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM177
AC   CVCL_W761
SY   Nm177
DR   Cosmic; 929195
DR   Wikidata; Q54930815
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM179
AC   CVCL_W762
DR   Cosmic; 929205
DR   Wikidata; Q54930816
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM182
AC   CVCL_W763
DR   cancercelllines; CVCL_W763
DR   Cosmic; 929193
DR   Wikidata; Q54930817
RX   PubMed=10338330;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23455323).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   NM2C5
AC   CVCL_B064
SY   NM-2C5
DR   BTO; BTO_0006144
DR   ATCC; CRL-2918
DR   BioSample; SAMN03151834
DR   cancercelllines; CVCL_B064
DR   Wikidata; Q54930818
RX   PubMed=14506175;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-derivative
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00377.
CC   Population: Caucasian.
CC   Doubling time: 32.24 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ATCC=CRL-2918
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0417 ! MDA-MB-435
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 32
//
ID   NM2C5 GFP
AC   CVCL_B065
SY   NM2C5-GFP; NM-2C5-GFP
DR   BTO; BTO_0006145
DR   ATCC; CRL-2919
DR   cancercelllines; CVCL_B065
DR   Wikidata; Q54930823
RX   PubMed=14506175;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-129-derivative
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00564.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): ATCC=CRL-2919
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B064 ! NM2C5
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 31
//
ID   NM39
AC   CVCL_W764
DR   cancercelllines; CVCL_W764
DR   Cosmic; 929204
DR   Cosmic; 1102378
DR   Wikidata; Q54930824
RX   PubMed=10338330;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23455323).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Unspecified (PubMed=23455323).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   NM47
AC   CVCL_W765
DR   Cosmic; 929196
DR   Wikidata; Q54930825
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NM78-AM
AC   CVCL_W286
DR   Wikidata; Q54930826
RX   PubMed=20590915;
CC   Population: Japanese.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W287 ! NM78-MM
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   NM78-MM
AC   CVCL_W287
DR   Wikidata; Q54930827
RX   PubMed=20590915;
CC   Population: Japanese.
CC   Doubling time: 62 hours (Note=At 5th passage), 55 hours (Note=At 21th passage) (PubMed=20590915).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W286 ! NM78-AM
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   NM87-26Xt
AC   CVCL_1Q39
SY   NM87-26XT
DR   Wikidata; Q54930828
RX   PubMed=8314575;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q38 ! GM07965
HI   CVCL_4595 ! UV135
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   NM88
AC   CVCL_W766
SY   Nm88
DR   Cosmic; 929197
DR   Wikidata; Q54930829
RX   PubMed=10338330;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 5
//
ID   NMB
AC   CVCL_2143
DR   BTO; BTO_0005872
DR   BioSample; SAMN03473470
DR   cancercelllines; CVCL_2143
DR   Cell_Model_Passport; SIDM01383
DR   Cosmic; 717422
DR   Cosmic; 848937
DR   Cosmic; 930073
DR   Cosmic; 1019940
DR   Cosmic; 1109119
DR   Cosmic; 1109368
DR   Cosmic; 1162001
DR   Cosmic; 1167991
DR   Cosmic; 1518072
DR   Cosmic; 1526639
DR   Cosmic; 1543774
DR   Cosmic; 2239465
DR   DepMap; ACH-001367
DR   DSMZ; ACC-657
DR   DSMZCellDive; ACC-657
DR   GEO; GSM692862
DR   GEO; GSM2371251
DR   GEO; GSM2394366
DR   Wikidata; Q54930830
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=71759;
RX   PubMed=922665;
RX   PubMed=3000378;
RX   PubMed=6888561;
RX   PubMed=11550280;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=24466371;
RX   PubMed=28350380;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~40-50 hours (DSMZ=ACC-657).
CC   Karyotypic information: Hypotetraploid (PubMed=71759).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DepMap=ACH-001367; DSMZ=ACC-657
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 11,13
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 22,25
ST   Penta D: 5,11
ST   Penta E: 13,16
ST   TH01: 7,8
ST   TPOX: 7,9
ST   vWA: 17,18,20
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   NMB-7
AC   CVCL_8901
SY   NMB 7; NMB7
DR   BTO; BTO_0003534
DR   Cosmic; 922654
DR   Wikidata; Q54930831
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7139592;
RX   PubMed=8665486;
RX   PubMed=9815755;
RX   PubMed=15390183;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2143 ! NMB
SX   Female
AG   10M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   NMC-G1
AC   CVCL_1608
SY   NMCG-1; NMCG1; National Medical Center-Glioma 1
DR   CLO; CLO_0009897
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 967
DR   BioSample; SAMN03472793
DR   BioSample; SAMN10987927
DR   cancercelllines; CVCL_1608
DR   Cell_Model_Passport; SIDM00575
DR   CGH-DB; 150-1
DR   ChEMBL-Cells; CHEMBL3308842
DR   ChEMBL-Targets; CHEMBL2366349
DR   Cosmic; 685874
DR   Cosmic; 908449
DR   Cosmic; 1746963
DR   Cosmic; 2302335
DR   Cosmic; 2367540
DR   Cosmic-CLP; 908449
DR   DepMap; ACH-000200
DR   EGA; EGAS00001000978
DR   GDSC; 908449
DR   GEO; GSM326197
DR   GEO; GSM887457
DR   GEO; GSM888537
DR   GEO; GSM1670280
DR   IARC_TP53; 21587
DR   JCRB; IFO50467
DR   LiGeA; CCLE_668
DR   LINCS_LDP; LCL-1385
DR   PharmacoDB; NMCG1_1162_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1608
DR   PubChem_Cell_line; CVCL_1608
DR   Wikidata; Q54930832
RX   DOI=10.1007/978-4-431-68150-2_30;
RX   PubMed=8428960;
RX   PubMed=12068308;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=908449; DepMap=ACH-000200).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.52%; East Asian, South=18.48%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=908449; JCRB=IFO50467
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NMC-G2
AC   CVCL_JZ68
SY   NMCG-2; NMCG2; National Medical Center-Glioma 2
DR   Wikidata; Q54930833
RX   DOI=10.1007/978-4-431-68150-2_30;
CC   Population: Japanese.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   NMFH-1 [JCRB]
AC   CVCL_AT70
DR   JCRB; JCRB1507
DR   Wikidata; Q54930836
CC   Population: Japanese.
CC   Caution: There seem to be two NMFH-1 cell lines, both from myxofibrosarcomas (malignant fibrous histiocytomas). One from Niigata University (Kawashima H. et al) established from a 89 year old male patient and distributed by RCB and one from Shimada Y. established from a 43 year old male patient and distributed by JCRB. The two cell lines have very different STR profiles.
ST   Source(s): JCRB=JCRB1507
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,20
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 9
//
ID   NMFH-1 [RCB]
AC   CVCL_4661
SY   NMFH1
DR   CLO; CLO_0050023
DR   BioSample; SAMN03471964
DR   Cosmic; 1172182
DR   FANTOM5_SSTAR; 10684-109E9
DR   RCB; RCB2346
DR   Wikidata; Q54930837
RX   PubMed=15173092;
RX   PubMed=16080955;
RX   PubMed=19335880;
RX   PubMed=25760144;
CC   Population: Japanese.
CC   Doubling time: 46 hours (Note=At 50th passage), 42 hours (Note=At 100th passage) (PubMed=16080955); 44 hours (PubMed=19335880).
CC   Caution: There seem to be two NMFH-1 cell lines, both from myxofibrosarcomas (malignant fibrous histiocytomas). One from Niigata University (Kawashima H. et al) established from a 89 year old male patient and distributed by RCB and one from Shimada Y. established from a 43 year old male patient and distributed by JCRB. The two cell lines have very different STR profiles.
CC   Derived from site: In situ; Knee, hypodermis; UBERON=UBERON_0001465+UBERON_0002072.
ST   Source(s): RCB=RCB2346
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 22
//
ID   NMFH-2
AC   CVCL_4W18
SY   NMFH2
DR   GEO; GSM1098532
DR   Wikidata; Q54930838
RX   PubMed=19335880;
CC   Population: Japanese.
CC   Doubling time: 455 hours (PubMed=19335880).
CC   Derived from site: In situ; Arm, hypodermis; UBERON=UBERON_0001460+UBERON_0002072.
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 9
//
ID   NMH
AC   CVCL_A5PX
SY   Normal Mouse Hepatocytes
DR   Wikidata; Q107116572
RX   PubMed=7525051;
CC   Doubling time: 19 hours (PubMed=7525051).
CC   Karyotypic information: Near diploid karyotype.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2-3M
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   NMIi001-A
AC   CVCL_A9XL
SY   CTR1
DR   BioSamples; SAMEA7248998
DR   hPSCreg; NMIi001-A
DR   Wikidata; Q102114645
RX   PubMed=32911325;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NMIi002-A
AC   CVCL_A9XM
SY   SZ1a
DR   BioSamples; SAMEA7249000
DR   hPSCreg; NMIi002-A
DR   Wikidata; Q102114646
RX   PubMed=32911325;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XN ! NMIi002-B
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NMIi002-B
AC   CVCL_A9XN
SY   SZ1b; NMIi003-A
DR   BioSamples; SAMEA7513361
DR   hPSCreg; NMIi002-B
DR   Wikidata; Q102114647
RX   PubMed=32911325;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XM ! NMIi002-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NMIi004-A
AC   CVCL_A9XP
SY   SZ2
DR   BioSamples; SAMEA7249003
DR   hPSCreg; NMIi004-A
DR   Wikidata; Q102114648
RX   PubMed=32911325;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NMIi005-A
AC   CVCL_A9XQ
SY   SZ4
DR   BioSamples; SAMEA7249011
DR   hPSCreg; NMIi005-A
DR   Wikidata; Q102114649
RX   PubMed=32911325;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NMIi006-A
AC   CVCL_A9XR
SY   SZ5a
DR   BioSamples; SAMEA7249013
DR   hPSCreg; NMIi006-A
DR   Wikidata; Q102114651
RX   PubMed=32911325;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XS ! NMIi006-B
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NMIi006-B
AC   CVCL_A9XS
SY   SZ5b; NMIi007-A
DR   BioSamples; SAMEA7513362
DR   hPSCreg; NMIi006-B
DR   Wikidata; Q102114653
RX   PubMed=32911325;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9XR ! NMIi006-A
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   NMIi010-A
AC   CVCL_A8MQ
SY   AH.2
DR   BioSamples; SAMEA8843280
DR   hPSCreg; NMIi010-A
DR   Wikidata; Q108821052
RX   PubMed=34139596;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   NMIi011-A
AC   CVCL_C1V4
SY   B1.4
DR   BioSamples; SAMEA110068648
DR   hPSCreg; NMIi011-A
DR   Wikidata; Q114312556
RX   PubMed=36055119;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V5 ! NMIi011-B
OI   CVCL_C1V6 ! NMIi011-C
OI   CVCL_C1V7 ! NMIi011-D
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   NMIi011-B
AC   CVCL_C1V5
SY   B1.6
DR   BioSamples; SAMEA110192124
DR   hPSCreg; NMIi011-B
DR   Wikidata; Q114312557
RX   PubMed=36055119;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V4 ! NMIi011-A
OI   CVCL_C1V6 ! NMIi011-C
OI   CVCL_C1V7 ! NMIi011-D
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   NMIi011-C
AC   CVCL_C1V6
SY   B1.7
DR   BioSamples; SAMEA110068567
DR   hPSCreg; NMIi011-C
DR   Wikidata; Q114312558
RX   PubMed=36055119;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V4 ! NMIi011-A
OI   CVCL_C1V5 ! NMIi011-B
OI   CVCL_C1V7 ! NMIi011-D
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   NMIi011-D
AC   CVCL_C1V7
SY   B1.10
DR   BioSamples; SAMEA110063476
DR   hPSCreg; NMIi011-D
DR   Wikidata; Q114312559
RX   PubMed=36055119;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V4 ! NMIi011-A
OI   CVCL_C1V5 ! NMIi011-B
OI   CVCL_C1V6 ! NMIi011-C
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   NMIi012-A
AC   CVCL_C1V8
SY   DG1
DR   BioSamples; SAMEA110237416
DR   hPSCreg; NMIi012-A
DR   Wikidata; Q114312560
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V9 ! NMIi012-B
OI   CVCL_C1VA ! NMIi012-C
OI   CVCL_C1VB ! NMIi012-D
OI   CVCL_C1VC ! NMIi012-E
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NMIi012-B
AC   CVCL_C1V9
SY   DG2
DR   BioSamples; SAMEA110237421
DR   hPSCreg; NMIi012-B
DR   Wikidata; Q114312561
RX   PubMed=36528016;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V8 ! NMIi012-A
OI   CVCL_C1VA ! NMIi012-C
OI   CVCL_C1VB ! NMIi012-D
OI   CVCL_C1VC ! NMIi012-E
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   NMIi012-C
AC   CVCL_C1VA
SY   DG3
DR   BioSamples; SAMEA110237423
DR   hPSCreg; NMIi012-C
DR   Wikidata; Q114312562
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V8 ! NMIi012-A
OI   CVCL_C1V9 ! NMIi012-B
OI   CVCL_C1VB ! NMIi012-D
OI   CVCL_C1VC ! NMIi012-E
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NMIi012-D
AC   CVCL_C1VB
SY   DG4
DR   BioSamples; SAMEA110237425
DR   hPSCreg; NMIi012-D
DR   Wikidata; Q114312563
RX   PubMed=36528016;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V8 ! NMIi012-A
OI   CVCL_C1V9 ! NMIi012-B
OI   CVCL_C1VA ! NMIi012-C
OI   CVCL_C1VC ! NMIi012-E
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   NMIi012-E
AC   CVCL_C1VC
SY   DG5
DR   BioSamples; SAMEA110237430
DR   hPSCreg; NMIi012-E
DR   Wikidata; Q114312564
RX   PubMed=36528016;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a patient suffering from invasive lobular breast carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1V8 ! NMIi012-A
OI   CVCL_C1V9 ! NMIi012-B
OI   CVCL_C1VA ! NMIi012-C
OI   CVCL_C1VB ! NMIi012-D
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   NML
AC   CVCL_WH38
DR   Wikidata; Q98127945
RX   PubMed=24035468;
RX   PubMed=27292541;
RX   PubMed=30268330;
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
CC   Derived from site: In situ; Nail bed; UBERON=UBERON_0005273.
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   NMR-1
AC   CVCL_B912
SY   CDMLe012-A
DR   hPSCreg; CDMLe012-A
DR   NIHhESC; NIHhESC-12-0159
DR   Wikidata; Q54930839
RX   PubMed=31357114;
CC   From: University of Texas Health Science Center at Houston; Houston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0159.
CC   Anecdotal: Named after Nancy Morgan Runnells who helped fund the lab that established that cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 14
//
ID   NMR-iPSC clone 10
AC   CVCL_A4PU
DR   SKIP; SKIP000880
DR   Wikidata; Q105510397
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 11
AC   CVCL_A4PV
DR   SKIP; SKIP000881
DR   Wikidata; Q105510401
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 12
AC   CVCL_A4PW
DR   SKIP; SKIP000882
DR   Wikidata; Q105510405
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 13
AC   CVCL_A4PX
DR   SKIP; SKIP000883
DR   Wikidata; Q105510415
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 14
AC   CVCL_A4PY
DR   SKIP; SKIP000884
DR   Wikidata; Q105510419
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 24
AC   CVCL_A4PZ
DR   SKIP; SKIP000885
DR   Wikidata; Q105510421
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 26
AC   CVCL_A4QA
DR   SKIP; SKIP000886
DR   Wikidata; Q105510426
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 27
AC   CVCL_A4QB
DR   SKIP; SKIP000887
DR   Wikidata; Q105510429
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 4
AC   CVCL_A4PS
DR   SKIP; SKIP000878
DR   Wikidata; Q105510435
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR-iPSC clone 8
AC   CVCL_A4PT
DR   SKIP; SKIP000879
DR   Wikidata; Q105510443
RX   PubMed=27161380;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NMR52
AC   CVCL_J707
DR   CLO; CLO_0050339
DR   RCB; RCB2039
DR   Wikidata; Q54930840
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: nLc4Cer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   NMS-1
AC   CVCL_A9E1
SY   NMS1
DR   Wikidata; Q102114654
RX   PubMed=2822736;
RX   PubMed=3374507;
RX   PubMed=6376377;
RX   PubMed=6538202;
CC   Donor information: Established from a patient suffering from a mammary gland ptosis.
CC   Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NMS-2
AC   CVCL_4662
DR   CLO; CLO_0050138
DR   BioSample; SAMN03471965
DR   Cosmic; 1319814
DR   RCB; RCB2347
DR   Wikidata; Q54930841
RX   PubMed=9849858;
RX   PubMed=32642732;
RX   PubMed=34059954;
RX   PubMed=36818284;
CC   Population: Japanese.
CC   Doubling time: 50.2 hours (PubMed=9849858).
CC   Karyotypic information: Average ploidy of 4.56 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous; Note=By translocation (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (PubMed=36818284).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.7062+1G>T (c.6999+1G>T); ClinVar=VCV000803375; Zygosity=Heterozygous; Note=Splice donor mutation. Somatic (PubMed=36818284).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): RCB=RCB2347; PubMed=36818284
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13.2,14.2
ST   D21S11: 30
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L810 ! NMS-2PC
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   NMS-2PC
AC   CVCL_L810
DR   Wikidata; Q54930842
RX   PubMed=9849858;
RX   PubMed=32642732;
CC   Population: Japanese.
CC   Doubling time: 44.7 hours (PubMed=9849858).
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4662 ! NMS-2
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   NMSG 10
AC   CVCL_M832
SY   NMSG10
DR   Wikidata; Q54930843
RX   PubMed=1962790;
RX   PubMed=8927571;
CC   Population: Japanese.
CC   Doubling time: 35 hours (Note=At 40th passage) (PubMed=8927571).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   NMSUNLi001-A
AC   CVCL_QY85
SY   iUC-DAND5_455/10
DR   hPSCreg; NMSUNLi001-A
DR   Wikidata; Q54930844
RX   PubMed=29136563;
RX   PubMed=31869685;
CC   From: CEDOC, NOVA Medical School, Universidade Nova De Lisboa; Lisbon; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:26780; DAND5; Simple; p.Arg152His (c.455G>A); Zygosity=Heterozygous (PubMed=29136563).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C95834; Congenital heart disease
DI   ORDO; Orphanet_156532; Rare syndrome with cardiac malformations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   NMSUNLi001-A-1
AC   CVCL_YM55
SY   NMSUNLi003; iUC-DAND5_455/10C
DR   Wikidata; Q98127947
RX   PubMed=31869685;
CC   From: CEDOC, NOVA Medical School, Universidade Nova De Lisboa; Lisbon; Portugal.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:26780; DAND5; Simple_corrected; p.Arg152His (c.455G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31869685).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C95834; Congenital heart disease
DI   ORDO; Orphanet_156532; Rare syndrome with cardiac malformations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QY85 ! NMSUNLi001-A
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   NMSUNLi002-A
AC   CVCL_VN43
SY   NMSUNLi002; iUC-DAND5_455/control
DR   Wikidata; Q98127949
RX   PubMed=29730570;
CC   From: CEDOC, NOVA Medical School, Universidade Nova De Lisboa; Lisbon; Portugal.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 7
//
ID   NMT-1
AC   CVCL_VI69
DR   Wikidata; Q98127953
RX   PubMed=7507475;
RX   PubMed=8613682;
RX   PubMed=11295070;
CC   Doubling time: 16.0 hours (PubMed=7507475; PubMed=8613682).
CC   Breed/subspecies: Wistar Mishima (WM/Ms).
DI   NCIt; C60530; Rat yolk sac carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   NMT-1R
AC   CVCL_VI70
DR   Wikidata; Q98127955
RX   PubMed=8613682;
RX   PubMed=11295070;
CC   Characteristics: More radioresistant than parent cell line. Its radiation sensitivity is 165 +- 3 cGy.
CC   Doubling time: 13.6 hours (PubMed=8613682).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: Wistar Mishima (WM/Ms).
DI   NCIt; C60530; Rat yolk sac carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_VI69 ! NMT-1
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   NMU
AC   CVCL_3563
DR   CLO; CLO_0008183
DR   CLDB; cl3718
DR   ATCC; CRL-1743
DR   BCRC; 60099
DR   Wikidata; Q54930845
RX   PubMed=7118137;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   50D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   NMu2Li
AC   CVCL_S358
DR   ATCC; CRL-6446
DR   Wikidata; Q54930846
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6446; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   NMu3Li
AC   CVCL_6424
SY   Nmu3Li
DR   CLO; CLO_0008184
DR   ATCC; CRL-6447
DR   Wikidata; Q54930847
RX   PubMed=25277546;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   NMuLi
AC   CVCL_6425
DR   CLO; CLO_0008185
DR   ATCC; CRL-1638
DR   ATCC; CRL-6591
DR   IZSLER; BS CL 164
DR   Wikidata; Q54930848
RX   PubMed=4366196;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6591; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NMuMG
AC   CVCL_0075
DR   BTO; BTO_0004183
DR   CLO; CLO_0008186
DR   EFO; EFO_0022800
DR   CLDB; cl3719
DR   ATCC; CRL-1636
DR   BCRC; 60087
DR   BioSample; SAMN11397631
DR   ECACC; 94081121
DR   IZSLER; BS CL 188
DR   Wikidata; Q54930849
RX   PubMed=4366196;
RX   PubMed=9855001;
RX   PubMed=31220119;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-51.html
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Namru.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 27,28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   NMuMG-ST
AC   CVCL_5U35
DR   Wikidata; Q54930852
RX   PubMed=9855001;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0075 ! NMuMG
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   NMuMG/Fucci
AC   CVCL_E069
SY   NMuMG/Fucci #1; NMuMG-Fucci
DR   CLO; CLO_0050967
DR   RCB; RCB2813
DR   Wikidata; Q54930850
RX   PubMed=18267078;
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct.
CC   Characteristics: Transfected with the Fucci probe which consist of the fusion of monomeric Kusabira-Orange2 (mKO2) to the ubiquitination domain of human CDT1 (AA 30-120) and monomeric AzamiGreen (mAG) to the ubiquitination domain of human geminin (AA 1-110).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; HC91W; AzamiGreen (Note=Green fluorescent protein from G.fascicularis).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 134NN; mKusabira-Orange2 (Note=mKO2, orange fluorescent protein derived from F.concinna Kusabira-Orange (KO)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0075 ! NMuMG
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   NMuMG/Fucci2
AC   CVCL_U135
SY   NMuMG/Fucci2 #5; NMuMG-Fucci2
DR   CLO; CLO_0050968
DR   RCB; RCB2868
DR   Wikidata; Q54930851
RX   PubMed=21226962;
RX   PubMed=24786503;
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci2 (Fluorescent Ubiquitination-based Cell Cycle Indicator 2) construct.
CC   Characteristics: Transfected with the Fucci2 probe which consist of the fusion of mCherry) to the ubiquitination domain of human CDT1 (AA 30-120) and of monomeric Venus (mVenus) to the ubiquitination domain of human geminin (AA 1-110).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0075 ! NMuMG
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   NN [Human astrocytoma Bethesda]
AC   CVCL_A1IX
SY   Case 25
DR   Wikidata; Q102114655
RX   PubMed=6088716;
RX   PubMed=7459816;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   NN [Human glioblastoma Arizona]
AC   CVCL_Z600
DR   Wikidata; Q54930853
RX   PubMed=8943096;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z601 ! NNR
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NN-1
AC   CVCL_Z283
DR   ICLDB; nn-1
DR   NISES; SK0032
DR   Wikidata; Q54930854
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
RX   DOI=10.2183/pjab.60.198;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1563985; ! Nephotettix nigropictus (Rice green leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NN-2
AC   CVCL_UZ67
DR   ICLDB; nn-2
DR   Wikidata; Q98127958
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1563985; ! Nephotettix nigropictus (Rice green leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   NN-3
AC   CVCL_G674
DR   CLO; CLO_0008187
DR   ABCD; ABCD_AF006
DR   ATCC; HB-8474
DR   Wikidata; Q54930855
RX   Patent=US4752582;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8474.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   NN-4
AC   CVCL_G675
DR   CLO; CLO_0008188
DR   ATCC; HB-8473
DR   Wikidata; Q54930856
RX   Patent=US4752582;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8473.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   NN-5 [Mouse hybridoma against human GYPA]
AC   CVCL_G676
DR   CLO; CLO_0008189
DR   ATCC; HB-8476
DR   Wikidata; Q54930857
RX   Patent=US4752582;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8476.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24. Recognizes N blood group antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   NN-5 [Nephotettix]
AC   CVCL_UZ68
DR   ICLDB; nn-5
DR   Wikidata; Q98127960
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1563985; ! Nephotettix nigropictus (Rice green leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NN-7
AC   CVCL_UZ69
DR   ICLDB; nn-7
DR   Wikidata; Q98127963
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1563985; ! Nephotettix nigropictus (Rice green leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   NN10
AC   CVCL_B4H2
DR   Wikidata; Q110433104
RX   Patent=FR2550216A1;
RX   PubMed=2355917;
RX   PubMed=2735652;
RX   PubMed=3861324;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-235.
CC   Characteristics: Constitutively synthesizes and secretes erythropoietin (PubMed=3861324).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: ICFW.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   NNIi001-A
AC   CVCL_A8MR
SY   SCA3-B31
DR   BioSamples; SAMEA8686787
DR   hPSCreg; NNIi001-A
DR   Wikidata; Q108821053
CC   From: National Neuroscience Institute; Singapore; Singapore.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   NNIi002-A
AC   CVCL_A8MS
SY   iPSCBB108
DR   hPSCreg; NNIi002-A
DR   Wikidata; Q108821055
CC   From: National Neuroscience Institute; Singapore; Singapore.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   NNR
AC   CVCL_Z601
DR   Wikidata; Q54930858
RX   PubMed=8943096;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z600 ! NN [Human glioblastoma Arizona]
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NNUCSF1400564
AC   CVCL_D4CE
DR   NIHhESC; NIHhESC-23-0503
DR   Wikidata; Q127382964
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-23-0503.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   No Per
AC   CVCL_3321
DR   CLO; CLO_0008190
DR   ATCC; CRL-1327
DR   Wikidata; Q54930859
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   NO0001
AC   CVCL_8Y24
DR   ECACC; 02032223
DR   Wikidata; Q54930860
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX.ish(del)(22)(q11.2;q11.2) (ECACC=02032223).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35078; Tourette syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   NO3-AC
AC   CVCL_VJ77
SY   NO3 AC
DR   Cosmic; 2568863
DR   Wikidata; Q98127966
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ78 ! NO3-NS
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   NO3-NS
AC   CVCL_VJ78
SY   NO3 NS
DR   Cosmic; 2568850
DR   Wikidata; Q98127968
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ77 ! NO3-AC
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   NO36
AC   CVCL_2658
SY   No36
DR   BioSample; SAMN07624411
DR   cancercelllines; CVCL_2658
DR   CBA; CBA-0142
DR   Cosmic; 1522764
DR   Cosmic; 1963331
DR   DepMap; ACH-001977
DR   ECACC; 10092312
DR   FANTOM5_SSTAR; 10857-111G2
DR   GEO; GSM796439
DR   Progenetix; CVCL_2658
DR   Wikidata; Q54930861
RX   PubMed=1703129;
RX   PubMed=21642991;
RX   PubMed=25902174;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Phe118Leufs*69 (c.354delC); Zygosity=Heterozygous (PubMed=21642991; DepMap=ACH-001977).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CBA=CBA-0142
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 21,22
ST   D19S433: 15,16
ST   D21S11: 28,29
ST   D2S1338: 25
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36-62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   NO4-AC
AC   CVCL_VJ79
SY   NO4 AC
DR   Cosmic; 2568864
DR   Wikidata; Q98127972
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   NO6-NS
AC   CVCL_VJ80
SY   NO6 NS
DR   Cosmic; 2568851
DR   Wikidata; Q98127974
RX   PubMed=26708597;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   NOBAH-1
AC   CVCL_VI79
SY   Neonatal Olfactory Bulb Astrocyte High support-1
DR   Wikidata; Q98127978
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOBAH-2
AC   CVCL_VI80
SY   Neonatal Olfactory Bulb Astrocyte High support-2
DR   Wikidata; Q98127980
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOBAL-1
AC   CVCL_VI81
SY   Neonatal Olfactory Bulb Astrocyte Low support-1
DR   Wikidata; Q98127983
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOBAL-2
AC   CVCL_VI82
SY   Neonatal Olfactory Bulb Astrocyte Low support-2
DR   Wikidata; Q98127985
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOBAL-3
AC   CVCL_VI83
SY   Neonatal Olfactory Bulb Astrocyte Low support-3
DR   Wikidata; Q98127987
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOBAL-4
AC   CVCL_VI84
SY   Neonatal Olfactory Bulb Astrocyte Low support-4
DR   Wikidata; Q98127990
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOBAL-5
AC   CVCL_VI85
SY   Neonatal Olfactory Bulb Astrocyte Low support-5
DR   Wikidata; Q98127992
RX   PubMed=8374779;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Astrocyte of forebrain; CL=CL_0012000.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOBEC-1
AC   CVCL_VI86
SY   NOBEC; Neonatal Olfactory Bulb Ensheathing Cell-1
DR   Wikidata; Q98127994
RX   PubMed=8374779;
RX   PubMed=19786050;
CC   Doubling time: 68 hours (PubMed=8374779).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Olfactory ensheathing cell; CL=CL_0011028.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <10D
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   NOC-S
AC   CVCL_W495
DR   Wikidata; Q54930862
RX   PubMed=2085480;
CC   Population: Japanese.
CC   Doubling time: 32-36 hours (PubMed=2085480).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   NOC-Ts
AC   CVCL_W496
DR   Wikidata; Q54930864
RX   PubMed=1958631;
CC   Population: Japanese.
CC   Doubling time: 30-32 hours (PubMed=1958631).
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   NoCa1
AC   CVCL_HB90
DR   GEO; GSM29783
DR   GEO; GSM29784
DR   GEO; GSM29785
DR   Wikidata; Q54930865
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa10
AC   CVCL_HB99
DR   GEO; GSM29816
DR   GEO; GSM29817
DR   GEO; GSM29819
DR   Wikidata; Q54930866
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa11
AC   CVCL_HC00
DR   GEO; GSM29821
DR   GEO; GSM29822
DR   GEO; GSM29823
DR   Wikidata; Q54930867
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa12
AC   CVCL_HC01
DR   GEO; GSM29824
DR   GEO; GSM29825
DR   GEO; GSM29826
DR   Wikidata; Q54930868
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa13
AC   CVCL_HC02
DR   GEO; GSM29827
DR   GEO; GSM29828
DR   GEO; GSM29829
DR   Wikidata; Q54930869
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa14
AC   CVCL_HC03
DR   GEO; GSM29830
DR   GEO; GSM29831
DR   GEO; GSM29832
DR   Wikidata; Q54930870
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa15
AC   CVCL_HC04
DR   GEO; GSM29833
DR   GEO; GSM29834
DR   GEO; GSM29835
DR   Wikidata; Q54930871
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa2
AC   CVCL_HB91
DR   GEO; GSM29786
DR   GEO; GSM29787
DR   GEO; GSM29788
DR   Wikidata; Q54930872
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa3
AC   CVCL_HB92
DR   GEO; GSM29789
DR   GEO; GSM29790
DR   GEO; GSM29791
DR   Wikidata; Q54930873
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa4
AC   CVCL_HB93
DR   GEO; GSM29792
DR   GEO; GSM29793
DR   GEO; GSM29794
DR   Wikidata; Q54930874
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa5
AC   CVCL_HB94
DR   GEO; GSM29795
DR   GEO; GSM29796
DR   GEO; GSM29797
DR   Wikidata; Q54930875
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa6
AC   CVCL_HB95
DR   GEO; GSM29798
DR   GEO; GSM29799
DR   GEO; GSM29800
DR   Wikidata; Q54930876
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa7
AC   CVCL_HB96
DR   GEO; GSM29801
DR   GEO; GSM29802
DR   GEO; GSM29803
DR   Wikidata; Q54930877
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa8
AC   CVCL_HB97
DR   GEO; GSM29804
DR   GEO; GSM29805
DR   GEO; GSM29806
DR   Wikidata; Q54930878
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NoCa9
AC   CVCL_HB98
DR   GEO; GSM29807
DR   GEO; GSM29814
DR   GEO; GSM29815
DR   Wikidata; Q54930879
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   NOCC
AC   CVCL_GQ01
DR   Wikidata; Q54930880
RX   PubMed=27541369;
CC   Population: Japanese.
CC   Doubling time: ~29 hours (PubMed=27541369).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   NOCI 16
AC   CVCL_VQ04
SY   NOCI16
DR   Wikidata; Q98127996
RX   PubMed=10837406;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   NOCS-1
AC   CVCL_VQ29
DR   Wikidata; Q98128001
RX   PubMed=30171458;
CC   Population: Japanese.
CC   Doubling time: 29 hours (Note=At 12th passage), 26 hours (Note=At 30th passage) (PubMed=30171458).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=30171458
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 14,27
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 22,26
ST   Penta D: 8,11
ST   Penta E: 14,15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   NOD-iPS#11
AC   CVCL_B3R2
DR   Wikidata; Q110433105
RX   PubMed=21464439;
CC   Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NOD/Lt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B3R1 ! NOD-iPS#5
OI   CVCL_B3R3 ! NOD-iPS#17
SX   Male
AG   8W
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   NOD-iPS#17
AC   CVCL_B3R3
DR   Wikidata; Q110433106
RX   PubMed=21464439;
CC   Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NOD/Lt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B3R1 ! NOD-iPS#5
OI   CVCL_B3R2 ! NOD-iPS#11
SX   Male
AG   8W
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   NOD-iPS#5
AC   CVCL_B3R1
DR   Wikidata; Q110433107
RX   PubMed=21464439;
CC   Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NOD/Lt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B3R2 ! NOD-iPS#11
OI   CVCL_B3R3 ! NOD-iPS#17
SX   Male
AG   8W
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   NOD.ESA
AC   CVCL_U868
SY   NOD-ESA
DR   RCB; AES0118
DR   RCB; RCB2608
DR   SKIP; SKIP001664
DR   Wikidata; Q54930881
CC   Discontinued: RCB; RCB2608; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NOD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Nody-1
AC   CVCL_L368
SY   TL-1
DR   GEO; GSM2282269
DR   Wikidata; Q54930882
RX   PubMed=23196801;
RX   PubMed=27639374;
CC   Doubling time: 21.5 hours (PubMed=23196801).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Shiba; VBO=VBO_0201220.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   NOE
AC   CVCL_W381
DR   Wikidata; Q54930883
RX   PubMed=17645726;
CC   Population: Japanese.
CC   Doubling time: ~15.5 hours (Note=At 10th passage) (PubMed=17645726).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   NOF137
AC   CVCL_2G71
SY   Normal Ovarian Fibroblast 137
DR   Wikidata; Q54930884
RX   PubMed=17060621;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 8
//
ID   NOF150
AC   CVCL_2G72
SY   Normal Ovarian Fibroblast 150
DR   Wikidata; Q54930885
RX   PubMed=17060621;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 8
//
ID   NOF151
AC   CVCL_2G73
SY   Normal Ovarian Fibroblast 151
DR   EFO; EFO_0006699
DR   Wikidata; Q54930886
RX   PubMed=17060621;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 8
//
ID   NOF151-hTERT
AC   CVCL_2G76
SY   NOF151-hTert; IF-151; IF151
DR   GEO; GSE40266
DR   Wikidata; Q54930887
RX   PubMed=17060621;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G73 ! NOF151
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   NOG8
AC   CVCL_5846
DR   Wikidata; Q54930888
RX   PubMed=3127778;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0075 ! NMuMG
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   NoGFP-CD16.NK92
AC   CVCL_V429
DR   ATCC; PTA-6967
DR   Wikidata; Q54930889
RX   Patent=US9181322;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6967.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val).
CC   Discontinued: ATCC; PTA-6967; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
ST   Source(s): ATCC=PTA-6967
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   Nohm-1
AC   CVCL_VS17
SY   Nohm1
DR   Wikidata; Q98128003
RX   PubMed=4086513;
RX   PubMed=16880792;
CC   Population: African American.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   NOI-90
AC   CVCL_8462
SY   NOI90
DR   BioSample; SAMN03151906
DR   cancercelllines; CVCL_8462
DR   Wikidata; Q54930890
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9009088;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from peripheral blood of a 45 year old male patient with acute lymphoblastic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00245.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1650 ! Reh
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   NOK-1
AC   CVCL_E4A6
SY   NOK1
DR   ABCD; ABCD_AQ447
RX   Patent=US6946255;
RX   PubMed=7500022;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5044.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NOK-2
AC   CVCL_E4A7
SY   NOK2
DR   ABCD; ABCD_AQ448
RX   Patent=US6946255;
RX   PubMed=7500022;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5045.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NOK-3
AC   CVCL_E4A8
SY   NOK3
RX   Patent=US6946255;
RX   PubMed=7500022;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5046.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NOK-4
AC   CVCL_E4A9
SY   NOK4
RX   Patent=US6946255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5047.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NOK-5
AC   CVCL_E4AA
SY   NOK5
RX   Patent=US6946255;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5048.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P48023; Human FASLG/CD178.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   NOK-SI
AC   CVCL_BW57
SY   NOKSI; NOKsi; Normal Oral Keratinocytes-Spontaneously Immortalized
DR   Cosmic; 2296312
DR   Wikidata; Q54930891
RX   PubMed=20463891;
RX   PubMed=25275298;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HaCaT derivative (ICLAC). Originally thought to originate from normal oral keratinocytes from a female donor.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00589.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Unspecified (PubMed=25275298).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=25275298
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 12
ST   D21S11: 28,30.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 24
ST   Penta D: 11,13
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   NOKT-1
AC   CVCL_C0UY
DR   Wikidata; Q114312565
RX   DOI=10.2485/jhtb.30.97;
CC   Population: Japanese.
CC   Doubling time: 27 hours (Note=At 15th passage), 23 hours (Note=At 30th passage) (DOI=10.2485/jhtb.30.97).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DOI=10.2485/jhtb.30.97
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 15,20
ST   TH01: 7
ST   TPOX: 10
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NOKT-1-XG
AC   CVCL_C0UZ
DR   Wikidata; Q114312566
RX   DOI=10.2485/jhtb.30.97;
CC   Population: Japanese.
CC   Characteristics: The parent cell line was transplanted subcutaneously into nude mice and a xenograft was formed from which this cell line was established.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DOI=10.2485/jhtb.30.97
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 13,14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 7
ST   TPOX: 10
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0UY ! NOKT-1
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NOL-3
AC   CVCL_Y587
DR   Wikidata; Q54930892
RX   CelloPub=CLPUB00157;
RX   PubMed=1465024;
RX   PubMed=9737686;
RX   PubMed=9738977;
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   nOLIG1
AC   CVCL_IR51
DR   Wikidata; Q54930893
RX   PubMed=20978004;
CC   Derived from site: In situ; Brain, right fronto-temporo-parietal lobe.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   6Y6M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   NOM1
AC   CVCL_RN35
SY   Nagoya Ovarian Mucinous 1
DR   Wikidata; Q54930894
RX   PubMed=8978593;
RX   PubMed=9344045;
RX   PubMed=9891486;
CC   Population: Japanese.
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   NOM9-CT
AC   CVCL_AT83
SY   NOM9-TK; NOM9/TK; Normal oral mucosa 9-CDK4/TERT immortalized
DR   Wikidata; Q54930895
RX   PubMed=20145189;
RX   PubMed=21868764;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   NOM9/TKp53
AC   CVCL_AT84
DR   Wikidata; Q54930896
RX   PubMed=21868764;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AT83 ! NOM9-CT
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   NOMH-1
AC   CVCL_L038
DR   Wikidata; Q54930897
RX   PubMed=23379414;
CC   Population: Japanese.
CC   Doubling time: 273 hours (PubMed=23379414).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   NOMO-1
AC   CVCL_1609
SY   Nomo-1; NOMO1
DR   BTO; BTO_0005916
DR   CLO; CLO_0009851
DR   EFO; EFO_0022462
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 398
DR   BioSample; SAMN01821652
DR   BioSample; SAMN01821737
DR   BioSample; SAMN03473105
DR   BioSample; SAMN10988550
DR   cancercelllines; CVCL_1609
DR   Cell_Model_Passport; SIDM00580
DR   ChEMBL-Cells; CHEMBL3308243
DR   ChEMBL-Targets; CHEMBL2366198
DR   Cosmic; 787464
DR   Cosmic; 908451
DR   Cosmic; 975286
DR   Cosmic; 1281342
DR   Cosmic; 1523827
DR   Cosmic; 1524839
DR   Cosmic; 2131550
DR   Cosmic; 2297030
DR   Cosmic; 2306229
DR   Cosmic-CLP; 908451
DR   DepMap; ACH-000168
DR   DSMZ; ACC-542
DR   DSMZCellDive; ACC-542
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10764-110E8
DR   GDSC; 908451
DR   GEO; GSM236799
DR   GEO; GSM236835
DR   GEO; GSM482496
DR   GEO; GSM887458
DR   GEO; GSM888538
DR   GEO; GSM1374774
DR   GEO; GSM1446755
DR   GEO; GSM1670283
DR   IARC_TP53; 21588
DR   JCRB; IFO50474
DR   LiGeA; CCLE_531
DR   LINCS_LDP; LCL-1074
DR   PharmacoDB; NOMO1_1165_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1609
DR   PubChem_Cell_line; CVCL_1609
DR   Wikidata; Q54930898
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.3960/jslrt1961.28.19;
RX   PubMed=1699657;
RX   PubMed=1701357;
RX   PubMed=9738977;
RX   PubMed=14671638;
RX   PubMed=20164919;
RX   PubMed=21552520;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=28109323;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 55 hours (PubMed=25984343); ~35 hours (DSMZ=ACC-542).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=14671638).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.730-10T>C; ClinVar=VCV003011970; Zygosity=Heterozygous (Cosmic-CLP=908451; DepMap=ACH-000168).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (Cosmic-CLP=908451; DepMap=ACH-000168).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; Zygosity=Heterozygous (Cosmic-CLP=908451; DepMap=ACH-000168).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.4%; Native American=0.99%; East Asian, North=76.88%; East Asian, South=20.48%; South Asian=0%; European, North=0.98%; European, South=0.27% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=908451; DSMZ=ACC-542; JCRB=IFO50474; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 17,21.2 (DSMZ=ACC-542)
ST   D18S51: 17,22 (PubMed=25877200)
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 15,17
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   NOMO-1/ADM
AC   CVCL_3077
DR   CLO; CLO_0009852
DR   cancercelllines; CVCL_3077
DR   GEO; GSM827275
DR   JCRB; JCRB1069
DR   LINCS_LDP; LCL-1064
DR   Progenetix; CVCL_3077
DR   Wikidata; Q54930899
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: ~1.5 days (Note=Lot 10032003) (JCRB=JCRB1069).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.730-10T>C; ClinVar=VCV003011970; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1609 ! NOMO-1
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 26
//
ID   NOMO-1s
AC   CVCL_3078
DR   cancercelllines; CVCL_3078
DR   JCRB; IFO50475
DR   Wikidata; Q54930900
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.730-10T>C; ClinVar=VCV003011970; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): JCRB=IFO50475
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1609 ! NOMO-1
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 22
//
ID   NON,L
AC   CVCL_E795
SY   NON, L
DR   dbMHC; 48989
DR   ECACC; 94082292
DR   IHW; IHW09192
DR   IPD-IMGT/HLA; 11734
DR   Wikidata; Q54930901
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*01,10; B*51,55; C*01; DPB1*02:01:02,05:01; DQA1*01:03,03; DQB1*06:01,03:02; DRB1*04:06,08:03; DRB4*01:03 (IPD-IMGT/HLA=11734).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   NONI-A109
AC   CVCL_E8W5
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NONI-A14
AC   CVCL_E8W6
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NONI-A222
AC   CVCL_E8VX
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NONI-A26
AC   CVCL_E8W4
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NONI-B19
AC   CVCL_E8VZ
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NONI-B203
AC   CVCL_E8VY
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NONI-B4
AC   CVCL_E8W2
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NONI-B6
AC   CVCL_E8W3
RX   PubMed=16168396;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q93070; Human ART4/CD297.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NOOC1
AC   CVCL_C0N3
SY   4-NQO-induced Oral Cancer 1
DR   Kerafast; EMU061
DR   Wikidata; Q114312567
RX   PubMed=34594005;
CC   Characteristics: Tumorigenic.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   21W
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   NOP-1
AC   CVCL_M503
SY   NOP1
DR   Wikidata; Q54930902
RX   CelloPub=CLPUB00090;
RX   PubMed=9737686;
RX   PubMed=9738977;
RX   PubMed=10557056;
RX   PubMed=10936422;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=17229644;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: 36 hours (CelloPub=CLPUB00090).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   NOP-2
AC   CVCL_M502
SY   NOP2
DR   Wikidata; Q54930903
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1747447;
RX   PubMed=9738977;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   NOR-10
AC   CVCL_3939
SY   NOR 10; NOR10; Nor10; Normal fibroblast-10
DR   CLO; CLO_0008191
DR   CLDB; cl3720
DR   CLDB; cl5238
DR   ATCC; CCL-197
DR   BCRC; 60121
DR   ECACC; 90112701
DR   IZSLER; BS CL 114
DR   KCLB; 10197
DR   Wikidata; Q54930907
RX   PubMed=20889;
RX   PubMed=7065527;
CC   Characteristics: Control cell line for BLO-11 (Cellosaurus=CVCL_4129).
CC   Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
CC   Breed/subspecies: C57BL/10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Nor-iPSC
AC   CVCL_A4DT
DR   Wikidata; Q105510448
RX   PubMed=33189042;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 6
//
ID   NOR-P1
AC   CVCL_4716
SY   Nor-P1
DR   BTO; BTO_0003533
DR   CLO; CLO_0050103
DR   BioSample; SAMN03472013
DR   FANTOM5_SSTAR; 10698-109G5
DR   RCB; RCB2139
DR   TKG; TKG 0630
DR   Wikidata; Q54930908
RX   PubMed=10822130;
CC   Population: Japanese.
CC   Doubling time: 16 hours (PubMed=10822130).
CC   Discontinued: RCB; RCB2139; true.
CC   Discontinued: TKG; TKG 0630; true.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): RCB=RCB2139; TKG=TKG 0630
ST   Amelogenin: X,Y
ST   CSF1PO: 7,10
ST   D13S317: 11
ST   D16S539: 9,10 (TKG=TKG 0630)
ST   D16S539: 10 (RCB=RCB2139)
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   NORIg 7.16.2
AC   CVCL_J853
DR   ECACC; 11060818
DR   Wikidata; Q54930909
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat IgG2b heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   NORM-1
AC   CVCL_XI24
SY   Norm-1; NORM1
DR   Wikidata; Q98128004
RX   Patent=WO2005094159A2;
RX   Patent=WO2009104100A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2624.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   NORM-2
AC   CVCL_XI25
SY   Norm-2; NORM2
DR   Wikidata; Q98128005
RX   Patent=WO2005094159A2;
RX   Patent=WO2009104100A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2626.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   NORWAY1010 fibroblast
AC   CVCL_A9F6
SY   L140R
DR   Wikidata; Q102114656
RX   PubMed=12927431;
RX   PubMed=23847654;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Leu140Arg (c.419T>G); ClinVar=VCV000014507; Zygosity=Heterozygous (PubMed=12927431; PubMed=23847654).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9F8 ! NORWAY1010 LCL
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   NORWAY1010 fibroblast hTERT
AC   CVCL_A9F7
SY   L140R hTERT
DR   Wikidata; Q102114657
RX   PubMed=23847654;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector containing a LTR-loxP-hTERT-SV40p-hisD-PuroR-LTR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Leu140Arg (c.419T>G); ClinVar=VCV000014507; Zygosity=Heterozygous (PubMed=23847654).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9F6 ! NORWAY1010 fibroblast
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   NORWAY1010 LCL
AC   CVCL_A9F8
DR   Wikidata; Q102114658
RX   PubMed=12927431;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Leu140Arg (c.419T>G); ClinVar=VCV000014507; Zygosity=Heterozygous (PubMed=12927431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9F6 ! NORWAY1010 fibroblast
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   NOS-1 [Human HNSCC]
AC   CVCL_M837
DR   cancercelllines; CVCL_M837
DR   IARC_TP53; 17855
DR   Wikidata; Q54930910
RX   PubMed=11291288;
RX   PubMed=11337272;
CC   Population: Japanese.
CC   Doubling time: 16.1 hours (Note=At 100th passage) (PubMed=11291288; PubMed=11337272).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=11337272).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C8171; Lower gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   NOS-1 [Human osteosarcoma]
AC   CVCL_1610
SY   NOS1
DR   CLO; CLO_0050812
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472210
DR   cancercelllines; CVCL_1610
DR   Cell_Model_Passport; SIDM00242
DR   ChEMBL-Cells; CHEMBL3308836
DR   ChEMBL-Targets; CHEMBL2366141
DR   Cosmic; 925345
DR   Cosmic-CLP; 925345
DR   DepMap; ACH-002067
DR   EGA; EGAS00001000978
DR   GDSC; 925345
DR   GEO; GSM1670284
DR   LINCS_LDP; LCL-1432
DR   PharmacoDB; NOS1_1166_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1610
DR   RCB; RCB1032
DR   Wikidata; Q54930911
RX   PubMed=1449054;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 49.6 hours (PubMed=1449054).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.97%; East Asian, North=79.98%; East Asian, South=18.61%; South Asian=0.44%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Bone, left proximal tibia; UBERON=UBERON_0008772.
ST   Source(s): Cosmic-CLP=925345; RCB=RCB1032
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 9,12
ST   D16S539: 10,12,13
ST   D5S818: 10,12
ST   D7S820: 8,12,13 (RCB=RCB1032)
ST   D7S820: 8,13 (Cosmic-CLP=925345)
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   NOS-1.C8
AC   CVCL_T745
DR   Wikidata; Q54930912
RX   PubMed=8100098;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, left proximal tibia; UBERON=UBERON_0008772.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1610 ! NOS-1 [Human osteosarcoma]
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   NOS-10
AC   CVCL_4663
SY   NOS10
DR   CLO; CLO_0050013
DR   BioSample; SAMN03471966
DR   RCB; RCB2348
DR   Wikidata; Q54930913
RX   PubMed=15173092;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): RCB=RCB2348
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NOS-2
AC   CVCL_3351
SY   NOS2
DR   CLO; CLO_0050811
DR   BioSample; SAMN03472152
DR   RCB; RCB1033
DR   Wikidata; Q54930914
RX   PubMed=1449054;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 48.0 hours (PubMed=1449054).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
ST   Source(s): RCB=RCB1033
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   NOS1
AC   CVCL_RN32
SY   Nagoya Ovarian Serous 1
DR   Wikidata; Q54930915
RX   PubMed=8978593;
CC   Population: Japanese.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   NOS2
AC   CVCL_T747
SY   NOS-2; Nagoya Ovarian Serous 2
DR   BTO; BTO_0004923
DR   Wikidata; Q54930916
RX   PubMed=8097673;
RX   PubMed=9344045;
RX   PubMed=12767062;
CC   Population: Japanese.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 8
//
ID   NOS2AR
AC   CVCL_RN33
DR   Wikidata; Q54930917
RX   PubMed=8097673;
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T747 ! NOS2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   NOS2CR
AC   CVCL_RN29
DR   Wikidata; Q54930918
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T747 ! NOS2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   NOS2SNR
AC   CVCL_RN30
DR   Wikidata; Q54930919
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T747 ! NOS2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   NOS2VR
AC   CVCL_RN31
DR   Wikidata; Q54930920
RX   PubMed=8978593;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T747 ! NOS2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   NOS3
AC   CVCL_T746
SY   Nagoya Ovarian Serous 3
DR   Wikidata; Q54930921
RX   PubMed=8097673;
RX   PubMed=8978593;
RX   PubMed=9344045;
RX   PubMed=12767062;
CC   Population: Japanese.
CC   Misspelling: NOS1; Note=In Cellosaurus releases 8 to 24.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   NOS3AR
AC   CVCL_RN34
DR   Wikidata; Q54930923
RX   PubMed=8097673;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T746 ! NOS3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   NOS4
AC   CVCL_4464
SY   NOS-4; Nagoya Ovarian Serous 4
DR   BTO; BTO_0004924
DR   Wikidata; Q54930924
RX   PubMed=8978593;
RX   PubMed=9344045;
RX   PubMed=10403549;
RX   PubMed=11865194;
RX   PubMed=12767062;
CC   Population: Japanese.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   NOSCC1
AC   CVCL_A5GW
DR   Wikidata; Q107116573
RX   PubMed=33300248;
CC   Population: Japanese.
CC   Characteristics: Established from tumors in super-immunodeficient NSG (NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ) mice subcutanously injected with the patient tumor pieces (PubMed=33300248).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C177774; Ovarian dermoid cyst with somatic-type malignancy
DI   ORDO; Orphanet_398987; Malignant teratoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NOSE-06
AC   CVCL_X010
SY   NOSE06
DR   BioSample; SAMN03151635
DR   cancercelllines; CVCL_X010
DR   Wikidata; Q54930925
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00464.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6774 ! DOV13
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   NOSE-07
AC   CVCL_X011
SY   NOSE07
DR   BioSample; SAMN03151636
DR   cancercelllines; CVCL_X011
DR   Wikidata; Q54930926
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00465.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6774 ! DOV13
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   NOSE21R
AC   CVCL_C3H9
DR   Wikidata; Q114312568
RX   PubMed=17877616;
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   NOTT1
AC   CVCL_A000
SY   NOTT-1; Nott 1; Nott1; UNOTe001-A
DR   hPSCreg; UNOTe001-A
DR   SKIP; SKIP001899
DR   Wikidata; Q54930927
RX   PubMed=18772870;
RX   PubMed=20177995;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/nott-1.aspx
CC   From: University of Nottingham; Nottingham; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-001, Steering comm. appl. SCSC06-12.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   NOTT2
AC   CVCL_A001
SY   NOTT-2; Nott 2; Nott2; UNOTe002-A
DR   hPSCreg; UNOTe002-A
DR   SKIP; SKIP001900
DR   Wikidata; Q54930928
RX   PubMed=18772870;
RX   PubMed=20177995;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/nott-2.aspx
CC   From: University of Nottingham; Nottingham; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-002, Steering comm. appl. SCSC06-17.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   NOU-1
AC   CVCL_S912
SY   Nou-1; NOU1; AG13904
DR   CLO; CLO_0022358
DR   Coriell; AG13904
DR   Cosmic; 2030480
DR   Wikidata; Q54930929
RX   PubMed=12419584;
RX   PubMed=20944090;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=20944090).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   NOV-31
AC   CVCL_DD17
SY   Normal OVarian-31
DR   Wikidata; Q54930930
RX   Patent=US5710038;
RX   PubMed=11641787;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11733.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, epithelium; UBERON=UBERON_0004911.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   Novikoff-Hepatoma
AC   CVCL_1D01
SY   Novikoff Hepatoma; NK
DR   BTO; BTO_0000950
DR   CLS; 500373
DR   Wikidata; Q54930931
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_3551 ! N1-S1
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   NOVOe001-A
AC   CVCL_B4K7
SY   3053
DR   BioSamples; SAMEA9232316
DR   hPSCreg; NOVOe001-A
DR   Wikidata; Q110433108
CC   From: Novo Nordisk A/S; Bagsvaerd; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   Novoprotein Jurkat-NFAT
AC   CVCL_E2U5
WW   Provider; Novoprotein; XCC20; https://www.novoprotein.com.cn/product-detail?productNumber=XCC20
CC   Population: Caucasian.
CC   Characteristics: Transfected with a firefly luciferase reporter gene under the control of the NFAT response element (Novoprotein=XCC20).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   NovrA2
AC   CVCL_4Y50
DR   Wikidata; Q54930932
RX   PubMed=2433772;
RX   PubMed=2845588;
CC   Selected for resistance to: ChEBI; CHEBI_28368; Novobiocin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   NovrA41
AC   CVCL_4Y51
DR   Wikidata; Q54930933
RX   PubMed=2433772;
CC   Selected for resistance to: ChEBI; CHEBI_28368; Novobiocin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   NOX1-HEK293
AC   CVCL_ZL50
DR   Wikidata; Q98128006
RX   PubMed=19061439;
RX   PubMed=26861875;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7889; NOX1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   NOX4-HEK293
AC   CVCL_ZL51
DR   PRIDE; PXD003509
DR   Wikidata; Q98128007
RX   PubMed=19061439;
RX   PubMed=26861875;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7891; NOX4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   NOY1
AC   CVCL_0P30
SY   NOY-1; Nagoya Ovarian Yolk sac tumor cell line clone 1
DR   BTO; BTO_0005874
DR   Kerafast; ENG101
DR   Wikidata; Q54930934
RX   PubMed=18547965;
RX   PubMed=21150160;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=18547965).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P31 ! NOY2
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   NOY1-CR
AC   CVCL_0P32
DR   Wikidata; Q54930935
RX   PubMed=21150160;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P30 ! NOY1
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   NOY2
AC   CVCL_0P31
SY   Nagoya Ovarian Yolk sac tumor cell line clone 2
DR   Wikidata; Q54930936
RX   PubMed=18547965;
CC   Population: Japanese.
CC   Doubling time: 31 hours (PubMed=18547965).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0P30 ! NOY1
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NOZ
AC   CVCL_3079
SY   NOZAWA; NOZC-1
DR   EFO; EFO_0010973
DR   BioGRID_ORCS_Cell_line; 1160
DR   BioSample; SAMN03472480
DR   cancercelllines; CVCL_3079
DR   Cell_Model_Passport; SIDM01812
DR   Cosmic; 1122352
DR   Cosmic; 2629294
DR   Cosmic; 2674061
DR   DepMap; ACH-001607
DR   JCRB; JCRB1033
DR   JCRB; NIHS0283
DR   Wikidata; Q54930937
RX   CelloPub=CLPUB00469;
RX   DOI=10.1007/BF02348185;
RX   PubMed=2543327;
RX   PubMed=3154020;
RX   PubMed=32293552;
RX   PubMed=32899426;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 40-48 hours (CelloPub=CLPUB00469); 30 hours (PubMed=32293552); 48 hours (PubMed=3154020); 30 hours (Note=Lot 09162008) (JCRB=JCRB1033).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (DepMap=ACH-001607).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Unspecified (DepMap=ACH-001607).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: NO2; Cosmic=2629294.
CC   Discontinued: JCRB; NIHS0283; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001607; JCRB=JCRB1033
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 12
ST   D21S11: 30,31
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 9,14
ST   FGA: 17
ST   Penta D: 11,13
ST   Penta E: 12,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   NP cl.120
AC   CVCL_J900
DR   ECACC; 95040312
DR   Wikidata; Q54930938
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   NP cl.25
AC   CVCL_J901
DR   ECACC; 95051114
DR   Wikidata; Q54930939
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   NP-01
AC   CVCL_C7NE
SY   Clone 1; anti-NPTXR mAb-1
DR   Wikidata; Q117704726
RX   Patent=US12098205;
RX   PubMed=32847597;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02856.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95502; Human NPTXR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   NP-2
AC   CVCL_1R15
SY   NP 2; Case 4; NB3911
DR   cancercelllines; CVCL_1R15
DR   Cell_Model_Passport; SIDM01822
DR   DepMap; ACH-001608
DR   JCRB; JCRB1566
DR   RCB; RCB4498
DR   Wikidata; Q54930940
RX   CelloPub=CLPUB00260;
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=18415661;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 36 hours (Note=At 145th passage) (CelloPub=CLPUB00260).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (PubMed=8878451).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): DepMap=ACH-001608; JCRB=JCRB1566
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 9,10,11
ST   D18S51: 13,15
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14,17
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   NP-2/APJ
AC   CVCL_1R19
DR   cancercelllines; CVCL_1R19
DR   Wikidata; Q54930941
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   NP-2/CCR3
AC   CVCL_1R20
DR   cancercelllines; CVCL_1R20
DR   Wikidata; Q54930942
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   NP-2/CCR5
AC   CVCL_1R21
SY   NP2/CCR5
DR   cancercelllines; CVCL_1R21
DR   Wikidata; Q54930943
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   NP-2/CCR5/iGFP
AC   CVCL_UF01
DR   cancercelllines; CVCL_UF01
DR   Wikidata; Q98128009
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=22178016;
CC   Population: Japanese.
CC   Characteristics: GFP-inducible indicator cell line produced by transfection of the pHIV-LTR-GFP-NLS plasmid, containing HIV-1 long terminal repeat (LTR), eGFP, the nuclear localization signal (NLS) of HIV-1 Rev and pac.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UE99 ! NP-2/iGFP
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   NP-2/CCR8
AC   CVCL_1R22
DR   cancercelllines; CVCL_1R22
DR   Wikidata; Q54930944
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   NP-2/CD4
AC   CVCL_1R18
SY   NP2/CD4; NP2-CD4; NP-2/CD4/EcoVR
DR   cancercelllines; CVCL_1R18
DR   RCB; RCB5305
DR   Wikidata; Q54930945
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=10329384;
RX   PubMed=11112502;
RX   PubMed=18577234;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   NP-2/CD4/APJ
AC   CVCL_1R25
SY   NP-2/CD4/EcoVR/APJ
DR   cancercelllines; CVCL_1R25
DR   RCB; RCB5308
DR   Wikidata; Q54930946
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   NP-2/CD4/CCR3
AC   CVCL_1R26
DR   cancercelllines; CVCL_1R26
DR   Wikidata; Q54930947
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   NP-2/CD4/CCR5
AC   CVCL_1R27
SY   NP2/CD4/CCR5; NP2-CD4/CCR5; NP2/CD4/R5; NP-2/CD4/EcoVR/CCR5
DR   cancercelllines; CVCL_1R27
DR   RCB; RCB5307
DR   Wikidata; Q54930951
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=10623723;
RX   PubMed=11112502;
RX   PubMed=18577234;
RX   PubMed=22178016;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   NP-2/CD4/CCR5/iGFP
AC   CVCL_UF02
DR   cancercelllines; CVCL_UF02
DR   Wikidata; Q98128010
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=22178016;
CC   Population: Japanese.
CC   Characteristics: GFP-inducible indicator cell line produced by transfection of the pHIV-LTR-GFP-NLS plasmid, containing HIV-1 long terminal repeat (LTR), eGFP, the nuclear localization signal (NLS) of HIV-1 Rev and pac.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF00 ! NP-2/CD4/iGFP
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   NP-2/CD4/CCR6
AC   CVCL_A6UR
SY   NP-2/CD4/EcoVR/CCR6
DR   cancercelllines; CVCL_A6UR
DR   RCB; RCB5309
DR   Wikidata; Q107116575
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1607; CCR6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   NP-2/CD4/CCR8
AC   CVCL_1R28
SY   NP-2/CD4/EcoVR/CCR8
DR   cancercelllines; CVCL_1R28
DR   RCB; RCB5310
DR   Wikidata; Q54930952
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1609; CCR8.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   NP-2/CD4/CXCR4
AC   CVCL_1R29
SY   NP2/CD4/CXCR4; NP2-CD4/CXCR4; NP-2/CD4/EcoVR/CXCR4
DR   cancercelllines; CVCL_1R29
DR   RCB; RCB5306
DR   Wikidata; Q54930953
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=10623723;
RX   PubMed=11112502;
RX   PubMed=18577234;
RX   PubMed=22178016;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   NP-2/CD4/FPRL1
AC   CVCL_A6US
SY   NP-2/CD4/EcoVR/FPRL1
DR   cancercelllines; CVCL_A6US
DR   RCB; RCB5311
DR   Wikidata; Q107116576
RX   PubMed=18577234;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3827; FPR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   NP-2/CD4/GPR1
AC   CVCL_1R30
SY   NP-2/CD4/EcoVR/GPR1
DR   cancercelllines; CVCL_1R30
DR   RCB; RCB5312
DR   Wikidata; Q54930954
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=11112502;
RX   PubMed=18577234;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4463; CMKLR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   NP-2/CD4/iGFP
AC   CVCL_UF00
DR   cancercelllines; CVCL_UF00
DR   Wikidata; Q98128011
RX   PubMed=22178016;
CC   Population: Japanese.
CC   Characteristics: GFP-inducible indicator cell line produced by transfection of the pHIV-LTR-GFP-NLS plasmid, containing HIV-1 long terminal repeat (LTR), eGFP, the nuclear localization signal (NLS) of HIV-1 Rev and pac.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UE99 ! NP-2/iGFP
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   NP-2/CD4/RDC1
AC   CVCL_A7BP
SY   NP-2/CD4/EcoVR/RDC1
DR   cancercelllines; CVCL_A7BP
DR   RCB; RCB5313
DR   Wikidata; Q107116577
RX   PubMed=10623723;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:23692; ACKR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R18 ! NP-2/CD4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   NP-2/CXCR4
AC   CVCL_1R23
DR   cancercelllines; CVCL_1R23
DR   Wikidata; Q54930955
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   NP-2/GPR1
AC   CVCL_1R24
DR   cancercelllines; CVCL_1R24
DR   Wikidata; Q54930956
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4463; CMKLR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   NP-2/iGFP
AC   CVCL_UE99
DR   cancercelllines; CVCL_UE99
DR   Wikidata; Q98128012
RX   DOI=10.2974/kmj.62.1;
RX   PubMed=22178016;
CC   Population: Japanese.
CC   Characteristics: GFP-inducible indicator cell line produced by transfection of the pHIV-LTR-GFP-NLS plasmid, containing HIV-1 long terminal repeat (LTR), eGFP, the nuclear localization signal (NLS) of HIV-1 Rev and pac.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   NP-3
AC   CVCL_1R16
SY   NP 3; Case 2; NB3972
DR   cancercelllines; CVCL_1R16
DR   Cell_Model_Passport; SIDM01847
DR   DepMap; ACH-001609
DR   JCRB; JCRB1567
DR   RCB; RCB4504
DR   Wikidata; Q54930957
RX   CelloPub=CLPUB00260;
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=18415661;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 36 hours (Note=At 129th passage) (CelloPub=CLPUB00260).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Met199del (c.592_594ATG[1]) (c.595_597delATG); ClinVar=VCV000418437; Zygosity=Unspecified (PubMed=10551321).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): DepMap=ACH-001609; JCRB=JCRB1567
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 23
ST   D21S11: 32.2
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 20,22
ST   Penta D: 13
ST   Penta E: 16
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   NP-5
AC   CVCL_1R17
SY   NP 5; NP5; Case 5; NB4135
DR   cancercelllines; CVCL_1R17
DR   Cell_Model_Passport; SIDM01885
DR   DepMap; ACH-001610
DR   JCRB; JCRB1569
DR   RCB; RCB4505
DR   Wikidata; Q54930958
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=18415661;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Unspecified (PubMed=10551321; DepMap=ACH-001610).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8878451; DepMap=ACH-001610).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): DepMap=ACH-001610; JCRB=JCRB1569
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 10,12
ST   D18S51: 15,16
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 12,13
ST   D8S1179: 11,14
ST   FGA: 20
ST   Penta D: 9,10
ST   Penta E: 14,15,22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 19
//
ID   NP-8
AC   CVCL_4W66
SY   NP 8; NP8; Case 1
DR   cancercelllines; CVCL_4W66
DR   Cell_Model_Passport; SIDM01381
DR   DepMap; ACH-001611
DR   JCRB; JCRB1608
DR   Wikidata; Q54930959
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=18415661;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (PubMed=8878451).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): DepMap=ACH-001611; JCRB=JCRB1608
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 28,29
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 12,18
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   NP1
AC   CVCL_A9SL
SY   Normal Pleura 1
DR   Wikidata; Q102114659
RX   PubMed=32726133;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
ST   Source(s): PubMed=32726133
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 13,18
ST   D19S433: 11,14
ST   D21S11: 30,31
ST   D2S1338: 17,25
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 12,14
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 12,13
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   NP105
AC   CVCL_F0C9
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at 6 PDL (PubMed=24167620).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP105-Bmi-1
AC   CVCL_F0CP
SY   NP105Bmi-1
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at ~15 PDL (PubMed=24167620).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0C9 ! NP105
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP11
AC   CVCL_D557
SY   Nonparenchymal 11
DR   Wikidata; Q54930960
RX   PubMed=9648910;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   NP133
AC   CVCL_UW64
DR   Wikidata; Q98128013
RX   PubMed=3771439;
RX   PubMed=3942687;
RX   PubMed=8120409;
CC   Characteristics: Non-melanogenic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GS32 ! HFH-18
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   NP18
AC   CVCL_E3BN
DR   Cosmic; 968126
RX   PubMed=9788440;
CC   Characteristics: Established from a xenograft orthotopically implanted in nude mice (PubMed=9788440).
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NP2 [Human lung]
AC   CVCL_A9SM
SY   Normal Pleura 2
DR   Wikidata; Q102114660
RX   PubMed=32726133;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   NP2 [Human nose]
AC   CVCL_B7IQ
DR   Wikidata; Q112930202
RX   PubMed=34429452;
CC   Doubling time: 62 hours (PubMed=34429452).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D16S539: 10,11
ST   D18S51: 15
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D6S1043: 12,17
ST   D8S1179: 10,13
ST   vWA: 14,17
DI   NCIt; C3256; Nasal cavity polyp
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NP2/K4DT
AC   CVCL_B7IR
DR   Wikidata; Q112930205
RX   PubMed=34429452;
CC   Doubling time: 59 hours (PubMed=34429452).
CC   Karyotypic information: 46,XY [21/50]; 46,XY,del(6)(q21;qter) [29/50] (PubMed=34429452).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D16S539: 10,11
ST   D18S51: 15
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D6S1043: 12,17
ST   D8S1179: 10,13
ST   vWA: 14,17
DI   NCIt; C3256; Nasal cavity polyp
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7IQ ! NP2 [Human nose]
SX   Male
AG   19Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NP23(CF)
AC   CVCL_B7CE
DR   Wikidata; Q112930209
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 20 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C3256; Nasal cavity polyp
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   NP24(CF)
AC   CVCL_B7CF
DR   Wikidata; Q112930211
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 16 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C3256; Nasal cavity polyp
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   NP26
AC   CVCL_D558
SY   Nonparenchymal 26
DR   Wikidata; Q54930961
RX   PubMed=9648910;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   NP29
AC   CVCL_E3BR
DR   Cosmic; 968141
RX   PubMed=9788440;
CC   Characteristics: Established from a xenograft orthotopically implanted in nude mice (PubMed=9788440).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=9788440).
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   NP3 [Human lung]
AC   CVCL_A9SN
SY   Normal Pleura 3
DR   Wikidata; Q102114661
RX   PubMed=32726133;
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Lys286Glnfs*21 (c.855dupC); ClinVar=VCV000545892; Zygosity=Heterozygous (PubMed=32726133).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Donor information: Established from a patient suffering from an early stage malignant pleural mesothelioma.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   NP3 [Human nose]
AC   CVCL_B7IS
DR   Wikidata; Q112930213
RX   PubMed=34429452;
CC   Doubling time: 63 hours (PubMed=34429452).
CC   Transformant: NCBI_TaxID; 10598; Human papillomavirus type 58 (HPV58).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D6S1043: 12,13
ST   D8S1179: 14,15
ST   vWA: 14,17
DI   NCIt; C3256; Nasal cavity polyp
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NP361
AC   CVCL_F0CA
RX   PubMed=20827769;
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at 20 PDL (PubMed=20827769; PubMed=24167620).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with undifferentiated nasopharyngeal carcinoma (PubMed=20827769).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP361-Bmi-1
AC   CVCL_F0CD
SY   NP361Bmi-1
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at 29 PDL (PubMed=24167620).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with undifferentiated nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CA ! NP361
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP361-hTERT
AC   CVCL_F0CE
SY   NP361hTERT
RX   PubMed=20827769;
CC   Population: Chinese.
CC   Senescence: Senesces at ~30 PDL (PubMed=20827769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with undifferentiated nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CA ! NP361
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP361-LMP1
AC   CVCL_F0CF
SY   NP361LMP1
RX   PubMed=20827769;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; R4R994; Epstein-Barr virus (strain 2117) latent membrane protein 1 (LMP1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with undifferentiated nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CA ! NP361
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP361-LMP1/hTERT
AC   CVCL_F0CG
SY   NP361LMP1/hTERT
RX   PubMed=20827769;
CC   Population: Chinese.
CC   Senescence: Senesces at ~40 PDL (PubMed=20827769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; R4R994; Epstein-Barr virus (strain 2117) latent membrane protein 1 (LMP1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with undifferentiated nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CF ! NP361-LMP1
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP3/T
AC   CVCL_B7IT
DR   Wikidata; Q112930214
RX   PubMed=34429452;
CC   Doubling time: 62 hours (PubMed=34429452).
CC   Karyotypic information: 46,XY [5/50]; 47,XY,+4 [45/50] (PubMed=34429452).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Transformant: NCBI_TaxID; 10598; Human papillomavirus type 58 (HPV58).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D6S1043: 12,13
ST   D8S1179: 14,15
ST   vWA: 14,17
DI   NCIt; C3256; Nasal cavity polyp
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7IS ! NP3 [Human nose]
SX   Male
AG   11Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   NP31 [Human pancreatic carcinoma]
AC   CVCL_E3BS
DR   Cosmic; 968115
RX   PubMed=9788440;
CC   Characteristics: Established from a xenograft orthotopically implanted in nude mice (PubMed=9788440).
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NP31 [Rat liver]
AC   CVCL_D559
SY   Nonparenchymal 31
DR   Wikidata; Q54930962
RX   PubMed=9648910;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   NP32
AC   CVCL_D560
SY   Nonparenchymal 32
DR   Wikidata; Q54930963
RX   PubMed=9648910;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   6W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   NP34
AC   CVCL_B7CG
DR   Wikidata; Q112930215
RX   PubMed=1693627;
CC   Senescence: May have a finite life span; not cultured over 48 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3256; Nasal cavity polyp
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   NP361-CDK4R24C-hTert
AC   CVCL_B3Q4
SY   NP361CDK4R24C/hTert
DR   Wikidata; Q110433109
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3Q3 ! NP361hTert
OI   CVCL_B3Q5 ! NP361-cyclinD1-hTert
SX   Female
AG   50Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP361-cyclinD1-hTert
AC   CVCL_B3Q5
SY   NP361Cyclin D1/hTert; NP361-cyclinD-hTert
DR   Wikidata; Q110433111
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3Q3 ! NP361hTert
OI   CVCL_B3Q4 ! NP361-CDK4R24C-hTert
SX   Female
AG   50Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP361hTert
AC   CVCL_B3Q3
DR   Wikidata; Q110433112
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3Q4 ! NP361-CDK4R24C-hTert
OI   CVCL_B3Q5 ! NP361-cyclinD1-hTert
SX   Female
AG   50Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP369
AC   CVCL_E796
DR   dbMHC; 48990
DR   ECACC; 94082255
DR   IHW; IHW09155
DR   IPD-IMGT/HLA; 11698
DR   Wikidata; Q54930964
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*02,11; B*57; C*06,07; DPB1*04:01,05:01; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*02:02 (IPD-IMGT/HLA=11698).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   NP39E6/E7
AC   CVCL_F754
DR   Wikidata; Q54930965
RX   PubMed=12063178;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   NP4
AC   CVCL_A9SP
SY   Normal Pleura 4
DR   Wikidata; Q102114662
RX   PubMed=32726133;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
ST   Source(s): PubMed=32726133
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 15,16
ST   D19S433: 14,14.2
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 19,24
ST   Penta D: 8,12
ST   Penta E: 7,11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   NP446
AC   CVCL_F0CB
RX   PubMed=20827769;
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at 10 PDL (PubMed=20827769; PubMed=24167620).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP446-Bmi-1
AC   CVCL_F0CH
SY   NP446Bmi-1
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at 27 PDL (PubMed=24167620).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CB ! NP446
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP446-Bmi-1/hTert
AC   CVCL_F0CM
SY   NP446 Bmi-1/hTert
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Karyotypic information: 47,XX+5 [27] (PubMed=24167620).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CH ! NP446-Bmi-1
SX   Female
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP446-CDK4R24C-hTert
AC   CVCL_B3Q6
SY   NP446CDK4R24C/hTert
DR   Wikidata; Q110433113
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3Q7 ! NP446-cyclinD1-hTert
SX   Female
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP446-cyclinD1-hTert
AC   CVCL_B3Q7
SY   NP446Cyclin D1/hTert; NP446-cyclinD-hTert
DR   Wikidata; Q110433114
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3Q6 ! NP446-CDK4R24C-hTert
SX   Female
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP446-hTERT
AC   CVCL_F0CI
SY   NP446hTERT
RX   PubMed=20827769;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CB ! NP446
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP446-LMP1
AC   CVCL_F0CJ
SY   NP446LMP1
RX   PubMed=20827769;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; R4R994; Epstein-Barr virus (strain 2117) latent membrane protein 1 (LMP1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CB ! NP446
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP446-LMP1/hTERT
AC   CVCL_F0CK
SY   NP446LMP1/hTERT
RX   PubMed=20827769;
CC   Population: Chinese.
CC   Karyotypic information: 48,XX,+20 [32] (PubMed=20827769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; R4R994; Epstein-Barr virus (strain 2117) latent membrane protein 1 (LMP1).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CJ ! NP446-LMP1
SX   Female
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP460hTert
AC   CVCL_X205
SY   NP460 hTert; NP460
DR   Wikidata; Q54930966
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=16688717;
RX   PubMed=18196576;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
ST   Source(s): PubMed=18196576
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 9,10
ST   D16S539: 11,12
ST   D18S51: 13,21
ST   D19S433: 15,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 20,21
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   TH01: 7,10
ST   TPOX: 9,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Telomerase immortalized cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 10
//
ID   NP5
AC   CVCL_A9SQ
SY   Normal Pleura 5
DR   Wikidata; Q102114663
RX   PubMed=32726133;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
ST   Source(s): PubMed=32726133
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,14
ST   D18S51: 13
ST   D19S433: 15,16
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 15,18
ST   D5S818: 11,14
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 23,26
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   NP550
AC   CVCL_F0CC
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at 24 PDL (PubMed=24167620).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (PubMed=24167620).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP550-Bmi-1
AC   CVCL_F0CL
SY   NP550Bmi-1
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Senescence: Senesces at 57 PDL (PubMed=24167620).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CC ! NP550
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP550-Bmi-1/hTert
AC   CVCL_F0CN
SY   NP550Bmi-1/hTert
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Karyotypic information: Near tetraploid karyotype (PubMed=24167620).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CL ! NP550-Bmi-1
SX   Male
AG   76Y
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NP550-CDK4R24C-hTert
AC   CVCL_B3Q8
SY   NP550CDK4R24C/hTert
DR   Wikidata; Q110433115
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CC ! NP550
SX   Male
AG   76Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP550-cyclinD1-hTert
AC   CVCL_B3Q9
SY   NP550Cyclin D1/hTert; NP550-cyclinD-hTert
DR   Wikidata; Q110433116
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CC ! NP550
SX   Male
AG   76Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP550-hTert
AC   CVCL_B3QA
SY   P550hTert
DR   Cell_Model_Passport; SIDM02009
DR   Wikidata; Q110433117
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=23161911;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line).
CC   Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0CC ! NP550
SX   Male
AG   76Y
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   NP69SV40T
AC   CVCL_F755
SY   NP69; NP-69
DR   BTO; BTO_0006046
DR   ABM; T0634
DR   cancercelllines; CVCL_F755
DR   GEO; GSM375841
DR   Millipore; SCC197
DR   Progenetix; CVCL_F755
DR   Wikidata; Q54930967
RX   PubMed=12063178;
RX   PubMed=18196576;
RX   PubMed=19724690;
CC   Doubling time: 31-34 hours (ABM=T0634).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=PX-8).
CC   Discontinued: ABM; T0634; true.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
ST   Source(s): Millipore=SCC197; PubMed=18196576
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13,14,14.2
ST   D21S11: 31
ST   D2S1338: 19
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 15,16
ST   FGA: 21 (PubMed=18196576)
ST   FGA: 21,22 (Millipore=SCC197)
ST   Penta D: 8
ST   Penta E: 11,16
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   NP9
AC   CVCL_E3BT
DR   Cosmic; 968109
RX   PubMed=9788440;
CC   Characteristics: Established from a xenograft orthotopically implanted in nude mice (PubMed=9788440).
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NPA
AC   CVCL_0467
AS   CVCL_6475
SY   NPA-87; NPA'87; NPA 87; NPA87; NPA87-1; UCLA NPA-87-1; UCLA NPA871
DR   BTO; BTO_0004771
DR   MCCL; MCC:0000365
DR   BioSample; SAMN03151835
DR   cancercelllines; CVCL_0467
DR   Cosmic; 685605
DR   Cosmic; 686727
DR   Cosmic; 849968
DR   Cosmic; 886547
DR   Cosmic; 918183
DR   Cosmic; 928835
DR   Cosmic; 931239
DR   Cosmic; 990533
DR   Cosmic; 1005456
DR   Cosmic; 1021384
DR   Cosmic; 1071908
DR   Cosmic; 1094772
DR   Cosmic; 1132596
DR   Cosmic; 1152122
DR   Cosmic; 1155264
DR   Cosmic; 1155328
DR   Cosmic; 1161613
DR   Cosmic; 1162848
DR   Cosmic; 1176608
DR   Cosmic; 1699416
DR   IARC_TP53; 2129
DR   TOKU-E; 4068
DR   Wikidata; Q54930968
RX   PubMed=2551628;
RX   PubMed=8423216;
RX   PubMed=8871538;
RX   PubMed=11439348;
RX   PubMed=14522906;
RX   PubMed=15980887;
RX   PubMed=18713817;
RX   PubMed=20143388;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817; PubMed=20143388; PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00246.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (PubMed=8423216; PubMed=14522906).
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=18713817; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 13,17
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   NPC-204
AC   CVCL_A5WV
SY   NPC204
DR   Wikidata; Q107116578
RX   DOI=10.2183/pjab1945.46.453;
RX   PubMed=4377005;
RX   PubMed=7143149;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 24-30 hours (DOI=10.2183/pjab1945.46.453).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   NPC-B13
AC   CVCL_D3FG
DR   Wikidata; Q127382966
RX   Patent=US20220373534;
RX   PubMed=34204797;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-127019.
CC   Population: Chinese; Taiwan.
CC   Characteristics: Established from a patient-derived xenograft established in NOD/SCID mice (PubMed=34204797).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): Patent=US20220373534
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 13,15
ST   D12S391: 19,23
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,14.2
ST   D1S1656: 11,16,17
ST   D21S11: 29,30
ST   D22S1045: 16
ST   D2S1338: 18,23
ST   D2S441: 12,14
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 27
ST   Penta D: 8,12
ST   Penta E: 15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   NPC-BM00
AC   CVCL_B3QC
DR   Wikidata; Q110433118
RX   PubMed=19930697;
CC   Population: Chinese.
CC   Characteristics: Non-invasive subline of NPC-BM1.
CC   Doubling time: 18.7 hours (In 10% FBS), 30.7 hours (Note=In 2% FBS) (PubMed=19930697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6007 ! NPC-BM1
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 5
//
ID   NPC-BM1
AC   CVCL_6007
DR   Wikidata; Q54930969
RX   PubMed=9595045;
CC   Population: Chinese.
CC   Doubling time: 28.5 hours (PubMed=9595045).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   NPC-BM29
AC   CVCL_B3QB
DR   Wikidata; Q110433120
RX   PubMed=19930697;
CC   Population: Chinese.
CC   Characteristics: Invasive subline of NPC-BM1.
CC   Doubling time: 18.2 hours (In 10% FBS), 26.8 hours (Note=In 2% FBS) (PubMed=19930697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6007 ! NPC-BM1
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 5
//
ID   NPC-KT
AC   CVCL_X204
DR   TOKU-E; 4071
DR   Wikidata; Q54930970
RX   PubMed=3008992;
RX   PubMed=6088881;
RX   PubMed=6318711;
RX   PubMed=24991015;
CC   Characteristics: Hybrid of an EBV-positive NPC cells from 74 year old Japanese female with Ad-AH cells.
CC   Doubling time: 24 hours (PubMed=6088881).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X200 ! Ad-AH
CA   Hybrid cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   NPC-TW01
AC   CVCL_6008
SY   NPC-TW 01; NPC-tW01; TW 01; TW01; NPC-TW039; NPC-039; NPC-TW-039; NPC-TW 039; TW-039; TW 039
DR   BTO; BTO_0006373
DR   cancercelllines; CVCL_6008
DR   ChEMBL-Cells; CHEMBL3307329
DR   ChEMBL-Targets; CHEMBL614202
DR   Cosmic; 1193459
DR   GEO; GSM378799
DR   GEO; GSM378800
DR   IARC_TP53; 26406
DR   Progenetix; CVCL_6008
DR   PubChem_Cell_line; CVCL_6008
DR   TOKU-E; 3584
DR   Wikidata; Q54930971
RX   PubMed=2162997;
RX   PubMed=2397471;
RX   PubMed=7685844;
RX   PubMed=15448710;
CC   Population: Chinese.
CC   Virology: EBV-negative, but was originally EBV-positive.
CC   Doubling time: 10.5 hours (PubMed=2162997).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   NPC-TW02
AC   CVCL_6009
SY   NPC-TW 02; TW 02; TW02; NPC-TW076; NPC-076; NPC-TW-076; NPC-TW 076; TW 076
DR   BTO; BTO_0006372
DR   Wikidata; Q54930973
RX   PubMed=2162997;
RX   PubMed=7685844;
RX   PubMed=21617861;
CC   Population: Chinese.
CC   Virology: EBV-negative, but was originally EBV-positive.
CC   Doubling time: 10.8 hours (PubMed=2162997).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   NPC-TW03
AC   CVCL_6010
SY   NPC-TW 03; TW 03; TW-03; TW03; EBV (-) TW03
DR   BTO; BTO_0006139
DR   Wikidata; Q54930974
RX   PubMed=7685844;
RX   PubMed=10744066;
CC   Population: Chinese.
CC   Virology: EBV-negative, but was originally EBV-positive.
CC   Doubling time: ~13-14 hours (PubMed=10744066).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NPC-TW03 EBV(+)
AC   CVCL_ZF72
SY   EBV (+) TW03
DR   Wikidata; Q98128015
RX   PubMed=10744066;
CC   Population: Chinese.
CC   Characteristics: Compared to the parent cell line, shows increased tumorigenicity.
CC   Virology: In vitro infected with EBV isolate Akata with a neomycin-resistance gene (neo-Akata).
CC   Doubling time: ~13-14 hours (PubMed=10744066).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6010 ! NPC-TW03
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   NPC-TW04
AC   CVCL_6011
SY   NPC-TW 04; TW 04; TW04
DR   BTO; BTO_0003962
DR   Cosmic; 1193460
DR   Wikidata; Q54930975
RX   PubMed=7685844;
RX   PubMed=15448710;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   NPC-TW05
AC   CVCL_6012
SY   NPC-TW 05; NPC.T.W.05; TW 05; TW05
DR   Wikidata; Q54930976
RX   PubMed=7685844;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   NPC-TW06
AC   CVCL_6013
SY   NPC-TW 06; TW 06; TW06
DR   cancercelllines; CVCL_6013
DR   Cosmic; 1193461
DR   IARC_TP53; 26408
DR   Wikidata; Q54930977
RX   PubMed=7685844;
RX   PubMed=9212825;
RX   PubMed=15448710;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Heterozygous (PubMed=9212825; PubMed=15448710).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   NPC-TW07
AC   CVCL_6014
SY   NPC-TW 07; TW 07; TW07
DR   Wikidata; Q54930978
RX   PubMed=7685844;
CC   Population: Chinese.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   NPC-TW08
AC   CVCL_6015
SY   NPC-TW 08; TW 08; TW08
DR   Wikidata; Q54930979
RX   PubMed=7685844;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   NPC-TW09
AC   CVCL_6016
SY   NPC-TW 09; TW 09; TW09
DR   Wikidata; Q54930980
RX   PubMed=7685844;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   NPC-TY861
AC   CVCL_A5WW
SY   TY861
DR   Wikidata; Q107116579
RX   DOI=10.11334/jibi1954.34.1Supplement1_329;
RX   PubMed=1902254;
CC   Doubling time: 18 hours (DOI=10.11334/jibi1954.34.1Supplement1_329).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NPC/HK1
AC   CVCL_7084
SY   HK1; HK-1
DR   BTO; BTO_0004899
DR   EFO; EFO_0022551
DR   Cell_Model_Passport; SIDM01997
DR   Cosmic; 755503
DR   Cosmic; 923772
DR   Cosmic; 1017618
DR   Cosmic; 1300997
DR   Ubigene; YC-C095
DR   Wikidata; Q54930981
RX   PubMed=6259064;
RX   PubMed=12645650;
RX   PubMed=18196576;
RX   PubMed=39905741;
CC   Population: Chinese.
CC   Virology: EBV-negative.
CC   Doubling time: 28 +- 2 hours (PubMed=6259064).
CC   Karyotypic information: Near triploid (PubMed=39905741).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
ST   Source(s): PubMed=18196576; PubMed=39905741
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 26
ST   Penta D: 9,12
ST   Penta E: 15,18.4
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   NPC1-1#13
AC   CVCL_RM39
SY   WIBR-IPS-NPC1I1061T/I1061T #13
DR   SKIP; SKIP000695
DR   Wikidata; Q54930982
RX   PubMed=24936472;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA78 ! GM18453
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   NPC1-1#4
AC   CVCL_RM40
SY   WIBR-IPS-NPC1I1061T/I1061T #4
DR   SKIP; SKIP000694
DR   Wikidata; Q54930983
RX   PubMed=24936472;
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA78 ! GM18453
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   NPC1-2#26
AC   CVCL_RM41
SY   WIBR-IPS-NPC1P237S/I1061T #26
DR   SKIP; SKIP000697
DR   Wikidata; Q54930984
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   NPC1-2#9
AC   CVCL_RM42
SY   WIBR-IPS-NPC1P237S/I1061T #9
DR   SKIP; SKIP000696
DR   Wikidata; Q54930985
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   NPC1-2-Corr#31
AC   CVCL_RM43
SY   WIBR-IPS-NPC1P237S/I1062T-Corr #31
DR   SKIP; SKIP000981
DR   Wikidata; Q54930986
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple_corrected; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous; Note=By TALEN (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   NPC1-2-Corr#32
AC   CVCL_RM44
SY   WIBR-IPS-NPC1P237S/I1062T-Corr #32
DR   SKIP; SKIP000982
DR   Wikidata; Q54930987
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple_corrected; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous; Note=By TALEN (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   NPC1-2-Corr#36
AC   CVCL_RM45
SY   WIBR-IPS-NPC1P237S/I1062T-Corr #36
DR   SKIP; SKIP000983
DR   Wikidata; Q54930988
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple_corrected; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous; Note=By TALEN (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   NPC1-3#4
AC   CVCL_RM46
SY   WIBR-IPS-NPC11920delG/1009G>A #4
DR   SKIP; SKIP000698
DR   Wikidata; Q54930989
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DB17 ! GM22870
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   NPC1-3#47
AC   CVCL_RM47
SY   WIBR-IPS-NPC11920delG/1009G>A #47
DR   Wikidata; Q54930990
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DB17 ! GM22870
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   NPC1-4#17
AC   CVCL_RM48
SY   WIBR-IPS-NPC11920delG/1009G>A #17
DR   SKIP; SKIP000699
DR   Wikidata; Q54930991
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DB18 ! GM22871
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   NPC1-4#20
AC   CVCL_RM49
SY   WIBR-IPS-NPC11920delG/1009G>A #20
DR   SKIP; SKIP000700
DR   Wikidata; Q54930994
RX   PubMed=24936472;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; c.1554-1009G>A (IVS9-1009G>A); ClinVar=VCV000553804; Zygosity=Heterozygous (PubMed=24936472).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.His641Thrfs*2 (c.1920delG); ClinVar=VCV000281941; Zygosity=Heterozygous (PubMed=24936472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DB18 ! GM22871
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   NPC2-hTERT
AC   CVCL_B6EI
SY   NPC-hTERT
DR   Wikidata; Q112129462
RX   PubMed=20456367;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   NPC268
AC   CVCL_D5KT
DR   Cell_Model_Passport; SIDM01990
DR   EGA; EGAS00001007172
DR   GEO; GSE233426
DR   Wikidata; Q127382967
RX   PubMed=38358347;
CC   Population: Chinese; Malaysian.
CC   Doubling time: ~4.5 days (PubMed=38358347).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=38358347).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=38358347).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7413; MTAP; Zygosity=Homozygous (PubMed=38358347).
CC   Sequence variation: Mutation; HGNC; HGNC:391; AKT1; Simple; p.Glu17Lys (c.49G>A); ClinVar=VCV000013983; Zygosity=Heterozygous (PubMed=38358347).
CC   Sequence variation: Mutation; HGNC; HGNC:1541; CBL; Simple; p.Asp772Glu (c.2316T>G); ClinVar=VCV000477707; Zygosity=Heterozygous (PubMed=38358347).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Arg124His (c.371G>A); ClinVar=VCV000141538; Zygosity=Heterozygous (PubMed=38358347).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Asp7Gly (c.20A>G); ClinVar=VCV001251597; Zygosity=Homozygous (PubMed=38358347).
CC   Sequence variation: Mutation; HGNC; HGNC:9122; PMS2; Simple; p.Leu47Val (c.139C>G); ClinVar=VCV000219785; Zygosity=Heterozygous (PubMed=38358347).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=38358347
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D10S1248: 13,16
ST   D12S391: 21,24
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14.2,16.2
ST   D1S1656: 14,16
ST   D21S11: 30,32.2
ST   D22S1045: 15,17
ST   D2S1338: 23,24
ST   D2S441: 11,14
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 8,9
ST   Penta E: 11,13
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C54389; Nasopharyngeal differentiated carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   NPC38
AC   CVCL_UH63
DR   Cell_Model_Passport; SIDM01993
DR   Wikidata; Q98128016
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=30405107;
CC   Population: Chinese.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Shows histological features of squamous cell carcinoma, and no EBV infection. Hence it may represent an independent primary squamous cell carcinoma induced by radiotherapy at the recurrent site of NPC (PubMed=30405107).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
ST   Source(s): PubMed=30405107
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9,10
ST   D16S539: 10
ST   D18S51: 13,21
ST   D19S433: 13.2,15.2
ST   D21S11: 30,33.2
ST   D2S1338: 23,25
ST   D3S1358: 18,19
ST   D5S818: 10,12
ST   D7S820: 8,10,11,12
ST   D8S1179: 12,13,14
ST   FGA: 23,25
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   NPC43
AC   CVCL_UH64
DR   cancercelllines; CVCL_UH64
DR   Cell_Model_Passport; SIDM01992
DR   Wikidata; Q98128017
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=30405107;
CC   Population: Chinese.
CC   Virology: Contains 15-20 copies per cell of EBV genome.
CC   Doubling time: 8 days (Note=At 22th passage), 4 days (Note=At 90th passage), 2.5 days (Note=At 200th passage) (PubMed=30405107).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.158G>A); ClinVar=VCV000230285; Zygosity=Homozygous (PubMed=30405107).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
ST   Source(s): PubMed=30405107
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 13,15
ST   D21S11: 32
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 12,13
ST   D8S1179: 11
ST   FGA: 22
ST   Penta D: 8
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   NPC53
AC   CVCL_UH65
DR   Cell_Model_Passport; SIDM01991
DR   Wikidata; Q98128018
RX   DOI=10.1016/B978-0-12-814936-2.00005-5;
RX   PubMed=30405107;
CC   Population: Chinese.
CC   Virology: Seems to have lost most of its episomal copies of EBV during its establishment as a cell culture.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
ST   Source(s): PubMed=30405107
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 13,15
ST   D21S11: 28
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9.1,11
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 15,16
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   NPEC1
AC   CVCL_E9Z5
SY   NPEC
RX   PubMed=16778197;
CC   Population: Chinese.
CC   Senescence: Proliferates in culture for 8 to 10 passages before undergoing senescence (PubMed=16778197).
CC   Donor information: Established from the biopsy of a patient diagnosed with nonmalignant nasal disease (PubMed=16778197).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NPEC1-Bmi1-1
AC   CVCL_E9Z6
SY   NPEC-Bmi1-1; NPE2 Bmi-1
RX   PubMed=16778197;
RX   PubMed=24167620;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E9Z5 ! NPEC1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NPK
AC   CVCL_9T10
SY   Newborn Pig Kidney
DR   IZSLER; BS CL 24
DR   Wikidata; Q54930995
RX   PubMed=2555655;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   NPL-3
AC   CVCL_F1BK
SY   Northern Pike Larva-3
RX   PubMed=40559539;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 25 Celsius. Limited growth at 15 and 20 Celsius; slightly faster growth at 30 Celsius with accelerated aging. No growth at 10 Celsius. Cells die at 37 Celsius (PubMed=40559539).
CC   Virology: Susceptible to infection by European catfish virus (ECV), ictalurid herpesvirus 2 (IcHV-2), pike fry rhabdovirus (PFRV) and spring viraemia of carp virus (SVCV) (PubMed=40559539).
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8010; ! Esox lucius (Northern pike)
SX   Sex unspecified
AG   Larva 1D
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   NPLC/PRF/5
AC   CVCL_B449
SY   N-PLC/PRF/5
DR   BTO; BTO_0002906
DR   cancercelllines; CVCL_B449
DR   Wikidata; Q54930996
RX   PubMed=2827003;
CC   Population: African; Shangaan.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   NPM1
AC   CVCL_YP21
SY   Naked mole rat Peritoneal cavity Macrophage-1
DR   Wikidata; Q98128019
RX   PubMed=31784606;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
OX   NCBI_TaxID=10181; ! Heterocephalus glaber (Naked mole rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NPN 43C9
AC   CVCL_L686
SY   NPN 43C9 (SCRF 43.3); NPN43C9; SCRF 43.3
DR   Wikidata; Q54930997
RX   Patent=US5126258;
RX   PubMed=3413482;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9721.
CC   Characteristics: Produces a catalytic monoclonal antibody that acts as an amidase.
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 9
//
ID   NPrEC
AC   CVCL_0061
SY   PrEC; Prostate Epithelial Cell
DR   BTO; BTO_0005301
DR   ChEMBL-Cells; CHEMBL3307346
DR   ChEMBL-Targets; CHEMBL614239
DR   PubChem_Cell_line; CVCL_0061
DR   Wikidata; Q54930998
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   Nps2
AC   CVCL_ZU50
DR   Wikidata; Q98128021
RX   PubMed=12655141;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Asp93Leufs*26 (Ex4del); Zygosity=Homozygous (PubMed=12655141).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C135725; Cockayne syndrome type A
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   NPTh
AC   CVCL_9T11
SY   Newborn Pig Thyroid
DR   IZSLER; BS CL 124
DR   Wikidata; Q54930999
RX   PubMed=8264428;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   <1W
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   NPTr
AC   CVCL_8376
SY   Newborn Pig Trachea
DR   GEO; GSE52172
DR   IZSLER; BS CL 176
DR   Wikidata; Q54931000
RX   PubMed=12505635;
RX   PubMed=14535431;
RX   PubMed=24708855;
RX   PubMed=24885012;
RX   PubMed=31494300;
CC   Doubling time: 4.29 hours (PubMed=12505635).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   NQ1.40.1
AC   CVCL_C4V0
SY   NQ1-40.1
DR   Wikidata; Q116049899
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.1.12
AC   CVCL_C4V1
SY   NQ10/1.12; NQ10-1.12
DR   ABCD; ABCD_AE333
DR   Wikidata; Q116049900
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.11.1
AC   CVCL_C4V2
SY   NQ10/11.1; NQ10-11.1
DR   Wikidata; Q116049902
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.12.22
AC   CVCL_C4V3
SY   NQ10/12.22; NQ10-12.22
DR   ABCD; ABCD_AE330
DR   Wikidata; Q116049903
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.12.4.6
AC   CVCL_C4V4
SY   NQ10/12.4.6; NQ10-12.4.6
DR   Wikidata; Q116049905
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.12.4.7
AC   CVCL_C4V5
SY   NQ10/12.4.7; NQ10-12.4.7
DR   Wikidata; Q116049906
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.12.5
AC   CVCL_C4V6
SY   NQ10/12.5; NQ10-12.5
DR   Wikidata; Q116049907
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.15.3
AC   CVCL_C4V7
SY   NQ10/15.3; NQ10-15.3
DR   Wikidata; Q116049908
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.15.9
AC   CVCL_C4V8
SY   NQ10/15.9; NQ10-15.9
DR   Wikidata; Q116049909
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.2.12.4
AC   CVCL_C4V9
SY   NQ10/2.12.4; NQ10-2.12.4
DR   Wikidata; Q116049910
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.2.12.8
AC   CVCL_C4VA
SY   NQ10/2.12.8; NQ10-2.12.8
DR   Wikidata; Q116049911
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.2.2.5
AC   CVCL_C4VB
SY   NQ10/2.2.5; NQ10-2.2.5
DR   ABCD; ABCD_AE358
DR   Wikidata; Q116049912
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.2.22
AC   CVCL_C4VC
SY   NQ10/2.22; NQ10-2.22
DR   Wikidata; Q116049914
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.2.3
AC   CVCL_C4VD
SY   NQ10/2.3; NQ10-2.3
DR   ABCD; ABCD_AE332
DR   Wikidata; Q116049915
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.3.8
AC   CVCL_C4VE
SY   NQ10/3.8; NQ10-3.8
DR   ABCD; ABCD_AE331
DR   Wikidata; Q116049917
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.4.6
AC   CVCL_C4VF
SY   NQ10-4.6
DR   Wikidata; Q116049918
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.4.6.1
AC   CVCL_C4VG
SY   NQ10/4.6.1; NQ10-4.6.1
DR   Wikidata; Q116049919
RX   PubMed=3927173;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4VF ! NQ10.4.6
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ10.4.6.2
AC   CVCL_C4VH
SY   NQ10/4.6.2; NQ10-4.6.2
DR   Wikidata; Q116049920
RX   PubMed=3927173;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4VF ! NQ10.4.6
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.1.14
AC   CVCL_C4VI
SY   NQ11-1.14
DR   Wikidata; Q116049921
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.1.18
AC   CVCL_C4VJ
SY   NQ11/1.18; NQ11-1.18
DR   ABCD; ABCD_AE337
DR   Wikidata; Q116049923
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.14.5
AC   CVCL_C4VK
SY   NQ11/14.5; NQ11-14.5
DR   Wikidata; Q116049924
RX   PubMed=3927173;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.5.2
AC   CVCL_C4VL
SY   NQ11/5.2; NQ11-5.2
DR   ABCD; ABCD_AE336
DR   Wikidata; Q116049925
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.7.12
AC   CVCL_C4VM
SY   NQ11/7.12; NQ11-7.12
DR   Wikidata; Q116049926
RX   PubMed=3113977;
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.7.22
AC   CVCL_C4VN
SY   NQ11/7.22; NQ11-7.22
DR   Wikidata; Q116049928
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.8.1
AC   CVCL_C4VP
SY   NQ11/8.1; NQ11-8.1
DR   Wikidata; Q116049929
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ11.8.4
AC   CVCL_C4VQ
SY   NQ11/8.4; NQ11-8.4
DR   ABCD; ABCD_AE334
DR   Wikidata; Q116049930
RX   PubMed=3927173;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ16.113.8
AC   CVCL_C4VR
SY   NQ16/113.8; NQ16-113.8
DR   ABCD; ABCD_AH217
DR   Wikidata; Q116049931
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ16.38.18
AC   CVCL_C4VS
SY   NQ16/38.18; NQ16-38.18
DR   Wikidata; Q116049932
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ17.10.24
AC   CVCL_C4VT
SY   NQ17/10.24; NQ17-10.24
DR   Wikidata; Q116049933
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ18.36.44
AC   CVCL_C4VU
SY   NQ18/36.44; NQ18-36.44
DR   Wikidata; Q116049934
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ19.1.1
AC   CVCL_C4VV
SY   NQ19/1.1; NQ19-1.1
DR   Wikidata; Q116049936
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ19.16.37
AC   CVCL_C4VW
SY   NQ19/16.37; NQ19-16.37
DR   Wikidata; Q116049937
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ19.2.4
AC   CVCL_C4VX
SY   NQ19/2.4; NQ19-2.4
DR   ABCD; ABCD_AE305
DR   Wikidata; Q116049938
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ19.22.21
AC   CVCL_C4VY
SY   NQ19/22.21; NQ19-22.21
DR   Wikidata; Q116049939
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ19.8.1
AC   CVCL_C4VZ
SY   NQ19/8.1; NQ19-8.1
DR   ABCD; ABCD_AE308
DR   Wikidata; Q116049940
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.12.4
AC   CVCL_C4W0
SY   NQ2-12.4
DR   Wikidata; Q116049941
RX   PubMed=6401310;
RX   PubMed=6504141;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.16.2
AC   CVCL_C4W1
SY   NQ2-16.2
DR   Wikidata; Q116049942
RX   PubMed=6401310;
RX   PubMed=6504141;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.17.2
AC   CVCL_C4W2
SY   NQ2-17.2
DR   Wikidata; Q116049943
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.17.4
AC   CVCL_C4W3
SY   NQ2-17.4
DR   Wikidata; Q116049944
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.17.4.1
AC   CVCL_C4W4
SY   NQ2-17.4.1
DR   ABCD; ABCD_AE350
DR   Wikidata; Q116049945
RX   PubMed=6401310;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4W3 ! NQ2.17.4
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.20.5
AC   CVCL_C4W5
SY   NQ2-20.5
DR   Wikidata; Q116049946
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.20.5.3
AC   CVCL_C4W6
SY   NQ2-20.5.3
DR   Wikidata; Q116049947
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4W5 ! NQ2.20.5
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.21.2
AC   CVCL_C4W7
SY   NQ2-21.2
DR   Wikidata; Q116049948
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.24.1
AC   CVCL_C4W8
SY   NQ2-24.1
DR   Wikidata; Q116049949
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.3.1
AC   CVCL_C4W9
SY   NQ2-3.1
DR   Wikidata; Q116049950
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.39.3
AC   CVCL_C4WA
SY   NQ2-39.3
DR   Wikidata; Q116049951
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.45.1
AC   CVCL_C4WB
SY   NQ2/45.1; NQ2-45.1
DR   Wikidata; Q116049952
RX   PubMed=3927173;
RX   PubMed=6401310;
RX   PubMed=6504141;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.45.10.4
AC   CVCL_C4WC
SY   NQ2/45.10.4; NQ2-45.10.4
DR   Wikidata; Q116049953
RX   PubMed=3927173;
RX   PubMed=6401310;
RX   PubMed=6504141;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.46.2
AC   CVCL_C4WD
SY   NQ2-46.2
DR   Wikidata; Q116049955
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.48.2
AC   CVCL_C4WE
SY   NQ2-48.2
DR   Wikidata; Q116049956
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.48.2.2
AC   CVCL_C4WF
SY   NQ2-48.2.2
DR   Wikidata; Q116049957
RX   PubMed=6401310;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4WE ! NQ2.48.2
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ2.6.1
AC   CVCL_C4WG
SY   NQ2/6.1; NQ2-6.1
DR   Wikidata; Q116049958
RX   PubMed=3927173;
RX   PubMed=6401310;
RX   PubMed=6504141;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.10.17
AC   CVCL_C4WH
SY   NQ22/10.17; NQ22-10.17
DR   Wikidata; Q116049959
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.15.18
AC   CVCL_C4WI
SY   NQ22/15.18; NQ22-15.18
DR   ABCD; ABCD_AE307
DR   Wikidata; Q116049960
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.16.4
AC   CVCL_C4WJ
SY   NQ22/16.4; NQ22-16.4
DR   Wikidata; Q116049961
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.17.18
AC   CVCL_C4WK
SY   NQ22/17.18; NQ22-17.18
DR   Wikidata; Q116049962
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.18.7
AC   CVCL_C4WL
SY   NQ22/18.7; NQ22-18.7
DR   ABCD; ABCD_AE306
DR   Wikidata; Q116049963
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.33.4
AC   CVCL_C4WM
SY   NQ22/33.4; NQ22-33.4
DR   Wikidata; Q116049964
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.56.1
AC   CVCL_C4WN
SY   NQ22/56.1; NQ22-56.1
DR   Wikidata; Q116049965
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.61.1
AC   CVCL_C4WP
SY   NQ22/61.1; NQ22-61.1
DR   Wikidata; Q116049967
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.87.1
AC   CVCL_C4WQ
SY   NQ22/87.1; NQ22-87.1
DR   Wikidata; Q116049968
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.9.11
AC   CVCL_C4WR
SY   NQ22/9.11; NQ22-9.11
DR   Wikidata; Q116049969
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.9.24
AC   CVCL_C4WS
SY   NQ22/9.24; NQ22-9.24
DR   Wikidata; Q116049970
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ22.91.1
AC   CVCL_C4WT
SY   NQ22/91.1; NQ22-91.1
DR   Wikidata; Q116049971
RX   PubMed=3113977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.3.3
AC   CVCL_C4WU
SY   NQ5-3.3
DR   Wikidata; Q116049972
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.4.3
AC   CVCL_C4WV
SY   NQ5-4.3
DR   Wikidata; Q116049973
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.4.3.1
AC   CVCL_C4WW
SY   NQ5-4.3.1
DR   ABCD; ABCD_AE348
DR   Wikidata; Q116049974
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4WV ! NQ5.4.3
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.48.2
AC   CVCL_C4WX
SY   NQ5-48.2
DR   Wikidata; Q116049975
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.57.3
AC   CVCL_C4WY
SY   NQ5-57.3
DR   Wikidata; Q116049976
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.6.1
AC   CVCL_C4WZ
SY   NQ5-6.1
DR   Wikidata; Q116049978
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.61.1
AC   CVCL_C4X0
SY   NQ5-61.1
DR   Wikidata; Q116049979
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.61.1.2
AC   CVCL_C4X1
SY   NQ5-61.1.2
DR   ABCD; ABCD_AE351
DR   Wikidata; Q116049980
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4X0 ! NQ5.61.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.78.2
AC   CVCL_C4X2
SY   NQ5-78.2
DR   Wikidata; Q116049982
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.78.2.6
AC   CVCL_C4X3
SY   NQ5-78.2.6
DR   Wikidata; Q116049983
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4X2 ! NQ5.78.2
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.82.2
AC   CVCL_C4X4
SY   NQ5-82.2
DR   Wikidata; Q116049985
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.89.4
AC   CVCL_C4X5
SY   NQ5/89.4; NQ5-89.4
DR   Wikidata; Q116049986
RX   PubMed=3113977;
RX   PubMed=3927173;
RX   PubMed=6401310;
RX   PubMed=6504141;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.91.1
AC   CVCL_C4X6
SY   NQ5-91.1
DR   Wikidata; Q116049987
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.92.5
AC   CVCL_C4X7
SY   NQ5-92.5
DR   Wikidata; Q116049988
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ5.96.2
AC   CVCL_C4X8
SY   NQ5-96.2
DR   Wikidata; Q116049989
RX   PubMed=6401310;
RX   PubMed=6504141;
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ6.24.2
AC   CVCL_C4X9
SY   NQ6-24.2
DR   Wikidata; Q116049990
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ6.24.2.2
AC   CVCL_C4XA
SY   NQ6-24.2.2
DR   Wikidata; Q116049991
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4X9 ! NQ6.24.2
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ6.41.1
AC   CVCL_C4XB
SY   NQ6-41.1
DR   Wikidata; Q116049992
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ6.8.3
AC   CVCL_C4XC
SY   NQ6-8.3
DR   Wikidata; Q116049993
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ6.8.3.1
AC   CVCL_C4XD
SY   NQ6-8.3.1
DR   Wikidata; Q116049994
RX   PubMed=6877353;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4XC ! NQ6.8.3
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.1.3
AC   CVCL_C4XE
SY   NQ7-1.3
DR   ABCD; ABCD_AE359
DR   Wikidata; Q116049995
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.23.1
AC   CVCL_C4XF
SY   NQ7-23.1
DR   Wikidata; Q116049996
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.24.6
AC   CVCL_C4XG
SY   NQ7-24.6
DR   Wikidata; Q116049997
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.28.1
AC   CVCL_C4XH
SY   NQ7-28.1
DR   Wikidata; Q116049998
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.3.3
AC   CVCL_C4XI
SY   NQ7-3.3
DR   Wikidata; Q116049999
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.34.3
AC   CVCL_C4XJ
SY   NQ7-34.3
DR   ABCD; ABCD_AE360
DR   Wikidata; Q116050000
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.40.1
AC   CVCL_C4XK
SY   NQ7-40.1
DR   Wikidata; Q116050001
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.41.3
AC   CVCL_C4XL
SY   NQ7-41.3
DR   Wikidata; Q116050002
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.47.1
AC   CVCL_C4XM
SY   NQ7/47.1; NQ7-47.1
DR   ABCD; ABCD_AE335
DR   Wikidata; Q116050003
RX   PubMed=3927173;
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.5.3
AC   CVCL_C4XN
SY   NQ7-5.3
DR   Wikidata; Q116050004
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.51.3
AC   CVCL_C4XP
SY   NQ7-51.3
DR   Wikidata; Q116050005
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.56.2
AC   CVCL_C4XQ
SY   NQ7-56.2
DR   Wikidata; Q116050006
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.6.1
AC   CVCL_C4XR
SY   NQ7-6.1
DR   Wikidata; Q116050007
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.6.1.1
AC   CVCL_C4XS
SY   NQ7-6.1.1
DR   Wikidata; Q116050008
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4XR ! NQ7.6.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ7.7.1
AC   CVCL_C4XT
SY   NQ7/7.1; NQ7-7.1
DR   Wikidata; Q116050009
RX   PubMed=3927173;
RX   PubMed=6401310;
RX   PubMed=6504141;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ8.5.3
AC   CVCL_C4XU
SY   NQ8-5.3
DR   Wikidata; Q116050010
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ8.16.2
AC   CVCL_C4XV
SY   NQ8-16.2
DR   Wikidata; Q116050011
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NQ8.9.2
AC   CVCL_C4XW
SY   NQ8-9.2
DR   Wikidata; Q116050012
RX   PubMed=6401310;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_60296; 2-phenyloxazol-5(4H)-one (2-phenyloxazolone; phOX).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   NR-1
AC   CVCL_6689
SY   NR1
DR   Wikidata; Q54931001
RX   PubMed=302945;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NR-2
AC   CVCL_6690
SY   NR2
DR   Wikidata; Q54931002
RX   PubMed=302945;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NR-3
AC   CVCL_6691
SY   NR3
DR   Wikidata; Q54931003
RX   PubMed=302945;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NR-4
AC   CVCL_6692
SY   NR4
DR   Wikidata; Q54931004
RX   PubMed=302945;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NR-5
AC   CVCL_6693
SY   NR5
DR   Wikidata; Q54931005
RX   PubMed=302945;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NR-6
AC   CVCL_6694
SY   NR6
DR   BTO; BTO_0001867
DR   Wikidata; Q54931006
RX   PubMed=302945;
RX   PubMed=3465719;
RX   PubMed=8845302;
CC   Characteristics: Does not express EGFR (PubMed=8845302).
CC   Doubling time: 53.0 hours (PubMed=8845302).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   NR-6-R
AC   CVCL_6695
SY   NR6R; NR6R-3T3
DR   Wikidata; Q54931007
RX   PubMed=3465719;
WW   Provider; UNeMed; SKU 167; http://www.unemed.com/wp-content/uploads/2012/07/a0I50000004Hbez-1_0.pdf
CC   Characteristics: Can be employed in a wide variety of assays, such as soft agar assays and proliferation assays, to identify and measure FGF activity (UNeMed=SKU 167).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6694 ! NR-6
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   NR-7
AC   CVCL_6696
SY   NR7
DR   Wikidata; Q54931008
RX   PubMed=302945;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NR-8
AC   CVCL_6697
SY   NR8
DR   Wikidata; Q54931009
RX   PubMed=302945;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   nr-HaCat
AC   CVCL_A9W9
SY   nonresponsive HaCaT
DR   Wikidata; Q102114664
RX   PubMed=21185708;
CC   Population: Caucasian.
CC   Characteristics: Unable to undergo UVR-induced apoptosis.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NR1
AC   CVCL_C7XB
DR   Wikidata; Q123033196
RX   PubMed=20525500;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O01673; Acanthocheilonema viteae tropomyosin (Note=Also reacts with other hemalthemints, with filariids, nematodes, trematodes and also recognizes tropomyosin of oyster, squid and octopus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   NR22
AC   CVCL_IZ12
DR   Wikidata; Q54931010
RX   PubMed=19816092;
CC   Characteristics: Rat cell line model for Birt-Hogg-Dube syndrome.
CC   Doubling time: 76 hours (PubMed=19816092).
CC   Sequence variation: Mutation; RGD; 735088; Flcn; Simple; c.462_463insC; Zygosity=Hemizygous (PubMed=19816092).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley Nihon; RS=RS_0002326.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IZ13 ! NR24
OI   CVCL_IZ14 ! NR32
OI   CVCL_IZ15 ! NR45
OI   CVCL_IZ16 ! NR49
OI   CVCL_IZ17 ! NR54
OI   CVCL_IZ18 ! NR64
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   NR24
AC   CVCL_IZ13
DR   Wikidata; Q54931011
RX   PubMed=19816092;
CC   Characteristics: Rat cell line model for Birt-Hogg-Dube syndrome.
CC   Doubling time: 45 hours (PubMed=19816092).
CC   Sequence variation: Mutation; RGD; 735088; Flcn; Simple; c.462_463insC; Zygosity=Hemizygous (PubMed=19816092).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley Nihon; RS=RS_0002326.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IZ12 ! NR22
OI   CVCL_IZ14 ! NR32
OI   CVCL_IZ15 ! NR45
OI   CVCL_IZ16 ! NR49
OI   CVCL_IZ17 ! NR54
OI   CVCL_IZ18 ! NR64
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   NR32
AC   CVCL_IZ14
DR   Wikidata; Q54931012
RX   PubMed=19816092;
CC   Characteristics: Rat cell line model for Birt-Hogg-Dube syndrome.
CC   Doubling time: 52.6 hours (PubMed=19816092).
CC   Sequence variation: Mutation; RGD; 735088; Flcn; Simple; c.462_463insC; Zygosity=Hemizygous (PubMed=19816092).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley Nihon; RS=RS_0002326.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IZ12 ! NR22
OI   CVCL_IZ13 ! NR24
OI   CVCL_IZ15 ! NR45
OI   CVCL_IZ16 ! NR49
OI   CVCL_IZ17 ! NR54
OI   CVCL_IZ18 ! NR64
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   NR45
AC   CVCL_IZ15
DR   Wikidata; Q54931013
RX   PubMed=19816092;
CC   Characteristics: Rat cell line model for Birt-Hogg-Dube syndrome.
CC   Sequence variation: Mutation; RGD; 735088; Flcn; Simple; c.462_463insC; Zygosity=Hemizygous (PubMed=19816092).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley Nihon; RS=RS_0002326.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IZ12 ! NR22
OI   CVCL_IZ13 ! NR24
OI   CVCL_IZ14 ! NR32
OI   CVCL_IZ16 ! NR49
OI   CVCL_IZ17 ! NR54
OI   CVCL_IZ18 ! NR64
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   NR49
AC   CVCL_IZ16
DR   Wikidata; Q54931015
RX   PubMed=19816092;
CC   Characteristics: Rat cell line model for Birt-Hogg-Dube syndrome.
CC   Doubling time: 190 hours (PubMed=19816092).
CC   Sequence variation: Mutation; RGD; 735088; Flcn; Simple; c.462_463insC; Zygosity=Hemizygous (PubMed=19816092).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley Nihon; RS=RS_0002326.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IZ12 ! NR22
OI   CVCL_IZ13 ! NR24
OI   CVCL_IZ14 ! NR32
OI   CVCL_IZ15 ! NR45
OI   CVCL_IZ17 ! NR54
OI   CVCL_IZ18 ! NR64
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   NR54
AC   CVCL_IZ17
DR   Wikidata; Q54931016
RX   PubMed=19816092;
CC   Characteristics: Rat cell line model for Birt-Hogg-Dube syndrome.
CC   Sequence variation: Mutation; RGD; 735088; Flcn; Simple; c.462_463insC; Zygosity=Hemizygous (PubMed=19816092).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley Nihon; RS=RS_0002326.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IZ12 ! NR22
OI   CVCL_IZ13 ! NR24
OI   CVCL_IZ14 ! NR32
OI   CVCL_IZ15 ! NR45
OI   CVCL_IZ16 ! NR49
OI   CVCL_IZ18 ! NR64
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   NR64
AC   CVCL_IZ18
DR   Wikidata; Q54931017
RX   PubMed=19816092;
CC   Characteristics: Rat cell line model for Birt-Hogg-Dube syndrome.
CC   Doubling time: 171 hours (PubMed=19816092).
CC   Sequence variation: Mutation; RGD; 735088; Flcn; Simple; c.462_463insC; Zygosity=Hemizygous (PubMed=19816092).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Sprague Dawley Nihon; RS=RS_0002326.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IZ12 ! NR22
OI   CVCL_IZ13 ! NR24
OI   CVCL_IZ14 ! NR32
OI   CVCL_IZ15 ! NR45
OI   CVCL_IZ16 ! NR49
OI   CVCL_IZ17 ! NR54
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   NR6M
AC   CVCL_6698
DR   Wikidata; Q54931018
RX   PubMed=8845302;
CC   Doubling time: 15.4 hours (PubMed=8845302).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6694 ! NR-6
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   NR6V
AC   CVCL_6699
DR   Wikidata; Q54931019
RX   PubMed=8845302;
CC   Characteristics: Control cell line for NR6M (Cellosaurus=CVCL_6698) and NR6W (Cellosaurus=CVCL_6700) (PubMed=8845302).
CC   Doubling time: 54.5 hours (PubMed=8845302).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6694 ! NR-6
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   NR6W
AC   CVCL_6700
DR   Wikidata; Q54931020
RX   PubMed=8845302;
CC   Doubling time: 26.6 hours (PubMed=8845302).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6694 ! NR-6
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   NR6WT
AC   CVCL_XF60
DR   Wikidata; Q98128022
RX   PubMed=18638274;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6694 ! NR-6
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   NR8383
AC   CVCL_4396
SY   NR-8383; NR 8383; NR8383.1; NR8383 clone AgCl1X3A; AgC11x3A; Normal Rat, August 3, 1983
DR   BTO; BTO_0002907
DR   CLO; CLO_0008193
DR   ATCC; CRL-2192
DR   BCRC; 60423
DR   CCRID; 1101RAT-PUMC000663
DR   CCRID; 3101RATGNR9
DR   CLS; 305200
DR   KCB; KCB 2010189YJ
DR   Lonza; 1390
DR   Wikidata; Q54931021
RX   PubMed=2914814;
RX   PubMed=3497918;
RX   PubMed=9738661;
RX   PubMed=28242876;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-crl-2192
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Provides a homogenous source of highly responsive alveolar macrophages which can be used in vitro to study macrophage related activities (ATCC=CRL-2192).
CC   Anecdotal: Have been flown in space on the ISS in 2014-2015 to study growth and adaptation to microgravity (PubMed=28242876).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   NRBB
AC   CVCL_B6HE
DR   Wikidata; Q112129463
RX   PubMed=2303715;
CC   Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV).
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c H-2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 5
//
ID   NRbM
AC   CVCL_4397
DR   CLO; CLO_0008194
DR   ATCC; CRL-1839
DR   ECACC; 91073008
DR   Wikidata; Q54931022
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rabbit IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   NRC-12
AC   CVCL_WI00
DR   Wikidata; Q98128023
RX   PubMed=745323;
RX   PubMed=3986962;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=745323).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   NRC-13810
AC   CVCL_C6V4
SY   CS-18
DR   ABCD; ABCD_AW684
DR   Wikidata; Q117704727
RX   PubMed=34415957;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P9WGE7; Mycobacterium tuberculosis sodB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NRC-49680
AC   CVCL_C6V7
SY   Clone A
DR   ABCD; ABCD_AW681
DR   Wikidata; Q117704728
RX   PubMed=34415957;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P9WIE5; Mycobacterium tuberculosis katG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NRCAN-AP-5862-AFC-CAE
AC   CVCL_C2TU
DR   ICLDB; nrcan-ap-5862-afc-cae
DR   Wikidata; Q114312569
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=224129; ! Agrilus planipennis (Emerald ash borer)
OI   CVCL_C2TV ! NRCAN-AP-5862A
OI   CVCL_C2TW ! NRCAN-AP-5862B
OI   CVCL_C2TX ! NRCAN-AP-5862E
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-AP-5862A
AC   CVCL_C2TV
DR   ICLDB; nrcan-ap-5862a
DR   Wikidata; Q114312570
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=224129; ! Agrilus planipennis (Emerald ash borer)
OI   CVCL_C2TU ! NRCAN-AP-5862-AFC-CAE
OI   CVCL_C2TW ! NRCAN-AP-5862B
OI   CVCL_C2TX ! NRCAN-AP-5862E
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-AP-5862B
AC   CVCL_C2TW
DR   ICLDB; nrcan-ap-5862b
DR   Wikidata; Q114312571
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=224129; ! Agrilus planipennis (Emerald ash borer)
OI   CVCL_C2TU ! NRCAN-AP-5862-AFC-CAE
OI   CVCL_C2TV ! NRCAN-AP-5862A
OI   CVCL_C2TX ! NRCAN-AP-5862E
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-AP-5862E
AC   CVCL_C2TX
DR   ICLDB; nrcan-ap-5862e
DR   Wikidata; Q114312572
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=224129; ! Agrilus planipennis (Emerald ash borer)
OI   CVCL_C2TU ! NRCAN-AP-5862-AFC-CAE
OI   CVCL_C2TV ! NRCAN-AP-5862A
OI   CVCL_C2TW ! NRCAN-AP-5862B
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-CF-9
AC   CVCL_C2SR
DR   ICLDB; nrcan-cf-9
DR   Wikidata; Q114312574
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=7141; ! Choristoneura fumiferana (Spruce budworm moth)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-181
AC   CVCL_C2RD
DR   ICLDB; nrcan-ll-181
DR   Wikidata; Q114312575
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-182A
AC   CVCL_C2RE
DR   ICLDB; nrcan-ll-182a
DR   Wikidata; Q114312576
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-184
AC   CVCL_C2RF
DR   ICLDB; nrcan-ll-184
DR   Wikidata; Q114312577
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-185
AC   CVCL_C2RG
DR   ICLDB; nrcan-ll-185
DR   Wikidata; Q114312578
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-185A
AC   CVCL_C2RH
DR   ICLDB; nrcan-ll-185a
DR   Wikidata; Q114312579
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RG ! NRCAN-LL-185
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-21
AC   CVCL_C2RI
DR   ICLDB; nrcan-ll-21
DR   Wikidata; Q114312580
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-217
AC   CVCL_C2RJ
DR   ICLDB; nrcan-ll-217
DR   Wikidata; Q114312581
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-21A
AC   CVCL_C2RK
DR   ICLDB; nrcan-ll-21a
DR   Wikidata; Q114312582
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-27
AC   CVCL_C2RL
DR   ICLDB; nrcan-ll-27
DR   Wikidata; Q114312583
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-27A
AC   CVCL_C2RM
DR   ICLDB; nrcan-ll-27a
DR   Wikidata; Q114312585
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RL ! NRCAN-LL-27
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-31
AC   CVCL_C2RN
DR   ICLDB; nrcan-ll-31
DR   Wikidata; Q114312586
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-31A
AC   CVCL_C2RP
DR   ICLDB; nrcan-ll-31a
DR   Wikidata; Q114312587
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RN ! NRCAN-LL-31
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-32
AC   CVCL_C2RQ
DR   ICLDB; nrcan-ll-32
DR   Wikidata; Q114312588
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-32A
AC   CVCL_C2RR
DR   ICLDB; nrcan-ll-32a
DR   Wikidata; Q114312589
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RQ ! NRCAN-LL-32
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-33
AC   CVCL_C2RS
DR   ICLDB; nrcan-ll-33
DR   Wikidata; Q114312590
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-33A
AC   CVCL_C2RT
DR   ICLDB; nrcan-ll-33a
DR   Wikidata; Q114312591
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RS ! NRCAN-LL-33
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-34
AC   CVCL_C2RU
DR   ICLDB; nrcan-ll-34
DR   Wikidata; Q114312592
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-34A
AC   CVCL_C2RV
DR   ICLDB; nrcan-ll-34a
DR   Wikidata; Q114312593
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RU ! NRCAN-LL-34
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-36
AC   CVCL_C2RW
DR   ICLDB; nrcan-ll-36
DR   Wikidata; Q114312594
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-36A
AC   CVCL_C2RX
DR   ICLDB; nrcan-ll-36a
DR   Wikidata; Q114312595
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RW ! NRCAN-LL-36
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-37
AC   CVCL_C2RY
DR   ICLDB; nrcan-ll-37
DR   Wikidata; Q114312596
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-39
AC   CVCL_C2RZ
DR   ICLDB; nrcan-ll-39
DR   Wikidata; Q114312597
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-39A
AC   CVCL_C2S0
DR   ICLDB; nrcan-ll-39a
DR   Wikidata; Q114312598
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2RZ ! NRCAN-LL-39
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-40
AC   CVCL_C2S1
DR   ICLDB; nrcan-ll-40
DR   Wikidata; Q114312599
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-41
AC   CVCL_C2S2
DR   ICLDB; nrcan-ll-41
DR   Wikidata; Q114312600
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-41A
AC   CVCL_C2S3
DR   ICLDB; nrcan-ll-41a
DR   Wikidata; Q114312601
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2S2 ! NRCAN-LL-41
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-42
AC   CVCL_C2S4
DR   ICLDB; nrcan-ll-42
DR   Wikidata; Q114312602
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-42A
AC   CVCL_C2S5
DR   ICLDB; nrcan-ll-42a
DR   Wikidata; Q114312603
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2S4 ! NRCAN-LL-42
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   NRCAN-LL-83
AC   CVCL_C2S6
DR   ICLDB; nrcan-ll-83
DR   Wikidata; Q114312604
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-84
AC   CVCL_C2S7
DR   ICLDB; nrcan-ll-84
DR   Wikidata; Q114312607
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-84A
AC   CVCL_C2S8
DR   ICLDB; nrcan-ll-84a
DR   Wikidata; Q114312608
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2S7 ! NRCAN-LL-84
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-87
AC   CVCL_C2S9
DR   ICLDB; nrcan-ll-87
DR   Wikidata; Q114312609
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-87A
AC   CVCL_C2SA
DR   ICLDB; nrcan-ll-87a
DR   Wikidata; Q114312610
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2S9 ! NRCAN-LL-87
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-88
AC   CVCL_C2SB
DR   ICLDB; nrcan-ll-88
DR   Wikidata; Q114312611
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-88A
AC   CVCL_C2SC
DR   ICLDB; nrcan-ll-88a
DR   Wikidata; Q114312612
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2SB ! NRCAN-LL-88
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-95
AC   CVCL_C2SD
DR   ICLDB; nrcan-ll-95
DR   Wikidata; Q114312613
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-95A
AC   CVCL_C2SE
DR   ICLDB; nrcan-ll-95a
DR   Wikidata; Q114312614
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2SD ! NRCAN-LL-95
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-99
AC   CVCL_C2SF
DR   ICLDB; nrcan-ll-99
DR   Wikidata; Q114312615
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-LL-99A
AC   CVCL_C2SG
DR   ICLDB; nrcan-ll-99a
DR   Wikidata; Q114312616
CC   Group: Insect cell line.
CC   From: Doucet, Daniel; Great Lakes Forestry Centre, Canadian Forest Service; Sault Ste. Marie; Canada.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=50650; ! Lygus lineolaris (Tarnished plant bug)
HI   CVCL_C2SF ! NRCAN-LL-99
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   NRCAN-Tb521
AC   CVCL_LJ54
SY   NRCAN-TB-521
DR   ICLDB; nrcan-tb-521
DR   Wikidata; Q54931023
RX   PubMed=25952767;
CC   Group: Insect cell line.
CC   Doubling time: 255 hours (Note=At 22th passage) (PubMed=25952767).
OX   NCBI_TaxID=1562904; ! Tylonotus bimaculatus (Ash and privet borer)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   NRCC
AC   CVCL_U280
SY   LoMeT-ccRcc
DR   CCRID; 4201PAT-CCTCC00278
DR   Wikidata; Q54931024
RX   Patent=CN101550407B;
RX   PubMed=23442546;
RX   PubMed=27993170;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200910.
CC   Population: Chinese.
CC   Doubling time: 35.5 hours (PubMed=23442546).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 13
//
ID   NRCE
AC   CVCL_9Y58
SY   New zealand white Rabbit Corneal Endothelial cells
DR   Wikidata; Q54931025
RX   PubMed=19503740;
CC   Doubling time: 40.32 hours (Note=At 191th passage) (PubMed=19503740).
CC   Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985.
CC   Cell type: Endothelial cell of cornea; CL=CL_0000132.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   4-5W
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   NRCs
AC   CVCL_WJ27
SY   Normal Rat Cholangiocytes
DR   Wikidata; Q98128024
RX   PubMed=8569194;
RX   PubMed=16783394;
CC   Doubling time: ~16 hours (PubMed=8569194).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   NRel-4
AC   CVCL_C8BV
DR   Wikidata; Q123033197
RX   PubMed=9576878;
CC   Characteristics: Defective in dihydroxyacetone phosphate acyltransferase (PubMed=9576878).
CC   Characteristics: Selected using a two step protocol, first using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method and then two rounds of 12-(1'-pyrene)dodecanoic acid/ultraviolter (P12/UV) selection. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing (PubMed=9576878).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   NRG
AC   CVCL_5565
DR   CLO; CLO_0051028
DR   JCRB; JCRB1138
DR   RCB; RCB1921
DR   Wikidata; Q54931026
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L287 ! KUSA
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NRK
AC   CVCL_3758
SY   Normal Rat Kidney
DR   CLO; CLO_0008195
DR   CLO; CLO_0051425
DR   CLDB; cl3724
DR   CLDB; cl3725
DR   ATCC; CRL-6509
DR   CCRID; 1101RAT-PUMC000198
DR   CCRID; 1101RAT-PUMC000412
DR   CCRID; 3101RATGNR2
DR   CCRID; 4201RAT-CCTCC00096
DR   CCTCC; GDC0096
DR   ChEMBL-Cells; CHEMBL3307266
DR   ChEMBL-Targets; CHEMBL613518
DR   CLS; 305195
DR   ECACC; 86032002
DR   KCB; KCB 92014YJ
DR   Lonza; 798
DR   PubChem_Cell_line; CVCL_3758
DR   RCB; RCB0043
DR   TOKU-E; 2772
DR   Wikidata; Q54931027
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/nrk/nrkcells.html
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   NRK-49F
AC   CVCL_2144
SY   NRK 49F; NRK49F; NRK clone 49F; Normal Rat Kidney-49F
DR   BTO; BTO_0002409
DR   CLO; CLO_0008196
DR   CLO; CLO_0008197
DR   CLO; CLO_0051426
DR   CLDB; cl3726
DR   CLDB; cl3727
DR   CLDB; cl3728
DR   CLDB; cl3729
DR   CLDB; cl3730
DR   CLDB; cl3731
DR   ATCC; CRL-1570
DR   BCRC; 60084
DR   CCRID; 1101RAT-PUMC000413
DR   ChEMBL-Cells; CHEMBL3308395
DR   ChEMBL-Targets; CHEMBL614203
DR   CLS; 500427
DR   DSMZ; ACC-172
DR   DSMZCellDive; ACC-172
DR   ECACC; 86101301
DR   IZSLER; BS CL 71
DR   JCRB; IFO50481
DR   JCRB; JCRB9067
DR   Lonza; 1414
DR   PubChem_Cell_line; CVCL_2144
DR   RCB; RCB0112
DR   Wikidata; Q54931028
RX   DOI=10.11418/jtca1981.15.3_171;
RX   PubMed=304450;
RX   PubMed=6254071;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=NRK-49F
CC   Doubling time: ~30-40 hours (DSMZ=ACC-172).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   NRK-4xlambdaN22-3xmEGFP-M9
AC   CVCL_AV97
SY   NRK 4xlN22-3xmEGFP-M9
DR   CLS; 500672
DR   Wikidata; Q54931029
RX   PubMed=17603490;
CC   Characteristics: Transfected with a construct containing four copies to the 22-amino-acid peptide ligand from phage lambda N protein (lambda-N22), spaced by a 21 amino acid linker (PPLDGAGAGAGAGAGAGGLAT) and fused to 3 monomeric meGFP and a M9 nuclear localization signal. This construct allows binding to a 15-nt RNA hairpin termed boxB that can be fused to any RNA molecule allowing specific RNA visualization in live cells (PubMed=17603490).
CC   Genetic integration: Method=Transfection; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03045; Escherichia phage lambda N (Note=p.Met1_Asn22 = lambdaN22).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   NRK-52E
AC   CVCL_0468
SY   NRK 52E; NRK52E; NRK clone 52E; Normal Rat Kidney-52E; NRK-E52
DR   BTO; BTO_0002408
DR   CLO; CLO_0008198
DR   EFO; EFO_0022762
DR   MCCL; MCC:0000366
DR   CLDB; cl3732
DR   CLDB; cl3733
DR   ATCC; CRL-1571
DR   BCRC; 60086
DR   CCRID; 1101RAT-PUMC000822
DR   CCRID; 3101RATGNR8
DR   ChEMBL-Cells; CHEMBL4483159
DR   ChEMBL-Targets; CHEMBL4483282
DR   CLS; 305196
DR   DSMZ; ACC-199
DR   DSMZCellDive; ACC-199
DR   ECACC; 87012902
DR   GEO; GSM4009053
DR   GEO; GSM4009054
DR   GEO; GSM4009055
DR   JCRB; IFO50480
DR   Lonza; 147
DR   PRIDE; PXD021160
DR   PubChem_Cell_line; CVCL_0468
DR   TOKU-E; 2774
DR   Wikidata; Q54931030
RX   PubMed=304450;
RX   PubMed=7732277;
RX   PubMed=29460274;
RX   PubMed=33122286;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/lifespan-of-the-cell-line-nrk-52e-atcc-crl-1571
CC   Doubling time: ~45 hours (DSMZ=ACC-199).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   NRK-ASV
AC   CVCL_E3P2
RX   PubMed=6256083;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 (B77)).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NRK-EGFP-H2B
AC   CVCL_AV92
SY   NRK EGFP-H2B
DR   CLS; 500724
DR   Wikidata; Q54931031
RX   PubMed=17558394;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   NRK-EGFP2-Nup50
AC   CVCL_AV93
SY   NRK EGFP2-Nup50
DR   CLS; 500726
DR   Wikidata; Q54931032
RX   PubMed=15502822;
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=RGD; 3191; Npap60.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   NRK-EGFP3-Seh1
AC   CVCL_AV94
SY   NRK EGFP3-Seh1
DR   CLS; 500731
DR   Wikidata; Q54931033
RX   PubMed=15502822;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 6490353; Seh1l.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   NRK-IBB-DiHcRed1
AC   CVCL_AV95
SY   NRK IBB-DiHcRed1
DR   CLS; 500671
DR   Wikidata; Q54931034
RX   PubMed=19804719;
CC   Characteristics: Transfected with a IBB-DiHcRed construct containing the importin beta binding domain of importin alpha tagged with a tandem HcRed (PubMed=19804719).
CC   Genetic integration: Method=Transfection; Gene=FPbase; LP3PQ; HcRed (Note=Red fluorescent protein from H.crispa).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   NRK-Pom121-EGFP3
AC   CVCL_AV96
SY   NRK Pom121-EGFP3; NRK Pom121-3EGFP; NRK-Pom121-3EGFP
DR   CLS; 500669
DR   Wikidata; Q54931037
RX   PubMed=15502822;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 620680; Pom121.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 12
//
ID   NRK-tsASV clone 2
AC   CVCL_E3P3
RX   PubMed=6256083;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 ts mutant LA334).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NRK-tsASV clone 3
AC   CVCL_E3P4
RX   PubMed=6256083;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 ts mutant LA334).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NRK-tsASV clone 4
AC   CVCL_E3P5
RX   PubMed=6256083;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 ts mutant LA334).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   NRK/cCD20
AC   CVCL_A9PC
DR   Wikidata; Q102114665
RX   PubMed=32651429;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:52268; Dog MS4A1 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   NRK/cPD1
AC   CVCL_D2QT
DR   Wikidata; Q127382969
RX   PubMed=29571514;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:44334; Dog PDCD1 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NRK/cPDL1
AC   CVCL_D2QU
DR   Wikidata; Q127382971
RX   PubMed=29571514;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:38942; Dog CD274 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3758 ! NRK
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NRm
AC   CVCL_DR18
SY   NRL2
DR   CCRID; 5301MAM-KCB8508MZJ
DR   KCB; KCB 85008MZJ
DR   Wikidata; Q54931038
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   NRM 1
AC   CVCL_C7RQ
SY   NRM1; Normal Rat Mesothelial 1
DR   Wikidata; Q117704729
RX   PubMed=7627973;
CC   Caution: It is possible that M12C1 (Cellosaurus=CVCL_C7RN) and NRM 1 are the same cell line.
CC   Derived from site: In situ; Lung, parietal pleura; UBERON=UBERON_0002400.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   NRM 2
AC   CVCL_C7RR
SY   NRM2; Normal Rat Mesothelial 2
DR   Wikidata; Q117704730
RX   PubMed=7627973;
RX   PubMed=8205524;
RX   PubMed=9733279;
CC   Doubling time: 40 hours (PubMed=9733279).
CC   Caution: It is possible that M12C2 (Cellosaurus=CVCL_C7RP) and NRM 2 are the same cell line.
CC   Derived from site: In situ; Lung, parietal pleura; UBERON=UBERON_0002400.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   NRM 3
AC   CVCL_C7RS
SY   NRM3; Normal Rat Mesothelial 3
DR   Wikidata; Q117704731
RX   PubMed=7627973;
CC   Derived from site: In situ; Lung, parietal pleura; UBERON=UBERON_0002400.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   NRM 4
AC   CVCL_C7RT
SY   NRM4; Normal Rat Mesothelial 4
DR   Wikidata; Q117704732
RX   PubMed=7627973;
RX   PubMed=8205524;
CC   Derived from site: In situ; Lung, parietal pleura; UBERON=UBERON_0002400.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   NRP-152
AC   CVCL_4869
SY   NRP152
DR   BTO; BTO_0001349
DR   Wikidata; Q54931039
RX   PubMed=8012960;
RX   PubMed=8912849;
RX   PubMed=36636689;
CC   Characteristics: Non-tumorigenic (PubMed=8012960).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Transformant: ChEBI; CHEBI_9466; Testosterone propionate.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Lobund-Wistar (L-W).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   NRP-154
AC   CVCL_4870
SY   NRP154
DR   BTO; BTO_0001352
DR   Wikidata; Q54931040
RX   PubMed=8012960;
RX   PubMed=8912849;
RX   PubMed=36636689;
CC   Characteristics: Tumorigenic (PubMed=8012960).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Transformant: ChEBI; CHEBI_9466; Testosterone propionate.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Lobund-Wistar (L-W).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   NRS-1
AC   CVCL_4871
DR   CLO; CLO_0050021
DR   BioSample; SAMN03472176
DR   RCB; RCB1188
DR   Wikidata; Q54931041
RX   PubMed=7599791;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Doubling time: 68 hours (Note=At 15th passage), 64 hours (Note=At 25th passage) (PubMed=7599791).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=7599791).
CC   Derived from site: Metastatic; Left calf muscle; UBERON=UBERON_0004256.
ST   Source(s): RCB=RCB1188
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 18,20
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   NS-(f)iPS Isl1C
AC   CVCL_A5IN
SY   NS-(F) IPS ISL1C; NS-(f)iPS
DR   Wikidata; Q107116580
RX   PubMed=20026276;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/animal-stem-cells-catalogue-isenet.pdf
CC   Characteristics: Neural stem cell.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A5IK ! ips#202
SX   Sex unspecified
AG   <1D
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   NS-1-503
AC   CVCL_J593
DR   Wikidata; Q54931042
RX   PubMed=6869833;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   NS-3
AC   CVCL_8377
DR   BioSample; SAMN03151625
DR   cancercelllines; CVCL_8377
DR   JCRB; JCRB1076
DR   JCRB; NIHS0335
DR   Wikidata; Q54931043
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a COLO 201 derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00336.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; JCRB1076; true.
CC   Discontinued: JCRB; NIHS0335; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1076
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1987 ! COLO 201
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   NS-5
AC   CVCL_D1HI
SY   NS5
DR   BTO; BTO_0006551
DR   Wikidata; Q127382972
RX   PubMed=16086633;
RX   PubMed=20626555;
RX   PubMed=30748015;
CC   Characteristics: Can differentiate into both astrocytes and neurons (PubMed=16086633).
CC   Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct. Expresses eGFP under the control of the Sox-1 promoter (from parent cell line).
CC   Knockout cell: Method=Homologous recombination; RGD; 6487636; Sox1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y482 ! 46C
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   NS-8
AC   CVCL_G372
DR   RCB; RCB2089
DR   TKG; TKG 0339
DR   Wikidata; Q54931044
CC   Discontinued: RCB; RCB2089; true.
CC   Discontinued: TKG; TKG 0339; true.
ST   Source(s): TKG=TKG 0339
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   NS-A
AC   CVCL_ZX14
DR   Wikidata; Q102114666
RX   CelloPub=CLPUB00569;
RX   PubMed=3152871;
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Breed/subspecies: C3H.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   NS-D
AC   CVCL_ZX15
DR   Wikidata; Q102114667
RX   PubMed=3152871;
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Breed/subspecies: C3H.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   NS-E
AC   CVCL_ZX16
DR   Wikidata; Q102114668
RX   PubMed=3152871;
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Breed/subspecies: C3H.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   NS-G
AC   CVCL_ZX17
DR   Wikidata; Q102114669
RX   PubMed=3152871;
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Breed/subspecies: C3H.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   NS-Meg
AC   CVCL_S966
SY   NS-MEG
DR   Cosmic; 1012108
DR   Wikidata; Q54931045
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7719248;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=7719248).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=7719248; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   NS-SV-AC
AC   CVCL_UD37
SY   Normal Salivary gland-SV40 transformed-Acinar Cell line
DR   Wikidata; Q98128025
RX   CelloPub=CLPUB00653;
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=7687310;
RX   PubMed=29923277;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Salivary gland acinar cell; CL=CL_0002623.
ST   Source(s): CelloPub=CLPUB00653; PubMed=29923277
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UD38 ! NS-SV-DC
OI   CVCL_UD39 ! NS-SV-MC
OI   CVCL_UD40 ! NS-SV-SC
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   NS-SV-DC
AC   CVCL_UD38
SY   Normal Salivary gland-SV40 transformed-Duct Cell line
DR   Wikidata; Q98128026
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=7687310;
RX   PubMed=29923277;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
ST   Source(s): PubMed=29923277
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UD37 ! NS-SV-AC
OI   CVCL_UD39 ! NS-SV-MC
OI   CVCL_UD40 ! NS-SV-SC
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   NS-SV-MC
AC   CVCL_UD39
SY   Normal Salivary gland-SV40 transformed-Myoepithelial Cell line
DR   Wikidata; Q98128028
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=7687310;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Myoepithelial cell; CL=CL_0000185.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UD37 ! NS-SV-AC
OI   CVCL_UD38 ! NS-SV-DC
OI   CVCL_UD40 ! NS-SV-SC
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   NS-SV-SC
AC   CVCL_UD40
SY   Normal Salivary gland-SV40 transformed-Squamous Cell line
DR   Wikidata; Q98128029
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=7687310;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UD37 ! NS-SV-AC
OI   CVCL_UD38 ! NS-SV-DC
OI   CVCL_UD39 ! NS-SV-MC
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   NS0
AC   CVCL_3940
SY   NSO; NS/0; NS/O; NS-0; P3-NS0; P3/NS0; P3/NSO
DR   BTO; BTO_0004968
DR   CLO; CLO_0008203
DR   CLO; CLO_0008206
DR   CLO; CLO_0050179
DR   EFO; EFO_0022818
DR   CLDB; cl3737
DR   CLDB; cl3738
DR   CLDB; cl3739
DR   CancerTools; 153797
DR   ChEMBL-Cells; CHEMBL3307752
DR   ChEMBL-Targets; CHEMBL615003
DR   ECACC; 85110503
DR   FCS-free; 110-17-508-1-16-3
DR   IZSLER; BS TCL 48
DR   Lonza; 757
DR   NCBI_Iran; C142
DR   PubChem_Cell_line; CVCL_3940
DR   RCB; RCB0213
DR   TKG; TKG 0594
DR   Wikidata; Q20164415
RX   PubMed=18617141;
RX   PubMed=19003032;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/NS0_cell
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Commonly employed for monoclonal antibody expression.
CC   Characteristics: Lacks endogenous glutamine synthetase (GS) activity.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Discontinued: TKG; TKG 0594; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   NS0-hCD20
AC   CVCL_C6XI
SY   NS/0-hCD20; NSO/CD20
DR   Wikidata; Q117704733
RX   Patent=US8329181;
RX   PubMed=26659273;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7315; MS4A1.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   NS0-SFM
AC   CVCL_G345
SY   NSO-SFM; NS0-Serum-Free
DR   CancerTools; 155066
DR   ECACC; 03061601
DR   TKG; TKG 0596
DR   Wikidata; Q54931046
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Discontinued: TKG; TKG 0596; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   NS0-Turbodoma
AC   CVCL_G346
DR   CancerTools; 155067
DR   ECACC; 06020202
DR   Wikidata; Q54931047
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   NS01
AC   CVCL_VQ76
DR   Wikidata; Q98128030
RX   PubMed=7636305;
RX   PubMed=7876542;
CC   Derived from site: In situ; Trunk, skin, epidermis; UBERON=UBERON_0001085+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   NS0bcl-2
AC   CVCL_DD16
SY   NSObcl-2; NS0 Bcl-2; NSO-Bcl-2; NSO-bcl2; NS0-bcl2
DR   Wikidata; Q54931048
RX   Patent=US5565337;
RX   PubMed=8202525;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11705.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   NS1
AC   CVCL_IV58
SY   Nittby-Salford 1
DR   Wikidata; Q54931049
RX   DOI=10.4172/2475-3203.1000101;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   NS20Y
AC   CVCL_0469
SY   NS-20Y; NS20-Y
DR   BTO; BTO_0002639
DR   CLO; CLO_0008205
DR   MCCL; MCC:0000367
DR   CLDB; cl3736
DR   DSMZ; ACC-94
DR   DSMZCellDive; ACC-94
DR   ECACC; 08062517
DR   Wikidata; Q54931050
RX   PubMed=4400294;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-236.html
CC   Doubling time: ~30-50 hours (DSMZ=ACC-94).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   NS20Y-BU-2
AC   CVCL_4351
DR   ECACC; 08062502
DR   Wikidata; Q54931051
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0469 ! NS20Y
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   NS20Y-BU-4
AC   CVCL_4352
DR   ECACC; 08062503
DR   Wikidata; Q54931052
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0469 ! NS20Y
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   NS20Y-BU-5
AC   CVCL_4353
DR   ECACC; 08062504
DR   Wikidata; Q54931053
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0469 ! NS20Y
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   NS20Y-BU-6
AC   CVCL_4354
DR   ECACC; 08062507
DR   Wikidata; Q54931054
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0469 ! NS20Y
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   NS20Y-BU-7
AC   CVCL_4355
DR   ECACC; 08062510
DR   Wikidata; Q54931055
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0469 ! NS20Y
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   NS20Y-TG
AC   CVCL_4356
DR   ECACC; 08062512
DR   Wikidata; Q54931056
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0469 ! NS20Y
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   NS46C
AC   CVCL_A5EK
SY   LC-1; LC1
DR   Wikidata; Q107116581
RX   PubMed=16086633;
RX   PubMed=21454627;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/animal-stem-cells-catalogue-isenet.pdf
CC   Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct. Expresses eGFP under the control of the Sox-1 promoter (from parent cell line).
CC   Doubling time: ~24 hours (PubMed=16086633).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y482 ! 46C
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   NS47
AC   CVCL_VQ77
DR   Lonza; 1461
DR   Wikidata; Q98128031
RX   PubMed=7636305;
RX   PubMed=7876542;
CC   Derived from site: In situ; Trunk, skin, epidermis; UBERON=UBERON_0001085+UBERON_0001003.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   NSB
AC   CVCL_B7QE
SY   Nurse Shark Brain
DR   Wikidata; Q112930219
RX   CelloPub=CLPUB00705;
CC   Group: Fish cell line.
CC   Doubling time: 84 hours (Note=At 6th passage) (CelloPub=CLPUB00705).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=7801; ! Ginglymostoma cirratum (Nurse shark)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NSC-19
AC   CVCL_B6XY
SY   NSC 19; NSC19; Neuroblastoma x Spinal Cord-19
DR   Wikidata; Q112129464
RX   PubMed=1467557;
RX   PubMed=9291482;
CC   Characteristics: Produced by the fusion of motor neuron enriched, embryonic 12-14 days mouse spinal cord cells with N18TG2 (PubMed=1467557).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   NSC-34
AC   CVCL_D356
SY   NSC 34; NSC34; Neuroblastoma x Spinal Cord-34
DR   BTO; BTO_0004488
DR   Lonza; 5
DR   PRIDE; PXD000666
DR   PRIDE; PXD004913
DR   PRIDE; PXD007178
DR   Wikidata; Q54931057
RX   PubMed=1467557;
RX   PubMed=17896795;
RX   PubMed=25193168;
RX   PubMed=27242431;
RX   PubMed=28837265;
WW   Info; Wikipedia; -; https://it.wikipedia.org/wiki/NSC-34
WW   Provider; Cedarlane; CLU140; https://www.cedarlanelabs.com/Products/Detail/CLU140?lob=AllProducts
CC   Characteristics: Produced by the fusion of motor neuron enriched, embryonic 12-14 days mouse spinal cord cells with N18TG2 (PubMed=1467557).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Miscellaneous: STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 11
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 19.3,22.3
ST   Mouse STR 5-5: 14,15,17
ST   Mouse STR 6-4: 18.3,19,20
ST   Mouse STR 6-7: 12,15
ST   Mouse STR 7-1: 25.2,26.2,30
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 15,16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2,17.2,18.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 22,23
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 25,26,29
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   NSC-89-20 D-2
AC   CVCL_SA79
DR   Wikidata; Q54931058
RX   PubMed=7680416;
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA80 ! NSC-89-20 D-3
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   NSC-89-20 D-3
AC   CVCL_SA80
DR   Wikidata; Q54931059
RX   PubMed=7680416;
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_SA79 ! NSC-89-20 D-2
SX   Female
AG   76Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   NSC-H14
AC   CVCL_U174
DR   WiCell; nsc-h14
DR   Wikidata; Q54931060
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
ST   Source(s): WiCell=nsc-h14
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 10
//
ID   NSC-H14iPSZeng
AC   CVCL_U175
DR   WiCell; nsc-h14ipszeng
DR   Wikidata; Q54931061
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AS50 ! Zeng02i-iPSH14
SX   Male
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   NSC-H9
AC   CVCL_U176
DR   WiCell; nsc-h9
DR   Wikidata; Q54931062
RX   PubMed=19774075;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
ST   Source(s): WiCell=nsc-h9
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 11
//
ID   NSC-HyCu15B
AC   CVCL_ZF41
DR   Wikidata; Q98128032
RX   CelloPub=CLPUB00559;
RX   DOI=10.11416/jibs2001.71.25;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=39466; ! Hyphantria cunea (Fall webworm moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NSC34-G93A
AC   CVCL_C6JQ
DR   Wikidata; Q116050013
RX   PubMed=35204833;
CC   Characteristics: Transfected with a pcDNA3/mt-SOD1G93A-GFP construct (the "mt" stands for the mitochondrial targeting sequence of human COX8A).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11179; SOD1 (Note=With p.Gly94Ala).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D356 ! NSC-34
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   NSCLC-N6
AC   CVCL_H623
SY   NSCLCN6
DR   ChEMBL-Cells; CHEMBL3307850
DR   ChEMBL-Targets; CHEMBL614016
DR   PubChem_Cell_line; CVCL_H623
DR   Wikidata; Q54931063
RX   PubMed=1776865;
RX   PubMed=9568077;
CC   Doubling time: ~48 hours (PubMed=1776865).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   NSCLC-N6 clone C15
AC   CVCL_H624
SY   C15
DR   Wikidata; Q54931064
RX   PubMed=9568077;
CC   Doubling time: 91 hours (PubMed=9568077).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H623 ! NSCLC-N6
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   NSCLC-N6 clone C65
AC   CVCL_H625
SY   C65
DR   Wikidata; Q54931065
RX   PubMed=9568077;
CC   Doubling time: 70 hours (PubMed=9568077).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H623 ! NSCLC-N6
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   NSCLC-N6 clone C92
AC   CVCL_H626
SY   C92
DR   Wikidata; Q54931066
RX   PubMed=9568077;
CC   Doubling time: 108 hours (PubMed=9568077).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H623 ! NSCLC-N6
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   NSCLC-N6 clone C98
AC   CVCL_H627
SY   C98
DR   Wikidata; Q54931067
RX   PubMed=9568077;
CC   Doubling time: 57 hours (PubMed=9568077).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H623 ! NSCLC-N6
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   NSG-70
AC   CVCL_B7HV
DR   Wikidata; Q112930222
RX   PubMed=35430703;
CC   Group: Cancer stem cell line.
CC   Population: Indian.
CC   Doubling time: ~150 hours (PubMed=35430703).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NSG-70-GFP
AC   CVCL_B7HW
DR   Wikidata; Q112930223
RX   PubMed=35430703;
CC   Group: Cancer stem cell line.
CC   Population: Indian.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7HV ! NSG-70
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   NSG-70-WNT5A-GFP
AC   CVCL_B7HX
DR   Wikidata; Q112930224
RX   PubMed=35430703;
CC   Group: Cancer stem cell line.
CC   Population: Indian.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12784; WNT5A.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7HV ! NSG-70
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   NSHDMUi001-A
AC   CVCL_D0K9
SY   20201217LJJ
DR   BioSamples; SAMEA112650128
DR   hPSCreg; NSHDMUi001-A
DR   Wikidata; Q123033198
RX   PubMed=37028179;
CC   From: Department of Neurology, Second Hospital of Dalian Medical University; Dalian; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37028179
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 8,9
ST   D18S51: 13,15
ST   D19S433: 15.2,16.2
ST   D21S11: 31
ST   D2S1338: 21,24
ST   D2S441: 10,12
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 23,27
ST   Penta D: 8,9
ST   Penta E: 5,14
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,19
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NSI001-A
AC   CVCL_C0HK
SY   iR14T21-A
DR   BioSamples; SAMEA112442033
DR   hPSCreg; NSI001-A
DR   Wikidata; Q112930225
RX   PubMed=35381521;
CC   From: Stem Cell and Neurobiology Lab, National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Karyotypic information: 46,XX,rob(14;21) (PubMed=35381521).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188150; Robertsonian translocation Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0HL ! NSI001-B
OI   CVCL_C0HM ! NSI001-C
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 30-01-24; Version: 5
//
ID   NSI001-B
AC   CVCL_C0HL
SY   iR14T21-B
DR   hPSCreg; NSI001-B
DR   Wikidata; Q112930229
RX   PubMed=35381521;
CC   From: Stem Cell and Neurobiology Lab, National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Karyotypic information: 46,XX,rob(14;21) (PubMed=35381521).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188150; Robertsonian translocation Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0HK ! NSI001-A
OI   CVCL_C0HM ! NSI001-C
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NSI001-C
AC   CVCL_C0HM
SY   iR14T21-C
DR   hPSCreg; NSI001-C
DR   Wikidata; Q112930233
RX   PubMed=35381521;
CC   From: Stem Cell and Neurobiology Lab, National Centre for Cell Science; Pune; India.
CC   Population: Indian.
CC   Karyotypic information: 46,XX,rob(14;21) (PubMed=35381521).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188150; Robertsonian translocation Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0HK ! NSI001-A
OI   CVCL_C0HL ! NSI001-B
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   NSI002-A
AC   CVCL_C0HN
SY   AAVS1-EGFP-Tri
DR   hPSCreg; NSI002-A
DR   Wikidata; Q112930236
RX   PubMed=35961104;
CC   From: Stem Cell and Neurobiology Lab, National Centre for Cell Science; Pune; India.
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a PuroR-CAG-EGFP cassette was introduced in the AAVS1 safe harbor locus (PubMed=35961104).
CC   Genetic integration: Method=ZFN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1Y0 ! DS1-iPS4-Trisomic
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   NSI002-B
AC   CVCL_C0HP
SY   AAVS1-EGFP-Di
DR   hPSCreg; NSI002-B
DR   Wikidata; Q112930237
RX   PubMed=35961104;
CC   From: Stem Cell and Neurobiology Lab, National Centre for Cell Science; Pune; India.
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a PuroR-CAG-EGFP cassette was introduced in the AAVS1 safe harbor locus (PubMed=35961104).
CC   Karyotypic information: Lost the third copy of chromosome 21 (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1XZ ! DS1-iPS4-Disomic
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   NSI003-A
AC   CVCL_D0KA
SY   NSi-DS
DR   BioSamples; SAMEA112442035
DR   hPSCreg; NSI003-A
DR   Wikidata; Q123033200
RX   PubMed=36764067;
CC   From: Stem Cell and Neurobiology Lab, National Centre for Cell Science; Pune; India.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2430 ! Detroit 532
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NSI003-B
AC   CVCL_D0KB
SY   NSi-isoEu
DR   BioSamples; SAMEA112442037
DR   hPSCreg; NSI003-B
DR   Wikidata; Q123033201
RX   PubMed=36764067;
CC   From: Stem Cell and Neurobiology Lab, National Centre for Cell Science; Pune; India.
CC   Population: Caucasian.
CC   Characteristics: While originating from a Down syndrome patient, this cell line has lost the extra copy of chromosome 21.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2430 ! Detroit 532
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   NSK
AC   CVCL_8378
SY   Newborn Swine Kidney
DR   IZSLER; BS CL 177
DR   Wikidata; Q54931068
RX   PubMed=12505635;
RX   PubMed=14535431;
CC   Doubling time: 4.14 hours (PubMed=12505635).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   NSK-RC
AC   CVCL_X542
DR   Cosmic; 849383
DR   Wikidata; Q54931069
RX   PubMed=11146448;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   NSYM
AC   CVCL_A7FQ
DR   Wikidata; Q107116582
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Senescence: Not immortalized.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   NT-1 [Human leukemia]
AC   CVCL_X338
DR   cancercelllines; CVCL_X338
DR   Wikidata; Q54931070
RX   PubMed=25012564;
CC   Population: Chinese.
CC   Doubling time: ~72 hours (PubMed=25012564).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Unspecified (PubMed=25012564).
CC   Caution: According to PubMed=25012564 the TP53 mutation is p.Pro215Arg; which does not correspond to the DNA sequence shown in figure 3.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3519; Atypical chronic myeloid leukemia, BCR-ABL1 negative
DI   ORDO; Orphanet_98824; Atypical chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 14
//
ID   NT-1 [Human tongue SCC]
AC   CVCL_GZ02
DR   Wikidata; Q54931071
RX   DOI=10.3353/omp.9.133;
CC   Population: Japanese.
CC   Doubling time: 26.8 hours (DOI=10.3353/omp.9.133).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   NT-1 [Human trachea]
AC   CVCL_E1HC
DR   EFO; EFO_0002707
RX   PubMed=7689916;
RX   PubMed=12000003;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trachea; UBERON=UBERON_0003126.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 4
//
ID   NT-18LM
AC   CVCL_C4N5
DR   Wikidata; Q116050014
RX   PubMed=36269546;
CC   Doubling time: 6.35 days (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:2681; DAXX; Simple; p.Cys629Leufs*29 (c.1884dupC); Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg29Ter (c.85C>T); ClinVar=VCV000200970; Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:11633; TCF3; Simple; p.Lys101Arg (c.302A>G); ClinVar=VCV000810990; Zygosity=Unspecified (PubMed=36269546).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C172814; Pancreatic neuroendocrine tumor G3
DI   ORDO; Orphanet_97253; Neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4N6 ! NT-18P
OI   CVCL_C4N7 ! NT-36
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   NT-18P
AC   CVCL_C4N6
DR   Wikidata; Q116050015
RX   PubMed=36269546;
CC   Doubling time: 4.64 days (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:2681; DAXX; Simple; p.Cys629Leufs*29 (c.1884dupC); Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg29Ter (c.85C>T); ClinVar=VCV000200970; Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:11633; TCF3; Simple; p.Lys101Arg (c.302A>G); ClinVar=VCV000810990; Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Ser (c.472C>A); ClinVar=VCV001067910; Zygosity=Unspecified (PubMed=36269546).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C172814; Pancreatic neuroendocrine tumor G3
DI   ORDO; Orphanet_97253; Neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4N5 ! NT-18LM
OI   CVCL_C4N7 ! NT-36
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   NT-2
AC   CVCL_GZ03
DR   Wikidata; Q54931072
RX   DOI=10.3353/omp.9.133;
CC   Population: Japanese.
CC   Doubling time: 42.4 hours (DOI=10.3353/omp.9.133).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   NT-27
AC   CVCL_WV00
SY   NT 27
DR   Wikidata; Q98128033
RX   PubMed=2895109;
RX   PubMed=9288899;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 6
//
ID   NT-27a
AC   CVCL_WV01
DR   DSMZ; ACC-857
DR   DSMZCellDive; ACC-857
DR   Wikidata; Q98128034
CC   Doubling time: ~24-30 hours (DSMZ=ACC-857).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WV00 ! NT-27
SX   Male
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 7
//
ID   NT-3
AC   CVCL_VG81
DR   cancercelllines; CVCL_VG81
DR   Wikidata; Q54931073
RX   CelloPub=CLPUB00598;
RX   PubMed=29330294;
RX   PubMed=36269546;
CC   Doubling time: 10.9 +- 0.7 days (PubMed=29330294).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr541Ala (c.1621A>G); ClinVar=VCV000134640; Zygosity=Homozygous; Note=Probable SNP (PubMed=29330294).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C45835; Pancreatic neuroendocrine tumor G2
DI   ORDO; Orphanet_97253; Neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   NT-32
AC   CVCL_C4N8
DR   Wikidata; Q116050016
RX   PubMed=36269546;
CC   Doubling time: 5.35 days (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asn486_Pro490del (c.1457_1471del); ClinVar=VCV000666267; Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=36269546).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C95582; Pancreatic large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   NT-36
AC   CVCL_C4N7
DR   Wikidata; Q116050017
RX   PubMed=36269546;
CC   Doubling time: 7.09 days (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:2681; DAXX; Simple; p.Cys629Leufs*29 (c.1884dupC); Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Arg29Ter (c.85C>T); ClinVar=VCV000200970; Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:9816; RAD50; Simple; p.Glu723Glyfs*5 (c.2165dupA); ClinVar=VCV000141045; Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:11633; TCF3; Simple; p.Lys101Arg (c.302A>G); ClinVar=VCV000810990; Zygosity=Unspecified (PubMed=36269546).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C172814; Pancreatic neuroendocrine tumor G3
DI   ORDO; Orphanet_97253; Neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C4N5 ! NT-18LM
OI   CVCL_C4N6 ! NT-18P
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   NT-38
AC   CVCL_C4N9
DR   cancercelllines; CVCL_C4N9
DR   Wikidata; Q116050018
RX   PubMed=36269546;
CC   Doubling time: 5.21 days (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1346Ter (c.4037C>A); ClinVar=VCV001737245; Zygosity=Unspecified (PubMed=36269546).
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser259Phe (c.776C>T); ClinVar=VCV000040603; Zygosity=Unspecified (PubMed=36269546).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
DI   NCIt; C135080; Duodenal neuroendocrine tumor
DI   ORDO; Orphanet_100076; Duodenal neuroendocrine tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   NT-68
AC   CVCL_9713
DR   Wikidata; Q54931074
RX   PubMed=1320624;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NT-8e
AC   CVCL_E328
DR   Wikidata; Q54931075
RX   PubMed=9310268;
CC   Population: Indian.
CC   Doubling time: 27 hours (PubMed=9310268).
CC   Derived from site: In situ; Pharynx, hypopharynx, pyriform sinus; UBERON=UBERON_8480022.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   NT-92
AC   CVCL_2145
SY   NT 92
DR   DSMZ; ACC-639
DR   DSMZCellDive; ACC-639
DR   Wikidata; Q54931076
RX   CelloPub=CLPUB00363;
CC   Doubling time: ~3-4 days (DSMZ=ACC-639).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60372; Rat cholangiocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   NT-hESC
AC   CVCL_C807
SY   ITSe001-A
DR   hPSCreg; ITSe001-A
DR   SKIP; SKIP002269
DR   Wikidata; Q54931078
RX   PubMed=17112910;
CC   From: Department of Nephrology and Transplantation Medicine, Institute of Transplantation Sciences, Civil Hospital; Gujarat; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   NT-hESC-1
AC   CVCL_M327
SY   SCNT-hES-1; NT-1; Sooam-hES1; Sooam-hES-1
DR   Wikidata; Q54931079
RX   PubMed=14963337;
RX   PubMed=16410485;
RX   PubMed=24159464;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (PubMed=16410485).
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   NT-hESC-10
AC   CVCL_M328
DR   Wikidata; Q54931080
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-11
AC   CVCL_M329
DR   Wikidata; Q54931081
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-12
AC   CVCL_M330
DR   Wikidata; Q54931082
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-2
AC   CVCL_M331
DR   Wikidata; Q54931083
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   NT-hESC-3
AC   CVCL_M332
DR   Wikidata; Q54931084
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-4
AC   CVCL_M333
DR   Wikidata; Q54931086
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-5
AC   CVCL_M334
DR   Wikidata; Q54931087
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-6
AC   CVCL_M335
DR   Wikidata; Q54931088
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-7
AC   CVCL_M336
DR   Wikidata; Q54931089
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-8
AC   CVCL_M337
DR   Wikidata; Q54931090
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT-hESC-9
AC   CVCL_M338
DR   Wikidata; Q54931091
RX   PubMed=15905366;
RX   PubMed=16410485;
WW   Info; NYT; -; https://www.nytimes.com/2006/01/09/science/text-of-the-report-on-dr-hwang-woo-suk.html
CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (PubMed=16410485).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   NT/T-S
AC   CVCL_D886
DR   Wikidata; Q54931092
RX   PubMed=10875873;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   NT00669
AC   CVCL_V377
DR   IPD-IMGT/HLA; 14456
DR   Wikidata; Q54931093
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:BUVE,68:34; B*51:AFJH,58:BF; C*06:REV,18:AB; DRB1*12:GW,15:03 (IPD-IMGT/HLA=14456).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   NT00670
AC   CVCL_V378
DR   IPD-IMGT/HLA; 14455
DR   Wikidata; Q54931094
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BUWR,11:23; B*44:AJVH,57:GW; C*05:ANJN,07:02; DRB1*01:ANWV,04:AGCN (IPD-IMGT/HLA=14455).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   NT00671
AC   CVCL_V379
DR   IPD-IMGT/HLA; 14453
DR   Wikidata; Q54931095
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:02,74:MN; B*15:03,53:AD; C*02:16,04:01:01:01; DRB1*11:BK,11:NRV (IPD-IMGT/HLA=14453).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   NT00672
AC   CVCL_V380
DR   IPD-IMGT/HLA; 14454
DR   Wikidata; Q54931096
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,24; B*40:SUF,57:MY; C*03:27,06:02; DRB1*04:VZB,16:01 (IPD-IMGT/HLA=14454).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   NT00673
AC   CVCL_V381
DR   IPD-IMGT/HLA; 14452
DR   Wikidata; Q54931097
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,11:ANXJ; B*35:ADSB,57:AG; C*04:15:02,06:02; DRB1*01:EW,07:APA (IPD-IMGT/HLA=14452).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   NT00781
AC   CVCL_UV53
DR   IPD-IMGT/HLA; 15434
DR   Wikidata; Q98128035
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CNDW; B*15:142,15:DKGD; C*03:AKZD,03:PWX; DRB1*13:APRJ,13:ARCR (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT00793
AC   CVCL_UV54
DR   IPD-IMGT/HLA; 15602
DR   Wikidata; Q98128036
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:147,68:CSJM; B*15:ANPM,15:APFM; C*03:FJC,07:ET; DRB1*13:ARCR,15:VYF (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT00989
AC   CVCL_UV55
DR   IPD-IMGT/HLA; 15712
DR   Wikidata; Q98128037
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*02:ANNS,29:BCHD; B*07:AWCA,44:AXJM; C*07:02,14:10; DRB1*01:03,03:02 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT00997
AC   CVCL_UV56
DR   IPD-IMGT/HLA; 15744
DR   Wikidata; Q98128038
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:41,11:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01002
AC   CVCL_UV57
DR   IPD-IMGT/HLA; 15749
DR   Wikidata; Q98128039
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CNDW; B*08:AKNJ,14:01; C*07:60,08:02; DRB1*03:WHX,15:VYF (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01007
AC   CVCL_UV58
DR   IPD-IMGT/HLA; 15780
DR   Wikidata; Q98128041
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:TUS,25:01; B*18:RRG,49:01:02; C*07:ANNG,12:NP; DRB1*15:AAXP,15:DWK (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01010
AC   CVCL_UV59
DR   IPD-IMGT/HLA; 15784
DR   Wikidata; Q98128042
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26:XX,31:01:02; B*40:AZAY,51:60; C*03:04,15:02; DRB1*01:AD,11:YM (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01011
AC   CVCL_UV60
DR   IPD-IMGT/HLA; 15901
DR   Wikidata; Q98128043
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*07:16,08:01:01/01:03 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01012
AC   CVCL_UV61
SY   HN-749933
DR   IPD-IMGT/HLA; 16120
DR   Wikidata; Q98128044
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*01:CNJK,34:01:01; B*08:XKT,15:159; C*03:04,07:CVAG; DRB1*04:01:01,04:05:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01013
AC   CVCL_UV62
SY   HN-703138
DR   IPD-IMGT/HLA; 16121
DR   Wikidata; Q98128046
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:CFKP,03:50; B*15:DFRA,44:WRJ; C*03:04,05:AC; DRB1*04:01:01,15:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01014
AC   CVCL_UV63
SY   HN-756979
DR   IPD-IMGT/HLA; 16097
DR   Wikidata; Q98128047
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:35,24:CWFP; B*35:08:01,51:CVAE; C*04:CVAF,14:02:01; DRB1*12:CVT,13:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01015
AC   CVCL_UV64
SY   HN-763009
DR   IPD-IMGT/HLA; 16123
DR   Wikidata; Q98128048
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*03:51,23:DFKR; B*07:CZZS,35:BEZX; C*04:CVAF,07:WCP; DRB1*04:05:01,09:01:02 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01020
AC   CVCL_UV65
SY   HN-718979
DR   IPD-IMGT/HLA; 16099
DR   Wikidata; Q98128049
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,26:38; B*07:CZZS,35:BEZX; C*04:CVAF,07:WCP; DRB1*07:01:01,16:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01021
AC   CVCL_UV66
DR   IPD-IMGT/HLA; 16100
DR   Wikidata; Q98128050
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Pacific.
CC   HLA typing: A*01:ECAD,11:42; B*15:CKN,58:VE; C*03:BPSK,07:CVAG; DRB1*03:01:01,12:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   NT01022
AC   CVCL_UV67
SY   HN-756995
DR   IPD-IMGT/HLA; 16101
DR   Wikidata; Q98128052
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,23:21; B*41:02,42:01; C*17:MN; DRB1*03:02:01,13:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01023
AC   CVCL_UV68
SY   HN-692448
DR   IPD-IMGT/HLA; 16102
DR   Wikidata; Q98128053
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,24:CWFP; B*07:76,15:DFRA; C*03:BPSK,07:WCP; DRB1*04:01:01,15:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01024
AC   CVCL_UV69
SY   HN-697595
DR   IPD-IMGT/HLA; 16103
DR   Wikidata; Q98128054
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*24:CWFP,33:BEKE; B*15:158,58:02; C*02:16,06:02; DRB1*13:01:01,13:03:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01025
AC   CVCL_UV70
DR   IPD-IMGT/HLA; 16104
DR   Wikidata; Q98128055
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,31:CGAJ; B*27:02,38:19; C*02:02:02,12:03; DRB1*01:01:01,13:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01026
AC   CVCL_UV71
SY   HN-743688
DR   IPD-IMGT/HLA; 16105
DR   Wikidata; Q98128056
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,02:DFKP; B*35:BEZX,44:69; C*04:CVAF,16:01:01; DRB1*01:01:01,07:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01027
AC   CVCL_UV72
DR   IPD-IMGT/HLA; 16106
DR   Wikidata; Q98128057
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:177,11:BDFZ; B*18:RRG,40:90; C*05:AC,15:BJ; DRB1*03:01:01,16:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01028
AC   CVCL_UV73
SY   HN-777132
DR   IPD-IMGT/HLA; 16124
DR   Wikidata; Q98128058
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,24:CWFP; B*15:160,15:DFRA; C*03:BPSK,04:CVAF; DRB1*12:CVT,13:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01029
AC   CVCL_UV74
SY   HN-779823
DR   IPD-IMGT/HLA; 16125
DR   Wikidata; Q98128059
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,31:CGAJ; B*27:50,40:AZAY; C*02:02:02,03:04; DRB1*04:04,07:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01030
AC   CVCL_UV75
SY   HN-680161
DR   IPD-IMGT/HLA; 16107
DR   Wikidata; Q98128060
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,29:02:01; B*14:02:01,15:17; C*07:CVAG,08:23; DRB1*13:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01031
AC   CVCL_UV76
SY   HN-694436
DR   IPD-IMGT/HLA; 16111
DR   Wikidata; Q98128061
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:BDFZ,33:BEKE; B*13:01,44:03:02; C*04:03,07:69; DRB1*07:01:01,15:02:02 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01032
AC   CVCL_UV77
SY   HN-683991
DR   IPD-IMGT/HLA; 16119
DR   Wikidata; Q98128062
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:CNJK,02:DFKP; B*40:AZAY,44:WRJ; C*01:27,03:04; DRB1*08:01,09:01:02 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01033
AC   CVCL_UV78
SY   HN-686424
DR   IPD-IMGT/HLA; 16108
DR   Wikidata; Q98128064
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP; B*44:WRJ,57:01:01; C*05:AC,06:23; DRB1*01:01:01,04:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01034
AC   CVCL_UV79
SY   HN-690939
DR   IPD-IMGT/HLA; 16112
DR   Wikidata; Q98128065
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,03:CVAB; B*18:RRG,35:BEZX; C*04:CVAF,07:70; DRB1*11:04:01,13:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01036
AC   CVCL_UV80
SY   HN-699260
DR   IPD-IMGT/HLA; 16117
DR   Wikidata; Q98128066
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*29:02:01,68:01; B*40:16,44:03; C*02:27,16:01:01; DRB1*07:01:01,13:03:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01037
AC   CVCL_UV81
DR   IPD-IMGT/HLA; 16113
DR   Wikidata; Q98128067
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*02:DFKP,02:DFKR; B*35:BEZX,44:WRJ; C*07:71,07:ET; DRB1*01:01:01,03:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01038
AC   CVCL_UV82
SY   HN-726956
DR   IPD-IMGT/HLA; 16118
DR   Wikidata; Q98128068
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP,24:CWFP; B*27:EKN,35:02:01; C*01:26,04:CVAF; DRB1*08:01,11:04:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01039
AC   CVCL_UV83
SY   HN-727525
DR   IPD-IMGT/HLA; 16109
DR   Wikidata; Q98128069
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: A*24:CWFP,68:CAKR; B*35:08:01,44:WRJ; C*04:CVAF,07:68; DRB1*03:01:01,11:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01040
AC   CVCL_UV84
SY   HN-742987
DR   IPD-IMGT/HLA; 16110
DR   Wikidata; Q98128070
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*29:02:01,33:BEKE; B*45:AH,53:01:01; C*04:40,06:02; DRB1*08:06,11:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01041
AC   CVCL_UV85
SY   HN-749974
DR   IPD-IMGT/HLA; 16116
DR   Wikidata; Q98128071
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:DFKP; B*08:XKT,40:AVGG; C*02:26:01,07:CVAG; DRB1*01:01:01,03:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01042
AC   CVCL_UV86
SY   HN-764015
DR   IPD-IMGT/HLA; 16115
DR   Wikidata; Q98128072
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: A*02:DFKP,31:CGAJ; B*07:CZZS,15:DFRA; C*03:04,07:72; DRB1*04:01:01,15:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01044
AC   CVCL_UV87
DR   IPD-IMGT/HLA; 16439
DR   Wikidata; Q98128074
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:22:02,02:DFKP; B*35:AEYZ,48:01; C*04:ZFD,08:CF; DRB1*04:AAHZ,04:ZX (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01050
AC   CVCL_UV88
DR   IPD-IMGT/HLA; 16450
DR   Wikidata; Q98128076
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:WUS,29:BKZA; B*08:AKNJ,44:AXJM; C*07:CVAG,14:10; DRB1*03:VHY,07:APA (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01055
AC   CVCL_UV89
DR   IPD-IMGT/HLA; 16469
DR   Wikidata; Q98128077
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:178,32:01; B*18:AERZ,38:AF; C*07:ANNG,12:NP; DRB1*11:ARKC,13:ARCR (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01056
AC   CVCL_UV90
DR   IPD-IMGT/HLA; 16468
DR   Wikidata; Q98128078
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*24:07,33:DWH; B*15:35,58:01; C*03:60,07:WCP; DRB1*03:WHX,15:AAXP (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01058
AC   CVCL_UV91
DR   IPD-IMGT/HLA; 16446
DR   Wikidata; Q98128079
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*23:ANJU,66:AD; B*07:AWCA,58:02; C*06:BK,15:22; DRB1*13:AFWJ,13:APRJ (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01059
AC   CVCL_UV92
DR   IPD-IMGT/HLA; 16470
DR   Wikidata; Q98128080
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caucasian; Irish/Scottish.
CC   HLA typing: A*02:CNEJ,68:AJCN; B*27:JNZ; C*01:28,02:02:02; DRB1*01:03,11:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01060
AC   CVCL_UV93
DR   IPD-IMGT/HLA; 16459
DR   Wikidata; Q98128081
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANFV,30:YE; B*08:AVDM,18:ARVX; C*05:AC,07:73; DRB1*03:WHX,15:VYF (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01061
AC   CVCL_UV94
DR   IPD-IMGT/HLA; 16458
DR   Wikidata; Q98128082
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*02:DFKP,24:07; B*15:35,40:AZAY; C*03:CD,08:26N; DRB1*11:01:01,15:02:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01062
AC   CVCL_UV95
DR   IPD-IMGT/HLA; 16457
DR   Wikidata; Q98128084
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:05,33:24; B*50:01,58:01; C*03:BE,06:AJB; DRB1*07:APA,13:02 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01063
AC   CVCL_UV96
DR   IPD-IMGT/HLA; 16456
DR   Wikidata; Q98128085
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:ECAD,68:48; B*08:APTN,14:02; C*07:ANNG,08:02; DRB1*03:WZD,11:APNV (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01066
AC   CVCL_UV97
DR   IPD-IMGT/HLA; 16823
DR   Wikidata; Q98128086
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03:ANGK,68:PNP; B*50:01,57:25; C*06:AJB,06:REV; DRB1*07:01,11:03 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01068
AC   CVCL_UV98
DR   IPD-IMGT/HLA; 16821
DR   Wikidata; Q98128088
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANDA,25:01; B*40:AZAY,57:24; C*03:GFW,06:AJB; DRB1*07:APA,3:APWN (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   NT01069
AC   CVCL_UV99
DR   IPD-IMGT/HLA; 17393
DR   Wikidata; Q98128089
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:ANRC,29:BKZA; B*15:01:11,58:VE; C*03:GEC,07:ANSJ; DRB1*03:01,04:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01070
AC   CVCL_UW00
DR   IPD-IMGT/HLA; 16719
DR   Wikidata; Q98128090
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANFV,31:AF; B*15:164,51:CVAE; C*03:FJC,12:NP; DRB1*03:WHX,15:VYF (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01072
AC   CVCL_UW01
DR   IPD-IMGT/HLA; 16718
DR   Wikidata; Q98128091
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:YAG,02:ANGR; B*08:XKT,44:02:08; C*05:ANJN,07:ANNG; DRB1*03:WKH,04:AFMT (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01073
AC   CVCL_UW02
DR   IPD-IMGT/HLA; 16832
DR   Wikidata; Q98128092
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BANP,23:ANJU; B*27:04:03,45:AH; C*06:AJB,12:02; DRB1*11:APKF,14:04 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01105
AC   CVCL_UW03
DR   IPD-IMGT/HLA; 16872
DR   Wikidata; Q98128093
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Mexican.
CC   HLA typing: A*02:ANGN,03:ANGP; B*48:01,56:01; C*01:AEV,08:AJ; DRB1*04:79,11:04:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01106
AC   CVCL_UW04
DR   IPD-IMGT/HLA; 16873
DR   Wikidata; Q98128095
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: A*02:ANDC,11:XSH; B*27:02,55:XUB; C*03:PWX,07:AJB; DRB1*09:01:06,11:01:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01107
AC   CVCL_UW05
DR   IPD-IMGT/HLA; 16874
DR   Wikidata; Q98128096
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: B*07:CUCC,57:BC; C*07:ANHC,18:AB; DRB1*11:01:02,16:14 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01108
AC   CVCL_UW06
DR   IPD-IMGT/HLA; 16876
DR   Wikidata; Q98128098
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Native North American.
CC   HLA typing: A*01:ENWD,02:190; B*44:ANGD,57:VG; C*05:ARSE,06:ASCZ; DRB1*04:09,07:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01114
AC   CVCL_UW07
DR   IPD-IMGT/HLA; 18977
DR   Wikidata; Q98128099
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*23:NY; B*42:AB,53:01; C*04:01:11,17:MN; DRB1*08:BYC,13:02 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 6
//
ID   NT01121
AC   CVCL_UW08
DR   IPD-IMGT/HLA; 20179
DR   Wikidata; Q98128101
RX   PubMed=20860585;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:ANGN,03:ANGP; C*03:FJC,06:32; DRB1*07:01,13:01 (PubMed=20860585).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   NT2
AC   CVCL_JA57
DR   Wikidata; Q54931098
RX   PubMed=10910070;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   NT2-B9
AC   CVCL_4U33
SY   NT2/B9
DR   Wikidata; Q54931099
RX   PubMed=6144603;
RX   PubMed=6694356;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0034 ! NTERA-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   NT2-D1
AC   CVCL_3407
SY   NT2/D1; NT2D1; Nt2D1; NTERA-2 clone D1; NTERA2-cloneD1; NTERA-2 cl.D1; NTera2 cl.D1; NTERA-2cl.D1; NTera 2/cl.D1; NTERA2CLD1; NTERA-2/D1; NTera2/D1; NTERA2-D1; NTera-2D1; Ntera2/D1; NTERA2/D1; NTERA2D1; NTera2D1; Tera
DR   BTO; BTO_0000946
DR   CLO; CLO_0008207
DR   CLO; CLO_0037150
DR   EFO; EFO_0005236
DR   CLDB; cl3740
DR   CLDB; cl5088
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1973
DR   BCRC; 60356
DR   BCRJ; 0303
DR   cancercelllines; CVCL_3407
DR   Cell_Model_Passport; SIDM01203
DR   ChEMBL-Cells; CHEMBL3307482
DR   ChEMBL-Targets; CHEMBL614206
DR   Cosmic; 687052
DR   Cosmic; 908454
DR   Cosmic; 1995598
DR   Cosmic; 2077191
DR   Cosmic; 2163756
DR   Cosmic-CLP; 908454
DR   DepMap; ACH-002291
DR   ECACC; 01071221
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS374ENC
DR   ENCODE; ENCBS578HFO
DR   ENCODE; ENCBS631LTU
DR   ENCODE; ENCBS810EWQ
DR   FCS-free; 172-2-320-1-3-3
DR   GDSC; 908454
DR   GEO; GSM824855
DR   GEO; GSM824856
DR   GEO; GSM1040297
DR   GEO; GSM1040367
DR   GEO; GSM1670285
DR   IARC_TP53; 21589
DR   IARC_TP53; 21590
DR   ICLC; HTL97025
DR   IZSLER; BS TCL 204
DR   LINCS_LDP; LCL-1901
DR   Lonza; 1094
DR   PharmacoDB; NTERASclD1_1169_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_3407
DR   Wikidata; Q54931100
RX   PubMed=3293662;
RX   PubMed=6144603;
RX   PubMed=6694356;
RX   PubMed=8242627;
RX   PubMed=8411264;
RX   PubMed=23325432;
RX   PubMed=24812411;
RX   PubMed=25802994;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/NT2-D1_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-113.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/NTERA-2
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=1.78%; Native American=0%; East Asian, North=0.45%; East Asian, South=1.42%; South Asian=4.09%; European, North=53.03%; European, South=39.23% (PubMed=30894373).
CC   Misspelling: NTERA-S-cl-D1; ArrayExpress=E-MTAB-783; CLO=CLO_0037150; Cosmic=1995598.
CC   Misspelling: NTL-D1; Cosmic=2077191.
CC   Misspelling: NT2101; Cosmic=2163756; PubMed=24812411.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-1973; Cosmic-CLP=908454; ECACC=01071221
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,12,13
ST   D18S51: 14
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 22,25
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0034 ! NTERA-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   NT2-D3
AC   CVCL_4U27
SY   NT2/D3; NT2 D3
DR   Wikidata; Q54931101
RX   PubMed=6694356;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0034 ! NTERA-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   NT2-N
AC   CVCL_7929
SY   NT2N; NTERA-2N; hNT
DR   BTO; BTO_0002574
DR   EFO; EFO_0022400
DR   Wikidata; Q54931102
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3407 ! NT2-D1
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   NT2-Rho0
AC   CVCL_K047
SY   NT-2 rho(0); NT-2 rho0; NT2 rho0
DR   BTO; BTO_0005075
DR   Wikidata; Q54931104
RX   PubMed=16050988;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0034 ! NTERA-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   NT2.5
AC   CVCL_JA60
DR   GEO; GSM1155324
DR   Wikidata; Q54931105
RX   PubMed=18829490;
RX   PubMed=19642106;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JA57 ! NT2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   NT2.5 BO3
AC   CVCL_JA61
SY   BO3; Bo3
DR   GEO; GSM1155325
DR   Wikidata; Q54931106
RX   PubMed=19642106;
CC   Characteristics: Produced by injection of NT2.5 cells into the left cardiac ventricle of neu-N mice resulting in the formation of metastatic lesions in bone. These metastatic lesions were established in cell culture and subsequently reinjected into neu-N mice. This selection process was repeated until sublines with a bone preference were obtained.
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JA60 ! NT2.5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   NT2.5 BO6
AC   CVCL_JA62
SY   BO6; Bo6
DR   GEO; GSM1155326
DR   Wikidata; Q54931107
RX   PubMed=19642106;
CC   Characteristics: Produced by injection of NT2.5 cells into the left cardiac ventricle of neu-N mice resulting in the formation of metastatic lesions in bone. These metastatic lesions were established in cell culture and subsequently reinjected into neu-N mice. This selection process was repeated until sublines with a bone preference were obtained.
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JA61 ! NT2.5 BO3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   NT2.5 LI1
AC   CVCL_JA63
SY   LI1; Li1
DR   GEO; GSM1155327
DR   Wikidata; Q54931108
RX   PubMed=19642106;
CC   Characteristics: Produced by injection of NT2.5 cells into the left cardiac ventricle of neu-N mice resulting in the formation of metastatic lesions in liver. These metastatic lesions were established in cell culture and subsequently reinjected into neu-N mice. This selection process was repeated until sublines with a liver preference were obtained.
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JA60 ! NT2.5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   NT2.5 LI3
AC   CVCL_JA64
SY   LI3; Li3
DR   GEO; GSM1155328
DR   Wikidata; Q54931109
RX   PubMed=19642106;
CC   Characteristics: Produced by injection of NT2.5 cells into the left cardiac ventricle of neu-N mice resulting in the formation of metastatic lesions in liver. These metastatic lesions were established in cell culture and subsequently reinjected into neu-N mice. This selection process was repeated until sublines with a liver preference were obtained.
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JA63 ! NT2.5 LI1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   NT4
AC   CVCL_JA58
DR   Wikidata; Q54931110
RX   PubMed=10910070;
RX   PubMed=18829490;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   NT5
AC   CVCL_JA59
DR   Wikidata; Q54931111
RX   PubMed=10910070;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2.
CC   Breed/subspecies: FVB/N-Tg(MMTVneu)202Mul/J transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   NTERA-2
AC   CVCL_0034
SY   NTera-2; Ntera-2; NTera 2; NTERA2; NTera2; N-Tera-2; NT-2; NT2
DR   BTO; BTO_0000891
DR   CLO; CLO_0008208
DR   EFO; EFO_0002959
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472969
DR   CCRID; 1101HUM-PUMC000019
DR   ChEMBL-Cells; CHEMBL3308505
DR   ChEMBL-Targets; CHEMBL614205
DR   Cosmic; 821809
DR   Cosmic; 2439936
DR   Cosmic; 2560242
DR   Cosmic; 2806394
DR   Cosmic; 2807075
DR   DSMZ; ACC-527
DR   DSMZCellDive; ACC-527
DR   EGA; EGAS00001000610
DR   GEO; GSM7701436
DR   GEO; GSM7701437
DR   IBRC; C10509
DR   PharmacoDB; NTERA2_1167_2019
DR   PRIDE; PXD030251
DR   PubChem_Cell_line; CVCL_0034
DR   RSCB; RSCB0150
DR   Wikidata; Q17092091
RX   PubMed=3293662;
RX   PubMed=6694356;
RX   PubMed=16919167;
RX   PubMed=16957166;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=35084545;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/NTERA-2
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/nt2-ntera-2-xenograft-model/
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-527).
CC   HLA typing: A*01; B*08; C*07; DQB1*02; DRB1*03; DRB3*01 (PubMed=16919167).
CC   HLA typing: A*01:01,01:01; B*08:01,37:04; C*07:01,07:01; DRB1*03:01,14:76 (PubMed=26589293).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): DSMZ=ACC-527; PubMed=16919167; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,12,13
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 22,25
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2777 ! Tera-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   NTERA-2-R
AC   CVCL_C0QJ
DR   PRIDE; PXD030251
DR   Wikidata; Q112930238
RX   PubMed=35084545;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0034 ! NTERA-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   NTES-2
AC   CVCL_E142
SY   NTES2
DR   Wikidata; Q54931113
RX   PubMed=18253492;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   NTG-P
AC   CVCL_D5JD
DR   Wikidata; Q127382974
RX   DOI=10.1007/BF00327672;
RX   DOI=10.1007/BF02822702;
RX   DOI=10.1016/S0074-7696(08)62455-9;
RX   PubMed=16666458;
RX   PubMed=16667897;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (PubMed=16666458).
CC   Characteristics: Capable of growth in vitamin-free medium (PubMed=16667897).
CC   Characteristics: Can be used to prepare protoplasts (DOI=10.1007/BF00327672).
CC   Doubling time: ~14 days (PubMed=16666458).
CC   Derived from site: In situ; Vascular leaf; PO=PO_0009025.
OX   NCBI_TaxID=200322; ! Nicotiana glutinosa x Nicotiana tabacum (Hybrid tobacco)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   NtG20.i7
AC   CVCL_JA65
DR   cancercelllines; CVCL_JA65
DR   Wikidata; Q54931114
RX   PubMed=28338936;
CC   Population: Caucasian.
CC   Virology: Supports hepatitis B virus (HBV) replication for up to 35 days with production of infectious HBV in the culture supernatant.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10905; SLC10A1.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 18
//
ID   Nthy-ori 3-1
AC   CVCL_2659
SY   Nthy ori 3.1; Nthy-ori 3.1; NTHY-ORI3.1; HTori-3.1
DR   BTO; BTO_0004859
DR   CLO; CLO_0008209
DR   EFO; EFO_0022713
DR   CLDB; cl3741
DR   cancercelllines; CVCL_2659
DR   ECACC; 90011609
DR   GEO; GSM827409
DR   Progenetix; CVCL_2659
DR   Ubigene; YC-C089
DR   Wikidata; Q54931115
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=22087789;
RX   PubMed=30737244;
RX   PubMed=36599897;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
ST   Source(s): ECACC=90011609; PubMed=21868764; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 7,12
ST   D8S1179: 12
ST   FGA: 21,22
ST   TH01: 7 (ECACC=90011609; PubMed=21868764)
ST   TH01: 7,9.3 (PubMed=30737244)
ST   TPOX: 9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4W02 ! HTori-3
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   N-thy-ts.1
AC   CVCL_2660
SY   Nthy-ts1; ts.1
DR   CLO; CLO_0008210
DR   CLDB; cl3742
DR   ECACC; 90011610
DR   Wikidata; Q54931116
RX   PubMed=1697930;
CC   Characteristics: Grows at the permissive temperature (33 Celsius), but not at the restrictive temperature (40.5 Celsius).
CC   Doubling time: ~2 days (Note=In 10% FCS) (PubMed=1697930).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Follicular cell; CL=CL_0002258.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   NTI-4
AC   CVCL_3080
DR   BioSample; SAMN03471658
DR   JCRB; JCRB0220
DR   Wikidata; Q54931117
CC   Population: Japanese.
CC   Doubling time: ~20 hours (Note=Lot 01112008) (JCRB=JCRB0220).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB0220
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3081 ! NTI-5
SX   Female
AG   9FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   NTI-5
AC   CVCL_3081
DR   JCRB; JCRB0222
DR   Wikidata; Q54931118
CC   Population: Japanese.
CC   Senescence: Senesces at 13 PDL (JCRB=JCRB0222).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB0222
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3080 ! NTI-4
SX   Female
AG   9FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   NTM-5
AC   CVCL_5G34
SY   NTM5; Normal Trabecular Meshwork-5; NTM; HTM-5; Human Trabecular Meshwork-5
DR   Wikidata; Q54931119
RX   PubMed=8156826;
RX   PubMed=16303956;
RX   PubMed=33603369;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
ST   Source(s): PubMed=33603369
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13,16
ST   D12S391: 24
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 14,16
ST   D1S1656: 15,16
ST   D21S11: 28,29
ST   D22S1045: 15
ST   D2S1338: 17
ST   D2S441: 10,11
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13
ST   DYS391: 11
ST   FGA: 22,27
ST   Penta D: 8,11
ST   Penta E: 7,16
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G32 ! HTM-4
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   NTP-01
AC   CVCL_WB02
SY   NeuTroPenia-01
DR   IBRC; C10965
DR   Wikidata; Q98128102
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80520; Neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   NTP-02
AC   CVCL_WB03
SY   NeuTroPenia-02
DR   IBRC; C11120
DR   Wikidata; Q98128103
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80520; Neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   NTS-1
AC   CVCL_WT16
SY   NTS1
DR   GEO; GSM2322615
DR   Wikidata; Q98128104
RX   PubMed=27697772;
CC   HLA typing: A*02,29; B*08,51; C*02,07 (Direct_author_submission).
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   NTS-2
AC   CVCL_WT17
SY   NTS2
DR   GEO; GSM2322616
DR   Wikidata; Q98128105
RX   PubMed=27697772;
CC   HLA typing: A*23,25; B*18,49; C*07,12 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   NTS-3
AC   CVCL_WT18
SY   NTS3
DR   GEO; GSM2322617
DR   Wikidata; Q98128106
RX   PubMed=27697772;
CC   HLA typing: A*01,02; B*08,15; C*07 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   NTU
AC   CVCL_ZS76
DR   Wikidata; Q98128107
RX   PubMed=2778352;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   NTU-1-FFXF
AC   CVCL_WU80
DR   BCRC; SC81099
DR   Wikidata; Q98128108
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C108 ! NTUe001-A
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   NTU-G
AC   CVCL_M031
DR   Wikidata; Q54931120
RX   PubMed=8473267;
CC   Population: Chinese.
CC   Doubling time: 88 hours (Note=In F12 medium), 132 hours (Note=In MCDB 151 medium) (PubMed=8473267).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
DI   NCIt; C94524; Pituicytoma
DI   ORDO; Orphanet_251623; Pituicytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   NTU-h3
AC   CVCL_UH56
DR   Wikidata; Q98128109
RX   PubMed=9747328;
CC   Population: Chinese; Taiwan.
CC   Virology: Contains both episomal and chromosomal integrated forms of hepatitis B virus (HBV).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   NTU-LY-1
AC   CVCL_Z964
DR   Wikidata; Q54931122
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   PubMed=16989856;
CC   Group: Insect cell line.
CC   Doubling time: 177 hours (PubMed=16989856).
OX   NCBI_TaxID=78901; ! Lymantria xylina (Casuarma moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   NTU-LY-2
AC   CVCL_Z965
DR   Wikidata; Q54931123
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   PubMed=16989856;
CC   Group: Insect cell line.
CC   Doubling time: 74 hours (PubMed=16989856).
OX   NCBI_TaxID=78901; ! Lymantria xylina (Casuarma moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   NTU-LY-3
AC   CVCL_Z966
DR   Wikidata; Q54931124
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   PubMed=16989856;
CC   Group: Insect cell line.
CC   Doubling time: 105 hours (PubMed=16989856).
OX   NCBI_TaxID=78901; ! Lymantria xylina (Casuarma moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   NTU-LY-4
AC   CVCL_Z967
DR   Wikidata; Q54931125
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   PubMed=16989856;
CC   Group: Insect cell line.
CC   Doubling time: 66 hours (PubMed=16989856).
OX   NCBI_TaxID=78901; ! Lymantria xylina (Casuarma moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   NTU-MV
AC   CVCL_Z991
DR   Wikidata; Q54931126
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   PubMed=17521666;
CC   Group: Insect cell line.
CC   Doubling time: 46.53 hours (Note=In 0% FBS), 33.29 hours (Note=In 4% FBS), 27.76 hours (Note=In 8% FBS), 27.24 hours (Note=In 16% FBS), 37.47 hours (Note=In Sf-900 medium) (PubMed=17521666).
OX   NCBI_TaxID=497515; ! Maruca vitrata (Bean pod borer moth)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   NTU-Pn-HF
AC   CVCL_Z329
SY   NTU-PN-HF
DR   Wikidata; Q54931127
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   DOI=10.1303/aez.2002.171;
CC   Group: Insect cell line.
CC   Virology: Persistently infected by Perina nuda picorna-like virus (PnPV).
CC   Doubling time: 52 hours (Note=In TNM-FH + 8% FCS) (DOI=10.1303/aez.2002.171).
OX   NCBI_TaxID=497517; ! Perina nuda (Clearwing tussock moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NTU-Pn-HH
AC   CVCL_Z328
SY   NTU-PN-HH; PN-HH
DR   Wikidata; Q54931128
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   PubMed=8812599;
CC   Group: Insect cell line.
CC   Doubling time: 86 hours (Note=In TNM-FH + 10% FBS), 54 hours (Note=In TNM-FH + 20% FBS) (PubMed=8812599).
OX   NCBI_TaxID=497517; ! Perina nuda (Clearwing tussock moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   NTU-SE
AC   CVCL_Z963
DR   ICLDB; ntu-se
DR   Wikidata; Q54931129
RX   PubMed=22867846;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV) and Autographa californica multiple nucleopolyhedrovirus (AcMNPV).
CC   Doubling time: 35.5 hours (PubMed=22867846).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   NTU-YB
AC   CVCL_Z956
SY   YB
DR   Wikidata; Q54931130
RX   PubMed=19761771;
CC   Group: Insect cell line.
CC   Doubling time: 38.85 hours (Note=In 0% TNM-FH), 31.27 hours (Note=In 5% TNM-FH), 26.87 hours (Note=In 8% TNM-FH), 31.3 hours (Note=In 16% TNM-FH) (PubMed=19761771).
OX   NCBI_TaxID=76203; ! Eurema hecabe (Common grass yellow butterfly)
SX   Sex unspecified
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   NTUB1
AC   CVCL_RW29
DR   ChEMBL-Cells; CHEMBL4651373
DR   PubChem_Cell_line; CVCL_RW29
DR   Wikidata; Q54931131
RX   PubMed=1358347;
RX   PubMed=11062746;
RX   PubMed=12137851;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~21 hours (Note=At 32th passage) (PubMed=1358347).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   NTUB1/As
AC   CVCL_RW30
DR   Wikidata; Q54931132
RX   PubMed=12137851;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_30621; Diarsenic trioxide (ATO; As2O3).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW29 ! NTUB1
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   NTUB1/P[14]
AC   CVCL_RW31
SY   NTUB1/P
DR   Wikidata; Q54931134
RX   PubMed=11062746;
RX   PubMed=12137851;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW29 ! NTUB1
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   NTUB1/P[3]
AC   CVCL_UN52
DR   Wikidata; Q98128110
RX   PubMed=11062746;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW29 ! NTUB1
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   NTUB1/P[9]
AC   CVCL_UN53
DR   Wikidata; Q98128112
RX   PubMed=11062746;
CC   Population: Chinese; Taiwan.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW29 ! NTUB1
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   NTUe001-A
AC   CVCL_C108
SY   NTU1; National Taiwan University 1
DR   BCRC; SC81006
DR   GEO; GSM674604
DR   hPSCreg; NTUe001-A
DR   SKIP; SKIP002114
DR   Wikidata; Q54931135
RX   PubMed=17071820;
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   NTUe002-A
AC   CVCL_C109
SY   NTU2; National Taiwan University 2
DR   BCRC; SC81007
DR   hPSCreg; NTUe002-A
DR   SKIP; SKIP002115
DR   Wikidata; Q54931136
RX   PubMed=17071820;
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   NTUe003-A
AC   CVCL_C110
SY   NTU3; National Taiwan University 3
DR   BCRC; SC81008
DR   hPSCreg; NTUe003-A
DR   SKIP; SKIP002116
DR   Wikidata; Q54931137
RX   PubMed=17071820;
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   NTUH-iPSC-001-05
AC   CVCL_GT41
SY   NTUH-iPSC-01-05
DR   BCRC; SC81034
DR   BCRC; SC81114
DR   SKIP; SKIP005622
DR   SKIP; SKIP005718
DR   Wikidata; Q54931138
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   NTUH-iPSC-001-05-FFXF
AC   CVCL_WU79
SY   NTUH-iPS-01-05-FFXF
DR   BCRC; SC81100
DR   SKIP; SKIP005704
DR   Wikidata; Q98128113
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GT41 ! NTUH-iPSC-001-05
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   NTUH-iPSC-002-02
AC   CVCL_GT30
SY   NTUH-iPSC-02-02
DR   BCRC; SC81035
DR   BCRC; SC81117
DR   SKIP; SKIP005623
DR   SKIP; SKIP005721
DR   Wikidata; Q54931139
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 10
//
ID   NTUH-iPSC-003-40
AC   CVCL_VL32
DR   BCRC; SC81091
DR   SKIP; SKIP005687
DR   Wikidata; Q98128114
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   NTUH-iPSC-004-06
AC   CVCL_QY08
SY   NTUHi001-A
DR   BCRC; SC81064
DR   hPSCreg; NTUHi001-A
DR   SKIP; SKIP005545
DR   SKIP; SKIP005660
DR   Wikidata; Q54931140
RX   PubMed=31004936;
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 9
//
ID   NTUH-iPSC-005-02
AC   CVCL_RP91
DR   BCRC; SC81080
DR   SKIP; SKIP005676
DR   Wikidata; Q54931141
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   NTUH-iPSC-007-03
AC   CVCL_QY09
DR   BCRC; SC81065
DR   SKIP; SKIP005661
DR   Wikidata; Q54931142
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   NTUH-iPSC-008-1
AC   CVCL_E6X0
SY   NTUHi006-A
DR   BioSamples; SAMEA116288325
DR   hPSCreg; NTUHi006-A
RX   PubMed=39742630;
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26862; Polycystic ovary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NTUH-iPSC-008-11
AC   CVCL_RP90
DR   BCRC; SC81066
DR   SKIP; SKIP005662
DR   Wikidata; Q54931143
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   NTUH-iPSC-009-07
AC   CVCL_VL33
DR   BCRC; SC81092
DR   SKIP; SKIP005697
DR   Wikidata; Q98128115
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84554; Familial amyloid neuropathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   NTUH-iPSC-010-06
AC   CVCL_QY10
DR   BCRC; SC81067
DR   SKIP; SKIP005663
DR   Wikidata; Q54931144
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   NTUH-iPSC-011-05
AC   CVCL_RP92
DR   BCRC; SC81081
DR   SKIP; SKIP005677
DR   Wikidata; Q54931145
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   NTUH-iPSC-012-04
AC   CVCL_WU78
DR   BCRC; SC81101
DR   SKIP; SKIP005705
DR   Wikidata; Q98128116
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   NTUH-iPSC-013-01
AC   CVCL_XD55
DR   BCRC; SC81115
DR   SKIP; SKIP005719
DR   Wikidata; Q98128117
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   NTUH-iPSC-014-01
AC   CVCL_XD56
DR   BCRC; SC81116
DR   SKIP; SKIP005720
DR   Wikidata; Q98128118
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   IBMS-iPSC-071-01
AC   CVCL_E6X1
SY   NTUHi005-A
DR   BioSamples; SAMEA115474080
DR   hPSCreg; NTUHi005-A
RX   PubMed=39079398;
CC   From: National Taiwan University Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   NU
AC   CVCL_WI75
DR   cancercelllines; CVCL_WI75
DR   Cosmic; 1123032
DR   Cosmic; 1123045
DR   IARC_TP53; 1105
DR   Wikidata; Q98128119
RX   PubMed=1570156;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Glu (c.672G>A); ClinVar=VCV000080709; Zygosity=Unspecified; Note=Splice site mutation (PubMed=1570156).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   NU 2-26
AC   CVCL_Y104
DR   Wikidata; Q54931146
RX   PubMed=1541975;
RX   PubMed=6305379;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=6305379).
CC   Derived from site: Metastatic; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   NU-AmB-1
AC   CVCL_C249
SY   NU-AMB-1; Northwestern University-American Burkitt-1
DR   Wikidata; Q54931147
RX   PubMed=2581902;
CC   Population: Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 11
//
ID   NU-DHL-1
AC   CVCL_1876
SY   Nu-DHL-1; NUDHL1; NuDHL 1
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473488
DR   BioSample; SAMN10988456
DR   cancercelllines; CVCL_1876
DR   Cell_Model_Passport; SIDM01780
DR   ChEMBL-Cells; CHEMBL4523521
DR   ChEMBL-Targets; CHEMBL4523552
DR   Cosmic; 850208
DR   Cosmic; 1629931
DR   Cosmic; 2361378
DR   DepMap; ACH-000388
DR   DSMZ; ACC-583
DR   DSMZCellDive; ACC-583
DR   GEO; GSM380139
DR   GEO; GSM380140
DR   GEO; GSM887459
DR   GEO; GSM888539
DR   GEO; GSM1035330
DR   GEO; GSM1374775
DR   IARC_TP53; 28228
DR   LiGeA; CCLE_037
DR   PharmacoDB; NUDHL1_1170_2019
DR   Progenetix; CVCL_1876
DR   PubChem_Cell_line; CVCL_1876
DR   Wikidata; Q54931148
RX   PubMed=2581902;
RX   PubMed=8547074;
RX   PubMed=9787181;
RX   PubMed=19278952;
RX   PubMed=22460905;
RX   PubMed=23699601;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~30-50 hours (DSMZ=ACC-583).
CC   HLA typing: A*01:01,24:02; B*08:01,15:07; C*03:03,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,24:02:01; B*08:01:01,15:07:01; C*03:03:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,02:01:02; DQA1*03:01:01,05:01:01; DQB1*02:01:01,02:01:01; DRA*01:01:01,01:02:02; DRB1*03:01:01,04:04:01 (DSMZCellDive=ACC-583).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (DepMap=ACH-000388).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (DepMap=ACH-000388).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.04%; Native American=0.04%; East Asian, North=3.55%; East Asian, South=0%; South Asian=0%; European, North=56.54%; European, South=37.82% (PubMed=30894373).
CC   Derived from site: In situ; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): DSMZ=ACC-583
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 10,13
ST   D16S539: 11
ST   D18S51: 17,19
ST   D19S433: 15,16
ST   D21S11: 29,33.2
ST   D2S1338: 20,24
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 20,22
ST   Penta D: 10,12
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   NU-DUL-1
AC   CVCL_1877
SY   NUDUL-1; NUDUL1
DR   BTO; BTO_0006480
DR   CLO; CLO_0037051
DR   EFO; EFO_0006700
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2969
DR   BioSample; SAMN03473485
DR   BioSample; SAMN10988580
DR   cancercelllines; CVCL_1877
DR   Cell_Model_Passport; SIDM00443
DR   ChEMBL-Cells; CHEMBL4523589
DR   ChEMBL-Targets; CHEMBL4523592
DR   Cosmic; 1629936
DR   Cosmic-CLP; 1330982
DR   DepMap; ACH-000287
DR   DSMZ; ACC-579
DR   DSMZCellDive; ACC-579
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1330982
DR   GEO; GSM887460
DR   GEO; GSM888540
DR   GEO; GSM1035320
DR   GEO; GSM1670286
DR   IARC_TP53; 28303
DR   LiGeA; CCLE_504
DR   LINCS_LDP; LCL-1132
DR   PharmacoDB; NUDUL1_1171_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1877
DR   PubChem_Cell_line; CVCL_1877
DR   Wikidata; Q54931149
RX   PubMed=2581902;
RX   PubMed=19278952;
RX   PubMed=22460905;
RX   PubMed=23699601;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~30-36 hours (DSMZ=ACC-579).
CC   HLA typing: A*24:02,02:01; B*49:01,49:01; C*07:01,07:01; DQA1*05:01,05:01; DQB1*03:01,03:01; DRB1*12:01,03:02 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*49:01,49:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Asp119Asn (c.355G>A); ClinVar=VCV000040460; Zygosity=Heterozygous (Cosmic-CLP=1330982; DepMap=ACH-000287).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Met (c.427G>A); ClinVar=VCV000142657; Zygosity=Heterozygous (Cosmic-CLP=1330982; DepMap=ACH-000287).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=1330982; DepMap=ACH-000287).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.39%; East Asian, South=0.48%; South Asian=1.36%; European, North=63.99%; European, South=32.78% (PubMed=30894373).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
ST   Source(s): ATCC=CRL-2969; Cosmic-CLP=1330982; DSMZ=ACC-579
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 28,32.2
ST   D2S1338: 24,25
ST   D3S1358: 14,16
ST   D5S818: 12,14
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 10,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   NU-RMESO-14
AC   CVCL_A6JL
DR   RCB; RCB4945
DR   Wikidata; Q107116583
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   NU-RMESO-2
AC   CVCL_A6JJ
DR   RCB; RCB4943
DR   Wikidata; Q107116584
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   NU-RMESO-20
AC   CVCL_A6JM
DR   RCB; RCB4946
DR   Wikidata; Q107116585
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   NU-RMESO-26
AC   CVCL_A6JN
DR   RCB; RCB4948
DR   Wikidata; Q107116587
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   NU-RMESO-40
AC   CVCL_A6JP
DR   RCB; RCB4947
DR   Wikidata; Q107116588
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   NU-RMESO-79
AC   CVCL_A6JQ
DR   RCB; RCB4949
DR   Wikidata; Q107116590
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   NU-RMESO-9
AC   CVCL_A6JK
DR   RCB; RCB4944
DR   Wikidata; Q107116591
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   NU-T1
AC   CVCL_A7NR
DR   Wikidata; Q107116593
RX   PubMed=8709556;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   NU-T2
AC   CVCL_A7NS
DR   Wikidata; Q107116595
RX   PubMed=8709556;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P29016; Human CD1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Nu6-1
AC   CVCL_7085
SY   NU6-1; Nu-6-1; Nu 6-1
DR   Cosmic; 877397
DR   Cosmic; 1152492
DR   Wikidata; Q54931150
RX   PubMed=3422461;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7114 ! RH-SLC-L11
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Nu61
AC   CVCL_7086
SY   NU61; nu61; nu61-8-4000
DR   Wikidata; Q54931151
RX   PubMed=14755057;
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=80
CC   Characteristics: Established after 8 serial cycles of passage of the parental cell line in athymic nude mice and in vivo irradiation.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7118 ! SCC-61
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   NUB-20
AC   CVCL_5G81
DR   Wikidata; Q54931152
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2158399;
CC   Doubling time: 24 hours (PubMed=2158399).
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 4
//
ID   NUB-6
AC   CVCL_9896
SY   NUB6
DR   Wikidata; Q54931153
RX   PubMed=3243386;
CC   Doubling time: 48 hours (PubMed=3243386).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1Y9M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   NUB-7
AC   CVCL_9897
SY   NUB7; Nub7
DR   Wikidata; Q54931154
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=3243386;
RX   PubMed=8043511;
CC   Characteristics: Intermediate type (I-type) (PubMed=8043511).
CC   Doubling time: 38 hours (PubMed=3243386).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   NUC
AC   CVCL_F0J3
RX   PubMed=2606940;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Trypanosoma brucei brucei nucleus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   NUC-1 [Human choriocarcinoma]
AC   CVCL_M685
DR   IARC_TP53; 4345
DR   Wikidata; Q54931155
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=2878840;
RX   PubMed=6579923;
RX   PubMed=6682628;
RX   PubMed=7819056;
RX   PubMed=11014955;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=6579923).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu17Asp (c.51A>T); Zygosity=Unspecified (PubMed=7819056).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys24Asn (c.72A>T); Zygosity=Unspecified (PubMed=7819056).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   NUC-1 [Mouse urothelial]
AC   CVCL_2146
DR   CLO; CLO_0008211
DR   CLDB; cl3743
DR   DSMZ; ACC-225
DR   DSMZCellDive; ACC-225
DR   Wikidata; Q54931156
RX   PubMed=7687588;
CC   Doubling time: ~24 hours (DSMZ=ACC-225).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C3H/Law.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   3-5D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   NUC-5
AC   CVCL_2147
DR   CLO; CLO_0008212
DR   CLDB; cl3744
DR   DSMZ; ACC-226
DR   DSMZCellDive; ACC-226
DR   Wikidata; Q54931157
RX   PubMed=7687588;
CC   Doubling time: ~60-75 hours (DSMZ=ACC-226).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C3H/Law.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   3-5D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   NUC12N2
AC   CVCL_A8GI
DR   Wikidata; Q107116596
RX   PubMed=16964285;
RX   PubMed=20500518;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16412; NLRC4 (Note=With p.Leu152_Ala1024del, CARD domain, C12N2 construct).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct).
CC   Derived from site: Metastatic; Paragastric lymph node; UBERON=UBERON_8480059.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3082 ! NUGC-4
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   NUCOLL43
AC   CVCL_VN96
DR   CancerTools; 153716
DR   Wikidata; Q98128120
DR   Ximbio; 153716
RX   PubMed=30109783;
CC   Characteristics: Does not express TP53. Very high degree of loss of heterozygosity that affects 85% of the genome.
CC   Doubling time: 45 hours (Note=At 13th passage), 42 hours (Note=At 35th passage) (PubMed=30109783).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=30109783
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 11,13
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   NUE-1
AC   CVCL_YJ45
DR   Wikidata; Q98128122
RX   PubMed=3819523;
RX   PubMed=8847459;
CC   Population: Japanese.
CC   Doubling time: 40 hours (PubMed=3819523).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   NuE15-1
AC   CVCL_JF80
DR   Wikidata; Q54931158
RX   PubMed=6162701;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24FW
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   NUGC-2
AC   CVCL_1611
AS   CVCL_8370
SY   NuGC-2; NUGC2; NU-GC-2; Nagoya University-Gastric Cancer-2
DR   BTO; BTO_0002596
DR   CLO; CLO_0037143
DR   EFO; EFO_0006701
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472517
DR   BioSample; SAMN03473090
DR   BioSample; SAMN10988111
DR   cancercelllines; CVCL_1611
DR   Cell_Model_Passport; SIDM01779
DR   CGH-DB; 133-1
DR   Cosmic; 1187287
DR   DepMap; ACH-000761
DR   EGA; EGAS00001000610
DR   GEO; GSM887461
DR   GEO; GSM888541
DR   IARC_TP53; 28221
DR   JCRB; JCRB0821
DR   LiGeA; CCLE_199
DR   LINCS_LDP; LCL-1899
DR   PharmacoDB; NUGC2_1172_2019
DR   Progenetix; CVCL_1611
DR   Wikidata; Q54931159
RX   PubMed=1778766;
RX   PubMed=3172586;
RX   PubMed=3986962;
RX   PubMed=9290701;
RX   PubMed=15723654;
RX   PubMed=19132987;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 36.1 hours (PubMed=3172586).
CC   HLA typing: A*02:07,24:02; B*46:01,55:02; C*01:02,08:01; DQA1*03:02,03:02; DQB1*06:02,06:02; DRB1*08:02,09:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Thr58Ile (c.173C>T); ClinVar=VCV000012588; Zygosity=Heterozygous (DepMap=ACH-000761).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (DepMap=ACH-000761).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=74.56%; East Asian, South=24.67%; South Asian=0.16%; European, North=0%; European, South=0.61% (PubMed=30894373).
CC   Misspelling: MUGC-2; Cosmic=1187287; PubMed=19132987.
CC   Derived from site: Metastatic; Paragastric lymph node; UBERON=UBERON_8480059.
ST   Source(s): JCRB=JCRB0821; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 7 (PubMed=25877200)
ST   D16S539: 7,12 (JCRB=JCRB0821)
ST   D18S51: 21
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   NUGC-3
AC   CVCL_1612
AS   CVCL_8371
SY   NUGC3; NU-GC-3; Nagoya University-Gastric Cancer-3
DR   BTO; BTO_0002597
DR   CLO; CLO_0037144
DR   EFO; EFO_0006702
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 397
DR   BioSample; SAMN03473123
DR   BioSample; SAMN10988359
DR   cancercelllines; CVCL_1612
DR   Cell_Model_Passport; SIDM00572
DR   CGH-DB; 134-1
DR   ChEMBL-Cells; CHEMBL3307562
DR   ChEMBL-Targets; CHEMBL614208
DR   Cosmic; 801341
DR   Cosmic; 877046
DR   Cosmic; 908455
DR   Cosmic; 918499
DR   Cosmic; 968351
DR   Cosmic; 1187288
DR   Cosmic; 1518256
DR   Cosmic; 1995599
DR   Cosmic; 2484968
DR   Cosmic; 2807638
DR   Cosmic-CLP; 908455
DR   DepMap; ACH-000911
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908455
DR   GEO; GSM552367
DR   GEO; GSM827405
DR   GEO; GSM828828
DR   GEO; GSM844666
DR   GEO; GSM887462
DR   GEO; GSM888542
DR   GEO; GSM1374776
DR   GEO; GSM1670287
DR   IARC_TP53; 973
DR   JCRB; JCRB0822
DR   LiGeA; CCLE_449
DR   LINCS_LDP; LCL-1887
DR   PharmacoDB; NUGC3_1173_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1612
DR   PubChem_Cell_line; CVCL_1612
DR   Wikidata; Q54931160
RX   PubMed=1370612;
RX   PubMed=1778766;
RX   PubMed=3172586;
RX   PubMed=3325673;
RX   PubMed=9290701;
RX   PubMed=15723654;
RX   PubMed=15767549;
RX   PubMed=19132987;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 38.2 hours (PubMed=3172586); 29 hours (PubMed=29435981); ~26 hours (Note=Lot 06062005), 28-45 hours (Note=Lot 04272009), ~32 hours (Note=Lot 11042011), ~28 hours (Note=Lot 02262016), ~1 day (Note=Lot 11162017) (JCRB=JCRB0822).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02; DQA1*05:02,05:02; DQB1*06:01,06:01; DRB1*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=1370612).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.09%; East Asian, North=82.25%; East Asian, South=16.95%; South Asian=0%; European, North=0%; European, South=0.71% (PubMed=30894373).
CC   Misspelling: MUGC-3; Cosmic=1187288; PubMed=19132987.
CC   Misspelling: NVGC3; Cosmic=801341.
CC   Derived from site: Metastatic; Brachialis muscle; UBERON=UBERON_0001506.
ST   Source(s): Cosmic-CLP=908455; JCRB=JCRB0822; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 18,19
ST   D21S11: 30,31
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12,13,16,17
ST   FGA: 17
ST   Penta D: 11
ST   Penta E: 11,18
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   NUGC-3-Luc
AC   CVCL_4Y07
DR   cancercelllines; CVCL_4Y07
DR   JCRB; NIHS0731
DR   Wikidata; Q54931161
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0731; true.
CC   Derived from site: Metastatic; Brachialis muscle; UBERON=UBERON_0001506.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1612 ! NUGC-3
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   NUGC-3/5-FU/L
AC   CVCL_L502
SY   NUGC-3/5FU/L; NUGC-3/5-FU; NUGC-3/5FU
DR   cancercelllines; CVCL_L502
DR   Wikidata; Q54931162
RX   PubMed=8609072;
RX   PubMed=10359051;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Brachialis muscle; UBERON=UBERON_0001506.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1612 ! NUGC-3
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   NUGC-4
AC   CVCL_3082
AS   CVCL_8372
SY   NUGC4; NU-GC-4; Nagoya University-Gastric Cancer-4
DR   BTO; BTO_0005917
DR   CLO; CLO_0050789
DR   EFO; EFO_0006703
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821711
DR   BioSample; SAMN03473124
DR   BioSample; SAMN10987867
DR   cancercelllines; CVCL_3082
DR   Cell_Model_Passport; SIDM00570
DR   CGH-DB; 135-1
DR   ChEMBL-Cells; CHEMBL3307267
DR   ChEMBL-Targets; CHEMBL613519
DR   Cosmic; 1187289
DR   Cosmic; 1329186
DR   Cosmic; 1460702
DR   Cosmic; 1518257
DR   Cosmic; 1890473
DR   Cosmic; 2009530
DR   Cosmic; 2484971
DR   Cosmic; 2807639
DR   Cosmic-CLP; 1298357
DR   DepMap; ACH-000674
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10483-107A6
DR   GDSC; 1298357
DR   GEO; GSM552368
DR   GEO; GSM827575
DR   GEO; GSM844667
DR   GEO; GSM887463
DR   GEO; GSM888543
DR   GEO; GSM1374777
DR   GEO; GSM1670288
DR   IARC_TP53; 25015
DR   JCRB; JCRB0834
DR   LiGeA; CCLE_273
DR   LINCS_LDP; LCL-2001
DR   PharmacoDB; NUGC4_1174_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3082
DR   PubChem_Cell_line; CVCL_3082
DR   RCB; RCB1939
DR   TKG; TKG 0449
DR   Wikidata; Q54931165
RX   PubMed=1370612;
RX   PubMed=1778766;
RX   PubMed=2474525;
RX   PubMed=3172586;
RX   PubMed=9290701;
RX   PubMed=11314020;
RX   PubMed=15723654;
RX   PubMed=15900046;
RX   PubMed=19132987;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24587255;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 29.9 hours (PubMed=3172586); 27 hours (PubMed=29435981).
CC   HLA typing: A*02:01,24:02; B*46:01,51:02; C*01:02,15:02; DRB1*11:67,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1370612; PubMed=15900046).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.72%; East Asian, North=65.95%; East Asian, South=32.05%; South Asian=0%; European, North=0%; European, South=1.27% (PubMed=30894373).
CC   Misspelling: MUGC-4; Cosmic=1187289; PubMed=19132987.
CC   Derived from site: Metastatic; Paragastric lymph node; UBERON=UBERON_8480059.
ST   Source(s): Cosmic-CLP=1298357; JCRB=JCRB0834; PubMed=25877200; RCB=RCB1939
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9
ST   D18S51: 16,19
ST   D21S11: 30.3,31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 23,26
ST   Penta D: 9,12
ST   Penta E: 13,15
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   NUH2
AC   CVCL_N272
SY   NUH-2
DR   Wikidata; Q54931166
RX   Patent=US5227160;
RX   PubMed=2509467;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9762.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Disialogangliosides with binary 2-3 sialosyllactosamine structure.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 8
//
ID   NUIGi001-A
AC   CVCL_QX90
SY   ARO-iPSC1-11; iPSC ARO1-11
DR   BioSamples; SAMEA104243152
DR   hPSCreg; NUIGi001-A
DR   Wikidata; Q54931167
RX   PubMed=29034896;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:14974; SNX10; Simple; c.212+1G>T; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29034896).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29034896
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 22,26
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 15,17
ST   D19S433: 13,14
ST   D1S1656: 14
ST   D21S11: 29
ST   D2S1338: 16,18
ST   D3S1358: 15,17
ST   D5S818: 10
ST   D6S1043: 11,12
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 9,12
ST   Penta E: 7,21
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C150556; Autosomal recessive osteopetrosis 8
DI   ORDO; Orphanet_667; Autosomal recessive malignant osteopetrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   NUIGi002-A
AC   CVCL_WS86
SY   LQT001C1
DR   BioSamples; SAMEA5746314
DR   hPSCreg; NUIGi002-A
DR   Wikidata; Q98128123
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VD ! NUIGi002-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   NUIGi002-B
AC   CVCL_C1VD
SY   LQT001Cx
DR   hPSCreg; NUIGi002-B
DR   Wikidata; Q114312617
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS86 ! NUIGi002-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   NUIGi003-A
AC   CVCL_WU63
SY   LQT002C1
DR   BioSamples; SAMEA5945665
DR   hPSCreg; NUIGi003-A
DR   Wikidata; Q98128125
RX   PubMed=33002718;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Val822Met (c.2464G>A); ClinVar=VCV000014424; Zygosity=Heterozygous (PubMed=33002718).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT11 ! NUIGi003-B
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi003-B
AC   CVCL_YT11
SY   LQT002C2
DR   BioSamples; SAMEA9697034
DR   hPSCreg; NUIGi003-B
DR   Wikidata; Q98128126
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Val822Met (c.2464G>A); ClinVar=VCV000014424; Zygosity=Heterozygous (from autologous cell line NUIGi003-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU63 ! NUIGi003-A
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NUIGi004-A
AC   CVCL_WU50
SY   LQT003C1
DR   BioSamples; SAMEA9334969
DR   hPSCreg; NUIGi004-A
DR   Wikidata; Q98128127
RX   PubMed=34628246;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Val822Met (c.2464G>A); ClinVar=VCV000014424; Zygosity=Heterozygous (PubMed=34628246).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi005-A
AC   CVCL_WS87
SY   LQTS004C7; LQT004C7
DR   BioSamples; SAMEA5728499
DR   hPSCreg; NUIGi005-A
DR   Wikidata; Q98128128
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS88 ! NUIGi005-B
OI   CVCL_WS89 ! NUIGi005-C
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi005-B
AC   CVCL_WS88
SY   LQT004C9; LQTS004C9
DR   BioSamples; SAMEA5912490
DR   hPSCreg; NUIGi005-B
DR   Wikidata; Q98128130
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS87 ! NUIGi005-A
OI   CVCL_WS89 ! NUIGi005-C
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi005-C
AC   CVCL_WS89
SY   LQTS004Cx; LQT004Cx
DR   BioSamples; SAMEA5912492
DR   hPSCreg; NUIGi005-C
DR   Wikidata; Q98128131
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS87 ! NUIGi005-A
OI   CVCL_WS88 ! NUIGi005-B
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi006-A
AC   CVCL_WS90
SY   LQTS005C2; LQT005C2
DR   BioSamples; SAMEA5763654
DR   hPSCreg; NUIGi006-A
DR   Wikidata; Q98128132
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS91 ! NUIGi006-B
OI   CVCL_WS92 ! NUIGi006-C
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi006-B
AC   CVCL_WS91
SY   LQTS005C4; LQT005C4
DR   BioSamples; SAMEA5912493
DR   hPSCreg; NUIGi006-B
DR   Wikidata; Q98128133
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS90 ! NUIGi006-A
OI   CVCL_WS92 ! NUIGi006-C
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi006-C
AC   CVCL_WS92
SY   LQT005Cx; LQTS005Cx
DR   BioSamples; SAMEA5912494
DR   hPSCreg; NUIGi006-C
DR   Wikidata; Q98128135
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS90 ! NUIGi006-A
OI   CVCL_WS91 ! NUIGi006-B
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi007-A
AC   CVCL_WS93
SY   LQTS006C6; LQT006C6
DR   BioSamples; SAMEA5912495
DR   hPSCreg; NUIGi007-A
DR   Wikidata; Q98128136
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS94 ! NUIGi007-B
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi007-B
AC   CVCL_WS94
SY   LQTS006C8; LQT006C8
DR   BioSamples; SAMEA5912496
DR   hPSCreg; NUIGi007-B
DR   Wikidata; Q98128137
RX   PubMed=31415974;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser566Tyr (c.1697C>A) (p.Ser439Tyr, c.1316C>A); ClinVar=VCV000053005; Zygosity=Heterozygous (PubMed=31415974).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS93 ! NUIGi007-A
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi008-A
AC   CVCL_WS95
SY   LQTS007C1
DR   BioSamples; SAMEA5763662
DR   hPSCreg; NUIGi008-A
DR   Wikidata; Q98128138
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS96 ! NUIGi008-B
OI   CVCL_WS97 ! NUIGi008-C
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi008-B
AC   CVCL_WS96
SY   LQTS007C2
DR   BioSamples; SAMEA5912498
DR   hPSCreg; NUIGi008-B
DR   Wikidata; Q98128139
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS95 ! NUIGi008-A
OI   CVCL_WS97 ! NUIGi008-C
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi008-C
AC   CVCL_WS97
SY   LQTS007Cx
DR   BioSamples; SAMEA5912499
DR   hPSCreg; NUIGi008-C
DR   Wikidata; Q98128140
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS95 ! NUIGi008-A
OI   CVCL_WS96 ! NUIGi008-B
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi009-A
AC   CVCL_WS99
SY   LQTS008C1
DR   BioSamples; SAMEA5763663
DR   hPSCreg; NUIGi009-A
DR   Wikidata; Q98128141
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT00 ! NUIGi009-B
OI   CVCL_WT01 ! NUIGi009-C
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi009-B
AC   CVCL_WT00
SY   LQTS008C6
DR   BioSamples; SAMEA5912501
DR   hPSCreg; NUIGi009-B
DR   Wikidata; Q98128142
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS99 ! NUIGi009-A
OI   CVCL_WT01 ! NUIGi009-C
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi009-C
AC   CVCL_WT01
SY   LQTS008Cx
DR   BioSamples; SAMEA5912502
DR   hPSCreg; NUIGi009-C
DR   Wikidata; Q98128143
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS99 ! NUIGi009-A
OI   CVCL_WT00 ! NUIGi009-B
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi010-A
AC   CVCL_WT02
SY   LQTS009C2
DR   BioSamples; SAMEA5763664
DR   hPSCreg; NUIGi010-A
DR   Wikidata; Q98128144
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT03 ! NUIGi010-B
OI   CVCL_WT04 ! NUIGi010-C
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi010-B
AC   CVCL_WT03
SY   LQTS009C3
DR   BioSamples; SAMEA5912504
DR   hPSCreg; NUIGi010-B
DR   Wikidata; Q98128145
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT02 ! NUIGi010-A
OI   CVCL_WT04 ! NUIGi010-C
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi010-C
AC   CVCL_WT04
SY   LQTS009Cx
DR   BioSamples; SAMEA5912505
DR   hPSCreg; NUIGi010-C
DR   Wikidata; Q98128147
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT02 ! NUIGi010-A
OI   CVCL_WT03 ! NUIGi010-B
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi011-A
AC   CVCL_WT05
SY   LQTS010C3
DR   BioSamples; SAMEA5763665
DR   hPSCreg; NUIGi011-A
DR   Wikidata; Q98128149
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT06 ! NUIGi011-B
OI   CVCL_WT07 ! NUIGi011-C
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi011-B
AC   CVCL_WT06
SY   LQTS010C4
DR   BioSamples; SAMEA5912507
DR   hPSCreg; NUIGi011-B
DR   Wikidata; Q98128150
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT05 ! NUIGi011-A
OI   CVCL_WT07 ! NUIGi011-C
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi011-C
AC   CVCL_WT07
SY   LQTS010Cx
DR   BioSamples; SAMEA5912508
DR   hPSCreg; NUIGi011-C
DR   Wikidata; Q98128151
RX   PubMed=31765965;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg401Profs*62 (c.1201dupC) (p.Arg274Profs, c.820dupC); ClinVar=VCV000052972; Zygosity=Heterozygous (PubMed=31765965).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT05 ! NUIGi011-A
OI   CVCL_WT06 ! NUIGi011-B
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi012-A
AC   CVCL_WU31
SY   LQT011C8
DR   BioSamples; SAMEA9653365
DR   hPSCreg; NUIGi012-A
DR   Wikidata; Q98128152
RX   PubMed=34628246;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Ala614Val (c.1841C>T); ClinVar=VCV000029777; Zygosity=Heterozygous (PubMed=34628246).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi013-A
AC   CVCL_WU32
SY   LQT012C1
DR   hPSCreg; NUIGi013-A
DR   Wikidata; Q98128153
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   NUIGi014-A
AC   CVCL_WU33
SY   LQT013Cx
DR   hPSCreg; NUIGi014-A
DR   Wikidata; Q98128155
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   NUIGi015-A
AC   CVCL_WU34
SY   LQT014C7
DR   BioSamples; SAMEA9695520
DR   hPSCreg; NUIGi015-A
DR   Wikidata; Q98128157
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val411Met (c.1231G>A); ClinVar=VCV000067651; Zygosity=Unspecified (hPSCreg=NUIGi015-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU35 ! NUIGi015-B
OI   CVCL_WU36 ! NUIGi015-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi015-B
AC   CVCL_WU35
SY   LQT014C9
DR   BioSamples; SAMEA9695521
DR   hPSCreg; NUIGi015-B
DR   Wikidata; Q98128158
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val411Met (c.1231G>A); ClinVar=VCV000067651; Zygosity=Unspecified (hPSCreg=NUIGi015-B).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU34 ! NUIGi015-A
OI   CVCL_WU36 ! NUIGi015-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi015-C
AC   CVCL_WU36
SY   LQT014C12
DR   BioSamples; SAMEA9695522
DR   hPSCreg; NUIGi015-C
DR   Wikidata; Q98128159
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val411Met (c.1231G>A); ClinVar=VCV000067651; Zygosity=Unspecified (hPSCreg=NUIGi015-C).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU34 ! NUIGi015-A
OI   CVCL_WU35 ! NUIGi015-B
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi016-A
AC   CVCL_WU37
SY   LQT015C7
DR   hPSCreg; NUIGi016-A
DR   Wikidata; Q98128160
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU38 ! NUIGi016-B
OI   CVCL_WU39 ! NUIGi016-C
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 5
//
ID   NUIGi016-B
AC   CVCL_WU38
SY   LQT015C11
DR   hPSCreg; NUIGi016-B
DR   Wikidata; Q98128161
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU37 ! NUIGi016-A
OI   CVCL_WU39 ! NUIGi016-C
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 5
//
ID   NUIGi016-C
AC   CVCL_WU39
SY   LQT015Cx
DR   hPSCreg; NUIGi016-C
DR   Wikidata; Q98128162
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU37 ! NUIGi016-A
OI   CVCL_WU38 ! NUIGi016-B
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 5
//
ID   NUIGi017-A
AC   CVCL_WU40
SY   LQT016C2
DR   BioSamples; SAMEA6098955
DR   hPSCreg; NUIGi017-A
DR   Wikidata; Q98128163
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC13 ! NUIGi017-B
OI   CVCL_YC14 ! NUIGi017-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 05-10-23; Version: 7
//
ID   NUIGi017-B
AC   CVCL_YC13
SY   LQT016C6
DR   BioSamples; SAMEA6098957
DR   hPSCreg; NUIGi017-B
DR   Wikidata; Q98128164
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU40 ! NUIGi017-A
OI   CVCL_YC14 ! NUIGi017-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   NUIGi017-C
AC   CVCL_YC14
SY   LQT016C9
DR   BioSamples; SAMEA6098958
DR   hPSCreg; NUIGi017-C
DR   Wikidata; Q98128165
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU40 ! NUIGi017-A
OI   CVCL_YC13 ! NUIGi017-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   NUIGi018-A
AC   CVCL_WU41
SY   LQT017C1
DR   BioSamples; SAMEA8325237
DR   hPSCreg; NUIGi018-A
DR   Wikidata; Q98128167
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU42 ! NUIGi018-B
OI   CVCL_WU43 ! NUIGi018-C
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi018-B
AC   CVCL_WU42
SY   LQT017C3
DR   BioSamples; SAMEA8231227
DR   hPSCreg; NUIGi018-B
DR   Wikidata; Q98128169
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU41 ! NUIGi018-A
OI   CVCL_WU43 ! NUIGi018-C
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi018-C
AC   CVCL_WU43
SY   LQT017Cx
DR   BioSamples; SAMEA8231228
DR   hPSCreg; NUIGi018-C
DR   Wikidata; Q98128170
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU41 ! NUIGi018-A
OI   CVCL_WU42 ! NUIGi018-B
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi019-A
AC   CVCL_WU44
SY   LQT018C1
DR   BioSamples; SAMEA5873406
DR   hPSCreg; NUIGi019-A
DR   Wikidata; Q98128171
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   NUIGi020-A
AC   CVCL_WU45
SY   LQT019C1
DR   BioSamples; SAMEA8325238
DR   hPSCreg; NUIGi020-A
DR   Wikidata; Q98128172
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU46 ! NUIGi020-B
OI   CVCL_WU47 ! NUIGi020-C
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi020-B
AC   CVCL_WU46
SY   LQT019C4
DR   BioSamples; SAMEA8249586
DR   hPSCreg; NUIGi020-B
DR   Wikidata; Q98128173
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU45 ! NUIGi020-A
OI   CVCL_WU47 ! NUIGi020-C
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi020-C
AC   CVCL_WU47
SY   LQT019Cx
DR   BioSamples; SAMEA8249587
DR   hPSCreg; NUIGi020-C
DR   Wikidata; Q98128174
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU45 ! NUIGi020-A
OI   CVCL_WU46 ! NUIGi020-B
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi021-A
AC   CVCL_WU48
SY   LQT020C1
DR   BioSamples; SAMEA6098959
DR   hPSCreg; NUIGi021-A
DR   Wikidata; Q98128175
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC15 ! NUIGi021-B
OI   CVCL_YC16 ! NUIGi021-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 05-10-23; Version: 6
//
ID   NUIGi021-B
AC   CVCL_YC15
SY   LQT020C6
DR   BioSamples; SAMEA6098961
DR   hPSCreg; NUIGi021-B
DR   Wikidata; Q98128176
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU48 ! NUIGi021-A
OI   CVCL_YC16 ! NUIGi021-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   NUIGi021-C
AC   CVCL_YC16
SY   LQT020C8
DR   BioSamples; SAMEA6098962
DR   hPSCreg; NUIGi021-C
DR   Wikidata; Q98128177
CC   From: National University of Ireland Galway; Galway; Ireland.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU48 ! NUIGi021-A
OI   CVCL_YC15 ! NUIGi021-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   NUIGi022-A
AC   CVCL_WT08
SY   ND11C2
DR   BioSamples; SAMEA5780091
DR   hPSCreg; NUIGi022-A
DR   Wikidata; Q98128178
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31759289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI98 ! NUIGi022-B
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi022-B
AC   CVCL_XI98
SY   ND11C7
DR   BioSamples; SAMEA6032107
DR   hPSCreg; NUIGi022-B
DR   Wikidata; Q98128180
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31759289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT08 ! NUIGi022-A
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   NUIGi023-A
AC   CVCL_WU49
SY   ND12C12
DR   BioSamples; SAMEA6032108
DR   hPSCreg; NUIGi023-A
DR   Wikidata; Q98128182
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31759289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI92 ! NUIGi023-B
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi023-B
AC   CVCL_XI92
SY   ND12C2
DR   BioSamples; SAMEA6032110
DR   hPSCreg; NUIGi023-B
DR   Wikidata; Q98128183
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31759289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU49 ! NUIGi023-A
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   NUIGi024-A
AC   CVCL_XI94
SY   CND13C1
DR   BioSamples; SAMEA6080819
DR   hPSCreg; NUIGi024-A
DR   Wikidata; Q98128184
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI95 ! NUIGi024-B
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NUIGi024-B
AC   CVCL_XI95
SY   CND13C7
DR   BioSamples; SAMEA6081493
DR   hPSCreg; NUIGi024-B
DR   Wikidata; Q98128185
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI94 ! NUIGi024-A
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NUIGi025-A
AC   CVCL_XI96
SY   ND14C8
DR   BioSamples; SAMEA6080809
DR   hPSCreg; NUIGi025-A
DR   Wikidata; Q98128187
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31759289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI97 ! NUIGi025-B
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   NUIGi025-B
AC   CVCL_XI97
SY   ND14C9
DR   BioSamples; SAMEA6080811
DR   hPSCreg; NUIGi025-B
DR   Wikidata; Q98128188
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31759289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI96 ! NUIGi025-A
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   NUIGi026-A
AC   CVCL_XI93
SY   CND15C1
DR   BioSamples; SAMEA6081494
DR   hPSCreg; NUIGi026-A
DR   Wikidata; Q98128189
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ46 ! NUIGi026-B
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NUIGi026-B
AC   CVCL_XJ46
SY   CND15C6
DR   BioSamples; SAMEA6081496
DR   hPSCreg; NUIGi026-B
DR   Wikidata; Q98128190
RX   PubMed=31759289;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI93 ! NUIGi026-A
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   NUIGi027-A
AC   CVCL_YC17
SY   RP001C8
DR   BioSamples; SAMEA6298546
DR   hPSCreg; NUIGi027-A
DR   Wikidata; Q98128191
RX   PubMed=31954326;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple; p.Asp477Gly (c.1430A>G); ClinVar=VCV000750796; Zygosity=Heterozygous (PubMed=31954326).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi028-A
AC   CVCL_YC18
SY   RP002C12
DR   BioSamples; SAMEA6348710
DR   hPSCreg; NUIGi028-A
DR   Wikidata; Q98128192
RX   PubMed=31954326;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple; p.Asp477Gly (c.1430A>G); ClinVar=VCV000750796; Zygosity=Heterozygous (PubMed=31954326).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi029-A
AC   CVCL_YC19
SY   RP003C12
DR   BioSamples; SAMEA6348712
DR   hPSCreg; NUIGi029-A
DR   Wikidata; Q98128194
RX   PubMed=31954326;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple; p.Asp477Gly (c.1430A>G); ClinVar=VCV000750796; Zygosity=Heterozygous (PubMed=31954326).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi030-A
AC   CVCL_XJ47
SY   003ASD
DR   hPSCreg; NUIGi030-A
DR   Wikidata; Q98128195
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   NUIGi031-A
AC   CVCL_XJ08
SY   0031ASD
DR   hPSCreg; NUIGi031-A
DR   Wikidata; Q98128197
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   NUIGi032-A
AC   CVCL_XJ09
SY   0032ASD
DR   hPSCreg; NUIGi032-A
DR   Wikidata; Q98128198
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   NUIGi033-A
AC   CVCL_XJ10
SY   ASD012-Q
DR   BioSamples; SAMEA6577219
DR   hPSCreg; NUIGi033-A
DR   Wikidata; Q98128199
RX   PubMed=32097875;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi034-A
AC   CVCL_XJ11
SY   ASDC012-AI
DR   BioSamples; SAMEA6577222
DR   hPSCreg; NUIGi034-A
DR   Wikidata; Q98128200
RX   PubMed=32097875;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi035-A
AC   CVCL_XJ12
SY   02V-AD
DR   BioSamples; SAMEA6504177
DR   hPSCreg; NUIGi035-A
DR   Wikidata; Q98128201
RX   PubMed=33370872;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi036-A
AC   CVCL_XJ13
SY   03V-D
DR   BioSamples; SAMEA6504178
DR   hPSCreg; NUIGi036-A
DR   Wikidata; Q98128202
RX   PubMed=33370872;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi037-A
AC   CVCL_XJ14
SY   05C-J; 05C-L
DR   BioSamples; SAMEA6504180
DR   hPSCreg; NUIGi037-A
DR   Wikidata; Q98128203
RX   PubMed=33370872;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   NUIGi038-A
AC   CVCL_A1PY
SY   LQTH002C4
DR   BioSamples; SAMEA5945670
DR   hPSCreg; NUIGi038-A
DR   Wikidata; Q102114670
RX   PubMed=33002719;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PZ ! NUIGi038-B
OI   CVCL_A8MT ! NUIGi038-C
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi038-B
AC   CVCL_A1PZ
SY   LQTH002Cx
DR   BioSamples; SAMEA5781290
DR   hPSCreg; NUIGi038-B
DR   Wikidata; Q102114671
RX   PubMed=33002719;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PY ! NUIGi038-A
OI   CVCL_A8MT ! NUIGi038-C
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi038-C
AC   CVCL_A8MT
SY   LQTH002C1
DR   BioSamples; SAMEA9691708
DR   hPSCreg; NUIGi038-C
DR   Wikidata; Q108821056
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PY ! NUIGi038-A
OI   CVCL_A1PZ ! NUIGi038-B
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   NUIGi039-A
AC   CVCL_XJ06
SY   ND1C1
DR   BioSamples; SAMEA6456098
DR   hPSCreg; NUIGi039-A
DR   Wikidata; Q98128204
RX   PubMed=31893021;
RX   PubMed=33631419;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex6-15del; Zygosity=Heterozygous; Note=De novo mutation (PubMed=31893021; PubMed=33631419).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ07 ! NUIGi039-B
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi039-B
AC   CVCL_XJ07
SY   ND1C5
DR   BioSamples; SAMEA6456110
DR   hPSCreg; NUIGi039-B
DR   Wikidata; Q98128205
RX   PubMed=33631419;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex6-15del; Zygosity=Heterozygous; Note=De novo mutation (PubMed=33631419).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ06 ! NUIGi039-A
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   NUIGi040-A
AC   CVCL_YR00
SY   CND1C3
DR   BioSamples; SAMEA6456111
DR   hPSCreg; NUIGi040-A
DR   Wikidata; Q98128207
RX   PubMed=33631419;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5QN ! NUIGi040-B
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi040-A-1
AC   CVCL_YR01
SY   CND1 C7
DR   hPSCreg; NUIGi040-A-1
DR   Wikidata; Q98128209
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YR00 ! NUIGi040-A
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   NUIGi040-B
AC   CVCL_A5QN
SY   CND1C7
DR   BioSamples; SAMEA6456113
DR   hPSCreg; NUIGi040-B
DR   Wikidata; Q107116597
RX   PubMed=33631419;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR00 ! NUIGi040-A
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   NUIGi041-A
AC   CVCL_YQ98
SY   ND3C2
DR   BioSamples; SAMEA6464735
DR   hPSCreg; NUIGi041-A
DR   Wikidata; Q98128211
RX   PubMed=33578364;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=33578364).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ99 ! NUIGi041-B
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   NUIGi041-B
AC   CVCL_YQ99
SY   ND3C4
DR   BioSamples; SAMEA6465064
DR   hPSCreg; NUIGi041-B
DR   Wikidata; Q98128212
RX   PubMed=33578364;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=33578364).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ98 ! NUIGi041-A
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   NUIGi042-A
AC   CVCL_YQ96
SY   CND3C1
DR   BioSamples; SAMEA6486611
DR   hPSCreg; NUIGi042-A
DR   Wikidata; Q98128213
RX   PubMed=33578364;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ97 ! NUIGi042-B
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi042-B
AC   CVCL_YQ97
SY   CND3C3; CND3C4
DR   BioSamples; SAMEA6504175
DR   hPSCreg; NUIGi042-B
DR   Wikidata; Q98128214
RX   PubMed=33578364;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ96 ! NUIGi042-A
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi043-A
AC   CVCL_XI99
SY   ALS52C3
DR   BioSamples; SAMEA5781307
DR   hPSCreg; NUIGi043-A
DR   Wikidata; Q98128215
RX   PubMed=31514057;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ00 ! NUIGi043-B
OI   CVCL_XJ01 ! NUIGi043-C
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi043-B
AC   CVCL_XJ00
SY   ALS52C9
DR   BioSamples; SAMEA5781299
DR   hPSCreg; NUIGi043-B
DR   Wikidata; Q98128216
RX   PubMed=31514057;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI99 ! NUIGi043-A
OI   CVCL_XJ01 ! NUIGi043-C
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi043-C
AC   CVCL_XJ01
SY   ALS52C10
DR   BioSamples; SAMEA5781300
DR   hPSCreg; NUIGi043-C
DR   Wikidata; Q98128217
RX   PubMed=31514057;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XI99 ! NUIGi043-A
OI   CVCL_XJ00 ! NUIGi043-B
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi044-A
AC   CVCL_XJ02
SY   ALS69C1
DR   BioSamples; SAMEA5781301
DR   hPSCreg; NUIGi044-A
DR   Wikidata; Q98128218
RX   PubMed=31514057;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ03 ! NUIGi044-B
OI   CVCL_XJ04 ! NUIGi044-C
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi044-B
AC   CVCL_XJ03
SY   ALS69C4
DR   BioSamples; SAMEA5781303
DR   hPSCreg; NUIGi044-B
DR   Wikidata; Q98128220
RX   PubMed=31514057;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ02 ! NUIGi044-A
OI   CVCL_XJ04 ! NUIGi044-C
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi044-C
AC   CVCL_XJ04
SY   ALS69C6
DR   BioSamples; SAMEA5781304
DR   hPSCreg; NUIGi044-C
DR   Wikidata; Q98128221
RX   PubMed=31514057;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ02 ! NUIGi044-A
OI   CVCL_XJ03 ! NUIGi044-B
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   NUIGi045-A
AC   CVCL_XJ05
SY   ND2C1
DR   BioSamples; SAMEA6456128
DR   hPSCreg; NUIGi045-A
DR   Wikidata; Q98128222
RX   PubMed=31893021;
RX   PubMed=33578364;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8008; NRXN1; Unexplicit; Ex1-5del; Zygosity=Heterozygous (PubMed=31893021).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   NUIGi046-A
AC   CVCL_YQ84
SY   LQTH001C2
DR   BioSamples; SAMEA6098947
DR   hPSCreg; NUIGi046-A
DR   Wikidata; Q98128223
RX   PubMed=34844101;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ85 ! NUIGi046-B
OI   CVCL_YQ86 ! NUIGi046-C
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi046-B
AC   CVCL_YQ85
SY   LQTH001C3
DR   BioSamples; SAMEA6098949
DR   hPSCreg; NUIGi046-B
DR   Wikidata; Q98128224
RX   PubMed=34844101;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ84 ! NUIGi046-A
OI   CVCL_YQ86 ! NUIGi046-C
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi046-C
AC   CVCL_YQ86
SY   LQTH001C5
DR   BioSamples; SAMEA6098950
DR   hPSCreg; NUIGi046-C
DR   Wikidata; Q98128225
RX   PubMed=34844101;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ84 ! NUIGi046-A
OI   CVCL_YQ85 ! NUIGi046-B
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi047-A
AC   CVCL_YQ87
SY   LQTH003C5
DR   BioSamples; SAMEA6098951
DR   hPSCreg; NUIGi047-A
DR   Wikidata; Q98128226
RX   PubMed=34088016;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ88 ! NUIGi047-B
OI   CVCL_YQ89 ! NUIGi047-C
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   NUIGi047-B
AC   CVCL_YQ88
SY   LQTH003C6
DR   BioSamples; SAMEA6098953
DR   hPSCreg; NUIGi047-B
DR   Wikidata; Q98128227
RX   PubMed=34088016;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ87 ! NUIGi047-A
OI   CVCL_YQ89 ! NUIGi047-C
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   NUIGi047-C
AC   CVCL_YQ89
SY   LQTH003Cx
DR   BioSamples; SAMEA6098954
DR   hPSCreg; NUIGi047-C
DR   Wikidata; Q98128228
RX   PubMed=34088016;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ87 ! NUIGi047-A
OI   CVCL_YQ88 ! NUIGi047-B
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 7
//
ID   NUIGi048-A
AC   CVCL_YQ90
SY   ALSH84C2
DR   BioSamples; SAMEA6276787
DR   hPSCreg; NUIGi048-A
DR   Wikidata; Q98128230
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ91 ! NUIGi048-B
OI   CVCL_YQ92 ! NUIGi048-C
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi048-B
AC   CVCL_YQ91
SY   ALSH84C4
DR   BioSamples; SAMEA6276788
DR   hPSCreg; NUIGi048-B
DR   Wikidata; Q98128231
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ90 ! NUIGi048-A
OI   CVCL_YQ92 ! NUIGi048-C
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi048-C
AC   CVCL_YQ92
SY   ALSH84C5
DR   BioSamples; SAMEA6276789
DR   hPSCreg; NUIGi048-C
DR   Wikidata; Q98128232
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ90 ! NUIGi048-A
OI   CVCL_YQ91 ! NUIGi048-B
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi049-A
AC   CVCL_YQ93
SY   ALSH47C1
DR   BioSamples; SAMEA6276791
DR   hPSCreg; NUIGi049-A
DR   Wikidata; Q98128233
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ94 ! NUIGi049-B
OI   CVCL_YQ95 ! NUIGi049-C
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi049-B
AC   CVCL_YQ94
SY   ALSH47C2
DR   BioSamples; SAMEA6276794
DR   hPSCreg; NUIGi049-B
DR   Wikidata; Q98128234
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ93 ! NUIGi049-A
OI   CVCL_YQ95 ! NUIGi049-C
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi049-C
AC   CVCL_YQ95
SY   ALSH47C3
DR   BioSamples; SAMEA6276795
DR   hPSCreg; NUIGi049-C
DR   Wikidata; Q98128235
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ93 ! NUIGi049-A
OI   CVCL_YQ94 ! NUIGi049-B
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi050-A
AC   CVCL_YQ78
SY   ALS53C5
DR   BioSamples; SAMEA6276796
DR   hPSCreg; NUIGi050-A
DR   Wikidata; Q98128236
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ79 ! NUIGi050-B
OI   CVCL_YQ80 ! NUIGi050-C
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi050-B
AC   CVCL_YQ79
SY   ALS53C6
DR   BioSamples; SAMEA6276797
DR   hPSCreg; NUIGi050-B
DR   Wikidata; Q98128237
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ78 ! NUIGi050-A
OI   CVCL_YQ80 ! NUIGi050-C
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi050-C
AC   CVCL_YQ80
SY   ALS53C7
DR   BioSamples; SAMEA6276798
DR   hPSCreg; NUIGi050-C
DR   Wikidata; Q98128238
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ78 ! NUIGi050-A
OI   CVCL_YQ79 ! NUIGi050-B
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi051-A
AC   CVCL_YQ81
SY   ALS57C1
DR   BioSamples; SAMEA6276799
DR   hPSCreg; NUIGi051-A
DR   Wikidata; Q98128239
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ82 ! NUIGi051-B
OI   CVCL_YQ83 ! NUIGi051-C
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi051-B
AC   CVCL_YQ82
SY   ALS57C3
DR   BioSamples; SAMEA6276801
DR   hPSCreg; NUIGi051-B
DR   Wikidata; Q98128240
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ81 ! NUIGi051-A
OI   CVCL_YQ83 ! NUIGi051-C
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi051-C
AC   CVCL_YQ83
SY   ALS57C4
DR   BioSamples; SAMEA6276802
DR   hPSCreg; NUIGi051-C
DR   Wikidata; Q98128242
RX   PubMed=32208303;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ81 ! NUIGi051-A
OI   CVCL_YQ82 ! NUIGi051-B
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   NUIGi052-A
AC   CVCL_YQ75
SY   EP001C1
DR   BioSamples; SAMEA6724082
DR   hPSCreg; NUIGi052-A
DR   Wikidata; Q98128243
RX   PubMed=32540721;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6220; KCNA2; Simple; p.Leu290Arg (c.869T>G); ClinVar=VCV000985630; Zygosity=Heterozygous (PubMed=32540721).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155998; Developmental and epileptic encephalopathy 32
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ76 ! NUIGi052-B
OI   CVCL_YQ77 ! NUIGi052-C
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NUIGi052-B
AC   CVCL_YQ76
SY   EP001C8
DR   BioSamples; SAMEA6724083
DR   hPSCreg; NUIGi052-B
DR   Wikidata; Q98128244
RX   PubMed=32540721;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6220; KCNA2; Simple; p.Leu290Arg (c.869T>G); ClinVar=VCV000985630; Zygosity=Heterozygous (PubMed=32540721).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155998; Developmental and epileptic encephalopathy 32
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ75 ! NUIGi052-A
OI   CVCL_YQ77 ! NUIGi052-C
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NUIGi052-C
AC   CVCL_YQ77
SY   EP001C15
DR   BioSamples; SAMEA6722849
DR   hPSCreg; NUIGi052-C
DR   Wikidata; Q98128246
RX   PubMed=32540721;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6220; KCNA2; Simple; p.Leu290Arg (c.869T>G); ClinVar=VCV000985630; Zygosity=Heterozygous (PubMed=32540721).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155998; Developmental and epileptic encephalopathy 32
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YQ75 ! NUIGi052-A
OI   CVCL_YQ76 ! NUIGi052-B
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   NUIGi053-A
AC   CVCL_A4DF
DR   BioSamples; SAMEA7543705
DR   hPSCreg; NUIGi053-A
DR   Wikidata; Q105510453
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   NUIGi055-A
AC   CVCL_A4DC
SY   iPSC C1-15
DR   BioSamples; SAMEA7601555
DR   hPSCreg; NUIGi055-A
DR   Wikidata; Q105510458
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4DD ! NUIGi055-B
OI   CVCL_A4DE ! NUIGi055-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NUIGi055-B
AC   CVCL_A4DD
SY   iPSC C1-16
DR   BioSamples; SAMEA7601553
DR   hPSCreg; NUIGi055-B
DR   Wikidata; Q105510460
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4DC ! NUIGi055-A
OI   CVCL_A4DE ! NUIGi055-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NUIGi055-C
AC   CVCL_A4DE
SY   iPSC C1-17
DR   BioSamples; SAMEA8007651
DR   hPSCreg; NUIGi055-C
DR   Wikidata; Q105510466
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4DC ! NUIGi055-A
OI   CVCL_A4DD ! NUIGi055-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   NUIGi056-A
AC   CVCL_B0FM
SY   LQTS003C1
DR   BioSamples; SAMEA9240043
DR   hPSCreg; NUIGi056-A
DR   Wikidata; Q108821057
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 4
//
ID   NUIGi057-A
AC   CVCL_C6RM
SY   EP2004 C1
DR   BioSamples; SAMEA110703499
DR   hPSCreg; NUIGi057-A
DR   Wikidata; Q117704735
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RN ! NUIGi057-B
OI   CVCL_C6RP ! NUIGi057-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi057-B
AC   CVCL_C6RN
SY   EP2004 C7
DR   BioSamples; SAMEA110703508
DR   hPSCreg; NUIGi057-B
DR   Wikidata; Q117704736
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RM ! NUIGi057-A
OI   CVCL_C6RP ! NUIGi057-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi057-C
AC   CVCL_C6RP
SY   EP2004 C8
DR   BioSamples; SAMEA110703509
DR   hPSCreg; NUIGi057-C
DR   Wikidata; Q117704737
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RM ! NUIGi057-A
OI   CVCL_C6RN ! NUIGi057-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi058-A
AC   CVCL_C6RQ
SY   EP2C004 C2
DR   BioSamples; SAMEA110703510
DR   hPSCreg; NUIGi058-A
DR   Wikidata; Q117704738
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RR ! NUIGi058-B
OI   CVCL_C6RS ! NUIGi058-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi058-B
AC   CVCL_C6RR
SY   EP2C004 C4
DR   BioSamples; SAMEA110703512
DR   hPSCreg; NUIGi058-B
DR   Wikidata; Q117704739
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RQ ! NUIGi058-A
OI   CVCL_C6RS ! NUIGi058-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi058-C
AC   CVCL_C6RS
SY   EP2C004 C5
DR   BioSamples; SAMEA110703513
DR   hPSCreg; NUIGi058-C
DR   Wikidata; Q117704740
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RQ ! NUIGi058-A
OI   CVCL_C6RR ! NUIGi058-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi059-A
AC   CVCL_C6RT
SY   EP2001 C4
DR   BioSamples; SAMEA111454677
DR   hPSCreg; NUIGi059-A
DR   Wikidata; Q117704741
RX   PubMed=37659345;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6296; KCNQ2; Simple; p.Ala294Val (c.881C>T); ClinVar=VCV000205886; Zygosity=Heterozygous (PubMed=37659345).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RU ! NUIGi059-B
OI   CVCL_C6RV ! NUIGi059-C
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   NUIGi059-B
AC   CVCL_C6RU
SY   EP2001 C5
DR   BioSamples; SAMEA111454679
DR   hPSCreg; NUIGi059-B
DR   Wikidata; Q117704742
RX   PubMed=37659345;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6296; KCNQ2; Simple; p.Ala294Val (c.881C>T); ClinVar=VCV000205886; Zygosity=Heterozygous (PubMed=37659345).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RT ! NUIGi059-A
OI   CVCL_C6RV ! NUIGi059-C
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   NUIGi059-C
AC   CVCL_C6RV
SY   EP2001 C8
DR   BioSamples; SAMEA111454680
DR   hPSCreg; NUIGi059-C
DR   Wikidata; Q117704743
RX   PubMed=37659345;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6296; KCNQ2; Simple; p.Ala294Val (c.881C>T); ClinVar=VCV000205886; Zygosity=Heterozygous (PubMed=37659345).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RT ! NUIGi059-A
OI   CVCL_C6RU ! NUIGi059-B
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   NUIGi060-A
AC   CVCL_C6RW
SY   EP2C001 C1
DR   BioSamples; SAMEA111562830
DR   hPSCreg; NUIGi060-A
DR   Wikidata; Q117704744
RX   PubMed=37659345;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RX ! NUIGi060-B
OI   CVCL_C6RY ! NUIGi060-C
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NUIGi060-B
AC   CVCL_C6RX
SY   EP2C001 C2
DR   BioSamples; SAMEA114009104
DR   hPSCreg; NUIGi060-B
DR   Wikidata; Q117704745
RX   PubMed=37659345;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RW ! NUIGi060-A
OI   CVCL_C6RY ! NUIGi060-C
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NUIGi060-C
AC   CVCL_C6RY
SY   EP2C001 C4
DR   BioSamples; SAMEA114009105
DR   hPSCreg; NUIGi060-C
DR   Wikidata; Q117704746
RX   PubMed=37659345;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RW ! NUIGi060-A
OI   CVCL_C6RX ! NUIGi060-B
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NUIGi061-A
AC   CVCL_C6RZ
DR   hPSCreg; NUIGi061-A
DR   Wikidata; Q117704747
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S0 ! NUIGi061-B
OI   CVCL_C6S1 ! NUIGi061-C
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi061-B
AC   CVCL_C6S0
DR   hPSCreg; NUIGi061-B
DR   Wikidata; Q117704748
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RZ ! NUIGi061-A
OI   CVCL_C6S1 ! NUIGi061-C
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi061-C
AC   CVCL_C6S1
DR   hPSCreg; NUIGi061-C
DR   Wikidata; Q117704749
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6RZ ! NUIGi061-A
OI   CVCL_C6S0 ! NUIGi061-B
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi062-A
AC   CVCL_C6S2
SY   EP2C002 C5
DR   hPSCreg; NUIGi062-A
DR   Wikidata; Q117704750
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S3 ! NUIGi062-B
OI   CVCL_C6S4 ! NUIGi062-C
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi062-B
AC   CVCL_C6S3
SY   EP2C002 C6
DR   hPSCreg; NUIGi062-B
DR   Wikidata; Q117704751
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S2 ! NUIGi062-A
OI   CVCL_C6S4 ! NUIGi062-C
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi062-C
AC   CVCL_C6S4
SY   EP2C002 C7
DR   hPSCreg; NUIGi062-C
DR   Wikidata; Q117704752
CC   From: National University of Ireland Galway; Galway; Ireland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S2 ! NUIGi062-A
OI   CVCL_C6S3 ! NUIGi062-B
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   NUIGi063-A
AC   CVCL_C6S5
SY   EP2003 C2
DR   BioSamples; SAMEA112150353
DR   hPSCreg; NUIGi063-A
DR   Wikidata; Q117704753
RX   PubMed=37071954;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6296; KCNQ2; Simple; p.Arg213Gln (c.638C>T); ClinVar=VCV000039760; Zygosity=Heterozygous (PubMed=37071954).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S6 ! NUIGi063-B
OI   CVCL_C6S7 ! NUIGi063-C
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   NUIGi063-B
AC   CVCL_C6S6
SY   EP2003 C3
DR   BioSamples; SAMEA112150815
DR   hPSCreg; NUIGi063-B
DR   Wikidata; Q117704754
RX   PubMed=37071954;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6296; KCNQ2; Simple; p.Arg213Gln (c.638C>T); ClinVar=VCV000039760; Zygosity=Heterozygous (PubMed=37071954).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S5 ! NUIGi063-A
OI   CVCL_C6S7 ! NUIGi063-C
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   NUIGi063-C
AC   CVCL_C6S7
SY   EP2003 C4
DR   BioSamples; SAMEA112150819
DR   hPSCreg; NUIGi063-C
DR   Wikidata; Q117704755
RX   PubMed=37071954;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6296; KCNQ2; Simple; p.Arg213Gln (c.638C>T); ClinVar=VCV000039760; Zygosity=Heterozygous (PubMed=37071954).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S5 ! NUIGi063-A
OI   CVCL_C6S6 ! NUIGi063-B
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   NUIGi064-A
AC   CVCL_C6S8
SY   EP2C003 C1
DR   BioSamples; SAMEA112150821
DR   hPSCreg; NUIGi064-A
DR   Wikidata; Q117704756
RX   PubMed=37071954;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S9 ! NUIGi064-B
OI   CVCL_C6SA ! NUIGi064-C
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NUIGi064-B
AC   CVCL_C6S9
SY   EP2C003 C2
DR   BioSamples; SAMEA112150956
DR   hPSCreg; NUIGi064-B
DR   Wikidata; Q117704757
RX   PubMed=37071954;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S8 ! NUIGi064-A
OI   CVCL_C6SA ! NUIGi064-C
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NUIGi064-C
AC   CVCL_C6SA
SY   EP2C003 C4
DR   BioSamples; SAMEA112150980
DR   hPSCreg; NUIGi064-C
DR   Wikidata; Q117704758
RX   PubMed=37071954;
CC   From: National University of Ireland Galway; Galway; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6S8 ! NUIGi064-A
OI   CVCL_C6S9 ! NUIGi064-B
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   NUL1
AC   CVCL_R788
SY   NUL 1
DR   Wikidata; Q54931168
RX   PubMed=3001399;
RX   PubMed=3409226;
RX   PubMed=4067735;
RX   PubMed=6713549;
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   NUL1 clone B3
AC   CVCL_5U97
SY   NUL1 B3; NULB3; B3
DR   Wikidata; Q54931169
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=3409226;
RX   PubMed=9347924;
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R788 ! NUL1
AG   Adult
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   NUL1 clone B5
AC   CVCL_5U98
SY   NUL1 B5; NULB5; b5
DR   Wikidata; Q54931170
RX   PubMed=2152771;
RX   PubMed=2177605;
RX   PubMed=3409226;
RX   PubMed=9347924;
CC   Transformant: ChEBI; CHEBI_17967; Urethane.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21762; Adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R788 ! NUL1
AG   Adult
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   NULC-1
AC   CVCL_A5XB
SY   NULC 1; NU-LC-1; Nagoya University-Lung Cancer-1
DR   Wikidata; Q107116598
RX   PubMed=3325673;
CC   Population: Japanese.
DI   NCIt; C4878; Lung carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   NULC-2
AC   CVCL_A5XC
SY   NULC 2; NU-LC-2; Nagoya University-Lung Cancer-2
DR   Wikidata; Q107116599
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=3325673;
CC   Population: Japanese.
CC   Misspelling: MULC2; DOI=10.2995/jacsurg1987.4.6_755; Note=In table 2.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   NuLi-1
AC   CVCL_C455
SY   NuLi1; Normal Lung, University of Iowa-1
DR   ATCC; CRL-4011
DR   BioSample; SAMN03471719
DR   CancerTools; 154444
DR   Wikidata; Q54931171
RX   PubMed=12676769;
RX   PubMed=17191107;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4011
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 8,13
ST   D18S51: 11,12
ST   D19S433: 13,16
ST   D21S11: 31
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 12,13
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 5,13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   NuLi-2
AC   CVCL_S915
SY   Normal Lung, University of Iowa-2
DR   CancerTools; 154461
DR   Wikidata; Q54931172
RX   PubMed=12676769;
CC   Karyotypic information: 50,XX,+5,+7,+13,+20 [10] (PubMed=12676769).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   NuLi-3
AC   CVCL_C456
SY   Normal Lung, University of Iowa-3
DR   ATCC; CRL-4012
DR   BioSample; SAMN03471720
DR   CancerTools; 154460
DR   Wikidata; Q54931173
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-4012; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): ATCC=CRL-4012
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   NULLI-SCC1
AC   CVCL_3408
SY   Nulli SCC1; 129-LS402C-1684-spontaneous-Nulli SCC 1
DR   CLO; CLO_0008213
DR   CLDB; cl3745
DR   CLDB; cl7206
DR   ATCC; CRL-1566
DR   ICLC; ATL06001
DR   Wikidata; Q54931174
RX   DOI=10.1016/0092-8674(75)90035-5;
RX   PubMed=6644686;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 8
//
ID   NUNK1
AC   CVCL_C3LT
DR   Wikidata; Q116050019
RX   PubMed=36094314;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126348; Chronic active EBV disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   NUOC-1
AC   CVCL_IZ35
SY   Newcastle University Ovarian Cancer-1
DR   CancerTools; 153527
DR   Wikidata; Q54931175
DR   Ximbio; 153527
RX   PubMed=28460465;
CC   Characteristics: Established from a mixed ovarian carcinoma of the right ovary which was 80% endometrioid, 15% clear cell and 5% high grade serous (HGS).
CC   Doubling time: 58 hours (PubMed=28460465).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=28460465).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=28460465
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 7,8
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 15
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   NUOC-1-A1
AC   CVCL_IZ36
SY   Newcastle University Ovarian Cancer-1-A1
DR   Wikidata; Q54931176
RX   PubMed=28460465;
CC   Characteristics: Established from a mixed ovarian carcinoma of the right ovary which was 80% endometrioid, 15% clear cell and 5% high grade serous (HGS).
CC   Doubling time: 58 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=28460465).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Doubling time from personal communication of Edmondson, Richard J.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=28460465
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 7,8
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 15
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IZ35 ! NUOC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   NUOC-1-A2
AC   CVCL_IZ37
SY   Newcastle University Ovarian Cancer-1-A2
DR   Wikidata; Q54931177
RX   PubMed=28460465;
CC   Characteristics: Established from a mixed ovarian carcinoma of the right ovary which was 80% endometrioid, 15% clear cell and 5% high grade serous (HGS).
CC   Doubling time: 58 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=28460465).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Doubling time from personal communication of Edmondson, Richard J.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=28460465
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 7,8
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 15
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IZ35 ! NUOC-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   Nur-1
AC   CVCL_1Q60
DR   Wikidata; Q54931178
RX   PubMed=25627346;
CC   Population: Japanese.
CC   Doubling time: 6.1 days (Note=At 30th passage), 5.8 days (Note=At 60th passage), 5.6 days (Note=At 103th passage) (PubMed=25627346).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   NUT
AC   CVCL_WI02
DR   Wikidata; Q98128247
RX   PubMed=2425114;
CC   Population: Japanese.
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 8
//
ID   NUTLC-1
AC   CVCL_L423
SY   NUTLC 1; NUTLC1; Nagoya University Tumor of Lung Cancer-1
DR   Wikidata; Q54931179
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=8025020;
CC   Population: Japanese.
CC   Doubling time: 19.1 hours (PubMed=8025020).
CC   Derived from site: Metastatic; Mediastinal lymph node; UBERON=UBERON_0002524.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   NUTLC-2
AC   CVCL_L424
SY   NUTLC 2; NUTLC2; Nagoya University Tumor of Lung Cancer-2
DR   Wikidata; Q54931180
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=1339008;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Mediastinal lymph node; UBERON=UBERON_0002524.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   NUTLC-3
AC   CVCL_L425
SY   NUTLC 3; NUTLC3; Nagoya University Tumor of Lung Cancer-3
DR   Wikidata; Q54931181
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=8025020;
CC   Population: Japanese.
CC   Doubling time: 32.5 hours (PubMed=8025020).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   NUTLC-4
AC   CVCL_L426
SY   Nagoya University Tumor of Lung Cancer-4
DR   Wikidata; Q54931182
RX   PubMed=1339008;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   NUTLC-5
AC   CVCL_L427
SY   Nagoya University Tumor of Lung Cancer-5
DR   Wikidata; Q54931183
RX   PubMed=1339008;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   NUTOS
AC   CVCL_D658
DR   Wikidata; Q54931184
RX   PubMed=20712710;
CC   Population: Japanese.
CC   Doubling time: 14.1 hours (PubMed=20712710).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=20712710).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   NuTu-19
AC   CVCL_HA28
SY   NUTU-19; NuTu 19
DR   Wikidata; Q54931185
RX   PubMed=8168110;
RX   PubMed=8828419;
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   12-16W
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   NUZ
AC   CVCL_V411
SY   NUZ-1
DR   Cosmic; 877472
DR   Cosmic; 1152546
DR   Wikidata; Q54931186
RX   CelloPub=CLPUB00091;
CC   Population: Japanese.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   NV-5
AC   CVCL_UZ70
DR   Wikidata; Q98128248
RX   CelloPub=CLPUB00181;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1032906; ! Nephotettix virescens (Rice green leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   NV-8
AC   CVCL_UZ71
DR   Wikidata; Q98128250
RX   CelloPub=CLPUB00181;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1032906; ! Nephotettix virescens (Rice green leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   NVS3
AC   CVCL_WW00
SY   Navy Vivax Sporozoite 3
DR   Wikidata; Q98128251
RX   Patent=US6399062;
CC   Group: Malaria research cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10615.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P08677; Plasmodium vivax (strain Belem) circumsporozoite protein (CS) (Note=Also reacts with other strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 6
//
ID   NW-16
AC   CVCL_5219
SY   NW16
DR   BTO; BTO_0003055
DR   Wikidata; Q54931187
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   NW0004
AC   CVCL_8Y25
DR   ECACC; 03041506
DR   Wikidata; Q54931188
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03041506; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   NW0005
AC   CVCL_8Y26
DR   ECACC; 03041507
DR   Wikidata; Q54931189
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03041507; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   NW0006
AC   CVCL_8Y27
DR   ECACC; 03110420
DR   Wikidata; Q54931190
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03110420; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   NW145
AC   CVCL_2148
SY   NW-145; NW 145; NW-MEL-145; NW-Mel-145; EST57
DR   cancercelllines; CVCL_2148
DR   Cosmic; 972264
DR   Cosmic; 1047648
DR   Cosmic; 2163798
DR   ESTDAB; ESTDAB-057
DR   GEO; GSM156014
DR   IARC_TP53; 26075
DR   Progenetix; CVCL_2148
DR   Wikidata; Q54931191
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
CC   HLA typing: A*23:01,23:01; B*15:01:01:01,15:01:01:01; C*01:02,01:02; DPB1*04:02; DQB1*06:04,03:01:01; DRB1*04:01,11:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ESTDAB=ESTDAB-057
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10
ST   FGA: 20
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   NW145/E7
AC   CVCL_C538
SY   NW-145/E7; NW145 clone E7
DR   cancercelllines; CVCL_C538
DR   Cosmic; 972259
DR   ESTDAB; ESTDAB-058
DR   Wikidata; Q54931192
RX   PubMed=15592718;
RX   PubMed=19340423;
CC   HLA typing: A*23:01,23:01; B*15:01:01:01,15:01:01:01; C*01:02,01:02; DPB1*04:02,04:02; DQB1*03:01:01,03:01:01; DRB1*11:01,11:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
ST   Source(s): ESTDAB=ESTDAB-058
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10
ST   FGA: 20
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2148 ! NW145
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   NW1539
AC   CVCL_S590
SY   NW-1539; NW-MEL-1539; NW-Mel-1539
DR   BTO; BTO_0005427
DR   Wikidata; Q54931193
RX   PubMed=12747757;
RX   PubMed=15087389;
CC   HLA typing: A*03,11; B*44,51; C*w04,w05 (PubMed=12747757).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   NW38
AC   CVCL_S591
SY   NW-38; NW-MEL-38
DR   Wikidata; Q54931194
RX   PubMed=9432985;
RX   PubMed=12747757;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   NW450
AC   CVCL_S592
SY   MW-450; NW-MEL-450; NW-Mel-450
DR   Wikidata; Q54931195
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 5
//
ID   NW624
AC   CVCL_S589
SY   NW-624; NW-Mel-624
DR   BTO; BTO_0005428
DR   Wikidata; Q54931196
RX   PubMed=15087389;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   NW726
AC   CVCL_S593
SY   NW-726; NW-Mel-726
DR   Wikidata; Q54931197
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 5
//
ID   NW745
AC   CVCL_S594
SY   NW-745; NW-Mel-745
DR   Wikidata; Q54931198
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 5
//
ID   NWR 17626 iPSC-c501
AC   CVCL_B6YW
SY   17626-c501
DR   Wikidata; Q112129465
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6YX ! NWR 17626 iPSC-c5101
OI   CVCL_B6YY ! NWR 17626 iPSC-c5103
OI   CVCL_R793 ! NWR A
OI   CVCL_R794 ! NWR B
OI   CVCL_R795 ! NWR C
SX   Female
AG   9-10Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 17626 iPSC-c5101
AC   CVCL_B6YX
SY   17626-c5101
DR   Wikidata; Q112129466
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6YW ! NWR 17626 iPSC-c501
OI   CVCL_B6YY ! NWR 17626 iPSC-c5103
OI   CVCL_R793 ! NWR A
OI   CVCL_R794 ! NWR B
OI   CVCL_R795 ! NWR C
SX   Female
AG   9-10Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 17626 iPSC-c5103
AC   CVCL_B6YY
SY   17626-c5103
DR   Wikidata; Q112129467
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6YW ! NWR 17626 iPSC-c501
OI   CVCL_B6YX ! NWR 17626 iPSC-c5101
OI   CVCL_R793 ! NWR A
OI   CVCL_R794 ! NWR B
OI   CVCL_R795 ! NWR C
SX   Female
AG   9-10Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 5764 iPSC-c503
AC   CVCL_B6TV
SY   5764-c503
DR   Wikidata; Q112129468
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Nadi that lived in San Diego Zoo Safari Park and died in 2007.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 5765 iPSC-c506
AC   CVCL_TZ73
SY   5765-c506
DR   Wikidata; Q54931199
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Suni that lived in Dvur Kralove zoo and died in 2014.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6TS ! NWR 5765 iPSC-c507
OI   CVCL_B6TT ! NWR 5765 iPSC-c508
OI   CVCL_B6TU ! NWR 5765 iPSC-c509
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   NWR 5765 iPSC-c507
AC   CVCL_B6TS
SY   5765-c507
DR   Wikidata; Q112129469
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Suni that lived in Dvur Kralove zoo and died in 2014.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_TZ73 ! NWR 5765 iPSC-c506
OI   CVCL_B6TT ! NWR 5765 iPSC-c508
OI   CVCL_B6TU ! NWR 5765 iPSC-c509
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 5765 iPSC-c508
AC   CVCL_B6TT
SY   5765-c508
DR   Wikidata; Q112129470
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Suni that lived in Dvur Kralove zoo and died in 2014.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_TZ73 ! NWR 5765 iPSC-c506
OI   CVCL_B6TS ! NWR 5765 iPSC-c507
OI   CVCL_B6TU ! NWR 5765 iPSC-c509
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 5765 iPSC-c509
AC   CVCL_B6TU
SY   5765-c509
DR   Wikidata; Q112129471
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Suni that lived in Dvur Kralove zoo and died in 2014.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_TZ73 ! NWR 5765 iPSC-c506
OI   CVCL_B6TS ! NWR 5765 iPSC-c507
OI   CVCL_B6TT ! NWR 5765 iPSC-c508
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 6571 iPSC-c501
AC   CVCL_TZ74
SY   6571-c501
DR   Wikidata; Q54931200
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Dinka that lived in San Diego Zoo Safari Park and died in 1991.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6TW ! NWR 6571 iPSC-c502
OI   CVCL_B6TX ! NWR 6571 iPSC-c505
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   NWR 6571 iPSC-c502
AC   CVCL_B6TW
SY   6571-c502
DR   Wikidata; Q112129472
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Dinka that lived in San Diego Zoo Safari Park and died in 1991.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_TZ74 ! NWR 6571 iPSC-c501
OI   CVCL_B6TX ! NWR 6571 iPSC-c505
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 6571 iPSC-c505
AC   CVCL_B6TX
SY   6571-c505
DR   Wikidata; Q112129473
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Dinka that lived in San Diego Zoo Safari Park and died in 1991.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_TZ74 ! NWR 6571 iPSC-c501
OI   CVCL_B6TW ! NWR 6571 iPSC-c502
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 8173 iPSC-c505
AC   CVCL_B6TY
SY   8173-c505
DR   Wikidata; Q112129474
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from Najin, one the last two Northern white rhinoceros still alive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 8174 iPSC-c501
AC   CVCL_B6TZ
SY   8174-c501
DR   Wikidata; Q112129475
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Nasima that lived in Dvur Kralove zoo and died in 1992.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 8175 iPSC-c501
AC   CVCL_TZ75
SY   8175-c501
DR   Wikidata; Q54931201
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Nola that lived in San Diego Zoo Safari Park and died in 2015.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   NWR 9939 iPSC-c5101
AC   CVCL_B6U0
SY   9939-c5101
DR   Wikidata; Q112129476
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Saut that lived in San Diego Zoo Safari Park and died in 1997.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR 9947 iPSC-c501
AC   CVCL_TZ76
SY   9947-c501
DR   Wikidata; Q54931202
RX   DOI=10.1101/202499;
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Angalifu that lived in San Diego Zoo Safari Park and died in 2014.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6U4 ! NWR 9947 iPSC-c5101
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   NWR 9947 iPSC-c5101
AC   CVCL_B6U4
SY   9947-c5101
DR   Wikidata; Q112129477
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Angalifu that lived in San Diego Zoo Safari Park and died in 2014.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_TZ76 ! NWR 9947 iPSC-c501
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   NWR A
AC   CVCL_R793
SY   Northern White Rhinoceros iPSC line A
DR   Wikidata; Q54931203
RX   PubMed=21892153;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6YW ! NWR 17626 iPSC-c501
OI   CVCL_B6YX ! NWR 17626 iPSC-c5101
OI   CVCL_B6YY ! NWR 17626 iPSC-c5103
OI   CVCL_R794 ! NWR B
OI   CVCL_R795 ! NWR C
SX   Female
AG   9-10Y
CA   Induced pluripotent stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   NWR B
AC   CVCL_R794
SY   Northern White Rhinoceros iPSC line B
DR   Wikidata; Q54931204
RX   PubMed=21892153;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6YW ! NWR 17626 iPSC-c501
OI   CVCL_B6YX ! NWR 17626 iPSC-c5101
OI   CVCL_B6YY ! NWR 17626 iPSC-c5103
OI   CVCL_R793 ! NWR A
OI   CVCL_R795 ! NWR C
SX   Female
AG   9-10Y
CA   Induced pluripotent stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   NWR C
AC   CVCL_R795
SY   Northern White Rhinoceros iPSC line C
DR   Wikidata; Q54931207
RX   PubMed=21892153;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=310713; ! Ceratotherium simum cottoni (Northern white rhinoceros)
OI   CVCL_B6YW ! NWR 17626 iPSC-c501
OI   CVCL_B6YX ! NWR 17626 iPSC-c5101
OI   CVCL_B6YY ! NWR 17626 iPSC-c5103
OI   CVCL_R793 ! NWR A
OI   CVCL_R794 ! NWR B
SX   Female
AG   9-10Y
CA   Induced pluripotent stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   NWT-21
AC   CVCL_D206
SY   NWT21
DR   Wikidata; Q54931208
RX   PubMed=15050915;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5465; IGF1R.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   NY
AC   CVCL_1613
DR   CLO; CLO_0009877
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471633
DR   cancercelllines; CVCL_1613
DR   Cell_Model_Passport; SIDM00569
DR   ChEMBL-Cells; CHEMBL3308123
DR   ChEMBL-Targets; CHEMBL1075552
DR   Cosmic; 910849
DR   Cosmic-CLP; 910849
DR   DepMap; ACH-002178
DR   EGA; EGAS00001000978
DR   GDSC; 910849
DR   GEO; GSM320822
DR   GEO; GSM827276
DR   GEO; GSM1670289
DR   IARC_TP53; 21591
DR   JCRB; JCRB0614
DR   LINCS_LDP; LCL-1429
DR   PharmacoDB; NY_1175_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1613
DR   PubChem_Cell_line; CVCL_1613
DR   Wikidata; Q54931209
RX   PubMed=6596455;
RX   PubMed=9290701;
RX   PubMed=15289353;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 21 days (Note=At 18th passage) (PubMed=6596455); ~60 hours (Note=Lot 091198), ~30 hours (Note=Lot 09262016) (JCRB=JCRB0614).
CC   HLA typing: A*26:01; B*55:02; C*03:03 (PubMed=15289353).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.02%; Native American=0.2%; East Asian, North=78.63%; East Asian, South=19.14%; South Asian=0.88%; European, North=0.59%; European, South=0.55% (PubMed=30894373).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): Cosmic-CLP=910849; JCRB=JCRB0614
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10,13
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   NYAES-PR4A
AC   CVCL_Z961
DR   ICLDB; nyaes-pr4a
DR   Wikidata; Q54931210
RX   DOI=10.1016/0022-2011(88)90135-8;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   Nyevu
AC   CVCL_IU24
DR   Wikidata; Q54931213
RX   PubMed=178913;
RX   PubMed=4364259;
CC   Population: African; Kenyan.
CC   Virology: Contains 93 copies of the EBV genome (PubMed=178913).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   NYGCe001-A
AC   CVCL_YC46
SY   HUES66-DoxNGN-MAP2-tdTomato
DR   hPSCreg; NYGCe001-A
DR   Wikidata; Q98128252
RX   PubMed=31707212;
CC   From: New York Genome Center; New York; USA.
CC   Characteristics: Using CRISPR/Cas9 MAP2 has been endogenously tagged at the C-terminus with a T2A-tdTomato construct.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7764; NEUROG1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B201 ! HUES 66
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   NYGM
AC   CVCL_9278
DR   Wikidata; Q54931214
RX   PubMed=15859160;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=15859160).
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   NYH/187/162
AC   CVCL_0B24
SY   NYH/187; NYH/ICRF-187-1
DR   Wikidata; Q54931215
RX   PubMed=10416608;
RX   PubMed=12044890;
CC   Selected for resistance to: ChEBI; CHEBI_50223; (+)-dexrazoxane (Cardioxane; ICRF-187).
CC   Sequence variation: Mutation; HGNC; HGNC:11989; TOP2A; Simple; p.Arg162Gln (c.485G>A); Zygosity=Homozygous; Note=Responsible for resistance to bisdioxopiperazine drugs (PubMed=10416608).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex8del14; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8207 ! GLC-2
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   NYH/187/165
AC   CVCL_0B25
DR   Wikidata; Q54931216
RX   PubMed=12044890;
CC   Selected for resistance to: ChEBI; CHEBI_50223; (+)-dexrazoxane (Cardioxane; ICRF-187).
CC   Sequence variation: Mutation; HGNC; HGNC:11989; TOP2A; Simple; p.Tyr165Ser (c.494A>C); Zygosity=Heterozygous; Note=Responsible for resistance to bisdioxopiperazine drugs (PubMed=12044890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex8del14; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8207 ! GLC-2
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   NYH/CAM
AC   CVCL_0B26
DR   Wikidata; Q54931217
RX   PubMed=9062409;
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8207 ! GLC-2
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   NYH/CIS
AC   CVCL_0B27
DR   Wikidata; Q54931218
RX   PubMed=9062409;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8207 ! GLC-2
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   NYH/TPT
AC   CVCL_0B28
DR   Wikidata; Q54931219
RX   PubMed=7640225;
RX   PubMed=9062409;
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8207 ! GLC-2
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   NYH/VM
AC   CVCL_0B29
SY   OC-NYH/VM
DR   Wikidata; Q54931220
RX   PubMed=8390259;
RX   PubMed=9062409;
CC   Selected for resistance to: ChEBI; CHEBI_75988; Teniposide (VM-26).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8207 ! GLC-2
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   NYSCF-050882-01-MR
AC   CVCL_JW75
SY   050882-01-MR
DR   Wikidata; Q54931221
WW   Info; PGP; hu02C8E3; https://my.pgp-hms.org/profile_public?hex=hu02C8E3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1C92 ! GM24612
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-050921-01-MR
AC   CVCL_JW93
SY   050921-01-MR
DR   Wikidata; Q54931222
WW   Info; PGP; hu5FCE15; https://my.pgp-hms.org/profile_public?hex=hu5FCE15
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
DI   NCIt; C2878; Anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1C25 ! GM24116
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-050956-01-MR
AC   CVCL_JW94
SY   050956-01-MR
DR   Wikidata; Q54931223
WW   Info; PGP; hu6E8157; https://my.pgp-hms.org/profile_public?hex=hu6E8157
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-050967-01-MR
AC   CVCL_JW76
SY   050967-01-MR
DR   Wikidata; Q54931224
WW   Info; PGP; hu5D9DE3; https://my.pgp-hms.org/profile_public?hex=hu5D9DE3
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   NYSCF-050974-01-MR
AC   CVCL_JW77
SY   050974-01-MR
DR   Wikidata; Q54931225
WW   Info; PGP; hu72C17A; https://my.pgp-hms.org/profile_public?hex=hu72C17A
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1B91 ! GM24077
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   NYSCF-050985-01-MR
AC   CVCL_JW78
SY   050985-01-MR
DR   Wikidata; Q54931226
WW   Info; PGP; hu925B56; https://my.pgp-hms.org/profile_public?hex=hu925B56
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   NYSCF-051001-01-MR
AC   CVCL_JW79
SY   051001-01-MR
DR   Wikidata; Q54931227
WW   Info; PGP; hu6C733E; https://my.pgp-hms.org/profile_public?hex=hu6C733E
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1C18 ! GM24108
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051015-01-MR
AC   CVCL_JW95
SY   051015-01-MR
DR   Wikidata; Q54931228
WW   Info; PGP; hu661AD0; https://my.pgp-hms.org/profile_public?hex=hu661AD0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Hispanic.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1B84 ! GM24070
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   NYSCF-051024-01-MR
AC   CVCL_JW80
SY   051024-01-MR
DR   Wikidata; Q54931229
WW   Info; PGP; hu82436A; https://my.pgp-hms.org/profile_public?hex=hu82436A
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051032-01-MR
AC   CVCL_JW81
SY   051032-01-MR
DR   Wikidata; Q54931230
WW   Info; PGP; huF7F00C; https://my.pgp-hms.org/profile_public?hex=huF7F00C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051036-01-MR
AC   CVCL_JW82
SY   051036-01-MR
DR   Wikidata; Q54931231
WW   Info; PGP; huB4E868; https://my.pgp-hms.org/profile_public?hex=huB4E868
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051045-01-MR
AC   CVCL_JW83
SY   051045-01-MR
DR   Wikidata; Q54931232
WW   Info; PGP; hu016B28; https://my.pgp-hms.org/profile_public?hex=hu016B28
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1C42 ! GM24135
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051086-01-MR
AC   CVCL_JW84
SY   051086-01-MR
DR   Wikidata; Q54931233
WW   Info; PGP; huA7E205; https://my.pgp-hms.org/profile_public?hex=huA7E205
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   NYSCF-051088-01-MR
AC   CVCL_JW85
SY   051088-01-MR
DR   Wikidata; Q54931234
WW   Info; PGP; hu132B5C; https://my.pgp-hms.org/profile_public?hex=hu132B5C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1B85 ! GM24071
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051094-01-MR
AC   CVCL_JW86
SY   051094-01-MR
DR   Wikidata; Q54931235
WW   Info; PGP; hu032C04; https://my.pgp-hms.org/profile_public?hex=hu032C04
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1B99 ! GM24086
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051118-01-MR
AC   CVCL_JW87
SY   051118-01-MR
DR   Wikidata; Q54931236
WW   Info; PGP; hu2B78D0; https://my.pgp-hms.org/profile_public?hex=hu2B78D0
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051121-01-MR
AC   CVCL_JW88
SY   051121-01-MR
DR   Wikidata; Q54931237
WW   Info; PGP; hu04F220; https://my.pgp-hms.org/profile_public?hex=hu04F220
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
DI   NCIt; C2878; Anxiety disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1B81 ! GM24050
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051140-01-MR
AC   CVCL_JW89
SY   051140-01-MR
DR   Wikidata; Q54931238
WW   Info; PGP; hu8D8CFA; https://my.pgp-hms.org/profile_public?hex=hu8D8CFA
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051141-01-MR
AC   CVCL_JW90
SY   051141-01-MR
DR   Wikidata; Q54931239
WW   Info; PGP; hu1B2689; https://my.pgp-hms.org/profile_public?hex=hu1B2689
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051162-01-MR
AC   CVCL_JW91
SY   051162-01-MR
DR   Wikidata; Q54931240
WW   Info; PGP; hu3BE6EF; https://my.pgp-hms.org/profile_public?hex=hu3BE6EF
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-051167-01-MR
AC   CVCL_JW92
SY   051167-01-MR
DR   Wikidata; Q54931241
WW   Info; PGP; hu066C78; https://my.pgp-hms.org/profile_public?hex=hu066C78
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 5
//
ID   NYSCF-10005-1044-1044-Skin-mR-iPSC
AC   CVCL_AB86
DR   SKIP; SKIP004739
DR   Wikidata; Q54931242
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1046-1046-Skin-mR-iPSC
AC   CVCL_AB87
DR   SKIP; SKIP004740
DR   Wikidata; Q54931244
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1047-1047-Skin-mR-iPSC
AC   CVCL_AB88
DR   SKIP; SKIP004741
DR   Wikidata; Q54931245
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1048-1048-Skin-mR-iPSC
AC   CVCL_AB89
DR   SKIP; SKIP004742
DR   Wikidata; Q54931246
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1049-1049-Skin-mR-iPSC
AC   CVCL_AB90
DR   SKIP; SKIP004743
DR   Wikidata; Q54931247
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1050-1050-Skin-mR-iPSC
AC   CVCL_AB91
DR   SKIP; SKIP004744
DR   Wikidata; Q54931249
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1051-1051-Skin-mR-iPSC
AC   CVCL_AB92
DR   SKIP; SKIP004745
DR   Wikidata; Q54931250
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1058-1058-Skin-mR-iPSC
AC   CVCL_AB93
DR   SKIP; SKIP004746
DR   Wikidata; Q54931251
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1059-1059-Skin-mR-iPSC
AC   CVCL_AB94
DR   SKIP; SKIP004747
DR   Wikidata; Q54931252
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1062-1062-Skin-mR-iPSC
AC   CVCL_AB95
DR   SKIP; SKIP004748
DR   Wikidata; Q54931253
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1063-1063-Skin-mR-iPSC
AC   CVCL_AB96
DR   SKIP; SKIP004749
DR   Wikidata; Q54931254
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1064-1064-Skin-mR-iPSC
AC   CVCL_AB97
DR   SKIP; SKIP004750
DR   Wikidata; Q54931255
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1065-1065-Skin-mR-iPSC
AC   CVCL_AB98
DR   SKIP; SKIP004751
DR   Wikidata; Q54931256
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1067-1067-Skin-mR-iPSC
AC   CVCL_AB99
DR   SKIP; SKIP004752
DR   Wikidata; Q54931257
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1069-1069-Skin-mR-iPSC
AC   CVCL_AC00
DR   SKIP; SKIP004753
DR   Wikidata; Q54931258
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1070-1070-Skin-mR-iPSC
AC   CVCL_AC01
DR   SKIP; SKIP004754
DR   Wikidata; Q54931259
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1071-1071-Skin-mR-iPS
AC   CVCL_AC02
DR   SKIP; SKIP004755
DR   Wikidata; Q54931260
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1073-1073-Skin-mR-iPS
AC   CVCL_AC03
DR   SKIP; SKIP004756
DR   Wikidata; Q54931261
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1076-1076-Skin-mR-iPS
AC   CVCL_AC04
DR   SKIP; SKIP004757
DR   Wikidata; Q54931262
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1081-1081-Skin-mR-iPS
AC   CVCL_AC05
DR   SKIP; SKIP004758
DR   Wikidata; Q54931263
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1082-1082-Skin-mR-iPS
AC   CVCL_AC06
DR   SKIP; SKIP004759
DR   Wikidata; Q54931264
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-1085-1085-Skin-mR-iPS
AC   CVCL_AC07
DR   SKIP; SKIP004760
DR   Wikidata; Q54931265
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-117-117-Skin-sv-iPSC
AC   CVCL_AC08
DR   SKIP; SKIP004761
DR   Wikidata; Q54931266
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-118-118-Skin-mR-iPSC
AC   CVCL_AC09
DR   SKIP; SKIP004763
DR   Wikidata; Q54931267
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-128-128-Skin-mR-iPSC
AC   CVCL_AC10
DR   SKIP; SKIP004762
DR   Wikidata; Q54931268
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-141-141-Skin-mR-iPSC
AC   CVCL_AC11
DR   SKIP; SKIP004764
DR   Wikidata; Q54931269
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-177-177-Skin-mR-iPSC
AC   CVCL_AC12
DR   SKIP; SKIP004765
DR   Wikidata; Q54931270
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-186-186-Skin-mR-iPSC
AC   CVCL_AC13
DR   SKIP; SKIP004766
DR   Wikidata; Q54931271
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-370-370-Skin-mR-iPSC
AC   CVCL_AC14
DR   SKIP; SKIP004767
DR   Wikidata; Q54931272
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-375-375-Skin-mR-iPSC
AC   CVCL_AC15
DR   SKIP; SKIP004768
DR   Wikidata; Q54931273
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   NYSCF-10005-384-384-Skin-mR-iPSC
AC   CVCL_AC16
DR   SKIP; SKIP004769
DR   Wikidata; Q54931274
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-392-392-Skin-mR-iPSC
AC   CVCL_AC17
DR   SKIP; SKIP004770
DR   Wikidata; Q54931275
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-401-401-Skin-mR-iPSC
AC   CVCL_AC18
DR   SKIP; SKIP004771
DR   Wikidata; Q54931276
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-405-405-Skin-mR-iPSC
AC   CVCL_AC19
DR   SKIP; SKIP004772
DR   Wikidata; Q54931277
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-406-406-Skin-mR-iPSC
AC   CVCL_AC20
DR   SKIP; SKIP004773
DR   Wikidata; Q54931278
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-411-411-Skin-mR-iPSC
AC   CVCL_AC21
DR   SKIP; SKIP004774
DR   Wikidata; Q54931279
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-415-415-Skin-mR-iPSC
AC   CVCL_AC22
DR   SKIP; SKIP004775
DR   Wikidata; Q54931280
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-417-417-Skin-mR-iPSC
AC   CVCL_AC23
DR   SKIP; SKIP004776
DR   Wikidata; Q54931281
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-425-425-Skin-mR-iPSC
AC   CVCL_AC24
DR   SKIP; SKIP004777
DR   Wikidata; Q54931282
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-432-432-Skin-mR-iPSC
AC   CVCL_AC25
DR   SKIP; SKIP004778
DR   Wikidata; Q54931283
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-433-433-Skin-mR-iPSC
AC   CVCL_AC26
DR   SKIP; SKIP004779
DR   Wikidata; Q54931284
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-434-434-Skin-mR-iPSC
AC   CVCL_AC27
DR   SKIP; SKIP004780
DR   Wikidata; Q54931285
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-437-437-Skin-mR-iPSC
AC   CVCL_AC28
DR   SKIP; SKIP004781
DR   Wikidata; Q54931286
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-438-438-Skin-mR-iPSC
AC   CVCL_AC29
DR   SKIP; SKIP004782
DR   Wikidata; Q54931287
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-459-459-Skin-mR-iPSC
AC   CVCL_AC30
DR   SKIP; SKIP004783
DR   Wikidata; Q54931288
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-460-460-Skin-mR-iPSC
AC   CVCL_AC31
DR   SKIP; SKIP004784
DR   Wikidata; Q54931293
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-465-465-Skin-mR-iPSC
AC   CVCL_AC32
DR   SKIP; SKIP004785
DR   Wikidata; Q54931294
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-469-469-Skin-mR-iPSC
AC   CVCL_AC33
DR   SKIP; SKIP004786
DR   Wikidata; Q54931295
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-470-470-Skin-mR-iPSC
AC   CVCL_AC34
DR   SKIP; SKIP004787
DR   Wikidata; Q54931296
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-476-476-Skin-mR-iPSC
AC   CVCL_AC35
DR   SKIP; SKIP004788
DR   Wikidata; Q54931297
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-478-478-Skin-mR-iPSC
AC   CVCL_AC36
DR   SKIP; SKIP004789
DR   Wikidata; Q54931298
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-491-491-Skin-mR-iPSC
AC   CVCL_AC37
DR   SKIP; SKIP004790
DR   Wikidata; Q54931299
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-555-555-Skin-mR-iPSC
AC   CVCL_AC38
DR   SKIP; SKIP004791
DR   Wikidata; Q54931300
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-558-558-Skin-mR-iPSC
AC   CVCL_AC39
DR   SKIP; SKIP004792
DR   Wikidata; Q54931301
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-562-562-Skin-mR-iPSC
AC   CVCL_AC40
DR   SKIP; SKIP004793
DR   Wikidata; Q54931302
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-566-566-Skin-mR-iPSC
AC   CVCL_AC41
DR   SKIP; SKIP004794
DR   Wikidata; Q54931303
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-568-568-Skin-mR-iPSC
AC   CVCL_AC42
DR   SKIP; SKIP004795
DR   Wikidata; Q54931304
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-569-569-Skin-mR-iPSC
AC   CVCL_AC43
DR   SKIP; SKIP004796
DR   Wikidata; Q54931305
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-570-570-Skin-mR-iPSC
AC   CVCL_AC44
DR   SKIP; SKIP004797
DR   Wikidata; Q54931306
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-580-580-Skin-mR-iPSC
AC   CVCL_AC45
DR   SKIP; SKIP004798
DR   Wikidata; Q54931307
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-582-582-Skin-mR-iPSC
AC   CVCL_AC46
DR   SKIP; SKIP004799
DR   Wikidata; Q54931308
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-583-583-Skin-mR-iPSC
AC   CVCL_AC47
DR   SKIP; SKIP004800
DR   Wikidata; Q54931309
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-585-585-Skin-mR-iPSC
AC   CVCL_AC48
DR   SKIP; SKIP004801
DR   Wikidata; Q54931310
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-590-590-Skin-mR-iPSC
AC   CVCL_AC49
DR   SKIP; SKIP004802
DR   Wikidata; Q54931311
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-592-592-Skin-mR-iPSC
AC   CVCL_AC50
DR   SKIP; SKIP004803
DR   Wikidata; Q54931312
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-596-596-Skin-mR-iPSC
AC   CVCL_AC51
DR   SKIP; SKIP004804
DR   Wikidata; Q54931313
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-597-597-Skin-mR-iPSC
AC   CVCL_AC52
DR   SKIP; SKIP004805
DR   Wikidata; Q54931314
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-598-598-Skin-mR-iPSC
AC   CVCL_AC53
DR   SKIP; SKIP004806
DR   Wikidata; Q54931315
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-605-605-Skin-mR-iPSC
AC   CVCL_AC54
DR   SKIP; SKIP004807
DR   Wikidata; Q54931316
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-611-611-Skin-mR-iPSC
AC   CVCL_AC55
DR   SKIP; SKIP004808
DR   Wikidata; Q54931317
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-617-617-Skin-mR-iPSC
AC   CVCL_AC56
DR   SKIP; SKIP004809
DR   Wikidata; Q54931318
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-623-623-Skin-mR-iPSC
AC   CVCL_AC57
DR   SKIP; SKIP004810
DR   Wikidata; Q54931319
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-632-632-Skin-mR-iPSC
AC   CVCL_AC58
DR   SKIP; SKIP004811
DR   Wikidata; Q54931320
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-635-635-Skin-mR-iPSC
AC   CVCL_AC59
DR   SKIP; SKIP004812
DR   Wikidata; Q54931321
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-636-636-Skin-mR-iPSC
AC   CVCL_AC60
DR   SKIP; SKIP004813
DR   Wikidata; Q54931322
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-642-642-Skin-mR-iPSC
AC   CVCL_AC61
DR   SKIP; SKIP004814
DR   Wikidata; Q54931323
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-644-644-Skin-mR-iPSC
AC   CVCL_AC62
DR   SKIP; SKIP004815
DR   Wikidata; Q54931324
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-645-645-Skin-mR-iPSC
AC   CVCL_AC63
DR   SKIP; SKIP004816
DR   Wikidata; Q54931325
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   NYSCF-10005-648-648-Skin-mR-iPSC
AC   CVCL_AC64
DR   SKIP; SKIP004817
DR   Wikidata; Q54931326
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-650-650-Skin-mR-iPSC
AC   CVCL_AC65
DR   SKIP; SKIP004818
DR   Wikidata; Q54931327
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-660-660-Skin-mR-iPSC
AC   CVCL_AC66
DR   SKIP; SKIP004819
DR   Wikidata; Q54931328
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-661-661-Skin-mR-iPSC
AC   CVCL_AC67
DR   SKIP; SKIP004820
DR   Wikidata; Q54931329
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-669-669-Skin-mR-iPSC
AC   CVCL_AC68
DR   SKIP; SKIP004821
DR   Wikidata; Q54931330
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-675-675-Skin-mR-iPSC
AC   CVCL_AC69
DR   SKIP; SKIP004822
DR   Wikidata; Q54931331
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-684-684-Skin-mR-iPSC
AC   CVCL_AC70
DR   SKIP; SKIP004823
DR   Wikidata; Q54931332
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-686-686-Skin-mR-iPSC
AC   CVCL_AC71
DR   SKIP; SKIP004824
DR   Wikidata; Q54931339
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-687-687-Skin-mR-iPS
AC   CVCL_A4FU
DR   SKIP; SKIP004825
DR   Wikidata; Q105510470
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NYSCF-10005-689-689-Skin-mR-iPSC
AC   CVCL_AC72
DR   SKIP; SKIP004826
DR   Wikidata; Q54931340
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-694-694-Skin-mR-iPSC
AC   CVCL_AC73
DR   SKIP; SKIP004827
DR   Wikidata; Q54931341
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-699-699-Skin-mR-iPSC
AC   CVCL_AC74
DR   SKIP; SKIP004828
DR   Wikidata; Q54931342
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-700-700-Skin-mR-iPSC
AC   CVCL_AC75
DR   SKIP; SKIP004829
DR   Wikidata; Q54931343
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-702-702-Skin-mR-iPSC
AC   CVCL_AC76
DR   SKIP; SKIP004830
DR   Wikidata; Q54931344
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-705-705-Skin-mR-iPSC
AC   CVCL_AC77
DR   SKIP; SKIP004831
DR   Wikidata; Q54931345
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-709-709-Skin-mR-iPSC
AC   CVCL_AC78
DR   SKIP; SKIP004832
DR   Wikidata; Q54931346
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-716-716-Skin-mR-iPSC
AC   CVCL_AC79
DR   SKIP; SKIP004833
DR   Wikidata; Q54931347
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-733-733-Skin-mR-iPSC
AC   CVCL_AC80
DR   SKIP; SKIP004834
DR   Wikidata; Q54931348
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-739-739-Skin-mR-iPSC
AC   CVCL_AC81
DR   SKIP; SKIP004835
DR   Wikidata; Q54931349
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-743-743-Skin-mR-iPSC
AC   CVCL_AC82
DR   SKIP; SKIP004836
DR   Wikidata; Q54931350
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-750-750-Skin-mR-iPSC
AC   CVCL_AC83
DR   SKIP; SKIP004837
DR   Wikidata; Q54931351
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-752-752-Skin-mR-iPSC
AC   CVCL_AC84
DR   SKIP; SKIP004838
DR   Wikidata; Q54931352
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-767-767-Skin-mR-iPSC
AC   CVCL_AC85
DR   SKIP; SKIP004839
DR   Wikidata; Q54931353
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-773-773-Skin-mR-iPSC
AC   CVCL_AC86
DR   SKIP; SKIP004840
DR   Wikidata; Q54931354
CC   From: New York Stem Cell Foundation; New York; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   NYSCF-10005-780-780-Skin-mR-iPSC
AC   CVCL_AC87
DR   SKIP; SKIP004841
DR   Wikidata; Q54931355
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-794-794-Skin-mR-iPSC
AC   CVCL_AC88
DR   SKIP; SKIP004842
DR   Wikidata; Q54931356
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-808-808-Skin-mR-iPSC
AC   CVCL_AC89
DR   SKIP; SKIP004843
DR   Wikidata; Q54931357
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-818-818-Skin-mR-iPSC
AC   CVCL_AC90
DR   SKIP; SKIP004844
DR   Wikidata; Q54931358
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-819-819-Skin-mR-iPSC
AC   CVCL_AC91
DR   SKIP; SKIP004845
DR   Wikidata; Q54931359
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-824-824-Skin-mR-iPSC
AC   CVCL_AC92
DR   SKIP; SKIP004846
DR   Wikidata; Q54931360
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-825-825-Skin-mR-iPSC
AC   CVCL_AC93
DR   SKIP; SKIP004847
DR   Wikidata; Q54931361
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-830-830-Skin-mR-iPSC
AC   CVCL_AC94
DR   SKIP; SKIP004848
DR   Wikidata; Q54931362
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-835-835-Skin-mR-iPSC
AC   CVCL_AC95
DR   SKIP; SKIP004849
DR   Wikidata; Q54931363
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-841-841-Skin-mR-iPSC
AC   CVCL_AC96
DR   SKIP; SKIP004850
DR   Wikidata; Q54931364
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-845-845-Skin-mR-iPSC
AC   CVCL_AC97
DR   SKIP; SKIP004851
DR   Wikidata; Q54931365
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-861-861-Skin-mR-iPSC
AC   CVCL_AC98
DR   SKIP; SKIP004852
DR   Wikidata; Q54931366
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-876-876-Skin-mR-iPSC
AC   CVCL_AC99
DR   SKIP; SKIP004853
DR   Wikidata; Q54931367
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-882-882-Skin-mR-iPSC
AC   CVCL_AD00
DR   SKIP; SKIP004854
DR   Wikidata; Q54931368
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-885-885-Skin-mR-iPSC
AC   CVCL_AD01
DR   SKIP; SKIP004855
DR   Wikidata; Q54931369
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-888-888-Skin-mR-iPSC
AC   CVCL_AD02
DR   SKIP; SKIP004856
DR   Wikidata; Q54931370
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-10005-900-900-Skin-mR-iPSC
AC   CVCL_AD03
DR   SKIP; SKIP004857
DR   Wikidata; Q54931371
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   NYSCF-10005-901-901-Skin-mR-iPSC
AC   CVCL_AD04
DR   SKIP; SKIP004858
DR   Wikidata; Q54931372
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-AD-1000-ASC2-Dura-SV-iPSC1
AC   CVCL_AD05
SY   ASC2D-MSA-CP
DR   SKIP; SKIP004859
DR   Wikidata; Q54931373
RX   PubMed=24398250;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD06 ! NYSCF-AD-1000-ASC2-Skin-SV-iPSC1
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   NYSCF-AD-1000-ASC2-Skin-SV-iPSC1
AC   CVCL_AD06
SY   ASC2S-MSA-CP
DR   SKIP; SKIP004860
DR   Wikidata; Q54931374
RX   PubMed=24398250;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84909; Multiple system atrophy
DI   ORDO; Orphanet_102; Multiple system atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD05 ! NYSCF-AD-1000-ASC2-Dura-SV-iPSC1
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   NYSCF-AD-1001-ASC7-Dura-SV-iPSC1
AC   CVCL_AD07
SY   ASC7D-AD clone 1
DR   SKIP; SKIP004861
DR   Wikidata; Q54931375
RX   PubMed=24398250;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   NYSCF-AD-1007-ASC19-Dura-SV-iPSC1
AC   CVCL_AD08
SY   ASC19D-ALS clone 1
DR   SKIP; SKIP004862
DR   Wikidata; Q54931376
RX   PubMed=24398250;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   NYSCF-AD-1011-ASC27-Dura-SV-iPSC1
AC   CVCL_AD09
SY   ASC27D-HD clone 1
DR   SKIP; SKIP004863
DR   Wikidata; Q54931377
RX   PubMed=24398250;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD10 ! NYSCF-AD-1011-ASC27-Dura-SV-iPSC2
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 12
//
ID   NYSCF-AD-1011-ASC27-Dura-SV-iPSC2
AC   CVCL_AD10
SY   ASC27D-HD clone 2
DR   SKIP; SKIP004864
DR   Wikidata; Q54931378
RX   PubMed=24398250;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD09 ! NYSCF-AD-1011-ASC27-Dura-SV-iPSC1
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   NYSCF-AD-1012-ASC30-Dura-SV-iPSC1
AC   CVCL_AD11
SY   ASC30D-PD clone 1
DR   SKIP; SKIP004865
DR   Wikidata; Q54931383
RX   PubMed=24398250;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Brain, meningeal dura mater; UBERON=UBERON_0010506.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   NYSCF-AD-1013-AG06842-Skin-RV-IPSC1
AC   CVCL_AD12
SY   6842A
DR   SKIP; SKIP004866
DR   Wikidata; Q54931384
RX   PubMed=24416243;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H777 ! AG06842
SX   Male
AG   75Y3M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   NYSCF-AD-1015-AG07671-Skin-RV-IPSC1
AC   CVCL_AD13
SY   7671C
DR   SKIP; SKIP004867
DR   Wikidata; Q54931385
RX   PubMed=24416243;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=24416243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4P39 ! AG07671
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   NYSCF-AD-1016-AG07768-Skin-RV-IPSC1
AC   CVCL_AD14
SY   7768C
DR   SKIP; SKIP004868
DR   Wikidata; Q54931386
RX   PubMed=24416243;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=24416243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T877 ! AG07768
SX   Female
AG   30Y6M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   NYSCF-AD-1019-AG07889-Skin-RV-IPSC1
AC   CVCL_AD15
SY   7889SA
DR   SKIP; SKIP004869
DR   Wikidata; Q54931387
RX   PubMed=24416243;
RX   PubMed=27120160;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian; Italian.
CC   Donor information: At sampling donor was not affected with Alzheimer disease but has a 25% risk (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K02 ! AG07889
SX   Male
AG   17Y8M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   NYSCF-AD-1021-AG08446-Skin-RV-IPSC1
AC   CVCL_AD16
DR   SKIP; SKIP004870
DR   Wikidata; Q54931388
RX   PubMed=24416243;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Leu (c.436A>C); ClinVar=VCV000018123; Zygosity=Unspecified (PubMed=24416243).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K58 ! AG08446
SX   Male
AG   38Y1M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   NYSCF-AG0001-01-MR
AC   CVCL_RZ99
SY   AG0001-01-MR
DR   Wikidata; Q54931389
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Thr124Met (c.371C>T); ClinVar=VCV000014181; Zygosity=Unspecified (NYSCF).
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   NYSCF-AG0002-01-MR
AC   CVCL_B7E9
SY   AG0002-01-MR
DR   Wikidata; Q114312618
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.His361Tyr (c.1081C>T); ClinVar=VCV000637315; Zygosity=Unspecified (NYSCF).
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 4
//
ID   NYSCF-AG0003-01-MR
AC   CVCL_JW96
SY   AG0003-01-MR
DR   Wikidata; Q54931390
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.His39Pro (c.116A>C); ClinVar=VCV000217232; Zygosity=Unspecified (NYSCF).
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0005-01-SV
AC   CVCL_JW97
SY   AG0005-01-SV
DR   Wikidata; Q54931391
CC   From: New York Stem Cell Foundation; New York; USA.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   NYSCF-AG0007-01-MR
AC   CVCL_JW98
SY   AG0007-01-MR
DR   Wikidata; Q54931392
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Thr124Met (c.371C>T); ClinVar=VCV000014181; Zygosity=Unspecified (NYSCF).
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   NYSCF-AG0008-01-MR
AC   CVCL_JW99
SY   AG0008-01-MR
DR   Wikidata; Q54931393
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Trp740Ser (c.2219G>C); ClinVar=VCV000002269; Zygosity=Unspecified (NYSCF).
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   NYSCF-AG0009-02-MR
AC   CVCL_JX00
SY   AG0009-02-MR
DR   Wikidata; Q54931394
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Arg98Cys (c.292C>T); ClinVar=VCV000014175; Zygosity=Unspecified (NYSCF).
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0010-01-MR
AC   CVCL_JX01
SY   AG0010-01-MR
DR   Wikidata; Q54931395
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7739; NEFL; Simple; p.Glu396Lys (c.1186G>A); ClinVar=VCV000066671; Zygosity=Unspecified (NYSCF).
DI   NCIt; C134953; Charcot-Marie-Tooth disease type 2E
DI   ORDO; Orphanet_99939; Autosomal dominant Charcot-Marie-Tooth disease type 2E
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0011-01-MR
AC   CVCL_JX02
SY   AG0011-01-MR
DR   Wikidata; Q54931396
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16873; FIG4; Simple; p.Ile41Thr (c.122T>C); ClinVar=VCV000001721; Zygosity=Unspecified (NYSCF).
CC   Sequence variation: Mutation; HGNC; HGNC:16873; FIG4; Simple; p.Arg183Ter (c.547C>T); ClinVar=VCV000001723; Zygosity=Unspecified (NYSCF).
DI   NCIt; C134954; Charcot-Marie-Tooth disease type 4J
DI   ORDO; Orphanet_139515; Charcot-Marie-Tooth disease type 4J
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   NYSCF-AG0012-01-MR
AC   CVCL_JX03
SY   AG0012-01-MR
DR   Wikidata; Q54931397
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Arg75Trp (c.223C>T); ClinVar=VCV000021082; Zygosity=Hemizygous (NYSCF).
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0013-01-MR
AC   CVCL_JX04
SY   AG0013-01-MR
DR   Wikidata; Q54931398
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Glu102Gly (c.305A>G); ClinVar=VCV000216038; Zygosity=Hemizygous (NYSCF).
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0014-01-MR
AC   CVCL_JX05
SY   AG0014-01-MR
DR   Wikidata; Q54931399
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Gly97Glu (c.290G>A); ClinVar=VCV000218306; Zygosity=Unspecified (NYSCF).
DI   NCIt; C168974; Charcot-Marie-Tooth disease type 2Y
DI   ORDO; Orphanet_435387; Autosomal dominant Charcot-Marie-Tooth disease type 2Y
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   NYSCF-AG0015-01-MR
AC   CVCL_JX06
SY   AG0015-01-MR
DR   Wikidata; Q54931400
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg364Trp (c.1090C>T); ClinVar=VCV000002278; Zygosity=Unspecified (NYSCF).
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0016-01-MR
AC   CVCL_JX07
SY   AG0016-01-MR
DR   Wikidata; Q54931401
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7739; NEFL; Simple; p.Asn98Ser (c.293A>G); ClinVar=VCV000041236; Zygosity=Unspecified (NYSCF).
DI   NCIt; C134953; Charcot-Marie-Tooth disease type 2E
DI   ORDO; Orphanet_99939; Autosomal dominant Charcot-Marie-Tooth disease type 2E
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0017-01-MR
AC   CVCL_JX08
SY   AG0017-01-MR
DR   Wikidata; Q54931402
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Arg364Trp (c.1090C>T); ClinVar=VCV000002278; Zygosity=Unspecified (NYSCF).
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   NYSCF-AG0018-01-MR
AC   CVCL_JX09
SY   AG0018-01-MR
DR   Wikidata; Q54931403
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7739; NEFL; Simple; p.Glu396Lys (c.1186G>A); ClinVar=VCV000066671; Zygosity=Unspecified (NYSCF).
DI   NCIt; C134953; Charcot-Marie-Tooth disease type 2E
DI   ORDO; Orphanet_99939; Autosomal dominant Charcot-Marie-Tooth disease type 2E
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0019-01-MR
AC   CVCL_JX10
SY   AG0019-01-MR
DR   Wikidata; Q54931404
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Arg98Cys (c.292C>T); ClinVar=VCV000014175; Zygosity=Unspecified (NYSCF).
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   NYSCF-AG0020-01-MR
AC   CVCL_JX11
SY   AG0020-01-MR
DR   Wikidata; Q54931405
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (NYSCF).
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 6
//
ID   NYSCF-AG0021-01-MR
AC   CVCL_JX12
SY   AG0021-01-MR
DR   Wikidata; Q54931406
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (NYSCF).
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 6
//
ID   NYSCF-DE-1016-1016-Skin-RV-IPSC1
AC   CVCL_AD91
DR   SKIP; SKIP004873
DR   Wikidata; Q54931407
RX   PubMed=21979046;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1017-1017-Skin-MR1
AC   CVCL_VF67
DR   SKIP; SKIP004874
DR   Wikidata; Q54931408
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   NYSCF-DE-1018-1018-Skin-MR1
AC   CVCL_A4FV
DR   SKIP; SKIP004875
DR   Wikidata; Q105510474
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD17 ! NYSCF-DE-1018-1018-Skin-RV-IPSC11
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   NYSCF-DE-1018-1018-Skin-RV-IPSC11
AC   CVCL_AD17
DR   SKIP; SKIP004876
DR   Wikidata; Q54931409
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4FV ! NYSCF-DE-1018-1018-Skin-MR1
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1019-1019-Skin-MR-iPSC1
AC   CVCL_AD18
DR   SKIP; SKIP004878
DR   Wikidata; Q54931410
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD19 ! NYSCF-DE-1019-1019-Skin-RV-iPSC1
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1019-1019-Skin-RV-iPSC1
AC   CVCL_AD19
DR   SKIP; SKIP004877
DR   Wikidata; Q54931411
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD18 ! NYSCF-DE-1019-1019-Skin-MR-iPSC1
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1020-1020-Skin-MR-iPSC1
AC   CVCL_AD20
DR   SKIP; SKIP004879
DR   Wikidata; Q54931412
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1024-1024-Skin-MR-iPSC1
AC   CVCL_AD21
DR   SKIP; SKIP004880
DR   Wikidata; Q54931413
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD22 ! NYSCF-DE-1024-1024-Skin-RV-iPSC1
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1024-1024-Skin-RV-iPSC1
AC   CVCL_AD22
DR   SKIP; SKIP004881
DR   Wikidata; Q54931414
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD21 ! NYSCF-DE-1024-1024-Skin-MR-iPSC1
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1028-1028-Skin-MR-iPSC1
AC   CVCL_AD23
DR   SKIP; SKIP004882
DR   Wikidata; Q54931415
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1034-1034-Skin-RV-IPSC1
AC   CVCL_AD92
DR   SKIP; SKIP004884
DR   Wikidata; Q54931416
RX   PubMed=21979046;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD93 ! NYSCF-DE-1034-1034-Skin-SV-IPSC1
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1034-1034-Skin-SV-IPSC1
AC   CVCL_AD93
DR   SKIP; SKIP004883
DR   Wikidata; Q54931417
RX   PubMed=21979046;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD92 ! NYSCF-DE-1034-1034-Skin-RV-IPSC1
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1035-1035-Skin-MR-iPSC1
AC   CVCL_AD24
DR   SKIP; SKIP004885
DR   Wikidata; Q54931418
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1039-1039-Skin-MR-iPSC1
AC   CVCL_AD25
DR   SKIP; SKIP004886
DR   Wikidata; Q54931419
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1044-1044-Skin-MR-iPSC1
AC   CVCL_AD26
DR   SKIP; SKIP004887
DR   Wikidata; Q54931420
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1045-1045-Skin-MR-iPSC1
AC   CVCL_AD27
DR   SKIP; SKIP004888
DR   Wikidata; Q54931421
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1046-1046-Skin-MR-iPSC1
AC   CVCL_AD28
DR   SKIP; SKIP004889
DR   Wikidata; Q54931422
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1048-1048-Skin-MR-iPSC1
AC   CVCL_AD29
DR   SKIP; SKIP004890
DR   Wikidata; Q54931436
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1051-1051-Skin-MR-iPSC1
AC   CVCL_AD30
DR   SKIP; SKIP004891
DR   Wikidata; Q54931437
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1052-1052-Skin-MR-iPSC1
AC   CVCL_AD31
DR   SKIP; SKIP004892
DR   Wikidata; Q54931438
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1054-1054-Skin-MR-iPSC1
AC   CVCL_VF68
DR   SKIP; SKIP004893
DR   Wikidata; Q54931439
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   NYSCF-DE-1057-1057-Skin-MR-iPSC1
AC   CVCL_AD32
DR   SKIP; SKIP004894
DR   Wikidata; Q54931440
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1060-1060-Skin-MR-iPSC1
AC   CVCL_AD33
DR   SKIP; SKIP004895
DR   Wikidata; Q54931441
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1064-1064-Skin-MR-iPSC1
AC   CVCL_AD34
DR   SKIP; SKIP004896
DR   Wikidata; Q54931442
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1086-1086-Skin-MR-iPSC1
AC   CVCL_AD35
DR   SKIP; SKIP004897
DR   Wikidata; Q54931443
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1091-1091-Skin-MR-iPSC1
AC   CVCL_AD36
DR   SKIP; SKIP004898
DR   Wikidata; Q54931444
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1109-1109-Skin-MR-iPSC1
AC   CVCL_AD37
DR   SKIP; SKIP004899
DR   Wikidata; Q54931445
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1110-1110-Skin-SV-iPSC1
AC   CVCL_VF69
DR   SKIP; SKIP004900
DR   Wikidata; Q54931446
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   NYSCF-DE-1111-1111-Skin-SV-iPSC1
AC   CVCL_VF70
DR   SKIP; SKIP004901
DR   Wikidata; Q54931447
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   NYSCF-DE-1113-1113-Skin-MR-iPSC1
AC   CVCL_AD38
DR   SKIP; SKIP004902
DR   Wikidata; Q54931448
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-DE-1158-1158-Skin-MR-iPSC1
AC   CVCL_AD39
DR   SKIP; SKIP004903
DR   Wikidata; Q54931449
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   NYSCF-MS-1000-10006-101-Skin-mi-iPSC1
AC   CVCL_AD40
DR   SKIP; SKIP004904
DR   Wikidata; Q54931450
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1001-10006-102-Skin-mi-iPSC4
AC   CVCL_AD41
SY   iPSC102
DR   SKIP; SKIP004905
DR   Wikidata; Q54931451
RX   PubMed=25254339;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1002-10006-103-Skin-mi-iPSC4
AC   CVCL_AD42
DR   SKIP; SKIP004906
DR   Wikidata; Q54931452
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1003-10006-104-Skin-mi-iPSC1
AC   CVCL_AD43
SY   iPSC104
DR   SKIP; SKIP004907
DR   Wikidata; Q54931453
RX   PubMed=25254339;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1004-10006-105-Skin-mi-iPSC1
AC   CVCL_AD44
DR   SKIP; SKIP004908
DR   Wikidata; Q54931454
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1005-10006-106-Skin-mi-iPSC1
AC   CVCL_AD45
DR   SKIP; SKIP004909
DR   Wikidata; Q54931455
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1006-10006-107-Skin-mi-iPSC1
AC   CVCL_AD46
SY   iPSC107
DR   SKIP; SKIP004910
DR   Wikidata; Q54931456
RX   PubMed=25254339;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1007-10006-108-Skin-mi-iPSC1
AC   CVCL_AD47
DR   SKIP; SKIP004911
DR   Wikidata; Q54931457
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1008-10006-109-Skin-mi-iPSC1
AC   CVCL_AD48
SY   iPSC109
DR   SKIP; SKIP004912
DR   Wikidata; Q54931458
RX   PubMed=25254339;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1011-10006-112-Skin-mi-iPSC1
AC   CVCL_AD49
DR   SKIP; SKIP004913
DR   Wikidata; Q54931459
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1017-10006-113-Skin-mi-iPSC1
AC   CVCL_AD50
DR   SKIP; SKIP004914
DR   Wikidata; Q54931460
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-MS-1019-10006-115-Skin-mi-iPSC1
AC   CVCL_AD51
DR   SKIP; SKIP004915
DR   Wikidata; Q54931461
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   NYSCF-PD-1030-10001.130.01-Skin-SV-iPSC7
AC   CVCL_AD52
DR   SKIP; SKIP004916
DR   Wikidata; Q54931462
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2
AC   CVCL_AD53
DR   SKIP; SKIP004917
DR   Wikidata; Q54931463
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (NYSCF).
CC   Donor information: Established from monozygotic twin of NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4 (Cellosaurus=CVCL_AD55) and NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5 (Cellosaurus=CVCL_AD56). At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD54 ! NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5
AC   CVCL_AD54
DR   SKIP; SKIP004918
DR   Wikidata; Q54931464
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (NYSCF).
CC   Donor information: Established from monozygotic twin of NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4 (Cellosaurus=CVCL_AD55) and NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5 (Cellosaurus=CVCL_AD56). At sampling donor was not affected with Parkinson disease but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD53 ! NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4
AC   CVCL_AD55
DR   SKIP; SKIP004919
DR   Wikidata; Q54931465
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (NYSCF).
CC   Donor information: Established from monozygotic twin of NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2 (Cellosaurus=CVCL_AD53) and NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5 (Cellosaurus=CVCL_AD54).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD56 ! NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5
AC   CVCL_AD56
DR   SKIP; SKIP004920
DR   Wikidata; Q54931466
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (NYSCF).
CC   Donor information: Established from monozygotic twin of NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2 (Cellosaurus=CVCL_AD53) and NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5 (Cellosaurus=CVCL_AD54).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AD55 ! NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   NYSCF1
AC   CVCL_AD94
DR   Wikidata; Q54931467
RX   PubMed=21979046;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=21979046
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 14,18
ST   D21S11: 27,31.2
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 9,13
ST   D8S1179: 14
ST   FGA: 20,22
ST   Penta D: 2.2,13
ST   Penta E: 13
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   NYSCF2
AC   CVCL_AX70
DR   Wikidata; Q54931468
RX   PubMed=26982723;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   NYSCFe001-A
AC   CVCL_LC26
SY   NY0001-01-ES-001; NYSCF100
DR   BioSamples; SAMEA104618138
DR   hPSCreg; NYSCFe001-A
DR   NIHhESC; NIHhESC-17-0389
DR   Wikidata; Q54931469
RX   PubMed=29631040;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0389.
CC   Characteristics: Derived in feeder free and antibiotic free conditions.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   NYSCFe002-A
AC   CVCL_LC27
SY   NY0002-01-ES-001; NYSCF101
DR   BioSamples; SAMEA104618140
DR   hPSCreg; NYSCFe002-A
DR   NIHhESC; NIHhESC-17-0390
DR   Wikidata; Q54931470
RX   PubMed=29730569;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0390.
CC   Characteristics: Derived in feeder free and antibiotic free conditions.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   NYSCFe003-A
AC   CVCL_VE10
SY   NY0003-01-ES-001
DR   BioSamples; SAMEA104617259
DR   hPSCreg; NYSCFe003-A
DR   Wikidata; Q54931471
RX   PubMed=29161648;
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Characteristics: Derived in feeder free and antibiotic free conditions.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 4
//
ID   NYSCFi001-A
AC   CVCL_WT99
SY   AL0002-01-MR-131
DR   BioSamples; SAMEA5728489
DR   hPSCreg; NYSCFi001-A
DR   Wikidata; Q98128253
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU00 ! NYSCFi001-B
OI   CVCL_WU01 ! NYSCFi001-C
OI   CVCL_WU02 ! NYSCFi001-D
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   NYSCFi001-B
AC   CVCL_WU00
SY   AL0002-01-MR-132
DR   BioSamples; SAMEA5728491
DR   hPSCreg; NYSCFi001-B
DR   Wikidata; Q98128254
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT99 ! NYSCFi001-A
OI   CVCL_WU01 ! NYSCFi001-C
OI   CVCL_WU02 ! NYSCFi001-D
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   NYSCFi001-C
AC   CVCL_WU01
SY   AL0002-01-SV-008
DR   BioSamples; SAMEA5728492
DR   hPSCreg; NYSCFi001-C
DR   Wikidata; Q98128256
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT99 ! NYSCFi001-A
OI   CVCL_WU00 ! NYSCFi001-B
OI   CVCL_WU02 ! NYSCFi001-D
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   NYSCFi001-D
AC   CVCL_WU02
SY   AL0002-01-SV-010
DR   BioSamples; SAMEA5728493
DR   hPSCreg; NYSCFi001-D
DR   Wikidata; Q98128257
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT99 ! NYSCFi001-A
OI   CVCL_WU00 ! NYSCFi001-B
OI   CVCL_WU01 ! NYSCFi001-C
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   NYSCFi002-A
AC   CVCL_WU03
SY   AL0004-01-SV-002
DR   BioSamples; SAMEA5728494
DR   hPSCreg; NYSCFi002-A
DR   Wikidata; Q98128258
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU04 ! NYSCFi002-B
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   NYSCFi002-B
AC   CVCL_WU04
SY   AL0004-01-SV-008
DR   BioSamples; SAMEA5728496
DR   hPSCreg; NYSCFi002-B
DR   Wikidata; Q98128259
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU03 ! NYSCFi002-A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   NYSCFi003-A
AC   CVCL_B5IZ
SY   CO0002-01-SV-003
DR   BioSamples; SAMEA9370368
DR   hPSCreg; NYSCFi003-A
DR   Wikidata; Q110433121
CC   From: New York Stem Cell Foundation; New York; USA.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   NYU08-175
AC   CVCL_T592
DR   Wikidata; Q54931472
RX   PubMed=22404973;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   NYU09-085
AC   CVCL_T593
DR   Wikidata; Q54931474
RX   PubMed=22404973;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   NYU09-203
AC   CVCL_T594
DR   Wikidata; Q54931476
RX   PubMed=22404973;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   NYU10-040
AC   CVCL_T595
DR   Wikidata; Q54931478
RX   PubMed=22404973;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   NYU10-230
AC   CVCL_T596
DR   Wikidata; Q54931495
RX   PubMed=22404973;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   NYUES1
AC   CVCL_B869
SY   NYUES 1
DR   NIHhESC; NIHhESC-10-0045
DR   Wikidata; Q54931496
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0045.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NYUES10
AC   CVCL_B876
DR   NIHhESC; NIHhESC-13-0240
DR   Wikidata; Q54931497
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0240.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NYUES11
AC   CVCL_B877
DR   NIHhESC; NIHhESC-13-0236
DR   Wikidata; Q54931498
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0236.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C116344; Trisomy 14
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   NYUES12
AC   CVCL_B878
DR   NIHhESC; NIHhESC-13-0235
DR   Wikidata; Q54931500
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0235.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C37865; Trisomy 17
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   NYUES13
AC   CVCL_M246
DR   NIHhESC; NIHhESC-13-0237
DR   Wikidata; Q54931501
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0237.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 12
//
ID   NYUES2
AC   CVCL_B870
SY   NYUES 2
DR   NIHhESC; NIHhESC-10-0046
DR   Wikidata; Q54931503
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0046.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NYUES3
AC   CVCL_B871
SY   NYUES 3
DR   NIHhESC; NIHhESC-10-0047
DR   Wikidata; Q54931505
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0047.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NYUES4
AC   CVCL_B872
SY   NYUES 4
DR   NIHhESC; NIHhESC-10-0048
DR   Wikidata; Q54931507
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0048.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NYUES5
AC   CVCL_B873
SY   NYUES 5
DR   NIHhESC; NIHhESC-10-0049
DR   Wikidata; Q54931509
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0049.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NYUES6
AC   CVCL_B874
SY   NYUES 6
DR   NIHhESC; NIHhESC-10-0050
DR   Wikidata; Q54931511
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0050.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 16
//
ID   NYUES7
AC   CVCL_B875
SY   NYUES 7
DR   NIHhESC; NIHhESC-10-0051
DR   Wikidata; Q54931513
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0051.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   NYUES8
AC   CVCL_B879
DR   NIHhESC; NIHhESC-13-0238
DR   Wikidata; Q54931515
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0238.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   NYUES9
AC   CVCL_B880
DR   NIHhESC; NIHhESC-13-0239
DR   Wikidata; Q54931517
RX   PubMed=22204497;
CC   From: New York University School of Medicine; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0239.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   NZ-1.2
AC   CVCL_YA16
DR   Wikidata; Q98128260
RX   PubMed=23012488;
CC   Monoclonal antibody isotype: IgG2a, lambda.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   NZB 1-14.12
AC   CVCL_D5LE
SY   14.12
DR   Wikidata; Q127382975
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-14.13
AC   CVCL_D5LF
SY   14.13
DR   Wikidata; Q127382976
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-14.17
AC   CVCL_D5LG
SY   14.17
DR   Wikidata; Q127382978
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-16.7
AC   CVCL_D5LH
SY   16.7
DR   Wikidata; Q127382979
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-2.10
AC   CVCL_D5L8
SY   2.10
DR   Wikidata; Q127382980
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-2.12
AC   CVCL_D5L9
SY   2.12
DR   Wikidata; Q127382981
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-2.8
AC   CVCL_D5L7
SY   2.8
DR   Wikidata; Q127382982
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes (Note=Also reacts with sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-8.1
AC   CVCL_D5LA
SY   8.1
DR   Wikidata; Q127382984
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-9.10
AC   CVCL_D5LD
SY   9.10
DR   Wikidata; Q127382985
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes (Note=Also reacts with sheep).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-9.4
AC   CVCL_D5LB
SY   9.4
DR   Wikidata; Q127382986
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB 1-9.5
AC   CVCL_D5LC
SY   9.5
DR   Wikidata; Q127382987
RX   PubMed=6926851;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse antigen on erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   NZB-S-M
AC   CVCL_C5SN
DR   Wikidata; Q116050020
RX   PubMed=7341770;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: NZB/Scr.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   NZel-1
AC   CVCL_C8BG
DR   Wikidata; Q123033202
RX   PubMed=9114014;
RX   PubMed=9576878;
CC   Characteristics: Defective in alkyldihydroxyacetone phosphate (DHAP) synthase (PubMed=9114014).
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   NZG-0906
AC   CVCL_D7DP
SY   NZG0906
DR   EFO; EFO_0022357
RX   PubMed=32320427;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NZG-1003
AC   CVCL_D7DQ
SY   NZG1003
RX   PubMed=32320427;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   NZM001
AC   CVCL_D815
SY   NZM01; NZM1
DR   BioSample; SAMN07624439
DR   BioSample; SAMN14558285
DR   CBA; CBA-1389
DR   Cosmic; 2007642
DR   Cosmic; 2141929
DR   Wikidata; Q54931518
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 60 hours (PubMed=7718330); 70-80 hours (CBA=CBA-1389).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Obturator lymph node; UBERON=UBERON_0035171.
ST   Source(s): CBA=CBA-1389; PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 19
ST   D19S433: 13,15
ST   D21S11: 27,32.2
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 6,8
ST   TPOX: 10,12
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D823 ! NZM002
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   NZM002
AC   CVCL_D823
SY   NZM02; NZM2
DR   BioSample; SAMN07624442
DR   BioSample; SAMN14558313
DR   CBA; CBA-1378
DR   Cosmic; 2007643
DR   Wikidata; Q54931542
RX   CelloPub=CLPUB00227;
RX   PubMed=7999427;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 43.2 hours (CelloPub=CLPUB00227); 70 hours (CBA=CBA-1378).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Iliac lymph node; UBERON=UBERON_0015878.
ST   Source(s): CBA=CBA-1378; PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 19
ST   D19S433: 13,15
ST   D21S11: 27,32.2
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 6,8
ST   TPOX: 10,12
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D815 ! NZM001
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   NZM003
AC   CVCL_D828
SY   NZM03; NZM3
DR   BioSample; SAMN07624443
DR   BioSample; SAMN14558314
DR   cancercelllines; CVCL_D828
DR   CBA; CBA-1392
DR   Cosmic; 1660299
DR   Cosmic; 2007644
DR   Cosmic; 2406331
DR   DepMap; ACH-001982
DR   Wikidata; Q54931561
RX   CelloPub=CLPUB00227;
RX   PubMed=7999427;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 40.8 hours (CelloPub=CLPUB00227); 44-48 hours (CBA=CBA-1392).
CC   HLA typing: A*01:01,02:01; B*08:01,27:05; C*02:02,07:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790; DepMap=ACH-001982).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: The results of the Sequenom MassARRAY used in PubMed=32567790 contradicts the whole exome sequencing data for BRAF and indicates a p.Val600Lys (c.1798_1799delGTinsAA) variant.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): CBA=CBA-1392; DepMap=ACH-001982; PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 12,18
ST   D19S433: 12,15
ST   D21S11: 29,30.2
ST   D2S1338: 22,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,10 (CBA=CBA-1392; DepMap=ACH-001982)
ST   D7S820: 10 (PubMed=32567790)
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 10,14
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   NZM004
AC   CVCL_D831
SY   NZM04; NZM4
DR   BioSample; SAMN07624445
DR   BioSample; SAMN14558315
DR   cancercelllines; CVCL_D831
DR   CBA; CBA-1390
DR   Cosmic; 2007645
DR   Cosmic; 2141925
DR   IARC_TP53; 14964
DR   Wikidata; Q54931572
RX   CelloPub=CLPUB00227;
RX   PubMed=7999427;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=21912889;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 29.8 hours (CelloPub=CLPUB00227); 48 hours (CBA=CBA-1390).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Pro (c.721T>C); ClinVar=VCV000376664; Zygosity=Unspecified (PubMed=11216673; PubMed=21912889).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CBA=CBA-1390; PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15 (CBA=CBA-1390)
ST   D18S51: 15,20 (PubMed=32567790)
ST   D19S433: 12,15
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 15,18
ST   D5S818: 9
ST   D7S820: 8,9
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   NZM005
AC   CVCL_D837
SY   NZM05; NZM5
DR   BioSample; SAMN07624449
DR   BioSample; SAMN14558316
DR   cancercelllines; CVCL_D837
DR   CBA; CBA-1388
DR   Cosmic; 2007646
DR   Wikidata; Q54931584
RX   CelloPub=CLPUB00227;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 30 hours (PubMed=7718330); 48 hours (CBA=CBA-1388).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): CBA=CBA-1388; PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 12,14 (PubMed=32567790)
ST   D19S433: 12,14,15 (CBA=CBA-1388)
ST   D21S11: 28,31.2
ST   D2S1338: 17,26
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 9,13
ST   FGA: 21,23
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   NZM006
AC   CVCL_D842
SY   NZM06; NZM6
DR   BioSample; SAMN07624450
DR   BioSample; SAMN14558317
DR   cancercelllines; CVCL_D842
DR   CBA; CBA-1386
DR   Cosmic; 1660289
DR   Cosmic; 2007647
DR   Cosmic; 2406333
DR   Wikidata; Q54931595
RX   CelloPub=CLPUB00227;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 34 hours (PubMed=7718330); 50 hours (CBA=CBA-1386).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
ST   Source(s): CBA=CBA-1386; PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,14
ST   D16S539: 11
ST   D18S51: 13,15
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 20.1,23 (PubMed=32567790)
ST   FGA: 20.2,23 (CBA=CBA-1386)
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   NZM007
AC   CVCL_D843
SY   NZM07; NZM7
DR   BioSample; SAMN07624451
DR   BioSample; SAMN14558318
DR   cancercelllines; CVCL_D843
DR   CBA; CBA-1384
DR   Cosmic; 2007648
DR   Cosmic; 2141920
DR   DepMap; ACH-001990
DR   Wikidata; Q54931608
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=21912889;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 24 hours (PubMed=7718330); 49 hours (CBA=CBA-1384).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Pro (c.721T>C); ClinVar=VCV000376664; Zygosity=Unspecified (PubMed=11216673; PubMed=21912889).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): CBA=CBA-1384; PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 12,14
ST   D19S433: 11,14
ST   D21S11: 29
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   NZM007.2
AC   CVCL_D844
SY   NZM07.2; NZM7.2
DR   cancercelllines; CVCL_D844
DR   IARC_TP53; 14965
DR   Wikidata; Q54931609
RX   PubMed=11216673;
RX   PubMed=20041153;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Pro (c.721T>C); ClinVar=VCV000376664; Zygosity=Unspecified (PubMed=11216673).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D843 ! NZM007
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   NZM007.4
AC   CVCL_D845
SY   NZM07.4; NZM7.4
DR   cancercelllines; CVCL_D845
DR   Wikidata; Q54931610
RX   PubMed=11216673;
RX   PubMed=20041153;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Arg429Cys (c.1285C>T); dbSNP=rs201274282; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11216673).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D843 ! NZM007
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   NZM008
AC   CVCL_D846
SY   NZM08; NMZ8
DR   Wikidata; Q54931621
RX   PubMed=7718330;
CC   Doubling time: 100 hours (PubMed=7718330).
CC   Miscellaneous: Cell line has been lost.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   NZM009
AC   CVCL_D847
SY   NZM09; NZM9
DR   BioSample; SAMN14558319
DR   Cosmic; 2007649
DR   Cosmic; 2141930
DR   Wikidata; Q54931632
RX   CelloPub=CLPUB00227;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 45.6 hours (CelloPub=CLPUB00227).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12.3
ST   D19S433: 12,14
ST   D21S11: 29.3,30
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 11,17
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,21,22
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   NZM010
AC   CVCL_D816
SY   NZM10
DR   cancercelllines; CVCL_D816
DR   Cosmic; 1660296
DR   Cosmic; 2007650
DR   Wikidata; Q54931519
RX   PubMed=11216673;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 12
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 28
ST   D2S1338: 19
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   TH01: 7,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   NZM011
AC   CVCL_D817
SY   NZM11
DR   BioSample; SAMN07624440
DR   BioSample; SAMN14558320
DR   cancercelllines; CVCL_D817
DR   CBA; CBA-1398
DR   Cosmic; 2007651
DR   Cosmic; 2141926
DR   Wikidata; Q54931527
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 5-6 days (CBA=CBA-1398).
CC   HLA typing: A*01:01,02:01; B*07:02,08:01; C*07:01,07:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): CBA=CBA-1398; PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 15,18
ST   D19S433: 13,15.2
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 24
ST   Penta D: 12,14
ST   Penta E: 7
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   NZM012
AC   CVCL_D818
SY   NZM12
DR   BioSample; SAMN07624441
DR   BioSample; SAMN14558321
DR   cancercelllines; CVCL_D818
DR   CBA; CBA-1383
DR   Cosmic; 1660300
DR   Wikidata; Q54931528
RX   CelloPub=CLPUB00227;
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Doubling time: 25.9 hours (CelloPub=CLPUB00227); 40-42 hours (CBA=CBA-1383).
CC   HLA typing: A*02:01,32:01; B*44:02,44:02; C*01:02,05:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23755070; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
ST   Source(s): CBA=CBA-1383; PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 23,25
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 20,23
ST   Penta D: 9,13
ST   Penta E: 5,16
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   NZM013
AC   CVCL_D819
SY   NZM13
DR   BioSample; SAMN14558322
DR   cancercelllines; CVCL_D819
DR   Cosmic; 2007652
DR   Wikidata; Q54931529
RX   CelloPub=CLPUB00227;
RX   PubMed=11216673;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Doubling time: 76.8 hours (CelloPub=CLPUB00227).
CC   HLA typing: A*02:01,03:01; B*15:01,35:01; C*03:03,04:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Neck, hypodermis; UBERON=UBERON_0000974+UBERON_0002072.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 11,15
ST   FGA: 19,22
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   NZM014
AC   CVCL_D820
SY   NZM14
DR   BioSample; SAMN14558323
DR   cancercelllines; CVCL_D820
DR   Cosmic; 2007653
DR   Wikidata; Q54931530
RX   PubMed=11216673;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Thigh, skeletal muscle; UBERON=UBERON_0004252.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D19S433: 15
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 7,8
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   NZM015
AC   CVCL_D821
SY   NZM15
DR   BioSample; SAMN14558324
DR   cancercelllines; CVCL_D821
DR   Cosmic; 1660297
DR   Cosmic; 2007654
DR   Wikidata; Q54931532
RX   PubMed=11216673;
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   HLA typing: A*02:01,11:01; B*13:02,39:01; C*06:02,07:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Neck, hypodermis; UBERON=UBERON_0000974+UBERON_0002072.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 17,19
ST   D3S1358: 15,19
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   NZM016
AC   CVCL_S436
SY   NZM16
DR   Wikidata; Q54931533
RX   CelloPub=CLPUB00227;
RX   PubMed=32567790;
CC   Doubling time: 50.4 hours (CelloPub=CLPUB00227).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   NZM017
AC   CVCL_S437
SY   NZM17; NZM 017
DR   cancercelllines; CVCL_S437
DR   Cosmic; 2007655
DR   Cosmic; 2141931
DR   Wikidata; Q54931535
RX   CelloPub=CLPUB00227;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 43.2 hours (CelloPub=CLPUB00227).
CC   HLA typing: A*68:02,68:02; B*35:01,35:01; C*04:01,04:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 15,15.2
ST   D21S11: 28.3,29
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 20
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   NZM018
AC   CVCL_S438
SY   NZM18
DR   Wikidata; Q54931537
RX   CelloPub=CLPUB00227;
RX   PubMed=32567790;
CC   Doubling time: 62.5 hours (CelloPub=CLPUB00227).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 12,21
ST   D19S433: 13,14
ST   D21S11: 31,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 15,16
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   NZM019
AC   CVCL_D822
SY   NZM19
DR   Cosmic; 2007656
DR   Wikidata; Q54931540
RX   CelloPub=CLPUB00227;
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 63.1 hours (CelloPub=CLPUB00227).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 11,12
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 16,25
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,13
ST   D8S1179: 10,11
ST   FGA: 23,25
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   NZM020
AC   CVCL_D824
SY   NZM20
DR   BioSample; SAMN14558325
DR   cancercelllines; CVCL_D824
DR   Cosmic; 2007657
DR   Cosmic; 2141927
DR   Wikidata; Q54931544
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 12,15
ST   D21S11: 31,32
ST   D2S1338: 16,19
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 25
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   NZM021
AC   CVCL_S435
SY   NZM21
DR   BioSample; SAMN14558326
DR   Cosmic; 2007658
DR   Wikidata; Q54931546
RX   CelloPub=CLPUB00227;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 22.8 hours (CelloPub=CLPUB00227).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,14
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 27,29
ST   D2S1338: 17,19
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 9,15
ST   FGA: 23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   NZM022
AC   CVCL_D825
SY   NZM22
DR   BioSample; SAMN14558327
DR   cancercelllines; CVCL_D825
DR   Cosmic; 2007659
DR   Wikidata; Q54931548
RX   CelloPub=CLPUB00227;
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Doubling time: 81.4 hours (CelloPub=CLPUB00227).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly466Ala (c.1397G>C); ClinVar=VCV000376295; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg1362Ter (c.4084C>T); ClinVar=VCV000000344; Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 27,29
ST   D2S1338: 17,19
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   NZM023
AC   CVCL_D826
SY   NZM23
DR   BioSample; SAMN14558328
DR   Cosmic; 2007660
DR   Wikidata; Q54931549
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   HLA typing: A*24:02,24:02; B*44:05,44:05; C*02:02,02:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   NZM024
AC   CVCL_D827
SY   NZM24
DR   BioSample; SAMN14558329
DR   cancercelllines; CVCL_D827
DR   Cosmic; 2007661
DR   Wikidata; Q54931550
RX   CelloPub=CLPUB00227;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 39.4 hours (CelloPub=CLPUB00227).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   NZM025
AC   CVCL_S430
SY   NZM25
DR   Wikidata; Q54931552
RX   CelloPub=CLPUB00227;
RX   PubMed=32567790;
CC   Doubling time: 37.1 hours (CelloPub=CLPUB00227).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 17,19
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 25
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 20,23
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   NZM026
AC   CVCL_S431
SY   NZM26
DR   cancercelllines; CVCL_S431
DR   Wikidata; Q54931553
RX   CelloPub=CLPUB00227;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Doubling time: 63.1 hours (CelloPub=CLPUB00227).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23755070; PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   NZM027
AC   CVCL_S432
SY   NZM27
DR   Wikidata; Q54931558
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 12
ST   D21S11: 30,31.2
ST   D2S1338: 17,23
ST   D3S1358: 17,20
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,12
ST   FGA: 22,24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   NZM028
AC   CVCL_S433
SY   NZM28
DR   BioSample; SAMN14558330
DR   cancercelllines; CVCL_S433
DR   Cosmic; 2007662
DR   Wikidata; Q54931559
RX   CelloPub=CLPUB00227;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Doubling time: 38.4 hours (CelloPub=CLPUB00227).
CC   HLA typing: A*01:01,03:01; B*35:01,44:02; C*04:01,05:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Ala (c.1406G>C); ClinVar=VCV000013971; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu584Phe (c.1750C>T); ClinVar=VCV000802374; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   NZM029
AC   CVCL_S434
SY   NZM29
DR   Cosmic; 2007663
DR   Wikidata; Q54931560
RX   PubMed=23658559;
RX   PubMed=32567790;
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 31,32
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 19,24
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 8
//
ID   NZM030
AC   CVCL_D829
SY   NZM30
DR   BioSample; SAMN07624444
DR   BioSample; SAMN14558331
DR   cancercelllines; CVCL_D829
DR   CBA; CBA-1399
DR   Cosmic; 1660292
DR   Cosmic; 2007664
DR   Cosmic; 2406334
DR   Wikidata; Q54931562
RX   CelloPub=CLPUB00227;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 29.6 hours (CelloPub=CLPUB00227); 80-90 hours (CBA=CBA-1399).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): CBA=CBA-1399; PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 12,13
ST   D19S433: 14,17.2
ST   D21S11: 24.2,31
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   NZM031
AC   CVCL_S439
SY   NZM31
DR   BioSample; SAMN14558332
DR   cancercelllines; CVCL_S439
DR   Cosmic; 2007665
DR   Wikidata; Q54931563
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   NZM032
AC   CVCL_0D28
SY   NZM32
DR   BioSample; SAMN14558333
DR   cancercelllines; CVCL_0D28
DR   Wikidata; Q54931564
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10,13
ST   D16S539: 12,13
ST   D18S51: 10,15
ST   D19S433: 16
ST   D21S11: 31,32.2
ST   D2S1338: 20,23
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 11,12
ST   FGA: 19,21
ST   TH01: 8,9.3
ST   TPOX: 9,13
ST   vWA: 16,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM033
AC   CVCL_S440
SY   NZM33
DR   BioSample; SAMN14558334
DR   cancercelllines; CVCL_S440
DR   Cosmic; 2007666
DR   Wikidata; Q54931565
RX   CelloPub=CLPUB00227;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 62.4 hours (CelloPub=CLPUB00227).
CC   HLA typing: A*02:01,02:05; B*50:01,51:01; C*01:02,06:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=23658559; PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,15
ST   D16S539: 13
ST   D18S51: 12,13
ST   D19S433: 12,13
ST   D21S11: 27,30
ST   D2S1338: 17,26
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 19,24
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   NZM034
AC   CVCL_D830
SY   NZM34
DR   cancercelllines; CVCL_D830
DR   Cosmic; 1660290
DR   Cosmic; 2007667
DR   Cosmic; 2406335
DR   Wikidata; Q54931566
RX   CelloPub=CLPUB00227;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 40.8 hours (CelloPub=CLPUB00227).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 12,17
ST   D19S433: 13,16.2
ST   D21S11: 31
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 20,25
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 18
//
ID   NZM035
AC   CVCL_S427
SY   NZM35
DR   cancercelllines; CVCL_S427
DR   Cosmic; 2007668
DR   Wikidata; Q54931567
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 17
ST   D19S433: 13,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 17,21
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 22,26
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   NZM036
AC   CVCL_S428
SY   NZM36
DR   BioSample; SAMN14558335
DR   Cosmic; 2007669
DR   Wikidata; Q54931568
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   HLA typing: A*02:01,11:01; B*44:02,48:01; C*05:01,08:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 28,31.2
ST   D2S1338: 22,23
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   NZM037
AC   CVCL_S449
SY   NZM37
DR   BioSample; SAMN14558336
DR   cancercelllines; CVCL_S449
DR   Cosmic; 2007670
DR   Wikidata; Q54931569
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Thr599_Val600insThr (c.1794_1796dup) (p.Thr599dup); ClinVar=VCV000162793; Zygosity=Unspecified (PubMed=23658559).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   NZM038
AC   CVCL_S450
SY   NZM38
DR   cancercelllines; CVCL_S450
DR   Cosmic; 2007671
DR   Wikidata; Q54931570
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   NZM039
AC   CVCL_S429
SY   NZM39
DR   Cosmic; 2007672
DR   Wikidata; Q54931571
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 10,12
ST   D18S51: 13,19
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   NZM040
AC   CVCL_D832
SY   NZM40; NZM 040
DR   BioSample; SAMN07624446
DR   BioSample; SAMN14558337
DR   cancercelllines; CVCL_D832
DR   CBA; CBA-1381
DR   Cosmic; 1660293
DR   Cosmic; 2007673
DR   Cosmic; 2406332
DR   Wikidata; Q54931573
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Doubling time: 38 hours (CBA=CBA-1381).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Homozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=23755070; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249_Thr253del; Zygosity=Unspecified (PubMed=23755070).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): CBA=CBA-1381; PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 17,18
ST   D19S433: 11,13
ST   D21S11: 27,34.2
ST   D2S1338: 20
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 23,24
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   NZM041
AC   CVCL_S426
SY   NZM41
DR   BioSample; SAMN14558338
DR   cancercelllines; CVCL_S426
DR   Cosmic; 2007674
DR   Wikidata; Q54931575
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asp594Asn (c.1780G>A); ClinVar=VCV000044813; Zygosity=Unspecified (PubMed=23658559).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Asn1112fs (c.3335delA); Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln2582Ter (c.7744C>T); Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,19
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 25,26
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S424 ! NZM047
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   NZM042
AC   CVCL_D833
SY   NZM42
DR   BioSample; SAMN07624447
DR   BioSample; SAMN14558339
DR   cancercelllines; CVCL_D833
DR   CBA; CBA-1391
DR   Cosmic; 1660298
DR   DepMap; ACH-001986
DR   Wikidata; Q54931576
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=32567790;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 70-80 hours (CBA=CBA-1391).
CC   HLA typing: A*03:01,11:01; B*07:02,45:01; C*06:02,07:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=32567790; CBA=CBA-1391).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): CBA=CBA-1391; PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 15
ST   D21S11: 29,32.2
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 19,20
ST   Penta D: 13,15
ST   Penta E: 15,18
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S423 ! NZM048
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   NZM043
AC   CVCL_D834
SY   NZM43
DR   BioSample; SAMN07624448
DR   BioSample; SAMN14558340
DR   cancercelllines; CVCL_D834
DR   CBA; CBA-1396
DR   Cosmic; 1660291
DR   Cosmic; 2007675
DR   Wikidata; Q54931577
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 5-6 days (CBA=CBA-1396).
CC   HLA typing: A*03:01,24:02; B*07:02,52:01; C*07:02,12:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): CBA=CBA-1396; PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 13
ST   D21S11: 27,29
ST   D2S1338: 17,18
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,16
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 9,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   NZM044
AC   CVCL_S425
SY   NZM44
DR   Cosmic; 2007676
DR   Wikidata; Q54931578
RX   PubMed=23658559;
RX   PubMed=32567790;
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 15,17
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 22,25
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 8
//
ID   NZM045
AC   CVCL_D835
SY   NZM45
DR   BioSample; SAMN14558341
DR   cancercelllines; CVCL_D835
DR   Cosmic; 2007677
DR   Wikidata; Q54931579
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Arg183Cys (c.547C>T); ClinVar=VCV000548668; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,14
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,24
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   NZM046
AC   CVCL_D836
SY   NZM46
DR   cancercelllines; CVCL_D836
DR   Cosmic; 1660294
DR   Cosmic; 2007678
DR   Cosmic; 2406336
DR   Wikidata; Q54931580
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (PubMed=23658559).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 29,31.2
ST   D2S1338: 18
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 14,16
ST   FGA: 23
ST   TH01: 9.3
ST   TPOX: 9,10
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 17
//
ID   NZM047
AC   CVCL_S424
SY   NZM47
DR   BioSample; SAMN14558342
DR   cancercelllines; CVCL_S424
DR   Wikidata; Q54931581
RX   PubMed=32567790;
CC   HLA typing: A*03:01,03:01; B*35:01,44:02; C*04:01,05:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Asn1112fs (c.3335delA); Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln2582Ter (c.7744C>T); Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,19
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 25,26
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S426 ! NZM041
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   NZM048
AC   CVCL_S423
SY   NZM48
DR   BioSample; SAMN14558343
DR   cancercelllines; CVCL_S423
DR   Cosmic; 2007679
DR   Wikidata; Q54931582
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   HLA typing: A*03:01,11:01; B*45:01,45:01; C*06:02,07:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 15
ST   D21S11: 29,32.2
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 19,20
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D833 ! NZM042
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   NZM049
AC   CVCL_S422
SY   NZM49
DR   cancercelllines; CVCL_S422
DR   Cosmic; 2007680
DR   Wikidata; Q54931583
RX   PubMed=23658559;
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   NZM050
AC   CVCL_S421
SY   NZM50
DR   cancercelllines; CVCL_S421
DR   Wikidata; Q54931585
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Unspecified (PubMed=23755070).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 14
ST   D18S51: 15
ST   D19S433: 12,13
ST   D21S11: 31.2,32.2
ST   D2S1338: 20
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 15,16
ST   FGA: 25
ST   TH01: 6,9
ST   TPOX: 9,10
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   NZM051
AC   CVCL_S420
SY   NZM51
DR   Wikidata; Q54931586
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 6
//
ID   NZM052
AC   CVCL_D838
SY   NZM52
DR   BioSample; SAMN14558344
DR   cancercelllines; CVCL_D838
DR   Cosmic; 1660295
DR   Wikidata; Q54931587
RX   PubMed=20041153;
RX   PubMed=22475322;
RX   PubMed=32567790;
CC   HLA typing: A*01:01,32:01; B*07:02,35:01; C*04:01,07:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 28,31.2
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 10,14
ST   FGA: 20,26
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   NZM053
AC   CVCL_D839
SY   NZM53
DR   Wikidata; Q54931588
RX   PubMed=20041153;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 27,32.2
ST   D2S1338: 18,20
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 20,22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   NZM054
AC   CVCL_0D29
SY   NZM54
DR   BioSample; SAMN14558345
DR   cancercelllines; CVCL_0D29
DR   Wikidata; Q54931589
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM055
AC   CVCL_S419
SY   NZM55
DR   cancercelllines; CVCL_S419
DR   Cosmic; 2007681
DR   Cosmic; 2141921
DR   Wikidata; Q54931590
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 12,13
ST   D21S11: 28,31
ST   D2S1338: 18,19
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   NZM056
AC   CVCL_S418
SY   NZM56
DR   cancercelllines; CVCL_S418
DR   Cosmic; 2007682
DR   Wikidata; Q54931591
RX   CelloPub=CLPUB00227;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Doubling time: 33.6 hours (CelloPub=CLPUB00227).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   NZM057
AC   CVCL_D840
SY   NZM57
DR   Wikidata; Q54931592
RX   PubMed=20041153;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 17,20
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 19
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   NZM058
AC   CVCL_D841
SY   NZM58
DR   cancercelllines; CVCL_D841
DR   Cosmic; 2007683
DR   Wikidata; Q54931593
RX   PubMed=20041153;
RX   PubMed=23658559;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   NZM059
AC   CVCL_0B54
SY   NZM59
DR   BioSample; SAMN14558346
DR   cancercelllines; CVCL_0B54
DR   Wikidata; Q54931594
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 25
ST   D3S1358: 17,18
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM060
AC   CVCL_S416
SY   NZM60
DR   BioSample; SAMN14558347
DR   cancercelllines; CVCL_S416
DR   Wikidata; Q54931596
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Homozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 13,15.2
ST   D21S11: 29,34.1
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   TH01: 7,8
ST   TPOX: 9,10
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   NZM061
AC   CVCL_S417
SY   NZM61
DR   cancercelllines; CVCL_S417
DR   Cosmic; 2007684
DR   Cosmic; 2141922
DR   Wikidata; Q54931597
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 12,13
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 16,18
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 19,23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   NZM062
AC   CVCL_0D26
SY   NZM62
DR   cancercelllines; CVCL_0D26
DR   Wikidata; Q54931598
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D21S11: 30,31
ST   D2S1338: 21
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10
ST   FGA: 18,25
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0D27 ! NZM064
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM063
AC   CVCL_S441
SY   NZM63
DR   cancercelllines; CVCL_S441
DR   Cosmic; 2007685
DR   Cosmic; 2141932
DR   Wikidata; Q54931600
RX   PubMed=23658559;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 10
ST   D18S51: 16,20
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 17,25
ST   D3S1358: 11,16
ST   D5S818: 10,15
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 13,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   NZM064
AC   CVCL_0D27
SY   NZM64
DR   Wikidata; Q54931601
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0D26 ! NZM062
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM065
AC   CVCL_0D30
SY   NZM65
DR   cancercelllines; CVCL_0D30
DR   Wikidata; Q54931602
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM066
AC   CVCL_0D31
SY   NZM66
DR   cancercelllines; CVCL_0D31
DR   Wikidata; Q54931603
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 17,19
ST   D19S433: 14,16
ST   D21S11: 28,30.2
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 14
ST   FGA: 24,25
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM067
AC   CVCL_0D32
SY   NZM67
DR   cancercelllines; CVCL_0D32
DR   Wikidata; Q54931604
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 12,16
ST   D21S11: 28
ST   D2S1338: 20,24
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 14
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM068
AC   CVCL_0D33
SY   NZM68
DR   Wikidata; Q54931605
RX   PubMed=32567790;
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 30,32.2
ST   D2S1338: 17
ST   D3S1358: 8,9.3
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 22.2,24
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 5
//
ID   NZM069
AC   CVCL_0D34
SY   NZM69
DR   cancercelllines; CVCL_0D34
DR   Wikidata; Q54931607
RX   PubMed=32567790;
CC   HLA typing: A*01:01,25:01; B*35:03,40:01; C*03:04,12:03 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM070
AC   CVCL_0D35
SY   NZM70
DR   Wikidata; Q54931611
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM071
AC   CVCL_0C85
SY   NZM71
DR   cancercelllines; CVCL_0C85
DR   Wikidata; Q54931612
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,21
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 20
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM072
AC   CVCL_0D36
SY   NZM72
DR   BioSample; SAMN14558348
DR   cancercelllines; CVCL_0D36
DR   Wikidata; Q54931613
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg416Ter (c.1246C>T); ClinVar=VCV000404597; Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 12,13.2
ST   D21S11: 28,30
ST   D2S1338: 21,23
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 12
ST   FGA: 20,22
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM073
AC   CVCL_0D37
SY   NZM73
DR   cancercelllines; CVCL_0D37
DR   Wikidata; Q54931614
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 12,18
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM074
AC   CVCL_0D38
SY   NZM74
DR   cancercelllines; CVCL_0D38
DR   Wikidata; Q54931615
RX   PubMed=32567790;
CC   HLA typing: A*01:01,01:01; B*08:01,40:01; C*03:04,07:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM075
AC   CVCL_0D39
SY   NZM75
DR   Wikidata; Q54931616
RX   PubMed=32567790;
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 14,15
ST   D21S11: 28
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 16
ST   FGA: 20
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 5
//
ID   NZM076
AC   CVCL_0B51
SY   NZM76
DR   cancercelllines; CVCL_0B51
DR   Cosmic; 2141928
DR   Wikidata; Q54931617
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 8,9
ST   D18S51: 12,15
ST   D19S433: 13,14
ST   D21S11: 32.2
ST   D2S1338: 17,18
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 23,24
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM077
AC   CVCL_0D40
SY   NZM77
DR   BioSample; SAMN14558349
DR   cancercelllines; CVCL_0D40
DR   Wikidata; Q54931618
RX   PubMed=32567790;
CC   HLA typing: A*01:01,03:01; B*08:01,15:01; C*03:03,07:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Pro1323Ser (c.3967C>T); ClinVar=VCV000945186; Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,18
ST   D19S433: 13,14.2
ST   D21S11: 26,30
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 18,22
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   NZM078
AC   CVCL_0D41
SY   NZM78
DR   cancercelllines; CVCL_0D41
DR   Wikidata; Q54931619
RX   PubMed=32567790;
CC   HLA typing: A*02:01,11:01; B*07:02,51:08; C*07:02,16:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Thr992Ile (c.2975C>T) (p.Thr1010Ile, c.3029C>T); ClinVar=VCV000041624; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM079
AC   CVCL_0D42
SY   NZM79
DR   cancercelllines; CVCL_0D42
DR   Wikidata; Q54931620
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 19
ST   D19S433: 14,15
ST   D21S11: 27,31
ST   D2S1338: 17,19
ST   D3S1358: 16,17
ST   D5S818: 9
ST   D7S820: 8,9
ST   D8S1179: 14,16
ST   FGA: 18,19
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM080
AC   CVCL_0D43
SY   NZM80
DR   BioSample; SAMN14558350
DR   Wikidata; Q54931622
RX   PubMed=32567790;
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 14,18
ST   D19S433: 14,15.2
ST   D2S1338: 22
ST   D3S1358: 18,19
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 11,13
ST   FGA: 19,23
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 6
//
ID   NZM081
AC   CVCL_0D44
SY   NZM81
DR   cancercelllines; CVCL_0D44
DR   Wikidata; Q54931623
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM082
AC   CVCL_0B55
SY   NZM82
DR   BioSample; SAMN14558351
DR   cancercelllines; CVCL_0B55
DR   Wikidata; Q54931624
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM083
AC   CVCL_0D45
SY   NZM83
DR   cancercelllines; CVCL_0D45
DR   Wikidata; Q54931625
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Heterozygous (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 16,19
ST   D19S433: 14,16
ST   D21S11: 28,30
ST   D2S1338: 20,22
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM084
AC   CVCL_0D46
SY   NZM84
DR   Wikidata; Q54931626
RX   PubMed=32567790;
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 12,15
ST   D19S433: 12,14
ST   D21S11: 28,31.2
ST   D2S1338: 17,25
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 5
//
ID   NZM085
AC   CVCL_0B56
SY   NZM85
DR   BioSample; SAMN14558352
DR   cancercelllines; CVCL_0B56
DR   Wikidata; Q54931627
RX   PubMed=23755070;
RX   PubMed=32567790;
CC   HLA typing: A*02:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 30.2,31
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 11,13
ST   D8S1179: 14
ST   FGA: 21,22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM086
AC   CVCL_0B52
SY   NZM86
DR   BioSample; SAMN14558353
DR   cancercelllines; CVCL_0B52
DR   Cosmic; 2141923
DR   Wikidata; Q54931628
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14.2,17
ST   D21S11: 30,31.2
ST   D2S1338: 17,23
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 11,13
ST   FGA: 23,26
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM087
AC   CVCL_0D47
SY   NZM87
DR   BioSample; SAMN14558354
DR   cancercelllines; CVCL_0D47
DR   Wikidata; Q54931629
RX   PubMed=32567790;
CC   HLA typing: A*02:01,03:01; B*07:02,14:02; C*07:02,08:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.His1170Tyr; Zygosity=Unspecified (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Glu996Lys (c.2986G>A); ClinVar=VCV000822435; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D19S433: 12,13
ST   D21S11: 30,32.2
ST   D2S1338: 20,24
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 23,25
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 19,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM088
AC   CVCL_0D48
SY   NZM88
DR   Wikidata; Q54931630
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 19
ST   D19S433: 13,13.2
ST   D21S11: 29,31
ST   D2S1338: 16,24
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 12,15
ST   FGA: 20,24
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM089
AC   CVCL_0D49
SY   NZM89
DR   cancercelllines; CVCL_0D49
DR   Wikidata; Q54931631
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 20,22
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM090
AC   CVCL_0D50
SY   NZM90
DR   BioSample; SAMN14558355
DR   cancercelllines; CVCL_0D50
DR   Wikidata; Q54931633
RX   PubMed=32567790;
CC   HLA typing: A*02:01,26:01; B*07:02,38:01; C*07:02,12:03 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM091
AC   CVCL_0D51
SY   NZM91
DR   BioSample; SAMN14558356
DR   cancercelllines; CVCL_0D51
DR   Wikidata; Q54931634
RX   PubMed=32567790;
CC   HLA typing: A*02:01,02:01; B*08:01,44:02; C*05:01,07:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 15,16
ST   D21S11: 29,30
ST   D2S1338: 22,24
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10
ST   FGA: 22,25
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM092
AC   CVCL_0D52
SY   NZM92
DR   BioSample; SAMN14558357
DR   cancercelllines; CVCL_0D52
DR   Wikidata; Q54931635
RX   PubMed=32567790;
CC   HLA typing: A*01:01,01:01; B*08:01,44:02; C*05:01,07:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 27,29
ST   D2S1338: 17,19
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM093
AC   CVCL_0D53
SY   NZM93
DR   BioSample; SAMN14558358
DR   cancercelllines; CVCL_0D53
DR   Wikidata; Q54931636
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM094
AC   CVCL_0D54
SY   NZM94
DR   Wikidata; Q54931637
RX   PubMed=32567790;
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 12
ST   D18S51: 13,16
ST   D19S433: 14,15.2
ST   D21S11: 30.2
ST   D2S1338: 25
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 21,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 5
//
ID   NZM095
AC   CVCL_0D55
SY   NZM95
DR   Wikidata; Q54931638
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 12,14
ST   D21S11: 30,31
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   NZM096
AC   CVCL_0D56
SY   NZM96
DR   cancercelllines; CVCL_0D56
DR   Wikidata; Q54931639
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,15
ST   D13S317: 8,13
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 32,32.2
ST   D2S1338: 18,26
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 11,15
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM097
AC   CVCL_0D57
SY   NZM97
DR   BioSample; SAMN14558359
DR   cancercelllines; CVCL_0D57
DR   Wikidata; Q54931640
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 19,22
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM098
AC   CVCL_0D58
SY   NZM98
DR   cancercelllines; CVCL_0D58
DR   Wikidata; Q54931642
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,14
ST   D16S539: 13
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 31
ST   D2S1338: 17,21
ST   D3S1358: 14,17
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20,23
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM099
AC   CVCL_0D59
SY   NZM99
DR   cancercelllines; CVCL_0D59
DR   Wikidata; Q54931643
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Asp1071Asn (c.3211G>A); ClinVar=VCV000240346; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM100
AC   CVCL_0B53
DR   BioSample; SAMN14558360
DR   cancercelllines; CVCL_0B53
DR   Cosmic; 2141924
DR   Wikidata; Q54931520
RX   PubMed=23755070;
RX   PubMed=24455489;
RX   PubMed=32567790;
CC   HLA typing: A*01:01,11:01; B*08:01,08:01; C*04:01,07:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 12,15
ST   D21S11: 31,32
ST   D2S1338: 16,19
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 12,13
ST   FGA: 20,25
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM101
AC   CVCL_0D60
DR   BioSample; SAMN14558361
DR   cancercelllines; CVCL_0D60
DR   Wikidata; Q54931521
RX   PubMed=32567790;
CC   HLA typing: A*11:01,29:02; B*35:01,51:01; C*04:01,15:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 17,19
ST   D19S433: 12
ST   D21S11: 29,30
ST   D2S1338: 25,26
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 10,11
ST   FGA: 20,21
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM102
AC   CVCL_0D61
DR   BioSample; SAMN14558362
DR   cancercelllines; CVCL_0D61
DR   Wikidata; Q54931522
RX   PubMed=32567790;
CC   HLA typing: A*02:01,02:01; B*08:01,08:01; C*07:01,07:02 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   D13S317: 12
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   NZM103
AC   CVCL_0D62
DR   cancercelllines; CVCL_0D62
DR   Wikidata; Q54931523
RX   PubMed=32567790;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
ST   Source(s): PubMed=32567790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 13,18
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 7,9
ST   D8S1179: 13
ST   FGA: 22
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM104
AC   CVCL_0D63
DR   BioSample; SAMN14558363
DR   cancercelllines; CVCL_0D63
DR   Wikidata; Q54931524
RX   PubMed=32567790;
CC   HLA typing: A*31:01,31:01; B*44:02,44:02; C*05:01,05:01 (PubMed=32567790).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=32567790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   NZM105
AC   CVCL_0D64
DR   Wikidata; Q54931525
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 4
//
ID   NZM106
AC   CVCL_0D65
DR   Wikidata; Q54931526
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 4
//
ID   NZOV1
AC   CVCL_D811
SY   NZOV-1; NZ-OV1; New Zealand OVarian line 1
DR   Wikidata; Q54931644
RX   PubMed=7718330;
RX   PubMed=19493612;
RX   PubMed=21912889;
CC   Doubling time: 65 hours (PubMed=7718330).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His178Thr; Zygosity=Unspecified (PubMed=21912889).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   NZOV10
AC   CVCL_D814
SY   NZOV-10; New Zealand OVarian line 10
DR   Wikidata; Q54931645
RX   PubMed=7718330;
RX   PubMed=19493612;
RX   PubMed=21912889;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Phe (c.659A>T); Zygosity=Unspecified (PubMed=21912889).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   NZOV11
AC   CVCL_D810
SY   NZOV-11; New Zealand OVarian line 11
DR   cancercelllines; CVCL_D810
DR   Wikidata; Q54931646
RX   PubMed=7718330;
RX   PubMed=19493612;
RX   PubMed=21912889;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=21912889).
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   NZOV13
AC   CVCL_LJ77
SY   NZOV-13; New Zealand OVarian line 13
DR   Wikidata; Q54931647
RX   PubMed=7718330;
RX   PubMed=19493612;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   NZOV2
AC   CVCL_D812
SY   NZOV-2; New Zealand OVarian line 2
DR   cancercelllines; CVCL_D812
DR   Wikidata; Q54931648
RX   PubMed=19493612;
RX   PubMed=21912889;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Asp (c.658T>G); ClinVar=VCV000376689; Zygosity=Unspecified (PubMed=21912889).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   NZOV4
AC   CVCL_LJ74
SY   NZOV-4; New Zealand OVarian line 4
DR   Wikidata; Q54931649
RX   PubMed=19493612;
CC   Characteristics: Indicated to be a metastatic ovarian adenocarcinoma with a probable gastrointestinal primary site.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C3052; Digestive system neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 4
//
ID   NZOV5
AC   CVCL_LJ75
SY   NZOV-5; New Zealand OVarian line 5
DR   Wikidata; Q54931650
RX   PubMed=19493612;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 4
//
ID   NZOV7
AC   CVCL_LJ76
SY   NZOV-7; New Zealand OVarian line 7
DR   Wikidata; Q54931651
RX   PubMed=19493612;
CC   Characteristics: Indicated to be a metastatic mucinous carcinoma of ovary with a probable primary site from large bowel.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 4
//
ID   NZOV8
AC   CVCL_D813
SY   NZOV-8; New Zealand OVarian line 8
DR   cancercelllines; CVCL_D813
DR   Wikidata; Q54931652
RX   PubMed=19493612;
RX   PubMed=21912889;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Unspecified (PubMed=21912889).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   NZOV9
AC   CVCL_LJ73
SY   NZOV-9; New Zealand OVarian line 9
DR   BioSample; SAMN07624452
DR   cancercelllines; CVCL_LJ73
DR   CBA; CBA-1394
DR   DepMap; ACH-001991
DR   Wikidata; Q54931653
RX   PubMed=7718330;
RX   PubMed=19493612;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 30 hours (CBA=CBA-1394).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Tyr1021Cys (c.3062A>G); ClinVar=VCV000376246; Zygosity=Unspecified (CBA=CBA-1394; DepMap=ACH-001991).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gly (c.388C>G); ClinVar=VCV000375958; Zygosity=Unspecified (DepMap=ACH-001991).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): CBA=CBA-1394; DepMap=ACH-001991
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 14,18
ST   D19S433: 14
ST   D21S11: 28,30 (CBA=CBA-1394)
ST   D21S11: 28,30,31 (DepMap=ACH-001991)
ST   D2S1338: 21,22
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 10,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 15
//
ID   NZP-12
AC   CVCL_3759
SY   National Zoological Park-12
DR   CLO; CLO_0008216
DR   ATCC; CRL-1921
DR   Wikidata; Q54931654
CC   Senescence: Capable of at least 13 PDL (ATCC=CRL-1921).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=71111; ! Crossarchus obscurus (Long-nosed cusimanse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NZP-29
AC   CVCL_3760
SY   National Zoological Park-29
DR   CLO; CLO_0008217
DR   ATCC; CRL-1925
DR   Wikidata; Q54931655
CC   Senescence: Capable of at least 12 PDL (ATCC=CRL-1925).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=59534; ! Oryx dammah (Scimitar-horned oryx)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   NZP-36
AC   CVCL_3761
SY   National Zoological Park-36
DR   CLO; CLO_0008218
DR   ATCC; CRL-1922
DR   Wikidata; Q54931656
CC   Senescence: Capable of at least 10 PDL (ATCC=CRL-1922).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=89252; ! Equus quagga burchellii (Burchell's zebra)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   NZP-46
AC   CVCL_6340
SY   National Zoological Park-46
DR   ATCC; CRL-1926
DR   Wikidata; Q54931657
CC   Senescence: Capable of at least 17 PDL (ATCC=CRL-1926).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64678; ! Callosciurus notatus (Plantain squirrel)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   NZP-53
AC   CVCL_V311
SY   National Zoological Park-53
DR   ATCC; CRL-1920
DR   Wikidata; Q54931658
CC   Group: Endangered species/breed cell line.
CC   Senescence: Capable of at least 10 PDL (ATCC=CRL-1920).
CC   Discontinued: ATCC; CRL-1920; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9646; ! Ailuropoda melanoleuca (Giant panda)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   NZP-60
AC   CVCL_3762
SY   National Zoological Park-60
DR   CLO; CLO_0008220
DR   ATCC; CRL-1924
DR   Wikidata; Q54931659
CC   Group: Non-human primate cell line.
CC   Senescence: Capable of at least 12 PDL (ATCC=CRL-1924).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9482; ! Mico argentatus (Silvery marmoset)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   NZW-D-M
AC   CVCL_C5SP
DR   Wikidata; Q116050021
RX   PubMed=7341770;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: NZW/Scr.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   NZW-S1-M
AC   CVCL_C5SQ
DR   Wikidata; Q116050022
RX   PubMed=7341770;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: NZW/Scr.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   NZW-S2-M
AC   CVCL_C5SR
DR   Wikidata; Q116050023
RX   PubMed=7341770;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: NZW/Scr.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   O clone 1
AC   CVCL_D3XM
DR   Wikidata; Q127382988
RX   PubMed=38049592;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from the occipital region of a male patient with androgenic alopecia during hair transplantation.
CC   Derived from site: In situ; Hair follicle; UBERON=UBERON_0002073.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
DI   NCIt; C50575; Alopecia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3XJ ! F clone 1
OI   CVCL_D3XK ! F clone 2
OI   CVCL_D3XL ! F clone 3
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   O-342
AC   CVCL_5847
DR   CLS; 500305
DR   Wikidata; Q54931660
RX   PubMed=1744159;
RX   PubMed=2121738;
CC   Doubling time: ~24 hours (PubMed=1744159).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   O-342/DDP
AC   CVCL_5J47
DR   Wikidata; Q54931662
RX   PubMed=1744159;
RX   PubMed=2121738;
CC   Doubling time: ~24 hours (PubMed=1744159).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5847 ! O-342
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   O1-10
AC   CVCL_D7DA
RX   PubMed=24303921;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   O14-1
AC   CVCL_C4LD
DR   Wikidata; Q116050024
RX   PubMed=1315319;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P49134; Rat Itgb1/Cd29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   O24B
AC   CVCL_W083
DR   BioSamples; SAMEA100789
DR   cancercelllines; CVCL_W083
DR   Cosmic; 1522767
DR   GEO; GSM726280
DR   Progenetix; CVCL_W083
DR   Wikidata; Q54931663
RX   PubMed=21642991;
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Gln322fs*9 (c.966_978del13); Zygosity=Homozygous (PubMed=21642991).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   O26
AC   CVCL_C4LB
DR   Wikidata; Q116050025
RX   PubMed=1315319;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q63258; Rat Itga7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   O2A6B5
AC   CVCL_XK43
DR   Wikidata; Q98128261
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_7731; Ofloxacin (OFL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   O2B-3
AC   CVCL_D7DB
RX   PubMed=24303921;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   O3D4G9
AC   CVCL_XK44
DR   Wikidata; Q98128262
RX   PubMed=17511422;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_7731; Ofloxacin (OFL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 4
//
ID   O4-Cb-neu
AC   CVCL_IZ81
DR   Wikidata; Q54931664
RX   PubMed=7582098;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Activated EGFR-neu.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   6D
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   O4ANS
AC   CVCL_A5DX
DR   Wikidata; Q107116601
RX   PubMed=16766697;
RX   PubMed=23630160;
CC   Doubling time: ~30 hours (PubMed=16766697).
CC   Derived from site: In situ; Brain, subventricular zone; UBERON=UBERON_0014940.
CC   Cell type: Neural stem cell; CL=CL_0000047.
CC   Breed/subspecies: 129 x MF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   O5
AC   CVCL_C4LC
DR   Wikidata; Q116050026
RX   PubMed=1315319;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q63258; Rat Itga7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   O9-1
AC   CVCL_GS42
DR   Millipore; SCC049
DR   Wikidata; Q54931665
RX   PubMed=22889333;
RX   PubMed=30371662;
CC   Characteristics: Capable of differentiating into four cell types: osteoblasts, chondrocytes, smooth muscle cells and glial cells.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Neural crest; UBERON=UBERON_0002342.
CC   Breed/subspecies: Wnt1-Cre;R26R-GFP transgenic.
ST   Source(s): Millipore=SCC049
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 13,19
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 15,17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2,26.2
ST   Mouse STR 8-1: 14.3,16
ST   Mouse STR 11-2: 14,18
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 15.2,17
ST   Mouse STR 15-3: 20.3,22.3
ST   Mouse STR 17-2: 12
ST   Mouse STR 18-3: 16,18
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   8-9FD
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   OA-11a2
AC   CVCL_C6ER
SY   OA-11a
DR   Wikidata; Q116050027
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-2
AC   CVCL_D7DC
RX   PubMed=25077632;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   OA-2c
AC   CVCL_C6ES
DR   Wikidata; Q116050028
RX   PubMed=14505432;
RX   PubMed=15056927;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-3a2
AC   CVCL_C6ET
DR   Wikidata; Q116050029
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-4
AC   CVCL_D7DD
RX   PubMed=25077632;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   OA-5ca
AC   CVCL_C6F5
DR   Wikidata; Q116050031
RX   PubMed=15056927;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-5cg
AC   CVCL_C6EU
DR   Wikidata; Q116050032
RX   PubMed=14505432;
RX   PubMed=15056927;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-5ch
AC   CVCL_C6F6
DR   Wikidata; Q116050033
RX   PubMed=15056927;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-5cm
AC   CVCL_C6EV
DR   Wikidata; Q116050034
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-6b
AC   CVCL_C6EW
DR   Wikidata; Q116050035
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA-ab
AC   CVCL_C6EX
DR   Wikidata; Q116050036
RX   PubMed=14505432;
RX   PubMed=15056927;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OA051-140
AC   CVCL_C5HF
DR   Wikidata; Q116050037
RX   PubMed=21529295;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Z1G4; Mouse Atp6v0a1.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   OA051-7
AC   CVCL_C5HG
DR   Wikidata; Q116050038
RX   PubMed=21529295;
CC   Group: Bird cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Z1G4; Mouse Atp6v0a1.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5H4 ! MuH1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   OA1
AC   CVCL_3763
SY   Oa 1 Br; OA1.Br; NBL-13
DR   CLO; CLO_0008224
DR   CLDB; cl3754
DR   ATCC; CRL-6538
DR   IZSLER; BS CL 109
DR   Wikidata; Q54931666
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6538; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   OA2.Sk
AC   CVCL_S362
DR   ATCC; CRL-6539
DR   Wikidata; Q54931667
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6539; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   OA3.Bm
AC   CVCL_S363
DR   ATCC; CRL-6540
DR   Wikidata; Q54931668
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6540; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_R786 ! OA3.Lu
OI   CVCL_3764 ! OA3.Ts
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   OA3.Lu
AC   CVCL_R786
DR   ATCC; CRL-6541
DR   ATCC; CRL-6545
DR   Wikidata; Q54931669
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6541; true.
CC   Discontinued: ATCC; CRL-6545; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_S363 ! OA3.Bm
OI   CVCL_3764 ! OA3.Ts
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 5
//
ID   OA3.Ts
AC   CVCL_3764
SY   OAT-T3
DR   CLO; CLO_0008225
DR   ATCC; CRL-6546
DR   IZSLER; BS CL 234
DR   KCB; KCB 2016061YJ
DR   Wikidata; Q54931670
RX   PubMed=17823391;
RX   PubMed=33389257;
RX   PubMed=34737324;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Virology: Persistently infected by bovine viral diarrhea virus 2 (BVDV-2) (PubMed=34737324).
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_S363 ! OA3.Bm
OI   CVCL_R786 ! OA3.Lu
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OA4.Bm
AC   CVCL_3765
DR   CLO; CLO_0008226
DR   ATCC; CRL-6547
DR   Wikidata; Q54931671
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6547; true.
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_R785 ! OA4.K
OI   CVCL_S364 ! OA4.Tes
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   OA4.K
AC   CVCL_R785
DR   ATCC; CRL-6548
DR   Wikidata; Q54931672
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6548; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_3765 ! OA4.Bm
OI   CVCL_S364 ! OA4.Tes
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   OA4.K/S1
AC   CVCL_6426
SY   OA4.K/s1; OA4K/s1
DR   CLO; CLO_0008227
DR   ATCC; CRL-6549
DR   Wikidata; Q54931673
RX   PubMed=34737324;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_R785 ! OA4.K
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   OA4.Tes
AC   CVCL_S364
DR   ATCC; CRL-6550
DR   Wikidata; Q54931674
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6550; true.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_3765 ! OA4.Bm
OI   CVCL_R785 ! OA4.K
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   OACM4.1 C
AC   CVCL_2249
SY   OAC-M4.1 C
DR   Wikidata; Q54931675
RX   PubMed=11407472;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1843 ! OACP4 C
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   OACM5 1.C SC1
AC   CVCL_JX13
DR   Wikidata; Q54931677
RX   PubMed=28504813;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1842 ! OACM5.1 C
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 7
//
ID   OACM5.1 C
AC   CVCL_1842
SY   OAC-M5.1 C; OAC-M5.1; OACM5-1; OACM5.1; OACM5_1; OACM51
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 970
DR   BioSample; SAMN03473445
DR   cancercelllines; CVCL_1842
DR   Cell_Model_Passport; SIDM00444
DR   Cosmic; 1599344
DR   Cosmic-CLP; 1503363
DR   DepMap; ACH-001368
DR   DSMZ; ACC-696
DR   DSMZCellDive; ACC-696
DR   ECACC; 11012006
DR   EGA; EGAS00001000978
DR   GDSC; 1503363
DR   GEO; GSM1670290
DR   PharmacoDB; OACM51_1176_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54931676
RX   PubMed=11407472;
RX   PubMed=20075370;
RX   PubMed=23795680;
RX   PubMed=27397505;
RX   PubMed=27594985;
RX   PubMed=28504813;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (DSMZ=ACC-696).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0.02%; East Asian, North=0%; East Asian, South=0%; South Asian=1.6%; European, North=72.08%; European, South=26.29% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1503363; DSMZ=ACC-696; ECACC=11012006; PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 28,31
ST   D2S1338: 19,24
ST   D3S1358: 16,17
ST   D5S818: 11,12 (Cosmic-CLP=1503363; DSMZ=ACC-696; ECACC=11012006)
ST   D5S818: 12 (PubMed=20075370)
ST   D7S820: 8 (Cosmic-CLP=1503363; DSMZ=ACC-696; PubMed=20075370)
ST   D7S820: 8.2 (ECACC=11012006)
ST   D8S1179: 13 (DSMZ=ACC-696)
ST   D8S1179: 13,14 (PubMed=20075370)
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 7,14
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 19,20
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   OACP4 C
AC   CVCL_1843
SY   OAC-P4C; OACP4C; OACp4C
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473391
DR   cancercelllines; CVCL_1843
DR   Cell_Model_Passport; SIDM00445
DR   Cosmic; 1599345
DR   Cosmic-CLP; 1503362
DR   DepMap; ACH-002292
DR   DSMZ; ACC-704
DR   DSMZCellDive; ACC-704
DR   ECACC; 11012005
DR   EGA; EGAS00001000978
DR   GDSC; 1503362
DR   GEO; GSM1670291
DR   PharmacoDB; OACp4C_1177_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54931678
RX   PubMed=11407472;
RX   PubMed=20075370;
RX   PubMed=23795680;
RX   PubMed=27397505;
RX   PubMed=27594985;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~35-50 hours (DSMZ=ACC-704).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (PubMed=20075370; Cosmic-CLP=1503362; DepMap=ACH-002292).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.19%; Native American=0.55%; East Asian, North=0%; East Asian, South=1.33%; South Asian=0.08%; European, North=66.1%; European, South=31.76% (PubMed=30894373).
CC   Misspelling: OACP4CE; PubMed=23795680.
ST   Source(s): Cosmic-CLP=1503362; DSMZ=ACC-704; ECACC=11012005; PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 16,24
ST   D3S1358: 18
ST   D5S818: 9
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 20
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2249 ! OACM4.1 C
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   OAD2
AC   CVCL_Z080
DR   Wikidata; Q54931679
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   OAiAC
AC   CVCL_E5VI
SY   OA iAC; OsteoArthritic immortalized Articular Chondrocytes
DR   ABM; T0385
RX   PubMed=36647698;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from an osteoarthritic patient that had a hip fracture (PubMed=36647698).
CC   Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062.
CC   Cell type: Chondrocyte; CL=CL_0000138.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OAL-1
AC   CVCL_UZ64
DR   Wikidata; Q98128263
RX   PubMed=3065371;
CC   Derived from site: In situ; Cheek, skin; UBERON=UBERON_0008803.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   OAL-2
AC   CVCL_UZ65
DR   Wikidata; Q98128264
RX   PubMed=3065371;
CC   Derived from site: In situ; Cheek, skin; UBERON=UBERON_0008803.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   OANC1
AC   CVCL_W891
DR   cancercelllines; CVCL_W891
DR   Cosmic; 2030752
DR   Wikidata; Q54931680
RX   PubMed=24077944;
CC   Doubling time: ~48 hours (PubMed=24077944).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (PubMed=24077944).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Homozygous (PubMed=24077944).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): PubMed=24077944
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 13
ST   D18S51: 19
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
ID   OAM-S1
AC   CVCL_XZ98
DR   CCRID; 5301OVI-KCB96003ZJ
DR   KCB; KCB 96003ZJ
DR   Wikidata; Q98128265
RX   PubMed=15973503;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30527; ! Ovis ammon (Argali)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   OAR-L1
AC   CVCL_A9IJ
SY   SheepL1
DR   CCRID; 5301OVI-KCB90012ZJ
DR   KCB; KCB 90012ZJ
DR   Wikidata; Q108821059
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   OAR-S1
AC   CVCL_BS95
SY   DQSHS1
DR   CCRID; 5301OVI-KCB94026ZJ
DR   KCB; KCB 94026ZJ
DR   Wikidata; Q54831395
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Diqing; VBO=VBO_0015740.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 8
//
ID   OARSAi001-A
AC   CVCL_VN66
SY   S04
DR   BioSamples; SAMEA4760915
DR   hPSCreg; OARSAi001-A
DR   Wikidata; Q98128266
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Caucasian; Non-hispanic white.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 12
ST   D21S11: 28,32.2
ST   D3S1358: 13,18
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   OARSAi002-A
AC   CVCL_VN67
SY   S06
DR   hPSCreg; OARSAi002-A
DR   Wikidata; Q98128268
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Caucasian; Non-hispanic white.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 10,13
ST   D7S820: 8
ST   D8S1179: 8,13
ST   FGA: 20,23
ST   Penta D: 9
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OARSAi003-A
AC   CVCL_VN68
SY   S09
DR   hPSCreg; OARSAi003-A
DR   Wikidata; Q98128269
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Black or African American.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D21S11: 27,28
ST   D3S1358: 16,17
ST   D5S818: 8,11
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 22,25
ST   Penta D: 10
ST   Penta E: 8,13
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OARSAi004-A
AC   CVCL_VN69
SY   S10
DR   hPSCreg; OARSAi004-A
DR   Wikidata; Q98128270
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Black or African American.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 6.3,16
ST   D21S11: 28,31
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 7,9
ST   Penta E: 9,14
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 13,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OARSAi005-A
AC   CVCL_VN70
SY   S11
DR   hPSCreg; OARSAi005-A
DR   Wikidata; Q98128271
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Caucasian; Non-hispanic white.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 5,13
ST   D18S51: 12,15
ST   D21S11: 30,31
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   D8S1179: 10,15
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 11,19
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OARSAi006-A
AC   CVCL_VN71
SY   S12
DR   hPSCreg; OARSAi006-A
DR   Wikidata; Q98128272
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Caucasian; Non-hispanic white.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 14,17
ST   D21S11: 30
ST   D3S1358: 14,19
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 13,16
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OARSAi007-A
AC   CVCL_VN72
SY   S14
DR   hPSCreg; OARSAi007-A
DR   Wikidata; Q98128273
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 17,19
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 23,25
ST   Penta D: 10,12
ST   Penta E: 15,16
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OARSAi008-A
AC   CVCL_VN73
SY   S18
DR   hPSCreg; OARSAi008-A
DR   Wikidata; Q98128274
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 12,15
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 7,9
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 10,12
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OARSAi009-A
AC   CVCL_VN74
SY   S20
DR   hPSCreg; OARSAi009-A
DR   Wikidata; Q98128275
RX   PubMed=30099336;
CC   From: Office of Applied Research and Safety Assessment (OARSA), FDA; Laurel; USA.
CC   Population: Caucasian; Non-hispanic white.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=30099336
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D21S11: 30,31
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 7,13
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 13,20
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   OAT
AC   CVCL_JE77
DR   Wikidata; Q54931681
RX   DOI=10.2482/haigan.11.141;
RX   PubMed=4334634;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=4334634).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   OAT-1975
AC   CVCL_X185
SY   OAT 1975; OAT 75; Oat 75; Oat-75
DR   Wikidata; Q54931682
RX   PubMed=195719;
RX   PubMed=2437618;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=195719).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 11
//
ID   OAT1 HEK 293T/17
AC   CVCL_UE07
SY   OAT1-HEK
DR   ATCC; CRL-11268G-1
DR   Wikidata; Q98128276
RX   DOI=10.13140/RG.2.2.16542.54081;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10970; SLC22A6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-11268G-1
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13,14
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   OATL4
AC   CVCL_B7P6
DR   GEO; GSE168556
DR   Wikidata; Q114312619
RX   PubMed=34794206;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   OATL9
AC   CVCL_B7H5
SY   ATL9
DR   Wikidata; Q114312621
RX   PubMed=29930027;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   OAW28
AC   CVCL_1614
SY   OAW-28; OAW 28
DR   CLO; CLO_0008228
DR   EFO; EFO_0006704
DR   CLDB; cl3756
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 515
DR   BioSample; SAMN03472477
DR   BioSample; SAMN10988017
DR   cancercelllines; CVCL_1614
DR   Cell_Model_Passport; SIDM00481
DR   ChEMBL-Cells; CHEMBL3308479
DR   ChEMBL-Targets; CHEMBL1075553
DR   Cosmic; 946360
DR   Cosmic; 1707570
DR   Cosmic-CLP; 946360
DR   DepMap; ACH-000116
DR   ECACC; 85101601
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 946360
DR   GEO; GSM659383
DR   GEO; GSM711696
DR   GEO; GSM827435
DR   GEO; GSM887464
DR   GEO; GSM888544
DR   GEO; GSM1291143
DR   GEO; GSM1374778
DR   GEO; GSM1670292
DR   IARC_TP53; 27569
DR   LiGeA; CCLE_007
DR   LINCS_LDP; LCL-1698
DR   PharmacoDB; OAW28_1178_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1614
DR   PubChem_Cell_line; CVCL_1614
DR   Wikidata; Q54931684
RX   PubMed=2653399;
RX   PubMed=8795574;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 37 hours (PubMed=2653399); ~60 hours (Note=At 20th passage) (PubMed=8795574); 53.97 hours (JWGray panel).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Unspecified (PubMed=25230021).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.74%; Native American=0%; East Asian, North=2.29%; East Asian, South=0%; South Asian=1.87%; European, North=63.18%; European, South=31.91% (PubMed=30894373).
CC   Misspelling: OWA28; Cosmic=1707570.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=946360; ECACC=85101601; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12,14
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,15
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 7
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   OAW42
AC   CVCL_1615
SY   OAW-42; OAW 42
DR   CLO; CLO_0008229
DR   EFO; EFO_0006705
DR   CLDB; cl3757
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 971
DR   BioSample; SAMN03472455
DR   BioSample; SAMN10988015
DR   cancercelllines; CVCL_1615
DR   Cell_Model_Passport; SIDM00480
DR   ChEMBL-Cells; CHEMBL3308397
DR   ChEMBL-Targets; CHEMBL1075554
DR   CLS; 300304
DR   Cosmic; 688103
DR   Cosmic; 910548
DR   Cosmic; 1609537
DR   Cosmic; 1707560
DR   Cosmic-CLP; 910548
DR   DepMap; ACH-000704
DR   ECACC; 85073102
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910548
DR   GEO; GSM313710
DR   GEO; GSM659384
DR   GEO; GSM711697
DR   GEO; GSM827350
DR   GEO; GSM887465
DR   GEO; GSM888545
DR   GEO; GSM1291144
DR   GEO; GSM1374779
DR   GEO; GSM1670293
DR   GEO; GSM2474978
DR   IARC_TP53; 21594
DR   LiGeA; CCLE_343
DR   LINCS_LDP; LCL-1699
DR   PharmacoDB; OAW42_1179_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1615
DR   PubChem_Cell_line; CVCL_1615
DR   Wikidata; Q54931685
RX   PubMed=2653399;
RX   PubMed=6744227;
RX   PubMed=8795574;
RX   PubMed=11414198;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 19 hours (PubMed=2653399); ~34 hours (Note=At 97th passage) (PubMed=8795574); 40 hours (PubMed=25984343); 25-30 hours (CLS=300304); 28.75 hours (JWGray panel).
CC   HLA typing: A*03:01,03:01; B*07:02,18:01; C*05:01,07:02; DQB1*05:01,05:01; DRB1*01:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Unspecified (PubMed=25230021; PubMed=28273451).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=25230021).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.28%; Native American=0%; East Asian, North=3.68%; East Asian, South=0%; South Asian=0%; European, North=61.75%; European, South=32.29% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CLS=300304; Cosmic-CLP=910548; ECACC=85073102; PubMed=25230021; PubMed=25877200; PubMed=30485824; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13
ST   D12S391: 18.3,21
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 16,21
ST   D19S433: 13,14
ST   D1S1656: 11,12
ST   D21S11: 26
ST   D22S1045: 15,16
ST   D2S1338: 17
ST   D2S441: 12,14
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16 (PubMed=25230021)
ST   vWA: 15,16 (CLS=300304; Cosmic-CLP=910548; ECACC=85073102; PubMed=25877200; PubMed=30485824; Technion Genomics Center)
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   OAW42-A
AC   CVCL_W125
SY   OAW42A
DR   CancerTools; 157984
DR   ECACC; 20082613
DR   Wikidata; Q54931686
RX   PubMed=8100138;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=20082613
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 16,21
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1615 ! OAW42
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   ob 17
AC   CVCL_S603
SY   OB 17; ob17; Ob17
DR   Wikidata; Q54931687
RX   PubMed=216011;
RX   PubMed=6184607;
RX   PubMed=6352350;
CC   Doubling time: 12.5 hours (Note=In 10% FCS), 19 hours (Note=In 1% FCS) (PubMed=216011).
CC   Derived from site: In situ; Testis, epididymis, epididymal fat pad; UBERON=UBERON_0010412.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J ob/ob.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   OB-6
AC   CVCL_D626
DR   TOKU-E; 4092
DR   Wikidata; Q54931688
RX   PubMed=10412038;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: SAMR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   Ob1754
AC   CVCL_S606
DR   Wikidata; Q54931689
RX   PubMed=3800927;
CC   Derived from site: In situ; Testis, epididymis, epididymal fat pad; UBERON=UBERON_0010412.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J ob/ob.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S603 ! ob 17
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   Ob1771
AC   CVCL_0476
SY   OB1771; Ob 1771
DR   MCCL; MCC:0000374
DR   Wikidata; Q54931690
RX   PubMed=3800927;
RX   PubMed=3814078;
CC   Derived from site: In situ; Testis, epididymis, epididymal fat pad; UBERON=UBERON_0010412.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J ob/ob.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S603 ! ob 17
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   ob17MT
AC   CVCL_S604
SY   Ob17MT; ob17MT1
DR   Wikidata; Q54931691
RX   PubMed=6089203;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Testis, epididymis, epididymal fat pad; UBERON=UBERON_0010412.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J ob/ob.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S603 ! ob 17
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   ob17PY
AC   CVCL_S605
SY   Ob17PY; ob17PY1
DR   Wikidata; Q54931692
RX   PubMed=6089203;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Testis, epididymis, epididymal fat pad; UBERON=UBERON_0010412.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J ob/ob.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S603 ! ob 17
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   OBA-9
AC   CVCL_JE69
SY   OBA9
DR   BTO; BTO_0006371
DR   GEO; GSM1942373
DR   Wikidata; Q54931693
RX   PubMed=15088874;
RX   PubMed=27479086;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMT10D).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Epithelial cell of gingiva; CL=CL_0002621.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 12
//
ID   Oba-BL
AC   CVCL_W931
SY   OBA-BL; OBA BL; OBA
DR   Wikidata; Q54931694
RX   PubMed=2824665;
RX   PubMed=2898508;
RX   PubMed=2943927;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 12
//
ID   OBC13
AC   CVCL_9W25
DR   ABM; T0237
DR   Wikidata; Q54931695
RX   PubMed=2307979;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: C57BL/6 x CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   OBCK6
AC   CVCL_U886
DR   Wikidata; Q54931696
RX   PubMed=2246327;
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   19-20FD
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   OBGF400
AC   CVCL_AS93
DR   GEO; GSM422412
DR   GEO; GSM422413
DR   GEO; GSM422414
DR   Wikidata; Q54931697
RX   PubMed=18358537;
RX   PubMed=19937495;
CC   Doubling time: ~4 days (PubMed=18358537).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Cell type: Neuroblast; CL=CL_0000031.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   1D
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 9
//
ID   OBKI
AC   CVCL_E5TE
DR   ABM; T8093
RX   PubMed=34713776;
WW   Provider; TTU; -; https://ttu.flintbox.com/technologies/A91F88A103A04E31803D2DE91BBCE953
CC   Doubling time: 36-48 hours (ABM=T8093).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C215041; Feline sarcomatoid renal cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   OBL21
AC   CVCL_9W26
SY   OBL-21
DR   Wikidata; Q54931698
RX   PubMed=2307979;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   OBL21A
AC   CVCL_9W27
SY   OBL21a; OBL 21A
DR   ABM; T0239
DR   Wikidata; Q54931699
RX   PubMed=2307979;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9W26 ! OBL21
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   OBL24
AC   CVCL_9W28
DR   ABM; T0241
DR   Wikidata; Q54931700
RX   PubMed=2307979;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   ObSSC
AC   CVCL_C3MI
SY   Opsariichthys bidens Spermatogonial Stem Cell line
DR   Wikidata; Q116050039
RX   PubMed=36101449;
CC   Group: Fish cell line.
CC   Characteristics: Can be induced to differentiate into sperm and other different types of somatic cells (PubMed=36101449).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonial stem cell; CL=CL_0000016.
OX   NCBI_TaxID=141458; ! Opsariichthys bidens (Chinese hook snout carp)
SX   Male
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   OC
AC   CVCL_A1GZ
DR   Wikidata; Q102114673
RX   DOI=10.5282/edoc.3898;
RX   PubMed=15706405;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   Oc
AC   CVCL_E2VN
DR   BTO; BTO_0001977
DR   RIKEN_BRC_EPD; rpc00031
RX   DOI=10.1007/BF00428879;
RX   DOI=10.1093/oxfordjournals.pcp.a077122;
RX   DOI=10.1093/oxfordjournals.pcp.a078058;
RX   PubMed=8755553;
RX   PubMed=10557360;
RX   PubMed=10734215;
RX   PubMed=36778713;
CC   Group: Plant cell line.
CC   Characteristics: Can be used as source of nurse cells required for induction of protoplast division and calluses generation (DOI=10.1007/BF00428879).
CC   Characteristics: High capacity to convert indole-3-acetamide (IAM) to indole-3-acetic acid (auxin, IAA) (DOI=10.1093/oxfordjournals.pcp.a078058).
CC   Derived from site: In situ; Primary root; PO=PO_0020127.
CC   Breed/subspecies: Cultivar C5924.
OX   NCBI_TaxID=39946; ! Oryza sativa subsp. indica (Rice)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   OC 314
AC   CVCL_1616
SY   OC-314; OC314
DR   BTO; BTO_0006435
DR   CLO; CLO_0008231
DR   CLO; CLO_0037095
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 972
DR   BioSample; SAMN10988194
DR   cancercelllines; CVCL_1616
DR   Cell_Model_Passport; SIDM00220
DR   ChEMBL-Cells; CHEMBL3308244
DR   ChEMBL-Targets; CHEMBL2366288
DR   Cosmic; 909257
DR   Cosmic-CLP; 909257
DR   DepMap; ACH-000962
DR   EGA; EGAS00001000978
DR   GDSC; 909257
DR   GEO; GSM459736
DR   GEO; GSM887466
DR   GEO; GSM888546
DR   GEO; GSM1670294
DR   IARC_TP53; 21595
DR   ICLC; HTL98015
DR   LiGeA; CCLE_678
DR   LINCS_LDP; LCL-1516
DR   PharmacoDB; OC314_1182_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1616
DR   PubChem_Cell_line; CVCL_1616
DR   Wikidata; Q54931701
RX   PubMed=8690298;
RX   PubMed=15677628;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 19.19 hours (JWGray panel).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=15677628; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (Cosmic-CLP=909257; DepMap=ACH-000962).
CC   Sequence variation: Mutation; HGNC; HGNC:10447; RRAS; Simple; p.Pro26fs (c.74delC); Zygosity=Heterozygous (DepMap=ACH-000962).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (Cosmic-CLP=909257; DepMap=ACH-000962).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.66%; East Asian, North=1.17%; East Asian, South=0%; South Asian=0%; European, North=75.37%; European, South=21.79% (PubMed=30894373).
CC   Discontinued: ICLC; HTL98015; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=909257
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 10,11,12
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   OC 315
AC   CVCL_1617
SY   OC-315; OC315
DR   BTO; BTO_0006436
DR   CLO; CLO_0008232
DR   cancercelllines; CVCL_1617
DR   Cell_Model_Passport; SIDM01823
DR   DepMap; ACH-001144
DR   GEO; GSM459737
DR   ICLC; HTL98013
DR   PharmacoDB; OC315_1180_2019
DR   Progenetix; CVCL_1617
DR   Wikidata; Q54931702
RX   PubMed=8690298;
RX   PubMed=15677628;
RX   PubMed=31068700;
CC   Problematic cell line: Possibly contaminated. May be identical to OC 314 (Cellosaurus=CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=15677628).
CC   Discontinued: ICLC; HTL98013; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   OC 316
AC   CVCL_1618
SY   OC-316; OC316
DR   BTO; BTO_0006437
DR   CLO; CLO_0008233
DR   BioSample; SAMN10987675
DR   cancercelllines; CVCL_1618
DR   Cell_Model_Passport; SIDM00219
DR   DepMap; ACH-001145
DR   GEO; GSM887467
DR   GEO; GSM888547
DR   IARC_TP53; 21597
DR   ICLC; HTL98014
DR   PharmacoDB; OC316_1181_2019
DR   Progenetix; CVCL_1618
DR   Wikidata; Q54931703
RX   PubMed=8690298;
RX   PubMed=15677628;
RX   PubMed=22460905;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Contaminated. Identical to OC 314 according to STR profiling done at ICLC, to MSI data (PubMed=15677628) and to omic data (DepMap). Originally thought to originate from a 60 year old patient with a FIGO stage IV ovarian cancer.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=15677628; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (DepMap=ACH-001145).
CC   Sequence variation: Mutation; HGNC; HGNC:10447; RRAS; Simple; p.Pro26fs (c.74delC); Zygosity=Heterozygous (DepMap=ACH-001145).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (DepMap=ACH-001145).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.57%; East Asian, North=1.31%; East Asian, South=0%; South Asian=0%; European, North=75.5%; European, South=21.63% (PubMed=30894373).
CC   Discontinued: ICLC; HTL98014; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1616 ! OC 314
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   OC-1
AC   CVCL_WL07
SY   OC1
DR   Wikidata; Q98128278
RX   CelloPub=CLPUB00500;
RX   PubMed=10390151;
RX   PubMed=11297525;
RX   PubMed=26512696;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   OC-109
AC   CVCL_GT33
DR   Wikidata; Q54931704
RX   PubMed=7947929;
RX   PubMed=7959295;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   OC-109-VGH
AC   CVCL_GT34
DR   BCRC; 60601
DR   Wikidata; Q54931705
RX   CelloPub=CLPUB00352;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   OC-117-VGH
AC   CVCL_GT35
SY   VGH-OC-117
DR   BCRC; 60602
DR   Wikidata; Q54931706
RX   CelloPub=CLPUB00352;
RX   PubMed=10592434;
RX   PubMed=16138714;
RX   PubMed=23351415;
CC   Population: Chinese.
CC   Characteristics: ER-alpha, ER-beta and PR-negative (PubMed=16138714).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   OC-2
AC   CVCL_WL08
SY   OC2
DR   Wikidata; Q98128279
RX   CelloPub=CLPUB00500;
RX   PubMed=10390151;
RX   PubMed=11297525;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   OC-238
AC   CVCL_GT36
DR   Wikidata; Q54931707
RX   PubMed=7947929;
RX   PubMed=7959295;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   OC-3
AC   CVCL_WL09
SY   OC3
DR   Wikidata; Q98128280
RX   CelloPub=CLPUB00500;
RX   PubMed=10390151;
RX   PubMed=11297525;
RX   PubMed=26512696;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   OC-3-VGH
AC   CVCL_GT37
DR   BCRC; 60599
DR   ChEMBL-Cells; CHEMBL4630772
DR   ChEMBL-Targets; CHEMBL4630780
DR   PubChem_Cell_line; CVCL_GT37
DR   Wikidata; Q54931708
RX   PubMed=1611619;
RX   PubMed=3455323;
CC   Population: Chinese.
CC   Doubling time: 48 hours (PubMed=3455323).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   OC-7-NU
AC   CVCL_GT38
DR   Wikidata; Q54931709
RX   PubMed=7947929;
RX   PubMed=7959295;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   OC-89-VGH
AC   CVCL_GT39
SY   VGH-OC-89
DR   Wikidata; Q54931710
RX   CelloPub=CLPUB00350;
RX   PubMed=10592434;
CC   Population: Chinese.
CC   Doubling time: 51 hours (Note=At 20th passage) (CelloPub=CLPUB00350).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   OC-k1
AC   CVCL_D799
DR   Wikidata; Q54931711
RX   PubMed=10562438;
RX   PubMed=12382283;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   OC-k2
AC   CVCL_D800
DR   Wikidata; Q54931712
RX   PubMed=10562438;
RX   PubMed=12382283;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   OC-k3
AC   CVCL_D801
SY   OCk3
DR   Wikidata; Q54931713
RX   PubMed=10562438;
RX   PubMed=12382283;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   OC-k4
AC   CVCL_D802
DR   Wikidata; Q54931714
RX   PubMed=10562438;
RX   PubMed=12382283;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   OC/CDE 14
AC   CVCL_U975
SY   Oval Cell/Choline Deficient Ethionine-supplemented 14 weeks diet
DR   Wikidata; Q54931715
RX   PubMed=7679995;
CC   Doubling time: 36 hours (PubMed=7679995).
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic oval stem cell; CL=CL_0002196.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   OC/CDE 22
AC   CVCL_U976
SY   OC/CDE-22; OC/CDE22; Oval Cell/Choline Deficient Ethionine-supplemented 22 weeks diet
DR   BTO; BTO_0002198
DR   Wikidata; Q54931716
RX   PubMed=7526039;
RX   PubMed=7532542;
RX   PubMed=7679995;
RX   PubMed=11751433;
RX   PubMed=12075625;
CC   Doubling time: 45 hours (PubMed=7679995).
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic oval stem cell; CL=CL_0002196.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   OC/CDE 6
AC   CVCL_U977
SY   OC/CDE6; Oval Cell/Choline Deficient Ethionine-supplemented 6 weeks diet
DR   Wikidata; Q54931717
RX   PubMed=7526039;
RX   PubMed=7532542;
RX   PubMed=7679995;
CC   Doubling time: 52 hours (PubMed=7679995).
CC   Transformant: ChEBI; CHEBI_68664; DL-ethionine.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic oval stem cell; CL=CL_0002196.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   OC.4
AC   CVCL_E9YR
RX   PubMed=10816384;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Rat surface antigen on oval and bile ducts cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OC.5
AC   CVCL_E9YS
RX   PubMed=10816384;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Rat surface antigen on oval and bile ducts cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OC.6
AC   CVCL_E9YT
RX   PubMed=10816384;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Rat surface antigen areas of intestinal metaplasia and large mucin containing ducts.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OC.10
AC   CVCL_E9YU
RX   PubMed=10816384;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Rat surface antigen on oval and bile ducts cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OC002
AC   CVCL_JM66
DR   Wikidata; Q54931718
RX   PubMed=28455291;
RX   PubMed=28473707;
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 6
//
ID   OC002Cis
AC   CVCL_JM67
DR   Wikidata; Q54931719
RX   PubMed=28455291;
RX   PubMed=28473707;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JM66 ! OC002
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   OC1
AC   CVCL_RV33
DR   Wikidata; Q54931720
RX   PubMed=2156034;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 34 hours (PubMed=2156034).
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   OC10B
AC   CVCL_6G52
DR   Wikidata; Q54931721
RX   PubMed=9495512;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   OC125
AC   CVCL_LI57
DR   Wikidata; Q54931722
RX   PubMed=7028788;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   OC15
AC   CVCL_0E97
SY   OC 15
DR   Wikidata; Q54931723
RX   PubMed=988033;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   OC1C3
AC   CVCL_XA12
DR   Wikidata; Q98128281
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on ovarian epithelial carcinoma cells.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000600039). It was the sole source of information for this entry.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   OC2
AC   CVCL_RV34
DR   Wikidata; Q54931726
RX   PubMed=2156034;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 31 hours (PubMed=2156034).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   Oc2T(VX7)
AC   CVCL_S376
SY   OC 2T
DR   ATCC; CRL-6594
DR   Wikidata; Q54931727
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 10271; Rabbit fibroma virus (SFV).
CC   Discontinued: ATCC; CRL-6594; true.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
DI   NCIt; C133740; Rabbit fibroma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_T725 ! Oc4T/cc
OI   CVCL_3470 ! Vx7
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 6
//
ID   OC3
AC   CVCL_D859
SY   OC-3; Oral carcinoma 3
DR   BTO; BTO_0004006
DR   ABM; T8327
DR   GEO; GSM950305
DR   GEO; GSM950306
DR   GEO; GSM950307
DR   GEO; GSM950308
DR   Wikidata; Q54931728
RX   DOI=10.1016/j.bgm.2013.07.007;
RX   PubMed=14720193;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 16 hours (Note=At 8th passage) (PubMed=14720193); 24 hours (ABM=T8327).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a long term betel leaf chewer non smoker patient (PubMed=14720193).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): ABM=T8327
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,21
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 13,16
ST   D1S1656: 17.3
ST   D21S11: 30,31.2
ST   D2S1338: 21,22
ST   D2S441: 11,12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 24,25.2
ST   Penta D: 9,12
ST   Penta E: 11,17
ST   TH01: 7,10
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   OC3-I5
AC   CVCL_JY54
DR   Wikidata; Q54931729
RX   DOI=10.1016/j.bgm.2013.07.007;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D859 ! OC3
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   OC3-IV2
AC   CVCL_JY43
DR   Wikidata; Q54931730
RX   DOI=10.1016/j.bgm.2013.07.007;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Established from parent cell line through a passage in nude mice.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D859 ! OC3
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   Oc4T/cc
AC   CVCL_T725
SY   Oc 4T
DR   ATCC; CRL-6501
DR   Wikidata; Q54931732
RX   PubMed=6500159;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 10271; Rabbit fibroma virus (SFV).
CC   Discontinued: ATCC; CRL-6501; true.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
DI   NCIt; C133740; Rabbit fibroma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_S376 ! Oc2T(VX7)
OI   CVCL_3470 ! Vx7
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 6
//
ID   OCC-01
AC   CVCL_VX32
SY   Oral Cancer Cell-01
DR   IBRC; C10870
DR   Wikidata; Q98128282
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 15,16
ST   D21S11: 31,32.2
ST   D2S1338: 17,22
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 11,14
ST   FGA: 21,26
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-02
AC   CVCL_WG06
SY   Oral Cancer Cell-02
DR   IBRC; C10787
DR   Wikidata; Q98128283
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-03
AC   CVCL_WG07
SY   Oral Cancer Cell-03
DR   IBRC; C10953
DR   Wikidata; Q98128284
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-04
AC   CVCL_WG08
SY   Oral Cancer Cell-04
DR   IBRC; C10954
DR   Wikidata; Q98128285
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-05
AC   CVCL_VX33
SY   Oral Cancer Cell-05
DR   IBRC; C10955
DR   Wikidata; Q98128286
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 15
ST   FGA: 21,22.2
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-06
AC   CVCL_VX34
SY   Oral Cancer Cell-06
DR   IBRC; C10956
DR   Wikidata; Q98128287
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D18S51: 15,23
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 23,25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 10,12
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-07
AC   CVCL_WG09
SY   Oral Cancer Cell-07
DR   IBRC; C10983
DR   Wikidata; Q98128288
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-08
AC   CVCL_WG10
SY   Oral Cancer Cell-08
DR   IBRC; C10984
DR   Wikidata; Q98128289
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-09
AC   CVCL_WG11
SY   Oral Cancer Cell-09
DR   IBRC; C10985
DR   Wikidata; Q98128291
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-10
AC   CVCL_WG12
SY   Oral Cancer Cell-10
DR   IBRC; C10986
DR   Wikidata; Q98128292
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-11
AC   CVCL_WG13
SY   Oral Cancer Cell-11
DR   IBRC; C10987
DR   Wikidata; Q98128293
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-12
AC   CVCL_WG14
SY   Oral Cancer Cell-12
DR   IBRC; C10988
DR   Wikidata; Q98128294
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-13
AC   CVCL_WG15
SY   Oral Cancer Cell-13
DR   IBRC; C10989
DR   Wikidata; Q98128295
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-14
AC   CVCL_WG16
SY   Oral Cancer Cell-14
DR   IBRC; C10990
DR   Wikidata; Q98128296
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-15
AC   CVCL_VX35
SY   Oral Cancer Cell-15
DR   IBRC; C10991
DR   Wikidata; Q98128297
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D19S433: 15,15.2
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 26
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-16
AC   CVCL_VX36
SY   Oral Cancer Cell-16
DR   IBRC; C10993
DR   Wikidata; Q98128298
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D18S51: 11,12
ST   D19S433: 14.2,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4042; Lip squamous cell carcinoma
DI   ORDO; Orphanet_502366; Squamous cell carcinoma of the lip
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-17
AC   CVCL_WG17
SY   Oral Cancer Cell-17
DR   IBRC; C10994
DR   Wikidata; Q98128299
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-18
AC   CVCL_WG18
SY   Oral Cancer Cell-18
DR   IBRC; C10995
DR   Wikidata; Q98128300
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-19
AC   CVCL_VX37
SY   Oral Cancer Cell-19
DR   IBRC; C10996
DR   Wikidata; Q98128301
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 16,17
ST   D19S433: 13.2,14.2
ST   D21S11: 28,32
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   TH01: 9,9.3
ST   TPOX: 12
ST   vWA: 15
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-20
AC   CVCL_WG19
SY   Oral Cancer Cell-20
DR   IBRC; C10997
DR   Wikidata; Q98128302
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-21
AC   CVCL_VX38
SY   Oral Cancer Cell-21
DR   IBRC; C10998
DR   Wikidata; Q98128303
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 10,13
ST   D18S51: 13,15
ST   D19S433: 12,13.2
ST   D21S11: 29,30
ST   D2S1338: 19,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 19,24
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-22
AC   CVCL_VX26
SY   Oral Cancer Cell-22
DR   IBRC; C11066
DR   Wikidata; Q98128304
RX   PubMed=29285029;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-23
AC   CVCL_WG20
SY   Oral Cancer Cell-23
DR   IBRC; C11067
DR   Wikidata; Q98128305
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-24
AC   CVCL_WG21
SY   Oral Cancer Cell-24
DR   IBRC; C11068
DR   Wikidata; Q98128306
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-25
AC   CVCL_VX27
SY   Oral Cancer Cell-25
DR   IBRC; C11069
DR   Wikidata; Q98128308
RX   PubMed=29285029;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-26
AC   CVCL_VX39
SY   Oral Cancer Cell-26
DR   IBRC; C11070
DR   Wikidata; Q98128309
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 17,18
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 11,14
ST   D7S820: 7,11
ST   D8S1179: 11,14
ST   FGA: 20,21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-27
AC   CVCL_VX40
SY   Oral Cancer Cell-27
DR   IBRC; C11071
DR   Wikidata; Q98128310
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,18
ST   D19S433: 13,13.2
ST   D21S11: 29,30
ST   D2S1338: 21,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 16,19
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-28
AC   CVCL_VX41
SY   Oral Cancer Cell-28
DR   IBRC; C11072
DR   Wikidata; Q98128311
RX   PubMed=29672933;
ST   Source(s): PubMed=29672933
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 13,15
ST   D19S433: 15.2,16.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 16,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-29
AC   CVCL_WG23
SY   Oral Cancer Cell-29
DR   IBRC; C11073
DR   Wikidata; Q98128312
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-30
AC   CVCL_WG24
SY   Oral Cancer Cell-30
DR   IBRC; C11074
DR   Wikidata; Q98128313
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-31
AC   CVCL_VX28
SY   Oral Cancer Cell-31
DR   IBRC; C11075
DR   Wikidata; Q98128315
RX   PubMed=29285029;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-32
AC   CVCL_VX29
SY   Oral Cancer Cell-32
DR   IBRC; C11076
DR   Wikidata; Q98128316
RX   PubMed=29285029;
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-33
AC   CVCL_WG25
SY   Oral Cancer Cell-33
DR   IBRC; C11077
DR   Wikidata; Q98128317
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-34
AC   CVCL_VX30
SY   Oral Cancer Cell-34
DR   IBRC; C11078
DR   Wikidata; Q98128318
RX   PubMed=29285029;
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-35
AC   CVCL_WG27
SY   Oral Cancer Cell-35
DR   IBRC; C11079
DR   Wikidata; Q98128319
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-36
AC   CVCL_WG28
SY   Oral Cancer Cell-36
DR   IBRC; C11080
DR   Wikidata; Q98128320
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-37
AC   CVCL_WG29
SY   Oral Cancer Cell-37
DR   IBRC; C11081
DR   Wikidata; Q98128321
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-38
AC   CVCL_WG30
SY   Oral Cancer Cell-38
DR   IBRC; C11082
DR   Wikidata; Q98128322
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-39
AC   CVCL_WG31
SY   Oral Cancer Cell-39
DR   IBRC; C11083
DR   Wikidata; Q98128323
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-40
AC   CVCL_WG32
SY   Oral Cancer Cell-40
DR   IBRC; C11084
DR   Wikidata; Q98128324
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC-41
AC   CVCL_WG33
SY   Oral Cancer Cell-41
DR   IBRC; C11085
DR   Wikidata; Q98128325
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   OCC/PI
AC   CVCL_EG06
SY   OCC/Permanent I
DR   Wikidata; Q54931733
RX   PubMed=27356577;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   OCC/PII
AC   CVCL_EG07
SY   OCC/Permanent II
DR   Wikidata; Q54931734
RX   PubMed=27356577;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   OCC1
AC   CVCL_C829
SY   OCC-1
DR   Wikidata; Q54931735
RX   PubMed=2354825;
RX   PubMed=23415752;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Chinese.
CC   Doubling time: 36 hours (Note=At 10th passage), 38 hours (Note=At 40th passage) (PubMed=2354825).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   OCCC33
AC   CVCL_EI99
DR   Cosmic; 1493899
DR   Wikidata; Q54931736
RX   PubMed=21381030;
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 5
//
ID   OCCM-30
AC   CVCL_D4XK
SY   OCCM.30; OCCM30; OC/CM-30; OsteoCalcin/CeMentoblast-30
DR   Wikidata; Q127382989
RX   PubMed=10695940;
RX   PubMed=12814226;
RX   PubMed=14653387;
RX   PubMed=27180803;
RX   PubMed=28866368;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Cementoblast; CL=CL_0000061.
CC   Breed/subspecies: OC-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   40-42D
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   OCCM-30 Bsp KO clone 2
AC   CVCL_D4XM
SY   OCCM.30 Bsp KO clone 2
DR   Wikidata; Q127382990
RX   PubMed=28866368;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96389; Ibsp.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Cementoblast; CL=CL_0000061.
CC   Breed/subspecies: OC-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D4XK ! OCCM-30
SX   Sex unspecified
AG   40-42D
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   OCCM-30 shTbr2
AC   CVCL_D4XL
SY   shTbr2 OCCM-30
DR   Wikidata; Q127382991
RX   PubMed=27180803;
CC   Knockout cell: Method=shRNA knockdown; MGI; MGI:98729; Tgfbr2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Cementoblast; CL=CL_0000061.
CC   Breed/subspecies: OC-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D4XK ! OCCM-30
SX   Sex unspecified
AG   40-42D
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   OCD
AC   CVCL_5848
DR   CLS; 400417
DR   Wikidata; Q54931737
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: NMRI.
DI   NCIt; C22964; Osteochondroma of the mouse skeletal system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   OCE1
AC   CVCL_ZZ92
DR   ECACC; 20012016
DR   Wikidata; Q102114674
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ECACC; 20012016; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ89 ! FNE1
OI   CVCL_ZZ90 ! FNLE1
OI   CVCL_ZZ91 ! FNLER1
OI   CVCL_ZZ93 ! OCLE1
OI   CVCL_ZZ94 ! OCLER1
SX   Female
AG   56Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   OCE2
AC   CVCL_ZZ98
DR   ECACC; 20012019
DR   Wikidata; Q102114676
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ECACC; 20012019; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ95 ! FNE2
OI   CVCL_ZZ96 ! FNLE2
OI   CVCL_ZZ97 ! FNLER2
OI   CVCL_ZZ99 ! OCLE2
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   OCF [Amphiprion]
AC   CVCL_A2DN
SY   Ocellaris Clownfish Fin
DR   Wikidata; Q105510477
RX   PubMed=33208823;
CC   Group: Fish cell line.
CC   Doubling time: 40 hours (Note=At 25th passage) (PubMed=33208823).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=80972; ! Amphiprion ocellaris (Clown anemonefish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 6
//
ID   OCF [Pseudetroplus]
AC   CVCL_C5YW
SY   Orange Chromide Fin
DR   NRFC; NRFC076
DR   Wikidata; Q116050040
RX   DOI=10.1016/j.aquaculture.2021.737589;
WW   Provider; NRFC; NRFC076; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC076.
CC   Virology: Not susceptible to infection by Tilapia lake virus (TiLV) (DOI=10.1016/j.aquaculture.2021.737589).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=2926661; ! Pseudetroplus maculatus (Orange chromide)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OCGH_ATRT
AC   CVCL_A1GR
SY   AT/RT
DR   cancercelllines; CVCL_A1GR
DR   JCRB; JCRB1868
DR   Wikidata; Q102114678
RX   PubMed=32997328;
CC   Population: Japanese.
CC   Doubling time: 19.3 hours (PubMed=32997328).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg53Ter (c.157C>T); ClinVar=VCV000944246; Zygosity=Unspecified (PubMed=32997328).
CC   Misspelling: ATRT_OCGH; PubMed=32997328; Note=In abstract.
CC   Derived from site: In situ; Brain, pineal gland; UBERON=UBERON_0001905.
ST   Source(s): JCRB=JCRB1868; PubMed=32997328
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   OCI-AML-1
AC   CVCL_5228
SY   OCI/AML-1; OCI/AML1; OCI-AML1; OCI AML1; OCIAML1; Ontario Cancer Institute-Acute Myeloid Leukemia-1
DR   BioGRID_ORCS_Cell_line; 1780
DR   Cosmic; 787465
DR   Cosmic; 975287
DR   Cosmic; 1281343
DR   Cosmic; 1319544
DR   Cosmic; 2306230
DR   DSMZ; ACC-726
DR   DSMZCellDive; ACC-726
DR   Wikidata; Q54931738
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1698193;
RX   PubMed=2538684;
RX   PubMed=9096695;
CC   Characteristics: CSF2 dependent.
CC   Doubling time: ~3-4 days (DSMZ=ACC-726).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-726
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 10,11
ST   FGA: 23,25
ST   Penta D: 13
ST   Penta E: 5,17
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
ID   OCI-AML-11
AC   CVCL_QX97
SY   OCI-AML/11; OCI-AML11; OCI/AML11; Ontario Cancer Institute-Acute Myeloid Leukemia-11
DR   Wikidata; Q54931739
RX   PubMed=10637496;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 7
//
ID   OCI-AML-1a
AC   CVCL_5225
SY   OCI/AML-1a; OCI/AML1a; OCI-AML1a; OCI/AML 1a; Ontario Cancer Institute-Acute Myeloid Leukemia-1a
DR   Lonza; 26
DR   Wikidata; Q54931740
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1283544;
RX   PubMed=1698193;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=OCI%2fAML1a
CC   Characteristics: CSF3 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5228 ! OCI-AML-1
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   OCI-AML-2
AC   CVCL_1619
SY   OCI/AML-2; OCIAML-2; OCI-AML2; OCI/AML2; OCI AML2; OCIAML2; AML-2; Ontario Cancer Institute-Acute Myeloid Leukemia-2
DR   BTO; BTO_0004619
DR   CLO; CLO_0008235
DR   EFO; EFO_0006706
DR   CLDB; cl3760
DR   CLDB; cl7059
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0383
DR   BioGRID_ORCS_Cell_line; 213
DR   BioSample; SAMN03473106
DR   BioSample; SAMN10988499
DR   cancercelllines; CVCL_1619
DR   Cell_Model_Passport; SIDM00446
DR   ChEMBL-Cells; CHEMBL3308300
DR   ChEMBL-Targets; CHEMBL2366220
DR   Cosmic; 787466
DR   Cosmic; 910947
DR   Cosmic; 975288
DR   Cosmic; 1012109
DR   Cosmic; 1281344
DR   Cosmic; 1319545
DR   Cosmic; 1582386
DR   Cosmic; 2131551
DR   Cosmic; 2306231
DR   Cosmic; 2750868
DR   Cosmic-CLP; 910947
DR   DepMap; ACH-000113
DR   DSMZ; ACC-99
DR   DSMZCellDive; ACC-99
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   EGA; EGAS00001004741
DR   EGA; EGAS00001004743
DR   GDSC; 910947
DR   GEO; GSM482511
DR   GEO; GSM887468
DR   GEO; GSM888548
DR   GEO; GSM1374780
DR   GEO; GSM1446749
DR   GEO; GSM1670295
DR   IARC_TP53; 21598
DR   ICLC; HTL01010
DR   LiGeA; CCLE_626
DR   LINCS_LDP; LCL-1065
DR   Lonza; 327
DR   PharmacoDB; OCIAML2_1183_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1619
DR   PubChem_Cell_line; CVCL_1619
DR   Wikidata; Q54931741
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2538684;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343); ~30-50 hours (DSMZ=ACC-99).
CC   HLA typing: A*02:01,02:01; B*15:01,18:01; C*03:03,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (PubMed=25485619).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.2%; Native American=0%; East Asian, North=1.51%; East Asian, South=0%; South Asian=2.28%; European, North=62.12%; European, South=32.89% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=910947; DSMZ=ACC-99; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12,15
ST   FGA: 19,24
ST   Penta D: 12
ST   Penta E: 12,14
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   OCI-AML-20
AC   CVCL_UE33
SY   OCI-AML20; Ontario Cancer Institute-Acute Myeloid Leukemia-20
DR   cancercelllines; CVCL_UE33
DR   GEO; GSE120834
DR   Wikidata; Q98128326
RX   PubMed=30352278;
CC   Doubling time: 57 hours (PubMed=30352278).
CC   Karyotypic information: Monosomy of chromosome 7 (PubMed=30352278).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=30352278).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30352278
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 8,12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 19,20
DI   NCIt; C82426; Acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2) GATA2, MECOM
DI   ORDO; Orphanet_402020; Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   OCI-AML-3
AC   CVCL_1844
SY   OCI-Aml-3; OCI/AML-3; OCI-AML3; OCI/AML3; OCI AML3; OCIAML3; Ontario Cancer Institute-Acute Myeloid Leukemia-3
DR   BTO; BTO_0004620
DR   CLO; CLO_0009853
DR   EFO; EFO_0006289
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 214
DR   BioSample; SAMN03473107
DR   BioSample; SAMN10988470
DR   cancercelllines; CVCL_1844
DR   CCTCC; GDC0216
DR   Cell_Model_Passport; SIDM00462
DR   ChEMBL-Cells; CHEMBL4295392
DR   ChEMBL-Targets; CHEMBL4296479
DR   Cosmic; 787467
DR   Cosmic; 975289
DR   Cosmic; 1012110
DR   Cosmic; 1127258
DR   Cosmic; 1245831
DR   Cosmic; 1319546
DR   Cosmic; 1557602
DR   Cosmic; 1582387
DR   Cosmic; 1696140
DR   Cosmic; 1779129
DR   Cosmic; 2131552
DR   Cosmic; 2306232
DR   Cosmic; 2750869
DR   Cosmic-CLP; 1290455
DR   DepMap; ACH-000336
DR   DSMZ; ACC-582
DR   DSMZCellDive; ACC-582
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1290455
DR   GEO; GSM482512
DR   GEO; GSM887469
DR   GEO; GSM888549
DR   GEO; GSM1446756
DR   GEO; GSM1525022
DR   GEO; GSM1670296
DR   GEO; GSM2716711
DR   GEO; GSM2716712
DR   GEO; GSM2716774
DR   GEO; GSM2716775
DR   GEO; GSM2716776
DR   GEO; GSM2716777
DR   IARC_TP53; 30132
DR   LiGeA; CCLE_569
DR   LINCS_LDP; LCL-1066
DR   Lonza; 530
DR   PharmacoDB; OCIAML3_1184_2019
DR   Progenetix; CVCL_1844
DR   PubChem_Cell_line; CVCL_1844
DR   Ubigene; YC-C022
DR   Wikidata; Q54931742
RX   PubMed=2538684;
RX   PubMed=12393637;
RX   PubMed=16079892;
RX   PubMed=16408098;
RX   PubMed=21552520;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26434589;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28109323;
RX   PubMed=29491412;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31739141;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=25984343); ~35-40 hours (DSMZ=ACC-582).
CC   HLA typing: A*02:01,23:01; B*44:02,53:01; C*04:01,05:01 (PubMed=26589293).
CC   HLA typing: A*02:01:01,23:01:01; B*44:02:01,53:01:01; C*04:01:01,05:01:01 (DSMZCellDive=ACC-582).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882Cys (c.2644C>T); ClinVar=VCV000375882; Zygosity=Heterozygous (PubMed=26434589; PubMed=31160637; PubMed=31739141; Cosmic-CLP=1290455; DepMap=ACH-000336).
CC   Sequence variation: Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (PubMed=16079892).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (Cosmic-CLP=1290455; DepMap=ACH-000336).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.44%; East Asian, North=2.86%; East Asian, South=0%; South Asian=0.99%; European, North=55.94%; European, South=38.78% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1290455; DSMZ=ACC-582; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 12,18
ST   D19S433: 15,17
ST   D21S11: 29,30
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 8,9.3 (DSMZ=ACC-582)
ST   TH01: 8,10 (Cosmic-CLP=1290455; PubMed=25877200)
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   OCI-AML-4
AC   CVCL_5224
SY   OCI/AML-4; OCI-AML4; OCI/AML4; OCI AML4; OCIAML4; Ontario Cancer Institute-Acute Myeloid Leukemia-4
DR   cancercelllines; CVCL_5224
DR   Cosmic; 787468
DR   Cosmic; 975290
DR   Cosmic; 1281345
DR   Cosmic; 1319547
DR   Cosmic; 2306233
DR   DepMap; ACH-001613
DR   DSMZ; ACC-729
DR   DSMZCellDive; ACC-729
DR   Wikidata; Q54931743
RX   PubMed=1715961;
RX   PubMed=29533902;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~24-30 hours (DSMZ=ACC-729).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (DepMap=ACH-001613).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DepMap=ACH-001613; DSMZ=ACC-729
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 12,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,24
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 19,24
ST   Penta D: 12
ST   Penta E: 10,14
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   OCI-AML-5
AC   CVCL_1620
SY   OCI/AML-5; OCI-AML5; OCI/AML5; OCI AML5; OCIAML5; Ontario Cancer Institute-Acute Myeloid Leukemia-5
DR   BTO; BTO_0004621
DR   CLO; CLO_0008236
DR   EFO; EFO_0006707
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 215
DR   BioSample; SAMN03472968
DR   BioSample; SAMN03473389
DR   BioSample; SAMN10988502
DR   cancercelllines; CVCL_1620
DR   Cell_Model_Passport; SIDM00461
DR   ChEMBL-Cells; CHEMBL4523545
DR   ChEMBL-Targets; CHEMBL4523576
DR   Cosmic; 787469
DR   Cosmic; 975291
DR   Cosmic; 1012111
DR   Cosmic; 1281346
DR   Cosmic; 1319548
DR   Cosmic; 2131553
DR   Cosmic; 2306234
DR   Cosmic; 2750856
DR   Cosmic-CLP; 1330983
DR   DepMap; ACH-000065
DR   DSMZ; ACC-247
DR   DSMZCellDive; ACC-247
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1330983
DR   GEO; GSM887470
DR   GEO; GSM888550
DR   GEO; GSM1374781
DR   GEO; GSM1374782
DR   GEO; GSM1446751
DR   GEO; GSM1525023
DR   GEO; GSM1670297
DR   IARC_TP53; 30133
DR   LiGeA; CCLE_796
DR   LINCS_LDP; LCL-1067
DR   PharmacoDB; OCIAML5_1185_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1620
DR   PubChem_Cell_line; CVCL_1620
DR   Wikidata; Q54931744
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096695;
RX   PubMed=16408098;
RX   PubMed=21989985;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26434589;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=25984343); ~30-50 hours (DSMZ=ACC-247).
CC   HLA typing: A*11:01,32:01; B*51:01,57:01; C*07:01,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:25657; BCORL1; Simple; p.Lys1085Argfs*7 (c.3252delT); Zygosity=Unspecified (PubMed=21989985).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.01%; Native American=0.08%; East Asian, North=2.79%; East Asian, South=0%; South Asian=0%; European, North=64.96%; European, South=31.16% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1330983; DSMZ=ACC-247; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 11,13
ST   D18S51: 15,17
ST   D19S433: 12,16
ST   D21S11: 28,32.2
ST   D2S1338: 19,22
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 9
ST   Penta E: 13,18
ST   TH01: 7,9.3 (Cosmic-CLP=1330983; DSMZ=ACC-247)
ST   TH01: 9.3 (PubMed=25877200)
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   OCI-AML-6
AC   CVCL_5226
SY   OCI/AML-6; OCI-AML6; OCI/AML6; OCI AML6; OCIAML6; Ontario Cancer Institute-Acute Myeloid Leukemia-6
DR   Cosmic; 787470
DR   Cosmic; 975292
DR   Cosmic; 1281347
DR   DSMZ; ACC-730
DR   DSMZCellDive; ACC-730
DR   Wikidata; Q54931745
CC   Doubling time: ~3-5 days (DSMZ=ACC-730).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-730
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 14,18
ST   D21S11: 33.2
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 11,13
ST   FGA: 26
ST   Penta D: 9,10
ST   Penta E: 4
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   OCI-AML-8
AC   CVCL_QX96
SY   OCI-AML/8; OCI-AML8; OCI/AML8; OCI AML8; OCIAML8; Ontario Cancer Institute-Acute Myeloid Leukemia-8
DR   Wikidata; Q54931747
RX   PubMed=10637496;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 7
//
ID   OCI-AML3/HaABCG2 clone 3.3
AC   CVCL_D6NG
RX   PubMed=12393637;
CC   Population: Caucasian.
CC   Characteristics: Low level of expression of ABCG2 (PubMed=12393637).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882Cys (c.2644C>T); ClinVar=VCV000375882; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:74; ABCG2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1844 ! OCI-AML-3
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   OCI-AML3/HaABCG2 clone 6.2
AC   CVCL_5227
SY   OCI-AML6.2; OCI AML6.2; AML6.2
DR   Wikidata; Q54931746
RX   PubMed=12393637;
RX   PubMed=21679421;
CC   Population: Caucasian.
CC   Characteristics: High level of expression of ABCG2 (PubMed=12393637).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882Cys (c.2644C>T); ClinVar=VCV000375882; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:74; ABCG2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1844 ! OCI-AML-3
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   OCI-AML3DNR
AC   CVCL_D6NF
RX   PubMed=21679421;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882Cys (c.2644C>T); ClinVar=VCV000375882; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1844 ! OCI-AML-3
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   OCI-C1p
AC   CVCL_DH02
DR   ATCC; CRL-3548
DR   cancercelllines; CVCL_DH02
DR   ECACC; 20012001
DR   GEO; GSM1001406
DR   GEO; GSM1001443
DR   GEO; GSM1001467
DR   Progenetix; CVCL_DH02
DR   Wikidata; Q54931748
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro539Arg (c.1616C>G); ClinVar=VCV000376243; Zygosity=Unspecified (PubMed=26080861).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Leu (c.1637A>T); ClinVar=VCV000375899; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   OCI-C2p
AC   CVCL_DH03
DR   cancercelllines; CVCL_DH03
DR   GEO; GSM1001415
DR   GEO; GSM1001452
DR   GEO; GSM1001462
DR   Progenetix; CVCL_DH03
DR   Wikidata; Q54931749
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 8,13
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   OCI-C3x
AC   CVCL_DH04
DR   cancercelllines; CVCL_DH04
DR   GEO; GSM1001399
DR   GEO; GSM1001436
DR   GEO; GSM1001459
DR   Progenetix; CVCL_DH04
DR   Wikidata; Q54931750
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   OCI-C4p
AC   CVCL_DH05
SY   OCI-C4P; OCIC4P
DR   cancercelllines; CVCL_DH05
DR   DepMap; ACH-001719
DR   ECACC; 20012002
DR   GEO; GSM1001397
DR   GEO; GSM1001434
DR   Wikidata; Q54931751
RX   PubMed=26080861;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): DepMap=ACH-001719; PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 27,29
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 7,15
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   OCI-C5x
AC   CVCL_DH06
SY   OCIC5X
DR   ATCC; CRL-3553
DR   cancercelllines; CVCL_DH06
DR   Cell_Model_Passport; SIDM01380
DR   DepMap; ACH-001369
DR   ECACC; 20012003
DR   GEO; GSM1001396
DR   GEO; GSM1001433
DR   GEO; GSM1001495
DR   Progenetix; CVCL_DH06
DR   Wikidata; Q54931752
RX   PubMed=26080861;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (DepMap=ACH-001369).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): DepMap=ACH-001369; PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 11,13 (PubMed=26080861)
ST   CSF1PO: 11,13,14 (DepMap=ACH-001369)
ST   D13S317: 10,11,12
ST   D16S539: 10,11,12
ST   D18S51: 17,18,19,20
ST   D21S11: 28,31.2,32.2
ST   D3S1358: 14,16
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 18,19,23,24
ST   Penta D: 9
ST   Penta E: 11,17,18
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 18,21,22,23,24 (DepMap=ACH-001369)
ST   vWA: 18,22 (PubMed=26080861)
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   OCI-CSp
AC   CVCL_DH07
DR   ECACC; 20012010
DR   GEO; GSM1001416
DR   GEO; GSM1001453
DR   Wikidata; Q54931753
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 20012010; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   OCI-D1p
AC   CVCL_DH08
DR   cancercelllines; CVCL_DH08
DR   GEO; GSM1001408
DR   GEO; GSM1001445
DR   GEO; GSM1001458
DR   Progenetix; CVCL_DH08
DR   Wikidata; Q54931754
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8106; Ovarian dysgerminoma
DI   ORDO; Orphanet_99912; Malignant dysgerminomatous germ cell tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   OCI-E1p
AC   CVCL_DH09
DR   cancercelllines; CVCL_DH09
DR   ECACC; 20012012
DR   GEO; GSM1001400
DR   GEO; GSM1001437
DR   GEO; GSM1001463
DR   Progenetix; CVCL_DH09
DR   Wikidata; Q54931755
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 14,19
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   OCI-E2p
AC   CVCL_DH10
DR   GEO; GSM1001402
DR   GEO; GSM1001439
DR   Wikidata; Q54931756
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   OCI-E3x
AC   CVCL_DH11
DR   cancercelllines; CVCL_DH11
DR   GEO; GSM1001411
DR   GEO; GSM1001448
DR   GEO; GSM1001468
DR   Progenetix; CVCL_DH11
DR   Wikidata; Q54931757
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   OCI-EP1p
AC   CVCL_DH12
DR   cancercelllines; CVCL_DH12
DR   ECACC; 20012013
DR   GEO; GSM1001407
DR   GEO; GSM1001444
DR   GEO; GSM1001464
DR   Progenetix; CVCL_DH12
DR   Wikidata; Q54931758
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 20012013; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D5S818: 16,17
ST   D7S820: 10,13
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   OCI-Ly1
AC   CVCL_1879
SY   OCI-LY1; OCI-ly1; OCI-LY-1; OCI-Ly-1; Oci-Ly-1; OCI-Ly 1; OCI-Ly01; OCI Ly1; Ly1; LY1
DR   EFO; EFO_0005907
DR   BioGRID_ORCS_Cell_line; 1211
DR   cancercelllines; CVCL_1879
DR   ChEMBL-Cells; CHEMBL4295427
DR   ChEMBL-Targets; CHEMBL4296480
DR   Cosmic; 1134602
DR   Cosmic; 1295512
DR   Cosmic; 1329091
DR   Cosmic; 1517641
DR   Cosmic; 1541900
DR   Cosmic; 1629932
DR   Cosmic; 1636682
DR   Cosmic; 1945183
DR   Cosmic; 2276318
DR   DSMZ; ACC-722
DR   DSMZCellDive; ACC-722
DR   ENCODE; ENCBS397COL
DR   ENCODE; ENCBS729LWO
DR   ENCODE; ENCBS899DSB
DR   ENCODE; ENCBS945KYE
DR   GEO; GSM1957
DR   GEO; GSM380130
DR   GEO; GSM552450
DR   GEO; GSM1035341
DR   GEO; GSM1059803
DR   GEO; GSM1374783
DR   GEO; GSM3150250
DR   Lonza; 1352
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_1879
DR   PubChem_Cell_line; CVCL_1879
DR   Wikidata; Q54931759
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=10676951;
RX   PubMed=11807979;
RX   PubMed=12169673;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20628145;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=23699601;
RX   PubMed=25960936;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-722).
CC   HLA typing: A*02:01; C*05:01,05:01 (PubMed=25960936).
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: Ocl-Ly1; GEO=GSM3150250.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-722
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 21,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 8,15
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 7,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   OCI-Ly10
AC   CVCL_8795
SY   OCI-LY10; OCI-LY-10; OCI-Ly 10; OCILY-10; OCI Ly10; OCILY10; OCILy10; Ly10; LY10
DR   EFO; EFO_0006708
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03470849
DR   BioSample; SAMN10988192
DR   cancercelllines; CVCL_8795
DR   Cell_Model_Passport; SIDM01883
DR   ChEMBL-Cells; CHEMBL4482983
DR   ChEMBL-Targets; CHEMBL4483285
DR   Cosmic; 1134604
DR   Cosmic; 1329095
DR   Cosmic; 1486585
DR   Cosmic; 1487547
DR   Cosmic; 1517650
DR   Cosmic; 1541905
DR   Cosmic; 1550338
DR   Cosmic; 1945184
DR   Cosmic; 2139542
DR   Cosmic; 2276333
DR   Cosmic; 2437310
DR   DepMap; ACH-001146
DR   EGA; EGAS00001000610
DR   GEO; GSM1956
DR   GEO; GSM2015
DR   GEO; GSM2071
DR   GEO; GSM552455
DR   GEO; GSM1035340
DR   GEO; GSM1059800
DR   GEO; GSM1374784
DR   GEO; GSM1890029
DR   GEO; GSM1890030
DR   GEO; GSM1890031
DR   GEO; GSM1890032
DR   Lonza; 944
DR   PharmacoDB; OCILY10_1188_2019
DR   Progenetix; CVCL_8795
DR   PubChem_Cell_line; CVCL_8795
DR   Wikidata; Q54931760
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=10676951;
RX   PubMed=15122589;
RX   PubMed=20054396;
RX   PubMed=20628145;
RX   PubMed=20889926;
RX   PubMed=21179087;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26787899;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*40:02,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1698; CD79A; Simple; p.Leu191_Gly208del; Zygosity=Heterozygous (PubMed=20054396).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (PubMed=21179087).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.25%; Native American=0.93%; East Asian, North=0.48%; East Asian, South=0%; South Asian=0.05%; European, North=70.29%; European, South=28% (PubMed=30894373).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 14,18
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 14,17
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 36
//
ID   OCI-Ly11
AC   CVCL_M071
SY   OCI-LY11
DR   Wikidata; Q54931761
RX   PubMed=3567358;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   OCI-Ly12
AC   CVCL_8796
SY   OCI-LY12; OCI-LY-12; OCI-Ly 12; OCI Ly12; OCILY12; Ly12
DR   cancercelllines; CVCL_8796
DR   Cell_Model_Passport; SIDM01882
DR   DepMap; ACH-001147
DR   GEO; GSM1990
DR   Wikidata; Q54931762
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=10676951;
RX   PubMed=11807979;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Arg (c.712T>C); ClinVar=VCV000376576; Zygosity=Unspecified (DepMap=ACH-001147).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3465; Grade 1 follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   OCI-Ly13.1
AC   CVCL_M072
SY   OCI-LY13.1; OCI-Ly 13-1
DR   Cell_Model_Passport; SIDM01881
DR   Wikidata; Q54931763
RX   PubMed=3567358;
RX   PubMed=8574164;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8797 ! OCI-Ly13.2
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   OCI-Ly13.2
AC   CVCL_8797
SY   OCI-LY13.2; OCI-LY-13.2; OCI-Ly 13-2; OCI Ly13.2; OCILY132; Ly13.2
DR   cancercelllines; CVCL_8797
DR   Cell_Model_Passport; SIDM01877
DR   DepMap; ACH-001148
DR   GEO; GSM1989
DR   Wikidata; Q54931764
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=10676951;
RX   PubMed=11807979;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M072 ! OCI-Ly13.1
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   OCI-Ly14
AC   CVCL_M073
SY   OCI-LY14
DR   Wikidata; Q54931765
RX   PubMed=3567358;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   OCI-Ly15
AC   CVCL_M074
SY   OCI-LY15
DR   Wikidata; Q54931766
RX   PubMed=3567358;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7873; Adult immunoblastic lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   OCI-Ly16
AC   CVCL_M076
SY   OCI-LY16
DR   Wikidata; Q54931768
RX   PubMed=3567358;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Miscellaneous: Cell line has been lost (PubMed=3567358).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   OCI-Ly17
AC   CVCL_8798
SY   OCI-LY17; OCI-LY-17; OCI-Ly 17; OCI Ly17; Ly17
DR   Wikidata; Q54931769
RX   PubMed=1493476;
RX   PubMed=8574164;
RX   PubMed=11807979;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   OCI-Ly18
AC   CVCL_1880
AS   CVCL_9551
SY   OCI-LY18; OCI-LY-18; OCILY18; OCI-Ly 18; Ly18; LY18
DR   BioSample; SAMN03473448
DR   cancercelllines; CVCL_1880
DR   ChEMBL-Cells; CHEMBL4523522
DR   ChEMBL-Targets; CHEMBL4523553
DR   Cosmic; 1295513
DR   Cosmic; 1517651
DR   Cosmic; 1541906
DR   Cosmic; 1636683
DR   Cosmic; 2276334
DR   DepMap; ACH-001616
DR   DSMZ; ACC-699
DR   DSMZCellDive; ACC-699
DR   GEO; GSM380131
DR   GEO; GSM552456
DR   GEO; GSM1374785
DR   Progenetix; CVCL_1880
DR   PubChem_Cell_line; CVCL_1880
DR   Wikidata; Q54931770
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1311715;
RX   PubMed=8574164;
RX   PubMed=11807979;
RX   PubMed=19278952;
RX   PubMed=20628145;
RX   PubMed=26727417;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-699).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (DepMap=ACH-001616).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: OCI-LZ18; BioSample=SAMN03473448.
CC   Misspelling: SU-DHL-18; Cosmic=1295513.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001616; DSMZ=ACC-699
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D19S433: 13,14
ST   D21S11: 31
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 19,21
ST   Penta D: 10
ST   Penta E: 5,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   OCI-Ly19
AC   CVCL_1878
SY   OCI-LY19; OCI-LY-19; OCI-Ly 19; OCI Ly19; OCILY-19; OCILY19; OCILy19; Ly19; LY19
DR   CLO; CLO_0037052
DR   EFO; EFO_0006709
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 974
DR   BioSample; SAMN03471654
DR   BioSample; SAMN10988474
DR   cancercelllines; CVCL_1878
DR   Cell_Model_Passport; SIDM00460
DR   ChEMBL-Cells; CHEMBL4482985
DR   ChEMBL-Targets; CHEMBL4483262
DR   Cosmic; 1079258
DR   Cosmic; 1086340
DR   Cosmic; 1295509
DR   Cosmic; 1329093
DR   Cosmic; 1629933
DR   Cosmic; 1945185
DR   Cosmic; 2276335
DR   Cosmic-CLP; 1330984
DR   DepMap; ACH-000124
DR   DSMZ; ACC-528
DR   DSMZCellDive; ACC-528
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1330984
DR   GEO; GSM380132
DR   GEO; GSM552460
DR   GEO; GSM887471
DR   GEO; GSM888551
DR   GEO; GSM1035326
DR   GEO; GSM1374786
DR   GEO; GSM1670298
DR   IARC_TP53; 30134
DR   LiGeA; CCLE_704
DR   LINCS_LDP; LCL-1121
DR   PharmacoDB; OCILY19_1186_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1878
DR   PubChem_Cell_line; CVCL_1878
DR   Wikidata; Q54931771
RX   PubMed=8558920;
RX   PubMed=8574164;
RX   PubMed=19278952;
RX   PubMed=20054396;
RX   PubMed=20454443;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=23292937;
RX   PubMed=23699601;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=26787899;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (DSMZ=ACC-528).
CC   HLA typing: B*44:02,44:02; C*05:01,08:02; DQA1*03:02,02:01; DQB1*03,03; DRB1*04,04 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*56:01,56:01; C*07:02,07:02 (PubMed=26589293).
CC   HLA typing: A*03:01:01,03:01:01; B*56:01:01,56:01:01; C*07:02:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*06:01,06:01; DQA1*01:01:01,01:01:01; DQB1*05:01:01,05:01:01; DRA*01:01:01,01:01:01; DRB1*01:01:01,01:01:01 (DSMZCellDive=ACC-528).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=1330984; DepMap=ACH-000124).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.55%; Native American=0%; East Asian, North=4.58%; East Asian, South=0%; South Asian=0%; European, North=53.54%; European, South=39.33% (PubMed=30894373).
CC   Caution: While it was indicated to be EBV-positive (PubMed=20454443), this result has later been shown to be invalid (personal communication of Uphoff, Cord C.).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=1330984; DSMZ=ACC-528; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 20,23
ST   Penta D: 12,13
ST   Penta E: 12,15
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   OCI-Ly2
AC   CVCL_8799
SY   OCI-LY2; OCI-LY-2; OCI-Ly-2; OCI-Ly 2; OCI-Ly02; Ly2; LY2
DR   cancercelllines; CVCL_8799
DR   Cosmic; 1176630
DR   GEO; GSM1059810
DR   Progenetix; CVCL_8799
DR   Wikidata; Q54931772
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=11807979;
RX   PubMed=19358282;
RX   PubMed=23257783;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   OCI-Ly3
AC   CVCL_8800
SY   OCI-LY3; OCI-ly3; OCI-LY-3; Oci-Ly-3; OCI-Ly 3; OCILY-3; OCI-Ly03; OCI Ly3; OCILY3; Ly3; LY3
DR   EFO; EFO_0006710
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 745
DR   BioSample; SAMN10988130
DR   cancercelllines; CVCL_8800
DR   Cell_Model_Passport; SIDM01778
DR   ChEMBL-Cells; CHEMBL4523534
DR   ChEMBL-Targets; CHEMBL4523565
DR   Cosmic; 1290019
DR   Cosmic; 1329094
DR   Cosmic; 1486584
DR   Cosmic; 1487544
DR   Cosmic; 1517647
DR   Cosmic; 1541901
DR   Cosmic; 1548654
DR   Cosmic; 1550337
DR   Cosmic; 1945198
DR   Cosmic; 2276329
DR   Cosmic; 2437309
DR   DepMap; ACH-000158
DR   DSMZ; ACC-761
DR   DSMZCellDive; ACC-761
DR   EGA; EGAS00001000610
DR   ENCODE; ENCBS018GXW
DR   ENCODE; ENCBS757GPD
DR   GEO; GSM1963
DR   GEO; GSM2023
DR   GEO; GSM380133
DR   GEO; GSM552451
DR   GEO; GSM887472
DR   GEO; GSM888552
DR   GEO; GSM1035342
DR   GEO; GSM1059799
DR   GEO; GSM1374787
DR   GEO; GSM1890025
DR   GEO; GSM1890026
DR   GEO; GSM1890027
DR   GEO; GSM1890028
DR   GEO; GSM3150251
DR   IARC_TP53; 26922
DR   LiGeA; CCLE_060
DR   Lonza; 945
DR   PharmacoDB; OCILY3_1189_2019
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_8800
DR   PubChem_Cell_line; CVCL_8800
DR   Wikidata; Q54931773
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=10676951;
RX   PubMed=11807979;
RX   PubMed=15122589;
RX   PubMed=18323416;
RX   PubMed=19278952;
RX   PubMed=20054396;
RX   PubMed=20628145;
RX   PubMed=20889926;
RX   PubMed=21179087;
RX   PubMed=22460905;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=23321251;
RX   PubMed=23699601;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (DSMZ=ACC-761).
CC   HLA typing: A*01:01,03:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,03:01:01; B*08:01:01,08:01:01; C*07:01:01,07:01:01; DPA1*02:01:02,02:01:02; DPB1*01:01:01,01:01:01; DQA1*05:01:01,05:01:01; DQB1*02:01:01,02:01:01; DRA*01:02:02,01:02:02; DRB1*03:01:01,03:01:01 (DSMZCellDive=ACC-761).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:11242; SPIB; Name(s)=IGH-SPIB (PubMed=31160637; DSMZ=ACC-761).
CC   Sequence variation: Mutation; HGNC; HGNC:16393; CARD11; Simple; p.Leu251Pro (c.752T>C) (L244P); ClinVar=VCV001017661; Zygosity=Homozygous (PubMed=18323416; DepMap=ACH-000158).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Homozygous (PubMed=21179087; PubMed=23321251; DepMap=ACH-000158).
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.02%; Native American=0%; East Asian, North=4.08%; East Asian, South=0%; South Asian=0%; European, North=65.42%; European, South=30.48% (PubMed=30894373).
CC   Caution: A cell line, now termed GNE-587170 (Cellosaurus=CVCL_AT69), was mistakenly distributed by OCI to a number of groups under the designation OCI-Ly-3, the origin of that cell line is now known.
CC   Misspelling: Ocl-Ly3; GEO=GSM3150251.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-761
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 24
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 41
//
ID   OCI-Ly4
AC   CVCL_8801
SY   OCI-LY4; OCI-LY-4; OCI-Ly 4; Ly4; LY4
DR   cancercelllines; CVCL_8801
DR   Cosmic; 1517648
DR   Cosmic; 1541902
DR   Cosmic; 1636684
DR   Cosmic; 2276330
DR   GEO; GSM380134
DR   GEO; GSM552452
DR   GEO; GSM1035332
DR   GEO; GSM1374788
DR   IARC_TP53; 6447
DR   Progenetix; CVCL_8801
DR   Wikidata; Q54931774
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=11807979;
RX   PubMed=15126345;
RX   PubMed=19278952;
RX   PubMed=20628145;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (PubMed=8574164).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=8574164).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   OCI-Ly5
AC   CVCL_M075
SY   OCI-LY5
DR   Wikidata; Q54931775
RX   PubMed=3567358;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7540; Small lymphocytic lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   OCI-Ly6
AC   CVCL_8802
SY   OCI-LY6; OCI-LY-6; Ly6
DR   Wikidata; Q54931776
RX   PubMed=3567358;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   OCI-Ly7
AC   CVCL_1881
SY   OCI-LY7; OCI-LY-7; OCI-Ly-7; Oci-Ly-7; OCI-Ly 7; OCI-Ly07; OCILY7; Ly7; LY7
DR   BTO; BTO_0006414
DR   EFO; EFO_0006711
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 1398
DR   BioSample; SAMN03473439
DR   cancercelllines; CVCL_1881
DR   Cell_Model_Passport; SIDM00459
DR   ChEMBL-Cells; CHEMBL4523533
DR   ChEMBL-Targets; CHEMBL4523564
DR   Cosmic; 1329092
DR   Cosmic; 1517649
DR   Cosmic; 1541903
DR   Cosmic; 1629934
DR   Cosmic; 1945199
DR   Cosmic; 2276331
DR   Cosmic-CLP; 1659819
DR   DepMap; ACH-001617
DR   DSMZ; ACC-688
DR   DSMZCellDive; ACC-688
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS006VZG
DR   ENCODE; ENCBS040MJM
DR   ENCODE; ENCBS062JSC
DR   ENCODE; ENCBS121JKZ
DR   ENCODE; ENCBS141AMI
DR   ENCODE; ENCBS182NFY
DR   ENCODE; ENCBS304FAI
DR   ENCODE; ENCBS581USS
DR   ENCODE; ENCBS699NWP
DR   ENCODE; ENCBS865AAA
DR   ENCODE; ENCBS866AAA
DR   ENCODE; ENCBS886BJZ
DR   GDSC; 1659819
DR   GEO; GSM380135
DR   GEO; GSM552453
DR   GEO; GSM562825
DR   GEO; GSM1035333
DR   GEO; GSM1059809
DR   GEO; GSM1374789
DR   PharmacoDB; OCILY7_1187_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1881
DR   PubChem_Cell_line; CVCL_1881
DR   Wikidata; Q54931777
RX   PubMed=3567358;
RX   PubMed=8574164;
RX   PubMed=11807979;
RX   PubMed=15126345;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20054396;
RX   PubMed=20628145;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=23699601;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=27397505;
RX   PubMed=27566572;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Population: Caucasian.
CC   Characteristics: Genetically heterogeneous, consists of 2 subclones (PubMed=27566572).
CC   Doubling time: ~20-24 hours (DSMZ=ACC-688).
CC   HLA typing: A*01:01; B*13; C*04:01; DQA1*05:02,05:02; DQB1*03:09,03:09; DRB1*13:03,07:01 (PubMed=25960936).
CC   HLA typing: A*01:01:01,01:01:01; B*35:02:01,35:02:01; C*04:01:01,04:01:01; DPA1*01:03:01,01:03:01; DPB1*03:01:01,17:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:01; DRA*01:02:02,01:02:02; DRB1*13:03:01,13:03:01 (DSMZCellDive=ACC-688).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=31160637; DSMZ=ACC-688).
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.44%; Native American=0.13%; East Asian, North=0%; East Asian, South=0.31%; South Asian=1.19%; European, North=69.58%; European, South=28.35% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1659819; DepMap=ACH-001617; DSMZ=ACC-688
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 20
ST   D19S433: 14,16
ST   D21S11: 29,31.2
ST   D2S1338: 22,24
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 11,13
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   OCI-Ly8
AC   CVCL_8803
SY   OCI-LY8; OCI-LY-8; OCI-Ly-8; OCI-Ly 8; OCILy8; OCLY8; Ly8; LY8
DR   cancercelllines; CVCL_8803
DR   Cosmic; 1134603
DR   Cosmic; 1517603
DR   Cosmic; 1541904
DR   Cosmic; 1945186
DR   Cosmic; 2276332
DR   Cosmic; 2297007
DR   GEO; GSM116023
DR   GEO; GSM380136
DR   GEO; GSM552454
DR   GEO; GSM1035319
DR   GEO; GSM1374790
DR   Progenetix; CVCL_8803
DR   Wikidata; Q54931778
RX   PubMed=3567358;
RX   PubMed=7849311;
RX   PubMed=8574164;
RX   PubMed=11807979;
RX   PubMed=15126345;
RX   PubMed=16960149;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20628145;
RX   PubMed=23292937;
RX   PubMed=26727417;
RX   PubMed=26787899;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, immunoblastic-type.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   OCI-Ly9
AC   CVCL_QW65
SY   OCI-LY9; OCI-Ly 9
DR   Wikidata; Q54931779
RX   PubMed=3567358;
RX   PubMed=8574164;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   OCI-m/F1
AC   CVCL_LN39
DR   cancercelllines; CVCL_LN39
DR   Wikidata; Q54931780
RX   PubMed=3409229;
CC   Problematic cell line: Contaminated. Grand-parent cell line (Ej138) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN38 ! MGH-U1/OCI
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   OCI-M1
AC   CVCL_2149
SY   OCI M1; OCIM1
DR   BTO; BTO_0004622
DR   CLO; CLO_0009854
DR   EFO; EFO_0006712
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473108
DR   BioSample; SAMN10989554
DR   cancercelllines; CVCL_2149
DR   Cell_Model_Passport; SIDM00458
DR   Cosmic; 787471
DR   Cosmic; 924043
DR   Cosmic; 975293
DR   Cosmic; 1281348
DR   Cosmic; 2131554
DR   Cosmic; 2306235
DR   Cosmic-CLP; 1330985
DR   DepMap; ACH-000751
DR   DSMZ; ACC-529
DR   DSMZCellDive; ACC-529
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1330985
DR   GEO; GSM887473
DR   GEO; GSM888553
DR   GEO; GSM1374791
DR   GEO; GSM1446752
DR   GEO; GSM1670299
DR   IARC_TP53; 28326
DR   LiGeA; CCLE_286
DR   LINCS_LDP; LCL-1068
DR   PharmacoDB; OCIM1_1190_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2149
DR   Wikidata; Q54931781
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3166384;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (DSMZ=ACC-529).
CC   HLA typing: A*02:01,03:01; B*14:02,15:03; C*02:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Heterozygous (Cosmic-CLP=1330985; DepMap=ACH-000751).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=1330985; DepMap=ACH-000751).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.87%; Native American=0%; East Asian, North=4.72%; East Asian, South=0%; South Asian=3.18%; European, North=27.28%; European, South=60.94% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1330985; DSMZ=ACC-529; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12,14
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 15,16
ST   D21S11: 31.2,33.2
ST   D2S1338: 18,24
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 18,24
ST   Penta D: 6,11
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C8923; Acute erythroid leukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   OCI-M1p
AC   CVCL_DH13
DR   cancercelllines; CVCL_DH13
DR   ECACC; 20012014
DR   GEO; GSM1001395
DR   GEO; GSM1001432
DR   GEO; GSM1001465
DR   Progenetix; CVCL_DH13
DR   Wikidata; Q54931782
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 20012014; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 16,17
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   OCI-M2
AC   CVCL_2150
SY   OCI M2; OCIM2
DR   BTO; BTO_0004623
DR   EFO; EFO_0006713
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473109
DR   cancercelllines; CVCL_2150
DR   Cell_Model_Passport; SIDM01841
DR   Cosmic; 787472
DR   Cosmic; 924044
DR   Cosmic; 975294
DR   Cosmic; 1012112
DR   Cosmic; 1245830
DR   Cosmic; 1281349
DR   Cosmic; 1465962
DR   Cosmic; 2306236
DR   Cosmic; 2750870
DR   DepMap; ACH-001618
DR   DSMZ; ACC-619
DR   DSMZCellDive; ACC-619
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM1374792
DR   GEO; GSM1446760
DR   IARC_TP53; 347
DR   PharmacoDB; OCIM2_1191_2019
DR   Wikidata; Q54931783
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3166384;
RX   PubMed=16408098;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=31160637;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Doubling time: ~36 hours (DSMZ=ACC-619).
CC   HLA typing: A*02:01,02:01; B*08:01,44:02; C*05:01,07:06 (PubMed=26589293).
CC   HLA typing: A*02:01:01,02:01:01; B*08:01:01,44:02:01; C*05:01:01,07:01:01 (DSMZCellDive=ACC-619).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10471; RUNX1 + HGNC; HGNC:1268; TSPEAR; Name(s)=RUNX1-TSPEAR (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (DepMap=ACH-001618).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Asp (c.821T>A); ClinVar=VCV000376675; Zygosity=Unspecified (DepMap=ACH-001618).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): DepMap=ACH-001618; DSMZ=ACC-619; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 16,20
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 18,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 21
ST   Penta D: 9 (DSMZ=ACC-619; PubMed=25877200)
ST   Penta D: 9,12 (DepMap=ACH-001618)
ST   Penta E: 10,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8923; Acute erythroid leukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 31
//
ID   OCI-My1
AC   CVCL_E338
SY   OCI-MY1; OCI-My 1; OCIMy1; OCIMY1
DR   Cosmic; 2081400
DR   Cosmic; 2367265
DR   GEO; GSM1374793
DR   Lonza; 1458
DR   Wikidata; Q54931784
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1912582;
RX   PubMed=8138440;
RX   PubMed=10936422;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Doubling time: 24 hours (PubMed=1912582).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12033; TRAF3; Zygosity=Homozygous (PubMed=17692805).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   OCI-My2
AC   CVCL_E337
SY   OCI-MY2; OCI-My 2; OCIMy2
DR   Wikidata; Q54931785
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1912582;
RX   PubMed=8138440;
RX   PubMed=10936422;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Doubling time: 24 hours (PubMed=1912582).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   OCI-My3
AC   CVCL_E336
SY   OCI-MY3; OCI-My 3; OCIMy3
DR   Wikidata; Q54931786
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1912582;
RX   PubMed=8138440;
RX   PubMed=10936422;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Doubling time: 32 hours (PubMed=1912582).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   OCI-My4
AC   CVCL_E334
SY   OCI-MY4; OCI-My 4; OCIMy4
DR   Wikidata; Q54931787
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1912582;
RX   PubMed=8138440;
RX   PubMed=10936422;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 130 hours, 28 hours (Note=With PHA-LCM in culture media) (PubMed=1912582).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   OCI-My5
AC   CVCL_E332
SY   OCI-MY5; OCI-My 5; OCIMy5; OCIMY5; MY5
DR   BioSample; SAMN10989616
DR   cancercelllines; CVCL_E332
DR   Cell_Model_Passport; SIDM01876
DR   Cosmic; 720791
DR   Cosmic; 2081401
DR   Cosmic; 2302416
DR   Cosmic; 2367261
DR   DepMap; ACH-000854
DR   GEO; GSM1374794
DR   Wikidata; Q54931788
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1912582;
RX   PubMed=3137236;
RX   PubMed=8138440;
RX   PubMed=8943038;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Population: Caucasian.
CC   Characteristics: Produces IgA lambda (PubMed=3137236).
CC   Doubling time: 8 hours (PubMed=1912582).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Homozygous (DepMap=ACH-000854).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=3.85%; Native American=0%; East Asian, North=4.08%; East Asian, South=0%; South Asian=1.28%; European, North=54.74%; European, South=36.05% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 27
//
ID   OCI-My6
AC   CVCL_E335
SY   OCI-MY6; OCI-My 6; OCIMy6
DR   Wikidata; Q54931789
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1912582;
RX   PubMed=8138440;
RX   PubMed=10936422;
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Doubling time: 45 hours (PubMed=1912582).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   OCI-My7
AC   CVCL_E333
SY   OCI-MY7; OCI-My 7; OCIMy7; OCIMY7
DR   BioSample; SAMN10989617
DR   cancercelllines; CVCL_E333
DR   Cell_Model_Passport; SIDM01379
DR   Cosmic; 2081402
DR   Cosmic; 2367266
DR   DepMap; ACH-000436
DR   Wikidata; Q54931790
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1912582;
RX   PubMed=8138440;
RX   PubMed=10936422;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC   Population: Caucasian.
CC   Doubling time: 57 hours (PubMed=1912582).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000436).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=2.65%; Native American=0%; East Asian, North=2.7%; East Asian, South=1.34%; South Asian=7.94%; European, North=21.26%; European, South=64.1% (PubMed=30894373).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 25
//
ID   OCI-P1a
AC   CVCL_DH14
DR   cancercelllines; CVCL_DH14
DR   GEO; GSM1001410
DR   GEO; GSM1001447
DR   GEO; GSM1001470
DR   Progenetix; CVCL_DH14
DR   Wikidata; Q54931791
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 12,14
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,20
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   OCI-P2a
AC   CVCL_DH15
DR   cancercelllines; CVCL_DH15
DR   ECACC; 20012004
DR   GEO; GSM1001401
DR   GEO; GSM1001438
DR   GEO; GSM1001466
DR   Progenetix; CVCL_DH15
DR   Wikidata; Q54931792
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Gly (c.799C>G); ClinVar=VCV001761541; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   OCI-P3a
AC   CVCL_DH16
DR   GEO; GSM1001413
DR   GEO; GSM1001450
DR   Wikidata; Q54931793
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   OCI-P4p
AC   CVCL_DH17
DR   cancercelllines; CVCL_DH17
DR   GEO; GSM1001405
DR   GEO; GSM1001442
DR   GEO; GSM1001469
DR   Progenetix; CVCL_DH17
DR   Wikidata; Q54931794
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   OCI-P5x
AC   CVCL_DH18
SY   OCIP5X
DR   ATCC; CRL-3552
DR   cancercelllines; CVCL_DH18
DR   DepMap; ACH-001370
DR   ECACC; 20012005
DR   GEO; GSM1001414
DR   GEO; GSM1001451
DR   GEO; GSM1001457
DR   Progenetix; CVCL_DH18
DR   Wikidata; Q54931795
RX   PubMed=26080861;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001370).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Asn (c.706T>A); ClinVar=VCV000376694; Zygosity=Unspecified (PubMed=26080861; DepMap=ACH-001370).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): DepMap=ACH-001370; PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 12,13,15
ST   FGA: 20,24
ST   Penta D: 10
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   OCI-P6p
AC   CVCL_DH19
DR   GEO; GSM1001412
DR   GEO; GSM1001449
DR   Wikidata; Q54931796
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   OCI-P7a
AC   CVCL_DH20
DR   cancercelllines; CVCL_DH20
DR   ECACC; 20012006
DR   GEO; GSM1001409
DR   GEO; GSM1001446
DR   GEO; GSM1001460
DR   Progenetix; CVCL_DH20
DR   Wikidata; Q54931798
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 20012006; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 8,14
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,10
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   OCI-P8p
AC   CVCL_DH21
DR   cancercelllines; CVCL_DH21
DR   ECACC; 20012007
DR   GEO; GSM1001431
DR   GEO; GSM1001456
DR   Wikidata; Q54931799
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   OCI-P9a1
AC   CVCL_DH22
DR   ECACC; 20012008
DR   GEO; GSM1001403
DR   GEO; GSM1001440
DR   GEO; GSM1001461
DR   Wikidata; Q54931800
RX   PubMed=26080861;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 20012008; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 9,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH23 ! OCI-P9a2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 8
//
ID   OCI-P9a2
AC   CVCL_DH23
DR   ECACC; 20012015
DR   GEO; GSM1001418
DR   GEO; GSM1001455
DR   Wikidata; Q54931801
RX   PubMed=26080861;
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 20012015; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH22 ! OCI-P9a1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 8
//
ID   OCI-U1a
AC   CVCL_DH24
DR   cancercelllines; CVCL_DH24
DR   ECACC; 20012011
DR   GEO; GSM1001404
DR   GEO; GSM1001441
DR   GEO; GSM1001494
DR   Progenetix; CVCL_DH24
DR   Wikidata; Q54931802
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   OCL-1
AC   CVCL_6701
DR   BTO; BTO_0004802
DR   Wikidata; Q54931803
RX   PubMed=6420051;
CC   Population: Japanese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   OCL-3
AC   CVCL_6702
DR   BTO; BTO_0004840
DR   Wikidata; Q54931804
RX   PubMed=19501511;
CC   Miscellaneous: Not listed anywhere else than in PubMed=19501511.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   OCLE1
AC   CVCL_ZZ93
DR   ECACC; 20012017
DR   Wikidata; Q102114679
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 20012017; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ89 ! FNE1
OI   CVCL_ZZ90 ! FNLE1
OI   CVCL_ZZ91 ! FNLER1
OI   CVCL_ZZ92 ! OCE1
OI   CVCL_ZZ94 ! OCLER1
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   OCLE2
AC   CVCL_ZZ99
DR   ECACC; 20012020
DR   Wikidata; Q102114680
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 20012020; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ95 ! FNE2
OI   CVCL_ZZ96 ! FNLE2
OI   CVCL_ZZ97 ! FNLER2
OI   CVCL_ZZ98 ! OCE2
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   OCLER1
AC   CVCL_ZZ94
DR   ECACC; 20012018
DR   Wikidata; Q102114681
WW   Info; ECACC; -; https://www.culturecollections.org.uk/media/4694/ovarian-and-fallopian-tube-cell-line-collection.pdf
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 20012018; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZZ89 ! FNE1
OI   CVCL_ZZ90 ! FNLE1
OI   CVCL_ZZ91 ! FNLER1
OI   CVCL_ZZ92 ! OCE1
OI   CVCL_ZZ93 ! OCLE1
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   OCM-1
AC   CVCL_6934
SY   OCM1; Ocm1; Ocular Choroidal Melanoma-1
DR   BTO; BTO_0002736
DR   cancercelllines; CVCL_6934
DR   Cosmic; 848327
DR   Cosmic; 899892
DR   Cosmic; 916139
DR   Cosmic; 986617
DR   Cosmic; 1320368
DR   Cosmic; 1628408
DR   GEO; GSM276733
DR   Wikidata; Q54931805
RX   PubMed=2722439;
RX   PubMed=8621261;
RX   PubMed=9154388;
RX   PubMed=15714118;
RX   PubMed=16772116;
RX   PubMed=17487557;
RX   PubMed=18689700;
RX   PubMed=22236444;
RX   PubMed=23849826;
RX   PubMed=28940260;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=28940260). Originally thought to originate from a female patient with uveal melanoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00502.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22236444).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): PubMed=18689700
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 13,18
ST   D21S11: 30
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1395 ! M14
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   OCM-1A
AC   CVCL_6935
SY   OCM1A; OCM1a
DR   cancercelllines; CVCL_6935
DR   Cosmic; 1247863
DR   GEO; GSM1082693
DR   Wikidata; Q54931806
RX   PubMed=15299072;
CC   Problematic cell line: Contaminated. Parent cell line (OCM-1) has been shown to be a M14 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000234). It was one of the sources for the STR profile of this entry.
CC   Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6934 ! OCM-1
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   OCM-2
AC   CVCL_6936
SY   OCM2; Ocular Choroidal Melanoma-2
DR   Wikidata; Q54931807
RX   PubMed=2722439;
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   OCM-3
AC   CVCL_6937
SY   OCM3; Ocm3; ocm-3
DR   BioSample; SAMN06481119
DR   cancercelllines; CVCL_6937
DR   Cosmic; 916142
DR   Cosmic; 1320369
DR   Cosmic; 1628409
DR   Cosmic; 2163831
DR   ESTDAB; ESTDAB-129
DR   Wikidata; Q54931808
RX   PubMed=16772116;
RX   PubMed=18689700;
RX   PubMed=19340423;
RX   PubMed=22236444;
RX   PubMed=23851445;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
CC   From: Kan-Mitchell, June; Wayne State University; Detroit; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00503.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=22236444; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434_435TG>GT); Zygosity=Homozygous (PubMed=23851445).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
ST   Source(s): ESTDAB=ESTDAB-129; PubMed=18689700
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D21S11: 28,29
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   OCM-8
AC   CVCL_6938
SY   OCM8; Ocm8; ocm-8
DR   BioSample; SAMN06481120
DR   cancercelllines; CVCL_6938
DR   Cosmic; 1320370
DR   Cosmic; 1628410
DR   ESTDAB; ESTDAB-130
DR   Wikidata; Q54931810
RX   PubMed=16772116;
RX   PubMed=18689700;
RX   PubMed=19340423;
RX   PubMed=22236444;
RX   PubMed=23849826;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Originally thought to originate from an uveal melanoma.
CC   From: Kan-Mitchell, June; Wayne State University; Detroit; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00504.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=22236444).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
ST   Source(s): ESTDAB=ESTDAB-130; PubMed=18689700
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D21S11: 28,29
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   OCPC-2-VGH
AC   CVCL_GT40
SY   VGH-OCPC-2
DR   BCRC; 60603
DR   Wikidata; Q54931811
RX   CelloPub=CLPUB00351;
RX   PubMed=10592434;
CC   Population: Chinese.
CC   Doubling time: 44.85 +- 4.02 hours (Note=In 10% FCS), 46.69 +- 2.94 hours (Note=In 2% FCS), 58.98 +- 2.05 hours (Note=In 0% FCS) (CelloPub=CLPUB00351).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7278; Ovarian papillary cystadenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   Ocr_OCMM1X
AC   CVCL_C1G6
DR   Wikidata; Q114312622
RX   PubMed=30514258;
CC   Characteristics: Obtained after three passages of the tumor sample by subcutaneousl injection in nude mice.
CC   Doubling time: 59.9 +- 6 hours (PubMed=30514258).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Breed/subspecies: Yorkshire Terrier; VBO=VBO_0201448.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_C1G7 ! Ocr_OCMM1X passage 1
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   Ocr_OCMM1X passage 1
AC   CVCL_C1G7
DR   Wikidata; Q114312623
RX   PubMed=30514258;
CC   Characteristics: Obtained after one passage of the tumor sample by subcutaneousl injection in nude mice.
CC   Doubling time: 41.8 +- 8 hours (PubMed=30514258).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Breed/subspecies: Yorkshire Terrier; VBO=VBO_0201448.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_C1G6 ! Ocr_OCMM1X
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   Ocr_OCMM2 primary
AC   CVCL_C1G8
DR   Wikidata; Q114312624
RX   PubMed=30514258;
CC   Doubling time: 75.1 +- 8 hours (PubMed=30514258).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_C1G9 ! Ocr_OCMM2X
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   Ocr_OCMM2X
AC   CVCL_C1G9
DR   Wikidata; Q114312625
RX   PubMed=30514258;
CC   Characteristics: Obtained after three passages of the tumor sample by subcutaneousl injection in nude mice.
CC   Doubling time: 61.6 +- 4 hours (PubMed=30514258).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_C1G8 ! Ocr_OCMM2 primary
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   OCrF-1
AC   CVCL_B7QG
SY   Oreichthys Crenuchoides Fin-1
DR   NRFC; NRFC077
DR   Wikidata; Q114312626
WW   Provider; NRFC; NRFC077; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC077.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=1001913; ! Oreichthys crenuchoides (Drape fin barb)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   OCRG9
AC   CVCL_C395
DR   RCB; AES0152
DR   SKIP; SKIP002994
DR   Wikidata; Q54931813
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   OCT-1
AC   CVCL_WN86
SY   Oct-1; Osteocalcin-T antigen clone #1
DR   Wikidata; Q98128327
RX   CelloPub=CLPUB00508;
RX   CelloPub=CLPUB00625;
RX   PubMed=9421234;
RX   PubMed=16738320;
RX   PubMed=20232074;
CC   Doubling time: 27.3 hours (CelloPub=CLPUB00625).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 rat Bgla promoter T-Ag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_WN87 ! OCT-2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   OCT-2
AC   CVCL_WN87
SY   Osteocalcin-T antigen clone #2
DR   Wikidata; Q98128328
RX   CelloPub=CLPUB00508;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 rat Bgla promoter T-Ag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_WN86 ! OCT-1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   OCU-K3
AC   CVCL_DR19
SY   RABK3; RabbitK3; RABbit Kidney 3
DR   CCRID; 5301RAB-KCB06093ZJ
DR   KCB; KCB 200693ZJ
DR   Wikidata; Q54949083
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 11
//
ID   OCU-K4
AC   CVCL_A9EY
DR   CCRID; 5301RAB-KCB1469KZJ
DR   KCB; KCB 2014069KZJ
DR   Wikidata; Q108821060
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_A9EZ ! OCU-L1
OI   CVCL_A9EX ! OCU-M1
OI   CVCL_A9EV ! OCU-S2
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   OCU-L1
AC   CVCL_A9EZ
DR   CCRID; 5301RAB-KCB1469LZJ
DR   KCB; KCB 2014069LZJ
DR   Wikidata; Q108821061
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_A9EY ! OCU-K4
OI   CVCL_A9EX ! OCU-M1
OI   CVCL_A9EV ! OCU-S2
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   OCU-M1
AC   CVCL_A9EX
DR   CCRID; 5301RAB-KCB140069M
DR   KCB; KCB 2014069M
DR   Wikidata; Q108821063
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_A9EY ! OCU-K4
OI   CVCL_A9EZ ! OCU-L1
OI   CVCL_A9EV ! OCU-S2
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   OCU-MSC1
AC   CVCL_A9GQ
DR   CCRID; 5301RAB-KCB1283MSC
DR   KCB; KCB 2012083MSC
DR   Wikidata; Q108821064
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   OCU-MSC2
AC   CVCL_A9GR
DR   CCRID; 5301RAB-KCB1469MSC
DR   KCB; KCB 2014069MSC
DR   Wikidata; Q108821066
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   3D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   OCU-S1
AC   CVCL_A9EW
SY   RABS1; RabbitS1; DR-S1
DR   CCRID; 5301RAB-KCB04015ZJ
DR   KCB; KCB 200415ZJ
DR   Wikidata; Q108821067
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Black.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   OCU-S2
AC   CVCL_A9EV
DR   CCRID; 5301RAB-KCB140069S
DR   KCB; KCB 2014069S
DR   Wikidata; Q108821068
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_A9EY ! OCU-K4
OI   CVCL_A9EZ ! OCU-L1
OI   CVCL_A9EX ! OCU-M1
SX   Female
AG   3D
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   OCUB-1
AC   CVCL_L114
SY   Osaka City University Breast-1
DR   Wikidata; Q54931814
RX   PubMed=7873497;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   OCUB-F
AC   CVCL_3352
SY   OCUB-1F; OCUBF; OCUB-1 Floating
DR   CLO; CLO_0051610
DR   BioSample; SAMN03472189
DR   cancercelllines; CVCL_3352
DR   Cosmic; 997934
DR   Cosmic; 1046937
DR   Cosmic; 1289404
DR   GEO; GSM217593
DR   GEO; GSM219906
DR   GEO; GSM421882
DR   GEO; GSM459705
DR   GEO; GSM1661986
DR   IARC_TP53; 24358
DR   Progenetix; CVCL_3352
DR   RCB; RCB0882
DR   Wikidata; Q54931815
RX   PubMed=7873497;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19593635;
RX   PubMed=23601657;
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Val17fs*1 (c.49_163del115); Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala76Profs*70 (c.225delC); Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ser (c.730G>A); ClinVar=VCV000376600; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB0882
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 9,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L114 ! OCUB-1
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   OCUB-M
AC   CVCL_1621
SY   OCUBM; OCUB-1M; OCUB-1 Monolayered
DR   CLO; CLO_0051609
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 976
DR   BioSample; SAMN03472188
DR   cancercelllines; CVCL_1621
DR   Cell_Model_Passport; SIDM00241
DR   ChEMBL-Cells; CHEMBL3308245
DR   ChEMBL-Targets; CHEMBL2366121
DR   Cosmic; 909256
DR   Cosmic-CLP; 909256
DR   DepMap; ACH-002179
DR   EGA; EGAS00001000978
DR   GDSC; 909256
DR   GEO; GSM217594
DR   GEO; GSM1661987
DR   GEO; GSM1670300
DR   IARC_TP53; 21599
DR   LINCS_LDP; LCL-1489
DR   PharmacoDB; OCUBM_1192_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1621
DR   PubChem_Cell_line; CVCL_1621
DR   RCB; RCB0881
DR   Wikidata; Q54931816
RX   PubMed=7873497;
RX   PubMed=15677628;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15677628; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1919; CHD4; Simple; p.Lys945fs*28 (c.2835delA); Zygosity=Heterozygous (Cosmic-CLP=909256).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Homozygous (Cosmic-CLP=909256; DepMap=ACH-002179).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Gly383Asp (c.1148G>A); ClinVar=VCV002089401; Zygosity=Heterozygous (Cosmic-CLP=909256; DepMap=ACH-002179).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ser (c.730G>A); ClinVar=VCV000376600; Zygosity=Homozygous (Cosmic-CLP=909256; DepMap=ACH-002179).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.46%; Native American=1.63%; East Asian, North=78.49%; East Asian, South=13.1%; South Asian=0%; European, North=0%; European, South=4.31% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=909256; RCB=RCB0881
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 9,13
ST   TH01: 9
ST   TPOX: 7,8
ST   vWA: 18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L114 ! OCUB-1
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   OCUCh-LM1
AC   CVCL_L091
SY   Osaka City University Cholangiocarcinoma-Liver Metastasis 1
DR   Wikidata; Q54931817
RX   CelloPub=CLPUB00275;
RX   PubMed=7880737;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 31 hours (PubMed=7880737).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   OCUCh-LM1-H1
AC   CVCL_L092
DR   Wikidata; Q54931818
RX   PubMed=7880737;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L091 ! OCUCh-LM1
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   OCUG-1
AC   CVCL_3083
SY   OCUG1; Osaka City University Gallbladder-1
DR   CLO; CLO_0009938
DR   BioSample; SAMN03471651
DR   cancercelllines; CVCL_3083
DR   Cell_Model_Passport; SIDM01842
DR   Cosmic; 2629295
DR   Cosmic; 2674062
DR   DepMap; ACH-001619
DR   GEO; GSM827176
DR   JCRB; JCRB0191
DR   LINCS_LDP; LCL-1800
DR   Progenetix; CVCL_3083
DR   Wikidata; Q54931819
RX   PubMed=20215515;
RX   PubMed=21533512;
RX   PubMed=32899426;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 47.1 hours (PubMed=21533512).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Heterozygous (DepMap=ACH-001619).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Peritoneal effusion; UBERON=UBERON_0001268.
ST   Source(s): DepMap=ACH-001619; JCRB=JCRB0191
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 16,19
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 5,20
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,16 (JCRB=JCRB0191)
ST   vWA: 16 (DepMap=ACH-001619)
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OCUG-1-Luc#5
AC   CVCL_XD21
DR   cancercelllines; CVCL_XD21
DR   JCRB; JCRB1776
DR   JCRB; NIHS1213
DR   Wikidata; Q98128329
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1213; true.
CC   Derived from site: Metastatic; Peritoneal effusion; UBERON=UBERON_0001268.
ST   Source(s): JCRB=JCRB1776
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3083 ! OCUG-1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   OCUM-1
AC   CVCL_3084
SY   OCUM1; Osaka City University Medical school-1
DR   BTO; BTO_0005918
DR   CLO; CLO_0037145
DR   EFO; EFO_0006714
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471652
DR   BioSample; SAMN03473049
DR   BioSample; SAMN10987922
DR   cancercelllines; CVCL_3084
DR   Cell_Model_Passport; SIDM00568
DR   CGH-DB; 131-1
DR   Cosmic; 1889265
DR   Cosmic; 2009531
DR   Cosmic; 2443794
DR   Cosmic; 2484967
DR   Cosmic; 2807640
DR   Cosmic-CLP; 1298358
DR   DepMap; ACH-000247
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298358
DR   GEO; GSM552369
DR   GEO; GSM827576
DR   GEO; GSM887474
DR   GEO; GSM888554
DR   GEO; GSM1374795
DR   GEO; GSM1670301
DR   JCRB; JCRB0192
DR   LiGeA; CCLE_111
DR   LINCS_LDP; LCL-2002
DR   PharmacoDB; OCUM1_1193_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3084
DR   Wikidata; Q54931820
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1961183;
RX   PubMed=15723654;
RX   PubMed=20215515;
RX   PubMed=21115893;
RX   PubMed=22327936;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 33.2 hours (PubMed=1961183); 33 hours (PubMed=29435981); ~38 hours (Note=Lot 12222004), 49 hours (Note=Lot 09162009), ~64 hours (Note=Lot 11282012), ~26 hours (Note=Lot 08172016), ~34 hours (Note=Lot 06252018) (JCRB=JCRB0192).
CC   HLA typing: A*24:02,31:01; B*07:02,52:01; C*07:02,12:02; DQB1*06:04,06:04 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Gln56Pro (c.167A>C); ClinVar=VCV000375978; Zygosity=Hemizygous (PubMed=22327936).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.6%; East Asian, North=77.58%; East Asian, South=21.82%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1298358; JCRB=JCRB0192; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 9,10
ST   D7S820: 12
ST   D8S1179: 11,12
ST   FGA: 19,23
ST   Penta D: 12,13
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16,17 (JCRB=JCRB0192)
ST   vWA: 14,17 (Cosmic-CLP=1298358; PubMed=25877200)
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   OCUM-11
AC   CVCL_8379
SY   Osaka City University Medical school-11
DR   Wikidata; Q54931821
RX   PubMed=15546507;
CC   Population: Japanese.
CC   Doubling time: 11.3 hours (PubMed=15546507).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OCUM-12
AC   CVCL_8380
SY   Osaka City University Medical school-12
DR   Cosmic; 2009532
DR   Wikidata; Q54931822
RX   PubMed=20145613;
RX   PubMed=21115893;
CC   Population: Japanese.
CC   Doubling time: 13.4 hours (Note=At 190th passage) (PubMed=20145613).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OCUM-12/Hypo
AC   CVCL_8381
DR   Wikidata; Q54931823
RX   PubMed=20145613;
RX   PubMed=21965748;
CC   Population: Japanese.
CC   Characteristics: Hypoxia-resistant.
CC   Doubling time: 24.9 hours (Note=At 10th passage) (PubMed=20145613).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8380 ! OCUM-12
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OCUM-14
AC   CVCL_VV83
SY   Osaka City University Medical school-14
DR   Wikidata; Q98128330
RX   PubMed=30652228;
CC   Population: Japanese.
CC   Doubling time: 43.1 hours (PubMed=30652228).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=30652228
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 10
ST   D18S51: 13
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 18,22
ST   Penta D: 10,12
ST   Penta E: 11,20
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   OCUM-2D
AC   CVCL_8382
SY   OCUM2D; Osaka City University Medical school-2D
DR   Wikidata; Q54931824
RX   PubMed=7577468;
RX   PubMed=21115893;
CC   Population: Japanese.
CC   Doubling time: 23.6 hours (PubMed=7577468).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   OCUM-2M
AC   CVCL_8383
SY   OCUM2M; Osaka City University Medical school-2M
DR   Cosmic; 2009533
DR   Cosmic; 2802102
DR   Wikidata; Q54931825
RX   PubMed=7577468;
RX   PubMed=7731088;
RX   PubMed=11221876;
RX   PubMed=17505008;
RX   PubMed=21115893;
RX   PubMed=21533548;
CC   Population: Japanese.
CC   Doubling time: 37.3 hours (PubMed=7577468).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8382 ! OCUM-2D
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   OCUM-2M/5-FU
AC   CVCL_IV67
SY   OCUM-2M/5FU
DR   Wikidata; Q54931826
RX   PubMed=20393015;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-2M/DDP
AC   CVCL_8384
DR   Wikidata; Q54931827
RX   PubMed=9137537;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   OCUM-2M/GEM
AC   CVCL_IV68
DR   Wikidata; Q54931828
RX   PubMed=20393015;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-2M/OXA
AC   CVCL_IV69
DR   Wikidata; Q54931829
RX   PubMed=20393015;
RX   PubMed=27157913;
RX   PubMed=31916900;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   OCUM-2M/OXA SDF2 KO
AC   CVCL_E8NN
SY   SDF2-/- OCUM-2M/OXA
RX   PubMed=31916900;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10675; SDF2.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OCUM-2M/PTX
AC   CVCL_IV70
DR   Wikidata; Q54931830
RX   PubMed=20393015;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-2M/SN38
AC   CVCL_IV71
DR   Wikidata; Q54931831
RX   PubMed=20393015;
RX   PubMed=21997136;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-2MD3
AC   CVCL_8385
SY   OCUM-2 MD3; OCUM2-MD3; OCUM2MD3
DR   Wikidata; Q54931832
RX   PubMed=8912536;
RX   PubMed=11221876;
RX   PubMed=21115893;
CC   Population: Japanese.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   OCUM-2MLN
AC   CVCL_8386
SY   OCUM-2M LN; OCUM2MLN
DR   Wikidata; Q54931833
RX   PubMed=9626818;
RX   PubMed=11221876;
RX   PubMed=21115893;
RX   PubMed=21533548;
CC   Population: Japanese.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   OCUM-6
AC   CVCL_8387
SY   Osaka City University Medical school-6
DR   BioSample; SAMN03151875
DR   Wikidata; Q54931834
RX   PubMed=11605005;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCUM-11 derivative (PubMed=20143388). Originally thought to originate from the ascites effusion of a 65 year old male patient with a scirrhous gastric carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00337.
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8379 ! OCUM-11
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   OCUM-7
AC   CVCL_8388
SY   Osaka City University Medical school-7
DR   Wikidata; Q54931835
RX   PubMed=15254696;
CC   Population: Japanese.
CC   Doubling time: 23 hours (Note=At 25th passage) (PubMed=15254696).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=15254696).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OCUM-8
AC   CVCL_8389
SY   OCUM8; Osaka City University Medical school-8
DR   Wikidata; Q54931836
RX   PubMed=15546507;
RX   PubMed=31222839;
CC   Population: Japanese.
CC   Doubling time: 13.4 hours (PubMed=15546507).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:5465; IGF1R; Name(s)=CD44-IGFR1; Note=In frame. CD44 exon 1 fused to IGF1R exon 12 (PubMed=31222839).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (PubMed=31222839).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   OCUM-8/5-FU
AC   CVCL_IG91
DR   Wikidata; Q54931837
RX   PubMed=21997136;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:5465; IGF1R; Name(s)=CD44-IGFR1; Note=In frame. CD44 exon 1 fused to IGF1R exon 12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8389 ! OCUM-8
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-8/GEM
AC   CVCL_II63
DR   Wikidata; Q54931838
RX   PubMed=21997136;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:5465; IGF1R; Name(s)=CD44-IGFR1; Note=In frame. CD44 exon 1 fused to IGF1R exon 12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8389 ! OCUM-8
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-8/OXA
AC   CVCL_IL00
DR   Wikidata; Q54931839
RX   PubMed=21997136;
RX   PubMed=27157913;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:5465; IGF1R; Name(s)=CD44-IGFR1; Note=In frame. CD44 exon 1 fused to IGF1R exon 12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8389 ! OCUM-8
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-8/PTX
AC   CVCL_IP78
DR   Wikidata; Q54931840
RX   PubMed=21997136;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:5465; IGF1R; Name(s)=CD44-IGFR1; Note=In frame. CD44 exon 1 fused to IGF1R exon 12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8389 ! OCUM-8
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-8/SN38
AC   CVCL_IV66
DR   Wikidata; Q54931841
RX   PubMed=21997136;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:5465; IGF1R; Name(s)=CD44-IGFR1; Note=In frame. CD44 exon 1 fused to IGF1R exon 12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8389 ! OCUM-8
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   OCUM-9
AC   CVCL_8390
SY   OCUM9; Osaka City University Medical school-9
DR   Wikidata; Q54931842
RX   PubMed=21115893;
RX   PubMed=31222839;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:17950; BORCS5 + HGNC; HGNC:3495; ETV6; Name(s)=BORCS5-ETV6; Note=In frame. BORCS5 exon 1 fused to ETV6 exon 3 (PubMed=31222839).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   OCUP-A1
AC   CVCL_CW20
SY   Osaka City University Pancreas-A1
DR   cancercelllines; CVCL_CW20
DR   Cosmic; 2795399
DR   Wikidata; Q54931843
RX   PubMed=27067801;
CC   Population: Japanese.
CC   Doubling time: 20.6 +- 1.2 hours (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (PubMed=27067801).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-70Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   OCUP-A2
AC   CVCL_CW21
SY   Osaka City University Pancreas-A2
DR   cancercelllines; CVCL_CW21
DR   Cosmic; 2795400
DR   Wikidata; Q54931844
RX   PubMed=27067801;
CC   Population: Japanese.
CC   Doubling time: 20.6 +- 1.4 hours (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=27067801).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-40Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   OCUT-1
AC   CVCL_6017
SY   Ocut-1; OCUT1; Osaka City University Thyroid-1
DR   BTO; BTO_0004846
DR   cancercelllines; CVCL_6017
DR   Cosmic; 1152123
DR   Cosmic; 1239960
DR   Cosmic; 1280045
DR   Cosmic; 1507372
DR   Cosmic; 1533548
DR   Cosmic; 1536125
DR   Cosmic; 1889003
DR   Cosmic; 2054107
DR   Cosmic; 2319852
DR   Cosmic; 2791081
DR   Wikidata; Q54931845
RX   PubMed=12210034;
RX   PubMed=23833040;
RX   PubMed=24357248;
RX   PubMed=30737244;
CC   Population: Japanese.
CC   Doubling time: 34 hours (PubMed=12210034).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (PubMed=23833040).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Cell line has been lost (PubMed=24357248).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 19,20
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 11,13
ST   D8S1179: 15,17
ST   FGA: 21,22
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   OCUT-1C
AC   CVCL_B5GE
SY   Osaka City University Thyroid-1C
DR   cancercelllines; CVCL_B5GE
DR   JCRB; JCRB1891
DR   Wikidata; Q110433122
RX   PubMed=24357248;
RX   PubMed=26137260;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24357248).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): JCRB=JCRB1891
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 10,12
ST   D5S818: 9,13
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6017 ! OCUT-1
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   OCUT-1F
AC   CVCL_B5GF
SY   Osaka City University Thyroid-1F
DR   cancercelllines; CVCL_B5GF
DR   JCRB; JCRB1897
DR   Wikidata; Q110433123
RX   PubMed=24357248;
RX   PubMed=26137260;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24357248).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): JCRB=JCRB1897
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 10,12
ST   D5S818: 9,13
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6017 ! OCUT-1
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   OCUT-2
AC   CVCL_9814
SY   OCUT2; Osaka City University Thyroid-2
DR   BTO; BTO_0005143
DR   cancercelllines; CVCL_9814
DR   Cosmic; 1507373
DR   Cosmic; 1533549
DR   Cosmic; 1536126
DR   Cosmic; 1889004
DR   Cosmic; 2791082
DR   JCRB; JCRB1870
DR   Wikidata; Q54931846
RX   PubMed=15785737;
RX   PubMed=24357248;
RX   PubMed=26137260;
RX   PubMed=30737244;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24357248; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=24357248).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1870; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,26
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   OCUT-2C
AC   CVCL_W915
SY   Ocut-2C; OCUT2C; Osaka City University Thyroid-2C
DR   cancercelllines; CVCL_W915
DR   CCRID; 3101HUMSCSP553
DR   Cosmic; 2054108
DR   Wikidata; Q54931847
RX   PubMed=23833040;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23833040).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=23833040).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (PubMed=23833040).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CCRID=3101HUMSCSP553
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9814 ! OCUT-2
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 17
//
ID   OCUT-3
AC   CVCL_B5GA
SY   Osaka City University Thyroid-3
DR   cancercelllines; CVCL_B5GA
DR   JCRB; JCRB1892
DR   Wikidata; Q110433125
RX   PubMed=24357248;
RX   PubMed=26137260;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24357248).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1892
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   OCUT-4
AC   CVCL_B5GB
SY   Osaka City University Thyroid-4
DR   cancercelllines; CVCL_B5GB
DR   JCRB; JCRB1857
DR   Wikidata; Q110433126
RX   PubMed=24357248;
RX   PubMed=26137260;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24357248).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): JCRB=JCRB1857
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   OCUT-5
AC   CVCL_B5GC
SY   Osaka City University Thyroid-5
DR   cancercelllines; CVCL_B5GC
DR   Wikidata; Q110433127
RX   PubMed=24357248;
RX   PubMed=26137260;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24357248).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   OCUT-6
AC   CVCL_B5GD
SY   Osaka City University Thyroid-6
DR   cancercelllines; CVCL_B5GD
DR   JCRB; JCRB1872
DR   Wikidata; Q110433128
RX   PubMed=24357248;
RX   PubMed=26137260;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=24357248).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): JCRB=JCRB1872
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   OCUU-1
AC   CVCL_HF21
SY   OCUU1; Osaka City University Urology-1
DR   Wikidata; Q54931848
RX   PubMed=14534724;
RX   PubMed=15604581;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   OCUU-2
AC   CVCL_HF22
SY   OCUU2; Osaka City University Urology-2
DR   Wikidata; Q54931849
RX   PubMed=14534724;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   OCUU-3
AC   CVCL_HF23
SY   OCUU3; Osaka City University Urology-3
DR   Wikidata; Q54931850
RX   PubMed=15604581;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   OCUU-4
AC   CVCL_HF24
SY   OCUU4; Osaka City University Urology-4
DR   Wikidata; Q54931853
RX   PubMed=14534724;
RX   PubMed=15604581;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   OCUU-5
AC   CVCL_HF25
SY   OCUU5; Osaka City University Urology-5
DR   Wikidata; Q54931854
RX   PubMed=14534724;
RX   PubMed=15604581;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   OCUU-6
AC   CVCL_M615
SY   Osaka City University Urology-6
DR   Wikidata; Q54931855
RX   PubMed=15859154;
CC   Population: Japanese.
CC   Doubling time: 26 hours (PubMed=15859154).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Ocy454
AC   CVCL_UW31
SY   OCY454
DR   Wikidata; Q98128331
RX   PubMed=25953900;
RX   PubMed=30977540;
WW   Info; -; -; https://www.csr-mgh.org/wp-content/uploads/2017/04/OCY454-1.pdf
CC   Characteristics: Displays a dendritic morphology similar to other osteocytic cell lines.
CC   Characteristics: Expresses GFP Topaz under the control of the Dmp1 promoter.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; SY6TH; Topaz (Note=Green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone, long bone; UBERON=UBERON_0002495.
CC   Cell type: Osteocyte; CL=CL_0000137.
CC   Breed/subspecies: C57BL/6-Tg(Dmp1-Topaz)1Ikal/J x (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4W
CA   Conditionally immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   OD-3
AC   CVCL_G237
SY   OD3
DR   CLO; CLO_0008237
DR   ATCC; HB-10204
DR   Wikidata; Q54931856
RX   Patent=US5604107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10204.
CC   Doubling time: 14 hours (ATCC=HB-10204).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Discontinued: ATCC; HB-10204; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   ODA
AC   CVCL_0G09
SY   Oda
DR   Wikidata; Q54931857
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=9738977;
RX   PubMed=10557056;
RX   PubMed=11429052;
RX   PubMed=12886255;
CC   Population: Japanese.
CC   Characteristics: Produces IgD lambda.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   Odf2-deficient F9 cells
AC   CVCL_T374
DR   CLO; CLO_0050540
DR   RCB; RCB2808
DR   Wikidata; Q54931858
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0259 ! F9
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   ODM-2
AC   CVCL_B7GN
SY   ODM 2; ODM cl-2
DR   Wikidata; Q114312627
RX   PubMed=2553750;
RX   PubMed=8262911;
RX   PubMed=9268597;
RX   PubMed=9349525;
RX   PubMed=33603369;
CC   Doubling time: ~24 hours (PubMed=2553750).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=8-4).
CC   Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778.
CC   Cell type: Non-pigmented ciliary epithelial cell; CL=CL_0002304.
ST   Source(s): PubMed=33603369
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 15,16
ST   D12S391: 20,24
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 17,18
ST   D19S433: 12,13
ST   D1S1656: 13,14
ST   D21S11: 28,30
ST   D22S1045: 11
ST   D2S1338: 19,22
ST   D2S441: 11,13.3
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 12,15
ST   DYS391: 10
ST   FGA: 23,25
ST   Penta D: 10,13
ST   Penta E: 8,13
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y3M
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   Odora
AC   CVCL_C5NH
SY   odora
DR   Wikidata; Q116050041
RX   PubMed=10493727;
RX   PubMed=24980442;
CC   Characteristics: Targets olfactory receptors to the plasma membrane when differentiated (PubMed=10493727).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Nose, nasal cavity, olfactory epithelium; UBERON=UBERON_0001997.
CC   Cell type: Olfactory sensory neuron; CL=CL_0000207.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3D
CA   Conditionally immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   Odour
AC   CVCL_W935
DR   Cosmic; 931130
DR   Wikidata; Q54931859
RX   PubMed=170370;
RX   PubMed=9473234;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 9
//
ID   ODSBFC_28_10
AC   CVCL_C4ND
DR   Wikidata; Q116050042
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_28_13
AC   CVCL_C4NE
DR   Wikidata; Q116050043
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_28_4
AC   CVCL_C4NA
DR   Wikidata; Q116050044
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_28_7
AC   CVCL_C4NB
DR   Wikidata; Q116050045
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_28_8
AC   CVCL_C4NC
DR   Wikidata; Q116050046
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31->28_1
AC   CVCL_C4NF
DR   Wikidata; Q116050047
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31->28_12
AC   CVCL_C4NJ
DR   Wikidata; Q116050048
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31->28_13
AC   CVCL_C4NK
DR   Wikidata; Q116050049
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31->28_14
AC   CVCL_C4NL
DR   Wikidata; Q116050050
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31->28_2
AC   CVCL_C4NG
DR   Wikidata; Q116050051
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31->28_5
AC   CVCL_C4NH
DR   Wikidata; Q116050052
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31->28_7
AC   CVCL_C4NI
DR   Wikidata; Q116050053
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_1
AC   CVCL_C4NM
DR   Wikidata; Q116050054
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_12
AC   CVCL_C4NU
DR   Wikidata; Q116050055
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_13
AC   CVCL_C4NV
DR   Wikidata; Q116050056
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_14
AC   CVCL_C4NW
DR   Wikidata; Q116050058
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_2
AC   CVCL_C4NN
DR   Wikidata; Q116050059
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_3
AC   CVCL_C4NP
DR   Wikidata; Q116050060
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_5
AC   CVCL_C4NQ
DR   Wikidata; Q116050061
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_7
AC   CVCL_C4NR
DR   Wikidata; Q116050062
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_8
AC   CVCL_C4NS
DR   Wikidata; Q116050063
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODSBFC_31_9
AC   CVCL_C4NT
DR   Wikidata; Q116050064
RX   PubMed=36251152;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ODY1
AC   CVCL_C1JC
SY   ODY
DR   Wikidata; Q114312628
RX   PubMed=2998993;
RX   PubMed=4333769;
RX   PubMed=7316467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   OE
AC   CVCL_J350
SY   Okayama Endometrium
DR   BioSample; SAMN03151749
DR   Wikidata; Q54931860
RX   PubMed=1246601;
RX   PubMed=4946504;
RX   PubMed=5169552;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00082.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 21
//
ID   OE-1
AC   CVCL_D7DE
RX   PubMed=24303921;
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   OE-E6/E7
AC   CVCL_F597
SY   OE E6/E7
DR   BTO; BTO_0003067
DR   GEO; GSM2474979
DR   Wikidata; Q54931861
RX   PubMed=11468776;
RX   PubMed=28273451;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fallopian tube, ampulla; UBERON=UBERON_0012648.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   OE1
AC   CVCL_E3AX
RX   PubMed=2437192;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11411; Leuconostoc mesenteroides glucose-6-phosphate 1-dehydrogenase (zwf).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   OE19
AC   CVCL_1622
SY   OE-19; JROECL 19; JROECL19; OEC19
DR   CLO; CLO_0008238
DR   EFO; EFO_0002308
DR   CLDB; cl3761
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471032
DR   BioSample; SAMN10988362
DR   cancercelllines; CVCL_1622
DR   Cell_Model_Passport; SIDM00479
DR   ChEMBL-Cells; CHEMBL3308462
DR   ChEMBL-Targets; CHEMBL1075555
DR   Cosmic; 871232
DR   Cosmic; 910079
DR   Cosmic; 978854
DR   Cosmic; 997860
DR   Cosmic; 1175878
DR   Cosmic; 1599342
DR   Cosmic; 1618819
DR   Cosmic; 1995600
DR   Cosmic-CLP; 910079
DR   DepMap; ACH-000679
DR   DSMZ; ACC-700
DR   DSMZCellDive; ACC-700
DR   ECACC; 96071721
DR   EGA; EGAS00001000978
DR   GDSC; 910079
DR   GEO; GSM827301
DR   GEO; GSM887475
DR   GEO; GSM888555
DR   GEO; GSM1264050
DR   GEO; GSM1264051
DR   GEO; GSM1264052
DR   GEO; GSM1264053
DR   GEO; GSM1264054
DR   GEO; GSM1264092
DR   GEO; GSM1264093
DR   GEO; GSM1264094
DR   GEO; GSM1264095
DR   GEO; GSM1264096
DR   GEO; GSM1670302
DR   GEO; GSM7701391
DR   GEO; GSM7701392
DR   IARC_TP53; 21600
DR   IGRhCellID; OE19
DR   LiGeA; CCLE_923
DR   LINCS_LDP; LCL-1796
DR   PharmacoDB; OE19_1194_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1622
DR   PubChem_Cell_line; CVCL_1622
DR   Wikidata; Q54931862
RX   PubMed=9010035;
RX   PubMed=15511476;
RX   PubMed=16364037;
RX   PubMed=20075370;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23795680;
RX   PubMed=24083764;
RX   PubMed=25070024;
RX   PubMed=25877200;
RX   PubMed=26512696;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=34466148;
RX   PubMed=35839778;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/oe19/
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Characteristics: Contains a 100 fold amplification of ERBB2 (PubMed=15511476).
CC   Doubling time: ~50-60 hours (DSMZ=ACC-700).
CC   HLA typing: A*02:01,02:01; B*07:17,51:01; C*16:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Tyr42Ser (c.125A>C); Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000679).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn310Lysfs*27 (c.929dup) (c.929_930ins1); Zygosity=Heterozygous (Cosmic-CLP=910079; DepMap=ACH-000679).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=15.01%; Native American=0.16%; East Asian, North=1.83%; East Asian, South=0%; South Asian=11.79%; European, North=8.22%; European, South=62.99% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=910079; DSMZ=ACC-700; ECACC=96071721; PubMed=20075370; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 12 (PubMed=25877200)
ST   D18S51: 12,13 (DSMZ=ACC-700; PubMed=20075370)
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 18,19
ST   D3S1358: 15,18
ST   D5S818: 11,14
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 23,26
ST   Penta D: 9
ST   Penta E: 5,8
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17 (Cosmic-CLP=910079; ECACC=96071721)
ST   vWA: 16,17,18 (DSMZ=ACC-700; PubMed=20075370; PubMed=25877200)
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   OE21
AC   CVCL_2661
SY   OE-21; JROECL 21; JROECL21
DR   BTO; BTO_0004489
DR   CLO; CLO_0008239
DR   EFO; EFO_0002309
DR   CLDB; cl5089
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 396
DR   BioSample; SAMN03472891
DR   BioSample; SAMN10989579
DR   cancercelllines; CVCL_2661
DR   Cell_Model_Passport; SIDM00478
DR   Cosmic; 1339912
DR   Cosmic; 1995601
DR   Cosmic; 2009522
DR   Cosmic-CLP; 1298359
DR   DepMap; ACH-000544
DR   ECACC; 96062201
DR   EGA; EGAS00001000978
DR   GDSC; 1298359
DR   GEO; GSM827300
DR   GEO; GSM888556
DR   GEO; GSM1374796
DR   GEO; GSM1374797
DR   GEO; GSM1375727
DR   GEO; GSM1375728
DR   GEO; GSM1375729
DR   GEO; GSM1375730
DR   GEO; GSM1375739
DR   GEO; GSM1375740
DR   GEO; GSM1375741
DR   GEO; GSM1375742
DR   GEO; GSM1375751
DR   GEO; GSM1375752
DR   GEO; GSM1375753
DR   GEO; GSM1375754
DR   GEO; GSM1670303
DR   IGRhCellID; OE21
DR   LiGeA; CCLE_787
DR   LINCS_LDP; LCL-1558
DR   PharmacoDB; OE21_1195_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2661
DR   Wikidata; Q54931864
RX   PubMed=9010035;
RX   PubMed=16364037;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26512696;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*51:01,51:01; C*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.35%; East Asian, South=0.2%; South Asian=0%; European, North=64.63%; European, South=33.81% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=1298359; ECACC=96062201; PubMed=25877200
ST   Amelogenin: X (Cosmic-CLP=1298359)
ST   Amelogenin: X,Y (ECACC=96062201; PubMed=25877200)
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13 (Cosmic-CLP=1298359; PubMed=25877200)
ST   D16S539: 13 (ECACC=96062201)
ST   D18S51: 19
ST   D19S433: 15.2
ST   D21S11: 30,31
ST   D2S1338: 17,19
ST   D3S1358: 17
ST   D5S818: 12,13 (ECACC=96062201; PubMed=25877200)
ST   D5S818: 13 (Cosmic-CLP=1298359)
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 20
ST   Penta D: 11,12
ST   Penta E: 12
ST   TH01: 7,8 (Cosmic-CLP=1298359)
ST   TH01: 8 (ECACC=96062201; PubMed=25877200)
ST   TPOX: 8,11
ST   vWA: 15,16 (Cosmic-CLP=1298359)
ST   vWA: 16,17 (ECACC=96062201; PubMed=25877200)
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   OE33
AC   CVCL_0471
SY   OE-33; JROECL 33; JROECL33; OEC33
DR   BTO; BTO_0003541
DR   CLO; CLO_0008240
DR   EFO; EFO_0002310
DR   MCCL; MCC:0000369
DR   CLDB; cl3762
DR   AddexBio; C0013003/115
DR   AddexBio; C0013004/121
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 395
DR   BioSample; SAMN03472890
DR   BioSample; SAMN03473392
DR   BioSample; SAMN10987775
DR   cancercelllines; CVCL_0471
DR   Cell_Model_Passport; SIDM00477
DR   ChEMBL-Cells; CHEMBL3308776
DR   ChEMBL-Targets; CHEMBL1075556
DR   Cosmic; 871233
DR   Cosmic; 910549
DR   Cosmic; 978855
DR   Cosmic; 997861
DR   Cosmic; 1175877
DR   Cosmic; 1599343
DR   Cosmic; 1618820
DR   Cosmic-CLP; 910549
DR   DepMap; ACH-000383
DR   DSMZ; ACC-706
DR   DSMZCellDive; ACC-706
DR   ECACC; 96070808
DR   EGA; EGAS00001000978
DR   GDSC; 910549
DR   GEO; GSE36840
DR   GEO; GSM827306
DR   GEO; GSM887476
DR   GEO; GSM888557
DR   GEO; GSM1375731
DR   GEO; GSM1375732
DR   GEO; GSM1375733
DR   GEO; GSM1375734
DR   GEO; GSM1375743
DR   GEO; GSM1375744
DR   GEO; GSM1375745
DR   GEO; GSM1375746
DR   GEO; GSM1375755
DR   GEO; GSM1375756
DR   GEO; GSM1375757
DR   GEO; GSM1375758
DR   GEO; GSM1670304
DR   GEO; GSM3258552
DR   IARC_TP53; 21601
DR   IGRhCellID; OE33
DR   LiGeA; CCLE_490
DR   LINCS_LDP; LCL-1797
DR   PharmacoDB; OE33_1196_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0471
DR   PubChem_Cell_line; CVCL_0471
DR   Wikidata; Q54931865
RX   PubMed=9010035;
RX   PubMed=11520067;
RX   PubMed=20075370;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23795680;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26512696;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27594985;
RX   PubMed=27600491;
RX   PubMed=28196595;
RX   PubMed=28504813;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 33 hours (PubMed=25984343); ~30 hours (DSMZ=ACC-706).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:06,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Tyr (c.404G>A); ClinVar=VCV000141762; Zygosity=Unspecified (PubMed=20075370).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.01%; Native American=0%; East Asian, North=1.2%; East Asian, South=0.55%; South Asian=0%; European, North=67.21%; European, South=31.03% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=910549; DSMZ=ACC-706; ECACC=96070808; PubMed=20075370; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10 (ECACC=96070808; PubMed=25877200)
ST   CSF1PO: 10,11 (Cosmic-CLP=910549; DSMZ=ACC-706; PubMed=20075370)
ST   D13S317: 14
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 12,15,16
ST   D21S11: 29,31.2
ST   D2S1338: 17,19,20 (PubMed=25877200)
ST   D2S1338: 17,20 (DSMZ=ACC-706)
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 10,11,12 (DSMZ=ACC-706; PubMed=20075370)
ST   D8S1179: 10,12 (PubMed=25877200)
ST   FGA: 23
ST   Penta D: 8,9,11 (DSMZ=ACC-706)
ST   Penta D: 9,11 (PubMed=25877200)
ST   Penta E: 12,18
ST   TH01: 7 (DSMZ=ACC-706)
ST   TH01: 7,8 (Cosmic-CLP=910549; ECACC=96070808; PubMed=20075370; PubMed=25877200)
ST   TPOX: 8,11
ST   vWA: 14,17 (PubMed=25877200)
ST   vWA: 17 (Cosmic-CLP=910549; DSMZ=ACC-706; ECACC=96070808; PubMed=20075370)
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   OE47
AC   CVCL_4627
SY   OE-47; JROECL 47; JROECL47
DR   CLO; CLO_0008241
DR   CLDB; cl3763
DR   cancercelllines; CVCL_4627
DR   Cosmic; 997862
DR   ECACC; 96061336
DR   Wikidata; Q54931866
RX   PubMed=9010035;
RX   PubMed=10789716;
RX   PubMed=23795680;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a 76 year old male patient with an esophageal squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00546.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 96061336; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   OE50
AC   CVCL_4628
SY   OE-50; JROECL 50; JROECL50
DR   CLO; CLO_0008242
DR   CLDB; cl3764
DR   cancercelllines; CVCL_4628
DR   Cosmic; 997863
DR   ECACC; 96061337
DR   Wikidata; Q54931867
RX   PubMed=9010035;
RX   PubMed=10789716;
RX   PubMed=23795680;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a 71 year old female patient with an esophageal squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00547.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 96061337; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   OECM-1
AC   CVCL_6782
SY   OECM1; OEC-M1; Meng-1
DR   BTO; BTO_0003964
DR   EFO; EFO_0022621
DR   cancercelllines; CVCL_6782
DR   Millipore; SCC180
DR   Wikidata; Q54931868
RX   PubMed=8083436;
RX   PubMed=9877329;
RX   PubMed=14720193;
RX   PubMed=15466821;
RX   PubMed=24825747;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 27 hours (PubMed=8083436).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (PubMed=14720193).
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24825747; obtained from personal communication of Yuan, Ta-Chun.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): Millipore=SCC180; PubMed=24825747
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10,12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 15
ST   FGA: 22,27 (Millipore=SCC180)
ST   FGA: 22,28 (PubMed=24825747)
ST   Penta D: 9,10
ST   Penta E: 20
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   OEE-III
AC   CVCL_A764
DR   cancercelllines; CVCL_A764
DR   Cosmic; 1590844
DR   Wikidata; Q54931869
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=22038905;
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Met918Thr (c.2753T>C); ClinVar=VCV000013919; Zygosity=Unspecified; Note=Somatic (CelloPub=CLPUB00412).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   OELE
AC   CVCL_IW56
DR   BioSample; SAMN10988391
DR   DepMap; ACH-000494
DR   PharmacoDB; OELE_1197_2019
DR   Progenetix; CVCL_IW56
DR   Wikidata; Q54931870
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=25984343).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.73%; Native American=0.23%; East Asian, North=0%; East Asian, South=1.63%; South Asian=4.96%; European, North=40.72%; European, South=48.72% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   Oex2054SV.4
AC   CVCL_DQ96
DR   Wikidata; Q54931871
RX   PubMed=27346197;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Documento_Deposito_Lineas_iPS-OEX2054SV.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigaciones Biomedicas Alberto Sols; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Gln621Ter (c.1861C>T); Zygosity=Heterozygous (PubMed=27346197).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C169000; Optic atrophy 1
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   OF
AC   CVCL_M621
DR   BioSample; SAMN03151750
DR   Wikidata; Q54931872
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00149.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   OF-1a
AC   CVCL_C6EY
DR   Wikidata; Q116050065
RX   PubMed=14505432;
RX   PubMed=15056927;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, fimbria; UBERON=UBERON_8410010.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OF-4a2
AC   CVCL_C6EZ
DR   Wikidata; Q116050066
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, fimbria; UBERON=UBERON_8410010.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OF-4a3
AC   CVCL_C6F0
DR   Wikidata; Q116050067
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, fimbria; UBERON=UBERON_8410010.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OF20IMC
AC   CVCL_D1KN
SY   Olive Flounder 20 Immortalized Muscle Cells
DR   Wikidata; Q127382993
RX   PubMed=37759547;
CC   Group: Fish cell line.
CC   Doubling time: 28.2 hours (PubMed=37759547).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Muscle satellite cell; CL=CL_0000594.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   OF35Y-iPS
AC   CVCL_A8XY
DR   GEO; GSE165639
DR   Wikidata; Q108821069
RX   PubMed=34088004;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   OF4374
AC   CVCL_6F49
DR   Wikidata; Q54931873
RX   PubMed=12441130;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_6F46 ! F4374
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   OFC
AC   CVCL_A3AI
DR   CCLV; CCLV-RIE 0157
DR   Wikidata; Q105510483
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal eye, cornea; UBERON=UBERON_0005427.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   OFCOL II
AC   CVCL_HA27
SY   Ofcol II
DR   BCRJ; 0192
DR   Wikidata; Q54931874
RX   PubMed=18754721;
RX   PubMed=23146572;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   OFEC17-FEN
AC   CVCL_UD74
SY   OFEC-17FEN; Olive Flounder Embryonic Cell 17
DR   Wikidata; Q98128332
RX   PubMed=30324159;
CC   Group: Fish cell line.
CC   Doubling time: 114.34 hours (PubMed=30324159).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 5
//
ID   OFEC18-FGBC
AC   CVCL_B6YC
SY   FGBC8; Olive Flounder Embryonic Cell 18
DR   Wikidata; Q112129478
RX   DOI=10.47853/FAS.2021.e36;
RX   PubMed=33110952;
CC   Group: Fish cell line.
CC   Doubling time: 73.8 hours (PubMed=33110952).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 4
//
ID   OFi001-A
AC   CVCL_A0JQ
SY   ASD011-A; OFi011-A
DR   BioSamples; SAMEA9403242
DR   hPSCreg; OFi001-A
DR   Wikidata; Q108821070
RX   PubMed=34438162;
CC   From: OrganFactory; Kiheung; South Korea.
CC   Population: East Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): PubMed=34438162
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13,14.2
ST   D21S11: 30,31
ST   D2S1338: 19,24
ST   D3S1358: 15,19
ST   D5S818: 10,12
ST   D7S820: 8
ST   D8S1179: 13,16
ST   FGA: 19,22
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   OFi002-A
AC   CVCL_A0JR
SY   OFi015-A
DR   BioSamples; SAMEA9403243
DR   hPSCreg; OFi002-A
DR   Wikidata; Q108821071
RX   PubMed=34438162;
CC   From: OrganFactory; Kiheung; South Korea.
CC   Population: East Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): PubMed=34438162
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14.2
ST   D21S11: 29,31.2
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   FGA: 24
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   OFP8
AC   CVCL_L234
DR   Wikidata; Q54931875
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L235 ! OKP8
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   OFTu-hTERT
AC   CVCL_C7F5
SY   Ovine Fetal Turbinate-hTERT immortalized
DR   Wikidata; Q117704759
RX   PubMed=36619965;
CC   Virology: Susceptible to infection by Orf virus (ORFV) (PubMed=36619965).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal nose, nasal cavity, nasal turbinate; UBERON=UBERON_0035612.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   OG
AC   CVCL_JF81
SY   JTC-18; Japanese Tissue Culture-18
DR   Wikidata; Q54931876
RX   PubMed=5392337;
RX   PubMed=5625657;
CC   Population: Japanese.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 7
//
ID   Ogg1 KO MEF
AC   CVCL_6E74
SY   MEF OGG1 KO
DR   CancerTools; 151846
DR   ECACC; 16022531
DR   Wikidata; Q54931877
DR   Ximbio; 151846
RX   PubMed=10557315;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1097693; Ogg1.
CC   Discontinued: ECACC; 16022531; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   13-14FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   OGHFUi001-A
AC   CVCL_A8MU
SY   iPS84-1
DR   hPSCreg; OGHFUi001-A
DR   Wikidata; Q108821072
RX   PubMed=34087996;
RX   PubMed=35121198;
CC   From: Obstetrics and Gynecology Hospital of Fudan University; Shanghai; China.
CC   Sequence variation: Mutation; HGNC; HGNC:18060; ARX; Simple; p.Arg330Leu (c.989G>T); Zygosity=Hemizygous (PubMed=34087996).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179866; Developmental and epileptic encephalopathy 1
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   OGHFUi001-A-1
AC   CVCL_C0CK
SY   iPS84-1-R
DR   hPSCreg; OGHFUi001-A-1
DR   Wikidata; Q114312630
RX   PubMed=35121198;
CC   From: Obstetrics and Gynecology Hospital of Fudan University; Shanghai; China.
CC   Sequence variation: Mutation; HGNC; HGNC:18060; ARX; Simple_corrected; p.Arg330Leu (c.989G>T); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=35121198).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179866; Developmental and epileptic encephalopathy 1
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8MU ! OGHFUi001-A
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   OGIi001-A
AC   CVCL_D6L7
SY   OGIi001 clone A
DR   BioSamples; SAMEA114346938
DR   hPSCreg; OGIi001-A
DR   Wikidata; Q127382994
RX   PubMed=38134577;
CC   From: Ocular Genomics Institute at Mass Eye and Ear Hospital, Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6L8 ! OGIi001-B
OI   CVCL_D6L9 ! OGIi001-C
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   OGIi001-B
AC   CVCL_D6L8
SY   OGIi001 clone B
DR   Wikidata; Q127382995
RX   PubMed=38134577;
CC   From: Ocular Genomics Institute at Mass Eye and Ear Hospital, Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Miscellaneous: OGIi001-B and OGIi001-C (Cellosaurus=CVCL_D6L9) are only described in the supplementary methods of PubMed=38134577.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6L7 ! OGIi001-A
OI   CVCL_D6L9 ! OGIi001-C
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   OGIi001-C
AC   CVCL_D6L9
SY   OGIi001 clone C
DR   Wikidata; Q127382996
RX   PubMed=38134577;
CC   From: Ocular Genomics Institute at Mass Eye and Ear Hospital, Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Miscellaneous: OGIi001-B (Cellosaurus=CVCL_D6L8) and OGIi001-C are only described in the supplementary methods of PubMed=38134577.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6L7 ! OGIi001-A
OI   CVCL_D6L8 ! OGIi001-B
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   OGK-M
AC   CVCL_RP35
DR   cancercelllines; CVCL_RP35
DR   Wikidata; Q54931878
RX   PubMed=25365311;
CC   Population: Caucasian.
CC   Doubling time: 18 hours (PubMed=25365311).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Tyr (c.830G>A); ClinVar=VCV000185722; Zygosity=Homozygous (PubMed=25365311).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=25365311
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D21S11: 29
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   TH01: 6,10
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RP36 ! OGK-P
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   OGK-P
AC   CVCL_RP36
DR   cancercelllines; CVCL_RP36
DR   Wikidata; Q54931879
RX   PubMed=25365311;
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=25365311).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Tyr (c.830G>A); ClinVar=VCV000185722; Zygosity=Homozygous (PubMed=25365311).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25365311
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D21S11: 29
ST   D5S818: 10,13
ST   D7S820: 10,13
ST   TH01: 6,10
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RP35 ! OGK-M
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   OGU1
AC   CVCL_4664
DR   CLO; CLO_0050008
DR   BioSample; SAMN03471968
DR   RCB; RCB2351
DR   Wikidata; Q54931880
RX   PubMed=25846106;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=25846106).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB2351
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Ogun
AC   CVCL_V742
SY   OGUN; P4-Ogun; P-4-Ogun; OB4; OB 4
DR   CGH-DB; 9203-4
DR   Wikidata; Q54931881
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4169243;
RX   PubMed=4321974;
RX   PubMed=4866767;
RX   PubMed=4894370;
RX   PubMed=5786183;
RX   PubMed=6018567;
RX   PubMed=6060209;
CC   Population: African; Nigerian.
CC   Virology: EBV-negative.
CC   Caution: Indicated in PubMed=4169243 to originate from a male patient, but has a female karyotype according to PubMed=6018567.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 11
//
ID   OH-1
AC   CVCL_A765
SY   OH1; O-H-1
DR   Cosmic; 953984
DR   Wikidata; Q54931882
RX   PubMed=6108156;
RX   PubMed=6120760;
RX   PubMed=6264474;
RX   PubMed=6272398;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 10
//
ID   OH-2 [Human lung carcinoma]
AC   CVCL_X427
DR   Cosmic; 953986
DR   Wikidata; Q54931883
RX   PubMed=6304739;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   OH-2 [Human plasma cell myeloma]
AC   CVCL_5442
SY   OH2
DR   Wikidata; Q54931884
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8062895;
RX   PubMed=10936422;
RX   PubMed=11154231;
RX   PubMed=32123307;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=OH-2
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   OH-3
AC   CVCL_A766
SY   OH3
DR   Cosmic; 953982
DR   Wikidata; Q54931885
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   OH1
AC   CVCL_E3AY
RX   PubMed=2437192;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11411; Leuconostoc mesenteroides glucose-6-phosphate 1-dehydrogenase (zwf).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Oh13T
AC   CVCL_B7P3
DR   Wikidata; Q114312631
RX   PubMed=1472476;
RX   PubMed=1719236;
RX   PubMed=9357968;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   OH931
AC   CVCL_M833
DR   Wikidata; Q54931886
RX   PubMed=9109944;
CC   Population: Caucasian.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   OH94
AC   CVCL_RN46
DR   Wikidata; Q54931887
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690048;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   OHH1.K
AC   CVCL_4546
DR   CLO; CLO_0008243
DR   CLDB; cl3765
DR   ATCC; CRL-6193
DR   BCRC; 60281
DR   IZSLER; BS CL 123
DR   Wikidata; Q54931888
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9872; ! Odocoileus hemionus (Mule deer)
OI   CVCL_4547 ! OHH1.Li
OI   CVCL_4548 ! OHH1.Lu
OI   CVCL_S205 ! OHH1.Sp
SX   Male
AG   Fawn
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OHH1.Li
AC   CVCL_4547
DR   CLO; CLO_0008244
DR   ATCC; CRL-6194
DR   Wikidata; Q54931889
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9872; ! Odocoileus hemionus (Mule deer)
OI   CVCL_4546 ! OHH1.K
OI   CVCL_4548 ! OHH1.Lu
OI   CVCL_S205 ! OHH1.Sp
SX   Male
AG   Fawn
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   OHH1.Lu
AC   CVCL_4548
SY   OHH1.LU
DR   CLO; CLO_0008245
DR   ATCC; CRL-6195
DR   Wikidata; Q54931890
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6195; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9872; ! Odocoileus hemionus (Mule deer)
OI   CVCL_4546 ! OHH1.K
OI   CVCL_4547 ! OHH1.Li
OI   CVCL_S205 ! OHH1.Sp
SX   Male
AG   Fawn
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   OHH1.Sp
AC   CVCL_S205
DR   ATCC; CRL-6196
DR   Wikidata; Q54931891
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6196; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9872; ! Odocoileus hemionus (Mule deer)
OI   CVCL_4546 ! OHH1.K
OI   CVCL_4547 ! OHH1.Li
OI   CVCL_4548 ! OHH1.Lu
SX   Male
AG   Fawn
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   OHK [Human primary effusion lymphoma]
AC   CVCL_W730
DR   Wikidata; Q54931892
RX   PubMed=11841405;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=11841405).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   OHK [Human ovarian tumor]
AC   CVCL_W731
DR   cancercelllines; CVCL_W731
DR   Wikidata; Q54931893
RX   CelloPub=CLPUB00136;
CC   Population: Korean.
CC   Doubling time: 38.4 hours (CelloPub=CLPUB00136).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Unspecified (CelloPub=CLPUB00136).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4270; Malignant ovarian Brenner tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   OHN-GM
AC   CVCL_A662
SY   OHNGM
DR   cancercelllines; CVCL_A662
DR   Cosmic; 787473
DR   Cosmic; 975295
DR   Cosmic; 1281350
DR   GEO; GSM2124119
DR   Progenetix; CVCL_A662
DR   Wikidata; Q54931895
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9266938;
RX   PubMed=27750403;
RX   PubMed=29533902;
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Doubling time: ~60 hours (PubMed=9266938).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous (PubMed=27750403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Phe (c.514G>T); ClinVar=VCV000428909; Zygosity=Heterozygous (PubMed=27750403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Heterozygous (PubMed=27750403).
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
DI   NCIt; C8252; Therapy-related acute myeloid leukemia
DI   ORDO; Orphanet_86846; Therapy related acute myeloid leukemia and myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   OHP101.B11.1
AC   CVCL_J481
SY   OHP 101.B11.1
DR   JCRB; JCRB1316.2
DR   Wikidata; Q54931896
RX   PubMed=3312820;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17252; 17alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   OHP138.H8.1
AC   CVCL_J482
SY   OHP 138.H8.1
DR   JCRB; JCRB1316.3
DR   Wikidata; Q54931897
RX   PubMed=3312820;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17252; 17alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   OHP1E9.3.1
AC   CVCL_J483
SY   OHP 1E9.3.1; 1E9
DR   JCRB; JCRB1316.4
DR   Wikidata; Q54931898
RX   PubMed=3312820;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17252; 17alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   OHP4B2.2.3
AC   CVCL_J484
SY   OHP 4B2.2.3; 4B2
DR   JCRB; JCRB1316.5
DR   Wikidata; Q54931899
RX   PubMed=3312820;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17252; 17alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   OHP57.G6.1
AC   CVCL_J485
SY   OHP 57.G6.1
DR   JCRB; JCRB1316.1
DR   Wikidata; Q54931900
RX   PubMed=3312820;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17252; 17alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   OHP7D7.2.3
AC   CVCL_J486
SY   OHP 7D7.2.3; 7D7
DR   JCRB; JCRB1316.6
DR   Wikidata; Q54931901
RX   PubMed=3312820;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_17252; 17alpha-hydroxyprogesterone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   OHR
AC   CVCL_F503
DR   cancercelllines; CVCL_F503
DR   Cosmic; 1358200
DR   IARC_TP53; 5428
DR   Wikidata; Q54931902
RX   DOI=10.14930/jsma1939.51.429;
RX   PubMed=2562091;
RX   PubMed=8721685;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281His (c.841G>C); ClinVar=VCV000376588; Zygosity=Unspecified (PubMed=8721685).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   OHRI-MEL-13
AC   CVCL_A4BI
SY   Ottawa Hospital Research Institute-MELanoma-13
DR   ATCC; CRL-3427
DR   cancercelllines; CVCL_A4BI
DR   Wikidata; Q105510486
RX   PubMed=33555379;
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=33555379).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Homozygous (PubMed=33555379).
CC   Derived from site: Metastatic; Pelvic lymph node; UBERON=UBERON_0015876.
ST   Source(s): ATCC=CRL-3427
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 13,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   OHS
AC   CVCL_B450
SY   OHSX; OHS/X; OHS-50; OHS-50T
DR   cancercelllines; CVCL_B450
DR   Cosmic; 1529909
DR   GEO; GSM879220
DR   GEO; GSM1676308
DR   GEO; GSM1701642
DR   IARC_TP53; 2149
DR   Progenetix; CVCL_B450
DR   Wikidata; Q38098672
RX   PubMed=2233717;
RX   PubMed=3459716;
RX   PubMed=8198963;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
RX   PubMed=26351324;
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=21519327).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Unspecified (PubMed=19787792).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 16,19
ST   D5S818: 10
ST   D8S1179: 13
ST   FGA: 20,22
ST   SE33: 26.2
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   OHS-4
AC   CVCL_R724
SY   OHS4
DR   cancercelllines; CVCL_R724
DR   Wikidata; Q38098531
RX   PubMed=1860886;
RX   PubMed=8429272;
CC   Population: Caucasian.
CC   Doubling time: 39 hours (PubMed=1860886).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B450 ! OHS
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   OHSTMAM-4
AC   CVCL_D244
DR   Wikidata; Q54931904
RX   DOI=10.1016/0165-4608(96)85256-3;
RX   PubMed=21556597;
CC   Characteristics: Developed from a breast tumor xenograft developed in athymic mice.
CC   Derived from site: Metastatic; Submandibular region; UBERON=UBERON_0035775.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   OHSU-974
AC   CVCL_XX23
SY   OHSU-0974; OHSU974; OHSU-SCC-974
DR   cancercelllines; CVCL_XX23
DR   IARC_TP53; 21669
DR   Wikidata; Q98128333
RX   PubMed=15735012;
RX   PubMed=23613873;
RX   PubMed=25609062;
RX   PubMed=36912284;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser37Profs*7 (c.109delT); ClinVar=VCV001713031; Zygosity=Unspecified (PubMed=23613873).
CC   Caution: TP53 mutation indicated to be at p.Asp41fs (c.121delT) in PubMed=15735012.
CC   Caution: The 8 loci STR profile in PubMed=36912284 supp. table is incorrect and is that of NCI-H1299. The correct and extended (16 loci) profile is shown in this entry thanks to a personal communication of Wakefield, Leslie.
ST   Source(s): PubMed=36912284
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 9,11
ST   D18S51: 13
ST   D21S11: 31.2,33.2
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 13
ST   D8S1179: 10,13
ST   FGA: 21,22.2
ST   Penta D: 11,13
ST   Penta E: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_84; Fanconi anemia
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   OHTA
AC   CVCL_4665
DR   RCB; RCB0545
DR   Wikidata; Q54931905
CC   Breed/subspecies: ICR.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   OI-11a
AC   CVCL_C6F1
DR   Wikidata; Q116050068
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, isthmus; UBERON=UBERON_0016632.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OI-11c
AC   CVCL_C6F2
DR   Wikidata; Q116050069
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, isthmus; UBERON=UBERON_0016632.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F3 ! OI-14a
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OI-14a
AC   CVCL_C6F3
DR   Wikidata; Q116050070
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, isthmus; UBERON=UBERON_0016632.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F4 ! OI-7a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OI-7a
AC   CVCL_C6F4
DR   Wikidata; Q116050072
RX   PubMed=14505432;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oviduct, isthmus; UBERON=UBERON_0016632.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6ER ! OA-11a2
OI   CVCL_C6ES ! OA-2c
OI   CVCL_C6ET ! OA-3a2
OI   CVCL_C6F5 ! OA-5ca
OI   CVCL_C6EU ! OA-5cg
OI   CVCL_C6F6 ! OA-5ch
OI   CVCL_C6EV ! OA-5cm
OI   CVCL_C6EW ! OA-6b
OI   CVCL_C6EX ! OA-ab
OI   CVCL_C6EY ! OF-1a
OI   CVCL_C6EZ ! OF-4a2
OI   CVCL_C6F0 ! OF-4a3
OI   CVCL_C6F1 ! OI-11a
OI   CVCL_C6F2 ! OI-11c
OI   CVCL_C6F3 ! OI-14a
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OI-Pt1 iPSC
AC   CVCL_D4ZC
DR   Wikidata; Q127382997
RX   PubMed=38379122;
RX   PubMed=38878231;
CC   From: Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Gly536Valfs*5 (c.1607delG); Zygosity=Heterozygous (PubMed=38379122).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38379122
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 22,23
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 14,15.2
ST   D1S1656: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D6S1043: 17,18
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   Penta D: 11,13
ST   Penta E: 11,19
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   OI-Pt1 iPSC corrected
AC   CVCL_D4ZE
SY   Corrected OI-Pt1 iPSC
DR   Wikidata; Q127382998
RX   PubMed=38379122;
CC   From: Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple_corrected; p.Gly536Valfs*5 (c.1607delG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38379122).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38379122
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D12S391: 22,23
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 14,15.2
ST   D1S1656: 14,15
ST   D21S11: 30,33.2
ST   D2S1338: 17,23
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D6S1043: 17,18
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   Penta D: 11,13
ST   Penta E: 11,19
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D4ZC ! OI-Pt1 iPSC
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   OI-Pt2 iPSC
AC   CVCL_D4ZD
DR   Wikidata; Q127383000
RX   PubMed=38379122;
CC   From: Xiangya Hospital of Central South University; Changsha; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Gly536Valfs*5 (c.1607delG); Zygosity=Heterozygous (PubMed=38379122).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38379122
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,22
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D19S433: 13,15.2
ST   D1S1656: 16,18
ST   D21S11: 29,30
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 7,12
ST   D6S1043: 14,19
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 22,25
ST   Penta D: 10,12
ST   Penta E: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   OIF-KG4
AC   CVCL_XH02
DR   Wikidata; Q98128334
RX   Patent=CN1951967A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200409.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P20774; Human OGN/OIF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   OIH-1
AC   CVCL_4872
DR   CLO; CLO_0050990
DR   BioSample; SAMN03472124
DR   RCB; RCB1290
DR   Wikidata; Q54931906
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9631582;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=9631582).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1290
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   OK
AC   CVCL_0472
SY   Opossum Kidney; OK-WT
DR   BTO; BTO_0003069
DR   CLO; CLO_0008246
DR   MCCL; MCC:0000370
DR   CLDB; cl3766
DR   ATCC; CRL-1840
DR   CCRID; 3101MAMGNO20
DR   CLS; 606465
DR   ECACC; 91021202
DR   GEO; GSM4009046
DR   GEO; GSM4009050
DR   GEO; GSM4009051
DR   GEO; GSM4009052
DR   GEO; GSM4249049
DR   GEO; GSM4249050
DR   GEO; GSM4249051
DR   KCB; KCB 200824YJ
DR   TOKU-E; 2794
DR   Wikidata; Q25326634
RX   CelloPub=CLPUB00465;
RX   PubMed=566717;
RX   PubMed=1802405;
RX   PubMed=6394469;
RX   PubMed=28615248;
RX   PubMed=30379374;
RX   PubMed=33122286;
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-497.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/OK_cells
CC   Group: Marsupial cell line.
CC   Characteristics: Used to study X chromosome inactivation as well as to investigate proximal tubule ion transport and membrane trafficking.
CC   Doubling time: 18 hours (PubMed=566717).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9267; ! Didelphis virginiana (North American opossum)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   OK [Sheep]
AC   CVCL_X339
SY   Ovine Kidney
DR   ATCC; CRL-6551
DR   Wikidata; Q54931907
RX   PubMed=5587551;
RX   PubMed=14282199;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6551; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   OK-92
AC   CVCL_A767
SY   OK92
DR   Cosmic; 1118795
DR   Wikidata; Q54931908
RX   PubMed=15069686;
CC   Population: Japanese.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   OK6>Ras attP-L2
AC   CVCL_XF55
SY   OK6-2; OK6-2 attP
DR   DGRC; 287
DR   FlyBase_Cell_line; FBtc0000287
DR   Wikidata; Q98128335
CC   Group: Insect cell line.
CC   Characteristics: OK6-Gal4 driving UAS-RasV12 with an attP flanked cassette for RMCE.
CC   Discontinued: DGRC; 287; probable.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   OK6>Ras attP-L3
AC   CVCL_XF56
SY   OK6-3; OK6-3 attP
DR   DGRC; 281
DR   FlyBase_Cell_line; FBtc0000281
DR   Wikidata; Q98128336
CC   Group: Insect cell line.
CC   Characteristics: OK6-Gal4 driving UAS-RasV12 with an attP flanked cassette for RMCE.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   OK7A
AC   CVCL_W411
SY   OK7a; OK-7A
DR   Wikidata; Q54931909
RX   PubMed=7503230;
RX   PubMed=7681260;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9267; ! Didelphis virginiana (North American opossum)
HI   CVCL_0472 ! OK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   OKa-C-1
AC   CVCL_3085
SY   Oka-C1; OKAC1
DR   GEO; GSM1374798
DR   JCRB; JCRB1343
DR   JCRB; NIHS0544
DR   Wikidata; Q54931910
RX   PubMed=8641981;
CC   Population: Japanese.
CC   Doubling time: 95 hours (PubMed=8641981).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0544; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1343
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Okajima
AC   CVCL_9815
SY   OKAJIMA
DR   EFO; EFO_0006715
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03470905
DR   cancercelllines; CVCL_9815
DR   CGH-DB; 123-1
DR   CGH-DB; 9025-4
DR   Cosmic; 926117
DR   Cosmic; 1001656
DR   Cosmic; 1518258
DR   Cosmic; 2443795
DR   EGA; EGAS00001000610
DR   IARC_TP53; 999
DR   PharmacoDB; Okajima_1198_2019
DR   Wikidata; Q54931911
RX   CelloPub=CLPUB00584;
RX   PubMed=1933850;
RX   PubMed=3962675;
RX   PubMed=6862145;
RX   PubMed=15723654;
RX   PubMed=17505008;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Japanese.
CC   Doubling time: 36-40 hours (PubMed=3962675); 36-38 hours (CelloPub=CLPUB00584).
CC   HLA typing: A*11:01,31:01; B*15:27,51:01; C*03:03,15:02; DRB1*11:16,14:121 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=1933850).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: Okajama; IARC_TP53=999.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 9,11
ST   D18S51: 15,18
ST   D19S433: 14.2
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 19,25
ST   Penta D: 9,12
ST   Penta E: 17,21
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C5476; Gastric undifferentiated carcinoma
DI   ORDO; Orphanet_423786; Undifferentiated carcinoma of stomach
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   OKB
AC   CVCL_D041
SY   OK/B; Opossum Kidney clone B
DR   Wikidata; Q54931912
RX   PubMed=2539748;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9267; ! Didelphis virginiana (North American opossum)
HI   CVCL_0472 ! OK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   OKB1
AC   CVCL_F1KF
RX   PubMed=6413577;
RX   PubMed=6423012;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 188 kDa antigen on B-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OKB2 [Human keratinocyte]
AC   CVCL_L219
SY   OK-B2
DR   Wikidata; Q54931913
RX   PubMed=1708735;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L220 ! OKF4
OI   CVCL_L221 ! OKP4
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 10
//
ID   OKB2 [Mouse hybridoma against human B-cell antigen]
AC   CVCL_F1KG
RX   PubMed=6413577;
RX   PubMed=6423012;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on B-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OKB3
AC   CVCL_L239
SY   OK-B3
DR   Wikidata; Q54931914
RX   PubMed=1708735;
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   28-38Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 7
//
ID   OKB4 [Human keratinocyte]
AC   CVCL_L240
SY   OK-B4
DR   Wikidata; Q54931915
RX   PubMed=1708735;
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   28-38Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 8
//
ID   OKB4 [Mouse hybridoma against human B-cell antigen]
AC   CVCL_F1KH
RX   PubMed=6413577;
RX   PubMed=6423012;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 87 kDa antigen on B-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OKB7
AC   CVCL_F1KI
RX   PubMed=3159485;
RX   PubMed=6413577;
RX   PubMed=6423012;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20023; Human CR2/CD21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OKB8
AC   CVCL_L228
DR   Wikidata; Q54931916
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 8
//
ID   OKF4
AC   CVCL_L220
SY   OK-F4
DR   GEO; GSM1431137
DR   Wikidata; Q54931917
RX   PubMed=1708735;
RX   PubMed=10648628;
RX   PubMed=12077343;
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at ~32-37 PDL (PubMed=10648628; PubMed=12077343).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L219 ! OKB2 [Human keratinocyte]
OI   CVCL_L221 ! OKP4
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 14
//
ID   OKF4/E6E7
AC   CVCL_L226
SY   OKF4 E6E7
DR   GEO; GSM1431132
DR   Wikidata; Q54931918
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L220 ! OKF4
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   OKF4/TERT-1
AC   CVCL_L227
SY   OKF4 TERT; OKF4/TERT
DR   GEO; GSM1431131
DR   Wikidata; Q54931919
RX   PubMed=10648628;
RX   PubMed=12077343;
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L220 ! OKF4
SX   Male
AG   28Y
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 17
//
ID   OKF6
AC   CVCL_L222
SY   OK-F6; OKF-6; OKF/6
DR   BTO; BTO_0005374
DR   Wikidata; Q54931920
RX   PubMed=10648628;
RX   PubMed=22546478;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at ~45 PDL (PubMed=10648628).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   OKF6/E6E7
AC   CVCL_L223
SY   OKF6 E6E7
DR   GEO; GSM1431133
DR   Wikidata; Q54931921
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L222 ! OKF6
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 13
//
ID   OKF6/TERT-1
AC   CVCL_L224
SY   OKF6-TERT-1; OKF6 Tert 1; OKF6 TERT1; OKF6/TERT1
DR   Cell_Model_Passport; SIDM01994
DR   GEO; GSM1431135
DR   PRIDE; PXD002132
DR   PRIDE; PXD007637
DR   PRIDE; PXD011106
DR   PRIDE; PXD011318
DR   Wikidata; Q54931922
RX   PubMed=10648628;
RX   PubMed=21868764;
RX   PubMed=25169794;
RX   PubMed=29480433;
RX   PubMed=30767727;
RX   PubMed=31321732;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L222 ! OKF6
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   OKF6/TERT-2
AC   CVCL_L225
SY   OKF6 Tert 2; OKF6 TERT2
DR   GEO; GSM1431130
DR   Wikidata; Q54931923
RX   PubMed=10648628;
RX   PubMed=21868764;
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L222 ! OKF6
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   OKF6/TERT1-Shisha-2 month
AC   CVCL_C0R2
DR   PRIDE; PXD011106
DR   Wikidata; Q114312632
RX   PubMed=30767727;
CC   Characteristics: The parental cell line was chronically exposed with 0.5% shisha extract for 2 months.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L224 ! OKF6/TERT-1
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   OKF6/TERT1-Shisha-4 month
AC   CVCL_C0R3
DR   PRIDE; PXD011106
DR   Wikidata; Q114312633
RX   PubMed=30767727;
CC   Characteristics: The parental cell line was chronically exposed with 0.5% shisha extract for 4 months.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L224 ! OKF6/TERT-1
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   OKF6/TERT1-Shisha-6 month
AC   CVCL_C0R4
DR   PRIDE; PXD011106
DR   Wikidata; Q114312634
RX   PubMed=30767727;
CC   Characteristics: The parental cell line was chronically exposed with 0.5% shisha extract for 6 months.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L224 ! OKF6/TERT-1
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   OKF6/TERT1-Shisha-8 month
AC   CVCL_C0R5
DR   PRIDE; PXD011106
DR   PRIDE; PXD011318
DR   Wikidata; Q114312635
RX   PubMed=30767727;
RX   PubMed=31321732;
CC   Characteristics: The parental cell line was chronically exposed with 0.5% shisha extract for 8 months.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L224 ! OKF6/TERT-1
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   OKF6/TERT1-Smoke
AC   CVCL_C0R7
DR   PRIDE; PXD007637
DR   Wikidata; Q114312636
RX   PubMed=29480433;
CC   Characteristics: The parental cell line was chronically exposed to 0.1% cigarette smoke condensate (CSC) for a period of 12 months.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L224 ! OKF6/TERT-1
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   OKG12
AC   CVCL_L231
DR   Wikidata; Q54931924
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L241 ! GingF12
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 8
//
ID   OKG4
AC   CVCL_L229
SY   OK-G4
DR   Wikidata; Q54931925
RX   PubMed=1708735;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L230 ! OKHP1
SX   Sex unspecified
AG   27Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 10
//
ID   OKH
AC   CVCL_D042
SY   OK/H; Opossum Kidney clone H
DR   GEO; GSM4009047
DR   GEO; GSM4009048
DR   GEO; GSM4009049
DR   Wikidata; Q54931926
RX   PubMed=2539748;
RX   PubMed=33122286;
CC   Group: Marsupial cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9267; ! Didelphis virginiana (North American opossum)
HI   CVCL_0472 ! OK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   OKHP1
AC   CVCL_L230
SY   OK-HP1
DR   Wikidata; Q54931927
RX   PubMed=1708735;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L229 ! OKG4
SX   Sex unspecified
AG   27Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 10
//
ID   OKK-1
AC   CVCL_A5XG
DR   Wikidata; Q107116604
RX   PubMed=690749;
RX   PubMed=1842870;
RX   PubMed=3489826;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OKM-2T
AC   CVCL_5849
DR   BTO; BTO_0004184
DR   Wikidata; Q54931929
RX   PubMed=9802061;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   OKM-3T
AC   CVCL_VG03
DR   Wikidata; Q54931930
RX   PubMed=9802061;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   OKM-4
AC   CVCL_C396
DR   RCB; AES0050
DR   RCB; RCB2199
DR   SKIP; SKIP001660
DR   Wikidata; Q54931931
CC   Discontinued: RCB; RCB2199; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   OKM1
AC   CVCL_G132
SY   OKM 1
DR   CLO; CLO_0008247
DR   ATCC; CRL-8026
DR   BCRC; 60271
DR   ECACC; 88012702
DR   KCLB; 28026
DR   TKG; TKG 0432
DR   Wikidata; Q27554393
RX   Patent=US4364936;
RX   PubMed=6342816;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8026.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
CC   Discontinued: ATCC; CRL-8026; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   OKM10
AC   CVCL_2G58
DR   Wikidata; Q54931932
RX   PubMed=6342816;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   OKM3
AC   CVCL_2E68
DR   Wikidata; Q54931933
RX   PubMed=6342816;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   OKM5
AC   CVCL_2G54
DR   Wikidata; Q54931934
RX   PubMed=3900210;
RX   PubMed=6342816;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16671; Human CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   OKM6
AC   CVCL_2G55
DR   Wikidata; Q54931935
RX   PubMed=6342816;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   OKM8
AC   CVCL_2G56
DR   Wikidata; Q54931937
RX   PubMed=6342816;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16671; Human CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   OKM9
AC   CVCL_2G57
DR   Wikidata; Q54931938
RX   PubMed=6342816;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   Oko
AC   CVCL_R798
DR   Wikidata; Q54931939
RX   PubMed=1690682;
RX   PubMed=8891732;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   OKO160
AC   CVCL_W461
SY   OKO 160
DR   Wikidata; Q54931940
RX   PubMed=10612458;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3987 ! CGR8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   OKP
AC   CVCL_D040
SY   OK/P; OK-P; Opossum Kidney clone P
DR   EFO; EFO_0022794
DR   TOKU-E; 4061
DR   Wikidata; Q54931941
RX   PubMed=2539748;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9267; ! Didelphis virginiana (North American opossum)
HI   CVCL_0472 ! OK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   OKP-GS
AC   CVCL_L980
SY   GS
DR   CLO; CLO_0008248
DR   CLDB; cl3767
DR   Wikidata; Q54931942
RX   PubMed=3243360;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   OKP4
AC   CVCL_L221
SY   OK-P4
DR   Wikidata; Q54931943
RX   PubMed=1708735;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L219 ! OKB2 [Human keratinocyte]
OI   CVCL_L220 ! OKF4
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 27-11-25; Version: 10
//
ID   OKP7
AC   CVCL_L232
DR   GEO; GSM1431136
DR   Wikidata; Q54931944
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 9
//
ID   OKP7/bmi1/TERT
AC   CVCL_L233
SY   OKP7 bmi1 TERT; OKP7 bmi Tert
DR   GEO; GSM1431128
DR   Wikidata; Q54931945
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L232 ! OKP7
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   OKP8
AC   CVCL_L235
DR   Wikidata; Q54931946
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L234 ! OFP8
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   OKT 1
AC   CVCL_2662
SY   OKT1
DR   CLO; CLO_0008249
DR   ATCC; CRL-8000
DR   ECACC; 86022705
DR   NCBI_Iran; H164
DR   TKG; TKG 0459
DR   Wikidata; Q54931947
RX   Patent=US4363799;
RX   PubMed=314668;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8000.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   OKT 10
AC   CVCL_2663
SY   OKT10
DR   CLO; CLO_0008250
DR   ABCD; ABCD_AJ887
DR   ATCC; CRL-8022
DR   ECACC; 87021903
DR   NCBI_Iran; H103
DR   Wikidata; Q54931948
RX   Patent=US4364935;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8022.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
CC   Discontinued: ATCC; CRL-8022; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   OKT 11
AC   CVCL_2664
SY   OKT11
DR   CLO; CLO_0008251
DR   ATCC; CRL-8027
DR   CCRID; 1101MOU-PUMC000819
DR   CCRID; 3101ETCHYB56
DR   CLS; 300500
DR   ECACC; 86050802
DR   KCLB; 28027
DR   NCBI_Iran; H105
DR   Wikidata; Q54931949
RX   Patent=US4364937;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8027.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   OKT 16
AC   CVCL_F1KB
SY   OKT16
RX   PubMed=3902121;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OKT 3
AC   CVCL_2665
SY   OKT3
DR   CLO; CLO_0008252
DR   CLDB; cl5239
DR   ABCD; ABCD_AC852
DR   ATCC; CRL-8001
DR   BCRC; 60154
DR   CCRID; 3101ETCHYB58
DR   CLS; 300499
DR   ECACC; 86022706
DR   IZSLER; BS Hy 12
DR   NCBI_Iran; H104
DR   TKG; TKG 0235
DR   Wikidata; Q54931950
RX   DOI=10.1007/978-1-4899-1236-7_4;
RX   Patent=US4361549;
RX   PubMed=314668;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8001.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used as an immunosuppressant drug under the name Muromonab-CD3 (Orthoclone OKT3).
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized teplizumab (MGA031) therapeutic antibody.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P07766; Human CD3E.
CC   Anecdotal: OKT3 was the first monoclonal antibody to be approved for clinical use in humans.
CC   Discontinued: TKG; TKG 0235; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OKT 4
AC   CVCL_2666
SY   OKT4; OKT-4
DR   CLO; CLO_0008253
DR   CLDB; cl5240
DR   ABCD; ABCD_AN714
DR   ATCC; CRL-8002
DR   BCRC; 60235
DR   ECACC; 87012602
DR   IZSLER; BS Hy 13
DR   KCLB; 28002
DR   NCBI_Iran; H101
DR   TKG; TKG 0236
DR   Wikidata; Q54931951
RX   Patent=US4381295;
RX   PubMed=314668;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8002.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
CC   Discontinued: TKG; TKG 0236; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   OKT 5
AC   CVCL_2667
SY   OKT5
DR   CLO; CLO_0008254
DR   CLO; CLO_0008255
DR   ATCC; CRL-8013
DR   ATCC; CRL-8016
DR   ECACC; 88070705
DR   Wikidata; Q54931952
RX   Patent=US4364932;
RX   PubMed=6444649;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8013.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8016.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   OKT 6
AC   CVCL_2668
SY   OKT6
DR   CLO; CLO_0008256
DR   ATCC; CRL-8020
DR   ECACC; 87091001
DR   NCBI_Iran; H111
DR   Wikidata; Q54931953
RX   Patent=US4364933;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8020.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06126; Human CD1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   OKT 8
AC   CVCL_2669
SY   OKT8
DR   CLO; CLO_0008257
DR   CLDB; cl5241
DR   ABCD; ABCD_AD461
DR   ATCC; CRL-8014
DR   BCRC; 60257
DR   ECACC; 85112802
DR   IZSLER; BS Hy 16
DR   NCBI_Iran; H102
DR   TKG; TKG 0237
DR   Wikidata; Q54931954
RX   Patent=US4361550;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8014.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01732; Human CD8A.
CC   Discontinued: TKG; TKG 0237; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   OKT 9
AC   CVCL_2670
SY   OKT9; SFX.1
DR   CLO; CLO_0008258
DR   ATCC; CRL-8021
DR   ECACC; 86022707
DR   NCBI_Iran; H125
DR   TKG; TKG 0238
DR   Wikidata; Q54931955
RX   Patent=US4364934;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8021.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
CC   Discontinued: ATCC; CRL-8021; true.
CC   Discontinued: TKG; TKG 0238; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   OKT1
AC   CVCL_E233
DR   Wikidata; Q54931956
RX   PubMed=9826457;
CC   Population: Japanese.
CC   Doubling time: ~27 hours (PubMed=9826457).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C7982; Cervical small cell carcinoma
DI   ORDO; Orphanet_213777; High-grade neuroendocrine carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   OKT4
AC   CVCL_L236
SY   OK-T4
DR   Wikidata; Q54931957
RX   PubMed=1708735;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   28-38Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 9
//
ID   OKTr-1
AC   CVCL_9U40
DR   Wikidata; Q54931958
RX   PubMed=7724618;
CC   Group: Crustacean cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Oka organ; UBERON=UBERON_8480039.
OX   NCBI_TaxID=29019; ! Penaeus stylirostris (Pacific blue shrimp)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   OKTr-23
AC   CVCL_9U41
DR   Wikidata; Q54931959
RX   PubMed=7724618;
CC   Group: Crustacean cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Oka organ; UBERON=UBERON_8480039.
OX   NCBI_TaxID=29019; ! Penaeus stylirostris (Pacific blue shrimp)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   Oku-BL
AC   CVCL_7206
DR   Wikidata; Q54931960
RX   PubMed=12219084;
RX   PubMed=16051863;
RX   PubMed=21088132;
RX   PubMed=28960205;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   OL-1
AC   CVCL_U377
DR   Wikidata; Q54931961
RX   PubMed=17306496;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte precursor cell; CL=CL_0002453.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2D
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   OL-17
AC   CVCL_M762
SY   Oryzias Latipes-17
DR   Wikidata; Q54931962
RX   DOI=10.1007/BF02628830;
CC   Group: Fish cell line.
CC   Doubling time: 29 hours (DOI=10.1007/BF02628830).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Orange-red; VBO=VBO_0017510.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Male
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   OL-32
AC   CVCL_M755
SY   OL32; Oryzias Latipes-32
DR   Wikidata; Q54931963
RX   DOI=10.1007/BF02628830;
RX   PubMed=7881826;
RX   PubMed=16341864;
CC   Group: Fish cell line.
CC   Characteristics: Proliferates at 33 Celsius but not 37 Celsius (PubMed=7881826).
CC   Doubling time: 32 hours (DOI=10.1007/BF02628830).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: HB32; VBO=VBO_0017504.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Male
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   Olare
AC   CVCL_IU25
DR   Wikidata; Q54931964
RX   PubMed=178913;
RX   PubMed=4122458;
RX   PubMed=4364259;
CC   Population: African; Kenyan.
CC   Virology: Contains 198 copies of the EBV genome (PubMed=178913).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   OLC2-1
AC   CVCL_U897
DR   RCB; AES0154
DR   SKIP; SKIP002992
DR   Wikidata; Q54931965
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   OLCAB-2
AC   CVCL_M756
DR   Wikidata; Q54931966
RX   PubMed=16341864;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: Cab; VBO=VBO_0017503.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   OLCAB-e21
AC   CVCL_6D98
DR   Wikidata; Q54931968
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Cab; VBO=VBO_0017503.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   OLCAB-e3
AC   CVCL_M758
DR   CLO; CLO_0051615
DR   RCB; RCB2946
DR   Wikidata; Q54471866
RX   PubMed=16341864;
RX   PubMed=20624282;
RX   PubMed=29268113;
CC   Group: Fish cell line.
CC   Doubling time: 50.2 hours (PubMed=29268113).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Cab; VBO=VBO_0017503.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   OLCAB-e31
AC   CVCL_M757
AS   CVCL_6D99
SY   OLCAB-e1
DR   CLO; CLO_0051614
DR   RCB; RCB2944
DR   Wikidata; Q54931969
RX   PubMed=16341864;
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Cab; VBO=VBO_0017503.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   OLD1612
AC   CVCL_F504
DR   BioSamples; SAMEA100767
DR   cancercelllines; CVCL_F504
DR   Cosmic; 1522777
DR   GEO; GSM726281
DR   Progenetix; CVCL_F504
DR   Wikidata; Q54931970
RX   PubMed=21642991;
RX   PubMed=27605433;
RX   PubMed=28387650;
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   OLENDO
AC   CVCL_WS16
SY   Ovine Luteal ENDOthelial
DR   Wikidata; Q98128337
RX   PubMed=31154062;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, corpus luteum; UBERON=UBERON_0002512.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 7
//
ID   OLES1
AC   CVCL_6F85
SY   Oryzias Latipes Embryonic Stem cells 1
DR   Wikidata; Q54931971
RX   PubMed=8000476;
WW   Info; KAKEN; 06680717; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-06680717/
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: HNI; VBO=VBO_0017507.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   OLF-124
AC   CVCL_R980
SY   Oryzias Latipes Fin-124
DR   Wikidata; Q54931972
RX   CelloPub=CLPUB00092;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   OLF-136
AC   CVCL_3766
SY   Oryzias Latipes Fin-136
DR   CLO; CLO_0051619
DR   RCB; RCB0184
DR   Wikidata; Q54931973
RX   CelloPub=CLPUB00092;
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Doubling time: 43 hours (CelloPub=CLPUB00092).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Breed/subspecies: HB32C; VBO=VBO_0017505.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   OLF10.1.8
AC   CVCL_6F60
DR   Wikidata; Q54931974
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   OLF3.3
AC   CVCL_M961
DR   Wikidata; Q54931975
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF3.6
AC   CVCL_M962
DR   Wikidata; Q54931976
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.1
AC   CVCL_M963
DR   Wikidata; Q54931980
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.3
AC   CVCL_M964
DR   Wikidata; Q54931981
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.4.1
AC   CVCL_M965
DR   Wikidata; Q54931982
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.4.2
AC   CVCL_M966
SY   OLF442
DR   Wikidata; Q54931983
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.5.1
AC   CVCL_M967
DR   Wikidata; Q54931984
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.6.1
AC   CVCL_M968
DR   Wikidata; Q54931985
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.6.2
AC   CVCL_M969
DR   Wikidata; Q54931986
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.6.3
AC   CVCL_M970
DR   Wikidata; Q54931987
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLF4.7.8
AC   CVCL_M971
DR   Wikidata; Q54931988
RX   PubMed=8841984;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97357; Mycn.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, forebrain, olfactory bulb; UBERON=UBERON_0002264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   OLGA
AC   CVCL_E797
SY   Olga; OLL; TER175; TER346; Extract 215; Extract 363
DR   dbMHC; 48991
DR   dbMHC; 48992
DR   ECACC; 88052071
DR   IHW; IHW09071
DR   IHW; IHW09100
DR   IPD-IMGT/HLA; 11212
DR   IPD-IMGT/HLA; 11213
DR   Wikidata; Q54931989
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Native South American; Warao.
CC   HLA typing: A*31:01:02:01; B*15:01:01:01,15:20; C*01:02:30,03:04:01:02; DPA1*01:03:01:03,01:03:01:05; DPB1*03:01:01:01,04:02:01:02; DQA1*04:01:01/02/03; DQB1*04:02:01:04; DRA*01:02; DRB1*08:02:02,08:02:01:01 (IPD-IMGT/HLA=11212).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   OLGA-PH-J/92
AC   CVCL_U272
SY   OLGA PH J/92; OL-J/92
DR   ATCC; CRL-2576
DR   BioSample; SAMN03152023
DR   Wikidata; Q54472624
RX   CelloPub=CLPUB00251;
RX   PubMed=11125551;
RX   PubMed=21938590;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/olga-ph-j92-ol-j92-atcc-crl-2576
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Shown not to originate from the crayfish Orconectes limosus. May have been derived from contaminating fresh water amoeba that could have been present in the neural tissue of the originating crayfish (PubMed=21938590).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00378.
CC   Discontinued: ATCC; CRL-2576; true.
OX   NCBI_TaxID=32644; ! Unidentified organism (Unknown organism)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   OLGS1
AC   CVCL_EJ00
DR   Cosmic; 1494008
DR   Wikidata; Q54931990
RX   PubMed=21381030;
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   OLHdrR-e3
AC   CVCL_M759
DR   CLO; CLO_0051613
DR   RCB; RCB2943
DR   Wikidata; Q54931991
RX   PubMed=16341864;
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: HdrR; VBO=VBO_0017506.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   OLHE-131
AC   CVCL_4873
SY   Oryzias Latipes HEpatoma-131
DR   CLO; CLO_0051617
DR   RCB; RCB0187
DR   Wikidata; Q54931992
RX   CelloPub=CLPUB00092;
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Doubling time: 67 hours (CelloPub=CLPUB00092).
CC   Transformant: ChEBI; CHEBI_82341; Methylazoxymethanol acetate (MAM acetate).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: HO4C; VBO=VBO_0017508.
DI   NCIt; C134571; Medaka hepatoma
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   OLHNI-1
AC   CVCL_M754
DR   Wikidata; Q54931993
RX   PubMed=16341864;
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: HNI; VBO=VBO_0017507.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   OLHNI-2
AC   CVCL_J027
DR   CLO; CLO_0051616
DR   RCB; RCB2942
DR   Wikidata; Q54931994
RX   PubMed=16341864;
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: HNI; VBO=VBO_0017507.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   Oli-neu
AC   CVCL_IZ82
SY   Olineu; OliNeu; OLIneu
DR   GEO; GSE10291
DR   Millipore; SCC261
DR   Wikidata; Q54931995
RX   PubMed=7582098;
RX   PubMed=18439243;
RX   PubMed=21472765;
RX   PubMed=23825458;
RX   PubMed=26658258;
CC   Characteristics: Can be induced to differentiate after application of dibutyryl cAMP.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Activated EGFR-neu.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: NMRI.
ST   Source(s): Millipore=SCC261
ST   Mouse STR 1-1: 14,15
ST   Mouse STR 1-2: 14
ST   Mouse STR 3-2: 10,13
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 12
ST   Mouse STR 6-4: 16,17,18
ST   Mouse STR 6-7: 11,12
ST   Mouse STR 7-1: 25.2,29
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 19,20
ST   Mouse STR 13-1: 15
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 11,13
ST   Mouse STR X-1: 25
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   Oli-neuM
AC   CVCL_VL76
DR   Wikidata; Q98128338
RX   PubMed=26658258;
CC   Characteristics: Expression of MRF/Myrf promotes the differentiation of this cell line up to the premyelination stage without the addition of chemical compounds (PubMed=26658258).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:2684944; Myrf.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Activated EGFR-neu.
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IZ82 ! Oli-neu
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 7
//
ID   Oligo
AC   CVCL_A3AJ
DR   CCLV; CCLV-RIE 0221
DR   Wikidata; Q105510490
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 8
//
ID   OLKaga-e1
AC   CVCL_6D97
DR   Wikidata; Q54931996
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kaga; VBO=VBO_0017509.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   OLKaga-e2
AC   CVCL_M760
DR   Wikidata; Q54931997
RX   PubMed=16341864;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kaga; VBO=VBO_0017509.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   OLM
AC   CVCL_XE35
SY   Oryzias Latipes Muscle
DR   CCRID; 4201PAT-CCTCC01154
DR   Wikidata; Q98128340
RX   DOI=10.7541/2019.040;
RX   Patent=CN108624553B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201812.
CC   Doubling time: 34.60 +- 2.87 hours (DOI=10.7541/2019.040).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 9
//
ID   OLME-104
AC   CVCL_3767
SY   Oryzias Latipes MElanoma-104
DR   CLO; CLO_0051620
DR   RCB; RCB0188
DR   Wikidata; Q54931998
RX   CelloPub=CLPUB00092;
RX   PubMed=20624282;
CC   Group: Fish cell line.
CC   Doubling time: 77 hours (CelloPub=CLPUB00092).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: HB32C; VBO=VBO_0017505.
DI   NCIt; C134572; Medaka melanoma
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   OLN-93
AC   CVCL_5850
SY   OLN93; OLN 93
DR   BTO; BTO_0002400
DR   Lonza; 1510
DR   NCBI_Iran; C617
DR   PRIDE; PXD031878
DR   Wikidata; Q54931999
RX   PubMed=8843033;
RX   PubMed=10941146;
RX   PubMed=19266322;
CC   Doubling time: 16-18 hours (PubMed=8843033).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   OLN-t40
AC   CVCL_E8CD
RX   PubMed=19266322;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6893; MAPT (Note=Isoform T40/4R2N).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5850 ! OLN-93
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OLN-t40-A53T
AC   CVCL_E8CE
SY   OLN-A53T
RX   PubMed=19266322;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6893; MAPT (Note=Isoform T40/4R2N).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8CD ! OLN-t40
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OLN-t40-AS
AC   CVCL_E8CF
SY   OLN-t40-alpha-syn
RX   PubMed=19266322;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11138; SNCA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6893; MAPT (Note=Isoform T40/4R2N).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E8CD ! OLN-t40
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OLP6
AC   CVCL_U466
DR   CLO; CLO_0051390
DR   RCB; RCB2864
DR   Wikidata; Q54932000
RX   PubMed=16181743;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hypothalamus, suprachiasmatic nucleus; UBERON=UBERON_0002034.
CC   Cell type: Oligodendrocyte; CL=CL_0000128.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18W
CA   Conditionally immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   OLSOK-e7
AC   CVCL_M761
DR   Wikidata; Q54932001
RX   PubMed=16341864;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: SOK; VBO=VBO_0017511.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   OLV2-1
AC   CVCL_U896
DR   RCB; AES0153
DR   SKIP; SKIP002993
DR   Wikidata; Q54932002
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   OM
AC   CVCL_D7DY
RX   PubMed=26879013;
CC   From: Kochi Medical School, Kochi University; Kochi; Japan.
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   OM 3-1.1
AC   CVCL_G238
SY   OM3-1.1
DR   CLO; CLO_0008261
DR   ATCC; HB-134
DR   Wikidata; Q54932003
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02771; Human AFP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OM-1
AC   CVCL_W941
SY   OM1
DR   cancercelllines; CVCL_W941
DR   CGH-DB; 359-2
DR   ChEMBL-Cells; CHEMBL3307304
DR   ChEMBL-Targets; CHEMBL614136
DR   Cosmic; 930342
DR   Cosmic; 1046036
DR   Cosmic; 1120713
DR   Cosmic; 1123044
DR   IARC_TP53; 1106
DR   PubChem_Cell_line; CVCL_W941
DR   Wikidata; Q54932004
RX   PubMed=1570156;
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Unspecified (PubMed=1570156).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 14
//
ID   OM-2
AC   CVCL_W942
SY   OM2
DR   CGH-DB; 362-2
DR   Cosmic; 930343
DR   Cosmic; 1046037
DR   Wikidata; Q54932005
RX   PubMed=17052259;
RX   PubMed=17599052;
CC   Population: Japanese.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   OM-3E5-B6
AC   CVCL_C8HS
DR   Wikidata; Q123033203
RX   Patent=US8518408;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2936.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-4A4-D4
AC   CVCL_C8HT
DR   Wikidata; Q123033204
RX   Patent=US8518408;
RX   PubMed=20685314;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2931.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-522
AC   CVCL_C8BH
DR   Wikidata; Q123033205
RX   PubMed=2354189;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   OM-523
AC   CVCL_C8BI
DR   Wikidata; Q123033206
RX   PubMed=2354189;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   OM-524
AC   CVCL_C8BJ
DR   Wikidata; Q123033207
RX   PubMed=2354189;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   OM-612
AC   CVCL_C8BK
DR   Wikidata; Q123033208
RX   PubMed=2354189;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   OM-6D9-A6
AC   CVCL_C8HU
DR   Wikidata; Q123033209
RX   Patent=US8518408;
RX   PubMed=20685314;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2933.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-6E1-B5
AC   CVCL_C8HV
DR   Wikidata; Q123033210
RX   Patent=US8518408;
RX   PubMed=20685314;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2935.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-7C8-A8
AC   CVCL_C8HW
DR   Wikidata; Q123033211
RX   Patent=US8518408;
RX   PubMed=20685314;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2932.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-7D3-B3
AC   CVCL_C8HX
DR   Wikidata; Q123033212
RX   Patent=US8518408;
RX   PubMed=20685314;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2938.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-7D4-C1
AC   CVCL_C8HY
DR   Wikidata; Q123033213
RX   Patent=US8518408;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2934.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-8A9-A3
AC   CVCL_C8HZ
DR   Wikidata; Q123033214
RX   Patent=US8518408;
RX   PubMed=20685314;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2937.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; O95832; Human CLDN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OM-A
AC   CVCL_A6IA
DR   Wikidata; Q107116605
RX   PubMed=2456145;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OM-B
AC   CVCL_A6IB
DR   Wikidata; Q107116607
RX   PubMed=2456145;
RX   PubMed=8449829;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OM-C
AC   CVCL_A6IC
DR   Wikidata; Q107116609
RX   PubMed=2456145;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OM1
AC   CVCL_L098
DR   Wikidata; Q54932006
RX   Patent=US7611707;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5938.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   OM10.1
AC   CVCL_D567
SY   OM-10.1
DR   BEI_Resources; ARP-1319
DR   cancercelllines; CVCL_D567
DR   Wikidata; Q54932007
RX   PubMed=1678437;
CC   Population: Caucasian.
CC   Virology: In vitro infected by HIV-1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 24
//
ID   OM2
AC   CVCL_L099
DR   Wikidata; Q54932008
RX   Patent=US7611707;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5939.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   OM3
AC   CVCL_L097
DR   Wikidata; Q54932009
RX   Patent=US7611707;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5940.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   Om37
AC   CVCL_N327
SY   OM37
DR   Wikidata; Q54932010
RX   Patent=US4643971;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8233.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   OM4
AC   CVCL_L100
DR   Wikidata; Q54932011
RX   Patent=US7611707;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5941.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9HCN6; Human GP6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   OM421
AC   CVCL_X145
DR   Wikidata; Q54932012
RX   PubMed=6386741;
CC   Population: Caucasian.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   OM431
AC   CVCL_J308
SY   OM-431
DR   Wikidata; Q54932013
RX   PubMed=1531323;
RX   PubMed=6386741;
RX   PubMed=7573309;
RX   PubMed=7641843;
RX   PubMed=16772116;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=1531323).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   OM439
AC   CVCL_X146
DR   Wikidata; Q54932014
RX   PubMed=6386741;
CC   Population: Caucasian.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   OM443
AC   CVCL_X147
DR   Wikidata; Q54932015
RX   PubMed=6386741;
CC   Population: Caucasian.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   OM449
AC   CVCL_X148
DR   Wikidata; Q54932016
RX   PubMed=6386741;
CC   Population: Caucasian.
CC   Characteristics: Highly pigmented.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   OM464
AC   CVCL_J309
DR   Wikidata; Q54932017
RX   PubMed=1531323;
CC   Doubling time: >72 hours (PubMed=1531323).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OM467
AC   CVCL_J310
DR   Wikidata; Q54932018
RX   PubMed=1531323;
CC   Doubling time: 38 hours (PubMed=1531323).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OM482
AC   CVCL_J311
DR   Wikidata; Q54932019
RX   PubMed=1531323;
CC   Doubling time: 22 hours (PubMed=1531323).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   Om5
AC   CVCL_N328
SY   OM5; URO9; URO-9
DR   ATCC; HB-8270
DR   Wikidata; Q54932023
RX   Patent=US4643971;
RX   Patent=US4935344;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8270.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen URO9 on bladder cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   OM9;22
AC   CVCL_A663
SY   OM9:22; OM9-22; OM 9;22; OM 9:22
DR   Cosmic; 996293
DR   Cosmic; 998696
DR   Cosmic; 999743
DR   Cosmic; 1037735
DR   Cosmic; 2491089
DR   Wikidata; Q54932024
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7686604;
RX   PubMed=9067587;
RX   PubMed=9680106;
RX   PubMed=10071072;
RX   PubMed=10233379;
RX   PubMed=10576511;
RX   PubMed=14504097;
RX   PubMed=15302850;
CC   Population: Japanese.
CC   Characteristics: Can be differentiated into dendritic-like cells in culture with a combination of cytokines (IL1B, IL3, IL7, TNF, KITLG and CD40LG) (PubMed=15302850).
CC   Doubling time: ~80 hours (PubMed=7686604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=7686604; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 17
//
ID   OMA-AML-1
AC   CVCL_A110
DR   Cosmic; 787474
DR   Cosmic; 975296
DR   Cosmic; 1281351
DR   Wikidata; Q54932025
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1379848;
RX   PubMed=7517745;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7463; Acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   OMA-BL-1
AC   CVCL_M553
SY   OMA BL-1; OMA-BL1; Oma
DR   Wikidata; Q54932026
RX   PubMed=1848532;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   Omaka cells
AC   CVCL_6F86
DR   Wikidata; Q54932027
RX   PubMed=810810;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
OX   NCBI_TaxID=197572; ! Atule mate (Yellowtail scad)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   OmB
AC   CVCL_YB41
SY   Oreochromis mossambicus Brain
DR   ATCC; CRL-3481
DR   Wikidata; Q98128341
RX   PubMed=24797371;
RX   PubMed=33846462;
CC   Group: Fish cell line.
CC   Doubling time: ~24 hours (ATCC=CRL-3481).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8127; ! Oreochromis mossambicus (Mozambique tilapia)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   OMB-037
AC   CVCL_B0UR
SY   OMB 037
DR   Wikidata; Q108821073
RX   Patent=US5472868;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11086.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   OMB3
AC   CVCL_U136
DR   Wikidata; Q54932028
RX   PubMed=9185613;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: N-linked neutral oligosaccharides of glycoproteins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   OMB4
AC   CVCL_U137
DR   CLO; CLO_0050330
DR   RCB; RCB2048
DR   Wikidata; Q54932029
RX   PubMed=9185613;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: N-linked neutral oligosaccharides of glycoproteins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OMC-1 [Human cervical carcinoma]
AC   CVCL_1623
SY   OMC1; Osaka Medical College-1
DR   CLO; CLO_0050939
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03472225
DR   cancercelllines; CVCL_1623
DR   Cell_Model_Passport; SIDM00240
DR   ChEMBL-Cells; CHEMBL3308213
DR   ChEMBL-Targets; CHEMBL2366339
DR   Cosmic; 949154
DR   Cosmic; 1152541
DR   Cosmic; 1995602
DR   Cosmic-CLP; 949154
DR   DepMap; ACH-002180
DR   GDSC; 949154
DR   GEO; GSM1670305
DR   IARC_TP53; 27570
DR   LINCS_LDP; LCL-1546
DR   PharmacoDB; OMC1_1199_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1623
DR   RCB; RCB0753
DR   Wikidata; Q54932030
RX   DOI=10.1267/ahc.26.515;
RX   PubMed=2486664;
RX   PubMed=2531191;
RX   PubMed=3746026;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 43 hours (Note=At 15th passage) (PubMed=2486664).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=76.41%; East Asian, South=22.8%; South Asian=0%; European, North=0.62%; European, South=0.16% (PubMed=30894373).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): Cosmic-CLP=949154; RCB=RCB0753
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   OMC-1 [Human ovarian carcinoma]
AC   CVCL_9T73
DR   Cosmic; 2429302
DR   Wikidata; Q54932032
RX   DOI=10.15114/smj.55.153;
RX   PubMed=19154404;
RX   PubMed=22246397;
CC   Population: Japanese.
CC   Doubling time: 24 hours (DOI=10.15114/smj.55.153).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   OMC-2
AC   CVCL_3353
SY   OMC2; Osaka Medical College-2
DR   CLO; CLO_0050887
DR   BioSample; SAMN03471931
DR   Cosmic; 1152551
DR   FANTOM5_SSTAR; 10497-107C2
DR   GEO; GSM2599690
DR   GEO; GSM2599691
DR   RCB; RCB2830
DR   Wikidata; Q54932033
RX   PubMed=2624581;
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Doubling time: 55-139 hours (PubMed=2624581).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB2830
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 15
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   OMC-2 Prex2a shRNA type 1
AC   CVCL_A8Q6
SY   OMC-2, Prex2a shRNA type 1; OMC-2_Prex2a_shRNA1
DR   GEO; GSM2599695
DR   GEO; GSM2599696
DR   Wikidata; Q102114683
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:22950; PREX2.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3353 ! OMC-2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   OMC-2 Prex2a shRNA type 2
AC   CVCL_A8Q7
SY   OMC-2, Prex2a shRNA type 2; OMC-2_Prex2a_shRNA2
DR   GEO; GSM2599697
DR   GEO; GSM2599698
DR   Wikidata; Q102114684
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:22950; PREX2.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3353 ! OMC-2
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   OMC-3
AC   CVCL_3354
SY   OMC3; Osaka Medical College-3
DR   CLO; CLO_0051448
DR   BioSample; SAMN03472226
DR   Cosmic; 1152555
DR   RCB; RCB0755
DR   Wikidata; Q54932034
RX   DOI=10.1267/ahc.26.515;
RX   PubMed=2010102;
CC   Population: Japanese.
CC   Doubling time: 98 hours (Note=At 27th passage) (PubMed=2010102).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB0755
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   OMC-4
AC   CVCL_A108
SY   OMC4; Osaka Medical College-4
DR   cancercelllines; CVCL_A108
DR   Cosmic; 877474
DR   Cosmic; 1152547
DR   IARC_TP53; 4752
DR   Wikidata; Q54932035
RX   DOI=10.1267/ahc.26.515;
RX   PubMed=2531191;
RX   PubMed=3598280;
RX   PubMed=8380785;
CC   Population: Japanese.
CC   Doubling time: 63 hours (PubMed=3598280).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=8380785).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   OMC-5
AC   CVCL_9U42
SY   Osaka Medical College-5
DR   Wikidata; Q54932036
RX   DOI=10.11437/sanpunosinpo1949.40.17;
CC   Doubling time: 69 hours (DOI=10.11437/sanpunosinpo1949.40.17).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Breed/subspecies: ICR.
DI   NCIt; C24077; Mouse cervical squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   OMC-6
AC   CVCL_A109
SY   OMC6; Osaka Medical College-6
DR   Cosmic; 1152554
DR   Wikidata; Q54932037
RX   DOI=10.1267/ahc.26.515;
RX   PubMed=3225484;
CC   Population: Japanese.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
DI   NCIt; C8973; Endometrioid stromal sarcoma
DI   ORDO; Orphanet_213711; Endometrial stromal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   OMC-9
AC   CVCL_3355
SY   OMC9; Osaka Medical College-9
DR   CLO; CLO_0050888
DR   BioSample; SAMN03471932
DR   FANTOM5_SSTAR; 10448-106F7
DR   RCB; RCB2832
DR   Wikidata; Q54932038
RX   PubMed=18397474;
CC   Population: Japanese.
CC   Doubling time: 36.6 hours (Note=At 29th passage) (PubMed=18397474).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
ST   Source(s): RCB=RCB2832
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 19,20
DI   NCIt; C8973; Endometrioid stromal sarcoma
DI   ORDO; Orphanet_213711; Endometrial stromal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   OMC685
AC   CVCL_LI06
SY   Ovarian Mucinous Cystadenocarcinoma 685
DR   Wikidata; Q54932039
RX   PubMed=11718030;
RX   PubMed=26116706;
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from a 33 year old female patient with ovarian mucinous cystadenocarcinoma.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 25
ST   D13S317: 12,13.3
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   OME/CTVM21
AC   CVCL_Z172
DR   Wikidata; Q54932040
RX   PubMed=19252822;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6938; ! Ornithodoros moubata (Soft tick)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   OME/CTVM22
AC   CVCL_Z173
DR   Wikidata; Q54932041
RX   PubMed=19252822;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=29886187;
RX   PubMed=32778731;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6938; ! Ornithodoros moubata (Soft tick)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   OME/CTVM24
AC   CVCL_Z174
DR   Wikidata; Q54932042
RX   PubMed=19252822;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6938; ! Ornithodoros moubata (Soft tick)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   OME/CTVM25
AC   CVCL_Z175
DR   Wikidata; Q54932043
RX   PubMed=19252822;
RX   PubMed=22743047;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6938; ! Ornithodoros moubata (Soft tick)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   OME/CTVM26
AC   CVCL_Z176
DR   Wikidata; Q54932044
RX   PubMed=19252822;
RX   PubMed=22743047;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6938; ! Ornithodoros moubata (Soft tick)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   OME/CTVM27
AC   CVCL_Z177
DR   Wikidata; Q54932045
RX   PubMed=19252822;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=6938; ! Ornithodoros moubata (Soft tick)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   OME1
AC   CVCL_E6Z3
DR   ABM; T0415
RX   PubMed=32433794;
RX   PubMed=37899851;
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (ABM=T0415).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Donor information: Established from a patient with otitis media and mild 40 dB hearing loss (PubMed=37899851).
CC   Caution: The same name is used for the primary culture described in PubMed=32433794 and the immortalized cell line described in PubMed=37899851.
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C34885; Otitis media
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y8M
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OME2
AC   CVCL_E6Z4
DR   ABM; T0416
RX   PubMed=32433794;
RX   PubMed=37899851;
CC   Population: African American.
CC   Doubling time: 48-72 hours (ABM=T0415).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Donor information: Established from a patient with otitis media and mild unilateral 30-40 dB hearing loss (PubMed=37899851).
CC   Caution: The same name is used for the primary culture described in PubMed=32433794 and the immortalized cell line described in PubMed=37899851.
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C34885; Otitis media
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y10M
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OMEGA-E
AC   CVCL_2151
SY   Omega E
DR   CLO; CLO_0008264
DR   CLDB; cl3772
DR   CancerTools; 151463
DR   DSMZ; ACC-253
DR   DSMZCellDive; ACC-253
DR   Wikidata; Q54932046
DR   Ximbio; 151463
RX   PubMed=2194165;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-237.html
CC   Group: Retrovirus packaging cell line.
CC   Doubling time: ~20-30 hours (DSMZ=ACC-253).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   OMEGA-Z
AC   CVCL_DC35
DR   Wikidata; Q54932047
RX   PubMed=7153601;
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   OMG
AC   CVCL_A2SV
SY   Oncorhynchus Mykiss Gonad
DR   Wikidata; Q105510493
RX   DOI=10.1088/1755-1315/315/7/072006;
RX   Patent=RU2495120;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 75.
CC   Virology: Susceptible to infection by infectious pancreatic necrosis virus (IPNV), viral hemorrhagic septicemia virus (VHSV) and infectious haematopoetic necrosis virus (IHNV).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 8
//
ID   OmGFP10
AC   CVCL_WT71
DR   Wikidata; Q98128342
RX   PubMed=30882939;
RX   PubMed=31173397;
CC   Characteristics: Expresses GFP Topaz under the control of the Dmp1 promoter.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; SY6TH; Topaz (Note=Green/yellow fluorescent protein derived from GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteocyte; CL=CL_0000137.
CC   Breed/subspecies: C57BL/6-Tg(Dmp1-Topaz)1Ikal/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   OmGFP66
AC   CVCL_WT72
DR   Wikidata; Q98128343
RX   PubMed=30882939;
RX   PubMed=31173397;
CC   Characteristics: Model for osteocyte differentiation. Forms mineralized structures that closely mimick in vivo bone, with a highly organized bone-like appearance and clearly defined lacunae.
CC   Characteristics: Expresses GFP Topaz under the control of the Dmp1 promoter.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; SY6TH; Topaz (Note=Green/yellow fluorescent protein derived from GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteocyte; CL=CL_0000137.
CC   Breed/subspecies: C57BL/6-Tg(Dmp1-Topaz)1Ikal/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   OMJ
AC   CVCL_WH39
DR   Wikidata; Q98128344
RX   PubMed=24035468;
RX   PubMed=27292541;
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   OMK
AC   CVCL_WH40
DR   Wikidata; Q98128345
RX   PubMed=24035468;
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   OMK-210
AC   CVCL_L983
SY   OMK210; Owl Monkey Kidney-210
DR   Wikidata; Q54932048
RX   CelloPub=CLPUB00093;
RX   PubMed=76312;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9505; ! Aotus trivirgatus (Three-striped night monkey)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   OMK-637
AC   CVCL_4264
SY   OMK637; OMK (637-69); OMK(637-69); Owl Monkey Kidney-637
DR   CLO; CLO_0008265
DR   CLO; CLO_0008266
DR   CLDB; cl3773
DR   ATCC; CRL-1556
DR   ECACC; 90110510
DR   Wikidata; Q54932049
RX   PubMed=76312;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9505; ! Aotus trivirgatus (Three-striped night monkey)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   OmL
AC   CVCL_YB42
SY   Oreochromis mossambicus Lip
DR   Wikidata; Q98128346
RX   PubMed=24797371;
CC   Group: Fish cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Oral cavity, lip; UBERON=UBERON_0001833.
OX   NCBI_TaxID=8127; ! Oreochromis mossambicus (Mozambique tilapia)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   OML clone 13C
AC   CVCL_6427
SY   OML, clone 13C; Owl monkey 13C; Owl Monkey Lymphoblast clone 13C; 13C
DR   CLO; CLO_0008267
DR   ATCC; CRL-2312
DR   Wikidata; Q54932050
RX   PubMed=9081215;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9505; ! Aotus trivirgatus (Three-striped night monkey)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   OMM-1
AC   CVCL_6939
SY   OMM1; Omm1
DR   cancercelllines; CVCL_6939
DR   Cosmic; 848331
DR   Cosmic; 899895
DR   Cosmic; 916147
DR   Cosmic; 1628402
DR   Cosmic; 1669126
DR   Cosmic; 2036704
DR   DepMap; ACH-002017
DR   PRIDE; PXD051055
DR   Wikidata; Q54936368
RX   PubMed=8621261;
RX   PubMed=16772116;
RX   PubMed=22236444;
RX   PubMed=23849826;
RX   PubMed=24994677;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 34 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=22236444; PubMed=24994677).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): DepMap=ACH-002017; PubMed=22236444; PubMed=24994677
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12 (PubMed=22236444)
ST   D13S317: 12 (DepMap=ACH-002017; PubMed=24994677)
ST   D16S539: 9
ST   D18S51: 13,14
ST   D21S11: 30,30.2
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 13
ST   D8S1179: 10,16
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 5,7
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   OMM-2
AC   CVCL_6940
SY   OMM2
DR   Cosmic; 848332
DR   Cosmic; 899896
DR   Wikidata; Q54936369
RX   PubMed=8621261;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OMM-3
AC   CVCL_6941
SY   OMM3
DR   Cosmic; 848333
DR   Cosmic; 899897
DR   Wikidata; Q54936370
RX   PubMed=8621261;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OMM2.2
AC   CVCL_C305
SY   OMM2_2; OMM 2-2
DR   Cosmic; 899899
DR   Wikidata; Q54936371
RX   PubMed=9247253;
CC   From: Ksander, Bruce R.; Schepens Eye Research Institute; Boston; USA.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C302 ! Mel270
OI   CVCL_C306 ! OMM2.3
OI   CVCL_C307 ! OMM2.5
OI   CVCL_C308 ! OMM2.6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   OMM2.3
AC   CVCL_C306
SY   Omm2.3; OMM2_3; OMM-2.3; OMM 2-3; OMM1.3; Omm1_3; OMM1_3
DR   cancercelllines; CVCL_C306
DR   Cell_Model_Passport; SIDM01844
DR   Cosmic; 899900
DR   Cosmic; 916145
DR   Cosmic; 1628397
DR   Cosmic; 1669127
DR   Cosmic; 2036705
DR   PRIDE; PXD051055
DR   Wikidata; Q54936372
RX   PubMed=9247253;
RX   PubMed=16772116;
RX   PubMed=22236444;
RX   PubMed=28018010;
RX   PubMed=32430489;
RX   PubMed=39042403;
CC   From: Ksander, Bruce R.; Schepens Eye Research Institute; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Unspecified (PubMed=22236444).
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=22236444
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   FGA: 26
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C302 ! Mel270
OI   CVCL_C305 ! OMM2.2
OI   CVCL_C307 ! OMM2.5
OI   CVCL_C308 ! OMM2.6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   OMM2.5
AC   CVCL_C307
SY   Omm2.5; OMM2_5; OMM25; OMM1.5; Omm1_5
DR   cancercelllines; CVCL_C307
DR   Cell_Model_Passport; SIDM01843
DR   Cosmic; 916146
DR   Cosmic; 1628398
DR   DepMap; ACH-002018
DR   PRIDE; PXD051055
DR   Wikidata; Q54936373
RX   PubMed=9247253;
RX   PubMed=22236444;
RX   PubMed=23849826;
RX   PubMed=24994677;
RX   PubMed=28018010;
RX   PubMed=39042403;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ksander, Bruce R.; Schepens Eye Research Institute; Boston; USA.
CC   Doubling time: 50 hours (PubMed=24994677).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Unspecified (PubMed=22236444).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-002018; PubMed=22236444; PubMed=24994677
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 19
ST   D21S11: 28,29
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 8,13
ST   FGA: 26 (PubMed=22236444)
ST   FGA: 26,27 (DepMap=ACH-002018)
ST   Penta D: 15,16
ST   Penta E: 8,10
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C302 ! Mel270
OI   CVCL_C305 ! OMM2.2
OI   CVCL_C306 ! OMM2.3
OI   CVCL_C308 ! OMM2.6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 22
//
ID   OMM2.6
AC   CVCL_C308
SY   OMM2_6; OMM 2-6
DR   Cosmic; 899901
DR   Wikidata; Q54936374
RX   PubMed=9247253;
CC   From: Ksander, Bruce R.; Schepens Eye Research Institute; Boston; USA.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C302 ! Mel270
OI   CVCL_C305 ! OMM2.2
OI   CVCL_C306 ! OMM2.3
OI   CVCL_C307 ! OMM2.5
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   OMMT-ARK-1
AC   CVCL_IW23
DR   Wikidata; Q54936375
RX   PubMed=22498937;
CC   Population: African American.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   OMMT-ARK-2
AC   CVCL_IW24
DR   Wikidata; Q54936376
RX   PubMed=22498937;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   OMR5
AC   CVCL_U138
DR   CLO; CLO_0050331
DR   RCB; RCB2049
DR   Wikidata; Q54936377
RX   PubMed=9185613;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: F1-linked neutral oligosaccharides of glycoproteins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OMR6
AC   CVCL_U139
DR   CLO; CLO_0050332
DR   RCB; RCB2050
DR   Wikidata; Q54936378
RX   PubMed=9185613;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: M1-linked neutral oligosaccharides of glycoproteins.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OMS
AC   CVCL_WH41
DR   Wikidata; Q98128347
RX   PubMed=24035468;
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   OMT-1
AC   CVCL_0G03
SY   OMT
DR   CGH-DB; 9027-4
DR   IARC_TP53; 27002
DR   Wikidata; Q54936379
RX   PubMed=9596675;
RX   PubMed=10570904;
RX   PubMed=19220422;
RX   PubMed=19710698;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent. But can survive without IL2 for several weeks (PubMed=9596675).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   OMUL-1
AC   CVCL_E7BI
SY   Osaka Metropolitan University Lung-1
RX   PubMed=39552203;
CC   Population: Japanese.
CC   Characteristics: Tumorigenic (PubMed=39552203).
CC   Doubling time: 20 hours (PubMed=39552203).
CC   Omics: Phenotyping; Drug screening.
CC   Donor information: Established from a patient with a smoking history of two packs per day for 46 years (PubMed=39552203).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=39552203
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 12,13
ST   D21S11: 29,33.2
ST   D3S1358: 17
ST   D5S818: 9
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 22
ST   Penta D: 10,11
ST   Penta E: 10,18
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   OMW
AC   CVCL_E798
DR   dbMHC; 48993
DR   ECACC; 98092903
DR   IHW; IHW09058
DR   IPD-IMGT/HLA; 11215
DR   Wikidata; Q54936380
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: African.
CC   HLA typing: A*02:01:01:01; B*45:01:01; C*16:01:01:01; DPA1*02:01:08; DPB1*01:01:01; DQA1*01:03; DQB1*06:03:01; DRA*01:02; DRB1*13:01:01; DRB3*01:01 (IPD-IMGT/HLA=11215).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   OMYleb
AC   CVCL_A8UP
DR   Wikidata; Q108821074
RX   DOI=10.3390/app11062534;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   OMYsd
AC   CVCL_A8UQ
SY   OMYsd 1x; OMYsd1x
DR   Wikidata; Q108821075
RX   DOI=10.3390/app11062534;
RX   PubMed=22000680;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   On Ser
AC   CVCL_U693
SY   OnSer
DR   ATCC; CRL-1112
DR   TKG; TKG 0188
DR   Wikidata; Q54936381
RX   PubMed=559490;
RX   PubMed=6988327;
CC   Discontinued: ATCC; CRL-1112; true.
CC   Discontinued: TKG; TKG 0188; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   Onc-M10
AC   CVCL_0U30
DR   Wikidata; Q54936382
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9244.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M11
AC   CVCL_0U31
DR   Wikidata; Q54936383
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9245.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M12
AC   CVCL_0U32
DR   Wikidata; Q54936384
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9246.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M15
AC   CVCL_0U33
DR   Wikidata; Q54936385
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9247.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M16
AC   CVCL_0U34
DR   Wikidata; Q54936386
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9216.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M21
AC   CVCL_0U35
SY   ONC M21
DR   ATCC; HB-9248
DR   Wikidata; Q54936387
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9248.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M22
AC   CVCL_0U36
DR   Wikidata; Q54936388
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9249.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M23
AC   CVCL_0U37
DR   Wikidata; Q54936389
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9250.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M25
AC   CVCL_0U38
DR   Wikidata; Q54936390
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9217.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M26
AC   CVCL_0U39
DR   Wikidata; Q54936391
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9212.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M27
AC   CVCL_0U40
DR   Wikidata; Q54936393
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9229.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M29
AC   CVCL_0U41
DR   Wikidata; Q54936394
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9210.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M29.41
AC   CVCL_0U42
SY   ONC M29.41
DR   ATCC; HB-9243
DR   Wikidata; Q54936395
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9243.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0U41 ! Onc-M29
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M30
AC   CVCL_0U43
DR   Wikidata; Q54936396
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9211.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M38
AC   CVCL_0U44
SY   ONC M38
DR   ATCC; HB-9365
DR   Wikidata; Q54936397
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9365.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   Onc-M8
AC   CVCL_0U45
DR   Wikidata; Q54936398
RX   Patent=US5849876;
RX   Patent=US6004761;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9209.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   ONCO-DG-1
AC   CVCL_1882
SY   ONCO-DG 1; ONCO-DG1; ONCODG1
DR   BTO; BTO_0004847
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03151879
DR   BioSample; SAMN10988512
DR   cancercelllines; CVCL_1882
DR   Cell_Model_Passport; SIDM00093
DR   DepMap; ACH-000013
DR   DSMZ; ACC-507
DR   DSMZCellDive; ACC-507
DR   IARC_TP53; 27010
DR   LiGeA; CCLE_540
DR   PharmacoDB; ONCODG1_1200_2019
DR   Progenetix; CVCL_1882
DR   Wikidata; Q54936399
RX   PubMed=1381131;
RX   PubMed=14522906;
RX   PubMed=20143388;
RX   PubMed=23839242;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OVCAR-3 derivative (PubMed=20143388). Originally thought to originate from a 49 year old female patient with a thyroid gland papillary carcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00338.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (DSMZ=ACC-507).
CC   HLA typing: A*02:01,29:02; B*07:02,58:01; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (DepMap=ACH-000013).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=14522906; DepMap=ACH-000013).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=4.26%; East Asian, South=0%; South Asian=0%; European, North=61.21%; European, South=34.52% (PubMed=30894373).
CC   Discontinued: DSMZ; ACC-507; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-507
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14,17
ST   D21S11: 29,31.2
ST   D2S1338: 17,21
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 8,15
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   Onda 10
AC   CVCL_3075
SY   Onda-10; no.10; no-10; NO10; Case 6
DR   CLO; CLO_0009898
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 968
DR   BioSample; SAMN03472789
DR   cancercelllines; CVCL_3075
DR   Cell_Model_Passport; SIDM00574
DR   CGH-DB; 151-1
DR   ChEMBL-Cells; CHEMBL3308838
DR   ChEMBL-Targets; CHEMBL2366071
DR   Cosmic; 687579
DR   Cosmic; 908452
DR   Cosmic; 2367541
DR   Cosmic-CLP; 908452
DR   DepMap; ACH-001605
DR   EGA; EGAS00001000978
DR   GDSC; 908452
DR   GEO; GSM1670281
DR   IARC_TP53; 21593
DR   IARC_TP53; 23809
DR   JCRB; IFO50368
DR   JCRB; JCRB1606
DR   LINCS_LDP; LCL-1386
DR   PharmacoDB; no10_1163_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_3075
DR   RCB; RCB4499
DR   Wikidata; Q54936400
RX   CelloPub=CLPUB00089;
RX   PubMed=3188836;
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=16232199;
RX   PubMed=18415661;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8878451).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.63%; Native American=0.27%; East Asian, North=79.08%; East Asian, South=19.61%; South Asian=0%; European, North=0.4%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
ST   Source(s): Cosmic-CLP=908452; DepMap=ACH-001605; JCRB=IFO50368; JCRB=JCRB1606
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15,17
ST   D21S11: 29,32.2
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 23
ST   Penta D: 10,14
ST   Penta E: 16
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   Onda 11
AC   CVCL_3076
SY   Onda-11; no.11; no-11; NO11; Case 3
DR   CLO; CLO_0009899
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 969
DR   BioSample; SAMN03481112
DR   cancercelllines; CVCL_3076
DR   Cell_Model_Passport; SIDM00573
DR   CGH-DB; 152-1
DR   ChEMBL-Cells; CHEMBL3308224
DR   ChEMBL-Targets; CHEMBL2366326
DR   Cosmic; 687580
DR   Cosmic; 908450
DR   Cosmic; 2367542
DR   Cosmic-CLP; 908450
DR   DepMap; ACH-001606
DR   EGA; EGAS00001000978
DR   GDSC; 908450
DR   GEO; GSM1670282
DR   IARC_TP53; 21592
DR   IARC_TP53; 23806
DR   JCRB; IFO50369
DR   JCRB; JCRB1605
DR   LINCS_LDP; LCL-1387
DR   PharmacoDB; no11_1164_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_3076
DR   RCB; RCB4500
DR   Wikidata; Q54936401
RX   CelloPub=CLPUB00089;
RX   PubMed=3188836;
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=16232199;
RX   PubMed=18415661;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln17del (c.49_51delCAA); Zygosity=Unspecified (PubMed=10551321).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=8878451).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.72%; Native American=1.06%; East Asian, North=76.42%; East Asian, South=17.02%; South Asian=0%; European, North=1.56%; European, South=2.21% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): Cosmic-CLP=908450; DepMap=ACH-001606; JCRB=IFO50369; JCRB=JCRB1605
ST   Amelogenin: X
ST   CSF1PO: 9,10,12 (JCRB=JCRB1605)
ST   CSF1PO: 10,12 (Cosmic-CLP=908450; DepMap=ACH-001606; JCRB=IFO50369)
ST   D13S317: 8 (Cosmic-CLP=908450; DepMap=ACH-001606; JCRB=IFO50369)
ST   D13S317: 8,9 (JCRB=JCRB1605)
ST   D16S539: 11
ST   D18S51: 13,15
ST   D21S11: 30,31
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 11 (Cosmic-CLP=908450)
ST   D7S820: 11,12 (DepMap=ACH-001606; JCRB=IFO50369)
ST   D7S820: 11,12,13 (JCRB=JCRB1605)
ST   D8S1179: 10
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 13
ST   TH01: 6,8 (JCRB=JCRB1605)
ST   TH01: 8 (Cosmic-CLP=908450; DepMap=ACH-001606; JCRB=IFO50369)
ST   TPOX: 8 (Cosmic-CLP=908450; DepMap=ACH-001606; JCRB=IFO50369)
ST   TPOX: 8,11 (JCRB=JCRB1605)
ST   vWA: 14,15,17 (JCRB=JCRB1605)
ST   vWA: 14,17 (Cosmic-CLP=908450; DepMap=ACH-001606; JCRB=IFO50369)
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   Onda 7
AC   CVCL_4W67
SY   Onda-7; ONDA7; Case 9
DR   cancercelllines; CVCL_4W67
DR   Cell_Model_Passport; SIDM01846
DR   DepMap; ACH-001622
DR   JCRB; JCRB1575
DR   Wikidata; Q54936403
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=18415661;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp252Gly (c.755A>G); ClinVar=VCV000007849; Zygosity=Unspecified (PubMed=10551321).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): DepMap=ACH-001622; JCRB=JCRB1575
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D18S51: 15
ST   D21S11: 31,32.2
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   Onda 8
AC   CVCL_4W68
SY   Onda-8; ONDA8; Case 8
DR   cancercelllines; CVCL_4W68
DR   Cell_Model_Passport; SIDM01970
DR   DepMap; ACH-001623
DR   JCRB; JCRB1578
DR   Wikidata; Q54936404
RX   PubMed=8878451;
RX   PubMed=10551321;
RX   PubMed=18415661;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): DepMap=ACH-001623; JCRB=JCRB1578
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 31
ST   D3S1358: 18
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 17
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 5
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 12
//
ID   Onda 9
AC   CVCL_1R14
SY   Onda-9; ONDA9; No. 9; no.9; Case 10
DR   cancercelllines; CVCL_1R14
DR   Cell_Model_Passport; SIDM01875
DR   DepMap; ACH-001624
DR   JCRB; JCRB1576
DR   Wikidata; Q54936405
RX   PubMed=3188836;
RX   PubMed=8878451;
RX   PubMed=10359144;
RX   PubMed=10551321;
RX   PubMed=18415661;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 60 hours (Note=At passages 56 and 59) (PubMed=10359144).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile101del (c.301_303delATC); Zygosity=Unspecified (PubMed=10551321; DepMap=ACH-001624).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): DepMap=ACH-001624; JCRB=JCRB1576
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D21S11: 32.2
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 20,21,22
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4W69 ! Onda 9R
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 18
//
ID   Onda 9R
AC   CVCL_4W69
SY   Onda-9R; No. 9R
DR   Cell_Model_Passport; SIDM01874
DR   JCRB; JCRB1583
DR   Wikidata; Q54936406
RX   PubMed=10359144;
CC   Population: Japanese.
CC   Doubling time: 40 hours (Note=At passages 53 and 57) (PubMed=10359144).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile101del (c.301_303delATC); Zygosity=Unspecified (from autologous cell line Onda 9).
CC   Donor information: Established from a recurrent tumor (PubMed=10359144).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=JCRB1583
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 9,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1R14 ! Onda 9
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   Onda 9R-B12
AC   CVCL_4W70
SY   Onda-9R-B12
DR   Cell_Model_Passport; SIDM01922
DR   JCRB; JCRB1607
DR   Wikidata; Q54936407
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile101del (c.301_303delATC); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=JCRB1607
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 9,12
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4W69 ! Onda 9R
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   ONE58
AC   CVCL_2671
DR   BioSample; SAMN07624412
DR   BioSamples; SAMEA100744
DR   cancercelllines; CVCL_2671
DR   CBA; CBA-0143
DR   Cosmic; 1522773
DR   Cosmic; 1963332
DR   DepMap; ACH-001992
DR   ECACC; 10092313
DR   FANTOM5_SSTAR; 10858-111G3
DR   GEO; GSM726282
DR   Progenetix; CVCL_2671
DR   Wikidata; Q54936408
RX   PubMed=1703129;
RX   PubMed=21642991;
RX   PubMed=25902174;
RX   PubMed=28387650;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Gln1993Ter (c.5797C>T); Zygosity=Heterozygous (DepMap=ACH-001992).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Homozygous (DepMap=ACH-001992).
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CBA=CBA-0143
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 11,12
ST   D19S433: 12
ST   D21S11: 30,31.2
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 7,11
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   Onesmas
AC   CVCL_IU26
DR   Wikidata; Q54936409
RX   PubMed=4122458;
RX   PubMed=4142009;
RX   PubMed=4347031;
RX   PubMed=4364259;
RX   PubMed=4932228;
CC   Population: African; Kenyan.
CC   Karyotypic information: Has lost chromosome Y (PubMed=4142009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   OnH
AC   CVCL_A2GT
SY   Oreochromis niloticus Heart
DR   NRFC; NRFC071
DR   Wikidata; Q105510498
RX   PubMed=33035566;
WW   Provider; NRFC; NRFC071; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC071.
CC   Characteristics: Grows optimally in the temperature from 24 to 32 Celsius.
CC   Virology: Susceptible to infection by Tilapia lake virus (TiLV).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   ONH-UCCiPS1#1
AC   CVCL_VG54
SY   UCCiPS1-#1
DR   SKIP; SKIP001342
DR   Wikidata; Q54936415
RX   PubMed=27431206;
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Stromal cell; CL=CL_0000499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   ONHi001-A
AC   CVCL_D0KC
DR   hPSCreg; ONHi001-A
DR   Wikidata; Q123033215
RX   PubMed=37209469;
CC   From: Osaka National Hospital; Osaka; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Gln173Ter (c.517C>T); ClinVar=VCV000159773; Zygosity=Heterozygous (PubMed=37209469).
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Lys545Arg (c.1634A>G); ClinVar=VCV000159741; Zygosity=Heterozygous (PubMed=37209469).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202073; Neurodegeneration with brain iron accumulation 2A
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ONHL-1
AC   CVCL_QY36
DR   Wikidata; Q54936416
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2249898;
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=2249898).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   OnlB
AC   CVCL_VG73
SY   Oreochromis niloticus Brain
DR   Wikidata; Q54936417
RX   DOI=10.1016/j.aquaculture.2018.04.012;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Tilapia lake virus (TiLV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   OnlL
AC   CVCL_VG74
SY   Oreochromis niloticus Liver
DR   NRFC; NRFC052
DR   Wikidata; Q54936418
RX   DOI=10.1016/j.aquaculture.2018.04.012;
WW   Provider; NRFC; NRFC052; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC052.
CC   Virology: Susceptible to infection by Tilapia lake virus (TiLV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 10
//
ID   ONP
AC   CVCL_YB62
SY   Oreochromis Niloticus Peduncle
DR   Wikidata; Q98128348
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   ONS-12
AC   CVCL_S732
SY   ONS 12; ONS12; Osaka Neurological Surgery-12
DR   Wikidata; Q54936419
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2504489;
RX   PubMed=3496051;
RX   PubMed=3740860;
RX   PubMed=9310141;
RX   PubMed=20587068;
CC   Population: Japanese.
CC   Doubling time: 41.5 hours (PubMed=3740860).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   ONS-12/ACNU
AC   CVCL_QY37
SY   ONS 12/ACNU
DR   Wikidata; Q54936420
RX   PubMed=3496051;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_75270; Nimustine (ACNU).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S732 ! ONS-12
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   ONS-16
AC   CVCL_JZ70
SY   Osaka Neurological Surgery-16
DR   Wikidata; Q54936421
RX   PubMed=3740860;
CC   Population: Japanese.
CC   Doubling time: 60.9 hours (PubMed=3740860).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   ONS-20
AC   CVCL_A5XN
SY   Osaka Neurological Surgery-20
DR   Wikidata; Q107116610
RX   PubMed=1992917;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ONS-21
AC   CVCL_5G58
SY   Osaka Neurological Surgery-21
DR   Wikidata; Q54936422
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1992917;
RX   PubMed=2395860;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   ONS-21-C2
AC   CVCL_5G59
DR   Wikidata; Q54936423
RX   DOI=10.1007/978-4-431-68150-2_27;
RX   PubMed=2395860;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G58 ! ONS-21
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   ONS-6
AC   CVCL_JZ67
SY   Osaka Neurological Surgery-6
DR   Wikidata; Q54936424
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1992917;
RX   PubMed=2504489;
RX   PubMed=3740860;
CC   Population: Japanese.
CC   Doubling time: 30.5 hours (PubMed=3740860).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   ONS-75
AC   CVCL_S733
SY   Osaka Neurological Surgery-75
DR   Wikidata; Q54936425
RX   PubMed=9310141;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   ONS-76
AC   CVCL_1624
SY   ONS76; Osaka Neurological Surgery-76
DR   CLO; CLO_0009900
DR   EFO; EFO_0022571
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0294
DR   BioGRID_ORCS_Cell_line; 513
DR   BioSample; SAMN03470886
DR   BioSample; SAMN10988186
DR   cancercelllines; CVCL_1624
DR   Cell_Model_Passport; SIDM00567
DR   ChEMBL-Cells; CHEMBL3308540
DR   ChEMBL-Targets; CHEMBL2366068
DR   Cosmic; 909248
DR   Cosmic; 1995603
DR   Cosmic-CLP; 909248
DR   DepMap; ACH-000776
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10759-110E3
DR   GDSC; 909248
DR   GEO; GSM887477
DR   GEO; GSM888558
DR   GEO; GSM919364
DR   GEO; GSM1670306
DR   IARC_TP53; 21602
DR   JCRB; IFO50355
DR   LiGeA; CCLE_428
DR   LINCS_LDP; LCL-1578
DR   PharmacoDB; ONS76_1201_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1624
DR   PubChem_Cell_line; CVCL_1624
DR   Wikidata; Q54936426
RX   CelloPub=CLPUB00094;
RX   DOI=10.1007/978-4-431-68150-2_63;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1992917;
RX   PubMed=2504489;
RX   PubMed=2818910;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22951319;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27498314;
RX   PubMed=27812533;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31346954;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 18.6 hours (CelloPub=CLPUB00094; PubMed=2504489; PubMed=2818910); 22 +- 0.3 hours (PubMed=31346954); ~24 hours (Note=Lot 08192008), ~32 hours (Note=Lot 12042014) (JCRB=IFO50355).
CC   HLA typing: A*24:02,26:03; B*54:01,54:01; C*01:02,03:03; DRB1*07:01,09:07 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (Cosmic-CLP=909248; DepMap=ACH-000776).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=909248; DepMap=ACH-000776).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.13%; Native American=0%; East Asian, North=83.83%; East Asian, South=8.46%; South Asian=0%; European, North=0%; European, South=4.58% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=909248; JCRB=IFO50355; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 29,30.3
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 24
ST   Penta D: 12,13
ST   Penta E: 15,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C129443; Medulloblastoma, SHH-activated, TP53-wildtype
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   ONS-81
AC   CVCL_M702
SY   Osaka Neurological Surgery-81
DR   Wikidata; Q54936427
RX   CelloPub=CLPUB00094;
RX   DOI=10.1007/978-4-431-68150-2_63;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1992917;
RX   PubMed=2504489;
RX   PubMed=2818910;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Population: Japanese.
CC   Doubling time: 19.2 hours (CelloPub=CLPUB00094; PubMed=2504489; PubMed=2818910).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   ONS-82
AC   CVCL_A6FF
SY   Osaka Neurological Surgery-82
DR   Wikidata; Q107116611
RX   PubMed=1992917;
CC   Population: Japanese.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   ONS-84
AC   CVCL_A6FD
SY   Osaka Neurological Surgery-84
DR   Wikidata; Q107116612
RX   PubMed=1992917;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ONS-86
AC   CVCL_A6FE
SY   Osaka Neurological Surgery-86
DR   Wikidata; Q107116613
RX   PubMed=1992917;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ONS-99
AC   CVCL_A5XJ
SY   Osaka Neurological Surgery-99
DR   Wikidata; Q107116614
RX   PubMed=8687128;
CC   Population: Japanese.
DI   NCIt; C3717; Melanotic neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   ONS-B11
AC   CVCL_S734
DR   cancercelllines; CVCL_S734
DR   Wikidata; Q54936428
RX   PubMed=22951319;
CC   Population: Japanese.
CC   Selected for resistance to: NCIt; C129643; Cesium-137 gamma radiation.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129443; Medulloblastoma, SHH-activated, TP53-wildtype
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1624 ! ONS-76
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   ONS-F11
AC   CVCL_S735
DR   cancercelllines; CVCL_S735
DR   Wikidata; Q54936429
RX   PubMed=22951319;
CC   Population: Japanese.
CC   Selected for resistance to: NCIt; C129643; Cesium-137 gamma radiation.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129443; Medulloblastoma, SHH-activated, TP53-wildtype
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1624 ! ONS-76
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   ONS-F8
AC   CVCL_S736
DR   cancercelllines; CVCL_S736
DR   Wikidata; Q54936430
RX   PubMed=22951319;
CC   Population: Japanese.
CC   Selected for resistance to: NCIt; C129643; Cesium-137 gamma radiation.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129443; Medulloblastoma, SHH-activated, TP53-wildtype
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1624 ! ONS-76
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   ONS-M21
AC   CVCL_JZ66
DR   Wikidata; Q54936431
RX   PubMed=8217597;
RX   PubMed=9888477;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26006; Human ITGA3/CD49c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   ONSA-8
AC   CVCL_M601
SY   ONSA 8; ONcology SArcoma, line 8
DR   Wikidata; Q54936432
RX   PubMed=4471180;
CC   Population: Mexican.
CC   Doubling time: ~13 hours (PubMed=4471180).
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   OnyCap-1
AC   CVCL_IQ33
SY   Onycap-1; ONYCAP-1; ONYCAP1
DR   Wikidata; Q54936433
RX   Patent=US7303911;
CC   Group: Patented cell line.
CC   From: Onyvax, Ltd; London; United Kingdom.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032802.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4889 ! PNT2-C2
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   OnyCap-23
AC   CVCL_IQ34
SY   Onycap-23; ONYCAP-23; Onycap23; ONYCAP23; Ony-Cap 23
DR   Wikidata; Q54936434
RX   Patent=US7303911;
CC   Group: Patented cell line.
CC   From: Onyvax, Ltd; London; United Kingdom.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032801.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4889 ! PNT2-C2
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   OOS [Dog osteosarcoma]
AC   CVCL_L369
DR   Wikidata; Q54936435
RX   PubMed=9673952;
RX   PubMed=28283079;
CC   Doubling time: 45.0 +- 0.5 hours (PubMed=9673952).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 15
//
ID   OOS [Human B-cell IHW]
AC   CVCL_1M75
SY   GM06827; GM06827A
DR   CLO; CLO_0036521
DR   Coriell; GM06827
DR   Wikidata; Q54936436
RX   CelloPub=CLPUB00447;
RX   PubMed=6417008;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26; B*w56; C*w01 (Coriell=GM06827).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 12
//
ID   OP-1
AC   CVCL_DG77
SY   OP1
DR   Cosmic; 1524811
DR   GEO; GSM236800
DR   GEO; GSM236836
DR   Wikidata; Q54936437
RX   PubMed=8142640;
RX   PubMed=9446662;
DI   NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 6
//
ID   OP-9S
AC   CVCL_HC57
DR   Wikidata; Q54936438
RX   Patent=US9121008;
RX   PubMed=15650053;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10785.
CC   Characteristics: Slow-growing derivative of OP9.
CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC   Doubling time: 58-72 hours (PubMed=15650053).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4398 ! OP9
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 9
//
ID   OP-9S/LMJSN
AC   CVCL_HC58
DR   Wikidata; Q54936440
RX   Patent=US9121008;
RX   PubMed=15650053;
CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC   Doubling time: 58-72 hours (PubMed=15650053).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1098270; Jag2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HC57 ! OP-9S
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   OP27
AC   CVCL_WI58
SY   OP-27; Olfactory Placode 27
DR   BTO; BTO_0006226
DR   Wikidata; Q98128349
RX   CelloPub=CLPUB00748;
RX   PubMed=10630978;
RX   PubMed=12093156;
CC   Characteristics: At the permissive temperature (33 Celsius) expresses a transcriptional profile representing intermediate-late developmental stages in the olfactory receptor neuron (ORN) lineage. At the non-permissive temperature (39 Celsius) can be induced by all-trans retinoic acid to differentiate into a population of mature bipolar olfactory receptor neuron-like cells (CelloPub=CLPUB00748; PubMed=12093156).
CC   Doubling time: 52 hours (Note=At 33 Celsius) (CelloPub=CLPUB00748; PubMed=12093156).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Caution: PubMed=10630978 incorrectly describes this cell line as originating from a mouse neuroblastoma.
CC   Derived from site: In situ; Olfactory placode; UBERON=UBERON_0003050.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Conditionally immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   OP42
AC   CVCL_D676
DR   BCRJ; 0193
DR   Wikidata; Q54936441
RX   PubMed=7561035;
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   OP47
AC   CVCL_A5GF
SY   OP-47; Olfactory Placode 47
DR   Wikidata; Q123033216
RX   CelloPub=CLPUB00748;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). At the restrictive temperature (39 Celsius) ceases to proliferate and differentiates (CelloPub=CLPUB00748).
CC   Doubling time: 31 hours (Note=At 33 Celsius) (CelloPub=CLPUB00748).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Olfactory placode; UBERON=UBERON_0003050.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Conditionally immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   OP55
AC   CVCL_A5GG
SY   OP-55; Olfactory Placode 55
DR   Wikidata; Q123033217
RX   CelloPub=CLPUB00748;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). At the restrictive temperature (39 Celsius) ceases to proliferate and differentiates (CelloPub=CLPUB00748).
CC   Doubling time: 60 hours (Note=At 33 Celsius) (CelloPub=CLPUB00748).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Olfactory placode; UBERON=UBERON_0003050.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Conditionally immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   OP6
AC   CVCL_WI57
SY   OP-6; Olfactory Placode 6
DR   BTO; BTO_0006224
DR   Lonza; 1499
DR   Wikidata; Q98128350
RX   CelloPub=CLPUB00748;
RX   PubMed=10630978;
RX   PubMed=12093156;
CC   Characteristics: At the permissive temperature of 33 Celsius express a transcriptional profile representing intermediate-late developmental stages in the olfactory receptor neuron (ORN) lineage. At the non-permissive temperature of 39 Celsius can be induced by all-trans retinoic acid to differentiate into a population of mature bipolar olfactory receptor neuron-like cells (CelloPub=CLPUB00748; PubMed=12093156).
CC   Doubling time: 99 hours (Note=At 33 Celsius) (CelloPub=CLPUB00748; PubMed=12093156).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Caution: PubMed=10630978 incorrectly describes this cell line as originating from a mouse neuroblastoma.
CC   Derived from site: In situ; Olfactory placode; UBERON=UBERON_0003050.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Conditionally immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   OP9
AC   CVCL_4398
SY   OP-9
DR   BTO; BTO_0003295
DR   CLO; CLO_0008268
DR   ATCC; CRL-2749
DR   BCRC; 60566
DR   BCRJ; 0309
DR   CCRID; 1101MOU-PUMC000479
DR   CCRID; 3101MOUGNM17
DR   CCRID; 3101MOUSCSP227
DR   CLS; 305174
DR   GEO; GSM562062
DR   RCB; RCB1124
DR   Wikidata; Q50871278
RX   PubMed=8066449;
RX   PubMed=8990620;
RX   PubMed=20659712;
RX   PubMed=20810995;
RX   PubMed=23469264;
RX   PubMed=28176856;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=op9
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/OP9_cell
CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC   Characteristics: Used as feeder cells for the differentiation of ES cells and iPS cells into hematopoietic cells.
CC   Doubling time: ~26 hours (ATCC=CRL-2749).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   OP9-K
AC   CVCL_KB57
SY   OP9 clone K
DR   Wikidata; Q54936442
RX   PubMed=25409310;
CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC   Characteristics: Differentiates rapidly, robustly and reproducibly.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4398 ! OP9
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   OP9/G
AC   CVCL_B217
SY   OP9-GFP
DR   CLO; CLO_0050190
DR   GEO; GSM562063
DR   RCB; RCB2121
DR   RCB; RCB2924
DR   Wikidata; Q54936443
RX   PubMed=20810995;
CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: RCB; RCB2121; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4398 ! OP9
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   OP9/G-DLL1
AC   CVCL_B218
SY   OP9-DL1
DR   CLO; CLO_0050191
DR   GEO; GSM562064
DR   Millipore; SCC136
DR   RCB; RCB2122
DR   RCB; RCB2925
DR   Wikidata; Q54936444
RX   PubMed=20810995;
CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC   Characteristics: Transduced with a retroviral construct Dll1-IRES-eGFP thereby allowing bicistronic expression of Dll1 and eGFP (Millipore=SCC136).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104659; Dll1.
CC   Discontinued: RCB; RCB2122; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4398 ! OP9
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   OP9/N
AC   CVCL_B219
DR   CLO; CLO_0050189
DR   RCB; RCB2123
DR   RCB; RCB2926
DR   Wikidata; Q54936445
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7809; NGFR.
CC   Discontinued: RCB; RCB2123; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4398 ! OP9
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   OP9/N-DLL1
AC   CVCL_B220
DR   CLO; CLO_0050188
DR   RCB; RCB2124
DR   RCB; RCB2927
DR   Wikidata; Q54936446
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7809; NGFR.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104659; Dll1.
CC   Discontinued: RCB; RCB2124; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B219 ! OP9/N
SX   Sex unspecified
AG   Embryo
CA   Stromal cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   OPA1-null MEFs
AC   CVCL_L694
DR   ATCC; CRL-2995
DR   Wikidata; Q54936447
CC   Knockout cell: Method=KO mouse; MGI; MGI:1921393; Opa1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   Opasa
AC   CVCL_ZU77
SY   NK14; NK-14; NK 14
DR   Wikidata; Q98128351
RX   PubMed=4178827;
RX   PubMed=4878906;
RX   PubMed=5021706;
RX   PubMed=11515428;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 6
//
ID   OpC-109
AC   CVCL_T723
DR   Wikidata; Q54936448
RX   PubMed=4795513;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8597; ! Heterodon platirhinos (Eastern hognose snake)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   OpC-115
AC   CVCL_T722
DR   Wikidata; Q54936449
RX   PubMed=4795513;
CC   Group: Reptilian cell line.
CC   Doubling time: 3-4 days (PubMed=4795513).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=35024; ! Crotalus horridus (Timber rattlesnake)
OI   CVCL_T718 ! OpC-89
OI   CVCL_T719 ! OpC-90
OI   CVCL_T720 ! OpC-91
OI   CVCL_T721 ! OpC-94
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   OpC-80
AC   CVCL_T717
DR   Wikidata; Q54936450
RX   PubMed=4795513;
CC   Group: Reptilian cell line.
CC   Doubling time: 6-7 days (PubMed=4795513).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=165023; ! Lampropeltis getula nigrita (Western black kingsnake)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   OpC-89
AC   CVCL_T718
SY   C-89
DR   Wikidata; Q54936452
RX   PubMed=4347028;
RX   PubMed=4795513;
CC   Group: Reptilian cell line.
CC   Doubling time: 7-8 days (PubMed=4795513).
DI   NCIt; C134999; Rattlesnake fibroma
OX   NCBI_TaxID=35024; ! Crotalus horridus (Timber rattlesnake)
OI   CVCL_T719 ! OpC-90
OI   CVCL_T720 ! OpC-91
OI   CVCL_T721 ! OpC-94
OI   CVCL_T722 ! OpC-115
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   OpC-90
AC   CVCL_T719
DR   Wikidata; Q54936453
RX   PubMed=4795513;
CC   Group: Reptilian cell line.
CC   Doubling time: 5-6 days (PubMed=4795513).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=35024; ! Crotalus horridus (Timber rattlesnake)
OI   CVCL_T718 ! OpC-89
OI   CVCL_T720 ! OpC-91
OI   CVCL_T721 ! OpC-94
OI   CVCL_T722 ! OpC-115
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   OpC-91
AC   CVCL_T720
DR   Wikidata; Q54936454
RX   PubMed=4795513;
CC   Group: Reptilian cell line.
CC   Doubling time: 4-5 days (PubMed=4795513).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=35024; ! Crotalus horridus (Timber rattlesnake)
OI   CVCL_T718 ! OpC-89
OI   CVCL_T719 ! OpC-90
OI   CVCL_T721 ! OpC-94
OI   CVCL_T722 ! OpC-115
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   OpC-94
AC   CVCL_T721
DR   Wikidata; Q54936455
RX   PubMed=4795513;
CC   Group: Reptilian cell line.
CC   Doubling time: 3-4 days (PubMed=4795513).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=35024; ! Crotalus horridus (Timber rattlesnake)
OI   CVCL_T718 ! OpC-89
OI   CVCL_T719 ! OpC-90
OI   CVCL_T720 ! OpC-91
OI   CVCL_T722 ! OpC-115
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   OPC1
AC   CVCL_HP89
SY   Osteoblastic Precursor Cell line 1
DR   ABM; T0230
DR   Wikidata; Q54936456
RX   PubMed=10491220;
CC   Doubling time: 1.8 days (PubMed=10491220).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMx-1-SV40T).
CC   Derived from site: In situ; Fetal bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12-13FW
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   OPCA-iPSC1
AC   CVCL_L661
SY   OPCA-iPS1
DR   Wikidata; Q54936461
RX   PubMed=22301348;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[45] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Unspecified (PubMed=22301348).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L662 ! OPCA-iPSC2
OI   CVCL_L663 ! OPCA-iPSC3
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   OPCA-iPSC2
AC   CVCL_L662
SY   OPCA-iPS2
DR   Wikidata; Q54936462
RX   PubMed=22301348;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[45] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Unspecified (PubMed=22301348).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L661 ! OPCA-iPSC1
OI   CVCL_L663 ! OPCA-iPSC3
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   OPCA-iPSC3
AC   CVCL_L663
SY   OPCA-iPS3
DR   Wikidata; Q54936463
RX   PubMed=22301348;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[45] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Unspecified (PubMed=22301348).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L661 ! OPCA-iPSC1
OI   CVCL_L662 ! OPCA-iPSC2
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   OPCN-1
AC   CVCL_5566
SY   OPCN 1; OPCN1
DR   Wikidata; Q54936464
RX   CelloPub=CLPUB00242;
RX   CelloPub=CLPUB00396;
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/opc-prostate-and-normal-cell-lines/
CC   Doubling time: 2.7 +- 0.5 days (CelloPub=CLPUB00396).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5569 ! OPCT-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   OPCN-2
AC   CVCL_5567
SY   OPCN 2; OPCN2
DR   Wikidata; Q54936465
RX   CelloPub=CLPUB00242;
RX   CelloPub=CLPUB00396;
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/opc-prostate-and-normal-cell-lines/
CC   Doubling time: 2.9 +- 0.5 days (CelloPub=CLPUB00396).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5570 ! OPCT-2
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   OPCN-3
AC   CVCL_5568
SY   OPCN 3; OPCN3
DR   Wikidata; Q54936466
RX   CelloPub=CLPUB00242;
RX   CelloPub=CLPUB00396;
CC   Doubling time: 2.5 +- 0.5 days (CelloPub=CLPUB00396).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: BioIVT/Asterand Bioscience; Catalog number OPCN-3.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5571 ! OPCT-3
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OPCT-1
AC   CVCL_5569
SY   OPCT 1; OPCT1
DR   Wikidata; Q54936467
RX   CelloPub=CLPUB00242;
RX   CelloPub=CLPUB00396;
RX   PubMed=28094783;
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/opc-prostate-and-normal-cell-lines/
CC   Doubling time: 1.1 +- 0.02 days (CelloPub=CLPUB00396).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5566 ! OPCN-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   OPCT-1 clone P2B9
AC   CVCL_JQ55
SY   P2B9
DR   Wikidata; Q54936468
RX   PubMed=28094783;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5569 ! OPCT-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   OPCT-1 clone P4B6
AC   CVCL_JQ56
SY   P4B6
DR   Wikidata; Q54936469
RX   PubMed=28094783;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5569 ! OPCT-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   OPCT-1 clone P5B3
AC   CVCL_JQ57
SY   P5B3
DR   Wikidata; Q54936470
RX   PubMed=28094783;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5569 ! OPCT-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   OPCT-1 clone P6D4
AC   CVCL_JQ58
SY   P6D4
DR   Wikidata; Q54936471
RX   PubMed=28094783;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5569 ! OPCT-1
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   OPCT-2
AC   CVCL_5570
SY   OPCT 2; OPCT2
DR   Wikidata; Q54936472
RX   CelloPub=CLPUB00242;
RX   CelloPub=CLPUB00396;
RX   PubMed=28094783;
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/opc-prostate-and-normal-cell-lines/
CC   Doubling time: 1.8 +- 0.2 days (CelloPub=CLPUB00396).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5567 ! OPCN-2
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   OPCT-3
AC   CVCL_5571
SY   OPCT 3; OPCT3
DR   Wikidata; Q54936473
RX   CelloPub=CLPUB00242;
RX   CelloPub=CLPUB00396;
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/opc-prostate-and-normal-cell-lines/
CC   Doubling time: 1.9 +- 0.3 days (CelloPub=CLPUB00396).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5568 ! OPCN-3
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   OPL
AC   CVCL_A9LA
SY   Oplagnathus Punctatus Liver
DR   Wikidata; Q108821076
RX   DOI=10.3969/j.issn.1674-7968.2020.02.018;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=163135; ! Oplegnathus punctatus (Spotted knifejaw)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   OPL-1
AC   CVCL_X743
DR   Wikidata; Q54936474
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690530;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=8690530).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   OPL-2
AC   CVCL_X744
DR   Wikidata; Q54936475
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690530;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=8690530).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   OPL-3
AC   CVCL_X745
DR   Wikidata; Q54936476
RX   PubMed=14556658;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=14556658).
CC   Microsatellite instability: Instable (MSI) (PubMed=14556658).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   OPL-4
AC   CVCL_X746
DR   Wikidata; Q54936477
RX   PubMed=14556658;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Population: Japanese.
CC   Doubling time: 168 hours (PubMed=14556658).
CC   Microsatellite instability: Stable (MSS) (PubMed=14556658).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   OPL-5
AC   CVCL_X747
DR   Wikidata; Q54936479
RX   PubMed=14556658;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=14556658).
CC   Microsatellite instability: Stable (MSS) (PubMed=14556658).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   OPL-7
AC   CVCL_X748
DR   Wikidata; Q54936480
RX   PubMed=14556658;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Population: Japanese.
CC   Doubling time: 108 hours (PubMed=14556658).
CC   Microsatellite instability: Stable (MSS) (PubMed=14556658).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
ID   OPM-1
AC   CVCL_5210
SY   OPM1
DR   BioSample; SAMN10989618
DR   cancercelllines; CVCL_5210
DR   Cell_Model_Passport; SIDM00456
DR   Cosmic; 720768
DR   Cosmic; 2081431
DR   Cosmic; 2367299
DR   DepMap; ACH-000057
DR   Lonza; 28
DR   Wikidata; Q54936481
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3926660;
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: 36-42 hours (PubMed=3926660).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (DepMap=ACH-000057).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Lys650Glu (c.1948A>G); ClinVar=VCV000016331; Zygosity=Heterozygous (PubMed=11157491; DepMap=ACH-000057).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Leu87Arg (c.260T>G); Zygosity=Heterozygous (DepMap=ACH-000057).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (DepMap=ACH-000057).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0.52%; Native American=0%; East Asian, North=74.49%; East Asian, South=22.3%; South Asian=0%; European, North=0%; European, South=2.68% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 14
ST   D12S391: 17,18
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 13,14,15
ST   D19S433: 14,14.2
ST   D1S1656: 16,17.3
ST   D21S11: 30,33.2
ST   D22S1045: 11,17
ST   D2S1338: 19,25
ST   D2S441: 10
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 12,20,21
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1625 ! OPM-2
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   OPM-2
AC   CVCL_1625
SY   OPM2
DR   BTO; BTO_0005919
DR   CLO; CLO_0008269
DR   EFO; EFO_0006716
DR   CLDB; cl3774
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ArrayExpress; E-TABM-937
DR   BioGRID_ORCS_Cell_line; 977
DR   BioSample; SAMN03473240
DR   BioSample; SAMN10988562
DR   cancercelllines; CVCL_1625
DR   Cell_Model_Passport; SIDM00457
DR   CGH-DB; 36-1
DR   CGH-DB; 9158-4
DR   ChEMBL-Cells; CHEMBL3308883
DR   ChEMBL-Targets; CHEMBL2366353
DR   Cosmic; 720767
DR   Cosmic; 735529
DR   Cosmic; 759901
DR   Cosmic; 759907
DR   Cosmic; 760390
DR   Cosmic; 760403
DR   Cosmic; 909249
DR   Cosmic; 1889515
DR   Cosmic; 2081432
DR   Cosmic; 2302417
DR   Cosmic; 2367300
DR   Cosmic; 2391792
DR   Cosmic; 2809760
DR   Cosmic-CLP; 909249
DR   DepMap; ACH-000024
DR   DSMZ; ACC-50
DR   DSMZCellDive; ACC-50
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909249
DR   GEO; GSM143336
DR   GEO; GSM290303
DR   GEO; GSM562818
DR   GEO; GSM887478
DR   GEO; GSM888559
DR   GEO; GSM1374799
DR   GEO; GSM1670307
DR   IARC_TP53; 21603
DR   IARC_TP53; 28518
DR   LiGeA; CCLE_834
DR   LINCS_LDP; LCL-2048
DR   PharmacoDB; OPM2_1202_2019
DR   PRIDE; PXD030239
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1625
DR   PubChem_Cell_line; CVCL_1625
DR   Wikidata; Q54936482
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3926660;
RX   PubMed=8943038;
RX   PubMed=10087940;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=15215163;
RX   PubMed=16956823;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=20164919;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/opm2-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Doubling time: 30-36 hours (PubMed=3926660); 50 hours (PubMed=25984343); ~50-60 hours (DSMZ=ACC-50).
CC   HLA typing: A*24; B*07,15; C*04,07 (PubMed=25688540).
CC   HLA typing: A*24:02,24:02; B*07:02,15:27; C*04:01,07:02 (PubMed=26589293).
CC   HLA typing: A*24:02:01,24:02:01; B*07:02:01,15:27:01; C*04:01:01,07:02:01; DRA*01:01:01,01:01:01 (DSMZCellDive=ACC-50).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (Cosmic-CLP=909249).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Lys650Glu (c.1948A>G); ClinVar=VCV000016331; Zygosity=Heterozygous (PubMed=11157491; Cosmic-CLP=909249).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Leu87Arg (c.260T>G); Zygosity=Heterozygous (Cosmic-CLP=909249).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=21173094; Cosmic-CLP=909249).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.58%; Native American=0%; East Asian, North=74.2%; East Asian, South=23.62%; South Asian=0%; European, North=0.08%; European, South=1.51% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=909249; DSMZ=ACC-50; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D10S1248: 14
ST   D12S391: 17,18
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 13,14
ST   D19S433: 14,14.2 (Technion Genomics Center)
ST   D19S433: 14,15 (DSMZ=ACC-50)
ST   D1S1656: 16,17.3
ST   D21S11: 30,33.2
ST   D22S1045: 11,17
ST   D2S1338: 19,25
ST   D2S441: 10
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 12,21
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5210 ! OPM-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   OPM-2/BR
AC   CVCL_VJ35
SY   OPM2/BR
DR   cancercelllines; CVCL_VJ35
DR   Wikidata; Q98128352
RX   PubMed=25382610;
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Lys650Glu (c.1948A>G); ClinVar=VCV000016331; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Leu87Arg (c.260T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1625 ! OPM-2
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   OPM-2/BTZ
AC   CVCL_4V72
SY   OPM2/BTZ
DR   cancercelllines; CVCL_4V72
DR   Wikidata; Q54936484
RX   PubMed=20555361;
CC   Population: Japanese.
CC   Characteristics: Produces Ig lambda.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Lys650Glu (c.1948A>G); ClinVar=VCV000016331; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Leu87Arg (c.260T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1625 ! OPM-2
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   OPM-3
AC   CVCL_M529
DR   Wikidata; Q54936485
RX   PubMed=9858236;
RX   PubMed=10936422;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   OPMDCl2
AC   CVCL_6B29
DR   Wikidata; Q54936486
RX   PubMed=22040608;
CC   Sequence variation: Mutation; HGNC; HGNC:8565; PABPN1; Simple; p.Ala11_Gly12insAlaAla (c.21_26dup) (c.18_23dupGGCGGC) ((GCG)9); ClinVar=VCV002437738; Zygosity=Heterozygous (PubMed=22040608).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Cricopharyngeal muscle; UBERON=UBERON_0010928.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C84942; Oculopharyngeal muscular dystrophy
DI   ORDO; Orphanet_270; Oculopharyngeal muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   60Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 15
//
ID   OPT379-0000005
AC   CVCL_F0LH
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000006
AC   CVCL_F0LI
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000014
AC   CVCL_F0LJ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000015
AC   CVCL_F0LK
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000016
AC   CVCL_F0LL
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000024
AC   CVCL_F0LM
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000028
AC   CVCL_F0LN
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000030
AC   CVCL_F0LP
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000031
AC   CVCL_F0LQ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000032
AC   CVCL_F0LR
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000034
AC   CVCL_F0LS
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000035
AC   CVCL_F0LT
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000039
AC   CVCL_F0LU
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000042
AC   CVCL_F0LV
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000044
AC   CVCL_F0LW
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000048
AC   CVCL_F0LX
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000050
AC   CVCL_F0LY
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000051
AC   CVCL_F0LZ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000053
AC   CVCL_F0M0
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000055
AC   CVCL_F0M1
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000057
AC   CVCL_F0M2
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000058
AC   CVCL_F0M3
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000059
AC   CVCL_F0M4
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000061
AC   CVCL_F0M5
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000065
AC   CVCL_F0M6
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000067
AC   CVCL_F0M7
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000068
AC   CVCL_F0M8
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000069
AC   CVCL_F0M9
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000070
AC   CVCL_F0MA
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000071
AC   CVCL_F0MB
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000072
AC   CVCL_F0MC
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000073
AC   CVCL_F0MD
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000077
AC   CVCL_F0ME
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000079
AC   CVCL_F0MF
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000080
AC   CVCL_F0MG
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000081
AC   CVCL_F0MH
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000082
AC   CVCL_F0MI
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000084
AC   CVCL_F0MJ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0000086
AC   CVCL_F0MK
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100012
AC   CVCL_F0ML
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100014
AC   CVCL_F0MM
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100019
AC   CVCL_F0MN
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100021
AC   CVCL_F0MP
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100023
AC   CVCL_F0MQ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100026
AC   CVCL_F0MR
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100032
AC   CVCL_F0MS
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100037
AC   CVCL_F0MT
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100038
AC   CVCL_F0MU
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100041
AC   CVCL_F0MV
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100043
AC   CVCL_F0MW
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0100046
AC   CVCL_F0MX
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300007
AC   CVCL_F0MY
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300008
AC   CVCL_F0MZ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300009
AC   CVCL_F0N0
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300010
AC   CVCL_F0N1
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300013
AC   CVCL_F0N2
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Thoracic wall; UBERON=UBERON_0016403.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300014
AC   CVCL_F0N3
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300015
AC   CVCL_F0N4
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300018
AC   CVCL_F0N5
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300019
AC   CVCL_F0N6
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0300020
AC   CVCL_F0N7
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400002
AC   CVCL_F0N8
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400004
AC   CVCL_F0N9
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400008
AC   CVCL_F0NA
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400013
AC   CVCL_F0NB
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400015
AC   CVCL_F0NC
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400018
AC   CVCL_F0ND
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400019
AC   CVCL_F0NE
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400021
AC   CVCL_F0NF
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400023
AC   CVCL_F0NG
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400024
AC   CVCL_F0NH
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400025
AC   CVCL_F0NI
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400026
AC   CVCL_F0NJ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400028
AC   CVCL_F0NK
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400029
AC   CVCL_F0NL
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400030
AC   CVCL_F0NM
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400031
AC   CVCL_F0NN
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400034
AC   CVCL_F0NP
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400035
AC   CVCL_F0NQ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400036
AC   CVCL_F0NR
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400037
AC   CVCL_F0NS
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400038
AC   CVCL_F0NT
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400039
AC   CVCL_F0NU
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400040
AC   CVCL_F0NV
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400041
AC   CVCL_F0NW
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400042
AC   CVCL_F0NX
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400043
AC   CVCL_F0NY
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400046
AC   CVCL_F0NZ
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400048
AC   CVCL_F0P0
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400050
AC   CVCL_F0P1
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400051
AC   CVCL_F0P2
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400052
AC   CVCL_F0P3
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400053
AC   CVCL_F0P4
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0400056
AC   CVCL_F0P5
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500002
AC   CVCL_F0P6
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500009
AC   CVCL_F0P7
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500011
AC   CVCL_F0P8
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500014
AC   CVCL_F0P9
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500017
AC   CVCL_F0PA
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500018
AC   CVCL_F0PB
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500019
AC   CVCL_F0PC
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Uterus, adnexa; UBERON=UBERON_0036292.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500020
AC   CVCL_F0PD
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500021
AC   CVCL_F0PE
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500022
AC   CVCL_F0PF
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500024
AC   CVCL_F0PG
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Mediastinum; UBERON=UBERON_0003728.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500026
AC   CVCL_F0PH
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OPT379-0500027
AC   CVCL_F0PI
WW   Info; -; -; https://www.kanker.nl/trials/1266-optic---studie-dikkedarmkanker
WW   Provider; HUB Organoids; -; https://www.huborganoids.nl/
CC   Group: Cancer organoid.
CC   Part of: OPTIC organoid collection.
CC   Population: Caucasian; Dutch.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Or De
AC   CVCL_3322
DR   CLO; CLO_0008270
DR   CLDB; cl3775
DR   ATCC; CRL-1366
DR   BioSample; SAMN03471358
DR   Wikidata; Q54936487
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1366
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 13,16
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 20,29
ST   Penta D: 9,12
ST   Penta E: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C125698; Ehlers-Danlos syndrome, type III
DI   ORDO; Orphanet_285; Hypermobile Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   OR6 [Chlorocebus aethiops]
AC   CVCL_RW40
SY   ouaR6
DR   Wikidata; Q54936488
RX   PubMed=2826456;
RX   PubMed=2981832;
RX   PubMed=6324196;
RX   PubMed=8195174;
CC   Group: Non-human primate cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:799; ATP1A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88105; Atp1a1 (Note=With p.Ile798Thr).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   OR6 [Human]
AC   CVCL_VN30
SY   OR-6
DR   BTO; BTO_0006069
DR   cancercelllines; CVCL_VN30
DR   Wikidata; Q98128353
RX   PubMed=15766575;
RX   PubMed=21320556;
CC   Population: Japanese.
CC   Characteristics: Transfected with ORN/C-5B/KE RNA, a construct containing Renilla reniformis renilla-type luciferase, neo and genome-length HCV RNA from O strain (genotype 1b).
CC   Virology: Supports hepatitis C virus (HCV) replication.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 14
//
ID   OreniImMac
AC   CVCL_YD01
SY   Oreochromis niloticus immortalized macrophage cells
DR   Wikidata; Q98128354
RX   DOI=10.11964/jfc.20170410798;
CC   Group: Fish cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 6
//
ID   Org MHH.1
AC   CVCL_A5ZH
SY   Org MHH-1; MHH-1
DR   Wikidata; Q107116615
RX   PubMed=2989374;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   Ori-
AC   CVCL_JE64
DR   Wikidata; Q54936489
RX   PubMed=12221015;
RX   PubMed=19184294;
CC   Doubling time: 36.7 +- 3.5 hours (PubMed=19184294).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   ORI1
AC   CVCL_C1JD
SY   OR11
DR   Wikidata; Q114312637
RX   PubMed=2998993;
RX   PubMed=4333769;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   ORIONi001-A
AC   CVCL_ZE49
SY   iALS-1
DR   BioSamples; SAMEA7002446
DR   hPSCreg; ORIONi001-A
DR   Wikidata; Q98128355
RX   PubMed=32919353;
CC   From: Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University; Martin; Slovakia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   ORIONi002-A
AC   CVCL_C1QB
SY   iALS-2
DR   BioSamples; SAMEA12999351
DR   hPSCreg; ORIONi002-A
DR   Wikidata; Q114312638
RX   PubMed=35907349;
CC   From: Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University; Martin; Slovakia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35907349
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   ORIONi003-A
AC   CVCL_C9ED
SY   iDMD-1
DR   BioSamples; SAMEA112765862
DR   hPSCreg; ORIONi003-A
DR   Wikidata; Q123033218
RX   PubMed=37643496;
CC   From: Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University; Martin; Slovakia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Val2305Leufs*9 (c.6913_7309del) (Ex48-50del); Zygosity=Hemizygous (PubMed=37643496).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   ORL-115
AC   CVCL_S690
SY   ORL-115T; 115T
DR   BioGRID_ORCS_Cell_line; 1271
DR   cancercelllines; CVCL_S690
DR   Cell_Model_Passport; SIDM02007
DR   Cosmic; 2531643
DR   Cosmic; 2559735
DR   IARC_TP53; 25070
DR   Wikidata; Q54936490
RX   PubMed=17273794;
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Microsatellite instability: Stable (MSS) (PubMed=17273794).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>C; ClinVar=VCV000182416; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113del (c.339_341delCTT); Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 20,23
ST   TH01: 9
ST   TPOX: 9,10
ST   vWA: 15,16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   ORL-136
AC   CVCL_S691
SY   ORL-136T; 136T
DR   BioGRID_ORCS_Cell_line; 1272
DR   Cell_Model_Passport; SIDM02006
DR   Cosmic; 2531648
DR   Cosmic; 2559736
DR   IARC_TP53; 25071
DR   Wikidata; Q54936491
RX   PubMed=17273794;
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Microsatellite instability: Stable (MSS) (PubMed=17273794).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Gln3585Ter (c.10753C>T); Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=17273794; PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 12,16
ST   D21S11: 29.2,32.2
ST   D2S1338: 19,22
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 9,12
ST   D8S1179: 14,16
ST   FGA: 22
ST   TH01: 6,9
ST   TPOX: 9,10
ST   vWA: 16,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   ORL-150
AC   CVCL_VJ37
SY   ORL-150T; 150T
DR   BioGRID_ORCS_Cell_line; 1273
DR   Cell_Model_Passport; SIDM02005
DR   Cosmic; 2531650
DR   Cosmic; 2559737
DR   Wikidata; Q98128356
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Unspecified (PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 11
ST   D19S433: 14,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 23
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 14,16
ST   FGA: 19,24
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   ORL-153
AC   CVCL_VJ38
SY   ORL-153T; 153T
DR   BioGRID_ORCS_Cell_line; 1274
DR   cancercelllines; CVCL_VJ38
DR   Cell_Model_Passport; SIDM02004
DR   Cosmic; 2531651
DR   Cosmic; 2559738
DR   Wikidata; Q98128357
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Tyr997Ter (c.2991T>G); Zygosity=Unspecified (PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,14
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,16
ST   D21S11: 28,31
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   D8S1179: 10,17
ST   FGA: 21
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   ORL-156
AC   CVCL_VJ39
SY   ORL-156T; 156T
DR   BioGRID_ORCS_Cell_line; 1282
DR   Cell_Model_Passport; SIDM02003
DR   Cosmic; 2531641
DR   Cosmic; 2559739
DR   Wikidata; Q98128358
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 9
ST   D16S539: 12
ST   D21S11: 28
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   ORL-166
AC   CVCL_VJ40
SY   ORL-166T; 166T
DR   BioGRID_ORCS_Cell_line; 1283
DR   Cell_Model_Passport; SIDM02002
DR   Cosmic; 2531645
DR   Cosmic; 2559740
DR   Wikidata; Q98128359
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Malaysian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Val1532Serfs*2 (c.4593dupA); ClinVar=VCV000051681; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 13,15
ST   D21S11: 30.2,32.2
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   ORL-174
AC   CVCL_VJ41
SY   ORL-174T; 174T
DR   BioGRID_ORCS_Cell_line; 1275
DR   Cell_Model_Passport; SIDM02001
DR   Cosmic; 2531642
DR   Cosmic; 2559741
DR   Wikidata; Q98128361
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu88Ter (c.262G>T); ClinVar=VCV000376305; Zygosity=Heterozygous (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12,19
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 24,25
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   ORL-188
AC   CVCL_VJ42
SY   ORL-188T; 188T
DR   BioGRID_ORCS_Cell_line; 1276
DR   Cell_Model_Passport; SIDM02000
DR   Cosmic; 2531655
DR   Cosmic; 2559742
DR   Wikidata; Q98128362
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Malaysian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Heterozygous (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204_Tyr205del (c.609_614del); Zygosity=Unspecified (PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 17,19
ST   D19S433: 14,14.2
ST   D21S11: 31
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 24.2,27
ST   TH01: 7,8
ST   TPOX: 9
ST   vWA: 16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   ORL-195
AC   CVCL_VJ43
SY   ORL-195T; 195T
DR   BioGRID_ORCS_Cell_line; 1277
DR   cancercelllines; CVCL_VJ43
DR   Cell_Model_Passport; SIDM01999
DR   Cosmic; 2531647
DR   Cosmic; 2559743
DR   Wikidata; Q98128363
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met169Ilefs*4 (c.507delG); Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Lys (c.710T>A); ClinVar=VCV000376636; Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13,15.2
ST   D21S11: 29,31.2
ST   D2S1338: 19
ST   D3S1358: 17
ST   D5S818: 11,16
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 24
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   ORL-196
AC   CVCL_VJ44
SY   ORL-196T; 196T
DR   cancercelllines; CVCL_VJ44
DR   Cosmic; 2531646
DR   Cosmic; 2559744
DR   Wikidata; Q98128364
RX   PubMed=24224046;
RX   PubMed=27050151;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Leu398Phefs*6 (c.1193dup); Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys321Asnfs*24 (c.960delG); Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 14.2,16
ST   D21S11: 29,32.2
ST   D2S1338: 22,23
ST   D3S1358: 14,17
ST   D5S818: 13,14
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   ORL-204
AC   CVCL_VJ45
SY   ORL-204T; 204T
DR   BioGRID_ORCS_Cell_line; 1278
DR   cancercelllines; CVCL_VJ45
DR   Cell_Model_Passport; SIDM02008
DR   Cosmic; 2531649
DR   Cosmic; 2559745
DR   Wikidata; Q98128365
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:3688; FGFR1; Simple; p.Asn224Lysfs*8 (c.671dup); Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 11,13.2
ST   D21S11: 32,34.2
ST   D2S1338: 20,21
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 15
ST   FGA: 17
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   ORL-207
AC   CVCL_VJ46
SY   ORL-207T; 207T
DR   BioGRID_ORCS_Cell_line; 1279
DR   Cell_Model_Passport; SIDM01998
DR   Cosmic; 2531652
DR   Cosmic; 2559746
DR   Wikidata; Q98128366
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 12,18
ST   D19S433: 13,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,13
ST   D8S1179: 12,16
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   ORL-214
AC   CVCL_VJ47
SY   ORL-214T; 214T
DR   BioGRID_ORCS_Cell_line; 1280
DR   cancercelllines; CVCL_VJ47
DR   Cell_Model_Passport; SIDM01996
DR   Cosmic; 2531653
DR   Cosmic; 2559747
DR   Wikidata; Q98128367
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Val1532Serfs*2 (c.4593dupA); ClinVar=VCV000051681; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Glu3654Ter (c.10960G>T); Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012613; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Glu1408Ter (c.4222G>T); ClinVar=VCV000523597; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Ser (c.460G>A); ClinVar=VCV000133284; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 13
ST   D19S433: 12,13
ST   D21S11: 30,33.2
ST   D2S1338: 19,21
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13,16
ST   FGA: 23,25
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   ORL-215
AC   CVCL_VJ48
SY   ORL-215T; 215T
DR   BioGRID_ORCS_Cell_line; 1281
DR   Cell_Model_Passport; SIDM01995
DR   Cosmic; 2531644
DR   Cosmic; 2559748
DR   Wikidata; Q98128368
RX   PubMed=24224046;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=24224046; PubMed=27050151).
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14,18
ST   D19S433: 12,15.2
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10,16
ST   FGA: 22,23
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   ORL-247
AC   CVCL_VJ49
SY   ORL-247T; 247T
DR   Cosmic; 2531654
DR   Cosmic; 2559749
DR   Wikidata; Q98128369
RX   PubMed=24224046;
RX   PubMed=27050151;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>A; ClinVar=VCV000635365; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Glnfs*7 (c.642_643delTA); ClinVar=VCV000826394; Zygosity=Unspecified (PubMed=27050151).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D21S11: 29,32.2
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
ID   ORL-48
AC   CVCL_S692
SY   ORL-48T; 48T
DR   BioGRID_ORCS_Cell_line; 1270
DR   cancercelllines; CVCL_S692
DR   Cell_Model_Passport; SIDM01987
DR   Cosmic; 2296300
DR   Cosmic; 2531640
DR   Cosmic; 2559734
DR   IARC_TP53; 25069
DR   Wikidata; Q54936492
RX   PubMed=17273794;
RX   PubMed=24224046;
RX   PubMed=25275298;
RX   PubMed=27050151;
RX   PubMed=32990596;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Indian; Sikh.
CC   Microsatellite instability: Stable (MSS) (PubMed=17273794).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Unspecified (PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Serfs*51 (c.876delA) (p.Phe292fs); Zygosity=Unspecified (PubMed=17273794; PubMed=24224046; PubMed=27050151).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Unspecified (PubMed=17273794; PubMed=24224046; PubMed=27050151).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=25275298; PubMed=27050151
ST   Amelogenin: X
ST   CSF1PO: 10 (PubMed=25275298)
ST   CSF1PO: 10,11 (PubMed=27050151)
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 15
ST   D5S818: 11 (PubMed=25275298)
ST   D5S818: 11,12 (PubMed=27050151)
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 24,25
ST   Penta D: 9,11
ST   Penta E: 7,18
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   ORL11
AC   CVCL_VN28
SY   ORL-11
DR   Wikidata; Q98128370
RX   PubMed=19720094;
RX   PubMed=21320556;
CC   Population: Japanese.
CC   Characteristics: Supports HCV replication.
CC   Characteristics: Transfected with ORN/C-5B/QR,KE,SR RNA, a construct containing Renilla reniformis renilla-type luciferase, neo and genome-length HCV RNA from O strain (genotype 1b).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN26 ! Li-23
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   ORL8
AC   CVCL_VN29
SY   ORL-8
DR   BTO; BTO_0006071
DR   Wikidata; Q98128371
RX   PubMed=19720094;
RX   PubMed=21320556;
CC   Population: Japanese.
CC   Characteristics: Supports HCV replication.
CC   Characteristics: Transfected with ORN/C-5B/QR,KE,SR RNA, a construct containing Renilla reniformis renilla-type luciferase, neo and genome-length HCV RNA from O strain (genotype 1b).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN26 ! Li-23
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   ORMES-1
AC   CVCL_2U86
SY   ORMES1; Oregon Rhesus Monkey Embryonic Stem-1
DR   Wikidata; Q54936493
RX   PubMed=15200688;
RX   PubMed=16741224;
RX   PubMed=26999759;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ORMES-10
AC   CVCL_2U95
SY   Oregon Rhesus Monkey Embryonic Stem-10
DR   Wikidata; Q54936494
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-11
AC   CVCL_2U96
SY   Oregon Rhesus Monkey Embryonic Stem-11
DR   Wikidata; Q54936495
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-12
AC   CVCL_2U97
SY   Oregon Rhesus Monkey Embryonic Stem-12
DR   Wikidata; Q54936497
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-13
AC   CVCL_2U98
SY   Oregon Rhesus Monkey Embryonic Stem-13
DR   Wikidata; Q54936498
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-14
AC   CVCL_2U99
SY   Oregon Rhesus Monkey Embryonic Stem-14
DR   Wikidata; Q54936499
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-15
AC   CVCL_2V00
SY   Oregon Rhesus Monkey Embryonic Stem-15
DR   Wikidata; Q54936500
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-16
AC   CVCL_2V01
SY   Oregon Rhesus Monkey Embryonic Stem-16
DR   Wikidata; Q54936501
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-17
AC   CVCL_2V02
SY   Oregon Rhesus Monkey Embryonic Stem-17
DR   Wikidata; Q54936502
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-18
AC   CVCL_2V03
SY   Oregon Rhesus Monkey Embryonic Stem-18
DR   Wikidata; Q54936503
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-2
AC   CVCL_2U87
SY   Oregon Rhesus Monkey Embryonic Stem-2
DR   Wikidata; Q54936509
RX   PubMed=15200688;
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ORMES-3
AC   CVCL_2U88
SY   Oregon Rhesus Monkey Embryonic Stem-3
DR   Wikidata; Q54936510
RX   PubMed=15200688;
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ORMES-4
AC   CVCL_2U89
SY   Oregon Rhesus Monkey Embryonic Stem-4
DR   Wikidata; Q54936511
RX   PubMed=15200688;
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ORMES-5
AC   CVCL_2U90
SY   Oregon Rhesus Monkey Embryonic Stem-5
DR   Wikidata; Q54936512
RX   PubMed=15200688;
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ORMES-6
AC   CVCL_2U91
SY   Oregon Rhesus Monkey Embryonic Stem-6
DR   Wikidata; Q54936513
RX   PubMed=15200688;
RX   PubMed=16741224;
RX   PubMed=26999759;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   ORMES-7
AC   CVCL_2U92
SY   Oregon Rhesus Monkey Embryonic Stem-7
DR   Wikidata; Q54936514
RX   PubMed=15200688;
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   ORMES-8
AC   CVCL_2U93
SY   Oregon Rhesus Monkey Embryonic Stem-8
DR   Wikidata; Q54936515
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORMES-9
AC   CVCL_2U94
SY   Oregon Rhesus Monkey Embryonic Stem-9
DR   Wikidata; Q54936516
RX   PubMed=16741224;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   ORS [Goat]
AC   CVCL_IR22
SY   Outer Root Sheath
DR   Wikidata; Q54936517
RX   PubMed=22105552;
CC   Doubling time: ~52 hours (PubMed=22105552).
CC   Derived from site: In situ; Hair follicle, outer root sheath; UBERON=UBERON_0005942.
CC   Breed/subspecies: Jining Grey; VBO=VBO_0009438.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   1-3D
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 7
//
ID   ORS [Human Ewing sarcoma]
AC   CVCL_U565
DR   cancercelllines; CVCL_U565
DR   Cosmic; 2250465
DR   Wikidata; Q54936518
RX   DOI=10.5282/edoc.27750;
RX   PubMed=11423975;
RX   PubMed=25223734;
CC   From: Delattre, Olivier; Institut Curie; Paris; France.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 4 fusion (Ex10/Ex5) (PubMed=11423975).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Asp625fs; Zygosity=Unspecified (PubMed=25223734).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=25223734).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   ORS-Pop-93
AC   CVCL_Z460
SY   Pop 1
DR   Wikidata; Q54936519
RX   PubMed=8826086;
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Doubling time: 40 hours (Note=At 50th passage) (PubMed=8826086).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ORS-Pop-93 Pop 2
AC   CVCL_Z461
SY   Pop 2; ORS-Pop-2
DR   Wikidata; Q54936520
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
HI   CVCL_Z460 ! ORS-Pop-93
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ORS-Pop-93 Pop 3
AC   CVCL_Z462
SY   Pop 3; ORS-Pop-3
DR   Wikidata; Q54936522
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
HI   CVCL_Z460 ! ORS-Pop-93
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ORS-Pop-93 Pop 4
AC   CVCL_Z463
SY   Pop 4; ORS-Pop-4
DR   Wikidata; Q54936523
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
HI   CVCL_Z460 ! ORS-Pop-93
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   ORS-Pop-93 Pop cl 1A
AC   CVCL_Z464
SY   Pop cl 1A
DR   Wikidata; Q54936524
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
HI   CVCL_Z460 ! ORS-Pop-93
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ORS-Pop-93 Pop cl 2B
AC   CVCL_Z465
SY   Pop cl 2B
DR   Wikidata; Q54936525
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
HI   CVCL_Z460 ! ORS-Pop-93
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ORS-Pop-94A
AC   CVCL_Z466
SY   Pop A
DR   Wikidata; Q54936526
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
OI   CVCL_Z467 ! ORS-Pop-94B
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ORS-Pop-94B
AC   CVCL_Z467
SY   Pop B
DR   Wikidata; Q54936527
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
OI   CVCL_Z466 ! ORS-Pop-94A
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ORS-Pop-95
AC   CVCL_Z468
SY   Pop 95
DR   Wikidata; Q54936528
RX   PubMed=9338147;
RX   PubMed=22358547;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ORT
AC   CVCL_N815
DR   Cosmic; 1656045
DR   Wikidata; Q54936530
RX   PubMed=15274292;
RX   PubMed=22426987;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   OrydaEmb1
AC   CVCL_YD81
SY   Oryzias dancena Embryonic 1; Cell line 1
DR   Wikidata; Q98128372
RX   DOI=10.5657/FAS.2013.0177;
RX   PubMed=24916563;
CC   Group: Fish cell line.
CC   Doubling time: 29.84 hours (DOI=10.5657/FAS.2013.0177).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   OrydaEmb1 subline-1
AC   CVCL_YD83
SY   Oryzias dancena Embryonic 1 subline-1; Subline-1
DR   Wikidata; Q98128373
RX   PubMed=26239820;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
HI   CVCL_YD81 ! OrydaEmb1
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   OrydaEmb1 subline-2
AC   CVCL_YD84
SY   Oryzias dancena Embryonic 1 subline-2; Subline-2
DR   Wikidata; Q98128374
RX   PubMed=26239820;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
HI   CVCL_YD81 ! OrydaEmb1
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   OrydaEmb1 subline-3
AC   CVCL_YD85
SY   Oryzias dancena Embryonic 1 subline-3; Subline-3
DR   Wikidata; Q98128375
RX   PubMed=26239820;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
HI   CVCL_YD81 ! OrydaEmb1
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   OrydaEmb1 subline-4
AC   CVCL_YD86
SY   Oryzias dancena Embryonic 1 subline-4; Subline-4
DR   Wikidata; Q98128376
RX   PubMed=26239820;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
HI   CVCL_YD81 ! OrydaEmb1
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   OrydaEmb1 subline-5
AC   CVCL_YD87
SY   Oryzias dancena Embryonic 1 subline-5; Subline-5
DR   Wikidata; Q98128377
RX   PubMed=26239820;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
HI   CVCL_YD81 ! OrydaEmb1
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   OrydaEmb2
AC   CVCL_YD82
SY   Oryzias dancena Embryonic 2; Cell line 2
DR   Wikidata; Q98128378
RX   DOI=10.5657/FAS.2013.0177;
CC   Group: Fish cell line.
CC   Doubling time: 28.59 hours (DOI=10.5657/FAS.2013.0177).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=291360; ! Oryzias dancena (Indian ricefish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   OS 179
AC   CVCL_FA10
SY   OS-179
DR   Wikidata; Q54936531
RX   PubMed=15026342;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   OS 187
AC   CVCL_1R50
SY   OS-187; OS187
DR   BioSample; SAMN03151646
DR   cancercelllines; CVCL_1R50
DR   Wikidata; Q54936532
RX   PubMed=15026342;
RX   PubMed=18483362;
RX   PubMed=24046071;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HCT 15 derivative (PubMed=24046071). Originally thought to originate from an osteosarcoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00485.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg727Met (c.2180G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys993Asn (c.2979G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1417Leufs*2 (c.4248delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Ter (c.6496C>T); ClinVar=VCV000438883; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; c.68-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr30Ter (c.90C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000005592; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Asp549Asn (c.1645G>A); ClinVar=VCV000375900; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>C; ClinVar=VCV000635383; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0292 ! HCT 15
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   OS 99-1
AC   CVCL_F502
SY   OS99-1
DR   Wikidata; Q54936533
RX   PubMed=18247100;
RX   PubMed=20309879;
CC   Population: African American.
CC   Doubling time: ~16 hours (PubMed=18247100).
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   Os Te
AC   CVCL_3323
SY   OI strain no. 1262; WG0518; WG518
DR   CLO; CLO_0008272
DR   ATCC; CRL-1262
DR   Wikidata; Q54936534
RX   PubMed=643622;
RX   PubMed=1054840;
RX   PubMed=2981843;
RX   PubMed=6191221;
RX   PubMed=6221880;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   OS-1
AC   CVCL_S988
DR   Wikidata; Q54936535
RX   PubMed=16035505;
CC   Population: Japanese.
CC   Doubling time: ~30 hours (PubMed=16035505).
CC   Derived from site: Metastatic; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
DI   ORDO; Orphanet_370396; Small cell carcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   OS-A
AC   CVCL_0C23
DR   Cosmic; 2239090
DR   Wikidata; Q54936536
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   OS-F
AC   CVCL_VG01
DR   Wikidata; Q54936537
RX   CelloPub=CLPUB00427;
RX   PubMed=12738951;
CC   Population: Japanese.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 6
//
ID   OS-P2/HTLV-I
AC   CVCL_1T58
SY   OS-P2
DR   BEI_Resources; ARP-1393
DR   Wikidata; Q54936538
CC   Virology: HTLV-1 producing cell line.
CC   Doubling time: ~6 days (BEI_Resources=ARP-1393).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   OS-RC-1
AC   CVCL_C9CK
DR   Wikidata; Q123033219
RX   PubMed=7591954;
CC   From: Kinouchi, Toshiaki; The Center for Adult Diseases; Osaka; Japan.
CC   Population: Japanese.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   OS-RC-2
AC   CVCL_1626
SY   OSRC2; RC-2
DR   BTO; BTO_0002403
DR   CLO; CLO_0050889
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 512
DR   BioSample; SAMN03472222
DR   BioSample; SAMN10987712
DR   cancercelllines; CVCL_1626
DR   CCRID; 1101HUM-PUMC000292
DR   CCRID; 3101HUMTCHu40
DR   Cell_Model_Passport; SIDM00239
DR   ChEMBL-Cells; CHEMBL3308274
DR   ChEMBL-Targets; CHEMBL2366188
DR   CLS; 305086
DR   Cosmic; 909250
DR   Cosmic-CLP; 909250
DR   DepMap; ACH-000159
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10411-106B6
DR   GDSC; 909250
DR   GEO; GSM1670310
DR   IARC_TP53; 21604
DR   KCB; KCB 200779YJ
DR   LiGeA; CCLE_815
DR   LINCS_LDP; LCL-1768
DR   PharmacoDB; OSRC2_1203_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1626
DR   PubChem_Cell_line; CVCL_1626
DR   RCB; RCB0735
DR   Wikidata; Q54936539
RX   PubMed=4008433;
RX   PubMed=14534724;
RX   PubMed=15604581;
RX   PubMed=20164919;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~60 hours (Note=At 30th passage) (PubMed=4008433).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Cys211Serfs (c.631_634+12del16); Zygosity=Heterozygous (Cosmic-CLP=909250; DepMap=ACH-000159).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=909250; DepMap=ACH-000159).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.1%; Native American=0%; East Asian, North=77.03%; East Asian, South=20.25%; South Asian=0%; European, North=0.95%; European, South=1.66% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID; Cosmic-CLP=909250; RCB=RCB0735
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 20
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   OS052
AC   CVCL_C8FR
SY   PSS008
DR   DepMap; ACH-002471
DR   Wikidata; Q123033220
RX   PubMed=37703185;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Metastatic (PubMed=37703185).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu465Lysfs*13 (c.1392delA) (c.1391delA); ClinVar=VCV000954138; Zygosity=Homozygous (DepMap=ACH-002471).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Equivalence of OS052 with PSS008 from personal communication of Sayles, Leanne C.
CC   Derived from site: In situ; Bone, fibula; UBERON=UBERON_0001446.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   OS1 [Human lung carcinoma]
AC   CVCL_Z602
DR   Wikidata; Q54936540
RX   PubMed=1325431;
RX   PubMed=2161815;
RX   PubMed=8075973;
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1LN ! OS1-F
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   OS1 [Human osteosarcoma]
AC   CVCL_F864
DR   Wikidata; Q54936541
RX   PubMed=18931939;
RX   PubMed=19746444;
CC   Population: Chinese; Singaporian.
CC   Doubling time: 4.91 days (Note=At 50th passage) (PubMed=19746444).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 13
//
ID   OS1-CLS
AC   CVCL_5851
DR   CLS; 500369
DR   Wikidata; Q54936542
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   OS1-F
AC   CVCL_A1LN
DR   Wikidata; Q102114686
RX   PubMed=1646075;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z602 ! OS1 [Human lung carcinoma]
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   OS10
AC   CVCL_Z611
DR   Wikidata; Q54936543
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   OS15
AC   CVCL_Z612
DR   Wikidata; Q54936544
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   OS152
AC   CVCL_C8FS
DR   Wikidata; Q123033221
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Highly metastatic (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone, scapula; UBERON=UBERON_0006849.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,14
ST   D5S818: 8,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 19,20
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OS17
AC   CVCL_Z613
DR   Wikidata; Q54936545
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   OS186
AC   CVCL_C8FT
DR   Wikidata; Q123033222
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Not metastatic (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone, jaw, mandible; UBERON=UBERON_0001684.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 10,13
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18,19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OS18A
AC   CVCL_Z614
DR   Wikidata; Q54936546
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   OS2 [Human lung carcinoma]
AC   CVCL_Z603
DR   Wikidata; Q54936548
RX   PubMed=1325431;
RX   PubMed=2161815;
RX   PubMed=8075973;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z604 ! OS2-RA
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   OS2 [Human osteosarcoma]
AC   CVCL_F865
DR   Wikidata; Q54936549
RX   PubMed=19746444;
CC   Population: Chinese; Indonesia.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   OS2-RA
AC   CVCL_Z604
SY   OS2RA; OS2-R
DR   Wikidata; Q54936550
RX   PubMed=1325431;
RX   PubMed=1350752;
RX   PubMed=8075973;
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z603 ! OS2 [Human lung carcinoma]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   OS2-RA-R
AC   CVCL_A1LM
DR   Wikidata; Q102114687
RX   PubMed=1350752;
CC   Population: Japanese.
CC   Characteristics: Resistant to the cytostatic activity of lymphokine-activated killer (LAK) cells.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z604 ! OS2-RA
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   OS2.4
AC   CVCL_L370
SY   OS2_4
DR   GEO; GSM1974796
DR   Wikidata; Q54936551
RX   DOI=10.4236/ojvm.2012.24045;
RX   PubMed=9585065;
RX   PubMed=21801068;
RX   PubMed=27197945;
RX   PubMed=31175136;
RX   PubMed=36099278;
CC   Part of: FACC canine tumor cell line panel.
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Ile222Thr (c.665T>C); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231,239
ST   Dog FHC2054: 176
ST   Dog FHC2079: 275
ST   Dog PEZ1: 119
ST   Dog PEZ3: 121
ST   Dog PEZ5: 111
ST   Dog PEZ6: 176,179
ST   Dog PEZ8: 236,240
ST   Dog PEZ12: 285
ST   Dog PEZ20: 180
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   OS2.4/Doxo
AC   CVCL_L371
DR   Wikidata; Q54936555
RX   PubMed=17916018;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_L370 ! OS2.4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   OS2000
AC   CVCL_D881
DR   Wikidata; Q54936556
RX   PubMed=12898310;
RX   PubMed=15289353;
RX   PubMed=19818766;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*55:02,40:02; C*01:02 (PubMed=15289353).
CC   HLA typing: A*24; B*55,61; C*01 (PubMed=19818766).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   OS242
AC   CVCL_C5T5
DR   Wikidata; Q116050073
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS252
AC   CVCL_WU66
DR   cancercelllines; CVCL_WU66
DR   Cell_Model_Passport; SIDM01786
DR   DepMap; ACH-001814
DR   Wikidata; Q98128379
RX   PubMed=35312779;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): DepMap=ACH-001814
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 12
ST   D18S51: 12,18
ST   D21S11: 29
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 10
ST   Penta E: 7,8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   OS255
AC   CVCL_C5T6
DR   Wikidata; Q116050074
RX   PubMed=35312779;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OS3 [Human lung carcinoma]
AC   CVCL_Z605
DR   Cosmic; 1077282
DR   Wikidata; Q54936557
RX   PubMed=1325431;
RX   PubMed=2161815;
RX   PubMed=8075973;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z606 ! OS3-R5
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   OS3 [Human osteosarcoma]
AC   CVCL_F866
DR   Wikidata; Q54936558
RX   PubMed=19746444;
CC   Population: Chinese; Indonesia.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   OS3 [Mouse adrenocortical tumor]
AC   CVCL_5F73
DR   Wikidata; Q54936559
RX   PubMed=4311571;
RX   PubMed=6270152;
RX   PubMed=7588376;
RX   PubMed=15541570;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0585 ! Y1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   OS3 [Mouse brain]
AC   CVCL_U177
DR   CLO; CLO_0050904
DR   RCB; RCB1593
DR   Wikidata; Q54936560
RX   PubMed=1335367;
RX   PubMed=7783968;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Oligodendrocyte precursor cell; CL=CL_0002453.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   <1D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   OS3-HGPRT-
AC   CVCL_5G25
DR   Wikidata; Q54936561
RX   PubMed=198663;
RX   PubMed=6270152;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5F73 ! OS3 [Mouse adrenocortical tumor]
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   OS3-R5
AC   CVCL_Z606
SY   OS3R5
DR   Wikidata; Q54936562
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Z605 ! OS3 [Human lung carcinoma]
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   OS3-R5-GFP
AC   CVCL_A1JA
DR   Wikidata; Q102114690
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z606 ! OS3-R5
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   OS3-R5-GFP-CD9
AC   CVCL_A1JB
DR   Wikidata; Q102114691
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Characteristics: Transfected with CD9 fused to the C-terminal of eGFP with a 9 AA linker SGLRSRAQA (PubMed=12569360).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1709; CD9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z606 ! OS3-R5
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   OS3-R5-pZCD9
AC   CVCL_E3FA
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1709; CD9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z606 ! OS3-R5
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   OS300
AC   CVCL_C5T7
DR   Wikidata; Q116050075
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS301
AC   CVCL_C5T8
DR   Wikidata; Q116050076
RX   PubMed=35312779;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS308
AC   CVCL_C5T9
DR   Wikidata; Q116050078
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS322
AC   CVCL_C5TA
DR   Wikidata; Q116050079
RX   PubMed=35312779;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS337
AC   CVCL_C5TB
DR   Wikidata; Q116050080
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS340
AC   CVCL_C5TC
DR   Wikidata; Q116050081
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS342
AC   CVCL_C5TD
DR   Wikidata; Q116050082
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS343
AC   CVCL_C5TE
DR   Wikidata; Q116050083
RX   PubMed=35312779;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS354
AC   CVCL_C5TF
DR   Wikidata; Q116050084
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS355
AC   CVCL_C5TG
DR   Wikidata; Q116050086
RX   PubMed=35312779;
CC   Omics: Proteomics.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS365
AC   CVCL_C5TH
DR   Wikidata; Q116050087
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS366
AC   CVCL_C5TI
DR   Wikidata; Q116050088
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS368
AC   CVCL_C5TJ
DR   Wikidata; Q116050089
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS373
AC   CVCL_C5TK
DR   Wikidata; Q116050090
RX   PubMed=35312779;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   OS377
AC   CVCL_C5TL
DR   Wikidata; Q116050091
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS379
AC   CVCL_C5TM
DR   Wikidata; Q116050092
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS384
AC   CVCL_C8FU
SY   PSS131R
DR   DepMap; ACH-002834
DR   Wikidata; Q123033223
RX   PubMed=37703185;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Metastatic (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Equivalence of OS384 with PSS131R from personal communication of Sayles, Leanne C.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   OS396
AC   CVCL_C5TN
DR   Wikidata; Q116050093
RX   PubMed=35312779;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   OS4
AC   CVCL_Z607
DR   Wikidata; Q54936566
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   OS457
AC   CVCL_C8FV
DR   Wikidata; Q123033225
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Not metastatic (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 10
ST   D5S818: 7,13
ST   D7S820: 8,14
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OS5
AC   CVCL_Z608
DR   Wikidata; Q54936568
RX   PubMed=8075973;
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   OS525
AC   CVCL_C8FW
DR   Wikidata; Q123033226
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Highly metastatic (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OS526
AC   CVCL_C8FX
DR   Wikidata; Q123033227
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Metastatic (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OS6
AC   CVCL_Z609
DR   Wikidata; Q54936569
RX   PubMed=1325431;
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   OS7
AC   CVCL_Z610
DR   Wikidata; Q54936570
RX   PubMed=1325431;
RX   PubMed=8075973;
RX   PubMed=12569360;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   OS742
AC   CVCL_C8FY
DR   Wikidata; Q123033228
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Characteristics: Highly metastatic (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 11,14
ST   D16S539: 10
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OS766
AC   CVCL_C8FZ
DR   Wikidata; Q123033229
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,14
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OS774
AC   CVCL_D3W0
DR   Wikidata; Q127383001
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 7,12
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   OS833
AC   CVCL_C8G0
DR   Wikidata; Q123033231
RX   PubMed=37703185;
CC   Characteristics: Established from a patient-derived xenograft established by implantation of the original tumor under the renal capsule of NSG mice (PubMed=37703185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, fibula; UBERON=UBERON_0001446.
ST   Source(s): PubMed=37703185
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 15
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   OSA 1777
AC   CVCL_ZV94
DR   Wikidata; Q98128380
RX   PubMed=31736134;
RX   PubMed=40772425;
CC   Problematic cell line: Contaminated. Shown to be a SYO-1 derivative (PubMed=40772425). Originally thought to originate from a 19 year old female patient with a proximal femus osteosarcoma.
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=31736134).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
ST   Source(s): PubMed=31736134
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 9,13
ST   D18S51: 15,19
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 11
ST   D8S1179: 12,24
ST   FGA: 19,24
ST   Penta D: 9,12
ST   Penta E: 5,15
ST   TH01: 6,7
ST   TPOX: 9,12
ST   vWA: 17
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7146 ! SYO-1
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   OSA-80
AC   CVCL_EQ73
SY   OSA 80
DR   GDSC; 1298361
DR   PharmacoDB; OSA80_1204_2019
DR   Wikidata; Q54936563
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 6
//
ID   OSA344
AC   CVCL_6264
SY   OSA-344
DR   BTO; BTO_0004885
DR   Wikidata; Q54936564
RX   PubMed=20144850;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   OSC
AC   CVCL_IY73
SY   Ovarian Somatic Cells
DR   EFO; EFO_0005834
DR   DGRC; 288
DR   ENCODE; ENCBS251BEU
DR   FlyBase_Cell_line; FBtc0000288
DR   Wikidata; Q54936571
RX   PubMed=19812547;
RX   PubMed=24434506;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_1B45 ! fGS/OSS
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   OSC-1 [Human esophageal squamous cell carcinoma]
AC   CVCL_E312
SY   OSC1
DR   Wikidata; Q54936572
RX   PubMed=9216685;
CC   Doubling time: 36 hours (PubMed=9216685).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   OSC-1 [Human tongue SCC]
AC   CVCL_HF91
DR   Wikidata; Q54936574
RX   PubMed=7703799;
CC   Population: Japanese.
CC   Doubling time: 38.6 hours (PubMed=7703799).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   OSC-19
AC   CVCL_3086
SY   OSC19; Osc19
DR   CLO; CLO_0009949
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 978
DR   BioSample; SAMN03471655
DR   Cell_Model_Passport; SIDM00566
DR   Cosmic; 1120701
DR   Cosmic-CLP; 1298362
DR   DepMap; ACH-001625
DR   EGA; EGAS00001000978
DR   GDSC; 1298362
DR   GEO; GSM1670308
DR   JCRB; FDSC0050
DR   JCRB; JCRB0198
DR   LINCS_LDP; LCL-1219
DR   PharmacoDB; OSC19_1205_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54936575
RX   DOI=10.15114/tr.23.43;
RX   DOI=10.15114/tr.24.57;
RX   DOI=10.15114/tr.35.25;
RX   PubMed=19123955;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/28201/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 33.4 hours (Note=At 12th passage), 25.1 hours (Note=At 28th passage), 16.7 hours (Note=At 55th passage) (DOI=10.15114/tr.23.43); ~61 hours (Note=Lot 05112018), ~50 hours (Note=Lot 04012012), 60 hours (Note=Lot 04132010) (JCRB=JCRB0198).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (Cosmic-CLP=1298362; DepMap=ACH-001625).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.1%; Native American=0.32%; East Asian, North=72.98%; East Asian, South=24.24%; South Asian=0.65%; European, North=1.7%; European, South=0.01% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0050; true.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=1298362; DepMap=ACH-001625; JCRB=JCRB0198; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 13
ST   D21S11: 30,31
ST   D3S1358: 14,15
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14 (Cosmic-CLP=1298362; JCRB=JCRB0198)
ST   vWA: 14,18 (DepMap=ACH-001625; PubMed=21868764)
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   OSC-19LN1
AC   CVCL_AT74
SY   OSC19LN1
DR   Wikidata; Q54936576
RX   PubMed=21868764;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3086 ! OSC-19
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   OSC-19LN2
AC   CVCL_AT75
SY   OSC19LN2
DR   Wikidata; Q54936577
RX   PubMed=21868764;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AT74 ! OSC-19LN1
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   OSC-19LN3
AC   CVCL_AT76
SY   OSC19LN3
DR   Wikidata; Q54936578
RX   PubMed=21868764;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AT75 ! OSC-19LN2
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   OSC-19LN4
AC   CVCL_AT77
SY   OSC19LN4
DR   Wikidata; Q54936579
RX   PubMed=21868764;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AT76 ! OSC-19LN3
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   OSC-19LN5
AC   CVCL_AT78
SY   OSC19LN5
DR   Wikidata; Q54936580
RX   PubMed=21868764;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AT77 ! OSC-19LN4
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   OSC-2 [Human esophageal squamous cell carcinoma]
AC   CVCL_E313
SY   OSC2
DR   Wikidata; Q54936581
RX   PubMed=9216685;
CC   Doubling time: 50 hours (PubMed=9216685).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   OSC-2 [Human gingival squamous cell carcinoma]
AC   CVCL_HF92
DR   Wikidata; Q54936582
RX   PubMed=7703799;
CC   Population: Japanese.
CC   Doubling time: 22.9 hours (PubMed=7703799).
CC   Derived from site: Metastatic; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   OSC-20
AC   CVCL_3087
SY   OSC20
DR   CLO; CLO_0009950
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 979
DR   cancercelllines; CVCL_3087
DR   Cell_Model_Passport; SIDM00565
DR   Cosmic; 1120702
DR   Cosmic; 1995604
DR   Cosmic-CLP; 1240196
DR   DepMap; ACH-001626
DR   EGA; EGAS00001000978
DR   GDSC; 1240196
DR   GEO; GSM827220
DR   GEO; GSM1670309
DR   JCRB; FDSC0051
DR   JCRB; JCRB0197
DR   LINCS_LDP; LCL-1220
DR   PharmacoDB; OSC20_1206_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3087
DR   Wikidata; Q54936583
RX   DOI=10.15114/tr.25.93;
RX   DOI=10.15114/tr.35.25;
RX   PubMed=9119748;
RX   PubMed=12716470;
RX   PubMed=19123955;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 27.4 hours (Note=At 35th passage) (DOI=10.15114/tr.25.93); 65 hours (Note=Lot 02032003), ~49 hours (Note=Lot 11152011), ~35 hours (Note=Lot 07182019) (JCRB=JCRB0197).
CC   HLA typing: A*02,11; B*46,55; C*w01,w09 (PubMed=9119748).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro81Leu (c.242C>T); ClinVar=VCV000833629; Zygosity=Homozygous (Cosmic-CLP=1240196; DepMap=ACH-001626).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1048Arg (c.3143A>G); ClinVar=VCV000450316; Zygosity=Heterozygous (Cosmic-CLP=1240196; DepMap=ACH-001626).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (Cosmic-CLP=1240196; DepMap=ACH-001626).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.14%; Native American=0.23%; East Asian, North=75.72%; East Asian, South=16.66%; South Asian=0%; European, North=0%; European, South=4.24% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0051; true.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Cosmic-CLP=1240196; DepMap=ACH-001626
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 13
ST   D21S11: 29,32.2
ST   D3S1358: 16
ST   D5S818: 13 (Cosmic-CLP=1240196)
ST   D5S818: 13,14 (DepMap=ACH-001626)
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 14,16
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WW78 ! TcOSC-20
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   OSC-3
AC   CVCL_HF93
DR   Wikidata; Q54936584
RX   PubMed=7703799;
CC   Population: Japanese.
CC   Doubling time: 31.3 hours (PubMed=7703799).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   OSC-30
AC   CVCL_A399
SY   OSC30
DR   Cosmic; 1120703
DR   Wikidata; Q54936585
RX   DOI=10.15114/tr.35.25;
RX   PubMed=19123955;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   OSC-4
AC   CVCL_HF94
SY   OSC4
DR   Cosmic; 2546838
DR   Wikidata; Q54936586
RX   PubMed=7703799;
RX   PubMed=17325662;
CC   Population: Japanese.
CC   Doubling time: 21.2 hours (PubMed=7703799).
CC   Derived from site: Metastatic; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   OSC-40
AC   CVCL_A400
SY   OSC40
DR   Wikidata; Q54936587
RX   DOI=10.15114/tr.35.25;
RX   PubMed=19123955;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   OSC-5
AC   CVCL_HF95
SY   OSC5
DR   Cosmic; 2546839
DR   Wikidata; Q54936588
RX   PubMed=7703799;
RX   PubMed=17325662;
CC   Population: Japanese.
CC   Doubling time: 32.5 hours (PubMed=7703799).
CC   Derived from site: Metastatic; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   OSC-6
AC   CVCL_HF96
SY   OSC6
DR   Cosmic; 2546840
DR   Wikidata; Q54936589
RX   PubMed=7703799;
RX   PubMed=17325662;
CC   Population: Japanese.
CC   Doubling time: 39.4 hours (PubMed=7703799).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   OSC-7
AC   CVCL_HF97
DR   Wikidata; Q54936590
RX   PubMed=7703799;
CC   Population: Japanese.
CC   Doubling time: 54.7 hours (PubMed=7703799).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   OSC-70
AC   CVCL_A401
SY   OSC70
DR   Cosmic; 1120704
DR   Wikidata; Q54936591
RX   DOI=10.15114/tr.35.25;
RX   PubMed=19123955;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   OSC:eFH-piwi
AC   CVCL_C7G5
DR   DGRC; 322
DR   FlyBase_Cell_line; FBtc0000322
DR   GEO; GSE156058
DR   Wikidata; Q117704760
RX   PubMed=35639929;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 Piwi was endogenously tagged with a FLAG-HA tag (PubMed=35639929).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_IY73 ! OSC
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   OSCA-00
AC   CVCL_0A73
SY   OSCA-0
DR   Wikidata; Q54936592
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y6M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-01
AC   CVCL_L372
SY   OSCA-1
DR   Wikidata; Q54936593
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y9M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-02
AC   CVCL_0A74
SY   OSCA-2; OSCA2; OSA2
DR   Wikidata; Q54936594
RX   PubMed=21621658;
RX   PubMed=23365669;
RX   PubMed=36099278;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
ST   Source(s): PubMed=36099278
ST   Dog FHC2010: 226,238
ST   Dog FHC2054: 151,155
ST   Dog FHC2079: 287
ST   Dog PEZ1: 108,120
ST   Dog PEZ3: 120
ST   Dog PEZ5: 103
ST   Dog PEZ6: 175,179
ST   Dog PEZ8: 234,238
ST   Dog PEZ12: 274,286
ST   Dog PEZ20: 188
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   OSCA-03
AC   CVCL_0A75
SY   OSCA-3
DR   Wikidata; Q54936595
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y5M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-04
AC   CVCL_L388
SY   OSCA-4
DR   Wikidata; Q54936596
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Caution: Indicated as originating from a male dog in PubMed=21621658 and a female dog in PubMed=23311495.
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y11M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   OSCA-05
AC   CVCL_0A76
SY   OSCA-5
DR   Wikidata; Q54936597
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   3Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-06M
AC   CVCL_L397
SY   ACCR-6; OSCA-6
DR   Wikidata; Q54936601
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Rhodesian Ridgeback; VBO=VBO_0201135.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y4M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   OSCA-07
AC   CVCL_0A77
SY   OSCA-7
DR   Wikidata; Q54936602
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y3M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-08
AC   CVCL_L405
SY   OSCA-8; OSCA8; OSA8
DR   GEO; GSM1974797
DR   Kerafast; EMN001-FP
DR   Wikidata; Q54936603
RX   PubMed=20594083;
RX   PubMed=21621658;
RX   PubMed=23311495;
RX   PubMed=23365669;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
RX   PubMed=36099278;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 21 hours (PubMed=27257868); ~22 hours (Kerafast=EMN001-FP).
CC   Sequence variation: Mutation; VGNC; VGNC:54168; KDM6A; Simple; p.Thr986fs (c.2957delC); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 227
ST   Dog FHC2054: 156
ST   Dog FHC2079: 271,291
ST   Dog PEZ1: 107,111
ST   Dog PEZ3: 121,124
ST   Dog PEZ5: 111
ST   Dog PEZ6: 179
ST   Dog PEZ8: 236
ST   Dog PEZ12: 295
ST   Dog PEZ20: 176
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 24
//
ID   OSCA-09
AC   CVCL_0A78
SY   OSCA-9
DR   Wikidata; Q54936604
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Irish Setter; VBO=VBO_0200702.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y5M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   OSCA-10
AC   CVCL_0A79
DR   Wikidata; Q54936606
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y1M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-109
AC   CVCL_L373
DR   Wikidata; Q54936608
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Irish Setter; VBO=VBO_0200702.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y1M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-11M
AC   CVCL_L374
SY   OSCA-11
DR   Wikidata; Q54936609
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Caution: Indicated as originating from a female dog in PubMed=21621658 and a male dog in PubMed=23311495.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   OSCA-12
AC   CVCL_L375
DR   Wikidata; Q54936610
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-13
AC   CVCL_0A80
DR   Wikidata; Q54936611
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-14
AC   CVCL_0A81
DR   Wikidata; Q54936612
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-15
AC   CVCL_0A82
DR   Wikidata; Q54936613
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-16
AC   CVCL_L376
SY   OSCA-16M; OSA16
DR   Wikidata; Q54936615
RX   PubMed=20594083;
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y3M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   OSCA-17
AC   CVCL_L377
DR   Wikidata; Q54936616
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-18
AC   CVCL_0A83
DR   Wikidata; Q54936617
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y3M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-19
AC   CVCL_L378
DR   Wikidata; Q54936618
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y1M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-20
AC   CVCL_L379
DR   Wikidata; Q54936619
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-21
AC   CVCL_L380
DR   Wikidata; Q54936620
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y2M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-22
AC   CVCL_L381
DR   Wikidata; Q54936621
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y1M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-23
AC   CVCL_L382
DR   Wikidata; Q54936622
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-24
AC   CVCL_0A84
DR   Wikidata; Q54936623
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y8M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-25
AC   CVCL_L383
SY   OSCA 25
DR   Wikidata; Q54936625
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y1M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-26
AC   CVCL_0A85
DR   Wikidata; Q54936626
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y7M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-27
AC   CVCL_0A86
DR   Wikidata; Q54936627
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Irish Setter; VBO=VBO_0200702.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y6M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-28
AC   CVCL_0A87
DR   Wikidata; Q54936628
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Greyhound; VBO=VBO_0200638.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-29
AC   CVCL_L384
DR   Kerafast; EMN014-FP
DR   Wikidata; Q54936629
RX   PubMed=21621658;
RX   PubMed=23311495;
RX   PubMed=23365669;
CC   Doubling time: ~1 day (Kerafast=EMN014-FP).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y9M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   OSCA-30
AC   CVCL_L385
DR   Wikidata; Q54936630
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-31
AC   CVCL_0A88
DR   Wikidata; Q54936631
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-32
AC   CVCL_L386
SY   OSCA 32; OSA32
DR   Kerafast; EMN002-FP
DR   Wikidata; Q54936632
RX   PubMed=20594083;
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Doubling time: ~22 hours (Kerafast=EMN002-FP).
CC   Derived from site: In situ; Bone, radius; UBERON=UBERON_0001423.
CC   Breed/subspecies: Pyrenean mountain dog; VBO=VBO_0200629.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   OSCA-33
AC   CVCL_L387
DR   Wikidata; Q54936633
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y1M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-35
AC   CVCL_0A89
DR   Wikidata; Q54936634
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y6M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-36
AC   CVCL_0A90
SY   OSA36
DR   Wikidata; Q54936636
RX   PubMed=20594083;
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   OSCA-37
AC   CVCL_0A91
DR   Wikidata; Q54936637
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Greyhound; VBO=VBO_0200638.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y11M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-38
AC   CVCL_0A92
DR   Wikidata; Q54936638
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Pyrenean mountain dog; VBO=VBO_0200629.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-39
AC   CVCL_0A93
DR   Wikidata; Q54936639
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Great Dane; VBO=VBO_0200623.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y7M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-40
AC   CVCL_L389
DR   Kerafast; EMN003-FP
DR   Wikidata; Q54936640
RX   PubMed=21621658;
RX   PubMed=23311495;
RX   PubMed=23365669;
CC   Doubling time: ~22 hours (Kerafast=EMN003-FP).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
CC   Breed/subspecies: Saint Bernard; VBO=VBO_0201160.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 16
//
ID   OSCA-41
AC   CVCL_L390
SY   OSCA 41
DR   Wikidata; Q54936641
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Alaskan Malamute; VBO=VBO_0200017.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y1M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-42
AC   CVCL_0A94
DR   Wikidata; Q54936642
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Pyrenean mountain dog; VBO=VBO_0200629.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y8M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 6
//
ID   OSCA-43
AC   CVCL_0A95
DR   Wikidata; Q54936643
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   3Y5M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-44
AC   CVCL_0A96
DR   Wikidata; Q54936645
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Leonberger; VBO=VBO_0200819.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y2M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-45
AC   CVCL_L391
DR   Wikidata; Q54936646
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Irish Setter; VBO=VBO_0200702.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-46
AC   CVCL_0A97
DR   Wikidata; Q54936655
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   4Y5M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-47
AC   CVCL_0A98
DR   Wikidata; Q54936657
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Irish Setter; VBO=VBO_0200702.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y11M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-48
AC   CVCL_0A99
DR   Wikidata; Q54936658
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-49
AC   CVCL_0B00
DR   Wikidata; Q54936659
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-50
AC   CVCL_L392
DR   Wikidata; Q54936660
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   3Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-51
AC   CVCL_0B01
DR   Wikidata; Q54936661
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-52
AC   CVCL_0B02
DR   Wikidata; Q54936662
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y9M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-53M
AC   CVCL_0B03
DR   Wikidata; Q54936663
RX   PubMed=21621658;
CC   Derived from site: Metastatic; Not specified.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   4Y2M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-54
AC   CVCL_0B04
DR   Wikidata; Q54936664
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-55
AC   CVCL_L393
DR   Wikidata; Q54936665
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Borzoi; VBO=VBO_0200197.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y11M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-56
AC   CVCL_L394
DR   Wikidata; Q54936666
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-57
AC   CVCL_L395
DR   Wikidata; Q54936667
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y9M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-58
AC   CVCL_0B05
DR   Wikidata; Q54936668
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y9M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-59
AC   CVCL_L396
DR   Wikidata; Q54936670
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y5M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-60
AC   CVCL_L398
DR   Wikidata; Q54936671
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Mastiff; VBO=VBO_0200867.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-61
AC   CVCL_0B06
DR   Wikidata; Q54936672
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-62
AC   CVCL_0B17
DR   Wikidata; Q54936673
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-63
AC   CVCL_0B07
DR   Wikidata; Q54936674
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Scottish Deerhound; VBO=VBO_0201195.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-64M
AC   CVCL_0B08
DR   Wikidata; Q54936675
RX   PubMed=21621658;
CC   Derived from site: Metastatic; Not specified.
CC   Breed/subspecies: Rhodesian Ridgeback; VBO=VBO_0201135.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   OSCA-65
AC   CVCL_0B09
DR   Wikidata; Q54936676
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: American Bulldog; VBO=VBO_0200034.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-66
AC   CVCL_0B10
DR   Wikidata; Q54936677
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y7M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-67
AC   CVCL_L399
DR   Wikidata; Q54936678
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Mastiff; VBO=VBO_0200867.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y3M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-68
AC   CVCL_0B11
DR   Wikidata; Q54936679
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y1M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-69
AC   CVCL_0B12
DR   Wikidata; Q54936680
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y11M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-70
AC   CVCL_0B13
DR   Wikidata; Q54936681
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-71
AC   CVCL_L400
DR   Kerafast; EMN015-FP
DR   Wikidata; Q54936682
RX   PubMed=21621658;
RX   PubMed=23311495;
RX   PubMed=23365669;
CC   Doubling time: ~1 day (Kerafast=EMN015-FP).
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   6Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
ID   OSCA-72
AC   CVCL_0B14
DR   Wikidata; Q54936683
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-73
AC   CVCL_L401
DR   Wikidata; Q54936684
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   2Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-74
AC   CVCL_0B15
DR   Wikidata; Q54936685
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   OSCA-75
AC   CVCL_L402
DR   Wikidata; Q54936686
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-76
AC   CVCL_0B16
DR   Wikidata; Q54936687
RX   PubMed=21621658;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y5M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 7
//
ID   OSCA-77
AC   CVCL_L403
DR   Wikidata; Q54936688
RX   PubMed=21621658;
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Belgian Malinois; VBO=VBO_0200147.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y1M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-78
AC   CVCL_L404
DR   Kerafast; EMN004-FP
DR   Wikidata; Q54936689
RX   PubMed=21621658;
RX   PubMed=23311495;
RX   PubMed=23365669;
CC   Doubling time: ~22 hours (Kerafast=EMN004-FP).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y3M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 16
//
ID   OSCA-84
AC   CVCL_L406
DR   Wikidata; Q54936690
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-96
AC   CVCL_L407
DR   Wikidata; Q54936691
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Mastiff; VBO=VBO_0200867.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y2M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-98
AC   CVCL_L408
DR   Wikidata; Q54936692
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCA-99
AC   CVCL_L409
DR   Wikidata; Q54936693
RX   PubMed=23311495;
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
CC   Breed/subspecies: Labrador Retriever x Unspecified breed; VBO=VBO_0200800+VBO_0400024.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   OSCAR
AC   CVCL_B020
SY   INSERMe001-A; INSRMe001-A
DR   hPSCreg; INSRMe001-A
DR   SKIP; SKIP002308
DR   Wikidata; Q54936694
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_oscar.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-088-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   OSCC-1/KMC
AC   CVCL_KR33
DR   Wikidata; Q54936695
RX   PubMed=17587681;
CC   Population: Chinese.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 6
//
ID   OSCC-3
AC   CVCL_L894
SY   OSCC3
DR   Cosmic; 2550366
DR   Wikidata; Q54936696
RX   PubMed=8686749;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   OSCC-BD
AC   CVCL_2H27
DR   Wikidata; Q54936705
RX   PubMed=26234610;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu188_Pro191del (c.563_574del12); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C129863; Oral epithelial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1180 ! DOK
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   OSE
AC   CVCL_B7M8
DR   Wikidata; Q114312639
RX   PubMed=10079298;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln51Metfs*32 (c.151_154delCAAG); Zygosity=Homozygous (PubMed=10079298).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   OSE-MG63
AC   CVCL_WR53
DR   Wikidata; Q98128381
RX   PubMed=23675497;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing 6 tandem repeats of the osteoblastic specific element 2 (OSE2) and a minimal mOG2 promoter upstream of eGFP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   OSE10 sv
AC   CVCL_6703
SY   Ovarian Surface Epithelium 10 SV40-transformed
DR   Wikidata; Q54936706
RX   PubMed=11277643;
CC   Doubling time: 21.3 hours (PubMed=11277643).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OSE2a sv
AC   CVCL_6704
SY   OSE2a; Ovarian Surface Epithelium 2a SV40-transformed
DR   Wikidata; Q54936707
RX   PubMed=11277643;
RX   PubMed=12770728;
CC   Doubling time: 33.1 hours (PubMed=11277643).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6705 ! OSE2b sv
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OSE2b sv
AC   CVCL_6705
SY   Ovarian Surface Epithelium 2b SV40-transformed
DR   Wikidata; Q54936708
RX   PubMed=11277643;
CC   Doubling time: 26.1 hours (PubMed=11277643).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6704 ! OSE2a sv
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OSE2b-2 sv
AC   CVCL_6706
SY   OSE2b-2
DR   Wikidata; Q54936709
RX   PubMed=11277643;
RX   PubMed=12770728;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6705 ! OSE2b sv
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OSE4 sv
AC   CVCL_6707
SY   Ovarian Surface Epithelium 4 SV40-transformed
DR   Wikidata; Q54936710
RX   PubMed=11277643;
CC   Doubling time: 29.1 hours (PubMed=11277643).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OSE6 sv
AC   CVCL_6708
SY   Ovarian Surface Epithelium 6 SV40-transformed
DR   Wikidata; Q54936711
RX   PubMed=11277643;
CC   Doubling time: 26.1 hours (PubMed=11277643).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OSE7 sv
AC   CVCL_6709
SY   Ovarian Surface Epithelium 7 SV40-transformed
DR   Wikidata; Q54936712
RX   PubMed=11277643;
CC   Doubling time: 29.9 hours (PubMed=11277643).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-8-16).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OSEV
AC   CVCL_A5LR
DR   Wikidata; Q107116616
RX   PubMed=2293550;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OSFL
AC   CVCL_A5LS
DR   Wikidata; Q107116617
RX   PubMed=2293550;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OSFN
AC   CVCL_A5LT
DR   Wikidata; Q107116618
RX   PubMed=2293550;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OSHU-1
AC   CVCL_M604
DR   Wikidata; Q54936713
RX   PubMed=6931250;
CC   Doubling time: 70-80 hours (PubMed=6931250).
CC   Derived from site: In situ; Bone, pubis; UBERON=UBERON_0001275.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 30-01-24; Version: 8
//
ID   OSK43
AC   CVCL_ZF28
DR   Wikidata; Q98128382
RX   PubMed=22246506;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9NP58; Human ABCB6.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_ZF27 ! JMS-3
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   OSON
AC   CVCL_A5LU
DR   Wikidata; Q107116619
RX   PubMed=2293550;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OSPR
AC   CVCL_A5LV
SY   PR
DR   BTO; BTO_0002177
DR   Wikidata; Q107116620
RX   PubMed=2293550;
RX   PubMed=7515829;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   OSQ1
AC   CVCL_Z081
DR   Wikidata; Q54936714
RX   PubMed=12569360;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   OSrb/N-M
AC   CVCL_IP67
DR   Wikidata; Q54936716
RX   PubMed=10077219;
CC   Population: Japanese.
CC   Doubling time: 84.7 hours (PubMed=10077219).
CC   Donor information: Established from a patient that suffered from bilateral retinoblastoma at infancy.
CC   Derived from site: Metastatic; Bone, left humerus; UBERON=UBERON_0000976.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y5M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   OSRGa
AC   CVCL_4459
SY   OSRGA
DR   BTO; BTO_0003967
DR   Wikidata; Q54936717
RX   PubMed=15894525;
CC   Transformant: NCIt; C129639; Cerium-144 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   OSRi001-A
AC   CVCL_WN91
SY   PD-OPA1-A495V#72
DR   BioSamples; SAMEA5712221
DR   hPSCreg; OSRi001-A
DR   Wikidata; Q98128383
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Ala495Val (c.1484C>T); Zygosity=Heterozygous (hPSCreg=OSRi001-A).
CC   Derived from site: In situ; Arm, skeletal muscle; UBERON=UBERON_0001499.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
DI   NCIt; C169000; Optic atrophy 1
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   OSRi002-A
AC   CVCL_A1QA
SY   PD-OPA1-G488R#12
DR   hPSCreg; OSRi002-A
DR   Wikidata; Q102114692
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Gly488Arg (c.1462G>A); ClinVar=VCV000447893; Zygosity=Heterozygous (hPSCreg=OSRi002-A).
DI   NCIt; C169000; Optic atrophy 1
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   OSRi003-A
AC   CVCL_A1QB
SY   PD-OPA1-G488R#22
DR   hPSCreg; OSRi003-A
DR   Wikidata; Q102114693
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Gly488Arg (c.1462G>A); ClinVar=VCV000447893; Zygosity=Heterozygous (hPSCreg=OSRi003-A).
DI   NCIt; C169000; Optic atrophy 1
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   OSRi004-A
AC   CVCL_WN92
SY   ND#37
DR   BioSamples; SAMEA5712223
DR   hPSCreg; OSRi004-A
DR   Wikidata; Q98128384
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 7
//
ID   OSRi005-A
AC   CVCL_WT09
SY   ND#68
DR   hPSCreg; OSRi005-A
DR   Wikidata; Q98128385
CC   From: Ospedale San Raffaele; Milan; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   OSRi006-A
AC   CVCL_WT10
SY   ND#3.1
DR   hPSCreg; OSRi006-A
DR   Wikidata; Q98128386
CC   From: Ospedale San Raffaele; Milan; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   OSRi007-A
AC   CVCL_WT11
SY   ND#201-010
DR   hPSCreg; OSRi007-A
DR   Wikidata; Q98128387
CC   From: Ospedale San Raffaele; Milan; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   OSRi008-A
AC   CVCL_WT12
SY   ND#201-012
DR   hPSCreg; OSRi008-A
DR   Wikidata; Q98128388
CC   From: Ospedale San Raffaele; Milan; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   OSRi009-A
AC   CVCL_A0XY
SY   SGS_D868N
DR   BioSamples; SAMEA9679952
DR   hPSCreg; OSRi009-A
DR   Wikidata; Q108821078
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple; p.Asp868Asn (c.2602G>A); ClinVar=VCV000001032; Zygosity=Heterozygous (hPSCreg=OSRi009-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129308; Schinzel-Giedion midface-retraction syndrome
DI   ORDO; Orphanet_798; Schinzel-Giedion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   OSRi009-A-1
AC   CVCL_A0XZ
SY   SGS_D868D
DR   BioSamples; SAMEA9679973
DR   hPSCreg; OSRi009-A-1
DR   Wikidata; Q108821079
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple_corrected; p.Asp868Asn (c.2602G>A); ClinVar=VCV000001032; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=OSRi009-A-1).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129308; Schinzel-Giedion midface-retraction syndrome
DI   ORDO; Orphanet_798; Schinzel-Giedion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0XY ! OSRi009-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   OSRi010-A
AC   CVCL_A0YA
SY   SGS_I871T
DR   BioSamples; SAMEA9686048
DR   hPSCreg; OSRi010-A
DR   Wikidata; Q108821081
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple; p.Ile871Thr (c.2612T>C); ClinVar=VCV000001031; Zygosity=Heterozygous (hPSCreg=OSRi010-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129308; Schinzel-Giedion midface-retraction syndrome
DI   ORDO; Orphanet_798; Schinzel-Giedion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   OSRi010-A-1
AC   CVCL_A0YB
SY   SGS_I871I
DR   BioSamples; SAMEA9687262
DR   hPSCreg; OSRi010-A-1
DR   Wikidata; Q108821082
CC   From: Ospedale San Raffaele; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple_corrected; p.Ile871Thr (c.2612T>C); ClinVar=VCV000001031; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=OSRi010-A-1).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129308; Schinzel-Giedion midface-retraction syndrome
DI   ORDO; Orphanet_798; Schinzel-Giedion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0YA ! OSRi010-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   OSS
AC   CVCL_1B46
SY   Ovarian Somatic Sheath
DR   EFO; EFO_0005835
DR   DGRC; 190
DR   ENCODE; ENCBS977DNJ
DR   FlyBase_Cell_line; FBtc0000190
DR   Wikidata; Q54936718
RX   PubMed=17056713;
RX   PubMed=24434506;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 45 hours (DGRC=190).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_1B45 ! fGS/OSS
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   OSSK
AC   CVCL_A5LW
DR   Wikidata; Q107116621
RX   PubMed=2293550;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OSSM
AC   CVCL_A5LX
DR   Wikidata; Q107116622
RX   PubMed=2293550;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OST
AC   CVCL_8399
SY   Ost; OST-1; Osteogenic Sarcoma Takase
DR   BioSample; SAMN03151751
DR   ChEMBL-Cells; CHEMBL3307563
DR   ChEMBL-Targets; CHEMBL614210
DR   PubChem_Cell_line; CVCL_8399
DR   RCB; RCB0454
DR   Wikidata; Q54936720
RX   CelloPub=CLPUB00520;
RX   PubMed=1586971;
RX   PubMed=12645653;
RX   PubMed=15150091;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a 15 year old female patient with an osteosarcoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00339.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: RCB; RCB0454; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   OST 10 PT
AC   CVCL_W923
SY   OST10T
DR   Cosmic; 2053615
DR   Wikidata; Q54936721
RX   PubMed=24190505;
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   60Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   OST 7 PT
AC   CVCL_W924
SY   OST7T
DR   Cosmic; 2053621
DR   Wikidata; Q54936722
RX   PubMed=24190505;
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   13Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   OST 8 PT
AC   CVCL_W925
SY   OST8T
DR   Cosmic; 2053622
DR   Wikidata; Q54936723
RX   PubMed=24190505;
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   16Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   OST-1-PF
AC   CVCL_WW21
SY   OST-1-Protein Free
DR   Wikidata; Q98128389
RX   DOI=10.1007/978-94-011-0848-5_90;
RX   PubMed=1586971;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Parent cell line (OST) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8399 ! OST
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   OST-II
AC   CVCL_WW20
SY   Osteogenic Sarcoma Takase-II
DR   Wikidata; Q98128390
RX   CelloPub=CLPUB00520;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   OSTIM-1
AC   CVCL_VZ66
SY   OSTeogenesis IMperfecta-1
DR   IBRC; C10563
DR   Wikidata; Q98128391
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   OSU-2
AC   CVCL_RW39
DR   EFO; EFO_0022662
DR   Wikidata; Q54936724
RX   PubMed=9047387;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   OSU-CLL
AC   CVCL_Y382
DR   Wikidata; Q29052685
RX   PubMed=24130782;
CC   Doubling time: ~50 hours (PubMed=24130782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV04 ! OSU-NB
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 7
//
ID   OSU-NB
AC   CVCL_IV04
DR   Wikidata; Q29052695
RX   PubMed=24130782;
CC   Doubling time: ~30 hours (PubMed=24130782).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y382 ! OSU-CLL
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   OSU1
AC   CVCL_6428
SY   57.Thy
DR   CLO; CLO_0008273
DR   ATCC; CRL-6178
DR   Wikidata; Q54936725
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6178; true.
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   OSUMMER.1
AC   CVCL_C8S6
SY   OSUMMER1; Ohio State University and Moffitt Melanoma Exposed to Radiation 1
DR   BioSample; SAMN33138954
DR   GEO; GSM7026802
DR   Millipore; SCC445
DR   Wikidata; Q123033232
RX   PubMed=37341054;
CC   Doubling time: 1.51 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC445
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.10
AC   CVCL_C8SF
SY   OSUMMER10; Ohio State University and Moffitt Melanoma Exposed to Radiation 10
DR   BioSample; SAMN33138945
DR   GEO; GSM7026811
DR   Millipore; SCC454
DR   Wikidata; Q123033233
RX   PubMed=37341054;
CC   Doubling time: 1.96 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Arg (c.37G>C); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN13R (Tyr::CreER(T2)-driven, Nras).
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   OSUMMER.11
AC   CVCL_C8SG
SY   OSUMMER11; Ohio State University and Moffitt Melanoma Exposed to Radiation 11
DR   BioSample; SAMN33138944
DR   GEO; GSM7026812
DR   Millipore; SCC455
DR   Wikidata; Q123033234
RX   PubMed=37341054;
CC   Doubling time: 1.96 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC455
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15,17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.12
AC   CVCL_C8SH
SY   OSUMMER12; Ohio State University and Moffitt Melanoma Exposed to Radiation 12
DR   BioSample; SAMN33138943
DR   GEO; GSM7026813
DR   Millipore; SCC456
DR   Wikidata; Q123033235
RX   PubMed=37341054;
CC   Doubling time: 1.70 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC456
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15,17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.13
AC   CVCL_C8SI
SY   OSUMMER13; Ohio State University and Moffitt Melanoma Exposed to Radiation 13
DR   BioSample; SAMN33138942
DR   GEO; GSM7026814
DR   Millipore; SCC457
DR   Wikidata; Q123033236
RX   PubMed=37341054;
CC   Doubling time: 2.14 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC457
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15,17
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17,18
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.2
AC   CVCL_C8S7
SY   OSUMMER2; Ohio State University and Moffitt Melanoma Exposed to Radiation 2
DR   BioSample; SAMN33138953
DR   GEO; GSM7026803
DR   Millipore; SCC446
DR   Wikidata; Q123033237
RX   PubMed=37341054;
CC   Doubling time: 1.41 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC446
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.3
AC   CVCL_C8S8
SY   OSUMMER3; Ohio State University and Moffitt Melanoma Exposed to Radiation 3
DR   BioSample; SAMN33138952
DR   GEO; GSM7026804
DR   Millipore; SCC447
DR   Wikidata; Q123033238
RX   PubMed=37341054;
CC   Doubling time: 1.31 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   OSUMMER.4
AC   CVCL_C8S9
SY   OSUMMER4; Ohio State University and Moffitt Melanoma Exposed to Radiation 4
DR   BioSample; SAMN33138951
DR   GEO; GSM7026805
DR   Millipore; SCC448
DR   Wikidata; Q123033239
RX   PubMed=37341054;
CC   Doubling time: 2.06 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC448
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.5
AC   CVCL_C8SA
SY   OSUMMER5; Ohio State University and Moffitt Melanoma Exposed to Radiation 5
DR   BioSample; SAMN33138950
DR   GEO; GSM7026806
DR   Millipore; SCC449
DR   Wikidata; Q123033240
RX   PubMed=37341054;
CC   Doubling time: 2.25 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC449
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.6
AC   CVCL_C8SB
SY   OSUMMER6; Ohio State University and Moffitt Melanoma Exposed to Radiation 6
DR   BioSample; SAMN33138949
DR   GEO; GSM7026807
DR   Millipore; SCC450
DR   Wikidata; Q123033241
RX   PubMed=37341054;
CC   Doubling time: 2.15 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC450
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26,27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.7
AC   CVCL_C8SC
SY   OSUMMER7; Ohio State University and Moffitt Melanoma Exposed to Radiation 7
DR   BioSample; SAMN33138948
DR   GEO; GSM7026808
DR   Millipore; SCC451
DR   Wikidata; Q123033242
RX   PubMed=37341054;
CC   Doubling time: 1.97 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61R (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC451
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18,19
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSUMMER.8
AC   CVCL_C8SD
SY   OSUMMER8; Ohio State University and Moffitt Melanoma Exposed to Radiation 8
DR   BioSample; SAMN33138947
DR   GEO; GSM7026809
DR   Millipore; SCC452
DR   Wikidata; Q123033243
RX   PubMed=37341054;
CC   Doubling time: 1.75 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Lys (c.181C>A); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61K (Tyr::CreER(T2)-driven, Nras).
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   OSUMMER.9
AC   CVCL_C8SE
SY   OSUMMER9; Ohio State University and Moffitt Melanoma Exposed to Radiation 9
DR   BioSample; SAMN33138946
DR   GEO; GSM7026810
DR   Millipore; SCC453
DR   Wikidata; Q123033244
RX   PubMed=37341054;
CC   Doubling time: 1.86 days (PubMed=37341054).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gln61Leu (c.182A>T); Zygosity=Homozygous (PubMed=37341054).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: C57BL/6 TN61L (Tyr::CreER(T2)-driven, Nras).
ST   Source(s): Millipore=SCC453
ST   Mouse STR 1-1: 16
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26.2,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   OSW
AC   CVCL_0B19
SY   Oswald
DR   GEO; GSM1974798
DR   Wikidata; Q54936727
RX   Patent=US7897150;
RX   PubMed=17532464;
RX   PubMed=21908323;
RX   PubMed=23365669;
RX   PubMed=26842912;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=29674676;
RX   PubMed=31175136;
CC   Group: Patented cell line.
CC   Part of: FACC canine tumor cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9116.
CC   Doubling time: 16 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:38196; ASXL1; Simple; p.Gly618fs (c.1850dupG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:40797; FBXW7; Simple; p.Arg694Gln (c.2081G>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:42490; KMT2C; Simple; p.Gly976fs (c.2922delG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:42491; KMT2D; Simple; p.Gln5395fs (c.16183delC); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:43761; NF1; Simple; p.Asn58fs (c.167delA); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:44567; PTEN; Simple; p.Lys245fs (c.734delA); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:112756; SPEN; Simple; p.Ala8fs (c.13_14insG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Arg164His (c.491G>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: Airedale Terrier; VBO=VBO_0200008.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235,239
ST   Dog FHC2054: 151,156
ST   Dog FHC2079: 279
ST   Dog PEZ1: 115,123
ST   Dog PEZ3: 119,136
ST   Dog PEZ5: 103
ST   Dog PEZ6: 176,183
ST   Dog PEZ8: 240
ST   Dog PEZ12: 270,288
ST   Dog PEZ20: 180
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   OSWO
AC   CVCL_A5LY
DR   Wikidata; Q107116623
RX   PubMed=2293550;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   OT11
AC   CVCL_T370
SY   OT-11
DR   CLO; CLO_0050531
DR   RCB; RCB1926
DR   Wikidata; Q54936728
RX   PubMed=9374409;
CC   Knockout cell: Method=KO mouse; MGI; MGI:96522; Rbpj.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   OT13
AC   CVCL_T371
SY   OT-13
DR   CLO; CLO_0050532
DR   RCB; RCB1927
DR   Wikidata; Q54936729
RX   PubMed=9374409;
CC   Characteristics: Control cell line for OT11 (Cellosaurus=CVCL_T370).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Conditionally immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   OT145
AC   CVCL_CW44
DR   NCBI_Iran; H155
DR   Wikidata; Q54936730
RX   PubMed=3464003;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   OTATi001-A
AC   CVCL_D0KD
SY   HC4
DR   BioSamples; SAMEA112374009
DR   hPSCreg; OTATi001-A
DR   Wikidata; Q123033245
RX   PubMed=37156062;
CC   From: Office of Tissues and Advanced Therapies, CBER, FDA; Silver Spring; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: CD4-positive helper T cell; CL=CL_0000492.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OTATi002-A
AC   CVCL_D0KE
SY   HC8
DR   BioSamples; SAMEA112388011
DR   hPSCreg; OTATi002-A
DR   Wikidata; Q123033246
RX   PubMed=37156062;
CC   From: Office of Tissues and Advanced Therapies, CBER, FDA; Silver Spring; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   OTCD1TKB
AC   CVCL_L557
DR   CLO; CLO_0050656
DR   BioSample; SAMN03472272
DR   RCB; RCB0492
DR   Wikidata; Q54936732
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0492
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 13
//
ID   OTgill1PFR
AC   CVCL_E8BX
SY   Oncorhynchus Tshawytscha, gill 1, Plant and Food Research
RX   PubMed=38987436;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at 4 Celsius but perishes at 30 Celsius (PubMed=38987436).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   OTH-74D4
AC   CVCL_2152
SY   OTH74D4
DR   CLO; CLO_0008275
DR   DSMZ; ACC-478
DR   DSMZCellDive; ACC-478
DR   Wikidata; Q54936733
CC   Doubling time: ~40-50 hours (DSMZ=ACC-478).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   oTr1
AC   CVCL_E5ZD
SY   oTr-1; Ovine Trophectoderm cell line 1
DR   ABM; T0435
RX   PubMed=18339715;
RX   PubMed=20385232;
RX   PubMed=20844281;
RX   PubMed=27512152;
CC   Derived from site: In situ; Trophectoderm; UBERON=UBERON_0004345.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   OTT1
AC   CVCL_5345
DR   Wikidata; Q54936734
RX   PubMed=1883955;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=OTT1
CC   Characteristics: CFS2, IL3 or IL5 dependent.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   OTT6050
AC   CVCL_5572
SY   OTT 6050; OTT-6050
DR   JCRB; JCRB0720
DR   Wikidata; Q54936735
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0E97 ! OC15
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   OTT6050(A)
AC   CVCL_4U63
SY   OTT6050 (A); OTT6050-A
DR   TKG; TKG 0329
DR   Wikidata; Q54936736
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   OTT6050(B)
AC   CVCL_4U64
SY   OTT6050 (B); OTT6050-B
DR   RCB; RCB2848
DR   TKG; TKG 0330
DR   Wikidata; Q54936737
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 7
//
ID   OU-AML-1
AC   CVCL_8391
DR   BioSample; SAMN03151867
DR   Wikidata; Q54936738
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00247.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-AML-2
AC   CVCL_8392
DR   BioSample; SAMN03151868
DR   Wikidata; Q54936739
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00248.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-AML-3
AC   CVCL_8393
DR   BioSample; SAMN03151869
DR   Wikidata; Q54936740
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00249.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-AML-4
AC   CVCL_8394
DR   BioSample; SAMN03151870
DR   Wikidata; Q54936741
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00250.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-AML-5
AC   CVCL_8395
DR   BioSample; SAMN03151871
DR   Wikidata; Q54936744
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00251.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-AML-6
AC   CVCL_8396
DR   BioSample; SAMN03151872
DR   Wikidata; Q54936745
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00252.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-AML-7
AC   CVCL_8397
DR   BioSample; SAMN03151873
DR   Wikidata; Q54936746
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00253.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-AML-8
AC   CVCL_8398
DR   BioSample; SAMN03151874
DR   Wikidata; Q54936748
RX   PubMed=10027306;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OCI-AML-2 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00254.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1619 ! OCI-AML-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   OU-LC-A1
AC   CVCL_DI01
SY   Okayama University-Lung Carcinoma-A1
DR   Wikidata; Q54936749
RX   PubMed=10213231;
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*40:02; C*03:03; DQB1*04:02 (PubMed=10213231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   OU-LC-A2
AC   CVCL_DI02
SY   Okayama University-Lung Carcinoma-A2
DR   Wikidata; Q54936750
RX   PubMed=10213231;
CC   Population: Japanese.
CC   HLA typing: A*26:01; B*15:01; C*04:01; DQB1*03:02 (PubMed=10213231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   OU-LC-A3
AC   CVCL_DI03
SY   Okayama University-Lung Carcinoma-A3
DR   Wikidata; Q54936751
RX   PubMed=10213231;
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*51:01,54:01; C*01:02,14:02; DQB1*04:01 (PubMed=10213231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   OU-LC-A4
AC   CVCL_DI04
SY   Okayama University-Lung Carcinoma-A4
DR   Wikidata; Q54936755
RX   PubMed=10213231;
CC   Population: Japanese.
CC   HLA typing: A*24:02,31:12; B*07:02,51:01; C*07:02,14:02; DQB1*03:02,04:01 (PubMed=10213231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   OU-LC-AS1
AC   CVCL_DI05
SY   Okayama University-Lung Carcinoma-AS1
DR   Wikidata; Q54936757
RX   PubMed=10213231;
CC   Population: Japanese.
CC   HLA typing: A*11:01; B*55:02; C*01:02; DQB1*04:01 (PubMed=10213231).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   OU-LC-KI
AC   CVCL_DI06
SY   Okayama University-Lung Carcinoma-KI
DR   Wikidata; Q54936758
RX   PubMed=9538136;
RX   PubMed=10213231;
RX   PubMed=21048114;
RX   PubMed=22109656;
CC   Population: Japanese.
CC   HLA typing: A*02:01,02:06; B*39:01,51:01; C*14:02,03:04; DQB1*03:32;04:02 (PubMed=10213231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   OU-LC-KM
AC   CVCL_DI09
SY   Okayama University-Lung Carcinoma-KM
DR   Wikidata; Q54936761
RX   PubMed=21048114;
RX   PubMed=22109656;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   OU-LC-OK
AC   CVCL_DI07
SY   Okayama University-Lung Carcinoma-OK
DR   Wikidata; Q54936759
RX   PubMed=21048114;
RX   PubMed=22109656;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   OU-LC-ON
AC   CVCL_DI08
SY   Okayama University-Lung Carcinoma-ON
DR   Wikidata; Q54936760
RX   PubMed=21048114;
RX   PubMed=22109656;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   OU-LC-SK
AC   CVCL_DI10
SY   Okayama University-Lung Carcinoma-SK
DR   Wikidata; Q54936762
RX   PubMed=21048114;
RX   PubMed=22109656;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 5
//
ID   Oua1
AC   CVCL_UV29
DR   Wikidata; Q98128392
RX   PubMed=231040;
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 5
//
ID   Oua2
AC   CVCL_UV30
DR   Wikidata; Q98128393
RX   PubMed=231040;
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 5
//
ID   Oua3
AC   CVCL_UV31
DR   Wikidata; Q98128394
RX   PubMed=231040;
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 5
//
ID   Oua4
AC   CVCL_UV32
DR   Wikidata; Q98128395
RX   PubMed=231040;
RX   PubMed=663800;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 5
//
ID   Oua5
AC   CVCL_UV33
DR   Wikidata; Q98128396
RX   PubMed=231040;
RX   PubMed=663800;
RX   PubMed=664253;
CC   Group: Insect cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_UV25 ! B1C4
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 5
//
ID   OUC-SebSc-Skm-1
AC   CVCL_B7JG
DR   Wikidata; Q114312640
RX   PubMed=34352298;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=214486; ! Sebastes schlegelii (Korean rockfish)
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   OUMS-10
AC   CVCL_A7SL
SY   Okayama University Medical School-10
DR   Wikidata; Q107116624
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   OUMS-11A
AC   CVCL_A7SM
SY   Okayama University Medical School-11A
DR   Wikidata; Q107116625
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7SN ! OUMS-11B
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-11B
AC   CVCL_A7SN
SY   Okayama University Medical School-11B
DR   Wikidata; Q107116626
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7SM ! OUMS-11A
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-12
AC   CVCL_A7SP
SY   Okayama University Medical School-12
DR   Wikidata; Q107116627
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-13
AC   CVCL_A7SQ
SY   Okayama University Medical School-13
DR   Wikidata; Q107116628
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-14
AC   CVCL_A7VA
SY   Okayama University Medical School-14
DR   Wikidata; Q107116629
RX   CelloPub=CLPUB00631;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-15
AC   CVCL_A7VB
SY   Okayama University Medical School-15
DR   Wikidata; Q107116630
RX   CelloPub=CLPUB00631;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-16
AC   CVCL_A5WY
SY   Okayama University Medical School-16
DR   Wikidata; Q107116631
RX   CelloPub=CLPUB00631;
RX   PubMed=4377005;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a chronic lymphatic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-17
AC   CVCL_A7VC
SY   Okayama University Medical School-17
DR   Wikidata; Q107116632
RX   CelloPub=CLPUB00631;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a chronic lymphatic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-18
AC   CVCL_A7SA
SY   Okayama University Medical School-18
DR   Wikidata; Q107116634
RX   PubMed=4361078;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-19
AC   CVCL_JF57
SY   Okayama University Medical School-19
DR   Wikidata; Q54936765
RX   PubMed=196968;
RX   PubMed=4361078;
RX   PubMed=4377005;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   OUMS-20
AC   CVCL_A7SB
SY   Okayama University Medical School-20
DR   Wikidata; Q107116635
RX   PubMed=4361078;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-21 [1972]
AC   CVCL_A7SC
SY   Okayama University Medical School-21
DR   Wikidata; Q107116637
RX   PubMed=4361078;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Two cell lines named OUMS-21 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SC) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9131).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-21 [1993]
AC   CVCL_9131
SY   Okayama University Medical School-21
DR   Wikidata; Q54936766
RX   DOI=10.1007/978-1-4612-0411-4_32;
RX   PubMed=7683277;
RX   PubMed=14966424;
CC   Population: Japanese.
CC   Senescence: SV40-transformed but with a finite life span.
CC   Doubling time: 29.4 hours (PubMed=7683277).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Caution: Two cell lines named OUMS-21 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SC) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9131).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9132 ! OUMS-22 [1993]
SX   Sex unspecified
AG   18FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 22
//
ID   OUMS-22 [1972]
AC   CVCL_A7SD
SY   Okayama University Medical School-22
DR   Wikidata; Q107116638
RX   PubMed=4361078;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Two cell lines named OUMS-22 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SD) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9132).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-22 [1993]
AC   CVCL_9132
SY   Okayama University Medical School-22
DR   Wikidata; Q54936767
RX   DOI=10.1007/978-1-4612-0411-4_32;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=7683277;
CC   Population: Japanese.
CC   Doubling time: 41.1 hours (PubMed=7683277).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Caution: Two cell lines named OUMS-22 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SD) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9132).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9131 ! OUMS-21 [1993]
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   OUMS-23
AC   CVCL_3088
SY   OUMS23; Okayama University Medical School-23
DR   CLO; CLO_0009971
DR   EFO; EFO_0006717
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 511
DR   BioSample; SAMN03470828
DR   BioSample; SAMN03472537
DR   BioSample; SAMN10987626
DR   cancercelllines; CVCL_3088
DR   Cell_Model_Passport; SIDM00036
DR   ColonAtlas; OUMS23
DR   Cosmic; 1187312
DR   Cosmic; 1298363
DR   DepMap; ACH-000296
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GDSC; 1298363
DR   GEO; GSM827177
DR   GEO; GSM887479
DR   GEO; GSM888560
DR   GEO; GSM1448077
DR   IARC_TP53; 28324
DR   JCRB; JCRB1022
DR   JCRB; NIHS0292
DR   LiGeA; CCLE_011
DR   LINCS_LDP; LCL-1165
DR   PharmacoDB; OUMS23_1207_2019
DR   Progenetix; CVCL_3088
DR   Wikidata; Q54936768
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=8576285;
RX   PubMed=9359923;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 50.2 hours (Note=In 1% FBS), 42.1 hours (Note=In 10% FBS) (PubMed=8576285); ~40 hours (Note=Lot 01262009), ~41 hours (Note=Lot 10232015) (JCRB=JCRB1022).
CC   HLA typing: A*02:06,24:02; B*52:01,67:02; C*03:03,12:02; DQA1*03:02,05:02; DQB1*06:01,06:01; DRB1*12:05,14:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg657fs (c.1969_1970delAG); Zygosity=Heterozygous (DepMap=ACH-000296).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556fs*3 (c.4660_4661insA) (E1554fs); Zygosity=Heterozygous (DepMap=ACH-000296).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-000296).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Homozygous (DepMap=ACH-000296).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=82.03%; East Asian, South=16.25%; South Asian=0.32%; European, North=0%; European, South=1.41% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0292; true.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
ST   Source(s): JCRB=JCRB1022; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 13,16
ST   FGA: 23.2
ST   Penta D: 9,12
ST   Penta E: 5,9
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4910; Colon carcinoma
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   OUMS-24
AC   CVCL_B369
SY   OUMS24; Okayama University Medical School-24
DR   Wikidata; Q54936769
RX   PubMed=8428798;
RX   PubMed=8744932;
RX   PubMed=8790940;
RX   PubMed=8985102;
RX   PubMed=9338145;
CC   Population: Japanese.
CC   Senescence: Senesces at 62 PDL (PubMed=8428798).
CC   Doubling time: 83.0 +- 5.16 hours (Note=In 1% FBS), 40.8 +- 2.25 hours (Note=In 10% FBS) (PubMed=8428798).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6FW
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   OUMS-24/P1
AC   CVCL_VE88
DR   Wikidata; Q54936770
RX   PubMed=9338145;
CC   Population: Japanese.
CC   Senescence: Senesces at 88 PDL (PubMed=9338145).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B369 ! OUMS-24
SX   Female
AG   6FW
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 11
//
ID   OUMS-24/P1N
AC   CVCL_VE89
DR   Wikidata; Q54936771
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=9338145;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VE88 ! OUMS-24/P1
SX   Female
AG   6FW
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   OUMS-24/P6
AC   CVCL_VE90
DR   Wikidata; Q54936772
RX   PubMed=8985102;
RX   PubMed=9338145;
CC   Population: Japanese.
CC   Senescence: Senesces at 79 PDL (PubMed=8985102; PubMed=9338145).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B369 ! OUMS-24
SX   Female
AG   6FW
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 11
//
ID   OUMS-24/P6X
AC   CVCL_3089
SY   OUMS24/P6X
DR   JCRB; JCRB1051
DR   JCRB; NIHS0327
DR   Wikidata; Q54936773
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=8985102;
RX   PubMed=9338145;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Discontinued: JCRB; NIHS0327; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1051
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 8,9
ST   TPOX: 8,12
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VE90 ! OUMS-24/P6
SX   Female
AG   6FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   OUMS-24F
AC   CVCL_B370
SY   OUMS24F
DR   IARC_TP53; 5359
DR   Wikidata; Q54936774
RX   DOI=10.11418/jtca1981.12.4_313;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=8148305;
RX   PubMed=8428798;
RX   PubMed=8557247;
RX   PubMed=8744932;
RX   PubMed=8790940;
RX   PubMed=9290701;
RX   PubMed=9359923;
CC   Population: Japanese.
CC   Doubling time: 62.8 +- 8.99 hours (Note=In 1% FBS), 39.7 +- 1.98 hours (Note=In 10% FBS) (PubMed=8428798).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=8790940).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B369 ! OUMS-24
SX   Female
AG   6FW
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   OUMS-24F/p53
AC   CVCL_WH83
DR   Wikidata; Q98128397
RX   DOI=10.11418/jtca1981.12.4_313;
RX   PubMed=8148305;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B370 ! OUMS-24F
SX   Female
AG   6FW
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   OUMS-24F/RAS
AC   CVCL_WH82
DR   Wikidata; Q98128398
RX   DOI=10.11418/jtca1981.12.4_313;
RX   PubMed=8148305;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B370 ! OUMS-24F
SX   Female
AG   6FW
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   OUMS-25
AC   CVCL_9133
SY   Okayama University Medical School-25
DR   Wikidata; Q54936775
RX   PubMed=8168158;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Colorectum; UBERON=UBERON_0012652.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   OUMS-27
AC   CVCL_3090
SY   OUMS27; Okayama University Medical School-27
DR   BioSample; SAMN03472799
DR   BioSample; SAMN10987628
DR   cancercelllines; CVCL_3090
DR   Cell_Model_Passport; SIDM01872
DR   Cosmic; 1602478
DR   Cosmic; 1992325
DR   DepMap; ACH-001150
DR   GEO; GSM887480
DR   GEO; GSM888561
DR   IARC_TP53; 30137
DR   JCRB; IFO50488
DR   Lonza; 1500
DR   PharmacoDB; OUMS27_1208_2019
DR   Progenetix; CVCL_3090
DR   Wikidata; Q54936776
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=9359923;
RX   PubMed=9714054;
RX   PubMed=22057234;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 41 hours (PubMed=9714054).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; None_reported; -; Zygosity=- (PubMed=22057234).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.16%; Native American=0%; East Asian, North=79.69%; East Asian, South=17.75%; South Asian=0%; European, North=0%; European, South=2.39% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone, left proximal humerus; UBERON=UBERON_0004411.
ST   Source(s): JCRB=IFO50488
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 14
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   OUMS-29
AC   CVCL_9130
SY   Okayama University Medical School-29
DR   Wikidata; Q54936777
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=10670627;
RX   PubMed=11513080;
RX   PubMed=11575821;
RX   PubMed=11605014;
RX   PubMed=15375599;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21FW
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-29/H-11
AC   CVCL_B6EL
SY   OUMS-29/H11
DR   Wikidata; Q112129479
RX   PubMed=11605014;
RX   PubMed=15375599;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5024; HNF4A (Note=Isoform Alpha-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9130 ! OUMS-29
SX   Male
AG   21FW
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   OUMS-29/H-14
AC   CVCL_B6EM
DR   Wikidata; Q112129480
RX   PubMed=11605014;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5024; HNF4A (Note=Isoform Alpha-2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9130 ! OUMS-29
SX   Male
AG   21FW
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   OUMS-29/TK
AC   CVCL_B6EK
SY   OUMS-29/thymidine kinase
DR   Wikidata; Q112129481
RX   PubMed=11575821;
CC   Population: Japanese.
CC   Characteristics: The introduction of HSV-1 TK gene makes the cell line 100x as sensitive to ganciclovir (GCV) compared with unmodified cells. This suicide gene can be used as a safeguard in the use of this cell line in hybrid artificial liver (PubMed=11575821).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9130 ! OUMS-29
SX   Male
AG   21FW
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   OUMS-3
AC   CVCL_A7SE
SY   Okayama University Medical School-3
DR   Wikidata; Q107116639
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-31
AC   CVCL_9129
SY   Okayama University Medical School-31
DR   Wikidata; Q54936779
RX   PubMed=10476912;
CC   Doubling time: ~21 hours (PubMed=10476912).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C3H/AnLCsb-Csb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9134 ! OUMS-32
OI   CVCL_9135 ! OUMS-33
SX   Female
AG   2M2W
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   OUMS-32
AC   CVCL_9134
SY   Okayama University Medical School-32
DR   Wikidata; Q54936780
RX   PubMed=10476912;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C3H/AnLCsb-Csb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9129 ! OUMS-31
OI   CVCL_9135 ! OUMS-33
SX   Female
AG   2M2W
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   OUMS-33
AC   CVCL_9135
SY   Okayama University Medical School-33
DR   Wikidata; Q54936781
RX   PubMed=10476912;
CC   Doubling time: ~21 hours (PubMed=10476912).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C3H/AnLCsb-Csb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9129 ! OUMS-31
OI   CVCL_9134 ! OUMS-32
SX   Female
AG   2M2W
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   OUMS-34
AC   CVCL_9136
SY   Okayama University Medical School-34
DR   Wikidata; Q54936782
RX   PubMed=10476912;
CC   Doubling time: ~25 hours (PubMed=10476912).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C3H/AnLCsa-Csa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9137 ! OUMS-35
SX   Sex unspecified
AG   2M2W
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   OUMS-35
AC   CVCL_9137
SY   Okayama University Medical School-35
DR   Wikidata; Q54936783
RX   PubMed=10476912;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C3H/AnLCsa-Csa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9136 ! OUMS-34
SX   Sex unspecified
AG   2M2W
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   OUMS-36
AC   CVCL_3091
SY   Okayama University Medical School-36
DR   BioSample; SAMN03472528
DR   GEO; GSE39178
DR   JCRB; JCRB1006.0
DR   JCRB; NIHS0291.0
DR   Wikidata; Q54936784
RX   PubMed=23311377;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0291.0; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.0
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   OUMS-36T-1
AC   CVCL_3092
DR   JCRB; JCRB1006.1
DR   JCRB; NIHS0291.1
DR   Wikidata; Q54936785
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.1; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.1
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-1F
AC   CVCL_3093
DR   JCRB; JCRB1006.1F
DR   JCRB; NIHS0291.1S
DR   Wikidata; Q54936786
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.1S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.1F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-36T-2
AC   CVCL_3094
DR   JCRB; JCRB1006.2
DR   JCRB; NIHS0291.2
DR   Wikidata; Q54936787
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.2; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.2
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-2F
AC   CVCL_3095
DR   JCRB; JCRB1006.2F
DR   JCRB; NIHS0291.2S
DR   Wikidata; Q54936788
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.2S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.2F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-36T-3
AC   CVCL_3096
DR   JCRB; JCRB1006.3
DR   JCRB; NIHS0291.3
DR   Wikidata; Q54936789
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.3; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.3
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-3F
AC   CVCL_3097
DR   JCRB; JCRB1006.3F
DR   JCRB; NIHS0291.3S
DR   Wikidata; Q54936790
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.3S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.3F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-36T-4
AC   CVCL_3098
DR   JCRB; JCRB1006.4
DR   JCRB; NIHS0291.4
DR   Wikidata; Q54936791
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.4; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.4
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-4F
AC   CVCL_3099
DR   JCRB; JCRB1006.4F
DR   JCRB; NIHS0291.4S
DR   Wikidata; Q54936793
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.4S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.4F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-36T-5
AC   CVCL_3100
DR   JCRB; JCRB1006.5
DR   JCRB; NIHS0291.5
DR   Wikidata; Q54936794
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.5; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.5
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-5F
AC   CVCL_3101
DR   BioSample; SAMN03472529
DR   JCRB; JCRB1006.5F
DR   JCRB; NIHS0291.5S
DR   Wikidata; Q54936795
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.5S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.5F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-6
AC   CVCL_3102
DR   JCRB; JCRB1006.6
DR   JCRB; NIHS0291.6
DR   Wikidata; Q54936796
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.6; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.6
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-6F
AC   CVCL_3103
DR   JCRB; JCRB1006.6F
DR   JCRB; NIHS0291.6S
DR   Wikidata; Q54936797
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.6S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.6F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-36T-7
AC   CVCL_3104
DR   JCRB; JCRB1006.7
DR   JCRB; NIHS0291.7
DR   Wikidata; Q54936798
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.7; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.7
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-7F
AC   CVCL_3105
DR   JCRB; JCRB1006.7F
DR   JCRB; NIHS0291.7S
DR   Wikidata; Q54936799
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.7S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.7F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-36T-8
AC   CVCL_3106
DR   JCRB; JCRB1006.8
DR   JCRB; NIHS0291.8
DR   Wikidata; Q54936809
RX   DOI=10.11418/jtca1981.19.4_203;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.8; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.8
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   OUMS-36T-8F
AC   CVCL_3107
DR   JCRB; JCRB1006.8F
DR   JCRB; NIHS0291.8S
DR   Wikidata; Q54936811
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0291.8S; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1006.8F
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3091 ! OUMS-36
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   OUMS-37
AC   CVCL_9128
SY   OUMS37; Okayama University Medical School-37
DR   Wikidata; Q54936812
RX   PubMed=10548428;
CC   Derived from site: In situ; Fetal stomach; UBERON=UBERON_0000945.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   OUMS-4
AC   CVCL_A7SF
SY   Okayama University Medical School-4
DR   Wikidata; Q107116640
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-5
AC   CVCL_A7SG
SY   Okayama University Medical School-5
DR   Wikidata; Q107116641
RX   CelloPub=CLPUB00631;
RX   PubMed=4377005;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   OUMS-6
AC   CVCL_A7SH
SY   Okayama University Medical School-6
DR   Wikidata; Q107116642
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7SJ ! OUMS-8
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   OUMS-7
AC   CVCL_A7SI
SY   Okayama University Medical School-7
DR   Wikidata; Q107116643
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-8
AC   CVCL_A7SJ
SY   Okayama University Medical School-8
DR   Wikidata; Q107116644
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7SH ! OUMS-6
SX   Male
AG   80Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   OUMS-9
AC   CVCL_A7SK
SY   Okayama University Medical School-9
DR   Wikidata; Q107116645
RX   CelloPub=CLPUB00631;
RX   PubMed=5291085;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   OUN-1
AC   CVCL_JH32
SY   OUN1
DR   Wikidata; Q54936813
RX   PubMed=12351404;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   OUR-10
AC   CVCL_A416
SY   OUR10; Osaka University Renal carcinoma-10
DR   Cosmic; 849376
DR   TKG; TKG 0694
DR   Wikidata; Q54936814
RX   PubMed=40693;
RX   PubMed=3986962;
RX   PubMed=10929426;
RX   PubMed=11146448;
CC   Population: Japanese.
CC   Doubling time: ~32 hours (Note=At 50th passage) (PubMed=40693).
CC   Misspelling: OWR10; Note=Occasionally.
CC   Misspelling: OWR-10; Note=Occasionally.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): TKG=TKG 0694
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 13
ST   D5S818: 9,13
ST   D7S820: 10,11
ST   TH01: 6,7,9.3
ST   TPOX: 11,12
ST   vWA: 14,17,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   OUR-19
AC   CVCL_UY92
SY   OUR19; Osaka University Renal carcinoma-19
DR   Wikidata; Q98128399
RX   PubMed=1958632;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   OUR-20
AC   CVCL_A417
SY   OUR20; Osaka University Renal carcinoma-20
DR   Cosmic; 849367
DR   Wikidata; Q54936815
RX   PubMed=1958632;
RX   PubMed=11146448;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg335Leufs*7 (c.1005dupA) (c.1005_1006insA); Zygosity=Unspecified (PubMed=11146448).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   OUR-20P
AC   CVCL_A418
SY   OUR20P; Osaka University Renal carcinoma-20P
DR   Wikidata; Q54936816
RX   PubMed=1958632;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg335Leufs*7 (c.1005dupA) (c.1005_1006insA); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A417 ! OUR-20
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   OUR-20S
AC   CVCL_A419
SY   OUR20S; Osaka University Renal carcinoma-20S
DR   Wikidata; Q54936817
RX   PubMed=1958632;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg335Leufs*7 (c.1005dupA) (c.1005_1006insA); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A417 ! OUR-20
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   OUR-21
AC   CVCL_UY93
SY   OUR21; Osaka University Renal carcinoma-21
DR   Wikidata; Q98128400
RX   PubMed=1958632;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   OUR-23
AC   CVCL_UY94
SY   OUR23; Osaka University Renal carcinoma-23
DR   Wikidata; Q98128401
RX   PubMed=1958632;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   OUR-30
AC   CVCL_A420
SY   OUR30; Osaka University Renal carcinoma-30
DR   Wikidata; Q54936818
RX   PubMed=1958632;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   OUS-11
AC   CVCL_3108
SY   OUS11
DR   BTO; BTO_0003968
DR   BioSample; SAMN03472481
DR   GEO; GSM827565
DR   JCRB; JCRB1034
DR   JCRB; NIHS0313
DR   Wikidata; Q54936819
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: ~23 hours (Note=Lot 11102015) (JCRB=JCRB1034).
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from the normal tissue of a lung cancer patient.
CC   Discontinued: JCRB; NIHS0313; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1034
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   OV(hyg)CAR3
AC   CVCL_Y033
SY   Ov(hyg)CAR3
DR   cancercelllines; CVCL_Y033
DR   Wikidata; Q54936876
RX   PubMed=8824553;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_16976; Hygromycin B.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   OV-1063
AC   CVCL_4366
SY   Ov-1063; OV 1063; OV1063; 0V-1063
DR   ATCC; CRL-2183
DR   BioSample; SAMN03152024
DR   BioSample; SAMN03472561
DR   cancercelllines; CVCL_4366
DR   CCRID; 1101HUM-PUMC000361
DR   ChEMBL-Cells; CHEMBL3308411
DR   ChEMBL-Targets; CHEMBL614211
DR   Cosmic; 844352
DR   Cosmic; 849609
DR   Cosmic; 897432
DR   Cosmic; 948286
DR   Cosmic; 1044238
DR   Cosmic; 2582808
DR   Cosmic; 2674700
DR   PubChem_Cell_line; CVCL_4366
DR   Wikidata; Q54936820
RX   PubMed=2412195;
RX   PubMed=9698466;
RX   PubMed=11103784;
RX   PubMed=11565033;
RX   PubMed=20143388;
RX   PubMed=25846456;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially misidentified. The stock formerly distributed by ATCC and CCRID was misidentified and was actually DU145 (Cellosaurus=CVCL_0105). This is not the case of the original stock from Hadassah Medical Center.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00340.
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Glu40Ter (c.118G>T); Zygosity=Unspecified (PubMed=11565033).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Unspecified (PubMed=25846456).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Unspecified (PubMed=25846456).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Miscellaneous: STR profile from personal communication of Granit, Avital.
CC   Discontinued: ATCC; CRL-2183; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 16,17
ST   D12S391: 23
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 17,20
ST   D19S433: 13,16.2
ST   D1S1656: 14,15.3
ST   D21S11: 31,32.2
ST   D22S1045: 16
ST   D2S1338: 17
ST   D2S441: 10,14
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   D8S1179: 9,14
ST   FGA: 20
ST   Penta D: 12,15
ST   Penta E: 7,16
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   OV-1369(R2)
AC   CVCL_9T12
SY   OV1369(R2); OV-1369(2)
DR   cancercelllines; CVCL_9T12
DR   CancerTools; 161769
DR   GEO; GSM2474980
DR   Wikidata; Q54936821
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 2.45 +- 0.12 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Cys (c.730G>T); ClinVar=VCV000376599; Zygosity=Unspecified (PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,13
ST   D21S11: 30,31
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T17 ! TOV-1369
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   OV-1847
AC   CVCL_D703
SY   Ovary 1847; Ovary1847; OVARY1847
DR   BioSample; SAMN03151864
DR   cancercelllines; CVCL_D703
DR   Cosmic; 1709260
DR   GEO; GSM851927
DR   Wikidata; Q54936822
RX   PubMed=22328975;
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a OVCAR-8 derivative (PubMed=22710073).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00467.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1629 ! OVCAR-8
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 26
//
ID   OV-1946
AC   CVCL_4375
SY   OV1946
DR   cancercelllines; CVCL_4375
DR   CancerTools; 161771
DR   Cosmic; 1122315
DR   GEO; GSM2474982
DR   Wikidata; Q54936824
RX   PubMed=18507860;
RX   PubMed=22585861;
RX   PubMed=28273451;
CC   Doubling time: 2.5 +- 0.9 days (PubMed=18507860).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=18507860; PubMed=28273451).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 14,15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4062 ! TOV-1946
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   OV-2008
AC   CVCL_0473
AS   CVCL_4066
SY   OV2008; Ov2008; OV 2008; 2008; A2008
DR   BTO; BTO_0003792
DR   EFO; EFO_0022702
DR   MCCL; MCC:0000371
DR   BioSample; SAMN03151841
DR   BioSample; SAMN03151843
DR   cancercelllines; CVCL_0473
DR   ChEMBL-Cells; CHEMBL3308015
DR   ChEMBL-Targets; CHEMBL612818
DR   Cosmic; 849613
DR   Cosmic; 948293
DR   Cosmic; 988874
DR   Cosmic; 1102825
DR   Cosmic; 1524359
DR   Cosmic; 1707563
DR   Cosmic; 2582806
DR   Cosmic; 2674703
DR   GEO; GSM184384
DR   GEO; GSM184385
DR   GEO; GSM659387
DR   GEO; GSM711715
DR   GEO; GSM711718
DR   GEO; GSM851907
DR   GEO; GSM851925
DR   IARC_TP53; 25074
DR   Progenetix; CVCL_0473
DR   PubChem_Cell_line; CVCL_0473
DR   Wikidata; Q54936825
RX   PubMed=4118903;
RX   PubMed=9234707;
RX   PubMed=11314036;
RX   PubMed=19926575;
RX   PubMed=22710073;
RX   PubMed=24023729;
RX   PubMed=25846456;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-62.html
CC   Problematic cell line: Contaminated. Shown to be a ME-180 derivative (PubMed=22710073). Originally thought to originate from a female patient with an ovarian serous carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00466.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=25846456).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 13,15.2
ST   D21S11: 30,31
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   OV-2085
AC   CVCL_A1SI
SY   OV2085
DR   cancercelllines; CVCL_A1SI
DR   CancerTools; 161772
DR   Wikidata; Q105510506
RX   PubMed=32784519;
CC   Doubling time: 6.2 +- 2.2 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   OV-2295
AC   CVCL_9T13
SY   OV2295
DR   cancercelllines; CVCL_9T13
DR   CancerTools; 161773
DR   GEO; GSM2474983
DR   Wikidata; Q54936823
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 2.90 +- 0.10 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T14 ! OV-2295(R2)
OI   CVCL_9T18 ! TOV-2295(R)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   OV-2295(R2)
AC   CVCL_9T14
SY   OV2295(R2); OV-2295(2)
DR   cancercelllines; CVCL_9T14
DR   CancerTools; 161774
DR   GEO; GSM2474984
DR   Wikidata; Q54936826
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 2.73 +- 0.12 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T13 ! OV-2295
OI   CVCL_9T18 ! TOV-2295(R)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   OV-2978
AC   CVCL_A1SM
SY   OV2978
DR   cancercelllines; CVCL_A1SM
DR   CancerTools; 161898
DR   Wikidata; Q105510510
RX   PubMed=32784519;
CC   Doubling time: 3.8 +- 0.03 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.920-2A>G (IVS8-2A>G); ClinVar=VCV000043595; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 30,33.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U73 ! TOV-2978G
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   OV-3133(R)
AC   CVCL_9T15
SY   OV3133(R); OV-3133; OV3133
DR   cancercelllines; CVCL_9T15
DR   CancerTools; 161782
DR   GEO; GSM2474985
DR   Wikidata; Q54936828
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 2.94 +- 0.07 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Unspecified (PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 13
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T16 ! OV-3133(R2)
OI   CVCL_9T19 ! TOV-3133D
OI   CVCL_4064 ! TOV-3133G
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   OV-3133(R2)
AC   CVCL_9T16
SY   OV3133(R2); OV-3133(2)
DR   cancercelllines; CVCL_9T16
DR   CancerTools; 161783
DR   GEO; GSM2474986
DR   Wikidata; Q54936829
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 3.23 +- 0.12 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Unspecified (PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 13
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T15 ! OV-3133(R)
OI   CVCL_9T19 ! TOV-3133D
OI   CVCL_4064 ! TOV-3133G
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   OV-3291
AC   CVCL_A1SP
SY   OV3291
DR   cancercelllines; CVCL_A1SP
DR   CancerTools; 161900
DR   Wikidata; Q105510513
RX   PubMed=32784519;
CC   Doubling time: 4.4 +- 0.6 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:24224; CDK12; Simple; c.3095+1G>A; dbSNP=rs2146575887; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Trp (c.745A>T); ClinVar=VCV000141881; Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11
ST   D21S11: 28,30
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T25 ! TOV-3291G
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   OV-3331
AC   CVCL_A1SQ
SY   OV3331
DR   CancerTools; 161785
DR   Wikidata; Q105510517
RX   PubMed=32784519;
CC   Doubling time: 2.7 +- 0.3 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn210Lysfs*37 (c.630del); Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D21S11: 28
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   OV-4453
AC   CVCL_9T20
SY   OV4453
DR   cancercelllines; CVCL_9T20
DR   CancerTools; 161787
DR   Wikidata; Q54936830
RX   PubMed=26622941;
CC   Doubling time: 2.44 +- 0.03 days (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Glu1953Ter (c.5857G>T); ClinVar=VCV000051952; Zygosity=Unspecified (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:19291; CSMD3; Simple; p.Ser646Thr (c.1937G>C); Zygosity=Unspecified (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2490-5_2490-1del5; Zygosity=Unspecified (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=26622941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 30,31
ST   D5S818: 9
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   OV-4485
AC   CVCL_9T21
SY   OV4485
DR   cancercelllines; CVCL_9T21
DR   CancerTools; 161788
DR   Wikidata; Q54936831
RX   PubMed=26622941;
CC   Doubling time: 1.85 +- 0.29 days (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; c.4485-1G>T; ClinVar=VCV000246501; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=26622941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C36100; BRCA1 syndrome
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 17
//
ID   OV-866(2)
AC   CVCL_9T22
SY   OV866(2); OV-866 (2)
DR   cancercelllines; CVCL_9T22
DR   CancerTools; 161767
DR   Wikidata; Q54936832
RX   PubMed=26622941;
CC   Doubling time: 1.77 +- 0.32 days (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Trp (c.745A>T); ClinVar=VCV000141881; Zygosity=Unspecified (PubMed=26622941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 29,30.2
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   OV-90
AC   CVCL_3768
SY   OV90
DR   BTO; BTO_0004852
DR   CLO; CLO_0008276
DR   EFO; EFO_0002311
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3585
DR   ATCC; CRL-11732
DR   BioGRID_ORCS_Cell_line; 393
DR   BioSample; SAMN03471308
DR   BioSample; SAMN10987765
DR   cancercelllines; CVCL_3768
DR   CancerTools; 161765
DR   Cell_Model_Passport; SIDM01141
DR   ChEMBL-Cells; CHEMBL4295466
DR   ChEMBL-Targets; CHEMBL4296481
DR   Cosmic; 1102815
DR   Cosmic; 1113283
DR   Cosmic; 1139219
DR   Cosmic; 1305311
DR   Cosmic; 1709257
DR   Cosmic; 2186586
DR   Cosmic-CLP; 1240197
DR   DepMap; ACH-000291
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240197
DR   GEO; GSM274704
DR   GEO; GSM659389
DR   GEO; GSM711702
DR   GEO; GSM784576
DR   GEO; GSM851926
DR   GEO; GSM887483
DR   GEO; GSM888564
DR   GEO; GSM1001427
DR   GEO; GSM1001428
DR   GEO; GSM1001492
DR   GEO; GSM1291148
DR   GEO; GSM1374800
DR   GEO; GSM1670314
DR   GEO; GSM2474988
DR   IARC_TP53; 20198
DR   IGRhCellID; OV90
DR   LiGeA; CCLE_009
DR   LINCS_LDP; LCL-1523
DR   PharmacoDB; OV90_1210_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3768
DR   PubChem_Cell_line; CVCL_3768
DR   Wikidata; Q54936833
RX   Patent=US5710038;
RX   PubMed=10949993;
RX   PubMed=11641787;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=22141344;
RX   PubMed=22328975;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22710073;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=24675677;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11732.
CC   Population: Caucasian.
CC   Doubling time: 1.5 days (PubMed=10949993); 40 hours (PubMed=25984343); 46.34 hours (JWGray panel).
CC   HLA typing: A*02:05,02:05; B*15:05,50:01; C*06:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1790; CDKN2D + HGNC; HGNC:20482; WDFY2; Name(s)=CDKN2D-WDFY2 (PubMed=24675677).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (DepMap=ACH-000291).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (PubMed=10949993; PubMed=20204287; PubMed=24023729; PubMed=25230021; PubMed=28273451; DepMap=ACH-000291).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.24%; Native American=0%; East Asian, North=2.36%; East Asian, South=0%; South Asian=5.06%; European, North=37.26%; European, South=53.08% (PubMed=30894373).
CC   Misspelling: TOV-90; Cosmic=1139219.
CC   Discontinued: ATCC; CRL-11732; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-3585; Cosmic-CLP=1240197; Direct_author_submission; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 30,30.2
ST   D3S1358: 18
ST   D5S818: 11,15
ST   D7S820: 10 (Cosmic-CLP=1240197; Direct_author_submission)
ST   D7S820: 10,10.1 (ATCC=CRL-3585; PubMed=25230021; PubMed=25877200)
ST   D7S820: 10.1 (PubMed=30485824)
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 11,13
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   OV-MZ-01A
AC   CVCL_X950
AS   CVCL_X962
SY   OV-MZ-1a; OVMZ-1a; OV-MZ-01; OV-MZ-1; OVarian-MainZ-01A
DR   Wikidata; Q54936834
DR   Wikidata; Q54936841
RX   DOI=10.5282/edoc.3898;
RX   PubMed=1500230;
RX   PubMed=11242531;
RX   PubMed=15153938;
RX   PubMed=15706405;
CC   Doubling time: 38 hours (PubMed=1500230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Serfs*52 (c.582delT) (Leu194fs); ClinVar=VCV000634675; Zygosity=Unspecified (PubMed=15153938).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1AZ ! OV-MZ-01B
OI   CVCL_F1B0 ! OV-MZ-01C
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 9
//
ID   OV-MZ-01B
AC   CVCL_F1AZ
SY   OVarian-MainZ-01B
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X950 ! OV-MZ-01A
OI   CVCL_F1B0 ! OV-MZ-01C
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-01C
AC   CVCL_F1B0
SY   OVarian-MainZ-01C
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X950 ! OV-MZ-01A
OI   CVCL_F1AZ ! OV-MZ-01B
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-02
AC   CVCL_X951
SY   OV-MZ-2; OVarian-MainZ-02
DR   Wikidata; Q54936844
RX   DOI=10.5282/edoc.3898;
RX   PubMed=1500230;
RX   PubMed=11925137;
RX   PubMed=15706405;
CC   Doubling time: 24 hours (PubMed=1500230).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 9
//
ID   OV-MZ-02A
AC   CVCL_X955
SY   OV-MZ-2a; OVarian-MainZ-02A
DR   cancercelllines; CVCL_X955
DR   Wikidata; Q54936850
RX   PubMed=10741907;
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=15153938).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X951 ! OV-MZ-02
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 10
//
ID   OV-MZ-03
AC   CVCL_X952
SY   OV-MZ-3; OVarian-MainZ-03
DR   Wikidata; Q54936851
RX   PubMed=1500230;
RX   PubMed=11925137;
CC   Doubling time: 52 hours (PubMed=1500230).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-04
AC   CVCL_X953
SY   OV-MZ-4; OVMZ-4; OVarian-MainZ-04
DR   Wikidata; Q54936865
RX   PubMed=1500230;
RX   PubMed=11925137;
CC   Doubling time: 26 hours (PubMed=1500230).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 6
//
ID   OV-MZ-05
AC   CVCL_X954
SY   OV-MZ-5; OVarian-MainZ-05
DR   Wikidata; Q54936866
RX   PubMed=1500230;
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Doubling time: 40 hours (PubMed=1500230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
CC   Caution: Indicated as originating from the ascites of a 57 year old patient in PubMed=1500230 and from the ovary of a 49 year old patient in PubMed=11925137.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 10
//
ID   OV-MZ-06
AC   CVCL_4005
SY   OV-MZ-6; OVMZ-6; OVarian-MainZ-06
DR   BTO; BTO_0004487
DR   Wikidata; Q54936868
RX   DOI=10.5282/edoc.3898;
RX   PubMed=1500230;
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
RX   PubMed=15706405;
RX   PubMed=21559638;
CC   Doubling time: 28 hours (PubMed=1500230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Indicated as originating from a 70 year old patient in PubMed=1500230 and from a 59 year old patient in PubMed=11925137.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   OV-MZ-07A
AC   CVCL_X974
SY   OV-MZ-7a; OVMZ-7a; OVarian-MainZ-07A
DR   Wikidata; Q54936870
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C179334; Ovarian dedifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1AN ! OV-MZ-07B
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-07B
AC   CVCL_F1AN
SY   OVarian-MainZ-07B
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C179334; Ovarian dedifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X974 ! OV-MZ-07A
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-08
AC   CVCL_X958
SY   OV-MZ-8; OVarian-MainZ-08
DR   cancercelllines; CVCL_X958
DR   Wikidata; Q54936871
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala276Gly (c.827C>G); ClinVar=VCV000185319; Zygosity=Unspecified (PubMed=15153938).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C179334; Ovarian dedifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 11
//
ID   OV-MZ-09
AC   CVCL_X964
SY   OV-MZ-9; OVMZ-9; OVarian-MainZ-09
DR   Wikidata; Q54936872
RX   DOI=10.5282/edoc.3898;
RX   PubMed=11242531;
RX   PubMed=15706405;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 8
//
ID   OV-MZ-10
AC   CVCL_4003
SY   OVarian-MainZ-10
DR   BTO; BTO_0004485
DR   Wikidata; Q54936835
RX   PubMed=7510115;
RX   PubMed=11925137;
RX   PubMed=21559638;
CC   Doubling time: 27 hours (PubMed=7510115).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   OV-MZ-12
AC   CVCL_X965
SY   OVarian-MainZ-12
DR   Wikidata; Q54936836
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-12B
AC   CVCL_F1AP
SY   OVarian-MainZ-12B
RX   PubMed=11925137;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X965 ! OV-MZ-12
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-13
AC   CVCL_WH80
SY   OVarian-MainZ-13
DR   Wikidata; Q98128402
RX   PubMed=21559638;
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 4
//
ID   OV-MZ-14
AC   CVCL_X966
SY   OVMZ-14; OVarian-MainZ-14
DR   Wikidata; Q54936837
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-15
AC   CVCL_4004
SY   OVarian-MainZ-15
DR   BTO; BTO_0004486
DR   cancercelllines; CVCL_4004
DR   GEO; GSM313678
DR   Progenetix; CVCL_4004
DR   Wikidata; Q54936838
RX   DOI=10.5282/edoc.3898;
RX   PubMed=7510115;
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15706405;
RX   PubMed=21559638;
CC   Doubling time: 48 hours (PubMed=7510115).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   OV-MZ-16
AC   CVCL_X959
SY   OVMZ-16; OVarian-MainZ-16
DR   Wikidata; Q54936839
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 9
//
ID   OV-MZ-17A
AC   CVCL_F1AQ
SY   OVarian-MainZ-17A
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1AR ! OV-MZ-17C
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-17C
AC   CVCL_F1AR
SY   OVarian-MainZ-17C
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F1AQ ! OV-MZ-17A
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-18
AC   CVCL_F1AS
SY   OVarian-MainZ-18
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-19
AC   CVCL_6863
SY   OVarian-MainZ-19
DR   Wikidata; Q54936840
RX   PubMed=9735390;
RX   PubMed=11925137;
RX   PubMed=21559638;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 10
//
ID   OV-MZ-2 Delta(2,27)L1CAM
AC   CVCL_E6X4
RX   PubMed=15706405;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6470; L1CAM (Note=Isoform 3 which lacks exons 2 and 27 = Delta(2,27)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X951 ! OV-MZ-02
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 27-11-25; Version: 2
//
ID   OV-MZ-20
AC   CVCL_X967
SY   OVMZ-20; OVarian-MainZ-20
DR   Wikidata; Q54936845
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C179334; Ovarian dedifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-21
AC   CVCL_X968
SY   OVarian-MainZ-21
DR   Wikidata; Q54936846
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-22
AC   CVCL_E117
SY   OVarian-MainZ-22
DR   ABM; T8234
DR   Wikidata; Q54936847
RX   PubMed=11242531;
RX   PubMed=11733966;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Doubling time: 42 hours (PubMed=11733966).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 15
//
ID   OV-MZ-23
AC   CVCL_F1AT
SY   OVarian-MainZ-23
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-25
AC   CVCL_F1AU
SY   OVarian-MainZ-25
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-26
AC   CVCL_X969
SY   OVarian-MainZ-26
DR   Wikidata; Q54936848
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-27
AC   CVCL_X970
SY   OVarian-MainZ-27
DR   Wikidata; Q54936849
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-29
AC   CVCL_F1AV
SY   OVarian-MainZ-29
RX   PubMed=11925137;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-MZ-30
AC   CVCL_X971
SY   OVarian-MainZ-30
DR   Wikidata; Q54936852
RX   DOI=10.5282/edoc.3898;
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15706405;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 8
//
ID   OV-MZ-31
AC   CVCL_X972
SY   OVarian-MainZ-31
DR   Wikidata; Q54936858
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-32
AC   CVCL_X956
SY   OVMZ32; OVarian-MainZ-32
DR   Wikidata; Q54936859
RX   PubMed=10741907;
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-33
AC   CVCL_X973
SY   OVarian-MainZ-33
DR   Wikidata; Q54936860
RX   PubMed=11242531;
RX   PubMed=11925137;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-35
AC   CVCL_X957
SY   OVarian-MainZ-35
DR   cancercelllines; CVCL_X957
DR   Wikidata; Q54936861
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Unspecified (PubMed=15153938).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 10
//
ID   OV-MZ-36
AC   CVCL_X987
SY   OVarian-MainZ-36
DR   Wikidata; Q54936862
RX   PubMed=11242531;
RX   PubMed=15153938;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 9
//
ID   OV-MZ-37
AC   CVCL_X960
SY   OVarian-MainZ-37
DR   Wikidata; Q54936863
RX   PubMed=11242531;
RX   PubMed=15153938;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 5
//
ID   OV-MZ-38
AC   CVCL_X961
SY   OVarian-MainZ-38
DR   Wikidata; Q54936864
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15153938).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 9
//
ID   OV-MZ-6#8
AC   CVCL_X988
DR   Wikidata; Q54936869
RX   PubMed=12297307;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4005 ! OV-MZ-06
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 6
//
ID   OV-MZ-6#8-BAG
AC   CVCL_F1AW
RX   PubMed=12297307;
CC   Characteristics: Can be stained with the L-galactosidase substrate 5-bromo-4-chloro-3-indolyl L-D-galactoside (X-Gal) in order to follow spreading of tumors in in-vivo models (PubMed=12297307).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X988 ! OV-MZ-6#8
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-TRL-12B
AC   CVCL_DH78
SY   OV-TRL 12B; OV-TRL12B; TRL-12B
DR   cancercelllines; CVCL_DH78
DR   GEO; GSM313705
DR   Progenetix; CVCL_DH78
DR   Wikidata; Q54936873
RX   PubMed=19222485;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40093; Ovarian squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   OV-TRL-90T
AC   CVCL_DH79
SY   TRL-90T; TRL90T
DR   cancercelllines; CVCL_DH79
DR   GEO; GSM313687
DR   Progenetix; CVCL_DH79
DR   Wikidata; Q54936874
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 8
//
ID   OV-UL-01
AC   CVCL_F1AY
SY   OV-UL-1; OVarian-ULm-1
RX   PubMed=11925137;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV-UL-02
AC   CVCL_X963
SY   OV-UL-2; OVarian-ULm-2
DR   cancercelllines; CVCL_X963
DR   Wikidata; Q54936875
RX   PubMed=11242531;
RX   PubMed=11925137;
RX   PubMed=15153938;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Unspecified (PubMed=15153938).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C179334; Ovarian dedifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 11
//
ID   OV-UL-03
AC   CVCL_F1AX
SY   OV-UL-3; OVarian-ULm-3
RX   PubMed=11925137;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C179334; Ovarian dedifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV1/ADR
AC   CVCL_8744
SY   OV1/DXR
DR   cancercelllines; CVCL_8744
DR   Wikidata; Q54936877
RX   PubMed=2731146;
RX   PubMed=17934650;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   OV1/CDDP
AC   CVCL_8745
DR   cancercelllines; CVCL_8745
DR   Wikidata; Q54936878
RX   PubMed=2731146;
RX   PubMed=17934650;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   OV1/VCR
AC   CVCL_8746
DR   cancercelllines; CVCL_8746
DR   Wikidata; Q54936879
RX   PubMed=2731146;
RX   PubMed=2925277;
RX   PubMed=17934650;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys654Serfs*47 (c.1961delA); ClinVar=VCV000037438; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys1108Argfs*11 (c.3323delA) (p.Gln1107fs) (c.3320delA); ClinVar=VCV000225716; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg38Cys (c.112C>T); ClinVar=VCV000376493; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ter1069TrpinsLysAspAsn (c.3207A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly231Alafs*10 (c.692delG); ClinVar=VCV001756201; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu495Pro (c.1484T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Leufs*59 (c.267dupC) (c.267_268insC); ClinVar=VCV000634762; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1304 ! IGROV-1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   OV167
AC   CVCL_A402
SY   Ov167; OV-167; OV 167
DR   Cosmic; 1523766
DR   GEO; GSM659385
DR   GEO; GSM1340584
DR   Wikidata; Q54936880
RX   PubMed=9473353;
RX   PubMed=28196595;
RX   PubMed=30485824;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10
ST   D21S11: 30.2
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 8
ST   TPOX: 9
ST   vWA: 15,18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   OV176
AC   CVCL_6E73
SY   ov176
DR   Cosmic; 845143
DR   Wikidata; Q54936881
RX   PubMed=9625810;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 4
//
ID   OV177
AC   CVCL_A403
SY   Ov177; ov177; OV 177
DR   Cosmic; 845144
DR   Cosmic; 1523767
DR   GEO; GSM659386
DR   Wikidata; Q54936882
RX   PubMed=9473353;
RX   PubMed=9625810;
RX   PubMed=30485824;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 28
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   OV17R
AC   CVCL_2672
SY   OV-17R
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_2672
DR   Cell_Model_Passport; SIDM00476
DR   Cosmic-CLP; 1480361
DR   DepMap; ACH-001373
DR   ECACC; 96020763
DR   EGA; EGAS00001000978
DR   GDSC; 1480361
DR   GEO; GSM711699
DR   GEO; GSM1291145
DR   GEO; GSM1670311
DR   GEO; GSM2474981
DR   PharmacoDB; OV17R_1209_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54936883
RX   PubMed=7707437;
RX   PubMed=25230021;
RX   PubMed=27397505;
RX   PubMed=28273451;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1317Gln (c.3949G>C); ClinVar=VCV000000829; Zygosity=Unspecified (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Unspecified (PubMed=25230021; PubMed=28273451; DepMap=ACH-001373).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=2.39%; Native American=0%; East Asian, North=1.99%; East Asian, South=0%; South Asian=0%; European, North=60.17%; European, South=35.44% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1480361; DepMap=ACH-001373; ECACC=96020763; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 13,18
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 14
ST   TH01: 9 (Cosmic-CLP=1480361; ECACC=96020763)
ST   TH01: 9,9.3 (DepMap=ACH-001373; PubMed=25230021)
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   OV202
AC   CVCL_4067
SY   Ov202; ov202; OV-202; OV 202
DR   BTO; BTO_0003504
DR   Cosmic; 845145
DR   Cosmic; 1523768
DR   Wikidata; Q54936884
RX   PubMed=9473353;
RX   PubMed=9625810;
RX   PubMed=10690552;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   OV202 hp
AC   CVCL_4068
SY   OV-202 hp; OV202 high passage
DR   Wikidata; Q54936885
RX   PubMed=10690552;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4067 ! OV202
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   OV207
AC   CVCL_A404
SY   Ov207; ov207; OV 207
DR   Cosmic; 845146
DR   Cosmic; 1223314
DR   Cosmic; 1328063
DR   Cosmic; 1434892
DR   Cosmic; 1523769
DR   Cosmic; 1708376
DR   Cosmic; 2074244
DR   GEO; GSM659388
DR   Wikidata; Q54936886
RX   PubMed=9473353;
RX   PubMed=9625810;
RX   PubMed=22705003;
RX   PubMed=28196595;
RX   PubMed=30485824;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 31.2
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   OV25R
AC   CVCL_X502
DR   Wikidata; Q54936887
RX   PubMed=7707437;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 6
//
ID   OV266
AC   CVCL_A405
SY   Ov266; ov266; OV 266
DR   Cosmic; 845147
DR   Wikidata; Q54936889
RX   PubMed=9473353;
RX   PubMed=9625810;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   OV2944
AC   CVCL_E953
SY   OV 2944
DR   Wikidata; Q54936890
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C30037; Mouse malignant ovarian neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   OV2944-HM-1
AC   CVCL_E954
SY   HM-1
DR   CLO; CLO_0051455
DR   RCB; RCB1483
DR   Wikidata; Q54936891
RX   PubMed=2502522;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C30037; Mouse malignant ovarian neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E953 ! OV2944
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   OV2944-LM-1
AC   CVCL_E955
SY   LM-1
DR   Wikidata; Q54936892
RX   PubMed=2502522;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C30037; Mouse malignant ovarian neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E953 ! OV2944
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   OV2944-LM-3
AC   CVCL_E956
SY   LM-3
DR   Wikidata; Q54936893
RX   PubMed=2502522;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C30037; Mouse malignant ovarian neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E953 ! OV2944
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   OV3121
AC   CVCL_6547
DR   JCRB; JCRB1026
DR   JCRB; NIHS0255
DR   Wikidata; Q54936894
RX   PubMed=7775256;
RX   PubMed=15541573;
CC   Characteristics: Established from a tumor (6HF1 3121) transplanted sub-cutaneously on syngenic mouse (PubMed=7775256).
CC   Doubling time: 30 hours (PubMed=7775256).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Discontinued: JCRB; NIHS0255; true.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C24000; Mouse granulosa cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   OV3121-1
AC   CVCL_0474
DR   MCCL; MCC:0000372
DR   Wikidata; Q54936895
RX   PubMed=7775256;
CC   Doubling time: 30 hours (PubMed=7775256).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C24000; Mouse granulosa cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6547 ! OV3121
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   OV3121-2
AC   CVCL_F1XA
RX   PubMed=7775256;
CC   Doubling time: 28 hours (PubMed=7775256).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C24000; Mouse granulosa cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6547 ! OV3121
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   OV3121-ras4
AC   CVCL_6548
SY   OV312ras4; OV-ras4
DR   JCRB; JCRB0186
DR   Wikidata; Q54936896
RX   PubMed=7775256;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C24000; Mouse granulosa cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0474 ! OV3121-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   OV3121-ras7
AC   CVCL_6549
SY   OV312ras7; OV-ras7
DR   JCRB; JCRB0187
DR   Wikidata; Q54936897
RX   PubMed=7775256;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: C57BL/6N x C3H/He.
DI   NCIt; C24000; Mouse granulosa cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0474 ! OV3121-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   OV4Carbo
AC   CVCL_E5FL
DR   CancerTools; 161761
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1627 ! OVCAR-4
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ov4Carbo-Luc
AC   CVCL_E5FM
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FL ! OV4Carbo
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OV4Cis
AC   CVCL_E5FN
DR   CancerTools; 161760
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1627 ! OVCAR-4
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Ov4Cis-Luc
AC   CVCL_E5FP
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FN ! OV4Cis
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OV56
AC   CVCL_2673
SY   OV-56
DR   EFO; EFO_0006458
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472428
DR   BioSample; SAMN10987613
DR   cancercelllines; CVCL_2673
DR   Cell_Model_Passport; SIDM00475
DR   Cosmic-CLP; 1480362
DR   DepMap; ACH-000091
DR   ECACC; 96020759
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1480362
DR   GEO; GSM711700
DR   GEO; GSM887481
DR   GEO; GSM888562
DR   GEO; GSM1291146
DR   GEO; GSM1670312
DR   GEO; GSM2474987
DR   IARC_TP53; 30138
DR   LiGeA; CCLE_602
DR   PharmacoDB; OV56_1211_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2673
DR   Wikidata; Q54936898
RX   PubMed=7707437;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28273451;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*27:05,44:02; C*01:02,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asp2178Glyfs*47 (c.6527_6528insG); Zygosity=Heterozygous (PubMed=25230021; Cosmic-CLP=1480362).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=25230021; PubMed=28273451; Cosmic-CLP=1480362).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gly (c.388C>G); ClinVar=VCV000375958; Zygosity=Homozygous (PubMed=28273451; Cosmic-CLP=1480362; DepMap=ACH-000091).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys101_Thr102fs (c.303_304delAA); Zygosity=Heterozygous (PubMed=25230021; PubMed=28273451; Cosmic-CLP=1480362).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0.52%; South Asian=2.39%; European, North=69.8%; European, South=27.28% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1480362; ECACC=96020759; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 20,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 8,14
ST   FGA: 21
ST   Penta D: 13,15
ST   Penta E: 12,20
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 15,19
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   OV58
AC   CVCL_2674
SY   OV-58
DR   ECACC; 96020760
DR   Wikidata; Q54936899
RX   PubMed=7707437;
CC   Discontinued: ECACC; 96020760; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=96020760
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,13
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   OV7
AC   CVCL_2675
SY   OV-7
DR   CLO; CLO_0037293
DR   EFO; EFO_0006459
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 497
DR   BioSample; SAMN03473061
DR   BioSample; SAMN10988013
DR   cancercelllines; CVCL_2675
DR   Cell_Model_Passport; SIDM00474
DR   Cosmic-CLP; 1480360
DR   DepMap; ACH-000688
DR   ECACC; 96020764
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1480360
DR   GEO; GSM711698
DR   GEO; GSM887482
DR   GEO; GSM888563
DR   GEO; GSM1291147
DR   GEO; GSM1670313
DR   IARC_TP53; 30139
DR   LiGeA; CCLE_200
DR   PharmacoDB; OV7_1212_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2675
DR   Wikidata; Q54936905
RX   PubMed=7707437;
RX   PubMed=22460905;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 110 hours (PubMed=25984343).
CC   HLA typing: A*01:01,02:01; B*35:01,38:01; C*04:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=25230021; Cosmic-CLP=1480360; DepMap=ACH-000688).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu512Cysfs*10 (c.1534_1535delTT) (1533_1534del); Zygosity=Heterozygous (PubMed=25230021; Cosmic-CLP=1480360; DepMap=ACH-000688).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Ser (c.761T>G); ClinVar=VCV000659457; Zygosity=Homozygous (PubMed=25230021; Cosmic-CLP=1480360; DepMap=ACH-000688).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.94%; Native American=0%; East Asian, North=1.71%; East Asian, South=0%; South Asian=1.49%; European, North=63.24%; European, South=31.62% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1480360; ECACC=96020764; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 30,31.2
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,14
ST   FGA: 23
ST   Penta D: 12,14
ST   Penta E: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   OV90C-A
AC   CVCL_4Z23
DR   cancercelllines; CVCL_4Z23
DR   Wikidata; Q54936906
RX   PubMed=22141344;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1790; CDKN2D + HGNC; HGNC:20482; WDFY2; Name(s)=CDKN2D-WDFY2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3768 ! OV-90
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   OV90C-D
AC   CVCL_4Z24
DR   cancercelllines; CVCL_4Z24
DR   Wikidata; Q54936907
RX   PubMed=22141344;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1790; CDKN2D + HGNC; HGNC:20482; WDFY2; Name(s)=CDKN2D-WDFY2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3768 ! OV-90
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   OV90D-6
AC   CVCL_4Z25
DR   cancercelllines; CVCL_4Z25
DR   Wikidata; Q54936908
RX   PubMed=22141344;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1790; CDKN2D + HGNC; HGNC:20482; WDFY2; Name(s)=CDKN2D-WDFY2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3768 ! OV-90
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   OV90D-7
AC   CVCL_4Z26
DR   cancercelllines; CVCL_4Z26
DR   Wikidata; Q54936909
RX   PubMed=22141344;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1790; CDKN2D + HGNC; HGNC:20482; WDFY2; Name(s)=CDKN2D-WDFY2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3768 ! OV-90
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   OV90P-3
AC   CVCL_4Z27
DR   cancercelllines; CVCL_4Z27
DR   Wikidata; Q54936910
RX   PubMed=22141344;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1790; CDKN2D + HGNC; HGNC:20482; WDFY2; Name(s)=CDKN2D-WDFY2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3768 ! OV-90
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   OV90P-7
AC   CVCL_4Z28
DR   cancercelllines; CVCL_4Z28
DR   Wikidata; Q54936911
RX   PubMed=22141344;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1790; CDKN2D + HGNC; HGNC:20482; WDFY2; Name(s)=CDKN2D-WDFY2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg445Ter (c.1333C>T); ClinVar=VCV000024850; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.643A>C); ClinVar=VCV000428895; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3768 ! OV-90
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   OVAR79
AC   CVCL_E8WD
RX   PubMed=39769003;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Leu113Pro (c.338T>C); Zygosity=Heterozygous (PubMed=39769003).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.773+99_773+107dupATACATATT; dbSNP=rs1426397261; Zygosity=Heterozygous (PubMed=39769003).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): PubMed=39769003
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14
ST   D12S391: 21
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16,19
ST   D1S1656: 17.3
ST   D21S11: 29,30.2
ST   D22S1045: 16
ST   D2S441: 10,11.3
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 21
ST   SE33: 24.2
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OVAS
AC   CVCL_0V12
DR   BioSample; SAMN02800476
DR   BioSample; SAMN03472381
DR   cancercelllines; CVCL_0V12
DR   Cosmic; 1889264
DR   GEO; GSM416677
DR   JCRB; NIHS0403
DR   PRIDE; PXD000901
DR   Wikidata; Q54936912
RX   PubMed=20081105;
RX   PubMed=23430509;
RX   PubMed=26388441;
CC   From: Minaguchi, Hiroshi; School of Medicine, Yokohama City University; Yokohama; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=23430509).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0403; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=NIHS0403
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D5S818: 6,9,10,12
ST   D7S820: 10,11,12
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 16,17,18,19
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 19
//
ID   OVAS-21
AC   CVCL_A768
SY   OVAS21
DR   Cosmic; 945376
DR   Wikidata; Q54936913
RX   CelloPub=CLPUB00096;
RX   PubMed=8980248;
CC   Population: Japanese.
CC   Doubling time: 46 hours (CelloPub=CLPUB00096).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   OVB1
AC   CVCL_E4C8
RX   PubMed=2461982;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on ovarian cancer cell lines (Note=Immunized against OVCAR-3 (Cellosaurus=CVCL_0465)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   OVB3
AC   CVCL_3109
SY   OVB-3
DR   CLO; CLO_0008277
DR   ATCC; HB-9147
DR   Wikidata; Q54936914
RX   Patent=US4806494;
RX   PubMed=3135309;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9147.
CC   Monoclonal antibody isotype: IgG2a+IgG2b.
CC   Monoclonal antibody target: Human antigen on ovarian cancer cell lines (Note=Immunized against OVCAR-3 (Cellosaurus=CVCL_0465)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   OvBH-1
AC   CVCL_UY59
DR   ABM; T8163
DR   Wikidata; Q98128403
RX   CelloPub=CLPUB00470;
RX   PubMed=11062710;
RX   PubMed=12359050;
RX   PubMed=16364757;
RX   PubMed=26925792;
CC   Population: Caucasian; Polish.
CC   Characteristics: Shows temperature-sensitive growth characteristics. Grows well at 37 Celsius and stop growing when shifted to 31 Celsius (PubMed=12359050).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous; Note=2 out of 3 copies (PubMed=16364757).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   OvBRCA1
AC   CVCL_E2T0
RX   PubMed=38615309;
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Arg136Thrfs*5 (c.405_406del); Zygosity=Unspecified (PubMed=38615309).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; KETFB; OFP (Note=Orange fluorescent protein from Cerianthus sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   OvBRCA2
AC   CVCL_E2T1
RX   PubMed=38615309;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile605Thrfs*9 (c.1813delA); ClinVar=VCV000037763; Zygosity=Unspecified (PubMed=38615309).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; KETFB; OFP (Note=Orange fluorescent protein from Cerianthus sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   OVC-1
AC   CVCL_RK14
DR   Wikidata; Q54936915
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-100
AC   CVCL_RK24
DR   Wikidata; Q54936916
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-102
AC   CVCL_RK25
DR   Wikidata; Q54936917
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-105
AC   CVCL_RK26
DR   Wikidata; Q54936918
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-106
AC   CVCL_RK27
DR   Wikidata; Q54936919
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-2
AC   CVCL_RK15
DR   Wikidata; Q54936920
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-23
AC   CVCL_RK16
DR   Wikidata; Q54936922
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-44
AC   CVCL_RK17
DR   Wikidata; Q54936923
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-50
AC   CVCL_RK18
DR   Wikidata; Q54936924
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-52
AC   CVCL_RK19
DR   Wikidata; Q54936925
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-62
AC   CVCL_RK20
DR   Wikidata; Q54936926
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-66
AC   CVCL_RK21
DR   Wikidata; Q54936927
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-73
AC   CVCL_RK22
DR   Wikidata; Q54936928
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-77
AC   CVCL_RK23
DR   Wikidata; Q54936929
RX   PubMed=2573646;
RX   PubMed=2599460;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   OVC-FRT
AC   CVCL_ZF70
DR   Wikidata; Q98128404
RX   CelloPub=CLPUB00569;
RX   PubMed=5163649;
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   OVC.EX.1
AC   CVCL_JK99
DR   Wikidata; Q54936930
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.10
AC   CVCL_JL08
DR   Wikidata; Q54936931
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.11
AC   CVCL_JL09
DR   Wikidata; Q54936932
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.12
AC   CVCL_JL10
DR   Wikidata; Q54936933
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.13
AC   CVCL_JL11
DR   Wikidata; Q54936935
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.14
AC   CVCL_JL12
DR   Wikidata; Q54936936
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.15
AC   CVCL_JL13
DR   Wikidata; Q54936937
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.16
AC   CVCL_JL14
DR   Wikidata; Q54936938
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.2
AC   CVCL_JL00
DR   Wikidata; Q54936939
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.3
AC   CVCL_JL01
DR   Wikidata; Q54936940
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.4
AC   CVCL_JL02
DR   Wikidata; Q54936941
RX   PubMed=19327015;
RX   PubMed=21611190;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.5
AC   CVCL_JL03
DR   Wikidata; Q54936942
RX   PubMed=19327015;
RX   PubMed=21611190;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.6
AC   CVCL_JL04
DR   Wikidata; Q54936943
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.7
AC   CVCL_JL05
DR   Wikidata; Q54936944
RX   PubMed=19327015;
RX   PubMed=21611190;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.8
AC   CVCL_JL06
DR   Wikidata; Q54936945
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.EX.9
AC   CVCL_JL07
DR   Wikidata; Q54936946
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.1
AC   CVCL_JL15
DR   Wikidata; Q54936953
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.10
AC   CVCL_JL24
DR   Wikidata; Q54936954
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.11
AC   CVCL_JL25
DR   Wikidata; Q54936955
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.12
AC   CVCL_JL26
DR   Wikidata; Q54936956
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.13
AC   CVCL_JL27
DR   Wikidata; Q54936957
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.14
AC   CVCL_JL28
DR   Wikidata; Q54936958
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.15
AC   CVCL_JL29
DR   Wikidata; Q54936959
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.16
AC   CVCL_JL30
DR   Wikidata; Q54936961
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.17
AC   CVCL_JL31
DR   Wikidata; Q54936962
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.18
AC   CVCL_JL32
DR   Wikidata; Q54936963
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.19
AC   CVCL_JL33
DR   Wikidata; Q54936965
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.2
AC   CVCL_JL16
DR   Wikidata; Q54936966
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.20
AC   CVCL_JL34
DR   Wikidata; Q54936967
RX   PubMed=19327015;
RX   PubMed=21611190;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.21
AC   CVCL_JL35
DR   Wikidata; Q54936968
RX   PubMed=19327015;
RX   PubMed=21611190;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.22
AC   CVCL_JL36
DR   Wikidata; Q54936969
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.23
AC   CVCL_JL37
DR   Wikidata; Q54936970
RX   PubMed=19327015;
RX   PubMed=21611190;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.3
AC   CVCL_JL17
DR   Wikidata; Q54936971
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.4
AC   CVCL_JL18
DR   Wikidata; Q54936972
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.5
AC   CVCL_JL19
DR   Wikidata; Q54936973
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.6
AC   CVCL_JL20
DR   Wikidata; Q54936974
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.7
AC   CVCL_JL21
DR   Wikidata; Q54936975
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.8
AC   CVCL_JL22
DR   Wikidata; Q54936976
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC.ID.9
AC   CVCL_JL23
DR   Wikidata; Q54936977
RX   PubMed=19327015;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   OVC1-PI 32
AC   CVCL_9U97
DR   NCBI_Iran; C442
DR   Wikidata; Q54936978
RX   PubMed=24936210;
CC   Population: Iranian.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   OVCA-X
AC   CVCL_DH80
SY   OVCA X; OV-CAX
DR   cancercelllines; CVCL_DH80
DR   Cosmic; 1609528
DR   GEO; GSM313716
DR   Progenetix; CVCL_DH80
DR   Wikidata; Q54936979
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 6
//
ID   OVCA12
AC   CVCL_WS41
DR   FCS-free; 199-2-391-2-3-3
DR   Wikidata; Q98128405
RX   PubMed=22445873;
ST   Source(s): PubMed=22445873
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 4
//
ID   OVCA22
AC   CVCL_A0QI
DR   Wikidata; Q108821084
RX   Patent=US10683364;
RX   Patent=US10730945;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   OVCA400
AC   CVCL_IQ31
SY   OVCA 400
DR   Wikidata; Q54936980
RX   PubMed=7028788;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   OVCA420
AC   CVCL_3935
SY   OVCA 420; OvCa 420; OVCA-420; OVCAR-420; OVCAR 420; OVCAR420
DR   BTO; BTO_0002563
DR   EFO; EFO_0006720
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 980
DR   BioSample; SAMN03471874
DR   cancercelllines; CVCL_3935
DR   Cell_Model_Passport; SIDM00967
DR   Cosmic; 924145
DR   Cosmic; 927566
DR   Cosmic-CLP; 1480364
DR   DepMap; ACH-002181
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1480364
DR   GEO; GSM659390
DR   GEO; GSM711703
DR   GEO; GSM851928
DR   GEO; GSM1340585
DR   GEO; GSM1341130
DR   GEO; GSM1670315
DR   GEO; GSM2474990
DR   IARC_TP53; 28490
DR   PharmacoDB; OVCA420_1213_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54936981
RX   PubMed=1536252;
RX   PubMed=6346879;
RX   PubMed=7028788;
RX   PubMed=10318951;
RX   PubMed=10972993;
RX   PubMed=11793438;
RX   PubMed=12960427;
RX   PubMed=20204287;
RX   PubMed=22115851;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 47.62 hours (JWGray panel).
CC   HLA typing: A*30:01,30:01; B*42:01,48:17; C*04:01,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=20204287; PubMed=28273451).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=82.47%; Native American=0%; East Asian, North=2.6%; East Asian, South=0%; South Asian=2.8%; European, North=3.32%; European, South=8.81% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1480364; PubMed=22115851; PubMed=22710073; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 8
ST   D13S317: 12,13
ST   D16S539: 9 (PubMed=22115851; PubMed=22710073)
ST   D16S539: 9,12 (Cosmic-CLP=1480364; PubMed=25877200)
ST   D18S51: 14,17
ST   D19S433: 11,15.2
ST   D21S11: 30.2
ST   D2S1338: 19,22
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 8,11 (PubMed=25877200)
ST   D7S820: 11 (Cosmic-CLP=1480364; PubMed=22115851; PubMed=22710073)
ST   D8S1179: 14,15
ST   FGA: 21,22 (PubMed=25877200)
ST   FGA: 22 (PubMed=22115851; PubMed=22710073)
ST   Penta D: 12
ST   Penta E: 5,8
ST   TH01: 6 (PubMed=22710073; PubMed=25877200)
ST   TH01: 6,9 (Cosmic-CLP=1480364)
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   OVCA424
AC   CVCL_IQ30
SY   OVCA 424; OvCa 424
DR   Wikidata; Q54936982
RX   PubMed=6346879;
RX   PubMed=7028788;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   OVCA429
AC   CVCL_3936
SY   OVCA 429; OvCA 429; OVCA-429; OVCAR-429; OVCAR 429; OVCAR429; OV429
DR   BTO; BTO_0002564
DR   EFO; EFO_0006721
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03470937
DR   cancercelllines; CVCL_3936
DR   Cosmic; 924146
DR   Cosmic; 927567
DR   Cosmic; 1223315
DR   Cosmic; 1328064
DR   Cosmic; 1434898
DR   Cosmic; 2074245
DR   EGA; EGAS00001000610
DR   GEO; GSM95439
DR   GEO; GSM659391
DR   GEO; GSM711704
DR   GEO; GSM851929
DR   IARC_TP53; 28487
DR   PharmacoDB; OvCA429_1214_2019
DR   Progenetix; CVCL_3936
DR   Wikidata; Q54936983
RX   PubMed=1536252;
RX   PubMed=6346879;
RX   PubMed=7028788;
RX   PubMed=10318951;
RX   PubMed=10972993;
RX   PubMed=12080474;
RX   PubMed=12960427;
RX   PubMed=16380993;
RX   PubMed=16382445;
RX   PubMed=19926575;
RX   PubMed=20204287;
RX   PubMed=20596667;
RX   PubMed=22710073;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30485824;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 34.58 hours (JWGray panel).
CC   HLA typing: A*26:01,26:01; B*39:01,39:01; C*12:03,12:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (PubMed=20204287).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=20596667; PubMed=22710073; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12,13 (PubMed=20596667; PubMed=22710073; PubMed=25877200)
ST   CSF1PO: 12,13,14 (PubMed=30485824)
ST   D13S317: 7,12 (PubMed=22710073; PubMed=25877200; PubMed=30485824)
ST   D13S317: 12 (PubMed=20596667)
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   OVCA429/GFP
AC   CVCL_JY92
DR   cancercelllines; CVCL_JY92
DR   Cell_Biolabs; AKR-212
DR   Wikidata; Q54936984
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Cell_Biolabs; AKR-212; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3936 ! OVCA429
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   OVCA429/T40
AC   CVCL_CZ99
SY   OVCA429T40
DR   cancercelllines; CVCL_CZ99
DR   GEO; GSM95441
DR   Progenetix; CVCL_CZ99
DR   Wikidata; Q54936986
RX   PubMed=16382445;
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3936 ! OVCA429
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   OVCA429/TxT50
AC   CVCL_CZ98
SY   OVCA429TxT50; OV429 TxT50
DR   cancercelllines; CVCL_CZ98
DR   GEO; GSM95430
DR   Progenetix; CVCL_CZ98
DR   Wikidata; Q54936987
RX   PubMed=16382445;
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3936 ! OVCA429
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   OVCA432
AC   CVCL_3769
SY   OV-CA 432; OVCA 432; OvCA 432; OVCA-432; OVCA432_Bast; OVCAR-432; OVCAR 432; OVCAR432
DR   BTO; BTO_0002565
DR   CLO; CLO_0008278
DR   EFO; EFO_0006722
DR   CLDB; cl3778
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03470830
DR   cancercelllines; CVCL_3769
DR   Cosmic; 924147
DR   Cosmic; 991322
DR   Cosmic; 1524354
DR   EGA; EGAS00001000610
DR   GDSC; 1480366
DR   GEO; GSM659392
DR   GEO; GSM711705
DR   GEO; GSM851930
DR   GEO; GSM2474991
DR   IARC_TP53; 28488
DR   PharmacoDB; OvCA432_1215_2019
DR   Wikidata; Q54936988
RX   PubMed=1536252;
RX   PubMed=6346879;
RX   PubMed=7028788;
RX   PubMed=7836420;
RX   PubMed=10318951;
RX   PubMed=10972993;
RX   PubMed=11793438;
RX   PubMed=12960427;
RX   PubMed=20204287;
RX   PubMed=22585861;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28273451;
CC   Doubling time: 37.09 hours (JWGray panel).
CC   HLA typing: A*01:01,29:02; B*44:03,55:01; C*03:03,16:01; DQB1*02:02,03:02; DRB1*07:01,11:79 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Unspecified (PubMed=20204287; PubMed=28273451).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=22710073; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 15,16
ST   D19S433: 12,15
ST   D21S11: 29,31.2
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 20,24
ST   Penta D: 10,14
ST   Penta E: 13,19
ST   TH01: 10
ST   TPOX: 11
ST   vWA: 15,19
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IQ28 ! LAZ-446
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   OVCA433
AC   CVCL_0475
SY   OvCa433; OVCA 433; OvCa 433; OVCA-433; OVCA433_Bast; OVCAR-433; OVCAR 433; OVCAR433; SKOV-433; SK-OV-433; OV433
DR   BTO; BTO_0002566
DR   EFO; EFO_0006723
DR   MCCL; MCC:0000373
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473291
DR   cancercelllines; CVCL_0475
DR   Cell_Model_Passport; SIDM00966
DR   Cosmic; 924148
DR   Cosmic; 927568
DR   Cosmic; 1175882
DR   Cosmic; 1524355
DR   Cosmic; 1709258
DR   Cosmic-CLP; 1480367
DR   DepMap; ACH-002182
DR   EGA; EGAS00001000610
DR   GDSC; 1480367
DR   GEO; GSM95433
DR   GEO; GSM711706
DR   GEO; GSM851931
DR   GEO; GSM1670316
DR   GEO; GSM2474992
DR   PharmacoDB; OVCA433_1216_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0475
DR   Wikidata; Q54936989
RX   PubMed=1536252;
RX   PubMed=6346879;
RX   PubMed=7028788;
RX   PubMed=10318951;
RX   PubMed=10972993;
RX   PubMed=11793438;
RX   PubMed=16382445;
RX   PubMed=19926575;
RX   PubMed=22328975;
RX   PubMed=22585861;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=24434149;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28273451;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 102.24 hours (JWGray panel).
CC   HLA typing: A*01:01,26:01; B*15:17,39:01; C*07:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=1.3%; East Asian, North=0.31%; East Asian, South=0%; South Asian=0%; European, North=59.83%; European, South=38.24% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1480367; PubMed=22710073; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 7,12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IQ32 ! LAZ-444
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   OVCA433/T40
AC   CVCL_DA01
SY   OVCA433T40; 433T40
DR   cancercelllines; CVCL_DA01
DR   GEO; GSM95451
DR   Progenetix; CVCL_DA01
DR   Wikidata; Q54936990
RX   PubMed=16382445;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0475 ! OVCA433
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   OVCA433/TxT50
AC   CVCL_DA00
SY   OVCA433TxT50; OV433TxT50
DR   cancercelllines; CVCL_DA00
DR   GEO; GSM95432
DR   Progenetix; CVCL_DA00
DR   Wikidata; Q54936991
RX   PubMed=16382445;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0475 ! OVCA433
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   OVCA633
AC   CVCL_W776
DR   Wikidata; Q54936992
RX   PubMed=11793438;
RX   PubMed=15571795;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 7
//
ID   OVCA680
AC   CVCL_W781
DR   Wikidata; Q54936994
RX   PubMed=12492109;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 7
//
ID   OVCA702
AC   CVCL_W782
DR   Wikidata; Q54936995
RX   PubMed=12492109;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 7
//
ID   OVCA810
AC   CVCL_W783
DR   Wikidata; Q54936996
RX   PubMed=12492109;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 6
//
ID   OVCA832
AC   CVCL_ZL29
DR   Wikidata; Q98128406
RX   PubMed=16380993;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   OVCAR-10
AC   CVCL_4377
SY   NIH:OVCAR-10; OVCAR10
DR   EFO; EFO_0022668
DR   cancercelllines; CVCL_4377
DR   Cosmic; 1102813
DR   GEO; GSM185131
DR   GEO; GSM185132
DR   GEO; GSM313703
DR   GEO; GSM711711
DR   GEO; GSM851932
DR   Progenetix; CVCL_4377
DR   Wikidata; Q54937003
RX   PubMed=1348364;
RX   PubMed=2307530;
RX   PubMed=9041185;
RX   PubMed=22710073;
RX   PubMed=23415752;
CC   Doubling time: 32.31 hours (JWGray panel).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   OVCAR-2
AC   CVCL_3941
SY   NIH:OVCAR-2; OVCAR2; OVCAR 2
DR   BTO; BTO_0002560
DR   cancercelllines; CVCL_3941
DR   GEO; GSM185133
DR   GEO; GSM185134
DR   GEO; GSM711707
DR   GEO; GSM851933
DR   GEO; GSM1340586
DR   GEO; GSM1341131
DR   Progenetix; CVCL_3941
DR   Wikidata; Q54937004
RX   PubMed=1348364;
RX   PubMed=2307530;
RX   PubMed=3930572;
RX   PubMed=6372095;
RX   PubMed=6385258;
RX   PubMed=9041185;
RX   PubMed=22710073;
CC   Problematic cell line: Partially contaminated. Some stocks were contaminated by either Calu-6 or Caov-2 as identified by a STR profile (PubMed=22710073).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Campbell, Kerry S. at Fox Chase Cancer Center. The stocks of OVCAR-2 used for profiling were obtained in 1982 from Hamilton, Thomas C. lab, where OVCAR-2 was established.
CC   Caution: The STR profile reported by PubMed=22710073 was Amelogenin: X; CSF1PO: 12; D13S317: 11; D16S539: 13; D18S51: 12,16; D19S433: 13; D21S11: 31; D2S1338: 17,26; D3S1358: 16; D5S818: 11; D7S820: 10; D8S1179: 10,14; FGA: 22; TH01: 9; TPOX: 8; vWA: 17.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 13
ST   D18S51: 12
ST   D21S11: 30,32.2
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 9,14
ST   FGA: 20
ST   Penta D: 8,9,13
ST   Penta E: 13
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 20
//
ID   OVCAR-3
AC   CVCL_0465
SY   Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3
DR   BTO; BTO_0000812
DR   CLO; CLO_0008171
DR   CLO; CLO_0008279
DR   CLO; CLO_0051451
DR   EFO; EFO_0003061
DR   MCCL; MCC:0000363
DR   CLDB; cl3712
DR   CLDB; cl3780
DR   CLDB; cl5237
DR   Abcam; ab275471
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-161
DR   BCRC; 60551
DR   BCRJ; 0317
DR   BioGRID_ORCS_Cell_line; 981
DR   BioSample; SAMN01821585
DR   BioSample; SAMN03471390
DR   BioSample; SAMN05292457
DR   BioSample; SAMN10987888
DR   cancercelllines; CVCL_0465
DR   CCRID; 1101HUM-PUMC000362
DR   CCRID; 3101HUMTCHu228
DR   CCRID; 4201HUM-CCTCC00119
DR   CCTCC; GDC0119
DR   Cell_Model_Passport; SIDM00105
DR   ChEMBL-Cells; CHEMBL3307564
DR   ChEMBL-Targets; CHEMBL614213
DR   CLS; 300307
DR   Cosmic; 687926
DR   Cosmic; 688104
DR   Cosmic; 755845
DR   Cosmic; 809113
DR   Cosmic; 844347
DR   Cosmic; 845142
DR   Cosmic; 875859
DR   Cosmic; 897433
DR   Cosmic; 905933
DR   Cosmic; 906577
DR   Cosmic; 920357
DR   Cosmic; 924144
DR   Cosmic; 927564
DR   Cosmic; 949227
DR   Cosmic; 974296
DR   Cosmic; 991321
DR   Cosmic; 1044239
DR   Cosmic; 1092623
DR   Cosmic; 1093553
DR   Cosmic; 1102816
DR   Cosmic; 1139222
DR   Cosmic; 1175883
DR   Cosmic; 1218877
DR   Cosmic; 1305312
DR   Cosmic; 1312192
DR   Cosmic; 1312354
DR   Cosmic; 1436033
DR   Cosmic; 1482525
DR   Cosmic; 1524357
DR   Cosmic; 1709250
DR   Cosmic; 1998465
DR   Cosmic; 2186584
DR   Cosmic-CLP; 905933
DR   DepMap; ACH-000001
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS419ENC
DR   GDSC; 905933
DR   GEO; GSM2122
DR   GEO; GSM50219
DR   GEO; GSM50282
DR   GEO; GSM95463
DR   GEO; GSM185135
DR   GEO; GSM185136
DR   GEO; GSM274703
DR   GEO; GSM313683
DR   GEO; GSM459733
DR   GEO; GSM459741
DR   GEO; GSM645843
DR   GEO; GSM659393
DR   GEO; GSM711708
DR   GEO; GSM743474
DR   GEO; GSM743498
DR   GEO; GSM750817
DR   GEO; GSM784564
DR   GEO; GSM799362
DR   GEO; GSM799363
DR   GEO; GSM799425
DR   GEO; GSM799426
DR   GEO; GSM844668
DR   GEO; GSM847106
DR   GEO; GSM851934
DR   GEO; GSM887456
DR   GEO; GSM888536
DR   GEO; GSM1001493
DR   GEO; GSM1153434
DR   GEO; GSM1153435
DR   GEO; GSM1178508
DR   GEO; GSM1178509
DR   GEO; GSM1181276
DR   GEO; GSM1181278
DR   GEO; GSM1186813
DR   GEO; GSM1186814
DR   GEO; GSM1186815
DR   GEO; GSM1186816
DR   GEO; GSM1186827
DR   GEO; GSM1291149
DR   GEO; GSM1374771
DR   GEO; GSM1374772
DR   GEO; GSM1374773
DR   GEO; GSM1670317
DR   GEO; GSM2124645
DR   GEO; GSM2474989
DR   IARC_TP53; 1417
DR   ICLC; HTL97004
DR   IGRhCellID; OVCAR3
DR   IZSLER; BS TCL 131
DR   KCB; KCB 2006106YJ
DR   KCLB; 30161
DR   LiGeA; CCLE_502
DR   LINCS_LDP; LCL-1522
DR   Lonza; 31
DR   MetaboLights; MTBLS150
DR   MetaboLights; MTBLS152
DR   Millipore; SCC257
DR   NCBI_Iran; C430
DR   NCI-DTP; OVCAR-3
DR   PharmacoDB; OVCAR3_1217_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD003539
DR   PRIDE; PXD003668
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0465
DR   PubChem_Cell_line; CVCL_0465
DR   RCB; RCB2135
DR   SKY/M-FISH/CGH; 2742
DR   TKG; TKG 0602
DR   TOKU-E; 2754
DR   Ubigene; YC-D019
DR   Wikidata; Q54937005
RX   PubMed=1348364;
RX   PubMed=1892748;
RX   PubMed=2041050;
RX   PubMed=2307530;
RX   PubMed=2653399;
RX   PubMed=3335022;
RX   PubMed=3930572;
RX   PubMed=6372095;
RX   PubMed=6385258;
RX   PubMed=6604576;
RX   PubMed=8557231;
RX   PubMed=9041185;
RX   PubMed=9331090;
RX   PubMed=9698466;
RX   PubMed=10700174;
RX   PubMed=11414198;
RX   PubMed=11793438;
RX   PubMed=12417041;
RX   PubMed=12960427;
RX   PubMed=15748285;
RX   PubMed=16382445;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=18560578;
RX   PubMed=19372543;
RX   PubMed=19926575;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22328975;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=22710073;
RX   PubMed=23172893;
RX   PubMed=23351415;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24023729;
RX   PubMed=24279929;
RX   PubMed=24434149;
RX   PubMed=24670534;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26169745;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27235858;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=27807467;
RX   PubMed=28100988;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32612269;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-htb-161
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=22
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544485
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-239.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/ovarian-cancer-xenograft/ovcar-3-xenograft-model/
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=6604576); 35 hours (PubMed=2653399); 64 hours (PubMed=25984343); 34.7 hours (NCI-DTP=OVCAR-3); ~69 hours (PBCF); 53.77 hours (JWGray panel).
CC   HLA typing: A*02:01:01,29:02; B*07:02:01,58:01; C*07:02:01,07; DPB1*02:01:02,04:01; DQB1*04:02; DRB1*08:01:01,08:04:01 (PubMed=15748285).
CC   HLA typing: A*02:01,29:02; B*07:02,58:01; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (DepMap=ACH-000001).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095; PubMed=21912889; PubMed=24023729; PubMed=25230021; PubMed=28273451; DepMap=ACH-000001).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Glycomics; O-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=3.99%; East Asian, South=0%; South Asian=0%; European, North=60.92%; European, South=35.08% (PubMed=30894373).
CC   Misspelling: OVCA3; Note=Occasionally.
CC   Misspelling: OVOCAR3; Note=Occasionally.
CC   Misspelling: OVCAK3; GEO=GSM459741.
CC   Discontinued: ICLC; HTL97004; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=HTB-161; CCRID; CLS=300307; COG; Cosmic-CLP=905933; KCLB=30161; Millipore=SCC257; PubMed=19372543; PubMed=25230021; PubMed=25877200; PubMed=30485824; RCB=RCB2135; Technion Genomics Center; TKG=TKG 0602
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,15
ST   D12S391: 22
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 16.2
ST   D1S1656: 12,17.3
ST   D21S11: 29,31.2
ST   D22S1045: 16
ST   D2S1338: 17,21
ST   D2S441: 11,14
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,15
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 9 (Millipore=SCC257; Technion Genomics Center)
ST   TH01: 9,9.3 (ATCC=HTB-161; CCRID; CLS=300307; COG; Cosmic-CLP=905933; KCLB=30161; PubMed=19372543; PubMed=25230021; PubMed=25877200; RCB=RCB2135; TKG=TKG 0602)
ST   TH01: 9.3 (PubMed=30485824)
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   OVCAR-3 SimpleCell O-GalNAc
AC   CVCL_S033
SY   OVCAR-3 SimpleCell; OVCAR-3 SC
DR   cancercelllines; CVCL_S033
DR   Wikidata; Q54937006
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   OVCAR-3-Luc
AC   CVCL_C8Y2
DR   Ubigene; YC-D019-Luc-P
DR   Wikidata; Q123033248
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   OVCAR-3/CMV-Luc
AC   CVCL_4Y18
DR   cancercelllines; CVCL_4Y18
DR   JCRB; JCRB1609
DR   JCRB; NIHS0732
DR   Wikidata; Q54937007
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1609).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0732; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1609
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 17
//
ID   OVCAR-3/T40
AC   CVCL_DA03
SY   OVCAR-3T40
DR   cancercelllines; CVCL_DA03
DR   GEO; GSM95435
DR   Progenetix; CVCL_DA03
DR   Wikidata; Q54937008
RX   PubMed=16382445;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   OVCAR-3/TxT5
AC   CVCL_DA02
SY   OVCAR-3TxT5
DR   cancercelllines; CVCL_DA02
DR   GEO; GSM95456
DR   Progenetix; CVCL_DA02
DR   Wikidata; Q54937009
RX   PubMed=16382445;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   OVCAR-4
AC   CVCL_1627
SY   OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4
DR   BTO; BTO_0002561
DR   CLO; CLO_0037096
DR   EFO; EFO_0005442
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472889
DR   BioSample; SAMN10987768
DR   cancercelllines; CVCL_1627
DR   Cell_Model_Passport; SIDM00092
DR   ChEMBL-Cells; CHEMBL3307517
DR   ChEMBL-Targets; CHEMBL614051
DR   Cosmic; 688105
DR   Cosmic; 875860
DR   Cosmic; 897434
DR   Cosmic; 905990
DR   Cosmic; 974295
DR   Cosmic; 1044240
DR   Cosmic; 1092624
DR   Cosmic; 1175884
DR   Cosmic; 1305313
DR   Cosmic; 1312355
DR   Cosmic; 1436034
DR   Cosmic; 1998466
DR   Cosmic-CLP; 905990
DR   DepMap; ACH-000617
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905990
DR   GEO; GSM2174
DR   GEO; GSM50220
DR   GEO; GSM50284
DR   GEO; GSM185137
DR   GEO; GSM185138
DR   GEO; GSM186442
DR   GEO; GSM186443
DR   GEO; GSM743475
DR   GEO; GSM743494
DR   GEO; GSM750829
DR   GEO; GSM784572
DR   GEO; GSM799364
DR   GEO; GSM799427
DR   GEO; GSM844669
DR   GEO; GSM844670
DR   GEO; GSM847107
DR   GEO; GSM851935
DR   GEO; GSM887484
DR   GEO; GSM888565
DR   GEO; GSM1153436
DR   GEO; GSM1181279
DR   GEO; GSM1181286
DR   GEO; GSM1374801
DR   GEO; GSM1670318
DR   GEO; GSM2124646
DR   IARC_TP53; 21085
DR   IARC_TP53; 21126
DR   IARC_TP53; 30217
DR   LiGeA; CCLE_876
DR   LINCS_LDP; LCL-1697
DR   Millipore; SCC258
DR   NCI-DTP; OVCAR-4
DR   PharmacoDB; OVCAR4_1218_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1627
DR   PubChem_Cell_line; CVCL_1627
DR   SKY/M-FISH/CGH; 2817
DR   Wikidata; Q54937010
RX   PubMed=1348364;
RX   PubMed=2041050;
RX   PubMed=2307530;
RX   PubMed=3335022;
RX   PubMed=3930572;
RX   PubMed=6372095;
RX   PubMed=6385258;
RX   PubMed=7718330;
RX   PubMed=9041185;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12080474;
RX   PubMed=12960427;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23839242;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24023729;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32612269;
RX   PubMed=35839778;
RX   PubMed=35918200;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=23
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 34 hours (PubMed=7718330); 43 hours (PubMed=25984343); 41.4 hours (NCI-DTP=OVCAR-4).
CC   HLA typing: A*01:01:01,32:01; B*08:01,40:02; C*07,15; DPB1*04:01,13:01; DQB1*02:01,03:01:01; DRB1*03:01:01,04:01:01 (PubMed=15748285).
CC   HLA typing: A*01:01,32:03; B*08:01,40:02; C*07:01,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (PubMed=17088437; PubMed=24023729).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=3.58%; East Asian, South=0%; South Asian=0%; European, North=53.46%; European, South=42.96% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=905990; Millipore=SCC258; PubMed=19372543; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,15
ST   D12S391: 23
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 13,15
ST   D1S1656: 15
ST   D21S11: 28,31
ST   D22S1045: 11,15
ST   D2S1338: 23
ST   D2S441: 10,15
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 12,14
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 47
//
ID   OVCAR-5
AC   CVCL_1628
SY   OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5
DR   BTO; BTO_0001870
DR   CLO; CLO_0008280
DR   EFO; EFO_0005443
DR   CLDB; cl3781
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 982
DR   BioSample; SAMN03472888
DR   BioSample; SAMN10989589
DR   cancercelllines; CVCL_1628
DR   Cell_Model_Passport; SIDM00091
DR   ChEMBL-Cells; CHEMBL3307565
DR   ChEMBL-Targets; CHEMBL614214
DR   Cosmic; 875861
DR   Cosmic; 897435
DR   Cosmic; 905969
DR   Cosmic; 974297
DR   Cosmic; 1044241
DR   Cosmic; 1092625
DR   Cosmic; 1093554
DR   Cosmic; 1102824
DR   Cosmic; 1175885
DR   Cosmic; 1305314
DR   Cosmic; 1312356
DR   Cosmic; 1436035
DR   Cosmic; 1523763
DR   Cosmic; 1707573
DR   Cosmic; 1709255
DR   Cosmic; 1995605
DR   Cosmic; 1998467
DR   Cosmic; 2186583
DR   Cosmic-CLP; 905969
DR   DepMap; ACH-001151
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905969
DR   GEO; GSM2126
DR   GEO; GSM50221
DR   GEO; GSM50285
DR   GEO; GSM185139
DR   GEO; GSM185140
DR   GEO; GSM659394
DR   GEO; GSM711709
DR   GEO; GSM743476
DR   GEO; GSM743493
DR   GEO; GSM743512
DR   GEO; GSM743513
DR   GEO; GSM743514
DR   GEO; GSM743515
DR   GEO; GSM743516
DR   GEO; GSM743517
DR   GEO; GSM743518
DR   GEO; GSM743519
DR   GEO; GSM743520
DR   GEO; GSM743521
DR   GEO; GSM743522
DR   GEO; GSM743523
DR   GEO; GSM743524
DR   GEO; GSM750830
DR   GEO; GSM784573
DR   GEO; GSM799365
DR   GEO; GSM799428
DR   GEO; GSM844671
DR   GEO; GSM847108
DR   GEO; GSM851936
DR   GEO; GSM1153437
DR   GEO; GSM1178525
DR   GEO; GSM1178526
DR   GEO; GSM1181280
DR   GEO; GSM1181287
DR   GEO; GSM1340587
DR   GEO; GSM1374802
DR   GEO; GSM1670319
DR   GEO; GSM2124678
DR   GEO; GSM2474993
DR   Millipore; SCC259
DR   NCI-DTP; OVCAR-5
DR   PharmacoDB; OVCAR5_1219_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD003668
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1628
DR   PubChem_Cell_line; CVCL_1628
DR   SKY/M-FISH/CGH; 2818
DR   Wikidata; Q54937011
RX   PubMed=1348364;
RX   PubMed=2041050;
RX   PubMed=2307530;
RX   PubMed=3335022;
RX   PubMed=3930572;
RX   PubMed=6385258;
RX   PubMed=7718330;
RX   PubMed=9041185;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12417041;
RX   PubMed=12960427;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=19926575;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=22068913;
RX   PubMed=22328975;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24023729;
RX   PubMed=24279929;
RX   PubMed=24434149;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27353327;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35681748;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=24
CC   Problematic cell line: Possibly misclassified. Originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin (PubMed=27353327).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=7718330); 48.8 hours (NCI-DTP=OVCAR-5); 24.37 hours (JWGray panel).
CC   HLA typing: A*01,02; B*08,44; C*05,07; DPB1*04:01; DQB1*02:01,03:01:01; DRB1*03:01:01,04:01:01 (PubMed=15748285).
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=17088437; PubMed=28273451; Cosmic-CLP=905969; DepMap=ACH-001151).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.13%; East Asian, North=0.98%; East Asian, South=0%; South Asian=0.37%; European, North=67.06%; European, South=31.46% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=905969; Millipore=SCC259; PubMed=19372543; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 31
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11,13 (Cosmic-CLP=905969; PubMed=19372543; PubMed=25877200; PubMed=30485824)
ST   D5S818: 12,13 (Millipore=SCC259)
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 9,16 (PubMed=25877200)
ST   Penta E: 9,16,17 (Millipore=SCC259)
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   OVCAR-5 CBPR
AC   CVCL_E3AR
RX   PubMed=35681748;
CC   Problematic cell line: Possibly misclassified. Parent cell line (OVCAR-5) was originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Omics: Metabolomics.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1628 ! OVCAR-5
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   OVCAR-5-CisR
AC   CVCL_UI87
SY   OVCAR5-CisR
DR   cancercelllines; CVCL_UI87
DR   Wikidata; Q98128407
RX   PubMed=21372221;
RX   PubMed=30485824;
CC   Problematic cell line: Possibly misclassified. Parent cell line (OVCAR-5) was originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 11
ST   D21S11: 31
ST   D5S818: 11,13
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1628 ! OVCAR-5
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   OVCAR-5/RFP
AC   CVCL_JY85
DR   cancercelllines; CVCL_JY85
DR   Cell_Biolabs; AKR-254
DR   Wikidata; Q54937012
CC   Problematic cell line: Possibly misclassified. Parent cell line (OVCAR-5) was originally thought to be a high grade ovarian serous adenocarcinoma but suspected to have a upper gastrointestinal origin.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1628 ! OVCAR-5
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   OVCAR-7
AC   CVCL_DG79
SY   OVCAR7
DR   cancercelllines; CVCL_DG79
DR   GEO; GSM185141
DR   GEO; GSM185142
DR   Progenetix; CVCL_DG79
DR   Wikidata; Q54937013
RX   PubMed=1348364;
RX   PubMed=2307530;
RX   PubMed=9041185;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   OVCAR-8
AC   CVCL_1629
SY   OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8
DR   BTO; BTO_0003054
DR   EFO; EFO_0005444
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 392
DR   BioSample; SAMN03472794
DR   BioSample; SAMN10988023
DR   cancercelllines; CVCL_1629
DR   Cell_Model_Passport; SIDM00090
DR   ChEMBL-Cells; CHEMBL3307975
DR   ChEMBL-Targets; CHEMBL612555
DR   Cosmic; 688106
DR   Cosmic; 875862
DR   Cosmic; 905991
DR   Cosmic; 974298
DR   Cosmic; 1044242
DR   Cosmic; 1092626
DR   Cosmic; 1093555
DR   Cosmic; 1305315
DR   Cosmic; 1312357
DR   Cosmic; 1436036
DR   Cosmic; 1523764
DR   Cosmic; 1526923
DR   Cosmic; 1998468
DR   Cosmic; 2186582
DR   Cosmic-CLP; 905991
DR   DepMap; ACH-000696
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905991
DR   GEO; GSM2117
DR   GEO; GSM50222
DR   GEO; GSM50286
DR   GEO; GSM185143
DR   GEO; GSM185144
DR   GEO; GSM322534
DR   GEO; GSM322535
DR   GEO; GSM322536
DR   GEO; GSM459646
DR   GEO; GSM459647
DR   GEO; GSM711710
DR   GEO; GSM743477
DR   GEO; GSM743495
DR   GEO; GSM750819
DR   GEO; GSM750831
DR   GEO; GSM784574
DR   GEO; GSM799366
DR   GEO; GSM799429
DR   GEO; GSM844672
DR   GEO; GSM844673
DR   GEO; GSM847109
DR   GEO; GSM851937
DR   GEO; GSM887485
DR   GEO; GSM888566
DR   GEO; GSM1153438
DR   GEO; GSM1181299
DR   GEO; GSM1181339
DR   GEO; GSM1340588
DR   GEO; GSM1341132
DR   GEO; GSM1374803
DR   GEO; GSM1670320
DR   GEO; GSM2124679
DR   GEO; GSM2474994
DR   GEO; GSM2748150
DR   GEO; GSM2748151
DR   GEO; GSM2748152
DR   GEO; GSM2748153
DR   GEO; GSM2748154
DR   GEO; GSM2748155
DR   GEO; GSM3161724
DR   GEO; GSM3161725
DR   IARC_TP53; 18079
DR   IARC_TP53; 21121
DR   LiGeA; CCLE_464
DR   NCI-DTP; OVCAR-8
DR   PharmacoDB; OVCAR8_1220_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1629
DR   PubChem_Cell_line; CVCL_1629
DR   SKY/M-FISH/CGH; 1437
DR   Wikidata; Q54937014
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=1348364;
RX   PubMed=2041050;
RX   PubMed=2307530;
RX   PubMed=3335022;
RX   PubMed=7718330;
RX   PubMed=9041185;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12417041;
RX   PubMed=12960427;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24023729;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=25
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=7718330); 25 hours (PubMed=25984343); 26.1 hours (NCI-DTP=OVCAR-8); 31.93 hours (JWGray panel).
CC   HLA typing: A*01:01:01,25:01; B*57:01:01; C*06:02; DPB1*02:01:02,13:01; DQB1*03:03:02,06:02; DRB1*07:01,15:01:01 (PubMed=15748285).
CC   HLA typing: A*01:01,25:01; B*57:01,57:01; C*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (PubMed=28273451; Cosmic-CLP=905991).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (PubMed=28273451; Cosmic-CLP=905991).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=9331090; PubMed=20204287; PubMed=21912889; PubMed=28273451; Cosmic-CLP=905991).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.22%; Native American=0%; East Asian, North=3.41%; East Asian, South=0%; South Asian=0.98%; European, North=60.74%; European, South=34.66% (PubMed=30894373).
CC   Misspelling: OVACAR8; Cosmic=1526923.
CC   Misspelling: OVOCAR-8; Note=Occasionally.
CC   Misspelling: OVOCAR8; Note=Occasionally.
ST   Source(s): Cosmic-CLP=905991; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; PubMed=30485824; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14
ST   D12S391: 15,18
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 14,16
ST   D1S1656: 19.3
ST   D21S11: 28
ST   D22S1045: 11
ST   D2S1338: 19,23
ST   D2S441: 10,11
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   OVCAR-8 RIA
AC   CVCL_IM65
DR   cancercelllines; CVCL_IM65
DR   GEO; GSM322537
DR   GEO; GSM322538
DR   GEO; GSM322539
DR   Wikidata; Q54937016
RX   PubMed=18822129;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9388; PRKAR1A.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1629 ! OVCAR-8
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 15
//
ID   OVCAR-8 RIIB
AC   CVCL_IM66
DR   cancercelllines; CVCL_IM66
DR   GEO; GSM322540
DR   GEO; GSM322541
DR   GEO; GSM322542
DR   Wikidata; Q54937017
RX   PubMed=18822129;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9392; PRKAR2B.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1629 ! OVCAR-8
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 15
//
ID   OVCAR3-533533-R1
AC   CVCL_DH37
SY   533533-R1
DR   cancercelllines; CVCL_DH37
DR   GEO; GSM1186817
DR   GEO; GSM1186822
DR   GEO; GSM1186828
DR   Progenetix; CVCL_DH37
DR   Wikidata; Q54937018
RX   PubMed=24004674;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132239; PHA-533533.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   OVCAR3-533533-R3
AC   CVCL_DH38
DR   cancercelllines; CVCL_DH38
DR   GEO; GSM1186818
DR   GEO; GSM1186823
DR   GEO; GSM1186829
DR   Progenetix; CVCL_DH38
DR   Wikidata; Q54937019
RX   PubMed=24004674;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132239; PHA-533533.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   OVCAR3-533533-R5
AC   CVCL_DH39
DR   cancercelllines; CVCL_DH39
DR   GEO; GSM1186819
DR   GEO; GSM1186824
DR   GEO; GSM1186830
DR   Progenetix; CVCL_DH39
DR   Wikidata; Q54937020
RX   PubMed=24004674;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132239; PHA-533533.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   OVCAR3-533533-R6
AC   CVCL_DH40
SY   533533-R6
DR   cancercelllines; CVCL_DH40
DR   GEO; GSM1186820
DR   GEO; GSM1186825
DR   GEO; GSM1186831
DR   Progenetix; CVCL_DH40
DR   Wikidata; Q54937021
RX   PubMed=24004674;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132239; PHA-533533.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   OVCAR3-533533-R7
AC   CVCL_DH41
DR   cancercelllines; CVCL_DH41
DR   GEO; GSM1186821
DR   GEO; GSM1186826
DR   GEO; GSM1186832
DR   Progenetix; CVCL_DH41
DR   Wikidata; Q54937022
RX   PubMed=24004674;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132239; PHA-533533.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   OVCAR4-Luc
AC   CVCL_E5FK
RX   PubMed=35918200;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1627 ! OVCAR-4
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   OVHS-1
AC   CVCL_A769
SY   OVHS1
DR   cancercelllines; CVCL_A769
DR   Cosmic; 991319
DR   Cosmic; 1524356
DR   GEO; GSM2474995
DR   Wikidata; Q54937024
RX   PubMed=10381137;
RX   PubMed=18720132;
RX   PubMed=28273451;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu914Lys (c.2740G>A); ClinVar=VCV000479250; Zygosity=Unspecified (PubMed=28273451).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala305Gly; Zygosity=Unspecified (PubMed=28273451).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Unspecified (PubMed=28273451).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Unspecified (PubMed=28273451).
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: OVSH-1; GEO=GSM2474995.
CC   Misspelling: OVSH1; PubMed=28273451.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   OVI-P
AC   CVCL_W129
SY   OVI/p; OVIP; OV1-P; OV1/p
DR   Cosmic; 688107
DR   Cosmic; 1609527
DR   Wikidata; Q54937025
RX   PubMed=15677628;
CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 6
//
ID   OVISE
AC   CVCL_3116
DR   BTO; BTO_0003498
DR   CLO; CLO_0037097
DR   EFO; EFO_0006724
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 983
DR   BioSample; SAMN02800475
DR   BioSample; SAMN03472858
DR   BioSample; SAMN10988266
DR   cancercelllines; CVCL_3116
DR   Cell_Model_Passport; SIDM00564
DR   CGH-DB; 330-2
DR   Cosmic; 1223316
DR   Cosmic; 1328065
DR   Cosmic; 1434893
DR   Cosmic; 1708377
DR   Cosmic; 1995606
DR   Cosmic; 2074246
DR   Cosmic; 2482699
DR   Cosmic-CLP; 1240198
DR   DepMap; ACH-000527
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240198
DR   GEO; GSM416678
DR   GEO; GSM659395
DR   GEO; GSM827222
DR   GEO; GSM888567
DR   GEO; GSM1176280
DR   GEO; GSM1670321
DR   IARC_TP53; 30140
DR   JCRB; JCRB1043
DR   JCRB; NIHS0296
DR   JCRB; NIHS0338
DR   LiGeA; CCLE_251
DR   LINCS_LDP; LCL-1524
DR   PharmacoDB; OVISE_1222_2019
DR   PRIDE; PXD000901
DR   PRIDE; PXD003105
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3116
DR   Wikidata; Q54937026
RX   DOI=10.5795/jjscc.31.966;
RX   PubMed=7535723;
RX   PubMed=9328139;
RX   PubMed=11121861;
RX   PubMed=15677628;
RX   PubMed=17671176;
RX   PubMed=20081105;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26388441;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=7535723; PubMed=9328139; PubMed=11121861); 48 hours (PubMed=25984343); ~1.5 days (Note=Lots 04092007 and 06132011), ~49 hours (Note=Lot 05302016) (JCRB=JCRB1043).
CC   HLA typing: A*26:01,31:01; B*40:02,51:01; C*03:04,14:02; DRB1*11:30,11:30 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (DepMap=ACH-000527).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0%; East Asian, North=80.54%; East Asian, South=17.28%; South Asian=0%; European, North=0%; European, South=2.13% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0296; true.
CC   Discontinued: JCRB; NIHS0338; true.
CC   Derived from site: Metastatic; Pelvis, innominate bone; UBERON=UBERON_0001272.
ST   Source(s): Cosmic-CLP=1240198; JCRB=JCRB1043; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 19
ST   D21S11: 28,30
ST   D3S1358: 14,15
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 15,16
ST   FGA: 19,23
ST   Penta D: 9,11
ST   Penta E: 14
ST   TH01: 9,9.3 (Cosmic-CLP=1240198; JCRB=JCRB1043; PubMed=25877200)
ST   TH01: 9.3 (PubMed=30485824)
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   OVISE-3
AC   CVCL_U211
DR   cancercelllines; CVCL_U211
DR   Wikidata; Q54937027
RX   PubMed=7882618;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pelvis, innominate bone; UBERON=UBERON_0001272.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3116 ! OVISE
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   OVK18
AC   CVCL_3770
SY   OVK-18; OVK#18
DR   CLO; CLO_0051452
DR   EFO; EFO_0022631
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 495
DR   BioSample; SAMN03472087
DR   BioSample; SAMN10987740
DR   cancercelllines; CVCL_3770
DR   Cell_Model_Passport; SIDM00238
DR   Cosmic; 1066216
DR   Cosmic; 1708385
DR   Cosmic-CLP; 1480371
DR   DepMap; ACH-000947
DR   EGA; EGAS00001000978
DR   GDSC; 1480371
DR   GEO; GSM887486
DR   GEO; GSM888568
DR   GEO; GSM1670322
DR   IARC_TP53; 28375
DR   LiGeA; CCLE_457
DR   PharmacoDB; OVK18_1223_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3770
DR   RCB; RCB1903
DR   TKG; TKG 0323
DR   Wikidata; Q54937028
RX   PubMed=6584390;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=23839242;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=32612269;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=6584390).
CC   HLA typing: A*24:02,24:02; B*15:01,54:01; C*01:02,04:01; DQA1*05:02,05:02; DRB1*13:07,15:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Leu437fs*1 (c.1305delT); Zygosity=Heterozygous (Cosmic-CLP=1480371; DepMap=ACH-000947).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Gly (c.176C>G); Zygosity=Heterozygous (Cosmic-CLP=1480371; DepMap=ACH-000947).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Tyr366fs*17 (c.1096delT); Zygosity=Heterozygous (Cosmic-CLP=1480371; DepMap=ACH-000947).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Pro109fs*194 (c.322delC); Zygosity=Heterozygous (Cosmic-CLP=1480371; DepMap=ACH-000947).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Heterozygous (Cosmic-CLP=1480371; DepMap=ACH-000947).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=78.65%; East Asian, South=21.35%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1480371; PubMed=30485824; RCB=RCB1903; TKG=TKG 0323
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D21S11: 30,31
ST   D5S818: 8,13
ST   D7S820: 8 (RCB=RCB1903)
ST   D7S820: 8,13,14 (Cosmic-CLP=1480371; PubMed=30485824; TKG=TKG 0323)
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   OVK18#102
AC   CVCL_7171
DR   CLO; CLO_0051453
DR   BioSample; SAMN03471921
DR   cancercelllines; CVCL_7171
DR   Cosmic; 1066217
DR   RCB; RCB2535
DR   TKG; TKG 0357
DR   Wikidata; Q54937029
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Leu437fs*1 (c.1305delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Gly (c.176C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Tyr366fs*17 (c.1096delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Pro109fs*194 (c.322delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Argfs*18 (c.455delC); ClinVar=VCV000634779; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB2535; TKG=TKG 0357
ST   Amelogenin: X
ST   CSF1PO: 10 (TKG=TKG 0357)
ST   CSF1PO: 10,12 (RCB=RCB2535)
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D5S818: 8,11 (RCB=RCB2535)
ST   D5S818: 8,11,12 (TKG=TKG 0357)
ST   D7S820: 8 (RCB=RCB2535)
ST   D7S820: 8,13 (TKG=TKG 0357)
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3770 ! OVK18
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   OVKATE
AC   CVCL_3110
DR   BTO; BTO_0003503
DR   CLO; CLO_0037098
DR   EFO; EFO_0006725
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472859
DR   BioSample; SAMN10988314
DR   cancercelllines; CVCL_3110
DR   Cell_Model_Passport; SIDM00466
DR   CGH-DB; 338-2
DR   Cosmic; 1995607
DR   Cosmic-CLP; 1240199
DR   DepMap; ACH-000443
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240199
DR   GEO; GSM659396
DR   GEO; GSM887487
DR   GEO; GSM888569
DR   GEO; GSM1670323
DR   IARC_TP53; 28276
DR   JCRB; JCRB1044
DR   JCRB; NIHS0297
DR   JCRB; NIHS0339
DR   LINCS_LDP; LCL-1525
DR   PharmacoDB; OVKATE_1224_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3110
DR   Wikidata; Q54937030
RX   DOI=10.1016/j.jveb.2019.04.010;
RX   PubMed=9328139;
RX   PubMed=11121861;
RX   PubMed=15677628;
RX   PubMed=17671176;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=9328139; PubMed=11121861).
CC   HLA typing: A*26:01,26:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3942; MTOR; Simple; p.Thr1834_Thr1837delThrAlaAlaThr (c.5490_5501delGTGGTGGCGGCA); Zygosity=Heterozygous (Cosmic-CLP=1240199; DepMap=ACH-000443).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (Cosmic-CLP=1240199; DepMap=ACH-000443).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.37%; Native American=0%; East Asian, North=79.04%; East Asian, South=17.87%; South Asian=0%; European, North=0%; European, South=0.72% (PubMed=30894373).
CC   Anecdotal: Dogs were trained to recognize the odor of this cell line so as to later detect ovarian cancer from blood samples (DOI=10.1016/j.jveb.2019.04.010).
CC   Discontinued: JCRB; NIHS0297; true.
CC   Discontinued: JCRB; NIHS0339; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1240199; JCRB=JCRB1044; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 14,15.2
ST   D21S11: 30,33.2
ST   D2S1338: 18,23
ST   D3S1358: 18
ST   D5S818: 9,13
ST   D7S820: 11,12
ST   D8S1179: 11
ST   FGA: 19
ST   Penta D: 9,13
ST   Penta E: 5,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   OVMANA
AC   CVCL_3111
DR   BTO; BTO_0003500
DR   EFO; EFO_0006726
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 493
DR   BioSample; SAMN03472488
DR   BioSample; SAMN10988029
DR   cancercelllines; CVCL_3111
DR   Cell_Model_Passport; SIDM01378
DR   CGH-DB; 337-2
DR   Cosmic; 1223317
DR   Cosmic; 1305330
DR   Cosmic; 1328066
DR   Cosmic; 1434894
DR   Cosmic; 1708384
DR   Cosmic; 2074247
DR   Cosmic; 2482707
DR   DepMap; ACH-000646
DR   EGA; EGAS00001000610
DR   GEO; GSM416679
DR   GEO; GSM459731
DR   GEO; GSM659397
DR   GEO; GSM887488
DR   GEO; GSM888570
DR   GEO; GSM1176281
DR   IARC_TP53; 30141
DR   JCRB; JCRB1045
DR   JCRB; NIHS0298
DR   JCRB; NIHS0340
DR   LiGeA; CCLE_247
DR   PharmacoDB; OVMANA_1225_2019
DR   PRIDE; PXD003105
DR   Progenetix; CVCL_3111
DR   Wikidata; Q54937031
RX   PubMed=9328139;
RX   PubMed=11121861;
RX   PubMed=15677628;
RX   PubMed=17671176;
RX   PubMed=20081105;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=22710073;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 67 hours (PubMed=9328139; PubMed=11121861); 70 hours (PubMed=25984343); 50-60 hours (Note=Lot 02042008), ~55-60 hours (Note=Lot 09042012), ~38 hours (Note=Lot 05022017) (JCRB=JCRB1045).
CC   HLA typing: A*24:02,24:02; B*07:02,54:01; C*01:02,07:02; DQA1*03:02,03:02; DQB1*04:01,04:01; DRB1*15:01,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Val (c.1634A>T); ClinVar=VCV000375897; Zygosity=Unspecified (PubMed=22705003).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=79.88%; East Asian, South=19.76%; South Asian=0%; European, North=0.36%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0298; true.
CC   Discontinued: JCRB; NIHS0340; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): JCRB=JCRB1045; PubMed=22710073; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 21,24
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   OVMIU
AC   CVCL_3112
DR   CLO; CLO_0037099
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 985
DR   BioSample; SAMN03151882
DR   BioSample; SAMN03472489
DR   cancercelllines; CVCL_3112
DR   Cell_Model_Passport; SIDM00465
DR   Cosmic; 1995608
DR   Cosmic-CLP; 1240200
DR   DepMap; ACH-002183
DR   EGA; EGAS00001000978
DR   GDSC; 1240200
DR   GEO; GSM827252
DR   GEO; GSM1670324
DR   JCRB; JCRB1049
DR   JCRB; NIHS0302
DR   JCRB; NIHS0344
DR   LINCS_LDP; LCL-1526
DR   PharmacoDB; OVMIU_1226_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3112
DR   Wikidata; Q54937032
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a OVSAYO derivative (PubMed=20143388). Originally thought to originate from a 46 year old female patient with an ovarian adenocarcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00341.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Met (c.746G>T); ClinVar=VCV000376653; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.26%; Native American=0.2%; East Asian, North=75.07%; East Asian, South=23.44%; South Asian=1.02%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0302; true.
CC   Discontinued: JCRB; NIHS0344; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1240200; JCRB=JCRB1049
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3115 ! OVSAYO
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   OVMIU-II
AC   CVCL_3113
DR   BioSample; SAMN03472490
DR   JCRB; JCRB1050
DR   JCRB; NIHS0303
DR   JCRB; NIHS0345
DR   Wikidata; Q54937033
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0303; true.
CC   Discontinued: JCRB; NIHS0345; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): JCRB=JCRB1050
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 13,14
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   Ovn
AC   CVCL_E2SV
RX   PubMed=38615309;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; KETFB; OFP (Note=Orange fluorescent protein from Cerianthus sp.).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from a patient that underwent total hysterectomy and bilateral ovarian and fallopian tube resection for atypical endometrial hyperplasia (PubMed=38615309).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   OVNIS 5H
AC   CVCL_A9I7
SY   OVNIS-5H; OVNIS 5 H; OVine NIhil Serum 5H
DR   Wikidata; Q102114694
RX   CelloPub=CLPUB00572;
RX   PubMed=1726925;
RX   PubMed=3000830;
RX   PubMed=3709961;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   OVNIS 6H
AC   CVCL_3409
SY   OVNIS-6H; OVNIS 6 H; OVNIS; OVine NIhil Serum 6H
DR   CLO; CLO_0008281
DR   CLDB; cl3782
DR   ECACC; 93122324
DR   Wikidata; Q54937034
RX   CelloPub=CLPUB00572;
RX   PubMed=1726925;
RX   PubMed=3040495;
RX   PubMed=3286455;
RX   PubMed=3556752;
RX   PubMed=3709961;
CC   Discontinued: ECACC; 93122324; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   OVNIS 6H clone 1
AC   CVCL_A9I8
DR   Wikidata; Q102114695
RX   PubMed=3040495;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_3409 ! OVNIS 6H
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   OVNIS 6H clone 2
AC   CVCL_A9I9
DR   Wikidata; Q102114696
RX   PubMed=3040495;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_3409 ! OVNIS 6H
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   OVPA8
AC   CVCL_UC75
SY   OVPA-8
DR   cancercelllines; CVCL_UC75
DR   DSMZ; ACC-871
DR   DSMZCellDive; ACC-871
DR   ECACC; 19062601
DR   Wikidata; Q98128408
RX   PubMed=30018258;
CC   Population: Caucasian.
CC   Doubling time: ~44 hours (PubMed=30018258); 50-60 hours (DSMZ=ACC-871); 40-44 hours (ECACC=19062601).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1101; BRCA2; Zygosity=Heterozygous (PubMed=30018258).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Val1234Glnfs*8 (c.3695_3699GTAAA[1]) (c.3700_3704delGTAAA) (3819del5) (3819_3823delGTAAA); ClinVar=VCV000037542; Zygosity=Homozygous (PubMed=30018258).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=30018258).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-871; ECACC=19062601; PubMed=30018258
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 14,15
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 12,14
ST   D18S51: 12
ST   D19S433: 13,15
ST   D1S1656: 15
ST   D21S11: 29,30
ST   D22S1045: 15
ST   D2S1338: 21,25
ST   D2S441: 14
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 8,9
ST   D8S1179: 11,14 (DSMZ=ACC-871; PubMed=30018258)
ST   D8S1179: 14 (ECACC=19062601)
ST   FGA: 22,25
ST   Penta D: 13
ST   Penta E: 5
ST   TH01: 8
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 12
//
ID   OVSAHO
AC   CVCL_3114
DR   BTO; BTO_0003502
DR   EFO; EFO_0006727
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472860
DR   BioSample; SAMN10988236
DR   cancercelllines; CVCL_3114
DR   Cell_Model_Passport; SIDM01377
DR   CGH-DB; 334-2
DR   DepMap; ACH-000409
DR   EGA; EGAS00001000610
DR   GEO; GSM459648
DR   GEO; GSM659398
DR   GEO; GSM887489
DR   GEO; GSM888571
DR   IARC_TP53; 28252
DR   JCRB; JCRB1046
DR   JCRB; NIHS0299
DR   JCRB; NIHS0341
DR   LiGeA; CCLE_754
DR   Millipore; SCC294
DR   PharmacoDB; OVSAHO_1227_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD003668
DR   Progenetix; CVCL_3114
DR   Wikidata; Q54937035
RX   PubMed=9328139;
RX   PubMed=11121861;
RX   PubMed=15677628;
RX   PubMed=17671176;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=32612269;
RX   PubMed=35918200;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 56 hours (PubMed=9328139; PubMed=11121861); ~3 days (Note=Lot 09282010), ~43 hours (Note=Lots 04062015 and 12012017) (JCRB=JCRB1046).
CC   HLA typing: A*26:01,26:01; B*39:01,39:01; C*07:02,07:02; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*03:02,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (DepMap=ACH-000409).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.52%; East Asian, South=14.27%; South Asian=0.06%; European, North=0%; European, South=2.15% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0299; true.
CC   Discontinued: JCRB; NIHS0341; true.
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
ST   Source(s): JCRB=JCRB1046; Millipore=SCC294; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 16,20
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 11,14 (Millipore=SCC294)
ST   D8S1179: 14 (PubMed=25877200)
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14 (JCRB=JCRB1046; PubMed=25877200; PubMed=30485824)
ST   vWA: 14,16 (Millipore=SCC294)
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   OvsahoCarbo
AC   CVCL_E5FQ
DR   CancerTools; 161759
RX   PubMed=35918200;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3114 ! OVSAHO
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   OvsahoCis
AC   CVCL_E5FR
DR   CancerTools; 161763
RX   PubMed=35918200;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3114 ! OVSAHO
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   OVSAYO
AC   CVCL_3115
DR   BTO; BTO_0003501
DR   CLO; CLO_0037100
DR   cancercelllines; CVCL_3115
DR   Cell_Model_Passport; SIDM00464
DR   GEO; GSM416680
DR   JCRB; JCRB1047
DR   JCRB; NIHS0300
DR   JCRB; NIHS0342
DR   LINCS_LDP; LCL-1527
DR   PRIDE; PXD003105
DR   Wikidata; Q54937037
RX   PubMed=9328139;
RX   PubMed=11121861;
RX   PubMed=15677628;
RX   PubMed=20081105;
RX   PubMed=24023729;
RX   PubMed=26972028;
RX   PubMed=27141528;
CC   Problematic cell line: Misclassified. Originally thought to be an ovarian clear cell adenocarcinoma but shown to be a high grade ovarian serous adenocarcinoma (PubMed=24023729).
CC   Population: Japanese.
CC   Doubling time: 88 hours (PubMed=9328139; PubMed=11121861).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Met (c.746G>T); ClinVar=VCV000376653; Zygosity=Heterozygous (PubMed=24023729).
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0300; true.
CC   Discontinued: JCRB; NIHS0342; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): JCRB=JCRB1047
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   OVT2
AC   CVCL_W292
DR   Wikidata; Q54937038
RX   PubMed=12080474;
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 5
//
ID   OVTOKO
AC   CVCL_3117
DR   BTO; BTO_0003499
DR   CLO; CLO_0037101
DR   EFO; EFO_0006728
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 492
DR   BioSample; SAMN03472861
DR   BioSample; SAMN10987767
DR   cancercelllines; CVCL_3117
DR   Cell_Model_Passport; SIDM00425
DR   CGH-DB; 331-2
DR   Cosmic; 1223318
DR   Cosmic; 1328067
DR   Cosmic; 1434895
DR   Cosmic; 1708379
DR   Cosmic; 1889263
DR   Cosmic; 2074248
DR   Cosmic; 2482705
DR   Cosmic-CLP; 1298365
DR   DepMap; ACH-000663
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298365
DR   GEO; GSM416681
DR   GEO; GSM459732
DR   GEO; GSM659399
DR   GEO; GSM827253
DR   GEO; GSM887490
DR   GEO; GSM888572
DR   GEO; GSM1176282
DR   GEO; GSM1670325
DR   IARC_TP53; 30142
DR   JCRB; JCRB1048
DR   JCRB; NIHS0301
DR   JCRB; NIHS0343
DR   LiGeA; CCLE_135
DR   LINCS_LDP; LCL-1528
DR   PharmacoDB; OVTOKO_1228_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3117
DR   Wikidata; Q54937039
RX   PubMed=7535723;
RX   PubMed=9328139;
RX   PubMed=11121861;
RX   PubMed=15677628;
RX   PubMed=17671176;
RX   PubMed=20081105;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=23430509;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 70 hours (PubMed=7535723; PubMed=9328139; PubMed=11121861).
CC   HLA typing: A*26:01,33:03; B*35:01,44:03; C*03:03,14:03; DQB1*06:04,06:04; DRB1*13:10,14:18 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=82.47%; East Asian, South=16.63%; South Asian=0%; European, North=0%; European, South=0.89% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0301; true.
CC   Discontinued: JCRB; NIHS0343; true.
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
ST   Source(s): Cosmic-CLP=1298365; JCRB=JCRB1048; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 19
ST   D21S11: 29,31
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 21,23
ST   Penta D: 9,10
ST   Penta E: 14
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   OVTW59-P0
AC   CVCL_C6VP
SY   OVTW59 P0; OVTW-59-P0; OVTW59; OVTW-59
DR   Wikidata; Q117704761
RX   PubMed=17952116;
RX   PubMed=34824343;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 26 hours (PubMed=17952116).
CC   Miscellaneous: STR profile from personal communication of Yeh, Ting-Chih.
CC   Derived from site: In situ; Ovary, epithelium; UBERON=UBERON_0004911.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D21S11: 31
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,7,9
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   OVTW59-P1
AC   CVCL_C6VQ
DR   Wikidata; Q117704762
RX   PubMed=17952116;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Selected from parent cell line for invasion phenotype using Matrigel-coated transwell membranes. P1 are P0-derived cells that had invaded through the Matrigel (PubMed=17952116).
CC   Derived from site: In situ; Ovary, epithelium; UBERON=UBERON_0004911.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VP ! OVTW59-P0
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   OVTW59-P2
AC   CVCL_C6VR
DR   Wikidata; Q117704763
RX   PubMed=17952116;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Selected from parent cell line for invasion phenotype using Matrigel-coated transwell membranes. P2 are P1-derived cells that had invaded through the Matrigel (PubMed=17952116).
CC   Derived from site: In situ; Ovary, epithelium; UBERON=UBERON_0004911.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VQ ! OVTW59-P1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   OVTW59-P3
AC   CVCL_C6VS
DR   Wikidata; Q117704764
RX   PubMed=17952116;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Selected from parent cell line for invasion phenotype using Matrigel-coated transwell membranes. P3 are P2-derived cells that had invaded through the Matrigel (PubMed=17952116).
CC   Derived from site: In situ; Ovary, epithelium; UBERON=UBERON_0004911.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VR ! OVTW59-P2
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   OVTW59-P4
AC   CVCL_C6VT
SY   OVTW59 P4; OVTW-59-P4; OVTW-59-4
DR   Wikidata; Q117704765
RX   PubMed=17952116;
RX   PubMed=34824343;
CC   Population: Chinese; Taiwan.
CC   Characteristics: High invasive phenotype. Selected from parent cell line for invasion phenotype using Matrigel-coated transwell membranes. P4 are P3-derived cells that had invaded through the Matrigel (PubMed=17952116).
CC   Doubling time: 19 hours (PubMed=17952116).
CC   Karyotypic information: XXX,t(3;12),t(5;8),t(6;15),t(11;12),t(15;22),del(7)(q22),-4,+12,+14,+14,-18,-19,+21,-22,-22 (PubMed=17952116).
CC   Derived from site: In situ; Ovary, epithelium; UBERON=UBERON_0004911.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VS ! OVTW59-P3
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   OVTW59-P4-pBIG2i-hIGFBP3
AC   CVCL_C6VU
SY   P4-pBIG2i-hIGFBP3
DR   Wikidata; Q117704766
RX   PubMed=34824343;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Transduced with a doxycycline-induced expression plasmid pBIG2i that drives the expression of hIGFPB3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5472; IGFBP3.
CC   Derived from site: In situ; Ovary, epithelium; UBERON=UBERON_0004911.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VT ! OVTW59-P4
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   OVXF 1023
AC   CVCL_D166
SY   OVXF1023
DR   ChEMBL-Cells; CHEMBL3308696
DR   ChEMBL-Targets; CHEMBL615008
DR   PubChem_Cell_line; CVCL_D166
DR   Wikidata; Q54937040
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   OVXF 1353
AC   CVCL_D167
SY   OVXF1353
DR   ChEMBL-Cells; CHEMBL3307799
DR   ChEMBL-Targets; CHEMBL612271
DR   PubChem_Cell_line; CVCL_D167
DR   Wikidata; Q54937041
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   OVXF 1544
AC   CVCL_D168
DR   Wikidata; Q54937042
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   OVXF 1619L
AC   CVCL_D169
DR   Wikidata; Q54937043
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   OVXF 899L
AC   CVCL_D170
SY   OVXF 899
DR   Wikidata; Q54937044
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   OW-1
AC   CVCL_UD52
SY   OW1; OWI
DR   Wikidata; Q98128409
RX   PubMed=1997098;
RX   PubMed=2789934;
RX   PubMed=3182331;
CC   Doubling time: 12 hours (PubMed=3182331).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   OW90650
AC   CVCL_VI12
DR   Wikidata; Q54937045
RX   PubMed=9230208;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9230208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   OX-1
AC   CVCL_G677
SY   OX1
DR   ECACC; 84112004
DR   Wikidata; Q54937053
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-100
AC   CVCL_JX75
SY   OX100
DR   Wikidata; Q54937054
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-101
AC   CVCL_U017
SY   OX101
DR   ECACC; 03062503
DR   Wikidata; Q54937055
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P97829; Rat Cd47.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-102
AC   CVCL_U018
SY   OX102
DR   ECACC; 03062504
DR   Wikidata; Q54937056
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9ES58; Rat Cd200r1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-104
AC   CVCL_U019
SY   OX104
DR   ECACC; 03062505
DR   Wikidata; Q54937057
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P41217; Human CD200.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-106
AC   CVCL_X517
SY   OX106
DR   ECACC; 13082220
DR   Wikidata; Q54937058
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Rat antigen on neutrophils.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 5
//
ID   OX-107
AC   CVCL_JX76
SY   OX107
DR   Wikidata; Q54937059
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01830; Rat Thy1/Cd90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-108
AC   CVCL_X518
SY   OX108
DR   ABCD; ABCD_AF610
DR   ECACC; 13082222
DR   Wikidata; Q54937060
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TD46; Human CD200R1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   OX-109
AC   CVCL_U020
SY   OX109
DR   ECACC; 13082223
DR   Wikidata; Q54937061
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TD46; Human CD200R1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-11
AC   CVCL_KA94
SY   OX11; HDB2663
DR   Wikidata; Q54937062
RX   CelloPub=CLPUB00622;
RX   PubMed=6208121;
RX   PubMed=23691022;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 02-05-24; Version: 5
//
ID   OX-110
AC   CVCL_X519
SY   OX110
DR   ECACC; 13082225
DR   Wikidata; Q54937063
RX   PubMed=23691022;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ES57; Mouse Cd200r1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   OX-111
AC   CVCL_JX77
SY   OX111
DR   Wikidata; Q54937064
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ES57; Mouse Cd200r1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-114
AC   CVCL_U021
SY   OX114
DR   ECACC; 13082227
DR   Wikidata; Q54937065
RX   PubMed=14606962;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18572; Mouse Bsg/Cd147.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   OX-115
AC   CVCL_X520
SY   OX115
DR   ECACC; 13082229
DR   Wikidata; Q54937066
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18572; Mouse Bsg/Cd147.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   OX-116
AC   CVCL_X521
SY   OX116
DR   ECACC; 13082231
DR   Wikidata; Q54937067
RX   PubMed=15294972;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   OX-117
AC   CVCL_X522
SY   OX117
DR   ECACC; 13082233
DR   Wikidata; Q54937068
RX   PubMed=15294972;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   OX-118
AC   CVCL_X523
SY   OX118
DR   ECACC; 13082235
DR   Wikidata; Q54937069
RX   PubMed=15294972;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   OX-119
AC   CVCL_X524
SY   OX119
DR   ECACC; 13082237
DR   Wikidata; Q54937070
RX   PubMed=15294972;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 5
//
ID   OX-12
AC   CVCL_G678
SY   OX12
DR   ECACC; 88051301
DR   Wikidata; Q54937072
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Rat Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-120
AC   CVCL_F0JH
SY   OX120
RX   PubMed=17599905;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q07763; Mouse Cd244.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-121
AC   CVCL_F0JI
SY   OX121
RX   PubMed=17599905;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q07763; Mouse Cd244.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-122
AC   CVCL_F0JJ
SY   OX122
RX   PubMed=17599905;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q07763; Mouse Cd244.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-123
AC   CVCL_F0JG
SY   OX123
RX   DOI=10.1089/mab.2015.0051;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8BFX8; Mouse Sirpb1/Cd172b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-124
AC   CVCL_F0JB
SY   OX124
DR   ECACC; 15090212
RX   PubMed=16914752;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6 (Note=Recognizes domain SRCR 3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-125
AC   CVCL_F0JC
SY   OX125
DR   ECACC; 15090210
RX   PubMed=16914752;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6 (Note=Recognizes domain SRCR 3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-126
AC   CVCL_F0JD
SY   OX126
DR   ECACC; 15090208
RX   PubMed=16914752;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30203; Human CD6 (Note=Recognizes domain SRCR 3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-129
AC   CVCL_X525
SY   OX129
DR   ECACC; 13082239
DR   Wikidata; Q54937073
RX   PubMed=16914752;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q61003; Mouse Cd6 (Note=Recognizes domain SRCR 3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 6
//
ID   OX-130
AC   CVCL_F0JE
SY   OX130
DR   ECACC; 15090205
RX   PubMed=26871367;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00241; Human SIRPB1/CD172B (Note=Also recognizes SIRPA allele 1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-131
AC   CVCL_X526
SY   OX131
DR   ECACC; 13082241
DR   Wikidata; Q54937074
RX   PubMed=23691022;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9ES57; Mouse Cd200r1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   OX-132
AC   CVCL_U022
SY   OX132
DR   ECACC; 13082243
DR   Wikidata; Q54937075
RX   PubMed=23691022;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6XJV6; Mouse Cd200r1l.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   OX-133
AC   CVCL_A8RA
SY   OX133
DR   ECACC; 15090201
DR   Wikidata; Q108821085
RX   PubMed=26986548;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_189421; N-ethylmaleimide-cysteine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   OX-137
AC   CVCL_F0JF
SY   OX137
DR   ECACC; 15090203
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5JXA9; Human SIRPB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-14
AC   CVCL_G679
SY   OX14
DR   ECACC; 87112401
DR   Wikidata; Q54937076
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-16
AC   CVCL_KA90
SY   OX16
DR   Wikidata; Q54937077
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-17
AC   CVCL_J180
SY   MRC-OX17; OX17
DR   ECACC; 84112010
DR   Wikidata; Q54937078
RX   PubMed=6178598;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat MHC class II RT1-D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-18
AC   CVCL_G680
SY   MRC-OX18; OX18
DR   ECACC; 84112011
DR   Wikidata; Q54937079
RX   PubMed=6178598;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat MHC class II RT1-A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-19
AC   CVCL_G681
SY   OX19
DR   ECACC; 84112012
DR   Wikidata; Q54937081
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51882; Rat Cd5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-2
AC   CVCL_G682
SY   OX2
DR   ECACC; 84112005
DR   Wikidata; Q54937082
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-20
AC   CVCL_G683
SY   OX20
DR   ECACC; 88070801
DR   Wikidata; Q54937083
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Mouse Ig kappa light chains.
CC   Discontinued: ECACC; 88070801; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   OX-21
AC   CVCL_G684
SY   OX21
DR   ECACC; 91060417
DR   Wikidata; Q54937084
RX   PubMed=1706994;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05156; Human CFI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-22
AC   CVCL_G685
SY   OX22
DR   ECACC; 84112013
DR   Wikidata; Q54937085
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-23
AC   CVCL_U023
SY   MRC OX-23; MRC-OX23; OX23
DR   ECACC; 00010402
DR   Wikidata; Q54937086
RX   PubMed=6199050;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08603; Human CFH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-24
AC   CVCL_U024
SY   MRC OX-24; MRC-OX24; OX24
DR   ECACC; 00010403
DR   Wikidata; Q54937087
RX   PubMed=6199050;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08603; Human CFH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-26
AC   CVCL_J181
SY   MRC-OX26; OX26
DR   ABCD; ABCD_AF239
DR   ECACC; 84112014
DR   Wikidata; Q54937089
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99376; Rat Tfrc/Cd71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-27
AC   CVCL_J182
SY   OX27
DR   ECACC; 84112015
DR   Wikidata; Q54937091
RX   PubMed=3159821;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Rat MHC class I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-29
AC   CVCL_J183
SY   OX29
DR   ECACC; 88070802
DR   Wikidata; Q54937092
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-3
AC   CVCL_J184
SY   MRC-OX3; OX3
DR   ECACC; 84112006
DR   Wikidata; Q54937093
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-30
AC   CVCL_J185
SY   OX30
DR   ECACC; 86100901
DR   Wikidata; Q54937094
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-31
AC   CVCL_KA91
SY   OX31
DR   Wikidata; Q54937095
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-32
AC   CVCL_G686
SY   OX32
DR   ECACC; 88051302
DR   Wikidata; Q54937096
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-33
AC   CVCL_J186
SY   OX33
DR   ECACC; 86100902
DR   Wikidata; Q54937106
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-34
AC   CVCL_J187
SY   OX34
DR   ABCD; ABCD_AE634
DR   ECACC; 86100903
DR   Wikidata; Q54937107
RX   PubMed=3159821;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-35 clone 5
AC   CVCL_J188
SY   OX-35
DR   ECACC; 89041184
DR   Wikidata; Q54937108
RX   PubMed=3159821;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-36 clone 3
AC   CVCL_J189
SY   OX-36
DR   ECACC; 91051422
DR   Wikidata; Q54937109
RX   PubMed=3159821;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-37
AC   CVCL_KA92
SY   OX37
DR   Wikidata; Q54937110
RX   PubMed=3159821;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   OX-38
AC   CVCL_J190
SY   OX38
DR   ECACC; 88051303
DR   Wikidata; Q54937111
RX   PubMed=3159821;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-39
AC   CVCL_J191
SY   OX39
DR   ECACC; 86100905
DR   Wikidata; Q54937112
RX   PubMed=2828930;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26897; Rat Il2ra/Cd25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   OX-40
AC   CVCL_J192
SY   OX40
DR   ECACC; 86100906
DR   Wikidata; Q54937113
RX   PubMed=2828930;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15725; Rat Tnfrsf4/Cd134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-41
AC   CVCL_J193
SY   OX41
DR   ECACC; 88051304
DR   Wikidata; Q54937114
RX   PubMed=3512425;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P97710; Rat Sirpa/Cd172a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-42
AC   CVCL_J194
SY   OX42
DR   ECACC; 87081803
DR   Wikidata; Q54937115
RX   PubMed=3512425;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9JI30; Rat Itgam/Cd11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-43
AC   CVCL_J195
SY   OX43
DR   ECACC; 87081804
DR   Wikidata; Q54937116
RX   PubMed=2936678;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat 85 kDa antigen expressed on the luminal surface of blood vessels.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-44
AC   CVCL_J196
SY   OX44
DR   ECACC; 92102355
DR   Wikidata; Q54937117
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P24485; Rat Cd53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-45
AC   CVCL_J197
SY   OX45
DR   ECACC; 86100910
DR   Wikidata; Q54937118
RX   PubMed=2942461;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10252; Rat Cd48.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-46
AC   CVCL_U025
SY   OX46
DR   ECACC; 13082205
DR   Wikidata; Q54937119
RX   PubMed=2942461;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10252; Rat Cd48.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-47
AC   CVCL_J198
SY   OX47
DR   ECACC; 15090220
DR   ECACC; 90071611
DR   Wikidata; Q54937120
RX   PubMed=2828930;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26453; Rat Bsg/Cd147.
CC   Discontinued: ECACC; 90071611; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   OX-48
AC   CVCL_X512
SY   OX48
DR   ECACC; 13082207
DR   Wikidata; Q54937121
RX   PubMed=2828930;
RX   PubMed=14734622;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O35531; Rat Cd86.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   OX-49
AC   CVCL_J199
SY   OX49
DR   ECACC; 91062501
DR   Wikidata; Q54937122
RX   PubMed=2828930;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P26051; Rat Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-50
AC   CVCL_J200
SY   OX50
DR   ECACC; 91062502
DR   Wikidata; Q54937124
RX   PubMed=2828930;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26051; Rat Cd44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-52
AC   CVCL_J201
SY   OX52
DR   ECACC; 87081805
DR   Wikidata; Q54937125
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-53
AC   CVCL_J202
SY   OX53
DR   ECACC; 89081707
DR   Wikidata; Q54937127
RX   PubMed=3133442;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-54
AC   CVCL_J203
SY   OX54
DR   ECACC; 88070803
DR   Wikidata; Q54937128
RX   PubMed=3133442;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-55
AC   CVCL_J204
SY   OX55
DR   ECACC; 88070804
DR   Wikidata; Q54937129
RX   PubMed=3133442;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-56
AC   CVCL_KA93
SY   OX56
DR   Wikidata; Q54937130
RX   PubMed=1706994;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-57
AC   CVCL_J205
SY   OX57
DR   ECACC; 91051424
DR   Wikidata; Q54937131
RX   PubMed=1706994;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-58
AC   CVCL_J206
SY   OX58
DR   ECACC; 91051425
DR   Wikidata; Q54937132
RX   PubMed=1706994;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-59
AC   CVCL_J207
SY   OX59
DR   ECACC; 92102356
DR   Wikidata; Q54937133
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-6
AC   CVCL_J208
SY   MRC-OX6; OX6
DR   ECACC; 84112007
DR   Wikidata; Q54937134
RX   PubMed=6178598;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-60
AC   CVCL_J209
SY   OX60
DR   ECACC; 92102357
DR   Wikidata; Q54937135
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat IgD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-61
AC   CVCL_J210
SY   OX61
DR   ECACC; 91100409
DR   Wikidata; Q54937136
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P14740; Rat Dpp4/Cd26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-62
AC   CVCL_J211
SY   OX62
DR   ECACC; 91061805
DR   Wikidata; Q54937137
RX   PubMed=1588275;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; M0R6T8; Rat Itgae/Cd103.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-63
AC   CVCL_F0JP
SY   OX63
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-64
AC   CVCL_F0JQ
SY   OX64
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-65
AC   CVCL_F0JR
SY   OX65
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-66
AC   CVCL_F0JS
SY   OX66
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-67
AC   CVCL_F0JT
SY   OX67
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-68
AC   CVCL_J212
SY   OX68
DR   ECACC; 94011007
DR   Wikidata; Q54937139
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   OX-69
AC   CVCL_F0JU
SY   OX69
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-7
AC   CVCL_J213
SY   MRC-OX7; OX7
DR   ECACC; 84112008
DR   Wikidata; Q54937140
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01830; Rat Thy1/Cd90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-70
AC   CVCL_F0JV
SY   OX70
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-71
AC   CVCL_F0JW
SY   MRC-OX71; OX71
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4 (Note=Recognizes Ig domains 3 and 4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-72
AC   CVCL_F0JX
SY   OX72
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-73
AC   CVCL_F0JY
SY   OX73
RX   PubMed=8995673;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   OX-74
AC   CVCL_J214
SY   MRC-OX74; OX74
DR   ECACC; 91051426
DR   Wikidata; Q54937141
RX   PubMed=1706994;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-75
AC   CVCL_J215
SY   OX75
DR   ECACC; 91051427
DR   Wikidata; Q54937142
RX   PubMed=1706994;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-76
AC   CVCL_U026
SY   OX76
DR   ECACC; 13082209
DR   Wikidata; Q54937143
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Rat MHC class II.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-78
AC   CVCL_J216
SY   OX78
DR   ECACC; 92102358
DR   Wikidata; Q54937144
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P18181; Mouse Cd48.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-79
AC   CVCL_JX97
SY   OX79
DR   Wikidata; Q54937145
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q61451; Mouse Cd53.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-8
AC   CVCL_J217
SY   OX8
DR   ECACC; 84112009
DR   Wikidata; Q54937146
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07725; Rat Cd8a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   OX-80
AC   CVCL_U027
SY   OX80
DR   ECACC; 13082211
DR   Wikidata; Q54937147
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q61451; Mouse Cd53.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   OX-81
AC   CVCL_J218
SY   OX81
DR   ECACC; 95040518
DR   Wikidata; Q54937148
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20096; Rat Il4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-82
AC   CVCL_X513
SY   MRC-OX82; OX82
DR   ECACC; 13082213
DR   Wikidata; Q54937158
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat antigen on bone marrow cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 6
//
ID   OX-83
AC   CVCL_X514
SY   OX83
DR   ECACC; 13082214
DR   Wikidata; Q54937159
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Rat antigen on bone marrow cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 5
//
ID   OX-85
AC   CVCL_J219
SY   OX85
DR   ECACC; 95111405
DR   Wikidata; Q54937160
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P30836; Rat Sell/Cd62l.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-86
AC   CVCL_J220
SY   OX86
DR   ECACC; 96110601
DR   Wikidata; Q54937161
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P47741; Mouse Tnfrsf4/Cd134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   OX-87
AC   CVCL_J221
SY   OX87
DR   ECACC; 95102516
DR   Wikidata; Q54937162
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20096; Rat Il4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   OX-89
AC   CVCL_U028
SY   OX89
DR   ECACC; 03062501
DR   Wikidata; Q54937163
RX   PubMed=11359859;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P43488; Mouse Tnfsf4/Cd252.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   OX-90
AC   CVCL_U029
SY   OX90
DR   ECACC; 03062502
DR   Wikidata; Q54937164
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O54901; Mouse Cd200.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   OX-91
AC   CVCL_JX78
SY   OX91
DR   Wikidata; Q54937166
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-92
AC   CVCL_JX82
SY   OX92
DR   Wikidata; Q54937167
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O54901; Mouse Cd200.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-93
AC   CVCL_JX79
SY   OX93
DR   Wikidata; Q54937168
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P15725; Rat Tnfrsf4/Cd134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-94
AC   CVCL_JX80
SY   OX94
DR   Wikidata; Q54937169
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: UniProtKB; P15725; Rat Tnfrsf4/Cd134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-95
AC   CVCL_JX81
SY   OX95
DR   Wikidata; Q54937170
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P15725; Rat Tnfrsf4/Cd134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-96
AC   CVCL_X515
SY   OX96
DR   ECACC; 13082216
DR   Wikidata; Q54937171
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   OX-97
AC   CVCL_X516
SY   OX97
DR   ECACC; 13082218
DR   Wikidata; Q54937172
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   OX-98
AC   CVCL_JX73
SY   OX98
DR   Wikidata; Q54937173
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-99
AC   CVCL_JX74
SY   OX99
DR   Wikidata; Q54937175
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   OX-CO-1
AC   CVCL_B451
SY   OXCO-1; OXCO1
DR   GEO; GSM1448134
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54937176
RX   PubMed=17312135;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   OX-CO-2
AC   CVCL_2H53
SY   OXCO-2; OXCO2
DR   Cosmic; 2841375
DR   GEO; GSM1448146
DR   Wikidata; Q54937177
RX   PubMed=20606684;
RX   PubMed=25623215;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 17,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   OX-CO-2 R1 Cetux
AC   CVCL_A2CH
SY   OXCO-2 R1 Cetux
DR   Cosmic; 2841376
DR   Wikidata; Q105510522
RX   PubMed=25623215;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H53 ! OX-CO-2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   OX-CO-2 R2 Cetux
AC   CVCL_A2CI
SY   OXCO-2 R2 Cetux
DR   Cosmic; 2841377
DR   Wikidata; Q105510526
RX   PubMed=25623215;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ile491Met (c.1473A>G); ClinVar=VCV001404733; Zygosity=Heterozygous; Note=Acquired during resistance selection process (PubMed=25623215).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H53 ! OX-CO-2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   OXCO-2 R3 Cetux
AC   CVCL_A2CJ
DR   Cosmic; 2841378
DR   Wikidata; Q105510530
RX   PubMed=25623215;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser464Leu (c.1391C>T); Zygosity=Heterozygous; Note=Acquired during resistance selection process (PubMed=25623215).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H53 ! OX-CO-2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   OX-CO-3
AC   CVCL_B452
SY   OXCO-3; OXCO3
DR   GEO; GSM1448147
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54937178
RX   PubMed=17312135;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=25926053;
RX   PubMed=29101300;
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 28
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   OX1
AC   CVCL_A8Y7
DR   GEO; GSM1105120
DR   Wikidata; Q102114697
RX   PubMed=23951090;
RX   PubMed=28096185;
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: OX119; PubMed=28096185.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   OX2
AC   CVCL_A8Z0
DR   GEO; GSM2644505
DR   Wikidata; Q102114698
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   OxF1
AC   CVCL_B021
SY   OXF1
DR   Wikidata; Q54937180
RX   PubMed=20333479;
RX   PubMed=22528356;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-001, Steering comm. appl. SCSC10-40.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   OxF2
AC   CVCL_L185
SY   OXF2
DR   Wikidata; Q54937181
RX   PubMed=22528356;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/oxf2.aspx
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-002, Steering comm. appl. SCSC10-38.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   OxF3
AC   CVCL_L186
SY   OXF3
DR   Wikidata; Q54937182
RX   PubMed=22528356;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-003, Steering comm. appl. SCSC10-39.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   OxF4
AC   CVCL_L187
SY   OXF4
DR   Wikidata; Q54937183
RX   PubMed=22528356;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-11-004, Steering comm. appl. SCSC10-41.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   oxMMNK1-L
AC   CVCL_AE16
DR   Wikidata; Q54937184
RX   PubMed=26100205;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_16240; Hydrogen peroxide.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M266 ! MMNK-1
SX   Sex unspecified
AG   18FW
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   OYB
AC   CVCL_B3QP
DR   Wikidata; Q110433130
RX   PubMed=12967475;
RX   PubMed=31510952;
CC   Population: Japanese.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 4
//
ID   OZ [Human cholangiocarcinoma]
AC   CVCL_3118
DR   BioSample; SAMN03472539
DR   Cosmic; 1122353
DR   Cosmic; 1373552
DR   Cosmic; 2629291
DR   Cosmic; 2674046
DR   JCRB; JCRB1032
DR   JCRB; NIHS0282
DR   Wikidata; Q54937185
RX   CelloPub=CLPUB00275;
RX   CelloPub=CLPUB00469;
RX   PubMed=2889643;
RX   PubMed=21451941;
RX   PubMed=26956050;
RX   PubMed=32899426;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (CelloPub=CLPUB00469; PubMed=2889643).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: JCRB; NIHS0282; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1032
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10
ST   D5S818: 13,14
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   OZ [Human diffuse large B-cell lymphoma]
AC   CVCL_M710
SY   Oz
DR   cancercelllines; CVCL_M710
DR   Cosmic; 929818
DR   Cosmic; 2297001
DR   Cosmic; 2823077
DR   GEO; GSM115816
DR   GEO; GSM201347
DR   GEO; GSM1035306
DR   Progenetix; CVCL_M710
DR   Wikidata; Q54937186
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9600110;
RX   PubMed=16960149;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=9600110).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   OzA
AC   CVCL_W200
SY   OZA
DR   Wikidata; Q54937187
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   OZB
AC   CVCL_E799
SY   TER205; Extract 306
DR   dbMHC; 48994
DR   ECACC; 94022545
DR   IHW; IHW09216
DR   IPD-IMGT/HLA; 11224
DR   Wikidata; Q54937188
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:09,03:01:01; B*35:02,38:01; C*04:01:01,12:03:01; DPB1*04:02,10:01 (IPD-IMGT/HLA=11224).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   P-1
AC   CVCL_G239
SY   P1
DR   CLO; CLO_0008286
DR   ATCC; CRL-2588
DR   Wikidata; Q54937189
RX   PubMed=2835105;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13135; Bovine CPNS1 (Note=Also reacts with dog and human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   P-11A6
AC   CVCL_XB04
DR   Wikidata; Q98128410
RX   PubMed=15642994;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q83138; Peste-des-petits-ruminants virus (isolate Nigeria 75/1) (PPRV) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 4
//
ID   P-13A9
AC   CVCL_XB05
DR   Wikidata; Q98128411
RX   PubMed=15642994;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q83138; Peste-des-petits-ruminants virus (isolate Nigeria 75/1) (PPRV) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 4
//
ID   P-14C6
AC   CVCL_XB06
DR   Wikidata; Q98128412
RX   PubMed=15642994;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q83138; Peste-des-petits-ruminants virus (isolate Nigeria 75/1) (PPRV) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 4
//
ID   P-16(2)
AC   CVCL_6G32
DR   Wikidata; Q54937190
RX   PubMed=3879567;
RX   PubMed=7951345;
CC   Characteristics: Secretes a whole monomeric IgA and a mu chain (PubMed=3879567).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   P-3H12
AC   CVCL_XB07
DR   Wikidata; Q98128413
RX   Patent=US7303913;
RX   PubMed=15642994;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00104.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q83138; Peste-des-petits-ruminants virus (isolate Nigeria 75/1) (PPRV) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 5
//
ID   P-5F4
AC   CVCL_E4JM
SY   5F4
RX   Patent=US6210670;
RX   PubMed=7528571;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   P-6
AC   CVCL_G242
DR   CLO; CLO_0008339
DR   ATCC; CRL-2589
DR   Wikidata; Q54937191
RX   PubMed=1426051;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07384; Human CAPN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   P-9
AC   CVCL_G243
DR   CLO; CLO_0008343
DR   ATCC; CRL-2590
DR   Wikidata; Q54937192
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07384; Human CAPN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   P-9H10
AC   CVCL_XB08
DR   Wikidata; Q98128414
RX   PubMed=15642994;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q83138; Peste-des-petits-ruminants virus (isolate Nigeria 75/1) (PPRV) nucleocapsid protein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 4
//
ID   P-EP/SVTERT344
AC   CVCL_E0G3
DR   Evercyte; CLHT-053-0344
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Amnion, epithelium; UBERON=UBERON_0003254.
CC   Cell type: Epithelial cell of amnion; CL=CL_0002536.
ST   Source(s): Evercyte=CLHT-053-0344
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 9
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   p-hiPS01
AC   CVCL_C959
DR   SKIP; SKIP004335
DR   Wikidata; Q54937193
RX   PubMed=19481515;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2435 ! Detroit 573
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   p-hiPS02
AC   CVCL_C960
DR   SKIP; SKIP004336
DR   Wikidata; Q54937194
RX   PubMed=19481515;
CC   From: Harvard Medical School; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2435 ! Detroit 573
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   P-MSC-01
AC   CVCL_WG60
SY   Placental-Mesenchymal Stem Cells-1
DR   IBRC; C10895
DR   Wikidata; Q98128415
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Somatic stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   P-MSC/TERT308
AC   CVCL_B5SY
DR   Evercyte; CHT-051-0308
DR   Wikidata; Q112129482
CC   Doubling time: 30-36 hours (Evercyte=CHT-051-0308).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): Evercyte=CHT-051-0308
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5T2 ! CP-MSC/TERT308
OI   CVCL_B5SX ! RA-MSC/TERT308
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   P-SC(1)
AC   CVCL_6G33
SY   P-SC
DR   Wikidata; Q54937196
RX   PubMed=3879567;
RX   PubMed=7951345;
CC   Characteristics: Secretes a whole monomeric IgA and a mu chain (PubMed=3879567).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   P-STS
AC   CVCL_L298
SY   PSTS
DR   cancercelllines; CVCL_L298
DR   GEO; GSM966945
DR   PharmacoDB; PSTS_1278_2019
DR   Progenetix; CVCL_L298
DR   Wikidata; Q54937197
RX   PubMed=19528452;
RX   PubMed=22538498;
RX   PubMed=28465562;
RX   PubMed=29444910;
CC   Doubling time: ~4 days (PubMed=19528452); ~1 week (PubMed=28465562).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=29444910).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
ST   Source(s): PubMed=29444910
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 12,13
ST   D21S11: 29,31
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 20,21,22
DI   NCIt; C6422; Midgut neuroendocrine tumor G1
DI   ORDO; Orphanet_100093; Carcinoid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L296 ! H-STS
OI   CVCL_L297 ! L-STS
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   P-tyr-1
AC   CVCL_G188
DR   CLO; CLO_0008521
DR   ATCC; CRL-1955
DR   BCRC; 60342
DR   ECACC; 95092903
DR   Wikidata; Q54937199
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_74956; O(4)-phosphotyrosine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   P. T.
AC   CVCL_C8NU
DR   Wikidata; Q123033249
RX   PubMed=1374683;
CC   Doubling time: 67.2 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   P.H.
AC   CVCL_S460
DR   ATCC; CRL-6177
DR   Wikidata; Q54937200
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6177; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=71117; ! Paradoxurus hermaphroditus (Asian palm civet)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   P0318
AC   CVCL_W189
DR   Wikidata; Q54937201
RX   PubMed=20418894;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 7
//
ID   P1
AC   CVCL_Z996
DR   CLO; CLO_0008285
DR   CLDB; cl3802
DR   ECACC; 90070556
DR   Wikidata; Q54937203
CC   Group: Insect cell line.
CC   Discontinued: ECACC; 90070556; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   P1-iPSC
AC   CVCL_DD57
SY   P01-iPSC
DR   Wikidata; Q54937209
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (PubMed=25843045).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex3del; Zygosity=Heterozygous (PubMed=25843045).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D21S11: 28,32.2
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD47 ! ND30171
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   P1.17
AC   CVCL_3564
DR   CLO; CLO_0008288
DR   ATCC; TIB-10
DR   Wikidata; Q54937210
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   P1.1A3
AC   CVCL_A042
SY   P1-1A3
DR   BioSample; SAMN03151919
DR   cancercelllines; CVCL_A042
DR   Wikidata; Q54937211
RX   PubMed=7514905;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00150.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   P1.1C3
AC   CVCL_A043
DR   Wikidata; Q54937212
RX   PubMed=7514905;
CC   Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A037 ! PEC.1
SX   Sex unspecified
AG   6M
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   P1.2C8
AC   CVCL_A044
DR   Wikidata; Q54937213
RX   PubMed=7514905;
CC   Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A037 ! PEC.1
SX   Sex unspecified
AG   6M
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   P1.3F6
AC   CVCL_A045
DR   Wikidata; Q54937214
RX   PubMed=7514905;
CC   Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A037 ! PEC.1
SX   Sex unspecified
AG   6M
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   P1.4D6
AC   CVCL_A046
SY   P1-4D6
DR   BioSample; SAMN03151920
DR   cancercelllines; CVCL_A046
DR   Wikidata; Q54937215
RX   PubMed=7514905;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494; PubMed=20143388). Originally thought to be a thymic epithelial cell line from a 6 month old baby thymus.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00151.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   P1.HTR
AC   CVCL_4265
SY   P1.HTR1; P1.B5.4.8.12.16.2
DR   CLO; CLO_0008289
DR   CLDB; cl3803
DR   ECACC; 87121104
DR   Wikidata; Q54937216
RX   PubMed=3929396;
RX   PubMed=8609411;
RX   PubMed=9310829;
RX   PubMed=18432777;
CC   Characteristics: Highly transfectable (ECACC=87121104).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F735 ! P815-X2
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   P1.HTR.TK-
AC   CVCL_4266
SY   P1.HTR.tk-; P1.HTR1.tk-; P1.B5.4.8.12.16.2.1
DR   CLO; CLO_0008290
DR   CLDB; cl3804
DR   ECACC; 87121103
DR   Wikidata; Q54937217
RX   PubMed=3929396;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4265 ! P1.HTR
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   P101M3
AC   CVCL_QX13
SY   P101-M3
DR   Wikidata; Q54937218
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:9942; PRPH2; Simple; p.Trp316Gly (c.946T>G); ClinVar=VCV001175304; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX14 ! P101M6
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   P101M6
AC   CVCL_QX14
SY   P101-M6; 101M6
DR   Wikidata; Q54937219
RX   Patent=US10519422;
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:9942; PRPH2; Simple; p.Trp316Gly (c.946T>G); ClinVar=VCV001175304; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX13 ! P101M3
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
ID   P10E1
AC   CVCL_C5A6
DR   Wikidata; Q116050094
RX   PubMed=23244328;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q3Y5Z3; Bovine ADIPOQ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   P11
AC   CVCL_ZW08
DR   Wikidata; Q102114700
RX   PubMed=2160057;
RX   PubMed=2166533;
CC   Characteristics: Established from the transplantable tumor 7315a.
CC   Doubling time: ~25 hours (PubMed=2160057).
CC   Transformant: ChEBI; CHEBI_82545; 2,4,6-trimethylaniline (TMA).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_ZW09 ! SUP1
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   P11-90
AC   CVCL_9U43
DR   Wikidata; Q54937220
RX   PubMed=7586804;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Kunming.
DI   NCIt; C24068; Mouse cervical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9U22 ! L10-90
OI   CVCL_9U56 ! U14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   P114
AC   CVCL_L410
SY   p114
DR   GEO; GSM724827
DR   GEO; GSM724828
DR   GEO; GSM724841
DR   GEO; GSM724842
DR   GEO; GSM1075090
DR   GEO; GSM1075094
DR   GEO; GSM1075099
DR   GEO; GSM1290248
DR   GEO; GSM1290249
DR   GEO; GSM1889007
DR   GEO; GSM1889008
DR   Wikidata; Q54937221
RX   PubMed=9042250;
RX   PubMed=20453304;
CC   Doubling time: 26.9 hours (PubMed=20453304).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   P116
AC   CVCL_6429
DR   CLO; CLO_0008292
DR   ATCC; CRL-2676
DR   BioSample; SAMN03471760
DR   cancercelllines; CVCL_6429
DR   GDSC; 1330986
DR   GEO; GSM827152
DR   PharmacoDB; P116_1229_2019
DR   Progenetix; CVCL_6429
DR   TOKU-E; 2820
DR   Wikidata; Q54937222
RX   PubMed=9488454;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2676
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,21
ST   D19S433: 14,15.2
ST   D21S11: 31.2,34.2
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,11.3
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   P116.cl39
AC   CVCL_6430
SY   P116.c39
DR   CLO; CLO_0008293
DR   ATCC; CRL-2677
DR   BioSample; SAMN03471762
DR   cancercelllines; CVCL_6430
DR   LINCS_LDP; LCL-1032
DR   Wikidata; Q54937223
RX   PubMed=9488454;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12858; ZAP70 (Note=With a N-terminal Myc tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-2677
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,20
ST   D19S433: 14,15.2
ST   D21S11: 32.2,33.2,34.2
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,11.3
ST   D8S1179: 12,13,14
ST   FGA: 20,21
ST   Penta D: 11,12
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6429 ! P116
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   P12
AC   CVCL_CW37
SY   P 12; AGP12
DR   ATCC; HB-8551
DR   NCBI_Iran; H133
DR   Wikidata; Q54937224
RX   Patent=US4762800;
RX   Patent=US5168043;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8551.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   P12-Ichikawa
AC   CVCL_1630
SY   P12-ICHIKAWA; P12/ICHIKAWA; P12/Ichikawa; p12/Ichikawa; P12:ichikawa; P12ichikawa; P12ICHIKAWA; P12/ICH; P12/ICh; P12-ICH; P-12; P12
DR   BTO; BTO_0002839
DR   CLO; CLO_0008298
DR   CLDB; cl3807
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473354
DR   BioSample; SAMN10988545
DR   cancercelllines; CVCL_1630
DR   Cell_Model_Passport; SIDM00463
DR   ChEMBL-Cells; CHEMBL3307676
DR   ChEMBL-Targets; CHEMBL614660
DR   Cosmic; 721706
DR   Cosmic; 909251
DR   Cosmic; 913422
DR   Cosmic; 933543
DR   Cosmic; 1118465
DR   Cosmic; 1151789
DR   Cosmic; 1224371
DR   Cosmic; 1281381
DR   Cosmic; 1330492
DR   Cosmic; 1375582
DR   Cosmic; 1524812
DR   Cosmic; 1641387
DR   Cosmic; 1664526
DR   Cosmic; 1760529
DR   Cosmic; 2165715
DR   Cosmic; 2602929
DR   Cosmic-CLP; 909251
DR   DepMap; ACH-000372
DR   DSMZ; ACC-34
DR   DSMZCellDive; ACC-34
DR   EGA; EGAS00001000978
DR   GDSC; 909251
DR   GEO; GSM887491
DR   GEO; GSM888573
DR   GEO; GSM1670326
DR   GEO; GSM5137735
DR   IARC_TP53; 10568
DR   LiGeA; CCLE_538
DR   LINCS_LDP; LCL-1020
DR   PharmacoDB; P12ICHIKAWA_1230_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1630
DR   PubChem_Cell_line; CVCL_1630
DR   Wikidata; Q54937225
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6582512;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=9933131;
RX   PubMed=10071127;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=15472075;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/p12-ichikawa/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-34).
CC   HLA typing: A*02:01,24:02; B*52:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gly253Ser (c.757G>A); ClinVar=VCV000236647; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909251).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909251).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Ala1720_Val1721ins14 (c.5161_5162ins42); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=10071127; PubMed=22675565; Cosmic-CLP=909251).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Heterozygous (PubMed=10071127; PubMed=22675565; Cosmic-CLP=909251).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Pro (c.743G>C); ClinVar=VCV000237954; Zygosity=Heterozygous (PubMed=10071127; PubMed=22675565; Cosmic-CLP=909251).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.9%; Native American=0.31%; East Asian, North=84.31%; East Asian, South=13.48%; South Asian=0%; European, North=0.65%; European, South=0.35% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=909251; DSMZ=ACC-34
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 14,17
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 12,16
ST   FGA: 21
ST   Penta D: 10,13.4
ST   Penta E: 10,19
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   P120
AC   CVCL_JX24
SY   p120
DR   Wikidata; Q54937227
RX   PubMed=9042250;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   P153SV40T
AC   CVCL_4874
SY   P153SV40-T
DR   Wikidata; Q54937228
RX   PubMed=21544329;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   P1798
AC   CVCL_B453
SY   P-1798; P1798TC
DR   BTO; BTO_0000796
DR   Wikidata; Q54937229
RX   PubMed=6892700;
CC   Doubling time: 20-24 hours (PubMed=6892700).
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 9
//
ID   P19
AC   CVCL_2153
SY   P-19
DR   BTO; BTO_0000596
DR   CLO; CLO_0008301
DR   CLO; CLO_0008302
DR   EFO; EFO_0022774
DR   CLDB; cl3813
DR   CLDB; cl4980
DR   ATCC; CRL-1825
DR   BCRC; 60052
DR   BCRJ; 0419
DR   BioSample; SAMN11397635
DR   CCRID; 1101MOU-PUMC000020
DR   CCRID; 3101MOUTCM27
DR   ChEMBL-Cells; CHEMBL3307297
DR   ChEMBL-Targets; CHEMBL614064
DR   CLS; 400416
DR   DSMZ; ACC-316
DR   DSMZCellDive; ACC-316
DR   ECACC; 95102107
DR   IBRC; C10213
DR   ICLC; ATL99013
DR   IZSLER; BS TCL 206
DR   KCB; KCB 200844YJ
DR   Lonza; 797
DR   NCBI_Iran; C422
DR   PRIDE; PXD016871
DR   PRIDE; PXD016884
DR   PubChem_Cell_line; CVCL_2153
DR   RSCB; RSCB0346
DR   TOKU-E; 2822
DR   Wikidata; Q7117837
RX   PubMed=7056443;
RX   PubMed=7107698;
RX   PubMed=8069455;
RX   PubMed=8507558;
RX   PubMed=12757864;
RX   PubMed=19275242;
RX   PubMed=31220119;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/p19/p19cells.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-229.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/P19_cell
CC   Doubling time: ~2-3 days (DSMZ=ACC-316).
CC   Omics: Proteomics; 2DE-MS.
CC   Caution: There seem to be 3 distinct cell lines which were assigned NCBI_Iran catalog number C422.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 16,17
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 13,21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 26.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 12,14
ST   Mouse STR X-1: 26
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   P19C6
AC   CVCL_L988
DR   RCB; RCB1790
DR   Wikidata; Q54937230
RX   PubMed=11414696;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2153 ! P19
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 7
//
ID   P19CL6
AC   CVCL_L981
SY   P19Cl6; P19.CL6; P19 clone 6; P19Clone6; CL6
DR   CLO; CLO_0050544
DR   CLO; CLO_0050545
DR   RCB; RCB1539
DR   RCB; RCB2318
DR   Wikidata; Q28473091
RX   PubMed=8790939;
RX   PubMed=12757864;
RX   PubMed=15005574;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-475.html
CC   Characteristics: Can be differentiated to cardiomyocytes in monolayer culture in response to DMSO without a separate step for aggregation being necessary (PubMed=8790939).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2153 ! P19
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   P19Clone6 #1-23
AC   CVCL_E6F9
SY   P19EC clone #1-23; #1-23
RX   PubMed=15005574;
CC   Characteristics: Expresses GFP under the control of the MLC-2v promoter that is preceded by the enhancer portion of the CMV immediate early promoter (PubMed=15005574).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L981 ! P19CL6
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   P19S11
AC   CVCL_D6NC
SY   P19 clone S11
RX   PubMed=7107698;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2153 ! P19
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   P19S18
AC   CVCL_D6ND
SY   P19 clone S18
RX   PubMed=6656766;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2153 ! P19
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   P19S8
AC   CVCL_D6NE
SY   P19 clone S8
RX   PubMed=7107698;
CC   Karyotypic information: Tetraploid (PubMed=7107698).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2153 ! P19
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   P1B5
AC   CVCL_A8S7
DR   DSHB; P1B5
DR   Wikidata; Q102114701
RX   PubMed=1691191;
RX   PubMed=2527858;
RX   PubMed=2822727;
RX   PubMed=2846588;
RX   PubMed=8501119;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26006; Human ITGA3/CD49c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P1Bb1.1 (DBA/2)
AC   CVCL_7693
DR   CLO; CLO_0008306
DR   CLDB; cl3816
DR   ECACC; 87121102
DR   Wikidata; Q54937231
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F735 ! P815-X2
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   P1D6
AC   CVCL_A8S8
DR   DSHB; P1D6
DR   Wikidata; Q102114702
RX   PubMed=1691191;
RX   PubMed=2527858;
RX   PubMed=2846588;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P08648; Human ITGA5/CD49e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P1E6
AC   CVCL_A8S9
DR   DSHB; P1E6
DR   Wikidata; Q102114703
RX   PubMed=1691191;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P1F2
AC   CVCL_A8T0
DR   Wikidata; Q102114704
RX   PubMed=1691191;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P26006; Human ITGA3/CD49c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   P1F6
AC   CVCL_A8T1
DR   DSHB; P1F6
DR   Wikidata; Q102114705
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
CC   Monoclonal antibody target: UniProtKB; P18084; Human ITGB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P1F8
AC   CVCL_A8T2
DR   Wikidata; Q102114706
RX   PubMed=2846588;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08648; Human ITGA5/CD49e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   P1G12
AC   CVCL_A8T3
DR   DSHB; P1G12
DR   Wikidata; Q102114708
RX   PubMed=2831221;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P1H5
AC   CVCL_A8T4
DR   DSHB; P1H5
DR   Wikidata; Q102114709
RX   PubMed=1691191;
RX   PubMed=2822727;
RX   PubMed=2846588;
WW   Provider; DSHB; -; https://web.archive.org/web/20180703155153/http://dshb.biology.uiowa.edu/alpha-2-integrin_3
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
CC   Discontinued: DSHB; P1H5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   P1H6
AC   CVCL_A8T5
DR   DSHB; P1H6
DR   Wikidata; Q102114710
RX   PubMed=1691191;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P2
AC   CVCL_Z997
DR   CLO; CLO_0008307
DR   CLDB; cl3817
DR   ECACC; 90070558
DR   Wikidata; Q54937232
CC   Group: Insect cell line.
CC   Discontinued: ECACC; 90070558; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   P2 50D8
AC   CVCL_L684
DR   ATCC; HB-9506
DR   Wikidata; Q54937233
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9506.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   P2 57G4
AC   CVCL_L685
DR   Wikidata; Q54937234
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9505.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   p2#21
AC   CVCL_C5Q4
DR   Wikidata; Q116050095
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   p2#51
AC   CVCL_C5Q5
DR   Wikidata; Q116050096
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   p2#52
AC   CVCL_C5Q6
DR   Wikidata; Q116050097
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   p2#66
AC   CVCL_C5Q7
DR   Wikidata; Q116050098
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   P20.1
AC   CVCL_K262
DR   CLO; CLO_0050392
DR   RCB; RCB2815
DR   Wikidata; Q54937235
RX   PubMed=18787202;
RX   PubMed=18847346;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q96RI0; Human F2RL3/PAR4 (Note=Binds to the hexapeptide GYPGQV used in the TARGET tag system).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   P21/15
AC   CVCL_A0QD
DR   Wikidata; Q108821086
RX   PubMed=2146321;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P00751; Human CFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   P21PZ
AC   CVCL_UZ14
SY   P21 Peripheral Zone; P21d; P21 deep
DR   Wikidata; Q98128416
RX   CelloPub=CLPUB00472;
RX   PubMed=21109966;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, peripheral zone; UBERON=UBERON_8410026.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UZ16 ! P21TZ
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   P21PZ (clone-a)
AC   CVCL_UZ15
SY   P21d (clone-a)
DR   Wikidata; Q98128417
RX   CelloPub=CLPUB00472;
RX   PubMed=21109966;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Prostate, peripheral zone; UBERON=UBERON_8410026.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ14 ! P21PZ
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   P21TZ
AC   CVCL_UZ16
SY   P21 Transition Zone; P21s; P21 superficial
DR   Wikidata; Q98128418
RX   CelloPub=CLPUB00472;
RX   PubMed=21109966;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, transition zone; UBERON=UBERON_8410025.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UZ14 ! P21PZ
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   P21TZ 40 Gy (clone-a)
AC   CVCL_UZ17
SY   P21s 40Gy (clone-a)
DR   Wikidata; Q98128419
RX   CelloPub=CLPUB00472;
RX   PubMed=21109966;
CC   Characteristics: The parent cell line was irradiated with 40 Gy.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, transition zone; UBERON=UBERON_8410025.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ16 ! P21TZ
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   P25.15
AC   CVCL_N084
DR   ATCC; HB-9140
DR   Wikidata; Q54937237
RX   Patent=US4970299;
RX   Patent=US5177000;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9140.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   P25.48
AC   CVCL_G240
DR   CLO; CLO_0008312
DR   ATCC; HB-9119
DR   Wikidata; Q54937238
RX   Patent=US4970299;
RX   Patent=US5177000;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9119.
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   P25.91
AC   CVCL_N085
DR   Wikidata; Q54937239
RX   Patent=US4970299;
RX   Patent=US5177000;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9120.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   P2A4
AC   CVCL_A8T6
DR   DSHB; P2A4
DR   Wikidata; Q102114713
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05362; Human ICAM1/CD54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P2A8(6)
AC   CVCL_D5GJ
DR   Wikidata; Q127383002
RX   PubMed=11839251;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33527; Human ABCC1 (Note=Immunized with AA 246-260).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   P2B1
AC   CVCL_A8T7
DR   DSHB; P2B1
DR   Wikidata; Q102114714
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16284; Human PECAM1/CD31 (Note=Also reacts with mouse, rat and dog).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 5
//
ID   P2UR/K-562
AC   CVCL_L434
SY   P2URK562
DR   CLO; CLO_0050120
DR   DepMap; ACH-002061
DR   RCB; RCB1197
DR   Wikidata; Q54937240
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (DepMap=ACH-002061).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8541; P2RY2.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB1197
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 22
//
ID   P3 6D4
AC   CVCL_L683
SY   P3 6D4 (SCRF 43.1); SCRF 43.1
DR   CLO; CLO_0008314
DR   ATCC; HB-9168
DR   Wikidata; Q54937241
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9168.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   P3 8D2
AC   CVCL_G687
SY   P3 8D2 (SCRF 43.1); SCRF 43.1
DR   CLO; CLO_0008316
DR   ATCC; HB-9169
DR   Wikidata; Q54937242
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9169.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   P3-7B
AC   CVCL_C0EE
DR   Wikidata; Q114312641
DR   Ximbio; 160691
CC   From: Singer, Bernhard B.; University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q14002; Human CEACAM7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   P3-Ag8-gamma1-
AC   CVCL_UZ12
DR   Wikidata; Q98128420
RX   CelloPub=CLPUB00097;
RX   PubMed=6175400;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   P3.6.2.8.1
AC   CVCL_3565
DR   CLO; CLO_0008318
DR   ATCC; TIB-8
DR   JCRB; JCRB9109
DR   Wikidata; Q54937243
RX   PubMed=4758896;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T278 ! P3K
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   P3/NS1/1-Ag4.1
AC   CVCL_2155
SY   P3.NS1/1Ag-3.4.1; P3/NSI/1-AG4-1; P3/NSI/1-Ag4-1; P3/NS1/1-Ag4-1; P3/NS1/1-AG4-1; P3/NS1/Ag4-1; P3 NS1 Ag4/1; P3 NS1 Ag4; P3.NS-1/1.Ag4.1; P3-NS/1-Ag4-1; P3-NS1/1-Ag4-1; P3-NS1/1Ag 4.1; P3/NS-1; P3/NS1; NS1/1-Ag4.1; NS1-1 Ag4.1; NS-1-Ag4-1; NS1-Ag4/1; NS1-Ag 4/1; NS1-Ag4; P3-X63-NS/1; P3X63NS1; X63 NS; NS-I/1; NSI/1; NSI/1-Ag4-1; NS-1; NS1; MOPC-21 NS/1; P301; GM03573; GM-3573; GM03573A
DR   BTO; BTO_0001907
DR   CLO; CLO_0008317
DR   CLO; CLO_0008319
DR   CLO; CLO_0008320
DR   CLO; CLO_0017234
DR   CLO; CLO_0050176
DR   CLDB; cl3823
DR   CLDB; cl3824
DR   CLDB; cl3825
DR   CLDB; cl3826
DR   CLDB; cl3827
DR   CLDB; cl3828
DR   ATCC; TIB-18
DR   BCRC; 60036
DR   CCRID; 1101MOU-PUMC000384
DR   CCRID; 1102MOU-NIFDC00041
DR   CCRID; 3101MOUTCM25
DR   CCRID; 4201MOU-CCTCC00011
DR   CCTCC; GDC0011
DR   CLS; 305187
DR   CLS; 400108
DR   Coriell; GM03573
DR   DSMZ; ACC-145
DR   DSMZCellDive; ACC-145
DR   ECACC; 85011427
DR   IZSLER; BS TCL 50
DR   JCRB; JCRB0009
DR   JCRB; JCRB9107
DR   KCLB; 40018
DR   KCLB; 60059
DR   Lonza; 337
DR   NCBI_Iran; C522
DR   RCB; RCB0095
DR   TKG; TKG 0233
DR   Wikidata; Q54937244
RX   CelloPub=CLPUB00447;
RX   PubMed=825377;
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~24 hours (DSMZ=ACC-145).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C522.
CC   Misspelling: SP3-NS1-Ag-6-1; PubMed=3894247.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 38
//
ID   P30/OHK
AC   CVCL_1631
SY   P30-OHK; P30_OHK; P30 OHK; P30OHK; P30/Ohkubo; P30/OHKUBO; P30-OHKUBO; P30/0HK
DR   CLO; CLO_0051011
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821712
DR   BioSample; SAMN03471069
DR   cancercelllines; CVCL_1631
DR   Cell_Model_Passport; SIDM00364
DR   ChEMBL-Cells; CHEMBL3308275
DR   ChEMBL-Targets; CHEMBL2366165
DR   Cosmic; 909252
DR   Cosmic; 919141
DR   Cosmic; 998703
DR   Cosmic; 1037718
DR   Cosmic-CLP; 909252
DR   DepMap; ACH-002059
DR   DSMZ; ACC-727
DR   DSMZCellDive; ACC-727
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10430-106D7
DR   GDSC; 909252
DR   GEO; GSM827254
DR   GEO; GSM1670327
DR   GEO; GSM5137736
DR   GEO; GSM5137764
DR   IARC_TP53; 21273
DR   JCRB; JCRB0094
DR   LINCS_LDP; LCL-1038
DR   PharmacoDB; P30OHK_1231_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1631
DR   PubChem_Cell_line; CVCL_1631
DR   RCB; RCB1938
DR   TKG; TKG 0463
DR   Wikidata; Q54937245
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6983990;
RX   PubMed=9510473;
RX   PubMed=9680106;
RX   PubMed=10739008;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=29786757;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35124168;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~30 hours (PubMed=6983990); ~30 hours (DSMZ=ACC-727).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6997; MEF2D + HGNC; HGNC:17011; HNRNPUL1; Name(s)=MEF2D-HNRNPUL1 (PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Cys643Arg (c.1927T>C) (p.Cys644Arg, c.1930T>C); Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.09%; East Asian, South=24.91%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=909252; DSMZ=ACC-727; JCRB=JCRB0094; RCB=RCB1938; TKG=TKG 0463
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9,10 (DSMZ=ACC-727)
ST   D13S317: 10 (Cosmic-CLP=909252; JCRB=JCRB0094; RCB=RCB1938; TKG=TKG 0463)
ST   D16S539: 9 (Cosmic-CLP=909252; JCRB=JCRB0094; RCB=RCB1938; TKG=TKG 0463)
ST   D16S539: 9,10 (DSMZ=ACC-727)
ST   D18S51: 12,13,14,16,17
ST   D19S433: 12,13
ST   D21S11: 30.2,32.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 18
ST   Penta D: 9,11
ST   Penta E: 12,18
ST   TH01: 8,9 (DSMZ=ACC-727)
ST   TH01: 9 (Cosmic-CLP=909252; JCRB=JCRB0094; RCB=RCB1938; TKG=TKG 0463)
ST   TPOX: 10,11 (Cosmic-CLP=909252; JCRB=JCRB0094; RCB=RCB1938; TKG=TKG 0463)
ST   TPOX: 11 (DSMZ=ACC-727)
ST   vWA: 14,19 (DSMZ=ACC-727)
ST   vWA: 14,21 (Cosmic-CLP=909252; JCRB=JCRB0094; RCB=RCB1938; TKG=TKG 0463)
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   P31/FUJ
AC   CVCL_1632
SY   P31-FUJ; P31 FUJ; P31FUJ; P-31:FUJ; P31/Fujioka
DR   CLO; CLO_0009855
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 216
DR   BioSample; SAMN03471067
DR   BioSample; SAMN10987620
DR   cancercelllines; CVCL_1632
DR   Cell_Model_Passport; SIDM00363
DR   ChEMBL-Cells; CHEMBL3308276
DR   ChEMBL-Targets; CHEMBL2366370
DR   Cosmic; 717683
DR   Cosmic; 909253
DR   Cosmic; 996318
DR   Cosmic; 998749
DR   Cosmic; 1037670
DR   Cosmic; 2089656
DR   Cosmic; 2131555
DR   Cosmic-CLP; 909253
DR   DepMap; ACH-000770
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10770-110F5
DR   GDSC; 909253
DR   GEO; GSM827226
DR   GEO; GSM887492
DR   GEO; GSM888574
DR   GEO; GSM1670328
DR   IARC_TP53; 21274
DR   JCRB; JCRB0091
DR   LiGeA; CCLE_555
DR   LINCS_LDP; LCL-1069
DR   PharmacoDB; P31FUJ_1232_2019
DR   PRIDE; PXD000185
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1632
DR   PubChem_Cell_line; CVCL_1632
DR   Wikidata; Q54937246
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6962783;
RX   PubMed=9379676;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~80 hours (PubMed=6962783).
CC   HLA typing: A*02:06,31:01; B*48:01,51:01; C*08:01,14:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=11226526; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7132; KMT2A; Simple; p.Arg158fs*13 (c.472_473insTTCC); Zygosity=Heterozygous (Cosmic-CLP=909253; DepMap=ACH-000770).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (Cosmic-CLP=909253; DepMap=ACH-000770).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu7Ter (c.19G>T); ClinVar=VCV000493079; Zygosity=Heterozygous (Cosmic-CLP=909253; DepMap=ACH-000770).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.His208Arg (c.623A>G); ClinVar=VCV001903730; Zygosity=Heterozygous (PubMed=23955599; Cosmic-CLP=909253).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (Cosmic-CLP=909253; DepMap=ACH-000770).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Cys (c.707A>G); ClinVar=VCV000376693; Zygosity=Heterozygous (Cosmic-CLP=909253; DepMap=ACH-000770).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=79.39%; East Asian, South=20.61%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Caution: NRAS mutation indicated to be at p.Gly12Asp (c.35G>A) in PubMed=9379676.
CC   Misspelling: P31-FUF; Cosmic=717683; PubMed=9379676.
CC   Misspelling: P31/FUF; PubMed=9379676.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=909253; JCRB=JCRB0091
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 9,12,13
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 7,11
ST   vWA: 19,21
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   P32/ISH
AC   CVCL_3119
SY   P32/ish; P32-ISH; P32 ISH; P32ISH; P32/Ishida; P32; Ishida
DR   CLO; CLO_0037053
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471070
DR   cancercelllines; CVCL_3119
DR   Cell_Model_Passport; SIDM00362
DR   Cosmic; 1995609
DR   Cosmic; 2297027
DR   Cosmic-CLP; 1330987
DR   DepMap; ACH-002293
DR   EGA; EGAS00001000978
DR   GDSC; 1330987
DR   GEO; GSM115814
DR   GEO; GSM827227
DR   GEO; GSM1670329
DR   JCRB; JCRB0095
DR   LINCS_LDP; LCL-2023
DR   PharmacoDB; P32ISH_1233_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3119
DR   Wikidata; Q54937247
RX   PubMed=6667834;
RX   PubMed=16960149;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=29892436;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (Note=At 30th passage) (PubMed=6667834); ~1.3 days (Note=Lot 02122004) (JCRB=JCRB0095).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=72.36%; East Asian, South=27.64%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Cosmic-CLP=1330987; JCRB=JCRB0095
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   p34
AC   CVCL_UW54
SY   p 34
DR   Wikidata; Q98128421
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=16141719;
CC   Doubling time: 16 hours (PubMed=16141719).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   P388
AC   CVCL_7222
SY   P-388
DR   BTO; BTO_0000748
DR   CLO; CLO_0008321
DR   CLO; CLO_0050216
DR   CLDB; cl3829
DR   BCRJ; 0198
DR   CCRID; 1102MOU-NIFDC00073
DR   ChEMBL-Cells; CHEMBL3308401
DR   ChEMBL-Targets; CHEMBL389
DR   CLS; 305226
DR   JCRB; JCRB0017
DR   NCI-DTP; P388
DR   PubChem_Cell_line; CVCL_7222
DR   RCB; RCB2776
DR   TKG; TKG 0326
DR   Wikidata; Q54937248
RX   CelloPub=CLPUB00459;
RX   PubMed=3335022;
RX   PubMed=10516761;
RX   PubMed=13541471;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   P388 Pr8/22
AC   CVCL_4276
SY   Pr8/22; PR8/22; P388R
DR   CLO; CLO_0008482
DR   CancerTools; 153248
DR   ECACC; 93112518
DR   Wikidata; Q54937249
DR   Ximbio; 153248
RX   PubMed=6627597;
RX   PubMed=7917900;
CC   Doubling time: 28.5 hours (PubMed=6627597).
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: ECACC; 93112518; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   P388/A20
AC   CVCL_D642
DR   Wikidata; Q54937250
RX   PubMed=2824504;
CC   Selected for resistance to: ChEBI; CHEBI_2687; Amsacrine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D641 ! P388/amsacrine
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   P388/ADR
AC   CVCL_IZ75
SY   P388/Adr; P388/adr
DR   ChEMBL-Cells; CHEMBL3307566
DR   ChEMBL-Targets; CHEMBL614218
DR   NCI-DTP; P388/ADR
DR   PubChem_Cell_line; CVCL_IZ75
DR   Wikidata; Q54937256
RX   PubMed=1849151;
RX   PubMed=3335022;
RX   PubMed=3402281;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   P388/amsacrine
AC   CVCL_D641
DR   Wikidata; Q54937257
RX   PubMed=3037302;
CC   Selected for resistance to: ChEBI; CHEBI_2687; Amsacrine.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   P388/BR/A
AC   CVCL_4Y67
SY   BR/A
DR   Wikidata; Q54937258
RX   PubMed=7917900;
CC   Selected for resistance to: ChEBI; CHEBI_88353; Bryostatin-1.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/BR/B
AC   CVCL_4Y68
SY   BR/B
DR   Wikidata; Q54937260
RX   PubMed=7917900;
CC   Selected for resistance to: ChEBI; CHEBI_88353; Bryostatin-1.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/BR/C
AC   CVCL_4Y69
SY   BR/C
DR   Wikidata; Q54937261
RX   PubMed=7917900;
CC   Selected for resistance to: ChEBI; CHEBI_88353; Bryostatin-1.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/BR/D
AC   CVCL_4Y70
SY   BR/D
DR   Wikidata; Q54937262
RX   PubMed=7917900;
CC   Selected for resistance to: ChEBI; CHEBI_88353; Bryostatin-1.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/CPA
AC   CVCL_4Y58
DR   ChEMBL-Cells; CHEMBL3307336
DR   ChEMBL-Targets; CHEMBL614219
DR   PubChem_Cell_line; CVCL_4Y58
DR   Wikidata; Q54937263
RX   PubMed=6354439;
CC   Selected for resistance to: ChEBI; CHEBI_4027; Cyclophosphamide (CP; Endoxan).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 9
//
ID   P388/CPT45
AC   CVCL_D638
SY   P388CPT45; P388/CPT; CPT45
DR   ChEMBL-Cells; CHEMBL3307567
DR   ChEMBL-Targets; CHEMBL614223
DR   PubChem_Cell_line; CVCL_D638
DR   Wikidata; Q54937264
RX   PubMed=2172765;
RX   PubMed=14679002;
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   P388/DDP
AC   CVCL_1B39
DR   ChEMBL-Cells; CHEMBL3307305
DR   ChEMBL-Targets; CHEMBL614138
DR   PubChem_Cell_line; CVCL_1B39
DR   Wikidata; Q54937265
RX   PubMed=1556003;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   P388/Dx
AC   CVCL_9123
SY   P388/DX; P388/dx
DR   CLO; CLO_0008324
DR   CLDB; cl3832
DR   Wikidata; Q54937266
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   P388/NVB-0.63
AC   CVCL_4W03
SY   P388-N.63; N.63
DR   Wikidata; Q54937267
RX   PubMed=11488526;
RX   PubMed=18071633;
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/NVB-2.5
AC   CVCL_4W04
SY   P388-N2.5; N2.5
DR   Wikidata; Q54937268
RX   PubMed=11488526;
RX   PubMed=18071633;
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/PtR4
AC   CVCL_4V15
SY   P388PtR4
DR   ChEMBL-Cells; CHEMBL3307340
DR   ChEMBL-Targets; CHEMBL614225
DR   PubChem_Cell_line; CVCL_4V15
DR   Wikidata; Q54937269
RX   PubMed=3335002;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 9
//
ID   P388/S
AC   CVCL_D640
SY   p388/s; P388S; P388 sensitive; P388 leukemia-sensitive
DR   ChEMBL-Cells; CHEMBL3307337
DR   ChEMBL-Targets; CHEMBL614220
DR   PubChem_Cell_line; CVCL_D640
DR   Wikidata; Q54937270
RX   PubMed=3037302;
RX   PubMed=3402281;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   P388/VCR-20
AC   CVCL_1B38
SY   P388/VCR20
DR   ChEMBL-Cells; CHEMBL3307484
DR   ChEMBL-Targets; CHEMBL614221
DR   PubChem_Cell_line; CVCL_1B38
DR   Wikidata; Q54937271
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   P388/VFL-10
AC   CVCL_4W05
DR   Wikidata; Q54937272
RX   PubMed=11488526;
CC   Selected for resistance to: ChEBI; CHEBI_90241; Vinflunine (VFL; Javlor).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/VFL-2.5
AC   CVCL_4W06
DR   Wikidata; Q54937273
RX   PubMed=11488526;
CC   Selected for resistance to: ChEBI; CHEBI_90241; Vinflunine (VFL; Javlor).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 8
//
ID   P388/VMDRC.04
AC   CVCL_C8R7
DR   Wikidata; Q123033250
RX   PubMed=7905786;
CC   Characteristics: Cross-resistant to colchicine, vincristine and doxorubicin (PubMed=7905786).
CC   Doubling time: 12 hours (PubMed=7905786).
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 6
//
ID   P388/WT20
AC   CVCL_D643
DR   Wikidata; Q54937274
RX   PubMed=2824504;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   P388D1
AC   CVCL_0477
SY   P-388D1; P388-D1; P388.D1; P3 88 D1
DR   BTO; BTO_0000984
DR   CLO; CLO_0008315
DR   CLO; CLO_0008326
DR   CLO; CLO_0008327
DR   EFO; EFO_0022737
DR   MCCL; MCC:0000375
DR   CLDB; cl3833
DR   CLDB; cl3834
DR   ATCC; CCL-46
DR   BCRC; 60222
DR   CLS; 400308
DR   IZSLER; BS TCL 51
DR   JCRB; IFO50036
DR   JCRB; JCRB0016
DR   KCB; KCB 200775YJ
DR   KCLB; 10046
DR   PubChem_Cell_line; CVCL_0477
DR   Wikidata; Q54937275
RX   CelloPub=CLPUB00459;
RX   PubMed=1167564;
RX   PubMed=3792703;
RX   PubMed=3967303;
RX   PubMed=6687612;
RX   PubMed=10516761;
RX   PubMed=25277546;
RX   PubMed=33389257;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-231.html
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 20.6-26.2 hours (PubMed=3967303).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7222 ! P388
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 29
//
ID   P388D1 (IL-1)
AC   CVCL_0625
SY   P388D1(IL-1); P388 D1 IL-1
DR   CLO; CLO_0008325
DR   CLO; CLO_0008328
DR   CLDB; cl3835
DR   ATCC; TIB-63
DR   BCRC; 60341
DR   BCRJ; 0199
DR   CCRID; 1101MOU-PUMC000235
DR   CCRID; 3101MOUTCM11
DR   DSMZ; ACC-288
DR   DSMZCellDive; ACC-288
DR   Wikidata; Q54937276
RX   PubMed=25277546;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Characteristics: Produces high level of IL1.
CC   Doubling time: ~30-60 hours (Note=Depending on cell density) (DSMZ=ACC-288).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   P388D1 clone 3124
AC   CVCL_3410
SY   P388.D1 clone 3124; P388.D1 (clone 3124); P388.D1(cl3124)
DR   CLO; CLO_0008322
DR   CLO; CLO_0008323
DR   CLDB; cl3831
DR   CLDB; cl4921
DR   ECACC; 85011439
DR   ICLC; ATL97013
DR   Wikidata; Q54937277
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0477 ! P388D1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   P388LoSort
AC   CVCL_C8R9
DR   Wikidata; Q123033251
RX   PubMed=3402281;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D640 ! P388/S
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   P39
AC   CVCL_0478
SY   P39/TSU; P39-TSU; P39 TSU; P39TSU; P-39:TSU; P39/Tsugane; P39/TSUGANE; TSUGANE; Tsugane
DR   MCCL; MCC:0000376
DR   BioSample; SAMN03151775
DR   BioSample; SAMN03471068
DR   cancercelllines; CVCL_0478
DR   Cosmic; 717681
DR   Cosmic; 947362
DR   Cosmic; 998740
DR   Cosmic; 2089663
DR   IARC_TP53; 21275
DR   JCRB; JCRB0092
DR   Wikidata; Q54937278
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6597119;
RX   PubMed=9379676;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=20421273;
RX   PubMed=23955599;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388; PubMed=20421273). Originally thought to originate from the peripheral blood of a 69 year old male with acute myeloid leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00255.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=9379676).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0092
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   P3B1-C3
AC   CVCL_D5Y8
DR   Wikidata; Q127383003
RX   PubMed=6765321;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on lymphocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   P3D
AC   CVCL_G241
DR   CLO; CLO_0008329
DR   ATCC; HB-11129
DR   Wikidata; Q54937279
RX   Patent=WO1994010201A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11129.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q66T51; Brugia malayi beta-tubulin (Note=Also reacts with other nematods).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   P3E3
AC   CVCL_A8T8
DR   Wikidata; Q102114716
RX   Patent=US5730978;
RX   PubMed=2527858;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10212.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P13612; Human ITGA4/CD49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 5
//
ID   P3G2
AC   CVCL_A8T9
DR   Wikidata; Q102114717
RX   PubMed=1709170;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
CC   Monoclonal antibody target: UniProtKB; P18084; Human ITGB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   P3G8
AC   CVCL_A8U0
DR   DSHB; P3G8
DR   Wikidata; Q102114718
RX   PubMed=1709170;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P3H3
AC   CVCL_B066
DR   CLO; CLO_0008330
DR   CLDB; cl3836
DR   cancercelllines; CVCL_B066
DR   Cosmic; 931108
DR   Wikidata; Q54937281
RX   PubMed=9473234;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   P3H9
AC   CVCL_A8U1
DR   DSHB; P3H9
DR   Wikidata; Q102114719
RX   PubMed=2831221;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16070; Human CD44.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P3HR-1
AC   CVCL_2676
AS   CVCL_A1FV
SY   P 3 HR 1; P3HR1; P3HRI; P3HR1-BL; P3J HR-1; P3J-HR-1; P3JHR-1; P3JHR1; P3JHRI; P3J HR1-K; P3J.HR1K; HR-1; HR1; HRI; HR1K; PO
DR   CLO; CLO_0008282
DR   CLO; CLO_0008331
DR   EFO; EFO_0002312
DR   CLDB; cl3837
DR   CLDB; cl5159
DR   CLDB; cl5242
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-62
DR   BCRJ; 0338
DR   BioGRID_ORCS_Cell_line; 207
DR   BioSample; SAMN10987599
DR   cancercelllines; CVCL_2676
DR   Cell_Model_Passport; SIDM01254
DR   CGH-DB; 9199-4
DR   ChEMBL-Cells; CHEMBL3307242
DR   ChEMBL-Targets; CHEMBL612705
DR   CLS; 302310
DR   Cosmic; 724830
DR   Cosmic; 1517661
DR   Cosmic; 2808228
DR   Cosmic; 2822951
DR   DepMap; ACH-000707
DR   ECACC; 86010701
DR   GDSC; 1330988
DR   GEO; GSM887493
DR   GEO; GSM888575
DR   IARC_TP53; 177
DR   IGRhCellID; P3HR1
DR   IZSLER; BS TCL 99
DR   LiGeA; CCLE_098
DR   LINCS_LDP; LCL-2024
DR   PharmacoDB; P3HR1_1234_2019
DR   Progenetix; CVCL_2676
DR   PubChem_Cell_line; CVCL_2676
DR   Wikidata; Q54937282
RX   PubMed=168255;
RX   PubMed=170370;
RX   PubMed=327080;
RX   PubMed=913957;
RX   PubMed=1915267;
RX   PubMed=2052620;
RX   PubMed=2140233;
RX   PubMed=3518877;
RX   PubMed=4115493;
RX   PubMed=4122458;
RX   PubMed=4321017;
RX   PubMed=4321974;
RX   PubMed=4364259;
RX   PubMed=4912237;
RX   PubMed=4932228;
RX   PubMed=6231253;
RX   PubMed=6265077;
RX   PubMed=6276755;
RX   PubMed=6278187;
RX   PubMed=6278188;
RX   PubMed=6286763;
RX   PubMed=6287082;
RX   PubMed=8108117;
RX   PubMed=8220424;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=12068308;
RX   PubMed=12967475;
RX   PubMed=19358282;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Population: African; Nigerian.
CC   Doubling time: 17 hours (PubMed=8402660).
CC   HLA typing: A*03:01,03:01; B*58:01,58:01; C*04:01,04:01 (PubMed=26589293).
CC   HLA typing: A*03:01:01,74:01:01; B*53:01:01,58:01:01; C*04:01:01; DPB1*01:01:01,02:01:02; DQA1*01:02:01,05:05:01; DQB1*03:19:01,06:02:01; DRB1*11:02:01,15:03:01 (CLS=302310).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Pro72Ser (c.214C>T); ClinVar=VCV000012574; Zygosity=Unspecified (PubMed=8108117).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493; PubMed=8402660).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (PubMed=2052620; PubMed=8344493; PubMed=8402660).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=97.8%; Native American=0%; East Asian, North=0.68%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=1.51% (PubMed=30894373).
CC   Misspelling: HAI; Cosmic=2808228.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=HTB-62; CLS=302310; ECACC=86010701
ST   Amelogenin: X (CLS=302310; ECACC=86010701)
ST   Amelogenin: X,Y (ATCC=HTB-62)
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 12,19
ST   D19S433: 12,15
ST   D21S11: 28,36
ST   D2S1338: 21
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   Penta D: 2.2,12
ST   Penta E: 8
ST   TH01: 7,9
ST   TPOX: 6,8
ST   vWA: 15,18,19 (CLS=302310)
ST   vWA: 15,19 (ATCC=HTB-62; ECACC=86010701)
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1317 ! Jiyoye
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 42
//
ID   P3HR-5
AC   CVCL_E9ZN
SY   P3J-HR5
RX   PubMed=5260617;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1317 ! Jiyoye
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   P3HR-7
AC   CVCL_E9ZP
SY   P3J-HR7
RX   PubMed=5260617;
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1317 ! Jiyoye
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   P3K
AC   CVCL_T278
DR   Wikidata; Q54937283
RX   PubMed=5439579;
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T277 ! MOPC-21
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
ID   P3NP
AC   CVCL_D018
DR   Wikidata; Q54937284
CC   Group: Hybridoma fusion partner cell line.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   P3NP/PFn
AC   CVCL_4549
SY   P3NP/PFN
DR   CLO; CLO_0008283
DR   CLO; CLO_0008332
DR   CLDB; cl5243
DR   ATCC; HB-91
DR   IZSLER; BS Hy 18
DR   Wikidata; Q54937285
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D018 ! P3NP
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   P3X63Ag8
AC   CVCL_3411
SY   P3x63Ag8; P3Ag8X63; P3-X63-Ag8; P3/X63-Ag8; P3/X63 Ag8; P3/X63/Ag8; P3X63Ag.8; P3-X63Ag8; P3X63 Ag8; P3x63 Ag8; P3 x 63Ag8; P3 X 63 Ag8; X63/Ag8; X63-Ag8; X63-AG8; x63-Ag8; P3X63; X-63; X63; GM03571
DR   BTO; BTO_0001118
DR   CLO; CLO_0008334
DR   CLO; CLO_0017237
DR   CLDB; cl3840
DR   CLDB; cl3841
DR   CLDB; cl7165
DR   ATCC; TIB-9
DR   BCRC; 60340
DR   CCRID; 3101MOUTCM9
DR   CLS; 305171
DR   Coriell; GM03571
DR   ECACC; 85011401
DR   ICLC; ATL05001
DR   JCRB; JCRB9105
DR   Lonza; 186
DR   NCI-DTP; P3X63
DR   Wikidata; Q54937286
RX   CelloPub=CLPUB00447;
RX   PubMed=825377;
RX   PubMed=1172191;
RX   PubMed=2108149;
RX   PubMed=6769123;
RX   PubMed=14500745;
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 16-26 hours (ECACC=85011401).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Misspelling: P3-X67Ag8; PubMed=1172191; Note=In figures and table 1.
CC   Discontinued: CLS; 305171; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_T278 ! P3K
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   P3X63Ag8.653
AC   CVCL_4032
AS   CVCL_2243
SY   P3-X63-Ag8.653; P3-X63-Ag8-653; P3-x63-Ag8 653; P3-X63-Ag 8.653; P3-X63Ag8.653; P3-X63.Ag8.653; P3X-63-Ag8.653; P3/X63/Ag8.653; P3X63/Ag8.653; P3X63 Ag8.653; P3X63 AG8-653; P3X63-Ag8.653; P3x63-Ag8.653; P3X63 AG 8.653; P3X63Ag8653; P3-X63-Ag8-6-5-3; P3X63Ag8-6-5-3; P3.times.63 Ag8.653; P3.653; X63-Ag8-6.5.3; X63-Ag 8.6.5.3; X63-AG 8.653; X63-Ag8-653; X63-Ag8.653; X63.Ag8.653; X63Ag8-653; X63Ag8.653; X63AG8.653; P3-653; P3x653.Ag8; GM03570; GM3570; GM03570E; NS653; 8653
DR   CLO; CLO_0008335
DR   CLO; CLO_0009643
DR   CLO; CLO_0017240
DR   CLO; CLO_0050177
DR   CLDB; cl3842
DR   CLDB; cl3843
DR   CLDB; cl3844
DR   CLDB; cl3845
DR   CLDB; cl3846
DR   AddexBio; C0003028/4966
DR   ATCC; CRL-1580
DR   BioSample; SAMN11397629
DR   CCRID; 1102MOU-NIFDC00042
DR   CCRID; 3101MOUTCM10
DR   CCRID; 4201MOU-CCTCC00014
DR   CCTCC; GDC0014
DR   CLS; 400118
DR   Coriell; GM03570
DR   DSMZ; ACC-43
DR   DSMZCellDive; ACC-43
DR   ECACC; 85011420
DR   JCRB; JCRB9030
DR   KCLB; 21580
DR   NCBI_Iran; C109
DR   RCB; RCB0146
DR   TKG; TKG 0175
DR   TOKU-E; 4144
DR   Wikidata; Q54937287
RX   CelloPub=CLPUB00447;
RX   PubMed=113458;
RX   PubMed=6656882;
RX   PubMed=23430347;
RX   PubMed=31220119;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-230.html
CC   Group: Hybridoma fusion partner cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8008.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-251.
CC   Doubling time: ~30-60 hours (DSMZ=ACC-43).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Miscellaneous: PubMed=23430347 has a different value for STR 6-4 (17,18) than that of NIST (18,19) due to a change in the marker motif (personal communication of Almeida, Jamie L.).
CC   Misspelling: P3-X63-Ag8.563; Note=Occasionally.
CC   Misspelling: P3-X63-Ag8-635; Note=Occasionally.
CC   Misspelling: X63-Ag8 P635; Note=Occasionally.
CC   Misspelling: P3X63-A68.653; Note=Occasionally.
CC   Misspelling: P3X63 Ag8 651; Note=Occasionally.
CC   Discontinued: KCLB; 21580; probable.
CC   Discontinued: TKG; TKG 0175; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=23430347; PubMed=31220119
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26.2,28.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 9-2: 15,16
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 16,18
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 25
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   P3X63Ag8.653.1
AC   CVCL_A2HZ
DR   Wikidata; Q105510532
RX   PubMed=3954672;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   P3X63Ag8.653-Turbodoma
AC   CVCL_Z937
DR   ECACC; 03092502
DR   Wikidata; Q54937288
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   P3X63Ag8U.1
AC   CVCL_3412
AS   CVCL_4268
SY   P3-X63-Ag8-U1; P3-X63-Ag8.U1; P3-X63.Ag8.U1; P3-X63Ag8U1; P3X63-Ag8-U1; P3X63Ag8-U1; P3X63Ag8.U1; P3.x63.Ag8.U1; P3U1; P3UI; P3U-1; P3-U1; P3.U1
DR   CLO; CLO_0008333
DR   CLO; CLO_0008336
DR   CLDB; cl3839
DR   CLDB; cl3847
DR   CLDB; cl3848
DR   CLDB; cl3849
DR   CLDB; cl3850
DR   ATCC; CRL-1597
DR   ECACC; 85011417
DR   ECACC; 94120802
DR   ICLC; ATL96012
DR   JCRB; JCRB0708
DR   JCRB; JCRB9085
DR   NCBI_Iran; C579
DR   Wikidata; Q54937289
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   P3XBcl-2-13
AC   CVCL_B6NI
DR   Wikidata; Q112129483
RX   PubMed=9309429;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Enhances the outgrowth of hybridomas following somatic fusion with immune lymphocytes isolated from pooled peripheral lymph nodes (PLN) 8-14 days after the initial immunization (PubMed=9309429).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   P4
AC   CVCL_Z998
DR   CLO; CLO_0008337
DR   CLDB; cl3851
DR   ECACC; 90070557
DR   Wikidata; Q54937290
CC   Group: Insect cell line.
CC   Discontinued: ECACC; 90070557; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   P404
AC   CVCL_L411
DR   Wikidata; Q54937292
RX   PubMed=21801068;
DI   NCIt; C134944; Canine pancreatic carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   P43D09
AC   CVCL_J590
DR   Wikidata; Q54937293
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8594.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00543; Feline sarcoma virus (strain Snyder-Theilen) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 8
//
ID   P44E11
AC   CVCL_J542
DR   Wikidata; Q54937294
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8593.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00543; Feline sarcoma virus (strain Snyder-Theilen) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 8
//
ID   P493-6
AC   CVCL_6783
SY   P-493-6; p493-6
DR   BTO; BTO_0003291
DR   EFO; EFO_0022500
DR   DSMZ; ACC-915
DR   DSMZCellDive; ACC-915
DR   Millipore; SCC279
DR   PRIDE; PXD000589
DR   Wikidata; Q54937296
RX   PubMed=10956386;
RX   PubMed=25894527;
CC   Characteristics: The expression of the MYC gene is under the control of a tetracycline regulated promoter.
CC   Doubling time: ~36 hours (DSMZ=ACC-915).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-915; Millipore=SCC279
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 17,21
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 9,13
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W845 ! EREB2-5
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   P4980
AC   CVCL_WG83
SY   p4980; 4980
DR   Wikidata; Q98128422
RX   PubMed=10216098;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97849; Rag2.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   P4B4
AC   CVCL_A8U2
DR   Wikidata; Q102114722
RX   PubMed=1691191;
RX   PubMed=2846588;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   P4bis
AC   CVCL_D7CC
SY   P4Bis
RX   CelloPub=CLPUB00769;
RX   PubMed=698945;
RX   PubMed=4932229;
RX   PubMed=5979253;
CC   Characteristics: Tumorigenic. Produces sarcomas when inoculated subcutaneously into syngeneic mice (PubMed=4932229).
CC   Doubling time: 26 hours (CelloPub=CLPUB00769).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   P4bisRC
AC   CVCL_D7CD
RX   PubMed=4932229;
CC   Virology: Infected with Rauscher murine leukemia virus RCL- strain (PubMed=4932229).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7CC ! P4bis
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   P4bisRR
AC   CVCL_D7CE
RX   PubMed=4932229;
CC   Virology: Infected with Rauscher murine leukemia virus RRL+ strain (PubMed=4932229).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7CC ! P4bis
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   P4bisT
AC   CVCL_D7CK
SY   P4BisT
RX   CelloPub=CLPUB00769;
RX   PubMed=698945;
CC   Characteristics: Highly tumorigenic. Established from parent cell line after 36 passages in syngeneic mice (CelloPub=CLPUB00769).
CC   Doubling time: 12 hours (CelloPub=CLPUB00769).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7CC ! P4bis
SX   Female
AG   2M
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   P4C10
AC   CVCL_A8U3
DR   DSHB; P4C10
DR   Wikidata; Q102114723
RX   Patent=US5730978;
RX   PubMed=1691191;
RX   PubMed=8501119;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10214.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   P4C2
AC   CVCL_A8U4
DR   Wikidata; Q102114724
RX   Patent=US5730978;
RX   PubMed=2527858;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10215.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P13612; Human ITGA4/CD49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 5
//
ID   P4E6
AC   CVCL_2677
DR   BTO; BTO_0003540
DR   DepMap; ACH-001627
DR   ECACC; 10112301
DR   Wikidata; Q54937297
RX   PubMed=11121225;
RX   PubMed=17163777;
RX   PubMed=28094783;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): DepMap=ACH-001627; ECACC=10112301
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 16,18
ST   D21S11: 27,30.2
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 7,8
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 9,12
ST   Penta E: 11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   P4E7
AC   CVCL_A8U5
DR   Wikidata; Q102114725
RX   PubMed=2822727;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17301; Human ITGA2/CD49b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   P4G11
AC   CVCL_A8U6
DR   DSHB; P4G11_2
DR   Wikidata; Q102114726
RX   PubMed=8501119;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P4G6a
AC   CVCL_C5FN
DR   Wikidata; Q116050099
RX   PubMed=35448894;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Naja ashei three-finger toxins (3FTxs).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   P4G9
AC   CVCL_A8U7
DR   DSHB; P4G9
DR   Wikidata; Q102114727
RX   Patent=US5730978;
RX   PubMed=1691191;
RX   PubMed=2527858;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10213.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13612; Human ITGA4/CD49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   P4H9
AC   CVCL_A8U8
DR   DSHB; P4H9
DR   Wikidata; Q102114728
RX   PubMed=2530239;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P50
AC   CVCL_C5VF
DR   PRIDE; PXD008500
DR   Wikidata; Q116050100
RX   PubMed=25469497;
CC   HLA typing: A*23,24; B*14,27:05; C*02,08 (PubMed=25469497).
CC   Sequence variation: Mutation; HGNC; HGNC:29499; ERAP2; Simple; p.Lys392Asn (c.1176G>T); dbSNP=rs2549782; Zygosity=Heterozygous (PubMed=25469497).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   p53-def-MOSE
AC   CVCL_C563
SY   p53-deficient Mouse Ovarian Surface Epithelium
DR   JCRB; JCRB0151.1
DR   JCRB; NIHS0215
DR   Wikidata; Q54937298
RX   PubMed=9820870;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Discontinued: JCRB; NIHS0215; true.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   p53-RE-luc/A549
AC   CVCL_5J44
SY   P53-RE-luc/A549
DR   cancercelllines; CVCL_5J44
DR   Revvity/PerkinElmer; 119274
DR   Wikidata; Q54937305
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119274; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   p53HCT116
AC   CVCL_S744
SY   P53HCT116; p53-/- HCT116; p53(-/-) HCT-116; HCT116-p53-/-; HCT116-p53
DR   cancercelllines; CVCL_S744
DR   Cosmic; 1132690
DR   SKY/M-FISH/CGH; 1688
DR   SKY/M-FISH/CGH; 2781
DR   Wikidata; Q54937306
RX   PubMed=9822382;
RX   PubMed=19927377;
CC   Population: Caucasian.
CC   Knockout cell: Method=Gamma radiation; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   P53LMACO1
AC   CVCL_U220
DR   JCRB; JCRB0150
DR   JCRB; NIHS0213
DR   Wikidata; Q54937307
RX   PubMed=9299470;
CC   Doubling time: ~1 day (Note=Lot 09232004) (JCRB=JCRB0150).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Discontinued: JCRB; NIHS0213; true.
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: C57BL/6 x 129Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   p53NiS1
AC   CVCL_8902
SY   P53NiS1
DR   CLO; CLO_0008338
DR   ATCC; CRL-2619
DR   Wikidata; Q54937308
RX   PubMed=11984000;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Unexplicit; Deletion in exon 5; Zygosity=Hemizygous (PubMed=11984000).
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Misspelling: P53N1S1; Note=Occasionally.
CC   Derived from site: In situ; Leg; UBERON=UBERON_0000978.
CC   Breed/subspecies: C57BL/6 Trp53+/-.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   p53R
AC   CVCL_J916
DR   ATCC; CRL-2781
DR   ATCC; JHU-56
DR   BioSample; SAMN03471788
DR   cancercelllines; CVCL_J916
DR   Wikidata; Q54937309
RX   PubMed=12082016;
CC   Problematic cell line: Misidentified. Originally thought to derive from Hs 766T but was later (erratum) shown to be derived from RKO (PubMed=12082016).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2781; true.
CC   Discontinued: ATCC; JHU-56; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2781
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,10
ST   TPOX: 11
ST   vWA: 16,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   P5424
AC   CVCL_WG84
SY   p5424; 5424
DR   GEO; GSM1548403
DR   GEO; GSM1548404
DR   GEO; GSM1548405
DR   GEO; GSM1548406
DR   GEO; GSM1548407
DR   GEO; GSM1548408
DR   GEO; GSM1548409
DR   GEO; GSM1548410
DR   Wikidata; Q98128423
RX   PubMed=10216098;
RX   PubMed=25732733;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97848; Rag1.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; Pol2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   P56
AC   CVCL_B6J1
DR   Wikidata; Q112129484
RX   Patent=RU2435850;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-107.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P12004; Human PCNA.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   P59M8
AC   CVCL_T837
SY   59M8; P59-M08; HPS0061
DR   GEO; GSM1227442
DR   RCB; HPS0061
DR   SKIP; SKIP000143
DR   Wikidata; Q54937310
RX   Patent=US10519422;
RX   PubMed=21347327;
RX   PubMed=24527394;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Gly188Arg (c.562G>A); ClinVar=VCV000143081; Zygosity=Unspecified (PubMed=21347327).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX16 ! 59SCV3
OI   CVCL_QX17 ! 59SV3
OI   CVCL_QX18 ! 59SV4
OI   CVCL_QX19 ! 59SV9
OI   CVCL_QX67 ! P59M9
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   P59M9
AC   CVCL_QX67
SY   P59-M09
DR   Wikidata; Q54937311
RX   PubMed=21347327;
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Gly188Arg (c.562G>A); ClinVar=VCV000143081; Zygosity=Unspecified (PubMed=21347327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX16 ! 59SCV3
OI   CVCL_QX17 ! 59SV3
OI   CVCL_QX18 ! 59SV4
OI   CVCL_QX19 ! 59SV9
OI   CVCL_T837 ! P59M8
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   P5D2
AC   CVCL_A8U9
DR   DSHB; P5D2
DR   Wikidata; Q102114730
RX   PubMed=7683214;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P5E2-2F7-1B3
AC   CVCL_VI41
SY   1B3
DR   BEI_Resources; MRA-878
DR   Wikidata; Q54937312
RX   PubMed=2447164;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P68874; Plasmodium falciparum (isolate 3D7) PFS230.
CC   Discontinued: BEI_Resources; MRA-878; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   P5E2-2F7-2B4
AC   CVCL_VI42
SY   2B4
DR   Wikidata; Q54937313
RX   PubMed=2447164;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P68874; Plasmodium falciparum (isolate 3D7) PFS230.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 5
//
ID   P5H9
AC   CVCL_A8V0
DR   DSHB; P5H9
DR   Wikidata; Q102114731
RX   PubMed=1709170;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06756; Human ITGAV/CD51.
CC   Monoclonal antibody target: UniProtKB; P18084; Human ITGB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 4
//
ID   P6
AC   CVCL_C7R9
DR   EFO; EFO_0022763
DR   Wikidata; Q117704767
RX   PubMed=1701087;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Mycobacterium tuberculosis (Note=Reacts with strains H37Rv and 79112 but not with many other strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   p6#24
AC   CVCL_C5Q8
DR   Wikidata; Q116050101
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   p6#32
AC   CVCL_C5Q9
DR   Wikidata; Q116050102
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   p6#41
AC   CVCL_C5QA
DR   Wikidata; Q116050103
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   p6#42
AC   CVCL_C5QB
DR   Wikidata; Q116050104
RX   PubMed=18989973;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_81861; Forchlorfenuron (CPPU).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   P67.6
AC   CVCL_F1XP
SY   P67
RX   PubMed=1440849;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20138; Human CD33.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   P69SV40T
AC   CVCL_4875
SY   P69SV40-T; P69SV40 T; P69SV40; P69
DR   BTO; BTO_0005982
DR   ABM; T0854
DR   Cosmic; 1172630
DR   Wikidata; Q54937314
RX   PubMed=8077059;
RX   PubMed=9018337;
RX   PubMed=12725112;
RX   PubMed=15643173;
RX   PubMed=21544329;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   P69SV40T-M12
AC   CVCL_4860
SY   M12
DR   BTO; BTO_0005128
DR   Wikidata; Q54903461
RX   PubMed=9496902;
RX   PubMed=15643173;
CC   Population: African American.
CC   Characteristics: Metastatic to the lungs and/or diaphragm. Obtained by subcutaneous injection of parental cell line into male athymic nude miceObtained by subcutaneous injection of parental cell line into male athymic nude mice (PubMed=9496902).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4875 ! P69SV40T
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   P69SV40T-M15
AC   CVCL_4861
SY   M15
DR   Wikidata; Q54903478
RX   PubMed=9496902;
RX   PubMed=15643173;
CC   Population: African American.
CC   Characteristics: Metastatic to the lungs and/or diaphragm. Obtained by subcutaneous injection of parental cell line into male athymic nude mice (PubMed=9496902).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4875 ! P69SV40T
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 16
//
ID   P69SV40T-M1929
AC   CVCL_4864
SY   M1929
DR   Wikidata; Q54903497
RX   PubMed=8077059;
CC   Population: African American.
CC   Characteristics: Tumorigenic. Obtained by subcutaneous injection of parental cell line into male athymic nude mice (PubMed=8077059).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4875 ! P69SV40T
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   P69SV40T-M2182
AC   CVCL_4865
SY   M2182
DR   Wikidata; Q54903520
RX   PubMed=8077059;
RX   PubMed=9496902;
RX   PubMed=15643173;
CC   Population: African American.
CC   Characteristics: Tumorigenic. Obtained by subcutaneous injection of parental cell line into male athymic nude mice (PubMed=8077059).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4864 ! P69SV40T-M1929
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   P69SV40T-M2205
AC   CVCL_4866
SY   M2205
DR   Wikidata; Q54903525
RX   PubMed=8077059;
RX   PubMed=9496902;
RX   PubMed=12581899;
RX   PubMed=15643173;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4875 ! P69SV40T
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   P6C
AC   CVCL_T056
DR   Wikidata; Q38597126
RX   PubMed=23736004;
CC   Group: Cancer stem cell line.
CC   Doubling time: ~20 hours (PubMed=23736004).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   P6D9a
AC   CVCL_C5FP
DR   Wikidata; Q116050105
RX   PubMed=35448894;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Naja ashei three-finger toxins (3FTxs).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   P6D9b
AC   CVCL_C5FQ
DR   Wikidata; Q116050106
RX   PubMed=35448894;
CC   Group: Animal toxin research hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Naja ashei three-finger toxins (3FTxs).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   P72-9
AC   CVCL_Y455
DR   ATCC; CRL-6525
DR   Wikidata; Q54937315
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6525; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=34884; ! Callorhinus ursinus (Northern fur seal)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   P7731
AC   CVCL_RY01
DR   cancercelllines; CVCL_RY01
DR   Cosmic; 2814455
DR   EGA; EGAS00001002840
DR   GEO; GSM2769404
DR   GEO; GSM2769405
DR   GEO; GSM2769406
DR   GEO; GSM2785715
DR   Wikidata; Q54937316
RX   PubMed=28889351;
RX   PubMed=29468485;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Doubling time: ~24 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=28889351; PubMed=29468485).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys229Ter (c.687T>A); Zygosity=Unspecified (PubMed=28889351; PubMed=29468485).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Doubling time and age of donor from personal communication of Chenevix-Trench, Georgia.
CC   Miscellaneous: Conflicts in the STR profile of markers TH01 and vWA between PubMed=28889351 and PubMed=29468485 are clerical errors and are thus not recorded in the relevant section (personal communication of Chenevix-Trench, Georgia).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=28889351; PubMed=29468485
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 31,31.2
ST   D5S818: 9
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   P7E9C7
AC   CVCL_B6D2
DR   Wikidata; Q112129485
RX   Patent=EP0305960A2;
RX   Patent=EP0336405B1;
RX   PubMed=1369271;
RX   PubMed=1369279;
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1810.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50139.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6D1 ! PEA7-1-6D
HI   CVCL_Z044 ! TAW-925
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   P815
AC   CVCL_2154
SY   P-815; P 815
DR   BTO; BTO_0000985
DR   CLO; CLO_0008340
DR   CLO; CLO_0008341
DR   CLO; CLO_0050217
DR   CLDB; cl3784
DR   CLDB; cl3785
DR   CLDB; cl5244
DR   ATCC; TIB-64
DR   BCRC; 60178
DR   BCRJ; 0200
DR   BioSample; SAMN11397663
DR   CCRID; 1101MOU-PUMC000114
DR   CCRID; 3101MOUSCSP516
DR   CCRID; 3101MOUTCM12
DR   CCRID; 4201MOU-CCTCC00608
DR   CCTCC; GDC0608
DR   ChEMBL-Cells; CHEMBL3307568
DR   ChEMBL-Targets; CHEMBL614226
DR   CLS; 400242
DR   DSMZ; ACC-1
DR   DSMZCellDive; ACC-1
DR   IZSLER; BS TCL 118
DR   JCRB; IFO50029
DR   JCRB; JCRB0078
DR   KCB; KCB 93032YJ
DR   Lonza; 187
DR   NCBI_Iran; C550
DR   PubChem_Cell_line; CVCL_2154
DR   RCB; RCB1167
DR   TKG; TKG 0168
DR   Wikidata; Q54937317
RX   DOI=10.2220/biomedres.5.19;
RX   PubMed=1234049;
RX   PubMed=3792703;
RX   PubMed=4208429;
RX   PubMed=7513208;
RX   PubMed=10210327;
RX   PubMed=18432777;
RX   PubMed=25277546;
RX   PubMed=31220119;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-232.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-233.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~18-22 hours (DSMZ=ACC-1).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (PubMed=7513208; PubMed=10210327).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: P825; Note=Occasionally.
CC   Discontinued: CLS; 400242; true.
CC   Discontinued: JCRB; IFO50029; true.
CC   Breed/subspecies: DBA/2.
ST   Source(s): DSMZ=ACC-1; PubMed=31220119
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 14,17,18
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 13 (PubMed=31220119)
ST   Mouse STR 5-5: 13,14 (DSMZ=ACC-1)
ST   Mouse STR 6-4: 17 (DSMZ=ACC-1)
ST   Mouse STR 6-4: 17,18 (PubMed=31220119)
ST   Mouse STR 6-7: 12 (PubMed=31220119)
ST   Mouse STR 6-7: 12,13 (DSMZ=ACC-1)
ST   Mouse STR 7-1: 27
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16,17,18
ST   Mouse STR 12-1: 16,17 (DSMZ=ACC-1)
ST   Mouse STR 12-1: 17 (PubMed=31220119)
ST   Mouse STR 13-1: 17,18
ST   Mouse STR 15-3: 20.3,21.3 (PubMed=31220119)
ST   Mouse STR 15-3: 21.3 (DSMZ=ACC-1)
ST   Mouse STR 17-2: 17
ST   Mouse STR 18-3: 17 (PubMed=31220119)
ST   Mouse STR 18-3: 17,18 (DSMZ=ACC-1)
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 27 (PubMed=31220119)
ST   Mouse STR X-1: 27,28 (DSMZ=ACC-1)
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   P815 Hsp65-IL-2
AC   CVCL_A9JC
DR   Wikidata; Q108821087
RX   CelloPub=CLPUB00643;
CC   Characteristics: Transfected with a groL2/Hsp65-IL2 construct.
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P9WPE7; Mycobacterium tuberculosis groL2.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2154 ! P815
SX   Male
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   P815 MB
AC   CVCL_4Z63
DR   ATCC; CRL-6448
DR   Wikidata; Q54937318
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Discontinued: ATCC; CRL-6448; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2154 ! P815
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   P815-1-1
AC   CVCL_4269
DR   CLO; CLO_0008342
DR   CLDB; cl3852
DR   ECACC; 85011406
DR   Wikidata; Q54937319
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2154 ! P815
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   P815-X2
AC   CVCL_F735
SY   P815.X2; P815X2; P815-(X2); P815 subline X2
DR   Wikidata; Q54937320
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2154 ! P815
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   P815.Trh4
AC   CVCL_C0DF
DR   CancerTools; 157674
DR   Wikidata; Q114312642
DR   Ximbio; 157674
RX   PubMed=29399388;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1919199; Cers5.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2154 ! P815
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   P9
AC   CVCL_B6EF
DR   Wikidata; Q112129486
RX   PubMed=22358532;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=p6-1).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   P93AF
AC   CVCL_E2WH
SY   P-93AF
DR   BTO; BTO_0005376
RX   DOI=10.1007/BF00039691;
RX   PubMed=16586507;
RX   PubMed=20552456;
RX   PubMed=21692199;
RX   PubMed=22095859;
CC   Group: Plant cell line.
CC   Characteristics: Accumulates paclitaxel in response to methyl jasmonate (DOI=10.1007/BF00039691).
CC   Derived from site: In situ; Plant embryo; PO=PO_0009009.
OX   NCBI_TaxID=99806; ! Taxus cuspidata (Japanese yew)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   P991
AC   CVCL_E2WI
RX   DOI=10.1007/BF00039691;
RX   PubMed=16586507;
RX   PubMed=20552456;
RX   PubMed=21692199;
RX   PubMed=22530557;
CC   Group: Plant cell line.
CC   Characteristics: Produce high amounts of taxanes after methyl jasmonate elicitation (PubMed=22530557).
CC   Derived from site: In situ; Plant embryo; PO=PO_0009009.
OX   NCBI_TaxID=99806; ! Taxus cuspidata (Japanese yew)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PA
AC   CVCL_E800
SY   PA-PP
DR   dbMHC; 48995
DR   ECACC; 94050333
DR   IHW; IHW09217
DR   IPD-IMGT/HLA; 11226
DR   Wikidata; Q54937321
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*68:02,26:01; B*38,14; C*08,12:03; DPB1*04:01,04:02 (IPD-IMGT/HLA=11226).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   PA #2
AC   CVCL_1E44
SY   PA 2; PA-2
DR   Wikidata; Q54937322
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=3518877;
CC   Doubling time: 106 hours (Note=At 5th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Colon; UBERON=UBERON_0001155.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   PA 16/23
AC   CVCL_W771
DR   Wikidata; Q54937323
RX   PubMed=1320446;
RX   PubMed=8198972;
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C4650; Parotid gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   PA 3
AC   CVCL_AX17
SY   PA3
DR   Cosmic; 2361387
DR   Wikidata; Q54937324
RX   PubMed=8547074;
RX   PubMed=10936422;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 8
//
ID   Pa Coo
AC   CVCL_U790
DR   ATCC; CRL-1293
DR   Wikidata; Q54937325
CC   Discontinued: ATCC; CRL-1293; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Pa Kel-1
AC   CVCL_3324
DR   CLO; CLO_0008348
DR   ATCC; CRL-1341
DR   Wikidata; Q54937326
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3325 ! Pa Kel-2
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Pa Kel-2
AC   CVCL_3325
DR   CLO; CLO_0008349
DR   ATCC; CRL-1344
DR   Wikidata; Q54937327
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125696; Ehlers-Danlos syndrome, type I
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3324 ! Pa Kel-1
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Pa Mer
AC   CVCL_U684
DR   ATCC; CRL-1169
DR   Wikidata; Q54937328
CC   Discontinued: ATCC; CRL-1169; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   PA-1
AC   CVCL_0479
SY   PA1; PA I; PAI
DR   BTO; BTO_0001591
DR   CLO; CLO_0008350
DR   EFO; EFO_0006465
DR   MCCL; MCC:0000377
DR   CLDB; cl3856
DR   CLDB; cl3857
DR   CLDB; cl3858
DR   CLDB; cl3859
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1572
DR   BCRC; 60063
DR   BioSample; SAMN01821586
DR   BioSample; SAMN03472415
DR   BioSample; SAMN03473209
DR   cancercelllines; CVCL_0479
DR   CCRID; 1101HUM-PUMC000021
DR   Cell_Model_Passport; SIDM01140
DR   CGH-DB; 9358-4
DR   ChEMBL-Cells; CHEMBL3308812
DR   ChEMBL-Targets; CHEMBL614949
DR   CLS; 300402
DR   Cosmic; 688112
DR   Cosmic; 801353
DR   Cosmic; 809111
DR   Cosmic; 844343
DR   Cosmic; 909255
DR   Cosmic; 931368
DR   Cosmic; 1093560
DR   Cosmic; 1305331
DR   Cosmic; 1995610
DR   Cosmic-CLP; 909255
DR   DepMap; ACH-001374
DR   ECACC; 90013101
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10807-111A6
DR   GDSC; 909255
DR   GEO; GSM186444
DR   GEO; GSM186445
DR   GEO; GSM784566
DR   GEO; GSM1374804
DR   GEO; GSM1670330
DR   IARC_TP53; 1418
DR   IARC_TP53; 8338
DR   ICLC; HTL97002
DR   IZSLER; BS TCL 179
DR   JCRB; JCRB9061
DR   LINCS_LDP; LCL-1416
DR   PharmacoDB; PA1_1235_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0479
DR   PubChem_Cell_line; CVCL_0479
DR   RCB; RCB1946
DR   TKG; TKG 0573
DR   Wikidata; Q54937331
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=2653399;
RX   PubMed=6740333;
RX   PubMed=6931103;
RX   PubMed=9290701;
RX   PubMed=9359923;
RX   PubMed=9698466;
RX   PubMed=10567668;
RX   PubMed=11314036;
RX   PubMed=11330945;
RX   PubMed=15677628;
RX   PubMed=16080959;
RX   PubMed=20164919;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Doubling time: 36 hours (PubMed=2653399); ~24 hours (Note=Lot 01212002) (JCRB=JCRB9061); 22.77 hours (JWGray panel).
CC   HLA typing: A*68:02,68:02; B*37:04,44:03; C*07:01,07:01; DQB1*04:01,04:01; DRB1*03:02,03:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous; Note=Not found in early passages (PubMed=6740333).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro316Pro (c.948C>T); ClinVar=VCV000750727; Zygosity=Heterozygous (Cosmic-CLP=909255).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=21.08%; Native American=17.69%; East Asian, North=1.54%; East Asian, South=0.7%; South Asian=0.4%; European, North=26.01%; European, South=32.58% (PubMed=30894373).
CC   Caution: TP53 mutation indicated to be at p.Asn239Asp (c.715A>G) in DOI=10.11418/jtca1981.16.3_173 and PubMed=9359923.
CC   Discontinued: RCB; RCB1946; true.
CC   Discontinued: TKG; TKG 0573; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-1572; CCRID=1101HUM-PUMC000021; CLS=300402; COG; Cosmic-CLP=909255; DepMap=ACH-001374; ECACC=90013101; JCRB=JCRB9061; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10 (ATCC=CRL-1572; CCRID=1101HUM-PUMC000021; CLS=300402; COG; Cosmic-CLP=909255; DepMap=ACH-001374; ECACC=90013101; PubMed=25877200)
ST   D13S317: 9,10,13 (JCRB=JCRB9061)
ST   D16S539: 9 (CLS=300402)
ST   D16S539: 9,12 (ATCC=CRL-1572; CCRID=1101HUM-PUMC000021; COG; Cosmic-CLP=909255; DepMap=ACH-001374; ECACC=90013101; JCRB=JCRB9061; PubMed=25877200)
ST   D18S51: 15,18
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 14,20
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   PA-1 [Human dental papilla]
AC   CVCL_UI26
SY   PApilla-1
DR   Wikidata; Q98128424
RX   PubMed=15250834;
CC   Population: Japanese.
CC   Doubling time: 28.9 hours (PubMed=15250834).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Tooth bud, dental papilla; UBERON=UBERON_0001763.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   PA-1/6TG-r
AC   CVCL_3121
DR   cancercelllines; CVCL_3121
DR   JCRB; JCRB1052
DR   JCRB; NIHS0328
DR   Wikidata; Q54937332
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro316Pro (c.948C>T); ClinVar=VCV000750727; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: JCRB; NIHS0328; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1052
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0479 ! PA-1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   PA-23
AC   CVCL_J296
SY   PA23
DR   BTO; BTO_0004529
DR   Wikidata; Q54937333
RX   PubMed=19039943;
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   PA-CLS-52
AC   CVCL_5852
SY   PA-CLS 52
DR   CLS; 300386
DR   Wikidata; Q54937334
CC   Doubling time: ~45 hours (CLS=300386).
CC   Discontinued: CLS; 300386; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   PA-DUKX.153
AC   CVCL_E4IC
RX   PubMed=18629924;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PA-DUKX.153.8
AC   CVCL_E4IE
SY   PA DUKX 153.8; CHO PA-Dukx 153.8; PA-DUKX.153 subclone 8
RX   PubMed=18629924;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4IC ! PA-DUKX.153
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PA-DUKX.378
AC   CVCL_E4ID
SY   PA DUKX 378
RX   PubMed=18629924;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Pa-E-HNU6
AC   CVCL_Z571
SY   Pa-E-HNU 6
DR   Wikidata; Q54937335
RX   DOI=10.19603/j.cnki.1000-1190.1995.04.025;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=254370; ! Ctenoplusia agnata (Moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   PA-GRS1
AC   CVCL_6711
SY   PAGRS1
DR   Wikidata; Q54937336
RX   PubMed=1319328;
RX   PubMed=15541573;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   PA-hTERT
AC   CVCL_JE73
DR   Wikidata; Q54937337
RX   PubMed=17611690;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   PA-III
AC   CVCL_6D67
SY   PAIII
DR   Wikidata; Q54937338
RX   PubMed=1326342;
RX   PubMed=1661415;
CC   Breed/subspecies: Lobund-Wistar (L-W).
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   PA-JEB
AC   CVCL_WW22
DR   Wikidata; Q98128425
RX   PubMed=8832392;
RX   PubMed=9660880;
RX   PubMed=10811835;
RX   PubMed=12429829;
CC   Doubling time: ~36 hours (PubMed=9660880).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C162474; Epidermolysis bullosa, junctional, with pyloric atresia
DI   ORDO; Orphanet_79403; Junctional epidermolysis bullosa-pyloric atresia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   PA-JEB/beta4
AC   CVCL_WW23
SY   PA-JEB/b4
DR   Wikidata; Q98128427
RX   PubMed=10811835;
RX   PubMed=12429829;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6158; ITGB4.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C162474; Epidermolysis bullosa, junctional, with pyloric atresia
DI   ORDO; Orphanet_79403; Junctional epidermolysis bullosa-pyloric atresia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WW22 ! PA-JEB
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   PA-JEB/beta4-EGFP
AC   CVCL_WW24
SY   PA-JEB/b4-EGFP
DR   Wikidata; Q98128428
RX   PubMed=12429829;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6158; ITGB4.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C162474; Epidermolysis bullosa, junctional, with pyloric atresia
DI   ORDO; Orphanet_79403; Junctional epidermolysis bullosa-pyloric atresia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WW22 ! PA-JEB
SX   Sex unspecified
AG   5D
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   PA018
AC   CVCL_1G11
DR   cancercelllines; CVCL_1G11
DR   Cosmic; 1820268
DR   Wikidata; Q54937339
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PA028
AC   CVCL_1G12
DR   cancercelllines; CVCL_1G12
DR   Cosmic; 1820260
DR   Wikidata; Q54937341
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000177777; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PA055
AC   CVCL_1G13
DR   cancercelllines; CVCL_1G13
DR   Cosmic; 1820261
DR   Wikidata; Q54937342
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser149fs; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PA086
AC   CVCL_1G14
DR   cancercelllines; CVCL_1G14
DR   Cosmic; 1820265
DR   Wikidata; Q54937343
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PA090
AC   CVCL_1G15
DR   cancercelllines; CVCL_1G15
DR   Cosmic; 1820269
DR   Wikidata; Q54937344
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PA1
AC   CVCL_T887
DR   SKIP; SKIP000521
DR   Wikidata; Q54937345
RX   PubMed=23039195;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex2-4del; Zygosity=Homozygous (PubMed=23039195).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T885 ! PA9
OI   CVCL_T886 ! PA22
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   PA1 fat-1
AC   CVCL_E6ZI
DR   ABM; T6264
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6264).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro316Pro (c.948C>T); ClinVar=VCV000750727; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8114; Ovarian mixed germ cell tumor
DI   ORDO; Orphanet_180234; Mixed germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0479 ! PA-1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PA1-3F10
AC   CVCL_LC02
SY   PA1-3F10-1C1-3B1-4E2-2A5; 3F10
DR   Wikidata; Q54937346
RX   Patent=WO1996022310A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 1322CB.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PA107
AC   CVCL_1G16
DR   cancercelllines; CVCL_1G16
DR   Cosmic; 1820266
DR   Wikidata; Q54937347
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:24659; EXOC8; Simple; p.Arg388Ter; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Ter (c.811G>T); ClinVar=VCV001174012; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   PA12
AC   CVCL_0E98
DR   CCRID; 1101MOU-PUMC000022
DR   Wikidata; Q54937351
RX   PubMed=2985952;
CC   Group: Retrovirus packaging cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9116 ! NIH 3T3-TK-
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 12
//
ID   PA12-Rb
AC   CVCL_0E99
SY   PA12-RB
DR   ATCC; CRL-1916
DR   Wikidata; Q54937352
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9884; RB1.
CC   Discontinued: ATCC; CRL-1916; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0E98 ! PA12
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   PA122
AC   CVCL_1G17
DR   cancercelllines; CVCL_1G17
DR   Cosmic; 1820264
DR   Wikidata; Q54937353
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   PA167
AC   CVCL_1G18
DR   cancercelllines; CVCL_1G18
DR   Cosmic; 1820258
DR   Wikidata; Q54937354
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   PA182
AC   CVCL_1G19
DR   cancercelllines; CVCL_1G19
DR   Cosmic; 1820263
DR   Wikidata; Q54937355
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys101Ter (c.301A>T); Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   PA195
AC   CVCL_1G20
DR   cancercelllines; CVCL_1G20
DR   Cosmic; 1820259
DR   Wikidata; Q54937356
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.His92fs*2 (c.275delA); Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu330Arg (c.989T>G); ClinVar=VCV001510133; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   PA2.1
AC   CVCL_G245
DR   CLO; CLO_0008352
DR   ATCC; HB-117
DR   Wikidata; Q54937357
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes allele A*69).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   Pa2.2
AC   CVCL_E8FM
SY   Parthenogenetic 2.2
RX   PubMed=21966410;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PA2.6
AC   CVCL_G244
SY   PA 2.6
DR   CLO; CLO_0008347
DR   ATCC; HB-118
DR   Wikidata; Q54937358
RX   PubMed=95015;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PA202
AC   CVCL_1G21
DR   cancercelllines; CVCL_1G21
DR   Cosmic; 1820257
DR   Wikidata; Q54937359
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53fs; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   PA215
AC   CVCL_1G22
DR   cancercelllines; CVCL_1G22
DR   Cosmic; 1820262
DR   Wikidata; Q54937360
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Arg135Ter (c.403C>T); ClinVar=VCV000024802; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   PA22
AC   CVCL_T886
DR   SKIP; SKIP000207
DR   Wikidata; Q54937362
RX   PubMed=23039195;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex2-4del; Zygosity=Homozygous (PubMed=23039195).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T887 ! PA1
OI   CVCL_T885 ! PA9
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   PA254
AC   CVCL_1G23
DR   cancercelllines; CVCL_1G23
DR   Cosmic; 1820270
DR   Wikidata; Q54937364
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ala118Val (c.353C>T); ClinVar=VCV001691745; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//
ID   PA285
AC   CVCL_1G24
DR   cancercelllines; CVCL_1G24
DR   Cosmic; 1820267
DR   Wikidata; Q54937365
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7127; MLH1; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337His (c.1010G>A); ClinVar=VCV000012379; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   Pa3
AC   CVCL_E8FN
SY   Parthenogenetic 3
RX   PubMed=21966410;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PA317
AC   CVCL_3920
SY   pA317
DR   CLO; CLO_0008353
DR   CLDB; cl3864
DR   CLDB; cl3865
DR   CLDB; cl7178
DR   ATCC; CRL-9078
DR   CCRID; 1101MOU-PUMC000260
DR   CCRID; 4201MOU-CCTCC00126
DR   CCTCC; GDC0126
DR   ECACC; 89032007
DR   ICLC; HTL06006
DR   KCB; KCB 2011112YJ
DR   TOKU-E; 2844
DR   Wikidata; Q54937366
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9078.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9116 ! NIH 3T3-TK-
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   PA317 containing JR-gal
AC   CVCL_6505
DR   CLO; CLO_0008354
DR   ATCC; CRL-9995
DR   Wikidata; Q54937367
RX   Patent=US5215904;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9995.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   PA317 cyclin E-L
AC   CVCL_6506
DR   CLO; CLO_0008355
DR   ATCC; CRL-2187
DR   Wikidata; Q54937368
CC   Group: Retrovirus packaging cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PA317 cyclin E-S
AC   CVCL_6507
DR   CLO; CLO_0008356
DR   ATCC; CRL-2188
DR   Wikidata; Q54937370
CC   Group: Retrovirus packaging cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PA317 LXSN
AC   CVCL_6508
DR   CLO; CLO_0008357
DR   ATCC; CRL-2202
DR   Wikidata; Q54937371
CC   Group: Retrovirus packaging cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PA317 LXSN 16E6
AC   CVCL_6509
DR   CLO; CLO_0008358
DR   ATCC; CRL-2204
DR   Wikidata; Q54937372
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   PA317 LXSN 16E6E7
AC   CVCL_6510
SY   PA317 LXSN 16E6/E7; PA317/LXSN-16E6E7
DR   CLO; CLO_0008359
DR   ATCC; CRL-2203
DR   Wikidata; Q54937373
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   PA317 LXSN 16E7
AC   CVCL_6511
SY   PA317LXSN16E7
DR   CLO; CLO_0008360
DR   ATCC; CRL-2205
DR   Wikidata; Q54937374
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   PA317 LXSN 6E6
AC   CVCL_6512
DR   CLO; CLO_0008361
DR   ATCC; CRL-2206
DR   Wikidata; Q54937375
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06462; Human papillomavirus type 6b protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10600; Human papillomavirus type 6b (HPV6b).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   PA317 LXSN 6E7
AC   CVCL_6513
SY   PA317LXSN6E7
DR   CLO; CLO_0008362
DR   ATCC; CRL-2207
DR   Wikidata; Q54937376
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06464; Human papillomavirus type 6b protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10600; Human papillomavirus type 6b (HPV6b).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3920 ! PA317
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   PA333
AC   CVCL_1G25
DR   cancercelllines; CVCL_1G25
DR   Cosmic; 1820271
DR   Wikidata; Q54937377
RX   PubMed=22156295;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=22156295).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ile435fs; Zygosity=Unspecified (PubMed=22156295).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=22156295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PA682 BM1
AC   CVCL_IV25
SY   PA682BM-1; PA682BM
DR   Wikidata; Q54937378
RX   PubMed=1325212;
RX   PubMed=6316501;
RX   PubMed=8176200;
RX   PubMed=8568269;
RX   PubMed=9973220;
CC   Population: Caucasian; Norwegian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4AT ! PA682 BM2
OI   CVCL_C539 ! PA682 PB
OI   CVCL_IV26 ! PA682 PE1
OI   CVCL_E4AU ! PA682 PE2
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   PA682 BM2
AC   CVCL_E4AT
SY   PA682BM-2
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Population: Caucasian; Norwegian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV25 ! PA682 BM1
OI   CVCL_C539 ! PA682 PB
OI   CVCL_IV26 ! PA682 PE1
OI   CVCL_E4AU ! PA682 PE2
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PA682 PB
AC   CVCL_C539
SY   PA682(PB); PA682PB; Pa682PB; PA682; PA 682; PA-682
DR   cancercelllines; CVCL_C539
DR   Cosmic; 850212
DR   Cosmic; 931131
DR   Cosmic; 1515190
DR   Wikidata; Q54937379
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=2470097;
RX   PubMed=3026973;
RX   PubMed=3100061;
RX   PubMed=3927261;
RX   PubMed=6316501;
RX   PubMed=7519050;
RX   PubMed=8176200;
RX   PubMed=8568269;
RX   PubMed=9473234;
RX   PubMed=9787181;
RX   PubMed=9973220;
RX   PubMed=19358282;
RX   PubMed=24590883;
CC   Population: Caucasian; Norwegian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=7519050).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val166Leu (c.496G>C); ClinVar=VCV000639793; Zygosity=Unspecified (PubMed=9787181).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV25 ! PA682 BM1
OI   CVCL_E4AT ! PA682 BM2
OI   CVCL_IV26 ! PA682 PE1
OI   CVCL_E4AU ! PA682 PE2
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   PA682 PE1
AC   CVCL_IV26
SY   PA682PE-1; PA 682/PE-1; PA682PE
DR   Wikidata; Q54937380
RX   PubMed=1325212;
RX   PubMed=3100061;
RX   PubMed=6316501;
RX   PubMed=8176200;
RX   PubMed=8568269;
RX   PubMed=9973220;
CC   Population: Caucasian; Norwegian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV25 ! PA682 BM1
OI   CVCL_E4AT ! PA682 BM2
OI   CVCL_C539 ! PA682 PB
OI   CVCL_E4AU ! PA682 PE2
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   PA682 PE2
AC   CVCL_E4AU
SY   PA682PE-2
RX   PubMed=1325212;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Population: Caucasian; Norwegian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV25 ! PA682 BM1
OI   CVCL_E4AT ! PA682 BM2
OI   CVCL_C539 ! PA682 PB
OI   CVCL_IV26 ! PA682 PE1
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PA9
AC   CVCL_T885
DR   SKIP; SKIP000206
DR   Wikidata; Q54937381
RX   PubMed=23039195;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex2-4del; Zygosity=Homozygous (PubMed=23039195).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T887 ! PA1
OI   CVCL_T886 ! PA22
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   PAb 100
AC   CVCL_2156
SY   PAB-100; PAb100; Clone 7
DR   CLO; CLO_0008367
DR   CLO; CLO_0008371
DR   CLDB; cl3870
DR   ATCC; TIB-115
DR   DSMZ; ACC-188
DR   DSMZCellDive; ACC-188
DR   Wikidata; Q54937382
RX   PubMed=2419584;
RX   PubMed=6155477;
RX   PubMed=6281480;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   PAb 101
AC   CVCL_4609
SY   PAb101; Clone 412
DR   CLO; CLO_0008368
DR   ABCD; ABCD_AE467
DR   ATCC; TIB-117
DR   Wikidata; Q54937383
RX   PubMed=2419584;
RX   PubMed=6155477;
RX   PubMed=6281480;
RX   PubMed=7939414;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Recognizes C-terminus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   PAb 108
AC   CVCL_4610
DR   CLO; CLO_0008369
DR   ATCC; TIB-230
DR   Wikidata; Q54937384
RX   PubMed=2419584;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 7
//
ID   PAb 122
AC   CVCL_2157
SY   PAB-122; PAb122; Clone 122
DR   CLO; CLO_0008370
DR   CLO; CLO_0008372
DR   CLDB; cl3871
DR   ATCC; TIB-116
DR   DSMZ; ACC-166
DR   DSMZCellDive; ACC-166
DR   Wikidata; Q54937385
RX   PubMed=6155477;
RX   PubMed=6281480;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53 (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   PAb 1400
AC   CVCL_4562
SY   PAb1400
DR   CLO; CLO_0050286
DR   RCB; RCB0026
DR   Wikidata; Q54937386
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   PAb 402
AC   CVCL_XK47
SY   PAb402; L2
DR   Wikidata; Q98128430
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 404
AC   CVCL_XK48
SY   PAb404; L4
DR   Wikidata; Q98128431
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 405
AC   CVCL_XK49
SY   PAb405; L5
DR   ABCD; ABCD_AE468
DR   Wikidata; Q98128432
RX   PubMed=6169844;
RX   PubMed=6281480;
RX   PubMed=7939414;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Recognizes C-terminus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   PAb 406
AC   CVCL_XK50
SY   PAb406; L6
DR   Wikidata; Q98128433
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 407
AC   CVCL_XK51
SY   PAb407; L7
DR   Wikidata; Q98128434
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 409
AC   CVCL_XK52
SY   PAb409; L9
DR   Wikidata; Q98128435
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 410
AC   CVCL_XK53
SY   PAb410; L10
DR   Wikidata; Q98128436
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 413
AC   CVCL_XK54
SY   PAb413; L13
DR   Wikidata; Q98128438
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 414
AC   CVCL_XK55
SY   PAb414; L14
DR   Wikidata; Q98128439
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 416
AC   CVCL_XK56
SY   PAb416; L16
DR   Wikidata; Q98128440
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 418
AC   CVCL_XK57
SY   PAb418; L18
DR   Wikidata; Q98128441
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 419
AC   CVCL_B954
SY   PAb419; L19
DR   CLO; CLO_0050282
DR   ABCD; ABCD_AE466
DR   RCB; RCB0195
DR   Wikidata; Q54937389
RX   PubMed=6169844;
RX   PubMed=6281480;
RX   PubMed=7939414;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Recognizes N-terminus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 10
//
ID   PAb 420
AC   CVCL_XK58
SY   PAb420; L20
DR   Wikidata; Q98128442
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 421
AC   CVCL_XK59
SY   PAb421; L21
DR   Wikidata; Q98128443
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 423
AC   CVCL_XK60
SY   PAb423; L23
DR   Wikidata; Q98128444
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 427
AC   CVCL_XK61
SY   PAb427; L27
DR   Wikidata; Q98128445
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 430
AC   CVCL_XK62
SY   PAb430; L30
DR   Wikidata; Q98128446
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 431
AC   CVCL_XK63
SY   PAb431; L31
DR   Wikidata; Q98128447
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 432
AC   CVCL_XK64
SY   PAb432; L32
DR   Wikidata; Q98128448
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 433
AC   CVCL_XK65
SY   PAb433; L33
DR   Wikidata; Q98128449
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 435
AC   CVCL_XK66
SY   PAb435; L35
DR   Wikidata; Q98128450
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 436
AC   CVCL_XK67
SY   PAb436; L36
DR   Wikidata; Q98128451
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 437
AC   CVCL_XK68
SY   PAb437; L37
DR   Wikidata; Q98128452
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 438
AC   CVCL_XK69
SY   PAb438; L38
DR   Wikidata; Q98128453
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 439
AC   CVCL_XK70
SY   PAb439; L39
DR   Wikidata; Q98128455
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 440
AC   CVCL_XK71
SY   PAb440; L40
DR   Wikidata; Q98128456
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 441
AC   CVCL_XK72
SY   PAb441; L41
DR   Wikidata; Q98128457
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 442
AC   CVCL_XK73
SY   PAb442; L42
DR   Wikidata; Q98128458
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 443
AC   CVCL_XK74
SY   PAb443; L43
DR   Wikidata; Q98128459
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb 444
AC   CVCL_XK75
SY   PAb444; L44
DR   Wikidata; Q98128460
RX   PubMed=6169844;
RX   PubMed=6281480;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 4
//
ID   PAb1601
AC   CVCL_D6PU
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1602
AC   CVCL_D6PV
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1603
AC   CVCL_D6PW
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1604
AC   CVCL_D6PX
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus and murine polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1605
AC   CVCL_D6PY
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1606
AC   CVCL_D6PZ
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1607
AC   CVCL_D6Q0
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1608
AC   CVCL_D6Q1
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1609
AC   CVCL_D6Q2
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1610
AC   CVCL_D6Q3
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1611
AC   CVCL_D6Q4
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1612
AC   CVCL_D6Q5
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1613
AC   CVCL_D6Q6
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1614
AC   CVCL_D6Q7
RX   PubMed=6204863;
RX   PubMed=7523331;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus, murine polyomavirus and JC polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1615
AC   CVCL_D6Q8
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1616
AC   CVCL_D6Q9
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1617
AC   CVCL_D6QA
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1618
AC   CVCL_D6QB
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1619
AC   CVCL_D6QC
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1620
AC   CVCL_2158
SY   PAB-1620; PAb 1620
DR   CLO; CLO_0008373
DR   DSMZ; ACC-280
DR   DSMZCellDive; ACC-280
DR   Wikidata; Q54937387
RX   PubMed=6204863;
CC   Doubling time: ~24 hours (DSMZ=ACC-280).
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53 (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   PAb1621
AC   CVCL_D6QD
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1622
AC   CVCL_D6QE
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1623
AC   CVCL_D6QF
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1624
AC   CVCL_D6QG
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1625
AC   CVCL_D6QH
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1626
AC   CVCL_D6QI
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1627
AC   CVCL_D6QJ
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1628
AC   CVCL_D6QK
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1629
AC   CVCL_D6QL
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1630
AC   CVCL_D6QM
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1631
AC   CVCL_D6QN
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1632
AC   CVCL_D6QP
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1633
AC   CVCL_D6QQ
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1634
AC   CVCL_D6QR
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1635
AC   CVCL_D6QS
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PAb1636
AC   CVCL_D6QT
RX   PubMed=6204863;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Also reacts with BK polyomavirus).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   PaBrH01
AC   CVCL_DR67
DR   Wikidata; Q54937390
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR68 ! PaBrH02
OI   CVCL_DR69 ! PaBrH03
OI   CVCL_DR70 ! PaBrH04
OI   CVCL_DR71 ! PaBrH05
OI   CVCL_DR72 ! PaBrH06
OI   CVCL_DR73 ! PaBrH07
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaBrH02
AC   CVCL_DR68
DR   Wikidata; Q54937391
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR67 ! PaBrH01
OI   CVCL_DR69 ! PaBrH03
OI   CVCL_DR70 ! PaBrH04
OI   CVCL_DR71 ! PaBrH05
OI   CVCL_DR72 ! PaBrH06
OI   CVCL_DR73 ! PaBrH07
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaBrH03
AC   CVCL_DR69
DR   Wikidata; Q54937392
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR67 ! PaBrH01
OI   CVCL_DR68 ! PaBrH02
OI   CVCL_DR70 ! PaBrH04
OI   CVCL_DR71 ! PaBrH05
OI   CVCL_DR72 ! PaBrH06
OI   CVCL_DR73 ! PaBrH07
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaBrH04
AC   CVCL_DR70
DR   Wikidata; Q54937393
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR67 ! PaBrH01
OI   CVCL_DR68 ! PaBrH02
OI   CVCL_DR69 ! PaBrH03
OI   CVCL_DR71 ! PaBrH05
OI   CVCL_DR72 ! PaBrH06
OI   CVCL_DR73 ! PaBrH07
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaBrH05
AC   CVCL_DR71
DR   Wikidata; Q54937394
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR67 ! PaBrH01
OI   CVCL_DR68 ! PaBrH02
OI   CVCL_DR69 ! PaBrH03
OI   CVCL_DR70 ! PaBrH04
OI   CVCL_DR72 ! PaBrH06
OI   CVCL_DR73 ! PaBrH07
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaBrH06
AC   CVCL_DR72
DR   Wikidata; Q54937408
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR67 ! PaBrH01
OI   CVCL_DR68 ! PaBrH02
OI   CVCL_DR69 ! PaBrH03
OI   CVCL_DR70 ! PaBrH04
OI   CVCL_DR71 ! PaBrH05
OI   CVCL_DR73 ! PaBrH07
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaBrH07
AC   CVCL_DR73
DR   Wikidata; Q54937409
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR67 ! PaBrH01
OI   CVCL_DR68 ! PaBrH02
OI   CVCL_DR69 ! PaBrH03
OI   CVCL_DR70 ! PaBrH04
OI   CVCL_DR71 ! PaBrH05
OI   CVCL_DR72 ! PaBrH06
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaBrT01
AC   CVCL_DR74
DR   Wikidata; Q54937410
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR75 ! PaBrT02
OI   CVCL_DR76 ! PaBrT03
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PaBrT02
AC   CVCL_DR75
DR   Wikidata; Q54937411
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR74 ! PaBrT01
OI   CVCL_DR76 ! PaBrT03
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PaBrT03
AC   CVCL_DR76
DR   Wikidata; Q54937412
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR74 ! PaBrT01
OI   CVCL_DR75 ! PaBrT02
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PABSo-E
AC   CVCL_RW37
SY   PABSO-E
DR   Wikidata; Q54937413
RX   PubMed=10467943;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Tooth, enamel organ, dental epithelium; UBERON=UBERON_0003843.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   PAC1
AC   CVCL_U511
AS   CVCL_D258
SY   PAC-1; CS-54; CS54
DR   BTO; BTO_0003338
DR   Wikidata; Q54937414
RX   PubMed=1333373;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-506.html
CC   Derived from site: In situ; Lung, artery; UBERON=UBERON_0002012.
CC   Cell type: Pulmonary artery smooth muscle cell; CL=CL_0002591.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   PAC2
AC   CVCL_5853
SY   PAC-2
DR   EFO; EFO_0001224
DR   Lonza; 1136
DR   Wikidata; Q54937415
RX   CelloPub=CLPUB00276;
RX   PubMed=18377224;
RX   PubMed=20147193;
RX   PubMed=32990429;
CC   Group: Fish cell line.
CC   Doubling time: ~36 hours (Note=At 28 Celsius), ~24 hours (Note=At 32 Celsius) (CelloPub=CLPUB00276).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   2FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   PaCa 5061
AC   CVCL_C886
SY   PaCa-5061; PaCa5061
DR   cancercelllines; CVCL_C886
DR   Cosmic; 1352405
DR   IARC_TP53; 28456
DR   Wikidata; Q54937416
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=20553613;
RX   PubMed=21632553;
RX   PubMed=22490524;
CC   Doubling time: 30-48 hours (PubMed=20553613).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20553613).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20553613).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   PaCa 5072
AC   CVCL_C887
SY   PaCa-5072; PaCa5072
DR   Wikidata; Q54937417
RX   PubMed=21632553;
RX   PubMed=22490524;
CC   Doubling time: 56-60 hours (Direct_author_submission).
CC   Miscellaneous: Doubling time from personal communication of Gungor, Cenap.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   PaCa 5156
AC   CVCL_LM69
SY   PaCa-5156; PaCa5156
DR   Wikidata; Q54937418
RX   PubMed=21632553;
CC   Doubling time: 32-45 hours (Direct_author_submission).
CC   Miscellaneous: Age/sex of donor and doubling time from personal communication of Gungor, Cenap.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 6
//
ID   PaCa-3
AC   CVCL_4011
SY   MIA PaCa-3; Mia-Paca 3; Paca-3; PaCa3; PACA3; PC-3; PC 3; PC3; Pc3
DR   Cosmic; 710862
DR   Cosmic; 1108336
DR   Cosmic; 1320460
DR   Wikidata; Q54905681
RX   CelloPub=CLPUB00718;
RX   PubMed=8194712;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12800145;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/PaCa-3.html
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   PaCa-44
AC   CVCL_7087
AS   CVCL_B258
SY   PaCa 44; PACA 44; PaCa44; PC-44; PC 44; PC44
DR   BTO; BTO_0004848
DR   cancercelllines; CVCL_7087
DR   Cosmic; 710863
DR   Cosmic; 873001
DR   Cosmic; 933533
DR   Cosmic; 948378
DR   IARC_TP53; 2968
DR   Wikidata; Q54937419
RX   CelloPub=CLPUB00718;
RX   DOI=10.22029/jlupub-12385;
RX   PubMed=8194712;
RX   PubMed=8286197;
RX   PubMed=11169957;
RX   PubMed=11787853;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.526T>A); ClinVar=VCV000376570; Zygosity=Unspecified (PubMed=11787853).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   PaCaDD-119
AC   CVCL_1848
SY   PACADD-119; PACADD119
DR   cancercelllines; CVCL_1848
DR   Cell_Model_Passport; SIDM01354
DR   Cosmic; 1559062
DR   DepMap; ACH-001375
DR   DSMZ; ACC-709
DR   DSMZCellDive; ACC-709
DR   Wikidata; Q54937421
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=21683373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 47.45 hours (PubMed=21683373); ~3-4 days (DSMZ=ACC-709).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=21683373; DepMap=ACH-001375).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Unspecified (DepMap=ACH-001375).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas, head; UBERON=UBERON_0001069.
ST   Source(s): DepMap=ACH-001375; DSMZ=ACC-709
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 17,25
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 9,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   PaCaDD-135
AC   CVCL_1849
SY   PACADD-135; PACADD135
DR   cancercelllines; CVCL_1849
DR   Cell_Model_Passport; SIDM01353
DR   Cosmic; 1559064
DR   DepMap; ACH-001376
DR   DSMZ; ACC-710
DR   DSMZCellDive; ACC-710
DR   Wikidata; Q54937422
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=21683373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 43.83 hours (PubMed=21683373); ~72 hours (DSMZ=ACC-710).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=21683373; DepMap=ACH-001376).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249fs (c.746_750_delGGCCC); Zygosity=Unspecified (DepMap=ACH-001376).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): DepMap=ACH-001376; DSMZ=ACC-710
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 18,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 2,12 (DSMZ=ACC-710)
ST   Penta D: 12 (DepMap=ACH-001376)
ST   Penta E: 5,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   PaCaDD-137
AC   CVCL_1850
SY   PACADD-137; PACADD137
DR   cancercelllines; CVCL_1850
DR   Cell_Model_Passport; SIDM01352
DR   Cosmic; 1559066
DR   DepMap; ACH-001377
DR   DSMZ; ACC-711
DR   DSMZCellDive; ACC-711
DR   Wikidata; Q54937423
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=21683373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 24.24 hours (PubMed=21683373); ~2-3 days (DSMZ=ACC-711).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (DepMap=ACH-001377).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (DepMap=ACH-001377).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas, head; UBERON=UBERON_0001069.
ST   Source(s): DepMap=ACH-001377; DSMZ=ACC-711
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 12,13
ST   D21S11: 29.2,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 9,10
ST   D8S1179: 10 (DSMZ=ACC-711)
ST   D8S1179: 10,12 (DepMap=ACH-001377)
ST   FGA: 25,26
ST   Penta D: 9,11
ST   Penta E: 12,17
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18,19 (DSMZ=ACC-711)
ST   vWA: 18,19,20 (DepMap=ACH-001377)
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   PaCaDD-141
AC   CVCL_M464
SY   PACADD-141
DR   Cell_Model_Passport; SIDM01342
DR   Wikidata; Q54937424
RX   CelloPub=CLPUB00002;
CC   Population: Caucasian.
CC   Doubling time: 33.7 hours (CelloPub=CLPUB00002).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   PaCaDD-159
AC   CVCL_M465
SY   PACADD-159; PACADD159
DR   cancercelllines; CVCL_M465
DR   Cell_Model_Passport; SIDM01330
DR   DepMap; ACH-001378
DR   DSMZ; ACC-745
DR   DSMZCellDive; ACC-745
DR   Wikidata; Q54937425
RX   CelloPub=CLPUB00002;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 41.3 hours (CelloPub=CLPUB00002); ~1 week (DSMZ=ACC-745).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (CelloPub=CLPUB00002; DepMap=ACH-001378).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas, tail; UBERON=UBERON_0001151.
ST   Source(s): DepMap=ACH-001378; DSMZ=ACC-745
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 19.2 (DSMZ=ACC-745)
ST   D18S51: 20 (DepMap=ACH-001378)
ST   D19S433: 14
ST   D21S11: 27,32.2
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 11,15
ST   FGA: 19,20
ST   Penta D: 11,13
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   PaCaDD-161
AC   CVCL_M466
SY   PACADD-161; PACADD161
DR   cancercelllines; CVCL_M466
DR   Cell_Model_Passport; SIDM01329
DR   DepMap; ACH-001379
DR   DSMZ; ACC-746
DR   DSMZCellDive; ACC-746
DR   Wikidata; Q54937426
RX   CelloPub=CLPUB00002;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 20.6 hours (CelloPub=CLPUB00002); ~48 hours (DSMZ=ACC-746).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (CelloPub=CLPUB00002; DepMap=ACH-001379).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (DepMap=ACH-001379).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001379; DSMZ=ACC-746
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30.2,31
ST   D2S1338: 20,23
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 9,12
ST   Penta E: 7,15
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   PaCaDD-165
AC   CVCL_M467
SY   PACADD-165; PACADD165
DR   cancercelllines; CVCL_M467
DR   Cell_Model_Passport; SIDM01328
DR   DepMap; ACH-001380
DR   DSMZ; ACC-750
DR   DSMZCellDive; ACC-750
DR   Wikidata; Q54937427
RX   CelloPub=CLPUB00002;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 26.2 hours (CelloPub=CLPUB00002); ~35-45 hours (DSMZ=ACC-750).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Unspecified (DepMap=ACH-001380).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001380; DSMZ=ACC-750
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 16.3 (DSMZ=ACC-750)
ST   D18S51: 17 (DepMap=ACH-001380)
ST   D19S433: 12,14
ST   D21S11: 27
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   PaCaDD-183
AC   CVCL_M468
SY   PACADD-183
DR   cancercelllines; CVCL_M468
DR   Cell_Model_Passport; SIDM01327
DR   DSMZ; ACC-751
DR   DSMZCellDive; ACC-751
DR   Wikidata; Q54937429
RX   CelloPub=CLPUB00002;
CC   Population: Caucasian.
CC   Doubling time: 43.3 hours (CelloPub=CLPUB00002); ~2-3 days (DSMZ=ACC-751).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (CelloPub=CLPUB00002).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-751
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 28
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 11,13
ST   FGA: 24,25
ST   Penta D: 9,13
ST   Penta E: 10,11
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   PaCaDD-188
AC   CVCL_M469
SY   PACADD-188; PACADD188
DR   cancercelllines; CVCL_M469
DR   Cell_Model_Passport; SIDM01326
DR   DepMap; ACH-001382
DR   DSMZ; ACC-753
DR   DSMZCellDive; ACC-753
DR   Wikidata; Q54937430
RX   CelloPub=CLPUB00002;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 30.8 hours (CelloPub=CLPUB00002); ~2-4 days (DSMZ=ACC-753).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (CelloPub=CLPUB00002; DepMap=ACH-001382).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu326fs; Zygosity=Unspecified (DepMap=ACH-001382).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas, head; UBERON=UBERON_0001069.
ST   Source(s): DepMap=ACH-001382; DSMZ=ACC-753
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11,15
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 31,31.2
ST   D2S1338: 18,24
ST   D3S1358: 16,17
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 19,22
ST   Penta D: 11,13
ST   Penta E: 5,15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   PaCaDD-43
AC   CVCL_8781
SY   PACADD-43
DR   cancercelllines; CVCL_8781
DR   Cell_Model_Passport; SIDM01376
DR   Cosmic; 1559058
DR   Wikidata; Q54937431
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=21683373;
CC   Population: Caucasian.
CC   Doubling time: 44.74 hours (PubMed=21683373).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=21683373).
CC   Derived from site: In situ; Pancreas, head; UBERON=UBERON_0001069.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   PaCaDD-60
AC   CVCL_8782
SY   PACADD-60
DR   cancercelllines; CVCL_8782
DR   Cell_Model_Passport; SIDM01375
DR   Cosmic; 1559060
DR   Wikidata; Q54937432
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=21683373;
CC   Population: Caucasian.
CC   Doubling time: 22.19 hours (PubMed=21683373).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=21683373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   PACB-PE
AC   CVCL_E4AY
RX   PubMed=1325212;
RX   PubMed=8176200;
RX   PubMed=8568269;
CC   Characteristics: Transformed with supernatant derived from PA682 PE1 (Cellosaurus=CVCL_IV26) (PubMed=1325212; PubMed=8176200).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PACS1001i-GM27160
AC   CVCL_YZ38
DR   WiCell; PACS1001i-GM27160
DR   Wikidata; Q98128462
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VH43 ! GM27160
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   PACS1002i-GM27159
AC   CVCL_YZ39
DR   WiCell; pacs1002i-gm27159
DR   Wikidata; Q98128463
CC   Population: Caucasian and Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous; Note=De novo mutation (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VI93 ! GM27159
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   PACS1003i-GM27161
AC   CVCL_YZ40
DR   WiCell; pacs1003i-gm27161
DR   Wikidata; Q98128464
CC   Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous; Note=De novo mutation (from parent cell line).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150555; Schuurs-Hoeijmakers syndrome
DI   ORDO; Orphanet_329224; Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VI94 ! GM27161
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   PACSIIi001-A
AC   CVCL_D0KF
SY   PACS2iPS01-C5
DR   BioSamples; SAMEA112354707
DR   hPSCreg; PACSIIi001-A
DR   Wikidata; Q123033252
CC   From: PACS2 Research Foundation; Warsaw; Poland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PAE-20
AC   CVCL_UY89
SY   PAE 20; Porcine Aorta-derived Endothelial cell-20
DR   Wikidata; Q98128465
RX   PubMed=1367255;
RX   PubMed=1817644;
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   PAE-20cl-1
AC   CVCL_UY90
SY   PAE 20-cl-1; Porcine Aorta-derived Endothelial cell-20 clone-1
DR   Wikidata; Q98128466
RX   PubMed=1367255;
RX   PubMed=1817644;
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_UY89 ! PAE-20
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   PAE-iPS-1
AC   CVCL_E019
SY   Aries; PL-iPS-01
DR   GEO; GSM607993
DR   GEO; GSM607994
DR   GEO; GSM607995
DR   GEO; GSM608025
DR   SKIP; SKIP000352
DR   Wikidata; Q54937433
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   PAE-iPS-10
AC   CVCL_E020
SY   Capricornus; PL-iPS-10
DR   SKIP; SKIP000404
DR   Wikidata; Q54937434
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE-iPS-11
AC   CVCL_E021
SY   Aquarius; PL-iPS-11
DR   GEO; GSM520713
DR   GEO; GSM520714
DR   GEO; GSM520715
DR   GEO; GSM608000
DR   SKIP; SKIP000355
DR   Wikidata; Q54937436
RX   PubMed=21637780;
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PAE-iPS-12
AC   CVCL_E022
SY   Pisces; PL-iPS-12
DR   SKIP; SKIP000403
DR   Wikidata; Q54937437
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE-iPS-2
AC   CVCL_E023
SY   Taurus; PL-iPS-02
DR   SKIP; SKIP000397
DR   Wikidata; Q54937438
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE-iPS-3
AC   CVCL_E024
SY   Gemini; PL-iPS-03
DR   SKIP; SKIP000398
DR   Wikidata; Q54937439
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE-iPS-4
AC   CVCL_E025
SY   Cancer; PL-iPS-04
DR   GEO; GSM607996
DR   GEO; GSM607997
DR   SKIP; SKIP000353
DR   Wikidata; Q54937440
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   PAE-iPS-5
AC   CVCL_E026
SY   Leo; PL-iPS-05
DR   GEO; GSM607998
DR   GEO; GSM607999
DR   SKIP; SKIP000354
DR   Wikidata; Q54937441
RX   PubMed=21637780;
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PAE-iPS-6
AC   CVCL_E027
SY   Virgo; PL-iPS-06
DR   SKIP; SKIP000399
DR   Wikidata; Q54937442
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE-iPS-7
AC   CVCL_E028
SY   Libra; PL-iPS-07
DR   SKIP; SKIP000400
DR   Wikidata; Q54937443
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE-iPS-8
AC   CVCL_E029
SY   Scorpio; PL-iPS-08
DR   SKIP; SKIP000401
DR   Wikidata; Q54937444
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE-iPS-9
AC   CVCL_E030
SY   Sagittarius; PL-iPS-09
DR   SKIP; SKIP000402
DR   Wikidata; Q54937445
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D692 ! PAE551
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   PAE551
AC   CVCL_D692
SY   PL551Ar
DR   GEO; GSM520704
DR   GEO; GSM520705
DR   GEO; GSM520711
DR   GEO; GSM607992
DR   JCRB; JCRB1543
DR   Wikidata; Q54937446
RX   PubMed=21637780;
RX   PubMed=23631808;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
ST   Source(s): JCRB=JCRB1543; PubMed=21637780
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 6,9.3 (PubMed=21637780)
ST   TH01: 6,10 (JCRB=JCRB1543)
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8532 ! PL551SF
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   Paesun
AC   CVCL_UW74
DR   Wikidata; Q98128467
RX   PubMed=30711449;
CC   Virology: Used for the assessment of viral titers for vaccines.
CC   Anecdotal: Established in 1976 in the Democratic People's Republic of Korea and widely used there, but was not described in any publication before PubMed=30711449.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   PaF
AC   CVCL_XY57
SY   Pampus argenteus Fin
DR   Wikidata; Q98128468
RX   PubMed=31381181;
CC   Group: Fish cell line.
CC   Characteristics: Grows stably in a range of temperatures from 20 to 32 Celsius with a maximum growth rate of 28 Celsius.
CC   Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=206143; ! Pampus argenteus (Silver pomfret)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   PAF-R14
AC   CVCL_C4CH
DR   Wikidata; Q116050107
RX   Patent=EP0638648A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4723.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P25105; Human PTAFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   PaF4 IVE8
AC   CVCL_LB88
DR   CCRID; 4201PAT-CCTCC00018
DR   Wikidata; Q54937447
RX   Patent=GB2192185A;
RX   Patent=US4834976;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9129.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P72151; Pseudomonas aeruginosa B-type flagellin (fliC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 7
//
ID   PaFeT01
AC   CVCL_DR77
DR   Wikidata; Q54937448
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT02
AC   CVCL_DR78
DR   Wikidata; Q54937450
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT03
AC   CVCL_DR79
DR   Wikidata; Q54937451
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT04
AC   CVCL_DR80
DR   Wikidata; Q54937461
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT05
AC   CVCL_DR81
DR   Wikidata; Q54937462
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT06
AC   CVCL_DR82
DR   Wikidata; Q54937463
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT07
AC   CVCL_DR83
DR   Wikidata; Q54937464
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT08
AC   CVCL_DR84
DR   Wikidata; Q54937465
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR85 ! PaFeT09
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT09
AC   CVCL_DR85
DR   Wikidata; Q54937466
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR86 ! PaFeT10
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PaFeT10
AC   CVCL_DR86
DR   Wikidata; Q54937467
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR77 ! PaFeT01
OI   CVCL_DR78 ! PaFeT02
OI   CVCL_DR79 ! PaFeT03
OI   CVCL_DR80 ! PaFeT04
OI   CVCL_DR81 ! PaFeT05
OI   CVCL_DR82 ! PaFeT06
OI   CVCL_DR83 ! PaFeT07
OI   CVCL_DR84 ! PaFeT08
OI   CVCL_DR85 ! PaFeT09
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PAGRS-21
AC   CVCL_6640
SY   PA-GRS21; Grs-21
DR   Wikidata; Q54937468
RX   PubMed=2171916;
RX   PubMed=2845413;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   26D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   PAGRS-28
AC   CVCL_6641
SY   PA-GRS28; Grs-28
DR   Wikidata; Q54937469
RX   PubMed=2171916;
RX   PubMed=2845413;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   26D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   PAGS-6
AC   CVCL_W171
SY   PA-GS6
DR   Wikidata; Q54937470
RX   PubMed=2171916;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   25D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 7
//
ID   PAh1-1
AC   CVCL_D3QD
SY   217
DR   Wikidata; Q127383004
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10269.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P43237; Arachis hypogaea allergen Ara h 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PAh1-2
AC   CVCL_D3QE
SY   236
DR   Wikidata; Q127383005
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10270.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P43237; Arachis hypogaea allergen Ara h 1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PAh1-3
AC   CVCL_D3QF
SY   971
DR   Wikidata; Q127383006
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10270.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P43237; Arachis hypogaea allergen Ara h 1 (Note=Recognizes the heat denatured allergen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PAI
AC   CVCL_J288
SY   Ag8-PAI; PAIB3Ag8I; PA1
DR   JCRB; JCRB0113
DR   Wikidata; Q54937471
RX   CelloPub=CLPUB00097;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UZ12 ! P3-Ag8-gamma1-
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   PAI-0
AC   CVCL_Z070
SY   PAI-O; PAIO
DR   Wikidata; Q54937472
RX   CelloPub=CLPUB00097;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   Paju
AC   CVCL_U415
DR   Wikidata; Q54937473
RX   PubMed=6436232;
RX   PubMed=15218547;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-241.html
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   PaKiS
AC   CVCL_YM14
DR   Wikidata; Q98128469
RX   PubMed=33106404;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR87 ! PaKiT01
OI   CVCL_DR88 ! PaKiT02
OI   CVCL_DR89 ! PaKiT03
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   PaKiT01
AC   CVCL_DR87
DR   Wikidata; Q54937474
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_YM14 ! PaKiS
OI   CVCL_DR88 ! PaKiT02
OI   CVCL_DR89 ! PaKiT03
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PaKiT02
AC   CVCL_DR88
DR   Wikidata; Q54937475
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_YM14 ! PaKiS
OI   CVCL_DR87 ! PaKiT01
OI   CVCL_DR89 ! PaKiT03
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PaKiT03
AC   CVCL_DR89
DR   BioSample; SAMN04335741
DR   BioSample; SAMN04335743
DR   BioSample; SAMN04335748
DR   PRIDE; PXD001165
DR   Wikidata; Q54937476
RX   PubMed=20011515;
RX   PubMed=25398248;
RX   PubMed=26535029;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_YM14 ! PaKiS
OI   CVCL_DR87 ! PaKiT01
OI   CVCL_DR88 ! PaKiT02
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   Pal Man
AC   CVCL_X709
DR   ATCC; CRL-1116
DR   Wikidata; Q54937477
RX   PubMed=273925;
CC   Discontinued: ATCC; CRL-1116; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 8
//
ID   Pal-1
AC   CVCL_X749
SY   PAL-1; Pyothorax-associated lymphoma-1
DR   Wikidata; Q54937478
RX   PubMed=12028021;
RX   PubMed=17488335;
RX   PubMed=18079737;
CC   Population: Japanese.
CC   Virology: The Epstein-Barr virus genome is integrated in chromosome 1 of the cellular genome (PubMed=12028021).
CC   Doubling time: 48 hours (PubMed=12028021).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 27-11-25; Version: 9
//
ID   Pal-2
AC   CVCL_F1CC
SY   Pyothorax-associated lymphoma-2
RX   PubMed=23972300;
CC   Population: Japanese.
CC   Characteristics: Tumorigenic in nude mice (PubMed=23972300).
CC   Virology: Contains biclonal EBV genomes (PubMed=23972300).
CC   Doubling time: 48 hours (PubMed=23972300).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C45691; Pyothorax-associated lymphoma
DI   ORDO; Orphanet_300888; Diffuse large B-cell lymphoma with chronic inflammation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PAL-M1
AC   CVCL_XH03
DR   Wikidata; Q98128470
RX   PubMed=2366002;
RX   PubMed=3891875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   PAL-M2
AC   CVCL_XH04
DR   Wikidata; Q98128472
RX   PubMed=3891875;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on melanoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 4
//
ID   PAL1.K
AC   CVCL_S318
DR   ATCC; CRL-6292
DR   Wikidata; Q54937479
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6292; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9689; ! Panthera leo (Lion)
OI   CVCL_S319 ! PAL1.Ln
OI   CVCL_S320 ! PAL1.Ov
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   PAL1.Ln
AC   CVCL_S319
DR   ATCC; CRL-6293
DR   Wikidata; Q54937480
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6293; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9689; ! Panthera leo (Lion)
OI   CVCL_S318 ! PAL1.K
OI   CVCL_S320 ! PAL1.Ov
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 7
//
ID   PAL1.Ov
AC   CVCL_S320
DR   ATCC; CRL-6294
DR   Wikidata; Q54937481
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6294; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9689; ! Panthera leo (Lion)
OI   CVCL_S318 ! PAL1.K
OI   CVCL_S319 ! PAL1.Ln
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Pala
AC   CVCL_9W19
DR   Wikidata; Q54937482
RX   PubMed=1373173;
RX   PubMed=6160591;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   PALL-1
AC   CVCL_D694
SY   PALL-I; PALL1; Ph1-positive Acute Lymphoblastic Leukemia-1
DR   Wikidata; Q54937483
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2732004;
RX   PubMed=8428799;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=8428799; PubMed=10071072).
CC   Caution: Indicated as originating from a 23 year old male patient in PubMed=2732004 and from a 20 year old male patient in PubMed=8428799.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   PALL-2
AC   CVCL_3122
SY   PALL2; Ph1-positive Acute Lymphoblastic Leukemia-2
DR   JCRB; JCRB1345
DR   JCRB; NIHS0546
DR   SKIP; SKIP000748
DR   Wikidata; Q54937484
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8428799;
RX   PubMed=10071072;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=8428799; PubMed=10071072).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.His554Gln (c.1662C>G); ClinVar=VCV001680176; Zygosity=Heterozygous (PubMed=35124168).
CC   Discontinued: JCRB; NIHS0546; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1345
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   PaLuT01
AC   CVCL_DR90
DR   Wikidata; Q54937485
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR91 ! PaLuT02
OI   CVCL_DR92 ! PaLuT03
OI   CVCL_DR93 ! PaLuT04
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PaLuT02
AC   CVCL_DR91
DR   Wikidata; Q54937486
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR90 ! PaLuT01
OI   CVCL_DR92 ! PaLuT03
OI   CVCL_DR93 ! PaLuT04
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PaLuT03
AC   CVCL_DR92
DR   Wikidata; Q54937487
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR90 ! PaLuT01
OI   CVCL_DR91 ! PaLuT02
OI   CVCL_DR93 ! PaLuT04
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PaLuT04
AC   CVCL_DR93
DR   Wikidata; Q54937488
RX   PubMed=20011515;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9402; ! Pteropus alecto (Black flying fox)
OI   CVCL_DR90 ! PaLuT01
OI   CVCL_DR91 ! PaLuT02
OI   CVCL_DR92 ! PaLuT03
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   Pam 212
AC   CVCL_7694
SY   PAM 212; PAM212; Pam212; PAM 2-12; 212
DR   BTO; BTO_0005067
DR   ChEMBL-Cells; CHEMBL3307343
DR   ChEMBL-Targets; CHEMBL614231
DR   Lonza; 453
DR   PubChem_Cell_line; CVCL_7694
DR   TOKU-E; 4030
DR   Wikidata; Q54937489
RX   PubMed=7438101;
RX   PubMed=7636305;
RX   PubMed=9247255;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-242.html
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   <1D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Pam LU-1
AC   CVCL_Z592
SY   PAM LU1; LU-1
DR   Wikidata; Q54937490
RX   PubMed=9247255;
CC   Characteristics: Established from the lung tumor of athymic nude BALB/c mice inoculated with the parent cell line (PubMed=9247255).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7694 ! Pam 212
SX   Male
AG   <1D
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Pam LY-1
AC   CVCL_Z593
SY   PAM LY1
DR   Wikidata; Q54937491
RX   PubMed=9247255;
CC   Characteristics: Established from the lymph node of athymic nude BALB/c mice inoculated with the parent cell line (PubMed=9247255).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7694 ! Pam 212
SX   Male
AG   <1D
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Pam LY-2
AC   CVCL_Z594
SY   PAM LY2; PAM-LY2; LY-2
DR   Lonza; 982
DR   Wikidata; Q54937492
RX   PubMed=9247255;
CC   Characteristics: Established from the lymph node of athymic nude BALB/c mice inoculated with the parent cell line (PubMed=9247255).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7694 ! Pam 212
SX   Male
AG   <1D
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   PAM-1
AC   CVCL_XI17
SY   Clone 103/51; 103/51
DR   Wikidata; Q98128473
RX   PubMed=10188724;
RX   PubMed=11502861;
RX   PubMed=15719499;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; Q92896; Human GLG1/CFR1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   PAM-pCD163
AC   CVCL_VG78
SY   IPAM-CD163
DR   Wikidata; Q54937493
RX   PubMed=19900480;
RX   PubMed=28871180;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus type 1 and type 2 (PRRSV-1/2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0F14 ! IPAM 3D4/21
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   PAM-KNU-1
AC   CVCL_E5UQ
SY   PAM-KNU; Porcine Alveolar Macrophage-Kyungpook National University-1
DR   ABM; T0741
RX   PubMed=21889956;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_E5UR ! PAM-KNU-2
OI   CVCL_E5US ! PAM-KNU-3
OI   CVCL_E5UT ! PAM-KNU-4
SX   Sex unspecified
AG   8W
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PAM-KNU-2
AC   CVCL_E5UR
SY   Porcine Alveolar Macrophage-Kyungpook National University-2
RX   PubMed=21889956;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_E5UQ ! PAM-KNU-1
OI   CVCL_E5US ! PAM-KNU-3
OI   CVCL_E5UT ! PAM-KNU-4
SX   Sex unspecified
AG   8W
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PAM-KNU-3
AC   CVCL_E5US
SY   Porcine Alveolar Macrophage-Kyungpook National University-3
RX   PubMed=21889956;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_E5UQ ! PAM-KNU-1
OI   CVCL_E5UR ! PAM-KNU-2
OI   CVCL_E5UT ! PAM-KNU-4
SX   Sex unspecified
AG   8W
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PAM-KNU-4
AC   CVCL_E5UT
SY   Porcine Alveolar Macrophage-Kyungpook National University-4
RX   PubMed=21889956;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_E5UQ ! PAM-KNU-1
OI   CVCL_E5UR ! PAM-KNU-2
OI   CVCL_E5US ! PAM-KNU-3
SX   Sex unspecified
AG   8W
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PAM-T43
AC   CVCL_E7AQ
RX   PubMed=39770286;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) field strains (PubMed=39770286).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   2-3W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PAMC82
AC   CVCL_H271
SY   PAMC-82
DR   Cosmic; 2484975
DR   GEO; GSM1374805
DR   Wikidata; Q54937495
RX   PubMed=11351862;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   Pan-02-Luc
AC   CVCL_D7FV
DR   Ubigene; YC-C067-Luc-P
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   PAN-03-JCK
AC   CVCL_B454
SY   PAN-3-JCK; PAN03JCK
DR   cancercelllines; CVCL_B454
DR   Cosmic; 707258
DR   Cosmic; 1066190
DR   IARC_TP53; 14304
DR   Wikidata; Q54937496
RX   PubMed=7691144;
RX   PubMed=11115575;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Hemizygous (PubMed=11115575).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Gly (c.844C>G); ClinVar=VCV000140821; Zygosity=Unspecified (PubMed=11115575).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   PAN-07-JCK
AC   CVCL_B455
SY   PAN07JCK
DR   Cosmic; 1066191
DR   Wikidata; Q54937497
RX   PubMed=19265263;
CC   Population: Japanese.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   PAN-08-JCK
AC   CVCL_B456
SY   PAN08JCK
DR   Cosmic; 1066192
DR   Wikidata; Q54937498
CC   Population: Japanese.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   PAN-09-JCK
AC   CVCL_B457
SY   PAN09JCK
DR   Cosmic; 1066193
DR   Wikidata; Q54937499
CC   Population: Japanese.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Pan2M
AC   CVCL_A1II
DR   cancercelllines; CVCL_A1II
DR   Wikidata; Q102114732
RX   PubMed=30747829;
CC   Population: Japanese.
CC   Characteristics: Metastatic. Established from the orthopical implementation of the parent cell line in BALB/c nu/nu nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>A (IVS9+1G>A); ClinVar=VCV000528261; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3178 ! TCC-Pan2
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   Pan2MmLuc
AC   CVCL_A1IJ
DR   cancercelllines; CVCL_A1IJ
DR   JCRB; NIHS1359
DR   Wikidata; Q102114733
RX   PubMed=30747829;
CC   Population: Japanese.
CC   Characteristics: Metastatic. Established from the orthopical implementation of the TCC-pan2 cell line in BALB/c nu/nu nude mice.
CC   Doubling time: ~24 hours (PubMed=30747829).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=30747829).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=30747829).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=30747829).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>A (IVS9+1G>A); ClinVar=VCV000528261; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30747829).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS1359; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1II ! Pan2M
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 10
//
ID   Panc 01.28
AC   CVCL_7666
SY   Panc 1.28; Panc1.28
DR   ATCC; CRL-2548
DR   BioSample; SAMN03471609
DR   BioSample; SAMN06481121
DR   Wikidata; Q54937500
RX   PubMed=9612602;
RX   PubMed=18000365;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00519.
CC   Discontinued: ATCC; CRL-2548; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2548
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7664 ! Panc 04.21
OI   CVCL_7665 ! Panc 06.03
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   Panc 02.02
AC   CVCL_U875
SY   Panc 2.02
DR   Wikidata; Q54937501
RX   PubMed=18000365;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Panc 02.03
AC   CVCL_1633
AS   CVCL_H597
SY   PANC-02-03; Panc_02_03; Panc02.03; Panc 2.03; Panc2.03; Panc2_03; PANC 203; Panc203; PANC203; PANC0203; Panc0203
DR   CLO; CLO_0008374
DR   EFO; EFO_0006466
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2553
DR   BioGRID_ORCS_Cell_line; 491
DR   BioSample; SAMN03473181
DR   BioSample; SAMN10987714
DR   cancercelllines; CVCL_1633
DR   Cell_Model_Passport; SIDM01139
DR   ChEMBL-Cells; CHEMBL3307761
DR   ChEMBL-Targets; CHEMBL612584
DR   Cosmic; 2009528
DR   Cosmic; 2434088
DR   Cosmic-CLP; 1298475
DR   DepMap; ACH-000042
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298475
DR   GEO; GSM206527
DR   GEO; GSM621891
DR   GEO; GSM887494
DR   GEO; GSM888576
DR   GEO; GSM1024405
DR   GEO; GSM1374810
DR   GEO; GSM1670331
DR   IARC_TP53; 28226
DR   LiGeA; CCLE_407
DR   LINCS_LDP; LCL-1739
DR   PharmacoDB; Panc02_03_1239_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1633
DR   PubChem_Cell_line; CVCL_1633
DR   Wikidata; Q54937512
RX   PubMed=9612602;
RX   PubMed=18000365;
RX   PubMed=20037478;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Doubling time: 28.2 hours (PubMed=9612602).
CC   HLA typing: A*02:05,31:01; B*08:01,49:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; Cosmic-CLP=1298475; DepMap=ACH-000042).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=1298475; DepMap=ACH-000042).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.78%; Native American=0.75%; East Asian, North=2.77%; East Asian, South=0%; South Asian=0%; European, North=59.53%; European, South=35.18% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2553; Cosmic-CLP=1298475; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,16
ST   D21S11: 28,31
ST   D2S1338: 19,20
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 11,12
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 5,7
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   Panc 02.05
AC   CVCL_E278
AS   CVCL_U876
SY   Panc 2.05; PANC 2.5; Panc2.5; Pa21C
DR   Cosmic; 1473043
DR   Cosmic; 1509862
DR   GEO; GSM823384
DR   Wikidata; Q54937513
RX   PubMed=18000365;
RX   PubMed=22753594;
RX   PubMed=24810906;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   Panc 02.05-EYA2
AC   CVCL_C3HL
SY   Panc2.05-EYA2
DR   GEO; GSM823386
DR   Wikidata; Q114312643
RX   PubMed=24810906;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3520; EYA2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E278 ! Panc 02.05
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   Panc 02.08
AC   CVCL_E277
AS   CVCL_U877
SY   Panc 2.08; PANC 2.8; Panc2.8; Panc2_8; Pa104C
DR   Cosmic; 949523
DR   Cosmic; 1509880
DR   Wikidata; Q54937514
RX   PubMed=18000365;
RX   PubMed=22753594;
RX   PubMed=24810906;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   Panc 02.13
AC   CVCL_1634
SY   Panc 2.13; Panc-02.13; PANC-02-13; Panc2.13; PANC0213; PL1; PL-1
DR   CLO; CLO_0008375
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2554
DR   BioSample; SAMN03472905
DR   BioSample; SAMN10987902
DR   cancercelllines; CVCL_1634
DR   Cell_Model_Passport; SIDM01325
DR   DepMap; ACH-000031
DR   GEO; GSM887495
DR   GEO; GSM888577
DR   GEO; GSM1024406
DR   IARC_TP53; 28234
DR   LiGeA; CCLE_679
DR   PharmacoDB; Panc02_13_1240_2019
DR   Progenetix; CVCL_1634
DR   Wikidata; Q54937515
RX   PubMed=9612602;
RX   PubMed=14695172;
RX   PubMed=16912165;
RX   PubMed=18000365;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25877200;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Doubling time: 33.9 hours (PubMed=9612602).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000045115; Zygosity=Heterozygous (DepMap=ACH-000031).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (DepMap=ACH-000031).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.03%; Native American=0.98%; East Asian, North=0.28%; East Asian, South=0%; South Asian=0.04%; European, North=63.98%; European, South=32.69% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2554; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 11
ST   D19S433: 13.2,14
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 7,11
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   Penta D: 12
ST   Penta E: 8,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   Panc 02.43
AC   CVCL_E282
SY   PANC 2.43; Panc2.43; Pa113C
DR   Cosmic; 1473018
DR   Cosmic; 1509882
DR   Wikidata; Q54937516
RX   PubMed=18000365;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   Panc 03.27
AC   CVCL_1635
AS   CVCL_H601
SY   Panc 3.27; Panc-03.27; PANC-03-27; Panc_03_27; Panc-3_27; PANC3.27; Panc3.27; Panc3_27; Panc-327; PANC 327; Panc327; PANC0327; Panc0327; PL11; PL-11
DR   CLO; CLO_0008376
DR   EFO; EFO_0006467
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2549
DR   BioGRID_ORCS_Cell_line; 188
DR   BioSample; SAMN03473169
DR   BioSample; SAMN10988317
DR   cancercelllines; CVCL_1635
DR   Cell_Model_Passport; SIDM01138
DR   ChEMBL-Cells; CHEMBL3308124
DR   ChEMBL-Targets; CHEMBL1075557
DR   Cosmic; 925346
DR   Cosmic; 949522
DR   Cosmic; 1198222
DR   Cosmic; 2434102
DR   Cosmic-CLP; 925346
DR   DepMap; ACH-000139
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 925346
DR   GEO; GSM206528
DR   GEO; GSM621904
DR   GEO; GSM784705
DR   GEO; GSM887496
DR   GEO; GSM888578
DR   GEO; GSM1024407
DR   GEO; GSM1374811
DR   GEO; GSM1670332
DR   IARC_TP53; 27226
DR   LiGeA; CCLE_371
DR   LINCS_LDP; LCL-1740
DR   PharmacoDB; Panc03_27_1241_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1635
DR   PubChem_Cell_line; CVCL_1635
DR   Wikidata; Q54937517
RX   PubMed=9612602;
RX   PubMed=14695172;
RX   PubMed=16912165;
RX   PubMed=18000365;
RX   PubMed=19305140;
RX   PubMed=20037478;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Doubling time: 37.5 hours (PubMed=9612602); 51 hours (PubMed=25984343).
CC   HLA typing: A*02:01,24:02; B*07:02,56:01; C*01:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Unexplicit; Ex7-14; Zygosity=Homozygous (PubMed=19305140).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (ATCC=CRL-2549; Cosmic-CLP=925346; DepMap=ACH-000139).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.375+5G>T; ClinVar=VCV000634777; Zygosity=Homozygous (Cosmic-CLP=925346).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.16%; Native American=0%; East Asian, North=2.19%; East Asian, South=0%; South Asian=0.9%; European, North=56.57%; European, South=39.18% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2549; Cosmic-CLP=925346; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 18
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 17,26
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,13
ST   D8S1179: 13,14
ST   FGA: 22,26
ST   Penta D: 10,15
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   Panc 04.03
AC   CVCL_1636
SY   PANC-04-03; Panc_04_03; Panc04.03; Panc 4.03; PANC 4.03; Panc4.03; PANC0403; Panc0403; PANC403; Pa17C; Pa017C; PL5; PL-5; PL 5
DR   CLO; CLO_0008377
DR   EFO; EFO_0006468
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2555
DR   BioGRID_ORCS_Cell_line; 490
DR   BioSample; SAMN03473168
DR   BioSample; SAMN10988264
DR   cancercelllines; CVCL_1636
DR   Cell_Model_Passport; SIDM01137
DR   Cosmic; 1198213
DR   Cosmic; 1509872
DR   Cosmic; 2434101
DR   Cosmic-CLP; 1298476
DR   DepMap; ACH-000235
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298476
DR   GEO; GSM206529
DR   GEO; GSM621892
DR   GEO; GSM887497
DR   GEO; GSM888579
DR   GEO; GSM1024408
DR   GEO; GSM1374812
DR   GEO; GSM1435684
DR   GEO; GSM1435685
DR   GEO; GSM1435686
DR   GEO; GSM1670333
DR   IARC_TP53; 28220
DR   LiGeA; CCLE_793
DR   LINCS_LDP; LCL-1741
DR   PharmacoDB; Panc04_03_1242_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1636
DR   Wikidata; Q54937518
RX   PubMed=9612602;
RX   PubMed=16912165;
RX   PubMed=18000365;
RX   PubMed=20037478;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22753594;
RX   PubMed=23637631;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Doubling time: 50.5 hours (PubMed=9612602).
CC   HLA typing: A*32:01,32:01; B*27:05,27:05; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16935; ATG7 + HGNC; HGNC:9829; RAF1; Name(s)=ATG7-RAF1 (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556fs*3 (c.4660_4661insA) (E1554fs); Zygosity=Heterozygous (Cosmic-CLP=1298476; DepMap=ACH-000235).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; ATCC=CRL-2555; Cosmic-CLP=1298476; DepMap=ACH-000235).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (Cosmic-CLP=1298476; DepMap=ACH-000235).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.36%; Native American=0.03%; East Asian, North=3.59%; East Asian, South=0%; South Asian=1.72%; European, North=75.12%; European, South=19.17% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2555; Cosmic-CLP=1298476; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,16 (ATCC=CRL-2555)
ST   D18S51: 16 (PubMed=25877200)
ST   D19S433: 15
ST   D21S11: 28 (PubMed=25877200)
ST   D21S11: 28,29 (ATCC=CRL-2555)
ST   D2S1338: 18,19
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 10,15
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 13,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 14,16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Panc 04.03 MAP2K4(-/-)
AC   CVCL_HE14
SY   MAP2K4 (-/-) Panc 04.03; MKK4-/- cells
DR   cancercelllines; CVCL_HE14
DR   Horizon_Discovery; HD+109-002
DR   Wikidata; Q54937519
RX   PubMed=16740690;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16935; ATG7 + HGNC; HGNC:9829; RAF1; Name(s)=ATG7-RAF1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556fs*3 (c.4660_4661insA) (E1554fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1636 ! Panc 04.03
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   Panc 04.14
AC   CVCL_U872
SY   Panc 4.14; PL3; PL-3
DR   Wikidata; Q54937521
RX   PubMed=14695172;
RX   PubMed=16912165;
RX   PubMed=18000365;
RX   PubMed=20037478;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   Panc 04.21
AC   CVCL_7664
SY   Panc 4.21; Panc-04.21; Panc4.21
DR   ATCC; CRL-2556
DR   Wikidata; Q54937523
RX   PubMed=9612602;
RX   PubMed=18000365;
CC   Problematic cell line: Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Doubling time: 36.0 hours (PubMed=9612602).
CC   Discontinued: ATCC; CRL-2556; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2556
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7666 ! Panc 01.28
OI   CVCL_7665 ! Panc 06.03
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Panc 05.04
AC   CVCL_1637
AS   CVCL_X507
SY   Panc-05.04; Panc_05_04; Panc05.04; Panc 5.04; Panc5.04; PANC0504; Panc0504; Pa18C; PL-18; PL18
DR   CLO; CLO_0008378
DR   EFO; EFO_0006469
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2557
DR   BioSample; SAMN03473170
DR   BioSample; SAMN10988160
DR   cancercelllines; CVCL_1637
DR   Cell_Model_Passport; SIDM00054
DR   Cell_Model_Passport; SIDM01777
DR   Cosmic; 1473038
DR   Cosmic; 1509860
DR   Cosmic; 2434083
DR   Cosmic-CLP; 1240208
DR   DepMap; ACH-000093
DR   DepMap; ACH-002185
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240208
DR   GEO; GSM206530
DR   GEO; GSM621931
DR   GEO; GSM887498
DR   GEO; GSM888580
DR   GEO; GSM1024409
DR   GEO; GSM1435687
DR   GEO; GSM1435688
DR   GEO; GSM1435689
DR   GEO; GSM1670350
DR   IARC_TP53; 30143
DR   LiGeA; CCLE_637
DR   PharmacoDB; Panc05_04_1243_2019
DR   PharmacoDB; PL18_1271_2019
DR   PRIDE; PXD003198
DR   Progenetix; CVCL_1637
DR   Wikidata; Q54937525
RX   PubMed=9612602;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22753594;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Partially contaminated. Some stocks of this cell line such as the one used by Sanger cell line project were contaminated with a OCUG-1 derivative as shown by STR profile and SNP fingerprinting analysis (DepMap).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00614.
CC   Population: Caucasian.
CC   Doubling time: 46.0 hours (PubMed=9612602).
CC   HLA typing: A*02:06,11:01; B*27:05,55:01; C*03:03,03:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; DepMap=ACH-000093).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.48%; East Asian, South=0%; South Asian=2.41%; European, North=67.06%; European, South=30.05% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2557; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 28,33.2
ST   D2S1338: 17
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 11,13
ST   FGA: 19,23
ST   Penta D: 7,9
ST   Penta E: 5,18
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 15,20
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   Panc 06.03
AC   CVCL_7665
SY   Panc-06.03; Panc 6.03; PANC 6.03; Panc6.03; Pa19C; Pa019C
DR   ATCC; CRL-2550
DR   BioSample; SAMN06481122
DR   cancercelllines; CVCL_7665
DR   Cosmic; 1473096
DR   Cosmic; 1509873
DR   Wikidata; Q54937527
RX   PubMed=9612602;
RX   PubMed=14695172;
RX   PubMed=18000365;
RX   PubMed=22753594;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00521.
CC   Doubling time: 34.0 hours (PubMed=9612602).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (ATCC=CRL-2550).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-2550; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2550
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7666 ! Panc 01.28
OI   CVCL_7664 ! Panc 04.21
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Panc 08.13
AC   CVCL_1638
AS   CVCL_H599
SY   Panc 8.13; Panc-08.13; PANC-08-13; Panc_08_13; Panc08.13; Panc8.13; Panc-8_13; Panc-813; PANC 813; Panc813; PANC813; PANC0813; Panc0813; Pa14C; PL9; PL-9
DR   CLO; CLO_0008379
DR   EFO; EFO_0006470
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2551
DR   BioGRID_ORCS_Cell_line; 189
DR   BioSample; SAMN03472947
DR   BioSample; SAMN10988145
DR   cancercelllines; CVCL_1638
DR   Cell_Model_Passport; SIDM01136
DR   ChEMBL-Cells; CHEMBL3308777
DR   ChEMBL-Targets; CHEMBL1075558
DR   Cosmic; 925347
DR   Cosmic; 949526
DR   Cosmic; 1198215
DR   Cosmic; 1198221
DR   Cosmic; 1473126
DR   Cosmic; 1509858
DR   Cosmic; 2434104
DR   Cosmic-CLP; 925347
DR   DepMap; ACH-000417
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 925347
DR   GEO; GSM206531
DR   GEO; GSM621905
DR   GEO; GSM784709
DR   GEO; GSM827278
DR   GEO; GSM887499
DR   GEO; GSM888581
DR   GEO; GSM1024410
DR   GEO; GSM1374813
DR   GEO; GSM1670334
DR   LiGeA; CCLE_501
DR   LINCS_LDP; LCL-1742
DR   PharmacoDB; Panc08_13_1244_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1638
DR   PubChem_Cell_line; CVCL_1638
DR   Wikidata; Q54937528
RX   PubMed=9612602;
RX   PubMed=14695172;
RX   PubMed=16912165;
RX   PubMed=18000365;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22753594;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Doubling time: 20.0 hours (PubMed=9612602); 117 hours (PubMed=25984343).
CC   HLA typing: A*02:01,02:01; B*07:02,15:40; C*02:02,05:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=9612602; ATCC=CRL-2551).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Cys123Metfs*2 (c.366dupA) (c.366_367insA); Zygosity=Homozygous (ATCC=CRL-2551).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.26%; Native American=0.57%; East Asian, North=2.49%; East Asian, South=0%; South Asian=0%; European, North=62.31%; European, South=32.37% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2551; Cosmic-CLP=925347; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 13
ST   D18S51: 19
ST   D19S433: 13
ST   D21S11: 32.2
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 13,14
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 21,23
ST   Penta D: 10
ST   Penta E: 5,16,17
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Panc 09.06
AC   CVCL_U873
SY   Panc 9.06; Panc9.06; Panc9_06; PL13; PL-13
DR   ATCC; CRL-2552
DR   BioSample; SAMN03471670
DR   cancercelllines; CVCL_U873
DR   Cosmic; 949520
DR   Cosmic; 1198217
DR   Wikidata; Q54937529
RX   PubMed=9612602;
RX   PubMed=16912165;
RX   PubMed=18000365;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Doubling time: 34.3 hours (PubMed=9612602).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=9612602).
CC   Discontinued: ATCC; CRL-2552; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2552
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 11,14
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   Panc 09.06.94
AC   CVCL_E297
SY   PANC 9.6.94; Panc9.6.94; Pa221C
DR   Cosmic; 1473044
DR   Cosmic; 1509959
DR   Wikidata; Q54937530
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U873 ! Panc 09.06
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 12
//
ID   Panc 10.05
AC   CVCL_1639
AS   CVCL_H600
SY   Panc-10.05; Panc10.05; PANC-10-05; PANC 1005; PANC1005; Panc1005; Pa16C; PL12; PL-12
DR   CLO; CLO_0008380
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2547
DR   BioGRID_ORCS_Cell_line; 489
DR   BioSample; SAMN10988227
DR   cancercelllines; CVCL_1639
DR   Cell_Model_Passport; SIDM01135
DR   ChEMBL-Cells; CHEMBL3307991
DR   ChEMBL-Targets; CHEMBL612583
DR   CLS; 300599
DR   Cosmic; 925348
DR   Cosmic; 1198216
DR   Cosmic; 1473147
DR   Cosmic; 1509859
DR   Cosmic; 2046532
DR   Cosmic; 2434097
DR   Cosmic-CLP; 925348
DR   DepMap; ACH-000060
DR   EGA; EGAS00001000978
DR   GDSC; 925348
DR   GEO; GSM206533
DR   GEO; GSM784707
DR   GEO; GSM887500
DR   GEO; GSM888582
DR   GEO; GSM1024412
DR   GEO; GSM1374809
DR   GEO; GSM1435690
DR   GEO; GSM1435691
DR   GEO; GSM1435692
DR   GEO; GSM1670335
DR   IARC_TP53; 27227
DR   LiGeA; CCLE_911
DR   LINCS_LDP; LCL-1743
DR   PharmacoDB; Panc10_05_1245_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1639
DR   PubChem_Cell_line; CVCL_1639
DR   Wikidata; Q54937531
RX   PubMed=9612602;
RX   PubMed=18000365;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22753594;
RX   PubMed=25167228;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Population: Caucasian.
CC   Doubling time: 19.2 hours (PubMed=9612602); 30 hours (PubMed=25984343).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9612602; ATCC=CRL-2547; Cosmic-CLP=925348; DepMap=ACH-000060).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Asn (c.764T>A); ClinVar=VCV000232289; Zygosity=Homozygous (Cosmic-CLP=925348; DepMap=ACH-000060).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.61%; Native American=1.14%; East Asian, North=0.96%; East Asian, South=0%; South Asian=0.11%; European, North=66.18%; European, South=31% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-2547; CLS=300599; Cosmic-CLP=925348
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,20
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17,18
ST   D3S1358: 14
ST   D5S818: 13
ST   D6S1043: 17
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3567 ! PL45
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   Panc 10.05/Cas9-hyg
AC   CVCL_C9DS
DR   GeneCopoeia; SL570
DR   Wikidata; Q123033255
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL570).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Asn (c.764T>A); ClinVar=VCV000232289; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1639 ! Panc 10.05
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   PANC 1002
AC   CVCL_E283
SY   Panc1002; Pa231C
DR   Wikidata; Q54937533
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   Panc 12.01
AC   CVCL_Y004
DR   cancercelllines; CVCL_Y004
DR   Wikidata; Q54937532
RX   PubMed=9612602;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=9612602).
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 7
//
ID   PANC 185
AC   CVCL_E284
SY   Panc185; Pa37C
DR   Wikidata; Q54937535
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 198
AC   CVCL_E285
SY   Panc198; Pa20C
DR   Cosmic; 1473061
DR   Cosmic; 1509861
DR   Wikidata; Q54937536
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 215
AC   CVCL_E286
SY   Panc215; Pa09C
DR   Cosmic; 1473090
DR   Cosmic; 1509855
DR   Wikidata; Q54937538
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 233
AC   CVCL_E300
SY   Panc233; Pa223C
DR   Cosmic; 1477298
DR   Cosmic; 1509961
DR   Wikidata; Q54937539
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PANC 247
AC   CVCL_E287
SY   Panc247; Pa34C
DR   Wikidata; Q54937540
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 253
AC   CVCL_E288
SY   Panc253; Pa39C
DR   Wikidata; Q54937541
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   Panc 3.014
AC   CVCL_E298
SY   PANC 3.014; Panc3.014; 3.014; Pa28C
DR   Cosmic; 1473074
DR   Cosmic; 1509863
DR   GEO; GSM823387
DR   Wikidata; Q54937542
RX   PubMed=22753594;
RX   PubMed=24810906;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   Panc 3.014-EYA2
AC   CVCL_C3HK
SY   Panc3.014-EYA2
DR   GEO; GSM823390
DR   GEO; GSM823391
DR   Wikidata; Q114312644
RX   PubMed=24810906;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3520; EYA2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E298 ! Panc 3.014
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   PANC 430
AC   CVCL_H598
SY   Panc430; Panc-4_30
DR   ChEMBL-Cells; CHEMBL3307680
DR   ChEMBL-Targets; CHEMBL614673
DR   Cosmic; 1198223
DR   PubChem_Cell_line; CVCL_H598
DR   Wikidata; Q54937543
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   PANC 480
AC   CVCL_E289
SY   Panc480; Pa102C
DR   Cosmic; 1509879
DR   Wikidata; Q54937544
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 486
AC   CVCL_E290
SY   Panc486; Pa222C
DR   Cosmic; 1473045
DR   Cosmic; 1509960
DR   Wikidata; Q54937545
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 502
AC   CVCL_E291
SY   Panc502; Pa227C
DR   Wikidata; Q54937546
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 503
AC   CVCL_E292
SY   Panc503; Pa228C
DR   Wikidata; Q54937547
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC 504
AC   CVCL_E293
SY   Panc504; Pa229C
DR   Wikidata; Q54937548
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 10
//
ID   PANC-1
AC   CVCL_0480
SY   Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P
DR   BCGO; BCGO_0000122
DR   BTO; BTO_0000304
DR   CLO; CLO_0008381
DR   CLO; CLO_0050102
DR   EFO; EFO_0002713
DR   MCCL; MCC:0000378
DR   CLDB; cl3872
DR   CLDB; cl3873
DR   CLDB; cl3874
DR   4DN; 4DNSRDQPS1VU
DR   AddexBio; C0018010/4923
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-1469
DR   BCRC; 60284
DR   BCRJ; 0201
DR   BioGRID_ORCS_Cell_line; 190
DR   BioSample; SAMN01821587
DR   BioSample; SAMN03472068
DR   BioSample; SAMN05292439
DR   BioSample; SAMN10987682
DR   cancercelllines; CVCL_0480
DR   CCRID; 1101HUM-PUMC000023
DR   CCRID; 3101HUMSCSP535
DR   CCRID; 3101HUMTCHu98
DR   CCRID; 4201HUM-CCTCC00309
DR   CCRID; 5301HUM-KCB08009YJ
DR   CCTCC; GDC0309
DR   Cell_Model_Passport; SIDM00610
DR   CGH-DB; 180-1
DR   CGH-DB; 9267-4
DR   ChEMBL-Cells; CHEMBL3307545
DR   ChEMBL-Targets; CHEMBL614139
DR   CLS; 300228
DR   Cosmic; 707250
DR   Cosmic; 710864
DR   Cosmic; 724643
DR   Cosmic; 730533
DR   Cosmic; 753625
DR   Cosmic; 808171
DR   Cosmic; 868242
DR   Cosmic; 873000
DR   Cosmic; 913307
DR   Cosmic; 918054
DR   Cosmic; 922248
DR   Cosmic; 923171
DR   Cosmic; 932521
DR   Cosmic; 947397
DR   Cosmic; 948377
DR   Cosmic; 949235
DR   Cosmic; 968106
DR   Cosmic; 1006367
DR   Cosmic; 1108335
DR   Cosmic; 1122348
DR   Cosmic; 1198204
DR   Cosmic; 1299304
DR   Cosmic; 1320459
DR   Cosmic; 1366282
DR   Cosmic; 1477432
DR   Cosmic; 1518236
DR   Cosmic; 1534320
DR   Cosmic; 1571781
DR   Cosmic; 1609544
DR   Cosmic; 1644316
DR   Cosmic; 1768264
DR   Cosmic; 2434107
DR   Cosmic; 2546060
DR   Cosmic; 2664043
DR   Cosmic; 2755953
DR   DepMap; ACH-000164
DR   DSMZ; ACC-783
DR   DSMZCellDive; ACC-783
DR   ECACC; 87092802
DR   EGA; EGAS00001000610
DR   ENCODE; ENCBS101NPD
DR   ENCODE; ENCBS314FVF
DR   ENCODE; ENCBS397PLZ
DR   ENCODE; ENCBS399ENC
DR   ENCODE; ENCBS425ENC
DR   ENCODE; ENCBS465AAA
DR   ENCODE; ENCBS466AAA
DR   ENCODE; ENCBS467AAA
DR   ENCODE; ENCBS470AAA
DR   ENCODE; ENCBS492WPY
DR   ENCODE; ENCBS556WYR
DR   ENCODE; ENCBS729QZR
DR   ENCODE; ENCBS761TKL
DR   ENCODE; ENCBS808TSD
DR   ENCODE; ENCBS830QHD
DR   ENCODE; ENCBS945URM
DR   GEO; GSM206532
DR   GEO; GSM244423
DR   GEO; GSM383934
DR   GEO; GSM472938
DR   GEO; GSM472939
DR   GEO; GSM621900
DR   GEO; GSM784698
DR   GEO; GSM887501
DR   GEO; GSM888583
DR   GEO; GSM923421
DR   GEO; GSM945246
DR   GEO; GSM945261
DR   GEO; GSM1022632
DR   GEO; GSM1024411
DR   GEO; GSM1374806
DR   GEO; GSM1374807
DR   GEO; GSM1374808
DR   GEO; GSM1435699
DR   GEO; GSM1435700
DR   GEO; GSM1435701
DR   GEO; GSM1588613
DR   GEO; GSM1588625
DR   GEO; GSM3333104
DR   GEO; GSM3333105
DR   GEO; GSM3333108
DR   GEO; GSM3333109
DR   IARC_TP53; 317
DR   IBRC; C10156
DR   IZSLER; BS TCL 49
DR   KCB; KCB 200788YJ
DR   KCB; KCB 200809YJ
DR   KCLB; 21469
DR   LiGeA; CCLE_087
DR   LINCS_LDP; LCL-1726
DR   Lonza; 818
DR   MetaboLights; MTBLS812
DR   MetaboLights; MTBLS9283
DR   NCBI_Iran; C556
DR   PharmacoDB; PANC1_1246_2019
DR   PRIDE; PXD002192
DR   PRIDE; PXD003198
DR   PRIDE; PXD032263
DR   Progenetix; CVCL_0480
DR   PubChem_Cell_line; CVCL_0480
DR   RCB; RCB2095
DR   SKY/M-FISH/CGH; 2001
DR   TKG; TKG 0606
DR   TOKU-E; 2865
DR   Ubigene; YC-C130
DR   Wikidata; Q54937550
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/jpb.1000057;
RX   PubMed=1140870;
RX   PubMed=1630814;
RX   PubMed=1764370;
RX   PubMed=6435863;
RX   PubMed=7809022;
RX   PubMed=7961102;
RX   PubMed=8026879;
RX   PubMed=8194712;
RX   PubMed=8286197;
RX   PubMed=9023415;
RX   PubMed=9788440;
RX   PubMed=10027410;
RX   PubMed=11115575;
RX   PubMed=11169957;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12692724;
RX   PubMed=12800145;
RX   PubMed=14695172;
RX   PubMed=15126341;
RX   PubMed=15367885;
RX   PubMed=15688027;
RX   PubMed=15770730;
RX   PubMed=16912165;
RX   PubMed=18298655;
RX   PubMed=18380791;
RX   PubMed=18575732;
RX   PubMed=19077451;
RX   PubMed=20037478;
RX   PubMed=20418756;
RX   PubMed=21515691;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23325432;
RX   PubMed=25167228;
RX   PubMed=25394408;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=26884312;
RX   PubMed=27067801;
RX   PubMed=27259358;
RX   PubMed=28196595;
RX   PubMed=29894427;
RX   PubMed=30156359;
RX   PubMed=30894373;
RX   PubMed=31037374;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32058723;
RX   PubMed=32782605;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/panc-1/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/PANC-1_Myers_protocol.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/PANC-1.html
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=65
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544566
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-179.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/PANC-1
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/pancreatic-xenograft-models/panc-1-xenograft-model/
CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 52 hours (PubMed=1140870); 21 +- 1.6 hours (PubMed=21515691); 25.83 +- 2.03 hours (PubMed=25394408); 25.8 +- 2.8 hours (PubMed=27067801); 52 hours (CLS=300228); ~42 hours (DSMZ=ACC-783); ~32 hours (PBCF); 15.02 hours (JWGray panel).
CC   HLA typing: A*02:01,11:01; B*01,38; C*03,12 (PubMed=9023415).
CC   HLA typing: A*02,11; B*01,38; C*03,12 (PubMed=18575732).
CC   HLA typing: A*02:01,11:01; B*38:01,38:01; C*12:03,12:03; DQB1*06:07,06:07; DRB1*11:20,14:43 (PubMed=26589293).
CC   HLA typing: A*02:01:01,11:01:01; B*38:01:01; C*12:03:01; DPB1*12:01:02G,04:02:01G; DQA1*01:03:01; DQB1*06:03:01; DRB1*13:01:01 (CLS=300228).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853; PubMed=15367885).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=7809022; PubMed=7961102; PubMed=8026879; PubMed=11115575; PubMed=11787853; PubMed=15367885; PubMed=21607521; DepMap=ACH-000164).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=1630814; PubMed=1764370; PubMed=7961102; PubMed=8026879; PubMed=11115575; PubMed=11787853; PubMed=15367885; PubMed=21607521; DepMap=ACH-000164).
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.26%; Native American=0%; East Asian, North=2.09%; East Asian, South=0%; South Asian=0%; European, North=60%; European, South=35.65% (PubMed=30894373).
CC   Caution: Additional TP53 mutation in c.815T>C indicated incorrectly in PubMed=1630814.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): AddexBio=C0018010/4923; ATCC=CRL-1469; CCRID; CLS=300228; DSMZ=ACC-783; ECACC=87092802; KCLB=21469; PubMed=25877200; RCB=RCB2095; Technion Genomics Center; TKG=TKG 0606
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 14
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 11,16
ST   D1S1656: 12,14
ST   D21S11: 28
ST   D22S1045: 16
ST   D2S1338: 23,24
ST   D2S441: 10,14
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 14
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   PANC-1 Ecadherin EmGFP
AC   CVCL_A4BT
SY   PANC-1 ECAD-EmGFP
DR   ATCC; CRL-1469MET
DR   cancercelllines; CVCL_A4BT
DR   Wikidata; Q105510535
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 CDH1 has been tagged in one allele at the C-terminus with EmGFP. Allows to monitor the epithelial-to-mesenchymal transition (EMT) status of cells in vitro by monitoring EmGFP expression.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-1469MET
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   PANC-1-Cas9-554
AC   CVCL_WL48
DR   cancercelllines; CVCL_WL48
DR   CCRID; 1101HUM-PUMC000554
DR   Wikidata; Q98128474
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CCRID=1101HUM-PUMC000554
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 11,16
ST   D21S11: 28
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 15
//
ID   PANC-1-Cas9-555
AC   CVCL_WL49
DR   cancercelllines; CVCL_WL49
DR   CCRID; 1101HUM-PUMC000555
DR   Wikidata; Q98128475
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CCRID=1101HUM-PUMC000555
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 11,16
ST   D21S11: 28
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 15
//
ID   PANC-1-Cas9-556
AC   CVCL_WL50
DR   cancercelllines; CVCL_WL50
DR   CCRID; 1101HUM-PUMC000556
DR   Wikidata; Q98128476
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CCRID=1101HUM-PUMC000556
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 11,16
ST   D21S11: 28
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 15
//
ID   PANC-1-Cas9-557
AC   CVCL_WL51
DR   cancercelllines; CVCL_WL51
DR   CCRID; 1101HUM-PUMC000557
DR   Wikidata; Q98128477
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CCRID=1101HUM-PUMC000557
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 11,16
ST   D21S11: 28
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 15
//
ID   PANC-1-Cas9-558
AC   CVCL_WL52
DR   cancercelllines; CVCL_WL52
DR   CCRID; 1101HUM-PUMC000558
DR   Wikidata; Q98128478
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CCRID=1101HUM-PUMC000558
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 11,16
ST   D21S11: 28
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 15
//
ID   PANC-1-Cas9-559
AC   CVCL_WL53
DR   cancercelllines; CVCL_WL53
DR   CCRID; 1101HUM-PUMC000559
DR   Wikidata; Q98128479
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): CCRID=1101HUM-PUMC000559
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 22
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 11,16
ST   D21S11: 28
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D6S1043: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta E: 7,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 15
//
ID   Panc-1-CTC
AC   CVCL_VQ69
SY   Panc-1-Circulating Tumor Cells
DR   cancercelllines; CVCL_VQ69
DR   GEO; GSM3333106
DR   GEO; GSM3333107
DR   GEO; GSM3333110
DR   GEO; GSM3333111
DR   Wikidata; Q98128480
RX   PubMed=30156359;
CC   Population: Caucasian.
CC   Characteristics: Exhibits more profound migratory and invasive abilities than the parent cell line in vitro. Has a higher tumor-forming ability than the parent cell line in vivo (PubMed=30156359).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 27-11-25; Version: 12
//
ID   Panc-1-Luc
AC   CVCL_C8XX
DR   Ubigene; YC-C130-Luc-P
DR   Wikidata; Q123033256
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   PANC-1-Luc2
AC   CVCL_A4BU
DR   ATCC; CRL-1469-LUC2
DR   cancercelllines; CVCL_A4BU
DR   Wikidata; Q105510536
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1469-LUC2).
CC   Doubling time: ~23 hours (ATCC=CRL-1469-LUC2).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): ATCC=CRL-1469-LUC2
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   PANC-1/Gem
AC   CVCL_C0WS
SY   PANC-1/GEM
DR   cancercelllines; CVCL_C0WS
DR   Wikidata; Q114312645
RX   PubMed=31410021;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   PANC-1RG7
AC   CVCL_WS13
DR   cancercelllines; CVCL_WS13
DR   Wikidata; Q98128481
RX   PubMed=25394408;
CC   Population: Caucasian.
CC   Doubling time: 33.83 +- 2.15 hours (PubMed=25394408).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   Panc-4
AC   CVCL_IU72
DR   Wikidata; Q54937551
RX   PubMed=21475719;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7977; Pancreatic acinar cell carcinoma
DI   ORDO; Orphanet_424046; Acinar cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67-68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 7
//
ID   Panc.1.5C10.5D11
AC   CVCL_B7CT
SY   PA20
DR   Wikidata; Q114312646
RX   Patent=US9574007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4244.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 4
//
ID   Panc02
AC   CVCL_D627
SY   Panc-02; Panc 02; Pan02; Pan-02; PAN 02; Panc02-H0
DR   BTO; BTO_0005175
DR   CCRID; 1101MOU-PUMC000446
DR   ChEMBL-Cells; CHEMBL4483161
DR   ChEMBL-Targets; CHEMBL4483283
DR   CLS; 300501
DR   NCI-DTP; PAN 02
DR   PubChem_Cell_line; CVCL_D627
DR   Ubigene; YC-C067
DR   Wikidata; Q54937552
RX   PubMed=6692374;
RX   PubMed=11558631;
RX   PubMed=20805420;
RX   PubMed=21720167;
RX   PubMed=22208613;
RX   PubMed=24278292;
CC   Doubling time: 61 hours (PubMed=24278292).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Ubigene=YC-C067
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 16,18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 12-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 18-3: 15
ST   Mouse STR X-1: 29
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 18
//
ID   Panc02-H7
AC   CVCL_D628
DR   Wikidata; Q54937553
RX   PubMed=11558631;
RX   PubMed=22208613;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   Panc02-luc
AC   CVCL_A8QL
DR   Wikidata; Q108821088
RX   PubMed=22221605;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   Panc02-MUC1
AC   CVCL_E7SN
SY   Panc02.MUC1; Clone AA3
RX   PubMed=10022473;
WW   Provider; UNeMed; SKU 183; https://www.unemed.com/product/panc02-muc1-cells
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Panc02-Neo
AC   CVCL_E7SP
RX   PubMed=10022473;
CC   Characteristics: Control cell line for Panc02-MUC1 (Cellosaurus=CVCL_E7SN) (PubMed=10022473).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Panc03
AC   CVCL_1U10
SY   Panc-03; Panc 03
DR   Wikidata; Q54937555
RX   PubMed=6692374;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 9
//
ID   Panc1-bC2GnT-M
AC   CVCL_0Q69
DR   BTO; BTO_0005502
DR   cancercelllines; CVCL_0Q69
DR   Wikidata; Q54937556
RX   PubMed=10455130;
RX   PubMed=22525330;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:56968; Bovine GCNT1.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0Q68 ! Panc1-MUC1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   Panc1-F-RFP
AC   CVCL_E9C3
SY   Panc1-RFP
RX   PubMed=26999607;
RX   PubMed=35881881;
CC   Population: Caucasian.
CC   Characteristics: Expresses farnesylated RFP (PubMed=26999607).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Panc1-MUC1
AC   CVCL_0Q68
SY   Panc1/MUC1
DR   cancercelllines; CVCL_0Q68
DR   Wikidata; Q54937557
RX   PubMed=1814933;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7508; MUC1.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   PANC1/CD44v3-10
AC   CVCL_D2RB
DR   Wikidata; Q127383007
RX   PubMed=37489367;
RX   PubMed=37504249;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1681; CD44 (Note=Isoform v3-10; with a N-terminal GLEGGVAMPGAEDDVV = PA16-tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   PANC3
AC   CVCL_3921
SY   PANC-3
DR   BTO; BTO_0000979
DR   Wikidata; Q54937558
RX   PubMed=11332991;
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   PancTu-I
AC   CVCL_4012
SY   PancTu-1; PancTu 1; Panc-TU-I; Panc-Tu1; Panc-TuI; Panc Tu-I; Panc TUI; PancTuI; PancTUI; PaTu-I; PaTu I; PatuI; PaTu1
DR   EFO; EFO_0002715
DR   cancercelllines; CVCL_4012
DR   Cosmic; 710865
DR   Cosmic; 736275
DR   Cosmic; 933530
DR   Cosmic; 1534321
DR   GEO; GSM244424
DR   Progenetix; CVCL_4012
DR   Wikidata; Q54937559
RX   DOI=10.22029/jlupub-12385;
RX   PubMed=8426738;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12692724;
RX   PubMed=12800145;
RX   PubMed=18298655;
RX   PubMed=19077451;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/PaTu%201.html
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=8426738; PubMed=11169959; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.526T>A); ClinVar=VCV000376570; Zygosity=Unspecified (PubMed=8426738; PubMed=11169959; PubMed=11787853).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4013 ! PancTu-II
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   PancTu-II
AC   CVCL_4013
SY   PancTuII; Panc-TU-II; Panc-Tu2; Panc Tu-II; PaTu II; PaTuII; PaTu-II; Pa Tu-II; Patu-2; PATU2; PaCa-2
DR   cancercelllines; CVCL_4013
DR   Cosmic; 736276
DR   Cosmic; 808162
DR   Cosmic; 933531
DR   Cosmic; 2664045
DR   IARC_TP53; 1562
DR   Wikidata; Q54937567
RX   PubMed=1998727;
RX   PubMed=2161859;
RX   PubMed=8194712;
RX   PubMed=8286197;
RX   PubMed=8426738;
RX   PubMed=11169959;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/PaTu%20II.html
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=8426738; PubMed=11169959).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.526T>A); ClinVar=VCV000376570; Zygosity=Unspecified (PubMed=8426738; PubMed=11169959).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4012 ! PancTu-I
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   PANDA
AC   CVCL_B7A6
SY   PANncreatic Ductal Adenocarcinoma
DR   cancercelllines; CVCL_B7A6
DR   Wikidata; Q112129487
RX   PubMed=34818028;
CC   Doubling time: 36 hours (PubMed=34818028).
CC   Karyotypic information: Complex hypertriploid karyotype (PubMed=34818028).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=34818028).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=34818028).
CC   Omics: Metabolomics.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=34818028
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   PandPush
AC   CVCL_9W24
SY   PANDPUSH
DR   IPD-IMGT/HLA; 11279
DR   Wikidata; Q54937568
RX   PubMed=10372548;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,68:01:02; B*51:01:01,57:01; C*06:02,15:07 (IPD-IMGT/HLA=11279).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 10
//
ID   PAP 7
AC   CVCL_J770
SY   PAP7
DR   ECACC; 86080701
DR   Wikidata; Q54937570
RX   PubMed=3545314;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05994; Carica papaya proteinase 4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 6
//
ID   PAP 8
AC   CVCL_J771
SY   PAP8
DR   ECACC; 86080702
DR   Wikidata; Q54937571
RX   PubMed=3545314;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10056; Carica papaya proteinase 3 (omega).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 6
//
ID   PAP-HT25
AC   CVCL_4678
DR   BTO; BTO_0001527
DR   Wikidata; Q54937572
RX   PubMed=3303963;
RX   PubMed=8074186;
CC   Karyotypic information: Polyploid.
CC   Derived from site: In situ; Kidney, renal papilla; UBERON=UBERON_0001228.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_9702 ! GRB-PAP1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   PAPLiGs
AC   CVCL_LI19
DR   Wikidata; Q54937573
RX   PubMed=8076346;
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C6728; Gardner syndrome
DI   NCIt; C27322; Periampullary adenocarcinoma
DI   ORDO; Orphanet_79665; Gardner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   PAR
AC   CVCL_E801
DR   dbMHC; 48996
DR   ECACC; 94050315
DR   IHW; IHW09266
DR   IPD-IMGT/HLA; 11231
DR   Wikidata; Q54937574
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Indonesian.
CC   HLA typing: A*11:01:01,24:02; B*27:06,48:01; C*03:04:01,08:01; DPA1*02:02:02; DPB1*05:01,31:01; DQA1*01,05:01; DQB1*03:01,05:01:01; DRB1*11:01:01,15:02:01; DRB3*02:02:01 (IPD-IMGT/HLA=11231).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Par Bel
AC   CVCL_U680
DR   ATCC; CRL-1191
DR   Wikidata; Q54937575
RX   PubMed=3860870;
CC   Discontinued: ATCC; CRL-1191; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Par-C10
AC   CVCL_8903
SY   PAR-C10; ParC10; Parotid C10; C10; Pa-3
DR   Wikidata; Q54937576
RX   PubMed=9112124;
RX   PubMed=9542637;
RX   PubMed=9688590;
RX   PubMed=9825893;
RX   PubMed=20121592;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   21-42D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   Par-C5
AC   CVCL_D695
SY   PAR-C5; ParC5; Parotid C5; C5; Pa-4
DR   Wikidata; Q54937577
RX   PubMed=9112124;
RX   PubMed=9542637;
RX   PubMed=9825893;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   21-42D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   Pari-ICR
AC   CVCL_VR47
DR   Wikidata; Q98128482
RX   PubMed=30243716;
RX   PubMed=31244288;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Iranian.
CC   Doubling time: ~22 hours (PubMed=31244288).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   PARK4-14
AC   CVCL_T869
DR   SKIP; SKIP000195
DR   Wikidata; Q54937578
RX   PubMed=22848530;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=22848530).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   PARK4-4
AC   CVCL_T870
DR   SKIP; SKIP000194
DR   Wikidata; Q54937579
RX   PubMed=22848530;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=22848530).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F204 ! ND27760
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   Parks
AC   CVCL_DN32
SY   PARKS
DR   Wikidata; Q54937580
RX   PubMed=21908323;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks of this cell line seemed to have been contaminated by a unknown human cell line (PubMed=21908323).
CC   Part of: FACC canine tumor cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00444.
CC   Doubling time: 30 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:39068; CDKN1A; Simple; p.Asp33fs (c.97delG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:54830; EIF1AX; Simple; p.Gly6Ser (c.16G>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:43120; MED12; Simple; p.Pro22Ser (c.64C>T); Zygosity=Homozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 231,239
ST   Dog FHC2054: 156
ST   Dog FHC2079: 275,279
ST   Dog PEZ1: 115
ST   Dog PEZ3: 119
ST   Dog PEZ5: 111
ST   Dog PEZ6: 183
ST   Dog PEZ8: 240
ST   Dog PEZ12: 270
ST   Dog PEZ20: 176
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   PAS [Human LCL]
AC   CVCL_B7MA
DR   Wikidata; Q114312647
RX   PubMed=10079298;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln51Metfs*32 (c.151_154delCAAG); Zygosity=Heterozygous (PubMed=10079298).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   PAS [Rat]
AC   CVCL_JY46
SY   PAS T cell; PAS T
DR   Wikidata; Q54937581
RX   PubMed=7539749;
RX   PubMed=7690770;
CC   Characteristics: Encephalitogenic; recognizes myelin basic protein.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   PAS [Seriola]
AC   CVCL_R914
SY   Purplish Amberjack Skin
DR   Wikidata; Q54937582
RX   DOI=10.1577/1548-8667(1993)005<0127:COTCCL>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=41447; ! Seriola dumerili (Greater amberjack)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   Pas1CN1
AC   CVCL_D3QG
DR   Wikidata; Q127383008
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10263.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20206.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02662; Bovine CSN1S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Pas1CN2
AC   CVCL_D3QH
DR   Wikidata; Q127383009
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10264.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20207.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02662; Bovine CSN1S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Pas1CN3
AC   CVCL_D3QI
DR   Wikidata; Q127383010
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02662; Bovine CSN1S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Pas1CN4
AC   CVCL_D3QJ
DR   Wikidata; Q127383011
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02662; Bovine CSN1S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Pas1CN5
AC   CVCL_D3QK
DR   Wikidata; Q127383012
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02662; Bovine CSN1S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Pas1CN6
AC   CVCL_D3QL
DR   Wikidata; Q127383013
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02662; Bovine CSN1S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PASH-4
AC   CVCL_VT90
SY   PreAdipocitos Subcutaneos Humanos clona 4
DR   Wikidata; Q98128483
RX   CelloPub=CLPUB00477;
CC   Doubling time: 47-95 hours (CelloPub=CLPUB00477).
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   Pat Bru
AC   CVCL_X708
SY   PatBru
DR   ATCC; CRL-1121
DR   Wikidata; Q54937583
RX   PubMed=273925;
RX   PubMed=865488;
RX   PubMed=6458814;
RX   PubMed=7301938;
CC   Discontinued: ATCC; CRL-1121; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 9
//
ID   PAT-206
AC   CVCL_B6E0
DR   Wikidata; Q112129488
RX   PubMed=21559682;
RX   PubMed=22358691;
CC   Doubling time: ~36 hours (PubMed=21559682; PubMed=22358691).
CC   Karyotypic information: Has a modal chromosome number of 61 (PubMed=21559682).
CC   Donor information: Established from a patient with breast cancer metastasized to the peritoneal cavity.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   Pat5
AC   CVCL_0J19
SY   Pat 5
DR   Wikidata; Q54937584
RX   PubMed=17828574;
WW   Provider; Michigan TCPS; -; https://medresearch.umich.edu/office-research/about-office-research/biomedical-research-core-facilities/transgenic-animal-model/transgenic-core-products-services
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   Patas-BARF1
AC   CVCL_4T88
SY   P-BA
DR   Wikidata; Q54937585
RX   PubMed=9223671;
RX   PubMed=19724690;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03228; Epstein-Barr virus (strain B95-8) BARF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9538; ! Erythrocebus patas (Red guenon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   PATH.1
AC   CVCL_9W29
SY   Peripheral Adrenergic TH-expressing 1
DR   Wikidata; Q54937586
RX   Patent=US5591626;
RX   PubMed=7680068;
RX   PubMed=15541571;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: C57BL/6 x DBA/2 rTH promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9W30 ! PATH.2
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   PATH.2
AC   CVCL_9W30
SY   Peripheral Adrenergic TH-expressing 2
DR   Wikidata; Q54937587
RX   Patent=US5591626;
RX   PubMed=7665571;
RX   PubMed=7680068;
RX   PubMed=15541571;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: C57BL/6 x DBA/2 rTH promoter-TAg transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9W29 ! PATH.1
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   PathHunter A549 IkappaB Degradation
AC   CVCL_KW16
DR   cancercelllines; CVCL_KW16
DR   DiscoverX; 93-0538C15
DR   Wikidata; Q54937588
CC   Population: Caucasian.
CC   Characteristics: PathHunter degradation cell lines express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED). Pathway activation results in the degradation of the target protein. The degraded protein is detected by adding to the cell lysis buffer another beta-galactosidase fragment (Enzyme Acceptor=EA). Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   PathHunter BHK-21 rPTGER4 beta-arrestin
AC   CVCL_KW17
DR   DiscoverX; 93-0908C16
DR   Wikidata; Q54937590
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 628641; Ptger4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   PathHunter C2C12 CXCR4 beta-arrestin
AC   CVCL_KW18
DR   DiscoverX; 93-0203C7
DR   Wikidata; Q54937591
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter C2C12 CXCR5 beta-arrestin
AC   CVCL_KW19
DR   DiscoverX; 93-0204C7
DR   Wikidata; Q54937592
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1060; CXCR5.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter C2C12 KISS1R beta-arrestin
AC   CVCL_KW20
DR   DiscoverX; 93-0504C7
DR   Wikidata; Q54937593
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4510; KISS1R.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter C2C12 TACR1 beta-arrestin
AC   CVCL_KW21
DR   DiscoverX; 93-0344C7
DR   Wikidata; Q54937594
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11526; TACR1.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter CHO-K1 ADCYAP1R1 beta-arrestin
AC   CVCL_KW22
DR   DiscoverX; 93-0249C2
DR   Wikidata; Q54937595
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADORA1 beta-arrestin
AC   CVCL_KW23
DR   DiscoverX; 93-0787C2
DR   Wikidata; Q54937596
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:262; ADORA1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADORA3 beta-arrestin
AC   CVCL_KW24
DR   DiscoverX; 93-0586C2
DR   Wikidata; Q54937597
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:268; ADORA3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADRA1B beta-arrestin
AC   CVCL_KW25
DR   DiscoverX; 93-0274C2
DR   Wikidata; Q54937598
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:278; ADRA1B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADRA2A beta-arrestin
AC   CVCL_KW26
DR   DiscoverX; 93-0424C2
DR   Wikidata; Q54937599
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:281; ADRA2A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADRA2B beta-arrestin
AC   CVCL_KW27
DR   DiscoverX; 93-0641C2
DR   Wikidata; Q54937600
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:282; ADRA2B.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADRA2C beta-arrestin
AC   CVCL_KW28
DR   DiscoverX; 93-0511C2
DR   Wikidata; Q54937601
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:283; ADRA2C.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADRB1 beta-arrestin
AC   CVCL_KW29
DR   DiscoverX; 93-0488C2
DR   Wikidata; Q54937602
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:285; ADRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 ADRB2 beta-arrestin
AC   CVCL_KW30
DR   DiscoverX; 93-0182C2
DR   Wikidata; Q54937604
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 AGTR1 beta-arrestin
AC   CVCL_KW31
DR   DiscoverX; 93-0312C2
DR   Wikidata; Q54937605
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:336; AGTR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 AGTRL1 beta-arrestin
AC   CVCL_KW32
DR   DiscoverX; 93-0250C2
DR   Wikidata; Q54937606
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter CHO-K1 AGTRL1 beta-arrestin-1
AC   CVCL_KW33
DR   DiscoverX; 93-1050C2
DR   Wikidata; Q54937607
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter CHO-K1 AR Protein Interaction
AC   CVCL_KW34
DR   DiscoverX; 93-0454C2
DR   Wikidata; Q54937609
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:644; AR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 AVPR1B beta-arrestin
AC   CVCL_KW35
DR   DiscoverX; 93-0486C2
DR   Wikidata; Q54937624
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:896; AVPR1B.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 AVPR2 beta-arrestin
AC   CVCL_KW36
DR   DiscoverX; 93-0588C2
DR   Wikidata; Q54937625
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:897; AVPR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 BAI1 beta-arrestin
AC   CVCL_KW37
DR   DiscoverX; 93-0545C2
DR   Wikidata; Q54937626
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:943; ADGRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 BAI2 beta-arrestin
AC   CVCL_KW38
DR   DiscoverX; 93-0546C2
DR   Wikidata; Q54937627
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:944; ADGRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 BAI3 beta-arrestin
AC   CVCL_KW39
DR   DiscoverX; 93-0547C2
DR   Wikidata; Q54937629
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:945; ADGRB3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 BDKRB1 beta-arrestin
AC   CVCL_KW40
DR   DiscoverX; 93-0639C2
DR   Wikidata; Q54937630
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1029; BDKRB1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 BDKRB2 beta-arrestin
AC   CVCL_KW41
DR   DiscoverX; 93-0189C2
DR   Wikidata; Q54937631
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 beta-arrestin1-EA Parental
AC   CVCL_KW42
DR   DiscoverX; 93-0521
DR   Wikidata; Q54937632
CC   Characteristics: PathHunter beta-arrestin parental cell lines express a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA). They can be used to introduce a GPCR tagged with another beta-galactosidase fragment (ProLink=PK).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 beta-arrestin2-EA Parental
AC   CVCL_KW43
DR   DiscoverX; 93-0164
DR   Wikidata; Q54937634
CC   Characteristics: PathHunter beta-arrestin parental cell lines express a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA). They can be used to introduce a GPCR tagged with another beta-galactosidase fragment (ProLink=PK).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 BRS3 beta-arrestin
AC   CVCL_KW44
DR   DiscoverX; 93-0945C2
DR   Wikidata; Q54937635
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1113; BRS3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 C5AR1 beta-arrestin
AC   CVCL_KW45
DR   DiscoverX; 93-0557C2
DR   Wikidata; Q54937636
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1338; C5AR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 C5L2 beta-arrestin
AC   CVCL_KW46
DR   DiscoverX; 93-0645C2
DR   Wikidata; Q54937637
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4527; C5AR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CALCR beta-arrestin
AC   CVCL_KW47
DR   DiscoverX; 93-0566C2
DR   Wikidata; Q54937638
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CALCR-RAMP1 beta-arrestin
AC   CVCL_KW48
DR   DiscoverX; 93-0269C2
DR   Wikidata; Q54937639
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9843; RAMP1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter CHO-K1 CALCR-RAMP2 beta-arrestin
AC   CVCL_KW51
DR   DiscoverX; 93-0267C2
DR   Wikidata; Q54937642
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9844; RAMP2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter CHO-K1 CALCR-RAMP3 beta-arrestin
AC   CVCL_KW52
DR   DiscoverX; 93-0268C2
DR   Wikidata; Q54937643
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9845; RAMP3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter CHO-K1 CALCRL-RAMP2 beta-arrestin
AC   CVCL_KW49
DR   DiscoverX; 93-0270C2
DR   Wikidata; Q54937640
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9844; RAMP2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CALCRL-RAMP3 beta-arrestin
AC   CVCL_KW50
DR   DiscoverX; 93-0252C2
DR   Wikidata; Q54937641
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16709; CALCRL.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9845; RAMP3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCKAR beta-arrestin
AC   CVCL_KW53
DR   DiscoverX; 93-0190C2
DR   Wikidata; Q54937645
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1570; CCKAR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCKBR beta-arrestin
AC   CVCL_KW54
DR   DiscoverX; 93-0191C2
DR   Wikidata; Q54937646
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1571; CCKBR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR1 beta-arrestin
AC   CVCL_KW55
DR   DiscoverX; 93-0254C2
DR   Wikidata; Q54937648
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1602; CCR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR2 beta-arrestin
AC   CVCL_KW56
DR   DiscoverX; 93-0192C2
DR   Wikidata; Q54937650
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1603; CCR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR3 beta-arrestin
AC   CVCL_KW57
DR   DiscoverX; 93-0629C2
DR   Wikidata; Q54937651
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1604; CCR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR4 beta-arrestin
AC   CVCL_KW58
DR   DiscoverX; 93-0193C2
DR   Wikidata; Q54937652
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1605; CCR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR5 beta-arrestin
AC   CVCL_KW59
DR   DiscoverX; 93-0224C2
DR   Wikidata; Q54937653
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR6 beta-arrestin
AC   CVCL_KW60
DR   DiscoverX; 93-0194C2
DR   Wikidata; Q54937654
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1607; CCR6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR7 beta-arrestin
AC   CVCL_KW61
DR   DiscoverX; 93-0195C2
DR   Wikidata; Q54937655
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1608; CCR7.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR8 beta-arrestin
AC   CVCL_KW62
DR   DiscoverX; 93-0196C2
DR   Wikidata; Q54937656
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1609; CCR8.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCR9 beta-arrestin
AC   CVCL_KW63
DR   DiscoverX; 93-0296C2
DR   Wikidata; Q54937657
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1610; CCR9.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCRL1 beta-arrestin
AC   CVCL_KW64
DR   DiscoverX; 93-0946C2
DR   Wikidata; Q54937658
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2558; CX3CR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CCRL2 beta-arrestin
AC   CVCL_KW65
DR   DiscoverX; 93-0333C2A
DR   Wikidata; Q54937659
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1612; CCRL2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 cEDG5 beta-arrestin
AC   CVCL_KW66
DR   DiscoverX; 93-0581C2
DR   Wikidata; Q54937660
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:108257; Dog S1PR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CHRM1 beta-arrestin
AC   CVCL_KW67
DR   DiscoverX; 93-0197C2
DR   Wikidata; Q54937661
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Discontinued: DiscoverX; 93-0197C2; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CHRM2 beta-arrestin
AC   CVCL_KW68
DR   DiscoverX; 93-0198C2
DR   Wikidata; Q54937662
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1951; CHRM2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CHRM4 beta-arrestin
AC   CVCL_KW69
DR   DiscoverX; 93-0349C2
DR   Wikidata; Q54937663
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1953; CHRM4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CHRM5 beta-arrestin
AC   CVCL_KW70
DR   DiscoverX; 93-0519C2
DR   Wikidata; Q54937665
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1954; CHRM5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CMKLR1 beta-arrestin
AC   CVCL_KW71
DR   DiscoverX; 93-0313C2
DR   Wikidata; Q54937666
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2121; CMKLR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CNR1 beta-arrestin
AC   CVCL_KW72
DR   DiscoverX; 93-0959C2
DR   Wikidata; Q54937668
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2159; CNR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CNR2 beta-arrestin
AC   CVCL_KW73
DR   DiscoverX; 93-0706C2
DR   Wikidata; Q54937670
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2160; CNR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CRHR1 beta-arrestin
AC   CVCL_KW74
DR   DiscoverX; 93-0225C2
DR   Wikidata; Q54937671
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2357; CRHR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CRHR2 beta-arrestin
AC   CVCL_KW75
DR   DiscoverX; 93-0251C2
DR   Wikidata; Q54937679
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2358; CRHR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CRTH2 beta-arrestin
AC   CVCL_KW76
DR   DiscoverX; 93-0291C2
DR   Wikidata; Q54937680
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4502; PTGDR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CX3CR1 beta-arrestin
AC   CVCL_KW77
DR   DiscoverX; 93-0956C2
DR   Wikidata; Q54937681
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2558; CX3CR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CXCR2 beta-arrestin
AC   CVCL_KW78
DR   DiscoverX; 93-0202C2
DR   Wikidata; Q54937682
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6027; CXCR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CXCR3 beta-arrestin
AC   CVCL_KW79
DR   DiscoverX; 93-0271C2
DR   Wikidata; Q54937683
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CXCR5 beta-arrestin
AC   CVCL_KW80
DR   DiscoverX; 93-0514C2
DR   Wikidata; Q54937684
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1060; CXCR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CXCR6 beta-arrestin
AC   CVCL_KW81
DR   DiscoverX; 93-0205C2
DR   Wikidata; Q54937685
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16647; CXCR6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 CXCR7 beta-arrestin
AC   CVCL_KW82
DR   DiscoverX; 93-0248C2
DR   Wikidata; Q54937686
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23692; ACKR3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 cyno GPR120 beta-arrestin
AC   CVCL_KW83
DR   DiscoverX; 93-1029C2
DR   Wikidata; Q54937687
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; C8YUV0; Macaca fascicularis FFAR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 DARC beta-arrestin
AC   CVCL_KW84
DR   DiscoverX; 93-0548C2
DR   Wikidata; Q54937689
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4035; ACKR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 DRD1 beta-arrestin
AC   CVCL_KW85
DR   DiscoverX; 93-0590C2
DR   Wikidata; Q54937690
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3020; DRD1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 DRD2L beta-arrestin
AC   CVCL_KW86
DR   DiscoverX; 93-0579C2
DR   Wikidata; Q54937691
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3023; DRD2 (Note=Isoform long).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 DRD2S beta-arrestin
AC   CVCL_KW87
DR   DiscoverX; 93-0351C2
DR   Wikidata; Q54937692
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3023; DRD2 (Note=Isoform short).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 DRD3 beta-arrestin
AC   CVCL_KW88
DR   DiscoverX; 93-0591C2
DR   Wikidata; Q54937693
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3024; DRD3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 DRD4 beta-arrestin
AC   CVCL_KW89
DR   DiscoverX; 93-0690C2
DR   Wikidata; Q54937694
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3025; DRD4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 DRD5 beta-arrestin
AC   CVCL_KW90
DR   DiscoverX; 93-0426C2
DR   Wikidata; Q54937695
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3026; DRD5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EBI2 beta-arrestin
AC   CVCL_KW91
DR   DiscoverX; 93-0437C2A
DR   Wikidata; Q54937696
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3128; GPR183.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDG1 beta-arrestin
AC   CVCL_KW92
DR   DiscoverX; 93-0207C2
DR   Wikidata; Q54937697
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3165; S1PR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDG2 beta-arrestin
AC   CVCL_KW93
DR   DiscoverX; 93-0644C2
DR   Wikidata; Q54937698
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3166; LPAR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDG3 beta-arrestin
AC   CVCL_KW94
DR   DiscoverX; 93-0217C2
DR   Wikidata; Q54937699
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3167; S1PR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDG4 beta-arrestin
AC   CVCL_KW95
DR   DiscoverX; 93-0255C2
DR   Wikidata; Q54937700
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3168; LPAR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDG5 beta-arrestin
AC   CVCL_KW96
DR   DiscoverX; 93-0256C2
DR   Wikidata; Q54937701
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3169; S1PR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDG6 beta-arrestin
AC   CVCL_KW97
DR   DiscoverX; 93-0227C2
DR   Wikidata; Q54937702
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3170; S1PR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDG7 beta-arrestin
AC   CVCL_KW98
DR   DiscoverX; 93-0636C2
DR   Wikidata; Q54937703
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14298; LPAR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDNRA beta-arrestin
AC   CVCL_KW99
DR   DiscoverX; 93-0257C2
DR   Wikidata; Q54937704
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3179; EDNRA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 EDNRB beta-arrestin
AC   CVCL_KX00
DR   DiscoverX; 93-0593C2
DR   Wikidata; Q54937705
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3180; EDNRB.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 ERalpha Protein Interaction
AC   CVCL_KX01
DR   DiscoverX; 93-0453C2
DR   Wikidata; Q54937706
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 F2R beta-arrestin
AC   CVCL_KX02
DR   DiscoverX; 93-0278C2
DR   Wikidata; Q54937707
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3537; F2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 F2RL3 beta-arrestin
AC   CVCL_KX03
DR   DiscoverX; 93-0279C2
DR   Wikidata; Q54937708
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3540; F2RL3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 FFAR2 beta-arrestin
AC   CVCL_KX04
DR   DiscoverX; 93-1005C2
DR   Wikidata; Q54937709
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4501; FFAR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 FPR1 beta-arrestin
AC   CVCL_KX05
DR   DiscoverX; 93-0314C2
DR   Wikidata; Q54937710
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3826; FPR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 FPRL1 beta-arrestin
AC   CVCL_KX06
DR   DiscoverX; 93-0319C2
DR   Wikidata; Q54937711
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3827; FPR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 FSHR beta-arrestin
AC   CVCL_KX07
DR   DiscoverX; 93-0517C2
DR   Wikidata; Q54937712
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3969; FSHR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 FXR Protein Interaction
AC   CVCL_KX08
DR   DiscoverX; 93-0443C2
DR   Wikidata; Q54937713
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7669; NCOA2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7967; NR1H4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GALR1 beta-arrestin
AC   CVCL_KX09
DR   DiscoverX; 93-0228C2
DR   Wikidata; Q54937714
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4132; GALR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GALR2 beta-arrestin
AC   CVCL_KX10
DR   DiscoverX; 93-0759C2
DR   Wikidata; Q54937715
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4133; GALR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GCGR beta-arrestin
AC   CVCL_KX11
DR   DiscoverX; 93-0241C2
DR   Wikidata; Q54937716
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GCGR beta-arrestin-1
AC   CVCL_KX12
DR   DiscoverX; 93-0979C2
DR   Wikidata; Q54937717
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GHSR1b beta-arrestin
AC   CVCL_KX13
DR   DiscoverX; 93-0354C2A
DR   Wikidata; Q54937718
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4267; GHSR (Note=Isoform 1b).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GIPR beta-arrestin
AC   CVCL_KX14
DR   DiscoverX; 93-1095C2
DR   Wikidata; Q54937720
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4271; GIPR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GLP1R beta-arrestin
AC   CVCL_KX15
DR   DiscoverX; 93-0300C2
DR   Wikidata; Q54937734
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GLP1R beta-arrestin-1
AC   CVCL_KX16
DR   DiscoverX; 93-0914C2
DR   Wikidata; Q54937735
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GLP2R beta-arrestin
AC   CVCL_KX17
DR   DiscoverX; 93-0572C2
DR   Wikidata; Q54937736
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4325; GLP2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR1 beta-arrestin
AC   CVCL_KX18
DR   DiscoverX; 93-0335C2
DR   Wikidata; Q54937737
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4463; CMKLR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter CHO-K1 GPR101 beta-arrestin
AC   CVCL_KX19
DR   DiscoverX; 93-0831C2
DR   Wikidata; Q54937739
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14963; GPR101.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR103 beta-arrestin
AC   CVCL_KX20
DR   DiscoverX; 93-0376C2A
DR   Wikidata; Q54937740
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15565; QRFPR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR107 beta-arrestin
AC   CVCL_KX21
DR   DiscoverX; 93-0419C2A
DR   Wikidata; Q54937741
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17830; GPR107.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR109A beta-arrestin
AC   CVCL_KX22
DR   DiscoverX; 93-0301C2
DR   Wikidata; Q54937742
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24827; HCAR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR109B beta-arrestin
AC   CVCL_KX23
DR   DiscoverX; 93-0791C2
DR   Wikidata; Q54937743
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16824; HCAR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR12 beta-arrestin
AC   CVCL_KX24
DR   DiscoverX; 93-0329C2A
DR   Wikidata; Q54937744
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4466; GPR12.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR120L beta-arrestin
AC   CVCL_KX25
SY   PathHunter CHO-K1 GPR120 beta-arrestin
DR   DiscoverX; 93-0366C2
DR   Wikidata; Q54937745
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19061; FFAR4 (Note=Isoform 1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR120S beta-arrestin
AC   CVCL_KX26
DR   DiscoverX; 93-0924C2
DR   Wikidata; Q54937746
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19061; FFAR4 (Note=Isoform 2).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR120S beta-arrestin-1
AC   CVCL_KX27
DR   DiscoverX; 93-0978C2
DR   Wikidata; Q54937747
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19061; FFAR4 (Note=Isoform 2).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR123 beta-arrestin
AC   CVCL_KX28
DR   DiscoverX; 93-0417C2A
DR   Wikidata; Q54937748
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13838; ADGRA1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 GPR132 beta-arrestin
AC   CVCL_KX29
DR   DiscoverX; 93-0411C2A
DR   Wikidata; Q54937749
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17482; GPR132.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR135 beta-arrestin
AC   CVCL_KX30
DR   DiscoverX; 93-0431C2A
DR   Wikidata; Q54937750
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19991; GPR135.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR137 beta-arrestin
AC   CVCL_KX31
DR   DiscoverX; 93-0361C2A
DR   Wikidata; Q54937751
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24300; GPR137.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR139 beta-arrestin
AC   CVCL_KX32
DR   DiscoverX; 93-0954C2
DR   Wikidata; Q54937752
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19995; GPR139.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR141 beta-arrestin
AC   CVCL_KX33
DR   DiscoverX; 93-0385C2A
DR   Wikidata; Q54937753
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19997; GPR141.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR142 beta-arrestin
AC   CVCL_KX34
DR   DiscoverX; 93-0413C2A
DR   Wikidata; Q54937754
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20088; GPR142.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR143 beta-arrestin
AC   CVCL_KX35
DR   DiscoverX; 93-0362C2A
DR   Wikidata; Q54937755
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20145; GPR143.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR146 beta-arrestin
AC   CVCL_KX36
DR   DiscoverX; 93-0365C2A
DR   Wikidata; Q54937756
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:21718; GPR146.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR148 beta-arrestin
AC   CVCL_KX37
DR   DiscoverX; 93-0364C2A
DR   Wikidata; Q54937757
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23623; GPR148.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR149 beta-arrestin
AC   CVCL_KX38
DR   DiscoverX; 93-0420C2A
DR   Wikidata; Q54937758
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23627; GPR149.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR15 beta-arrestin
AC   CVCL_KX39
DR   DiscoverX; 93-0682C2
DR   Wikidata; Q54937759
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4469; GPR15.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR150 beta-arrestin
AC   CVCL_KX40
DR   DiscoverX; 93-0375C2A
DR   Wikidata; Q54937760
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23628; GPR150.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR151 beta-arrestin
AC   CVCL_KX41
DR   DiscoverX; 93-0381C2A
DR   Wikidata; Q54937761
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23624; GPR151.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR152 beta-arrestin
AC   CVCL_KX42
DR   DiscoverX; 93-0384C2A
DR   Wikidata; Q54937762
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23622; GPR152.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR157 beta-arrestin
AC   CVCL_KX43
DR   DiscoverX; 93-0414C2A
DR   Wikidata; Q54937763
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23687; GPR157.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR161 beta-arrestin
AC   CVCL_KX44
DR   DiscoverX; 93-0705C2
DR   Wikidata; Q54937764
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23694; GPR161.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR162 beta-arrestin
AC   CVCL_KX45
DR   DiscoverX; 93-0383C2A
DR   Wikidata; Q54937765
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16693; GPR162.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR171 beta-arrestin
AC   CVCL_KX46
DR   DiscoverX; 93-0415C2A
DR   Wikidata; Q54937766
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30057; GPR171.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR173 beta-arrestin
AC   CVCL_KX47
DR   DiscoverX; 93-0380C2A
DR   Wikidata; Q54937767
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18186; GPR173.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR176 beta-arrestin
AC   CVCL_KX48
DR   DiscoverX; 93-0382C2A
DR   Wikidata; Q54937768
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:32370; GPR176.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR18 beta-arrestin
AC   CVCL_KX49
DR   DiscoverX; 93-0560C2A
DR   Wikidata; Q54937769
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4472; GPR18.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR182 beta-arrestin
AC   CVCL_KX50
DR   DiscoverX; 93-0754C2
DR   Wikidata; Q54937770
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13708; GPR182.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR23 beta-arrestin
AC   CVCL_KX51
DR   DiscoverX; 93-0336C2A
DR   Wikidata; Q54937771
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4478; LPAR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR25 beta-arrestin
AC   CVCL_KX52
DR   DiscoverX; 93-0368C2A
DR   Wikidata; Q54937772
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4480; GPR25.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR26 beta-arrestin
AC   CVCL_KX53
DR   DiscoverX; 93-0392C2A
DR   Wikidata; Q54937773
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4481; GPR26.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR27 beta-arrestin
AC   CVCL_KX54
DR   DiscoverX; 93-0334C2A
DR   Wikidata; Q54937774
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4482; GPR27.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR3 beta-arrestin
AC   CVCL_KX55
DR   DiscoverX; 93-0626C2
DR   Wikidata; Q54937782
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4484; GPR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR30 beta-arrestin
AC   CVCL_KX56
DR   DiscoverX; 93-0373C2A
DR   Wikidata; Q54937783
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4485; GPER1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR31 beta-arrestin
AC   CVCL_KX57
DR   DiscoverX; 93-0406C2
DR   Wikidata; Q54937784
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4486; GPR31.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR32 beta-arrestin
AC   CVCL_KX58
DR   DiscoverX; 93-0321C2A
DR   Wikidata; Q54937786
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4487; GPR32.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR35 beta-arrestin
AC   CVCL_KX59
DR   DiscoverX; 93-0942C2
DR   Wikidata; Q54937787
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4492; GPR35.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR37 beta-arrestin
AC   CVCL_KX60
DR   DiscoverX; 93-0339C2A
DR   Wikidata; Q54937788
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4494; GPR37.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR37L1 beta-arrestin
AC   CVCL_KX61
DR   DiscoverX; 93-0378C2A
DR   Wikidata; Q54937789
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14923; GPR37L1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR39 beta-arrestin
AC   CVCL_KX62
DR   DiscoverX; 93-0338C2
DR   Wikidata; Q54937790
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4496; GPR39.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR4 beta-arrestin
AC   CVCL_KX63
DR   DiscoverX; 93-0369C2A
DR   Wikidata; Q54937791
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4497; GPR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR45 beta-arrestin
AC   CVCL_KX64
DR   DiscoverX; 93-0374C2A
DR   Wikidata; Q54937792
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4503; GPR45.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR50 beta-arrestin
AC   CVCL_KX65
DR   DiscoverX; 93-0648C2
DR   Wikidata; Q54937793
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4506; GPR50.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR52 beta-arrestin
AC   CVCL_KX66
DR   DiscoverX; 93-0371C2A
DR   Wikidata; Q54937794
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4508; GPR52.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR55 beta-arrestin
AC   CVCL_KX67
DR   DiscoverX; 93-0245C2
DR   Wikidata; Q54937795
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4511; GPR55.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR6 beta-arrestin
AC   CVCL_KX68
DR   DiscoverX; 93-0634C2
DR   Wikidata; Q54937796
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4515; GPR6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR61 beta-arrestin
AC   CVCL_KX69
DR   DiscoverX; 93-0407C2A
DR   Wikidata; Q54937797
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13300; GPR61.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR65 beta-arrestin
AC   CVCL_KX70
DR   DiscoverX; 93-0428C2A
DR   Wikidata; Q54937798
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4517; GPR65.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR75 beta-arrestin
AC   CVCL_KX71
DR   DiscoverX; 93-0363C2A
DR   Wikidata; Q54937799
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4526; GPR75.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR78 beta-arrestin
AC   CVCL_KX72
DR   DiscoverX; 93-0370C2A
DR   Wikidata; Q54937800
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4528; GPR78.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR79 beta-arrestin
AC   CVCL_KX73
DR   DiscoverX; 93-0408C2A
DR   Wikidata; Q54937801
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4529; GPR79.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR83 beta-arrestin
AC   CVCL_KX74
DR   DiscoverX; 93-0441C2A
DR   Wikidata; Q54937802
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4523; GPR83.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR84 beta-arrestin
AC   CVCL_KX75
DR   DiscoverX; 93-0647C2
DR   Wikidata; Q54937803
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4535; GPR84.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR85 beta-arrestin
AC   CVCL_KX76
DR   DiscoverX; 93-0409C2A
DR   Wikidata; Q54937804
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4536; GPR85.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR88 beta-arrestin
AC   CVCL_KX77
DR   DiscoverX; 93-0357C2A
DR   Wikidata; Q54937805
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4539; GPR88.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR92 beta-arrestin
AC   CVCL_KX78
DR   DiscoverX; 93-0372C2
DR   Wikidata; Q54937806
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13307; LPAR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 GPR97 beta-arrestin
AC   CVCL_KX79
DR   DiscoverX; 93-0410C2A
DR   Wikidata; Q54937807
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13728; ADGRG3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 GR Protein Interaction
AC   CVCL_KX80
DR   DiscoverX; 93-0456C2
DR   Wikidata; Q54937808
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 HCRTR1 beta-arrestin
AC   CVCL_KX81
DR   DiscoverX; 93-0258C2
DR   Wikidata; Q54937809
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4848; HCRTR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 HCRTR2 beta-arrestin
AC   CVCL_KX82
DR   DiscoverX; 93-0427C2
DR   Wikidata; Q54937810
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4849; HCRTR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 HRH1 beta-arrestin
AC   CVCL_KX83
DR   DiscoverX; 93-0503C2
DR   Wikidata; Q54937811
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5182; HRH1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 HRH2 beta-arrestin
AC   CVCL_KX84
DR   DiscoverX; 93-0208C2
DR   Wikidata; Q54937812
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5183; HRH2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 HRH3 beta-arrestin
AC   CVCL_KX85
DR   DiscoverX; 93-0509C2
DR   Wikidata; Q54937813
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5184; HRH3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 HTR1A beta-arrestin
AC   CVCL_KX86
DR   DiscoverX; 93-0696C2
DR   Wikidata; Q54937815
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5286; HTR1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 LGR4 beta-arrestin
AC   CVCL_KX87
DR   DiscoverX; 93-0516C2A
DR   Wikidata; Q54937817
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13299; LGR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 LGR5 beta-arrestin
AC   CVCL_KX88
DR   DiscoverX; 93-0526C2A
DR   Wikidata; Q54937818
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4504; LGR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 LGR6 beta-arrestin
AC   CVCL_KX89
DR   DiscoverX; 93-0527C2A
DR   Wikidata; Q54937820
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19719; LGR6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 LHCGR beta-arrestin
AC   CVCL_KX90
DR   DiscoverX; 93-0957C2
DR   Wikidata; Q54937821
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6585; LHCGR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 LTB4R beta-arrestin
AC   CVCL_KX91
DR   DiscoverX; 93-0292C2
DR   Wikidata; Q54937823
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6713; LTB4R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 LXRalpha Protein Interaction
AC   CVCL_KX92
DR   DiscoverX; 93-0389C2
DR   Wikidata; Q54937824
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7669; NCOA2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7966; NR1H3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 LXRbeta Protein Interaction
AC   CVCL_KX93
DR   DiscoverX; 93-0442C2
DR   Wikidata; Q54937825
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7671; NCOA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7965; NR1H2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mADCYAP1R1 beta-arrestin
AC   CVCL_KX94
DR   DiscoverX; 93-0594C2
DR   Wikidata; Q54937826
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:108449; Adcyap1r1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mADORA2B beta-arrestin
AC   CVCL_KX95
DR   DiscoverX; 93-0469C2
DR   Wikidata; Q54937840
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99403; Adora2b.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mADORA3 beta-arrestin
AC   CVCL_KX96
DR   DiscoverX; 93-0683C2
DR   Wikidata; Q54937841
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104847; Adora3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mAGTRL1 beta-arrestin
AC   CVCL_KX97
DR   DiscoverX; 93-0565C2
DR   Wikidata; Q54937842
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1346086; Aplnr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter CHO-K1 mC5AR1 beta-arrestin
AC   CVCL_KX98
DR   DiscoverX; 93-0577C2
DR   Wikidata; Q54937843
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88232; C5ar1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MC5R beta-arrestin
AC   CVCL_KX99
DR   DiscoverX; 93-0231C2
DR   Wikidata; Q54937844
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6933; MC5R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCCR3 beta-arrestin
AC   CVCL_KY00
DR   DiscoverX; 93-0522C2
DR   Wikidata; Q54937846
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104616; Ccr3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCCR4 beta-arrestin
AC   CVCL_KY01
DR   DiscoverX; 93-0515C2
DR   Wikidata; Q54937847
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107824; Ccr4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCCR5 beta-arrestin
AC   CVCL_KY02
DR   DiscoverX; 93-0470C2
DR   Wikidata; Q54937848
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107182; Ccr5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCCR6 beta-arrestin
AC   CVCL_KY03
DR   DiscoverX; 93-0694C2
DR   Wikidata; Q54937849
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1333797; Ccr6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCCR7 beta-arrestin
AC   CVCL_KY04
DR   DiscoverX; 93-0528C2
DR   Wikidata; Q54937850
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:103011; Ccr7.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCCR8 beta-arrestin
AC   CVCL_KY05
DR   DiscoverX; 93-0556C2
DR   Wikidata; Q54937851
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1201402; Ccr8.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCCR9 beta-arrestin
AC   CVCL_KY06
DR   DiscoverX; 93-0734C2
DR   Wikidata; Q54937852
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1341902; Ccr9.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCMKLR1 beta-arrestin
AC   CVCL_KY07
DR   DiscoverX; 93-0537C2
DR   Wikidata; Q54937853
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109603; Cmklr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCNR1 beta-arrestin
AC   CVCL_KY08
DR   DiscoverX; 93-0471C2
DR   Wikidata; Q54937854
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104615; Cnr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCNR2 beta-arrestin
AC   CVCL_KY09
DR   DiscoverX; 93-0472C2
DR   Wikidata; Q54937855
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104650; Cnr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCRHR1 beta-arrestin
AC   CVCL_KY10
DR   DiscoverX; 93-0473C2
DR   Wikidata; Q54937856
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88498; Crhr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCRTH2 beta-arrestin
AC   CVCL_KY11
DR   DiscoverX; 93-0584C2
DR   Wikidata; Q54937857
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1330275; Ptgdr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCXCR2 beta-arrestin
AC   CVCL_KY12
DR   DiscoverX; 93-0513C2
DR   Wikidata; Q54937858
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:105303; Cxcr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCXCR3 beta-arrestin
AC   CVCL_KY13
DR   DiscoverX; 93-0553C2
DR   Wikidata; Q54937859
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1277207; Cxcr3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCXCR5 beta-arrestin
AC   CVCL_KY14
DR   DiscoverX; 93-0474C2
DR   Wikidata; Q54937860
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:103567; Cxcr5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mCXCR6 beta-arrestin
AC   CVCL_KY15
DR   DiscoverX; 93-0512C2
DR   Wikidata; Q54937861
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1934582; Cxcr6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mDRD5 beta-arrestin
AC   CVCL_KY16
DR   DiscoverX; 93-0573C2
DR   Wikidata; Q54937862
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94927; Drd5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mEBI2 beta-arrestin
AC   CVCL_KY17
DR   DiscoverX; 93-0953C2
DR   Wikidata; Q54937863
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2442034; Gpr183.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mEDG1 beta-arrestin
AC   CVCL_KY18
DR   DiscoverX; 93-0476C2
DR   Wikidata; Q54937865
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1096355; S1pr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mEDG3 beta-arrestin
AC   CVCL_KY19
DR   DiscoverX; 93-1013C2
DR   Wikidata; Q54937866
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1339365; S1pr3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mEDG5 beta-arrestin
AC   CVCL_KY20
DR   DiscoverX; 93-0601C2
DR   Wikidata; Q54937867
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99569; S1pr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mEDNRA beta-arrestin
AC   CVCL_KY21
DR   DiscoverX; 93-0685C2
DR   Wikidata; Q54937868
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:105923; Ednra.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mEDNRB beta-arrestin
AC   CVCL_KY22
DR   DiscoverX; 93-0602C2
DR   Wikidata; Q54937870
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:102720; Ednrb.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mFPR1 beta-arrestin
AC   CVCL_KY23
DR   DiscoverX; 93-0570C2
DR   Wikidata; Q54937871
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107443; Fpr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mFPR2 beta-arrestin
AC   CVCL_KY24
DR   DiscoverX; 93-1034C2
DR   Wikidata; Q54937872
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1278319; Fpr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGALR2 beta-arrestin
AC   CVCL_KY25
DR   DiscoverX; 93-0604C2
DR   Wikidata; Q54937873
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1337018; Galr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGCGR beta-arrestin
AC   CVCL_KY26
DR   DiscoverX; 93-0575C2
DR   Wikidata; Q54937874
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99572; Gcgr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGCGR beta-arrestin-1
AC   CVCL_KY27
DR   DiscoverX; 93-0973C2
DR   Wikidata; Q54937875
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99572; Gcgr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGHSR1a beta-arrestin
AC   CVCL_KY28
SY   PathHunter CHO-K1 mGHSR beta-arrestin
DR   DiscoverX; 93-0605C2
DR   Wikidata; Q54937876
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2441906; Ghsr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGLP1R beta-arrestin
AC   CVCL_KY29
DR   DiscoverX; 93-0478C2
DR   Wikidata; Q54937877
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99571; Glp1r.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGLP1R beta-arrestin-1
AC   CVCL_KY30
DR   DiscoverX; 93-0974C2
DR   Wikidata; Q54937878
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:99571; Glp1r.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGPR1 beta-arrestin
AC   CVCL_KY31
DR   DiscoverX; 93-0571C2
DR   Wikidata; Q54937880
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2385324; Gpr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mGPR84 beta-arrestin
AC   CVCL_KY32
DR   DiscoverX; 93-1083C2
DR   Wikidata; Q54937881
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1934129; Gpr84.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mHTR2A beta-arrestin
AC   CVCL_KY33
DR   DiscoverX; 93-0567C2
DR   Wikidata; Q54937882
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109521; Htr2a.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MLNR beta-arrestin
AC   CVCL_KY34
DR   DiscoverX; 93-0323C2
DR   Wikidata; Q54937883
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4495; MLNR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mLTB4R1 beta-arrestin
AC   CVCL_KY35
DR   DiscoverX; 93-0574C2
DR   Wikidata; Q54937892
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1309472; Ltb4r1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mMCHR1 beta-arrestin
AC   CVCL_KY36
DR   DiscoverX; 93-0479C2
DR   Wikidata; Q54937893
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2180756; Mchr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mNPY2R beta-arrestin
AC   CVCL_KY37
DR   DiscoverX; 93-0569C2
DR   Wikidata; Q54937894
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:108418; Npy2r.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mOPRD1 beta-arrestin
AC   CVCL_KY38
DR   DiscoverX; 93-0611C2
DR   Wikidata; Q54937895
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97438; Oprd1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mOPRK1 beta-arrestin
AC   CVCL_KY39
DR   DiscoverX; 93-0480C2
DR   Wikidata; Q54937896
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97439; Oprk1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mOXTR beta-arrestin
AC   CVCL_KY40
DR   DiscoverX; 93-0612C2
DR   Wikidata; Q54937898
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109147; Oxtr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mP2RY12 beta-arrestin
AC   CVCL_KY41
DR   DiscoverX; 93-0613C2
DR   Wikidata; Q54937899
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1918089; P2ry12.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mPPYR1 beta-arrestin
AC   CVCL_KY42
DR   DiscoverX; 93-0774C2
DR   Wikidata; Q54937900
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:105374; Npy4r.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mPTAFR beta-arrestin
AC   CVCL_KY43
DR   DiscoverX; 93-0614C2
DR   Wikidata; Q54937901
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:106066; Ptafr.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MR Protein Interaction
AC   CVCL_KY44
DR   DiscoverX; 93-0758C2
DR   Wikidata; Q54937902
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7979; NR3C2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 MRGPRD beta-arrestin
AC   CVCL_KY45
DR   DiscoverX; 93-0926C2
DR   Wikidata; Q54937903
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:29626; MRGPRD.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MRGPRE beta-arrestin
AC   CVCL_KY46
DR   DiscoverX; 93-0438C2A
DR   Wikidata; Q54937905
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30694; MRGPRE.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MRGPRF beta-arrestin
AC   CVCL_KY47
DR   DiscoverX; 93-0433C2A
DR   Wikidata; Q54937906
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24828; MRGPRF.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MRGPRX1 beta-arrestin
AC   CVCL_KY48
DR   DiscoverX; 93-0919C2
DR   Wikidata; Q54937907
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17962; MRGPRX1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MRGPRX2 beta-arrestin
AC   CVCL_KY49
DR   DiscoverX; 93-0309C2
DR   Wikidata; Q54937908
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17983; MRGPRX2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MRGPRX4 beta-arrestin
AC   CVCL_KY50
DR   DiscoverX; 93-0541C2A
DR   Wikidata; Q54937909
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17617; MRGPRX4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mRXFP3 beta-arrestin
AC   CVCL_KY51
DR   DiscoverX; 93-0928C2
DR   Wikidata; Q54937910
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2441827; Rxfp3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mRXFP4 beta-arrestin
AC   CVCL_KY52
DR   DiscoverX; 93-0929C2
DR   Wikidata; Q54937911
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2182926; Rxfp4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mSSTR2 beta-arrestin
AC   CVCL_KY53
DR   DiscoverX; 93-0616C2
DR   Wikidata; Q54937912
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98328; Sstr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mSSTR5 beta-arrestin
AC   CVCL_KY54
DR   DiscoverX; 93-0627C2
DR   Wikidata; Q54937913
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:894282; Sstr5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MTNR1A beta-arrestin
AC   CVCL_KY55
DR   DiscoverX; 93-0951C2
DR   Wikidata; Q54937914
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7463; MTNR1A.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 MTNR1B beta-arrestin
AC   CVCL_KY56
DR   DiscoverX; 93-0630C2
DR   Wikidata; Q54937915
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7464; MTNR1B.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mUTR2 beta-arrestin
AC   CVCL_KY57
DR   DiscoverX; 93-0525C2
DR   Wikidata; Q54937916
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2183450; Uts2r.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 mVIPR1 beta-arrestin
AC   CVCL_KY58
DR   DiscoverX; 93-0619C2
DR   Wikidata; Q54937918
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109272; Vipr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 NMBR beta-arrestin
AC   CVCL_KY59
DR   DiscoverX; 93-0925C2
DR   Wikidata; Q54937919
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7843; NMBR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 NPBWR1 beta-arrestin
AC   CVCL_KY60
DR   DiscoverX; 93-0818C2
DR   Wikidata; Q54937920
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4522; NPBWR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 NPBWR2 beta-arrestin
AC   CVCL_KY61
DR   DiscoverX; 93-0638C2
DR   Wikidata; Q54937921
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4530; NPBWR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 NPFFR1 beta-arrestin
AC   CVCL_KY62
DR   DiscoverX; 93-0944C2
DR   Wikidata; Q54937922
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17425; NPFFR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 NPR1 Functional Assay
AC   CVCL_KY63
DR   DiscoverX; 93-0804C2
DR   Wikidata; Q54937923
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7943; NPR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 9
//
ID   PathHunter CHO-K1 NPY1R beta-arrestin
AC   CVCL_KY64
DR   DiscoverX; 93-0397C2
DR   Wikidata; Q54937924
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7956; NPY1R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 NPY2R beta-arrestin
AC   CVCL_KY65
DR   DiscoverX; 93-0212C2
DR   Wikidata; Q54937925
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7957; NPY2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 NTSR1 beta-arrestin
AC   CVCL_KY66
DR   DiscoverX; 93-0280C2
DR   Wikidata; Q54937926
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8039; NTSR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 OPN5 beta-arrestin
AC   CVCL_KY67
DR   DiscoverX; 93-0704C2
DR   Wikidata; Q54937927
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19992; OPN5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 OPRD1 beta-arrestin
AC   CVCL_KY68
DR   DiscoverX; 93-0400C2
DR   Wikidata; Q54937928
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8153; OPRD1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 OPRL1 beta-arrestin
AC   CVCL_KY69
DR   DiscoverX; 93-0264C2
DR   Wikidata; Q54937929
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8155; OPRL1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 OPRM1 beta-arrestin
AC   CVCL_KY70
DR   DiscoverX; 93-0213C2
DR   Wikidata; Q54937930
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8156; OPRM1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 OXER1 beta-arrestin
AC   CVCL_KY71
DR   DiscoverX; 93-0867C2
DR   Wikidata; Q54937931
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24884; OXER1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 OXGR1 beta-arrestin
AC   CVCL_KY72
DR   DiscoverX; 93-0693C2
DR   Wikidata; Q54937932
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4531; OXGR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 OXTR beta-arrestin
AC   CVCL_KY73
DR   DiscoverX; 93-0261C2
DR   Wikidata; Q54937933
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8529; OXTR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 P2RY11 beta-arrestin
AC   CVCL_KY74
DR   DiscoverX; 93-0281C2
DR   Wikidata; Q54937934
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8540; P2RY11.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 P2RY12 beta-arrestin
AC   CVCL_KY75
DR   DiscoverX; 93-0262C2
DR   Wikidata; Q54937943
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18124; P2RY12.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 P2RY4 beta-arrestin
AC   CVCL_KY76
DR   DiscoverX; 93-0263C2
DR   Wikidata; Q54937944
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8542; P2RY4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 P2RY6 beta-arrestin
AC   CVCL_KY77
DR   DiscoverX; 93-0500C2
DR   Wikidata; Q54937945
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8543; P2RY6.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 P2RY8 beta-arrestin
AC   CVCL_KY78
DR   DiscoverX; 93-0635C2
DR   Wikidata; Q54937946
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15524; P2RY8.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PPARalpha Protein Interaction
AC   CVCL_KY79
DR   DiscoverX; 93-0457C2
DR   Wikidata; Q54937947
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9234; MED1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9232; PPARA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PPARdelta Protein Interaction
AC   CVCL_KY80
DR   DiscoverX; 93-0492C2
DR   Wikidata; Q54937948
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9234; MED1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9235; PPARD.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PPARgamma Protein Interaction
AC   CVCL_KY81
DR   DiscoverX; 93-0390C2
DR   Wikidata; Q54937949
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9234; MED1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9236; PPARG.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PPYR1 beta-arrestin
AC   CVCL_KY82
DR   DiscoverX; 93-0233C2
DR   Wikidata; Q54937950
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9329; NPY4R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PRLHR beta-arrestin
AC   CVCL_KY83
DR   DiscoverX; 93-0302C2
DR   Wikidata; Q54937951
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4464; PRLHR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PROKR1 beta-arrestin
AC   CVCL_KY84
DR   DiscoverX; 93-0303C2
DR   Wikidata; Q54937952
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4524; PROKR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PROKR2 beta-arrestin
AC   CVCL_KY85
DR   DiscoverX; 93-0282C2
DR   Wikidata; Q54937953
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15836; PROKR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PTAFR beta-arrestin
AC   CVCL_KY86
DR   DiscoverX; 93-0236C2
DR   Wikidata; Q54937954
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9582; PTAFR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PTGER2 beta-arrestin
AC   CVCL_KY87
DR   DiscoverX; 93-0214C2
DR   Wikidata; Q54937955
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9594; PTGER2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PTGER3 beta-arrestin
AC   CVCL_KY88
DR   DiscoverX; 93-0640C2
DR   Wikidata; Q54937956
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9595; PTGER3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PTGIR beta-arrestin
AC   CVCL_KY89
DR   DiscoverX; 93-0305C2
DR   Wikidata; Q54937957
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9602; PTGIR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PTHR1 beta-arrestin
AC   CVCL_KY90
DR   DiscoverX; 93-0315C2
DR   Wikidata; Q54937958
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9608; PTH1R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 PTHR2 beta-arrestin
AC   CVCL_KY91
DR   DiscoverX; 93-0306C2
DR   Wikidata; Q54937960
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9609; PTH2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 RARalpha Protein Interaction
AC   CVCL_KY92
DR   DiscoverX; 93-0325C2
DR   Wikidata; Q54937961
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9234; MED1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9864; RARA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 RARbeta Protein Interaction
AC   CVCL_KY93
DR   DiscoverX; 93-0326C2
DR   Wikidata; Q54937962
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7669; NCOA2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9865; RARB.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rCHRM4 beta-arrestin
AC   CVCL_KY94
DR   DiscoverX; 93-0870C2
DR   Wikidata; Q54937963
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2344; Chrm4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rCRTH2 beta-arrestin
AC   CVCL_KY95
DR   DiscoverX; 93-0580C2
DR   Wikidata; Q54937964
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 1311986; Ptgdr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rDRD1 beta-arrestin
AC   CVCL_KY96
DR   DiscoverX; 93-0620C2
DR   Wikidata; Q54937965
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2518; Drd1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rDRD2L beta-arrestin
AC   CVCL_KY97
DR   DiscoverX; 93-0785C2
DR   Wikidata; Q54937966
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2520; Drd2 (Note=Isoform long).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rDRD2S beta-arrestin
AC   CVCL_KY98
DR   DiscoverX; 93-0778C2
DR   Wikidata; Q54937967
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2520; Drd2 (Note=Isoform short).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rEDG5 beta-arrestin
AC   CVCL_KY99
DR   DiscoverX; 93-0582C2
DR   Wikidata; Q54937968
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 68334; S1pr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rGPR120 beta-arrestin
AC   CVCL_KZ00
DR   DiscoverX; 93-1031C2
DR   Wikidata; Q54937969
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 1308252; Ffar4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rGPR35 beta-arrestin
AC   CVCL_KZ01
DR   DiscoverX; 93-0887C2
DR   Wikidata; Q54937970
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 1309404; Gpr35.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rOPRM1 beta-arrestin
AC   CVCL_KZ02
DR   DiscoverX; 93-0494C2
DR   Wikidata; Q54937971
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3234; Oprm1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rPROKR1 beta-arrestin
AC   CVCL_KZ03
DR   DiscoverX; 93-0544C2
DR   Wikidata; Q54937972
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 708443; Prokr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rPROKR2 beta-arrestin
AC   CVCL_KZ04
DR   DiscoverX; 93-0482C2
DR   Wikidata; Q54937973
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 708445; Prokr2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 rVIPR1 beta-arrestin
AC   CVCL_KZ05
DR   DiscoverX; 93-0913C2
DR   Wikidata; Q54937974
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3961; Vipr1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 RXFP3 beta-arrestin
AC   CVCL_KZ06
DR   DiscoverX; 93-0692C2
DR   Wikidata; Q54937975
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24883; RXFP3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 RXFP4 beta-arrestin
AC   CVCL_KZ07
DR   DiscoverX; 93-0701C2
DR   Wikidata; Q54937976
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14666; RXFP4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 RXRgamma Protein Interaction
AC   CVCL_KZ08
DR   DiscoverX; 93-0327C2
DR   Wikidata; Q54937977
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7671; NCOA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10479; RXRG.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 SCTR beta-arrestin
AC   CVCL_KZ09
DR   DiscoverX; 93-0237C2
DR   Wikidata; Q54937978
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10608; SCTR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 sEDG5 beta-arrestin
AC   CVCL_KZ10
DR   DiscoverX; 93-0622C2
DR   Wikidata; Q54937979
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:77144; Macaca mulatta S1PR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 SSTR2 Activated GPCR Internalization
AC   CVCL_KZ11
SY   PathHunter SSTR2 Activated GPCR Internalization CHO-K1
DR   DiscoverX; 93-0676C2
DR   Wikidata; Q54937980
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11331; SSTR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 SSTR2 beta-arrestin
AC   CVCL_KZ12
DR   DiscoverX; 93-0181C2
DR   Wikidata; Q54937981
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11331; SSTR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 SSTR3 beta-arrestin
AC   CVCL_KZ13
DR   DiscoverX; 93-0244C2
DR   Wikidata; Q54937982
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11332; SSTR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 SSTR4 beta-arrestin
AC   CVCL_KZ14
DR   DiscoverX; 93-0308C2
DR   Wikidata; Q54937983
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11333; SSTR4.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 SSTR5 beta-arrestin
AC   CVCL_KZ15
DR   DiscoverX; 93-0402C2
DR   Wikidata; Q54937993
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11334; SSTR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 TAAR5 beta-arrestin
AC   CVCL_KZ16
DR   DiscoverX; 93-0718C2
DR   Wikidata; Q54937994
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30236; TAAR5.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 TACR1 beta-arrestin
AC   CVCL_KZ17
DR   DiscoverX; 93-0344C2
DR   Wikidata; Q54937995
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11526; TACR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 TACR2 beta-arrestin
AC   CVCL_KZ18
DR   DiscoverX; 93-0238C2
DR   Wikidata; Q54937996
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11527; TACR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 TACR3 beta-arrestin
AC   CVCL_KZ19
DR   DiscoverX; 93-0501C2
DR   Wikidata; Q54937997
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11528; TACR3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 THRalpha Protein Interaction
AC   CVCL_KZ20
DR   DiscoverX; 93-0324C2
DR   Wikidata; Q54937998
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7669; NCOA2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11796; THRA.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 THRbeta Protein Interaction
AC   CVCL_KZ21
DR   DiscoverX; 93-0391C2
DR   Wikidata; Q54937999
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9234; MED1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11799; THRB.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 TRHR beta-arrestin
AC   CVCL_KZ22
DR   DiscoverX; 93-0239C2
DR   Wikidata; Q54938000
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12299; TRHR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 UTR2 beta-arrestin
AC   CVCL_KZ23
DR   DiscoverX; 93-0283C2
DR   Wikidata; Q54938001
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4468; UTS2R.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 VIPR1 beta-arrestin
AC   CVCL_KZ24
DR   DiscoverX; 93-0316C2
DR   Wikidata; Q54938002
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12694; VIPR1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 VIPR2 beta-arrestin
AC   CVCL_KZ25
DR   DiscoverX; 93-0317C2
DR   Wikidata; Q54938003
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12695; VIPR2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter CHO-K1 XCR1 beta-arrestin
AC   CVCL_KZ26
DR   DiscoverX; 93-0958C2
DR   Wikidata; Q54938004
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1625; XCR1.
CC   Discontinued: DiscoverX; 93-0958C2; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter DLD1 FFAR1 beta-arrestin
AC   CVCL_KZ27
DR   DiscoverX; 93-0950C13
DR   Wikidata; Q54938005
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4498; FFAR1.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   PathHunter DLD1 HTR6 beta-arrestin
AC   CVCL_KZ28
DR   DiscoverX; 93-0294C13
DR   Wikidata; Q54938006
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5301; HTR6.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   PathHunter DLD1 mPTGER4 beta-arrestin
AC   CVCL_KZ29
DR   DiscoverX; 93-0982C13
DR   Wikidata; Q54938007
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104311; Ptger4.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   PathHunter DLD1 MTNR1A Total GPCR Internalization
AC   CVCL_KZ30
SY   PathHunter MTNR1A Total GPCR Internalization DLD1
DR   DiscoverX; 93-0847C13
DR   Wikidata; Q54938008
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7463; MTNR1A.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   PathHunter HEK 293 ADRA1D(82-572) beta-arrestin
AC   CVCL_KZ31
DR   DiscoverX; 93-0983C1
DR   Wikidata; Q54938009
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:280; ADRA1D.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PathHunter HEK 293 ADRB2 Total GPCR Internalization
AC   CVCL_KZ32
SY   PathHunter ADRB2 Total GPCR Internalization HEK 293
DR   DiscoverX; 93-0800C1
DR   Wikidata; Q54938010
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PathHunter HEK 293 AVPR2 beta-arrestin
AC   CVCL_KZ33
DR   DiscoverX; 93-0187C1
DR   Wikidata; Q54938011
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:897; AVPR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 BDKRB2 beta-arrestin
AC   CVCL_KZ34
DR   DiscoverX; 93-0189C1
DR   Wikidata; Q54938013
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 beta-arrestin1-EA Parental
AC   CVCL_KZ35
DR   DiscoverX; 93-0798
DR   Wikidata; Q54938014
CC   Characteristics: PathHunter beta-arrestin parental cell lines express a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA). They can be used to introduce a GPCR tagged with another beta-galactosidase fragment (ProLink=PK).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PathHunter HEK 293 beta-arrestin2-EA Parental
AC   CVCL_KZ36
DR   DiscoverX; 93-0165
DR   Wikidata; Q54938015
CC   Characteristics: PathHunter beta-arrestin parental cell lines express a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA). They can be used to introduce a GPCR tagged with another beta-galactosidase fragment (ProLink=PK).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PathHunter HEK 293 CCKAR beta-arrestin
AC   CVCL_KZ37
DR   DiscoverX; 93-0190C1
DR   Wikidata; Q54938017
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1570; CCKAR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 CCR2 beta-arrestin
AC   CVCL_KZ38
DR   DiscoverX; 93-0192C1
DR   Wikidata; Q54938018
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1603; CCR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 CCR7 beta-arrestin
AC   CVCL_KZ39
DR   DiscoverX; 93-0195C1
DR   Wikidata; Q54938019
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1608; CCR7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 CNR2 beta-arrestin
AC   CVCL_KZ40
DR   DiscoverX; 93-0201C1
DR   Wikidata; Q54938020
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2160; CNR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 CXCR2 beta-arrestin
AC   CVCL_KZ41
DR   DiscoverX; 93-0202C1
DR   Wikidata; Q54938021
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6027; CXCR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 CXCR6 beta-arrestin
AC   CVCL_KZ42
DR   DiscoverX; 93-0205C1
DR   Wikidata; Q54938022
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16647; CXCR6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 cyno CXCR1 beta-arrestin
AC   CVCL_KZ43
DR   DiscoverX; 93-0980C1
DR   Wikidata; Q54938023
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G7PLE8; Macaca fascicularis CXCR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 cyno CXCR2 beta-arrestin
AC   CVCL_KZ44
DR   DiscoverX; 93-0981C1
DR   Wikidata; Q54938024
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G7PLE7; Macaca fascicularis CXCR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 EDG1 Total GPCR Internalization
AC   CVCL_KZ45
SY   PathHunter EDG1 Total GPCR Internalization HEK 293
DR   DiscoverX; 93-0784C1
DR   Wikidata; Q54938025
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3165; S1PR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PathHunter HEK 293 EDG3 beta-arrestin
AC   CVCL_KZ46
DR   DiscoverX; 93-0217C1
DR   Wikidata; Q54938026
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3167; S1PR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 F2RL1 beta-arrestin
AC   CVCL_KZ47
DR   DiscoverX; 93-0235C1
DR   Wikidata; Q54938028
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3538; F2RL1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 FFAR1 beta-arrestin-1
AC   CVCL_KZ48
DR   DiscoverX; 93-0977C1
DR   Wikidata; Q54938029
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4498; FFAR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 GCGR Total GPCR Internalization
AC   CVCL_KZ49
SY   PathHunter GCGR Total GPCR Internalization HEK 293
DR   DiscoverX; 93-0820C1
DR   Wikidata; Q54938030
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4192; GCGR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PathHunter HEK 293 GPR119 beta-arrestin
AC   CVCL_KZ50
DR   DiscoverX; 93-0356C1
DR   Wikidata; Q54938031
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19060; GPR119.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 GPR120L Total GPCR Internalization
AC   CVCL_KZ51
SY   PathHunter GPR120L Total GPCR Internalization HEK 293
DR   DiscoverX; 93-0801C1
DR   Wikidata; Q54938032
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19061; FFAR4 (Note=Isoform 1).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PathHunter HEK 293 GPR150 beta-arrestin
AC   CVCL_KZ52
DR   DiscoverX; 93-0375C1A
DR   Wikidata; Q54938033
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23628; GPR150.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 GPR152 beta-arrestin
AC   CVCL_KZ53
DR   DiscoverX; 93-0384C1A
DR   Wikidata; Q54938034
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23622; GPR152.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 GPR173 beta-arrestin
AC   CVCL_KZ54
DR   DiscoverX; 93-0380C1A
DR   Wikidata; Q54938035
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18186; GPR173.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 GPR20 beta-arrestin
AC   CVCL_KZ55
DR   DiscoverX; 93-0405C1
DR   Wikidata; Q54938048
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4475; GPR20.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 GPR45 beta-arrestin
AC   CVCL_KZ56
DR   DiscoverX; 93-0374C1A
DR   Wikidata; Q54938049
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4503; GPR45.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 GRPR beta-arrestin
AC   CVCL_KZ57
DR   DiscoverX; 93-0229C1
DR   Wikidata; Q54938050
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4609; GRPR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 IkappaB Degradation
AC   CVCL_KZ58
DR   DiscoverX; 93-0538C1
DR   Wikidata; Q54938051
CC   Characteristics: PathHunter degradation cell lines express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED). Pathway activation results in the degradation of the target protein. The degraded protein is detected by adding to the cell lysis buffer another beta-galactosidase fragment (Enzyme Acceptor=EA). Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 LXRbeta-NCoR1 Protein Interaction
AC   CVCL_KZ59
DR   DiscoverX; 93-0856C1
DR   Wikidata; Q54938052
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7672; NCOR1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7965; NR1H2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 mGPR120 beta-arrestin
AC   CVCL_KZ60
DR   DiscoverX; 93-0849C1
DR   Wikidata; Q54938053
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2147577; Ffar4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 P2RY4 beta-arrestin
AC   CVCL_KZ61
DR   DiscoverX; 93-0263C1
DR   Wikidata; Q54938054
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8542; P2RY4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 PTGER2 beta-arrestin
AC   CVCL_KZ62
DR   DiscoverX; 93-0214C1
DR   Wikidata; Q54938055
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9594; PTGER2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 PTGER4 beta-arrestin
AC   CVCL_KZ63
DR   DiscoverX; 93-0304C1
DR   Wikidata; Q54938056
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9596; PTGER4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 PTGIR beta-arrestin
AC   CVCL_KZ64
DR   DiscoverX; 93-0305C1
DR   Wikidata; Q54938058
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9602; PTGIR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 RELA-IkappaB Nuclear Translocation
AC   CVCL_KZ65
SY   PathHunter HEK 293 RELA Nuclear Translocation
DR   DiscoverX; 93-0907C1
DR   Wikidata; Q54938059
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9955; RELA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 SCTR beta-arrestin
AC   CVCL_KZ66
DR   DiscoverX; 93-0237C1
DR   Wikidata; Q54938060
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10608; SCTR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter HEK 293 SSTR3 beta-arrestin
AC   CVCL_KZ67
DR   DiscoverX; 93-0244C1
DR   Wikidata; Q54938061
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11332; SSTR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PathHunter Jurkat IkappaB Degradation
AC   CVCL_KZ68
DR   cancercelllines; CVCL_KZ68
DR   DiscoverX; 93-1121C19
DR   Wikidata; Q54938062
CC   Population: Caucasian.
CC   Characteristics: PathHunter degradation cell lines express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED). Pathway activation results in the degradation of the target protein. The degraded protein is detected by adding to the cell lysis buffer another beta-galactosidase fragment (Enzyme Acceptor=EA). Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 17
//
ID   PathHunter NCI-H460 CDC25A Degradation
AC   CVCL_KZ69
DR   cancercelllines; CVCL_KZ69
DR   DiscoverX; 93-0776C12
DR   Wikidata; Q54938063
CC   Population: Caucasian.
CC   Characteristics: PathHunter degradation cell lines express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED). Pathway activation results in the degradation of the target protein. The degraded protein is detected by adding to the cell lysis buffer another beta-galactosidase fragment (Enzyme Acceptor=EA). Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1725; CDC25A.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   PathHunter THP-1 IkappaB Degradation
AC   CVCL_KZ70
DR   cancercelllines; CVCL_KZ70
DR   DiscoverX; 93-0538C14
DR   Wikidata; Q54938064
CC   Population: Japanese.
CC   Characteristics: PathHunter degradation cell lines express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED). Pathway activation results in the degradation of the target protein. The degraded protein is detected by adding to the cell lysis buffer another beta-galactosidase fragment (Enzyme Acceptor=EA). Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   PathHunter U2OS ADCYAP1R1 Total GPCR Internalization
AC   CVCL_KZ71
SY   PathHunter ADCYAP1R1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0885C3
DR   Wikidata; Q54938066
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS ADRA2C Total GPCR Internalization
AC   CVCL_KZ72
SY   PathHunter ADRA2C Total GPCR Internalization U2OS
DR   DiscoverX; 93-0923C3
DR   Wikidata; Q54938067
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:283; ADRA2C.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS AGTRL1 Activated GPCR Internalization
AC   CVCL_KZ73
SY   PathHunter AGTRL1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0710C3
DR   Wikidata; Q54938068
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   PathHunter U2OS AHR Protein Interaction
AC   CVCL_KZ74
DR   DiscoverX; 93-1113C3
DR   Wikidata; Q54938069
CC   Population: Caucasian.
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:348; AHR.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:700; ARNT (Note=With p.Met1_Lys155del and p.Ser271_Glu789del).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS AVPR1A beta-arrestin
AC   CVCL_KZ75
DR   DiscoverX; 93-0587C3
DR   Wikidata; Q54938070
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:895; AVPR1A.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS AVPR1A Total GPCR Internalization
AC   CVCL_KZ76
SY   PathHunter AVPR1A Total GPCR Internalization U2OS
DR   DiscoverX; 93-0751C3
DR   Wikidata; Q54938072
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:895; AVPR1A.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS AVPR1B Activated GPCR Internalization
AC   CVCL_KZ77
SY   PathHunter AVPR1B Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0722C3
DR   Wikidata; Q54938073
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:896; AVPR1B.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS AVPR2 Activated GPCR Internalization
AC   CVCL_KZ78
SY   PathHunter AVPR2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0709C3
DR   Wikidata; Q54938074
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:897; AVPR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS BDKRB2 Activated GPCR Internalization
AC   CVCL_KZ79
SY   PathHunter BDKRB2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0725C3
DR   Wikidata; Q54938076
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS beta-arrestin1-EA Parental
AC   CVCL_KZ80
DR   DiscoverX; 93-0318
DR   Wikidata; Q54938077
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin parental cell lines express a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA). They can be used to introduce a GPCR tagged with another beta-galactosidase fragment (ProLink=PK).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS beta-arrestin2-EA Parental
AC   CVCL_KZ81
DR   DiscoverX; 93-0166
DR   Wikidata; Q54938078
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin parental cell lines express a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA). They can be used to introduce a GPCR tagged with another beta-galactosidase fragment (ProLink=PK).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS beta-Catenin Nuclear Translocation
AC   CVCL_KZ82
DR   DiscoverX; 93-0743C3
DR   Wikidata; Q54938079
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2514; CTNNB1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS C3AR1 Activated GPCR Internalization
AC   CVCL_KZ83
SY   PathHunter C3AR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0771C3
DR   Wikidata; Q54938081
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1319; C3AR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS C3AR1 beta-arrestin
AC   CVCL_KZ84
DR   DiscoverX; 93-0814C3
DR   Wikidata; Q54938082
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1319; C3AR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS C5AR1 Activated GPCR Internalization
AC   CVCL_KZ85
SY   PathHunter C5AR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0777C3
DR   Wikidata; Q54938083
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1338; C5AR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS C5L2 Activated GPCR Internalization
AC   CVCL_KZ86
SY   PathHunter C5L2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0736C3
DR   Wikidata; Q54938084
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4527; C5AR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CALCR beta-arrestin
AC   CVCL_KZ87
DR   DiscoverX; 93-0566C3
DR   Wikidata; Q54938085
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1440; CALCR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCKAR Activated GPCR Internalization
AC   CVCL_KZ88
SY   PathHunter CCKAR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0650C3
DR   Wikidata; Q54938086
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1570; CCKAR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCKBR Activated GPCR Internalization
AC   CVCL_KZ89
SY   PathHunter CCKBR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0708C3
DR   Wikidata; Q54938087
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1571; CCKBR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCR1 Activated GPCR Internalization
AC   CVCL_KZ90
SY   PathHunter CCR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0651C3
DR   Wikidata; Q54938088
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1602; CCR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCR1 beta-arrestin-1
AC   CVCL_KZ91
DR   DiscoverX; 93-0254C3
DR   Wikidata; Q54938090
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1602; CCR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCR10 Activated GPCR Internalization
AC   CVCL_KZ92
SY   PathHunter CCR10 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0783C3
DR   Wikidata; Q54938091
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4474; CCR10.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCR10 beta-arrestin
AC   CVCL_KZ93
DR   DiscoverX; 93-0276C3
DR   Wikidata; Q54938092
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4474; CCR10.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCR2 Total GPCR Internalization
AC   CVCL_KZ94
SY   PathHunter CCR2 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0679C3
DR   Wikidata; Q54938093
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1603; CCR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS CCR4 Total GPCR Internalization
AC   CVCL_KZ95
SY   PathHunter CCR4 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0845C3
DR   Wikidata; Q54938104
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1605; CCR4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS CCR5 Activated GPCR Internalization
AC   CVCL_KZ96
SY   PathHunter CCR5 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0653C3
DR   Wikidata; Q54938105
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCR6 Activated GPCR Internalization
AC   CVCL_KZ97
SY   PathHunter CCR6 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0966C3
DR   Wikidata; Q54938106
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1607; CCR6.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CCR7 Activated GPCR Internalization
AC   CVCL_KZ98
SY   PathHunter CCR7 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0740C3
DR   Wikidata; Q54938107
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1608; CCR7.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CDC25A Degradation
AC   CVCL_KZ99
DR   DiscoverX; 93-0765C3
DR   Wikidata; Q54938108
CC   Population: Caucasian.
CC   Characteristics: PathHunter degradation cell lines express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED). Pathway activation results in the degradation of the target protein. The degraded protein is detected by adding to the cell lysis buffer another beta-galactosidase fragment (Enzyme Acceptor=EA). Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1725; CDC25A.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   PathHunter U2OS CHRM1 Activated GPCR Internalization
AC   CVCL_LA00
SY   PathHunter CHRM1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0655C3
DR   Wikidata; Q54938109
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CHRM1 beta-arrestin
AC   CVCL_LA01
DR   DiscoverX; 93-0859C3
DR   Wikidata; Q54938110
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CHRM2 Activated GPCR Internalization
AC   CVCL_LA02
SY   PathHunter CHRM2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0656C3
DR   Wikidata; Q54938112
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1951; CHRM2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CHRM3 beta-arrestin
AC   CVCL_LA03
DR   DiscoverX; 93-0860C3
DR   Wikidata; Q54938113
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1952; CHRM3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CHRM3 Total GPCR Internalization
AC   CVCL_LA04
SY   PathHunter CHRM3 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0775C3
DR   Wikidata; Q54938114
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1952; CHRM3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS CHRM4 Total GPCR Internalization
AC   CVCL_LA05
SY   PathHunter CHRM4 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0902C3
DR   Wikidata; Q54938115
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1953; CHRM4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS CHRM5 Activated GPCR Internalization
AC   CVCL_LA06
SY   PathHunter CHRM5 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0657C3
DR   Wikidata; Q54938116
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1954; CHRM5.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CMKLR1 Activated GPCR Internalization
AC   CVCL_LA07
SY   PathHunter CMKLR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0720C3
DR   Wikidata; Q54938117
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2121; CMKLR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CRHR1 Activated GPCR Internalization
AC   CVCL_LA08
SY   PathHunter CRHR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0726C3
DR   Wikidata; Q54938118
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2357; CRHR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CRHR2 Activated GPCR Internalization
AC   CVCL_LA09
SY   PathHunter CRHR2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0752C3
DR   Wikidata; Q54938119
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2358; CRHR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CRTH2 beta-arrestin
AC   CVCL_LA10
DR   DiscoverX; 93-0559C3
DR   Wikidata; Q54938120
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4502; PTGDR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CXCR1 Activated GPCR Internalization
AC   CVCL_LA11
SY   PathHunter CXCR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0659C3
DR   Wikidata; Q54938121
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6026; CXCR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CXCR1 beta-arrestin
AC   CVCL_LA12
DR   DiscoverX; 93-0226C3
DR   Wikidata; Q54938122
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6026; CXCR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CXCR2 Activated GPCR Internalization
AC   CVCL_LA13
SY   PathHunter CXCR2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0934C3
DR   Wikidata; Q54938123
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6027; CXCR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CXCR3 Activated GPCR Internalization
AC   CVCL_LA14
SY   PathHunter CXCR3 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0661C3
DR   Wikidata; Q54938124
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CXCR3 beta-arrestin
AC   CVCL_LA15
DR   DiscoverX; 93-0271C3
DR   Wikidata; Q54938125
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS CXCR4 Total GPCR Internalization
AC   CVCL_LA16
SY   PathHunter CXCR4 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0890C3
DR   Wikidata; Q54938126
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2561; CXCR4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS CXCR5 beta-arrestin
AC   CVCL_RQ22
DR   DiscoverX; 93-0204C3
DR   Wikidata; Q54938127
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1060; CXCR5.
CC   Discontinued: DiscoverX; 93-0204C3; true.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   PathHunter U2OS CXCR6 Total GPCR Internalization
AC   CVCL_LA17
SY   PathHunter CXCR6 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0886C3
DR   Wikidata; Q54938128
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16647; CXCR6.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS CXCR7 Activated GPCR Internalization
AC   CVCL_LA18
SY   PathHunter CXCR7 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0738C3
DR   Wikidata; Q54938129
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23692; ACKR3.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS DRD1 Total GPCR Internalization
AC   CVCL_LA19
SY   PathHunter DRD1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0748C3
DR   Wikidata; Q54938131
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3020; DRD1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS DRD3 beta-arrestin
AC   CVCL_LA20
DR   DiscoverX; 93-0591C3
DR   Wikidata; Q54938133
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3024; DRD3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS EBI2 Total GPCR Internalization
AC   CVCL_LA21
SY   PathHunter EBI2 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0910C3
DR   Wikidata; Q54938134
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3128; GPR183.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS EDG2 Activated GPCR Internalization
AC   CVCL_LA22
SY   PathHunter EDG2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0839C3
DR   Wikidata; Q54938135
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3166; LPAR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS EDG3 Activated GPCR Internalization
AC   CVCL_LA23
SY   PathHunter EDG3 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0663C3
DR   Wikidata; Q54938136
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3167; S1PR3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS EDG5 Activated GPCR Internalization
AC   CVCL_LA24
SY   PathHunter EDG5 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0735C3
DR   Wikidata; Q54938137
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3169; S1PR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS EDG7 Activated GPCR Internalization
AC   CVCL_LA25
SY   PathHunter EDG7 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0664C3
DR   Wikidata; Q54938138
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14298; LPAR3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS EDNRB Total GPCR Internalization
AC   CVCL_LA26
SY   PathHunter EDNRB Total GPCR Internalization U2OS
DR   DiscoverX; 93-0874C3
DR   Wikidata; Q54938139
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3180; EDNRB.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS F2RL1 Activated GPCR Internalization
AC   CVCL_LA27
SY   PathHunter F2RL1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0747C3
DR   Wikidata; Q54938141
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3538; F2RL1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS F2RL1 beta-arrestin
AC   CVCL_LA28
DR   DiscoverX; 93-0235C3
DR   Wikidata; Q54938142
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3538; F2RL1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS F2RL3 Activated GPCR Internalization
AC   CVCL_LA29
SY   PathHunter F2RL3 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0753C3
DR   Wikidata; Q54938143
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3540; F2RL3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS FOXO3 Nuclear Translocation
AC   CVCL_LA30
DR   DiscoverX; 93-0876C3
DR   Wikidata; Q54938144
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3821; FOXO3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS FPR1 Total GPCR Internalization
AC   CVCL_LA31
SY   PathHunter FPR1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0873C3
DR   Wikidata; Q54938145
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3826; FPR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS FPRL1 Activated GPCR Internalization
AC   CVCL_LA32
SY   PathHunter FPRL1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0666C3
DR   Wikidata; Q54938146
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3827; FPR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GALR1 Total GPCR Internalization
AC   CVCL_LA33
SY   PathHunter GALR1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0781C3
DR   Wikidata; Q54938147
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4132; GALR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS GHSR1a beta-arrestin-1
AC   CVCL_LA34
SY   PathHunter U2OS GHSR1 beta-arrestin-1
DR   DiscoverX; 93-0242C3
DR   Wikidata; Q54938158
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4267; GHSR (Note=Isoform 1a).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GLP1R Activated GPCR Internalization
AC   CVCL_LA35
SY   PathHunter GLP1R Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0724C3
DR   Wikidata; Q54938159
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GLP1R Total GPCR Internalization
AC   CVCL_LA36
SY   PathHunter GLP1R Total GPCR Internalization U2OS
DR   DiscoverX; 93-1075C3
DR   Wikidata; Q54938161
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4324; GLP1R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS GLP2R Activated GPCR Internalization
AC   CVCL_LA37
SY   PathHunter GLP2R Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0750C3
DR   Wikidata; Q54938162
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4325; GLP2R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPBAR1 beta-arrestin
AC   CVCL_LA38
DR   DiscoverX; 93-0794C3
DR   Wikidata; Q54938163
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19680; GPBAR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPR1 Total GPCR Internalization
AC   CVCL_LA39
SY   PathHunter GPR1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0749C3
DR   Wikidata; Q54938164
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4463; CMKLR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   PathHunter U2OS GPR119 beta-arrestin
AC   CVCL_LA40
DR   DiscoverX; 93-0356C3
DR   Wikidata; Q54938165
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19060; GPR119.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPR17 beta-arrestin
AC   CVCL_LA41
DR   DiscoverX; 93-0633C3
DR   Wikidata; Q54938166
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4471; GPR17.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPR22 beta-arrestin
AC   CVCL_LA42
DR   DiscoverX; 93-1085C3
DR   Wikidata; Q54938167
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4477; GPR22.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPR35 Activated GPCR Internalization
AC   CVCL_LA43
SY   PathHunter GPR35 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0968C3
DR   Wikidata; Q54938168
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4492; GPR35.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPR52 beta-arrestin
AC   CVCL_LA44
DR   DiscoverX; 93-0371C3
DR   Wikidata; Q54938169
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4508; GPR52.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPR6 beta-arrestin
AC   CVCL_LA45
DR   DiscoverX; 93-0634C3
DR   Wikidata; Q54938170
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4515; GPR6.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GPR85 beta-arrestin
AC   CVCL_LA46
DR   DiscoverX; 93-0409C3
DR   Wikidata; Q54938171
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4536; GPR85.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GRPR Activated GPCR Internalization
AC   CVCL_LA47
SY   PathHunter GRPR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0667C3
DR   Wikidata; Q54938172
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4609; GRPR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS GRPR beta-arrestin
AC   CVCL_LA48
DR   DiscoverX; 93-0229C3
DR   Wikidata; Q54938173
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4609; GRPR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HCRTR1 Total GPCR Internalization
AC   CVCL_LA49
SY   PathHunter HCRTR1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0729C3
DR   Wikidata; Q54938174
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4848; HCRTR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS HCRTR2 Total GPCR Internalization
AC   CVCL_LA50
SY   PathHunter HCRTR2 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0730C3
DR   Wikidata; Q54938175
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4849; HCRTR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS HRH4 beta-arrestin
AC   CVCL_LA51
DR   DiscoverX; 93-0209C3
DR   Wikidata; Q54938176
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17383; HRH4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HTR1B beta-arrestin
AC   CVCL_LA52
DR   DiscoverX; 93-0697C3
DR   Wikidata; Q54938177
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5287; HTR1B.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HTR1E beta-arrestin
AC   CVCL_LA53
DR   DiscoverX; 93-1030C3
DR   Wikidata; Q54938180
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5291; HTR1E.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HTR1F beta-arrestin
AC   CVCL_LA54
DR   DiscoverX; 93-0699C3
DR   Wikidata; Q54938181
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5292; HTR1F.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HTR2A beta-arrestin
AC   CVCL_LA55
DR   DiscoverX; 93-0401C3
DR   Wikidata; Q54938182
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5293; HTR2A.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HTR2A Total GPCR Internalization
AC   CVCL_LA56
SY   PathHunter HTR2A Total GPCR Internalization U2OS
DR   DiscoverX; 93-0807C3
DR   Wikidata; Q54938183
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5293; HTR2A.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS HTR2C Activated GPCR Internalization
AC   CVCL_LA57
SY   PathHunter HTR2C Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0669C3
DR   Wikidata; Q54938184
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HTR2C beta-arrestin
AC   CVCL_LA58
DR   DiscoverX; 93-0289C3
DR   Wikidata; Q54938185
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS HTR2C(VGV) beta-arrestin
AC   CVCL_LA59
DR   DiscoverX; 93-0932C3
DR   Wikidata; Q54938186
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C (Note=With p.Ile156Val, p.Asn158Gly and p.Ile160Val).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   PathHunter U2OS HTR2C(VNV) beta-arrestin
AC   CVCL_LA60
DR   DiscoverX; 93-0938C3
DR   Wikidata; Q54938187
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C (Note=With p.Ile156Val and p.Ile160Val).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   PathHunter U2OS HTR2C(VSV) beta-arrestin
AC   CVCL_LA61
DR   DiscoverX; 93-0921C3
DR   Wikidata; Q54938188
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C (Note=With p.Ile156Val, p.Asn158Ser and p.Ile160Val).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   PathHunter U2OS HTR5A beta-arrestin
AC   CVCL_LA62
DR   DiscoverX; 93-0700C3
DR   Wikidata; Q54938189
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5300; HTR5A.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS IkappaB Degradation
AC   CVCL_LA63
DR   DiscoverX; 93-0538C3
DR   Wikidata; Q54938191
CC   Population: Caucasian.
CC   Characteristics: PathHunter degradation cell lines express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED). Pathway activation results in the degradation of the target protein. The degraded protein is detected by adding to the cell lysis buffer another beta-galactosidase fragment (Enzyme Acceptor=EA). Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   PathHunter U2OS Keap1-NRF2 Nuclear Translocation
AC   CVCL_LA64
DR   DiscoverX; 93-0821C3
DR   Wikidata; Q54938192
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23177; KEAP1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7782; NFE2L2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS KISS1R beta-arrestin
AC   CVCL_LA65
DR   DiscoverX; 93-0927C3
DR   Wikidata; Q54938193
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4510; KISS1R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS LTB4R Total GPCR Internalization
AC   CVCL_LA66
SY   PathHunter LTB4R Total GPCR Internalization U2OS
DR   DiscoverX; 93-0810C3
DR   Wikidata; Q54938194
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6713; LTB4R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS MC1R beta-arrestin
AC   CVCL_LA67
DR   DiscoverX; 93-0861C3
DR   Wikidata; Q54938195
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6929; MC1R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MC3R beta-arrestin
AC   CVCL_LA68
DR   DiscoverX; 93-0984C3
DR   Wikidata; Q54938196
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6931; MC3R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MC3R Total GPCR Internalization
AC   CVCL_LA69
SY   PathHunter MC3R Total GPCR Internalization U2OS
DR   DiscoverX; 93-0837C3
DR   Wikidata; Q54938197
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6931; MC3R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS MC4R beta-arrestin
AC   CVCL_LA70
DR   DiscoverX; 93-0211C3
DR   Wikidata; Q54938198
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6932; MC4R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MC5R beta-arrestin
AC   CVCL_LA71
DR   DiscoverX; 93-0231C3
DR   Wikidata; Q54938199
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6933; MC5R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mCCR1 beta-arrestin
AC   CVCL_LA72
DR   DiscoverX; 93-0561C3
DR   Wikidata; Q54938200
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104618; Ccr1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mCCR2 beta-arrestin
AC   CVCL_LA73
DR   DiscoverX; 93-0543C3
DR   Wikidata; Q54938201
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:106185; Ccr2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MCHR1 beta-arrestin
AC   CVCL_LA74
DR   DiscoverX; 93-0940C3
DR   Wikidata; Q54938215
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4479; MCHR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MCHR1 beta-arrestin-1
AC   CVCL_LA75
DR   DiscoverX; 93-0243C3
DR   Wikidata; Q54938216
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4479; MCHR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MCHR1 Total GPCR Internalization
AC   CVCL_LA76
SY   PathHunter MCHR1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0947C3
DR   Wikidata; Q54938217
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4479; MCHR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS MCHR2 beta-arrestin
AC   CVCL_LA77
DR   DiscoverX; 93-0691C3
DR   Wikidata; Q54938218
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20867; MCHR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mCXCR4 beta-arrestin
AC   CVCL_LA78
DR   DiscoverX; 93-0481C3
DR   Wikidata; Q54938219
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109563; Cxcr4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mCXCR7 beta-arrestin
AC   CVCL_LA79
DR   DiscoverX; 93-0689C3
DR   Wikidata; Q54938221
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109562; Ackr3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mFFAR1 beta-arrestin
AC   CVCL_LA80
DR   DiscoverX; 93-0975C3
DR   Wikidata; Q54938222
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2684079; Ffar1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mGIPR beta-arrestin
AC   CVCL_LA81
DR   DiscoverX; 93-0846C3
DR   Wikidata; Q54938223
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1352753; Gipr.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mHTR2C beta-arrestin
AC   CVCL_LA82
DR   DiscoverX; 93-0790C3
DR   Wikidata; Q54938224
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96281; Htr2c.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MLNR Activated GPCR Internalization
AC   CVCL_LA83
SY   PathHunter MLNR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0737C3
DR   Wikidata; Q54938225
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4495; MLNR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mNPY1R beta-arrestin
AC   CVCL_LA84
DR   DiscoverX; 93-0610C3
DR   Wikidata; Q54938226
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104963; Npy1r.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mOPRM1 beta-arrestin
AC   CVCL_LA85
DR   DiscoverX; 93-0524C3
DR   Wikidata; Q54938227
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97441; Oprm1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS mP2RY12 beta-arrestin
AC   CVCL_LA86
DR   DiscoverX; 93-0695C3
DR   Wikidata; Q54938228
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1918089; P2ry12.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS MTNR1B Total GPCR Internalization
AC   CVCL_LA87
SY   PathHunter MTNR1B Total GPCR Internalization U2OS
DR   DiscoverX; 93-0881C3
DR   Wikidata; Q54938229
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7464; MTNR1B.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS NMBR Total GPCR Internalization
AC   CVCL_LA88
SY   PathHunter NMBR Total GPCR Internalization U2OS
DR   DiscoverX; 93-0939C3
DR   Wikidata; Q54938230
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7843; NMBR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS NMU1R beta-arrestin
AC   CVCL_LA89
DR   DiscoverX; 93-0232C3
DR   Wikidata; Q54938231
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4518; NMUR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS NMU1R Total GPCR Internalization
AC   CVCL_LA90
SY   PathHunter NMU1R Total GPCR Internalization U2OS
DR   DiscoverX; 93-0782C3
DR   Wikidata; Q54938232
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4518; NMUR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS NPSR1 beta-arrestin
AC   CVCL_LA91
DR   DiscoverX; 93-0822C3
DR   Wikidata; Q54938233
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23631; NPSR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS NPY2R Activated GPCR Internalization
AC   CVCL_LA92
SY   PathHunter NPY2R Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0721C3
DR   Wikidata; Q54938234
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7957; NPY2R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS NTSR1 Activated GPCR Internalization
AC   CVCL_LA93
SY   PathHunter NTSR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0671C3
DR   Wikidata; Q54938235
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8039; NTSR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS OPRD1 Activated GPCR Internalization
AC   CVCL_LA94
SY   PathHunter OPRD1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0673C3
DR   Wikidata; Q54938236
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8153; OPRD1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS OPRD1 beta-arrestin
AC   CVCL_LA95
DR   DiscoverX; 93-0400C3
DR   Wikidata; Q54938237
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8153; OPRD1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS OPRD1 beta-arrestin-1
AC   CVCL_LA96
DR   DiscoverX; 93-1084C3
DR   Wikidata; Q54938238
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8153; OPRD1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS OPRK1 beta-arrestin
AC   CVCL_LA97
DR   DiscoverX; 93-0234C3
DR   Wikidata; Q54938239
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8154; OPRK1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS OPRK1 Total GPCR Internalization
AC   CVCL_LA98
SY   PathHunter OPRK1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0828C3
DR   Wikidata; Q54938241
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8154; OPRK1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS OPRL1 Total GPCR Internalization
AC   CVCL_LA99
SY   PathHunter OPRL1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0904C3
DR   Wikidata; Q54938242
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8155; OPRL1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS OPRM1 beta-arrestin
AC   CVCL_LB00
DR   DiscoverX; 93-0213C3
DR   Wikidata; Q54938244
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8156; OPRM1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS OPRM1 beta-arrestin-1
AC   CVCL_LB01
DR   DiscoverX; 93-0878C3
DR   Wikidata; Q54938245
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8156; OPRM1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS OPRM1 Total GPCR Internalization
AC   CVCL_LB02
SY   PathHunter OPRM1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0745C3
DR   Wikidata; Q54938246
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8156; OPRM1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS OXER1 Total GPCR Internalization
AC   CVCL_LB03
SY   PathHunter OXER1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0955C3
DR   Wikidata; Q54938247
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24884; OXER1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS OXTR Activated GPCR Internalization
AC   CVCL_LB04
SY   PathHunter OXTR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0715C3
DR   Wikidata; Q54938248
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8529; OXTR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS P2RY1 Activated GPCR Internalization
AC   CVCL_LB05
SY   PathHunter P2RY1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0967C3
DR   Wikidata; Q54938249
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8539; P2RY1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS P2RY1 beta-arrestin
AC   CVCL_LB06
DR   DiscoverX; 93-0941C3
DR   Wikidata; Q54938251
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8539; P2RY1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS P2RY12 Total GPCR Internalization
AC   CVCL_LB07
SY   PathHunter P2RY12 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0952C3
DR   Wikidata; Q54938252
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18124; P2RY12.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS P2RY2 Activated GPCR Internalization
AC   CVCL_LB08
SY   PathHunter P2RY2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0719C3
DR   Wikidata; Q54938253
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8541; P2RY2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS P2RY2 beta-arrestin
AC   CVCL_LB09
DR   DiscoverX; 93-0628C3
DR   Wikidata; Q54938254
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8541; P2RY2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS P2RY4 Activated GPCR Internalization
AC   CVCL_LB10
SY   PathHunter P2RY4 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0741C3
DR   Wikidata; Q54938255
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8542; P2RY4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS p53 Nuclear Translocation
AC   CVCL_LB11
DR   DiscoverX; 93-0757C3
DR   Wikidata; Q54938256
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS PRalpha Protein Interaction
AC   CVCL_LB12
DR   DiscoverX; 93-0852C3
DR   Wikidata; Q54938257
CC   Population: Caucasian.
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7671; NCOA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8910; PGR (Note=Isoform A).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PRbeta Protein Interaction
AC   CVCL_LB13
DR   DiscoverX; 93-0851C3
DR   Wikidata; Q54938258
CC   Population: Caucasian.
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7671; NCOA4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8910; PGR (Note=Isoform B).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PRLHR Activated GPCR Internalization
AC   CVCL_LB14
SY   PathHunter PRLHR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0766C3
DR   Wikidata; Q54938270
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4464; PRLHR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PROKR1 Total GPCR Internalization
AC   CVCL_LB15
SY   PathHunter PROKR1 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0764C3
DR   Wikidata; Q54938272
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4524; PROKR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS PROKR2 Total GPCR Internalization
AC   CVCL_LB16
SY   PathHunter PROKR2 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0728C3
DR   Wikidata; Q54938273
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15836; PROKR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS PTAFR Activated GPCR Internalization
AC   CVCL_LB17
SY   PathHunter PTAFR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0680C3
DR   Wikidata; Q54938275
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9582; PTAFR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PTGER1 beta-arrestin
AC   CVCL_LB18
DR   DiscoverX; 93-0937C3
DR   Wikidata; Q54938276
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9593; PTGER1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PTGER4 Activated GPCR Internalization
AC   CVCL_LB19
SY   PathHunter PTGER4 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0772C3
DR   Wikidata; Q54938277
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9596; PTGER4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PTGER4 beta-arrestin
AC   CVCL_LB20
DR   DiscoverX; 93-0304C3
DR   Wikidata; Q54938279
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9596; PTGER4.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PTGFR beta-arrestin
AC   CVCL_LB21
DR   DiscoverX; 93-0936C3
DR   Wikidata; Q54938280
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9600; PTGFR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PTGFR Total GPCR Internalization
AC   CVCL_LB22
SY   PathHunter PTGFR Total GPCR Internalization U2OS
DR   DiscoverX; 93-0872C3
DR   Wikidata; Q54938281
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9600; PTGFR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS PTGIR Total GPCR Internalization
AC   CVCL_LB23
SY   PathHunter PTGIR Total GPCR Internalization U2OS
DR   DiscoverX; 93-0838C3
DR   Wikidata; Q54938282
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9602; PTGIR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS PTHR1 Activated GPCR Internalization
AC   CVCL_LB24
SY   PathHunter PTHR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0770C3
DR   Wikidata; Q54938283
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9608; PTH1R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS PTHR2 Total GPCR Internalization
AC   CVCL_LB25
SY   PathHunter PTHR2 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0763C3
DR   Wikidata; Q54938284
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9609; PTH2R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS RANK-IkappaB Functional Assay
AC   CVCL_LB26
DR   DiscoverX; 93-0994C3
DR   Wikidata; Q54938285
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7797; NFKBIA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11908; TNFRSF11A.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   PathHunter U2OS rFFAR1 beta-arrestin
AC   CVCL_LB27
DR   DiscoverX; 93-0976C3
DR   Wikidata; Q54938286
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 628613; Ffar1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS rHTR2C beta-arrestin
AC   CVCL_LB28
DR   DiscoverX; 93-0915C3
DR   Wikidata; Q54938288
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2848; Htr2c.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS RXFP3 Total GPCR Internalization
AC   CVCL_LB29
SY   PathHunter RXFP3 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0948C3
DR   Wikidata; Q54938289
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24883; RXFP3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS RXRalpha Protein Interaction
AC   CVCL_LB30
DR   DiscoverX; 93-0439C3
DR   Wikidata; Q54938290
CC   Population: Caucasian.
CC   Characteristics: PathHunter NHR protein interaction cell lines co-express a NHR tagged with a beta-galactosidase fragment (ProLink=PK) and a receptor co-activator tagged with another fragment (Enzyme Acceptor=EA). Activation of the NHR results in co-activator-EA recruitment thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7669; NCOA2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS SCTR Activated GPCR Internalization
AC   CVCL_LB31
SY   PathHunter SCTR Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0675C3
DR   Wikidata; Q54938292
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10608; SCTR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS SREBP2 Nuclear Translocation
AC   CVCL_LB32
DR   DiscoverX; 93-0830C3
DR   Wikidata; Q54938293
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11290; SREBF2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS SSTR1 beta-arrestin
AC   CVCL_LB33
DR   DiscoverX; 93-0307C3
DR   Wikidata; Q54938294
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11330; SSTR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS SSTR5 beta-arrestin
AC   CVCL_LB34
DR   DiscoverX; 93-0402C3
DR   Wikidata; Q54938295
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11334; SSTR5.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS TACR1 Activated GPCR Internalization
AC   CVCL_LB35
SY   PathHunter TACR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0717C3
DR   Wikidata; Q54938296
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11526; TACR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS TACR2 Activated GPCR Internalization
AC   CVCL_LB36
SY   PathHunter TACR2 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0677C3
DR   Wikidata; Q54938298
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11527; TACR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS TACR3 Activated GPCR Internalization
AC   CVCL_LB37
SY   PathHunter TACR3 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0678C3
DR   Wikidata; Q54938299
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11528; TACR3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS TBXA2R Activated GPCR Internalization
AC   CVCL_LB38
SY   PathHunter TBXA2R Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0918C3
DR   Wikidata; Q54938300
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11608; TBXA2R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS TBXA2R beta-arrestin
AC   CVCL_LB39
DR   DiscoverX; 93-0322C3
DR   Wikidata; Q54938301
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11608; TBXA2R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS TORC1 Nuclear Translocation
AC   CVCL_LB40
DR   DiscoverX; 93-0833C3
DR   Wikidata; Q54938302
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16062; CRTC1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS TORC2 Nuclear Translocation
AC   CVCL_LB41
DR   DiscoverX; 93-0813C3
DR   Wikidata; Q54938303
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27301; CRTC2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS TORC3 Nuclear Translocation
AC   CVCL_LB42
DR   DiscoverX; 93-1120C3
DR   Wikidata; Q54938304
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26148; CRTC3.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS TRHR Total GPCR Internalization
AC   CVCL_LB43
SY   PathHunter TRHR Total GPCR Internalization U2OS
DR   DiscoverX; 93-0949C3
DR   Wikidata; Q54938306
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12299; TRHR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS TSHR(L) beta-arrestin
AC   CVCL_LB44
DR   DiscoverX; 93-0760C3
DR   Wikidata; Q54938307
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR (Note=Isoform long).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS TSHR(L) beta-arrestin-1
AC   CVCL_LB45
DR   DiscoverX; 93-0912C3
DR   Wikidata; Q54938308
CC   Population: Caucasian.
CC   Characteristics: PathHunter beta-arrestin cell lines co-express a GPCR tagged with a beta-galactosidase fragment (ProLink=PK) and a beta-arrestin tagged with another fragment (Enzyme Acceptor=EA). Activation of the GPCR-PK induces beta-arrestin-EA recruitment and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:711; ARRB1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12373; TSHR (Note=Isoform long).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS UTR2 Total GPCR Internalization
AC   CVCL_LB46
SY   PathHunter UTR2 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0746C3
DR   Wikidata; Q54938309
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4468; UTS2R.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS VIPR1 Activated GPCR Internalization
AC   CVCL_LB47
SY   PathHunter VIPR1 Activated GPCR Internalization U2OS
DR   DiscoverX; 93-0739C3
DR   Wikidata; Q54938310
CC   Population: Caucasian.
CC   Characteristics: PathHunter activated GPCR internalization cell lines co-express an untagged GPCR, a beta-arrestin tagged with a beta-galactosidase fragment (Enzyme Acceptor=EA) and a second beta-galactosidase fragment (ProLink=PK) localized to the endosomes. Beta-arrestin recruitment is followed by internalization of the GPCR/arrestin-EA complex in PK-tagged endosomes and allowing complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12694; VIPR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   PathHunter U2OS VIPR2 Total GPCR Internalization
AC   CVCL_LB48
SY   PathHunter VIPR2 Total GPCR Internalization U2OS
DR   DiscoverX; 93-0824C3
DR   Wikidata; Q54938312
CC   Population: Caucasian.
CC   Characteristics: PathHunter total GPCR internalization cell lines co-express a tagged with a beta-galactosidase fragment (ProLink=PK) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the endosomes. Activation of the GPCR-PK induces internalization of the receptor in EA-tagged endosomes and complementation of the PK and EA enzyme fragments thus resulting into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12695; VIPR2.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   PathHunter U2OS XBP1 Nuclear Translocation
AC   CVCL_LB49
DR   DiscoverX; 93-0857C3
DR   Wikidata; Q54938313
CC   Population: Caucasian.
CC   Characteristics: PathHunter nuclear translocation cell lines co-express a target protein tagged with a beta-galactosidase fragment (Enzyme Donor=ED) and a second beta-galactosidase fragment (Enzyme Acceptor=EA) localized to the nucleus. Complementation of the ED and EA enzyme fragments result into a catalytically active enzyme that generate a chemiluminescent signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12801; XBP1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   Patrick
AC   CVCL_IU34
SY   NK45; NK-45
DR   Wikidata; Q54938314
RX   PubMed=4320167;
RX   PubMed=5021706;
CC   Population: African; Kenyan.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   Patscl-52
AC   CVCL_8400
SY   PatScl 52; Patscl52; PatScl
DR   Wikidata; Q54938316
RX   DOI=10.22029/jlupub-12385;
RX   PubMed=15770730;
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   Patski
AC   CVCL_Y494
SY   PATSKI
DR   EFO; EFO_0005481
DR   4DN; 4DNSRJ2LKIV4
DR   ENCODE; ENCBS171ENC
DR   ENCODE; ENCBS172ENC
DR   ENCODE; ENCBS380LVP
DR   ENCODE; ENCBS463JXY
DR   ENCODE; ENCBS912AOM
DR   ENCODE; ENCBS954KGH
DR   GEO; GSM1014171
DR   Wikidata; Q54938317
RX   PubMed=9500539;
RX   PubMed=20363980;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/Patski_Stam_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus (Hybrid mouse)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 8
//
ID   PaTu 8902
AC   CVCL_1845
SY   PA-TU-8902; PATU-8902; PaTu8902; PATU8902; 8902; PaCL2
DR   BTO; BTO_0006485
DR   CLO; CLO_0008382
DR   EFO; EFO_0006729
DR   CLDB; cl3860
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 191
DR   BioSample; SAMN03473078
DR   BioSample; SAMN10987803
DR   cancercelllines; CVCL_1845
DR   Cell_Model_Passport; SIDM00455
DR   Cosmic; 873004
DR   Cosmic; 948381
DR   Cosmic; 2434100
DR   Cosmic-CLP; 1298526
DR   DepMap; ACH-000599
DR   DSMZ; ACC-179
DR   DSMZCellDive; ACC-179
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298526
DR   GEO; GSM206534
DR   GEO; GSM887502
DR   GEO; GSM888584
DR   GEO; GSM1670336
DR   IARC_TP53; 2966
DR   IARC_TP53; 25073
DR   LiGeA; CCLE_026
DR   LINCS_LDP; LCL-1744
DR   NCBI_Iran; C557
DR   PharmacoDB; PATU8902_1236_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1845
DR   Wikidata; Q54938318
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=8194712;
RX   PubMed=8287116;
RX   PubMed=10700188;
RX   PubMed=11668190;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~25-40 hours (DSMZ=ACC-179).
CC   HLA typing: A*02:01,02:01; B*51:01,51:01; C*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Ser1650Tyr (c.4949C>A); Zygosity=Heterozygous (PubMed=10700188; Cosmic-CLP=1298526; DepMap=ACH-000599).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (Cosmic-CLP=1298526; DepMap=ACH-000599).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.526T>A); ClinVar=VCV000376570; Zygosity=Homozygous (PubMed=8194712; PubMed=10700188; Cosmic-CLP=1298526; DepMap=ACH-000599).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.21%; East Asian, North=1.73%; East Asian, South=0%; South Asian=0%; European, North=62.61%; European, South=35.45% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): Cosmic-CLP=1298526; DSMZ=ACC-179; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 20
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 12,15
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   PaTu 8988s
AC   CVCL_1846
SY   PA-TU-8988S; PaTu8988s; PaTu8988S; PATU8988S; PaTu 8988 S; PaTu-8988s; PATU-8988S; PATU-S; PA-TU S
DR   BTO; BTO_0005879
DR   CLO; CLO_0008383
DR   EFO; EFO_0006730
DR   CLDB; cl3861
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 258
DR   BioSample; SAMN10987622
DR   cancercelllines; CVCL_1846
DR   Cell_Model_Passport; SIDM00452
DR   Cosmic; 873007
DR   Cosmic; 2046530
DR   Cosmic; 2434103
DR   DepMap; ACH-000022
DR   DSMZ; ACC-204
DR   DSMZCellDive; ACC-204
DR   EGA; EGAS00001000610
DR   GEO; GSM887503
DR   GEO; GSM888585
DR   IARC_TP53; 2967
DR   IARC_TP53; 30144
DR   LiGeA; CCLE_100
DR   LINCS_LDP; LCL-1745
DR   PharmacoDB; PATU8988S_1237_2019
DR   Progenetix; CVCL_1846
DR   Wikidata; Q54938329
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=1348891;
RX   PubMed=8194712;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 2-2.6 days (PubMed=1348891); ~40-60 hours (DSMZ=ACC-204).
CC   HLA typing: A*31:01,32:01; B*27:05,35:01; C*02:02,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (DepMap=ACH-000022).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (DepMap=ACH-000022).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.16%; Native American=0%; East Asian, North=1.35%; East Asian, South=0%; South Asian=0%; European, North=59.03%; European, South=38.45% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at p.Cys176Ser (c.451C>T) in PubMed=8194712.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DSMZ=ACC-204; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 26
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 7,8
ST   D8S1179: 13,16
ST   FGA: 23
ST   Penta D: 8
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1847 ! PaTu 8988t
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   PaTu 8988t
AC   CVCL_1847
SY   PA-TU-8988T; PaTu8988t; PaTu8988T; PATU8988T; PaTu 8988 T; PaTu-8988t; PATU-8988T; PATU-T; PA-TU T; 8988T; PaCL4
DR   BTO; BTO_0005878
DR   CLO; CLO_0008384
DR   EFO; EFO_0005713
DR   CLDB; cl3862
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 986
DR   BioSample; SAMN03473157
DR   BioSample; SAMN10988386
DR   cancercelllines; CVCL_1847
DR   Cell_Model_Passport; SIDM00453
DR   ChEMBL-Cells; CHEMBL4295420
DR   ChEMBL-Targets; CHEMBL4296488
DR   CLS; 305133
DR   Cosmic; 873006
DR   Cosmic; 948382
DR   Cosmic; 1524020
DR   Cosmic; 1995611
DR   Cosmic; 2046531
DR   Cosmic; 2434111
DR   Cosmic-CLP; 1240201
DR   DepMap; ACH-000023
DR   DSMZ; ACC-162
DR   DSMZCellDive; ACC-162
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS158AAA
DR   GDSC; 1240201
DR   GEO; GSM206535
DR   GEO; GSM385524
DR   GEO; GSM385535
DR   GEO; GSM816667
DR   GEO; GSM827178
DR   GEO; GSM887504
DR   GEO; GSM888586
DR   GEO; GSM16703371
DR   IGRhCellID; PA-TU-8988T%20GEO
DR   LiGeA; CCLE_005
DR   LINCS_LDP; LCL-1746
DR   PharmacoDB; PATU8988T_1238_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1847
DR   PubChem_Cell_line; CVCL_1847
DR   Wikidata; Q54938330
RX   DOI=10.22029/jlupub-12385;
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=1348891;
RX   PubMed=10408907;
RX   PubMed=10700188;
RX   PubMed=11668190;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/8988T_Crawford_protocol.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 4.7-5.2 days (PubMed=1348891); ~22-30 hours (DSMZ=ACC-162).
CC   HLA typing: A*31:01,32:01; B*27:05,35:01; C*02:02,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=10408907).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Unexplicit; Ex17-19del (c.4342del448); Zygosity=Homozygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=1240201; DepMap=ACH-000023).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (PubMed=10700188; Cosmic-CLP=1240201; DepMap=ACH-000023).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.4%; Native American=0%; East Asian, North=0.58%; East Asian, South=0.47%; South Asian=0%; European, North=61.7%; European, South=36.86% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Cosmic-CLP=1240201; DSMZ=ACC-162; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 26
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 7,8
ST   D8S1179: 13,16
ST   FGA: 23
ST   Penta D: 8
ST   Penta E: 14
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1846 ! PaTu 8988s
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   PaTuO2
AC   CVCL_L218
SY   PaTuO-2
DR   BTO; BTO_0005398
DR   Wikidata; Q54938331
RX   PubMed=20709028;
CC   Caution: Only mentioned as a pancreatic adenocarcinoma cell line in PubMed=20709028. That papers states they obtained the cell line from ATCC which is not correct. So the real identity of this cell line is not clear.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   PAV-1
AC   CVCL_7995
DR   BTO; BTO_0003523
DR   Wikidata; Q54938333
RX   PubMed=12007639;
RX   PubMed=17760834;
RX   PubMed=37371073;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   >8M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   PaVo
AC   CVCL_E9V1
RX   PubMed=6437965;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PAX-C002
AC   CVCL_D7E6
SY   PAXC002
DR   EFO; EFO_0022552
DR   CCRID; 4201PAT-CCTCC00330
RX   Patent=CN102329775B;
RX   PubMed=22076649;
RX   PubMed=22325559;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201010.
CC   Population: Chinese.
CC   Characteristics: Established from a xenograft produced by subcutaneous injection of tumor cells into SCID mice (PubMed=22076649).
CC   Characteristics: Gemcitabine resistant (Patent=CN102329775B; PubMed=22076649).
CC   Doubling time: 47.65 hours (Patent=CN102329775B); ~48 hours (PubMed=22076649).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=22325559
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   PAX-C003
AC   CVCL_D7E0
SY   PAXC003
DR   CCRID; 4201PAT-CCTCC00329
RX   Patent=CN102250840B;
RX   PubMed=22076649;
RX   PubMed=22325559;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201007.
CC   Population: Chinese.
CC   Characteristics: Established from a xenograft produced by subcutaneous injection of tumor cells into SCID mice (PubMed=22076649).
CC   Doubling time: 33.79 hours (Patent=CN102250840B); ~34 hours (PubMed=22076649).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=22325559
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PAX-C010
AC   CVCL_D7E5
DR   CCRID; 4201PAT-CCTCC00384
RX   Patent=CN102719403B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201074.
CC   Population: Chinese.
CC   Doubling time: 48.49 hours (Patent=CN102719403B).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): Patent=CN102719403B
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PAZ6
AC   CVCL_GS29
SY   Paz6; PAZ-6
DR   ABM; T0729
DR   GEO; GSM1543670
DR   GEO; GSM1543671
DR   Wikidata; Q54938334
RX   Patent=US6071747;
RX   PubMed=9133667;
RX   PubMed=18283285;
RX   PubMed=22649407;
RX   PubMed=25925588;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1531.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 13
//
ID   PB-1 [Human]
AC   CVCL_8443
SY   PB1
DR   Wikidata; Q54938335
RX   PubMed=11021758;
RX   PubMed=11737246;
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   PB-1 [Mouse mast cell]
AC   CVCL_Y654
DR   Wikidata; Q54938336
RX   PubMed=3493490;
RX   PubMed=6873525;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   PB-1 [Mouse pre-B cell]
AC   CVCL_2159
DR   CLO; CLO_0008385
DR   CLDB; cl836
DR   DSMZ; ACC-241
DR   DSMZCellDive; ACC-241
DR   Wikidata; Q54938337
RX   PubMed=10699580;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PB-1
CC   Characteristics: IL7 dependent.
CC   Doubling time: ~50 hours (DSMZ=ACC-241).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   PB-1049
AC   CVCL_LI21
DR   Wikidata; Q54938338
RX   PubMed=2989064;
CC   Population: Japanese.
CC   Doubling time: 33.6 hours (PubMed=2989064).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI20 ! LN-1049
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   Pb-19
AC   CVCL_E5K4
RX   PubMed=1692303;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P05533; Mouse Ly6a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PB-3c
AC   CVCL_5346
SY   PB-3C; PB-3
DR   JCRB; IFO50267
DR   Wikidata; Q54938339
RX   PubMed=3079807;
RX   PubMed=3493490;
RX   PubMed=6873525;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   PB(DF)
AC   CVCL_ZX89
SY   DF(PB); PB(Dermal Fibroblast)
DR   Wikidata; Q102114735
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from child cell lines PB1; PB2; PB18; PB20).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX88 ! PB(LCL)
OI   CVCL_ZX90 ! PB(T-cell)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   PB(LCL)
AC   CVCL_ZX88
SY   LCL(PB)
DR   GEO; GSM2185121
DR   Wikidata; Q102114736
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from autologous cell line PB(DF)).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX89 ! PB(DF)
OI   CVCL_ZX90 ! PB(T-cell)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   PB(T-cell)
AC   CVCL_ZX90
SY   T-cell(PB)
DR   Wikidata; Q102114737
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from autologous cell line PB(DF)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZX89 ! PB(DF)
OI   CVCL_ZX88 ! PB(LCL)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   PB1
AC   CVCL_T881
DR   SKIP; SKIP000202
DR   Wikidata; Q54938341
RX   PubMed=23039195;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (PubMed=23039195).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX89 ! PB(DF)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   PB11
AC   CVCL_GR17
DR   Wikidata; Q54938342
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   PB13
AC   CVCL_Y593
DR   Wikidata; Q54938343
RX   PubMed=22514597;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial progenitor cell; CL=CL_0002546.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   PB150.18
AC   CVCL_2H73
SY   BALB/cByJ-PB150.18
DR   Wikidata; Q54938344
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001026P8productspec.pdf
CC   From: Predictive Biology, Inc.; Carlsbad; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/cByJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PB151.24
AC   CVCL_2H74
SY   C3H/HeJ-PB151.24
DR   Wikidata; Q54938345
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000659P10productspec.pdf
CC   From: Predictive Biology, Inc.; Carlsbad; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PB17
AC   CVCL_GR18
DR   Wikidata; Q54938346
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial progenitor cell; CL=CL_0002546.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   PB18
AC   CVCL_T883
DR   SKIP; SKIP000204
DR   Wikidata; Q54938347
RX   PubMed=23039195;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (PubMed=23039195).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX89 ! PB(DF)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   PB1BrTr
AC   CVCL_E3BF
RX   DOI=10.21077/ijf.2024.71.2.144886-09;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 20 to 32 Celsius, the optimal temperature is 28 Celsius (DOI=10.21077/ijf.2024.71.2.144886-09).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=80991; ! Premnas biaculeatus (Spinecheek anemonefish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PB2
AC   CVCL_T882
SY   iPS_PB2
DR   GEO; GSM2038549
DR   SKIP; SKIP000203
DR   Wikidata; Q54086283
RX   PubMed=23039195;
RX   PubMed=26905201;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (PubMed=23039195).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX89 ! PB(DF)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   PB2.33
AC   CVCL_XJ89
SY   PB2iPSC c33
DR   Wikidata; Q98128484
RX   PubMed=26549847;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas (CIEMAT); Madrid; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   PB20
AC   CVCL_T884
SY   iPS_PB20
DR   GEO; GSM2038550
DR   SKIP; SKIP000205
DR   Wikidata; Q54938348
RX   PubMed=23039195;
RX   PubMed=26905201;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (PubMed=23039195).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX89 ! PB(DF)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   PB30
AC   CVCL_GR19
DR   Wikidata; Q54938349
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 3
//
ID   PB32
AC   CVCL_GR24
DR   Wikidata; Q54938350
RX   PubMed=27879209;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   PB32-1
AC   CVCL_GR25
DR   Wikidata; Q54938351
RX   PubMed=27879209;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GR24 ! PB32
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   PB32-4
AC   CVCL_GR26
DR   Wikidata; Q54938352
RX   PubMed=27879209;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GR24 ! PB32
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   PB32-5
AC   CVCL_GR27
DR   Wikidata; Q54938353
RX   PubMed=27879209;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GR24 ! PB32
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   PB33
AC   CVCL_GR20
DR   Wikidata; Q54938354
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 5
//
ID   PB35.17
AC   CVCL_2H75
SY   NZW/LacJ-PB35.17
DR   Wikidata; Q54938355
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001058P9productspec.pdf
CC   From: Predictive Biology, Inc.; Carlsbad; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NZW/LacJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PB48
AC   CVCL_GQ02
SY   IPSC RETC634Y
DR   Wikidata; Q54938356
RX   PubMed=27558615;
RX   PubMed=29197744;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys634Tyr (c.1901G>A); ClinVar=VCV000013909; Zygosity=Heterozygous (PubMed=27558615).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C46099; Hereditary thyroid gland medullary carcinoma
DI   NCIt; C3226; Multiple endocrine neoplasia type 2A
DI   ORDO; Orphanet_99361; Familial medullary thyroid carcinoma
DI   ORDO; Orphanet_247698; Multiple endocrine neoplasia type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   PB60.6
AC   CVCL_2H76
SY   BTBR T+ Itpr3tf/J-PB60.6
DR   Wikidata; Q54938358
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/002282P9productspec.pdf
CC   From: Predictive Biology, Inc.; Carlsbad; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BTBR T+ Itpr3tf/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PB61.11
AC   CVCL_2H77
SY   MRL/MpJ-PB61.11
DR   Wikidata; Q54938359
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000486P9productspec.pdf
CC   From: Predictive Biology, Inc.; Carlsbad; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: MRL/MpJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PB84.3
AC   CVCL_2H78
SY   FVB/NJ-PB84.3
DR   Wikidata; Q54938360
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/001800P9-10productspec.pdf
CC   From: Predictive Biology, Inc.; Carlsbad; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/NJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PBD005
AC   CVCL_VQ71
DR   Wikidata; Q98128485
RX   PubMed=7719337;
RX   PubMed=9668159;
CC   Sequence variation: Mutation; HGNC; HGNC:9719; PEX5; Simple; p.Arg427Ter (c.1279C>T) (R390*); ClinVar=VCV000009144; Zygosity=Homozygous (PubMed=7719337).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155750; Peroxisome biogenesis disorder 2A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   PBD009
AC   CVCL_VQ72
DR   Wikidata; Q98128486
RX   PubMed=9398847;
CC   Sequence variation: Mutation; HGNC; HGNC:8850; PEX1; Simple; p.Gly843Asp (c.2528G>4); Zygosity=Heterozygous (PubMed=9398847).
CC   Sequence variation: Mutation; HGNC; HGNC:8850; PEX1; Simple; c.2926+1G>A; ClinVar=VCV000188729; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=9398847).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155748; Peroxisome biogenesis disorder 1A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   PBD018
AC   CVCL_VQ73
DR   Wikidata; Q98128487
RX   PubMed=7719337;
RX   PubMed=9668159;
CC   Sequence variation: Mutation; HGNC; HGNC:9719; PEX5; Simple; p.Asn526Lys (c.1578T>G) (N489K); ClinVar=VCV000009143; Zygosity=Homozygous (PubMed=7719337).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155751; Peroxisome biogenesis disorder 2B
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   PBD097
AC   CVCL_VQ74
DR   Wikidata; Q98128488
RX   PubMed=9090384;
CC   Sequence variation: Mutation; HGNC; HGNC:8854; PEX12; Simple; p.Leu245Cysfs*19 (c.730_733dupGCCT) (c.733_734insGCCT); ClinVar=VCV000371737; Zygosity=Heterozygous (PubMed=9090384).
CC   Sequence variation: Mutation; HGNC; HGNC:8854; PEX12; Simple; p.Thr249Tyrfs*14 (c.744dupT) (c.744_745insT); ClinVar=VCV000553741; Zygosity=Heterozygous (PubMed=9090384).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155752; Peroxisome biogenesis disorder 3A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   PBD1-Fib
AC   CVCL_WC38
SY   Peroxisome Biogenesis Disorder 1-Fibroblast
DR   IBRC; C10511
DR   Wikidata; Q98128489
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   PBD2-Fib
AC   CVCL_WC39
SY   Peroxisome Biogenesis Disorder 2-Fibroblast
DR   IBRC; C10508
DR   Wikidata; Q98128490
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85047; Rhizomelic chondrodysplasia punctata
DI   ORDO; Orphanet_177; Rhizomelic chondrodysplasia punctata
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   PBDEP-4
AC   CVCL_ZF31
SY   Peripheral Blood-Derived Erythroid progenitor-4
DR   Wikidata; Q98128491
RX   PubMed=32358867;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:992; BCL2L1 (Note=Isoform Bcl-xL).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   PBDEP-4-dGYPA
AC   CVCL_ZF32
DR   Wikidata; Q98128492
RX   PubMed=32358867;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4702; GYPA.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:992; BCL2L1 (Note=Isoform Bcl-xL).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZF31 ! PBDEP-4
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   PBE2
AC   CVCL_C4ZZ
DR   Wikidata; Q116050108
RX   PubMed=1714441;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04464; Triticum aestivum calmodulin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   PBEI
AC   CVCL_8270
DR   BioSample; SAMN03151852
DR   cancercelllines; CVCL_8270
DR   Wikidata; Q54938361
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NALM-6 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00152.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   PBG04
AC   CVCL_B0N3
SY   PBG-04
DR   Wikidata; Q108821089
RX   Patent=WO2004031383A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2577.
CC   Monoclonal antibody isotype: IgM, lambda.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B0MU ! H-CB-P1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PBG.PK-21
AC   CVCL_WJ92
SY   PBG.PK2.1
DR   Wikidata; Q98128493
RX   PubMed=31005427;
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: ProBioGen AG; Berlin; Germany.
CC   Virology: Free from porcine circovirus 1 (PCV1) infection.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   PBL-1
AC   CVCL_LH74
SY   PlasmaBlastic Lymphoma-1
DR   Wikidata; Q54938362
RX   PubMed=28860565;
CC   Population: Japanese.
CC   Characteristics: IL6 dependent.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   PBL-Om
AC   CVCL_G007
DR   Wikidata; Q54938363
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F912 ! ILT-Om
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   PBLE
AC   CVCL_R845
SY   Peripheral Blood Leukocyte Eel
DR   Wikidata; Q54938365
RX   PubMed=17163780;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7938; ! Anguilla rostrata (American eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   PBMC iPSC #1
AC   CVCL_WR41
DR   Wikidata; Q98128494
RX   PubMed=27579041;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   PBMC iPSC #2
AC   CVCL_WR42
DR   Wikidata; Q98128495
RX   PubMed=27579041;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   PBMC iPSC #3
AC   CVCL_WR43
DR   Wikidata; Q98128496
RX   PubMed=27579041;
CC   From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   PBMC2-iPS4F8
AC   CVCL_JL70
SY   GENYOi003-A
DR   BioSamples; SAMEA7124958
DR   hPSCreg; GENYOi003-A
DR   Wikidata; Q54938370
RX   PubMed=28412998;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_iPS-PBMC2-iPS4F8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_iPS-PBMC2-iPS4F8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28412998
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D21S11: 28,29
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   PBMC2-iPS4F8 CBFA2T3-GLIS2
AC   CVCL_VL52
SY   PBMC2-iPS4F8-CBFA2T3-GLIS2; GENYOi003-B
DR   hPSCreg; GENYOi003-B
DR   Wikidata; Q98128497
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SOLICITUD+DEP%C3%93SITO+iPS-PBMC2-iPS4F8-CBFA2T3-GLIS2_v3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1537; CBFA2T3 (Note=CBFA2T3-GLIS2 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:29450; GLIS2 (Note=CBFA2T3-GLIS2 fusion).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D21S11: 28,29
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL70 ! PBMC2-iPS4F8
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   PBMC2-iPS4F8 Neo
AC   CVCL_VL51
DR   Wikidata; Q98128498
RX   PubMed=28412998;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28412998
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11,14
ST   D16S539: 11,13
ST   D21S11: 28,29
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL70 ! PBMC2-iPS4F8
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   PBMC2-iPS4F8 RM
AC   CVCL_JL71
SY   PBMC2-iPS4F8 RBM15-MKL1
DR   Wikidata; Q54938371
RX   PubMed=28412998;
WW   Provider; BNLC; -; https://web.archive.org/web/20230515002056/https://www.isciii.es/QueHacemos/Servicios/BIOBANCOS/BNLC/Lists/Lneas%20iPS/Attachments/143/Caracteristicas%20-%20Deposito_PBMC2-iPS4F8-RBM15-MKL1_v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:14334; MRTFA (Note=RBM15-MKL1 fusion).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:14959; RBM15 (Note=RBM15-MKL1 fusion).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=28412998
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11,14
ST   D16S539: 11,13
ST   D21S11: 28,29
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL70 ! PBMC2-iPS4F8
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   PBS-1
AC   CVCL_1K16
DR   Wikidata; Q54938372
RX   DOI=10.4172/2157-7560.1000345;
RX   PubMed=18524432;
RX   PubMed=25903999;
CC   Group: Bird cell line.
CC   Group: Vaccine production cell line.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_Y589 ! CHCC-OU2
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   PBS-12SF
AC   CVCL_1K17
SY   PBS-12 SF; PBS12SF
DR   FCS-free; 212-28-432-1-16-12
DR   FCS-free; 212-28-432-1-6
DR   Wikidata; Q54938373
RX   DOI=10.4172/2157-7560.1000345;
RX   Patent=US8716016;
RX   PubMed=18524432;
RX   PubMed=21911025;
RX   PubMed=25903999;
WW   Provider; MSUT; TEC2007-0090; http://msut.technologypublisher.com/technology/7783
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8565.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_1K16 ! PBS-1
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   PBW1
AC   CVCL_D3QM
SY   376
DR   Wikidata; Q127383014
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10272.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A9NJG2; Fagopyrum tataricum 13S globulin seed storage protein (Note=AA 321-515 = Beta chain/24 kDA allergenic protein).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PBW2
AC   CVCL_D3QN
SY   505
DR   Wikidata; Q127383015
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10273.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fagopyrum tartaricum 76 kDa allergenic protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PBW3
AC   CVCL_D3QP
SY   506
DR   Wikidata; Q127383016
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10274.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Fagopyrum tartaricum 76 kDa allergenic protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PC
AC   CVCL_UU13
DR   cancercelllines; CVCL_UU13
DR   IARC_TP53; 16743
DR   Wikidata; Q98128499
RX   PubMed=11787853;
CC   From: Andren-Sandberg, Ake; Karolinska Institutet; Stockholm; Sweden.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp355Gly (c.1064A>G); Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=11787853).
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   PC 61-5-3
AC   CVCL_4550
SY   PC 61 5.3; PC 61.5.3; PC615.3; PC 61
DR   CLO; CLO_0008390
DR   CLO; CLO_0008391
DR   CLDB; cl5246
DR   ATCC; TIB-222
DR   BCRC; 60492
DR   CCRID; 3101ETCHYB52
DR   CLS; 305001
DR   ECACC; 88041902
DR   IZSLER; BS Hy 23
DR   Wikidata; Q54938379
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 15
//
ID   PC-0199-BR
AC   CVCL_Z242
DR   Wikidata; Q54938380
RX   PubMed=11562717;
CC   Group: Insect cell line.
CC   Doubling time: 26 hours (PubMed=11562717).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=869071; ! Psorophora confinnis (Dark rice field mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   PC-1 [Hamster]
AC   CVCL_L900
SY   PC1
DR   BTO; BTO_0002747
DR   Wikidata; Q54938381
RX   PubMed=2000935;
RX   PubMed=2173932;
RX   PubMed=2539915;
RX   PubMed=7728976;
RX   PubMed=8382114;
RX   PubMed=8863680;
CC   Doubling time: 38 hours (PubMed=2539915); 22 hours (PubMed=7728976).
CC   Sequence variation: Mutation; UniProtKB; A0A1U7QTX5; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (PubMed=2173932).
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   8W
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   PC-1 [Human lung carcinoma]
AC   CVCL_S978
SY   PC 1; PC1
DR   EFO; EFO_0002842
DR   Cosmic; 1089227
DR   Cosmic; 1571733
DR   Cosmic; 2645027
DR   IARC_TP53; 11869
DR   IARC_TP53; 21086
DR   Wikidata; Q54938382
RX   PubMed=758928;
RX   PubMed=1847845;
RX   PubMed=3731100;
RX   PubMed=8385084;
RX   PubMed=10536175;
RX   PubMed=11583962;
RX   PubMed=12794755;
RX   PubMed=17511773;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly334Val (c.1001G>T); Zygosity=Unspecified (PubMed=10536175).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   PC-1 [Human pancreatic carcinoma]
AC   CVCL_S969
DR   cancercelllines; CVCL_S969
DR   Cosmic; 965556
DR   Wikidata; Q54938383
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2118052;
RX   PubMed=14640107;
CC   Population: Chinese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 47 hours (PubMed=2118052).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=14640107).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   PC-1 [Plagionotus]
AC   CVCL_Z274
SY   Plagionotus Christophi-1
DR   Wikidata; Q54938384
RX   PubMed=18946707;
CC   Group: Insect cell line.
CC   Doubling time: 3.79 days (PubMed=18946707).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=157322; ! Plagionotus christophi (Longicorn beetle)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   PC-1.0
AC   CVCL_L901
SY   PC-1-0; PC1.0
DR   BTO; BTO_0002746
DR   Wikidata; Q54938385
RX   PubMed=1530768;
RX   PubMed=2173932;
RX   PubMed=8382114;
RX   PubMed=8863680;
CC   Sequence variation: Mutation; UniProtKB; A0A1U7QTX5; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (PubMed=2173932).
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_L900 ! PC-1 [Hamster]
SX   Male
AG   8W
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   PC-1.2
AC   CVCL_L902
SY   PC-1-2; PC1.2
DR   Wikidata; Q54938386
RX   PubMed=1530768;
RX   PubMed=8863680;
CC   Sequence variation: Mutation; UniProtKB; A0A1U7QTX5; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_L900 ! PC-1 [Hamster]
SX   Male
AG   8W
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   PC-10
AC   CVCL_7088
SY   PC 10; PC10
DR   BTO; BTO_0004886
DR   EFO; EFO_0002843
DR   cancercelllines; CVCL_7088
DR   CGH-DB; 190-1
DR   CGH-DB; 9175-4
DR   ChEMBL-Cells; CHEMBL3307345
DR   ChEMBL-Targets; CHEMBL614234
DR   Cosmic; 713859
DR   Cosmic; 801575
DR   Cosmic; 844813
DR   Cosmic; 876168
DR   Cosmic; 917999
DR   Cosmic; 929155
DR   Cosmic; 1089228
DR   Cosmic; 1219087
DR   Cosmic; 1239915
DR   Cosmic; 1571736
DR   Cosmic; 2125280
DR   Cosmic; 2668325
DR   IARC_TP53; 2383
DR   PubChem_Cell_line; CVCL_7088
DR   Wikidata; Q54938387
RX   PubMed=758928;
RX   PubMed=3731100;
RX   PubMed=8263009;
RX   PubMed=8385084;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11583962;
RX   PubMed=12794755;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=17511773;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=23381221;
RX   PubMed=25120651;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified (PubMed=8263009; PubMed=10536175; PubMed=12794755; PubMed=20557307).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   PC-12
AC   CVCL_S979
SY   PC 12; PC12
DR   Wikidata; Q54938388
RX   PubMed=758928;
RX   PubMed=3731100;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   PC-12 Adh
AC   CVCL_F659
SY   PC-12 ADH; PC-12Adh; PC-12 Adherent
DR   AddexBio; C0032002/4998
DR   ATCC; CRL-1721.1
DR   BCRJ; 0202
DR   Wikidata; Q54938389
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/pc-12-cells-atcc-crl-1721-vs-atcc-crl-1721-1
CC   Characteristics: Adherent subline of PC12.
CC   Doubling time: 48 hours (ATCC=CRL-1721.1).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   PC-12 HD-Q23 cell 14
AC   CVCL_AU97
DR   Wikidata; Q54938390
DR   Ximbio; 152416
RX   PubMed=11532992;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=1st exon with 23-Q run).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   PC-12 HD-Q23 cell 7
AC   CVCL_AU98
DR   Wikidata; Q54938391
DR   Ximbio; 152416
RX   PubMed=11532992;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=1st exon with 23-Q run).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   PC-12 HD-Q74 cell 10
AC   CVCL_AU99
DR   Wikidata; Q54938392
DR   Ximbio; 152417
RX   PubMed=11532992;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=1st exon with 74-Q run).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   PC-12 HD-Q74 cell 1b
AC   CVCL_AV00
DR   Wikidata; Q54938393
DR   Ximbio; 152417
RX   PubMed=11532992;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=1st exon with 74-Q run).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   PC-12TG
AC   CVCL_5574
SY   PC12TG
DR   JCRB; IFO50496
DR   Wikidata; Q54938394
RX   PubMed=7763725;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   PC-13
AC   CVCL_B259
SY   PC 13; PC13
DR   cancercelllines; CVCL_B259
DR   CGH-DB; 9184-4
DR   ChEMBL-Cells; CHEMBL3307865
DR   ChEMBL-Targets; CHEMBL614100
DR   Cosmic; 801576
DR   Cosmic; 809128
DR   Cosmic; 844835
DR   Cosmic; 876173
DR   Cosmic; 917996
DR   Cosmic; 946059
DR   Cosmic; 1239926
DR   Cosmic; 2125281
DR   Cosmic; 2668332
DR   IARC_TP53; 11871
DR   PubChem_Cell_line; CVCL_B259
DR   Wikidata; Q54938395
RX   PubMed=1847845;
RX   PubMed=3731100;
RX   PubMed=4094096;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=17511773;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=In 10% of cells (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly334Val (c.1001G>T); Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   PC-14
AC   CVCL_1640
SY   PC 14; PC14
DR   BTO; BTO_0002877
DR   CLO; CLO_0008394
DR   EFO; EFO_0002844
DR   CLDB; cl3880
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 388
DR   BioSample; SAMN10987800
DR   cancercelllines; CVCL_1640
DR   Cell_Model_Passport; SIDM00237
DR   CGH-DB; 205-1
DR   CGH-DB; 9169-4
DR   ChEMBL-Cells; CHEMBL3307306
DR   ChEMBL-Targets; CHEMBL614140
DR   Cosmic; 753608
DR   Cosmic; 801577
DR   Cosmic; 876138
DR   Cosmic; 897744
DR   Cosmic; 932924
DR   Cosmic; 946060
DR   Cosmic; 1239897
DR   Cosmic; 1571737
DR   Cosmic; 1656894
DR   Cosmic; 1995612
DR   Cosmic; 2125282
DR   Cosmic; 2668308
DR   Cosmic-CLP; 753608
DR   DepMap; ACH-000030
DR   ECACC; 90071810
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10408-106B3
DR   GDSC; 753608
DR   GEO; GSM827410
DR   GEO; GSM887505
DR   GEO; GSM888587
DR   GEO; GSM1670338
DR   IARC_TP53; 11872
DR   IARC_TP53; 21133
DR   LiGeA; CCLE_627
DR   LINCS_LDP; LCL-1656
DR   PharmacoDB; PC14_1247_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1640
DR   PubChem_Cell_line; CVCL_1640
DR   RCB; RCB0446
DR   Wikidata; Q54938396
RX   PubMed=1847845;
RX   PubMed=4094096;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11416159;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=15901131;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22313637;
RX   PubMed=22460905;
RX   PubMed=25120651;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; RCB; -; https://cell.brc.riken.jp/en/rcb/rcb0446_announce
CC   Problematic cell line: Contaminated. Shown to be a PC-9 derivative (RCB=RCB0446).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Chinese; Han and Japanese.
CC   HLA typing: A*02:06,24:02; B*39:01,55:01; C*03:03,07:02; DQB1*05:01,06:02; DRB1*01:01,15:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=15901131; Cosmic-CLP=753608).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.88%; Native American=0%; East Asian, North=83.17%; East Asian, South=13.42%; South Asian=0.81%; European, North=0%; European, South=1.72% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at c.742C>T in PubMed=10536175 and PubMed=20557307.
CC   Discontinued: RCB; RCB0446; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=753608; ECACC=90071810; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 15
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 10 (ECACC=90071810)
ST   D7S820: 10,11 (Cosmic-CLP=753608)
ST   D8S1179: 11,15
ST   FGA: 23,25
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   PC-14-PM4
AC   CVCL_9W69
SY   PC-14 PM4
DR   cancercelllines; CVCL_9W69
DR   Wikidata; Q54938397
RX   PubMed=9563004;
CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Caution: PC-14-PM4 and PC14PE6 (Cellosaurus=CVCL_9W70) could be identical.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1640 ! PC-14
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   PC-2 [Human pancreatic carcinoma China]
AC   CVCL_S970
SY   PC2
DR   cancercelllines; CVCL_S970
DR   Cosmic; 965557
DR   Wikidata; Q54938399
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=2118052;
RX   PubMed=11169957;
RX   PubMed=14640107;
CC   Population: Chinese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Doubling time: 58 hours (PubMed=2118052).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=14640107).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   PC-2 [Human pancreatic carcinoma Germany]
AC   CVCL_C1YF
SY   PC 2; PC2
DR   Wikidata; Q114312648
RX   CelloPub=CLPUB00718;
RX   PubMed=8194712;
RX   PubMed=11169957;
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   PC-2 [Rat liver]
AC   CVCL_1G62
DR   Wikidata; Q54938400
RX   PubMed=4277389;
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1G61 ! RLN-E7
SX   Male
AG   Embryo
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   PC-295
AC   CVCL_4876
DR   Wikidata; Q54938401
RX   PubMed=8780407;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   PC-3
AC   CVCL_0035
SY   PC3; PC.3
DR   BTO; BTO_0001061
DR   CLO; CLO_0008395
DR   CLO; CLO_0051535
DR   EFO; EFO_0002074
DR   MCCL; MCC:0000380
DR   CLDB; cl3881
DR   CLDB; cl3883
DR   Abcam; ab275472
DR   AddexBio; C0019002/61
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1435
DR   ATCC; CRL-7934
DR   BCRC; 60122
DR   BCRJ; 0269
DR   BioGRID_ORCS_Cell_line; 193
DR   BioSample; SAMN01821588
DR   BioSample; SAMN01821653
DR   BioSample; SAMN01821713
DR   BioSample; SAMN03472063
DR   BioSample; SAMN05292438
DR   BioSample; SAMN10988356
DR   cancercelllines; CVCL_0035
DR   CCRID; 1101HUM-PUMC000115
DR   CCRID; 3101HUMSCSP532
DR   CCRID; 3101HUMTCHu158
DR   CCRID; 4201HUM-CCTCC00095
DR   CCTCC; GDC0095
DR   Cell_Model_Passport; SIDM00088
DR   ChEMBL-Cells; CHEMBL3307570
DR   ChEMBL-Targets; CHEMBL390
DR   CLS; 300312
DR   Cosmic; 688118
DR   Cosmic; 704849
DR   Cosmic; 713868
DR   Cosmic; 719680
DR   Cosmic; 721366
DR   Cosmic; 721556
DR   Cosmic; 755297
DR   Cosmic; 759894
DR   Cosmic; 801350
DR   Cosmic; 809225
DR   Cosmic; 850414
DR   Cosmic; 869157
DR   Cosmic; 873002
DR   Cosmic; 875892
DR   Cosmic; 876396
DR   Cosmic; 897455
DR   Cosmic; 905934
DR   Cosmic; 911997
DR   Cosmic; 918502
DR   Cosmic; 920968
DR   Cosmic; 921048
DR   Cosmic; 922551
DR   Cosmic; 923957
DR   Cosmic; 943175
DR   Cosmic; 948379
DR   Cosmic; 949249
DR   Cosmic; 974299
DR   Cosmic; 1028650
DR   Cosmic; 1028702
DR   Cosmic; 1071477
DR   Cosmic; 1075273
DR   Cosmic; 1092627
DR   Cosmic; 1172628
DR   Cosmic; 1175888
DR   Cosmic; 1188436
DR   Cosmic; 1212489
DR   Cosmic; 1219448
DR   Cosmic; 1305380
DR   Cosmic; 1312367
DR   Cosmic; 1330910
DR   Cosmic; 1436048
DR   Cosmic; 1689714
DR   Cosmic; 1995613
DR   Cosmic; 1998469
DR   Cosmic; 2301588
DR   Cosmic; 2580130
DR   Cosmic; 2585153
DR   Cosmic; 2585230
DR   Cosmic; 2621167
DR   Cosmic; 2651772
DR   Cosmic; 2669172
DR   Cosmic; 2674178
DR   Cosmic-CLP; 905934
DR   DepMap; ACH-000090
DR   DSMZ; ACC-465
DR   DSMZCellDive; ACC-465
DR   ECACC; 90112714
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS420VDY
DR   ENCODE; ENCBS451OVM
DR   ENCODE; ENCBS504WVV
DR   ENCODE; ENCBS596CTT
DR   ENCODE; ENCBS608AAA
DR   ENCODE; ENCBS609AAA
DR   FANTOM5_SSTAR; 10439-106E7
DR   FCS-free; 16-2-16-3-6-4
DR   GDSC; 905934
DR   GEO; GSM2171
DR   GEO; GSM50225
DR   GEO; GSM50289
DR   GEO; GSM91930
DR   GEO; GSM142459
DR   GEO; GSM142460
DR   GEO; GSM482670
DR   GEO; GSM525804
DR   GEO; GSM595615
DR   GEO; GSM648823
DR   GEO; GSM743480
DR   GEO; GSM750835
DR   GEO; GSM784792
DR   GEO; GSM799370
DR   GEO; GSM799433
DR   GEO; GSM844674
DR   GEO; GSM844675
DR   GEO; GSM847110
DR   GEO; GSM887506
DR   GEO; GSM888588
DR   GEO; GSM1153442
DR   GEO; GSM1178542
DR   GEO; GSM1178543
DR   GEO; GSM1181274
DR   GEO; GSM1181303
DR   GEO; GSM1374817
DR   GEO; GSM1374818
DR   GEO; GSM1670339
DR   GEO; GSM2124647
DR   GEO; GSM4962583
DR   GEO; GSM4962584
DR   GEO; GSM4962585
DR   GEO; GSM4962586
DR   GEO; GSM4962587
DR   GEO; GSM4962588
DR   GEO; GSM4962589
DR   GEO; GSM4962590
DR   GEO; GSM4962591
DR   GEO; GSM7701363
DR   GEO; GSM7701364
DR   IARC_TP53; 752
DR   IARC_TP53; 21276
DR   ICLC; HTL97018
DR   IZSLER; BS TCL 175
DR   JCRB; JCRB9110
DR   KCB; KCB 200725YJ
DR   KCLB; 21435
DR   LiGeA; CCLE_525
DR   LINCS_HMS; 50454
DR   LINCS_LDP; LCL-1299
DR   Lonza; 125
DR   MeSH; D000078722
DR   NCBI_Iran; C427
DR   NCI-DTP; PC-3
DR   PharmacoDB; PC3_1248_2019
DR   PRIDE; PRD000228
DR   PRIDE; PRD000597
DR   PRIDE; PXD000661
DR   PRIDE; PXD002107
DR   PRIDE; PXD003105
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD008184
DR   PRIDE; PXD030304
DR   PRIDE; PXD032264
DR   Progenetix; CVCL_0035
DR   PubChem_Cell_line; CVCL_0035
DR   RCB; RCB2145
DR   SKY/M-FISH/CGH; 2799
DR   TKG; TKG 0600
DR   TOKU-E; 2868
DR   Ubigene; YC-C010
DR   Wikidata; Q7118483
RX   CelloPub=CLPUB00698;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=447482;
RX   PubMed=571045;
RX   PubMed=1873816;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=8104329;
RX   PubMed=8687134;
RX   PubMed=9018337;
RX   PubMed=9331090;
RX   PubMed=9460501;
RX   PubMed=9823299;
RX   PubMed=10687853;
RX   PubMed=10700174;
RX   PubMed=10702678;
RX   PubMed=10754530;
RX   PubMed=10972993;
RX   PubMed=11135431;
RX   PubMed=11172901;
RX   PubMed=11304728;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=12606952;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=15486987;
RX   PubMed=15748285;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=17254797;
RX   PubMed=17440963;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=21432867;
RX   PubMed=22068913;
RX   PubMed=22275356;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23671654;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24504141;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26256267;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29194687;
RX   PubMed=30244336;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31404090;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32968452;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-1435
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160328064204/http://capcelllines.ca/details.asp?id=37
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=53
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544570
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-96.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/PC3
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/prostate-cancer-xenograft/pc-3-xenograft-model/
WW   Provider; BRICS; BRICS0128; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3931
WW   Provider; CH3 Biosystems; 940012; https://ch3biosystems.com/shop/pc-3/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 29 +- 3 hours (PubMed=10687853); 25.34 +- 0.02 hours (PubMed=32968452); 25 hours (ATCC=CRL-7934); 40 +- 10 hours (CLS=300312); ~50 hours (DSMZ=ACC-465); 27.1 hours (NCI-DTP=PC-3); ~25 hours (PBCF).
CC   HLA typing: A*01:01:01,24:02:01; B*13:02,55:01; C*01,06; DPB1*04:01; DQB1*02:02,06:03; DRB1*07:01,13:01:01 (PubMed=15748285).
CC   HLA typing: A*01:01,24:01; B*13:02,55:01; C*01:02,06:02 (PubMed=25960936).
CC   HLA typing: A*01:01,24:02; B*13:02,55:01; C*01:02,06:02; DRB1*13:01,13:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=1873816; PubMed=8104329; PubMed=17088437; Cosmic-CLP=905934; DepMap=ACH-000090).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.41%; Native American=0%; East Asian, North=0.52%; East Asian, South=0%; South Asian=1.19%; European, North=65.73%; European, South=32.14% (PubMed=30894373).
CC   Caution: There seem to be two distinct cell lines which were assigned NCBI_Iran catalog number C427.
CC   Discontinued: ATCC; CRL-7934; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): AddexBio=C0019002/61; ATCC=CRL-1435; CCRID; CLS=300312; Cosmic-CLP=905934; DOI=10.4172/2157-7145.S2-005; DSMZ=ACC-465; ECACC=90112714; JCRB=JCRB9110; KCLB=21435; PubMed=11416159; PubMed=14518029; PubMed=17254797; PubMed=19372543; PubMed=25877200; RCB=RCB2145; Technion Genomics Center; TKG=TKG 0600
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 16
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13,14 (PubMed=17254797)
ST   D18S51: 14,15 (ATCC=CRL-1435; CCRID; CLS=300312; DOI=10.4172/2157-7145.S2-005; DSMZ=ACC-465; PubMed=11416159; PubMed=14518029; PubMed=19372543; PubMed=25877200; Technion Genomics Center)
ST   D19S433: 14
ST   D1S1656: 12,16
ST   D21S11: 29,31 (PubMed=17254797)
ST   D21S11: 29,31.2 (ATCC=CRL-1435; CCRID; CLS=300312; DOI=10.4172/2157-7145.S2-005; DSMZ=ACC-465; PubMed=11416159; PubMed=14518029; PubMed=19372543; PubMed=25877200; Technion Genomics Center)
ST   D22S1045: 15
ST   D2S1338: 18,20 (ATCC=CRL-1435; CCRID; DOI=10.4172/2157-7145.S2-005; PubMed=19372543)
ST   D2S1338: 20 (DSMZ=ACC-465; Technion Genomics Center)
ST   D2S441: 10,11
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8 (PubMed=17254797; TKG=TKG 0600)
ST   D7S820: 8,11 (AddexBio=C0019002/61; ATCC=CRL-1435; CCRID; CLS=300312; Cosmic-CLP=905934; DOI=10.4172/2157-7145.S2-005; DSMZ=ACC-465; ECACC=90112714; JCRB=JCRB9110; KCLB=21435; PubMed=14518029; PubMed=19372543; PubMed=25877200; RCB=RCB2145; Technion Genomics Center)
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,17
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 53
//
ID   PC-3 [Human lung carcinoma]
AC   CVCL_S982
SY   PC-3; PC3; JPC-3; PC3JPC3
DR   CLO; CLO_0037036
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471064
DR   cancercelllines; CVCL_S982
DR   Cell_Model_Passport; SIDM00361
DR   Cosmic; 801572
DR   Cosmic; 844833
DR   Cosmic; 876135
DR   Cosmic; 917973
DR   Cosmic; 929150
DR   Cosmic; 932923
DR   Cosmic; 946056
DR   Cosmic; 1154599
DR   Cosmic; 1239894
DR   Cosmic; 1571734
DR   Cosmic; 1995465
DR   Cosmic; 2125283
DR   Cosmic; 2668305
DR   Cosmic-CLP; 1240202
DR   DepMap; ACH-002184
DR   EGA; EGAS00001000978
DR   GDSC; 1240202
DR   GEO; GSM827580
DR   GEO; GSM1670340
DR   IARC_TP53; 2384
DR   JCRB; JCRB0077
DR   LINCS_LDP; LCL-1664
DR   PharmacoDB; PC3_JPC3_1249_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_S982
DR   Wikidata; Q54938404
RX   PubMed=1847845;
RX   PubMed=8263009;
RX   PubMed=8286010;
RX   PubMed=9290701;
RX   PubMed=9673367;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=15999539;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
CC   Doubling time: 41.7 hours (PubMed=8286010); ~90 hours (Note=Lot 01072008), ~45 hours (Note=Lot 09302011), 2-4 days (Note=Lot 07162019) (JCRB=JCRB0077).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9673367).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Ala750delinsPro (c.2239_2248delinsC) (c.2239_2248TTAAGAGAAG>C); ClinVar=VCV000177684; Zygosity=Unspecified (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=8263009; PubMed=10536175; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.27%; Native American=0%; East Asian, North=77.82%; East Asian, South=20.28%; South Asian=0%; European, North=0%; European, South=1.63% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1240202; JCRB=JCRB0077
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 11,12
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 33
//
ID   PC-3 [Human pancreatic carcinoma]
AC   CVCL_X130
DR   cancercelllines; CVCL_X130
DR   Cosmic; 965558
DR   Wikidata; Q54938405
RX   PubMed=14640107;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=14640107).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   PC-3 9-7-11
AC   CVCL_D3N6
SY   PSMA/PC-3; Clone 9-7-11
DR   Wikidata; Q127383017
RX   PubMed=24403448;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3788; FOLH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PC-3 cFER AS-B1
AC   CVCL_F0RW
SY   AS-B1
RX   PubMed=10687853;
CC   Population: Caucasian.
CC   Doubling time: 35 +- 4 hours (PubMed=10687853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:40818; Dog FER (Note=420 bp fragment of coding region in antisense orientation).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PC-3 cFER AS-B3
AC   CVCL_F0RX
SY   AS-B3
RX   PubMed=10687853;
CC   Population: Caucasian.
CC   Doubling time: 42 +- 4 hours (PubMed=10687853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:40818; Dog FER (Note=420 bp fragment of coding region in antisense orientation).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PC-3 cFER AS-C3
AC   CVCL_F0RY
SY   AS-C3
RX   PubMed=10687853;
CC   Population: Caucasian.
CC   Doubling time: 42 +- 4 hours (PubMed=10687853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:40818; Dog FER (Note=420 bp fragment of coding region in antisense orientation).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PC-3 cFER S-A2
AC   CVCL_F0RZ
SY   S-A2
RX   PubMed=10687853;
CC   Population: Caucasian.
CC   Doubling time: 31 +- 2 hours (PubMed=10687853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:40818; Dog FER (Note=420 bp fragment of coding region in sense orientation).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PC-3 D12
AC   CVCL_4Y40
DR   cancercelllines; CVCL_4Y40
DR   Wikidata; Q54938406
RX   PubMed=21982118;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   PC-3 D8
AC   CVCL_4Y41
DR   cancercelllines; CVCL_4Y41
DR   Wikidata; Q54938408
RX   PubMed=21982118;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   PC-3 fat-1
AC   CVCL_E6ZJ
DR   ABM; T6270
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Population: Caucasian.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6270).
CC   Doubling time: 18-26 hours (ABM=T6270).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=8510267).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PC-3 MC
AC   CVCL_6E88
DR   cancercelllines; CVCL_6E88
DR   Wikidata; Q54938409
RX   PubMed=1773917;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   PC-3 MK
AC   CVCL_6E89
SY   PC-3 Metastasis in Knee bone
DR   cancercelllines; CVCL_6E89
DR   Wikidata; Q54938410
RX   PubMed=1773917;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   PC-3 ML
AC   CVCL_6E90
SY   PC3-ML; PC-3 Metastasis in Lumbar vertebrae
DR   BTO; BTO_0006369
DR   cancercelllines; CVCL_6E90
DR   Wikidata; Q54938411
RX   PubMed=1352184;
RX   PubMed=1773917;
RX   PubMed=22275356;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   PC-3 ML-Luc
AC   CVCL_ZC63
SY   PC-3-ML-Luciferase
DR   cancercelllines; CVCL_ZC63
DR   Kerafast; EDX002
DR   Wikidata; Q98128500
RX   PubMed=22275356;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Kerafast; EDX002; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E90 ! PC-3 ML
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   PC-3 MR
AC   CVCL_6E91
SY   PC-3 Metastasis in Rib cartilage
DR   cancercelllines; CVCL_6E91
DR   Wikidata; Q54938412
RX   PubMed=1773917;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   PC-3-1A
AC   CVCL_4877
DR   cancercelllines; CVCL_4877
DR   Wikidata; Q54938414
RX   PubMed=7176035;
RX   PubMed=15643172;
CC   Population: Caucasian.
CC   Characteristics: Established from tumors obtained after subcutaneous injection of the parent cell line in nude mice (PubMed=7176035).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   PC-3-AR
AC   CVCL_C3HH
SY   PC3-AR
DR   cancercelllines; CVCL_C3HH
DR   GEO; GSM3407115
DR   GEO; GSM3407116
DR   GEO; GSM3407117
DR   GEO; GSM3407118
DR   GEO; GSM3407119
DR   GEO; GSM3407120
DR   GEO; GSM3407121
DR   GEO; GSM3407122
DR   GEO; GSM3407123
DR   Wikidata; Q114312649
RX   PubMed=30305041;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   PC-3-Cas9-576
AC   CVCL_XD72
DR   cancercelllines; CVCL_XD72
DR   CCRID; 1101HUM-PUMC000576
DR   Wikidata; Q98128501
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): CCRID=1101HUM-PUMC000576
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,17
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PC-3-Cas9-577
AC   CVCL_XD73
DR   cancercelllines; CVCL_XD73
DR   CCRID; 1101HUM-PUMC000577
DR   Wikidata; Q98128502
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): CCRID=1101HUM-PUMC000577
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,17
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PC-3-Cas9-578
AC   CVCL_XD74
DR   cancercelllines; CVCL_XD74
DR   CCRID; 1101HUM-PUMC000578
DR   Wikidata; Q98128503
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): CCRID=1101HUM-PUMC000578
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,17
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PC-3-Cas9-579
AC   CVCL_XD75
DR   cancercelllines; CVCL_XD75
DR   CCRID; 1101HUM-PUMC000579
DR   Wikidata; Q98128504
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): CCRID=1101HUM-PUMC000579
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 21
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 10,17
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PC-3-Luc
AC   CVCL_J265
DR   cancercelllines; CVCL_J265
DR   JCRB; JCRB1406
DR   JCRB; NIHS0656
DR   Wikidata; Q54938415
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0656; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): JCRB=JCRB1406
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   PC-3-Luc2
AC   CVCL_A4BV
DR   ATCC; CRL-1435-LUC2
DR   cancercelllines; CVCL_A4BV
DR   Wikidata; Q105510539
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-1435-LUC2).
CC   Doubling time: ~16 hours (ATCC=CRL-1435-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-1435-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   PC-3-luc2
AC   CVCL_5J26
DR   cancercelllines; CVCL_5J26
DR   Revvity/PerkinElmer; 124089
DR   Wikidata; Q54938416
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124089; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   PC-3-luc2-GFP
AC   CVCL_5J29
DR   cancercelllines; CVCL_5J29
DR   Revvity/PerkinElmer; 133416
DR   Wikidata; Q54938418
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 133416; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   PC-3-R
AC   CVCL_C0QS
DR   cancercelllines; CVCL_C0QS
DR   Wikidata; Q112930250
RX   PubMed=30244336;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   PC-3-Red-FLuc
AC   CVCL_5J08
SY   PC3-Red-FLuc; PC3 Red-FLuc; Bioware Brite PC3 Red-FLuc; IVISbrite PC3 Red F-luc
DR   cancercelllines; CVCL_5J08
DR   Revvity/PerkinElmer; BW128444
DR   Wikidata; Q54938419
CC   Population: Caucasian.
CC   Doubling time: 24 hours (Revvity/PerkinElmer=BW128444).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   PC-3-Red-FLuc-GFP
AC   CVCL_5J09
SY   PC3-Red-FLuc-GFP; PC3 Red-FLuc-GFP; Bioware Brite PC3 Red-FLuc-GFP; IVISbrite PC3 Red F-luc-GFP
DR   cancercelllines; CVCL_5J09
DR   Revvity/PerkinElmer; BW133416
DR   Wikidata; Q54938420
CC   Population: Caucasian.
CC   Doubling time: 24 hours (Revvity/PerkinElmer=BW133416).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 15
//
ID   PC-3-TxR
AC   CVCL_ZX05
DR   cancercelllines; CVCL_ZX05
DR   Wikidata; Q102114738
RX   PubMed=17440963;
RX   PubMed=29662635;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   PC-3-TxR/CxR
AC   CVCL_ZX06
DR   cancercelllines; CVCL_ZX06
DR   Wikidata; Q102114740
RX   PubMed=29662635;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX05 ! PC-3-TxR
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   PC-3/DTX
AC   CVCL_A2FD
DR   cancercelllines; CVCL_A2FD
DR   Wikidata; Q105510544
RX   PubMed=32968452;
CC   Population: Caucasian.
CC   Doubling time: 28.87 +- 0.75 hours (PubMed=32968452).
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   PC-3/IF
AC   CVCL_E7UP
SY   PC-3/IntraFemoral
RX   PubMed=9717832;
WW   Provider; WSU OTC; 98-448; http://wayne.technologypublisher.com/technology/5217
CC   Population: Caucasian.
CC   Characteristics: Established from a tumor produced in nude mice following intrafemoral injection of the parent cell line (PubMed=9717832).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PC-3/MA2
AC   CVCL_6E87
SY   PC-3 MA2; PC3-MA2; PC3mA2; PC3MA2
DR   cancercelllines; CVCL_6E87
DR   Wikidata; Q54938451
RX   PubMed=447482;
RX   PubMed=7459854;
RX   PubMed=8612713;
RX   PubMed=10754530;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   PC-3/nKR
AC   CVCL_M060
SY   PC3/nKR
DR   cancercelllines; CVCL_M060
DR   KCLB; 60069
DR   PRIDE; PXD008184
DR   Wikidata; Q54938421
RX   PubMed=31404090;
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, has an increased cell migration capability and a higher number of invaded cell. Established from nude mice that were implanted with the parent cell line without anti-NK treatment.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): KCLB=60069
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,11
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   PC-310
AC   CVCL_4878
DR   Wikidata; Q54938423
RX   PubMed=8780407;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PC-324
AC   CVCL_4879
DR   Wikidata; Q54938424
RX   PubMed=8780407;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PC-329
AC   CVCL_4880
DR   Wikidata; Q54938425
RX   PubMed=8780407;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PC-339
AC   CVCL_4881
DR   Wikidata; Q54938430
RX   PubMed=8780407;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PC-346
AC   CVCL_4882
SY   PC346
DR   Wikidata; Q54938431
RX   CelloPub=CLPUB00699;
RX   PubMed=8780407;
RX   PubMed=10861745;
CC   Miscellaneous: This is not a cell line but a xenograft, it is the parent tumor for many cell lines.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   PC-346C
AC   CVCL_4883
SY   PC346C
DR   BTO; BTO_0002831
DR   GEO; GSM539100
DR   GEO; GSM539101
DR   GEO; GSM539102
DR   GEO; GSM539103
DR   GEO; GSM539104
DR   GEO; GSM539105
DR   GEO; GSM539106
DR   GEO; GSM539107
DR   GEO; GSM539108
DR   GEO; GSM539109
DR   GEO; GSM539110
DR   GEO; GSM539111
DR   GEO; GSM1374819
DR   IARC_TP53; 21087
DR   Wikidata; Q54938432
RX   CelloPub=CLPUB00698;
RX   CelloPub=CLPUB00699;
RX   PubMed=11304728;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=15900601;
RX   PubMed=20976069;
CC   Characteristics: Established from the PC-346 xenograft (CelloPub=CLPUB00699).
CC   Characteristics: Optimal proliferation of the cell line requires androgens and is inhibited by the antiandrogen hydroxyflutamide.
CC   Doubling time: 4-5 days (CelloPub=CLPUB00699).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=14518029).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=11304728; PubMed=14518029
ST   Amelogenin: X (PubMed=14518029_clone_2)
ST   Amelogenin: X,Y (PubMed=11304728; PubMed=14518029_clone_1)
ST   D13S317: 14
ST   D18S51: 12,13
ST   D21S11: 29,34.2
ST   D3S1358: 16,18 (PubMed=11304728; PubMed=14518029_clone_1)
ST   D3S1358: 16,19 (PubMed=14518029_clone_2)
ST   D5S818: 12,14
ST   D7S820: 7,12
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   vWA: 18,19 (PubMed=11304728; PubMed=14518029_clone_1)
ST   vWA: 19 (PubMed=14518029_clone_2)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4882 ! PC-346
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   PC-346CF
AC   CVCL_B7J2
SY   PC346CF
DR   Wikidata; Q112930251
RX   CelloPub=CLPUB00699;
CC   Characteristics: Established from tumors in male nude mice injected with the parent cell line.
CC   Characteristics: Androgen insensitive.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4883 ! PC-346C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   PC-374
AC   CVCL_4884
DR   Wikidata; Q54938433
RX   PubMed=8780407;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PC-3H
AC   CVCL_B289
SY   PC3H
DR   BTO; BTO_0004853
DR   cancercelllines; CVCL_B289
DR   Wikidata; Q54938434
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   PC-3M
AC   CVCL_9555
SY   PC3-M; PC-3/M; PC3M; Pc3M
DR   BTO; BTO_0005220
DR   EFO; EFO_0022442
DR   cancercelllines; CVCL_9555
DR   ChEMBL-Cells; CHEMBL4295486
DR   ChEMBL-Targets; CHEMBL4296484
DR   CLS; 305061
DR   Cosmic; 1945877
DR   GEO; GSM1178559
DR   GEO; GSM1178560
DR   GEO; GSM1178561
DR   KCLB; 80020
DR   KYinno; KC-3937
DR   NCI-DTP; PC-3/M
DR   PubChem_Cell_line; CVCL_9555
DR   TOKU-E; 3851
DR   Wikidata; Q54938435
RX   PubMed=447482;
RX   PubMed=3335022;
RX   PubMed=7017212;
RX   PubMed=7471073;
CC   Population: Caucasian.
CC   Characteristics: Established from a xenografted tumor of nude mice injected with the parent cell line (PubMed=447482).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): KCLB=80020
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,11
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 30
//
ID   PC-3M-1E8
AC   CVCL_G257
SY   PC-3M IE8; PC-3M-IE8; PC3M-1E8; PC3M-IE8; 1E8-H
DR   cancercelllines; CVCL_G257
DR   CCRID; 1101HUM-PUMC000199
DR   Wikidata; Q54938438
RX   PubMed=18060641;
RX   PubMed=20388373;
CC   Population: Caucasian.
CC   Characteristics: High metastatic potential.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): CCRID=1101HUM-PUMC000199
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16,20
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24,25
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   PC-3M-2B4
AC   CVCL_G256
SY   PC-3M 2B4; PC3M-2B4; 2B4-L; 2B4
DR   cancercelllines; CVCL_G256
DR   CCRID; 1101HUM-PUMC000200
DR   CCRID; 4201HUM-CCTCC00331
DR   CCTCC; GDC0331
DR   Wikidata; Q54938437
RX   PubMed=18060641;
RX   PubMed=20388373;
CC   Population: Caucasian.
CC   Characteristics: Low metastatic potential.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,20
ST   D3S1358: 16,20
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24,25
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   PC-3M-LN1
AC   CVCL_L155
DR   cancercelllines; CVCL_L155
DR   Wikidata; Q54938439
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   PC-3M-LN2
AC   CVCL_L156
DR   cancercelllines; CVCL_L156
DR   Wikidata; Q54938440
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L155 ! PC-3M-LN1
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   PC-3M-LN3
AC   CVCL_L157
DR   cancercelllines; CVCL_L157
DR   Wikidata; Q54938441
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L156 ! PC-3M-LN2
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   PC-3M-LN4
AC   CVCL_D578
SY   PC3M-LN4; PC3MLN4
DR   BTO; BTO_0005221
DR   cancercelllines; CVCL_D578
DR   Wikidata; Q54938442
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L157 ! PC-3M-LN3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   PC-3M-luc-C6
AC   CVCL_D577
DR   cancercelllines; CVCL_D577
DR   Revvity/PerkinElmer; 119270
DR   Wikidata; Q54938443
RX   PubMed=14713107;
RX   PubMed=14713108;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: Revvity/PerkinElmer; 119270; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 21
//
ID   PC-3M-luc2
AC   CVCL_5J25
DR   cancercelllines; CVCL_5J25
DR   Revvity/PerkinElmer; 128444
DR   Wikidata; Q54938445
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 128444; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   PC-3M-Pro1
AC   CVCL_L158
DR   cancercelllines; CVCL_L158
DR   Wikidata; Q54938447
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   PC-3M-Pro2
AC   CVCL_L159
DR   Wikidata; Q54938448
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139fs*31 (c.413delC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L158 ! PC-3M-Pro1
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   PC-3M-Pro3
AC   CVCL_L301
DR   cancercelllines; CVCL_L301
DR   Wikidata; Q54938449
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L159 ! PC-3M-Pro2
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   PC-3M-Pro4
AC   CVCL_D579
SY   PC-3M-Pro-4; PC3MPro4; PC3MPRO4
DR   BTO; BTO_0005222
DR   cancercelllines; CVCL_D579
DR   Wikidata; Q54938450
RX   PubMed=9816342;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L301 ! PC-3M-Pro3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   PC-3M-Red-FLuc
AC   CVCL_5J10
SY   PC3M-Red-FLuc; PC3M Red-FLuc; Bioware Brite PC3M Red-FLuc
DR   cancercelllines; CVCL_5J10
DR   Revvity/PerkinElmer; BW124089
DR   Wikidata; Q54938446
CC   Population: Caucasian.
CC   Doubling time: 20 hours (Revvity/PerkinElmer=BW124089).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Revvity/PerkinElmer; BW124089; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   PC-3N
AC   CVCL_4886
SY   PC3N
DR   cancercelllines; CVCL_4886
DR   Wikidata; Q54938452
RX   PubMed=10487836;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   PC-3rVCR20
AC   CVCL_RS45
DR   cancercelllines; CVCL_RS45
DR   Wikidata; Q54938453
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   PC-3rYM155_20nM
AC   CVCL_RS41
SY   PC-3rYM155(20nM)
DR   cancercelllines; CVCL_RS41
DR   Wikidata; Q54938454
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_139608; Sepantronium bromide (YM155).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   PC-3U
AC   CVCL_0482
DR   MCCL; MCC:0000381
DR   cancercelllines; CVCL_0482
DR   Wikidata; Q54938455
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   PC-3U-hrGFP
AC   CVCL_E9DS
SY   PC-3U-GFP
RX   PubMed=32591581;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a CAG-hrGFP-PuroR construct was introduced in the AAVS1 safe harbor locus (PubMed=32591581).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 84CGO; rrGFP (Note=hrGFP; luorescent protein published in 2007, green fluorescent protein derived from R.reniformis).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0482 ! PC-3U
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PC-4
AC   CVCL_X128
DR   cancercelllines; CVCL_X128
DR   Cosmic; 965559
DR   Wikidata; Q54938456
RX   PubMed=14640107;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=14640107).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   PC-5 [Human lung carcinoma]
AC   CVCL_A1IE
SY   PC 5; PC5
DR   Wikidata; Q102114741
RX   PubMed=758928;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   PC-5 [Human prostate carcinoma]
AC   CVCL_M124
DR   cancercelllines; CVCL_M124
DR   Wikidata; Q54938458
RX   PubMed=8200854;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   PC-53
AC   CVCL_W802
SY   PC53
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   Cosmic; 2491090
DR   Wikidata; Q54938459
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2314113;
RX   PubMed=9067587;
RX   PubMed=34940123;
CC   Characteristics: Established at the 3rd relapse.
CC   Doubling time: 70-80 hours (PubMed=2314113).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8017; NSMAF + HGNC; HGNC:29923; NUCKS1; Name(s)=NSMAF-NUCKS1; Note=NSMAF exon 1/NUCKS1 exon 2 fusion (PubMed=34940123).
CC   Sequence variation: Mutation; HGNC; HGNC:8619; PAX5; Simple; p.Arg38His (c.113G>A); Zygosity=Heterozygous (PubMed=34940123).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W803 ! PC-53A
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   PC-53A
AC   CVCL_W803
SY   PC53A
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   Wikidata; Q54938460
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2314113;
RX   PubMed=34940123;
CC   Characteristics: Established at the final progression phase.
CC   Doubling time: 70-80 hours (PubMed=2314113).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Mutation; HGNC; HGNC:8619; PAX5; Simple; p.Arg38His (c.113G>A); Zygosity=Heterozygous (PubMed=34940123).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W802 ! PC-53
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   PC-5Ly
AC   CVCL_A5WX
DR   Wikidata; Q107116647
RX   PubMed=196968;
RX   PubMed=4377005;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a lung carcinoma.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   PC-6
AC   CVCL_C002
SY   PC 6; PC6
DR   EFO; EFO_0002845
DR   CGH-DB; 105-1
DR   CGH-DB; 9051-4
DR   ChEMBL-Cells; CHEMBL3307571
DR   ChEMBL-Targets; CHEMBL614235
DR   Cosmic; 1212199
DR   Cosmic; 1571745
DR   PubChem_Cell_line; CVCL_C002
DR   Wikidata; Q54938461
RX   PubMed=2982333;
RX   PubMed=3731100;
RX   PubMed=9259410;
RX   PubMed=10912951;
RX   PubMed=12107105;
RX   PubMed=15185009;
RX   PubMed=17237272;
RX   PubMed=17511773;
RX   PubMed=18445659;
RX   PubMed=21128075;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 15
//
ID   PC-6/ADM2-1
AC   CVCL_ZZ74
DR   Wikidata; Q102114742
RX   PubMed=10912951;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   PC-6/AMR-OH
AC   CVCL_ZZ79
DR   Wikidata; Q102114743
RX   PubMed=21128075;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=21128075).
CC   Selected for resistance to: ChEBI; CHEBI_156204; Amrubicinol.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   PC-6/CDDP2-7
AC   CVCL_ZZ75
DR   Wikidata; Q102114744
RX   PubMed=10912951;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   PC-6/CPT2-2
AC   CVCL_ZZ76
DR   Wikidata; Q102114745
RX   PubMed=10912951;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   PC-6/FU23-26
AC   CVCL_ZZ73
DR   Wikidata; Q102114746
RX   PubMed=10912951;
RX   PubMed=17237272;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   PC-6/SN2-5
AC   CVCL_S850
DR   Wikidata; Q54938462
RX   PubMed=9259410;
RX   PubMed=10912951;
RX   PubMed=17237272;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   PC-6/TAX1-1
AC   CVCL_S849
SY   PC-6/Tax1-1
DR   Wikidata; Q54938463
RX   PubMed=10912951;
RX   PubMed=17237272;
RX   PubMed=18445659;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 9
//
ID   PC-6/VCR29-9
AC   CVCL_ZZ77
DR   Wikidata; Q102114747
RX   PubMed=10912951;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   PC-6/VP1-1
AC   CVCL_ZZ78
DR   Wikidata; Q102114749
RX   PubMed=10912951;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C002 ! PC-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 4
//
ID   PC-7
AC   CVCL_A786
SY   PC 7; PC7
DR   BTO; BTO_0005440
DR   EFO; EFO_0002846
DR   cancercelllines; CVCL_A786
DR   Cosmic; 801573
DR   Cosmic; 844834
DR   Cosmic; 876136
DR   Cosmic; 918000
DR   Cosmic; 946057
DR   Cosmic; 1239895
DR   Cosmic; 2125284
DR   Cosmic; 2668306
DR   IARC_TP53; 11870
DR   Wikidata; Q54938464
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=758928;
RX   PubMed=1332703;
RX   PubMed=1847845;
RX   PubMed=2168285;
RX   PubMed=3731100;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
CC   Doubling time: 35.5 hours (PubMed=2168285).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gly719Ser (c.2155G>A); ClinVar=VCV000016612; Zygosity=Unspecified (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 21
//
ID   PC-7 [Human pancreatic carcinoma]
AC   CVCL_X129
DR   cancercelllines; CVCL_X129
DR   Cosmic; 965560
DR   Wikidata; Q54938465
RX   PubMed=14640107;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=14640107).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   PC-7/CPT
AC   CVCL_A787
DR   cancercelllines; CVCL_A787
DR   Wikidata; Q54938466
RX   PubMed=1332703;
RX   PubMed=2168285;
CC   Population: Japanese.
CC   Doubling time: 45.8 hours (PubMed=2168285).
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gly719Ser (c.2155G>A); ClinVar=VCV000016612; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Thr729Ala (c.2185G>A); Zygosity=Unspecified (PubMed=1332703).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A786 ! PC-7
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 18
//
ID   PC-8
AC   CVCL_4Z01
SY   PC 8
DR   ChEMBL-Cells; CHEMBL3307866
DR   ChEMBL-Targets; CHEMBL614101
DR   PubChem_Cell_line; CVCL_4Z01
DR   Wikidata; Q54938467
RX   PubMed=758928;
RX   PubMed=1367039;
RX   PubMed=3902783;
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   PC-82
AC   CVCL_4887
SY   PC 82
DR   Cosmic; 704851
DR   Wikidata; Q54938468
RX   PubMed=1873816;
RX   PubMed=7279800;
CC   Population: Caucasian.
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   PC-9
AC   CVCL_B260
SY   PC9; PC-9/S1; PC-9S1
DR   BTO; BTO_0005518
DR   CLO; CLO_0050067
DR   EFO; EFO_0002847
DR   BCRJ; 0331
DR   BioGRID_ORCS_Cell_line; 1203
DR   BioSample; SAMN03470946
DR   BioSample; SAMN10989619
DR   cancercelllines; CVCL_B260
DR   Cell_Model_Passport; SIDM00236
DR   ChEMBL-Cells; CHEMBL3307867
DR   ChEMBL-Targets; CHEMBL614102
DR   CLS; 305045
DR   Cosmic; 713867
DR   Cosmic; 801574
DR   Cosmic; 876137
DR   Cosmic; 897746
DR   Cosmic; 911753
DR   Cosmic; 915329
DR   Cosmic; 917985
DR   Cosmic; 929156
DR   Cosmic; 946058
DR   Cosmic; 1001658
DR   Cosmic; 1002731
DR   Cosmic; 1047092
DR   Cosmic; 1128254
DR   Cosmic; 1146943
DR   Cosmic; 1239896
DR   Cosmic; 1336875
DR   Cosmic; 1571735
DR   Cosmic; 1656893
DR   Cosmic; 1731370
DR   Cosmic; 1745414
DR   Cosmic; 2015224
DR   Cosmic; 2125285
DR   Cosmic; 2668307
DR   DepMap; ACH-000779
DR   ENCODE; ENCBS177ANS
DR   ENCODE; ENCBS480XRH
DR   ENCODE; ENCBS761VSF
DR   ENCODE; ENCBS987JQH
DR   GEO; GSM434290
DR   GEO; GSM481160
DR   GEO; GSM784274
DR   GEO; GSM794406
DR   GEO; GSM827407
DR   GEO; GSM1374821
DR   GEO; GSM5599283
DR   IARC_TP53; 2385
DR   IGRhCellID; PC9GEO
DR   LINCS_HMS; 50038
DR   LINCS_LDP; LCL-1630
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   Progenetix; CVCL_B260
DR   PubChem_Cell_line; CVCL_B260
DR   RCB; RCB4455
DR   Ubigene; YC-C114
DR   Wikidata; Q54938469
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=758928;
RX   PubMed=1737336;
RX   PubMed=1847845;
RX   PubMed=4094096;
RX   PubMed=8263009;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9538136;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11078804;
RX   PubMed=16105816;
RX   PubMed=17332333;
RX   PubMed=17511773;
RX   PubMed=19472407;
RX   PubMed=19799608;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22313637;
RX   PubMed=23733853;
RX   PubMed=25877200;
RX   PubMed=26202522;
RX   PubMed=26554430;
RX   PubMed=28196595;
RX   PubMed=28290473;
RX   PubMed=29681454;
RX   PubMed=31068700;
RX   PubMed=34320349;
RX   PubMed=38639832;
RX   PubMed=39061985;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC   Population: Chinese; Han and Japanese.
CC   HLA typing: A*02:06,24:02; B*07:02,55:02; C*03:03,07:02 (PubMed=9178645).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (PubMed=16105816; PubMed=17332333; DepMap=ACH-000779).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=8263009; PubMed=10536175; PubMed=20557307; DepMap=ACH-000779).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13
ST   D12S391: 18
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D1S1656: 15
ST   D21S11: 30
ST   D22S1045: 16,17
ST   D2S1338: 19,20
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 23
ST   Penta D: 13
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 42
//
ID   PC-9-GR-high
AC   CVCL_S706
DR   cancercelllines; CVCL_S706
DR   Cosmic; 1896429
DR   Wikidata; Q54938470
RX   PubMed=23542356;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   PC-9-GR-step
AC   CVCL_S707
DR   cancercelllines; CVCL_S707
DR   Cosmic; 1896428
DR   Wikidata; Q54938471
RX   PubMed=23542356;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   PC-9/BR
AC   CVCL_T015
SY   PC-9BR; PC-9/BRc1; PC-9BRc1
DR   cancercelllines; CVCL_T015
DR   Cosmic; 2015227
DR   Wikidata; Q54938480
RX   PubMed=21734175;
RX   PubMed=23733853;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_61390; Afatinib (BIBW-2992).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 21
//
ID   PC-9/CDDP
AC   CVCL_ZZ72
DR   cancercelllines; CVCL_ZZ72
DR   Wikidata; Q102114750
RX   PubMed=17237272;
RX   PubMed=18445659;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   PC-9/DR1
AC   CVCL_DI33
SY   PC-9 DR1
DR   cancercelllines; CVCL_DI33
DR   GEO; GSM481167
DR   Progenetix; CVCL_DI33
DR   Wikidata; Q54938481
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/DR2
AC   CVCL_DI34
SY   PC-9 DR2
DR   cancercelllines; CVCL_DI34
DR   GEO; GSM481168
DR   Progenetix; CVCL_DI34
DR   Wikidata; Q54938482
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/DR3
AC   CVCL_DI35
SY   PC-9 DR3
DR   cancercelllines; CVCL_DI35
DR   GEO; GSM481169
DR   Progenetix; CVCL_DI35
DR   Wikidata; Q54938483
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/DR4
AC   CVCL_DI36
SY   PC-9 DR4
DR   cancercelllines; CVCL_DI36
DR   GEO; GSM481170
DR   Progenetix; CVCL_DI36
DR   Wikidata; Q54938484
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/DR5
AC   CVCL_DI37
SY   PC-9 DR5
DR   cancercelllines; CVCL_DI37
DR   GEO; GSM481171
DR   Progenetix; CVCL_DI37
DR   Wikidata; Q54938485
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/DR6
AC   CVCL_DI38
SY   PC-9 DR6
DR   cancercelllines; CVCL_DI38
DR   GEO; GSM481172
DR   Progenetix; CVCL_DI38
DR   Wikidata; Q54938486
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_132268; Dacomitinib (PF-00299804).
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/ER/WR
AC   CVCL_DG28
DR   cancercelllines; CVCL_DG28
DR   Wikidata; Q54938488
RX   PubMed=26980747;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/ER1
AC   CVCL_D778
SY   PC-9-ER1; PC9-ER1
DR   cancercelllines; CVCL_D778
DR   Cosmic; 1731371
DR   Wikidata; Q54938489
RX   PubMed=22815900;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   PC-9/ER3
AC   CVCL_D726
SY   PC-9-ER3
DR   cancercelllines; CVCL_D726
DR   Cosmic; 1745415
DR   Wikidata; Q54938491
RX   PubMed=22712764;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   PC-9/f14
AC   CVCL_U149
SY   PC9/f14
DR   cancercelllines; CVCL_U149
DR   Cosmic; 915331
DR   Wikidata; Q54938492
RX   PubMed=11506965;
RX   PubMed=12696064;
RX   PubMed=17982658;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: Highly metastatic. Established after five additional passages of the parent cell line in nude mice (PubMed=11506965).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U150 ! PC-9/f9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   PC-9/f9
AC   CVCL_U150
SY   PC-9-f9; PC9/f9
DR   cancercelllines; CVCL_U150
DR   Cosmic; 915330
DR   Wikidata; Q54938493
RX   PubMed=11078804;
RX   PubMed=11506965;
RX   PubMed=12696064;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: Highly metastatic. Established after nine passages of the parent cell line in nude mice (PubMed=11078804).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 19
//
ID   PC-9/GR
AC   CVCL_E7RA
RX   PubMed=39080187;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PC-9/GR/WR
AC   CVCL_DG27
DR   cancercelllines; CVCL_DG27
DR   Wikidata; Q54938500
RX   PubMed=26980747;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/GR1
AC   CVCL_DI28
SY   PC-9 GR1
DR   cancercelllines; CVCL_DI28
DR   GEO; GSM481161
DR   Progenetix; CVCL_DI28
DR   Wikidata; Q54938494
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Responsible for gefitinib resistance (PubMed=20118985).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/GR2
AC   CVCL_DI29
SY   PC-9 GR2; PC9-GR2
DR   cancercelllines; CVCL_DI29
DR   GEO; GSM481162
DR   GEO; GSM1960268
DR   GEO; GSM1960269
DR   GEO; GSM1960270
DR   GEO; GSM1960271
DR   Progenetix; CVCL_DI29
DR   Wikidata; Q54938495
RX   PubMed=20118985;
RX   PubMed=26828195;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Responsible for gefitinib resistance (PubMed=20118985).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   PC-9/GR3
AC   CVCL_DI30
SY   PC-9 GR3; PC9-GR3
DR   cancercelllines; CVCL_DI30
DR   GEO; GSM481163
DR   GEO; GSM1960272
DR   GEO; GSM1960273
DR   GEO; GSM1960274
DR   GEO; GSM1960275
DR   Progenetix; CVCL_DI30
DR   Wikidata; Q54938496
RX   PubMed=20118985;
RX   PubMed=26828195;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Responsible for gefitinib resistance (PubMed=20118985).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   PC-9/GR4
AC   CVCL_DH34
SY   PC-9 GR4; PC9GR4; GR4
DR   cancercelllines; CVCL_DH34
DR   GEO; GSM481164
DR   GEO; GSM925738
DR   Progenetix; CVCL_DH34
DR   Wikidata; Q54938497
RX   PubMed=20118985;
RX   PubMed=22961667;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Responsible for gefitinib resistance (PubMed=20118985).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   PC-9/GR5
AC   CVCL_DI31
SY   PC-9 GR5
DR   cancercelllines; CVCL_DI31
DR   GEO; GSM481165
DR   Progenetix; CVCL_DI31
DR   Wikidata; Q54938498
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Responsible for gefitinib resistance (PubMed=20118985).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/GR6
AC   CVCL_DI32
SY   PC-9 GR6
DR   cancercelllines; CVCL_DI32
DR   GEO; GSM481166
DR   Progenetix; CVCL_DI32
DR   Wikidata; Q54938499
RX   PubMed=20118985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Responsible for gefitinib resistance (PubMed=20118985).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/IR
AC   CVCL_DP47
SY   PC-9-IR; PC9-IR; PC9/IR; PC9IR; PC9/gef
DR   cancercelllines; CVCL_DP47
DR   PRIDE; PXD001548
DR   PRIDE; PXD002224
DR   Wikidata; Q54938501
RX   PubMed=26202522;
RX   PubMed=26554430;
RX   PubMed=28290473;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Subcellular; Membrane.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   PC-9/R
AC   CVCL_S750
SY   PC-9R; PC-9/ER; PC-9ER
DR   cancercelllines; CVCL_S750
DR   Cosmic; 1890454
DR   Cosmic; 2015225
DR   Wikidata; Q54938502
RX   PubMed=21734175;
RX   PubMed=22773810;
RX   PubMed=23733853;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified; Note=Acquired during resistance selection process (PubMed=22773810).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 21
//
ID   PC-9/S2
AC   CVCL_T016
SY   PC-9S2
DR   cancercelllines; CVCL_T016
DR   Cosmic; 2015226
DR   Wikidata; Q54938503
RX   PubMed=23733853;
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 20
//
ID   PC-9/WR
AC   CVCL_DG29
DR   cancercelllines; CVCL_DG29
DR   Wikidata; Q54938504
RX   PubMed=26980747;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/WZR09
AC   CVCL_DG30
SY   WZR09; WZR9
DR   cancercelllines; CVCL_DG30
DR   GEO; GSM925739
DR   Progenetix; CVCL_DG30
DR   Wikidata; Q54938505
RX   PubMed=22961667;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/WZR10
AC   CVCL_DG31
SY   WZR10
DR   cancercelllines; CVCL_DG31
DR   GEO; GSM925740
DR   Progenetix; CVCL_DG31
DR   Wikidata; Q54938506
RX   PubMed=22961667;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/WZR11
AC   CVCL_DG32
SY   WZR11
DR   cancercelllines; CVCL_DG32
DR   GEO; GSM925741
DR   Progenetix; CVCL_DG32
DR   Wikidata; Q54938507
RX   PubMed=22961667;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/WZR12
AC   CVCL_DG33
SY   WZR12
DR   cancercelllines; CVCL_DG33
DR   GEO; GSM925742
DR   Progenetix; CVCL_DG33
DR   Wikidata; Q54938508
RX   PubMed=22961667;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Selected for resistance to: ChEBI; CHEBI_61400; WZ4002 (N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH34 ! PC-9/GR4
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 15
//
ID   PC-9/ZD
AC   CVCL_V337
SY   PC9 ZD
DR   cancercelllines; CVCL_V337
DR   Cosmic; 911754
DR   GEO; GSM1374824
DR   Wikidata; Q54938509
RX   PubMed=15761868;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 20
//
ID   PC-9(gFGFR1)
AC   CVCL_E8FK
DR   ABM; T6465
RX   PubMed=30562682;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: FGFR1 gene expression was genetically up-regulated. First transduced with a CRISPR-based Synergistic Activation Mediator (SAM) system composed of two lentiviral vectors dCAS-VP64_Blast (EF1a-dCas9-VP64-Bsd-WPE) and MS2-P65-HSF1-Hygro (EF1a-MS2(N55K)-SV40(NLS)-RELA-HSF1-hygR-WPRE) and then a PiggyBac transposon containing three unique SAM compatible gRNAs spanning the promoter region of FGFR1 (gFGFR1) and a puroR-IRES-AsRed-CMV construct (PubMed=30562682).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; 8TL1P; AsRed2 (Note=Red fluorescent protein derived from Anemonia sulcata).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03612; Escherichia phage MS2 capsid protein (Note=With p.Asn56Lys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PC-93
AC   CVCL_4888
DR   BioSample; SAMN03151752
DR   Wikidata; Q54086637
RX   PubMed=6602397;
RX   PubMed=12725112;
RX   PubMed=14518029;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=14518029; PubMed=20143388). Originally thought to originate from a moderately differentiated primary adenocarcinoma of the prostate.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00256.
CC   Population: African American.
CC   Doubling time: 20 hours (PubMed=6602397).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   PC-B-142CA
AC   CVCL_B7I1
DR   cancercelllines; CVCL_B7I1
DR   Wikidata; Q112930252
RX   PubMed=34651665;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: ER-negative, PR-negative, ERBB2-positive.
CC   Doubling time: 45 +- 3 hours (PubMed=34651665).
CC   Karyotypic information: 38 chromosomes with a chr X monosomy (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871Leu (c.2612C>T); ClinVar=VCV000041812; Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser425Cys (c.1274C>G); Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.7806-14T>C; ClinVar=VCV000126158; Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Glu839Lys (c.2515G>A); ClinVar=VCV000013862; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln224Ter (c.670C>T); Zygosity=Homozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Thr (c.695T>C); ClinVar=VCV000141224; Zygosity=Homozygous (PubMed=34651665).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=34651665
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 31.2
ST   D2S1338: 16,24
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   PC-B-148CA
AC   CVCL_B7I2
DR   cancercelllines; CVCL_B7I2
DR   Wikidata; Q112930253
RX   PubMed=34651665;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 155.7 +- 5.2 hours (PubMed=34651665).
CC   Karyotypic information: 47-58 chromosomes with loss of both copies of chr X (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (PubMed=34651665).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (PubMed=34651665).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=34651665
ST   CSF1PO: 13
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 11,12
ST   D19S433: 13.2,14.2
ST   D21S11: 29,31
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 14,17
ST   FGA: 18
ST   TH01: 6,9
ST   TPOX: 9,12
ST   vWA: 18,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   PC-DR-LUC
AC   CVCL_C0Q0
DR   Wikidata; Q112930254
RX   PubMed=17532181;
CC   Biotechnology: Used in an assay that can be used to identify compounds that have thyromimetic or TH-antagonistic effects, and that could be useful for detecting thyroid-disrupting chemicals in environmental samples (PubMed=17532181).
CC   Characteristics: Expression of luciferase is under the control of a promoter containing two thyroid hormone response elements (TREs) separated by four nucleotides (DR4) followed by a SV40 promoter (PubMed=17532181).
CC   Genetic integration: Method=Transduction; Gene=CGNC; 155; THRA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0PZ ! PC12 cA4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   PC-E1
AC   CVCL_B7JA
DR   Wikidata; Q112930255
RX   PubMed=9892213;
CC   HLA typing: DRB1*04,07 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   PC-EN
AC   CVCL_X063
DR   cancercelllines; CVCL_X063
DR   Cosmic; 965561
DR   Wikidata; Q54938510
RX   PubMed=11869555;
RX   PubMed=14640107;
CC   Population: Chinese.
CC   Characteristics: Established from a xenograft established in a nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=14640107).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C45843; Pancreatic mixed adenoneuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   PC-H1
AC   CVCL_B7JB
DR   Wikidata; Q112930256
RX   PubMed=9892213;
CC   Senescence: SV40-transformed but with a finite life span.
CC   HLA typing: DRB1*03,06 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   PC-J
AC   CVCL_X641
DR   BTO; BTO_0004191
DR   cancercelllines; CVCL_X641
DR   Wikidata; Q54938511
RX   PubMed=18649734;
CC   Population: Caucasian.
CC   Characteristics: Androgen-independent clone of PC-3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   PC-MDS
AC   CVCL_1Q81
DR   BioSample; SAMN03151810
DR   Wikidata; Q54938512
RX   PubMed=17350682;
RX   PubMed=17917092;
RX   PubMed=19344951;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=19344951).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00379.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 22
//
ID   PC-p53(143Ala) Cl1
AC   CVCL_XG15
SY   PC-p53(143Ala) clone 1
DR   Wikidata; Q98128505
RX   PubMed=7478522;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6712 ! PCCL3
SX   Sex unspecified
AG   1Y6M
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   PC-p53(143Ala) Cl4
AC   CVCL_XG16
SY   PC-p53(143Ala) clone 4
DR   Wikidata; Q98128506
RX   PubMed=7478522;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6712 ! PCCL3
SX   Sex unspecified
AG   1Y6M
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   PC-p53(143Ala) Cl5
AC   CVCL_XG17
SY   PC-p53(143Ala) clone 5
DR   Wikidata; Q98128507
RX   PubMed=7478522;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6712 ! PCCL3
SX   Sex unspecified
AG   1Y6M
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   PC-R1
AC   CVCL_B7JC
DR   Wikidata; Q112930257
RX   PubMed=9892213;
CC   HLA typing: DRB1*02,04 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   PC-S1
AC   CVCL_B7JD
DR   Wikidata; Q112930258
RX   PubMed=9892213;
CC   HLA typing: DRB1*04,12 (PubMed=9892213).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   PC/AA
AC   CVCL_B261
SY   AA
DR   IARC_TP53; 23785
DR   Wikidata; Q54938513
RX   DOI=10.1007/978-1-4612-0411-4_28;
RX   PubMed=2253215;
RX   PubMed=2369746;
RX   PubMed=6746117;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=2253215).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   PC/AA/C1
AC   CVCL_IQ04
SY   AA/C1
DR   IARC_TP53; 23788
DR   Wikidata; Q54938514
RX   DOI=10.1007/978-1-4612-0411-4_28;
RX   PubMed=2369746;
RX   PubMed=16465285;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B261 ! PC/AA
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   PC/AA/C1/SB
AC   CVCL_IQ05
SY   AA/C1/SB
DR   Wikidata; Q54938515
RX   DOI=10.1007/978-1-4612-0411-4_28;
RX   PubMed=2369746;
CC   Selected for resistance to: ChEBI; CHEBI_64103; Sodium butyrate.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ04 ! PC/AA/C1
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 6
//
ID   PC/AA/C1/SB10
AC   CVCL_IQ06
SY   PC/AA/C1/SB/10; AA/C1/SB10
DR   IARC_TP53; 23789
DR   Wikidata; Q54938516
RX   DOI=10.1007/978-1-4612-0411-4_28;
RX   PubMed=2369746;
RX   PubMed=16465285;
CC   Selected for resistance to: ChEBI; CHEBI_64103; Sodium butyrate.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ05 ! PC/AA/C1/SB
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   PC/BH
AC   CVCL_IQ07
DR   IARC_TP53; 23787
DR   Wikidata; Q54938517
RX   PubMed=6746117;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   PC/BH/C1
AC   CVCL_IQ08
DR   Wikidata; Q54938518
RX   PubMed=16465285;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IQ07 ! PC/BH
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   PC/FF
AC   CVCL_IQ09
DR   Wikidata; Q54938519
RX   PubMed=6746117;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   PC/JW
AC   CVCL_B262
SY   PC-JW; PCJW; JW
DR   Cosmic; 876725
DR   Cosmic; 948837
DR   Cosmic; 1043823
DR   Cosmic; 1312308
DR   Cosmic; 2760079
DR   Cosmic; 2800582
DR   GEO; GSM1374825
DR   IARC_TP53; 21709
DR   IARC_TP53; 21755
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54938520
RX   PubMed=2253215;
RX   PubMed=6746117;
RX   PubMed=8464898;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=29101300;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.74+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=16418264).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   PC/JW/FI
AC   CVCL_IQ10
SY   PC/JW/Feeder Independent
DR   Wikidata; Q54938521
RX   PubMed=16465285;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.74+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B262 ! PC/JW
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   PC1 [Mouse hybridoma against human TNNI3]
AC   CVCL_E2RL
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PC1 [Mouse proximal caput]
AC   CVCL_6B05
SY   Proximal Caput 1
DR   ABM; T0598
DR   Wikidata; Q54938525
RX   PubMed=12399533;
RX   PubMed=17233813;
WW   Provider; VCCTC; MKT14144; https://vanderbilt.technologypublisher.com/technology/15863
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Testis, epididymis, proximal caput; UBERON=UBERON_0004358.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   PC12
AC   CVCL_0481
SY   PC-12; PC 12; PC12.1
DR   BTO; BTO_0001009
DR   CLO; CLO_0008392
DR   CLO; CLO_0050821
DR   EFO; EFO_0001225
DR   MCCL; MCC:0000379
DR   CLDB; cl3876
DR   CLDB; cl3877
DR   CLDB; cl3878
DR   CLDB; cl4922
DR   CLDB; cl5245
DR   Abcam; ab279978
DR   AddexBio; C0032001/4927
DR   ATCC; CRL-1721
DR   BCRC; 60048
DR   BCRJ; 0203
DR   CCRID; 1101RAT-PUMC000024
DR   CCRID; 3101RATSCSP517
DR   CCRID; 3101RATTCR3
DR   CCRID; 4201RAT-CCTCC00006
DR   CCRID; 5301RAT-KCB07036YJ
DR   CCTCC; GDC0006
DR   ChEMBL-Cells; CHEMBL3307976
DR   ChEMBL-Targets; CHEMBL612556
DR   CLS; 500311
DR   DSMZ; ACC-159
DR   DSMZCellDive; ACC-159
DR   ECACC; 88022401
DR   ICLC; ATL98004
DR   IZSLER; BS TCL 91
DR   JCRB; IFO50278
DR   JCRB; JCRB0733
DR   KCB; KCB 200735YJ
DR   KCB; KCB 200736YJ
DR   KCB; KCB 93033YJ
DR   KCLB; 21721
DR   Lonza; 124
DR   MeSH; D016716
DR   NCBI_Iran; C153
DR   PubChem_Cell_line; CVCL_0481
DR   RCB; RCB0009
DR   TOKU-E; 2867
DR   TOKU-E; 3554
DR   Ubigene; YC-C047
DR   Wikidata; Q7118481
RX   PubMed=682602;
RX   PubMed=1065897;
RX   PubMed=2187480;
RX   PubMed=2493070;
RX   PubMed=2759161;
RX   PubMed=6500171;
RX   PubMed=8282765;
RX   PubMed=9886495;
RX   PubMed=15541571;
RX   PubMed=16223334;
RX   PubMed=18005394;
RX   PubMed=22538498;
RX   PubMed=33171774;
RX   PubMed=34348336;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/pc-12-cells-atcc-crl-1721-vs-atcc-crl-1721-1
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PC12
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-11.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/PC12_cell
WW   Provider; CH3 Biosystems; 910001; https://ch3biosystems.com/shop/pc12-cell-line/
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Responds reversibly to NGF by induction of a neuronal phenotype.
CC   Doubling time: 40 hours (PubMed=9886495); 92 hours (CLS=500311; ECACC=88022401); ~50-60 hours (DSMZ=ACC-159).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   PC12 6c
AC   CVCL_C0PY
DR   Wikidata; Q112930259
RX   PubMed=8385673;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   PC12 cA4
AC   CVCL_C0PZ
SY   TRalpha-1-PC12; TRalpha1-expressing PC12
DR   Wikidata; Q112930262
RX   PubMed=8385673;
RX   PubMed=17532181;
CC   Genetic integration: Method=Transduction; Gene=CGNC; 155; THRA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0PY ! PC12 6c
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   PC12 HTT-SW2-Q145 clone 14
AC   CVCL_DN60
SY   PC12, Htt-SW2-Q145, rdm, 1-3144, human, clone 14; PC12-SW2-FLHtt145-CL14; CHDI-90000424; CH00288
DR   Coriell; CH00288
DR   Wikidata; Q54938526
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=With 145-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PC12 HTT-SW2-Q145-TagRFP clone 5
AC   CVCL_DN61
SY   PC12, Htt-SW2-Q145-TagRFP, rdm, 1-3144, human, clone 5; PC12-SW2-FLHttQ145-TagRFP-CL5; CHDI-90000425; CH00289
DR   Coriell; CH00289
DR   Wikidata; Q54938527
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=With 145-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   PC12 HTT-SW2-Q23 clone 28
AC   CVCL_DN62
SY   PC12, Htt-SW2-Q23, MIX, 1-3144, human, clone 28; PC12-SW2-FLHttQ23-CL28; CHDI-90000415; CH00284
DR   Coriell; CH00284
DR   Wikidata; Q54938528
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=With 23-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 12
//
ID   PC12 HTT-SW2-Q23-TagRFP clone 34
AC   CVCL_DN63
SY   PC12, Htt-SW2-Q23-TAGRFP, mix, 1-3144, human, clone 34; PC12-SW2-FLHttQ23-TAGRFP-CL34; CHDI-90000417; CH00285
DR   Coriell; CH00285
DR   Wikidata; Q54938529
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=With 23-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   PC12 HTT-SW2-Q73 clone 29
AC   CVCL_DN64
SY   PC12, Htt-SW2-Q73, rdm, 1-3144, human, clone 29; PC12-SW2-FLHtt73-CL29; CHDI-90000419; CH00286
DR   Coriell; CH00286
DR   Wikidata; Q54938530
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=With 73-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   PC12 HTT-SW2-Q73-TagRFP clone 17
AC   CVCL_DN65
SY   PC12, Htt-SW2-Q73-TagRFP, rdm, 1-3144, human, clone 17; PC12-SW2-FLHttQ73TagRFP-CL17; CHDI-90000422; CH00287
DR   Coriell; CH00287
DR   Wikidata; Q54938531
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4851; HTT (Note=With 73-Q run).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   PC12 Tet-Off
AC   CVCL_V361
DR   Wikidata; Q54938532
WW   Provider; Takara Bio; 630906; https://www.takarabio.com/documents/Certificate%20of%20Analysis/630906/630906-011916.pdf
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   PC12 Tet-On
AC   CVCL_V333
DR   Wikidata; Q54938533
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630912.
CC   Discontinued: Takara/Clontech; Catalog number 631137.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   PC12-1
AC   CVCL_C0PQ
SY   PC12 clone 1
DR   Wikidata; Q112930265
RX   PubMed=9933147;
RX   PubMed=12106430;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   PC12-15
AC   CVCL_C0PR
SY   PC12 clone 15
DR   Wikidata; Q112930268
RX   PubMed=1657914;
RX   PubMed=9856988;
RX   PubMed=10517799;
RX   PubMed=12106430;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   PC12-16A
AC   CVCL_C0PS
SY   PC12 clone 16A
DR   Wikidata; Q112930272
RX   PubMed=1657914;
RX   PubMed=12106430;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   PC12-19
AC   CVCL_C0PT
SY   PC12 clone 19
DR   Wikidata; Q112930274
RX   PubMed=9933147;
RX   PubMed=12106430;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   PC12-1G2
AC   CVCL_VH13
DR   Wikidata; Q54938535
RX   PubMed=11341965;
CC   Characteristics: Releases very low levels of dopamine in response to high-K+ depolarization. The origin of the deficiency is likely to involve defects in L-type Ca2+channels.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   PC12-21
AC   CVCL_C0PU
SY   PC12 clone 21
DR   Wikidata; Q112930275
RX   PubMed=1657914;
RX   PubMed=9933147;
RX   PubMed=12106430;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   PC12-27
AC   CVCL_C0PV
SY   PC 12-27; PC12 clone 27
DR   TOKU-E; 3553
DR   Wikidata; Q112930276
RX   PubMed=1657914;
RX   PubMed=8900203;
RX   PubMed=9856988;
RX   PubMed=9933147;
RX   PubMed=10517799;
RX   PubMed=12106430;
CC   Characteristics: Fully incompetent for both branches of regulated secretion, those of dense granules and synaptic-like microvesicles, possibly because of the impairment of a general expression control system that appears to operate independently of neuroendocrine cell differentiation (PubMed=8900203).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   PC12-27 c7
AC   CVCL_C0PW
SY   PC12 clone 27 subclone c7
DR   Wikidata; Q112930278
RX   PubMed=8900203;
RX   PubMed=9856988;
CC   Characteristics: Neurosecretion incompetent (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1930; CHGB.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C0PV ! PC12-27
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   PC12-2B3
AC   CVCL_VH10
DR   Wikidata; Q54938536
RX   PubMed=11341965;
CC   Characteristics: Not responsive to high-K(+)-induced depolarization and ionomycin.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   PC12-615
AC   CVCL_C130
SY   PC12(615); PC-12 615; PC12 (615); 615
DR   Wikidata; Q54938537
RX   PubMed=1384575;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   PC12-AC
AC   CVCL_J442
DR   BTO; BTO_0003060
DR   Wikidata; Q54938538
RX   PubMed=15456758;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   PC12-C3
AC   CVCL_VH11
DR   Wikidata; Q54938539
RX   PubMed=9345269;
CC   Characteristics: Produces high level of acetylcholine.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   PC12-C41
AC   CVCL_E6BM
SY   PC12-clone 41
RX   PubMed=8282765;
WW   Provider; CH3 Biosystems; 910002; https://ch3biosystems.com/shop/pc12-c41-cell-line/
CC   Characteristics: Exhibits enhanced nerve growth factor-induced neurite outgrowth (PubMed=8282765).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PC12-D60
AC   CVCL_VH12
DR   Wikidata; Q54938540
RX   PubMed=11341965;
CC   Characteristics: Shows very low catecholamine reuptake.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   PC12-F7
AC   CVCL_T752
DR   CLO; CLO_0050822
DR   RCB; RCB2800
DR   Wikidata; Q54938541
RX   PubMed=1352065;
CC   Characteristics: Devoid of Syt1 and Syt2 expression. Survived selective killing with an anti-synaptotagmin antibody.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   PC12-FR
AC   CVCL_C0PX
SY   PC12-Fast Responding; PC12-251; PC12 clone 251
DR   Wikidata; Q112930281
RX   PubMed=6303817;
RX   PubMed=6577005;
RX   PubMed=8900203;
RX   PubMed=9856988;
CC   Characteristics: Established after 3 passages by subcutaneous injection of the parent cell line into Deaconess rats.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   PC12-G11
AC   CVCL_T753
DR   CLO; CLO_0050823
DR   RCB; RCB2801
DR   Wikidata; Q54938543
RX   PubMed=1352065;
RX   PubMed=11341965;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   PC12-Mn
AC   CVCL_E6BN
SY   PC12Mn
RX   PubMed=9828105;
WW   Provider; CH3 Biosystems; 910003; https://ch3biosystems.com/shop/pc12mn-cell-line/
CC   Characteristics: Adapted to adhere to collagen and selected for manganese responsiveness (PubMed=9828105).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PC12-P1D10
AC   CVCL_C4US
DR   TKG; TKG 0816
DR   Wikidata; Q116050109
RX   PubMed=33171774;
CC   Characteristics: Hyposensitive for neuritogenesis to temperature-controlled repeated thermal stimulation (TRTS) (PubMed=33171774).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 7
//
ID   PC12-P1F1
AC   CVCL_C4UT
DR   TKG; TKG 0815
DR   Wikidata; Q116050110
RX   PubMed=33171774;
CC   Characteristics: Hypersensitive for neuritogenesis to temperature-controlled repeated thermal stimulation (TRTS) (PubMed=33171774).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   PC12.4
AC   CVCL_C0PP
DR   Wikidata; Q112930284
RX   PubMed=9886495;
CC   Characteristics: Has high ethanol sensitivity. Highly adhesive.
CC   Doubling time: 24 hours (PubMed=9886495).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   PC12.P3
AC   CVCL_5573
SY   PC-12.P3
DR   JCRB; JCRB0130
DR   JCRB; JCRB0130.1
DR   JCRB; NIHS0197
DR   JCRB; NIHS0373
DR   Wikidata; Q54938544
CC   Group: Serum/protein free medium cell line.
CC   Discontinued: JCRB; NIHS0197; true.
CC   Discontinued: JCRB; NIHS0373; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC12D
AC   CVCL_4681
SY   PC-12D
DR   BTO; BTO_0001676
DR   Wikidata; Q54938545
RX   PubMed=2493070;
RX   PubMed=3033256;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC12h
AC   CVCL_JX88
SY   PC-12h; PC 12h; PC12 subclone h
DR   EFO; EFO_0022761
DR   Wikidata; Q54938546
RX   PubMed=2246260;
RX   PubMed=6116517;
RX   PubMed=6286607;
RX   PubMed=7530581;
CC   Characteristics: Shows NGF-mediated increase of tyrosine hydroxlyase activity.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   PC12h-R
AC   CVCL_JX89
SY   PC-12H-R; PC 12h-R
DR   Wikidata; Q54938547
RX   PubMed=2246260;
RX   PubMed=7530581;
CC   Characteristics: Shows NGF-mediated increase of tyrosine hydroxlyase activity. Rapidly respond to NGF by extending its neurites without any delay.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_JX88 ! PC12h
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   PC12HS
AC   CVCL_J438
SY   PC12 clone HS
DR   JCRB; JCRB0263
DR   JCRB; JCRB0266
DR   JCRB; NIHS0375
DR   Wikidata; Q54938548
RX   PubMed=1493541;
CC   Discontinued: JCRB; JCRB0263; true.
CC   Discontinued: JCRB; NIHS0375; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   PC12HS.P3
AC   CVCL_J439
SY   PC12 clone HS.P3
DR   JCRB; JCRB0263.1
DR   JCRB; NIHS0374
DR   Wikidata; Q54938549
CC   Group: Serum/protein free medium cell line.
CC   Discontinued: JCRB; NIHS0374; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_J438 ! PC12HS
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   PC12IS
AC   CVCL_J440
SY   PC12 clone IS
DR   JCRB; JCRB0265
DR   JCRB; JCRB0268
DR   JCRB; NIHS0377
DR   Wikidata; Q54938550
RX   PubMed=1493541;
CC   Discontinued: JCRB; JCRB0265; true.
CC   Discontinued: JCRB; NIHS0377; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   PC12K
AC   CVCL_4925
SY   PC-12K
DR   BTO; BTO_0005061
DR   Wikidata; Q54938551
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC12MS
AC   CVCL_J441
SY   PC12 clone MS
DR   JCRB; JCRB0264
DR   JCRB; JCRB0267
DR   JCRB; NIHS0376
DR   Wikidata; Q54938552
RX   PubMed=1493541;
CC   Discontinued: JCRB; JCRB0264; true.
CC   Discontinued: JCRB; NIHS0376; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   PC12nnr14
AC   CVCL_C126
SY   PC12 not nerve growth factor responsive clone 14
DR   Wikidata; Q54938553
RX   PubMed=3005338;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   PC12nnr3
AC   CVCL_C127
SY   PC12 not nerve growth factor responsive clone 3
DR   Wikidata; Q54938554
RX   PubMed=3005338;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   PC12nnr5
AC   CVCL_C128
SY   PC12 not nerve growth factor responsive clone 5
DR   Wikidata; Q54938556
RX   PubMed=3005338;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   PC12nnr6
AC   CVCL_C129
SY   PC12 not nerve growth factor responsive clone 6
DR   Wikidata; Q54938557
RX   PubMed=3005338;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   PC14Br
AC   CVCL_9W71
DR   cancercelllines; CVCL_9W71
DR   Wikidata; Q54938558
RX   PubMed=10987313;
CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1640 ! PC-14
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   PC14HM
AC   CVCL_J032
DR   cancercelllines; CVCL_J032
DR   Wikidata; Q54938559
RX   PubMed=22922681;
CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1640 ! PC-14
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   PC14PE6
AC   CVCL_9W70
SY   PC14-PE6; PC14/PE6
DR   cancercelllines; CVCL_9W70
DR   Wikidata; Q54938560
RX   PubMed=10741721;
RX   PubMed=10987313;
RX   PubMed=19771249;
CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Caution: PC-14-PM4 (Cellosaurus=CVCL_9W69) and PC14PE6 could be identical.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1640 ! PC-14
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   PC14PE6/AS2
AC   CVCL_9W72
DR   cancercelllines; CVCL_9W72
DR   Wikidata; Q54938561
RX   PubMed=16518408;
CC   Problematic cell line: Contaminated. Grand-parent cell line (PC-14) has been shown to be a PC-9 derivative.
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W70 ! PC14PE6
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   PC1CpTr
AC   CVCL_1G93
SY   Pomacentrus Caeruleus 1 Caudal peduncle Trypsinised
DR   NRFC; NRFC035
DR   Wikidata; Q54938562
RX   CelloPub=CLPUB00750;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1007/s40011-016-0751-x;
WW   Provider; NRFC; NRFC035; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC035.
CC   Doubling time: 48 hours (Note=At 73th passage) (CelloPub=CLPUB00750).
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=586851; ! Pomacentrus caeruleus (Caerulean damsel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PC1F1Ex
AC   CVCL_1G94
SY   Pomacentrus Caeruleus 1 Fin 1 Explant
DR   NRFC; NRFC036
DR   Wikidata; Q54938564
RX   CelloPub=CLPUB00750;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1007/s40011-016-0751-x;
WW   Provider; NRFC; NRFC036; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC036.
CC   Doubling time: 48 hours (Note=At 73th passage) (CelloPub=CLPUB00750).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=586851; ! Pomacentrus caeruleus (Caerulean damsel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PC1L1Tr
AC   CVCL_1G95
SY   Pomacentrus Caeruleus 1 Liver 1 Trypsinised
DR   NRFC; NRFC037
DR   Wikidata; Q54938565
RX   CelloPub=CLPUB00750;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1007/s40011-016-0751-x;
WW   Provider; NRFC; NRFC037; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC037.
CC   Doubling time: 36 hours (Note=At 73th passage) (CelloPub=CLPUB00750).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=586851; ! Pomacentrus caeruleus (Caerulean damsel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   PC2 [Mouse hybridoma against human CGB]
AC   CVCL_D5Y1
DR   Wikidata; Q127383018
RX   PubMed=6208130;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   PC2 [Rat pheochromocytoma]
AC   CVCL_0483
AS   CVCL_7089
SY   PC12/PC2
DR   MCCL; MCC:0000382
DR   Wikidata; Q54938567
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC21A1
AC   CVCL_1Q49
DR   Wikidata; Q54938568
RX   PubMed=6641706;
RX   PubMed=6686281;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C522 ! 2102EP
HI   CVCL_1Q47 ! PCC4AO
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   PC3
AC   CVCL_E2RM
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PC3-eGFP-Neo
AC   CVCL_D5K8
DR   Imanis; CL123
DR   Wikidata; Q127383019
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-eGFP-P2A-Neo vector encoding for eGFP under control of the spleen focus-forming virus (SFFV) promoter linked to the Neo gene via a P2A cleavage peptide (Imanis=CL123).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   PC3-eGFP-Neo/Fluc-Puro
AC   CVCL_D5K9
DR   Imanis; CL125
DR   Wikidata; Q127383020
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-eGFP-P2A-Neo and LV-Fluc-P2A-Puro vectors. LV-eGFP-P2A-Neo encodes for eGFP linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter and LV-Fluc-P2A-Puro encodes for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL125).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   PC3-EMT1
AC   CVCL_B0CN
DR   cancercelllines; CVCL_B0CN
DR   GEO; GSM1063982
DR   Wikidata; Q108821090
RX   PubMed=24124593;
CC   Population: Caucasian.
CC   Characteristics: Selected from a mesenchymal sub-population of the parent cell line.
CC   Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0CB ! PC3-epi
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   PC3-EMT12
AC   CVCL_B0E4
DR   cancercelllines; CVCL_B0E4
DR   GEO; GSM1063983
DR   Wikidata; Q108821091
RX   PubMed=24124593;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0CB ! PC3-epi
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   PC3-EMT14
AC   CVCL_B0E3
SY   PC3-emt; PC3-EMT; PCE EMT
DR   ATCC; CRL-3471
DR   cancercelllines; CVCL_B0E3
DR   GEO; GSM1063984
DR   Wikidata; Q108821093
RX   PubMed=24124593;
RX   PubMed=25426557;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0CB ! PC3-epi
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   PC3-epi
AC   CVCL_B0CB
SY   PC3-Epi
DR   ATCC; CRL-3470
DR   cancercelllines; CVCL_B0CB
DR   GEO; GSM1063981
DR   Wikidata; Q108821094
RX   PubMed=24124593;
RX   PubMed=25426557;
CC   Population: Caucasian.
CC   Characteristics: Selected based on an epithelial cell morphology, bioluminescent intensity and expression of E-cadherin. Selection was repeated twice and a stable epithelial population was obtained (PubMed=24124593).
CC   Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   PC3-Fluc-Neo/iRFP-Puro
AC   CVCL_D5K6
DR   Imanis; CL124
DR   Wikidata; Q127383021
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with both the LV-Fluc-P2A-Neo and LV-iRFP-P2A-Puro vectors. LV-Fluc-P2A-Neo encodes for luciferase linked via a P2A cleavage peptide to the neo gene and under control of the spleen focus-forming virus (SFFV) promoter. LV-iRFP-P2A-Puro encodes for iRFP linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL124).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DGXFA; iRFP (Note=iRFP713, near infra-red fluorescent protein from R.palustris).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   PC3-Fluc-Puro
AC   CVCL_D5K7
DR   Imanis; CL122
DR   Wikidata; Q127383022
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL122).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   PC3-FOLH1
AC   CVCL_E9XY
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3788; FOLH1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: Cell line information from personal communication of Zhang, Jing-Jing.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PC3-MM2
AC   CVCL_4885
SY   PC3MM2; PC-3MM2; PC-3 MM2; PC-3M-MM2
DR   BTO; BTO_0005071
DR   cancercelllines; CVCL_4885
DR   KCLB; 80021
DR   Wikidata; Q54938569
RX   CelloPub=CLPUB00698;
RX   PubMed=11304728;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=11304728).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=11304728
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 14,15
ST   D21S11: 29,31.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   PC3-neo
AC   CVCL_D5ZR
DR   Wikidata; Q127383023
RX   PubMed=17575147;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for PC3-STEAP-1 (Cellosaurus=CVCL_D5ZS) (PubMed=17575147).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   PC3-PIP
AC   CVCL_E9XK
SY   PC3/PIP; PC3-PSMA+
RX   PubMed=10397265;
RX   PubMed=10933046;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3788; FOLH1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PC3-R-caba
AC   CVCL_WM76
DR   cancercelllines; CVCL_WM76
DR   Wikidata; Q98128508
RX   PubMed=27198502;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   PC3-STEAP-1
AC   CVCL_D5ZS
DR   Wikidata; Q127383024
RX   PubMed=17575147;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11378; STEAP1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   PC3/DX
AC   CVCL_C3M5
DR   Wikidata; Q116050111
RX   DOI=10.29228/jrp.195;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   PC3/DX/AR+
AC   CVCL_C3M6
DR   Wikidata; Q116050112
RX   DOI=10.29228/jrp.195;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3M5 ! PC3/DX
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   PC3.1
AC   CVCL_U140
DR   CLO; CLO_0050388
DR   RCB; RCB2306
DR   Wikidata; Q54938574
RX   PubMed=1409580;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q64361; Rat Lxn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   PC3#33 rho-0
AC   CVCL_D8GR
DR   CancerTools; 162187
DR   Kerafast; ESA124
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   PC346Abi101
AC   CVCL_RA53
DR   Wikidata; Q54938575
RX   PubMed=24200698;
CC   Selected for resistance to: ChEBI; CHEBI_68642; Abiraterone.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4883 ! PC-346C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   PC346DCC
AC   CVCL_IP21
DR   GEO; GSM539100
DR   GEO; GSM539101
DR   GEO; GSM539102
DR   GEO; GSM539103
DR   Wikidata; Q54938576
RX   PubMed=15900601;
RX   PubMed=20976069;
CC   Characteristics: Proliferation of this cell line is androgen-independent.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4883 ! PC-346C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   PC346Enza
AC   CVCL_RA54
DR   Wikidata; Q54938577
RX   PubMed=24200698;
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4883 ! PC-346C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   PC346Flu1
AC   CVCL_IP22
SY   PC346FLU1
DR   GEO; GSM539104
DR   GEO; GSM539105
DR   GEO; GSM539106
DR   GEO; GSM539107
DR   GEO; GSM1374820
DR   Wikidata; Q54938578
RX   PubMed=15900601;
RX   PubMed=20976069;
CC   Characteristics: Proliferation of this cell line is androgen-independent.
CC   Selected for resistance to: ChEBI; CHEBI_5132; Flutamide.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4883 ! PC-346C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   PC346Flu2
AC   CVCL_IP23
DR   cancercelllines; CVCL_IP23
DR   GEO; GSM539108
DR   GEO; GSM539109
DR   GEO; GSM539110
DR   GEO; GSM539111
DR   Wikidata; Q54938579
RX   PubMed=15900601;
RX   PubMed=20976069;
CC   Characteristics: Proliferation of this cell line is androgen-independent.
CC   Selected for resistance to: ChEBI; CHEBI_5132; Flutamide.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (PubMed=15900601).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4883 ! PC-346C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 14
//
ID   PC3B1
AC   CVCL_D689
SY   PC3-B1
DR   BTO; BTO_0005121
DR   cancercelllines; CVCL_D689
DR   Wikidata; Q54938580
RX   PubMed=19491258;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   PC3PR
AC   CVCL_B7P9
SY   PC3-PR
DR   cancercelllines; CVCL_B7P9
DR   Wikidata; Q112930288
RX   PubMed=20687223;
RX   PubMed=23876400;
RX   PubMed=27687545;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   PC4 [Mouse hybridoma against human TNNI3]
AC   CVCL_E2RN
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PC4 [Rat pheochromocytoma]
AC   CVCL_7090
DR   Wikidata; Q54938581
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   PC6
AC   CVCL_7091
SY   PC-6; PC 6
DR   BTO; BTO_0002752
DR   Wikidata; Q54938582
RX   PubMed=8396168;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-94.html
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   PC6-1
AC   CVCL_7092
DR   BTO; BTO_0002753
DR   Wikidata; Q54938583
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-10
AC   CVCL_7093
DR   BTO; BTO_0002762
DR   Wikidata; Q54938585
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-11
AC   CVCL_7094
DR   BTO; BTO_0002763
DR   Wikidata; Q54938586
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-12
AC   CVCL_7095
DR   Wikidata; Q54938587
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   PC6-13
AC   CVCL_7096
DR   BTO; BTO_0002764
DR   Wikidata; Q54938588
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-14
AC   CVCL_7097
DR   BTO; BTO_0002765
DR   Wikidata; Q54938590
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-15
AC   CVCL_7098
DR   BTO; BTO_0002766
DR   Wikidata; Q54938591
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-16
AC   CVCL_7099
DR   BTO; BTO_0002755
DR   Wikidata; Q54938592
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-2
AC   CVCL_7100
DR   BTO; BTO_0002754
DR   Wikidata; Q54938593
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-3
AC   CVCL_7101
DR   BTO; BTO_0002751
DR   Wikidata; Q54938594
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-4
AC   CVCL_7102
DR   BTO; BTO_0002756
DR   Wikidata; Q54938595
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-5
AC   CVCL_7103
DR   BTO; BTO_0002757
DR   Wikidata; Q54938596
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-6
AC   CVCL_7104
DR   BTO; BTO_0002758
DR   Wikidata; Q54938597
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-7
AC   CVCL_7105
DR   BTO; BTO_0002759
DR   Wikidata; Q54938598
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-8
AC   CVCL_7106
DR   BTO; BTO_0002760
DR   Wikidata; Q54938599
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC6-9
AC   CVCL_7107
DR   BTO; BTO_0002761
DR   Wikidata; Q54938600
RX   PubMed=8396168;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7091 ! PC6
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PC60.21.14.4
AC   CVCL_WI54
SY   PC60 clone 21.14; PC60
DR   Wikidata; Q98128510
RX   PubMed=2230118;
RX   PubMed=6979720;
RX   PubMed=8344349;
CC   Doubling time: 18 hours (PubMed=8344349).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI52 ! B6.1.SF.1
HI   CVCL_8948 ! C58(NT)D.1.G.OUAR.1
CA   Hybrid cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   PC880
AC   CVCL_U147
DR   Wikidata; Q54938601
RX   PubMed=12694655;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40022; Primary peritoneal carcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   PC9 BIR
AC   CVCL_E4DL
SY   PC9BIR
RX   PubMed=39061985;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_232716; (20R)-10,15,20-trimethyl-2-[(4-methylpiperazin-1-yl)methyl]-18,19,20,21-tetrahydro-15H,17H-12,8-(metheno)pyrazolo[3',4':2,3][1,5,10,12]oxatriazacycloheptadecino[12,11-a]benzimidazol-7(6H)-one (BI-4020).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PC9 fat-1
AC   CVCL_E6ZD
SY   f-PC9
DR   ABM; T6263
RX   DOI=10.1158/1538-7445.AM2016-4651;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6263).
CC   Doubling time: 18-26 hours (ABM=T6263).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PC9-BrM3
AC   CVCL_XA19
DR   cancercelllines; CVCL_XA19
DR   GEO; GSM354013
DR   GEO; GSM354014
DR   GEO; GSM2194119
DR   GEO; GSM2194120
DR   GEO; GSM2194121
DR   Wikidata; Q98128511
RX   PubMed=19576624;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: Brain metastatic derivative of parental cell line. Established after 3 passages in nude mice from intracardial injection. Obtained from mice bearing brain tumors.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA18 ! PC9-TGL
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PC9-DPE2
AC   CVCL_S977
DR   cancercelllines; CVCL_S977
DR   Wikidata; Q54938602
RX   PubMed=9052401;
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3148; TYMP.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 18
//
ID   PC9-LeptoM
AC   CVCL_XA20
SY   PC9 LeptoM
DR   cancercelllines; CVCL_XA20
DR   GEO; GSM2194124
DR   GEO; GSM2194125
DR   Wikidata; Q98128512
RX   PubMed=28283064;
WW   Info; BrMPanel; -; https://apps.cnio.es/app/BrainMetastasis/CellLines
CC   Part of: Brain metastasis cell lines panel.
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: Brain leptomeningeal space metastatic derivative of parental cell line. Established after 3 passages in nude mice from intracisternal injection, followed by one passage from intracardiac injection and obtained from mice bearing leptomeningeal metastases.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA18 ! PC9-TGL
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PC9-OR#1
AC   CVCL_D7FL
RX   PubMed=34145930;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: The parent cell line transiently expressing the luciferase gene was injected into the leptomeningeal space of SHO mice, after which the mice were treated daily with osimertinib. After continuous treatment with osimertinib for 2 weeks, the mice developed osimertinib resistance and were subsequently treated daily with osimertinib for 2 weeks (PubMed=34145930).
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-OR#2
AC   CVCL_D7FM
RX   PubMed=34145930;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: The parent cell line transiently expressing the luciferase gene was injected into the leptomeningeal space of SHO mice, after which the mice were treated daily with osimertinib. After continuous treatment with osimertinib for 2 weeks, the mice developed osimertinib resistance and were subsequently treated daily with osimertinib for 2 weeks (PubMed=34145930).
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous; Note=Acquired (PubMed=34145930).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-OR#3
AC   CVCL_D7FN
RX   PubMed=34145930;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: The parent cell line transiently expressing the luciferase gene was injected into the leptomeningeal space of SHO mice, after which the mice were treated daily with osimertinib. After continuous treatment with osimertinib for 2 weeks, the mice developed osimertinib resistance and were subsequently treated daily with osimertinib for 2 weeks (PubMed=34145930).
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-OR1
AC   CVCL_D7FG
RX   PubMed=31555510;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-OR2
AC   CVCL_D7FH
RX   PubMed=31555510;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-OR3
AC   CVCL_D7FI
RX   PubMed=31555510;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-OR4
AC   CVCL_D7FJ
RX   PubMed=31555510;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-OR5
AC   CVCL_D7FK
RX   PubMed=31555510;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PC9-TGL
AC   CVCL_XA18
DR   cancercelllines; CVCL_XA18
DR   GEO; GSM354009
DR   GEO; GSM354010
DR   GEO; GSM2194116
DR   GEO; GSM2194117
DR   GEO; GSM2194118
DR   Wikidata; Q98128513
RX   PubMed=19576624;
RX   PubMed=28283064;
CC   Population: Chinese; Han and Japanese.
CC   Characteristics: Transfected with HSV1-TK/GFP/Fluc (TGL).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: In PubMed=19576624, PubMed=28283064 and the associated GEO data sets H2030-TGL is termed PC9 Parental.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 12
//
ID   PC9/3-14
AC   CVCL_E4DE
RX   PubMed=28422737;
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28422737).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PC9/3-2
AC   CVCL_E4DF
RX   PubMed=28422737;
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28422737).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PC9/TS1
AC   CVCL_B7N9
DR   cancercelllines; CVCL_B7N9
DR   Wikidata; Q112930291
RX   PubMed=21487406;
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   PC9/TS2
AC   CVCL_B7NA
DR   cancercelllines; CVCL_B7NA
DR   Wikidata; Q112930292
RX   PubMed=21487406;
CC   Population: Chinese; Han and Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   PCA 31.1
AC   CVCL_G246
DR   CLO; CLO_0008397
DR   ATCC; HB-12314
DR   Wikidata; Q54938604
RX   Patent=USRE39760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12314.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2497.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human colorectal carcinoma-associated antigen (CCAA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PCA 33.28
AC   CVCL_G247
DR   CLO; CLO_0008398
DR   ATCC; HB-12315
DR   Wikidata; Q54938606
RX   Patent=USRE39760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12315.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5413.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human colorectal carcinoma-associated antigen (CCAA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PCA-23
AC   CVCL_W864
SY   PCA 23; PC23
DR   Wikidata; Q54938607
RX   PubMed=1318270;
CC   Population: African; Ugandan.
CC   Derived from site: In situ; Penis; UBERON=UBERON_0000989.
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF94 ! PCA-5
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   PCA-5
AC   CVCL_VF94
SY   PCA 5
DR   Wikidata; Q54938608
RX   PubMed=1318270;
RX   PubMed=3499854;
CC   Population: African; Ugandan.
CC   Derived from site: In situ; Penis; UBERON=UBERON_0000989.
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W864 ! PCA-23
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   PcBra1
AC   CVCL_LE04
SY   Prostate cancer Brazil 1
DR   Wikidata; Q54938611
RX   PubMed=19538771;
RX   PubMed=19997870;
CC   Doubling time: 50 hours (PubMed=19997870).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=19997870
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13.2,14
ST   D21S11: 30.2,32.2
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   PcBra2
AC   CVCL_LE05
SY   Prostate cancer Brazil 2
DR   Wikidata; Q54938612
RX   PubMed=19997870;
CC   Doubling time: 35 hours (PubMed=19997870).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=19997870
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 28,32
ST   D2S1338: 19,23
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   PcBra3
AC   CVCL_LE06
SY   Prostate cancer Brazil 3
DR   Wikidata; Q54938613
RX   PubMed=19997870;
CC   Doubling time: 48 hours (PubMed=19997870).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=19997870
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 22.2,24
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   PCC1
AC   CVCL_5T86
DR   Wikidata; Q54938614
RX   PubMed=61803;
RX   PubMed=4599372;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   PCC2
AC   CVCL_5T87
DR   Wikidata; Q54938616
RX   PubMed=4599372;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   PCC3
AC   CVCL_5T85
DR   Wikidata; Q54938617
RX   PubMed=61803;
RX   PubMed=2412863;
RX   PubMed=4599372;
RX   PubMed=6479493;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   PCC3/A/1
AC   CVCL_E064
SY   PCC3-A/1
DR   CLO; CLO_0050538
DR   RCB; RCB1791
DR   Wikidata; Q54938618
RX   PubMed=61803;
RX   PubMed=78963;
RX   PubMed=276874;
RX   PubMed=650144;
RX   PubMed=886245;
RX   PubMed=1893874;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5T85 ! PCC3
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 12
//
ID   PCC4
AC   CVCL_5854
DR   JCRB; JCRB0205
DR   Wikidata; Q54938619
RX   PubMed=61803;
RX   PubMed=4599372;
CC   Discontinued: JCRB; JCRB0205; true.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   PCC4 [Mouse lung papillary tumor]
AC   CVCL_5U82
SY   Peter's Clara Cell 4
DR   Wikidata; Q54938623
RX   PubMed=2548715;
RX   PubMed=9149863;
RX   PubMed=9347924;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Club cell; CL=CL_0000158.
CC   Breed/subspecies: BALB/cJ.
DI   NCIt; C21763; Papillary adenoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   PCC4 AG
AC   CVCL_5855
SY   PCC4 AG-r
DR   JCRB; JCRB0206
DR   Wikidata; Q54938624
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5854 ! PCC4
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   PCC4 AG Cap
AC   CVCL_5856
SY   PCC4 AG-r Cap-r
DR   JCRB; JCRB0216
DR   Wikidata; Q54938625
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5855 ! PCC4 AG
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   PCC4 Neo
AC   CVCL_D3W7
DR   TKG; TKG 0812
DR   Wikidata; Q127383026
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5854 ! PCC4
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   PCC4 Type I
AC   CVCL_U221
SY   PCC4 TypeI
DR   JCRB; JCRB0204
DR   Wikidata; Q54938626
CC   Discontinued: JCRB; JCRB0204; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C566 ! L6TG Cap
HI   CVCL_5854 ! PCC4
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   PCC4 Type III
AC   CVCL_U222
SY   PCC4 TypeIII
DR   JCRB; JCRB0203
DR   Wikidata; Q54938627
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C566 ! L6TG Cap
HI   CVCL_5854 ! PCC4
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   PCC4-azal
AC   CVCL_5857
SY   PCC4-Azal; PCC-4-azal; PCC4Azal; PCC4-aza1; PCC4 aza1; PCC4.aza 1
DR   CLO; CLO_0008400
DR   CLDB; cl3887
DR   CLS; 400313
DR   Wikidata; Q54938628
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5854 ! PCC4
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   PCC4-Azal-ECA2
AC   CVCL_G076
SY   PCC4-Aza1-ECA2; ECA2
DR   Wikidata; Q54938629
RX   PubMed=2479740;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5857 ! PCC4-azal
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   PCC4-AzaR
AC   CVCL_5912
SY   PCC4/AzaR; PCC-4 AzaR; PCC4.azaR; PCC4 azaR; PCC4 AzaR; PCC4-azaR 1; PCC4/AzaR1; PCC4/AzaRl; PCC4 azaR1
DR   Wikidata; Q54938630
RX   PubMed=276874;
RX   PubMed=4599372;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5854 ! PCC4
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   PCC4-F
AC   CVCL_5911
SY   PCC4/F; PCC4F
DR   Wikidata; Q54938631
RX   PubMed=276874;
RX   PubMed=558822;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5854 ! PCC4
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   PCC4AO
AC   CVCL_1Q47
SY   PCC4 8azaR OuR
DR   Wikidata; Q54938632
RX   PubMed=6686281;
RX   PubMed=6951167;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5854 ! PCC4
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 9
//
ID   PCC7-Mz1
AC   CVCL_J426
SY   PCC7-MZ1; Mz1
DR   Wikidata; Q54938633
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Breed/subspecies: C57BL/6 x 129.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J430 ! PCC7-S-AzaRt clone 1009
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   PCC7-S
AC   CVCL_J429
DR   Wikidata; Q54938634
RX   PubMed=78963;
CC   Breed/subspecies: C57BL/6 x 129.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   PCC7-S-AzaRt clone 1009
AC   CVCL_J430
SY   Clone 1009
DR   Wikidata; Q54938635
RX   PubMed=78963;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Breed/subspecies: C57BL/6 x 129.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J429 ! PCC7-S
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   PCCL3
AC   CVCL_6712
SY   PC Cl 3; PC Cl3; PCCl3; PCCL-3; PCCL 3
DR   BTO; BTO_0003800
DR   EFO; EFO_0022751
DR   BCRJ; 0204
DR   Wikidata; Q54938636
RX   PubMed=3670314;
RX   PubMed=7478522;
CC   Doubling time: 24 hours (PubMed=3670314).
CC   Discontinued: BCRJ; 0204; probable.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1Y6M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   PCD-1
AC   CVCL_A6XB
DR   RCB; RCB5262
DR   Wikidata; Q107116648
RX   PubMed=3539943;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10287; Mouse Cdh3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   PCD1
AC   CVCL_D3BE
SY   PCD1-6-Cr3
DR   Wikidata; Q127383027
WW   Provider; CReM; 756; https://stemcellbank.bu.edu/Catalog/Item/Details/756
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2950; DNAH5; Simple; p.Trp4206Ter (c.12617G>A); ClinVar=VCV000557901; Zygosity=Homozygous (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Boston University
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,13
ST   D16S539: 11
ST   D18S51: 15,21
ST   D21S11: 30,32.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 11,15
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C172392; Primary ciliary dyskinesia 3
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   PCD2
AC   CVCL_D3BF
SY   PCD2-14-Cr2
DR   Wikidata; Q127383028
WW   Provider; CReM; 752; https://stemcellbank.bu.edu/Catalog/Item/Details/752
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2954; DNAI1; Simple; c.48+2dupT (IVS1+2_3insT); ClinVar=VCV000005604; Zygosity=Homozygous (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C128117; Primary ciliary dyskinesia 1
DI   ORDO; Orphanet_98861; Primary ciliary dyskinesia, Kartagener type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PCD3
AC   CVCL_D3BG
SY   PCD3-9
DR   Wikidata; Q127383029
WW   Provider; CReM; 831; https://stemcellbank.bu.edu/Catalog/Item/Details/831
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:40050; MCIDAS; Simple; p.Pro384His (c.1151C>A); ClinVar=VCV001502494; Zygosity=Unspecified (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202610; Primary ciliary dyskinesia 42
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PCE
AC   CVCL_1G96
SY   Puntius Chelynoides Eye
DR   Wikidata; Q54938637
RX   CelloPub=CLPUB00463;
RX   PubMed=22465535;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=547593; ! Puntius chelynoides (Dark mahseer)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   PCF
AC   CVCL_W975
SY   Puntius Chelynoides Fin
DR   NRFC; NRFC001
DR   Wikidata; Q54938638
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=24852132;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC001.
CC   Miscellaneous: Cell line is available for distribution but not authenticated (NRFC=NRFC001).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=547593; ! Puntius chelynoides (Dark mahseer)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   PGC29-Fibro
AC   CVCL_E3G6
RX   PubMed=38216643;
CC   From: Nagoya University; Nagoya; Japan.
CC   Miscellaneous: Derived from primordial germ cells (PGCs).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: White Leghorn WL-M/O.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PCG.G6
AC   CVCL_1Q50
DR   Wikidata; Q54938639
RX   PubMed=6641706;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1Q46 ! G3.32.2
HI   CVCL_1Q47 ! PCC4AO
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   PCH41-43
AC   CVCL_K257
DR   CLO; CLO_0050299
DR   RCB; RCB0673
DR   Wikidata; Q54938640
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PCH41-44
AC   CVCL_K258
DR   CLO; CLO_0050353
DR   RCB; RCB0674
DR   Wikidata; Q54938641
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PCH42-58
AC   CVCL_K259
DR   CLO; CLO_0050354
DR   RCB; RCB0676
DR   Wikidata; Q54938642
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   PCH42-63
AC   CVCL_K260
DR   CLO; CLO_0050302
DR   RCB; RCB0669
DR   Wikidata; Q54938643
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PCH54-37
AC   CVCL_K261
DR   CLO; CLO_0050300
DR   RCB; RCB0678
DR   Wikidata; Q54938645
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PCI
AC   CVCL_E6Z2
DR   ABM; T0412
RX   PubMed=32433794;
RX   PubMed=37899851;
CC   Population: African American.
CC   Doubling time: 48-72 hours (ABM=T0412).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Donor information: Established from a patient with bilateral profound sensorineural hearing loss undergoing cochlear implantation (PubMed=37899851).
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y5M
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PCI-01
AC   CVCL_C167
SY   PCI-1
DR   Wikidata; Q54938646
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=17312569;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   PCI-02
AC   CVCL_C168
SY   PCI-2
DR   Wikidata; Q54938647
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   PCI-03
AC   CVCL_C169
SY   PCI-3
DR   BioSample; SAMN03151894
DR   cancercelllines; CVCL_C169
DR   Wikidata; Q54938648
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a 50 year old male patient with a retromolar trigone squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00420.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   PCI-04A
AC   CVCL_C170
SY   PCI-4A; PCI-4T; PCI-4.1
DR   Wikidata; Q54938649
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=14996750;
RX   PubMed=17312569;
CC   Population: Caucasian.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C171 ! PCI-04B
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 13
//
ID   PCI-04B
AC   CVCL_C171
SY   PCI-4B; PCI4B; PCI-4M; PCI-4.2
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 989
DR   cancercelllines; CVCL_C171
DR   Cell_Model_Passport; SIDM00043
DR   Cosmic-CLP; 1298531
DR   DepMap; ACH-002297
DR   EGA; EGAS00001000978
DR   GDSC; 1298531
DR   GEO; GSM827146
DR   GEO; GSM1670344
DR   PharmacoDB; PCI4B_1253_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_C171
DR   Wikidata; Q54938650
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=14996750;
RX   PubMed=17312569;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.38%; Native American=0%; East Asian, North=1.29%; East Asian, South=0%; South Asian=0%; European, North=61.21%; European, South=37.12% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1298531
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C170 ! PCI-04A
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   PCI-05
AC   CVCL_C172
SY   PCI-5
DR   Wikidata; Q54938651
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   PCI-06A
AC   CVCL_C173
SY   PCI-6A; PCI6A; PCI-6T; PCI-6.1
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 990
DR   cancercelllines; CVCL_C173
DR   Cell_Model_Passport; SIDM00115
DR   Cosmic-CLP; 1240206
DR   DepMap; ACH-002298
DR   EGA; EGAS00001000978
DR   GDSC; 1240206
DR   GEO; GSM1670345
DR   PharmacoDB; PCI6A_1254_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54938652
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=14996750;
RX   PubMed=17312569;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Gly17Glu (c.50G>A); Zygosity=Heterozygous (Cosmic-CLP=1240206; DepMap=ACH-002298).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (Cosmic-CLP=1240206; DepMap=ACH-002298).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1101-2A>T; ClinVar=VCV001264355; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=1240206; DepMap=ACH-002298).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.89%; Native American=0%; East Asian, North=1.02%; East Asian, South=0%; South Asian=0.59%; European, North=68.64%; European, South=28.85% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): Cosmic-CLP=1240206
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,13,14
ST   D16S539: 11,14
ST   D5S818: 11
ST   D7S820: 7,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C174 ! PCI-06B
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 32
//
ID   PCI-06B
AC   CVCL_C174
SY   PCI-6B; PCI-6M; PCI-6.2
DR   Wikidata; Q54938653
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=14996750;
RX   PubMed=17312569;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C173 ! PCI-06A
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   PCI-07
AC   CVCL_C175
SY   PCI-7
DR   Wikidata; Q54938655
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, tongue, base; UBERON=UBERON_0010033.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   PCI-08
AC   CVCL_C176
DR   Wikidata; Q54938656
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   PCI-09A
AC   CVCL_C177
SY   PCI-9A; PCI9
DR   Wikidata; Q54938657
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, tongue, base; UBERON=UBERON_0010033.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C178 ! PCI-09B
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   PCI-09B
AC   CVCL_C178
SY   PCI-9B
DR   Wikidata; Q54938658
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C177 ! PCI-09A
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   PCI-10 [Human HNSCC]
AC   CVCL_C179
DR   Wikidata; Q54938659
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, tongue, base; UBERON=UBERON_0010033.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   PCI-10 [Human pancreatic adenocarcinoma]
AC   CVCL_5193
DR   Wikidata; Q54938660
RX   PubMed=7687590;
RX   PubMed=7804431;
RX   PubMed=8797870;
RX   PubMed=17312569;
CC   Doubling time: 34.0 hours (PubMed=7804431).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PCI-11
AC   CVCL_C180
DR   Wikidata; Q54938661
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=17312569;
CC   Derived from site: In situ; Pharynx, hypopharynx, pyriform sinus; UBERON=UBERON_8480022.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   PCI-12
AC   CVCL_C181
DR   Wikidata; Q54938662
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   PCI-13
AC   CVCL_C182
SY   PCI13
DR   Cosmic; 2131852
DR   Wikidata; Q54938663
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=17312569;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-522.html
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   PCI-14
AC   CVCL_C183
DR   Wikidata; Q54938664
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   PCI-15A
AC   CVCL_C184
SY   PCI15A; PCI-15; PCI-15T; PCI-15.1
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 987
DR   cancercelllines; CVCL_C184
DR   Cell_Model_Passport; SIDM00270
DR   Cosmic; 2131853
DR   Cosmic-CLP; 1240204
DR   DepMap; ACH-002294
DR   EGA; EGAS00001000978
DR   GDSC; 1240204
DR   GEO; GSM1670341
DR   PharmacoDB; PCI15A_1250_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54938668
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=14996750;
RX   PubMed=17312569;
RX   PubMed=21868764;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0.36%; Native American=0.21%; East Asian, North=2.01%; East Asian, South=0%; South Asian=0.21%; European, North=62.27%; European, South=34.95% (PubMed=30894373).
CC   Derived from site: In situ; Pharynx, hypopharynx, pyriform sinus; UBERON=UBERON_8480022.
ST   Source(s): Cosmic-CLP=1240204; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C756 ! PCI-15B
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   PCI-15B
AC   CVCL_C756
SY   PCI-15b; PCI15B; PCI-15; PCI-15M; PCI-15.2; 15b
DR   Cosmic; 2131854
DR   Wikidata; Q54938669
RX   PubMed=2766286;
RX   PubMed=8084624;
RX   PubMed=14996750;
RX   PubMed=17312569;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C184 ! PCI-15A
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   PCI-16
AC   CVCL_C185
DR   Wikidata; Q54938670
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   PCI-17
AC   CVCL_C186
DR   Wikidata; Q54938671
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   PCI-18
AC   CVCL_C187
DR   Wikidata; Q54938672
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2766286;
RX   PubMed=17312569;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   PCI-19 [Human HNSCC]
AC   CVCL_RJ83
DR   Wikidata; Q54938673
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PCI-19 [Human pancreatic adenocarcinoma]
AC   CVCL_5194
DR   Cosmic; 1066195
DR   Wikidata; Q54938674
RX   PubMed=7687590;
RX   PubMed=7804431;
RX   PubMed=8797870;
CC   Doubling time: 38.4 hours (PubMed=7804431).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PCI-20
AC   CVCL_RJ72
DR   Wikidata; Q54938675
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 5
//
ID   PCI-21
AC   CVCL_RJ73
DR   Wikidata; Q54938676
RX   PubMed=17312569;
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   PCI-22A
AC   CVCL_1T56
SY   PCI-22.1
DR   BioSample; SAMN03152034
DR   Wikidata; Q54938677
RX   PubMed=8084624;
RX   PubMed=17312569;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Supposed to be isogenic with PCI-22B (Cellosaurus=CVCL_1T57) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00418.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   PCI-22B
AC   CVCL_1T57
SY   PCI-22.2
DR   BioSample; SAMN03152035
DR   Wikidata; Q54938678
RX   PubMed=8084624;
RX   PubMed=17312569;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Supposed to be isogenic with PCI-22A (Cellosaurus=CVCL_1T56) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00419.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   PCI-24 [Human OCSCC]
AC   CVCL_AT94
SY   PCI24
DR   Wikidata; Q54938679
RX   PubMed=17312569;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 12
//
ID   PCI-24 [Human pancreatic adenocarcinoma]
AC   CVCL_5195
DR   Cosmic; 1066196
DR   Cosmic; 1644308
DR   Wikidata; Q54938680
RX   PubMed=7687590;
RX   PubMed=7804431;
RX   PubMed=8093857;
RX   PubMed=8797870;
CC   Doubling time: 39.2 hours (PubMed=7804431).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   PCI-25
AC   CVCL_RJ74
DR   Wikidata; Q54938682
RX   PubMed=8084624;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PCI-26
AC   CVCL_RJ75
DR   Wikidata; Q54938683
RX   PubMed=8084624;
RX   PubMed=17312569;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   PCI-27
AC   CVCL_RJ76
DR   Wikidata; Q54938684
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PCI-28
AC   CVCL_RJ77
DR   Wikidata; Q54938685
RX   PubMed=8084624;
RX   PubMed=17312569;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   PCI-29
AC   CVCL_RJ78
DR   Wikidata; Q54938686
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   PCI-30
AC   CVCL_C757
SY   PCI30
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1049
DR   Cell_Model_Passport; SIDM00044
DR   Cosmic-CLP; 1298529
DR   DepMap; ACH-002295
DR   EGA; EGAS00001000978
DR   GDSC; 1298529
DR   GEO; GSM937840
DR   GEO; GSM937841
DR   GEO; GSM1670342
DR   PharmacoDB; PCI30_1251_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54938687
RX   PubMed=8084624;
RX   PubMed=17312569;
RX   PubMed=20215515;
RX   PubMed=23419152;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (Cosmic-CLP=1298529; DepMap=ACH-002295).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.38%; Native American=0%; East Asian, North=0.85%; East Asian, South=0.5%; South Asian=4.81%; European, North=42.64%; European, South=50.82% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1298529
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 27
//
ID   PCI-31
AC   CVCL_RJ79
DR   Wikidata; Q54938688
RX   PubMed=8084624;
RX   PubMed=17312569;
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PCI-32
AC   CVCL_RJ80
DR   Wikidata; Q54938689
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PCI-33
AC   CVCL_RJ81
DR   Wikidata; Q54938690
RX   PubMed=8084624;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   PCI-34
AC   CVCL_RJ82
DR   Wikidata; Q54938691
RX   PubMed=8084624;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   PCI-35 [Human OCSCC]
AC   CVCL_RJ84
DR   Wikidata; Q54938692
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   PCI-35 [Human pancreatic adenocarcinoma]
AC   CVCL_5191
SY   PCI35
DR   BTO; BTO_0003286
DR   cancercelllines; CVCL_5191
DR   Cosmic; 707259
DR   Cosmic; 1066197
DR   Cosmic; 1644309
DR   Wikidata; Q54938693
RX   PubMed=7687590;
RX   PubMed=7804431;
RX   PubMed=8797870;
RX   PubMed=11115575;
CC   Doubling time: 33.6 hours (PubMed=7804431).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11115575).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   PCI-36
AC   CVCL_RJ85
DR   Wikidata; Q54938694
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PCI-37A
AC   CVCL_C758
SY   PCI-37a; UPCI-37A; PCI-37T; PCI-37.1
DR   Wikidata; Q54938695
RX   PubMed=8084624;
RX   PubMed=14996750;
RX   PubMed=17312569;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C759 ! PCI-37B
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   PCI-37B
AC   CVCL_C759
SY   UPCI-37B; PCI-37M; PCI-37.2
DR   Wikidata; Q54938697
RX   PubMed=8084624;
RX   PubMed=14996750;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C758 ! PCI-37A
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   PCI-38
AC   CVCL_M471
SY   PCI38
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 988
DR   Cell_Model_Passport; SIDM00155
DR   Cosmic-CLP; 1240205
DR   DepMap; ACH-002296
DR   EGA; EGAS00001000978
DR   GDSC; 1240205
DR   GEO; GSM1670343
DR   PharmacoDB; PCI38_1252_2019
DR   Wikidata; Q54938698
RX   PubMed=8084624;
RX   PubMed=17312569;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=3.33%; Native American=0%; East Asian, North=3.92%; East Asian, South=0%; South Asian=6.82%; European, North=30.5%; European, South=55.42% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240205
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   PCI-39
AC   CVCL_RJ86
DR   Wikidata; Q54938699
RX   PubMed=8084624;
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PCI-40
AC   CVCL_RJ87
DR   Wikidata; Q54938701
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PCI-41
AC   CVCL_RJ88
DR   Wikidata; Q54938702
RX   PubMed=17312569;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PCI-42
AC   CVCL_RJ89
DR   Wikidata; Q54938703
RX   PubMed=17312569;
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PCI-43 [Human OCSCC]
AC   CVCL_RJ90
DR   Wikidata; Q54938704
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   PCI-43 [Human pancreatic adenocarcinoma]
AC   CVCL_5139
SY   PCI43
DR   BTO; BTO_0003285
DR   Cosmic; 1066198
DR   Cosmic; 1644310
DR   Wikidata; Q54938705
RX   PubMed=7687590;
RX   PubMed=7804431;
RX   PubMed=8797870;
CC   Doubling time: 52.8 hours (PubMed=7804431).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   PCI-44
AC   CVCL_RJ91
DR   Wikidata; Q54938706
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   PCI-45
AC   CVCL_RJ92
DR   Wikidata; Q54938707
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PCI-46
AC   CVCL_RJ93
DR   Wikidata; Q54938708
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PCI-47
AC   CVCL_RJ94
DR   Wikidata; Q54938709
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PCI-50
AC   CVCL_M470
DR   Wikidata; Q54938710
RX   PubMed=7873144;
RX   PubMed=8001029;
RX   PubMed=8443824;
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   PCI-51
AC   CVCL_RJ98
SY   PCI51
DR   BTO; BTO_0006368
DR   Wikidata; Q54938716
RX   PubMed=17312569;
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   PCI-52
AC   CVCL_RJ99
DR   Wikidata; Q54938717
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PCI-55
AC   CVCL_5196
DR   cancercelllines; CVCL_5196
DR   Cosmic; 707260
DR   Cosmic; 1066199
DR   Cosmic; 1644311
DR   IARC_TP53; 14305
DR   Wikidata; Q54938718
RX   PubMed=7804431;
RX   PubMed=8797870;
RX   PubMed=11115575;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11115575).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (PubMed=11115575).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   PCI-6
AC   CVCL_5197
DR   Cosmic; 1066194
DR   Cosmic; 1644307
DR   Wikidata; Q54938719
RX   PubMed=7687590;
RX   PubMed=7804431;
RX   PubMed=8797870;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PCI-64
AC   CVCL_5198
DR   Cosmic; 1066200
DR   Cosmic; 1644312
DR   Wikidata; Q54938720
RX   PubMed=7804431;
RX   PubMed=8797870;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   PCI-66
AC   CVCL_5199
DR   cancercelllines; CVCL_5199
DR   Cosmic; 707261
DR   Cosmic; 1066201
DR   Wikidata; Q54938721
RX   PubMed=8797870;
RX   PubMed=11115575;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Hemizygous (PubMed=11115575).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   PCI-68
AC   CVCL_5200
DR   Wikidata; Q54938723
RX   PubMed=11173548;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   PCI-72
AC   CVCL_5201
DR   Wikidata; Q54938724
RX   PubMed=11173548;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   PCI-79
AC   CVCL_5422
DR   Wikidata; Q54938725
RX   PubMed=11173548;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   PCi-AFR1
AC   CVCL_UI79
SY   PCi-AFR
DR   Wikidata; Q98128514
RX   PubMed=38101399;
WW   Provider; Phenocell; -; https://web.archive.org/web/20200920120235/https://phenocell.com/products/pci-afr1
CC   From: Phenocell SAS; Grasse; France.
CC   Population: African.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   PCi-AFR2
AC   CVCL_A9QE
DR   Wikidata; Q102114751
WW   Provider; Phenocell; -; https://web.archive.org/web/20200815201257/https://phenocell.com/products/pci-afr2
CC   From: Phenocell SAS; Grasse; France.
CC   Population: African.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   PCi-AFR3
AC   CVCL_E8B2
RX   PubMed=38101399;
CC   From: Phenocell SAS; Grasse; France.
CC   Population: African.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PCi-ASI1
AC   CVCL_UI80
SY   PCi-ASI
DR   Wikidata; Q98128515
WW   Provider; Phenocell; -; https://web.archive.org/web/20200920105858/https://phenocell.com/products/pci-asi1
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   PCi-ASI2
AC   CVCL_A9QF
DR   Wikidata; Q102114752
WW   Provider; Phenocell; -; https://web.archive.org/web/20200920102456/https://phenocell.com/products/pci-asi2
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Chinese.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   PCi-CAU1
AC   CVCL_UI81
SY   PCi-Cau1; PCi-CAU
DR   Wikidata; Q98128516
RX   PubMed=38101399;
WW   Provider; Phenocell; -; https://phenocell.com/products/pci-cau1
WW   Provider; Phenocell; -; https://uploads-ssl.webflow.com/5e788caddfe409570d1dcbd9/5e79211592433f66f0bbcda9_Product_sheet_2020_PCi-CAU.pdf
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 5
//
ID   PCIi001-A
AC   CVCL_UI56
SY   PC124
DR   BioSamples; SAMEA5248236
DR   hPSCreg; PCIi001-A
DR   Wikidata; Q98128517
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   PCIi002-A
AC   CVCL_UI57
DR   BioSamples; SAMEA5248238
DR   hPSCreg; PCIi002-A
DR   Wikidata; Q98128518
CC   From: Phenocell SAS; Grasse; France.
CC   Miscellaneous: Cell line no longer available. Donor has withdrawn its consent for dissemination of the iPSC line (hPSCreg=PCIi002-A).
CC   Discontinued: hPSCreg; PCIi002-A; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   PCIi003-A
AC   CVCL_UI58
SY   PC126
DR   BioSamples; SAMEA5266886
DR   hPSCreg; PCIi003-A
DR   Wikidata; Q98128520
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   PCIi004-A
AC   CVCL_UI59
SY   PC127
DR   BioSamples; SAMEA5248232
DR   hPSCreg; PCIi004-A
DR   Wikidata; Q98128521
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   PCIi005-A
AC   CVCL_UI60
SY   PC137
DR   BioSamples; SAMEA5248234
DR   hPSCreg; PCIi005-A
DR   Wikidata; Q98128522
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84735; Glycogen storage disease type IIb
DI   ORDO; Orphanet_34587; Glycogen storage disease due to LAMP-2 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   PCIi007-A
AC   CVCL_A9QG
SY   PC153
DR   BioSamples; SAMEA7222560
DR   hPSCreg; PCIi007-A
DR   Wikidata; Q102114757
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi008-A
AC   CVCL_A9QH
SY   PC154
DR   BioSamples; SAMEA7222568
DR   hPSCreg; PCIi008-A
DR   Wikidata; Q102114758
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi009-A
AC   CVCL_A9QI
SY   PC168
DR   BioSamples; SAMEA7249859
DR   hPSCreg; PCIi009-A
DR   Wikidata; Q102114759
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi010-A
AC   CVCL_A9QJ
SY   PC169
DR   BioSamples; SAMEA7249868
DR   hPSCreg; PCIi010-A
DR   Wikidata; Q102114761
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi011-A
AC   CVCL_A9QK
SY   PC170
DR   BioSamples; SAMEA7258629
DR   hPSCreg; PCIi011-A
DR   Wikidata; Q102114762
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi012-A
AC   CVCL_A9QL
SY   PC171
DR   BioSamples; SAMEA7258632
DR   hPSCreg; PCIi012-A
DR   Wikidata; Q102114763
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi015-A
AC   CVCL_A9QP
SY   PC191
DR   BioSamples; SAMEA7258635
DR   hPSCreg; PCIi015-A
DR   Wikidata; Q102114764
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi016-A
AC   CVCL_A9QQ
SY   PC192
DR   BioSamples; SAMEA7267288
DR   hPSCreg; PCIi016-A
DR   Wikidata; Q102114765
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi017-A
AC   CVCL_A9QR
SY   PC198
DR   BioSamples; SAMEA7267290
DR   hPSCreg; PCIi017-A
DR   Wikidata; Q102114766
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi018-A
AC   CVCL_A9QS
SY   PC199
DR   BioSamples; SAMEA7267292
DR   hPSCreg; PCIi018-A
DR   Wikidata; Q102114767
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi019-A
AC   CVCL_A9QM
SY   PC200
DR   BioSamples; SAMEA7513366
DR   hPSCreg; PCIi019-A
DR   Wikidata; Q102114768
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi020-A
AC   CVCL_A9QN
SY   PC201
DR   BioSamples; SAMEA7513368
DR   hPSCreg; PCIi020-A
DR   Wikidata; Q102114770
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi021-A
AC   CVCL_A1DH
SY   PC202
DR   BioSamples; SAMEA7513370
DR   hPSCreg; PCIi021-A
DR   Wikidata; Q102114771
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi022-A
AC   CVCL_A1DI
SY   PC203
DR   BioSamples; SAMEA7513372
DR   hPSCreg; PCIi022-A
DR   Wikidata; Q102114772
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi023-A
AC   CVCL_A1MS
SY   PC204
DR   BioSamples; SAMEA7628697
DR   hPSCreg; PCIi023-A
DR   Wikidata; Q102114773
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi024-A
AC   CVCL_A1MT
SY   PC205
DR   BioSamples; SAMEA7628699
DR   hPSCreg; PCIi024-A
DR   Wikidata; Q102114774
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   PCIi025-A
AC   CVCL_A1WN
SY   PC084
DR   BioSamples; SAMEA7683948
DR   hPSCreg; PCIi025-A
DR   Wikidata; Q105510548
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   PCIi026-A
AC   CVCL_A5CA
SY   PC085
DR   BioSamples; SAMEA7807670
DR   hPSCreg; PCIi026-A
DR   Wikidata; Q107116649
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   PCIi027-A
AC   CVCL_A5CB
SY   PC086
DR   BioSamples; SAMEA7807672
DR   hPSCreg; PCIi027-A
DR   Wikidata; Q107116650
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   PCIi028-A
AC   CVCL_A5CC
SY   PC037
DR   BioSamples; SAMEA7807681
DR   hPSCreg; PCIi028-A
DR   Wikidata; Q107116651
CC   From: Phenocell SAS; Grasse; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   PCIi029-A
AC   CVCL_A8DF
SY   PC076
DR   BioSamples; SAMEA8944194
DR   hPSCreg; PCIi029-A
DR   Wikidata; Q107116652
RX   PubMed=36989619;
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8617; PAX3; Simple; c.-70_85+366del; Zygosity=Heterozygous (PubMed=36989619).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75008; Waardenburg syndrome type 1
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   PCIi030-A
AC   CVCL_A8DG
SY   PC078
DR   BioSamples; SAMEA8944199
DR   hPSCreg; PCIi030-A
DR   Wikidata; Q107116653
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   PCIi031-A
AC   CVCL_A8DH
SY   PC079
DR   BioSamples; SAMEA8944202
DR   hPSCreg; PCIi031-A
DR   Wikidata; Q107116654
RX   PubMed=36989619;
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8617; PAX3; Simple; c.-70_85+366del; Zygosity=Heterozygous (PubMed=36989619).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75008; Waardenburg syndrome type 1
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   PCIi032-A
AC   CVCL_A0XW
SY   PC087
DR   BioSamples; SAMEA9147904
DR   hPSCreg; PCIi032-A
DR   Wikidata; Q108821096
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85222; Waardenburg syndrome
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   PCIi033-A
AC   CVCL_A0XX
AS   CVCL_A9QD
SY   PCi-CAU2
DR   BioSamples; SAMEA9699308
DR   hPSCreg; PCIi033-A
DR   Wikidata; Q102114753
WW   Provider; Phenocell; -; https://web.archive.org/web/20200815193120/https://phenocell.com/products/pci-cau2
CC   From: Phenocell SAS; Grasse; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   PCIi034-A
AC   CVCL_E4E6
SY   PC138
DR   BioSamples; SAMEA115113557
DR   hPSCreg; PCIi034-A
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C206077; Aicardi-Goutieres syndrome
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PCIi035-A
AC   CVCL_E4E7
SY   PC139
DR   BioSamples; SAMEA115116697
DR   hPSCreg; PCIi035-A
CC   From: Phenocell SAS; Grasse; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C206077; Aicardi-Goutieres syndrome
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PCK-CCL
AC   CVCL_WJ26
DR   Wikidata; Q98128523
RX   PubMed=16783394;
CC   Characteristics: Animal model of autosomal recessive polycystic kidney disease (PubMed=16783394).
CC   Doubling time: 28.8 hours (PubMed=16783394).
CC   Sequence variation: Mutation; RGD; 1308476; Pkhd1; Unexplicit; IVS35-2A>T; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=16783394).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Cholangiocyte; CL=CL_1000488.
CC   Breed/subspecies: PCK/CrljCrl-Pkhd1pck/Crl; RS=RS_0001381.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-3M
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   PCL12
AC   CVCL_2H32
SY   PCL-12
DR   DSMZ; ACC-794
DR   DSMZCellDive; ACC-794
DR   Wikidata; Q38098382
RX   PubMed=26110819;
RX   PubMed=26222697;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-794).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-794
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 20,23
ST   Penta D: 8,9
ST   Penta E: 10,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 13
//
ID   PCL1643
AC   CVCL_F002
DR   Cosmic; 922666
DR   Wikidata; Q54938726
RX   PubMed=8665486;
RX   PubMed=15390183;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PCL1691
AC   CVCL_F003
DR   Cosmic; 922667
DR   Wikidata; Q54938728
RX   PubMed=8665486;
RX   PubMed=15390183;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PCL1771
AC   CVCL_F004
DR   Cosmic; 922668
DR   Wikidata; Q54938729
RX   PubMed=8665486;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PCL2021
AC   CVCL_B3QQ
DR   Wikidata; Q110433131
RX   PubMed=15390183;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   PCL3014
AC   CVCL_F005
DR   Cosmic; 922669
DR   Wikidata; Q54938730
RX   PubMed=8665486;
RX   PubMed=15390183;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PCL3091
AC   CVCL_F006
DR   Cosmic; 922670
DR   Wikidata; Q54938731
RX   PubMed=8665486;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PCL4199
AC   CVCL_M496
DR   Wikidata; Q54938732
RX   PubMed=15390183;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   PCM6
AC   CVCL_4666
SY   PCM-6
DR   CLO; CLO_0051009
DR   BioSample; SAMN03472144
DR   BioSample; SAMN10987723
DR   cancercelllines; CVCL_4666
DR   Cell_Model_Passport; SIDM01776
DR   DepMap; ACH-001162
DR   FANTOM5_SSTAR; 10474-106I6
DR   GEO; GSM887507
DR   GEO; GSM888589
DR   IARC_TP53; 28305
DR   PharmacoDB; PCM6_1255_2019
DR   Progenetix; CVCL_4666
DR   RCB; RCB1460
DR   Wikidata; Q54938733
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8112425;
RX   PubMed=10936422;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   Doubling time: ~40-50 hours (PubMed=8112425).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DepMap=ACH-001162).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.03%; Native American=0.38%; East Asian, North=74.85%; East Asian, South=22.81%; South Asian=0.86%; European, North=0%; European, South=0.08% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): RCB=RCB1460
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   PcMab-47
AC   CVCL_D2TX
DR   ABCD; ABCD_AI317
DR   Wikidata; Q127383030
RX   Patent=US10906972;
RX   PubMed=28384052;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O00592; Human PODXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PcMab-6
AC   CVCL_D2TY
DR   ABCD; ABCD_AI316
DR   Wikidata; Q127383031
RX   Patent=US10906972;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O00592; Human PODXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PcMab-60
AC   CVCL_D2TZ
DR   Wikidata; Q127383032
RX   PubMed=33088928;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O00592; Human PODXL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PCNSL-MSK
AC   CVCL_B3QJ
SY   Primary CNS Lymphoma-Memorial Sloan Kettering
DR   Wikidata; Q110433132
RX   PubMed=28619981;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   PCNY1
AC   CVCL_C6LS
SY   PCNY-1
DR   Wikidata; Q116050113
RX   PubMed=21565982;
RX   PubMed=32133047;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=21565982).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gly (c.742C>G); ClinVar=VCV000376652; Zygosity=Heterozygous (PubMed=21565982; PubMed=32133047).
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   PCRP-ABTB1-1C5
AC   CVCL_KC02
SY   YP155.1.1C5
DR   DSHB; PCRP-ABTB1-1C5
DR   Wikidata; Q54938734
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q969K4; Human ABTB1.
CC   Discontinued: DSHB; PCRP-ABTB1-1C5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   PCRP-AGO3-1C5
AC   CVCL_KC03
DR   DSHB; PCRP-AGO3-1C5
DR   Wikidata; Q54938735
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H9G7; Human AGO3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-AKNA-1C7
AC   CVCL_KC04
DR   DSHB; PCRP-AKNA-1C7
DR   Wikidata; Q54938736
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z591; Human AKNA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ANAPC2-2B6
AC   CVCL_KC05
DR   DSHB; PCRP-ANAPC2-2B6
DR   Wikidata; Q54938737
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ANAPC2-2D1
AC   CVCL_KC06
DR   DSHB; PCRP-ANAPC2-2D1
DR   Wikidata; Q54938738
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
CC   Discontinued: DSHB; PCRP-ANAPC2-2D1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ANAPC2-2D2
AC   CVCL_KC07
DR   DSHB; PCRP-ANAPC2-2D2
DR   Wikidata; Q54938739
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
CC   Discontinued: DSHB; PCRP-ANAPC2-2D2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ANAPC2-2F2
AC   CVCL_KC08
DR   DSHB; PCRP-ANAPC2-2F2
DR   Wikidata; Q54938740
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
CC   Discontinued: DSHB; PCRP-ANAPC2-2F2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ANAPC2-3D1
AC   CVCL_KC09
DR   DSHB; PCRP-ANAPC2-3D1
DR   Wikidata; Q54938741
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
CC   Discontinued: DSHB; PCRP-ANAPC2-3D1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ANAPC2-3F7
AC   CVCL_KC10
DR   DSHB; PCRP-ANAPC2-3F7
DR   Wikidata; Q54938742
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
CC   Discontinued: DSHB; PCRP-ANAPC2-3F7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ANAPC2-3H3
AC   CVCL_KC11
DR   DSHB; PCRP-ANAPC2-3H3
DR   Wikidata; Q54938744
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ANAPC2-3H7
AC   CVCL_KC12
DR   DSHB; PCRP-ANAPC2-3H7
DR   Wikidata; Q54938745
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ANAPC2-4F2
AC   CVCL_KC13
DR   DSHB; PCRP-ANAPC2-4F2
DR   Wikidata; Q54938746
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
CC   Discontinued: DSHB; PCRP-ANAPC2-4F2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ANAPC2-5F1
AC   CVCL_KC14
DR   DSHB; PCRP-ANAPC2-5F1
DR   Wikidata; Q54938747
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJX6; Human ANAPC2.
CC   Discontinued: DSHB; PCRP-ANAPC2-5F1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ANKHD1-1B3
AC   CVCL_KC15
DR   DSHB; PCRP-ANKHD1-1B3
DR   Wikidata; Q54938748
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HA95; Human ANKHD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ANKZF1-1A12
AC   CVCL_KC16
DR   DSHB; PCRP-ANKZF1-1A12
DR   Wikidata; Q54938749
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H8Y5; Human ANKZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ANKZF1-1C11
AC   CVCL_KC17
DR   DSHB; PCRP-ANKZF1-1C11
DR   Wikidata; Q54938750
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H8Y5; Human ANKZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ANKZF1-1C6
AC   CVCL_KC18
DR   DSHB; PCRP-ANKZF1-1C6
DR   Wikidata; Q54938751
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H8Y5; Human ANKZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ARID2-1A1
AC   CVCL_KC19
DR   DSHB; PCRP-ARID2-1A1
DR   Wikidata; Q54938753
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q68CP9; Human ARID2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ARID3A-1E9
AC   CVCL_KC20
DR   DSHB; PCRP-ARID3A-1E9
DR   Wikidata; Q54938754
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99856; Human ARID3A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ARNT-2D11
AC   CVCL_KC21
DR   DSHB; PCRP-ARNT-2D11
DR   Wikidata; Q54938755
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27540; Human ARNT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ARNT-2D12
AC   CVCL_KC22
DR   DSHB; PCRP-ARNT-2D12
DR   Wikidata; Q54938756
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27540; Human ARNT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ARNT2-1A3
AC   CVCL_KC23
DR   DSHB; PCRP-ARNT2-1A3
DR   Wikidata; Q54938757
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9HBZ2; Human ARNT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ARNTL-1C12
AC   CVCL_KC24
DR   DSHB; PCRP-ARNTL-1C12
DR   Wikidata; Q54938758
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00327; Human BMAL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 6
//
ID   PCRP-ASCL4-2G8
AC   CVCL_KC25
DR   DSHB; PCRP-ASCL4-2G8
DR   Wikidata; Q54938759
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6XD76; Human ASCL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ASF1A-1H3
AC   CVCL_KC26
DR   DSHB; PCRP-ASF1A-1H3
DR   Wikidata; Q54938767
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y294; Human ASF1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ATAD2-1D11
AC   CVCL_KC27
DR   DSHB; PCRP-ATAD2-1D11
DR   Wikidata; Q54938768
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6PL18; Human ATAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ATAD2-1F12
AC   CVCL_KC28
DR   DSHB; PCRP-ATAD2-1F12
DR   Wikidata; Q54938769
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6PL18; Human ATAD2.
CC   Discontinued: DSHB; PCRP-ATAD2-1F12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ATAD2-2A8
AC   CVCL_KC29
DR   DSHB; PCRP-ATAD2-2A8
DR   Wikidata; Q54938770
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6PL18; Human ATAD2.
CC   Discontinued: DSHB; PCRP-ATAD2-2A8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ATAD2-2C3
AC   CVCL_KC30
DR   Wikidata; Q54938771
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6PL18; Human ATAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ATAD2-2D9
AC   CVCL_KC31
DR   DSHB; PCRP-ATAD2-2D9
DR   Wikidata; Q54938772
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6PL18; Human ATAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ATAD2-2E5
AC   CVCL_KC32
DR   DSHB; PCRP-ATAD2-2E5
DR   Wikidata; Q54938773
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6PL18; Human ATAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ATF2-1B4
AC   CVCL_KC33
SY   YP185.1.1B4
DR   DSHB; PCRP-ATF2-1B4
DR   Wikidata; Q54938774
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15336; Human ATF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ATF7-2C10
AC   CVCL_KC34
DR   DSHB; PCRP-ATF7-2C10
DR   Wikidata; Q54938775
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17544; Human ATF7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ATRX-1E4
AC   CVCL_KC35
DR   DSHB; PCRP-ATRX-1E4
DR   Wikidata; Q54938776
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P46100; Human ATRX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BACH1-1A2
AC   CVCL_KC36
DR   DSHB; PCRP-BACH1-1A2
DR   Wikidata; Q54938777
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14867; Human BACH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BACH1-2G3
AC   CVCL_KC37
DR   DSHB; PCRP-BACH1-2G3
DR   Wikidata; Q54938778
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14867; Human BACH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BACH2-1E4
AC   CVCL_KC38
DR   DSHB; PCRP-BACH2-1E4
DR   Wikidata; Q54938779
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BYV9; Human BACH2.
CC   Discontinued: DSHB; PCRP-BACH2-1E4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-BACH2-2C5
AC   CVCL_KC39
DR   DSHB; PCRP-BACH2-2C5
DR   Wikidata; Q54938780
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BYV9; Human BACH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BACH2-3B8
AC   CVCL_KC40
DR   DSHB; PCRP-BACH2-3B8
DR   Wikidata; Q54938781
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BYV9; Human BACH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BACH2-5B11
AC   CVCL_KC41
DR   DSHB; PCRP-BACH2-5B11
DR   Wikidata; Q54938782
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BYV9; Human BACH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BATF-1C10
AC   CVCL_KC42
DR   DSHB; PCRP-BATF-1C10
DR   Wikidata; Q54938783
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16520; Human BATF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BATF-1E10
AC   CVCL_KC43
DR   DSHB; PCRP-BATF-1E10
DR   Wikidata; Q54938784
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16520; Human BATF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BATF-2E8
AC   CVCL_KC44
DR   DSHB; PCRP-BATF-2E8
DR   Wikidata; Q54938785
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16520; Human BATF.
CC   Discontinued: DSHB; PCRP-BATF-2E8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-BATF-4G2
AC   CVCL_KC45
DR   DSHB; PCRP-BATF-4G2
DR   Wikidata; Q54938786
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16520; Human BATF.
CC   Discontinued: DSHB; PCRP-BATF-4G2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-BATF2-2B9
AC   CVCL_KC46
DR   DSHB; PCRP-BATF2-2B9
DR   Wikidata; Q54938787
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N1L9; Human BATF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BATF3-1E5
AC   CVCL_KC47
DR   DSHB; PCRP-BATF3-1E5
DR   Wikidata; Q54938788
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NR55; Human BATF3.
CC   Discontinued: DSHB; PCRP-BATF3-1E5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-BATF3-1H12
AC   CVCL_KC48
DR   DSHB; PCRP-BATF3-1H12
DR   Wikidata; Q54938789
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NR55; Human BATF3.
CC   Discontinued: DSHB; PCRP-BATF3-1H12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-BATF3-1H3
AC   CVCL_KC49
DR   DSHB; PCRP-BATF3-1H3
DR   Wikidata; Q54938790
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NR55; Human BATF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BBX-2F6
AC   CVCL_KC50
DR   DSHB; PCRP-BBX-2F6
DR   Wikidata; Q54938791
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WY36; Human BBX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BCL11A-1G10
AC   CVCL_YE79
DR   DSHB; PCRP-BCL11A-1G10
DR   Wikidata; Q98128524
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H165; Human BCL11A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   PCRP-BCL2L2-1A4
AC   CVCL_KC51
DR   Wikidata; Q54938792
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92843; Human BCL2L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-BCL6-1B1
AC   CVCL_KC52
DR   DSHB; PCRP-BCL6-1B1
DR   Wikidata; Q54938793
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P41182; Human BCL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BCL6-1D3
AC   CVCL_KC53
DR   DSHB; PCRP-BCL6-1D3
DR   Wikidata; Q54938794
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P41182; Human BCL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BHLHA9-1D1
AC   CVCL_KC54
DR   DSHB; PCRP-BHLHA9-1D1
DR   Wikidata; Q54938795
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7RTU4; Human BHLHA9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BMI1-1G9
AC   CVCL_KC55
DR   DSHB; PCRP-BMI1-1G9
DR   Wikidata; Q54938796
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35226; Human BMI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BMI1-1H1
AC   CVCL_KC56
DR   DSHB; PCRP-BMI1-1H1
DR   Wikidata; Q54938797
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35226; Human BMI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BOLA3-1A5
AC   CVCL_KC57
DR   DSHB; PCRP-BOLA3-1A5
DR   Wikidata; Q54938799
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q53S33; Human BOLA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BOLA3-1C10
AC   CVCL_KC58
DR   DSHB; PCRP-BOLA3-1C10
DR   Wikidata; Q54938800
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q53S33; Human BOLA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BOLA3-2B8
AC   CVCL_KC59
DR   DSHB; PCRP-BOLA3-2B8
DR   Wikidata; Q54938801
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q53S33; Human BOLA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRD1-1B5
AC   CVCL_KC60
DR   DSHB; PCRP-BRD1-1B5
DR   Wikidata; Q54938802
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O95696; Human BRD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRD1-2B7
AC   CVCL_KC61
DR   DSHB; PCRP-BRD1-2B7
DR   Wikidata; Q54938803
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95696; Human BRD1.
CC   Discontinued: DSHB; PCRP-BRD1-2B7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-BRD1-2E4
AC   CVCL_KC62
DR   DSHB; PCRP-BRD1-2E4
DR   Wikidata; Q54938804
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95696; Human BRD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRD1-2H2
AC   CVCL_KC63
DR   DSHB; PCRP-BRD1-2H2
DR   Wikidata; Q54938805
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95696; Human BRD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRD3-1C12
AC   CVCL_KC64
DR   DSHB; PCRP-BRD3-1C12
DR   Wikidata; Q54938806
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15059; Human BRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRD3-1D12
AC   CVCL_KC65
DR   Wikidata; Q54938807
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15059; Human BRD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-BRD9-1H8
AC   CVCL_KC66
DR   DSHB; PCRP-BRD9-1H8
DR   Wikidata; Q54938817
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H8M2; Human BRD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRPF1-1B2
AC   CVCL_KC67
DR   DSHB; PCRP-BRPF1-1B2
DR   Wikidata; Q54938818
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55201; Human BRPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRPF1-1E2
AC   CVCL_KC68
DR   DSHB; PCRP-BRPF1-1E2
DR   Wikidata; Q54938819
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55201; Human BRPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRPF1-2A12
AC   CVCL_KC69
DR   Wikidata; Q54938820
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P55201; Human BRPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-BRPF1-2E11
AC   CVCL_KC70
DR   DSHB; PCRP-BRPF1-2E11
DR   Wikidata; Q54938821
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P55201; Human BRPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRWD1-1E12
AC   CVCL_KC71
DR   DSHB; PCRP-BRWD1-1E12
DR   Wikidata; Q54938822
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NSI6; Human BRWD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BRWD1-2C12
AC   CVCL_KC72
DR   DSHB; PCRP-BRWD1-2C12
DR   Wikidata; Q54938823
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NSI6; Human BRWD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BSX-4D10
AC   CVCL_KC73
DR   DSHB; PCRP-BSX-4D10
DR   Wikidata; Q54938824
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q3C1V8; Human BSX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BSX-5H1
AC   CVCL_KC74
DR   DSHB; PCRP-BSX-5H1
DR   Wikidata; Q54938825
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q3C1V8; Human BSX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-BSX-8F2
AC   CVCL_KC75
DR   DSHB; PCRP-BSX-8F2
DR   Wikidata; Q54938826
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q3C1V8; Human BSX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CAMKK2-1H7
AC   CVCL_KC76
DR   DSHB; PCRP-CAMKK2-1H7
DR   Wikidata; Q54938827
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96RR4; Human CAMKK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CARM1-1B4
AC   CVCL_KC77
DR   DSHB; PCRP-CARM1-1B4
DR   Wikidata; Q54938828
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86X55; Human CARM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CARM1-1D9
AC   CVCL_YE80
DR   DSHB; PCRP-CARM1-1D9
DR   Wikidata; Q98128525
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86X55; Human CARM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   PCRP-CASP8AP2-1D2
AC   CVCL_KC78
DR   DSHB; PCRP-CASP8AP2-1D2
DR   Wikidata; Q54938829
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UKL3; Human CASP8AP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CASP8AP2-1D6
AC   CVCL_KC79
DR   DSHB; PCRP-CASP8AP2-1D6
DR   Wikidata; Q54938830
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UKL3; Human CASP8AP2.
CC   Discontinued: DSHB; PCRP-CASP8AP2-1D6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CASP8AP2-2A5
AC   CVCL_KC80
DR   DSHB; PCRP-CASP8AP2-2A5
DR   Wikidata; Q54938831
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UKL3; Human CASP8AP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CBFB-1A8
AC   CVCL_KC81
DR   Wikidata; Q54938832
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-CBFB-1B2
AC   CVCL_KC82
DR   Wikidata; Q54938833
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-CBFB-1B5
AC   CVCL_KC83
DR   DSHB; PCRP-CBFB-1B5
DR   Wikidata; Q54938834
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
CC   Discontinued: DSHB; PCRP-CBFB-1B5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CBFB-1C5
AC   CVCL_KC84
DR   DSHB; PCRP-CBFB-1C5
DR   Wikidata; Q54938835
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CBFB-1E12
AC   CVCL_KC85
DR   Wikidata; Q54938836
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-CBFB-1E6
AC   CVCL_KC86
DR   DSHB; PCRP-CBFB-1E6
DR   Wikidata; Q54938837
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
CC   Discontinued: DSHB; PCRP-CBFB-1E6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CBFB-1F6
AC   CVCL_KC87
DR   DSHB; PCRP-CBFB-1F6
DR   Wikidata; Q54938838
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
CC   Discontinued: DSHB; PCRP-CBFB-1F6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CBFB-2C12
AC   CVCL_KC88
DR   DSHB; PCRP-CBFB-2C12
DR   Wikidata; Q54938839
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
CC   Misspelling: PCRP-CBEB-2C12; Note=In an obsoleted version of DSHB.
CC   Discontinued: DSHB; PCRP-CBFB-2C12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 7
//
ID   PCRP-CBFB-3B9
AC   CVCL_KC89
DR   DSHB; PCRP-CBFB-3B9
DR   Wikidata; Q54938840
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CBFB-3D4
AC   CVCL_KC90
DR   Wikidata; Q54938841
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-CBFB-4D9
AC   CVCL_KC91
DR   DSHB; PCRP-CBFB-4D9
DR   Wikidata; Q54938842
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13951; Human CBFB.
CC   Discontinued: DSHB; PCRP-CBFB-4D9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CBX1-1A4
AC   CVCL_KC92
DR   DSHB; PCRP-CBX1-1A4
DR   Wikidata; Q54938843
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P83916; Human CBX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CBX2-2B10
AC   CVCL_KC93
DR   DSHB; PCRP-CBX2-2B10
DR   Wikidata; Q54938844
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14781; Human CBX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CBX3-2E1
AC   CVCL_KC94
DR   DSHB; PCRP-CBX3-2E1
DR   Wikidata; Q54938845
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13185; Human CBX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CBX5-2A7
AC   CVCL_KC95
DR   DSHB; PCRP-CBX5-2A7
DR   Wikidata; Q54938847
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P45973; Human CBX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CBX5-2D8
AC   CVCL_KC96
DR   DSHB; PCRP-CBX5-2D8
DR   Wikidata; Q54938848
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P45973; Human CBX5.
CC   Discontinued: DSHB; PCRP-CBX5-2D8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CC2D1A-1A1
AC   CVCL_KC97
DR   DSHB; PCRP-CC2D1A-1A1
DR   Wikidata; Q54938849
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6P1N0; Human CC2D1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CC2D1A-1B1
AC   CVCL_KC98
DR   DSHB; PCRP-CC2D1A-1B1
DR   Wikidata; Q54938850
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6P1N0; Human CC2D1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CC2D1A-1C2
AC   CVCL_KC99
DR   DSHB; PCRP-CC2D1A-1C2
DR   Wikidata; Q54938851
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6P1N0; Human CC2D1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CCDC101-1B12
AC   CVCL_KD00
DR   DSHB; PCRP-CCDC101-1B12
DR   Wikidata; Q54938852
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96ES7; Human SGF29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CCDC101-1D10
AC   CVCL_KD01
DR   DSHB; PCRP-CCDC101-1D10
DR   Wikidata; Q54938853
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96ES7; Human SGF29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CCDC97-4B11
AC   CVCL_KD02
DR   DSHB; PCRP-CCDC97-4B11
DR   Wikidata; Q54938854
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96F63; Human CCDC97.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CDC5L-2C6
AC   CVCL_KD03
DR   DSHB; PCRP-CDC5L-2C6
DR   Wikidata; Q54938855
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99459; Human CDC5L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CDX2-1A3
AC   CVCL_KD04
DR   DSHB; PCRP-CDX2-1A3
DR   Wikidata; Q54938856
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99626; Human CDX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CDX2-1A6
AC   CVCL_KD05
DR   DSHB; PCRP-CDX2-1A6
DR   Wikidata; Q54938858
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99626; Human CDX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CEBPB-2A12
AC   CVCL_KD06
DR   DSHB; PCRP-CEBPB-2A12
DR   Wikidata; Q54938866
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17676; Human CEBPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CEBPB-3D10
AC   CVCL_KD07
DR   DSHB; PCRP-CEBPB-3D10
DR   Wikidata; Q54938867
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17676; Human CEBPB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CEBPE-1B2
AC   CVCL_KD08
DR   DSHB; PCRP-CEBPE-1B2
DR   Wikidata; Q54938868
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15744; Human CEBPE.
CC   Discontinued: DSHB; PCRP-CEBPE-1B2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CEBPE-1F8
AC   CVCL_KD09
DR   DSHB; PCRP-CEBPE-1F8
DR   Wikidata; Q54938869
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15744; Human CEBPE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CEBPE-1G12
AC   CVCL_KD10
DR   DSHB; PCRP-CEBPE-1G12
DR   Wikidata; Q54938870
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15744; Human CEBPE.
CC   Discontinued: DSHB; PCRP-CEBPE-1G12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CEBPE-1H1
AC   CVCL_KD11
DR   DSHB; PCRP-CEBPE-1H1
DR   Wikidata; Q54938871
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15744; Human CEBPE.
CC   Discontinued: DSHB; PCRP-CEBPE-1H1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CEBPE-2A9
AC   CVCL_KD12
DR   DSHB; PCRP-CEBPE-2A9
DR   Wikidata; Q54938872
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15744; Human CEBPE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CEBPE-4E10
AC   CVCL_KD13
DR   DSHB; PCRP-CEBPE-4E10
DR   Wikidata; Q54938873
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15744; Human CEBPE.
CC   Discontinued: DSHB; PCRP-CEBPE-4E10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CEBPE-4F2
AC   CVCL_KD14
DR   DSHB; PCRP-CEBPE-4F2
DR   Wikidata; Q54938874
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15744; Human CEBPE.
CC   Discontinued: DSHB; PCRP-CEBPE-4F2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CEBPZ-2D8
AC   CVCL_KD15
DR   DSHB; PCRP-CEBPZ-2D8
DR   Wikidata; Q54938875
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03701; Human CEBPZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CEBPZ-3C7
AC   CVCL_KD16
DR   DSHB; PCRP-CEBPZ-3C7
DR   Wikidata; Q54938876
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03701; Human CEBPZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CELF4-1C3
AC   CVCL_KD17
DR   DSHB; PCRP-CELF4-1C3
DR   Wikidata; Q54938877
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BZC1; Human CELF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CELF6-1A4
AC   CVCL_KD18
DR   DSHB; PCRP-CELF6-1A4
DR   Wikidata; Q54938878
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96J87; Human CELF6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CHAMP1-1F8
AC   CVCL_KD19
DR   DSHB; PCRP-CHAMP1-1F8
DR   Wikidata; Q54938879
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96JM3; Human CHAMP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CHEK2-1A4
AC   CVCL_KD20
DR   DSHB; PCRP-CHEK2-1A4
DR   Wikidata; Q54938880
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O96017; Human CHEK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CHEK2-1A9
AC   CVCL_KD21
DR   DSHB; PCRP-CHEK2-1A9
DR   Wikidata; Q54938881
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O96017; Human CHEK2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CHEK2-1C4
AC   CVCL_KD22
DR   DSHB; PCRP-CHEK2-1C4
DR   Wikidata; Q54938882
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O96017; Human CHEK2.
CC   Discontinued: DSHB; PCRP-CHEK2-1C4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CHEK2-2A2
AC   CVCL_KD23
DR   DSHB; PCRP-CHEK2-2A2
DR   Wikidata; Q54938883
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O96017; Human CHEK2.
CC   Discontinued: DSHB; PCRP-CHEK2-2A2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CIAO1-2C11
AC   CVCL_KD24
DR   DSHB; PCRP-CIAO1-2C11
DR   Wikidata; Q54938884
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O76071; Human CIAO1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CIZ1-1A2
AC   CVCL_KD25
DR   DSHB; PCRP-CIZ1-1A2
DR   Wikidata; Q54938885
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9ULV3; Human CIZ1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CLOCK-1A10
AC   CVCL_KD26
DR   DSHB; PCRP-CLOCK-1A10
DR   Wikidata; Q54938886
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15516; Human CLOCK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CNOT10-1D5
AC   CVCL_KD27
DR   DSHB; PCRP-CNOT10-1D5
DR   Wikidata; Q54938887
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9H9A5; Human CNOT10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-COPS3-2D9
AC   CVCL_KD28
DR   DSHB; PCRP-COPS3-2D9
DR   Wikidata; Q54938888
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNS2; Human COPS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CPEB3-1C1
AC   CVCL_KD29
DR   DSHB; PCRP-CPEB3-1C1
DR   Wikidata; Q54938889
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NE35; Human CPEB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CPEB3-1H4
AC   CVCL_KD30
DR   DSHB; PCRP-CPEB3-1H4
DR   Wikidata; Q54938890
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NE35; Human CPEB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CPEB4-1B5
AC   CVCL_KD31
DR   DSHB; PCRP-CPEB4-1B5
DR   Wikidata; Q54938891
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q17RY0; Human CPEB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CREB1-1A6
AC   CVCL_KD32
DR   DSHB; PCRP-CREB1-1A6
DR   Wikidata; Q54938892
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16220; Human CREB1.
CC   Discontinued: DSHB; PCRP-CREB1-1A6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CREB3L1-1B1
AC   CVCL_KD33
DR   DSHB; PCRP-CREB3L1-1B1
DR   Wikidata; Q54938894
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96BA8; Human CREB3L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CREB3L3-2D10
AC   CVCL_KD34
DR   DSHB; PCRP-CREB3L3-2D10
DR   Wikidata; Q54938895
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q68CJ9; Human CREB3L3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CREB3L4-1A3
AC   CVCL_KD35
DR   DSHB; PCRP-CREB3L4-1A3
DR   Wikidata; Q54938896
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TEY5; Human CREB3L4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CREB3L4-1E4
AC   CVCL_KD36
DR   DSHB; PCRP-CREB3L4-1E4
DR   Wikidata; Q54938897
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TEY5; Human CREB3L4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CREB5-1B8
AC   CVCL_KD37
DR   Wikidata; Q54938898
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02930; Human CREB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-CREB5-1G8
AC   CVCL_KD38
DR   DSHB; PCRP-CREB5-1G8
DR   Wikidata; Q54938899
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q02930; Human CREB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CREBL2-1A11
AC   CVCL_KD39
DR   DSHB; PCRP-CREBL2-1A11
DR   Wikidata; Q54938900
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60519; Human CREBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CREBL2-1A3
AC   CVCL_KD40
DR   Wikidata; Q54938901
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60519; Human CREBL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-CSDE1-1B2
AC   CVCL_KD41
DR   DSHB; PCRP-CSDE1-1B2
DR   Wikidata; Q54938902
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75534; Human CSDE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CSTF2-1A11
AC   CVCL_KD42
DR   DSHB; PCRP-CSTF2-1A11
DR   Wikidata; Q54938904
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33240; Human CSTF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CSTF2-1A5
AC   CVCL_KD43
DR   DSHB; PCRP-CSTF2-1A5
DR   Wikidata; Q54938905
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33240; Human CSTF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CSTF2T-1A3
AC   CVCL_KD44
DR   DSHB; PCRP-CSTF2T-1A3
DR   Wikidata; Q54938906
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H0L4; Human CSTF2T.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CTBP1-1A1
AC   CVCL_KD45
DR   DSHB; PCRP-CTBP1-1A1
DR   Wikidata; Q54938907
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13363; Human CTBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CTBP1-1A4
AC   CVCL_KD46
DR   DSHB; PCRP-CTBP1-1A4
DR   Wikidata; Q54938917
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13363; Human CTBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CTBP2-2B11
AC   CVCL_KD47
DR   DSHB; PCRP-CTBP2-2B11
DR   Wikidata; Q54938918
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P56545; Human CTBP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CTBP2-2C7
AC   CVCL_KD48
DR   DSHB; PCRP-CTBP2-2C7
DR   Wikidata; Q54938919
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P56545; Human CTBP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CTBP2-2D11
AC   CVCL_KD49
DR   DSHB; PCRP-CTBP2-2D11
DR   Wikidata; Q54938920
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P56545; Human CTBP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CXXC1-1B6
AC   CVCL_KD50
DR   DSHB; PCRP-CXXC1-1B6
DR   Wikidata; Q54938922
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9P0U4; Human CXXC1.
CC   Discontinued: DSHB; PCRP-CXXC1-1B6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CXXC1-1C7
AC   CVCL_KD51
DR   DSHB; PCRP-CXXC1-1C7
DR   Wikidata; Q54938923
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P0U4; Human CXXC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CXXC1-1E5
AC   CVCL_KD52
DR   DSHB; PCRP-CXXC1-1E5
DR   Wikidata; Q54938924
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P0U4; Human CXXC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CXXC1-2A1
AC   CVCL_KD53
DR   DSHB; PCRP-CXXC1-2A1
DR   Wikidata; Q54938925
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P0U4; Human CXXC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-CXXC1-2A7
AC   CVCL_KD54
DR   DSHB; PCRP-CXXC1-2A7
DR   Wikidata; Q54938926
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P0U4; Human CXXC1.
CC   Discontinued: DSHB; PCRP-CXXC1-2A7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CXXC1-2C3
AC   CVCL_KD55
DR   DSHB; PCRP-CXXC1-2C3
DR   Wikidata; Q54938927
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9P0U4; Human CXXC1.
CC   Discontinued: DSHB; PCRP-CXXC1-2C3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-CXXC1-2D3
AC   CVCL_KD56
DR   DSHB; PCRP-CXXC1-2D3
DR   Wikidata; Q54938928
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P0U4; Human CXXC1.
CC   Discontinued: DSHB; PCRP-CXXC1-2D3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DACH1-1C9
AC   CVCL_KD57
DR   DSHB; PCRP-DACH1-1C9
DR   Wikidata; Q54938929
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UI36; Human DACH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DAXX-1D7
AC   CVCL_KD58
DR   Wikidata; Q54938930
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DAXX-1F6
AC   CVCL_KD59
DR   Wikidata; Q54938931
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DAXX-2B3
AC   CVCL_KD60
DR   DSHB; PCRP-DAXX-2B3
DR   Wikidata; Q54938932
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DAXX-5C12
AC   CVCL_KD61
DR   Wikidata; Q54938933
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DAXX-5G11
AC   CVCL_KD62
DR   DSHB; PCRP-DAXX-5G11
DR   Wikidata; Q54938934
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
CC   Discontinued: DSHB; PCRP-DAXX-5G11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DAXX-5H2
AC   CVCL_KD63
DR   DSHB; PCRP-DAXX-5H2
DR   Wikidata; Q54938935
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DAXX-6A7
AC   CVCL_KD64
DR   Wikidata; Q54938936
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DAXX-6A8
AC   CVCL_KD65
DR   Wikidata; Q54938938
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DAXX-6E11
AC   CVCL_KD66
DR   Wikidata; Q54938939
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DAXX-6E9
AC   CVCL_KD67
DR   DSHB; PCRP-DAXX-6E9
DR   Wikidata; Q54938940
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
CC   Discontinued: DSHB; PCRP-DAXX-6E9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DAXX-8B5
AC   CVCL_KD68
DR   DSHB; PCRP-DAXX-8B5
DR   Wikidata; Q54938941
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DAXX-8B7
AC   CVCL_KD69
DR   Wikidata; Q54938942
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UER7; Human DAXX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DBX2-1D8
AC   CVCL_KD70
DR   DSHB; PCRP-DBX2-1D8
DR   Wikidata; Q54938943
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6ZNG2; Human DBX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DBX2-1E4
AC   CVCL_KD71
DR   DSHB; PCRP-DBX2-1E4
DR   Wikidata; Q54938944
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6ZNG2; Human DBX2.
CC   Discontinued: DSHB; PCRP-DBX2-1E4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DBX2-1E5
AC   CVCL_KD72
DR   DSHB; PCRP-DBX2-1E5
DR   Wikidata; Q54938945
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6ZNG2; Human DBX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DBX2-2B7
AC   CVCL_KD73
DR   DSHB; PCRP-DBX2-2B7
DR   Wikidata; Q54938946
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6ZNG2; Human DBX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DCP2-1D6
AC   CVCL_KD74
DR   DSHB; PCRP-DCP2-1D6
DR   Wikidata; Q54938947
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IU60; Human DCP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DDIT3-1A10
AC   CVCL_KD75
DR   DSHB; PCRP-DDIT3-1A10
DR   Wikidata; Q54938948
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35638; Human DDIT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DDIT3-1D10
AC   CVCL_KD76
DR   DSHB; PCRP-DDIT3-1D10
DR   Wikidata; Q54938950
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35638; Human DDIT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DDX41-1A10
AC   CVCL_KD77
DR   DSHB; PCRP-DDX41-1A10
DR   Wikidata; Q54938951
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJV9; Human DDX41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DDX41-1B4
AC   CVCL_KD78
DR   DSHB; PCRP-DDX41-1B4
DR   Wikidata; Q54938952
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UJV9; Human DDX41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DDX43-1B1
AC   CVCL_KD79
DR   DSHB; PCRP-DDX43-1B1
DR   Wikidata; Q54938953
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NXZ2; Human DDX43.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DDX43-1E7
AC   CVCL_KD80
DR   Wikidata; Q54938954
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NXZ2; Human DDX43.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DDX53-3B3
AC   CVCL_KD81
DR   DSHB; PCRP-DDX53-3B3
DR   Wikidata; Q54938955
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86TM3; Human DDX53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DDX58-3D8
AC   CVCL_KD82
DR   DSHB; PCRP-DDX58-3D8
DR   Wikidata; Q54938956
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95786; Human RIGI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 6
//
ID   PCRP-DEAF1-1A10
AC   CVCL_KD83
DR   DSHB; PCRP-DEAF1-1A10
DR   Wikidata; Q54938957
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75398; Human DEAF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DGCR8-1A1
AC   CVCL_KD84
DR   DSHB; PCRP-DGCR8-1A1
DR   Wikidata; Q54938958
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8WYQ5; Human DGCR8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DIS3-1A7
AC   CVCL_KD85
DR   DSHB; PCRP-DIS3-1A7
DR   Wikidata; Q54938959
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2L1; Human DIS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DIS3-1D7
AC   CVCL_KD86
DR   DSHB; PCRP-DIS3-1D7
DR   Wikidata; Q54938969
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2L1; Human DIS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DLX3-2C4
AC   CVCL_KD87
DR   DSHB; PCRP-DLX3-2C4
DR   Wikidata; Q54938970
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60479; Human DLX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DMRT2-1B11
AC   CVCL_KD88
DR   DSHB; PCRP-DMRT2-1B11
DR   Wikidata; Q54938971
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y5R5; Human DMRT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DMRTB1-1B3
AC   CVCL_KD89
DR   DSHB; PCRP-DMRTB1-1B3
DR   Wikidata; Q54938972
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96MA1; Human DMRTB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DMRTB1-1C10
AC   CVCL_KD90
DR   DSHB; PCRP-DMRTB1-1C10
DR   Wikidata; Q54938973
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96MA1; Human DMRTB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DMTF1-1A8
AC   CVCL_KD91
DR   DSHB; PCRP-DMTF1-1A8
DR   Wikidata; Q54938974
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y222; Human DMTF1.
CC   Misspelling: PCRP-DMITF1-1A8; Note=In an obsoleted version of DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 6
//
ID   PCRP-DMTF1-1B7
AC   CVCL_KD92
DR   DSHB; PCRP-DMTF1-1B7
DR   Wikidata; Q54938975
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y222; Human DMTF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DNMT3A-1E2
AC   CVCL_KD93
DR   DSHB; PCRP-DNMT3A-1E2
DR   Wikidata; Q54938976
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y6K1; Human DNMT3A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DNMT3L-1D5
AC   CVCL_KD94
DR   DSHB; PCRP-DNMT3L-1D5
DR   Wikidata; Q54938977
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UJW3; Human DNMT3L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DNMT3L-1E3
AC   CVCL_KD95
DR   DSHB; PCRP-DNMT3L-1E3
DR   Wikidata; Q54938978
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UJW3; Human DNMT3L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DPF1-1A4
AC   CVCL_KD96
DR   DSHB; PCRP-DPF1-1A4
DR   Wikidata; Q54938980
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92782; Human DPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DPF1-1A9
AC   CVCL_KD97
DR   DSHB; PCRP-DPF1-1A9
DR   Wikidata; Q54938981
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92782; Human DPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DPF1-1B3
AC   CVCL_KD98
DR   Wikidata; Q54938982
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92782; Human DPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-DPF1-1B6
AC   CVCL_KD99
DR   DSHB; PCRP-DPF1-1B6
DR   Wikidata; Q54938983
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92782; Human DPF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DPRX-2F5
AC   CVCL_KE00
DR   DSHB; PCRP-DPRX-2F5
DR   Wikidata; Q54938984
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A6NFQ7; Human DPRX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DPRX-3A1
AC   CVCL_KE01
DR   DSHB; PCRP-DPRX-3A1
DR   Wikidata; Q54938986
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A6NFQ7; Human DPRX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DPRX-3C4
AC   CVCL_KE02
DR   DSHB; PCRP-DPRX-3C4
DR   Wikidata; Q54938987
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NFQ7; Human DPRX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DPRX-4A5
AC   CVCL_KE03
DR   DSHB; PCRP-DPRX-4A5
DR   Wikidata; Q54938988
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NFQ7; Human DPRX.
CC   Discontinued: DSHB; PCRP-DPRX-4A5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DR1-1A12
AC   CVCL_KE04
DR   DSHB; PCRP-DR1-1A12
DR   Wikidata; Q54938989
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q01658; Human DR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DRAP1-1A12
AC   CVCL_KE05
DR   DSHB; PCRP-DRAP1-1A12
DR   Wikidata; Q54938990
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14919; Human DRAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DRAP1-1A8
AC   CVCL_KE06
DR   DSHB; PCRP-DRAP1-1A8
DR   Wikidata; Q54938991
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14919; Human DRAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DRGX-3F1
AC   CVCL_KE07
DR   DSHB; PCRP-DRGX-3F1
DR   Wikidata; Q54938992
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A6NNA5; Human DRGX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DVL2-1A4
AC   CVCL_KE08
DR   DSHB; PCRP-DVL2-1A4
DR   Wikidata; Q54938993
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14641; Human DVL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DVL2-1C7
AC   CVCL_KE09
DR   DSHB; PCRP-DVL2-1C7
DR   Wikidata; Q54938994
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O14641; Human DVL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DVL3-1A11
AC   CVCL_KE10
DR   DSHB; PCRP-DVL3-1A11
DR   Wikidata; Q54938995
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92997; Human DVL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DVL3-1B1
AC   CVCL_KE11
DR   DSHB; PCRP-DVL3-1B1
DR   Wikidata; Q54938996
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92997; Human DVL3.
CC   Discontinued: DSHB; PCRP-DVL3-1B1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DVL3-1B10
AC   CVCL_KE12
DR   DSHB; PCRP-DVL3-1B10
DR   Wikidata; Q54938997
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92997; Human DVL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DVL3-2D6
AC   CVCL_KE13
DR   DSHB; PCRP-DVL3-2D6
DR   Wikidata; Q54938998
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92997; Human DVL3.
CC   Discontinued: DSHB; PCRP-DVL3-2D6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DVL3-2E12
AC   CVCL_KE14
DR   DSHB; PCRP-DVL3-2E12
DR   Wikidata; Q54938999
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92997; Human DVL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-DVL3-3A9
AC   CVCL_KE15
DR   DSHB; PCRP-DVL3-3A9
DR   Wikidata; Q54939000
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92997; Human DVL3.
CC   Discontinued: DSHB; PCRP-DVL3-3A9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-DVL3-3D6
AC   CVCL_KE16
DR   DSHB; PCRP-DVL3-3D6
DR   Wikidata; Q54939001
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92997; Human DVL3.
CC   Discontinued: DSHB; PCRP-DVL3-3D6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-E2F4-2H10
AC   CVCL_KE17
DR   DSHB; PCRP-E2F4-2H10
DR   Wikidata; Q54939002
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16254; Human E2F4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-E2F4-3C9
AC   CVCL_KE18
DR   DSHB; PCRP-E2F4-3C9
DR   Wikidata; Q54939003
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16254; Human E2F4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-E2F6-1F6
AC   CVCL_KE19
DR   DSHB; PCRP-E2F6-1F6
DR   Wikidata; Q54939004
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75461; Human E2F6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-E2F6-1F8
AC   CVCL_KE20
DR   Wikidata; Q54939005
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75461; Human E2F6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-E2F8-1A10
AC   CVCL_KE21
DR   DSHB; PCRP-E2F8-1A10
DR   Wikidata; Q54939006
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A0AVK6; Human E2F8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-E2F8-1G6
AC   CVCL_KE22
DR   DSHB; PCRP-E2F8-1G6
DR   Wikidata; Q54939007
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A0AVK6; Human E2F8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-E4F1-2D1
AC   CVCL_KE23
DR   DSHB; PCRP-E4F1-2D1
DR   Wikidata; Q54939008
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q66K89; Human E4F1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EBF1-1B1
AC   CVCL_KE24
DR   DSHB; PCRP-EBF1-1B1
DR   Wikidata; Q54939009
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UH73; Human EBF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ECD-1C11
AC   CVCL_KE25
DR   DSHB; PCRP-ECD-1C11
DR   Wikidata; Q54939010
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O95905; Human ECD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ECD-1D10
AC   CVCL_KE26
DR   DSHB; PCRP-ECD-1D10
DR   Wikidata; Q54939027
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95905; Human ECD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EDF1-1A3
AC   CVCL_KE27
DR   DSHB; PCRP-EDF1-1A3
DR   Wikidata; Q54939028
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O60869; Human EDF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EEA1-1F8
AC   CVCL_KE28
DR   DSHB; PCRP-EEA1-1F8
DR   Wikidata; Q54939029
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15075; Human EEA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EEA1-2H11
AC   CVCL_KE29
DR   DSHB; PCRP-EEA1-2H11
DR   Wikidata; Q54939030
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15075; Human EEA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EHMT2-3D9
AC   CVCL_KE30
DR   DSHB; PCRP-EHMT2-3D9
DR   Wikidata; Q54939031
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96KQ7; Human EHMT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EIF2S1-1C11
AC   CVCL_KE31
DR   DSHB; PCRP-EIF2S1-1C11
DR   Wikidata; Q54939032
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05198; Human EIF2S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EIF2S1-1E2
AC   CVCL_KE32
DR   DSHB; PCRP-EIF2S1-1E2
DR   Wikidata; Q54939033
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05198; Human EIF2S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EIF2S1-2A10
AC   CVCL_KE33
DR   DSHB; PCRP-EIF2S1-2A10
DR   Wikidata; Q54939034
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05198; Human EIF2S1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EIF4A2-2B5
AC   CVCL_KE34
DR   DSHB; PCRP-EIF4A2-2B5
DR   Wikidata; Q54939035
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q14240; Human EIF4A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EIF4A3-3A2
AC   CVCL_KE35
DR   DSHB; PCRP-EIF4A3-3A2
DR   Wikidata; Q54939036
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P38919; Human EIF4A3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EIF4E-1D3
AC   CVCL_KE36
DR   DSHB; PCRP-EIF4E-1D3
DR   Wikidata; Q54939037
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06730; Human EIF4E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELF1-1A3
AC   CVCL_KE37
DR   DSHB; PCRP-ELF1-1A3
DR   Wikidata; Q54939038
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P32519; Human ELF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELF1-1C9
AC   CVCL_KE38
DR   DSHB; PCRP-ELF1-1C9
DR   Wikidata; Q54939039
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P32519; Human ELF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELF2-1B5
AC   CVCL_KE39
DR   Wikidata; Q54939040
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15723; Human ELF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ELF2-1F1
AC   CVCL_KE40
DR   DSHB; PCRP-ELF2-1F1
DR   Wikidata; Q54939041
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15723; Human ELF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELF2-1H10
AC   CVCL_KE41
DR   DSHB; PCRP-ELF2-1H10
DR   Wikidata; Q54939043
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15723; Human ELF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELF2-3A9
AC   CVCL_KE42
DR   Wikidata; Q54939044
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15723; Human ELF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ELF2-3H4
AC   CVCL_KE43
DR   DSHB; PCRP-ELF2-3H4
DR   Wikidata; Q54939045
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q15723; Human ELF2.
CC   Discontinued: DSHB; PCRP-ELF2-3H4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ELF2-5A5
AC   CVCL_KE44
DR   DSHB; PCRP-ELF2-5A5
DR   Wikidata; Q54939046
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15723; Human ELF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELF3-8F6
AC   CVCL_KE45
DR   DSHB; PCRP-ELF3-8F6
DR   Wikidata; Q54939047
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P78545; Human ELF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELK1-1B9
AC   CVCL_KE46
DR   DSHB; PCRP-ELK1-1B9
DR   Wikidata; Q54939048
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19419; Human ELK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ELK1-1D9
AC   CVCL_KE47
DR   DSHB; PCRP-ELK1-1D9
DR   Wikidata; Q54939049
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P19419; Human ELK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ERG-2C6
AC   CVCL_KE48
DR   DSHB; PCRP-ERG-2C6
DR   Wikidata; Q54939050
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11308; Human ERG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ESR1-1A12
AC   CVCL_KE49
DR   DSHB; PCRP-ESR1-1A12
DR   Wikidata; Q54939051
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P03372; Human ESR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ESRP2-1D2
AC   CVCL_KE50
DR   DSHB; PCRP-ESRP2-1D2
DR   Wikidata; Q54939052
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H6T0; Human ESRP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ESRRA-1B10
AC   CVCL_KE51
DR   DSHB; PCRP-ESRRA-1B10
DR   Wikidata; Q54939053
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11474; Human ESRRA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ESRRB-2A6
AC   CVCL_KE52
DR   DSHB; PCRP-ESRRB-2A6
DR   Wikidata; Q54939054
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95718; Human ESRRB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ESRRG-3A6
AC   CVCL_KE53
DR   DSHB; PCRP-ESRRG-3A6
DR   Wikidata; Q54939055
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P62508; Human ESRRG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ETS1-1C8
AC   CVCL_KE54
DR   DSHB; PCRP-ETS1-1C8
DR   Wikidata; Q54939056
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P14921; Human ETS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ETS1-1F1
AC   CVCL_KE55
DR   DSHB; PCRP-ETS1-1F1
DR   Wikidata; Q54939058
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14921; Human ETS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ETS2-1D9
AC   CVCL_KE56
DR   DSHB; PCRP-ETS2-1D9
DR   Wikidata; Q54939059
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15036; Human ETS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ETV6-1A7
AC   CVCL_KE57
DR   DSHB; PCRP-ETV6-1A7
DR   Wikidata; Q54939060
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P41212; Human ETV6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ETV6-1A9
AC   CVCL_KE58
DR   DSHB; PCRP-ETV6-1A9
DR   Wikidata; Q54939061
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P41212; Human ETV6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ETV7-1A1
AC   CVCL_KE59
DR   DSHB; PCRP-ETV7-1A1
DR   Wikidata; Q54939062
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y603; Human ETV7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ETV7-1A6
AC   CVCL_KE60
DR   DSHB; PCRP-ETV7-1A6
DR   Wikidata; Q54939063
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y603; Human ETV7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-EZH2-1B3
AC   CVCL_KE61
DR   DSHB; PCRP-EZH2-1B3
DR   Wikidata; Q54939064
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15910; Human EZH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FEZF2-1A7
AC   CVCL_KE62
DR   DSHB; PCRP-FEZF2-1A7
DR   Wikidata; Q54939066
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TBJ5; Human FEZF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FEZF2-1B1
AC   CVCL_KE63
DR   DSHB; PCRP-FEZF2-1B1
DR   Wikidata; Q54939067
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TBJ5; Human FEZF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FLI1-4H6
AC   CVCL_KE64
DR   DSHB; PCRP-FLI1-4H6
DR   Wikidata; Q54939068
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01543; Human FLI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOS-1A7
AC   CVCL_KE65
DR   DSHB; PCRP-FOS-1A7
DR   Wikidata; Q54939069
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01100; Human FOS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOSB-1C9
AC   CVCL_KE66
DR   DSHB; PCRP-FOSB-1C9
DR   Wikidata; Q54939074
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P53539; Human FOSB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOSB-1D8
AC   CVCL_KE67
DR   DSHB; PCRP-FOSB-1D8
DR   Wikidata; Q54939076
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P53539; Human FOSB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOSL1-1E3
AC   CVCL_KE68
DR   DSHB; PCRP-FOSL1-1E3
DR   Wikidata; Q54939077
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15407; Human FOSL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOSL1-1G1
AC   CVCL_KE69
DR   DSHB; PCRP-FOSL1-1G1
DR   Wikidata; Q54939078
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15407; Human FOSL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOSL2-1B1
AC   CVCL_KE70
DR   DSHB; PCRP-FOSL2-1B1
DR   Wikidata; Q54939080
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15408; Human FOSL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXA2-3A2
AC   CVCL_KE71
DR   DSHB; PCRP-FOXA2-3A2
DR   Wikidata; Q54939081
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y261; Human FOXA2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXA3-2A9
AC   CVCL_KE72
DR   DSHB; PCRP-FOXA3-2A9
DR   Wikidata; Q54939082
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55318; Human FOXA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXB2-2B2
AC   CVCL_KE73
DR   DSHB; PCRP-FOXB2-2B2
DR   Wikidata; Q54939083
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5VYV0; Human FOXB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXC2-1B1
AC   CVCL_KE74
DR   DSHB; PCRP-FOXC2-1B1
DR   Wikidata; Q54939084
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99958; Human FOXC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXC2-1B6
AC   CVCL_KE75
DR   DSHB; PCRP-FOXC2-1B6
DR   Wikidata; Q54939085
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99958; Human FOXC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXI1-1C4
AC   CVCL_KE76
DR   Wikidata; Q54939086
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q12951; Human FOXI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-FOXI1-1F8
AC   CVCL_KE77
DR   DSHB; PCRP-FOXI1-1F8
DR   Wikidata; Q54939087
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q12951; Human FOXI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXI1-1G11
AC   CVCL_KE78
DR   DSHB; PCRP-FOXI1-1G11
DR   Wikidata; Q54939088
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q12951; Human FOXI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXJ2-1D3
AC   CVCL_KE79
DR   DSHB; PCRP-FOXJ2-1D3
DR   Wikidata; Q54939089
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9P0K8; Human FOXJ2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXL1-2B4
AC   CVCL_KE80
DR   DSHB; PCRP-FOXL1-2B4
DR   Wikidata; Q54939090
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q12952; Human FOXL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXL2-1B4
AC   CVCL_KE81
DR   DSHB; PCRP-FOXL2-1B4
DR   Wikidata; Q54939091
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P58012; Human FOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXM1-1H4
AC   CVCL_KE82
DR   DSHB; PCRP-FOXM1-1H4
DR   Wikidata; Q54939092
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08050; Human FOXM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXM1-2E6
AC   CVCL_KE83
DR   DSHB; PCRP-FOXM1-2E6
DR   Wikidata; Q54939093
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q08050; Human FOXM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXN1-2B8
AC   CVCL_KE84
DR   DSHB; PCRP-FOXN1-2B8
DR   Wikidata; Q54939094
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15353; Human FOXN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXN1-2C1
AC   CVCL_KE85
DR   DSHB; PCRP-FOXN1-2C1
DR   Wikidata; Q54939096
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15353; Human FOXN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXN3-1A3
AC   CVCL_KE86
DR   DSHB; PCRP-FOXN3-1A3
DR   Wikidata; Q54939097
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O00409; Human FOXN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXO3-1B7
AC   CVCL_KE87
DR   DSHB; PCRP-FOXO3-1B7
DR   Wikidata; Q54939098
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43524; Human FOXO3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXO3-1G5
AC   CVCL_KE88
DR   DSHB; PCRP-FOXO3-1G5
DR   Wikidata; Q54939099
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43524; Human FOXO3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXP3-1B2
AC   CVCL_KE89
DR   DSHB; PCRP-FOXP3-1B2
DR   Wikidata; Q54939100
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BZS1; Human FOXP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXP4-1A10
AC   CVCL_KE90
DR   DSHB; PCRP-FOXP4-1A10
DR   Wikidata; Q54939101
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IVH2; Human FOXP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXP4-1D1
AC   CVCL_KE91
DR   DSHB; PCRP-FOXP4-1D1
DR   Wikidata; Q54939102
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IVH2; Human FOXP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXP4-1G7
AC   CVCL_KE92
DR   DSHB; PCRP-FOXP4-1G7
DR   Wikidata; Q54939103
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IVH2; Human FOXP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXQ1-2D2
AC   CVCL_KE93
DR   DSHB; PCRP-FOXQ1-2D2
DR   Wikidata; Q54939104
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9C009; Human FOXQ1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXQ1-2F10
AC   CVCL_KE94
DR   DSHB; PCRP-FOXQ1-2F10
DR   Wikidata; Q54939105
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9C009; Human FOXQ1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-FOXR1-1F8
AC   CVCL_KE95
DR   DSHB; PCRP-FOXR1-1F8
DR   Wikidata; Q54939106
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6PIV2; Human FOXR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-G3BP1-2H8
AC   CVCL_KE96
DR   DSHB; PCRP-G3BP1-2H8
DR   Wikidata; Q54939107
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13283; Human G3BP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-G3BP2-1C7
AC   CVCL_KE97
DR   DSHB; PCRP-G3BP2-1C7
DR   Wikidata; Q54939108
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UN86; Human G3BP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GABPA-2G3
AC   CVCL_KE98
DR   DSHB; PCRP-GABPA-2G3
DR   Wikidata; Q54939109
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q06546; Human GABPA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GABPB1-1A2
AC   CVCL_KE99
DR   DSHB; PCRP-GABPB1-1A2
DR   Wikidata; Q54939110
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q06547; Human GABPB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GATA4-1A7
AC   CVCL_KF00
DR   DSHB; PCRP-GATA4-1A7
DR   Wikidata; Q54939111
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P43694; Human GATA4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GBX1-2B3
AC   CVCL_KF01
DR   DSHB; PCRP-GBX1-2B3
DR   Wikidata; Q54939112
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14549; Human GBX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GBX1-2F8
AC   CVCL_KF02
DR   DSHB; PCRP-GBX1-2F8
DR   Wikidata; Q54939113
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14549; Human GBX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GCM2-1B3
AC   CVCL_KF03
DR   DSHB; PCRP-GCM2-1B3
DR   Wikidata; Q54939115
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75603; Human GCM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GLI1-1A1
AC   CVCL_KF04
DR   DSHB; PCRP-GLI1-1A1
DR   Wikidata; Q54939116
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08151; Human GLI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GLI1-1E6
AC   CVCL_KF05
DR   DSHB; PCRP-GLI1-1E6
DR   Wikidata; Q54939117
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08151; Human GLI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GLIS3-1B11
AC   CVCL_KF06
DR   DSHB; PCRP-GLIS3-1B11
DR   Wikidata; Q54939130
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NEA6; Human GLIS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GLIS3-1D10
AC   CVCL_KF07
DR   DSHB; PCRP-GLIS3-1D10
DR   Wikidata; Q54939131
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NEA6; Human GLIS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GMEB1-1C1
AC   CVCL_KF08
DR   DSHB; PCRP-GMEB1-1C1
DR   Wikidata; Q54939132
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y692; Human GMEB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GMEB2-1C6
AC   CVCL_KF09
DR   DSHB; PCRP-GMEB2-1C6
DR   Wikidata; Q54939133
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UKD1; Human GMEB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GRAMD4-1A10
AC   CVCL_KF10
DR   DSHB; PCRP-GRAMD4-1A10
DR   Wikidata; Q54939134
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6IC98; Human GRAMD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GRAMD4-1A6
AC   CVCL_KF11
DR   DSHB; PCRP-GRAMD4-1A6
DR   Wikidata; Q54939136
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6IC98; Human GRAMD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GRHL1-1B6
AC   CVCL_KF12
DR   DSHB; PCRP-GRHL1-1B6
DR   Wikidata; Q54939137
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZI5; Human GRHL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GRHL1-1D11
AC   CVCL_KF13
DR   Wikidata; Q54939138
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZI5; Human GRHL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-GRHL1-1F9
AC   CVCL_KF14
DR   DSHB; PCRP-GRHL1-1F9
DR   Wikidata; Q54939139
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZI5; Human GRHL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GRHL2-1A6
AC   CVCL_KF15
DR   DSHB; PCRP-GRHL2-1A6
DR   Wikidata; Q54939140
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q6ISB3; Human GRHL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2A1-1F2
AC   CVCL_KF16
DR   DSHB; PCRP-GTF2A1-1F2
DR   Wikidata; Q54939141
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P52655; Human GTF2A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2B-1D1
AC   CVCL_KF17
DR   DSHB; PCRP-GTF2B-1D1
DR   Wikidata; Q54939142
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q00403; Human GTF2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2B-1H2
AC   CVCL_KF18
DR   DSHB; PCRP-GTF2B-1H2
DR   Wikidata; Q54939143
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00403; Human GTF2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2E1-2C12
AC   CVCL_KF19
DR   DSHB; PCRP-GTF2E1-2C12
DR   Wikidata; Q54939144
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P29083; Human GTF2E1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2F2-1A8
AC   CVCL_KF20
DR   Wikidata; Q54939145
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13984; Human GTF2F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-GTF2F2-1B3
AC   CVCL_KF21
DR   DSHB; PCRP-GTF2F2-1B3
DR   Wikidata; Q54939146
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13984; Human GTF2F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2F2-1B4
AC   CVCL_KF22
DR   DSHB; PCRP-GTF2F2-1B4
DR   Wikidata; Q54939147
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13984; Human GTF2F2.
CC   Discontinued: DSHB; PCRP-GTF2F2-1B4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-GTF2H1-1A10
AC   CVCL_KF23
DR   DSHB; PCRP-GTF2H1-1A10
DR   Wikidata; Q54939148
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P32780; Human GTF2H1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2H2-1B9
AC   CVCL_KF24
DR   DSHB; PCRP-GTF2H2-1B9
DR   Wikidata; Q54939149
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13888; Human GTF2H2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2H2C-2C9
AC   CVCL_KF25
DR   DSHB; PCRP-GTF2H2C-2C9
DR   Wikidata; Q54939150
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6P1K8; Human GTF2H2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2I-1A7
AC   CVCL_KF26
DR   DSHB; PCRP-GTF2I-1A7
DR   Wikidata; Q54939151
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P78347; Human GTF2I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2I-1B10
AC   CVCL_KF27
DR   DSHB; PCRP-GTF2I-1B10
DR   Wikidata; Q54939152
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P78347; Human GTF2I.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2IRD2-1B12
AC   CVCL_KF28
DR   DSHB; PCRP-GTF2IRD2-1B12
DR   Wikidata; Q54939153
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86UP8; Human GTF2IRD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-GTF2IRD2-1B4
AC   CVCL_KF29
DR   Wikidata; Q54939155
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86UP8; Human GTF2IRD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-HAND1-1D5
AC   CVCL_KF30
DR   DSHB; PCRP-HAND1-1D5
DR   Wikidata; Q54939156
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O96004; Human HAND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HAND1-2A9
AC   CVCL_KF31
DR   DSHB; PCRP-HAND1-2A9
DR   Wikidata; Q54939157
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O96004; Human HAND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HAND2-1C6
AC   CVCL_KF32
DR   DSHB; PCRP-HAND2-1C6
DR   Wikidata; Q54939158
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P61296; Human HAND2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HAT1-1G5
AC   CVCL_KF33
DR   DSHB; PCRP-HAT1-1G5
DR   Wikidata; Q54939159
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14929; Human HAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC1-2B9
AC   CVCL_KF34
DR   DSHB; PCRP-HDAC1-2B9
DR   Wikidata; Q54939160
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13547; Human HDAC1.
CC   Discontinued: DSHB; PCRP-HDAC1-2B9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HDAC1-2E12
AC   CVCL_KF35
DR   DSHB; PCRP-HDAC1-2E12
DR   Wikidata; Q54939161
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13547; Human HDAC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC10-1B2
AC   CVCL_KF36
DR   DSHB; PCRP-HDAC10-1B2
DR   Wikidata; Q54939162
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q969S8; Human HDAC10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC11-1B7
AC   CVCL_KF37
DR   Wikidata; Q54939163
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96DB2; Human HDAC11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-HDAC3-2D4
AC   CVCL_KF38
DR   DSHB; PCRP-HDAC3-2D4
DR   Wikidata; Q54939164
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15379; Human HDAC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC3-3C9
AC   CVCL_KF39
DR   Wikidata; Q54939165
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15379; Human HDAC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-HDAC6-1A4
AC   CVCL_KF40
DR   DSHB; PCRP-HDAC6-1A4
DR   Wikidata; Q54939166
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UBN7; Human HDAC6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC6-1D9
AC   CVCL_KF41
DR   DSHB; PCRP-HDAC6-1D9
DR   Wikidata; Q54939167
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UBN7; Human HDAC6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC7-1A3
AC   CVCL_KF42
DR   DSHB; PCRP-HDAC7-1A3
DR   Wikidata; Q54939168
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8WUI4; Human HDAC7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC7-1C4
AC   CVCL_KF43
DR   DSHB; PCRP-HDAC7-1C4
DR   Wikidata; Q54939169
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8WUI4; Human HDAC7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC8-2A3
AC   CVCL_KF44
DR   DSHB; PCRP-HDAC8-2A3
DR   Wikidata; Q54939170
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BY41; Human HDAC8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDAC8-2C8
AC   CVCL_KF45
DR   DSHB; PCRP-HDAC8-2C8
DR   Wikidata; Q54939171
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BY41; Human HDAC8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDGF-1D1
AC   CVCL_KF46
DR   DSHB; PCRP-HDGF-1D1
DR   Wikidata; Q54939179
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P51858; Human HDGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDGF-1F2
AC   CVCL_KF47
DR   DSHB; PCRP-HDGF-1F2
DR   Wikidata; Q54939180
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P51858; Human HDGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDGFL1-1A11
AC   CVCL_KF48
DR   DSHB; PCRP-HDGFL1-1A11
DR   Wikidata; Q54939181
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5TGJ6; Human HDGFL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDGFRP2-3C4
AC   CVCL_KF49
DR   DSHB; PCRP-HDGFRP2-3C4
DR   Wikidata; Q54939182
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q7Z4V5; Human HDGFRP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HDGFRP2-3D1
AC   CVCL_KF50
DR   DSHB; PCRP-HDGFRP2-3D1
DR   Wikidata; Q54939183
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z4V5; Human HDGFRP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HELLS-2A3
AC   CVCL_KF51
DR   DSHB; PCRP-HELLS-2A3
DR   Wikidata; Q54939184
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NRZ9; Human HELLS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HES1-1A10
AC   CVCL_KF52
DR   DSHB; PCRP-HES1-1A10
DR   Wikidata; Q54939185
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14469; Human HES1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HES1-1A3
AC   CVCL_KF53
DR   DSHB; PCRP-HES1-1A3
DR   Wikidata; Q54939186
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14469; Human HES1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HES1-1B11
AC   CVCL_KF54
DR   DSHB; PCRP-HES1-1B11
DR   Wikidata; Q54939187
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14469; Human HES1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HES1-2C1
AC   CVCL_KF55
DR   DSHB; PCRP-HES1-2C1
DR   Wikidata; Q54939188
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14469; Human HES1.
CC   Discontinued: DSHB; PCRP-HES1-2C1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HES1-2E8
AC   CVCL_KF56
DR   DSHB; PCRP-HES1-2E8
DR   Wikidata; Q54939189
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14469; Human HES1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HES1-4A11
AC   CVCL_KF57
DR   DSHB; PCRP-HES1-4A11
DR   Wikidata; Q54939190
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14469; Human HES1.
CC   Discontinued: DSHB; PCRP-HES1-4A11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HES3-1A10
AC   CVCL_KF58
DR   DSHB; PCRP-HES3-1A10
DR   Wikidata; Q54939192
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5TGS1; Human HES3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HESX1-1A11
AC   CVCL_KF59
DR   DSHB; PCRP-HESX1-1A11
DR   Wikidata; Q54939193
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UBX0; Human HESX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HEY2-1H10
AC   CVCL_KF60
DR   DSHB; PCRP-HEY2-1H10
DR   Wikidata; Q54939194
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UBP5; Human HEY2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HEY2-1H7
AC   CVCL_KF61
DR   DSHB; PCRP-HEY2-1H7
DR   Wikidata; Q54939195
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UBP5; Human HEY2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HEY2-3A7
AC   CVCL_KF62
DR   DSHB; PCRP-HEY2-3A7
DR   Wikidata; Q54939196
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UBP5; Human HEY2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HEYL-1G9
AC   CVCL_KF63
DR   DSHB; PCRP-HEYL-1G9
DR   Wikidata; Q54939197
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NQ87; Human HEYL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HHEX-1C3
AC   CVCL_KF64
DR   DSHB; PCRP-HHEX-1C3
DR   Wikidata; Q54939198
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03014; Human HHEX.
CC   Discontinued: DSHB; PCRP-HHEX-1C3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HHEX-1D3
AC   CVCL_KF65
DR   DSHB; PCRP-HHEX-1D3
DR   Wikidata; Q54939199
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03014; Human HHEX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HHEX-1H3
AC   CVCL_KF66
DR   DSHB; PCRP-HHEX-1H3
DR   Wikidata; Q54939200
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03014; Human HHEX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HHEX-2B6
AC   CVCL_KF67
DR   DSHB; PCRP-HHEX-2B6
DR   Wikidata; Q54939201
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03014; Human HHEX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HIC2-1B1
AC   CVCL_KF68
DR   DSHB; PCRP-HIC2-1B1
DR   Wikidata; Q54939203
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96JB3; Human HIC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HIC2-2F8
AC   CVCL_KF69
DR   DSHB; PCRP-HIC2-2F8
DR   Wikidata; Q54939204
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96JB3; Human HIC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HIF3A-1C6
AC   CVCL_KF70
DR   DSHB; PCRP-HIF3A-1C6
DR   Wikidata; Q54939206
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y2N7; Human HIF3A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HINFP-1A1
AC   CVCL_KF71
DR   DSHB; PCRP-HINFP-1A1
DR   Wikidata; Q54939207
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BQA5; Human HINFP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HLF-1C5
AC   CVCL_KF72
DR   Wikidata; Q54939208
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16534; Human HLF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-HMG20B-1B5
AC   CVCL_KF73
DR   DSHB; PCRP-HMG20B-1B5
DR   Wikidata; Q54939209
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P0W2; Human HMG20B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGA1-1B6
AC   CVCL_KF74
DR   DSHB; PCRP-HMGA1-1B6
DR   Wikidata; Q54939210
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17096; Human HMGA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGA1-1C3
AC   CVCL_KF75
DR   DSHB; PCRP-HMGA1-1C3
DR   Wikidata; Q54939211
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17096; Human HMGA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGB1-1E4
AC   CVCL_KF76
DR   Wikidata; Q54939212
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-HMGB1-2G1
AC   CVCL_KF77
DR   DSHB; PCRP-HMGB1-2G1
DR   Wikidata; Q54939213
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGB1-3A7
AC   CVCL_KF78
DR   Wikidata; Q54939214
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-HMGB1-3B10
AC   CVCL_KF79
DR   DSHB; PCRP-HMGB1-3B10
DR   Wikidata; Q54939215
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
CC   Discontinued: DSHB; PCRP-HMGB1-3B10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HMGB1-4C10
AC   CVCL_KF80
DR   DSHB; PCRP-HMGB1-4C10
DR   Wikidata; Q54939216
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
CC   Discontinued: DSHB; PCRP-HMGB1-4C10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HMGB1-4F10
AC   CVCL_KF81
DR   DSHB; PCRP-HMGB1-4F10
DR   Wikidata; Q54939217
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGB1-6B7
AC   CVCL_KF82
DR   DSHB; PCRP-HMGB1-6B7
DR   Wikidata; Q54939218
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
CC   Discontinued: DSHB; PCRP-HMGB1-6B7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HMGB1-6E1
AC   CVCL_KF83
DR   DSHB; PCRP-HMGB1-6E1
DR   Wikidata; Q54939219
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09429; Human HMGB1.
CC   Discontinued: DSHB; PCRP-HMGB1-6E1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HMGN1-1B2
AC   CVCL_KF84
DR   DSHB; PCRP-HMGN1-1B2
DR   Wikidata; Q54939220
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05114; Human HMGN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGN1-1G10
AC   CVCL_KF85
DR   DSHB; PCRP-HMGN1-1G10
DR   Wikidata; Q54939221
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05114; Human HMGN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGN5-2E6
AC   CVCL_KF86
DR   DSHB; PCRP-HMGN5-2E6
DR   Wikidata; Q54939234
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P82970; Human HMGN5.
CC   Discontinued: DSHB; PCRP-HMGN5-2E6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HMGXB4-1B3
AC   CVCL_KF87
DR   DSHB; PCRP-HMGXB4-1B3
DR   Wikidata; Q54939236
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UGU5; Human HMGXB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMGXB4-3F4
AC   CVCL_KF88
DR   DSHB; PCRP-HMGXB4-3F4
DR   Wikidata; Q54939237
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UGU5; Human HMGXB4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMX3-4C5
AC   CVCL_KF89
DR   DSHB; PCRP-HMX3-4C5
DR   Wikidata; Q54939238
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NHT5; Human HMX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HMX3-4E5
AC   CVCL_KF90
DR   DSHB; PCRP-HMX3-4E5
DR   Wikidata; Q54939239
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NHT5; Human HMX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HNF4A-2A8
AC   CVCL_KF91
DR   DSHB; PCRP-HNF4A-2A8
DR   Wikidata; Q54939240
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P41235; Human HNF4A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOMEZ-1A5
AC   CVCL_KF92
DR   DSHB; PCRP-HOMEZ-1A5
DR   Wikidata; Q54939241
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IX15; Human HOMEZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOMEZ-1B5
AC   CVCL_KF93
DR   DSHB; PCRP-HOMEZ-1B5
DR   Wikidata; Q54939242
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IX15; Human HOMEZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOPX-1A1
AC   CVCL_KF94
DR   DSHB; PCRP-HOPX-1A1
DR   Wikidata; Q54939243
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BPY8; Human HOPX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOPX-1A5
AC   CVCL_KF95
DR   DSHB; PCRP-HOPX-1A5
DR   Wikidata; Q54939244
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BPY8; Human HOPX.
CC   Discontinued: DSHB; PCRP-HOPX-1A5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HOXB2-1C9
AC   CVCL_KF96
DR   DSHB; PCRP-HOXB2-1C9
DR   Wikidata; Q54939245
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P14652; Human HOXB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOXB2-1F2
AC   CVCL_KF97
DR   DSHB; PCRP-HOXB2-1F2
DR   Wikidata; Q54939246
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P14652; Human HOXB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOXB5-1C3
AC   CVCL_KF98
DR   DSHB; PCRP-HOXB5-1C3
DR   Wikidata; Q54939247
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09067; Human HOXB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOXB6-1A4
AC   CVCL_KF99
DR   DSHB; PCRP-HOXB6-1A4
DR   Wikidata; Q54939248
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17509; Human HOXB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOXB9-1E6
AC   CVCL_KG00
DR   DSHB; PCRP-HOXB9-1E6
DR   Wikidata; Q54939249
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P17482; Human HOXB9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOXC8-1D3
AC   CVCL_KG01
DR   DSHB; PCRP-HOXC8-1D3
DR   Wikidata; Q54939250
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P31273; Human HOXC8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HOXD9-1A4
AC   CVCL_KG02
DR   DSHB; PCRP-HOXD9-1A4
DR   Wikidata; Q54939251
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28356; Human HOXD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HSF1-1A10
AC   CVCL_KG03
DR   DSHB; PCRP-HSF1-1A10
DR   Wikidata; Q54939252
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q00613; Human HSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HSF1-1A6
AC   CVCL_KG04
DR   DSHB; PCRP-HSF1-1A6
DR   Wikidata; Q54939253
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q00613; Human HSF1.
CC   Discontinued: DSHB; PCRP-HSF1-1A6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HSF1-1A8
AC   CVCL_KG05
DR   DSHB; PCRP-HSF1-1A8
DR   Wikidata; Q54939254
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00613; Human HSF1.
CC   Discontinued: DSHB; PCRP-HSF1-1A8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HSF1-1A9
AC   CVCL_KG06
DR   DSHB; PCRP-HSF1-1A9
DR   Wikidata; Q54939255
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00613; Human HSF1.
CC   Discontinued: DSHB; PCRP-HSF1-1A9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-HSF1-1C1
AC   CVCL_KG07
DR   DSHB; PCRP-HSF1-1C1
DR   Wikidata; Q54939256
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00613; Human HSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HSF1-1D11
AC   CVCL_KG08
DR   DSHB; PCRP-HSF1-1D11
DR   Wikidata; Q54939257
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00613; Human HSF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HSF2-2C1
AC   CVCL_KG09
DR   DSHB; PCRP-HSF2-2C1
DR   Wikidata; Q54939258
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03933; Human HSF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-HSF5-1A1
AC   CVCL_KG10
DR   DSHB; PCRP-HSF5-1A1
DR   Wikidata; Q54939260
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q4G112; Human HSF5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID1-1E5
AC   CVCL_KG11
DR   DSHB; PCRP-ID1-1E5
DR   Wikidata; Q54939261
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P41134; Human ID1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID1-2C10
AC   CVCL_KG12
DR   DSHB; PCRP-ID1-2C10
DR   Wikidata; Q54939262
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P41134; Human ID1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID1-2F11
AC   CVCL_KG13
DR   DSHB; PCRP-ID1-2F11
DR   Wikidata; Q54939263
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P41134; Human ID1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID2-1A8
AC   CVCL_KG14
DR   DSHB; PCRP-ID2-1A8
DR   Wikidata; Q54939264
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q02363; Human ID2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID3-2C8
AC   CVCL_KG15
DR   DSHB; PCRP-ID3-2C8
DR   Wikidata; Q54939266
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q02535; Human ID3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID3-2G4
AC   CVCL_KG16
DR   DSHB; PCRP-ID3-2G4
DR   Wikidata; Q54939267
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02535; Human ID3.
CC   Discontinued: DSHB; PCRP-ID3-2G4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ID3-2H2
AC   CVCL_KG17
DR   DSHB; PCRP-ID3-2H2
DR   Wikidata; Q54939268
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02535; Human ID3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID3-3D6
AC   CVCL_KG18
DR   DSHB; PCRP-ID3-3D6
DR   Wikidata; Q54939269
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02535; Human ID3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID4-1A1
AC   CVCL_KG19
DR   DSHB; PCRP-ID4-1A1
DR   Wikidata; Q54939270
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P47928; Human ID4.
CC   Discontinued: DSHB; PCRP-ID4-1A1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ID4-1A10
AC   CVCL_KG20
DR   DSHB; PCRP-ID4-1A10
DR   Wikidata; Q54939271
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P47928; Human ID4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID4-1A6
AC   CVCL_KG21
DR   DSHB; PCRP-ID4-1A6
DR   Wikidata; Q54939272
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P47928; Human ID4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID4-1B8
AC   CVCL_KG22
DR   DSHB; PCRP-ID4-1B8
DR   Wikidata; Q54939273
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P47928; Human ID4.
CC   Discontinued: DSHB; PCRP-ID4-1B8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ID4-1D6
AC   CVCL_KG23
DR   DSHB; PCRP-ID4-1D6
DR   Wikidata; Q54939274
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P47928; Human ID4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ID4-2D6
AC   CVCL_KG24
DR   DSHB; PCRP-ID4-2D6
DR   Wikidata; Q54939275
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P47928; Human ID4.
CC   Discontinued: DSHB; PCRP-ID4-2D6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ID4-3C6
AC   CVCL_KG25
DR   DSHB; PCRP-ID4-3C6
DR   Wikidata; Q54939276
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P47928; Human ID4.
CC   Discontinued: DSHB; PCRP-ID4-3C6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IGF2BP1-2D4
AC   CVCL_KG26
DR   DSHB; PCRP-IGF2BP1-2D4
DR   Wikidata; Q54939290
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NZI8; Human IGF2BP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IKZF1-1B8
AC   CVCL_KG27
DR   DSHB; PCRP-IKZF1-1B8
DR   Wikidata; Q54939291
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13422; Human IKZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ING1-1C2
AC   CVCL_KG28
DR   DSHB; PCRP-ING1-1C2
DR   Wikidata; Q54939292
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UK53; Human ING1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ING4-3B3
AC   CVCL_KG29
DR   DSHB; PCRP-ING4-3B3
DR   Wikidata; Q54939293
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNL4; Human ING4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-INSM1-1A6
AC   CVCL_KG30
DR   DSHB; PCRP-INSM1-1A6
DR   Wikidata; Q54939294
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q01101; Human INSM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRF2-1A4
AC   CVCL_KG31
DR   DSHB; PCRP-IRF2-1A4
DR   Wikidata; Q54939295
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14316; Human IRF2.
CC   Discontinued: DSHB; PCRP-IRF2-1A4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRF2-1B2
AC   CVCL_KG32
DR   DSHB; PCRP-IRF2-1B2
DR   Wikidata; Q54939296
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14316; Human IRF2.
CC   Discontinued: DSHB; PCRP-IRF2-1B2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRF3-1D11
AC   CVCL_KG33
DR   DSHB; PCRP-IRF3-1D11
DR   Wikidata; Q54939297
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRF3-1E11
AC   CVCL_KG34
DR   Wikidata; Q54939298
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-1E3
AC   CVCL_KG35
DR   Wikidata; Q54939299
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-1G7
AC   CVCL_KG36
DR   DSHB; PCRP-IRF3-1G7
DR   Wikidata; Q54939300
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRF3-2C5
AC   CVCL_KG37
DR   DSHB; PCRP-IRF3-2C5
DR   Wikidata; Q54939301
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
CC   Discontinued: DSHB; PCRP-IRF3-2C5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRF3-2D9
AC   CVCL_KG38
DR   Wikidata; Q54939302
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-2F9
AC   CVCL_KG39
DR   Wikidata; Q54939303
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-3B2
AC   CVCL_KG40
DR   Wikidata; Q54939304
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-4D7
AC   CVCL_KG41
DR   DSHB; PCRP-IRF3-4D7
DR   Wikidata; Q54939305
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
CC   Discontinued: DSHB; PCRP-IRF3-4D7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRF3-4F5
AC   CVCL_KG42
DR   Wikidata; Q54939306
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-4G8
AC   CVCL_KG43
DR   Wikidata; Q54939307
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-5B12
AC   CVCL_KG44
DR   Wikidata; Q54939308
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-6A11
AC   CVCL_KG45
DR   DSHB; PCRP-IRF3-6A11
DR   Wikidata; Q54939309
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
CC   Discontinued: DSHB; PCRP-IRF3-6A11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRF3-6C2
AC   CVCL_KG46
DR   DSHB; PCRP-IRF3-6C2
DR   Wikidata; Q54939310
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
CC   Discontinued: DSHB; PCRP-IRF3-6C2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRF3-6C8
AC   CVCL_KG47
DR   Wikidata; Q54939311
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF3-6H10
AC   CVCL_KG48
DR   Wikidata; Q54939312
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14653; Human IRF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-IRF4-1A5
AC   CVCL_KG49
DR   DSHB; PCRP-IRF4-1A5
DR   Wikidata; Q54939313
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15306; Human IRF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRF4-1A8
AC   CVCL_KG50
DR   DSHB; PCRP-IRF4-1A8
DR   Wikidata; Q54939314
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15306; Human IRF4.
CC   Discontinued: DSHB; PCRP-IRF4-1A8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRF8-1A12
AC   CVCL_KG51
DR   DSHB; PCRP-IRF8-1A12
DR   Wikidata; Q54939315
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02556; Human IRF8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRF9-2B7
AC   CVCL_KG52
DR   DSHB; PCRP-IRF9-2B7
DR   Wikidata; Q54939317
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q00978; Human IRF9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRF9-2F8
AC   CVCL_KG53
DR   DSHB; PCRP-IRF9-2F8
DR   Wikidata; Q54939318
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q00978; Human IRF9.
CC   Discontinued: DSHB; PCRP-IRF9-2F8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-IRX2-1B7
AC   CVCL_KG54
DR   DSHB; PCRP-IRX2-1B7
DR   Wikidata; Q54939319
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BZI1; Human IRX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRX2-1C1
AC   CVCL_KG55
DR   DSHB; PCRP-IRX2-1C1
DR   Wikidata; Q54939320
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BZI1; Human IRX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRX5-1B4
AC   CVCL_KG56
DR   DSHB; PCRP-IRX5-1B4
DR   Wikidata; Q54939321
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P78411; Human IRX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IRX5-1C11
AC   CVCL_KG57
DR   DSHB; PCRP-IRX5-1C11
DR   Wikidata; Q54939322
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P78411; Human IRX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ISL1-1A9
AC   CVCL_KG58
DR   DSHB; PCRP-ISL1-1A9
DR   Wikidata; Q54939323
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P61371; Human ISL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ISL1-1C2
AC   CVCL_KG59
DR   DSHB; PCRP-ISL1-1C2
DR   Wikidata; Q54939325
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P61371; Human ISL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ISL1-1D4
AC   CVCL_KG60
DR   DSHB; PCRP-ISL1-1D4
DR   Wikidata; Q54939326
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P61371; Human ISL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-IVNS1ABP-1B10
AC   CVCL_KG61
DR   DSHB; PCRP-IVNS1ABP-1B10
DR   Wikidata; Q54939327
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Y0; Human IVNS1ABP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-JAZF1-1A5
AC   CVCL_KG62
DR   DSHB; PCRP-JAZF1-1A5
DR   Wikidata; Q54939329
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86VZ6; Human JAZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-JAZF1-1B8
AC   CVCL_KG63
DR   DSHB; PCRP-JAZF1-1B8
DR   Wikidata; Q54939330
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86VZ6; Human JAZF1.
CC   Discontinued: DSHB; PCRP-JAZF1-1B8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-JAZF1-1C1
AC   CVCL_KG64
DR   DSHB; PCRP-JAZF1-1C1
DR   Wikidata; Q54939331
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86VZ6; Human JAZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-JAZF1-1C2
AC   CVCL_KG65
DR   DSHB; PCRP-JAZF1-1C2
DR   Wikidata; Q54939332
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86VZ6; Human JAZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-JUNB-3G11
AC   CVCL_KG66
DR   DSHB; PCRP-JUNB-3G11
DR   Wikidata; Q54939340
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P17275; Human JUNB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-JUNB-3G2
AC   CVCL_KG67
DR   DSHB; PCRP-JUNB-3G2
DR   Wikidata; Q54939341
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17275; Human JUNB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-JUP-1B1
AC   CVCL_KG68
DR   DSHB; PCRP-JUP-1B1
DR   Wikidata; Q54939342
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P14923; Human JUP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KBTBD10-4B8
AC   CVCL_KG69
DR   DSHB; PCRP-KBTBD10-4B8
DR   Wikidata; Q54939344
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60662; Human KLHL41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-KCMF1-1H4
AC   CVCL_KG70
DR   DSHB; PCRP-KCMF1-1H4
DR   Wikidata; Q54939345
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9P0J7; Human KCMF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KDM1A-1A10
AC   CVCL_KG71
DR   DSHB; PCRP-KDM1A-1A10
DR   Wikidata; Q54939346
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O60341; Human KDM1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KDM1A-1A4
AC   CVCL_KG72
DR   DSHB; PCRP-KDM1A-1A4
DR   Wikidata; Q54939347
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60341; Human KDM1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KDM1A-1B2
AC   CVCL_KG73
DR   DSHB; PCRP-KDM1A-1B2
DR   Wikidata; Q54939348
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60341; Human KDM1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KDM5C-1A11
AC   CVCL_KG74
DR   DSHB; PCRP-KDM5C-1A11
DR   Wikidata; Q54939349
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P41229; Human KDM5C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KDM8-1A2
AC   CVCL_KG75
DR   DSHB; PCRP-KDM8-1A2
DR   Wikidata; Q54939350
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N371; Human KDM8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KHDRBS1-2E2
AC   CVCL_KG76
DR   DSHB; PCRP-KHDRBS1-2E2
DR   Wikidata; Q54939351
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q07666; Human KHDRBS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KHDRBS3-1D11
AC   CVCL_KG77
DR   DSHB; PCRP-KHDRBS3-1D11
DR   Wikidata; Q54939352
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75525; Human KHDRBS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KHDRBS3-1D3
AC   CVCL_KG78
DR   DSHB; PCRP-KHDRBS3-1D3
DR   Wikidata; Q54939353
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75525; Human KHDRBS3.
CC   Misspelling: PCRP-KHDRBSE-1D3; Note=In an obsoleted version of DSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 6
//
ID   PCRP-KIAA1967-1B5
AC   CVCL_KG79
DR   DSHB; PCRP-KIAA1967-1B5
DR   Wikidata; Q54939354
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N163; Human CCAR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KIAA1967-1C8
AC   CVCL_KG80
DR   DSHB; PCRP-KIAA1967-1C8
DR   Wikidata; Q54939355
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N163; Human CCAR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KIAA1967-1D10
AC   CVCL_KG81
DR   DSHB; PCRP-KIAA1967-1D10
DR   Wikidata; Q54939356
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N163; Human CCAR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF1-2C4
AC   CVCL_KG82
DR   DSHB; PCRP-KLF1-2C4
DR   Wikidata; Q54939357
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q13351; Human KLF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF10-1D3
AC   CVCL_KG83
DR   DSHB; PCRP-KLF10-1D3
DR   Wikidata; Q54939358
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13118; Human KLF10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF10-1D6
AC   CVCL_KG84
DR   DSHB; PCRP-KLF10-1D6
DR   Wikidata; Q54939359
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13118; Human KLF10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF10-1G2
AC   CVCL_KG85
DR   DSHB; PCRP-KLF10-1G2
DR   Wikidata; Q54939360
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13118; Human KLF10.
CC   Discontinued: DSHB; PCRP-KLF10-1G2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-KLF10-2A10
AC   CVCL_KG86
DR   DSHB; PCRP-KLF10-2A10
DR   Wikidata; Q54939361
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13118; Human KLF10.
CC   Discontinued: DSHB; PCRP-KLF10-2A10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-KLF10-3E3
AC   CVCL_KG87
DR   DSHB; PCRP-KLF10-3E3
DR   Wikidata; Q54939362
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13118; Human KLF10.
CC   Discontinued: DSHB; PCRP-KLF10-3E3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-KLF10-4B1
AC   CVCL_KG88
DR   DSHB; PCRP-KLF10-4B1
DR   Wikidata; Q54939363
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13118; Human KLF10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF12-1E3
AC   CVCL_KG89
DR   DSHB; PCRP-KLF12-1E3
DR   Wikidata; Q54939364
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y4X4; Human KLF12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF12-1H9
AC   CVCL_KG90
DR   DSHB; PCRP-KLF12-1H9
DR   Wikidata; Q54939365
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y4X4; Human KLF12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF14-1C12
AC   CVCL_KG91
DR   DSHB; PCRP-KLF14-1C12
DR   Wikidata; Q54939366
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TD94; Human KLF14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF14-1H1
AC   CVCL_KG92
DR   DSHB; PCRP-KLF14-1H1
DR   Wikidata; Q54939367
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TD94; Human KLF14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF15-1F11
AC   CVCL_KG93
DR   DSHB; PCRP-KLF15-1F11
DR   Wikidata; Q54939368
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UIH9; Human KLF15.
CC   Discontinued: DSHB; PCRP-KLF15-1F11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-KLF15-1H1
AC   CVCL_KG94
DR   DSHB; PCRP-KLF15-1H1
DR   Wikidata; Q54939369
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UIH9; Human KLF15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF15-1H3
AC   CVCL_KG95
DR   DSHB; PCRP-KLF15-1H3
DR   Wikidata; Q54939370
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UIH9; Human KLF15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF15-2A8
AC   CVCL_KG96
DR   DSHB; PCRP-KLF15-2A8
DR   Wikidata; Q54939371
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UIH9; Human KLF15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF16-1E9
AC   CVCL_KG97
DR   DSHB; PCRP-KLF16-1E9
DR   Wikidata; Q54939372
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BXK1; Human KLF16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF16-2E5
AC   CVCL_KG98
DR   DSHB; PCRP-KLF16-2E5
DR   Wikidata; Q54939373
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BXK1; Human KLF16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF16-3B3
AC   CVCL_KG99
DR   DSHB; PCRP-KLF16-3B3
DR   Wikidata; Q54939374
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BXK1; Human KLF16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF17-1G2
AC   CVCL_KH00
DR   DSHB; PCRP-KLF17-1G2
DR   Wikidata; Q54939375
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5JT82; Human KLF17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF17-2F4
AC   CVCL_KH01
DR   DSHB; PCRP-KLF17-2F4
DR   Wikidata; Q54939376
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5JT82; Human KLF17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF5-1A3
AC   CVCL_KH02
DR   DSHB; PCRP-KLF5-1A3
DR   Wikidata; Q54939377
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13887; Human KLF5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF7-1C11
AC   CVCL_KH03
DR   DSHB; PCRP-KLF7-1C11
DR   Wikidata; Q54939378
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75840; Human KLF7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-KLF7-1C4
AC   CVCL_KH04
DR   DSHB; PCRP-KLF7-1C4
DR   Wikidata; Q54939379
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75840; Human KLF7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-L3MBTL4-4D1
AC   CVCL_KH05
DR   DSHB; PCRP-L3MBTL4-4D1
DR   Wikidata; Q54939380
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NA19; Human L3MBTL4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LCOR-1A7
AC   CVCL_KH06
DR   DSHB; PCRP-LCOR-1A7
DR   Wikidata; Q54939389
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96JN0; Human LCOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LCOR-1B1
AC   CVCL_KH07
DR   DSHB; PCRP-LCOR-1B1
DR   Wikidata; Q54939390
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96JN0; Human LCOR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LCORL-1H11
AC   CVCL_KH08
DR   DSHB; PCRP-LCORL-1H11
DR   Wikidata; Q54939391
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N3X6; Human LCORL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LDB1-1C5
AC   CVCL_KH09
DR   DSHB; PCRP-LDB1-1C5
DR   Wikidata; Q54939392
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86U70; Human LDB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LDB2-1A10
AC   CVCL_KH10
DR   DSHB; PCRP-LDB2-1A10
DR   Wikidata; Q54939393
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43679; Human LDB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LDB2-1B1
AC   CVCL_KH11
DR   DSHB; PCRP-LDB2-1B1
DR   Wikidata; Q54939394
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43679; Human LDB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LDB2-1B10
AC   CVCL_KH12
DR   DSHB; PCRP-LDB2-1B10
DR   Wikidata; Q54939395
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O43679; Human LDB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LEUTX-1B6
AC   CVCL_KH13
DR   DSHB; PCRP-LEUTX-1B6
DR   Wikidata; Q54939396
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A8MZ59; Human LEUTX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LEUTX-1B8
AC   CVCL_KH14
DR   DSHB; PCRP-LEUTX-1B8
DR   Wikidata; Q54939397
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; A8MZ59; Human LEUTX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LHX2-1C11
AC   CVCL_KH15
DR   DSHB; PCRP-LHX2-1C11
DR   Wikidata; Q54939398
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P50458; Human LHX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LHX2-2C10
AC   CVCL_KH16
DR   DSHB; PCRP-LHX2-2C10
DR   Wikidata; Q54939399
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P50458; Human LHX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LHX2-2D12
AC   CVCL_KH17
DR   DSHB; PCRP-LHX2-2D12
DR   Wikidata; Q54939400
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50458; Human LHX2.
CC   Discontinued: DSHB; PCRP-LHX2-2D12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-LHX2-2E3
AC   CVCL_KH18
DR   DSHB; PCRP-LHX2-2E3
DR   Wikidata; Q54939401
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P50458; Human LHX2.
CC   Discontinued: DSHB; PCRP-LHX2-2E3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-LHX2-2G5
AC   CVCL_KH19
DR   DSHB; PCRP-LHX2-2G5
DR   Wikidata; Q54939402
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P50458; Human LHX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LHX2-3B11
AC   CVCL_KH20
DR   DSHB; PCRP-LHX2-3B11
DR   Wikidata; Q54939403
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P50458; Human LHX2.
CC   Discontinued: DSHB; PCRP-LHX2-3B11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-LHX4-1A8
AC   CVCL_KH21
DR   Wikidata; Q54939404
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q969G2; Human LHX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-LHX4-1B6
AC   CVCL_KH22
DR   DSHB; PCRP-LHX4-1B6
DR   Wikidata; Q54939405
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q969G2; Human LHX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LHX4-1C11
AC   CVCL_KH23
DR   DSHB; PCRP-LHX4-1C11
DR   Wikidata; Q54939406
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q969G2; Human LHX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LHX5-1B7
AC   CVCL_KH24
DR   DSHB; PCRP-LHX5-1B7
DR   Wikidata; Q54939407
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H2C1; Human LHX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LIN28A-1E2
AC   CVCL_KH25
DR   DSHB; PCRP-LIN28A-1E2
DR   Wikidata; Q54939408
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H9Z2; Human LIN28A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LRRFIP1-3A8
AC   CVCL_KH26
DR   DSHB; PCRP-LRRFIP1-3A8
DR   Wikidata; Q54939409
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q32MZ4; Human LRRFIP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-LZTR1-1C7
AC   CVCL_KH27
DR   DSHB; PCRP-LZTR1-1C7
DR   Wikidata; Q54939410
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N653; Human LZTR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAFB-1A10
AC   CVCL_KH28
DR   DSHB; PCRP-MAFB-1A10
DR   Wikidata; Q54939411
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y5Q3; Human MAFB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAFF-1A8
AC   CVCL_KH29
DR   DSHB; PCRP-MAFF-1A8
DR   Wikidata; Q54939412
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9ULX9; Human MAFF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAFG-1H7
AC   CVCL_KH30
DR   DSHB; PCRP-MAFG-1H7
DR   Wikidata; Q54939413
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15525; Human MAFG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAP3K7-1B9
AC   CVCL_KH31
DR   DSHB; PCRP-MAP3K7-1B9
DR   Wikidata; Q54939415
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43318; Human MAP3K7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAPK1-1D1
AC   CVCL_KH32
DR   DSHB; PCRP-MAPK1-1D1
DR   Wikidata; Q54939416
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P28482; Human MAPK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAT2B-1G7
AC   CVCL_KH33
DR   DSHB; PCRP-MAT2B-1G7
DR   Wikidata; Q54939417
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NZL9; Human MAT2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAT2B-4B6
AC   CVCL_KH34
DR   DSHB; PCRP-MAT2B-4B6
DR   Wikidata; Q54939418
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NZL9; Human MAT2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAX-1E7
AC   CVCL_KH35
DR   DSHB; PCRP-MAX-1E7
DR   Wikidata; Q54939419
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P61244; Human MAX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MAZ-1D5
AC   CVCL_KH36
DR   DSHB; PCRP-MAZ-1D5
DR   Wikidata; Q54939420
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P56270; Human MAZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MBD2-1B6
AC   CVCL_KH37
DR   DSHB; PCRP-MBD2-1B6
DR   Wikidata; Q54939421
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UBB5; Human MBD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MBD3-1C4
AC   CVCL_KH38
DR   DSHB; PCRP-MBD3-1C4
DR   Wikidata; Q54939422
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95983; Human MBD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MBD3-1C5
AC   CVCL_KH39
DR   DSHB; PCRP-MBD3-1C5
DR   Wikidata; Q54939423
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95983; Human MBD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MBD3-2C4
AC   CVCL_KH40
DR   DSHB; PCRP-MBD3-2C4
DR   Wikidata; Q54939425
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95983; Human MBD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MBNL3-1D11
AC   CVCL_KH41
DR   DSHB; PCRP-MBNL3-1D11
DR   Wikidata; Q54939426
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NUK0; Human MBNL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED1-1A11
AC   CVCL_KH42
DR   DSHB; PCRP-MED1-1A11
DR   Wikidata; Q54939427
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15648; Human MED1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED1-1A9
AC   CVCL_KH43
DR   DSHB; PCRP-MED1-1A9
DR   Wikidata; Q54939428
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15648; Human MED1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED21-4B5
AC   CVCL_KH44
DR   DSHB; PCRP-MED21-4B5
DR   Wikidata; Q54939429
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13503; Human MED21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED21-4F3
AC   CVCL_KH45
DR   DSHB; PCRP-MED21-4F3
DR   Wikidata; Q54939430
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13503; Human MED21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED22-1E4
AC   CVCL_KH46
DR   DSHB; PCRP-MED22-1E4
DR   Wikidata; Q54939439
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q15528; Human MED22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED22-2A7
AC   CVCL_KH47
DR   DSHB; PCRP-MED22-2A7
DR   Wikidata; Q54939440
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15528; Human MED22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED30-1B12
AC   CVCL_KH48
DR   DSHB; PCRP-MED30-1B12
DR   Wikidata; Q54939441
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96HR3; Human MED30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED30-1C3
AC   CVCL_KH49
DR   DSHB; PCRP-MED30-1C3
DR   Wikidata; Q54939443
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96HR3; Human MED30.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED4-1A6
AC   CVCL_KH50
DR   DSHB; PCRP-MED4-1A6
DR   Wikidata; Q54939444
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NPJ6; Human MED4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED6-3D10
AC   CVCL_KH51
DR   DSHB; PCRP-MED6-3D10
DR   Wikidata; Q54939446
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75586; Human MED6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED7-1B8
AC   CVCL_KH52
DR   DSHB; PCRP-MED7-1B8
DR   Wikidata; Q54939447
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43513; Human MED7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED7-1C4
AC   CVCL_KH53
DR   DSHB; PCRP-MED7-1C4
DR   Wikidata; Q54939448
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O43513; Human MED7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED8-1A4
AC   CVCL_KH54
DR   DSHB; PCRP-MED8-1A4
DR   Wikidata; Q54939449
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96G25; Human MED8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MED8-1B4
AC   CVCL_YE81
DR   DSHB; PCRP-MED8-1B4
DR   Wikidata; Q98128526
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96G25; Human MED8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   PCRP-MED9-1D6
AC   CVCL_KH55
DR   DSHB; PCRP-MED9-1D6
DR   Wikidata; Q54939450
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NWA0; Human MED9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEF2A-1B7
AC   CVCL_KH56
DR   DSHB; PCRP-MEF2A-1B7
DR   Wikidata; Q54939451
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q02078; Human MEF2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEF2A-1F7
AC   CVCL_KH57
DR   DSHB; PCRP-MEF2A-1F7
DR   Wikidata; Q54939452
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q02078; Human MEF2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEF2B-2A11
AC   CVCL_KH58
DR   DSHB; PCRP-MEF2B-2A11
DR   Wikidata; Q54939453
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q02080; Human MEF2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEF2B-2F9
AC   CVCL_KH59
DR   DSHB; PCRP-MEF2B-2F9
DR   Wikidata; Q54939454
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q02080; Human MEF2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEF2C-1D4
AC   CVCL_KH60
DR   DSHB; PCRP-MEF2C-1D4
DR   Wikidata; Q54939455
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q06413; Human MEF2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEF2D-3A4
AC   CVCL_KH61
DR   DSHB; PCRP-MEF2D-3A4
DR   Wikidata; Q54939456
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14814; Human MEF2D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEIS2-1A11
AC   CVCL_KH62
DR   DSHB; PCRP-MEIS2-1A11
DR   Wikidata; Q54939457
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14770; Human MEIS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEIS2-2B3
AC   CVCL_KH63
DR   DSHB; PCRP-MEIS2-2B3
DR   Wikidata; Q54939458
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14770; Human MEIS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEIS2-2B4
AC   CVCL_KH64
DR   DSHB; PCRP-MEIS2-2B4
DR   Wikidata; Q54939459
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14770; Human MEIS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEIS3-1A10
AC   CVCL_KH65
DR   DSHB; PCRP-MEIS3-1A10
DR   Wikidata; Q54939460
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99687; Human MEIS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEIS3-1D5
AC   CVCL_KH66
DR   DSHB; PCRP-MEIS3-1D5
DR   Wikidata; Q54939461
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99687; Human MEIS3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEN1-1H6
AC   CVCL_KH67
DR   DSHB; PCRP-MEN1-1H6
DR   Wikidata; Q54939462
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00255; Human MEN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MEN1-2B1
AC   CVCL_KH68
DR   DSHB; PCRP-MEN1-2B1
DR   Wikidata; Q54939464
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00255; Human MEN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MESP1-1D11
AC   CVCL_KH69
DR   DSHB; PCRP-MESP1-1D11
DR   Wikidata; Q54939465
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BRJ9; Human MESP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MESP2-1D4
AC   CVCL_KH70
DR   DSHB; PCRP-MESP2-1D4
DR   Wikidata; Q54939466
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q0VG99; Human MESP2.
CC   Discontinued: DSHB; PCRP-MESP2-1D4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-METTL21A-2D2
AC   CVCL_KH71
DR   DSHB; PCRP-METTL21A-2D2
DR   Wikidata; Q54939467
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WXB1; Human METTL21A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MINA-1A7
AC   CVCL_KH72
DR   DSHB; PCRP-MINA-1A7
DR   Wikidata; Q54939468
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IUF8; Human RIOX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MINA-1D1
AC   CVCL_KH73
DR   DSHB; PCRP-MINA-1D1
DR   Wikidata; Q54939469
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IUF8; Human RIOX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MIS18BP1-1B10
AC   CVCL_KH74
DR   DSHB; PCRP-MIS18BP1-1B10
DR   Wikidata; Q54939470
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6P0N0; Human MIS18BP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MITF-1D9
AC   CVCL_KH75
DR   DSHB; PCRP-MITF-1D9
DR   Wikidata; Q54939471
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75030; Human MITF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MLLT10-1C10
AC   CVCL_KH76
DR   DSHB; PCRP-MLLT10-1C10
DR   Wikidata; Q54939472
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P55197; Human MLLT10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MLLT10-1D4
AC   CVCL_KH77
DR   DSHB; PCRP-MLLT10-1D4
DR   Wikidata; Q54939473
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55197; Human MLLT10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MLLT3-2B6
AC   CVCL_KH78
DR   DSHB; PCRP-MLLT3-2B6
DR   Wikidata; Q54939474
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P42568; Human MLLT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MLX-1G8
AC   CVCL_KH79
DR   DSHB; PCRP-MLX-1G8
DR   Wikidata; Q54939475
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UH92; Human MLX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MLXIP-1A10
AC   CVCL_KH80
DR   DSHB; PCRP-MLXIP-1A10
DR   Wikidata; Q54939476
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HAP2; Human MLXIP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MORF4L1-1G12
AC   CVCL_KH81
DR   DSHB; PCRP-MORF4L1-1G12
DR   Wikidata; Q54939477
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UBU8; Human MORF4L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MXD3-1A3
AC   CVCL_KH82
DR   DSHB; PCRP-MXD3-1A3
DR   Wikidata; Q54939478
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BW11; Human MXD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MXD3-2B4
AC   CVCL_KH83
DR   DSHB; PCRP-MXD3-2B4
DR   Wikidata; Q54939479
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BW11; Human MXD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MXD4-2B6
AC   CVCL_KH84
DR   DSHB; PCRP-MXD4-2B6
DR   Wikidata; Q54939480
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14582; Human MXD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MXI1-1A3
AC   CVCL_KH85
DR   DSHB; PCRP-MXI1-1A3
DR   Wikidata; Q54939481
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P50539; Human MXI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYCL1-1A3
AC   CVCL_KH86
DR   DSHB; PCRP-MYCL1-1A3
DR   Wikidata; Q54939489
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12524; Human MYCL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYCL1-2D5
AC   CVCL_KH87
DR   DSHB; PCRP-MYCL1-2D5
DR   Wikidata; Q54939490
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P12524; Human MYCL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYCL1-2E1
AC   CVCL_KH88
DR   DSHB; PCRP-MYCL1-2E1
DR   Wikidata; Q54939491
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P12524; Human MYCL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYCN-1A9
AC   CVCL_KH89
DR   DSHB; PCRP-MYCN-1A9
DR   Wikidata; Q54939492
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04198; Human MYCN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYCN-2C7
AC   CVCL_KH90
DR   DSHB; PCRP-MYCN-2C7
DR   Wikidata; Q54939493
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04198; Human MYCN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYO1B-2B4
AC   CVCL_KH91
DR   DSHB; PCRP-MYO1B-2B4
DR   Wikidata; Q54939495
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43795; Human MYO1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYOD1-2A5
AC   CVCL_KH92
DR   DSHB; PCRP-MYOD1-2A5
DR   Wikidata; Q54939496
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15172; Human MYOD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MYOG-1C5
AC   CVCL_KH93
DR   DSHB; PCRP-MYOG-1C5
DR   Wikidata; Q54939497
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P15173; Human MYOG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MZF1-1D7
AC   CVCL_KH94
DR   DSHB; PCRP-MZF1-1D7
DR   Wikidata; Q54939498
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P28698; Human MZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-MZF1-1E8
AC   CVCL_KH95
DR   DSHB; PCRP-MZF1-1E8
DR   Wikidata; Q54939500
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P28698; Human MZF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NAB2-2G1
AC   CVCL_KH96
DR   DSHB; PCRP-NAB2-2G1
DR   Wikidata; Q54939501
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15742; Human NAB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NACC1-1A1
AC   CVCL_KH97
DR   DSHB; PCRP-NACC1-1A1
DR   Wikidata; Q54939502
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96RE7; Human NACC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NACC1-1A8
AC   CVCL_KH98
DR   DSHB; PCRP-NACC1-1A8
DR   Wikidata; Q54939503
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96RE7; Human NACC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NACC1-1B10
AC   CVCL_KH99
DR   DSHB; PCRP-NACC1-1B10
DR   Wikidata; Q54939504
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96RE7; Human NACC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NACC2-1C7
AC   CVCL_KI00
DR   DSHB; PCRP-NACC2-1C7
DR   Wikidata; Q54939505
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96BF6; Human NACC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NACC2-3E5
AC   CVCL_KI01
DR   DSHB; PCRP-NACC2-3E5
DR   Wikidata; Q54939506
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96BF6; Human NACC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NACC2-4B7
AC   CVCL_KI02
DR   DSHB; PCRP-NACC2-4B7
DR   Wikidata; Q54939507
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96BF6; Human NACC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NANOGP1-2D8
AC   CVCL_KI03
DR   DSHB; PCRP-NANOGP1-2D8
DR   Wikidata; Q54939508
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N7R0; Human NANOGP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NAP1L5-1A7
AC   CVCL_KI04
DR   DSHB; PCRP-NAP1L5-1A7
DR   Wikidata; Q54939509
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96NT1; Human NAP1L5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NCBP1-1C7
AC   CVCL_KI05
DR   DSHB; PCRP-NCBP1-1C7
DR   Wikidata; Q54939510
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q09161; Human NCBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NCOA1-1B11
AC   CVCL_KI06
DR   DSHB; PCRP-NCOA1-1B11
DR   Wikidata; Q54939511
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15788; Human NCOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NCOA1-1E8
AC   CVCL_KI07
DR   DSHB; PCRP-NCOA1-1E8
DR   Wikidata; Q54939512
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15788; Human NCOA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NCOA3-1A11
AC   CVCL_KI08
DR   DSHB; PCRP-NCOA3-1A11
DR   Wikidata; Q54939513
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Q9; Human NCOA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NCOA3-1B9
AC   CVCL_KI09
DR   DSHB; PCRP-NCOA3-1B9
DR   Wikidata; Q54939514
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Q9; Human NCOA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NCOA3-1C10
AC   CVCL_KI10
DR   DSHB; PCRP-NCOA3-1C10
DR   Wikidata; Q54939515
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9Y6Q9; Human NCOA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NEDD4L-2B4
AC   CVCL_KI11
DR   DSHB; PCRP-NEDD4L-2B4
DR   Wikidata; Q54939516
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96PU5; Human NEDD4L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NEDD4L-2B9
AC   CVCL_KI12
DR   DSHB; PCRP-NEDD4L-2B9
DR   Wikidata; Q54939517
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96PU5; Human NEDD4L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NEUROD2-1G1
AC   CVCL_KI13
DR   DSHB; PCRP-NEUROD2-1G1
DR   Wikidata; Q54939518
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15784; Human NEUROD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NEUROG3-2A6
AC   CVCL_KI14
DR   DSHB; PCRP-NEUROG3-2A6
DR   Wikidata; Q54939519
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y4Z2; Human NEUROG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFATC1-1A2
AC   CVCL_KI15
DR   DSHB; PCRP-NFATC1-1A2
DR   Wikidata; Q54939520
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95644; Human NFATC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFATC1-1F4
AC   CVCL_KI16
DR   DSHB; PCRP-NFATC1-1F4
DR   Wikidata; Q54939521
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95644; Human NFATC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFATC3-2A12
AC   CVCL_KI17
DR   DSHB; PCRP-NFATC3-2A12
DR   Wikidata; Q54939522
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q12968; Human NFATC3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFE2L2-1D12
AC   CVCL_KI18
DR   DSHB; PCRP-NFE2L2-1D12
DR   Wikidata; Q54939523
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16236; Human NFE2L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFE2L2-3D2
AC   CVCL_KI19
DR   DSHB; PCRP-NFE2L2-3D2
DR   Wikidata; Q54939524
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16236; Human NFE2L2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFIA-1B8
AC   CVCL_KI20
DR   DSHB; PCRP-NFIA-1B8
DR   Wikidata; Q54939525
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q12857; Human NFIA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFIA-2B12
AC   CVCL_KI21
DR   DSHB; PCRP-NFIA-2B12
DR   Wikidata; Q54939526
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q12857; Human NFIA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFIA-2C6
AC   CVCL_KI22
DR   DSHB; PCRP-NFIA-2C6
DR   Wikidata; Q54939527
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q12857; Human NFIA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFIB-1B5
AC   CVCL_KI23
DR   DSHB; PCRP-NFIB-1B5
DR   Wikidata; Q54939528
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00712; Human NFIB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFIL3-2B5
AC   CVCL_KI24
DR   DSHB; PCRP-NFIL3-2B5
DR   Wikidata; Q54939530
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16649; Human NFIL3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFIX-2D3
AC   CVCL_KI25
DR   DSHB; PCRP-NFIX-2D3
DR   Wikidata; Q54939531
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14938; Human NFIX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFIX-3B4
AC   CVCL_KI26
DR   DSHB; PCRP-NFIX-3B4
DR   Wikidata; Q54939541
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14938; Human NFIX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFKB1-2B9
AC   CVCL_KI27
DR   DSHB; PCRP-NFKB1-2B9
DR   Wikidata; Q54939542
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P19838; Human NFKB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFKB2-1E1
AC   CVCL_KI28
DR   DSHB; PCRP-NFKB2-1E1
DR   Wikidata; Q54939544
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q00653; Human NFKB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFKB2-7H5
AC   CVCL_KI29
DR   DSHB; PCRP-NFKB2-7H5
DR   Wikidata; Q54939545
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00653; Human NFKB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFX1-1A4
AC   CVCL_KI30
DR   DSHB; PCRP-NFX1-1A4
DR   Wikidata; Q54939546
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q12986; Human NFX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFYB-1A2
AC   CVCL_KI31
DR   DSHB; PCRP-NFYB-1A2
DR   Wikidata; Q54939547
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P25208; Human NFYB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NFYC-1A11
AC   CVCL_KI32
DR   DSHB; PCRP-NFYC-1A11
DR   Wikidata; Q54939548
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13952; Human NFYC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NHLH2-1C9
AC   CVCL_KI33
DR   DSHB; PCRP-NHLH2-1C9
DR   Wikidata; Q54939549
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q02577; Human NHLH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NINJ2-2B10
AC   CVCL_KI34
DR   DSHB; PCRP-NINJ2-2B10
DR   Wikidata; Q54939550
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NZG7; Human NINJ2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NKX2-5-1E6
AC   CVCL_KI35
DR   DSHB; PCRP-NKX2-5-1E6
DR   Wikidata; Q54939551
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52952; Human NKX2-5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NKX2-5-3B4
AC   CVCL_KI36
DR   DSHB; PCRP-NKX2-5-3B4
DR   Wikidata; Q54939552
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P52952; Human NKX2-5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NKX2-5-3F2
AC   CVCL_KI37
DR   DSHB; PCRP-NKX2-5-3F2
DR   Wikidata; Q54939553
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P52952; Human NKX2-5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NKX3-1-1E5
AC   CVCL_KI38
DR   DSHB; PCRP-NKX3-1-1E5
DR   Wikidata; Q54939554
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99801; Human NKX3-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NMI-1C1
AC   CVCL_KI39
DR   DSHB; PCRP-NMI-1C1
DR   Wikidata; Q54939555
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13287; Human NMI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NOC4L-1B2
AC   CVCL_KI40
DR   DSHB; PCRP-NOC4L-1B2
DR   Wikidata; Q54939556
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9BVI4; Human NOC4L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NOC4L-1D12
AC   CVCL_KI41
DR   DSHB; PCRP-NOC4L-1D12
DR   Wikidata; Q54939557
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BVI4; Human NOC4L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NOC4L-1E3
AC   CVCL_KI42
DR   DSHB; PCRP-NOC4L-1E3
DR   Wikidata; Q54939559
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BVI4; Human NOC4L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NPM1-1B4
AC   CVCL_KI43
DR   DSHB; PCRP-NPM1-1B4
DR   Wikidata; Q54939560
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P06748; Human NPM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NPM3-1D5
AC   CVCL_KI44
DR   DSHB; PCRP-NPM3-1D5
DR   Wikidata; Q54939561
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75607; Human NPM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR0B1-1A10
AC   CVCL_KI45
DR   DSHB; PCRP-NR0B1-1A10
DR   Wikidata; Q54939562
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51843; Human NR0B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR0B1-1F12
AC   CVCL_KI46
DR   DSHB; PCRP-NR0B1-1F12
DR   Wikidata; Q54939564
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51843; Human NR0B1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR1D1-1D2
AC   CVCL_KI47
DR   DSHB; PCRP-NR1D1-1D2
DR   Wikidata; Q54939565
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20393; Human NR1D1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR1D1-1F1
AC   CVCL_KI48
DR   DSHB; PCRP-NR1D1-1F1
DR   Wikidata; Q54939566
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P20393; Human NR1D1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR1D2-1B12
AC   CVCL_KI49
DR   DSHB; PCRP-NR1D2-1B12
DR   Wikidata; Q54939567
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14995; Human NR1D2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR1H2-1D11
AC   CVCL_KI50
DR   DSHB; PCRP-NR1H2-1D11
DR   Wikidata; Q54939568
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P55055; Human NR1H2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR1H3-1A1
AC   CVCL_KI51
DR   DSHB; PCRP-NR1H3-1A1
DR   Wikidata; Q54939569
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q13133; Human NR1H3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR2C1-2B12
AC   CVCL_KI52
DR   DSHB; PCRP-NR2C1-2B12
DR   Wikidata; Q54939570
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13056; Human NR2C1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR2C1-2C3
AC   CVCL_KI53
DR   DSHB; PCRP-NR2C1-2C3
DR   Wikidata; Q54939571
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13056; Human NR2C1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR2E3-2B6
AC   CVCL_KI54
DR   DSHB; PCRP-NR2E3-2B6
DR   Wikidata; Q54939572
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9Y5X4; Human NR2E3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR2F1-1D5
AC   CVCL_KI55
DR   DSHB; PCRP-NR2F1-1D5
DR   Wikidata; Q54939573
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10589; Human NR2F1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR2F2-1G3
AC   CVCL_KI56
DR   DSHB; PCRP-NR2F2-1G3
DR   Wikidata; Q54939574
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P24468; Human NR2F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR3C2-1A3
AC   CVCL_KI57
DR   DSHB; PCRP-NR3C2-1A3
DR   Wikidata; Q54939575
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08235; Human NR3C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR3C2-1E3
AC   CVCL_KI58
DR   DSHB; PCRP-NR3C2-1E3
DR   Wikidata; Q54939576
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08235; Human NR3C2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR5A1-1A4
AC   CVCL_KI59
DR   DSHB; PCRP-NR5A1-1A4
DR   Wikidata; Q54939577
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13285; Human NR5A1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR5A2-1A11
AC   CVCL_KI60
DR   DSHB; PCRP-NR5A2-1A11
DR   Wikidata; Q54939579
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00482; Human NR5A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR5A2-1B2
AC   CVCL_KI61
DR   DSHB; PCRP-NR5A2-1B2
DR   Wikidata; Q54939580
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O00482; Human NR5A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NR5A2-1B8
AC   CVCL_KI62
DR   DSHB; PCRP-NR5A2-1B8
DR   Wikidata; Q54939581
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O00482; Human NR5A2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NRF1-3D4
AC   CVCL_KI63
DR   DSHB; PCRP-NRF1-3D4
DR   Wikidata; Q54939582
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16656; Human NRF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NRF1-3H1
AC   CVCL_KI64
DR   DSHB; PCRP-NRF1-3H1
DR   Wikidata; Q54939583
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16656; Human NRF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-NRF1-3H3
AC   CVCL_KI65
DR   DSHB; PCRP-NRF1-3H3
DR   Wikidata; Q54939584
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16656; Human NRF1.
CC   Discontinued: DSHB; PCRP-NRF1-3H3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-NRF1-4A3
AC   CVCL_KI66
DR   DSHB; PCRP-NRF1-4A3
DR   Wikidata; Q54939592
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16656; Human NRF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-OBFC1-1B4
AC   CVCL_KI67
DR   DSHB; PCRP-OBFC1-1B4
DR   Wikidata; Q54939593
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H668; Human STN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-OLIG2-1E9
AC   CVCL_KI68
DR   DSHB; PCRP-OLIG2-1E9
DR   Wikidata; Q54939594
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13516; Human OLIG2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ONECUT1-1A1
AC   CVCL_KI69
DR   DSHB; PCRP-ONECUT1-1A1
DR   Wikidata; Q54939595
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UBC0; Human ONECUT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ONECUT2-1A1
AC   CVCL_KI70
DR   DSHB; PCRP-ONECUT2-1A1
DR   Wikidata; Q54939596
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95948; Human ONECUT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ORC1-1C4
AC   CVCL_KI71
DR   DSHB; PCRP-ORC1-1C4
DR   Wikidata; Q54939597
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13415; Human ORC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-OTX2-1E10
AC   CVCL_KI72
DR   DSHB; PCRP-OTX2-1E10
DR   Wikidata; Q54939598
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P32243; Human OTX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-OTX2-1F7
AC   CVCL_KI73
DR   DSHB; PCRP-OTX2-1F7
DR   Wikidata; Q54939599
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P32243; Human OTX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-OVOL2-1G9
AC   CVCL_KI74
DR   DSHB; PCRP-OVOL2-1G9
DR   Wikidata; Q54939600
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BRP0; Human OVOL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-OVOL2-1H12
AC   CVCL_KI75
DR   DSHB; PCRP-OVOL2-1H12
DR   Wikidata; Q54939601
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BRP0; Human OVOL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-OVOL2-2A1
AC   CVCL_KI76
DR   DSHB; PCRP-OVOL2-2A1
DR   Wikidata; Q54939602
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BRP0; Human OVOL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PARP11-1C4
AC   CVCL_KI77
DR   DSHB; PCRP-PARP11-1C4
DR   Wikidata; Q54939603
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NR21; Human PARP11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PARP11-1H1
AC   CVCL_KI78
DR   DSHB; PCRP-PARP11-1H1
DR   Wikidata; Q54939604
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NR21; Human PARP11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PAWR-1C3
AC   CVCL_KI79
DR   DSHB; PCRP-PAWR-1C3
DR   Wikidata; Q54939605
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96IZ0; Human PAWR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PAX2-1A7
AC   CVCL_KI80
DR   DSHB; PCRP-PAX2-1A7
DR   Wikidata; Q54939606
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q02962; Human PAX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PAX3-1B3
AC   CVCL_KI81
DR   DSHB; PCRP-PAX3-1B3
DR   Wikidata; Q54939607
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P23760; Human PAX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PAX5-1B1
AC   CVCL_KI82
DR   DSHB; PCRP-PAX5-1B1
DR   Wikidata; Q54939608
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02548; Human PAX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PAX5-1B7
AC   CVCL_KI83
DR   DSHB; PCRP-PAX5-1B7
DR   Wikidata; Q54939609
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q02548; Human PAX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PAX9-1G1
AC   CVCL_KI84
DR   DSHB; PCRP-PAX9-1G1
DR   Wikidata; Q54939610
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P55771; Human PAX9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PBX1-2D10
AC   CVCL_KI85
DR   DSHB; PCRP-PBX1-2D10
DR   Wikidata; Q54939611
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P40424; Human PBX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PBX1-3C8
AC   CVCL_KI86
DR   DSHB; PCRP-PBX1-3C8
DR   Wikidata; Q54939613
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P40424; Human PBX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PBX2-1C4
AC   CVCL_KI87
DR   DSHB; PCRP-PBX2-1C4
DR   Wikidata; Q54939614
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P40425; Human PBX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PBX4-1C11
AC   CVCL_KI88
DR   DSHB; PCRP-PBX4-1C11
DR   Wikidata; Q54939615
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BYU1; Human PBX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PBX4-1H1
AC   CVCL_KI89
DR   DSHB; PCRP-PBX4-1H1
DR   Wikidata; Q54939616
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BYU1; Human PBX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PBX4-2H1
AC   CVCL_KI90
DR   DSHB; PCRP-PBX4-2H1
DR   Wikidata; Q54939617
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BYU1; Human PBX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PCGF3-1B4
AC   CVCL_KI91
DR   DSHB; PCRP-PCGF3-1B4
DR   Wikidata; Q54939618
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q3KNV8; Human PCGF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PCGF3-1D5
AC   CVCL_KI92
DR   DSHB; PCRP-PCGF3-1D5
DR   Wikidata; Q54939619
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q3KNV8; Human PCGF3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PCGF6-1A11
AC   CVCL_KI93
DR   DSHB; PCRP-PCGF6-1A11
DR   Wikidata; Q54939620
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BYE7; Human PCGF6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PCGF6-1A2
AC   CVCL_KI94
DR   DSHB; PCRP-PCGF6-1A2
DR   Wikidata; Q54939621
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BYE7; Human PCGF6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PDX1-2C11
AC   CVCL_KI95
DR   DSHB; PCRP-PDX1-2C11
DR   Wikidata; Q54939622
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P52945; Human PDX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PGBD1-2A3
AC   CVCL_KI96
DR   DSHB; PCRP-PGBD1-2A3
DR   Wikidata; Q54939623
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q96JS3; Human PGBD1.
CC   Discontinued: DSHB; PCRP-PGBD1-2A3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PGBD1-3C5
AC   CVCL_KI97
DR   DSHB; PCRP-PGBD1-3C5
DR   Wikidata; Q54939624
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96JS3; Human PGBD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PGBD1-3E1
AC   CVCL_KI98
DR   DSHB; PCRP-PGBD1-3E1
DR   Wikidata; Q54939625
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96JS3; Human PGBD1.
CC   Discontinued: DSHB; PCRP-PGBD1-3E1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PGBD1-3H9
AC   CVCL_KI99
DR   DSHB; PCRP-PGBD1-3H9
DR   Wikidata; Q54939626
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96JS3; Human PGBD1.
CC   Discontinued: DSHB; PCRP-PGBD1-3H9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PGBD1-4C8
AC   CVCL_KJ00
DR   DSHB; PCRP-PGBD1-4C8
DR   Wikidata; Q54939627
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96JS3; Human PGBD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PGD-1A2
AC   CVCL_KJ01
DR   DSHB; PCRP-PGD-1A2
DR   Wikidata; Q54939628
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P52209; Human PGD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF10-2A10
AC   CVCL_KJ02
DR   DSHB; PCRP-PHF10-2A10
DR   Wikidata; Q54939629
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8WUB8; Human PHF10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF17-1H6
AC   CVCL_KJ03
DR   DSHB; PCRP-PHF17-1H6
DR   Wikidata; Q54939630
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6IE81; Human JADE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF19-2B8
AC   CVCL_KJ04
DR   DSHB; PCRP-PHF19-2B8
DR   Wikidata; Q54939631
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5T6S3; Human PHF19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF19-2C7
AC   CVCL_KJ05
DR   DSHB; PCRP-PHF19-2C7
DR   Wikidata; Q54939632
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5T6S3; Human PHF19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF19-2D9
AC   CVCL_KJ06
DR   DSHB; PCRP-PHF19-2D9
DR   Wikidata; Q54939643
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5T6S3; Human PHF19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF21B-1A4
AC   CVCL_KJ07
DR   DSHB; PCRP-PHF21B-1A4
DR   Wikidata; Q54939644
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96EK2; Human PHF21B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF21B-1G3
AC   CVCL_KJ08
DR   DSHB; PCRP-PHF21B-1G3
DR   Wikidata; Q54939645
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96EK2; Human PHF21B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF7-1A1
AC   CVCL_KJ09
DR   DSHB; PCRP-PHF7-1A1
DR   Wikidata; Q54939646
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BWX1; Human PHF7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PHF7-1F3
AC   CVCL_KJ10
DR   DSHB; PCRP-PHF7-1F3
DR   Wikidata; Q54939647
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9BWX1; Human PHF7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PIKFYVE-1A5
AC   CVCL_KJ11
DR   DSHB; PCRP-PIKFYVE-1A5
DR   Wikidata; Q54939648
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y2I7; Human PIKFYVE.
CC   Discontinued: DSHB; PCRP-PIKFYVE-1A5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PIKFYVE-1B8
AC   CVCL_KJ12
DR   DSHB; PCRP-PIKFYVE-1B8
DR   Wikidata; Q54939649
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2I7; Human PIKFYVE.
CC   Discontinued: DSHB; PCRP-PIKFYVE-1B8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PIKFYVE-1F9
AC   CVCL_KJ13
DR   DSHB; PCRP-PIKFYVE-1F9
DR   Wikidata; Q54939650
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2I7; Human PIKFYVE.
CC   Discontinued: DSHB; PCRP-PIKFYVE-1F9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PIKFYVE-1H2
AC   CVCL_KJ14
DR   DSHB; PCRP-PIKFYVE-1H2
DR   Wikidata; Q54939651
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y2I7; Human PIKFYVE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PIKFYVE-2B2
AC   CVCL_KJ15
DR   DSHB; PCRP-PIKFYVE-2B2
DR   Wikidata; Q54939652
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y2I7; Human PIKFYVE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PIKFYVE-3C9
AC   CVCL_KJ16
DR   DSHB; PCRP-PIKFYVE-3C9
DR   Wikidata; Q54939653
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2I7; Human PIKFYVE.
CC   Discontinued: DSHB; PCRP-PIKFYVE-3C9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PIKFYVE-4G10
AC   CVCL_KJ17
DR   DSHB; PCRP-PIKFYVE-4G10
DR   Wikidata; Q54939654
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2I7; Human PIKFYVE.
CC   Discontinued: DSHB; PCRP-PIKFYVE-4G10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PKNOX2-2F8
AC   CVCL_KJ18
DR   DSHB; PCRP-PKNOX2-2F8
DR   Wikidata; Q54939655
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96KN3; Human PKNOX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PKNOX2-3C6
AC   CVCL_KJ19
DR   DSHB; PCRP-PKNOX2-3C6
DR   Wikidata; Q54939656
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96KN3; Human PKNOX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PLAG1-1F5
AC   CVCL_KJ20
DR   DSHB; PCRP-PLAG1-1F5
DR   Wikidata; Q54939657
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6DJT9; Human PLAG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PLXNB1-3A7
AC   CVCL_KJ21
DR   DSHB; PCRP-PLXNB1-3A7
DR   Wikidata; Q54939658
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43157; Human PLXNB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PLXNB1-3G4
AC   CVCL_KJ22
DR   DSHB; PCRP-PLXNB1-3G4
DR   Wikidata; Q54939659
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O43157; Human PLXNB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PMS1-2E11
AC   CVCL_KJ23
DR   DSHB; PCRP-PMS1-2E11
DR   Wikidata; Q54939660
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54277; Human PMS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POGZ-1B2
AC   CVCL_KJ24
DR   DSHB; PCRP-POGZ-1B2
DR   Wikidata; Q54939661
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z3K3; Human POGZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POLE3-2B11
AC   CVCL_KJ25
DR   DSHB; PCRP-POLE3-2B11
DR   Wikidata; Q54939662
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NRF9; Human POLE3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POLE3-2F10
AC   CVCL_KJ26
DR   DSHB; PCRP-POLE3-2F10
DR   Wikidata; Q54939663
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NRF9; Human POLE3.
CC   Discontinued: DSHB; PCRP-POLE3-2F10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-POLE3-2F4
AC   CVCL_KJ27
DR   DSHB; PCRP-POLE3-2F4
DR   Wikidata; Q54939664
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NRF9; Human POLE3.
CC   Discontinued: DSHB; PCRP-POLE3-2F4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-POLE3-3A4
AC   CVCL_KJ28
DR   DSHB; PCRP-POLE3-3A4
DR   Wikidata; Q54939665
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NRF9; Human POLE3.
CC   Discontinued: DSHB; PCRP-POLE3-3A4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-POLE3-3D3
AC   CVCL_KJ29
DR   DSHB; PCRP-POLE3-3D3
DR   Wikidata; Q54939666
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NRF9; Human POLE3.
CC   Discontinued: DSHB; PCRP-POLE3-3D3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-POLE3-4E1
AC   CVCL_KJ30
DR   DSHB; PCRP-POLE3-4E1
DR   Wikidata; Q54939667
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NRF9; Human POLE3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POU3F2-1A3
AC   CVCL_KJ31
DR   DSHB; PCRP-POU3F2-1A3
DR   Wikidata; Q54939669
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P20265; Human POU3F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POU3F2-3E6
AC   CVCL_KJ32
DR   DSHB; PCRP-POU3F2-3E6
DR   Wikidata; Q54939670
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20265; Human POU3F2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POU3F3-1G10
AC   CVCL_YE82
DR   DSHB; PCRP-POU3F3-1G10
DR   Wikidata; Q98128527
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20264; Human POU3F3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 4
//
ID   PCRP-POU5F1-1A4
AC   CVCL_KJ33
DR   DSHB; PCRP-POU5F1-1A4
DR   Wikidata; Q54939671
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01860; Human POU5F1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POU5F1-1D2
AC   CVCL_KJ34
DR   DSHB; PCRP-POU5F1-1D2
DR   Wikidata; Q54939672
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01860; Human POU5F1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POU5F1-1D9
AC   CVCL_KJ35
DR   DSHB; PCRP-POU5F1-1D9
DR   Wikidata; Q54939673
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01860; Human POU5F1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-POU6F1-1A1
AC   CVCL_KJ36
DR   DSHB; PCRP-POU6F1-1A1
DR   Wikidata; Q54939674
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14863; Human POU6F1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPARA-2B9
AC   CVCL_KJ37
DR   DSHB; PCRP-PPARA-2B9
DR   Wikidata; Q54939675
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q07869; Human PPARA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPARD-1D5
AC   CVCL_KJ38
DR   DSHB; PCRP-PPARD-1D5
DR   Wikidata; Q54939676
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
CC   Discontinued: DSHB; PCRP-PPARD-1D5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PPARD-1E3
AC   CVCL_KJ39
DR   DSHB; PCRP-PPARD-1E3
DR   Wikidata; Q54939677
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPARD-1F7
AC   CVCL_KJ40
DR   DSHB; PCRP-PPARD-1F7
DR   Wikidata; Q54939678
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPARD-2C10
AC   CVCL_KJ41
DR   DSHB; PCRP-PPARD-2C10
DR   Wikidata; Q54939679
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
CC   Discontinued: DSHB; PCRP-PPARD-2C10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PPARD-2H3
AC   CVCL_KJ42
DR   DSHB; PCRP-PPARD-2H3
DR   Wikidata; Q54939680
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
CC   Discontinued: DSHB; PCRP-PPARD-2H3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PPARD-4A11
AC   CVCL_KJ43
DR   DSHB; PCRP-PPARD-4A11
DR   Wikidata; Q54939681
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
CC   Discontinued: DSHB; PCRP-PPARD-4A11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PPARD-4B7
AC   CVCL_KJ44
DR   DSHB; PCRP-PPARD-4B7
DR   Wikidata; Q54939682
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
CC   Discontinued: DSHB; PCRP-PPARD-4B7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PPARD-4C2
AC   CVCL_KJ45
DR   DSHB; PCRP-PPARD-4C2
DR   Wikidata; Q54939683
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
CC   Discontinued: DSHB; PCRP-PPARD-4C2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PPARD-4H2
AC   CVCL_KJ46
DR   DSHB; PCRP-PPARD-4H2
DR   Wikidata; Q54939694
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q03181; Human PPARD.
CC   Discontinued: DSHB; PCRP-PPARD-4H2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PPP1R10-1A2
AC   CVCL_KJ47
DR   DSHB; PCRP-PPP1R10-1A2
DR   Wikidata; Q54939695
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96QC0; Human PPP1R10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPP1R10-1G12
AC   CVCL_KJ48
DR   DSHB; PCRP-PPP1R10-1G12
DR   Wikidata; Q54939696
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96QC0; Human PPP1R10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPP1R13L-2G4
AC   CVCL_KJ49
DR   DSHB; PCRP-PPP1R13L-2G4
DR   Wikidata; Q54939697
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WUF5; Human PPP1R13L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPP5C-1F7
AC   CVCL_KJ50
DR   DSHB; PCRP-PPP5C-1F7
DR   Wikidata; Q54939698
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P53041; Human PPP5C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PPP5C-1H9
AC   CVCL_KJ51
DR   DSHB; PCRP-PPP5C-1H9
DR   Wikidata; Q54939699
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P53041; Human PPP5C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM1-2B9
AC   CVCL_KJ52
DR   DSHB; PCRP-PRDM1-2B9
DR   Wikidata; Q54939700
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75626; Human PRDM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM1-2C5
AC   CVCL_KJ53
DR   DSHB; PCRP-PRDM1-2C5
DR   Wikidata; Q54939701
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75626; Human PRDM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM13-1D8
AC   CVCL_KJ54
DR   DSHB; PCRP-PRDM13-1D8
DR   Wikidata; Q54939702
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H4Q3; Human PRDM13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM13-2C12
AC   CVCL_KJ55
DR   DSHB; PCRP-PRDM13-2C12
DR   Wikidata; Q54939703
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H4Q3; Human PRDM13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM16-1A11
AC   CVCL_KJ56
DR   DSHB; PCRP-PRDM16-1A11
DR   Wikidata; Q54939704
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM16-1B9
AC   CVCL_KJ57
DR   DSHB; PCRP-PRDM16-1B9
DR   Wikidata; Q54939705
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM16-1C10
AC   CVCL_KJ58
DR   DSHB; PCRP-PRDM16-1C10
DR   Wikidata; Q54939706
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
CC   Discontinued: DSHB; PCRP-PRDM16-1C10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PRDM16-1E6
AC   CVCL_KJ59
DR   DSHB; PCRP-PRDM16-1E6
DR   Wikidata; Q54939707
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
CC   Discontinued: DSHB; PCRP-PRDM16-1E6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PRDM16-2B2
AC   CVCL_KJ60
DR   DSHB; PCRP-PRDM16-2B2
DR   Wikidata; Q54939708
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM16-2B8
AC   CVCL_KJ61
DR   DSHB; PCRP-PRDM16-2B8
DR   Wikidata; Q54939709
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
CC   Discontinued: DSHB; PCRP-PRDM16-2B8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PRDM16-2B9
AC   CVCL_KJ62
DR   DSHB; PCRP-PRDM16-2B9
DR   Wikidata; Q54939710
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
CC   Discontinued: DSHB; PCRP-PRDM16-2B9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PRDM16-2D7
AC   CVCL_KJ63
DR   DSHB; PCRP-PRDM16-2D7
DR   Wikidata; Q54939711
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9HAZ2; Human PRDM16.
CC   Discontinued: DSHB; PCRP-PRDM16-2D7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PRDM2-2A1
AC   CVCL_KJ64
DR   DSHB; PCRP-PRDM2-2A1
DR   Wikidata; Q54939712
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13029; Human PRDM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM2-2A4
AC   CVCL_KJ65
DR   DSHB; PCRP-PRDM2-2A4
DR   Wikidata; Q54939713
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13029; Human PRDM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM4-2B3
AC   CVCL_KJ66
DR   DSHB; PCRP-PRDM4-2B3
DR   Wikidata; Q54939715
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UKN5; Human PRDM4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM4-2B4
AC   CVCL_KJ67
DR   DSHB; PCRP-PRDM4-2B4
DR   Wikidata; Q54939716
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UKN5; Human PRDM4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM4-2D1
AC   CVCL_KJ68
DR   DSHB; PCRP-PRDM4-2D1
DR   Wikidata; Q54939717
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UKN5; Human PRDM4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM5-1H5
AC   CVCL_KJ69
DR   DSHB; PCRP-PRDM5-1H5
DR   Wikidata; Q54939718
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NQX1; Human PRDM5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM7-1B11
AC   CVCL_KJ70
DR   DSHB; PCRP-PRDM7-1B11
DR   Wikidata; Q54939719
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NQW5; Human PRDM7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM7-2C10
AC   CVCL_KJ71
DR   DSHB; PCRP-PRDM7-2C10
DR   Wikidata; Q54939720
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NQW5; Human PRDM7.
CC   Discontinued: DSHB; PCRP-PRDM7-2C10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PRDM7-3C6
AC   CVCL_KJ72
DR   DSHB; PCRP-PRDM7-3C6
DR   Wikidata; Q54939721
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NQW5; Human PRDM7.
CC   Discontinued: DSHB; PCRP-PRDM7-3C6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-PRDM7-3D3
AC   CVCL_KJ73
DR   DSHB; PCRP-PRDM7-3D3
DR   Wikidata; Q54939722
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NQW5; Human PRDM7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM7-3F10
AC   CVCL_KJ74
DR   DSHB; PCRP-PRDM7-3F10
DR   Wikidata; Q54939723
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NQW5; Human PRDM7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRDM8-1A1
AC   CVCL_KJ75
DR   DSHB; PCRP-PRDM8-1A1
DR   Wikidata; Q54939725
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NQV8; Human PRDM8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRKRA-3A4
AC   CVCL_KJ76
DR   DSHB; PCRP-PRKRA-3A4
DR   Wikidata; Q54939726
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75569; Human PRKRA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRKRIR-1B11
AC   CVCL_KJ77
DR   DSHB; PCRP-PRKRIR-1B11
DR   Wikidata; Q54939727
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43422; Human THAP12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRMT6-1H4
AC   CVCL_KJ78
DR   DSHB; PCRP-PRMT6-1H4
DR   Wikidata; Q54939728
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96LA8; Human PRMT6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRMT6-2C9
AC   CVCL_KJ79
DR   DSHB; PCRP-PRMT6-2C9
DR   Wikidata; Q54939729
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96LA8; Human PRMT6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRMT7-1A4
AC   CVCL_KJ80
DR   DSHB; PCRP-PRMT7-1A4
DR   Wikidata; Q54939730
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NVM4; Human PRMT7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRMT7-1A7
AC   CVCL_KJ81
DR   DSHB; PCRP-PRMT7-1A7
DR   Wikidata; Q54939731
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NVM4; Human PRMT7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PROX1-1A6
AC   CVCL_KJ82
DR   DSHB; PCRP-PROX1-1A6
DR   Wikidata; Q54939732
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92786; Human PROX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PROX2-1E1
AC   CVCL_KJ83
DR   DSHB; PCRP-PROX2-1E1
DR   Wikidata; Q54939733
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q3B8N5; Human PROX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PROX2-1F5
AC   CVCL_KJ84
DR   DSHB; PCRP-PROX2-1F5
DR   Wikidata; Q54939734
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q3B8N5; Human PROX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRRX2-1G11
AC   CVCL_KJ85
DR   DSHB; PCRP-PRRX2-1G11
DR   Wikidata; Q54939735
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99811; Human PRRX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRRX2-4F12
AC   CVCL_KJ86
DR   DSHB; PCRP-PRRX2-4F12
DR   Wikidata; Q54939745
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99811; Human PRRX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PRRX2-5A10
AC   CVCL_KJ87
DR   DSHB; PCRP-PRRX2-5A10
DR   Wikidata; Q54939746
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q99811; Human PRRX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PUM1-1C3
AC   CVCL_KJ88
DR   DSHB; PCRP-PUM1-1C3
DR   Wikidata; Q54939747
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14671; Human PUM1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PUM2-1B11
AC   CVCL_KJ89
DR   DSHB; PCRP-PUM2-1B11
DR   Wikidata; Q54939748
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8TB72; Human PUM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-PWWP2B-1C8
AC   CVCL_KJ90
DR   DSHB; PCRP-PWWP2B-1C8
DR   Wikidata; Q54939749
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6NUJ5; Human PWWP2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-QKI-2F10
AC   CVCL_KJ91
DR   DSHB; PCRP-QKI-2F10
DR   Wikidata; Q54939750
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q96PU8; Human QKI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RARB-1E7
AC   CVCL_KJ92
DR   DSHB; PCRP-RARB-1E7
DR   Wikidata; Q54939751
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10826; Human RARB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RAX-1B4
AC   CVCL_KJ93
DR   DSHB; PCRP-RAX-1B4
DR   Wikidata; Q54939752
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2V3; Human RAX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RAX-1C8
AC   CVCL_KJ94
DR   DSHB; PCRP-RAX-1C8
DR   Wikidata; Q54939754
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y2V3; Human RAX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RAX-1G11
AC   CVCL_KJ95
DR   DSHB; PCRP-RAX-1G11
DR   Wikidata; Q54939755
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9Y2V3; Human RAX.
CC   Discontinued: DSHB; PCRP-RAX-1G11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-RAX-2D12
AC   CVCL_KJ96
DR   DSHB; PCRP-RAX-2D12
DR   Wikidata; Q54939756
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y2V3; Human RAX.
CC   Discontinued: DSHB; PCRP-RAX-2D12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-RBBP5-1C3
AC   CVCL_KJ97
DR   DSHB; PCRP-RBBP5-1C3
DR   Wikidata; Q54939757
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15291; Human RBBP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RBM8A-1A5
AC   CVCL_KJ98
DR   Wikidata; Q54939758
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9Y5S9; Human RBM8A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-RBM8A-1B4
AC   CVCL_KJ99
DR   Wikidata; Q54939759
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y5S9; Human RBM8A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-RBMS2-1B2
AC   CVCL_KK00
DR   DSHB; PCRP-RBMS2-1B2
DR   Wikidata; Q54939760
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15434; Human RBMS2.
CC   Discontinued: DSHB; PCRP-RBMS2-1B2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-RBMS2-1B6
AC   CVCL_KK01
DR   DSHB; PCRP-RBMS2-1B6
DR   Wikidata; Q54939761
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15434; Human RBMS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RCOR2-1E10
AC   CVCL_KK02
DR   DSHB; PCRP-RCOR2-1E10
DR   Wikidata; Q54939762
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8IZ40; Human RCOR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RCOR2-3F4
AC   CVCL_KK03
DR   DSHB; PCRP-RCOR2-3F4
DR   Wikidata; Q54939763
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IZ40; Human RCOR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RCOR3-1B2
AC   CVCL_KK04
DR   DSHB; PCRP-RCOR3-1B2
DR   Wikidata; Q54939764
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P2K3; Human RCOR3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RCOR3-1B6
AC   CVCL_KK05
DR   DSHB; PCRP-RCOR3-1B6
DR   Wikidata; Q54939765
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P2K3; Human RCOR3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RELA-1E3
AC   CVCL_KK06
DR   DSHB; PCRP-RELA-1E3
DR   Wikidata; Q54939766
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q04206; Human RELA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RELA-2B6
AC   CVCL_KK07
DR   DSHB; PCRP-RELA-2B6
DR   Wikidata; Q54939767
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04206; Human RELA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RELB-1A7
AC   CVCL_KK08
DR   DSHB; PCRP-RELB-1A7
DR   Wikidata; Q54939768
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q01201; Human RELB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RELB-1B1
AC   CVCL_KK09
DR   DSHB; PCRP-RELB-1B1
DR   Wikidata; Q54939769
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01201; Human RELB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RELB-1B4
AC   CVCL_KK10
DR   Wikidata; Q54939770
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01201; Human RELB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-RFX2-1A11
AC   CVCL_KK11
DR   DSHB; PCRP-RFX2-1A11
DR   Wikidata; Q54939771
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48378; Human RFX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RFX3-1D11
AC   CVCL_KK12
DR   DSHB; PCRP-RFX3-1D11
DR   Wikidata; Q54939772
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P48380; Human RFX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RFX5-1C12
AC   CVCL_KK13
DR   DSHB; PCRP-RFX5-1C12
DR   Wikidata; Q54939773
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48382; Human RFX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RFX5-1D11
AC   CVCL_KK14
DR   DSHB; PCRP-RFX5-1D11
DR   Wikidata; Q54939774
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P48382; Human RFX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RFX5-1E5
AC   CVCL_KK15
DR   DSHB; PCRP-RFX5-1E5
DR   Wikidata; Q54939775
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48382; Human RFX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RFX6-1B12
AC   CVCL_KK16
DR   DSHB; PCRP-RFX6-1B12
DR   Wikidata; Q54939776
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8HWS3; Human RFX6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RFX6-3D3
AC   CVCL_KK17
DR   DSHB; PCRP-RFX6-3D3
DR   Wikidata; Q54939777
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8HWS3; Human RFX6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RFXANK-1A9
AC   CVCL_KK18
DR   DSHB; PCRP-RFXANK-1A9
DR   Wikidata; Q54939778
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14593; Human RFXANK.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RGCC-2C4
AC   CVCL_KK19
DR   DSHB; PCRP-RGCC-2C4
DR   Wikidata; Q54939780
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H4X1; Human RGCC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RHOXF2-1C2
AC   CVCL_KK20
DR   DSHB; PCRP-RHOXF2-1C2
DR   Wikidata; Q54939782
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BQY4; Human RHOXF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RHOXF2-1D7
AC   CVCL_KK21
DR   Wikidata; Q54939783
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BQY4; Human RHOXF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-RNF113B-2F4
AC   CVCL_KK22
DR   DSHB; PCRP-RNF113B-2F4
DR   Wikidata; Q54939784
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IZP6; Human RNF113B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RNF113B-3D10
AC   CVCL_KK23
DR   DSHB; PCRP-RNF113B-3D10
DR   Wikidata; Q54939785
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IZP6; Human RNF113B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RNF17-1B9
AC   CVCL_KK24
DR   DSHB; PCRP-RNF17-1B9
DR   Wikidata; Q54939786
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9BXT8; Human RNF17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RNF2-1D4
AC   CVCL_KK25
DR   DSHB; PCRP-RNF2-1D4
DR   Wikidata; Q54939787
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q99496; Human RNF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RNF20-1D7
AC   CVCL_KK26
DR   DSHB; PCRP-RNF20-1D7
DR   Wikidata; Q54939797
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5VTR2; Human RNF20.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RORA-2C2
AC   CVCL_KK27
DR   DSHB; PCRP-RORA-2C2
DR   Wikidata; Q54939798
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35398; Human RORA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RPRD1A-1B2
AC   CVCL_KK28
DR   DSHB; PCRP-RPRD1A-1B2
DR   Wikidata; Q54939799
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96P16; Human RPRD1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RPRD1A-1D9
AC   CVCL_KK29
DR   DSHB; PCRP-RPRD1A-1D9
DR   Wikidata; Q54939800
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96P16; Human RPRD1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RPS6KA5-1A8
AC   CVCL_KK30
DR   DSHB; PCRP-RPS6KA5-1A8
DR   Wikidata; Q54939801
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75582; Human RPS6KA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RPS6KA5-1F10
AC   CVCL_KK31
DR   DSHB; PCRP-RPS6KA5-1F10
DR   Wikidata; Q54939802
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75582; Human RPS6KA5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RUNX1-3D7
AC   CVCL_KK32
DR   DSHB; PCRP-RUNX1-3D7
DR   Wikidata; Q54939804
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q01196; Human RUNX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RUNX2-1B7
AC   CVCL_KK33
DR   DSHB; PCRP-RUNX2-1B7
DR   Wikidata; Q54939805
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13950; Human RUNX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RUNX2-1B9
AC   CVCL_KK34
DR   DSHB; PCRP-RUNX2-1B9
DR   Wikidata; Q54939806
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13950; Human RUNX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RUVBL1-1A1
AC   CVCL_KK35
DR   DSHB; PCRP-RUVBL1-1A1
DR   Wikidata; Q54939807
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y265; Human RUVBL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RXRA-2A8
AC   CVCL_KK36
DR   DSHB; PCRP-RXRA-2A8
DR   Wikidata; Q54939808
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19793; Human RXRA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RXRB-2B6
AC   CVCL_KK37
DR   DSHB; PCRP-RXRB-2B6
DR   Wikidata; Q54939809
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P28702; Human RXRB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RXRG-5C9
AC   CVCL_KK38
DR   DSHB; PCRP-RXRG-5C9
DR   Wikidata; Q54939810
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P48443; Human RXRG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RXRG-5G6
AC   CVCL_KK39
DR   DSHB; PCRP-RXRG-5G6
DR   Wikidata; Q54939811
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P48443; Human RXRG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-RXRG-5H4
AC   CVCL_KK40
DR   DSHB; PCRP-RXRG-5H4
DR   Wikidata; Q54939812
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P48443; Human RXRG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SAMD4B-1H3
AC   CVCL_KK41
DR   DSHB; PCRP-SAMD4B-1H3
DR   Wikidata; Q54939813
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q5PRF9; Human SAMD4B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SAMD4B-2A6
AC   CVCL_KK42
DR   DSHB; PCRP-SAMD4B-2A6
DR   Wikidata; Q54939814
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q5PRF9; Human SAMD4B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SATB1-1D8
AC   CVCL_KK43
DR   DSHB; PCRP-SATB1-1D8
DR   Wikidata; Q54939815
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01826; Human SATB1.
CC   Discontinued: DSHB; PCRP-SATB1-1D8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-SATB1-3B6
AC   CVCL_KK44
DR   DSHB; PCRP-SATB1-3B6
DR   Wikidata; Q54939816
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01826; Human SATB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SATB1-3C2
AC   CVCL_KK45
DR   DSHB; PCRP-SATB1-3C2
DR   Wikidata; Q54939817
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01826; Human SATB1.
CC   Discontinued: DSHB; PCRP-SATB1-3C2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-SATB1-3E9
AC   CVCL_KK46
DR   DSHB; PCRP-SATB1-3E9
DR   Wikidata; Q54939818
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01826; Human SATB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SATB1-3H2
AC   CVCL_KK47
DR   DSHB; PCRP-SATB1-3H2
DR   Wikidata; Q54939819
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01826; Human SATB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SATB1-4H8
AC   CVCL_KK48
DR   DSHB; PCRP-SATB1-4H8
DR   Wikidata; Q54939820
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q01826; Human SATB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCAND1-1D12
AC   CVCL_KK49
DR   DSHB; PCRP-SCAND1-1D12
DR   Wikidata; Q54939821
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P57086; Human SCAND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCAND1-3D11
AC   CVCL_KK50
DR   DSHB; PCRP-SCAND1-3D11
DR   Wikidata; Q54939822
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P57086; Human SCAND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCAND1-3E7
AC   CVCL_KK51
DR   DSHB; PCRP-SCAND1-3E7
DR   Wikidata; Q54939823
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P57086; Human SCAND1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCAND3-1B7
AC   CVCL_KK52
DR   DSHB; PCRP-SCAND3-1B7
DR   Wikidata; Q54939824
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6R2W3; Human SCAND3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCAND3-1C2
AC   CVCL_KK53
DR   DSHB; PCRP-SCAND3-1C2
DR   Wikidata; Q54939825
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6R2W3; Human SCAND3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCAND3-1D9
AC   CVCL_KK54
DR   DSHB; PCRP-SCAND3-1D9
DR   Wikidata; Q54939826
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6R2W3; Human SCAND3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCML2-1D12
AC   CVCL_KK55
DR   DSHB; PCRP-SCML2-1D12
DR   Wikidata; Q54939827
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9UQR0; Human SCML2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCML4-1D6
AC   CVCL_KK56
DR   DSHB; PCRP-SCML4-1D6
DR   Wikidata; Q54939828
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N228; Human SCML4.
CC   Discontinued: DSHB; PCRP-SCML4-1D6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-SCML4-1F9
AC   CVCL_KK57
DR   DSHB; PCRP-SCML4-1F9
DR   Wikidata; Q54939829
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N228; Human SCML4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCRT1-1A11
AC   CVCL_KK58
DR   DSHB; PCRP-SCRT1-1A11
DR   Wikidata; Q54939830
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BWW7; Human SCRT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCRT1-1B1
AC   CVCL_KK59
DR   DSHB; PCRP-SCRT1-1B1
DR   Wikidata; Q54939831
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BWW7; Human SCRT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCXA-1D2
AC   CVCL_KK60
DR   DSHB; PCRP-SCXA-1D2
DR   Wikidata; Q54939832
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7RTU7; Human SCX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SCXA-2D11
AC   CVCL_KK61
DR   DSHB; PCRP-SCXA-2D11
DR   Wikidata; Q54939834
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q7RTU7; Human SCX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SET-1C6
AC   CVCL_KK62
DR   DSHB; PCRP-SET-1C6
DR   Wikidata; Q54939835
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01105; Human SET.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SETD6-1E8
AC   CVCL_KK63
DR   DSHB; PCRP-SETD6-1E8
DR   Wikidata; Q54939836
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TBK2; Human SETD6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SFMBT1-2C1
AC   CVCL_KK64
DR   DSHB; PCRP-SFMBT1-2C1
DR   Wikidata; Q54939837
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UHJ3; Human SFMBT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SFMBT2-1B7
AC   CVCL_KK65
DR   DSHB; PCRP-SFMBT2-1B7
DR   Wikidata; Q54939838
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q5VUG0; Human SFMBT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SFMBT2-2E1
AC   CVCL_KK66
DR   DSHB; PCRP-SFMBT2-2E1
DR   Wikidata; Q54939845
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q5VUG0; Human SFMBT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SFMBT2-2E12
AC   CVCL_KK67
DR   Wikidata; Q54939846
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5VUG0; Human SFMBT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-SHARPIN-1A5
AC   CVCL_KK68
DR   DSHB; PCRP-SHARPIN-1A5
DR   Wikidata; Q54939847
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H0F6; Human SHARPIN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SHARPIN-1A8
AC   CVCL_KK69
DR   DSHB; PCRP-SHARPIN-1A8
DR   Wikidata; Q54939848
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H0F6; Human SHARPIN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SHOX-1A8
AC   CVCL_KK70
DR   DSHB; PCRP-SHOX-1A8
DR   Wikidata; Q54939849
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15266; Human SHOX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIN3B-1A9
AC   CVCL_KK71
DR   DSHB; PCRP-SIN3B-1A9
DR   Wikidata; Q54939850
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75182; Human SIN3B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIRT1-1E11
AC   CVCL_KK72
DR   DSHB; PCRP-SIRT1-1E11
DR   Wikidata; Q54939851
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96EB6; Human SIRT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIRT1-1F6
AC   CVCL_KK73
DR   DSHB; PCRP-SIRT1-1F6
DR   Wikidata; Q54939852
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96EB6; Human SIRT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIRT2-1A2
AC   CVCL_KK74
DR   DSHB; PCRP-SIRT2-1A2
DR   Wikidata; Q54939853
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IXJ6; Human SIRT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIRT2-1A8
AC   CVCL_KK75
DR   DSHB; PCRP-SIRT2-1A8
DR   Wikidata; Q54939855
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IXJ6; Human SIRT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIRT3-1C10
AC   CVCL_KK76
DR   DSHB; PCRP-SIRT3-1C10
DR   Wikidata; Q54939856
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9NTG7; Human SIRT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIRT5-1D4
AC   CVCL_KK77
DR   DSHB; PCRP-SIRT5-1D4
DR   Wikidata; Q54939857
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NXA8; Human SIRT5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIRT6-1E2
AC   CVCL_KK78
DR   DSHB; PCRP-SIRT6-1E2
DR   Wikidata; Q54939858
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N6T7; Human SIRT6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIX5-2B11
AC   CVCL_KK79
DR   DSHB; PCRP-SIX5-2B11
DR   Wikidata; Q54939859
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SIX5-2H4
AC   CVCL_KK80
DR   DSHB; PCRP-SIX5-2H4
DR   Wikidata; Q54939860
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SKIL-1D1
AC   CVCL_KK81
DR   DSHB; PCRP-SKIL-1D1
DR   Wikidata; Q54939861
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P12757; Human SKIL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SLC25A24-3G2
AC   CVCL_KK82
DR   DSHB; PCRP-SLC25A24-3G2
DR   Wikidata; Q54939862
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6NUK1; Human SLC25A24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SLC30A9-1C3
AC   CVCL_KK83
DR   DSHB; PCRP-SLC30A9-1C3
DR   Wikidata; Q54939863
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6PML9; Human SLC30A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD1-1B12
AC   CVCL_KK84
DR   DSHB; PCRP-SMAD1-1B12
DR   Wikidata; Q54939864
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15797; Human SMAD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD1-1B4
AC   CVCL_KK85
DR   DSHB; PCRP-SMAD1-1B4
DR   Wikidata; Q54939865
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15797; Human SMAD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD2-1B10
AC   CVCL_KK86
DR   DSHB; PCRP-SMAD2-1B10
DR   Wikidata; Q54939866
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q15796; Human SMAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD2-1C12
AC   CVCL_KK87
DR   DSHB; PCRP-SMAD2-1C12
DR   Wikidata; Q54939867
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15796; Human SMAD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD3-1A2
AC   CVCL_KK88
DR   DSHB; PCRP-SMAD3-1A2
DR   Wikidata; Q54939868
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P84022; Human SMAD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD4-1C10
AC   CVCL_KK89
DR   DSHB; PCRP-SMAD4-1C10
DR   Wikidata; Q54939869
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD4-1D12
AC   CVCL_KK90
DR   DSHB; PCRP-SMAD4-1D12
DR   Wikidata; Q54939870
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD4-1D3
AC   CVCL_KK91
DR   DSHB; PCRP-SMAD4-1D3
DR   Wikidata; Q54939871
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD4-1G11
AC   CVCL_KK92
DR   DSHB; PCRP-SMAD4-1G11
DR   Wikidata; Q54939872
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
CC   Discontinued: DSHB; PCRP-SMAD4-1G11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-SMAD4-1G12
AC   CVCL_KK93
DR   DSHB; PCRP-SMAD4-1G12
DR   Wikidata; Q54939873
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
CC   Discontinued: DSHB; PCRP-SMAD4-1G12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-SMAD4-1H2
AC   CVCL_KK94
DR   Wikidata; Q54939874
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-SMAD4-2A5
AC   CVCL_KK95
DR   Wikidata; Q54939875
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-SMAD4-2B3
AC   CVCL_KK96
DR   Wikidata; Q54939876
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-SMAD4-2D1
AC   CVCL_KK97
DR   DSHB; PCRP-SMAD4-2D1
DR   Wikidata; Q54939877
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13485; Human SMAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD7-1D7
AC   CVCL_KK98
DR   DSHB; PCRP-SMAD7-1D7
DR   Wikidata; Q54939879
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15105; Human SMAD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMAD9-2F4
AC   CVCL_KK99
DR   DSHB; PCRP-SMAD9-2F4
DR   Wikidata; Q54939880
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15198; Human SMAD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCAL1-1C4
AC   CVCL_KL00
DR   DSHB; PCRP-SMARCAL1-1C4
DR   Wikidata; Q54939881
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZC9; Human SMARCAL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCAL1-1G2
AC   CVCL_KL01
DR   DSHB; PCRP-SMARCAL1-1G2
DR   Wikidata; Q54939882
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZC9; Human SMARCAL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCAL1-1G7
AC   CVCL_KL02
DR   DSHB; PCRP-SMARCAL1-1G7
DR   Wikidata; Q54939883
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NZC9; Human SMARCAL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCB1-2C4
AC   CVCL_KL03
DR   DSHB; PCRP-SMARCB1-2C4
DR   Wikidata; Q54939885
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q12824; Human SMARCB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCC1-1F1
AC   CVCL_KL04
DR   DSHB; PCRP-SMARCC1-1F1
DR   Wikidata; Q54939886
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92922; Human SMARCC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCC2-1A3
AC   CVCL_KL05
DR   DSHB; PCRP-SMARCC2-1A3
DR   Wikidata; Q54939887
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TAQ2; Human SMARCC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCC2-7B6
AC   CVCL_KL06
DR   DSHB; PCRP-SMARCC2-7B6
DR   Wikidata; Q54939896
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TAQ2; Human SMARCC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCD1-2B3
AC   CVCL_KL07
DR   DSHB; PCRP-SMARCD1-2B3
DR   Wikidata; Q54939897
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q96GM5; Human SMARCD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCD1-2B5
AC   CVCL_KL08
DR   DSHB; PCRP-SMARCD1-2B5
DR   Wikidata; Q54939898
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96GM5; Human SMARCD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCE1-1G7
AC   CVCL_KL09
DR   DSHB; PCRP-SMARCE1-1G7
DR   Wikidata; Q54939899
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q969G3; Human SMARCE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCE1-2E9
AC   CVCL_KL10
DR   DSHB; PCRP-SMARCE1-2E9
DR   Wikidata; Q54939900
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q969G3; Human SMARCE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMARCE1-2F1
AC   CVCL_KL11
DR   DSHB; PCRP-SMARCE1-2F1
DR   Wikidata; Q54939901
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q969G3; Human SMARCE1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMNDC1-1A9
AC   CVCL_KL12
DR   DSHB; PCRP-SMNDC1-1A9
DR   Wikidata; Q54939902
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75940; Human SMNDC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMNDC1-2E7
AC   CVCL_KL13
DR   DSHB; PCRP-SMNDC1-2E7
DR   Wikidata; Q54939903
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75940; Human SMNDC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMURF1-1A10
AC   CVCL_KL14
DR   DSHB; PCRP-SMURF1-1A10
DR   Wikidata; Q54939904
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9HCE7; Human SMURF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SMURF1-1E8
AC   CVCL_KL15
DR   DSHB; PCRP-SMURF1-1E8
DR   Wikidata; Q54939905
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HCE7; Human SMURF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SNAI3-1G2
AC   CVCL_KL16
DR   DSHB; PCRP-SNAI3-1G2
DR   Wikidata; Q54939906
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q3KNW1; Human SNAI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SNAI3-2D12
AC   CVCL_KL17
DR   Wikidata; Q54939908
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q3KNW1; Human SNAI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-SNAPC4-1G11
AC   CVCL_KL18
DR   DSHB; PCRP-SNAPC4-1G11
DR   Wikidata; Q54939909
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5SXM2; Human SNAPC4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SNAPC4-3A7
AC   CVCL_KL19
DR   DSHB; PCRP-SNAPC4-3A7
DR   Wikidata; Q54939910
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5SXM2; Human SNAPC4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SNW1-1C12
AC   CVCL_KL20
DR   DSHB; PCRP-SNW1-1C12
DR   Wikidata; Q54939911
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13573; Human SNW1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SNW1-2A1
AC   CVCL_KL21
DR   DSHB; PCRP-SNW1-2A1
DR   Wikidata; Q54939912
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13573; Human SNW1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOHLH1-2B1
AC   CVCL_KL22
DR   DSHB; PCRP-SOHLH1-2B1
DR   Wikidata; Q54939913
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5JUK2; Human SOHLH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOHLH1-2D12
AC   CVCL_KL23
DR   DSHB; PCRP-SOHLH1-2D12
DR   Wikidata; Q54939914
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5JUK2; Human SOHLH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX10-1D8
AC   CVCL_KL24
DR   DSHB; PCRP-SOX10-1D8
DR   Wikidata; Q54939916
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P56693; Human SOX10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX12-1C4
AC   CVCL_KL25
DR   DSHB; PCRP-SOX12-1C4
DR   Wikidata; Q54939917
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15370; Human SOX12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX12-1E4
AC   CVCL_KL26
DR   DSHB; PCRP-SOX12-1E4
DR   Wikidata; Q54939918
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15370; Human SOX12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX13-1C4
AC   CVCL_KL27
DR   DSHB; PCRP-SOX13-1C4
DR   Wikidata; Q54939919
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UN79; Human SOX13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX2-1B3
AC   CVCL_KL28
DR   DSHB; PCRP-SOX2-1B3
DR   Wikidata; Q54939920
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P48431; Human SOX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX3-1A1
AC   CVCL_KL29
DR   DSHB; PCRP-SOX3-1A1
DR   Wikidata; Q54939921
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P41225; Human SOX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX4-1D6
AC   CVCL_KL30
DR   DSHB; PCRP-SOX4-1D6
DR   Wikidata; Q54939922
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q06945; Human SOX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX4-1F1
AC   CVCL_KL31
DR   DSHB; PCRP-SOX4-1F1
DR   Wikidata; Q54939923
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q06945; Human SOX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX4-3B5
AC   CVCL_KL32
DR   DSHB; PCRP-SOX4-3B5
DR   Wikidata; Q54939924
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q06945; Human SOX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX4-3F12
AC   CVCL_KL33
DR   DSHB; PCRP-SOX4-3F12
DR   Wikidata; Q54939925
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q06945; Human SOX4.
CC   Discontinued: DSHB; PCRP-SOX4-3F12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-SOX5-1C12
AC   CVCL_KL34
DR   DSHB; PCRP-SOX5-1C12
DR   Wikidata; Q54939926
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35711; Human SOX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX5-1E3
AC   CVCL_KL35
DR   DSHB; PCRP-SOX5-1E3
DR   Wikidata; Q54939927
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35711; Human SOX5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX8-2B9
AC   CVCL_KL36
DR   DSHB; PCRP-SOX8-2B9
DR   Wikidata; Q54939928
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P57073; Human SOX8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX8-2C6
AC   CVCL_KL37
DR   Wikidata; Q54939929
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P57073; Human SOX8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-SOX8-2D11
AC   CVCL_KL38
DR   DSHB; PCRP-SOX8-2D11
DR   Wikidata; Q54939930
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P57073; Human SOX8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX9-1A2
AC   CVCL_KL39
DR   DSHB; PCRP-SOX9-1A2
DR   Wikidata; Q54939931
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P48436; Human SOX9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SOX9-1E5
AC   CVCL_KL40
DR   DSHB; PCRP-SOX9-1E5
DR   Wikidata; Q54939932
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P48436; Human SOX9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SP100-1B9
AC   CVCL_KL41
DR   DSHB; PCRP-SP100-1B9
DR   Wikidata; Q54939933
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P23497; Human SP100.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SP110-1C5
AC   CVCL_KL42
DR   DSHB; PCRP-SP110-1C5
DR   Wikidata; Q54939934
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9HB58; Human SP110.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SP110-1D9
AC   CVCL_KL43
DR   DSHB; PCRP-SP110-1D9
DR   Wikidata; Q54939935
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HB58; Human SP110.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SP140-1G12
AC   CVCL_KL44
DR   DSHB; PCRP-SP140-1G12
DR   Wikidata; Q54939936
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13342; Human SP140.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SP140-3G1
AC   CVCL_KL45
DR   DSHB; PCRP-SP140-3G1
DR   Wikidata; Q54939937
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13342; Human SP140.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SP140L-2A10
AC   CVCL_KL46
DR   DSHB; PCRP-SP140L-2A10
DR   Wikidata; Q54946049
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H930; Human SP140L.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SP5-2A5
AC   CVCL_KL47
DR   DSHB; PCRP-SP5-2A5
DR   Wikidata; Q54946050
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6BEB4; Human SP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SPIC-1F10
AC   CVCL_KL48
DR   DSHB; PCRP-SPIC-1F10
DR   Wikidata; Q54946051
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N5J4; Human SPIC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SPIC-2C11
AC   CVCL_KL49
DR   DSHB; PCRP-SPIC-2C11
DR   Wikidata; Q54946052
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N5J4; Human SPIC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SPIC-2C5
AC   CVCL_KL50
DR   DSHB; PCRP-SPIC-2C5
DR   Wikidata; Q54946053
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N5J4; Human SPIC.
CC   Discontinued: DSHB; PCRP-SPIC-2C5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-SRF-1F1
AC   CVCL_KL51
DR   DSHB; PCRP-SRF-1F1
DR   Wikidata; Q54946054
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11831; Human SRF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SRF-1F7
AC   CVCL_KL52
DR   DSHB; PCRP-SRF-1F7
DR   Wikidata; Q54946055
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P11831; Human SRF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SRRT-1F5
AC   CVCL_KL53
DR   DSHB; PCRP-SRRT-1F5
DR   Wikidata; Q54946056
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BXP5; Human SRRT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SRY-1D10
AC   CVCL_KL54
DR   DSHB; PCRP-SRY-1D10
DR   Wikidata; Q54946057
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q05066; Human SRY.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SRY-1D7
AC   CVCL_KL55
DR   DSHB; PCRP-SRY-1D7
DR   Wikidata; Q54946059
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q05066; Human SRY.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SRY-2C6
AC   CVCL_KL56
DR   DSHB; PCRP-SRY-2C6
DR   Wikidata; Q54946060
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q05066; Human SRY.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SSBP4-3B5
AC   CVCL_KL57
DR   DSHB; PCRP-SSBP4-3B5
DR   Wikidata; Q54946061
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BWG4; Human SSBP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SSBP4-3D5
AC   CVCL_KL58
DR   DSHB; PCRP-SSBP4-3D5
DR   Wikidata; Q54946062
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BWG4; Human SSBP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SSBP4-4G8
AC   CVCL_KL59
DR   DSHB; PCRP-SSBP4-4G8
DR   Wikidata; Q54946063
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BWG4; Human SSBP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT1-1G5
AC   CVCL_KL60
DR   Wikidata; Q54946064
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P42224; Human STAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-STAT1-3D6
AC   CVCL_KL61
DR   DSHB; PCRP-STAT1-3D6
DR   Wikidata; Q54946065
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P42224; Human STAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT1-4H11
AC   CVCL_KL62
DR   DSHB; PCRP-STAT1-4H11
DR   Wikidata; Q54946066
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P42224; Human STAT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT2-1B3
AC   CVCL_KL63
DR   Wikidata; Q54946067
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52630; Human STAT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-STAT2-1B6
AC   CVCL_KL64
DR   Wikidata; Q54946068
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P52630; Human STAT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-STAT2-1E5
AC   CVCL_KL65
DR   DSHB; PCRP-STAT2-1E5
DR   Wikidata; Q54946069
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52630; Human STAT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT2-1G7
AC   CVCL_KL66
DR   Wikidata; Q54946071
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52630; Human STAT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-STAT2-1H10
AC   CVCL_KL67
DR   DSHB; PCRP-STAT2-1H10
DR   Wikidata; Q54946072
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52630; Human STAT2.
CC   Discontinued: DSHB; PCRP-STAT2-1H10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-STAT2-2B9
AC   CVCL_KL68
DR   DSHB; PCRP-STAT2-2B9
DR   Wikidata; Q54946073
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52630; Human STAT2.
CC   Discontinued: DSHB; PCRP-STAT2-2B9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-STAT3-2E3
AC   CVCL_KL69
DR   DSHB; PCRP-STAT3-2E3
DR   Wikidata; Q54946074
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P40763; Human STAT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT3-2F12
AC   CVCL_KL70
DR   DSHB; PCRP-STAT3-2F12
DR   Wikidata; Q54946075
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P40763; Human STAT3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT4-2A2
AC   CVCL_KL71
DR   DSHB; PCRP-STAT4-2A2
DR   Wikidata; Q54946076
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14765; Human STAT4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT5A-1A11
AC   CVCL_KL72
DR   DSHB; PCRP-STAT5A-1A11
DR   Wikidata; Q54946077
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P42229; Human STAT5A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT5A-1A9
AC   CVCL_KL73
DR   DSHB; PCRP-STAT5A-1A9
DR   Wikidata; Q54946078
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P42229; Human STAT5A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT5B-1B10
AC   CVCL_KL74
DR   DSHB; PCRP-STAT5B-1B10
DR   Wikidata; Q54946079
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P51692; Human STAT5B.
CC   Discontinued: DSHB; PCRP-STAT5B-1B10; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-STAT5B-1B5
AC   CVCL_KL75
DR   DSHB; PCRP-STAT5B-1B5
DR   Wikidata; Q54946080
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P51692; Human STAT5B.
CC   Discontinued: DSHB; PCRP-STAT5B-1B5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-STAT5B-1H5
AC   CVCL_KL76
DR   DSHB; PCRP-STAT5B-1H5
DR   Wikidata; Q54946081
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P51692; Human STAT5B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT5B-3E9
AC   CVCL_KL77
DR   DSHB; PCRP-STAT5B-3E9
DR   Wikidata; Q54946082
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51692; Human STAT5B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-STAT6-1C6
AC   CVCL_KL78
DR   DSHB; PCRP-STAT6-1C6
DR   Wikidata; Q54946083
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P42226; Human STAT6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-SYAP1-2B8
AC   CVCL_KL79
DR   DSHB; PCRP-SYAP1-2B8
DR   Wikidata; Q54946084
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96A49; Human SYAP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-T-1A2
AC   CVCL_KL80
DR   DSHB; PCRP-T-1A2
DR   Wikidata; Q54946085
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O15178; Human T.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-T-1A5
AC   CVCL_KL81
DR   DSHB; PCRP-T-1A5
DR   Wikidata; Q54946086
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O15178; Human T.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TADA1-1C9
AC   CVCL_KL82
DR   DSHB; PCRP-TADA1-1C9
DR   Wikidata; Q54946087
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96BN2; Human TADA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TADA2A-3C4
AC   CVCL_KL83
DR   DSHB; PCRP-TADA2A-3C4
DR   Wikidata; Q54946088
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; O75478; Human TADA2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TADA2B-1.1A3
AC   CVCL_KL84
DR   DSHB; PCRP-TADA2B-1.1A3
DR   Wikidata; Q54946089
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86TJ2; Human TADA2B.
CC   Discontinued: DSHB; PCRP-TADA2B-1.1A3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-TADA3-1F3
AC   CVCL_KL85
DR   DSHB; PCRP-TADA3-1F3
DR   Wikidata; Q54946090
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75528; Human TADA3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TAF10-1A10
AC   CVCL_KL86
DR   DSHB; PCRP-TAF10-1A10
DR   Wikidata; Q54946104
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q12962; Human TAF10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TAF10-1A2
AC   CVCL_KL87
DR   DSHB; PCRP-TAF10-1A2
DR   Wikidata; Q54946105
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q12962; Human TAF10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TARBP2-1B9
AC   CVCL_KL88
DR   DSHB; PCRP-TARBP2-1B9
DR   Wikidata; Q54946107
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15633; Human TARBP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TARBP2-1E5
AC   CVCL_KL89
DR   Wikidata; Q54946108
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15633; Human TARBP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-TAX1BP1-1D4
AC   CVCL_KL90
DR   DSHB; PCRP-TAX1BP1-1D4
DR   Wikidata; Q54946109
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86VP1; Human TAX1BP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TAX1BP1-1D8
AC   CVCL_KL91
DR   DSHB; PCRP-TAX1BP1-1D8
DR   Wikidata; Q54946111
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86VP1; Human TAX1BP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TBC1D23-2E4
AC   CVCL_KL92
DR   DSHB; PCRP-TBC1D23-2E4
DR   Wikidata; Q54946112
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NUY8; Human TBC1D23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TBL1X-2C3
AC   CVCL_KL93
DR   DSHB; PCRP-TBL1X-2C3
DR   Wikidata; Q54946113
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60907; Human TBL1X.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TBX19-1B5
AC   CVCL_KL94
DR   DSHB; PCRP-TBX19-1B5
DR   Wikidata; Q54946114
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60806; Human TBX19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TBX19-2A12
AC   CVCL_KL95
DR   DSHB; PCRP-TBX19-2A12
DR   Wikidata; Q54946115
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60806; Human TBX19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TBX19-2B2
AC   CVCL_KL96
DR   DSHB; PCRP-TBX19-2B2
DR   Wikidata; Q54946116
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60806; Human TBX19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TBX4-1B11
AC   CVCL_KL97
DR   DSHB; PCRP-TBX4-1B11
DR   Wikidata; Q54946118
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P57082; Human TBX4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TCEAL8-1C4
AC   CVCL_KL98
DR   DSHB; PCRP-TCEAL8-1C4
DR   Wikidata; Q54946120
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IYN2; Human TCEAL8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TCF24-1D6
AC   CVCL_KL99
DR   DSHB; PCRP-TCF24-1D6
DR   Wikidata; Q54946121
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7RTU0; Human TCF24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TCF24-2E11
AC   CVCL_KM00
DR   Wikidata; Q54946123
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7RTU0; Human TCF24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-TCF25-1A11
AC   CVCL_KM01
DR   DSHB; PCRP-TCF25-1A11
DR   Wikidata; Q54946124
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BQ70; Human TCF25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TCF25-1A9
AC   CVCL_KM02
DR   Wikidata; Q54946125
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BQ70; Human TCF25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-TCF25-1F12
AC   CVCL_KM03
DR   DSHB; PCRP-TCF25-1F12
DR   Wikidata; Q54946126
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BQ70; Human TCF25.
CC   Discontinued: DSHB; PCRP-TCF25-1F12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-TCF7L1-1A6
AC   CVCL_KM04
DR   DSHB; PCRP-TCF7L1-1A6
DR   Wikidata; Q54946127
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9HCS4; Human TCF7L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TCF7L1-1A9
AC   CVCL_KM05
DR   DSHB; PCRP-TCF7L1-1A9
DR   Wikidata; Q54946128
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HCS4; Human TCF7L1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TDRKH-1H2
AC   CVCL_KM06
DR   DSHB; PCRP-TDRKH-1H2
DR   Wikidata; Q54946130
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y2W6; Human TDRKH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TEAD3-1A4
AC   CVCL_KM07
DR   DSHB; PCRP-TEAD3-1A4
DR   Wikidata; Q54946131
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q99594; Human TEAD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TEAD4-1G7
AC   CVCL_KM08
DR   DSHB; PCRP-TEAD4-1G7
DR   Wikidata; Q54946132
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15561; Human TEAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TEAD4-2F4
AC   CVCL_KM09
DR   DSHB; PCRP-TEAD4-2F4
DR   Wikidata; Q54946133
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15561; Human TEAD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TERF1-1E5
AC   CVCL_KM10
DR   DSHB; PCRP-TERF1-1E5
DR   Wikidata; Q54946135
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P54274; Human TERF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TERF2-1G5
AC   CVCL_KM11
DR   DSHB; PCRP-TERF2-1G5
DR   Wikidata; Q54946136
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15554; Human TERF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TERF2IP-1B6
AC   CVCL_KM12
DR   DSHB; PCRP-TERF2IP-1B6
DR   Wikidata; Q54946138
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NYB0; Human TERF2IP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2A-1C6
AC   CVCL_KM13
DR   DSHB; PCRP-TFAP2A-1C6
DR   Wikidata; Q54946139
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05549; Human TFAP2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2A-2C2
AC   CVCL_KM14
DR   DSHB; PCRP-TFAP2A-2C2
DR   Wikidata; Q54946140
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05549; Human TFAP2A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2B-2A4
AC   CVCL_KM15
DR   DSHB; PCRP-TFAP2B-2A4
DR   Wikidata; Q54946141
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q92481; Human TFAP2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2B-2E1
AC   CVCL_KM16
DR   DSHB; PCRP-TFAP2B-2E1
DR   Wikidata; Q54946142
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92481; Human TFAP2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2C-1A7
AC   CVCL_KM17
DR   DSHB; PCRP-TFAP2C-1A7
DR   Wikidata; Q54946143
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92754; Human TFAP2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2C-1B9
AC   CVCL_KM18
DR   DSHB; PCRP-TFAP2C-1B9
DR   Wikidata; Q54946144
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q92754; Human TFAP2C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2D-1A11
AC   CVCL_KM19
DR   DSHB; PCRP-TFAP2D-1A11
DR   Wikidata; Q54946145
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z6R9; Human TFAP2D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFAP2D-1A12
AC   CVCL_KM20
DR   DSHB; PCRP-TFAP2D-1A12
DR   Wikidata; Q54946146
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z6R9; Human TFAP2D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TFCP2-3B1
AC   CVCL_KM21
DR   DSHB; PCRP-TFCP2-3B1
DR   Wikidata; Q54946147
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q12800; Human TFCP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TGIF1-2G6
AC   CVCL_KM22
DR   DSHB; PCRP-TGIF1-2G6
DR   Wikidata; Q54946148
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15583; Human TGIF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TGIF2LX-1H4
AC   CVCL_KM23
DR   DSHB; PCRP-TGIF2LX-1H4
DR   Wikidata; Q54946150
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IUE1; Human TGIF2LX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP10-2B9
AC   CVCL_KM24
DR   DSHB; PCRP-THAP10-2B9
DR   Wikidata; Q54946151
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P2Z0; Human THAP10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP10-3A9
AC   CVCL_KM25
DR   DSHB; PCRP-THAP10-3A9
DR   Wikidata; Q54946152
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P2Z0; Human THAP10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP4-1A7
AC   CVCL_KM26
DR   DSHB; PCRP-THAP4-1A7
DR   Wikidata; Q54946169
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WY91; Human THAP4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP5-2B7
AC   CVCL_KM27
DR   DSHB; PCRP-THAP5-2B7
DR   Wikidata; Q54946170
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z6K1; Human THAP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP5-2D4
AC   CVCL_KM28
DR   DSHB; PCRP-THAP5-2D4
DR   Wikidata; Q54946171
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z6K1; Human THAP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP7-3H4
AC   CVCL_KM29
DR   DSHB; PCRP-THAP7-3H4
DR   Wikidata; Q54946172
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BT49; Human THAP7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP9-1A10
AC   CVCL_KM30
DR   DSHB; PCRP-THAP9-1A10
DR   Wikidata; Q54946173
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H5L6; Human THAP9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP9-1A12
AC   CVCL_KM31
DR   DSHB; PCRP-THAP9-1A12
DR   Wikidata; Q54946174
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H5L6; Human THAP9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP9-1B7
AC   CVCL_KM32
DR   DSHB; PCRP-THAP9-1B7
DR   Wikidata; Q54946175
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9H5L6; Human THAP9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THAP9-2B3
AC   CVCL_KM33
DR   DSHB; PCRP-THAP9-2B3
DR   Wikidata; Q54946176
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H5L6; Human THAP9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THRA-1F10
AC   CVCL_KM34
DR   DSHB; PCRP-THRA-1F10
DR   Wikidata; Q54946177
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P10827; Human THRA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-THRB-1A6
AC   CVCL_KM35
DR   DSHB; PCRP-THRB-1A6
DR   Wikidata; Q54946178
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10828; Human THRB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TOX3-1A5
AC   CVCL_KM36
DR   DSHB; PCRP-TOX3-1A5
DR   Wikidata; Q54946180
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15405; Human TOX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TOX3-1A6
AC   CVCL_KM37
DR   DSHB; PCRP-TOX3-1A6
DR   Wikidata; Q54946181
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15405; Human TOX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TOX3-1C7
AC   CVCL_KM38
DR   DSHB; PCRP-TOX3-1C7
DR   Wikidata; Q54946182
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15405; Human TOX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TP53-1D9
AC   CVCL_KM39
DR   DSHB; PCRP-TP53-1D9
DR   Wikidata; Q54946184
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TP53-1F7
AC   CVCL_KM40
DR   DSHB; PCRP-TP53-1F7
DR   Wikidata; Q54946185
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TP53-2A10
AC   CVCL_KM41
DR   DSHB; PCRP-TP53-2A10
DR   Wikidata; Q54946187
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TP73-1A8
AC   CVCL_KM42
DR   DSHB; PCRP-TP73-1A8
DR   Wikidata; Q54946188
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15350; Human TP73.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TRDMT1-1E8
AC   CVCL_KM43
DR   DSHB; PCRP-TRDMT1-1E8
DR   Wikidata; Q54946189
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14717; Human TRDMT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TRIM24-1B12
AC   CVCL_KM44
DR   DSHB; PCRP-TRIM24-1B12
DR   Wikidata; Q54946190
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15164; Human TRIM24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TRIM27-1B3
AC   CVCL_KM45
DR   DSHB; PCRP-TRIM27-1B3
DR   Wikidata; Q54946191
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P14373; Human TRIM27.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TRIM28-2G5
AC   CVCL_KM46
DR   DSHB; PCRP-TRIM28-2G5
DR   Wikidata; Q54946192
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q13263; Human TRIM28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TRIM28-2G8
AC   CVCL_KM47
DR   DSHB; PCRP-TRIM28-2G8
DR   Wikidata; Q54946193
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q13263; Human TRIM28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TSC22D1-1A2
AC   CVCL_KM48
DR   DSHB; PCRP-TSC22D1-1A2
DR   Wikidata; Q54946194
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15714; Human TSC22D1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TSC22D3-1G10
AC   CVCL_KM49
DR   DSHB; PCRP-TSC22D3-1G10
DR   Wikidata; Q54946195
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q99576; Human TSC22D3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TSC22D4-1C11
AC   CVCL_KM50
DR   DSHB; PCRP-TSC22D4-1C11
DR   Wikidata; Q54946196
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y3Q8; Human TSC22D4.
CC   Discontinued: DSHB; PCRP-TSC22D4-1C11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-TSC22D4-2B11
AC   CVCL_KM51
DR   DSHB; PCRP-TSC22D4-2B11
DR   Wikidata; Q54946197
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y3Q8; Human TSC22D4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TSC22D4-3E10
AC   CVCL_KM52
DR   DSHB; PCRP-TSC22D4-3E10
DR   Wikidata; Q54946199
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y3Q8; Human TSC22D4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-TSC22D4-4A4
AC   CVCL_KM53
DR   DSHB; PCRP-TSC22D4-4A4
DR   Wikidata; Q54946200
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y3Q8; Human TSC22D4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-U2AF1-1A8
AC   CVCL_KM54
DR   DSHB; PCRP-U2AF1-1A8
DR   Wikidata; Q54946201
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q01081; Human U2AF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-UBE2B-1C7
AC   CVCL_KM55
DR   DSHB; PCRP-UBE2B-1C7
DR   Wikidata; Q54946202
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P63146; Human UBE2B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-UBE3A-1A10
AC   CVCL_KM56
DR   DSHB; PCRP-UBE3A-1A10
DR   Wikidata; Q54946203
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q05086; Human UBE3A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-UBE3A-1A2
AC   CVCL_KM57
DR   DSHB; PCRP-UBE3A-1A2
DR   Wikidata; Q54946204
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q05086; Human UBE3A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-UBP1-1G1
AC   CVCL_KM58
DR   DSHB; PCRP-UBP1-1G1
DR   Wikidata; Q54946205
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZI7; Human UBP1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-UBQLN2-1C7
AC   CVCL_KM59
DR   DSHB; PCRP-UBQLN2-1C7
DR   Wikidata; Q54946206
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UHD9; Human UBQLN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-UBR2-1D12
AC   CVCL_KM60
DR   DSHB; PCRP-UBR2-1D12
DR   Wikidata; Q54946207
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IWV8; Human UBR2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-USF1-1B8
AC   CVCL_KM61
DR   DSHB; PCRP-USF1-1B8
DR   Wikidata; Q54946209
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P22415; Human USF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-USF1-1C10
AC   CVCL_KM62
DR   DSHB; PCRP-USF1-1C10
DR   Wikidata; Q54946210
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P22415; Human USF1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-USF2-1A1
AC   CVCL_KM63
DR   DSHB; PCRP-USF2-1A1
DR   Wikidata; Q54946212
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q15853; Human USF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-USF2-1A11
AC   CVCL_KM64
DR   DSHB; PCRP-USF2-1A11
DR   Wikidata; Q54946213
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q15853; Human USF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-USF2-1A7
AC   CVCL_KM65
DR   DSHB; PCRP-USF2-1A7
DR   Wikidata; Q54946214
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15853; Human USF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-USP13-2H7
AC   CVCL_KM66
DR   DSHB; PCRP-USP13-2H7
DR   Wikidata; Q54946227
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q92995; Human USP13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-USP16-1B2
AC   CVCL_KM67
DR   DSHB; PCRP-USP16-1B2
DR   Wikidata; Q54946229
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y5T5; Human USP16.
CC   Discontinued: DSHB; PCRP-USP16-1B2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-USP7-1B6
AC   CVCL_KM68
DR   DSHB; PCRP-USP7-1B6
DR   Wikidata; Q54946230
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q93009; Human USP7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-VDR-1F11
AC   CVCL_KM69
DR   DSHB; PCRP-VDR-1F11
DR   Wikidata; Q54946231
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P11473; Human VDR.
CC   Discontinued: DSHB; PCRP-VDR-1F11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-VENTX-2A9
AC   CVCL_KM70
DR   DSHB; PCRP-VENTX-2A9
DR   Wikidata; Q54946232
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95231; Human VENTX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-VENTX-2B9
AC   CVCL_KM71
DR   DSHB; PCRP-VENTX-2B9
DR   Wikidata; Q54946233
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95231; Human VENTX.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-WDHD1-1A5
AC   CVCL_KM72
DR   DSHB; PCRP-WDHD1-1A5
DR   Wikidata; Q54946234
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75717; Human WDHD1.
CC   Discontinued: DSHB; PCRP-WDHD1-1A5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-WDHD1-1B10
AC   CVCL_KM73
DR   Wikidata; Q54946235
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75717; Human WDHD1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-WDR11-1B3
AC   CVCL_KM74
DR   DSHB; PCRP-WDR11-1B3
DR   Wikidata; Q54946236
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q9BZH6; Human WDR11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-WDR12-1C3
AC   CVCL_KM75
DR   DSHB; PCRP-WDR12-1C3
DR   Wikidata; Q54946237
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9GZL7; Human WDR12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-WDR5-1F5
AC   CVCL_KM76
DR   DSHB; PCRP-WDR5-1F5
DR   Wikidata; Q54946238
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P61964; Human WDR5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-WHSC1-2A1
AC   CVCL_KM77
DR   DSHB; PCRP-WHSC1-2A1
DR   Wikidata; Q54946239
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O96028; Human NSD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-WHSC1-2A11
AC   CVCL_KM78
DR   DSHB; PCRP-WHSC1-2A11
DR   Wikidata; Q54946241
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O96028; Human NSD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-WTAP-1A4
AC   CVCL_KM79
DR   DSHB; PCRP-WTAP-1A4
DR   Wikidata; Q54946243
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15007; Human WTAP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-WTAP-1B11
AC   CVCL_KM80
DR   DSHB; PCRP-WTAP-1B11
DR   Wikidata; Q54946244
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15007; Human WTAP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YBX1-1A8
AC   CVCL_KM81
DR   DSHB; PCRP-YBX1-1A8
DR   Wikidata; Q54946245
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P67809; Human YBX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YBX2-1C2
AC   CVCL_KM82
DR   DSHB; PCRP-YBX2-1C2
DR   Wikidata; Q54946246
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2T7; Human YBX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YBX2-1D8
AC   CVCL_KM83
DR   DSHB; PCRP-YBX2-1D8
DR   Wikidata; Q54946247
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9Y2T7; Human YBX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YBX3-1D8
AC   CVCL_KM84
DR   DSHB; PCRP-YBX3-1D8
DR   Wikidata; Q54946248
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16989; Human YBX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YBX3-2D12
AC   CVCL_KM85
DR   DSHB; PCRP-YBX3-2D12
DR   Wikidata; Q54946249
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16989; Human YBX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YEATS2-1B3
AC   CVCL_KM86
DR   DSHB; PCRP-YEATS2-1B3
DR   Wikidata; Q54946251
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9ULM3; Human YEATS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YEATS4-1C5
AC   CVCL_KM87
DR   Wikidata; Q54946252
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95619; Human YEATS4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-YEATS4-1D2
AC   CVCL_KM88
DR   DSHB; PCRP-YEATS4-1D2
DR   Wikidata; Q54946253
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95619; Human YEATS4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YY1-1A5
AC   CVCL_KM89
DR   DSHB; PCRP-YY1-1A5
DR   Wikidata; Q54946254
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P25490; Human YY1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YY1-1B2
AC   CVCL_KM90
DR   DSHB; PCRP-YY1-1B2
DR   Wikidata; Q54946255
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P25490; Human YY1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-YY2-1A8
AC   CVCL_KM91
DR   DSHB; PCRP-YY2-1A8
DR   Wikidata; Q54946256
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15391; Human YY2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBED1-1C8
AC   CVCL_KM92
DR   DSHB; PCRP-ZBED1-1C8
DR   Wikidata; Q54946257
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O96006; Human ZBED1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBED1-1D4
AC   CVCL_KM93
DR   DSHB; PCRP-ZBED1-1D4
DR   Wikidata; Q54946258
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O96006; Human ZBED1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBED1-1E1
AC   CVCL_KM94
DR   DSHB; PCRP-ZBED1-1E1
DR   Wikidata; Q54946259
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O96006; Human ZBED1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBED3-2D9
AC   CVCL_KM95
DR   DSHB; PCRP-ZBED3-2D9
DR   Wikidata; Q54946260
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q96IU2; Human ZBED3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB14-1B12
AC   CVCL_KM96
DR   DSHB; PCRP-ZBTB14-1B12
DR   Wikidata; Q54946262
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43829; Human ZBTB14.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB16-1B7
AC   CVCL_KM97
DR   DSHB; PCRP-ZBTB16-1B7
DR   Wikidata; Q54946263
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q05516; Human ZBTB16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB16-1D6
AC   CVCL_KM98
DR   DSHB; PCRP-ZBTB16-1D6
DR   Wikidata; Q54946264
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q05516; Human ZBTB16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB16-1F2
AC   CVCL_KM99
DR   DSHB; PCRP-ZBTB16-1F2
DR   Wikidata; Q54946266
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q05516; Human ZBTB16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB17-1D3
AC   CVCL_KN00
DR   DSHB; PCRP-ZBTB17-1D3
DR   Wikidata; Q54946267
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q13105; Human ZBTB17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB18-1B2
AC   CVCL_KN01
DR   DSHB; PCRP-ZBTB18-1B2
DR   Wikidata; Q54946268
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q99592; Human ZBTB18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB2-46F2
AC   CVCL_KN02
DR   DSHB; PCRP-ZBTB2-46F2
DR   Wikidata; Q54946269
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N680; Human ZBTB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB22-1A2
AC   CVCL_KN03
DR   DSHB; PCRP-ZBTB22-1A2
DR   Wikidata; Q54946270
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15209; Human ZBTB22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB22-1F7
AC   CVCL_KN04
DR   DSHB; PCRP-ZBTB22-1F7
DR   Wikidata; Q54946271
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15209; Human ZBTB22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB24-1E9
AC   CVCL_KN05
DR   DSHB; PCRP-ZBTB24-1E9
DR   Wikidata; Q54946272
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43167; Human ZBTB24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB25-1B10
AC   CVCL_KN06
DR   DSHB; PCRP-ZBTB25-1B10
DR   Wikidata; Q54946286
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P24278; Human ZBTB25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB25-1D12
AC   CVCL_KN07
DR   DSHB; PCRP-ZBTB25-1D12
DR   Wikidata; Q54946287
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P24278; Human ZBTB25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB3-2B2
AC   CVCL_KN08
DR   DSHB; PCRP-ZBTB3-2B2
DR   Wikidata; Q54946288
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H5J0; Human ZBTB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB3-2E10
AC   CVCL_KN09
DR   DSHB; PCRP-ZBTB3-2E10
DR   Wikidata; Q54946289
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H5J0; Human ZBTB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB3-2G4
AC   CVCL_KN10
DR   DSHB; PCRP-ZBTB3-2G4
DR   Wikidata; Q54946290
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H5J0; Human ZBTB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB32-2A7
AC   CVCL_KN11
DR   DSHB; PCRP-ZBTB32-2A7
DR   Wikidata; Q54946291
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y2Y4; Human ZBTB32.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB32-2D2
AC   CVCL_KN12
DR   DSHB; PCRP-ZBTB32-2D2
DR   Wikidata; Q54946293
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y2Y4; Human ZBTB32.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB37-1G10
AC   CVCL_KN13
DR   DSHB; PCRP-ZBTB37-1G10
DR   Wikidata; Q54946294
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5TC79; Human ZBTB37.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB39-1A11
AC   CVCL_KN14
DR   DSHB; PCRP-ZBTB39-1A11
DR   Wikidata; Q54946295
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15060; Human ZBTB39.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB46-1D1
AC   CVCL_KN15
DR   DSHB; PCRP-ZBTB46-1D1
DR   Wikidata; Q54946296
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86UZ6; Human ZBTB46.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB46-2B8
AC   CVCL_KN16
DR   DSHB; PCRP-ZBTB46-2B8
DR   Wikidata; Q54946297
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86UZ6; Human ZBTB46.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB46-2C1
AC   CVCL_KN17
DR   DSHB; PCRP-ZBTB46-2C1
DR   Wikidata; Q54946298
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86UZ6; Human ZBTB46.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB48-3C4
AC   CVCL_KN18
DR   DSHB; PCRP-ZBTB48-3C4
DR   Wikidata; Q54946299
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10074; Human ZBTB48.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB48-3G1
AC   CVCL_KN19
DR   DSHB; PCRP-ZBTB48-3G1
DR   Wikidata; Q54946300
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10074; Human ZBTB48.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB5-1B3
AC   CVCL_KN20
DR   DSHB; PCRP-ZBTB5-1B3
DR   Wikidata; Q54946301
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15062; Human ZBTB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB5-1C4
AC   CVCL_KN21
DR   DSHB; PCRP-ZBTB5-1C4
DR   Wikidata; Q54946302
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15062; Human ZBTB5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB7B-1B6
AC   CVCL_KN22
DR   DSHB; PCRP-ZBTB7B-1B6
DR   Wikidata; Q54946303
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15156; Human ZBTB7B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB7B-1F7
AC   CVCL_KN23
DR   DSHB; PCRP-ZBTB7B-1F7
DR   Wikidata; Q54946304
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O15156; Human ZBTB7B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB7C-2B11
AC   CVCL_KN24
DR   DSHB; PCRP-ZBTB7C-2B11
DR   Wikidata; Q54946305
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A1YPR0; Human ZBTB7C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB7C-4E10
AC   CVCL_KN25
DR   DSHB; PCRP-ZBTB7C-4E10
DR   Wikidata; Q54946306
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A1YPR0; Human ZBTB7C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZBTB7C-4E12
AC   CVCL_KN26
DR   DSHB; PCRP-ZBTB7C-4E12
DR   Wikidata; Q54946307
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; A1YPR0; Human ZBTB7C.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZC3H15-1C12
AC   CVCL_KN27
DR   DSHB; PCRP-ZC3H15-1C12
DR   Wikidata; Q54946308
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WU90; Human ZC3H15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZC3H15-1D1
AC   CVCL_KN28
DR   DSHB; PCRP-ZC3H15-1D1
DR   Wikidata; Q54946309
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WU90; Human ZC3H15.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZC3H7A-1D6
AC   CVCL_KN29
DR   DSHB; PCRP-ZC3H7A-1D6
DR   Wikidata; Q54946310
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IWR0; Human ZC3H7A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZC3H7A-2G9
AC   CVCL_KN30
DR   DSHB; PCRP-ZC3H7A-2G9
DR   Wikidata; Q54946312
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IWR0; Human ZC3H7A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZCCHC7-1A2
AC   CVCL_KN31
DR   Wikidata; Q54946313
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZCCHC7-1A3
AC   CVCL_KN32
DR   DSHB; PCRP-ZCCHC7-1A3
DR   Wikidata; Q54946314
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZCCHC7-1B4
AC   CVCL_KN33
DR   DSHB; PCRP-ZCCHC7-1B4
DR   Wikidata; Q54946316
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZCCHC7-1C1
AC   CVCL_KN34
DR   DSHB; PCRP-ZCCHC7-1C1
DR   Wikidata; Q54946317
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
CC   Discontinued: DSHB; PCRP-ZCCHC7-1C1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZCCHC7-1C2
AC   CVCL_KN35
DR   DSHB; PCRP-ZCCHC7-1C2
DR   Wikidata; Q54946318
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
CC   Discontinued: DSHB; PCRP-ZCCHC7-1C2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZCCHC7-1D1
AC   CVCL_KN36
DR   DSHB; PCRP-ZCCHC7-1D1
DR   Wikidata; Q54946319
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
CC   Discontinued: DSHB; PCRP-ZCCHC7-1D1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZCCHC7-1E3
AC   CVCL_KN37
DR   DSHB; PCRP-ZCCHC7-1E3
DR   Wikidata; Q54946320
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
CC   Discontinued: DSHB; PCRP-ZCCHC7-1E3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZCCHC7-1F2
AC   CVCL_KN38
DR   DSHB; PCRP-ZCCHC7-1F2
DR   Wikidata; Q54946321
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
CC   Discontinued: DSHB; PCRP-ZCCHC7-1F2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZCCHC7-1H5
AC   CVCL_KN39
DR   Wikidata; Q54946322
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZCCHC7-2E4
AC   CVCL_KN40
DR   DSHB; PCRP-ZCCHC7-2E4
DR   Wikidata; Q54946323
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
CC   Discontinued: DSHB; PCRP-ZCCHC7-2E4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZCCHC7-2F4
AC   CVCL_KN41
DR   DSHB; PCRP-ZCCHC7-2F4
DR   Wikidata; Q54946324
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZCCHC7-2H8
AC   CVCL_KN42
DR   DSHB; PCRP-ZCCHC7-2H8
DR   Wikidata; Q54946325
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N3Z6; Human ZCCHC7.
CC   Discontinued: DSHB; PCRP-ZCCHC7-2H8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZEB2-1C6
AC   CVCL_KN43
DR   DSHB; PCRP-ZEB2-1C6
DR   Wikidata; Q54946326
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60315; Human ZEB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZEB2-1E11
AC   CVCL_KN44
DR   DSHB; PCRP-ZEB2-1E11
DR   Wikidata; Q54946327
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60315; Human ZEB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZEB2-2A11
AC   CVCL_KN45
DR   DSHB; PCRP-ZEB2-2A11
DR   Wikidata; Q54946328
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60315; Human ZEB2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFAT-2D2
AC   CVCL_KN46
DR   DSHB; PCRP-ZFAT-2D2
DR   Wikidata; Q54946338
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P243; Human ZFAT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP28-2B8
AC   CVCL_KN47
DR   DSHB; PCRP-ZFP28-2B8
DR   Wikidata; Q54946339
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NHY6; Human ZFP28.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP3-1A5
AC   CVCL_KN48
DR   DSHB; PCRP-ZFP3-1A5
DR   Wikidata; Q54946340
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96NJ6; Human ZFP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP3-1B3
AC   CVCL_KN49
DR   DSHB; PCRP-ZFP3-1B3
DR   Wikidata; Q54946341
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96NJ6; Human ZFP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP41-1A1
AC   CVCL_KN50
DR   DSHB; PCRP-ZFP41-1A1
DR   Wikidata; Q54946342
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8N8Y5; Human ZFP41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP64-1A10
AC   CVCL_KN51
DR   DSHB; PCRP-ZFP64-1A10
DR   Wikidata; Q54946343
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NPA5; Human ZFP64.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP64-1H2
AC   CVCL_KN52
DR   DSHB; PCRP-ZFP64-1H2
DR   Wikidata; Q54946344
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NPA5; Human ZFP64.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP90-1C5
AC   CVCL_KN53
DR   DSHB; PCRP-ZFP90-1C5
DR   Wikidata; Q54946346
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TF47; Human ZFP90.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP92-2A7
AC   CVCL_KN54
DR   DSHB; PCRP-ZFP92-2A7
DR   Wikidata; Q54946347
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A6NM28; Human ZFP92.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFP92-2B9
AC   CVCL_KN55
DR   DSHB; PCRP-ZFP92-2B9
DR   Wikidata; Q54946348
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NM28; Human ZFP92.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFPM2-2D5
AC   CVCL_KN56
DR   DSHB; PCRP-ZFPM2-2D5
DR   Wikidata; Q54946349
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WW38; Human ZFPM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFYVE19-3C5
AC   CVCL_KN57
DR   DSHB; PCRP-ZFYVE19-3C5
DR   Wikidata; Q54946350
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96K21; Human ZFYVE19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFYVE20-1C3
AC   CVCL_KN58
DR   DSHB; PCRP-ZFYVE20-1C3
DR   Wikidata; Q54946352
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H1K0; Human RBSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFYVE20-1E2
AC   CVCL_KN59
DR   DSHB; PCRP-ZFYVE20-1E2
DR   Wikidata; Q54946353
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H1K0; Human RBSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZFYVE20-1F6
AC   CVCL_KN60
DR   DSHB; PCRP-ZFYVE20-1F6
DR   Wikidata; Q54946354
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H1K0; Human RBSN.
CC   Discontinued: DSHB; PCRP-ZFYVE20-1F6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZFYVE20-2B9
AC   CVCL_KN61
DR   DSHB; PCRP-ZFYVE20-2B9
DR   Wikidata; Q54946355
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H1K0; Human RBSN.
CC   Discontinued: DSHB; PCRP-ZFYVE20-2B9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZFYVE20-2E3
AC   CVCL_KN62
DR   DSHB; PCRP-ZFYVE20-2E3
DR   Wikidata; Q54946356
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H1K0; Human RBSN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZHX2-1B2
AC   CVCL_KN63
DR   DSHB; PCRP-ZHX2-1B2
DR   Wikidata; Q54946357
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9Y6X8; Human ZHX2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZHX3-1D11
AC   CVCL_KN64
DR   DSHB; PCRP-ZHX3-1D11
DR   Wikidata; Q54946358
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H4I2; Human ZHX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZHX3-1G3
AC   CVCL_KN65
DR   DSHB; PCRP-ZHX3-1G3
DR   Wikidata; Q54946360
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9H4I2; Human ZHX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZIC1-1E3
AC   CVCL_KN66
DR   DSHB; PCRP-ZIC1-1E3
DR   Wikidata; Q54946361
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15915; Human ZIC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZIC2-2A2
AC   CVCL_KN67
DR   DSHB; PCRP-ZIC2-2A2
DR   Wikidata; Q54946362
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95409; Human ZIC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZIM2-1C2
AC   CVCL_KN68
DR   DSHB; PCRP-ZIM2-1C2
DR   Wikidata; Q54946363
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NZV7; Human ZIM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZIM2-1D10
AC   CVCL_KN69
DR   DSHB; PCRP-ZIM2-1D10
DR   Wikidata; Q54946365
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NZV7; Human ZIM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZIM2-1F10
AC   CVCL_KN70
DR   DSHB; PCRP-ZIM2-1F10
DR   Wikidata; Q54946366
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NZV7; Human ZIM2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZKSCAN1-1F10
AC   CVCL_KN71
DR   DSHB; PCRP-ZKSCAN1-1F10
DR   Wikidata; Q54946367
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P17029; Human ZKSCAN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZKSCAN2-1G10
AC   CVCL_KN72
DR   DSHB; PCRP-ZKSCAN2-1G10
DR   Wikidata; Q54946368
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q63HK3; Human ZKSCAN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZKSCAN2-2C6
AC   CVCL_KN73
DR   DSHB; PCRP-ZKSCAN2-2C6
DR   Wikidata; Q54946369
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q63HK3; Human ZKSCAN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZKSCAN3-1D9
AC   CVCL_KN74
DR   DSHB; PCRP-ZKSCAN3-1D9
DR   Wikidata; Q54946370
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
CC   Discontinued: DSHB; PCRP-ZKSCAN3-1D9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZKSCAN3-1E12
AC   CVCL_KN75
DR   DSHB; PCRP-ZKSCAN3-1E12
DR   Wikidata; Q54946372
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
CC   Discontinued: DSHB; PCRP-ZKSCAN3-1E12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZKSCAN3-1E8
AC   CVCL_KN76
DR   DSHB; PCRP-ZKSCAN3-1E8
DR   Wikidata; Q54946373
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZKSCAN3-1F4
AC   CVCL_KN77
DR   DSHB; PCRP-ZKSCAN3-1F4
DR   Wikidata; Q54946374
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
CC   Discontinued: DSHB; PCRP-ZKSCAN3-1F4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZKSCAN3-1F9
AC   CVCL_KN78
DR   DSHB; PCRP-ZKSCAN3-1F9
DR   Wikidata; Q54946375
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZKSCAN3-2A4
AC   CVCL_KN79
DR   DSHB; PCRP-ZKSCAN3-2A4
DR   Wikidata; Q54946376
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZKSCAN3-2A9
AC   CVCL_KN80
DR   DSHB; PCRP-ZKSCAN3-2A9
DR   Wikidata; Q54946377
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
CC   Discontinued: DSHB; PCRP-ZKSCAN3-2A9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZKSCAN3-2E1
AC   CVCL_KN81
DR   DSHB; PCRP-ZKSCAN3-2E1
DR   Wikidata; Q54946379
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BRR0; Human ZKSCAN3.
CC   Discontinued: DSHB; PCRP-ZKSCAN3-2E1; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZKSCAN7-1C4
AC   CVCL_KN82
DR   Wikidata; Q54946380
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P0L1; Human ZKSCAN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZKSCAN7-2B10
AC   CVCL_KN83
DR   DSHB; PCRP-ZKSCAN7-2B10
DR   Wikidata; Q54946381
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P0L1; Human ZKSCAN7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZMAT2-1E5
AC   CVCL_KN84
DR   DSHB; PCRP-ZMAT2-1E5
DR   Wikidata; Q54946382
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96NC0; Human ZMAT2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZMAT4-1A6
AC   CVCL_KN85
DR   DSHB; PCRP-ZMAT4-1A6
DR   Wikidata; Q54946384
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H898; Human ZMAT4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZMYM3-1C11
AC   CVCL_KN86
DR   DSHB; PCRP-ZMYM3-1C11
DR   Wikidata; Q54946400
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14202; Human ZMYM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZMYM3-1H3
AC   CVCL_KN87
DR   DSHB; PCRP-ZMYM3-1H3
DR   Wikidata; Q54946403
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14202; Human ZMYM3.
CC   Discontinued: DSHB; PCRP-ZMYM3-1H3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZMYM3-2B9
AC   CVCL_KN88
DR   DSHB; PCRP-ZMYM3-2B9
DR   Wikidata; Q54946405
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14202; Human ZMYM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZMYM3-2C3
AC   CVCL_KN89
DR   DSHB; PCRP-ZMYM3-2C3
DR   Wikidata; Q54946406
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q14202; Human ZMYM3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZMYM3-6D7
AC   CVCL_KN90
DR   DSHB; PCRP-ZMYM3-6D7
DR   Wikidata; Q54946407
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q14202; Human ZMYM3.
CC   Discontinued: DSHB; PCRP-ZMYM3-6D7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF134-1A2
AC   CVCL_KN91
DR   DSHB; PCRP-ZNF134-1A2
DR   Wikidata; Q54946408
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P52741; Human ZNF134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF134-3E11
AC   CVCL_KN92
DR   DSHB; PCRP-ZNF134-3E11
DR   Wikidata; Q54946410
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P52741; Human ZNF134.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF140-2D1
AC   CVCL_KN93
DR   Wikidata; Q54946412
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P52738; Human ZNF140.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF140-5C1
AC   CVCL_KN94
DR   DSHB; PCRP-ZNF140-5C1
DR   Wikidata; Q54946413
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P52738; Human ZNF140.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF143-1A10
AC   CVCL_KN95
DR   DSHB; PCRP-ZNF143-1A10
DR   Wikidata; Q54946414
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P52747; Human ZNF143.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF155-1A5
AC   CVCL_KN96
DR   DSHB; PCRP-ZNF155-1A5
DR   Wikidata; Q54946415
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q12901; Human ZNF155.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF157-1A6
AC   CVCL_KN97
DR   DSHB; PCRP-ZNF157-1A6
DR   Wikidata; Q54946416
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51786; Human ZNF157.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF157-1A8
AC   CVCL_KN98
DR   DSHB; PCRP-ZNF157-1A8
DR   Wikidata; Q54946417
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51786; Human ZNF157.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF165-2D3
AC   CVCL_KN99
DR   DSHB; PCRP-ZNF165-2D3
DR   Wikidata; Q54946418
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P49910; Human ZNF165.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF165-2F4
AC   CVCL_KP00
DR   DSHB; PCRP-ZNF165-2F4
DR   Wikidata; Q54946419
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P49910; Human ZNF165.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF169-1A4
AC   CVCL_KP01
DR   DSHB; PCRP-ZNF169-1A4
DR   Wikidata; Q54946420
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q14929; Human ZNF169.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF174-1D12
AC   CVCL_KP02
DR   DSHB; PCRP-ZNF174-1D12
DR   Wikidata; Q54946421
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15697; Human ZNF174.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF175-1A2
AC   CVCL_KP03
DR   DSHB; PCRP-ZNF175-1A2
DR   Wikidata; Q54946422
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y473; Human ZNF175.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF18-3E5
AC   CVCL_KP04
DR   DSHB; PCRP-ZNF18-3E5
DR   Wikidata; Q54946424
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17022; Human ZNF18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF18-4B5
AC   CVCL_KP05
DR   DSHB; PCRP-ZNF18-4B5
DR   Wikidata; Q54946425
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17022; Human ZNF18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF189-3C5
AC   CVCL_KP06
DR   DSHB; PCRP-ZNF189-3C5
DR   Wikidata; Q54946426
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O75820; Human ZNF189.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF192-1F10
AC   CVCL_KP07
DR   DSHB; PCRP-ZNF192-1F10
DR   Wikidata; Q54946427
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15776; Human ZKSCAN8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF197-2D1
AC   CVCL_KP08
DR   DSHB; PCRP-ZNF197-2D1
DR   Wikidata; Q54946428
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O14709; Human ZNF197.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF2-1D2
AC   CVCL_KP09
DR   Wikidata; Q54946429
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9BSG1; Human ZNF2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF200-1A3
AC   CVCL_KP10
DR   DSHB; PCRP-ZNF200-1A3
DR   Wikidata; Q54946430
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P98182; Human ZNF200.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF200-1A7
AC   CVCL_KP11
DR   DSHB; PCRP-ZNF200-1A7
DR   Wikidata; Q54946431
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P98182; Human ZNF200.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF202-1C2
AC   CVCL_KP12
DR   DSHB; PCRP-ZNF202-1C2
DR   Wikidata; Q54946432
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95125; Human ZNF202.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF202-1C4
AC   CVCL_KP13
DR   DSHB; PCRP-ZNF202-1C4
DR   Wikidata; Q54946433
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O95125; Human ZNF202.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF202-3D3
AC   CVCL_KP14
DR   DSHB; PCRP-ZNF202-3D3
DR   Wikidata; Q54946434
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O95125; Human ZNF202.
CC   Discontinued: DSHB; PCRP-ZNF202-3D3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF202-3G1
AC   CVCL_KP15
DR   DSHB; PCRP-ZNF202-3G1
DR   Wikidata; Q54946435
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O95125; Human ZNF202.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF207-1A6
AC   CVCL_KP16
DR   DSHB; PCRP-ZNF207-1A6
DR   Wikidata; Q54946436
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43670; Human ZNF207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF207-1A7
AC   CVCL_KP17
DR   DSHB; PCRP-ZNF207-1A7
DR   Wikidata; Q54946439
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43670; Human ZNF207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF207-2D8
AC   CVCL_KP18
DR   DSHB; PCRP-ZNF207-2D8
DR   Wikidata; Q54946440
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43670; Human ZNF207.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF212-1A3
AC   CVCL_KP19
DR   DSHB; PCRP-ZNF212-1A3
DR   Wikidata; Q54946441
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UDV6; Human ZNF212.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF217-1G2
AC   CVCL_KP20
DR   DSHB; PCRP-ZNF217-1G2
DR   Wikidata; Q54946442
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75362; Human ZNF217.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF217-3C3
AC   CVCL_KP21
DR   DSHB; PCRP-ZNF217-3C3
DR   Wikidata; Q54946444
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75362; Human ZNF217.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF217-5H9
AC   CVCL_KP22
DR   DSHB; PCRP-ZNF217-5H9
DR   Wikidata; Q54946445
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75362; Human ZNF217.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF222-2C5
AC   CVCL_KP23
DR   DSHB; PCRP-ZNF222-2C5
DR   Wikidata; Q54946446
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UK12; Human ZNF222.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF23-2A2
AC   CVCL_KP24
DR   DSHB; PCRP-ZNF23-2A2
DR   Wikidata; Q54946447
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17027; Human ZNF23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF23-2A5
AC   CVCL_KP25
DR   DSHB; PCRP-ZNF23-2A5
DR   Wikidata; Q54946448
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P17027; Human ZNF23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF230-1E1
AC   CVCL_KP26
DR   DSHB; PCRP-ZNF230-1E1
DR   Wikidata; Q54946463
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UIE0; Human ZNF230.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF230-3C11
AC   CVCL_KP27
DR   DSHB; PCRP-ZNF230-3C11
DR   Wikidata; Q54946464
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UIE0; Human ZNF230.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF230-4B6
AC   CVCL_KP28
DR   DSHB; PCRP-ZNF230-4B6
DR   Wikidata; Q54946465
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UIE0; Human ZNF230.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF230-4D11
AC   CVCL_KP29
DR   DSHB; PCRP-ZNF230-4D11
DR   Wikidata; Q54946466
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UIE0; Human ZNF230.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF232-1B10
AC   CVCL_KP30
DR   DSHB; PCRP-ZNF232-1B10
DR   Wikidata; Q54946467
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF232-1D5
AC   CVCL_KP31
DR   DSHB; PCRP-ZNF232-1D5
DR   Wikidata; Q54946468
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF232-2A5
AC   CVCL_KP32
DR   DSHB; PCRP-ZNF232-2A5
DR   Wikidata; Q54946470
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
CC   Discontinued: DSHB; PCRP-ZNF232-2A5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF232-2B3
AC   CVCL_KP33
DR   DSHB; PCRP-ZNF232-2B3
DR   Wikidata; Q54946471
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
CC   Discontinued: DSHB; PCRP-ZNF232-2B3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF232-2B6
AC   CVCL_KP34
DR   DSHB; PCRP-ZNF232-2B6
DR   Wikidata; Q54946472
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
CC   Discontinued: DSHB; PCRP-ZNF232-2B6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF232-2C7
AC   CVCL_KP35
DR   DSHB; PCRP-ZNF232-2C7
DR   Wikidata; Q54946473
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
CC   Discontinued: DSHB; PCRP-ZNF232-2C7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF232-2G7
AC   CVCL_KP36
DR   DSHB; PCRP-ZNF232-2G7
DR   Wikidata; Q54946474
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
CC   Discontinued: DSHB; PCRP-ZNF232-2G7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF232-3F3
AC   CVCL_KP37
DR   DSHB; PCRP-ZNF232-3F3
DR   Wikidata; Q54946476
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9UNY5; Human ZNF232.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF239-2A10
AC   CVCL_KP38
DR   DSHB; PCRP-ZNF239-2A10
DR   Wikidata; Q54946478
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16600; Human ZNF239.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF239-2F6
AC   CVCL_KP39
DR   DSHB; PCRP-ZNF239-2F6
DR   Wikidata; Q54946479
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16600; Human ZNF239.
CC   Discontinued: DSHB; PCRP-ZNF239-2F6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF239-3C2
AC   CVCL_KP40
DR   DSHB; PCRP-ZNF239-3C2
DR   Wikidata; Q54946480
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16600; Human ZNF239.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF24-1E12
AC   CVCL_KP41
DR   DSHB; PCRP-ZNF24-1E12
DR   Wikidata; Q54946481
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17028; Human ZNF24.
CC   Discontinued: DSHB; PCRP-ZNF24-1E12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF24-1G5
AC   CVCL_KP42
DR   DSHB; PCRP-ZNF24-1G5
DR   Wikidata; Q54946482
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P17028; Human ZNF24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF263-1C11
AC   CVCL_KP43
DR   DSHB; PCRP-ZNF263-1C11
DR   Wikidata; Q54946483
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O14978; Human ZNF263.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF264-1D5
AC   CVCL_KP44
DR   DSHB; PCRP-ZNF264-1D5
DR   Wikidata; Q54946484
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43296; Human ZNF264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF264-1H4
AC   CVCL_KP45
DR   DSHB; PCRP-ZNF264-1H4
DR   Wikidata; Q54946485
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O43296; Human ZNF264.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF276-1A5
AC   CVCL_KP46
DR   DSHB; PCRP-ZNF276-1A5
DR   Wikidata; Q54946486
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8N554; Human ZNF276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF277-1A2
AC   CVCL_KP47
DR   DSHB; PCRP-ZNF277-1A2
DR   Wikidata; Q54946488
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NRM2; Human ZNF277.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF277-1E10
AC   CVCL_KP48
DR   DSHB; PCRP-ZNF277-1E10
DR   Wikidata; Q54946489
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NRM2; Human ZNF277.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF280A-1C4
AC   CVCL_KP49
DR   DSHB; PCRP-ZNF280A-1C4
DR   Wikidata; Q54946490
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P59817; Human ZNF280A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF280D-1D11
AC   CVCL_KP50
DR   Wikidata; Q54946491
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6N043; Human ZNF280D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF296-1B11
AC   CVCL_KP51
DR   DSHB; PCRP-ZNF296-1B11
DR   Wikidata; Q54946493
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WUU4; Human ZNF296.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF296-1D6
AC   CVCL_KP52
DR   DSHB; PCRP-ZNF296-1D6
DR   Wikidata; Q54946494
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8WUU4; Human ZNF296.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF311-1A10
AC   CVCL_KP53
DR   DSHB; PCRP-ZNF311-1A10
DR   Wikidata; Q54946495
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5JNZ3; Human ZNF311.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF324-1B7
AC   CVCL_KP54
DR   DSHB; PCRP-ZNF324-1B7
DR   Wikidata; Q54946496
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75467; Human ZNF324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF324-1B9
AC   CVCL_KP55
DR   DSHB; PCRP-ZNF324-1B9
DR   Wikidata; Q54946498
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75467; Human ZNF324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF326-3E7
AC   CVCL_KP56
DR   DSHB; PCRP-ZNF326-3E7
DR   Wikidata; Q54946499
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q5BKZ1; Human ZNF326.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF333-1H4
AC   CVCL_KP57
DR   DSHB; PCRP-ZNF333-1H4
DR   Wikidata; Q54946500
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96JL9; Human ZNF333.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF333-2A12
AC   CVCL_KP58
DR   DSHB; PCRP-ZNF333-2A12
DR   Wikidata; Q54946501
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96JL9; Human ZNF333.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF334-1B3
AC   CVCL_KP59
DR   DSHB; PCRP-ZNF334-1B3
DR   Wikidata; Q54946502
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9HCZ1; Human ZNF334.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF335-2C1
AC   CVCL_KP60
DR   DSHB; PCRP-ZNF335-2C1
DR   Wikidata; Q54946503
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9H4Z2; Human ZNF335.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF341-2C5
AC   CVCL_KP61
DR   DSHB; PCRP-ZNF341-2C5
DR   Wikidata; Q54946504
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BYN7; Human ZNF341.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF341-3B10
AC   CVCL_KP62
DR   DSHB; PCRP-ZNF341-3B10
DR   Wikidata; Q54946505
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BYN7; Human ZNF341.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF354A-1B6
AC   CVCL_KP63
DR   DSHB; PCRP-ZNF354A-1B6
DR   Wikidata; Q54946507
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O60765; Human ZNF354A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF354A-1D7
AC   CVCL_KP64
DR   DSHB; PCRP-ZNF354A-1D7
DR   Wikidata; Q54946508
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O60765; Human ZNF354A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF354B-1A2
AC   CVCL_KP65
DR   DSHB; PCRP-ZNF354B-1A2
DR   Wikidata; Q54946510
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96LW1; Human ZNF354B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF354B-1A6
AC   CVCL_KP66
DR   DSHB; PCRP-ZNF354B-1A6
DR   Wikidata; Q54946520
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96LW1; Human ZNF354B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF354B-1A8
AC   CVCL_KP67
DR   DSHB; PCRP-ZNF354B-1A8
DR   Wikidata; Q54946521
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96LW1; Human ZNF354B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF358-1A6
AC   CVCL_KP68
DR   DSHB; PCRP-ZNF358-1A6
DR   Wikidata; Q54946522
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NW07; Human ZNF358.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF384-1C11
AC   CVCL_KP69
DR   DSHB; PCRP-ZNF384-1C11
DR   Wikidata; Q54946523
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8TF68; Human ZNF384.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF384-1E8
AC   CVCL_KP70
DR   DSHB; PCRP-ZNF384-1E8
DR   Wikidata; Q54946524
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TF68; Human ZNF384.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF385A-1H9
AC   CVCL_KP71
DR   DSHB; PCRP-ZNF385A-1H9
DR   Wikidata; Q54946525
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96PM9; Human ZNF385A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF385B-1A1
AC   CVCL_KP72
DR   DSHB; PCRP-ZNF385B-1A1
DR   Wikidata; Q54946527
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q569K4; Human ZNF385B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF385B-1B5
AC   CVCL_KP73
DR   DSHB; PCRP-ZNF385B-1B5
DR   Wikidata; Q54946528
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q569K4; Human ZNF385B.
CC   Discontinued: DSHB; PCRP-ZNF385B-1B5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF394-1C1
AC   CVCL_KP74
DR   DSHB; PCRP-ZNF394-1C1
DR   Wikidata; Q54946529
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q53GI3; Human ZNF394.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF397-2F6
AC   CVCL_KP75
DR   DSHB; PCRP-ZNF397-2F6
DR   Wikidata; Q54946531
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8NF99; Human ZNF397.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF397-6B9
AC   CVCL_KP76
DR   DSHB; PCRP-ZNF397-6B9
DR   Wikidata; Q54946533
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NF99; Human ZNF397.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF398-1A1
AC   CVCL_KP77
DR   DSHB; PCRP-ZNF398-1A1
DR   Wikidata; Q54946534
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q8TD17; Human ZNF398.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF398-1A8
AC   CVCL_KP78
DR   DSHB; PCRP-ZNF398-1A8
DR   Wikidata; Q54946535
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TD17; Human ZNF398.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF408-1E5
AC   CVCL_KP79
DR   DSHB; PCRP-ZNF408-1E5
DR   Wikidata; Q54946536
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H9D4; Human ZNF408.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF408-1F6
AC   CVCL_KP80
DR   DSHB; PCRP-ZNF408-1F6
DR   Wikidata; Q54946538
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9H9D4; Human ZNF408.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF410-1A12
AC   CVCL_KP81
DR   DSHB; PCRP-ZNF410-1A12
DR   Wikidata; Q54946539
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86VK4; Human ZNF410.
CC   Discontinued: DSHB; PCRP-ZNF410-1A12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF410-1C7
AC   CVCL_KP82
DR   DSHB; PCRP-ZNF410-1C7
DR   Wikidata; Q54946540
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86VK4; Human ZNF410.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF410-1D7
AC   CVCL_KP83
DR   DSHB; PCRP-ZNF410-1D7
DR   Wikidata; Q54946541
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86VK4; Human ZNF410.
CC   Discontinued: DSHB; PCRP-ZNF410-1D7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF410-1H9
AC   CVCL_KP84
DR   DSHB; PCRP-ZNF410-1H9
DR   Wikidata; Q54946543
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86VK4; Human ZNF410.
CC   Discontinued: DSHB; PCRP-ZNF410-1H9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF410-2B4
AC   CVCL_KP85
DR   DSHB; PCRP-ZNF410-2B4
DR   Wikidata; Q54946544
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86VK4; Human ZNF410.
CC   Discontinued: DSHB; PCRP-ZNF410-2B4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF410-2B7
AC   CVCL_KP86
DR   DSHB; PCRP-ZNF410-2B7
DR   Wikidata; Q54946545
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86VK4; Human ZNF410.
CC   Discontinued: DSHB; PCRP-ZNF410-2B7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF410-2C9
AC   CVCL_KP87
DR   DSHB; PCRP-ZNF410-2C9
DR   Wikidata; Q54946546
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q86VK4; Human ZNF410.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF417-2B5
AC   CVCL_KP88
DR   DSHB; PCRP-ZNF417-2B5
DR   Wikidata; Q54946547
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TAU3; Human ZNF417.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF428-1D6
AC   CVCL_KP89
DR   DSHB; PCRP-ZNF428-1D6
DR   Wikidata; Q54946548
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96B54; Human ZNF428.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF438-1A11
AC   CVCL_KP90
DR   DSHB; PCRP-ZNF438-1A11
DR   Wikidata; Q54946549
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7Z4V0; Human ZNF438.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF438-1H5
AC   CVCL_KP91
DR   DSHB; PCRP-ZNF438-1H5
DR   Wikidata; Q54946550
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7Z4V0; Human ZNF438.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF444-1E11
AC   CVCL_KP92
DR   DSHB; PCRP-ZNF444-1E11
DR   Wikidata; Q54946551
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8N0Y2; Human ZNF444.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF446-1B4
AC   CVCL_KP93
DR   DSHB; PCRP-ZNF446-1B4
DR   Wikidata; Q54946552
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9NWS9; Human ZNF446.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF446-2C7
AC   CVCL_KP94
DR   DSHB; PCRP-ZNF446-2C7
DR   Wikidata; Q54946553
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NWS9; Human ZNF446.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF446-3C8
AC   CVCL_KP95
DR   DSHB; PCRP-ZNF446-3C8
DR   Wikidata; Q54946554
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NWS9; Human ZNF446.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF467-2H7
AC   CVCL_KP96
DR   Wikidata; Q54946555
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7Z7K2; Human ZNF467.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF48-1B3
AC   CVCL_KP97
DR   DSHB; PCRP-ZNF48-1B3
DR   Wikidata; Q54946556
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96MX3; Human ZNF48.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF48-1B9
AC   CVCL_KP98
DR   DSHB; PCRP-ZNF48-1B9
DR   Wikidata; Q54946557
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96MX3; Human ZNF48.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF483-1A1
AC   CVCL_KP99
DR   DSHB; PCRP-ZNF483-1A1
DR   Wikidata; Q54946559
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TF39; Human ZNF483.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF483-1C11
AC   CVCL_KQ00
DR   DSHB; PCRP-ZNF483-1C11
DR   Wikidata; Q54946562
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TF39; Human ZNF483.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF485-1G1
AC   CVCL_KQ01
DR   DSHB; PCRP-ZNF485-1G1
DR   Wikidata; Q54946563
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NCK3; Human ZNF485.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF488-1A6
AC   CVCL_KQ02
DR   DSHB; PCRP-ZNF488-1A6
DR   Wikidata; Q54946564
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96MN9; Human ZNF488.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF488-1B6
AC   CVCL_KQ03
DR   DSHB; PCRP-ZNF488-1B6
DR   Wikidata; Q54946566
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96MN9; Human ZNF488.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF496-1C1
AC   CVCL_KQ04
DR   DSHB; PCRP-ZNF496-1C1
DR   Wikidata; Q54946567
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96IT1; Human ZNF496.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF496-1C5
AC   CVCL_KQ05
DR   DSHB; PCRP-ZNF496-1C5
DR   Wikidata; Q54946569
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96IT1; Human ZNF496.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF503-AS2-1B7
AC   CVCL_KQ06
DR   DSHB; PCRP-ZNF503-AS2-1B7
DR   Wikidata; Q54946580
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A6NEH8; Human ZNF503-AS2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF521-1A3
AC   CVCL_KQ07
DR   DSHB; PCRP-ZNF521-1A3
DR   Wikidata; Q54946581
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96K83; Human ZNF521.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF524-2B4
AC   CVCL_KQ08
DR   DSHB; PCRP-ZNF524-2B4
DR   Wikidata; Q54946582
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96C55; Human ZNF524.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF526-1E5
AC   CVCL_KQ09
DR   DSHB; PCRP-ZNF526-1E5
DR   Wikidata; Q54946583
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8TF50; Human ZNF526.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF526-1H7
AC   CVCL_KQ10
DR   DSHB; PCRP-ZNF526-1H7
DR   Wikidata; Q54946584
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TF50; Human ZNF526.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF526-2A4
AC   CVCL_KQ11
DR   DSHB; PCRP-ZNF526-2A4
DR   Wikidata; Q54946585
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8TF50; Human ZNF526.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF543-1A8
AC   CVCL_KQ12
DR   DSHB; PCRP-ZNF543-1A8
DR   Wikidata; Q54946586
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08ER8; Human ZNF543.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF548-1E11
AC   CVCL_KQ13
DR   DSHB; PCRP-ZNF548-1E11
DR   Wikidata; Q54946587
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8NEK5; Human ZNF548.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF549-2A2
AC   CVCL_KQ14
DR   DSHB; PCRP-ZNF549-2A2
DR   Wikidata; Q54946589
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6P9A3; Human ZNF549.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF550-1B4
AC   CVCL_KQ15
DR   DSHB; PCRP-ZNF550-1B4
DR   Wikidata; Q54946590
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7Z398; Human ZNF550.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF554-1B3
AC   CVCL_KQ16
DR   Wikidata; Q54946591
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86TJ5; Human ZNF554.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF556-1C3
AC   CVCL_KQ17
DR   DSHB; PCRP-ZNF556-1C3
DR   Wikidata; Q54946592
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9HAH1; Human ZNF556.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF556-1G1
AC   CVCL_KQ18
DR   DSHB; PCRP-ZNF556-1G1
DR   Wikidata; Q54946593
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9HAH1; Human ZNF556.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF562-1A1
AC   CVCL_KQ19
DR   DSHB; PCRP-ZNF562-1A1
DR   Wikidata; Q54946595
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q6V9R5; Human ZNF562.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF562-1B12
AC   CVCL_KQ20
DR   DSHB; PCRP-ZNF562-1B12
DR   Wikidata; Q54946596
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6V9R5; Human ZNF562.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF570-1B3
AC   CVCL_KQ21
DR   DSHB; PCRP-ZNF570-1B3
DR   Wikidata; Q54946597
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96NI8; Human ZNF570.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF574-1G10
AC   CVCL_KQ22
DR   DSHB; PCRP-ZNF574-1G10
DR   Wikidata; Q54946598
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6ZN55; Human ZNF574.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF574-2A9
AC   CVCL_KQ23
DR   Wikidata; Q54946599
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6ZN55; Human ZNF574.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF581-1A12
AC   CVCL_KQ24
DR   DSHB; PCRP-ZNF581-1A12
DR   Wikidata; Q54946600
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9P0T4; Human ZNF581.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF583-1E5
AC   CVCL_KQ25
DR   DSHB; PCRP-ZNF583-1E5
DR   Wikidata; Q54946601
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96ND8; Human ZNF583.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF584-1E10
AC   CVCL_KQ26
DR   Wikidata; Q54946602
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IVC4; Human ZNF584.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF585B-1D2
AC   CVCL_KQ27
DR   DSHB; PCRP-ZNF585B-1D2
DR   Wikidata; Q54946603
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q52M93; Human ZNF585B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF585B-1D8
AC   CVCL_KQ28
DR   DSHB; PCRP-ZNF585B-1D8
DR   Wikidata; Q54946604
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q52M93; Human ZNF585B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF597-1C12
AC   CVCL_KQ29
DR   DSHB; PCRP-ZNF597-1C12
DR   Wikidata; Q54946605
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96LX8; Human ZNF597.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF597-1C4
AC   CVCL_KQ30
DR   DSHB; PCRP-ZNF597-1C4
DR   Wikidata; Q54946606
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96LX8; Human ZNF597.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF598-1A12
AC   CVCL_KQ31
DR   DSHB; PCRP-ZNF598-1A12
DR   Wikidata; Q54946608
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q86UK7; Human ZNF598.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF608-1A10
AC   CVCL_KQ32
DR   DSHB; PCRP-ZNF608-1A10
DR   Wikidata; Q54946609
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9ULD9; Human ZNF608.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF622-1C11
AC   CVCL_KQ33
DR   DSHB; PCRP-ZNF622-1C11
DR   Wikidata; Q54946610
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q969S3; Human ZNF622.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF623-2C3
AC   CVCL_KQ34
DR   DSHB; PCRP-ZNF623-2C3
DR   Wikidata; Q54946611
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O75123; Human ZNF623.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF639-1D3
AC   CVCL_KQ35
DR   DSHB; PCRP-ZNF639-1D3
DR   Wikidata; Q54946612
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UID6; Human ZNF639.
CC   Discontinued: DSHB; PCRP-ZNF639-1D3; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF639-1E7
AC   CVCL_KQ36
DR   DSHB; PCRP-ZNF639-1E7
DR   Wikidata; Q54946613
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UID6; Human ZNF639.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF639-1F10
AC   CVCL_KQ37
DR   DSHB; PCRP-ZNF639-1F10
DR   Wikidata; Q54946614
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UID6; Human ZNF639.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF639-1F2
AC   CVCL_KQ38
DR   DSHB; PCRP-ZNF639-1F2
DR   Wikidata; Q54946615
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UID6; Human ZNF639.
CC   Discontinued: DSHB; PCRP-ZNF639-1F2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZNF639-2B2
AC   CVCL_KQ39
DR   DSHB; PCRP-ZNF639-2B2
DR   Wikidata; Q54946617
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UID6; Human ZNF639.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF648-1B3
AC   CVCL_KQ40
DR   DSHB; PCRP-ZNF648-1B3
DR   Wikidata; Q54946618
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q5T619; Human ZNF648.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF648-1C5
AC   CVCL_KQ41
DR   DSHB; PCRP-ZNF648-1C5
DR   Wikidata; Q54946620
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q5T619; Human ZNF648.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF654-1C7
AC   CVCL_KQ42
DR   DSHB; PCRP-ZNF654-1C7
DR   Wikidata; Q54946621
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IZM8; Human ZNF654.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF654-1E4
AC   CVCL_KQ43
DR   DSHB; PCRP-ZNF654-1E4
DR   Wikidata; Q54946622
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IZM8; Human ZNF654.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF654-1G11
AC   CVCL_KQ44
DR   DSHB; PCRP-ZNF654-1G11
DR   Wikidata; Q54946624
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IZM8; Human ZNF654.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF654-2E6
AC   CVCL_KQ45
DR   DSHB; PCRP-ZNF654-2E6
DR   Wikidata; Q54946625
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IZM8; Human ZNF654.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF654-4C3
AC   CVCL_KQ46
DR   DSHB; PCRP-ZNF654-4C3
DR   Wikidata; Q54946637
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IZM8; Human ZNF654.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF683-1E4
AC   CVCL_KQ47
DR   DSHB; PCRP-ZNF683-1E4
DR   Wikidata; Q54946639
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8IZ20; Human ZNF683.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF689-1A4
AC   CVCL_KQ48
DR   DSHB; PCRP-ZNF689-1A4
DR   Wikidata; Q54946640
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96CS4; Human ZNF689.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF69-1H1
AC   CVCL_KQ49
DR   DSHB; PCRP-ZNF69-1H1
DR   Wikidata; Q54946641
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9UC07; Human ZNF69.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF692-1D2
AC   CVCL_KQ50
DR   DSHB; PCRP-ZNF692-1D2
DR   Wikidata; Q54946642
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BU19; Human ZNF692.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF692-1G6
AC   CVCL_KQ51
DR   DSHB; PCRP-ZNF692-1G6
DR   Wikidata; Q54946643
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BU19; Human ZNF692.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF692-2B10
AC   CVCL_KQ52
DR   Wikidata; Q54946644
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BU19; Human ZNF692.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF696-1D7
AC   CVCL_KQ53
DR   DSHB; PCRP-ZNF696-1D7
DR   Wikidata; Q54946645
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9H7X3; Human ZNF696.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF697-1A8
AC   CVCL_KQ54
DR   DSHB; PCRP-ZNF697-1A8
DR   Wikidata; Q54946646
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5TEC3; Human ZNF697.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF7-1B10
AC   CVCL_KQ55
DR   DSHB; PCRP-ZNF7-1B10
DR   Wikidata; Q54946648
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17097; Human ZNF7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF7-1C12
AC   CVCL_KQ56
DR   DSHB; PCRP-ZNF7-1C12
DR   Wikidata; Q54946649
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17097; Human ZNF7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF701-1C5
AC   CVCL_KQ57
DR   DSHB; PCRP-ZNF701-1C5
DR   Wikidata; Q54946650
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NV72; Human ZNF701.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF704-3C10
AC   CVCL_KQ58
DR   DSHB; PCRP-ZNF704-3C10
DR   Wikidata; Q54946651
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q6ZNC4; Human ZNF704.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF746-1B7
AC   CVCL_KQ59
DR   DSHB; PCRP-ZNF746-1B7
DR   Wikidata; Q54946652
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6NUN9; Human ZNF746.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF746-1D7
AC   CVCL_KQ60
DR   DSHB; PCRP-ZNF746-1D7
DR   Wikidata; Q54946653
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6NUN9; Human ZNF746.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF75A-1B6
AC   CVCL_KQ61
DR   DSHB; PCRP-ZNF75A-1B6
DR   Wikidata; Q54946654
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96N20; Human ZNF75A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF75A-1E5
AC   CVCL_KQ62
DR   DSHB; PCRP-ZNF75A-1E5
DR   Wikidata; Q54946655
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96N20; Human ZNF75A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF770-1D7
AC   CVCL_KQ63
DR   DSHB; PCRP-ZNF770-1D7
DR   Wikidata; Q54946656
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6IQ21; Human ZNF770.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF772-2B11
AC   CVCL_KQ64
DR   DSHB; PCRP-ZNF772-2B11
DR   Wikidata; Q54946657
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q68DY9; Human ZNF772.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF772-2B2
AC   CVCL_KQ65
DR   DSHB; PCRP-ZNF772-2B2
DR   Wikidata; Q54946659
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q68DY9; Human ZNF772.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF774-3F7
AC   CVCL_KQ66
DR   DSHB; PCRP-ZNF774-3F7
DR   Wikidata; Q54946660
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q6NX45; Human ZNF774.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF783-1A1
AC   CVCL_KQ67
DR   DSHB; PCRP-ZNF783-1A1
DR   Wikidata; Q54946661
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6ZMS7; Human ZNF783.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF783-1B8
AC   CVCL_KQ68
DR   DSHB; PCRP-ZNF783-1B8
DR   Wikidata; Q54946662
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6ZMS7; Human ZNF783.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF783-2A8
AC   CVCL_KQ69
DR   DSHB; PCRP-ZNF783-2A8
DR   Wikidata; Q54946663
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q6ZMS7; Human ZNF783.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF784-1A4
AC   CVCL_KQ70
DR   DSHB; PCRP-ZNF784-1A4
DR   Wikidata; Q54946664
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8NCA9; Human ZNF784.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF784-1A7
AC   CVCL_KQ71
DR   DSHB; PCRP-ZNF784-1A7
DR   Wikidata; Q54946665
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8NCA9; Human ZNF784.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF792-2C6
AC   CVCL_KQ72
DR   DSHB; PCRP-ZNF792-2C6
DR   Wikidata; Q54946666
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q3KQV3; Human ZNF792.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF8-1B7
AC   CVCL_KQ73
DR   DSHB; PCRP-ZNF8-1B7
DR   Wikidata; Q54946667
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17098; Human ZNF8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF8-1B8
AC   CVCL_KQ74
DR   DSHB; PCRP-ZNF8-1B8
DR   Wikidata; Q54946668
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P17098; Human ZNF8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF800-1C11
AC   CVCL_KQ75
DR   DSHB; PCRP-ZNF800-1C11
DR   Wikidata; Q54946670
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q2TB10; Human ZNF800.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF800-2C12
AC   CVCL_KQ76
DR   DSHB; PCRP-ZNF800-2C12
DR   Wikidata; Q54946671
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q2TB10; Human ZNF800.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF804A-1H8
AC   CVCL_KQ77
DR   DSHB; PCRP-ZNF804A-1H8
DR   Wikidata; Q54946672
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7Z570; Human ZNF804A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF81-2C7
AC   CVCL_KQ78
DR   DSHB; PCRP-ZNF81-2C7
DR   Wikidata; Q54946673
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P51508; Human ZNF81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF81-2G2
AC   CVCL_KQ79
DR   DSHB; PCRP-ZNF81-2G2
DR   Wikidata; Q54946674
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P51508; Human ZNF81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF830-1B4
AC   CVCL_KQ80
DR   Wikidata; Q54946676
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96NB3; Human ZNF830.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF830-1C5
AC   CVCL_KQ81
DR   Wikidata; Q54946677
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q96NB3; Human ZNF830.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZNF846-1D7
AC   CVCL_KQ82
DR   DSHB; PCRP-ZNF846-1D7
DR   Wikidata; Q54946678
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q147U1; Human ZNF846.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF846-1E12
AC   CVCL_KQ83
DR   DSHB; PCRP-ZNF846-1E12
DR   Wikidata; Q54946679
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q147U1; Human ZNF846.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF846-1F9
AC   CVCL_KQ84
DR   DSHB; PCRP-ZNF846-1F9
DR   Wikidata; Q54946681
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q147U1; Human ZNF846.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF85-2A11
AC   CVCL_KQ85
DR   DSHB; PCRP-ZNF85-2A11
DR   Wikidata; Q54946682
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q03923; Human ZNF85.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNF98-1A11
AC   CVCL_KQ86
DR   DSHB; PCRP-ZNF98-1A11
DR   Wikidata; Q54946698
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A6NK75; Human ZNF98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNFX1-1D3
AC   CVCL_KQ87
DR   DSHB; PCRP-ZNFX1-1D3
DR   Wikidata; Q54946699
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9P2E3; Human ZNFX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZNFX1-1E6
AC   CVCL_KQ88
DR   DSHB; PCRP-ZNFX1-1E6
DR   Wikidata; Q54946700
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9P2E3; Human ZNFX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN12-1A9
AC   CVCL_KQ89
DR   DSHB; PCRP-ZSCAN12-1A9
DR   Wikidata; Q54946701
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43309; Human ZSCAN12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN12-2D1
AC   CVCL_KQ90
DR   DSHB; PCRP-ZSCAN12-2D1
DR   Wikidata; Q54946702
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; O43309; Human ZSCAN12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN12-2F2
AC   CVCL_KQ91
DR   DSHB; PCRP-ZSCAN12-2F2
DR   Wikidata; Q54946703
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; O43309; Human ZSCAN12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN2-1F8
AC   CVCL_KQ92
DR   DSHB; PCRP-ZSCAN2-1F8
DR   Wikidata; Q54946704
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q7Z7L9; Human ZSCAN2.
CC   Discontinued: DSHB; PCRP-ZSCAN2-1F8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN2-1G6
AC   CVCL_KQ93
DR   DSHB; PCRP-ZSCAN2-1G6
DR   Wikidata; Q54946705
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z7L9; Human ZSCAN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN2-2D7
AC   CVCL_KQ94
DR   DSHB; PCRP-ZSCAN2-2D7
DR   Wikidata; Q54946706
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q7Z7L9; Human ZSCAN2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN2-2G2
AC   CVCL_KQ95
DR   DSHB; PCRP-ZSCAN2-2G2
DR   Wikidata; Q54946707
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7Z7L9; Human ZSCAN2.
CC   Discontinued: DSHB; PCRP-ZSCAN2-2G2; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN2-3A12
AC   CVCL_KQ96
DR   DSHB; PCRP-ZSCAN2-3A12
DR   Wikidata; Q54946708
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q7Z7L9; Human ZSCAN2.
CC   Discontinued: DSHB; PCRP-ZSCAN2-3A12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN2-4B5
AC   CVCL_KQ97
DR   DSHB; PCRP-ZSCAN2-4B5
DR   Wikidata; Q54946709
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q7Z7L9; Human ZSCAN2.
CC   Discontinued: DSHB; PCRP-ZSCAN2-4B5; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN21-1B2
AC   CVCL_KQ98
DR   DSHB; PCRP-ZSCAN21-1B2
DR   Wikidata; Q54946710
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9Y5A6; Human ZSCAN21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN22-1A12
AC   CVCL_KQ99
DR   DSHB; PCRP-ZSCAN22-1A12
DR   Wikidata; Q54946711
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10073; Human ZSCAN22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN22-1C12
AC   CVCL_KR00
DR   DSHB; PCRP-ZSCAN22-1C12
DR   Wikidata; Q54946712
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10073; Human ZSCAN22.
CC   Discontinued: DSHB; PCRP-ZSCAN22-1C12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN22-1C7
AC   CVCL_KR01
DR   DSHB; PCRP-ZSCAN22-1C7
DR   Wikidata; Q54946713
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10073; Human ZSCAN22.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN23-3G2
AC   CVCL_KR02
DR   DSHB; PCRP-ZSCAN23-3G2
DR   Wikidata; Q54946714
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q3MJ62; Human ZSCAN23.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN25-1A6
AC   CVCL_KR03
DR   DSHB; PCRP-ZSCAN25-1A6
DR   Wikidata; Q54946715
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q6NSZ9; Human ZSCAN25.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN26-1F12
AC   CVCL_KR04
DR   DSHB; PCRP-ZSCAN26-1F12
DR   Wikidata; Q54946716
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q16670; Human ZSCAN26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN31-1B6
AC   CVCL_KR05
DR   DSHB; PCRP-ZSCAN31-1B6
DR   Wikidata; Q54946717
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96LW9; Human ZSCAN31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN31-1B9
AC   CVCL_KR06
DR   DSHB; PCRP-ZSCAN31-1B9
DR   Wikidata; Q54946718
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96LW9; Human ZSCAN31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN5A-1B7
AC   CVCL_KR07
DR   DSHB; PCRP-ZSCAN5A-1B7
DR   Wikidata; Q54946719
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
CC   Discontinued: DSHB; PCRP-ZSCAN5A-1B7; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN5A-1G7
AC   CVCL_KR08
DR   DSHB; PCRP-ZSCAN5A-1G7
DR   Wikidata; Q54946720
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN5A-2B5
AC   CVCL_KR09
DR   DSHB; PCRP-ZSCAN5A-2B5
DR   Wikidata; Q54946722
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN5A-2F11
AC   CVCL_KR10
DR   DSHB; PCRP-ZSCAN5A-2F11
DR   Wikidata; Q54946723
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
CC   Discontinued: DSHB; PCRP-ZSCAN5A-2F11; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN5A-2H4
AC   CVCL_KR11
DR   DSHB; PCRP-ZSCAN5A-2H4
DR   Wikidata; Q54946724
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
CC   Discontinued: DSHB; PCRP-ZSCAN5A-2H4; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN5A-2H8
AC   CVCL_KR12
DR   DSHB; PCRP-ZSCAN5A-2H8
DR   Wikidata; Q54946725
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
CC   Discontinued: DSHB; PCRP-ZSCAN5A-2H8; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN5A-3F9
AC   CVCL_KR13
DR   DSHB; PCRP-ZSCAN5A-3F9
DR   Wikidata; Q54946726
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
CC   Discontinued: DSHB; PCRP-ZSCAN5A-3F9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN5A-4A9
AC   CVCL_KR14
DR   DSHB; PCRP-ZSCAN5A-4A9
DR   Wikidata; Q54946727
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
CC   Discontinued: DSHB; PCRP-ZSCAN5A-4A9; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZSCAN5A-4B5
AC   CVCL_KR15
DR   DSHB; PCRP-ZSCAN5A-4B5
DR   Wikidata; Q54946728
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9BUG6; Human ZSCAN5A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZSCAN9-2A6
AC   CVCL_KR16
DR   DSHB; PCRP-ZSCAN9-2A6
DR   Wikidata; Q54946729
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; O15535; Human ZSCAN9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZUFSP-1A2
AC   CVCL_KR17
DR   DSHB; PCRP-ZUFSP-1A2
DR   Wikidata; Q54946730
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q96AP4; Human ZUFSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZUFSP-1C12
AC   CVCL_KR18
DR   DSHB; PCRP-ZUFSP-1C12
DR   Wikidata; Q54946731
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q96AP4; Human ZUFSP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZXDC-1H12
AC   CVCL_KR19
DR   DSHB; PCRP-ZXDC-1H12
DR   Wikidata; Q54946732
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q2QGD7; Human ZXDC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZXDC-2B5
AC   CVCL_KR20
DR   DSHB; PCRP-ZXDC-2B5
DR   Wikidata; Q54946733
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2QGD7; Human ZXDC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZXDC-3B6
AC   CVCL_KR21
DR   DSHB; PCRP-ZXDC-3B6
DR   Wikidata; Q54946734
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2QGD7; Human ZXDC.
CC   Discontinued: DSHB; PCRP-ZXDC-3B6; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZXDC-3C12
AC   CVCL_KR22
DR   DSHB; PCRP-ZXDC-3C12
DR   Wikidata; Q54946735
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2QGD7; Human ZXDC.
CC   Discontinued: DSHB; PCRP-ZXDC-3C12; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   PCRP-ZXDC-3D1
AC   CVCL_KR23
DR   DSHB; PCRP-ZXDC-3D1
DR   Wikidata; Q54946737
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q2QGD7; Human ZXDC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZXDC-4B9
AC   CVCL_KR24
DR   Wikidata; Q54946738
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q2QGD7; Human ZXDC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   PCRP-ZZZ3-1B11
AC   CVCL_KR25
DR   DSHB; PCRP-ZZZ3-1B11
DR   Wikidata; Q54946739
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IYH5; Human ZZZ3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCRP-ZZZ3-1B2
AC   CVCL_KR26
DR   DSHB; PCRP-ZZZ3-1B2
DR   Wikidata; Q54946758
CC   Part of: NIH Protein Capture Reagents Program (PCRP) hybridoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IYH5; Human ZZZ3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   PCTH-3
AC   CVCL_JX85
DR   Wikidata; Q54946759
RX   PubMed=6152636;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04177; Rat Th.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   PCTH-4
AC   CVCL_JX86
DR   Wikidata; Q54946760
RX   PubMed=6152636;
CC   Characteristics: The monoclonal antibody produced by this hybridoma inhibits the catalytic activity of TH.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04177; Rat Th.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   PCTH-7
AC   CVCL_JX87
DR   Wikidata; Q54946763
RX   PubMed=6152636;
CC   Characteristics: The monoclonal antibody produced by this hybridoma inhibits the catalytic activity of TH.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04177; Rat Th.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   PD PaCa
AC   CVCL_8401
SY   PDPaCa; Poorly Differentiated Pancreatic adenoCarcinoma; PD
DR   Wikidata; Q54946764
RX   PubMed=3971476;
RX   PubMed=6435863;
RX   PubMed=6805945;
RX   PubMed=8863680;
CC   Doubling time: ~18 hours (PubMed=3971476).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   PD(H39)
AC   CVCL_Y454
DR   ATCC; CRL-6491
DR   Wikidata; Q54946765
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6491; true.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   PD-1.3
AC   CVCL_DF55
SY   PD1.3; PD1.3.1; PD1 3.1
DR   Wikidata; Q54946766
RX   Patent=US9637546;
RX   Patent=US9896507;
RX   Patent=US10005839;
RX   PubMed=20587542;
RX   PubMed=20693422;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4122.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 8
//
ID   PD-1.6
AC   CVCL_B7F0
SY   PD1.6; PD1.6.4; PD1 6.4
DR   Wikidata; Q112930293
RX   Patent=US9637546;
RX   Patent=US9896507;
RX   PubMed=20587542;
RX   PubMed=20693422;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   PD-BP001-iPSC
AC   CVCL_JJ80
DR   Wikidata; Q54946767
RX   PubMed=28413004;
CC   From: Jilin University First Hospital; Changchun; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   PD-BP15-iPSC
AC   CVCL_JL85
DR   Wikidata; Q54946768
RX   PubMed=28395804;
CC   From: National Neuroscience Institute; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Asn551Lys (c.1653C>G); ClinVar=VCV000039139; Zygosity=Heterozygous (PubMed=28395804).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   PD-BP19-iPSC
AC   CVCL_JL86
DR   Wikidata; Q54946769
RX   PubMed=28395802;
CC   From: National Neuroscience Institute; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1628Pro (c.4883G>C); ClinVar=VCV000039198; Zygosity=Heterozygous (PubMed=28395802).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   PD-BP26-iPSC
AC   CVCL_JL87
DR   Wikidata; Q54946770
RX   PubMed=28395803;
CC   From: National Neuroscience Institute; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1398His (c.4193G>A); ClinVar=VCV000039178; Zygosity=Heterozygous (PubMed=28395803).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   PD-BP44-iPSC
AC   CVCL_JL88
DR   Wikidata; Q54946771
RX   PubMed=28395805;
CC   From: National Neuroscience Institute; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Ser1647Thr (c.4939T>A); ClinVar=VCV000039201; Zygosity=Heterozygous (PubMed=28395805).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   PD-iPS1 [Human iPSC China]
AC   CVCL_L664
DR   SKIP; SKIP005477
DR   Wikidata; Q54946773
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*11,31; B*35,67 (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D12S391: 17,21
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 13.2,15
ST   D21S11: 28,29
ST   D2S1338: 22,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 19,20
ST   D7S820: 11,14
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 19,21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L665 ! PD-iPS2
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   PD-iPS1 [Human iPSC USA]
AC   CVCL_C952
SY   PD-IPS1
DR   Wikidata; Q54946774
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L781 ! AG20446
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   PD-iPS11
AC   CVCL_C953
SY   PD-IPS11
DR   Wikidata; Q54946775
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L781 ! AG20446
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   PD-iPS2
AC   CVCL_L665
DR   SKIP; SKIP005478
DR   Wikidata; Q54946776
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*11,31; B*35,67 (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D12S391: 17,21
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 13.2,15
ST   D21S11: 28,29
ST   D2S1338: 22,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 19,20
ST   D7S820: 11,14
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 19,21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L664 ! PD-iPS1 [Human iPSC China]
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   PD-iPS5
AC   CVCL_C954
SY   PD-IPS5
DR   Wikidata; Q54946777
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L781 ! AG20446
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   PD-L1.1
AC   CVCL_DF56
SY   PDL1.1
DR   Wikidata; Q54946778
RX   Patent=US9637546;
RX   PubMed=20587542;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4080.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
ID   PD-L1.2
AC   CVCL_DF57
SY   PDL1.2
DR   Wikidata; Q54946780
RX   Patent=US9637546;
RX   PubMed=20587542;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4081.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
ID   PD-L1.3
AC   CVCL_B7F9
SY   PDL1.3; PD-L1.3.1
DR   Wikidata; Q112930295
RX   Patent=US9637546;
RX   Patent=US9896507;
RX   PubMed=20587542;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   PD-L2.1
AC   CVCL_B7F8
SY   PDL2.1
DR   Wikidata; Q112930297
RX   Patent=US9896507;
RX   PubMed=20587542;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BQ51; Human PDCD1LG2/CD273.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   PD-Mel
AC   CVCL_M743
SY   PDMel
DR   Wikidata; Q54946781
RX   PubMed=11121133;
CC   From: Guadagni, Fiorella; Regina Elena Institute for Cancer Research; Rome; Italy.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   PD12-1
AC   CVCL_B7DK
DR   Wikidata; Q112930298
RX   PubMed=28858313;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7DI ! 783E2
OI   CVCL_B7DF ! 1274A8
OI   CVCL_B7DE ! 1274A15
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   PD17-7
AC   CVCL_B7DD
DR   Wikidata; Q112930299
RX   PubMed=28233934;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   PD20 RV:D2
AC   CVCL_AK49
SY   PD.20hygro:RV; PD20-wtD2
DR   Wikidata; Q54946782
RX   PubMed=12361951;
WW   Provider; OHSU; -; https://apps.ohsu.edu/research/fanconi-anemia/cell_line/
CC   Characteristics: Transfection of wild type FANCD2 restores the full activity of the protein which is mutated in the parent cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3585; FANCD2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125706; Fanconi anemia, complementation group D2
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G042 ! GM16633
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   PD3
AC   CVCL_D5Y2
DR   Wikidata; Q127383033
RX   PubMed=6208130;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01215; Human CGA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   PD352.F
AC   CVCL_AK48
SY   PD352-F; PD.352.F; PD352
DR   Wikidata; Q54946783
RX   PubMed=12361951;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125708; Fanconi anemia, complementation group G
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   PD41
AC   CVCL_C8A8
SY   PD41.84
DR   Wikidata; Q123033257
RX   Patent=US5314996;
RX   Patent=WO1993014775A1;
RX   PubMed=1705172;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11094.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human prostate mucin antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   PD42
AC   CVCL_B4UI
DR   PRIDE; PXD006939
DR   PRIDE; PXD012308
DR   Wikidata; Q110433133
RX   PubMed=28832583;
RX   PubMed=29242379;
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*02:06,24:02; B*07:02,55:01; C*01:02,07:02 (PubMed=28832583).
CC   HLA typing: DPA1*01:03,02:02; DPB1*04:01,05:01; DQA1*01:01,01:02; DQB1*05:01,06:02; DRB1*01:02,15:01; DRB5*01:01 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   PD5
AC   CVCL_4270
SY   PD 5; Philips-Duphar 5
DR   CLO; CLO_0008402
DR   CLO; CLO_0008403
DR   CLDB; cl3889
DR   CLDB; cl3890
DR   ECACC; 93120830
DR   IZSLER; BS CL 99
DR   Wikidata; Q54946785
RX   PubMed=6182101;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   PDA-01
AC   CVCL_WB04
SY   Patent Ductus Arteriosus-01
DR   IBRC; C11094
DR   Wikidata; Q98128528
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84492; Patent ductus arteriosus
DI   ORDO; Orphanet_95485; Arterial duct anomaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   PDA3F-1
AC   CVCL_0G96
DR   SKIP; SKIP000542
DR   Wikidata; Q54946787
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N797 ! AG20443
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDA3F-5
AC   CVCL_0G97
DR   SKIP; SKIP000589
DR   Wikidata; Q54946788
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N797 ! AG20443
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDAC-X3
AC   CVCL_E4BW
RX   PubMed=39012569;
CC   Population: Chinese.
CC   Doubling time: 50 hours (PubMed=39012569).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=39012569
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 18
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14
ST   D1S1656: 16
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 18,23
ST   Penta D: 11,12
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PDB1lox-17GFP-29
AC   CVCL_RJ32
DR   SKIP; SKIP000959
DR   Wikidata; Q54946790
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ49 ! PDB2lox-17
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   PDB1lox-17GFP-55
AC   CVCL_RJ33
DR   SKIP; SKIP000960
DR   Wikidata; Q54946791
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ49 ! PDB2lox-17
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   PDB1lox-17Puro-10
AC   CVCL_RJ35
DR   SKIP; SKIP000962
DR   Wikidata; Q54946792
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ49 ! PDB2lox-17
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-17Puro-12
AC   CVCL_RJ36
DR   SKIP; SKIP000963
DR   Wikidata; Q54946793
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ49 ! PDB2lox-17
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-17Puro-31
AC   CVCL_RJ37
DR   SKIP; SKIP000964
DR   Wikidata; Q54946794
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ49 ! PDB2lox-17
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-17Puro-33
AC   CVCL_RJ38
DR   SKIP; SKIP000965
DR   Wikidata; Q54946795
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ49 ! PDB2lox-17
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-17Puro-5
AC   CVCL_RJ34
DR   SKIP; SKIP000961
DR   Wikidata; Q54946796
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ49 ! PDB2lox-17
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-21GFP-19
AC   CVCL_RJ39
DR   SKIP; SKIP000966
DR   Wikidata; Q54946797
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   PDB1lox-21GFP-41
AC   CVCL_RJ40
DR   SKIP; SKIP000974
DR   Wikidata; Q54946799
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   PDB1lox-21Puro-12
AC   CVCL_RJ42
DR   SKIP; SKIP000968
DR   Wikidata; Q54946800
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-21Puro-13
AC   CVCL_RJ43
DR   SKIP; SKIP000969
DR   Wikidata; Q54946801
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-21Puro-18
AC   CVCL_RJ44
DR   SKIP; SKIP000970
DR   Wikidata; Q54946802
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-21Puro-20
AC   CVCL_RJ45
DR   SKIP; SKIP000971
DR   Wikidata; Q54946803
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-21Puro-26
AC   CVCL_RJ46
DR   SKIP; SKIP000972
DR   Wikidata; Q54946804
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-21Puro-28
AC   CVCL_RJ47
DR   SKIP; SKIP000973
DR   Wikidata; Q54946805
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB1lox-21Puro-5
AC   CVCL_RJ41
DR   SKIP; SKIP000967
DR   Wikidata; Q54946810
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RJ50 ! PDB2lox-21
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDB2lox-17
AC   CVCL_RJ49
DR   SKIP; SKIP000763
DR   Wikidata; Q54946811
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   PDB2lox-21
AC   CVCL_RJ50
DR   SKIP; SKIP000764
DR   Wikidata; Q54946812
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   PDB2lox-22
AC   CVCL_RJ51
DR   SKIP; SKIP000765
DR   Wikidata; Q54946813
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   PDB2lox-5
AC   CVCL_RJ48
DR   SKIP; SKIP000762
DR   Wikidata; Q54946814
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   PDB3F-1
AC   CVCL_0G98
DR   SKIP; SKIP000590
DR   Wikidata; Q54946815
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB3F-5
AC   CVCL_0G99
DR   SKIP; SKIP000591
DR   Wikidata; Q54946816
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB3F-8
AC   CVCL_0H00
DR   SKIP; SKIP000592
DR   Wikidata; Q54946817
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB3F-9
AC   CVCL_0H01
DR   SKIP; SKIP000593
DR   Wikidata; Q54946818
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB3F-d12
AC   CVCL_0H02
DR   SKIP; SKIP000594
DR   Wikidata; Q54946819
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB4F-1
AC   CVCL_0H03
DR   SKIP; SKIP000595
DR   Wikidata; Q54946821
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB4F-2
AC   CVCL_0H04
DR   SKIP; SKIP000596
DR   Wikidata; Q54946822
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB4F-3
AC   CVCL_0H05
DR   SKIP; SKIP000597
DR   Wikidata; Q54946823
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB4F-4
AC   CVCL_0H06
DR   SKIP; SKIP000598
DR   Wikidata; Q54946824
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDB4F-5
AC   CVCL_0H07
DR   SKIP; SKIP000599
DR   Wikidata; Q54946826
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X806 ! AG20442
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDC3F-1
AC   CVCL_0H08
DR   SKIP; SKIP000600
DR   Wikidata; Q54946827
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L781 ! AG20446
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD3F-1
AC   CVCL_0H09
DR   SKIP; SKIP000601
DR   Wikidata; Q54946829
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD3F-4
AC   CVCL_0H10
DR   SKIP; SKIP000602
DR   Wikidata; Q54946830
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD3F-7
AC   CVCL_0H11
DR   SKIP; SKIP000603
DR   Wikidata; Q54946831
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD4F-1
AC   CVCL_0H12
DR   SKIP; SKIP000604
DR   Wikidata; Q54946832
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD4F-4
AC   CVCL_0H13
DR   SKIP; SKIP000605
DR   Wikidata; Q54946833
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD4F-5
AC   CVCL_0H14
DR   SKIP; SKIP000606
DR   Wikidata; Q54946834
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD4F-8
AC   CVCL_0H15
DR   SKIP; SKIP000607
DR   Wikidata; Q54946836
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDD4F-9
AC   CVCL_0H16
DR   SKIP; SKIP000608
DR   Wikidata; Q54946837
RX   PubMed=19269371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X807 ! AG20445
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PDE3F-3
AC   CVCL_0H17
DR   SKIP; SKIP000609
DR   Wikidata; Q54946838
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N795 ! AG08395
SX   Female
AG   85Y9M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDE3F-4
AC   CVCL_0H18
DR   SKIP; SKIP000610
DR   Wikidata; Q54946839
RX   PubMed=19269371;
CC   Population: Caucasian.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N795 ! AG08395
SX   Female
AG   85Y9M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PDF
AC   CVCL_1G97
SY   Puntius Denisonii Fin
DR   NRFC; NRFC009
DR   Wikidata; Q54946840
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=21136193;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC009.
CC   Doubling time: 28 hours (Note=At 50th passage) (PubMed=21136193).
CC   Miscellaneous: Cell line is no longer available (NRFC=NRFC009).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=2985178; ! Dawkinsia denisonii (Denison barb)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 15
//
ID   PDFS
AC   CVCL_M435
DR   Wikidata; Q54946841
RX   PubMed=10720059;
RX   PubMed=15541569;
RX   PubMed=31728905;
CC   Doubling time: 23.8 hours (PubMed=10720059).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Cell type: Folliculostellate cell; CL=CL_0000642.
DI   NCIt; C121721; Non-functioning pituitary gland macroadenoma
DI   ORDO; Orphanet_91349; Non-functioning pituitary adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PDH
AC   CVCL_1G98
SY   Puntius Denisonii Heart
DR   Wikidata; Q54946842
RX   CelloPub=CLPUB00463;
RX   PubMed=21136193;
CC   Group: Fish cell line.
CC   Doubling time: 30 hours (Note=At 50th passage) (PubMed=21136193).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=2985178; ! Dawkinsia denisonii (Denison barb)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 11
//
ID   PDIS-1
AC   CVCL_RN04
SY   HEK-293T/GnT-1-KO 1
DR   Wikidata; Q54946843
RX   PubMed=28101903;
CC   Knockout cell: Method=TALEN; HGNC; HGNC:7044; MGAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   PDIS-12
AC   CVCL_RN05
SY   HEK-293T/GnT-1-KO 2
DR   Wikidata; Q54946844
RX   PubMed=28101903;
CC   Knockout cell: Method=TALEN; HGNC; HGNC:7044; MGAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   PDIS-13
AC   CVCL_D2TP
SY   LN229/hPODXL-knockout
DR   Wikidata; Q127383035
RX   PubMed=28384052;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   PDIS-14
AC   CVCL_RN06
SY   CHO-S/SLC35A1-KO
DR   ABM; T6040
DR   Wikidata; Q54946845
RX   PubMed=28101903;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; O08520; Slc35a1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 6
//
ID   PDIS-2
AC   CVCL_RN07
SY   HEK-293T/hPDPN-knockout; HEK-293T/hPDPN-KO
DR   Wikidata; Q54946846
RX   PubMed=26937552;
RX   PubMed=27031228;
RX   PubMed=27328060;
RX   PubMed=27564251;
RX   PubMed=28101903;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   PDIS-22
AC   CVCL_RN08
SY   HEK-293T/SLC35A1-KO
DR   Wikidata; Q54946847
RX   PubMed=28101903;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   PDIS-4
AC   CVCL_D2UH
SY   COS-7/hPDPN-KO
DR   ABM; T6039
DR   Wikidata; Q127383036
RX   PubMed=27031228;
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S8J3; PDPN (Note=Not from Chlorocebus aethiops but from Chlorocebus sabaeus, the closest currently available sequenced species).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0224 ! COS-7
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PDIS-6
AC   CVCL_RN09
SY   LN319/hPDPN-KO
DR   cancercelllines; CVCL_RN09
DR   Wikidata; Q54946849
RX   PubMed=27031228;
RX   PubMed=27328060;
RX   PubMed=27564251;
RX   PubMed=28101903;
CC   Problematic cell line: Contaminated. Parent cell line (LN-319) has been shown to be a LN-992 derivative.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3958 ! LN-319
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   PDIS-9
AC   CVCL_RN10
SY   CHO-S/GnT-1-KO
DR   Wikidata; Q54946850
RX   PubMed=28101903;
CC   Knockout cell: Method=TALEN; UniProtKB; Q924C0; Mgat1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 6
//
ID   PDL 1
AC   CVCL_B5XR
DR   Wikidata; Q112129489
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 10
AC   CVCL_B5Y0
DR   Wikidata; Q112129490
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 11
AC   CVCL_B5Y1
DR   Wikidata; Q112129491
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 2
AC   CVCL_B5XS
DR   Wikidata; Q112129493
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 3
AC   CVCL_B5XT
DR   Wikidata; Q112129494
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 4
AC   CVCL_B5XU
DR   Wikidata; Q112129495
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 5
AC   CVCL_B5XV
DR   Wikidata; Q112129496
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 6
AC   CVCL_B5XW
DR   Wikidata; Q112129497
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 7
AC   CVCL_B5XX
DR   Wikidata; Q112129498
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 8
AC   CVCL_B5XY
DR   Wikidata; Q112129499
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL 9
AC   CVCL_B5XZ
DR   Wikidata; Q112129500
RX   PubMed=16297161;
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PDL-1
AC   CVCL_G248
DR   CLO; CLO_0008407
DR   ATCC; CRL-1882
DR   Wikidata; Q54946851
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   PDL-hTERT
AC   CVCL_C3S0
SY   PerioDontal Ligament-hTERT-immortalized
DR   Wikidata; Q116050114
RX   PubMed=20473831;
RX   PubMed=33120924;
CC   Doubling time: ~90 hours (PubMed=20473831).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <25Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   PDL-L2
AC   CVCL_6B13
SY   PDL-L 2
DR   Wikidata; Q54946852
RX   PubMed=12356921;
RX   PubMed=17233813;
RX   PubMed=24949082;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   PDOA1
AC   CVCL_D3QQ
SY   948G11
DR   Wikidata; Q127383037
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10275.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB (Note=Recognizes reduced carboxymethylated ovalbumin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PDOA2
AC   CVCL_D3QR
SY   962B8
DR   Wikidata; Q127383038
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10276.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB (Note=Recognizes reduced carboxymethylated ovalbumin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PDOM1
AC   CVCL_D3QS
SY   628E1
DR   Wikidata; Q127383039
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10277.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01005; Chicken ovomucoid (Note=Recognizes reduced carboxymethylated ovomucoid).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PDOM2
AC   CVCL_D3QT
SY   648A9
DR   Wikidata; Q127383041
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10278.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01005; Chicken ovomucoid (Note=Recognizes reduced carboxymethylated ovomucoid).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PDSH723R01#12
AC   CVCL_RL25
SY   H723R clone #12
DR   SKIP; SKIP001747
DR   Wikidata; Q54946853
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Homozygous (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL24 ! PDSH723R01#5
OI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   PDSH723R01#16
AC   CVCL_RL26
SY   H723R clone #16; H723R #16
DR   SKIP; SKIP001746
DR   Wikidata; Q54946854
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Homozygous (PubMed=28052261).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL24 ! PDSH723R01#5
OI   CVCL_RL25 ! PDSH723R01#12
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   PDSH723R01#5
AC   CVCL_RL24
SY   H723R clone #5
DR   SKIP; SKIP001748
DR   Wikidata; Q54946860
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Homozygous (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL25 ! PDSH723R01#12
OI   CVCL_RL26 ! PDSH723R01#16
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   PDSHM147V#13
AC   CVCL_RL28
SY   M147V clone #13
DR   SKIP; SKIP001750
DR   Wikidata; Q54946861
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Met147Val (c.439A>G); ClinVar=VCV000691508; Zygosity=Heterozygous (PubMed=28052261).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous (PubMed=28052261).
CC   Misspelling: PDSHM147V#14; SKIP=SKIP001750.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL27 ! PDSHM147V#3
OI   CVCL_RL29 ! PDSHM147V#18
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PDSHM147V#18
AC   CVCL_RL29
SY   M147V clone #18
DR   SKIP; SKIP001749
DR   Wikidata; Q54946862
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Met147Val (c.439A>G); ClinVar=VCV000691508; Zygosity=Heterozygous (PubMed=28052261).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL27 ! PDSHM147V#3
OI   CVCL_RL28 ! PDSHM147V#13
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PDSHM147V#3
AC   CVCL_RL27
SY   M147V clone #3
DR   SKIP; SKIP001751
DR   Wikidata; Q54946863
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Met147Val (c.439A>G); ClinVar=VCV000691508; Zygosity=Heterozygous (PubMed=28052261).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.His723Arg (c.2168A>G); ClinVar=VCV000004825; Zygosity=Heterozygous (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL28 ! PDSHM147V#13
OI   CVCL_RL29 ! PDSHM147V#18
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PDSHT410M#11
AC   CVCL_RL31
SY   T410M clone #11
DR   SKIP; SKIP001753
DR   Wikidata; Q54946864
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Thr410Met (c.1229C>T); ClinVar=VCV000043498; Zygosity=Homozygous (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL30 ! PDSHT410M#3
OI   CVCL_RL32 ! PDSHT410M#12
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   PDSHT410M#12
AC   CVCL_RL32
SY   T410M clone #12
DR   SKIP; SKIP001752
DR   Wikidata; Q54946865
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Thr410Met (c.1229C>T); ClinVar=VCV000043498; Zygosity=Homozygous (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL30 ! PDSHT410M#3
OI   CVCL_RL31 ! PDSHT410M#11
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   PDSHT410M#3
AC   CVCL_RL30
SY   T410M clone #3
DR   SKIP; SKIP001754
DR   Wikidata; Q54946867
RX   PubMed=28052261;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; p.Thr410Met (c.1229C>T); ClinVar=VCV000043498; Zygosity=Homozygous (PubMed=28052261).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL31 ! PDSHT410M#11
OI   CVCL_RL32 ! PDSHT410M#12
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   PDSS-26
AC   CVCL_B458
SY   Poorly Differentiated Synovial Sarcoma-26 year old
DR   Cosmic; 1212218
DR   Wikidata; Q54946868
RX   PubMed=14553945;
CC   Doubling time: ~72 hours (Note=At 25-30th passages) (PubMed=14553945).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=14553945).
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   PDV
AC   CVCL_5858
DR   CLS; 400314
DR   Wikidata; Q54946870
RX   PubMed=102384;
RX   PubMed=1855225;
RX   PubMed=1934268;
RX   PubMed=2185890;
RX   PubMed=2414007;
RX   PubMed=6190961;
RX   PubMed=12807763;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C57BL/10 LP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   PDVC 57B
AC   CVCL_4271
SY   PDVC57B; PDVC57b; PDVC57; PDV.C57; PDV C57
DR   CancerTools; 151630
DR   ECACC; 01022129
DR   Wikidata; Q54946871
DR   Ximbio; 151630
RX   PubMed=1855225;
RX   PubMed=1934268;
RX   PubMed=2185890;
RX   PubMed=2414007;
RX   PubMed=12807763;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: ECACC; 01022129; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: C57BL/10 LP.
DI   NCIt; C21810; Spindle-cell squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5858 ! PDV
SX   Sex unspecified
AG   <1D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   PDX1 C18R iPSC1
AC   CVCL_A4MX
DR   SKIP; SKIP003040
DR   Wikidata; Q105510551
RX   PubMed=27879214;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6107; PDX1; Simple; p.Cys18Arg (c.52T>C); ClinVar=VCV000008862; Zygosity=Heterozygous (PubMed=27879214).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129746; PDX1-associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   PDX1 P33T iPSC1
AC   CVCL_A4MW
DR   SKIP; SKIP003041
DR   Wikidata; Q105510553
RX   PubMed=27879211;
CC   From: Helmholtz Zentrum Munchen; Neuherberg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6107; PDX1; Simple; p.Pro33Thr (c.97C>T); ClinVar=VCV000036414; Zygosity=Heterozygous (PubMed=27879211).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129746; PDX1-associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   PDXPC1
AC   CVCL_YP13
DR   cancercelllines; CVCL_YP13
DR   Wikidata; Q98128529
RX   PubMed=32124956;
CC   Population: Chinese.
CC   Characteristics: Established from a 3rd generation xenograft obtained by subcutaneously implantation into female BALB/c nude mice of the parent tumor cells.
CC   Doubling time: 37.2 hours (PubMed=32124956).
CC   Sequence variation: Mutation; HGNC; HGNC:4392; GNAS; Simple; p.His69Asn (c.205C>A); Zygosity=Heterozygous (PubMed=32124956).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=32124956).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=32124956).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=32124956
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 9,11
ST   D7S820: 10,11,11.3
ST   TH01: 7,9
ST   TPOX: 10,12
ST   vWA: 15,16,20
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   PE
AC   CVCL_1D86
DR   ChEMBL-Cells; CHEMBL3308676
DR   ChEMBL-Targets; CHEMBL614846
DR   PubChem_Cell_line; CVCL_1D86
DR   Wikidata; Q54946872
RX   PubMed=2871947;
WW   Provider; NIH OTT; E-100-2008-34; https://web.archive.org/web/20150923174727/http://www.ott.nih.gov/erma/mouse-keratinocyte-tumor-cell-line-pe
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: SENCAR.
DI   NCIt; C21803; Papilloma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   PE 9
AC   CVCL_XC30
SY   PE9; HB PE9
DR   CCRID; 4201PAT-CCTCC00052
DR   Wikidata; Q98128530
RX   Patent=US5147783;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1607.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04179; Human SOD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   PE-1 [Human]
AC   CVCL_QX06
SY   PE1
DR   Cosmic; 720792
DR   Cosmic; 2081403
DR   Cosmic; 2367292
DR   Wikidata; Q54946875
RX   CelloPub=CLPUB00604;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: IL6 dependent.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   PE-1 [Pig]
AC   CVCL_6G49
SY   Porcine Endometrial cells-1
DR   Wikidata; Q54946876
RX   PubMed=1280756;
CC   Doubling time: ~48 hours (PubMed=1280756).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   PE-2
AC   CVCL_QX07
SY   PE2
DR   Cosmic; 2081404
DR   Wikidata; Q54946877
RX   CelloPub=CLPUB00604;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   Pe-LCL
AC   CVCL_6D81
DR   Wikidata; Q54946881
RX   PubMed=8127151;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   PE/CA-PJ15
AC   CVCL_2678
SY   PE-CA-PJ15; PE/CA PJ15; PE/CA-PJ-15; PE_CA-PJ15; PE CA PJ15; PECAPJ15
DR   CLO; CLO_0009951
DR   EFO; EFO_0006733
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 991
DR   BioSample; SAMN03473150
DR   BioSample; SAMN10988005
DR   cancercelllines; CVCL_2678
DR   Cell_Model_Passport; SIDM00473
DR   Cosmic; 1339923
DR   Cosmic; 1995614
DR   Cosmic-CLP; 1240207
DR   DepMap; ACH-000619
DR   ECACC; 96121230
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240207
DR   GEO; GSM827436
DR   GEO; GSM887508
DR   GEO; GSM888590
DR   GEO; GSM1374826
DR   GEO; GSM1374827
DR   GEO; GSM1670346
DR   IARC_TP53; 28304
DR   LiGeA; CCLE_253
DR   LINCS_HMS; 50039
DR   LINCS_LDP; LCL-1212
DR   PharmacoDB; PE_CAPJ15_1256_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2678
DR   Wikidata; Q54946882
RX   PubMed=9876219;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=32990596;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,25:01; B*18:01,44:03; C*12:03,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (DepMap=ACH-000619).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.75%; Native American=0%; East Asian, North=3.5%; East Asian, South=0%; South Asian=0%; European, North=59.74%; European, South=35% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Cosmic-CLP=1240207; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D18S51: 17
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   PE/CA-PJ34 (clone C12)
AC   CVCL_2679
SY   PECAPJ34CLONEC12; PE-CA-PJ34-cl C12; PE/CA-PJ34; PE/CA-PJ-34; PE CA PJ34; PECAPJ34; PJ34; Plaepi 34
DR   CLO; CLO_0008408
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 488
DR   BioSample; SAMN10988009
DR   cancercelllines; CVCL_2679
DR   Cell_Model_Passport; SIDM01324
DR   Cosmic; 1339919
DR   DepMap; ACH-000606
DR   ECACC; 97062513
DR   GEO; GSM887509
DR   GEO; GSM888591
DR   GEO; GSM1374828
DR   GEO; GSM1374829
DR   GEO; GSM1643589
DR   IARC_TP53; 28363
DR   LiGeA; CCLE_922
DR   PharmacoDB; PE_CAPJ34_cloneC12_1257_2019
DR   Progenetix; CVCL_2679
DR   Wikidata; Q54946883
RX   PubMed=9876219;
RX   PubMed=21868764;
RX   PubMed=22460905;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (DepMap=ACH-000606).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.76%; Native American=0%; East Asian, North=3.52%; East Asian, South=0%; South Asian=0%; European, North=53.71%; European, South=39.01% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
ST   Source(s): ECACC=97062513; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C37290; Head and neck basaloid carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   PE/CA-PJ41 (clone D2)
AC   CVCL_2680
SY   PECAPJ41CLONED2; PE-CA-PJ41-cl D2; PE/CA-PJ-41; PE CA PJ41; PECAPJ41; Plaepi 41
DR   CLO; CLO_0008409
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988012
DR   cancercelllines; CVCL_2680
DR   Cell_Model_Passport; SIDM01323
DR   Cosmic; 1339922
DR   DepMap; ACH-000732
DR   ECACC; 98020207
DR   GEO; GSM887510
DR   GEO; GSM888592
DR   GEO; GSM1374830
DR   GEO; GSM1374831
DR   IARC_TP53; 28261
DR   LiGeA; CCLE_664
DR   PharmacoDB; PE_CAPJ41_cloneD2_1258_2019
DR   Progenetix; CVCL_2680
DR   Wikidata; Q54946884
RX   PubMed=9876219;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.920-2A>T (IVS8-2A>T); ClinVar=VCV002461841; Zygosity=Homozygous; Note=Splice acceptor mutation (DepMap=ACH-000732).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.91%; Native American=0%; East Asian, North=3.3%; East Asian, South=0%; South Asian=0%; European, North=62.2%; European, South=31.58% (PubMed=30894373).
CC   Misspelling: PECAPJ34CLONED2; GEO=GSM1374830.
ST   Source(s): ECACC=98020207
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   PE/CA-PJ49
AC   CVCL_2681
SY   PE CA PJ49; PECAPJ49
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988008
DR   cancercelllines; CVCL_2681
DR   Cell_Model_Passport; SIDM01322
DR   Cosmic; 1339918
DR   DepMap; ACH-000735
DR   ECACC; 00060606
DR   GEO; GSM887511
DR   GEO; GSM888593
DR   GEO; GSM1374832
DR   GEO; GSM1374833
DR   IARC_TP53; 28397
DR   LiGeA; CCLE_841
DR   PharmacoDB; PE_CAPJ49_1259_2019
DR   Progenetix; CVCL_2681
DR   Wikidata; Q54946885
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*32:01,32:01; B*40:02,40:02; C*02:02,02:02; DQA1*01:02;05:02; DQB1*06:03;06:03; DRB1*03:17;13:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.94%; Native American=0%; East Asian, North=4.31%; East Asian, South=0%; South Asian=0%; European, North=59.12%; European, South=33.63% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ECACC=00060606
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 8,12
ST   D7S820: 8,9
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   PE117
AC   CVCL_E802
SY   PE 117
DR   dbMHC; 48997
DR   ECACC; 88052028
DR   IHW; IHW09028
DR   IPD-IMGT/HLA; 11643
DR   Wikidata; Q54946887
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Native North American.
CC   HLA typing: A*24:02:01:01,24:02:01:14; B*40:01:02:01,40:02:01:01; C*03:04:01:01,03:04:01:02; DPA1*01; DPB1*04:01:01; DQA1*03:01; DQB1*03:02:01; DRA*01:01; DRB1*04:04:01; DRB4*01:01 (IPD-IMGT/HLA=11643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   PEA
AC   CVCL_UD53
DR   Wikidata; Q98128531
RX   PubMed=1997098;
RX   PubMed=2789934;
RX   PubMed=3182331;
CC   Doubling time: 72 hours (PubMed=3182331).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 4
//
ID   PEA-10
AC   CVCL_2684
SY   PEA 10; PEA10; Primary Embryonic Fibroblasts-10; LRP-1(+/-) MEF
DR   CLO; CLO_0008412
DR   CLDB; cl5105
DR   ATCC; CRL-2215
DR   ECACC; 97040310
DR   Wikidata; Q54946889
RX   PubMed=8006085;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96828; Lrp1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 11
//
ID   PEA-13
AC   CVCL_2685
SY   PEA 13; PEA13; Primary Embryonic Fibroblasts-13; LRP-1(-/-) MEF; MEF-2
DR   BTO; BTO_0002832
DR   CLO; CLO_0008413
DR   ATCC; CRL-2216
DR   ECACC; 97040311
DR   Wikidata; Q54946891
RX   PubMed=8006085;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96828; Lrp1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   PEA1
AC   CVCL_2682
DR   cancercelllines; CVCL_2682
DR   CancerTools; 151678
DR   Cell_Model_Passport; SIDM01426
DR   Cosmic; 1305317
DR   DepMap; ACH-001628
DR   ECACC; 10032306
DR   GEO; GSM459742
DR   GEO; GSM459851
DR   GEO; GSM2474996
DR   GEO; GSM4973219
DR   GEO; GSM4973225
DR   GEO; GSM4973231
DR   GEO; GSM4973237
DR   GEO; GSM4973243
DR   GEO; GSM4973249
DR   GEO; GSM4973255
DR   GEO; GSM4973261
DR   GEO; GSM4973267
DR   PRIDE; PXD020764
DR   Progenetix; CVCL_2682
DR   Wikidata; Q54946892
DR   Ximbio; 151678
RX   PubMed=3167863;
RX   PubMed=20581869;
RX   PubMed=22183581;
RX   PubMed=23415752;
RX   PubMed=25230021;
RX   PubMed=28273451;
RX   PubMed=35028612;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Doubling time: 37 hours (PubMed=3167863).
CC   Sequence variation: Mutation; HGNC; HGNC:952; BARD1; Simple; p.Trp218Ter (c.653G>A); ClinVar=VCV000482781; Zygosity=Unspecified (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; Zygosity=Unspecified (PubMed=25230021; DepMap=ACH-001628).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 10032306; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001628; ECACC=10032306; PubMed=22183581; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 11,14,17 (PubMed=22183581)
ST   D18S51: 14,17 (DepMap=ACH-001628; PubMed=25230021)
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 22,25
ST   Penta D: 13,15
ST   Penta E: 7,12,13 (DepMap=ACH-001628)
ST   Penta E: 7,13 (PubMed=25230021)
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2683 ! PEA2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   PEA2
AC   CVCL_2683
DR   cancercelllines; CVCL_2683
DR   CancerTools; 151679
DR   Cell_Model_Passport; SIDM01425
DR   ECACC; 10032307
DR   GEO; GSM459852
DR   GEO; GSM659401
DR   GEO; GSM2474997
DR   GEO; GSM4973220
DR   GEO; GSM4973226
DR   GEO; GSM4973232
DR   GEO; GSM4973238
DR   GEO; GSM4973244
DR   GEO; GSM4973250
DR   GEO; GSM4973256
DR   GEO; GSM4973262
DR   GEO; GSM4973268
DR   PRIDE; PXD020764
DR   Progenetix; CVCL_2683
DR   Wikidata; Q54946893
DR   Ximbio; 151679
RX   PubMed=3167863;
RX   PubMed=20581869;
RX   PubMed=22183581;
RX   PubMed=23415752;
RX   PubMed=25230021;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=35028612;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Doubling time: 66 hours (PubMed=3167863).
CC   Sequence variation: Mutation; HGNC; HGNC:952; BARD1; Simple; p.Trp218Ter (c.653G>A); ClinVar=VCV000482781; Zygosity=Unspecified (PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; Zygosity=Unspecified (PubMed=25230021).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 10032307; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=10032307; PubMed=22183581; PubMed=25230021; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 17
ST   D19S433: 12,13
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 25
ST   Penta D: 13,15
ST   Penta E: 7,13
ST   TH01: 9
ST   TPOX: 8 (ECACC=10032307)
ST   TPOX: 8,12 (PubMed=22183581; PubMed=25230021; PubMed=30485824)
ST   vWA: 17,18
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2682 ! PEA1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   PEA5
AC   CVCL_C6EP
DR   Wikidata; Q116050115
RX   PubMed=11170150;
CC   Characteristics: Responsive to androgen (PubMed=11170150).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Prostate, ventral lobe; UBERON=UBERON_0007615.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   PEA7-1-6D
AC   CVCL_B6D1
DR   Wikidata; Q112129501
RX   Patent=EP0305960A2;
RX   Patent=EP0336405B1;
RX   PubMed=1369279;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1809.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50138.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a healthy donor infected with Pseudomonas aeruginosa.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 6
//
ID   PEAA-3B5
AC   CVCL_XV55
DR   CCRID; 4201PAT-CCTCC00553
DR   Wikidata; Q98128532
RX   Patent=CN104459137B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014222.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_144925; 1-(4-methoxyphenyl)-2-{[4-(4-nitrophenyl)butan-2-yl]amino}ethanol (Phenylethylamine A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   Peace
AC   CVCL_WH25
DR   Wikidata; Q98128533
RX   PubMed=28283079;
DI   NCIt; C158786; Canine nephroblastoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   pEAK Rapid
AC   CVCL_3772
SY   pEAK-Rapid; Peak Rapid; PEAKrapid; PeakRapid; HEK-293 PEAKrapid; PEAK 293; PEAK
DR   BTO; BTO_0003615
DR   CLO; CLO_0008414
DR   ATCC; CRL-2828
DR   Wikidata; Q54946894
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2828
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D18S51: 18
ST   D19S433: 18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   PEAZ-1
AC   CVCL_8437
DR   BioSample; SAMN03151782
DR   cancercelllines; CVCL_8437
DR   Cell_Model_Passport; SIDM00830
DR   Wikidata; Q54946897
RX   CelloPub=CLPUB00698;
RX   PubMed=11433418;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-1080 derivative (PubMed=20143388; CelloPub=CLPUB00698). Originally thought to originate from a prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00257.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
ST   Source(s): CelloPub=CLPUB00698
ST   Amelogenin: X,Y
ST   D13S317: 12
ST   D18S51: 12,18
ST   D21S11: 28,30
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   vWA: 14,19
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   PEC
AC   CVCL_A5SS
DR   Wikidata; Q107116655
RX   PubMed=31426793;
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=31426793).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   PEC-1-10-2SCH
AC   CVCL_C8K0
DR   Wikidata; Q123033258
RX   PubMed=3106406;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06886; Staphylococcus aureus toxic shock syndrome toxin-1 (tst).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PEC.1
AC   CVCL_A037
DR   Wikidata; Q54946898
RX   PubMed=7514905;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6M
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   PECA
AC   CVCL_5859
DR   CLS; 400189
DR   Wikidata; Q54946899
CC   Characteristics: Forms primary metastatic lesions in the lung (CLS=400189).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: NMRI.
DI   NCIt; C21806; Squamous cell carcinoma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PECA-4197
AC   CVCL_5860
SY   PECA 4197; PECA4197
DR   Wikidata; Q54946900
RX   PubMed=1961926;
RX   PubMed=7908310;
RX   PubMed=11966317;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   PECA-4451
AC   CVCL_5861
SY   PECA 4451; PECA4451
DR   Wikidata; Q54946901
RX   PubMed=1961926;
RX   PubMed=7908310;
RX   PubMed=11966317;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   PeCa-UkHb-01
AC   CVCL_2H31
DR   Wikidata; Q54946902
RX   PubMed=26193922;
CC   Doubling time: 34.7 +- 3.8 hours (PubMed=26193922).
ST   Source(s): PubMed=26193922
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 27,29,30
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 10,15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4549; Conjunctival squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 5
//
ID   Peccary.K
AC   CVCL_6431
SY   Peccary K
DR   CLO; CLO_0008415
DR   ATCC; CRL-6488
DR   Wikidata; Q54946903
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9829; ! Pecari tajacu (Collared peccary)
SX   Female
AG   10W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   PED GGTA1+/-
AC   CVCL_C7HV
SY   PED+/-
DR   Wikidata; Q117704768
RX   PubMed=15140978;
CC   Knockout cell: Method=Homologous recombination; VGNC; VGNC:112761; GGTA1 (Note=1 of 2 alleles).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C7HS ! PEDSV.15
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   PEDNSV1.1
AC   CVCL_C7HR
DR   Wikidata; Q117704769
RX   PubMed=11208191;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   Pedro
AC   CVCL_A0WX
DR   Wikidata; Q108821099
RX   PubMed=22704137;
RX   PubMed=31816142;
RX   PubMed=34079834;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia.
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   PEDSV.15
AC   CVCL_C7HS
SY   PED
DR   CLS; 305211
DR   Wikidata; Q117704770
RX   PubMed=8623401;
RX   PubMed=11208191;
RX   PubMed=15140978;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   PEDSV.20
AC   CVCL_C7HT
DR   Wikidata; Q117704772
RX   PubMed=8623401;
RX   PubMed=11208191;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   PEDSV.4
AC   CVCL_C7HU
DR   Wikidata; Q117704773
RX   PubMed=8623401;
RX   PubMed=11208191;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
CC   Breed/subspecies: Miniature boar (d/d haplotype).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   PEE
AC   CVCL_IJ29
SY   Porcine Endometrial Endothelial
DR   Wikidata; Q54946904
RX   PubMed=23220338;
CC   Doubling time: 40 hours (Note=At 5th passage), 41.1 hours (Note=At 15th passage), 36.6 hours (Note=At 30th passage), 37 hours (Note=At 50th passage) (PubMed=23220338).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Jiangquhai; VBO=VBO_0012794.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 9
//
ID   Peer
AC   CVCL_1913
SY   PEER
DR   BTO; BTO_0001959
DR   CLO; CLO_0008416
DR   CLO; CLO_0050081
DR   EFO; EFO_0022420
DR   CLDB; cl4115
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN01821654
DR   BioSample; SAMN03472523
DR   BioSample; SAMN03473496
DR   BioSample; SAMN10988124
DR   cancercelllines; CVCL_1913
DR   Cell_Model_Passport; SIDM00991
DR   Cosmic; 721704
DR   Cosmic; 801731
DR   Cosmic; 933548
DR   Cosmic; 998727
DR   Cosmic; 1037685
DR   Cosmic; 1115597
DR   Cosmic; 1118460
DR   Cosmic; 1130238
DR   Cosmic; 1281382
DR   Cosmic; 1330494
DR   Cosmic; 1375591
DR   Cosmic; 1524813
DR   Cosmic; 1641383
DR   Cosmic; 1760530
DR   Cosmic; 2165707
DR   Cosmic; 2361369
DR   Cosmic; 2602908
DR   DepMap; ACH-000519
DR   DSMZ; ACC-6
DR   DSMZCellDive; ACC-6
DR   GEO; GSM887512
DR   GEO; GSM888594
DR   GEO; GSM5137737
DR   IARC_TP53; 10566
DR   IARC_TP53; 30193
DR   JCRB; JCRB0830
DR   LiGeA; CCLE_494
DR   LINCS_LDP; LCL-2062
DR   NCBI_Iran; C511
DR   PharmacoDB; PEER_1261_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_1913
DR   RCB; RCB1879
DR   TKG; TKG 0377
DR   Wikidata; Q2067085
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373528;
RX   PubMed=2241089;
RX   PubMed=2523930;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6181032;
RX   PubMed=6582512;
RX   PubMed=8127147;
RX   PubMed=8547074;
RX   PubMed=8641406;
RX   PubMed=9290701;
RX   PubMed=9933131;
RX   PubMed=10071127;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14768698;
RX   PubMed=15361874;
RX   PubMed=15472075;
RX   PubMed=17170727;
RX   PubMed=17308084;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/2016/07/06/peer/
WW   Info; Wikipedia; -; https://de.wikipedia.org/wiki/Peer_(Zelllinie)
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-6); ~40-50 hours (Note=Lot 06202003), ~39 hours (Note=Lot 10012019) (JCRB=JCRB0830).
CC   HLA typing: A*23:01,24:02; B*35:02,44:03; C*04:01,04:01; DQA1*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:8064; NUP214; Name(s)=NUP214-ABL1; Note=NUP214 exon 34 fused to ABL1 exon 2 (PubMed=15361874; PubMed=35354797; DSMZ=ACC-6).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (PubMed=22675565; DepMap=ACH-000519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Heterozygous (PubMed=10071127; PubMed=22675565; DepMap=ACH-000519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.73%; Native American=0.87%; East Asian, North=2.76%; East Asian, South=0.35%; South Asian=9.54%; European, North=10.64%; European, South=72.11% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-6; JCRB=JCRB0830; RCB=RCB1879; TKG=TKG 0377
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,14 (DSMZ=ACC-6; RCB=RCB1879; TKG=TKG 0377)
ST   D13S317: 14 (JCRB=JCRB0830)
ST   D16S539: 8,13
ST   D18S51: 11,15
ST   D19S433: 13
ST   D21S11: 28,33.2
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 11,13
ST   Penta E: 13,15
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   PEF_NCC1
AC   CVCL_JJ66
SY   Pig Embryonic Fibroblasts_NCC1
DR   Wikidata; Q54946905
RX   PubMed=24589663;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_JJ67 ! PEF_NCC2
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   PEF_NCC2
AC   CVCL_JJ67
SY   Pig Embryonic Fibroblasts_NCC2
DR   Wikidata; Q54946906
RX   PubMed=24589663;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_JJ66 ! PEF_NCC1
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 11
//
ID   PEIi001-A
AC   CVCL_YC47
DR   BioSamples; SAMEA114277733
DR   hPSCreg; PEIi001-A
DR   Wikidata; Q98128534
RX   PubMed=31698189;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:9330; PQBP1; Simple; p.Arg153Serfs*41 (c.451_452AG[4]) (c.459_462delAGAG); ClinVar=VCV000010980; Zygosity=Hemizygous (PubMed=31698189).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165533; Renpenning syndrome
DI   ORDO; Orphanet_3242; Renpenning syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   PEIi002-A
AC   CVCL_YC48
SY   AGS-A
DR   hPSCreg; PEIi002-A
DR   Wikidata; Q98128535
RX   PubMed=32062129;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Unexplicit; Ex14-15del; Zygosity=Homozygous (PubMed=32062129).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC49 ! PEIi002-B
OI   CVCL_YC50 ! PEIi002-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   PEIi002-B
AC   CVCL_YC49
SY   AGS-2
DR   hPSCreg; PEIi002-B
DR   Wikidata; Q98128536
RX   PubMed=32062129;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Unexplicit; Ex14-15del; Zygosity=Homozygous (PubMed=32062129).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC48 ! PEIi002-A
OI   CVCL_YC50 ! PEIi002-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   PEIi002-C
AC   CVCL_YC50
SY   AGS-AB
DR   hPSCreg; PEIi002-C
DR   Wikidata; Q98128537
RX   PubMed=32062129;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:15925; SAMHD1; Unexplicit; Ex14-15del; Zygosity=Homozygous (PubMed=32062129).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168564; Aicardi-Goutieres syndrome 5
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC48 ! PEIi002-A
OI   CVCL_YC49 ! PEIi002-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   PEIi003-A
AC   CVCL_YC51
SY   healthy-1
DR   hPSCreg; PEIi003-A
DR   Wikidata; Q98128538
RX   PubMed=31837633;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   PEK
AC   CVCL_WH48
DR   CLO; CLO_0008418
DR   CLDB; cl3894
DR   Wikidata; Q98128539
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   PEL-5
AC   CVCL_9583
DR   EFO; EFO_0002075
DR   BioSamples; SAMEA365903
DR   BioSamples; SAMEA365997
DR   GEO; GSM38806
DR   GEO; GSM38807
DR   Wikidata; Q54946907
RX   PubMed=15613351;
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   PEL16
AC   CVCL_1Q41
SY   PEL 16; GM11938
DR   CLO; CLO_0020217
DR   Coriell; GM11938
DR   Wikidata; Q54946908
RX   PubMed=2722195;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   PEL40
AC   CVCL_1Q42
SY   PEL 40
DR   Wikidata; Q54946916
RX   PubMed=2722195;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   PeLe-01
AC   CVCL_VY42
DR   IBRC; C10488
DR   Wikidata; Q98128540
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9693; ! Panthera pardus saxicolor (Northern Persian leopard)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   PeLe-02
AC   CVCL_VY43
DR   IBRC; C10489
DR   Wikidata; Q98128541
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9693; ! Panthera pardus saxicolor (Northern Persian leopard)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   PeLe-03
AC   CVCL_VY44
DR   IBRC; C10748
DR   Wikidata; Q98128542
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9693; ! Panthera pardus saxicolor (Northern Persian leopard)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   Pell-1
AC   CVCL_B7AR
DR   Wikidata; Q112129502
RX   PubMed=34821060;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=34821060).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=34821060
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12,13
ST   D16S539: 12,16
ST   D21S11: 32.2,33
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
ID   PEMf
AC   CVCL_YQ47
SY   Piedmontese Ear Marginal fibroblasts
DR   Wikidata; Q98128543
RX   DOI=10.5897/AJB10.2616;
CC   Doubling time: ~24 hours (DOI=10.5897/AJB10.2616).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Piedmont; VBO=VBO_0000332.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   Pen-3
AC   CVCL_IQ93
DR   Wikidata; Q54946917
RX   Patent=US7915004;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 04004.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P26022; Human PTX3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   Peng-EBV
AC   CVCL_WK46
AS   CVCL_WI93
SY   Peng EBV; Peng; EBV-Human; KM0501
DR   CCRID; 5301HUM-KCB05046ZJ
DR   KCB; KCB 200546ZJ
DR   Wikidata; Q94426196
RX   PubMed=30962723;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): CCRID=5301HUM-KCB05046ZJ
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 30,33.2
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 14,16
ST   FGA: 24
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   Penl1
AC   CVCL_VF93
DR   ABM; T8328
DR   cancercelllines; CVCL_VF93
DR   Cosmic; 2806800
DR   Cosmic; 2806954
DR   Wikidata; Q54946918
RX   PubMed=27351128;
RX   PubMed=28344882;
RX   PubMed=29880898;
CC   Population: Chinese.
CC   Characteristics: Sensitive to both cisplatin and epirubicin however is resistant to anti-EGFR therapy and unresponsive to androgen (ABM=T8328).
CC   Doubling time: ~27 hours (PubMed=27351128); 28.16 hours (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=27351128; PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg283Pro (c.848G>C); ClinVar=VCV000486555; Zygosity=Unspecified (PubMed=27351128; PubMed=29880898).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=27351128; PubMed=29880898
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 15
//
ID   Penl2
AC   CVCL_VF95
DR   ABM; T8329
DR   cancercelllines; CVCL_VF95
DR   Cosmic; 2806955
DR   Wikidata; Q54946919
RX   PubMed=28344882;
RX   PubMed=29880898;
CC   Population: Chinese.
CC   Doubling time: 28.38 hours (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ser1613Gly (c.4837A>G); ClinVar=VCV000041827; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Arg922Gln (c.2765G>A); ClinVar=VCV000410514; Zygosity=Unspecified (PubMed=29880898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=29880898).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=28344882; PubMed=29880898
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 7,11
ST   D7S820: 11,13
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 15
//
ID   PENN001i-87-2
AC   CVCL_EK01
SY   Penn001i-87-2; iPS-87-098-SeV2
DR   SKIP; SKIP005051
DR   WiCell; penn001i-87-2
DR   Wikidata; Q54946920
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN002i-442-1
AC   CVCL_EK02
SY   Penn002i-442-1; iPS-442-SeV1
DR   SKIP; SKIP005000
DR   WiCell; penn002i-442-1
DR   Wikidata; Q54946921
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN003i-661-4
AC   CVCL_EK03
SY   Penn003i-661-4; 661-SeV4
DR   SKIP; SKIP005026
DR   WiCell; penn003i-661-4
DR   Wikidata; Q54946923
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN004i-277-1
AC   CVCL_EK04
SY   Penn004i-277-1; iPS-277-SeV1
DR   SKIP; SKIP004965
DR   WiCell; penn004i-277-1
DR   Wikidata; Q54946924
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN005i-35-3
AC   CVCL_EK05
SY   Penn005i-35-3; iPS-35-1360-010-SeV3
DR   SKIP; SKIP004983
DR   WiCell; penn005i-35-3
DR   Wikidata; Q54946926
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN006i-149-1
AC   CVCL_EK06
SY   Penn006i-149-1; iPS-149-SeV1
DR   SKIP; SKIP004938
DR   WiCell; penn006i-149-1
DR   Wikidata; Q54946927
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN007i-765-3
AC   CVCL_EK07
SY   Penn007i-765-3; 765-SeV3
DR   SKIP; SKIP005040
DR   WiCell; penn007i-765-3
DR   Wikidata; Q54946928
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 12
//
ID   PENN008i-77-5
AC   CVCL_EK08
SY   Penn008i-77-5; iPS-77-1638-SeV5
DR   SKIP; SKIP005041
DR   WiCell; penn008i-77-5
DR   Wikidata; Q54946929
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN009i-57-52
AC   CVCL_EK09
SY   Penn009i-57-52; iPS-57-1673-SeV52
DR   SKIP; SKIP005014
DR   WiCell; penn009i-57-52
DR   Wikidata; Q54946930
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN010i-486-2
AC   CVCL_EK10
SY   Penn010i-486-2; iPS-486-1610-080-SeV2
DR   SKIP; SKIP005003
DR   WiCell; penn010i-486-2
DR   Wikidata; Q54946931
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN011i-719-2
AC   CVCL_EK11
SY   Penn011i-719-2; iPS-719-SeV2
DR   SKIP; SKIP005032
DR   WiCell; penn011i-719-2
DR   Wikidata; Q54946932
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN012i-93-2
AC   CVCL_EK12
SY   Penn012i-93-2; iPS-93-1385-SeV2
DR   SKIP; SKIP005055
DR   WiCell; penn012i-93-2
DR   Wikidata; Q54946933
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN013i-72-1
AC   CVCL_EK13
SY   Penn013i-72-1; iPS-72-1677-SeV1
DR   SKIP; SKIP005033
DR   WiCell; penn013i-72-1
DR   Wikidata; Q54946934
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN014i-37-3
AC   CVCL_EK14
SY   Penn014i-37-3; iPS-37-1189-SeV3
DR   SKIP; SKIP004987
DR   WiCell; penn014i-37-3
DR   Wikidata; Q54946935
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN015i-668-5
AC   CVCL_EK15
SY   Penn015i-668-5; iPS-668-SeV5
DR   SKIP; SKIP005027
DR   WiCell; penn015i-668-5
DR   Wikidata; Q54946936
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN016i-821-1
AC   CVCL_EK16
SY   Penn016i-821-1; iPS-821-SeV1
DR   SKIP; SKIP005048
DR   WiCell; penn016i-821-1
DR   Wikidata; Q54946937
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK61 ! PENN061i-821-2
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN017i-638-2
AC   CVCL_EK17
SY   Penn017i-638-2; iPS-638-SeV2
DR   SKIP; SKIP005025
DR   WiCell; penn017i-638-2
DR   Wikidata; Q54946939
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN018i-487-4
AC   CVCL_EK18
SY   Penn018i-487-4; iPS-487-1410-005-SeV4
DR   SKIP; SKIP005004
DR   WiCell; penn018i-487-4
DR   Wikidata; Q54946940
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN019i-136-2
AC   CVCL_EK19
SY   Penn019i-136-2; iPS-136-SeV2
DR   SKIP; SKIP004936
DR   WiCell; penn019i-136-2
DR   Wikidata; Q54946941
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN020i-588-6
AC   CVCL_EK20
SY   Penn020i-588-6; iPS-588-SeV6
DR   SKIP; SKIP005015
DR   WiCell; penn020i-588-6
DR   Wikidata; Q54946942
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK91 ! PENN091i-588-2
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN021i-749-4
AC   CVCL_EK21
SY   Penn021i-749-4; 749-SeV4
DR   SKIP; SKIP005035
DR   WiCell; penn021i-749-4
DR   Wikidata; Q54946943
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN022i-89-1
AC   CVCL_EK22
SY   Penn022i-89-1; iPS-89-1342-SeV1
DR   SKIP; SKIP005053
DR   WiCell; penn022i-89-1
DR   Wikidata; Q54946944
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN023i-82-1
AC   CVCL_EK23
SY   Penn023i-82-1; iPS-82-1572-SeV1
DR   SKIP; SKIP005046
DR   WiCell; penn023i-82-1
DR   Wikidata; Q54946945
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN024i-370-3
AC   CVCL_EK24
SY   Penn024i-370-3; iPS-370-SeV3
DR   SKIP; SKIP004988
DR   WiCell; penn024i-370-3
DR   Wikidata; Q54946946
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN025i-71-58
AC   CVCL_EK25
SY   Penn025i-71-58; iPS-71-044-SeV58
DR   SKIP; SKIP005031
DR   WiCell; penn025i-71-58
DR   Wikidata; Q54946947
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN026i-124-1
AC   CVCL_EK26
SY   Penn026i-124-1; iPS-124-1125-SeV1
DR   SKIP; SKIP004929
DR   WiCell; penn026i-124-1
DR   Wikidata; Q54946948
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN027i-40-2
AC   CVCL_EK27
SY   Penn027i-40-2; iPS-40-139-SeV2
DR   SKIP; SKIP004992
DR   WiCell; penn027i-40-2
DR   Wikidata; Q54946949
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN028i-637-2
AC   CVCL_EK28
SY   Penn028i-637-2; iPS-637-SeV2
DR   SKIP; SKIP005024
DR   WiCell; penn028i-637-2
DR   Wikidata; Q54946950
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN029i-752-3
AC   CVCL_EK29
SY   Penn029i-752-3; iPS-752-SeV3
DR   SKIP; SKIP005037
DR   WiCell; penn029i-752-3
DR   Wikidata; Q54946951
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN030i-384-4
AC   CVCL_EK30
SY   Penn030i-384-4; iPS-384-SeV4
DR   SKIP; SKIP004990
DR   WiCell; penn030i-384-4
DR   Wikidata; Q54946952
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN031i-56-1
AC   CVCL_EK31
SY   Penn031i-56-1; iPS-56-061-SeV1
DR   SKIP; SKIP005011
DR   WiCell; penn031i-56-1
DR   Wikidata; Q54946953
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN032i-15-5
AC   CVCL_EK32
SY   Penn032i-15-5; iPS-15-1203-024-SeV5
DR   SKIP; SKIP004939
DR   WiCell; penn032i-15-5
DR   Wikidata; Q54946954
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN033i-182-2
AC   CVCL_EK33
SY   Penn033i-182-2; iPS-182-SeV2
DR   SKIP; SKIP004945
DR   WiCell; penn033i-182-2
DR   Wikidata; Q54946955
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN034i-322-1
AC   CVCL_EK34
SY   Penn034i-322-1; iPS-322-1725-058-SeV1
DR   SKIP; SKIP004978
DR   WiCell; penn034i-322-1
DR   Wikidata; Q54946956
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN035i-746-3
AC   CVCL_EK35
SY   Penn035i-746-3; iPS-746-SeV3
DR   SKIP; SKIP005034
DR   WiCell; penn035i-746-3
DR   Wikidata; Q54946957
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN036i-286-3
AC   CVCL_EK36
SY   Penn036i-286-3; iPS-286-SeV3
DR   SKIP; SKIP004971
DR   WiCell; penn036i-286-3
DR   Wikidata; Q54946958
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN037i-90-3
AC   CVCL_EK37
SY   Penn037i-90-3; iPS-90-1481-SeV3
DR   SKIP; SKIP005054
DR   WiCell; penn037i-90-3
DR   Wikidata; Q54946972
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN038i-366-6
AC   CVCL_EK38
SY   Penn038i-366-6; iPS-366-SeV6
DR   SKIP; SKIP004986
DR   WiCell; penn038i-366-6
DR   Wikidata; Q54946973
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN039i-63-1
AC   CVCL_EK39
SY   Penn039i-63-1; iPS-63-1622-SeV1
DR   SKIP; SKIP005022
DR   WiCell; penn039i-63-1
DR   Wikidata; Q54946974
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN040i-134-2
AC   CVCL_EK40
SY   Penn040i-134-2; iPS-134-SeV2
DR   SKIP; SKIP004935
DR   WiCell; penn040i-134-2
DR   Wikidata; Q54946975
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN041i-177-46
AC   CVCL_EK41
SY   Penn041i-177-46; iPS-177-SeV46
DR   SKIP; SKIP004943
DR   WiCell; penn041i-177-46
DR   Wikidata; Q54946977
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN042i-258-12
AC   CVCL_EK42
SY   Penn042i-258-12; iPS-258-SeV12
DR   SKIP; SKIP004961
DR   WiCell; penn042i-258-12
DR   Wikidata; Q54946978
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN043i-633-3
AC   CVCL_EK43
SY   Penn043i-633-3; iPS-633-1310-003-SeV3
DR   SKIP; SKIP005023
DR   WiCell; penn043i-633-3
DR   Wikidata; Q54946980
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN044i-51-1
AC   CVCL_EK44
SY   Penn044i-51-1; iPS-51-031-SeV1
DR   SKIP; SKIP005006
DR   WiCell; penn044i-51-1
DR   Wikidata; Q54946981
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN045i-25-12
AC   CVCL_EK45
SY   Penn045i-25-12; iPS-25-1371-101-SeV12
DR   SKIP; SKIP004958
DR   WiCell; penn045i-25-12
DR   Wikidata; Q54946983
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN046i-271-1
AC   CVCL_EK46
SY   Penn046i-271-1; iPS-271-SeV1
DR   SKIP; SKIP004964
DR   WiCell; penn046i-271-1
DR   Wikidata; Q54946984
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN047i-254-60
AC   CVCL_EK47
SY   Penn047i-254-60; iPS-254-SeV60
DR   SKIP; SKIP004960
DR   WiCell; penn047i-254-60
DR   Wikidata; Q54946985
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN048i-41-6
AC   CVCL_EK48
SY   Penn048i-41-6; iPS-41-1282-SeV6
DR   SKIP; SKIP004994
DR   WiCell; penn048i-41-6
DR   Wikidata; Q54946986
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN049i-334-8
AC   CVCL_EK49
SY   Penn049i-334-8; iPS-334-SeV8
DR   SKIP; SKIP004981
DR   WiCell; penn049i-334-8
DR   Wikidata; Q54946987
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN050i-245-10
AC   CVCL_EK50
SY   Penn050i-245-10; iPS-245-clone10
DR   SKIP; SKIP004957
DR   WiCell; penn050i-245-10
DR   Wikidata; Q54946988
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN051i-108-1
AC   CVCL_EK51
SY   Penn051i-108-1; iPS-108-1665-SeV1
DR   SKIP; SKIP004923
DR   WiCell; penn051i-108-1
DR   Wikidata; Q54946989
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN052i-444-2
AC   CVCL_EK52
SY   Penn052i-444-2; iPS-444-SeV2
DR   SKIP; SKIP005002
DR   WiCell; penn052i-444-2
DR   Wikidata; Q54946990
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL20 ! PENN120i-444-1
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN053i-292-3
AC   CVCL_EK53
SY   Penn053i-292-3; iPS-292-SeV3
DR   SKIP; SKIP004972
DR   WiCell; penn053i-292-3
DR   Wikidata; Q54946991
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN054i-225-33
AC   CVCL_EK54
SY   Penn054i-225-33; iPS-225-SeV33
DR   SKIP; SKIP004953
DR   WiCell; penn054i-225-33
DR   Wikidata; Q54946993
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN055i-106-2
AC   CVCL_EK55
SY   Penn055i-106-2; iPS-106-1231-SeV2
DR   SKIP; SKIP004922
DR   WiCell; penn055i-106-2
DR   Wikidata; Q54946994
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN056i-1-1
AC   CVCL_EK56
SY   Penn056i-1-1; iPS-1-030-SeV1
DR   SKIP; SKIP004921
DR   WiCell; penn056i-1-1
DR   Wikidata; Q54946995
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN057i-427-3
AC   CVCL_EK57
SY   Penn057i-427-3; iPS-427-SeV3
DR   SKIP; SKIP004998
DR   WiCell; penn057i-427-3
DR   Wikidata; Q54946996
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK66 ! PENN066i-427-6
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN058i-285-3
AC   CVCL_EK58
SY   Penn058i-285-3; iPS-285-SeV3
DR   SKIP; SKIP004970
DR   WiCell; penn058i-285-3
DR   Wikidata; Q54946997
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN059i-555-1
AC   CVCL_EK59
SY   Penn059i-555-1; iPS-555-SeV1
DR   SKIP; SKIP005009
DR   WiCell; penn059i-555-1
DR   Wikidata; Q54946998
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK84 ! PENN084i-555-2
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN060i-23-1
AC   CVCL_EK60
SY   Penn060i-23-1; iPS-23-1346-028-SeV1
DR   SKIP; SKIP004954
DR   WiCell; penn060i-23-1
DR   Wikidata; Q54947000
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN061i-821-2
AC   CVCL_EK61
SY   Penn061i-821-2; iPS-821-SeV2
DR   SKIP; SKIP005047
DR   WiCell; penn061i-821-2
DR   Wikidata; Q54947002
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK16 ! PENN016i-821-1
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN062i-278-2
AC   CVCL_EK62
SY   Penn062i-278-2; iPS-278-SeV2
DR   SKIP; SKIP004968
DR   WiCell; penn062i-278-2
DR   Wikidata; Q54947003
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK86 ! PENN086i-278-1
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN063i-114-1
AC   CVCL_EK63
SY   Penn063i-114-1; iPS-114-1160-SeV1
DR   SKIP; SKIP004926
DR   WiCell; penn063i-114-1
DR   Wikidata; Q54947004
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN064i-22-2
AC   CVCL_EK64
SY   Penn064i-22-2; iPS-22-1158-SeV2
DR   SKIP; SKIP004951
DR   WiCell; penn064i-22-2
DR   Wikidata; Q54947005
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN065i-553-2
AC   CVCL_EK65
SY   Penn065i-553-2; iPS-553-1631-SeV2
DR   SKIP; SKIP005008
DR   WiCell; penn065i-553-2
DR   Wikidata; Q54947006
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN066i-427-6
AC   CVCL_EK66
SY   Penn066i-427-6; iPS-427-SeV6
DR   SKIP; SKIP004997
DR   WiCell; penn066i-427-6
DR   Wikidata; Q54947007
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK57 ! PENN057i-427-3
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN067i-312-1
AC   CVCL_EK67
SY   Penn067i-312-1; iPS-312-clone1
DR   SKIP; SKIP004975
DR   WiCell; penn067i-312-1
DR   Wikidata; Q54947008
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN068i-697-3
AC   CVCL_EK68
SY   Penn068i-697-3; 697-SeV3
DR   SKIP; SKIP005030
DR   WiCell; penn068i-697-3
DR   Wikidata; Q54947009
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN069i-60-1
AC   CVCL_EK69
SY   Penn069i-60-1; iPS-60-099-SeV1
DR   SKIP; SKIP005017
DR   WiCell; penn069i-60-1
DR   Wikidata; Q54947010
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN070i-408-1
AC   CVCL_EK70
SY   Penn070i-408-1; iPS-408-SeV1
DR   SKIP; SKIP004993
DR   WiCell; penn070i-408-1
DR   Wikidata; Q54947011
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN071i-216-13
AC   CVCL_EK71
SY   Penn071i-216-13; iPS-216-SeV13
DR   SKIP; SKIP004949
DR   WiCell; penn071i-216-13
DR   Wikidata; Q54947013
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN072i-187-3
AC   CVCL_EK72
SY   Penn072i-187-3; iPS-187-1563-146-SeV3
DR   SKIP; SKIP004946
DR   WiCell; penn072i-187-3
DR   Wikidata; Q54947014
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN073i-133-8
AC   CVCL_EK73
SY   Penn073i-133-8; iPS-133-SeV8
DR   SKIP; SKIP004934
DR   WiCell; penn073i-133-8
DR   Wikidata; Q54947015
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN074i-415-3
AC   CVCL_EK74
SY   Penn074i-415-3; iPS-415-SeV3
DR   SKIP; SKIP004995
DR   WiCell; penn074i-415-3
DR   Wikidata; Q54947016
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL27 ! PENN127i-415-1
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN075i-309-1
AC   CVCL_EK75
SY   Penn075i-309-1; iPS-309-SeV1
DR   SKIP; SKIP004974
DR   WiCell; penn075i-309-1
DR   Wikidata; Q54947017
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN076i-361-2
AC   CVCL_EK76
SY   Penn076i-361-2; iPS-361-SeV2
DR   SKIP; SKIP004985
DR   WiCell; penn076i-361-2
DR   Wikidata; Q54947018
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN077i-521-1
AC   CVCL_EK77
SY   Penn077i-521-1; iPS-521-SeV1
DR   SKIP; SKIP005007
DR   WiCell; penn077i-521-1
DR   Wikidata; Q54947035
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN078i-SV10
AC   CVCL_EK78
SY   Penn078i-SV10; iPS-SV10
DR   SKIP; SKIP005091
DR   WiCell; penn078i-sv10
DR   Wikidata; Q54947036
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN079i-33-1
AC   CVCL_EK79
SY   Penn079i-33-1; iPS-33-016-SeV1
DR   SKIP; SKIP004979
DR   WiCell; penn079i-33-1
DR   Wikidata; Q54947037
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN080i-603-1
AC   CVCL_EK80
SY   Penn080i-603-1; iPS-603-SeV1
DR   SKIP; SKIP005018
DR   WiCell; penn080i-603-1
DR   Wikidata; Q54947038
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN081i-352-4
AC   CVCL_EK81
SY   Penn081i-352-4; iPS-352-SeV4
DR   SKIP; SKIP004984
DR   WiCell; penn081i-352-4
DR   Wikidata; Q54947039
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN082i-562-6
AC   CVCL_EK82
SY   Penn082i-562-6; iPS-562-SeV6
DR   SKIP; SKIP005013
DR   WiCell; penn082i-562-6
DR   Wikidata; Q54947040
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN083i-679-4
AC   CVCL_EK83
SY   Penn083i-679-4; 679-SeV4
DR   SKIP; SKIP005028
DR   WiCell; penn083i-679-4
DR   Wikidata; Q54947041
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN084i-555-2
AC   CVCL_EK84
SY   Penn084i-555-2; iPS-555-SeV2
DR   SKIP; SKIP005010
DR   WiCell; penn084i-555-2
DR   Wikidata; Q54947042
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK59 ! PENN059i-555-1
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN085i-76-5
AC   CVCL_EK85
SY   Penn085i-76-5; iPS-76-1544-SeV5
DR   SKIP; SKIP005039
DR   WiCell; penn085i-76-5
DR   Wikidata; Q54947043
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN086i-278-1
AC   CVCL_EK86
SY   Penn086i-278-1; iPS-278-SeV1
DR   SKIP; SKIP004967
DR   WiCell; penn086i-278-1
DR   Wikidata; Q54947044
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK62 ! PENN062i-278-2
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN087i-38-1
AC   CVCL_EK87
SY   Penn087i-38-1; iPS-38-1298-SeV1
DR   SKIP; SKIP004989
DR   WiCell; penn087i-38-1
DR   Wikidata; Q54947045
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN088i-854-7
AC   CVCL_EK88
SY   Penn088i-854-7; iPS-854-SeV7
DR   SKIP; SKIP005049
DR   WiCell; penn088i-854-7
DR   Wikidata; Q54947047
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN089i-758-4
AC   CVCL_EK89
SY   Penn089i-758-4; 758-SeV4
DR   SKIP; SKIP005038
DR   WiCell; penn089i-758-4
DR   Wikidata; Q54947048
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 12
//
ID   PENN090i-111-4
AC   CVCL_EK90
SY   Penn090i-111-4; iPS-111-1008-SeV4
DR   SKIP; SKIP004924
DR   WiCell; penn090i-111-4
DR   Wikidata; Q54947050
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN091i-588-2
AC   CVCL_EK91
SY   Penn091i-588-2; iPS-588 SeV2
DR   SKIP; SKIP005016
DR   WiCell; penn091i-588-2
DR   Wikidata; Q54947051
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK20 ! PENN020i-588-6
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN092i-560-3
AC   CVCL_EK92
SY   Penn092i-560-3; 560-SeV3
DR   SKIP; SKIP005012
DR   WiCell; penn092i-560-3
DR   Wikidata; Q54947052
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN093i-16-7
AC   CVCL_EK93
SY   Penn093i-16-7; iPS-16-1174-SeV7
DR   SKIP; SKIP004940
DR   WiCell; penn093i-16-7
DR   Wikidata; Q54947053
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN094i-161-1
AC   CVCL_EK94
SY   Penn094i-161-1; iPS-161-SeV1
DR   SKIP; SKIP004941
DR   WiCell; penn094i-161-1
DR   Wikidata; Q54947054
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN095i-123-7
AC   CVCL_EK95
SY   Penn095i-123-7; iPS-123-1031-SeV7
DR   SKIP; SKIP004928
DR   WiCell; penn095i-123-7
DR   Wikidata; Q54947055
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN096i-44-4
AC   CVCL_EK96
SY   Penn096i-44-4; iPS-44-1336-SeV4
DR   SKIP; SKIP004999
DR   WiCell; penn096i-44-4
DR   Wikidata; Q54947056
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN097i-17-1
AC   CVCL_EK97
SY   Penn097i-17-1; iPS-17-1446-SeV1
DR   SKIP; SKIP004942
DR   WiCell; penn097i-17-1
DR   Wikidata; Q54947057
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN098i-50-18
AC   CVCL_EK98
SY   Penn098i-50-18; iPS-50-1394-SeV18
DR   SKIP; SKIP005005
DR   WiCell; penn098i-50-18
DR   Wikidata; Q54947058
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN099i-218-1
AC   CVCL_EK99
SY   Penn099i-218-1; iPS-218-SeV1
DR   SKIP; SKIP004950
DR   WiCell; penn099i-218-1
DR   Wikidata; Q54947059
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN100i-623-3
AC   CVCL_EL00
SY   Penn100i-623-3; iPS-623-085-SeV3
DR   SKIP; SKIP005020
DR   WiCell; penn100i-623-3
DR   Wikidata; Q54947060
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN101i-263-39
AC   CVCL_EL01
SY   Penn101i-263-39; iPS-263-SeV39
DR   SKIP; SKIP004963
DR   WiCell; penn101i-263-39
DR   Wikidata; Q54947061
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN102i-96-1
AC   CVCL_EL02
SY   Penn102i-96-1; iPS-96-11592-SeV1
DR   SKIP; SKIP005056
DR   WiCell; penn102i-96-1
DR   Wikidata; Q54947063
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN103i-330-4
AC   CVCL_EL03
SY   Penn103i-330-4; iPS-330-SeV4
DR   SKIP; SKIP004980
DR   WiCell; penn103i-330-4
DR   Wikidata; Q54947064
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 12
//
ID   PENN104i-321-6
AC   CVCL_EL04
SY   Penn104i-321-6; iPS-321-SeV6
DR   SKIP; SKIP004977
DR   WiCell; penn104i-321-6
DR   Wikidata; Q54947065
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN105i-342-5
AC   CVCL_EL05
SY   Penn105i-342-5; iPS-342-SeV5
DR   SKIP; SKIP004982
DR   WiCell; penn105i-342-5
DR   Wikidata; Q54947066
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN106i-75-39
AC   CVCL_EL06
SY   Penn106i-75-39; iPS-75-1681-SeV39
DR   SKIP; SKIP005036
DR   WiCell; penn106i-75-39
DR   Wikidata; Q54947067
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN107i-145-1
AC   CVCL_EL07
SY   Penn107i-145-1; iPS-145-SeV1
DR   SKIP; SKIP004937
DR   WiCell; penn107i-145-1
DR   Wikidata; Q54947068
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN108i-781-3
AC   CVCL_EL08
SY   Penn108i-781-3; 781-SeV3
DR   SKIP; SKIP005043
DR   WiCell; penn108i-781-3
DR   Wikidata; Q54947069
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN109i-802-2
AC   CVCL_EL09
SY   Penn109i-802-2; iPS-802-SeV2
DR   SKIP; SKIP005045
DR   WiCell; penn109i-802-2
DR   Wikidata; Q54947070
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN110i-389-6
AC   CVCL_EL10
SY   Penn110i-389-6; iPS-389-SeV6
DR   SKIP; SKIP004991
DR   WiCell; penn110i-389-6
DR   Wikidata; Q54947072
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN111i-222-5
AC   CVCL_EL11
SY   Penn111i-222-5; iPS-222-SeV5
DR   SKIP; SKIP004952
DR   WiCell; penn111i-222-5
DR   Wikidata; Q54947073
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN112i-304-6
AC   CVCL_EL12
SY   Penn112i-304-6; iPS-304-SeV6
DR   SKIP; SKIP004966
DR   WiCell; penn112i-304-6
DR   Wikidata; Q54947074
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN113i-126-66
AC   CVCL_EL13
SY   Penn113i-126-66; iPS-126-1650-SeV66
DR   SKIP; SKIP004931
DR   WiCell; penn113i-126-66
DR   Wikidata; Q54947075
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN114i-127-2
AC   CVCL_EL14
SY   Penn114i-127-2; iPS-127-1188-SeV2
DR   SKIP; SKIP004932
DR   WiCell; penn114i-127-2
DR   Wikidata; Q54947076
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN115i-316-1
AC   CVCL_EL15
SY   Penn115i-316-1; iPS-316-SeV1
DR   SKIP; SKIP004976
DR   WiCell; penn115i-316-1
DR   Wikidata; Q54947077
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN116i-125-16
AC   CVCL_EL16
SY   Penn116i-125-16; iPS-125-1006-SeV16
DR   SKIP; SKIP004930
DR   WiCell; penn116i-125-16
DR   Wikidata; Q54947078
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN117i-88-32
AC   CVCL_EL17
SY   Penn117i-88-32; iPS-88-1451-SeV32
DR   SKIP; SKIP005052
DR   WiCell; penn117i-88-32
DR   Wikidata; Q54947084
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN118i-113-2
AC   CVCL_EL18
SY   Penn118i-113-2; iPS-113-1138-SeV2
DR   SKIP; SKIP004925
DR   WiCell; penn118i-113-2
DR   Wikidata; Q54947085
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN119i-197-25
AC   CVCL_EL19
SY   Penn119i-197-25; iPS-197-SeV25
DR   SKIP; SKIP004947
DR   WiCell; penn119i-197-25
DR   Wikidata; Q54947086
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN120i-444-1
AC   CVCL_EL20
SY   Penn120i-444-1; iPS-444 SeV1
DR   SKIP; SKIP005001
DR   WiCell; penn120i-444-1
DR   Wikidata; Q54947087
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK52 ! PENN052i-444-2
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN121i-69-1
AC   CVCL_EL21
SY   Penn121i-69-1; iPS-69-1313-008-SeV1
DR   SKIP; SKIP005029
DR   WiCell; penn121i-69-1
DR   Wikidata; Q54947088
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN122i-627-5
AC   CVCL_EL22
SY   Penn122i-627-5; iPS-627-SeV5
DR   SKIP; SKIP005021
DR   WiCell; penn122i-627-5
DR   Wikidata; Q54947089
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN123i-SV20
AC   CVCL_EL23
SY   Penn123i-SV20; iPS-SV20; SV20; PENNi001-A; Control-6 iPSC
DR   hPSCreg; PENNi001-A
DR   SKIP; SKIP005092
DR   WiCell; penn123i-sv20
DR   Wikidata; Q54947090
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 13
//
ID   PENN124i-28-3
AC   CVCL_EL24
SY   Penn124i-28-3; iPS-28-1619-SeV3
DR   SKIP; SKIP004969
DR   WiCell; penn124i-28-3
DR   Wikidata; Q54947091
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN125i-233-4
AC   CVCL_EL25
SY   Penn125i-233-4; iPS-233-SeV4
DR   SKIP; SKIP004955
DR   WiCell; penn125i-233-4
DR   Wikidata; Q54947092
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN126i-120-1
AC   CVCL_EL26
SY   Penn126i-120-1; iPS-120-1042-SeV1
DR   SKIP; SKIP004927
DR   WiCell; penn126i-120-1
DR   Wikidata; Q54947093
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN127i-415-1
AC   CVCL_EL27
SY   Penn127i-415-1; iPS-415 SeV1
DR   SKIP; SKIP004996
DR   WiCell; penn127i-415-1
DR   Wikidata; Q54947094
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK74 ! PENN074i-415-3
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN128i-8-4
AC   CVCL_EL28
SY   Penn128i-8-4; iPS-8-1433-023-SeV4
DR   SKIP; SKIP005044
DR   WiCell; penn128i-8-4
DR   Wikidata; Q54947095
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN129i-20-14
AC   CVCL_EL29
SY   Penn129i-20-14; iPS-20-138-SeV14
DR   SKIP; SKIP004948
DR   WiCell; penn129i-20-14
DR   Wikidata; Q54947098
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN130i-78-3
AC   CVCL_EL30
SY   Penn130i-78-3; iPS-78-045-SeV3
DR   SKIP; SKIP005042
DR   WiCell; penn130i-78-3
DR   Wikidata; Q54947100
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN131i-86-3
AC   CVCL_EL31
SY   Penn131i-86-3; iPS-86-1380-SeV3
DR   SKIP; SKIP005050
DR   WiCell; penn131i-86-3
DR   Wikidata; Q54947101
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN132i-131-5
AC   CVCL_EL32
SY   Penn132i-131-5; iPS-131-SeV5
DR   SKIP; SKIP004933
DR   WiCell; penn132i-131-5
DR   Wikidata; Q54947102
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN133i-252-23
AC   CVCL_EL33
SY   Penn133i-252-23; iPS-252-SeV23
DR   SKIP; SKIP004959
DR   WiCell; penn133i-252-23
DR   Wikidata; Q54947103
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN134i-61-26
AC   CVCL_EL34
SY   Penn134i-61-26; iPS-61-1559-060-SeV26
DR   SKIP; SKIP005019
DR   WiCell; penn134i-61-26
DR   Wikidata; Q54947104
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN135i-30-8
AC   CVCL_EL35
SY   Penn135i-30-8; iPS-30-135-SeV8
DR   SKIP; SKIP004973
DR   WiCell; penn135i-30-8
DR   Wikidata; Q54947105
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN136i-262-1
AC   CVCL_EL36
SY   Penn136i-262-1; iPS-262-SeV1
DR   SKIP; SKIP004962
DR   WiCell; penn136i-262-1
DR   Wikidata; Q54947106
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN137i-18-11
AC   CVCL_EL37
SY   Penn137i-18-11; iPS-18-1418-025-SeV11
DR   SKIP; SKIP004944
DR   WiCell; penn137i-18-11
DR   Wikidata; Q54947107
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN138i-24-4
AC   CVCL_EL38
SY   Penn138i-24-4; iPS-24-1311-SeV4
DR   SKIP; SKIP004956
DR   WiCell; penn138i-24-4
DR   Wikidata; Q54947108
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN139i-M5-4
AC   CVCL_EL39
SY   Penn139i-M5-4; iPS-M5-SeV4
DR   SKIP; SKIP005082
DR   WiCell; penn139i-m5-4
DR   Wikidata; Q54947109
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Unexplicit; Ex3-6del; Zygosity=Homozygous (WiCell=penn139i-m5-4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL67 ! PENN167i-M5-3
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 19
//
ID   PENN140i-M12-7
AC   CVCL_EL40
SY   Penn140i-M12-7; M12-7
DR   SKIP; SKIP005063
DR   WiCell; penn140i-m12-7
DR   Wikidata; Q54947110
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL58 ! PENN158i-M12-4
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN141i-M6-2
AC   CVCL_EL41
SY   Penn141i-M6-2; iPS-M6-PB-SeV2; Control-3 iPSC-1
DR   SKIP; SKIP005084
DR   WiCell; penn141i-m6-2
DR   Wikidata; Q54947112
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL60 ! PENN160i-M6-6
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   PENN142i-M3-19
AC   CVCL_EL42
SY   Penn142i-M3-19; iPS-M3-SeV19; Hetero-1 iPSC-1
DR   SKIP; SKIP005078
DR   WiCell; penn142i-m3-19
DR   Wikidata; Q54947114
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Lys531Asn (c.1593G>T); Zygosity=Heterozygous (PubMed=25904599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL55 ! PENN155i-M3-21
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   PENN143i-M10-11
AC   CVCL_EL43
SY   Penn143i-M10-11; iPS-M10-SeV11; TD-2 iPSC-1; TD-1-3; M10-11
DR   SKIP; SKIP005059
DR   WiCell; penn143i-m10-11
DR   Wikidata; Q54947115
RX   PubMed=25904599;
RX   PubMed=28330813;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Glu1005Ter (c.3013G>T); Zygosity=Homozygous (PubMed=25904599; PubMed=28330813).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85182; Tangier disease
DI   ORDO; Orphanet_31150; Tangier disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL61 ! PENN161i-M10-5
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 17
//
ID   PENN144i-M7-16
AC   CVCL_EL44
SY   Penn144i-M7-16; iPS-M7-SeV16
DR   SKIP; SKIP005086
DR   WiCell; penn144i-m7-16
DR   Wikidata; Q54947116
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7467; MTTP; Simple; p.Arg46Gly (c.136C>G); ClinVar=VCV000347020; Zygosity=Homozygous (WiCell=penn144i-m7-16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84525; Abetalipoproteinemia
DI   ORDO; Orphanet_14; Abetalipoproteinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL50 ! PENN150i-M7-9
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   PENN145i-M16-2
AC   CVCL_EL45
SY   Penn145i-M16-2; M16-SeV2
DR   SKIP; SKIP005069
DR   WiCell; penn145i-m16-2
DR   Wikidata; Q54947117
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Latino and Native American.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Leu605Glufs*38; Zygosity=Heterozygous (WiCell=penn145i-m16-2).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Unexplicit; Ex4-6del; Zygosity=Heterozygous (WiCell=penn145i-m16-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL68 ! PENN168i-M16-1
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 19
//
ID   PENN146i-M11-5
AC   CVCL_EL46
SY   Penn146i-M11-5; iPS-M11-SeV5; Control-2 iPSC-1; Control-1-3; M11-5
DR   SKIP; SKIP005061
DR   WiCell; penn146i-m11-5
DR   Wikidata; Q54947118
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL64 ! PENN164i-M11-1
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   PENN147i-M9-7
AC   CVCL_EL47
SY   Penn147i-M9-7; M9-7
DR   SKIP; SKIP005089
DR   WiCell; penn147i-m9-7
DR   Wikidata; Q54947119
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Trp483Ter (c.1448G>A); ClinVar=VCV000226356; Zygosity=Heterozygous (WiCell=penn147i-m9-7).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Gly549Asp (c.1646G>A); ClinVar=VCV000003698; Zygosity=Heterozygous (WiCell=penn147i-m9-7).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL71 ! PENN171i-M9-9
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 19
//
ID   PENN148i-M8-3
AC   CVCL_EL48
SY   Penn148i-M8-3; iPS-M8-PB-SeV3; Control-4 iPSC-1
DR   SKIP; SKIP005087
DR   WiCell; penn148i-m8-3
DR   Wikidata; Q54947121
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL56 ! PENN156i-M8-2
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   PENN149i-M1-6
AC   CVCL_EL49
SY   Penn149i-M1-6; iPS-M1-SeV6
DR   SKIP; SKIP005057
DR   WiCell; penn149i-m1-6
DR   Wikidata; Q54947122
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL51 ! PENN151i-M1-5
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN150i-M7-9
AC   CVCL_EL50
SY   Penn150i-M7-9; iPS-M7-PB-SeV9
DR   SKIP; SKIP005085
DR   WiCell; penn150i-m7-9
DR   Wikidata; Q54947123
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7467; MTTP; Simple; p.Arg46Gly (c.136C>G); ClinVar=VCV000347020; Zygosity=Homozygous (WiCell=penn150i-m7-9).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84525; Abetalipoproteinemia
DI   ORDO; Orphanet_14; Abetalipoproteinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL44 ! PENN144i-M7-16
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   PENN151i-M1-5
AC   CVCL_EL51
SY   Penn151i-M1-5; iPS-M1-SeV5
DR   SKIP; SKIP005058
DR   WiCell; penn151i-m1-5
DR   Wikidata; Q54947124
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL49 ! PENN149i-M1-6
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN152i-M18-1
AC   CVCL_EL52
SY   Penn152i-M18-1; M18-SeV1
DR   SKIP; SKIP005074
DR   WiCell; penn152i-m18-1
DR   Wikidata; Q54947125
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL54 ! PENN154i-M18-2
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN153i-M4-10
AC   CVCL_EL53
SY   Penn153i-M4-10; iPS-M4-SeV10; Control-2-2; M4-10
DR   SKIP; SKIP005080
DR   WiCell; penn153i-m4-10
DR   Wikidata; Q54947126
RX   PubMed=28330813;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL63 ! PENN163i-M4-4
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   PENN154i-M18-2
AC   CVCL_EL54
SY   Penn154i-M18-2; M18-SeV2
DR   SKIP; SKIP005073
DR   WiCell; penn154i-m18-2
DR   Wikidata; Q54947127
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL52 ! PENN152i-M18-1
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN155i-M3-21
AC   CVCL_EL55
SY   Penn155i-M3-21; iPS-M3-SeV21; Hetero-1 iPSC-2
DR   SKIP; SKIP005077
DR   WiCell; penn155i-m3-21
DR   Wikidata; Q54947128
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Lys531Asn (c.1593G>T); Zygosity=Heterozygous (PubMed=25904599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL42 ! PENN142i-M3-19
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   PENN156i-M8-2
AC   CVCL_EL56
SY   Penn156i-M8-2; iPS-M8-SeV2; Control-4 iPSC-2
DR   SKIP; SKIP005088
DR   WiCell; penn156i-m8-2
DR   Wikidata; Q54947129
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL48 ! PENN148i-M8-3
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   PENN157i-M2-6
AC   CVCL_EL57
SY   Penn157i-M2-6; iPS-M2-SeV6; TD-1 iPSC-1
DR   SKIP; SKIP005076
DR   WiCell; penn157i-m2-6
DR   Wikidata; Q54947144
RX   PubMed=25904599;
RX   PubMed=28330813;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Lys531Asn (c.1593G>T); Zygosity=Heterozygous (PubMed=25904599; PubMed=28330813).
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Ser2046Arg (c.6138T>A); ClinVar=VCV002780158; Zygosity=Heterozygous (PubMed=25904599; PubMed=28330813).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85182; Tangier disease
DI   ORDO; Orphanet_31150; Tangier disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL65 ! PENN165i-M2-21
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   PENN158i-M12-4
AC   CVCL_EL58
SY   Penn158i-M12-4; M12-4
DR   SKIP; SKIP005064
DR   WiCell; penn158i-m12-4
DR   Wikidata; Q54947145
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL40 ! PENN140i-M12-7
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN159i-M14-4
AC   CVCL_EL59
SY   Penn159i-M14-4; M14-4
DR   SKIP; SKIP005066
DR   WiCell; penn159i-m14-4
DR   Wikidata; Q54947146
RX   PubMed=26965621;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1664; SCARB1; Simple; p.Pro376Leu (c.1127C>T); ClinVar=VCV000253091; Zygosity=Homozygous (WiCell=penn159i-m14-4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168987; High density lipoprotein cholesterol level quantitative trait locus 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL62 ! PENN162i-M14-11
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   PENN160i-M6-6
AC   CVCL_EL60
SY   Penn160i-M6-6; iPS-M6-SeV6; Control-3 iPSC-2
DR   SKIP; SKIP005083
DR   WiCell; penn160i-m6-6
DR   Wikidata; Q54947147
RX   PubMed=25904599;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL41 ! PENN141i-M6-2
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   PENN161i-M10-5
AC   CVCL_EL61
SY   Penn161i-M10-5; iPS-M10-PB-SeV5; TD-2 iPSC-2; M10-5; TD-1-1
DR   SKIP; SKIP005060
DR   WiCell; penn161i-m10-5
DR   Wikidata; Q54947148
RX   PubMed=25904599;
RX   PubMed=28330813;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Glu1005Ter (c.3013G>T); Zygosity=Homozygous (PubMed=25904599; PubMed=28330813).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85182; Tangier disease
DI   ORDO; Orphanet_31150; Tangier disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL43 ! PENN143i-M10-11
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 15
//
ID   PENN162i-M14-11
AC   CVCL_EL62
SY   Penn162i-M14-11; M14-11
DR   SKIP; SKIP005065
DR   WiCell; penn162i-m14-11
DR   Wikidata; Q54947149
RX   PubMed=26965621;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1664; SCARB1; Simple; p.Pro376Leu (c.1127C>T); ClinVar=VCV000253091; Zygosity=Homozygous (WiCell=penn162i-m14-11).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168987; High density lipoprotein cholesterol level quantitative trait locus 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL59 ! PENN159i-M14-4
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   PENN163i-M4-4
AC   CVCL_EL63
SY   Penn163i-M4-4; iPs-M4-SeV4; Control-2-1; M4-4
DR   SKIP; SKIP005079
DR   WiCell; penn163i-m4-4
DR   Wikidata; Q54947150
RX   PubMed=28330813;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL53 ! PENN153i-M4-10
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   PENN164i-M11-1
AC   CVCL_EL64
SY   Penn164i-M11-1; iPS-M11-PB-SeV1; Control-2 iPSC-2; Control-1-1; M11-1
DR   SKIP; SKIP005062
DR   WiCell; penn164i-m11-1
DR   Wikidata; Q54947151
RX   PubMed=25904599;
RX   PubMed=28330813;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL46 ! PENN146i-M11-5
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   PENN165i-M2-21
AC   CVCL_EL65
SY   Penn165i-M2-21; iPS-M2-SeV21; TD-1 iPSC-2; TD-2-2; M2-21
DR   SKIP; SKIP005075
DR   WiCell; penn165i-m2-21
DR   Wikidata; Q54947152
RX   PubMed=25904599;
RX   PubMed=28330813;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Lys531Asn (c.1593G>T); Zygosity=Heterozygous (PubMed=25904599; PubMed=28330813).
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Ser2046Arg (c.6138T>A); ClinVar=VCV002780158; Zygosity=Heterozygous (PubMed=25904599; PubMed=28330813).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85182; Tangier disease
DI   ORDO; Orphanet_31150; Tangier disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL57 ! PENN157i-M2-6
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 17
//
ID   PENN166i-M15-4
AC   CVCL_EL66
SY   Penn166i-M15-4; M15-4
DR   SKIP; SKIP005067
DR   WiCell; penn166i-m15-4
DR   Wikidata; Q54947154
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL72 ! PENN172i-M15-10
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENN167i-M5-3
AC   CVCL_EL67
SY   Penn167i-M5-3; iPS-M5-PB-SeV3
DR   SKIP; SKIP005081
DR   WiCell; penn167i-m5-3
DR   Wikidata; Q54947155
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Unexplicit; Ex3-6del; Zygosity=Homozygous (WiCell=penn167i-m5-3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL39 ! PENN139i-M5-4
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 19
//
ID   PENN168i-M16-1
AC   CVCL_EL68
SY   Penn168i-M16-1; M16-SeV1
DR   SKIP; SKIP005070
DR   WiCell; penn168i-m16-1
DR   Wikidata; Q54947156
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Latino and Native American.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Leu605Glufs*38; Zygosity=Heterozygous (WiCell=penn168i-m16-1).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Unexplicit; Ex4-6del; Zygosity=Heterozygous (WiCell=penn168i-m16-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL45 ! PENN145i-M16-2
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 19
//
ID   PENN169i-M17-3
AC   CVCL_EL69
SY   Penn169i-M17-3; iPS-M17-SeV3
DR   SKIP; SKIP005072
DR   WiCell; penn169i-m17-3
DR   Wikidata; Q54947158
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Arg1270Ter (c.3808C>T); dbSNP=rs575627531; Zygosity=Heterozygous (WiCell=penn169i-m17-3).
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Unexplicit; IVS32-25G>C; Zygosity=Heterozygous (WiCell=penn169i-m17-3).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85182; Tangier disease
DI   ORDO; Orphanet_31150; Tangier disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL70 ! PENN170i-M17-4
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   PENN170i-M17-4
AC   CVCL_EL70
SY   Penn170i-M17-4; iPS-M17-SeV4
DR   SKIP; SKIP005071
DR   WiCell; penn170i-m17-4
DR   Wikidata; Q54947159
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Simple; p.Arg1270Ter (c.3808C>T); dbSNP=rs575627531; Zygosity=Heterozygous (WiCell=penn170i-m17-4).
CC   Sequence variation: Mutation; HGNC; HGNC:29; ABCA1; Unexplicit; IVS32-25G>C; Zygosity=Heterozygous (WiCell=penn170i-m17-4).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85182; Tangier disease
DI   ORDO; Orphanet_31150; Tangier disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL69 ! PENN169i-M17-3
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   PENN171i-M9-9
AC   CVCL_EL71
SY   Penn171i-M9-9; M9-9
DR   SKIP; SKIP005090
DR   WiCell; penn171i-m9-9
DR   Wikidata; Q54947160
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Trp483Ter (c.1448G>A); ClinVar=VCV000226356; Zygosity=Heterozygous (WiCell=penn171i-m9-9).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Gly549Asp (c.1646G>A); ClinVar=VCV000003698; Zygosity=Heterozygous (WiCell=penn171i-m9-9).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL47 ! PENN147i-M9-7
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 19
//
ID   PENN172i-M15-10
AC   CVCL_EL72
SY   Penn172i-M15-10; M15-10
DR   SKIP; SKIP005068
DR   WiCell; penn172i-m15-10
DR   Wikidata; Q54947161
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rader, Daniel James; University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL66 ! PENN166i-M15-4
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   PENNi001-A-1
AC   CVCL_A8MV
SY   SV20 ACE2KO D1
DR   hPSCreg; PENNi001-A-1
DR   Wikidata; Q108821100
CC   From: University of Pennsylvania; Philadelphia; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13557; ACE2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EL23 ! PENN123i-SV20
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   Penny
AC   CVCL_A0WY
DR   Wikidata; Q108821102
RX   PubMed=22704137;
RX   PubMed=31816142;
RX   PubMed=34079834;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia.
CC   Derived from site: In situ; Bone, tail; UBERON=UBERON_0006068.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   PEO1
AC   CVCL_2686
SY   PE01; PEO-1; PEO
DR   BTO; BTO_0005796
DR   EFO; EFO_0005445
DR   ArrayExpress; E-MTAB-691
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 992
DR   BioSample; SAMN03473296
DR   cancercelllines; CVCL_2686
DR   CancerTools; 151672
DR   Cell_Model_Passport; SIDM00472
DR   ChEMBL-Cells; CHEMBL4295441
DR   ChEMBL-Targets; CHEMBL4296485
DR   Cosmic; 991317
DR   Cosmic; 1102826
DR   Cosmic; 1305316
DR   Cosmic; 1524353
DR   Cosmic; 1709263
DR   Cosmic-CLP; 1480372
DR   DepMap; ACH-001630
DR   ECACC; 10032308
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1480372
DR   GEO; GSM185145
DR   GEO; GSM185146
DR   GEO; GSM459703
DR   GEO; GSM459853
DR   GEO; GSM711726
DR   GEO; GSM723253
DR   GEO; GSM743505
DR   GEO; GSM851938
DR   GEO; GSM1340589
DR   GEO; GSM1670347
DR   GEO; GSM4973221
DR   GEO; GSM4973227
DR   GEO; GSM4973233
DR   GEO; GSM4973239
DR   GEO; GSM4973245
DR   GEO; GSM4973251
DR   GEO; GSM4973257
DR   GEO; GSM4973263
DR   GEO; GSM4973269
DR   PharmacoDB; PE01_1260_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD020764
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2686
DR   PubChem_Cell_line; CVCL_2686
DR   Wikidata; Q54947162
DR   Ximbio; 151672
RX   CelloPub=CLPUB00667;
RX   PubMed=1348364;
RX   PubMed=3167863;
RX   PubMed=3583449;
RX   PubMed=8824553;
RX   PubMed=9041185;
RX   PubMed=19654294;
RX   PubMed=20581869;
RX   PubMed=22183581;
RX   PubMed=22328975;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35028612;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 53 hours (PubMed=3583449); 37 hours (PubMed=3167863); 44.92 hours (CelloPub=CLPUB00667); 37.48 hours (JWGray panel).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02; DQB1*03:04,03:04 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*07:02,37:04; C*07:02,07:02; DRB1*11:01,11:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Ter (c.4965C>G) (5193C>G); ClinVar=VCV000037936; Zygosity=Hemizygous (PubMed=19654294; PubMed=22183581; PubMed=25230021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Unspecified (CelloPub=CLPUB00667; PubMed=25230021).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.14%; East Asian, North=0.57%; East Asian, South=0%; South Asian=0%; European, North=70.43%; European, South=28.85% (PubMed=30894373).
CC   Discontinued: ECACC; 10032308; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1480372; DepMap=ACH-001630; ECACC=10032308; PubMed=22710073; PubMed=25230021; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 16,17
ST   D19S433: 13,15
ST   D21S11: 32.2
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13 (PubMed=25877200)
ST   D8S1179: 13,14 (DepMap=ACH-001630; PubMed=22710073; PubMed=25230021)
ST   FGA: 20
ST   Penta D: 14
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C5228; Ovarian cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2690 ! PEO4
OI   CVCL_2691 ! PEO6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   PEO1-CDDP
AC   CVCL_Y032
SY   PEO1CDDP; PEO1 cDDPr
DR   cancercelllines; CVCL_Y032
DR   CancerTools; 151784
DR   ECACC; 16012001
DR   Wikidata; Q54947163
DR   Ximbio; 151784
RX   PubMed=8824553;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Ter (c.4965C>G) (5193C>G); ClinVar=VCV000037936; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: ECACC; 16012001; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=16012001
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 16,17
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 14
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C5228; Ovarian cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2686 ! PEO1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 19
//
ID   PEO14
AC   CVCL_2687
SY   PE014; PEO-14
DR   EFO; EFO_0005446
DR   ArrayExpress; E-MTAB-691
DR   cancercelllines; CVCL_2687
DR   CancerTools; 151675
DR   Cell_Model_Passport; SIDM01419
DR   Cosmic; 1305318
DR   ECACC; 10032311
DR   GEO; GSM313700
DR   GEO; GSM459856
DR   GEO; GSM659402
DR   GEO; GSM2474998
DR   GEO; GSM4973223
DR   GEO; GSM4973229
DR   GEO; GSM4973235
DR   GEO; GSM4973241
DR   GEO; GSM4973247
DR   GEO; GSM4973253
DR   GEO; GSM4973259
DR   GEO; GSM4973265
DR   GEO; GSM4973271
DR   PRIDE; PXD020764
DR   Progenetix; CVCL_2687
DR   Wikidata; Q54947165
DR   Ximbio; 151675
RX   PubMed=3167863;
RX   PubMed=8824553;
RX   PubMed=20581869;
RX   PubMed=22183581;
RX   PubMed=23415752;
RX   PubMed=25230021;
RX   PubMed=25960936;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=35028612;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Doubling time: 108 hours (PubMed=3167863).
CC   HLA typing: A*11:01,11:01; B*35:01,35:01; C*04:01,04:01; DQB1*05:01,05:01; DRB1*01:03,01:03 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Unspecified (PubMed=25230021; PubMed=28273451).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 10032311; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=10032311; PubMed=22183581; PubMed=25230021; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 27,30
ST   D2S1338: 19
ST   D3S1358: 16,18
ST   D5S818: 11,12 (ECACC=10032311)
ST   D5S818: 12 (PubMed=22183581; PubMed=25230021; PubMed=30485824)
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2689 ! PEO23
OI   CVCL_2734 ! TO14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   PEO16
AC   CVCL_2688
SY   PE016
DR   CancerTools; 151676
DR   ECACC; 10032312
DR   Wikidata; Q54947166
DR   Ximbio; 151676
RX   PubMed=3167863;
RX   PubMed=25230021;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Doubling time: 40 hours (PubMed=3167863); ~120 hours (ECACC=10032312).
CC   Discontinued: ECACC; 10032312; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=10032312; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 12,19
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 19,22
ST   Penta D: 13
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   PEO1X
AC   CVCL_B3UQ
DR   cancercelllines; CVCL_B3UQ
DR   Wikidata; Q110433135
RX   CelloPub=CLPUB00667;
CC   Population: Caucasian.
CC   Doubling time: 47.84 hours (CelloPub=CLPUB00667).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Ter (c.4965C>G) (5193C>G); ClinVar=VCV000037936; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Unspecified (CelloPub=CLPUB00667).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C5228; Ovarian cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2686 ! PEO1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   PEO23
AC   CVCL_2689
SY   PE023
DR   EFO; EFO_0005447
DR   ArrayExpress; E-MTAB-691
DR   cancercelllines; CVCL_2689
DR   CancerTools; 151677
DR   Cell_Model_Passport; SIDM01418
DR   ECACC; 10032313
DR   GEO; GSM459857
DR   GEO; GSM2475001
DR   GEO; GSM4973224
DR   GEO; GSM4973230
DR   GEO; GSM4973236
DR   GEO; GSM4973242
DR   GEO; GSM4973248
DR   GEO; GSM4973254
DR   GEO; GSM4973260
DR   GEO; GSM4973266
DR   GEO; GSM4973272
DR   PRIDE; PXD020764
DR   Progenetix; CVCL_2689
DR   Wikidata; Q54947167
DR   Ximbio; 151677
RX   PubMed=3167863;
RX   PubMed=20581869;
RX   PubMed=22183581;
RX   PubMed=23415752;
RX   PubMed=25230021;
RX   PubMed=25960936;
RX   PubMed=28273451;
RX   PubMed=35028612;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Doubling time: 120 hours (PubMed=3167863).
CC   HLA typing: A*11:01,11:01; B*35:01,35:01; C*04:01,04:01; DQB1*05:01,05:01; DRB1*01:01,01:01 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Unspecified (PubMed=25230021; PubMed=28273451).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 10032313; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=10032313; PubMed=22183581; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 27,30
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11,12 (ECACC=10032313)
ST   D5S818: 12 (PubMed=22183581; PubMed=25230021)
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2687 ! PEO14
OI   CVCL_2734 ! TO14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   PEO4
AC   CVCL_2690
SY   PE04; PEO-4
DR   BTO; BTO_0005797
DR   EFO; EFO_0005448
DR   ArrayExpress; E-MTAB-691
DR   BioGRID_ORCS_Cell_line; 993
DR   cancercelllines; CVCL_2690
DR   CancerTools; 151673
DR   Cell_Model_Passport; SIDM00471
DR   Cosmic; 1709261
DR   DepMap; ACH-001632
DR   ECACC; 10032309
DR   GEO; GSM185147
DR   GEO; GSM185148
DR   GEO; GSM459657
DR   GEO; GSM459854
DR   GEO; GSM743510
DR   GEO; GSM851939
DR   GEO; GSM1340590
DR   GEO; GSM2475002
DR   GEO; GSM4973222
DR   GEO; GSM4973228
DR   GEO; GSM4973234
DR   GEO; GSM4973240
DR   GEO; GSM4973246
DR   GEO; GSM4973252
DR   GEO; GSM4973258
DR   GEO; GSM4973264
DR   GEO; GSM4973270
DR   PRIDE; PXD003668
DR   PRIDE; PXD020764
DR   Progenetix; CVCL_2690
DR   Wikidata; Q54947168
DR   Ximbio; 151673
RX   CelloPub=CLPUB00667;
RX   PubMed=1348364;
RX   PubMed=3167863;
RX   PubMed=3583449;
RX   PubMed=8824553;
RX   PubMed=9041185;
RX   PubMed=19654294;
RX   PubMed=20581869;
RX   PubMed=22183581;
RX   PubMed=22328975;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=25230021;
RX   PubMed=25960936;
RX   PubMed=27235858;
RX   PubMed=27561551;
RX   PubMed=28273451;
RX   PubMed=30971826;
RX   PubMed=35028612;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 59 hours (PubMed=3583449); 36 hours (PubMed=3167863); 75.67 hours (CelloPub=CLPUB00667).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02; DRB1*11:01,04:05 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Tyr (c.4965C>T) (5193C>T); ClinVar=VCV001657967; Zygosity=Hemizygous; Note=De novo mutation that cancels the c.4965C>G (5193C>G) mutation in the patient (PubMed=19654294).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg160Trp (c.478A>T); ClinVar=VCV000412204; Zygosity=Homozygous (CelloPub=CLPUB00667; DepMap=ACH-001632).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Homozygous (CelloPub=CLPUB00667; PubMed=25230021; PubMed=28273451; DepMap=ACH-001632).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 10032309; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001632; ECACC=10032309; PubMed=22183581; PubMed=22710073; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 16,17
ST   D19S433: 13,15
ST   D21S11: 30,32.2
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,14
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C5228; Ovarian cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2686 ! PEO1
OI   CVCL_2691 ! PEO6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   PEO4-iPSC-OSKM-03
AC   CVCL_B7JI
DR   Wikidata; Q114312650
RX   PubMed=34343671;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Tyr (c.4965C>T) (5193C>T); ClinVar=VCV001657967; Zygosity=Hemizygous; Note=De novo mutation that cancels the c.4965C>G (5193C>G) mutation in the patient (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg160Trp (c.478A>T); ClinVar=VCV000412204; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C5228; Ovarian cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2690 ! PEO4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   PEO4-iPSC-OSKM-05
AC   CVCL_B7JJ
DR   Wikidata; Q114312651
RX   PubMed=34343671;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Tyr (c.4965C>T) (5193C>T); ClinVar=VCV001657967; Zygosity=Hemizygous; Note=De novo mutation that cancels the c.4965C>G (5193C>G) mutation in the patient (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg160Trp (c.478A>T); ClinVar=VCV000412204; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C5228; Ovarian cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2690 ! PEO4
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   PEO6
AC   CVCL_2691
SY   PE06; PEO-6
DR   BTO; BTO_0005798
DR   EFO; EFO_0005449
DR   cancercelllines; CVCL_2691
DR   CancerTools; 151674
DR   Cell_Model_Passport; SIDM00470
DR   ECACC; 10032310
DR   GEO; GSM459855
DR   GEO; GSM659400
DR   GEO; GSM1340591
DR   GEO; GSM1341133
DR   GEO; GSM2475003
DR   Progenetix; CVCL_2691
DR   Wikidata; Q54947169
DR   Ximbio; 151674
RX   PubMed=3167863;
RX   PubMed=19654294;
RX   PubMed=20581869;
RX   PubMed=22183581;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=28273451;
RX   PubMed=30485824;
CC   Population: Caucasian.
CC   Doubling time: 77 hours (PubMed=3167863).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Tyr (c.4965C>T) (5193C>T); ClinVar=VCV001657967; Zygosity=Hemizygous; Note=De novo mutation that cancels the c.4965C>G (5193C>G) mutation in the patient (PubMed=19654294).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Unspecified (PubMed=28273451).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 10032310; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC=10032310; PubMed=22183581; PubMed=22710073; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 30 (PubMed=22710073)
ST   D21S11: 30,32.2 (PubMed=22183581; PubMed=30485824)
ST   D2S1338: 20,21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C36101; BRCA2 syndrome
DI   NCIt; C5228; Ovarian cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2686 ! PEO1
OI   CVCL_2690 ! PEO4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   pep#1 P4-E12
AC   CVCL_C7KD
DR   Wikidata; Q117704774
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   pep#1 P6-A7
AC   CVCL_C7KE
DR   Wikidata; Q117704775
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   pep#2 #20-H12
AC   CVCL_C7KF
DR   Wikidata; Q117704776
RX   Patent=JP2016114360A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE ABP-01967.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   pep#2 P1-A12
AC   CVCL_C7KG
DR   Wikidata; Q117704777
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   pep#2 P3-E3
AC   CVCL_C7KH
DR   Wikidata; Q117704778
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   pep#3 #21-1
AC   CVCL_C7KI
DR   Wikidata; Q117704779
RX   Patent=JP2016114360A;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   pep#3 #91-1
AC   CVCL_C7KJ
DR   Wikidata; Q117704780
RX   Patent=JP2016114360A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE ABP-01968.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q2Q067; Human T-cell leukemia virus 1 (HTLV-1) HBZ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Per Sel
AC   CVCL_3327
DR   CLO; CLO_0008419
DR   ATCC; CRL-1107
DR   Wikidata; Q54947170
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   PER-106
AC   CVCL_8904
SY   PER 106
DR   IARC_TP53; 23832
DR   Wikidata; Q54947171
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=1581878;
CC   Doubling time: 10.5 days (Note=For non-adherent), >30 days (Note=For adherent) (PubMed=1581878).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8905 ! PER-107
OI   CVCL_8906 ! PER-108
SX   Male
AG   1Y5M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   PER-107
AC   CVCL_8905
SY   PER 107
DR   IARC_TP53; 23833
DR   Wikidata; Q54947172
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=1581878;
CC   Doubling time: 5.75 days (PubMed=1581878).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8904 ! PER-106
OI   CVCL_8906 ! PER-108
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   PER-108
AC   CVCL_8906
SY   PER 108
DR   IARC_TP53; 23834
DR   Wikidata; Q54947173
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=1581878;
CC   Doubling time: 3.25 days (PubMed=1581878).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8904 ! PER-106
OI   CVCL_8905 ! PER-107
SX   Male
AG   2Y8M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   PER-117
AC   CVCL_W979
SY   PER 117
DR   Wikidata; Q54947174
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3472019;
RX   PubMed=7541097;
RX   PubMed=10556553;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 55-65 hours (PubMed=3472019); 56 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11,12
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 16,17
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   PER-145
AC   CVCL_W976
DR   Wikidata; Q54947175
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2720661;
RX   PubMed=3472651;
RX   PubMed=7540895;
RX   PubMed=7541097;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 108 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 16
ST   D21S11: 30,33.2
ST   D2S1338: 16,19
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 9,11
ST   FGA: 19,20
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W977 ! PER-163
OI   CVCL_W978 ! PER-164
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   PER-163
AC   CVCL_W977
DR   Wikidata; Q54947176
RX   PubMed=2720661;
RX   PubMed=3472651;
RX   PubMed=7540895;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W976 ! PER-145
OI   CVCL_W978 ! PER-164
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   PER-164
AC   CVCL_W978
DR   Wikidata; Q54947177
RX   PubMed=2720661;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W976 ! PER-145
OI   CVCL_W977 ! PER-163
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   PER-255
AC   CVCL_W980
SY   PER 255
DR   Wikidata; Q54947178
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2546623;
RX   PubMed=7541097;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 84-95 hours (PubMed=2546623); 66 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 19
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 23,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 10
//
ID   PER-271
AC   CVCL_RM22
DR   Wikidata; Q54947179
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7541097;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PER-278
AC   CVCL_W981
DR   Wikidata; Q54947180
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2340491;
RX   PubMed=7541097;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 62-68 hours (PubMed=2340491); 104 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 13
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 23,25
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 24,27
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   PER-288
AC   CVCL_RM23
DR   Wikidata; Q54947182
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7541097;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PER-315
AC   CVCL_C7XV
DR   Wikidata; Q123033259
RX   PubMed=2164120;
RX   PubMed=8429680;
CC   Population: Caucasian.
CC   Characteristics: IL2 dependent.
CC   Miscellaneous: Cell line stopped growing after 1 year (PubMed=8429680).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K242 ! PER-423
OI   CVCL_C7XW ! PER-423-9
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   PER-365
AC   CVCL_A474
DR   Cosmic; 1130241
DR   Wikidata; Q54947183
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7536459;
CC   Doubling time: 6.6 days (PubMed=7536459).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A475 ! PER-377
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   PER-371
AC   CVCL_W982
DR   Wikidata; Q54947184
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 69 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 10,17
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 23,25
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   PER-377
AC   CVCL_A475
SY   PER377
DR   Cosmic; 1130242
DR   Wikidata; Q54947186
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7536459;
RX   PubMed=7541097;
RX   PubMed=12883040;
RX   PubMed=14671638;
RX   PubMed=17117183;
CC   Doubling time: 3.6 days (PubMed=7536459); 66 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D21S11: 31.2,32
ST   D2S1338: 19,21
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A474 ! PER-365
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   PER-403
AC   CVCL_C8YK
SY   Per403
DR   Wikidata; Q123033260
RX   PubMed=1785673;
RX   PubMed=17934517;
RX   PubMed=21447744;
RX   PubMed=23128391;
RX   PubMed=24518598;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 11 fused to NUTM1 exon 2 (PubMed=23128391; PubMed=24518598; PubMed=29348827).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thoracic cavity; UBERON=UBERON_0002224.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   PER-423
AC   CVCL_K242
SY   PER 423
DR   Wikidata; Q54947188
RX   PubMed=7541097;
RX   PubMed=8429680;
CC   Population: Caucasian.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7XV ! PER-315
OI   CVCL_C7XW ! PER-423-9
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   PER-423-9
AC   CVCL_C7XW
DR   Wikidata; Q123033261
RX   PubMed=8429680;
CC   Population: Caucasian.
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7XV ! PER-315
OI   CVCL_K242 ! PER-423
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   PER-427
AC   CVCL_W983
DR   Wikidata; Q54947189
RX   PubMed=7541097;
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Characteristics: IL2 dependent.
CC   Doubling time: 209 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 14,18
ST   D19S433: 12,13
ST   D21S11: 29
ST   D2S1338: 21,26
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 21,24
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 15,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   PER-450
AC   CVCL_RN50
DR   Wikidata; Q54947195
RX   PubMed=7541097;
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   PER-452
AC   CVCL_IX11
SY   PER 452
DR   Wikidata; Q54947196
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7513543;
RX   PubMed=17442120;
CC   Doubling time: 4.38 days (PubMed=7513543).
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C114812; Childhood pineoblastoma
DI   ORDO; Orphanet_251909; Pineoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX12 ! PER-453
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PER-453
AC   CVCL_IX12
SY   PER 453
DR   Wikidata; Q54947197
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7513543;
RX   PubMed=17442120;
CC   Characteristics: Expresses FOXO1A at very high levels.
CC   Doubling time: 2.73 days (PubMed=7513543).
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C114812; Childhood pineoblastoma
DI   ORDO; Orphanet_251909; Pineoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IX11 ! PER-452
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PER-480
AC   CVCL_IX13
SY   PER 480
DR   Wikidata; Q54947198
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=9428362;
RX   PubMed=17442120;
CC   Doubling time: 2.6 days (PubMed=9428362).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114812; Childhood pineoblastoma
DI   ORDO; Orphanet_251909; Pineoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   PER-485
AC   CVCL_W984
AS   CVCL_IY97
SY   PER-485A
DR   Wikidata; Q54947199
RX   PubMed=12883040;
RX   PubMed=17117183;
RX   PubMed=27443263;
RX   PubMed=33937032;
CC   Doubling time: 53 hours (PubMed=17117183); 48 hours (PubMed=27443263).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=17117183; PubMed=27443263; PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 14,16.2
ST   D21S11: 30.2,31.2
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15,16
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8JU ! PER-494
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   PER-487
AC   CVCL_W985
DR   Wikidata; Q54947201
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Characteristics: IL2 dependent.
CC   Doubling time: 363 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 13
ST   D16S539: 10,12
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D7S820: 9,11
ST   D8S1179: 8,13
ST   FGA: 23,24
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 7
//
ID   PER-490
AC   CVCL_W986
AS   CVCL_IY98
SY   PER-490A
DR   Wikidata; Q54947203
RX   PubMed=12883040;
RX   PubMed=17117183;
RX   PubMed=27443263;
RX   PubMed=33937032;
CC   Doubling time: 97 hours (PubMed=17117183); 72 hours (PubMed=27443263).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=17117183; PubMed=27443263; PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 13,15
ST   D21S11: 31,33.2
ST   D2S1338: 23,26
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9D
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   PER-494
AC   CVCL_A8JU
DR   Wikidata; Q108821103
RX   PubMed=33937032;
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D21S11: 30.2,31.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15,16
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W984 ! PER-485
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   PER-495
AC   CVCL_W987
DR   Wikidata; Q54947205
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 53 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,14
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 19
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 11,12
ST   FGA: 22,26
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 7
//
ID   PER-535
AC   CVCL_C8YY
DR   Wikidata; Q123033262
RX   PubMed=24518598;
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C156714; Malignant abdominal neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PER-537
AC   CVCL_W988
DR   Wikidata; Q54947206
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 223 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,14
ST   D16S539: 12
ST   D18S51: 11,15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 20,26
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 7
//
ID   PER-547
AC   CVCL_IX14
DR   Wikidata; Q54947207
RX   PubMed=17442120;
RX   PubMed=19077040;
CC   Doubling time: ~75 hours (PubMed=19077040).
DI   NCIt; C4956; Desmoplastic/nodular medulloblastoma
DI   ORDO; Orphanet_251863; Desmoplastic/nodular medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PER-550
AC   CVCL_W989
DR   Wikidata; Q54947209
RX   PubMed=12883040;
RX   PubMed=17117183;
CC   Doubling time: 252 hours (PubMed=17117183).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 10,12
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 20,24
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W991 ! PER-606
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   PER-568
AC   CVCL_IX15
DR   Wikidata; Q54947210
RX   PubMed=17442120;
RX   PubMed=19077040;
CC   Doubling time: ~209 hours (PubMed=19077040).
CC   Derived from site: Metastatic; Left caudate nucleus; UBERON=UBERON_0001873.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7-8Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PER-604
AC   CVCL_W990
DR   Wikidata; Q54947211
RX   PubMed=17117183;
CC   Doubling time: 181 hours (PubMed=17117183).
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 11,12,17
ST   D19S433: 14,16.2
ST   D21S11: 30,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   PER-606
AC   CVCL_W991
DR   Wikidata; Q54947212
RX   PubMed=17117183;
CC   Doubling time: 442 hours (PubMed=17117183).
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 10,12
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 20,24
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W989 ! PER-550
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   PER-607
AC   CVCL_W992
DR   Wikidata; Q54947215
RX   PubMed=17117183;
CC   Doubling time: 216 hours (PubMed=17117183).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15,22
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 13,16
ST   FGA: 22,26
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   PER-608
AC   CVCL_W993
DR   Wikidata; Q54947216
RX   PubMed=17117183;
CC   Doubling time: 260 hours (PubMed=17117183).
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 9,10
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 16,19
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
ID   PER-624
AC   CVCL_C8YW
DR   Wikidata; Q123033263
RX   PubMed=23128391;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 15 fused to NUTM1 exon 2 (PubMed=23128391; PubMed=29348827).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   PER-703
AC   CVCL_IY99
SY   PER-703A
DR   Wikidata; Q54947217
RX   PubMed=27443263;
RX   PubMed=33937032;
CC   Doubling time: 60 hours (PubMed=27443263).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=27443263; PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ00 ! PER-703S
OI   CVCL_IZ01 ! PER-733S
SX   Female
AG   1M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   PER-703S
AC   CVCL_IZ00
DR   Wikidata; Q54947218
RX   PubMed=27443263;
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line is no longer in use (personal communication of Kotecha, Rishi S.).
ST   Source(s): PubMed=27443263
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY99 ! PER-703
OI   CVCL_IZ01 ! PER-733S
SX   Female
AG   1M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   PER-704
AC   CVCL_C8YX
DR   Wikidata; Q123033264
RX   PubMed=23128391;
RX   PubMed=24518598;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 15 fused to NUTM1 exon 2 (PubMed=24518598; PubMed=29348827).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   PER-733S
AC   CVCL_IZ01
DR   Wikidata; Q54947219
RX   PubMed=27443263;
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line is no longer in use (personal communication of Kotecha, Rishi S.).
ST   Source(s): PubMed=27443263
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IY99 ! PER-703
OI   CVCL_IZ00 ! PER-703S
SX   Female
AG   1M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   PER-784
AC   CVCL_IZ02
SY   PER-784A
DR   Wikidata; Q54947220
RX   PubMed=27443263;
RX   PubMed=33937032;
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=27443263; PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 10,12,13
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D21S11: 27,30
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ05 ! PER-826
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   PER-785
AC   CVCL_IZ03
SY   PER-785A
DR   Wikidata; Q54947221
RX   PubMed=27443263;
RX   PubMed=33937032;
CC   Doubling time: 60 hours (PubMed=27443263).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=27443263; PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 30,30.2
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ04 ! PER-785S
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   PER-785S
AC   CVCL_IZ04
DR   Wikidata; Q54947222
RX   PubMed=27443263;
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line is no longer in use (personal communication of Kotecha, Rishi S.).
ST   Source(s): PubMed=27443263
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 30,30.2
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ03 ! PER-785
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   PER-826
AC   CVCL_IZ05
SY   PER-826A
DR   Wikidata; Q54947223
RX   PubMed=27443263;
RX   PubMed=33937032;
CC   Doubling time: 192 hours (PubMed=27443263).
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33937032
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D21S11: 27,30
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ02 ! PER-784
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   PER-904N
AC   CVCL_C9CP
SY   P896-FB
DR   Wikidata; Q123033266
RX   PubMed=29348827;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9CN ! PER-909
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   PER-909
AC   CVCL_C9CN
SY   P896-CL
DR   Wikidata; Q123033267
RX   PubMed=26551281;
RX   PubMed=29348827;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 15 fused to NUTM1 exon 2 (PubMed=26551281).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9CP ! PER-904N
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   PER-910
AC   CVCL_A8JV
DR   Wikidata; Q108821105
RX   PubMed=33937032;
CC   Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33937032
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 12,14
ST   D21S11: 28,30
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   Per113
AC   CVCL_E3RU
RX   PubMed=3689673;
CC   Doubling time: 32 hours (Note=At 15th passage), 40 hours (Note=At 29th passage) (PubMed=3689673).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Per192
AC   CVCL_E3RV
RX   PubMed=1649163;
RX   PubMed=3689673;
CC   Doubling time: 24 hours (Note=At 20th passage), 20 hours (Note=At 50th passage) (PubMed=3689673).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Per192N
AC   CVCL_E3RY
RX   PubMed=1649163;
CC   Characteristics: Established from tumors formed after subcutaneous injection of the parent cell line in athymic nude mice (Swiss/nu/nu) (PubMed=1649163).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3RV ! Per192
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Per192NR
AC   CVCL_E3S1
RX   PubMed=1649163;
CC   Characteristics: Established from tumors formed after passage of the parent cell line in the syngeneic rat host (PubMed=1649163).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3RY ! Per192N
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Per237
AC   CVCL_E3RW
RX   PubMed=3689673;
CC   Doubling time: 35 hours (Note=At 15th passage), 30 hours (Note=At 44th passage) (PubMed=3689673).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Per305
AC   CVCL_E3RX
RX   PubMed=1649163;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Per305N1
AC   CVCL_E3RZ
RX   PubMed=1649163;
CC   Characteristics: Established from tumors formed after subcutaneous injection of the parent cell line in athymic nude mice (Swiss/nu/nu) (PubMed=1649163).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3RX ! Per305
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Per305N2a
AC   CVCL_E3S0
RX   PubMed=1649163;
CC   Characteristics: Established from tumors formed after subcutaneous injection of the parent cell line in athymic nude mice (Swiss/nu/nu) (PubMed=1649163).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3RX ! Per305
SX   Male
AG   36W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   PER-VAS
AC   CVCL_DI60
DR   Wikidata; Q54947224
RX   PubMed=26345430;
CC   Doubling time: 16.5 hours (PubMed=26345430).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C128121; Canine lymphoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 7
//
ID   PER.C6
AC   CVCL_G704
SY   Per.C6; PER C6; PERC6; PerC6; Perc6; PER cell clone 6
DR   EFO; EFO_0022685
DR   FCS-free; 39-13-46-1-8-11
DR   Wikidata; Q54947225
RX   Patent=US6602706;
RX   Patent=US9469865;
RX   PubMed=9741429;
RX   PubMed=11257414;
RX   PubMed=16566444;
RX   PubMed=18052336;
RX   PubMed=23123018;
RX   PubMed=25903999;
RX   PubMed=28450423;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-452.html
WW   Provider; Crucell; -; https://web.archive.org/web/20121219090924/http://www.dsm.com/en_US/downloads/dpp/PER.C6_Brochure.pdf
WW   Provider; Crucell; -; https://web.archive.org/web/20140721200546/http://www.crucell.com/page/downloads/Factsheet_PER.C6_Technology.pdf
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   From: Johnson & Johnson Janssen (originally Crucell); Beerse; Belgium.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 96022940.
CC   Biotechnology: Used for the production of follitropin delta (Trade name: Rekovelle).
CC   Virology: Supports replication of all three poliovirus serotypes (PubMed=23123018).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Misspelling: Per.Co6; Note=Occasionally.
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
CC   Cell type: Retinoblast; CL=CL_4023129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1K15 ! 911
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 25
//
ID   PER.C6 TetR
AC   CVCL_A7ME
DR   Wikidata; Q107116656
WW   Info; EMA; -; https://www.ema.europa.eu/en/documents/assessment-report/covid-19-vaccine-janssen-epar-public-assessment-report_en.pdf
CC   Group: Vaccine production cell line.
CC   From: Johnson & Johnson Janssen; Beerse; Belgium.
CC   Biotechnology: Used for the production of the Janssen SARS-CoV-2 (COVID-19) vaccine (Trade name: Ad26.COV2.S) (DrugBank=DB15857). In the context of the vaccine production, the tetR repressor blocks the expression of the SARS-CoV-2 spike protein gene during production of the recombinant adenoviral vector, thereby optimising vector production.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
CC   Cell type: Retinoblast; CL=CL_4023129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G704 ! PER.C6
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Peri-iPS-C1
AC   CVCL_UG62
SY   Peri-iPS-C1P20
DR   GEO; GSM807100
DR   Wikidata; Q98128545
RX   PubMed=20036631;
RX   PubMed=21949351;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, periosteum; UBERON=UBERON_0002515.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG63 ! Peri-iPS-C2
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   Peri-iPS-C2
AC   CVCL_UG63
SY   Peri-iPS-C2P20
DR   GEO; GSM807101
DR   Wikidata; Q98128546
RX   PubMed=20036631;
RX   PubMed=21949351;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, periosteum; UBERON=UBERON_0002515.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG62 ! Peri-iPS-C1
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   Peri.4U
AC   CVCL_1E62
DR   Wikidata; Q54947226
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20170829203824/http://axiogenesis.com/products/neuronal-cells/peri-4u-hipsc-peripheral-neurons.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Cell type: Peripheral nervous system neuron; CL=CL_2000032.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ52 ! Astro.4U
OI   CVCL_1E61 ! Dopa.4U
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   PERK-KO-DR
AC   CVCL_B067
DR   ATCC; CRL-2976
DR   Wikidata; Q54947227
CC   Knockout cell: Method=KO mouse; MGI; MGI:1341830; Eif2ak3.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   PERU
AC   CVCL_A1YQ
DR   Wikidata; Q105510557
RX   PubMed=19276180;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 58.9 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   PES 41
AC   CVCL_VP91
SY   PES-41; PES41; PE-MEL-41; PE-Mel-41
DR   cancercelllines; CVCL_VP91
DR   Wikidata; Q98128547
RX   PubMed=16638848;
RX   PubMed=21424129;
RX   PubMed=21863025;
RX   PubMed=29492214;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=29492214).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP92 ! PES 43
OI   CVCL_VP93 ! PES 47
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   PES 43
AC   CVCL_VP92
SY   PES-43; PES43; PE-MEL-43; PE-Mel-43
DR   cancercelllines; CVCL_VP92
DR   Wikidata; Q98128548
RX   PubMed=10837406;
RX   PubMed=12488552;
RX   PubMed=16638848;
RX   PubMed=21424129;
RX   PubMed=21863025;
RX   PubMed=29492214;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=29492214).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP91 ! PES 41
OI   CVCL_VP93 ! PES 47
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   PES 47
AC   CVCL_VP93
SY   PES-47; PES47; PE-MEL-47; PE-Mel-47
DR   cancercelllines; CVCL_VP93
DR   Wikidata; Q98128549
RX   PubMed=10837406;
RX   PubMed=12488552;
RX   PubMed=16638848;
RX   PubMed=21424129;
RX   PubMed=21863025;
RX   PubMed=29492214;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=29492214).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP91 ! PES 41
OI   CVCL_VP92 ! PES 43
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   PESU-B5L
AC   CVCL_RW88
DR   Wikidata; Q54947228
RX   PubMed=22993147;
CC   Group: Bat cell line.
CC   Virology: Susceptible to infection by human coronavirus NL63 (HCoV-NL63) and SARS coronavirus (SARS-CoV).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=27672; ! Perimyotis subflavus (Eastern pipistrelle)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PET
AC   CVCL_N816
DR   Cosmic; 1656048
DR   Wikidata; Q54947229
RX   PubMed=15274292;
RX   PubMed=22426987;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PeTa
AC   CVCL_LC73
SY   PETA
DR   Cell_Model_Passport; SIDM01848
DR   DepMap; ACH-001170
DR   PRIDE; PXD008181
DR   Wikidata; Q54947234
RX   PubMed=23563200;
RX   PubMed=27121059;
RX   PubMed=30873613;
RX   PubMed=31889939;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 2-3 days (PubMed=30873613).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D21S11: 30.2,32
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 9,13
ST   D8S1179: 14,15
ST   FGA: 19,21
ST   Penta D: 11,13
ST   Penta E: 10,16
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   PETCAT 1
AC   CVCL_VG33
SY   Petcat 1
DR   Wikidata; Q54947230
RX   CelloPub=CLPUB00429;
RX   CelloPub=CLPUB00430;
RX   PubMed=1726925;
RX   PubMed=1841731;
RX   PubMed=10588824;
CC   Doubling time: 34 hours (CelloPub=CLPUB00429).
CC   Derived from site: In situ; Thyroid gland; Note=From a goiter; UBERON=UBERON_0002046.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   12Y
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   PETCAT 2
AC   CVCL_VG34
SY   Petcat 2
DR   Wikidata; Q54947231
RX   CelloPub=CLPUB00429;
RX   PubMed=1726925;
RX   PubMed=10588824;
CC   Doubling time: 72 hours (CelloPub=CLPUB00429).
CC   Derived from site: In situ; Thyroid gland; Note=From a goiter; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   PETCAT 3
AC   CVCL_VG35
SY   Petcat 3
DR   Wikidata; Q54947232
RX   CelloPub=CLPUB00429;
RX   PubMed=1726925;
RX   PubMed=10588824;
CC   Doubling time: 49 hours (CelloPub=CLPUB00429).
CC   Derived from site: In situ; Thyroid gland; Note=From a goiter; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   PETCAT 4
AC   CVCL_VG36
SY   Petcat 4
DR   Wikidata; Q54947233
RX   CelloPub=CLPUB00429;
RX   PubMed=1726925;
RX   PubMed=1841731;
RX   PubMed=10588824;
CC   Doubling time: 33 hours (CelloPub=CLPUB00429).
CC   Derived from site: In situ; Thyroid gland; Note=From a goiter; UBERON=UBERON_0002046.
CC   Breed/subspecies: Mixed breed.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   14Y
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   PETCH
AC   CVCL_E803
DR   dbMHC; 48998
DR   ECACC; 94092801
DR   IHW; IHW09205
DR   IPD-IMGT/HLA; 11246
DR   Wikidata; Q54947235
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*24; B*18:02,15:13; C*07:04,08 (IPD-IMGT/HLA=11246).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Peter
AC   CVCL_ZI19
DR   Wikidata; Q98128550
RX   PubMed=4122458;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   PF
AC   CVCL_R981
SY   Poecilia Fry
DR   Wikidata; Q54947236
RX   CelloPub=CLPUB00098;
CC   Group: Fish cell line.
CC   Doubling time: ~1.5 days (CelloPub=CLPUB00098).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=48698; ! Poecilia formosa (Amazon molly)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 10
//
ID   PF-1 [Human mantle cell lymphoma]
AC   CVCL_UJ04
DR   ATCC; CRL-3379
DR   Wikidata; Q98128551
RX   PubMed=24611650;
RX   PubMed=29666304;
RX   PubMed=30209121;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1582; CCND1 + HGNC; HGNC:5477; IGH; Name(s)=IGH-CCND1 (PubMed=24611650).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3379; PubMed=24611650
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 28,32.2
ST   D5S818: 11,13
ST   D7S820: 11
ST   FGA: 21,24
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 11
//
ID   PF-1 [Perca]
AC   CVCL_F1BL
SY   Perch Fin-1
RX   PubMed=40559539;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 25 Celsius (PubMed=40559539).
CC   Virology: Susceptible to infection by European catfish virus (ECV) and ictalurid herpesvirus 2 (IcHV-2) (PubMed=40559539).
CC   Virology: Not susceptible to infection by pike fry rhabdovirus (PFRV) and spring viraemia of carp virus (SVCV) (PubMed=40559539).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8168; ! Perca fluviatilis (European perch)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PF-2
AC   CVCL_UJ27
DR   Wikidata; Q98128552
RX   PubMed=30209121;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   PF-3
AC   CVCL_UJ28
DR   Wikidata; Q98128553
RX   PubMed=30209121;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   PF-382
AC   CVCL_1641
SY   PF382
DR   CLO; CLO_0008421
DR   CLDB; cl3895
DR   CLDB; cl4993
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 487
DR   BioSample; SAMN03473327
DR   BioSample; SAMN10988497
DR   cancercelllines; CVCL_1641
DR   Cell_Model_Passport; SIDM00451
DR   ChEMBL-Cells; CHEMBL3308246
DR   ChEMBL-Targets; CHEMBL2366235
DR   Cosmic; 909260
DR   Cosmic; 913414
DR   Cosmic; 1012113
DR   Cosmic; 1115593
DR   Cosmic; 1151790
DR   Cosmic; 1224370
DR   Cosmic; 1524814
DR   Cosmic; 1641384
DR   Cosmic; 2165708
DR   Cosmic-CLP; 909260
DR   DepMap; ACH-000937
DR   DSMZ; ACC-38
DR   DSMZCellDive; ACC-38
DR   EGA; EGAS00001000978
DR   GDSC; 909260
DR   GEO; GSM887513
DR   GEO; GSM888595
DR   GEO; GSM1670348
DR   GEO; GSM5137738
DR   IARC_TP53; 21278
DR   ICLC; HTL00006
DR   LiGeA; CCLE_260
DR   LINCS_LDP; LCL-1021
DR   PharmacoDB; PF382_1262_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1641
DR   PubChem_Cell_line; CVCL_1641
DR   Wikidata; Q54947238
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2410652;
RX   PubMed=3210814;
RX   PubMed=3499548;
RX   PubMed=15472075;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/pf-382/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=2410652); ~70 hours (DSMZ=ACC-38).
CC   HLA typing: A*01:01,11:01; B*08:01,44:02; C*05:01,07:06; DQB1*02:02,03:04; DRB1*03:05,12:27 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2493fs*67 (c.7476_7477ins11); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (Cosmic-CLP=909260).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.02%; Native American=0%; East Asian, North=0.88%; East Asian, South=0.06%; South Asian=8.99%; European, North=36.79%; European, South=53.26% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=909260; DSMZ=ACC-38
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 21
ST   Penta D: 11,12
ST   Penta E: 5,17
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   PF-4
AC   CVCL_UJ29
DR   Wikidata; Q98128554
RX   PubMed=30209121;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   PF-5
AC   CVCL_UJ30
DR   Wikidata; Q98128555
RX   PubMed=30209121;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   PF-6
AC   CVCL_UJ31
DR   Wikidata; Q98128556
RX   PubMed=30209121;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   PF-R
AC   CVCL_0I61
SY   PF
DR   CCLV; CCLV-RIE 0200
DR   Wikidata; Q54947239
RX   PubMed=19941903;
CC   Group: Bird cell line.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   PF04015
AC   CVCL_E804
SY   PF 04015
DR   dbMHC; 48999
DR   ECACC; 95052212
DR   IHW; IHW09088
DR   IPD-IMGT/HLA; 11645
DR   PRIDE; PXD001205
DR   Wikidata; Q54947244
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=25502872;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*01:01:01:01; B*08:01:01:01; C*07:01:01:01; DPA1*01,02:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01; DQB1*02:01:01; DRA*01:02; DRB1*03:01:01; DRB3*01:01 (IPD-IMGT/HLA=11645).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   PF1-11-2-1
AC   CVCL_A0DK
SY   11.2.1; LN 15919
DR   Wikidata; Q108821106
RX   Patent=US7824679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6863.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF1-11.2.1.4
AC   CVCL_A0DL
SY   11.2.1.4; LN 15890
DR   Wikidata; Q108821107
RX   Patent=US7824679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5169.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0DK ! PF1-11-2-1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF1-4-1-1
AC   CVCL_A0DG
SY   4.1.1; LN 15918
DR   Wikidata; Q108821108
RX   Patent=US7824679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6862.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF1-4.1.1.1
AC   CVCL_A0DH
SY   4.1.1.1; LN 15887
DR   Wikidata; Q108821109
RX   Patent=US7824679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5166.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0DG ! PF1-4-1-1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF1-4.13.1.1
AC   CVCL_A0DI
SY   4.13.1.1; LN 15888
DR   ATCC; PTA-5167
DR   Wikidata; Q108821110
RX   Patent=US7824679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5167.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
CC   Misspelling: PF1-1.13.1.1; ATCC=PTA-5167.
CC   Discontinued: ATCC; PTA-5167; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF1-46/5
AC   CVCL_F0UV
RX   PubMed=1584066;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Penicillium glabrum conidia and mycelium wall layer (Note=Also reacts with Aspergillus versicolor and Penicillium verrucosum).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PF1-6.1.1.3
AC   CVCL_A0DJ
SY   6.1.1.3; LN 15889
DR   Wikidata; Q108821111
RX   Patent=US7824679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5168.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF130
AC   CVCL_A7EV
DR   Wikidata; Q107116657
RX   PubMed=33669371;
CC   Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Glu102_Lys104delinsGln (c.303_310del8ins); Zygosity=Unspecified (PubMed=33669371).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C165497; Spitz melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   PF2A1-8F8
AC   CVCL_C2D9
SY   PF2A1(8F8); PF2A1; 8F8
DR   Wikidata; Q114312652
RX   PubMed=15975577;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35080; Human PFN2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   PF2A2-6D1
AC   CVCL_C2DA
SY   PF2A2(6D1); PF2A2; 6D1
DR   Wikidata; Q114312653
RX   PubMed=15975577;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35080; Human PFN2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   PF2A3-6D10
AC   CVCL_C2DB
SY   PF2A3(6D10); PF2A3; 6D10
DR   DSHB; PF2A3-6D10
DR   Wikidata; Q114312654
RX   PubMed=15975577;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35080; Human PFN2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   PF2A4-5A6
AC   CVCL_C2DC
SY   PF2A4(5A6); PF2A4; 5A6
DR   Wikidata; Q114312655
RX   PubMed=15975577;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35080; Human PFN2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   PF2A5-6B3
AC   CVCL_C2DD
SY   PF2A5(6B3); PF2A5; 6B3
DR   DSHB; PF2A5-6B3
DR   Wikidata; Q114312657
RX   PubMed=15975577;
WW   Provider; CIND; -; http://www.glennmorris.org.uk/mabs/Spinal.htm
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35080; Human PFN2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   PF2A6-9G7
AC   CVCL_C2DE
SY   PF2A6(9G7); PF2A6; 9G7
DR   Wikidata; Q114312658
RX   PubMed=15975577;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P35080; Human PFN2 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   PF8-1-116-1
AC   CVCL_A0CR
SY   1-116-1; LN 15902
DR   Wikidata; Q108821113
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6566.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-1-132-1
AC   CVCL_A0CS
SY   1-132-1; LN 15903
DR   Wikidata; Q108821114
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6567.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-1-136-3
AC   CVCL_A0CT
SY   1-136-3; LN 15904
DR   Wikidata; Q108821116
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6568.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-1-257-1
AC   CVCL_A0CU
SY   1-257-1; LN 15905
DR   Wikidata; Q108821117
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6569.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-1-268-1
AC   CVCL_A0CV
SY   1-268-1; LN 15906
DR   Wikidata; Q108821118
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6570.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-1-314-1
AC   CVCL_A0CW
SY   1-314-1; LN 15907
DR   Wikidata; Q108821120
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6571.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-1-46-1
AC   CVCL_A0CX
SY   1-46-1; LN 15908
DR   Wikidata; Q108821121
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6572.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-1-66-1
AC   CVCL_A0CY
SY   1-66-1; LN 15909
DR   Wikidata; Q108821123
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6573.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-2-112-1
AC   CVCL_A0CZ
SY   2-112-1; LN 15910
DR   Wikidata; Q108821124
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6574.
CC   Monoclonal antibody isotype: IgG4, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-2-177-1
AC   CVCL_A0DA
SY   2-177-1; LN 15912
DR   Wikidata; Q108821125
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6576.
CC   Monoclonal antibody isotype: IgG4, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF8-2-43-1
AC   CVCL_A0DB
SY   2-43-1; LN 15911
DR   Wikidata; Q108821126
RX   Patent=US7807159;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6575.
CC   Monoclonal antibody isotype: IgG4, kappa.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PF97387
AC   CVCL_E805
SY   PF 97387
DR   CLDB; cl7226
DR   dbMHC; 49000
DR   ECACC; 95042722
DR   ICLC; HTL14004
DR   IHW; IHW09027
DR   IPD-IMGT/HLA; 11644
DR   Wikidata; Q54947246
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*29:02:01:01; B*44:03:01:01; C*16:01:01:01; DPA1*01:03; DPB1*04:01:01,04:02:01; DQA1*03; DQB1*03:01:01; DRB1*04:01:01 (IPD-IMGT/HLA=11644).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   PFAT
AC   CVCL_ZF49
SY   PFAT-MT
DR   Wikidata; Q98128557
RX   PubMed=8858520;
RX   PubMed=9499454;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PFB
AC   CVCL_C5YT
SY   Parrot Fish Brain
DR   NRFC; NRFC072
DR   Wikidata; Q116050116
RX   DOI=10.1016/j.aquaculture.2022.738711;
WW   Provider; NRFC; NRFC072; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC072.
CC   Characteristics: Optimal growth at 32 Celsius (DOI=10.1016/j.aquaculture.2022.738711).
CC   Virology: Susceptible to infection by Tilapia lake virus (TiLV) (DOI=10.1016/j.aquaculture.2022.738711).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=1527459; ! Paraneetroplus synspilus x Amphilophus citrinellus (Red parrot cichlid)
OI   CVCL_C5YU ! PFH
OI   CVCL_C5YV ! PFS
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   PFC
AC   CVCL_6F45
SY   Pig Fibroblast Cell line
DR   ABM; T0760
DR   Wikidata; Q54947247
RX   PubMed=26341227;
CC   Doubling time: 40.2 hours (Note=At 10th passage), 37.0 hours (Note=At 20th passage), 35.5 hours (Note=At 30th passage), 35.7 hours (Note=At 40th passage) (PubMed=26341227).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=VGNC; VGNC:93883; Pig TERT.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Jiangquhai; VBO=VBO_0012794.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   2W
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   PFC6
AC   CVCL_S883
DR   Wikidata; Q54947248
RX   PubMed=6184607;
CC   Derived from site: In situ; Testis, epididymis, epididymal fat pad; UBERON=UBERON_0010412.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: C57BL/6J ob/ob.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   Pfeiffer
AC   CVCL_3326
SY   PFEIFFER
DR   BTO; BTO_0006364
DR   CLO; CLO_0008423
DR   EFO; EFO_0006472
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2632
DR   BioGRID_ORCS_Cell_line; 743
DR   BioSample; SAMN03471758
DR   BioSample; SAMN10988533
DR   cancercelllines; CVCL_3326
DR   Cell_Model_Passport; SIDM01775
DR   ChEMBL-Cells; CHEMBL4295442
DR   ChEMBL-Targets; CHEMBL4296489
DR   Cosmic; 1670184
DR   Cosmic; 1714155
DR   Cosmic; 1945187
DR   Cosmic; 2276336
DR   Cosmic; 2437318
DR   DepMap; ACH-000140
DR   EGA; EGAS00001000610
DR   GEO; GSM380141
DR   GEO; GSM552461
DR   GEO; GSM887514
DR   GEO; GSM888596
DR   GEO; GSM1035334
DR   GEO; GSM3150252
DR   IGRhCellID; Pfeiffer
DR   LiGeA; CCLE_851
DR   LINCS_LDP; LCL-1122
DR   PharmacoDB; Pfeiffer_1263_2019
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_3326
DR   PubChem_Cell_line; CVCL_3326
DR   Wikidata; Q54947249
RX   PubMed=10485273;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=20889926;
RX   PubMed=22460905;
RX   PubMed=23292937;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31638226;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Produces IgG kappa (ATCC=CRL-2632).
CC   Doubling time: 24-30 hours (ATCC=CRL-2632).
CC   HLA typing: A*01:01,33:01; B*14:02,57:01; C*06:02,08:02; DQA1*01:01,05:01; DQB1*03:01,05:01; DRB1*01:02,13:05 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1171Cys (c.3511C>T); ClinVar=VCV000133518; Zygosity=Heterozygous (DepMap=ACH-000140).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.72%; Native American=0.65%; East Asian, North=0%; East Asian, South=2.24%; South Asian=9.82%; European, North=22.11%; European, South=63.47% (PubMed=30894373).
CC   Misspelling: Pfeifer; Note=Occasionally.
CC   Misspelling: Pfieffer; Cosmic=1945187; GEO=GSM3150252; PubMed=23292937.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2632
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 19
ST   D3S1358: 13,18
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 14,17
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 17,18
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   PFF
AC   CVCL_R806
SY   Puntius Fasciatus Fin
DR   Wikidata; Q54947250
RX   PubMed=23933168;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=1503185; ! Haludaria fasciata (Melon barb)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   PFGC
AC   CVCL_ZF48
DR   Wikidata; Q98128558
RX   PubMed=9499454;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PFH
AC   CVCL_C5YU
SY   Parrot Fish Heart
DR   NRFC; NRFC073
DR   Wikidata; Q116050117
RX   DOI=10.1016/j.aquaculture.2022.738711;
WW   Provider; NRFC; NRFC073; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC073.
CC   Characteristics: Optimal growth at 28-32 Celsius (DOI=10.1016/j.aquaculture.2022.738711).
CC   Virology: Susceptible to infection by Tilapia lake virus (TiLV) (DOI=10.1016/j.aquaculture.2022.738711).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=1527459; ! Paraneetroplus synspilus x Amphilophus citrinellus (Red parrot cichlid)
OI   CVCL_C5YT ! PFB
OI   CVCL_C5YV ! PFS
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   PFHR-9
AC   CVCL_3566
SY   PFHR 9; PFHR9; PF HR-9
DR   CLO; CLO_0008424
DR   EFO; EFO_0022817
DR   ATCC; CRL-2423
DR   Wikidata; Q54947251
RX   PubMed=558822;
RX   PubMed=1917782;
CC   Characteristics: Not tumorigenic when injected subcutaneously into 129/Sv mice (ATCC=CRL-2423).
CC   Doubling time: 12 hours (ATCC=CRL-2423).
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5911 ! PCC4-F
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   PFI-285
AC   CVCL_A664
DR   Cosmic; 1086320
DR   Wikidata; Q54947253
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2307225;
RX   PubMed=8558920;
CC   Doubling time: ~24 hours (PubMed=2307225).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   PFIZi001-A
AC   CVCL_9S31
SY   EM1-3F; PFIZi026-A
DR   hPSCreg; PFIZi001-A
DR   SKIP; SKIP002630
DR   Wikidata; Q54947254
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ser241Thr (c.721T>A); ClinVar=VCV000006351; Zygosity=Heterozygous (PubMed=27099175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S32 ! PFIZi002-A
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   PFIZi002-A
AC   CVCL_9S32
SY   EM1-7M
DR   hPSCreg; PFIZi002-A
DR   SKIP; SKIP002631
DR   Wikidata; Q54947255
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ser241Thr (c.721T>A); ClinVar=VCV000006351; Zygosity=Heterozygous (PubMed=27099175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S31 ! PFIZi001-A
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   PFIZi003-A
AC   CVCL_9S33
SY   EM2-7M
DR   hPSCreg; PFIZi003-A
DR   SKIP; SKIP002632
DR   Wikidata; Q54947256
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=27099175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S34 ! PFIZi004-A
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   PFIZi004-A
AC   CVCL_9S34
SY   EM2-7F
DR   hPSCreg; PFIZi004-A
DR   SKIP; SKIP002633
DR   Wikidata; Q54947257
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=27099175).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S33 ! PFIZi003-A
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   PFIZi006-A
AC   CVCL_VE66
DR   BioSamples; SAMEA4084491
DR   EBiSC; PFIZi006-A
DR   ECACC; 66540157
DR   hPSCreg; PFIZi006-A
DR   Wikidata; Q54947258
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: EBiSC; PFIZi006-A; true.
CC   Discontinued: ECACC; 66540157; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   PFIZi007-A
AC   CVCL_VE67
DR   BioSamples; SAMEA4084680
DR   EBiSC; PFIZi007-A
DR   ECACC; 66540158
DR   hPSCreg; PFIZi007-A
DR   Wikidata; Q54947259
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: EBiSC; PFIZi007-A; true.
CC   Discontinued: ECACC; 66540158; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   PFIZi008-A
AC   CVCL_VE68
DR   BioSamples; SAMEA4084718
DR   EBiSC; PFIZi008-A
DR   ECACC; 66540160
DR   hPSCreg; PFIZi008-A
DR   Wikidata; Q54947260
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: EBiSC; PFIZi008-A; true.
CC   Discontinued: ECACC; 66540160; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   PFIZi009-A
AC   CVCL_RG04
SY   RCi188
DR   BioSamples; SAMEA4085222
DR   EBiSC; PFIZi009-A
DR   ECACC; 66540164
DR   hPSCreg; PFIZi009-A
DR   Wikidata; Q54947261
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Thr105Ile (c.314C>T); ClinVar=VCV000206927; Zygosity=Heterozygous (EBiSC=PFIZi009-A).
CC   Discontinued: ECACC; 66540164; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   PFIZi010-A
AC   CVCL_VE69
SY   FB65c7
DR   BioSamples; SAMEA4090921
DR   EBiSC; PFIZi010-A
DR   ECACC; 66540170
DR   hPSCreg; PFIZi010-A
DR   Wikidata; Q54947262
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: ECACC; 66540170; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120408; Chromosome 16p11.2 deletion syndrome
DI   ORDO; Orphanet_261197; Proximal 16p11.2 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE70 ! PFIZi010-B
OI   CVCL_VE71 ! PFIZi010-C
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   PFIZi010-B
AC   CVCL_VE70
SY   FB65c16
DR   BioSamples; SAMEA4091043
DR   EBiSC; PFIZi010-B
DR   ECACC; 66540171
DR   hPSCreg; PFIZi010-B
DR   Wikidata; Q54947263
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: ECACC; 66540171; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120408; Chromosome 16p11.2 deletion syndrome
DI   ORDO; Orphanet_261197; Proximal 16p11.2 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE69 ! PFIZi010-A
OI   CVCL_VE71 ! PFIZi010-C
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   PFIZi010-C
AC   CVCL_VE71
SY   FB65c20
DR   BioSamples; SAMEA4090955
DR   EBiSC; PFIZi010-C
DR   ECACC; 66540172
DR   hPSCreg; PFIZi010-C
DR   Wikidata; Q54947264
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: ECACC; 66540172; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120408; Chromosome 16p11.2 deletion syndrome
DI   ORDO; Orphanet_261197; Proximal 16p11.2 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE69 ! PFIZi010-A
OI   CVCL_VE70 ! PFIZi010-B
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   PFIZi011-A
AC   CVCL_VE72
SY   FB67c2; RCi199
DR   BioSamples; SAMEA4097152
DR   EBiSC; PFIZi011-A
DR   ECACC; 66540227
DR   hPSCreg; PFIZi011-A
DR   Wikidata; Q54947265
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: ECACC; 66540227; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120408; Chromosome 16p11.2 deletion syndrome
DI   ORDO; Orphanet_261197; Proximal 16p11.2 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   PFIZi012-A
AC   CVCL_VE73
SY   FB66c17; RCi198
DR   BioSamples; SAMEA4097192
DR   EBiSC; PFIZi012-A
DR   ECACC; 66540228
DR   hPSCreg; PFIZi012-A
DR   Wikidata; Q54947266
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: ECACC; 66540228; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C120408; Chromosome 16p11.2 deletion syndrome
DI   ORDO; Orphanet_261197; Proximal 16p11.2 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   PFIZi013-A
AC   CVCL_IJ00
SY   RCFB59 C9; RCi215
DR   BioSamples; SAMEA4343623
DR   EBiSC; PFIZi013-A
DR   ECACC; 66540322
DR   hPSCreg; PFIZi013-A
DR   SKIP; SKIP002832
DR   Wikidata; Q54947267
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous (EBiSC=PFIZi013-A).
CC   Discontinued: ECACC; 66540322; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE65 ! PFIZi013-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 15
//
ID   PFIZi013-B
AC   CVCL_VE65
SY   RCi216
DR   BioSamples; SAMEA4447666
DR   EBiSC; PFIZi013-B
DR   ECACC; 66540498
DR   hPSCreg; PFIZi013-B
DR   Wikidata; Q54947268
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous (hPSCreg=PFIZi013-B).
CC   Discontinued: EBiSC; PFIZi013-B; true.
CC   Discontinued: ECACC; 66540498; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IJ00 ! PFIZi013-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   PFIZi014-A
AC   CVCL_IJ01
SY   OD002-s7
DR   BioSamples; SAMEA4454946
DR   EBiSC; PFIZi014-A
DR   ECACC; 66540375
DR   hPSCreg; PFIZi014-A
DR   SKIP; SKIP002864
DR   Wikidata; Q54947269
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Ala371Val (c.1112C>T); ClinVar=VCV000206759; Zygosity=Heterozygous (EBiSC=PFIZi014-A).
CC   Discontinued: ECACC; 66540375; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   PFIZi015-A
AC   CVCL_IJ02
SY   OD003-s5
DR   BioSamples; SAMEA4454948
DR   EBiSC; PFIZi015-A
DR   ECACC; 66540376
DR   hPSCreg; PFIZi015-A
DR   SKIP; SKIP002865
DR   Wikidata; Q54947270
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Ser551Profs*6 (c.1650delC); Zygosity=Heterozygous (EBiSC=PFIZi015-A).
CC   Discontinued: ECACC; 66540376; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   PFIZi016-A
AC   CVCL_IJ03
SY   OD005-s9
DR   BioSamples; SAMEA4454950
DR   EBiSC; PFIZi016-A
DR   ECACC; 66540377
DR   hPSCreg; PFIZi016-A
DR   SKIP; SKIP002866
DR   Wikidata; Q54947271
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Val1353Cysfs*5; Zygosity=Heterozygous (EBiSC=PFIZi016-A).
CC   Discontinued: ECACC; 66540377; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   PFIZi017-A
AC   CVCL_RF96
SY   BC142c7; RCi209
DR   BioSamples; SAMEA4458848
DR   EBiSC; PFIZi017-A
DR   hPSCreg; PFIZi017-A
DR   Wikidata; Q54947272
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Cys1741Ser (c.5222G>C) (C1730S); ClinVar=VCV000577486; Zygosity=Heterozygous (EBiSC=PFIZi017-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   PFIZi018-A
AC   CVCL_RF97
SY   BC143c8; RCi207
DR   BioSamples; SAMEA4458850
DR   EBiSC; PFIZi018-A
DR   ECACC; 66540419
DR   hPSCreg; PFIZi018-A
DR   Wikidata; Q54947273
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Arg1245Ter (c.3733C>T) (R1234*); ClinVar=VCV000167639; Zygosity=Heterozygous (EBiSC=PFIZi018-A).
CC   Discontinued: ECACC; 66540419; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   PFIZi019-A
AC   CVCL_RF98
SY   BC145c6; RCi202
DR   BioSamples; SAMEA4458852
DR   EBiSC; PFIZi019-A
DR   ECACC; 66540420
DR   hPSCreg; PFIZi019-A
DR   Wikidata; Q54947274
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Tyr1508fs (c.4522delT); Zygosity=Heterozygous (EBiSC=PFIZi019-A).
CC   Discontinued: ECACC; 66540420; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   PFIZi020-A
AC   CVCL_VE74
SY   BC189c8; RCi217
DR   BioSamples; SAMEA4561626
DR   EBiSC; PFIZi020-A
DR   ECACC; 66540421
DR   hPSCreg; PFIZi020-A
DR   Wikidata; Q54947275
CC   From: Pfizer, Inc.; New York; USA.
CC   Discontinued: EBiSC; PFIZi020-A; true.
CC   Discontinued: ECACC; 66540421; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   PFIZi021-A
AC   CVCL_RF99
SY   OD001-S7
DR   BioSamples; SAMEA4563388
DR   EBiSC; PFIZi021-A
DR   hPSCreg; PFIZi021-A
DR   Wikidata; Q54947276
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Thr1721Lys (c.5162C>A); ClinVar=VCV000206859; Zygosity=Heterozygous; Note=De novo mutation (hPSCreg=PFIZi021-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   PFIZi022-A
AC   CVCL_RG00
SY   B219c2
DR   BioSamples; SAMEA104236750
DR   EBiSC; PFIZi022-A
DR   ECACC; 66540607
DR   hPSCreg; PFIZi022-A
DR   Wikidata; Q54947277
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:30881; ALG13; Simple; p.Asn107Ser (c.320A>G) (N29S); ClinVar=VCV000066086; Zygosity=Heterozygous (hPSCreg=PFIZi022-A).
CC   Discontinued: ECACC; 66540607; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142803; Developmental and epileptic encephalopathy 36
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   PFIZi023-A
AC   CVCL_VE75
SY   B217c8
DR   BioSamples; SAMEA104236752
DR   EBiSC; PFIZi023-A
DR   ECACC; 66540608
DR   hPSCreg; PFIZi023-A
DR   Wikidata; Q54947278
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4512; ADGRG1; Simple; p.Val316Leufs*8 (c.944_945dupTT); ClinVar=VCV000211096; Zygosity=Heterozygous (hPSCreg=PFIZi023-A).
CC   Sequence variation: Mutation; HGNC; HGNC:4512; ADGRG1; Simple; p.Leu503Pro (c.1508T>C) (p.Leu497Pro, c.1490T>C); ClinVar=VCV000158620; Zygosity=Heterozygous (hPSCreg=PFIZi023-A).
CC   Discontinued: ECACC; 66540608; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148367; Bilateral frontoparietal polymicrogyria
DI   ORDO; Orphanet_101070; Bilateral frontoparietal polymicrogyria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   PFIZi024-A
AC   CVCL_RG01
SY   B218c6
DR   BioSamples; SAMEA104236754
DR   EBiSC; PFIZi024-A
DR   ECACC; 66540609
DR   hPSCreg; PFIZi024-A
DR   Wikidata; Q54947279
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4075; GABRA1; Simple; p.Arg147Gln (c.440G>A); ClinVar=VCV000807607; Zygosity=Heterozygous (hPSCreg=PFIZi024-A).
CC   Discontinued: ECACC; 66540609; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142802; Developmental and epileptic encephalopathy 19
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   PFIZi025-A
AC   CVCL_RG02
SY   B220c16
DR   BioSamples; SAMEA104236756
DR   EBiSC; PFIZi025-A
DR   ECACC; 66540610
DR   hPSCreg; PFIZi025-A
DR   Wikidata; Q54947280
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6233; KCNC1; Simple; p.Arg320His (c.959G>A); ClinVar=VCV000162519; Zygosity=Heterozygous (hPSCreg=PFIZi025-A).
CC   Discontinued: ECACC; 66540610; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142804; Epilepsy, progressive myoclonic 7
DI   ORDO; Orphanet_435438; Progressive myoclonic epilepsy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   PFIZi027-A
AC   CVCL_RG03
SY   B221c13
DR   BioSamples; SAMEA104243150
DR   EBiSC; PFIZi027-A
DR   ECACC; 66540612
DR   hPSCreg; PFIZi027-A
DR   Wikidata; Q54947281
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2714; DCX; Unexplicit; Ex5-8del; Zygosity=Heterozygous (hPSCreg=PFIZi027-A).
CC   Discontinued: ECACC; 66540612; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116573; Dravet syndrome
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PFIZi028-A
AC   CVCL_VE76
SY   B212c7
DR   BioSamples; SAMEA104491452
DR   EBiSC; PFIZi028-A
DR   ECACC; 66540639
DR   hPSCreg; PFIZi028-A
DR   Wikidata; Q54947282
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:29521; C12orf57; Simple; p.Gln62Ter (c.184C>T); ClinVar=VCV000155861; Zygosity=Heterozygous (hPSCreg=PFIZi028-A).
CC   Discontinued: ECACC; 66540639; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148371; Temtamy syndrome
DI   ORDO; Orphanet_1777; Temtamy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   PFIZi029-A
AC   CVCL_VE77
SY   B222c4
DR   BioSamples; SAMEA104491453
DR   EBiSC; PFIZi029-A
DR   ECACC; 66540640
DR   hPSCreg; PFIZi029-A
DR   Wikidata; Q54947283
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1917; CHD2; Simple; p.Arg1546Ter (c.4636C>T); ClinVar=VCV000423473; Zygosity=Heterozygous (EBiSC=PFIZi029-A).
CC   Discontinued: ECACC; 66540640; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172100; Developmental and epileptic encephalopathy 94
DI   ORDO; Orphanet_1942; Epilepsy with myoclonic-atonic seizures
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 11
//
ID   PFIZi030-A
AC   CVCL_VE78
SY   B216c13
DR   BioSamples; SAMEA104492931
DR   EBiSC; PFIZi030-A
DR   ECACC; 66540641
DR   hPSCreg; PFIZi030-A
DR   Wikidata; Q54947284
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7944; NPR2; Simple; p.Thr297Met (c.890C>T); ClinVar=VCV002925447; Zygosity=Unspecified (EBiSC=PFIZi030-A).
CC   Discontinued: ECACC; 66540641; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116573; Dravet syndrome
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 12
//
ID   PFIZi031-A
AC   CVCL_VE79
SY   B213c1
DR   BioSamples; SAMEA104494773
DR   EBiSC; PFIZi031-A
DR   ECACC; 66540884
DR   hPSCreg; PFIZi031-A
DR   Wikidata; Q54947297
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10588; SCN2A; Simple; p.Lys1422Glu (c.4264A>G); ClinVar=VCV000206999; Zygosity=Heterozygous (EBiSC=PFIZi031-A).
CC   Discontinued: ECACC; 66540884; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172096; Developmental and epileptic encephalopathy 11
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   PFIZi032-A
AC   CVCL_VE80
SY   B214c8
DR   BioSamples; SAMEA104494774
DR   EBiSC; PFIZi032-A
DR   ECACC; 66540885
DR   hPSCreg; PFIZi032-A
DR   Wikidata; Q54947298
CC   From: Pfizer, Inc.; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Unexplicit; Not described; Zygosity=Unspecified (EBiSC=PFIZi032-A).
CC   Discontinued: ECACC; 66540885; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116573; Dravet syndrome
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   PFL-R
AC   CVCL_RX34
DR   CCLV; CCLV-RIE 0067
DR   Wikidata; Q54947299
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   111-113FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   PfLu
AC   CVCL_RX35
DR   CCLV; CCLV-RIE 0129
DR   Wikidata; Q54947300
CC   Doubling time: ~30 hours (CCLV=CCLV-RIE 0129).
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
ID   PFM-R
AC   CVCL_XH13
DR   CCLV; CCLV-RIE 0068
DR   Wikidata; Q98128559
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   111-113FD
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   PFN-R
AC   CVCL_RX36
DR   CCLV; CCLV-RIE 0123
DR   Wikidata; Q54947301
RX   PubMed=25531820;
CC   Virology: Susceptible to infection by equine herpesviruses (CCLV=CCLV-RIE 0123).
CC   Virology: Susceptible to infection by Middle East respiratory syndrome-related coronavirus (MERS-CoV) (PubMed=25531820).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 6
//
ID   PFS
AC   CVCL_C5YV
SY   Parrot Fish Spleen
DR   NRFC; NRFC074
DR   Wikidata; Q116050118
RX   DOI=10.1016/j.aquaculture.2022.738711;
WW   Provider; NRFC; NRFC074; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC074.
CC   Characteristics: Optimal growth at 28-32 Celsius (DOI=10.1016/j.aquaculture.2022.738711).
CC   Virology: Highly susceptible to infection by Tilapia lake virus (TiLV) (DOI=10.1016/j.aquaculture.2022.738711).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=1527459; ! Paraneetroplus synspilus x Amphilophus citrinellus (Red parrot cichlid)
OI   CVCL_C5YT ! PFB
OI   CVCL_C5YU ! PFH
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   PFSK-1
AC   CVCL_1642
SY   PFSk-1; PFSK1; PFSK
DR   CLO; CLO_0008425
DR   EFO; EFO_0005234
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2060
DR   BioSample; SAMN03471425
DR   cancercelllines; CVCL_1642
DR   Cell_Model_Passport; SIDM01132
DR   ChEMBL-Cells; CHEMBL3308802
DR   ChEMBL-Targets; CHEMBL1075560
DR   Cosmic; 683667
DR   Cosmic; 923655
DR   Cosmic; 973260
DR   Cosmic; 1728490
DR   Cosmic; 1995615
DR   Cosmic-CLP; 683667
DR   DepMap; ACH-001711
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS054ENC
DR   GDSC; 683667
DR   GEO; GSM923430
DR   GEO; GSM1670349
DR   IARC_TP53; 21279
DR   IZSLER; BS TCL 202
DR   LINCS_LDP; LCL-1407
DR   PharmacoDB; PFSK1_1264_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1642
DR   Wikidata; Q54947302
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1316433;
RX   PubMed=20164919;
RX   PubMed=23325432;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/PFSK-1_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (ATCC=CRL-2060).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Gly (c.823T>G); ClinVar=VCV001414106; Zygosity=Homozygous (Cosmic-CLP=683667).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=0%; East Asian, North=2.03%; East Asian, South=0%; South Asian=0.77%; European, North=66.34%; European, South=30.55% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): ATCC=CRL-2060; Cosmic-CLP=683667; DepMap=ACH-001711
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,14
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 13.2,14
ST   D21S11: 28,32.2
ST   D2S1338: 17,20
ST   D3S1358: 15,16,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 12,17
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   PFV
AC   CVCL_DR64
SY   Pig Flip-in Visualize
DR   Wikidata; Q54947303
RX   PubMed=20336379;
CC   Characteristics: Transfected with a construct that contains a Sleeping Beauty (SB) DNA transposon, a puromycin resistance gene, an EGFP reporter gene and an Flp recombinase site for locus-directed gene insertion.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Gottingen minipig; VBO=VBO_0016899.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   <1M
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   PG [Esox]
AC   CVCL_4272
DR   CLO; CLO_0008426
DR   ECACC; 95070629
DR   Wikidata; Q54947304
RX   DOI=10.1007/BF02618036;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=8010; ! Esox lucius (Northern pike)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   PG [Human lung carcinoma]
AC   CVCL_4389
DR   BTO; BTO_0002412
DR   Cosmic; 2664113
DR   Wikidata; Q54947305
RX   PubMed=3004853;
RX   PubMed=10374431;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7110 ! PLA-801D
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   PG 11
AC   CVCL_XC31
SY   PG11; HB PG 11
DR   CCRID; 4201PAT-CCTCC00053
DR   Wikidata; Q98128560
RX   Patent=US5147783;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1608.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04179; Human SOD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   PG-4 (S+L-)
AC   CVCL_3413
SY   PG-4(S+L-); PG-4 S+L-; PG-4; PG4
DR   CLO; CLO_0008429
DR   CLO; CLO_0008430
DR   CLDB; cl3898
DR   CLDB; cl3899
DR   ATCC; CRL-2032
DR   BCRC; 60470
DR   CCRID; 1102MAM-NIFDC00080
DR   CCRID; 4201MAM-CCTCC00140
DR   CCTCC; GDC0140
DR   ECACC; 94102703
DR   ICLC; ATL97002
DR   JCRB; JCRB9125
DR   Wikidata; Q54947307
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_GR56 ! G355
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 19
//
ID   PG-49
AC   CVCL_D539
SY   PG49
DR   ChEMBL-Cells; CHEMBL3308677
DR   ChEMBL-Targets; CHEMBL614847
DR   PubChem_Cell_line; CVCL_D539
DR   Wikidata; Q54947308
RX   PubMed=25433501;
CC   Population: Chinese.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   PG-BE1
AC   CVCL_4390
SY   PGBE1
DR   BTO; BTO_0002413
DR   CCRID; 4201HUM-CCTCC00332
DR   CCTCC; GDC0332
DR   Wikidata; Q54947309
RX   PubMed=7656376;
RX   PubMed=20388373;
CC   Population: Chinese.
CC   Characteristics: High metastatic potential.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4389 ! PG [Human lung carcinoma]
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   PG-CL3
AC   CVCL_4391
SY   PGCL3
DR   BTO; BTO_0002414
DR   Wikidata; Q54947310
RX   PubMed=7656376;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4389 ! PG [Human lung carcinoma]
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   PG-ES-3
AC   CVCL_A1WZ
SY   Parthenogenetic ESC-3
DR   GEO; GSM3391896
DR   GEO; GSM3391897
DR   GEO; GSM3391898
DR   Wikidata; Q105510560
RX   PubMed=31257130;
RX   PubMed=32160914;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   PG-ES-7
AC   CVCL_A1WX
SY   Parthenogenetic ESC-7; SNUARTe001-A
DR   BioSamples; SAMEA7655491
DR   GEO; GSM3391899
DR   GEO; GSM3391900
DR   GEO; GSM3391901
DR   Wikidata; Q105510564
RX   PubMed=31257130;
RX   PubMed=32160914;
RX   PubMed=33232901;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   PG-ES-8
AC   CVCL_A1XA
SY   Parthenogenetic ESC-8
DR   Wikidata; Q105510569
RX   PubMed=31257130;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   PG-LH7
AC   CVCL_4392
SY   PGLH7
DR   BTO; BTO_0002415
DR   Wikidata; Q54947311
RX   PubMed=7656376;
RX   PubMed=20388373;
CC   Population: Chinese.
CC   Characteristics: Low metastatic potential.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000202). It was the sole source for the STR profile of this entry.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 18
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13,15
ST   FGA: 19
ST   TH01: 7
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4389 ! PG [Human lung carcinoma]
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   PG-M1
AC   CVCL_WT30
DR   Wikidata; Q98128561
RX   PubMed=7684194;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P34810; Human CD68.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   PG/B95-8
AC   CVCL_Y555
SY   PG-B95-8; PG-EBV
DR   Cell_Model_Passport; SIDM01849
DR   DSMZ; ACC-776
DR   DSMZCellDive; ACC-776
DR   Wikidata; Q54947312
RX   PubMed=2836321;
RX   PubMed=23297799;
CC   Population: Caucasian.
CC   Doubling time: ~35 hours (DSMZ=ACC-776).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-776
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 18
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y545 ! PGA-1
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 13
//
ID   PG1-iPS-1
AC   CVCL_L666
SY   PG1-IPS-1; PG1-iPSC_HGPS
DR   SKIP; SKIP003112
DR   Wikidata; Q54947313
RX   PubMed=21185252;
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H766 ! AG11498
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   PG1-iPS-2
AC   CVCL_L667
SY   PG1-IPS-2
DR   Wikidata; Q54947314
RX   PubMed=21185252;
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H766 ! AG11498
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   PG100
AC   CVCL_Z278
SY   PG-100
DR   Wikidata; Q54947315
RX   PubMed=20658094;
RX   PubMed=27920471;
CC   Population: Brazilian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PG13
AC   CVCL_4273
DR   CLO; CLO_0008427
DR   CLDB; cl3900
DR   ATCC; CRL-3597
DR   ATCC; CRL-10686
DR   ECACC; 95110215
DR   TOKU-E; 2880
DR   Wikidata; Q54947316
RX   Patent=US5470726;
RX   PubMed=1850008;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10686.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P21415; Gibbon ape leukemia virus (GALV) env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Discontinued: ATCC; CRL-10686; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9116 ! NIH 3T3-TK-
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PG13/LN c8
AC   CVCL_8933
SY   PG13/LNc8
DR   CLO; CLO_0008428
DR   ATCC; CRL-10685
DR   Wikidata; Q54947317
RX   Patent=US5470726;
RX   PubMed=1850008;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10685.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P21415; Gibbon ape leukemia virus (GALV) env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Discontinued: ATCC; CRL-10685; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4273 ! PG13
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   PG19
AC   CVCL_S409
SY   C57Bl melanoma clone PG 19; PG 19
DR   Wikidata; Q54947318
RX   PubMed=893544;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0192 ! C57/B1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   PG19T3
AC   CVCL_S407
DR   Wikidata; Q54947319
RX   PubMed=510081;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S409 ! PG19
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   PG19T3:MTXR10-4M
AC   CVCL_4Y71
SY   PG19T3:MTXR.10-4 M
DR   Wikidata; Q54947320
RX   PubMed=510081;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_S407 ! PG19T3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   PG2-iPS-1
AC   CVCL_L668
SY   PG2-IPS-1; PG2-iPSC_HGPS
DR   SKIP; SKIP003113
DR   Wikidata; Q54947321
RX   PubMed=21185252;
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H765 ! AG06297
SX   Male
AG   8Y2M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   PG2-iPS-2
AC   CVCL_L669
SY   PG2-IPS-2
DR   Wikidata; Q54947322
RX   PubMed=21185252;
CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H765 ! AG06297
SX   Male
AG   8Y2M
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   PG64SV.2
AC   CVCL_DQ62
DR   Wikidata; Q54947323
RX   PubMed=27345795;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/c9fc96b0-6411-7edc-4d56-6194cd93f49b
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Instituto de Investigaciones Biomedicas Alberto Sols; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9179; POLG; Simple; p.Trp748Ser (c.2243G>C); ClinVar=VCV000013507; Zygosity=Homozygous (PubMed=27345795).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157267; POLG-related spectrum disorders
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   PGA-1
AC   CVCL_Y545
SY   PGA1; PG A1; CLL-PGA
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   cancercelllines; CVCL_Y545
DR   Cell_Model_Passport; SIDM01855
DR   DepMap; ACH-001634
DR   DSMZ; ACC-766
DR   DSMZCellDive; ACC-766
DR   NCBI_Iran; C583
DR   Wikidata; Q54947324
RX   PubMed=2836321;
RX   PubMed=23297799;
RX   PubMed=31160637;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-766).
CC   HLA typing: A*02:01:01,03:01:01; B*35:03:01,39:01:01; C*07:02:01,12:03:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,02:01:02; DQA1*01:02:01,05:05:01; DQB1*03:01:01,06:09:01; DRA*01:02:02,01:02:02; DRB1*12:01:01,13:02:01 (DSMZCellDive=ACC-766).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): DepMap=ACH-001634; DSMZ=ACC-766
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 9,14
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y555 ! PG/B95-8
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 15
//
ID   PGC-2
AC   CVCL_6713
SY   Porcine Granulosa Cell line-2
DR   Wikidata; Q54947325
RX   PubMed=8916040;
RX   PubMed=15541573;
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   PGF
AC   CVCL_E806
SY   pGF; GM03107; GM3107
DR   CLO; CLO_0013567
DR   Coriell; GM03107
DR   dbMHC; 49001
DR   ECACC; 94050342
DR   IHW; IHW09318
DR   IPD-IMGT/HLA; 11248
DR   Wikidata; Q54947326
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=6808075;
RX   PubMed=15140828;
RX   PubMed=16440057;
RX   PubMed=16702430;
RX   PubMed=18193213;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; English.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01:03:01:02; DPB1*04:01:01; DQA1*01:02:01:05; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01; DRB6*02:01 (IPD-IMGT/HLA=11248).
CC   HLA typing: A*03:01:01:01; B*07:02:01; C*07:02:01:03; DPA1*01:03:01:02; DPB1*04:01:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 21
//
ID   PGF2-2
AC   CVCL_A1HC
SY   PGF2-2,Type 3
DR   ABM; T0812
DR   GEO; GSM2995304
DR   Wikidata; Q127383042
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF2-4
AC   CVCL_A1HD
SY   PGF2-4,Other
DR   GEO; GSM2995305
DR   Wikidata; Q127383043
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF2-5
AC   CVCL_A1HE
SY   PGF2-5,Type 3
DR   ABM; T0813
DR   GEO; GSM2995306
DR   Wikidata; Q127383044
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF2-8
AC   CVCL_A1HF
SY   PGF2-8,Type 1
DR   ABM; T0803
DR   GEO; GSM2995307
DR   Wikidata; Q127383045
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF3-11
AC   CVCL_A1HG
SY   PGF3-11,Type 1
DR   ABM; T0815
DR   GEO; GSM2995313
DR   Wikidata; Q127383047
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF3-15
AC   CVCL_A1HH
SY   PGF3-15,Type 3
DR   ABM; T0802
DR   GEO; GSM2995314
DR   Wikidata; Q127383048
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF3-2
AC   CVCL_A1HI
SY   PGF3-2,Type 2
DR   ABM; T0808
DR   GEO; GSM2995308
DR   Wikidata; Q127383049
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF3-3
AC   CVCL_A1HJ
SY   PGF3-3,Type 3
DR   ABM; T0814
DR   GEO; GSM2995309
DR   Wikidata; Q127383051
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF3-4
AC   CVCL_A1HK
SY   PGF3-4,Type 1
DR   ABM; T0801
DR   GEO; GSM2995310
DR   Wikidata; Q127383052
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF3-5
AC   CVCL_A1HL
SY   PGF3-5,Other
DR   GEO; GSM2995311
DR   Wikidata; Q127383053
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGF3-6
AC   CVCL_A1HM
SY   PGF3-6,Other
DR   GEO; GSM2995312
DR   Wikidata; Q127383054
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, perigonadal; UBERON=UBERON_0003428.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PGGG
AC   CVCL_A0UT
SY   Pearl Gentian Grouper Gill
DR   Wikidata; Q108821127
RX   PubMed=33396134;
CC   Group: Fish cell line.
CC   Characteristics: Can be used to investigate the effect of the heavy metal cadmium on cytotoxicity and oxidative stress (PubMed=33396134).
CC   Doubling time: 41.8 hours (Note=At 20th passage), 41.4 hours (Note=At 40th passage), 37.7 hours (Note=At 60th passage) (PubMed=33396134).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=1074816; ! Epinephelus fuscoguttatus x Epinephelus lanceolatus (Hybrid giant tiger grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   PGK12.1
AC   CVCL_AS07
SY   Pgk12.1; PGK 12.1
DR   BioSample; SAMN00672592
DR   GEO; GSM761213
DR   GEO; GSM1081335
DR   Wikidata; Q54947327
RX   PubMed=8156596;
RX   PubMed=8538762;
RX   PubMed=12874099;
RX   PubMed=16244654;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: PGK x 129P2/Ola/Hsd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   PGL1
AC   CVCL_D3QU
DR   Wikidata; Q127383055
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10267.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20210.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGL2
AC   CVCL_D3QV
DR   Wikidata; Q127383056
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10268.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20211.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGL3
AC   CVCL_D3QW
DR   Wikidata; Q127383057
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGL4
AC   CVCL_D3QX
DR   Wikidata; Q127383058
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGL5
AC   CVCL_D3QY
DR   Wikidata; Q127383059
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGL6
AC   CVCL_D3QZ
DR   Wikidata; Q127383060
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGL7
AC   CVCL_D3R0
DR   Wikidata; Q127383061
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGL8
AC   CVCL_D3R1
DR   Wikidata; Q127383062
RX   Patent=US7943334;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Triticum aestivum flour gliadin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PGLC-33H
AC   CVCL_HA64
SY   PGLC-33h; PGLC 33H; PGLC33H
DR   Wikidata; Q54947328
RX   CelloPub=CLPUB00749;
RX   PubMed=62390;
RX   PubMed=788925;
RX   PubMed=824057;
RX   PubMed=4177061;
RX   PubMed=4504337;
RX   PubMed=4599625;
RX   PubMed=4882745;
RX   PubMed=4886119;
RX   PubMed=5641111;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0T9 ! PGLC-33J
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 27-11-25; Version: 10
//
ID   PGLC-33J
AC   CVCL_F0T9
SY   PGLC 33J
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HA64 ! PGLC-33H
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-42D
AC   CVCL_F0TA
SY   PGLC 42D
RX   PubMed=4177061;
RX   PubMed=4882745;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TB ! PGLC-42F
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-42F
AC   CVCL_F0TB
SY   PGLC 42F
RX   PubMed=4177061;
RX   PubMed=4882745;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TA ! PGLC-42D
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-44B
AC   CVCL_F0TC
SY   PGLC 44B
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-50B
AC   CVCL_F0TD
SY   PGLC 50B
RX   PubMed=4177061;
RX   PubMed=4882745;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TE ! PGLC-50D
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-50D
AC   CVCL_F0TE
SY   PGLC 50D
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TD ! PGLC-50B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-51D
AC   CVCL_F0TF
SY   PGLC 51D
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TG ! PGLC-51E
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-51E
AC   CVCL_F0TG
SY   PGLC 51E
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TF ! PGLC-51D
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-53B
AC   CVCL_F0TH
SY   PGLC 53B
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TI ! PGLC-53D
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-53D
AC   CVCL_F0TI
SY   PGLC 53D
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TH ! PGLC-53B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-54B
AC   CVCL_F0TJ
SY   PGLC 54B
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-55B
AC   CVCL_F0TK
SY   PGLC 55B
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TL ! PGLC-55E
OI   CVCL_F0TM ! PGLC-55F
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-55E
AC   CVCL_F0TL
SY   PGLC 55E
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TK ! PGLC-55B
OI   CVCL_F0TM ! PGLC-55F
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-55F
AC   CVCL_F0TM
SY   PGLC 55F
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F0TK ! PGLC-55B
OI   CVCL_F0TL ! PGLC-55E
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGLC-56B
AC   CVCL_F0TN
SY   PGLC 56B
RX   PubMed=4177061;
RX   PubMed=4882745;
RX   PubMed=4886119;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PGME1
AC   CVCL_0F77
SY   PGME 1
DR   Wikidata; Q54947329
RX   PubMed=2612208;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0F71 ! MB63
CA   Hybrid cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   PGNMi001-A
AC   CVCL_D0KP
SY   AG08C5; C5
DR   BioSamples; SAMEA112891307
DR   hPSCreg; PGNMi001-A
DR   Wikidata; Q123033268
RX   PubMed=25355730;
CC   From: Institut NeuroMyoGene, Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM); Lyon; France.
CC   Population: Asian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y51 ! AG08498
SX   Male
AG   1Y1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PGNMi001-A-1
AC   CVCL_D0KQ
SY   AG08-iNIL
DR   BioSamples; SAMEA114409261
DR   hPSCreg; PGNMi001-A-1
DR   Wikidata; Q123033269
CC   From: Institut NeuroMyoGene, Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM); Lyon; France.
CC   Population: Asian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0KP ! PGNMi001-A
SX   Male
AG   1Y1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PGNMi001-A-2
AC   CVCL_D0KR
SY   AG08-iNGN2
DR   hPSCreg; PGNMi001-A-2
DR   Wikidata; Q123033270
CC   From: Institut NeuroMyoGene, Pathophysiology and Genetics of Neuron and Muscle (INMG-PGNM); Lyon; France.
CC   Population: Asian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0KP ! PGNMi001-A
SX   Male
AG   1Y1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PGPC1_30
AC   CVCL_B5N8
SY   Personal Genome Project Canada 1 clone 30
DR   Wikidata; Q112129503
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5N9 ! PGPC1_67
OI   CVCL_B5NA ! PGPC1_73
OI   CVCL_B5NB ! PGPC1_96
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PGPC1_67
AC   CVCL_B5N9
SY   Personal Genome Project Canada 1 clone 67
DR   Wikidata; Q112129505
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5N8 ! PGPC1_30
OI   CVCL_B5NA ! PGPC1_73
OI   CVCL_B5NB ! PGPC1_96
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PGPC1_73
AC   CVCL_B5NA
SY   Personal Genome Project Canada 1 clone 73
DR   EGA; EGAS00001003684
DR   GEO; GSM4087812
DR   Wikidata; Q112129506
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3581; BPTF; Simple; p.Lys1039Ter (c.3115A>T); Zygosity=Heterozygous (PubMed=31813827).
CC   Sequence variation: Mutation; HGNC; HGNC:3039; DSCAM; Simple; c.509-1G>A; dbSNP=rs1569089053; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31813827).
CC   Sequence variation: Mutation; HGNC; HGNC:4199; GCN1; Simple; p.Ser2475Profs*19 (c.7423delT); Zygosity=Heterozygous (PubMed=31813827).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5N8 ! PGPC1_30
OI   CVCL_B5N9 ! PGPC1_67
OI   CVCL_B5NB ! PGPC1_96
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   PGPC1_96
AC   CVCL_B5NB
SY   Personal Genome Project Canada 1 clone 96
DR   Wikidata; Q112129507
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5N8 ! PGPC1_30
OI   CVCL_B5N9 ! PGPC1_67
OI   CVCL_B5NA ! PGPC1_73
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PGPC14_16
AC   CVCL_B5NC
SY   Personal Genome Project Canada 14 clone 16
DR   Wikidata; Q112129508
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5ND ! PGPC14_26
OI   CVCL_B5NE ! PGPC14_70
OI   CVCL_B5NF ! PGPC14_94
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PGPC14_26
AC   CVCL_B5ND
SY   Personal Genome Project Canada 14 clone 26
DR   EGA; EGAS00001003684
DR   GEO; GSM3834428
DR   Wikidata; Q112129509
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25491; FRMD4A; Simple; c.563+1G>T; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=31813827).
CC   Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Heterozygous (PubMed=31813827).
CC   Sequence variation: Mutation; HGNC; HGNC:32669; TRIM71; Simple; p.Arg655Ter (c.1963C>T); Zygosity=Heterozygous (PubMed=31813827).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NC ! PGPC14_16
OI   CVCL_B5NE ! PGPC14_70
OI   CVCL_B5NF ! PGPC14_94
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   PGPC14_70
AC   CVCL_B5NE
SY   Personal Genome Project Canada 14 clone 70
DR   Wikidata; Q112129510
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NC ! PGPC14_16
OI   CVCL_B5ND ! PGPC14_26
OI   CVCL_B5NF ! PGPC14_94
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PGPC14_94
AC   CVCL_B5NF
SY   Personal Genome Project Canada 14 clone 94
DR   Wikidata; Q112129511
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NC ! PGPC14_16
OI   CVCL_B5ND ! PGPC14_26
OI   CVCL_B5NE ! PGPC14_70
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PGPC17_11
AC   CVCL_B5NG
SY   Personal Genome Project Canada 17 clone 11
DR   EGA; EGAS00001003684
DR   GEO; GSM3834429
DR   Wikidata; Q112129512
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10250; ROBO2; Simple; p.Trp874Ter (c.2621G>A); Zygosity=Heterozygous (PubMed=31813827).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NJ ! PGPC17_4
OI   CVCL_B5NK ! PGPC17_45
OI   CVCL_B5NL ! PGPC17_80
OI   CVCL_B5NI ! PGPC17_142
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   PGPC17_11_MYBPC3_KO
AC   CVCL_B5NH
DR   Wikidata; Q112129513
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7551; MYBPC3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5NG ! PGPC17_11
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   PGPC17_142
AC   CVCL_B5NI
SY   Personal Genome Project Canada 17 clone 142
DR   Wikidata; Q112129514
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NJ ! PGPC17_4
OI   CVCL_B5NG ! PGPC17_11
OI   CVCL_B5NK ! PGPC17_45
OI   CVCL_B5NL ! PGPC17_80
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PGPC17_4
AC   CVCL_B5NJ
SY   Personal Genome Project Canada 17 clone 4
DR   Wikidata; Q112129515
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NG ! PGPC17_11
OI   CVCL_B5NK ! PGPC17_45
OI   CVCL_B5NL ! PGPC17_80
OI   CVCL_B5NI ! PGPC17_142
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PGPC17_45
AC   CVCL_B5NK
SY   Personal Genome Project Canada 17 clone 45
DR   Wikidata; Q112129516
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NJ ! PGPC17_4
OI   CVCL_B5NG ! PGPC17_11
OI   CVCL_B5NL ! PGPC17_80
OI   CVCL_B5NI ! PGPC17_142
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PGPC17_80
AC   CVCL_B5NL
SY   Personal Genome Project Canada 17 clone 80
DR   Wikidata; Q112129517
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NJ ! PGPC17_4
OI   CVCL_B5NG ! PGPC17_11
OI   CVCL_B5NK ! PGPC17_45
OI   CVCL_B5NI ! PGPC17_142
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PGPC3_23
AC   CVCL_B5NM
SY   Personal Genome Project Canada 3 clone 23
DR   Wikidata; Q112129518
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NN ! PGPC3_66
OI   CVCL_B5NP ! PGPC3_75
OI   CVCL_B5NQ ! PGPC3_87
OI   CVCL_B5NR ! PGPC3_93
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PGPC3_66
AC   CVCL_B5NN
SY   Personal Genome Project Canada 3 clone 66
DR   Wikidata; Q112129519
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NM ! PGPC3_23
OI   CVCL_B5NP ! PGPC3_75
OI   CVCL_B5NQ ! PGPC3_87
OI   CVCL_B5NR ! PGPC3_93
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PGPC3_75
AC   CVCL_B5NP
SY   Personal Genome Project Canada 3 clone 75
DR   EGA; EGAS00001003684
DR   GEO; GSM3834427
DR   Wikidata; Q112129520
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (PubMed=31813827).
CC   Sequence variation: Mutation; HGNC; HGNC:13077; ZNF283; Simple; p.Cys21Ter (c.63C>A); Zygosity=Heterozygous (PubMed=31813827).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NM ! PGPC3_23
OI   CVCL_B5NN ! PGPC3_66
OI   CVCL_B5NQ ! PGPC3_87
OI   CVCL_B5NR ! PGPC3_93
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   PGPC3_87
AC   CVCL_B5NQ
SY   Personal Genome Project Canada 3 clone 87
DR   Wikidata; Q112129521
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NM ! PGPC3_23
OI   CVCL_B5NN ! PGPC3_66
OI   CVCL_B5NP ! PGPC3_75
OI   CVCL_B5NR ! PGPC3_93
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PGPC3_93
AC   CVCL_B5NR
SY   Personal Genome Project Canada 3 clone 93
DR   Wikidata; Q112129522
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5NM ! PGPC3_23
OI   CVCL_B5NN ! PGPC3_66
OI   CVCL_B5NP ! PGPC3_75
OI   CVCL_B5NQ ! PGPC3_87
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   pgsA-745
AC   CVCL_4589
SY   PgsA-745; pgsA745; PgsA745; S745; 745; Mutant 745; CHO-745; (CHO) 745
DR   CLO; CLO_0008434
DR   ATCC; CRL-2242
DR   CCLV; CCLV-RIE 0316
DR   CCRID; 1102HAM-NIFDC00109
DR   Lonza; 1119
DR   Wikidata; Q54947330
RX   PubMed=3858816;
CC   Characteristics: Deficient in xylosyltransferase. Does not produce glycosaminoglycans.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   pgsB-618
AC   CVCL_4590
SY   PgsB-618; 618; Mutant 618; CHO-pgsB618; CHO pgsB-618
DR   CLO; CLO_0008435
DR   ATCC; CRL-2241
DR   Wikidata; Q54947331
RX   PubMed=2957376;
CC   Characteristics: Deficient in beta-1,4-galactosyltransferase 7 activity.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   pgsB-650
AC   CVCL_4591
SY   PgsB-650; 650; Mutant 650
DR   CLO; CLO_0008436
DR   ATCC; CRL-2243
DR   Wikidata; Q54947332
RX   PubMed=2957376;
CC   Characteristics: Deficient in galactosyltransferase 1 activity.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   pgsC-605
AC   CVCL_4592
SY   PgsC-605; 605; Mutant 605
DR   CLO; CLO_0008437
DR   ATCC; CRL-2245
DR   Wikidata; Q54947333
RX   PubMed=3782085;
CC   Characteristics: Deficient in sulfate transporter.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   pgsD-677
AC   CVCL_4593
SY   PgsD-677 pgsD677; 677; Mutant 677; CHO-677; CHO 677
DR   CLO; CLO_0008438
DR   ATCC; CRL-2244
DR   Wikidata; Q54947334
RX   PubMed=1532254;
CC   Characteristics: Lacks both N-acetylglucosaminyltransferase and glucuronyltransferase activities that are required for synthesis of heparan sulfate.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   pgsE-606
AC   CVCL_4594
SY   PgsE-606; Mutant 606; CHO-pgsE606; CHO-606
DR   CLO; CLO_0008439
DR   ATCC; CRL-2246
DR   BCRC; 60542
DR   CCLV; CCLV-RIE 0317
DR   Wikidata; Q54947335
RX   PubMed=2524478;
RX   PubMed=7945269;
CC   Characteristics: Partially deficient in heparin sulfate N sulfotransferase. Lacks expression of NDST1.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   pgsF-17
AC   CVCL_VQ78
SY   pgsF17; Mutant 17; CHO-pgsF17
DR   Wikidata; Q98128562
RX   PubMed=8663454;
CC   Characteristics: Deficient in heparan sulfate hexuronic acid 2-o-sulfation.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 7
//
ID   pgsG-224
AC   CVCL_VQ79
SY   pgsG224
DR   Wikidata; Q98128564
RX   PubMed=10224052;
CC   Characteristics: Deficient in glucuronosyltransferase I (GlcAT-I).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 7
//
ID   PGV
AC   CVCL_W866
SY   Porcine Granulosa cell-Virus transformed
DR   Wikidata; Q54947336
RX   PubMed=15832078;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
ID   PH [Human]
AC   CVCL_L107
DR   ATCC; CRL-9851
DR   BioSample; SAMN03471075
DR   cancercelllines; CVCL_L107
DR   Wikidata; Q54947337
RX   Patent=US5447861;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00527.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9851.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-9851; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-9851
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 22
//
ID   PH [Lateolabrax]
AC   CVCL_UW77
SY   Perch Heart
DR   Wikidata; Q98128565
RX   DOI=10.1007/BF02623580;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   PH [Sardinops]
AC   CVCL_R915
SY   Pilchard Heart
DR   Wikidata; Q54947342
RX   PubMed=15801155;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=59687; ! Sardinops neopilchardus (Australian pilchard)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   Ph 310
AC   CVCL_T588
SY   Ph-310; SPPC-PH310
DR   Wikidata; Q54947343
RX   PubMed=183370;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9054; ! Phasianus colchicus (Common pheasant)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   PH-1
AC   CVCL_UA29
SY   PH1; Podocnemis Heart-1
DR   Wikidata; Q98128566
RX   PubMed=5800666;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=227871; ! Podocnemis unifilis (Yellow-spotted Amazon river turtle)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   PH-2 [Human glioblastoma]
AC   CVCL_ZV53
DR   Cosmic; 850747
DR   Wikidata; Q98128567
RX   PubMed=9070656;
RX   PubMed=9090379;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   PH-2 [Monkey]
AC   CVCL_EJ71
SY   PH2
DR   Wikidata; Q54947347
RX   Patent=US5830638;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2165.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_EJ70 ! Vero M
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 05-10-23; Version: 10
//
ID   PH-2 [Turtle]
AC   CVCL_UA30
SY   PH2; Podocnemis Heart-2
DR   Wikidata; Q98128568
RX   PubMed=5800666;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=227871; ! Podocnemis unifilis (Yellow-spotted Amazon river turtle)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   PH-6
AC   CVCL_UA31
SY   Podocnemis Heart-6
DR   Wikidata; Q98128569
RX   PubMed=5800666;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=44507; ! Podocnemis expansa (Giant South American river turtle)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   PH1-Fib-hiPSC4F1
AC   CVCL_DQ60
SY   PH1-hFib4F-3.23
DR   Wikidata; Q54947348
RX   PubMed=27345794;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_PH1-hFib4F-3.23_v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_PH1-hiPSC.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigacion Medica Aplicada (CIMA); Pamplona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=27345794).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,24
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 19,20
ST   TH01: 6,9
ST   TPOX: 7,11
ST   vWA: 15,16
DI   NCIt; C123212; Primary hyperoxaluria type I
DI   ORDO; Orphanet_93598; Primary hyperoxaluria type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ61 ! PH1-PBMCs-hiPSC4F1
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 14
//
ID   PH1-iPSC#1
AC   CVCL_A4WC
DR   Wikidata; Q107116659
RX   PubMed=31151050;
CC   From: University of Bordeaux; Bordeaux; France.
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123212; Primary hyperoxaluria type I
DI   ORDO; Orphanet_93598; Primary hyperoxaluria type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4WD ! PH1-iPSC#2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   PH1-iPSC#2
AC   CVCL_A4WD
DR   Wikidata; Q107116660
RX   PubMed=31151050;
CC   From: University of Bordeaux; Bordeaux; France.
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123212; Primary hyperoxaluria type I
DI   ORDO; Orphanet_93598; Primary hyperoxaluria type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4WC ! PH1-iPSC#1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   PH1-iPSC#2-TTRp-AGXT
AC   CVCL_A4WG
DR   Wikidata; Q107116661
RX   PubMed=31151050;
CC   From: University of Bordeaux; Bordeaux; France.
CC   Characteristics: The transduced AGXT gene expression is under the control of transthyretin promoter (TTRp) (PubMed=31151050).
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Heterozygous; Note=No longer homozygous because of transduced wild-type gene (PubMed=31151050).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:341; AGXT.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123212; Primary hyperoxaluria type I
DI   ORDO; Orphanet_93598; Primary hyperoxaluria type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4WD ! PH1-iPSC#2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   PH1-iPSC#2-TTRp-eGFP
AC   CVCL_A4WH
DR   Wikidata; Q107116662
RX   PubMed=31151050;
CC   From: University of Bordeaux; Bordeaux; France.
CC   Characteristics: The transduced eGFP gene expression is under the control of transthyretin promoter (TTRp) (PubMed=31151050).
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123212; Primary hyperoxaluria type I
DI   ORDO; Orphanet_93598; Primary hyperoxaluria type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4WD ! PH1-iPSC#2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   PH1-PBMCs-hiPSC4F1
AC   CVCL_DQ61
SY   PH1-hPBMC4F-2.4
DR   Wikidata; Q54947349
RX   PubMed=27345794;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Deposito_PH1-hPBMC4F-2.4-v2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_PH1-hiPSC.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigacion Medica Aplicada (CIMA); Pamplona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=27345794).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 10,11
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,24
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 19,20
ST   TH01: 6,9
ST   TPOX: 7,11
ST   vWA: 15,16
DI   NCIt; C123212; Primary hyperoxaluria type I
DI   ORDO; Orphanet_93598; Primary hyperoxaluria type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ60 ! PH1-Fib-hiPSC4F1
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   PH101
AC   CVCL_RT30
DR   Wikidata; Q54947350
RX   DOI=10.5833/jjgs.28.12;
RX   PubMed=8473041;
RX   PubMed=8507543;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   PH2MT
AC   CVCL_XG27
DR   Wikidata; Q98128570
RX   PubMed=11888918;
RX   PubMed=15705902;
CC   Characteristics: Derived from a tumor formed in athymic mice by injection of the parent cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG25 ! MSU-1.1-T24 2
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   PH3MT
AC   CVCL_XG28
DR   Wikidata; Q98128571
RX   PubMed=11888918;
RX   PubMed=18048363;
RX   PubMed=19008219;
CC   Characteristics: Growth factor-independent, form large-sized colonies in agarose and form fibrosarcomas in athymic mice at the site of injection with a very short latency.
CC   Characteristics: Derived from a tumor formed in athymic mice by injection of the parent cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG26 ! MSU-1.1-T24 3
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   PH5
AC   CVCL_5862
SY   PH-5; Porcine Hyalocyte-derived cell line 5
DR   BTO; BTO_0004273
DR   Wikidata; Q54947351
RX   PubMed=17707370;
RX   PubMed=19878119;
CC   Doubling time: 56.9 +- 22.6 hours (PubMed=17707370).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, vitreous body; UBERON=UBERON_0001798.
CC   Cell type: Hyalocyte; CL=CL_0000142.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   2Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   PH5CH
AC   CVCL_VK96
DR   BTO; BTO_0006047
DR   Wikidata; Q98128573
RX   PubMed=8925135;
RX   PubMed=9714233;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TAg).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK97 ! PH5T
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   PH5CH1
AC   CVCL_VK98
SY   PH5CH-1
DR   BTO; BTO_0006049
DR   Wikidata; Q98128575
RX   PubMed=9714233;
CC   Population: Japanese.
CC   Characteristics: Supports HCV replication.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TAg).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VK96 ! PH5CH
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   PH5CH7
AC   CVCL_VK99
SY   PH5CH-7
DR   BTO; BTO_0006050
DR   Wikidata; Q98128576
RX   PubMed=9714233;
CC   Population: Japanese.
CC   Characteristics: Supports HCV replication.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TAg).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VK96 ! PH5CH
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   PH5CH8
AC   CVCL_VL00
SY   PH5CH-8
DR   BTO; BTO_0006048
DR   EFO; EFO_0022644
DR   Wikidata; Q98128577
RX   PubMed=9714233;
RX   PubMed=15766575;
CC   Population: Japanese.
CC   Characteristics: Supports HCV replication.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-TAg).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VK96 ! PH5CH
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 9
//
ID   PH5T
AC   CVCL_VK97
DR   Wikidata; Q98128578
RX   PubMed=7832798;
RX   PubMed=8925135;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141fs (c.422delG); Zygosity=Unspecified (PubMed=8925135).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK96 ! PH5CH
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   PH61-N
AC   CVCL_D282
SY   PH61N
DR   BioSample; SAMN03151845
DR   BioSample; SAMN03472485
DR   cancercelllines; CVCL_D282
DR   CGH-DB; 181-1
DR   JCRB; JCRB1038
DR   Wikidata; Q54947352
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a MIA PaCa-2 derivative (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00342.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: JCRB; JCRB1038; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1038
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 10,13
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   TH01: 10
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0428 ! MIA PaCa-2
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 26
//
ID   PHA00356IN
AC   CVCL_E187
DR   Wikidata; Q54947353
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PHA00357IN
AC   CVCL_E188
DR   Wikidata; Q54947354
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PHA00358IN
AC   CVCL_E189
DR   Wikidata; Q54947355
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PHAi001-A
AC   CVCL_YM61
SY   iPSC-QPH01-I; PIDi001-A
DR   hPSCreg; PHAi001-A
DR   Wikidata; Q98128579
RX   PubMed=31689593;
CC   From: Pan-Hammarstrom Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31689593
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D10S1248: 15
ST   D12S391: 17,24
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 15,16
ST   D1S1656: 12,17.2
ST   D21S11: 28,31.2
ST   D22S1045: 11,15
ST   D2S1338: 17,21
ST   D2S441: 14,16
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 10
ST   DYS391: 10
ST   FGA: 20,22
ST   SE33: 16,20
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM62 ! PHAi001-B
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   PHAi001-B
AC   CVCL_YM62
SY   iPSC-QPH01-II; PIDi001-B
DR   hPSCreg; PHAi001-B
DR   Wikidata; Q98128580
RX   PubMed=31689593;
CC   From: Pan-Hammarstrom Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31689593
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D10S1248: 15
ST   D12S391: 17,24
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 15,16
ST   D1S1656: 12,17.2
ST   D21S11: 28,31.2
ST   D22S1045: 11,15
ST   D2S1338: 17,21
ST   D2S441: 14,16
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 10
ST   DYS391: 10
ST   FGA: 20,22
ST   SE33: 16,20
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM61 ! PHAi001-A
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   PHAi002-A
AC   CVCL_YM63
SY   iPSC-QPH02-I; PIDi002-A
DR   hPSCreg; PHAi002-A
DR   Wikidata; Q98128581
RX   PubMed=31689593;
CC   From: Pan-Hammarstrom Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31689593
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 13,15
ST   D12S391: 18,25
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D1S1656: 11,16.3
ST   D21S11: 29,30
ST   D22S1045: 16,17
ST   D2S1338: 17,25
ST   D2S441: 10,14
ST   D3S1358: 13,17
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 11
ST   FGA: 22,24
ST   SE33: 20,25.2
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,20
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM64 ! PHAi002-B
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   PHAi002-B
AC   CVCL_YM64
SY   iPSC-QPH02-II; PIDi002-B
DR   hPSCreg; PHAi002-B
DR   Wikidata; Q98128582
RX   PubMed=31689593;
CC   From: Pan-Hammarstrom Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31689593
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 13,15
ST   D12S391: 18,25
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D1S1656: 11,16.3
ST   D21S11: 29,30
ST   D22S1045: 16,17
ST   D2S1338: 17,25
ST   D2S441: 10,14
ST   D3S1358: 13,17
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 11
ST   FGA: 22,24
ST   SE33: 20,25.2
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,20
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM63 ! PHAi002-A
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   PHAi003-A
AC   CVCL_YM65
SY   iPSC-QPH03-I; PIDi003-A
DR   BioSamples; SAMEA6324717
DR   hPSCreg; PHAi003-A
DR   Wikidata; Q98128583
RX   PubMed=31678777;
CC   From: Pan-Hammarstrom Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Population: Iranian; Persian.
CC   Sequence variation: Mutation; HGNC; HGNC:11937; CD70; Simple; p.Ser84Profs*27 (c.250delT); ClinVar=VCV000599338; Zygosity=Homozygous (PubMed=31678777).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31678777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13
ST   D12S391: 18,20
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 11,14
ST   D19S433: 13,14.2
ST   D1S1656: 10,11
ST   D21S11: 30,31.2
ST   D22S1045: 11,15
ST   D2S1338: 16,24
ST   D2S441: 14
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,23
ST   SE33: 18,19
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C168591; CD70 deficiency
DI   ORDO; Orphanet_538958; Severe combined immunodeficiency due to CD70 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM66 ! PHAi003-B
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   PHAi003-B
AC   CVCL_YM66
SY   iPSC-QPH03-II; PIDi003-B
DR   BioSamples; SAMEA6324719
DR   hPSCreg; PHAi003-B
DR   Wikidata; Q98128584
RX   PubMed=31678777;
CC   From: Pan-Hammarstrom Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Population: Iranian; Persian.
CC   Sequence variation: Mutation; HGNC; HGNC:11937; CD70; Simple; p.Ser84Profs*27 (c.250delT); ClinVar=VCV000599338; Zygosity=Homozygous (PubMed=31678777).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31678777
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13
ST   D12S391: 18,20
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 11,14
ST   D19S433: 13,14.2
ST   D1S1656: 10,11
ST   D21S11: 30,31.2
ST   D22S1045: 11,15
ST   D2S1338: 16,24
ST   D2S441: 14
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 20,23
ST   SE33: 18,19
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C168591; CD70 deficiency
DI   ORDO; Orphanet_538958; Severe combined immunodeficiency due to CD70 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM65 ! PHAi003-A
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   PhB1
AC   CVCL_D6FU
DR   Wikidata; Q127383063
RX   PubMed=8140859;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=8140859; PubMed=10071072; PubMed=10576511).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   PHEC1
AC   CVCL_6G48
SY   Permanent Human Endothelial Cells 1
DR   Wikidata; Q54947356
RX   PubMed=8835314;
CC   Doubling time: 24 hours (PubMed=8835314).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   PHF
AC   CVCL_UF08
SY   Pangasianodon Hypophthalmus Fin
DR   NRFC; NRFC057
DR   Wikidata; Q98128585
RX   PubMed=29545155;
WW   Provider; NRFC; NRFC057; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC057.
CC   Characteristics: Can grow at temperatures ranging from 24 to 32 Celsius with an optimum temperature of 28 Celsius (PubMed=29545155).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=310915; ! Pangasianodon hypophthalmus (Striped catfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   PHF-1
AC   CVCL_A2IY
SY   PHF1
DR   Wikidata; Q105510572
RX   Patent=US5811310;
WW   Provider; AlzForum; -; https://www.alzforum.org/antibodies/tau-phos-ser396ser404-phf-1
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11743.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT (Note=Phosphorylated on p.Ser396 and p.Ser404).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   PHG
AC   CVCL_B7H1
SY   Pangasianodon Hypophthalmus Gill
DR   Wikidata; Q112930332
RX   PubMed=35169909;
CC   Group: Fish cell line.
CC   Doubling time: ~42 hours (Note=At 11th passage) (PubMed=35169909).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=310915; ! Pangasianodon hypophthalmus (Striped catfish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   Phi-1
AC   CVCL_4274
SY   Phi 1
DR   CLO; CLO_0008440
DR   CLDB; cl3903
DR   ECACC; 85061101
DR   Wikidata; Q54947358
RX   PubMed=6149229;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5125 ! Fu5-5
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   PhIP12-1
AC   CVCL_AS17
DR   TKG; TKG 0718
DR   Wikidata; Q54947359
RX   PubMed=11289141;
CC   Transformant: ChEBI; CHEBI_76290; 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344 x Sprague Dawley; RS=RS_0000215+RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   PhIP7-4
AC   CVCL_AS18
DR   TKG; TKG 0717
DR   Wikidata; Q54947360
RX   PubMed=11289141;
CC   Transformant: ChEBI; CHEBI_76290; 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344 x Sprague Dawley; RS=RS_0000215+RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   PHK-T
AC   CVCL_XX44
DR   Wikidata; Q98128586
RX   PubMed=5668122;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   PHK16-0b
AC   CVCL_3123
SY   PHK160b
DR   BioSample; SAMN03470808
DR   JCRB; JCRB0141
DR   JCRB; NIHS0203
DR   Wikidata; Q54947361
RX   PubMed=1848315;
RX   PubMed=2173586;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=1848315).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0203; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB0141
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   PHL
AC   CVCL_5863
SY   Pacific Herring Larva
DR   CLO; CLO_0008441
DR   ATCC; CRL-2750
DR   Wikidata; Q54947362
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=10813363;
RX   PubMed=19002917;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=30724; ! Clupea pallasii (Pacific herring)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   PHM1-31
AC   CVCL_R869
SY   Pregnant Human Myometrial 1-31
DR   Wikidata; Q54947363
RX   PubMed=16371591;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Myometrial cell; CL=CL_0002366.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   PHM1-41
AC   CVCL_8566
SY   Pregnant Human Myometrial 1-41
DR   ATCC; CRL-3046
DR   Wikidata; Q54947364
RX   PubMed=8828850;
CC   Characteristics: Show response to oxytocyin stimulation (PubMed=8828850).
CC   Doubling time: ~43.2 hours (ATCC=CRL-3046).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from the cesarean section in a term pregnant patient (PubMed=8828850).
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Myometrial cell; CL=CL_0002366.
ST   Source(s): ATCC=CRL-3046
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 21
//
ID   PHMLEB
AC   CVCL_DG84
DR   cancercelllines; CVCL_DG84
DR   GEO; GSM232917
DR   GEO; GSM232918
DR   Progenetix; CVCL_DG84
DR   Wikidata; Q54947365
RX   PubMed=11156605;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   PHMLER
AC   CVCL_DG85
SY   HMLER
DR   cancercelllines; CVCL_DG85
DR   GEO; GSM232914
DR   GEO; GSM232915
DR   GEO; GSM232916
DR   Progenetix; CVCL_DG85
DR   Wikidata; Q54947366
RX   PubMed=11156605;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DG84 ! PHMLEB
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   Phoenix-Ampho
AC   CVCL_H716
SY   Phoenix-AMPHO; Phoenix-ampho; Phoenix Ampho; Phoenix ampho; AmphoPhoenix; Phoenix-A; Phoenix A; PhoenixA; AmphoPack 293
DR   BTO; BTO_0006327
DR   ATCC; CRL-3213
DR   ATCC; SD-3443
DR   Wikidata; Q54947367
WW   Info; -; -; http://web.stanford.edu/group/nolan/_OldWebsite/retroviral_systems/phx.html
CC   Group: Retrovirus packaging cell line.
CC   Characteristics: Capable of delivering genes to dividing cells of most mammalian species, including human.
CC   Doubling time: ~16 hours (ATCC=CRL-3213).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: ATCC; SD-3443; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3213
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12,13,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 17,18
ST   D21S11: 27,28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8,10
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   Phoenix-Eco
AC   CVCL_H717
SY   Phoenix-ECO; Phoenix Eco; PhoenixEco; Phoenix-E; Phoenix E
DR   ATCC; CRL-3214
DR   ATCC; SD-3444
DR   Wikidata; Q54947368
WW   Info; -; -; http://web.stanford.edu/group/nolan/_OldWebsite/retroviral_systems/phx.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-534.html
CC   Group: Retrovirus packaging cell line.
CC   Characteristics: Capable of delivering genes to dividing murine or rat cells.
CC   Doubling time: ~16 hours (ATCC=CRL-3214).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: ATCC; SD-3444; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3214
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12,13
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 17,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,16,17
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   Phoenix-gp
AC   CVCL_H718
SY   Phoenix-GP; Phoenix GP; PhoenixGP
DR   ATCC; CRL-3215
DR   Wikidata; Q54947369
WW   Info; -; -; http://web.stanford.edu/group/nolan/_OldWebsite/tutorials/retpkg_7_phx_sys.html
CC   Group: Retrovirus packaging cell line.
CC   Doubling time: ~16 hours (ATCC=CRL-3215).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3215
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 17,18
ST   D21S11: 28,30.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16,17
ST   D5S818: 8,9
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1926 ! HEK293T/17
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   PHT
AC   CVCL_E3BG
SY   Pangasianodon Hypophthalmus Thymus
DR   NRFC; NRFC078
RX   DOI=10.56093/ijans.v93i2.128796;
WW   Provider; NRFC; NRFC078; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC078.
CC   Characteristics: Can grow at temperatures ranging from 24 to 32 Celsius with an optimum temperature of 28 Celsius (DOI=10.56093/ijans.v93i2.128796).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=310915; ! Pangasianodon hypophthalmus (Striped catfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   PI 125/10
AC   CVCL_LI05
SY   PI125/10
DR   Wikidata; Q54947370
RX   PubMed=424740;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   PI 153/3
AC   CVCL_G250
SY   PI153/3; GM04278; GM04278A
DR   CLO; CLO_0008442
DR   CLO; CLO_0019597
DR   ATCC; TIB-198
DR   Coriell; GM04278
DR   Wikidata; Q54947371
RX   CelloPub=CLPUB00447;
RX   PubMed=424740;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human glycoprotein expressed on neuroectoderm derived tumors (neuroblastoma, retinoblastoma and glioblastoma).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   Pi Kar
AC   CVCL_0F70
DR   ATCC; CRL-1102
DR   Wikidata; Q54947372
CC   Discontinued: ATCC; CRL-1102; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   PI-11
AC   CVCL_G249
DR   CLO; CLO_0008445
DR   ATCC; CRL-2591
DR   Wikidata; Q54947373
RX   PubMed=1426051;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P20810; Human CAST.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   PI-1353-C7
AC   CVCL_RK99
SY   1353 C7
DR   Wikidata; Q54947374
RX   PubMed=22567022;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (PubMed=22567022).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PI-1679-C20
AC   CVCL_RL00
SY   1679 C20
DR   Wikidata; Q54947375
RX   PubMed=22567022;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (PubMed=22567022).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PI-1754-C7
AC   CVCL_RK97
SY   SNCA-Tri-C1; SNCA_Tri-C1
DR   SKIP; SKIP001296
DR   Wikidata; Q54947376
RX   PubMed=26610207;
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=26610207).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK98 ! PI-1754-MIT
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   PI-1754-MIT
AC   CVCL_RK98
SY   SNCA-Tri-C2; SNCA_Tri-C2
DR   Wikidata; Q54947377
RX   PubMed=26610207;
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=26610207).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK97 ! PI-1754-C7
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   PI-1761-C1
AC   CVCL_RK95
SY   PI-1761-C1(Control1)
DR   SKIP; SKIP001297
DR   Wikidata; Q54947379
RX   PubMed=26610207;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   PI-1815-C7
AC   CVCL_RK96
SY   1815 C7; PI-1815-C7(Control2)
DR   SKIP; SKIP001298
DR   Wikidata; Q54947380
RX   PubMed=22567022;
RX   PubMed=26610207;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   PI-1827-A34-1
AC   CVCL_RL01
SY   1827 A34-1
DR   Wikidata; Q54947381
RX   PubMed=22567022;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   PI-1828-B2
AC   CVCL_RL02
SY   1828 B2
DR   Wikidata; Q54947382
RX   PubMed=22567022;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (PubMed=22567022).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   PI1
AC   CVCL_V129
DR   CLO; CLO_0008444
DR   CLDB; cl3904
DR   IHW; 11w 8021
DR   Wikidata; Q54947383
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   PiBB1
AC   CVCL_D2X1
DR   Wikidata; Q127383064
RX   PubMed=32619491;
WW   Provider; CReM; 529; https://stemcellbank.bu.edu/Catalog/Item/Details/529
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Pro387Argfs*12 (c.1158delC); ClinVar=VCV000444037; Zygosity=Homozygous; Note=Q0 Bolton (PubMed=32619491).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiCa
AC   CVCL_LF69
DR   Wikidata; Q54947384
RX   PubMed=23383219;
RX   PubMed=28476783;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   PICALM6A
AC   CVCL_B3QV
DR   Wikidata; Q110433136
RX   PubMed=26075887;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion).
CC   Transformant: KMT2A-MLLT1.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: fit1 Picalmfit1-5R.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   PICALM6B
AC   CVCL_B3QW
DR   Wikidata; Q110433137
RX   PubMed=26075887;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion).
CC   Transformant: KMT2A-MLLT1.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   PICALM6D
AC   CVCL_B3QX
DR   Wikidata; Q110433138
RX   PubMed=26075887;
CC   Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion).
CC   Transformant: KMT2A-MLLT1.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   PICAT
AC   CVCL_ZI14
DR   cancercelllines; CVCL_ZI14
DR   Wikidata; Q98128587
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   PICATPO-1
AC   CVCL_ZI15
SY   PICATPO
DR   Wikidata; Q98128588
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI14 ! PICAT
HI   CVCL_2676 ! P3HR-1
CA   Hybrid cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 4
//
ID   PICM-19
AC   CVCL_V146
SY   ARS-PICM-19; Pig Inner Cell Mass-19
DR   Wikidata; Q54947385
RX   PubMed=7534591;
RX   PubMed=8354665;
RX   PubMed=8635514;
RX   PubMed=12097833;
RX   PubMed=20333478;
RX   PubMed=20669140;
RX   PubMed=23148238;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Requires feeder cells.
CC   Anecdotal: Have been flown in space on shuttle flight STS-126 to study growth and differentiation in microgravity (PubMed=20333478).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   8FD
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   PICM-19B
AC   CVCL_5T67
DR   Wikidata; Q54947387
RX   PubMed=20669140;
RX   PubMed=23148238;
CC   Characteristics: Requires feeder cells.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_V146 ! PICM-19
SX   Sex unspecified
AG   8FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   PICM-19FF
AC   CVCL_5T69
SY   PICM-19 Feeder Free
DR   Wikidata; Q54947396
RX   PubMed=23148238;
RX   PubMed=23397443;
CC   Characteristics: Does not require feeder cells.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_V146 ! PICM-19
SX   Sex unspecified
AG   8FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   PICM-19H
AC   CVCL_5T68
DR   Wikidata; Q54947399
RX   PubMed=20669140;
RX   PubMed=23148238;
CC   Characteristics: Requires feeder cells.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_V146 ! PICM-19
SX   Sex unspecified
AG   8FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   PID0102
AC   CVCL_T906
DR   SKIP; SKIP000146
DR   Wikidata; Q54947400
CC   Population: Japanese.
CC   Caution: Could be identical to HPS0265 (Cellosaurus=CVCL_T940) or HPS0266 (Cellosaurus=CVCL_6C85) or HPS0266 (Cellosaurus=CVCL_6C85).
CC   Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   PID0401
AC   CVCL_T907
DR   SKIP; SKIP000145
DR   Wikidata; Q54947401
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T908 ! PID0402
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   PID0402
AC   CVCL_T908
DR   SKIP; SKIP000144
DR   Wikidata; Q54947402
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26788; Chronic granulomatous disease
DI   ORDO; Orphanet_379; Chronic granulomatous disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T907 ! PID0401
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   PIE
AC   CVCL_HC68
SY   Porcine Intestinal Epitheliocytes cell line
DR   GEO; GSE77095
DR   Wikidata; Q54947403
RX   PubMed=18082146;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Landrace x Large White x Duroc (LWD); VBO=VBO_0001161+VBO_0001163+VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   PIEC
AC   CVCL_C0W5
SY   Porcine Iliac Artery Endothelial Cells
DR   CCRID; 3101SWIGNO15
DR   CLS; 305213
DR   Wikidata; Q114312659
CC   Derived from site: In situ; Iliac artery, endothelium; UBERON=UBERON_0019196.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   PifZ1
AC   CVCL_D2X2
SY   PiFZ1-12-Cr3
DR   Wikidata; Q127383065
RX   PubMed=32619491;
WW   Provider; CReM; 534; https://stemcellbank.bu.edu/Catalog/Item/Details/534
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Arg247Cys (c.739C>T); ClinVar=VCV000017961; Zygosity=Heterozygous; Note=F allele (PubMed=32619491).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PIG1
AC   CVCL_S410
SY   PIGI
DR   ATCC; CRL-2208
DR   BioSample; SAMN03472565
DR   CancerTools; 154099
DR   Wikidata; Q54947405
RX   PubMed=9028834;
RX   PubMed=10937834;
RX   PubMed=18594937;
CC   Doubling time: 1.16 days (PubMed=10937834).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-2208; true.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
ST   Source(s): ATCC=CRL-2208
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 8,11
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FB ! Mf9013
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 21
//
ID   PIG21
AC   CVCL_E5FC
DR   CancerTools; 154100
RX   PubMed=18594937;
CC   Characteristics: Lightly pigmented (PubMed=18594937).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FA ! Mf9012
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PIG22
AC   CVCL_E5FD
RX   PubMed=18594937;
CC   Characteristics: Pigmented (PubMed=18594937).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Melanocyte of foreskin; CL=CL_2000045.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FA ! Mf9012
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   PIG3V
AC   CVCL_VR17
DR   Wikidata; Q98128589
RX   PubMed=10937834;
RX   PubMed=18594937;
CC   Population: Caucasian.
CC   Doubling time: 1.6 days (PubMed=10937834).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C26915; Vitiligo
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E5FE ! Ma9308
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   PiGAS
AC   CVCL_B6JN
DR   Wikidata; Q112129523
RX   Patent=RU2619643;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-161.
CC   Characteristics: Transfected with a construct pGL3-6xGAS-FFL-Neo that contains six gamma-interferon-activated sites (GAS) followed by a minimum SV40 promoter and the Luc gene.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6JM ! Mel P
SX   Sex unspecified
AG   50Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   PIGMAMBRc-
AC   CVCL_D1HW
DR   ABM; T0820
DR   Wikidata; Q127383066
RX   PubMed=26379698;
CC   Knockout cell: Method=miRNA knockdown; VGNC; VGNC:85869; BRCA1.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: ABM wrongly indicates that this cell line is immortalized using TERT (ABM=T0820).
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PigMel
AC   CVCL_C7UI
DR   GEO; GSM134581
DR   Wikidata; Q123033271
RX   PubMed=12859625;
RX   PubMed=18442364;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: 35 hours (PubMed=12859625).
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: Meishan; VBO=VBO_0001175.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   3-6M
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   PIL
AC   CVCL_E807
DR   IHW; 9w 0204
DR   Wikidata; Q54947406
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*03; B*07; C*w07 (IHW=9w 0204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   PIL-6
AC   CVCL_5347
DR   Wikidata; Q54947407
RX   PubMed=2785799;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PIL-6
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4001 ! MOPC-104E
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   PiMZ1
AC   CVCL_D2X3
DR   Wikidata; Q127383067
WW   Provider; CReM; 533; https://stemcellbank.bu.edu/Catalog/Item/Details/533
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   PIN,LJ
AC   CVCL_E808
SY   PIN, LJ
DR   dbMHC; 49002
DR   ECACC; 94082208
DR   IHW; IHW09109
DR   IPD-IMGT/HLA; 11654
DR   Wikidata; Q54947408
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01; B*08:01,57:01:01; C*06:02; DPB1*04:01; DQA1*01:01,02:01; DQB1*05:01,03:03; DRB1*01:03,07; DRB4*01:01 (IPD-IMGT/HLA=11654).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   PipNi/1
AC   CVCL_RX20
DR   Wikidata; Q54947409
RX   PubMed=23232719;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=59474; ! Pipistrellus pipistrellus (Common pipistrelle)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   PipNi/3
AC   CVCL_RX21
SY   PipNi-3
DR   Wikidata; Q54947410
RX   CelloPub=CLPUB00422;
RX   PubMed=23232719;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=59474; ! Pipistrellus pipistrellus (Common pipistrelle)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   piPS10
AC   CVCL_A4IC
DR   SKIP; SKIP005483
DR   Wikidata; Q105510575
RX   PubMed=22310243;
CC   From: National Institute of Biological Sciences; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=22310243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4IA ! piPS2
OI   CVCL_A4IB ! piPS7
OI   CVCL_A4ID ! piPS13
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   piPS13
AC   CVCL_A4ID
DR   SKIP; SKIP005484
DR   Wikidata; Q105510576
RX   PubMed=22310243;
CC   From: National Institute of Biological Sciences; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=22310243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4IA ! piPS2
OI   CVCL_A4IB ! piPS7
OI   CVCL_A4IC ! piPS10
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   piPS2
AC   CVCL_A4IA
DR   SKIP; SKIP005481
DR   Wikidata; Q105510579
RX   PubMed=22310243;
CC   From: National Institute of Biological Sciences; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=22310243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4IB ! piPS7
OI   CVCL_A4IC ! piPS10
OI   CVCL_A4ID ! piPS13
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   piPS7
AC   CVCL_A4IB
DR   GEO; GSM748373
DR   GEO; GSM748374
DR   GEO; GSM748375
DR   SKIP; SKIP005482
DR   Wikidata; Q105510584
RX   PubMed=22310243;
CC   From: National Institute of Biological Sciences; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Homozygous (PubMed=22310243).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4IA ! piPS2
OI   CVCL_A4IC ! piPS10
OI   CVCL_A4ID ! piPS13
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   PipNi/4
AC   CVCL_RX61
SY   PipNi-4
DR   Wikidata; Q54947411
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=59474; ! Pipistrellus pipistrellus (Common pipistrelle)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   PIR-P3
AC   CVCL_DD11
SY   CHO PIR-P3
DR   Wikidata; Q54947412
RX   Patent=US5272070;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11378.
CC   Selected for resistance to: ChEBI; CHEBI_9367; Swainsonine (Sw).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DD10 ! SwR-100
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   PIR-P8
AC   CVCL_IQ79
SY   CHO PIR-P8
DR   Wikidata; Q54947413
RX   Patent=US5272070;
CC   Group: Patented cell line.
CC   Selected for resistance to: ChEBI; CHEBI_9367; Swainsonine (Sw).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DD10 ! SwR-100
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   PIS-1
AC   CVCL_ZY04
SY   Pulmonary Intimal Sarcoma-1
DR   JCRB; JCRB1806
DR   Wikidata; Q102114775
RX   PubMed=30925179;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1806
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 9,12
ST   D5S818: 10
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C142825; Pulmonary artery intimal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 5
//
ID   PiSZ1
AC   CVCL_D2X4
SY   PiSZ1-9-Cr1
DR   GEO; GSM4182801
DR   GEO; GSM4182813
DR   GEO; GSM4182825
DR   Wikidata; Q127383068
RX   PubMed=32619491;
WW   Provider; CReM; 530; https://stemcellbank.bu.edu/Catalog/Item/Details/530
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu288Val (c.863A>T); ClinVar=VCV000017969; Zygosity=Heterozygous; Note=S allele (PubMed=32619491).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiSZ2
AC   CVCL_D2X5
SY   PiSZ2-4-Cr1
DR   GEO; GSM4182837
DR   GEO; GSM4182849
DR   GEO; GSM4182861
DR   Wikidata; Q127383069
RX   PubMed=32619491;
WW   Provider; CReM; 531; https://stemcellbank.bu.edu/Catalog/Item/Details/531
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu288Val (c.863A>T); ClinVar=VCV000017969; Zygosity=Heterozygous; Note=S allele (PubMed=32619491).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiSZ3
AC   CVCL_D2X6
SY   PiSZ3-6-Cr3
DR   GEO; GSM4182790
DR   GEO; GSM4182802
DR   GEO; GSM4182873
DR   Wikidata; Q127383070
RX   PubMed=32619491;
WW   Provider; CReM; 532; https://stemcellbank.bu.edu/Catalog/Item/Details/532
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu288Val (c.863A>T); ClinVar=VCV000017969; Zygosity=Heterozygous; Note=S allele (PubMed=32619491).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Pit1/0
AC   CVCL_U367
DR   Wikidata; Q54947414
RX   PubMed=20829390;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: CD-1 Pit-Tag+hGH/BAC transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   Pit1/Prl
AC   CVCL_U368
DR   Wikidata; Q54947415
RX   PubMed=20829390;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: CD-1 GH-Tag+hGH/BAC transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   Pit1/Triple
AC   CVCL_U369
DR   Wikidata; Q54947416
RX   PubMed=20829390;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: CD-1 Pit-Tag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   20W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   PITOUT
AC   CVCL_E809
DR   EFO; EFO_0022660
DR   dbMHC; 49003
DR   ECACC; 94070711
DR   IHW; IHW09051
DR   IPD-IMGT/HLA; 11255
DR   PRIDE; PXD001205
DR   Wikidata; Q54947417
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=25502872;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*29:02:01:01; B*44:03:01:01; C*16:01:01:01; DPA1*01; DPB1*04:01:01; DQA1*02:01; DQB1*02:02:01; DRA*01:01; DRB1*07:01:01; DRB4*01:01 (IPD-IMGT/HLA=11255).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   PiZMh1
AC   CVCL_D2X7
SY   PiZMh1-18-Cr5
DR   Wikidata; Q127383071
RX   PubMed=32619491;
WW   Provider; CReM; 528; https://stemcellbank.bu.edu/Catalog/Item/Details/528
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (PubMed=32619491).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Pro393Leu (c.1178C>T); ClinVar=VCV000017965; Zygosity=Heterozygous; Note=M Heerlen allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ1
AC   CVCL_D2X8
SY   PiZZ1-1-Cr4
DR   GEO; GSM4182845
DR   GEO; GSM4182857
DR   GEO; GSM4182869
DR   Wikidata; Q127383072
RX   PubMed=32619491;
WW   Provider; CReM; 535; https://stemcellbank.bu.edu/Catalog/Item/Details/535
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ1-MAN1B1del
AC   CVCL_D2X9
DR   Wikidata; Q127383073
WW   Provider; CReM; 538; https://stemcellbank.bu.edu/Catalog/Item/Details/538
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6823; MAN1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2X8 ! PiZZ1
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ1-MM
AC   CVCL_D2XA
SY   PiZZ1 MM; PiZZ1-1-Cr4-MM1
DR   Wikidata; Q127383074
RX   PubMed=32619491;
WW   Provider; CReM; 537; https://stemcellbank.bu.edu/Catalog/Item/Details/537
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple_corrected; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=By CRISPR/Cas9. Z allele (PubMed=32619491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2X8 ! PiZZ1
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ1-MZ
AC   CVCL_D2XB
SY   PiZZ1 MZ; PiZZ1-1-Cr4-MZ3-7
DR   Wikidata; Q127383075
WW   Provider; CReM; 536; https://stemcellbank.bu.edu/Catalog/Item/Details/536
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple_corrected; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Z allele (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2X8 ! PiZZ1
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   PiZZ100-MM
AC   CVCL_D2XI
SY   100-3-Cr1-MM56
DR   Wikidata; Q127383076
RX   PubMed=32619491;
WW   Provider; CReM; 520; https://stemcellbank.bu.edu/Catalog/Item/Details/520
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple_corrected; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=By CRISPR/Cas9. Z allele (PubMed=32619491).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C933 ! RC2 100 3 Cr-1
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ100-MZ
AC   CVCL_D2XJ
SY   100-3-Cr1-MZ58
DR   Wikidata; Q127383077
WW   Provider; CReM; 519; https://stemcellbank.bu.edu/Catalog/Item/Details/519
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple_corrected; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Z allele (Boston University).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C933 ! RC2 100 3 Cr-1
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   PiZZ101
AC   CVCL_D2XK
SY   PiZZ101-9-Cr6; 101-9Cr6; RC2 101
DR   Wikidata; Q127383079
RX   PubMed=32619491;
WW   Provider; CReM; 524; https://stemcellbank.bu.edu/Catalog/Item/Details/524
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ2
AC   CVCL_D2XC
SY   PiZZ2-5-Cr1
DR   GEO; GSM4182798
DR   GEO; GSM4182810
DR   GEO; GSM4182881
DR   Wikidata; Q127383080
RX   PubMed=32619491;
WW   Provider; CReM; 539; https://stemcellbank.bu.edu/Catalog/Item/Details/539
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ3
AC   CVCL_D2XD
SY   PIZZ3; PiZZ3-1-Cr3
DR   GEO; GSM4182822
DR   GEO; GSM4182834
DR   GEO; GSM4182846
DR   Wikidata; Q127383081
RX   PubMed=32619491;
WW   Provider; CReM; 540; https://stemcellbank.bu.edu/Catalog/Item/Details/540
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ6
AC   CVCL_D2XE
SY   PiZZ6S-3
DR   GEO; GSM4182858
DR   GEO; GSM4182870
DR   GEO; GSM4182882
DR   Wikidata; Q127383082
RX   PubMed=32619491;
WW   Provider; CReM; 541; https://stemcellbank.bu.edu/Catalog/Item/Details/541
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PiZZ6-MM
AC   CVCL_D2XF
SY   PIZZ6-S3-MM2
DR   Wikidata; Q127383083
WW   Provider; CReM; 543; https://stemcellbank.bu.edu/Catalog/Item/Details/543
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple_corrected; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=By CRISPR/Cas9. Z allele (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2XE ! PiZZ6
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   PiZZ6-MZ
AC   CVCL_D2XG
SY   PiZZ6-S3-MZ13
DR   Wikidata; Q127383086
WW   Provider; CReM; 542; https://stemcellbank.bu.edu/Catalog/Item/Details/542
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=Z allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple_corrected; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Z allele (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2XE ! PiZZ6
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   PJ-2
AC   CVCL_D338
SY   PJ2
DR   Wikidata; Q54947418
RX   PubMed=15372243;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   PJHINU
AC   CVCL_JK49
DR   JCRB; KURB2847
DR   Wikidata; Q54947420
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PJS1JTO
AC   CVCL_3124
SY   PJ1; Peutz-Jeghers Syndrome 1 Japan TOkyo
DR   JCRB; JCRB0320
DR   JCRB; KURB2083
DR   Wikidata; Q54947421
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0320
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   PJS1JTO(SVT)
AC   CVCL_4W90
DR   JCRB; KURB2084
DR   Wikidata; Q54947422
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3124 ! PJS1JTO
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   PJS2JTO
AC   CVCL_YP46
SY   PJ2; Peutz-Jeghers Syndrome 2 Japan TOkyo
DR   JCRB; KURB2091
DR   Wikidata; Q98128590
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   PJS21JTO
AC   CVCL_YP49
SY   PJ21; Peutz-Jeghers Syndrome 21 Japan TOkyo
DR   JCRB; KURB2085
DR   Wikidata; Q98128591
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   PJS22JTO
AC   CVCL_YP50
SY   PJ22; Peutz-Jeghers Syndrome 22 Japan TOkyo
DR   JCRB; KURB2094
DR   Wikidata; Q98128592
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   PJS23JTO
AC   CVCL_YP51
SY   PJ23; Peutz-Jeghers Syndrome 23 Japan TOkyo
DR   JCRB; KURB2095
DR   Wikidata; Q98128593
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   PJS3JTO
AC   CVCL_JG66
SY   PJ3; Peutz-Jeghers Syndrome 3 Japan TOkyo
DR   JCRB; KURB2081
DR   Wikidata; Q54947423
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   PJS5JTO
AC   CVCL_3125
SY   PJ5; Peutz-Jeghers Syndrome 5 Japan TOkyo
DR   JCRB; JCRB0321
DR   JCRB; KURB2086
DR   Wikidata; Q54947425
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0321
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   PJS5JTO hTERT-1
AC   CVCL_YP52
DR   JCRB; KURB2089
DR   Wikidata; Q98128594
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3125 ! PJS5JTO
SX   Male
AG   15Y
CA   Telomerase immortalized cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   PJS5JTO hTERT-2
AC   CVCL_YP53
DR   JCRB; KURB2090
DR   Wikidata; Q98128595
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3125 ! PJS5JTO
SX   Male
AG   15Y
CA   Telomerase immortalized cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   PJS6JTO
AC   CVCL_JG67
SY   PJ6; Peutz-Jeghers Syndrome 6 Japan TOkyo
DR   JCRB; KURB2082
DR   Wikidata; Q54947426
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   PJS7JTO
AC   CVCL_YP47
SY   PJ7; Peutz-Jeghers Syndrome 7 Japan TOkyo
DR   JCRB; KURB2097
DR   Wikidata; Q98128596
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   PJS8JTO
AC   CVCL_YP48
SY   PJ8; Peutz-Jeghers Syndrome 8 Japan TOkyo
DR   JCRB; KURB2096
DR   Wikidata; Q98128597
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   PK [Human penis carcinoma]
AC   CVCL_A1RQ
DR   Wikidata; Q105510587
RX   PubMed=5920635;
CC   Population: Japanese.
CC   Derived from site: In situ; Penis; UBERON=UBERON_0000989.
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   PK [Pig kidney]
AC   CVCL_AZ81
SY   Pig Kidney; Porcine Kidney
DR   Wikidata; Q54947427
RX   PubMed=13744439;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 8
//
ID   PK(D1)
AC   CVCL_6432
DR   CLO; CLO_0008449
DR   ATCC; CRL-6490
DR   Wikidata; Q54947463
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6490; true.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   PK0809
AC   CVCL_C0Z3
SY   PK-0809; PK 0809; PK 032495; PK032495
DR   Wikidata; Q114312660
RX   Patent=US5911999;
RX   PubMed=17494075;
RX   PubMed=24398227;
CC   From: Draayer, Hans A.; Beecham Laboratories; Whitehall; USA.
CC   Miscellaneous: Identity of PK0809 with PK032495 and origin of cell line from personal commuincation of Calvert J.G.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   PK-1
AC   CVCL_4717
SY   PK1
DR   BTO; BTO_0004854
DR   CLO; CLO_0050105
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 486
DR   BioSample; SAMN03472897
DR   BioSample; SAMN10988147
DR   cancercelllines; CVCL_4717
DR   Cell_Model_Passport; SIDM01321
DR   Cosmic; 707253
DR   Cosmic; 1066176
DR   Cosmic; 1644297
DR   Cosmic; 2046536
DR   DepMap; ACH-000307
DR   GEO; GSM862564
DR   GEO; GSM862566
DR   GEO; GSM887515
DR   GEO; GSM888597
DR   GEO; GSM1588614
DR   GEO; GSM1588626
DR   IARC_TP53; 14301
DR   LiGeA; CCLE_500
DR   PharmacoDB; PK1_1265_2019
DR   Progenetix; CVCL_4717
DR   RCB; RCB1972
DR   TKG; TKG 0239
DR   Wikidata; Q54947429
RX   PubMed=3547771;
RX   PubMed=6205469;
RX   PubMed=8872523;
RX   PubMed=11115575;
RX   PubMed=22460905;
RX   PubMed=22490663;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=3547771; PubMed=6205469); 24.1 hours (PubMed=8872523).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=11115575; PubMed=22490663; DepMap=ACH-000307).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (PubMed=11115575; PubMed=22490663; DepMap=ACH-000307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.26%; Native American=0%; East Asian, North=88.21%; East Asian, South=8.65%; South Asian=0.93%; European, North=0.7%; European, South=1.25% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=25877200; RCB=RCB1972; TKG=TKG 0239
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 9,20
ST   TH01: 9 (TKG=TKG 0239)
ST   TH01: 9,10 (PubMed=25877200; RCB=RCB1972)
ST   TPOX: 9,11
ST   vWA: 15,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   PK-12
AC   CVCL_D711
DR   Cosmic; 1066179
DR   Cosmic; 1644300
DR   Wikidata; Q54947430
RX   PubMed=3547771;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft.
CC   Doubling time: 82 hours (PubMed=3547771).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   PK-13
AC   CVCL_6433
SY   PK13; Porcine Kidney-13
DR   CLO; CLO_0008450
DR   ATCC; CRL-6489
DR   Wikidata; Q54947431
RX   PubMed=19508353;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Can be used for isolation and growth of rubella virus.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_S287 ! PK-2a
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   PK-14
AC   CVCL_D712
DR   Cosmic; 1066180
DR   Cosmic; 1644301
DR   Wikidata; Q54947432
RX   PubMed=3547771;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft.
CC   Doubling time: 41.3 hours (PubMed=3547771).
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   PK-15
AC   CVCL_2160
SY   PK(15); PK (15); PK 15; PK15; Porcine Kidney-15
DR   BTO; BTO_0001865
DR   CLO; CLO_0008447
DR   CLO; CLO_0008448
DR   CLO; CLO_0050908
DR   CLDB; cl3906
DR   CLDB; cl3907
DR   CLDB; cl3908
DR   ATCC; CCL-33
DR   ATCC; CRL-6593
DR   BCRC; 60057
DR   BCRJ; 0355
DR   CCLV; CCLV-RIE 0005
DR   CCRID; 1101SWI-PUMC000385
DR   CCRID; 1102SWI-NIFDC00089
DR   CCRID; 4201SWI-CCTCC00061
DR   CCTCC; GDC0061
DR   CLS; 607426
DR   DSMZ; ACC-640
DR   DSMZCellDive; ACC-640
DR   FCS-free; 42-15-47-1-8-9
DR   GEO; GSM422415
DR   GEO; GSM422416
DR   GEO; GSM422417
DR   IZSLER; BS CL 72
DR   JCRB; JCRB9040
DR   KCB; KCB 2010002YJ
DR   KCLB; 10033
DR   RCB; RCB0534
DR   Wikidata; Q54947433
RX   DOI=10.1007/BF02618370;
RX   PubMed=2686830;
RX   PubMed=3009166;
RX   PubMed=3173126;
RX   PubMed=4132403;
RX   PubMed=4151202;
RX   PubMed=5962858;
RX   PubMed=6160900;
RX   PubMed=6988327;
RX   PubMed=15731278;
RX   PubMed=17889922;
RX   PubMed=19508353;
RX   PubMed=19937495;
RX   PubMed=19941903;
RX   PubMed=24398227;
RX   PubMed=26456528;
RX   PubMed=31216434;
RX   PubMed=32258794;
RX   PubMed=34737324;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PK15
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: PK-15 from ATCC was found to be infected with porcine circovirus 1 (PCV1) (PubMed=2686830; PubMed=4151202).
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15731278).
CC   Doubling time: 12.1 +- 0.7 hours (PubMed=17889922); ~25 hours (DSMZ=ACC-640).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-6593; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_S287 ! PK-2a
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   PK-15/A11
AC   CVCL_B0NA
DR   Wikidata; Q108821128
RX   Patent=RU2201960;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 54.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   PK-15(CD163)
AC   CVCL_A5AA
SY   PK-15CD163
DR   BTO; BTO_0006240
DR   Wikidata; Q107116663
RX   PubMed=23835031;
CC   Characteristics: A construct containing a CMV promoter-pig CD163 and EF1a promoter-GFP-T2-Pac was transferred using a piggyBac transposon vector.
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus type 1 and type 2 (PRRSV-1/2).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   PK-15A
AC   CVCL_JF19
SY   PK15A; PK15a
DR   Wikidata; Q54947434
RX   PubMed=10565907;
CC   Virology: Not infected with porcine circovirus 1 (PCV1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   PK-15S
AC   CVCL_YB14
DR   Wikidata; Q98128599
RX   Patent=US20190300863;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3307.
CC   Virology: Highly susceptible to infection by influenza A virus and Newcastle disease virus (NDV) (Patent=US20190300863).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 7
//
ID   PK-16
AC   CVCL_D713
DR   Cosmic; 1066181
DR   Cosmic; 1644302
DR   Wikidata; Q54947435
RX   PubMed=3547771;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft.
CC   Doubling time: 60 hours (PubMed=3547771).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PK-2
AC   CVCL_5348
DR   Wikidata; Q54947436
RX   PubMed=2679911;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PK-2
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   PK-2a
AC   CVCL_S287
SY   PK 2 a; PK2a; PK2A
DR   Wikidata; Q54947437
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_AZ81 ! PK [Pig kidney]
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   PK-2a/CL 13
AC   CVCL_6434
DR   CLO; CLO_0008452
DR   ATCC; CRL-6492
DR   Wikidata; Q54947439
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6492; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_S287 ! PK-2a
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   PK-36
AC   CVCL_D719
DR   Cosmic; 1066182
DR   Cosmic; 1644303
DR   Wikidata; Q54947440
RX   PubMed=7622937;
CC   Population: Japanese.
CC   Doubling time: 51 hours (PubMed=7622937).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   PK-45H
AC   CVCL_6748
SY   PK-45 H; PK45H
DR   CLO; CLO_0050106
DR   EFO; EFO_0006734
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 485
DR   BioSample; SAMN03472048
DR   BioSample; SAMN03472949
DR   BioSample; SAMN10988107
DR   cancercelllines; CVCL_6748
DR   Cell_Model_Passport; SIDM01320
DR   Cosmic; 1066184
DR   DepMap; ACH-000468
DR   EGA; EGAS00001000610
DR   GEO; GSM887516
DR   GEO; GSM888598
DR   GEO; GSM1588610
DR   GEO; GSM1588622
DR   IARC_TP53; 30147
DR   LiGeA; CCLE_565
DR   PharmacoDB; PK45H_1266_2019
DR   Progenetix; CVCL_6748
DR   RCB; RCB1973
DR   TKG; TKG 0491
DR   Wikidata; Q54947442
RX   PubMed=11115575;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03; DQA1*01:02,01:02; DQB1*06:04,06:04; DRB1*03:01,13:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (DepMap=ACH-000468).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.31%; Native American=0.12%; East Asian, North=85.33%; East Asian, South=10.26%; South Asian=2.18%; European, North=0%; European, South=0.8% (PubMed=30894373).
ST   Source(s): PubMed=25877200; RCB=RCB1973; TKG=TKG 0491
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 5,15
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18 (RCB=RCB1973; TKG=TKG 0491)
ST   vWA: 18 (PubMed=25877200)
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6749 ! PK-45P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   PK-45P
AC   CVCL_6749
SY   PK-45 P; PK45P
DR   CLO; CLO_0050107
DR   EFO; EFO_0006735
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472015
DR   BioSample; SAMN03472900
DR   cancercelllines; CVCL_6749
DR   Cell_Model_Passport; SIDM01319
DR   Cosmic; 1066183
DR   Cosmic; 1644304
DR   EGA; EGAS00001000610
DR   PharmacoDB; PK45P_1267_2019
DR   RCB; RCB2141
DR   TKG; TKG 0493
DR   Wikidata; Q54947443
RX   PubMed=11115575;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
CC   Population: Japanese.
CC   HLA typing: A*24:02,33:03; B*15:18,44:03; C*07:04,14:03; DQA1*01:02,03:02; DQB1*06:04,06:04; DRB1*04:01,13:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from autologous cell line PK-45H).
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=25877200; RCB=RCB2141; TKG=TKG 0493
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 5,15
ST   TH01: 9
ST   TPOX: 8,11 (PubMed=25877200; RCB=RCB2141)
ST   TPOX: 11 (TKG=TKG 0493)
ST   vWA: 16,18 (RCB=RCB2141)
ST   vWA: 18 (PubMed=25877200; TKG=TKG 0493)
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6748 ! PK-45H
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   PK-47
AC   CVCL_D720
DR   Cosmic; 1066185
DR   Cosmic; 1644305
DR   Wikidata; Q54947452
RX   PubMed=7622937;
CC   Population: Japanese.
CC   Doubling time: 47 hours (PubMed=7622937).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   PK-59
AC   CVCL_4897
SY   PK59
DR   BTO; BTO_0005487
DR   CLO; CLO_0050100
DR   EFO; EFO_0006736
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472950
DR   BioSample; SAMN10988281
DR   cancercelllines; CVCL_4897
DR   Cell_Model_Passport; SIDM01774
DR   Cosmic; 707257
DR   Cosmic; 1066186
DR   Cosmic; 1299305
DR   Cosmic; 1644306
DR   DepMap; ACH-000205
DR   EGA; EGAS00001000610
DR   GEO; GSM862572
DR   GEO; GSM862574
DR   GEO; GSM887517
DR   GEO; GSM888599
DR   GEO; GSM1588611
DR   GEO; GSM1588623
DR   IARC_TP53; 30148
DR   LiGeA; CCLE_425
DR   PharmacoDB; PK59_1268_2019
DR   Progenetix; CVCL_4897
DR   RCB; RCB1901
DR   TKG; TKG 0492
DR   Wikidata; Q54947453
RX   PubMed=7622937;
RX   PubMed=11115575;
RX   PubMed=22460905;
RX   PubMed=22490663;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=7622937).
CC   HLA typing: A*31:01,33:03; B*35:01,58:01; C*03:02,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=11115575; PubMed=22490663; DepMap=ACH-000205).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.12%; East Asian, North=83.8%; East Asian, South=14.64%; South Asian=0%; European, North=0%; European, South=1.44% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=25877200; RCB=RCB1901; TKG=TKG 0492
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 30,31
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 11
ST   FGA: 19
ST   Penta D: 8,11
ST   Penta E: 16,22
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   PK-8
AC   CVCL_4718
SY   PK8
DR   BTO; BTO_0004855
DR   CLO; CLO_0050112
DR   EFO; EFO_0006737
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472951
DR   cancercelllines; CVCL_4718
DR   Cosmic; 707254
DR   Cosmic; 1066177
DR   Cosmic; 1644298
DR   DepMap; ACH-002039
DR   EGA; EGAS00001000610
DR   IARC_TP53; 14302
DR   PharmacoDB; PK8_1269_2019
DR   RCB; RCB2096
DR   RCB; RCB2700
DR   TKG; TKG 0383
DR   Wikidata; Q54947454
RX   PubMed=3547771;
RX   PubMed=11115575;
RX   PubMed=16912165;
RX   PubMed=20037478;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft.
CC   Doubling time: 56 hours (PubMed=3547771).
CC   HLA typing: A*24:02,31:01; B*27:04,35:01; C*04:01,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Hemizygous (PubMed=11115575).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln167Ter (c.499C>T); ClinVar=VCV000528250; Zygosity=Unspecified (PubMed=11115575).
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: RCB; RCB2096; true.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-002039; PubMed=25877200; RCB=RCB2700; TKG=TKG 0383
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 23 (PubMed=25877200)
ST   FGA: 23,26 (DepMap=ACH-002039)
ST   Penta D: 9
ST   Penta E: 13,15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   PK-82
AC   CVCL_8402
DR   CLO; CLO_0008453
DR   CLDB; cl3909
DR   Wikidata; Q54947455
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   PK-87-19
AC   CVCL_V285
SY   PK87-19; GM10612
DR   CLO; CLO_0024540
DR   Coriell; GM10612
DR   Wikidata; Q54947456
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=2307476;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 19 mapping. Contains a complete copy of chromosome 19.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V283 ! GM07890
HI   CVCL_4595 ! UV135
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 10
//
ID   PK-87-9
AC   CVCL_V286
SY   PK87-9; GM10611
DR   CLO; CLO_0024543
DR   Coriell; GM10611
DR   Wikidata; Q54947458
RX   CelloPub=CLPUB00447;
RX   PubMed=2005900;
RX   PubMed=2276735;
RX   PubMed=2307476;
RX   PubMed=8314568;
RX   PubMed=8661047;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 9 mapping. Contains a complete copy of chromosome 9.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V283 ! GM07890
HI   CVCL_4595 ! UV135
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 10
//
ID   PK-89-12
AC   CVCL_V284
SY   PK89-12; GM10868
DR   CLO; CLO_0024131
DR   Coriell; GM10868
DR   Wikidata; Q54947459
RX   CelloPub=CLPUB00447;
RX   PubMed=2276735;
RX   PubMed=8314568;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid for chromosome 12 mapping. Contains a complete copy of chromosome 12.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V283 ! GM07890
HI   CVCL_4595 ! UV135
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 10
//
ID   PK-89-6A
AC   CVCL_V287
SY   PK89-6A; GM11580
DR   CLO; CLO_0021219
DR   Coriell; GM11580
DR   Wikidata; Q54947460
RX   CelloPub=CLPUB00447;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V283 ! GM07890
HI   CVCL_4595 ! UV135
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 9
//
ID   PK-9 [Human]
AC   CVCL_D721
SY   PK 9; Pk 9; PK9
DR   BTO; BTO_0005486
DR   cancercelllines; CVCL_D721
DR   ChEMBL-Cells; CHEMBL4295487
DR   ChEMBL-Targets; CHEMBL4296486
DR   Cosmic; 707255
DR   Cosmic; 1066178
DR   Cosmic; 1644299
DR   GEO; GSM862568
DR   GEO; GSM862570
DR   GEO; GSM1588618
DR   GEO; GSM1588630
DR   IARC_TP53; 14303
DR   PubChem_Cell_line; CVCL_D721
DR   RCB; RCB2140
DR   TKG; TKG 0240
DR   Wikidata; Q54947461
RX   DOI=10.22029/jlupub-12385;
RX   PubMed=3547771;
RX   PubMed=7622937;
RX   PubMed=8872523;
RX   PubMed=11115575;
RX   PubMed=15770730;
RX   PubMed=16912165;
RX   PubMed=20037478;
RX   PubMed=22490663;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=3547771; PubMed=7622937); 51.4 hours (PubMed=8872523).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11115575; PubMed=22490663).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=11115575; PubMed=22490663).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Discontinued: RCB; RCB2140; true.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): TKG=TKG 0240
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 15,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 26
//
ID   PK-9 [Pig]
AC   CVCL_C0ZC
SY   PK9
DR   Wikidata; Q114312661
RX   Patent=US11351244;
RX   PubMed=17494075;
RX   PubMed=24398227;
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) and produces progeny virus (PubMed=17494075).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112737; Pig CD163 (Note=Isoform CD163v1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C0Z3 ! PK0809
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 9
//
ID   PK-SV40
AC   CVCL_9W55
DR   Wikidata; Q54947462
RX   PubMed=6314331;
CC   Doubling time: 42 hours (Note=At 38th passage) (PubMed=6314331).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   PK136
AC   CVCL_7695
SY   PK-136
DR   CLO; CLO_0008451
DR   ATCC; HB-191
DR   CCRID; 3101ETCHYB46
DR   Wikidata; Q54947464
RX   PubMed=6500587;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/anti-nk1-1-mouse-monoclonal-antibody-clone-pk136
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 787.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P27814; Mouse Klrb1c/Cd161c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   PK136-SFM
AC   CVCL_QZ04
DR   TKG; TKG 0628
DR   Wikidata; Q54947465
CC   Group: Serum/protein free medium cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse antigen on natural killer (NK) cells.
CC   Discontinued: TKG; TKG 0628; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7695 ! PK136
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 5
//
ID   PK15 PERV-inactivated clone 15
AC   CVCL_YE75
SY   PK15 clone 15; PK15-15
DR   Wikidata; Q98128600
RX   PubMed=26456528;
RX   PubMed=31667881;
CC   Characteristics: Using CRISPR/Cas9 all 62 copies of the PERV pol gene were inactivated (PubMed=26456528).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   PK15 PERV-inactivated clone 20
AC   CVCL_YE76
SY   PK15 clone 20; PK15-20
DR   Wikidata; Q98128601
RX   PubMed=26456528;
CC   Characteristics: Using CRISPR/Cas9 all 62 copies of the PERV pol gene were inactivated (PubMed=26456528).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   PK15 PERV-inactivated clone 29
AC   CVCL_YE77
SY   PK15 clone 29; PK15-29
DR   Wikidata; Q98128602
RX   PubMed=26456528;
CC   Characteristics: Using CRISPR/Cas9 all 62 copies of the PERV pol gene were inactivated (PubMed=26456528).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   PK15 PERV-inactivated clone 38
AC   CVCL_YE78
SY   PK15 clone 38; PK15-38
DR   Wikidata; Q98128603
RX   PubMed=26456528;
CC   Characteristics: Using CRISPR/Cas9 all 62 copies of the PERV pol gene were inactivated (PubMed=26456528).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   PK15-1A6
AC   CVCL_A9EK
DR   Wikidata; Q108821129
RX   PubMed=32258794;
CC   Virology: Highly susceptible to infection by classical swine fever virus (CSFV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   PK15-1C8
AC   CVCL_A9EH
DR   Wikidata; Q108821130
RX   DOI=10.3864/j.issn.0578-1752.2021.06.017;
CC   Characteristics: Grows adherently.
CC   Virology: Can produce high titers of porcine circovirus 2 (PCV2).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   PK15-1E5
AC   CVCL_A9EI
DR   Wikidata; Q108821131
RX   DOI=10.3864/j.issn.0578-1752.2021.06.017;
CC   Characteristics: Grows adherently.
CC   Virology: Can produce high titers of porcine circovirus 2 (PCV2).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   PK15-2F11
AC   CVCL_A9EJ
DR   Wikidata; Q108821132
RX   DOI=10.3864/j.issn.0578-1752.2021.06.017;
CC   Characteristics: Grows adherently.
CC   Virology: Can produce high titers of porcine circovirus 2 (PCV2).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   PK15-3B1
AC   CVCL_A9EL
DR   Wikidata; Q108821133
RX   PubMed=32258794;
CC   Virology: Low susceptibility to infection by classical swine fever virus (CSFV).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   PK15-A2
AC   CVCL_JF20
DR   Wikidata; Q54947466
RX   PubMed=17889922;
CC   Doubling time: 10.7 +- 0.5 hours (PubMed=17889922).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   PK15-B1
AC   CVCL_A9EE
DR   CCRID; 4201PAT-CCTCC00295
DR   Wikidata; Q108821134
RX   DOI=10.16656/j.issn.1673-4696.2011.01.007;
RX   Patent=CN101665781B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200936.
CC   Virology: Can produce high titers of porcine circovirus 2 (PCV2).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   PK15-C1
AC   CVCL_JF21
DR   Wikidata; Q54947467
RX   Patent=US8518696;
RX   PubMed=17889922;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8244.
CC   Virology: Highly susceptible to infection by porcine circovirus 2 (PCV2).
CC   Doubling time: 16.9 +- 1.1 hours (PubMed=17889922).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   PK15-IFNgRan
AC   CVCL_A9EF
DR   Wikidata; Q108821135
RX   PubMed=31216434;
CC   Characteristics: Contains a randomly integrated pTEG-IFNg-Fc vector containing a fusion of pig IFNG with pig IgG Fc domain.
CC   Virology: Highly susceptible to infection by porcine circovirus 2 (PCV2).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=VGNC; VGNC:89040; Pig IFNG.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   PK15-IFNgSB
AC   CVCL_A9EG
DR   Wikidata; Q108821136
RX   PubMed=31216434;
CC   Characteristics: Contains a sleeping beauty (SB) integrated pTEG-IFNg-Fc vector containing a fusion of pig IFNG with pig IgG Fc domain.
CC   Virology: Highly susceptible to infection by porcine circovirus 2 (PCV2).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=VGNC; VGNC:89040; Pig IFNG.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   PK15-IL-2
AC   CVCL_XE83
SY   PK15-IL2
DR   CCRID; 4201PAT-CCTCC01203
DR   Wikidata; Q98128604
RX   PubMed=27760373;
CC   Group: Patented cell line.
CC   Virology: Porcine circovirus 2 (PCV2) proliferation is significantly enhanced compared to the parent cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:98935; Pig IL2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PK15CD163
AC   CVCL_C0Z4
DR   Wikidata; Q114312662
RX   PubMed=24398227;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=24398227).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 9
//
ID   PK15cl28/BS
AC   CVCL_W715
SY   PK15-28; PK15 clone 28
DR   IZSLER; BS CL 179
DR   Wikidata; Q54947468
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   PK15S1
AC   CVCL_C3VM
SY   PK15(S1); PK-15 Siglec-1; rPK
DR   Wikidata; Q116050119
RX   PubMed=12857889;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome (PRRSV).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:108736; Pig SIGLEC1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   PK15S1-CD163
AC   CVCL_C3VN
SY   PK15(S1-CD163); PK15Sn-CD163
DR   Wikidata; Q116050121
RX   PubMed=30021620;
RX   PubMed=34205087;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome (PRRSV).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:108736; Pig SIGLEC1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C3VM ! PK15S1
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   PK15S10
AC   CVCL_C3VI
SY   PK15(S10); PK-15S10+; PK-15(S10+); PK-15 Siglec-10
DR   Wikidata; Q116050122
RX   PubMed=28742001;
RX   PubMed=30021620;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome (PRRSV).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:112760; Pig SIGLEC10.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   PK15S10-CD163
AC   CVCL_C3VJ
SY   PK15(S10-CD163)
DR   Wikidata; Q116050123
RX   PubMed=30021620;
RX   PubMed=34205087;
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome (PRRSV).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:112737; Pig CD163.
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:112760; Pig SIGLEC10.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C3VI ! PK15S10
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   PK4A
AC   CVCL_WB21
DR   Wikidata; Q98128605
RX   PubMed=23407165;
RX   PubMed=25675507;
RX   PubMed=28685754;
CC   Doubling time: ~24 hours (Direct_author_submission).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Miscellaneous: Doubling time and sex of donor from personal communication of Gouirand, Victoire.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Pdx1-Cre;Ink4a/Arffl/fl;LSL-KrasG12D transgenic.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   PK4A sg-PRODH1_clone3
AC   CVCL_WB22
SY   sg-PRODH1_clone3
DR   Wikidata; Q98128606
RX   PubMed=28685754;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97770; Prodh.
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Pdx1-Cre;Ink4a/Arffl/fl;LSL-KrasG12D transgenic.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WB21 ! PK4A
SX   Male
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   PK4A sg-PRODH1_clone9
AC   CVCL_WB23
SY   sg-PRODH1_clone9
DR   Wikidata; Q98128607
RX   PubMed=28685754;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97770; Prodh.
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (from inference of genetic background of transgenic mouse used).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Pdx1-Cre;Ink4a/Arffl/fl;LSL-KrasG12D transgenic.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WB21 ! PK4A
SX   Male
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   PK565C
AC   CVCL_A9J1
DR   Wikidata; Q102114777
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 4
//
ID   PK565C CMV-Luc#7
AC   CVCL_A9J2
DR   JCRB; NIHS1297
DR   Wikidata; Q102114778
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=NIHS1297).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS1297; true.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9J1 ! PK565C
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   PK565C CMV-Luc/EF-1a/RFP-Pur#1
AC   CVCL_A9J3
DR   JCRB; NIHS1298
DR   Wikidata; Q102114779
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=NIHS1298).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1298; true.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9J1 ! PK565C
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   PKD2.78
AC   CVCL_XJ90
SY   PKD2iPSC c78
DR   Wikidata; Q98128608
RX   PubMed=26549847;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas (CIEMAT); Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9020; PKLR; Simple; p.Ser120Phe (c.359C>T); ClinVar=VCV002432664; Zygosity=Heterozygous (PubMed=26549847).
CC   Sequence variation: Mutation; HGNC; HGNC:9020; PKLR; Simple; p.Asp390Asn (c.1168G>A); ClinVar=VCV001469002; Zygosity=Heterozygous (PubMed=26549847).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99037; Pyruvate kinase deficiency
DI   ORDO; Orphanet_766; Hemolytic anemia due to red cell pyruvate kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   PKD3.54
AC   CVCL_XJ91
SY   PKD3iPSC c54
DR   Wikidata; Q98128609
RX   PubMed=26549847;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas (CIEMAT); Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9020; PKLR; Simple; c.1269+1G>C (IVS9+1G>C); Zygosity=Homozygous; Note=Splice donor mutation (PubMed=26549847).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99037; Pyruvate kinase deficiency
DI   ORDO; Orphanet_766; Hemolytic anemia due to red cell pyruvate kinase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   PKE20
AC   CVCL_IW61
DR   Wikidata; Q54947469
RX   PubMed=2845797;
CC   Selected for resistance to: ChEBI; CHEBI_136538; Ethylisopropylamiloride (EIPA).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_IP75 ! LLC-PK1/Cl4
SX   Male
AG   3-4W
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   PKE5
AC   CVCL_IW62
SY   PKE 5
DR   Wikidata; Q54947471
RX   PubMed=2833317;
RX   PubMed=3022596;
CC   Characteristics: Devoid of sodium-proton antiporter activity.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_IP75 ! LLC-PK1/Cl4
SX   Male
AG   3-4W
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   PKF
AC   CVCL_2692
SY   Pig Kidney Fibroblastic
DR   JCRB; IFO50422
DR   Wikidata; Q54947472
CC   Virology: Susceptible to infection by vaccinia virus (JCRB=IFO50422).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   PKR
AC   CVCL_2693
SY   Pig Kidney Rough
DR   JCRB; IFO50423
DR   Wikidata; Q54947473
CC   Virology: Susceptible to infection by vaccinia virus (JCRB=IFO50423).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PKR KO (C57)
AC   CVCL_C0LB
SY   PKR KO (C57) Macrophage Cell Line
DR   Kerafast; ENH181-FP
DR   Wikidata; Q112930334
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1353449; Eif2ak2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   PKS
AC   CVCL_2694
SY   Pig Kidney Smooth
DR   JCRB; IFO50421
DR   Wikidata; Q54947474
CC   Virology: Susceptible to infection by vaccinia virus (JCRB=IFO50421).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   PKSU
AC   CVCL_XH37
DR   CCLV; CCLV-RIE 0009
DR   Wikidata; Q98128610
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 5
//
ID   PKSV-PCT
AC   CVCL_0484
DR   MCCL; MCC:0000383
DR   Wikidata; Q54947475
RX   PubMed=7474657;
RX   PubMed=8100235;
RX   PubMed=17219250;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal convoluted tubule; UBERON=UBERON_0001287.
CC   Breed/subspecies: L-PK/Tag1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   PKSV-PR
AC   CVCL_W355
DR   Wikidata; Q54947476
RX   PubMed=8100235;
RX   PubMed=17219250;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal straight tubule; UBERON=UBERON_0001290.
CC   Breed/subspecies: L-PK/Tag1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   PKU-1
AC   CVCL_C065
SY   PKU1; BJMUe001-A
DR   hPSCreg; BJMUe001-A
DR   SKIP; SKIP002117
DR   Wikidata; Q54947477
RX   PubMed=16143641;
CC   From: Peking University Third Hospital; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   PKU-2
AC   CVCL_C066
SY   PKU2; BJMUe002-A
DR   hPSCreg; BJMUe002-A
DR   SKIP; SKIP002118
DR   Wikidata; Q54947478
RX   PubMed=16143641;
CC   From: Peking University Third Hospital; Beijing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   PKU-UiPSC 3
AC   CVCL_YP22
SY   PKUC3-P10
DR   Wikidata; Q98128611
RX   PubMed=29862149;
CC   From: Key Laboratory for Rare Disease Research of Shandong Province; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
ID   PKW-LWHT
AC   CVCL_A8VW
SY   PKW-LWHT1; Pigmy Killer Whale-Liu Wen Hua Transformed
DR   Wikidata; Q108821137
RX   PubMed=29596530;
CC   Group: Cetacean cell line.
CC   Doubling time: 14.41 hours (PubMed=29596530).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tail, skin, dermis; UBERON=UBERON_0003534+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=103592; ! Feresa attenuata (Pygmy killer whale)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   PL [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC27
DR   Wikidata; Q98128613
RX   PubMed=20889926;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   PL [Lateolabrax]
AC   CVCL_UW78
SY   Perch Liver
DR   Wikidata; Q98128614
RX   DOI=10.1007/BF02623580;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 7
//
ID   PL [Sardinops]
AC   CVCL_R916
SY   Pilchard Liver
DR   Wikidata; Q29581406
RX   PubMed=15801155;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=59687; ! Sardinops neopilchardus (Australian pilchard)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   Pl 1Ut
AC   CVCL_3771
SY   Pl 1Ut (NBL-9); Pl 1 Ut (NBL-9); NBL-9; Pl.1 Ut; Pl 1 UT; Pl 1 Ut; Procyon lotor 1 Uterus
DR   CLO; CLO_0008287
DR   CLO; CLO_0008443
DR   CLDB; cl3910
DR   ATCC; CCL-74
DR   ATCC; CRL-6596
DR   ECACC; 90111909
DR   Wikidata; Q54947483
RX   DOI=10.1007/BF02618370;
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/fibroblastindex
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Misspelling: P1 1Ut; Note=Occasionally.
CC   Discontinued: ATCC; CRL-6596; true.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9654; ! Procyon lotor (Raccoon)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   PL-14
AC   CVCL_L412
DR   Wikidata; Q54947479
RX   PubMed=640319;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=640319).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   PL-20
AC   CVCL_0C86
DR   Wikidata; Q54947480
RX   PubMed=20453304;
CC   Doubling time: 158 hours (PubMed=20453304).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   PL-21
AC   CVCL_2161
SY   PL21
DR   BTO; BTO_0005928
DR   CLO; CLO_0009856
DR   EFO; EFO_0006473
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 217
DR   BioSample; SAMN01821655
DR   BioSample; SAMN01821714
DR   BioSample; SAMN03473265
DR   BioSample; SAMN10988496
DR   cancercelllines; CVCL_2161
DR   Cell_Model_Passport; SIDM00450
DR   Cosmic; 787419
DR   Cosmic; 975297
DR   Cosmic; 999725
DR   Cosmic; 1524840
DR   Cosmic; 2131556
DR   Cosmic; 2306237
DR   Cosmic-CLP; 1330991
DR   DepMap; ACH-000218
DR   DSMZ; ACC-536
DR   DSMZCellDive; ACC-536
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1330991
DR   GEO; GSM236801
DR   GEO; GSM236837
DR   GEO; GSM887518
DR   GEO; GSM888600
DR   GEO; GSM1374834
DR   GEO; GSM1446753
DR   GEO; GSM1670351
DR   JCRB; JCRB1319
DR   LiGeA; CCLE_483
DR   LINCS_LDP; LCL-1070
DR   PharmacoDB; PL21_1270_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2161
DR   Wikidata; Q54947481
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1571549;
RX   PubMed=6362749;
RX   PubMed=6576961;
RX   PubMed=12529668;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 48-64 hours (PubMed=6362749); ~40-50 hours (DSMZ=ACC-536).
CC   HLA typing: A*24:02,26:01; B*13:01,40:06; C*03:04,03:04; DQA1*05:02,05:02; DRB1*09:01,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Unspecified (PubMed=12529668).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Val (c.437C>T); ClinVar=VCV000375962; Zygosity=Heterozygous (Cosmic-CLP=1330991; DepMap=ACH-000218).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro36fs*8 (c.107delC); Zygosity=Heterozygous (Cosmic-CLP=1330991).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.5%; East Asian, North=78.62%; East Asian, South=18.83%; South Asian=0%; European, North=0%; European, South=1.05% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1330991; DSMZ=ACC-536; JCRB=JCRB1319; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 23,27
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 12,13
ST   D8S1179: 10
ST   FGA: 21,24
ST   Penta D: 11,13
ST   Penta E: 5,17
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C208352; Acute promyelocytic leukemia
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   PL-29018
AC   CVCL_M704
SY   PL29018
DR   cancercelllines; CVCL_M704
DR   Cosmic; 2297024
DR   GEO; GSM115812
DR   Progenetix; CVCL_M704
DR   Wikidata; Q54947482
RX   PubMed=16960149;
CC   Omics: Variations; Array-based CGH.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   PL08
AC   CVCL_XH95
DR   Wikidata; Q98128615
RX   Patent=CN102965334B;
RX   Patent=CN103122335B;
RX   Patent=CN103289951B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201297.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   PL1
AC   CVCL_JM54
DR   JCRB; KURB2034
DR   Wikidata; Q54947484
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM55 ! PL10
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL10
AC   CVCL_JM55
DR   JCRB; KURB2035
DR   Wikidata; Q54947485
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM54 ! PL1
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL11
AC   CVCL_JM44
DR   JCRB; KURB2036
DR   Wikidata; Q54947487
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL12
AC   CVCL_JM28
DR   JCRB; KURB2014
DR   Wikidata; Q54947489
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL14 [Human familial adenomatous polyposis]
AC   CVCL_JM57
DR   JCRB; KURB2027
DR   Wikidata; Q54947490
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM56 ! PL2
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL14 [Human pancreatic adenocarcinoma]
AC   CVCL_X982
DR   Cosmic; 949525
DR   Wikidata; Q54947492
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   PL16
AC   CVCL_JM29
DR   JCRB; KURB2019
DR   Wikidata; Q54947493
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL16B
AC   CVCL_VI88
DR   RCB; RCB5399
DR   Wikidata; Q98128616
RX   PubMed=16232198;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VI89 ! PL16T
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 7
//
ID   PL16T
AC   CVCL_VI89
DR   RCB; RCB5400
DR   Wikidata; Q98128617
RX   PubMed=16232198;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5665; Atypical adenomatous lung hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VI88 ! PL16B
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   PL17
AC   CVCL_JM45
DR   JCRB; KURB2033
DR   Wikidata; Q54947494
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL18
AC   CVCL_JM46
DR   JCRB; KURB2040
DR   Wikidata; Q54947495
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   PL19
AC   CVCL_JM47
DR   JCRB; KURB2042
DR   Wikidata; Q54947505
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL2
AC   CVCL_JM56
DR   JCRB; KURB2026
DR   Wikidata; Q54947507
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JM57 ! PL14 [Human familial adenomatous polyposis]
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL21
AC   CVCL_JM48
DR   JCRB; KURB2039
DR   Wikidata; Q54947508
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL22
AC   CVCL_JM49
DR   JCRB; KURB2041
DR   Wikidata; Q54947510
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL24
AC   CVCL_JM50
DR   JCRB; KURB2037
DR   Wikidata; Q54947511
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL25
AC   CVCL_JM30
DR   JCRB; KURB2011
DR   Wikidata; Q54947512
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL26
AC   CVCL_JM51
DR   JCRB; KURB2043
DR   Wikidata; Q54947513
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL28
AC   CVCL_JM31
DR   JCRB; KURB2009
DR   Wikidata; Q54947514
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL29
AC   CVCL_JM32
DR   JCRB; KURB2012
DR   Wikidata; Q54947515
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL32
AC   CVCL_JM33
DR   JCRB; KURB2013
DR   Wikidata; Q54947516
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL35
AC   CVCL_JM34
DR   JCRB; KURB2010
DR   Wikidata; Q54947517
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL36
AC   CVCL_JM35
DR   JCRB; KURB2008
DR   Wikidata; Q54947518
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL37
AC   CVCL_JM52
DR   JCRB; KURB2025
DR   Wikidata; Q54947519
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL377
AC   CVCL_S875
DR   Wikidata; Q54947520
RX   PubMed=12904596;
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   PL4
AC   CVCL_S976
SY   PL-4
DR   CLO; CLO_0037112
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 994
DR   cancercelllines; CVCL_S976
DR   Cell_Model_Passport; SIDM00042
DR   Cosmic; 1198212
DR   Cosmic-CLP; 1298533
DR   DepMap; ACH-002186
DR   EGA; EGAS00001000978
DR   GDSC; 1298533
DR   GEO; GSM621906
DR   GEO; GSM1670352
DR   LINCS_HMS; 50040
DR   LINCS_LDP; LCL-1098
DR   PharmacoDB; PL4_1272_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54947521
RX   PubMed=14695172;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=1298533; DepMap=ACH-002186).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Homozygous (Cosmic-CLP=1298533; DepMap=ACH-002186).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.4%; Native American=0%; East Asian, North=1.3%; East Asian, South=1.55%; South Asian=0%; European, North=64.99%; European, South=31.75% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1298533
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 26
//
ID   PL40
AC   CVCL_JM36
DR   JCRB; KURB2018
DR   Wikidata; Q54947523
CC   Population: Japanese.
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   PL45
AC   CVCL_3567
SY   PL-45; PL 45
DR   CLO; CLO_0008454
DR   EFO; EFO_0006474
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-2558
DR   BioSample; SAMN03473284
DR   cancercelllines; CVCL_3567
DR   Cell_Model_Passport; SIDM01115
DR   Cosmic; 725721
DR   Cosmic; 932513
DR   Cosmic; 949236
DR   Cosmic; 949524
DR   Cosmic; 1006372
DR   Cosmic; 2046533
DR   Cosmic; 2434098
DR   DepMap; ACH-001171
DR   EGA; EGAS00001000610
DR   GEO; GSM206536
DR   GEO; GSM383936
DR   GEO; GSM621890
DR   GEO; GSM887519
DR   GEO; GSM888601
DR   GEO; GSM1024413
DR   IARC_TP53; 22817
DR   LINCS_LDP; LCL-1727
DR   PharmacoDB; PL45_1273_2019
DR   PRIDE; PXD003198
DR   Progenetix; CVCL_3567
DR   Wikidata; Q54947524
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,31:01; B*40:01,49:01; C*03:04,07:01; DQA1*03:02,05:02; DRB1*04:03,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (ATCC=CRL-2558).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Asn (c.764T>A); ClinVar=VCV000232289; Zygosity=Homozygous (from autologous cell line Panc 10.05).
CC   Omics: Metabolomics.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.25%; Native American=0%; East Asian, North=1.71%; East Asian, South=0%; South Asian=0%; European, North=62.06%; European, South=34.98% (PubMed=30894373).
ST   Source(s): ATCC=CRL-2558; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,16
ST   D12S391: 17,20
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 13,14
ST   D1S1656: 12,14
ST   D21S11: 30
ST   D22S1045: 15
ST   D2S1338: 17,18
ST   D2S441: 11,13
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1639 ! Panc 10.05
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   PL5
AC   CVCL_JM37
DR   JCRB; KURB2020
DR   Wikidata; Q54947525
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL502
AC   CVCL_3126
DR   JCRB; JCRB1125
DR   JCRB; NIHS0421
DR   SKIP; SKIP000706
DR   Wikidata; Q54947526
CC   Discontinued: JCRB; NIHS0421; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1125
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10,12
ST   D16S539: 9,10
ST   D5S818: 9,11,13
ST   D7S820: 9,10,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL504
AC   CVCL_8305
DR   BioSample; SAMN03472382
DR   JCRB; JCRB1126
DR   JCRB; NIHS0423
DR   SKIP; SKIP000707
DR   Wikidata; Q54947527
CC   Discontinued: JCRB; NIHS0423; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1126
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   PL505
AC   CVCL_3127
DR   BioSample; SAMN03472461
DR   JCRB; JCRB1128
DR   JCRB; NIHS0424
DR   SKIP; SKIP000708
DR   Wikidata; Q54947528
CC   Discontinued: JCRB; NIHS0424; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1128
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   PL506
AC   CVCL_RH61
DR   SKIP; SKIP001295
DR   Wikidata; Q54947530
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   PL507
AC   CVCL_3128
DR   BioSample; SAMN03472462
DR   JCRB; JCRB1130
DR   JCRB; NIHS0426
DR   SKIP; SKIP000709
DR   Wikidata; Q54947531
CC   Discontinued: JCRB; NIHS0426; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1130
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL508
AC   CVCL_3129
DR   BioSample; SAMN03472429
DR   JCRB; JCRB1194
DR   JCRB; NIHS0429
DR   SKIP; SKIP000740
DR   Wikidata; Q54947532
CC   Discontinued: JCRB; NIHS0429; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1194
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   PL509
AC   CVCL_8310
DR   BioSample; SAMN03472432
DR   JCRB; JCRB1197
DR   JCRB; NIHS0430
DR   SKIP; SKIP000741
DR   Wikidata; Q54947533
CC   Discontinued: JCRB; NIHS0430; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1197
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D5S818: 9,10
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL51
AC   CVCL_B6DZ
SY   PL-51
DR   Wikidata; Q112129524
RX   DOI=10.1007/978-94-011-0848-5_31;
RX   PubMed=7686026;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: FOS+HRAS.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Lymphocyte; CL=CL_0000542.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   PL512
AC   CVCL_3130
DR   BioSample; SAMN03472449
DR   JCRB; JCRB1229
DR   JCRB; NIHS0565
DR   SKIP; SKIP000743
DR   Wikidata; Q54947534
CC   Discontinued: JCRB; NIHS0565; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1229
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   PL514
AC   CVCL_3131
DR   BioSample; SAMN03472390
DR   JCRB; JCRB1300
DR   JCRB; NIHS0566
DR   SKIP; SKIP000744
DR   Wikidata; Q54947535
CC   Discontinued: JCRB; NIHS0566; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1300
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL516
AC   CVCL_3132
DR   BioSample; SAMN03472392
DR   JCRB; JCRB1302
DR   JCRB; NIHS0569
DR   SKIP; SKIP000746
DR   Wikidata; Q54947536
CC   Discontinued: JCRB; NIHS0569; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1302
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 9,13
ST   D7S820: 12,13
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL517
AC   CVCL_8314
DR   BioSample; SAMN03472395
DR   JCRB; JCRB1306
DR   JCRB; NIHS0570
DR   SKIP; SKIP000745
DR   Wikidata; Q54947537
CC   Discontinued: JCRB; NIHS0570; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1306
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   PL518
AC   CVCL_3133
DR   BioSample; SAMN03472396
DR   JCRB; JCRB1307
DR   JCRB; NIHS0571
DR   SKIP; SKIP000747
DR   Wikidata; Q54947538
CC   Discontinued: JCRB; NIHS0571; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1307
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL519
AC   CVCL_8436
DR   JCRB; JCRB1360
DR   JCRB; NIHS0575
DR   SKIP; SKIP000749
DR   Wikidata; Q54947539
CC   Discontinued: JCRB; NIHS0575; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1360
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10
ST   D5S818: 9,12
ST   D7S820: 12,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL520
AC   CVCL_8322
DR   JCRB; JCRB1364
DR   JCRB; NIHS0576
DR   SKIP; SKIP000750
DR   Wikidata; Q54947540
CC   Discontinued: JCRB; NIHS0576; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1364
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL521
AC   CVCL_8530
DR   JCRB; JCRB1423
DR   SKIP; SKIP000753
DR   Wikidata; Q54947542
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1423
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   PL523
AC   CVCL_8531
DR   JCRB; JCRB1420
DR   SKIP; SKIP000752
DR   Wikidata; Q54947544
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1420
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 10,12
ST   D7S820: 11,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   PL532
AC   CVCL_3134
DR   BioSample; SAMN03472444
DR   JCRB; JCRB1219
DR   JCRB; NIHS0516
DR   SKIP; SKIP000742
DR   Wikidata; Q54947545
CC   Discontinued: JCRB; NIHS0516; true.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): JCRB=JCRB1219
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   PL551SF
AC   CVCL_8532
DR   JCRB; JCRB1412
DR   SKIP; SKIP000751
DR   Wikidata; Q54947546
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   PL6
AC   CVCL_JM38
DR   JCRB; KURB2005
DR   Wikidata; Q54947547
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL7
AC   CVCL_JM39
DR   JCRB; KURB2006
DR   Wikidata; Q54947549
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL7-6
AC   CVCL_E4A2
RX   PubMed=1381405;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PL79
AC   CVCL_JM53
DR   JCRB; KURB2038
DR   Wikidata; Q54947550
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL8
AC   CVCL_JM40
DR   JCRB; KURB2007
DR   Wikidata; Q54947551
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL80
AC   CVCL_JM41
DR   JCRB; KURB2016
DR   Wikidata; Q54947561
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL81
AC   CVCL_JM42
DR   JCRB; KURB2017
DR   Wikidata; Q54947562
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PL9
AC   CVCL_JM43
DR   JCRB; KURB2015
DR   Wikidata; Q54947563
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   PLA-801
AC   CVCL_7108
SY   PLA801
DR   Wikidata; Q54947564
RX   PubMed=2550196;
RX   PubMed=6676078;
CC   Population: Chinese.
CC   Doubling time: 29 hours (PubMed=6676078).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   PLA-801A
AC   CVCL_WW01
DR   Wikidata; Q98128618
RX   PubMed=2550196;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7108 ! PLA-801
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   PLA-801C
AC   CVCL_7109
SY   PLA801C; PLA801-95C; 95C
DR   BTO; BTO_0002183
DR   EFO; EFO_0022628
DR   Wikidata; Q54947565
RX   PubMed=2550196;
RX   PubMed=12748951;
CC   Population: Chinese.
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7108 ! PLA-801
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   PLA-801D
AC   CVCL_7110
SY   PLA801D; PLA801-95D; 95D; 95-D; 801-D
DR   BTO; BTO_0002182
DR   CCRID; 4201HUM-CCTCC00330
DR   CCTCC; GDC0330
DR   Cosmic; 911995
DR   Cosmic; 2664112
DR   KCB; KCB 200690YJ
DR   Wikidata; Q54947566
RX   PubMed=1839254;
RX   PubMed=2550196;
RX   PubMed=12748951;
CC   Population: Chinese.
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CCRID=4201HUM-CCTCC00330
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 19
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7108 ! PLA-801
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   PLA-801E
AC   CVCL_WW02
DR   Wikidata; Q98128619
RX   PubMed=2550196;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7108 ! PLA-801
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   PLA-802
AC   CVCL_AX34
SY   PLA 802; PLA802
DR   Cosmic; 2296988
DR   Wikidata; Q54947567
RX   CelloPub=CLPUB00322;
RX   PubMed=27008654;
CC   Population: Chinese.
CC   Doubling time: 42 hours (CelloPub=CLPUB00322).
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   PLAFMCi002-A
AC   CVCL_A1MN
DR   Wikidata; Q102114780
RX   PubMed=33068887;
CC   From: Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Ser843Pro (c.2527T>C); ClinVar=VCV000997278; Zygosity=Heterozygous (PubMed=33068887).
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Met3091Arg (c.9272T>G); Zygosity=Heterozygous (PubMed=33068887).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   PLAFMCi003-A
AC   CVCL_A4XI
DR   Wikidata; Q107116664
RX   PubMed=33485185;
CC   From: Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9008; PKD1; Zygosity=Heterozygous (PubMed=33485185).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12363; TSC2; Zygosity=Heterozygous (PubMed=33485185).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177539; Polycystic kidney disease, infantile severe, with tuberous sclerosis
DI   ORDO; Orphanet_88924; Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   PLAFMCi004-A
AC   CVCL_A7JC
DR   Wikidata; Q107116665
RX   PubMed=33878710;
CC   From: Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   PLAFMCi005-A
AC   CVCL_A0ZS
DR   Wikidata; Q108821138
RX   PubMed=34359001;
CC   From: Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11630; HNF1B; Simple; c.544+3_544+6delAAGT; ClinVar=VCV000635668; Zygosity=Heterozygous (PubMed=34359001).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123018; Renal cysts and diabetes syndrome
DI   ORDO; Orphanet_93111; HNF1B-related autosomal dominant tubulointerstitial kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   Plat-A
AC   CVCL_B489
SY   Platinum-A
DR   Cell_Biolabs; RV-102
DR   IBRC; C10145
DR   Wikidata; Q54947568
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   Plat-E
AC   CVCL_B488
SY   Platinum-E
DR   EFO; EFO_0022553
DR   Cell_Biolabs; RV-101
DR   IBRC; C10157
DR   Wikidata; Q54947569
RX   PubMed=10871756;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   Plat-GP
AC   CVCL_B490
SY   Platinum-GP; PlatGP; PLAT-gp
DR   Cell_Biolabs; RV-103
DR   Wikidata; Q54947570
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   PLB-985
AC   CVCL_2162
SY   PLB 985; PLB985
DR   BTO; BTO_0002908
DR   CLO; CLO_0008457
DR   EFO; EFO_0002313
DR   CLDB; cl3912
DR   ArrayExpress; E-MTAB-38
DR   BioSample; SAMN03151776
DR   BioSample; SAMN10989584
DR   cancercelllines; CVCL_2162
DR   Cell_Model_Passport; SIDM00811
DR   Cosmic; 787475
DR   Cosmic; 1089520
DR   DepMap; ACH-000034
DR   DSMZ; ACC-139
DR   DSMZCellDive; ACC-139
DR   GEO; GSM1446750
DR   GEO; GSM2690922
DR   GEO; GSM2690923
DR   GEO; GSM2690924
DR   GEO; GSM2690925
DR   GEO; GSM2690926
DR   GEO; GSM2690927
DR   GEO; GSM2690928
DR   GEO; GSM2690929
DR   GEO; GSM2690930
DR   GEO; GSM2690931
DR   GEO; GSM2690932
DR   GEO; GSM2690933
DR   IGRhCellID; PLB985
DR   Lonza; 281
DR   Progenetix; CVCL_2162
DR   Wikidata; Q54947571
RX   PubMed=3475136;
RX   PubMed=8234321;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=25984343;
RX   PubMed=28287132;
RX   PubMed=29967760;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=36982453;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-65.html
CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 38 year old female patient with acute nonlymphocytic leukemia.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00258.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=25984343); ~24 hours (DSMZ=ACC-139).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (DepMap=ACH-000034).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (DepMap=ACH-000034).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.99%; Native American=0%; East Asian, North=1.35%; East Asian, South=0%; South Asian=0%; European, North=69.55%; European, South=28.11% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-139
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 22,24
ST   Penta D: 10,11
ST   Penta E: 13,14
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 38
//
ID   PLB-985 CYBB KO
AC   CVCL_C3HD
SY   NOX2-KO PLB-985; NOX2-/- PLB-985; gp91Phox targeted PLB-985
DR   cancercelllines; CVCL_C3HD
DR   GEO; GSM2690934
DR   GEO; GSM2690935
DR   GEO; GSM2690936
DR   GEO; GSM2690937
DR   GEO; GSM2690938
DR   GEO; GSM2690939
DR   GEO; GSM2690940
DR   GEO; GSM2690941
DR   GEO; GSM2690942
DR   GEO; GSM2690943
DR   GEO; GSM2690944
DR   Wikidata; Q114312663
RX   PubMed=8234321;
RX   PubMed=29967760;
CC   Problematic cell line: Contaminated. Parent cell line (PLB-985) was shown to be a HL-60 derivative.
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:2578; CYBB.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2162 ! PLB-985
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   PLB-985 NCF1 DeltaGT
AC   CVCL_C8HI
DR   Wikidata; Q123033272
RX   PubMed=28287132;
RX   PubMed=33365312;
CC   Problematic cell line: Contaminated. Parent cell line (PLB-985) was shown to be a HL-60 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7660; NCF1; Simple_edited; p.Tyr26Hisfs*26 (c.73_74GT[1]) (c.75_76delGT); ClinVar=VCV000002249; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=28287132).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2162 ! PLB-985
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   PLC/AN/2
AC   CVCL_5A03
SY   Primary Liver Carcinoma/ANcona/2
DR   Wikidata; Q54947572
RX   PubMed=1694812;
CC   Doubling time: 20 hours (Note=In 2% and 10% FCS), 26 hours (Note=In serum and hormone free medium) (PubMed=1694812).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   PLC/NUT/1
AC   CVCL_LJ92
SY   Primary Liver Carcinoma/Newcastle Upon Tyne/1
DR   Wikidata; Q54947573
RX   CelloPub=CLPUB00406;
RX   DOI=10.1007/978-4-431-68349-0_4;
CC   Characteristics: Tumorigenic. When heterotransplanted subcutaneously into male athymic mice tumors develop at the site of inoculation.
CC   Virology: Contains at least 3 copies of integrated hepatitis B virus (HBV) genomes.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   PLC/PRF/5
AC   CVCL_0485
AS   CVCL_6714
SY   PLC-PRF-5; PLC PRF 5; PLC/PRF5; PLCPRF5; PLC-8024; PLC8024; PLC; Alexander cells; Alexander; Primary Liver Carcinoma/Poliomyelitis Research Foundation/5
DR   BTO; BTO_0003492
DR   CLO; CLO_0008458
DR   CLO; CLO_0008459
DR   EFO; EFO_0006291
DR   MCCL; MCC:0000384
DR   CLDB; cl3914
DR   CLDB; cl3915
DR   CLDB; cl3916
DR   CLDB; cl5248
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-8024
DR   BCRC; 60223
DR   BCRJ; 0274
DR   BioGRID_ORCS_Cell_line; 484
DR   BioSample; SAMN03471130
DR   BioSample; SAMN03473236
DR   BioSample; SAMN10988112
DR   cancercelllines; CVCL_0485
DR   CCRID; 1101HUM-PUMC000674
DR   CCRID; 1102HUM-NIFDC00071
DR   CCRID; 3101HUMTCHu119
DR   CCRID; 4201HUM-CCTCC00644
DR   Cell_Model_Passport; SIDM01318
DR   CGH-DB; 9070-4
DR   ChEMBL-Cells; CHEMBL3308140
DR   ChEMBL-Targets; CHEMBL1075561
DR   CLS; 300315
DR   Cosmic; 721061
DR   Cosmic; 808505
DR   Cosmic; 871514
DR   Cosmic; 873402
DR   Cosmic; 925349
DR   Cosmic; 945155
DR   Cosmic; 948065
DR   Cosmic; 1019318
DR   Cosmic; 1351513
DR   Cosmic; 1518224
DR   Cosmic; 2023861
DR   Cosmic; 2162538
DR   Cosmic; 2321033
DR   Cosmic; 2674231
DR   Cosmic; 2773187
DR   DepMap; ACH-001318
DR   ECACC; 85061113
DR   EGA; EGAS00001000610
DR   GDSC; 925349
DR   GEO; GSM207051
DR   GEO; GSM565881
DR   GEO; GSM827153
DR   GEO; GSM886865
DR   GEO; GSM887520
DR   GEO; GSM887930
DR   GEO; GSM888602
DR   GEO; GSM936773
DR   GEO; GSM2551580
DR   GEO; GSM2551581
DR   IARC_TP53; 107
DR   IARC_TP53; 30016
DR   IZSLER; BS TCL 122
DR   JCRB; IFO50069
DR   JCRB; JCRB0406
DR   KCB; KCB 200785YJ
DR   KCLB; 28024
DR   LiGeA; CCLE_292
DR   LIMORE; PLC8024
DR   LIMORE; PLCPRF5
DR   LINCS_LDP; LCL-1942
DR   NCBI_Iran; C145
DR   PharmacoDB; PLCPRF5_1274_2019
DR   Progenetix; CVCL_0485
DR   PubChem_Cell_line; CVCL_0485
DR   RCB; RCB1887
DR   TKG; TKG 0376
DR   TOKU-E; 2898
DR   Ubigene; YC-C125
DR   Wikidata; Q54947574
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=63998;
RX   PubMed=184551;
RX   PubMed=187208;
RX   PubMed=1317878;
RX   PubMed=1661347;
RX   PubMed=2414854;
RX   PubMed=2439335;
RX   PubMed=2542205;
RX   PubMed=2992761;
RX   PubMed=2992762;
RX   PubMed=3023526;
RX   PubMed=3431441;
RX   PubMed=6160110;
RX   PubMed=6225510;
RX   PubMed=6248960;
RX   PubMed=6268737;
RX   PubMed=6275024;
RX   PubMed=6288577;
RX   PubMed=6302689;
RX   PubMed=6317496;
RX   PubMed=6555060;
RX   PubMed=6889516;
RX   PubMed=7874267;
RX   PubMed=8050184;
RX   PubMed=8224613;
RX   PubMed=8389256;
RX   PubMed=8835345;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=9359923;
RX   PubMed=10523694;
RX   PubMed=11050057;
RX   PubMed=12029633;
RX   PubMed=15767549;
RX   PubMed=20069059;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29892436;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/PLC.PRF5
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; BRICS; BRICS0076; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3890
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8024.
CC   Population: African; Shangaan.
CC   Virology: Contains at least 7 copies of integrated hepatitis B virus (HBV) genomes. Secretes hepatitis virus B surface antigen (HBsAg) but no other HBV proteins (PubMed=6302689; PubMed=6317496).
CC   Virology: Susceptible to infection by adenovirus types 40 (Ad40) and 41 (Ad41) (PubMed=1317878).
CC   Doubling time: 35-40 hours (PubMed=63998); 20.05-28.76 hours (PubMed=31378681).
CC   HLA typing: A*33:02; B*42:01,53:01; C*04:01,17:01 (PubMed=9178645).
CC   HLA typing: A*03:01,33:03; B*42:02,53:01; C*04:01,17:01; DQB1*06:07,06:07; DRB1*11:73,11:73 (PubMed=26589293).
CC   HLA typing: A*03:01:01,09:03:01; B*42:02:01,53:01:01; C*04:01,04; DPB1*17,18:01; DQA1*01:03:01,04:01:02; DQB1*03:19:01,06:03:01; DRB1*08:04:01,13:01:01 (CLS=300315).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (PubMed=31378681; DepMap=ACH-001318).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (PubMed=8224613; PubMed=8389256; DepMap=ACH-001318).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (DepMap=ACH-001318).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=95.79%; Native American=0%; East Asian, North=1.61%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=2.59% (PubMed=30894373).
CC   Caution: Often called PLC8024 in Chinese literature probably because of a concatenation between PLC/PRF/5 and ATCC-8024.
CC   Misspelling: PCL/PRF/5; Cosmic=873402.
CC   Discontinued: RCB; RCB1887; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-8024; CCRID; CLS=300315; ECACC=85061113; JCRB=IFO50069; JCRB=JCRB0406; KCLB=28024; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 15,20 (CCRID)
ST   D12S391: 20 (CLS=300315; PubMed=25877200)
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 17
ST   D19S433: 11,13
ST   D1S1656: 14
ST   D21S11: 30,33.2
ST   D2S1338: 19 (CLS=300315; PubMed=25877200)
ST   D2S1338: 19,22 (ATCC=CRL-8024; CCRID)
ST   D2S441: 12,14
ST   D3S1358: 15
ST   D5S818: 12
ST   D6S1043: 13,21
ST   D7S820: 9,11
ST   D8S1179: 13,16
ST   FGA: 19.2,25
ST   Penta D: 6,10
ST   Penta E: 10,16
ST   TH01: 7,8 (CLS=300315; ECACC=85061113; JCRB=IFO50069; JCRB=JCRB0406; KCLB=28024; PubMed=25877200; PubMed=31378681)
ST   TH01: 8 (ATCC=CRL-8024; CCRID)
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   PLC/PRF/5 Luciferase/GFP
AC   CVCL_LJ87
SY   Luciferase/GFP dual-labeled PLC/PRF/5; PLC/PRF/5 dual-labeled
DR   cancercelllines; CVCL_LJ87
DR   GeneCopoeia; SCL-C09-HLG
DR   Wikidata; Q54947575
WW   Provider; GeneCopoeia; SCL-C09-HLG; https://www.genecopoeia.com/wp-content/uploads/oldpdfs/product/Luciferase-GFP/datasheet_SCL-C09-HLG.pdf
CC   Population: African; Shangaan.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Discontinued: GeneCopoeia; SCL-C09-HLG; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 15
//
ID   PLC/PRF/5-Cas9-705
AC   CVCL_XB32
DR   cancercelllines; CVCL_XB32
DR   CCRID; 1101HUM-PUMC000705
DR   Wikidata; Q98128620
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-706
AC   CVCL_XB33
DR   cancercelllines; CVCL_XB33
DR   CCRID; 1101HUM-PUMC000706
DR   Wikidata; Q98128621
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-707
AC   CVCL_XB34
DR   cancercelllines; CVCL_XB34
DR   CCRID; 1101HUM-PUMC000707
DR   Wikidata; Q98128622
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-708
AC   CVCL_XB35
DR   cancercelllines; CVCL_XB35
DR   CCRID; 1101HUM-PUMC000708
DR   Wikidata; Q98128623
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-709
AC   CVCL_XB36
DR   cancercelllines; CVCL_XB36
DR   CCRID; 1101HUM-PUMC000709
DR   Wikidata; Q98128625
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-710
AC   CVCL_XB37
DR   cancercelllines; CVCL_XB37
DR   CCRID; 1101HUM-PUMC000710
DR   Wikidata; Q98128626
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-711
AC   CVCL_XB38
DR   cancercelllines; CVCL_XB38
DR   CCRID; 1101HUM-PUMC000711
DR   Wikidata; Q98128627
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-712
AC   CVCL_XB39
DR   cancercelllines; CVCL_XB39
DR   CCRID; 1101HUM-PUMC000712
DR   Wikidata; Q98128628
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-713
AC   CVCL_XB40
DR   cancercelllines; CVCL_XB40
DR   CCRID; 1101HUM-PUMC000713
DR   Wikidata; Q98128630
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-714
AC   CVCL_XB41
DR   cancercelllines; CVCL_XB41
DR   CCRID; 1101HUM-PUMC000714
DR   Wikidata; Q98128631
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5-Cas9-715
AC   CVCL_XB42
DR   cancercelllines; CVCL_XB42
DR   CCRID; 1101HUM-PUMC000715
DR   Wikidata; Q98128632
CC   Population: African; Shangaan.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   PLC/PRF/5/Cas9-hyg
AC   CVCL_C9DF
DR   GeneCopoeia; SL531
DR   Wikidata; Q123033273
CC   Population: African; Shangaan.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL531).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0485 ! PLC/PRF/5
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   PLF1
AC   CVCL_VQ08
SY   PLF 1
DR   Wikidata; Q98128633
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ09 ! PLF2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   PLF2
AC   CVCL_VQ09
SY   PLF 2
DR   Wikidata; Q98128634
RX   PubMed=8618233;
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ08 ! PLF1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   PLG1
AC   CVCL_D3R2
SY   PbetaLG1; 751
DR   Wikidata; Q127383087
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10281.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PLG2
AC   CVCL_D3R3
SY   PbetaLG2; 763
DR   Wikidata; Q127383088
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10282.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PLG3
AC   CVCL_D3R4
SY   PbetaLG3; 796
DR   Wikidata; Q127383089
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10283.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02754; Bovine LGB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PLH
AC   CVCL_E810
DR   EFO; EFO_0022642
DR   CLS; 302137
DR   dbMHC; 49004
DR   ECACC; 88052047
DR   IHW; IHW09047
DR   IPD-IMGT/HLA; 11258
DR   PRIDE; PXD001205
DR   Wikidata; Q54947577
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6334310;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=25502872;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Scandinavian.
CC   HLA typing: A*03:01:01:01,03:01:01:05; B*47:01:01:03; C*06:02:01:01; DPA1*01:03:01; DPB1*15:01:01; DQA1*02:01; DQB1*02:02:01; DRA*01:01; DRB1*07:01:01; DRB4*01:01 (IPD-IMGT/HLA=11258).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C129302; Adrenal gland hyperplasia III
DI   ORDO; Orphanet_90794; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   PLHC-1
AC   CVCL_3466
SY   Poeciliopsis Lucida Hepatocellular Carcinoma-1; PLHC-1/wt; PLHC1
DR   BTO; BTO_0002331
DR   CLO; CLO_0008460
DR   ATCC; CRL-2406
DR   Wikidata; Q54947578
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.3390/fishes7060354;
RX   PubMed=1868789;
RX   PubMed=9734273;
RX   PubMed=21392495;
RX   PubMed=22281180;
CC   Group: Fish cell line.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C134962; Poeciliopsis lucida hepatocellular carcinoma
OX   NCBI_TaxID=56613; ! Poeciliopsis lucida (Desert topminnow)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   PLHC-1/dox
AC   CVCL_S585
DR   BTO; BTO_0005429
DR   Wikidata; Q54947579
RX   PubMed=18950875;
RX   PubMed=21392495;
CC   Group: Fish cell line.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C134962; Poeciliopsis lucida hepatocellular carcinoma
OX   NCBI_TaxID=56613; ! Poeciliopsis lucida (Desert topminnow)
HI   CVCL_3466 ! PLHC-1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   PLJ-4.7
AC   CVCL_0486
SY   PLJ-47; CFPAC-PLJ-4.7; PLJ-CFTR-4.7
DR   MCCL; MCC:0000385
DR   cancercelllines; CVCL_0486
DR   Wikidata; Q54947580
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Arg (c.724T>C); ClinVar=VCV000449512; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1884; CFTR.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2975; Cystic fibrosis
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1119 ! CFPAC-1
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   PLS-1
AC   CVCL_4U94
SY   PLS1
DR   Wikidata; Q54947581
RX   PubMed=20419128;
RX   PubMed=26373732;
CC   Doubling time: ~1.6 days (PubMed=26373732).
DI   NCIt; C8795; Recurrent undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   PLS10
AC   CVCL_Z945
SY   PLS-10
DR   Wikidata; Q54947583
RX   PubMed=9045956;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   PLS20
AC   CVCL_Z946
SY   PLS-20
DR   Wikidata; Q54947584
RX   PubMed=9045956;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   PLS30
AC   CVCL_Z947
SY   PLS-30
DR   Wikidata; Q54947585
RX   PubMed=9045956;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 5
//
ID   PLT-1
AC   CVCL_UI27
DR   Wikidata; Q98128635
RX   PubMed=15250834;
CC   Population: Japanese.
CC   Doubling time: 54.3 hours (PubMed=15250834).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   PLT-2
AC   CVCL_L208
DR   Wikidata; Q54947586
RX   PubMed=14712486;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C4664; T-cell large granular lymphocyte leukemia
DI   ORDO; Orphanet_86872; T-cell large granular lymphocyte leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2127 ! MOTN-1
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   PLT460F_(DDR2)
AC   CVCL_JY47
DR   Wikidata; Q54947587
RX   Patent=US20150225369;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2731; DDR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   PLum-AD
AC   CVCL_AV66
SY   Prostate Luminal-Androgen Dependent
DR   Wikidata; Q54947588
RX   PubMed=27036046;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   PLum-AI
AC   CVCL_AV67
SY   Prostate Luminal-Androgen Independent
DR   Wikidata; Q54947589
RX   PubMed=27036046;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   PLum-C
AC   CVCL_AV68
SY   Prostate Luminal-Clone
DR   Wikidata; Q54947590
RX   PubMed=22022528;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   PluriStem 129S6
AC   CVCL_C319
SY   PluriStem 129/S6; 129S6
DR   BTO; BTO_0004750
DR   Millipore; SCR012
DR   Wikidata; Q54947592
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   PluriStem BALB/c
AC   CVCL_E924
DR   Millipore; SCC052
DR   Wikidata; Q54947593
CC   Discontinued: Millipore; SCC052; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   PluriStem C3H/HeN
AC   CVCL_E925
DR   Millipore; SCC055
DR   Wikidata; Q54947594
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   PluriStem C57BL/6N
AC   CVCL_E926
DR   Millipore; SCC050
DR   Wikidata; Q54947595
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   PluriStem DBA/2N
AC   CVCL_E927
DR   Millipore; SCC054
DR   Wikidata; Q54947596
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   PluriStem FVB/N
AC   CVCL_E928
DR   Millipore; SCC053
DR   Wikidata; Q54947597
CC   Discontinued: Millipore; SCC053; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   PluriStem NOD
AC   CVCL_GS43
DR   Millipore; SCC051
DR   Wikidata; Q54947598
CC   Discontinued: Millipore; SCC051; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NOD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   PlyI
AC   CVCL_H636
DR   Wikidata; Q54947600
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2917127;
RX   PubMed=15356658;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   PM-1 [Human oral dysplasia]
AC   CVCL_LN13
SY   PM1
DR   CancerTools; 153571
DR   Cosmic; 2688661
DR   GEO; GSM2611476
DR   GEO; GSM2611477
DR   GEO; GSM2611478
DR   Wikidata; Q54947601
DR   Ximbio; 153571
RX   PubMed=10772384;
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Asn86Ser (c.257A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly177Glu (c.530G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Forehead, skin; UBERON=UBERON_0016475.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,21
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C129863; Oral epithelial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN09 ! MET-1
OI   CVCL_LN10 ! MET-2
OI   CVCL_LN11 ! MET-3
OI   CVCL_LN12 ! MET-4
OI   CVCL_VJ50 ! SCCT9
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   PM-1 [Human/mouse hybridoma]
AC   CVCL_XI21
SY   PM-I; Pm-I
DR   Wikidata; Q98128636
RX   Patent=US7772372;
RX   Patent=WO2009104100A2;
RX   PubMed=12775891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2599.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   PM-2
AC   CVCL_XI22
SY   Pm-2
DR   Wikidata; Q98128637
RX   Patent=US7772372;
RX   Patent=WO2009104100A2;
RX   PubMed=12775891;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2600.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: Human antigen on cancer cells.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   PM-81
AC   CVCL_D5DX
DR   Wikidata; Q127383090
RX   PubMed=6486796;
RX   PubMed=6574189;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61352; Alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp (Lewis-X pentasaccharide; Lacto-N-fucopentaose III).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   PM-LGSOC-01
AC   CVCL_XX32
SY   Peritoneal Metastasis-Low Grade Serous Ovarian Carcinoma-01
DR   cancercelllines; CVCL_XX32
DR   CLS; 300305
DR   Wikidata; Q98128638
RX   PubMed=32317693;
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 42 hours (Note=At 5th passage), 23 hours (Note=At 22th passage) (PubMed=32317693).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=32317693).
CC   Miscellaneous: Age of donor from personal communication of De Wever, Olivier.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): CLS=300305; PubMed=32317693
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 10,11 (PubMed=32317693)
ST   D16S539: 10,13 (CLS=300305)
ST   D18S51: 12,17
ST   D19S433: 12,16
ST   D21S11: 28,32
ST   D2S1338: 24,25
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 13
//
ID   PM-LGSOC-01 luc-EGFP
AC   CVCL_ZE89
DR   cancercelllines; CVCL_ZE89
DR   Wikidata; Q98128639
RX   PubMed=32317693;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=32317693).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX32 ! PM-LGSOC-01
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   PM-WK
AC   CVCL_A665
AS   CVCL_W800
SY   PMWK; WK
DR   EFO; EFO_0022371
DR   ATCC; CRL-2624
DR   Cosmic; 706111
DR   Cosmic; 1054843
DR   Cosmic; 1507621
DR   Cosmic; 2233665
DR   Cosmic; 2630485
DR   Wikidata; Q54947604
RX   PubMed=1867326;
RX   PubMed=7680081;
RX   PubMed=8429233;
RX   PubMed=9141475;
RX   PubMed=9692547;
RX   PubMed=10766161;
RX   PubMed=11606052;
RX   PubMed=17308088;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=9692547; PubMed=10766161).
CC   Discontinued: ATCC; CRL-2624; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-2624
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 7
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   PM0001
AC   CVCL_8Y28
DR   ECACC; 01020501
DR   Wikidata; Q54947606
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 01020501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   PM1
AC   CVCL_9472
DR   BEI_Resources; ARP-3038
DR   cancercelllines; CVCL_9472
DR   Wikidata; Q54947607
RX   PubMed=7745720;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0337 ! HuT 78
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   PM1-CCR5-Luc
AC   CVCL_YX98
DR   cancercelllines; CVCL_YX98
DR   Wikidata; Q98128640
RX   PubMed=32135162;
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene expression is under the control of a Tat-inducible SIV LTR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YX97 ! PM1-Luc
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 14
//
ID   PM1-Luc
AC   CVCL_YX97
DR   cancercelllines; CVCL_YX97
DR   Wikidata; Q98128641
RX   PubMed=32135162;
CC   Population: Caucasian.
CC   Characteristics: The luciferase reporter gene expression is under the control of a Tat-inducible SIV LTR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9472 ! PM1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 13
//
ID   PM1015
AC   CVCL_UD97
SY   PM 1015
DR   cancercelllines; CVCL_UD97
DR   IARC_TP53; 5553
DR   Wikidata; Q98128642
RX   PubMed=7821846;
RX   PubMed=8557231;
CC   Doubling time: 48 hours (PubMed=7821846).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (PubMed=8557231).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   PM9726F
AC   CVCL_LM90
DR   Wikidata; Q54947616
RX   PubMed=17668376;
CC   From: Galliera Genetic Bank, E.O. Ospedali Galliera; Genova; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19FW
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   PMab-1
AC   CVCL_YA15
DR   Wikidata; Q98128644
RX   PubMed=23012488;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q62011; Mouse Pdpn (Note=Recognizes and binds to the MAP/MAP16 protein purification tags).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   PMab-117
AC   CVCL_D3EJ
DR   ABCD; ABCD_AI315
DR   Wikidata; Q127383091
RX   Patent=US11306152;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN (Note=With O-glycosylated Thr-85).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-2
AC   CVCL_D2UK
DR   Wikidata; Q127383092
RX   PubMed=26683179;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q64294; Rat Pdpn (Note=Recognizes and binds to the RAP/RAP14/RAP16 protein purification tags).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-202
AC   CVCL_UG46
DR   Wikidata; Q98128645
RX   PubMed=30362932;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F6ZBL8; Horse PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 5
//
ID   PMab-210
AC   CVCL_D2V3
DR   Wikidata; Q127383093
RX   PubMed=30681406;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; F1SUY1; Pig PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-213
AC   CVCL_D2V2
DR   Wikidata; Q127383095
RX   PubMed=30802179;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; F1SUY1; Pig PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-219
AC   CVCL_YA06
DR   Wikidata; Q98128646
RX   PubMed=30766925;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; F6ZBL8; Horse PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   PMab-225
AC   CVCL_D2V6
DR   Wikidata; Q127383096
RX   PubMed=30997422;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A6J0AGQ3; Vicugna pacos PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-231
AC   CVCL_D2UZ
DR   Wikidata; Q127383097
RX   PubMed=31009336;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A8C9K7D8; Panthera tigris altaica PDPN (Note=Also reacts with cat and lion).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-233
AC   CVCL_D2V9
DR   Wikidata; Q127383098
RX   PubMed=30984883;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; G3WRM2; Sarcophilus harrisii PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-235
AC   CVCL_D2V4
DR   Wikidata; Q127383099
RX   PubMed=31338471;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A452F5L0; Capra hircus PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PMab-237
AC   CVCL_D3CH
DR   Wikidata; Q127383100
RX   PubMed=31161965;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A2Y9EM55; Physeter macrocephalus PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-241
AC   CVCL_D3CE
DR   Wikidata; Q127383101
RX   PubMed=31721640;
RX   PubMed=34161160;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A384CET4; Ursus maritimus PDPN (Note=Also reacts with Mustela putorius furo).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-247
AC   CVCL_D3CF
DR   Wikidata; Q127383102
RX   PubMed=31061899;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A384CET4; Ursus maritimus PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-253
AC   CVCL_D2RZ
DR   Wikidata; Q127383103
RX   PubMed=32679010;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; W5PMJ8; Sheep PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-256
AC   CVCL_D3CI
DR   Wikidata; Q127383104
RX   PubMed=32349619;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; W5PMJ8; Sheep PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-260
AC   CVCL_D2S0
DR   Wikidata; Q127383105
RX   PubMed=32679010;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; W5PMJ8; Sheep PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-265
AC   CVCL_D3CL
DR   Wikidata; Q127383107
RX   PubMed=34042502;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; G3T5I4; Loxodonta africana PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-269
AC   CVCL_D2S1
DR   Wikidata; Q127383109
RX   PubMed=34042540;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A6J2BQN3; Zalophus californianus PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-281
AC   CVCL_D3CU
DR   Wikidata; Q127383110
RX   PubMed=35483059;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q401Z9; Cricetulus griseus Pdpn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-292
AC   CVCL_D3CP
DR   Wikidata; Q127383111
RX   PubMed=35471053;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; G9KFV5; Mustela putorius furo PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-295
AC   CVCL_D3CM
DR   Wikidata; Q127383112
RX   PubMed=35917562;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; G3T5I4; Loxodonta africana PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-301
AC   CVCL_D3CV
DR   Wikidata; Q127383113
RX   PubMed=38150189;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Giraffa camelopardalis PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PMab-32
AC   CVCL_D2UM
DR   Wikidata; Q127383114
RX   PubMed=26788987;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; G1SPW9; Rabbit PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-38
AC   CVCL_D2UV
DR   Wikidata; Q127383116
RX   PubMed=27380308;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q95152; Dog PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-43
AC   CVCL_D2US
DR   Wikidata; Q127383117
RX   PubMed=27267652;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q402A0; Bovine PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-44
AC   CVCL_D2UP
DR   Wikidata; Q127383118
RX   PubMed=27267652;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q402A0; Bovine PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-45
AC   CVCL_D2UT
DR   Wikidata; Q127383119
RX   PubMed=27267652;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q402A0; Bovine PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-46
AC   CVCL_D2UU
DR   Wikidata; Q127383120
RX   PubMed=27267652;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q402A0; Bovine PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-48
AC   CVCL_D2UX
DR   Wikidata; Q127383121
RX   PubMed=29256716;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q95152; Dog PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMab-52
AC   CVCL_D2RQ
DR   Wikidata; Q127383122
RX   PubMed=28737447;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; M3W7Y4; Cat PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   PMAC1
AC   CVCL_B7B0
SY   Peter MacCallum Anal Cancer 1
DR   cancercelllines; CVCL_B7B0
DR   EGA; EGAD00001007001
DR   Wikidata; Q112129526
RX   PubMed=34663790;
CC   Doubling time: 47 hours (PubMed=34663790).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Gln88Ter (c.262C>T); Zygosity=Unspecified (PubMed=34663790).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu726Lys (c.2176G>A); ClinVar=VCV000376476; Zygosity=Unspecified (PubMed=34663790).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Anal canal; UBERON=UBERON_0000159.
ST   Source(s): PubMed=34663790
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,13
ST   D21S11: 30.2,32
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   PMAC2
AC   CVCL_B7B1
SY   Peter MacCallum Anal Cancer 2
DR   EGA; EGAD00001007001
DR   Wikidata; Q112129527
RX   PubMed=34663790;
CC   Doubling time: 41 hours (PubMed=34663790).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Glu458Ter (c.1372G>T); Zygosity=Unspecified (PubMed=34663790).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Anal canal; UBERON=UBERON_0000159.
ST   Source(s): PubMed=34663790
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   PMAC3
AC   CVCL_B7B2
SY   Peter MacCallum Anal Cancer 3
DR   cancercelllines; CVCL_B7B2
DR   EGA; EGAD00001007001
DR   Wikidata; Q112129528
RX   PubMed=34663790;
CC   Doubling time: 33 hours (PubMed=34663790).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Pro (c.1637A>C); ClinVar=VCV000375898; Zygosity=Unspecified (PubMed=34663790).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Anal canal; UBERON=UBERON_0000159.
ST   Source(s): PubMed=34663790
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   PMAC4
AC   CVCL_B7B3
SY   Peter MacCallum Anal Cancer 4
DR   EGA; EGAD00001007001
DR   Wikidata; Q112129530
RX   PubMed=34663790;
CC   Doubling time: 25 hours (PubMed=34663790).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Glu1750Ter (c.5248G>T); Zygosity=Unspecified (PubMed=34663790).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Anal canal; UBERON=UBERON_0000159.
ST   Source(s): PubMed=34663790
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D21S11: 30,32.2
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   PMAC5
AC   CVCL_B7B4
SY   Peter MacCallum Anal Cancer 5
DR   cancercelllines; CVCL_B7B4
DR   EGA; EGAD00001007001
DR   Wikidata; Q112129531
RX   PubMed=34663790;
CC   Doubling time: 24 hours (PubMed=34663790).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=34663790).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly279Trp (c.835G>T); Zygosity=Unspecified (PubMed=34663790).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Anal canal; UBERON=UBERON_0000159.
ST   Source(s): PubMed=34663790
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 9,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   PMC2
AC   CVCL_3773
SY   PMC-2
DR   CLO; CLO_0008469
DR   ATCC; CRL-9852
DR   BioSample; SAMN03471077
DR   Wikidata; Q54947617
RX   Patent=US5447861;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9852.
CC   Discontinued: ATCC; CRL-9852; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-9852
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   PMC42
AC   CVCL_5215
SY   PMC-42; PMC 42; PMC42-ET; PMC-42 ET; PMC42ET
DR   cancercelllines; CVCL_5215
DR   GEO; GSM217595
DR   GEO; GSM1172988
DR   GEO; GSM3145572
DR   GEO; GSM3145729
DR   PharmacoDB; PMC42_1275_2019
DR   Progenetix; CVCL_5215
DR   Wikidata; Q54947618
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=2228321;
RX   PubMed=6381852;
RX   PubMed=6572752;
RX   PubMed=6606728;
RX   PubMed=11044355;
RX   PubMed=11161701;
RX   PubMed=24176112;
RX   PubMed=28889351;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/pmc42.htm
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 2.3 days (PubMed=6572752).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 11,12
ST   D7S820: 7,9
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   PMC42-LA
AC   CVCL_5216
SY   PMC42LA
DR   Millipore; SCC139
DR   Wikidata; Q54947619
RX   PubMed=12649344;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Millipore=SCC139
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 7,9
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5215 ! PMC42
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   PMD1-15
AC   CVCL_Y529
DR   SKIP; SKIP000516
DR   Wikidata; Q54947620
RX   PubMed=24936452;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Ser253Thr (c.757T>A); Zygosity=Hemizygous (PubMed=24936452).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y531 ! PMD1-7
OI   CVCL_Y530 ! PMD1-27
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 10
//
ID   PMD1-27
AC   CVCL_Y530
DR   SKIP; SKIP000517
DR   Wikidata; Q54947621
RX   PubMed=24936452;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Ser253Thr (c.757T>A); Zygosity=Hemizygous (PubMed=24936452).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y531 ! PMD1-7
OI   CVCL_Y529 ! PMD1-15
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 10
//
ID   PMD1-7
AC   CVCL_Y531
DR   SKIP; SKIP000515
DR   Wikidata; Q54947622
RX   PubMed=24936452;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Ser253Thr (c.757T>A); Zygosity=Hemizygous (PubMed=24936452).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y529 ! PMD1-15
OI   CVCL_Y530 ! PMD1-27
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 10
//
ID   PMD2-10
AC   CVCL_Y532
DR   SKIP; SKIP000519
DR   Wikidata; Q54947624
RX   PubMed=24936452;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro216Ser (c.646C>T) (P215S); ClinVar=VCV000011073; Zygosity=Hemizygous (PubMed=24936452).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y534 ! PMD2-6
OI   CVCL_Y533 ! PMD2-22
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   PMD2-22
AC   CVCL_Y533
DR   SKIP; SKIP000520
DR   Wikidata; Q54947625
RX   PubMed=24936452;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro216Ser (c.646C>T) (P215S); ClinVar=VCV000011073; Zygosity=Hemizygous (PubMed=24936452).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y534 ! PMD2-6
OI   CVCL_Y532 ! PMD2-10
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   PMD2-6
AC   CVCL_Y534
DR   SKIP; SKIP000518
DR   Wikidata; Q54947626
RX   PubMed=24936452;
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Pro216Ser (c.646C>T) (P215S); ClinVar=VCV000011073; Zygosity=Hemizygous (PubMed=24936452).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y532 ! PMD2-10
OI   CVCL_Y533 ! PMD2-22
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   PMD4-11
AC   CVCL_T965
SY   PMD 4-11; HPS0090
DR   Wikidata; Q54947627
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y935 ! PMD4-14
OI   CVCL_Y936 ! PMD4-16
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   PMD4-14
AC   CVCL_Y935
SY   PMD 4-14; HPS0091
DR   Wikidata; Q54947628
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T965 ! PMD4-11
OI   CVCL_Y936 ! PMD4-16
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   PMD4-16
AC   CVCL_Y936
SY   PMD 4-16; HPS0092
DR   Wikidata; Q54947629
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T965 ! PMD4-11
OI   CVCL_Y935 ! PMD4-14
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   PMDC05
AC   CVCL_5G47
DR   Wikidata; Q54947630
RX   PubMed=19443030;
RX   PubMed=25075025;
WW   Info; -; -; https://web.archive.org/web/20160706131224/http://www.clg.niigata-u.ac.jp:80/~matak/eng/resmat12.pdf
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=19443030).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasmacytoid dendritic cell; CL=CL_0000784.
DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   PME1
AC   CVCL_IU82
DR   Cosmic; 2559135
DR   Wikidata; Q54947631
RX   PubMed=25653542;
CC   Doubling time: ~22 hours (PubMed=25653542).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
ID   PMF No.1
AC   CVCL_0H64
DR   Wikidata; Q54947632
RX   PubMed=24859480;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H65 ! PMF No.2
OI   CVCL_0H66 ! PMF No.4
OI   CVCL_0H67 ! PMF No.5
OI   CVCL_0H68 ! PMF No.7
OI   CVCL_0H69 ! PMF No.11
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   PMF No.11
AC   CVCL_0H69
DR   Wikidata; Q54947633
RX   PubMed=24859480;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H64 ! PMF No.1
OI   CVCL_0H65 ! PMF No.2
OI   CVCL_0H66 ! PMF No.4
OI   CVCL_0H67 ! PMF No.5
OI   CVCL_0H68 ! PMF No.7
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   PMF No.2
AC   CVCL_0H65
DR   SKIP; SKIP000563
DR   Wikidata; Q54947634
RX   PubMed=24859480;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H64 ! PMF No.1
OI   CVCL_0H66 ! PMF No.4
OI   CVCL_0H67 ! PMF No.5
OI   CVCL_0H68 ! PMF No.7
OI   CVCL_0H69 ! PMF No.11
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   PMF No.4
AC   CVCL_0H66
DR   Wikidata; Q54947635
RX   PubMed=24859480;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H64 ! PMF No.1
OI   CVCL_0H65 ! PMF No.2
OI   CVCL_0H67 ! PMF No.5
OI   CVCL_0H68 ! PMF No.7
OI   CVCL_0H69 ! PMF No.11
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   PMF No.5
AC   CVCL_0H67
DR   Wikidata; Q54947636
RX   PubMed=24859480;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H64 ! PMF No.1
OI   CVCL_0H65 ! PMF No.2
OI   CVCL_0H66 ! PMF No.4
OI   CVCL_0H68 ! PMF No.7
OI   CVCL_0H69 ! PMF No.11
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   PMF No.7
AC   CVCL_0H68
DR   SKIP; SKIP000564
DR   Wikidata; Q54947637
RX   PubMed=24859480;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H64 ! PMF No.1
OI   CVCL_0H65 ! PMF No.2
OI   CVCL_0H66 ! PMF No.4
OI   CVCL_0H67 ! PMF No.5
OI   CVCL_0H69 ! PMF No.11
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   PMF-ko14
AC   CVCL_8747
AS   CVCL_H196
SY   PMF-Ko14; PMFko14; PMFKO14
DR   BTO; BTO_0006511
DR   CLO; CLO_0050629
DR   BioSample; SAMN03472136
DR   BioSample; SAMN03472887
DR   cancercelllines; CVCL_8747
DR   Cosmic; 1187313
DR   DepMap; ACH-002022
DR   RCB; RCB1426
DR   Wikidata; Q54947639
RX   PubMed=10853016;
RX   PubMed=25714623;
RX   PubMed=25877200;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a KM12 derivative (PubMed=25714623). Originally thought to originate from a Japanese 51 year old female patient suffering from a peritoneal disseminated moderately differentiated adenocarcinoma of the cecum.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00629.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (Note=At 30th passage), 24 hours (Note=At 50th passage) (PubMed=10853016).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8031; NTRK1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-NTRK1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn1819fs*7 (c.5454_5455insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn1784Hisfs*7 (c.5350_5351delAA); ClinVar=VCV000037959; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Ter (c.385G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: RMFko14; Cosmic=1187313.
CC   Discontinued: DepMap; ACH-002022; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): DepMap=ACH-002022; PubMed=25877200; RCB=RCB1426
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13,14,15,16 (DepMap=ACH-002022)
ST   D13S317: 13,14,15 (PubMed=25877200; RCB=RCB1426)
ST   D16S539: 11,12 (PubMed=25877200; RCB=RCB1426)
ST   D16S539: 11,12,13 (DepMap=ACH-002022)
ST   D18S51: 14
ST   D19S433: 11,14
ST   D21S11: 27,33.2,34.2
ST   D2S1338: 22,23
ST   D3S1358: 14,15
ST   D5S818: 11 (RCB=RCB1426)
ST   D5S818: 11,15,16,17,18 (DepMap=ACH-002022)
ST   D5S818: 11,16 (PubMed=25877200)
ST   D7S820: 8 (RCB=RCB1426)
ST   D7S820: 8,8.3 (DepMap=ACH-002022; PubMed=25877200)
ST   D8S1179: 11,12,13 (DepMap=ACH-002022)
ST   D8S1179: 13 (PubMed=25877200)
ST   FGA: 20,22
ST   Penta D: 12
ST   Penta E: 14,17,18,19 (DepMap=ACH-002022)
ST   Penta E: 14,18,19 (PubMed=25877200)
ST   TH01: 9.3 (DepMap=ACH-002022; RCB=RCB1426)
ST   TH01: 9.3,11 (PubMed=25877200)
ST   TPOX: 11,12
ST   vWA: 17 (PubMed=25877200)
ST   vWA: 17,18 (RCB=RCB1426)
ST   vWA: 17,18,19 (DepMap=ACH-002022)
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1331 ! KM12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   PMG075
AC   CVCL_E811
DR   dbMHC; 49005
DR   ECACC; 88052077
DR   IHW; IHW09078
DR   IPD-IMGT/HLA; 11646
DR   Wikidata; Q54947640
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01:01,33:01:01:01; B*14:02:01:01; C*08:02:01:01; DPA1*01,02:01; DPB1*104:01,04:01:01; DQA1*01:01:02; DQB1*05:01:01; DRA*01:01; DRB1*01:02:01; DRB6*01:01 (IPD-IMGT/HLA=11646).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   PMH161
AC   CVCL_E812
DR   dbMHC; 49006
DR   ECACC; 94062301
DR   IHW; IHW09351
DR   IPD-IMGT/HLA; 11261
DR   Wikidata; Q54947641
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Korean.
CC   HLA typing: A*24,26; B*54,61; C*01,10; DQA1*03:01,05:01; DQB1*04:01,03:01; DRB1*04:05,11:06; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11261).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   PMJ2-PC
AC   CVCL_5864
DR   CLO; CLO_0008470
DR   ATCC; CRL-2457
DR   Wikidata; Q54947643
RX   PubMed=7683328;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5865 ! PMJ2-R
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   PMJ2-R
AC   CVCL_5865
SY   PMJ2R
DR   CLO; CLO_0008471
DR   ATCC; CRL-2458
DR   PRIDE; PXD015164
DR   PRIDE; PXD016227
DR   PRIDE; PXD022133
DR   Wikidata; Q54947645
RX   PubMed=7683328;
RX   PubMed=31909125;
RX   PubMed=34204832;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Transformant: Recombinant retrovirus J2.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5864 ! PMJ2-PC
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   PMK
AC   CVCL_4275
SY   pMK; Primary Macaque Kidney
DR   CLO; CLO_0008472
DR   ECACC; 98020308
DR   Wikidata; Q54947646
CC   Group: Non-human primate cell line.
CC   Discontinued: ECACC; 98020308; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   PmLyO-Sf9
AC   CVCL_A8SX
DR   NRFC; NRFC082
DR   Wikidata; Q108821139
RX   PubMed=33264652;
RX   PubMed=33826940;
WW   Provider; NRFC; NRFC082; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Crustacean cell line.
CC   Group: Insect cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC082.
CC   Characteristics: Fusion of Sf9 cells with shrimp lymphoid organ cells (PubMed=33826940).
CC   Virology: Susceptible to infection by white spot syndrome virus (WSSV) (PubMed=33264652).
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
OX   NCBI_TaxID=6687; ! Penaeus monodon (Giant tiger prawn)
HI   CVCL_0549 ! Sf9
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   PMM2-CDG FiPS01-Sv4F-11
AC   CVCL_E6XQ
SY   PMM2 CDG FiPS01-Sv4F-11
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+PMM2+CDG+FiPS01-Sv4F-11+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+PMM2+CDG+FiPS01-Sv4F-11+Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Gln33Ter (c.97C>T); ClinVar=VCV000803211; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:9115; PMM2; Simple; p.Val44Ala (c.131C>T); ClinVar=VCV000007725; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 16,20
DI   NCIt; C126868; Congenital disorder of glycosylation type Ia
DI   ORDO; Orphanet_79318; PMM2-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   PMN 29
AC   CVCL_D5DY
DR   Wikidata; Q127383123
RX   PubMed=6486796;
RX   PubMed=6752945;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61352; Alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp (Lewis-X pentasaccharide; Lacto-N-fucopentaose III).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   PMN 6
AC   CVCL_D5DZ
DR   Wikidata; Q127383124
RX   PubMed=6486796;
RX   PubMed=6752945;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61352; Alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp (Lewis-X pentasaccharide; Lacto-N-fucopentaose III).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   PMN7C3
AC   CVCL_F0TP
SY   7C3
RX   PubMed=6309281;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PMO
AC   CVCL_V647
SY   Penaeus Monodon Oka
DR   CCRID; 4201PAT-CCTCC00147
DR   Wikidata; Q54947648
RX   DOI=10.1016/0044-8486(95)01048-3;
RX   Patent=US6143547;
RX   PubMed=15994770;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Originally deposited as a shrimp (Penaeus mondodon) cell line, is in fact a Anguilla japonica cell line (PubMed=15994770).
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200004.
OX   NCBI_TaxID=7937; ! Anguilla japonica (Japanese eel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 13
//
ID   PMUi001-A
AC   CVCL_C1VK
SY   Alice; BMACA-CT2-A
DR   BioSamples; SAMEA11496797
DR   hPSCreg; PMUi001-A
DR   Wikidata; Q114312664
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VL ! PMUi001-B
OI   CVCL_C1VM ! PMUi001-C
OI   CVCL_C1VN ! PMUi001-D
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PMUi001-B
AC   CVCL_C1VL
SY   Betty; BMACA-CT2-B
DR   BioSamples; SAMEA11496808
DR   hPSCreg; PMUi001-B
DR   Wikidata; Q114312665
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VK ! PMUi001-A
OI   CVCL_C1VM ! PMUi001-C
OI   CVCL_C1VN ! PMUi001-D
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PMUi001-C
AC   CVCL_C1VM
SY   Chantal; BMACA-CT2-C
DR   BioSamples; SAMEA11506037
DR   hPSCreg; PMUi001-C
DR   Wikidata; Q114312666
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VK ! PMUi001-A
OI   CVCL_C1VL ! PMUi001-B
OI   CVCL_C1VN ! PMUi001-D
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PMUi001-D
AC   CVCL_C1VN
SY   Jacky; BMACA-CT2-J
DR   BioSamples; SAMEA11506087
DR   hPSCreg; PMUi001-D
DR   Wikidata; Q114312667
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VK ! PMUi001-A
OI   CVCL_C1VL ! PMUi001-B
OI   CVCL_C1VM ! PMUi001-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PMUi002-A
AC   CVCL_C1VP
SY   Cornelius; UCB144-CT2-C
DR   BioSamples; SAMEA11496652
DR   hPSCreg; PMUi002-A
DR   Wikidata; Q114312668
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VT ! PMUi002-B
OI   CVCL_C1VU ! PMUi002-C
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PMUi002-A-1
AC   CVCL_C1VQ
SY   Cornelius DOCK2KO clone 19; UCB144-CT2-C DOCK2KO clone 19
DR   BioSamples; SAMEA11980793
DR   hPSCreg; PMUi002-A-1
DR   Wikidata; Q114312669
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2988; DOCK2.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1VP ! PMUi002-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   PMUi002-A-2
AC   CVCL_C1VR
SY   Cornelius DOCK2KO clone 20; UCB144-CT2-C DOCK2KO clone 20
DR   BioSamples; SAMEA11980792
DR   hPSCreg; PMUi002-A-2
DR   Wikidata; Q114312670
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2988; DOCK2.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1VP ! PMUi002-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   PMUi002-A-3
AC   CVCL_C1VS
SY   Cornelius DOCK2KO clone 22; UCB144-CT2-C DOCK2KO clone 22
DR   BioSamples; SAMEA11980794
DR   hPSCreg; PMUi002-A-3
DR   Wikidata; Q114312671
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2988; DOCK2.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1VP ! PMUi002-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   PMUi002-B
AC   CVCL_C1VT
SY   Gustav; UCB144-CT1-G
DR   BioSamples; SAMEA11496763
DR   hPSCreg; PMUi002-B
DR   Wikidata; Q114312672
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VP ! PMUi002-A
OI   CVCL_C1VU ! PMUi002-C
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PMUi002-C
AC   CVCL_C1VU
SY   Henry; UCB144-CT1-H
DR   BioSamples; SAMEA11496783
DR   hPSCreg; PMUi002-C
DR   Wikidata; Q114312673
CC   From: Institute of Experimental and Clinical Cell Therapy, Paracelsus Medical University; Salzburg; Austria.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VP ! PMUi002-A
OI   CVCL_C1VT ! PMUi002-B
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PN-1
AC   CVCL_VK47
DR   Cosmic; 1085911
DR   Wikidata; Q98128647
RX   PubMed=9738976;
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   PN-R
AC   CVCL_RX37
DR   CCLV; CCLV-RIE 0144
DR   Wikidata; Q54947649
RX   PubMed=25531820;
CC   Virology: Susceptible to infection by equine herpesviruses (CCLV=CCLV-RIE 0144).
CC   Virology: Susceptible to infection by Middle East respiratory syndrome-related coronavirus (MERS-CoV) (PubMed=25531820).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Sex unspecified
AG   106FD
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 6
//
ID   PN1-iPSC
AC   CVCL_A4VQ
SY   PN1
DR   Wikidata; Q107116666
RX   PubMed=26987923;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:25792; USB1; Simple; c.693+1G>T; ClinVar=VCV000496749; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26987923).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177535; Poikiloderma with neutropenia
DI   ORDO; Orphanet_221046; Poikiloderma with neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4VR ! PN2-iPSC
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   PN16.1B3
AC   CVCL_C3BM
SY   PN 16.1B3; 16.1B3
DR   Wikidata; Q114312674
RX   PubMed=20363856;
RX   PubMed=24240360;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type IV.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   PN16.4B4
AC   CVCL_C3BN
SY   PN 16.4B4; 16.4B4
DR   Wikidata; Q114312675
RX   PubMed=20363856;
RX   PubMed=24240360;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Arabinogalactan type III.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   PN2-iPSC
AC   CVCL_A4VR
SY   PN2
DR   Wikidata; Q107116667
RX   PubMed=26987923;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:25792; USB1; Simple; c.693+1G>T; ClinVar=VCV000496749; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26987923).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177535; Poikiloderma with neutropenia
DI   ORDO; Orphanet_221046; Poikiloderma with neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4VQ ! PN1-iPSC
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   PNA-M1
AC   CVCL_A9HK
DR   CCRID; 5301OVI-KCB1565MZJ
DR   KCB; KCB 2015065MZJ
DR   Wikidata; Q108821140
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Fibroblast of skeletal muscle; CL=CL_0011027.
OX   NCBI_TaxID=59542; ! Pseudois nayaur (Bharal)
OI   CVCL_A9HL ! PNA-T1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   PNA-T1
AC   CVCL_A9HL
DR   CCRID; 5301OVI-KCB1565TZJ
DR   KCB; KCB 2015065TZJ
DR   Wikidata; Q108821142
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=59542; ! Pseudois nayaur (Bharal)
OI   CVCL_A9HK ! PNA-M1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   PNEC25
AC   CVCL_B068
DR   Wikidata; Q54947650
RX   PubMed=15060276;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: CR2-TAg transgenic.
DI   NCIt; C21743; Invasive neuroendocrine carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   PNEC28
AC   CVCL_B069
DR   Wikidata; Q54947651
RX   PubMed=15060276;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: CR2-TAg transgenic.
DI   NCIt; C21743; Invasive neuroendocrine carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   PNEC30
AC   CVCL_B070
DR   ATCC; CRL-2930
DR   Wikidata; Q54947652
RX   PubMed=15060276;
CC   Doubling time: ~50 hours (ATCC=CRL-2930).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: CR2-TAg transgenic.
DI   NCIt; C21743; Invasive neuroendocrine carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   PNEC30-3
AC   CVCL_B071
DR   Wikidata; Q54947653
RX   PubMed=15060276;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: CR2-TAg transgenic.
DI   NCIt; C21743; Invasive neuroendocrine carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B070 ! PNEC30
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   PNET
AC   CVCL_4431
SY   Primary Neural Ectodermal Tumor cell
DR   Wikidata; Q54947654
CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1960 but was never distributed.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   PNET-1
AC   CVCL_A5PP
SY   PNET1; Primitive NeuroEctodermal Tumour cell line-1
DR   Wikidata; Q107116669
RX   PubMed=7687927;
RX   PubMed=8490657;
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   PNET-2
AC   CVCL_4432
SY   PNET2; Primitive NeuroEctodermal Tumour cell line-2
DR   BTO; BTO_0004011
DR   Wikidata; Q54947655
RX   PubMed=7646434;
RX   PubMed=7687927;
RX   PubMed=8490657;
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   PNG-1
AC   CVCL_4J78
SY   Papua New Guinea-1; Hagahai cell line
DR   Wikidata; Q54947656
RX   DOI=10.24135/pjr.v4i1.622;
RX   Patent=US5397696;
WW   Info; -; -; http://www.culturalsurvival.org/publications/cultural-survival-quarterly/papua-new-guinea/national-institutes-health-and-papua-new-g
WW   Info; NYT; -; https://www.nytimes.com/1995/11/27/business/patents-recent-patent-papua-new-guinea-tribe-s-cell-line-prompts-outrage-charges.html
WW   Info; WIPO Magazine; -; https://www.wipo.int/en/web/wipo-magazine/articles/bioethics-and-patent-law-the-cases-of-moore-and-the-hagahai-people-35439
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10528.
CC   Population: Papuan; Hagahai.
CC   Virology: HTLV-1 isolate PNG producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Anecdotal: The patent concerning this cell line caused a highly mediatized controversy. The cell line is derived from a member of the Hagahai people from New Guinea and it was deemed outrageous that a patent be deposited on biological material originating from an indigenous population without an explicit consent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PNG211D
AC   CVCL_E8TS
SY   G211D; 211D
RX   PubMed=1723648;
RX   PubMed=10656666;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5 (Note=May also recognize another protein on the surface of osteoclasts).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PNG312G
AC   CVCL_E8TT
SY   G312G
RX   PubMed=1723648;
RX   PubMed=10656666;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5 (Note=May also recognize another protein on the surface of osteoclasts).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PNK-86
AC   CVCL_A5YA
DR   Wikidata; Q107116670
RX   Patent=SU1613487;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 27.
CC   Virology: Susceptible to infection by herpes simplex virus, adenovirus type 7 (Ad7) and parainfluenza viruses types 1 to 3.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
AG   <1D
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   PNKT-3
AC   CVCL_T685
SY   ProNephric Kidney Tumour-3
DR   Wikidata; Q54947657
RX   PubMed=221384;
RX   PubMed=1087310;
CC   Group: Amphibian cell line.
CC   Characteristics: Derived from primary explants of a pronephric tumour induced after embryo inoculation of the RaHV-1 infected WMPa/V208 cell line (Cellosaurus=CVCL_D6A0) (PubMed=1087310).
CC   Transformant: NCBI_TaxID; 85655; Ranid herpesvirus 1 (RaHV-1).
CC   Derived from site: In situ; Embryonic kidney, pronephros; UBERON=UBERON_0002120.
DI   NCIt; C134771; Frog pronephric kidney tumor
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
OI   CVCL_T686 ! PRKT
AG   Larval stage
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 9
//
ID   PNKT-4
AC   CVCL_T687
SY   PNKT4; ProNephric Kidney Tumour-4
DR   Wikidata; Q54947658
RX   PubMed=221384;
RX   PubMed=1087310;
CC   Group: Amphibian cell line.
CC   Characteristics: Derived from primary explants of a pronephric tumour induced after embryo inoculation of the RaHV-1 infected WMPa/V208 cell line (Cellosaurus=CVCL_D6A0) (PubMed=1087310).
CC   Transformant: NCBI_TaxID; 85655; Ranid herpesvirus 1 (RaHV-1).
CC   Derived from site: In situ; Embryonic kidney, pronephros; UBERON=UBERON_0002120.
DI   NCIt; C134771; Frog pronephric kidney tumor
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
AG   Larval stage
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 10
//
ID   PNKT-4B
AC   CVCL_T688
SY   PNKT4B; ProNephric Kidney Tumour-4B
DR   Wikidata; Q54947659
RX   DOI=10.3354/dao027001;
RX   PubMed=221384;
RX   PubMed=2328547;
CC   Group: Amphibian cell line.
CC   Characteristics: Derived from primary explants of a pronephric tumour induced after embryo inoculation of the RaHV-1 infected WMPa/V208 cell line (Cellosaurus=CVCL_D6A0) (from parent cell line).
CC   Transformant: NCBI_TaxID; 85655; Ranid herpesvirus 1 (RaHV-1).
CC   Derived from site: In situ; Embryonic kidney, pronephros; UBERON=UBERON_0002120.
DI   NCIt; C134771; Frog pronephric kidney tumor
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_T687 ! PNKT-4
AG   Larval stage
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 10
//
ID   PNL-P2 clone C1
AC   CVCL_LN41
SY   PNL-P2C1
DR   Wikidata; Q54947671
RX   PubMed=295045;
CC   Transformant: NCIt; C141343; Strontium-90 beta radiation.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Miniature pig.
DI   NCIt; C141365; Porcine leukemia
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 4
//
ID   PNL2
AC   CVCL_B3XT
DR   Wikidata; Q110433139
RX   PubMed=12748255;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanocyte-associated antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   PNM-Mel
AC   CVCL_M744
DR   cancercelllines; CVCL_M744
DR   Wikidata; Q54947672
RX   PubMed=11121133;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   From: Guadagni, Fiorella; Regina Elena Institute for Cancer Research; Rome; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly101Trp (c.301G>T) (p.Arg115Leu, c.344G>T); ClinVar=VCV000009412; Zygosity=Unspecified (PubMed=29492214).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G320 ! PNP-Mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   PNMR 120E
AC   CVCL_U057
SY   120E
DR   ECACC; 01080926
DR   Wikidata; Q54947673
RX   PubMed=11461669;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   PNMR 160D
AC   CVCL_U058
SY   160D
DR   ECACC; 01080923
DR   Wikidata; Q54947674
RX   PubMed=11461669;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   PNMR OE
AC   CVCL_U059
SY   OE
DR   ECACC; 01080925
DR   Wikidata; Q54947675
RX   PubMed=11461669;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   Pno
AC   CVCL_1K10
DR   Wikidata; Q54947676
RX   PubMed=10910922;
RX   PubMed=11564178;
RX   PubMed=14962098;
CC   Doubling time: 72 hours (PubMed=10910922).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   PNOA1
AC   CVCL_D3R5
SY   304E4
DR   Wikidata; Q127383125
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10265.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20208.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PNOA2
AC   CVCL_D3R6
SY   306B2
DR   Wikidata; Q127383126
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10266.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-20209.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19121; Chicken ALB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PNOM1
AC   CVCL_D3R7
SY   47E5
DR   Wikidata; Q127383127
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10279.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P01005; Chicken ovomucoid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PNOM2
AC   CVCL_D3R8
SY   50A12
DR   Wikidata; Q127383129
RX   Patent=US7943334;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10280.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01005; Chicken ovomucoid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PNP-Mel
AC   CVCL_G320
SY   PNP Mel
DR   cancercelllines; CVCL_G320
DR   Cosmic; 1295330
DR   Wikidata; Q54947677
RX   PubMed=11121133;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   From: Guadagni, Fiorella; Regina Elena Institute for Cancer Research; Rome; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly101Trp (c.301G>T) (p.Arg115Leu, c.344G>T); ClinVar=VCV000009412; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M744 ! PNM-Mel
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   PNQ310A
AC   CVCL_E8TU
SY   310A
RX   PubMed=7768539;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PNQ312D
AC   CVCL_E8TV
SY   312D
RX   PubMed=7768539;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5 (Note=Also reacts with prostatic acid phosphatase).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PNT1
AC   CVCL_4804
DR   Wikidata; Q54947678
RX   PubMed=1714974;
RX   PubMed=8977636;
CC   Doubling time: 40 hours (PubMed=1714974).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   PNT1A
AC   CVCL_2163
SY   PNT1a; PNT-1A; PNT1-a; PNT1/A
DR   BTO; BTO_0003068
DR   CLO; CLO_0008475
DR   CLDB; cl3926
DR   ChEMBL-Cells; CHEMBL4513117
DR   ChEMBL-Targets; CHEMBL4513131
DR   ECACC; 95012614
DR   GEO; GSM827411
DR   GEO; GSM1374835
DR   PubChem_Cell_line; CVCL_2163
DR   Wikidata; Q54947679
RX   PubMed=7558421;
RX   PubMed=11416159;
RX   PubMed=11694337;
RX   PubMed=20215515;
RX   PubMed=21556542;
CC   Doubling time: 25 hours (PubMed=7558421); 29.93 +- 1.29 hours (PubMed=21556542).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 16
ST   D21S11: 27,28
ST   D8S1179: 10,12
ST   FGA: 24
ST   TH01: 6
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4804 ! PNT1
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 28
//
ID   PNT1A serum free
AC   CVCL_JX33
SY   PNT1A (SERUM FREE)
DR   ECACC; 07052901
DR   Wikidata; Q54947680
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2163 ! PNT1A
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   PNT1B
AC   CVCL_W767
SY   PNT1b; PNT-1B
DR   Wikidata; Q54947681
RX   PubMed=7558421;
RX   PubMed=11135431;
RX   PubMed=11416159;
RX   PubMed=21556542;
CC   Doubling time: 48 hours (PubMed=7558421); 27.88 +- 1.58 hours (PubMed=21556542).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 16
ST   D21S11: 27,28
ST   D8S1179: 10,12
ST   FGA: 24
ST   TH01: 6
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4804 ! PNT1
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 17
//
ID   PNT2
AC   CVCL_2164
SY   PNT 2; PNT-2
DR   BTO; BTO_0002399
DR   CLO; CLO_0008476
DR   EFO; EFO_0022595
DR   CLDB; cl3927
DR   ChEMBL-Cells; CHEMBL4632325
DR   ChEMBL-Targets; CHEMBL4632332
DR   ECACC; 95012613
DR   GEO; GSM827351
DR   PubChem_Cell_line; CVCL_2164
DR   Wikidata; Q54947682
RX   PubMed=11135431;
RX   PubMed=11416159;
RX   PubMed=17644708;
RX   PubMed=20215515;
RX   PubMed=21556542;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/pnt2/
CC   Doubling time: 35.9 +- 1.56 hours (PubMed=21556542).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ECACC=95012613; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 9
ST   D18S51: 16,17
ST   D21S11: 29,33.2
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   PNT2 serum free
AC   CVCL_JX34
SY   PNT2 (SERUM FREE)
DR   ECACC; 07042701
DR   Wikidata; Q54947683
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2164 ! PNT2
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   PNT2-C2
AC   CVCL_4889
SY   PNT2.C2; PNT2/C2; PNT2C2
DR   BTO; BTO_0003539
DR   Wikidata; Q54947684
RX   PubMed=15254154;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2164 ! PNT2
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   PNT2-LSD
AC   CVCL_W768
SY   PNT2-Less Serum Dependent
DR   Wikidata; Q54947685
RX   PubMed=21556542;
CC   Doubling time: 29.2 +- 1.44 hours (PubMed=21556542).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2164 ! PNT2
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 14
//
ID   PNUH-12
AC   CVCL_S889
SY   Pusan National University Hospital-12
DR   cancercelllines; CVCL_S889
DR   Wikidata; Q54947688
RX   CelloPub=CLPUB00003;
RX   CelloPub=CLPUB00626;
RX   PubMed=15886465;
RX   PubMed=17923759;
CC   Population: Korean.
CC   Doubling time: 48 hours (CelloPub=CLPUB00003).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Unspecified (CelloPub=CLPUB00003).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   PNUH-12 R1
AC   CVCL_A6IU
DR   cancercelllines; CVCL_A6IU
DR   Wikidata; Q107116671
RX   CelloPub=CLPUB00626;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S889 ! PNUH-12
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   PNUi001-A
AC   CVCL_VK73
SY   SCZ1258_2-2
DR   hPSCreg; PNUi001-A
DR   Wikidata; Q98128648
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:17021; ASTN2; Zygosity=Heterozygous (from autologous cell line PNUi001-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK74 ! PNUi001-B
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   PNUi001-B
AC   CVCL_VK74
SY   SCZ1258_2-6
DR   hPSCreg; PNUi001-B
DR   Wikidata; Q98128649
RX   PubMed=29803967;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:17021; ASTN2; Zygosity=Heterozygous (PubMed=29803967).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29803967
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D21S11: 29,30
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK73 ! PNUi001-A
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   PNUi002-A
AC   CVCL_VP75
SY   NMI005_1-13
DR   hPSCreg; PNUi002-A
DR   Wikidata; Q98128651
RX   PubMed=30144654;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP76 ! PNUi002-B
OI   CVCL_VP77 ! PNUi002-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   PNUi002-B
AC   CVCL_VP76
SY   NMI005_3-3
DR   hPSCreg; PNUi002-B
DR   Wikidata; Q98128652
RX   PubMed=30144654;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP75 ! PNUi002-A
OI   CVCL_VP77 ! PNUi002-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   PNUi002-C
AC   CVCL_VP77
SY   NMI005_3-7
DR   hPSCreg; PNUi002-C
DR   Wikidata; Q98128653
RX   PubMed=30144654;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126692; Chromosome 15q11-q13 duplication syndrome
DI   ORDO; Orphanet_238446; 15q11q13 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VP75 ! PNUi002-A
OI   CVCL_VP76 ! PNUi002-B
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   PNUi003-A
AC   CVCL_C1VE
SY   SCZ0714_1-4
DR   hPSCreg; PNUi003-A
DR   Wikidata; Q114312676
RX   PubMed=35944312;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Karyotypic information: Has also a 16p13.11 duplication (PubMed=35944312).
CC   Sequence variation: Gene deletion; HGNC; HGNC:2183; VPS13B; Zygosity=Heterozygous (PubMed=35944312).
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Has also a 16p13.11 duplication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35944312
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D21S11: 29,30
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VF ! PNUi003-B
OI   CVCL_C1VG ! PNUi003-C
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   PNUi003-B
AC   CVCL_C1VF
SY   SCZ0714_4-7
DR   hPSCreg; PNUi003-B
DR   Wikidata; Q114312677
RX   PubMed=35944312;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Karyotypic information: Has also a 16p13.11 duplication (PubMed=35944312).
CC   Sequence variation: Gene deletion; HGNC; HGNC:2183; VPS13B; Zygosity=Heterozygous (PubMed=35944312).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35944312
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D21S11: 29,30
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VE ! PNUi003-A
OI   CVCL_C1VG ! PNUi003-C
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   PNUi003-C
AC   CVCL_C1VG
SY   SCZ0714_4-10
DR   hPSCreg; PNUi003-C
DR   Wikidata; Q114312678
RX   PubMed=35944312;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Karyotypic information: Has also a 16p13.11 duplication (PubMed=35944312).
CC   Sequence variation: Gene deletion; HGNC; HGNC:2183; VPS13B; Zygosity=Heterozygous (PubMed=35944312).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35944312
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D21S11: 29,30
ST   D5S818: 9,10
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1VE ! PNUi003-A
OI   CVCL_C1VF ! PNUi003-B
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   PNUi004-A
AC   CVCL_E4E8
SY   SCZ1188_1-1
DR   BioSamples; SAMEA115988672
DR   hPSCreg; PNUi004-A
RX   PubMed=39288675;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Karyotypic information: Has a heterozygous 1q21.1 deletion (PubMed=39288675).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4E9 ! PNUi004-B
OI   CVCL_E4EA ! PNUi004-C
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   PNUi004-B
AC   CVCL_E4E9
SY   SCZ1188_1-5
DR   BioSamples; SAMEA115988711
DR   hPSCreg; PNUi004-B
RX   PubMed=39288675;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Karyotypic information: Has a heterozygous 1q21.1 deletion (PubMed=39288675).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4E8 ! PNUi004-A
OI   CVCL_E4EA ! PNUi004-C
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   PNUi004-C
AC   CVCL_E4EA
SY   SCZ1188_1-6
DR   BioSamples; SAMEA115991980
DR   hPSCreg; PNUi004-C
RX   PubMed=39288675;
CC   From: Department of Psychiatry, Nagoya University Graduate School of Medicine; Nagoya; Japan.
CC   Population: Japanese.
CC   Karyotypic information: Has a heterozygous 1q21.1 deletion (PubMed=39288675).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4E8 ! PNUi004-A
OI   CVCL_E4E9 ! PNUi004-B
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   PNUSCRi001-A
AC   CVCL_C1VH
SY   GBA PD iPSC7; GBA PD7
DR   BioSamples; SAMEA110465759
DR   hPSCreg; PNUSCRi001-A
DR   Wikidata; Q114312679
RX   PubMed=36332465;
CC   From: Convergence Stem Cell Research Center, Pusan National University; Yangsan; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn227Ser (c.680A>G) (N188S); ClinVar=VCV000004314; Zygosity=Heterozygous (PubMed=36332465).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   PNUSCRi002-A
AC   CVCL_C1VI
SY   GBA PD iPSC9; GBA PD9
DR   BioSamples; SAMEA110647800
DR   hPSCreg; PNUSCRi002-A
DR   Wikidata; Q114312680
RX   PubMed=36274270;
CC   From: Convergence Stem Cell Research Center, Pusan National University; Yangsan; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg159Trp (c.475C>T) (R120W); ClinVar=VCV000065570; Zygosity=Heterozygous (PubMed=36274270).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   PNUSCRi003-A
AC   CVCL_C7TV
SY   GBA Gaucher iPSC1
DR   BioSamples; SAMEA112283524
DR   hPSCreg; PNUSCRi003-A
DR   Wikidata; Q117704781
CC   From: Convergence Stem Cell Research Center, Pusan National University; Yangsan; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg87Cys (c.259C>T); ClinVar=VCV000004321; Zygosity=Unspecified (hPSCreg=PNUSCRi003-A).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg296Gln (c.887G>A) (R247Q); ClinVar=VCV000004328; Zygosity=Unspecified (hPSCreg=PNUSCRi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   PNUSCRi004-A
AC   CVCL_C7TW
SY   GBA PD iPSC8; GBA PD8
DR   BioSamples; SAMEA112286244
DR   hPSCreg; PNUSCRi004-A
DR   Wikidata; Q117704783
RX   PubMed=36805467;
CC   From: Convergence Stem Cell Research Center, Pusan National University; Yangsan; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=36805467).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Ala495Pro (c.1483G>C) (A456P); ClinVar=VCV000093450; Zygosity=Heterozygous (PubMed=36805467).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Val499Val (c.1497G>C) (V460V); ClinVar=VCV000093451; Zygosity=Heterozygous (PubMed=36805467).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   PNUSCRi005-A
AC   CVCL_E4EB
DR   BioSamples; SAMEA116043891
DR   hPSCreg; PNUSCRi005-A
CC   From: Convergence Stem Cell Research Center, Pusan National University; Yangsan; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; c.418+495_1006+1304del; Zygosity=Hemizygous (hPSCreg=PNUSCRi005-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   PNUYHi002-A
AC   CVCL_D6J6
SY   iPN-P12A
DR   BioSamples; SAMEA114523472
DR   hPSCreg; PNUYHi002-A
DR   Wikidata; Q127383130
RX   PubMed=38437769;
CC   From: iPSC and neurodegenerative disease center, Pusan National University Yangsan Hospital; Yangsan; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:9449; PRNP; Simple; p.Met232Arg (c.695T>G); ClinVar=VCV000013406; Zygosity=Heterozygous (PubMed=38437769).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   PNUYHi003-A
AC   CVCL_E8TR
SY   iPN-SC0110
DR   BioSamples; SAMEA117737656
DR   hPSCreg; PNUYHi003-A
RX   PubMed=40267536;
CC   From: iPSC and neurodegenerative disease center, Pusan National University Yangsan Hospital; Yangsan; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=75 GGC repeats (PubMed=40267536).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40267536
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 14,19
ST   D19S433: 13,16.2
ST   D21S11: 32.2
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C122655; Neuronal intranuclear inclusion disease
DI   ORDO; Orphanet_2289; Neuronal intranuclear inclusion disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PNV35B
AC   CVCL_U068
SY   V35B
DR   ECACC; 01080924
DR   Wikidata; Q54947689
RX   PubMed=10656666;
CC   Monoclonal antibody isotype: IgG+IgM.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
CC   Caution: Stated to be generated by fusion with Ag876 myeloma cells (PubMed=10656666), but AG876 is a Burkitt lymphoma cell line.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 5
//
ID   PO
AC   CVCL_N593
DR   CCLV; CCLV-RIE 0017
DR   Wikidata; Q54947690
RX   PubMed=19941903;
RX   PubMed=24457147;
RX   PubMed=25565633;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PO-2
AC   CVCL_9498
DR   CLO; CLO_0008477
DR   CLDB; cl3928
DR   Wikidata; Q54947692
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 6
//
ID   PO-88
AC   CVCL_B5YJ
DR   Wikidata; Q112129532
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PO714
AC   CVCL_9279
DR   CCLV; CCLV-RIE 0714
DR   Wikidata; Q54947693
RX   PubMed=15381362;
CC   Virology: Infected with bovine leukemia virus of the Belgian subgroup.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_N593 ! PO
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   PO93X
AC   CVCL_E2WJ
SY   P093X
RX   PubMed=16586507;
RX   PubMed=20552456;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Plant embryo; PO=PO_0009009.
OX   NCBI_TaxID=99806; ! Taxus cuspidata (Japanese yew)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   PoB1
AC   CVCL_A2EZ
SY   Paralichthys olivaceus Brain 1
DR   Wikidata; Q105510590
RX   DOI=10.1007/s11802-020-4435-z;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   PoB2
AC   CVCL_A2FA
SY   Paralichthys olivaceus Brain 2
DR   Wikidata; Q105510594
RX   DOI=10.1007/s11802-020-4435-z;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   POBC
AC   CVCL_6E00
SY   Paralichthys Olivaceus Brain Cell line
DR   Wikidata; Q54947694
RX   PubMed=25974130;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   PoBf
AC   CVCL_A2FB
DR   Wikidata; Q105510597
RX   DOI=10.1007/s11802-020-4435-z;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   PoBh
AC   CVCL_A2FC
SY   Paralichthys olivaceus Brain hypothalamus
DR   Wikidata; Q105510602
RX   DOI=10.1007/s11802-020-4435-z;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   POC
AC   CVCL_0B89
DR   Wikidata; Q54947695
RX   PubMed=3034934;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   POCO
AC   CVCL_WH54
DR   Wikidata; Q98128654
RX   PubMed=30268330;
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   PoCo83-3
AC   CVCL_B5ZN
DR   Wikidata; Q112129533
RX   PubMed=28052271;
CC   Doubling time: 20.3 hours (Note=At 18th passage), 20.47 hours (Note=At 34th passage) (PubMed=28052271).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   3W
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PODO/SVTERT152
AC   CVCL_B5ST
DR   Evercyte; CLHT-033-0152
DR   Wikidata; Q112129534
CC   Doubling time: 24-32 hours (Evercyte=CLHT-033-0152).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte; CL=CL_0000653.
ST   Source(s): Evercyte=CLHT-033-0152
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   PODO/TERT252
AC   CVCL_B5TG
DR   Wikidata; Q112129535
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Cell line available upon request to Evercyte.
CC   Miscellaneous: Cell line information from personal communication of Evercyte.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Podocyte; CL=CL_0000653.
ST   Source(s): Evercyte
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D5S818: 9,10
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <30Y
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   PODO/TERT255
AC   CVCL_B5TH
DR   Wikidata; Q112129536
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: Cell line available upon request to Evercyte.
CC   Miscellaneous: Cell line information from personal communication of Evercyte.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Podocyte; CL=CL_0000653.
ST   Source(s): Evercyte
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   PODO/TERT256
AC   CVCL_JL76
DR   Evercyte; CHT-033-0256
DR   Wikidata; Q54947696
CC   Doubling time: 36-48 hours (Evercyte=CHT-033-0256).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Podocyte; CL=CL_0000653.
ST   Source(s): Evercyte=CHT-033-0256
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   POE
AC   CVCL_EJ01
SY   Poe
DR   cancercelllines; CVCL_EJ01
DR   Cosmic; 2250466
DR   GEO; GSM5359682
DR   GEO; GSM5359683
DR   GEO; GSM5359684
DR   GEO; GSM5359685
DR   GEO; GSM5359686
DR   GEO; GSM5359687
DR   GEO; GSM5362938
DR   GEO; GSM5362939
DR   GEO; GSM5362940
DR   GEO; GSM5362941
DR   GEO; GSM5362942
DR   GEO; GSM5362943
DR   GEO; GSM5363986
DR   GEO; GSM5363987
DR   GEO; GSM5363988
DR   GEO; GSM5363989
DR   GEO; GSM5363990
DR   Wikidata; Q54947697
RX   DOI=10.5282/edoc.27750;
RX   PubMed=11423975;
RX   PubMed=25223734;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   From: Delattre, Olivier; Institut Curie; Paris; France.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=11423975; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Unspecified (PubMed=25223734).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   POE9n
AC   CVCL_L237
DR   Wikidata; Q54947698
RX   PubMed=10648628;
RX   PubMed=12077343;
RX   PubMed=22546478;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at ~85 PDL (PubMed=10648628).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=12077343).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C129863; Oral epithelial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   POE9n/TERT
AC   CVCL_L238
SY   POE9n Tert; POE9n TERT
DR   GEO; GSM1431129
DR   Wikidata; Q54947699
RX   PubMed=10648628;
RX   PubMed=25169794;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C129863; Oral epithelial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L237 ! POE9n
SX   Male
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   PoEFCI
AC   CVCL_C6WL
DR   Wikidata; Q117704784
RX   PubMed=36584834;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PoEFCII
AC   CVCL_C6WM
DR   Wikidata; Q117704786
RX   PubMed=36584834;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PoEFCIII
AC   CVCL_C6WN
DR   Wikidata; Q117704787
RX   PubMed=36584834;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PoEFCIV
AC   CVCL_C6WP
DR   Wikidata; Q117704788
RX   PubMed=36584834;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PoEKC
AC   CVCL_A4ZV
SY   Paralichthys olivaceus Embryo Kupffer vesicle stage Cell line
DR   Wikidata; Q107116672
RX   DOI=10.4194/1303-2712-v21_4_01;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Kupffer vesicle stage embryo
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 5
//
ID   PoF7
AC   CVCL_C3PJ
DR   CCRID; 4201PAT-CCTCC02093
DR   Wikidata; Q116050126
RX   Patent=CN115057926A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2022106.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Diaporthe eres.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   POG-1382.2
AC   CVCL_9513
DR   Wikidata; Q54947702
RX   DOI=10.1007/0-306-46872-7_2;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y5M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   POG-1643
AC   CVCL_9514
DR   Wikidata; Q54947703
RX   DOI=10.1007/0-306-46872-7_2;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   POG-1691
AC   CVCL_9515
DR   Wikidata; Q54947704
RX   DOI=10.1007/0-306-46872-7_2;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   POG-1771
AC   CVCL_9516
DR   Wikidata; Q54947705
RX   DOI=10.1007/0-306-46872-7_2;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y10M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   POGRS-1
AC   CVCL_7111
AS   CVCL_6710
SY   PO-GRS1; P0-GRS1; POGRS1
DR   BTO; BTO_0002287
DR   Wikidata; Q54947706
RX   PubMed=2170421;
RX   PubMed=2171916;
RX   PubMed=8961254;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   25D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   POGS-5
AC   CVCL_7112
SY   PO-GS5; POGS5
DR   BTO; BTO_0002286
DR   Wikidata; Q54947707
RX   PubMed=2171916;
RX   PubMed=8961254;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   25D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   PoIEC
AC   CVCL_E7B3
SY   Paralichthys olivaceus Intestinal Epithelial Cell
RX   DOI=10.1016/j.aquaculture.2023.740325;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   POLH KO
AC   CVCL_J376
SY   Nalm-6-MSH+/TK+/-/POLH-/-
DR   cancercelllines; CVCL_J376
DR   JCRB; JCRB1477
DR   Wikidata; Q54947708
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9181; POLH.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1477
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   POLH KO MSH-
AC   CVCL_M247
SY   Nalm-6-MSH-/TK+/-/POLH-/-
DR   cancercelllines; CVCL_M247
DR   JCRB; JCRB1482
DR   Wikidata; Q54947709
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9181; POLH.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1482
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD96 ! Nalm-6-TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   POLK CD
AC   CVCL_JH01
SY   Nalm-6-MSH+/TK+/-/POLK D198A/D199A
DR   cancercelllines; CVCL_JH01
DR   JCRB; JCRB1524
DR   Wikidata; Q54947710
RX   PubMed=24461735;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9183; POLK; Simple_edited; p.Asp198Ala; Zygosity=Unspecified; Note=By homologous recombination. Loss of activity (PubMed=24461735).
CC   Sequence variation: Mutation; HGNC; HGNC:9183; POLK; Simple_edited; p.Asp199Ala; Zygosity=Unspecified; Note=By homologous recombination. Loss of activity (PubMed=24461735).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1524
ST   Amelogenin: X,Y
ST   CSF1PO: 15
ST   D13S317: 10,14
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 17
//
ID   POLK CD MSH-
AC   CVCL_JH02
SY   Nalm-6-MSH-/TK+/-/POLK D198A,D199A
DR   cancercelllines; CVCL_JH02
DR   JCRB; JCRB1523
DR   Wikidata; Q54947711
RX   PubMed=24461735;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9183; POLK; Simple_edited; p.Asp198Ala; Zygosity=Unspecified; Note=By homologous recombination. Loss of activity (PubMed=24461735).
CC   Sequence variation: Mutation; HGNC; HGNC:9183; POLK; Simple_edited; p.Asp199Ala; Zygosity=Unspecified; Note=By homologous recombination. Loss of activity (PubMed=24461735).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1523
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,14
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD96 ! Nalm-6-TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   POLK F171A MSH-
AC   CVCL_4W71
SY   Nalm-6-MSH-/TK+/-/POLK-/F171A
DR   cancercelllines; CVCL_4W71
DR   JCRB; JCRB1517
DR   Wikidata; Q54947712
RX   PubMed=24461735;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK (Note=1 of 2 alleles).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9183; POLK; Simple_edited; p.Phe171Ala; Zygosity=Unspecified; Note=By homologous recombination (PubMed=24461735).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1517
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD96 ! Nalm-6-TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   POLK KO
AC   CVCL_JH05
SY   Nalm-6-MSH+/TK+/-/POLK-/-
DR   cancercelllines; CVCL_JH05
DR   JCRB; JCRB1513
DR   Wikidata; Q54947713
RX   PubMed=24461735;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1513
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   POLK KO hetero MSH-
AC   CVCL_4W72
SY   Nalm-6-MSH-/TK+/-/POLK+/-
DR   cancercelllines; CVCL_4W72
DR   JCRB; JCRB1518
DR   Wikidata; Q54947715
RX   PubMed=24461735;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK (Note=1 of 2 alleles).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1518
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD96 ! Nalm-6-TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   POLK KO homo MSH-
AC   CVCL_4W73
SY   Nalm-6-MSH-/TK+/-/POLK-/-
DR   cancercelllines; CVCL_4W73
DR   JCRB; JCRB1514
DR   Wikidata; Q54947730
RX   PubMed=24461735;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1514
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD96 ! Nalm-6-TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   POLK KO-CD comp
AC   CVCL_JH00
SY   Nalm-6-MSH+/TK+/-/POLK-/- complemented POLK D198A/D199A
DR   cancercelllines; CVCL_JH00
DR   JCRB; JCRB1526
DR   Wikidata; Q54947731
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9183; POLK (Note=With p.Asp198Ala and p.Asp199Ala).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1526
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   POLK KO-comp
AC   CVCL_JH07
SY   Nalm-6-MSH+/TK+/-/POLK-/- complemented POLK
DR   cancercelllines; CVCL_JH07
DR   JCRB; JCRB1506
DR   Wikidata; Q54947732
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9183; POLK.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1506
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   POLK KO-POLH-/-
AC   CVCL_JG97
SY   Nalm-6-MSH+/TK+/-/POLH-/-/POLK-/-
DR   cancercelllines; CVCL_JG97
DR   JCRB; JCRB1530
DR   Wikidata; Q54947733
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9181; POLH.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1530
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 15
//
ID   POLK SG MSH-
AC   CVCL_JH03
SY   Nalm-6-MSH-/TK+/-/POLK-/Y112A
DR   cancercelllines; CVCL_JH03
DR   JCRB; JCRB1519
DR   Wikidata; Q54947734
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK (Note=1 of 2 alleles).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9183; POLK; Simple_edited; p.Tyr112Ala; Zygosity=Unspecified; Note=By homologous recombination (JCRB=JCRB1519).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1519
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD96 ! Nalm-6-TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 14
//
ID   POLZ CD MSH-
AC   CVCL_JH08
SY   Nalm-6-REV3L D2781A,D2783A
DR   cancercelllines; CVCL_JH08
DR   JCRB; JCRB1498
DR   Wikidata; Q54947735
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Asp2781Ala; Zygosity=Unspecified; Note=By homologous recombination. Loss of activity (JCRB=JCRB1498).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Asp2783Ala; Zygosity=Unspecified; Note=By homologous recombination. Loss of activity (JCRB=JCRB1498).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1498
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 17
//
ID   POLZ D2781N
AC   CVCL_JH09
SY   Nalm-6-MSH+/TK+/-/REV3L D2781N
DR   cancercelllines; CVCL_JH09
DR   JCRB; JCRB1489
DR   Wikidata; Q54947736
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Asp2781Asn; Zygosity=Unspecified; Note=By homologous recombination (JCRB=JCRB1489).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1489
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   POLZ KO
AC   CVCL_M248
SY   Nalm-6-MSH+/REV3L-/-
DR   cancercelllines; CVCL_M248
DR   JCRB; JCRB1488
DR   Wikidata; Q54947737
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9968; REV3L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1488
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J365 ! Nalm-6-MSH+
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   POLZ KO MSH-
AC   CVCL_M249
SY   Nalm-6-REV3L-/-
DR   cancercelllines; CVCL_M249
DR   JCRB; JCRB1494
DR   Wikidata; Q54947738
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9968; REV3L.
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1494
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   POLZ L2618F
AC   CVCL_JH04
SY   Nalm-6-MSH+/TK+/-REV3L L2618F
DR   cancercelllines; CVCL_JH04
DR   JCRB; JCRB1515
DR   Wikidata; Q54947739
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Leu2618Phe; Zygosity=Unspecified; Note=By homologous recombination (JCRB=JCRB1515).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1515
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   POLZ L2618M
AC   CVCL_M250
SY   Nalm-6-MSH+/TK+/-/REV3L L2618M
DR   cancercelllines; CVCL_M250
DR   JCRB; JCRB1490
DR   Wikidata; Q54947740
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Leu2618Met; Zygosity=Unspecified; Note=By homologous recombination (JCRB=JCRB1490).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1490
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   POLZ Y2779F
AC   CVCL_JH06
SY   Nalm-6-MSH+/TK+/-/REV3L Y2779F
DR   cancercelllines; CVCL_JH06
DR   JCRB; JCRB1510
DR   Wikidata; Q54947741
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Tyr2779Phe; Zygosity=Unspecified; Note=By homologous recombination (JCRB=JCRB1510).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1510
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   POLZ Y2779F-POLH+/-
AC   CVCL_JG99
SY   Nalm-6-MSH+/TK+/-/POLH+/-/REV3L Y2779F
DR   cancercelllines; CVCL_JG99
DR   JCRB; JCRB1527
DR   Wikidata; Q54947742
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9181; POLH (Note=1 of 2 alleles).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Tyr2779Phe; Zygosity=Unspecified; Note=By homologous recombination (JCRB=JCRB1527).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1527
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   POLZ Y2779F-POLK+/-
AC   CVCL_JG98
SY   Nalm-6-MSH+/TK+/-/POLK+/-/REV3L Y2779F
DR   cancercelllines; CVCL_JG98
DR   JCRB; JCRB1528
DR   Wikidata; Q54947743
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9183; POLK (Note=1 of 2 alleles).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11830; TK1 (Note=1 of 2 alleles).
CC   Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9968; REV3L; Simple_edited; p.Tyr2779Phe; Zygosity=Unspecified; Note=By homologous recombination (JCRB=JCRB1528).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7325; MSH2 (Note=Exons 9 to 16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1528
ST   Amelogenin: X,Y
ST   CSF1PO: 14
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD71 ! Nalm-6-MSH+/TK+/-
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 16
//
ID   Pom2
AC   CVCL_6C24
SY   PoM2
DR   Wikidata; Q54947744
RX   PubMed=20444515;
RX   PubMed=28239090;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   PomD-iPSC A10
AC   CVCL_IM67
DR   GEO; GSM674579
DR   Wikidata; Q54947745
RX   PubMed=21926084;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asp645Glu (c.1935C>A); ClinVar=VCV000004029; Zygosity=Homozygous (PubMed=21926084).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IM68 ! PomD-iPSC A17
OI   CVCL_IM69 ! PomD-iPSC A25
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 13
//
ID   PomD-iPSC A17
AC   CVCL_IM68
DR   GEO; GSM674580
DR   Wikidata; Q54947747
RX   PubMed=21926084;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asp645Glu (c.1935C>A); ClinVar=VCV000004029; Zygosity=Homozygous (PubMed=21926084).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IM67 ! PomD-iPSC A10
OI   CVCL_IM69 ! PomD-iPSC A25
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 13
//
ID   PomD-iPSC A25
AC   CVCL_IM69
DR   GEO; GSM674582
DR   Wikidata; Q54947748
RX   PubMed=21926084;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asp645Glu (c.1935C>A); ClinVar=VCV000004029; Zygosity=Homozygous (PubMed=21926084).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IM67 ! PomD-iPSC A10
OI   CVCL_IM68 ! PomD-iPSC A17
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   PomD-iPSC B03
AC   CVCL_IM70
DR   GEO; GSM674581
DR   Wikidata; Q54947749
RX   PubMed=21926084;
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Asp645Glu (c.1935C>A); ClinVar=VCV000004029; Zygosity=Heterozygous (PubMed=21926084).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; c.2040+1G>T; ClinVar=VCV000370998; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=21926084).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   Porco Clawn iPSC
AC   CVCL_5G27
DR   Wikidata; Q54947751
RX   PubMed=22889279;
RX   PubMed=23913699;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Clawn miniature; VBO=VBO_0017516.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   35FD
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 6
//
ID   Porco Rosso-4 iPSC
AC   CVCL_5G28
DR   Wikidata; Q54947752
RX   PubMed=22889279;
RX   PubMed=23913699;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: [(Landrace x Large White) x Duroc] humanized Kusabira-Orange transgenic.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   35FD
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Porco Rosso-6 iPSC
AC   CVCL_5G29
DR   Wikidata; Q54947753
RX   PubMed=22889279;
RX   PubMed=23913699;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: [(Landrace x Large White) x Duroc] humanized Kusabira-Orange transgenic.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   35FD
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Porco Rosso-622-14 iPSC
AC   CVCL_5G30
DR   Wikidata; Q54947754
RX   PubMed=23913699;
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: [(Landrace x Large White) x Duroc] humanized Kusabira-Orange transgenic.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   pORF121-mAb-3D9
AC   CVCL_B5E6
DR   Wikidata; Q110433140
RX   PubMed=34871462;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; K7PC12; Cyprinid herpesvirus 2 ORF121.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   Porthos
AC   CVCL_2695
SY   PORTHOS; PORTHOS-6 H; PORTHOS-6H; PORcine THyroid 'O' Serum
DR   CLO; CLO_0008478
DR   CLDB; cl3929
DR   ECACC; 93122323
DR   Wikidata; Q54947755
RX   CelloPub=CLPUB00572;
RX   PubMed=1726925;
RX   PubMed=8514246;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   PORTU8010 fibroblast
AC   CVCL_A9F9
SY   R133L
DR   Wikidata; Q102114781
RX   PubMed=12927431;
RX   PubMed=23847654;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Leu (c.398G>T); ClinVar=VCV000014488; Zygosity=Heterozygous; Note=De novo mutation (PubMed=12927431; PubMed=23847654).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9G1 ! PORTU8010 LCL
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   PORTU8010 fibroblast hTERT
AC   CVCL_A9G0
SY   R133L hTERT
DR   Wikidata; Q102114782
RX   PubMed=23847654;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector containing a LTR-loxP-hTERT-SV40p-hisD-PuroR-LTR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Leu (c.398G>T); ClinVar=VCV000014488; Zygosity=Heterozygous; Note=De novo mutation (PubMed=23847654).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9F9 ! PORTU8010 fibroblast
SX   Female
AG   18Y
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   PORTU8010 LCL
AC   CVCL_A9G1
DR   Wikidata; Q102114783
RX   PubMed=12927431;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Leu (c.398G>T); ClinVar=VCV000014488; Zygosity=Heterozygous; Note=De novo mutation (PubMed=12927431).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_79474; Atypical Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9F9 ! PORTU8010 fibroblast
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   POS [Dog osteosarcoma]
AC   CVCL_L413
DR   BTO; BTO_0005399
DR   PRIDE; PXD008986
DR   Wikidata; Q54947757
RX   PubMed=7696411;
RX   PubMed=23758893;
RX   PubMed=28283079;
RX   PubMed=31959767;
RX   PubMed=33446089;
CC   Doubling time: ~33 hours (PubMed=7696411).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   1-2Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   POS [Human B-cell IHW]
AC   CVCL_F579
SY   TER253
DR   IPD-IMGT/HLA; 11273
DR   Wikidata; Q54947758
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*02:01,03:01; DQB1*05:01,05:03; DRB1*01:01,14:01; DRB3*02:03 (IPD-IMGT/HLA=11273).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   POS-1
AC   CVCL_0J71
DR   Wikidata; Q54947759
RX   PubMed=12406567;
CC   From: Kanagawa Cancer Center; Kanagawa; Japan.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: C3H.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 5
//
ID   POSC
AC   CVCL_YL75
SY   Paralichthys Olivaceus Sertoli Cells
DR   Wikidata; Q98128655
RX   DOI=10.1007/s00343-016-5091-4;
CC   Group: Fish cell line.
CC   Doubling time: 30.1 +- 2.8 hours (DOI=10.1007/s00343-016-5091-4).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   POT1a F/F
AC   CVCL_JM06
DR   ATCC; CRL-3321
DR   Wikidata; Q54947760
RX   PubMed=16839877;
CC   Characteristics: Embryonic fibroblasts that have loxP sites on both sides of the 3rd coding exon of mouse Pot1a gene. Pot1a knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3321).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   POT1a F/F POT1b F/F (#20431-5)
AC   CVCL_UJ01
SY   POT1a F/F POT1b F/F(#20431-5)
DR   ATCC; CRL-3323
DR   Wikidata; Q98128656
RX   PubMed=16839877;
CC   Characteristics: Embryonic fibroblasts that have loxP sites on both sides of the 3rd coding exon of mouse Pot1a and Pot1b genes. Pot1a anb Pot1b knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3323).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129P2/Ola x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   POT1b F/- (#12436-2)
AC   CVCL_UJ00
DR   ATCC; CRL-3322
DR   Wikidata; Q98128657
RX   PubMed=16839877;
CC   Characteristics: Embryonic fibroblasts that have loxP sites on both sides of the 3rd coding exon of one allele of mouse Pot1b. The second allele is deleted. Pot1b knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3322).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: 129P2/Ola x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 5
//
ID   Potelligent CHOK1SV
AC   CVCL_DR96
DR   Wikidata; Q54947762
WW   Provider; Lonza; -; https://www.lonza.com/news/2018-03-22-14-00
CC   Group: Serum/protein free medium cell line.
CC   Knockout cell: Method=ZFN; UniProtKB; G3HCE4; Fut8.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DR95 ! CHOK1SV
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   POVD
AC   CVCL_Y194
DR   cancercelllines; CVCL_Y194
DR   ChEMBL-Cells; CHEMBL3833601
DR   Cosmic; 1434970
DR   PubChem_Cell_line; CVCL_Y194
DR   Wikidata; Q54947764
RX   PubMed=7506562;
RX   PubMed=9134423;
RX   PubMed=9274917;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Unspecified (PubMed=9274917).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 10
//
ID   Powder
AC   CVCL_B6PU
DR   cancercelllines; CVCL_B6PU
DR   Rockland; CB-0111
DR   Wikidata; Q112129537
WW   Info; Cellaria; -; https://web.archive.org/web/20230325110858/https://cellariainc.com/product/powder-cell-model/
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11119; SMO; Simple; p.Leu23dup (c.49CTG[8]); ClinVar=VCV000769335; Zygosity=Heterozygous (Cellaria).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cellaria
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14,19
ST   D21S11: 28,31.2
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 12,13
ST   Penta E: 13,17
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   PP-9
AC   CVCL_Z843
SY   PP9; Phlebotomus Papatasi-9
DR   PRIDE; PXD002115
DR   Wikidata; Q54947765
RX   PubMed=11126533;
RX   PubMed=23773405;
RX   PubMed=26307495;
CC   Group: Insect cell line.
CC   Omics: Proteomics.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29031; ! Phlebotomus papatasi (Sandfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   PP1084
AC   CVCL_5J49
DR   cancercelllines; CVCL_5J49
DR   Wikidata; Q54947766
RX   PubMed=8344493;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8344493).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   PP109
AC   CVCL_C233
SY   PP 109; pp109
DR   cancercelllines; CVCL_C233
DR   Wikidata; Q54947768
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=19002021;
CC   Doubling time: 28.46 +- 5.49 hours (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Phe (c.514G>T); ClinVar=VCV000428909; Zygosity=Unspecified (PubMed=19002021).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   PP117
AC   CVCL_C234
SY   PP 117; pp117
DR   cancercelllines; CVCL_C234
DR   Wikidata; Q54947769
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=19002021;
CC   Doubling time: 32.67 +- 0.71 hours (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leu (c.569C>T); ClinVar=VCV000418517; Zygosity=Unspecified (PubMed=19002021).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   PP161
AC   CVCL_C235
SY   PP 161; pp161
DR   cancercelllines; CVCL_C235
DR   Wikidata; Q54947770
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=19002021;
CC   Doubling time: 31.37 +- 11.49 hours (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Ter; Zygosity=Homozygous (PubMed=19002021).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   PP78
AC   CVCL_C236
SY   PP 78; pp78
DR   cancercelllines; CVCL_C236
DR   Wikidata; Q54947771
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=19002021;
CC   Doubling time: 27.4 +- 2.49 hours (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (PubMed=19002021).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281_Arg282delinsGlu; Zygosity=Unspecified (PubMed=19002021).
DI   NCIt; C5721; Pancreatic adenosquamous carcinoma
DI   ORDO; Orphanet_424039; Squamous cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   PP984
AC   CVCL_F007
DR   cancercelllines; CVCL_F007
DR   Cosmic; 931132
DR   IARC_TP53; 179
DR   Wikidata; Q54947772
RX   PubMed=2052620;
RX   PubMed=9473234;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=2052620).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   PPA00322IN
AC   CVCL_E185
DR   Wikidata; Q54947773
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PPA00378IN
AC   CVCL_E186
DR   Wikidata; Q54947774
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PPAC1-iPSCs
AC   CVCL_D1GV
SY   PPAC1
DR   GEO; GSM7192020
DR   GEO; GSM7192021
DR   GEO; GSM7192022
DR   GEO; GSM7192030
DR   Wikidata; Q127383131
RX   PubMed=37679035;
CC   Sequence variation: Mutation; HGNC; HGNC:12771; CCN6; Simple; p.Cys52Ter (c.156C>A); ClinVar=VCV000006381; Zygosity=Homozygous (PubMed=37679035).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202612; Progressive pseudorheumatoid dysplasia
DI   ORDO; Orphanet_1159; Progressive pseudorheumatoid arthropathy of childhood
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PPAC1-C-iPSCs
AC   CVCL_D1GW
SY   PPAC1-C; PPAC1C
DR   GEO; GSM7192017
DR   GEO; GSM7192018
DR   GEO; GSM7192019
DR   GEO; GSM7192031
DR   Wikidata; Q127383132
RX   PubMed=37679035;
CC   Sequence variation: Mutation; HGNC; HGNC:12771; CCN6; Simple; p.Cys52Ter (c.156C>A); ClinVar=VCV000006381; Zygosity=Heterozygous (PubMed=37679035).
CC   Sequence variation: Mutation; HGNC; HGNC:12771; CCN6; Simple_corrected; p.Cys52Ter (c.156C>A); ClinVar=VCV000006381; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37679035).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202612; Progressive pseudorheumatoid dysplasia
DI   ORDO; Orphanet_1159; Progressive pseudorheumatoid arthropathy of childhood
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D1GV ! PPAC1-iPSCs
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PPAC4-iPSCs
AC   CVCL_D1GX
SY   PPAC4
DR   GEO; GSM7192023
DR   GEO; GSM7192024
DR   GEO; GSM7192025
DR   Wikidata; Q127383133
RX   PubMed=37679035;
CC   Sequence variation: Mutation; HGNC; HGNC:12771; CCN6; Simple; c.49-763G>T (IVS1-763G>T); ClinVar=VCV002136453; Zygosity=Heterozygous (PubMed=37679035).
CC   Sequence variation: Mutation; HGNC; HGNC:12771; CCN6; Simple; p.Cys52Ter (c.156C>A); ClinVar=VCV000006381; Zygosity=Heterozygous (PubMed=37679035).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202612; Progressive pseudorheumatoid dysplasia
DI   ORDO; Orphanet_1159; Progressive pseudorheumatoid arthropathy of childhood
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   PPAP-10
AC   CVCL_C1LV
DR   Wikidata; Q114312681
RX   PubMed=16356832;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: K5-HPV16-E6/E7-2303 transgenic.
DI   NCIt; C188988; Mouse lung small cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   PPAP-9
AC   CVCL_C1LW
DR   Wikidata; Q114312682
RX   PubMed=16356832;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: K5-HPV16-E6/E7-2303 transgenic.
DI   NCIt; C188988; Mouse lung small cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   PPC-1
AC   CVCL_4778
SY   Primary Prostate Carcinoma-1; Specimen P-3
DR   BTO; BTO_0001062
DR   ATCC; HTB-190
DR   BioSample; SAMN03151895
DR   cancercelllines; CVCL_4778
DR   ChEMBL-Cells; CHEMBL3307780
DR   ChEMBL-Targets; CHEMBL1626502
DR   Cosmic; 948074
DR   GEO; GSM91929
DR   Progenetix; CVCL_4778
DR   PubChem_Cell_line; CVCL_4778
DR   Wikidata; Q54947777
RX   CelloPub=CLPUB00698;
RX   PubMed=2016798;
RX   PubMed=2583869;
RX   PubMed=8616865;
RX   PubMed=11304728;
RX   PubMed=12725112;
RX   PubMed=15486987;
RX   PubMed=20143388;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160321231613/http://capcelllines.ca/details.asp?id=171
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=11304728; PubMed=20143388; CelloPub=CLPUB00698). Originally thought to originate from a 67 year old male patient with prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00153.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (PubMed=11304728).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: ATCC; HTB-190; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=HTB-190; PubMed=11304728
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 29,31.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   PPIA-/- Jurkat
AC   CVCL_1H23
SY   Jurkat CypA -/-
DR   BEI_Resources; ARP-10095
DR   cancercelllines; CVCL_1H23
DR   Wikidata; Q54947786
RX   PubMed=11250896;
CC   Population: Caucasian.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:9253; PPIA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   PPK-66B
AC   CVCL_A5XU
SY   PPK-66b; CPK-66b
DR   Wikidata; Q107116673
RX   DOI=10.3103/S1068367415020056;
RX   PubMed=9081441;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   PPL/LULS49
AC   CVCL_C1YM
DR   Wikidata; Q114312683
RX   PubMed=34680640;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Characteristics: Cured of Wolbachia strain wPap infection by tetracycline.
CC   Breed/subspecies: Strain Turkey.
OX   NCBI_TaxID=29031; ! Phlebotomus papatasi (Sandfly)
HI   CVCL_C1YL ! PPL/LULS49/wPap
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   PPL/LULS49/wPap
AC   CVCL_C1YL
DR   Wikidata; Q114312684
RX   PubMed=34680640;
CC   Group: Insect cell line.
CC   Characteristics: Infected by the intracellular symbiont Wolbachia wPap.
CC   Breed/subspecies: Strain Turkey.
OX   NCBI_TaxID=29031; ! Phlebotomus papatasi (Sandfly)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   PPM-Mill
AC   CVCL_E110
SY   PPM Mill; PPMMill; Mill
DR   Wikidata; Q54947788
RX   PubMed=21454801;
RX   PubMed=22893632;
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   PPM-Phi
AC   CVCL_V417
SY   Phi
DR   Wikidata; Q54947789
RX   PubMed=22552293;
RX   PubMed=22893632;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   PPMI.I.1001.1
AC   CVCL_D5LK
SY   PPMI3186; PPMI_3186; CDIi027-A; FCDI_11308
DR   BioSamples; SAMEA115473788
DR   hPSCreg; CDIi027-A
DR   Wikidata; Q127383134
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3186 and PPMI_3186 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LL ! PPMI.I.1001.2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1001.2
AC   CVCL_D5LL
SY   PPMI3186; PPMI_3186; CDIi027-A; FCDI_11308
DR   BioSamples; SAMEA115473788
DR   hPSCreg; CDIi027-A
DR   Wikidata; Q127383135
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3186 and PPMI_3186 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LK ! PPMI.I.1001.1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1002.1
AC   CVCL_D5LM
SY   PPMI3220; PPMI_3220; CDIi040-A; FCDI_11327
DR   BioSamples; SAMEA115473814
DR   hPSCreg; CDIi040-A
DR   Wikidata; Q127383136
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3220 and PPMI_3220 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LN ! PPMI.I.1002.2
OI   CVCL_D5LP ! PPMI.I.1002.3
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1002.2
AC   CVCL_D5LN
SY   PPMI3220; PPMI_3220; CDIi040-A; FCDI_11327
DR   BioSamples; SAMEA115473814
DR   hPSCreg; CDIi040-A
DR   Wikidata; Q127383137
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3220 and PPMI_3220 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LM ! PPMI.I.1002.1
OI   CVCL_D5LP ! PPMI.I.1002.3
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1002.3
AC   CVCL_D5LP
SY   PPMI3220; PPMI_3220; CDIi040-A; FCDI_11327
DR   BioSamples; SAMEA115473814
DR   hPSCreg; CDIi040-A
DR   Wikidata; Q127383138
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3220 and PPMI_3220 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LM ! PPMI.I.1002.1
OI   CVCL_D5LN ! PPMI.I.1002.2
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1003.1
AC   CVCL_D5LQ
SY   PPMI3234; PPMI_3234; CDIi018-A; FCDI_11298
DR   BioSamples; SAMEA115473770
DR   hPSCreg; CDIi018-A
DR   Wikidata; Q127383139
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3234 and PPMI_3234 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LR ! PPMI.I.1003.2
OI   CVCL_D5LS ! PPMI.I.1003.3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1003.2
AC   CVCL_D5LR
SY   PPMI3234; PPMI_3234; CDIi018-A; FCDI_11298
DR   BioSamples; SAMEA115473770
DR   hPSCreg; CDIi018-A
DR   Wikidata; Q127383140
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3234 and PPMI_3234 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LQ ! PPMI.I.1003.1
OI   CVCL_D5LS ! PPMI.I.1003.3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1003.3
AC   CVCL_D5LS
SY   PPMI3234; PPMI_3234; CDIi018-A; FCDI_11298
DR   BioSamples; SAMEA115473770
DR   hPSCreg; CDIi018-A
DR   Wikidata; Q127383141
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3234 and PPMI_3234 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LQ ! PPMI.I.1003.1
OI   CVCL_D5LR ! PPMI.I.1003.2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1004.1
AC   CVCL_D5LT
SY   PPMI3404
DR   Wikidata; Q127383142
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3404 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LU ! PPMI.I.1004.2
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1004.2
AC   CVCL_D5LU
SY   PPMI3404
DR   Wikidata; Q127383143
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3404 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LT ! PPMI.I.1004.1
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1005.1
AC   CVCL_D5LV
SY   PPMI3406
DR   Wikidata; Q127383144
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3406 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LW ! PPMI.I.1005.2
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1005.2
AC   CVCL_D5LW
SY   PPMI3406
DR   Wikidata; Q127383145
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3406 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LV ! PPMI.I.1005.1
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1006.1
AC   CVCL_D5LX
SY   PPMI3407
DR   Wikidata; Q127383146
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3407 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LY ! PPMI.I.1006.2
OI   CVCL_D5LZ ! PPMI.I.1006.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1006.2
AC   CVCL_D5LY
SY   PPMI3407
DR   Wikidata; Q127383149
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3407 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LX ! PPMI.I.1006.1
OI   CVCL_D5LZ ! PPMI.I.1006.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1006.3
AC   CVCL_D5LZ
SY   PPMI3407
DR   Wikidata; Q127383150
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3407 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5LX ! PPMI.I.1006.1
OI   CVCL_D5LY ! PPMI.I.1006.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1007.1
AC   CVCL_D5M0
SY   PPMI3409; PPMI_3409; CDIi013-A; FCDI_11287
DR   BioSamples; SAMEA115473760
DR   hPSCreg; CDIi013-A
DR   Wikidata; Q127383151
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3409 and PPMI_3409 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M1 ! PPMI.I.1007.2
OI   CVCL_D5M2 ! PPMI.I.1007.3
OI   CVCL_D5M3 ! PPMI.I.1007.4
OI   CVCL_D5M4 ! PPMI.I.1007.5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1007.2
AC   CVCL_D5M1
SY   PPMI3409; PPMI_3409; CDIi013-A; FCDI_11287
DR   BioSamples; SAMEA115473760
DR   hPSCreg; CDIi013-A
DR   Wikidata; Q127383152
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3409 and PPMI_3409 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M0 ! PPMI.I.1007.1
OI   CVCL_D5M2 ! PPMI.I.1007.3
OI   CVCL_D5M3 ! PPMI.I.1007.4
OI   CVCL_D5M4 ! PPMI.I.1007.5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1007.3
AC   CVCL_D5M2
SY   PPMI3409; PPMI_3409; CDIi013-A; FCDI_11287
DR   BioSamples; SAMEA115473760
DR   hPSCreg; CDIi013-A
DR   Wikidata; Q127383153
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3409 and PPMI_3409 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M0 ! PPMI.I.1007.1
OI   CVCL_D5M1 ! PPMI.I.1007.2
OI   CVCL_D5M3 ! PPMI.I.1007.4
OI   CVCL_D5M4 ! PPMI.I.1007.5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1007.4
AC   CVCL_D5M3
SY   PPMI3409
DR   Wikidata; Q127383154
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3409 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M0 ! PPMI.I.1007.1
OI   CVCL_D5M1 ! PPMI.I.1007.2
OI   CVCL_D5M2 ! PPMI.I.1007.3
OI   CVCL_D5M4 ! PPMI.I.1007.5
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1007.5
AC   CVCL_D5M4
SY   PPMI3409
DR   Wikidata; Q127383155
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3409 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M0 ! PPMI.I.1007.1
OI   CVCL_D5M1 ! PPMI.I.1007.2
OI   CVCL_D5M2 ! PPMI.I.1007.3
OI   CVCL_D5M3 ! PPMI.I.1007.4
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1008.1
AC   CVCL_D5M5
SY   PPMI3411; PPMI_3411; CDIi016-A; FCDI_11295
DR   BioSamples; SAMEA115473766
DR   hPSCreg; CDIi016-A
DR   Wikidata; Q127383156
RX   PubMed=34434090;
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3411 and PPMI_3411 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M6 ! PPMI.I.1008.2
OI   CVCL_D5M7 ! PPMI.I.1008.3
OI   CVCL_D5M8 ! PPMI.I.1008.4
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1008.2
AC   CVCL_D5M6
SY   PPMI3411; PPMI_3411; CDIi016-A; FCDI_11295
DR   BioSamples; SAMEA115473766
DR   hPSCreg; CDIi016-A
DR   Wikidata; Q127383157
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3411 and PPMI_3411 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M5 ! PPMI.I.1008.1
OI   CVCL_D5M7 ! PPMI.I.1008.3
OI   CVCL_D5M8 ! PPMI.I.1008.4
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1008.3
AC   CVCL_D5M7
SY   PPMI3411; PPMI_3411; CDIi016-A; FCDI_11295
DR   BioSamples; SAMEA115473766
DR   hPSCreg; CDIi016-A
DR   Wikidata; Q127383158
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3411 and PPMI_3411 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M5 ! PPMI.I.1008.1
OI   CVCL_D5M6 ! PPMI.I.1008.2
OI   CVCL_D5M8 ! PPMI.I.1008.4
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1008.4
AC   CVCL_D5M8
SY   PPMI3411
DR   Wikidata; Q127383159
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3411 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5M5 ! PPMI.I.1008.1
OI   CVCL_D5M6 ! PPMI.I.1008.2
OI   CVCL_D5M7 ! PPMI.I.1008.3
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1009.1
AC   CVCL_D5M9
SY   PPMI3415
DR   Wikidata; Q127383160
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1010.1
AC   CVCL_D5MA
SY   PPMI3419; PPMI_3419; CDIi015-A; FCDI_11294
DR   BioSamples; SAMEA115473764
DR   hPSCreg; CDIi015-A
DR   Wikidata; Q127383161
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3419 and PPMI_3419 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MB ! PPMI.I.1010.2
OI   CVCL_D5MC ! PPMI.I.1010.3
OI   CVCL_D5MD ! PPMI.I.1010.4
OI   CVCL_D5ME ! PPMI.I.1010.5
OI   CVCL_D5MF ! PPMI.I.1010.6
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1010.2
AC   CVCL_D5MB
SY   PPMI3419; PPMI_3419; CDIi015-A; FCDI_11294
DR   BioSamples; SAMEA115473764
DR   hPSCreg; CDIi015-A
DR   Wikidata; Q127383162
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3419 and PPMI_3419 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MA ! PPMI.I.1010.1
OI   CVCL_D5MC ! PPMI.I.1010.3
OI   CVCL_D5MD ! PPMI.I.1010.4
OI   CVCL_D5ME ! PPMI.I.1010.5
OI   CVCL_D5MF ! PPMI.I.1010.6
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1010.3
AC   CVCL_D5MC
SY   PPMI3419; PPMI_3419; CDIi015-A; FCDI_11294
DR   BioSamples; SAMEA115473764
DR   hPSCreg; CDIi015-A
DR   Wikidata; Q127383163
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3419 and PPMI_3419 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MA ! PPMI.I.1010.1
OI   CVCL_D5MB ! PPMI.I.1010.2
OI   CVCL_D5MD ! PPMI.I.1010.4
OI   CVCL_D5ME ! PPMI.I.1010.5
OI   CVCL_D5MF ! PPMI.I.1010.6
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1010.4
AC   CVCL_D5MD
SY   PPMI3419
DR   Wikidata; Q127383164
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3419 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MA ! PPMI.I.1010.1
OI   CVCL_D5MB ! PPMI.I.1010.2
OI   CVCL_D5MC ! PPMI.I.1010.3
OI   CVCL_D5ME ! PPMI.I.1010.5
OI   CVCL_D5MF ! PPMI.I.1010.6
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1010.5
AC   CVCL_D5ME
SY   PPMI3419
DR   Wikidata; Q127383165
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3419 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MA ! PPMI.I.1010.1
OI   CVCL_D5MB ! PPMI.I.1010.2
OI   CVCL_D5MC ! PPMI.I.1010.3
OI   CVCL_D5MD ! PPMI.I.1010.4
OI   CVCL_D5MF ! PPMI.I.1010.6
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1010.6
AC   CVCL_D5MF
SY   PPMI3419
DR   Wikidata; Q127383166
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3419 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MA ! PPMI.I.1010.1
OI   CVCL_D5MB ! PPMI.I.1010.2
OI   CVCL_D5MC ! PPMI.I.1010.3
OI   CVCL_D5MD ! PPMI.I.1010.4
OI   CVCL_D5ME ! PPMI.I.1010.5
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1011.1
AC   CVCL_D5MG
SY   PPMI3422; PPMI_3422; CDIi053-A; FCDI_11347
DR   BioSamples; SAMEA115473840
DR   hPSCreg; CDIi053-A
DR   Wikidata; Q127383167
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3422 and PPMI_3422 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MH ! PPMI.I.1011.2
OI   CVCL_D5MI ! PPMI.I.1011.3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1011.2
AC   CVCL_D5MH
SY   PPMI3422; PPMI_3422; CDIi053-A; FCDI_11347
DR   BioSamples; SAMEA115473840
DR   hPSCreg; CDIi053-A
DR   Wikidata; Q127383168
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3422 and PPMI_3422 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MG ! PPMI.I.1011.1
OI   CVCL_D5MI ! PPMI.I.1011.3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1011.3
AC   CVCL_D5MI
SY   PPMI3422; PPMI_3422; CDIi053-A; FCDI_11347
DR   BioSamples; SAMEA115473840
DR   hPSCreg; CDIi053-A
DR   Wikidata; Q127383169
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3422 and PPMI_3422 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MG ! PPMI.I.1011.1
OI   CVCL_D5MH ! PPMI.I.1011.2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1012.1
AC   CVCL_D5MJ
SY   PPMI3428
DR   Wikidata; Q127383170
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3428 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MK ! PPMI.I.1012.2
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1012.2
AC   CVCL_D5MK
SY   PPMI3428
DR   Wikidata; Q127383171
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3428 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MJ ! PPMI.I.1012.1
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1013.1
AC   CVCL_D5ML
SY   PPMI3429
DR   Wikidata; Q127383172
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3429 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MM ! PPMI.I.1013.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1013.2
AC   CVCL_D5MM
SY   PPMI3429
DR   Wikidata; Q127383173
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3429 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ML ! PPMI.I.1013.1
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1014.1
AC   CVCL_D5MN
SY   PPMI3430
DR   Wikidata; Q127383174
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3430 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MP ! PPMI.I.1014.2
OI   CVCL_D5MQ ! PPMI.I.1014.3
OI   CVCL_D5MR ! PPMI.I.1014.4
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1014.2
AC   CVCL_D5MP
SY   PPMI3430
DR   Wikidata; Q127383175
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3430 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MN ! PPMI.I.1014.1
OI   CVCL_D5MQ ! PPMI.I.1014.3
OI   CVCL_D5MR ! PPMI.I.1014.4
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1014.3
AC   CVCL_D5MQ
SY   PPMI3430
DR   Wikidata; Q127383176
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3430 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MN ! PPMI.I.1014.1
OI   CVCL_D5MP ! PPMI.I.1014.2
OI   CVCL_D5MR ! PPMI.I.1014.4
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1014.4
AC   CVCL_D5MR
SY   PPMI3430
DR   Wikidata; Q127383177
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3430 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MN ! PPMI.I.1014.1
OI   CVCL_D5MP ! PPMI.I.1014.2
OI   CVCL_D5MQ ! PPMI.I.1014.3
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1015.1
AC   CVCL_D5MS
SY   PPMI3431
DR   Wikidata; Q127383179
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3431 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MT ! PPMI.I.1015.2
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1015.2
AC   CVCL_D5MT
SY   PPMI3431
DR   Wikidata; Q127383180
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3431 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MS ! PPMI.I.1015.1
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1016.1
AC   CVCL_D5MU
SY   PPMI3433
DR   Wikidata; Q127383181
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3433 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MV ! PPMI.I.1016.2
SX   Female
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1016.2
AC   CVCL_D5MV
SY   PPMI3433
DR   Wikidata; Q127383182
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3433 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MU ! PPMI.I.1016.1
SX   Female
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1017.1
AC   CVCL_D5MW
SY   PPMI3434
DR   Wikidata; Q127383183
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3434 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MX ! PPMI.I.1017.2
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1017.2
AC   CVCL_D5MX
SY   PPMI3434
DR   Wikidata; Q127383184
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3434 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MW ! PPMI.I.1017.1
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1018.1
AC   CVCL_D5MY
SY   PPMI3435
DR   Wikidata; Q127383185
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3435 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MZ ! PPMI.I.1018.2
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1018.2
AC   CVCL_D5MZ
SY   PPMI3435
DR   Wikidata; Q127383186
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3435 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5MY ! PPMI.I.1018.1
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1019.1
AC   CVCL_D5N0
SY   PPMI3443
DR   Wikidata; Q127383187
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1020.1
AC   CVCL_D5N1
SY   PPMI3444
DR   Wikidata; Q127383188
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3444 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N2 ! PPMI.I.1020.2
OI   CVCL_D5N3 ! PPMI.I.1020.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1020.2
AC   CVCL_D5N2
SY   PPMI3444
DR   Wikidata; Q127383189
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3444 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N1 ! PPMI.I.1020.1
OI   CVCL_D5N3 ! PPMI.I.1020.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1020.3
AC   CVCL_D5N3
SY   PPMI3444
DR   Wikidata; Q127383190
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3444 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N1 ! PPMI.I.1020.1
OI   CVCL_D5N2 ! PPMI.I.1020.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1021.1
AC   CVCL_D5N4
SY   PPMI3445
DR   Wikidata; Q127383191
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3445 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N5 ! PPMI.I.1021.2
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1021.2
AC   CVCL_D5N5
SY   PPMI3445
DR   Wikidata; Q127383192
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3445 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N4 ! PPMI.I.1021.1
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1022.1
AC   CVCL_D5N6
SY   PPMI3446; PPMI_3446; CDIi017-A; FCDI_11296
DR   BioSamples; SAMEA115473768
DR   hPSCreg; CDIi017-A
DR   Wikidata; Q127383193
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3446 and PPMI_3446 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N7 ! PPMI.I.1022.2
OI   CVCL_D5N8 ! PPMI.I.1022.3
OI   CVCL_D5N9 ! PPMI.I.1022.4
OI   CVCL_D5NA ! PPMI.I.1022.5
OI   CVCL_D5NB ! PPMI.I.1022.6
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1022.2
AC   CVCL_D5N7
SY   PPMI3446; PPMI_3446; CDIi017-A; FCDI_11296
DR   BioSamples; SAMEA115473768
DR   hPSCreg; CDIi017-A
DR   Wikidata; Q127383194
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3446 and PPMI_3446 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N6 ! PPMI.I.1022.1
OI   CVCL_D5N8 ! PPMI.I.1022.3
OI   CVCL_D5N9 ! PPMI.I.1022.4
OI   CVCL_D5NA ! PPMI.I.1022.5
OI   CVCL_D5NB ! PPMI.I.1022.6
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1022.3
AC   CVCL_D5N8
SY   PPMI3446; PPMI_3446; CDIi017-A; FCDI_11296
DR   BioSamples; SAMEA115473768
DR   hPSCreg; CDIi017-A
DR   Wikidata; Q127383195
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3446 and PPMI_3446 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N6 ! PPMI.I.1022.1
OI   CVCL_D5N7 ! PPMI.I.1022.2
OI   CVCL_D5N9 ! PPMI.I.1022.4
OI   CVCL_D5NA ! PPMI.I.1022.5
OI   CVCL_D5NB ! PPMI.I.1022.6
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1022.4
AC   CVCL_D5N9
SY   PPMI3446
DR   Wikidata; Q127383196
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3446 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N6 ! PPMI.I.1022.1
OI   CVCL_D5N7 ! PPMI.I.1022.2
OI   CVCL_D5N8 ! PPMI.I.1022.3
OI   CVCL_D5NA ! PPMI.I.1022.5
OI   CVCL_D5NB ! PPMI.I.1022.6
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1022.5
AC   CVCL_D5NA
SY   PPMI3446
DR   Wikidata; Q127383197
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3446 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N6 ! PPMI.I.1022.1
OI   CVCL_D5N7 ! PPMI.I.1022.2
OI   CVCL_D5N8 ! PPMI.I.1022.3
OI   CVCL_D5N9 ! PPMI.I.1022.4
OI   CVCL_D5NB ! PPMI.I.1022.6
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1022.6
AC   CVCL_D5NB
SY   PPMI3446
DR   Wikidata; Q127383199
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3446 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5N6 ! PPMI.I.1022.1
OI   CVCL_D5N7 ! PPMI.I.1022.2
OI   CVCL_D5N8 ! PPMI.I.1022.3
OI   CVCL_D5N9 ! PPMI.I.1022.4
OI   CVCL_D5NA ! PPMI.I.1022.5
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1023.1
AC   CVCL_D5NC
SY   PPMI3448; PPMI_3448; CDIi023-A; FCDI_11303
DR   BioSamples; SAMEA115473780
DR   hPSCreg; CDIi023-A
DR   Wikidata; Q127383200
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3448 and PPMI_3448 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5ND ! PPMI.I.1023.2
OI   CVCL_D5NE ! PPMI.I.1023.3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1023.2
AC   CVCL_D5ND
SY   PPMI3448; PPMI_3448; CDIi023-A; FCDI_11303
DR   BioSamples; SAMEA115473780
DR   hPSCreg; CDIi023-A
DR   Wikidata; Q127383201
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3448 and PPMI_3448 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NC ! PPMI.I.1023.1
OI   CVCL_D5NE ! PPMI.I.1023.3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1023.3
AC   CVCL_D5NE
SY   PPMI3448; PPMI_3448; CDIi023-A; FCDI_11303
DR   BioSamples; SAMEA115473780
DR   hPSCreg; CDIi023-A
DR   Wikidata; Q127383203
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3448 and PPMI_3448 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NC ! PPMI.I.1023.1
OI   CVCL_D5ND ! PPMI.I.1023.2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1024.1
AC   CVCL_D5NF
SY   PPMI3451; PPMI_3451; CDIi031-A; FCDI_11312
DR   BioSamples; SAMEA115473796
DR   hPSCreg; CDIi031-A
DR   Wikidata; Q127383205
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3451 and PPMI_3451 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NG ! PPMI.I.1024.2
OI   CVCL_D5NH ! PPMI.I.1024.3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1024.2
AC   CVCL_D5NG
SY   PPMI3451; PPMI_3451; CDIi031-A; FCDI_11312
DR   BioSamples; SAMEA115473796
DR   hPSCreg; CDIi031-A
DR   Wikidata; Q127383206
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3451 and PPMI_3451 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NF ! PPMI.I.1024.1
OI   CVCL_D5NH ! PPMI.I.1024.3
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1024.3
AC   CVCL_D5NH
SY   PPMI3451; PPMI_3451; CDIi031-A; FCDI_11312
DR   BioSamples; SAMEA115473796
DR   hPSCreg; CDIi031-A
DR   Wikidata; Q127383207
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3451 and PPMI_3451 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NF ! PPMI.I.1024.1
OI   CVCL_D5NG ! PPMI.I.1024.2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1025.1
AC   CVCL_D5NI
SY   PPMI3452; PPMI_3452; CDIi051-A; FCDI_11345
DR   BioSamples; SAMEA115473836
DR   hPSCreg; CDIi051-A
DR   Wikidata; Q127383208
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1026.1
AC   CVCL_D5NJ
SY   PPMI3459; PPMI_3459; CDIi021-A; FCDI_11301
DR   BioSamples; SAMEA115473776
DR   hPSCreg; CDIi021-A
DR   Wikidata; Q127383209
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3459 and PPMI_3459 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NK ! PPMI.I.1026.2
OI   CVCL_D5NL ! PPMI.I.1026.3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1026.2
AC   CVCL_D5NK
SY   PPMI3459; PPMI_3459; CDIi021-A; FCDI_11301
DR   BioSamples; SAMEA115473776
DR   hPSCreg; CDIi021-A
DR   Wikidata; Q127383210
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3459 and PPMI_3459 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NJ ! PPMI.I.1026.1
OI   CVCL_D5NL ! PPMI.I.1026.3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1026.3
AC   CVCL_D5NL
SY   PPMI3459; PPMI_3459; CDIi021-A; FCDI_11301
DR   BioSamples; SAMEA115473776
DR   hPSCreg; CDIi021-A
DR   Wikidata; Q127383211
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3459 and PPMI_3459 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NJ ! PPMI.I.1026.1
OI   CVCL_D5NK ! PPMI.I.1026.2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1027.1
AC   CVCL_D5NM
SY   PPMI3460; PPMI_3460; CDIi022-A; FCDI_11302
DR   BioSamples; SAMEA115473778
DR   hPSCreg; CDIi022-A
DR   Wikidata; Q127383212
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3460 and PPMI_3460 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NN ! PPMI.I.1027.2
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1027.2
AC   CVCL_D5NN
SY   PPMI3460; PPMI_3460; CDIi022-A; FCDI_11302
DR   BioSamples; SAMEA115473778
DR   hPSCreg; CDIi022-A
DR   Wikidata; Q127383213
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3460 and PPMI_3460 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NM ! PPMI.I.1027.1
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1028.1
AC   CVCL_D5NP
SY   PPMI3465; PPMI_3465; CDIi033-A; FCDI_11314
DR   BioSamples; SAMEA115473800
DR   hPSCreg; CDIi033-A
DR   Wikidata; Q127383214
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the SWEDD (scans without evidence for dopaminergic deficit) stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SWEDD.
CC   Caution: The PPMI3465 and PPMI_3465 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NQ ! PPMI.I.1028.2
OI   CVCL_D5NR ! PPMI.I.1028.3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1028.2
AC   CVCL_D5NQ
SY   PPMI3465; PPMI_3465; CDIi033-A; FCDI_11314
DR   BioSamples; SAMEA115473800
DR   hPSCreg; CDIi033-A
DR   Wikidata; Q127383215
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the SWEDD (scans without evidence for dopaminergic deficit) stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SWEDD.
CC   Caution: The PPMI3465 and PPMI_3465 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NP ! PPMI.I.1028.1
OI   CVCL_D5NR ! PPMI.I.1028.3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1028.3
AC   CVCL_D5NR
SY   PPMI3465; PPMI_3465; CDIi033-A; FCDI_11314
DR   BioSamples; SAMEA115473800
DR   hPSCreg; CDIi033-A
DR   Wikidata; Q127383216
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the SWEDD (scans without evidence for dopaminergic deficit) stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SWEDD.
CC   Caution: The PPMI3465 and PPMI_3465 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NP ! PPMI.I.1028.1
OI   CVCL_D5NQ ! PPMI.I.1028.2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1029.1
AC   CVCL_D5NS
SY   PPMI3467; PPMI_3467; CDIi078-A; FCDI_11469
DR   BioSamples; SAMEA115473890
DR   hPSCreg; CDIi078-A
DR   Wikidata; Q127383217
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3467 and PPMI_3467 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NT ! PPMI.I.1029.2
OI   CVCL_D5NU ! PPMI.I.1029.3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1029.2
AC   CVCL_D5NT
SY   PPMI3467; PPMI_3467; CDIi078-A; FCDI_11469
DR   BioSamples; SAMEA115473890
DR   hPSCreg; CDIi078-A
DR   Wikidata; Q127383218
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3467 and PPMI_3467 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NS ! PPMI.I.1029.1
OI   CVCL_D5NU ! PPMI.I.1029.3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1029.3
AC   CVCL_D5NU
SY   PPMI3467; PPMI_3467; CDIi078-A; FCDI_11469
DR   BioSamples; SAMEA115473890
DR   hPSCreg; CDIi078-A
DR   Wikidata; Q127383219
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3467 and PPMI_3467 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NS ! PPMI.I.1029.1
OI   CVCL_D5NT ! PPMI.I.1029.2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1030.1
AC   CVCL_D5NV
SY   PPMI3469; PPMI_3469; CDIi077-A; FCDI_11468
DR   BioSamples; SAMEA115473888
DR   hPSCreg; CDIi077-A
DR   Wikidata; Q127383220
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1031.1
AC   CVCL_D5NW
SY   PPMI3473; PPMI_3473; CDIi063-A; FCDI_11437
DR   BioSamples; SAMEA115473860
DR   hPSCreg; CDIi063-A
DR   Wikidata; Q127383221
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1032.1
AC   CVCL_D5NX
SY   PPMI3475; PPMI_3475; CDIi064-A; FCDI_11438
DR   BioSamples; SAMEA115473862
DR   hPSCreg; CDIi064-A
DR   Wikidata; Q127383222
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1033.1
AC   CVCL_D5NY
SY   PPMI3480; PPMI_3480; CDIi049-A; FCDI_11343
DR   BioSamples; SAMEA115473832
DR   hPSCreg; CDIi049-A
DR   Wikidata; Q127383223
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3480 and PPMI_3480 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NZ ! PPMI.I.1033.2
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1033.2
AC   CVCL_D5NZ
SY   PPMI3480; PPMI_3480; CDIi049-A; FCDI_11343
DR   BioSamples; SAMEA115473832
DR   hPSCreg; CDIi049-A
DR   Wikidata; Q127383224
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3480 and PPMI_3480 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5NY ! PPMI.I.1033.1
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1034.1
AC   CVCL_D5P0
SY   PPMI3588; PPMI_3588; CDIi065-A; FCDI_11442
DR   BioSamples; SAMEA115473864
DR   hPSCreg; CDIi065-A
DR   Wikidata; Q127383226
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3588 and PPMI_3588 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P1 ! PPMI.I.1034.2
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1034.2
AC   CVCL_D5P1
SY   PPMI3588; PPMI_3588; CDIi065-A; FCDI_11442
DR   BioSamples; SAMEA115473864
DR   hPSCreg; CDIi065-A
DR   Wikidata; Q127383228
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3588 and PPMI_3588 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P0 ! PPMI.I.1034.1
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1035.1
AC   CVCL_D5P2
SY   PPMI3591; PPMI_3591; CDIi097-A; FCDI_11527
DR   BioSamples; SAMEA115473928
DR   hPSCreg; CDIi097-A
DR   Wikidata; Q127383229
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3591 and PPMI_3591 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P3 ! PPMI.I.1035.2
OI   CVCL_D5P4 ! PPMI.I.1035.3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1035.2
AC   CVCL_D5P3
SY   PPMI3591; PPMI_3591; CDIi097-A; FCDI_11527
DR   BioSamples; SAMEA115473928
DR   hPSCreg; CDIi097-A
DR   Wikidata; Q127383230
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3591 and PPMI_3591 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P2 ! PPMI.I.1035.1
OI   CVCL_D5P4 ! PPMI.I.1035.3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1035.3
AC   CVCL_D5P4
SY   PPMI3591; PPMI_3591; CDIi097-A; FCDI_11527
DR   BioSamples; SAMEA115473928
DR   hPSCreg; CDIi097-A
DR   Wikidata; Q127383231
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3591 and PPMI_3591 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P2 ! PPMI.I.1035.1
OI   CVCL_D5P3 ! PPMI.I.1035.2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1036.1
AC   CVCL_D5P5
SY   PPMI3658; PPMI_3658; CDIi032-A; FCDI_11313
DR   BioSamples; SAMEA115473798
DR   hPSCreg; CDIi032-A
DR   Wikidata; Q127383232
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3658 and PPMI_3658 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P6 ! PPMI.I.1036.2
OI   CVCL_D5P7 ! PPMI.I.1036.3
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1036.2
AC   CVCL_D5P6
SY   PPMI3658; PPMI_3658; CDIi032-A; FCDI_11313
DR   BioSamples; SAMEA115473798
DR   hPSCreg; CDIi032-A
DR   Wikidata; Q127383233
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3658 and PPMI_3658 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P5 ! PPMI.I.1036.1
OI   CVCL_D5P7 ! PPMI.I.1036.3
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1036.3
AC   CVCL_D5P7
SY   PPMI3658; PPMI_3658; CDIi032-A; FCDI_11313
DR   BioSamples; SAMEA115473798
DR   hPSCreg; CDIi032-A
DR   Wikidata; Q127383234
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3658 and PPMI_3658 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P5 ! PPMI.I.1036.1
OI   CVCL_D5P6 ! PPMI.I.1036.2
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1037.1
AC   CVCL_D5P8
SY   PPMI3664; PPMI_3664; CDIi028-A; FCDI_11309
DR   BioSamples; SAMEA115473790
DR   hPSCreg; CDIi028-A
DR   Wikidata; Q127383236
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3664 and PPMI_3664 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P9 ! PPMI.I.1037.2
OI   CVCL_D5PA ! PPMI.I.1037.3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1037.2
AC   CVCL_D5P9
SY   PPMI3664; PPMI_3664; CDIi028-A; FCDI_11309
DR   BioSamples; SAMEA115473790
DR   hPSCreg; CDIi028-A
DR   Wikidata; Q127383238
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3664 and PPMI_3664 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P8 ! PPMI.I.1037.1
OI   CVCL_D5PA ! PPMI.I.1037.3
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1037.3
AC   CVCL_D5PA
SY   PPMI3664; PPMI_3664; CDIi028-A; FCDI_11309
DR   BioSamples; SAMEA115473790
DR   hPSCreg; CDIi028-A
DR   Wikidata; Q127383239
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3664 and PPMI_3664 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5P8 ! PPMI.I.1037.1
OI   CVCL_D5P9 ! PPMI.I.1037.2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1038.1
AC   CVCL_D5PB
SY   PPMI3665; PPMI_3665; CDIi029-A; FCDI_11310
DR   BioSamples; SAMEA115473792
DR   hPSCreg; CDIi029-A
DR   Wikidata; Q127383240
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1039.1
AC   CVCL_D5PC
SY   PPMI3666; PPMI_3666; CDIi069-A; FCDI_11449
DR   BioSamples; SAMEA115473872
DR   hPSCreg; CDIi069-A
DR   Wikidata; Q127383241
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3666 and PPMI_3666 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PD ! PPMI.I.1039.2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1039.2
AC   CVCL_D5PD
SY   PPMI3666; PPMI_3666; CDIi069-A; FCDI_11449
DR   BioSamples; SAMEA115473872
DR   hPSCreg; CDIi069-A
DR   Wikidata; Q127383242
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3666 and PPMI_3666 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PC ! PPMI.I.1039.1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1040.1
AC   CVCL_D5PE
SY   PPMI3668; PPMI_3668; CDIi030-A; FCDI_11311
DR   BioSamples; SAMEA115473794
DR   hPSCreg; CDIi030-A
DR   Wikidata; Q127383243
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3668 and PPMI_3668 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PF ! PPMI.I.1040.2
OI   CVCL_D5PG ! PPMI.I.1040.3
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1040.2
AC   CVCL_D5PF
SY   PPMI3668; PPMI_3668; CDIi030-A; FCDI_11311
DR   BioSamples; SAMEA115473794
DR   hPSCreg; CDIi030-A
DR   Wikidata; Q127383244
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3668 and PPMI_3668 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PE ! PPMI.I.1040.1
OI   CVCL_D5PG ! PPMI.I.1040.3
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1040.3
AC   CVCL_D5PG
SY   PPMI3668; PPMI_3668; CDIi030-A; FCDI_11311
DR   BioSamples; SAMEA115473794
DR   hPSCreg; CDIi030-A
DR   Wikidata; Q127383245
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3668 and PPMI_3668 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PE ! PPMI.I.1040.1
OI   CVCL_D5PF ! PPMI.I.1040.2
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1041.1
AC   CVCL_D5PH
SY   PPMI3952; PPMI_3952; CDIi045-A; FCDI_11337
DR   BioSamples; SAMEA115473824
DR   hPSCreg; CDIi045-A
DR   Wikidata; Q127383246
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3952 and PPMI_3952 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PI ! PPMI.I.1041.2
OI   CVCL_D5PJ ! PPMI.I.1041.3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1041.2
AC   CVCL_D5PI
SY   PPMI3952; PPMI_3952; CDIi045-A; FCDI_11337
DR   BioSamples; SAMEA115473824
DR   hPSCreg; CDIi045-A
DR   Wikidata; Q127383247
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3952 and PPMI_3952 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PH ! PPMI.I.1041.1
OI   CVCL_D5PJ ! PPMI.I.1041.3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1041.3
AC   CVCL_D5PJ
SY   PPMI3952; PPMI_3952; CDIi045-A; FCDI_11337
DR   BioSamples; SAMEA115473824
DR   hPSCreg; CDIi045-A
DR   Wikidata; Q127383249
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3952 and PPMI_3952 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PH ! PPMI.I.1041.1
OI   CVCL_D5PI ! PPMI.I.1041.2
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1042.1
AC   CVCL_D5PK
SY   PPMI3953; PPMI_3953; CDIi093-A; FCDI_11505
DR   BioSamples; SAMEA115473920
DR   hPSCreg; CDIi093-A
DR   Wikidata; Q127383250
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3953 and PPMI_3953 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PL ! PPMI.I.1042.2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1042.2
AC   CVCL_D5PL
SY   PPMI3953; PPMI_3953; CDIi093-A; FCDI_11505
DR   BioSamples; SAMEA115473920
DR   hPSCreg; CDIi093-A
DR   Wikidata; Q127383251
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3953 and PPMI_3953 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PK ! PPMI.I.1042.1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1043.1
AC   CVCL_D5PM
SY   PPMI3954; PPMI_3954; CDIi085-A; FCDI_11484
DR   BioSamples; SAMEA115473904
DR   hPSCreg; CDIi085-A
DR   Wikidata; Q127383252
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3954 and PPMI_3954 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PN ! PPMI.I.1043.2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1043.2
AC   CVCL_D5PN
SY   PPMI3954; PPMI_3954; CDIi085-A; FCDI_11484
DR   BioSamples; SAMEA115473904
DR   hPSCreg; CDIi085-A
DR   Wikidata; Q127383253
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (from autologous cell line PPMI.I.1043.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3954 and PPMI_3954 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PM ! PPMI.I.1043.1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1044.1
AC   CVCL_D5PP
SY   PPMI3957
DR   Wikidata; Q127383254
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3957 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PQ ! PPMI.I.1044.2
OI   CVCL_D5PR ! PPMI.I.1044.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1044.2
AC   CVCL_D5PQ
SY   PPMI3957
DR   Wikidata; Q127383255
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3957 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PP ! PPMI.I.1044.1
OI   CVCL_D5PR ! PPMI.I.1044.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1044.3
AC   CVCL_D5PR
SY   PPMI3957
DR   Wikidata; Q127383257
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3957 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PP ! PPMI.I.1044.1
OI   CVCL_D5PQ ! PPMI.I.1044.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1045.1
AC   CVCL_D5PS
SY   PPMI3960; PPMI_3960; CDIi067-A; FCDI_11447
DR   BioSamples; SAMEA115473868
DR   hPSCreg; CDIi067-A
DR   Wikidata; Q127383258
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3960 and PPMI_3960 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PT ! PPMI.I.1045.2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1045.2
AC   CVCL_D5PT
SY   PPMI3960; PPMI_3960; CDIi067-A; FCDI_11447
DR   BioSamples; SAMEA115473868
DR   hPSCreg; CDIi067-A
DR   Wikidata; Q127383259
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3960 and PPMI_3960 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PS ! PPMI.I.1045.1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1046.1
AC   CVCL_D5PU
SY   PPMI3961
DR   Wikidata; Q127383260
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Native North American; Alaskan.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3961 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PV ! PPMI.I.1046.2
OI   CVCL_D5PW ! PPMI.I.1046.3
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1046.2
AC   CVCL_D5PV
SY   PPMI3961
DR   Wikidata; Q127383261
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Native North American; Alaskan.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3961 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PU ! PPMI.I.1046.1
OI   CVCL_D5PW ! PPMI.I.1046.3
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1046.3
AC   CVCL_D5PW
SY   PPMI3961
DR   Wikidata; Q127383262
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Native North American; Alaskan.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3961 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PU ! PPMI.I.1046.1
OI   CVCL_D5PV ! PPMI.I.1046.2
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1047.1
AC   CVCL_D5PX
SY   PPMI3964
DR   Wikidata; Q127383263
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Asian.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3964 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PY ! PPMI.I.1047.2
OI   CVCL_D5PZ ! PPMI.I.1047.3
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1047.2
AC   CVCL_D5PY
SY   PPMI3964
DR   Wikidata; Q127383264
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Asian.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3964 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PX ! PPMI.I.1047.1
OI   CVCL_D5PZ ! PPMI.I.1047.3
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1047.3
AC   CVCL_D5PZ
SY   PPMI3964
DR   Wikidata; Q127383265
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Asian.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3964 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5PX ! PPMI.I.1047.1
OI   CVCL_D5PY ! PPMI.I.1047.2
SX   Male
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1048.1
AC   CVCL_D5Q0
SY   PPMI3966; PPMI_3966; CDIi070-A; FCDI_11450
DR   BioSamples; SAMEA115473874
DR   hPSCreg; CDIi070-A
DR   Wikidata; Q127383266
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3966 and PPMI_3966 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q1 ! PPMI.I.1048.2
OI   CVCL_D5Q2 ! PPMI.I.1048.3
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1048.2
AC   CVCL_D5Q1
SY   PPMI3966; PPMI_3966; CDIi070-A; FCDI_11450
DR   BioSamples; SAMEA115473874
DR   hPSCreg; CDIi070-A
DR   Wikidata; Q127383267
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3966 and PPMI_3966 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q0 ! PPMI.I.1048.1
OI   CVCL_D5Q2 ! PPMI.I.1048.3
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1048.3
AC   CVCL_D5Q2
SY   PPMI3966; PPMI_3966; CDIi070-A; FCDI_11450
DR   BioSamples; SAMEA115473874
DR   hPSCreg; CDIi070-A
DR   Wikidata; Q127383268
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3966 and PPMI_3966 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q0 ! PPMI.I.1048.1
OI   CVCL_D5Q1 ! PPMI.I.1048.2
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1049.1
AC   CVCL_D5Q3
SY   PPMI3970
DR   Wikidata; Q127383269
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3970 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q4 ! PPMI.I.1049.2
OI   CVCL_D5Q5 ! PPMI.I.1049.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1049.2
AC   CVCL_D5Q4
SY   PPMI3970
DR   Wikidata; Q127383270
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3970 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q3 ! PPMI.I.1049.1
OI   CVCL_D5Q5 ! PPMI.I.1049.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1049.3
AC   CVCL_D5Q5
SY   PPMI3970
DR   Wikidata; Q127383271
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI3970 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q3 ! PPMI.I.1049.1
OI   CVCL_D5Q4 ! PPMI.I.1049.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.1
AC   CVCL_D5Q6
SY   PPMI4051
DR   Wikidata; Q127383272
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q7 ! PPMI.I.1050.2
OI   CVCL_D5Q8 ! PPMI.I.1050.3
OI   CVCL_D5Q9 ! PPMI.I.1050.4
OI   CVCL_D5QA ! PPMI.I.1050.5
OI   CVCL_D5QB ! PPMI.I.1050.6
OI   CVCL_D5QC ! PPMI.I.1050.7
OI   CVCL_D5QD ! PPMI.I.1050.8
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.2
AC   CVCL_D5Q7
SY   PPMI4051
DR   Wikidata; Q127383273
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q6 ! PPMI.I.1050.1
OI   CVCL_D5Q8 ! PPMI.I.1050.3
OI   CVCL_D5Q9 ! PPMI.I.1050.4
OI   CVCL_D5QA ! PPMI.I.1050.5
OI   CVCL_D5QB ! PPMI.I.1050.6
OI   CVCL_D5QC ! PPMI.I.1050.7
OI   CVCL_D5QD ! PPMI.I.1050.8
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.3
AC   CVCL_D5Q8
SY   PPMI4051
DR   Wikidata; Q127383274
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q6 ! PPMI.I.1050.1
OI   CVCL_D5Q7 ! PPMI.I.1050.2
OI   CVCL_D5Q9 ! PPMI.I.1050.4
OI   CVCL_D5QA ! PPMI.I.1050.5
OI   CVCL_D5QB ! PPMI.I.1050.6
OI   CVCL_D5QC ! PPMI.I.1050.7
OI   CVCL_D5QD ! PPMI.I.1050.8
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.4
AC   CVCL_D5Q9
SY   PPMI4051
DR   Wikidata; Q127383275
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q6 ! PPMI.I.1050.1
OI   CVCL_D5Q7 ! PPMI.I.1050.2
OI   CVCL_D5Q8 ! PPMI.I.1050.3
OI   CVCL_D5QA ! PPMI.I.1050.5
OI   CVCL_D5QB ! PPMI.I.1050.6
OI   CVCL_D5QC ! PPMI.I.1050.7
OI   CVCL_D5QD ! PPMI.I.1050.8
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.5
AC   CVCL_D5QA
SY   PPMI4051
DR   Wikidata; Q127383277
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q6 ! PPMI.I.1050.1
OI   CVCL_D5Q7 ! PPMI.I.1050.2
OI   CVCL_D5Q8 ! PPMI.I.1050.3
OI   CVCL_D5Q9 ! PPMI.I.1050.4
OI   CVCL_D5QB ! PPMI.I.1050.6
OI   CVCL_D5QC ! PPMI.I.1050.7
OI   CVCL_D5QD ! PPMI.I.1050.8
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.6
AC   CVCL_D5QB
SY   PPMI4051
DR   Wikidata; Q127383278
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q6 ! PPMI.I.1050.1
OI   CVCL_D5Q7 ! PPMI.I.1050.2
OI   CVCL_D5Q8 ! PPMI.I.1050.3
OI   CVCL_D5Q9 ! PPMI.I.1050.4
OI   CVCL_D5QA ! PPMI.I.1050.5
OI   CVCL_D5QC ! PPMI.I.1050.7
OI   CVCL_D5QD ! PPMI.I.1050.8
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.7
AC   CVCL_D5QC
SY   PPMI4051
DR   Wikidata; Q127383279
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q6 ! PPMI.I.1050.1
OI   CVCL_D5Q7 ! PPMI.I.1050.2
OI   CVCL_D5Q8 ! PPMI.I.1050.3
OI   CVCL_D5Q9 ! PPMI.I.1050.4
OI   CVCL_D5QA ! PPMI.I.1050.5
OI   CVCL_D5QB ! PPMI.I.1050.6
OI   CVCL_D5QD ! PPMI.I.1050.8
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1050.8
AC   CVCL_D5QD
SY   PPMI4051
DR   Wikidata; Q127383280
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4051 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5Q6 ! PPMI.I.1050.1
OI   CVCL_D5Q7 ! PPMI.I.1050.2
OI   CVCL_D5Q8 ! PPMI.I.1050.3
OI   CVCL_D5Q9 ! PPMI.I.1050.4
OI   CVCL_D5QA ! PPMI.I.1050.5
OI   CVCL_D5QB ! PPMI.I.1050.6
OI   CVCL_D5QC ! PPMI.I.1050.7
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1051.1
AC   CVCL_D5QE
SY   PPMI4055; PPMI_4055; CDIi014-A; FCDI_11292
DR   BioSamples; SAMEA115473762
DR   hPSCreg; CDIi014-A
DR   Wikidata; Q127383281
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4055 and PPMI_4055 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QF ! PPMI.I.1051.2
OI   CVCL_D5QG ! PPMI.I.1051.3
OI   CVCL_D5QH ! PPMI.I.1051.4
OI   CVCL_D5QI ! PPMI.I.1051.5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1051.2
AC   CVCL_D5QF
SY   PPMI4055; PPMI_4055; CDIi014-A; FCDI_11292
DR   BioSamples; SAMEA115473762
DR   hPSCreg; CDIi014-A
DR   Wikidata; Q127383282
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4055 and PPMI_4055 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QE ! PPMI.I.1051.1
OI   CVCL_D5QG ! PPMI.I.1051.3
OI   CVCL_D5QH ! PPMI.I.1051.4
OI   CVCL_D5QI ! PPMI.I.1051.5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1051.3
AC   CVCL_D5QG
SY   PPMI4055; PPMI_4055; CDIi014-A; FCDI_11292
DR   BioSamples; SAMEA115473762
DR   hPSCreg; CDIi014-A
DR   Wikidata; Q127383284
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4055 and PPMI_4055 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QE ! PPMI.I.1051.1
OI   CVCL_D5QF ! PPMI.I.1051.2
OI   CVCL_D5QH ! PPMI.I.1051.4
OI   CVCL_D5QI ! PPMI.I.1051.5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1051.4
AC   CVCL_D5QH
SY   PPMI4055
DR   Wikidata; Q127383285
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4055 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QE ! PPMI.I.1051.1
OI   CVCL_D5QF ! PPMI.I.1051.2
OI   CVCL_D5QG ! PPMI.I.1051.3
OI   CVCL_D5QI ! PPMI.I.1051.5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1051.5
AC   CVCL_D5QI
SY   PPMI4055
DR   Wikidata; Q127383286
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4055 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QE ! PPMI.I.1051.1
OI   CVCL_D5QF ! PPMI.I.1051.2
OI   CVCL_D5QG ! PPMI.I.1051.3
OI   CVCL_D5QH ! PPMI.I.1051.4
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1052.1
AC   CVCL_D5QJ
SY   PPMI4058
DR   Wikidata; Q127383287
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1053.1
AC   CVCL_D5QK
SY   PPMI4091; PPMI_4091; CDIi052-A; FCDI_11346
DR   BioSamples; SAMEA115473838
DR   hPSCreg; CDIi052-A
DR   Wikidata; Q127383288
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4091 and PPMI_4091 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QL ! PPMI.I.1053.2
OI   CVCL_D5QM ! PPMI.I.1053.3
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1053.2
AC   CVCL_D5QL
SY   PPMI4091; PPMI_4091; CDIi052-A; FCDI_11346
DR   BioSamples; SAMEA115473838
DR   hPSCreg; CDIi052-A
DR   Wikidata; Q127383289
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4091 and PPMI_4091 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QK ! PPMI.I.1053.1
OI   CVCL_D5QM ! PPMI.I.1053.3
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1053.3
AC   CVCL_D5QM
SY   PPMI4091; PPMI_4091; CDIi052-A; FCDI_11346
DR   BioSamples; SAMEA115473838
DR   hPSCreg; CDIi052-A
DR   Wikidata; Q127383290
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4091 and PPMI_4091 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QK ! PPMI.I.1053.1
OI   CVCL_D5QL ! PPMI.I.1053.2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1054.1
AC   CVCL_D5QN
SY   PPMI4098; PPMI_4098; CDIi050-A; FCDI_11344
DR   BioSamples; SAMEA115473834
DR   hPSCreg; CDIi050-A
DR   Wikidata; Q127383291
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI4098 and PPMI_4098 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QP ! PPMI.I.1054.2
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1054.2
AC   CVCL_D5QP
SY   PPMI4098; PPMI_4098; CDIi050-A; FCDI_11344
DR   BioSamples; SAMEA115473834
DR   hPSCreg; CDIi050-A
DR   Wikidata; Q127383292
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1054.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI4098 and PPMI_4098 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QN ! PPMI.I.1054.1
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1055.1
AC   CVCL_D5QQ
SY   PPMI4099; PPMI_4099; CDIi082-A; FCDI_11475
DR   BioSamples; SAMEA115473898
DR   hPSCreg; CDIi082-A
DR   Wikidata; Q127383293
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4099 and PPMI_4099 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QR ! PPMI.I.1055.2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1055.2
AC   CVCL_D5QR
SY   PPMI4099; PPMI_4099; CDIi082-A; FCDI_11475
DR   BioSamples; SAMEA115473898
DR   hPSCreg; CDIi082-A
DR   Wikidata; Q127383294
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4099 and PPMI_4099 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QQ ! PPMI.I.1055.1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1056.1
AC   CVCL_D5QS
SY   PPMI4101; PPMI_4101; CDIi072-A; FCDI_11459
DR   BioSamples; SAMEA115473878
DR   hPSCreg; CDIi072-A
DR   Wikidata; Q127383295
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4101 and PPMI_4101 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QT ! PPMI.I.1056.2
OI   CVCL_D5QU ! PPMI.I.1056.3
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1056.2
AC   CVCL_D5QT
SY   PPMI4101; PPMI_4101; CDIi072-A; FCDI_11459
DR   BioSamples; SAMEA115473878
DR   hPSCreg; CDIi072-A
DR   Wikidata; Q127383296
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4101 and PPMI_4101 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QS ! PPMI.I.1056.1
OI   CVCL_D5QU ! PPMI.I.1056.3
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1056.3
AC   CVCL_D5QU
SY   PPMI4101; PPMI_4101; CDIi072-A; FCDI_11459
DR   BioSamples; SAMEA115473878
DR   hPSCreg; CDIi072-A
DR   Wikidata; Q127383297
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4101 and PPMI_4101 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QS ! PPMI.I.1056.1
OI   CVCL_D5QT ! PPMI.I.1056.2
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1057.1
AC   CVCL_D5QV
SY   PPMI4102
DR   Wikidata; Q127383299
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4102 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QW ! PPMI.I.1057.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1057.2
AC   CVCL_D5QW
SY   PPMI4102
DR   Wikidata; Q127383300
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4102 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QV ! PPMI.I.1057.1
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1058.1
AC   CVCL_D5QX
SY   PPMI4105
DR   Wikidata; Q127383303
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI4105 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QY ! PPMI.I.1058.2
OI   CVCL_D5QZ ! PPMI.I.1058.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1058.2
AC   CVCL_D5QY
SY   PPMI4105
DR   Wikidata; Q127383304
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI4105 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QX ! PPMI.I.1058.1
OI   CVCL_D5QZ ! PPMI.I.1058.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1058.3
AC   CVCL_D5QZ
SY   PPMI4105
DR   Wikidata; Q127383305
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI4105 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5QX ! PPMI.I.1058.1
OI   CVCL_D5QY ! PPMI.I.1058.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1059.1
AC   CVCL_D5R0
SY   PPMI4106; PPMI_4106; CDIi087-A; FCDI_11491
DR   BioSamples; SAMEA115473908
DR   hPSCreg; CDIi087-A
DR   Wikidata; Q127383306
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1060.1
AC   CVCL_D5R1
SY   PPMI4107; PPMI_4107; CDIi088-A; FCDI_11492
DR   BioSamples; SAMEA115473910
DR   hPSCreg; CDIi088-A
DR   Wikidata; Q127383307
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1061.1
AC   CVCL_D5R2
SY   PPMI4108; PPMI_4108; CDIi071-A; FCDI_11455
DR   BioSamples; SAMEA115473876
DR   hPSCreg; CDIi071-A
DR   Wikidata; Q127383308
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1062.1
AC   CVCL_D5R3
SY   PPMI4109; PPMI_4109; CDIi089-A; FCDI_11493
DR   BioSamples; SAMEA115473912
DR   hPSCreg; CDIi089-A
DR   Wikidata; Q127383310
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4109 and PPMI_4109 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5R4 ! PPMI.I.1062.2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1062.2
AC   CVCL_D5R4
SY   PPMI4109; PPMI_4109; CDIi089-A; FCDI_11493
DR   BioSamples; SAMEA115473912
DR   hPSCreg; CDIi089-A
DR   Wikidata; Q127383311
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4109 and PPMI_4109 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5R3 ! PPMI.I.1062.1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1063.1
AC   CVCL_D5R5
SY   PPMI4110; PPMI_4110; CDIi090-A; FCDI_11494
DR   BioSamples; SAMEA115473914
DR   hPSCreg; CDIi090-A
DR   Wikidata; Q127383312
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1064.1
AC   CVCL_D5R6
SY   PPMI4111; PPMI_4111; CDIi066-A; FCDI_11446
DR   BioSamples; SAMEA115473866
DR   hPSCreg; CDIi066-A
DR   Wikidata; Q127383314
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4111 and PPMI_4111 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5R7 ! PPMI.I.1064.2
OI   CVCL_D5R8 ! PPMI.I.1064.3
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1064.2
AC   CVCL_D5R7
SY   PPMI4111; PPMI_4111; CDIi066-A; FCDI_11446
DR   BioSamples; SAMEA115473866
DR   hPSCreg; CDIi066-A
DR   Wikidata; Q127383315
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4111 and PPMI_4111 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5R6 ! PPMI.I.1064.1
OI   CVCL_D5R8 ! PPMI.I.1064.3
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1064.3
AC   CVCL_D5R8
SY   PPMI4111; PPMI_4111; CDIi066-A; FCDI_11446
DR   BioSamples; SAMEA115473866
DR   hPSCreg; CDIi066-A
DR   Wikidata; Q127383316
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4111 and PPMI_4111 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5R6 ! PPMI.I.1064.1
OI   CVCL_D5R7 ! PPMI.I.1064.2
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1065.1
AC   CVCL_D5R9
SY   PPMI4113
DR   Wikidata; Q127383317
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1066.1
AC   CVCL_D5RA
SY   PPMI4115
DR   Wikidata; Q127383318
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4115 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RB ! PPMI.I.1066.2
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1066.2
AC   CVCL_D5RB
SY   PPMI4115
DR   Wikidata; Q127383319
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4115 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RA ! PPMI.I.1066.1
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1067.1
AC   CVCL_D5RC
SY   PPMI4116
DR   Wikidata; Q127383320
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI4116 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RD ! PPMI.I.1067.2
OI   CVCL_D5RE ! PPMI.I.1067.3
OI   CVCL_D5RF ! PPMI.I.1067.4
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1067.2
AC   CVCL_D5RD
SY   PPMI4116
DR   Wikidata; Q127383323
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI4116 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RC ! PPMI.I.1067.1
OI   CVCL_D5RE ! PPMI.I.1067.3
OI   CVCL_D5RF ! PPMI.I.1067.4
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1067.3
AC   CVCL_D5RE
SY   PPMI4116
DR   Wikidata; Q127383325
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI4116 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RC ! PPMI.I.1067.1
OI   CVCL_D5RD ! PPMI.I.1067.2
OI   CVCL_D5RF ! PPMI.I.1067.4
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1067.4
AC   CVCL_D5RF
SY   PPMI4116
DR   Wikidata; Q127383327
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI4116 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RC ! PPMI.I.1067.1
OI   CVCL_D5RD ! PPMI.I.1067.2
OI   CVCL_D5RE ! PPMI.I.1067.3
SX   Male
AG   >65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1068.1
AC   CVCL_D5RG
SY   PPMI4117
DR   Wikidata; Q127383330
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4117 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RH ! PPMI.I.1068.2
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1068.2
AC   CVCL_D5RH
SY   PPMI4117
DR   Wikidata; Q127383332
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Caution: The PPMI4117 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RG ! PPMI.I.1068.1
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1069.1
AC   CVCL_D5RI
SY   PPMI12593
DR   Wikidata; Q127383334
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI12593 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RJ ! PPMI.I.1069.2
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1069.2
AC   CVCL_D5RJ
SY   PPMI12593
DR   Wikidata; Q127383336
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI12593 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RI ! PPMI.I.1069.1
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1070.1
AC   CVCL_D5RK
SY   PPMI13424
DR   Wikidata; Q127383339
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI13424 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RL ! PPMI.I.1070.2
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1070.2
AC   CVCL_D5RL
SY   PPMI13424
DR   Wikidata; Q127383341
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI13424 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RK ! PPMI.I.1070.1
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1071.1
AC   CVCL_D5RM
SY   PPMI18567; PPMI_18567; CDIi086-A; FCDI_11486
DR   BioSamples; SAMEA115473906
DR   hPSCreg; CDIi086-A
DR   Wikidata; Q127383343
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1072.1
AC   CVCL_D5RN
SY   PPMI40273; PPMI_40273; CDIi025-A; FCDI_11306
DR   BioSamples; SAMEA115473784
DR   hPSCreg; CDIi025-A
DR   Wikidata; Q127383347
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI40273 and PPMI_40273 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RP ! PPMI.I.1072.2
OI   CVCL_D5RR ! PPMI.I.1072.3
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1072.2
AC   CVCL_D5RP
SY   PPMI40273; PPMI_40273; CDIi025-A; FCDI_11306
DR   BioSamples; SAMEA115473784
DR   hPSCreg; CDIi025-A
DR   Wikidata; Q127383350
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI40273 and PPMI_40273 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RN ! PPMI.I.1072.1
OI   CVCL_D5RR ! PPMI.I.1072.3
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1072.2.ISO.1
AC   CVCL_D5RQ
DR   Wikidata; Q127383352
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5RP ! PPMI.I.1072.2
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1072.3
AC   CVCL_D5RR
SY   PPMI40273; PPMI_40273; CDIi025-A; FCDI_11306
DR   BioSamples; SAMEA115473784
DR   hPSCreg; CDIi025-A
DR   Wikidata; Q127383355
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI40273 and PPMI_40273 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RN ! PPMI.I.1072.1
OI   CVCL_D5RP ! PPMI.I.1072.2
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1073.1
AC   CVCL_D5RS
SY   PPMI40758
DR   Wikidata; Q127383357
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Caution: The PPMI40758 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RT ! PPMI.I.1073.2
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1073.2
AC   CVCL_D5RT
SY   PPMI40758
DR   Wikidata; Q127383359
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Caution: The PPMI40758 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RS ! PPMI.I.1073.1
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1074.1
AC   CVCL_D5RU
SY   PPMI40760; PPMI_40760; CDIi101-A; FCDI_11556
DR   BioSamples; SAMEA115473936
DR   hPSCreg; CDIi101-A
DR   Wikidata; Q127383361
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1074.1.ISO.1
AC   CVCL_D5RV
DR   Wikidata; Q127383363
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5RU ! PPMI.I.1074.1
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1074.1.ISO.2
AC   CVCL_D5RW
DR   Wikidata; Q127383365
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5RU ! PPMI.I.1074.1
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1074.1.ISO.3
AC   CVCL_D5RX
DR   Wikidata; Q127383368
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5RU ! PPMI.I.1074.1
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1075.1
AC   CVCL_D5RY
SY   PPMI41401
DR   Wikidata; Q127383370
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41401 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RZ ! PPMI.I.1075.2
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1075.2
AC   CVCL_D5RZ
SY   PPMI41401
DR   Wikidata; Q127383373
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41401 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5RY ! PPMI.I.1075.1
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1076.1
AC   CVCL_D5S0
SY   PPMI41430; PPMI_41430; CDIi102-A; FCDI_11557
DR   BioSamples; SAMEA115473938
DR   hPSCreg; CDIi102-A
DR   Wikidata; Q127383375
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Caution: The PPMI41430 and PPMI_41430 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S1 ! PPMI.I.1076.2
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1076.2
AC   CVCL_D5S1
SY   PPMI41430; PPMI_41430; CDIi102-A; FCDI_11557
DR   BioSamples; SAMEA115473938
DR   hPSCreg; CDIi102-A
DR   Wikidata; Q127383377
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line PPMI.I.1076.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Caution: The PPMI41430 and PPMI_41430 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S0 ! PPMI.I.1076.1
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1077.1
AC   CVCL_D5S2
SY   PPMI41471
DR   Wikidata; Q127383379
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41471 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S3 ! PPMI.I.1077.2
OI   CVCL_D5S4 ! PPMI.I.1077.3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1077.2
AC   CVCL_D5S3
SY   PPMI41471
DR   Wikidata; Q127383382
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41471 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S2 ! PPMI.I.1077.1
OI   CVCL_D5S4 ! PPMI.I.1077.3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1077.3
AC   CVCL_D5S4
SY   PPMI41471
DR   Wikidata; Q127383384
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41471 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S2 ! PPMI.I.1077.1
OI   CVCL_D5S3 ! PPMI.I.1077.2
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1078.1
AC   CVCL_D5S5
SY   PPMI41486; PPMI_41486; CDIi042-A; FCDI_11329
DR   BioSamples; SAMEA115473818
DR   hPSCreg; CDIi042-A
DR   Wikidata; Q127383387
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1078.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41486 and PPMI_41486 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S6 ! PPMI.I.1078.2
OI   CVCL_D5S7 ! PPMI.I.1078.3
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1078.2
AC   CVCL_D5S6
SY   PPMI41486; PPMI_41486; CDIi042-A; FCDI_11329
DR   BioSamples; SAMEA115473818
DR   hPSCreg; CDIi042-A
DR   Wikidata; Q127383389
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41486 and PPMI_41486 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S5 ! PPMI.I.1078.1
OI   CVCL_D5S7 ! PPMI.I.1078.3
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1078.3
AC   CVCL_D5S7
SY   PPMI41486; PPMI_41486; CDIi042-A; FCDI_11329
DR   BioSamples; SAMEA115473818
DR   hPSCreg; CDIi042-A
DR   Wikidata; Q127383391
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1078.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41486 and PPMI_41486 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S5 ! PPMI.I.1078.1
OI   CVCL_D5S6 ! PPMI.I.1078.2
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1079.1
AC   CVCL_D5S8
SY   PPMI41568; PPMI_41568; CDIi105-A; FCDI_14555
DR   BioSamples; SAMEA115473944
DR   hPSCreg; CDIi105-A
DR   Wikidata; Q127383393
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41568 and PPMI_41568 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S9 ! PPMI.I.1079.2
OI   CVCL_D5SA ! PPMI.I.1079.3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1079.2
AC   CVCL_D5S9
SY   PPMI41568; PPMI_41568; CDIi105-A; FCDI_14555
DR   BioSamples; SAMEA115473944
DR   hPSCreg; CDIi105-A
DR   Wikidata; Q127383395
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous (from autologous cell line PPMI.I.1079.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41568 and PPMI_41568 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S8 ! PPMI.I.1079.1
OI   CVCL_D5SA ! PPMI.I.1079.3
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1079.3
AC   CVCL_D5SA
SY   PPMI41568; PPMI_41568; CDIi105-A; FCDI_14555
DR   BioSamples; SAMEA115473944
DR   hPSCreg; CDIi105-A
DR   Wikidata; Q127383397
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Arg1441Gly (c.4321C>G); ClinVar=VCV000001936; Zygosity=Heterozygous (from autologous cell line PPMI.I.1079.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI41568 and PPMI_41568 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5S8 ! PPMI.I.1079.1
OI   CVCL_D5S9 ! PPMI.I.1079.2
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1080.1
AC   CVCL_D5SB
SY   PPMI42000
DR   Wikidata; Q127383399
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1081.1
AC   CVCL_D5SC
SY   PPMI42072; PPMI_42072; CDIi036-A; FCDI_11319
DR   BioSamples; SAMEA115473806
DR   hPSCreg; CDIi036-A
DR   Wikidata; Q127383401
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PPMI).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Caution: The PPMI42072 and PPMI_42072 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SD ! PPMI.I.1081.2
OI   CVCL_D5SH ! PPMI.I.1081.3
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1081.2
AC   CVCL_D5SD
SY   PPMI42072; PPMI_42072; CDIi036-A; FCDI_11319
DR   BioSamples; SAMEA115473806
DR   hPSCreg; CDIi036-A
DR   Wikidata; Q127383404
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Caution: The PPMI42072 and PPMI_42072 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SC ! PPMI.I.1081.1
OI   CVCL_D5SH ! PPMI.I.1081.3
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1081.2.ISO.1
AC   CVCL_D5SE
DR   Wikidata; Q127383407
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5SD ! PPMI.I.1081.2
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1081.2.ISO.2
AC   CVCL_D5SF
DR   Wikidata; Q127383410
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5SD ! PPMI.I.1081.2
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1081.2.ISO.3
AC   CVCL_D5SG
DR   Wikidata; Q127383412
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_corrected; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5SD ! PPMI.I.1081.2
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1081.3
AC   CVCL_D5SH
SY   PPMI42072; PPMI_42072; CDIi036-A; FCDI_11319
DR   BioSamples; SAMEA115473806
DR   hPSCreg; CDIi036-A
DR   Wikidata; Q127383414
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PPMI).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup SNCA + hyposmia.
CC   Caution: The PPMI42072 and PPMI_42072 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SC ! PPMI.I.1081.1
OI   CVCL_D5SD ! PPMI.I.1081.2
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1082.1
AC   CVCL_D5SI
SY   PPMI42240
DR   Wikidata; Q127383416
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + GBA.
CC   Caution: The PPMI42240 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SJ ! PPMI.I.1082.2
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1082.2
AC   CVCL_D5SJ
SY   PPMI42240
DR   Wikidata; Q127383418
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + GBA.
CC   Caution: The PPMI42240 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SI ! PPMI.I.1082.1
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1083.1
AC   CVCL_D5SK
SY   PPMI42378; PPMI_42378; CDIi100-A; FCDI_11555
DR   BioSamples; SAMEA115473934
DR   hPSCreg; CDIi100-A
DR   Wikidata; Q127383421
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line PPMI.I.1083.3).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Caution: The PPMI42378 and PPMI_42378 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SL ! PPMI.I.1083.2
OI   CVCL_D5SM ! PPMI.I.1083.3
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1083.2
AC   CVCL_D5SL
SY   PPMI42378; PPMI_42378; CDIi100-A; FCDI_11555
DR   BioSamples; SAMEA115473934
DR   hPSCreg; CDIi100-A
DR   Wikidata; Q127383423
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from autologous cell line PPMI.I.1083.3).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Caution: The PPMI42378 and PPMI_42378 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SK ! PPMI.I.1083.1
OI   CVCL_D5SM ! PPMI.I.1083.3
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1083.3
AC   CVCL_D5SM
SY   PPMI42378; PPMI_42378; CDIi100-A; FCDI_11555
DR   BioSamples; SAMEA115473934
DR   hPSCreg; CDIi100-A
DR   Wikidata; Q127383425
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup SNCA.
CC   Caution: The PPMI42378 and PPMI_42378 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SK ! PPMI.I.1083.1
OI   CVCL_D5SL ! PPMI.I.1083.2
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1084.1
AC   CVCL_D5SN
SY   PPMI42379
DR   Wikidata; Q127383427
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI42379 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SP ! PPMI.I.1084.2
OI   CVCL_D5SQ ! PPMI.I.1084.3
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1084.2
AC   CVCL_D5SP
SY   PPMI42379
DR   Wikidata; Q127383429
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI42379 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SN ! PPMI.I.1084.1
OI   CVCL_D5SQ ! PPMI.I.1084.3
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1084.3
AC   CVCL_D5SQ
SY   PPMI42379
DR   Wikidata; Q127383432
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI42379 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SN ! PPMI.I.1084.1
OI   CVCL_D5SP ! PPMI.I.1084.2
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1085.1
AC   CVCL_D5SR
SY   PPMI50086; PPMI_50086; CDIi054-A; FCDI_11348
DR   BioSamples; SAMEA115473842
DR   hPSCreg; CDIi054-A
DR   Wikidata; Q127383435
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50086 and PPMI_50086 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SS ! PPMI.I.1085.2
OI   CVCL_D5SU ! PPMI.I.1085.3
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1085.2
AC   CVCL_D5SS
SY   PPMI50086; PPMI_50086; CDIi054-A; FCDI_11348
DR   BioSamples; SAMEA115473842
DR   hPSCreg; CDIi054-A
DR   Wikidata; Q127383437
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50086 and PPMI_50086 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SR ! PPMI.I.1085.1
OI   CVCL_D5SU ! PPMI.I.1085.3
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1085.2.ISO.1
AC   CVCL_D5ST
DR   Wikidata; Q127383439
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5SS ! PPMI.I.1085.2
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1085.3
AC   CVCL_D5SU
SY   PPMI50086; PPMI_50086; CDIi054-A; FCDI_11348
DR   BioSamples; SAMEA115473842
DR   hPSCreg; CDIi054-A
DR   Wikidata; Q127383442
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50086 and PPMI_50086 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SR ! PPMI.I.1085.1
OI   CVCL_D5SS ! PPMI.I.1085.2
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1086.1
AC   CVCL_D5SV
SY   PPMI50184; PPMI_50184; CDIi044-A; FCDI_11334
DR   BioSamples; SAMEA115473822
DR   hPSCreg; CDIi044-A
DR   Wikidata; Q127383445
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1086.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50184 and PPMI_50184 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SW ! PPMI.I.1086.2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1086.2
AC   CVCL_D5SW
SY   PPMI50184; PPMI_50184; CDIi044-A; FCDI_11334
DR   BioSamples; SAMEA115473822
DR   hPSCreg; CDIi044-A
DR   Wikidata; Q127383449
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50184 and PPMI_50184 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SV ! PPMI.I.1086.1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1087.1
AC   CVCL_D5SX
SY   PPMI50219
DR   Wikidata; Q127383452
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50219 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SY ! PPMI.I.1087.2
OI   CVCL_D5SZ ! PPMI.I.1087.3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1087.2
AC   CVCL_D5SY
SY   PPMI50219
DR   Wikidata; Q127383454
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50219 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SX ! PPMI.I.1087.1
OI   CVCL_D5SZ ! PPMI.I.1087.3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1087.3
AC   CVCL_D5SZ
SY   PPMI50219
DR   Wikidata; Q127383458
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50219 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5SX ! PPMI.I.1087.1
OI   CVCL_D5SY ! PPMI.I.1087.2
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1088.1
AC   CVCL_D5T0
SY   PPMI50379
DR   Wikidata; Q127383461
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50379 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T1 ! PPMI.I.1088.2
OI   CVCL_D5T2 ! PPMI.I.1088.3
OI   CVCL_D5T3 ! PPMI.I.1088.4
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1088.2
AC   CVCL_D5T1
SY   PPMI50379
DR   Wikidata; Q127383465
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50379 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T0 ! PPMI.I.1088.1
OI   CVCL_D5T2 ! PPMI.I.1088.3
OI   CVCL_D5T3 ! PPMI.I.1088.4
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1088.3
AC   CVCL_D5T2
SY   PPMI50379
DR   Wikidata; Q127383467
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50379 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T0 ! PPMI.I.1088.1
OI   CVCL_D5T1 ! PPMI.I.1088.2
OI   CVCL_D5T3 ! PPMI.I.1088.4
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1088.4
AC   CVCL_D5T3
SY   PPMI50379
DR   Wikidata; Q127383470
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50379 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T0 ! PPMI.I.1088.1
OI   CVCL_D5T1 ! PPMI.I.1088.2
OI   CVCL_D5T2 ! PPMI.I.1088.3
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1089.1
AC   CVCL_D5T4
SY   PPMI50670
DR   Wikidata; Q127383472
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50670 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T5 ! PPMI.I.1089.2
OI   CVCL_D5T6 ! PPMI.I.1089.3
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1089.2
AC   CVCL_D5T5
SY   PPMI50670
DR   Wikidata; Q127383475
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50670 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T4 ! PPMI.I.1089.1
OI   CVCL_D5T6 ! PPMI.I.1089.3
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1089.3
AC   CVCL_D5T6
SY   PPMI50670
DR   Wikidata; Q127383477
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI50670 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T4 ! PPMI.I.1089.1
OI   CVCL_D5T5 ! PPMI.I.1089.2
SX   Female
AG   55-65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1090.1
AC   CVCL_D5T7
SY   PPMI50860
DR   Wikidata; Q127383479
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1091.1
AC   CVCL_D5T8
SY   PPMI51330; PPMI_51330; CDIi035-A; FCDI_11318
DR   BioSamples; SAMEA115473804
DR   hPSCreg; CDIi035-A
DR   Wikidata; Q127383481
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + GBA.
CC   Caution: The PPMI51330 and PPMI_51330 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T9 ! PPMI.I.1091.2
OI   CVCL_D5TA ! PPMI.I.1091.3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1091.2
AC   CVCL_D5T9
SY   PPMI51330; PPMI_51330; CDIi035-A; FCDI_11318
DR   BioSamples; SAMEA115473804
DR   hPSCreg; CDIi035-A
DR   Wikidata; Q127383483
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1091.1).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1091.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + GBA.
CC   Caution: The PPMI51330 and PPMI_51330 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T8 ! PPMI.I.1091.1
OI   CVCL_D5TA ! PPMI.I.1091.3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1091.3
AC   CVCL_D5TA
SY   PPMI51330; PPMI_51330; CDIi035-A; FCDI_11318
DR   BioSamples; SAMEA115473804
DR   hPSCreg; CDIi035-A
DR   Wikidata; Q127383486
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1091.1).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1091.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + GBA.
CC   Caution: The PPMI51330 and PPMI_51330 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5T8 ! PPMI.I.1091.1
OI   CVCL_D5T9 ! PPMI.I.1091.2
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1092.1
AC   CVCL_D5TB
SY   PPMI51440; PPMI_51440; CDIi034-A; FCDI_11317
DR   BioSamples; SAMEA115473802
DR   hPSCreg; CDIi034-A
DR   Wikidata; Q127383488
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1092.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51440 and PPMI_51440 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TC ! PPMI.I.1092.2
OI   CVCL_D5TD ! PPMI.I.1092.3
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1092.2
AC   CVCL_D5TC
SY   PPMI51440; PPMI_51440; CDIi034-A; FCDI_11317
DR   BioSamples; SAMEA115473802
DR   hPSCreg; CDIi034-A
DR   Wikidata; Q127383491
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1092.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51440 and PPMI_51440 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TB ! PPMI.I.1092.1
OI   CVCL_D5TD ! PPMI.I.1092.3
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1092.3
AC   CVCL_D5TD
SY   PPMI51440; PPMI_51440; CDIi034-A; FCDI_11317
DR   BioSamples; SAMEA115473802
DR   hPSCreg; CDIi034-A
DR   Wikidata; Q127383493
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51440 and PPMI_51440 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TB ! PPMI.I.1092.1
OI   CVCL_D5TC ! PPMI.I.1092.2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1093.1
AC   CVCL_D5TE
SY   PPMI51518; PPMI_51518; CDIi068-A; FCDI_11448
DR   BioSamples; SAMEA115473870
DR   hPSCreg; CDIi068-A
DR   Wikidata; Q127383495
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51518 and PPMI_51518 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TG ! PPMI.I.1093.2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1093.1.ISO.1
AC   CVCL_D5TF
DR   Wikidata; Q127383497
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5TE ! PPMI.I.1093.1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1093.2
AC   CVCL_D5TG
SY   PPMI51518; PPMI_51518; CDIi068-A; FCDI_11448
DR   BioSamples; SAMEA115473870
DR   hPSCreg; CDIi068-A
DR   Wikidata; Q127383499
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51518 and PPMI_51518 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TE ! PPMI.I.1093.1
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1094.1
AC   CVCL_D5TH
SY   PPMI51625; PPMI_51625; CDIi026-A; FCDI_11307
DR   BioSamples; SAMEA115473786
DR   hPSCreg; CDIi026-A
DR   Wikidata; Q127383502
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1094.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51625 and PPMI_51625 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TI ! PPMI.I.1094.2
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1094.2
AC   CVCL_D5TI
SY   PPMI51625; PPMI_51625; CDIi026-A; FCDI_11307
DR   BioSamples; SAMEA115473786
DR   hPSCreg; CDIi026-A
DR   Wikidata; Q127383503
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51625 and PPMI_51625 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TH ! PPMI.I.1094.1
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1095.1
AC   CVCL_D5TJ
SY   PPMI51714; PPMI_51714; CDIi091-A; FCDI_11498
DR   BioSamples; SAMEA115473916
DR   hPSCreg; CDIi091-A
DR   Wikidata; Q127383506
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1095.3).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51714 and PPMI_51714 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TK ! PPMI.I.1095.2
OI   CVCL_D5TL ! PPMI.I.1095.3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1095.2
AC   CVCL_D5TK
SY   PPMI51714; PPMI_51714; CDIi091-A; FCDI_11498
DR   BioSamples; SAMEA115473916
DR   hPSCreg; CDIi091-A
DR   Wikidata; Q127383509
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1095.3).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51714 and PPMI_51714 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TJ ! PPMI.I.1095.1
OI   CVCL_D5TL ! PPMI.I.1095.3
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1095.3
AC   CVCL_D5TL
SY   PPMI51714; PPMI_51714; CDIi091-A; FCDI_11498
DR   BioSamples; SAMEA115473916
DR   hPSCreg; CDIi091-A
DR   Wikidata; Q127383511
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51714 and PPMI_51714 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TJ ! PPMI.I.1095.1
OI   CVCL_D5TK ! PPMI.I.1095.2
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1096.1
AC   CVCL_D5TM
SY   PPMI51755; PPMI_51755; CDIi058-A; FCDI_11362
DR   BioSamples; SAMEA115473850
DR   hPSCreg; CDIi058-A
DR   Wikidata; Q127383514
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51755 and PPMI_51755 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TN ! PPMI.I.1096.2
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1096.2
AC   CVCL_D5TN
SY   PPMI51755; PPMI_51755; CDIi058-A; FCDI_11362
DR   BioSamples; SAMEA115473850
DR   hPSCreg; CDIi058-A
DR   Wikidata; Q127383516
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1096.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51755 and PPMI_51755 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TM ! PPMI.I.1096.1
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1097.1
AC   CVCL_D5TP
SY   PPMI51782
DR   Wikidata; Q127383518
RX   PubMed=34434090;
RX   PubMed=35895835;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=35895835).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51782 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TQ ! PPMI.I.1097.2
OI   CVCL_D5TR ! PPMI.I.1097.3
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1097.2
AC   CVCL_D5TQ
SY   PPMI51782
DR   Wikidata; Q127383521
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1097.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51782 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TP ! PPMI.I.1097.1
OI   CVCL_D5TR ! PPMI.I.1097.3
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1097.3
AC   CVCL_D5TR
SY   PPMI51782
DR   Wikidata; Q127383523
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1097.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI51782 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TP ! PPMI.I.1097.1
OI   CVCL_D5TQ ! PPMI.I.1097.2
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1098.1
AC   CVCL_D5TS
SY   PPMI51844; PPMI_51844; CDIi080-A; FCDI_11473
DR   BioSamples; SAMEA115473894
DR   hPSCreg; CDIi080-A
DR   Wikidata; Q127383525
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI51844 and PPMI_51844 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TT ! PPMI.I.1098.2
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1098.2
AC   CVCL_D5TT
SY   PPMI51844; PPMI_51844; CDIi080-A; FCDI_11473
DR   BioSamples; SAMEA115473894
DR   hPSCreg; CDIi080-A
DR   Wikidata; Q127383527
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1098.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI51844 and PPMI_51844 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TS ! PPMI.I.1098.1
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1099.1
AC   CVCL_D5TU
SY   PPMI51867; PPMI_51867; CDIi024-A; FCDI_11305
DR   BioSamples; SAMEA115473782
DR   hPSCreg; CDIi024-A
DR   Wikidata; Q127383529
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1099.3).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + hyposmia.
CC   Caution: The PPMI51867 and PPMI_51867 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TV ! PPMI.I.1099.2
OI   CVCL_D5TW ! PPMI.I.1099.3
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1099.2
AC   CVCL_D5TV
SY   PPMI51867; PPMI_51867; CDIi024-A; FCDI_11305
DR   BioSamples; SAMEA115473782
DR   hPSCreg; CDIi024-A
DR   Wikidata; Q127383532
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1099.3).
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + hyposmia.
CC   Caution: The PPMI51867 and PPMI_51867 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TU ! PPMI.I.1099.1
OI   CVCL_D5TW ! PPMI.I.1099.3
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1099.3
AC   CVCL_D5TW
SY   PPMI51867; PPMI_51867; CDIi024-A; FCDI_11305
DR   BioSamples; SAMEA115473782
DR   hPSCreg; CDIi024-A
DR   Wikidata; Q127383534
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2 + hyposmia.
CC   Caution: The PPMI51867 and PPMI_51867 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TU ! PPMI.I.1099.1
OI   CVCL_D5TV ! PPMI.I.1099.2
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1100.1
AC   CVCL_D5TX
SY   PPMI51971; PPMI_51971; CDIi056-A; FCDI_11353
DR   BioSamples; SAMEA115473846
DR   hPSCreg; CDIi056-A
DR   Wikidata; Q127383536
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1101.1
AC   CVCL_D5TY
SY   PPMI52062; PPMI_52062; CDIi019-A; FCDI_11299
DR   BioSamples; SAMEA115473772
DR   hPSCreg; CDIi019-A
DR   Wikidata; Q127383538
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1102.1
AC   CVCL_D5TZ
SY   PPMI52146
DR   Wikidata; Q127383540
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI52146 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U0 ! PPMI.I.1102.2
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1102.2
AC   CVCL_D5U0
SY   PPMI52146
DR   Wikidata; Q127383542
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI52146 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5TZ ! PPMI.I.1102.1
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1103.1
AC   CVCL_D5U1
SY   PPMI52400; PPMI_52400; CDIi073-A; FCDI_11460
DR   BioSamples; SAMEA115473880
DR   hPSCreg; CDIi073-A
DR   Wikidata; Q127383544
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52400 and PPMI_52400 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U2 ! PPMI.I.1103.2
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1103.2
AC   CVCL_D5U2
SY   PPMI52400; PPMI_52400; CDIi073-A; FCDI_11460
DR   BioSamples; SAMEA115473880
DR   hPSCreg; CDIi073-A
DR   Wikidata; Q127383546
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1103.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52400 and PPMI_52400 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U1 ! PPMI.I.1103.1
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1104.1
AC   CVCL_D5U3
SY   PPMI52517; PPMI_52517; CDIi094-A; FCDI_11508
DR   BioSamples; SAMEA115473922
DR   hPSCreg; CDIi094-A
DR   Wikidata; Q127383549
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1104.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52517 and PPMI_52517 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U4 ! PPMI.I.1104.2
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1104.2
AC   CVCL_D5U4
SY   PPMI52517; PPMI_52517; CDIi094-A; FCDI_11508
DR   BioSamples; SAMEA115473922
DR   hPSCreg; CDIi094-A
DR   Wikidata; Q127383551
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52517 and PPMI_52517 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U3 ! PPMI.I.1104.1
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1105.1
AC   CVCL_D5U5
SY   PPMI52524; PPMI_52524; CDIi083-A; FCDI_11478
DR   BioSamples; SAMEA115473900
DR   hPSCreg; CDIi083-A
DR   Wikidata; Q127383553
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52524 and PPMI_52524 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U6 ! PPMI.I.1105.2
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1105.2
AC   CVCL_D5U6
SY   PPMI52524; PPMI_52524; CDIi083-A; FCDI_11478
DR   BioSamples; SAMEA115473900
DR   hPSCreg; CDIi083-A
DR   Wikidata; Q127383556
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52524 and PPMI_52524 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U5 ! PPMI.I.1105.1
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1105.2.ISO.1
AC   CVCL_D5U7
DR   Wikidata; Q127383558
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5U6 ! PPMI.I.1105.2
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1105.2.ISO.2
AC   CVCL_D5U8
DR   Wikidata; Q127383560
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5U6 ! PPMI.I.1105.2
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1106.1
AC   CVCL_D5U9
SY   PPMI52530; PPMI_52530; CDIi037-A; FCDI_11321
DR   BioSamples; SAMEA115473808
DR   hPSCreg; CDIi037-A
DR   Wikidata; Q127383562
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI52530 and PPMI_52530 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UA ! PPMI.I.1106.2
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1106.2
AC   CVCL_D5UA
SY   PPMI52530; PPMI_52530; CDIi037-A; FCDI_11321
DR   BioSamples; SAMEA115473808
DR   hPSCreg; CDIi037-A
DR   Wikidata; Q127383564
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1106.1).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI52530 and PPMI_52530 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5U9 ! PPMI.I.1106.1
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1107.1
AC   CVCL_D5UB
SY   PPMI52604
DR   Wikidata; Q127383566
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52604 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UC ! PPMI.I.1107.2
OI   CVCL_D5UD ! PPMI.I.1107.3
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1107.2
AC   CVCL_D5UC
SY   PPMI52604
DR   Wikidata; Q127383569
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52604 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UB ! PPMI.I.1107.1
OI   CVCL_D5UD ! PPMI.I.1107.3
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1107.3
AC   CVCL_D5UD
SY   PPMI52604
DR   Wikidata; Q127383571
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52604 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UB ! PPMI.I.1107.1
OI   CVCL_D5UC ! PPMI.I.1107.2
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1108.1
AC   CVCL_D5UE
SY   PPMI52783
DR   Wikidata; Q127383572
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52783 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UF ! PPMI.I.1108.2
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1108.2
AC   CVCL_D5UF
SY   PPMI52783
DR   Wikidata; Q127383574
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52783 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UE ! PPMI.I.1108.1
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1109.1
AC   CVCL_D5UG
SY   PPMI52787
DR   Wikidata; Q127383577
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1110.1
AC   CVCL_D5UH
SY   PPMI52828; PPMI_52828; CDIi059-A; FCDI_11363
DR   BioSamples; SAMEA115473852
DR   hPSCreg; CDIi059-A
DR   Wikidata; Q127383578
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1110.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI52828 and PPMI_52828 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UI ! PPMI.I.1110.2
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1110.2
AC   CVCL_D5UI
SY   PPMI52828; PPMI_52828; CDIi059-A; FCDI_11363
DR   BioSamples; SAMEA115473852
DR   hPSCreg; CDIi059-A
DR   Wikidata; Q127383581
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI52828 and PPMI_52828 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UH ! PPMI.I.1110.1
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1111.1
AC   CVCL_D5UJ
SY   PPMI52932; PPMI_52932; CDIi098-A; FCDI_11545
DR   BioSamples; SAMEA115473930
DR   hPSCreg; CDIi098-A
DR   Wikidata; Q127383583
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52932 and PPMI_52932 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UK ! PPMI.I.1111.2
OI   CVCL_D5UL ! PPMI.I.1111.3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1111.2
AC   CVCL_D5UK
SY   PPMI52932; PPMI_52932; CDIi098-A; FCDI_11545
DR   BioSamples; SAMEA115473930
DR   hPSCreg; CDIi098-A
DR   Wikidata; Q127383585
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52932 and PPMI_52932 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UJ ! PPMI.I.1111.1
OI   CVCL_D5UL ! PPMI.I.1111.3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1111.3
AC   CVCL_D5UL
SY   PPMI52932; PPMI_52932; CDIi098-A; FCDI_11545
DR   BioSamples; SAMEA115473930
DR   hPSCreg; CDIi098-A
DR   Wikidata; Q127383587
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI52932 and PPMI_52932 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UJ ! PPMI.I.1111.1
OI   CVCL_D5UK ! PPMI.I.1111.2
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1111.3.ISO.1
AC   CVCL_D5UM
DR   Wikidata; Q127383589
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5UL ! PPMI.I.1111.3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1111.3.ISO.2
AC   CVCL_D5UN
DR   Wikidata; Q127383591
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5UL ! PPMI.I.1111.3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1112.1
AC   CVCL_D5UP
SY   PPMI53033
DR   Wikidata; Q127383593
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI53033 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UQ ! PPMI.I.1112.2
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1112.2
AC   CVCL_D5UQ
SY   PPMI53033
DR   Wikidata; Q127383596
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI53033 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UP ! PPMI.I.1112.1
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1113.1
AC   CVCL_D5UR
SY   PPMI53339; PPMI_53339; CDIi038-A; FCDI_11323
DR   BioSamples; SAMEA115473810
DR   hPSCreg; CDIi038-A
DR   Wikidata; Q127383598
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1113.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53339 and PPMI_53339 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5US ! PPMI.I.1113.2
OI   CVCL_D5UT ! PPMI.I.1113.3
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1113.2
AC   CVCL_D5US
SY   PPMI53339; PPMI_53339; CDIi038-A; FCDI_11323
DR   BioSamples; SAMEA115473810
DR   hPSCreg; CDIi038-A
DR   Wikidata; Q127383600
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53339 and PPMI_53339 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UR ! PPMI.I.1113.1
OI   CVCL_D5UT ! PPMI.I.1113.3
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1113.3
AC   CVCL_D5UT
SY   PPMI53339; PPMI_53339; CDIi038-A; FCDI_11323
DR   BioSamples; SAMEA115473810
DR   hPSCreg; CDIi038-A
DR   Wikidata; Q127383602
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1113.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53339 and PPMI_53339 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UR ! PPMI.I.1113.1
OI   CVCL_D5US ! PPMI.I.1113.2
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1114.1
AC   CVCL_D5UU
SY   PPMI53340
DR   Wikidata; Q127383604
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI53340 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UV ! PPMI.I.1114.2
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1114.2
AC   CVCL_D5UV
SY   PPMI53340
DR   Wikidata; Q127383606
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI53340 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UU ! PPMI.I.1114.1
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1115.1
AC   CVCL_D5UW
SY   PPMI53423
DR   Wikidata; Q127383608
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1116.1
AC   CVCL_D5UX
SY   PPMI53518; PPMI_53518; CDIi099-A; FCDI_11546
DR   BioSamples; SAMEA115473932
DR   hPSCreg; CDIi099-A
DR   Wikidata; Q127383610
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1116.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI53518 and PPMI_53518 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UY ! PPMI.I.1116.2
OI   CVCL_D5UZ ! PPMI.I.1116.3
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1116.2
AC   CVCL_D5UY
SY   PPMI53518; PPMI_53518; CDIi099-A; FCDI_11546
DR   BioSamples; SAMEA115473932
DR   hPSCreg; CDIi099-A
DR   Wikidata; Q127383612
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI53518 and PPMI_53518 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UX ! PPMI.I.1116.1
OI   CVCL_D5UZ ! PPMI.I.1116.3
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1116.3
AC   CVCL_D5UZ
SY   PPMI53518; PPMI_53518; CDIi099-A; FCDI_11546
DR   BioSamples; SAMEA115473932
DR   hPSCreg; CDIi099-A
DR   Wikidata; Q127383614
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1116.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI53518 and PPMI_53518 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5UX ! PPMI.I.1116.1
OI   CVCL_D5UY ! PPMI.I.1116.2
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1117.1
AC   CVCL_D5V0
SY   PPMI53600
DR   Wikidata; Q127383617
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53600 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5V1 ! PPMI.I.1117.2
OI   CVCL_D5V2 ! PPMI.I.1117.3
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1117.2
AC   CVCL_D5V1
SY   PPMI53600
DR   Wikidata; Q127383619
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53600 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5V0 ! PPMI.I.1117.1
OI   CVCL_D5V2 ! PPMI.I.1117.3
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1117.3
AC   CVCL_D5V2
SY   PPMI53600
DR   Wikidata; Q127383621
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53600 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5V0 ! PPMI.I.1117.1
OI   CVCL_D5V1 ! PPMI.I.1117.2
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1118.1
AC   CVCL_D5V3
SY   PPMI53988; PPMI_53988; CDIi095-A; FCDI_11512
DR   BioSamples; SAMEA115473924
DR   hPSCreg; CDIi095-A
DR   Wikidata; Q127383623
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53988 and PPMI_53988 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5V4 ! PPMI.I.1118.2
OI   CVCL_D5V5 ! PPMI.I.1118.3
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1118.2
AC   CVCL_D5V4
SY   PPMI53988; PPMI_53988; CDIi095-A; FCDI_11512
DR   BioSamples; SAMEA115473924
DR   hPSCreg; CDIi095-A
DR   Wikidata; Q127383625
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53988 and PPMI_53988 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5V3 ! PPMI.I.1118.1
OI   CVCL_D5V5 ! PPMI.I.1118.3
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1118.3
AC   CVCL_D5V5
SY   PPMI53988; PPMI_53988; CDIi095-A; FCDI_11512
DR   BioSamples; SAMEA115473924
DR   hPSCreg; CDIi095-A
DR   Wikidata; Q127383627
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI53988 and PPMI_53988 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5V3 ! PPMI.I.1118.1
OI   CVCL_D5V4 ! PPMI.I.1118.2
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1118.3.ISO.1
AC   CVCL_D5V6
DR   Wikidata; Q127383629
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5V5 ! PPMI.I.1118.3
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1118.3.ISO.2
AC   CVCL_D5V7
DR   Wikidata; Q127383631
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5V5 ! PPMI.I.1118.3
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1118.3.ISO.3
AC   CVCL_D5V8
DR   Wikidata; Q127383633
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5V5 ! PPMI.I.1118.3
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1119.1
AC   CVCL_D5V9
SY   PPMI54048; PPMI_54048; CDIi104-A; FCDI_11578
DR   BioSamples; SAMEA115473942
DR   hPSCreg; CDIi104-A
DR   Wikidata; Q127383635
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1120.1
AC   CVCL_D5VA
SY   PPMI54144; PPMI_54144; CDIi020-A; FCDI_11300
DR   BioSamples; SAMEA115473774
DR   hPSCreg; CDIi020-A
DR   Wikidata; Q127383638
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1120.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI54144 and PPMI_54144 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VB ! PPMI.I.1120.2
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1120.2
AC   CVCL_D5VB
SY   PPMI54144; PPMI_54144; CDIi020-A; FCDI_11300
DR   BioSamples; SAMEA115473774
DR   hPSCreg; CDIi020-A
DR   Wikidata; Q127383641
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI54144 and PPMI_54144 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VA ! PPMI.I.1120.1
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1121.1
AC   CVCL_D5VC
SY   PPMI54262; PPMI_54262; CDIi043-A; FCDI_11331
DR   BioSamples; SAMEA115473820
DR   hPSCreg; CDIi043-A
DR   Wikidata; Q127383643
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI54262 and PPMI_54262 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VD ! PPMI.I.1121.2
OI   CVCL_D5VE ! PPMI.I.1121.3
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1121.2
AC   CVCL_D5VD
SY   PPMI54262; PPMI_54262; CDIi043-A; FCDI_11331
DR   BioSamples; SAMEA115473820
DR   hPSCreg; CDIi043-A
DR   Wikidata; Q127383645
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1121.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI54262 and PPMI_54262 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VC ! PPMI.I.1121.1
OI   CVCL_D5VE ! PPMI.I.1121.3
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1121.3
AC   CVCL_D5VE
SY   PPMI54262; PPMI_54262; CDIi043-A; FCDI_11331
DR   BioSamples; SAMEA115473820
DR   hPSCreg; CDIi043-A
DR   Wikidata; Q127383647
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1121.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI54262 and PPMI_54262 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VC ! PPMI.I.1121.1
OI   CVCL_D5VD ! PPMI.I.1121.2
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1122.1
AC   CVCL_D5VF
SY   PPMI54265
DR   Wikidata; Q127383649
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI54265 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VG ! PPMI.I.1122.2
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1122.2
AC   CVCL_D5VG
SY   PPMI54265
DR   Wikidata; Q127383651
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI54265 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VF ! PPMI.I.1122.1
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1123.1
AC   CVCL_D5VH
SY   PPMI54908; PPMI_54908; CDIi074-A; FCDI_11462
DR   BioSamples; SAMEA115473882
DR   hPSCreg; CDIi074-A
DR   Wikidata; Q127383653
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA + hyposmia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1124.1
AC   CVCL_D5VI
SY   PPMI54991; PPMI_54991; CDIi075-A; FCDI_11463
DR   BioSamples; SAMEA115473884
DR   hPSCreg; CDIi075-A
DR   Wikidata; Q127383655
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI54991 and PPMI_54991 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VJ ! PPMI.I.1124.2
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1124.2
AC   CVCL_D5VJ
SY   PPMI54991; PPMI_54991; CDIi075-A; FCDI_11463
DR   BioSamples; SAMEA115473884
DR   hPSCreg; CDIi075-A
DR   Wikidata; Q127383657
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1124.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI54991 and PPMI_54991 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VI ! PPMI.I.1124.1
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1125.1
AC   CVCL_D5VK
SY   PPMI55124
DR   Wikidata; Q127383659
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1125.1.ISO.1
AC   CVCL_D5VL
DR   Wikidata; Q127383661
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5VK ! PPMI.I.1125.1
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1125.1.ISO.2
AC   CVCL_D5VM
DR   Wikidata; Q127383664
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5VK ! PPMI.I.1125.1
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1125.1.ISO.3
AC   CVCL_D5VN
DR   Wikidata; Q127383667
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_corrected; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5VK ! PPMI.I.1125.1
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1126.1
AC   CVCL_D5VP
SY   PPMI55251; PPMI_55251; CDIi060-A; FCDI_11370
DR   BioSamples; SAMEA115473854
DR   hPSCreg; CDIi060-A
DR   Wikidata; Q127383669
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1127.1
AC   CVCL_D5VQ
SY   PPMI55380; PPMI_55380; CDIi061-A; FCDI_11371
DR   BioSamples; SAMEA115473856
DR   hPSCreg; CDIi061-A
DR   Wikidata; Q127383671
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI55380 and PPMI_55380 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VR ! PPMI.I.1127.2
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1127.2
AC   CVCL_D5VR
SY   PPMI55380; PPMI_55380; CDIi061-A; FCDI_11371
DR   BioSamples; SAMEA115473856
DR   hPSCreg; CDIi061-A
DR   Wikidata; Q127383674
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1127.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI55380 and PPMI_55380 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VQ ! PPMI.I.1127.1
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1128.1
AC   CVCL_D5VS
SY   PPMI55577
DR   Wikidata; Q127383677
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1129.1
AC   CVCL_D5VT
SY   PPMI56169; PPMI_56169; CDIi092-A; FCDI_11500
DR   BioSamples; SAMEA115473918
DR   hPSCreg; CDIi092-A
DR   Wikidata; Q127383679
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1130.1
AC   CVCL_D5VU
SY   PPMI56435; PPMI_56435; CDIi041-A; FCDI_11328
DR   BioSamples; SAMEA115473816
DR   hPSCreg; CDIi041-A
DR   Wikidata; Q127383681
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1130.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI56435 and PPMI_56435 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VV ! PPMI.I.1130.2
OI   CVCL_D5VW ! PPMI.I.1130.3
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1130.2
AC   CVCL_D5VV
SY   PPMI56435; PPMI_56435; CDIi041-A; FCDI_11328
DR   BioSamples; SAMEA115473816
DR   hPSCreg; CDIi041-A
DR   Wikidata; Q127383683
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI56435 and PPMI_56435 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VU ! PPMI.I.1130.1
OI   CVCL_D5VW ! PPMI.I.1130.3
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1130.3
AC   CVCL_D5VW
SY   PPMI56435; PPMI_56435; CDIi041-A; FCDI_11328
DR   BioSamples; SAMEA115473816
DR   hPSCreg; CDIi041-A
DR   Wikidata; Q127383685
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1130.2).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI56435 and PPMI_56435 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VU ! PPMI.I.1130.1
OI   CVCL_D5VV ! PPMI.I.1130.2
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1131.1
AC   CVCL_D5VX
SY   PPMI56558
DR   Wikidata; Q127383687
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI56558 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VY ! PPMI.I.1131.2
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1131.2
AC   CVCL_D5VY
SY   PPMI56558
DR   Wikidata; Q127383690
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI56558 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VX ! PPMI.I.1131.1
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1132.1
AC   CVCL_D5VZ
SY   PPMI56571
DR   Wikidata; Q127383692
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56571 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W0 ! PPMI.I.1132.2
OI   CVCL_D5W1 ! PPMI.I.1132.3
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1132.2
AC   CVCL_D5W0
SY   PPMI56571
DR   Wikidata; Q127383694
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56571 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VZ ! PPMI.I.1132.1
OI   CVCL_D5W1 ! PPMI.I.1132.3
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1132.3
AC   CVCL_D5W1
SY   PPMI56571
DR   Wikidata; Q127383696
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56571 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5VZ ! PPMI.I.1132.1
OI   CVCL_D5W0 ! PPMI.I.1132.2
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1133.1
AC   CVCL_D5W2
SY   PPMI56680; PPMI_56680; CDIi076-A; FCDI_11465
DR   BioSamples; SAMEA115473886
DR   hPSCreg; CDIi076-A
DR   Wikidata; Q127383698
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56680 and PPMI_56680 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W3 ! PPMI.I.1133.2
OI   CVCL_D5W4 ! PPMI.I.1133.3
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1133.2
AC   CVCL_D5W3
SY   PPMI56680; PPMI_56680; CDIi076-A; FCDI_11465
DR   BioSamples; SAMEA115473886
DR   hPSCreg; CDIi076-A
DR   Wikidata; Q127383700
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1133.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56680 and PPMI_56680 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W2 ! PPMI.I.1133.1
OI   CVCL_D5W4 ! PPMI.I.1133.3
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1133.3
AC   CVCL_D5W4
SY   PPMI56680; PPMI_56680; CDIi076-A; FCDI_11465
DR   BioSamples; SAMEA115473886
DR   hPSCreg; CDIi076-A
DR   Wikidata; Q127383704
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1133.1).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56680 and PPMI_56680 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W2 ! PPMI.I.1133.1
OI   CVCL_D5W3 ! PPMI.I.1133.2
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1134.1
AC   CVCL_D5W5
SY   PPMI56761; PPMI_56761; CDIi039-A; FCDI_11325
DR   BioSamples; SAMEA115473812
DR   hPSCreg; CDIi039-A
DR   Wikidata; Q127383706
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI; PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI56761 and PPMI_56761 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W7 ! PPMI.I.1134.2
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1134.1.ISO.1
AC   CVCL_D5W6
DR   Wikidata; Q127383708
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PPMI).
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5W5 ! PPMI.I.1134.1
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1134.2
AC   CVCL_D5W7
SY   PPMI56761; PPMI_56761; CDIi039-A; FCDI_11325
DR   BioSamples; SAMEA115473812
DR   hPSCreg; CDIi039-A
DR   Wikidata; Q127383710
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PPMI).
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup LRRK2.
CC   Caution: The PPMI56761 and PPMI_56761 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W5 ! PPMI.I.1134.1
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1135.1
AC   CVCL_D5W8
SY   PPMI56779; PPMI_56779; CDIi046-A; FCDI_11340
DR   BioSamples; SAMEA115473826
DR   hPSCreg; CDIi046-A
DR   Wikidata; Q127383712
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1135.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI56779 and PPMI_56779 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W9 ! PPMI.I.1135.2
OI   CVCL_D5WA ! PPMI.I.1135.3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1135.2
AC   CVCL_D5W9
SY   PPMI56779; PPMI_56779; CDIi046-A; FCDI_11340
DR   BioSamples; SAMEA115473826
DR   hPSCreg; CDIi046-A
DR   Wikidata; Q127383714
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI56779 and PPMI_56779 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W8 ! PPMI.I.1135.1
OI   CVCL_D5WA ! PPMI.I.1135.3
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1135.3
AC   CVCL_D5WA
SY   PPMI56779; PPMI_56779; CDIi046-A; FCDI_11340
DR   BioSamples; SAMEA115473826
DR   hPSCreg; CDIi046-A
DR   Wikidata; Q127383716
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (from autologous cell line PPMI.I.1135.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI56779 and PPMI_56779 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5W8 ! PPMI.I.1135.1
OI   CVCL_D5W9 ! PPMI.I.1135.2
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1136.1
AC   CVCL_D5WB
SY   PPMI56954; PPMI_56954; CDIi057-A; FCDI_11355
DR   BioSamples; SAMEA115473848
DR   hPSCreg; CDIi057-A
DR   Wikidata; Q127383718
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1136.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56954 and PPMI_56954 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WC ! PPMI.I.1136.2
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1136.2
AC   CVCL_D5WC
SY   PPMI56954; PPMI_56954; CDIi057-A; FCDI_11355
DR   BioSamples; SAMEA115473848
DR   hPSCreg; CDIi057-A
DR   Wikidata; Q127383720
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI56954 and PPMI_56954 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WB ! PPMI.I.1136.1
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1137.1
AC   CVCL_D5WD
SY   PPMI57037
DR   Wikidata; Q127383721
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI57037 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WE ! PPMI.I.1137.2
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1137.2
AC   CVCL_D5WE
SY   PPMI57037
DR   Wikidata; Q127383723
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI57037 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WD ! PPMI.I.1137.1
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1138.1
AC   CVCL_D5WF
SY   PPMI57090
DR   Wikidata; Q127383727
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI57090 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WG ! PPMI.I.1138.2
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1138.2
AC   CVCL_D5WG
SY   PPMI57090
DR   Wikidata; Q127383729
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI57090 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WF ! PPMI.I.1138.1
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1139.1
AC   CVCL_D5WH
SY   PPMI57170
DR   Wikidata; Q127383732
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI57170 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WI ! PPMI.I.1139.2
OI   CVCL_D5WJ ! PPMI.I.1139.3
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1139.2
AC   CVCL_D5WI
SY   PPMI57170
DR   Wikidata; Q127383734
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI57170 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WH ! PPMI.I.1139.1
OI   CVCL_D5WJ ! PPMI.I.1139.3
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1139.3
AC   CVCL_D5WJ
SY   PPMI57170
DR   Wikidata; Q127383737
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI57170 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WH ! PPMI.I.1139.1
OI   CVCL_D5WI ! PPMI.I.1139.2
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1140.1
AC   CVCL_D5WK
SY   PPMI57277
DR   Wikidata; Q127383739
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI57277 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WL ! PPMI.I.1140.2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1140.2
AC   CVCL_D5WL
SY   PPMI57277
DR   Wikidata; Q127383740
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI57277 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WK ! PPMI.I.1140.1
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1141.1
AC   CVCL_D5WM
SY   PPMI57292; PPMI_57292; CDIi084-A; FCDI_11483
DR   BioSamples; SAMEA115473902
DR   hPSCreg; CDIi084-A
DR   Wikidata; Q127383742
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1141.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI57292 and PPMI_57292 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WN ! PPMI.I.1141.2
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1141.2
AC   CVCL_D5WN
SY   PPMI57292; PPMI_57292; CDIi084-A; FCDI_11483
DR   BioSamples; SAMEA115473902
DR   hPSCreg; CDIi084-A
DR   Wikidata; Q127383745
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI57292 and PPMI_57292 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WM ! PPMI.I.1141.1
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1142.1
AC   CVCL_D5WP
SY   PPMI57447; PPMI_57447; CDIi081-A; FCDI_11474
DR   BioSamples; SAMEA115473896
DR   hPSCreg; CDIi081-A
DR   Wikidata; Q127383747
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (PubMed=36950378).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1143.1
AC   CVCL_D5WQ
SY   PPMI57670; PPMI_57670; CDIi079-A; FCDI_11471
DR   BioSamples; SAMEA115473892
DR   hPSCreg; CDIi079-A
DR   Wikidata; Q127383749
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1143.3).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI57670 and PPMI_57670 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WR ! PPMI.I.1143.2
OI   CVCL_D5WS ! PPMI.I.1143.3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1143.2
AC   CVCL_D5WR
SY   PPMI57670; PPMI_57670; CDIi079-A; FCDI_11471
DR   BioSamples; SAMEA115473892
DR   hPSCreg; CDIi079-A
DR   Wikidata; Q127383751
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1143.3).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI57670 and PPMI_57670 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WQ ! PPMI.I.1143.1
OI   CVCL_D5WS ! PPMI.I.1143.3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1143.3
AC   CVCL_D5WS
SY   PPMI57670; PPMI_57670; CDIi079-A; FCDI_11471
DR   BioSamples; SAMEA115473892
DR   hPSCreg; CDIi079-A
DR   Wikidata; Q127383754
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI57670 and PPMI_57670 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WQ ! PPMI.I.1143.1
OI   CVCL_D5WR ! PPMI.I.1143.2
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1144.1
AC   CVCL_D5WT
SY   PPMI57869
DR   Wikidata; Q127383758
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI57869 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WU ! PPMI.I.1144.2
OI   CVCL_D5WV ! PPMI.I.1144.3
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1144.2
AC   CVCL_D5WU
SY   PPMI57869
DR   Wikidata; Q127383760
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI57869 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WT ! PPMI.I.1144.1
OI   CVCL_D5WV ! PPMI.I.1144.3
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1144.3
AC   CVCL_D5WV
SY   PPMI57869
DR   Wikidata; Q127383763
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI57869 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WT ! PPMI.I.1144.1
OI   CVCL_D5WU ! PPMI.I.1144.2
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1145.1
AC   CVCL_D5WW
SY   PPMI57961; PPMI_57961; CDIi096-A; FCDI_11526
DR   BioSamples; SAMEA115473926
DR   hPSCreg; CDIi096-A
DR   Wikidata; Q127383765
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line PPMI.I.1145.2).
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI57961 and PPMI_57961 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WX ! PPMI.I.1145.2
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1145.2
AC   CVCL_D5WX
SY   PPMI57961; PPMI_57961; CDIi096-A; FCDI_11526
DR   BioSamples; SAMEA115473926
DR   hPSCreg; CDIi096-A
DR   Wikidata; Q127383767
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup GBA.
CC   Caution: The PPMI57961 and PPMI_57961 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WW ! PPMI.I.1145.1
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1146.1
AC   CVCL_D5WY
SY   PPMI58027
DR   Wikidata; Q127383769
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI58027 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WZ ! PPMI.I.1146.2
OI   CVCL_D5X0 ! PPMI.I.1146.3
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1146.2
AC   CVCL_D5WZ
SY   PPMI58027
DR   Wikidata; Q127383771
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI58027 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WY ! PPMI.I.1146.1
OI   CVCL_D5X0 ! PPMI.I.1146.3
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1146.3
AC   CVCL_D5X0
SY   PPMI58027
DR   Wikidata; Q127383773
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Caution: The PPMI58027 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5WY ! PPMI.I.1146.1
OI   CVCL_D5WZ ! PPMI.I.1146.2
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1147.1
AC   CVCL_D5X1
SY   PPMI58182; PPMI_58182; CDIi103-A; FCDI_11571
DR   BioSamples; SAMEA115473940
DR   hPSCreg; CDIi103-A
DR   Wikidata; Q127383775
RX   PubMed=34434090;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=36950378).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   PPMI.I.1148.1
AC   CVCL_D5X2
SY   PPMI58454
DR   Wikidata; Q127383776
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI58454 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X3 ! PPMI.I.1148.2
OI   CVCL_D5X4 ! PPMI.I.1148.3
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1148.2
AC   CVCL_D5X3
SY   PPMI58454
DR   Wikidata; Q127383778
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI58454 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X2 ! PPMI.I.1148.1
OI   CVCL_D5X4 ! PPMI.I.1148.3
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1148.3
AC   CVCL_D5X4
SY   PPMI58454
DR   Wikidata; Q127383780
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup GBA.
CC   Caution: The PPMI58454 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X2 ! PPMI.I.1148.1
OI   CVCL_D5X3 ! PPMI.I.1148.2
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1149.1
AC   CVCL_D5X5
SY   PPMI59483
DR   Wikidata; Q127383782
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup LRRK2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1150.1
AC   CVCL_D5X6
SY   PPMI60003; PPMI_60003; CDIi055-A; FCDI_11349
DR   BioSamples; SAMEA115473844
DR   hPSCreg; CDIi055-A
DR   Wikidata; Q127383785
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup RBD.
CC   Caution: The PPMI60003 and PPMI_60003 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Perip$heral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X7 ! PPMI.I.1150.2
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1150.2
AC   CVCL_D5X7
SY   PPMI60003; PPMI_60003; CDIi055-A; FCDI_11349
DR   BioSamples; SAMEA115473844
DR   hPSCreg; CDIi055-A
DR   Wikidata; Q127383788
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling established from a patient at the prodromal stage of Parkinson disease.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup RBD.
CC   Caution: The PPMI60003 and PPMI_60003 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X6 ! PPMI.I.1150.1
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1151.1
AC   CVCL_D5X8
SY   PPMI60013
DR   Wikidata; Q127383792
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup RBD + hyposmia.
CC   Caution: The PPMI60013 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X9 ! PPMI.I.1151.2
OI   CVCL_D5XA ! PPMI.I.1151.3
OI   CVCL_D5XB ! PPMI.I.1151.4
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1151.2
AC   CVCL_D5X9
SY   PPMI60013
DR   Wikidata; Q127383795
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup RBD + hyposmia.
CC   Caution: The PPMI60013 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X8 ! PPMI.I.1151.1
OI   CVCL_D5XA ! PPMI.I.1151.3
OI   CVCL_D5XB ! PPMI.I.1151.4
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1151.3
AC   CVCL_D5XA
SY   PPMI60013
DR   Wikidata; Q127383797
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup RBD + hyposmia.
CC   Caution: The PPMI60013 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X8 ! PPMI.I.1151.1
OI   CVCL_D5X9 ! PPMI.I.1151.2
OI   CVCL_D5XB ! PPMI.I.1151.4
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1151.4
AC   CVCL_D5XB
SY   PPMI60013
DR   Wikidata; Q127383800
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup RBD + hyposmia.
CC   Caution: The PPMI60013 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5X8 ! PPMI.I.1151.1
OI   CVCL_D5X9 ! PPMI.I.1151.2
OI   CVCL_D5XA ! PPMI.I.1151.3
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1152.1
AC   CVCL_D5XC
SY   PPMI90456; PPMI_90456; CDIi062-A; FCDI_11436
DR   BioSamples; SAMEA115473858
DR   hPSCreg; CDIi062-A
DR   Wikidata; Q127383803
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI90456 and PPMI_90456 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XD ! PPMI.I.1152.2
OI   CVCL_D5XE ! PPMI.I.1152.3
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1152.2
AC   CVCL_D5XD
SY   PPMI90456; PPMI_90456; CDIi062-A; FCDI_11436
DR   BioSamples; SAMEA115473858
DR   hPSCreg; CDIi062-A
DR   Wikidata; Q127383807
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI90456 and PPMI_90456 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XC ! PPMI.I.1152.1
OI   CVCL_D5XE ! PPMI.I.1152.3
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1152.3
AC   CVCL_D5XE
SY   PPMI90456; PPMI_90456; CDIi062-A; FCDI_11436
DR   BioSamples; SAMEA115473858
DR   hPSCreg; CDIi062-A
DR   Wikidata; Q127383809
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI90456 and PPMI_90456 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XC ! PPMI.I.1152.1
OI   CVCL_D5XD ! PPMI.I.1152.2
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1153.1
AC   CVCL_D5XF
SY   PPMI91097
DR   Wikidata; Q127383813
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI91097 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XG ! PPMI.I.1153.2
OI   CVCL_D5XH ! PPMI.I.1153.3
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1153.2
AC   CVCL_D5XG
SY   PPMI91097
DR   Wikidata; Q127383817
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI91097 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XF ! PPMI.I.1153.1
OI   CVCL_D5XH ! PPMI.I.1153.3
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1153.3
AC   CVCL_D5XH
SY   PPMI91097
DR   Wikidata; Q127383819
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Hispanic.
CC   Donor information: At sampling donor was not affected with Parkinson disease but at risk for disease. Was suffering from hyposmia.
CC   Miscellaneous: PPMI study cohort prodromal, PPMI study subgroup hyposmia.
CC   Caution: The PPMI91097 identifier corresponds to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, this identifier should not be cited in a publication.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XF ! PPMI.I.1153.1
OI   CVCL_D5XG ! PPMI.I.1153.2
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1154.1
AC   CVCL_D5XI
SY   PPMI3453; PPMI_3453; CDIi048-A; FCDI_11342
DR   BioSamples; SAMEA115473830
DR   hPSCreg; CDIi048-A
DR   Wikidata; Q127383823
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3453 and PPMI_3453 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XJ ! PPMI.I.1154.2
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1154.2
AC   CVCL_D5XJ
SY   PPMI3453; PPMI_3453; CDIi048-A; FCDI_11342
DR   BioSamples; SAMEA115473830
DR   hPSCreg; CDIi048-A
DR   Wikidata; Q127383827
RX   PubMed=34434090;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Miscellaneous: PPMI study cohort HC, PPMI study subgroup healthy control.
CC   Caution: The PPMI3453 and PPMI_3453 identifiers correspond to an internal donor ID at PPMI. As multiple iPSC clones have been established from the cells of this donor, these identifiers should not be cited in a publication. Note that FujiFilm Cellular Dynamics, Inc (FCDI) and hPSCreg have assigned only a single identifier for all of the PBMC derived clones.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D5XI ! PPMI.I.1154.1
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMI.I.1155.1
AC   CVCL_D5XK
SY   PPMI3471; PPMI_3471; CDIi047-A; FCDI_11341
DR   BioSamples; SAMEA115473828
DR   hPSCreg; CDIi047-A
DR   Wikidata; Q127383830
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   Info; PPMI; -; https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
WW   Info; PPMI; -; https://www.ppmi-info.org/access-data-specimens/download-data
CC   Part of: Parkinson's Progression Markers Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genomics; Whole genome sequencing.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PPMX0501
AC   CVCL_IY28
SY   PPZ2919
DR   Wikidata; Q54947792
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-21017.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0502
AC   CVCL_IY29
SY   PPZ3124
DR   Wikidata; Q54947793
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10809.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0503
AC   CVCL_IY30
SY   PPZ3135
DR   Wikidata; Q54947795
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-21019.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0504
AC   CVCL_IY31
SY   PPZ3148
DR   Wikidata; Q54947796
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10810.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0507
AC   CVCL_IY32
SY   PPZ3122
DR   Wikidata; Q54947797
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10811.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0508
AC   CVCL_IY33
SY   PPZ3133
DR   Wikidata; Q54947798
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10812.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0509
AC   CVCL_IY34
SY   PPZ2913
DR   Wikidata; Q54947799
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-21037.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0510
AC   CVCL_IY35
SY   PPZ2952
DR   Wikidata; Q54947800
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-21038.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0511
AC   CVCL_IY36
SY   PPZ3130
DR   Wikidata; Q54947801
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-21039.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   PPMX0519
AC   CVCL_IY37
SY   PPZ3145
DR   Wikidata; Q54947802
RX   Patent=US8273859;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10813.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q86SJ2; Human AMIGO2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 5
//
ID   pPS1
AC   CVCL_AD95
DR   Wikidata; Q54947803
RX   PubMed=21979046;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=21979046
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 19
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   PPT2
AC   CVCL_RU11
DR   cancercelllines; CVCL_RU11
DR   Millipore; SCC104
DR   Wikidata; Q54947804
RX   PubMed=24086245;
CC   Problematic cell line: Contaminated. Shown to be a HCT 116 derivative (STR profile). Originally thought to originate from a male patient with prostate carcinoma.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Millipore; SCC104; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Millipore=SCC104
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 10,11,13
ST   D16S539: 11,13,14
ST   D18S51: 17,18
ST   D21S11: 29,30
ST   D3S1358: 12,18,19
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,22,23
ST   Penta D: 9,13
ST   Penta E: 13,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18,21,22
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   PPY00327IN
AC   CVCL_E190
DR   Wikidata; Q54947805
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PPY00328IN
AC   CVCL_E191
DR   Wikidata; Q54947806
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PPY00329IN
AC   CVCL_E192
DR   Wikidata; Q54947808
RX   PubMed=18477388;
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PPY00330IN
AC   CVCL_E193
DR   Wikidata; Q54947809
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PPY00331IN
AC   CVCL_E194
DR   Wikidata; Q54947810
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PQXB1/2
AC   CVCL_A6JY
SY   PQXB 1/2
DR   ECACC; 89050503
DR   Wikidata; Q107116674
RX   DOI=10.1007/978-94-011-2044-9_61;
RX   DOI=10.1007/BF00138538;
RX   PubMed=7766007;
RX   PubMed=8267405;
RX   PubMed=18623591;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat.
CC   Discontinued: ECACC; 89050503; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   PQXB2/2
AC   CVCL_A6JZ
SY   PQXB 2/2
DR   Wikidata; Q107116675
RX   DOI=10.1007/BF00138538;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   Pr-111
AC   CVCL_Z948
SY   Pr111
DR   Wikidata; Q54947811
RX   PubMed=11896566;
RX   PubMed=12235003;
CC   Doubling time: ~40 hours (PubMed=11896566).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the promoter of rat Psbpc3/Scgb2a2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a mouse suffering from a prostatic intraepithelial neoplasia (PIN) lesion.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: FVB-Tg(C3-1-TAg)cJeg/JegJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 7
//
ID   Pr-117
AC   CVCL_Z949
SY   Pr117
DR   Wikidata; Q54947812
RX   PubMed=11896566;
RX   PubMed=12235003;
CC   Doubling time: ~22 hours (PubMed=11896566).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the promoter of rat Psbpc3/Scgb2a2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Donor information: Established from a mouse suffering from a prostatic intraepithelial neoplasia (PIN) lesion.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: FVB-Tg(C3-1-TAg)cJeg/JegJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 7
//
ID   Pr-14
AC   CVCL_Z950
SY   Pr14
DR   Wikidata; Q54947813
RX   PubMed=9428383;
RX   PubMed=12235003;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   Pr-14C1
AC   CVCL_Z951
SY   Pr14C1
DR   Wikidata; Q54947815
RX   PubMed=12235003;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z950 ! Pr-14
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   Pr-14C2
AC   CVCL_Z952
SY   Pr14C2
DR   Wikidata; Q54947817
RX   PubMed=12235003;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z950 ! Pr-14
SX   Male
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   PR-57
AC   CVCL_ZF46
SY   PR 57; Pr57
DR   ICLDB; pr-57
DR   Wikidata; Q98128658
RX   PubMed=15038778;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Pr-E-HNU9
AC   CVCL_Z573
DR   ICLDB; pr-e-hnu9
DR   Wikidata; Q54947818
RX   DOI=10.19603/j.cnki.1000-1190.1995.03.022;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   Pr-E-HNU9(A)
AC   CVCL_ZF36
SY   Pr-E(A)
DR   Wikidata; Q98128659
RX   DOI=10.19603/j.cnki.1000-1190.1995.03.022;
RX   DOI=10.19603/j.cnki.1000-1190.1995.04.025;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
HI   CVCL_Z573 ! Pr-E-HNU9
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   Pr-E-HNU9(B)
AC   CVCL_ZF37
SY   Pr-E(B)
DR   Wikidata; Q98128660
RX   DOI=10.19603/j.cnki.1000-1190.1995.03.022;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
HI   CVCL_Z573 ! Pr-E-HNU9
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   Pr-E-HNU9(C)
AC   CVCL_ZF38
SY   Pr-E(C)
DR   Wikidata; Q98128661
RX   DOI=10.19603/j.cnki.1000-1190.1995.03.022;
RX   DOI=10.19603/j.cnki.1000-1190.1995.04.025;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=64459; ! Pieris rapae (Small white butterfly)
HI   CVCL_Z573 ! Pr-E-HNU9
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   PR-GTL-16
AC   CVCL_7696
DR   cancercelllines; CVCL_7696
DR   Wikidata; Q54947819
RX   PubMed=21208906;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_90197; PHA-665752.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7668 ! GTL-16
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   PR-Mel
AC   CVCL_7113
SY   PRMel
DR   BTO; BTO_0003789
DR   cancercelllines; CVCL_7113
DR   Cosmic; 1088702
DR   Cosmic; 1109801
DR   Cosmic; 1295341
DR   GEO; GSM276750
DR   Wikidata; Q54947821
RX   PubMed=11121133;
RX   PubMed=11851879;
RX   PubMed=12696065;
RX   PubMed=18384130;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Microsatellite instability: Instable (MSI) (PubMed=11851879).
CC   Sequence variation: Mutation; HGNC; HGNC:904; AXIN2; Simple; p.Thr672_Arg675del (c.2013_2024del); ClinVar=VCV000182018; Zygosity=Heterozygous; Note=Germline (PubMed=18384130).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=18384130).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   PR00002
AC   CVCL_2V04
DR   CLO; CLO_0017726
DR   BioSamples; SAME39239
DR   Coriell; PR00002
DR   Wikidata; Q54947822
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00002; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
OI   CVCL_1G38 ! AG05252
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00003
AC   CVCL_2V05
DR   CLO; CLO_0017710
DR   BioSamples; SAME39238
DR   Coriell; PR00003
DR   Wikidata; Q54947823
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00003; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00011
AC   CVCL_2V06
DR   CLO; CLO_0017712
DR   BioSamples; SAME39282
DR   Coriell; PR00011
DR   Wikidata; Q54947824
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00011; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00013
AC   CVCL_2V07
DR   CLO; CLO_0017711
DR   BioSamples; SAME39456
DR   Coriell; PR00013
DR   Wikidata; Q54947825
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00013; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00017
AC   CVCL_2V08
DR   CLO; CLO_0017714
DR   BioSamples; SAME39276
DR   Coriell; PR00017
DR   Wikidata; Q54947827
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00017; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=90387; ! Macaca leonina (Northern pig-tailed macaque)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00019
AC   CVCL_2V09
DR   CLO; CLO_0017713
DR   BioSamples; SAME39274
DR   Coriell; PR00019
DR   Wikidata; Q54947828
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00019; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00020
AC   CVCL_2V10
DR   CLO; CLO_0017716
DR   BioSamples; SAME39469
DR   Coriell; PR00020
DR   Wikidata; Q54947829
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00020; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00024
AC   CVCL_2V11
DR   CLO; CLO_0017715
DR   BioSamples; SAME39427
DR   Coriell; PR00024
DR   Wikidata; Q54947830
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00024; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00030
AC   CVCL_2V12
DR   CLO; CLO_0017718
DR   BioSamples; SAME39200
DR   Coriell; PR00030
DR   Wikidata; Q54947831
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00030; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00033
AC   CVCL_2V13
DR   CLO; CLO_0017717
DR   BioSamples; SAME39203
DR   Coriell; PR00033
DR   Wikidata; Q54947833
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00033; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00036
AC   CVCL_2V14
DR   CLO; CLO_0017719
DR   BioSamples; SAME39198
DR   Coriell; PR00036
DR   Wikidata; Q54947834
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00036; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_2V15 ! PR00037
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00037
AC   CVCL_2V15
DR   CLO; CLO_0017872
DR   BioSamples; SAME39199
DR   Coriell; PR00037
DR   Wikidata; Q54947835
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00037; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
OI   CVCL_2V14 ! PR00036
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00039
AC   CVCL_2V16
DR   CLO; CLO_0017874
DR   BioSamples; SAME39205
DR   Coriell; PR00039
DR   Wikidata; Q54947846
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00039; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00041
AC   CVCL_DN72
DR   Coriell; PR00041
DR   Wikidata; Q54947847
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00041; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00042
AC   CVCL_2V17
DR   CLO; CLO_0017875
DR   BioSamples; SAME39380
DR   Coriell; PR00042
DR   Wikidata; Q54947848
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00042; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00045
AC   CVCL_2V18
DR   CLO; CLO_0017878
DR   BioSamples; SAME39374
DR   Coriell; PR00045
DR   Wikidata; Q54947849
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00045; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00048
AC   CVCL_2V19
DR   CLO; CLO_0017868
DR   BioSamples; SAME39385
DR   Coriell; PR00048
DR   Wikidata; Q54947850
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00048; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30611; ! Otolemur garnettii (Small-eared galago)
SX   Female
AG   1Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00049
AC   CVCL_2V20
DR   CLO; CLO_0017869
DR   BioSamples; SAME39384
DR   Coriell; PR00049
DR   Wikidata; Q54947851
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00049; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30611; ! Otolemur garnettii (Small-eared galago)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00050
AC   CVCL_2V21
DR   CLO; CLO_0017870
DR   BioSamples; SAME39417
DR   Coriell; PR00050
DR   Wikidata; Q54947852
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00050; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00051
AC   CVCL_2V22
DR   CLO; CLO_0017871
DR   BioSamples; SAME39418
DR   Coriell; PR00051
DR   Wikidata; Q54947853
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00051; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00052
AC   CVCL_2V23
DR   Coriell; PR00052
DR   Wikidata; Q54947855
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00052; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR00053
AC   CVCL_2V24
DR   CLO; CLO_0017863
DR   BioSamples; SAME39416
DR   Coriell; PR00053
DR   Wikidata; Q54947856
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00053; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00054
AC   CVCL_2V25
DR   CLO; CLO_0017865
DR   BioSamples; SAME39419
DR   Coriell; PR00054
DR   Wikidata; Q54947859
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00054; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
OI   CVCL_DP06 ! PR01003
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00055
AC   CVCL_2V26
DR   CLO; CLO_0017848
DR   BioSamples; SAME39460
DR   Coriell; PR00055
DR   Wikidata; Q54947860
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00055; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00058
AC   CVCL_2V27
DR   CLO; CLO_0017846
DR   BioSamples; SAME39423
DR   Coriell; PR00058
DR   Wikidata; Q54947861
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00058; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00062
AC   CVCL_2V28
DR   CLO; CLO_0017847
DR   BioSamples; SAME39306
DR   Coriell; PR00062
DR   Wikidata; Q54947862
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00062; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00075
AC   CVCL_2V29
DR   CLO; CLO_0017842
DR   BioSamples; SAME39349
DR   Coriell; PR00075
DR   Wikidata; Q54947863
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00075; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00077
AC   CVCL_2V30
DR   CLO; CLO_0017845
DR   BioSamples; SAME39394
DR   Coriell; PR00077
DR   Wikidata; Q54947865
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00077; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00085
AC   CVCL_UD21
DR   Coriell; PR00085
DR   Wikidata; Q98128662
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00085; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   PR00087
AC   CVCL_UD22
DR   Coriell; PR00087
DR   Wikidata; Q98128663
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00087; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   PR00092
AC   CVCL_2V31
DR   CLO; CLO_0017840
DR   BioSamples; SAME39257
DR   Coriell; PR00092
DR   Wikidata; Q54947866
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00092; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00095
AC   CVCL_2V32
DR   CLO; CLO_0017841
DR   BioSamples; SAME39256
DR   Coriell; PR00095
DR   Wikidata; Q54947867
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00095; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00096
AC   CVCL_2V33
DR   CLO; CLO_0017838
DR   BioSamples; SAME39332
DR   Coriell; PR00096
DR   Wikidata; Q54947869
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00096; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00099
AC   CVCL_2V34
DR   CLO; CLO_0017839
DR   BioSamples; SAME39431
DR   Coriell; PR00099
DR   Wikidata; Q54947871
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00099; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=336983; ! Colobus angolensis palliatus (Peters' Angolan colobus)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00100
AC   CVCL_2V35
DR   CLO; CLO_0017836
DR   BioSamples; SAME39470
DR   Coriell; PR00100
DR   Wikidata; Q54947874
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00100; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00101
AC   CVCL_2V36
DR   CLO; CLO_0017939
DR   BioSamples; SAME39471
DR   Coriell; PR00101
DR   Wikidata; Q54947875
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00101; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00103
AC   CVCL_2V37
DR   CLO; CLO_0017938
DR   BioSamples; SAME39472
DR   Coriell; PR00103
DR   Wikidata; Q54947876
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00103; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00105
AC   CVCL_2V38
DR   CLO; CLO_0017927
DR   BioSamples; SAME39474
DR   Coriell; PR00105
DR   Wikidata; Q54947878
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00105; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00107
AC   CVCL_2V39
DR   CLO; CLO_0017928
DR   BioSamples; SAME39476
DR   Coriell; PR00107
DR   Wikidata; Q54947879
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00107; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00108
AC   CVCL_2V40
DR   CLO; CLO_0017929
DR   BioSamples; SAME39463
DR   Coriell; PR00108
DR   Wikidata; Q54947880
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00108; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=336983; ! Colobus angolensis palliatus (Peters' Angolan colobus)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00111
AC   CVCL_DN73
DR   Coriell; PR00111
DR   Wikidata; Q54947881
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00111; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PR00112
AC   CVCL_2V41
DR   CLO; CLO_0017931
DR   BioSamples; SAME39429
DR   Coriell; PR00112
DR   Wikidata; Q54947882
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00112; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00115
AC   CVCL_2V42
DR   CLO; CLO_0017932
DR   BioSamples; SAME39433
DR   Coriell; PR00115
DR   Wikidata; Q54947883
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00115; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00119
AC   CVCL_2V43
DR   CLO; CLO_0017933
DR   BioSamples; SAME39426
DR   Coriell; PR00119
DR   Wikidata; Q54947884
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00119; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00120
AC   CVCL_2V44
DR   CLO; CLO_0017934
DR   BioSamples; SAME39201
DR   Coriell; PR00120
DR   Wikidata; Q54947885
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00120; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00122
AC   CVCL_2V45
DR   CLO; CLO_0017935
DR   BioSamples; SAME39222
DR   Coriell; PR00122
DR   Wikidata; Q54947886
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00122; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9455; ! Varecia variegata (Black-and-white ruffed lemur)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00123
AC   CVCL_2V46
DR   CLO; CLO_0017908
DR   BioSamples; SAME39223
DR   Coriell; PR00123
DR   Wikidata; Q54947887
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00123; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9455; ! Varecia variegata (Black-and-white ruffed lemur)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00124
AC   CVCL_2V47
DR   CLO; CLO_0017907
DR   BioSamples; SAME39228
DR   Coriell; PR00124
DR   Wikidata; Q54947889
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00124; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00126
AC   CVCL_2V48
DR   CLO; CLO_0017905
DR   BioSamples; SAME39226
DR   Coriell; PR00126
DR   Wikidata; Q54947890
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00126; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00127
AC   CVCL_2V49
DR   CLO; CLO_0017899
DR   BioSamples; SAME39227
DR   Coriell; PR00127
DR   Wikidata; Q54947891
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00127; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=87288; ! Eulemur flavifrons (Blue-eyed black lemur)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00128
AC   CVCL_2V50
DR   CLO; CLO_0017900
DR   BioSamples; SAME39232
DR   Coriell; PR00128
DR   Wikidata; Q54947892
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00128; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=87288; ! Eulemur flavifrons (Blue-eyed black lemur)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00129
AC   CVCL_2V51
DR   CLO; CLO_0017897
DR   BioSamples; SAME39233
DR   Coriell; PR00129
DR   Wikidata; Q54947893
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00129; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34829; ! Eulemur rubriventer (Red-bellied lemur)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00130
AC   CVCL_2V52
DR   CLO; CLO_0017898
DR   BioSamples; SAME39187
DR   Coriell; PR00130
DR   Wikidata; Q54947894
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00130; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34829; ! Eulemur rubriventer (Red-bellied lemur)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00131
AC   CVCL_2V53
DR   CLO; CLO_0017902
DR   BioSamples; SAME39186
DR   Coriell; PR00131
DR   Wikidata; Q54947895
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00131; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00132
AC   CVCL_2V54
DR   CLO; CLO_0017903
DR   BioSamples; SAME39435
DR   Coriell; PR00132
DR   Wikidata; Q54947904
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00132; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00133
AC   CVCL_2V55
DR   CLO; CLO_0017901
DR   BioSamples; SAME39188
DR   Coriell; PR00133
DR   Wikidata; Q54947905
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00133; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9509; ! Ateles geoffroyi (Black-handed spider monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00134
AC   CVCL_DN74
DR   Coriell; PR00134
DR   Wikidata; Q54947906
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00134; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9509; ! Ateles geoffroyi (Black-handed spider monkey)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00174
AC   CVCL_2V56
DR   CLO; CLO_0018370
DR   BioSamples; SAME39341
DR   Coriell; PR00174
DR   Wikidata; Q54947907
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00174; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00175
AC   CVCL_2V57
DR   CLO; CLO_0018377
DR   BioSamples; SAME39340
DR   Coriell; PR00175
DR   Wikidata; Q54947908
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00175; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00198
AC   CVCL_2V58
DR   CLO; CLO_0018378
DR   BioSamples; SAME39413
DR   Coriell; PR00198
DR   Wikidata; Q54947909
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00198; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00219
AC   CVCL_2V59
DR   CLO; CLO_0018375
DR   BioSamples; SAME39459
DR   Coriell; PR00219
DR   Wikidata; Q54947910
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00219; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00220
AC   CVCL_2V60
DR   CLO; CLO_0018376
DR   BioSamples; SAME39194
DR   Coriell; PR00220
DR   Wikidata; Q54947912
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00220; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00221
AC   CVCL_2V61
DR   CLO; CLO_0018373
DR   BioSamples; SAME39313
DR   Coriell; PR00221
DR   Wikidata; Q54947913
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00221; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00222
AC   CVCL_2V62
DR   CLO; CLO_0018374
DR   BioSamples; SAME39196
DR   Coriell; PR00222
DR   Wikidata; Q54947914
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00222; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00223
AC   CVCL_2V63
DR   CLO; CLO_0018371
DR   BioSamples; SAME39195
DR   Coriell; PR00223
DR   Wikidata; Q54947915
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00223; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00224
AC   CVCL_2V64
DR   CLO; CLO_0018372
DR   BioSamples; SAME39190
DR   Coriell; PR00224
DR   Wikidata; Q54947916
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00224; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00226
AC   CVCL_2V65
DR   CLO; CLO_0018359
DR   BioSamples; SAME39192
DR   Coriell; PR00226
DR   GEO; GSM349157
DR   Wikidata; Q54947917
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00226; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00227
AC   CVCL_2V66
DR   CLO; CLO_0018360
DR   BioSamples; SAME39191
DR   Coriell; PR00227
DR   Wikidata; Q54947918
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00227; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34825; ! Propithecus verreauxi (White sifaka)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00228
AC   CVCL_2V67
DR   CLO; CLO_0018361
DR   BioSamples; SAME39289
DR   Coriell; PR00228
DR   Wikidata; Q54947919
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00228; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=31869; ! Daubentonia madagascariensis (Aye-aye)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00230
AC   CVCL_2V68
DR   CLO; CLO_0018366
DR   BioSamples; SAME39273
DR   Coriell; PR00230
DR   Wikidata; Q54947920
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00230; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00232
AC   CVCL_2V69
DR   CLO; CLO_0018367
DR   BioSamples; SAME39237
DR   Coriell; PR00232
DR   Wikidata; Q54947921
RX   PubMed=16214744;
RX   PubMed=16326750;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00232; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9568; ! Mandrillus leucophaeus (Drill)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00235
AC   CVCL_2V70
DR   CLO; CLO_0018368
DR   BioSamples; SAME39236
DR   Coriell; PR00235
DR   Wikidata; Q54947923
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00235; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00236
AC   CVCL_2V71
DR   CLO; CLO_0018369
DR   BioSamples; SAME39234
DR   Coriell; PR00236
DR   Wikidata; Q54947924
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00236; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00237
AC   CVCL_2V72
DR   CLO; CLO_0018362
DR   BioSamples; SAME39235
DR   Coriell; PR00237
DR   Wikidata; Q54947926
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00237; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00238
AC   CVCL_2V73
DR   CLO; CLO_0018363
DR   BioSamples; SAME39224
DR   Coriell; PR00238
DR   GEO; GSM349595
DR   Wikidata; Q54947927
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00238; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00239
AC   CVCL_2V74
DR   CLO; CLO_0018364
DR   BioSamples; SAME39225
DR   Coriell; PR00239
DR   Wikidata; Q54947929
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00239; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=43777; ! Pithecia pithecia (White-faced saki)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00240
AC   CVCL_2V75
DR   CLO; CLO_0018365
DR   BioSamples; SAME39243
DR   Coriell; PR00240
DR   Wikidata; Q54947930
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00240; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00241
AC   CVCL_2V76
DR   CLO; CLO_0018351
DR   BioSamples; SAME39281
DR   Coriell; PR00241
DR   Wikidata; Q54947932
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00241; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00242
AC   CVCL_2V77
DR   CLO; CLO_0018349
DR   BioSamples; SAME39280
DR   Coriell; PR00242
DR   Wikidata; Q54947933
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00242; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00243
AC   CVCL_2V78
DR   CLO; CLO_0018350
DR   BioSamples; SAME39279
DR   Coriell; PR00243
DR   Wikidata; Q54947935
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00243; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9589; ! Hylobates pileatus (Pileated gibbon)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00244
AC   CVCL_2V79
DR   CLO; CLO_0018354
DR   BioSamples; SAME39278
DR   Coriell; PR00244
DR   Wikidata; Q54947936
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00244; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=1215604; ! Eulemur albifrons (White-headed lemur)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00245
AC   CVCL_2V80
DR   CLO; CLO_0018355
DR   BioSamples; SAME39277
DR   Coriell; PR00245
DR   Wikidata; Q54947937
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00245; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=1215604; ! Eulemur albifrons (White-headed lemur)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00247
AC   CVCL_2V81
DR   CLO; CLO_0018352
DR   BioSamples; SAME39275
DR   Coriell; PR00247
DR   Wikidata; Q54947938
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00247; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=47178; ! Eulemur fulvus collaris (Collared brown lemur)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00251
AC   CVCL_2V82
DR   CLO; CLO_0018353
DR   BioSamples; SAME39310
DR   Coriell; PR00251
DR   Wikidata; Q54947939
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00251; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00253
AC   CVCL_2V83
DR   CLO; CLO_0018357
DR   BioSamples; SAME39311
DR   Coriell; PR00253
DR   Wikidata; Q54947941
RX   PubMed=16214744;
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00253; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00254
AC   CVCL_2V84
DR   CLO; CLO_0018358
DR   BioSamples; SAME39305
DR   Coriell; PR00254
DR   Wikidata; Q54947942
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00254; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00255
AC   CVCL_2V85
DR   CLO; CLO_0018356
DR   BioSamples; SAME39449
DR   Coriell; PR00255
DR   Wikidata; Q54947943
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00255; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=47178; ! Eulemur fulvus collaris (Collared brown lemur)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00257
AC   CVCL_2V86
DR   CLO; CLO_0018339
DR   BioSamples; SAME39308
DR   Coriell; PR00257
DR   Wikidata; Q54947944
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00257; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=13557; ! Hapalemur griseus (Gray gentle lemur)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00258
AC   CVCL_2V87
DR   CLO; CLO_0018340
DR   BioSamples; SAME39303
DR   Coriell; PR00258
DR   Wikidata; Q54947945
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00258; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=13557; ! Hapalemur griseus (Gray gentle lemur)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00259
AC   CVCL_2V88
DR   CLO; CLO_0018341
DR   BioSamples; SAME39304
DR   Coriell; PR00259
DR   Wikidata; Q54947946
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00259; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00260
AC   CVCL_2V89
DR   CLO; CLO_0018342
DR   BioSamples; SAME39367
DR   Coriell; PR00260
DR   Wikidata; Q54947947
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00260; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00261
AC   CVCL_2V90
DR   CLO; CLO_0018343
DR   BioSamples; SAME39344
DR   Coriell; PR00261
DR   Wikidata; Q54947948
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00261; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00262
AC   CVCL_2V91
DR   CLO; CLO_0018344
DR   BioSamples; SAME39347
DR   Coriell; PR00262
DR   Wikidata; Q54947950
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00262; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis (Mt. Kenya guereza)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00265
AC   CVCL_DN75
DR   Coriell; PR00265
DR   Wikidata; Q54947951
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00265; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00266
AC   CVCL_2V92
DR   CLO; CLO_0018345
DR   BioSamples; SAME39351
DR   Coriell; PR00266
DR   Wikidata; Q54947961
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00266; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00267
AC   CVCL_2V93
DR   CLO; CLO_0018346
DR   BioSamples; SAME39350
DR   Coriell; PR00267
DR   Wikidata; Q54947962
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00267; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00268
AC   CVCL_2V94
DR   CLO; CLO_0018347
DR   BioSamples; SAME39338
DR   Coriell; PR00268
DR   Wikidata; Q54947964
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00268; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00269
AC   CVCL_2V95
DR   CLO; CLO_0018348
DR   BioSamples; SAME39337
DR   Coriell; PR00269
DR   Wikidata; Q54947965
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00269; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00270
AC   CVCL_2V96
DR   CLO; CLO_0018338
DR   BioSamples; SAME39379
DR   Coriell; PR00270
DR   Wikidata; Q54947966
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00270; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00273
AC   CVCL_2V97
DR   CLO; CLO_0018337
DR   BioSamples; SAME39363
DR   Coriell; PR00273
DR   Wikidata; Q54947967
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00273; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34829; ! Eulemur rubriventer (Red-bellied lemur)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00275
AC   CVCL_2V98
DR   Coriell; PR00275
DR   Wikidata; Q54947968
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00275; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30608; ! Microcebus murinus (Gray mouse lemur)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR00276
AC   CVCL_DN76
DR   Coriell; PR00276
DR   Wikidata; Q54947970
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00276; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00279
AC   CVCL_2V99
DR   CLO; CLO_0018336
DR   BioSamples; SAME39386
DR   Coriell; PR00279
DR   Wikidata; Q54947971
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00279; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00280
AC   CVCL_2W00
DR   CLO; CLO_0018335
DR   BioSamples; SAME39358
DR   Coriell; PR00280
DR   Wikidata; Q54947972
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00280; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00281
AC   CVCL_2W01
DR   CLO; CLO_0018334
DR   BioSamples; SAME39357
DR   Coriell; PR00281
DR   Wikidata; Q54947973
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00281; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34825; ! Propithecus verreauxi (White sifaka)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00282
AC   CVCL_2W02
DR   CLO; CLO_0018333
DR   BioSamples; SAME39356
DR   Coriell; PR00282
DR   Wikidata; Q54947974
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00282; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34825; ! Propithecus verreauxi (White sifaka)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00283
AC   CVCL_DP26
DR   Coriell; PR00283
DR   Wikidata; Q54947975
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00283; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=100224; ! Allochrocebus lhoesti (L'Hoest's monkey)
SX   Male
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PR00285
AC   CVCL_2W03
DR   CLO; CLO_0018332
DR   BioSamples; SAME39360
DR   Coriell; PR00285
DR   Wikidata; Q54947976
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00285; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=87288; ! Eulemur flavifrons (Blue-eyed black lemur)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00288
AC   CVCL_2W04
DR   CLO; CLO_0018331
DR   BioSamples; SAME39411
DR   Coriell; PR00288
DR   Wikidata; Q54947977
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00288; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00289
AC   CVCL_2W05
DR   CLO; CLO_0018330
DR   BioSamples; SAME39450
DR   Coriell; PR00289
DR   Wikidata; Q54947979
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00289; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00290
AC   CVCL_2W06
DR   CLO; CLO_0018329
DR   BioSamples; SAME39403
DR   Coriell; PR00290
DR   Wikidata; Q54947980
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00290; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9455; ! Varecia variegata (Black-and-white ruffed lemur)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00291
AC   CVCL_2W07
DR   CLO; CLO_0018328
DR   BioSamples; SAME39404
DR   Coriell; PR00291
DR   Wikidata; Q54947981
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00291; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00292
AC   CVCL_2W08
DR   CLO; CLO_0018327
DR   BioSamples; SAME39405
DR   Coriell; PR00292
DR   Wikidata; Q54947982
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00292; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00293
AC   CVCL_2W09
DR   CLO; CLO_0018324
DR   BioSamples; SAME39406
DR   Coriell; PR00293
DR   Wikidata; Q54947983
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00293; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00294
AC   CVCL_2W10
DR   CLO; CLO_0018323
DR   BioSamples; SAME39407
DR   Coriell; PR00294
DR   Wikidata; Q54947985
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00294; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00295
AC   CVCL_2W11
DR   CLO; CLO_0018326
DR   BioSamples; SAME39408
DR   Coriell; PR00295
DR   Wikidata; Q54947986
RX   PubMed=16214744;
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00295; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9495; ! Callimico goeldii (Goeldi's marmoset)
SX   Female
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00296
AC   CVCL_2W12
DR   CLO; CLO_0018325
DR   BioSamples; SAME39409
DR   Coriell; PR00296
DR   Wikidata; Q54947987
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00296; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=336983; ! Colobus angolensis palliatus (Peters' Angolan colobus)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00301
AC   CVCL_2W13
DR   CLO; CLO_0018320
DR   BioSamples; SAME39333
DR   Coriell; PR00301
DR   Wikidata; Q54947988
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00301; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00302
AC   CVCL_2W14
DR   CLO; CLO_0018319
DR   BioSamples; SAME39330
DR   Coriell; PR00302
DR   Wikidata; Q54947989
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00302; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34825; ! Propithecus verreauxi (White sifaka)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00303
AC   CVCL_2W15
DR   CLO; CLO_0018322
DR   BioSamples; SAME39331
DR   Coriell; PR00303
DR   Wikidata; Q54947990
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00303; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00304
AC   CVCL_2W16
DR   CLO; CLO_0018321
DR   BioSamples; SAME39211
DR   Coriell; PR00304
DR   Wikidata; Q54947992
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00304; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30603; ! Eulemur macaco macaco (Black lemur)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00306
AC   CVCL_2W17
DR   CLO; CLO_0018314
DR   BioSamples; SAME39334
DR   Coriell; PR00306
DR   Wikidata; Q54947993
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00306; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00307
AC   CVCL_DP27
DR   Coriell; PR00307
DR   Wikidata; Q54947995
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00307; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   PR00316
AC   CVCL_2W18
DR   CLO; CLO_0018312
DR   BioSamples; SAME39399
DR   Coriell; PR00316
DR   Wikidata; Q54947996
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00316; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=40322; ! Eulemur fulvus fulvus (Brown lemur)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00319
AC   CVCL_2W19
DR   CLO; CLO_0018311
DR   BioSamples; SAME39294
DR   Coriell; PR00319
DR   Wikidata; Q54947997
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00319; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=13514; ! Eulemur coronatus (Crowned lemur)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00320
AC   CVCL_2W20
DR   CLO; CLO_0018318
DR   BioSamples; SAME39263
DR   Coriell; PR00320
DR   Wikidata; Q54947998
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00320; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=13514; ! Eulemur coronatus (Crowned lemur)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00322
AC   CVCL_2W21
DR   CLO; CLO_0018317
DR   BioSamples; SAME39265
DR   Coriell; PR00322
DR   Wikidata; Q54947999
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00322; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00323
AC   CVCL_2W22
DR   CLO; CLO_0018316
DR   BioSamples; SAME39266
DR   Coriell; PR00323
DR   Wikidata; Q54948001
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00323; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00324
AC   CVCL_2W23
DR   CLO; CLO_0018315
DR   BioSamples; SAME39267
DR   Coriell; PR00324
DR   Wikidata; Q54948002
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00324; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR00326
AC   CVCL_2W24
DR   CLO; CLO_0018306
DR   BioSamples; SAME39269
DR   Coriell; PR00326
DR   Wikidata; Q54948003
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00326; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34825; ! Propithecus verreauxi (White sifaka)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00330
AC   CVCL_2W25
DR   CLO; CLO_0018304
DR   BioSamples; SAME39217
DR   Coriell; PR00330
DR   Wikidata; Q54948005
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00330; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54180; ! Trachypithecus francoisi (Francois' leaf monkey)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00331
AC   CVCL_2W26
DR   CLO; CLO_0018301
DR   BioSamples; SAME39212
DR   Coriell; PR00331
DR   Wikidata; Q54948006
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00331; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9447; ! Lemur catta (Ring-tailed lemur)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00333
AC   CVCL_2W27
DR   CLO; CLO_0018292
DR   BioSamples; SAME39208
DR   Coriell; PR00333
DR   Wikidata; Q54948007
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00333; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00334
AC   CVCL_2W28
DR   CLO; CLO_0018291
DR   BioSamples; SAME39229
DR   Coriell; PR00334
DR   Wikidata; Q54948010
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00334; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00335
AC   CVCL_2W29
DR   CLO; CLO_0018295
DR   BioSamples; SAME39259
DR   Coriell; PR00335
DR   Wikidata; Q54948020
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00335; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00336
AC   CVCL_2W30
DR   CLO; CLO_0018294
DR   BioSamples; SAME39262
DR   Coriell; PR00336
DR   Wikidata; Q54948021
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00336; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=40322; ! Eulemur fulvus fulvus (Brown lemur)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00337
AC   CVCL_2W31
DR   CLO; CLO_0018297
DR   BioSamples; SAME39219
DR   Coriell; PR00337
DR   Wikidata; Q54948022
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00337; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=859984; ! Eulemur rufifrons (Bennett's brown lemur)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00338
AC   CVCL_2W32
DR   Coriell; PR00338
DR   Wikidata; Q54948023
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00338; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   PR00340
AC   CVCL_2W33
DR   CLO; CLO_0018296
DR   BioSamples; SAME39295
DR   Coriell; PR00340
DR   Wikidata; Q54948024
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00340; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=13557; ! Hapalemur griseus (Gray gentle lemur)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00341
AC   CVCL_2W34
DR   CLO; CLO_0018299
DR   BioSamples; SAME39189
DR   Coriell; PR00341
DR   Wikidata; Q54948025
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00341; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34829; ! Eulemur rubriventer (Red-bellied lemur)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00342
AC   CVCL_2W35
DR   CLO; CLO_0018298
DR   BioSamples; SAME39288
DR   Coriell; PR00342
DR   Wikidata; Q54948026
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00342; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=47178; ! Eulemur fulvus collaris (Collared brown lemur)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00344
AC   CVCL_2W36
DR   CLO; CLO_0018283
DR   BioSamples; SAME39184
DR   Coriell; PR00344
DR   Wikidata; Q54948027
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00344; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=87288; ! Eulemur flavifrons (Blue-eyed black lemur)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00345
AC   CVCL_2W37
DR   CLO; CLO_0018281
DR   BioSamples; SAME39185
DR   Coriell; PR00345
DR   Wikidata; Q54948028
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00345; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00357
AC   CVCL_2W38
DR   CLO; CLO_0018496
DR   BioSamples; SAME39475
DR   Coriell; PR00357
DR   Wikidata; Q54948029
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00357; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=859984; ! Eulemur rufifrons (Bennett's brown lemur)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00366
AC   CVCL_2W39
DR   CLO; CLO_0018483
DR   BioSamples; SAME39430
DR   Coriell; PR00366
DR   Wikidata; Q54948030
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00366; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00367
AC   CVCL_DN77
DR   Coriell; PR00367
DR   Wikidata; Q54948031
RX   PubMed=16214744;
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00367; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PR00370
AC   CVCL_2W40
DR   Coriell; PR00370
DR   Wikidata; Q54948033
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00370; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34828; ! Eulemur mongoz (Mongoose lemur)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   PR00381
AC   CVCL_2W41
DR   CLO; CLO_0018484
DR   BioSamples; SAME39339
DR   Coriell; PR00381
DR   Wikidata; Q54948034
RX   PubMed=16214744;
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00381; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61852; ! Nomascus gabriellae (Red-cheeked gibbon)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00389
AC   CVCL_2W42
DR   CLO; CLO_0018485
DR   BioSamples; SAME39376
DR   Coriell; PR00389
DR   Wikidata; Q54948035
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00389; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=1215604; ! Eulemur albifrons (White-headed lemur)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00398
AC   CVCL_DN78
DR   Coriell; PR00398
DR   Wikidata; Q54948036
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00398; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9561; ! Mandrillus sphinx (Mandrill)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00399
AC   CVCL_2W43
DR   CLO; CLO_0018486
DR   BioSamples; SAME39309
DR   Coriell; PR00399
DR   Wikidata; Q54948037
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00399; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9561; ! Mandrillus sphinx (Mandrill)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00400
AC   CVCL_2W44
DR   CLO; CLO_0018479
DR   BioSamples; SAME39387
DR   Coriell; PR00400
DR   Wikidata; Q54948038
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00400; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00408
AC   CVCL_DN79
DR   Coriell; PR00408
DR   Wikidata; Q54948039
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00408; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   PR00418
AC   CVCL_2W45
DR   CLO; CLO_0018480
DR   BioSamples; SAME39307
DR   Coriell; PR00418
DR   Wikidata; Q54948040
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00418; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00430
AC   CVCL_UD25
DR   Coriell; PR00430
DR   Wikidata; Q98128664
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00430; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9530; ! Cercocebus torquatus (Red-capped mangabey)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   PR00431
AC   CVCL_UD26
DR   Coriell; PR00431
DR   Wikidata; Q98128665
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00431; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9530; ! Cercocebus torquatus (Red-capped mangabey)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   PR00445
AC   CVCL_UD27
DR   Coriell; PR00445
DR   Wikidata; Q98128666
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00445; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
OI   CVCL_DN80 ! PR00446
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   PR00446
AC   CVCL_DN80
DR   Coriell; PR00446
DR   Wikidata; Q54948041
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00446; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
OI   CVCL_UD27 ! PR00445
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PR00474
AC   CVCL_2W46
DR   CLO; CLO_0018481
DR   BioSamples; SAME39312
DR   Coriell; PR00474
DR   Wikidata; Q54948042
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00474; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis (Bolivian squirrel monkey)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00485
AC   CVCL_2W47
DR   CLO; CLO_0018482
DR   BioSamples; SAME39270
DR   Coriell; PR00485
DR   Wikidata; Q54948043
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00485; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9530; ! Cercocebus torquatus (Red-capped mangabey)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00486
AC   CVCL_2W48
DR   CLO; CLO_0018487
DR   BioSamples; SAME39271
DR   Coriell; PR00486
DR   Wikidata; Q54948044
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00486; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=263448; ! Cercopithecus wolfi (Wolf's monkey)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00488
AC   CVCL_DN81
DR   Coriell; PR00488
DR   Wikidata; Q54948045
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00488; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00494
AC   CVCL_2W49
DR   CLO; CLO_0018474
DR   BioSamples; SAME39301
DR   Coriell; PR00494
DR   Wikidata; Q54948046
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00494; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=40322; ! Eulemur fulvus fulvus (Brown lemur)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00495
AC   CVCL_2W50
DR   Coriell; PR00495
DR   Wikidata; Q54948048
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00495; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9580; ! Hylobates lar (Common gibbon)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   PR00496
AC   CVCL_2W51
DR   CLO; CLO_0018472
DR   BioSamples; SAME39299
DR   Coriell; PR00496
DR   GEO; GSM349596
DR   Wikidata; Q54948049
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00496; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00503
AC   CVCL_2W52
DR   CLO; CLO_0018465
DR   BioSamples; SAME39206
DR   Coriell; PR00503
DR   Wikidata; Q54948050
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00503; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54600; ! Macaca nigra (Celebes black macaque)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00510
AC   CVCL_UD23
DR   Coriell; PR00510
DR   Wikidata; Q98128667
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00510; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   PR00512
AC   CVCL_DN82
DR   Coriell; PR00512
DR   Wikidata; Q54948051
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00512; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PR00519
AC   CVCL_2W53
DR   CLO; CLO_0018466
DR   BioSamples; SAME39438
DR   Coriell; PR00519
DR   Wikidata; Q54948052
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00519; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30609; ! Galago moholi (South African galago)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00522
AC   CVCL_2W54
DR   Coriell; PR00522
DR   Wikidata; Q54948053
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00522; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9536; ! Cercopithecus hamlyni (Owl-faced monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   PR00524
AC   CVCL_2W55
DR   CLO; CLO_0018463
DR   BioSamples; SAME39443
DR   Coriell; PR00524
DR   Wikidata; Q54948054
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00524; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00525
AC   CVCL_2W56
DR   CLO; CLO_0018464
DR   BioSamples; SAME39447
DR   Coriell; PR00525
DR   Wikidata; Q54948055
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00525; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9519; ! Lagothrix lagotricha (Brown woolly monkey)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00527
AC   CVCL_2W57
DR   CLO; CLO_0018461
DR   BioSamples; SAME39264
DR   Coriell; PR00527
DR   Wikidata; Q54948056
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00527; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9535; ! Cercopithecus cephus (Moustached monkey)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00530
AC   CVCL_2W58
DR   CLO; CLO_0018462
DR   BioSamples; SAME39242
DR   Coriell; PR00530
DR   Wikidata; Q54948057
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00530; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=263448; ! Cercopithecus wolfi (Wolf's monkey)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00531
AC   CVCL_2W59
DR   CLO; CLO_0018459
DR   BioSamples; SAME39241
DR   Coriell; PR00531
DR   Wikidata; Q54948058
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00531; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9535; ! Cercopithecus cephus (Moustached monkey)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00534
AC   CVCL_UD24
DR   Coriell; PR00534
DR   Wikidata; Q98128668
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00534; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   PR00548
AC   CVCL_2W60
DR   CLO; CLO_0018460
DR   BioSamples; SAME39302
DR   Coriell; PR00548
DR   Wikidata; Q54948059
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00548; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00550
AC   CVCL_2W61
DR   CLO; CLO_0020703
DR   BioSamples; SAME39364
DR   Coriell; PR00550
DR   Wikidata; Q54948060
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00550; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30586; ! Saguinus midas (Golden-handed tamarin)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00551
AC   CVCL_2W62
DR   CLO; CLO_0020704
DR   BioSamples; SAME39292
DR   Coriell; PR00551
DR   Wikidata; Q54948061
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00551; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30586; ! Saguinus midas (Golden-handed tamarin)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00553
AC   CVCL_2W63
DR   CLO; CLO_0020705
DR   BioSamples; SAME39290
DR   Coriell; PR00553
DR   Wikidata; Q54948069
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00553; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30601; ! Propithecus tattersalli (Golden-crowned Sifaka)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00554
AC   CVCL_2W64
DR   CLO; CLO_0020706
DR   BioSamples; SAME39296
DR   Coriell; PR00554
DR   Wikidata; Q54948070
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00554; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30586; ! Saguinus midas (Golden-handed tamarin)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00559
AC   CVCL_2W65
DR   CLO; CLO_0020699
DR   BioSamples; SAME39381
DR   Coriell; PR00559
DR   Wikidata; Q54948071
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00559; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00566
AC   CVCL_2W66
DR   CLO; CLO_0020700
DR   BioSamples; SAME39424
DR   Coriell; PR00566
DR   Wikidata; Q54948072
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00566; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti (Schmidt's red-tailed monkey)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00573
AC   CVCL_DN83
DR   Coriell; PR00573
DR   Wikidata; Q54948073
RX   PubMed=16214744;
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00573; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00576
AC   CVCL_2W67
DR   CLO; CLO_0020701
DR   BioSamples; SAME39383
DR   Coriell; PR00576
DR   Wikidata; Q54948074
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00576; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00578
AC   CVCL_2W68
DR   CLO; CLO_0020702
DR   BioSamples; SAME39465
DR   Coriell; PR00578
DR   Wikidata; Q54948075
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00578; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00582
AC   CVCL_2W69
DR   CLO; CLO_0020688
DR   BioSamples; SAME39441
DR   Coriell; PR00582
DR   Wikidata; Q54948076
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00582; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00586
AC   CVCL_2W70
DR   CLO; CLO_0020686
DR   BioSamples; SAME39252
DR   Coriell; PR00586
DR   Wikidata; Q54948077
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00586; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00592
AC   CVCL_2W71
DR   CLO; CLO_0020690
DR   BioSamples; SAME39400
DR   Coriell; PR00592
DR   Wikidata; Q54948078
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00592; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9590; ! Symphalangus syndactylus (Siamang)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00594
AC   CVCL_2W72
DR   CLO; CLO_0020697
DR   BioSamples; SAME39452
DR   Coriell; PR00594
DR   Wikidata; Q54948079
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00594; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9590; ! Symphalangus syndactylus (Siamang)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00597
AC   CVCL_2W73
DR   CLO; CLO_0020698
DR   BioSamples; SAME39396
DR   Coriell; PR00597
DR   Wikidata; Q54948081
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00597; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9572; ! Colobus polykomos (Western black-and-white colobus monkey)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00598
AC   CVCL_2W74
DR   CLO; CLO_0020695
DR   BioSamples; SAME39410
DR   Coriell; PR00598
DR   Wikidata; Q54948082
RX   PubMed=16214744;
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00598; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9590; ! Symphalangus syndactylus (Siamang)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00603
AC   CVCL_2W75
DR   CLO; CLO_0020696
DR   BioSamples; SAME39355
DR   Coriell; PR00603
DR   Wikidata; Q54948083
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00603; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9521; ! Saimiri sciureus (Common squirrel monkey)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00604
AC   CVCL_2W76
DR   CLO; CLO_0020693
DR   BioSamples; SAME39354
DR   Coriell; PR00604
DR   Wikidata; Q54948084
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00604; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54180; ! Trachypithecus francoisi (Francois' leaf monkey)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00605
AC   CVCL_2W77
DR   CLO; CLO_0020694
DR   BioSamples; SAME39353
DR   Coriell; PR00605
DR   Wikidata; Q54948085
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00605; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00608
AC   CVCL_2W78
DR   CLO; CLO_0020691
DR   BioSamples; SAME39361
DR   Coriell; PR00608
DR   Wikidata; Q54948086
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00608; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=255237; ! Cercocebus agilis (Agile mangabey)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00609
AC   CVCL_2W79
DR   CLO; CLO_0020692
DR   BioSamples; SAME39448
DR   Coriell; PR00609
DR   Wikidata; Q54948087
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00609; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=75566; ! Lophocebus aterrimus (Black crested mangabey)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00612
AC   CVCL_2W80
DR   CLO; CLO_0020845
DR   BioSamples; SAME39401
DR   Coriell; PR00612
DR   Wikidata; Q54948088
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00612; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9521; ! Saimiri sciureus (Common squirrel monkey)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00615
AC   CVCL_2W81
DR   CLO; CLO_0020826
DR   BioSamples; SAME39397
DR   Coriell; PR00615
DR   Wikidata; Q54948089
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00615; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9460; ! Cheirogaleus medius (Fat-tailed dwarf lemur)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00616
AC   CVCL_2W82
DR   CLO; CLO_0020825
DR   BioSamples; SAME39398
DR   Coriell; PR00616
DR   Wikidata; Q54948090
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00616; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=75566; ! Lophocebus aterrimus (Black crested mangabey)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00622
AC   CVCL_2W83
DR   CLO; CLO_0020824
DR   BioSamples; SAME39437
DR   Coriell; PR00622
DR   Wikidata; Q54948091
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00622; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00623
AC   CVCL_2W84
DR   CLO; CLO_0020823
DR   BioSamples; SAME39352
DR   Coriell; PR00623
DR   Wikidata; Q54948092
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00623; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00626
AC   CVCL_2W85
DR   CLO; CLO_0020822
DR   BioSamples; SAME39440
DR   Coriell; PR00626
DR   Wikidata; Q54948093
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00626; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti (Schmidt's red-tailed monkey)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00627
AC   CVCL_2W86
DR   CLO; CLO_0020821
DR   BioSamples; SAME39439
DR   Coriell; PR00627
DR   Wikidata; Q54948094
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00627; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=37293; ! Aotus nancymaae (Ma's night monkey)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00628
AC   CVCL_2W87
DR   Coriell; PR00628
DR   Wikidata; Q54948095
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00628; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=37293; ! Aotus nancymaae (Ma's night monkey)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR00631
AC   CVCL_2W88
DR   CLO; CLO_0020820
DR   BioSamples; SAME39176
DR   Coriell; PR00631
DR   Wikidata; Q54948096
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00631; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9470; ! Nycticebus coucang (Slow loris)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00632
AC   CVCL_2W89
DR   CLO; CLO_0020819
DR   BioSamples; SAME39174
DR   Coriell; PR00632
DR   Wikidata; Q54948097
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00632; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=57176; ! Aotus vociferans (Spix's owl monkey)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00634
AC   CVCL_2W90
DR   CLO; CLO_0020818
DR   BioSamples; SAME39173
DR   Coriell; PR00634
DR   Wikidata; Q54948098
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00634; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti (Schmidt's red-tailed monkey)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00636
AC   CVCL_2W91
DR   CLO; CLO_0020817
DR   BioSamples; SAME39171
DR   Coriell; PR00636
DR   Wikidata; Q54948099
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00636; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=57176; ! Aotus vociferans (Spix's owl monkey)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00643
AC   CVCL_DN84
DR   Coriell; PR00643
DR   Wikidata; Q54948100
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00643; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   PR00644
AC   CVCL_2W92
DR   CLO; CLO_0020855
DR   BioSamples; SAME39213
DR   Coriell; PR00644
DR   Wikidata; Q54948101
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00644; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9493; ! Cebuella pygmaea (Pygmy marmoset)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00648
AC   CVCL_2W93
DR   CLO; CLO_0020857
DR   BioSamples; SAME39210
DR   Coriell; PR00648
DR   Wikidata; Q54948102
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00648; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00650
AC   CVCL_2W94
DR   CLO; CLO_0020856
DR   BioSamples; SAME39250
DR   Coriell; PR00650
DR   Wikidata; Q54948103
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00650; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00652
AC   CVCL_2W95
DR   CLO; CLO_0020852
DR   BioSamples; SAME39251
DR   Coriell; PR00652
DR   Wikidata; Q54948104
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00652; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61852; ! Nomascus gabriellae (Red-cheeked gibbon)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00655
AC   CVCL_DN85
DR   Coriell; PR00655
DR   Wikidata; Q54948105
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00655; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=33548; ! Colobus guereza (Mantled guereza)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00657
AC   CVCL_2W96
DR   CLO; CLO_0020851
DR   BioSamples; SAME39253
DR   Coriell; PR00657
DR   Wikidata; Q54948106
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00657; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00660
AC   CVCL_DN86
DR   Coriell; PR00660
DR   Wikidata; Q54948107
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00660; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   PR00661
AC   CVCL_2W97
DR   CLO; CLO_0020854
DR   BioSamples; SAME39345
DR   Coriell; PR00661
DR   Wikidata; Q54948108
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00661; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00663
AC   CVCL_2W98
DR   CLO; CLO_0020853
DR   BioSamples; SAME39342
DR   Coriell; PR00663
DR   Wikidata; Q54948109
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00663; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00664
AC   CVCL_2W99
DR   Coriell; PR00664
DR   Wikidata; Q54948116
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00664; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR00669
AC   CVCL_2X00
DR   CLO; CLO_0020849
DR   BioSamples; SAME39348
DR   Coriell; PR00669
DR   Wikidata; Q54948117
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00669; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00671
AC   CVCL_2X01
DR   CLO; CLO_0020848
DR   BioSamples; SAME39388
DR   Coriell; PR00671
DR   Wikidata; Q54948118
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00671; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00674
AC   CVCL_2X02
DR   CLO; CLO_0020850
DR   BioSamples; SAME39390
DR   Coriell; PR00674
DR   Wikidata; Q54948119
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00674; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=43780; ! Nasalis larvatus (Proboscis monkey)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00677
AC   CVCL_2X03
DR   CLO; CLO_0020889
DR   BioSamples; SAME39389
DR   Coriell; PR00677
DR   Wikidata; Q54948120
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00677; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=881949; ! Leontocebus fuscicollis nigrifrons (Geoffroy's saddle-back tamarin)
SX   Male
AG   1D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00678
AC   CVCL_2X04
DR   CLO; CLO_0020888
DR   BioSamples; SAME39393
DR   Coriell; PR00678
DR   Wikidata; Q54948121
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00678; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=100224; ! Allochrocebus lhoesti (L'Hoest's monkey)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00679
AC   CVCL_2X05
DR   CLO; CLO_0020887
DR   BioSamples; SAME39180
DR   Coriell; PR00679
DR   Wikidata; Q54948122
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00679; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=43780; ! Nasalis larvatus (Proboscis monkey)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00680
AC   CVCL_2X06
DR   CLO; CLO_0020886
DR   BioSamples; SAME39434
DR   Coriell; PR00680
DR   Wikidata; Q54948123
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00680; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9519; ! Lagothrix lagotricha (Brown woolly monkey)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00707
AC   CVCL_2X07
DR   CLO; CLO_0020883
DR   BioSamples; SAME39284
DR   Coriell; PR00707
DR   Wikidata; Q54948125
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00707; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00708
AC   CVCL_2X08
DR   CLO; CLO_0020882
DR   BioSamples; SAME39283
DR   Coriell; PR00708
DR   Wikidata; Q54948126
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00708; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=121123; ! Alouatta sara (Bolivian red howler monkey)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00710
AC   CVCL_DN87
DR   Coriell; PR00710
DR   Wikidata; Q54948127
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00710; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Male
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00711
AC   CVCL_2X09
DR   CLO; CLO_0020880
DR   BioSamples; SAME39246
DR   Coriell; PR00711
DR   Wikidata; Q54948129
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00711; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54602; ! Macaca thibetana (Pere David's macaque)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00712
AC   CVCL_2X10
DR   CLO; CLO_0020879
DR   BioSamples; SAME39314
DR   Coriell; PR00712
DR   Wikidata; Q54948130
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00712; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=61853; ! Nomascus leucogenys (Northern white-cheeked gibbon)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00715
AC   CVCL_2X11
DR   Coriell; PR00715
DR   Wikidata; Q54948131
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00715; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9580; ! Hylobates lar (Common gibbon)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   PR00716
AC   CVCL_2X12
DR   CLO; CLO_0020885
DR   BioSamples; SAME39249
DR   Coriell; PR00716
DR   Wikidata; Q54948132
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00716; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=36231; ! Miopithecus talapoin (Angolan talapoin)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00718
AC   CVCL_DN88
DR   Coriell; PR00718
DR   Wikidata; Q54948133
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00718; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9561; ! Mandrillus sphinx (Mandrill)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00721
AC   CVCL_DN89
DR   Coriell; PR00721
DR   Wikidata; Q54948134
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00721; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9590; ! Symphalangus syndactylus (Siamang)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00722
AC   CVCL_2X13
DR   Coriell; PR00722
DR   Wikidata; Q54948135
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00722; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9590; ! Symphalangus syndactylus (Siamang)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   PR00724
AC   CVCL_2X14
DR   CLO; CLO_0020884
DR   BioSamples; SAME39207
DR   Coriell; PR00724
DR   Wikidata; Q54948136
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00724; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00726
AC   CVCL_2X15
DR   CLO; CLO_0020914
DR   BioSamples; SAME39209
DR   Coriell; PR00726
DR   Wikidata; Q54948137
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00726; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54600; ! Macaca nigra (Celebes black macaque)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00729
AC   CVCL_2X16
DR   CLO; CLO_0020916
DR   BioSamples; SAME39445
DR   Coriell; PR00729
DR   Wikidata; Q54948138
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00729; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=52231; ! Callithrix geoffroyi (Geoffroy's marmoset)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00730
AC   CVCL_2X17
DR   CLO; CLO_0020915
DR   BioSamples; SAME39170
DR   Coriell; PR00730
DR   Wikidata; Q54948139
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00730; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00732
AC   CVCL_2X18
DR   CLO; CLO_0020918
DR   BioSamples; SAME39168
DR   Coriell; PR00732
DR   Wikidata; Q54948141
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00732; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00738
AC   CVCL_2X19
DR   CLO; CLO_0020917
DR   BioSamples; SAME39220
DR   Coriell; PR00738
DR   GEO; GSM349644
DR   Wikidata; Q54948142
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00738; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00739
AC   CVCL_2X20
DR   CLO; CLO_0020910
DR   BioSamples; SAME39175
DR   Coriell; PR00739
DR   Wikidata; Q54948143
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00739; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=88029; ! Semnopithecus entellus (Northern plains gray langur)
SX   Male
AG   10D
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00741
AC   CVCL_2X21
DR   Coriell; PR00741
DR   Wikidata; Q54948145
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00741; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=70928; ! Saimiri oerstedii (Central American squirrel monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 11
//
ID   PR00742
AC   CVCL_2X22
DR   CLO; CLO_0020909
DR   BioSamples; SAME39197
DR   Coriell; PR00742
DR   Wikidata; Q54948146
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00742; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9523; ! Plecturocebus moloch (Dusky titi monkey)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00744
AC   CVCL_DN90
DR   Coriell; PR00744
DR   Wikidata; Q54948147
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00744; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PR00748
AC   CVCL_2X23
DR   CLO; CLO_0020912
DR   BioSamples; SAME39204
DR   Coriell; PR00748
DR   Wikidata; Q54948148
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00748; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00756
AC   CVCL_DP11
DR   Coriell; PR00756
DR   Wikidata; Q54948149
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00756; probable.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Male
CA   Undefined cell line type
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   PR00762
AC   CVCL_2X24
DR   CLO; CLO_0020911
DR   BioSamples; SAME39432
DR   Coriell; PR00762
DR   Wikidata; Q54948150
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00762; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=100487; ! Cercopithecus petaurista (Lesser spot-nosed monkey)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00772
AC   CVCL_2X25
DR   CLO; CLO_0020913
DR   BioSamples; SAME39420
DR   Coriell; PR00772
DR   Wikidata; Q54948151
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00772; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9579; ! Hylobates agilis (Agile gibbon)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00773
AC   CVCL_2X26
DR   Coriell; PR00773
DR   Wikidata; Q54948152
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00773; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9579; ! Hylobates agilis (Agile gibbon)
SX   Sex unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR00782
AC   CVCL_DP28
DR   Coriell; PR00782
DR   Wikidata; Q54948153
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00782; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   PR00786
AC   CVCL_DN91
DR   Coriell; PR00786
DR   Wikidata; Q54948154
RX   PubMed=16214744;
RX   PubMed=16326750;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00786; probable.
OX   NCBI_TaxID=30588; ! Leontopithecus rosalia (Golden lion tamarin)
SX   Sex unspecified
CA   Undefined cell line type
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   PR00788
AC   CVCL_2X27
DR   CLO; CLO_0020943
DR   BioSamples; SAME39335
DR   Coriell; PR00788
DR   Wikidata; Q54948156
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00788; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9468; ! Loris tardigradus (Slender loris)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00789
AC   CVCL_2X28
DR   CLO; CLO_0020944
DR   BioSamples; SAME39202
DR   Coriell; PR00789
DR   Wikidata; Q54948157
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00789; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=52231; ! Callithrix geoffroyi (Geoffroy's marmoset)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00793
AC   CVCL_2X29
DR   CLO; CLO_0020941
DR   BioSamples; SAME39453
DR   Coriell; PR00793
DR   Wikidata; Q54948158
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00793; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=202457; ! Plecturocebus cupreus (Coppery titi monkey)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00794
AC   CVCL_2X30
DR   CLO; CLO_0020942
DR   BioSamples; SAME39462
DR   Coriell; PR00794
DR   Wikidata; Q54948159
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00794; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9460; ! Cheirogaleus medius (Fat-tailed dwarf lemur)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00796
AC   CVCL_2X31
DR   CLO; CLO_0020939
DR   BioSamples; SAME39425
DR   Coriell; PR00796
DR   Wikidata; Q54948160
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00796; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9470; ! Nycticebus coucang (Slow loris)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00807
AC   CVCL_DN92
DR   Coriell; PR00807
DR   Wikidata; Q54948168
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00807; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00814
AC   CVCL_2X32
DR   CLO; CLO_0020940
DR   BioSamples; SAME39436
DR   Coriell; PR00814
DR   Wikidata; Q54948169
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00814; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00818
AC   CVCL_2X33
DR   CLO; CLO_0020948
DR   BioSamples; SAME39444
DR   Coriell; PR00818
DR   Wikidata; Q54948170
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00818; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00818-iPS
AC   CVCL_2Z83
SY   PR00818 iPSC-2; Chimpanzee iPS2
DR   GEO; GSM1153514
DR   GEO; GSM1153516
DR   Wikidata; Q54948171
RX   PubMed=24153179;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_2X33 ! PR00818
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   PR00825
AC   CVCL_2X34
DR   CLO; CLO_0020951
DR   BioSamples; SAME39319
DR   Coriell; PR00825
DR   Wikidata; Q54948172
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00825; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00827
AC   CVCL_2X35
DR   CLO; CLO_0020945
DR   BioSamples; SAME39318
DR   Coriell; PR00827
DR   Wikidata; Q54948173
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00827; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9470; ! Nycticebus coucang (Slow loris)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00833
AC   CVCL_2X36
DR   CLO; CLO_0020946
DR   BioSamples; SAME39373
DR   Coriell; PR00833
DR   Wikidata; Q54948174
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00833; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54601; ! Macaca silenus (Lion-tailed macaque)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00834
AC   CVCL_2X37
DR   CLO; CLO_0020973
DR   BioSamples; SAME39368
DR   Coriell; PR00834
DR   Wikidata; Q54948175
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00834; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00838
AC   CVCL_2X38
DR   CLO; CLO_0020974
DR   BioSamples; SAME39365
DR   Coriell; PR00838
DR   Wikidata; Q54948176
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00838; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00839
AC   CVCL_2X39
DR   CLO; CLO_0020975
DR   BioSamples; SAME39366
DR   Coriell; PR00839
DR   Wikidata; Q54948177
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00839; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9493; ! Cebuella pygmaea (Pygmy marmoset)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR00841
AC   CVCL_DN93
DR   Coriell; PR00841
DR   Wikidata; Q54948178
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00841; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00871
AC   CVCL_2X40
DR   CLO; CLO_0020969
DR   BioSamples; SAME39402
DR   Coriell; PR00871
DR   Wikidata; Q54948179
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00871; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=47180; ! Mirza coquereli (Coquerel's giant mouse lemur)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00943
AC   CVCL_2X41
DR   CLO; CLO_0020970
DR   BioSamples; SAME39183
DR   Coriell; PR00943
DR   Wikidata; Q54948180
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00943; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00949
AC   CVCL_2X42
DR   CLO; CLO_0020971
DR   BioSamples; SAME39178
DR   Coriell; PR00949
DR   Wikidata; Q54948181
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00949; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=100487; ! Cercopithecus petaurista (Lesser spot-nosed monkey)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00950
AC   CVCL_2X43
DR   CLO; CLO_0020972
DR   BioSamples; SAME39248
DR   Coriell; PR00950
DR   Wikidata; Q54948182
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00950; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00951
AC   CVCL_2X44
DR   CLO; CLO_0020977
DR   BioSamples; SAME39454
DR   Coriell; PR00951
DR   Wikidata; Q54948183
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00951; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00953
AC   CVCL_DN94
DR   Coriell; PR00953
DR   Wikidata; Q54948184
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00953; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 9
//
ID   PR00960
AC   CVCL_DN95
DR   Coriell; PR00960
DR   Wikidata; Q54948185
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00960; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=30588; ! Leontopithecus rosalia (Golden lion tamarin)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00961
AC   CVCL_DN96
DR   Coriell; PR00961
DR   Wikidata; Q54948186
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00961; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=30588; ! Leontopithecus rosalia (Golden lion tamarin)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00963
AC   CVCL_DN97
DR   Coriell; PR00963
DR   Wikidata; Q54948187
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00963; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=30588; ! Leontopithecus rosalia (Golden lion tamarin)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00969
AC   CVCL_2X45
DR   CLO; CLO_0020978
DR   BioSamples; SAME39372
DR   Coriell; PR00969
DR   Wikidata; Q54948188
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00969; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9590; ! Symphalangus syndactylus (Siamang)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR00976
AC   CVCL_2X46
DR   CLO; CLO_0020980
DR   BioSamples; SAME39221
DR   Coriell; PR00976
DR   Wikidata; Q54948189
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00976; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9556; ! Papio cynocephalus (Yellow baboon)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00978
AC   CVCL_2X47
DR   CLO; CLO_0020991
DR   BioSamples; SAME39215
DR   Coriell; PR00978
DR   Wikidata; Q54948191
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00978; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9555; ! Papio anubis (Olive baboon)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00980
AC   CVCL_2X48
DR   CLO; CLO_0020992
DR   BioSamples; SAME39414
DR   Coriell; PR00980
DR   Wikidata; Q54948192
RX   PubMed=16214744;
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00980; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=33548; ! Colobus guereza (Mantled guereza)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00981
AC   CVCL_DN98
DR   Coriell; PR00981
DR   Wikidata; Q54948193
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00981; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36227; ! Cercopithecus neglectus (De Brazza's monkey)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00983
AC   CVCL_DN99
DR   Coriell; PR00983
DR   Wikidata; Q54948194
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00983; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36227; ! Cercopithecus neglectus (De Brazza's monkey)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00985
AC   CVCL_DP00
DR   Coriell; PR00985
DR   Wikidata; Q54948196
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00985; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36227; ! Cercopithecus neglectus (De Brazza's monkey)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00987
AC   CVCL_DP01
DR   Coriell; PR00987
DR   Wikidata; Q54948197
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00987; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00990
AC   CVCL_2X49
DR   CLO; CLO_0020989
DR   BioSamples; SAME39298
DR   Coriell; PR00990
DR   Wikidata; Q54948198
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00990; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00991
AC   CVCL_DP02
DR   Coriell; PR00991
DR   Wikidata; Q54948200
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00991; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00993
AC   CVCL_DP03
DR   Coriell; PR00993
DR   Wikidata; Q54948201
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00993; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00995
AC   CVCL_DP04
DR   Coriell; PR00995
DR   Wikidata; Q54948202
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00995; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR00996
AC   CVCL_2X50
DR   CLO; CLO_0020990
DR   BioSamples; SAME39300
DR   Coriell; PR00996
DR   Wikidata; Q54948203
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR00996; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR00997
AC   CVCL_DP05
DR   Coriell; PR00997
DR   Wikidata; Q54948204
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR00997; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=36225; ! Cercopithecus mitis (Blue monkey)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR01003
AC   CVCL_DP06
DR   Coriell; PR01003
DR   Wikidata; Q54948205
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01003; probable.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
OI   CVCL_2V25 ! PR00054
SX   Male
AG   4Y
CA   Undefined cell line type
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   PR01008
AC   CVCL_2X51
DR   Coriell; PR01008
DR   Wikidata; Q54948206
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01008; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=37010; ! Pan troglodytes schweinfurthii (Eastern chimpanzee)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PR01009
AC   CVCL_2X52
DR   Coriell; PR01009
DR   GEO; GSM349653
DR   Wikidata; Q54948207
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01009; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=37010; ! Pan troglodytes schweinfurthii (Eastern chimpanzee)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PR01010
AC   CVCL_2X53
DR   Coriell; PR01010
DR   Wikidata; Q54948208
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01010; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01011
AC   CVCL_DP07
DR   Coriell; PR01011
DR   Wikidata; Q54948210
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01011; probable.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Sex unspecified
CA   Undefined cell line type
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   PR01013
AC   CVCL_2X54
DR   CLO; CLO_0020995
DR   BioSamples; SAME39395
DR   Coriell; PR01013
DR   Wikidata; Q54948211
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01013; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01017
AC   CVCL_2X55
SY   PR1017
DR   CLO; CLO_0020996
DR   BioSamples; SAME39412
DR   Coriell; PR01017
DR   Wikidata; Q54948217
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01017; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=31869; ! Daubentonia madagascariensis (Aye-aye)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01023
AC   CVCL_2X56
DR   CLO; CLO_0020993
DR   BioSamples; SAME39272
DR   Coriell; PR01023
DR   Wikidata; Q54948219
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01023; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01030
AC   CVCL_2X57
DR   CLO; CLO_0020994
DR   BioSamples; SAME39261
DR   Coriell; PR01030
DR   Wikidata; Q54948220
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01030; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=34825; ! Propithecus verreauxi (White sifaka)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01034
AC   CVCL_2X58
DR   CLO; CLO_0021000
DR   BioSamples; SAME39247
DR   Coriell; PR01034
DR   Wikidata; Q54948221
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01034; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9465; ! Galago senegalensis (Northern lesser bushbaby)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01035
AC   CVCL_2X59
DR   CLO; CLO_0021001
DR   BioSamples; SAME39244
DR   Coriell; PR01035
DR   Wikidata; Q54948222
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01035; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30609; ! Galago moholi (South African galago)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01037
AC   CVCL_2X60
DR   Coriell; PR01037
DR   Wikidata; Q54948223
RX   PubMed=21878684;
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01037; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=61853; ! Nomascus leucogenys (Northern white-cheeked gibbon)
SX   Sex unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01038
AC   CVCL_2X61
DR   CLO; CLO_0021047
DR   BioSamples; SAME39468
DR   Coriell; PR01038
DR   Wikidata; Q54948225
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01038; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61853; ! Nomascus leucogenys (Northern white-cheeked gibbon)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR01040
AC   CVCL_2X62
DR   CLO; CLO_0021019
DR   BioSamples; SAME39181
DR   Coriell; PR01040
DR   Wikidata; Q54948227
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01040; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=47180; ! Mirza coquereli (Coquerel's giant mouse lemur)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01044
AC   CVCL_2X63
DR   CLO; CLO_0021020
DR   BioSamples; SAME39182
DR   Coriell; PR01044
DR   Wikidata; Q54948228
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01044; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=47180; ! Mirza coquereli (Coquerel's giant mouse lemur)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01048
AC   CVCL_DP08
DR   Coriell; PR01048
DR   Wikidata; Q54948229
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01048; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9561; ! Mandrillus sphinx (Mandrill)
SX   Male
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR01052
AC   CVCL_2X64
DR   CLO; CLO_0021021
DR   BioSamples; SAME39455
DR   Coriell; PR01052
DR   Wikidata; Q54948231
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01052; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01054
AC   CVCL_DP09
DR   Coriell; PR01054
DR   Wikidata; Q54948232
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01054; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR01057
AC   CVCL_2X65
DR   CLO; CLO_0021022
DR   BioSamples; SAME39451
DR   Coriell; PR01057
DR   Wikidata; Q54948233
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01057; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01084
AC   CVCL_2X66
DR   CLO; CLO_0021023
DR   BioSamples; SAME39346
DR   Coriell; PR01084
DR   Wikidata; Q54948234
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01084; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01086
AC   CVCL_2X67
DR   CLO; CLO_0021024
DR   BioSamples; SAME39362
DR   Coriell; PR01086
DR   Wikidata; Q54948235
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01086; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01086-iPS
AC   CVCL_2Z81
SY   PR01086 iPSC-1; Bonobo iPS1
DR   GEO; GSM1153521
DR   GEO; GSM1153523
DR   Wikidata; Q54948236
RX   PubMed=24153179;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9597; ! Pan paniscus (Pygmy chimpanzee)
HI   CVCL_2X67 ! PR01086
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   PR01089
AC   CVCL_2X68
DR   CLO; CLO_0021025
DR   BioSamples; SAME39343
DR   Coriell; PR01089
DR   Wikidata; Q54948237
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01089; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01094
AC   CVCL_2X69
DR   CLO; CLO_0021026
DR   BioSamples; SAME39328
DR   Coriell; PR01094
DR   Wikidata; Q54948238
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01094; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=52231; ! Callithrix geoffroyi (Geoffroy's marmoset)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01097
AC   CVCL_DP29
DR   Coriell; PR01097
DR   GEO; GSM349654
DR   Wikidata; Q54948239
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01097; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PR01099
AC   CVCL_2X70
DR   CLO; CLO_0021027
DR   BioSamples; SAME39446
DR   Coriell; PR01099
DR   Wikidata; Q54948241
RX   PubMed=16214744;
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01099; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54180; ! Trachypithecus francoisi (Francois' leaf monkey)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01103
AC   CVCL_2X71
DR   CLO; CLO_0021100
DR   BioSamples; SAME39172
DR   Coriell; PR01103
DR   Wikidata; Q54948242
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01103; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01105
AC   CVCL_2X72
DR   Coriell; PR01105
DR   GEO; GSM349679
DR   Wikidata; Q54948243
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01105; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01106
AC   CVCL_2X73
DR   CLO; CLO_0021101
DR   BioSamples; SAME39422
DR   Coriell; PR01106
DR   Wikidata; Q54948244
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01106; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01107
AC   CVCL_2X74
DR   CLO; CLO_0021102
DR   BioSamples; SAME39464
DR   Coriell; PR01107
DR   Wikidata; Q54948245
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01107; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01110
AC   CVCL_2X75
DR   CLO; CLO_0021103
DR   BioSamples; SAME39461
DR   Coriell; PR01110
DR   Wikidata; Q54948246
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01110; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9601; ! Pongo abelii (Sumatran orangutan)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01119
AC   CVCL_2X76
DR   CLO; CLO_0021104
DR   BioSamples; SAME39457
DR   Coriell; PR01119
DR   Wikidata; Q54948248
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01119; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=31869; ! Daubentonia madagascariensis (Aye-aye)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01121
AC   CVCL_DP10
DR   Coriell; PR01121
DR   Wikidata; Q54948249
RX   PubMed=16214744;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01121; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=36227; ! Cercopithecus neglectus (De Brazza's monkey)
SX   Female
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   PR01126
AC   CVCL_2X77
DR   CLO; CLO_0021105
DR   BioSamples; SAME39320
DR   Coriell; PR01126
DR   Wikidata; Q54948250
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01126; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=100224; ! Allochrocebus lhoesti (L'Hoest's monkey)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR01131
AC   CVCL_2X78
DR   CLO; CLO_0021106
DR   BioSamples; SAME39218
DR   Coriell; PR01131
DR   Wikidata; Q54948251
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01131; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9580; ! Hylobates lar (Common gibbon)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01134
AC   CVCL_2X79
SY   PR1134
DR   CLO; CLO_0021087
DR   BioSamples; SAME39216
DR   Coriell; PR01134
DR   Wikidata; Q54948252
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01134; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=31869; ! Daubentonia madagascariensis (Aye-aye)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01137
AC   CVCL_2X80
DR   CLO; CLO_0021084
DR   BioSamples; SAME39458
DR   Coriell; PR01137
DR   Wikidata; Q54948253
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01137; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=31869; ! Daubentonia madagascariensis (Aye-aye)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01143
AC   CVCL_2X81
DR   CLO; CLO_0021083
DR   BioSamples; SAME39254
DR   Coriell; PR01143
DR   Wikidata; Q54948254
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01143; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01144
AC   CVCL_2X82
DR   CLO; CLO_0021094
DR   BioSamples; SAME39258
DR   Coriell; PR01144
DR   Wikidata; Q54948255
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01144; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=36227; ! Cercopithecus neglectus (De Brazza's monkey)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01149
AC   CVCL_2X83
DR   CLO; CLO_0021095
DR   BioSamples; SAME39260
DR   Coriell; PR01149
DR   Wikidata; Q54948256
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01149; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01150
AC   CVCL_2X84
DR   CLO; CLO_0021092
DR   BioSamples; SAME39285
DR   Coriell; PR01150
DR   Wikidata; Q54948258
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01150; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01152
AC   CVCL_2X85
DR   CLO; CLO_0021093
DR   BioSamples; SAME39286
DR   Coriell; PR01152
DR   Wikidata; Q54948259
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01152; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01154
AC   CVCL_2X86
DR   CLO; CLO_0021098
DR   BioSamples; SAME39287
DR   Coriell; PR01154
DR   Wikidata; Q54948260
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01154; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01159
AC   CVCL_2X87
DR   CLO; CLO_0021099
DR   BioSamples; SAME39317
DR   Coriell; PR01159
DR   Wikidata; Q54948261
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01159; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01160
AC   CVCL_2X88
DR   CLO; CLO_0021096
DR   BioSamples; SAME39322
DR   Coriell; PR01160
DR   Wikidata; Q54948262
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01160; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01161
AC   CVCL_2X89
DR   CLO; CLO_0021097
DR   BioSamples; SAME39321
DR   Coriell; PR01161
DR   Wikidata; Q54948263
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01161; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01162
AC   CVCL_2X90
DR   CLO; CLO_0021071
DR   BioSamples; SAME39324
DR   Coriell; PR01162
DR   Wikidata; Q54948273
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01162; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01163
AC   CVCL_2X91
DR   CLO; CLO_0021070
DR   BioSamples; SAME39323
DR   Coriell; PR01163
DR   Wikidata; Q54948274
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01163; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01168
AC   CVCL_2X92
DR   CLO; CLO_0021080
DR   BioSamples; SAME39316
DR   Coriell; PR01168
DR   Wikidata; Q54948275
CC   Group: Endangered species/breed cell line.
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01168; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=554167; ! Varecia rubra (Red ruffed lemur)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 16
//
ID   PR01169
AC   CVCL_2X93
DR   CLO; CLO_0021076
DR   BioSamples; SAME39315
DR   Coriell; PR01169
DR   Wikidata; Q54948276
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01169; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=75566; ! Lophocebus aterrimus (Black crested mangabey)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01171
AC   CVCL_2X94
DR   CLO; CLO_0021077
DR   BioSamples; SAME39371
DR   Coriell; PR01171
DR   Wikidata; Q54948280
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01171; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01179
AC   CVCL_2X95
DR   CLO; CLO_0021078
DR   BioSamples; SAME39370
DR   Coriell; PR01179
DR   Wikidata; Q54948281
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01179; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01182
AC   CVCL_2X96
DR   CLO; CLO_0021079
DR   BioSamples; SAME39428
DR   Coriell; PR01182
DR   Wikidata; Q54948283
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01182; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30591; ! Aotus azarae (Southern owl monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01190
AC   CVCL_2X97
DR   CLO; CLO_0021072
DR   BioSamples; SAME39467
DR   Coriell; PR01190
DR   Wikidata; Q54948284
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01190; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01193
AC   CVCL_2X98
DR   CLO; CLO_0021073
DR   BioSamples; SAME39442
DR   Coriell; PR01193
DR   Wikidata; Q54948286
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01193; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01197
AC   CVCL_2X99
DR   CLO; CLO_0021074
DR   BioSamples; SAME39466
DR   Coriell; PR01197
DR   Wikidata; Q54948287
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01197; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01198
AC   CVCL_2Y00
DR   CLO; CLO_0021075
DR   BioSamples; SAME39473
DR   Coriell; PR01198
DR   Wikidata; Q54948288
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01198; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01205
AC   CVCL_2Y01
DR   CLO; CLO_0021059
DR   BioSamples; SAME39375
DR   Coriell; PR01205
DR   Wikidata; Q54948290
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01205; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01209
AC   CVCL_2Y02
DR   CLO; CLO_0021068
DR   BioSamples; SAME39391
DR   Coriell; PR01209
DR   Wikidata; Q54948291
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01209; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01209-iPS
AC   CVCL_2Z82
SY   PR01209 iPSC-1; Chimpanzee iPS1
DR   GEO; GSM1153517
DR   GEO; GSM1153519
DR   Wikidata; Q54948292
RX   PubMed=24153179;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_2Y02 ! PR01209
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   PR01213
AC   CVCL_2Y03
DR   CLO; CLO_0021069
DR   BioSamples; SAME39329
DR   Coriell; PR01213
DR   Wikidata; Q54948294
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; PR01213; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01215
AC   CVCL_2Y04
DR   CLO; CLO_0021066
DR   BioSamples; SAME39327
DR   Coriell; PR01215
DR   Wikidata; Q54948295
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01215; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=75566; ! Lophocebus aterrimus (Black crested mangabey)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01216
AC   CVCL_2Y05
DR   CLO; CLO_0021067
DR   BioSamples; SAME39326
DR   Coriell; PR01216
DR   Wikidata; Q54948296
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01216; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=75566; ! Lophocebus aterrimus (Black crested mangabey)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01217
AC   CVCL_2Y06
DR   CLO; CLO_0021064
DR   BioSamples; SAME39325
DR   Coriell; PR01217
DR   Wikidata; Q54948297
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01217; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=75566; ! Lophocebus aterrimus (Black crested mangabey)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01218
AC   CVCL_2Y07
DR   CLO; CLO_0021065
DR   BioSamples; SAME39336
DR   Coriell; PR01218
DR   Wikidata; Q54948298
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01218; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9493; ! Cebuella pygmaea (Pygmy marmoset)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR01231
AC   CVCL_2Y08
DR   CLO; CLO_0021062
DR   BioSamples; SAME39415
DR   Coriell; PR01231
DR   Wikidata; Q54948299
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01231; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01238
AC   CVCL_2Y09
DR   CLO; CLO_0021063
DR   BioSamples; SAME39255
DR   Coriell; PR01238
DR   Wikidata; Q54948300
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01238; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01239
AC   CVCL_2Y10
DR   CLO; CLO_0021060
DR   BioSamples; SAME39421
DR   Coriell; PR01239
DR   Wikidata; Q54948301
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01239; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 15
//
ID   PR01240
AC   CVCL_2Y11
DR   CLO; CLO_0021061
DR   BioSamples; SAME39230
DR   Coriell; PR01240
DR   Wikidata; Q54948302
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01240; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis (Allen's swamp monkey)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 14
//
ID   PR01241
AC   CVCL_2Y12
DR   CLO; CLO_0021311
DR   BioSamples; SAME39231
DR   Coriell; PR01241
DR   Wikidata; Q54948303
RX   PubMed=21878684;
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01241; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=263448; ! Cercopithecus wolfi (Wolf's monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01257
AC   CVCL_2Y13
DR   CLO; CLO_0021310
DR   BioSamples; SAME39193
DR   Coriell; PR01257
DR   Wikidata; Q54948305
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01257; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01271
AC   CVCL_2Y14
DR   CLO; CLO_0021309
DR   BioSamples; SAME39392
DR   Coriell; PR01271
DR   Wikidata; Q54948306
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01271; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01375
AC   CVCL_2Y15
DR   CLO; CLO_0021318
DR   BioSamples; SAME39382
DR   Coriell; PR01375
DR   Wikidata; Q54948307
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01375; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01377
AC   CVCL_2Y16
DR   CLO; CLO_0021317
DR   BioSamples; SAME39240
DR   Coriell; PR01377
DR   Wikidata; Q54948308
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01377; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01378
AC   CVCL_2Y17
DR   CLO; CLO_0021316
DR   BioSamples; SAME39377
DR   Coriell; PR01378
DR   Wikidata; Q54948309
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01378; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01379
AC   CVCL_2Y18
DR   CLO; CLO_0021315
DR   BioSamples; SAME39378
DR   Coriell; PR01379
DR   Wikidata; Q54948310
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01379; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01380
AC   CVCL_2Y19
DR   CLO; CLO_0021314
DR   BioSamples; SAME39268
DR   Coriell; PR01380
DR   Wikidata; Q54948311
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01380; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01390
AC   CVCL_2Y20
DR   CLO; CLO_0021313
DR   BioSamples; SAME39359
DR   Coriell; PR01390
DR   Wikidata; Q54948312
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01390; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01391
AC   CVCL_2Y21
DR   CLO; CLO_0021312
DR   BioSamples; SAME39293
DR   Coriell; PR01391
DR   Wikidata; Q54948313
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01391; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01393
AC   CVCL_2Y22
DR   CLO; CLO_0021340
DR   BioSamples; SAME39291
DR   Coriell; PR01393
DR   Wikidata; Q54948314
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01393; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 13
//
ID   PR01396
AC   CVCL_2Y23
DR   CLO; CLO_0021339
DR   BioSamples; SAME39369
DR   Coriell; PR01396
DR   Wikidata; Q54948317
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01396; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01398
AC   CVCL_2Y24
DR   CLO; CLO_0021342
DR   BioSamples; SAME39297
DR   Coriell; PR01398
DR   Wikidata; Q54948319
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01398; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Female
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01402
AC   CVCL_2Y25
DR   CLO; CLO_0021341
DR   BioSamples; SAME39214
DR   Coriell; PR01402
DR   Wikidata; Q54948320
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01402; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01403
AC   CVCL_2Y26
DR   CLO; CLO_0021346
DR   BioSamples; SAME39169
DR   Coriell; PR01403
DR   Wikidata; Q54948321
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01403; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01410
AC   CVCL_2Y27
DR   CLO; CLO_0021345
DR   BioSamples; SAME39245
DR   Coriell; PR01410
DR   Wikidata; Q54948322
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01410; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01411
AC   CVCL_2Y28
DR   CLO; CLO_0021348
DR   BioSamples; SAME39177
DR   Coriell; PR01411
DR   Wikidata; Q54948323
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01411; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR01413
AC   CVCL_2Y29
DR   CLO; CLO_0021347
DR   BioSamples; SAME39179
DR   Coriell; PR01413
DR   Wikidata; Q54948331
CC   Group: Non-human primate cell line.
CC   Part of: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC   Discontinued: Coriell; PR01413; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Male
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   PR1 [Human diffuse large B-cell lymphoma]
AC   CVCL_DH43
SY   PR-1
DR   cancercelllines; CVCL_DH43
DR   Cosmic; 2297006
DR   GEO; GSM119484
DR   GEO; GSM1035329
DR   Progenetix; CVCL_DH43
DR   Wikidata; Q54948332
RX   PubMed=16960149;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   PR1 [Rat pituitary tumor]
AC   CVCL_0487
SY   PR-1
DR   CLO; CLO_0008481
DR   MCCL; MCC:0000386
DR   DSMZ; ACC-486
DR   DSMZCellDive; ACC-486
DR   Wikidata; Q54948334
RX   PubMed=7585526;
CC   Doubling time: ~90 hours (DSMZ=ACC-486).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   PR18
AC   CVCL_A0AW
DR   BEI_Resources; ARP-12863
DR   Wikidata; Q108821143
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P28906; Human CD34.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0AV ! K6.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   PR1A3
AC   CVCL_C7K0
SY   PR1.A3
DR   Wikidata; Q117704789
RX   Patent=US5965710;
RX   PubMed=2434440;
RX   PubMed=7514303;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PR2D3
AC   CVCL_C7K1
SY   PR2.D3; PR2 D3
DR   Wikidata; Q117704790
RX   PubMed=3301906;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on myofibroblasts.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 3
//
ID   PR310
AC   CVCL_H730
SY   PR 310
DR   Cosmic; 716173
DR   Wikidata; Q54948335
RX   PubMed=6320174;
RX   PubMed=6928987;
CC   Miscellaneous: This is not a cell line but a xenograft.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   PR371
AC   CVCL_L210
SY   PR 371
DR   Wikidata; Q54948337
RX   PubMed=6320174;
RX   PubMed=6928987;
CC   Miscellaneous: This is not a cell line but a xenograft.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 7
//
ID   PR3A5
AC   CVCL_C7K3
SY   PR3.A5
DR   Wikidata; Q117704791
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human goblet-cell mucus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PR3B10
AC   CVCL_C7K4
SY   PR3.B10
DR   Wikidata; Q117704792
RX   PubMed=2304917;
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PR4B10
AC   CVCL_C7K5
SY   PR4.B10
DR   Wikidata; Q117704793
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on epithelial cell membranes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 3
//
ID   PR4D1
AC   CVCL_C7K6
SY   PR4.D1
DR   Wikidata; Q117704794
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human goblet-cell mucus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PR4D4
AC   CVCL_C7K7
SY   PR4.D4
DR   Wikidata; Q117704795
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human goblet-cell mucus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PR4D2
AC   CVCL_C7K8
SY   PR4.D2
DR   Wikidata; Q117704796
RX   PubMed=2434440;
RX   PubMed=2482313;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_62265; Beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcpNAc (Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   PR4D6
AC   CVCL_C7K9
SY   PR4.D6
DR   Wikidata; Q117704797
RX   PubMed=2304917;
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on epithelial cell membranes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 3
//
ID   PR5C5
AC   CVCL_C7KA
SY   PR5.C5
DR   Wikidata; Q117704798
RX   PubMed=2304917;
RX   PubMed=2434440;
RX   PubMed=2482313;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_62265; Beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-D-GlcpNAc (Lewis A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   PR5D5
AC   CVCL_C7KB
SY   PR5.D5
DR   Wikidata; Q117704799
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human goblet-cell mucus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PR6B5
AC   CVCL_C7KC
SY   PR6.B5
DR   Wikidata; Q117704800
RX   PubMed=2304917;
RX   PubMed=2434440;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PR8
AC   CVCL_Z909
SY   PR-8
DR   DGRC; 204
DR   FlyBase_Cell_line; FBtc0000204
DR   Wikidata; Q54948338
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 45 hours (DGRC=204).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   PR9
AC   CVCL_Z910
DR   DGRC; 205
DR   FlyBase_Cell_line; FBtc0000205
DR   Wikidata; Q54948339
CC   Group: Insect cell line.
CC   Discontinued: DGRC; 205; probable.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   PRA1
AC   CVCL_C1JE
DR   Wikidata; Q114312685
RX   PubMed=2998993;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PRC-94TT
AC   CVCL_E4AQ
RX   PubMed=6784634;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E4AN ! RL-PR-C
SX   Female
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   PRCA157
AC   CVCL_A0QJ
DR   Wikidata; Q108821144
RX   Patent=US10683364;
RX   Patent=US10730945;
RX   PubMed=22615450;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Pre-i3Neuron NGN2 iPSC clone 1
AC   CVCL_C7XJ
SY   i3N iPSC clone 1
DR   Wikidata; Q123033274
RX   PubMed=28966121;
CC   Population: Japanese.
CC   Characteristics: Using TALEN a PuroR-CAG-rtTA3G-NEUROG2 construct was introduced in both alleles of the AAVS1 safe harbor locus thus providing doxycycline-inducible expression of NEUROG2/NGN2 (PubMed=28966121).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   Pre-i3Neuron NGN2 iPSC LRRK2-p.G2019S knock-in
AC   CVCL_C7XK
DR   Wikidata; Q123033275
CC   Population: Japanese.
CC   Characteristics: Using TALEN a PuroR-CAG-rtTA3G-NEUROG2 construct was introduced in both alleles of the AAVS1 safe harbor locus thus providing doxycycline-inducible expression of NEUROG2/NGN2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: Cell line information from personal communication of Dou, Dan.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7XJ ! Pre-i3Neuron NGN2 iPSC clone 1
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   Pre-Alp
AC   CVCL_IU85
SY   PRE-ALP; PreALP
DR   Cosmic; 2491073
DR   Wikidata; Q54948341
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7919343;
RX   PubMed=8464241;
RX   PubMed=9067587;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Doubling time: ~24 hours (PubMed=8464241).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757; PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Arg23Lys (c.68G>A); ClinVar=VCV000351377; Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   Pre2.8
AC   CVCL_AS21
SY   PrE2.8; PRE2.8
DR   Wikidata; Q54948342
RX   PubMed=11416159;
RX   PubMed=15258184;
RX   PubMed=17244020;
CC   Characteristics: At the permissive temperature (33 Celsius) proliferates. At the restrictive temperature (39 Celsius) proliferation ceases and the cells undergo morphological changes consistent with the early stages of differentiation.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 12,14
ST   D21S11: 29,30
ST   D8S1179: 13
ST   FGA: 20
ST   TH01: 9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF75 ! S2.13
SX   Male
AG   71Y
CA   Conditionally immortalized cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 10
//
ID   PRE3441
AC   CVCL_ZC76
SY   C9-Asymptomatic line 3441
DR   Wikidata; Q98128669
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia and/or amyotrophic lateral sclerosis but at risk for disease.
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   PRE3475
AC   CVCL_ZC77
SY   C9-Asymptomatic line 3475
DR   Wikidata; Q98128670
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia and/or amyotrophic lateral sclerosis but at risk for disease.
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   PRE3679
AC   CVCL_C9CZ
SY   C9-Asymptomatic line 3679
DR   Wikidata; Q123033276
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia and/or amyotrophic lateral sclerosis but at risk for disease.
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   PRE3763
AC   CVCL_C9D0
SY   C9-Asymptomatic line 3763
DR   Wikidata; Q123033278
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia and/or amyotrophic lateral sclerosis but at risk for disease.
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   PRE3797
AC   CVCL_C9D1
SY   C9-Asymptomatic line 3797
DR   Wikidata; Q123033279
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Heterozygous (Direct_author_submission).
CC   Donor information: At sampling donor was not affected with frontotemporal dementia and/or amyotrophic lateral sclerosis but at risk for disease.
CC   Miscellaneous: Cell line information from personal communication of Shaw, Allan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   PrEC LH
AC   CVCL_V626
SY   LH; PRECLH
DR   BioSample; SAMN10988400
DR   Cell_Model_Passport; SIDM01871
DR   DepMap; ACH-000170
DR   PharmacoDB; PrECLH_1276_2019
DR   Progenetix; CVCL_V626
DR   Wikidata; Q54948343
RX   PubMed=15604246;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole exome sequencing.
CC   Genome ancestry: African=0.32%; Native American=0%; East Asian, North=0.26%; East Asian, South=0%; South Asian=1%; European, North=67.13%; European, South=31.28% (PubMed=30894373).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U68 ! PrEC LHMK
OI   CVCL_9U69 ! PrEC LHS
OI   CVCL_E123 ! PrEC LHSR
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 19
//
ID   PrEC LHMK
AC   CVCL_9U68
SY   LHMK
DR   Wikidata; Q54948344
RX   PubMed=15604246;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8975; PIK3CA.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V626 ! PrEC LH
OI   CVCL_9U69 ! PrEC LHS
OI   CVCL_E123 ! PrEC LHSR
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   PrEC LHS
AC   CVCL_9U69
SY   LHS
DR   Wikidata; Q54948345
RX   PubMed=15604246;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V626 ! PrEC LH
OI   CVCL_9U68 ! PrEC LHMK
OI   CVCL_E123 ! PrEC LHSR
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   PrEC LHS-AR
AC   CVCL_E3G1
SY   LHS-AR
RX   PubMed=15604246;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U69 ! PrEC LHS
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   PrEC LHSR
AC   CVCL_E123
SY   LHSR
DR   EFO; EFO_0002797
DR   Wikidata; Q54948346
RX   PubMed=15604246;
RX   PubMed=21747944;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V626 ! PrEC LH
OI   CVCL_9U68 ! PrEC LHMK
OI   CVCL_9U69 ! PrEC LHS
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   PrEC LHSR-AR
AC   CVCL_E3G2
SY   LHSR-AR
RX   PubMed=15604246;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E123 ! PrEC LHSR
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   PrecisION hASIC3-HEK
AC   CVCL_D1JC
SY   PrecisION hASIC3
DR   DiscoverX; CYL3055
DR   Wikidata; Q127383833
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:101; ASIC3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hCav2.2 alpha1B/beta3/alpha2delta1-HEK
AC   CVCL_D1JJ
SY   PrecisION hCav2.2 alpha1B/beta3/alpha2delta1
DR   DiscoverX; CYL3054
DR   Wikidata; Q127383837
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1389; CACNA1B.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1399; CACNA2D1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1403; CACNB3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hCav1.2 alpha1C/beta2a/alpha2delta1-HEK
AC   CVCL_RQ69
SY   PrecisION hCav1.2 alpha1C/beta2a/alpha2delta1
DR   DiscoverX; CYL3051
DR   Wikidata; Q54948347
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1390; CACNA1C.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1399; CACNA2D1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1402; CACNB2 (Note=Isoform 2a).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: DiscoverX; CYL3051; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hCav3.2-HEK
AC   CVCL_D1JF
SY   PrecisION hCav3.2
DR   DiscoverX; CYL3075
DR   Wikidata; Q127383841
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1395; CACNA1H.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hCFTR-HEK
AC   CVCL_D1JE
SY   PrecisION hCFTR
DR   DiscoverX; CYL3088
DR   Wikidata; Q127383844
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1884; CFTR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hERG-CHO
AC   CVCL_D1JG
SY   PrecisION hERG
DR   DiscoverX; CYL3038
DR   Wikidata; Q127383848
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6251; KCNH2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hERG-HEK
AC   CVCL_LC62
SY   PrecisION hERG; hERG-HEK
DR   DiscoverX; CYL3039
DR   Wikidata; Q54948348
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6251; KCNH2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PrecisION hGABAA alpha1/beta3/gamma2-HEK
AC   CVCL_D1JK
SY   PrecisION hGABAA alpha1/beta3/gamma2
DR   DiscoverX; CYL3053
DR   Wikidata; Q127383851
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4075; GABRA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4083; GABRB3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hGABAA alpha2/beta3/gamma2-HEK
AC   CVCL_D1KP
SY   PrecisION hGABAA alpha2/beta3/gamma2
DR   DiscoverX; CYL3072
DR   Wikidata; Q127383854
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4076; GABRA2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4083; GABRB3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: DiscoverX; CYL3072; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hGABAA alpha3/beta3/gamma2-HEK
AC   CVCL_D1JL
SY   PrecisION hGABAA alpha3/beta3/gamma2
DR   DiscoverX; CYL3068
DR   Wikidata; Q127383857
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4077; GABRA3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4083; GABRB3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hGABAA alpha4/beta3/gamma2-HEK
AC   CVCL_D1JM
SY   PrecisION hGABAA alpha4/beta3/gamma2
DR   DiscoverX; CYL3085
DR   Wikidata; Q127383860
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4078; GABRA4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4083; GABRB3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hGABAA alpha5/beta3/gamma2-HEK
AC   CVCL_D1JN
SY   PrecisION hGABAA alpha5/beta3/gamma2
DR   DiscoverX; CYL3073
DR   Wikidata; Q127383863
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4079; GABRA5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4083; GABRB3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hGABAA alpha6/beta3/gamma2-HEK
AC   CVCL_D1JP
SY   PrecisION hGABAA alpha6/beta3/gamma2
DR   DiscoverX; CYL3086
DR   Wikidata; Q127383867
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4080; GABRA6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4083; GABRB3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4087; GABRG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hGluR6-HEK
AC   CVCL_D1JQ
SY   PrecisION hGluR6
DR   DiscoverX; CYL3049
DR   Wikidata; Q127383869
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4580; GRIK2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hGlyRA1-HEK
AC   CVCL_D1JR
SY   PrecisION hGlyRA1
DR   DiscoverX; CYL3056
DR   Wikidata; Q127383871
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4326; GLRA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hHCN1-HEK
AC   CVCL_RQ84
SY   PrecisION hHCN1
DR   DiscoverX; CYL3040
DR   Wikidata; Q54948349
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4845; HCN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hHCN2-HEK
AC   CVCL_RQ85
SY   PrecisION hHCN2
DR   DiscoverX; CYL3041
DR   Wikidata; Q54948350
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4846; HCN2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hHCN3-HEK
AC   CVCL_RQ83
SY   PrecisION hHCN3
DR   DiscoverX; CYL3042
DR   Wikidata; Q54948352
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:19183; HCN3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hHCN4-CHO
AC   CVCL_RQ82
SY   PrecisION hHCN4
DR   DiscoverX; CYL3012
DR   Wikidata; Q54948353
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16882; HCN4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hKCNQ1/hminK-CHO
AC   CVCL_LC64
SY   PrecisION hKCNQ1/hminK
DR   DiscoverX; CYL3007
DR   Wikidata; Q54948354
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6240; KCNE1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6294; KCNQ1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   PrecisION hKir2.1-HEK
AC   CVCL_D1JS
SY   PrecisION hKir2.1
DR   DiscoverX; CYL3032
DR   Wikidata; Q127383873
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6263; KCNJ2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKir6.2/SUR2A (KATP)-HEK
AC   CVCL_D1JT
SY   PrecisION hKir6.2/SUR2A (KATP)
DR   DiscoverX; CYL3099
DR   Wikidata; Q127383875
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:60; ABCC9 (Note=Isoform SUR2A).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6257; KCNJ11.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hKv1.1-CHO
AC   CVCL_D1JU
SY   PrecisION hKv1.1
DR   DiscoverX; CYL3014
DR   Wikidata; Q127383877
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6218; KCNA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv1.2-CHO
AC   CVCL_D1JV
SY   PrecisION hKv1.2
DR   DiscoverX; CYL3015
DR   Wikidata; Q127383880
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6220; KCNA2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv1.3-CHO
AC   CVCL_D1JW
SY   PrecisION hKv1.3
DR   DiscoverX; CYL3016
DR   Wikidata; Q127383882
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6221; KCNA3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv1.4-CHO
AC   CVCL_D1JX
SY   PrecisION hKv1.4
DR   DiscoverX; CYL3017
DR   Wikidata; Q127383884
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6222; KCNA4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv1.5-CHO
AC   CVCL_LC65
SY   PrecisION hKv1.5
DR   DiscoverX; CYL3018
DR   Wikidata; Q54948355
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6224; KCNA5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PrecisION hKv1.6-CHO
AC   CVCL_D1JY
SY   PrecisION hKv1.6
DR   DiscoverX; CYL3019
DR   Wikidata; Q127383886
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6225; KCNA6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv1.7-CHO
AC   CVCL_D1JZ
SY   PrecisION hKv1.7
DR   DiscoverX; CYL3020
DR   Wikidata; Q127383888
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6226; KCNA7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv1.8-CHO
AC   CVCL_D1K0
SY   PrecisION hKv1.8
DR   DiscoverX; CYL3021
DR   Wikidata; Q127383890
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6219; KCNA10.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv12.2-HEK
AC   CVCL_D1K1
SY   PrecisION hKv12.2
DR   DiscoverX; CYL3089
DR   Wikidata; Q127383892
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6252; KCNH3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv2.1-CHO
AC   CVCL_D1K2
SY   PrecisION hKv2.1
DR   DiscoverX; CYL3022
DR   Wikidata; Q127383894
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6231; KCNB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv2.1/Kv9.2-CHO
AC   CVCL_D1K3
SY   PrecisION hKv2.1/Kv9.2
DR   DiscoverX; CYL3067
DR   Wikidata; Q127383897
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6231; KCNB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6301; KCNS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hKv3.1-CHO
AC   CVCL_D1K4
SY   PrecisION hKv3.1
DR   DiscoverX; CYL3043
DR   Wikidata; Q127383899
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6233; KCNC1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv3.2-CHO
AC   CVCL_D1K5
SY   PrecisION hKv3.2
DR   DiscoverX; CYL3044
DR   Wikidata; Q127383901
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6234; KCNC2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv3.3-CHO
AC   CVCL_D1K6
SY   PrecisION hKv3.3
DR   DiscoverX; CYL3045
DR   Wikidata; Q127383904
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6235; KCNC3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv4.2/KCHiP2-CHO
AC   CVCL_D1K7
SY   PrecisION hKv4.2/KCHiP2
DR   DiscoverX; CYL3026
DR   Wikidata; Q127383906
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6238; KCND2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15522; KCNIP2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hKv4.3/KCHiP1-CHO
AC   CVCL_D1K8
SY   PrecisION hKv4.3/KCHiP1
DR   DiscoverX; CYL3027
DR   Wikidata; Q127383908
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6239; KCND3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15521; KCNIP1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv4.3/KChiP2-HEK
AC   CVCL_D1K9
SY   PrecisION hKv4.3/KChiP2
DR   DiscoverX; CYL3069
DR   Wikidata; Q127383911
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6239; KCND3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15522; KCNIP2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hKv7.2/Kv7.3-CHO
AC   CVCL_D1KA
SY   PrecisION hKv7.2/Kv7.3
DR   DiscoverX; CYL3059
DR   Wikidata; Q127383913
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6296; KCNQ2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6297; KCNQ3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hKv7.3/Kv7.5-HEK
AC   CVCL_D1KB
SY   PrecisION hKv7.3/Kv7.5
DR   DiscoverX; CYL3060
DR   Wikidata; Q127383915
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6297; KCNQ3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6299; KCNQ5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hKv7.4-HEK
AC   CVCL_D1KC
SY   PrecisION hKv7.4
DR   DiscoverX; CYL3092
DR   Wikidata; Q127383918
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6298; KCNQ4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hKv7.4/Kv7.5-HEK
AC   CVCL_D1KD
SY   PrecisION hKv7.4/Kv7.5
DR   DiscoverX; CYL3096
DR   Wikidata; Q127383920
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6298; KCNQ4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6299; KCNQ5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hnAChR alpha1/beta1/delta/epsilon-HEK
AC   CVCL_D1KE
SY   PrecisION hnAChR alpha1/beta1/delta/epsilon
DR   DiscoverX; CYL3052
DR   Wikidata; Q127383923
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1955; CHRNA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1961; CHRNB1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1965; CHRND.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1966; CHRNE.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hnAChR alpha3/beta4-HEK
AC   CVCL_D1KF
SY   PrecisION hnAChR alpha3/beta4
DR   DiscoverX; CYL3057
DR   Wikidata; Q127383925
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1957; CHRNA3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1964; CHRNB4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hnAChR alpha4/alpha6/beta2-HEK
AC   CVCL_D1KG
SY   PrecisION hnAChR alpha4/alpha6/beta2
DR   DiscoverX; CYL3107
DR   Wikidata; Q127383927
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1958; CHRNA4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15963; CHRNA6.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1962; CHRNB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: DiscoverX; CYL3107; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hnAChR alpha4/beta2-HEK
AC   CVCL_D1KH
SY   PrecisION hnAChR alpha4/beta2
DR   DiscoverX; CYL3106
DR   Wikidata; Q127383929
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1958; CHRNA4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1962; CHRNB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hnAChR alpha7/ric3-HEK
AC   CVCL_D1KI
SY   PrecisION hnAChR alpha7/ric3
DR   DiscoverX; CYL3097
DR   Wikidata; Q127383932
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1960; CHRNA7.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:30338; RIC3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hNav1.1-HEK
AC   CVCL_RQ81
SY   PrecisION hNav1.1
DR   DiscoverX; CYL3009
DR   Wikidata; Q54948356
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10585; SCN1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hNav1.2-CHO
AC   CVCL_LC66
SY   PrecisION hNav1.2
DR   DiscoverX; CYL3023
DR   Wikidata; Q54948357
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10588; SCN2A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PrecisION hNav1.3-CHO
AC   CVCL_RQ79
SY   PrecisION hNav1.3
DR   DiscoverX; CYL3003
DR   Wikidata; Q54948358
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10590; SCN3A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hNav1.4-HEK
AC   CVCL_D1KJ
SY   PrecisION hNav1.4
DR   DiscoverX; CYL3024
DR   Wikidata; Q127383934
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10591; SCN4A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hNav1.5-HEK
AC   CVCL_LC67
SY   PrecisION hNav1.5
DR   DiscoverX; CYL3004
DR   Wikidata; Q54948359
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10593; SCN5A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PrecisION hNav1.6-HEK
AC   CVCL_LC68
SY   PrecisION hNav1.6
DR   DiscoverX; CYL3010
DR   Wikidata; Q54948360
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10596; SCN8A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   PrecisION hNav1.7-HEK
AC   CVCL_RQ80
SY   PrecisION hNav1.7
DR   DiscoverX; CYL3011
DR   Wikidata; Q54948361
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10597; SCN9A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   PrecisION hNav1.8/beta1-HEK
AC   CVCL_D1KK
SY   PrecisION hNav1.8/beta1
DR   DiscoverX; CYL3025
DR   Wikidata; Q127383936
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10582; SCN10A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10586; SCN1B.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hTRPA1-HEK
AC   CVCL_D1KL
SY   PrecisION hTRPA1
DR   DiscoverX; CYL3066
DR   Wikidata; Q127383938
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:497; TRPA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hTRPV1-HEK
AC   CVCL_D1JB
SY   PrecisION hTRPV1; hTRPV1-HEK293; TRPV1-HEK; TRPV1-HEK293
DR   DiscoverX; CYL3063
DR   Wikidata; Q127383941
WW   Info; Millipore; -; https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/388/185/cyl3063-m1.pdf
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12716; TRPV1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   PrecisION hTRPV3-HEK
AC   CVCL_D1KM
SY   PrecisION hTRPV3
DR   DiscoverX; CYL3065
DR   Wikidata; Q127383943
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18084; TRPV3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION hTRPV4-HEK
AC   CVCL_D1JD
SY   PrecisION hTRPV4
DR   DiscoverX; CYL3064
DR   Wikidata; Q127383945
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:18083; TRPV4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   PrecisION rNav1.8-ND7-23
AC   CVCL_D1JH
SY   PrecisION rNav1.8
DR   DiscoverX; CYL3050
DR   Wikidata; Q127383947
WW   Info; Millipore; -; https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/244/082/cyl3050-m4.pdf
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3629; Scn10a.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: DiscoverX; CYL3050; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4259 ! ND7/23
CA   Hybrid cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   pREP4 cont/CHO-S #5
AC   CVCL_EG61
DR   JCRB; JCRB1626
DR   Wikidata; Q54948362
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 8
//
ID   pREP4 cont/CHO-S #5/sf
AC   CVCL_EG60
SY   pREP4 c/CHO-S #5/sf; pREP4 cont/CHO-S #5/serum free
DR   JCRB; JCRB1636
DR   JCRB; JCRB1636.01
DR   Wikidata; Q54948363
CC   Group: Serum/protein free medium cell line.
CC   From: Mebiopharm Co., Ltd; Tokyo; Japan.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_EG61 ! pREP4 cont/CHO-S #5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 8
//
ID   PRG-3/293T-Rex
AC   CVCL_C4CU
DR   Wikidata; Q116050127
RX   Patent=US20100111851;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:25993; PLPPR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U427 ! Flp-In-T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 8
//
ID   PRHC-1
AC   CVCL_A7NW
SY   Poliovirus Resistant HeLa Cells-1
DR   Wikidata; Q107116676
RX   PubMed=3037186;
CC   Population: African American.
CC   Virology: Resistant of the cytopathogenic effect of poliovirus infection (PubMed=3037186).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   Priess
AC   CVCL_E813
SY   PRIESS
DR   EFO; EFO_0022635
DR   dbMHC; 49007
DR   ECACC; 86052111
DR   IHW; IHW09301
DR   IPD-IMGT/HLA; 11277
DR   PRIDE; PXD002439
DR   Wikidata; Q54948364
RX   PubMed=7615790;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Danish.
CC   HLA typing: A*02; B*62; C*03; DPA1*01:03:01; DPB1*03:01:01,04:01:01; DQA1*03; DQB1*03:02:01; DRB1*04:01:01; DRB4*01:01:01 (IPD-IMGT/HLA=11277).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 17
//
ID   PRKT
AC   CVCL_T686
SY   ProRenal Kidney Tumour
DR   Wikidata; Q54948365
RX   PubMed=221384;
RX   PubMed=1087310;
RX   PubMed=1429360;
CC   Group: Amphibian cell line.
CC   Characteristics: Derived from cell dissociation of a pronephric tumour induced after embryo inoculation of the RaHV-1 infected WMPa/V208 cell line (Cellosaurus=CVCL_D6A0) (PubMed=1087310).
CC   Transformant: NCBI_TaxID; 85655; Ranid herpesvirus 1 (RaHV-1).
CC   Derived from site: In situ; Embryonic kidney, pronephros; UBERON=UBERON_0002120.
DI   NCIt; C134771; Frog pronephric kidney tumor
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
OI   CVCL_T685 ! PNKT-3
AG   Larval stage
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 9
//
ID   PRMT6-KO-10
AC   CVCL_A4CZ
SY   HKUe001-A
DR   hPSCreg; HKUe001-A
DR   Wikidata; Q105510606
RX   PubMed=33383404;
CC   From: School of Biomedical Sciences, LKS Faculty of Medicine, University of Hong Kong; Hong Kong; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18241; PRMT6.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   PRMT6-KO-24
AC   CVCL_A4DA
SY   HKUe001-A-1
DR   hPSCreg; HKUe001-A-1
DR   Wikidata; Q105510609
RX   PubMed=33383404;
CC   From: School of Biomedical Sciences, LKS Faculty of Medicine, University of Hong Kong; Hong Kong; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18241; PRMT6.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   pRNS-1-1
AC   CVCL_4890
SY   MLCSV40
DR   Wikidata; Q54948366
RX   PubMed=8977636;
RX   PubMed=9276642;
RX   PubMed=9772298;
RX   PubMed=21544329;
RX   PubMed=21566988;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   pRNS-1-1/ras
AC   CVCL_4891
DR   Wikidata; Q54948367
RX   PubMed=9276642;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160321225449/http://capcelllines.ca/details.asp?id=173
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4890 ! pRNS-1-1
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   PRO
AC   CVCL_N817
DR   Wikidata; Q54948368
RX   PubMed=15274292;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Pro104.C25.1
AC   CVCL_A0CH
SY   Pro104C25.1
DR   Wikidata; Q108821145
RX   Patent=US8080650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6076.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Pro104.C55.1
AC   CVCL_A0CI
SY   Pro104C55.1
DR   Wikidata; Q108821146
RX   Patent=US8080650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5277.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Pro104.D9.1
AC   CVCL_A0CJ
SY   Pro104D9.1; D9.1
DR   Wikidata; Q108821147
RX   Patent=US8080650;
RX   PubMed=32511276;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6077.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Pro104.K81.15
AC   CVCL_A0CK
SY   Pro104K81.15
DR   Wikidata; Q108821148
RX   Patent=US8080650;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6078.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   Pro9ad
AC   CVCL_C6EQ
DR   Wikidata; Q116050128
RX   PubMed=9655262;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Prostate, ventral lobe; UBERON=UBERON_0007615.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Probasco
AC   CVCL_DN66
DR   ABM; T8276
DR   Wikidata; Q54948369
RX   PubMed=25043424;
CC   Doubling time: ~18 hours (PubMed=25043424).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10-11Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   Probasco-Luc
AC   CVCL_E8GR
DR   ABM; T8277
RX   PubMed=25043424;
CC   Doubling time: 18-28 hours (ABM=T8277).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_DN66 ! Probasco
SX   Male
AG   10-11Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ProPak-A.52
AC   CVCL_8967
SY   PP-A.52; ProPak-A.52 Clone #52
DR   CLO; CLO_0008487
DR   ATCC; CRL-12479
DR   Wikidata; Q54948370
RX   Patent=US6017761;
RX   PubMed=9231077;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12479.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-12479; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-12479
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   ProPak-A.6
AC   CVCL_8968
SY   ProPakA.6; PPA.6; PP-A.6
DR   CLO; CLO_0008488
DR   ATCC; CRL-12006
DR   Wikidata; Q54948371
RX   Patent=US6017761;
RX   PubMed=9231077;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12006.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-12006; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-12006
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   ProPak-X.36
AC   CVCL_8969
SY   PP-X.36
DR   CLO; CLO_0008489
DR   ATCC; CRL-12007
DR   Wikidata; Q54948372
RX   Patent=US6017761;
RX   PubMed=9231077;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12007.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-12007; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-12007
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   Prost 130
AC   CVCL_A0EA
SY   PROST 130
DR   ATCC; HB-11427
DR   Wikidata; Q108821149
RX   Patent=US6767711;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11427.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost 16
AC   CVCL_A0EB
DR   Wikidata; Q108821150
RX   Patent=US6767711;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost 185
AC   CVCL_A0EC
SY   PROST 185
DR   ATCC; HB-11425
DR   Wikidata; Q108821151
RX   Patent=US6767711;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11425.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost 30
AC   CVCL_A0ED
SY   PROST 30
DR   ATCC; HB-11424
DR   Wikidata; Q108821152
RX   Patent=US6767711;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11424.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human prostate epithelial-specific antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost 410
AC   CVCL_6435
SY   PROST 410
DR   CLO; CLO_0008490
DR   ATCC; HB-11426
DR   Wikidata; Q54948373
RX   Patent=US6767711;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11426.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Prost C219
AC   CVCL_A0EE
SY   PROST C219; C219
DR   ATCC; HB-11893
DR   Wikidata; Q108821153
RX   Patent=US6767711;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11893.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost C37
AC   CVCL_A0EF
SY   C37
DR   Wikidata; Q108821154
RX   Patent=US6767711;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11892.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost E99
AC   CVCL_B0HS
SY   E99
DR   ATCC; HB-12101
DR   Wikidata; Q108821155
RX   Patent=US7666425;
RX   PubMed=9288760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12101.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost J415
AC   CVCL_B0HT
SY   J415
DR   ATCC; HB-12109
DR   Wikidata; Q108821156
RX   Patent=US7666425;
RX   PubMed=9288760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12109.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost J533
AC   CVCL_B0HU
SY   J533
DR   ATCC; HB-12127
DR   Wikidata; Q108821157
RX   Patent=US7666425;
RX   PubMed=9288760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12127.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Prost J591
AC   CVCL_B0HV
SY   J591
DR   Wikidata; Q108821158
RX   Patent=US7666425;
RX   PubMed=9288760;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12126.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PrP::hSNCAA53T
AC   CVCL_JJ83
DR   Wikidata; Q54948375
RX   PubMed=28413000;
CC   Characteristics: Expresses human mutant SNCA p.Ala53Thr under the control of the mouse prion (PrP) promoter.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: B6;C3-Tg(Prnp-SNCA*A53T)83Vle/J transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   PRT-HU2
AC   CVCL_7207
SY   PRT-Hu2; HU2
DR   Wikidata; Q54948380
RX   PubMed=1320358;
CC   Doubling time: 48 hours (PubMed=1320358).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   PRU-1
AC   CVCL_VN19
DR   Wikidata; Q98128671
RX   PubMed=25351656;
DI   NCIt; C114483; Childhood Langerhans cell histiocytosis
DI   ORDO; Orphanet_389; Langerhans cell histiocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   PRU-TA-42
AC   CVCL_Z236
SY   TA-42
DR   Wikidata; Q54948381
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1093/jmedent/17.4.338;
RX   PubMed=6126429;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   PRU-TA-9
AC   CVCL_Z237
SY   TA-9
DR   Wikidata; Q54948384
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1093/jmedent/17.4.338;
RX   PubMed=6126429;
CC   Group: Insect cell line.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   PRX-129X1/SvJ #1
AC   CVCL_2H79
SY   PRX-129X1/SvJ; PRX-129/X1 #1; 129X1/SvJ-PRX-129X1 #1
DR   Wikidata; Q54948385
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000691P10productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PRX-B6-albino #1
AC   CVCL_2H80
SY   B6(Cg)-Tyrc-2J/J-PRX-B6-albino #1
DR   Wikidata; Q54948386
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000058P10productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: B6(Cg)-Tyrc-2J/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PRX-B6N #1
AC   CVCL_2H81
SY   C57BL/6N-PRX-B6N #1; PrxB6N
DR   Wikidata; Q54948387
RX   PubMed=25277546;
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/012448P8productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PRX-Balb/cJ #9
AC   CVCL_2H82
SY   BALB/cJ-PRX-BALB/cJ #9
DR   Wikidata; Q54948388
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000651P10productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PRX-C3H #2
AC   CVCL_2H83
SY   C3H/HeJ-PRX-C3H #2
DR   Wikidata; Q54948389
WW   Provider; JAX; -; https://jackson.jax.org/rs/444-BUH-304/images/000659P10-2productspec.pdf
CC   From: Primogenix, Inc.; Saint Louis; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   PS 36
AC   CVCL_0E47
SY   PS36
DR   ATCC; CRL-1801
DR   Wikidata; Q54948390
RX   PubMed=3880813;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01179; Rat Oxt.
CC   Discontinued: ATCC; CRL-1801; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   PS 38
AC   CVCL_G251
SY   PS38
DR   CLO; CLO_0008492
DR   ATCC; CRL-1950
DR   Wikidata; Q54948391
RX   PubMed=3880813;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01179; Rat Oxt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   PS 4-1
AC   CVCL_D6CZ
DR   Wikidata; Q127383949
RX   PubMed=4364526;
CC   Characteristics: Not pigmented. Amelanotic subclone of parent cell line (PubMed=4364526).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5ZZ ! PS 4-wt
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   PS 4-15
AC   CVCL_D6D0
DR   Wikidata; Q127383952
RX   PubMed=4364526;
CC   Characteristics: Not pigmented. Amelanotic subclone of parent cell line (PubMed=4364526).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5ZZ ! PS 4-wt
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   PS 4-17
AC   CVCL_D6D1
DR   Wikidata; Q127383954
RX   PubMed=4364526;
CC   Characteristics: Not pigmented. Amelanotic subclone of parent cell line (PubMed=4364526).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5ZZ ! PS 4-wt
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   PS 4-3
AC   CVCL_D6D2
DR   Wikidata; Q127383956
RX   PubMed=4364526;
CC   Characteristics: Not pigmented. Amelanotic subclone of parent cell line (PubMed=4364526).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D5ZZ ! PS 4-wt
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   PS 4-wt
AC   CVCL_D5ZZ
DR   Wikidata; Q127383958
RX   PubMed=4364526;
CC   Characteristics: Highly pigmented (PubMed=4364526).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4512 ! Clone M-3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   PS 41
AC   CVCL_G252
SY   PS41
DR   CLO; CLO_0008493
DR   ATCC; CRL-1799
DR   Wikidata; Q54948393
RX   PubMed=3880813;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01186; Rat Avp.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   PS 45
AC   CVCL_G253
SY   PS45
DR   CLO; CLO_0008494
DR   ATCC; CRL-1798
DR   Wikidata; Q54948395
RX   PubMed=3880813;
CC   Monoclonal antibody isotype: IgG3, kappa (PubMed=3880813); IgG2b (ATCC=CRL-1798).
CC   Monoclonal antibody target: UniProtKB; P01186; Rat Avp.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   PS 46
AC   CVCL_0E48
SY   PS46
DR   Wikidata; Q54948396
RX   PubMed=3880813;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01186; Rat Avp.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   PS 60
AC   CVCL_G254
SY   PS60
DR   CLO; CLO_0008495
DR   ATCC; CRL-1800
DR   Wikidata; Q54948397
RX   PubMed=3880813;
CC   Monoclonal antibody isotype: IgG3, kappa (PubMed=3880813); IgG2b (ATCC=CRL-1800).
CC   Monoclonal antibody target: UniProtKB; P01179; Rat Oxt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   PS 67
AC   CVCL_G255
SY   PS67
DR   CLO; CLO_0008496
DR   ATCC; CRL-1797
DR   Wikidata; Q54948398
RX   PubMed=3880813;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01179; Rat Oxt.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   PS-1 [Human urinary bladder carcinoma]
AC   CVCL_4892
SY   PS1; PSI
DR   Cosmic; 2037953
DR   GEO; GSM136241
DR   Wikidata; Q54948399
RX   PubMed=81814;
RX   PubMed=3708594;
RX   PubMed=6244232;
RX   PubMed=11416159;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=27270441;
RX   PubMed=29732388;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11416159; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 11,12
ST   D21S11: 30,31.2
ST   D5S818: 12
ST   D7S820: 9,13
ST   D8S1179: 11,13
ST   FGA: 23
ST   TH01: 7,8
ST   TPOX: 9
ST   vWA: 15,16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   PS-1 [Rat prostate]
AC   CVCL_4893
SY   PS1
DR   Lonza; 697
DR   Wikidata; Q54948400
RX   PubMed=8603596;
RX   PubMed=18462435;
CC   Derived from site: In situ; Prostate, smooth muscle; UBERON=UBERON_0004243.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   PS-12
AC   CVCL_R982
SY   PS 12; Pike Sarcoma-12
DR   Wikidata; Q54948401
CC   Group: Fish cell line.
DI   NCIt; C134949; Pike sarcoma
OX   NCBI_TaxID=8010; ! Esox lucius (Northern pike)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   PS-17
AC   CVCL_F1XH
RX   Patent=US20250115879;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2024154.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_61642; Polystyrene polymer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PS-6A7-C4
AC   CVCL_C8I7
DR   Wikidata; Q123033280
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PS-7B11-E3
AC   CVCL_C8I8
DR   Wikidata; Q123033281
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   PS-8
AC   CVCL_F1XI
RX   Patent=US20250115879;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2024144.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: ChEBI; CHEBI_61642; Polystyrene polymer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PS-BME-L6
AC   CVCL_U228
SY   Penn State Bovine Mammary Epithelial Line-6
DR   Wikidata; Q54948403
RX   DOI=10.1007/BF02634376;
RX   PubMed=1890074;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of bovine origin but found to be a mouse COMMA-D derivative (DOI=10.1007/BF02634376).
CC   Doubling time: 8.2-12.7 hours (Note=Depending on the growth conditions) (PubMed=1890074).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   PS-BME-L7
AC   CVCL_U229
SY   Penn State Bovine Mammary Epithelial Line-7
DR   Wikidata; Q54948405
RX   DOI=10.1007/BF02634376;
RX   PubMed=1890074;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of bovine origin but found to be a mouse COMMA-D derivative (DOI=10.1007/BF02634376).
CC   Doubling time: 10.5-20.4 hours (Note=Depending on the growth conditions) (PubMed=1890074).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5731 ! COMMA-D
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   PS-C3H
AC   CVCL_C4K9
DR   Wikidata; Q116050129
RX   PubMed=191529;
RX   PubMed=2991384;
RX   PubMed=3027416;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C3H.SW/SnJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   PS-iPS1
AC   CVCL_CW46
DR   Wikidata; Q54948406
RX   PubMed=23400930;
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.10949del2501; Zygosity=Heteroplasmic (PubMed=23400930).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW47 ! PS-iPS2
OI   CVCL_CW48 ! PS-iPS3
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   PS-iPS2
AC   CVCL_CW47
DR   Wikidata; Q54948407
RX   PubMed=23400930;
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.10949del2501; Zygosity=Heteroplasmic (PubMed=23400930).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW46 ! PS-iPS1
OI   CVCL_CW48 ! PS-iPS3
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   PS-iPS3
AC   CVCL_CW48
DR   Wikidata; Q54948408
RX   PubMed=23400930;
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.10949del2501; Zygosity=Heteroplasmic (PubMed=23400930).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_CW46 ! PS-iPS1
OI   CVCL_CW47 ! PS-iPS2
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   PS-SW
AC   CVCL_C4KA
DR   Wikidata; Q116050130
RX   PubMed=191529;
RX   PubMed=2991384;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   PS/2
AC   CVCL_9225
DR   CLO; CLO_0008497
DR   ATCC; CRL-1911
DR   ECACC; 93091302
DR   Wikidata; Q54948409
RX   PubMed=1997648;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   PS/c4
AC   CVCL_F0LB
RX   Patent=RU2339693;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, All-Russian Scientific Research Institute of Experimental Veterinary Medicine (VNIIVViM); 60.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=34875; ! Saiga tatarica (Saiga antelope)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   PS1
AC   CVCL_A8DL
DR   JCRB; JCRB3070
DR   JCRB; KURB2002
DR   Wikidata; Q107116677
CC   Discontinued: JCRB; KURB2002; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3070
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D5S818: 9
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 6
//
ID   PS1-2
AC   CVCL_T873
DR   SKIP; SKIP000198
DR   SKIP; SKIP001014
DR   Wikidata; Q54948410
RX   PubMed=21900357;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=21900357).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T877 ! AG07768
SX   Female
AG   30Y6M
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   PS1-4
AC   CVCL_T874
DR   SKIP; SKIP000199
DR   SKIP; SKIP001014
DR   Wikidata; Q54948411
RX   PubMed=21900357;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Unspecified (PubMed=21900357).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T877 ! AG07768
SX   Female
AG   30Y6M
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   PS120
AC   CVCL_0488
SY   PS-120
DR   EFO; EFO_0022748
DR   MCCL; MCC:0000387
DR   TOKU-E; 4033
DR   Wikidata; Q54948412
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-272.html
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2886 ! Dede
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   PS1P351
AC   CVCL_A0BB
DR   Wikidata; Q108821159
RX   Patent=US6482599;
RX   PubMed=10866804;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PS1R163
AC   CVCL_A0BC
DR   Wikidata; Q108821160
RX   Patent=US6482599;
RX   PubMed=10866804;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PS1Z125
AC   CVCL_A0BJ
SY   PS1Z125.3
DR   Wikidata; Q108821161
RX   Patent=US6423503;
RX   Patent=US6482599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4229.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PS1Z134
AC   CVCL_A0BI
DR   Wikidata; Q108821162
RX   Patent=US6423503;
RX   Patent=US6482599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4228.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PS2-1
AC   CVCL_T875
DR   GEO; GSM701544
DR   SKIP; SKIP000196
DR   SKIP; SKIP001015
DR   Wikidata; Q54948413
RX   PubMed=21900357;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=21900357).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T872 ! AG09908
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   PS2-2
AC   CVCL_T876
DR   GEO; GSM701545
DR   SKIP; SKIP000197
DR   SKIP; SKIP001015
DR   Wikidata; Q54948414
RX   PubMed=21900357;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=21900357).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T872 ! AG09908
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   PS2C109
AC   CVCL_A0BD
SY   PS2C109.1
DR   Wikidata; Q108821163
RX   Patent=US6423503;
RX   Patent=US6482599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4227.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PS2C501
AC   CVCL_A0BH
DR   Wikidata; Q108821164
RX   Patent=US6423503;
RX   Patent=US6482599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4226.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PS2C634
AC   CVCL_A0BG
DR   Wikidata; Q108821165
RX   Patent=US6423503;
RX   Patent=US6482599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4225.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PS2C807
AC   CVCL_A0BE
DR   Wikidata; Q108821166
RX   Patent=US6423503;
RX   Patent=US6482599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4223.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PS2C837
AC   CVCL_A0BF
DR   Wikidata; Q108821167
RX   Patent=US6423503;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4224.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   PS30
AC   CVCL_LF78
DR   Wikidata; Q54948415
RX   PubMed=11061945;
RX   PubMed=16153146;
RX   PubMed=18462435;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   PSA1
AC   CVCL_4277
AS   CVCL_3600
SY   PSA-1; PSA 1; SCC-PSA1
DR   CLO; CLO_0008505
DR   CLO; CLO_0008970
DR   CLDB; cl3942
DR   ATCC; CRL-1535
DR   BCRC; 60387
DR   ECACC; 85011403
DR   Wikidata; Q54948417
RX   PubMed=271982;
RX   PubMed=590624;
CC   Breed/subspecies: 129/Sv-SlJ-CP.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5T83 ! SIKR
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   PSA1-NG2
AC   CVCL_7221
SY   PSA-1-NG2; PSA 1-NG2; NG 2; NG2
DR   CLO; CLO_0008506
DR   CLDB; cl3943
DR   ECACC; 85011404
DR   Wikidata; Q54948418
RX   PubMed=271982;
RX   PubMed=3428508;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: ECACC; 85011404; true.
CC   Breed/subspecies: 129/Sv-SlJ-CP.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4277 ! PSA1
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   PSA399
AC   CVCL_A0AX
DR   Wikidata; Q108821168
RX   Patent=US6482599;
RX   PubMed=10866804;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PSA4
AC   CVCL_A7BF
DR   Wikidata; Q107116678
RX   PubMed=72666;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   PSA5-E
AC   CVCL_A7BG
DR   Wikidata; Q107116679
RX   PubMed=72666;
RX   PubMed=2412863;
RX   PubMed=3539943;
CC   Derived from site: In situ; Visceral endoderm; UBERON=UBERON_0004877.
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   PSADFN086
AC   CVCL_1Z05
SY   HGADFN086
DR   Wikidata; Q54948420
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; c.1968+1G>A; ClinVar=VCV000066879; Zygosity=Unspecified; Note=Splice donor mutation (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z87 ! PSALBV083
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSADFN257
AC   CVCL_1Z06
DR   Wikidata; Q54948421
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Met540Thr (c.1619T>C); ClinVar=VCV000066858; Zygosity=Homozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   PSADFN317
AC   CVCL_1Z15
DR   Wikidata; Q54948423
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Pro248Leu (c.743C>T); ClinVar=VCV000004275; Zygosity=Heterozygous (PRF).
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Trp450Ter (c.1349G>A); ClinVar=VCV000030586; Zygosity=Heterozygous (PRF).
CC   Misspelling: PSADNF317; Note=Occasionally.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSADFN318
AC   CVCL_1Z16
DR   Wikidata; Q54948425
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Pro248Leu (c.743C>T); ClinVar=VCV000004275; Zygosity=Heterozygous (PRF).
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Trp450Ter (c.1349G>A); ClinVar=VCV000030586; Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSADFN325
AC   CVCL_1Z07
DR   Wikidata; Q54948426
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; c.1968+5G>C; ClinVar=VCV000162416; Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   PSADFN328
AC   CVCL_1Z10
DR   Wikidata; Q54948427
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Ser (c.1822G>A); ClinVar=VCV000014501; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z99 ! PSALBV296
SX   Female
AG   12Y5M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSADFN363
AC   CVCL_1Z12
DR   Wikidata; Q54948428
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Asp325Asn (c.973G>A); Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   PSADFN373
AC   CVCL_1Z19
DR   Wikidata; Q54948436
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Homozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A01 ! PSALBV341
SX   Male
AG   5Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   PSADFN386
AC   CVCL_YU43
DR   Wikidata; Q98128672
RX   PubMed=27920058;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; c.1968+2T>C; ClinVar=VCV000162415; Zygosity=Mosaic; Note=Splice donor mutation. In 100% of the skin fibroblast cells. The patient blood is mosaic for 4.7% c.1968+2T>C (causing mild HGPS) and 41.3% c.1968+2T>A (severe HGPS) (PubMed=27920058).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27920058
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 28,33.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   PSADFN392
AC   CVCL_1Z22
DR   Wikidata; Q54948437
RX   PubMed=27920058;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; c.1968+2T>C; ClinVar=VCV000162415; Zygosity=Unspecified; Note=Splice donor mutation (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y4M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSADFN412
AC   CVCL_1Z25
DR   Wikidata; Q54948438
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Cys588Arg (c.1762T>C); ClinVar=VCV000066865; Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z26 ! PSADFN414
SX   Male
AG   7Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   PSADFN414
AC   CVCL_1Z26
DR   Wikidata; Q54948439
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Cys588Arg (c.1762T>C); ClinVar=VCV000066865; Zygosity=Heterozygous (PRF).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z25 ! PSADFN412
SX   Male
AG   12Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 12
//
ID   PSADFN423
AC   CVCL_YU46
DR   Wikidata; Q98128673
RX   PubMed=27920058;
CC   Part of: Progeria Research Foundation cell lines.
CC   Doubling time: 28.8 days (Note=At 8th passage) (PubMed=27920058).
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; c.1968+2T>A; ClinVar=VCV000162414; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=27920058).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   PSADFN425
AC   CVCL_1Z27
DR   Wikidata; Q54948440
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Glu111Lys (c.331G>A); Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z96 ! PSALBV295
SX   Male
AG   20Y11M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   PSADFN485
AC   CVCL_YU36
DR   Wikidata; Q98128675
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Glu138Lys (c.412G>A); ClinVar=VCV000066897; Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y5M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 8
//
ID   PSADFN489
AC   CVCL_YU40
DR   Wikidata; Q98128676
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Sequence variation: Mutation; HGNC; HGNC:2468; SMC3; Simple; p.Lys188Glu (c.562A>G); ClinVar=VCV000383548; Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y2M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   PSADFN542
AC   CVCL_C3PG
DR   Wikidata; Q116050131
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg644Cys (c.1930C>T); ClinVar=VCV000014527; Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y2M
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   PSADFSV40T317
AC   CVCL_DP35
DR   Wikidata; Q54948441
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Pro248Leu (c.743C>T); ClinVar=VCV000004275; Zygosity=Heterozygous (PRF).
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Trp450Ter (c.1349G>A); ClinVar=VCV000030586; Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z15 ! PSADFN317
SX   Male
AG   3Y9M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   PSADFSV40T318
AC   CVCL_DP36
DR   Wikidata; Q54948442
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z16 ! PSADFN318
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PSADFSV40T373
AC   CVCL_DP39
DR   Wikidata; Q54948443
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Homozygous (PRF).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z19 ! PSADFN373
SX   Male
AG   5Y9M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   PSALBV083
AC   CVCL_1Z87
DR   Wikidata; Q54948444
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; c.1968+1G>A; ClinVar=VCV000066879; Zygosity=Unspecified; Note=Splice donor mutation (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z05 ! PSADFN086
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 16
//
ID   PSALBV199
AC   CVCL_1Z90
DR   Wikidata; Q54948445
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Thr623Ser (c.1868C>G); ClinVar=VCV000066869; Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSALBV229
AC   CVCL_1Z95
DR   Wikidata; Q54948446
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Ser (c.1822G>A); ClinVar=VCV000014501; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSALBV245
AC   CVCL_1Z93
DR   Wikidata; Q54948447
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Cys (c.1579C>T) (c.1791C>T); ClinVar=VCV000014487; Zygosity=Homozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSALBV295
AC   CVCL_1Z96
DR   Wikidata; Q54948448
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Glu111Lys (c.331G>A); Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z27 ! PSADFN425
SX   Male
AG   17Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSALBV296
AC   CVCL_1Z99
DR   Wikidata; Q54948449
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Ser (c.1822G>A); ClinVar=VCV000014501; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z10 ! PSADFN328
SX   Female
AG   10Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSALBV339
AC   CVCL_1Z94
DR   Wikidata; Q54948450
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Cys (c.1579C>T) (c.1791C>T); ClinVar=VCV000014487; Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSALBV341
AC   CVCL_2A01
DR   Wikidata; Q54948451
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Homozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z19 ! PSADFN373
SX   Male
AG   5Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSALBV342
AC   CVCL_2A02
DR   Wikidata; Q54948452
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Homozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSALBV379
AC   CVCL_2A00
DR   Wikidata; Q54948453
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; c.1968+1G>A; ClinVar=VCV000066879; Zygosity=Heterozygous; Note=Splice donor mutation (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 16
//
ID   PSALBV406
AC   CVCL_2A05
DR   Wikidata; Q54948454
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Ser (c.1822G>A); ClinVar=VCV000014501; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSALBV427
AC   CVCL_2A06
DR   Wikidata; Q54948455
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Val607Val (c.1821G>A); ClinVar=VCV000014516; Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 15
//
ID   PSALBV432
AC   CVCL_2A07
DR   Wikidata; Q54948456
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Leu (c.1580G>T); ClinVar=VCV000919926; Zygosity=Homozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34951; Progeria
DI   ORDO; Orphanet_740; Hutchinson-Gilford progeria syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y5M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 16
//
ID   PSB-D
AC   CVCL_D5H0
SY   PSBD
DR   ArrayExpress; E-MTAB-3019
DR   ArrayExpress; E-MTAB-3046
DR   ArrayExpress; E-MTAB-3754
DR   ArrayExpress; E-MTAB-3915
DR   ArrayExpress; E-MTAB-6513
DR   ArrayExpress; E-MTAB-7761
DR   GEO; GSE48793
DR   GEO; GSE53422
DR   PRIDE; PXD001473
DR   PRIDE; PXD001562
DR   PRIDE; PXD008355
DR   PRIDE; PXD023022
DR   PRIDE; PXD028534
DR   PRIDE; PXD036285
DR   Wikidata; Q127383960
RX   PubMed=17947977;
RX   PubMed=21720954;
RX   PubMed=24453163;
RX   PubMed=25521792;
RX   PubMed=26187819;
RX   PubMed=30833711;
RX   PubMed=31578252;
RX   PubMed=35258835;
RX   PubMed=35657526;
WW   Provider; ABRC; CCL84840; https://abrc.osu.edu/stocks/282
CC   Group: Plant cell line.
CC   Characteristics: Grown in darkness (ABRC).
CC   Characteristics: Can be genetically transformed with Agrobacterium (PubMed=35258835).
CC   Characteristics: Can be used to prepare protoplasts (PubMed=17947977).
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; S-sulfenylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Landsberg erecta.
OX   NCBI_TaxID=3702; ! Arabidopsis thaliana (Mouse-ear cress)
HI   CVCL_D5GY ! MM2d
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PSB-L
AC   CVCL_D5H1
SY   PSBL
DR   Wikidata; Q127383963
RX   PubMed=12231968;
RX   PubMed=17426018;
RX   PubMed=18619442;
RX   PubMed=25521792;
RX   PubMed=27543091;
RX   PubMed=28586477;
RX   PubMed=34021140;
WW   Provider; ABRC; CCL84841; https://abrc.osu.edu/stocks/283
CC   Group: Plant cell line.
CC   Characteristics: Grown in light/dark cycles (PubMed=18619442).
CC   Characteristics: Can be genetically transformed with Agrobacterium (PubMed=17426018).
CC   Characteristics: Can be used to prepare protoplasts (PubMed=27543091; PubMed=34021140).
CC   Caution: It is unclear why PubMed=29853640 states that PSB-L is derived from MM2d and cites PubMed=25521792. PubMed=34156108 also states that PSB-L is derived from MM2d cells but does not provide any reference.
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Landsberg erecta.
OX   NCBI_TaxID=3702; ! Arabidopsis thaliana (Mouse-ear cress)
HI   CVCL_D5GX ! MM1
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   PSB999
AC   CVCL_A0AY
DR   Wikidata; Q108821170
RX   Patent=US6482599;
RX   PubMed=10866804;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PSC-THP1
AC   CVCL_IR08
DR   cancercelllines; CVCL_IR08
DR   Wikidata; Q54948457
RX   Patent=US20090181007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 05005.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   PSC-THP1-chondrocyte-like
AC   CVCL_IR09
DR   cancercelllines; CVCL_IR09
DR   Wikidata; Q54948458
RX   Patent=US20090181007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 06001.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IR08 ! PSC-THP1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   PSC-THP1-EP
AC   CVCL_W367
DR   cancercelllines; CVCL_W367
DR   Wikidata; Q54948459
RX   Patent=US20110045519;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 06005.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IR08 ! PSC-THP1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   PSC-THP1-EP-FAST
AC   CVCL_W368
DR   cancercelllines; CVCL_W368
DR   Wikidata; Q54948460
RX   Patent=US20110045519;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 06008.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W367 ! PSC-THP1-EP
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   PSC-THP1-EPEP
AC   CVCL_W369
DR   Wikidata; Q54948461
RX   Patent=US20110045519;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 06007.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
HI   CVCL_W367 ! PSC-THP1-EP
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   PSC-THP1-HEP
AC   CVCL_W370
DR   Wikidata; Q54948462
RX   Patent=US20110045519;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 06006.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
HI   CVCL_W367 ! PSC-THP1-EP
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   Psc3-1
AC   CVCL_D5XR
DR   DGRC; 340
DR   FlyBase_Cell_line; FBtc0000340
DR   Wikidata; Q127383965
RX   PubMed=27557709;
CC   Group: Insect cell line.
CC   Characteristics: Established from embryos carrying Act5C-GAL4 and UAS-Ras[V12].
CC   Knockout cell: Method=X-ray; FlyBase_Gene; FBgn0005624; Psc.
CC   Knockout cell: Method=X-ray; FlyBase_Gene; FBgn0265623; Su(z)-2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Df(2R)Su(z)2-1.b8.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Psc4-1
AC   CVCL_D5XS
DR   DGRC; 337
DR   FlyBase_Cell_line; FBtc0000337
DR   Wikidata; Q127383967
RX   PubMed=27557709;
CC   Group: Insect cell line.
CC   Characteristics: Established from embryos carrying Act5C-GAL4 and UAS-Ras[V12].
CC   Knockout cell: Method=X-ray; FlyBase_Gene; FBgn0005624; Psc.
CC   Knockout cell: Method=X-ray; FlyBase_Gene; FBgn0265623; Su(z)-2.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Df(2R)Su(z)2-1.b8.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   PSCF
AC   CVCL_Z518
SY   Puntius Sophore Caudal Fin
DR   Wikidata; Q54948463
RX   PubMed=21463303;
CC   Group: Fish cell line.
CC   Doubling time: 48 hours (Note=At 25th passage), 25 hours (Note=At 100th passage) (PubMed=21463303).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=205134; ! Puntius sophore (Pool barb)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 10
//
ID   PSD-LWHT
AC   CVCL_B6XI
SY   Pantropical Spotted Dolphin-Liu Wen Hua Transformed
DR   Wikidata; Q112041621
RX   PubMed=30064049;
RX   PubMed=33412449;
CC   Group: Cetacean cell line.
CC   Doubling time: 68.9 hours (PubMed=30064049).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9735; ! Stenella attenuata (Pantropical spotted dolphin)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   PSEN2-141 N-hiPSC
AC   CVCL_C0CW
DR   Wikidata; Q114312686
RX   PubMed=34634760;
CC   From: IxCells Biotechnologies, LLC; San Diego; USA.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple_corrected; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34634760).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0CV ! PSEN2-N141I-hiPSC
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   PSEN2-N141I-hiPSC
AC   CVCL_C0CV
SY   N141I-hiPSC
DR   Wikidata; Q114312687
RX   PubMed=34634760;
CC   From: IxCells Biotechnologies, LLC; San Diego; USA.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=34634760).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T872 ! AG09908
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   PSF [Etroplus]
AC   CVCL_R809
SY   PearlSpot Fin
DR   NRFC; NRFC065
DR   Wikidata; Q54948464
RX   DOI=10.1016/j.aquaculture.2021.737589;
RX   PubMed=20577829;
WW   Provider; NRFC; NRFC065; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC065.
CC   Virology: Not susceptible to infection by Tilapia lake virus (TiLV) (DOI=10.1016/j.aquaculture.2021.737589).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=238232; ! Etroplus suratensis (Green chromide)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   PSF [Human AOA3 fibroblast]
AC   CVCL_ZW04
DR   Wikidata; Q102114784
RX   PubMed=16540636;
RX   PubMed=17347666;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173403; Ataxia-oculomotor apraxia type 3
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZT68 ! ATL2ABR
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   PSF [Pelodiscus]
AC   CVCL_DC16
SY   Pelodiscus Sinensis Fibroblast
DR   Wikidata; Q54948465
RX   PubMed=27059326;
CC   Group: Reptilian cell line.
CC   Doubling time: 51.1 hours (PubMed=27059326).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=13735; ! Pelodiscus sinensis (Chinese softshell turtle)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   PSF [Poecilia]
AC   CVCL_RB20
DR   Wikidata; Q54948466
RX   DOI=10.9734/AJOB/2017/34783;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=8081; ! Poecilia reticulata (Guppy)
SX   Male
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   PSF-hTERT
AC   CVCL_ZW05
DR   Wikidata; Q102114786
RX   PubMed=25868131;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173403; Ataxia-oculomotor apraxia type 3
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZW04 ! PSF [Human AOA3 fibroblast]
CA   Telomerase immortalized cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   PSF-SV
AC   CVCL_ZW06
SY   PSFSV
DR   Wikidata; Q102114787
RX   PubMed=25868131;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173403; Ataxia-oculomotor apraxia type 3
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZW04 ! PSF [Human AOA3 fibroblast]
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   PSFDFN319
AC   CVCL_1Z17
DR   Wikidata; Q54948467
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y0M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSFDFN327
AC   CVCL_1Z09
DR   Wikidata; Q54948468
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y3M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSFDFN365
AC   CVCL_1Z14
DR   Wikidata; Q54948469
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y2M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSFDFN376
AC   CVCL_1Z21
DR   Wikidata; Q54948470
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A04 ! PSFLBV344
SX   Male
AG   32Y6M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   PSFDFN388
AC   CVCL_YU45
DR   Wikidata; Q98128677
RX   PubMed=27920058;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27920058
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 15,18
ST   D19S433: 15
ST   D21S11: 30,33.2
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 20,21
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y1M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   PSFDFN394
AC   CVCL_1Z24
DR   Wikidata; Q54948471
RX   PubMed=27920058;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y1M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSFDFN714
AC   CVCL_YU41
DR   Wikidata; Q98128678
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y6M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   PSFDFSV40T319
AC   CVCL_DP37
DR   Wikidata; Q54948472
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z17 ! PSFDFN319
SX   Male
AG   39Y0M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PSFDFSV40T376
AC   CVCL_DP46
DR   Wikidata; Q54948473
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z21 ! PSFDFN376
SX   Male
AG   32Y6M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   PSFLBV084
AC   CVCL_1Z88
DR   Wikidata; Q54948474
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y9M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   PSFLBV239
AC   CVCL_1Z92
DR   Wikidata; Q54948476
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Cys (c.1579C>T) (c.1791C>T); ClinVar=VCV000014487; Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSFLBV344
AC   CVCL_2A04
DR   Wikidata; Q54948485
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z21 ! PSFDFN376
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   PSFLBV361
AC   CVCL_1Z98
DR   Wikidata; Q54948486
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y8M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   PSGK-60
AC   CVCL_K266
DR   Wikidata; Q54948488
RX   DOI=10.3103/S1068367415020056;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=72544; ! Capra sibirica (Siberian ibex)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   PSGK-S-85
AC   CVCL_K267
SY   PSGK-s-85
DR   Wikidata; Q54948489
WW   Provider; RCCC-V; -; https://web.archive.org/web/20200220021323/http://www.sevin.ru/collections/cellcolls/rcccm/lines_list.html
OX   NCBI_TaxID=72544; ! Capra sibirica (Siberian ibex)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   PSHi001-A
AC   CVCL_A8ZE
SY   PSH-Microtia-001
DR   hPSCreg; PSHi001-A
DR   Wikidata; Q108821171
RX   PubMed=34087987;
CC   From: Plastic Surgery Hospital of Chinese Academy of Medical Sciences; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C180842; Congenital microtia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   PSHi002-A
AC   CVCL_A8ZG
SY   PSH-TCS-iPSC
DR   hPSCreg; PSHi002-A
DR   Wikidata; Q108821172
RX   PubMed=34247110;
CC   From: Plastic Surgery Hospital of Chinese Academy of Medical Sciences; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11654; TCOF1; Simple; p.Ser657Trpfs*25 (c.1966_1969dup); Zygosity=Heterozygous (PubMed=34247110).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75018; Treacher Collins syndrome
DI   ORDO; Orphanet_861; Treacher-Collins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   PSI-1
AC   CVCL_6A79
SY   Pig Small Intestine-1; PSIc1
DR   Wikidata; Q54948490
RX   CelloPub=CLPUB00287;
RX   PubMed=20444515;
RX   PubMed=22193509;
RX   PubMed=28239090;
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   Psi-2
AC   CVCL_2165
SY   PSI-2; psi 2; Psi2
DR   CLO; CLO_0008508
DR   CLDB; cl3945
DR   CCRID; 1101MOU-PUMC000030
DR   DSMZ; ACC-238
DR   DSMZCellDive; ACC-238
DR   TOKU-E; 4143
DR   Wikidata; Q54948492
RX   PubMed=6678608;
CC   Group: Retrovirus packaging cell line.
CC   Doubling time: ~34 hours (DSMZ=ACC-238).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   Psi-AM22b
AC   CVCL_W642
SY   Psi AM22b; psi AM22b; psi-am22b; psi AM 22b; Psi-Am; Psi Am; 84 PSI AM
DR   Wikidata; Q54948493
RX   Patent=US5698436;
RX   PubMed=6093098;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8859.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   Psi-CRE
AC   CVCL_4278
SY   psi-CRE; Psi CRE; Psi Cre; psiCRE
DR   CLO; CLO_0008509
DR   CLDB; cl3946
DR   ECACC; 94090902
DR   Wikidata; Q54948495
CC   Group: Retrovirus packaging cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Psi-CRE-MFGts-c-src
AC   CVCL_T377
DR   CLO; CLO_0050582
DR   RCB; RCB1117
DR   Wikidata; Q54948496
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98397; Src.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4278 ! Psi-CRE
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   Psi-CRE-MFGtsT
AC   CVCL_U114
DR   CLO; CLO_0050584
DR   RCB; RCB1119
DR   Wikidata; Q54948498
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4278 ! Psi-CRE
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   Psi-CRIP
AC   CVCL_4279
SY   psi-CRIP
DR   CLO; CLO_0008510
DR   CLDB; cl3947
DR   ECACC; 94090901
DR   Wikidata; Q54948500
CC   Group: Retrovirus packaging cell line.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Psi-CRIP-ATR-bsr
AC   CVCL_T379
DR   CLO; CLO_0050589
DR   RCB; RCB1573
DR   Wikidata; Q54948501
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Psi-CRIP-GklacZ
AC   CVCL_U236
DR   RCB; RCB1121
DR   Wikidata; Q54948502
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Discontinued: RCB; RCB1121; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   Psi-CRIP-hBax-i-hCD25-CS
AC   CVCL_T380
DR   CLO; CLO_0050588
DR   RCB; RCB1572
DR   Wikidata; Q54948503
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:959; BAX.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-hp53-bsr
AC   CVCL_T381
DR   CLO; CLO_0050598
DR   RCB; RCB1583
DR   Wikidata; Q54948505
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   Psi-CRIP-hSSR-bsr
AC   CVCL_T382
DR   CLO; CLO_0050602
DR   RCB; RCB1588
DR   Wikidata; Q54948506
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11330; SSTR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   Psi-CRIP-MFG-T37
AC   CVCL_T383
DR   CLO; CLO_0050595
DR   RCB; RCB1580
DR   Wikidata; Q54948507
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Psi-CRIP-MFG-Z
AC   CVCL_T384
DR   CLO; CLO_0050594
DR   RCB; RCB1579
DR   Wikidata; Q54948508
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   Psi-CRIP-MFGhM-CSF
AC   CVCL_T385
DR   CLO; CLO_0050569
DR   RCB; RCB1104
DR   Wikidata; Q54948509
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2432; CSF1.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-MFGhMIF
AC   CVCL_T386
DR   CLO; CLO_0050571
DR   RCB; RCB1106
DR   Wikidata; Q54948510
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7097; MIF.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-MFGhOncost-M
AC   CVCL_T387
DR   CLO; CLO_0050574
DR   RCB; RCB1109
DR   Wikidata; Q54948511
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8506; OSM.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-MFGHSVtk
AC   CVCL_T388
DR   CLO; CLO_0050581
DR   RCB; RCB1116
DR   Wikidata; Q54948513
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Psi-CRIP-MFGhTNF-alpha
AC   CVCL_T389
DR   CLO; CLO_0050566
DR   RCB; RCB1101
DR   Wikidata; Q54948514
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11892; TNF.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-MFGmB7
AC   CVCL_T390
DR   CLO; CLO_0050575
DR   RCB; RCB1110
DR   Wikidata; Q54948515
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmB7-2
AC   CVCL_T391
DR   CLO; CLO_0050576
DR   RCB; RCB1111
DR   Wikidata; Q54948517
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101773; Cd86.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmG-CSF
AC   CVCL_T392
DR   CLO; CLO_0050568
DR   RCB; RCB1103
DR   Wikidata; Q54948518
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339751; Csf3.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmGM-CSF
AC   CVCL_T393
DR   CLO; CLO_0050555
DR   RCB; RCB1089
DR   Wikidata; Q54948519
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1339752; Csf2.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIFN-gamma
AC   CVCL_T394
DR   CLO; CLO_0050570
DR   RCB; RCB1105
DR   Wikidata; Q54948521
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:107656; Ifng.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-10
AC   CVCL_T395
DR   CLO; CLO_0050562
DR   RCB; RCB1097
DR   Wikidata; Q54948522
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96537; Il10.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-12p35
AC   CVCL_T396
DR   CLO; CLO_0050564
DR   RCB; RCB1099
DR   Wikidata; Q54948523
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96539; Il12a.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-12p40
AC   CVCL_T397
DR   CLO; CLO_0050563
DR   RCB; RCB1098
DR   Wikidata; Q54948524
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96540; Il12b.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-1alpha
AC   CVCL_T398
DR   CLO; CLO_0050556
DR   RCB; RCB1090
DR   Wikidata; Q54948525
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96542; Il1a.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-1RA
AC   CVCL_T399
DR   CLO; CLO_0050557
DR   RCB; RCB1091
DR   Wikidata; Q54948526
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96547; Il1rn.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-2
AC   CVCL_T400
DR   CLO; CLO_0050558
DR   RCB; RCB1092
DR   Wikidata; Q54948527
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96548; Il2.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-3
AC   CVCL_T401
DR   CLO; CLO_0050559
DR   RCB; RCB1093
DR   Wikidata; Q54948528
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96552; Il3.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-4
AC   CVCL_T402
DR   CLO; CLO_0050586
DR   RCB; RCB1094
DR   Wikidata; Q54948530
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96556; Il4.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-6
AC   CVCL_T403
DR   CLO; CLO_0050560
DR   RCB; RCB1095
DR   Wikidata; Q54948531
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96559; Il6.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmIL-7
AC   CVCL_T404
DR   CLO; CLO_0050561
DR   RCB; RCB1096
DR   Wikidata; Q54948532
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96561; Il7.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmKitLigand
AC   CVCL_T405
DR   CLO; CLO_0050573
DR   RCB; RCB1108
DR   Wikidata; Q54948533
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96974; Kitl.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmLIF
AC   CVCL_T406
DR   CLO; CLO_0050572
DR   RCB; RCB1107
DR   Wikidata; Q54948534
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96787; Lif.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmLT
AC   CVCL_T407
DR   CLO; CLO_0050567
DR   RCB; RCB1102
DR   Wikidata; Q54948539
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:104797; Lta.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGmTNF-alpha
AC   CVCL_T408
DR   CLO; CLO_0050565
DR   RCB; RCB1100
DR   Wikidata; Q54948540
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:104798; Tnf.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGneo
AC   CVCL_T409
DR   CLO; CLO_0050580
DR   RCB; RCB1115
DR   Wikidata; Q54948541
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   Psi-CRIP-MFGrab-IL1RA
AC   CVCL_T410
DR   CLO; CLO_0050578
DR   RCB; RCB1113
DR   Wikidata; Q54948542
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Psi-CRIP-MFGratGM-CSF
AC   CVCL_T411
DR   CLO; CLO_0050579
DR   RCB; RCB1114
DR   Wikidata; Q54948544
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 621065; Csf2.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   Psi-CRIP-MFGtr-gammaIFNR
AC   CVCL_T412
DR   CLO; CLO_0050577
DR   RCB; RCB1112
DR   Wikidata; Q54948545
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:107655; Ifngr1.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGts-c-src
AC   CVCL_T413
DR   CLO; CLO_0050583
DR   RCB; RCB1118
DR   Wikidata; Q54948546
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98397; Src.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi-CRIP-MFGtsT
AC   CVCL_T414
DR   CLO; CLO_0050587
DR   RCB; RCB1120
DR   Wikidata; Q54948547
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Psi-CRIP-mPCNF1-bsr
AC   CVCL_T427
DR   CLO; CLO_0050593
DR   RCB; RCB1577
DR   Wikidata; Q54948548
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:107164; Ppp3ca.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   Psi-CRIP-MSHR
AC   CVCL_T415
DR   CLO; CLO_0050596
DR   RCB; RCB1581
DR   Wikidata; Q54948550
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6929; MC1R.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-NCre
AC   CVCL_T416
DR   CLO; CLO_0050597
DR   RCB; RCB1582
DR   Wikidata; Q54948551
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Psi-CRIP-P131
AC   CVCL_T417
DR   CLO; CLO_0050554
DR   RCB; RCB1088
DR   Wikidata; Q54948552
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Psi-CRIP-Rx-crmA-bsr
AC   CVCL_T418
DR   CLO; CLO_0050591
DR   RCB; RCB1575
DR   Wikidata; Q54948553
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P07385; Cowpox virus crmA.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 13
//
ID   Psi-CRIP-Rx-ETBR-bsr
AC   CVCL_T419
DR   CLO; CLO_0050592
DR   RCB; RCB1576
DR   Wikidata; Q54948554
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3180; EDNRB.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Psi-CRIP-RxBcl-XL-i-bsr
AC   CVCL_T420
DR   CLO; CLO_0050599
DR   RCB; RCB1584
DR   Wikidata; Q54948555
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:992; BCL2L1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Psi-CRIP-RxhCD82
AC   CVCL_T421
DR   CLO; CLO_0050590
DR   RCB; RCB1574
DR   Wikidata; Q54948556
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6210; CD82.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-RxhFAS-i-CD80
AC   CVCL_T422
DR   CLO; CLO_0050600
DR   RCB; RCB1585
DR   Wikidata; Q54948557
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11920; FAS.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   Psi-CRIP-RxhSecR-bsr
AC   CVCL_T423
DR   CLO; CLO_0050601
DR   RCB; RCB1587
DR   Wikidata; Q54948558
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10608; SCTR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Psi-CRIP-RxhVIPR-bsr
AC   CVCL_T424
DR   CLO; CLO_0050585
DR   RCB; RCB1590
DR   Wikidata; Q54948559
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12694; VIPR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   Psi-CRIP-RxmPCNT1-i-bsr
AC   CVCL_T425
DR   CLO; CLO_0050603
DR   RCB; RCB1589
DR   Wikidata; Q54948560
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:107164; Ppp3ca.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   Psi-CRIP-RxnZ
AC   CVCL_T426
DR   CLO; CLO_0050604
DR   RCB; RCB1564
DR   Wikidata; Q54948561
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4279 ! Psi-CRIP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   Psi2 12S6
AC   CVCL_8934
SY   PSI-2 12S6; PSI 2 12s6
DR   CLO; CLO_0009740
DR   ATCC; CRL-1808
DR   Wikidata; Q54948563
RX   PubMed=2966895;
CC   Characteristics: Transfected with a retroviral vector LTR-hybrid adenovirus 2/5 E1A 12s-SV40 promoter-Neo-pBR ori-LTR. This cell line can be used to transform epithelial cells (PubMed=2966895).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2165 ! Psi-2
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   Psi2 13s1
AC   CVCL_8935
DR   CLO; CLO_0009741
DR   ATCC; CRL-1809
DR   Wikidata; Q54948564
RX   PubMed=2966895;
CC   Characteristics: Transfected with a retroviral vector LTR-hybrid adenovirus 2/5 E1A 13s-SV40 promoter-Neo-pBR ori-LTR. This cell line can be used to transform epithelial cells (PubMed=2966895).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2165 ! Psi-2
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   Psi2 BAG alpha
AC   CVCL_7697
SY   psi 2 BAG alpha; PSI 2 BAG alpha
DR   CLO; CLO_0008507
DR   CLO; CLO_0009739
DR   CLDB; cl3944
DR   ATCC; CRL-9560
DR   Wikidata; Q54948565
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9560.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-9560; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2165 ! Psi-2
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   Psi2 DAP
AC   CVCL_8936
SY   Psi2-DAP; Psi-2-DAP; Psi-2 DAP
DR   CLO; CLO_0009742
DR   ATCC; CRL-1949
DR   CCRID; 3101MOUGNM23
DR   CLS; 305179
DR   Wikidata; Q54948566
RX   PubMed=1731342;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2165 ! Psi-2
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   PSJ206
AC   CVCL_A0AZ
DR   Wikidata; Q108821173
RX   Patent=US6482599;
RX   PubMed=10866804;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PSK-1
AC   CVCL_4894
SY   PSK-I; Prostatic Small-cell carcinoma derived from a Klinefelter syndrome patient-1
DR   cancercelllines; CVCL_4894
DR   IARC_TP53; 18893
DR   Wikidata; Q54948568
RX   CelloPub=CLPUB00698;
RX   PubMed=10679758;
RX   PubMed=14518029;
RX   PubMed=14518030;
CC   Population: Japanese.
CC   Doubling time: ~34 hours (Note=At 15th passage), ~28 hours (Note=At 35th passage) (PubMed=10679758).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly279Glu (c.836G>A); ClinVar=VCV000419454; Zygosity=Unspecified (PubMed=14518029).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=14518029
ST   Amelogenin: X,Y
ST   D13S317: 11
ST   D18S51: 17
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   vWA: 14,18
DI   NCIt; C34752; Klinefelter syndrome
DI   NCIt; C6766; Prostate small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   PsL-EGFmAb-2
AC   CVCL_XB53
DR   CCRID; 4201PAT-CCTCC00203
DR   Wikidata; Q98128679
RX   Patent=CN100564395C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200634.
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   PsL-EGFmAb-CSRJZT-1
AC   CVCL_XB52
DR   Wikidata; Q98128680
RX   Patent=CN1264859C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200312.
CC   Monoclonal antibody isotype: IgG2, kappa.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   PSM-1
AC   CVCL_R917
SY   PSM; Platyfish-Swordtail Melanoma-1
DR   Wikidata; Q28471245
RX   PubMed=6778612;
CC   Group: Fish cell line.
CC   Doubling time: ~2 days (PubMed=6778612).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
DI   NCIt; C135006; Fish melanoma
OX   NCBI_TaxID=1075644; ! Xiphophorus hellerii x Xiphophorus maculatus (Hybrid swordtail)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   PSM-B
AC   CVCL_7698
DR   CLO; CLO_0008511
DR   CLDB; cl3948
DR   ECACC; 85061802
DR   Wikidata; Q54948570
CC   Discontinued: ECACC; 85061802; true.
CC   Breed/subspecies: SIM.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 7
//
ID   PSM-P12
AC   CVCL_DN67
DR   Wikidata; Q54948571
RX   Patent=US20030013191;
RX   PubMed=11170126;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2280.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
ID   PSM773
AC   CVCL_A0BA
SY   PSM 773; PSM-773
DR   Wikidata; Q108821174
RX   Patent=US6482599;
RX   PubMed=10866804;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PSMA 1.8.3
AC   CVCL_D3N7
SY   1.8.3
DR   Wikidata; Q127383969
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3906.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA 10.3
AC   CVCL_D3N8
SY   10.3
DR   ABCD; ABCD_AG057
DR   Wikidata; Q127383971
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3347.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA 3.11
AC   CVCL_D3N9
SY   3.11
DR   Wikidata; Q127383974
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3269.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA 3.7
AC   CVCL_D3NA
SY   3.7
DR   Wikidata; Q127383975
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3257.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA 3.9
AC   CVCL_D3NB
SY   3.9
DR   Wikidata; Q127383977
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3258.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA 5.4
AC   CVCL_D3NC
SY   5.4
DR   Wikidata; Q127383979
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3268.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA 7.1
AC   CVCL_D3ND
SY   7.1
DR   Wikidata; Q127383981
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3292.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA 7.3
AC   CVCL_D3NE
SY   7.3
DR   Wikidata; Q127383984
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3293.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA A3.1.3
AC   CVCL_D3NF
SY   A3.1.3
DR   Wikidata; Q127383986
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3904.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMA A3.3.1
AC   CVCL_D3NG
SY   A3.3.1
DR   Wikidata; Q127383988
RX   Patent=US8114965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3905.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PSMDFN320
AC   CVCL_1Z18
DR   Wikidata; Q54948572
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSMDFN326
AC   CVCL_1Z08
DR   Wikidata; Q54948573
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSMDFN346
AC   CVCL_1Z11
DR   Wikidata; Q54948574
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSMDFN364
AC   CVCL_1Z13
DR   Wikidata; Q54948575
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y10M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSMDFN375
AC   CVCL_1Z20
DR   Wikidata; Q54948576
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Heterozygous (PRF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2A03 ! PSMLBV343
SX   Female
AG   32Y9M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 12
//
ID   PSMDFN387
AC   CVCL_YU44
DR   Wikidata; Q98128681
RX   PubMed=27920058;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27920058
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 28,31.2
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 21,23
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y5M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   PSMDFN393
AC   CVCL_1Z23
DR   Wikidata; Q54948577
RX   PubMed=27920058;
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y8M
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   PSMDFN713
AC   CVCL_YU42
DR   Wikidata; Q98128682
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y11M
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   PSMDFSV40T320
AC   CVCL_DP38
DR   Wikidata; Q54948579
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z18 ! PSMDFN320
SX   Female
AG   36Y8M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   PSMDFSV40T375
AC   CVCL_DP40
DR   Wikidata; Q54948580
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Z20 ! PSMDFN375
SX   Female
AG   32Y9M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   PSMi001-A
AC   CVCL_WJ40
SY   SA6.27-iPS; SA 6.27
DR   hPSCreg; PSMi001-A
DR   Wikidata; Q98128683
RX   PubMed=31398660;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ala341Val (c.1022C>T) (p.Ala214Val, c.641C>T); ClinVar=VCV000003121; Zygosity=Heterozygous (PubMed=31398660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   PSMi002-A
AC   CVCL_VE81
SY   HDF30-JLNS-iPS
DR   hPSCreg; PSMi002-A
DR   Wikidata; Q54948581
RX   PubMed=29677589;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg190Trp (c.568C>T) (p.Arg63Trp, c.187C>T); ClinVar=VCV000053070; Zygosity=Heterozygous (PubMed=29677589).
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg594Gln (c.1781G>A); ClinVar=VCV000053018; Zygosity=Heterozygous (PubMed=29677589).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29677589
ST   F13A01: 6,14
ST   F13B: 8
ST   FESFPS: 10
ST   LPL: 10,11
ST   Penta C: 11,13
ST   Penta D: 10,13
ST   Penta E: 8,15
DI   NCIt; C84793; Jervell and Lange Nielsen syndrome
DI   ORDO; Orphanet_90647; Jervell and Lange-Nielsen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 15
//
ID   PSMi003-A
AC   CVCL_VE98
SY   HDF32-ARLQT-iPS
DR   hPSCreg; PSMi003-A
DR   Wikidata; Q54948582
RX   PubMed=29684900;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly179Ser (c.535G>A); ClinVar=VCV000053063; Zygosity=Homozygous (PubMed=29684900).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   PSMi004-A
AC   CVCL_WJ36
SY   HDF28-LQT1-iPS
DR   hPSCreg; PSMi004-A
DR   Wikidata; Q98128684
RX   PubMed=30974404;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg594Gln (c.1781G>A); ClinVar=VCV000053018; Zygosity=Heterozygous (PubMed=30974404).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   PSMi005-A
AC   CVCL_WJ33
SY   HDF29-LQT1-iPS
DR   hPSCreg; PSMi005-A
DR   Wikidata; Q98128685
RX   PubMed=31009818;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg190Trp (c.568C>T) (p.Arg63Trp, c.187C>T); ClinVar=VCV000053070; Zygosity=Heterozygous (PubMed=31009818).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   PSMi006-A
AC   CVCL_WJ37
SY   HDF39-ARLQT-iPS
DR   hPSCreg; PSMi006-A
DR   Wikidata; Q98128686
RX   PubMed=31785541;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly179Ser (c.535G>A); ClinVar=VCV000053063; Zygosity=Homozygous (PubMed=31785541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   PSMi007-A
AC   CVCL_WG47
SY   SA13.5-iPS
DR   hPSCreg; PSMi007-A
DR   Wikidata; Q98128687
RX   PubMed=30878014;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ala341Val (c.1022C>T) (p.Ala214Val, c.641C>T); ClinVar=VCV000003121; Zygosity=Heterozygous (PubMed=30878014).
CC   Sequence variation: Mutation; HGNC; HGNC:16859; NOS1AP; Simple; chr1:g.162060117A>T; dbSNP=rs4657139; Zygosity=Homozygous (PubMed=30878014).
CC   Sequence variation: Mutation; HGNC; HGNC:16859; NOS1AP; Simple; chr1:g.162065484T>C (g.694T>C); dbSNP=rs16847548; Zygosity=Homozygous (PubMed=30878014).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 11
//
ID   PSMi008-A
AC   CVCL_WJ38
SY   SA2.3-iPS
DR   hPSCreg; PSMi008-A
DR   Wikidata; Q98128688
RX   PubMed=31398660;
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:16859; NOS1AP; Simple; chr1:g.162065484T>C (g.694T>C); dbSNP=rs16847548; Zygosity=Heterozygous (PubMed=31398660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   PSMi009-A
AC   CVCL_WJ39
DR   hPSCreg; PSMi009-A
DR   Wikidata; Q98128689
CC   From: Institution Fondazione IRCCS Policlinico San Matteo; Pavia; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   PSMLBV085
AC   CVCL_1Z89
DR   Wikidata; Q54948583
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   PSMLBV238
AC   CVCL_1Z91
DR   Wikidata; Q54948584
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg527Cys (c.1579C>T) (c.1791C>T); ClinVar=VCV000014487; Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   PSMLBV343
AC   CVCL_2A03
DR   Wikidata; Q54948594
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Sequence variation: Mutation; HGNC; HGNC:12877; ZMPSTE24; Simple; p.Leu425Pro (c.1274T>C); Zygosity=Heterozygous (PRF).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1Z20 ! PSMDFN375
SX   Female
AG   32Y2M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 13
//
ID   PSMLBV360
AC   CVCL_1Z97
DR   Wikidata; Q54948595
WW   Provider; PRF; -; https://www.progeriaresearch.org/available-cell-lines/
CC   Part of: Progeria Research Foundation cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y1M
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 10
//
ID   PSN1
AC   CVCL_1644
SY   PSN-1
DR   BTO; BTO_0005179
DR   CLO; CLO_0008512
DR   EFO; EFO_0006739
DR   CLDB; cl3949
DR   CLDB; cl3950
DR   AddexBio; C0018013/4990
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3211
DR   ATCC; CRM-CRL-3211
DR   BioGRID_ORCS_Cell_line; 483
DR   BioSample; SAMN03481109
DR   BioSample; SAMN10988384
DR   cancercelllines; CVCL_1644
DR   Cell_Model_Passport; SIDM00469
DR   CGH-DB; 182-1
DR   CGH-DB; 9281-4
DR   ChEMBL-Cells; CHEMBL3307348
DR   ChEMBL-Targets; CHEMBL614241
DR   Cosmic; 710867
DR   Cosmic; 716172
DR   Cosmic; 733176
DR   Cosmic; 808165
DR   Cosmic; 808504
DR   Cosmic; 910546
DR   Cosmic; 2434092
DR   Cosmic-CLP; 910546
DR   DepMap; ACH-000320
DR   ECACC; 94060601
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910546
DR   GEO; GSM206537
DR   GEO; GSM887521
DR   GEO; GSM888603
DR   GEO; GSM1374836
DR   GEO; GSM1670353
DR   IARC_TP53; 945
DR   ICLC; HTL97008
DR   LiGeA; CCLE_595
DR   LINCS_LDP; LCL-1749
DR   PharmacoDB; PSN1_1277_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1644
DR   PubChem_Cell_line; CVCL_1644
DR   Wikidata; Q54948596
RX   PubMed=1764370;
RX   PubMed=3009377;
RX   PubMed=3778442;
RX   PubMed=11787853;
RX   PubMed=18380791;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Established from a frozen tumor that had been stored at -80 Celsius for 1.5 years and which has then been passaged into a nude mice.
CC   Doubling time: 21 hours (PubMed=3778442); 35 hours (PubMed=25984343).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02; DRB1*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=11787853; PubMed=18380791).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=3778442; PubMed=11787853; Cosmic-CLP=910546; DepMap=ACH-000320).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Homozygous (PubMed=1764370; PubMed=11787853; Cosmic-CLP=910546; DepMap=ACH-000320).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.56%; East Asian, South=16.44%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): AddexBio=C0018013/4990; ATCC=CRL-3211; Cosmic-CLP=910546; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10,11 (AddexBio=C0018013/4990; ATCC=CRL-3211; PubMed=25877200)
ST   D16S539: 11 (Cosmic-CLP=910546)
ST   D18S51: 21
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 14,15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Pso-1
AC   CVCL_3135
DR   JCRB; JCRB0641
DR   Wikidata; Q54948597
CC   Discontinued: JCRB; JCRB0641; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Pso-2
AC   CVCL_3136
DR   JCRB; JCRB0642
DR   Wikidata; Q54948598
CC   Discontinued: JCRB; JCRB0642; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Pso-3
AC   CVCL_3137
DR   JCRB; JCRB0643
DR   Wikidata; Q54948599
CC   Discontinued: JCRB; JCRB0643; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Pso-4
AC   CVCL_3138
DR   JCRB; JCRB0644
DR   Wikidata; Q54948600
CC   Discontinued: JCRB; JCRB0644; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Pso-5
AC   CVCL_3139
DR   JCRB; JCRB0645
DR   Wikidata; Q54948601
CC   Discontinued: JCRB; JCRB0645; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Pso-6
AC   CVCL_3140
DR   JCRB; JCRB0646
DR   Wikidata; Q54948602
CC   Discontinued: JCRB; JCRB0646; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Pso-7
AC   CVCL_3141
DR   JCRB; JCRB0647
DR   Wikidata; Q54948604
CC   Discontinued: JCRB; JCRB0647; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   PSP [Pig]
AC   CVCL_4919
DR   CLO; CLO_0008513
DR   CLDB; cl3951
DR   Wikidata; Q54948605
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   PSP [Puntius]
AC   CVCL_S010
SY   Puntius Schwanenfeldii Peduncle
DR   Wikidata; Q54948606
RX   CelloPub=CLPUB00099;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 30 Celsius.
CC   Virology: Susceptible to infection by snakehead retrovirus (SnRV) released from SSN-1 cell line (Cellosaurus=CVCL_4306).
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=1906136; ! Barbonymus schwanefeldii (Tinfoil barb)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   PSP-36
AC   CVCL_3774
SY   PSP 36; PSP36; PSP-36-SAH
DR   CLO; CLO_0008514
DR   Wikidata; Q54948608
RX   Patent=US6251404;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11171.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60710; ! Chlorocebus pygerythrus (Vervet monkey)
HI   CVCL_3845 ! MA-104
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   PSP00359IN
AC   CVCL_E195
DR   Wikidata; Q54948609
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61183; ! Papio sp. (Baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PSP00360IN
AC   CVCL_E196
DR   Wikidata; Q54948610
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61183; ! Papio sp. (Baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PSP00361IN
AC   CVCL_E197
DR   Wikidata; Q54948611
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61183; ! Papio sp. (Baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PSP00362IN
AC   CVCL_E198
DR   Wikidata; Q54948612
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=61183; ! Papio sp. (Baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PSPA
AC   CVCL_IN46
SY   Porcine Subcutaneous PreAdipocyte
DR   RCB; RCB4920
DR   Wikidata; Q54948613
RX   DOI=10.6090/jarq.49.85;
RX   PubMed=22497428;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: ([(Landrace x Large White) x Duroc] x Landrace).
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   85FD
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   PSSCPi
AC   CVCL_C3P8
SY   Porcine Spermatogonial Stem Cell Puro immortalized
DR   Wikidata; Q116050132
RX   PubMed=32308978;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonial stem cell; CL=CL_0000016.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   PSSCTi
AC   CVCL_C3P9
SY   Porcine Spermatogonial Stem Cell Ttag immortalized
DR   Wikidata; Q116050133
RX   PubMed=32308978;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonial stem cell; CL=CL_0000016.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   PST-S2
AC   CVCL_4679
DR   CLO; CLO_0050250
DR   RCB; RCB1913
DR   Wikidata; Q54948615
RX   CelloPub=CLPUB00232;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   PSU-AL-WS40NE
AC   CVCL_VT56
SY   WS40NE; Portland State University-Austrofundulus Limnaeus-Wourms' Stage 40 NeuroEpithelial
DR   Wikidata; Q98128690
RX   PubMed=30802492;
CC   Group: Fish cell line.
CC   Characteristics: Can survive anoxia for close to 50 days at 30 Celsius (PubMed=30802492).
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=52670; ! Austrofundulus limnaeus (Annual killifish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   PSU-SK-1
AC   CVCL_IU86
DR   Cosmic; 2569715
DR   Wikidata; Q54948616
RX   PubMed=27698927;
CC   Senescence: Senesces at 35 PDL (PubMed=27698927).
CC   Doubling time: 24 hours (Note=At 7th passage), 72 hours (Note=At 30th passage) (PubMed=27698927).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Pro (c.133T>C); ClinVar=VCV000017589; Zygosity=Unspecified (PubMed=27698927).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg433Ter (c.1297C>T) (R413*) (R430*); Zygosity=Unspecified (PubMed=27698927).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_654; Nephroblastoma
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 15
//
ID   PSV811
AC   CVCL_3142
SY   PSV 811; AG07066; AG07066B
DR   CLO; CLO_0035650
DR   BioSample; SAMN03152041
DR   BioSample; SAMN03471630
DR   Coriell; AG07066
DR   JCRB; JCRB0604
DR   RCB; RCB0223
DR   Wikidata; Q54948617
RX   CelloPub=CLPUB00597;
RX   PubMed=2762303;
RX   PubMed=3002148;
RX   PubMed=9230208;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a WI-38 derivative (PubMed=20143388). Originally thought to originate from the skin fibroblasts of a 29 year old female patient with Werner syndrome.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00343.
CC   Population: Caucasian; Swedish.
CC   Discontinued: RCB; RCB0223; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB0604
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 10
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   PSVK1
AC   CVCL_8403
DR   BioSample; SAMN03472508
DR   JCRB; JCRB1093
DR   JCRB; NIHS0240
DR   Wikidata; Q54948618
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; NIHS0240; true.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): JCRB=JCRB1093
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   PSYLMUi001-A
AC   CVCL_C1QL
DR   BioSamples; SAMEA10450708
DR   hPSCreg; PSYLMUi001-A
DR   Wikidata; Q114312688
RX   PubMed=35053357;
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   PSYLMUi002-A
AC   CVCL_C1QM
SY   MC1_M
DR   EBiSC; PSYLMUi002-A
DR   hPSCreg; PSYLMUi002-A
DR   Wikidata; Q114312689
RX   PubMed=35053357;
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   PSYLMUi003-A
AC   CVCL_C1QN
SY   MC11_M
DR   EBiSC; PSYLMUi003-A
DR   hPSCreg; PSYLMUi003-A
DR   Wikidata; Q114312690
RX   PubMed=35053357;
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   PSYLMUi004-A
AC   CVCL_C1QP
SY   MC12_6
DR   EBiSC; PSYLMUi004-A
DR   hPSCreg; PSYLMUi004-A
DR   Wikidata; Q114312691
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi005-A
AC   CVCL_C1QQ
SY   MC14_M_V22
DR   EBiSC; PSYLMUi005-A
DR   hPSCreg; PSYLMUi005-A
DR   Wikidata; Q114312692
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi006-A
AC   CVCL_C1QR
DR   EBiSC; PSYLMUi006-A
DR   hPSCreg; PSYLMUi006-A
DR   Wikidata; Q114312693
RX   PubMed=35053357;
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   PSYLMUi007-A
AC   CVCL_C1QS
DR   EBiSC; PSYLMUi007-A
DR   hPSCreg; PSYLMUi007-A
DR   Wikidata; Q114312694
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi008-A
AC   CVCL_C1QT
SY   MC3_2
DR   EBiSC; PSYLMUi008-A
DR   hPSCreg; PSYLMUi008-A
DR   Wikidata; Q114312695
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi009-A
AC   CVCL_C1QU
DR   EBiSC; PSYLMUi009-A
DR   hPSCreg; PSYLMUi009-A
DR   Wikidata; Q114312696
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi010-A
AC   CVCL_C1QV
SY   MC6_M_V21
DR   EBiSC; PSYLMUi010-A
DR   hPSCreg; PSYLMUi010-A
DR   Wikidata; Q114312697
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi011-A
AC   CVCL_C1QW
SY   MC7_M
DR   EBiSC; PSYLMUi011-A
DR   hPSCreg; PSYLMUi011-A
DR   Wikidata; Q114312698
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi012-A
AC   CVCL_C1QX
SY   MC8_M
DR   EBiSC; PSYLMUi012-A
DR   hPSCreg; PSYLMUi012-A
DR   Wikidata; Q114312699
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi013-A
AC   CVCL_C1QY
SY   MC9_M
DR   EBiSC; PSYLMUi013-A
DR   hPSCreg; PSYLMUi013-A
DR   Wikidata; Q114312700
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi014-A
AC   CVCL_C1QZ
SY   MR1_M
DR   EBiSC; PSYLMUi014-A
DR   hPSCreg; PSYLMUi014-A
DR   Wikidata; Q114312701
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi015-A
AC   CVCL_C1R0
DR   EBiSC; PSYLMUi015-A
DR   hPSCreg; PSYLMUi015-A
DR   Wikidata; Q114312702
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi016-A
AC   CVCL_C1R1
SY   MR4_M
DR   EBiSC; PSYLMUi016-A
DR   hPSCreg; PSYLMUi016-A
DR   Wikidata; Q114312703
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi017-A
AC   CVCL_C1R2
DR   EBiSC; PSYLMUi017-A
DR   hPSCreg; PSYLMUi017-A
DR   Wikidata; Q114312704
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi018-A
AC   CVCL_C1R3
SY   MS12_M
DR   EBiSC; PSYLMUi018-A
DR   hPSCreg; PSYLMUi018-A
DR   Wikidata; Q114312705
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi019-A
AC   CVCL_C1R4
SY   MS14_7
DR   EBiSC; PSYLMUi019-A
DR   hPSCreg; PSYLMUi019-A
DR   Wikidata; Q114312706
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi020-A
AC   CVCL_C1R5
DR   EBiSC; PSYLMUi020-A
DR   hPSCreg; PSYLMUi020-A
DR   Wikidata; Q114312707
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi021-A
AC   CVCL_C1R6
SY   MS17_M_V18
DR   EBiSC; PSYLMUi021-A
DR   hPSCreg; PSYLMUi021-A
DR   Wikidata; Q114312708
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi022-A
AC   CVCL_C1R7
SY   MS18_M1
DR   EBiSC; PSYLMUi022-A
DR   hPSCreg; PSYLMUi022-A
DR   Wikidata; Q114312709
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi023-A
AC   CVCL_C1R8
SY   MS19_M
DR   EBiSC; PSYLMUi023-A
DR   hPSCreg; PSYLMUi023-A
DR   Wikidata; Q114312710
RX   PubMed=35053357;
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   PSYLMUi024-A
AC   CVCL_C1R9
SY   MS2_M
DR   EBiSC; PSYLMUi024-A
DR   hPSCreg; PSYLMUi024-A
DR   Wikidata; Q114312711
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi025-A
AC   CVCL_C1RA
SY   MS20_1
DR   EBiSC; PSYLMUi025-A
DR   hPSCreg; PSYLMUi025-A
DR   Wikidata; Q114312712
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi026-A
AC   CVCL_C1RB
SY   MS21_M
DR   EBiSC; PSYLMUi026-A
DR   hPSCreg; PSYLMUi026-A
DR   Wikidata; Q114312713
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi027-A
AC   CVCL_C1RC
SY   MS22_M
DR   EBiSC; PSYLMUi027-A
DR   hPSCreg; PSYLMUi027-A
DR   Wikidata; Q114312714
RX   PubMed=35053357;
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
ID   PSYLMUi028-A
AC   CVCL_C1RD
SY   MS23_M
DR   EBiSC; PSYLMUi028-A
DR   hPSCreg; PSYLMUi028-A
DR   Wikidata; Q114312715
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi029-A
AC   CVCL_C1RE
SY   MS24_M
DR   EBiSC; PSYLMUi029-A
DR   hPSCreg; PSYLMUi029-A
DR   Wikidata; Q114312716
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi030-A
AC   CVCL_C1RF
DR   EBiSC; PSYLMUi030-A
DR   hPSCreg; PSYLMUi030-A
DR   Wikidata; Q114312717
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi031-A
AC   CVCL_C1RG
SY   MS29_M
DR   EBiSC; PSYLMUi031-A
DR   hPSCreg; PSYLMUi031-A
DR   Wikidata; Q114312718
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi032-A
AC   CVCL_C1RH
SY   MS3_M
DR   EBiSC; PSYLMUi032-A
DR   hPSCreg; PSYLMUi032-A
DR   Wikidata; Q114312719
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi033-A
AC   CVCL_C1RI
DR   EBiSC; PSYLMUi033-A
DR   hPSCreg; PSYLMUi033-A
DR   Wikidata; Q114312720
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi034-A
AC   CVCL_C1RJ
SY   MS6_M
DR   EBiSC; PSYLMUi034-A
DR   hPSCreg; PSYLMUi034-A
DR   Wikidata; Q114312721
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi035-A
AC   CVCL_C1RK
SY   MS7_M
DR   EBiSC; PSYLMUi035-A
DR   hPSCreg; PSYLMUi035-A
DR   Wikidata; Q114312722
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi036-A
AC   CVCL_C1RL
DR   EBiSC; PSYLMUi036-A
DR   hPSCreg; PSYLMUi036-A
DR   Wikidata; Q114312723
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi037-A
AC   CVCL_C1RM
DR   EBiSC; PSYLMUi037-A
DR   hPSCreg; PSYLMUi037-A
DR   Wikidata; Q114312724
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi038-A
AC   CVCL_C1RN
DR   EBiSC; PSYLMUi038-A
DR   hPSCreg; PSYLMUi038-A
DR   Wikidata; Q114312725
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi039-A
AC   CVCL_C1RP
DR   EBiSC; PSYLMUi039-A
DR   hPSCreg; PSYLMUi039-A
DR   Wikidata; Q114312726
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi040-A
AC   CVCL_C1RQ
DR   EBiSC; PSYLMUi040-A
DR   hPSCreg; PSYLMUi040-A
DR   Wikidata; Q114312727
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi041-A
AC   CVCL_C1RR
DR   EBiSC; PSYLMUi041-A
DR   hPSCreg; PSYLMUi041-A
DR   Wikidata; Q114312728
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi042-A
AC   CVCL_C1RS
DR   EBiSC; PSYLMUi042-A
DR   hPSCreg; PSYLMUi042-A
DR   Wikidata; Q114312729
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi043-A
AC   CVCL_C1RT
DR   EBiSC; PSYLMUi043-A
DR   hPSCreg; PSYLMUi043-A
DR   Wikidata; Q114312731
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi044-A
AC   CVCL_C1RU
DR   EBiSC; PSYLMUi044-A
DR   hPSCreg; PSYLMUi044-A
DR   Wikidata; Q114312734
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi045-A
AC   CVCL_C1RV
DR   EBiSC; PSYLMUi045-A
DR   hPSCreg; PSYLMUi045-A
DR   Wikidata; Q114312736
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi046-A
AC   CVCL_C1RW
DR   EBiSC; PSYLMUi046-A
DR   hPSCreg; PSYLMUi046-A
DR   Wikidata; Q114312738
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PSYLMUi047-A
AC   CVCL_C1RX
DR   EBiSC; PSYLMUi047-A
DR   hPSCreg; PSYLMUi047-A
DR   Wikidata; Q114312739
CC   From: Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilians University of Munich; Munich; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   PT [Pig]
AC   CVCL_YP15
SY   Pig Tonsil
DR   Wikidata; Q98128691
RX   PubMed=32122591;
CC   Virology: Susceptible to infection by Japanese encephalitis virus (JEV).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Oral cavity, palatine tonsil; UBERON=UBERON_0002373.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 12
//
ID   PT [Sheep kidney]
AC   CVCL_0I96
DR   CCLV; CCLV-RIE 0011
DR   Wikidata; Q54948621
RX   PubMed=24973239;
RX   PubMed=25565633;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Pt K1
AC   CVCL_0489
SY   Pt K1 (NBL-3); NBL-3; PTK-1; PTK 1; PtK 1; PTK1; PtK1; Pt-K1; Ptk1; Potorous tridactylus Kidney 1
DR   BTO; BTO_0000813
DR   CLO; CLO_0008515
DR   CLO; CLO_0008517
DR   MCCL; MCC:0000388
DR   CLDB; cl3952
DR   CLDB; cl3953
DR   CLDB; cl3954
DR   CLDB; cl5249
DR   ATCC; CCL-35
DR   ATCC; CRL-6493
DR   CCRID; 3101MAMGNO19
DR   CLS; 608393
DR   ECACC; 91013163
DR   IZSLER; BS CL 125
DR   JCRB; JCRB9039
DR   KCB; KCB 82005YJ
DR   KCLB; 10035
DR   Lonza; 201
DR   Wikidata; Q54948622
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1071/BI9770445;
RX   PubMed=569474;
RX   PubMed=4531035;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/ptk1/ptk1cells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-of-atcc-ccl-35
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
CC   Group: Marsupial cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Karyotypic information: As the diploid chromosome number of P.tridactylus is quite small (2n=12), this cell line is suited to the study of mitosis and to easily visualize the chromosomes under a microscope.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   Pt K2
AC   CVCL_0514
SY   Pt K2 (NBL-5); NBL-5; Pt-K2; PTK-2; Ptk-2; PTK 2; PtK 2; PTK2; PtK2; Ptk2; Potorous tridactylus Kidney 2
DR   BTO; BTO_0002282
DR   CLO; CLO_0008518
DR   CLO; CLO_0008519
DR   CLDB; cl3957
DR   ATCC; CCL-56
DR   ATCC; CRL-6494
DR   BCRC; 60335
DR   CCLV; CCLV-RIE 0047
DR   CLS; 608316
DR   ECACC; 88031601
DR   JCRB; IFO50012
DR   JCRB; JCRB0007
DR   JCRB; JCRB9052
DR   KCB; KCB 82026YJ
DR   Wikidata; Q17130857
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1071/BI9770445;
RX   PubMed=569474;
RX   PubMed=976012;
RX   PubMed=4116062;
RX   PubMed=4398660;
RX   PubMed=14004541;
RX   PubMed=26252667;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/ptk2/ptk2cells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Ptk2_cells
CC   Group: Marsupial cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Karyotypic information: As the diploid chromosome number of P.tridactylus is quite small (2n=12), this cell line is suited to the study of mitosis and to easily visualize the chromosomes under a microscope.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-6494; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   PT-18
AC   CVCL_5444
SY   PT18; PT18-A17; PT18(A17); A17
DR   Wikidata; Q54948623
RX   CelloPub=CLPUB00340;
RX   PubMed=2940298;
RX   PubMed=3262677;
RX   PubMed=6811593;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PT-18
CC   Characteristics: IL3 and CSF2 dependent.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: C3H.SW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   PT-80
AC   CVCL_4629
DR   CLDB; cl3955
DR   CLDB; cl3956
DR   Wikidata; Q54948624
RX   PubMed=24000610;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   PT-K75
AC   CVCL_6436
DR   CLO; CLO_0008520
DR   ATCC; CRL-2528
DR   IZSLER; BS CL 220
DR   Wikidata; Q54948625
RX   PubMed=19508353;
CC   Derived from site: In situ; Nose, nasal cavity, nasal turbinate; UBERON=UBERON_0035612.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   PT-KM-035
AC   CVCL_E1P0
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1P1 ! PT-KP-035
OI   CVCL_E1P2 ! PT-KT-035
SX   Female
AG   45Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KP-035
AC   CVCL_E1P1
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1P0 ! PT-KM-035
OI   CVCL_E1P2 ! PT-KT-035
SX   Female
AG   45Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KT-035
AC   CVCL_E1P2
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1P0 ! PT-KM-035
OI   CVCL_E1P1 ! PT-KP-035
SX   Female
AG   45Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KM-045
AC   CVCL_E1NX
SY   PT-KM-045-stb-CL
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38915394
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 13,18
ST   D21S11: 31,35
ST   D2S1338: 20,25
ST   D3S1358: 14,15
ST   D5S818: 8,11
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   Penta D: 9,10
ST   Penta E: 5,13
ST   TH01: 7,9
ST   TPOX: 8,9,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1NY ! PT-KP-045
OI   CVCL_E1NZ ! PT-KT-045
SX   Female
AG   31Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KP-045
AC   CVCL_E1NY
SY   PT-KP-045-stb-CL
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38915394
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 13,18
ST   D21S11: 31,35
ST   D2S1338: 20,25
ST   D3S1358: 14,15
ST   D5S818: 8,11
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   Penta D: 9,10
ST   Penta E: 5,13
ST   TH01: 7,9
ST   TPOX: 8,9,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1NX ! PT-KM-045
OI   CVCL_E1NZ ! PT-KT-045
SX   Female
AG   31Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KT-045
AC   CVCL_E1NZ
SY   PT-KT-045-stb-CL
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38915394
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 13,18
ST   D21S11: 31,35
ST   D2S1338: 20,25
ST   D3S1358: 14,15
ST   D5S818: 8,11
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   Penta D: 9,10
ST   Penta E: 5,13
ST   TH01: 7,9
ST   TPOX: 8,9,10
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1NX ! PT-KM-045
OI   CVCL_E1NY ! PT-KP-045
SX   Female
AG   31Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KM-046
AC   CVCL_E1P3
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1P4 ! PT-KP-046
OI   CVCL_E1P5 ! PT-KT-046
SX   Female
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KP-046
AC   CVCL_E1P4
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1P3 ! PT-KM-046
OI   CVCL_E1P5 ! PT-KT-046
SX   Female
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-KT-046
AC   CVCL_E1P5
RX   PubMed=38915394;
CC   Population: African.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ear, skin, dermis; Note=From a keloid; UBERON=UBERON_0001459+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E1P3 ! PT-KM-046
OI   CVCL_E1P4 ! PT-KP-046
SX   Female
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT-r
AC   CVCL_HF63
DR   RCB; RCB4548
DR   Wikidata; Q54948626
RX   PubMed=1700579;
RX   PubMed=2768284;
RX   PubMed=3472208;
RX   PubMed=20558332;
RX   PubMed=24627164;
CC   Doubling time: ~20 hours (PubMed=3472208).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   PT-r 1
AC   CVCL_HF64
DR   Wikidata; Q54948627
RX   PubMed=1700579;
CC   Doubling time: 20 hours (PubMed=1700579).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HF63 ! PT-r
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   PT-r 2
AC   CVCL_HF65
DR   Wikidata; Q54948629
RX   PubMed=1700579;
CC   Doubling time: 17 hours (PubMed=1700579).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HF63 ! PT-r
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   PT-r 3
AC   CVCL_HF66
DR   Wikidata; Q54948631
RX   PubMed=1700579;
CC   Doubling time: 21 hours (PubMed=1700579).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HF63 ! PT-r
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   PT-r 4
AC   CVCL_HF67
DR   Wikidata; Q54948632
RX   PubMed=1700579;
CC   Doubling time: 12 hours (PubMed=1700579).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HF63 ! PT-r
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   Pt.Kich-1
AC   CVCL_0I21
DR   Wikidata; Q54948633
RX   PubMed=25655355;
CC   Doubling time: 5-6 days (PubMed=25655355).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
DI   NCIt; C4906; Parathyroid gland carcinoma
DI   ORDO; Orphanet_143; Parathyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   PT.M1
AC   CVCL_F1BS
RX   PubMed=10600031;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A2K6CGN4; Macaca nemestrina VCAM1/CD106.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PT.M2
AC   CVCL_F1BT
RX   PubMed=10600031;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A2K6C433; Macaca nemestrina ICAM1/CD54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PT.M3
AC   CVCL_F1BU
RX   PubMed=10600031;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A2K6BQ36; Macaca nemestrina ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PT.M4
AC   CVCL_F1BV
RX   PubMed=10600031;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; A0A2K6C433; Macaca nemestrina ICAM1/CD54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   PT1-1
AC   CVCL_XJ64
DR   Wikidata; Q98128692
RX   PubMed=26800878;
CC   Characteristics: Transfected with a vector carrying cDNA of the heavy and light chain of a murine IgG2a antibody.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 9
//
ID   PT1-30
AC   CVCL_XJ66
DR   Wikidata; Q98128693
RX   PubMed=26800878;
CC   Characteristics: Transfected with a vector carrying cDNA of the heavy and light chain of a murine IgG2a antibody.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 9
//
ID   PT1-55
AC   CVCL_XJ67
DR   Wikidata; Q98128694
RX   PubMed=26800878;
CC   Characteristics: Transfected with a vector carrying cDNA of the heavy and light chain of a murine IgG2a antibody.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 9
//
ID   PT1-7
AC   CVCL_XJ65
DR   Wikidata; Q98128695
RX   PubMed=26800878;
CC   Characteristics: Transfected with a vector carrying cDNA of the heavy and light chain of a murine IgG2a antibody.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 9
//
ID   PT1.K
AC   CVCL_S271
DR   ATCC; CRL-6310
DR   Wikidata; Q54948634
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Anecdotal: Established from Jama, the first chimpanzee diagnosed with trisomy 22 (equivalent to human Down syndrome). Jama died at 17 months during an operation to try to fix a heart problem.
CC   Discontinued: ATCC; CRL-6310; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C146897; Chimpanzee trisomy 22
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_S350 ! PT1.Li
OI   CVCL_S321 ! PT1.Ln
OI   CVCL_S322 ! PT1.Lu
OI   CVCL_S323 ! PT1.Sk
OI   CVCL_S351 ! PT1.Sp
OI   CVCL_S352 ! PT1.Thy
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PT1.Li
AC   CVCL_S350
DR   ATCC; CRL-6311
DR   Wikidata; Q54948635
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Anecdotal: Established from Jama, the first chimpanzee diagnosed with trisomy 22 (equivalent to human Down syndrome). Jama died at 17 months during an operation to try to fix a heart problem.
CC   Discontinued: ATCC; CRL-6311; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C146897; Chimpanzee trisomy 22
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_S271 ! PT1.K
OI   CVCL_S321 ! PT1.Ln
OI   CVCL_S322 ! PT1.Lu
OI   CVCL_S323 ! PT1.Sk
OI   CVCL_S351 ! PT1.Sp
OI   CVCL_S352 ! PT1.Thy
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PT1.Ln
AC   CVCL_S321
DR   ATCC; CRL-6312
DR   Wikidata; Q54948636
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Anecdotal: Established from Jama, the first chimpanzee diagnosed with trisomy 22 (equivalent to human Down syndrome). Jama died at 17 months during an operation to try to fix a heart problem.
CC   Discontinued: ATCC; CRL-6312; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C146897; Chimpanzee trisomy 22
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_S271 ! PT1.K
OI   CVCL_S350 ! PT1.Li
OI   CVCL_S322 ! PT1.Lu
OI   CVCL_S323 ! PT1.Sk
OI   CVCL_S351 ! PT1.Sp
OI   CVCL_S352 ! PT1.Thy
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   PT1.Lu
AC   CVCL_S322
DR   ATCC; CRL-6313
DR   Wikidata; Q54948637
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Anecdotal: Established from Jama, the first chimpanzee diagnosed with trisomy 22 (equivalent to human Down syndrome). Jama died at 17 months during an operation to try to fix a heart problem.
CC   Discontinued: ATCC; CRL-6313; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C146897; Chimpanzee trisomy 22
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_S271 ! PT1.K
OI   CVCL_S350 ! PT1.Li
OI   CVCL_S321 ! PT1.Ln
OI   CVCL_S323 ! PT1.Sk
OI   CVCL_S351 ! PT1.Sp
OI   CVCL_S352 ! PT1.Thy
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PT1.Sk
AC   CVCL_S323
DR   ATCC; CRL-6314
DR   Wikidata; Q54948638
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Anecdotal: Established from Jama, the first chimpanzee diagnosed with trisomy 22 (equivalent to human Down syndrome). Jama died at 17 months during an operation to try to fix a heart problem.
CC   Discontinued: ATCC; CRL-6314; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C146897; Chimpanzee trisomy 22
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_S271 ! PT1.K
OI   CVCL_S350 ! PT1.Li
OI   CVCL_S321 ! PT1.Ln
OI   CVCL_S322 ! PT1.Lu
OI   CVCL_S351 ! PT1.Sp
OI   CVCL_S352 ! PT1.Thy
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PT1.Sp
AC   CVCL_S351
DR   ATCC; CRL-6315
DR   Wikidata; Q54948639
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Anecdotal: Established from Jama, the first chimpanzee diagnosed with trisomy 22 (equivalent to human Down syndrome). Jama died at 17 months during an operation to try to fix a heart problem.
CC   Discontinued: ATCC; CRL-6315; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C146897; Chimpanzee trisomy 22
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_S271 ! PT1.K
OI   CVCL_S350 ! PT1.Li
OI   CVCL_S321 ! PT1.Ln
OI   CVCL_S322 ! PT1.Lu
OI   CVCL_S323 ! PT1.Sk
OI   CVCL_S352 ! PT1.Thy
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PT1.Thy
AC   CVCL_S352
DR   ATCC; CRL-6316
DR   Wikidata; Q54948640
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Donor information: Established from Jama, the first chimpanzee diagnosed with trisomy 22 (equivalent to human Down syndrome). Jama died at 17 months during an operation to try to fix a heart problem.
CC   Discontinued: ATCC; CRL-6316; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
DI   NCIt; C146897; Chimpanzee trisomy 22
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_S271 ! PT1.K
OI   CVCL_S350 ! PT1.Li
OI   CVCL_S321 ! PT1.Ln
OI   CVCL_S322 ! PT1.Lu
OI   CVCL_S323 ! PT1.Sk
OI   CVCL_S351 ! PT1.Sp
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   PT101
AC   CVCL_8404
SY   R101
DR   Wikidata; Q54948647
RX   PubMed=15548371;
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   PT103
AC   CVCL_8405
SY   RPT103
DR   Wikidata; Q54948648
RX   PubMed=15548371;
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   PT115
AC   CVCL_8406
SY   RPT115
DR   Wikidata; Q54948649
RX   PubMed=15548371;
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   PT12
AC   CVCL_A9E6
DR   Wikidata; Q102114788
RX   PubMed=22821401;
RX   PubMed=27565181;
RX   PubMed=30317423;
CC   Characteristics: ER/PR-positive and ERBB2-negative. Established from a mouse xenograft.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   PT13
AC   CVCL_E3DY
RX   PubMed=10771091;
RX   PubMed=11330054;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Characteristics: Transfected with a GFP N-terminally tagged with peroxisomal PTS2 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3DW ! CHOPS2a
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT1590
AC   CVCL_0C61
SY   PT-1590
DR   cancercelllines; CVCL_0C61
DR   GEO; GSM1264065
DR   GEO; GSM1264066
DR   GEO; GSM1264067
DR   GEO; GSM1264078
DR   GEO; GSM1264079
DR   GEO; GSM1264080
DR   GEO; GSM1264081
DR   GEO; GSM1264091
DR   GEO; GSM1264107
DR   GEO; GSM1264108
DR   GEO; GSM1264109
DR   GEO; GSM1264120
DR   GEO; GSM1264121
DR   GEO; GSM1264122
DR   GEO; GSM1264123
DR   GEO; GSM1264133
DR   Progenetix; CVCL_0C61
DR   Wikidata; Q54948650
RX   PubMed=11156375;
RX   PubMed=25070024;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>A); ClinVar=VCV000480961; Zygosity=Unspecified (PubMed=11156375).
CC   Caution: TP53 mutation indicated (PubMed=11156375) to change a His-176 into Arg, but the DNA change corresponds to the mutation reported in this entry.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C60 ! LN1590
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   PT1590-GFP
AC   CVCL_0C62
SY   GFP-PT1590
DR   cancercelllines; CVCL_0C62
DR   Wikidata; Q54948652
RX   PubMed=19847813;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>A); ClinVar=VCV000480961; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0C61 ! PT1590
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   PT32
AC   CVCL_E3DZ
RX   PubMed=10771091;
RX   PubMed=11330054;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Characteristics: Transfected with a GFP N-terminally tagged with peroxisomal PTS2 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3DW ! CHOPS2a
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT45
AC   CVCL_8407
SY   PT 45; PT-45
DR   cancercelllines; CVCL_8407
DR   ChEMBL-Cells; CHEMBL3307992
DR   ChEMBL-Targets; CHEMBL612586
DR   Cosmic; 755304
DR   Cosmic; 808170
DR   IARC_TP53; 946
DR   PubChem_Cell_line; CVCL_8407
DR   Wikidata; Q54948654
RX   PubMed=1764370;
RX   PubMed=18298655;
CC   From: DiRenzo, Maria Flavia; Department of Biomedical Sciences and Human Oncology, University of Turin; Turin; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (PubMed=1764370).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   PT45-P1
AC   CVCL_8408
SY   PT-45-P1; PT 45-P1; PT 45 P1; PT 45P1; PT45P1; Pt45P1
DR   EFO; EFO_0002716
DR   cancercelllines; CVCL_8408
DR   Cosmic; 710869
DR   Cosmic; 736277
DR   Cosmic; 933519
DR   Wikidata; Q54948655
RX   PubMed=1906154;
RX   PubMed=8426738;
RX   PubMed=11787853;
RX   PubMed=12692724;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=8426738; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (PubMed=8426738; PubMed=11787853).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8407 ! PT45
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   PT45-P1res
AC   CVCL_8409
DR   cancercelllines; CVCL_8409
DR   Wikidata; Q54948656
RX   PubMed=16474845;
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8408 ! PT45-P1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   PT54
AC   CVCL_E3E0
RX   PubMed=10771091;
RX   PubMed=11330054;
CC   Characteristics: Defective in Pex2 (PubMed=10771091).
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Characteristics: Transfected with a GFP N-terminally tagged with peroxisomal PTS2 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3DW ! CHOPS2a
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   PT6216
AC   CVCL_0C59
DR   cancercelllines; CVCL_0C59
DR   Cosmic; 2218354
DR   Wikidata; Q54948657
RX   PubMed=25070024;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=25070024).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0C58 ! LN6216c
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   PT64
AC   CVCL_8410
SY   RPT64
DR   Wikidata; Q54948658
RX   PubMed=15548371;
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   PT67
AC   CVCL_9093
SY   RetroPack PT67; PT-67
DR   CLO; CLO_0008516
DR   ATCC; CRL-3613
DR   ATCC; CRL-12284
DR   CCRID; 1101MOU-PUMC000662
DR   CCRID; 4201MOU-CCTCC00189
DR   CCTCC; GDC0189
DR   TOKU-E; 2916
DR   Wikidata; Q54948659
RX   Patent=US5766945;
RX   PubMed=8764070;
WW   Provider; Takara Bio; 631510; https://www.takarabio.com/products/gene-function/viral-transduction/retrovirus/packaging-systems-and-cells
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12284.
CC   Discontinued: ATCC; CRL-12284; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9116 ! NIH 3T3-TK-
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   PT89
AC   CVCL_8411
DR   Wikidata; Q54948660
RX   PubMed=15548371;
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   PT96
AC   CVCL_8412
DR   Wikidata; Q54948661
RX   PubMed=15548371;
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   PTC032210
AC   CVCL_W918
DR   cancercelllines; CVCL_W918
DR   Cosmic; 2054117
DR   Wikidata; Q54948662
RX   PubMed=23833040;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23833040).
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   PTCC
AC   CVCL_L414
DR   Wikidata; Q54948663
RX   DOI=10.4236/ojvm.2012.24045;
CC   From: Knapp, Deborah W.; Purdue University College of Veterinary Medicine; WestLafayette; USA.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 7
//
ID   Pten 1
AC   CVCL_1B62
SY   Pten-1
DR   DGRC; 202
DR   FlyBase_Cell_line; FBtc0000202
DR   Wikidata; Q54948664
RX   PubMed=22363644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   Pten 1A
AC   CVCL_1B63
SY   Pten-1A
DR   DGRC; 203
DR   FlyBase_Cell_line; FBtc0000203
DR   Wikidata; Q54948665
RX   PubMed=22363644;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   Pten X
AC   CVCL_1B64
SY   Pten-X
DR   DGRC; 201
DR   FlyBase_Cell_line; FBtc0000201
DR   Wikidata; Q54948667
RX   PubMed=22363644;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 3 days (DGRC=201).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 9
//
ID   Pten+/- Ctnnb1 ex3del CP1
AC   CVCL_VQ84
SY   CP1
DR   Wikidata; Q98128697
CC   Characteristics: Prostate cell line with Ctnnb1 gain of function mutation. Established from a mouse prostate epithelium tumor in a mouse with probasin Cre driven exon 3 deletion of one Ctnnb1 allele and a Pten heterozygous deletion.
CC   Characteristics: Tumorigenic in immunocompromised mice (CD-1 nudes) and in immunocompetent mice (C57BL/6J- WT colony controls) as prostate orthografts.
CC   Doubling time: ~13 hours (Note=In DMEM with glutamine + 10% FBS) (Direct_author_submission).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Miscellaneous: Cell line information from personal communication of Patel, Rachana.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6J Ctnnb1pc(ex3)delta/+ Ptenpcfl/+.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   Pten+/- Ctnnb1 ex3del CP2
AC   CVCL_VQ85
SY   CP2
DR   Wikidata; Q98128698
CC   Characteristics: Prostate cell line with Ctnnb1 gain of function mutation. Established from a mouse prostate epithelium tumor in a mouse with probasin Cre driven exon 3 deletion of one Ctnnb1 allele and a Pten heterozygous deletion.
CC   Characteristics: Tumorigenic in immunocompromised mice (CD-1 nudes) and in immunocompetent mice (C57BL/6J- WT colony controls) as prostate orthografts.
CC   Doubling time: ~12 hours (Note=In DMEM with glutamine + 10% FBS) (Direct_author_submission).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Miscellaneous: Cell line information from personal communication of Patel, Rachana.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6J Ctnnb1pc(ex3)delta/+ Ptenpcfl/+.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   Pten-/- P1
AC   CVCL_VQ82
SY   P1
DR   Wikidata; Q98128699
CC   Characteristics: From a primary prostate tumour from a Ptenpcfl/fl mice (probasin Cre driven Pten deletion in murine prostate epithelium).
CC   Characteristics: Tumorigenic in immunocompromised mice (CD-1 nudes) as prostate orthografts.
CC   Doubling time: ~19 hours (Note=In DMEM with glutamine + 10% FBS) (Direct_author_submission).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Miscellaneous: Cell line information from personal communication of Patel, Rachana.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6J Ptenpcfl/fl.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y2M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   Pten-/- P2
AC   CVCL_VQ83
SY   P2
DR   Wikidata; Q98128702
CC   Characteristics: From a primary prostate tumour in a Ptenpcfl/fl mice (probasin Cre driven Pten deletion in murine prostate epithelium).
CC   Characteristics: Tumorigenic in immunocompromised mice (CD-1 nudes) as prostate orthografts.
CC   Doubling time: ~18.2 hours (Note=In DMEM with glutamine + 10% FBS) (Direct_author_submission).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Miscellaneous: Cell line information from personal communication of Patel, Rachana.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6J Ptenpcfl/fl.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1Y1M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   Pten-/- Spry2+/- SP1
AC   CVCL_VQ86
SY   SP1
DR   Wikidata; Q98128703
CC   Characteristics: From a primary prostate tumour from a Ptenpcfl/fl Spry2fl/+ mice (Probasin Cre driven Pten deletion and Spry2 heterozygous loss in murine prostate epithelium).
CC   Characteristics: Tumorigenic in immunocompromised mice (CD-1 nudes) as prostate orthografts.
CC   Doubling time: ~15 hours (Note=In DMEM with glutamine + 10% FBS) (Direct_author_submission).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Miscellaneous: Cell line information from personal communication of Patel, Rachana.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6J Ptenpcfl/fl Spry2fl/+.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   9M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   Pten-/- Spry2+/- SP2
AC   CVCL_VQ87
SY   SP2
DR   Wikidata; Q98128704
CC   Characteristics: From a primary prostate tumour from a Ptenpcfl/fl Spry2fl/+ mice (Probasin Cre driven Pten deletion and Spry2 heterozygous loss in murine prostate epithelium).
CC   Characteristics: Tumorigenic in immunocompromised mice (CD-1 nudes) as prostate orthografts.
CC   Doubling time: ~15.2 hours (Note=In DMEM with glutamine + 10% FBS) (Direct_author_submission).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Miscellaneous: Cell line information from personal communication of Patel, Rachana.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6J Ptenpcfl/fl Spry2fl/+.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   PTEN-CaP2
AC   CVCL_0F36
DR   Wikidata; Q54948670
RX   PubMed=17616663;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0F34 ! PTEN-P2
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   PTEN-CaP8
AC   CVCL_0F37
DR   ATCC; CRL-3033
DR   Wikidata; Q54948671
RX   PubMed=17616663;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0F35 ! PTEN-P8
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   PTEN-KO BMSC
AC   CVCL_B6BB
DR   Wikidata; Q112041622
RX   PubMed=29387984;
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G1SVU9; PTEN.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   PTEN-P2
AC   CVCL_0F34
DR   Wikidata; Q54948672
RX   PubMed=17616663;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0F35 ! PTEN-P8
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   PTEN-P8
AC   CVCL_0F35
DR   ATCC; CRL-3031
DR   Wikidata; Q54948673
RX   PubMed=17616663;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0F34 ! PTEN-P2
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   PTH-C1
AC   CVCL_HF62
DR   Wikidata; Q54948674
RX   PubMed=24627164;
CC   Characteristics: Produces parathyroid hormone and expresses the calcium sensing receptor (Casr) gene and other genes known to be involved in parathyroid function (PubMed=24627164).
CC   Doubling time: ~15 hours (PubMed=24627164).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HF63 ! PT-r
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   PTHrP-GBK
AC   CVCL_IU76
DR   Wikidata; Q54948675
RX   PubMed=11837712;
CC   Population: Japanese.
CC   Characteristics: Produces high level of parathyroid hormone-related peptide (PTHrP).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   PtK1TG
AC   CVCL_JZ52
SY   PG
DR   Wikidata; Q54948676
RX   PubMed=569474;
RX   PubMed=4531035;
CC   Group: Marsupial cell line.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
HI   CVCL_0489 ! Pt K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   PtK2BN1
AC   CVCL_JZ53
SY   PtK2 BN1
DR   Wikidata; Q54948677
RX   DOI=10.1071/BI9770445;
RX   DOI=10.1071/BI9770461;
RX   PubMed=569474;
CC   Group: Marsupial cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
HI   CVCL_0514 ! Pt K2
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   PtK2TN1
AC   CVCL_JZ54
DR   Wikidata; Q54948678
RX   PubMed=569474;
CC   Group: Marsupial cell line.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
HI   CVCL_0514 ! Pt K2
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   PTLC-1
AC   CVCL_W353
SY   Post-Transplant Lymphoma Cell line-1
DR   Wikidata; Q54948679
RX   PubMed=7829391;
CC   Population: Japanese.
CC   Doubling time: ~18.9 hours (PubMed=7829391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   PTLD1
AC   CVCL_IU59
SY   PTLD-1
DR   Wikidata; Q54948680
RX   PubMed=21088132;
CC   From: Rooney, Cliona M.; Center for Cell and Gene Therapy, Baylor College of Medicine; Houston; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C27696; EBV-related post-transplant lymphoproliferative disorder
DI   ORDO; Orphanet_70568; Post-transplant lymphoproliferative disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 7
//
ID   PTM
AC   CVCL_WL77
SY   Potato Tuber Moth
DR   Wikidata; Q98128705
RX   CelloPub=CLPUB00496;
RX   PubMed=26820856;
CC   Group: Insect cell line.
CC   Doubling time: ~25 hours (CelloPub=CLPUB00496).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=192464; ! Phthorimaea operculella (Potato tuber moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   PtM3
AC   CVCL_X920
SY   Pig-tailed Macaque 3
DR   Wikidata; Q54948682
RX   PubMed=2579038;
RX   PubMed=6093374;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9545; ! Macaca nemestrina (Pig-tailed macaque)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   pTr
AC   CVCL_YB17
SY   porcine Trophectoderm
DR   Wikidata; Q98128706
RX   PubMed=11356676;
CC   Derived from site: In situ; Trophectoderm; UBERON=UBERON_0004345.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   PTR00319IN
AC   CVCL_E199
DR   Wikidata; Q54948685
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=37010; ! Pan troglodytes schweinfurthii (Eastern chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   PTR00320IN
AC   CVCL_E200
DR   Wikidata; Q54948686
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=37010; ! Pan troglodytes schweinfurthii (Eastern chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   PTR00321IN
AC   CVCL_E201
DR   Wikidata; Q54948687
RX   PubMed=18477388;
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   PTR00323IN
AC   CVCL_E202
DR   Wikidata; Q54948688
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=37012; ! Pan troglodytes verus (Western chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   PTR00324IN
AC   CVCL_E203
DR   Wikidata; Q54948689
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=37012; ! Pan troglodytes verus (Western chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   PTR00325IN
AC   CVCL_E204
DR   Wikidata; Q54948690
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=37012; ! Pan troglodytes verus (Western chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   PTR00355IN
AC   CVCL_E205
DR   Wikidata; Q54948691
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=37012; ! Pan troglodytes verus (Western chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   pTr2
AC   CVCL_YB18
SY   PTr2; porcine Trophectoderm 2
DR   Wikidata; Q98128708
RX   PubMed=15961561;
RX   PubMed=31670096;
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus-2 (PRRSV-2) (PubMed=31670096).
CC   Derived from site: In situ; Trophectoderm; UBERON=UBERON_0004345.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_YB17 ! pTr
SX   Female
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   PU-34
AC   CVCL_4795
SY   PU 34
DR   Wikidata; Q54948692
RX   PubMed=2015398;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=PU-34
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   PU5-1.8
AC   CVCL_2696
SY   Pu5-1.8; PU 5.1.8; Pu-518; PU5-18; PU5-1R
DR   CLO; CLO_0008522
DR   CLO; CLO_0008523
DR   CLO; CLO_0050172
DR   CLDB; cl3959
DR   ATCC; TIB-61
DR   ECACC; 85051501
DR   RCB; RCB0538
DR   Wikidata; Q54948693
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=301553;
RX   PubMed=1083890;
RX   PubMed=3792703;
RX   PubMed=3967303;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-428.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 17.2-20.3 hours (PubMed=3967303).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   PUC-GBC1
AC   CVCL_ZE15
SY   Pontificia Universidad Catolica-GallBladder Cancer 1
DR   Wikidata; Q98128709
RX   PubMed=32293552;
CC   Population: Chilean.
CC   Doubling time: 60 hours (PubMed=32293552).
CC   Karyotypic information: Has lost chromosome X.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=32293552
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D21S11: 33.2
ST   D5S818: 7,11
ST   D7S820: 7,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE16 ! PUC-GBC2
OI   CVCL_ZE17 ! PUC-GBC3
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   PUC-GBC2
AC   CVCL_ZE16
SY   Pontificia Universidad Catolica-GallBladder Cancer 2
DR   Wikidata; Q98128710
RX   PubMed=32293552;
CC   Population: Chilean.
CC   Doubling time: 36 hours (PubMed=32293552).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=32293552
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D21S11: 33.2
ST   D5S818: 7,11
ST   D7S820: 7,10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE15 ! PUC-GBC1
OI   CVCL_ZE17 ! PUC-GBC3
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   PUC-GBC3
AC   CVCL_ZE17
SY   Pontificia Universidad Catolica-GallBladder Cancer 3
DR   Wikidata; Q98128711
RX   PubMed=32293552;
CC   Population: Chilean.
CC   Doubling time: 44 hours (PubMed=32293552).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=32293552
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D21S11: 33.2
ST   D5S818: 7,11
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZE15 ! PUC-GBC1
OI   CVCL_ZE16 ! PUC-GBC2
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   PUC4-2
AC   CVCL_5A62
DR   Wikidata; Q54948694
RX   PubMed=220255;
RX   PubMed=2595452;
CC   Selected for resistance to: ChEBI; CHEBI_35668; 6-azauridine (6AUR).
CC   Selected for resistance to: ChEBI; CHEBI_90284; Pyrazofurin (Pirazofurin; PF).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A61 ! V79 A3
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 27-11-25; Version: 11
//
ID   PuD2
AC   CVCL_WN37
DR   Wikidata; Q98128712
RX   DOI=10.11513/jrrsabst.2003.0_394_3;
RX   PubMed=20135361;
CC   Transformant: NCIt; C160658; Plutonium-239 alpha particle radiation.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64112; Carcinoma of the rat lung
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   Puddin
AC   CVCL_VL65
DR   Wikidata; Q98128713
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   PUFHi001-A
AC   CVCL_A2XY
SY   QZY-iPSC
DR   hPSCreg; PUFHi001-A
DR   Wikidata; Q105510611
RX   PubMed=33232902;
CC   From: Peking University First Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6220; KCNA2; Simple; p.Pro405Leu (c.1214C>T); ClinVar=VCV000190325; Zygosity=Heterozygous (PubMed=33232902).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33232902
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 19,22
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 13
ST   D19S433: 13,15.2
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D2S441: 12
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D6S1043: 10,12
ST   D7S820: 9,12
ST   D8S1179: 14,15
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C155998; Developmental and epileptic encephalopathy 32
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   PUFHi002-A
AC   CVCL_A8MW
DR   hPSCreg; PUFHi002-A
DR   Wikidata; Q108821175
CC   From: Peking University First Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUFHi003-A
AC   CVCL_A8MX
DR   hPSCreg; PUFHi003-A
DR   Wikidata; Q108821176
CC   From: Peking University First Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUFHi004-A
AC   CVCL_C1VJ
DR   BioSamples; SAMEA14299767
DR   hPSCreg; PUFHi004-A
DR   Wikidata; Q114312740
CC   From: Peking University First Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:25380; TMEM163; Simple; p.Leu76Pro (c.227T>C); ClinVar=VCV002443749; Zygosity=Heterozygous (hPSCreg=PUFHi004-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61253; Leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-4Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   PUMC-CRC1
AC   CVCL_A9DD
SY   Peking Union Medical College-ColoRectal Cancer 1
DR   cancercelllines; CVCL_A9DD
DR   CCRID; 1101HUM-PUMC000859
DR   Wikidata; Q108821177
RX   PubMed=34162944;
CC   Population: Chinese.
CC   Doubling time: 44 hours (PubMed=34162944).
CC   Microsatellite instability: Stable (MSS) (PubMed=34162944).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1493fs (c.4476_4479delCACGinsACA); Zygosity=Heterozygous (PubMed=34162944).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=34162944).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Val506Glu (c.1517T>C); Zygosity=Homozygous (PubMed=34162944).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): CCRID=1101HUM-PUMC000859; PubMed=34162944
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,18
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 13,13.2
ST   D21S11: 30,32
ST   D2S1338: 18,24
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D6S1043: 11,14
ST   D7S820: 7,11
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   PUMC-mips-A2
AC   CVCL_A9BS
DR   CCRID; 1101MOU-PUMC000424
DR   Wikidata; Q108821178
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BT ! PUMC-mips-A4
OI   CVCL_A9BU ! PUMC-mips-A5
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-A4
AC   CVCL_A9BT
DR   CCRID; 1101MOU-PUMC000425
DR   Wikidata; Q108821179
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BS ! PUMC-mips-A2
OI   CVCL_A9BU ! PUMC-mips-A5
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-A5
AC   CVCL_A9BU
DR   CCRID; 1101MOU-PUMC000426
DR   Wikidata; Q108821180
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BS ! PUMC-mips-A2
OI   CVCL_A9BT ! PUMC-mips-A4
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-B1
AC   CVCL_A9BV
DR   CCRID; 1101MOU-PUMC000427
DR   Wikidata; Q108821181
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BW ! PUMC-mips-B2
OI   CVCL_A9BX ! PUMC-mips-B4
OI   CVCL_A9BY ! PUMC-mips-B5
OI   CVCL_A9BZ ! PUMC-mips-B6
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-B2
AC   CVCL_A9BW
DR   CCRID; 1101MOU-PUMC000428
DR   Wikidata; Q108821182
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BV ! PUMC-mips-B1
OI   CVCL_A9BX ! PUMC-mips-B4
OI   CVCL_A9BY ! PUMC-mips-B5
OI   CVCL_A9BZ ! PUMC-mips-B6
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-B4
AC   CVCL_A9BX
DR   CCRID; 1101MOU-PUMC000429
DR   Wikidata; Q108821183
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BV ! PUMC-mips-B1
OI   CVCL_A9BW ! PUMC-mips-B2
OI   CVCL_A9BY ! PUMC-mips-B5
OI   CVCL_A9BZ ! PUMC-mips-B6
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-B5
AC   CVCL_A9BY
DR   CCRID; 1101MOU-PUMC000430
DR   Wikidata; Q108821184
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BV ! PUMC-mips-B1
OI   CVCL_A9BW ! PUMC-mips-B2
OI   CVCL_A9BX ! PUMC-mips-B4
OI   CVCL_A9BZ ! PUMC-mips-B6
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-B6
AC   CVCL_A9BZ
DR   CCRID; 1101MOU-PUMC000431
DR   Wikidata; Q108821185
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9BV ! PUMC-mips-B1
OI   CVCL_A9BW ! PUMC-mips-B2
OI   CVCL_A9BX ! PUMC-mips-B4
OI   CVCL_A9BY ! PUMC-mips-B5
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-C2
AC   CVCL_A9CA
DR   CCRID; 1101MOU-PUMC000432
DR   Wikidata; Q108821186
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9CB ! PUMC-mips-C4
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-C4
AC   CVCL_A9CB
DR   CCRID; 1101MOU-PUMC000433
DR   Wikidata; Q108821187
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9CA ! PUMC-mips-C2
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-D2
AC   CVCL_A9CC
DR   CCRID; 1101MOU-PUMC000434
DR   Wikidata; Q108821188
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9CD ! PUMC-mips-D3
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMC-mips-D3
AC   CVCL_A9CD
DR   CCRID; 1101MOU-PUMC000435
DR   Wikidata; Q108821189
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A9CC ! PUMC-mips-D2
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi001-A
AC   CVCL_YC52
SY   IPS-34
DR   BioSamples; SAMEA6032303
DR   hPSCreg; PUMCHi001-A
DR   SKIP; SKIP005586
DR   Wikidata; Q98128714
RX   PubMed=31794942;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg349Trp (c.1045C>T); ClinVar=VCV000066762; Zygosity=Heterozygous (PubMed=31794942).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165527; Familial partial lipodystrophy type 2
DI   ORDO; Orphanet_2348; Familial partial lipodystrophy, Dunnigan type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   PUMCHi001-A-1
AC   CVCL_YT12
SY   IPS-34-R-17; IPS34-R-17
DR   BioSamples; SAMEA7059978
DR   hPSCreg; PUMCHi001-A-1
DR   SKIP; SKIP005732
DR   Wikidata; Q98128715
RX   PubMed=32213461;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple_corrected; p.Arg349Trp (c.1045C>T); ClinVar=VCV000066762; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32213461).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165527; Familial partial lipodystrophy type 2
DI   ORDO; Orphanet_2348; Familial partial lipodystrophy, Dunnigan type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YC52 ! PUMCHi001-A
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   PUMCHi002-A
AC   CVCL_ZI85
SY   20180908R-AE3; PUMCH-IRC
DR   BioSamples; SAMEA7002732
DR   hPSCreg; PUMCHi002-A
DR   Wikidata; Q98128716
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62798; Restrictive cardiomyopathy
DI   ORDO; Orphanet_217632; Restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   PUMCHi003-A
AC   CVCL_ZL87
DR   BioSamples; SAMEA6983565
DR   hPSCreg; PUMCHi003-A
DR   SKIP; SKIP005780
DR   Wikidata; Q98128717
RX   PubMed=32559633;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9603; PTGIS; Simple; p.Arg252Glu (c.755G>A); Zygosity=Heterozygous (PubMed=32559633).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   PUMCHi004-A
AC   CVCL_ZX53
SY   PUMCH-hATTR004
DR   BioSamples; SAMEA7002522
DR   hPSCreg; PUMCHi004-A
DR   Wikidata; Q102114789
RX   PubMed=33038745;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Asp38Asn (c.112G>A); ClinVar=VCV000571867; Zygosity=Heterozygous (PubMed=33038745).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   PUMCHi005-A
AC   CVCL_A9T3
SY   PUMCH-CA-
DR   BioSamples; SAMEA7211859
DR   hPSCreg; PUMCHi005-A
DR   Wikidata; Q102114790
RX   PubMed=32858486;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Phe53Val (c.157T>G); Zygosity=Heterozygous (PubMed=32858486).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   PUMCHi006-A
AC   CVCL_A4EL
DR   hPSCreg; PUMCHi006-A
DR   Wikidata; Q105510616
RX   PubMed=33221675;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9603; PTGIS; Simple; p.Ala447Thr (c.1339G>A); dbSNP=rs146531327; Zygosity=Heterozygous (PubMed=33221675).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   PUMCHi007-A
AC   CVCL_B5S8
DR   hPSCreg; PUMCHi007-A
DR   Wikidata; Q112041623
CC   From: Peking Union Medical College Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi008-A
AC   CVCL_B5S9
DR   hPSCreg; PUMCHi008-A
DR   Wikidata; Q112041624
CC   From: Peking Union Medical College Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi009-A
AC   CVCL_B5SA
DR   hPSCreg; PUMCHi009-A
DR   Wikidata; Q112041625
CC   From: Peking Union Medical College Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi010-A
AC   CVCL_B5SB
DR   hPSCreg; PUMCHi010-A
DR   Wikidata; Q112041626
CC   From: Peking Union Medical College Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi011-A
AC   CVCL_B5SC
DR   hPSCreg; PUMCHi011-A
DR   Wikidata; Q112041627
CC   From: Peking Union Medical College Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi012-A
AC   CVCL_B5SD
DR   hPSCreg; PUMCHi012-A
DR   Wikidata; Q112041628
CC   From: Peking Union Medical College Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi013-A
AC   CVCL_B5SE
DR   hPSCreg; PUMCHi013-A
DR   Wikidata; Q112041629
CC   From: Peking Union Medical College Hospital; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   PUMCHi014-A
AC   CVCL_A7IZ
SY   SRF-BCD01
DR   hPSCreg; PUMCHi014-A
DR   Wikidata; Q107116681
RX   PubMed=33857831;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:23198; CYP4V2; Simple; c.802-8_810del17insGC (IVS6-8 del/insGC); ClinVar=VCV000039271; Zygosity=Heterozygous (PubMed=33857831).
CC   Sequence variation: Mutation; HGNC; HGNC:23198; CYP4V2; Simple; p.Trp340Ter (c.1020G>A); ClinVar=VCV000039248; Zygosity=Heterozygous (PubMed=33857831).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179299; Bietti crystalline corneoretinal dystrophy
DI   ORDO; Orphanet_41751; Bietti crystalline dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   PUMCHi015-A
AC   CVCL_B0GR
SY   SRF-USH2A-1
DR   hPSCreg; PUMCHi015-A
DR   Wikidata; Q108821190
RX   PubMed=34419747;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys934Trp (c.2802T>G); ClinVar=VCV000143179; Zygosity=Heterozygous (PubMed=34419747).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Arg4187His (c.12560G>A); ClinVar=VCV000865757; Zygosity=Heterozygous (PubMed=34419747).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_791; Retinitis pigmentosa
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   PUMCHi016-A
AC   CVCL_B0GS
SY   SRF-USH2A-2
DR   hPSCreg; PUMCHi016-A
DR   Wikidata; Q108821191
RX   PubMed=34419747;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; c.8559-2A>G (p.Tyr2854_Arg2894del); ClinVar=VCV000048604; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=34419747).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_791; Retinitis pigmentosa
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   PUMCHi017-A
AC   CVCL_B5S7
SY   SRF-CHM01
DR   hPSCreg; PUMCHi017-A
DR   Wikidata; Q112041630
RX   PubMed=35032821;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Unexplicit; Ex1-2del; Zygosity=Hemizygous (PubMed=35032821).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PUMCHi018-A
AC   CVCL_B5S6
SY   SRF-RDH12-01
DR   hPSCreg; PUMCHi018-A
DR   Wikidata; Q112041632
RX   PubMed=35016144;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Arg62Ter (c.184C>T); ClinVar=VCV000002050; Zygosity=Heterozygous (PubMed=35016144).
CC   Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Val146Asp (c.437T>A); ClinVar=VCV000841398; Zygosity=Heterozygous (PubMed=35016144).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PUMCHi019-A
AC   CVCL_B5SF
DR   BioSamples; SAMEA12789792
DR   hPSCreg; PUMCHi019-A
DR   Wikidata; Q112041633
RX   PubMed=35152176;
CC   From: Peking Union Medical College Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Ser269Pro (c.805T>C); ClinVar=VCV001185094; Zygosity=Heterozygous; Note=De novo mutation (PubMed=35152176).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C169000; Optic atrophy 1
DI   ORDO; Orphanet_98673; Autosomal dominant optic atrophy, classic form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   PUMCi001-A
AC   CVCL_A9YV
SY   D17; K-iPSCs
DR   hPSCreg; PUMCi001-A
DR   SKIP; SKIP005823
DR   Wikidata; Q102114791
RX   PubMed=32763824;
CC   From: Peking Union Medical College; Beijing; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Simple; p.Pro154His (c.461C>A); ClinVar=VCV001457103; Zygosity=Heterozygous (PubMed=32763824).
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Simple; p.Gly415Glu (c.1244G>A); ClinVar=VCV001334157; Zygosity=Heterozygous (PubMed=32763824).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32763824
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 19
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 12.2,14
ST   D21S11: 28.2,30
ST   D2S1338: 19,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 10,19
ST   D7S820: 12
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta E: 10,13
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   PUMCi002-A
AC   CVCL_A9YW
SY   C1; AF-iPSCs
DR   BioSamples; SAMEA111399454
DR   hPSCreg; PUMCi002-A
DR   Wikidata; Q102114792
RX   PubMed=36270068;
CC   From: Peking Union Medical College; Beijing; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:4115; GALC; Simple; p.Pro154His (c.461C>A); ClinVar=VCV001457103; Zygosity=Heterozygous (PubMed=36270068).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   PUMCi003-A
AC   CVCL_C0HA
SY   PUMC-iPS-PSEN1-1115M
DR   hPSCreg; PUMCi003-A
DR   Wikidata; Q114312741
RX   PubMed=35421846;
CC   From: Peking Union Medical College; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Glu363Gln (c.1087G>C); Zygosity=Heterozygous (PubMed=35421846).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   PUMCi004-A
AC   CVCL_C6SB
DR   hPSCreg; PUMCi004-A
DR   Wikidata; Q117704801
CC   From: Peking Union Medical College; Beijing; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   PUMCi005-A
AC   CVCL_D0KG
SY   P-iPSCs
DR   BioSamples; SAMEA112850192
DR   hPSCreg; PUMCi005-A
DR   Wikidata; Q123033283
RX   PubMed=38295749;
CC   From: Peking Union Medical College; Beijing; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:1160; TWNK; Simple; p.Arg265His (c.794G>A); ClinVar=VCV002418962; Zygosity=Heterozygous (PubMed=38295749).
CC   Sequence variation: Mutation; HGNC; HGNC:1160; TWNK; Simple; p.Arg394His (c.1181G>A); ClinVar=VCV001320817; Zygosity=Heterozygous (PubMed=38295749).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38295749
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D21S11: 29,32.2
ST   D5S818: 10
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C206102; Perrault syndrome 5
DI   ORDO; Orphanet_2855; Perrault syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   PUMCi006-A
AC   CVCL_D0KH
SY   PUMC-iPS-PSEN2-LSM
DR   BioSamples; SAMEA113557271
DR   hPSCreg; PUMCi006-A
DR   Wikidata; Q123033284
RX   PubMed=38531230;
CC   From: Peking Union Medical College; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Met239Thr (c.716T>C); Zygosity=Heterozygous (PubMed=38531230).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123413; Alzheimer's disease 4
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   PUMCSMi001-A
AC   CVCL_A7IW
SY   LL-001-A
DR   BioSamples; SAMEA8268539
DR   hPSCreg; PUMCSMi001-A
DR   Wikidata; Q107116682
RX   PubMed=33812336;
CC   From: School of Basic Medicine, Peking Union Medical College; Beijing; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   PUT
AC   CVCL_ZI12
DR   cancercelllines; CVCL_ZI12
DR   Cosmic; 1070697
DR   Cosmic; 1071882
DR   Cosmic; 1176614
DR   Wikidata; Q98128718
RX   PubMed=6245297;
RX   PubMed=6278187;
RX   PubMed=6278188;
RX   PubMed=6811418;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   Puti
AC   CVCL_0E94
SY   PUTI
DR   ATCC; CRL-1850
DR   Wikidata; Q54948706
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-1850; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9600; ! Pongo pygmaeus (Bornean orangutan)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   PUTKO
AC   CVCL_2697
SY   Putko; PUTKO-1
DR   CLO; CLO_0008524
DR   CLDB; cl3960
DR   ECACC; 88042802
DR   Wikidata; Q54948707
RX   PubMed=3930277;
RX   PubMed=6245297;
RX   PubMed=6278188;
RX   PubMed=6811418;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI12 ! PUT
HI   CVCL_0004 ! K-562
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   PUTRAL
AC   CVCL_ZI17
DR   Wikidata; Q98128719
RX   PubMed=6811418;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI12 ! PUT
HI   CVCL_7208 ! Rael
CA   Hybrid cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 4
//
ID   PV-1
AC   CVCL_8970
SY   PV1
DR   CLO; CLO_0008525
DR   ATCC; HB-12352
DR   Wikidata; Q54948708
RX   Patent=US5948893;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11944.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12352.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P31041; Mouse Cd28.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   PV014
AC   CVCL_B4GQ
DR   Wikidata; Q110433141
RX   CelloPub=CLPUB00671;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Thr238Ter (c.712_713delAC) (T237X); Zygosity=Heterozygous (CelloPub=CLPUB00671).
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4F0 ! WG3377
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   PV1.Pl
AC   CVCL_M887
SY   PV1Pl
DR   ATCC; CRL-6526
DR   Wikidata; Q54948709
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6526; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C135000; Seal lymphosarcoma
OX   NCBI_TaxID=9720; ! Phoca vitulina (Harbor seal)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   PV10
AC   CVCL_C856
SY   PV-10
DR   Cosmic; 877454
DR   Cosmic; 1152532
DR   Wikidata; Q54948710
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   Pv11-Hsf1-/-
AC   CVCL_C0VA
DR   Wikidata; Q114312742
RX   PubMed=34071490;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 Hsf1 was disrupted by insertion of a AcGFP1-P2A-ZeoR construct (PubMed=34071490).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; E1AC50; Hsf1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 6ORKJ; AcGFP1 (Note=Green fluorescent protein from A.coerulescens).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=319348; ! Polypedilum vanderplanki (Sleeping chironomid midge)
HI   CVCL_WH44 ! NIAS-Pv-11
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   Pv11-KH
AC   CVCL_WH46
DR   Wikidata; Q98128720
RX   PubMed=27757696;
CC   Group: Insect cell line.
CC   Characteristics: Dessication tolerant. Cells can be preserved in the dry state for over 6 months and retain their proliferation potential.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 6ORKJ; AcGFP1 (Note=Green fluorescent protein from A.coerulescens).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=319348; ! Polypedilum vanderplanki (Sleeping chironomid midge)
HI   CVCL_WH44 ! NIAS-Pv-11
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   Pv11-Luc
AC   CVCL_WH47
DR   Wikidata; Q98128721
RX   PubMed=28747745;
CC   Group: Insect cell line.
CC   Characteristics: Dessication tolerant. Cells can be preserved in the dry state for 372 days and retain their proliferation potential.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=319348; ! Polypedilum vanderplanki (Sleeping chironomid midge)
HI   CVCL_WH44 ! NIAS-Pv-11
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   PV2
AC   CVCL_S458
DR   ATCC; CRL-6527
DR   Wikidata; Q54948711
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6527; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9720; ! Phoca vitulina (Harbor seal)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   PV3
AC   CVCL_S459
DR   ATCC; CRL-6528
DR   Wikidata; Q54948712
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6528; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9720; ! Phoca vitulina (Harbor seal)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   PV4.Pl
AC   CVCL_S330
DR   ATCC; CRL-6605
DR   Wikidata; Q54948713
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6605; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9720; ! Phoca vitulina (Harbor seal)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   PVD9902
AC   CVCL_J420
SY   Porcine Vas Deferens 9902
DR   Wikidata; Q54948714
RX   PubMed=16421205;
CC   Derived from site: In situ; Vas deferens; UBERON=UBERON_0001000.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   PW
AC   CVCL_QY93
DR   Wikidata; Q54948716
RX   PubMed=11741286;
RX   PubMed=11859408;
CC   From: Giaccia, Amato J.; Stanford University; Stanford; USA.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   PWC-HS01
AC   CVCL_IU62
SY   Pembroke Welsh Corgi-Histiocytic Sarcoma 01
DR   Wikidata; Q54948718
RX   PubMed=28178429;
RX   PubMed=30884050;
CC   Doubling time: 64.8 hours (PubMed=28178429).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
CC   Breed/subspecies: Corgi; VBO=VBO_0200995.
DI   NCIt; C128125; Canine histiocytic sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y5M
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   PWH-S1
AC   CVCL_V487
SY   PWH-SI; Prince of Wales Hospital-Squamous 1
DR   Wikidata; Q54948719
RX   DOI=10.1007/978-2-8178-0765-2_34;
RX   PubMed=7788927;
CC   Doubling time: ~28 hours (PubMed=7788927).
CC   Caution: Said to originate from a female patient but karyotype in PubMed=7788927 shows a Y chromosome.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   PWR-1E
AC   CVCL_3775
SY   PWR1E
DR   BTO; BTO_0005178
DR   CLO; CLO_0008671
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-11611
DR   BioSample; SAMN03471342
DR   cancercelllines; CVCL_3775
DR   Cell_Model_Passport; SIDM01114
DR   ChEMBL-Cells; CHEMBL4295467
DR   ChEMBL-Targets; CHEMBL4296487
DR   Cosmic-CLP; 1330993
DR   DepMap; ACH-001383
DR   EGA; EGAS00001000978
DR   GDSC; 1330993
DR   GEO; GSM827268
DR   GEO; GSM1670354
DR   PharmacoDB; PWR1E_1279_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3775
DR   PubChem_Cell_line; CVCL_3775
DR   Wikidata; Q54948720
RX   Patent=US5814452;
RX   PubMed=8761420;
RX   PubMed=8977636;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11611.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.52%; Native American=0%; East Asian, North=2.82%; East Asian, South=0%; South Asian=0%; European, North=64.08%; European, South=30.58% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-11611; true.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-11611; Cosmic-CLP=1330993
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   PWS iPS del 1-1
AC   CVCL_U523
DR   Wikidata; Q54948722
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   PWS iPS del 1-2
AC   CVCL_U524
DR   Wikidata; Q54948724
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   PWS iPS del 1-3
AC   CVCL_U525
DR   Wikidata; Q54948725
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   PWS iPS del 1-4
AC   CVCL_U526
DR   Wikidata; Q54948726
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   PWS iPS del 1-5
AC   CVCL_U527
DR   Wikidata; Q54948727
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   PWS iPS del 1-6
AC   CVCL_U528
DR   Wikidata; Q54948728
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   PWS iPS del 1-7
AC   CVCL_U529
SY   PWS1-7
DR   Kerafast; ECN002
DR   Kerafast; ECN015
DR   SKIP; SKIP005164
DR   Wikidata; Q54948729
RX   PubMed=20876107;
CC   Discontinued: Kerafast; ECN002; true.
CC   Discontinued: Kerafast; ECN015; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   PWS iPS del 1-8
AC   CVCL_U530
DR   Wikidata; Q54948730
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   PWS iPS del 1-9
AC   CVCL_U531
DR   Wikidata; Q54948731
RX   PubMed=20876107;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   PWS SD fibroblast
AC   CVCL_ZJ46
SY   PWS Small atypical Deletion fibroblast
DR   Wikidata; Q98128722
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-1 iPSC
AC   CVCL_ZJ47
SY   PWS SD 2-1
DR   Wikidata; Q98128723
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-2 iPSC
AC   CVCL_ZJ48
SY   PWS SD 2-2
DR   Wikidata; Q98128724
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-3 iPSC
AC   CVCL_ZJ49
SY   PWS SD 2-3
DR   Wikidata; Q98128725
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-4 iPSC
AC   CVCL_ZJ50
SY   PWS SD 2-4
DR   Wikidata; Q98128726
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-5 iPSC
AC   CVCL_ZJ51
SY   PWS SD 2-5
DR   Wikidata; Q98128727
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-6 iPSC
AC   CVCL_ZJ52
SY   PWS SD 2-6
DR   Wikidata; Q98128728
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-7 iPSC
AC   CVCL_ZJ53
SY   PWS SD 2-7
DR   Wikidata; Q98128729
RX   PubMed=24363065;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   PWS SD 2-8 iPSC
AC   CVCL_ZJ54
SY   PWS SD 2-8
DR   Wikidata; Q98128730
RX   PubMed=24363065;
CC   Characteristics: Has a high propensities to differentiate into neurons due to the robust expression of neural lineage markers and silencing of the pluripotency genes (PubMed=24363065).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   PWS SD 2-9 iPSC
AC   CVCL_ZJ55
SY   PWS SD 2-9; PWS2.9; PWS small atypical deletion clone 9
DR   Wikidata; Q98128731
RX   PubMed=24363065;
WW   Provider; FPWR; -; https://www.fpwr.org/hubfs/Research%20Docs/PWS2.9%20Validation%20QC%20Package.pdf
WW   Provider; FPWR; -; https://www.fpwr.org/ipsc-biobank
CC   Characteristics: Has a high propensities to differentiate into neurons due to the robust expression of neural lineage markers and silencing of the pluripotency genes (PubMed=24363065).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): FPWR
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 10,12
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ46 ! PWS SD fibroblast
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   PWS UPD 1.2
AC   CVCL_ZJ75
SY   PWSUPD1.2; PWS maternal UniParental Disomy line 1.2
DR   Wikidata; Q98128732
RX   PubMed=29228278;
WW   Provider; FPWR; -; https://www.fpwr.org/hubfs/Research%20Docs/PWS%20UPD1.2%20Validation%20QC%20Package.pdf
WW   Provider; FPWR; -; https://www.fpwr.org/ipsc-biobank
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): FPWR
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   PWS-iPSC-1-A
AC   CVCL_5I48
DR   Wikidata; Q54948732
RX   PubMed=24816254;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   PWS-iPSC-1-B
AC   CVCL_5I49
DR   Wikidata; Q54948733
RX   PubMed=24816254;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5I47 ! WG1534
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   PWS-iPSC-2-A
AC   CVCL_5I50
DR   Wikidata; Q54948735
RX   PubMed=24816254;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U542 ! GM21889
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   PWS-iPSC-2-B
AC   CVCL_5I51
DR   Wikidata; Q54948736
RX   PubMed=24816254;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U542 ! GM21889
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   PWS-Yamaguchi
AC   CVCL_L556
DR   CLO; CLO_0050713
DR   BioSample; SAMN03472105
DR   RCB; RCB1560
DR   Wikidata; Q54948737
RX   PubMed=17395773;
CC   Population: Japanese.
CC   Senescence: Senesces at 32 PDL (PubMed=17395773).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB1560
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 9
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 15
//
ID   pWS88-c0
AC   CVCL_RI75
DR   SKIP; SKIP001248
DR   Wikidata; Q54948738
RX   PubMed=27509850;
CC   Donor information: Established from a patient that harbors a partial deletion in the WBS critical region.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI76 ! pWS88-c1
OI   CVCL_RI77 ! pWS88-c2
OI   CVCL_RI78 ! pWS88-c15
OI   CVCL_RI79 ! pWS88-c18
SX   Male
AG   14Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   pWS88-c1
AC   CVCL_RI76
DR   SKIP; SKIP001249
DR   Wikidata; Q54948739
RX   PubMed=27509850;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a patient that harbors a partial deletion in the WBS critical region.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI75 ! pWS88-c0
OI   CVCL_RI77 ! pWS88-c2
OI   CVCL_RI78 ! pWS88-c15
OI   CVCL_RI79 ! pWS88-c18
SX   Male
AG   14Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   pWS88-c15
AC   CVCL_RI78
DR   SKIP; SKIP001251
DR   Wikidata; Q54948740
RX   PubMed=27509850;
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a patient that harbors a partial deletion in the WBS critical region.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI75 ! pWS88-c0
OI   CVCL_RI76 ! pWS88-c1
OI   CVCL_RI77 ! pWS88-c2
OI   CVCL_RI79 ! pWS88-c18
SX   Male
AG   14Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   pWS88-c18
AC   CVCL_RI79
DR   SKIP; SKIP001252
DR   Wikidata; Q54948741
RX   PubMed=27509850;
CC   Donor information: Established from a patient that harbors a partial deletion in the WBS critical region.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI75 ! pWS88-c0
OI   CVCL_RI76 ! pWS88-c1
OI   CVCL_RI77 ! pWS88-c2
OI   CVCL_RI78 ! pWS88-c15
SX   Male
AG   14Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   pWS88-c2
AC   CVCL_RI77
DR   SKIP; SKIP001250
DR   Wikidata; Q54948742
RX   PubMed=27509850;
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Established from a patient that harbors a partial deletion in the WBS critical region.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI75 ! pWS88-c0
OI   CVCL_RI76 ! pWS88-c1
OI   CVCL_RI78 ! pWS88-c15
OI   CVCL_RI79 ! pWS88-c18
SX   Male
AG   14Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   PX-1187
AC   CVCL_Z387
DR   ICLDB; px-1187
DR   Wikidata; Q54948743
RX   DOI=10.1016/0022-2011(92)90029-4;
RX   DOI=10.6660/TESFE.1994042;
CC   Group: Insect cell line.
CC   Doubling time: 27 hours (Note=At 28 Celsius) (DOI=10.1016/0022-2011(92)90029-4).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   Px-E-HNU12
AC   CVCL_0A21
DR   ICLDB; px-e-hnu12
DR   Wikidata; Q54948744
RX   DOI=10.16380/j.kcxb.2011.05.007;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   PX1
AC   CVCL_ZR66
DR   Wikidata; Q98128733
RX   PubMed=3795172;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=9310; ! Potorous tridactylus (Potoroo)
HI   CVCL_0514 ! Pt K2
HI   CVCL_ZR65 ! XP2OS(SV)neo
CA   Hybrid cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   PX2
AC   CVCL_W373
DR   cancercelllines; CVCL_W373
DR   Wikidata; Q54948745
RX   PubMed=21166887;
CC   Problematic cell line: Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0473 ! OV-2008
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   PX24
AC   CVCL_W374
DR   cancercelllines; CVCL_W374
DR   Wikidata; Q54948746
RX   PubMed=21166887;
CC   Problematic cell line: Contaminated. Parent cell line (OV-2008) has been shown to be a ME-180 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0473 ! OV-2008
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   PxE-Po#5A3
AC   CVCL_C2VX
SY   PxE-PO
DR   ICLDB; pxe-po
DR   Wikidata; Q114312743
RX   CelloPub=CLPUB00722;
CC   Group: Insect cell line.
CC   Misspelling: PxE-PO#583; CelloPub=CLPUB00722.
OX   NCBI_TaxID=51655; ! Plutella xylostella (Diamondback moth)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   PXN/94
AC   CVCL_4994
SY   PXN-94; PXN 94; PXN94; PxN94
DR   Cosmic; 688108
DR   Cosmic; 1609540
DR   Wikidata; Q54948747
RX   PubMed=1423261;
RX   PubMed=1892748;
RX   PubMed=2653399;
RX   PubMed=15677628;
CC   Characteristics: Established from a xenograft established in female nude mice (PubMed=2653399).
CC   Doubling time: 23 hours (PubMed=2653399).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Py 1-18 MuLV
AC   CVCL_F743
DR   CLO; CLO_0008673
DR   CLDB; cl4039
DR   Wikidata; Q54948749
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   Py-3Y1-S2
AC   CVCL_H225
DR   JCRB; JCRB0736
DR   RCB; RCB0350
DR   Wikidata; Q54948750
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   Py-4-1
AC   CVCL_A336
SY   PY-41; PY41; PY-4.1; PY4.1
DR   BTO; BTO_0002837
DR   Wikidata; Q54948751
RX   PubMed=1893941;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Skin, dermis, microvascular endothelium; UBERON=UBERON_0002067.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
CC   Breed/subspecies: Py-4 transgenic.
DI   NCIt; C21833; Hemangioma of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   Py-AL/N
AC   CVCL_L812
SY   PY-AL/N; Py AL/N
DR   Wikidata; Q54948760
RX   PubMed=174816;
RX   PubMed=4331720;
RX   PubMed=4564284;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AL/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6312 ! AL/N
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   Py230
AC   CVCL_AQ08
DR   ATCC; CRL-3279
DR   Wikidata; Q54948761
RX   PubMed=22531600;
RX   PubMed=24368187;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Miscellaneous: STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6 MMTV-PyMT transgenic.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,17
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   Py2T
AC   CVCL_C7XI
DR   Millipore; SCC416
DR   Wikidata; Q123033285
RX   PubMed=23144919;
CC   Characteristics: Undergoes epithelial-mesenchymal transition (EMT) in response to TGF-beta in vitro (PubMed=23144919).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Miscellaneous: Age at sampling from personal communication of Christofori, Gerhard M.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: FVB/N MMTV-PyMT transgenic.
ST   Source(s): Millipore=SCC416
ST   Mouse STR 1-1: 10,11
ST   Mouse STR 1-2: 13,17
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 15
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 20
ST   Mouse STR 13-1: 15.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12-13W
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   Py8119
AC   CVCL_AQ09
SY   PY8119
DR   ATCC; CRL-3278
DR   Wikidata; Q54948762
RX   PubMed=22531600;
RX   PubMed=24368187;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Miscellaneous: STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6 MMTV-PyMT transgenic.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 26,27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,17
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   PYD1
AC   CVCL_D3SY
DR   DSHB; PYD1
DR   Wikidata; Q127383989
RX   PubMed=21508316;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q8MQQ3; Drosophila melanogaster pyd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PYD2
AC   CVCL_D3SZ
DR   DSHB; PYD2
DR   Wikidata; Q127383990
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8MQQ3; Drosophila melanogaster pyd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   PyMT-1099
AC   CVCL_D3FN
DR   Millipore; SCC422
DR   Wikidata; Q127383992
RX   PubMed=30108334;
CC   Characteristics: Undergoes epithelial-mesenchymal transition (EMT) in response to TGF-beta addition in vitro and undergoes a complete mesenchymal to epithelial transition (MET) upon TGF-beta withdrawal (PubMed=30108334).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Miscellaneous: Age at sampling from personal communication of Christofori, Gerhard M.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: FVB/N MMTV-PyMT transgenic.
ST   Source(s): Millipore=SCC422
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 16,17
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 15,16
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 15
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 14,15
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 27,28
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   12-13W
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   PYo5#21
AC   CVCL_C8KM
DR   Wikidata; Q123033286
RX   PubMed=18690684;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78780; Pyraclostrobin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   PYo5#31
AC   CVCL_C8KN
DR   Wikidata; Q123033287
RX   PubMed=18690684;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78780; Pyraclostrobin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   PYo5#32
AC   CVCL_C8KP
DR   Wikidata; Q123033288
RX   PubMed=18690684;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78780; Pyraclostrobin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   PYo5#33
AC   CVCL_C8KQ
DR   Wikidata; Q123033289
RX   PubMed=18690684;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78780; Pyraclostrobin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   PYo5#34
AC   CVCL_C8KR
DR   Wikidata; Q123033290
RX   PubMed=18690684;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78780; Pyraclostrobin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   PYo5#37
AC   CVCL_C8KS
DR   Wikidata; Q123033291
RX   PubMed=18690684;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78780; Pyraclostrobin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   PYo5#38
AC   CVCL_C8KT
DR   Wikidata; Q123033292
RX   PubMed=18690684;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_78780; Pyraclostrobin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   PYS
AC   CVCL_2166
SY   PYS-1; PYS 1
DR   CLO; CLO_0008674
DR   DSMZ; ACC-284
DR   DSMZCellDive; ACC-284
DR   Wikidata; Q54948763
RX   PubMed=1917782;
RX   PubMed=4858519;
CC   Doubling time: ~24 hours (DSMZ=ACC-284).
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   PYS-2
AC   CVCL_3776
SY   PYS 2
DR   CLO; CLO_0008675
DR   ATCC; CRL-2745
DR   BCRC; 60514
DR   Wikidata; Q54948764
RX   PubMed=276874;
RX   PubMed=1917782;
RX   PubMed=2412863;
RX   PubMed=4858519;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5572 ! OTT6050
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 14
//
ID   PYS-2/11
AC   CVCL_S144
SY   P11
DR   Wikidata; Q54948765
RX   PubMed=1917782;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3776 ! PYS-2
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   PYS-2/12
AC   CVCL_S145
SY   P12
DR   Wikidata; Q54948766
RX   PubMed=1917782;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3776 ! PYS-2
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   PYS-2/3
AC   CVCL_S143
SY   P3
DR   Wikidata; Q54948767
RX   PubMed=1917782;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3776 ! PYS-2
SX   Male
AG   Embryo
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   PZ-HPV-7
AC   CVCL_3777
DR   BTO; BTO_0003762
DR   CLO; CLO_0008676
DR   ATCC; CRL-2221
DR   BCRC; 60136
DR   BioSample; SAMN03472569
DR   Lonza; 1646
DR   Lonza; 1674
DR   Wikidata; Q54948768
RX   PubMed=7923200;
RX   PubMed=8977636;
RX   PubMed=11135431;
RX   PubMed=12725112;
RX   PubMed=21544329;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2221
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 13
ST   D21S11: 30,32.2
ST   D2S1338: 17,24
ST   D3S1358: 16
ST   D5S818: 9,13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 13,17
ST   Penta E: 12,14
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   PZ-TR
AC   CVCL_C0NN
SY   Clone 4
DR   cancercelllines; CVCL_C0NN
DR   Wikidata; Q114312744
RX   PubMed=26208032;
CC   Population: Caucasian.
CC   Biotechnology: Used for as reporter cell line for the assessment of thyroid receptor (TR) transcriptional activity. Triiodothyronine (T3) induced luciferase activity in a dose-dependent manner, and the sensitivity of assay allowed for the detection of nanomolar T3 concentrations (PubMed=26208032).
CC   Characteristics: Expression of luciferase is under the control of a promoter containing two thyroid hormone response elements (TREs) separated by four nucleotides (DR4) followed by a SV40 promoter (PubMed=26208032).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   Pz01.F3
AC   CVCL_IQ66
DR   ABCD; ABCD_AF502
DR   Wikidata; Q54948770
RX   Patent=US7615216;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2681.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   Pz02.1C11
AC   CVCL_IQ90
DR   ABCD; ABCD_AF503
DR   Wikidata; Q54948771
RX   Patent=US7615216;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2682.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   Pz03.1C5
AC   CVCL_IQ80
DR   ABCD; ABCD_AF504
DR   Wikidata; Q54948772
RX   Patent=US7615216;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2683.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   Pz04.1F6
AC   CVCL_IQ91
DR   Wikidata; Q54948773
RX   Patent=US7615216;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2684.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   Q10
AC   CVCL_T591
SY   LSQC-Q10
DR   Wikidata; Q54948776
RX   PubMed=199997;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   Q201
AC   CVCL_A9QZ
DR   Wikidata; Q102114794
RX   PubMed=1687647;
RX   PubMed=8138999;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   Q2700-5
AC   CVCL_E5JU
RX   Patent=CN118979016A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202496.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P02745; Human C1QA.
CC   Monoclonal antibody target: UniProtKB; P02746; Human C1QB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Q3
AC   CVCL_T480
AS   CVCL_M210
SY   Q- clone 3; LSQC-Q3(-); 3Q; 3Q-; QCl-3; Qcl3
DR   Wikidata; Q54948777
RX   PubMed=67703;
RX   PubMed=4344942;
RX   PubMed=6574464;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   Q34
AC   CVCL_VS16
DR   Wikidata; Q98128734
RX   PubMed=12417717;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met53Thr (c.158T>C); ClinVar=VCV001480737; Zygosity=Heterozygous (PubMed=12417717).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp108Asn (c.322G>A) (p.Arg122Gln, c.365G>A); ClinVar=VCV000216275; Zygosity=Heterozygous (PubMed=12417717).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VS15 ! Hmel-p16-2
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   Q5
AC   CVCL_T589
DR   Wikidata; Q54948778
RX   PubMed=199997;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   Q8
AC   CVCL_T590
SY   LSQC-Q8
DR   Wikidata; Q54948779
RX   PubMed=199997;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   QA1
AC   CVCL_D1FN
DR   Wikidata; Q127383994
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   QA5
AC   CVCL_D1FM
DR   Wikidata; Q127383996
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   QAU-Bd-E-2
AC   CVCL_B0JL
DR   ICLDB; qau-bd-e-2
DR   Wikidata; Q108821192
RX   PubMed=34435282;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Bactrocera dorsalis cripavirus (BdCV).
CC   Doubling time: 31.9 hours (PubMed=34435282).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=27457; ! Bactrocera dorsalis (Oriental fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   QAU-BTI-Tn9-4s
AC   CVCL_AV37
SY   QB-Tn9-4s
DR   ICLDB; qau-bti-tn9-4s
DR   Wikidata; Q54948780
RX   DOI=10.1111/j.1744-7917.2008.00229.x;
RX   PubMed=21979569;
RX   PubMed=25373171;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Doubling time: 22.9-24.1 hours (Note=In serum-free Sf-900 III medium), 27.4 hours (Note=In TNM-FH medium) (PubMed=25373171); 22.6 hours (PubMed=21979569).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   QAU-Ho-E-3
AC   CVCL_Z428
SY   Ho-3
DR   Wikidata; Q54948781
RX   PubMed=24464351;
CC   Group: Insect cell line.
CC   Doubling time: 101.1 hours (PubMed=24464351).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=644536; ! Holotrichia oblita (Chafer beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   QAU-Ho-E-4
AC   CVCL_Z429
SY   Ho-4
DR   Wikidata; Q54948782
RX   PubMed=24464351;
CC   Group: Insect cell line.
CC   Doubling time: 105.2 hours (PubMed=24464351).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=644536; ! Holotrichia oblita (Chafer beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   QAU-Ho-E-6
AC   CVCL_Z430
SY   Ho-6
DR   Wikidata; Q54948783
RX   PubMed=24464351;
CC   Group: Insect cell line.
CC   Doubling time: 83.6 hours (PubMed=24464351).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=644536; ! Holotrichia oblita (Chafer beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   QAU-Ho-E-6-22
AC   CVCL_XY03
SY   Ho-6-22
DR   CCRID; 4201PAT-CCTCC01188
DR   Wikidata; Q98128735
RX   Patent=CN111321106B;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201866.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=644536; ! Holotrichia oblita (Chafer beetle)
HI   CVCL_Z430 ! QAU-Ho-E-6
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 8
//
ID   QAU-Hp-E-9-2
AC   CVCL_XY04
DR   CCRID; 4201PAT-CCTCC01189
DR   Wikidata; Q98128736
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=93412; ! Holotrichia parallela (Dark black chafer beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   QAU-Ms-E-10
AC   CVCL_RA60
SY   Ms-10
DR   ICLDB; qau-ms-e-10
DR   Wikidata; Q54948784
RX   PubMed=28664308;
CC   Group: Insect cell line.
CC   Doubling time: 46.2 hours (PubMed=28664308).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   QAU-Ms-E-10c
AC   CVCL_RA61
SY   Ms-10c
DR   ICLDB; qau-ms-e-10c
DR   Wikidata; Q54948786
RX   PubMed=28664308;
CC   Group: Insect cell line.
CC   Doubling time: 42.2 hours (PubMed=28664308).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
HI   CVCL_RA60 ! QAU-Ms-E-10
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   Qau-Se-E-1
AC   CVCL_VL69
SY   Se-1
DR   ICLDB; qau-se-e-1
DR   Wikidata; Q98128737
RX   PubMed=25999173;
CC   Group: Insect cell line.
CC   Doubling time: 59.03 hours (PubMed=25999173).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   Qau-Se-E-2
AC   CVCL_VL70
SY   Se-2
DR   ICLDB; qau-se-e-2
DR   Wikidata; Q98128738
RX   PubMed=25999173;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV).
CC   Doubling time: 49.08 hours (PubMed=25999173).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   Qau-Se-E-3
AC   CVCL_VL71
SY   Se-3
DR   ICLDB; qau-se-e-3
DR   Wikidata; Q98128739
RX   PubMed=25999173;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV).
CC   Doubling time: 49.91 hours (PubMed=25999173).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   QAU-Tn-E-7
AC   CVCL_XY05
DR   CCRID; 4201PAT-CCTCC01187
DR   Wikidata; Q98128740
RX   Patent=CN108531442B;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201865.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 8
//
ID   QB-CL-A
AC   CVCL_AV38
DR   ICLDB; qb-cl
DR   Wikidata; Q54948787
RX   PubMed=21979569;
CC   Group: Insect cell line.
CC   Doubling time: 21.7 hours (PubMed=21979569).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_AV37 ! QAU-BTI-Tn9-4s
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   QB-CL-B
AC   CVCL_AV39
SY   QB-TN9-4s-CL-B
DR   CCRID; 4201PAT-CCTCC00364
DR   ICLDB; qb-cl-b
DR   Wikidata; Q54948788
RX   Patent=CN101935634B;
RX   PubMed=21979569;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201046.
CC   Doubling time: 20.2 hours (PubMed=21979569).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_AV37 ! QAU-BTI-Tn9-4s
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 12
//
ID   QB-CL-F
AC   CVCL_XY06
SY   QB-Tn9-4S-Cl-F; QB-Tn9-CL-F
DR   ICLDB; qb-cl-f
DR   Wikidata; Q98128741
RX   DOI=10.4172/2157-7560.S1.022;
RX   Patent=CN103305469B;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201327.
CC   Characteristics: Adapted to growth in SF-900 III SFM.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_AV37 ! QAU-BTI-Tn9-4s
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   QB-Ha-E-1
AC   CVCL_0A14
DR   ICLDB; qb-ha-e-1
DR   Wikidata; Q54948789
RX   DOI=10.16380/j.kcxb.2010.02.013;
CC   Group: Insect cell line.
CC   Doubling time: 63.7 hours (DOI=10.16380/j.kcxb.2010.02.013).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   QB-Ha-E-5
AC   CVCL_0A15
DR   ICLDB; qb-ha-e-5
DR   Wikidata; Q54948790
RX   DOI=10.16380/j.kcxb.2010.02.013;
CC   Group: Insect cell line.
CC   Doubling time: 66.9 hours (DOI=10.16380/j.kcxb.2010.02.013).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   QB-Ms1-8
AC   CVCL_0A16
DR   ICLDB; qb-ms1-8
DR   Wikidata; Q54948791
RX   DOI=10.16380/j.kcxb.2010.11.006;
CC   Group: Insect cell line.
CC   Doubling time: 51 hours (DOI=10.16380/j.kcxb.2010.11.006).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   QB-Ms2-2
AC   CVCL_0A17
DR   ICLDB; qb-ms2-2
DR   Wikidata; Q54948792
RX   DOI=10.16380/j.kcxb.2010.11.006;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 31 hours (DOI=10.16380/j.kcxb.2010.11.006).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   QB-Ms2-7
AC   CVCL_0A18
DR   ICLDB; qb-ms2-7
DR   Wikidata; Q54948793
RX   DOI=10.16380/j.kcxb.2010.11.006;
CC   Group: Insect cell line.
CC   Doubling time: 49 hours (DOI=10.16380/j.kcxb.2010.11.006).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7130; ! Manduca sexta (Tobacco hawkmoth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   QBC939
AC   CVCL_6942
SY   QBC(939); QBC-939
DR   ABM; T9189
DR   Wikidata; Q54948794
RX   CelloPub=CLPUB00275;
RX   CelloPub=CLPUB00728;
RX   PubMed=20111907;
RX   PubMed=29913454;
RX   PubMed=35640676;
CC   Population: Chinese.
CC   Doubling time: 23.6 hours (PubMed=20111907).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   QBC939/ADM
AC   CVCL_LJ49
DR   Wikidata; Q54948795
RX   PubMed=20111907;
CC   Population: Chinese.
CC   Doubling time: 32.2 hours (PubMed=20111907).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6942 ! QBC939
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   QBL
AC   CVCL_E814
SY   GM06824; GM06824A
DR   CLO; CLO_0036520
DR   Coriell; GM06824
DR   dbMHC; 49008
DR   ECACC; 94070713
DR   IHW; IHW09020
DR   IPD-IMGT/HLA; 11282
DR   Wikidata; Q54948796
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=6417008;
RX   PubMed=8813743;
RX   PubMed=16440057;
RX   PubMed=16702430;
RX   PubMed=16948657;
RX   PubMed=18193213;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*26:01:01:01; B*18:01:01:01; C*05:01:01:01; DPA1*01:03; DPB1*02:02; DQA1*05:01:01; DQB1*02:01:01; DRA*01:01; DRB1*03:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=11282).
CC   HLA typing: A*26:01:01:01; B*18:01:01:01; C*05:01:01:01; DPA1*01:03:01:01; DPB1*02:02; DQA1*05:01:01:01; DQB1*02:01:01; DRB1*03:01:01; DRB3*02:02:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   QBRIi001-A
AC   CVCL_YR08
SY   Ctr1
DR   BioSamples; SAMEA6276811
DR   hPSCreg; QBRIi001-A
DR   SKIP; SKIP005870
DR   Wikidata; Q98128742
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR09 ! QBRIi001-B
OI   CVCL_YR10 ! QBRIi001-C
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi001-B
AC   CVCL_YR09
DR   BioSamples; SAMEA6276813
DR   hPSCreg; QBRIi001-B
DR   SKIP; SKIP005872
DR   Wikidata; Q98128743
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR08 ! QBRIi001-A
OI   CVCL_YR10 ! QBRIi001-C
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi001-C
AC   CVCL_YR10
DR   BioSamples; SAMEA6276814
DR   hPSCreg; QBRIi001-C
DR   SKIP; SKIP005873
DR   Wikidata; Q98128744
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR08 ! QBRIi001-A
OI   CVCL_YR09 ! QBRIi001-B
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi002-A
AC   CVCL_YR11
DR   BioSamples; SAMEA6276807
DR   hPSCreg; QBRIi002-A
DR   SKIP; SKIP005874
DR   Wikidata; Q98128747
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR12 ! QBRIi002-B
OI   CVCL_YR13 ! QBRIi002-C
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi002-B
AC   CVCL_YR12
DR   BioSamples; SAMEA6276809
DR   hPSCreg; QBRIi002-B
DR   SKIP; SKIP005876
DR   Wikidata; Q98128748
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR11 ! QBRIi002-A
OI   CVCL_YR13 ! QBRIi002-C
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi002-C
AC   CVCL_YR13
DR   BioSamples; SAMEA6276810
DR   hPSCreg; QBRIi002-C
DR   SKIP; SKIP005877
DR   Wikidata; Q98128749
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR11 ! QBRIi002-A
OI   CVCL_YR12 ! QBRIi002-B
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi005-A
AC   CVCL_YR14
DR   BioSamples; SAMEA6276803
DR   hPSCreg; QBRIi005-A
DR   SKIP; SKIP005878
DR   Wikidata; Q98128750
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR15 ! QBRIi005-B
OI   CVCL_YR16 ! QBRIi005-C
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi005-B
AC   CVCL_YR15
DR   BioSamples; SAMEA6276805
DR   hPSCreg; QBRIi005-B
DR   SKIP; SKIP005879
DR   Wikidata; Q98128752
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR14 ! QBRIi005-A
OI   CVCL_YR16 ! QBRIi005-C
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi005-C
AC   CVCL_YR16
DR   BioSamples; SAMEA6276806
DR   hPSCreg; QBRIi005-C
DR   SKIP; SKIP005880
DR   Wikidata; Q98128753
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR14 ! QBRIi005-A
OI   CVCL_YR15 ! QBRIi005-B
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   QBRIi006-A
AC   CVCL_YB72
DR   BioSamples; SAMEA6260532
DR   hPSCreg; QBRIi006-A
DR   SKIP; SKIP005882
DR   Wikidata; Q98128754
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB73 ! QBRIi006-B
OI   CVCL_YB74 ! QBRIi006-C
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   QBRIi006-B
AC   CVCL_YB73
DR   BioSamples; SAMEA6260531
DR   hPSCreg; QBRIi006-B
DR   SKIP; SKIP005883
DR   Wikidata; Q98128755
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB72 ! QBRIi006-A
OI   CVCL_YB74 ! QBRIi006-C
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   QBRIi006-C
AC   CVCL_YB74
DR   BioSamples; SAMEA6260530
DR   hPSCreg; QBRIi006-C
DR   SKIP; SKIP005884
DR   Wikidata; Q98128756
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3346; Psoriasis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB72 ! QBRIi006-A
OI   CVCL_YB73 ! QBRIi006-B
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   QBRIi007-A
AC   CVCL_YR07
SY   GLUT2 Mut-int iPSCs
DR   BioSamples; SAMEA6597985
DR   hPSCreg; QBRIi007-A
DR   SKIP; SKIP005881
DR   Wikidata; Q98128757
RX   PubMed=32146263;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Sequence variation: Mutation; HGNC; HGNC:11006; SLC2A2; Simple; c.613-7T>G (IVS5-7T>G); ClinVar=VCV001339449; Zygosity=Homozygous (PubMed=32146263).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168998; Glycogen storage disease type XI
DI   ORDO; Orphanet_2088; Fanconi-Bickel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NT ! QBRIi007-B
OI   CVCL_A4NU ! QBRIi007-C
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   QBRIi007-B
AC   CVCL_A4NT
DR   SKIP; SKIP005868
DR   Wikidata; Q105510619
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Sequence variation: Mutation; HGNC; HGNC:11006; SLC2A2; Simple; c.613-7T>G (IVS5-7T>G); ClinVar=VCV001339449; Zygosity=Homozygous (from autologous cell line QBRIi007-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168998; Glycogen storage disease type XI
DI   ORDO; Orphanet_2088; Fanconi-Bickel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR07 ! QBRIi007-A
OI   CVCL_A4NU ! QBRIi007-C
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   QBRIi007-C
AC   CVCL_A4NU
DR   SKIP; SKIP005867
DR   Wikidata; Q105510621
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Sequence variation: Mutation; HGNC; HGNC:11006; SLC2A2; Simple; c.613-7T>G (IVS5-7T>G); ClinVar=VCV001339449; Zygosity=Homozygous (from autologous cell line QBRIi007-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168998; Glycogen storage disease type XI
DI   ORDO; Orphanet_2088; Fanconi-Bickel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YR07 ! QBRIi007-A
OI   CVCL_A4NT ! QBRIi007-B
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   QBRIi008-A
AC   CVCL_YR06
DR   hPSCreg; QBRIi008-A
DR   Wikidata; Q98128758
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   QBRIi009-A
AC   CVCL_YR05
SY   FOXA2+/- iPSCs
DR   BioSamples; SAMEA7059979
DR   hPSCreg; QBRIi009-A
DR   SKIP; SKIP005852
DR   Wikidata; Q98128759
RX   PubMed=31991389;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Bengali.
CC   Sequence variation: Gene deletion; HGNC; HGNC:5022; FOXA2; Zygosity=Heterozygous (PubMed=31991389).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   QBRIi010-A
AC   CVCL_A4NV
SY   GCK-MODY2 iPSCs
DR   hPSCreg; QBRIi010-A
DR   SKIP; SKIP005885
DR   Wikidata; Q105510623
RX   PubMed=32971462;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:4195; GCK; Simple; p.Leu146Pro (c.437T>C); ClinVar=VCV002428681; Zygosity=Heterozygous (PubMed=32971462).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129741; Glucokinase-associated diabetes mellitus
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NX ! QBRIi010-B
OI   CVCL_A4NY ! QBRIi010-C
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   QBRIi010-B
AC   CVCL_A4NX
DR   SKIP; SKIP005886
DR   Wikidata; Q105510626
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:4195; GCK; Simple; p.Leu146Pro (c.437T>C); ClinVar=VCV002428681; Zygosity=Heterozygous (from autologous cell line QBRIi010-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129741; Glucokinase-associated diabetes mellitus
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NV ! QBRIi010-A
OI   CVCL_A4NY ! QBRIi010-C
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   QBRIi010-C
AC   CVCL_A4NY
DR   SKIP; SKIP005887
DR   Wikidata; Q105510627
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:4195; GCK; Simple; p.Leu146Pro (c.437T>C); ClinVar=VCV002428681; Zygosity=Heterozygous (from autologous cell line QBRIi010-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129741; Glucokinase-associated diabetes mellitus
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4NV ! QBRIi010-A
OI   CVCL_A4NX ! QBRIi010-B
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   QBRIi011-A
AC   CVCL_A4NW
SY   GCK-PNDM iPSCs
DR   hPSCreg; QBRIi011-A
DR   SKIP; SKIP005888
DR   Wikidata; Q105510632
RX   PubMed=32971462;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:4195; GCK; Simple; p.Leu146Pro (c.437T>C); ClinVar=VCV002428681; Zygosity=Homozygous (PubMed=32971462).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114902; Permanent neonatal diabetes mellitus
DI   ORDO; Orphanet_99885; Permanent neonatal diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   QBRIi012-A
AC   CVCL_A8MY
SY   GLUT2-exo-mut iPSCs
DR   hPSCreg; QBRIi012-A
DR   Wikidata; Q108821194
RX   PubMed=34171785;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:11006; SLC2A2; Simple; p.Arg301Ter (c.901C>T); ClinVar=VCV000016093; Zygosity=Homozygous (PubMed=34171785).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168998; Glycogen storage disease type XI
DI   NCIt; C114902; Permanent neonatal diabetes mellitus
DI   ORDO; Orphanet_2088; Fanconi-Bickel syndrome
DI   ORDO; Orphanet_99885; Permanent neonatal diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   QBRIi013-A
AC   CVCL_A8ZX
SY   ASD-NDRC-1
DR   BioSamples; SAMEA9197490
DR   hPSCreg; QBRIi013-A
DR   Wikidata; Q108821195
RX   PubMed=34438163;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Egyptian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   QBRIi014-A
AC   CVCL_C1VV
SY   NDD01; NDD_01; hiPSC_11080401_c1
DR   BioSamples; SAMEA111347413
DR   hPSCreg; QBRIi014-A
DR   Wikidata; Q114312745
RX   PubMed=36272305;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:15751; NAPB; Simple; c.354+2T>G; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=36272305).
CC   Donor information: Established from monozygotic triplet of QBRIi015-A (Cellosaurus=CVCL_C1VW) and QBRIi016-A (Cellosaurus=CVCL_C1VX).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C190869; Developmental and epileptic encephalopathy 107
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   QBRIi015-A
AC   CVCL_C1VW
SY   NDD04; NDD_04; hiPSC_11080404_c1
DR   BioSamples; SAMEA111396555
DR   hPSCreg; QBRIi015-A
DR   Wikidata; Q114312746
RX   PubMed=36272305;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:15751; NAPB; Simple; c.354+2T>G; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=36272305).
CC   Donor information: Established from monozygotic triplet of QBRIi014-A (Cellosaurus=CVCL_C1VV) and QBRIi016-A (Cellosaurus=CVCL_C1VX).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C190869; Developmental and epileptic encephalopathy 107
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   QBRIi016-A
AC   CVCL_C1VX
SY   NDD05; NDD_05; hiPSC_11080405_c1
DR   BioSamples; SAMEA111396557
DR   hPSCreg; QBRIi016-A
DR   Wikidata; Q114312747
RX   PubMed=36272305;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:15751; NAPB; Simple; c.354+2T>G; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=36272305).
CC   Donor information: Established from monozygotic triplet of QBRIi014-A (Cellosaurus=CVCL_C1VV) and QBRIi015-A (Cellosaurus=CVCL_C1VW).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C190869; Developmental and epileptic encephalopathy 107
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   QBRIi017-A
AC   CVCL_C1VY
SY   CtrlM; hiPSC_11080402_c1
DR   BioSamples; SAMEA111396559
DR   hPSCreg; QBRIi017-A
DR   Wikidata; Q114312748
RX   PubMed=36272305;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:15751; NAPB; Simple; c.354+2T>G; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=36272305).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   QBRIi018-A
AC   CVCL_C1VZ
SY   CtrlF; hiPSC_11080403_c1
DR   BioSamples; SAMEA111396561
DR   hPSCreg; QBRIi018-A
DR   Wikidata; Q114312749
RX   PubMed=36272305;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:15751; NAPB; Simple; c.354+2T>G; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=36272305).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   QBRIi019-A
AC   CVCL_D0KI
SY   ASD047
DR   BioSamples; SAMEA114317185
DR   hPSCreg; QBRIi019-A
DR   Wikidata; Q123033293
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   QBRIi020-A
AC   CVCL_D0KJ
SY   ASD024
DR   BioSamples; SAMEA114347153
DR   hPSCreg; QBRIi020-A
DR   Wikidata; Q123033294
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   QBRIi021-A
AC   CVCL_D0KK
SY   ASD021
DR   BioSamples; SAMEA114347154
DR   hPSCreg; QBRIi021-A
DR   Wikidata; Q123033295
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0KL ! QBRIi021-B
SX   Male
AG   2Y11M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   QBRIi021-B
AC   CVCL_D0KL
DR   BioSamples; SAMEA114347155
DR   hPSCreg; QBRIi021-B
DR   Wikidata; Q123033296
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0KK ! QBRIi021-A
SX   Male
AG   2Y11M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   QBRIi022-A
AC   CVCL_D0KM
SY   CNT046
DR   BioSamples; SAMEA114347156
DR   hPSCreg; QBRIi022-A
DR   Wikidata; Q123033297
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0KN ! QBRIi022-B
SX   Male
AG   2Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   QBRIi022-B
AC   CVCL_D0KN
DR   BioSamples; SAMEA114347157
DR   hPSCreg; QBRIi022-B
DR   Wikidata; Q123033298
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0KM ! QBRIi022-A
SX   Male
AG   2Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   QBRIi023-A
AC   CVCL_E4EC
SY   ASD002
DR   BioSamples; SAMEA115159978
DR   hPSCreg; QBRIi023-A
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4ED ! QBRIi023-B
SX   Male
AG   3Y6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi023-B
AC   CVCL_E4ED
DR   BioSamples; SAMEA115286699
DR   hPSCreg; QBRIi023-B
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EC ! QBRIi023-A
SX   Male
AG   3Y6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi024-A
AC   CVCL_E4EE
DR   BioSamples; SAMEA115286700
DR   hPSCreg; QBRIi024-A
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EF ! QBRIi024-B
SX   Male
AG   2Y8M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi024-B
AC   CVCL_E4EF
SY   ASD007
DR   BioSamples; SAMEA115286702
DR   hPSCreg; QBRIi024-B
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EE ! QBRIi024-A
SX   Male
AG   2Y8M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi025-A
AC   CVCL_E4EG
SY   ASD020
DR   BioSamples; SAMEA115286703
DR   hPSCreg; QBRIi025-A
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EH ! QBRIi025-B
SX   Male
AG   3Y9M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi025-B
AC   CVCL_E4EH
DR   BioSamples; SAMEA115286705
DR   hPSCreg; QBRIi025-B
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EG ! QBRIi025-A
SX   Male
AG   3Y9M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi026-A
AC   CVCL_E4EI
SY   CNT020
DR   BioSamples; SAMEA115286706
DR   hPSCreg; QBRIi026-A
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y8M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi027-A
AC   CVCL_E4EJ
DR   BioSamples; SAMEA11528670
DR   hPSCreg; QBRIi027-A
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EK ! QBRIi027-B
SX   Male
AG   3Y8M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QBRIi027-B
AC   CVCL_E4EK
SY   CNT022
DR   BioSamples; SAMEA11528671
DR   hPSCreg; QBRIi027-B
RX   PubMed=38896970;
CC   From: Qatar Biomedical Research Institute; Doha; Quatar.
CC   Population: Arab; Qatari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EJ ! QBRIi027-A
SX   Male
AG   3Y8M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   QCE-6
AC   CVCL_J616
SY   QCE6
DR   Wikidata; Q54948797
RX   PubMed=7875372;
RX   PubMed=8575063;
RX   PubMed=9053328;
CC   Group: Bird cell line.
CC   Doubling time: 10.3 hours (PubMed=8575063).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Cardiac mesoderm; UBERON=UBERON_0007005.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   QCPN
AC   CVCL_0R15
DR   BCRJ; 0207
DR   DSHB; QCPN
DR   Wikidata; Q54948799
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Coturnix japonica cell marker.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 8
//
ID   QCRL-1
AC   CVCL_G201
SY   QCRL1
DR   CLO; CLO_0008678
DR   ATCC; HB-11765
DR   Wikidata; Q54948800
RX   Patent=US5882875;
RX   PubMed=7954400;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11765.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33527; Human ABCC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   QCRL-2
AC   CVCL_DB38
DR   Wikidata; Q54948801
RX   PubMed=7954400;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P33527; Human ABCC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 5
//
ID   QCRL-3
AC   CVCL_G202
SY   QCRL3
DR   CLO; CLO_0008679
DR   AddexBio; C0033010/5001
DR   ATCC; HB-11766
DR   Wikidata; Q54948802
RX   Patent=US5882875;
RX   PubMed=7954400;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11766.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P33527; Human ABCC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 8
//
ID   QCRL-4
AC   CVCL_DB39
DR   Wikidata; Q54948803
RX   PubMed=7954400;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33527; Human ABCC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 5
//
ID   QCRL-6
AC   CVCL_DB40
DR   Wikidata; Q54948812
RX   PubMed=7954400;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P33527; Human ABCC1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 5
//
ID   QDMHi001-A
AC   CVCL_A8MZ
SY   PBMC20190809-01 SeVC5
DR   BioSamples; SAMEA8268544
DR   hPSCreg; QDMHi001-A
DR   Wikidata; Q108821196
RX   PubMed=34087733;
CC   From: Qingdao Municipal Hospital; Qingdao; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2258Arg (c.6772T>C); ClinVar=VCV000379489; Zygosity=Heterozygous (PubMed=34087733).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   QE.2E5
AC   CVCL_C8GE
DR   Wikidata; Q123033299
RX   PubMed=8810264;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   QEC(MC29)
AC   CVCL_9254
SY   MC 2
DR   CLO; CLO_0007572
DR   CLDB; cl3348
DR   Wikidata; Q54948813
RX   PubMed=2986135;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11868; Avian myelocytomatosis virus 29.
CC   Derived from site: In situ; Embryonic tibia, cartilage; UBERON=UBERON_0010849.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   QG-56
AC   CVCL_6943
SY   QG 56; QG56
DR   EFO; EFO_0002848
DR   cancercelllines; CVCL_6943
DR   CCRID; 3101HUMTCHu92
DR   ChEMBL-Cells; CHEMBL3307796
DR   ChEMBL-Targets; CHEMBL612268
DR   Cosmic; 1336876
DR   Cosmic; 1571741
DR   Cosmic; 2645026
DR   Cosmic; 2664121
DR   IARC_TP53; 18792
DR   PubChem_Cell_line; CVCL_6943
DR   Wikidata; Q54948814
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=229054;
RX   PubMed=758928;
RX   PubMed=1737336;
RX   PubMed=1778766;
RX   PubMed=3986962;
RX   PubMed=8385084;
RX   PubMed=8752176;
RX   PubMed=9023415;
RX   PubMed=9538136;
RX   PubMed=11583962;
RX   PubMed=12569360;
RX   PubMed=12794755;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   HLA typing: A*26:01; B*46:01; C*01:02 (PubMed=9023415).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=12794755).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   QG-90
AC   CVCL_S980
SY   QG 90; QG90
DR   cancercelllines; CVCL_S980
DR   ChEMBL-Cells; CHEMBL3307349
DR   ChEMBL-Targets; CHEMBL614242
DR   PubChem_Cell_line; CVCL_S980
DR   Wikidata; Q54948815
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=229054;
RX   PubMed=758928;
RX   PubMed=1737336;
RX   PubMed=1778766;
RX   PubMed=2485219;
RX   PubMed=2540905;
RX   PubMed=11583962;
RX   PubMed=17511773;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=11583962).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   QG-95
AC   CVCL_S847
SY   QG95
DR   ChEMBL-Cells; CHEMBL3307290
DR   ChEMBL-Targets; CHEMBL614052
DR   PubChem_Cell_line; CVCL_S847
DR   Wikidata; Q54948816
RX   PubMed=229054;
RX   PubMed=571828;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   QG-96
AC   CVCL_S981
SY   QG 96; QG96
DR   ChEMBL-Cells; CHEMBL3307378
DR   ChEMBL-Targets; CHEMBL614382
DR   PubChem_Cell_line; CVCL_S981
DR   Wikidata; Q54948817
RX   PubMed=2485219;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   QG-H
AC   CVCL_A462
SY   QGH
DR   Cosmic; 877462
DR   Cosmic; 1152544
DR   Wikidata; Q54948819
RX   PubMed=571828;
RX   PubMed=3029293;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   QG-K
AC   CVCL_IM29
DR   Wikidata; Q54948820
RX   PubMed=571828;
RX   PubMed=6991350;
CC   Population: Japanese.
CC   Doubling time: 53 hours (PubMed=6991350).
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   QG-U
AC   CVCL_3778
SY   QGU
DR   CLO; CLO_0050919
DR   BioSample; SAMN03472215
DR   Cosmic; 877463
DR   Cosmic; 925360
DR   Cosmic; 1152543
DR   RCB; RCB0688
DR   Wikidata; Q54948821
RX   PubMed=571828;
RX   PubMed=3029293;
RX   PubMed=6991350;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=6991350).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST   Source(s): RCB=RCB0688
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   QGP-1
AC   CVCL_3143
SY   QGP 1; QGP1
DR   BTO; BTO_0005500
DR   CLO; CLO_0037113
DR   EFO; EFO_0006741
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472832
DR   BioSample; SAMN03472892
DR   BioSample; SAMN10988306
DR   cancercelllines; CVCL_3143
DR   Cell_Model_Passport; SIDM00360
DR   CGH-DB; 9375-4
DR   Cosmic; 736280
DR   Cosmic; 922260
DR   Cosmic; 933517
DR   Cosmic; 1620106
DR   Cosmic; 1879412
DR   Cosmic; 2433551
DR   Cosmic; 2530677
DR   Cosmic-CLP; 1298534
DR   DepMap; ACH-000347
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10781-110G7
DR   GDSC; 1298534
DR   GEO; GSM600373
DR   GEO; GSM827299
DR   GEO; GSM830112
DR   GEO; GSM887522
DR   GEO; GSM888604
DR   GEO; GSM1374837
DR   GEO; GSM1670355
DR   IARC_TP53; 30149
DR   JCRB; JCRB0183
DR   LiGeA; CCLE_506
DR   LINCS_LDP; LCL-1754
DR   PharmacoDB; QGP1_1280_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3143
DR   Wikidata; Q54948822
RX   CelloPub=CLPUB00598;
RX   DOI=10.5772/30884;
RX   PubMed=1971195;
RX   PubMed=6205259;
RX   PubMed=7227711;
RX   PubMed=8426738;
RX   PubMed=11169959;
RX   PubMed=20215515;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=22929519;
RX   PubMed=23119007;
RX   PubMed=25485619;
RX   PubMed=25612765;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26087898;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29330294;
RX   PubMed=29444439;
RX   PubMed=29444910;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36180704;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/QGP-1.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~3.5 days (PubMed=7227711); 61 hours (PubMed=25984343); 1.6 +- 0.3 days (PubMed=29330294); 40-50 hours (Note=Lot 04152003), ~2 days (Note=Lot 02162009), ~42 hours (Note=Lot 04112012), ~74 hours (Note=Lot 05312016) (JCRB=JCRB0183).
CC   HLA typing: A*24:02,24:02; B*15:11,67:02; C*01:21,12:03; DRB1*13:26,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2166Gln (c.6497G>A); ClinVar=VCV000230267; Zygosity=Heterozygous (PubMed=25612765; PubMed=29444910; Cosmic-CLP=1298534; DepMap=ACH-000347).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=21607521; PubMed=25612765; PubMed=29444910; Cosmic-CLP=1298534; DepMap=ACH-000347).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leufs*25 (c.293delC); Zygosity=Heterozygous (PubMed=25612765; PubMed=29444910; Cosmic-CLP=1298534; DepMap=ACH-000347).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=82.5%; East Asian, South=17.02%; South Asian=0.48%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Misspelling: QGP; CGH-DB=9375-4; GEO=GSM600373.
CC   Misspelling: QCP-1; DOI=10.5772/30884.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic delta cell; CL=CL_0000173.
ST   Source(s): Cosmic-CLP=1298534; JCRB=JCRB0183; PubMed=25877200; PubMed=29444910
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 10,12 (Cosmic-CLP=1298534; JCRB=JCRB0183; PubMed=29444910)
ST   D16S539: 12 (PubMed=25877200)
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 5,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17,18 (JCRB=JCRB0183)
ST   vWA: 14,18 (Cosmic-CLP=1298534; PubMed=25877200; PubMed=29444910)
DI   NCIt; C95595; Pancreatic somatostatinoma
DI   ORDO; Orphanet_97283; Somatostatinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   QGY-7701
AC   CVCL_6859
SY   QGY 7701; QGY7701
DR   GEO; GSM936774
DR   GEO; GSM1374838
DR   Wikidata; Q54948823
RX   PubMed=18579001;
RX   PubMed=23505090;
RX   PubMed=28807831;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00551.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000700042). It was the sole source for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   QGY-7703
AC   CVCL_6715
SY   QGY7703; QGY
DR   BTO; BTO_0005721
DR   ChEMBL-Cells; CHEMBL4295478
DR   ChEMBL-Targets; CHEMBL4296490
DR   GEO; GSM936775
DR   GEO; GSM1374839
DR   PubChem_Cell_line; CVCL_6715
DR   Wikidata; Q54948825
RX   CelloPub=CLPUB00100;
RX   PubMed=6280941;
RX   PubMed=10567879;
RX   PubMed=19139770;
RX   PubMed=23505090;
RX   PubMed=28807831;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=28807831). Originally thought to originate from a 35 year old female patient with hepatocellular carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00552.
CC   Population: African American.
CC   Doubling time: 20.5 hours (PubMed=6280941); 36.3 +- 1.5 hours (PubMed=19139770).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000700043). It was the sole source for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   QGY-8105
AC   CVCL_M346
DR   Wikidata; Q54948827
RX   PubMed=1849045;
CC   Population: Chinese.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   QGY/cDDP
AC   CVCL_M360
SY   QGY/CDDP
DR   Wikidata; Q54948828
RX   PubMed=12478896;
RX   PubMed=19139770;
CC   Problematic cell line: Contaminated. Parent cell line (QGY-7703) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 45.7 +- 1.7 hours (PubMed=19139770).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6715 ! QGY-7703
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   QHJI01s01
AC   CVCL_C1E0
SY   QHJI 01s01
DR   Wikidata; Q114312750
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/QHJI01s01_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   QHJI01s04
AC   CVCL_C1E1
SY   QHJI 01s04
DR   Wikidata; Q114312751
RX   PubMed=31497180;
RX   PubMed=32668747;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/QHJI01s01_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; C*12:01; DPB1*:09:01; DQB1*:06:01; DRB1*15:02 (PubMed=32668747).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   QHJI14s03
AC   CVCL_C1E2
SY   QHJI 14s03
DR   Wikidata; Q114312752
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/QHJI14s03_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1DN ! QHJI14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   QHJI14s04
AC   CVCL_C1DN
SY   QHJI 14s04
DR   Wikidata; Q114312753
RX   PubMed=31497180;
RX   PubMed=35304548;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/QHJI14s04_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   QianhefenA26
AC   CVCL_M632
DR   IPD-IMGT/HLA; 16442
DR   Wikidata; Q54948829
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,26:01:08; B*15:01,46:01; C*01:02,03:03; DQB1*03:03,06:02; DRB1*09:01,15:01 (IPD-IMGT/HLA=16442).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   QIMR-AMB
AC   CVCL_M651
SY   QIMR-AMB-BL
DR   Wikidata; Q54948830
RX   PubMed=2824665;
RX   PubMed=5649156;
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   QIMR-AMB/1
AC   CVCL_M649
SY   AMB/1
DR   Wikidata; Q54948831
RX   PubMed=5248028;
RX   PubMed=5649156;
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M651 ! QIMR-AMB
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   QIMR-AMB/2
AC   CVCL_M650
SY   AMB/2
DR   Wikidata; Q54948832
RX   PubMed=5248028;
RX   PubMed=5649156;
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M651 ! QIMR-AMB
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   QIMR-BAH1
AC   CVCL_VS43
SY   BAH1; QIMR-B001
DR   cancercelllines; CVCL_VS43
DR   GEO; GSM3347669
DR   Wikidata; Q98128760
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 79.5 +- 3.3 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val133Ile (c.397G>A); ClinVar=VCV000971265; Zygosity=Hemizygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 9,11
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-DAR
AC   CVCL_W749
SY   DAR
DR   Wikidata; Q54948833
RX   PubMed=5248028;
RX   PubMed=6074953;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   QIMR-FIN
AC   CVCL_W752
SY   FIN
DR   Wikidata; Q54948834
RX   PubMed=5246694;
RX   PubMed=5248028;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   QIMR-FPW1
AC   CVCL_VS44
SY   FPW1; QIMR-B002
DR   cancercelllines; CVCL_VS44
DR   GEO; GSM3347670
DR   Wikidata; Q98128761
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 48.1 +- 4.7 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gln (c.389G>A); ClinVar=VCV000007829; Zygosity=Homozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D21S11: 27,30
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-GOE
AC   CVCL_W750
SY   GOE
DR   Wikidata; Q54948835
RX   PubMed=5248028;
RX   PubMed=6074953;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   QIMR-GOR
AC   CVCL_M648
SY   QIMR-GOR-BL; GOR
DR   Wikidata; Q54948836
RX   PubMed=2824665;
RX   PubMed=4894385;
RX   PubMed=5248028;
RX   PubMed=6066443;
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 16
//
ID   QIMR-HW1
AC   CVCL_VS45
SY   HW1; QIMR-B003
DR   cancercelllines; CVCL_VS45
DR   GEO; GSM3347671
DR   Wikidata; Q98128762
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 55.8 +- 2.7 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ala289Val (c.866C>T); ClinVar=VCV000376209; Zygosity=Heterozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right fronto-parietal lobe.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-JK2
AC   CVCL_VS46
SY   JK2; QIMR-B004
DR   cancercelllines; CVCL_VS46
DR   GEO; GSM3347672
DR   Wikidata; Q98128763
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 94.2 +- 6.0 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 28
ST   D5S818: 10,11
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-MMK1
AC   CVCL_VS47
SY   MMK1; QIMR-B005
DR   cancercelllines; CVCL_VS47
DR   GEO; GSM3347673
DR   Wikidata; Q98128764
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 52.4 +- 4.5 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Tyr183Cys (c.548A>G); ClinVar=VCV000134517; Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Phe56Val (c.166T>G); ClinVar=VCV000924880; Zygosity=Homozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D21S11: 27,33.2
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-MN1
AC   CVCL_VS48
SY   MN1; QIMR-B006
DR   GEO; GSM3347674
DR   Wikidata; Q98128765
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 44.9 +- 1.0 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D21S11: 29,31.2
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   QIMR-PB1
AC   CVCL_VS49
SY   PB1; QIMR-B007
DR   cancercelllines; CVCL_VS49
DR   GEO; GSM3347675
DR   Wikidata; Q98128766
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 79.4 +- 6.3 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Ter (c.388C>T); ClinVar=VCV000007819; Zygosity=Homozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   QIMR-RKI1
AC   CVCL_VS50
SY   RKI1; QIMR-B008
DR   cancercelllines; CVCL_VS50
DR   GEO; GSM3347676
DR   Wikidata; Q98128767
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 72.9 +- 5.3 hours (PubMed=30894629).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D21S11: 29,33.2
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-RN1
AC   CVCL_VS51
SY   RN1; QIMR-B009
DR   cancercelllines; CVCL_VS51
DR   GEO; GSM3347677
DR   Wikidata; Q98128768
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 37.5 +- 1.9 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Thr992Ile (c.2975C>T) (p.Thr1010Ile, c.3029C>T); ClinVar=VCV000041624; Zygosity=Heterozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-SB2b
AC   CVCL_VS52
SY   SB2b; QIMR-B010
DR   cancercelllines; CVCL_VS52
DR   GEO; GSM3347678
DR   Wikidata; Q98128769
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/commercial-collaborations/partner-with-us/q-cell/
CC   Doubling time: 108.7 +- 6.9 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ala289Val (c.866C>T); ClinVar=VCV000376209; Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.His304Tyr (c.910C>T); Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:6973; MDM2; Simple; p.Trp329Cys (c.987G>T); Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Cys800Phe (c.2399G>T) (p.Cys818Phe, c.2453G>T); ClinVar=VCV000648391; Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Tyr1021His (c.3061T>C); ClinVar=VCV001691391; Zygosity=Heterozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 28,32
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   QIMR-SJH1
AC   CVCL_VS53
SY   SJH1; QIMR-B011
DR   cancercelllines; CVCL_VS53
DR   GEO; GSM3347679
DR   Wikidata; Q98128770
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/our-research/commercialisation/q-cell/
CC   Doubling time: 67.3 +- 4.7 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.His289Arg (c.866A>G); ClinVar=VCV000664840; Zygosity=Heterozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly105Cys (c.313G>T); ClinVar=VCV001802439; Zygosity=Homozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-STE
AC   CVCL_W751
SY   STE
DR   Wikidata; Q54948837
RX   PubMed=5248028;
RX   PubMed=6074953;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   QIMR-WIL
AC   CVCL_1645
SY   QIMRWIL; WIL
DR   CLO; CLO_0008680
DR   CLDB; cl4042
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1645
DR   Cell_Model_Passport; SIDM00467
DR   ChEMBL-Cells; CHEMBL3308301
DR   ChEMBL-Targets; CHEMBL2366337
DR   Cosmic; 910545
DR   Cosmic; 2131557
DR   Cosmic-CLP; 910545
DR   DepMap; ACH-002299
DR   ECACC; 86030601
DR   EGA; EGAS00001000978
DR   GDSC; 910545
DR   GEO; GSM1670356
DR   IARC_TP53; 21280
DR   LINCS_LDP; LCL-1075
DR   PharmacoDB; QIMRWIL_1281_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1645
DR   Wikidata; Q54948838
RX   PubMed=4894385;
RX   PubMed=5246694;
RX   PubMed=5248028;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0.26%; European, North=70.81%; European, South=28.92% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=910545
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   QIMR-WK1
AC   CVCL_VS54
SY   WK1; QIMR-B012
DR   cancercelllines; CVCL_VS54
DR   GEO; GSM3347680
DR   Wikidata; Q98128771
RX   PubMed=30894629;
RX   PubMed=31965010;
WW   Provider; Qcell; -; https://www.qimrberghofer.edu.au/our-research/commercialisation/q-cell/
CC   Doubling time: 46.2 +- 1.0 hours (PubMed=30894629).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (QCell).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (QCell).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Tyr (c.3139C>T); ClinVar=VCV000039705; Zygosity=Heterozygous (QCell).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
ST   Source(s): PubMed=30894629
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D21S11: 27,28
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   QIMR-WW1-BL
AC   CVCL_W779
SY   QIMR-W1-BL; Wew 1; WW1-BL; WW-1-BL; WW1 BL
DR   Cosmic; 931135
DR   Wikidata; Q54948839
RX   PubMed=2824665;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=3037521;
RX   PubMed=7601573;
RX   PubMed=9473234;
CC   Population: Papuan.
CC   HLA typing: A*11,24; B*27,62 (PubMed=3037521).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W930 ! QIMR-WW1-LCL
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 9
//
ID   QIMR-WW1-LCL
AC   CVCL_W930
SY   WW1-LCL; WW1 LCL; WW-1-LCL
DR   Wikidata; Q54948841
RX   PubMed=2898508;
RX   PubMed=3037521;
RX   PubMed=7601573;
CC   Population: Papuan.
CC   HLA typing: A*11,24; B*27,62 (PubMed=3037521).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Could be identical to WeWak1 (Cellosaurus=CVCL_E871).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W779 ! QIMR-WW1-BL
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   QIMR-WW2-BL
AC   CVCL_W780
SY   QIMR-W2-BL; Wew 2; WW2-BL; WW2 BL
DR   Cosmic; 931157
DR   Wikidata; Q54948842
RX   PubMed=2824665;
RX   PubMed=2898508;
RX   PubMed=2985508;
RX   PubMed=7601573;
RX   PubMed=9473234;
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W932 ! QIMR-WW2-LCL
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 02-05-24; Version: 8
//
ID   QIMR-WW2-LCL
AC   CVCL_W932
SY   WW2-LCL; WW2 LCL
DR   Wikidata; Q54948843
RX   PubMed=2898508;
RX   PubMed=7601573;
CC   Population: Papuan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W780 ! QIMR-WW2-BL
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   QK2.K
AC   CVCL_S329
DR   ATCC; CRL-6559
DR   Wikidata; Q54948844
CC   Group: Marsupial cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6559; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=30670; ! Setonix brachyurus (Quokka)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   QM5
AC   CVCL_M211
SY   Quail Muscle Clone 5
DR   Wikidata; Q54948845
RX   PubMed=1985013;
RX   PubMed=19653212;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_3451 ! QT6
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   QM7
AC   CVCL_3450
SY   QM-7; Quail Muscle clone 7
DR   CLO; CLO_0008681
DR   ATCC; CRL-1962
DR   CCLV; CCLV-RIE 0466
DR   Wikidata; Q54948846
RX   PubMed=1985013;
RX   PubMed=1985014;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_3451 ! QT6
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   QM9
AC   CVCL_0I49
SY   QM-9
DR   CCLV; CCLV-RIE 0999
DR   Wikidata; Q54948847
RX   PubMed=19941903;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_3450 ! QM7
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   QMMuC-1
AC   CVCL_UW39
SY   QMMuC1; Queen's university Murine Muller glia Clone-1
DR   Wikidata; Q98128772
RX   PubMed=29625493;
CC   Characteristics: Morphology and phenotype are similar to those of primary Muller glial cultures (PubMed=29625493).
CC   Doubling time: 27.63 hours (PubMed=29625493).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 7
//
ID   QN10S
AC   CVCL_UG18
SY   S+L- AH927
DR   Wikidata; Q98128773
RX   PubMed=8825325;
RX   PubMed=19122411;
RX   PubMed=21029758;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_UG12 ! AH927
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   QNR ts NY-68
AC   CVCL_JF56
DR   Wikidata; Q54948848
RX   PubMed=6300691;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin) (Note=tsNY68).
CC   Derived from site: In situ; Embryonic eye, retina, neuroretina; UBERON=UBERON_0005425.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   7FD
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 10
//
ID   QNR/D
AC   CVCL_3779
DR   CLO; CLO_0008682
DR   ATCC; CRL-2532
DR   Wikidata; Q54948849
RX   PubMed=6300691;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin) (Note=tsNY68).
CC   Derived from site: In situ; Embryonic eye, retina, neuroretina; UBERON=UBERON_0005425.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_JF56 ! QNR ts NY-68
SX   Sex unspecified
AG   7FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   QNR/K2
AC   CVCL_3780
DR   CLO; CLO_0008683
DR   ATCC; CRL-2533
DR   BCRC; 60493
DR   Wikidata; Q54948850
RX   PubMed=6313126;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin) (Note=tsNY68).
CC   Derived from site: In situ; Embryonic eye, retina, neuroretina; UBERON=UBERON_0005425.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_JF56 ! QNR ts NY-68
SX   Sex unspecified
AG   7FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   QOR/2E11
AC   CVCL_1K18
DR   Wikidata; Q54948851
RX   PubMed=22373530;
RX   PubMed=25903999;
CC   Group: Bird cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9014; ! Colinus virginianus (Northern bobwhite)
HI   CVCL_B7FX ! QOR2-sf
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   QOR1 CJ07-18/1/F6
AC   CVCL_B7FY
SY   QOR1 CJ07
DR   Wikidata; Q114312754
RX   Patent=US9388380;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08020603.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9014; ! Colinus virginianus (Northern bobwhite)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   QOR2-sf
AC   CVCL_B7FX
SY   QOR2-SF (RE017169); QOR/RE07-169
DR   Wikidata; Q114312755
RX   Patent=US9388380;
RX   PubMed=22373530;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08020602.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9014; ! Colinus virginianus (Northern bobwhite)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   QPCEF
AC   CVCL_IS32
SY   Qingyuan Partridge Chicken Embryonic Fibroblasts
DR   Wikidata; Q54948852
RX   PubMed=20460668;
CC   Group: Bird cell line.
CC   Doubling time: ~72 hours (PubMed=20460668).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Qingyuan partridge; VBO=VBO_0006742.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Mixed sex
AG   8FD
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   QPN1 12C9
AC   CVCL_G203
SY   QPN1 12C9 (SCRF 43.2); SCRF 43.2
DR   CLO; CLO_0008685
DR   ATCC; HB-9500
DR   Wikidata; Q54948854
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9500.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   QPN1 13E10
AC   CVCL_L677
DR   ATCC; HB-9503
DR   Wikidata; Q54948855
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9503.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   QPN1 17G8
AC   CVCL_L678
DR   ATCC; HB-9504
DR   Wikidata; Q54948856
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9504.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   QPN1 21G2
AC   CVCL_L679
DR   ATCC; HB-9507
DR   Wikidata; Q54948864
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9507.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   QPN1 22F5
AC   CVCL_G204
SY   QPN1 22F5 (SCRF 43.2); SCRF 43.2
DR   CLO; CLO_0008686
DR   ATCC; HB-9509
DR   Wikidata; Q54948865
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9509.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   QPN1 37G2
AC   CVCL_L680
DR   ATCC; HB-9508
DR   Wikidata; Q54948867
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9508.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   QPN1 44A2
AC   CVCL_L681
DR   ATCC; HB-9501
DR   Wikidata; Q54948868
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9501.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   QPN1 7E5
AC   CVCL_L682
DR   ATCC; HB-9502
DR   Wikidata; Q54948870
RX   Patent=US5126258;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9502.
CC   Characteristics: Produces a catalytic monoclonal antibody.
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   QQ-2A10-A5
AC   CVCL_C8I9
DR   Wikidata; Q123033300
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   QQ-4A3-A1
AC   CVCL_C8IA
DR   Wikidata; Q123033301
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   QQ-4G9-A6
AC   CVCL_C8IB
DR   Wikidata; Q123033302
RX   PubMed=23081796;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q8WTV0; Human SCARB1/CD36.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   QQ0010
AC   CVCL_8Y29
DR   ECACC; 89022807
DR   Wikidata; Q54948871
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0082
AC   CVCL_8Y30
DR   ECACC; 90030707
DR   Wikidata; Q54948872
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY; 46,XY,t(2;4)(2qter->2p15::4p12->4pter;4qter->4p12::2p16.2->2pter) (ECACC=90030707).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0083
AC   CVCL_8Y31
DR   ECACC; 90031204
DR   Wikidata; Q54948873
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(3;6)(p21;p21) (ECACC=90031204).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75019; Sotos syndrome
DI   ORDO; Orphanet_821; Sotos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0106
AC   CVCL_8Y32
DR   ECACC; 90100407
DR   Wikidata; Q54948875
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 90100407; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0112
AC   CVCL_8Y33
DR   ECACC; 90110910
DR   Wikidata; Q54948876
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0113
AC   CVCL_8Y34
DR   ECACC; 90110911
DR   Wikidata; Q54948877
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0167
AC   CVCL_8Y35
DR   ECACC; 91030804
DR   Wikidata; Q54948878
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0233
AC   CVCL_8Y36
DR   ECACC; 91032008
DR   Wikidata; Q54948879
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(X)(Xpter->Xq21::Xq22->Xqter?) (ECACC=91032008).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032008; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0234
AC   CVCL_8Y37
DR   ECACC; 91032009
DR   Wikidata; Q54948880
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(X)(Xpter->Xq21::Xq22->Xqter) (ECACC=91032009).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y11M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0249
AC   CVCL_8Y38
DR   ECACC; 91032614
DR   Wikidata; Q54948881
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0253
AC   CVCL_8Y39
DR   ECACC; 91041209
DR   Wikidata; Q54948882
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(X)(Xpter->Xq21.1::Xq21.3->Xqter) (ECACC=91041209).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91041209; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0270
AC   CVCL_8Y40
DR   ECACC; 91042401
DR   Wikidata; Q54948883
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,del(X)(Xpter->Xq21.1::Xq21.3->Xqter) (ECACC=91042401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91042401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0271
AC   CVCL_8Y41
DR   ECACC; 91042402
DR   Wikidata; Q54948884
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,delXY,der(Xpter->Xq21.1::Xq21.3->Xqter) (ECACC=91042402).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34469; Choroideremia
DI   ORDO; Orphanet_180; Choroideremia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0286
AC   CVCL_8Y42
DR   ECACC; 91050329
DR   Wikidata; Q54948886
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,inv(5)(q15;q32) (ECACC=91050329).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050329; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0287
AC   CVCL_8Y43
DR   ECACC; 91050330
DR   Wikidata; Q54948887
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91050330; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   QQ0296
AC   CVCL_8Y44
DR   ECACC; 91052004
DR   Wikidata; Q54948888
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052004; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   QQ0297
AC   CVCL_8Y45
DR   ECACC; 91052005
DR   Wikidata; Q54948890
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0298
AC   CVCL_8Y46
DR   ECACC; 91052006
DR   Wikidata; Q54948891
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052006; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0299
AC   CVCL_8Y47
DR   ECACC; 91052007
DR   Wikidata; Q54948892
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   QQ0300
AC   CVCL_8Y48
DR   ECACC; 91052008
DR   Wikidata; Q54948893
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   QQ0322
AC   CVCL_8Y49
DR   ECACC; 91052903
DR   Wikidata; Q54948894
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,X,i(X) (ECACC=91052903).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91052903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0373
AC   CVCL_8Y50
DR   ECACC; 91080901
DR   Wikidata; Q54948895
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,dir dup (17)(p11.2->p12) (ECACC=91080901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0377
AC   CVCL_8Y51
DR   ECACC; 91091308
DR   Wikidata; Q54948896
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(4:11)(q35;q23.3) (ECACC=91091308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91091308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0422
AC   CVCL_8Y52
DR   ECACC; 92021001
DR   Wikidata; Q54948897
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(4)(q13.1;q21.2) (ECACC=92021001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0444
AC   CVCL_8Y53
DR   ECACC; 92030308
DR   Wikidata; Q54948898
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XY,t(4;16)(q22;q23) (ECACC=92030308).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92030308; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0445
AC   CVCL_8Y54
DR   ECACC; 92030422
DR   Wikidata; Q54948899
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,-1,+der(1),t(1;4)(p36.3;q28.2) (ECACC=92030422).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0456
AC   CVCL_8Y55
DR   ECACC; 92031018
DR   Wikidata; Q54948900
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(2;4)(p13;q35) (ECACC=92031018).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0468
AC   CVCL_8Y56
DR   ECACC; 92051505
DR   Wikidata; Q54948901
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(4)(q31.3->q33) (ECACC=92051505).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0470
AC   CVCL_8Y57
DR   ECACC; 92060416
DR   Wikidata; Q54948902
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,t(9;15)(q32;q21.2) (ECACC=92060416).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125598; Spondylocostal dysostosis
DI   ORDO; Orphanet_2311; Autosomal recessive spondylocostal dysostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0483
AC   CVCL_8Y58
DR   ECACC; 92080503
DR   Wikidata; Q54948903
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(4)(q33;q35.1) (ECACC=92080503).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 92080503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0484
AC   CVCL_8Y59
DR   ECACC; 92081202
DR   Wikidata; Q54948904
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,del(4)t(3:4)(p22;q35)pat (ECACC=92081202).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0486
AC   CVCL_8Y60
DR   ECACC; 92082715
DR   Wikidata; Q54948905
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,?ins(p15.1;q11.21;q11.23)?del(7)(q21.3) (ECACC=92082715).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0520
AC   CVCL_8Y61
DR   ECACC; 93010401
DR   Wikidata; Q54948906
CC   Part of: ECACC chromosomal abnormality collection.
CC   Karyotypic information: 46,XX,ins(4;11;16;18) (ECACC=93010401).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0525
AC   CVCL_8Y62
DR   ECACC; 93021834
DR   Wikidata; Q54948907
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93021834; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0526
AC   CVCL_8Y63
DR   ECACC; 93021835
DR   Wikidata; Q54948909
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0527
AC   CVCL_8Y64
DR   ECACC; 93030573
DR   Wikidata; Q54948922
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93030573; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y2M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   QQ0528
AC   CVCL_8Y65
DR   ECACC; 93030574
DR   Wikidata; Q54948924
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 93030574; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   QQ0588
AC   CVCL_8Y66
DR   ECACC; 94060108
DR   Wikidata; Q54948925
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y3M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QQ0592
AC   CVCL_8Y67
DR   ECACC; 94061504
DR   Wikidata; Q54948927
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y9M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0594
AC   CVCL_8Y68
DR   ECACC; 94062007
DR   Wikidata; Q54948928
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,r(14) (ECACC=94062007).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
DI   NCIt; C185638; Ring chromosome 14 syndrome
DI   ORDO; Orphanet_1440; Ring chromosome 14 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   QQ0598
AC   CVCL_8Y69
DR   ECACC; 94072924
DR   Wikidata; Q54948929
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,4q+ (ECACC=94072924).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 8
//
ID   QQ0611
AC   CVCL_8Y70
DR   ECACC; 95012611
DR   Wikidata; Q54948930
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95012611; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0612
AC   CVCL_8Y71
DR   ECACC; 95012612
DR   Wikidata; Q54948931
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95012612; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0613
AC   CVCL_8Y72
DR   ECACC; 95031001
DR   Wikidata; Q54948932
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,-7,+der(7)ins(7;?)(q31.2;?) (ECACC=95031001).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0661
AC   CVCL_8Y73
DR   ECACC; 96012101
DR   Wikidata; Q54948933
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,del(11)(p13:p14.3) (ECACC=96012101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y10M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   QQ0662
AC   CVCL_8Y74
DR   ECACC; 96012102
DR   Wikidata; Q54948934
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96012102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0663
AC   CVCL_8Y75
DR   ECACC; 96012103
DR   Wikidata; Q54948935
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 96012103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y7M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   QQ0703
AC   CVCL_8Y76
DR   ECACC; 97052902
DR   Wikidata; Q54948936
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,(6;9)(p21;q21.2); de novo (ECACC=97052902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y1M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   QQ0706
AC   CVCL_8Y77
DR   ECACC; 98013011
DR   Wikidata; Q54948937
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,t(9;18)(q32;q21.3) (ECACC=98013011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125487; Opitz G/BBB syndrome
DI   ORDO; Orphanet_2745; Opitz G/BBB syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   QSG-7701
AC   CVCL_6944
SY   QSG7701
DR   TOKU-E; 4021
DR   Wikidata; Q54948938
RX   CelloPub=CLPUB00100;
RX   PubMed=20564214;
RX   PubMed=26116706;
RX   PubMed=28807831;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from an immortalized but non-transformed hepatocytes from a 35 year old female.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00553.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3131C0001000200007). It was one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,8,17
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   QT-1-TC
AC   CVCL_G370
SY   QT-1
DR   TKG; TKG 0086
DR   TKG; TKG 0653
DR   Wikidata; Q54948939
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   QT2
AC   CVCL_T464
SY   CHQC-QT2; Quail Tumor 2
DR   Wikidata; Q54948940
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT24
AC   CVCL_T468
SY   CHQC-QT24; Quail Tumor 24
DR   Wikidata; Q54948941
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT27
AC   CVCL_T469
SY   CHQC-QT27; Quail Tumor 27
DR   Wikidata; Q54948942
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT29
AC   CVCL_T470
SY   CHQC-QT29; Quail Tumor 29
DR   Wikidata; Q54948944
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT35
AC   CVCL_4280
SY   QT-35; QT 35; CHQC-QT35; Quail Tumor 35
DR   CLO; CLO_0008687
DR   CLDB; cl4043
DR   CLDB; cl4044
DR   ECACC; 93120832
DR   IZSLER; BS TCL 53
DR   Wikidata; Q54948945
RX   PubMed=194709;
RX   PubMed=6303292;
RX   PubMed=11879695;
RX   PubMed=14535544;
RX   PubMed=18766641;
RX   PubMed=32005267;
RX   PubMed=34737324;
CC   Group: Bird cell line.
CC   Virology: Susceptible to infection by aquatic bird bornavirus 1 (ABBV-1) strain UoG-CG (PubMed=32005267).
CC   Virology: When inoculated with avian reticuloendotheliosis viruses develops distinctive focal cytopathic effects (focus formation) followed by cytonecrosis (PubMed=6303292).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   QT4
AC   CVCL_T465
SY   CHQC-QT4; Quail Tumor 4
DR   Wikidata; Q54948946
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT46
AC   CVCL_T471
SY   CHQC-QT46; Quail Tumor 46
DR   Wikidata; Q54948947
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT5
AC   CVCL_T466
SY   CHQC-QT5; Quail Tumor 5
DR   Wikidata; Q54948948
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT51
AC   CVCL_T472
SY   CHQC-QT51; Quail Tumor 51
DR   Wikidata; Q54948949
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT53
AC   CVCL_T473
SY   CHQC-QT53; Quail Tumor 53
DR   Wikidata; Q54948950
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT54
AC   CVCL_T474
SY   CHQC-QT54; Quail Tumor 54
DR   Wikidata; Q54948951
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   QT6
AC   CVCL_3451
SY   QT-6; QT 6; CHQC-QT6; Quail Tumor 6
DR   CLO; CLO_0008688
DR   EFO; EFO_0022743
DR   CLDB; cl4045
DR   CLDB; cl4046
DR   ATCC; CRL-1708
DR   ECACC; 93120831
DR   IZSLER; BS TCL 52
DR   TOKU-E; 2933
DR   Wikidata; Q54948952
RX   PubMed=194709;
RX   PubMed=18638503;
RX   PubMed=18766641;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/q/cell-lines-detail-98.html
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   QT7
AC   CVCL_T467
SY   CHQC-QT7; Quail Tumor 7
DR   Wikidata; Q54948953
RX   PubMed=194709;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   QTTK-
AC   CVCL_X196
DR   Wikidata; Q54948954
RX   PubMed=1832032;
CC   Group: Bird cell line.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_4280 ! QT35
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   QU-DB
AC   CVCL_U106
DR   NCBI_Iran; C565
DR   Wikidata; Q54948955
RX   PubMed=3719556;
RX   PubMed=7736387;
RX   PubMed=10100721;
CC   Doubling time: 10-12 hours (PubMed=3719556).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   Quad-GL261
AC   CVCL_A5EJ
SY   GL261-Quad; GL261-QUAD; GL261-OVA
DR   Wikidata; Q107116683
RX   PubMed=23248259;
RX   PubMed=23686484;
RX   PubMed=24878890;
CC   Characteristics: Transfected with the Quad Ag cassette encoding four peptides presented by H-2b class I or II molecules as a single coding sequence. The peptides are human PMEL/gp100 AA 25-33 (presented by H-2Db), chicken OVA epitope OT-I (AA 258-265; presented by H-2Kb), chicken OVA epitope OT-II (AA 324-340; presented by I-Ab) and mouse H2-Ea/I-Ea AA 77-93(52-68) (presented by I-Ab). To facilitate processing, each peptide is flanked on both sides by the 6 amino acid residues that surrounded the peptide in the corresponding native protein.
CC   Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14 (Note=With p.Met1_Ser251del, p.Asn272_Ser317del and p.Glu347_Pro386del).
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10880; PMEL (Note=With p.Met1_Leu18del and p.Arg40_Val661del).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95900; H2-Ea (Note=With p.Met1_Leu70del and p.Glu100_Leu255del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   QV-6A8-F2-C4
AC   CVCL_C8I0
DR   Wikidata; Q123033303
RX   PubMed=23704981;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60033; Human CD81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   QZG
AC   CVCL_A5VN
DR   BTO; BTO_0004884
DR   Wikidata; Q107116684
RX   PubMed=11819822;
RX   PubMed=12717835;
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Undefined cell line type
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   R-1
AC   CVCL_VH07
DR   Wikidata; Q54948956
RX   DOI=10.1093/oxfordjournals.jjco.a038751;
CC   Doubling time: ~15 hours (DOI=10.1093/oxfordjournals.jjco.a038751).
CC   Transformant: ChEBI; CHEBI_140674; N-methyl-N-pentylnitrosamine (N-amyl-N-methylnitrosamine; AMN).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C63892; Squamous cell carcinoma of the rat esophagus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   R-1-TC
AC   CVCL_BW62
SY   R-1
DR   TKG; TKG 0134
DR   TKG; TKG 0691
DR   Wikidata; Q54948957
RX   PubMed=220752;
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 5
//
ID   R-2
AC   CVCL_VH08
DR   Wikidata; Q54948958
RX   DOI=10.1093/oxfordjournals.jjco.a038751;
CC   Doubling time: ~16 hours (DOI=10.1093/oxfordjournals.jjco.a038751).
CC   Transformant: ChEBI; CHEBI_140674; N-methyl-N-pentylnitrosamine (N-amyl-N-methylnitrosamine; AMN).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C63892; Squamous cell carcinoma of the rat esophagus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   R-3
AC   CVCL_VH09
DR   TKG; TKG 0731
DR   Wikidata; Q54948959
RX   DOI=10.1093/oxfordjournals.jjco.a038751;
CC   Doubling time: ~21 hours (DOI=10.1093/oxfordjournals.jjco.a038751).
CC   Transformant: ChEBI; CHEBI_140674; N-methyl-N-pentylnitrosamine (N-amyl-N-methylnitrosamine; AMN).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C63892; Squamous cell carcinoma of the rat esophagus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   R-3327-AT-1
AC   CVCL_3568
AS   CVCL_L302
SY   AT-1; AT1; AT-1-TC; Dunning R-3327 AT-1; R3327-AT1
DR   CLO; CLO_0001757
DR   CLO; CLO_0008714
DR   CLDB; cl290
DR   ATCC; JHU-29
DR   CancerTools; 156406
DR   CLS; 500121
DR   ECACC; 94101449
DR   TKG; TKG 0118
DR   TKG; TKG 0474
DR   Wikidata; Q54948960
RX   PubMed=3174494;
RX   PubMed=3774632;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/5871-R-3327-AT-1-Rat-Prostatic-Cancer-Cell-Line.html
CC   Discontinued: ATCC; JHU-29; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   R-3327-AT-2
AC   CVCL_L303
SY   R3327-AT-2; R-3327 AT.2; AT-2; AT2; AT-2-TC; Dunning R3327-AT2
DR   CancerTools; 156411
DR   TKG; TKG 0119
DR   TKG; TKG 0475
DR   Wikidata; Q54948962
DR   Ximbio; 156411
RX   PubMed=3174494;
RX   PubMed=3774632;
RX   PubMed=7910810;
RX   PubMed=23467722;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 10
//
ID   R-3327-AT-2.1
AC   CVCL_3569
AS   CVCL_L304
SY   AT-2.1; AT2.1; Dunning AT2.1
DR   CLO; CLO_0001758
DR   CLO; CLO_0008715
DR   ATCC; JHU-30
DR   ECACC; 94101450
DR   KCLB; 60050
DR   Wikidata; Q54948963
RX   PubMed=2065333;
RX   PubMed=3174494;
CC   Discontinued: ATCC; JHU-30; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L303 ! R-3327-AT-2
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   R-3327-AT-3
AC   CVCL_0146
AS   CVCL_M054
SY   R3327 AT-3; AT-3; AT3; AT-3-TC; Dunning R3327 AT-3
DR   MCCL; MCC:0000039
DR   TKG; TKG 0120
DR   Wikidata; Q54948964
RX   PubMed=3174494;
RX   PubMed=3774632;
RX   PubMed=7910810;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   R-3327-AT-3.1
AC   CVCL_3570
AS   CVCL_M055
SY   R-3327-3.1; AT-3.1; AT3.1; Dunning AT3.1
DR   CLO; CLO_0001759
DR   CLO; CLO_0008716
DR   CLDB; cl291
DR   ATCC; JHU-31
DR   CancerTools; 156407
DR   ECACC; 94101451
DR   KCLB; 60051
DR   Wikidata; Q54948965
RX   PubMed=1596907;
RX   PubMed=2065333;
CC   Discontinued: ATCC; JHU-31; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0146 ! R-3327-AT-3
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   R-3327-AT-4
AC   CVCL_Y660
SY   AT-4; AT4
DR   Wikidata; Q54948970
RX   PubMed=3174494;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   R-3327-AT-5
AC   CVCL_Y661
SY   AT-5; AT5
DR   Wikidata; Q54948971
RX   PubMed=3174494;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   R-3327-AT-6.1
AC   CVCL_4030
SY   R-3327-AT6.1; AT-6.1; AT6.1
DR   BTO; BTO_0004587
DR   CLO; CLO_0001761
DR   CLDB; cl292
DR   CancerTools; 156405
DR   ECACC; 94101452
DR   Wikidata; Q54948972
RX   PubMed=1596907;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   R-3327-G
AC   CVCL_3572
SY   R-3327 G; R3327-G; R3327G; Du-G; G
DR   CLO; CLO_0003413
DR   CLO; CLO_0008717
DR   CLDB; cl1403
DR   ATCC; JHU-3
DR   CancerTools; 156408
DR   ECACC; 94101453
DR   Wikidata; Q54948973
RX   PubMed=3684786;
RX   PubMed=3774632;
CC   Discontinued: ATCC; JHU-3; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   R-3327-H
AC   CVCL_Y658
SY   R3327-H; R3327H; H
DR   Wikidata; Q54948974
RX   PubMed=3174494;
RX   PubMed=3774632;
CC   Miscellaneous: This is not a cell line but a xenograft, it is the parent tumor for many cell lines.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_3572 ! R-3327-G
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   R-3327-H-G8-A1
AC   CVCL_J423
SY   R3327H-G8-A1; R3327H-G8A1
DR   Wikidata; Q54948976
RX   PubMed=6299542;
RX   PubMed=6708513;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   R-7
AC   CVCL_B6YA
DR   Wikidata; Q112041634
RX   PubMed=37652434;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Vibrissa, skin, dermal papilla; UBERON=UBERON_0011933+UBERON_0000412.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
CC   Breed/subspecies: White Rex; VBO=VBO_0017529.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   4M
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   R.B
AC   CVCL_F580
SY   TER351; TER-351; Ter 351; TER405; TER-405; Ter 405; TER528; TER-528; Ter-528; Ter 528
DR   IPD-IMGT/HLA; 11283
DR   Wikidata; Q54948979
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/333cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX393report_Final.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*04:01,04:02; DQA1*03:01,04:01; DQB1*03:02,04:02; DRB1*04:01,13:17; DRB3*02:02; DRB4*01:03 (IPD-IMGT/HLA=11283).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   R.M.
AC   CVCL_C8G8
DR   Wikidata; Q123033305
RX   PubMed=4342611;
CC   Doubling time: 6 days (PubMed=4342611).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   R/3.2-L
AC   CVCL_V130
DR   CLO; CLO_0008695
DR   CLDB; cl4066
DR   IHW; 11w 8114
DR   Wikidata; Q54948977
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   R/ADR
AC   CVCL_UJ11
DR   cancercelllines; CVCL_UJ11
DR   Wikidata; Q98128774
RX   CelloPub=CLPUB00458;
RX   PubMed=8099376;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   r/mHM-SFME-1
AC   CVCL_A6JU
SY   r/mHM-1; HM-1
DR   RCB; RCB4592
DR   Wikidata; Q107116685
RX   DOI=10.1007/978-94-011-2044-9_3;
RX   PubMed=8376308;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Established after 7 passages of the original cell line into BALB/c mice.
CC   Characteristics: Spontaneously metastasize into the lungs of syngeneic mice when injected subcutaneously.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97250; Myc.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6JT ! ras/mycSFME
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   R/R1H-L
AC   CVCL_V131
DR   CLO; CLO_0008696
DR   CLDB; cl4067
DR   IHW; 11w 8102
DR   Wikidata; Q54948978
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   R/VP-16
AC   CVCL_UJ12
DR   cancercelllines; CVCL_UJ12
DR   Wikidata; Q98128775
RX   CelloPub=CLPUB00458;
RX   PubMed=8099376;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   r#101
AC   CVCL_C4CB
SY   rat_CD147_#101
DR   ABCD; ABCD_AR158
DR   Wikidata; Q116050134
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147 (Note=Also reacts with Macaca fascicularis).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   r#110
AC   CVCL_C4CC
SY   rat_CD147_#110
DR   ABCD; ABCD_AR159
DR   Wikidata; Q116050135
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147 (Note=Also reacts with Macaca fascicularis).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   r#131
AC   CVCL_C4CD
SY   rat_CD147_#131
DR   ABCD; ABCD_AR160
DR   Wikidata; Q116050136
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147 (Note=Also reacts with Macaca fascicularis).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   r#84
AC   CVCL_C4CE
SY   rat_CD147_#84
DR   ABCD; ABCD_AR157
DR   Wikidata; Q116050137
RX   Patent=US11459387;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P35613; Human BSG/CD147 (Note=Also reacts with Macaca fascicularis).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R05R
AC   CVCL_Z551
DR   Wikidata; Q54948980
RX   PubMed=19540275;
CC   Group: Bat cell line.
CC   Doubling time: ~6 days (PubMed=19540275).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1).
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
OI   CVCL_S504 ! R06E
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   R05T
AC   CVCL_S503
SY   R-05T
DR   BEI_Resources; NR-49169
DR   DSMZ; ACC-754
DR   DSMZCellDive; ACC-754
DR   Wikidata; Q54948981
RX   PubMed=19540275;
RX   PubMed=33389257;
CC   Group: Bat cell line.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: ~50 hours (PubMed=19540275; DSMZ=ACC-754).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1).
CC   Derived from site: In situ; Fetal head; UBERON=UBERON_0008816.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   R06E
AC   CVCL_S504
SY   R-06E; RO6E; AGE1.R06E; AGE1.RO
DR   BEI_Resources; NR-49168
DR   DSMZ; ACC-756
DR   DSMZCellDive; ACC-756
DR   Wikidata; Q54948982
RX   Patent=US8679839;
RX   PubMed=19540275;
RX   PubMed=20808767;
RX   PubMed=22754654;
RX   PubMed=33389257;
WW   Info; -; -; https://journals.plos.org/plosntds/article/comment?id=10.1371/annotation/6f6a0bf0-169c-4fd7-93e5-5f75fe8a28b8
WW   Provider; ProBioGen; -; https://www.probiogen.de/virus-production-cell-lines.html
CC   Group: Bat cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Partially contaminated. Some cultures of R06E are contaminated with the Vero cell line (PubMed=22754654), this is the case of the culture used in PubMed=20808767.
CC   From: ProBioGen AG; Berlin; Germany.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2902.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: ~50 hours (PubMed=19540275); ~40 hours (DSMZ=ACC-756).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1).
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
OI   CVCL_Z551 ! R05R
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   R1 [Mouse hybridoma against human INHA]
AC   CVCL_F0VV
RX   PubMed=1690174;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05111; Human INHA (Note=Immunized with AA 233-264. Also reacts with bovine and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   R1 [Mouse hybridoma against human HLA-DQA]
AC   CVCL_U055
SY   R1A1
DR   ECACC; 99043005
DR   Wikidata; Q54948983
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 5
//
ID   R1 [Oncorhynchus]
AC   CVCL_4607
DR   CLDB; cl4068
DR   DSMZ; ACC-56
DR   DSMZCellDive; ACC-56
DR   Wikidata; Q54948984
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=4024776;
RX   PubMed=28374170;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Oncorhynchus mykiss (trout) origin but found to be from Oncorhynchus tshawytscha (DSMZ=ACC-56).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00581.
CC   Doubling time: ~160 hours (DSMZ=ACC-56).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=74940; ! Oncorhynchus tshawytscha (Chinook salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   R1-2
AC   CVCL_9226
DR   CLO; CLO_0008701
DR   ATCC; HB-227
DR   Wikidata; Q54948986
RX   PubMed=2463092;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   R1-5D9
AC   CVCL_9227
SY   R1-5D9.1A8; 5D9
DR   CLO; CLO_0008704
DR   ATCC; CRL-2360
DR   Wikidata; Q54948987
RX   PubMed=8576576;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P43432; Mouse Il12b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   R1-Dnmt1WT-1
AC   CVCL_D0QI
SY   R1(Dnmt1WT-1)
DR   Wikidata; Q123033306
RX   PubMed=37320987;
CC   Characteristics: Expresses Dnmt1 at a level twice of that of the parent cell line. Transfected with a PGK1-DNMT1-IRES-Neo construct (PubMed=37320987).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94912; Dnmt1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   R1-hiPSC1
AC   CVCL_C888
SY   Royan hiPSC1; hiPSC1; R.1.H.iPSC.1; RIi001-A
DR   hPSCreg; RIi001-A
DR   RSCB; RSCB0042
DR   SKIP; SKIP002396
DR   SKIP; SKIP005820
DR   Wikidata; Q54948988
RX   PubMed=19876814;
RX   PubMed=21198400;
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   R1-hiPSC10
AC   CVCL_C889
SY   R.1.H.iPSC.10
DR   RSCB; RSCB0088
DR   Wikidata; Q54948989
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC11
AC   CVCL_C890
SY   R.1.H.iPSC.11
DR   RSCB; RSCB0089
DR   Wikidata; Q54948990
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC13
AC   CVCL_C891
SY   R.1.H.iPSC.13
DR   RSCB; RSCB0090
DR   Wikidata; Q54948991
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC14
AC   CVCL_C892
SY   R.1.H.iPSC.14
DR   RSCB; RSCB0091
DR   Wikidata; Q54948992
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC15
AC   CVCL_C893
SY   R.1.H.iPSC.15
DR   RSCB; RSCB0092
DR   Wikidata; Q54948993
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC2
AC   CVCL_C894
SY   R.1.H.iPSC.2
DR   RSCB; RSCB0080
DR   Wikidata; Q54948994
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC3
AC   CVCL_C895
SY   R.1.H.iPSC.3
DR   RSCB; RSCB0081
DR   Wikidata; Q54948996
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC4
AC   CVCL_C896
SY   Royan hiPSC4; hiPSC4; R.1.H.iPSC.4; RIi007-A
DR   hPSCreg; RIi007-A
DR   RSCB; RSCB0082
DR   SKIP; SKIP002402
DR   SKIP; SKIP005842
DR   Wikidata; Q54948997
RX   PubMed=19876814;
RX   PubMed=21198400;
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   R1-hiPSC5
AC   CVCL_C897
SY   R.1.H.iPSC.5
DR   RSCB; RSCB0083
DR   Wikidata; Q54948999
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC6
AC   CVCL_C898
SY   R.1.H.iPSC.6
DR   RSCB; RSCB0084
DR   Wikidata; Q54949000
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC7
AC   CVCL_C899
SY   hiPSC7; R.1.H.iPSC.7
DR   RSCB; RSCB0085
DR   Wikidata; Q54949001
RX   PubMed=19876814;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC8
AC   CVCL_C900
SY   hiPSC8; R.1.H.iPSC.8
DR   RSCB; RSCB0086
DR   Wikidata; Q54949002
RX   PubMed=19876814;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C901 ! R1-hiPSC9
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   R1-hiPSC9
AC   CVCL_C901
SY   hiPSC9; R.1.H.iPSC.9; RIi008-A
DR   hPSCreg; RIi008-A
DR   RSCB; RSCB0087
DR   SKIP; SKIP002403
DR   SKIP; SKIP005844
DR   Wikidata; Q54949003
RX   PubMed=19876814;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C888 ! R1-hiPSC1
OI   CVCL_C894 ! R1-hiPSC2
OI   CVCL_C895 ! R1-hiPSC3
OI   CVCL_C896 ! R1-hiPSC4
OI   CVCL_C897 ! R1-hiPSC5
OI   CVCL_C898 ! R1-hiPSC6
OI   CVCL_C899 ! R1-hiPSC7
OI   CVCL_C900 ! R1-hiPSC8
OI   CVCL_C889 ! R1-hiPSC10
OI   CVCL_C890 ! R1-hiPSC11
OI   CVCL_C891 ! R1-hiPSC13
OI   CVCL_C892 ! R1-hiPSC14
OI   CVCL_C893 ! R1-hiPSC15
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   R1-miPSC1
AC   CVCL_9484
DR   RSCB; RSCB0028
DR   Wikidata; Q54949005
CC   From: Royan Institute; Theran; Iran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   R1-miPSC2
AC   CVCL_9485
DR   RSCB; RSCB0029
DR   Wikidata; Q54949006
CC   From: Royan Institute; Theran; Iran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   R1-miPSC3
AC   CVCL_9486
DR   RSCB; RSCB0030
DR   Wikidata; Q54949007
CC   From: Royan Institute; Theran; Iran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   R1-miPSC4
AC   CVCL_9487
DR   RSCB; RSCB0031
DR   Wikidata; Q54949008
CC   From: Royan Institute; Theran; Iran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   R1-miPSC5
AC   CVCL_9488
DR   RSCB; RSCB0032
DR   Wikidata; Q54949009
CC   From: Royan Institute; Theran; Iran.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 4
//
ID   R1-Oct4-EGFP
AC   CVCL_WS52
DR   FCS-free; 102-5-153-2-4-3
DR   Wikidata; Q98128776
RX   PubMed=22714273;
CC   Characteristics: Transfected with a construct containing Pou5f1/Oct4-eGFP and PGKp-neo-pA.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:101893; Pou5f1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2167 ! ES-R1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   R1.1
AC   CVCL_6514
SY   R1; R1 (TL+)
DR   CLO; CLO_0008698
DR   ATCC; TIB-42
DR   Wikidata; Q54949010
RX   DOI=10.1007/BF01576940;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: C58/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   R1.G1
AC   CVCL_6515
DR   CLO; CLO_0008699
DR   ATCC; TIB-44
DR   Wikidata; Q54949011
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: C58/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6514 ! R1.1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   R105
AC   CVCL_M670
DR   Wikidata; Q54949012
RX   PubMed=1692307;
CC   Characteristics: Established from a xenograft maintained in nude mice (PubMed=1692307).
CC   Doubling time: 40 +- 9 hours (Note=At 40th passage) (PubMed=1692307).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 8
//
ID   R118
AC   CVCL_C4JC
DR   Wikidata; Q116050138
RX   Patent=US10851162;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96D31; Human ORAI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   R1192
AC   CVCL_AT71
SY   BE; BEAN; R1192MB
DR   ATCC; CRL-7935
DR   Wikidata; Q54949013
CC   Problematic cell line: Probably contaminated. Shown to be a Caki-1 derivative (based on STR profile). Originally thought to originate from abnormal skin from a 33 year old male donor.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-7935; true.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-7935
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0234 ! Caki-1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   R14-212-6
AC   CVCL_C4E2
DR   Wikidata; Q116050139
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R14-7-20
AC   CVCL_C4E3
DR   Wikidata; Q116050140
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R14-85-1
AC   CVCL_C4E4
DR   ABCD; ABCD_AE812
DR   Wikidata; Q116050141
RX   PubMed=2122240;
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R15_Spike
AC   CVCL_A7AC
SY   R15
DR   Wikidata; Q107116688
RX   PubMed=33524396;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   R15E6
AC   CVCL_L635
DR   Wikidata; Q54949015
RX   Patent=US7973142;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7580.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P23467; Human PTPRB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 7
//
ID   R17 208.2
AC   CVCL_9228
SY   RI7 208.2; RI7 208
DR   CLO; CLO_0008705
DR   ATCC; TIB-220
DR   Wikidata; Q54949020
RX   PubMed=6290505;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q62351; Mouse Tfrc/Cd71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   R17 217.1.3
AC   CVCL_9229
SY   RI7 217.1.3
DR   ABCD; ABCD_AJ714
DR   ATCC; TIB-219
DR   Wikidata; Q54949021
RX   PubMed=6319033;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q62351; Mouse Tfrc/Cd71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   R187
AC   CVCL_9230
DR   CLO; CLO_0008706
DR   ATCC; CRL-1912
DR   Wikidata; Q54949023
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   R198 [Human bladder carcinoma]
AC   CVCL_4895
DR   Wikidata; Q54949024
RX   PubMed=6467211;
CC   Population: Caucasian.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   R198 [Rat hybridoma against human ORAI1]
AC   CVCL_C4JD
DR   Wikidata; Q116050142
RX   Patent=US10851162;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q96D31; Human ORAI1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   R1B
AC   CVCL_0595
SY   R-1B; R1b
DR   Wikidata; Q54949025
RX   PubMed=1851167;
RX   PubMed=2536702;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
HI   CVCL_0593 ! Mv1Lu
SX   Mixed sex
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   R1B-L17
AC   CVCL_0596
SY   R-1B/L17; R-1B (L17); Mv1Lu/R1B-L17
DR   Wikidata; Q54949026
RX   PubMed=8047140;
RX   PubMed=8242742;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
HI   CVCL_0595 ! R1B
SX   Mixed sex
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   R1B19
AC   CVCL_DB49
SY   R1.B19; R1-B19
DR   ATCC; HB-83
DR   Wikidata; Q54949027
RX   PubMed=7055645;
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: ATCC; HB-83; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   R1E/TL8x.1
AC   CVCL_8971
SY   R1 (TL-)
DR   CLO; CLO_0008707
DR   ATCC; TIB-43
DR   Wikidata; Q54949028
RX   DOI=10.1007/BF01576940;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: C58/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6514 ! R1.1
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   R1E/TL8x.1.G1.OUAr.1
AC   CVCL_8972
DR   CLO; CLO_0008708
DR   ATCC; TIB-45
DR   Wikidata; Q54949029
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: C58/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8971 ! R1E/TL8x.1
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 7
//
ID   R1E4
AC   CVCL_ZC50
DR   Wikidata; Q98128777
RX   PubMed=1717839;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7675 ! IR983F
CA   Hybridoma
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   R2-10F6
AC   CVCL_9231
SY   R2-10F6.3C10.3F9; 10F6
DR   CLO; CLO_0008709
DR   ATCC; CRL-2358
DR   Wikidata; Q54949030
RX   PubMed=8576576;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P43432; Mouse Il12b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   R2-9A5
AC   CVCL_9232
SY   R2-9A5.2A2.1A10; 9A5
DR   CLO; CLO_0008710
DR   ATCC; CRL-2357
DR   Wikidata; Q54949031
RX   PubMed=8576576;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P43431; Mouse Il12a.
CC   Monoclonal antibody target: UniProtKB; P43432; Mouse Il12b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   R201C
AC   CVCL_6540
DR   JCRB; JCRB1199
DR   Wikidata; Q54949032
RX   PubMed=11504597;
RX   PubMed=27844419;
CC   Problematic cell line: Contaminated/misidentified. Not from strain C57BL/6 as originally assigned but from a C57BL/6 x CBA cross (PubMed=27844419).
CC   Knockout cell: Method=KO mouse; MGI; MGI:88151; Glb1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4298; GLB1 (Note=With p.Arg201Cys).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E938 ! SV
AG   4D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   R21-1B
AC   CVCL_UZ05
DR   Wikidata; Q98128778
RX   PubMed=1559705;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   R22_Spike
AC   CVCL_A7AD
SY   R22
DR   Wikidata; Q107116689
RX   PubMed=33524396;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   R24
AC   CVCL_D295
SY   R.sub.24; R 24; M-18
DR   CLO; CLO_0008694
DR   ABCD; ABCD_AD862
DR   ATCC; HB-8445
DR   BCRJ; 0208
DR   Wikidata; Q54949033
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8445.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_89636; Ganglioside GD3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   R278.5
AC   CVCL_2U73
SY   R278
DR   Wikidata; Q54949034
RX   Patent=US5843780;
RX   PubMed=7544005;
RX   PubMed=15200688;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 9
//
ID   R27H1
AC   CVCL_C5GX
DR   Wikidata; Q116050143
RX   PubMed=2045661;
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 17.29 hours (PubMed=2045661).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GW ! HU3R27N
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R27H2
AC   CVCL_C5GY
DR   Wikidata; Q116050144
RX   PubMed=2045661;
CC   Group: Bird cell line.
CC   Doubling time: 18.93 hours (PubMed=2045661).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GW ! HU3R27N
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R27H3
AC   CVCL_C5GZ
DR   Wikidata; Q116050145
RX   PubMed=2045661;
CC   Group: Bird cell line.
CC   Doubling time: 16.97 hours (PubMed=2045661).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GW ! HU3R27N
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R27H4
AC   CVCL_C5H0
DR   Wikidata; Q116050146
RX   PubMed=2045661;
RX   PubMed=8959651;
CC   Group: Bird cell line.
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: 13.80 hours (PubMed=2045661).
CC   Selected for resistance to: ChEBI; CHEBI_75179; Trifluridine (Trifluorothymidine; TFT).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_C5GW ! HU3R27N
CA   Hybrid cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R28
AC   CVCL_5I35
SY   Rochester 28
DR   ABM; T0575
DR   Kerafast; EUR201
DR   Kerafast; EUR203
DR   Kerafast; EUR205
DR   Lonza; 202
DR   Wikidata; Q54949035
RX   DOI=10.7167/2013/261063;
RX   PubMed=9233983;
RX   PubMed=24644404;
WW   Info; Kerafast; -; https://news.kerafast.com/2012/10/31/on-the-road-to-retinal-cells/
CC   Doubling time: 24 hours (Kerafast=EUR201).
CC   Transformant: Psi2 defective retrovirus adenovirus E1A.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye, retina, neuroretina; UBERON=UBERON_0003902.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5I34 ! E1A-NR.3
SX   Female
AG   6D
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 18
//
ID   R2C
AC   CVCL_3571
SY   R 2 C
DR   CLO; CLO_0008691
DR   CLO; CLO_0008711
DR   CLDB; cl4071
DR   CLDB; cl4072
DR   AddexBio; C0028001/4889
DR   ATCC; CCL-97
DR   ECACC; 89031606
DR   IZSLER; BS TCL 56
DR   JCRB; JCRB9055
DR   KCLB; 10097
DR   Wikidata; Q54949036
RX   DOI=10.1007/BF02618370;
RX   PubMed=4868022;
RX   PubMed=15541572;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C60429; Rat Leydig cell adenoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   R2F
AC   CVCL_UZ35
SY   R2-F
DR   Wikidata; Q98128779
RX   PubMed=3130603;
RX   PubMed=12077343;
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Senescence: Senesces at 80 PDL (PubMed=12077343).
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   R2F/HTERT
AC   CVCL_UZ36
DR   Wikidata; Q98128780
RX   PubMed=12077343;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ35 ! R2F
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   R2J
AC   CVCL_UJ98
DR   Wikidata; Q98128782
RX   PubMed=30583471;
CC   Characteristics: Tumorigenic and possesses cancer stem cells (CSC) properties (PubMed=30583471).
CC   Karyotypic information: Has lost chromosome Y (PubMed=30583471).
CC   Derived from site: Metastatic; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   R2LBLN
AC   CVCL_3781
DR   CLO; CLO_0008712
DR   ATCC; CRL-6070
DR   Wikidata; Q54949037
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6070; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   R3
AC   CVCL_8973
SY   33-10ras3
DR   CLO; CLO_0008713
DR   ATCC; CRL-2764
DR   Wikidata; Q54949038
RX   PubMed=3049071;
RX   PubMed=12210843;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-3D
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   R3/1
AC   CVCL_XX96
DR   Wikidata; Q98128783
RX   PubMed=15221420;
RX   PubMed=15856276;
RX   PubMed=19103287;
CC   Characteristics: Alveolar epithelial type I-like.
CC   Doubling time: ~38 hours (Note=In RPMI 1640 + 10% FCS) (PubMed=15221420).
CC   Derived from site: In situ; Embryonic lung; UBERON=UBERON_0005597.
CC   Breed/subspecies: Wistar-Han; RS=RS_0005006.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   20FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   R31_Spike
AC   CVCL_A7AE
SY   R31
DR   Wikidata; Q107116690
RX   PubMed=33524396;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   R3230AC clone D
AC   CVCL_0P17
SY   Clone D
DR   CLO; CLO_0002507
DR   CLDB; cl800
DR   Wikidata; Q54949041
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F741 ! EPI
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   R3230AC clone H
AC   CVCL_0P18
SY   Clone H
DR   CLO; CLO_0002508
DR   CLDB; cl801
DR   Wikidata; Q54949042
RX   PubMed=1540965;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F741 ! EPI
OI   CVCL_0P19 ! R3230AC clone I
OI   CVCL_0P20 ! R3230AC clone L
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   R3230AC clone I
AC   CVCL_0P19
SY   Clone I
DR   CLO; CLO_0002509
DR   CLDB; cl802
DR   Wikidata; Q54949044
RX   PubMed=1540965;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F741 ! EPI
OI   CVCL_0P18 ! R3230AC clone H
OI   CVCL_0P20 ! R3230AC clone L
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   R3230AC clone L
AC   CVCL_0P20
SY   Clone L
DR   CLO; CLO_0002510
DR   CLDB; cl803
DR   Wikidata; Q54949045
RX   PubMed=1540965;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F741 ! EPI
OI   CVCL_0P18 ! R3230AC clone H
OI   CVCL_0P19 ! R3230AC clone I
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 7
//
ID   R366.4
AC   CVCL_A9LF
SY   R366
DR   Wikidata; Q108821197
RX   Patent=US5843780;
RX   PubMed=7544005;
RX   PubMed=15200688;
RX   PubMed=24381507;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   R367B
AC   CVCL_A9LG
SY   R367
DR   Wikidata; Q108821198
RX   Patent=US5843780;
RX   PubMed=7544005;
RX   PubMed=15200688;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   R394.2
AC   CVCL_A9LH
SY   R394
DR   Wikidata; Q108821199
RX   Patent=US5843780;
RX   PubMed=15200688;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   R3M
AC   CVCL_D5H6
DR   Wikidata; Q127383999
RX   PubMed=23759106;
RX   PubMed=26493146;
CC   Group: Plant cell line.
CC   Characteristics: Accumulates anthocyanins in the light (PubMed=26493146).
CC   Derived from site: In situ; Callus; PO=PO_0005052.
CC   Breed/subspecies: Cultivar Flakkese.
OX   NCBI_TaxID=79200; ! Daucus carota subsp. sativus (Carrot)
HI   CVCL_D5H5 ! K1 [D.carota]
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   R4-6A2
AC   CVCL_9233
DR   CLO; CLO_0008718
DR   ATCC; HB-170
DR   BCRJ; 0209
DR   ECACC; 91032502
DR   TKG; TKG 0241
DR   Wikidata; Q54949046
RX   PubMed=6425450;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01580; Mouse Ifng.
CC   Discontinued: TKG; TKG 0241; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   R4.2
AC   CVCL_0070
SY   R4-2; Mv1Lu R4-2; Mv1Lu clone 4.2
DR   Wikidata; Q54949047
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
HI   CVCL_0593 ! Mv1Lu
SX   Mixed sex
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   R42
AC   CVCL_E7CF
RX   PubMed=39528525;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Wing, plagiopatagium; UBERON=UBERON_0010867.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
SX   Female
AG   <1Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   R420
AC   CVCL_A9LI
DR   Wikidata; Q108821200
RX   PubMed=15200688;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   R42IM
AC   CVCL_E7CG
RX   PubMed=39528525;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Wing, plagiopatagium; UBERON=UBERON_0010867.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
HI   CVCL_E7CF ! R42
SX   Female
AG   <1Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   R45-109-22
AC   CVCL_C4E5
DR   ABCD; ABCD_AE811
DR   Wikidata; Q116050147
RX   PubMed=2122240;
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R45-180-7
AC   CVCL_C4E6
DR   Wikidata; Q116050148
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R45-200-7
AC   CVCL_C4E7
DR   ABCD; ABCD_AE815
DR   Wikidata; Q116050149
RX   PubMed=2122240;
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R45-246-2
AC   CVCL_C4E8
DR   Wikidata; Q116050150
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R45-269-2
AC   CVCL_C4E9
DR   Wikidata; Q116050151
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R45-45-11
AC   CVCL_C4EA
DR   ABCD; ABCD_AE814
DR   Wikidata; Q116050152
RX   PubMed=2122240;
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R45-620-40
AC   CVCL_C4EB
DR   Wikidata; Q116050153
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R45-83-40
AC   CVCL_C4EC
DR   Wikidata; Q116050154
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   R456
AC   CVCL_A9LJ
DR   Wikidata; Q108821201
RX   PubMed=15200688;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   R46
AC   CVCL_E7CH
RX   PubMed=39528525;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Wing, plagiopatagium; UBERON=UBERON_0010867.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
SX   Female
AG   <1Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   R460
AC   CVCL_A9LK
DR   Wikidata; Q108821202
RX   PubMed=15200688;
RX   PubMed=37863046;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   R46IM
AC   CVCL_E7CI
RX   PubMed=39528525;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Wing, plagiopatagium; UBERON=UBERON_0010867.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
HI   CVCL_E7CH ! R46
SX   Female
AG   <1Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   R475
AC   CVCL_A9LL
DR   Wikidata; Q108821203
RX   PubMed=15200688;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   R49
AC   CVCL_E7CJ
RX   PubMed=39528525;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Wing, plagiopatagium; UBERON=UBERON_0010867.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
SX   Female
AG   <1Y
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   R49IM
AC   CVCL_E7CK
RX   PubMed=39528525;
CC   Group: Bat cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Wing, plagiopatagium; UBERON=UBERON_0010867.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
HI   CVCL_E7CJ ! R49
SX   Female
AG   <1Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   R4A9
AC   CVCL_KB10
SY   R4-A9
DR   RCB; RCB2930
DR   Wikidata; Q54949048
RX   PubMed=1755316;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Mouse cell surface antigen of stromal cells in bone marrow and spleen.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   R4G
AC   CVCL_D5H7
DR   Wikidata; Q127384001
RX   PubMed=26493146;
RX   PubMed=33195137;
CC   Group: Plant cell line.
CC   Characteristics: Accumulates anthocyanins in the dark (PubMed=26493146).
CC   Derived from site: In situ; Callus; PO=PO_0005052.
CC   Breed/subspecies: Cultivar Flakkese.
OX   NCBI_TaxID=79200; ! Daucus carota subsp. sativus (Carrot)
HI   CVCL_D5H6 ! R3M
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   R5-28
AC   CVCL_H535
DR   Wikidata; Q54949049
RX   PubMed=16419609;
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   R5-28 clone C4
AC   CVCL_H536
SY   C4
DR   Wikidata; Q54949050
RX   PubMed=23150138;
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_H535 ! R5-28
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   R5-28 clone C7
AC   CVCL_H537
SY   C7
DR   Wikidata; Q54949051
RX   PubMed=23150138;
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_H535 ! R5-28
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   R5-28 clone D6
AC   CVCL_H538
SY   D6
DR   Wikidata; Q54949052
RX   PubMed=23150138;
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_H535 ! R5-28
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 7
//
ID   R5-MaRBLE
AC   CVCL_E8AW
RX   PubMed=17182760;
CC   Population: Japanese.
CC   Characteristics: Reporter cell line to measure HIV-1 infectivity and thus evaluate susceptibility to anti-HIV-1 drugs (PubMed=17182760).
CC   Characteristics: Transfected with three constructs. 1) 53LTRN-lucneoR#1 which contains the HIV-1 strain HXB2 LTR driving the expression of a Luc-DsRed fusion protein. This allows HIV-1 replication to be quantitatively evaluated by using luciferase activity when the LTR is activated by Tat, and the DsRed gene allows HIV-1 infected cells to be identified by red fluorescence. 2) pRenillaPac where Renilla luciferase is under the control of a CMV promoter and is used to monitor cell numbers and viability, 3) pCCR5/CEP4 which contains CCR5 under the control of a CMV promoter (PubMed=17182760).
CC   Virology: Infected with Moloney murine leukemia virus (MoMuLV) from MiCl1 (S+L-) (Cellosaurus=CVCL_3405) cells (from parent cell line).
CC   Virology: Susceptible to infection by both CCR5-tropic (example JRCSF) and CXCR4-tropic HIV-1 strains (PubMed=17182760).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AV ! X4-MaRBLE
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   R5.3
AC   CVCL_C950
DR   Wikidata; Q54949053
RX   PubMed=19485710;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   R5.5
AC   CVCL_C951
DR   Wikidata; Q54949055
RX   PubMed=19485710;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   R52.120
AC   CVCL_C5SW
DR   Wikidata; Q116050155
RX   PubMed=2469765;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26955; Mouse Csf2rb/Cd131.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   R52.625
AC   CVCL_C5SX
DR   Wikidata; Q116050156
RX   PubMed=2469765;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26955; Mouse Csf2rb/Cd131.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   R52_Spike
AC   CVCL_A7AF
SY   R52
DR   RCB; RCB5391
DR   Wikidata; Q107116691
RX   PubMed=33524396;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   R59
AC   CVCL_F276
DR   JCRB; JCRB3005
DR   JCRB; KURB2344
DR   Wikidata; Q54949056
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2344; probable.
CC   Derived from site: Metastatic; Eye socket; UBERON=UBERON_0001697.
ST   Source(s): JCRB=JCRB3005
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JG68 ! RB188
OI   CVCL_JG69 ! RB188Tu
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   R6.5.D6.E9.B2
AC   CVCL_G148
SY   R6-5-D6
DR   CLO; CLO_0008719
DR   ABCD; ABCD_AH397
DR   ATCC; HB-9580
DR   BCRC; 60534
DR   Wikidata; Q54949057
RX   Patent=US5284931;
RX   Patent=US5475091;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9580.
CC   Biotechnology: Was used to produce the monoclonal antibody enlimomab (BIRR-1) which is used in clinical trials in refractory rheumatoid arthritis and to reduce the incidence of acute rejection after kidney and liver allograft transplantations.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05362; Human ICAM1/CD54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   R604
AC   CVCL_B0LD
DR   Wikidata; Q108821204
RX   Patent=US20100098706;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3692.
CC   Characteristics: Produces the chimeric monoclonal antibody EMAB604 against human LDLR.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   R681
AC   CVCL_5U33
SY   R 681
DR   Wikidata; Q54949059
RX   PubMed=2985973;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0362 ! JB6 Cl 41-5a
SX   Sex unspecified
AG   Newborn
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   R6H1
AC   CVCL_E6IU
RX   PubMed=10577517;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51684; Human CCR6/CD196.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   R6H2
AC   CVCL_E6IV
RX   PubMed=10577517;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P51684; Human CCR6/CD196.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   R70-15
AC   CVCL_VU46
DR   Wikidata; Q98128784
RX   PubMed=8668197;
RX   PubMed=9724713;
CC   Doubling time: 16-20 hours (PubMed=8668197).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4055; XRCC6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   R7080-20
AC   CVCL_VU47
DR   Wikidata; Q98128785
RX   PubMed=8668197;
CC   Doubling time: 16-20 hours (PubMed=8668197).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12833; XRCC5.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4055; XRCC6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_VU46 ! R70-15
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   R7080-6
AC   CVCL_VU48
DR   Wikidata; Q98128786
RX   PubMed=8668197;
RX   PubMed=9724713;
CC   Doubling time: 16-20 hours (PubMed=8668197).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12833; XRCC5.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4055; XRCC6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_VU46 ! R70-15
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   R72/3
AC   CVCL_C7X7
DR   Wikidata; Q123033307
RX   PubMed=6939365;
RX   PubMed=7440648;
CC   Characteristics: Established from a tumor produced by the parent cell line (PubMed=7440648).
CC   Doubling time: 9.1-10 hours (PubMed=7440648).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7X6 ! WIRL-3BS
SX   Male
AG   4W
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   R72/3B
AC   CVCL_C7X8
DR   Wikidata; Q123033308
RX   PubMed=6939365;
RX   PubMed=7440648;
CC   Doubling time: 11.5 hours (PubMed=7440648).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7X7 ! R72/3
SX   Male
AG   4W
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   R73
AC   CVCL_J772
DR   ECACC; 90091904
DR   Wikidata; Q54949060
RX   PubMed=2783336;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat T-cell receptor (TcR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   R74
AC   CVCL_4281
DR   CLO; CLO_0008721
DR   CLDB; cl4073
DR   ECACC; 93120215
DR   Wikidata; Q54949063
RX   PubMed=1326448;
RX   PubMed=9570350;
CC   Characteristics: Tumorigenic (PubMed=1326448; PubMed=9570350).
CC   Virology: Expresses the viral genome of Rous sarcoma virus (PubMed=1326448; PubMed=9570350).
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=RSV-33).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   R7T1
AC   CVCL_AW02
DR   BCGO; BCGO_0000123
DR   GEO; GSM321551
DR   GEO; GSM321552
DR   GEO; GSM321553
DR   GEO; GSM321554
DR   GEO; GSM321555
DR   GEO; GSM321556
DR   GEO; GSM321557
DR   GEO; GSM321558
DR   GEO; GSM321559
DR   GEO; GSM321560
DR   GEO; GSM321561
DR   GEO; GSM321562
DR   GEO; GSM321563
DR   GEO; GSM321564
DR   GEO; GSM321565
DR   GEO; GSM321566
DR   Wikidata; Q54949064
RX   PubMed=11714200;
CC   Characteristics: Undergoes growth arrest within 6 days of transfer to culture in the absence of doxycycline (PubMed=11714200).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: RIP7-rtTA x tetTAG transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   R80-1
AC   CVCL_VU49
DR   Wikidata; Q98128787
RX   PubMed=8668197;
RX   PubMed=9724713;
CC   Doubling time: 16-20 hours (PubMed=8668197).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12833; XRCC5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   R80-6
AC   CVCL_VU50
DR   Wikidata; Q98128788
RX   PubMed=9724713;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12833; XRCC5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   R89
AC   CVCL_8413
DR   Wikidata; Q54949065
RX   PubMed=15548371;
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   R9
AC   CVCL_4282
DR   CLO; CLO_0008723
DR   EFO; EFO_0022788
DR   CLDB; cl4075
DR   ECACC; 93120214
DR   Wikidata; Q54949066
RX   PubMed=1326448;
RX   PubMed=9570350;
CC   Characteristics: Highly tumorigenic (PubMed=1326448; PubMed=9570350).
CC   Virology: Expresses the viral genome of Rous sarcoma virus (PubMed=1326448; PubMed=9570350).
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=RSV-33).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   R9ab
AC   CVCL_3782
SY   R9AB; R 9 ab; R9 ab
DR   CLO; CLO_0008692
DR   CLO; CLO_0008726
DR   CLDB; cl4077
DR   CLDB; cl4078
DR   ATCC; CCL-193
DR   ECACC; 88011502
DR   IZSLER; BS CL 105
DR   Lonza; 1401
DR   Wikidata; Q54949070
RX   PubMed=7065527;
RX   PubMed=7989438;
CC   Senescence: Capable of at least 60 PDL (ATCC=CCL-193).
CC   Virology: Susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   RA
AC   CVCL_C6JY
DR   PRIDE; PXD020079
DR   Wikidata; Q116050157
RX   PubMed=30695232;
RX   PubMed=33592498;
CC   HLA typing: A*02:01,24:02; B*35:03,51:01; C*04:01,14:02; DPA1*01:03,02:07; DPB1*04:01,19:01; DQA1*03:01,04:01; DQB1*03:02,04:02; DRB1*04:01,08:01; DRB4*01:03 (PubMed=33592498).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   Ra Bot
AC   CVCL_3573
DR   CLO; CLO_0008727
DR   ATCC; CRL-1265
DR   Wikidata; Q54949071
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Ra Lot
AC   CVCL_3574
DR   CLO; CLO_0008728
DR   ATCC; CRL-1289
DR   Wikidata; Q54949072
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Ra-1
AC   CVCL_2698
DR   JCRB; JCRB1313
DR   Wikidata; Q54949073
RX   PubMed=6088346;
RX   PubMed=6301915;
RX   PubMed=12707056;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   Ra-IIA
AC   CVCL_X689
DR   Wikidata; Q54949074
RX   PubMed=2118885;
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
ID   RA-CIITA
AC   CVCL_C6JZ
DR   PRIDE; PXD020079
DR   Wikidata; Q116050158
RX   PubMed=33592498;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7067; CIITA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6JY ! RA
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   RA-MSC/TERT308
AC   CVCL_B5SX
DR   Evercyte; CHT-050-0308
DR   Wikidata; Q112041635
CC   Doubling time: 28-34 hours (Evercyte=CHT-050-0308).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile and sex of donor from personal communication of Evercyte.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
CC   Cell type: Mesenchymal stem cell of amnion; CL=CL_0002537.
ST   Source(s): Evercyte=CHT-050-0308
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5T2 ! CP-MSC/TERT308
OI   CVCL_B5SY ! P-MSC/TERT308
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Ra-SLN
AC   CVCL_ZF71
DR   Wikidata; Q98128789
RX   PubMed=7928626;
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 4
//
ID   RA/1
AC   CVCL_C1M5
SY   Rabbit Aorta/1
DR   Wikidata; Q114312756
RX   PubMed=13972081;
RX   PubMed=14157820;
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description and of a another rabbit cell line from the same group (Cellosaurus=CVCL_C1M6).
CC   Derived from site: In situ; Dorsal aorta; UBERON=UBERON_0005805.
CC   Cell type: Endothelial cell of aorta; CL=CL_0002544.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Ra01
AC   CVCL_VZ55
SY   Ra 01
DR   IBRC; C10069
DR   Wikidata; Q98128790
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   Ra2
AC   CVCL_0510
SY   Ra-2
DR   BTO; BTO_0005582
DR   MCCL; MCC:0000408
DR   Wikidata; Q54949075
RX   Patent=US6673605;
RX   PubMed=9738928;
RX   PubMed=11054807;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7061.
CC   Characteristics: CSF2 dependent.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6J(H-2b).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   RA3-2C2/1
AC   CVCL_9234
SY   RA3-2C2
DR   CLO; CLO_0008729
DR   ATCC; TIB-145
DR   Wikidata; Q54949076
RX   PubMed=6787164;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   RA3-3A1/6.1
AC   CVCL_9235
SY   RA3-3A1
DR   CLO; CLO_0008730
DR   ATCC; TIB-146
DR   BCRC; 60189
DR   IZSLER; BS Hy 64
DR   Wikidata; Q54949078
RX   PubMed=6970340;
WW   Provider; Stanford OTL; S82-010; https://stanford.resoluteinnovation.com/technologies/S82-010_a-monoclonal-antibody-specific-for
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   RA3-6B2
AC   CVCL_D679
DR   BCRJ; 0210
DR   Wikidata; Q54949079
WW   Provider; Stanford OTL; S82-011; https://stanford.resoluteinnovation.com/technologies/S82-011_a-monoclonal-antibody-specific-for
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
CC   Discontinued: BCRJ; 0210; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   RA957
AC   CVCL_B4UJ
DR   PRIDE; PXD006939
DR   PRIDE; PXD012308
DR   Wikidata; Q110433142
RX   PubMed=28832583;
RX   PubMed=29242379;
RX   PubMed=31611696;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*02:20,68:01; B*35:03,39:01; C*04:01,07:02 (PubMed=28832583).
CC   HLA typing: DPA1*01:03; DPB1*04:01(105:01),04:02(126:01); DQA1*03:03,04:01; DQB1*03:01,04:02; DRB1*04:01,08:01; DRB4*01:03 (PubMed=31611696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   RAB-9
AC   CVCL_3783
SY   RAB9; Rab 9
DR   CLO; CLO_0008732
DR   CLDB; cl4079
DR   CLDB; cl4080
DR   ATCC; CRL-1414
DR   ECACC; 87042203
DR   IZSLER; BS CL 104
DR   Wikidata; Q54949080
RX   PubMed=7989438;
CC   Senescence: Can undergo 40 PDL.
CC   Virology: Susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   RaBE
AC   CVCL_AR51
SY   Rat Bronchial Epithelial cells
DR   ECACC; 04100601
DR   Wikidata; Q54949081
RX   CelloPub=CLPUB00361;
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   RaBE (Slow Growth)
AC   CVCL_HF35
SY   Rat Bronchial Epithelial cells (Slow Growth)
DR   ECACC; 04100602
DR   Wikidata; Q54949082
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_AR51 ! RaBE
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   RABHU.01
AC   CVCL_A5ZA
DR   Wikidata; Q107116692
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5ZB ! RABHU.02
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RABHU.02
AC   CVCL_A5ZB
DR   Wikidata; Q107116693
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5ZA ! RABHU.01
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RAC-10P
AC   CVCL_B4GF
DR   Wikidata; Q110433143
RX   PubMed=3034568;
RX   PubMed=3756929;
CC   Doubling time: 23 hours (PubMed=3756929).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4GB ! RAC-1P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-11P
AC   CVCL_B4GG
DR   Wikidata; Q110433145
RX   PubMed=3756929;
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4GF ! RAC-10P
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-1P
AC   CVCL_B4GB
DR   Wikidata; Q110433146
RX   PubMed=3756929;
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B4GE ! RAC-2C
OI   CVCL_B4G7 ! RAC-3C
OI   CVCL_B4GD ! RAC-4E
OI   CVCL_B4GC ! RAC-5E
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-2C
AC   CVCL_B4GE
DR   Wikidata; Q110433147
RX   PubMed=3756929;
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B4GB ! RAC-1P
OI   CVCL_B4G7 ! RAC-3C
OI   CVCL_B4GD ! RAC-4E
OI   CVCL_B4GC ! RAC-5E
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-31C
AC   CVCL_B4G9
DR   Wikidata; Q110433148
RX   PubMed=3034568;
RX   PubMed=3756929;
CC   Doubling time: 15 hours (PubMed=3756929).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Misspelling: RAC-31P; PubMed=3034568; Note=In figure 1 legend.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4G7 ! RAC-3C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-311C
AC   CVCL_B4GA
SY   RAC311C; RAC311c
DR   Wikidata; Q110433149
RX   PubMed=3034568;
RX   PubMed=3034569;
RX   PubMed=3756929;
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4G9 ! RAC-31C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-3C
AC   CVCL_B4G7
DR   Wikidata; Q110433150
RX   PubMed=3756929;
CC   Doubling time: 23 hours (PubMed=3756929).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B4GB ! RAC-1P
OI   CVCL_B4GE ! RAC-2C
OI   CVCL_B4GD ! RAC-4E
OI   CVCL_B4GC ! RAC-5E
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-34E
AC   CVCL_B4G8
DR   Wikidata; Q110433151
RX   PubMed=3034568;
RX   PubMed=3756929;
CC   Doubling time: 9.4 hours (PubMed=3756929).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4G7 ! RAC-3C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-4E
AC   CVCL_B4GD
DR   Wikidata; Q110433152
RX   PubMed=3756929;
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B4GB ! RAC-1P
OI   CVCL_B4GE ! RAC-2C
OI   CVCL_B4G7 ! RAC-3C
OI   CVCL_B4GC ! RAC-5E
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC-5E
AC   CVCL_B4GC
DR   Wikidata; Q110433154
RX   PubMed=3034568;
RX   PubMed=3756929;
CC   Doubling time: 9 hours (PubMed=3756929).
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B4GB ! RAC-1P
OI   CVCL_B4GE ! RAC-2C
OI   CVCL_B4G7 ! RAC-3C
OI   CVCL_B4GD ! RAC-4E
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RAC/MV7
AC   CVCL_B4FD
SY   RAC-MV7; RAC311c/MV7
DR   Wikidata; Q110433155
RX   PubMed=8049493;
RX   PubMed=10197631;
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/c77e7043-59be-47a7-b1b6-2329366ad930
CC   Characteristics: Control cell line for RAC/Wnt-1 (Cellosaurus=CVCL_B4FE).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4GA ! RAC-311C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   RAC/Wnt-1
AC   CVCL_B4FE
SY   RAC-Wnt-1; RAC311c/MVWnt-1
DR   Wikidata; Q110433156
RX   PubMed=8049493;
RX   PubMed=10197631;
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/c77e7043-59be-47a7-b1b6-2329366ad930
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4GA ! RAC-311C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   RAC/Wnt-1 #9
AC   CVCL_B4FF
SY   RAC-Wnt-1 #9
DR   Wikidata; Q110433157
RX   PubMed=10197631;
WW   Provider; Cornell TTO; -; https://cornell.flintbox.com/technologies/c77e7043-59be-47a7-b1b6-2329366ad930
CC   Characteristics: Expresses Wnt1 at a high level (PubMed=10197631).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4FE ! RAC/Wnt-1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   RAC65
AC   CVCL_J421
SY   P19S18RAC65; P19/RAC65
DR   Wikidata; Q54949085
RX   PubMed=6656766;
CC   Characteristics: Does not differentiate in the presence of retinoic acid (RA) (PubMed=6656766).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D6ND ! P19S18
SX   Male
AG   7FD
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   RAD5.2
AC   CVCL_5G12
DR   ABM; T0862
DR   Wikidata; Q54949087
RX   PubMed=10906754;
RX   PubMed=15541571;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   RADA-1-TC
AC   CVCL_G373
SY   RADA-1; RADA1
DR   TKG; TKG 0169
DR   TKG; TKG 0579
DR   Wikidata; Q54949088
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   RadC1
AC   CVCL_HC20
DR   GEO; GSM29881
DR   GEO; GSM29882
DR   GEO; GSM29883
DR   Wikidata; Q54949089
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a Hodgkin lymphoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC10
AC   CVCL_HC29
DR   GEO; GSM29908
DR   GEO; GSM29909
DR   GEO; GSM29910
DR   Wikidata; Q54949091
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a tonsil carcinoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC11
AC   CVCL_HC30
DR   GEO; GSM29955
DR   GEO; GSM29956
DR   GEO; GSM29957
DR   Wikidata; Q54949092
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a tongue carcinoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC12
AC   CVCL_HC31
DR   GEO; GSM29958
DR   GEO; GSM29959
DR   GEO; GSM29960
DR   Wikidata; Q54949093
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a breast cancer patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC13
AC   CVCL_HC32
DR   GEO; GSM29961
DR   GEO; GSM29962
DR   GEO; GSM29963
DR   Wikidata; Q54949095
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a breast cancer patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC2
AC   CVCL_HC21
DR   GEO; GSM29884
DR   GEO; GSM29885
DR   GEO; GSM29886
DR   Wikidata; Q54949096
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a mixed cell lymphoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC3
AC   CVCL_HC22
DR   GEO; GSM29887
DR   GEO; GSM29888
DR   GEO; GSM29889
DR   Wikidata; Q54949097
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a large cell lymphoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC4
AC   CVCL_HC23
DR   GEO; GSM29890
DR   GEO; GSM29891
DR   GEO; GSM29892
DR   Wikidata; Q54949098
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a Hodgkin lymphoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC5
AC   CVCL_HC24
DR   GEO; GSM29893
DR   GEO; GSM29894
DR   GEO; GSM29895
DR   Wikidata; Q54949099
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a salivary gland carcinoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC6
AC   CVCL_HC25
DR   GEO; GSM29896
DR   GEO; GSM29897
DR   GEO; GSM29898
DR   Wikidata; Q54949100
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from an oropharynx carcinoma patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC7
AC   CVCL_HC26
DR   GEO; GSM29899
DR   GEO; GSM29900
DR   GEO; GSM29901
DR   Wikidata; Q54949101
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a breast cancer patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC8
AC   CVCL_HC27
DR   GEO; GSM29902
DR   GEO; GSM29903
DR   GEO; GSM29904
DR   Wikidata; Q54949102
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a breast cancer patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadC9
AC   CVCL_HC28
DR   GEO; GSM29905
DR   GEO; GSM29906
DR   GEO; GSM29907
DR   Wikidata; Q54949103
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a breast cancer patient with limited toxicity to radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS1
AC   CVCL_HC33
DR   GEO; GSM29964
DR   GEO; GSM29965
DR   GEO; GSM29966
DR   Wikidata; Q54949104
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive breast cancer patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS10
AC   CVCL_HC42
DR   GEO; GSM29991
DR   GEO; GSM29992
DR   GEO; GSM29993
DR   Wikidata; Q54949105
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive Hodgkin lymphoma patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS11
AC   CVCL_HC43
DR   GEO; GSM29994
DR   GEO; GSM29995
DR   GEO; GSM29996
DR   Wikidata; Q54949107
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive brain stem arteriovenous malformation patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS12
AC   CVCL_HC44
DR   GEO; GSM29997
DR   GEO; GSM29998
DR   GEO; GSM29999
DR   Wikidata; Q54949108
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive breast cancer patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS13
AC   CVCL_HC45
DR   GEO; GSM30000
DR   GEO; GSM30001
DR   GEO; GSM30002
DR   Wikidata; Q54949109
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive endometrial cancer patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS14
AC   CVCL_HC46
DR   GEO; GSM30003
DR   GEO; GSM30004
DR   GEO; GSM30005
DR   Wikidata; Q54949110
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive breast cancer patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS2
AC   CVCL_HC34
DR   GEO; GSM29967
DR   GEO; GSM29968
DR   GEO; GSM29969
DR   Wikidata; Q54949111
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive low grade lymphoma patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS3
AC   CVCL_HC35
DR   GEO; GSM29970
DR   GEO; GSM29971
DR   GEO; GSM29972
DR   Wikidata; Q54949112
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive tongue carcinoma patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS4
AC   CVCL_HC36
DR   GEO; GSM29973
DR   GEO; GSM29974
DR   GEO; GSM29975
DR   Wikidata; Q54949113
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive breast cancer patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS5
AC   CVCL_HC37
DR   GEO; GSM29976
DR   GEO; GSM29977
DR   GEO; GSM29978
DR   Wikidata; Q54949114
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive orbital pseudotumor patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS6
AC   CVCL_HC38
DR   GEO; GSM29979
DR   GEO; GSM29980
DR   GEO; GSM29981
DR   Wikidata; Q54949115
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive Hodgkin lymphoma patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS7
AC   CVCL_HC39
DR   GEO; GSM29982
DR   GEO; GSM29983
DR   GEO; GSM29984
DR   Wikidata; Q54949125
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive low grade lymphoma patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS8
AC   CVCL_HC40
DR   GEO; GSM29985
DR   GEO; GSM29986
DR   GEO; GSM29987
DR   Wikidata; Q54949126
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive Hodgkin lymphoma patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RadS9
AC   CVCL_HC41
DR   GEO; GSM29988
DR   GEO; GSM29989
DR   GEO; GSM29990
DR   Wikidata; Q54949127
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a radiation-sensitive salivary gland carcinoma patient that suffered from acute toxicity of radiation therapy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27962; Radiation toxicity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   RAE/CTVM1
AC   CVCL_Z159
SY   RAE/CTVM 1
DR   ECACC; 94022805
DR   Wikidata; Q54949129
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=21955214;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022805; true.
OX   NCBI_TaxID=34631; ! Rhipicephalus appendiculatus (Brown ear tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   RAE/PIPM38
AC   CVCL_UD47
DR   Wikidata; Q98128791
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34631; ! Rhipicephalus appendiculatus (Brown ear tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   RAE25
AC   CVCL_Z161
SY   RAE-25; RAE 25
DR   Wikidata; Q54949128
RX   PubMed=2766897;
RX   PubMed=6644089;
RX   PubMed=7131199;
RX   PubMed=8812616;
RX   PubMed=15053931;
RX   PubMed=16593348;
RX   PubMed=17662657;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34631; ! Rhipicephalus appendiculatus (Brown ear tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rael
AC   CVCL_7208
SY   Rael-BL; RAEL
DR   Cosmic; 931109
DR   Cosmic; 2361385
DR   NCBI_Iran; C186
DR   Wikidata; Q54949130
RX   PubMed=3026973;
RX   PubMed=4122458;
RX   PubMed=4347031;
RX   PubMed=4364259;
RX   PubMed=6231253;
RX   PubMed=6811418;
RX   PubMed=7316467;
RX   PubMed=8547074;
RX   PubMed=9473234;
RX   PubMed=16051863;
RX   PubMed=24590883;
RX   PubMed=28960205;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Raf1 FF SV40 MEF
AC   CVCL_6D90
SY   Raf-1FF/FF MEF; MEF Raf1 FF/FF KI
DR   CancerTools; 151629
DR   ECACC; 16012205
DR   Wikidata; Q54949131
DR   Ximbio; 151629
RX   PubMed=11296227;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97847; Raf1 (Note=With p.Tyr340Phe and p.Tyr341Phe).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 16012205; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   Raf1 KI D486A
AC   CVCL_UW75
SY   C-Raf KI D486A
DR   CancerTools; 151631
DR   ECACC; 16012201
DR   Wikidata; Q98128792
DR   Ximbio; 151631
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97847; Raf1 (Note=With p.Asp486Ala).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 16012201; true.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   Raf1 KO SV40 MEF
AC   CVCL_6D89
SY   Raf-1-/- MEF; MEF RAF1 KO
DR   CancerTools; 151576
DR   ECACC; 16012209
DR   Wikidata; Q54949132
DR   Ximbio; 151576
RX   PubMed=11296227;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97847; Raf1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 16012209; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   RAG
AC   CVCL_3575
SY   Rag
DR   BTO; BTO_0000871
DR   CLO; CLO_0008733
DR   CLDB; cl4082
DR   CLDB; cl4083
DR   CLDB; cl4084
DR   ATCC; CCL-142
DR   BCRC; 60404
DR   CCRID; 3101MOUTCM35
DR   CLS; 305190
DR   ECACC; 89040605
DR   KCLB; 10142
DR   Wikidata; Q54949133
RX   PubMed=4318843;
RX   PubMed=4920091;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Rag2-/- pro-B cells
AC   CVCL_B3QD
SY   RAG2KO pro-B cells
DR   Wikidata; Q110433158
RX   PubMed=16025120;
RX   PubMed=18176567;
RX   PubMed=20971928;
CC   Characteristics: Rag2-/- pro-B cells maintained on OP42 stromal cells.
CC   Knockout cell: Method=KO mouse; MGI; MGI:97849; Rag2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: 129S6/SvEvTac-Rag2tm1Fwa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   RAH-1
AC   CVCL_5F88
DR   Wikidata; Q54949134
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   RAH-2
AC   CVCL_5F89
DR   GEO; GSM1253007
DR   GEO; GSM1253008
DR   GEO; GSM1253009
DR   Wikidata; Q54949135
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   RAH-3
AC   CVCL_5F90
DR   Wikidata; Q54949136
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   RAH-4
AC   CVCL_5F91
DR   Wikidata; Q54949138
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   RAH-6
AC   CVCL_5F92
DR   GEO; GSM1253004
DR   GEO; GSM1253005
DR   GEO; GSM1253006
DR   Wikidata; Q54949139
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   RAH-7
AC   CVCL_5F93
DR   Wikidata; Q54949140
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   RAH-8
AC   CVCL_5F94
DR   Wikidata; Q54949141
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   RAH-9
AC   CVCL_5F95
DR   Wikidata; Q54949142
RX   PubMed=24360884;
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dark Agouti; RS=RS_0000014.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   Raji
AC   CVCL_0511
SY   RAJI; P1-Raji; GM04671
DR   BTO; BTO_0001154
DR   CLO; CLO_0008734
DR   CLO; CLO_0019014
DR   CLO; CLO_0050995
DR   EFO; EFO_0002324
DR   MCCL; MCC:0000409
DR   CLDB; cl4086
DR   CLDB; cl4088
DR   CLDB; cl4089
DR   CLDB; cl4090
DR   CLDB; cl4091
DR   CLDB; cl4092
DR   CLDB; cl4990
DR   Abcam; ab271145
DR   Abcam; ab275473
DR   AddexBio; C0003009/4668
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CCL-86
DR   ATCC; CRL-7936
DR   BCRC; 60116
DR   BCRJ; 0211
DR   BEI_Resources; ARP-9944
DR   BioGRID_ORCS_Cell_line; 272
DR   BioSample; SAMN01821589
DR   BioSample; SAMN01821656
DR   BioSample; SAMN01821715
DR   BioSample; SAMN01821738
DR   BioSample; SAMN03473128
DR   BioSample; SAMN10987653
DR   cancercelllines; CVCL_0511
DR   CCRID; 1101HUM-PUMC000046
DR   CCRID; 1102HUM-NIFDC00025
DR   CCRID; 3101HUMTCHu44
DR   CCRID; 4201HUM-CCTCC00191
DR   CCTCC; GDC0191
DR   Cell_Model_Passport; SIDM00844
DR   CGH-DB; 9204-4
DR   ChEMBL-Cells; CHEMBL3307663
DR   ChEMBL-Targets; CHEMBL614628
DR   CLS; 300359
DR   Coriell; GM04671
DR   Cosmic; 687850
DR   Cosmic; 850211
DR   Cosmic; 850387
DR   Cosmic; 851997
DR   Cosmic; 909262
DR   Cosmic; 919136
DR   Cosmic; 929816
DR   Cosmic; 931110
DR   Cosmic; 932761
DR   Cosmic; 991549
DR   Cosmic; 998718
DR   Cosmic; 1019313
DR   Cosmic; 1037703
DR   Cosmic; 1070707
DR   Cosmic; 1071883
DR   Cosmic; 1082517
DR   Cosmic; 1093788
DR   Cosmic; 1107179
DR   Cosmic; 1127266
DR   Cosmic; 1176615
DR   Cosmic; 1191688
DR   Cosmic; 1483367
DR   Cosmic; 1517664
DR   Cosmic; 1818346
DR   Cosmic; 2301566
DR   Cosmic; 2361386
DR   Cosmic; 2649241
DR   Cosmic; 2814541
DR   Cosmic; 2815215
DR   Cosmic; 2823074
DR   Cosmic-CLP; 909262
DR   DepMap; ACH-000654
DR   DSMZ; ACC-319
DR   DSMZCellDive; ACC-319
DR   ECACC; 85011429
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS260AAA
DR   FANTOM5_SSTAR; 10476-106I8
DR   GDSC; 909262
DR   GEO; GSM33154
DR   GEO; GSM99387
DR   GEO; GSM887523
DR   GEO; GSM888605
DR   GEO; GSM1374840
DR   GEO; GSM1374841
DR   GEO; GSM1374842
DR   GEO; GSM1602232
DR   GEO; GSM1602233
DR   GEO; GSM1602234
DR   GEO; GSM1602235
DR   GEO; GSM1602236
DR   GEO; GSM1602237
DR   GEO; GSM1602238
DR   GEO; GSM1602241
DR   GEO; GSM1602242
DR   GEO; GSM1602243
DR   GEO; GSM1602244
DR   GEO; GSM1670357
DR   GEO; GSM3150253
DR   IARC_TP53; 704
DR   IARC_TP53; 21706
DR   ICLC; HTL00002
DR   IGRhCellID; Raji
DR   IHW; IHW04994
DR   IPD-IMGT/HLA; 11295
DR   IZSLER; BS TCL 54
DR   JCRB; IFO50046
DR   JCRB; JCRB9012
DR   LiGeA; CCLE_651
DR   LINCS_LDP; LCL-2025
DR   Lonza; 726
DR   NCBI_Iran; C127
DR   PharmacoDB; Raji_1282_2019
DR   PRIDE; PXD005704
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0511
DR   PubChem_Cell_line; CVCL_0511
DR   RCB; RCB1647
DR   RCB; RCB3673
DR   TKG; TKG 0371
DR   TOKU-E; 2967
DR   Wikidata; Q4215980
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00458;
RX   DOI=10.1007/BF02618370;
RX   PubMed=168255;
RX   PubMed=170370;
RX   PubMed=216485;
RX   PubMed=1086134;
RX   PubMed=1325212;
RX   PubMed=1915267;
RX   PubMed=2140233;
RX   PubMed=2470097;
RX   PubMed=2985879;
RX   PubMed=2998993;
RX   PubMed=3026973;
RX   PubMed=3034807;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=3159941;
RX   PubMed=3518877;
RX   PubMed=3874327;
RX   PubMed=3905596;
RX   PubMed=4122458;
RX   PubMed=4169243;
RX   PubMed=4321017;
RX   PubMed=4321974;
RX   PubMed=4325933;
RX   PubMed=4347031;
RX   PubMed=4364259;
RX   PubMed=4366935;
RX   PubMed=4550511;
RX   PubMed=4736620;
RX   PubMed=4894370;
RX   PubMed=5260617;
RX   PubMed=6018567;
RX   PubMed=6231253;
RX   PubMed=6265077;
RX   PubMed=6286763;
RX   PubMed=6306472;
RX   PubMed=6419122;
RX   PubMed=6500159;
RX   PubMed=6547209;
RX   PubMed=6582512;
RX   PubMed=6592381;
RX   PubMed=6600440;
RX   PubMed=6806672;
RX   PubMed=6954533;
RX   PubMed=7060222;
RX   PubMed=7316467;
RX   PubMed=7849311;
RX   PubMed=8176200;
RX   PubMed=8316623;
RX   PubMed=8344493;
RX   PubMed=8515068;
RX   PubMed=8547074;
RX   PubMed=8558913;
RX   PubMed=8568269;
RX   PubMed=8847894;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9510473;
RX   PubMed=9685479;
RX   PubMed=9737686;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=9973220;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=11416159;
RX   PubMed=12145705;
RX   PubMed=12967475;
RX   PubMed=14086209;
RX   PubMed=14982850;
RX   PubMed=15028022;
RX   PubMed=15457187;
RX   PubMed=15901131;
RX   PubMed=18357372;
RX   PubMed=19358282;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20454443;
RX   PubMed=22460905;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25753668;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=27397505;
RX   PubMed=27566572;
RX   PubMed=28196595;
RX   PubMed=29892436;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/ccl-86-morphology-and-growth
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Raji_Farnham_protocol.pdf
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-27.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Raji_cell
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/raji-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African; Nigerian.
CC   Characteristics: Genetically heterogeneous, consists of 2 subclones (PubMed=27566572).
CC   Virology: Contains 50-60 integrated copies of the EBV genome. One copy is integrated in intron 1 of the BACH2 gene (PubMed=14982850).
CC   Doubling time: 23.2 hours (PubMed=8847894); ~24-36 hours (DSMZ=ACC-319); ~20 hours (BEI_Resources=ARP-9944).
CC   HLA typing: A*03:01,03:01; B*15:10,15:10; C*04:01,03:04; DQA1*05:01,01:01; DQB1*05:01,02:01; DRB1*10:01,03:01 (PubMed=25960936).
CC   HLA typing: A*03:01:01:01; B*15:10,15:CXU; C*03:04:02,04:01:01:01; DPB1*01:01:01; DQA1*01:01:01,05:01:01:01; DQB1*02:01:01,05:01:01; DRA*01:01:01:01; DRB1*03:01:01:01,10:01:01:01; DRB3*02 (IPD-IMGT/HLA=11295).
CC   HLA typing: A*03:01:01; B*15:10:01; C*03:04:02,04:01:01; DPB1*01:01:01; DQA1*01:05:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*03:01:01,10:01:01 (CLS=300359).
CC   HLA typing: A*03:01:01,03:01:01; B*15:10:01,15:10:01; C*03:04:02,04:01:01; DPA1*02:02:02,02:02:02; DPB1*01:01:01,01:01:01; DQA1*01:05:01,05:01:01; DQB1*02:01:01,05:01:01; DRA*01:01:01,01:01:01; DRB1*03:01:01,10:01:01 (DSMZCellDive=ACC-319).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6306472; PubMed=6419122; PubMed=6806672).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (PubMed=8344493; PubMed=15901131; Cosmic-CLP=909262; DepMap=ACH-000654).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (PubMed=8344493; PubMed=15901131; Cosmic-CLP=909262; DepMap=ACH-000654).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=99.39%; Native American=0%; East Asian, North=0.6%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Misspelling: BAJI; Cosmic=998718.
CC   Discontinued: ATCC; CRL-7936; true.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): AddexBio=C0003009/4668; ATCC=CCL-86; CCRID; CLS=300359; Cosmic-CLP=909262; DSMZ=ACC-319; ECACC=85011429; JCRB=IFO50046; JCRB=JCRB9012; PubMed=11416159; PubMed=25877200; RCB=RCB1647; Technion Genomics Center; TKG=TKG 0371
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 12,13
ST   D12S391: 18,19
ST   D13S317: 13
ST   D16S539: 8,11
ST   D18S51: 17
ST   D19S433: 14,14.2 (ATCC=CCL-86; CCRID; Technion Genomics Center)
ST   D19S433: 14,15 (DSMZ=ACC-319)
ST   D1S1656: 14
ST   D21S11: 28,31
ST   D22S1045: 15,18
ST   D2S1338: 21,22 (DSMZ=ACC-319)
ST   D2S1338: 22 (ATCC=CCL-86; CCRID; Technion Genomics Center)
ST   D2S441: 11,12
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   DYS391: 10
ST   FGA: 19,27
ST   Penta D: 3.2,9 (ATCC=CCL-86; CLS=300359; PubMed=25877200; Technion Genomics Center)
ST   Penta D: 3.2,9,10 (DSMZ=ACC-319)
ST   Penta E: 5,13
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 52
//
ID   RAJI 'A'
AC   CVCL_2699
SY   RAJI A; Raji A; RAJI'A'
DR   CLO; CLO_0008737
DR   CLDB; cl4093
DR   cancercelllines; CVCL_2699
DR   ECACC; 85022102
DR   Wikidata; Q54949145
RX   PubMed=4122458;
RX   PubMed=4364259;
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ECACC=85022102
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 8,11
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 17,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   Raji 6-TGR
AC   CVCL_Y035
DR   cancercelllines; CVCL_Y035
DR   Wikidata; Q54949146
RX   DOI=10.2177/jsci.11.346;
RX   PubMed=3267026;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 20
//
ID   Raji 6-TGR-neoR
AC   CVCL_E8U5
RX   DOI=10.2177/jsci.11.346;
RX   PubMed=2273757;
RX   PubMed=3267026;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y035 ! Raji 6-TGR
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Raji B2M KO
AC   CVCL_C3CD
DR   cancercelllines; CVCL_C3CD
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312757
CC   Population: African; Nigerian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Sigma-Aldrich=HLA001
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 8,11
ST   D18S51: 17
ST   D21S11: 28,31
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,27
ST   Penta D: 3.2,9
ST   Penta E: 5,13
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji CD19 High
AC   CVCL_YN95
DR   cancercelllines; CVCL_YN95
DR   Sigma-Aldrich; ATG001
DR   Wikidata; Q98128793
CC   Population: African; Nigerian.
CC   Characteristics: Expresses CD19 at high level (Sigma-Aldrich=ATG001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN94 ! Raji CD19 Knockout
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 13
//
ID   Raji CD19 Knockout
AC   CVCL_YN94
SY   Raji CD19-/-
DR   cancercelllines; CVCL_YN94
DR   Sigma-Aldrich; ATG001
DR   Wikidata; Q98128794
CC   Population: African; Nigerian.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Sigma-Aldrich=ATG001
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 8,11
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 13
//
ID   Raji CD19 Low
AC   CVCL_YN96
DR   cancercelllines; CVCL_YN96
DR   Sigma-Aldrich; ATG001
DR   Wikidata; Q98128795
CC   Population: African; Nigerian.
CC   Characteristics: Expresses CD19 at low level (Sigma-Aldrich=ATG001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1633; CD19.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN94 ! Raji CD19 Knockout
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 13
//
ID   Raji HLA-A*01:01
AC   CVCL_C3D0
DR   cancercelllines; CVCL_C3D0
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312758
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*01:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji HLA-A*02:01
AC   CVCL_C3D1
DR   cancercelllines; CVCL_C3D1
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312759
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji HLA-A*03:01
AC   CVCL_C3D2
DR   cancercelllines; CVCL_C3D2
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312760
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*03:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji HLA-A*11:01
AC   CVCL_C3D3
DR   cancercelllines; CVCL_C3D3
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312761
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*11:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji HLA-A*24:02
AC   CVCL_C3D4
DR   cancercelllines; CVCL_C3D4
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312762
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-A fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*24:02).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji HLA-B*07:02
AC   CVCL_C3D5
DR   cancercelllines; CVCL_C3D5
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312763
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07:02).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji HLA-B*15:10
AC   CVCL_C3D6
DR   cancercelllines; CVCL_C3D6
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312764
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*15:10).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   Raji HLA-B*40:01
AC   CVCL_C3D7
DR   cancercelllines; CVCL_C3D7
DR   Sigma-Aldrich; HLA001
DR   Wikidata; Q114312765
CC   Population: African; Nigerian.
CC   Characteristics: Transduced with a lentiviral construct that contains a B2M-HLA-B fusion protein (Sigma-Aldrich=HLA001).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:914; B2M.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:914; B2M.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*40:01).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CD ! Raji B2M KO
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 8
//
ID   RAJI TK+
AC   CVCL_2700
SY   Raji TK+
DR   CLO; CLO_0008736
DR   CLDB; cl4094
DR   cancercelllines; CVCL_2700
DR   CLS; 302160
DR   ECACC; 91112124
DR   NCBI_Iran; C124
DR   Wikidata; Q54949148
RX   PubMed=17254797;
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 8,11
ST   D18S51: 17
ST   D21S11: 27,30
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 19,27
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 17,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   RAJI TK-
AC   CVCL_2701
SY   Raji TK-
DR   CLO; CLO_0008735
DR   CLDB; cl4095
DR   cancercelllines; CVCL_2701
DR   CLS; 302161
DR   ECACC; 91112125
DR   NCBI_Iran; C138
DR   Wikidata; Q54949147
RX   PubMed=17254797;
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ECACC=91112125; PubMed=17254797
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11 (PubMed=17254797)
ST   CSF1PO: 10,12 (ECACC=91112125)
ST   D13S317: 13,15 (ECACC=91112125)
ST   D13S317: 13,16 (PubMed=17254797)
ST   D16S539: 8,11
ST   D18S51: 17
ST   D21S11: 27,30
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,27
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   Raji-APC-hPD-L1
AC   CVCL_E3JC
DR   InvivoGen; rajkt-hpd1
CC   Population: African; Nigerian.
CC   Biotechnology: Used in the Jurkat-Raji PD-1/PD-L1 assay (Bio-IC) specifically designed for screening antibody-, Fc-fusion protein-, or small-molecule antagonists of the PD-1/PD-L1 immune checkpoint (IC) axis (InvivoGen=rajkt-hpd1).
CC   Characteristics: Transfected with a specific antigenic peptide complexed with HLA molecules ([HLA::peptide]) (InvivoGen=rajkt-hpd1).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Raji-APC-Null
AC   CVCL_E3JB
DR   InvivoGen; raji-apc-null
CC   Population: African; Nigerian.
CC   Biotechnology: Activating control antigen presenting cell (APC) for anti-immune checkpoint cell-based assay (InvivoGen=raji-apc-null).
CC   Characteristics: Transfected with a specific antigenic peptide complexed with HLA molecules ([HLA::peptide]) (InvivoGen=raji-apc-null).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Raji-Fluc-EmGFP
AC   CVCL_D5KM
DR   Imanis; CL159
DR   Wikidata; Q127384003
CC   Population: African; Nigerian.
CC   Characteristics: Reporter cell line, transduced with the LV-SFFV-Luc2-P2A-EmGFP vector encoding for luciferase linked via a P2A cleavage site to emerald GFP (EmGFP) and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL159).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: Raji-Fluc-eGFP; Imanis=CL159; Note=In old versions.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Raji-Fluc-Puro
AC   CVCL_D5KN
DR   Imanis; CL161
DR   Wikidata; Q127384006
CC   Population: African; Nigerian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL161).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Raji-h4-1BB
AC   CVCL_A7ZV
DR   cancercelllines; CVCL_A7ZV
DR   InvivoGen; raji-h41bb
DR   Wikidata; Q107116694
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11924; TNFRSF9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hCTLA4
AC   CVCL_A7ZW
DR   cancercelllines; CVCL_A7ZW
DR   InvivoGen; raji-hctla4
DR   Wikidata; Q107116695
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2505; CTLA4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hEGFR
AC   CVCL_A7ZX
DR   cancercelllines; CVCL_A7ZX
DR   InvivoGen; raji-hegfr
DR   Wikidata; Q107116696
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-HER2
AC   CVCL_A7ZY
DR   cancercelllines; CVCL_A7ZY
DR   InvivoGen; raji-her2
DR   Wikidata; Q107116697
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hICOS
AC   CVCL_A7ZZ
DR   cancercelllines; CVCL_A7ZZ
DR   InvivoGen; raji-hicos
DR   Wikidata; Q107116698
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5351; ICOS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hLAG3
AC   CVCL_A8AA
DR   cancercelllines; CVCL_A8AA
DR   InvivoGen; raji-hlag3
DR   Wikidata; Q107116699
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6476; LAG3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hOX40
AC   CVCL_A8AC
DR   cancercelllines; CVCL_A8AC
DR   InvivoGen; raji-hox40
DR   Wikidata; Q107116702
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11918; TNFRSF4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hPD-1
AC   CVCL_A8AD
DR   cancercelllines; CVCL_A8AD
DR   InvivoGen; raji-hpd1
DR   Wikidata; Q107116703
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8760; PDCD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hPD-L1
AC   CVCL_A8AE
DR   cancercelllines; CVCL_A8AE
DR   InvivoGen; raji-hpdl1
DR   Wikidata; Q107116704
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hTIGIT
AC   CVCL_A8AF
DR   cancercelllines; CVCL_A8AF
DR   InvivoGen; raji-htigit
DR   Wikidata; Q107116705
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26838; TIGIT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-hVISTA
AC   CVCL_A8AG
DR   cancercelllines; CVCL_A8AG
DR   InvivoGen; raji-hvista
DR   Wikidata; Q107116706
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30085; VSIR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji-Luc2
AC   CVCL_C9CV
DR   ATCC; CCL-86-LUC2
DR   Wikidata; Q123033309
CC   Population: African; Nigerian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-86-LUC2).
CC   Doubling time: ~22 hours (ATCC=CCL-86-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-86-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 8,11
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   Raji-Null
AC   CVCL_A8AB
DR   cancercelllines; CVCL_A8AB
DR   InvivoGen; raji-null
DR   Wikidata; Q107116707
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   Raji(A44)
AC   CVCL_VL72
SY   RAJI(A44)
DR   cancercelllines; CVCL_VL72
DR   Wikidata; Q98128796
RX   PubMed=182883;
CC   Population: African; Nigerian.
CC   Virology: Infected with human herpesvirus 1 (HHV-1) strain A44.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 14
//
ID   Raji-GFP
AC   CVCL_LK62
DR   cancercelllines; CVCL_LK62
DR   Wikidata; Q54949151
WW   Provider; ProMab; PM-RAJI-GFP; https://www.promab.com/products/car-t-car-nk/car-t-cells/engineered-car-t-target-cells/raji-gfp-cells
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 17
//
ID   Raji-TG
AC   CVCL_DD98
DR   cancercelllines; CVCL_DD98
DR   Wikidata; Q54949153
RX   PubMed=844867;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 18
//
ID   Raji/18V
AC   CVCL_KU31
SY   R18V
DR   cancercelllines; CVCL_KU31
DR   Wikidata; Q54949154
RX   PubMed=18357372;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   Raji/A
AC   CVCL_C0HU
DR   cancercelllines; CVCL_C0HU
DR   Wikidata; Q114312766
RX   PubMed=25916297;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   Raji/DC-SIGN
AC   CVCL_0R22
SY   Raji DC-SIGN+
DR   BEI_Resources; ARP-9945
DR   cancercelllines; CVCL_0R22
DR   Wikidata; Q54949155
RX   PubMed=14972530;
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 20
//
ID   RaKSM-2.5i
AC   CVCL_YZ04
DR   Wikidata; Q98128797
RX   PubMed=32094589;
CC   Group: Bat cell line.
CC   Doubling time: 1.5-2 days (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Doubling time and age of donor from personal communication of Letko, Michael.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   RAL
AC   CVCL_WH09
DR   cancercelllines; CVCL_WH09
DR   IARC_TP53; 9935
DR   Wikidata; Q98128798
RX   PubMed=9809028;
RX   PubMed=10574245;
RX   PubMed=10841287;
RX   PubMed=26919099;
CC   Doubling time: ~65 hours (PubMed=9809028).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=9809028).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Cys (c.730G>T); ClinVar=VCV000376599; Zygosity=Unspecified (PubMed=9809028; PubMed=10841287).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   RAL-2
AC   CVCL_UY95
SY   RAL2; Rat Adult Liver-2
DR   Wikidata; Q98128799
RX   PubMed=126004;
CC   Doubling time: 21 hours (PubMed=126004).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   40D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   RAL-3
AC   CVCL_UY96
SY   RAL3; Rat Adult Liver-3
DR   Wikidata; Q98128800
RX   PubMed=126004;
CC   Doubling time: 32 hours (PubMed=126004).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   RAL-4
AC   CVCL_UY97
SY   RAL4; Rat Adult Liver-4
DR   Wikidata; Q98128801
RX   PubMed=126004;
CC   Doubling time: 17 hours (PubMed=126004).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   RAL-5
AC   CVCL_UY84
SY   RAL5; Rat Adult Liver-5
DR   Wikidata; Q98128802
RX   PubMed=90011;
RX   PubMed=126004;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   RAL-6
AC   CVCL_UY98
SY   RAL6; Rat Adult Liver-6
DR   Wikidata; Q98128803
RX   PubMed=126004;
CC   Doubling time: 26 hours (PubMed=126004).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   RAL-7
AC   CVCL_UY85
SY   RAL7; Rat Adult Liver-7
DR   Wikidata; Q98128804
RX   PubMed=90011;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 6
//
ID   RALA255-10G
AC   CVCL_WY58
SY   RALA255-10g; RALA25510G; RALA 255-10G
DR   Wikidata; Q98128805
RX   PubMed=2888530;
RX   PubMed=3431441;
RX   PubMed=6877237;
CC   Characteristics: Grows faster and achieves higher cell densities at the permissive temperature (33 Celsius) than at the non-permissive temperature (40 Celsius) (PubMed=6877237).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   RAM
AC   CVCL_F404
DR   CLO; CLO_0051145
DR   RCB; HSC0027
DR   Wikidata; Q54949156
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chilean; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 16
//
ID   Rama 25
AC   CVCL_Y673
SY   RAMA 25; Rat mammary 25
DR   Wikidata; Q54949158
RX   PubMed=375233;
RX   PubMed=699048;
RX   PubMed=2419187;
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Rama 25-I1
AC   CVCL_Y675
SY   Rama 25-Intermediate 1
DR   Wikidata; Q54949159
RX   PubMed=2419187;
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y673 ! Rama 25
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Rama 25-I2
AC   CVCL_Y676
SY   Rama 25-Intermediate 2
DR   Wikidata; Q54949160
RX   PubMed=2419187;
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y673 ! Rama 25
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Rama 25-I4
AC   CVCL_Y677
SY   Rama 25-Intermediate 4
DR   Wikidata; Q54949161
RX   PubMed=2419187;
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y673 ! Rama 25
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Rama 29
AC   CVCL_Y674
SY   Rat mammary 29
DR   Wikidata; Q54949162
RX   PubMed=699048;
RX   PubMed=2419187;
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y673 ! Rama 25
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Rama 37
AC   CVCL_T286
SY   Rat mammary 37; R37
DR   Wikidata; Q54949163
RX   PubMed=6418941;
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   Rama 37-OPN
AC   CVCL_T288
SY   R37-OPN
DR   Wikidata; Q54949164
RX   PubMed=19192273;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3752; Spp1.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T286 ! Rama 37
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   Rama 37E
AC   CVCL_Y683
SY   Rama 37 E
DR   Wikidata; Q54949165
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T286 ! Rama 37
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 401
AC   CVCL_Y900
SY   Rat mammary 401
DR   Wikidata; Q54949166
RX   PubMed=2418247;
RX   PubMed=7199047;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Myoepithelial cell of mammary gland; CL=CL_0002324.
CC   Breed/subspecies: ICRF-Wistar.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Rama 50
AC   CVCL_Y684
SY   Rat mammary 50
DR   Wikidata; Q54949167
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y683 ! Rama 37E
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 52
AC   CVCL_Y685
SY   Rat mammary 52
DR   Wikidata; Q54949168
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y683 ! Rama 37E
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 53
AC   CVCL_Y686
SY   Rat mammary 53
DR   Wikidata; Q54949169
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y683 ! Rama 37E
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 54
AC   CVCL_Y687
SY   Rat mammary 54
DR   Wikidata; Q54949170
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y683 ! Rama 37E
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 55
AC   CVCL_Y688
SY   Rat mammary 55
DR   Wikidata; Q54949171
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y683 ! Rama 37E
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 59
AC   CVCL_Y689
SY   Rat mammary 59
DR   Wikidata; Q54949178
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y683 ! Rama 37E
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 60
AC   CVCL_Y690
SY   Rat mammary 60
DR   Wikidata; Q54949179
RX   PubMed=6713401;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y683 ! Rama 37E
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Rama 600
AC   CVCL_Y902
SY   Rat mammary 600
DR   Wikidata; Q54949180
RX   PubMed=2579259;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y901 ! LICR LON TR2CL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   Rama 622
AC   CVCL_Y903
SY   Rat mammary 622
DR   Wikidata; Q54949182
RX   PubMed=2579259;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y901 ! LICR LON TR2CL
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   Rama 704
AC   CVCL_Y678
SY   Rat mammary 704; R704
DR   Wikidata; Q54949183
RX   PubMed=3891719;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: ICRF-Wistar.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   1-7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Rama 704E
AC   CVCL_Y679
DR   Wikidata; Q54949184
RX   PubMed=2418247;
RX   PubMed=3891719;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: ICRF-Wistar.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y678 ! Rama 704
SX   Female
AG   1-7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Rama 710
AC   CVCL_Y680
SY   Rat mammary 710; R710
DR   Wikidata; Q54949185
RX   PubMed=3891719;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: ICRF-Wistar.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y678 ! Rama 704
SX   Female
AG   1-7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Rama 711
AC   CVCL_Y681
SY   Rat mammary 711; R711
DR   Wikidata; Q54949186
RX   PubMed=3891719;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: ICRF-Wistar.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y678 ! Rama 704
SX   Female
AG   1-7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Rama 712
AC   CVCL_Y682
SY   Rat mammary 712; R712
DR   Wikidata; Q54949187
RX   PubMed=3891719;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: ICRF-Wistar.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y678 ! Rama 704
SX   Female
AG   1-7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   Rama 800
AC   CVCL_T287
SY   Rat mammary 800
DR   Wikidata; Q54949189
RX   PubMed=6488188;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L174 ! TMT-081MS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   Rama 801
AC   CVCL_Y668
SY   Rat mammary 801
DR   Wikidata; Q54949190
RX   PubMed=6488188;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L174 ! TMT-081MS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   Rama 802
AC   CVCL_Y669
SY   Rat mammary 802
DR   Wikidata; Q54949191
RX   PubMed=6488188;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L174 ! TMT-081MS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   Rama 803
AC   CVCL_Y670
SY   Rat mammary 803
DR   Wikidata; Q54949192
RX   PubMed=6488188;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L174 ! TMT-081MS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   Rama 804
AC   CVCL_Y671
SY   Rat mammary 804
DR   Wikidata; Q54949193
RX   PubMed=6488188;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L174 ! TMT-081MS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   Rama 805
AC   CVCL_Y672
SY   Rat mammary 805
DR   Wikidata; Q54949194
RX   PubMed=6488188;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L174 ! TMT-081MS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   Rama 900
AC   CVCL_Y904
SY   Rat mammary 900
DR   Wikidata; Q54949195
RX   PubMed=2736223;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_3601 ! SMT/2A LNM
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 8
//
ID   RAMAK-1
AC   CVCL_8271
DR   BioSample; SAMN03151951
DR   cancercelllines; CVCL_8271
DR   Wikidata; Q54949197
RX   PubMed=9542641;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00154.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Ramia
AC   CVCL_B7K7
SY   RA; Ra
DR   Wikidata; Q114312767
RX   PubMed=1538137;
RX   PubMed=1852002;
RX   PubMed=3133120;
RX   PubMed=7951244;
RX   PubMed=10725724;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; c.338-25_338del (752delG26bp) (752delG-25) (26-BP DEL, NT752) (I5E6-25_I5E6+1); ClinVar=VCV001435455; Zygosity=Homozygous (PubMed=10725724).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Ramos
AC   CVCL_0597
SY   RAMOS; Ramos 1; RA 1; RA.1; Ra #1; Ra No. 1; Ramos(RA1); Ramos-RA1; Ramos (RA 1); Ramos (RA #1); Ramos (RA)
DR   BTO; BTO_0003079
DR   CLO; CLO_0008738
DR   CLO; CLO_0008739
DR   EFO; EFO_0002077
DR   MCCL; MCC:0000410
DR   CLDB; cl4096
DR   CLDB; cl4097
DR   CLDB; cl4098
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-1596
DR   BCRC; 60252
DR   BEI_Resources; ARP-9938
DR   BioGRID_ORCS_Cell_line; 151
DR   BioSample; SAMN01821590
DR   BioSample; SAMN01821657
DR   BioSample; SAMN03472718
DR   cancercelllines; CVCL_0597
DR   CCRID; 1101HUM-PUMC000048
DR   CCRID; 1102HUM-NIFDC00052
DR   Cell_Model_Passport; SIDM01094
DR   CGH-DB; 9205-4
DR   ChEMBL-Cells; CHEMBL3307664
DR   ChEMBL-Targets; CHEMBL614629
DR   CLS; 302007
DR   Cosmic; 929817
DR   Cosmic; 931111
DR   Cosmic; 991547
DR   Cosmic; 998719
DR   Cosmic; 1037704
DR   Cosmic; 1226864
DR   Cosmic; 1509204
DR   Cosmic; 1517660
DR   Cosmic; 1762459
DR   Cosmic; 1818347
DR   Cosmic; 2750875
DR   Cosmic; 2759408
DR   Cosmic; 2814542
DR   Cosmic; 2823075
DR   DepMap; ACH-001636
DR   DSMZ; ACC-603
DR   DSMZCellDive; ACC-603
DR   ECACC; 85030802
DR   ECACC; 91030710
DR   EGA; EGAS00001000610
DR   FCS-free; 243-2-490-3-4-12
DR   GEO; GSM99388
DR   GEO; GSM987747
DR   GEO; GSM987748
DR   GEO; GSM987749
DR   GEO; GSM1374843
DR   GEO; GSM1374844
DR   GEO; GSM3150254
DR   IARC_TP53; 180
DR   JCRB; JCRB9119
DR   KCLB; 21596
DR   LINCS_HMS; 50811
DR   LINCS_LDP; LCL-1097
DR   Lonza; 725
DR   NCBI_Iran; C128
DR   PharmacoDB; RAMOS_1283_2019
DR   PRIDE; PXD000447
DR   PRIDE; PXD012087
DR   PubChem_Cell_line; CVCL_0597
DR   Wikidata; Q54949198
RX   PubMed=62724;
RX   PubMed=175026;
RX   PubMed=181343;
RX   PubMed=1850347;
RX   PubMed=1915267;
RX   PubMed=2052620;
RX   PubMed=2835030;
RX   PubMed=2985879;
RX   PubMed=2998993;
RX   PubMed=3026973;
RX   PubMed=3159941;
RX   PubMed=3518877;
RX   PubMed=3874327;
RX   PubMed=6231253;
RX   PubMed=6286763;
RX   PubMed=7316467;
RX   PubMed=7757991;
RX   PubMed=8316623;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8896424;
RX   PubMed=9192833;
RX   PubMed=9225077;
RX   PubMed=9473234;
RX   PubMed=9563901;
RX   PubMed=9973220;
RX   PubMed=10739008;
RX   PubMed=10918597;
RX   PubMed=11226526;
RX   PubMed=12967475;
RX   PubMed=18211290;
RX   PubMed=20922763;
RX   PubMed=22885699;
RX   PubMed=24590883;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=31160637;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Ramos
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-485.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/ramos-xenograft-model/
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: 20.4 +- 1.5 hours (PubMed=9225077); 23 hours (PubMed=8402660); 26 hours (PubMed=9563901); 14 hours (PubMed=20922763); ~48 hours (DSMZ=ACC-603).
CC   HLA typing: A*03:01,03:01; B*44:03,51:01; C*16:01,16:01; DQA1*02:01,02:01; DQB1*02:01,02:01; DRB1*07:01,14:103 (PubMed=25960936).
CC   HLA typing: A*03:01,03:01; B*44:03,51:01; C*16:01,16:01; DQA1*02:01,02:01; DQB1*02:01,02:01; DRB1*07:01,14:05 (PubMed=26589293).
CC   HLA typing: A*03:01:01; B*44:160Q,51:01:01; C*16:01:01; DPB1*04:01:01,104:01:01; DQA1*02:01:01; DQB1*02:02:01; DRB1*07:01:01 (CLS=302007).
CC   HLA typing: A*03:01:01,03:01:01; B*44:03:01,51:01:01; C*16:01:01,16:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,104:01; DQA1*02:01:01,02:01:01; DRA*01:01:01,01:01:01; DRB1*07:01:01,07:01:01 (DSMZCellDive=ACC-603).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=10918597).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (PubMed=1915267; PubMed=2052620; PubMed=8344493).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1596; CCRID; CLS=302007; COG; DepMap=ACH-001636; DSMZ=ACC-603; ECACC=85030802; JCRB=JCRB9119; KCLB=21596; PubMed=20922763; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 14,15
ST   D12S391: 19,22
ST   D13S317: 12,13,14 (CLS=302007)
ST   D13S317: 13,14 (ATCC=CRL-1596; CCRID; COG; DepMap=ACH-001636; DSMZ=ACC-603; ECACC=85030802; JCRB=JCRB9119; KCLB=21596; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
ST   D16S539: 10,13
ST   D18S51: 14,15 (CLS=302007; DSMZ=ACC-603)
ST   D18S51: 15 (ATCC=CRL-1596; CCRID; DepMap=ACH-001636; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
ST   D19S433: 14,15.2
ST   D1S1656: 12,15.3
ST   D21S11: 30
ST   D22S1045: 15
ST   D2S1338: 20,23
ST   D2S441: 11,14
ST   D3S1358: 14,15
ST   D5S818: 7,12
ST   D6S1043: 13,15
ST   D7S820: 11
ST   D8S1179: 13 (CLS=302007)
ST   D8S1179: 13,16 (ATCC=CRL-1596; CCRID; DepMap=ACH-001636; DSMZ=ACC-603; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 6,8,21 (CLS=302007)
ST   Penta E: 8,21 (ATCC=CRL-1596; CCRID; DepMap=ACH-001636; DSMZ=ACC-603; PubMed=25877200; Technion Genomics Center)
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   Ramos B7
AC   CVCL_JL65
SY   B7
DR   Wikidata; Q54949199
RX   PubMed=9225077;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8.
CC   Doubling time: 15.6 +- 1.0 hours (PubMed=9225077).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Ramos B7 and Ramos/B95-8 (Cellosaurus=CVCL_ZU79) could be identical.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 14
//
ID   Ramos-AW
AC   CVCL_2702
SY   RAMOS-AW; AW-Ramos; AW-Ra #1
DR   BTO; BTO_0003077
DR   CLO; CLO_0008741
DR   CLDB; cl4099
DR   ECACC; 85062003
DR   Wikidata; Q54949201
RX   PubMed=62724;
RX   PubMed=181343;
RX   PubMed=2835030;
RX   PubMed=3518877;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ECACC=85062003
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13,14
ST   D16S539: 10,13
ST   D5S818: 7,12
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   Ramos-Blue
AC   CVCL_X591
DR   InvivoGen; rms-sp
DR   Wikidata; Q54949202
CC   Population: Caucasian.
CC   Characteristics: Can be used to study the NF-kappaB and AP-1 signaling pathways in B-lymphocytes and in particular the TLR3, TLR7, TLR9 and NOD1 signaling pathways (InvivoGen=rms-sp).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter (InvivoGen=rms-sp).
CC   Virology: EBV-negative.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 20
//
ID   Ramos-Blue KD-Myd
AC   CVCL_X592
DR   InvivoGen; rms-kdmyd
DR   Wikidata; Q54949203
CC   Population: Caucasian.
CC   Characteristics: MyD88-deficient. This cell line does not respond or respond weakly to the activation of receptors which signaling is dependent on MyD88, such as TLR7 and TLR9. However, they are still responsive to TLR3 which is MyD88-independent (InvivoGen=rms-kdmyd).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter (InvivoGen=rms-kdmyd).
CC   Virology: EBV-negative.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 23
//
ID   Ramos-EHRA
AC   CVCL_C003
SY   RAMOS-EHRA; EHRA-RAMOS; EHR-A-Ramos; EHRA-Ra #1
DR   Wikidata; Q54949204
RX   PubMed=62724;
RX   PubMed=181343;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   Ramos-EHRB
AC   CVCL_2703
SY   RAMOS-EHRB; EHRB-RAMOS; EHRB-Ramos; EHR-B-Ramos; EHRB-Ra #1
DR   BTO; BTO_0003078
DR   CLO; CLO_0008742
DR   CLDB; cl4100
DR   ECACC; 85030804
DR   Wikidata; Q54949206
RX   PubMed=62724;
RX   PubMed=181343;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   Ramos.2G6.4C10
AC   CVCL_1646
SY   RAMOS.2G6.4C10; Ramos-2G6-4C10; RAMOS-2G6-4C10; Ramos 2G6.4C10; Ramos 2G6 4C10; RAMOS2G64C10; Ramos.G6.C10; Ramos G6.C10
DR   CLO; CLO_0008740
DR   CLO; CLO_0037054
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1923
DR   BioSample; SAMN03471265
DR   cancercelllines; CVCL_1646
DR   Cell_Model_Passport; SIDM01247
DR   ChEMBL-Cells; CHEMBL3308341
DR   ChEMBL-Targets; CHEMBL2366170
DR   Cosmic; 687851
DR   Cosmic; 910401
DR   Cosmic-CLP; 910401
DR   DepMap; ACH-002300
DR   EGA; EGAS00001000978
DR   GDSC; 910401
DR   GEO; GSM1670358
DR   LINCS_LDP; LCL-2027
DR   PharmacoDB; Ramos2G64C10_1284_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1646
DR   Wikidata; Q54949208
RX   PubMed=1698879;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (DepMap=ACH-002300).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.71%; Native American=43.61%; East Asian, North=3.64%; East Asian, South=0%; South Asian=0%; European, North=22.74%; European, South=25.29% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1923; Cosmic-CLP=910401
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,13
ST   D18S51: 15
ST   D19S433: 14,15.2
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 14,15
ST   D5S818: 7,12
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 8,21
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   Ramos/B95-8
AC   CVCL_ZU79
DR   Wikidata; Q98128806
RX   PubMed=2835030;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Caution: Ramos B7 (Cellosaurus=CVCL_JL65) and Ramos/B95-8 could be identical.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   Ramos/DC-SIGN
AC   CVCL_S546
SY   Ramos DC-SIGN+
DR   BEI_Resources; ARP-9939
DR   Wikidata; Q54949207
RX   PubMed=14972530;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   Ramos/NPC
AC   CVCL_ZU80
DR   Wikidata; Q98128807
RX   PubMed=2835030;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from NPC-KT cell line (Cellosaurus=CVCL_X204).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   Ran De
AC   CVCL_3144
DR   CLO; CLO_0008743
DR   ATCC; CRL-1287
DR   Wikidata; Q54949209
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Ran Nor
AC   CVCL_3145
DR   ATCC; CRL-1135
DR   BioSample; SAMN03472361
DR   JCRB; JCRB9079
DR   Wikidata; Q54949211
CC   Discontinued: ATCC; CRL-1135; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB9079
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   RAN-2
AC   CVCL_G149
SY   Ran-2; alpha RAN-2; 4B6
DR   CLO; CLO_0008744
DR   ATCC; TIB-119
DR   Wikidata; Q54949212
RX   PubMed=7006734;
RX   PubMed=9788274;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13635; Rat Cp (Note=Recognizes a GPI-anchored isoform that is known as the Ran-2 antigen).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   RAN/CTVM3
AC   CVCL_Z160
SY   RAN/CTVM 3
DR   ECACC; 94022806
DR   Wikidata; Q54949213
RX   PubMed=15053931;
RX   PubMed=17662657;
RX   PubMed=22743047;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Discontinued: ECACC; 94022806; true.
OX   NCBI_TaxID=34631; ! Rhipicephalus appendiculatus (Brown ear tick)
SX   Sex unspecified
AG   Moulting nymph
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   RAO-1
AC   CVCL_B0CJ
SY   HMEC 4-hTERT
DR   Wikidata; Q108821205
RX   PubMed=16395697;
RX   PubMed=16729884;
RX   PubMed=29022488;
CC   Doubling time: 36 hours (PubMed=29022488).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   RAO-2
AC   CVCL_B0CK
DR   Wikidata; Q108821206
RX   PubMed=16395697;
RX   PubMed=16729884;
CC   Characteristics: Does not show anchorage-independent growth in soft agar and is not tumorigenic in nude mice (PubMed=16395697).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0CJ ! RAO-1
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   RAO-3
AC   CVCL_B0CL
DR   EFO; EFO_0022699
DR   Wikidata; Q108821207
RX   PubMed=16395697;
RX   PubMed=16729884;
CC   Characteristics: Tumorigenic. Generates human mammary spindle cell carcinomas when injected into nude mice (PubMed=16395697).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0CJ ! RAO-1
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   RAO-4
AC   CVCL_B0CM
DR   Wikidata; Q108821208
RX   PubMed=16395697;
RX   PubMed=16729884;
RX   PubMed=29022488;
CC   Characteristics: Tumorigenic. Generates human mammary epithelial carcinoma when injected into nude mice (PubMed=16395697).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0CJ ! RAO-1
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   Rao-gcl-29
AC   CVCL_6716
DR   Wikidata; Q54949214
RX   PubMed=8397119;
RX   PubMed=15541573;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   Rap1 F/F (#73493-6)
AC   CVCL_UE14
DR   ATCC; CRL-3319
DR   Wikidata; Q98128808
CC   Characteristics: Embryonic fibroblasts that have loxP sites on both sides of the 2nd coding exon of mouse Rap1. Rap1 knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3319).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129P2/Ola x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   RARE
AC   CVCL_M787
DR   Wikidata; Q54949215
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=15126569;
RX   PubMed=17786610;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   Ras-attP-L1
AC   CVCL_5I24
DR   DGRC; 249
DR   FlyBase_Cell_line; FBtc0000249
DR   Wikidata; Q54949216
RX   PubMed=26500255;
CC   Group: Insect cell line.
CC   Doubling time: 75 hours (DGRC=249).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   Ras-attP-L2
AC   CVCL_5I25
DR   DGRC; 250
DR   FlyBase_Cell_line; FBtc0000250
DR   Wikidata; Q54949217
RX   PubMed=26500255;
CC   Group: Insect cell line.
CC   Doubling time: 76 hours (DGRC=250).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   ras/mycSFME
AC   CVCL_A6JT
SY   ras/myc SFME
DR   Wikidata; Q107116708
RX   PubMed=2011405;
RX   PubMed=8376308;
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6JS ! rasSFME
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   Ras[V12]-H1
AC   CVCL_5I26
SY   Ras H1; R1
DR   DGRC; 251
DR   FlyBase_Cell_line; FBtc0000251
DR   Kerafast; EF4003
DR   Wikidata; Q54949219
RX   PubMed=26438832;
CC   Group: Insect cell line.
CC   Doubling time: 41 hours (DGRC=251).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 14
//
ID   Ras[V12]-H3
AC   CVCL_1B60
SY   Ras-H3; Ras H3; R3
DR   DGRC; 200
DR   FlyBase_Cell_line; FBtc0000200
DR   Kerafast; EF4004
DR   Wikidata; Q54949221
RX   PubMed=18670627;
RX   PubMed=26438832;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 45 hours (DGRC=200).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   Ras[V12]-H4
AC   CVCL_5I27
SY   Ras-H4; Ras H4; R4
DR   DGRC; 252
DR   FlyBase_Cell_line; FBtc0000252
DR   Kerafast; EF4005
DR   Wikidata; Q54949222
RX   PubMed=26438832;
CC   Group: Insect cell line.
CC   Doubling time: ~39 hours (DGRC=252).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 14
//
ID   Ras[V12]-H7
AC   CVCL_1B61
SY   Ras-H7; Ras H7; R7
DR   DGRC; 199
DR   FlyBase_Cell_line; FBtc0000199
DR   Kerafast; EF4006
DR   Wikidata; Q54949224
RX   PubMed=18670627;
RX   PubMed=26438832;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Doubling time: 65 hours (DGRC=199).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   Ras[V12]-line-7
AC   CVCL_IY70
DR   DGRC; 188
DR   FlyBase_Cell_line; FBtc0000188
DR   Wikidata; Q54949225
RX   PubMed=18670627;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Discontinued: DGRC; 188; probable.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 9
//
ID   Ras[V12]-wts[RNAi]
AC   CVCL_IY71
SY   Ras[v12];wts[RNAi]; WRR-1
DR   DGRC; 189
DR   FlyBase_Cell_line; FBtc0000189
DR   Wikidata; Q54949226
RX   PubMed=18670627;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Characteristics: Established from embryos carrying Act5C-GAL4, UAS-Ras[V12] and UAS-wts[RNAi] transposons.
CC   Doubling time: 2 days (DGRC=189).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 11
//
ID   RASMC
AC   CVCL_JE54
DR   CLO; CLO_0008746
DR   CLDB; cl4103
DR   Wikidata; Q54949231
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   rasSFME
AC   CVCL_A6JS
SY   Ha-ras-SFME
DR   Wikidata; Q107116709
RX   PubMed=1973170;
CC   Group: Serum/protein free medium cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9102 ! BALB SFME
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   Raszip 6
AC   CVCL_5866
DR   CLO; CLO_0008747
DR   ATCC; CRL-1917
DR   Wikidata; Q54949232
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2165 ! Psi-2
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Rat-1/BB16
AC   CVCL_U152
SY   BB16
DR   BTO; BTO_0004966
DR   Wikidata; Q54949233
RX   PubMed=8856496;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 (B77)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   Rat-1/T7-Cdt1 Cy CB4
AC   CVCL_E3DA
RX   PubMed=16835273;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24576; CDT1 (Note=With mutated cyclin-binding motif and a N-terminal T7 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Rat-1/T7-Cdt1 WB4
AC   CVCL_E3DB
RX   PubMed=16835273;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24576; CDT1 (Note=With a N-terminal T7 tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Rat-1/tsLA29
AC   CVCL_U153
DR   BTO; BTO_0004967
DR   Wikidata; Q54949234
RX   PubMed=8856496;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain tsLA29).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   Rat-2 FGFR-1L
AC   CVCL_C8GY
DR   Wikidata; Q123033310
RX   PubMed=1715572;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95522; Fgfr1 (Note=Isoform long).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Rat-2 FGFR-1S
AC   CVCL_C8GZ
DR   Wikidata; Q123033311
RX   PubMed=1715572;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95522; Fgfr1 (Note=Isoform short).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Rat-BBN-BC
AC   CVCL_ZF58
DR   Wikidata; Q98128809
RX   PubMed=151485;
CC   Doubling time: ~30 hours (PubMed=151485).
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the cell line description.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   Rat-F
AC   CVCL_E2VL
SY   F7.6
RX   PubMed=7523858;
RX   PubMed=8792159;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3657; FES.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Rat-MF
AC   CVCL_E2VM
SY   MF10.4
RX   PubMed=7523858;
RX   PubMed=8792159;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3657; FES (Note=With p.Gly2_Phe3insSerSerLysSerLys to produce an activated myristoylated kinase).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Rat1
AC   CVCL_0492
SY   Rat-1; RAT-1; Rat 1
DR   BTO; BTO_0003293
DR   CLO; CLO_0050238
DR   EFO; EFO_0022730
DR   MCCL; MCC:0000389
DR   ChEMBL-Cells; CHEMBL3307665
DR   ChEMBL-Targets; CHEMBL614630
DR   PubChem_Cell_line; CVCL_0492
DR   RCB; RCB1830
DR   Wikidata; Q54949236
RX   PubMed=3677083;
RX   PubMed=6307528;
RX   PubMed=8668197;
RX   PubMed=9724713;
RX   PubMed=39791722;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-373.html
CC   Doubling time: 16-20 hours (PubMed=8668197).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8352 ! F2408
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Rat1-GFP
AC   CVCL_D5JS
DR   Wikidata; Q127384008
RX   PubMed=33893343;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   Rat1-R12
AC   CVCL_4695
DR   BTO; BTO_0003294
DR   CLO; CLO_0008748
DR   ATCC; CRL-2210
DR   TOKU-E; 2973
DR   Wikidata; Q54949237
CC   Discontinued: ATCC; CRL-2210; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Rat1A
AC   CVCL_0512
SY   RAT1A; Rat1a; Rat-1A; Rat 1A
DR   MCCL; MCC:0000411
DR   ATCC; CRL-2786
DR   ATCC; JHU-25
DR   Wikidata; Q54949238
CC   Discontinued: ATCC; CRL-2786; true.
CC   Discontinued: ATCC; JHU-25; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   Rat1A-myc
AC   CVCL_J915
SY   Rat1a-myc
DR   ATCC; JHU-26
DR   Wikidata; Q54949239
RX   PubMed=8041712;
CC   Discontinued: ATCC; JHU-26; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0512 ! Rat1A
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   Rat2
AC   CVCL_0513
SY   RAT2; Rat-2; RAT-2; Rat 2
DR   BTO; BTO_0002874
DR   CLO; CLO_0008749
DR   CLO; CLO_0008750
DR   EFO; EFO_0022780
DR   MCCL; MCC:0000412
DR   CLDB; cl4104
DR   CLDB; cl4105
DR   CLDB; cl4106
DR   ATCC; CRL-1764
DR   BCRC; 60322
DR   ECACC; 94050409
DR   IZSLER; BS CL 231
DR   JCRB; IFO50282
DR   Lonza; 379
DR   TOKU-E; 2974
DR   Wikidata; Q54949241
RX   PubMed=3677083;
RX   PubMed=6307528;
RX   PubMed=7269249;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-277.html
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Rat2 lambda/lacI
AC   CVCL_W995
SY   Rat2lambdalacI
DR   Wikidata; Q54949242
RX   PubMed=7885368;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03023; Escherichia coli lacI.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   Rat2/Tyro3
AC   CVCL_E9CH
RX   PubMed=8058320;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:104294; Tyro3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0513 ! Rat2
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   raTAL
AC   CVCL_0G07
SY   rat Thick Ascending Limb
DR   Wikidata; Q54949243
RX   PubMed=17670898;
RX   PubMed=29460274;
CC   Derived from site: In situ; Kidney, nephron, thick ascending limb of loop of Henle; UBERON=UBERON_0001291.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   RatB1a
AC   CVCL_G296
SY   RatB1A; Rat-B1A; Rat-B1a; Rat B1a; Rat B1A; Rat1 B1a(+/+)
DR   Wikidata; Q54949244
RX   PubMed=8502998;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   RatCE
AC   CVCL_6E32
SY   Rat Corneal Epithelial
DR   Wikidata; Q54949245
RX   PubMed=7513119;
CC   Doubling time: 18.3 hours (PubMed=7513119).
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   RATV-NRK
AC   CVCL_6437
DR   CLO; CLO_0008751
DR   ATCC; CRL-6510
DR   Wikidata; Q54949247
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6510; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   RAUi001-A
AC   CVCL_D0KS
SY   Lil-8
DR   BioSamples; SAMEA113441832
DR   hPSCreg; RAUi001-A
DR   Wikidata; Q123033312
RX   PubMed=37354743;
CC   From: Russian-Armenian University; Yerevan; Armenia.
CC   Population: Caucasian; Armenian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0KT ! RAUi001-B
OI   CVCL_D0KU ! RAUi001-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RAUi001-B
AC   CVCL_D0KT
SY   Lil-11
DR   BioSamples; SAMEA113542864
DR   hPSCreg; RAUi001-B
DR   Wikidata; Q123033313
RX   PubMed=37354743;
CC   From: Russian-Armenian University; Yerevan; Armenia.
CC   Population: Caucasian; Armenian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0KS ! RAUi001-A
OI   CVCL_D0KU ! RAUi001-C
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RAUi001-C
AC   CVCL_D0KU
SY   Lil-13
DR   BioSamples; SAMEA113543411
DR   hPSCreg; RAUi001-C
DR   Wikidata; Q123033314
RX   PubMed=37354743;
CC   From: Russian-Armenian University; Yerevan; Armenia.
CC   Population: Caucasian; Armenian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0KS ! RAUi001-A
OI   CVCL_D0KT ! RAUi001-B
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RAUi002-A
AC   CVCL_E4EL
DR   BioSamples; SAMEA115177875
DR   hPSCreg; RAUi002-A
RX   PubMed=38892289;
CC   From: Russian-Armenian University; Yerevan; Armenia.
CC   Population: Caucasian; Armenian.
CC   Sequence variation: Mutation; HGNC; HGNC:6998; MEFV; Simple; p.Met694Val (c.2080A>G); ClinVar=VCV000002538; Zygosity=Homozygous (PubMed=38892289).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84707; Familial Mediterranean fever
DI   ORDO; Orphanet_342; Familial Mediterranean fever
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RAW 264
AC   CVCL_4478
SY   RAW264
DR   CLO; CLO_0008752
DR   CLDB; cl4108
DR   ECACC; 85062803
DR   RCB; RCB0535
DR   Wikidata; Q28335587
RX   PubMed=212198;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   RAW 264.7
AC   CVCL_0493
SY   RAW264; RAW2647; RAW264.7; RAW-264.7; Raw 264.7; Raw264.7
DR   BTO; BTO_0003292
DR   CLO; CLO_0008753
DR   CLO; CLO_0051424
DR   EFO; EFO_0001231
DR   MCCL; MCC:0000390
DR   CLDB; cl4110
DR   CLDB; cl7129
DR   Abcam; ab275474
DR   AddexBio; C0003008/444
DR   ATCC; TIB-71
DR   BCRC; 60001
DR   BCRJ; 0212
DR   BioSample; SAMN11397665
DR   CCRID; 1101MOU-PUMC000146
DR   CCRID; 3101MOUSCSP5036
DR   CCRID; 3101MOUTCM13
DR   CCRID; 4201MOU-CCTCC00143
DR   CCRID; 6101MOU-CERC000109
DR   CCTCC; GDC0143
DR   ChEMBL-Cells; CHEMBL3307977
DR   ChEMBL-Targets; CHEMBL612557
DR   CLS; 400319
DR   ECACC; 91062702
DR   FCS-free; 225-5-468-2-3-3
DR   IBRC; C10072
DR   ICLC; ATL02001
DR   IZSLER; BS TCL 177
DR   KCB; KCB 200603YJ
DR   KCLB; 40071
DR   Lonza; 674
DR   MeSH; D000067996
DR   MetaboLights; MTBLS23
DR   MetaboLights; MTBL1140
DR   MetaboLights; MTBLS636
DR   MetaboLights; MTBLS696
DR   NCBI_Iran; C639
DR   PRIDE; PXD000984
DR   PRIDE; PXD001293
DR   PRIDE; PXD001905
DR   PRIDE; PXD001935
DR   PRIDE; PXD003545
DR   PubChem_Cell_line; CVCL_0493
DR   TOKU-E; 2976
DR   TOKU-E; 4095
DR   Ubigene; YC-C020
DR   Wikidata; Q28335461
RX   DOI=10.5897/IJBMBR2013.0154;
RX   PubMed=212198;
RX   PubMed=3792703;
RX   PubMed=16948499;
RX   PubMed=19057837;
RX   PubMed=19144319;
RX   PubMed=22735334;
RX   PubMed=23430347;
RX   PubMed=25277546;
RX   PubMed=25504905;
RX   PubMed=29889899;
RX   PubMed=31220119;
RX   PubMed=31947698;
RX   PubMed=33389257;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-tib-71
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/tib-71-growth-and-morphology
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=RAW264.7
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-325.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 11 hours (Note=From cell counting), 12 hours (Note=From absorbance) (DOI=10.5897/IJBMBR2013.0154); ~30 hours (CLS=400319).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Omics: Metabolomics.
CC   Omics: Proteomics; Subcellular; Phagosome.
CC   Omics: Proteomics; Subcellular; Phagosome; Quantitative.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: PubMed=23430347 has a different value for STR 6-4 (17) than that of NIST (18) due to a change in the marker motif (personal communication of Almeida, Jamie L.).
CC   Misspelling: RAW 267.4; Note=Occasionally.
CC   Misspelling: Raw 267.4; Note=Occasionally.
CC   Misspelling: RAW267.4; Note=Occasionally.
CC   Misspelling: RAW 274; Note=Occasionally.
CC   Misspelling: RAW-274; Note=Occasionally.
CC   Misspelling: RAW274; Note=Occasionally.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=23430347; PubMed=31220119; Ubigene=YC-C020
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 22.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 9-2: 15
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 14,16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 24
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4478 ! RAW 264
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   RAW 264.7 Atg16l1 KO
AC   CVCL_D7EZ
SY   RAW 264.7 Atg16L1 KO
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1924290; Atg16l1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL71 ! RAW 264.7 LRRK2 parental
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   RAW 264.7 Clcn7 KO
AC   CVCL_F1Z3
SY   RAW 264.7 Clc-7KO
RX   DOI=10.1101/2025.11.19.689251;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1347048; Clcn7.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   RAW 264.7 Ern1 KO
AC   CVCL_C8RU
SY   IRE-1 KO RAW 264.7
DR   Wikidata; Q123033315
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1930134; Ern1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 Gabarap KO
AC   CVCL_D7F0
SY   RAW 264.7 GABARAP KO
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1861742; Gabarap.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL71 ! RAW 264.7 LRRK2 parental
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   RAW 264.7 Gabarap KO + HA-human GABARAP
AC   CVCL_E2WX
SY   RAW 264.7 GABARAP KO + HA-Gabarap (human)
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1861742; Gabarap.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4067; GABARAP (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7F0 ! RAW 264.7 Gabarap KO
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 gammaNO(-)
AC   CVCL_6517
SY   RAW 264.7 gamma NO(-)
DR   CLO; CLO_0008754
DR   ATCC; CRL-2278
DR   BioSample; SAMN11397644
DR   Wikidata; Q54949248
RX   PubMed=31220119;
CC   Characteristics: Unlike the parental cell line, does not produce nitric oxide upon treatment with interferon-gamma alone, but requires LPS for full activation (ATCC=CRL-2278).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 22.3,23.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 14,16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12,14
ST   Mouse STR X-1: 25
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   RAW 264.7 Gba KO
AC   CVCL_C8RT
SY   GBA KO RAW 264.7
DR   Wikidata; Q123033316
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95665; Gba.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 Gys1 KO
AC   CVCL_F0Q7
SY   RAW 264.7-KO-Gys1; RAW 264.7-mGys1_02-B10_KO
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:101805; Gys1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Zhang, Ai-Hua.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RAW 264.7 Gys1-Flag OE
AC   CVCL_F0Q8
SY   RAW 264.7-OE-Gys1; Raw264.7-mGys1-FLAG_OE (Puro)
CC   Characteristics: Transduced with a EF1a-mGys1-FLAG-PGKp-PuroR construct (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:101805; Gys1 (Note=With a C-terminal FLAG tag).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Zhang, Ai-Hua.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RAW 264.7 Ikbke KO
AC   CVCL_D7F1
SY   RAW 264.7 IKKe KO
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1929612; Ikbke.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL71 ! RAW 264.7 LRRK2 parental
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   RAW 264.7 Irf3 KO
AC   CVCL_C8HB
SY   IRF3 KO RAW 264.7
DR   Wikidata; Q123033317
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1859179; Irf3.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 LRRK2 KO
AC   CVCL_UL72
SY   LRRK2 KO RAW 264.7
DR   ATCC; SC-6004
DR   Wikidata; Q98128810
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 7
//
ID   RAW 264.7 Lrrk2 KO
AC   CVCL_C8HC
SY   LRRK2 KO RAW 264.7
DR   Wikidata; Q123033318
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1913975; Lrrk2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 4
//
ID   RAW 264.7 Lrrk2 KO + HA-human GABARAP
AC   CVCL_E2WY
SY   RAW 264.7 LRRR2KO + HA-Gabarap (human)
RX   PubMed=39812709;
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4067; GABARAP (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL72 ! RAW 264.7 LRRK2 KO
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Lrrk2 KO + HALO-human LRRK2
AC   CVCL_D7F8
SY   RAW 264.7 LRRK2KO + HALO-LRRK2 (human)
RX   PubMed=39812709;
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18618; LRRK2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL72 ! RAW 264.7 LRRK2 KO
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Lrrk2 KO + HALO-human LRRK2 LIR1 mutant + HA-human GABARAP
AC   CVCL_E2WZ
SY   RAW 264.7 LRRK2KO + HALO-LRRK2 (LIR1 mutant, human) + HA-Gabarap (human)
RX   PubMed=39812709;
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4067; GABARAP (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18618; LRRK2 (Note=With p.Trp109Ala and p.Leu112Ala = LIR1 mutant).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E2WY ! RAW 264.7 Lrrk2 KO + HA-human GABARAP
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Lrrk2 KO + HALO-human LRRK2 LIR1+LIR2 mutant + HA-human GABARAP
AC   CVCL_E2X1
SY   RAW 264.7 LRRK2KO + HALO-LRRK2 (LIR1+LIR2 mutant, human) + HA-Gabarap (human)
RX   PubMed=39812709;
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4067; GABARAP (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18618; LRRK2 (Note=With p.Trp109Ala, p.Leu112Ala, p.Trp875Ala and p.Ile878Ala = LIR1+LIR2 mutant).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E2WY ! RAW 264.7 Lrrk2 KO + HA-human GABARAP
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Lrrk2 KO + HALO-human LRRK2 LIR2 mutant + HA-human GABARAP
AC   CVCL_E2X0
SY   RAW 264.7 LRRK2KO + HALO-LRRK2 (LIR2 mutant, human) + HA-Gabarap (human)
RX   PubMed=39812709;
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4067; GABARAP (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18618; LRRK2 (Note=With p.Trp875Ala and p.Ile878Ala = LIR2 mutant).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E2WY ! RAW 264.7 Lrrk2 KO + HA-human GABARAP
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Lrrk2 KO + HALO-human LRRK2 + HA-human GABARAP
AC   CVCL_D7F9
SY   RAW 264.7 LRRK2KO + HALO-human LRRK2 + HA-human GABARAP
RX   PubMed=39812709;
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4067; GABARAP (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18618; LRRK2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7F8 ! RAW 264.7 Lrrk2 KO + HALO-human LRRK2
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Lrrk2 KO + HALO-human LRRK2(3xRabmut)
AC   CVCL_F1Z4
SY   RAW 264.7 LRRK2 KO+Halo-human LRRK2(Rab binding mutant)
RX   DOI=10.1101/2025.11.19.689251;
CC   Knockout cell: Method=ZFN; MGI; MGI:1913975; Lrrk2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18618; LRRK2 (Note=With p.Lys17Ala, p.Lys18Ala, p.Glu240Arg and p.Lys439Glu).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL72 ! RAW 264.7 LRRK2 KO
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   RAW 264.7 LRRK2 parental
AC   CVCL_UL71
SY   LRRK2 parental RAW 264.7
DR   ATCC; SC-6003
DR   Wikidata; Q98128811
CC   Characteristics: Control cell line for RAW 264.7 LRRK2 KO and RAW 264.7 LRRK2 T1348N mut.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RAW 264.7 LRRK2 T1348N mut
AC   CVCL_UL73
SY   LRRK2 T1348N mut RAW 264.7
DR   ATCC; SC-6005
DR   Wikidata; Q98128812
CC   Sequence variation: Mutation; MGI; MGI:1913975; Lrrk2; Simple_edited; p.Thr1348Asn (c.4043A>C); Zygosity=Homozygous; Note=By ZFN (ATCC=SC-6005).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   RAW 264.7 mCherry-SopF
AC   CVCL_D7F2
RX   PubMed=39812709;
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; Q8ZPY9; Salmonella typhimurium sopF.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL71 ! RAW 264.7 LRRK2 parental
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Ppm1h KO
AC   CVCL_C8RV
SY   PPM1H KO RAW 264.7
DR   Wikidata; Q123033319
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2442087; Ppm1h.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 Rab10 KO
AC   CVCL_C8RW
SY   Rab10 KO RAW 264.7
DR   Wikidata; Q123033320
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:105066; Rab10.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 Rab29 KO
AC   CVCL_C8RX
SY   Rab29 KO RAW 264.7
DR   Wikidata; Q123033321
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2385107; Rab29.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 Rab8a KO
AC   CVCL_C8RY
SY   Rab8 KO RAW 264.7
DR   Wikidata; Q123033322
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96960; Rab8a.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 Rb1cc1 KO
AC   CVCL_E2WW
SY   RAW 264.7 FIP200 KO; RAW 264.7 FIP200KO
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341850; Rb1cc1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL71 ! RAW 264.7 LRRK2 parental
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   RAW 264.7 shRNA-RSK2
AC   CVCL_ZD89
SY   RSK2 Knockdown RAW264.7 Cell Line
DR   Kerafast; EMN023-FP
DR   Wikidata; Q98128813
RX   PubMed=29563609;
CC   Knockout cell: Method=shRNA knockdown; MGI; MGI:104557; Rps6ka3.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   RAW 264.7 Sting1 KO
AC   CVCL_D7F3
SY   RAW 264.7 STING KO
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919762; Sting1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Sting1 KO + Sting1
AC   CVCL_D7F4
SY   RAW 264.7 STING KO + mouse STING (WT)
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7F3 ! RAW 264.7 Sting1 KO
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Sting1 KO + Sting1 (AA 1-339)
AC   CVCL_D7F5
SY   RAW 264.7 STING KO + mouse STING (amino acids 1-339)
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=MGI; MGI:1919762; Sting1 (Note=With p.Val340_Ile378del).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7F3 ! RAW 264.7 Sting1 KO
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   RAW 264.7 Sting1 R330A/R333A
AC   CVCL_C8HE
DR   Wikidata; Q123033324
CC   Sequence variation: Mutation; MGI; MGI:1919762; Sting1; Simple_edited; p.Arg330Ala; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Sequence variation: Mutation; MGI; MGI:1919762; Sting1; Simple_edited; p.Arg333Ala; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RAW 264.7 Tbk1 KO
AC   CVCL_D7F6
SY   RAW 264.7 TBK1 KO
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1929658; Tbk1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UL71 ! RAW 264.7 LRRK2 parental
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   RAW 264.7 Tbk1 KO + Ikbke KO
AC   CVCL_D7F7
SY   RAW 264.7 TBK1 KO + IKKe KO
RX   PubMed=39812709;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1929612; Ikbke.
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1929658; Tbk1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7F6 ! RAW 264.7 Tbk1 KO
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   RAW 264.7-EGFP
AC   CVCL_C8WQ
DR   Ubigene; YC-C020-EGFP-P
DR   Wikidata; Q123033327
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   RAW 264.7/LR5
AC   CVCL_6717
SY   RAW/LR5
DR   BTO; BTO_0002601
DR   Wikidata; Q54949268
RX   PubMed=9348306;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03023; Escherichia coli lacI.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   RAW 309
AC   CVCL_L110
DR   Wikidata; Q54949249
RX   PubMed=212198;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   RAW 309 Cr.1
AC   CVCL_3576
SY   RAW 309Cr.1; RAW309Cr.1
DR   CLO; CLO_0008755
DR   ATCC; TIB-69
DR   KCLB; 40069
DR   Wikidata; Q54949251
RX   PubMed=212198;
RX   PubMed=3792703;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L110 ! RAW 309
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   RAW 309F.1.1
AC   CVCL_3577
SY   RAW309F.1.1; RAW 309F.1
DR   CLO; CLO_0008756
DR   ATCC; TIB-51
DR   IZSLER; BS TCL 244
DR   Wikidata; Q54949252
RX   PubMed=212198;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_L110 ! RAW 309
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   RAW 8.1
AC   CVCL_3578
DR   CLO; CLO_0008757
DR   ATCC; TIB-50
DR   Wikidata; Q54949253
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   RAW-ASC
AC   CVCL_A7ZG
DR   InvivoGen; raw-asc
DR   Wikidata; Q107116710
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   RAW-ASC KO-CASP11
AC   CVCL_A7ZI
DR   InvivoGen; raw-kocasp11
DR   Wikidata; Q107116711
CC   Knockout cell: Method=Not specified; MGI; MGI:107700; Casp4.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7ZG ! RAW-ASC
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   RAW-ASC KO-GSDMD
AC   CVCL_A7ZH
DR   InvivoGen; raw-kogsdmd
DR   Wikidata; Q107116713
CC   Knockout cell: Method=Not specified; MGI; MGI:1916396; Gsdmd.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7ZG ! RAW-ASC
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   RAW-ASC KO-NLRC4
AC   CVCL_A7ZJ
DR   InvivoGen; raw-konlrc4
DR   Wikidata; Q107116714
CC   Knockout cell: Method=Not specified; MGI; MGI:3036243; Nlrc4.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7ZG ! RAW-ASC
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   RAW-Blue
AC   CVCL_X594
DR   InvivoGen; raw-blue
DR   Wikidata; Q54949254
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter (InvivoGen=raw-blue).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 15
//
ID   RAW-Blue ISG
AC   CVCL_X595
DR   InvivoGen; raw-isg
DR   Wikidata; Q54949255
WW   Provider; InvivoGen; raw-isg; https://web.archive.org/web/20200918124645/www.invivogen.com/raw-blue-isg
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE (InVivoGen=raw-isg).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Discontinued: InvivoGen; raw-isg; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 15
//
ID   RAW-D
AC   CVCL_F681
SY   RAW264 cell D; D clone; RAW264.7D; RAW264 cell Differentiation
DR   Wikidata; Q54949256
RX   PubMed=14709158;
RX   PubMed=15452179;
RX   PubMed=15812249;
CC   Characteristics: Differentiates into osteoclast-like multinucleated cells at a very high rate even at low concentrations of RANKL (PubMed=14709158).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   RAW-Difluo mLC3
AC   CVCL_A8CB
DR   InvivoGen; rawdf-mlc3
DR   Wikidata; Q107116715
CC   Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy. Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen=rawdf-mlc3).
CC   Characteristics: Stably expresses a RFP-GFP-Map1lc3b construct (InvivoGen=rawdf-mlc3).
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1914693; Map1lc3b.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   RAW-Dual
AC   CVCL_A7ZK
SY   RAW IRF-Lucia/KI-[MIP-2]SEAP
DR   InvivoGen; rawd-ismip
DR   Wikidata; Q107116716
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. ALPP expression depends on the activation of the endogenous MIP-2/CXCL2 promoter as the Cxcl2 gene has been replaced by ALPP. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawd-ismip).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1340094; Cxcl2.
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   RAW-Dual KO-TLR4
AC   CVCL_A7ZL
DR   InvivoGen; rawd-kotlr4
DR   Wikidata; Q107116717
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. ALPP expression depends on the activation of the endogenous MIP-2/CXCL2 promoter as the Cxcl2 gene has been replaced by ALPP. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawd-kotlr4).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1340094; Cxcl2.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96824; Tlr4.
CC   Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A7ZK ! RAW-Dual
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   RAW-E6
AC   CVCL_C3NB
DR   Wikidata; Q116050159
RX   PubMed=22117523;
RX   PubMed=24341278;
CC   Characteristics: Expresses a EGFP-ESAT-6 fusion protein (PubMed=22117523).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P9WNK7; Mycobacterium tuberculosis ESAT-6 (esxA).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   RAW-EGFP
AC   CVCL_C3NC
DR   Wikidata; Q116050160
RX   PubMed=22117523;
RX   PubMed=24341278;
CC   Characteristics: Control cell line for RAW-E6 (Cellosaurus=CVCL_C3NB).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   RAW-Kb
AC   CVCL_C8H9
SY   Raw264.7-Kb
DR   Wikidata; Q123033328
RX   PubMed=23674617;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   RAW-Kb-Mito gB30-694
AC   CVCL_C8HA
DR   Wikidata; Q123033329
RX   PubMed=23674617;
CC   Characteristics: Transfected with a pIRES-gB30-694-Mito vector that contains the mitochondrial matrix-targeting sequence from human COX8A followed by HSV-1 gB30-694 (PubMed=23674617).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2294; COX8A (Note=With p.Pro30_Glu69del).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06436; Human herpesvirus 1 glycoprotein B (gB) (Note=With p.Met1_Ala29del and p.Asp695_Leu903del = gB30-694).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8H9 ! RAW-Kb
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   RAW-Kb-Mito gB30-694 Cd14 KO
AC   CVCL_F0LD
SY   RAW 264.7 Cd14 KO; CD14 KO RAW 264.7
CC   Characteristics: Transfected with a pIRES-gB30-694-Mito vector that contains the mitochondrial matrix-targeting sequence from human COX8A followed by HSV-1 gB30-694 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88318; Cd14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2294; COX8A (Note=With p.Pro30_Glu69del).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06436; Human herpesvirus 1 glycoprotein B (gB) (Note=With p.Met1_Ala29del and p.Asp695_Leu903del = gB30-694).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8HA ! RAW-Kb-Mito gB30-694
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RAW-Kb-Mito gB30-694 Sting1 KO
AC   CVCL_C8HD
SY   RAW 264.7 Sting1 KO; STING KO RAW 264.7
DR   Wikidata; Q123033323
CC   Characteristics: Transfected with a pIRES-gB30-694-Mito vector that contains the mitochondrial matrix-targeting sequence from human COX8A followed by HSV-1 gB30-694 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2294; COX8A (Note=With p.Pro30_Glu69del).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06436; Human herpesvirus 1 glycoprotein B (gB) (Note=With p.Met1_Ala29del and p.Asp695_Leu903del = gB30-694).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8HA ! RAW-Kb-Mito gB30-694
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   RAW-Kb-Mito gB30-694 Xbp1 KO
AC   CVCL_C8HF
SY   RAW 264.7 Xbp1 KO; XBP1 KO RAW 264.7
DR   Wikidata; Q123033325
CC   Characteristics: Transfected with a pIRES-gB30-694-Mito vector that contains the mitochondrial matrix-targeting sequence from human COX8A followed by HSV-1 gB30-694 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98970; Xbp1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2294; COX8A (Note=With p.Pro30_Glu69del).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06436; Human herpesvirus 1 glycoprotein B (gB) (Note=With p.Met1_Ala29del and p.Asp695_Leu903del = gB30-694).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Miscellaneous: Cell line information from personal communication of Rodriguez-Moya, Lilia.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8HA ! RAW-Kb-Mito gB30-694
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   RAW-Lucia ISG
AC   CVCL_X596
DR   InvivoGen; rawl-isg
DR   Wikidata; Q54949257
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-isg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 16
//
ID   RAW-Lucia ISG-KO-cGAS
AC   CVCL_5I67
DR   InvivoGen; rawl-kocgas
DR   Wikidata; Q54949258
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-kocgas).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2442261; Cgas.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   RAW-Lucia ISG-KO-IFI16
AC   CVCL_5I68
DR   InvivoGen; rawl-koif16
DR   Wikidata; Q54949259
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koif16).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96429; Ifi204.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   RAW-Lucia ISG-KO-IRF1
AC   CVCL_A7ZA
DR   InvivoGen; rawl-koirf1
DR   Wikidata; Q107116718
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koirf1).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96590; Irf1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   RAW-Lucia ISG-KO-IRF3
AC   CVCL_5I69
DR   InvivoGen; rawl-koirf3
DR   Wikidata; Q54949260
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koirf3).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1859179; Irf3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   RAW-Lucia ISG-KO-IRF5
AC   CVCL_A7ZC
DR   InvivoGen; rawl-koirf5
DR   Wikidata; Q107116719
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koirf5).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1350924; Irf5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   RAW-Lucia ISG-KO-IRF7
AC   CVCL_A7ZD
DR   InvivoGen; rawl-koirf7
DR   Wikidata; Q107116720
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koirf7).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1859212; Irf7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   RAW-Lucia ISG-KO-MAVS
AC   CVCL_A7ZE
DR   InvivoGen; rawl-komavs
DR   Wikidata; Q107116721
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-komavs).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2444773; Mavs.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   RAW-Lucia ISG-KO-MDA5
AC   CVCL_A7ZF
DR   InvivoGen; rawl-komda5
DR   Wikidata; Q107116722
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-komda5).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1918836; Ifih1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   RAW-Lucia ISG-KO-RIG-I
AC   CVCL_5I70
DR   InvivoGen; rawl-korigi
DR   Wikidata; Q54949261
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-korigi).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2442858; Ddx58.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   RAW-Lucia ISG-KO-STING
AC   CVCL_X597
DR   InvivoGen; rawl-kostg
DR   Wikidata; Q54949263
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-kostg).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 18
//
ID   RAW-Lucia ISG-KO-TBK1
AC   CVCL_5I71
DR   InvivoGen; rawl-kotbk
DR   Wikidata; Q54949264
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-kotbk).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1929658; Tbk1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   RAW-Lucia ISG-KO-TREX1
AC   CVCL_5I72
DR   InvivoGen; rawl-kotrex
DR   Wikidata; Q54949265
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-kotrex).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1328317; Trex1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   RAW-Lucia ISG-KO-TRIF
AC   CVCL_A7ZB
DR   InvivoGen; rawl-kotrif
DR   Wikidata; Q107116723
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-kotrif).
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:2147032; Ticam1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_X596 ! RAW-Lucia ISG
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   RAW-N
AC   CVCL_C6WW
SY   RAW264 cell N; N clone; RAW264 cell Non-differentiation
DR   Wikidata; Q117704802
RX   PubMed=14709158;
RX   PubMed=15452179;
CC   Characteristics: Incapable of differentiating into osteoclast-like multinucleated cells (PubMed=14709158).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW-TT10
AC   CVCL_9W02
DR   Wikidata; Q54949266
RX   PubMed=10548109;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   RAW264-TG3
AC   CVCL_1P00
SY   RAW 264-TG3
DR   Wikidata; Q54949269
RX   Patent=US4970162;
RX   PubMed=3741419;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 11
//
ID   RAW264.7 clone C1
AC   CVCL_C6WZ
DR   Wikidata; Q117704803
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C10
AC   CVCL_C6X8
DR   Wikidata; Q117704804
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C11
AC   CVCL_C6X9
DR   Wikidata; Q117704805
RX   PubMed=16948499;
CC   Characteristics: Differentiates well into osteoclast upon treatment with RANK (PubMed=16948499).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C12
AC   CVCL_C6XA
DR   Wikidata; Q117704806
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C2
AC   CVCL_C6X0
DR   Wikidata; Q117704807
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C3
AC   CVCL_C6X1
DR   Wikidata; Q117704808
RX   PubMed=16948499;
CC   Characteristics: Differentiates well into osteoclast upon treatment with RANK (PubMed=16948499).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C4
AC   CVCL_C6X2
DR   Wikidata; Q117704809
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C5
AC   CVCL_C6X3
DR   Wikidata; Q117704810
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C6
AC   CVCL_C6X4
DR   Wikidata; Q117704811
RX   PubMed=16948499;
CC   Characteristics: Differentiates well into osteoclast upon treatment with RANK (PubMed=16948499).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C7
AC   CVCL_C6X5
DR   Wikidata; Q117704812
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C8
AC   CVCL_C6X6
DR   Wikidata; Q117704814
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone C9
AC   CVCL_C6X7
DR   Wikidata; Q117704815
RX   PubMed=16948499;
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone H9
AC   CVCL_C6WX
SY   H9.2d5
DR   Wikidata; Q117704816
RX   PubMed=31947698;
CC   Characteristics: Forms osteoclast-like cells capable of bone resorption faster than the parent cell line. Presents a higher expression of osteoclast markers in cultures without added RANKL compared to the parental cell line (PubMed=31947698).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7 clone J8
AC   CVCL_C6WY
SY   J8.2g6
DR   Wikidata; Q117704817
RX   PubMed=31947698;
CC   Characteristics: Compared to parent cell line, does not form multinucleated TRAP-positive cells or exhibit other osteoclast-characteristics (PubMed=31947698).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   RAW264.7/HNP
AC   CVCL_C6XG
DR   Wikidata; Q117704818
RX   PubMed=8329717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2761; DEFA1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   Ray Hot
AC   CVCL_3784
DR   CLO; CLO_0008758
DR   ATCC; CRL-1226
DR   Wikidata; Q54949270
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   RB [Aotus]
AC   CVCL_L985
DR   BioSample; SAMN03151877
DR   Wikidata; Q54949272
RX   PubMed=68093;
RX   PubMed=265539;
RX   PubMed=7005696;
RX   PubMed=7192801;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=29533902;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NYT; -; https://www.nytimes.com/1981/01/22/us/cells-in-disease-study-said-to-come-from-monkeys.html
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to derive from OMK-210 from owl monkey (PubMed=7192801; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00083.
CC   Anecdotal: Part of a set of 4 cell lines that were fraudulently stated to originate from Hodgkin lymphoma (PubMed=265539).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9505; ! Aotus trivirgatus (Three-striped night monkey)
HI   CVCL_L983 ! OMK-210
SX   Female
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   RB [Human LGMD2B myoblast]
AC   CVCL_VG63
DR   Wikidata; Q54949273
WW   Provider; Jain Foundation; -; https://www.jain-foundation.org/research/access-resources/research-tools/cell-lines/
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Glu1833Ter (c.5497G>T) (p.Glu1872Ter, c.5614G>T); ClinVar=VCV000094339; Zygosity=Heterozygous (Jain Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; c.6063+1G>A (c.5946+1G>A); ClinVar=VCV000094349; Zygosity=Heterozygous; Note=Splice donor mutation (Jain Foundation).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Forearm, muscle; UBERON=UBERON_0004254.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142080; Limb-girdle muscular dystrophy type 2B
DI   ORDO; Orphanet_268; Dysferlin-related limb-girdle muscular dystrophy R2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Telomerase immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 15
//
ID   RB 4087
AC   CVCL_A2MR
SY   RB4087; ND1BE
DR   Wikidata; Q105510636
RX   Patent=US5773219;
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=8643543;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4361
AC   CVCL_A2NG
DR   Wikidata; Q105510638
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 4436
AC   CVCL_A2MS
SY   RB4436; ND2BE
DR   Wikidata; Q105510643
RX   Patent=US5773219;
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=8643543;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4468
AC   CVCL_A2MT
SY   RB4468; ND3BE
DR   Wikidata; Q105510646
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4470
AC   CVCL_A2MU
SY   RB4470; ND4BE
DR   Wikidata; Q105510650
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4492
AC   CVCL_A2MV
SY   RB4492: ND5BE
DR   Wikidata; Q105510653
RX   Patent=US5773219;
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
RX   PubMed=8643543;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4494
AC   CVCL_A2MW
SY   RB4494; ND6BE
DR   Wikidata; Q105510656
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4581
AC   CVCL_A2MX
SY   RB4581; ND7BE
DR   Wikidata; Q105510659
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4582
AC   CVCL_A2MY
SY   RB4582; ND8BE
DR   Wikidata; Q105510664
RX   PubMed=3941662;
RX   PubMed=6621576;
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 4963
AC   CVCL_A2MZ
SY   AD2BE
DR   Wikidata; Q105510668
RX   PubMed=3941662;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 5014
AC   CVCL_A2NN
DR   Wikidata; Q105510673
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 5053
AC   CVCL_A2NA
SY   AD3BE
DR   Wikidata; Q105510675
RX   PubMed=3941662;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 5061
AC   CVCL_A2NC
DR   Wikidata; Q105510677
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 5062
AC   CVCL_A2NH
DR   Wikidata; Q105510680
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 5064
AC   CVCL_A2NI
DR   Wikidata; Q105510684
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 5065
AC   CVCL_A2ND
DR   Wikidata; Q105510687
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 5175
AC   CVCL_A2NB
SY   AD4BE
DR   Wikidata; Q105510689
RX   PubMed=3941662;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 5204
AC   CVCL_A2NJ
DR   Wikidata; Q105510692
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 5205
AC   CVCL_A2NE
DR   Wikidata; Q105510695
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 5206
AC   CVCL_A2NF
DR   Wikidata; Q105510697
RX   PubMed=6726265;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RB 5207
AC   CVCL_A2NK
DR   Wikidata; Q105510700
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 5333
AC   CVCL_A2NL
DR   Wikidata; Q105510703
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 5360
AC   CVCL_A2NM
DR   Wikidata; Q105510708
RX   PubMed=6726265;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RB 6044
AC   CVCL_A2NP
DR   Wikidata; Q105510710
RX   PubMed=8643543;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Rb-1
AC   CVCL_4680
DR   BTO; BTO_0004566
DR   Wikidata; Q54949274
RX   PubMed=2681130;
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   RB-iPS-1
AC   CVCL_A4MU
DR   SKIP; SKIP001288
DR   Wikidata; Q105510715
RX   PubMed=27879208;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser888Asn (c.2663G>A); ClinVar=VCV000527935; Zygosity=Heterozygous (PubMed=27879208).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4MV ! RB-iPS-2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   RB-iPS-2
AC   CVCL_A4MV
DR   SKIP; SKIP001289
DR   Wikidata; Q105510718
RX   PubMed=27879208;
CC   From: National Engineering and Research Center of Human Stem Cells; Changsha; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser888Asn (c.2663G>A); ClinVar=VCV000527935; Zygosity=Heterozygous (PubMed=27879208).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4MU ! RB-iPS-1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   RB/1
AC   CVCL_C1M6
SY   Rabbit Brain 1
DR   Wikidata; Q114312768
RX   PubMed=13996355;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   RB(E)-3
AC   CVCL_ZF24
DR   Wikidata; Q98128814
RX   PubMed=19686387;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   RB(E)-5
AC   CVCL_ZF25
DR   Wikidata; Q98128815
RX   PubMed=19686387;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   RB1-MAbP2
AC   CVCL_A0RS
SY   RB1-MAB P2; RB1-MABP2; HB RB1-MabP2
DR   CCRID; 4201PAT-CCTCC00073
DR   Wikidata; Q108821209
RX   Patent=EP0390530B1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10093.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P06400; Human RB1.
CC   Misspelling: HB RBI-MabP2; CCRID=4201PAT-CCTCC00073.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RB1021
AC   CVCL_S624
SY   RB 1021
DR   Wikidata; Q54949275
RX   PubMed=11520568;
RX   PubMed=15326157;
RX   PubMed=18036396;
RX   PubMed=19686387;
RX   PubMed=23498719;
RX   PubMed=27115612;
RX   PubMed=32123578;
CC   Miscellaneous: STR profile from personal communication of Bremner, Rod.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 13
ST   D21S11: 29,32.2
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   RB1037
AC   CVCL_ZF17
DR   Wikidata; Q98128816
RX   PubMed=19686387;
RX   PubMed=23498719;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   RB110F/gpt
AC   CVCL_S614
DR   Wikidata; Q54949276
RX   PubMed=1359829;
CC   Doubling time: 46 hours (PubMed=1359829).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   RB116
AC   CVCL_S608
DR   Kerafast; EEE001
DR   Wikidata; Q54949278
RX   PubMed=23233783;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; None_reported; -; Zygosity=- (PubMed=23233783).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   RB1210
AC   CVCL_ZF19
DR   Wikidata; Q98128817
RX   PubMed=19686387;
CC   From: Gallie, Brenda Louise; Department of Medical Genetics, University of Toronto; Toronto; Canada.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   RB1224
AC   CVCL_ZF20
DR   Wikidata; Q98128818
RX   PubMed=19686387;
CC   From: Gallie, Brenda Louise; Department of Medical Genetics, University of Toronto; Toronto; Canada.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   RB1335
AC   CVCL_ZF21
DR   Wikidata; Q98128819
RX   PubMed=23498719;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   RB1355
AC   CVCL_ZF22
DR   Wikidata; Q98128820
RX   PubMed=19686387;
CC   From: Gallie, Brenda Louise; Department of Medical Genetics, University of Toronto; Toronto; Canada.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   RB143
AC   CVCL_5I30
SY   Rb143
DR   Kerafast; EEE002
DR   Wikidata; Q54949286
RX   PubMed=20371623;
RX   PubMed=23233783;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex3-17del; Zygosity=Unspecified (PubMed=20371623).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   RB1442
AC   CVCL_ZF39
DR   Wikidata; Q98128821
RX   PubMed=19686387;
CC   From: Gallie, Brenda Louise; Department of Medical Genetics, University of Toronto; Toronto; Canada.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   RB1518
AC   CVCL_ZF23
DR   Wikidata; Q98128822
RX   PubMed=19686387;
CC   From: Gallie, Brenda Louise; Department of Medical Genetics, University of Toronto; Toronto; Canada.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   RB16KY
AC   CVCL_3146
SY   RB16; RBFuTo
DR   JCRB; JCRB0311
DR   JCRB; KURB2110
DR   Wikidata; Q54949294
RX   PubMed=7057793;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0311
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_357027; Hereditary retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   RB16KY hTERT
AC   CVCL_V559
DR   JCRB; KURB2112
DR   Wikidata; Q54949295
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_357027; Hereditary retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3146 ! RB16KY
SX   Male
AG   4Y
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   RB16KY(SVT)
AC   CVCL_C3QQ
DR   JCRB; KURB2111
DR   Wikidata; Q116050161
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_357027; Hereditary retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3146 ! RB16KY
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   RB174
AC   CVCL_WY53
SY   Rb174
DR   Wikidata; Q98128823
RX   PubMed=20508032;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   RB176
AC   CVCL_WY54
DR   GEO; GSM1486289
DR   GEO; GSM2043877
DR   Wikidata; Q98128824
RX   PubMed=19524506;
RX   PubMed=27115612;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   RB177
AC   CVCL_WY55
SY   Rb177
DR   Wikidata; Q98128825
RX   PubMed=19524506;
RX   PubMed=20508032;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   RB178
AC   CVCL_WY56
DR   Wikidata; Q98128826
RX   PubMed=19524506;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   RB17SV
AC   CVCL_RR27
DR   JCRB; KURB3015
DR   Wikidata; Q54949287
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_357027; Hereditary retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   RB182
AC   CVCL_VF09
DR   JCRB; KURB2325
DR   Wikidata; Q98128827
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF10 ! RB182(L)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   RB182(L)
AC   CVCL_VF10
DR   JCRB; KURB2971
DR   Wikidata; Q98128828
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF09 ! RB182
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RB182F
AC   CVCL_JH21
DR   JCRB; KURB2330
DR   Wikidata; Q54949288
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JH22 ! RB182F(L)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   RB182F(L)
AC   CVCL_JH22
DR   JCRB; JCRB3038
DR   JCRB; KURB2329
DR   JCRB; KURB2972
DR   Wikidata; Q54949289
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; KURB2329; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB3038
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10,12
ST   D16S539: 11,13
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JH21 ! RB182F
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 9
//
ID   RB182M
AC   CVCL_JH23
DR   JCRB; KURB2332
DR   Wikidata; Q54949290
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   RB188
AC   CVCL_JG68
DR   JCRB; KURB2342
DR   Wikidata; Q54949291
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F276 ! R59
OI   CVCL_JG69 ! RB188Tu
SX   Female
AG   9M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
ID   RB188Tu
AC   CVCL_JG69
DR   JCRB; KURB2343
DR   Wikidata; Q54949292
CC   Population: Japanese.
CC   Derived from site: Metastatic; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F276 ! R59
OI   CVCL_JG68 ! RB188
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 9
//
ID   RB191
AC   CVCL_WY57
DR   Wikidata; Q98128829
RX   PubMed=20508032;
RX   PubMed=27115612;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   RB1KO
AC   CVCL_V558
DR   JCRB; KURB2670
DR   Wikidata; Q54949293
RX   PubMed=7338842;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_357027; Hereditary retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   RB1KY
AC   CVCL_A1JQ
DR   JCRB; KURB2671
DR   Wikidata; Q102114796
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_357027; Hereditary retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   RB1KYF
AC   CVCL_A1JR
DR   JCRB; KURB2672
DR   Wikidata; Q102114797
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   RB1KYM
AC   CVCL_A1JS
DR   JCRB; KURB2673
DR   Wikidata; Q102114798
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   RB22
AC   CVCL_F595
SY   TER239; TER-239; Ter 239; TER266; TER-266; Ter 266; TER499; TER-499; Ter-499; Ter 499; TER511; TER-511; Ter-511; Ter 511; Extract 87; Extract 301; Extract 432
DR   IPD-IMGT/HLA; 11298
DR   Wikidata; Q54949296
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/336cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/380cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/385cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,02:01; B*35:04:01,82:01; C*03:02,04:01; DPB1*01:01:01,04:02; DQA1*03:03,05:03; DQB1*03:01,03:02; DRB1*04:05,14:02; DRB3*01:01; DRB4*01:03 (IPD-IMGT/HLA=11298).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   RB247C
AC   CVCL_2704
SY   RB247c; RB247; RB 247; Rb247; RB247C-3; RB247C3; RB247c3
DR   ECACC; 06070601
DR   GEO; GSM2043878
DR   Wikidata; Q54949297
RX   PubMed=1682862;
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=2751270;
RX   PubMed=11520568;
RX   PubMed=15326157;
RX   PubMed=18036396;
RX   PubMed=23498719;
RX   PubMed=27115612;
RX   PubMed=30584916;
RX   PubMed=32123578;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Pro39Argfs*26 (c.116delC); Zygosity=Heterozygous (PubMed=30584916).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly617Argfs*36 (c.1848dup); Zygosity=Heterozygous (PubMed=30584916).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   RB24KY
AC   CVCL_3147
DR   JCRB; JCRB0312
DR   Wikidata; Q54949298
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0312
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,15
ST   D16S539: 9,13
ST   D5S818: 9,10
ST   D7S820: 9,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   RB257(L)
AC   CVCL_JG81
DR   JCRB; KURB2446
DR   Wikidata; Q54949299
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   RB257F(L)
AC   CVCL_JG82
DR   JCRB; JCRB3037
DR   JCRB; KURB2447
DR   Wikidata; Q54949300
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: JCRB; KURB2447; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB3037
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 7
//
ID   RB257M(L)
AC   CVCL_JG83
DR   JCRB; KURB2448
DR   Wikidata; Q54949301
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   RB267
AC   CVCL_HF31
DR   Wikidata; Q54949303
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=3762576;
RX   PubMed=4018796;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   RB28KY
AC   CVCL_3148
DR   JCRB; JCRB0313
DR   Wikidata; Q54949304
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_357034; Non-hereditary retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   RB3
AC   CVCL_D1FP
DR   Wikidata; Q127384010
RX   PubMed=24293631;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   RB32SV
AC   CVCL_RR28
DR   JCRB; KURB3019
DR   Wikidata; Q54949305
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   RB355
AC   CVCL_S611
SY   RB 355; RB-355
DR   cancercelllines; CVCL_S611
DR   Wikidata; Q54949306
RX   PubMed=1679230;
RX   PubMed=1682862;
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=2751270;
RX   PubMed=2917337;
RX   PubMed=4018796;
RX   PubMed=23498719;
RX   PubMed=25326674;
RX   PubMed=29192327;
RX   PubMed=30584916;
CC   Problematic cell line: Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a male patient with retinoblastoma.
CC   Population: Caucasian.
CC   Doubling time: 81.4 +- 5.7 hours (PubMed=2751270); 66 hours (PubMed=25326674).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   RB355 CDDP-R
AC   CVCL_B7IH
SY   RB-355 cisplatin-resistant; RB-355 CisPt
DR   Wikidata; Q114312769
RX   PubMed=29192327;
CC   Problematic cell line: Contaminated. Parent cell line (RB355) has been shown to be a Y-79 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S611 ! RB355
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   RB355 Eto-R
AC   CVCL_B7II
SY   RB-355 etoposide-resistant; RB-355 Etop
DR   Wikidata; Q114312771
RX   PubMed=29192327;
CC   Problematic cell line: Contaminated. Parent cell line (RB355) has been shown to be a Y-79 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S611 ! RB355
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   RB381
AC   CVCL_S625
SY   RB 381; RB-381
DR   GEO; GSM2043879
DR   Wikidata; Q54949307
RX   PubMed=4018796;
RX   PubMed=27115612;
RX   PubMed=32123578;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   RB3823
AC   CVCL_ZF07
SY   RB 3823
DR   Wikidata; Q98128830
RX   PubMed=30584916;
RX   PubMed=32123578;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; None_reported; -; Zygosity=- (PubMed=30584916).
CC   Miscellaneous: STR profile from personal communication of Bremner, Rod.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11,14
ST   D21S11: 27,28
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   RB383
AC   CVCL_S626
SY   Rb383; RB 383
DR   GEO; GSM2043880
DR   Wikidata; Q54949308
RX   PubMed=1682862;
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=2751270;
RX   PubMed=2917337;
RX   PubMed=4018796;
RX   PubMed=11520568;
RX   PubMed=18036396;
RX   PubMed=25326674;
RX   PubMed=27115612;
RX   PubMed=30584916;
CC   Doubling time: 97 hours (PubMed=25326674).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; None_reported; -; Zygosity=- (PubMed=30584916).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   RB405
AC   CVCL_S627
DR   Wikidata; Q54949309
RX   PubMed=4018796;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RB409
AC   CVCL_S628
DR   Wikidata; Q54949310
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=3762576;
RX   PubMed=4018796;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   RB412
AC   CVCL_S629
SY   Rb412
DR   Wikidata; Q54949311
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=4018796;
RX   PubMed=7689221;
RX   PubMed=11520568;
RX   PubMed=23498719;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000092839; Zygosity=Homozygous (PubMed=23498719).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   RB414
AC   CVCL_S630
SY   Rb414
DR   Wikidata; Q54949312
RX   PubMed=4018796;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RB429
AC   CVCL_HF32
DR   Wikidata; Q54949313
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=3762576;
RX   PubMed=7689221;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   RB430
AC   CVCL_S631
DR   Wikidata; Q54949315
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=4018796;
CC   Derived from site: Metastatic; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   RB44-10D5.19-21
AC   CVCL_VT99
DR   Wikidata; Q98128831
RX   Patent=US6710226;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5129.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JJ88 ! SPAZ-4
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 5
//
ID   RB507
AC   CVCL_VA41
DR   Wikidata; Q54949316
RX   PubMed=1682862;
RX   PubMed=2751270;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   RB522
AC   CVCL_ZF04
DR   Wikidata; Q98128832
RX   PubMed=23498719;
RX   PubMed=30584916;
RX   PubMed=32123578;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; None_reported; -; Zygosity=- (PubMed=30584916).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   RB522A
AC   CVCL_S634
DR   Wikidata; Q54949317
RX   PubMed=7689221;
RX   PubMed=19686387;
CC   From: Gallie, Brenda Louise; Department of Medical Genetics, University of Toronto; Toronto; Canada.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RB529
AC   CVCL_S632
DR   Wikidata; Q54949318
RX   PubMed=15326157;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RB544
AC   CVCL_S633
DR   Wikidata; Q54949319
RX   PubMed=7689221;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RB6-8C5
AC   CVCL_J603
SY   RB6
DR   TKG; TKG 0620
DR   Wikidata; Q54949320
RX   PubMed=8360469;
WW   Provider; Stanford OTL; S82-008; https://stanford.resoluteinnovation.com/technologies/S82-008_a-monoclonal-antibody-specific-for
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P35461; Mouse Ly6g.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   RB778
AC   CVCL_ZF14
DR   Wikidata; Q98128833
RX   PubMed=19686387;
RX   PubMed=23498719;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   RB805
AC   CVCL_ZF15
DR   Wikidata; Q98128834
RX   PubMed=23498719;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   RB80F/250R/ori-
AC   CVCL_S613
DR   Wikidata; Q54949322
RX   PubMed=1359829;
CC   Doubling time: 19 hours (PubMed=1359829).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Transformant: NCIt; C17262; X-Ray.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RB82-037
AC   CVCL_D5J2
DR   JCRB; KURB2688
DR   Wikidata; Q127384012
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,t(13;X)(p11.21;q12.3) (JCRB=KURB2688).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   RB893
AC   CVCL_ZF16
DR   Wikidata; Q98128835
RX   PubMed=19686387;
RX   PubMed=23498719;
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   RB898
AC   CVCL_ZF18
DR   Wikidata; Q98128836
RX   PubMed=19686387;
CC   From: Gallie, Brenda Louise; Department of Medical Genetics, University of Toronto; Toronto; Canada.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   RB8B
AC   CVCL_WR50
DR   Wikidata; Q98128837
RX   PubMed=24704492;
CC   From: Harvard University; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=24704492).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   RB9d
AC   CVCL_X726
DR   Wikidata; Q54949323
RX   PubMed=24704492;
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (PubMed=24704492).
CC   Derived from site: In situ; Forearm, skin, dermis; UBERON=UBERON_0003403+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 14
//
ID   RBA
AC   CVCL_3579
DR   BTO; BTO_0002598
DR   CLO; CLO_0008760
DR   ATCC; CRL-1747
DR   BCRC; 60555
DR   IZSLER; BS TCL 174
DR   Wikidata; Q54949324
RX   PubMed=4220124;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   50D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   RBA-1
AC   CVCL_0494
SY   RBA1; Rat Brain Astrocyte-1
DR   MCCL; MCC:0000391
DR   Wikidata; Q54949326
RX   PubMed=3865993;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   RBA-2
AC   CVCL_4031
SY   RBA2; Rat Brain Astrocyte-2
DR   BTO; BTO_0002599
DR   BCRC; 60584
DR   Wikidata; Q54949328
RX   PubMed=10386986;
RX   PubMed=11746779;
RX   PubMed=15985361;
RX   PubMed=16178011;
RX   PubMed=18067549;
CC   Characteristics: Type-2 astrocyte. A2B5, GFAP and glutamine synthetase positive (PubMed=10386986).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0494 ! RBA-1
SX   Sex unspecified
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   RBCF-1
AC   CVCL_R918
SY   Radiation Biology Center Fish-1
DR   Wikidata; Q54949329
RX   DOI=10.1016/B978-0-444-82033-4.50019-2;
RX   PubMed=2193772;
RX   PubMed=7409028;
CC   Group: Fish cell line.
CC   Karyotypic information: Diploid karyotype.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 13
//
ID   RBE
AC   CVCL_4896
DR   CLO; CLO_0050848
DR   BioSample; SAMN03472125
DR   cancercelllines; CVCL_4896
DR   CCRID; 1101HUM-PUMC000675
DR   CCRID; 3101HUMTCHu179
DR   Cell_Model_Passport; SIDM01850
DR   CLS; 305019
DR   Cosmic; 1187341
DR   Cosmic; 1571785
DR   Cosmic; 2629289
DR   DepMap; ACH-001856
DR   KCB; KCB 2014049YJ
DR   RCB; RCB1292
DR   Wikidata; Q54949330
RX   CelloPub=CLPUB00275;
RX   PubMed=9358283;
RX   PubMed=15767549;
RX   PubMed=27231123;
RX   PubMed=31077409;
RX   PubMed=35640676;
RX   PubMed=39026794;
WW   Info; RCB; -; https://cell.brc.riken.jp/en/rcb/rbessp-25_announce
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=9358283).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Ser (c.394C>A); ClinVar=VCV000375893; Zygosity=Unspecified (PubMed=27231123; DepMap=ACH-001856).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (DepMap=ACH-001856).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: RBA; CelloPub=CLPUB00275.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID; DepMap=ACH-001856; RCB=RCB1292
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 10,11
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta D: 12
ST   Penta E: 18
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   RBE-Luc2-tdT
AC   CVCL_A9CU
DR   cancercelllines; CVCL_A9CU
DR   CCRID; 1101HUM-PUMC000806
DR   Wikidata; Q108821210
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Ser (c.394C>A); ClinVar=VCV000375893; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): CCRID=1101HUM-PUMC000806
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18
ST   D13S317: 9
ST   D16S539: 10,11
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D6S1043: 14
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   Penta E: 18
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4896 ! RBE
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   RBE/LULS58
AC   CVCL_C1GX
DR   Wikidata; Q114312772
RX   PubMed=35744603;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=67831; ! Rhipicephalus bursa (Anatolian brown tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RBE/LULS62
AC   CVCL_E1ND
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Miscellaneous: Cell line information from personal communication of Bell-Sakyi, Lesley.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=67831; ! Rhipicephalus bursa (Anatolian brown tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   RBE4
AC   CVCL_0495
SY   RBE-4; Rat Brain Endothelial 4
DR   MCCL; MCC:0000392
DR   ChEMBL-Cells; CHEMBL4295418
DR   ChEMBL-Targets; CHEMBL4296491
DR   PubChem_Cell_line; CVCL_0495
DR   Wikidata; Q54949337
RX   Patent=WO1993006222A1;
RX   PubMed=7908023;
RX   PubMed=12164376;
RX   PubMed=12958429;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1142.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Caution: Indicated as originating from a Sprague Dawley rat in PubMed=7908023 and from a Lewis rat in Patent=WO1993006222A1.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   RBHF-1
AC   CVCL_Y465
DR   BioSample; SAMN03152025
DR   Wikidata; Q54949339
RX   PubMed=8020907;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be a human hepatocellular carcinoma cell line but shown not to be of human origin (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00155.
OX   NCBI_TaxID=32644; ! Unidentified organism (Unknown organism)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   rBHK
AC   CVCL_HA32
DR   Wikidata; Q54949340
RX   PubMed=24249083;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   RBi001-A
AC   CVCL_9S35
SY   RB101; Fb101
DR   BioSamples; SAMEA3368212
DR   EBiSC; RBi001-A
DR   ECACC; 66540025
DR   hPSCreg; RBi001-A
DR   SKIP; SKIP002541
DR   Wikidata; Q54949341
CC   From: R Biomedical, Ltd; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540025; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XJ87 ! RBi001-B
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 14
//
ID   RBi001-B
AC   CVCL_XJ87
SY   FB83c1
DR   hPSCreg; RBi001-B
DR   Wikidata; Q98128838
CC   From: R Biomedical, Ltd; Edinburgh; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S35 ! RBi001-A
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   RBIL001-2
AC   CVCL_E3J9
SY   RBIL001; RBIL1-2; RBIL1; F_PDO_000012
DR   CancerTools; 160894
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RbiPSC
AC   CVCL_QW46
DR   Wikidata; Q54949343
RX   PubMed=28677530;
CC   From: BioTalentum, Ltd; Godollo; Hungary.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Hycole hybrid; VBO=VBO_0017528.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   12FD
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 8
//
ID   RBK-D5
AC   CVCL_D5B8
DR   Wikidata; Q127384015
RX   DOI=10.32592/ari.2023.78.5.1528;
CC   Virology: Has the highest susceptibility to infection by bovine herpesvirus-1 (BoHV-1) of the clones derived from the parent cell line (DOI=10.32592/ari.2023.78.5.1528).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_9V28 ! IRKHBK
SX   Male
AG   2D
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   RBL SX-38
AC   CVCL_C4MP
SY   RBL-SX38; RBL-2H3-SX38; SX-38
DR   Wikidata; Q116050162
RX   PubMed=8683119;
RX   PubMed=12609531;
RX   PubMed=18534732;
RX   PubMed=19538351;
RX   PubMed=25149487;
CC   Biotechnology: Can be used in human allergy assays. Because it expresses human Fc-epsilon RI, following sensitization with IgE from a subset of allergic donors, these cells can be triggered by exposure to anti-IgE or to very low concentrations of specific allergen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3609; FCER1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3611; FCER1G.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7316; MS4A2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0591 ! RBL-2H3
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   RBL-01
AC   CVCL_5U61
DR   Wikidata; Q54949344
RX   PubMed=2936252;
CC   Doubling time: 1.033 +- 0.292 days (PubMed=2936252).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   RBL-1
AC   CVCL_0496
SY   RBL 1; RBL-I; RBL; Rat Basophilic Leukemia-1
DR   BTO; BTO_0000994
DR   CLO; CLO_0008761
DR   CLO; CLO_0008762
DR   MCCL; MCC:0000393
DR   CLDB; cl4111
DR   CLDB; cl4112
DR   CLDB; cl4113
DR   CLDB; cl4114
DR   CLDB; cl5542
DR   ATCC; CRL-1378
DR   BCRC; 60198
DR   CCRID; 1101RAT-PUMC000203
DR   CCRID; 4201RAT-CCTCC00315
DR   CCTCC; GDC0315
DR   ChEMBL-Cells; CHEMBL3307698
DR   ChEMBL-Targets; CHEMBL614772
DR   CLS; 500389
DR   DSMZ; ACC-147
DR   DSMZCellDive; ACC-147
DR   ECACC; 86061001
DR   ICLC; ATL01001
DR   IZSLER; BS TCL 55
DR   JCRB; IFO50034
DR   Lonza; 724
DR   PubChem_Cell_line; CVCL_0496
DR   TOKU-E; 2983
DR   Wikidata; Q7275940
RX   PubMed=4812630;
RX   PubMed=6166481;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/RBL_cells
CC   Doubling time: ~24 hours (CLS=500389); ~25 hours (DSMZ=ACC-147).
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E3P6 ! RBL-IV
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   RBL-IV
AC   CVCL_E3P6
RX   PubMed=6166481;
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0496 ! RBL-1
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RBL-IV HR+
AC   CVCL_E3P7
SY   RBL-HR+; AB-CBF1-MCT-1; MCT-1
RX   PubMed=72105;
RX   PubMed=102698;
RX   PubMed=6166481;
RX   PubMed=19669619;
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be a mouse cell line, but later found to be derivative of RBL-IV (PubMed=102698; PubMed=6166481).
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3P6 ! RBL-IV
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RBL-2H3
AC   CVCL_0591
SY   RBL2H3; RBL 2H3; RBL.2H3
DR   BTO; BTO_0000833
DR   CLO; CLO_0008763
DR   CLO; CLO_0051024
DR   MCCL; MCC:0000394
DR   AddexBio; C0003007/376
DR   ATCC; CRL-2256
DR   BCRC; 60310
DR   CCRID; 1101RAT-PUMC000817
DR   CCRID; 3101RATSCSP518
DR   CCRID; 3101RATTCR7
DR   CCRID; 4201SWI-CCTCC00213
DR   CCTCC; GDC0213
DR   ChEMBL-Cells; CHEMBL3307666
DR   ChEMBL-Targets; CHEMBL614632
DR   CLS; 305194
DR   DSMZ; ACC-312
DR   DSMZCellDive; ACC-312
DR   JCRB; JCRB0023
DR   KCB; KCB 2018046YJ
DR   KCLB; 22256
DR   Lonza; 1035
DR   NCBI_Iran; C536
DR   PubChem_Cell_line; CVCL_0591
DR   RCB; RCB2782
DR   TKG; TKG 0321
DR   Wikidata; Q54949346
RX   DOI=10.57844/arcadia-3207-4695;
RX   PubMed=2940298;
RX   PubMed=3262677;
RX   PubMed=6166481;
RX   PubMed=6173265;
RX   PubMed=17210052;
RX   PubMed=19301096;
RX   PubMed=19669619;
RX   PubMed=25149487;
RX   PubMed=36125550;
WW   Info; protocols.io; -; https://dx.doi.org/10.17504/protocols.io.14egn67qpl5d/v1
CC   Characteristics: Degranulates as a consequence of Fc-epsilon-R stimulation. Histamine-releasing (PubMed=19669619).
CC   Characteristics: Compound 48/80 which is used to promote mast cell degranulation is toxic to this cell line (DOI=10.57844/arcadia-3207-4695).
CC   Doubling time: ~50-60 hours (DSMZ=ACC-312).
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3P7 ! RBL-IV HR+
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 28
//
ID   RBL-2H3 ADORA2A Gq
AC   CVCL_KU64
DR   DiscoverX; 95-1008C11
DR   Wikidata; Q54949347
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:263; ADORA2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0591 ! RBL-2H3
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   RBL-2H3 MRGPRX1 Gq
AC   CVCL_KU65
DR   DiscoverX; 95-1019C11
DR   Wikidata; Q54949348
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17962; MRGPRX1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0591 ! RBL-2H3
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   RBL-3
AC   CVCL_C8R2
DR   Wikidata; Q123033330
RX   PubMed=4867923;
RX   PubMed=6064953;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RBL-30/25
AC   CVCL_C4MQ
DR   Wikidata; Q116050163
RX   PubMed=15969682;
RX   PubMed=17210052;
RX   PubMed=18534732;
RX   PubMed=25149487;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3609; FCER1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0591 ! RBL-2H3
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   RBL-4
AC   CVCL_C8R3
DR   Wikidata; Q123033331
RX   PubMed=4867923;
RX   PubMed=6064953;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RBL-5
AC   CVCL_J303
DR   BTO; BTO_0006550
DR   Wikidata; Q54949349
RX   PubMed=185295;
RX   PubMed=564410;
RX   PubMed=864745;
RX   PubMed=6970130;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 11
//
ID   RBL-hEIalpha-2B12
AC   CVCL_C4MR
SY   RBL-hEIa-2B12
DR   Wikidata; Q116050164
RX   PubMed=18534732;
RX   PubMed=25149487;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3609; FCER1A.
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0591 ! RBL-2H3
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   RBL13
AC   CVCL_S616
SY   RBL-13
DR   cancercelllines; CVCL_S616
DR   DSMZCellDive; RBL13
DR   Wikidata; Q54949350
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=7959682;
RX   PubMed=25326674;
RX   PubMed=30584916;
CC   Doubling time: 6 days (PubMed=2365495); 97 hours (PubMed=25326674).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Heterozygous (PubMed=25326674).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu797Ter (c.2390T>G); Zygosity=Heterozygous (PubMed=25326674).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   RBL14
AC   CVCL_S617
DR   DSMZ; ACC-912
DR   DSMZCellDive; ACC-912
DR   Wikidata; Q54949352
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=7959682;
CC   Doubling time: 10 days (PubMed=2365495); ~2-3 weeks (Note=After thawing), 8-12 days (Note=Later) (DSMZ=ACC-912).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): DSMZ=ACC-912
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 14,16
ST   D21S11: 27,29
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 22
ST   Penta D: 7,10
ST   Penta E: 12,16
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   1Y11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   RBL15
AC   CVCL_S618
SY   RBL-15
DR   DSMZ; ACC-943
DR   Wikidata; Q54949353
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=7959682;
RX   PubMed=25326674;
RX   PubMed=30584916;
CC   Doubling time: 8 days (PubMed=2365495); 45 hours (PubMed=25326674); ~5-7 days (DSMZ=ACC-943).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (PubMed=25326674).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): DSMZ=ACC-943
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 12,18
ST   D19S433: 12,15
ST   D21S11: 29,30
ST   D2S1338: 19,21
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 10,13
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   RBL162T
AC   CVCL_3149
SY   RB162(L)
DR   JCRB; JCRB0328
DR   JCRB; KURB2293
DR   Wikidata; Q54949354
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0328
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   RBL18
AC   CVCL_S619
DR   DSMZ; ACC-913
DR   DSMZCellDive; ACC-913
DR   Wikidata; Q54949355
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=7959682;
CC   Doubling time: 9 days (PubMed=2365495; DSMZ=ACC-913).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Met484Valfs*8 (c.1450_1451delAT); ClinVar=VCV000855427; Zygosity=Homozygous (DSMZ=ACC-913).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): DSMZ=ACC-913
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11
ST   D16S539: 14
ST   D18S51: 13,16
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17,19
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 10,15
ST   FGA: 19,24
ST   Penta D: 13,16
ST   Penta E: 11,13
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   RBL182T
AC   CVCL_3150
SY   RB182(L)
DR   JCRB; JCRB0330
DR   JCRB; KURB2326
DR   Wikidata; Q54949356
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0330
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   RBL20
AC   CVCL_S620
DR   DSMZ; ACC-944
DR   Wikidata; Q54949357
RX   PubMed=2090524;
RX   PubMed=2365495;
CC   Doubling time: 14 days (PubMed=2365495); 1-2 weeks (Note=After thawing), ~5-8 days (Note=At later passages) (DSMZ=ACC-944).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (DSMZ=ACC-944).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.607+1G>T (IVS6+1G>T); ClinVar=VCV000013093; Zygosity=Heterozygous; Note=Splice donor mutation (DSMZ=ACC-944).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): DSMZ=ACC-944
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 15,16
ST   D21S11: 28,33.2
ST   D2S1338: 17,20
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 12
ST   Penta E: 7
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,20
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   RBL221T
AC   CVCL_3151
DR   JCRB; JCRB0329
DR   Wikidata; Q54949358
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0329
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 13
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   RBL30
AC   CVCL_S621
SY   RBL-30
DR   cancercelllines; CVCL_S621
DR   DSMZ; ACC-945
DR   Wikidata; Q54949359
RX   PubMed=2090524;
RX   PubMed=2365495;
RX   PubMed=25326674;
RX   PubMed=30584916;
CC   Doubling time: 6 days (PubMed=2365495); 94 hours (PubMed=25326674); ~5 days (DSMZ=ACC-945).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg255Ter (c.763C>T); ClinVar=VCV000126820; Zygosity=Homozygous (PubMed=25326674; PubMed=30584916).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): DSMZ=ACC-945
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 31.2,32.2
ST   D2S1338: 16,23
ST   D3S1358: 14,19
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 8,11
ST   FGA: 19,21
ST   Penta D: 9,10
ST   Penta E: 5,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C8714; Unilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 14
//
ID   RBL7
AC   CVCL_S622
DR   DSMZ; ACC-942
DR   Wikidata; Q54949360
RX   PubMed=2090524;
RX   PubMed=2365495;
CC   Doubling time: 6 days (PubMed=2365495); 8-12 days (DSMZ=ACC-942).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): DSMZ=ACC-942
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 13,18
ST   D19S433: 12,14
ST   D21S11: 30,30.2
ST   D2S1338: 20,25
ST   D3S1358: 14,17
ST   D5S818: 7,10
ST   D7S820: 8,10
ST   D8S1179: 11,12
ST   FGA: 25,26
ST   Penta D: 10,14
ST   Penta E: 7
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 17,18
DI   NCIt; C8713; Bilateral retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RBM-1
AC   CVCL_VZ67
SY   Rat Bone Marrow-1
DR   IBRC; C10163
DR   Wikidata; Q98128839
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RBM-2
AC   CVCL_VZ68
SY   Rat Bone Marrow-2
DR   IBRC; C10164
DR   Wikidata; Q98128840
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RBM-3
AC   CVCL_VZ69
SY   Rat Bone Marrow-3
DR   IBRC; C10165
DR   Wikidata; Q98128841
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RBM-4
AC   CVCL_VZ70
SY   Rat Bone Marrow-4
DR   IBRC; C10166
DR   Wikidata; Q98128842
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RBM-Ad
AC   CVCL_S887
SY   RBM AD
DR   Wikidata; Q54949361
RX   PubMed=7545105;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4-5W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   RBM1 [Human esophagogastric carcinoma]
AC   CVCL_WL02
SY   Rib Bone Marrow 1
DR   Wikidata; Q98128843
RX   PubMed=11297525;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9296; Gastroesophageal junction adenocarcinoma
DI   ORDO; Orphanet_70482; Carcinoma of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   RBM1 [Human renal cell carcinoma]
AC   CVCL_5T98
SY   Renal cancer Bone Metastasis 1
DR   Wikidata; Q54949362
RX   PubMed=12131367;
CC   Doubling time: 32 hours (PubMed=12131367).
CC   Derived from site: Metastatic; Bone, left humerus; UBERON=UBERON_0000976.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   RBM1-IT4
AC   CVCL_WK99
SY   Renal cancer Bone Metastasis 1-Intra Tibial 4
DR   Wikidata; Q98128844
RX   PubMed=12131367;
RX   PubMed=12782601;
RX   PubMed=17332933;
CC   Characteristics: Established from a xenograft obtained by intratibial injection of the parent cell line in nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asp179Thrfs*21 (c.535delG); Zygosity=Hemizygous (PubMed=17332933).
CC   Derived from site: Metastatic; Bone, left humerus; UBERON=UBERON_0000976.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5T98 ! RBM1 [Human renal cell carcinoma]
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   RBM129
AC   CVCL_5G95
SY   Rat Brain Microglial 129
DR   Wikidata; Q54949363
RX   PubMed=1331896;
CC   Characteristics: Proliferated actively at 37 Celsius. The dividing rate is significantly decreased at 40.5 Celsius (PubMed=1331896).
CC   Doubling time: ~16 hours (PubMed=1331896).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   RBM2
AC   CVCL_WL03
SY   Rib Bone Marrow 2
DR   Wikidata; Q98128845
RX   PubMed=11297525;
CC   Derived from site: Metastatic; Rib, bone marrow; UBERON=UBERON_0002228+UBERON_0002371.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   RbM2
AC   CVCL_B3QR
DR   Wikidata; Q110433159
RX   PubMed=2203677;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rabbit 50 Kda lysosomal membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   RBM3
AC   CVCL_WL04
SY   Rib Bone Marrow 3
DR   Wikidata; Q98128847
RX   PubMed=11297525;
CC   Derived from site: Metastatic; Rib, bone marrow; UBERON=UBERON_0002228+UBERON_0002371.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   RBM4
AC   CVCL_WL05
SY   Rib Bone Marrow 4
DR   Wikidata; Q98128848
RX   PubMed=11297525;
CC   Derived from site: Metastatic; Rib, bone marrow; UBERON=UBERON_0002228+UBERON_0002371.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   RBM5
AC   CVCL_WL06
SY   Rib Bone Marrow 5
DR   Wikidata; Q98128849
RX   PubMed=11297525;
CC   Derived from site: Metastatic; Rib, bone marrow; UBERON=UBERON_0002228+UBERON_0002371.
DI   NCIt; C9296; Gastroesophageal junction adenocarcinoma
DI   ORDO; Orphanet_70482; Carcinoma of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RBME-6
AC   CVCL_A0CQ
SY   RBME6; Rhipicephalus Boophilus Microplus Embryonic 6th passage
DR   Wikidata; Q108821211
RX   PubMed=34230000;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Doubling time: ~63 hours (PubMed=34230000).
OX   NCBI_TaxID=6941; ! Rhipicephalus microplus (Cattle tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   RBMSC
AC   CVCL_A9JU
SY   Rat Bone Marrow Mesenchymal Stem Cells
DR   CCRID; 5301RAT-KCB1917BMS
DR   KCB; KCB 2019017BMS
DR   Wikidata; Q108821212
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   rBSCB-1
AC   CVCL_LH99
SY   rat Blood-Spinal Cord Barrier-1
DR   Wikidata; Q54949364
RX   DOI=10.1111/cen3.12045;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spinal cord, microvascular endothelium; UBERON=UBERON_0002240+UBERON_0008339.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   5W
CA   Conditionally immortalized cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 10
//
ID   RBSV1A
AC   CVCL_B4K1
DR   Wikidata; Q110433160
RX   PubMed=174085;
RX   PubMed=198418;
RX   PubMed=1260760;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   RBSV3
AC   CVCL_B4K2
DR   Wikidata; Q110433161
RX   PubMed=174085;
RX   PubMed=1260760;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   RBT-H
AC   CVCL_B7QF
SY   RainBow Trout-Heart
DR   NRFC; NRFC075
DR   Wikidata; Q114312773
WW   Provider; NRFC; NRFC075; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC075.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   RBTE 45
AC   CVCL_R919
SY   RainBow Trout Embryo 45
DR   Wikidata; Q54949365
RX   DOI=10.1577/1548-8667(1994)006<0260:SOFNSC>2.3.CO;2;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   RC
AC   CVCL_9U45
DR   ATCC; CRL-3382
DR   Wikidata; Q54949366
RX   PubMed=20664054;
RX   PubMed=26515759;
RX   PubMed=29416618;
RX   PubMed=29666304;
CC   Doubling time: ~4-5 days (PubMed=26515759).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=26515759).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=26515759).
CC   Miscellaneous: STR profile in PubMed=26515759 table 3 is erroneous; correct STR profile obtained from personal communication of Pham, Lan V.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3382; PubMed=26515759
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 8,12
ST   D18S51: 17
ST   D21S11: 28,30
ST   D3S1358: 17,19
ST   D5S818: 12,13
ST   D7S820: 10,13
ST   D8S1179: 13,15
ST   FGA: 19,21
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 18
//
ID   RC 37
AC   CVCL_W670
SY   RC-37; RC37; 37 RC; 37RC
DR   CLO; CLO_0001317
DR   CLDB; cl61
DR   IZSLER; BS CL 189
DR   Wikidata; Q54949367
RX   PubMed=106777;
RX   PubMed=28046048;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
CA   Undefined cell line type
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   RC-1 [Human renal cell carcinoma]
AC   CVCL_LF74
DR   Wikidata; Q54949368
RX   PubMed=3455754;
CC   Characteristics: Produces EPO.
CC   Doubling time: 48 hours (Note=At 37th passage), 29 hours (Note=At 40th passage), 24 hours (Note=At 53th passage) (PubMed=3455754).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   RC-1 [Rabbit cornea]
AC   CVCL_2705
SY   Rabbit Cornea-1
DR   JCRB; JCRB0246
DR   Wikidata; Q54949369
CC   Doubling time: ~60 hours (Note=Lot 04142003) (JCRB=JCRB0246).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   RC-10
AC   CVCL_C781
SY   RC10; RCe014-A
DR   hPSCreg; RCe014-A
DR   SKIP; SKIP002489
DR   Wikidata; Q54949370
RX   PubMed=27346029;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-11.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346029
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 14,15
ST   D21S11: 27,28
ST   D2S1338: 19,26
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 15
ST   FGA: 24,25
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   RC-11
AC   CVCL_C782
SY   RC11; RCe015-A
DR   hPSCreg; RCe015-A
DR   SKIP; SKIP002490
DR   Wikidata; Q54949371
RX   PubMed=26607962;
RX   PubMed=27558602;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-038, Steering comm. appl. SCSC11-02.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27558602
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 18,20
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   RC-12
AC   CVCL_C783
SY   RC12; RCe016-A
DR   hPSCreg; RCe016-A
DR   SKIP; SKIP002491
DR   Wikidata; Q54949373
RX   PubMed=27346204;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-039, Steering comm. appl. SCSC11-05.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346204
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 11,14
ST   D19S433: 14
ST   D21S11: 27,29
ST   D2S1338: 24,25
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23,26
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   RC-123T/E
AC   CVCL_VV24
DR   Wikidata; Q98128850
RX   CelloPub=CLPUB00483;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (CelloPub=CLPUB00483).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3DN ! GUMC-29
OI   CVCL_E3DP ! GUMC-30
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   RC-124
AC   CVCL_5867
DR   CLS; 300251
DR   Wikidata; Q54949374
CC   Population: Caucasian.
CC   Discontinued: CLS; 300251; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): CLS=300251
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13,14
ST   D16S539: 10,12
ST   D18S51: 17,23
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22,26
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   RC-13
AC   CVCL_L202
SY   RC13; EDe007-A; RCe017-A
DR   hPSCreg; RCe017-A
DR   SKIP; SKIP002492
DR   Wikidata; Q54949375
RX   PubMed=27346201;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-040, Steering comm. appl. SCSC11-04.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346201
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 12,14
ST   D19S433: 13,14
ST   D21S11: 27,29
ST   D2S1338: 24
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,26
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   RC-131
AC   CVCL_AX13
DR   CLS; 300242
DR   Wikidata; Q54949376
WW   Provider; IAZ; -; https://web.archive.org/web/20220128194816/http://i-a-z-zellkultur.de/haupt_de/produkte/zell/rc131.htm
CC   Population: Caucasian.
CC   Discontinued: CLS; 300242; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300242
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 9,16
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 22,26
ST   Penta D: 9,12
ST   Penta E: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   RC-134
AC   CVCL_AX16
DR   Wikidata; Q54949378
WW   Provider; IAZ; -; https://web.archive.org/web/20160807003610/http://www.i-a-z-zellkultur.de/haupt_en/zell/rc134.htm
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 7
//
ID   RC-138
AC   CVCL_AX14
DR   CLS; 300232
DR   Wikidata; Q54949379
CC   Discontinued: CLS; 300232; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 7
//
ID   RC-14
AC   CVCL_L203
SY   RC14; RCe018-A
DR   hPSCreg; RCe018-A
DR   SKIP; SKIP002494
DR   Wikidata; Q54949380
RX   PubMed=27346202;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-041, Steering comm. appl. SCSC11-35.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346202
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 10,12
ST   D18S51: 16
ST   D19S433: 13,16
ST   D21S11: 30,31.2
ST   D2S1338: 17,24
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 8.2,12
ST   D8S1179: 12
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   RC-15
AC   CVCL_L204
SY   RC15; RCe019-A
DR   hPSCreg; RCe019-A
DR   SKIP; SKIP002495
DR   Wikidata; Q54949382
RX   PubMed=27346200;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-042, Steering comm. appl. SCSC11-36.
CC   HLA typing: A*01,02; B*08,56; C*01,07; DQB1*02,03; DRB1*03,04; DRB3*01; DRB4*01 (PubMed=27346200).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,26
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 8.2,13
ST   D8S1179: 10,14
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   RC-16
AC   CVCL_L205
SY   RC16; RCe020-A
DR   hPSCreg; RCe020-A
DR   SKIP; SKIP002497
DR   Wikidata; Q54949383
RX   PubMed=27346205;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-043, Steering comm. appl. SCSC11-37.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346205
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,25
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   RC-165N/hTERT
AC   CVCL_X477
SY   RC165N/hTERT
DR   Wikidata; Q54949390
RX   PubMed=15816512;
RX   PubMed=16413016;
CC   Population: African American.
CC   Doubling time: 35 hours (PubMed=16413016).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 9
//
ID   RC-17
AC   CVCL_L206
SY   RC17; RCe021-A
DR   BioSamples; SAMEA104620770
DR   hPSCreg; RCe021-A
DR   SKIP; SKIP002498
DR   Wikidata; Q54949391
RX   PubMed=26607962;
RX   PubMed=27558596;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/eutcd_grade_.aspx
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-044, Steering comm. appl. SCSC11-38.
CC   HLA typing: A*01,03; B*07,08; C*07; DQB1*02,03; DRB1*03,11; DRB3*01 (PubMed=27558596).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27558596
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 12,14
ST   D21S11: 28,29
ST   D2S1338: 21,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 20
ST   TH01: 7,9
ST   TPOX: 9,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   RC-17 SNCA+/- clone 4-4
AC   CVCL_UL62
DR   Wikidata; Q98128851
RX   PubMed=30472757;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L206 ! RC-17
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   RC-17 SNCA+/- clone L5-4
AC   CVCL_UL63
DR   Wikidata; Q98128852
RX   PubMed=30472757;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L206 ! RC-17
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   RC-17 SNCA-/- clone L5-3
AC   CVCL_UL64
DR   Wikidata; Q98128853
RX   PubMed=30472757;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L206 ! RC-17
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 5
//
ID   RC-17 SNCA-/- clone M1-4
AC   CVCL_UL65
DR   Wikidata; Q98128854
RX   PubMed=30472757;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L206 ! RC-17
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 5
//
ID   RC-170N/hTERT
AC   CVCL_X478
SY   RC170N/hTERT
DR   Wikidata; Q54949392
RX   PubMed=16413016;
CC   Population: Caucasian.
CC   Doubling time: 34 hours (PubMed=16413016).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 9
//
ID   RC-18
AC   CVCL_Y640
SY   RC18
DR   Wikidata; Q54949393
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Characteristics: Exists as early seed stock, not yet extensively characterized. Not yet available (personal communication of De Sousa, Paul Alexandre).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   RC-19
AC   CVCL_Y641
SY   RC19
DR   Wikidata; Q54949394
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Characteristics: Exists as early seed stock, not yet extensively characterized. Not yet available (personal communication of De Sousa, Paul Alexandre).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   RC-2
AC   CVCL_C784
SY   RC2; RCe006-A
DR   hPSCreg; RCe006-A
DR   SKIP; SKIP002481
DR   Wikidata; Q54949395
RX   PubMed=27346014;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-09-008, Steering comm. appl. SCSC08-31.
CC   HLA typing: A*01,26; B*08,37; C*06,07; DQB1*02,05; DRB1*03,10; DRB3*02 (PubMed=27346014).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346014
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 20,22
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 7,8.2
ST   D8S1179: 12,14
ST   TH01: 7,9
ST   TPOX: Not_detected
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   RC-20
AC   CVCL_Y642
SY   RC20
DR   Wikidata; Q54949397
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Characteristics: Exists as early seed stock, not yet extensively characterized. Not yet available (personal communication of De Sousa, Paul Alexandre).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   RC-2A
AC   CVCL_L808
DR   BioSample; SAMN03151621
DR   cancercelllines; CVCL_L808
DR   Wikidata; Q54949398
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6980663;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of an adult male patient with acute myelomonocytic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00259.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 27
//
ID   RC-3
AC   CVCL_C785
SY   RC3; RCe007-A
DR   hPSCreg; RCe007-A
DR   SKIP; SKIP002482
DR   Wikidata; Q54949399
RX   PubMed=27346192;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-09-009, Steering comm. appl. SCSC08-32.
CC   HLA typing: A*01; B*08,37; C*06,07; DQB1*02,05; DRB1*01,03; DRB3*01 (PubMed=27346192).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   RC-4
AC   CVCL_C786
SY   RC4; RCe008-A
DR   hPSCreg; RCe008-A
DR   SKIP; SKIP002483
DR   Wikidata; Q54949400
RX   PubMed=27346193;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-09-017, Steering comm. appl. SCSC08-33.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   RC-4B/C
AC   CVCL_3785
SY   RC-4B
DR   CLO; CLO_0008764
DR   ATCC; CRL-1903
DR   BCRC; 60186
DR   Wikidata; Q54949401
RX   PubMed=2161825;
RX   PubMed=15541569;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-crl-1903-growth-medium
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: ACI x Fischer 344; RS=RS_0000012+RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   RC-4B/C1
AC   CVCL_4283
DR   CLO; CLO_0008765
DR   CLDB; cl4116
DR   ECACC; 94020810
DR   Wikidata; Q54949403
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: ACI x Fischer 344; RS=RS_0000012+RS_0000215.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3785 ! RC-4B/C
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   RC-5
AC   CVCL_C787
SY   RC5; RCe009-A
DR   hPSCreg; RCe009-A
DR   SKIP; SKIP002484
DR   Wikidata; Q54949404
RX   PubMed=27346004;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-09-014, Steering comm. appl. SCSC08-34.
CC   HLA typing: A*01,32; B*40,57; C*02,06; DQB1*06; DRB1*13; DRB3*02 (PubMed=27346004).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346004
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D18S51: 10,15
ST   D19S433: 14.2,15
ST   D21S11: 29,30
ST   D2S1338: 17,21
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   RC-58T/hTERT
AC   CVCL_4767
SY   RC58T/hTERT
DR   Wikidata; Q54949405
RX   PubMed=11753687;
RX   PubMed=16413016;
WW   Info; CaP CLDb; -; https://web.archive.org/web/20160322003131/http://capcelllines.ca/details.asp?id=172
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   RC-58T/hTERT/SA#4
AC   CVCL_X475
SY   RC-58T/hTERT SA#4; RC58T/hTERT/SA4; RC-58T/h/SA#4
DR   Wikidata; Q54949406
RX   PubMed=16413016;
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=16413016).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4767 ! RC-58T/hTERT
SX   Male
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 9
//
ID   RC-6
AC   CVCL_C788
SY   RC6; RCe010-A
DR   hPSCreg; RCe010-A
DR   SKIP; SKIP002485
DR   Wikidata; Q54949407
RX   PubMed=27346019;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-09-018, Steering comm. appl. SCSC09-16.
CC   HLA typing: A*01,03; B*08,44; C*05,07; DQB1*02,03; DRB1*03,04; DRB3*01; DRB4*01 (PubMed=27346019).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346019
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: Not_detected
ST   D8S1179: Not_detected
ST   FGA: 20,24
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   RC-7
AC   CVCL_C789
SY   RC7; RCe011-A
DR   BioSamples; SAMEA104620772
DR   hPSCreg; RCe011-A
DR   SKIP; SKIP002486
DR   Wikidata; Q54949408
RX   PubMed=27346020;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-18-046, Steering comm. appl. SCSC09-48.
CC   HLA typing: A*02,24; B*27,40; C*01,02; DQB1*03,05; DRB1*01,11; DRB3*02 (PubMed=27346020).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346020
ST   Amelogenin: X,Y
ST   CSF1PO: Not_detected
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D18S51: 15,18
ST   D19S433: 13
ST   D21S11: 31,32.2
ST   D2S1338: 18,20
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 8.2,13
ST   D8S1179: 11,12
ST   FGA: 21,24
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 15,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   RC-77N/E
AC   CVCL_V258
DR   Wikidata; Q54949410
RX   PubMed=21042716;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V259 ! RC-77T/E
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   RC-77T/E
AC   CVCL_V259
DR   Wikidata; Q54949411
RX   PubMed=21042716;
RX   PubMed=30787054;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V258 ! RC-77N/E
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   RC-8
AC   CVCL_C790
SY   RC8; RCe012-A
DR   hPSCreg; RCe012-A
DR   SKIP; SKIP002487
DR   Wikidata; Q54949412
RX   PubMed=27346021;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-18-047, Steering comm. appl. SCSC10-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346021
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,16
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 8.2,10
ST   D8S1179: 14,16
ST   FGA: 23,26
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   RC-9
AC   CVCL_C791
SY   RC9; RCe013-A
DR   hPSCreg; RCe013-A
DR   SKIP; SKIP002488
DR   Wikidata; Q54949413
RX   PubMed=26607962;
RX   PubMed=27558601;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   Group: Clinical grade pluripotent cell line.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-037, Steering comm. appl. SCSC10-15.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Complete STR profile from personal communication of De Sousa, Paul Alexandre.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27558601; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 13,21,22
ST   D19S433: 14,15
ST   D21S11: 30.2,32.2
ST   D2S1338: 18,23
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 8,9
ST   Penta E: 11,15
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   RC-9/E6E7
AC   CVCL_E4C2
RX   PubMed=12738999;
CC   Karyotypic information: Hyperdiploid karyotype, 47,XY+9-15+(M1=15p+) (PubMed=12738999).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   RC-92a/hTERT
AC   CVCL_X479
SY   RC92a/hTERT
DR   Wikidata; Q54949414
RX   PubMed=16413016;
CC   Population: Caucasian.
CC   Doubling time: 29 hours (PubMed=16413016).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Telomerase immortalized cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 9
//
ID   RC-IAL
AC   CVCL_DF11
SY   Rim de Coelho-Instituto Adolfo Lutz
DR   Wikidata; Q54949415
RX   PubMed=1342530;
RX   PubMed=10973154;
CC   Virology: Can be used for isolation and growth of rubella virus.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Albino.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   8D
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
ID   RC-K8
AC   CVCL_1883
SY   RCK-8; RCK8; Rck8
DR   CLO; CLO_0037055
DR   EFO; EFO_0006742
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473539
DR   cancercelllines; CVCL_1883
DR   Cell_Model_Passport; SIDM00448
DR   ChEMBL-Cells; CHEMBL4523532
DR   ChEMBL-Targets; CHEMBL4523563
DR   Cosmic; 1289990
DR   Cosmic; 1517655
DR   Cosmic; 1541907
DR   Cosmic; 1945188
DR   Cosmic; 2276319
DR   Cosmic; 2297020
DR   Cosmic; 2437319
DR   Cosmic-CLP; 1330995
DR   DepMap; ACH-001638
DR   DSMZ; ACC-561
DR   DSMZCellDive; ACC-561
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1330995
DR   GEO; GSM119551
DR   GEO; GSM380142
DR   GEO; GSM1035315
DR   GEO; GSM1374845
DR   GEO; GSM1670366
DR   JCRB; JCRB1334
DR   JCRB; NIHS0537
DR   LINCS_LDP; LCL-1950
DR   PharmacoDB; RCK8_1285_2019
DR   Progenetix; CVCL_1883
DR   PubChem_Cell_line; CVCL_1883
DR   Wikidata; Q54949416
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1465024;
RX   PubMed=1720549;
RX   PubMed=3918906;
RX   PubMed=9738977;
RX   PubMed=16960149;
RX   PubMed=19278952;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=26194763;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 48-60 hours (PubMed=3918906); ~36 hours (DSMZ=ACC-561).
CC   HLA typing: A*24:02,26:01; B*51:01,54:15; C*01:02,01:02; DQA1*01:03,01:03; DQB1*06:01,06:01; DRB1*08:03,08:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.19%; East Asian, North=73.44%; East Asian, South=24.52%; South Asian=0.79%; European, North=0.06%; European, South=0% (PubMed=30894373).
CC   Caution: Was originally classified as originating from a histiocytic lymphoma.
CC   Discontinued: JCRB; NIHS0537; true.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
ST   Source(s): Cosmic-CLP=1330995; DepMap=ACH-001638; DSMZ=ACC-561; JCRB=JCRB1334
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 10
ST   D18S51: 16,18.3 (DSMZ=ACC-561)
ST   D18S51: 16,19 (DepMap=ACH-001638)
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 19,23
ST   D3S1358: 15,16
ST   D5S818: 10,11 (JCRB=JCRB1334)
ST   D5S818: 11 (Cosmic-CLP=1330995; DepMap=ACH-001638; DSMZ=ACC-561)
ST   D7S820: 10.3,12 (DepMap=ACH-001638; JCRB=JCRB1334)
ST   D7S820: 11,12 (Cosmic-CLP=1330995; DSMZ=ACC-561)
ST   D8S1179: 14,15
ST   FGA: 23.2,24
ST   Penta D: 9,11
ST   Penta E: 14
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   RC.SV1
AC   CVCL_WW29
SY   Renal Cortical.SV40 transformed 1
DR   Wikidata; Q98128856
RX   PubMed=1645927;
RX   PubMed=2550481;
CC   Doubling time: 20 hours (PubMed=2550481).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain LP).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   <6M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   RC.SV2
AC   CVCL_WW30
SY   Renal Cortical.SV40 transformed 2
DR   Wikidata; Q98128857
RX   PubMed=1645927;
RX   PubMed=2550481;
RX   PubMed=8381014;
CC   Doubling time: 30 hours (PubMed=2550481).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain LP).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   <6M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   RC.SV3
AC   CVCL_WW25
SY   R.C. SV3; Renal Cortical.SV40 transformed 3
DR   Wikidata; Q98128858
RX   PubMed=1645927;
RX   PubMed=2550481;
RX   PubMed=8381014;
RX   PubMed=9807025;
CC   Doubling time: 26 hours (PubMed=2550481).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain LP).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   <6M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   RC.SVtsA58
AC   CVCL_WW31
SY   Renal Cortical.SV40 tsA58 transformed
DR   Wikidata; Q98128859
RX   PubMed=1645927;
RX   PubMed=1709172;
RX   PubMed=8023893;
CC   Characteristics: Exhibits rapid cell growth at the permissive temperature (33 Celsius). Growth is totally inhibited within 48 hours when cells are shifted to the restrictive temperature (39.5 Celsius).
CC   Doubling time: 53.5 +- 2.4 hours (Note=At 33 Celsius) (PubMed=1709172).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   <6M
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   RC01001-A
AC   CVCL_A8HA
SY   RC01001; nciPS01; iPS-M; BJTTHi001-A
DR   BioSamples; SAMEA8172001
DR   hPSCreg; BJTTHi001-A
DR   Wikidata; Q107113465
RX   PubMed=34247112;
RX   PubMed=34583279;
RX   PubMed=35576811;
RX   PubMed=35961105;
RX   PubMed=38547667;
CC   From: Nuwacell Biotechnologies Co.; Hefei; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   RC01001-B
AC   CVCL_D6S9
SY   nciPS02; iPS-F
CC   From: Nuwacell Biotechnologies Co.; Hefei; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   RC1
AC   CVCL_J282
DR   JCRB; IFO50466
DR   Wikidata; Q54949417
RX   PubMed=2215915;
CC   Doubling time: ~24 hours (Note=Lot 06282002) (JCRB=IFO50466).
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Mouse antigen on radial glia and neural progenitor cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   RC2 100 3
AC   CVCL_C932
SY   iPS AAT #100-3
DR   Wikidata; Q54949418
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20715179).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   RC2 100 3 Cr-1
AC   CVCL_C933
SY   100 3Cr-1; iPS AAT #100-3Cr-1; 100-3-Cr1; 100-3; PiZZ100
DR   GEO; GSM4182788
DR   GEO; GSM4182800
DR   GEO; GSM4182812
DR   Wikidata; Q54949420
RX   PubMed=20715179;
RX   PubMed=32619491;
WW   Provider; CReM; 518; https://stemcellbank.bu.edu/Catalog/Item/Details/518
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20715179; PubMed=32619491).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C932 ! RC2 100 3
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   RC2 100 3 Cr-6
AC   CVCL_C934
SY   RC2 100-3-Cr-6; 100 3Cr-6; 100-3-Cr6; iPS AAT #100-3Cr-6
DR   Wikidata; Q54949421
RX   PubMed=20715179;
WW   Provider; CReM; 521; https://stemcellbank.bu.edu/Catalog/Item/Details/521
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20715179).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C932 ! RC2 100 3
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   RC2 102 37 Cr-1
AC   CVCL_C935
SY   102 37Cr-1; RC2 102; PiZZ102
DR   Wikidata; Q54949422
RX   PubMed=20715179;
RX   PubMed=32619491;
WW   Provider; CReM; 525; https://stemcellbank.bu.edu/Catalog/Item/Details/525
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20715179; PubMed=32619491).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C936 ! RC2 102 37 Cr-3
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   RC2 102 37 Cr-3
AC   CVCL_C936
SY   102 37Cr-3
DR   Wikidata; Q54949423
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20715179).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C935 ! RC2 102 37 Cr-1
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   RC2 103 43 Cr-1
AC   CVCL_C937
SY   103 43Cr-1; RC2 103; 103-3-Cr1; PiZZ103; PiZZ103-3-Cr1
DR   Wikidata; Q54949424
RX   PubMed=20715179;
RX   PubMed=32619491;
WW   Provider; CReM; 526; https://stemcellbank.bu.edu/Catalog/Item/Details/526
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20715179; PubMed=32619491).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C938 ! RC2 103 43 Cr-3
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   RC2 103 43 Cr-3
AC   CVCL_C938
SY   103 43Cr-3
DR   Wikidata; Q54949425
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (PubMed=20715179).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84397; Alpha-1 antitrypsin deficiency
DI   ORDO; Orphanet_60; Alpha-1 antitrypsin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C937 ! RC2 103 43 Cr-1
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   RC2 202 2
AC   CVCL_C939
SY   RC2 202; RC2 202-2Cr7
DR   Wikidata; Q54949427
RX   PubMed=20715179;
WW   Provider; CReM; 559; https://stemcellbank.bu.edu/Catalog/Item/Details/559
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20715179).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C940 ! RC2 202 4
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   RC2 202 4
AC   CVCL_C940
DR   Wikidata; Q54949428
RX   PubMed=20715179;
CC   From: Boston University School of Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20715179).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C939 ! RC2 202 2
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   RC2 204
AC   CVCL_D3C1
SY   RC2 204-14a-Cr-3
DR   Wikidata; Q127384017
RX   PubMed=20715179;
WW   Provider; CReM; 561; https://stemcellbank.bu.edu/Catalog/Item/Details/561
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20715179).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   RC2-1-10
AC   CVCL_D3C0
SY   2-1-10; 2/1/10
DR   Wikidata; Q127384020
RX   PubMed=25772471;
WW   Provider; CReM; 689; https://stemcellbank.bu.edu/Catalog/Item/Details/689
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous; Note=By ZFN (PubMed=25772471).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C939 ! RC2 202 2
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   RC4 [Human blood]
AC   CVCL_E4D8
SY   UR-HCL-2; University of Rochester-Human Cell Line-2
RX   PubMed=304748;
CC   Population: Caucasian.
CC   Doubling time: 60 hours (PubMed=304748).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RC4 [Rabbit eye]
AC   CVCL_6718
SY   Rabbit Cornea 4
DR   CLO; CLO_0050408
DR   RCB; RCB0782
DR   Wikidata; Q54949429
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   RC4-11-10
AC   CVCL_D3D5
SY   4-11-10
DR   Wikidata; Q127384022
RX   PubMed=25772471;
WW   Provider; CReM; 690; https://stemcellbank.bu.edu/Catalog/Item/Details/690
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous; Note=By ZFN (PubMed=25772471).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3C1 ! RC2 204
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   RC4H1Tr
AC   CVCL_1G99
SY   Rachycentron Canadum 4 Heart 1 Trypsinised
DR   NRFC; NRFC027
DR   Wikidata; Q54949430
RX   DOI=10.1007/s40009-015-0365-5;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC027.
CC   Miscellaneous: Cell line is available for distribution but not authenticated (NRFC=NRFC027).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=141264; ! Rachycentron canadum (Cobia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   RC5397
AC   CVCL_M834
DR   Wikidata; Q54949431
RX   PubMed=21335544;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RC654
AC   CVCL_F581
SY   TER25
DR   IPD-IMGT/HLA; 11304
DR   Wikidata; Q54949432
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01; B*08:01,78:02:01; C*05:01,07:01 (IPD-IMGT/HLA=11304).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   RCA
AC   CVCL_R735
SY   HCT-RCA; HCT RCA
DR   Cosmic; 1131687
DR   Wikidata; Q54949433
RX   PubMed=3349466;
RX   PubMed=6437669;
RX   PubMed=6578361;
RX   PubMed=7329817;
RX   PubMed=17363507;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   Rca-B
AC   CVCL_5U48
DR   CCRID; 4201PAT-CCTCC00162
DR   Wikidata; Q54949434
RX   Patent=CN101469320A;
RX   PubMed=18001591;
RX   PubMed=26605681;
CC   Doubling time: 26.34 hours (Note=At 21th passage), 25.44 hours (Note=At 65th passage) (Patent=CN101469320A; PubMed=18001591); 25.09 hours (PubMed=26605681).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   Rca-T
AC   CVCL_DR21
DR   CCRID; 4201PAT-CCTCC00161
DR   Wikidata; Q54949441
RX   Patent=CN101469320A;
CC   Doubling time: 23.13 hours (Note=At 21th passage), 22.94 hours (Note=At 65th passage) (Patent=CN101469320A).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   RCAC
AC   CVCL_9Y60
DR   Wikidata; Q54949442
RX   Patent=US8337829;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Heart, atrium; UBERON=UBERON_0002079.
CC   Cell type: Cardiocyte; CL=CL_0002494.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   rCalu-6
AC   CVCL_F0Q6
RX   PubMed=28273808;
CC   Population: Caucasian.
CC   Characteristics: Can be maintained in the presence of 20 muM of 5-fluorouracil. Shows cross-resistance to 5'-deoxy-5-fluorouridine (5'-DFUR), oxaliplatin (L-OHP) and cisplatin (PubMed=28273808).
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.180_181TC>CA) (c.180_181delinsCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0236 ! Calu-6
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RCBBF
AC   CVCL_WK61
DR   CCRID; 1101RAB-PUMC000147
DR   Wikidata; Q98128860
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   RCC BA85#21
AC   CVCL_T986
SY   RCC85#21; RCC BA85#21 (ELTHEM); BA85-RCC; Elthem
DR   ABM; T8337
DR   ECACC; 13051601
DR   Wikidata; Q54949443
RX   Patent=US8128923;
RX   PubMed=27278998;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 04006.
CC   Doubling time: 72 hours (PubMed=27278998).
CC   Microsatellite instability: Stable (MSS) (PubMed=27278998).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=13051601
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   RCC-1
AC   CVCL_D2QP
SY   Raji Co-Culture No.1
DR   Wikidata; Q127384025
RX   Patent=US5849564;
RX   Patent=US5861500;
RX   PubMed=8523568;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11734.
CC   Population: African; Nigerian.
CC   Virology: Infected with human herpesvirus 8 (HHV-8/KSHV). Produced by the co-cultivation of Raji cells with BC-1 cells (Cellosaurus=CVCL_1079) separated by filter tissue culture inserts to prevent cross-contamination (PubMed=8523568).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   RCC-1 clone 2F5
AC   CVCL_D2QQ
SY   RCC-1(2F5)
DR   Wikidata; Q127384027
RX   Patent=US5849564;
RX   Patent=US5861500;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11735.
CC   Population: African; Nigerian.
CC   Virology: Infected with human herpesvirus 8 (HHV-8/KSHV). Produced by the co-cultivation of Raji cells with BC-1 cells (Cellosaurus=CVCL_1079) separated by filter tissue culture inserts to prevent cross-contamination (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D2QP ! RCC-1
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   RCC-26
AC   CVCL_VQ70
SY   RCC26
DR   Lonza; 754
DR   Wikidata; Q98128861
RX   PubMed=8409397;
RX   PubMed=11175312;
RX   PubMed=11809699;
RX   PubMed=15755994;
RX   PubMed=15997395;
RX   PubMed=16045799;
RX   PubMed=16261161;
CC   HLA typing: A*02:01,33:03; B*41:01,51:01; C*15:02,17:01 (PubMed=11175312).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3HP ! LCL-26
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   RCC-26/CD80
AC   CVCL_C3HQ
SY   RCC-26/B7.1
DR   Wikidata; Q114312774
RX   PubMed=11175312;
RX   PubMed=15755994;
RX   PubMed=15997395;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ70 ! RCC-26
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RCC-26/CD80/IL-2
AC   CVCL_C3HM
DR   Wikidata; Q114312775
RX   PubMed=15755994;
RX   PubMed=15997395;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ70 ! RCC-26
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RCC-26/CD80/IL-7
AC   CVCL_C3HN
DR   Wikidata; Q114312776
RX   PubMed=15755994;
RX   PubMed=15997395;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6023; IL7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VQ70 ! RCC-26
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RCC-53
AC   CVCL_C3HR
SY   RCC53
DR   GEO; GSE40301
DR   Wikidata; Q114312777
RX   PubMed=16045799;
RX   PubMed=16261161;
RX   PubMed=23667903;
CC   HLA typing: A*02:01,25:01; B*15:01,18:01; C*03:03,12:03 (PubMed=16045799).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   RCC-AL4
AC   CVCL_AX15
DR   CLS; 300240
DR   Wikidata; Q54949444
CC   Discontinued: CLS; 300240; true.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   RCC-FG2 + PBRM1 Clone 13
AC   CVCL_E3WA
DR   CancerTools; 161867
CC   Population: Caucasian.
CC   Characteristics: PBRM1 is expressed upon doxycycline induction.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Phe148Leufs*11 (c.444delT); ClinVar=VCV000223212; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5873 ! KTCTL-26A
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   RCC-FG2 + PBRM1 Clone 6
AC   CVCL_E3WB
DR   CancerTools; 161866
CC   Population: Caucasian.
CC   Characteristics: PBRM1 is expressed upon doxycycline induction.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Phe148Leufs*11 (c.444delT); ClinVar=VCV000223212; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5873 ! KTCTL-26A
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   RCC-GH
AC   CVCL_5874
DR   CLS; 300252
DR   Wikidata; Q54949445
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300252
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12,14
ST   D16S539: 8,10,12
ST   D18S51: 12,17,18,23
ST   D21S11: 28,29,30
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,10,11
ST   D8S1179: 12,13,15
ST   FGA: 21,22,24,26
ST   Penta D: 9,11,12
ST   Penta E: 5,7,10,12
ST   TH01: 6,9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   RCC-GW
AC   CVCL_5876
DR   CLS; 300256
DR   Wikidata; Q54949446
CC   Population: Caucasian.
CC   Discontinued: CLS; 300256; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): CLS=300256
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 30,33.2
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,15
ST   FGA: 22
ST   Penta D: 10,12
ST   Penta E: 7
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   RCC-KL
AC   CVCL_5881
SY   RCCKL
DR   CLS; 300281
DR   Wikidata; Q54949447
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,08:01:01; B*35:01:01,49:01:01; C*04:01:01,07:01:01; DPB1*02:01,19:01; DQA1*01:02:01,01:04:01; DQB1*05:03:01,06:04:01; DRB1*13:02:01,14:01:01 (CLS=300281).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300281
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13,14
ST   D16S539: 10,12
ST   D18S51: 17,23
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22,26
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   RCC-MF + PBRM1 Clone 1
AC   CVCL_E3WC
DR   CancerTools; 161864
RX   PubMed=35902118;
CC   Population: Caucasian.
CC   Characteristics: PBRM1 is expressed upon doxycycline induction.
CC   Sequence variation: Mutation; HGNC; HGNC:30064; PBRM1; Simple; p.Asn528Metfs*41 (c.1583del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5884 ! KTCTL-1M
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   RCC-MF + PBRM1 Clone 3
AC   CVCL_E3WD
DR   CancerTools; 161865
CC   Population: Caucasian.
CC   Characteristics: PBRM1 is expressed upon doxycycline induction.
CC   Sequence variation: Mutation; HGNC; HGNC:30064; PBRM1; Simple; p.Asn528Metfs*41 (c.1583del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:30064; PBRM1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5884 ! KTCTL-1M
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   RCC-PR
AC   CVCL_5887
DR   CLS; 300267
DR   Wikidata; Q54949448
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300267
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,18
ST   D21S11: 29,31.2
ST   D3S1358: 15,16
ST   D5S818: 9
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   Penta D: 11,12
ST   Penta E: 7
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   RCC09HYF
AC   CVCL_U284
DR   Wikidata; Q54949450
RX   Patent=US9386762;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201130.
CC   Population: Chinese; Han.
CC   Doubling time: 18 hours (Patent=US9386762).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C27893; Sarcomatoid renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   RCC10
AC   CVCL_6265
SY   RCC-10
DR   BTO; BTO_0004932
DR   EFO; EFO_0022449
DR   Wikidata; Q54949451
RX   PubMed=11114720;
RX   PubMed=15985433;
CC   From: Bauer, Christian; Institute of Physiology, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Lys159fs (c.474_477del); Zygosity=Unspecified (PubMed=11114720).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   RCC10RGB
AC   CVCL_1647
SY   RCC-10RGB; RCC10 RGB; 10RGB; RGB; Hpt.10
DR   BTO; BTO_0003731
DR   CLO; CLO_0050890
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 385
DR   BioSample; SAMN03472161
DR   BioSample; SAMN10987699
DR   cancercelllines; CVCL_1647
DR   Cell_Model_Passport; SIDM00235
DR   ChEMBL-Cells; CHEMBL3308302
DR   ChEMBL-Targets; CHEMBL2366191
DR   Cosmic; 909974
DR   Cosmic-CLP; 909974
DR   DepMap; ACH-000189
DR   EGA; EGAS00001000978
DR   GDSC; 909974
DR   GEO; GSM887524
DR   GEO; GSM888606
DR   GEO; GSM1670359
DR   IARC_TP53; 21281
DR   LiGeA; CCLE_799
DR   LINCS_LDP; LCL-1769
DR   PharmacoDB; RCC10RGB_1293_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1647
DR   PubChem_Cell_line; CVCL_1647
DR   RCB; RCB1151
DR   Wikidata; Q54949452
RX   PubMed=10929426;
RX   PubMed=11416159;
RX   PubMed=14534724;
RX   PubMed=15604581;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:06,24:02; B*39:01,54:01; C*01:02,07:02; DQA1*01:02,03:02; DQB1*04:01,06:02; DRB1*11:02,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.11%; Native American=0%; East Asian, North=84.52%; East Asian, South=15.29%; South Asian=0%; European, North=0%; European, South=0.08% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=909974; PubMed=11416159; RCB=RCB1151
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D21S11: 29,30
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   D8S1179: 12,16
ST   FGA: 24,25
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   RCC11
AC   CVCL_W849
DR   Wikidata; Q54949453
RX   PubMed=11114720;
CC   From: Bauer, Christian; Institute of Physiology, University of Zurich; Zurich; Switzerland.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 7
//
ID   RCC149
AC   CVCL_X893
DR   CGH-DB; 9327-4
DR   Wikidata; Q54949454
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC19
AC   CVCL_X890
DR   CGH-DB; 9324-4
DR   Wikidata; Q54949455
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC2
AC   CVCL_C8J1
DR   Wikidata; Q123033332
RX   PubMed=11114720;
CC   From: Bauer, Christian; Institute of Physiology, University of Zurich; Zurich; Switzerland.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RCC213
AC   CVCL_X894
DR   CGH-DB; 9328-4
DR   Wikidata; Q54949456
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC217
AC   CVCL_X895
DR   CGH-DB; 9329-4
DR   Wikidata; Q54949457
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC23
AC   CVCL_X891
DR   CGH-DB; 9325-4
DR   Wikidata; Q54949458
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC266
AC   CVCL_X898
DR   Wikidata; Q54949460
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 6
//
ID   RCC270
AC   CVCL_X896
DR   CGH-DB; 9330-4
DR   Wikidata; Q54949461
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC31
AC   CVCL_X892
DR   CGH-DB; 9326-4
DR   Wikidata; Q54949462
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC4
AC   CVCL_0498
SY   RCC-4
DR   BTO; BTO_0005691
DR   EFO; EFO_0022430
DR   MCCL; MCC:0000395
DR   cancercelllines; CVCL_0498
DR   Cell_Model_Passport; SIDM01851
DR   ChEMBL-Cells; CHEMBL4483144
DR   ChEMBL-Targets; CHEMBL4483279
DR   Cosmic; 1352067
DR   Cosmic; 1497327
DR   Cosmic; 1751968
DR   Cosmic; 2520642
DR   DepMap; ACH-001175
DR   PharmacoDB; RCC4_1286_2019
DR   Progenetix; CVCL_0498
DR   PubChem_Cell_line; CVCL_0498
DR   TOKU-E; 3632
DR   Wikidata; Q54949463
RX   PubMed=10353251;
RX   PubMed=21258414;
RX   PubMed=22949125;
RX   PubMed=27993170;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser65Trp (c.194C>G); ClinVar=VCV000043597; Zygosity=Hemizygous (PubMed=10353251; PubMed=21258414).
CC   Genome ancestry: African=1.89%; Native American=0%; East Asian, North=3.32%; East Asian, South=0%; South Asian=0.27%; European, North=55.04%; European, South=39.47% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   RCC4/empty vector
AC   CVCL_UY81
SY   RCC4 plus vector alone
DR   cancercelllines; CVCL_UY81
DR   Cell_Model_Passport; SIDM01921
DR   ECACC; 03112702
DR   Wikidata; Q98128863
RX   PubMed=10353251;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser65Trp (c.194C>G); ClinVar=VCV000043597; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=03112702
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8.2
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0498 ! RCC4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   RCC4/VHL
AC   CVCL_2706
SY   RCC4plusVHL; RCC4 VHL(+); RCC4-pVHL
DR   cancercelllines; CVCL_2706
DR   Cell_Model_Passport; SIDM01920
DR   ChEMBL-Cells; CHEMBL4483154
DR   ChEMBL-Targets; CHEMBL4483265
DR   ECACC; 03112703
DR   PubChem_Cell_line; CVCL_2706
DR   Wikidata; Q54949465
RX   PubMed=10353251;
RX   PubMed=21258414;
RX   PubMed=22949125;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser65Trp (c.194C>G); ClinVar=VCV000043597; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12687; VHL.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=03112703
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8.2
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0498 ! RCC4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   RCC5
AC   CVCL_E055
SY   RCC-5
DR   Cosmic; 1352068
DR   Wikidata; Q54949467
RX   PubMed=12351398;
RX   PubMed=15941683;
CC   HLA typing: A*09,32; B*07,49; C*w07 (PubMed=12351398).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 9
//
ID   RCC52
AC   CVCL_X534
DR   Wikidata; Q54949468
RX   PubMed=18704411;
RX   PubMed=24222125;
CC   Population: Chinese.
CC   Doubling time: 23.4 hours (PubMed=24222125).
CC   HLA typing: A*02,11; B*46,60(40); C*w01,w07 (PubMed=18704411).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ala6Profs*1 (c.16delG); Zygosity=Heterozygous (PubMed=18704411).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous; Note=Total loss of HLA class 1 expression (PubMed=18704411).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C27893; Sarcomatoid renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   RCC6 [France]
AC   CVCL_E056
SY   RCC-6
DR   cancercelllines; CVCL_E056
DR   Cosmic; 1497326
DR   Wikidata; Q54949469
RX   PubMed=12351398;
RX   PubMed=15661891;
RX   PubMed=21258414;
CC   HLA typing: A*01,02; B*08,51; C*w07,w14 (PubMed=12351398).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser111Gly (c.331A>G); ClinVar=VCV000633016; Zygosity=Hemizygous (PubMed=21258414).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   RCC6 [Switzerland]
AC   CVCL_C8J3
DR   Wikidata; Q123033333
RX   PubMed=11114720;
CC   From: Bauer, Christian; Institute of Physiology, University of Zurich; Zurich; Switzerland.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Val130Leu (c.388G>C); ClinVar=VCV000002229; Zygosity=Unspecified (PubMed=11114720).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   RCC6/VHL
AC   CVCL_UY82
SY   RCC6-pVHL
DR   cancercelllines; CVCL_UY82
DR   Wikidata; Q98128864
RX   PubMed=21258414;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser111Gly (c.331A>G); ClinVar=VCV000633016; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12687; VHL.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E056 ! RCC6 [France]
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 10
//
ID   RCC63
AC   CVCL_6266
SY   RCC10wt63
DR   Wikidata; Q54949470
RX   PubMed=11114720;
RX   PubMed=15985433;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Lys159fs (c.474_477del); Zygosity=Unspecified (PubMed=11114720).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12687; VHL.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6265 ! RCC10
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   RCC7 [France]
AC   CVCL_E057
SY   RCC-7
DR   Wikidata; Q54949472
RX   PubMed=12351398;
RX   PubMed=15941683;
RX   PubMed=21258414;
CC   HLA typing: A*02,29; B*44,51; C*w15,w16 (PubMed=12351398).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 9
//
ID   RCC7 [Switzerland]
AC   CVCL_C8J4
DR   Wikidata; Q123033334
RX   PubMed=11114720;
CC   From: Bauer, Christian; Institute of Physiology, University of Zurich; Zurich; Switzerland.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RCC8
AC   CVCL_C8J2
DR   Wikidata; Q123033335
RX   PubMed=11114720;
CC   From: Bauer, Christian; Institute of Physiology, University of Zurich; Zurich; Switzerland.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RCC826
AC   CVCL_X897
DR   CGH-DB; 9331-4
DR   Wikidata; Q54949473
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 7
//
ID   RCC9
AC   CVCL_C8J5
DR   Wikidata; Q123033336
RX   PubMed=11114720;
CC   From: Bauer, Christian; Institute of Physiology, University of Zurich; Zurich; Switzerland.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   RCC96
AC   CVCL_IV50
DR   Wikidata; Q54949474
RX   PubMed=28055232;
CC   Population: Chinese.
CC   Doubling time: 52 hours (PubMed=28055232).
CC   Derived from site: Metastatic; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   RCC98
AC   CVCL_X535
DR   Wikidata; Q54949475
RX   PubMed=18704411;
CC   Population: Chinese.
CC   HLA typing: A*02,24; B*35,46; C*w01,w09(3) (PubMed=18704411).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4146; Chromophobe renal cell carcinoma
DI   ORDO; Orphanet_319303; Chromophobe renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   RCCD1
AC   CVCL_E043
SY   RCCD-1; RCCD(1); Rat Cortical Collecting Duct 1
DR   TOKU-E; 4120
DR   Wikidata; Q54949476
RX   PubMed=8840262;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-491.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   RCCD2
AC   CVCL_8414
SY   RCCD-2; RCCD(2); Rat Cortical Collecting Duct 2
DR   BTO; BTO_0003784
DR   Wikidata; Q54949477
RX   PubMed=11518773;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E043 ! RCCD1
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   RCCT-28A
AC   CVCL_6E94
SY   28A; Rabbit Cortical Collecting Tubule-28A
DR   Wikidata; Q54949480
RX   PubMed=2472075;
RX   PubMed=8381889;
RX   PubMed=9950954;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   RCCT-28A(P+)
AC   CVCL_6E95
SY   Rabbit Cortical Collecting Tubule-28A(Peanut lectin+)
DR   Wikidata; Q54949481
RX   PubMed=8381890;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_6E94 ! RCCT-28A
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   RCDMD
AC   CVCL_9W53
DR   Wikidata; Q54949482
RX   Patent=US8337829;
RX   PubMed=7520531;
RX   PubMed=20395455;
CC   Doubling time: ~3 days (PubMed=7520531).
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   RCE
AC   CVCL_4284
SY   K'RCE; RCEC; Rabbit Corneal Epithelial cells
DR   CLO; CLO_0008769
DR   CLDB; cl4117
DR   ECACC; 95081046
DR   Wikidata; Q54949483
RX   PubMed=7688358;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   RCE1
AC   CVCL_S897
SY   Rabbit Corneal Epithelial 1
DR   Wikidata; Q54949485
RX   PubMed=7527059;
CC   Doubling time: ~15 hours (PubMed=7527059).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
CC   Breed/subspecies: Albino.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RCER002-2
AC   CVCL_E3QC
SY   RCER002; RCER2-2; RCER2; F_PDO_000058
DR   CancerTools; 160895
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C40187; Cervical keratinizing squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCER003-2
AC   CVCL_E3QD
SY   RCER003; RCER3-2; RCER3; F_PDO_000060
DR   CancerTools; 160896
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C36095; Cervical mucinous adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCFBF
AC   CVCL_WK62
DR   CCRID; 1101RAB-PUMC000148
DR   Wikidata; Q98128865
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   RCH-ACV
AC   CVCL_1851
SY   RCHACV; RCH
DR   BTO; BTO_0003376
DR   EFO; EFO_0002314
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1760
DR   BioSample; SAMN03473533
DR   BioSample; SAMN10989563
DR   cancercelllines; CVCL_1851
DR   Cell_Model_Passport; SIDM00449
DR   Cosmic; 1130248
DR   Cosmic; 1191705
DR   Cosmic; 2396141
DR   Cosmic; 2396180
DR   Cosmic; 2427703
DR   Cosmic; 2491074
DR   Cosmic-CLP; 1330994
DR   DepMap; ACH-000922
DR   DSMZ; ACC-548
DR   DSMZCellDive; ACC-548
DR   EGA; EGAS00001000978
DR   GDSC; 1330994
DR   GEO; GSM887525
DR   GEO; GSM888607
DR   GEO; GSM931332
DR   GEO; GSM931333
DR   GEO; GSM931334
DR   GEO; GSM1670365
DR   GEO; GSM5137739
DR   GEO; GSM5137765
DR   IARC_TP53; 30150
DR   IGRhCellID; RCHACV
DR   LiGeA; CCLE_152
DR   PharmacoDB; RCHACV_1294_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1851
DR   Wikidata; Q54949486
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1720549;
RX   PubMed=1967982;
RX   PubMed=3455845;
RX   PubMed=9067587;
RX   PubMed=10490826;
RX   PubMed=11843816;
RX   PubMed=16523483;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29786757;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31305009;
RX   PubMed=31978347;
RX   PubMed=35124168;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 36 hours (PubMed=3455845); ~30-50 hours (DSMZ=ACC-548).
CC   HLA typing: A*02:01,68:01; B*39:01,44:02; C*05:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=11843816; PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg677Cys (c.2029C>T); ClinVar=VCV000950520; Zygosity=Heterozygous (Cosmic-CLP=1330994; DepMap=ACH-000922).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Ala11Thr (c.31G>A); ClinVar=VCV000178860; Zygosity=Heterozygous (Cosmic-CLP=1330994; DepMap=ACH-000922).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Val14Ile (c.40G>A); ClinVar=VCV000012589; Zygosity=Heterozygous (Cosmic-CLP=1330994; DepMap=ACH-000922).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0.59%; East Asian, North=1.16%; East Asian, South=0%; South Asian=2.04%; European, North=65.94%; European, South=30.22% (PubMed=30894373).
CC   Misspelling: RCH-AVC; Cosmic=1191705; Note=Prior to 2020.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=1330994; DSMZ=ACC-548
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 11
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 23,26
ST   Penta D: 9,10
ST   Penta E: 7,11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y458 ! RCH-ADD
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 42
//
ID   RCH-ADD
AC   CVCL_Y458
DR   Wikidata; Q54949487
RX   PubMed=1720549;
RX   PubMed=1967982;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1851 ! RCH-ACV
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   RCHO
AC   CVCL_6F08
DR   Wikidata; Q54949488
RX   PubMed=1418418;
RX   PubMed=2323851;
RX   PubMed=8493450;
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
DI   NCIt; C60377; Rat choriocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_7996 ! Rcho-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   Rcho-1
AC   CVCL_7996
SY   Rcho1; Rat choriocarcinoma-1
DR   BTO; BTO_0001556
DR   TOKU-E; 4100
DR   Wikidata; Q54949494
RX   PubMed=1954876;
RX   PubMed=8781972;
RX   PubMed=8895376;
RX   PubMed=16251742;
WW   Info; -; -; https://web.archive.org/web/20141104152231/http://www2.kumc.edu/soalab/LabLinks/cell%20lines/rcho1.htm
CC   Characteristics: Capable of differentiating along the trophoblast giant cell lineage (PubMed=1954876).
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
DI   NCIt; C60377; Rat choriocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_6F08 ! RCHO
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   rCHO(hBMP2)-C8
AC   CVCL_C3ND
SY   rCHO(hBMP-2)
DR   Wikidata; Q116050165
RX   PubMed=17168321;
RX   PubMed=18724709;
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1069; BMP2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   RCHT
AC   CVCL_9Y61
SY   RCHT-1
DR   ABM; T0692
DR   Wikidata; Q54949495
RX   PubMed=11355881;
RX   PubMed=12829417;
RX   PubMed=15777081;
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   RCi001-A
AC   CVCL_9S41
SY   RCi88; Thp3C-6; EM3-6
DR   BioSamples; SAMEA3105842
DR   EBiSC; RCi001-A
DR   ECACC; 66540016
DR   hPSCreg; RCi001-A
DR   SKIP; SKIP002466
DR   Wikidata; Q54949496
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Val400Met (c.1198G>A); ClinVar=VCV000538468; Zygosity=Heterozygous (PubMed=27099175).
CC   Discontinued: ECACC; 66540016; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S42 ! RCi001-B
SX   Male
AG   >10Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   RCi001-B
AC   CVCL_9S42
SY   RCi89; Thp3C-9
DR   BioSamples; SAMEA3106040
DR   EBiSC; RCi001-B
DR   ECACC; 66540048
DR   hPSCreg; RCi001-B
DR   SKIP; SKIP002467
DR   Wikidata; Q54949498
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Val400Met (c.1198G>A); ClinVar=VCV000538468; Zygosity=Heterozygous (PubMed=27099175).
CC   Discontinued: ECACC; 66540048; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S41 ! RCi001-A
SX   Male
AG   >10Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   RCi002-A
AC   CVCL_9S43
SY   RCi92; FP5C-14; EM5-14; PFIZi033-A
DR   BioSamples; SAMEA3105892
DR   EBiSC; RCi002-A
DR   ECACC; 66540049
DR   hPSCreg; RCi002-A
DR   SKIP; SKIP002474
DR   Wikidata; Q54949499
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Phe1460Val (c.4378T>G) (p.Phe1449Val, c.4345T>G); ClinVar=VCV000006352; Zygosity=Heterozygous (PubMed=27099175).
CC   Discontinued: ECACC; 66540049; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S44 ! RCi002-B
SX   Female
AG   <2Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   RCi002-B
AC   CVCL_9S44
SY   RCi93; FP5C-16; EM5-16
DR   BioSamples; SAMEA3106075
DR   EBiSC; RCi002-B
DR   ECACC; 66540050
DR   hPSCreg; RCi002-B
DR   SKIP; SKIP002475
DR   Wikidata; Q54949501
RX   PubMed=27099175;
CC   From: Pfizer, Inc.; New York; USA.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Phe1460Val (c.4378T>G) (p.Phe1449Val, c.4345T>G); ClinVar=VCV000006352; Zygosity=Heterozygous (PubMed=27099175).
CC   Discontinued: ECACC; 66540050; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S43 ! RCi002-A
SX   Female
AG   <2Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   RCi003-A
AC   CVCL_9S45
SY   RCi115; CIP11A-5
DR   BioSamples; SAMEA3105949
DR   EBiSC; RCi003-A
DR   ECACC; 66540051
DR   hPSCreg; RCi003-A
DR   SKIP; SKIP002476
DR   Wikidata; Q54949502
CC   From: Pfizer, Inc.; New York; USA.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10583; SCN11A; Unexplicit; Not described; Zygosity=Unspecified (EBiSC=RCi003-A).
CC   Discontinued: ECACC; 66540051; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125388; Neuropathy, hereditary sensory and autonomic, type VII
DI   ORDO; Orphanet_391397; Hereditary sensory and autonomic neuropathy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S46 ! RCi003-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   RCi003-B
AC   CVCL_9S46
SY   RCi117; CIP11A-9
DR   BioSamples; SAMEA3106143
DR   EBiSC; RCi003-B
DR   ECACC; 66540052
DR   hPSCreg; RCi003-B
DR   SKIP; SKIP002477
DR   Wikidata; Q54949503
CC   From: Pfizer, Inc.; New York; USA.
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10583; SCN11A; Unexplicit; Not described; Zygosity=Unspecified (EBiSC=RCi003-B).
CC   Discontinued: ECACC; 66540052; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125388; Neuropathy, hereditary sensory and autonomic, type VII
DI   ORDO; Orphanet_391397; Hereditary sensory and autonomic neuropathy type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S45 ! RCi003-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   RCi004-A
AC   CVCL_9S47
SY   RCi150; PDSC-10
DR   BioSamples; SAMEA3106011
DR   EBiSC; RCi004-A
DR   ECACC; 66540024
DR   EGA; EGAS00001002755
DR   hPSCreg; RCi004-A
DR   SKIP; SKIP002478
DR   Wikidata; Q54949504
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[~40] (c.52CAG(~40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=RCi004-A).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: ECACC; 66540024; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S48 ! RCi004-B
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 19
//
ID   RCi004-B
AC   CVCL_9S48
SY   RCi68; PDSC-3
DR   BioSamples; SAMEA3106205
DR   EBiSC; RCi004-B
DR   ECACC; 66540014
DR   EGA; EGAS00001002755
DR   hPSCreg; RCi004-B
DR   SKIP; SKIP002479
DR   Wikidata; Q54949507
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[~40] (c.52CAG(~40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (EBiSC=RCi004-B).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: At sampling donor was not affected with Huntington's disease but at risk for disease (HTT has CAG repeat length greater than or equal to 36).
CC   Discontinued: ECACC; 66540014; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S47 ! RCi004-A
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 19
//
ID   RCi005-A
AC   CVCL_II96
SY   RCi171; FB71c4
DR   BioSamples; SAMEA3961534
DR   EBiSC; RCi005-A
DR   ECACC; 66540044
DR   EGA; EGAS00001002755
DR   hPSCreg; RCi005-A
DR   SKIP; SKIP002623
DR   Wikidata; Q54949508
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:30299; LRIF1; Simple; p.Arg346Ter (c.1036C>T); Zygosity=Homozygous (EBiSC=RCi005-A).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540044; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 15
//
ID   RCi006-A
AC   CVCL_EE36
SY   RCi169; FB69c4
DR   BioSamples; SAMEA3962402
DR   EBiSC; RCi006-A
DR   ECACC; 66540107
DR   EGA; EGAS00001002755
DR   hPSCreg; RCi006-A
DR   SKIP; SKIP002624
DR   Wikidata; Q54949509
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:30299; LRIF1; Simple; p.Arg346Ter (c.1036C>T); Zygosity=Homozygous (EBiSC=RCi006-A).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540107; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   RCi007-A
AC   CVCL_RF95
SY   FB70c1; RCi170
DR   BioSamples; SAMEA3961596
DR   EBiSC; RCi007-A
DR   ECACC; 66540045
DR   hPSCreg; RCi007-A
DR   SKIP; SKIP002671
DR   Wikidata; Q54949510
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:30299; LRIF1; Simple; p.Arg346Ter (c.1036C>T); Zygosity=Heterozygous (EBiSC=RCi007-A).
CC   Discontinued: ECACC; 66540045; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU25 ! RCi007-B
OI   CVCL_II97 ! RCi007-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   RCi007-B
AC   CVCL_WU25
DR   BioSamples; SAMEA4084816
DR   EBiSC; RCi007-B
DR   hPSCreg; RCi007-B
DR   Wikidata; Q98128866
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:30299; LRIF1; Simple; p.Arg346Ter (c.1036C>T); Zygosity=Heterozygous (from autologous cell lines RCi007-A; RCi007-C).
CC   Discontinued: EBiSC; RCi007-B; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RF95 ! RCi007-A
OI   CVCL_II97 ! RCi007-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   RCi007-C
AC   CVCL_II97
DR   BioSamples; SAMEA4084916
DR   EBiSC; RCi007-C
DR   ECACC; 66540163
DR   EGA; EGAS00001002755
DR   hPSCreg; RCi007-C
DR   Wikidata; Q54949511
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:30299; LRIF1; Simple; p.Arg346Ter (c.1036C>T); Zygosity=Heterozygous (EBiSC=RCi007-C).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540163; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RF95 ! RCi007-A
OI   CVCL_WU25 ! RCi007-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   RCi009-A
AC   CVCL_EE37
SY   RCi201; FB73c6
DR   BioSamples; SAMEA4339688
DR   EBiSC; RCi009-A
DR   ECACC; 66540260
DR   EGA; EGAS00001002755
DR   hPSCreg; RCi009-A
DR   SKIP; SKIP002787
DR   Wikidata; Q54949513
CC   From: Censo Biotechnologies, Ltd (Roslin Cells, Ltd); Roslin; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:30299; LRIF1; Simple; p.Arg346Ter (c.1036C>T); Zygosity=Homozygous (EBiSC=RCi009-A).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540260; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   RCJ 3.1
AC   CVCL_B0BW
SY   RCJ3.1
DR   Wikidata; Q108821214
RX   PubMed=2551636;
RX   PubMed=3384856;
RX   PubMed=8855373;
CC   Characteristics: Differentiates into myotubes, adipocytes, chondrocytes and osteoblasts in the presence of the glucocorticosteroid dexamethasone (Dex) (PubMed=3384856).
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   21FD
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RCJ 3.1C5
AC   CVCL_B0BX
SY   C5
DR   Wikidata; Q108821215
RX   PubMed=2551636;
RX   PubMed=8855373;
CC   Characteristics: Differentiates to form discrete cartilage nodules. Nodule formation is regulated by Dex and vitamin D3 metabolites in a dose- and time-dependent manner (PubMed=2551636).
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B0BW ! RCJ 3.1
AG   21FD
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RCJ 3.1C5.18
AC   CVCL_B0BY
SY   RCJ 3.1c5.18; RCJ 3.1 C5.18; RCJ3.1C5.18; C5.18
DR   Wikidata; Q108821216
RX   PubMed=8855373;
RX   PubMed=9857207;
RX   PubMed=10098531;
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B0BX ! RCJ 3.1C5
AG   21FD
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RCJ 3.1C5.25
AC   CVCL_B0BZ
SY   C5.25
DR   Wikidata; Q108821217
RX   PubMed=8855373;
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B0BX ! RCJ 3.1C5
AG   21FD
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RCK105
AC   CVCL_WM71
SY   RCK 105
DR   Wikidata; Q98128867
RX   PubMed=2436934;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08729; Human KRT7 (Note=Also reacts with mouse, rat, dog, pig, etc.).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   RCK106
AC   CVCL_WM72
SY   RCK 106
DR   Wikidata; Q98128868
RX   PubMed=2436934;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   RCL-1
AC   CVCL_C8R4
DR   Wikidata; Q123033337
RX   PubMed=6064953;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RCM-1 [Human ESC]
AC   CVCL_C099
SY   RCM1; Roslin Cells Manchester-1; RCe005-A
DR   hPSCreg; RCe005-A
DR   SKIP; SKIP002480
DR   Wikidata; Q54949514
RX   PubMed=19393594;
RX   PubMed=27346018;
WW   Provider; Roslin; -; https://web.archive.org/web/20150217024450/http://roslincells.com/clinical-research-grade-lines/
CC   From: Roslin Cells, Ltd; Roslin; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-019, Steering comm. appl. SCSC08-12.
CC   Miscellaneous: STR profile from personal communication of De Sousa, Paul Alexandre.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 14,16
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   D8S1179: 10,14
ST   FGA: 22.2,25
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RCM-1 [Human rectal adenocarcinoma]
AC   CVCL_1648
SY   RCM1
DR   CLO; CLO_0009972
DR   EFO; EFO_0006476
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 996
DR   BioSample; SAMN03472886
DR   BioSample; SAMN10988165
DR   cancercelllines; CVCL_1648
DR   Cell_Model_Passport; SIDM00359
DR   ChEMBL-Cells; CHEMBL3308125
DR   ChEMBL-Targets; CHEMBL1075562
DR   ColonAtlas; RCM1
DR   Cosmic; 873704
DR   Cosmic; 909263
DR   Cosmic; 1122329
DR   Cosmic; 1184088
DR   Cosmic; 1187314
DR   Cosmic; 1995616
DR   Cosmic-CLP; 909263
DR   DepMap; ACH-000565
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909263
DR   GEO; GSM827229
DR   GEO; GSM887526
DR   GEO; GSM888608
DR   GEO; GSM1374846
DR   GEO; GSM1448098
DR   GEO; GSM1670367
DR   IARC_TP53; 21282
DR   JCRB; JCRB0256
DR   LiGeA; CCLE_779
DR   LINCS_LDP; LCL-1290
DR   PharmacoDB; RCM1_1295_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1648
DR   PubChem_Cell_line; CVCL_1648
DR   Wikidata; Q54949516
RX   PubMed=2570482;
RX   PubMed=3198327;
RX   PubMed=8348978;
RX   PubMed=9247707;
RX   PubMed=9290701;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: 71.4 hours (PubMed=2570482).
CC   HLA typing: A*24:02,24:02; B*51:01,54:01; C*01:02,14:02; DQA1*01:02,05:02; DQB1*05:01,05:01; DRB1*01:01,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg216Ter (c.646C>T); ClinVar=VCV000127312; Zygosity=Heterozygous (Cosmic-CLP=909263; DepMap=ACH-000565).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Gln1740Ter (c.5218C>T); Zygosity=Heterozygous (Cosmic-CLP=909263; DepMap=ACH-000565).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=909263; DepMap=ACH-000565).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Homozygous (PubMed=16418264; Cosmic-CLP=909263; DepMap=ACH-000565).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.97%; Native American=0%; East Asian, North=75.44%; East Asian, South=22.81%; South Asian=0.01%; European, North=0%; European, South=0.77% (PubMed=30894373).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): Cosmic-CLP=909263; JCRB=JCRB0256; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,11,12 (Cosmic-CLP=909263)
ST   D16S539: 11,12 (JCRB=JCRB0256; PubMed=25877200; PubMed=25926053)
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11 (PubMed=25926053)
ST   D5S818: 11,12 (Cosmic-CLP=909263; JCRB=JCRB0256; PubMed=25877200)
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 9
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 20
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   RCM-2
AC   CVCL_WL36
DR   Wikidata; Q98128869
RX   PubMed=8348978;
RX   PubMed=9247707;
CC   Population: Japanese.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RCM-25
AC   CVCL_B5N1
DR   Wikidata; Q112041636
RX   PubMed=7068600;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04460; Rabbit MYH6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   RCM-3
AC   CVCL_WL37
DR   Wikidata; Q98128870
RX   PubMed=8348978;
RX   PubMed=9247707;
CC   Population: Japanese.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RCM-37
AC   CVCL_B5N2
DR   Wikidata; Q112041637
RX   PubMed=7068600;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04460; Rabbit MYH6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   RcMab-1
AC   CVCL_D3E8
DR   Wikidata; Q127384029
RX   PubMed=23750482;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   RCMGi001-A
AC   CVCL_YT36
SY   P1L5
DR   BioSamples; SAMEA6599779
DR   hPSCreg; RCMGi001-A
DR   Wikidata; Q98128871
RX   PubMed=32777768;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=32777768).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32777768
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 15,20
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 8,14
ST   FGA: 24.2,26
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   RCMGi002-A
AC   CVCL_YT37
SY   P7L2
DR   BioSamples; SAMEA6703339
DR   hPSCreg; RCMGi002-A
DR   Wikidata; Q98128872
RX   PubMed=33684631;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=33684631).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   RCMGi003-A
AC   CVCL_A9H8
SY   P3L1
DR   BioSamples; SAMEA7211804
DR   hPSCreg; RCMGi003-A
DR   Wikidata; Q102114800
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 4
//
ID   RCMGi004-A
AC   CVCL_A9H9
SY   P6L2
DR   BioSamples; SAMEA7211806
DR   hPSCreg; RCMGi004-A
DR   Wikidata; Q102114801
RX   PubMed=33607467;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=33607467).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (PubMed=33607467).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WP ! RCMGi004-B
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   RCMGi004-B
AC   CVCL_A1WP
SY   P6L8
DR   BioSamples; SAMEA7361093
DR   hPSCreg; RCMGi004-B
DR   Wikidata; Q105510724
RX   PubMed=33607467;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=33607467).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Heterozygous (PubMed=33607467).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9H9 ! RCMGi004-A
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RCMGi005-A
AC   CVCL_A5FT
SY   P5L1
DR   BioSamples; SAMEA7976384
DR   hPSCreg; RCMGi005-A
DR   Wikidata; Q107116724
RX   PubMed=36067639;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=36067639).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0C6 ! RCMGi005-B
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   RCMGi005-B
AC   CVCL_C0C6
SY   P5L5
DR   BioSamples; SAMEA14263260
DR   hPSCreg; RCMGi005-B
DR   Wikidata; Q114312778
RX   PubMed=36067639;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=36067639).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5FT ! RCMGi005-A
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   RCMGi006-A
AC   CVCL_A0CP
SY   VII_MAK_C
DR   BioSamples; SAMEA9211458
DR   hPSCreg; RCMGi006-A
DR   Wikidata; Q108821218
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian; Russian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RCMGi007-A
AC   CVCL_B5LM
SY   P8L2
DR   BioSamples; SAMEA10401757
DR   hPSCreg; RCMGi007-A
DR   Wikidata; Q112041639
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 4
//
ID   RCMGi008-A
AC   CVCL_C0C5
SY   P9L1
DR   BioSamples; SAMEA14092090
DR   hPSCreg; RCMGi008-A
DR   Wikidata; Q114312779
RX   PubMed=35843019;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser18Argfs*16 (c.54-5940_273+10250del) (CFTRdele2,3); ClinVar=VCV000066105; Zygosity=Heterozygous (PubMed=35843019).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=35843019).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   RCMGi009-A
AC   CVCL_C9HC
SY   P14L1
DR   BioSamples; SAMEA112366029
DR   hPSCreg; RCMGi009-A
DR   Wikidata; Q123033338
RX   PubMed=37307755;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=37307755).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   RCMGi010-A
AC   CVCL_C9HB
DR   hPSCreg; RCMGi010-A
DR   Wikidata; Q123033339
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RCMGi011-A
AC   CVCL_C9H9
SY   P10L1
DR   BioSamples; SAMEA112696500
DR   hPSCreg; RCMGi011-A
DR   Wikidata; Q123033340
RX   PubMed=37643494;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian; Russian.
CC   Sequence variation: Mutation; HGNC; HGNC:13733; CDH23; Simple; p.Arg269Trp (c.805C>T); ClinVar=VCV001687042; Zygosity=Heterozygous (PubMed=37643494).
CC   Sequence variation: Mutation; HGNC; HGNC:13733; CDH23; Simple; p.Val2331Ala (c.6992T>C); ClinVar=VCV001687043; Zygosity=Heterozygous (PubMed=37643494).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Tyr270Asp (c.808T>G); ClinVar=VCV000284172; Zygosity=Heterozygous (PubMed=37643494).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Unexplicit; Insertion of a pseudogene in intron 5; Zygosity=Heterozygous (PubMed=37643494).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C201586; Deafness, autosomal recessive 12
DI   NCIt; C84902; Mucopolysaccharidosis type IVB
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
DI   ORDO; Orphanet_309310; Mucopolysaccharidosis type 4B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9HA ! RCMGi011-B
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   RCMGi011-B
AC   CVCL_C9HA
SY   P10L2
DR   BioSamples; SAMEA112751261
DR   hPSCreg; RCMGi011-B
DR   Wikidata; Q123033342
RX   PubMed=37643494;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian; Russian.
CC   Sequence variation: Mutation; HGNC; HGNC:13733; CDH23; Simple; p.Arg269Trp (c.805C>T); ClinVar=VCV001687042; Zygosity=Heterozygous (PubMed=37643494).
CC   Sequence variation: Mutation; HGNC; HGNC:13733; CDH23; Simple; p.Val2331Ala (c.6992T>C); ClinVar=VCV001687043; Zygosity=Heterozygous (PubMed=37643494).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Tyr270Asp (c.808T>G); ClinVar=VCV000284172; Zygosity=Heterozygous (PubMed=37643494).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Unexplicit; Insertion of a pseudogene in intron 5; Zygosity=Heterozygous (PubMed=37643494).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C201586; Deafness, autosomal recessive 12
DI   NCIt; C84902; Mucopolysaccharidosis type IVB
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
DI   ORDO; Orphanet_309310; Mucopolysaccharidosis type 4B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9H9 ! RCMGi011-A
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   RCMGi012-A
AC   CVCL_C9HD
SY   P11L3
DR   BioSamples; SAMEA113401540
DR   hPSCreg; RCMGi012-A
DR   Wikidata; Q123033343
RX   PubMed=38006675;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:714; ARSB; Simple; p.Trp322Ter (c.966G>A); ClinVar=VCV000559831; Zygosity=Heterozygous (PubMed=38006675).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61264; Maroteaux-Lamy syndrome
DI   ORDO; Orphanet_583; Mucopolysaccharidosis type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   RCMGi013-A
AC   CVCL_D0KV
SY   P2L2
DR   BioSamples; SAMEA114427315
DR   hPSCreg; RCMGi013-A
DR   Wikidata; Q123033344
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (hPSCreg=RCMGi013-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   RCMGi014-A
AC   CVCL_E4EM
SY   P20L7
DR   BioSamples; SAMEA114786333
DR   hPSCreg; RCMGi014-A
RX   DOI=10.1134/S1062360424700048;
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (DOI=10.1134/S1062360424700048).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCMGi015-A
AC   CVCL_E4EN
SY   P16L4
DR   BioSamples; SAMEA115108458
DR   hPSCreg; RCMGi015-A
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Arg83Cys (c.247C>T); ClinVar=VCV000011998; Zygosity=Heterozygous (hPSCreg=RCMGi015-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCMGi016-A
AC   CVCL_E4EP
SY   P17L16
DR   BioSamples; SAMEA115109065
DR   hPSCreg; RCMGi016-A
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4056; G6PC1; Simple; p.Arg83Cys (c.247C>T); ClinVar=VCV000011998; Zygosity=Homozygous (hPSCreg=RCMGi016-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162398; Glycogen storage disease type Ia
DI   ORDO; Orphanet_79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCMGi017-A
AC   CVCL_E4EQ
SY   P12L3
DR   BioSamples; SAMEA115128016
DR   hPSCreg; RCMGi017-A
CC   From: Research Centre for Medical Genetics; Moscow; Russia.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCMH
AC   CVCL_9W52
DR   PRIDE; PXD001974
DR   Wikidata; Q54949517
RX   Patent=US8337829;
RX   PubMed=1373077;
RX   PubMed=9350011;
RX   PubMed=20395455;
RX   PubMed=26781476;
CC   Doubling time: ~24 hours (PubMed=1373077).
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Omics: Proteomics.
CC   Miscellaneous: Sex assignment using analysis of proteomics identifications (personal communication of Bairoch, Amos).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   RCN-9
AC   CVCL_5349
DR   CLO; CLO_0051585
DR   JCRB; FDSC0024
DR   JCRB; JCRB0167
DR   RCB; RCB0511
DR   Wikidata; Q54949518
RX   PubMed=1900274;
RX   PubMed=8902504;
RX   PubMed=9655087;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Discontinued: JCRB; FDSC0024; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   20W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RCNSi001-A
AC   CVCL_A1WQ
SY   HU-DM2-A-1
DR   hPSCreg; RCNSi001-A
DR   Wikidata; Q105510730
RX   PubMed=33099106;
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of RCNSi002-A (Cellosaurus=CVCL_A1WS) and RCNSi002-B (Cellosaurus=CVCL_A1WT).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33099106
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 28,31.2
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WR ! RCNSi001-B
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RCNSi001-B
AC   CVCL_A1WR
SY   HU-DM2-A-2
DR   hPSCreg; RCNSi001-B
DR   Wikidata; Q105510737
RX   PubMed=33099106;
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of RCNSi002-A (Cellosaurus=CVCL_A1WS) and RCNSi002-B (Cellosaurus=CVCL_A1WT).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33099106
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 28,31.2
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WQ ! RCNSi001-A
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RCNSi002-A
AC   CVCL_A1WS
SY   HU-DM2-B-1
DR   hPSCreg; RCNSi002-A
DR   Wikidata; Q105510742
RX   PubMed=33099106;
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of RCNSi001-A (Cellosaurus=CVCL_A1WQ) and RCNSi001-B (Cellosaurus=CVCL_A1WR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33099106
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 28,31.2
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WT ! RCNSi002-B
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RCNSi002-B
AC   CVCL_A1WT
SY   HU-DM2-B-2
DR   hPSCreg; RCNSi002-B
DR   Wikidata; Q105510751
RX   PubMed=33099106;
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of RCNSi001-A (Cellosaurus=CVCL_A1WQ) and RCNSi001-B (Cellosaurus=CVCL_A1WR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33099106
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 28,31.2
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1WS ! RCNSi002-A
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RCNSi003-A
AC   CVCL_E4ER
SY   2GMB7
DR   BioSamples; SAMEA115537609
DR   hPSCreg; RCNSi003-A
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCNSi005-A
AC   CVCL_E4ES
SY   2GF-A2
DR   BioSamples; SAMEA115537699
DR   hPSCreg; RCNSi005-A
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCNSi006-A
AC   CVCL_E4ET
SY   2FD1-11
DR   BioSamples; SAMEA115537696
DR   hPSCreg; RCNSi006-A
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCNSi007-A
AC   CVCL_E4EU
SY   2MA2-13
DR   BioSamples; SAMEA115537697
DR   hPSCreg; RCNSi007-A
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCNSi008-A
AC   CVCL_E4EV
SY   2PB2-11
DR   BioSamples; SAMEA115537698
DR   hPSCreg; RCNSi008-A
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EW ! RCNSi008-B
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCNSi008-B
AC   CVCL_E4EW
SY   2PB2-12
DR   BioSamples; SAMEA115537700
DR   hPSCreg; RCNSi008-B
CC   From: RCNS-Institute of Enzymology; Budapest; Hungary.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E4EV ! RCNSi008-A
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCN-H-4
AC   CVCL_5575
SY   RCN-H4
DR   CLO; CLO_0051584
DR   RCB; RCB0512
DR   Wikidata; Q54949519
RX   PubMed=9655087;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5349 ! RCN-9
SX   Male
AG   20W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   RCOL002-2
AC   CVCL_E3QE
SY   RCOL002; RCOL2-2; RCOL2; F_PDO_000153
DR   CancerTools; 160900
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCOL003-3
AC   CVCL_E3QF
SY   RCOL003; RCOL3-3; RCOL3; F_PDO_000096
DR   CancerTools; 160901
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCOL004-3
AC   CVCL_E3QG
SY   RCOL004; RCOL4-3; RCOL4; F_PDO_000098
DR   CancerTools; 160902
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCOL005-2
AC   CVCL_E3QH
SY   RCOL005; RCOL5-2; RCOL5; F_PDO_000100
DR   CancerTools; 160903
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCOL009
AC   CVCL_E3QI
SY   RCOL9; F_PDO_000175
DR   CancerTools; 160904
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCOL010
AC   CVCL_E3QJ
SY   RCOL10; F_PDO_000212
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RCP
AC   CVCL_4285
SY   Rat Choroid Plexus
DR   ECACC; 00031626
DR   Wikidata; Q54949520
RX   PubMed=10964665;
CC   Transformant: Ad-SV40 hybrid virus (Note=TSOri-).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   RCPCMi001-A
AC   CVCL_UK94
SY   ATXN1ACL4
DR   BioSamples; SAMEA5176975
DR   hPSCreg; RCPCMi001-A
DR   Wikidata; Q98128873
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Discontinued: hPSCreg; RCPCMi001-A; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   RCPCMi002-A
AC   CVCL_UK95
SY   HD76
DR   BioSamples; SAMEA5230327
DR   hPSCreg; RCPCMi002-A
DR   Wikidata; Q98128874
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 9
//
ID   RCPCMi003-A
AC   CVCL_UK96
SY   ATXN1KCl2
DR   BioSamples; SAMEA5230329
DR   hPSCreg; RCPCMi003-A
DR   Wikidata; Q98128875
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 9
//
ID   RCPCMi004-A
AC   CVCL_XY76
SY   Park14-4; IPS PARK14-4
DR   BioSamples; SAMEA6169988
DR   hPSCreg; RCPCMi004-A
DR   SKIP; SKIP005727
DR   Wikidata; Q98128876
RX   PubMed=32151951;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex2del; Zygosity=Heterozygous (PubMed=32151951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32151951
ST   Amelogenin: X,Y
ST   CSF1PO: 10.3
ST   D10S1248: 14,15
ST   D12S391: 19.1
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 15,16.1
ST   D1S1656: 14,15
ST   D21S11: 33.3
ST   D22S1045: 16
ST   D2S441: 10,14
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 19,21.2
ST   SE33: 22.2,29
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   RCPCMi005-A
AC   CVCL_XY77
SY   IPSP12-1
DR   BioSamples; SAMEA6171395
DR   hPSCreg; RCPCMi005-A
DR   Wikidata; Q98128877
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   RCPCMi007-A
AC   CVCL_A8DJ
SY   IPSFF1S
DR   BioSamples; SAMEA8944451
DR   hPSCreg; RCPCMi007-A
DR   Wikidata; Q107116725
RX   PubMed=34237591;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   RCPCMi007-A-1
AC   CVCL_A8DK
SY   IPSFF1S deltab2m cl 12; IPSFF1Sdeltab2m cl12
DR   BioSamples; SAMEA8944453
DR   hPSCreg; RCPCMi007-A-1
DR   Wikidata; Q107116727
RX   PubMed=34237591;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8DJ ! RCPCMi007-A
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   RCPCMi008-A
AC   CVCL_A8NA
SY   IPS SCA17 sev cln4
DR   BioSamples; SAMEA8958139
DR   hPSCreg; RCPCMi008-A
DR   Wikidata; Q108821219
RX   PubMed=34171784;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11588; TBP; Repeat_expansion; CAG[47]; Zygosity=Heterozygous (PubMed=34171784).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179861; Spinocerebellar ataxia type 17
DI   ORDO; Orphanet_98759; Spinocerebellar ataxia type 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   RCPCMi009-A
AC   CVCL_C6SC
SY   IPSRG4S; UEF-3B
DR   BioSamples; SAMEA112142625
DR   hPSCreg; RCPCMi009-A
DR   Wikidata; Q117704819
RX   DOI=10.1134/S1062360423060048;
RX   DOI=10.17816/gc623799;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   RCPCMi009-A-1
AC   CVCL_C6SD
SY   IPSRG4S-206
DR   BioSamples; SAMEA113581024
DR   hPSCreg; RCPCMi009-A-1
DR   Wikidata; Q117704820
RX   DOI=10.1134/S1062360423060048;
RX   DOI=10.17816/gc623799;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12472; UBE2A.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6SC ! RCPCMi009-A
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   RCPCMi010-A
AC   CVCL_D0KW
SY   iPS 67-7
DR   BioSamples; SAMEA114008352
DR   hPSCreg; RCPCMi010-A
DR   Wikidata; Q123033346
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202069; Intellectual developmental disorder, X-linked, syndromic, Nascimento type
DI   ORDO; Orphanet_163956; X-linked intellectual disability, Nascimento type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   RCPCMi011-A
AC   CVCL_E4EX
SY   IPSFIL24S
DR   BioSamples; SAMEA115657229
DR   hPSCreg; RCPCMi011-A
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183309; Familial restrictive cardiomyopathy 5
DI   ORDO; Orphanet_75249; Familial isolated restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RCPFi001-A
AC   CVCL_QX62
SY   RP2-FiPS4F1
DR   hPSCreg; RCPFi001-A
DR   SKIP; SKIP003170
DR   Wikidata; Q54949521
RX   PubMed=28677533;
RX   PubMed=33994920;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/RP2-FiPS4F1%2520Solicitud%2520deposito.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:17340; PRPF8; Simple; p.Val2325_Glu2331del (c.6974_6994del21); ClinVar=VCV000916436; Zygosity=Heterozygous (PubMed=28677533; PubMed=33994920).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28677533
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 29,31
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 15
//
ID   RCPFi002-A
AC   CVCL_E6XR
SY   Ctrl1-FiPS4F1
DR   hPSCreg; RCPFi002-A
RX   PubMed=33994920;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_deposito_Ctrl1-FiPS4F1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_de_los_resultados_de_caracterizacion_de_la_linea_Ctrl-FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   RCPFi003-A
AC   CVCL_UL77
SY   RP1-FiPS4F1
DR   hPSCreg; RCPFi003-A
DR   Wikidata; Q98128878
RX   PubMed=26263531;
RX   PubMed=30612079;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_Deposito__RP1-FiPS4F1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_RP1-FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7027; MERTK; Simple; p.Ser331Cysfs*5 (c.992_993delCA); ClinVar=VCV000801735; Zygosity=Homozygous (PubMed=26263531).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   RCPFi003-A-1
AC   CVCL_UL78
SY   RP1-FiPS4F1-GC1
DR   hPSCreg; RCPFi003-A-1
DR   Wikidata; Q98128879
RX   PubMed=30612079;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+RP1-FiPS4F1-GC1+Solicitud+de+dep%C3%B3sito-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7027; MERTK; Simple; p.Ser331Cysfs*5 (c.992_993delCA); ClinVar=VCV000801735; Zygosity=Heterozygous (PubMed=30612079).
CC   Sequence variation: Mutation; HGNC; HGNC:7027; MERTK; Simple_corrected; p.Ser331Cysfs*5 (c.992_993delCA); ClinVar=VCV000801735; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=30612079).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL77 ! RCPFi003-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   RCPFi003-A-2
AC   CVCL_UL79
SY   RP1-FiPS4F1-GC2
DR   hPSCreg; RCPFi003-A-2
DR   Wikidata; Q98128880
RX   PubMed=30612079;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_RP1-FiPS4F1-GC2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7027; MERTK; Simple_corrected; p.Ser331Cysfs*5 (c.992_993delCA); ClinVar=VCV000801735; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=30612079).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL77 ! RCPFi003-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   RCPFi004-A
AC   CVCL_A8HL
SY   PLANFiPS1-Sv4F-1
DR   hPSCreg; RCPFi004-A
DR   Wikidata; Q107116728
RX   PubMed=34087982;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+PLANFiPS1-Sv4F-1+Solicitud+de+dep%C3%B3sito.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Glu786Lys (c.2356G>A); ClinVar=VCV001012262; Zygosity=Homozygous (PubMed=34087982).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   RCPFi005-A
AC   CVCL_A8HM
SY   PLANFiPS2-Sv4F-1
DR   hPSCreg; RCPFi005-A
DR   Wikidata; Q107116729
RX   PubMed=34087982;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+PLANFiPS2-Sv4F-1+Solicitud+de+dep%C3%B3sito.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Leu337Gln (c.1010T>A); Zygosity=Heterozygous (PubMed=34087982).
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Ala343Thr (c.1027G>A); ClinVar=VCV000159725; Zygosity=Heterozygous (PubMed=34087982).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   RCPFi006-A
AC   CVCL_A8HN
SY   PLANFiPS3-Sv4F-1
DR   hPSCreg; RCPFi006-A
DR   Wikidata; Q107116730
RX   PubMed=34087982;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+PLANFiPS3-Sv4F-1+Solicitud+de+dep%C3%B3sito.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Tyr790Ter (c.2370T>G); ClinVar=VCV000006195; Zygosity=Homozygous (PubMed=34087982).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84927; Infantile neuroaxonal dystrophy
DI   ORDO; Orphanet_35069; Infantile neuroaxonal dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   RCPFi007-A
AC   CVCL_UF40
SY   LCA-FiPS4F1; CIPFi001-A
DR   hPSCreg; RCPFi007-A
DR   Wikidata; Q93453603
RX   PubMed=30366342;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Formulario%2520de%2520deposito%2520LCA-FiPS4F1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Principe Felipe Centro de Investigacion; Valencia; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:359; AIPL1; Simple; p.Cys89Arg (c.265T>C); ClinVar=VCV000574505; Zygosity=Homozygous (PubMed=30366342).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   RCPTH
AC   CVCL_9Y59
DR   Wikidata; Q54949522
RX   CelloPub=CLPUB00311;
CC   Doubling time: 30 hours (CelloPub=CLPUB00311).
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   RCR-1
AC   CVCL_4856
DR   CLO; CLO_0051385
DR   CLO; CLO_0051386
DR   JCRB; JCRB0129.1
DR   JCRB; NIHS0229
DR   RCB; RCB0075
DR   RCB; RCB1456
DR   Wikidata; Q54949524
RX   PubMed=6368741;
CC   Discontinued: JCRB; NIHS0229; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RCR-1.P3
AC   CVCL_8308
DR   JCRB; JCRB0129.0
DR   JCRB; JCRB0129.2
DR   JCRB; NIHS0198
DR   JCRB; NIHS0355
DR   Wikidata; Q54949525
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: ~30 hours (JCRB=JCRB0129.2).
CC   Discontinued: JCRB; NIHS0198; true.
CC   Discontinued: JCRB; NIHS0355; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4856 ! RCR-1
SX   Sex unspecified
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RCS
AC   CVCL_S122
SY   Rat Chondrosarcoma Swarm
DR   Wikidata; Q54949526
RX   PubMed=7499238;
RX   PubMed=9990041;
CC   Characteristics: Established from the transplantable Swarm rat chondrosarcoma.
CC   Doubling time: <24 hours (PubMed=7499238).
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60376; Rat chondrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S123 ! RCS-LTC
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   RCS-LTC
AC   CVCL_S123
SY   RCS-Long Term Cultured; LTC
DR   Wikidata; Q54949527
RX   PubMed=12874833;
CC   Characteristics: Established from the transplantable Swarm rat chondrosarcoma.
CC   Doubling time: ~1 day (PubMed=12874833).
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60376; Rat chondrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S122 ! RCS
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   RCSIi001-A
AC   CVCL_YX99
SY   iPDK
DR   BioSamples; SAMEA5100026
DR   hPSCreg; RCSIi001-A
DR   Wikidata; Q98128881
CC   From: Royal College of Surgeons in Ireland; Dublin; Ireland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   RCSN-3
AC   CVCL_6719
SY   RCSN3; RC SN3; RC SN-3
DR   BTO; BTO_0004200
DR   Wikidata; Q54949528
RX   Patent=US8337829;
RX   PubMed=11299314;
RX   PubMed=11355881;
RX   PubMed=18522901;
CC   Doubling time: 52 hours (PubMed=11299314).
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Brain, substantia nigra; UBERON=UBERON_0002038.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   4M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   RCT-1
AC   CVCL_E271
SY   Rat Calvarial large T-fraction 1 cells
DR   Wikidata; Q54949529
RX   PubMed=2470584;
RX   PubMed=8456584;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   19FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   RCT-3
AC   CVCL_E272
SY   Rat Calvarial large T-fraction 3 cells
DR   Wikidata; Q54949530
RX   PubMed=2470584;
RX   PubMed=8456584;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   19FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   RCTi001-A
AC   CVCL_UK97
SY   204314P/R9_15
DR   BioSamples; SAMEA104616420
DR   hPSCreg; RCTi001-A
DR   Wikidata; Q98128882
CC   From: Catalent GmbH (RheinCell Therapeutics GmbH); Langenfeld; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   RCV20
AC   CVCL_B5A9
DR   Wikidata; Q110433162
RX   PubMed=26992832;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03524; Rabies virus glycoprotein (G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: IgG memory B cell; CL=CL_0000979.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5AA ! RCV58
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   RCV58
AC   CVCL_B5AA
DR   Wikidata; Q110433164
RX   PubMed=26992832;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P03524; Rabies virus glycoprotein (G).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: IgG memory B cell; CL=CL_0000979.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5A9 ! RCV20
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   RCVC
AC   CVCL_9W57
DR   Wikidata; Q54949531
RX   Patent=US8337829;
RX   PubMed=7693953;
CC   Doubling time: ~20 hours (PubMed=7693953).
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   RD
AC   CVCL_1649
AS   CVCL_S332
SY   R D; RD-2; RD 2; 130T; 130-T; 130 T; TE-32; TE 32; TE32; TE 32.T; Te 32.T
DR   BTO; BTO_0005377
DR   CLO; CLO_0008693
DR   CLO; CLO_0008770
DR   EFO; EFO_0002315
DR   CLDB; cl4119
DR   CLDB; cl4120
DR   CLDB; cl4121
DR   CLDB; cl4122
DR   CLDB; cl4123
DR   CLDB; cl4124
DR   CLDB; cl4125
DR   CLDB; cl4126
DR   CLDB; cl4127
DR   AddexBio; C0035001/4950
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-136
DR   ATCC; CRL-7713
DR   ATCC; CRL-7731
DR   ATCC; HTB-97
DR   BCRC; 60113
DR   BCRJ; 0260
DR   BioGRID_ORCS_Cell_line; 482
DR   BioSample; SAMN01821591
DR   BioSample; SAMN01821716
DR   BioSample; SAMN03472710
DR   BioSample; SAMN10988441
DR   cancercelllines; CVCL_1649
DR   CCRID; 1101HUM-PUMC000293
DR   CCRID; 1102HUM-NIFDC00079
DR   CCRID; 3101HUMTCHu45
DR   CCRID; 4201HUM-CCTCC00295
DR   CCTCC; GDC0295
DR   Cell_Model_Passport; SIDM00847
DR   ChEMBL-Cells; CHEMBL3307547
DR   ChEMBL-Targets; CHEMBL614144
DR   CLS; 300401
DR   Cosmic; 724833
DR   Cosmic; 801358
DR   Cosmic; 801760
DR   Cosmic; 802045
DR   Cosmic; 909264
DR   Cosmic; 1037298
DR   Cosmic; 1048111
DR   Cosmic; 1097753
DR   Cosmic; 1309330
DR   Cosmic; 1509195
DR   Cosmic; 1620036
DR   Cosmic; 1718099
DR   Cosmic; 2296987
DR   Cosmic; 2301590
DR   Cosmic; 2355912
DR   Cosmic-CLP; 909264
DR   DepMap; ACH-000169
DR   ECACC; 85111502
DR   EGA; EGAS00001000978
DR   GDSC; 909264
DR   GEO; GSM185149
DR   GEO; GSM186446
DR   GEO; GSM219726
DR   GEO; GSM887528
DR   GEO; GSM888610
DR   GEO; GSM1012752
DR   GEO; GSM1670368
DR   GEO; GSM1676309
DR   GEO; GSM1701643
DR   IARC_TP53; 767
DR   IGRhCellID; RD
DR   IZSLER; BS TCL 57
DR   JCRB; JCRB9072
DR   KCLB; 10136
DR   LiGeA; CCLE_882
DR   LINCS_LDP; LCL-1411
DR   Lonza; 1536
DR   PharmacoDB; RD_1296_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD007755
DR   PRIDE; PXD030304
DR   PRIDE; PXD039480
DR   Progenetix; CVCL_1649
DR   PubChem_Cell_line; CVCL_1649
DR   TOKU-E; 2986
DR   Wikidata; Q54949532
RX   CelloPub=CLPUB00569;
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1917385;
RX   PubMed=2216456;
RX   PubMed=2302710;
RX   PubMed=3158613;
RX   PubMed=3518877;
RX   PubMed=4241949;
RX   PubMed=6220172;
RX   PubMed=6304521;
RX   PubMed=7309287;
RX   PubMed=8275086;
RX   PubMed=8383879;
RX   PubMed=10899454;
RX   PubMed=12068308;
RX   PubMed=16518851;
RX   PubMed=17471488;
RX   PubMed=18082704;
RX   PubMed=19235922;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20922763;
RX   PubMed=21948088;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=22541669;
RX   PubMed=23578105;
RX   PubMed=23828214;
RX   PubMed=23882450;
RX   PubMed=25894527;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31448612;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36768928;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
WW   Provider; Vircell; -; https://www.vircell.com/en/products/rd-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=20922763).
CC   HLA typing: A*01; B*08,w15 (PubMed=77569).
CC   HLA typing: A*01:01,01:01; B*37:01,37:01; C*06:02,06:02; DQA1*04:01,04:01; DQB1*06:04,06:04; DRB1*10:01,13:05 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (PubMed=3158613; PubMed=12068308; PubMed=16518851; PubMed=22142829; ATCC=CCL-136; Cosmic-CLP=909264; DepMap=ACH-000169).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=2216456; ATCC=CCL-136; Cosmic-CLP=909264; DepMap=ACH-000169).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.96%; Native American=0%; East Asian, North=4.77%; East Asian, South=0%; South Asian=0%; European, North=53.65%; European, South=37.61% (PubMed=30894373).
CC   Anecdotal: One of the 3 cell lines (HT-1080, RD and SK-N-SH) where the NRAS oncogene was first identified (PubMed=6304521).
CC   Discontinued: ATCC; CRL-7713; true.
CC   Discontinued: ATCC; CRL-7731; true.
CC   Discontinued: ATCC; HTB-97; true.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
ST   Source(s): AddexBio=C0035001/4950; ATCC=CCL-136; CCRID; CLS=300401; Cosmic-CLP=909264; COG; ECACC=85111502; JCRB=JCRB9072; KCLB=10136; PubMed=20922763; PubMed=21948088
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D19S433: 11,14
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   RD rho-0
AC   CVCL_C1YP
DR   cancercelllines; CVCL_C1YP
DR   Wikidata; Q114312780
RX   PubMed=10899454;
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0). Obtained by growth of parental cell line with ethidium bromide.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   RD-5
AC   CVCL_UZ72
DR   Wikidata; Q98128883
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1582033; ! Recilia dorsalis (Zigzag leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RD-6
AC   CVCL_UZ73
DR   Wikidata; Q98128885
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1582033; ! Recilia dorsalis (Zigzag leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RD-7
AC   CVCL_UZ74
DR   Wikidata; Q98128886
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1582033; ! Recilia dorsalis (Zigzag leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RD-8
AC   CVCL_UZ75
DR   Wikidata; Q98128887
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1582033; ! Recilia dorsalis (Zigzag leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RD-9
AC   CVCL_UZ76
DR   Wikidata; Q98128888
RX   CelloPub=CLPUB00181;
RX   CelloPub=CLPUB00536;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1582033; ! Recilia dorsalis (Zigzag leafhopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RD-C2
AC   CVCL_8748
DR   CLO; CLO_0050203
DR   RCB; RCB2695
DR   Wikidata; Q54949533
RX   PubMed=17226753;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99829; Runx2.
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18-19FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   RD-C6
AC   CVCL_8749
DR   CLO; CLO_0050204
DR   RCB; RCB2696
DR   Wikidata; Q54949534
RX   PubMed=17226753;
CC   Knockout cell: Method=KO mouse; MGI; MGI:99829; Runx2.
CC   Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18-19FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   RD-DJ
AC   CVCL_E815
SY   IND-1; TER302; TER359
DR   dbMHC; 48906
DR   IHW; IHW09378
DR   IPD-IMGT/HLA; 12446
DR   Wikidata; Q54949535
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*24:02:01:01,32:01:01; B*41:02:01,51:01:01; C*16:02:01,17:03; DPA1*01:03:01:04,02:02:01; DPB1*04:01:01:01,19:01; DQA1*01:02:01:07,01:03:01:02; DQB1*06:03:01,06:09:01; DRB1*13:01:01,13:36; DRB3*02:02:01:02,03:01:01 (IPD-IMGT/HLA=12446).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   RD-ES
AC   CVCL_2169
SY   RDES; RDES-1
DR   BTO; BTO_0004202
DR   CLO; CLO_0008774
DR   EFO; EFO_0002316
DR   CLDB; cl4128
DR   CLDB; cl4129
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-166
DR   BCRJ; 0267
DR   BioGRID_ORCS_Cell_line; 194
DR   BioSample; SAMN03470929
DR   BioSample; SAMN10987904
DR   cancercelllines; CVCL_2169
DR   Cell_Model_Passport; SIDM01316
DR   CLS; 300410
DR   Cosmic; 759890
DR   Cosmic; 1078386
DR   Cosmic; 1082506
DR   Cosmic; 1085906
DR   Cosmic; 1381107
DR   Cosmic; 1718429
DR   Cosmic; 2228230
DR   Cosmic; 2250477
DR   Cosmic; 2294586
DR   DepMap; ACH-000041
DR   DSMZ; ACC-260
DR   DSMZCellDive; ACC-260
DR   GDSC; 1330996
DR   GEO; GSM393042
DR   GEO; GSM510006
DR   GEO; GSM887527
DR   GEO; GSM888609
DR   GEO; GSM1676310
DR   GEO; GSM1701644
DR   GEO; GSM5359730
DR   GEO; GSM5359731
DR   GEO; GSM5359732
DR   GEO; GSM5359733
DR   GEO; GSM5359734
DR   GEO; GSM5359735
DR   GEO; GSM5362971
DR   GEO; GSM5362972
DR   GEO; GSM5362973
DR   GEO; GSM5362974
DR   GEO; GSM5362975
DR   GEO; GSM5362976
DR   GEO; GSM5363991
DR   GEO; GSM5363992
DR   GEO; GSM5363993
DR   GEO; GSM5363994
DR   GEO; GSM5363995
DR   IARC_TP53; 1272
DR   IARC_TP53; 8400
DR   IGRhCellID; RDES
DR   LiGeA; CCLE_906
DR   LINCS_LDP; LCL-1455
DR   PharmacoDB; RDES_1297_2019
DR   Progenetix; CVCL_2169
DR   Wikidata; Q54949536
RX   DOI=10.5282/edoc.27750;
RX   PubMed=8040301;
RX   PubMed=8221663;
RX   PubMed=8378080;
RX   PubMed=9738976;
RX   PubMed=11423975;
RX   PubMed=18082704;
RX   PubMed=18160777;
RX   PubMed=19787792;
RX   PubMed=20215515;
RX   PubMed=21822310;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=25010205;
RX   PubMed=25223734;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=26428435;
RX   PubMed=28196595;
RX   PubMed=29464090;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-260).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777; PubMed=19787792).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=8040301; PubMed=9738976; PubMed=11423975; PubMed=25010205; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8221663; PubMed=8378080; PubMed=19787792; PubMed=25010205; PubMed=25223734; DepMap=ACH-000041).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.21%; Native American=0.02%; East Asian, North=3.1%; East Asian, South=0%; South Asian=0%; European, North=61.77%; European, South=33.89% (PubMed=30894373).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): ATCC=HTB-166; CLS=300410; DSMZ=ACC-260; PubMed=19787792; PubMed=25010205; PubMed=25877200; PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 11,13
ST   SE33: 17,18
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   RD-Luc
AC   CVCL_XD25
DR   cancercelllines; CVCL_XD25
DR   JCRB; JCRB1802
DR   JCRB; NIHS1212
DR   Wikidata; Q98128889
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1212; true.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
ST   Source(s): JCRB=JCRB1802
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   RD-SCARB2
AC   CVCL_A5IA
SY   RDS
DR   cancercelllines; CVCL_A5IA
DR   Wikidata; Q107116731
RX   PubMed=23919614;
CC   Population: Caucasian.
CC   Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1665; SCARB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   RD.TG6
AC   CVCL_DP30
SY   RD-TG.6
DR   cancercelllines; CVCL_DP30
DR   Wikidata; Q54949552
RX   PubMed=7707048;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   RD/12
AC   CVCL_IU94
SY   RD12
DR   cancercelllines; CVCL_IU94
DR   Wikidata; Q54949537
RX   PubMed=1917385;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   RD/15
AC   CVCL_VH40
SY   RD15
DR   cancercelllines; CVCL_VH40
DR   Wikidata; Q54949538
RX   PubMed=1917385;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   RD/18
AC   CVCL_IU87
SY   RD18
DR   cancercelllines; CVCL_IU87
DR   Cosmic; 1082514
DR   Wikidata; Q54949541
RX   PubMed=1917385;
RX   PubMed=8617485;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   RD/19
AC   CVCL_VH41
SY   RD19
DR   cancercelllines; CVCL_VH41
DR   Wikidata; Q54949542
RX   PubMed=1917385;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   RD/7
AC   CVCL_VH39
SY   RD7
DR   cancercelllines; CVCL_VH39
DR   Wikidata; Q54949551
RX   PubMed=1917385;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   RD/VCR-F3
AC   CVCL_A2HQ
DR   cancercelllines; CVCL_A2HQ
DR   Wikidata; Q105510758
RX   PubMed=7309287;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   RD01g-p
AC   CVCL_F1H2
WW   Provider; ARI-TOX MWCB; RD01g-p; https://aritox.com/mwcb/mwcb-rd01g-p/
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=83653; ! Grampus griseus (Risso's dolphin)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   RDD6960-2
AC   CVCL_RT60
DR   Wikidata; Q54949553
RX   PubMed=22328974;
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   RDD8107
AC   CVCL_M835
DR   Wikidata; Q54949554
RX   PubMed=22170698;
CC   Misspelling: RDD2213; PubMed=22170698; Note=In one instance in the text.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   RDD8107-2
AC   CVCL_RT58
DR   Wikidata; Q54949555
RX   PubMed=22328974;
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M835 ! RDD8107
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   RDDF-1
AC   CVCL_XH93
SY   Red Drum Dorsal Fin-1
DR   Wikidata; Q98128890
RX   DOI=10.1577/1548-8667(1995)007<0231:LIRD>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=76340; ! Sciaenops ocellatus (Red drum)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   RDEB-iPSC26
AC   CVCL_GQ03
DR   Wikidata; Q54949556
RX   PubMed=27558600;
CC   From: Department of Dermatology, Jikei University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Arg669Ter (c.2005C>T); ClinVar=VCV000374052; Zygosity=Heterozygous (PubMed=27558600).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Glu2857Ter (c.8569G>T); ClinVar=VCV001339053; Zygosity=Heterozygous (PubMed=27558600).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156446; Epidermolysis bullosa dystrophica, autosomal recessive
DI   ORDO; Orphanet_79408; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 15
//
ID   rdES2-1
AC   CVCL_X723
DR   RCB; AES0174
DR   SKIP; SKIP001638
DR   Wikidata; Q54949557
RX   PubMed=20670936;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dutch Belted; VBO=VBO_0017527.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 7
//
ID   rdES4
AC   CVCL_K093
DR   RCB; AES0175
DR   SKIP; SKIP001639
DR   Wikidata; Q54949558
RX   PubMed=20670936;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Dutch Belted; VBO=VBO_0017527.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   RDF
AC   CVCL_A9E0
SY   R.D.F.
DR   Wikidata; Q102114802
RX   PubMed=2822736;
RX   PubMed=3374507;
CC   Donor information: Established from a patient suffering from renal failure.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   RDF 21
AC   CVCL_1J88
SY   RDF21; RD114 clone 21
DR   Wikidata; Q54949560
RX   Patent=US7015035;
RX   PubMed=14599814;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4440.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1J87 ! GP101
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 11
//
ID   RDFD2
AC   CVCL_D5XL
DR   Wikidata; Q127384031
RX   PubMed=2879579;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   RDFD2-25
AC   CVCL_D5XM
DR   Wikidata; Q127384034
RX   PubMed=2879579;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5XL ! RDFD2
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   RDFD2-4
AC   CVCL_D5XN
DR   Wikidata; Q127384036
RX   PubMed=2879579;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D5XL ! RDFD2
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   RDLD-1
AC   CVCL_QZ54
DR   Wikidata; Q54949561
RX   PubMed=22490663;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:2704; DCK; Simple; p.Trp92Ter (c.276G>A); Zygosity=Unspecified (PubMed=22490663).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   RDM-4
AC   CVCL_K176
SY   RDM 4; RDM4
DR   Wikidata; Q54949562
RX   PubMed=479148;
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   RdMab-13
AC   CVCL_D2R1
DR   Wikidata; Q127384039
RX   PubMed=36496472;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTD1; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Replicase polyprotein 1ab (Note=AA 4757-5324 = RNA-directed RNA polymerase nsp12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   RdMab-15
AC   CVCL_D3EM
DR   Wikidata; Q127384041
RX   PubMed=36496472;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTD1; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Replicase polyprotein 1ab (Note=AA 4757-5324 = RNA-directed RNA polymerase nsp12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   RdMab-16
AC   CVCL_D3EN
DR   Wikidata; Q127384043
RX   PubMed=36496472;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTD1; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Replicase polyprotein 1ab (Note=AA 4757-5324 = RNA-directed RNA polymerase nsp12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   RdMab-2
AC   CVCL_D2R0
DR   Wikidata; Q127384045
RX   PubMed=36496472;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTD1; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Replicase polyprotein 1ab (Note=AA 4757-5324 = RNA-directed RNA polymerase nsp12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   RdMab-20
AC   CVCL_D2R2
DR   Wikidata; Q127384047
RX   PubMed=36496472;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTD1; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Replicase polyprotein 1ab (Note=AA 4757-5324 = RNA-directed RNA polymerase nsp12).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   RDP 45/20
AC   CVCL_G150
SY   RDP45/20; Clone 45
DR   CLO; CLO_0008775
DR   ATCC; TIB-98
DR   Wikidata; Q54949563
RX   PubMed=567562;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4090 ! 45.6.TG1.7
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RDP4-1
AC   CVCL_0E52
DR   Wikidata; Q54949564
RX   PubMed=1472061;
RX   PubMed=2176558;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   RE
AC   CVCL_U263
SY   Rohu Eye
DR   NRFC; NRFC044
DR   Wikidata; Q54949565
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=19236559;
WW   Provider; AAHL; -; https://aahl.res.in/rohu-labeo-rohita-eye-re-and-gill-lrg-cell-lines/
WW   Provider; NRFC; NRFC044; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC044.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   RE 2
AC   CVCL_B6QY
SY   RE2
DR   Wikidata; Q112044472
RX   PubMed=2655894;
RX   PubMed=3028610;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RE 6
AC   CVCL_B6QZ
SY   RE6
DR   Wikidata; Q112044473
RX   PubMed=2655894;
RX   PubMed=3028610;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Re Car
AC   CVCL_U791
DR   ATCC; CRL-1175
DR   Wikidata; Q54949566
RX   PubMed=7471105;
CC   Discontinued: ATCC; CRL-1175; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Re-1
AC   CVCL_N292
SY   RE-1
DR   ATCC; HB-8482
DR   Wikidata; Q54949568
RX   Patent=US4683196;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8482.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Salmonella minnesota Re glycolipid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   Re-2
AC   CVCL_N293
SY   RE-2
DR   ATCC; HB-8481
DR   Wikidata; Q54949569
RX   Patent=US4683196;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8481.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Salmonella minnesota Re glycolipid.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   RE-25-HOM
AC   CVCL_C577
DR   ESTDAB; ESTDAB-059
DR   Wikidata; Q54949571
RX   PubMed=15592718;
WW   Info; ESTDAB; ESTDAB-059; https://web.archive.org/web/20160416073921/http://www.ebi.ac.uk/cgi-bin/ipd/estdab/print_cell.cgi?ESTDAB-059
CC   Problematic cell line: Probably contaminated. The STR profile and HLA typing information are nearly identical to that of the A-549 cell line. Originally thought to originate from a melanoma patient along with a sister cell line, SH-39-HOM (Cellosaurus=CVCL_C585).
CC   Population: Caucasian.
CC   HLA typing: A*25:01,30:01; B*18:01,44:03:01; C*12:03,16:01; DQB1*03:01:01,02:01; DRB1*07:01,11:03:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ESTDAB=ESTDAB-059
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 10
//
ID   RE1
AC   CVCL_C3SN
SY   RE 1
DR   Wikidata; Q116050166
RX   PubMed=2983000;
RX   PubMed=3004943;
RX   PubMed=4367306;
RX   PubMed=6299508;
CC   Transformant: NCBI_TaxID; 10315; Human herpesvirus 2 (HHV-2) (strain HG52).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   RE2A
AC   CVCL_C3SP
SY   RE 2A
DR   Wikidata; Q116050167
RX   PubMed=2983000;
RX   PubMed=3004943;
RX   PubMed=6298356;
RX   PubMed=6299508;
CC   Transformant: NCBI_TaxID; 10303; Human herpesvirus 1 (strain HFEM) (HHV-1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   RE7
AC   CVCL_C3SQ
SY   RE 7
DR   Wikidata; Q116050168
RX   PubMed=2983000;
RX   PubMed=3004943;
RX   PubMed=4367306;
RX   PubMed=6299508;
CC   Transformant: NCBI_TaxID; 10315; Human herpesvirus 2 (HHV-2) (strain HG52).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   REalpha
AC   CVCL_C3SR
SY   RE alpha
DR   Wikidata; Q116050169
RX   PubMed=2983000;
RX   PubMed=3004943;
RX   PubMed=6299508;
CC   Transformant: NCBI_TaxID; 10303; Human herpesvirus 1 (strain HFEM) (HHV-1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   REAsyn+C
AC   CVCL_C3SS
SY   RE Asyn + C
DR   Wikidata; Q116050170
RX   PubMed=2983000;
RX   PubMed=3004943;
RX   PubMed=6299508;
CC   Transformant: NCBI_TaxID; 10299; Human herpesvirus 1 (strain 17) (HHV-1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 3
//
ID   REC-1
AC   CVCL_1884
SY   Rec-1; REC 1; REC1; Rec1; rec1; REC
DR   BTO; BTO_0003558
DR   CLO; CLO_0037056
DR   EFO; EFO_0002317
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-3004
DR   BioSample; SAMN01821592
DR   BioSample; SAMN01821658
DR   BioSample; SAMN03471664
DR   BioSample; SAMN10989553
DR   cancercelllines; CVCL_1884
DR   Cell_Model_Passport; SIDM01773
DR   ChEMBL-Cells; CHEMBL4482987
DR   ChEMBL-Targets; CHEMBL4483266
DR   Cosmic; 1047111
DR   Cosmic; 1086341
DR   Cosmic; 1291033
DR   Cosmic; 2088020
DR   Cosmic; 2296993
DR   Cosmic; 2756235
DR   DepMap; ACH-000068
DR   DSMZ; ACC-584
DR   DSMZCellDive; ACC-584
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM95565
DR   GEO; GSM95566
DR   GEO; GSM95570
DR   GEO; GSM104462
DR   GEO; GSM104463
DR   GEO; GSM115804
DR   GEO; GSM155072
DR   GEO; GSM155073
DR   GEO; GSM155074
DR   GEO; GSM629498
DR   GEO; GSM629499
DR   GEO; GSM887529
DR   GEO; GSM888611
DR   GEO; GSM1266771
DR   GEO; GSM1266772
DR   GEO; GSM2322622
DR   GEO; GSM3150255
DR   IARC_TP53; 25018
DR   IARC_TP53; 30218
DR   IGRhCellID; REC1
DR   IZSLER; BS TCL 227
DR   LiGeA; CCLE_530
DR   LINCS_LDP; LCL-1123
DR   PharmacoDB; REC1_1298_2019
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_1884
DR   PubChem_Cell_line; CVCL_1884
DR   Wikidata; Q54949572
RX   PubMed=1572647;
RX   PubMed=7504521;
RX   PubMed=8558920;
RX   PubMed=14973505;
RX   PubMed=15126345;
RX   PubMed=16448697;
RX   PubMed=16960149;
RX   PubMed=17332242;
RX   PubMed=20215515;
RX   PubMed=21746927;
RX   PubMed=22460905;
RX   PubMed=24362935;
RX   PubMed=25315077;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 38 hours (PubMed=25315077); ~38 hours (ATCC=CRL-3004); ~20-40 hours (DSMZ=ACC-584).
CC   HLA typing: A*26:01,36:04; B*35:01,57:01; C*04:01,06:02; DQA1*01:02,01:02; DRB1*04:03,04:03 (PubMed=25960936).
CC   HLA typing: A*01,03; B*35,57; C*04,06 (PubMed=25688540).
CC   HLA typing: A*01:01,24:02; B*35:01,57:01; C*04:01,06:02; DQA1*01:02,01:02; DQB1*03:02,03:02; DRB1*01:01,01:01 (PubMed=26589293).
CC   HLA typing: B*35:01:01,57:01:01; C*04:01:01,06:02:01 (DSMZCellDive=ACC-584).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16448697).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Heterozygous (DepMap=ACH-000068).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Heterozygous (DepMap=ACH-000068).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.88%; Native American=0%; East Asian, North=2.34%; East Asian, South=0%; South Asian=0%; European, North=48.87%; European, South=46.91% (PubMed=30894373).
CC   Caution: Wrongly indicated as originating from the lymph node of a 57 year old patient in ATCC.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-3004; DSMZ=ACC-584; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 11,12
ST   FGA: 22,23
ST   Penta D: 9,13
ST   Penta E: 7 (PubMed=25877200)
ST   Penta E: 7,19 (DSMZ=ACC-584)
ST   Penta E: 19 (ATCC=CRL-3004)
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   RECA
AC   CVCL_ER23
SY   CC-2
DR   Wikidata; Q54949573
RX   PubMed=1691480;
RX   PubMed=8764055;
CC   Virology: Contains a copy of the HPV16 genome.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 8
//
ID   RECC-(CLONE 1)
AC   CVCL_9W41
SY   REVT clone 1
DR   Wikidata; Q54949574
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RECC-(CLONE 7)
AC   CVCL_9W42
SY   REVT clone 7
DR   Wikidata; Q54949575
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RECC-(CLONE A4)
AC   CVCL_9W43
SY   REVT clone A4
DR   Wikidata; Q54949576
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RECC-(CLONE B3)
AC   CVCL_9W44
SY   REVT clone B3
DR   Wikidata; Q54949579
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RECC-(CLONE B4)
AC   CVCL_9W45
SY   REVT clone B4
DR   Wikidata; Q54949580
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RECC-(CLONE C1)
AC   CVCL_9W46
SY   REVT clone C1
DR   Wikidata; Q54949581
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Misspelling: RECC-CCLONE C1); Note=In Cellosaurus releases 16 to 23.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   RECC-(CLONE C3)
AC   CVCL_9W47
SY   REVT clone C3
DR   Wikidata; Q54949582
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RECC-(CLONE D1)
AC   CVCL_9W48
SY   REVT clone D1
DR   Wikidata; Q54949583
RX   PubMed=6274086;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RECC-CU60
AC   CVCL_9W38
SY   CU-60
DR   Wikidata; Q54949584
RX   PubMed=3496613;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: P2a.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RECC-CU64
AC   CVCL_9W39
SY   CU-64
DR   Wikidata; Q54949585
RX   PubMed=3496613;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: UCD-003.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RECC-CU66
AC   CVCL_9W40
SY   CU-66
DR   Wikidata; Q54949586
RX   PubMed=3496613;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Caution: Said to originate from RECC-CU60 in PubMed=18766641.
CC   Breed/subspecies: P2a.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_9W38 ! RECC-CU60
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   RECC-HU3
AC   CVCL_C5GL
SY   HU3
DR   Wikidata; Q116050171
RX   PubMed=2793228;
RX   PubMed=3273463;
CC   Group: Bird cell line.
CC   Doubling time: 16.8 hours (PubMed=3273463); 18.34 hours (PubMed=2793228).
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   RECC-KU1
AC   CVCL_T485
SY   KU1
DR   Wikidata; Q54949587
RX   PubMed=18766641;
RX   PubMed=18770134;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   RECC-KU10
AC   CVCL_T489
SY   RECC-KU 10; KU10
DR   Wikidata; Q54949588
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T530 ! RECC-KU9
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-KU11
AC   CVCL_T490
SY   RECC-KU 11; KU11
DR   Wikidata; Q54949589
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-KU12
AC   CVCL_T491
SY   RECC-KU 12; KU12
DR   Wikidata; Q54949590
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU13
AC   CVCL_T492
SY   RECC-KU 13; KU13
DR   Wikidata; Q54949591
RX   PubMed=18679862;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU14
AC   CVCL_T493
SY   RECC-KU 14; KU14
DR   Wikidata; Q54949592
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T494 ! RECC-KU15
OI   CVCL_T495 ! RECC-KU16
OI   CVCL_T496 ! RECC-KU17
OI   CVCL_T497 ! RECC-KU18
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU15
AC   CVCL_T494
SY   RECC-KU 15; KU15
DR   Wikidata; Q54949594
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T493 ! RECC-KU14
OI   CVCL_T495 ! RECC-KU16
OI   CVCL_T496 ! RECC-KU17
OI   CVCL_T497 ! RECC-KU18
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU16
AC   CVCL_T495
SY   RECC-KU 16; KU16
DR   Wikidata; Q54949595
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T493 ! RECC-KU14
OI   CVCL_T494 ! RECC-KU15
OI   CVCL_T496 ! RECC-KU17
OI   CVCL_T497 ! RECC-KU18
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU17
AC   CVCL_T496
SY   RECC-KU 17; KU17
DR   Wikidata; Q54949605
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T493 ! RECC-KU14
OI   CVCL_T494 ! RECC-KU15
OI   CVCL_T495 ! RECC-KU16
OI   CVCL_T497 ! RECC-KU18
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU18
AC   CVCL_T497
SY   RECC-KU 18; KU18
DR   Wikidata; Q54949607
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T493 ! RECC-KU14
OI   CVCL_T494 ! RECC-KU15
OI   CVCL_T495 ! RECC-KU16
OI   CVCL_T496 ! RECC-KU17
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU19
AC   CVCL_T498
SY   RECC-KU 19; KU19
DR   Wikidata; Q54949608
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T499 ! RECC-KU20
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU2
AC   CVCL_T486
SY   KU2
DR   Wikidata; Q54949610
RX   PubMed=18766641;
RX   PubMed=18770134;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   RECC-KU20
AC   CVCL_T499
SY   RECC-KU 20; KU20
DR   Wikidata; Q54949612
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T498 ! RECC-KU19
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU21
AC   CVCL_T500
SY   RECC-KU 21; KU21
DR   Wikidata; Q54949613
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU22
AC   CVCL_T501
SY   RECC-KU 22; KU22
DR   Wikidata; Q54949614
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU23
AC   CVCL_T502
SY   RECC-KU 23; KU23
DR   Wikidata; Q54949615
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU24
AC   CVCL_T503
SY   RECC-KU 24; KU24
DR   Wikidata; Q54949616
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU25
AC   CVCL_T504
SY   RECC-KU 25; KU25
DR   Wikidata; Q54949617
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU26
AC   CVCL_T505
SY   RECC-KU 26; KU26
DR   Wikidata; Q54949618
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU27
AC   CVCL_T506
SY   RECC-KU 27; KU27
DR   Wikidata; Q54949619
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU28
AC   CVCL_T507
SY   RECC-KU 28; KU28
DR   Wikidata; Q54949620
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU29
AC   CVCL_T508
SY   RECC-KU 29; KU29
DR   Wikidata; Q54949621
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T509 ! RECC-KU30
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU3
AC   CVCL_T487
SY   KU3
DR   Wikidata; Q54949622
RX   PubMed=18766641;
RX   PubMed=18770134;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   RECC-KU30
AC   CVCL_T509
SY   RECC-KU 30; KU30
DR   Wikidata; Q54949624
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T510 ! RECC-KU31
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU31
AC   CVCL_T510
SY   RECC-KU 31; KU31
DR   Wikidata; Q54949625
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T500 ! RECC-KU21
OI   CVCL_T501 ! RECC-KU22
OI   CVCL_T502 ! RECC-KU23
OI   CVCL_T503 ! RECC-KU24
OI   CVCL_T504 ! RECC-KU25
OI   CVCL_T505 ! RECC-KU26
OI   CVCL_T506 ! RECC-KU27
OI   CVCL_T507 ! RECC-KU28
OI   CVCL_T508 ! RECC-KU29
OI   CVCL_T509 ! RECC-KU30
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU32
AC   CVCL_T511
SY   RECC-KU 32; KU32
DR   Wikidata; Q54949626
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T512 ! RECC-KU33
OI   CVCL_T513 ! RECC-KU34
OI   CVCL_T514 ! RECC-KU35
OI   CVCL_T515 ! RECC-KU36
OI   CVCL_T516 ! RECC-KU37
OI   CVCL_T517 ! RECC-KU38
OI   CVCL_T518 ! RECC-KU39
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU33
AC   CVCL_T512
SY   RECC-KU 33; KU33
DR   Wikidata; Q54949627
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T511 ! RECC-KU32
OI   CVCL_T513 ! RECC-KU34
OI   CVCL_T514 ! RECC-KU35
OI   CVCL_T515 ! RECC-KU36
OI   CVCL_T516 ! RECC-KU37
OI   CVCL_T517 ! RECC-KU38
OI   CVCL_T518 ! RECC-KU39
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU34
AC   CVCL_T513
SY   RECC-KU 34; KU34
DR   Wikidata; Q54949629
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T511 ! RECC-KU32
OI   CVCL_T512 ! RECC-KU33
OI   CVCL_T514 ! RECC-KU35
OI   CVCL_T515 ! RECC-KU36
OI   CVCL_T516 ! RECC-KU37
OI   CVCL_T517 ! RECC-KU38
OI   CVCL_T518 ! RECC-KU39
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU35
AC   CVCL_T514
SY   RECC-KU 35; KU35
DR   Wikidata; Q54949630
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T511 ! RECC-KU32
OI   CVCL_T512 ! RECC-KU33
OI   CVCL_T513 ! RECC-KU34
OI   CVCL_T515 ! RECC-KU36
OI   CVCL_T516 ! RECC-KU37
OI   CVCL_T517 ! RECC-KU38
OI   CVCL_T518 ! RECC-KU39
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU36
AC   CVCL_T515
SY   RECC-KU 36; KU36
DR   Wikidata; Q54949632
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T511 ! RECC-KU32
OI   CVCL_T512 ! RECC-KU33
OI   CVCL_T513 ! RECC-KU34
OI   CVCL_T514 ! RECC-KU35
OI   CVCL_T516 ! RECC-KU37
OI   CVCL_T517 ! RECC-KU38
OI   CVCL_T518 ! RECC-KU39
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU37
AC   CVCL_T516
SY   RECC-KU 37; KU37
DR   Wikidata; Q54949633
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T511 ! RECC-KU32
OI   CVCL_T512 ! RECC-KU33
OI   CVCL_T513 ! RECC-KU34
OI   CVCL_T514 ! RECC-KU35
OI   CVCL_T515 ! RECC-KU36
OI   CVCL_T517 ! RECC-KU38
OI   CVCL_T518 ! RECC-KU39
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU38
AC   CVCL_T517
SY   RECC-KU 38; KU38
DR   Wikidata; Q54949634
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T511 ! RECC-KU32
OI   CVCL_T512 ! RECC-KU33
OI   CVCL_T513 ! RECC-KU34
OI   CVCL_T514 ! RECC-KU35
OI   CVCL_T515 ! RECC-KU36
OI   CVCL_T516 ! RECC-KU37
OI   CVCL_T518 ! RECC-KU39
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU39
AC   CVCL_T518
SY   RECC-KU 39; KU39
DR   Wikidata; Q54949636
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T511 ! RECC-KU32
OI   CVCL_T512 ! RECC-KU33
OI   CVCL_T513 ! RECC-KU34
OI   CVCL_T514 ! RECC-KU35
OI   CVCL_T515 ! RECC-KU36
OI   CVCL_T516 ! RECC-KU37
OI   CVCL_T517 ! RECC-KU38
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU4
AC   CVCL_T488
SY   KU4
DR   Wikidata; Q54949638
RX   PubMed=18766641;
RX   PubMed=18770134;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   RECC-KU40
AC   CVCL_T519
SY   RECC-KU 40; KU40
DR   Wikidata; Q54949639
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T520 ! RECC-KU41
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU41
AC   CVCL_T520
SY   RECC-KU 41; KU41
DR   Wikidata; Q54949640
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T519 ! RECC-KU40
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU42
AC   CVCL_T521
SY   RECC-KU 42; KU42
DR   Wikidata; Q54949641
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T522 ! RECC-KU43
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU43
AC   CVCL_T522
SY   RECC-KU 43; KU43
DR   Wikidata; Q54949642
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T521 ! RECC-KU42
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU44
AC   CVCL_T523
SY   RECC-KU 44; KU44
DR   Wikidata; Q54949643
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-KU45
AC   CVCL_T524
SY   RECC-KU 45; KU45
DR   Wikidata; Q54949644
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T525 ! RECC-KU46
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU46
AC   CVCL_T525
SY   RECC-KU 46; KU46
DR   Wikidata; Q54949646
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T524 ! RECC-KU45
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU5
AC   CVCL_T526
SY   RECC-KU 5; KU5
DR   Wikidata; Q54949647
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-KU6
AC   CVCL_T527
SY   RECC-KU 6; KU6
DR   Wikidata; Q54949649
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T528 ! RECC-KU7
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-KU7
AC   CVCL_T528
SY   RECC-KU 7; KU7
DR   Wikidata; Q54949650
RX   PubMed=18679862;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T527 ! RECC-KU6
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-KU8
AC   CVCL_T529
SY   RECC-KU 8; KU8
DR   Wikidata; Q54949651
RX   PubMed=18679862;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-KU9
AC   CVCL_T530
SY   RECC-KU 9; KU9
DR   Wikidata; Q54949652
RX   PubMed=18679862;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
OI   CVCL_T489 ! RECC-KU10
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-RELB
AC   CVCL_9W49
SY   RE-LB
DR   Wikidata; Q54949654
RX   PubMed=6296206;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV).
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   RECC-RP13
AC   CVCL_T892
DR   Wikidata; Q54949655
RX   PubMed=6278061;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 353768; Chick syncytial virus.
DI   NCIt; C135004; Chicken lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   RECC-RP14
AC   CVCL_T749
DR   Wikidata; Q54949666
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: RPRL-7.
DI   NCIt; C135004; Chicken lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-RP15
AC   CVCL_T750
DR   Wikidata; Q54949667
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: RPRL-7.
DI   NCIt; C135004; Chicken lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-RP20
AC   CVCL_T751
DR   Wikidata; Q54949668
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: RPRL-7.
DI   NCIt; C135004; Chicken lymphoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RECC-UG5
AC   CVCL_T482
SY   RECC-UG 5
DR   Wikidata; Q54949670
RX   PubMed=2415611;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UG6
AC   CVCL_T483
SY   RECC-UG 6
DR   Wikidata; Q54949671
RX   PubMed=2415611;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UG8
AC   CVCL_T484
SY   RECC-UG 8
DR   Wikidata; Q54949673
RX   PubMed=2415611;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT1
AC   CVCL_T531
SY   RECC-UT 1; cBMC
DR   Wikidata; Q54949674
RX   PubMed=4443191;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   RECC-UT2
AC   CVCL_T532
SY   RTF; REV-transformed fibroblasts
DR   Wikidata; Q54949675
RX   PubMed=201089;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   RECC-UT310
AC   CVCL_T533
SY   RECC-UT 310
DR   Wikidata; Q54949676
RX   PubMed=6187691;
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT311
AC   CVCL_T534
SY   RECC-UT 311
DR   Wikidata; Q54949677
RX   PubMed=6269747;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT312
AC   CVCL_T535
SY   RECC-UT 312
DR   Wikidata; Q54949678
RX   PubMed=6269747;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT313
AC   CVCL_T536
SY   RECC-UT 313
DR   Wikidata; Q54949679
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT314
AC   CVCL_T537
SY   RECC-UT 314
DR   Wikidata; Q54949680
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT316
AC   CVCL_T538
SY   RECC-UT 316
DR   Wikidata; Q54949681
RX   PubMed=6187691;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT317
AC   CVCL_T539
SY   RECC-UT 317
DR   Wikidata; Q54949682
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT322
AC   CVCL_T540
SY   RECC-UT 322
DR   Wikidata; Q54949683
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT323
AC   CVCL_T541
SY   RECC-UT 323
DR   Wikidata; Q54949684
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT327
AC   CVCL_T542
SY   RECC-UT 327
DR   Wikidata; Q54949685
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT328
AC   CVCL_T543
SY   RECC-UT 328
DR   Wikidata; Q54949686
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT331
AC   CVCL_T544
SY   RECC-UT 331
DR   Wikidata; Q54949687
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RECC-UT336
AC   CVCL_T545
SY   RECC-UT 336
DR   Wikidata; Q54949688
RX   PubMed=6269747;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Hy-Line SC.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RED-1
AC   CVCL_2170
SY   RED.1
DR   CLO; CLO_0008776
DR   CLO; CLO_0008777
DR   CLDB; cl4131
DR   DSMZ; ACC-407
DR   DSMZCellDive; ACC-407
DR   ECACC; 85092601
DR   Wikidata; Q54949689
RX   PubMed=6956768;
CC   Doubling time: ~24 hours (DSMZ=ACC-407).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   RED-2
AC   CVCL_HM44
DR   Wikidata; Q54949690
RX   PubMed=6956768;
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 3
//
ID   RED-3
AC   CVCL_8907
DR   BioSample; SAMN03151777
DR   cancercelllines; CVCL_8907
DR   Wikidata; Q54949691
RX   CelloPub=CLPUB00690;
RX   CelloPub=CLPUB00691;
RX   PubMed=2659902;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 24 year old male patient suffering from acute lymphoblastic leukemia in second relapse.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00260.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (CelloPub=CLPUB00690; CelloPub=CLPUB00691).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=2659902).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 31
//
ID   RED-4
AC   CVCL_2171
DR   CLO; CLO_0008778
DR   DSMZ; ACC-425
DR   DSMZCellDive; ACC-425
DR   Wikidata; Q54949692
RX   PubMed=6956768;
CC   Doubling time: ~24 hours (DSMZ=ACC-425).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_2172 ! RED-5
OI   CVCL_2173 ! RED-6
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   RED-5
AC   CVCL_2172
DR   CLO; CLO_0008779
DR   DSMZ; ACC-451
DR   DSMZCellDive; ACC-451
DR   Wikidata; Q54949693
RX   PubMed=6956768;
CC   Doubling time: ~30 hours (DSMZ=ACC-451).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_2171 ! RED-4
OI   CVCL_2173 ! RED-6
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   RED-6
AC   CVCL_2173
DR   CLO; CLO_0008780
DR   DSMZ; ACC-466
DR   DSMZCellDive; ACC-466
DR   Wikidata; Q54949694
RX   PubMed=6956768;
CC   Doubling time: ~18 hours (DSMZ=ACC-466).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_2171 ! RED-4
OI   CVCL_2172 ! RED-5
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   REE,GD
AC   CVCL_E816
SY   REE, GD
DR   dbMHC; 49009
DR   ECACC; 94082231
DR   IHW; IHW09132
DR   IPD-IMGT/HLA; 11675
DR   Wikidata; Q54949698
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01,24; B*08; DPB1*01:01:01,02:01:02; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*01:01 (IPD-IMGT/HLA=11675).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   REE/CTVM28
AC   CVCL_Z206
DR   Wikidata; Q54949695
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60190; ! Rhipicephalus evertsi (Red-legged tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   REE/CTVM29
AC   CVCL_Z207
DR   Wikidata; Q54949696
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60190; ! Rhipicephalus evertsi (Red-legged tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   REE/CTVM31
AC   CVCL_Z208
DR   Wikidata; Q54949697
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60190; ! Rhipicephalus evertsi (Red-legged tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   REF-4A
AC   CVCL_GR59
DR   Wikidata; Q54949700
RX   PubMed=6133866;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6848 ! REF52
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   REF-RGB
AC   CVCL_U898
DR   CLO; CLO_0051587
DR   RCB; RCB0165
DR   Wikidata; Q54949701
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   REF-WT10A
AC   CVCL_B5G1
DR   Wikidata; Q110433165
RX   PubMed=6315714;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6848 ! REF52
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   REF-WT1A
AC   CVCL_B5G2
DR   Wikidata; Q110433166
RX   PubMed=6315714;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6848 ! REF52
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   REF-WT2A
AC   CVCL_B5G3
SY   REF52-WT2A
DR   Wikidata; Q110433168
RX   PubMed=2564397;
RX   PubMed=6315714;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6848 ! REF52
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   REF-WT6A
AC   CVCL_B5G4
SY   REF52-WT2A
DR   Wikidata; Q110433169
RX   PubMed=2564397;
RX   PubMed=6315714;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6848 ! REF52
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   REF52
AC   CVCL_6848
SY   REF-52; REF 52; Rat Embryo Fibroblast 52
DR   BTO; BTO_0001955
DR   EFO; EFO_0022770
DR   TOKU-E; 3889
DR   Wikidata; Q54949702
RX   PubMed=2564397;
RX   PubMed=2830582;
RX   PubMed=3510745;
RX   PubMed=6133866;
RX   PubMed=6315714;
RX   PubMed=7314451;
CC   Omics: Proteomics; 2DE.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Reg4-G7
AC   CVCL_XF13
DR   CCRID; 4201PAT-CCTCC00216
DR   Wikidata; Q98128891
RX   Patent=CN101270161B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200728.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BYZ8; Human REG4.
CC   Misspelling: Reg_G7; CCRID=4201PAT-CCTCC00216.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   Regea06/015
AC   CVCL_B354
SY   Regea 06/015; UTAe001-A
DR   hPSCreg; UTAe001-A
DR   SKIP; SKIP001895
DR   Wikidata; Q54949703
RX   PubMed=20419109;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Regea06/040
AC   CVCL_B355
SY   Regea 06/040; UTAe002-A
DR   hPSCreg; UTAe002-A
DR   SKIP; SKIP001896
DR   Wikidata; Q54949704
RX   PubMed=20419109;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Regea07/027
AC   CVCL_B356
SY   Regea 07/027; UTAe003-A
DR   hPSCreg; UTAe003-A
DR   SKIP; SKIP001948
DR   Wikidata; Q54949705
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   Regea07/046
AC   CVCL_B357
SY   Regea 07/046; UTAe004-A
DR   hPSCreg; UTAe004-A
DR   SKIP; SKIP001949
DR   Wikidata; Q54949707
RX   PubMed=20419109;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Regea08/013
AC   CVCL_B358
SY   Regea 08/013; UTAe005-A
DR   hPSCreg; UTAe005-A
DR   SKIP; SKIP002338
DR   Wikidata; Q54949708
RX   PubMed=20419109;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Regea08/017
AC   CVCL_B359
SY   Regea 08/017; UTAe006-A
DR   hPSCreg; UTAe006-A
DR   SKIP; SKIP002339
DR   Wikidata; Q54949709
RX   PubMed=20177999;
RX   PubMed=22315618;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Regea08/023
AC   CVCL_B360
SY   Regea 08/023; UTAe007-A
DR   hPSCreg; UTAe007-A
DR   SKIP; SKIP002340
DR   Wikidata; Q54949715
RX   PubMed=20177999;
RX   PubMed=23341440;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Regea08/056
AC   CVCL_B361
SY   Regea 08/056; UTAe008-A
DR   hPSCreg; UTAe008-A
DR   SKIP; SKIP002341
DR   Wikidata; Q54949717
RX   PubMed=20177999;
CC   From: Regea Institute for Regenerative Medicine; Tampere; Finland.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   REGUi001-A
AC   CVCL_VT49
SY   IPS4FLV
DR   BioSamples; SAMEA5574030
DR   hPSCreg; REGUi001-A
DR   Wikidata; Q98128892
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   REGUi002-A
AC   CVCL_VT50
SY   IPS6FLV
DR   BioSamples; SAMEA5574033
DR   hPSCreg; REGUi002-A
DR   Wikidata; Q98128893
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   REGUi003-A
AC   CVCL_XC58
SY   WRN iPSC; WERNER iPSC
DR   hPSCreg; REGUi003-A
DR   Wikidata; Q98128894
RX   CelloPub=CLPUB00552;
RX   PubMed=31404747;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Tyr1263Ter (c.3789C>G); Zygosity=Homozygous (PubMed=31404747).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31404747
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D18S51: 16,17
ST   D21S11: 30,31
ST   D3S1358: 16,18
ST   D5S818: 10,12
ST   D7S820: 9
ST   D8S1179: 10,15
ST   FGA: 21,23
ST   Penta D: 11,14
ST   Penta E: 5,13
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   REGUi004-A
AC   CVCL_YM43
SY   BLM iPSC; BLOOM iPSC
DR   hPSCreg; REGUi004-A
DR   Wikidata; Q98128895
RX   CelloPub=CLPUB00552;
RX   PubMed=31918214;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Ser706Leufs*11 (c.2116delT); Zygosity=Homozygous (PubMed=31918214).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31918214
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 14
ST   D21S11: 28,32
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 20,25
ST   Penta D: 9,11
ST   Penta E: 7
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C2903; Bloom syndrome
DI   ORDO; Orphanet_125; Bloom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   REGUi005-A
AC   CVCL_YM44
SY   RT iPSC; ROTHMUND THOMSON iPSC
DR   hPSCreg; REGUi005-A
DR   Wikidata; Q98128896
RX   CelloPub=CLPUB00552;
RX   PubMed=32416578;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.Gln757Ter (c.2269C>T); ClinVar=VCV000006063; Zygosity=Homozygous (CelloPub=CLPUB00552; PubMed=32416578).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32416578
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D21S11: 30
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 11,14
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3335; Rothmund-Thomson syndrome
DI   ORDO; Orphanet_2909; Rothmund-Thomson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   REGUi006-A
AC   CVCL_YZ90
SY   IPSC-MSC PEN
DR   hPSCreg; REGUi006-A
DR   Wikidata; Q98128897
RX   PubMed=32200258;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   REGUi007-A
AC   CVCL_YZ91
SY   IPSC-MSC DAP
DR   hPSCreg; REGUi007-A
DR   Wikidata; Q98128898
RX   PubMed=32200258;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   REGUi008-A
AC   CVCL_YZ92
SY   IPSC-MSC 1514
DR   hPSCreg; REGUi008-A
DR   Wikidata; Q98128899
RX   PubMed=32200258;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C3293; Osteoarthritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   REGUi009-A
AC   CVCL_A1QD
SY   hiPS 5-9016
DR   BioSamples; SAMEA7628702
DR   hPSCreg; REGUi009-A
DR   Wikidata; Q102114803
RX   PubMed=33370874;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:2226; COLQ; Simple; p.Cys427Cys (c.1281C>T); ClinVar=VCV000536241; Zygosity=Homozygous; Note=Activates a cryptic splice site (PubMed=33370874).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84647; Congenital myasthenic syndrome
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   REGUi011-A
AC   CVCL_A7KY
SY   HGPS
DR   hPSCreg; REGUi011-A
DR   Wikidata; Q107116732
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   REGUi012-A
AC   CVCL_A7KV
SY   iPSC-MSC56; iPSC-MSC 56
DR   hPSCreg; REGUi012-A
DR   Wikidata; Q107116733
RX   PubMed=33780731;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): PubMed=33780731
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 29,33
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 24,25
ST   Penta D: 11,12
ST   Penta E: 7,8
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   REGUi013-A
AC   CVCL_A7KW
SY   iPSC-MSC58; iPSC-MSC 58
DR   hPSCreg; REGUi013-A
DR   Wikidata; Q107116734
RX   PubMed=33780731;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): PubMed=33780731
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,14
ST   D18S51: 12,18
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 11,16
ST   FGA: 19,23
ST   Penta D: 12,13
ST   Penta E: 7,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   REGUi014-A
AC   CVCL_A7KX
SY   iPSC-MSC119; iPSC-MSC 119
DR   hPSCreg; REGUi014-A
DR   Wikidata; Q107116735
RX   PubMed=33780731;
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): PubMed=33780731
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 17,20
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 13,15
ST   TH01: 7,10
ST   TPOX: 10,11
ST   vWA: 13,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   REGUi015-A
AC   CVCL_C1W0
DR   hPSCreg; REGUi015-A
DR   Wikidata; Q114312781
CC   From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Reh
AC   CVCL_1650
SY   REH
DR   BTO; BTO_0001163
DR   CLO; CLO_0008781
DR   CLO; CLO_0008782
DR   EFO; EFO_0022409
DR   CLDB; cl4132
DR   AddexBio; C0003031/4985
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-8286
DR   BCRJ; 0321
DR   BioGRID_ORCS_Cell_line; 1761
DR   BioSample; SAMN03471040
DR   BioSample; SAMN03473380
DR   BioSample; SAMN10988185
DR   cancercelllines; CVCL_1650
DR   CCRID; 3101HUMTCHu131
DR   Cell_Model_Passport; SIDM00447
DR   ChEMBL-Cells; CHEMBL3308823
DR   ChEMBL-Targets; CHEMBL2366320
DR   CLS; 300320
DR   Cosmic; 798668
DR   Cosmic; 801720
DR   Cosmic; 909696
DR   Cosmic; 919149
DR   Cosmic; 991551
DR   Cosmic; 994183
DR   Cosmic; 996287
DR   Cosmic; 998706
DR   Cosmic; 999751
DR   Cosmic; 1012114
DR   Cosmic; 1037725
DR   Cosmic; 1067440
DR   Cosmic; 1093790
DR   Cosmic; 1118468
DR   Cosmic; 1130244
DR   Cosmic; 1191700
DR   Cosmic; 1483360
DR   Cosmic; 1524815
DR   Cosmic; 2491075
DR   Cosmic; 2523595
DR   Cosmic; 2649233
DR   Cosmic-CLP; 909696
DR   DepMap; ACH-000960
DR   DSMZ; ACC-22
DR   DSMZCellDive; ACC-22
DR   EGA; EGAS00001000978
DR   GDSC; 909696
DR   GEO; GSM236802
DR   GEO; GSM236838
DR   GEO; GSM482492
DR   GEO; GSM499514
DR   GEO; GSM499538
DR   GEO; GSM499727
DR   GEO; GSM499733
DR   GEO; GSM887530
DR   GEO; GSM888612
DR   GEO; GSM931330
DR   GEO; GSM931331
DR   GEO; GSM1195448
DR   GEO; GSM1374847
DR   GEO; GSM1670369
DR   GEO; GSM2373798
DR   GEO; GSM2373799
DR   GEO; GSM5137740
DR   GEO; GSM5137741
DR   GEO; GSM7701448
DR   GEO; GSM7701449
DR   IARC_TP53; 21284
DR   IARC_TP53; 28432
DR   LiGeA; CCLE_618
DR   LINCS_LDP; LCL-1039
DR   Lonza; 58
DR   PharmacoDB; REH_1299_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1650
DR   PubChem_Cell_line; CVCL_1650
DR   Wikidata; Q29958043
RX   DOI=10.1007/BF00204739;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=194778;
RX   PubMed=197411;
RX   PubMed=279400;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3866637;
RX   PubMed=3874327;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8704231;
RX   PubMed=8847894;
RX   PubMed=9067587;
RX   PubMed=9108419;
RX   PubMed=9510473;
RX   PubMed=9680106;
RX   PubMed=9823951;
RX   PubMed=10490826;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=16523483;
RX   PubMed=20164919;
RX   PubMed=20575032;
RX   PubMed=21552520;
RX   PubMed=22460905;
RX   PubMed=24056532;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=27922598;
RX   PubMed=28196595;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31305009;
RX   PubMed=31978347;
RX   PubMed=35124168;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8286.
CC   Doubling time: 34.7 hours (PubMed=8847894); 30 hours (PubMed=25984343); ~50-70 hours (DSMZ=ACC-22).
CC   HLA typing: A*23:01:01,32:01:01; B*35:02:01,50:01:01; C*04:01:01,06:02:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,04:01:01; DQA1*05:05:01,05:05:01; DQB1*03:01:01,03:01:01; DRA*01:02:02,01:02:02; DRB1*11:01:01,12:01:01 (DSMZCellDive=ACC-22).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=8704231; PubMed=9067587; PubMed=15843827; PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Gln527Ter (c.1579C>T) (p.Gln528Ter, c.1582C>T); Zygosity=Homozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (Cosmic-CLP=909696; DepMap=ACH-000960).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (Cosmic-CLP=909696; DepMap=ACH-000960).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=21.18%; Native American=0.09%; East Asian, North=1.57%; East Asian, South=2%; South Asian=1.52%; European, North=15.6%; European, South=58.04% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003031/4985; ATCC=CRL-8286; CLS=300320; Cosmic-CLP=909696; DSMZ=ACC-22; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11,12 (AddexBio=C0003031/4985; ATCC=CRL-8286; PubMed=25877200)
ST   CSF1PO: 12,13 (CLS=300320; Cosmic-CLP=909696; DSMZ=ACC-22)
ST   D13S317: 10,11,14 (DSMZ=ACC-22)
ST   D13S317: 11,12,13 (CLS=300320)
ST   D13S317: 11,13 (AddexBio=C0003031/4985; ATCC=CRL-8286; PubMed=25877200)
ST   D13S317: 11,14 (Cosmic-CLP=909696)
ST   D16S539: 9 (AddexBio=C0003031/4985; ATCC=CRL-8286; PubMed=25877200)
ST   D16S539: 9,10,12,13 (CLS=300320)
ST   D16S539: 9,13 (Cosmic-CLP=909696; DSMZ=ACC-22)
ST   D18S51: 10,11,14 (CLS=300320)
ST   D18S51: 10,14 (ATCC=CRL-8286; PubMed=25877200)
ST   D18S51: 10,14,15 (DSMZ=ACC-22)
ST   D19S433: 12,14
ST   D21S11: 27,28,30,31 (DSMZ=ACC-22)
ST   D21S11: 28,29,30,31 (CLS=300320)
ST   D21S11: 28,30 (ATCC=CRL-8286; PubMed=25877200)
ST   D2S1338: 20,22
ST   D3S1358: 18
ST   D5S818: 11,12 (Cosmic-CLP=909696; DSMZ=ACC-22)
ST   D5S818: 11,12,13 (CLS=300320)
ST   D5S818: 11,13 (AddexBio=C0003031/4985; ATCC=CRL-8286; PubMed=25877200)
ST   D7S820: 9,10,12,13 (CLS=300320)
ST   D7S820: 9,12 (AddexBio=C0003031/4985; ATCC=CRL-8286; Cosmic-CLP=909696; DSMZ=ACC-22; PubMed=25877200)
ST   D8S1179: 13,14,16,17 (CLS=300320)
ST   D8S1179: 13,15 (ATCC=CRL-8286; DSMZ=ACC-22; PubMed=25877200)
ST   FGA: 13,22,23 (DSMZ=ACC-22)
ST   FGA: 22,23 (ATCC=CRL-8286; PubMed=25877200)
ST   FGA: 22,23,24 (CLS=300320)
ST   Penta D: 9,11 (ATCC=CRL-8286; PubMed=25877200)
ST   Penta D: 9,12 (CLS=300320)
ST   Penta D: 10,11 (DSMZ=ACC-22)
ST   Penta E: 7,11 (ATCC=CRL-8286; DSMZ=ACC-22; PubMed=25877200)
ST   Penta E: 10,11 (CLS=300320)
ST   TH01: 7 (AddexBio=C0003031/4985; ATCC=CRL-8286; CLS=300320; PubMed=25877200)
ST   TH01: 7,9 (Cosmic-CLP=909696; DSMZ=ACC-22)
ST   TPOX: 8
ST   vWA: 14,15 (AddexBio=C0003031/4985; ATCC=CRL-8286; Cosmic-CLP=909696; PubMed=25877200)
ST   vWA: 14,15,16 (CLS=300320; DSMZ=ACC-22)
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   Reh/EphA3
AC   CVCL_ZV66
SY   Reh/A3
DR   cancercelllines; CVCL_ZV66
DR   Wikidata; Q98128900
RX   PubMed=27922598;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3387; EPHA3.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1650 ! Reh
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   Reh 6
AC   CVCL_L803
SY   Reh-6; REH-6; REH 6
DR   BioSample; SAMN03152026
DR   NCBI_Iran; C642
DR   Wikidata; Q54949718
RX   PubMed=202576;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00261.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   REH-R
AC   CVCL_0I75
DR   CCLV; CCLV-RIE 0822
DR   Wikidata; Q54949719
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9858; ! Capreolus capreolus (European roe deer)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   REI-S
AC   CVCL_C3ST
SY   RE I-S
DR   Wikidata; Q116050172
RX   PubMed=6299508;
CC   Transformant: NCBI_TaxID; 10299; Human herpesvirus 1 (strain 17) (HHV-1).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   17-20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 27-11-25; Version: 3
//
ID   Relicell hES1
AC   CVCL_B362
SY   ReliCellhES1; Rel Cell hES 271204 p32 NSO Col; DALCe001-A
DR   hPSCreg; DALCe001-A
DR   SKIP; SKIP002160
DR   Wikidata; Q54949720
RX   Patent=US7811817;
RX   PubMed=16533307;
RX   PubMed=16919167;
WW   Provider; Reliance; -; https://web.archive.org/web/20180602015113/http://www.rellife.com/rm_cellsresearch.html
CC   Group: Patented cell line.
CC   From: Reliance Life Sciences, Ltd; Navi Mumbai; India.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8172.
CC   HLA typing: A*01:02; B*56:01,35; C*01:04; DQB1*05; DRB1*01,01 (PubMed=16919167).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16533307; PubMed=16919167
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   Relicell hES2
AC   CVCL_B363
SY   ReliCellhES2
DR   Wikidata; Q54949721
RX   PubMed=20826120;
WW   Provider; Reliance; -; https://web.archive.org/web/20180602015113/http://www.rellife.com/rm_cellsresearch.html
CC   From: Reliance Life Sciences, Ltd; Navi Mumbai; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20826120
ST   Amelogenin: X
ST   D16S539: 11,13
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D8S1179: 14
ST   TH01: 8,9.3
ST   TPOX: 10,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   Relicell hES3
AC   CVCL_B364
SY   ReliCellhES3
DR   Wikidata; Q54949722
RX   PubMed=20826120;
WW   Provider; Reliance; -; https://web.archive.org/web/20180602015113/http://www.rellife.com/rm_cellsresearch.html
CC   From: Reliance Life Sciences, Ltd; Navi Mumbai; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20826120
ST   Amelogenin: X
ST   D16S539: 11
ST   D2S1338: 19,25
ST   D8S1179: 10,13
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   Relicell hES4
AC   CVCL_C114
SY   ReliCellhES4
DR   Wikidata; Q54949723
RX   PubMed=23242925;
CC   From: Reliance Life Sciences, Ltd; Navi Mumbai; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=23242925
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 15,20
ST   D19S433: 13,14.2
ST   D21S11: 27,30
ST   D2S1338: 23,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 7,11
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   TH01: 7,9
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   REM 111
AC   CVCL_5A69
DR   Wikidata; Q54949724
RX   PubMed=6389148;
RX   PubMed=6542015;
CC   Doubling time: ~48 hours (PubMed=6389148).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   REM 134
AC   CVCL_T997
SY   REM134
DR   ECACC; 12122002
DR   Wikidata; Q54949725
RX   PubMed=6389148;
RX   PubMed=6542015;
RX   PubMed=7138772;
RX   PubMed=19891692;
CC   Doubling time: ~24 hours (PubMed=6389148).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   REM 367
AC   CVCL_5A70
DR   Wikidata; Q54949726
RX   PubMed=6389148;
RX   PubMed=6542015;
CC   Doubling time: ~60 hours (PubMed=6389148).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   REM 885
AC   CVCL_2707
DR   ECACC; 06070401
DR   Wikidata; Q54949727
RX   PubMed=16369530;
CC   Sequence variation: Gene amplification; HGNC; HGNC:620; APP; Duplication; Zygosity=Unspecified (PubMed=16369530).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   REME002-2
AC   CVCL_E3Q2
SY   REME002; REME2-2; REME2; F_PDO_000111
DR   CancerTools; 160905
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   REME009-2
AC   CVCL_E3Q3
SY   REME009; REME9-2; REME9; F_PDO_000062
DR   CancerTools; 160909
RX   PubMed=29917168;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: ~5 days (PubMed=29917168).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8719; Endometrial squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   REME011-2
AC   CVCL_E3Q4
SY   REME011; REME11-2; REME11; F_PDO_000063
DR   CancerTools; 160911
RX   PubMed=29917168;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: ~8 days (PubMed=29917168).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   REME012-2
AC   CVCL_E3Q5
SY   REME012; REME12-2; REME12; F_PDO_000065
DR   CancerTools; 160912
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   REME014-2
AC   CVCL_E3Q6
SY   REME014; REME14-2; REME14; F_PDO_000069
DR   CancerTools; 160914
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8719; Endometrial squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   REME016-2
AC   CVCL_E3Q7
SY   REME016; REME16-2; REME16; F_PDO_000073
DR   CancerTools; 160916
RX   PubMed=29917168;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: ~6 days (PubMed=29917168).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   REME021
AC   CVCL_E3Q8
SY   REME21; F_PDO_000123
DR   CancerTools; 160921
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   REN
AC   CVCL_M202
SY   Ren
DR   EFO; EFO_0022351
DR   Cosmic; 1963334
DR   Wikidata; Q54949728
RX   PubMed=8010779;
RX   PubMed=8174104;
RX   PubMed=12063468;
RX   PubMed=12707267;
RX   PubMed=18223230;
RX   PubMed=22552293;
CC   Characteristics: Established from a SCID nude mouse xenograft (PubMed=8010779).
CC   Miscellaneous: STR profile from personal communication of Pentimalli, Francesca.
CC   Miscellaneous: Sex and age of donor and site of origin from personal communication of Smythe, William Roy through Pentimalli, Francesca.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 12
//
ID   REN-1
AC   CVCL_5V10
DR   Wikidata; Q54949729
RX   PubMed=6293962;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Nb.
DI   NCIt; C60478; Rat nephroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5V11 ! REN-2
SX   Male
AG   7M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 4
//
ID   REN-2
AC   CVCL_5V11
DR   Wikidata; Q54949730
RX   PubMed=6293962;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Nb.
DI   NCIt; C60478; Rat nephroblastoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5V10 ! REN-1
SX   Male
AG   7M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 4
//
ID   REN-R
AC   CVCL_0I76
DR   CCLV; CCLV-RIE 0821
DR   Wikidata; Q54949731
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9858; ! Capreolus capreolus (European roe deer)
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   REN/CTVM32
AC   CVCL_DC00
DR   Wikidata; Q54949732
RX   PubMed=26210950;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60190; ! Rhipicephalus evertsi (Red-legged tick)
SX   Sex unspecified
AG   Moulting nymph
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   REN/green
AC   CVCL_C8CW
DR   Wikidata; Q123033348
RX   PubMed=18223230;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M202 ! REN
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 4
//
ID   REN/luc
AC   CVCL_C8CX
DR   Wikidata; Q123033349
RX   PubMed=18223230;
RX   PubMed=22552293;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M202 ! REN
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   REN/PIPA34
AC   CVCL_UD48
DR   Wikidata; Q98128901
RX   PubMed=29886187;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=60190; ! Rhipicephalus evertsi (Red-legged tick)
SX   Sex unspecified
AG   Moulting nymph
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   RenCa
AC   CVCL_2174
SY   Renca; RENCA; Renal Carcinoma
DR   ATCC; CRL-2947
DR   BCRJ; 0346
DR   BioGRID_ORCS_Cell_line; 1259
DR   BioSample; SAMN11397652
DR   CCRID; 6101MOU-CERC000110
DR   ChEMBL-Cells; CHEMBL3307979
DR   ChEMBL-Targets; CHEMBL612568
DR   CLS; 400321
DR   KCLB; 80022
DR   PubChem_Cell_line; CVCL_2174
DR   Wikidata; Q54949734
RX   PubMed=3486710;
RX   PubMed=31220119;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/renca-xenograft-model/
CC   Doubling time: ~24 hours (ATCC=CRL-2947).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 16,17,18
ST   Mouse STR 1-2: 16,18
ST   Mouse STR 2-1: 15,16,17
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 23.2,25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 15,17
ST   Mouse STR 18-3: 18,20
ST   Mouse STR 19-2: 13,14
ST   Mouse STR X-1: 25
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   RenCa-IL2
AC   CVCL_5944
SY   RENCA-IL-2
DR   CLS; 400322
DR   Wikidata; Q54949735
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96548; Il2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2174 ! RenCa
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Renca-lacZ
AC   CVCL_KS92
DR   Wikidata; Q54949737
RX   PubMed=9635594;
RX   PubMed=10208432;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2174 ! RenCa
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   Renca-lacZ/EGFR
AC   CVCL_KS94
DR   Wikidata; Q54949738
RX   PubMed=10208432;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_KS92 ! Renca-lacZ
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   Renca-lacZ/EGFRvIII
AC   CVCL_KS95
DR   Wikidata; Q54949739
RX   PubMed=10208432;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_KS92 ! Renca-lacZ
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   Renca-lacZ/ErbB2
AC   CVCL_KS93
SY   Renca-lacZ/erbB-2
DR   Wikidata; Q54949741
RX   PubMed=9635594;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_KS92 ! Renca-lacZ
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   RenCa/CA-IX
AC   CVCL_5M65
SY   Renca/CA-IX; RENCA/CA-IX; RENCA/carbonic anhydrase-IX
DR   Wikidata; Q54949743
RX   PubMed=17095063;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1383; CA9.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2174 ! RenCa
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   RenCa/IL2Hi
AC   CVCL_E3G7
RX   PubMed=8698622;
CC   Characteristics: High level of IL2 secretion (PubMed=8698622).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2174 ! RenCa
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   RenCa/IL2Mo
AC   CVCL_E3G8
RX   PubMed=8698622;
CC   Characteristics: Modest amount of IL2 secretion (PubMed=8698622).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2174 ! RenCa
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   RenCares
AC   CVCL_YT60
DR   Wikidata; Q98128902
RX   PubMed=31031856;
CC   Selected for resistance to: ChEBI; CHEBI_68478; Everolimus (RAD001).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C124802; Mouse kidney carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2174 ! RenCa
SX   Male
AG   6W
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 5
//
ID   ReNcell CX
AC   CVCL_E922
DR   Lonza; 1441
DR   Millipore; SCC007
DR   Millipore; SCC009
DR   Wikidata; Q54949744
RX   PubMed=17531091;
CC   From: ReNeuron, Ltd; Pencoed; United Kingdom.
CC   Doubling time: 20-30 hours (Millipore=SCC007).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   ReNcell VM
AC   CVCL_E921
DR   Millipore; SCC008
DR   PRIDE; PXD010846
DR   Wikidata; Q54949745
RX   PubMed=16475233;
RX   PubMed=17531091;
RX   PubMed=19763270;
RX   PubMed=30778261;
CC   From: ReNeuron, Ltd; Pencoed; United Kingdom.
CC   Doubling time: ~24 hours (PubMed=16475233); 20-30 hours (Millipore=SCC008).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: v-Myc.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Fetal brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neural progenitor cell; CL=CL_0011020.
ST   Source(s): PubMed=19763270
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D18S51: 10,17
ST   D21S11: 28,32
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,16
ST   FGA: 20,25
ST   Penta D: 9,13
ST   Penta E: 7,21
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10FW
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 16
//
ID   RENE1
AC   CVCL_4286
SY   RENE 1
DR   CLO; CLO_0008783
DR   CLDB; cl4136
DR   ECACC; 92092510
DR   Wikidata; Q54949746
RX   PubMed=1694289;
CC   Doubling time: 48 hours (ECACC=92092510).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   21-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   RENE2
AC   CVCL_4287
SY   RENE 2
DR   CLO; CLO_0008784
DR   CLDB; cl4137
DR   ECACC; 92092511
DR   Wikidata; Q54949747
RX   PubMed=1694289;
CC   Doubling time: 48 hours (ECACC=92092511).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   21-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   RENT4
AC   CVCL_4288
SY   RENT 4
DR   CLO; CLO_0008785
DR   CLDB; cl4138
DR   ECACC; 92092512
DR   Wikidata; Q54949748
RX   PubMed=1694289;
CC   Doubling time: 48 hours (ECACC=92092512).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   21-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   RENTR01
AC   CVCL_4289
SY   RENT RO1
DR   CLO; CLO_0008786
DR   CLDB; cl4139
DR   ECACC; 92092513
DR   Wikidata; Q54949751
RX   PubMed=1694289;
CC   Doubling time: 35 hours (ECACC=92092513).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   21-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   RENTR03
AC   CVCL_4290
SY   RENT RO3
DR   CLO; CLO_0008787
DR   CLDB; cl4140
DR   ECACC; 92092514
DR   Wikidata; Q54949752
RX   PubMed=1694289;
CC   Doubling time: 35 hours (ECACC=92092514).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   21-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   RENTts1.1
AC   CVCL_4292
SY   RENT ts1.1; RENT tsS1.1; RENTtsS1.1
DR   CLO; CLO_0008789
DR   CLDB; cl4142
DR   ECACC; 92092515
DR   Wikidata; Q54949753
RX   PubMed=1666043;
CC   Doubling time: 48 hours (ECACC=92092515).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4291 ! RENTts3.1
SX   Female
AG   21-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   RENTts3.1
AC   CVCL_4291
SY   RENT ts3.1
DR   CLO; CLO_0008788
DR   CLDB; cl4141
DR   ECACC; 92092516
DR   Wikidata; Q54949754
RX   PubMed=1666043;
CC   Doubling time: 48 hours (ECACC=92092516).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4292 ! RENTts1.1
SX   Female
AG   21-28D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   REP
AC   CVCL_C3HU
DR   GEO; GSE59781
DR   Wikidata; Q114312782
RX   PubMed=1711532;
RX   PubMed=25180270;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pX8 ori-).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal testis, epididymis, epithelium; UBERON=UBERON_0004544.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3HV ! RVP
SX   Male
AG   18-22FW
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   REPC
AC   CVCL_W815
SY   Renal EPO-Producing Cells
DR   BioSample; SAMN03151768
DR   Wikidata; Q54949755
RX   DOI=10.1182/blood-2014-04-571752;
RX   PubMed=21406725;
WW   Info; -; -; https://retractionwatch.com/2014/04/29/contaminated-cells-force-retraction-of-blood-paper/
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Hep 3B2.1-7 derivative (DOI=10.1182/blood-2014-04-571752). Was originally thought to be established from the tumor-free renal tissue of an anonymized male patient suffering from a kidney tumor.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00487.
CC   Population: African American.
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Caution: DOI=10.1182/blood-2014-04-571752 is a retractation of PubMed=21406725.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 22
//
ID   Replic
AC   CVCL_XY58
SY   REP cell-lineage immortalized and cultivable
DR   TKG; TKG 0750
DR   Wikidata; Q98128903
RX   PubMed=31375751;
CC   Characteristics: Established from renal erythropoietin-producing (REP) cells (PubMed=31375751).
CC   Knockout cell: Method=KO mouse; MGI; MGI:95407; Epo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: ISAM-REC (EpoGFP/GFP:Rosa26CAG-LSL-tdTomato/WT:Tg3.3K-Epo:TgEpoCre) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   11-14W
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   repo>Ras bratdsRNA-L6
AC   CVCL_XF57
SY   RbR6
DR   DGRC; 282
DR   FlyBase_Cell_line; FBtc0000282
DR   Wikidata; Q98128906
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: repo-Gal4 driving UAS-RasV12 and UAS-bratdsRNA (P{y[+t7.7] v[+t1.8]=TRiP.HMS01121}attP2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 30-01-24; Version: 7
//
ID   repo>Ras bratdsRNA-L6-Clone2
AC   CVCL_C7G9
SY   Rbr6-2
DR   DGRC; 326
DR   FlyBase_Cell_line; FBtc0000326
DR   Wikidata; Q117704822
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: repo-Gal4 driving UAS-RasV12 and UAS-bratdsRNA (P{y[+t7.7] v[+t1.8]=TRiP.HMS01121}attP2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_XF57 ! repo>Ras bratdsRNA-L6
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   repo>Ras bratdsRNA-L6-Clone4
AC   CVCL_C7GA
SY   Rbr6-4
DR   DGRC; 327
DR   FlyBase_Cell_line; FBtc0000327
DR   Wikidata; Q117704823
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: repo-Gal4 driving UAS-RasV12 and UAS-bratdsRNA (P{y[+t7.7] v[+t1.8]=TRiP.HMS01121}attP2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_XF57 ! repo>Ras bratdsRNA-L6
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   repo>Ras bratdsRNA-L6-CloneF9
AC   CVCL_C7GB
SY   Rbr6-F9
DR   DGRC; 328
DR   FlyBase_Cell_line; FBtc0000328
DR   Wikidata; Q117704824
RX   PubMed=37470241;
CC   Group: Insect cell line.
CC   Characteristics: repo-Gal4 driving UAS-RasV12 and UAS-bratdsRNA (P{y[+t7.7] v[+t1.8]=TRiP.HMS01121}attP2).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_XF57 ! repo>Ras bratdsRNA-L6
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   RERF-GC-1B
AC   CVCL_3152
SY   RERFGC1B; RerfGC1B; Radiation Effects Research Foundation-Gastric Cancer-1B
DR   CLO; CLO_0037146
DR   EFO; EFO_0006743
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 997
DR   BioSample; SAMN03473262
DR   BioSample; SAMN10987634
DR   cancercelllines; CVCL_3152
DR   Cell_Model_Passport; SIDM00358
DR   CGH-DB; 132-1
DR   Cosmic; 1995617
DR   Cosmic; 2807642
DR   Cosmic-CLP; 1240209
DR   DepMap; ACH-000144
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240209
DR   GEO; GSM552370
DR   GEO; GSM827399
DR   GEO; GSM887531
DR   GEO; GSM888613
DR   GEO; GSM1670370
DR   IARC_TP53; 28339
DR   JCRB; JCRB1009
DR   LiGeA; CCLE_399
DR   LINCS_LDP; LCL-1537
DR   PharmacoDB; RERFGC1B_1300_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3152
DR   Wikidata; Q54949757
RX   PubMed=15723654;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~2 days (Note=Lot 10292008), 49 hours (Note=Lot 07192016) (JCRB=JCRB1009).
CC   HLA typing: A*02:06,31:01; B*40:02,51:01; C*03:04,14:02; DQB1*03:09,03:09; DRB1*11:01,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=1240209; DepMap=ACH-000144).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.94%; Native American=0.65%; East Asian, North=82%; East Asian, South=14.34%; South Asian=0.5%; European, North=0%; European, South=1.57% (PubMed=30894373).
CC   Derived from site: Metastatic; Pyloric lymph node; UBERON=UBERON_0015866.
ST   Source(s): Cosmic-CLP=1240209; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 10,13
ST   D8S1179: 15,17
ST   FGA: 22
ST   Penta D: 8,11
ST   Penta E: 12,24
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   RERF-LC-A1
AC   CVCL_4402
SY   RERF-LC-AI; RERF-LCAI; RERFLCAI; AOI; Radiation Effects Research Foundation-Lung Cancer-AI
DR   BTO; BTO_0006227
DR   CLO; CLO_0050027
DR   EFO; EFO_0002850
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 481
DR   BioSample; SAMN03472317
DR   BioSample; SAMN10987780
DR   cancercelllines; CVCL_4402
DR   Cell_Model_Passport; SIDM00307
DR   ChEMBL-Cells; CHEMBL3307414
DR   ChEMBL-Targets; CHEMBL614633
DR   Cosmic; 934471
DR   Cosmic; 946074
DR   Cosmic; 1048225
DR   Cosmic; 1089229
DR   Cosmic; 1571723
DR   Cosmic; 2060524
DR   Cosmic; 2645025
DR   DepMap; ACH-000261
DR   FANTOM5_SSTAR; 10501-107C6
DR   GEO; GSM887534
DR   GEO; GSM888616
DR   IARC_TP53; 18791
DR   IARC_TP53; 21634
DR   IARC_TP53; 30152
DR   LiGeA; CCLE_053
DR   PharmacoDB; RERFLCAI_1303_2019
DR   Progenetix; CVCL_4402
DR   PubChem_Cell_line; CVCL_4402
DR   RCB; RCB0444
DR   Wikidata; Q54949758
RX   PubMed=7790314;
RX   PubMed=7834619;
RX   PubMed=9023415;
RX   PubMed=9538136;
RX   PubMed=11416159;
RX   PubMed=12794755;
RX   PubMed=15901131;
RX   PubMed=16105816;
RX   PubMed=17511773;
RX   PubMed=21559605;
RX   PubMed=22460905;
RX   PubMed=22576795;
RX   PubMed=24002593;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Chinese; Taiwan.
CC   HLA typing: A*24:02; B*52:01; C*12:02 (PubMed=9023415).
CC   HLA typing: A*24:02,24:02; B*35:06,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Homozygous (PubMed=12794755; PubMed=15901131; DepMap=ACH-000261).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.35%; Native American=0%; East Asian, North=91.19%; East Asian, South=6.87%; South Asian=0.45%; European, North=1.14%; European, South=0% (PubMed=30894373).
CC   Misspelling: PERF-LC-AI; PubMed=12794755.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=11416159; RCB=RCB0444
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 21
ST   D21S11: 29,32.2
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 25
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   RERF-LC-A1/hPDPN
AC   CVCL_D2U4
SY   RERF-LC-AI/hPDPN
DR   Wikidata; Q127384050
RX   PubMed=25080943;
RX   PubMed=28387591;
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4402 ! RERF-LC-A1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   RERF-LC-Ad1
AC   CVCL_1651
SY   RERF-LC-AD1; RERFLCAD1; RERFLCAd1; Radiation Effects Research Foundation-Lung Cancer-Adenocarcinoma 1
DR   CLO; CLO_0037037
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 710
DR   BioSample; SAMN03472535
DR   BioSample; SAMN10988297
DR   cancercelllines; CVCL_1651
DR   Cell_Model_Passport; SIDM01331
DR   Cosmic; 946061
DR   Cosmic; 1571719
DR   DepMap; ACH-000791
DR   GEO; GSM274668
DR   GEO; GSM887532
DR   GEO; GSM888614
DR   IARC_TP53; 28282
DR   JCRB; JCRB1020
DR   JCRB; NIHS0277
DR   LiGeA; CCLE_162
DR   LINCS_LDP; LCL-1657
DR   PharmacoDB; RERFLCAd1_1301_2019
DR   Progenetix; CVCL_1651
DR   Wikidata; Q54949759
RX   PubMed=16105816;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~65 hours (Note=Lot 04132008) (JCRB=JCRB1020).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (DepMap=ACH-000791).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Phe (c.832_833CC>TT); Zygosity=Homozygous (DepMap=ACH-000791).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=76.75%; East Asian, South=22.67%; South Asian=0%; European, North=0%; European, South=0.57% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0277; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1020
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   RERF-LC-Ad2
AC   CVCL_1652
SY   RERF-LC-AD2; RERFLCAD2; RERFLCAd2; Radiation Effects Research Foundation-Lung Cancer-Adenocarcinoma 2
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472536
DR   BioSample; SAMN10987625
DR   cancercelllines; CVCL_1652
DR   Cell_Model_Passport; SIDM01332
DR   Cosmic; 946062
DR   DepMap; ACH-000774
DR   GEO; GSM827564
DR   GEO; GSM887533
DR   GEO; GSM888615
DR   IARC_TP53; 28364
DR   IARC_TP53; 30151
DR   JCRB; JCRB1021
DR   JCRB; NIHS0278
DR   LiGeA; CCLE_354
DR   PharmacoDB; RERFLCAd2_1302_2019
DR   Progenetix; CVCL_1652
DR   Wikidata; Q54949760
RX   PubMed=16105816;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~2.4 days (Note=Lot 07022019) (JCRB=JCRB1021).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Ala750delinsPro (c.2239_2248delinsC) (c.2239_2248TTAAGAGAAG>C); ClinVar=VCV000177684; Zygosity=Unspecified (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (DepMap=ACH-000774).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Val (c.476C>T); ClinVar=VCV000458545; Zygosity=Homozygous (DepMap=ACH-000774).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.21%; Native American=0%; East Asian, North=77.51%; East Asian, South=19.75%; South Asian=0%; European, North=0%; European, South=2.52% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0278; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1021
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   RERF-LC-FM
AC   CVCL_1653
SY   LC-FM; RERFLCFM; Radiation Effects Research Foundation-Lung Cancer-FM
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03471072
DR   cancercelllines; CVCL_1653
DR   Cell_Model_Passport; SIDM00357
DR   Cosmic; 713884
DR   Cosmic; 929161
DR   Cosmic; 930081
DR   Cosmic; 1995618
DR   Cosmic-CLP; 930081
DR   DepMap; ACH-002193
DR   GEO; GSM1670371
DR   IARC_TP53; 27228
DR   JCRB; JCRB0102
DR   PharmacoDB; RERFLCFM_1304_2019
DR   Wikidata; Q54949761
RX   PubMed=8263009;
RX   PubMed=8286010;
RX   PubMed=9290701;
RX   PubMed=9413215;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 58.9 hours (PubMed=8286010); 60 hours (Note=Lot 101698) (JCRB=JCRB0102).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (Cosmic-CLP=930081; DepMap=ACH-002193).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.25%; Native American=0%; East Asian, North=77.86%; East Asian, South=20.45%; South Asian=0.87%; European, North=0%; European, South=0.57% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=930081; JCRB=JCRB0102
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   RERF-LC-KJ
AC   CVCL_1654
SY   RERFLCKJ; KJ; Radiation Effects Research Foundation-Lung Cancer-KJ
DR   CLO; CLO_0050047
DR   EFO; EFO_0002851
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470804
DR   BioSample; SAMN03472623
DR   BioSample; SAMN10988172
DR   cancercelllines; CVCL_1654
DR   Cell_Model_Passport; SIDM00356
DR   CGH-DB; 208-1
DR   Cosmic; 946063
DR   Cosmic; 1154603
DR   Cosmic; 1571721
DR   Cosmic-CLP; 1298537
DR   DepMap; ACH-000482
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298537
DR   GEO; GSM274674
DR   GEO; GSM784282
DR   GEO; GSM827375
DR   GEO; GSM887535
DR   GEO; GSM888617
DR   GEO; GSM1670372
DR   IARC_TP53; 21635
DR   JCRB; JCRB0137
DR   JCRB; NIHS0210
DR   LiGeA; CCLE_848
DR   LINCS_LDP; LCL-1658
DR   PharmacoDB; RERFLCKJ_1305_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1654
DR   RCB; RCB1313
DR   Wikidata; Q54949763
RX   PubMed=7790314;
RX   PubMed=15746151;
RX   PubMed=15901131;
RX   PubMed=16105816;
RX   PubMed=20215515;
RX   PubMed=21559605;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 56 hours (Note=Lot 092499), 53 hours (Note=Lot 070599) (JCRB=JCRB0137).
CC   HLA typing: A*24:02,26:01; B*40:02,52:01; C*03:04,12:02; DQA1*01:02,01:02; DQB1*06:06,06:06; DRB1*13:05,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Valfs (c.670_671insTGTCT); Zygosity=Unspecified (PubMed=15901131).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.56%; Native American=0%; East Asian, North=81.6%; East Asian, South=9.57%; South Asian=0%; European, North=0%; European, South=5.26% (PubMed=30894373).
CC   Misspelling: REAF-LC-KJ2; Cosmic=1571721.
CC   Discontinued: JCRB; NIHS0210; true.
ST   Source(s): Cosmic-CLP=1298537; JCRB=JCRB0137; PubMed=25877200; RCB=RCB1313
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 21,26
ST   Penta D: 10
ST   Penta E: 11,17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   RERF-LC-KJ/CMV-Luc
AC   CVCL_4Y17
DR   JCRB; JCRB1558
DR   JCRB; NIHS0733
DR   Wikidata; Q54949770
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1558).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Valfs (c.670_671insTGTCT); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0733; true.
ST   Source(s): JCRB=JCRB1558
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1654 ! RERF-LC-KJ
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   RERF-LC-MA
AC   CVCL_3153
SY   RERF-LCMA; LC-MA; LCMA; Radiation Effects Research Foundation-Lung Cancer-MA; Matsushima
DR   CLO; CLO_0037038
DR   BioSample; SAMN03151921
DR   BioSample; SAMN03472512
DR   cancercelllines; CVCL_3153
DR   Cell_Model_Passport; SIDM01152
DR   Cosmic; 713883
DR   Cosmic; 801613
DR   Cosmic; 876160
DR   Cosmic; 929152
DR   GEO; GSM827581
DR   IARC_TP53; 2386
DR   JCRB; JCRB0812
DR   LINCS_LDP; LCL-1820
DR   Progenetix; CVCL_3153
DR   Wikidata; Q54949771
RX   PubMed=8263009;
RX   PubMed=9290701;
RX   PubMed=9673367;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=20215515;
RX   PubMed=23136038;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-MES-1 derivative (PubMed=23136038). Originally thought to originate from a small cell lung carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00386.
CC   Population: Caucasian.
CC   Doubling time: ~1.5 days (Note=Lot 01252008) (JCRB=JCRB0812).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Homozygous (PubMed=8263009; PubMed=10536175).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB0812
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13,14
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0630 ! SK-MES-1
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   RERF-LC-MK
AC   CVCL_A1FQ
SY   Radiation Effects Research Foundation-Lung Cancer-MK
DR   Cosmic; 934467
DR   Wikidata; Q102114804
RX   PubMed=7834619;
CC   Population: Japanese.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RERF-LC-MS
AC   CVCL_1655
SY   RERF-LCMS; RERFLCMS; LC-MS; LCMS; Radiation Effects Research Foundation-Lung Cancer-MS
DR   CLO; CLO_0037039
DR   EFO; EFO_0002852
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471374
DR   BioSample; SAMN10987805
DR   cancercelllines; CVCL_1655
DR   Cell_Model_Passport; SIDM00355
DR   CGH-DB; 206-1
DR   CGH-DB; 9166-4
DR   ChEMBL-Cells; CHEMBL3308463
DR   ChEMBL-Targets; CHEMBL1075563
DR   Cosmic; 713865
DR   Cosmic; 801585
DR   Cosmic; 844844
DR   Cosmic; 876141
DR   Cosmic; 889095
DR   Cosmic; 910931
DR   Cosmic; 917984
DR   Cosmic; 929154
DR   Cosmic; 932931
DR   Cosmic; 934468
DR   Cosmic; 946064
DR   Cosmic; 1066167
DR   Cosmic; 1219067
DR   Cosmic; 1239898
DR   Cosmic; 1571722
DR   Cosmic; 1995619
DR   Cosmic; 2125190
DR   Cosmic; 2668309
DR   Cosmic-CLP; 910931
DR   DepMap; ACH-000062
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910931
DR   GEO; GSM274673
DR   GEO; GSM827590
DR   GEO; GSM887536
DR   GEO; GSM888618
DR   GEO; GSM1670373
DR   IARC_TP53; 11878
DR   IARC_TP53; 28452
DR   JCRB; JCRB0081
DR   LiGeA; CCLE_605
DR   LINCS_LDP; LCL-1665
DR   PharmacoDB; RERFLCMS_1306_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1655
DR   PubChem_Cell_line; CVCL_1655
DR   Wikidata; Q54949773
RX   PubMed=7834619;
RX   PubMed=8263009;
RX   PubMed=8286010;
RX   PubMed=9023415;
RX   PubMed=9290701;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12569360;
RX   PubMed=14581340;
RX   PubMed=15746151;
RX   PubMed=15999539;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 39.9 hours (PubMed=8286010); 42.7 hours (Note=Lot 012194), 30-38 hours (Note=Lot 08102009) (JCRB=JCRB0081).
CC   HLA typing: A*11:01; B*54:01; C*01:02 (PubMed=9023415).
CC   HLA typing: A*11:01,11:01; B*54:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.74%; Native American=0.17%; East Asian, North=85.02%; East Asian, South=8.67%; South Asian=0%; European, North=0%; European, South=4.39% (PubMed=30894373).
CC   Misspelling: REAF-LC-MS; Cosmic=1571722.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=910931; JCRB=JCRB0081; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 24
ST   Penta D: 10
ST   Penta E: 14,15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   RERF-LC-MT
AC   CVCL_A473
SY   Radiation Effects Research Foundation-Lung Cancer-MT
DR   Cosmic; 934470
DR   Cosmic; 1089223
DR   Wikidata; Q54949774
RX   PubMed=7834619;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   RERF-LC-OK
AC   CVCL_3154
SY   RERF-LCOK; RERFLCOK; LC-OK; LCOK; Radiation Effects Research Foundation-Lung Cancer-OK
DR   EFO; EFO_0006744
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03151836
DR   BioSample; SAMN03471743
DR   cancercelllines; CVCL_3154
DR   Cell_Model_Passport; SIDM00385
DR   CGH-DB; 207-1
DR   CGH-DB; 9167-4
DR   Cosmic; 753609
DR   Cosmic; 801580
DR   Cosmic; 876139
DR   Cosmic; 889096
DR   Cosmic; 917974
DR   Cosmic; 932927
DR   Cosmic; 934469
DR   Cosmic; 946065
DR   Cosmic; 1066168
DR   Cosmic; 1219088
DR   Cosmic; 1239899
DR   Cosmic; 1571720
DR   Cosmic; 2125286
DR   Cosmic; 2668321
DR   EGA; EGAS00001000610
DR   GEO; GSM274667
DR   IARC_TP53; 11873
DR   IARC_TP53; 28443
DR   JCRB; JCRB0811
DR   PharmacoDB; RERFLCOK_1307_2019
DR   Wikidata; Q54949775
RX   PubMed=7834619;
RX   PubMed=9290701;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=19472407;
RX   PubMed=20143388;
RX   PubMed=20557307;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a Marcus derivative (PubMed=20143388). Originally thought to originate from a lung adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00344.
CC   Population: Caucasian.
CC   HLA typing: A*03:02,24:02; B*08:01,35:08; C*03:03,07:01; DRB1*04:22,04:22 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: PERF-LC-OK; Cosmic=2125286.
CC   Misspelling: REAF-LC-OK; Cosmic=1571720.
CC   Misspelling: RERF-LOCK; IARC_TP53=11873; PubMed=10536175.
CC   Discontinued: JCRB; JCRB0811; true.
ST   Source(s): JCRB=JCRB0811; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 15
ST   Penta E: 12,20
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3019 ! Marcus
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   RERF-LC-Sq1
AC   CVCL_1656
SY   RERF-LC-Sq-1; RERFLCSQ1; RERFLCSq1; Radiation Effects Research Foundation-Lung Cancer-Squamous 1
DR   CLO; CLO_0037040
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 998
DR   BioSample; SAMN03472534
DR   BioSample; SAMN10988238
DR   cancercelllines; CVCL_1656
DR   Cell_Model_Passport; SIDM00354
DR   Cosmic; 946073
DR   Cosmic; 1995620
DR   Cosmic-CLP; 1298538
DR   DepMap; ACH-000442
DR   EGA; EGAS00001000978
DR   GDSC; 1298538
DR   GEO; GSM827378
DR   GEO; GSM887537
DR   GEO; GSM888619
DR   GEO; GSM1374848
DR   GEO; GSM1670374
DR   JCRB; JCRB1019
DR   JCRB; NIHS0276
DR   LiGeA; CCLE_663
DR   LINCS_LDP; LCL-1592
DR   PharmacoDB; RERFLCSq1_1308_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1656
DR   Wikidata; Q54949776
RX   PubMed=16105816;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 4-5 days (Note=Lot 09022008) (JCRB=JCRB1019).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (Cosmic-CLP=1298538; DepMap=ACH-000442).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.28%; East Asian, South=17.4%; South Asian=0%; European, North=0%; European, South=1.32% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0276; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=1298538; JCRB=JCRB1019
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   RERF-LC-Sq1/CMV-Luc
AC   CVCL_JG36
SY   RERF-LC-Sq1 CMV-Luc
DR   cancercelllines; CVCL_JG36
DR   JCRB; JCRB1691
DR   JCRB; NIHS1048
DR   Wikidata; Q54949777
CC   Population: Japanese.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1691).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS1048; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1691
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1656 ! RERF-LC-Sq1
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   Res1-6
AC   CVCL_B6ZC
DR   CCRID; 4201PAT-CCTCC01778
DR   Wikidata; Q112044474
RX   Patent=CN114009399B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021234.
CC   Characteristics: Resistant to antibodies against CD274/PD-L1 (Patent=CN114009399B).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Res186
AC   CVCL_DG03
SY   Res 186; Res-186
DR   BTO; BTO_0005880
DR   cancercelllines; CVCL_DG03
DR   Wikidata; Q54949778
RX   PubMed=15814657;
RX   PubMed=19365568;
RX   PubMed=33385022;
CC   Doubling time: 46 hours (PubMed=19365568).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4047; Pilocytic astrocytoma
DI   ORDO; Orphanet_251612; Pilocytic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   Res196
AC   CVCL_DG04
SY   Res 196
DR   Wikidata; Q54949779
RX   PubMed=15814657;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Res199
AC   CVCL_DG05
SY   Res 199
DR   Wikidata; Q54949780
RX   PubMed=15814657;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4047; Pilocytic astrocytoma
DI   ORDO; Orphanet_251612; Pilocytic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Res251
AC   CVCL_DG06
SY   Res 251
DR   Wikidata; Q54949781
RX   PubMed=15814657;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Res253
AC   CVCL_DG07
SY   Res 253
DR   Wikidata; Q54949782
RX   PubMed=15814657;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Res254
AC   CVCL_DG08
SY   Res 254
DR   Wikidata; Q54949783
RX   PubMed=15814657;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   Res256
AC   CVCL_DG09
SY   RES256; Res 256; Res-256; R256
DR   cancercelllines; CVCL_DG09
DR   GEO; GSM919365
DR   Progenetix; CVCL_DG09
DR   Wikidata; Q54949784
RX   PubMed=15814657;
RX   PubMed=20847082;
RX   PubMed=22723427;
RX   PubMed=24297863;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 14
//
ID   Res259
AC   CVCL_DG10
SY   Res 259; Res-259
DR   BTO; BTO_0005881
DR   cancercelllines; CVCL_DG10
DR   Wikidata; Q54949786
RX   PubMed=15814657;
RX   PubMed=19365568;
RX   PubMed=33385022;
CC   Doubling time: 24 hours (PubMed=19365568).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   Res262
AC   CVCL_VU83
SY   RES262; Res 262; R262
DR   cancercelllines; CVCL_VU83
DR   Cell_Model_Passport; SIDM01317
DR   DepMap; ACH-001173
DR   Wikidata; Q98128907
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=24297863;
RX   PubMed=25211508;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Bobola, Michael S.; University of Washington; Seattle; USA.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 12
//
ID   Res280
AC   CVCL_DG11
SY   Res 280
DR   Wikidata; Q54949787
RX   PubMed=15814657;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Res286
AC   CVCL_DG12
SY   Res 286
DR   Wikidata; Q54949788
RX   PubMed=15814657;
RX   PubMed=33385022;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   Res300
AC   CVCL_VU84
SY   RES300; Res-300; R300
DR   Wikidata; Q98128909
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=22723427;
RX   PubMed=25211508;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   From: Bobola, Michael S.; University of Washington; Seattle; USA.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   Res308
AC   CVCL_VU85
SY   R308
DR   Wikidata; Q98128910
RX   PubMed=20847082;
RX   PubMed=24297863;
CC   From: Bobola, Michael S.; University of Washington; Seattle; USA.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   rES8-2
AC   CVCL_X718
DR   Wikidata; Q54949789
RX   PubMed=18983757;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   rES9-1
AC   CVCL_X719
DR   Wikidata; Q54949790
RX   PubMed=18983757;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_X720 ! rES9-2
OI   CVCL_X721 ! rES9-6
OI   CVCL_X722 ! rES9-7
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   rES9-2
AC   CVCL_X720
DR   Wikidata; Q54949791
RX   PubMed=18983757;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_X719 ! rES9-1
OI   CVCL_X721 ! rES9-6
OI   CVCL_X722 ! rES9-7
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   rES9-6
AC   CVCL_X721
DR   Wikidata; Q54949792
RX   PubMed=18983757;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_X719 ! rES9-1
OI   CVCL_X720 ! rES9-2
OI   CVCL_X722 ! rES9-7
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   rES9-7
AC   CVCL_X722
DR   Wikidata; Q54949793
RX   PubMed=18983757;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_X719 ! rES9-1
OI   CVCL_X720 ! rES9-2
OI   CVCL_X721 ! rES9-6
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 8
//
ID   RESC
AC   CVCL_UR69
SY   Rohita Embryonic Stem-like Cell
DR   Wikidata; Q98128911
RX   CelloPub=CLPUB00463;
RX   PubMed=22707190;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 4
//
ID   rESC 051A
AC   CVCL_VP60
SY   051A
DR   Wikidata; Q98128912
RX   PubMed=29973581;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Embryo is sibling to that giving rise to rESC 051B (Cellosaurus=CVCL_VP61).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=73337; ! Ceratotherium simum simum (Southern white rhinoceros)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   rESC 051B
AC   CVCL_VP61
SY   051B
DR   Wikidata; Q98128913
RX   PubMed=29973581;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Embryo is sibling to that giving rise to rESC 051A (Cellosaurus=CVCL_VP60).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=73337; ! Ceratotherium simum simum (Southern white rhinoceros)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   RESO001
AC   CVCL_E3Q9
SY   RESO1; F_PDO_000207
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RET981
AC   CVCL_VJ81
DR   Cosmic; 2539064
DR   Wikidata; Q98128914
RX   PubMed=9723034;
RX   PubMed=25316813;
ST   Source(s): PubMed=25316813
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D16S539: 9,12
ST   D5S818: 9,14
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8025; Malignant mixed tumor of the salivary gland
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   RETC-RP21
AC   CVCL_9W37
DR   Wikidata; Q54949794
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11636; Avian reticuloendotheliosis virus (REV) (Note=Strain T).
CC   Breed/subspecies: Nicholas; VBO=VBO_0001710.
OX   NCBI_TaxID=9103; ! Meleagris gallopavo (Wild turkey)
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   RETEC
AC   CVCL_W732
SY   Rat Eustachian Tube Epithelial Cells
DR   Wikidata; Q54949795
RX   PubMed=12389862;
CC   Doubling time: 36.92 hours (PubMed=12389862).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Ear, Eustachian tube; UBERON=UBERON_0002393.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   Rev1-iPSC
AC   CVCL_A4TS
DR   SKIP; SKIP003022
DR   Wikidata; Q107116736
RX   PubMed=29357927;
CC   From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan.
CC   Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple_corrected; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=29357927).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
DI   NCIt; C75020; Cleidocranial dysplasia
DI   ORDO; Orphanet_1452; Cleidocranial dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4TH ! CCD1-iPS 2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   Rev-CEM
AC   CVCL_1E04
SY   RevCEM
DR   BEI_Resources; ARP-11467
DR   cancercelllines; CVCL_1E04
DR   Wikidata; Q54949797
RX   PubMed=17627502;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pNL-GFP-RRE(SA) construct that results in the expression of the GFP gene under the control of the HIV-1 LTR promoter in HIV-1 infected cells when Tat and Rev are present.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J318 ! CEM-SS
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   Rev-CEM-D4
AC   CVCL_A9NQ
SY   RevCEM-D4; RevCEM clone D4
DR   BEI_Resources; ARP-13437
DR   cancercelllines; CVCL_A9NQ
DR   Wikidata; Q108821220
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pNL-GFP-RRE(SA) construct that results in the expression of the GFP gene under the control of the HIV-1 LTR promoter in HIV-1 infected cells when Tat and Rev are present.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E04 ! Rev-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   Rev-CEM-E7
AC   CVCL_A9NR
SY   RevCEM-E7; RevCEM clone E7
DR   BEI_Resources; ARP-13435
DR   cancercelllines; CVCL_A9NR
DR   Wikidata; Q108821221
RX   PubMed=27812216;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pNL-GFP-RRE(SA) construct that results in the expression of the GFP gene under the control of the HIV-1 LTR promoter in HIV-1 infected cells when Tat and Rev are present.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E04 ! Rev-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   Rev-CEM-G2
AC   CVCL_A9NS
SY   RevCEM-G2; RevCEM clone G2
DR   BEI_Resources; ARP-13436
DR   cancercelllines; CVCL_A9NS
DR   Wikidata; Q108821222
RX   PubMed=27812216;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pNL-GFP-RRE(SA) construct that results in the expression of the GFP gene under the control of the HIV-1 LTR promoter in HIV-1 infected cells when Tat and Rev are present.
CC   Characteristics: Expresses the mCherry gene under the control of a EF-1a promoter.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9NR ! Rev-CEM-E7
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   REX
AC   CVCL_B501
DR   cancercelllines; CVCL_B501
DR   Cosmic; 913421
DR   Cosmic; 1524816
DR   Wikidata; Q54949798
RX   PubMed=3100614;
RX   PubMed=15472075;
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Thr2466Met (c.7397C>T); ClinVar=VCV000241169; Zygosity=Heterozygous (PubMed=15472075).
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   RF [Labeo]
AC   CVCL_S939
SY   Rohu Fin
DR   NRFC; NRFC006
DR   Wikidata; Q54949799
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=20730759;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC006.
CC   Miscellaneous: Cell line is available for distribution but not authenticated (NRFC=NRFC006).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   RF [Sebastes]
AC   CVCL_WY75
SY   Rockfish Fin
DR   Wikidata; Q98128915
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=214486; ! Sebastes schlegelii (Korean rockfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   RF-1
AC   CVCL_3580
SY   RF1
DR   ATCC; CRL-1864
DR   Cell_Model_Passport; SIDM01091
DR   Cosmic; 687560
DR   Cosmic; 868238
DR   Wikidata; Q54949800
RX   PubMed=7750094;
RX   PubMed=12226758;
CC   Problematic cell line: Misclassified. From a B-cell lymphoma and not from a gastric adenocarcinoma (PubMed=12226758).
CC   Discontinued: ATCC; CRL-1864; true.
ST   Source(s): ATCC=CRL-1864
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1657 ! RF-48
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   RF-48
AC   CVCL_1657
SY   RF48
DR   CLO; CLO_0037147
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1863
DR   BioSample; SAMN03471256
DR   cancercelllines; CVCL_1657
DR   Cell_Model_Passport; SIDM01092
DR   Cosmic; 909697
DR   Cosmic-CLP; 909697
DR   DepMap; ACH-002301
DR   EGA; EGAS00001000978
DR   GDSC; 909697
DR   GEO; GSM1670375
DR   IARC_TP53; 21286
DR   IZSLER; BS TCL 208
DR   LINCS_LDP; LCL-1896
DR   PharmacoDB; RF48_1309_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54949801
RX   PubMed=7750094;
RX   PubMed=12226758;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Problematic cell line: Misclassified. From a B-cell lymphoma and not from the ascites of a gastric adenocarcinoma (PubMed=12226758).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.29%; Native American=31.68%; East Asian, North=3.25%; East Asian, South=0%; South Asian=2.87%; European, North=27.68%; European, South=29.24% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-1863; true.
ST   Source(s): ATCC=CRL-1863; Cosmic-CLP=909697
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C3208; Lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3580 ! RF-1
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   RF-851
AC   CVCL_XC05
SY   RF-L1; RFL1
DR   CCRID; 5301MAM-KCB85012ZJ
DR   KCB; KCB 85012ZJ
DR   Wikidata; Q98128916
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   RF-88k
AC   CVCL_BS84
SY   RF-88K; Red Fox-1988 kidney
DR   CCRID; 5301MAM-KCB8811KZJ
DR   KCB; KCB 88011KZJ
DR   Wikidata; Q54949804
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
OI   CVCL_BS85 ! RF-88l
OI   CVCL_BS86 ! RF-88s
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 10
//
ID   RF-88l
AC   CVCL_BS85
SY   RF-88L; Red Fox-1988 lung
DR   CCRID; 5301MAM-KCB8811LZJ
DR   KCB; KCB 88011LZJ
DR   Wikidata; Q54949805
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
OI   CVCL_BS84 ! RF-88k
OI   CVCL_BS86 ! RF-88s
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   RF-88s
AC   CVCL_BS86
SY   RF-88S; Red Fox-1988 skin
DR   CCRID; 5301MAM-KCB8811SZJ
DR   KCB; KCB 88011SZJ
DR   Wikidata; Q54949806
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
OI   CVCL_BS84 ! RF-88k
OI   CVCL_BS85 ! RF-88l
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   RF-89l/t
AC   CVCL_4232
SY   KCB89018
DR   CLO; CLO_0007085
DR   ECACC; 93052111
DR   KCB; KCB 89018
DR   Wikidata; Q54949808
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
OI   CVCL_XZ86 ! RF-89s
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   RF-89s
AC   CVCL_XZ86
DR   KCB; KCB 89007
DR   Wikidata; Q98128917
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
OI   CVCL_4232 ! RF-89l/t
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   RF-S1
AC   CVCL_A6KD
DR   Wikidata; Q107116737
RX   PubMed=2091939;
RX   PubMed=19003328;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
HI   CVCL_0014 ! RPMI-8226
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   RF-89s/t
AC   CVCL_XZ87
DR   KCB; KCB 89018F
DR   Wikidata; Q98128918
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9627; ! Vulpes vulpes (Red fox)
HI   CVCL_XZ86 ! RF-89s
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   RF/6A
AC   CVCL_4552
DR   CLO; CLO_0008790
DR   ATCC; CRL-1780
DR   BCRC; 60558
DR   ChEMBL-Cells; CHEMBL4513118
DR   ChEMBL-Targets; CHEMBL4513132
DR   CLS; 305150
DR   GEO; GSE113674
DR   Lonza; 1179
DR   PubChem_Cell_line; CVCL_4552
DR   Wikidata; Q54949809
RX   PubMed=3102454;
RX   PubMed=3771439;
RX   PubMed=27259688;
RX   PubMed=30508043;
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Probably misidentified. While originally thought to be an endothelial cell line, it has been shown to lack functional and transcriptomic characteristics of such cell type (PubMed=30508043).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal eye, choroid; UBERON=UBERON_0010312+UBERON_0001776.
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   64FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   RF/6A 135
AC   CVCL_J443
DR   CLO; CLO_0050230
DR   KCB; KCB 93022YJ
DR   RCB; RCB1556
DR   Wikidata; Q54949810
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Probably misidentified. Parent cell line (RF/6A) was originally thought to be an endothelial cell line but has been shown to lack functional and transcriptomic characteristics of such cell type.
CC   Derived from site: In situ; Fetal eye, choroid; UBERON=UBERON_0010312+UBERON_0001776.
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_4552 ! RF/6A
SX   Sex unspecified
AG   64FD
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   RF8
AC   CVCL_T793
DR   Wikidata; Q54949811
RX   PubMed=8943057;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   RFAL3
AC   CVCL_J773
SY   RFAL-3
DR   ECACC; 87100702
DR   Wikidata; Q54949812
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RFF
AC   CVCL_B6FE
SY   Rabbit Fish Fin
DR   Wikidata; Q112044475
RX   PubMed=32738512;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=225757; ! Siganus fuscescens (Mottled spinefoot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   RFGd10WE
AC   CVCL_5576
DR   CLO; CLO_0008792
DR   ATCC; CRL-6190
DR   Wikidata; Q54949813
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6190; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   RFGd11WE
AC   CVCL_5577
DR   CLO; CLO_0008793
DR   ATCC; CRL-6191
DR   Wikidata; Q54949814
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6191; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RFGd12WE
AC   CVCL_5578
DR   CLO; CLO_0008794
DR   ATCC; CRL-6192
DR   Wikidata; Q54949815
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6192; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RFGd2WE
AC   CVCL_5579
DR   CLO; CLO_0008795
DR   ATCC; CRL-6182
DR   Wikidata; Q54949824
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6182; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RFGd3WE
AC   CVCL_5580
DR   CLO; CLO_0008796
DR   ATCC; CRL-6183
DR   Wikidata; Q54949825
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6183; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RFGd4WE
AC   CVCL_5581
DR   CLO; CLO_0008797
DR   ATCC; CRL-6184
DR   Wikidata; Q54949826
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6184; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RFGd5WE
AC   CVCL_5582
DR   CLO; CLO_0008798
DR   ATCC; CRL-6185
DR   Wikidata; Q54949827
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6185; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RFGd6WE
AC   CVCL_S230
DR   ATCC; CRL-6186
DR   Wikidata; Q54949828
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6186; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   RFGd7WE
AC   CVCL_S231
DR   ATCC; CRL-6187
DR   Wikidata; Q54949829
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6187; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   RFGd8WE
AC   CVCL_S232
DR   ATCC; CRL-6188
DR   Wikidata; Q54949830
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6188; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   RFGd9WE
AC   CVCL_S233
DR   ATCC; CRL-6189
DR   Wikidata; Q54949831
CC   Group: Bird cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6189; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   RFL-6
AC   CVCL_2708
SY   RFL6; RFL 6; Rat Fetal Lung-6
DR   BTO; BTO_0004490
DR   CLO; CLO_0008799
DR   CLDB; cl4144
DR   CLDB; cl4145
DR   ATCC; CCL-192
DR   BCRJ; 0213
DR   ChEMBL-Cells; CHEMBL3833602
DR   ECACC; 86072501
DR   IZSLER; BS CL 73
DR   Lonza; 390
DR   PubChem_Cell_line; CVCL_2708
DR   Wikidata; Q54949832
RX   DOI=10.1016/B978-012361946-4/50009-0;
RX   PubMed=7065527;
CC   Senescence: Capable of at least 45 PDL.
CC   Derived from site: In situ; Embryonic lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   RFM
AC   CVCL_B6FD
SY   Rabbit Fish Macrophage
DR   Wikidata; Q112044477
RX   PubMed=36420515;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=225757; ! Siganus fuscescens (Mottled spinefoot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   RfM26-1
AC   CVCL_X921
SY   Red-faced Macaque 26-1
DR   Wikidata; Q54949833
RX   PubMed=2579038;
CC   Group: Non-human primate cell line.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
OI   CVCL_X922 ! RfM26-2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   RfM26-2
AC   CVCL_X922
SY   Red-faced Macaque 26-2
DR   Wikidata; Q54949834
RX   PubMed=2579038;
CC   Group: Non-human primate cell line.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9540; ! Macaca arctoides (Stump-tailed macaque)
OI   CVCL_X921 ! RfM26-1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   RFP-1
AC   CVCL_F0UW
RX   PubMed=2112113;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P14373; Human TRIM27 (Note=Immunized with AA 148-163).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   RFP-2
AC   CVCL_F0UX
RX   PubMed=2112113;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P14373; Human TRIM27 (Note=Immunized with AA 148-163).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   RG-1 [Human lung carcinoma]
AC   CVCL_0C24
DR   Cosmic; 2239086
DR   Wikidata; Q54949837
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9559344;
CC   Doubling time: 64.2 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   RG-1 [Labeo]
AC   CVCL_R810
SY   Rohu Gill-1
DR   Wikidata; Q54949838
RX   PubMed=9201509;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   RG-1 [Mouse hybridoma against HPV16 L2]
AC   CVCL_E6EM
RX   PubMed=17928339;
WW   Provider; JHTV; C10337; https://jhu.technologypublisher.com/technology/54049
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P03107; Human papillomavirus type 16 minor capsid protein L2 (Note=Also recognizes many other HPV genotypes).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   RG-100
AC   CVCL_B538
SY   SI-100; RGIe024-A
DR   hPSCreg; RGIe024-A
DR   SKIP; SKIP002122
DR   Wikidata; Q54949839
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-101
AC   CVCL_B539
SY   SI-101; RGIe023-A
DR   hPSCreg; RGIe023-A
DR   SKIP; SKIP002121
DR   Wikidata; Q54949840
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-102
AC   CVCL_B540
SY   SI-102; RGIe025-A
DR   hPSCreg; RGIe025-A
DR   SKIP; SKIP002123
DR   Wikidata; Q54949841
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-103
AC   CVCL_B541
SY   SI-103; RGIe026-A
DR   hPSCreg; RGIe026-A
DR   SKIP; SKIP002124
DR   Wikidata; Q54949843
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-104
AC   CVCL_B542
SY   SI-104; RGIe027-A
DR   hPSCreg; RGIe027-A
DR   SKIP; SKIP002125
DR   Wikidata; Q54949844
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-105
AC   CVCL_B543
SY   SI-105; RGIe028-A
DR   hPSCreg; RGIe028-A
DR   SKIP; SKIP002126
DR   Wikidata; Q54949846
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-106
AC   CVCL_B544
SY   SI-106; RGIe029-A
DR   hPSCreg; RGIe029-A
DR   SKIP; SKIP002127
DR   Wikidata; Q54949847
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-107
AC   CVCL_B545
SY   SI-107; RGIe030-A
DR   hPSCreg; RGIe030-A
DR   SKIP; SKIP002128
DR   Wikidata; Q54949849
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-108
AC   CVCL_B546
SY   SI-108; RGIe031-A
DR   hPSCreg; RGIe031-A
DR   SKIP; SKIP002129
DR   Wikidata; Q54949850
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-109
AC   CVCL_B547
SY   SI-109; RGIe032-A
DR   hPSCreg; RGIe032-A
DR   SKIP; SKIP002130
DR   Wikidata; Q54949852
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-110
AC   CVCL_B548
SY   SI-110; RGIe033-A
DR   hPSCreg; RGIe033-A
DR   SKIP; SKIP002131
DR   Wikidata; Q54949853
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-111
AC   CVCL_B549
SY   SI-111; RGIe034-A
DR   hPSCreg; RGIe034-A
DR   SKIP; SKIP002132
DR   Wikidata; Q54949854
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-114
AC   CVCL_B550
SY   SI-114; RGIe035-A
DR   hPSCreg; RGIe035-A
DR   SKIP; SKIP002133
DR   Wikidata; Q54949855
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-115
AC   CVCL_B551
SY   SI-115; RGIe036-A
DR   hPSCreg; RGIe036-A
DR   SKIP; SKIP002134
DR   Wikidata; Q54949857
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-122
AC   CVCL_B552
SY   SI-122; RGIe037-A
DR   hPSCreg; RGIe037-A
DR   SKIP; SKIP002135
DR   Wikidata; Q54949859
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-123
AC   CVCL_B553
SY   SI-123; RGIe038-A
DR   hPSCreg; RGIe038-A
DR   SKIP; SKIP002136
DR   Wikidata; Q54949860
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-124
AC   CVCL_B554
SY   SI-124; RGIe039-A
DR   hPSCreg; RGIe039-A
DR   SKIP; SKIP002137
DR   Wikidata; Q54949861
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-125
AC   CVCL_B555
SY   SI-125; hESC 125; RGIe041-A
DR   hPSCreg; RGIe041-A
DR   SKIP; SKIP002139
DR   Wikidata; Q54949862
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-126
AC   CVCL_B556
SY   SI-126; RGIe042-A
DR   hPSCreg; RGIe042-A
DR   SKIP; SKIP002140
DR   Wikidata; Q54949863
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-128
AC   CVCL_B557
SY   SI-128; hESC 128; RGIe040-A
DR   hPSCreg; RGIe040-A
DR   SKIP; SKIP002138
DR   Wikidata; Q54949864
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-130
AC   CVCL_B558
SY   SI-130; RGIe043-A
DR   hPSCreg; RGIe043-A
DR   SKIP; SKIP002141
DR   Wikidata; Q54949866
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-131
AC   CVCL_B559
SY   SI-131; RGIe044-A
DR   hPSCreg; RGIe044-A
DR   SKIP; SKIP002142
DR   Wikidata; Q54949867
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-132
AC   CVCL_B560
SY   SI-132; RGIe045-A
DR   hPSCreg; RGIe045-A
DR   SKIP; SKIP002143
DR   Wikidata; Q54949868
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-133
AC   CVCL_B561
SY   SI-133; RGIe046-A
DR   hPSCreg; RGIe046-A
DR   SKIP; SKIP002144
DR   Wikidata; Q54949869
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-134
AC   CVCL_B562
SY   SI-134; RGIe047-A
DR   hPSCreg; RGIe047-A
DR   SKIP; SKIP002145
DR   Wikidata; Q54949870
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-135
AC   CVCL_B563
SY   SI-135; RGIe048-A
DR   hPSCreg; RGIe048-A
DR   SKIP; SKIP002146
DR   Wikidata; Q54949871
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-137
AC   CVCL_B564
SY   SI-137; hESC 137; RGIe049-A
DR   hPSCreg; RGIe049-A
DR   SKIP; SKIP002147
DR   Wikidata; Q54949872
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Trp1831Ter (c.5492G>A) (p.Trp1810Ter, c.5429G>A); ClinVar=VCV000431656; Zygosity=Unspecified (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-138
AC   CVCL_B565
SY   SI-138; hESC 138; RGIe050-A
DR   hPSCreg; RGIe050-A
DR   SKIP; SKIP002148
DR   Wikidata; Q54949886
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Trp1831Ter (c.5492G>A) (p.Trp1810Ter, c.5429G>A); ClinVar=VCV000431656; Zygosity=Unspecified (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-139
AC   CVCL_B566
SY   SI-139; hESC 139; RGIe051-A
DR   hPSCreg; RGIe051-A
DR   SKIP; SKIP002149
DR   Wikidata; Q54949888
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Trp1831Ter (c.5492G>A) (p.Trp1810Ter, c.5429G>A); ClinVar=VCV000431656; Zygosity=Unspecified (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-140
AC   CVCL_B567
SY   SI-140; hESC 140; RGIe052-A
DR   hPSCreg; RGIe052-A
DR   SKIP; SKIP002150
DR   Wikidata; Q54949889
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Trp1831Ter (c.5492G>A) (p.Trp1810Ter, c.5429G>A); ClinVar=VCV000431656; Zygosity=Unspecified (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-141
AC   CVCL_B568
SY   SI-141; hESC 141; RGIe053-A
DR   hPSCreg; RGIe053-A
DR   SKIP; SKIP002151
DR   Wikidata; Q54949891
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Trp1831Ter (c.5492G>A) (p.Trp1810Ter, c.5429G>A); ClinVar=VCV000431656; Zygosity=Unspecified (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-144
AC   CVCL_B569
SY   SI-144; RGIe054-A
DR   hPSCreg; RGIe054-A
DR   SKIP; SKIP002152
DR   Wikidata; Q54949892
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-145
AC   CVCL_B570
SY   SI-145; RGIe055-A
DR   hPSCreg; RGIe055-A
DR   SKIP; SKIP002153
DR   Wikidata; Q54949893
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-146
AC   CVCL_B571
SY   SI-146; RGIe056-A
DR   hPSCreg; RGIe056-A
DR   SKIP; SKIP002154
DR   Wikidata; Q54949894
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-148
AC   CVCL_B572
SY   SI-148; hESC 148; RGIe057-A
DR   hPSCreg; RGIe057-A
DR   SKIP; SKIP002155
DR   Wikidata; Q54949895
RX   PubMed=15705304;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-149
AC   CVCL_B573
SY   SI-149; RGIe058-A
DR   hPSCreg; RGIe058-A
DR   SKIP; SKIP002156
DR   Wikidata; Q54949896
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-15
AC   CVCL_B574
SY   SI-15; RGIe001-A
DR   hPSCreg; RGIe001-A
DR   SKIP; SKIP002094
DR   Wikidata; Q54949897
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-150
AC   CVCL_B575
SY   SI-150; RGIe059-A
DR   hPSCreg; RGIe059-A
DR   SKIP; SKIP002157
DR   Wikidata; Q54949898
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-151
AC   CVCL_B576
SY   SI-151; RGIe060-A
DR   hPSCreg; RGIe060-A
DR   SKIP; SKIP002158
DR   Wikidata; Q54949900
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-153
AC   CVCL_B577
SY   SI-153; hESC 153; RGIe061-A
DR   hPSCreg; RGIe061-A
DR   SKIP; SKIP002159
DR   Wikidata; Q54949901
RX   PubMed=15705304;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-154
AC   CVCL_B578
SY   SI-154; hESC 154; RGIe062-A
DR   hPSCreg; RGIe062-A
DR   SKIP; SKIP002161
DR   Wikidata; Q54949902
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2571Tyr (c.7712G>A); ClinVar=VCV000549422; Zygosity=Unspecified (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   RG-155
AC   CVCL_B579
SY   SI-155; SC-155; RGIe063-A
DR   hPSCreg; RGIe063-A
DR   SKIP; SKIP002162
DR   Wikidata; Q54949903
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-156
AC   CVCL_B580
SY   SI-156; RGIe064-A
DR   hPSCreg; RGIe064-A
DR   SKIP; SKIP002163
DR   Wikidata; Q54949904
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-157
AC   CVCL_B581
SY   SI-157; RGIe065-A
DR   hPSCreg; RGIe065-A
DR   SKIP; SKIP002164
DR   Wikidata; Q54949905
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-158
AC   CVCL_B582
SY   SI-158; hESC 158; RGIe066-A
DR   hPSCreg; RGIe066-A
DR   SKIP; SKIP002165
DR   Wikidata; Q54949907
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.93-21G>A (IVS1,G>A,+110); ClinVar=VCV000015454; Zygosity=Heterozygous (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   RG-159
AC   CVCL_B583
SY   SI-159; SC-159; RGIe067-A
DR   hPSCreg; RGIe067-A
DR   SKIP; SKIP002166
DR   Wikidata; Q54949908
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-160
AC   CVCL_B584
SY   SI-160; SC-160; RGIe068-A
DR   hPSCreg; RGIe068-A
DR   SKIP; SKIP002167
DR   Wikidata; Q54949909
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-161
AC   CVCL_B585
SY   SI-161; RGIe069-A
DR   hPSCreg; RGIe069-A
DR   SKIP; SKIP002168
DR   Wikidata; Q54949912
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-162
AC   CVCL_B586
SY   SI-162; RGIe070-A
DR   hPSCreg; RGIe070-A
DR   SKIP; SKIP002169
DR   Wikidata; Q54949913
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-163
AC   CVCL_B587
SY   SI-163; RGIe071-A
DR   hPSCreg; RGIe071-A
DR   SKIP; SKIP002170
DR   Wikidata; Q54949914
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-164
AC   CVCL_B588
SY   SI-164; hESC 164; RGIe072-A
DR   hPSCreg; RGIe072-A
DR   SKIP; SKIP002171
DR   Wikidata; Q54949915
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-165
AC   CVCL_B589
SY   SI-165; RGIe073-A
DR   hPSCreg; RGIe073-A
DR   SKIP; SKIP002172
DR   Wikidata; Q54949916
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-167
AC   CVCL_B590
SY   SI-167; RGIe074-A
DR   hPSCreg; RGIe074-A
DR   SKIP; SKIP002173
DR   Wikidata; Q54949918
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-168
AC   CVCL_B591
SY   SI-168; RGIe075-A
DR   hPSCreg; RGIe075-A
DR   SKIP; SKIP002174
DR   Wikidata; Q54949920
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-169
AC   CVCL_B592
SY   SI-169; RGIe076-A
DR   hPSCreg; RGIe076-A
DR   SKIP; SKIP002175
DR   Wikidata; Q54949921
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-170
AC   CVCL_B593
SY   SI-170; hESC 170; RGIe077-A
DR   hPSCreg; RGIe077-A
DR   SKIP; SKIP002176
DR   Wikidata; Q54949922
RX   PubMed=15705304;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-171
AC   CVCL_B594
SY   SI-171; RGIe078-A
DR   hPSCreg; RGIe078-A
DR   SKIP; SKIP002177
DR   Wikidata; Q54949923
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-172
AC   CVCL_B595
SY   SI-172; RGIe079-A
DR   hPSCreg; RGIe079-A
DR   SKIP; SKIP002178
DR   Wikidata; Q54949924
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-174
AC   CVCL_B596
SY   SI-174; RGIe080-A
DR   hPSCreg; RGIe080-A
DR   SKIP; SKIP002179
DR   Wikidata; Q54949925
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-175
AC   CVCL_B597
SY   SI-175; RGIe081-A
DR   hPSCreg; RGIe081-A
DR   SKIP; SKIP002180
DR   Wikidata; Q54949926
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   RG-176
AC   CVCL_B598
SY   SI-176; RGIe082-A
DR   hPSCreg; RGIe082-A
DR   SKIP; SKIP002181
DR   Wikidata; Q54949928
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-177
AC   CVCL_B599
SY   SI-177; RGIe083-A
DR   hPSCreg; RGIe083-A
DR   SKIP; SKIP002182
DR   Wikidata; Q54949929
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-178
AC   CVCL_B600
SY   SI-178; RGIe084-A
DR   hPSCreg; RGIe084-A
DR   SKIP; SKIP002183
DR   Wikidata; Q54949930
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-179
AC   CVCL_B601
SY   SI-179; RGIe085-A
DR   hPSCreg; RGIe085-A
DR   SKIP; SKIP002184
DR   Wikidata; Q54949931
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-18
AC   CVCL_B602
SY   SI-18; RGIe002-A
DR   hPSCreg; RGIe002-A
DR   SKIP; SKIP002095
DR   Wikidata; Q54949932
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-180
AC   CVCL_B603
SY   SI-180; hESC 180; RGIe086-A
DR   hPSCreg; RGIe086-A
DR   SKIP; SKIP002185
DR   Wikidata; Q54949933
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-182
AC   CVCL_B604
SY   SI-182; RGIe087-A
DR   hPSCreg; RGIe087-A
DR   SKIP; SKIP002186
DR   Wikidata; Q54949934
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-183
AC   CVCL_B605
SY   SI-183; SC-183; RGIe088-A
DR   hPSCreg; RGIe088-A
DR   SKIP; SKIP002187
DR   Wikidata; Q54949955
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-184
AC   CVCL_B606
SY   SI-184; SC-184; RGIe089-A
DR   hPSCreg; RGIe089-A
DR   SKIP; SKIP002188
DR   Wikidata; Q54949956
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-185
AC   CVCL_B607
SY   SI-185; SC-185; RGIe090-A
DR   hPSCreg; RGIe090-A
DR   SKIP; SKIP002189
DR   Wikidata; Q54949957
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-186
AC   CVCL_B608
SY   SI-186; hESC 186; RGIe091-A
DR   hPSCreg; RGIe091-A
DR   SKIP; SKIP002190
DR   Wikidata; Q54949958
RX   PubMed=15705304;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RG-187
AC   CVCL_B609
SY   SI-187; hESC 187; RGIe092-A
DR   hPSCreg; RGIe092-A
DR   SKIP; SKIP002191
DR   Wikidata; Q54949959
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-188
AC   CVCL_B610
SY   SI-188; RGIe093-A
DR   hPSCreg; RGIe093-A
DR   SKIP; SKIP002192
DR   Wikidata; Q54949961
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-189
AC   CVCL_B611
SY   SI-189; RGIe094-A
DR   hPSCreg; RGIe094-A
DR   SKIP; SKIP002193
DR   Wikidata; Q54949962
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-191
AC   CVCL_B612
SY   SI-191; RGIe095-A
DR   hPSCreg; RGIe095-A
DR   SKIP; SKIP002194
DR   Wikidata; Q54949963
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-192
AC   CVCL_B613
SY   SI-192; RGIe096-A
DR   hPSCreg; RGIe096-A
DR   SKIP; SKIP002195
DR   Wikidata; Q54949964
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-193
AC   CVCL_B614
SY   SI-193; RGIe097-A
DR   hPSCreg; RGIe097-A
DR   SKIP; SKIP002196
DR   Wikidata; Q54949966
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-194
AC   CVCL_B615
SY   SI-194; hESC 194; RGIe098-A
DR   hPSCreg; RGIe098-A
DR   SKIP; SKIP002197
DR   Wikidata; Q54949967
RX   PubMed=15705304;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RG-195
AC   CVCL_B616
SY   SI-195; RGIe099-A
DR   hPSCreg; RGIe099-A
DR   SKIP; SKIP002198
DR   Wikidata; Q54949968
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-196
AC   CVCL_B617
SY   SI-196; RGIe100-A
DR   hPSCreg; RGIe100-A
DR   SKIP; SKIP002199
DR   Wikidata; Q54949969
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-197
AC   CVCL_B618
SY   SI-197; RGIe101-A
DR   hPSCreg; RGIe101-A
DR   SKIP; SKIP002200
DR   Wikidata; Q54949970
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-198
AC   CVCL_B619
SY   SI-198; RGIe102-A
DR   hPSCreg; RGIe102-A
DR   SKIP; SKIP002201
DR   Wikidata; Q54949972
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-199
AC   CVCL_B620
SY   SI-199; SC-199; RGIe103-A
DR   hPSCreg; RGIe103-A
DR   SKIP; SKIP002202
DR   Wikidata; Q54949973
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-200
AC   CVCL_B621
SY   SI-200; RGIe104-A
DR   hPSCreg; RGIe104-A
DR   SKIP; SKIP002203
DR   Wikidata; Q54949974
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-201
AC   CVCL_B622
SY   SI-201; RGIe105-A
DR   hPSCreg; RGIe105-A
DR   SKIP; SKIP002204
DR   Wikidata; Q54949975
RX   PubMed=15705304;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Gln472Argfs*83 (c.1415_1416delAG) (1801delAG); ClinVar=VCV000011303; Zygosity=Hemizygous (PubMed=15705304).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   RG-202
AC   CVCL_B623
SY   SI-202; RGIe106-A
DR   hPSCreg; RGIe106-A
DR   SKIP; SKIP002205
DR   Wikidata; Q54949976
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-203
AC   CVCL_B624
SY   SI-203; RGIe107-A
DR   hPSCreg; RGIe107-A
DR   SKIP; SKIP002206
DR   Wikidata; Q54949977
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-204
AC   CVCL_B625
SY   SI-204; RGIe108-A
DR   hPSCreg; RGIe108-A
DR   SKIP; SKIP002207
DR   Wikidata; Q54949978
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-205
AC   CVCL_B626
SY   SI-205; RGIe109-A
DR   hPSCreg; RGIe109-A
DR   SKIP; SKIP002208
DR   Wikidata; Q54949979
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-206
AC   CVCL_B627
SY   SI-206; SC-206; RGIe110-A
DR   hPSCreg; RGIe110-A
DR   SKIP; SKIP002209
DR   Wikidata; Q54949981
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-208
AC   CVCL_B628
SY   SI-208; RGIe111-A
DR   hPSCreg; RGIe111-A
DR   SKIP; SKIP002210
DR   Wikidata; Q54949983
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-209
AC   CVCL_B629
SY   SI-209; SC-209; RGIe112-A
DR   hPSCreg; RGIe112-A
DR   SKIP; SKIP002211
DR   Wikidata; Q54949984
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-21
AC   CVCL_B630
SY   SI-21; RGIe003-A
DR   hPSCreg; RGIe003-A
DR   SKIP; SKIP002096
DR   Wikidata; Q54949985
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-210
AC   CVCL_B631
SY   SI-210; RGIe113-A
DR   hPSCreg; RGIe113-A
DR   SKIP; SKIP002212
DR   Wikidata; Q54949986
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-211
AC   CVCL_B632
SY   SI-211; RGIe114-A
DR   hPSCreg; RGIe114-A
DR   SKIP; SKIP002213
DR   Wikidata; Q54949987
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-213
AC   CVCL_B633
SY   SI-213; RGIe115-A
DR   hPSCreg; RGIe115-A
DR   SKIP; SKIP002214
DR   Wikidata; Q54949989
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.93-21G>A (IVS1,G>A,+110); ClinVar=VCV000015454; Zygosity=Heterozygous (ISCR=429).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-214
AC   CVCL_B634
SY   SI-214; RGIe116-A
DR   hPSCreg; RGIe116-A
DR   SKIP; SKIP002215
DR   Wikidata; Q54949990
RX   PubMed=24289922;
RX   PubMed=27690107;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[138-450]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=24289922).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   RG-215
AC   CVCL_B635
SY   SI-215; RGIe117-A
DR   hPSCreg; RGIe117-A
DR   SKIP; SKIP002216
DR   Wikidata; Q54949991
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-216
AC   CVCL_B636
SY   SI-216; RGIe118-A
DR   hPSCreg; RGIe118-A
DR   SKIP; SKIP002217
DR   Wikidata; Q54949992
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-217
AC   CVCL_B637
SY   SI-217; SC-217; RGIe130-A
DR   hPSCreg; RGIe130-A
DR   SKIP; SKIP002229
DR   Wikidata; Q54949993
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-218
AC   CVCL_B638
SY   SI-218; RGIe119-A
DR   hPSCreg; RGIe119-A
DR   SKIP; SKIP002218
DR   Wikidata; Q54949994
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-219
AC   CVCL_B639
SY   SI-219; RGIe120-A
DR   hPSCreg; RGIe120-A
DR   SKIP; SKIP002219
DR   Wikidata; Q54949995
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-220
AC   CVCL_B640
SY   SI-220; SC-220; RGIe121-A
DR   hPSCreg; RGIe121-A
DR   SKIP; SKIP002220
DR   Wikidata; Q54949996
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-221
AC   CVCL_B641
SY   SI-221; SC-221; RGIe122-A
DR   hPSCreg; RGIe122-A
DR   SKIP; SKIP002221
DR   Wikidata; Q54949997
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-222
AC   CVCL_B642
SY   SI-222; RGIe123-A
DR   hPSCreg; RGIe123-A
DR   SKIP; SKIP002222
DR   Wikidata; Q54949998
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-223
AC   CVCL_B643
SY   SI-223; RGIe124-A
DR   hPSCreg; RGIe124-A
DR   SKIP; SKIP002223
DR   Wikidata; Q54949999
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-224
AC   CVCL_B644
SY   SI-224; RGIe125-A
DR   hPSCreg; RGIe125-A
DR   SKIP; SKIP002224
DR   Wikidata; Q54950000
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-226
AC   CVCL_B645
SY   SI-226; RGIe126-A
DR   hPSCreg; RGIe126-A
DR   SKIP; SKIP002225
DR   Wikidata; Q54950011
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-227
AC   CVCL_B646
SY   SI-227; RGIe127-A
DR   hPSCreg; RGIe127-A
DR   SKIP; SKIP002226
DR   Wikidata; Q54950012
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-228
AC   CVCL_B647
SY   SI-228; RGIe128-A
DR   hPSCreg; RGIe128-A
DR   SKIP; SKIP002227
DR   Wikidata; Q54950013
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-230
AC   CVCL_B648
SY   SI-230; RGIe129-A
DR   hPSCreg; RGIe129-A
DR   SKIP; SKIP002228
DR   Wikidata; Q54950014
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-231
AC   CVCL_B649
SY   SI-231; RGIe131-A
DR   hPSCreg; RGIe131-A
DR   SKIP; SKIP002230
DR   Wikidata; Q54950015
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-232
AC   CVCL_B650
SY   SI-232; RGIe132-A
DR   hPSCreg; RGIe132-A
DR   SKIP; SKIP002231
DR   Wikidata; Q54950016
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-233
AC   CVCL_B651
SY   SI-233; SC233; RGIe133-A
DR   hPSCreg; RGIe133-A
DR   SKIP; SKIP002232
DR   Wikidata; Q54950017
RX   PubMed=20541472;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=20541472).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RG-234
AC   CVCL_B652
SY   SI-234
DR   Wikidata; Q54950018
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-235
AC   CVCL_B653
SY   SI-235; RGIe134-A
DR   hPSCreg; RGIe134-A
DR   SKIP; SKIP002233
DR   Wikidata; Q54950019
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-236
AC   CVCL_B654
SY   SI-236; RGIe135-A
DR   hPSCreg; RGIe135-A
DR   SKIP; SKIP002234
DR   Wikidata; Q54950020
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-237
AC   CVCL_B655
SY   SI-237; RGIe136-A
DR   hPSCreg; RGIe136-A
DR   SKIP; SKIP002235
DR   Wikidata; Q54950021
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-238
AC   CVCL_B656
SY   SI-238; RGIe137-A
DR   hPSCreg; RGIe137-A
DR   SKIP; SKIP002236
DR   Wikidata; Q54950022
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-239
AC   CVCL_B657
SY   SI-239; RGIe138-A
DR   hPSCreg; RGIe138-A
DR   SKIP; SKIP002237
DR   Wikidata; Q54950023
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-24
AC   CVCL_B658
SY   SI-24; RGIe004-A
DR   hPSCreg; RGIe004-A
DR   SKIP; SKIP002097
DR   Wikidata; Q54950024
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-240
AC   CVCL_B659
SY   SI-240; SC-240; RGIe139-A
DR   hPSCreg; RGIe139-A
DR   SKIP; SKIP002238
DR   Wikidata; Q54950025
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-241
AC   CVCL_B660
SY   SI-241; RGIe140-A
DR   hPSCreg; RGIe140-A
DR   SKIP; SKIP002239
DR   Wikidata; Q54950026
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-242
AC   CVCL_B661
SY   SI-242; RGIe141-A
DR   hPSCreg; RGIe141-A
DR   SKIP; SKIP002240
DR   Wikidata; Q54950027
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-243
AC   CVCL_B662
SY   SI-243; SC-243; RGIe142-A
DR   hPSCreg; RGIe142-A
DR   SKIP; SKIP002241
DR   Wikidata; Q54950028
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-244
AC   CVCL_B663
SY   SI-244; RGIe143-A
DR   hPSCreg; RGIe143-A
DR   SKIP; SKIP002242
DR   Wikidata; Q54950029
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-245
AC   CVCL_B664
SY   SI-245; SC-245; RGIe144-A
DR   hPSCreg; RGIe144-A
DR   SKIP; SKIP002243
DR   Wikidata; Q54950030
RX   PubMed=19146778;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-246
AC   CVCL_B665
SY   SI-246; RGIe145-A
DR   hPSCreg; RGIe145-A
DR   SKIP; SKIP002244
DR   Wikidata; Q54950031
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84685; Emery-Dreifuss muscular dystrophy
DI   ORDO; Orphanet_261; Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RG-247
AC   CVCL_B666
SY   SI-247; RGIe146-A
DR   hPSCreg; RGIe146-A
DR   SKIP; SKIP002245
DR   Wikidata; Q54950032
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-248
AC   CVCL_B667
SY   SI-248; RGIe147-A
DR   hPSCreg; RGIe147-A
DR   SKIP; SKIP002246
DR   Wikidata; Q54950033
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-249
AC   CVCL_B668
SY   SI-249; RGIe148-A
DR   hPSCreg; RGIe148-A
DR   SKIP; SKIP002247
DR   Wikidata; Q54950034
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-250
AC   CVCL_B669
SY   SI-250; RGIe149-A
DR   hPSCreg; RGIe149-A
DR   SKIP; SKIP002248
DR   Wikidata; Q54950035
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-251
AC   CVCL_B670
SY   SI-251; RGIe150-A
DR   hPSCreg; RGIe150-A
DR   SKIP; SKIP002249
DR   Wikidata; Q54950037
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-252
AC   CVCL_B671
SY   SI-252; RGIe151-A
DR   hPSCreg; RGIe151-A
DR   SKIP; SKIP002250
DR   Wikidata; Q54950038
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-253
AC   CVCL_B672
SY   SI-253; SC-253; RGIe152-A
DR   hPSCreg; RGIe152-A
DR   SKIP; SKIP002251
DR   Wikidata; Q54950039
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-254
AC   CVCL_B673
SY   SI-254; RGIe153-A
DR   hPSCreg; RGIe153-A
DR   SKIP; SKIP002252
DR   Wikidata; Q54950040
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-255
AC   CVCL_B674
SY   SI-255; RGIe154-A
DR   hPSCreg; RGIe154-A
DR   SKIP; SKIP002253
DR   Wikidata; Q54950042
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-256
AC   CVCL_B675
SY   SI-256; RGIe155-A
DR   hPSCreg; RGIe155-A
DR   SKIP; SKIP002254
DR   Wikidata; Q54950043
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-257
AC   CVCL_B676
SY   SI-257; RGIe156-A
DR   hPSCreg; RGIe156-A
DR   SKIP; SKIP002255
DR   Wikidata; Q54950044
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RG-259
AC   CVCL_B677
SY   SI-259
DR   Wikidata; Q54950045
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-260
AC   CVCL_B678
SY   SI-260
DR   Wikidata; Q54950046
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-261
AC   CVCL_B679
SY   SI-261
DR   Wikidata; Q54950048
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-262
AC   CVCL_B680
SY   SI-262
DR   Wikidata; Q54950049
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-263
AC   CVCL_B681
SY   SI-263
DR   Wikidata; Q54950050
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-264
AC   CVCL_B682
SY   SI-264
DR   Wikidata; Q54950051
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-265
AC   CVCL_B683
SY   SI-265
DR   Wikidata; Q54950052
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-266
AC   CVCL_B684
SY   SI-266
DR   Wikidata; Q54950054
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-267
AC   CVCL_B685
SY   SI-267; SC-267
DR   Wikidata; Q54950067
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-269
AC   CVCL_B686
SY   SI-269; SC-269
DR   Wikidata; Q54950069
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-27
AC   CVCL_B687
SY   SI-27; RGIe005-A
DR   hPSCreg; RGIe005-A
DR   SKIP; SKIP002098
DR   Wikidata; Q54950070
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-270
AC   CVCL_B688
SY   SC-270
DR   Wikidata; Q54950071
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-271
AC   CVCL_B689
DR   Wikidata; Q54950072
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   RG-272
AC   CVCL_B690
DR   Wikidata; Q54950073
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-273
AC   CVCL_B691
DR   Wikidata; Q54950074
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-274
AC   CVCL_B692
DR   Wikidata; Q54950075
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-275
AC   CVCL_B693
DR   Wikidata; Q54950076
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-276
AC   CVCL_B694
DR   Wikidata; Q54950077
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-277
AC   CVCL_B695
DR   Wikidata; Q54950078
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.93-21G>A (IVS1,G>A,+110); ClinVar=VCV000015454; Zygosity=Homozygous (ISCR=475).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   RG-278
AC   CVCL_B696
DR   Wikidata; Q54950079
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-279
AC   CVCL_B697
DR   Wikidata; Q54950080
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118785; Ocular albinism type 1
DI   ORDO; Orphanet_54; X-linked recessive ocular albinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   RG-28
AC   CVCL_B698
SY   SI-28; RGIe006-A
DR   hPSCreg; RGIe006-A
DR   SKIP; SKIP002099
DR   Wikidata; Q54950081
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-282
AC   CVCL_B699
SY   SI-282
DR   Wikidata; Q54950082
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-283
AC   CVCL_B700
SY   SI-283
DR   Wikidata; Q54950083
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-284
AC   CVCL_B701
SY   SI-284; SC-284
DR   Wikidata; Q54950085
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-285
AC   CVCL_B702
SY   SI-285; SC-285
DR   Wikidata; Q54950086
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118785; Ocular albinism type 1
DI   ORDO; Orphanet_54; X-linked recessive ocular albinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-286
AC   CVCL_B703
SY   SI-286
DR   Wikidata; Q54950087
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-288
AC   CVCL_B704
SY   SI-288
DR   Wikidata; Q54950088
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ISCR=629).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   RG-289
AC   CVCL_B705
SY   SI-289
DR   Wikidata; Q54950089
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ISCR=630).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   RG-294
AC   CVCL_B706
SY   SI-294; SC-294
DR   Wikidata; Q54950090
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-295
AC   CVCL_B707
SY   SI-295; SC-295
DR   Wikidata; Q54950091
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-296
AC   CVCL_B708
SY   SI-296
DR   Wikidata; Q54950092
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-297
AC   CVCL_B709
SY   SI-297; SC-297
DR   Wikidata; Q54950093
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-298
AC   CVCL_B710
SY   SI-298
DR   Wikidata; Q54950094
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-299
AC   CVCL_B711
SY   SI-299
DR   Wikidata; Q54950096
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-300
AC   CVCL_B712
SY   SI-300; SC-300
DR   Wikidata; Q54950097
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-301
AC   CVCL_B713
SY   SI-301
DR   Wikidata; Q54950098
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-302
AC   CVCL_B714
SY   SI-302; SC-302
DR   Wikidata; Q54950099
RX   PubMed=19146778;
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   RG-304
AC   CVCL_B715
SY   SI-304
DR   Wikidata; Q54950100
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-308
AC   CVCL_B716
SY   SI-308
DR   Wikidata; Q54950101
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   RG-31
AC   CVCL_B717
SY   SI-31; RGIe007-A
DR   hPSCreg; RGIe007-A
DR   SKIP; SKIP002100
DR   Wikidata; Q54950102
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-310
AC   CVCL_B718
SY   SI-310
DR   Wikidata; Q54950103
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-311
AC   CVCL_B719
SY   SI-311
DR   Wikidata; Q54950104
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-313
AC   CVCL_B720
SY   SI-313
DR   Wikidata; Q54950106
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   RG-315
AC   CVCL_B721
SY   SI-315
DR   Wikidata; Q54950107
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg1968Ter (c.5902C>T) (p.Arg1947Ter, c.5839C>T); ClinVar=VCV000000343; Zygosity=Heterozygous (ISCR=635).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   RG-316
AC   CVCL_B722
SY   SI-316
DR   Wikidata; Q54950108
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; c.663+1G>A (IVS7+1G>A); ClinVar=VCV000049076; Zygosity=Heterozygous; Note=Splice donor mutation (ISCR=636).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   RG-317
AC   CVCL_B805
SY   SI-317
DR   Wikidata; Q54950109
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   RG-320
AC   CVCL_B723
SY   SI-320
DR   Wikidata; Q54950110
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; c.663+1G>A (IVS7+1G>A); ClinVar=VCV000049076; Zygosity=Heterozygous; Note=Splice donor mutation (ISCR=637).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   RG-321
AC   CVCL_B724
SY   SI-321; SC-321; SC321
DR   Wikidata; Q54950121
RX   PubMed=19146778;
RX   PubMed=22344463;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-03.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-323
AC   CVCL_B806
SY   SI-323
DR   Wikidata; Q54950122
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   RG-324
AC   CVCL_B807
SY   SI-324
DR   Wikidata; Q54950123
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   RG-325
AC   CVCL_B725
SY   SI-325; SC-325
DR   Wikidata; Q54950124
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-326
AC   CVCL_B726
SY   SI-326
DR   Wikidata; Q54950125
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:6121; IRF6; Simple; p.Arg84His (c.251G>A); ClinVar=VCV000003415; Zygosity=Unspecified (ISCR=638).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118786; Autosomal dominant popliteal pterygium syndrome
DI   ORDO; Orphanet_1300; Autosomal dominant popliteal pterygium syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   RG-327
AC   CVCL_B727
SY   SI-327; SC-327
DR   Wikidata; Q54950127
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   RG-328
AC   CVCL_B728
SY   SI-328
DR   Wikidata; Q54950128
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-329
AC   CVCL_B729
SY   SI-329
DR   Wikidata; Q54950129
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-33
AC   CVCL_B730
SY   SI-33; RGIe008-A
DR   hPSCreg; RGIe008-A
DR   SKIP; SKIP002101
DR   Wikidata; Q54950130
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-330
AC   CVCL_B731
SY   SI-330
DR   Wikidata; Q54950131
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-331
AC   CVCL_B732
SY   SI-331; SC-331
DR   Wikidata; Q54950132
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-333
AC   CVCL_B733
SY   SI-333
DR   Wikidata; Q54950133
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-334
AC   CVCL_B734
SY   SI-334; SC-334
DR   Wikidata; Q54950134
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-335
AC   CVCL_B735
SY   SI-335; SC-335
DR   Wikidata; Q54950135
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-336
AC   CVCL_B736
SY   SI-336; SC-336
DR   Wikidata; Q54950136
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-337
AC   CVCL_B737
SY   SI-337; SC-337
DR   Wikidata; Q54950137
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-338
AC   CVCL_B738
SY   SI-338; SC-338
DR   Wikidata; Q54950138
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-339
AC   CVCL_B739
SY   SI-339
DR   Wikidata; Q54950139
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-340
AC   CVCL_B740
SY   SI-340; SC-340
DR   Wikidata; Q54950140
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-341
AC   CVCL_B741
SY   SI-341
DR   Wikidata; Q54950141
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-342
AC   CVCL_B742
SY   SI-342; SC-342
DR   Wikidata; Q54950142
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-343
AC   CVCL_B743
SY   SI-343; SC-343
DR   Wikidata; Q54950143
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   RG-344
AC   CVCL_B744
SY   SI-344; SC-344
DR   Wikidata; Q54950144
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-345
AC   CVCL_B745
SY   SI-345; SC-345
DR   Wikidata; Q54950145
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-349
AC   CVCL_B746
SY   SI-349
DR   Wikidata; Q54950147
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-350
AC   CVCL_B747
SY   SI-350
DR   Wikidata; Q54950148
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-351
AC   CVCL_B748
SY   SI-351
DR   Wikidata; Q54950150
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-353
AC   CVCL_B749
SY   SI-353
DR   Wikidata; Q54950151
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-354
AC   CVCL_B750
SY   SI-354; SC-354
DR   Wikidata; Q54950153
RX   PubMed=19146778;
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-356
AC   CVCL_B751
SY   SI-356
DR   Wikidata; Q54950154
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   RG-357
AC   CVCL_B752
SY   SI-357
DR   Wikidata; Q54950155
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   RG-358
AC   CVCL_B753
SY   SI-358
DR   Wikidata; Q54950156
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   RG-359
AC   CVCL_B754
SY   SI-359
DR   Wikidata; Q54950157
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-363
AC   CVCL_B755
SY   SI-363
DR   Wikidata; Q54950158
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-366
AC   CVCL_B756
SY   SI-366
DR   Wikidata; Q54950159
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-367
AC   CVCL_B757
SY   SI-367
DR   Wikidata; Q54950160
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-369
AC   CVCL_B758
SY   SI-369
DR   Wikidata; Q54950161
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-386
AC   CVCL_B759
SY   SI-386
DR   Wikidata; Q54950162
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-395
AC   CVCL_B760
SY   SI-395
DR   Wikidata; Q54950163
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-396
AC   CVCL_B761
SY   SI-396
DR   Wikidata; Q54950164
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-397
AC   CVCL_B762
SY   SI-397
DR   Wikidata; Q54950174
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-399
AC   CVCL_B763
SY   SI-399
DR   Wikidata; Q54950175
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-401
AC   CVCL_B764
SY   SI-401
DR   Wikidata; Q54950176
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-402
AC   CVCL_B765
SY   SI-402
DR   Wikidata; Q54950177
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-403
AC   CVCL_B766
SY   SI-403
DR   Wikidata; Q54950178
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RG-404
AC   CVCL_B767
SY   SI-404
DR   Wikidata; Q54950180
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   RG-405
AC   CVCL_B768
SY   SI-405
DR   Wikidata; Q54950181
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   RG-406
AC   CVCL_B769
SY   SI-406
DR   Wikidata; Q54950182
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RG-407
AC   CVCL_B770
SY   SI-407
DR   Wikidata; Q54950183
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75018; Treacher Collins syndrome
DI   ORDO; Orphanet_861; Treacher-Collins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-408
AC   CVCL_B771
SY   SI-408
DR   Wikidata; Q54950184
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75018; Treacher Collins syndrome
DI   ORDO; Orphanet_861; Treacher-Collins syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-410
AC   CVCL_B772
SY   SI-410
DR   Wikidata; Q54950185
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (ISCR=868).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asn1303Lys (c.3909C>G); ClinVar=VCV000007136; Zygosity=Heterozygous (ISCR=868).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   RG-411
AC   CVCL_B773
SY   SI-411
DR   Wikidata; Q54950186
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ISCR=869).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-412
AC   CVCL_B774
SY   SI-412
DR   Wikidata; Q54950187
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (ISCR=870).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   RG-413
AC   CVCL_B775
SY   SI-413
DR   Wikidata; Q54950188
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   RG-414
AC   CVCL_B776
SY   SI-414
DR   Wikidata; Q54950189
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RG-415
AC   CVCL_B777
SY   SI-415
DR   Wikidata; Q54950192
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RG-416
AC   CVCL_B778
SY   SI-416
DR   Wikidata; Q54950193
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (ISCR=654).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1585-1G>A (IVS10AS,G>A,-1) (1717-1G>A); ClinVar=VCV000007112; Zygosity=Heterozygous; Note=Splice acceptor mutation (ISCR=654).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   RG-417
AC   CVCL_B779
SY   SI-417
DR   Wikidata; Q54950194
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (ISCR=655).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.1585-1G>A (IVS10AS,G>A,-1) (1717-1G>A); ClinVar=VCV000007112; Zygosity=Heterozygous; Note=Splice acceptor mutation (ISCR=655).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   RG-418
AC   CVCL_B780
SY   SI-418
DR   Wikidata; Q54950195
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Ser10Valfs*14 (c.27dupG) (c.27_28insG) (cd8/9+G); ClinVar=VCV000036308; Zygosity=Heterozygous (ISCR=656).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; chr11:g.71609_72227del619; ClinVar=VCV000038701; Zygosity=Heterozygous (ISCR=656).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   RG-419
AC   CVCL_B781
SY   SI-419
DR   Wikidata; Q54950196
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-420
AC   CVCL_B782
SY   SI-420
DR   Wikidata; Q54950197
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Ser10Valfs*14 (c.27dupG) (c.27_28insG) (cd8/9+G); ClinVar=VCV000036308; Zygosity=Heterozygous (ISCR=657).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; chr11:g.71609_72227del619; ClinVar=VCV000038701; Zygosity=Heterozygous (ISCR=657).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   RG-421
AC   CVCL_B804
SY   SI-421
DR   Wikidata; Q54950198
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   RG-422
AC   CVCL_B783
SY   SI-422
DR   Wikidata; Q54950199
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (ISCR=658).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Asn1303Lys (c.3909C>G); ClinVar=VCV000007136; Zygosity=Heterozygous (ISCR=658).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   RG-423
AC   CVCL_B784
SY   SI-423
DR   Wikidata; Q54950200
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (ISCR=659).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   RG-424
AC   CVCL_B785
SY   SI-424
DR   Wikidata; Q54950201
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Met918Thr (c.2753T>C); ClinVar=VCV000013919; Zygosity=Heterozygous (ISCR=660).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3227; Multiple endocrine neoplasia type 2B
DI   ORDO; Orphanet_247709; Multiple endocrine neoplasia type 2B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   RG-425
AC   CVCL_B786
SY   SI-425
DR   Wikidata; Q54950202
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-426
AC   CVCL_B787
SY   SI-426
DR   Wikidata; Q54950204
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   RG-427
AC   CVCL_B788
DR   Wikidata; Q54950206
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   RG-428
AC   CVCL_B789
SY   SI-428
DR   Wikidata; Q54950207
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; c.663+1G>A (IVS7+1G>A); ClinVar=VCV000049076; Zygosity=Heterozygous; Note=Splice donor mutation (ISCR=662).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75122; Tuberous sclerosis 1
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   RG-53
AC   CVCL_B790
SY   SI-53; RGIe009-A
DR   hPSCreg; RGIe009-A
DR   SKIP; SKIP002102
DR   Wikidata; Q54950208
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-60
AC   CVCL_B791
SY   SI-60; RGIe010-A
DR   hPSCreg; RGIe010-A
DR   SKIP; SKIP002103
DR   Wikidata; Q54950209
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-62
AC   CVCL_B792
SY   SI-62; RGIe011-A
DR   hPSCreg; RGIe011-A
DR   SKIP; SKIP002104
DR   Wikidata; Q54950210
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-63
AC   CVCL_B793
SY   SI-63; RGIe012-A
DR   hPSCreg; RGIe012-A
DR   SKIP; SKIP002105
DR   Wikidata; Q54950211
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-79
AC   CVCL_B794
SY   SI-79; RGIe013-A
DR   hPSCreg; RGIe013-A
DR   SKIP; SKIP002106
DR   Wikidata; Q54950212
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-80
AC   CVCL_B795
SY   SI-80; RGIe014-A
DR   hPSCreg; RGIe014-A
DR   SKIP; SKIP002107
DR   Wikidata; Q54950213
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-81
AC   CVCL_B796
SY   SI-81; RGIe015-A
DR   hPSCreg; RGIe015-A
DR   SKIP; SKIP002108
DR   Wikidata; Q54950215
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-93
AC   CVCL_B797
SY   SI-93; RGIe016-A
DR   hPSCreg; RGIe016-A
DR   SKIP; SKIP002109
DR   Wikidata; Q54950216
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-94
AC   CVCL_B798
SY   SI-94; RGIe017-A
DR   hPSCreg; RGIe017-A
DR   SKIP; SKIP002110
DR   Wikidata; Q54950217
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-95
AC   CVCL_B799
SY   SI-95; RGIe018-A
DR   hPSCreg; RGIe018-A
DR   SKIP; SKIP002111
DR   Wikidata; Q54950218
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-96
AC   CVCL_B800
SY   SI-96; RGIe019-A
DR   hPSCreg; RGIe019-A
DR   SKIP; SKIP002112
DR   Wikidata; Q54950219
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-97
AC   CVCL_B801
SY   SI-97; RGIe020-A
DR   hPSCreg; RGIe020-A
DR   SKIP; SKIP002113
DR   Wikidata; Q54950236
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-98
AC   CVCL_B802
SY   SI-98; RGIe021-A
DR   hPSCreg; RGIe021-A
DR   SKIP; SKIP002119
DR   Wikidata; Q54950237
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   RG-99
AC   CVCL_B803
SY   SI-99; RGIe022-A
DR   hPSCreg; RGIe022-A
DR   SKIP; SKIP002120
DR   Wikidata; Q54950239
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RG-TL
AC   CVCL_B808
SY   SI-TL
DR   Wikidata; Q54950240
CC   From: Reproductive Genetics Institute; Chicago; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   RG11/15
AC   CVCL_A6FG
SY   HDB2665
DR   Wikidata; Q107116738
RX   CelloPub=CLPUB00622;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   RG11/39.4
AC   CVCL_G151
SY   RG11/39; HDB2667
DR   CLO; CLO_0008800
DR   ATCC; TIB-170
DR   Wikidata; Q54950241
RX   CelloPub=CLPUB00622;
RX   PubMed=6208128;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Rat IgG1 (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RG17
AC   CVCL_C0XM
SY   Retinal Glia 17
DR   ABM; T0176
DR   Wikidata; Q114312783
RX   PubMed=35377941;
CC   Doubling time: 58.47 hours (Note=At 5th passage), 60.90 hours (Note=At 20th passage) (PubMed=35377941).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: GLAST-CreERT, Rbfl/fl transgenic.
ST   Source(s): PubMed=35377941
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 18,19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 15.3
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 15.2,17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   RG2
AC   CVCL_3581
SY   RG-2; Rat Glioma-2; D74; D74-RG2
DR   CLO; CLO_0008802
DR   ATCC; CRL-2433
DR   CCRID; 3101RATTCR14
DR   ChEMBL-Cells; CHEMBL3307505
DR   ChEMBL-Targets; CHEMBL614001
DR   CLS; 300649
DR   PubChem_Cell_line; CVCL_3581
DR   Wikidata; Q54950242
RX   PubMed=7435138;
RX   PubMed=19381449;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   20FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   RG37
AC   CVCL_RW59
DR   Wikidata; Q54950243
RX   PubMed=16407825;
CC   Population: African American.
CC   Characteristics: Transfected with the DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84723; Galactosemia
DI   ORDO; Orphanet_352; Galactosemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7299 ! GM00639
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   RG7/1.30
AC   CVCL_G152
SY   RG7/1; HDB2668
DR   CLO; CLO_0008803
DR   ATCC; TIB-173
DR   Wikidata; Q54950244
RX   CelloPub=CLPUB00622;
RX   PubMed=6208128;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Rat IgG2a (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RG7/11.1
AC   CVCL_G153
SY   RG7/11; HDB2669
DR   CLO; CLO_0008804
DR   ATCC; TIB-174
DR   Wikidata; Q54950245
RX   CelloPub=CLPUB00622;
RX   PubMed=6208128;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Rat IgG2b (Fc).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RG7/7.6 HL
AC   CVCL_G154
SY   HDB2666
DR   CLO; CLO_0008805
DR   ATCC; TIB-172
DR   Wikidata; Q54950246
RX   CelloPub=CLPUB00622;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Rat Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RG7/9.1 HLK
AC   CVCL_G155
SY   HDB2664
DR   CLO; CLO_0008806
DR   ATCC; TIB-169
DR   Wikidata; Q54950247
RX   CelloPub=CLPUB00622;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Rat Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RG9/6.13 HLK
AC   CVCL_G156
SY   RG9/6; HDB2670
DR   CLO; CLO_0008807
DR   ATCC; TIB-167
DR   Wikidata; Q54950248
RX   CelloPub=CLPUB00622;
RX   PubMed=6208128;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Rat IgG2a (Fab').
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RGA-1
AC   CVCL_6720
DR   ABM; T0758
DR   Wikidata; Q54950249
RX   PubMed=11517187;
RX   PubMed=15541573;
CC   Characteristics: At the permissive temperature (33 Celsius) proliferates but reverts to a differentiated phenotype at the restrictive temperature (39 Celsius) (PubMed=11517187).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   27D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   RGA-41S
AC   CVCL_6721
DR   Wikidata; Q54950250
RX   PubMed=2481820;
RX   PubMed=15541573;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   RGAS001-2
AC   CVCL_E3QA
SY   RGAS001; RGAS1-2; RGAS1; F_PDO_000154
DR   CancerTools; 160931
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RGB
AC   CVCL_R846
SY   Rockfish Grouper Brain
DR   Wikidata; Q54950251
RX   DOI=10.1016/j.aquaculture.2009.05.010;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=308564; ! Epinephelus quoyanus (Longfin grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   RGB3T3-1
AC   CVCL_T375
DR   CLO; CLO_0050543
DR   RCB; RCB0163
DR   Wikidata; Q54950252
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RGB3T3-5
AC   CVCL_T376
DR   CLO; CLO_0050541
DR   RCB; RCB0164
DR   Wikidata; Q54950254
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RGC-5
AC   CVCL_4059
SY   RGC5
DR   BTO; BTO_0005118
DR   BioSample; SAMN03151607
DR   TOKU-E; 3594
DR   Wikidata; Q54950255
RX   Patent=US7303915;
RX   PubMed=11165366;
RX   PubMed=19443730;
RX   PubMed=23975727;
RX   PubMed=24021353;
RX   PubMed=24472671;
RX   PubMed=24664692;
RX   PubMed=29203899;
WW   Info; -; -; https://web.archive.org/web/20150311223958/http://cellbiology.med.unsw.edu.au/units/lab/cells/cell_RGC5.htm
WW   Info; ICLAC; -; https://iclac.org/education/rgc-5/
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of rat origin but found to be from mouse (PubMed=19443730; PubMed=24664692). Is probably identical to 661W (PubMed=23975727; PubMed=24021353). But the originator of the 661W cell is partially contesting this claim (PubMed=24472671).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00472.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6600.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=Under the control of the IRBP promoter).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Retinal cone cell; CL=CL_0000573.
CC   Breed/subspecies: C57BL/6N transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6240 ! 661W
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   RGE
AC   CVCL_2175
SY   Rat Glomerular Endothelial
DR   CLO; CLO_0008811
DR   CLDB; cl4146
DR   DSMZ; ACC-262
DR   DSMZCellDive; ACC-262
DR   Wikidata; Q54950256
RX   PubMed=8394476;
CC   Doubling time: ~17 hours (DSMZ=ACC-262).
CC   Transformant: NCBI_TaxID; 10529; Adenovirus 31.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Glomerular endothelial cell; CL=CL_0002188.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   6W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   RGE-2
AC   CVCL_R847
DR   Wikidata; Q54950258
RX   DOI=10.1111/j.0022-1112.2004.00521.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 9
//
ID   RGE1-01
AC   CVCL_6B57
DR   Wikidata; Q54950260
RX   PubMed=12207048;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16-18W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RGE1-02
AC   CVCL_6B58
DR   Wikidata; Q54950261
RX   PubMed=12207048;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16-18W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RGE1-03
AC   CVCL_6B59
DR   Wikidata; Q54950262
RX   PubMed=12207048;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16-18W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RGE1-21
AC   CVCL_6B60
DR   Wikidata; Q54950264
RX   PubMed=12207048;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16-18W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RGE1-22
AC   CVCL_6B61
DR   Wikidata; Q54950265
RX   PubMed=12207048;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16-18W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RGE2-01
AC   CVCL_6B62
DR   Wikidata; Q54950267
RX   PubMed=12207048;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic stomach, fundus; UBERON=UBERON_0001160.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   20FD
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RGF [Rat liver]
AC   CVCL_0Q70
DR   Wikidata; Q54950268
RX   PubMed=25822334;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast of hepatic portal; CL=CL_0009100.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   RGF [Salmo]
AC   CVCL_R848
DR   Wikidata; Q54950269
RX   DOI=10.1111/j.0022-1112.2004.00521.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   RGF-N2
AC   CVCL_0Q71
DR   Wikidata; Q54950272
RX   PubMed=25822334;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast of hepatic portal; CL=CL_0009100.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   RGG
AC   CVCL_R849
SY   Rockfish Grouper Gill
DR   Wikidata; Q54950274
RX   DOI=10.1016/j.aquaculture.2009.05.010;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=308564; ! Epinephelus quoyanus (Longfin grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   RGH
AC   CVCL_R850
SY   Rockfish Grouper Heart
DR   Wikidata; Q54950275
RX   DOI=10.1016/j.aquaculture.2009.05.010;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=308564; ! Epinephelus quoyanus (Longfin grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   RGL-1
AC   CVCL_A8KA
DR   Wikidata; Q108821223
RX   PubMed=2415631;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Rat antigen on intestinal intraepithelial lymphocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   RGLI001-2
AC   CVCL_E3IZ
SY   RGLI001; RGLI1-2; RGLI1; F_PDO_000126
DR   CancerTools; 160985
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RGLI002-2
AC   CVCL_E3NN
SY   RGLI002; RGLI2-2; RGLI2; F_PDO_000171
DR   CancerTools; 160986
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RGM1
AC   CVCL_0499
SY   RGM-1
DR   BTO; BTO_0004494
DR   CLO; CLO_0050842
DR   MCCL; MCC:0000396
DR   RCB; RCB0876
DR   Wikidata; Q54950276
RX   PubMed=9658308;
CC   Derived from site: In situ; Stomach, epithelium; UBERON=UBERON_0001276.
CC   Cell type: Epithelial cell of stomach; CL=CL_0002178.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RGN1
AC   CVCL_UE06
SY   RGN 1
DR   Wikidata; Q98128919
RX   PubMed=1323719;
RX   PubMed=3013426;
RX   PubMed=8543165;
CC   Virology: Contains both episomal (~20 copies per cell) and chromosomally integrated (2 per cell) copies of the EBV genome (PubMed=1323719).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RGS
AC   CVCL_1G60
SY   Red-spotted Grouper Skin
DR   Wikidata; Q54950277
RX   PubMed=22252337;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=215347; ! Epinephelus akaara (Hong Kong grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 9
//
ID   RGS-2
AC   CVCL_8415
SY   Rat Glandular Stomach-2
DR   Wikidata; Q54950278
RX   PubMed=599719;
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   RGS-3A
AC   CVCL_VH27
SY   Rat Glandular Stomach-3A
DR   Wikidata; Q54950279
RX   PubMed=599719;
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   RGS-4A
AC   CVCL_VH28
SY   Rat Glandular Stomach-4A
DR   Wikidata; Q54950280
RX   PubMed=599719;
CC   Doubling time: 25.9 hours (PubMed=599719).
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_VH29 ! RGS-4B
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   RGS-4B
AC   CVCL_VH29
SY   Rat Glandular Stomach-4B
DR   Wikidata; Q54950281
RX   PubMed=599719;
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_VH28 ! RGS-4A
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   RGS-5
AC   CVCL_8416
SY   Rat Glandular Stomach-5
DR   Wikidata; Q54950282
RX   PubMed=599719;
CC   Doubling time: 28.8 hours (PubMed=599719).
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   RGS-6
AC   CVCL_VH30
SY   Rat Glandular Stomach-6
DR   Wikidata; Q54950283
RX   PubMed=599719;
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   RGS-7A
AC   CVCL_VH31
SY   Rat Glandular Stomach-7A
DR   Wikidata; Q54950284
RX   PubMed=599719;
CC   Doubling time: 50.4 hours (PubMed=599719).
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   RGS-8
AC   CVCL_8417
SY   Rat Glandular Stomach-8
DR   Wikidata; Q54950296
RX   PubMed=599719;
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   RGS-9
AC   CVCL_VH32
SY   Rat Glandular Stomach-9
DR   Wikidata; Q54950297
RX   PubMed=599719;
CC   Derived from site: In situ; Fetal stomach, glandular region; UBERON=UBERON_0011953.
CC   Cell type: Glandular cell of stomach; CL=CL_0002659.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   9D
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   RH [Human]
AC   CVCL_S570
DR   CLO; CLO_0008812
DR   CLDB; cl4147
DR   Wikidata; Q54950298
RX   PubMed=239575;
RX   PubMed=4357539;
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   RH [Labeo]
AC   CVCL_S940
SY   Rohu Heart
DR   Wikidata; Q54950299
RX   CelloPub=CLPUB00463;
RX   PubMed=20730759;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   RH 1
AC   CVCL_B6ET
DR   Wikidata; Q112044479
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6F1 ! RH 9
OI   CVCL_B6EU ! RH 10
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 10
AC   CVCL_B6EU
DR   Wikidata; Q112044481
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6F1 ! RH 9
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 2
AC   CVCL_B6EV
DR   Wikidata; Q112044482
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6F1 ! RH 9
OI   CVCL_B6EU ! RH 10
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 3
AC   CVCL_B6EW
DR   Wikidata; Q112044483
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6F1 ! RH 9
OI   CVCL_B6EU ! RH 10
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 4
AC   CVCL_B6EX
DR   Wikidata; Q112044484
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6F1 ! RH 9
OI   CVCL_B6EU ! RH 10
SX   Male
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 6
AC   CVCL_B6EY
DR   Wikidata; Q112044485
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6F1 ! RH 9
OI   CVCL_B6EU ! RH 10
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 7
AC   CVCL_B6EZ
DR   Wikidata; Q112044487
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6F1 ! RH 9
OI   CVCL_B6EU ! RH 10
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 8
AC   CVCL_B6F0
DR   Wikidata; Q112044489
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F1 ! RH 9
OI   CVCL_B6EU ! RH 10
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH 9
AC   CVCL_B6F1
DR   Wikidata; Q112044492
RX   PubMed=15561280;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_B6ET ! RH 1
OI   CVCL_B6EV ! RH 2
OI   CVCL_B6EW ! RH 3
OI   CVCL_B6EX ! RH 4
OI   CVCL_B6EY ! RH 6
OI   CVCL_B6EZ ! RH 7
OI   CVCL_B6F0 ! RH 8
OI   CVCL_B6EU ! RH 10
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   RH-1
AC   CVCL_E3SB
SY   RH-I
RX   PubMed=239575;
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-104
AC   CVCL_E3S9
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-106
AC   CVCL_E3SA
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-28
AC   CVCL_D7CP
RX   PubMed=945468;
CC   Group: Human/rodent somatic cell hybrid.
CC   Characteristics: Hybrid between human leukocytes and RAG (PubMed=945468).
CC   Karyotypic information: Has 4 copies of the human chromosome Y and one copy of chromosome 17 (PubMed=945468).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3575 ! RAG
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   RH-40
AC   CVCL_E3S2
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-50
AC   CVCL_E3S3
RX   PubMed=239575;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-53
AC   CVCL_E3SC
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-54
AC   CVCL_E3SD
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-55
AC   CVCL_E3S4
RX   PubMed=239575;
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-56
AC   CVCL_E3S5
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-60
AC   CVCL_E3S6
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-78
AC   CVCL_E3S7
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-82
AC   CVCL_E3SE
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-85
AC   CVCL_E3S8
RX   PubMed=4446550;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   RH-L4
AC   CVCL_K240
SY   L4; RigsHospitalet-Lymphoma 4
DR   Wikidata; Q54950300
RX   PubMed=2433033;
RX   PubMed=3106068;
RX   PubMed=3484432;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=L4
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RH-PA
AC   CVCL_S571
DR   Wikidata; Q54950301
RX   PubMed=2517003;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S570 ! RH [Human]
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   rh-r.1
AC   CVCL_0A41
DR   Wikidata; Q54950303
RX   PubMed=9542648;
RX   PubMed=10844251;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   rh-r.2
AC   CVCL_0A42
DR   Wikidata; Q54950304
RX   PubMed=9542648;
RX   PubMed=10844251;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   rh-r.3
AC   CVCL_0A43
DR   Wikidata; Q54950306
RX   PubMed=9542648;
RX   PubMed=10844251;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   rh-r.4
AC   CVCL_0A44
DR   Wikidata; Q54950307
RX   PubMed=9542648;
RX   PubMed=10844251;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   rh-r.5
AC   CVCL_0A45
DR   Wikidata; Q54950308
RX   PubMed=9542648;
RX   PubMed=10844251;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   rh-r.6
AC   CVCL_0A46
DR   Wikidata; Q54950309
RX   PubMed=9542648;
RX   PubMed=10844251;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7153; ! Chironomus tentans (Midge)
HI   CVCL_0A36 ! Chironomus tentans epithelial cell line
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   RH-SCC-L10
AC   CVCL_U974
SY   RigsHospitalet-Small Cell lung Carcinoma-L10
DR   Wikidata; Q54950310
RX   PubMed=2433033;
RX   PubMed=6089998;
CC   Doubling time: ~55 hours (PubMed=6089998).
CC   Misspelling: RH-SLC-L10; Note=In Cellosaurus releases 9 to 27.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   RH-SLC-L11
AC   CVCL_7114
SY   SLC-L11; RigsHospitalet-Squamous Lung Carcinoma-L11
DR   Wikidata; Q54950311
RX   Patent=EP0184906A1;
RX   PubMed=2433033;
RX   PubMed=2433892;
RX   PubMed=2445477;
RX   PubMed=2450645;
RX   PubMed=6089998;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85061403.
CC   Doubling time: ~30-40 hours (PubMed=6089998).
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   RH-SLC-L12
AC   CVCL_U972
SY   SLC-L12; RigsHospitalet-Squamous Lung Carcinoma-L11
DR   Wikidata; Q54950312
RX   PubMed=2433033;
RX   PubMed=2450645;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U973 ! RH-SLC-L13
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   RH-SLC-L13
AC   CVCL_U973
SY   SLC-L13; RigsHospitalet-Squamous Lung Carcinoma-L11
DR   Wikidata; Q54950313
RX   PubMed=2450645;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U972 ! RH-SLC-L12
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   RH/66A
AC   CVCL_S531
DR   BEI_Resources; ARP-1271
DR   Wikidata; Q54950314
RX   PubMed=8376938;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_S532 ! RH/66E
OI   CVCL_S533 ! RH/66F
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   RH/66E
AC   CVCL_S532
DR   Wikidata; Q54950316
RX   PubMed=8376938;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_S531 ! RH/66A
OI   CVCL_S533 ! RH/66F
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RH/66F
AC   CVCL_S533
DR   Wikidata; Q54950317
RX   PubMed=8376938;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_S531 ! RH/66A
OI   CVCL_S532 ! RH/66E
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RH/K29
AC   CVCL_S534
DR   Wikidata; Q54950318
RX   PubMed=8376938;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   RH/K30
AC   CVCL_S535
DR   ATCC; CRL-2560
DR   BEI_Resources; ARP-1274
DR   Wikidata; Q54950320
RX   PubMed=8376938;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: ATCC; CRL-2560; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 16
//
ID   RH/K32
AC   CVCL_S536
DR   Wikidata; Q54950321
RX   PubMed=8376938;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 14
//
ID   RH/K34
AC   CVCL_S537
DR   ATCC; CRL-2561
DR   BEI_Resources; ARP-1276
DR   Wikidata; Q54950323
RX   PubMed=8376938;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 16
//
ID   RH/Thy2
AC   CVCL_B6F6
SY   RH/Thy-2
DR   Wikidata; Q112044494
RX   PubMed=8376938;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Thymocyte; CL=CL_0000893.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   RH/Thy66A
AC   CVCL_B6F7
DR   Wikidata; Q112044496
RX   PubMed=8376938;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Thymocyte; CL=CL_0000893.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   RH1 [Human ESC]
AC   CVCL_C355
SY   RH 1; RH-1; EDe001-A
DR   hPSCreg; EDe001-A
DR   SKIP; SKIP001488
DR   SKIP; SKIP001901
DR   Wikidata; Q54950325
RX   PubMed=17196096;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-029, Steering comm. appl. SCSC06-16(1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   RH1 [Mouse/rat hybridoma against mouse Clec7a]
AC   CVCL_A0GB
DR   Wikidata; Q108821224
RX   Patent=US7915041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10152.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Rh10
AC   CVCL_8750
SY   RH10; Rh 10
DR   Wikidata; Q54950326
RX   CelloPub=CLPUB00569;
RX   PubMed=3607778;
RX   PubMed=6950170;
RX   PubMed=23882450;
CC   Characteristics: Established from a immuno-deficient mice xenograft (HxRh10).
CC   Doubling time: 66.7 hours (PubMed=3607778).
CC   Derived from site: In situ; Perineus, muscle; UBERON=UBERON_0002379.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   Rh12
AC   CVCL_S638
SY   RH12
DR   Wikidata; Q54950329
RX   PubMed=23882450;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   Rh18
AC   CVCL_1659
AS   CVCL_5918
SY   RH18; RH-18; Rh-18; Rh 18; SJRH-18; SJRH18
DR   BTO; BTO_0005380
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473565
DR   BioSample; SAMN10989566
DR   cancercelllines; CVCL_1659
DR   Cell_Model_Passport; SIDM00454
DR   ChEMBL-Cells; CHEMBL3308533
DR   ChEMBL-Targets; CHEMBL2366350
DR   Cosmic; 687954
DR   Cosmic; 801757
DR   Cosmic; 802046
DR   Cosmic; 971774
DR   Cosmic; 1037296
DR   Cosmic; 1048109
DR   Cosmic; 1097747
DR   Cosmic; 1104560
DR   Cosmic; 1108739
DR   Cosmic; 1509196
DR   Cosmic; 1620037
DR   Cosmic-CLP; 971774
DR   DepMap; ACH-000689
DR   DSMZ; ACC-491
DR   DSMZCellDive; ACC-491
DR   EGA; EGAS00001000978
DR   GDSC; 971774
DR   GEO; GSM219745
DR   GEO; GSM1670377
DR   GEO; GSM1676325
DR   GEO; GSM1701658
DR   IARC_TP53; 24981
DR   IARC_TP53; 27702
DR   LiGeA; CCLE_325
DR   PharmacoDB; RH18_1311_2019
DR   PRIDE; PXD030304
DR   PRIDE; PXD039480
DR   PubChem_Cell_line; CVCL_1659
DR   Wikidata; Q54950333
RX   CelloPub=CLPUB00569;
RX   PubMed=3607778;
RX   PubMed=6950170;
RX   PubMed=7536457;
RX   PubMed=8275086;
RX   PubMed=8383879;
RX   PubMed=9802058;
RX   PubMed=9823299;
RX   PubMed=11051265;
RX   PubMed=19235922;
RX   PubMed=20164919;
RX   PubMed=20922763;
RX   PubMed=23578105;
RX   PubMed=23882450;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32758582;
RX   PubMed=35839778;
RX   PubMed=36768928;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-557.html
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Rhabdomyosarcoma/Rh18%20Cell%20Line%20Data%20Sheet.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: African American.
CC   Characteristics: Established from a immuno-deficient mice xenograft (HxRh18).
CC   Doubling time: 57.8 hours (PubMed=3607778); 83 hours (PubMed=20922763); ~60-70 hours (DSMZ=ACC-491); 65 hours (COG).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=7536457; PubMed=8275086; PubMed=23578105).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9802058).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=74.53%; Native American=0.16%; East Asian, North=4.19%; East Asian, South=0%; South Asian=0%; European, North=5.05%; European, South=16.06% (PubMed=30894373).
CC   Derived from site: In situ; Perineus, muscle; UBERON=UBERON_0002379.
ST   Source(s): COG; Cosmic-CLP=971774; DSMZ=ACC-491; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 16,17
ST   D19S433: 12,14
ST   D21S11: 32.2,33.2
ST   D2S1338: 19,24
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 7,12
ST   Penta E: 8,13
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   Rh18c
AC   CVCL_DG02
SY   RH18C
DR   cancercelllines; CVCL_DG02
DR   Cosmic; 1718357
DR   GEO; GSM186447
DR   GEO; GSM186448
DR   Progenetix; CVCL_DG02
DR   Wikidata; Q54950334
RX   PubMed=22142829;
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Derived from site: In situ; Perineus, muscle; UBERON=UBERON_0002379.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1659 ! Rh18
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   Rh2
AC   CVCL_A460
SY   RH2; SJRH-2; SJRH2
DR   Cosmic; 1097751
DR   Cosmic; 1104557
DR   Wikidata; Q54950335
RX   PubMed=7536457;
RX   PubMed=8275086;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   Rh28
AC   CVCL_8752
AS   CVCL_5919
SY   RH28; Rh-28; Rh 28; SJRH-28; SJRH 28; SJRH28
DR   BTO; BTO_0005384
DR   EFO; EFO_0022619
DR   cancercelllines; CVCL_8752
DR   Cell_Model_Passport; SIDM01333
DR   Cosmic; 687955
DR   Cosmic; 1097748
DR   Cosmic; 1104561
DR   Cosmic; 1108740
DR   Cosmic; 1718360
DR   Cosmic; 2356025
DR   Cosmic; 2820091
DR   DepMap; ACH-001740
DR   GEO; GSM1676332
DR   GEO; GSM1701664
DR   IARC_TP53; 24980
DR   PRIDE; PXD000589
DR   PRIDE; PXD039480
DR   Wikidata; Q54950336
RX   CelloPub=CLPUB00569;
RX   PubMed=3607778;
RX   PubMed=7536457;
RX   PubMed=8275086;
RX   PubMed=8383879;
RX   PubMed=9802058;
RX   PubMed=9823299;
RX   PubMed=11051265;
RX   PubMed=21948088;
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=23882450;
RX   PubMed=25894527;
RX   PubMed=26351324;
RX   PubMed=28196595;
RX   PubMed=36768928;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Characteristics: Established from a immuno-deficient mice xenograft (HxRh28).
CC   Doubling time: 58.8 hours (PubMed=3607778).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=7536457; PubMed=8275086).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Heterozygous (DepMap=ACH-001740).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9802058).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): COG; PubMed=21948088
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 15,20
ST   D19S433: 14,15.2
ST   D21S11: 31.2,32.2
ST   D2S1338: 18,25
ST   D3S1358: 14,17
ST   D5S818: 7,11
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L415 ! Rh3
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   Rh28/L-PAM
AC   CVCL_Y584
SY   Rh28 L-PAM; Rh28/LPAM; RH28/LPAM; Rh 28/LPAM; Rh28 PX11/LPAM; Rh-28 PX11/LPAM
DR   GEO; GSM1676360
DR   GEO; GSM1701690
DR   Wikidata; Q54950337
RX   PubMed=2890432;
RX   PubMed=23882450;
RX   PubMed=26351324;
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8752 ! Rh28
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   Rh3
AC   CVCL_L415
AS   CVCL_A461
SY   RH3; Rh-3; SJRH-3; SJRH3
DR   BTO; BTO_0005383
DR   Cell_Model_Passport; SIDM01334
DR   Cosmic; 687956
DR   Cosmic; 1097743
DR   Cosmic; 1104558
DR   Cosmic; 1108741
DR   Cosmic; 2820090
DR   Wikidata; Q54950338
RX   PubMed=7536457;
RX   PubMed=8275086;
RX   PubMed=9823299;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=7536457; PubMed=8275086).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8752 ! Rh28
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   RH3
AC   CVCL_C356
SY   RH 3; RH-3; EDe002-A
DR   hPSCreg; EDe002-A
DR   SKIP; SKIP001489
DR   SKIP; SKIP001902
DR   Wikidata; Q54950339
RX   PubMed=17196096;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-030, Steering comm. appl. SCSC06-16(2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   Rh30
AC   CVCL_0041
AS   CVCL_1696; CVCL_UF98
SY   RH30; RH-30; Rh-30; RH30SJ; SJRH-30; SJRH30; SJ-RH30; SJ-Rh 30; SJRH 30; SJCRH30; RC13; RMS-13; RMS 13; RMS13
DR   BTO; BTO_0005379
DR   CLO; CLO_0009030
DR   CLO; CLO_0037074
DR   CLO; CLO_0037076
DR   EFO; EFO_0005722
DR   4DN; 4DNSR3QR626J
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2061
DR   BCRC; 60420
DR   BCRJ; 0344
DR   BioGRID_ORCS_Cell_line; 479
DR   BioSample; SAMN03471424
DR   BioSample; SAMN03473112
DR   BioSample; SAMN03473563
DR   BioSample; SAMN10987899
DR   BioSample; SAMN10988045
DR   cancercelllines; CVCL_0041
DR   Cell_Model_Passport; SIDM01095
DR   ChEMBL-Cells; CHEMBL3308364
DR   ChEMBL-Targets; CHEMBL1075575
DR   Cosmic; 687957
DR   Cosmic; 687964
DR   Cosmic; 801758
DR   Cosmic; 909716
DR   Cosmic; 1037297
DR   Cosmic; 1048110
DR   Cosmic; 1082515
DR   Cosmic; 1097749
DR   Cosmic; 1104562
DR   Cosmic; 1108737
DR   Cosmic; 1309335
DR   Cosmic; 1509197
DR   Cosmic; 1620038
DR   Cosmic; 1718361
DR   Cosmic; 2355914
DR   Cosmic; 2820087
DR   Cosmic-CLP; 909716
DR   DepMap; ACH-000833
DR   DepMap; ACH-001189
DR   DepMap; ACH-001741
DR   DSMZ; ACC-489
DR   DSMZCellDive; ACC-489
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS504BIZ
DR   ENCODE; ENCBS516AAA
DR   ENCODE; ENCBS517AAA
DR   GDSC; 909716
DR   GEO; GSM186449
DR   GEO; GSM186450
DR   GEO; GSM186451
DR   GEO; GSM186452
DR   GEO; GSM219757
DR   GEO; GSM887573
DR   GEO; GSM888620
DR   GEO; GSM888656
DR   GEO; GSM1670425
DR   GEO; GSM1676311
DR   GEO; GSM1676315
DR   GEO; GSM1701645
DR   GEO; GSM1701649
DR   GEO; GSM7701380
DR   GEO; GSM7701381
DR   IARC_TP53; 356
DR   IARC_TP53; 24983
DR   IARC_TP53; 27704
DR   IGRhCellID; SJRH30
DR   LiGeA; CCLE_004
DR   LINCS_HMS; 50041
DR   LINCS_LDP; LCL-1408
DR   LINCS_LDP; LCL-1414
DR   PharmacoDB; RH30_1312_2019
DR   PRIDE; PXD007755
DR   PRIDE; PXD030304
DR   PRIDE; PXD039480
DR   Progenetix; CVCL_0041
DR   PubChem_Cell_line; CVCL_0041
DR   Wikidata; Q54950341
RX   PubMed=2766305;
RX   PubMed=3691179;
RX   PubMed=7536457;
RX   PubMed=8275086;
RX   PubMed=8383879;
RX   PubMed=8617485;
RX   PubMed=9802058;
RX   PubMed=11051265;
RX   PubMed=16957166;
RX   PubMed=17354236;
RX   PubMed=17471488;
RX   PubMed=19147553;
RX   PubMed=19235922;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20922763;
RX   PubMed=21948088;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=23578105;
RX   PubMed=23665679;
RX   PubMed=23828214;
RX   PubMed=23882450;
RX   PubMed=25485619;
RX   PubMed=25749379;
RX   PubMed=25806826;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31448612;
RX   PubMed=31978347;
RX   PubMed=32758582;
RX   PubMed=35760101;
RX   PubMed=35839778;
RX   PubMed=36768928;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Rhabdomyosarcoma/Rh30%20Cell%20Line%20Data%20Sheet.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 37 hours (PubMed=20922763); 35.5 +- 3.6 hours (PubMed=35760101); ~35 hours (DSMZ=ACC-489); 35 hours (COG).
CC   HLA typing: A*11:17,24:08; B*35:01,35:01; C*18:01,18:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=8275086; PubMed=17471488; PubMed=23578105; PubMed=25485619; PubMed=25806826).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Pro9Leu (c.26C>T); Zygosity=Heterozygous (Cosmic-CLP=909716; DepMap=ACH-000833).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Heterozygous (Cosmic-CLP=909716; DepMap=ACH-000833).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (PubMed=9802058; PubMed=19147553; PubMed=25749379; Cosmic-CLP=909716; DepMap=ACH-000833).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (Cosmic-CLP=909716; DepMap=ACH-000833).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.64%; Native American=0.36%; East Asian, North=1.57%; East Asian, South=0.14%; South Asian=4.15%; European, North=49.28%; European, South=41.87% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-001741; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2061; COG; Cosmic-CLP=909716; DepMap=ACH-000833; DSMZ=ACC-489; PubMed=20922763; PubMed=21948088; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X (COG)
ST   Amelogenin: X,Y (ATCC=CRL-2061; Cosmic-CLP=909716; DepMap=ACH-000833; DSMZ=ACC-489; PubMed=20922763; PubMed=21948088; PubMed=25877200; Technion Genomics Center)
ST   CSF1PO: 10,11
ST   D10S1248: 12
ST   D12S391: 20
ST   D13S317: 10,11 (PubMed=21948088)
ST   D13S317: 11 (ATCC=CRL-2061; COG; DepMap=ACH-000833; DSMZ=ACC-489; PubMed=20922763; PubMed=25877200; Technion Genomics Center)
ST   D16S539: 12
ST   D18S51: 15,16
ST   D19S433: 14,15.2 (ATCC=CRL-2061; COG; PubMed=20922763; Technion Genomics Center)
ST   D19S433: 14,16 (DSMZ=ACC-489)
ST   D1S1656: 12,16
ST   D21S11: 29,31.2 (ATCC=CRL-2061; COG; DepMap=ACH-000833; DSMZ=ACC-489; PubMed=20922763; Technion Genomics Center)
ST   D21S11: 31.2 (PubMed=25877200)
ST   D22S1045: 16,17
ST   D2S1338: 17,20
ST   D2S441: 11,14
ST   D3S1358: 15
ST   D5S818: 12,13 (ATCC=CRL-2061; COG; Cosmic-CLP=909716; DepMap=ACH-000833; PubMed=20922763; PubMed=21948088; PubMed=25877200; Technion Genomics Center)
ST   D5S818: 12,13,14 (DSMZ=ACC-489)
ST   D7S820: 10
ST   D8S1179: 12,15
ST   FGA: 22
ST   Penta D: 11 (PubMed=25877200)
ST   Penta D: 11,12 (ATCC=CRL-2061; DepMap=ACH-000833; DSMZ=ACC-489; Technion Genomics Center)
ST   Penta E: 7 (PubMed=25877200)
ST   Penta E: 7,17 (ATCC=CRL-2061; DepMap=ACH-000833; DSMZ=ACC-489; Technion Genomics Center)
ST   TH01: 9,9.3
ST   TPOX: 8,11 (ATCC=CRL-2061; COG; Cosmic-CLP=909716; DepMap=ACH-000833; DSMZ=ACC-489; PubMed=20922763; PubMed=21948088; Technion Genomics Center)
ST   TPOX: 11 (PubMed=25877200)
ST   vWA: 17,18
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   Rh30rVCR10
AC   CVCL_RR39
DR   cancercelllines; CVCL_RR39
DR   Wikidata; Q54950342
RX   PubMed=19147553;
RX   PubMed=25749379;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Pro9Leu (c.26C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (PubMed=19147553; PubMed=25749379).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0041 ! Rh30
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   Rh36
AC   CVCL_M599
SY   RH36; RH-36; Birch; BIRCH
DR   cancercelllines; CVCL_M599
DR   Cell_Model_Passport; SIDM01350
DR   Cosmic; 724814
DR   Cosmic; 802042
DR   DepMap; ACH-001751
DR   GEO; GSM186453
DR   GEO; GSM186454
DR   GEO; GSM1676312
DR   GEO; GSM1701646
DR   PRIDE; PXD007755
DR   PRIDE; PXD039480
DR   Progenetix; CVCL_M599
DR   Wikidata; Q54950343
RX   CelloPub=CLPUB00569;
RX   PubMed=10602515;
RX   PubMed=11051265;
RX   PubMed=12068308;
RX   PubMed=23882450;
RX   PubMed=26351324;
RX   PubMed=28196595;
RX   PubMed=31448612;
RX   PubMed=36768928;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Unspecified (PubMed=12068308; DepMap=ACH-001751).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Subcellular; Exosome.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 31,32
ST   D2S1338: 18
ST   D3S1358: 14,16
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 25
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 24
//
ID   Rh4
AC   CVCL_5916
AS   CVCL_L416
SY   RH4; Rh-4; SJRH-4; SJRH4; SJ-RH4; SJ-Rh 4
DR   BTO; BTO_0005381
DR   EFO; EFO_0022574
DR   cancercelllines; CVCL_5916
DR   Cell_Model_Passport; SIDM01349
DR   Cosmic; 687959
DR   Cosmic; 801756
DR   Cosmic; 1037295
DR   Cosmic; 1048108
DR   Cosmic; 1097744
DR   Cosmic; 1104559
DR   Cosmic; 1108738
DR   Cosmic; 1309336
DR   Cosmic; 2820088
DR   DepMap; ACH-001765
DR   GEO; GSM219756
DR   GEO; GSM1012758
DR   Lonza; 486
DR   PRIDE; PXD000589
DR   PRIDE; PXD039480
DR   Wikidata; Q54950344
RX   PubMed=7536457;
RX   PubMed=8275086;
RX   PubMed=9823299;
RX   PubMed=19235922;
RX   PubMed=23578105;
RX   PubMed=23665679;
RX   PubMed=23882450;
RX   PubMed=25806826;
RX   PubMed=25894527;
RX   PubMed=36768928;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=8275086; PubMed=23578105; PubMed=25806826).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2176 ! Rh41
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   RH4
AC   CVCL_C357
SY   RH 4; RH-4; EDe003-A
DR   hPSCreg; EDe003-A
DR   SKIP; SKIP001490
DR   SKIP; SKIP001903
DR   Wikidata; Q54950345
RX   PubMed=17196096;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-031, Steering comm. appl. SCSC06-16(3).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   Rh41
AC   CVCL_2176
SY   RH41; RH-41; Rh-41; SJ-Rh41
DR   CLO; CLO_0037075
DR   EFO; EFO_0022719
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473491
DR   BioSample; SAMN10988473
DR   cancercelllines; CVCL_2176
DR   Cell_Model_Passport; SIDM00426
DR   Cosmic; 1620039
DR   Cosmic; 1718364
DR   Cosmic; 1995621
DR   Cosmic; 2820089
DR   Cosmic-CLP; 1240210
DR   DepMap; ACH-000100
DR   DSMZ; ACC-592
DR   DSMZCellDive; ACC-592
DR   EGA; EGAS00001000978
DR   GDSC; 1240210
DR   GEO; GSM219748
DR   GEO; GSM887538
DR   GEO; GSM888621
DR   GEO; GSM1670378
DR   GEO; GSM1676313
DR   GEO; GSM1701647
DR   LiGeA; CCLE_645
DR   LINCS_LDP; LCL-1415
DR   PharmacoDB; RH41_1313_2019
DR   PRIDE; PXD007755
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2176
DR   Wikidata; Q54950346
RX   PubMed=11051265;
RX   PubMed=17471488;
RX   PubMed=19235922;
RX   PubMed=20922763;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=23665679;
RX   PubMed=23882450;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31448612;
RX   PubMed=31978347;
RX   PubMed=32758582;
RX   PubMed=35839778;
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Rhabdomyosarcoma/Rh41%20Cell%20Line%20Data%20Sheet.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 44 hours (PubMed=20922763); ~2-3 days (DSMZ=ACC-592); 60 hours (COG).
CC   HLA typing: A*68:01,68:01; B*14:02,40:01; C*01:04,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=17471488).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.24%; East Asian, South=0%; South Asian=0%; European, North=66.46%; European, South=32.3% (PubMed=30894373).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): COG; Cosmic-CLP=1240210; DSMZ=ACC-592; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 17,21
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 11,17
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5916 ! Rh4
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   Rh41-807R
AC   CVCL_8670
DR   Wikidata; Q54950359
RX   PubMed=20807811;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88339; BMS-754807.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2176 ! Rh41
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   Rh41-MAB391R
AC   CVCL_8751
DR   Wikidata; Q54950360
RX   PubMed=20807811;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2176 ! Rh41
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   Rh5
AC   CVCL_5917
AS   CVCL_L417
SY   RH5; Rh-5; SJRH-5; SJRH5
DR   BTO; BTO_0005382
DR   Cosmic; 687960
DR   Cosmic; 1097745
DR   Cosmic; 1108742
DR   PRIDE; PXD039480
DR   Wikidata; Q54950361
RX   PubMed=8275086;
RX   PubMed=9823299;
RX   PubMed=23665679;
RX   PubMed=36768928;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=8275086).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   RH5
AC   CVCL_C358
SY   RH 5; RH-5; EDe004-A
DR   hPSCreg; EDe004-A
DR   SKIP; SKIP001486
DR   SKIP; SKIP001904
DR   Wikidata; Q54950363
RX   PubMed=17196096;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-032, Steering comm. appl. SCSC06-16(4).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   Rh6
AC   CVCL_S639
SY   RH6
DR   Wikidata; Q54950364
RX   PubMed=23882450;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RH6
AC   CVCL_C359
SY   RH 6; RH-6; EDe005-A
DR   hPSCreg; EDe005-A
DR   SKIP; SKIP001487
DR   SKIP; SKIP001925
DR   Wikidata; Q54950365
RX   PubMed=17196096;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-033, Steering comm. appl. SCSC06-16(5).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   Rh7
AC   CVCL_Y583
SY   RH7; SJRH-7; SJRH7
DR   Cosmic; 1097746
DR   Wikidata; Q54950366
RX   PubMed=8275086;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=8275086).
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   RH7
AC   CVCL_C360
SY   RH 7; RH-7; EDe006-A
DR   hPSCreg; EDe006-A
DR   SKIP; SKIP001491
DR   SKIP; SKIP001926
DR   Wikidata; Q54950367
RX   PubMed=17196096;
CC   From: University of Edinburgh; Edinburgh; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-06-034, Steering comm. appl. SCSC06-16(6).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   RH7777 GFP-LYVE-1
AC   CVCL_C6IH
DR   Wikidata; Q116050173
RX   PubMed=30058195;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:2136348; Lyve1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0444 ! McA-RH7777
SX   Female
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   RH7777-p2y5
AC   CVCL_E5J3
RX   PubMed=19386608;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15520; LPAR6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0444 ! McA-RH7777
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RH7777-vector
AC   CVCL_E5J4
RX   PubMed=19386608;
CC   Characteristics: Control cell line for RH7777-p2y5 (Cellosaurus=CVCL_E5J3) (PubMed=19386608).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0444 ! McA-RH7777
SX   Female
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RH7777/EDG3
AC   CVCL_KA18
DR   GenScript; M00476
DR   Wikidata; Q54950368
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3167; S1PR3.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Discontinued: GenScript; M00476; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0444 ! McA-RH7777
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   RH7777/EDG4
AC   CVCL_H521
DR   GenScript; M00463
DR   Wikidata; Q54950369
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3168; LPAR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0444 ! McA-RH7777
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   RH7777/EDG6
AC   CVCL_H522
SY   McA-RH7777/EDG6
DR   GenScript; M00465
DR   Wikidata; Q54950370
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3170; S1PR4.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Discontinued: GenScript; M00465; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0444 ! McA-RH7777
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   RH7777/P2Y5
AC   CVCL_H523
SY   McA-RH7777/P2Y5
DR   GenScript; M00472
DR   Wikidata; Q54950371
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15520; LPAR6.
CC   Transformant: ChEBI; CHEBI_189414; N-2-fluorenylphthalamic acid (2-FPA).
CC   Discontinued: GenScript; M00472; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0444 ! McA-RH7777
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   RH9
AC   CVCL_U264
DR   cancercelllines; CVCL_U264
DR   Wikidata; Q54950372
RX   Patent=US5580772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12043.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1240 ! H9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   RH9/CB
AC   CVCL_U265
DR   cancercelllines; CVCL_U265
DR   IZSLER; BS TCL 164
DR   Wikidata; Q54950373
RX   Patent=US5580772;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11622.
CC   Population: Caucasian.
CC   Characteristics: Established from parent cell line by co-cultivation with peripheral blood mononuclear cells isolated from a patient with idiopathic CD4 + T lymphocitopenia (ICL). Contains human intracisternal A-type particles type II (HIAP-II) (IZSLER=BS TCL 164).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U264 ! RH9
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   RHB1
AC   CVCL_RY57
DR   cancercelllines; CVCL_RY57
DR   Wikidata; Q54950374
RX   DOI=10.25904/1912/1434;
RX   PubMed=28889351;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Gly (c.403T>G); ClinVar=VCV000376563; Zygosity=Unspecified (PubMed=28889351).
ST   Source(s): PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 31
ST   D5S818: 12,13
ST   D7S820: 7,12
ST   TH01: 9.3
ST   TPOX: 10
ST   vWA: 14
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   RHCT-138
AC   CVCL_K277
DR   ATCC; CRL-2563
DR   Wikidata; Q54950375
RX   PubMed=8627039;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
DI   NCIt; C133741; Rabbit cutaneous lymphoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 8
//
ID   RHD5
AC   CVCL_XI32
DR   Wikidata; Q98128920
RX   Patent=US8784816;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 6165CB.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00451; Human F8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   RHE-X76
AC   CVCL_S538
DR   ATCC; CRL-2562
DR   Wikidata; Q54950377
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: ATCC; CRL-2562; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C133883; Rabbit uterine carcinoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   RHEK-1
AC   CVCL_5161
DR   BTO; BTO_0004792
DR   EFO; EFO_0022425
DR   Wikidata; Q54950378
RX   DOI=10.1007/978-1-4612-0411-4_3;
RX   PubMed=2579430;
RX   PubMed=2682464;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   RHEK-1/200R
AC   CVCL_5162
DR   Wikidata; Q54950379
RX   PubMed=9078297;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5161 ! RHEK-1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   RHEK-1/400R
AC   CVCL_5163
DR   Wikidata; Q54950381
RX   PubMed=9078297;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5161 ! RHEK-1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   RHEK-1/600R
AC   CVCL_5164
DR   Wikidata; Q54950382
RX   PubMed=9078297;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5161 ! RHEK-1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   RHEK-1/800R
AC   CVCL_5165
DR   Wikidata; Q54950383
RX   PubMed=9078297;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5161 ! RHEK-1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   RHEK-1/ras
AC   CVCL_IP79
SY   RHEK-1 pSV2 ras
DR   Wikidata; Q54950384
RX   DOI=10.1007/978-1-4612-0411-4_3;
RX   PubMed=2682464;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5161 ! RHEK-1
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   RHF14
AC   CVCL_9Q59
SY   RHF 14
DR   ATCC; CRL-2792
DR   Wikidata; Q54950385
CC   Discontinued: ATCC; CRL-2792; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9116 ! NIH 3T3-TK-
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   RHF407
AC   CVCL_9Q60
SY   RHF 407
DR   ATCC; CRL-2791
DR   Wikidata; Q54950386
RX   PubMed=8502470;
CC   Discontinued: ATCC; CRL-2791; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9116 ! NIH 3T3-TK-
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   rhfs1
AC   CVCL_C8IR
SY   rhfs-1; rhesus foreskin 1
DR   Wikidata; Q123033350
RX   PubMed=4348467;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   150-160FD
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   rhfs2
AC   CVCL_C8IS
SY   rhfs-2; rhesus foreskin 2
DR   Wikidata; Q123033353
RX   PubMed=4348467;
RX   PubMed=4626796;
CC   Group: Non-human primate cell line.
CC   Virology: Susceptible to infection by a wide range of human and simian viruses (PubMed=4348467).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   150-160FD
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   rhfs3
AC   CVCL_C8J0
SY   rhsf-3; rhesus foreskin 3
DR   Wikidata; Q123033354
RX   PubMed=4348467;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   150-160FD
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RhiBrain/4p
AC   CVCL_RX63
SY   RhiBrain-4p
DR   Wikidata; Q54950389
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=249024; ! Rhinolophus alcyone (Halcyon horseshoe bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   RhiEuLu
AC   CVCL_RX62
DR   Wikidata; Q54950390
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=109476; ! Rhinolophus euryale (Mediterranean horsehoe bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   RhiFeLu
AC   CVCL_RX65
DR   Wikidata; Q54950391
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=59479; ! Rhinolophus ferrumequinum (Greater horseshoe bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   Rhileki
AC   CVCL_C1G5
SY   R101Ki 7A1; Rhinolophus lepidus kidney
DR   ABM; T0177
DR   Wikidata; Q114312784
RX   PubMed=35638834;
RX   PubMed=37199653;
CC   Group: Bat cell line.
CC   Virology: Susceptible to infection by human coronavirus 229E (HCoV-229E) (PubMed=37199653).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=35638834).
CC   Doubling time: 38 hours (Note=At post-thawing with increasing time with passaging) (Direct_author_submission).
CC   Miscellaneous: Age/sex of donor and doubling time from personal communication of Smith, Gavin James D.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=188570; ! Rhinolophus lepidus (Blyth's horseshoe bat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   RhiLu/1.1
AC   CVCL_RX22
SY   RhiLu-1.1; RhiLu1.1; RhiLu
DR   Wikidata; Q54950392
RX   CelloPub=CLPUB00422;
RX   PubMed=23232719;
RX   PubMed=24023659;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=519039; ! Rhinolophus landeri (Lander's horseshoe bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   RhiNi/1.2
AC   CVCL_RX64
SY   RhiNi1.2; RhiNi/40.1
DR   Wikidata; Q54950393
RX   CelloPub=CLPUB00422;
RX   PubMed=32094589;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=249024; ! Rhinolophus alcyone (Halcyon horseshoe bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   RhJT
AC   CVCL_VU81
SY   RHJT; RH-JT
DR   cancercelllines; CVCL_VU81
DR   Cell_Model_Passport; SIDM01348
DR   DepMap; ACH-001745
DR   Wikidata; Q98128921
RX   PubMed=8383879;
RX   PubMed=22541669;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Houghton, Peter J.; King's College London; London; United Kingdom.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   RhMK
AC   CVCL_U238
SY   RHMK; Rhesus Macaque Kidney
DR   ATCC; CRL-6317
DR   Wikidata; Q54950396
CC   Group: Non-human primate cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6317; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   RHO
AC   CVCL_F405
DR   CLO; CLO_0051142
DR   RCB; HSC0013
DR   Wikidata; Q54950397
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   RhRKM-P4
AC   CVCL_Y585
SY   RHRKMP-4; RHRKMP4
DR   Wikidata; Q54950394
RX   PubMed=11306473;
RX   PubMed=12239174;
RX   PubMed=23665679;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   RhRKM-T4
AC   CVCL_Y586
DR   Wikidata; Q54950395
RX   PubMed=11306473;
CC   Characteristics: Established from parent cell line after a passage in the peritoneal cavity of an athymic nude mouse.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y585 ! RhRKM-P4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   RHT-16
AC   CVCL_S539
SY   RHT16
DR   BEI_Resources; ARP-340
DR   Wikidata; Q54950398
RX   PubMed=1518821;
RX   PubMed=8376938;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 13
//
ID   rHypoE-1
AC   CVCL_X989
DR   Wikidata; Q54950399
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-10
AC   CVCL_X999
DR   Wikidata; Q54950400
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-11
AC   CVCL_D489
SY   R11
DR   Wikidata; Q54950401
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU205; https://www.cedarlanelabs.com/Products/Detail/CLU205?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-12
AC   CVCL_X990
DR   Wikidata; Q54950402
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-13
AC   CVCL_D490
SY   R13
DR   Wikidata; Q54950409
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU206; https://www.cedarlanelabs.com/Products/Detail/CLU206?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-14
AC   CVCL_X991
DR   Wikidata; Q54950410
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-15
AC   CVCL_D491
SY   R15
DR   Wikidata; Q54950411
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU207; https://www.cedarlanelabs.com/Products/Detail/CLU207?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-16
AC   CVCL_D492
SY   R16
DR   Wikidata; Q54950412
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU208.
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   rHypoE-17
AC   CVCL_X992
DR   Wikidata; Q54950413
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-18
AC   CVCL_D493
SY   R18
DR   Wikidata; Q54950414
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU209; https://www.cedarlanelabs.com/Products/Detail/CLU209?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-19
AC   CVCL_D494
SY   R19
DR   Wikidata; Q54950415
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU210; https://www.cedarlanelabs.com/Products/Detail/CLU210?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-2
AC   CVCL_X993
DR   Wikidata; Q54950417
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-20
AC   CVCL_D495
SY   R20
DR   Wikidata; Q54950418
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU211; https://www.cedarlanelabs.com/Products/Detail/CLU211?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-21
AC   CVCL_D496
SY   R21
DR   Wikidata; Q54950419
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU212; https://www.cedarlanelabs.com/Products/Detail/CLU212?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-22
AC   CVCL_D497
SY   R22
DR   BTO; BTO_0006066
DR   Wikidata; Q54950420
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU213; https://www.cedarlanelabs.com/Products/Detail/CLU213?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-23
AC   CVCL_D498
SY   R23
DR   Wikidata; Q54950421
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU214.
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   rHypoE-24
AC   CVCL_D499
SY   R24
DR   Wikidata; Q54950422
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU215; https://www.cedarlanelabs.com/Products/Detail/CLU215?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-25
AC   CVCL_D500
SY   R25
DR   Wikidata; Q54950423
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU216; https://www.cedarlanelabs.com/Products/Detail/CLU216?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-26
AC   CVCL_X994
DR   Wikidata; Q54950425
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-27
AC   CVCL_D501
SY   R27
DR   Wikidata; Q54950426
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU217; https://www.cedarlanelabs.com/Products/Detail/CLU217?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-28
AC   CVCL_D502
SY   R28
DR   Wikidata; Q54950427
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU218.
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   rHypoE-29
AC   CVCL_D503
SY   R29
DR   Wikidata; Q54950428
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU219; https://www.cedarlanelabs.com/Products/Detail/CLU219?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-3
AC   CVCL_X995
DR   Wikidata; Q54950430
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-30
AC   CVCL_D504
SY   R30
DR   Wikidata; Q54950431
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU220; https://www.cedarlanelabs.com/Products/Detail/CLU220?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-31
AC   CVCL_D505
SY   R31
DR   Wikidata; Q54950433
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU221; https://www.cedarlanelabs.com/Products/Detail/CLU221?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-32
AC   CVCL_X998
DR   Wikidata; Q54950434
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-33
AC   CVCL_D506
SY   R33
DR   Wikidata; Q54950435
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU222; https://www.cedarlanelabs.com/Products/Detail/CLU222?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-4
AC   CVCL_X996
DR   Wikidata; Q54950436
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-5
AC   CVCL_X997
DR   Wikidata; Q54950437
RX   PubMed=19463905;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 13
//
ID   rHypoE-6
AC   CVCL_D507
SY   R6
DR   Wikidata; Q54950438
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU201; https://www.cedarlanelabs.com/Products/Detail/CLU201?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-7
AC   CVCL_D508
SY   R7
DR   Wikidata; Q54950439
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU202; https://www.cedarlanelabs.com/Products/Detail/CLU202?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-8
AC   CVCL_D509
SY   R8
DR   Wikidata; Q54950440
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU203; https://www.cedarlanelabs.com/Products/Detail/CLU203?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   rHypoE-9
AC   CVCL_D510
SY   R9
DR   Wikidata; Q54950441
RX   PubMed=19463905;
WW   Provider; Cedarlane; CLU204; https://www.cedarlanelabs.com/Products/Detail/CLU204?lob=AllProducts
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic brain, hypothalamus; UBERON=UBERON_0006238+UBERON_0001898.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   Ri-1
AC   CVCL_1885
AS   CVCL_H211
SY   RI-1; RI1; RIVA; Riva
DR   CLO; CLO_0008814
DR   EFO; EFO_0006477
DR   CLDB; cl5090
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03472482
DR   BioSample; SAMN10988505
DR   cancercelllines; CVCL_1885
DR   Cell_Model_Passport; SIDM01858
DR   Cosmic; 919144
DR   Cosmic; 1086342
DR   Cosmic; 1517635
DR   Cosmic; 2297018
DR   Cosmic; 2437312
DR   DepMap; ACH-000398
DR   DSMZ; ACC-585
DR   DSMZCellDive; ACC-585
DR   ECACC; 96090512
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM119557
DR   GEO; GSM887539
DR   GEO; GSM888622
DR   GEO; GSM907521
DR   GEO; GSM1035305
DR   GEO; GSM1374849
DR   IARC_TP53; 28266
DR   LiGeA; CCLE_317
DR   PharmacoDB; RI1_1314_2019
DR   Progenetix; CVCL_1885
DR   Wikidata; Q54950442
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3098690;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=8558920;
RX   PubMed=9510473;
RX   PubMed=16960149;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31395879;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~48-72 hours (DSMZ=ACC-585).
CC   HLA typing: A*02:01,03:01; B*44:02,47:01; C*05:01,06:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,02:01:01; B*44:02:01,47:01:01; C*05:01:01,06:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQB1*06:03:01,06:03:01; DRA*01:02:02,01:02:02 (DSMZCellDive=ACC-585).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Heterozygous (DepMap=ACH-000398).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Heterozygous (DepMap=ACH-000398).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.88%; Native American=0%; East Asian, North=3.34%; East Asian, South=0%; South Asian=0%; European, North=45.33%; European, South=47.45% (PubMed=30894373).
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, lymphocytic type.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-585; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,13
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 11,12
ST   Penta E: 7,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   RI-T
AC   CVCL_6722
DR   JCRB; JCRB1088
DR   JCRB; NIHS0361
DR   Wikidata; Q54950443
RX   DOI=10.1016/S1386-6346(99)00010-8;
RX   PubMed=10475269;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Discontinued: JCRB; NIHS0361; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   RIAM
AC   CVCL_WH34
DR   Wikidata; Q98128922
RX   PubMed=30268330;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   Ric Mil
AC   CVCL_0F67
DR   ATCC; CRL-1125
DR   Wikidata; Q54950444
CC   Discontinued: ATCC; CRL-1125; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 8
//
ID   RIC-2
AC   CVCL_S922
DR   Wikidata; Q54950445
RX   PubMed=8039117;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   RicR14
AC   CVCL_HA83
SY   RicR 14
DR   Wikidata; Q54950446
RX   PubMed=1161015;
RX   PubMed=1275903;
RX   PubMed=6292449;
RX   PubMed=6456144;
RX   PubMed=7084475;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   RicR15
AC   CVCL_HA84
SY   RicR 15
DR   Wikidata; Q54950447
RX   PubMed=1161015;
RX   PubMed=1275903;
RX   PubMed=6456144;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   RicR17
AC   CVCL_HA85
SY   RicR 17
DR   Wikidata; Q54950448
RX   PubMed=1161015;
RX   PubMed=1275903;
RX   PubMed=6456144;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   RicR19
AC   CVCL_HA86
SY   RicR 19
DR   Wikidata; Q54950449
RX   PubMed=1161015;
RX   PubMed=1275903;
RX   PubMed=6456144;
RX   PubMed=7084475;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   RicR21
AC   CVCL_HA87
SY   RicR 21
DR   Wikidata; Q54950450
RX   PubMed=1161015;
RX   PubMed=1275903;
RX   PubMed=6456144;
RX   PubMed=7084475;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   RicR7
AC   CVCL_HA88
SY   RicR 7
DR   Wikidata; Q54950453
RX   PubMed=1161015;
RX   PubMed=1275903;
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   Rid Mor
AC   CVCL_X706
SY   CRL 1220; Normal 1220
DR   ATCC; CRL-1220
DR   Wikidata; Q54950454
RX   PubMed=420857;
RX   PubMed=450131;
RX   PubMed=503099;
RX   PubMed=3762576;
RX   PubMed=6458814;
RX   PubMed=6726265;
RX   PubMed=7301938;
RX   PubMed=22282976;
CC   Discontinued: ATCC; CRL-1220; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 11
//
ID   RIE-1
AC   CVCL_6723
SY   RIE1; Rat Intestinal Epithelioid-1
DR   BTO; BTO_0004203
DR   Wikidata; Q54950462
RX   PubMed=6204784;
CC   Doubling time: 40 hours (Note=At 8th passage), 30 hours (Note=At 17th passage) (PubMed=6204784).
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   RIF-1
AC   CVCL_H611
SY   Radiation-Induced Fibrosarcoma-1; RIF/Pts1; RIF platinum-sensitive line 1; Pts
DR   ChEMBL-Cells; CHEMBL3307730
DR   ChEMBL-Targets; CHEMBL614878
DR   PubChem_Cell_line; CVCL_H611
DR   Wikidata; Q54950463
RX   PubMed=6928244;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H/Km.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   RIF/Ptr1
AC   CVCL_H612
SY   RIF/platinum-resistant subline 1; Ptr1
DR   Wikidata; Q54950464
RX   PubMed=2713851;
RX   PubMed=21552886;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: C3H/Km.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H611 ! RIF-1
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 8
//
ID   RIG-I(-/-) 293T
AC   CVCL_ZU61
DR   Wikidata; Q98128923
RX   PubMed=32072786;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   RIi002-A-1
AC   CVCL_C1W1
DR   BioSamples; SAMEA13928828
DR   hPSCreg; RIi002-A-1
DR   Wikidata; Q114312785
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Unexplicit_edited; Ex2del; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=RIi002-A-1).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C438 ! BOM1-hiPSC1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   RIIIMT
AC   CVCL_3582
DR   CLO; CLO_0008815
DR   ATCC; CRL-6449
DR   Wikidata; Q54950465
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6449; true.
CC   Breed/subspecies: RIII.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   RIL-175
AC   CVCL_B7TK
SY   RIL175
DR   Wikidata; Q114312786
RX   DOI=10.5282/edoc.26548;
RX   PubMed=23796475;
RX   PubMed=32652772;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   RIL-175-GM-CSF
AC   CVCL_B7TL
DR   Wikidata; Q114312787
RX   PubMed=23796475;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1339752; Csf2.
CC   Caution: We are not certain that the Csf2 gene is from mouse or from human as the paper does not mention the source of the construct.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7TK ! RIL-175
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   RIL-175-KC
AC   CVCL_B7TM
DR   Wikidata; Q114312788
RX   PubMed=23796475;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:108068; Cxcl1.
CC   Caution: We are not certain that the Cxcl1 gene is from mouse or from human as the paper does not mention the source of the construct.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7TK ! RIL-175
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   RIL175-R
AC   CVCL_B7TN
DR   Wikidata; Q114312789
RX   DOI=10.5282/edoc.26548;
RX   PubMed=32652772;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7TK ! RIL-175
SX   Sex unspecified
AG   Embryo
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   RIM9
AC   CVCL_B6KW
DR   Wikidata; Q112044498
RX   Patent=RU2402605;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 722D.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07498; Human CASK (Note=AA 57-134 = Lactapin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   RiMi1
AC   CVCL_V176
DR   Wikidata; Q54950466
RX   CelloPub=CLPUB00798;
WW   Provider; BNLC; -; https://www.isciii.es/documents/d/guest/proyectos-aprobados-lineas-generadas-2004-2012
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   Characteristics: Established from parthenogenetically activated oocytes (CelloPub=CLPUB00798).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   RIMVEC-11
AC   CVCL_C0WT
SY   Rat Intestinal MicroVascular Endothelial Cell line-11
DR   Wikidata; Q114312790
RX   PubMed=34116500;
CC   Doubling time: 19.76 hours (PubMed=34116500).
CC   Derived from site: In situ; Intestine, microvascular endothelium; UBERON=UBERON_0000160+UBERON_0008339.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   5D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RIN 100/1
AC   CVCL_C1KE
DR   Wikidata; Q114312791
RX   PubMed=8157682;
CC   Characteristics: Transfected with Slc2a2 at high (100) passage.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U435 ! RIN 1046-38
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   RIN 100/2
AC   CVCL_C1KF
DR   Wikidata; Q114312792
RX   PubMed=8157682;
CC   Characteristics: Transfected with Slc2a2 at high (100) passage.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U435 ! RIN 1046-38
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   RIN 100/6
AC   CVCL_C1KG
DR   Wikidata; Q114312793
RX   PubMed=8157682;
CC   Characteristics: Transfected with Slc2a2 at high (100) passage.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U435 ! RIN 1046-38
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   RIN 1027-B2
AC   CVCL_U434
SY   RIN-1027-B2; RIN 1027 B2; Rin 1027-B2; RIN1027-B2; 1027-B2
DR   Wikidata; Q54950467
RX   PubMed=2879852;
RX   PubMed=10417352;
CC   Characteristics: Secretes somatostatin (PubMed=2879852).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D163 ! RIN-r
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   RIN 1046-38
AC   CVCL_U435
SY   RIN-1046-38; RIN1046-38; RINr1046-38; 1046-38; RIN-38; RIN 38
DR   Wikidata; Q54950468
RX   PubMed=1505450;
RX   PubMed=1701127;
RX   PubMed=2284010;
RX   PubMed=2879852;
RX   PubMed=8157682;
RX   PubMed=9166666;
RX   PubMed=9166667;
RX   PubMed=9549052;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-102.html
CC   Characteristics: Secretes insulin (PubMed=1701127; PubMed=2879852).
CC   Characteristics: Loses glucose responsiveness as well as GLUT2 and glucokinase expression with time in culture (PubMed=1701127; PubMed=8157682).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D163 ! RIN-r
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   RIN 1046-43
AC   CVCL_A7QF
SY   1046-43
DR   Wikidata; Q107116739
RX   PubMed=2284010;
RX   PubMed=2879852;
CC   Characteristics: Secretes insulin and somatostatin (PubMed=2879852).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D163 ! RIN-r
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   RIN 1046-44
AC   CVCL_A7QE
SY   1046-44
DR   Wikidata; Q107116741
RX   PubMed=1505450;
RX   PubMed=2284010;
RX   PubMed=2879852;
CC   Characteristics: Does not secrete glucagon, nor insulin, nor somatostatin (PubMed=2879852).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D163 ! RIN-r
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   RIN 1056A
AC   CVCL_U436
SY   RIN 1056a; RIN1056A; 1056-A; 1056A
DR   Wikidata; Q54950469
RX   PubMed=2879852;
CC   Characteristics: Secretes glucagon, insulin and somatostatin (PubMed=2879852).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U434 ! RIN 1027-B2
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   RIN 30/10
AC   CVCL_C1KH
DR   Wikidata; Q114312794
RX   PubMed=8157682;
CC   Characteristics: Transfected with Slc2a2 at intermediate (30) passage.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U435 ! RIN 1046-38
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   RIN 30/7
AC   CVCL_C1KI
DR   Wikidata; Q114312795
RX   PubMed=8157682;
CC   Characteristics: Transfected with Slc2a2 at intermediate (30) passage.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3705; Slc2a2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U435 ! RIN 1046-38
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   RIN-14B
AC   CVCL_3583
SY   Rin-14B; RIN14B; Rin14B; RIN-m 14B; RIN-m clone 14B; 14B
DR   CLO; CLO_0008816
DR   AddexBio; C0018020/5022
DR   ATCC; CRL-2059
DR   Wikidata; Q54950470
RX   PubMed=1847683;
RX   PubMed=6141566;
RX   PubMed=6295859;
RX   PubMed=9271225;
CC   Characteristics: Produces somatostatin and aromatic-L-amino-acid decarboxylase (DDC). Secretes insulin but at lower level than the parent cell line (PubMed=6141566; PubMed=6295859).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic delta cell; CL=CL_0000173.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3584 ! RIN-m
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   RIN-5AH
AC   CVCL_0500
SY   RINm5F clone 5AH; RIN-m5AH; RINm5AH; RIN 5AH; RIN5AH; 5AH
DR   MCCL; MCC:0000397
DR   KCB; KCB 2012034YJ
DR   Wikidata; Q54950471
RX   PubMed=2550270;
RX   PubMed=2982576;
RX   PubMed=6295859;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   RIN-5AH-T2
AC   CVCL_A7QG
SY   RINm5AH-T2
DR   Wikidata; Q107116742
RX   PubMed=2550270;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0500 ! RIN-5AH
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RIN-5AH-T2B
AC   CVCL_0502
SY   RIN5AHT2B; RIN-5AHT2B; RIN-5AH-T2-B; RIN-5AH-T2 B; RINm5AH-T2-B
DR   MCCL; MCC:0000399
DR   Wikidata; Q54950472
RX   PubMed=2550270;
RX   PubMed=2674691;
CC   Characteristics: Secretes more insulin than the RIN-5AH cell line.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A7QG ! RIN-5AH-T2
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   RIN-5F-Bcl-2
AC   CVCL_5T79
DR   Wikidata; Q54950474
RX   DOI=10.1016/j.bej.2003.09.013;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   RIN-5F-CrmA
AC   CVCL_5T80
DR   Wikidata; Q54950476
RX   DOI=10.1016/j.bej.2003.09.013;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P07385; Cowpox virus crmA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   RIN-A12
AC   CVCL_D164
SY   RINm5F-A12; RIN A12; Rin A12; A12
DR   Wikidata; Q54950477
RX   PubMed=2090331;
RX   PubMed=2156672;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   RIN-A13
AC   CVCL_D165
SY   A13
DR   Wikidata; Q54950479
RX   PubMed=2090331;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   RIN-AhGh
AC   CVCL_A7QC
SY   AhGh
DR   Wikidata; Q107116743
RX   PubMed=2090331;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RIN-AhLh
AC   CVCL_A7QD
SY   AhLh
DR   Wikidata; Q107116744
RX   PubMed=2090331;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0501 ! RIN-m5F
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RIN-m
AC   CVCL_3584
SY   RINm
DR   CLO; CLO_0008818
DR   EFO; EFO_0022764
DR   CLDB; cl4151
DR   ATCC; CRL-2057
DR   ECACC; 95071701
DR   Wikidata; Q54950480
RX   PubMed=6106192;
RX   PubMed=6129963;
RX   PubMed=6141566;
RX   PubMed=6295859;
RX   PubMed=8697299;
RX   PubMed=8806089;
RX   PubMed=22538498;
CC   Characteristics: Established from the transplantable insulinoma RIN.
CC   Characteristics: Secretes insulin and somatostatin (PubMed=6106192; PubMed=6141566).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0352 ! INS-1
OI   CVCL_J993 ! INS-2
OI   CVCL_D163 ! RIN-r
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   RIN-m5F
AC   CVCL_0501
AS   CVCL_2177
SY   RIN m5F; Rin-M-5F; Rin-m-5F; RIN-m 5F; RINm-5F; RINm5F; RIN-m clone 5F; RIN Cl-5F; RIN-5F; Rin-5F; RIN 5F; RIN5F; m5F; 5F
DR   BTO; BTO_0001185
DR   CLO; CLO_0008817
DR   CLO; CLO_0008819
DR   MCCL; MCC:0000398
DR   CLDB; cl4150
DR   ATCC; CRL-2058
DR   ATCC; CRL-11605
DR   BCRC; 60410
DR   CCRID; 1101RAT-PUMC000386
DR   CCRID; 4201RAT-CCTCC00223
DR   CCTCC; GDC0223
DR   ECACC; 95090402
DR   IBRC; C10101
DR   Lonza; 1056
DR   NCBI_Iran; C526
DR   Wikidata; Q54950473
RX   DOI=10.1016/j.bej.2003.09.013;
RX   PubMed=2090331;
RX   PubMed=2156672;
RX   PubMed=2550270;
RX   PubMed=2569024;
RX   PubMed=2997172;
RX   PubMed=3902821;
RX   PubMed=6129963;
RX   PubMed=6141566;
RX   PubMed=6295859;
RX   PubMed=8697299;
RX   PubMed=10417352;
RX   PubMed=22538498;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=RINm5F
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11605.
CC   Characteristics: Secretes mainly insulin and little somatostatin (PubMed=6141566; PubMed=6295859).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3584 ! RIN-m
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   RIN-r
AC   CVCL_D163
SY   RINr
DR   Wikidata; Q54950483
RX   PubMed=6106192;
RX   PubMed=8697299;
RX   PubMed=22538498;
CC   Characteristics: Established from the transplantable insulinoma RIN.
CC   Characteristics: Secretes insulin and somatostatin (PubMed=6106192).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121566; Rat insulinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0352 ! INS-1
OI   CVCL_J993 ! INS-2
OI   CVCL_3584 ! RIN-m
SX   Male
AG   666D
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   RION
AC   CVCL_WH35
DR   Wikidata; Q98128924
RX   PubMed=30268330;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   riPSC05
AC   CVCL_C8D3
DR   Wikidata; Q123033355
RX   PubMed=37976652;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   100FD
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 02-05-24; Version: 3
//
ID   RIRI-BR1
AC   CVCL_Z331
SY   Research Institute of Resource Insects-Blaps Rhynchoptera 1
DR   Wikidata; Q29579505
RX   PubMed=25278088;
CC   Group: Insect cell line.
CC   Doubling time: 79.5 hours (PubMed=25278088).
OX   NCBI_TaxID=1379410; ! Blaps rhynchoptera (Churchyard beetle)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   RIRI-GG1
AC   CVCL_VM10
SY   Research Institute of Resource Insects-Gampsocleis Gratiosa 1
DR   Wikidata; Q98128925
RX   Patent=CN102776149A;
RX   PubMed=21424241;
CC   Group: Insect cell line.
CC   Doubling time: ~122.1 hours (PubMed=21424241).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=420844; ! Gampsocleis gratiosa (Chinese bush-cricket)
SX   Sex unspecified
AG   Embryo 5-7D
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   RIRI-GG2
AC   CVCL_C0W9
SY   Research Institute of Resource Insects-Gampsocleis Gratiosa 2
DR   Wikidata; Q114312796
RX   Patent=CN102776149A;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=420844; ! Gampsocleis gratiosa (Chinese bush-cricket)
SX   Sex unspecified
AG   Embryo 5-7D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   RIRI-GG3
AC   CVCL_C0WA
SY   Research Institute of Resource Insects-Gampsocleis Gratiosa 3
DR   Wikidata; Q114312797
RX   Patent=CN102776149A;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=420844; ! Gampsocleis gratiosa (Chinese bush-cricket)
SX   Sex unspecified
AG   Embryo 5-7D
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   RIRI-PA1
AC   CVCL_VM09
SY   Research Institute of Resource Insects-Periplaneta Americana 1
DR   Wikidata; Q98128926
RX   PubMed=29313222;
RX   PubMed=35460045;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Autographa californica nuclear polyhedrosis virus (AcMNPV) (PubMed=35460045).
CC   Doubling time: ~84.8 hours (Note=At 40th passage) (PubMed=29313222).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6978; ! Periplaneta americana (American cockroach)
SX   Sex unspecified
AG   Embryo 20D
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   RIRI-PaDe
AC   CVCL_9U46
SY   Research Institute of Resource Insects-Papilio Demoleus
DR   Wikidata; Q54950485
RX   PubMed=23299317;
CC   Group: Insect cell line.
CC   Doubling time: 55 hours (PubMed=23299317).
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 6
//
ID   RIRI-PaDe-1
AC   CVCL_IM32
SY   Research Institute of Resource Insects-Papilio Demoleus-1
DR   Wikidata; Q54950486
RX   DOI=10.16380/j.kcxb.2015.08.002;
RX   PubMed=29368143;
RX   PubMed=32737835;
CC   Group: Insect cell line.
CC   Doubling time: 69.77 hours (DOI=10.16380/j.kcxb.2015.08.002).
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   RIRI-PaDe-1-C1
AC   CVCL_A9S3
SY   Research Institute of Resource Insects-Papilio Demoleus-1-Clone 1
DR   Wikidata; Q102114805
RX   PubMed=32737835;
CC   Group: Insect cell line.
CC   Characteristics: Can be adapted to growth in serum-free culture conditions.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM32 ! RIRI-PaDe-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   RIRI-PaDe-1-C2
AC   CVCL_A9S4
SY   Research Institute of Resource Insects-Papilio Demoleus-1-Clone 2
DR   Wikidata; Q102114807
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM32 ! RIRI-PaDe-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-1-C3
AC   CVCL_A9S5
SY   Research Institute of Resource Insects-Papilio Demoleus-1-Clone 3
DR   Wikidata; Q102114809
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM32 ! RIRI-PaDe-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-1-C4
AC   CVCL_A9S6
SY   Research Institute of Resource Insects-Papilio Demoleus-1-Clone 4
DR   Wikidata; Q102114810
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM32 ! RIRI-PaDe-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-1-C5
AC   CVCL_A9S7
SY   Research Institute of Resource Insects-Papilio Demoleus-1-Clone 5
DR   Wikidata; Q102114811
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM32 ! RIRI-PaDe-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-1-C6
AC   CVCL_A9S8
SY   Research Institute of Resource Insects-Papilio Demoleus-1-Clone 6
DR   Wikidata; Q102114812
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM32 ! RIRI-PaDe-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-2
AC   CVCL_IM33
SY   Research Institute of Resource Insects-Papilio Demoleus-2
DR   Wikidata; Q54950487
RX   DOI=10.16380/j.kcxb.2015.08.002;
RX   PubMed=29368143;
RX   PubMed=32737835;
CC   Group: Insect cell line.
CC   Doubling time: 67.42 hours (DOI=10.16380/j.kcxb.2015.08.002).
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   RIRI-PaDe-2-C18
AC   CVCL_A9SD
SY   Research Institute of Resource Insects-Papilio Demoleus-2-Clone 18
DR   Wikidata; Q102114813
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM33 ! RIRI-PaDe-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-2-C19
AC   CVCL_A9SE
SY   Research Institute of Resource Insects-Papilio Demoleus-2-Clone 19
DR   Wikidata; Q102114815
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM33 ! RIRI-PaDe-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-2-C5
AC   CVCL_A9S9
SY   Research Institute of Resource Insects-Papilio Demoleus-2-Clone 5
DR   Wikidata; Q102114816
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM33 ! RIRI-PaDe-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-2-C6
AC   CVCL_A9SA
SY   Research Institute of Resource Insects-Papilio Demoleus-2-Clone 6
DR   Wikidata; Q102114817
RX   PubMed=32737835;
CC   Group: Insect cell line.
CC   Characteristics: Can be adapted to growth in serum-free culture conditions.
CC   Doubling time: 66.92 hours (Note=Before serum-free medium adaptation), 87.59 hours (Note=In serum-free medium) (PubMed=32737835).
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM33 ! RIRI-PaDe-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   RIRI-PaDe-2-C7
AC   CVCL_A9SB
SY   Research Institute of Resource Insects-Papilio Demoleus-2-Clone 7
DR   Wikidata; Q102114818
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM33 ! RIRI-PaDe-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-2-C8
AC   CVCL_A9SC
SY   Research Institute of Resource Insects-Papilio Demoleus-2-Clone 8
DR   Wikidata; Q102114819
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM33 ! RIRI-PaDe-2
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3
AC   CVCL_IM34
SY   Research Institute of Resource Insects-Papilio Demoleus-3
DR   Wikidata; Q54950488
RX   DOI=10.16380/j.kcxb.2015.08.002;
RX   PubMed=29368143;
RX   PubMed=29633063;
RX   PubMed=32737835;
CC   Group: Insect cell line.
CC   Doubling time: 81.48 hours (DOI=10.16380/j.kcxb.2015.08.002).
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 7
//
ID   RIRI-PaDe-3-C15
AC   CVCL_VF71
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 15
DR   Wikidata; Q54950489
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C26
AC   CVCL_VF72
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 26
DR   Wikidata; Q54950490
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C27
AC   CVCL_VF73
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 27
DR   Wikidata; Q54950491
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C28
AC   CVCL_VF74
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 28
DR   Wikidata; Q54950492
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C30
AC   CVCL_VF75
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 30
DR   Wikidata; Q54950493
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C31
AC   CVCL_VF76
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 31
DR   Wikidata; Q54950494
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C4
AC   CVCL_VF77
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 4
DR   Wikidata; Q54950495
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C41
AC   CVCL_VF78
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 41
DR   Wikidata; Q54950497
RX   PubMed=29633063;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C42
AC   CVCL_A9SG
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 42
DR   Wikidata; Q102114821
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C47
AC   CVCL_A9SH
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 47
DR   Wikidata; Q102114824
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C48
AC   CVCL_A9SI
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 48
DR   Wikidata; Q102114827
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C52
AC   CVCL_A9SJ
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 52
DR   Wikidata; Q102114829
RX   PubMed=32737835;
CC   Group: Insect cell line.
CC   Characteristics: Can be adapted to growth in serum-free culture conditions.
CC   Doubling time: 75.79 hours (Note=Before serum-free medium adaptation), 108.34 hours (Note=In serum-free Ex-Cell 405 medium), 38.22 hours (Note=In serum-free Express Five SFM medium) (PubMed=32737835).
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   RIRI-PaDe-3-C53
AC   CVCL_A9SK
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 53
DR   Wikidata; Q102114830
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PaDe-3-C8
AC   CVCL_VF79
SY   Research Institute of Resource Insects-Papilio Demoleus-3-Clone 8
DR   Wikidata; Q54950498
RX   PubMed=29633063;
RX   PubMed=32737835;
CC   Group: Insect cell line.
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
HI   CVCL_IM34 ! RIRI-PaDe-3
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   RIRI-PaDe-4
AC   CVCL_IM42
SY   Research Institute of Resource Insects-Papilio Demoleus-4
DR   Wikidata; Q54950499
RX   DOI=10.16380/j.kcxb.2015.08.002;
RX   PubMed=29368143;
CC   Group: Insect cell line.
CC   Doubling time: 65.43 hours (DOI=10.16380/j.kcxb.2015.08.002).
OX   NCBI_TaxID=76202; ! Papilio demoleus (Citrus swallowtail butterfly)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 5
//
ID   RIRI-PX1
AC   CVCL_Z962
SY   Research Institute of Resource Insects-Papilio Xuthus 1
DR   ICLDB; riri-px1
DR   Wikidata; Q54950500
RX   DOI=10.16380/j.kcxb.2019.03.004;
RX   Patent=CN102776149A;
RX   PubMed=22386749;
RX   PubMed=35653076;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Autographa californica nuclear polyhedrosis virus (AcMNPV) (DOI=10.16380/j.kcxb.2019.03.004).
CC   Doubling time: 42.5 hours (Note=At 50th passage), 42.1 hours (Note=At 60th passage) (PubMed=22386749).
OX   NCBI_TaxID=66420; ! Papilio xuthus (Asian swallowtail butterfly)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   RIRI-PX1-C24
AC   CVCL_C0W7
SY   Research Institute of Resource Insects-Papilio Xuthus 1-Clone 24
DR   Wikidata; Q114312798
RX   DOI=10.16380/j.kcxb.2019.03.004;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Autographa californica nuclear polyhedrosis virus (AcMNPV) (DOI=10.16380/j.kcxb.2019.03.004).
OX   NCBI_TaxID=66420; ! Papilio xuthus (Asian swallowtail butterfly)
HI   CVCL_Z962 ! RIRI-PX1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   RIRI-PX1-C31
AC   CVCL_C0W8
SY   Research Institute of Resource Insects-Papilio Xuthus 1-Clone 31
DR   Wikidata; Q114312799
RX   PubMed=35653076;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Autographa californica nuclear polyhedrosis virus (AcMNPV) (PubMed=35653076).
OX   NCBI_TaxID=66420; ! Papilio xuthus (Asian swallowtail butterfly)
HI   CVCL_Z962 ! RIRI-PX1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   RIT-1b
AC   CVCL_A8US
SY   RIT 1b; Radiation-Induced Tumor-1b
DR   IARC_TP53; 690
DR   Wikidata; Q108821225
RX   PubMed=1933904;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.748_755del8; Zygosity=Unspecified (PubMed=1933904).
CC   Donor information: Established from a patient originally treated by radiation therapy for a pituitary adenoma (PubMed=1933904).
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   RIT-2
AC   CVCL_RK39
SY   RIT 2; Radiation-Induced Tumor-2
DR   cancercelllines; CVCL_RK39
DR   IARC_TP53; 691
DR   Wikidata; Q54950501
RX   PubMed=1933904;
RX   PubMed=2253180;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=1933904).
CC   Donor information: Established from a patient originally treated by radiation therapy for a breast carcinoma (PubMed=2253180).
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   RIT-3
AC   CVCL_RK40
SY   RIT 3; Radiation-Induced Tumor-3
DR   Wikidata; Q54950502
RX   PubMed=1574572;
RX   PubMed=1933904;
RX   PubMed=2253180;
CC   Donor information: Established from a patient originally treated by radiation therapy for a rhabdomyosarcoma (PubMed=2253180).
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   RIT-5
AC   CVCL_RK41
SY   RIT 5; Radiation-Induced Tumor-5
DR   Wikidata; Q54950503
RX   PubMed=1933904;
RX   PubMed=2253180;
CC   Donor information: Established from a patient originally treated by radiation therapy for a Hodgkin lymphoma (PubMed=2253180).
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   RIT-6
AC   CVCL_RK42
SY   RIT 6; Radiation-Induced Tumor-6
DR   Wikidata; Q54950504
RX   PubMed=1933904;
RX   PubMed=2253180;
CC   Donor information: Established from a patient originally treated by radiation therapy for a Wilms tumor (PubMed=2253180).
DI   NCIt; C27005; Spindle cell sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   RIV6
AC   CVCL_CW52
SY   RIV-6
DR   Wikidata; Q54950505
RX   PubMed=1459588;
RX   PubMed=2144833;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   RIV7
AC   CVCL_CW53
SY   RIV-7
DR   NCBI_Iran; H166
DR   Wikidata; Q54950506
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   RIV9
AC   CVCL_CW54
SY   RIV-9
DR   Wikidata; Q54950514
RX   PubMed=1827821;
RX   PubMed=2144833;
RX   PubMed=2523112;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P07766; Human CD3E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 6
//
ID   RJ002L
AC   CVCL_H197
DR   Cosmic; 1247860
DR   Wikidata; Q54950515
RX   PubMed=15299072;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   Rj2.2.5
AC   CVCL_3414
SY   RJ2.2.5; RJ-2.2.5; RJ 2.2.5; RJ2.25; Raji 2.2.5
DR   CLDB; cl7125
DR   cancercelllines; CVCL_3414
DR   CLS; 300360
DR   GEO; GSM1602239
DR   GEO; GSM1602240
DR   GEO; GSM1602245
DR   GEO; GSM1602246
DR   ICLC; HTL02002
DR   Wikidata; Q54950516
RX   PubMed=1538137;
RX   PubMed=1852002;
RX   PubMed=2511169;
RX   PubMed=6403646;
RX   PubMed=8402893;
RX   PubMed=8441650;
RX   PubMed=25753668;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-28.html
WW   Provider; Emory OTT; 17039; https://emoryott.technologypublisher.com/techcase/17039
CC   Population: African; Nigerian.
CC   Characteristics: Deficient in expression of HLA class II antigens.
CC   HLA typing: A*03:01:01; B*15:10:01; C*03:04:02,04:01:01; DPB1*01:01:01; DQA1*01:05:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*03:01:01,10:01:01 (CLS=300360).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7067; CIITA; Zygosity=Heterozygous (PubMed=8402893).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Unexplicit; Major internal deletion; Zygosity=Heterozygous (PubMed=8402893).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=300360
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 8,11
ST   D18S51: 17
ST   D21S11: 28,31
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,27
ST   Penta D: 3.2,9
ST   Penta E: 5,13
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   RJH4
AC   CVCL_X710
SY   RJH 4; RJH-4
DR   Wikidata; Q54950517
RX   PubMed=3860870;
CC   From: Trimmer, Roy W.; National Cancer Institute; Bethesda; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 7
//
ID   RJK 849
AC   CVCL_V564
SY   RJK849
DR   Wikidata; Q54950518
RX   PubMed=3296189;
RX   PubMed=6087154;
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Unexplicit; Ex4-9del; Zygosity=Hemizygous (PubMed=3296189; PubMed=6087154).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   RJK 853
AC   CVCL_M275
SY   RJK-853; RJK853
DR   Wikidata; Q54950519
RX   PubMed=3296189;
RX   PubMed=6087154;
CC   Sequence variation: Gene deletion; HGNC; HGNC:5157; HPRT1; Zygosity=Hemizygous (PubMed=3296189; PubMed=6087154).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   RJK0
AC   CVCL_5A59
SY   RJKO; RJK-0; RJK 0
DR   Wikidata; Q54950521
RX   PubMed=6877239;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A61 ! V79 A3
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   RJK526
AC   CVCL_5A68
SY   Clone 526; 526
DR   Wikidata; Q54950522
RX   PubMed=1170021;
RX   PubMed=6877239;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A61 ! V79 A3
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   RJK88
AC   CVCL_V244
SY   RJK 88; GM10658
DR   CLO; CLO_0024581
DR   Coriell; GM10658
DR   Wikidata; Q54950523
RX   CelloPub=CLPUB00447;
RX   PubMed=6877239;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A59 ! RJK0
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   RJWIs03
AC   CVCL_C1EE
SY   RJWI s03
DR   Wikidata; Q114312800
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/RJWIs03_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*54:01; DRB1*04:05 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1ED ! Ff-WIs03
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RK 13
AC   CVCL_3155
SY   RK-13; RK13; Rk13; R.K.13; GL RK/13; GLRK 13; GLRK/13; GLRK13; Glaxo Laboratories Rabbit Kidney 13
DR   BTO; BTO_0002909
DR   CLO; CLO_0008820
DR   CLO; CLO_0008822
DR   CLO; CLO_0008823
DR   CLO; CLO_0050249
DR   EFO; EFO_0022765
DR   CLDB; cl4152
DR   CLDB; cl4153
DR   CLDB; cl4155
DR   CLDB; cl4156
DR   CLDB; cl4157
DR   CLDB; cl4158
DR   ATCC; CCL-37
DR   BCRC; 60010
DR   CCLV; CCLV-RIE 0109
DR   CCRID; 1102RAB-NIFDC00088
DR   CCRID; 4201RAB-CCTCC00101
DR   CCTCC; GDC0101
DR   ECACC; 00021715
DR   IZSLER; BS CL 74
DR   KCB; KCB 2013030YJ
DR   NCBI_Iran; C523
DR   RCB; RCB0183
DR   Wikidata; Q54950525
RX   DOI=10.1016/S0140-6736(63)90434-3;
RX   PubMed=4297026;
RX   PubMed=6988327;
RX   PubMed=7989438;
RX   PubMed=13881104;
RX   PubMed=13881105;
RX   PubMed=16494729;
RX   PubMed=19941903;
RX   PubMed=25565633;
RX   PubMed=34737324;
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-593.html
CC   Virology: Susceptible to infection by herpes simplex virus, pseudorabies virus, vaccinia virus, rabbitpox virus, myxoma virus, simian adenoviruses, and rubella virus (ATCC=CCL-37).
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=16494729).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Doubling time: ~75 hours (PubMed=4297026).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   RK 13/1
AC   CVCL_4477
DR   CLO; CLO_0008821
DR   CLDB; cl5250
DR   IZSLER; BS CL 133
DR   Wikidata; Q54950526
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 9
//
ID   RK 13/91
AC   CVCL_M730
SY   RK-13/91
DR   Wikidata; Q54950527
RX   Patent=RU2065496;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 46.
CC   Characteristics: Capable of multiplying both in a monolayer and in suspension on semi-synthetic nutrient media (Patent=RU2065496).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   RK-13-KY
AC   CVCL_JK51
SY   RK-13 KY; HP-RK-13[KY]; RK-13 (KY); RK13 Kentucky
DR   Wikidata; Q54950529
RX   PubMed=26430037;
CC   Virology: Used for isolation and propagation of equine arteritis virus (EAV).
CC   Virology: Contaminated with a noncytopathic bovine viral diarrhea virus 1 (PubMed=26430037).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 9
//
ID   RK-13/CD40L
AC   CVCL_A0TL
DR   CCRID; 4201PAT-CCTCC01291
DR   Wikidata; Q108821226
RX   Patent=CN109234232A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018180.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; G1SKP7; Rabbit CD40LG.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   RK1
AC   CVCL_A9IP
DR   CCRID; 5301RAT-KCB0705KZJ
DR   KCB; KCB 200705KZJ
DR   Wikidata; Q108821227
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RK13-DrdI
AC   CVCL_0I47
DR   CCLV; CCLV-RIE 0950
DR   Wikidata; Q54950530
RX   PubMed=17426144;
CC   Characteristics: Transfected with a Suid herpesvirus 1 (strain Kaplan) DrdI-fragment (nucleotides 28099-33282) (PubMed=17426144).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   RK13-UL11
AC   CVCL_B0BE
DR   Wikidata; Q108821228
RX   PubMed=12692236;
RX   PubMed=15731276;
CC   Characteristics: Expression of UL11 is under the control of the CMV promoter (PubMed=15731276).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q85040; Suid herpesvirus 1 (strain Kaplan) cytoplasmic envelopment protein 3 (UL11).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   RK13-UL37
AC   CVCL_B0BD
DR   Wikidata; Q108821229
RX   PubMed=11533156;
CC   Characteristics: Expression of UL37 is under the control of the CMV promoter (PubMed=15731276).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q911W0; Suid herpesvirus 1 (strain Kaplan) tegument protein UL37.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   RK13-UL51
AC   CVCL_B0BC
DR   Wikidata; Q108821230
RX   PubMed=15731276;
CC   Characteristics: Expression of UL51 is under the control of the CMV promoter (PubMed=15731276).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q85227; Suid herpesvirus 1 (strain Kaplan) tegument protein UL51.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   RK13.6
AC   CVCL_W712
DR   IZSLER; BS CL 196
DR   Wikidata; Q54950532
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 8
//
ID   RK22
AC   CVCL_C3VF
DR   Wikidata; Q116050175
RX   Patent=US10189896;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   RK35
AC   CVCL_C3VG
DR   ABCD; ABCD_AI744
DR   Wikidata; Q116050176
RX   Patent=US9926368;
RX   PubMed=16837207;
CC   Group: Patented cell line.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized domagrozumab (PF-06252616) therapeutic antibody which was used in clinical trials for the treatment of Duchenne muscular dystrophy.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O14793; Human MSTN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   RK3E
AC   CVCL_0503
DR   CLO; CLO_0008824
DR   MCCL; MCC:0000400
DR   ATCC; CRL-1895
DR   TOKU-E; 3012
DR   Wikidata; Q54950533
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=1825351;
CC   Transformant: Adenovirus E1A.
CC   Misspelling: RK3A; DOI=10.1007/978-94-011-3550-4_4.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RK3E-ras
AC   CVCL_C5TP
SY   RK3E-RAS
DR   Wikidata; Q116050177
RX   PubMed=1825351;
CC   Characteristics: Tumorigenic.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Adenovirus E1A.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0503 ! RK3E
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 8
//
ID   RK4
AC   CVCL_A1KW
DR   Wikidata; Q102114831
RX   PubMed=8652393;
CC   Karyotypic information: 48,XY,+12,+5 (PubMed=8652393).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Leu).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   RK9ML-1
AC   CVCL_L418
DR   Wikidata; Q54950534
RX   PubMed=2796377;
CC   Doubling time: 38-45 hours (PubMed=2796377).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   2-3Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
//
ID   RKC1
AC   CVCL_C3NJ
SY   Rat Kupffer Cell line 1
DR   Wikidata; Q116050178
RX   PubMed=17502155;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Kupffer cell; CL=CL_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   RKC1-11
AC   CVCL_0A23
DR   Wikidata; Q54950535
RX   CelloPub=CLPUB00223;
RX   PubMed=22673102;
CC   Characteristics: Persistently infected chronic wasting disease (CWD) prions (PubMed=22673102).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P67986; Elk prion protein.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_0A22 ! elkRK13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   RKC2
AC   CVCL_C3NK
SY   RKC-2; Rat Kupffer Cell line 2
DR   Wikidata; Q116050179
RX   PubMed=17502155;
RX   PubMed=28871174;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Kupffer cell; CL=CL_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C3NJ ! RKC1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   RKF
AC   CVCL_A8VT
SY   RyuKin Fin
DR   Wikidata; Q108821231
RX   PubMed=23999703;
CC   Group: Fish cell line.
CC   Virology: Not susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=23999703).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Breed/subspecies: Ryukin; VBO=VBO_0017500.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   RKID001
AC   CVCL_E3NU
SY   RKID1; F_PDO_000190
DR   CancerTools; 160932
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RKID002
AC   CVCL_E3NV
SY   RKID2; F_PDO_000211
DR   CancerTools; 160952
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RKN
AC   CVCL_3156
DR   CLO; CLO_0037102
DR   EFO; EFO_0006745
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 478
DR   BioSample; SAMN03471002
DR   BioSample; SAMN10987621
DR   cancercelllines; CVCL_3156
DR   Cell_Model_Passport; SIDM00353
DR   Cosmic-CLP; 1298539
DR   DepMap; ACH-000505
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1298539
DR   GEO; GSM827213
DR   GEO; GSM887540
DR   GEO; GSM888623
DR   GEO; GSM1670379
DR   IARC_TP53; 28219
DR   JCRB; FDSC0033
DR   JCRB; IFO50317
DR   JCRB; JCRB0176
DR   LiGeA; CCLE_288
DR   LINCS_LDP; LCL-1803
DR   PharmacoDB; RKN_1315_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3156
DR   Wikidata; Q54950536
RX   PubMed=6512337;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 65 hours (PubMed=25984343); 31.2 hours (JCRB=JCRB0176).
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03; DQB1*04:01,04:01; DRB1*03:42,03:42 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (Cosmic-CLP=1298539; DepMap=ACH-000505).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (Cosmic-CLP=1298539; DepMap=ACH-000505).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.67%; East Asian, South=22.19%; South Asian=0%; European, North=0%; European, South=0.14% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0033; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Cosmic-CLP=1298539; JCRB=IFO50317; JCRB=JCRB0176; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C5234; Ovarian leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   RKO
AC   CVCL_0504
DR   BTO; BTO_0001890
DR   CLO; CLO_0008825
DR   EFO; EFO_0001232
DR   MCCL; MCC:0000401
DR   AddexBio; C0009012/374
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2577
DR   BioGRID_ORCS_Cell_line; 477
DR   BioSample; SAMN03471682
DR   BioSample; SAMN03472274
DR   BioSample; SAMN10988176
DR   cancercelllines; CVCL_0504
DR   CCRID; 1101HUM-PUMC000668
DR   CCRID; 3101HUMTCHu116
DR   Cell_Model_Passport; SIDM01090
DR   ChEMBL-Cells; CHEMBL3307731
DR   ChEMBL-Targets; CHEMBL614879
DR   CLS; 305035
DR   ColonAtlas; RKO
DR   Cosmic; 873164
DR   Cosmic; 887214
DR   Cosmic; 909698
DR   Cosmic; 948133
DR   Cosmic; 1043824
DR   Cosmic; 1131688
DR   Cosmic; 1132576
DR   Cosmic; 1132687
DR   Cosmic; 1154653
DR   Cosmic; 1184099
DR   Cosmic; 1184330
DR   Cosmic; 1187315
DR   Cosmic; 1223146
DR   Cosmic; 1303884
DR   Cosmic; 1310948
DR   Cosmic; 1312309
DR   Cosmic; 1479607
DR   Cosmic; 1537488
DR   Cosmic; 1552178
DR   Cosmic; 1676744
DR   Cosmic; 1708414
DR   Cosmic; 1805264
DR   Cosmic; 1888954
DR   Cosmic; 1995622
DR   Cosmic; 2302003
DR   Cosmic; 2550355
DR   Cosmic; 2588706
DR   Cosmic; 2646668
DR   Cosmic; 2650776
DR   Cosmic; 2667884
DR   Cosmic; 2667968
DR   Cosmic; 2668257
DR   Cosmic; 2727473
DR   Cosmic; 2787542
DR   Cosmic; 2811055
DR   Cosmic-CLP; 909698
DR   DepMap; ACH-000943
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS740UAH
DR   ENCODE; ENCBS954LTA
DR   GDSC; 909698
DR   GEO; GSM206538
DR   GEO; GSM274765
DR   GEO; GSM274766
DR   GEO; GSM383863
DR   GEO; GSM741254
DR   GEO; GSM844676
DR   GEO; GSM887541
DR   GEO; GSM888624
DR   GEO; GSM1346884
DR   GEO; GSM1374850
DR   GEO; GSM1374851
DR   GEO; GSM1374852
DR   GEO; GSM1448132
DR   GEO; GSM1670380
DR   GEO; GSM2550011
DR   KCB; KCB 2011102YJ
DR   LiGeA; CCLE_267
DR   LINCS_LDP; LCL-1168
DR   Lonza; 59
DR   MetaboLights; MTBLS227
DR   PharmacoDB; RKO_1316_2019
DR   PRIDE; PXD001550
DR   PRIDE; PXD002395
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0504
DR   PubChem_Cell_line; CVCL_0504
DR   TOKU-E; 3013
DR   Ubigene; YC-C002
DR   Wikidata; Q54950538
RX   PubMed=2253215;
RX   PubMed=2835152;
RX   PubMed=6437669;
RX   PubMed=7329817;
RX   PubMed=7700629;
RX   PubMed=7761852;
RX   PubMed=7798274;
RX   PubMed=7824277;
RX   PubMed=8387205;
RX   PubMed=9515795;
RX   PubMed=9715273;
RX   PubMed=11314036;
RX   PubMed=12615714;
RX   PubMed=15161374;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=17363507;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22278370;
RX   PubMed=22460905;
RX   PubMed=24042735;
RX   PubMed=24618588;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25841592;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28179481;
RX   PubMed=28192450;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34320349;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-85.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/rko-xenograft-model/
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   Doubling time: 36.34 hours (PubMed=25944804); 21 hours (PubMed=25984343).
CC   HLA typing: A*03:01,03:01; B*18:01,35:08; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (PubMed=12615714; Cosmic-CLP=909698; DepMap=ACH-000943).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20570890; PubMed=24042735; PubMed=24755471; PubMed=28683746; ATCC=CRL-2577; Cosmic-CLP=909698; DepMap=ACH-000943).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=20570890; PubMed=24042735; PubMed=24755471; PubMed=28683746; Cosmic-CLP=909698; DepMap=ACH-000943).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=2253215; PubMed=9715273; PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=81.43%; Native American=2.85%; East Asian, North=1.14%; East Asian, South=0%; South Asian=0%; European, North=7.64%; European, South=6.93% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009012/374; ATCC=CRL-2577; CCRID; Cosmic-CLP=909698; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 8,10 (AddexBio=C0009012/374; CCRID; Cosmic-CLP=909698; PubMed=25877200)
ST   CSF1PO: 8,10,11 (ATCC=CRL-2577)
ST   CSF1PO: 8,11 (PubMed=25926053)
ST   D12S391: 15,20
ST   D13S317: 8,11
ST   D16S539: 11,12,13 (PubMed=25926053)
ST   D16S539: 12,13 (AddexBio=C0009012/374; ATCC=CRL-2577; Cosmic-CLP=909698; PubMed=25877200)
ST   D16S539: 13 (CCRID)
ST   D18S51: 11,12
ST   D19S433: 14
ST   D21S11: 27,30 (CCRID; PubMed=25877200)
ST   D21S11: 28,30 (PubMed=25926053)
ST   D2S1338: 16
ST   D3S1358: 16,19
ST   D5S818: 11,12,13,14 (PubMed=25926053)
ST   D5S818: 11,13 (AddexBio=C0009012/374; CCRID; Cosmic-CLP=909698; PubMed=25877200)
ST   D5S818: 11,13,15 (ATCC=CRL-2577)
ST   D6S1043: 14.1,19
ST   D7S820: 8,10 (AddexBio=C0009012/374; ATCC=CRL-2577; CCRID; Cosmic-CLP=909698; PubMed=25877200)
ST   D7S820: 8,10,11 (PubMed=25926053)
ST   D8S1179: 9,13,14
ST   FGA: 20,21,22,23
ST   Penta D: 10,11
ST   Penta E: 11,13
ST   TH01: 6,10
ST   TPOX: 9,10,11 (PubMed=25926053)
ST   TPOX: 11 (AddexBio=C0009012/374; ATCC=CRL-2577; CCRID; Cosmic-CLP=909698; PubMed=25877200)
ST   vWA: 15,16,17 (AddexBio=C0009012/374)
ST   vWA: 15,16,17,22 (ATCC=CRL-2577; PubMed=25877200)
ST   vWA: 16 (PubMed=25926053)
ST   vWA: 16,17,22 (Cosmic-CLP=909698)
ST   vWA: 16,22 (CCRID)
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   RKO BRAF(+/-/-)
AC   CVCL_HE15
SY   BRAF (+/-/-) RKO
DR   cancercelllines; CVCL_HE15
DR   Horizon_Discovery; HD+106-003
DR   Wikidata; Q54950539
RX   PubMed=19661383;
CC   Characteristics: RKO carries a stable triplication of the BRAF gene with one wild-type (V-600) and two mutant alleles (E-600). This KO cell line carries the wild-type allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1097; BRAF (Note=2 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   RKO BRAF(V600E/+/-)
AC   CVCL_HE16
SY   BRAF (V600E/+/-) RKO
DR   cancercelllines; CVCL_HE16
DR   Horizon_Discovery; HD+R05-012
DR   Wikidata; Q54950540
RX   PubMed=19661383;
CC   Characteristics: RKO carries a stable triplication of the BRAF gene with one wild-type (V-600) and two mutant alleles (E-600). This KO cell line carries both the wild-type and mutant alleles.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1097; BRAF (Note=1 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+R05-012).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   RKO BRAF(V600E/-/-)
AC   CVCL_HE17
SY   BRAF (V600E/-/-) RKO
DR   cancercelllines; CVCL_HE17
DR   Horizon_Discovery; HD+106-004
DR   Wikidata; Q54950541
RX   PubMed=19661383;
CC   Characteristics: RKO carries a stable triplication of the BRAF gene with one wild-type (V-600) and two mutant alleles (E-600). This KO cell line carries only the mutant allele.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:1097; BRAF (Note=2 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous; Note=By method not specified (Horizon_Discovery=HD+106-004).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   RKO Cas9
AC   CVCL_DX82
DR   Horizon_Discovery; HD+Cas9-007
DR   Wikidata; Q127384052
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-007).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RKO DICER1(-/-)
AC   CVCL_HE18
SY   DICER1 (-/-) RKO
DR   cancercelllines; CVCL_HE18
DR   Horizon_Discovery; HD+R05-001
DR   Wikidata; Q54950542
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:17098; DICER1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   RKO EGFR (C240Y/+)
AC   CVCL_LD06
SY   EGFR (C240Y/+) RKO
DR   cancercelllines; CVCL_LD06
DR   Horizon_Discovery; HD+106-022
DR   Wikidata; Q54950543
CC   Characteristics: Heterozygous knockin of a EGFR mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Cys240Tyr (c.719G>A); Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+106-022).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   RKO EGFR (delE746-A750/+)
AC   CVCL_LE01
SY   EGFR (delE746-A750/+) RKO
DR   cancercelllines; CVCL_LE01
DR   Horizon_Discovery; HD+106-009
DR   Wikidata; Q54950544
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Glu746_Ala750del; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+106-009).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   RKO EGFR (L858R/+)
AC   CVCL_LD07
SY   EGFR (L858R/+) RKO
DR   cancercelllines; CVCL_LD07
DR   Horizon_Discovery; HD+106-006
DR   Wikidata; Q54950545
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+106-006).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   RKO EGFR (L861Q/+)
AC   CVCL_LD08
SY   EGFR (L861Q/+) RKO
DR   cancercelllines; CVCL_LD08
DR   Horizon_Discovery; HD+106-007
DR   Wikidata; Q54950546
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Leu861Gln (c.2582T>A); ClinVar=VCV000163380; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+106-007).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   RKO EGFR (S768I/+)
AC   CVCL_LD09
SY   EGFR (S768I/+) RKO
DR   cancercelllines; CVCL_LD09
DR   Horizon_Discovery; HD+106-021
DR   Wikidata; Q54950547
CC   Characteristics: Heterozygous knockin of a EGFR mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Ser768Ile (c.2303G>T); ClinVar=VCV000045251; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+106-021).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   RKO EGFR (T790M/+)
AC   CVCL_LD10
SY   EGFR (T790M/+) RKO
DR   cancercelllines; CVCL_LD10
DR   Horizon_Discovery; HD+106-005
DR   Wikidata; Q54950548
CC   Characteristics: Heterozygous knockin of a EGFR mutation conferring drug resistance.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+106-005).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   RKO FANCC(+/-/-)
AC   CVCL_HE19
SY   FANCC (+/-/-) RKO
DR   cancercelllines; CVCL_HE19
DR   Horizon_Discovery; HD+R05-004
DR   Wikidata; Q54950549
RX   PubMed=16762635;
CC   Characteristics: RKO carries a stable triplication of the FANCC gene.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3584; FANCC (Note=1 of 3 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   RKO FANCC(-/-/-)
AC   CVCL_HE20
SY   FANCC (-/-/-) RKO
DR   cancercelllines; CVCL_HE20
DR   Horizon_Discovery; HD+R05-006
DR   Wikidata; Q54950550
RX   PubMed=16762635;
CC   Characteristics: RKO carries a stable triplication of the FANCC gene.
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3584; FANCC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   RKO FANCG(+/-)
AC   CVCL_HE21
SY   FANCG (+/-) RKO
DR   cancercelllines; CVCL_HE21
DR   Horizon_Discovery; HD+R05-002
DR   Wikidata; Q54950551
RX   PubMed=16762635;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3588; FANCG (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   RKO FANCG(-/-)
AC   CVCL_HE22
SY   FANCG (-/-) RKO
DR   cancercelllines; CVCL_HE22
DR   Horizon_Discovery; HD+R05-005
DR   Wikidata; Q54950552
RX   PubMed=16762635;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:3588; FANCG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   RKO MIR21(-/-)
AC   CVCL_HE23
SY   MIR21 (-/-) RKO; RKO miR-21 KO
DR   cancercelllines; CVCL_HE23
DR   Horizon_Discovery; HD+R05-013
DR   Wikidata; Q54950553
RX   PubMed=19826040;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:31586; MIR21.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   RKO RC07-14
AC   CVCL_E7ER
SY   RC07-14
RX   PubMed=8202487;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO RC07-6
AC   CVCL_E7EQ
SY   RC07-6
RX   PubMed=8202487;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO RC10-2
AC   CVCL_E7ET
SY   RC10-2
RX   PubMed=8202487;
RX   PubMed=8387205;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO RC10-3
AC   CVCL_E7EU
SY   RC10-3
RX   PubMed=8202487;
RX   PubMed=8387205;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO RC10-4
AC   CVCL_E7EV
SY   RC10-4
RX   PubMed=8387205;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO RCneo-1
AC   CVCL_E7EW
SY   RCneo-1; RCneo.1
RX   PubMed=8202487;
RX   PubMed=8387205;
CC   Characteristics: Control cell line for RKO HPV-16 protein E6 or E7 transfected cell lines (PubMed=8202487; PubMed=8387205).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO SIRT1 KO
AC   CVCL_ZC46
DR   cancercelllines; CVCL_ZC46
DR   Kerafast; ENH132-FP
DR   Wikidata; Q98128927
CC   From: Li, Xiao-Ling; National Institute of Environmental Health Sciences, NIH; Bethesda; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   RKO SLC2A1(-/-)
AC   CVCL_HE24
SY   GLUT1 (-/-) RKO
DR   cancercelllines; CVCL_HE24
DR   Horizon_Discovery; HD+R05-011
DR   Wikidata; Q54950554
RX   PubMed=19661383;
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:11005; SLC2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   RKO TP53(-/-)
AC   CVCL_HE25
SY   TP53 (-/-) RKO
DR   cancercelllines; CVCL_HE25
DR   Horizon_Discovery; HD+106-002
DR   Wikidata; Q54950556
RX   PubMed=19225112;
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   RKO-AS45-1
AC   CVCL_3786
SY   RKO-AS-45-1; RKOAS451; RKO_AS45
DR   BTO; BTO_0001892
DR   CLO; CLO_0008826
DR   ATCC; CRL-2579
DR   BioSample; SAMN03471685
DR   cancercelllines; CVCL_3786
DR   CCRID; 3101HUMTCHu117
DR   CLS; 305146
DR   Cosmic; 1187316
DR   GEO; GSM206539
DR   GEO; GSM274767
DR   GEO; GSM274768
DR   Wikidata; Q54950557
RX   PubMed=7973727;
RX   PubMed=8631022;
CC   Characteristics: Expresses a high level of GADD45A in an antisense orientation. Blocks de novo synthesis of GADD45A in response to DNA damage (PubMed=7973727).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4095; GADD45A (Note=In antisense orientation).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: RKO-AS4; Cosmic=1187316.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2579
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 8,11
ST   D16S539: 12.1,13
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 6,10
ST   TPOX: 10,11
ST   vWA: 16,24
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   RKO-E6
AC   CVCL_3787
SY   RKO E6; RKOE6; RC10-1
DR   BTO; BTO_0001891
DR   CLO; CLO_0008827
DR   EFO; EFO_0002318
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-2578
DR   BioSample; SAMN03471683
DR   BioSample; SAMN03472970
DR   cancercelllines; CVCL_3787
DR   CCRID; 3101HUMTCHu118
DR   Cell_Model_Passport; SIDM01253
DR   CLS; 305135
DR   ColonAtlas; RKOE6
DR   Cosmic; 1184102
DR   Cosmic; 1187317
DR   EGA; EGAS00001000610
DR   IGRhCellID; RKOE6
DR   PharmacoDB; RKOE6_1317_2019
DR   Progenetix; CVCL_3787
DR   Wikidata; Q54950558
RX   PubMed=7700629;
RX   PubMed=8202487;
RX   PubMed=8387205;
RX   PubMed=15161374;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*03:01,03:01; B*18:01,37:04; C*07:01,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Caution: We believe that the clone called RKO-E6 by PubMed=7700629 is the clone RC10-1 originally described by PubMed=8387205 but it is also possible that it is RKO RC10-2 (Cellosaurus=CVCL_E7ET) or RKO RC10-3 (Cellosaurus=CVCL_E7EU) or RKO RC10-4 (Cellosaurus=CVCL_E7EV).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2578; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 8,12
ST   D16S539: 13,13.1
ST   D18S51: 11,13
ST   D21S11: 28,30
ST   D3S1358: 16,19
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 9,13,14
ST   FGA: 19,22
ST   Penta D: 10,11
ST   Penta E: 11,13
ST   TH01: 6,10 (PubMed=25877200)
ST   TH01: 6.2,10 (ATCC=CRL-2578)
ST   TPOX: 10,11
ST   vWA: 16
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   RKO-EGFP
AC   CVCL_C8W5
DR   Ubigene; YC-C002-EGFP-P
DR   Wikidata; Q123033356
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   RKO-Luc
AC   CVCL_C8V3
DR   Ubigene; YC-C002-Luc-P
DR   Wikidata; Q123033357
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   RKO/5FUR
AC   CVCL_AU13
DR   cancercelllines; CVCL_AU13
DR   Wikidata; Q54950559
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   RKO/BEVA
AC   CVCL_AU14
DR   cancercelllines; CVCL_AU14
DR   Wikidata; Q54950567
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Selected for resistance to: DrugBank; DB00112; Bevacizumab (Avastin).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   RKO/Cas9-hyg
AC   CVCL_C9ET
DR   GeneCopoeia; SL539
DR   Wikidata; Q123033358
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL539).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   RKO/OXR
AC   CVCL_AU15
DR   cancercelllines; CVCL_AU15
DR   Wikidata; Q54950571
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   RKO.mp53
AC   CVCL_E7EX
RX   PubMed=1323840;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO.mp53.1
AC   CVCL_E7EY
RX   PubMed=1323840;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7EX ! RKO.mp53
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO.mp53.13
AC   CVCL_E7EZ
SY   MP53.13
RX   PubMed=1323840;
RX   PubMed=15161374;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7EX ! RKO.mp53
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO.mp53.2
AC   CVCL_E7F0
RX   PubMed=1323840;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7EX ! RKO.mp53
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKO.mp53.8
AC   CVCL_E7F1
RX   PubMed=1323840;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7EX ! RKO.mp53
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RKOP
AC   CVCL_6754
SY   Revertant of KOP
DR   CLO; CLO_0050528
DR   RCB; RCB2149
DR   Wikidata; Q54950573
RX   PubMed=16198317;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346865; Mapk14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6876; MAPK14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6753 ! KOP
SX   Female
AG   12-13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   Rkt11
AC   CVCL_E5UK
SY   Rat kidney T155g-converted cell line 11
RX   PubMed=12075990;
CC   Characteristics: Produces GDNF at physiological concentrations (PubMed=12075990).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney, cortex; UBERON=UBERON_0001225.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Rkt3
AC   CVCL_E5UH
SY   Rat kidney T155g-converted cell line 3
RX   PubMed=12075990;
CC   Characteristics: Produces GDNF at physiological concentrations (PubMed=12075990).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney, cortex; UBERON=UBERON_0001225.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Rkt5
AC   CVCL_E5UI
SY   Rat kidney T155g-converted cell line 5
RX   PubMed=12075990;
CC   Characteristics: Produces GDNF at physiological concentrations (PubMed=12075990).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney, cortex; UBERON=UBERON_0001225.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Rkt6
AC   CVCL_E5UJ
SY   Rat kidney T155g-converted cell line 6
RX   PubMed=12075990;
CC   Characteristics: Produces GDNF at physiological concentrations (PubMed=12075990).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney, cortex; UBERON=UBERON_0001225.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RL
AC   CVCL_1660
DR   BTO; BTO_0003230
DR   CLO; CLO_0008828
DR   EFO; EFO_0002319
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2261
DR   BioSample; SAMN01821593
DR   BioSample; SAMN01821659
DR   BioSample; SAMN03471851
DR   BioSample; SAMN03472493
DR   BioSample; SAMN10988269
DR   cancercelllines; CVCL_1660
DR   Cell_Model_Passport; SIDM01089
DR   ChEMBL-Cells; CHEMBL3308515
DR   ChEMBL-Targets; CHEMBL2366175
DR   Cosmic; 910861
DR   Cosmic; 1945189
DR   Cosmic; 2022593
DR   Cosmic; 2297011
DR   Cosmic-CLP; 910861
DR   DepMap; ACH-000371
DR   DSMZ; ACC-613
DR   DSMZCellDive; ACC-613
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910861
DR   GEO; GSM115984
DR   GEO; GSM179647
DR   GEO; GSM887543
DR   GEO; GSM888626
DR   GEO; GSM1035303
DR   GEO; GSM1105702
DR   GEO; GSM1670381
DR   IARC_TP53; 21288
DR   IARC_TP53; 25030
DR   IGRhCellID; RL
DR   LiGeA; CCLE_654
DR   LINCS_LDP; LCL-1133
DR   Lonza; 1366
DR   PharmacoDB; RL_1318_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1660
DR   PubChem_Cell_line; CVCL_1660
DR   Wikidata; Q54950574
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2313723;
RX   PubMed=16960149;
RX   PubMed=17363600;
RX   PubMed=17495976;
RX   PubMed=19358282;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/lymphoma-xenograft/rl-nhl-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~5-8 days (DSMZ=ACC-613).
CC   HLA typing: A*02:01,02:01; B*07:02,07:02; C*07:02,07:02; DQA1*01:01,01:01; DQB1*05:01,05:01; DRB1*01:03,01:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala138Pro (c.412G>C); ClinVar=VCV000012376; Zygosity=Homozygous (PubMed=17363600; Cosmic-CLP=910861; DepMap=ACH-000371).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.05%; East Asian, North=0.17%; East Asian, South=0%; South Asian=1.47%; European, North=68.96%; European, South=28.35% (PubMed=30894373).
CC   Misspelling: RL-2261; Note=Based on the ATCC catalog number.
CC   Misspelling: RL2261; Note=Based on the ATCC catalog number.
CC   Misspelling: CRL; PubMed=17363600.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-2261; Cosmic-CLP=910861; DSMZ=ACC-613; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8 (PubMed=25877200)
ST   D13S317: 8,11 (ATCC=CRL-2261; Cosmic-CLP=910861; DSMZ=ACC-613)
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 12,14
ST   FGA: 23,24
ST   Penta D: 11
ST   Penta E: 12,17
ST   TH01: 9,10
ST   TPOX: 9,11
ST   vWA: 19,20
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   RL male 1
AC   CVCL_C832
SY   RL-male-1; Radiation-leukemia male 1; Gloria; RL1(Gloria)
DR   CLO; CLO_0050215
DR   RCB; RCB2784
DR   TKG; TKG 0292
DR   Wikidata; Q54950575
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   RL-PR-C
AC   CVCL_E4AN
RX   PubMed=3431441;
RX   PubMed=6784634;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RL(B77)
AC   CVCL_AW07
DR   Wikidata; Q54950583
RX   PubMed=4347422;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV) (Note=Strain Bratislava-77 (B77)).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 10
//
ID   RL(MSV)
AC   CVCL_HE59
DR   Wikidata; Q54950584
RX   PubMed=4347422;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
ID   RL-1
AC   CVCL_WH85
SY   Rat Liver-1
DR   Wikidata; Q98128928
RX   PubMed=137072;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   RL-19
AC   CVCL_8272
SY   RL 19; Rat Liver-19
DR   BTO; BTO_0001937
DR   Wikidata; Q54950576
RX   DOI=10.1016/S0014-4908(76)80012-9;
RX   PubMed=3031937;
RX   PubMed=6891157;
CC   Donor information: Established from livers pooled from 3 rats (DOI=10.1016/S0014-4908(76)80012-9).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   RL-251
AC   CVCL_S900
SY   RL251
DR   Wikidata; Q54950577
RX   PubMed=11502840;
RX   PubMed=21924324;
CC   Doubling time: 36 hours (PubMed=11502840).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RL-33
AC   CVCL_2709
SY   Rabbit Lung-33
DR   JCRB; JCRB0131
DR   JCRB; NIHS0180
DR   Wikidata; Q54950578
RX   PubMed=916355;
CC   Discontinued: JCRB; NIHS0180; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Japanese white; VBO=VBO_0013632.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   RL-33 [Rat]
AC   CVCL_WH86
SY   Rat Liver-33
DR   Wikidata; Q98128929
RX   PubMed=137072;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   27D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   RL-34
AC   CVCL_5583
SY   RL34; Rat Liver-34
DR   JCRB; JCRB0247
DR   Wikidata; Q54950579
RX   DOI=10.11418/jtca1981.15.2_141;
RX   PubMed=137072;
RX   PubMed=282624;
RX   PubMed=3552263;
RX   PubMed=6244092;
CC   Doubling time: ~1 day (Note=Lot 03022017) (JCRB=JCRB0247).
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Unexplicit; TC->GA in 3'splicing signal of intron 4; Zygosity=Unspecified (DOI=10.11418/jtca1981.15.2_141).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   RL-36
AC   CVCL_WH87
SY   Rat Liver-36
DR   Wikidata; Q98128930
RX   PubMed=137072;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 6
//
ID   RL-5
AC   CVCL_X618
SY   RL5
DR   ABM; T8164
DR   BEI_Resources; ARP-341
DR   Wikidata; Q54950580
RX   DOI=10.1007/BF01561430;
RX   PubMed=1328042;
RX   PubMed=2454470;
CC   Virology: Susceptible to infection by HIV-1 (PubMed=2454470).
CC   Doubling time: 14 hours (BEI_Resources=ARP-341).
CC   Transformant: NCBI_TaxID; 85618; Ateline herpesvirus 3 (Herpesvirus ateles).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: B/J; VBO=VBO_0017526.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 12
//
ID   RL-65
AC   CVCL_3788
SY   Rat Lung-65
DR   CLO; CLO_0008829
DR   ATCC; CRL-10354
DR   Wikidata; Q54950582
RX   Patent=US5364785;
RX   PubMed=2260675;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10354.
CC   Doubling time: 17 hours (Patent=US5364785; PubMed=2260675).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   5D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RL1
AC   CVCL_XB51
SY   Rat Lung 1
DR   CCRID; 5301RAT-KCB0705LZJ
DR   KCB; KCB 200705LZJ
DR   Wikidata; Q98128931
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   RL119
AC   CVCL_A0DN
DR   Wikidata; Q108821232
RX   PubMed=2415592;
RX   PubMed=3877761;
RX   PubMed=11994445;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P18572; Mouse Bsg/Cd147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   RL14
AC   CVCL_4U19
DR   Wikidata; Q54950585
RX   Patent=US7223599;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1499.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U14 ! DWFb1-rho0
CA   Hybrid cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   RL159
AC   CVCL_AS76
DR   Wikidata; Q54950586
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 27
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   RL2
AC   CVCL_LJ72
DR   TKG; TKG 0170
DR   Wikidata; Q54950587
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   RL34-BP
AC   CVCL_WH88
SY   RL34BP
DR   Wikidata; Q98128932
RX   PubMed=6244092;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Unexplicit; TC->GA in 3'splicing signal of intron 4; Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5583 ! RL-34
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RL34-EC
AC   CVCL_WH90
SY   RL34EC
DR   Wikidata; Q98128933
RX   PubMed=6244092;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Unexplicit; TC->GA in 3'splicing signal of intron 4; Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH89 ! RL34-ESA
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RL34-ESA
AC   CVCL_WH89
SY   RL34 ESA
DR   Wikidata; Q98128934
RX   PubMed=137072;
RX   PubMed=6244092;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Unexplicit; TC->GA in 3'splicing signal of intron 4; Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5583 ! RL-34
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RL34-HII
AC   CVCL_WH91
SY   RL34HII
DR   Wikidata; Q98128935
RX   PubMed=137072;
RX   PubMed=6244092;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Unexplicit; TC->GA in 3'splicing signal of intron 4; Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5583 ! RL-34
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RL34-HT
AC   CVCL_WH93
SY   RL34HT
DR   Wikidata; Q98128936
RX   PubMed=6244092;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Unexplicit; TC->GA in 3'splicing signal of intron 4; Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH91 ! RL34-HII
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RL34-NQ
AC   CVCL_WH92
SY   RL34NQ
DR   Wikidata; Q98128937
RX   PubMed=6244092;
CC   Sequence variation: Mutation; RGD; 3889; Tp53; Unexplicit; TC->GA in 3'splicing signal of intron 4; Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5583 ! RL-34
SX   Male
AG   7D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RL388
AC   CVCL_A0DP
DR   Wikidata; Q108821233
RX   PubMed=2415592;
RX   PubMed=3877761;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P10852; Mouse Slc3a2/Cd98.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RL7
AC   CVCL_LK41
SY   RL-7
DR   TKG; TKG 0297
DR   Wikidata; Q54950588
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3430; ERBB2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   RL73
AC   CVCL_A0DQ
SY   RL73.2
DR   Wikidata; Q108821234
RX   PubMed=2415592;
RX   PubMed=3877761;
RX   PubMed=11994445;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P18572; Mouse Bsg/Cd147.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   RL95-2
AC   CVCL_0505
SY   RL95_2; RL-95-2; RL-952; RL952; RL95
DR   BTO; BTO_0004491
DR   CLO; CLO_0008830
DR   EFO; EFO_0002320
DR   MCCL; MCC:0000402
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1671
DR   BCRC; 60103
DR   BCRJ; 0366
DR   BioGRID_ORCS_Cell_line; 999
DR   BioSample; SAMN03473219
DR   BioSample; SAMN10987787
DR   cancercelllines; CVCL_0505
DR   CCRID; 3101HUMTCHu198
DR   CCRID; 4201HUM-CCTCC00113
DR   CCTCC; GDC0113
DR   Cell_Model_Passport; SIDM01088
DR   ChEMBL-Cells; CHEMBL3308843
DR   ChEMBL-Targets; CHEMBL2366168
DR   CLS; 305062
DR   Cosmic; 713477
DR   Cosmic; 713489
DR   Cosmic; 809132
DR   Cosmic; 846175
DR   Cosmic; 871556
DR   Cosmic; 889117
DR   Cosmic; 930082
DR   Cosmic; 980637
DR   Cosmic; 1007165
DR   Cosmic; 1066226
DR   Cosmic; 1070808
DR   Cosmic; 1102377
DR   Cosmic; 1177623
DR   Cosmic; 1223487
DR   Cosmic; 1576464
DR   Cosmic; 1622899
DR   Cosmic; 1696756
DR   Cosmic; 2030481
DR   Cosmic; 2301551
DR   Cosmic; 2646617
DR   Cosmic; 2702441
DR   Cosmic-CLP; 930082
DR   DepMap; ACH-000965
DR   EGA; EGAS00001000978
DR   GDSC; 930082
DR   GEO; GSM374977
DR   GEO; GSM375436
DR   GEO; GSM844677
DR   GEO; GSM887542
DR   GEO; GSM888625
DR   GEO; GSM1670382
DR   GEO; GSM3161728
DR   GEO; GSM3161729
DR   IARC_TP53; 1114
DR   IGRhCellID; RL952
DR   KCB; KCB 2013033YJ
DR   LiGeA; CCLE_166
DR   LINCS_LDP; LCL-1506
DR   Lonza; 1501
DR   PharmacoDB; RL952_1319_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0505
DR   PubChem_Cell_line; CVCL_0505
DR   Wikidata; Q54950589
RX   PubMed=1541432;
RX   PubMed=2436984;
RX   PubMed=6339371;
RX   PubMed=7798295;
RX   PubMed=8123477;
RX   PubMed=9887230;
RX   PubMed=12893190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20944090;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=33174010;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=1541432).
CC   HLA typing: A*02:10,24:02; B*55:01,55:01; C*03:03,03:03; DQA1*01:02,05:02; DQB1*05:03,05:03; DRB1*14:01,14:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Arg693Ter (c.2077C>T); Zygosity=Heterozygous (Cosmic-CLP=930082; DepMap=ACH-000965).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61His (c.183G>T); ClinVar=VCV000376318; Zygosity=Heterozygous (ATCC=CRL-1671; Cosmic-CLP=930082; DepMap=ACH-000965).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (Cosmic-CLP=930082; DepMap=ACH-000965).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323fs*2 (c.968_969insA); Zygosity=Heterozygous (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323Metfs*21 (c.968delA); ClinVar=VCV000653412; Zygosity=Heterozygous (PubMed=20944090).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Trpfs*50 (c.216delC) (p.P72fs); ClinVar=VCV000428897; Zygosity=Heterozygous (PubMed=9887230; Cosmic-CLP=930082; DepMap=ACH-000965).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Heterozygous (PubMed=9887230; Cosmic-CLP=930082; DepMap=ACH-000965).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.33%; East Asian, North=1.49%; East Asian, South=0%; South Asian=1.52%; European, North=68.38%; European, South=28.28% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): ATCC=CRL-1671; Cosmic-CLP=930082; PubMed=25877200; PubMed=33174010; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 14,15
ST   D12S391: 15,21
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 10,14
ST   D19S433: 15
ST   D1S1656: 13,19.3
ST   D21S11: 28,29
ST   D22S1045: 15
ST   D2S1338: 22,23
ST   D2S441: 11,14
ST   D3S1358: 14,16
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 5,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,20
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   RLA209-15
AC   CVCL_6C62
DR   Wikidata; Q54950590
RX   PubMed=2581111;
RX   PubMed=3431441;
RX   PubMed=6166615;
CC   Doubling time: ~24 hours (PubMed=6166615).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   RLA255-4
AC   CVCL_6C63
DR   Wikidata; Q54950591
RX   PubMed=2581111;
RX   PubMed=6248862;
CC   Characteristics: At the permissive temperature (33 Celsius) expresses a transformed phenotype (rapid growth, high cell density, etc) and at the restrictive temperature (44 Celsius) expresses a non-transformed phenotype (slower growth, lower saturation density, etc).
CC   Doubling time: 15 hours (PubMed=6248862).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   RLC [Rat liver]
AC   CVCL_C4MB
SY   Rat Liver Cell line
DR   Wikidata; Q116050180
RX   PubMed=4394388;
RX   PubMed=4554574;
CC   Doubling time: 2 days (Note=In monolayer culture), 4 days (Note=In suspension culture) (PubMed=4394388).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   RLC [Rat lymphosarcoma]
AC   CVCL_6D47
DR   CLO; CLO_0008831
DR   CLDB; cl4159
DR   Wikidata; Q54950592
CC   Transformant: ChEBI; CHEBI_82315; 3,3'-dichlorbenzedine.
DI   NCIt; C179055; Rat lymphosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 6
//
ID   RLC-1
AC   CVCL_WI62
SY   Rat Liver Cells-1
DR   Wikidata; Q98128938
RX   PubMed=4956140;
RX   PubMed=4956141;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI81 ! RLD-1 [Rat]
SX   Sex unspecified
AG   9D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-10
AC   CVCL_5U43
SY   Rat Liver Cells-10
DR   Wikidata; Q54950593
RX   PubMed=4647843;
RX   PubMed=8390914;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   11D
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   RLC-10(2)
AC   CVCL_WI76
DR   Wikidata; Q98128939
RX   PubMed=171466;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5U43 ! RLC-10
SX   Female
AG   11D
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-10.P3
AC   CVCL_J372
DR   JCRB; JCRB0718
DR   JCRB; JCRB0718.1
DR   JCRB; NIHS0367
DR   Wikidata; Q54950594
RX   DOI=10.1247/csf.5.315;
RX   PubMed=3242846;
CC   Group: Serum/protein free medium cell line.
CC   Discontinued: JCRB; NIHS0367; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5U43 ! RLC-10
SX   Female
AG   11D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   RLC-16
AC   CVCL_3861
SY   Rat Liver Cells-16
DR   CLO; CLO_0050611
DR   CLO; CLO_0050612
DR   RCB; RCB0069
DR   RCB; RCB1474
DR   Wikidata; Q54950595
RX   PubMed=1223332;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   6W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   RLC-17
AC   CVCL_WI31
SY   Rat Liver Cells-17
DR   Wikidata; Q98128940
RX   PubMed=1223332;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   8D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-18
AC   CVCL_2178
SY   C18; Rat Liver Cells-18
DR   CLO; CLO_0008833
DR   CLO; CLO_0050608
DR   CLO; CLO_0050609
DR   DSMZ; ACC-332
DR   DSMZCellDive; ACC-332
DR   RCB; RCB0070
DR   RCB; RCB1484
DR   Wikidata; Q54950596
RX   PubMed=1223332;
CC   Doubling time: ~35-40 hours (DSMZ=ACC-332).
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   RLC-19
AC   CVCL_WI32
SY   Rat Liver Cells-19
DR   Wikidata; Q98128941
RX   PubMed=1223332;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   4W
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-2
AC   CVCL_WI63
SY   Rat Liver Cells-2
DR   Wikidata; Q98128942
RX   PubMed=4956140;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI98 ! RLD-7
SX   Sex unspecified
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   RLC-20
AC   CVCL_WI33
SY   Rat Liver Cells-20
DR   Wikidata; Q98128943
RX   PubMed=1223332;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   11D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-21
AC   CVCL_WI34
SY   Rat Liver Cells-21
DR   Wikidata; Q98128944
RX   PubMed=1223332;
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   15-22FD
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   RLC-22
AC   CVCL_WI35
SY   Rat Liver Cells-22
DR   Wikidata; Q98128945
RX   PubMed=1223332;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   4D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-23
AC   CVCL_WI36
SY   Rat Liver Cells-23
DR   Wikidata; Q98128946
RX   PubMed=1223332;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   14D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-24
AC   CVCL_WI37
SY   Rat Liver Cells-24
DR   Wikidata; Q98128947
RX   PubMed=1223332;
RX   PubMed=8390914;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-2.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   28D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-27
AC   CVCL_3862
SY   RLC 27; C27; Rat Liver Cells-27
DR   CLO; CLO_0008832
DR   CLO; CLO_0050610
DR   CLO; CLO_0050614
DR   CLDB; cl4160
DR   ECACC; 90071811
DR   RCB; RCB0072
DR   RCB; RCB1489
DR   Wikidata; Q54950597
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   13D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   RLC-3
AC   CVCL_WI38
SY   Rat Liver Cells-3
DR   Wikidata; Q98128949
RX   PubMed=4956140;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI99 ! RLD-8
OI   CVCL_WJ00 ! RLD-9
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 6
//
ID   RLC-4
AC   CVCL_WI64
SY   Rat Liver Cells-4
DR   Wikidata; Q98128951
RX   PubMed=4956140;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WJ03 ! RLD-12
SX   Sex unspecified
AG   9D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLC-5
AC   CVCL_WI65
SY   Rat Liver Cells-5
DR   Wikidata; Q98128952
RX   PubMed=4956140;
RX   PubMed=5295515;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WJ04 ! RLD-13
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RLCNR
AC   CVCL_5U62
SY   Rat Lung Cancer in NaRa
DR   Wikidata; Q54950598
RX   PubMed=15596300;
CC   Doubling time: 19.2 hours (PubMed=15596300).
CC   Sequence variation: Mutation; RGD; 2981; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Unspecified (PubMed=15596300).
CC   Transformant: ChEBI; CHEBI_131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64112; Carcinoma of the rat lung
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   31W
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 11
//
ID   RLD-0
AC   CVCL_WI80
SY   Rat Liver DAB-added-0
DR   Wikidata; Q98129081
RX   PubMed=4956140;
RX   PubMed=4956141;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-1 [Mouse]
AC   CVCL_2179
SY   RLD; Rauscher Lymphoid DBA/2
DR   CLO; CLO_0008834
DR   DSMZ; ACC-415
DR   DSMZCellDive; ACC-415
DR   Wikidata; Q54950599
RX   PubMed=3792703;
RX   PubMed=6604701;
CC   Doubling time: ~20-30 hours (DSMZ=ACC-415).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   RLD-1 [Rat]
AC   CVCL_WI81
SY   Rat Liver DAB-added-1
DR   Wikidata; Q98129082
RX   PubMed=4956140;
RX   PubMed=4956141;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI62 ! RLC-1
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-10
AC   CVCL_WJ01
SY   Rat Liver DAB-added-10
DR   Wikidata; Q98129083
RX   PubMed=4955551;
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WJ02 ! RLD-11
SX   Sex unspecified
AG   8D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-11
AC   CVCL_WJ02
SY   Rat Liver DAB-added-11
DR   Wikidata; Q98129084
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WJ01 ! RLD-10
SX   Sex unspecified
AG   8D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-12
AC   CVCL_WJ03
SY   Rat Liver DAB-added-12
DR   Wikidata; Q98129085
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI64 ! RLC-4
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-13
AC   CVCL_WJ04
SY   Rat Liver DAB-added-13
DR   Wikidata; Q98129086
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI65 ! RLC-5
SX   Sex unspecified
AG   12D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-14
AC   CVCL_A9A9
SY   Rat Liver DAB-added-14
DR   Wikidata; Q102114832
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   12D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 5
//
ID   RLD-17
AC   CVCL_A9B0
SY   Rat Liver DAB-added-17
DR   Wikidata; Q102114833
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   25D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLD-2
AC   CVCL_WI82
SY   Rat Liver DAB-added-2
DR   Wikidata; Q98129087
RX   PubMed=4956140;
RX   PubMed=4956141;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI83 ! RLD-3
SX   Sex unspecified
AG   18D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-20(12)
AC   CVCL_A9B7
SY   Rat Liver DAB-added-20(12)
DR   Wikidata; Q102114834
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B6 ! RLD-20(8)
SX   Sex unspecified
AG   23D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLD-20(8)
AC   CVCL_A9B6
SY   Rat Liver DAB-added-20(8)
DR   Wikidata; Q102114835
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B7 ! RLD-20(12)
SX   Sex unspecified
AG   23D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLD-22
AC   CVCL_A9B5
SY   Rat Liver DAB-added-22
DR   Wikidata; Q102114836
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B4 ! RLM-22(4)
OI   CVCL_A9B9 ! RLM-22(12)
SX   Sex unspecified
AG   26D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLD-23(8)
AC   CVCL_A9B8
SY   Rat Liver DAB-added-23(8)
DR   Wikidata; Q102114837
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   27D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLD-3
AC   CVCL_WI83
SY   Rat Liver DAB-added-3
DR   Wikidata; Q98129088
RX   PubMed=4956140;
RX   PubMed=4956141;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI82 ! RLD-2
SX   Sex unspecified
AG   18D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-35
AC   CVCL_A9C0
SY   Rat Liver DAB-added-35
DR   Wikidata; Q102114838
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_UZ08 ! RLN-35
SX   Sex unspecified
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLD-36(2)
AC   CVCL_A9C1
SY   Rat Liver DAB-added-36
DR   Wikidata; Q102114840
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_UZ09 ! RLN-36
SX   Sex unspecified
AG   15D
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLD-4
AC   CVCL_WI84
SY   Rat Liver DAB-added-4
DR   Wikidata; Q98129089
RX   PubMed=4956140;
RX   PubMed=4956141;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI85 ! RLD-5
SX   Sex unspecified
AG   16D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-5
AC   CVCL_WI85
SY   Rat Liver DAB-added-5
DR   Wikidata; Q98129090
RX   PubMed=4956140;
RX   PubMed=4956141;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI84 ! RLD-4
SX   Sex unspecified
AG   18D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-6
AC   CVCL_WI86
SY   Rat Liver DAB-added-6
DR   Wikidata; Q98129091
RX   PubMed=4956140;
RX   PubMed=4956141;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 6
//
ID   RLD-7
AC   CVCL_WI98
SY   Rat Liver DAB-added-7
DR   Wikidata; Q98129092
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI63 ! RLC-2
SX   Sex unspecified
AG   13D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   RLD-8
AC   CVCL_WI99
SY   Rat Liver DAB-added-8
DR   Wikidata; Q98129093
RX   PubMed=4955551;
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI38 ! RLC-3
OI   CVCL_WJ00 ! RLD-9
SX   Sex unspecified
AG   10D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   RLD-9
AC   CVCL_WJ00
SY   Rat Liver DAB-added-9
DR   Wikidata; Q98129095
RX   PubMed=4956140;
CC   Transformant: ChEBI; CHEBI_17903; 4-(dimethylamino)azobenzene (DAB; Methyl yellow).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_WI38 ! RLC-3
OI   CVCL_WI99 ! RLD-8
SX   Sex unspecified
AG   10D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 7
//
ID   RLE-6T
AC   CVCL_LB71
SY   Rat Lung Epithelial-6-T-antigen
DR   Wikidata; Q54950600
RX   PubMed=8528500;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4693 ! RLE-6TN
SX   Male
AG   56D
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   RLE-6TN
AC   CVCL_4693
SY   Rat Lung Epithelial-6-T-antigen Negative
DR   BTO; BTO_0003510
DR   CLO; CLO_0008835
DR   AddexBio; C0016014/4948
DR   ATCC; CRL-2300
DR   IZSLER; BS CL 206
DR   Wikidata; Q54950601
RX   PubMed=8528500;
RX   PubMed=12740220;
CC   Characteristics: While transfected with SV40 pRSV-T, does not express SV40 T antigen thus said to be derived from a spontaneous transformant.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_LB71 ! RLE-6T
SX   Male
AG   56D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   Rlff-K4D
AC   CVCL_E3SM
SY   Ryukyu long-furred rat-K4D
RX   PubMed=36971906;
CC   Group: Endangered species/breed cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=106283; ! Diplothrix legata (Ryukyu long-tailed giant rat)
OI   CVCL_E3SN ! Rlff-K4DT
OI   CVCL_E3SP ! Rlff-SV40
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Rlff-K4DT
AC   CVCL_E3SN
SY   Ryukyu long-furred rat-K4DT
RX   PubMed=36971906;
CC   Group: Endangered species/breed cell line.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=106283; ! Diplothrix legata (Ryukyu long-tailed giant rat)
OI   CVCL_E3SM ! Rlff-K4D
OI   CVCL_E3SP ! Rlff-SV40
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Rlff-SV40
AC   CVCL_E3SP
SY   Ryukyu long-furred rat-SV40
RX   PubMed=36971906;
CC   Group: Endangered species/breed cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=106283; ! Diplothrix legata (Ryukyu long-tailed giant rat)
OI   CVCL_E3SM ! Rlff-K4D
OI   CVCL_E3SN ! Rlff-K4DT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLI-R
AC   CVCL_A3AK
SY   Rabbit Liver Immortalized-R
DR   CCLV; CCLV-RIE 0750
DR   Wikidata; Q105510762
RX   PubMed=17112688;
RX   PubMed=25565633;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
AG   Adult
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RLK-1-R
AC   CVCL_XH36
DR   CCLV; CCLV-RIE 0037
DR   Wikidata; Q98129101
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   RLK-R
AC   CVCL_XH28
DR   CCLV; CCLV-RIE 0034
DR   Wikidata; Q98129102
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   RlKd
AC   CVCL_RX66
DR   Wikidata; Q54950603
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=519039; ! Rhinolophus landeri (Lander's horseshoe bat)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   RLM-22(12)
AC   CVCL_A9B9
SY   Rat Liver 3'-Me-DAB-added-22(12)
DR   Wikidata; Q102114842
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B5 ! RLD-22
OI   CVCL_A9B4 ! RLM-22(4)
SX   Sex unspecified
AG   26D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLM-22(4)
AC   CVCL_A9B4
SY   Rat Liver 3'-Me-DAB-added-22(4)
DR   Wikidata; Q102114843
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B5 ! RLD-22
OI   CVCL_A9B9 ! RLM-22(12)
SX   Sex unspecified
AG   26D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLM-39(12)
AC   CVCL_A9B2
SY   Rat Liver 3'-Me-DAB-added-39(12)
DR   Wikidata; Q102114844
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B1 ! RLM-39(4)
OI   CVCL_A9B3 ! RLM-39(24)
OI   CVCL_UZ11 ! RLN-39
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLM-39(24)
AC   CVCL_A9B3
SY   Rat Liver 3'-Me-DAB-added-39(24)
DR   Wikidata; Q102114845
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B1 ! RLM-39(4)
OI   CVCL_A9B2 ! RLM-39(12)
OI   CVCL_UZ11 ! RLN-39
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLM-39(4)
AC   CVCL_A9B1
SY   Rat Liver 3'-Me-DAB-added-39(4)
DR   Wikidata; Q102114847
RX   PubMed=4955550;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B2 ! RLM-39(12)
OI   CVCL_A9B3 ! RLM-39(24)
OI   CVCL_UZ11 ! RLN-39
SX   Sex unspecified
AG   9D
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   RLN-10
AC   CVCL_5350
SY   Rat Liver Normal-10
DR   JCRB; JCRB0415
DR   Wikidata; Q54950604
RX   PubMed=4304710;
RX   PubMed=4955551;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   RLN-21
AC   CVCL_UZ07
SY   Rat Liver Normal-21
DR   Wikidata; Q98129103
RX   PubMed=4304710;
RX   PubMed=4955550;
RX   PubMed=4955551;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   25D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   RLN-35
AC   CVCL_UZ08
SY   Rat Liver Normal-35
DR   Wikidata; Q98129104
RX   PubMed=4304710;
RX   PubMed=4955550;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9C0 ! RLD-35
SX   Sex unspecified
AG   20D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   RLN-36
AC   CVCL_UZ09
SY   Rat Liver Normal-36
DR   Wikidata; Q98129106
RX   PubMed=4304710;
RX   PubMed=4955550;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9C1 ! RLD-36(2)
SX   Sex unspecified
AG   15D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   RLN-38
AC   CVCL_UZ10
SY   Rat Liver Normal-38
DR   Wikidata; Q98129107
RX   PubMed=4304710;
RX   PubMed=4955550;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   17D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   RLN-39
AC   CVCL_UZ11
SY   Rat Liver Normal-39
DR   Wikidata; Q98129108
RX   PubMed=4304710;
RX   PubMed=4955550;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A9B1 ! RLM-39(4)
OI   CVCL_A9B2 ! RLM-39(12)
OI   CVCL_A9B3 ! RLM-39(24)
SX   Sex unspecified
AG   9D
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 7
//
ID   RLN-8
AC   CVCL_5351
SY   Rat Liver Normal-8
DR   JCRB; JCRB0414
DR   Wikidata; Q54950605
RX   PubMed=4304710;
RX   PubMed=4955551;
RX   PubMed=8407585;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   9D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   RLN-B2
AC   CVCL_5352
SY   B2
DR   JCRB; JCRB0402
DR   Wikidata; Q54950606
RX   PubMed=90011;
RX   PubMed=4280238;
CC   Doubling time: ~38 hours (Note=Lot 09132010) (JCRB=JCRB0402).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5353 ! RLN-J-5-2
SX   Male
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   RLN-E7
AC   CVCL_1G61
DR   Wikidata; Q54950607
RX   PubMed=4277389;
RX   PubMed=5308529;
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Embryo
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 9
//
ID   RLN-J-5-2
AC   CVCL_5353
SY   J-5-2
DR   JCRB; JCRB0407
DR   Wikidata; Q54950609
RX   PubMed=4280238;
RX   PubMed=6158258;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5352 ! RLN-B2
SX   Male
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   RLN-J-5-2 CL-1
AC   CVCL_C6JS
SY   J-5-2 CL-1
DR   Wikidata; Q116050181
RX   PubMed=6158258;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5353 ! RLN-J-5-2
SX   Male
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   RLO
AC   CVCL_E817
DR   IHW; 9w 1004
DR   Wikidata; Q54950610
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*03,26; B*38,41 (IHW=9w 1004).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   RLSD06
AC   CVCL_G157
SY   Anti-PA 1; DB90 5D5.4.3
DR   CLO; CLO_0008836
DR   ATCC; HB-8527
DR   Wikidata; Q54950611
RX   Patent=US4690890;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8527.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RLSD09
AC   CVCL_G158
SY   Anti-PA 3; Anti-PA 2; DB90 5CT3.5.2
DR   CLO; CLO_0008837
DR   ATCC; HB-8525
DR   Wikidata; Q54950612
RX   Patent=US4690890;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8525.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RLT-2M
AC   CVCL_5U44
DR   Wikidata; Q54950613
RX   PubMed=2872200;
CC   Doubling time: 33 hours (PubMed=2872200).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   RLT-3C
AC   CVCL_5U45
SY   RLT-2M3C
DR   Wikidata; Q54950622
RX   PubMed=2872200;
CC   Doubling time: 48 hours (PubMed=2872200).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5U44 ! RLT-2M
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   RLT-5G
AC   CVCL_5U46
SY   RLT-2M5G
DR   Wikidata; Q54950623
RX   PubMed=2872200;
CC   Doubling time: 30 hours (PubMed=2872200).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5U44 ! RLT-2M
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   RLT-9F
AC   CVCL_5U47
SY   RLT-2M9F
DR   Wikidata; Q54950624
RX   PubMed=2872200;
CC   Doubling time: 72 hours (PubMed=2872200).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5U44 ! RLT-2M
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   RLT-PSC
AC   CVCL_A5TG
SY   i-hPSC
DR   Wikidata; Q107116745
RX   PubMed=16127427;
RX   PubMed=30621293;
CC   Doubling time: 28.6 +- 2.5 hours (PubMed=30621293).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
DI   NCIt; C84637; Chronic pancreatitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   RLTM01
AC   CVCL_G159
SY   Anti-PAP 1; DB87 8G2.7.4
DR   CLO; CLO_0008838
DR   ATCC; HB-8526
DR   Wikidata; Q54950625
RX   Patent=US4690890;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8526.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15309; Human ACPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RLTM02
AC   CVCL_G160
SY   Anti-PAP 2; DB91 5A3.3.2
DR   CLO; CLO_0008839
DR   ATCC; HB-8523
DR   Wikidata; Q54950627
RX   Patent=US4690890;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8523.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P15309; Human ACPP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RLUN001-2
AC   CVCL_E3NW
SY   RLUN001; RLUN1-2; RLUN1; F_PDO_000150
DR   CancerTools; 160933
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN002-3
AC   CVCL_E3NX
SY   RLUN002; RLUN2-3; RLUN2; F_PDO_000136
DR   CancerTools; 160934
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN004-2
AC   CVCL_E3NY
SY   RLUN004; RLUN4-2; RLUN4; F_PDO_000116
DR   CancerTools; 160935
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN005-2
AC   CVCL_E3NZ
SY   RLUN005; RLUN5-2; RLUN5; F_PDO_000027
DR   CancerTools; 160936
RX   PubMed=31137590;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: 5 days (PubMed=31137590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN007-3
AC   CVCL_E3JA
SY   RLUN007; RLUN7-3; RLUN7; F_PDO_000209
DR   CancerTools; 160938
RX   PubMed=34180908;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN008-2
AC   CVCL_E3P0
SY   RLUN008; RLUN8-2; RLUN8; F_PDO_000032
DR   CancerTools; 160939
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN010-2
AC   CVCL_E3P1
SY   RLUN010; RLUN10-2; RLUN10; F_PDO_000077
DR   CancerTools; 160940
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C45512; Lung colloid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN012-2
AC   CVCL_E3PD
SY   RLUN012; RLUN12-2; RLUN12; F_PDO_000081
DR   CancerTools; 160942
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN014-2
AC   CVCL_E3PE
SY   RLUN014; RLUN14-2; RLUN14; F_PDO_000083
DR   CancerTools; 160943
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN016-2
AC   CVCL_E3PF
SY   RLUN016; RLUN16-2; RLUN16; F_PDO_000124
DR   CancerTools; 160945
RX   PubMed=31137590;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: 7 days (PubMed=31137590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN017-2
AC   CVCL_E3PG
SY   RLUN017; RLUN17-2; RLUN17; F_PDO_000088
DR   CancerTools; 160946
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN018-4
AC   CVCL_E3PH
SY   RLUN018; RLUN18-4; RLUN18; F_PDO_000089
DR   CancerTools; 160947
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C136709; Invasive lung mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN020
AC   CVCL_E3PI
SY   RLUN20; F_PDO_000090
DR   CancerTools; 160948
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C45512; Lung colloid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN021
AC   CVCL_E3PJ
SY   RLUN21; F_PDO_000091
DR   CancerTools; 160949
RX   PubMed=31137590;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: 10 days (PubMed=31137590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN022
AC   CVCL_E3PK
SY   RLUN22; F_PDO_000092
DR   CancerTools; 160950
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN023
AC   CVCL_E3PL
SY   RLUN23; F_PDO_000093
DR   CancerTools; 160951
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN027
AC   CVCL_E3PM
SY   RLUN27; F_PDO_000140
DR   CancerTools; 160954
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5672; Lung large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RLUN029
AC   CVCL_E3PN
SY   RLUN29; F_PDO_000146
DR   CancerTools; 160955
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C5650; Lung papillary adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RM-1 [Macaca kidney]
AC   CVCL_A9JX
DR   CCRID; 5301MON-KCB82013YJ
DR   KCB; KCB 82013YJ
DR   Wikidata; Q108821235
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   RM-1 [Mouse prostate carcinoma]
AC   CVCL_B459
SY   RM1
DR   BTO; BTO_0003780
DR   ATCC; CRL-3310
DR   CCRID; 3101MOUTCM14
DR   CLS; 305168
DR   Ubigene; YC-C049
DR   Wikidata; Q54950629
RX   PubMed=7538321;
CC   Transformant: Recombinant retrovirus Zipras/myc9 (v-Ha-Ras and v-Myc).
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Ubigene=YC-C049
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17,18
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 15
ST   Mouse STR 12-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 18-3: 16
ST   Mouse STR X-1: 27
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   RM-2 [Macaca kidney]
AC   CVCL_A9JY
DR   CCRID; 5301MON-KCB04004ZJ
DR   KCB; KCB 200404ZJ
DR   Wikidata; Q108821236
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   RM-2 [Mouse prostate carcinoma]
AC   CVCL_B460
DR   ATCC; CRL-3311
DR   Wikidata; Q54950630
RX   PubMed=7538321;
CC   Transformant: Recombinant retrovirus Zipras/myc9 (v-Ha-Ras and v-Myc).
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   RM-3
AC   CVCL_A9JW
DR   CCRID; 5301MON-KCB04006ZJ
DR   KCB; KCB 200406ZJ
DR   Wikidata; Q108821237
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RM-82
AC   CVCL_9714
SY   RM 82; RM82
DR   EFO; EFO_0002853
DR   cancercelllines; CVCL_9714
DR   Cosmic; 1388893
DR   GEO; GSM510007
DR   IARC_TP53; 709
DR   Progenetix; CVCL_9714
DR   Wikidata; Q54950632
RX   PubMed=1320624;
RX   PubMed=8335680;
RX   PubMed=8378080;
RX   PubMed=11004677;
RX   PubMed=15150091;
RX   PubMed=19787792;
RX   PubMed=21822310;
RX   PubMed=26428435;
RX   PubMed=30879952;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=15150091).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=8378080; PubMed=19787792).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=19787792; PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 12,16
ST   D21S11: 28,32.2
ST   D2S1338: 20,25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 18
ST   SE33: 26.2
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   RM-9
AC   CVCL_B461
DR   ATCC; CRL-3312
DR   Wikidata; Q54950633
RX   PubMed=7538321;
CC   Transformant: Recombinant retrovirus Zipras/myc9 (v-Ha-Ras and v-Myc).
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   RM-HS1
AC   CVCL_N851
DR   Wikidata; Q54950634
RX   PubMed=2432306;
CC   Population: Caucasian.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   RM-P1
AC   CVCL_JG30
DR   JCRB; JCRB1650
DR   Wikidata; Q54950635
RX   PubMed=12215016;
RX   PubMed=19521981;
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
ST   Source(s): JCRB=JCRB1650
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 12
ST   D5S818: 9,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 8
//
ID   RM-R
AC   CVCL_XH29
DR   CCLV; CCLV-RIE 0035
DR   Wikidata; Q98129109
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   RM-S1
AC   CVCL_A9II
DR   CCRID; 5301MON-KCB00016ZJ
DR   KCB; KCB 200016ZJ
DR   Wikidata; Q108821238
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   RM1 [Human Wilms tumor]
AC   CVCL_M845
SY   W4
DR   Wikidata; Q54950636
RX   PubMed=8266105;
CC   Characteristics: Established by subcuntaous inoculation of the minced tumor in nude mice (PubMed=8266105).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   RM1 [Rat muscle]
AC   CVCL_XB60
SY   Rat Muscle 1
DR   CCRID; 5301RAT-KCB0705MZJ
DR   KCB; KCB 200705MZJ
DR   Wikidata; Q98129112
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   RM1 fat-1
AC   CVCL_E6ZK
DR   ABM; T6272
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6272).
CC   Doubling time: 20-25 hours (ABM=T6272).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B459 ! RM-1 [Mouse prostate carcinoma]
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RM1-4
AC   CVCL_JY22
DR   Wikidata; Q54950637
RX   PubMed=8056457;
CC   Characteristics: ER-negative and PR-negative.
CC   Doubling time: 16 hours (PubMed=8056457).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   22-24M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   RM10
AC   CVCL_8463
SY   RM-10
DR   BioSample; SAMN03151811
DR   Wikidata; Q54950638
RX   PubMed=2167410;
RX   PubMed=10071072;
RX   PubMed=10516762;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=10516762; PubMed=12592342; PubMed=20143388). Originally thought to originate from the bone marrow of a 44 year old female patient with chronic myelogenous leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00262.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   RM17-5R
AC   CVCL_JY23
DR   Wikidata; Q54950639
RX   PubMed=7529136;
RX   PubMed=8056457;
CC   Characteristics: ER-negative and PR-negative.
CC   Doubling time: 29 hours (PubMed=8056457).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   22-24M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   RM22-F5
AC   CVCL_JY24
DR   Wikidata; Q54950640
RX   PubMed=8056457;
CC   Characteristics: ER-positive and PR-negative.
CC   Doubling time: 24 hours (PubMed=8056457).
CC   Sequence variation: Mutation; RGD; 2827; Hras; Simple; p.Gly12Glu (c.35G>A); Zygosity=Hemizygous (PubMed=8056457).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C64039; Carcinosarcoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   22-24M
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   RM3/1
AC   CVCL_A0DX
DR   Wikidata; Q108821239
RX   PubMed=3450546;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RM43
AC   CVCL_YQ08
DR   Wikidata; Q98129114
RX   PubMed=23992230;
RX   PubMed=24013424;
RX   PubMed=25015330;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 5
//
ID   RMA
AC   CVCL_J385
DR   BTO; BTO_0006562
DR   CLO; CLO_0037201
DR   CCRID; 1101MOU-PUMC000414
DR   Wikidata; Q54950642
RX   PubMed=3877776;
RX   PubMed=11132152;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J303 ! RBL-5
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 14
//
ID   RMA-B7H6
AC   CVCL_VA23
SY   RMA/B7H6
DR   Wikidata; Q54950644
RX   PubMed=25830550;
RX   PubMed=29453518;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:42400; NCR3LG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J385 ! RMA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 27-11-25; Version: 10
//
ID   RMA-CD112alpha
AC   CVCL_E8G4
RX   PubMed=15752754;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97822; Nectin2 (Note=Isoform alpha; with a N-terminal FLAG tag).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J385 ! RMA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   RMA-CD112delta
AC   CVCL_E8G5
RX   PubMed=15752754;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:97822; Nectin2 (Note=Isoform delta; with a N-terminal FLAG tag).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J385 ! RMA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   RMA-CD155
AC   CVCL_E8G6
RX   PubMed=15752754;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:107741; Pvr (Note=With a N-terminal FLAG tag).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J385 ! RMA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   RMA-S
AC   CVCL_2180
SY   RMA/S; RMAS
DR   BTO; BTO_0006563
DR   ChEMBL-Cells; CHEMBL3307428
DR   ChEMBL-Targets; CHEMBL614880
DR   Lonza; 60
DR   PubChem_Cell_line; CVCL_2180
DR   TOKU-E; 4090
DR   Wikidata; Q54950645
RX   PubMed=2066183;
RX   PubMed=11132152;
RX   PubMed=17982631;
CC   Characteristics: Deficient in antigen processing.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J385 ! RMA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 18
//
ID   RMA-S-A*2402
AC   CVCL_WK58
DR   Wikidata; Q98129117
RX   PubMed=17982631;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*24:02).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2180 ! RMA-S
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 27-11-25; Version: 10
//
ID   RMA-S.Trh4
AC   CVCL_C0DD
DR   CancerTools; 157675
DR   Wikidata; Q114312801
DR   Ximbio; 157675
RX   PubMed=21898382;
RX   PubMed=29399388;
CC   Characteristics: This cell line provides a model to help to understand T-cell recognition through Cers5/Trh4 expression (Ximbio=157675).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1919199; Cers5.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2180 ! RMA-S
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   RMA-SKb+
AC   CVCL_YB11
DR   Wikidata; Q98129119
RX   PubMed=11132152;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2180 ! RMA-S
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 6
//
ID   RMA-SKb-
AC   CVCL_YB12
DR   Wikidata; Q98129121
RX   PubMed=11132152;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2180 ! RMA-S
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 6
//
ID   RMA-SKb- Ec7.1
AC   CVCL_YB13
SY   Ec7.1
DR   Wikidata; Q98129125
RX   PubMed=11132152;
CC   Characteristics: Lacks H-2D(B) and H2-K(B) expression.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_YB12 ! RMA-SKb-
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 6
//
ID   RMA.Trh4
AC   CVCL_C0DC
DR   CancerTools; 157676
DR   Wikidata; Q114312802
DR   Ximbio; 157676
RX   PubMed=21898382;
RX   PubMed=29399388;
CC   Characteristics: This cell line provides a model to help to understand T-cell recognition through Cers5/Trh4 expression (Ximbio=157676).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1919199; Cers5.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J385 ! RMA
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 9
//
ID   RMA.Trh4 Db KO
AC   CVCL_C0DE
SY   RMA.Trh4.Db-/-
DR   CancerTools; 157677
DR   Wikidata; Q114312803
DR   Ximbio; 157677
RX   PubMed=29399388;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95896; H2-D1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1919199; Cers5.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DC ! RMA.Trh4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   RMA.Trh4 Kb KO
AC   CVCL_C0DQ
SY   RMA.Trh4.kb-/-
DR   CancerTools; 157678
DR   Wikidata; Q114312805
DR   Ximbio; 157678
RX   PubMed=29399388;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95904; H2-K1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1919199; Cers5.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C0DC ! RMA.Trh4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 27-11-25; Version: 8
//
ID   RMab-22
AC   CVCL_D3E9
DR   Wikidata; Q127384055
RX   PubMed=23376717;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   RMab-3
AC   CVCL_D3EA
DR   Wikidata; Q127384057
RX   PubMed=22396072;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   RMAM001
AC   CVCL_E3NT
SY   RMAM1; F_PDO_000035
DR   CancerTools; 160989
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RMAM007-3
AC   CVCL_E3PP
SY   RMAM007; RMAM7-3; RMAM7; F_PDO_000187
DR   CancerTools; 160957
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C7362; Breast scirrhous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RMB-1
AC   CVCL_2181
DR   CLO; CLO_0008844
DR   DSMZ; ACC-391
DR   DSMZCellDive; ACC-391
DR   Wikidata; Q54950646
RX   PubMed=6937267;
CC   Doubling time: ~30-35 hours (DSMZ=ACC-391).
CC   Transformant: NCBI_TaxID; 11938; Rauscher murine leukemia virus (R-MuLV).
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   RMC
AC   CVCL_0506
SY   Rat Mesangial Cell
DR   BTO; BTO_0006362
DR   CLO; CLO_0008845
DR   MCCL; MCC:0000403
DR   ATCC; CRL-2573
DR   BCRC; 60415
DR   CCRID; 1101RAT-PUMC000415
DR   Wikidata; Q54950647
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/rmc/rmccells.html
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Kidney, mesangium; UBERON=UBERON_0002319.
CC   Cell type: Mesangial cell; CL=CL_0000650.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   RMC-1
AC   CVCL_5354
DR   CLO; CLO_0051598
DR   RCB; RCB2299
DR   Wikidata; Q54950649
RX   PubMed=28174618;
CC   Genetic integration: Method=Transgenic rat; Gene=HGNC; HGNC:5173; HRAS.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jcl:SD-Tg(HRAS)128Ncc/Jcl (Hras128/Jcl) transgenic; RS=RS_0004930.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   rMC-1
AC   CVCL_8140
SY   retinal Muller Cell line-1
DR   BTO; BTO_0003559
DR   ABM; T0576
DR   GEO; GSM3497788
DR   GEO; GSM3497789
DR   GEO; GSM3497790
DR   Kerafast; ENW001
DR   PRIDE; PXD001463
DR   Wikidata; Q54950650
RX   PubMed=9430566;
RX   PubMed=26854824;
RX   PubMed=30677389;
RX   PubMed=31372389;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/6586-Immortalized-Retinal-M-ller-Cell-Line-rMC-1.html
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   RMC-11
AC   CVCL_5355
DR   CLO; CLO_0051601
DR   RCB; RCB2303
DR   Wikidata; Q54950651
RX   PubMed=28174618;
CC   Genetic integration: Method=Transgenic rat; Gene=HGNC; HGNC:5173; HRAS.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jcl:SD-Tg(HRAS)128Ncc/Jcl (Hras128/Jcl) transgenic; RS=RS_0004930.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RMC-17
AC   CVCL_5356
DR   CLO; CLO_0051602
DR   RCB; RCB2304
DR   Wikidata; Q54950652
RX   PubMed=28174618;
CC   Genetic integration: Method=Transgenic rat; Gene=HGNC; HGNC:5173; HRAS.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jcl:SD-Tg(HRAS)128Ncc/Jcl (Hras128/Jcl) transgenic; RS=RS_0004930.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RMC-2
AC   CVCL_5357
DR   CLO; CLO_0051597
DR   RCB; RCB2300
DR   Wikidata; Q54950653
RX   PubMed=28174618;
CC   Genetic integration: Method=Transgenic rat; Gene=HGNC; HGNC:5173; HRAS.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jcl:SD-Tg(HRAS)128Ncc/Jcl (Hras128/Jcl) transgenic; RS=RS_0004930.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RMC-3
AC   CVCL_5358
DR   CLO; CLO_0051599
DR   RCB; RCB2301
DR   Wikidata; Q54950654
RX   PubMed=28174618;
CC   Genetic integration: Method=Transgenic rat; Gene=HGNC; HGNC:5173; HRAS.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jcl:SD-Tg(HRAS)128Ncc/Jcl (Hras128/Jcl) transgenic; RS=RS_0004930.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RMC-6
AC   CVCL_5359
DR   CLO; CLO_0051600
DR   RCB; RCB2302
DR   Wikidata; Q54950655
RX   PubMed=28174618;
CC   Genetic integration: Method=Transgenic rat; Gene=HGNC; HGNC:5173; HRAS.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Jcl:SD-Tg(HRAS)128Ncc/Jcl (Hras128/Jcl) transgenic; RS=RS_0004930.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RMC1
AC   CVCL_5U81
DR   Wikidata; Q54950657
RX   PubMed=2105838;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RMC2C
AC   CVCL_B3PS
DR   Wikidata; Q110433170
RX   PubMed=32359397;
CC   Population: African American.
CC   Doubling time: 32 hours (PubMed=32359397).
CC   Karyotypic information: Near hypertriploid karyotype (PubMed=32359397).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=32359397).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   RmcB
AC   CVCL_G161
DR   CLO; CLO_0008846
DR   ATCC; CRL-2379
DR   Wikidata; Q54950658
RX   PubMed=2451756;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P78310; Human CXADR/CAR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   RMCCA-1
AC   CVCL_M257
SY   RM-CC-A1; RMCC-A1; RMCCA1
DR   Wikidata; Q54950659
RX   CelloPub=CLPUB00275;
RX   PubMed=17072981;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 48 hours (PubMed=17072981).
DI   NCIt; C96805; Small duct intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 12
//
ID   RMCGENi005-A
AC   CVCL_C9I0
SY   IPS15-00009
DR   BioSamples; SAMEA113611953
DR   hPSCreg; RMCGENi005-A
DR   Wikidata; Q123033359
RX   PubMed=37441824;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Val256Val (c.768G>T); ClinVar=VCV000099505; Zygosity=Homozygous; Note=Affects splicing (PubMed=37441824).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   RMCGENi005-A-1
AC   CVCL_C9I1
SY   IPS21-00158
DR   BioSamples; SAMEA113682895
DR   hPSCreg; RMCGENi005-A-1
DR   Wikidata; Q123033360
RX   PubMed=37480818;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple_corrected; p.Val256Val (c.768G>T); ClinVar=VCV000099505; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37480818).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9I0 ! RMCGENi005-A
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   RMCGENi020-A
AC   CVCL_D4XJ
SY   IPS15-00004
DR   BioSamples; SAMEA114482613
DR   hPSCreg; RMCGENi020-A
DR   Wikidata; Q127384059
RX   PubMed=37979432;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Karyotypic information: Has an heterozygous deletion in chromosome 1p22.3 detected between positions g.86,398,969-90,924,388 (~4.5 Mb), which is not found in the original fibroblast line (PubMed=37979432).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Phe608Ile (c.1822T>A); ClinVar=VCV000236087; Zygosity=Heterozygous (PubMed=37979432).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.4253+43G>A; ClinVar=VCV000099265; Zygosity=Heterozygous (PubMed=37979432).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.6006-609T>A; Zygosity=Heterozygous (PubMed=37979432).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   RMCGENi021-A
AC   CVCL_D6J7
SY   IPS22-00087
DR   BioSamples; SAMEA114490598
DR   hPSCreg; RMCGENi021-A
DR   Wikidata; Q127384061
RX   PubMed=38607040;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Glu1087Lys (c.3259G>A); ClinVar=VCV000099211; Zygosity=Heterozygous (PubMed=38607040).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Gln2272_Asp2273ins*11 (c.6817-713A>G); Zygosity=Heterozygous (PubMed=38607040).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   RME
AC   CVCL_XX93
DR   CCRID; 4201PAT-CCTCC00833
DR   Wikidata; Q98129127
RX   Patent=CN105837684A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201619.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_21891; N6-methyladenosine (m6A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   RME-5-1
AC   CVCL_JJ73
DR   Wikidata; Q54950660
RX   PubMed=6983989;
CC   Doubling time: 18.7 hours (PubMed=6983989).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5T95 ! RME-5-3-1
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   RME-5-1/TMT
AC   CVCL_JJ74
DR   Wikidata; Q54950661
RX   PubMed=6983989;
CC   Characteristics: Established from tumors induced by implantation of the parent cell line in C3H/He mice.
CC   Doubling time: 14.4 hours (PubMed=6983989).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JJ73 ! RME-5-1
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   RME-5-3-1
AC   CVCL_5T95
DR   Wikidata; Q54950662
RX   PubMed=6983989;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_JJ73 ! RME-5-1
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   RME1
AC   CVCL_JJ71
DR   Wikidata; Q54950663
RX   PubMed=25832766;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 28 Celsius. Grow slowly at 23 Celsius. Do not grow at all at 18 Celsius (PubMed=25832766).
CC   Doubling time: 18.73 hours (Note=Grown with no fish embryo extract), 18.78 hours (Note=With 1 ml-1 fish embryo extract), 20.32 hours (Note=With 2 ml-1 fish embryo extract) (PubMed=25832766).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=435243; ! Gnathopogon caerulescens (Willow shiner)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   RMF
AC   CVCL_F0B9
SY   Rare Minnow Fin
RX   DOI=10.3724/SP.J.1035.2009.40767;
CC   Group: Fish cell line.
CC   Characteristics: Can grow between 15 to 30 Celsius, with an optimal growth temperature of 25 Celsius (DOI=10.3724/SP.J.1035.2009.40767).
CC   Doubling time: ~24 hours (Note=At 25 Celsius and with 20% FBS), ~30 hours (Note=With 15% FBS), ~36 hours (Note=With 10% FBS) (DOI=10.3724/SP.J.1035.2009.40767).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=143606; ! Gobiocypris rarus (Chinese rare minnow)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RMF/EG
AC   CVCL_E7G3
SY   Reduction Mammary Fibroblasts immortalized with human Telomere and GFP
RX   PubMed=15051869;
CC   Characteristics: Used humanize the fat pad of NOD/SCID mice prior to engrafting patient samples to generate PDX models (PubMed=15051869).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11766; TGFB1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: Fibroblast of breast; CL=CL_4006000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29-37Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   RMG-I
AC   CVCL_1662
SY   RMGI; RMG1; RMG-1
DR   BTO; BTO_0004930
DR   CLO; CLO_0037103
DR   EFO; EFO_0006746
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1000
DR   BioSample; SAMN03471003
DR   BioSample; SAMN10988355
DR   cancercelllines; CVCL_1662
DR   Cell_Model_Passport; SIDM00352
DR   CGH-DB; 336-2
DR   CGH-DB; 9362-4
DR   ChEMBL-Cells; CHEMBL3308778
DR   ChEMBL-Targets; CHEMBL1075564
DR   Cosmic; 909699
DR   Cosmic; 931360
DR   Cosmic; 945377
DR   Cosmic; 1152556
DR   Cosmic; 1223319
DR   Cosmic; 1328068
DR   Cosmic; 1708378
DR   Cosmic; 1889262
DR   Cosmic; 2482708
DR   Cosmic; 2582799
DR   Cosmic-CLP; 909699
DR   DepMap; ACH-000719
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909699
DR   GEO; GSM416682
DR   GEO; GSM659403
DR   GEO; GSM827210
DR   GEO; GSM887544
DR   GEO; GSM888627
DR   GEO; GSM1001429
DR   GEO; GSM1001430
DR   GEO; GSM1176283
DR   GEO; GSM1340592
DR   GEO; GSM1670383
DR   GEO; GSM2475004
DR   IARC_TP53; 21289
DR   JCRB; FDSC0027
DR   JCRB; IFO50315
DR   JCRB; JCRB0172
DR   LiGeA; CCLE_443
DR   LINCS_LDP; LCL-1805
DR   PharmacoDB; RMGI_1320_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1662
DR   PubChem_Cell_line; CVCL_1662
DR   Wikidata; Q54950664
RX   CelloPub=CLPUB00481;
RX   PubMed=3154025;
RX   PubMed=8980248;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
RX   PubMed=20081105;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=23430509;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25485619;
RX   PubMed=25846456;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=3154025); 40 hours (PubMed=25984343); ~3 days (Note=Lot 07022008), ~72 hours (Note=Lot 12252012), ~57 hours (Note=Lot 01212019) (JCRB=IFO50315); ~30 hours (Note=Lot 07052011), ~31 hours (Note=Lot 07142017), ~33 hours (Note=Lot 02042020) (JCRB=JCRB0172).
CC   HLA typing: A*24:02,24:02; B*40:02,40:02; C*03:04,03:04 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*40:02,40:02; C*03:04,03:04; DRB1*11:02,11:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=8980248).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Arg (c.174A>C) (p.Ser73Arg, c.217A>C); ClinVar=VCV000128200; Zygosity=Unspecified (PubMed=25846456).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=909699; DepMap=ACH-000719).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.61%; East Asian, North=81.67%; East Asian, South=17.3%; South Asian=0%; European, North=0.42%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0027; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=909699; JCRB=IFO50315; JCRB=JCRB0172; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 13,15
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 15,16
ST   FGA: 25,26
ST   Penta D: 9,10
ST   Penta E: 15,16
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   RMG-I-C
AC   CVCL_IS64
SY   RMG-1-C
DR   Wikidata; Q54950665
RX   PubMed=15649251;
RX   PubMed=18686606;
RX   PubMed=25502083;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1662 ! RMG-I
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   RMG-I-H
AC   CVCL_IS65
SY   RMG-1-H
DR   Wikidata; Q54950666
RX   PubMed=15649251;
RX   PubMed=18686606;
RX   PubMed=19771531;
RX   PubMed=25502083;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4012; FUT1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1662 ! RMG-I
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 14
//
ID   RMG-II
AC   CVCL_2803
SY   RMG2; RMG-2
DR   BTO; BTO_0004929
DR   BioSample; SAMN03470819
DR   cancercelllines; CVCL_2803
DR   CGH-DB; 335-2
DR   CGH-DB; 9363-4
DR   Cosmic; 1152557
DR   Cosmic; 2582801
DR   GEO; GSM1176284
DR   JCRB; FDSC0028
DR   JCRB; IFO50316
DR   JCRB; JCRB0172.1
DR   Progenetix; CVCL_2803
DR   Wikidata; Q54950667
RX   PubMed=1715339;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
RX   PubMed=24023729;
RX   PubMed=25846456;
RX   PubMed=25960936;
CC   Population: Japanese.
CC   Doubling time: ~58 hours (PubMed=1715339); 84 hours (Note=Lot 07132004), ~51 hours (Note=Lot 02032016) (JCRB=JCRB0172.1).
CC   HLA typing: A*02:07,02:07; B*35:01,35:01; C*03:03,03:03; DQB1*02:02,02:02 (PubMed=25960936).
CC   Discontinued: JCRB; IFO50316; true.
CC   Discontinued: JCRB; FDSC0028; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB0172.1
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   RMG-V
AC   CVCL_M716
DR   JCRB; JCRB1729
DR   TKG; TKG 0720
DR   Wikidata; Q54950672
RX   PubMed=17022146;
CC   Population: Japanese.
CC   Doubling time: 15.5 hours (PubMed=17022146).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1729
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 10,11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 13
//
ID   RMKN-28
AC   CVCL_QZ55
DR   cancercelllines; CVCL_QZ55
DR   Wikidata; Q54950673
RX   PubMed=22490663;
CC   Problematic cell line: Contaminated. Parent cell line (MKN28) has been shown to be a MKN74 derivative.
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Leu (c.751A>C); ClinVar=VCV000182937; Zygosity=Unspecified (PubMed=22490663).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1416 ! MKN28
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   RML
AC   CVCL_E818
SY   REM; TER244; TER-244; Ter 244; TER325; TER-325; Ter 325; Extract 111; Extract 315
DR   dbMHC; 49010
DR   ECACC; 88052106
DR   IHW; IHW09016
DR   IPD-IMGT/HLA; 11316
DR   Wikidata; Q54950674
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=11782282;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Native South American; Warao.
CC   HLA typing: A*02:04; B*51:01:01:01; C*15:02:01:01; DPA1*01:03; DPB1*04:02:01; DQA1*05:05; DQB1*03:01:01; DRA*01:01; DRB1*16:02:01; DRB5*02:02; DRB6*02:02 (IPD-IMGT/HLA=11316).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   RML-12
AC   CVCL_Z829
SY   RML12; Rocky Mountain Laboratory-12
DR   Wikidata; Q54950676
RX   DOI=10.1016/B978-0-12-470270-7.50022-7;
RX   PubMed=2563994;
RX   PubMed=6137452;
RX   PubMed=18836024;
RX   PubMed=19951376;
RX   PubMed=20976219;
RX   PubMed=26519596;
RX   PubMed=29973702;
CC   Group: Insect cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Aedes aegypti origin but found to be from Aedes albopictus (PubMed=19951376).
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   RML-14
AC   CVCL_Z181
SY   Rocky Mountain Laboratory-14
DR   Wikidata; Q54950677
RX   CelloPub=CLPUB00496;
RX   Patent=US4447537;
RX   PubMed=592041;
CC   Group: Tick cell line.
CC   Doubling time: ~70 hours (PubMed=592041).
CC   Miscellaneous: Cell line no longer exist. As described in Patent=US4447537 it 'has accidentally been extinguished by toxic culture medium and bacterial contamination of frozen stocks'.
OX   NCBI_TaxID=60255; ! Dermacentor parumapertus (Rabbit tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   RML-16
AC   CVCL_Z183
SY   Rocky Mountain Laboratory-16
DR   Wikidata; Q54950678
RX   Patent=US4447537;
RX   PubMed=7275139;
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8053.
CC   Miscellaneous: Cell line no longer available (personal communication of Schwan, Tom G. to Bell-Sakyi, Lesley).
OX   NCBI_TaxID=60255; ! Dermacentor parumapertus (Rabbit tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   RML-17
AC   CVCL_Z184
SY   Rocky Mountain Laboratory-17
DR   ATCC; CRL-8054
DR   Wikidata; Q54950679
RX   Patent=US4447537;
RX   PubMed=7275139;
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8054.
CC   Miscellaneous: Cell line no longer available (personal communication of Schwan, Tom G. to Bell-Sakyi, Lesley).
CC   Discontinued: ATCC; CRL-8054; true.
OX   NCBI_TaxID=60255; ! Dermacentor parumapertus (Rabbit tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   RML-18
AC   CVCL_Z185
SY   Rocky Mountain Laboratory-18
DR   ATCC; CRL-8055
DR   Wikidata; Q54950680
RX   Patent=US4447537;
RX   PubMed=7275139;
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8055.
CC   Miscellaneous: Cell line no longer available (personal communication of Schwan, Tom G. to Bell-Sakyi, Lesley).
OX   NCBI_TaxID=34621; ! Dermacentor variabilis (American dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   RML-19
AC   CVCL_Z186
SY   Rocky Mountain Laboratory-19
DR   Wikidata; Q54950681
RX   Patent=US4447537;
RX   PubMed=7275139;
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8056.
CC   Miscellaneous: Cell line no longer available (personal communication of Schwan, Tom G. to Bell-Sakyi, Lesley).
OX   NCBI_TaxID=34621; ! Dermacentor variabilis (American dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   RML-2
AC   CVCL_C2T5
SY   Rocky Mountain Laboratory-2
DR   ICLDB; rml-2
DR   Wikidata; Q114312806
RX   DOI=10.1016/B978-0-12-470270-7.50022-7;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=180277; ! Opodiphthera eucalypti (Emperor gum moth)
HI   CVCL_Z109 ! Ae
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   RML-20
AC   CVCL_Z187
SY   Rocky Mountain Laboratory-20
DR   ATCC; CRL-8057
DR   Wikidata; Q54950682
RX   Patent=US4447537;
RX   PubMed=7275139;
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8057.
CC   Miscellaneous: Cell line no longer available (personal communication of Schwan, Tom G. to Bell-Sakyi, Lesley).
CC   Discontinued: ATCC; CRL-8057; true.
OX   NCBI_TaxID=34621; ! Dermacentor variabilis (American dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   RML-RSE
AC   CVCL_Z182
SY   RML-15
DR   Wikidata; Q54950684
RX   Patent=US4447537;
RX   PubMed=7275139;
RX   PubMed=22743047;
RX   PubMed=26210950;
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Patented cell line.
CC   Group: Tick cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of Dermacentor variabilis origin but found to be from Rhipicephalus sanguineus (PubMed=26210950).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00583.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8052.
OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus (Brown dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   RML-Yoshi
AC   CVCL_L435
DR   CLO; CLO_0050687
DR   BioSample; SAMN03472106
DR   RCB; RCB1561
DR   Wikidata; Q54950685
RX   PubMed=17395773;
CC   Population: Japanese.
CC   Senescence: Senesces at 22 PDL (PubMed=17395773).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB1561
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 02-05-24; Version: 12
//
ID   RML12.wMelPopCLA
AC   CVCL_ZF40
DR   Wikidata; Q98129129
RX   PubMed=18836024;
RX   PubMed=20976219;
CC   Group: Insect cell line.
CC   Problematic cell line: Misidentified. Parent cell line (RML-12) was originally thought to be of Aedes aegypti origin but found to be from Aedes albopictus.
CC   Characteristics: Infected by Wolbachia pipientis strain wMelPop-CLA.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z829 ! RML-12
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   RMM-A1
AC   CVCL_A6UV
DR   RCB; RCB5295
DR   Wikidata; Q107116746
RX   DOI=10.24729/00000673;
CC   Characteristics: Tumorigenic.
CC   Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60451; Rat malignant melanoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6UU ! RMM-C
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RMM-C
AC   CVCL_A6UU
DR   RCB; RCB5294
DR   Wikidata; Q107116747
RX   DOI=10.24729/00000673;
RX   PubMed=26949998;
CC   Characteristics: Established from the transplantable tumor RMM.
CC   Doubling time: 17.2 hours (Note=At 10th passage), 14.8 hours (Note=At 30th passage) (PubMed=26949998).
CC   Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60451; Rat malignant melanoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RMM-CAF
AC   CVCL_A6UW
SY   RMM-Cancer-Associated Fibroblasts
DR   RCB; RCB5296
DR   Wikidata; Q107116748
RX   DOI=10.24729/00000673;
CC   Characteristics: Non-tumorigenic.
CC   Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60451; Rat malignant melanoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A6UU ! RMM-C
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RMNE6
AC   CVCL_D887
DR   Wikidata; Q54950687
RX   PubMed=18407253;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   RMO1
AC   CVCL_Y563
DR   Wikidata; Q54950686
RX   PubMed=23076971;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Doubling time: 28.8 hours (PubMed=23076971).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=435243; ! Gnathopogon caerulescens (Willow shiner)
SX   Female
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   RMS
AC   CVCL_W527
DR   cancercelllines; CVCL_W527
DR   Cosmic; 687961
DR   Cosmic; 801754
DR   Cosmic; 1037299
DR   Cosmic; 1048112
DR   GEO; GSM219593
DR   GEO; GSM1012753
DR   IARC_TP53; 768
DR   PRIDE; PXD039480
DR   Progenetix; CVCL_W527
DR   Wikidata; Q54950688
RX   PubMed=2216456;
RX   PubMed=2486618;
RX   PubMed=18082704;
RX   PubMed=19235922;
RX   PubMed=23578105;
RX   PubMed=23665679;
RX   PubMed=36768928;
CC   Population: Japanese.
CC   Doubling time: 20-24 hours (PubMed=2486618).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Unspecified (PubMed=2216456).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   4Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   RMS-1
AC   CVCL_UF94
DR   Wikidata; Q98129132
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RMS-11
AC   CVCL_UF97
DR   Wikidata; Q98129133
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RMS-14
AC   CVCL_UF99
DR   Wikidata; Q98129135
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   RMS-15
AC   CVCL_UG00
DR   Wikidata; Q98129136
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RMS-16
AC   CVCL_UG01
DR   Wikidata; Q98129137
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RMS-17
AC   CVCL_UG02
DR   Wikidata; Q98129138
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RMS-18
AC   CVCL_UG03
DR   Wikidata; Q98129139
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 6
//
ID   RMS-19
AC   CVCL_UG04
DR   Wikidata; Q98129141
RX   PubMed=2766305;
RX   PubMed=23665679;
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   RMS-20
AC   CVCL_UG05
DR   Wikidata; Q98129143
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RMS-21
AC   CVCL_UG06
DR   Wikidata; Q98129144
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   RMS-4
AC   CVCL_UF95
DR   Wikidata; Q98129145
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 6
//
ID   RMS-5
AC   CVCL_UF96
DR   Wikidata; Q98129147
RX   PubMed=2766305;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   RMS-A1
AC   CVCL_EJ67
DR   Cosmic; 922461
DR   Wikidata; Q54950689
RX   PubMed=8703847;
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   RMS-E2
AC   CVCL_EJ68
DR   Cosmic; 922459
DR   Wikidata; Q54950690
RX   PubMed=8703847;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   RMS-E3
AC   CVCL_EJ69
DR   Cosmic; 922460
DR   Wikidata; Q54950691
RX   PubMed=8703847;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   RMS-GR
AC   CVCL_Y577
DR   Wikidata; Q54950692
RX   PubMed=9685856;
RX   PubMed=10470293;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Doubling time: ~42 hours (PubMed=9685856).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   RMS-YM
AC   CVCL_A792
SY   RMSYM
DR   CLO; CLO_0050151
DR   BioSample; SAMN03472121
DR   Cosmic; 687962
DR   DepMap; ACH-002048
DR   FANTOM5_SSTAR; 10477-106I9
DR   GEO; GSM219743
DR   RCB; RCB1695
DR   Wikidata; Q54950693
RX   PubMed=1906291;
RX   PubMed=19235922;
RX   PubMed=23828214;
RX   PubMed=23882450;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~30 hours (PubMed=1906291).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Arg1163Ter (c.3487C>T); ClinVar=VCV000954289; Zygosity=Homozygous (DepMap=ACH-002048).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urachus; UBERON=UBERON_0002068.
ST   Source(s): RCB=RCB1695
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   RMS/0
AC   CVCL_0P64
SY   RMS 0; RMS0
DR   Wikidata; Q54950694
RX   PubMed=1938276;
CC   Characteristics: Strong lung metastatic phenotype.
CC   Transformant: ChEBI; CHEBI_28112; Nickel atom.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0P65 ! RMS/8
OI   CVCL_0P66 ! S4T
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   RMS/8
AC   CVCL_0P65
SY   RMS 8; RMS8
DR   Wikidata; Q54950695
RX   DOI=10.1007/BF01049456;
RX   PubMed=1938276;
CC   Characteristics: Weak lung metastatic phenotype.
CC   Transformant: ChEBI; CHEBI_28112; Nickel atom.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0P64 ! RMS/0
OI   CVCL_0P66 ! S4T
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   RMS10
AC   CVCL_S105
DR   Wikidata; Q54950696
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   RMS11
AC   CVCL_S106
DR   Wikidata; Q54950697
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS114
AC   CVCL_S107
DR   Wikidata; Q54950699
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Leg; UBERON=UBERON_0000978.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS117
AC   CVCL_S108
DR   Wikidata; Q54950700
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ear; UBERON=UBERON_0001690.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS119
AC   CVCL_S109
DR   Wikidata; Q54950701
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   RMS122
AC   CVCL_S110
DR   Wikidata; Q54950702
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   RMS123
AC   CVCL_S111
DR   Wikidata; Q54950704
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   RMS13
AC   CVCL_S112
DR   Wikidata; Q54950706
RX   PubMed=9823299;
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 11
//
ID   RMS14
AC   CVCL_S113
DR   Wikidata; Q54950707
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hip; UBERON=UBERON_0001464.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS176
AC   CVCL_QW87
SY   RMS-176
DR   Wikidata; Q54950708
RX   PubMed=19706776;
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RMS29
AC   CVCL_S114
DR   Wikidata; Q54950710
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS31
AC   CVCL_S115
DR   Wikidata; Q54950711
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Leg; UBERON=UBERON_0000978.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS33
AC   CVCL_S116
DR   Wikidata; Q54950712
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Leg; UBERON=UBERON_0000978.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS43
AC   CVCL_S117
DR   Wikidata; Q54950713
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   RMS54
AC   CVCL_S118
DR   Wikidata; Q54950714
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Sternum; UBERON=UBERON_0000975.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS559
AC   CVCL_S640
SY   RMS559/R31
DR   Cosmic; 1718097
DR   Cosmic; 2355958
DR   Wikidata; Q54950715
RX   PubMed=12370270;
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Sequence variation: Mutation; HGNC; HGNC:3691; FGFR4; Simple; p.Val550Leu (c.1648G>C); Zygosity=Unspecified (PubMed=22142829).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   RMS7
AC   CVCL_S119
DR   Wikidata; Q54950716
RX   PubMed=14704789;
CC   Characteristics: Highly metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, spine; UBERON=UBERON_0001130.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   RMS740
AC   CVCL_S120
DR   Wikidata; Q54950717
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Diaphragm; UBERON=UBERON_0001103.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   RMS772
AC   CVCL_S121
DR   Wikidata; Q54950726
RX   PubMed=14704789;
CC   Characteristics: Poor metastatic phenotype.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Breed/subspecies: FVB/N x C57BL/6 HGF/SF Ink4/Arf-/- transgenic.
DI   NCIt; C24022; Mouse rhabdomyosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   rMSC-GFP
AC   CVCL_8419
SY   RMSC-GFP; GFP-rMSC
DR   JCRB; JCRB1310
DR   Wikidata; Q54950727
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   rMSC-LacZ
AC   CVCL_8420
DR   JCRB; JCRB1312
DR   Wikidata; Q54950728
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   rMSC-Luci
AC   CVCL_8421
DR   JCRB; JCRB1315
DR   Wikidata; Q54950729
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   RMT-1 E4
AC   CVCL_5360
SY   RMT-1 clone E4; RMT-1 clone Epithelial 4
DR   JCRB; JCRB0242
DR   Wikidata; Q54950730
RX   PubMed=2411993;
CC   Doubling time: 14 hours (PubMed=2411993).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5361 ! RMT-1 M2
SX   Female
AG   20W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   RMT-1 M2
AC   CVCL_5361
SY   RMT-1 clone M2; RMT-1 clone Myoepithelial-like 2
DR   JCRB; JCRB0245
DR   Wikidata; Q54950731
RX   PubMed=2411993;
CC   Doubling time: 24.4 hours (PubMed=2411993).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5360 ! RMT-1 E4
SX   Female
AG   20W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   RMT1
AC   CVCL_Y564
DR   Wikidata; Q54950732
RX   PubMed=23076971;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Doubling time: 24.4 hours (PubMed=23076971).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=435243; ! Gnathopogon caerulescens (Willow shiner)
SX   Male
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   RMUG-L
AC   CVCL_3157
SY   RMUGL
DR   BioSample; SAMN03151923
DR   BioSample; SAMN03472785
DR   CGH-DB; 346-2
DR   CGH-DB; 9364-4
DR   Cosmic; 2429303
DR   GEO; GSM1001421
DR   GEO; GSM1001422
DR   JCRB; IFO50319
DR   Wikidata; Q54950734
RX   CelloPub=CLPUB00481;
RX   PubMed=2083224;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
RX   PubMed=19154404;
RX   PubMed=22246397;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SNG-II derivative. Originally thought to originate from a 62 year old female patient with an ovarian mucinous cystadenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00421.
CC   Population: Japanese.
CC   Doubling time: 53 hours (PubMed=2083224).
CC   Discontinued: JCRB; IFO50319; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=IFO50319
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,9,11
ST   D16S539: 12,13,14
ST   D5S818: 6,12,13
ST   D7S820: 8,9,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,16,17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3170 ! SNG-II
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   RMUG-S
AC   CVCL_3158
SY   RMUGS
DR   CLO; CLO_0037297
DR   EFO; EFO_0006747
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 476
DR   BioSample; SAMN03471004
DR   BioSample; SAMN10987616
DR   cancercelllines; CVCL_3158
DR   Cell_Model_Passport; SIDM01347
DR   CGH-DB; 347-2
DR   CGH-DB; 350-3
DR   Cosmic; 1305332
DR   Cosmic; 2429304
DR   DepMap; ACH-000701
DR   EGA; EGAS00001000610
DR   GEO; GSM659404
DR   GEO; GSM887545
DR   GEO; GSM888628
DR   IARC_TP53; 28251
DR   JCRB; IFO50320
DR   LiGeA; CCLE_579
DR   PharmacoDB; RMUGS_1321_2019
DR   Progenetix; CVCL_3158
DR   Wikidata; Q54950735
RX   CelloPub=CLPUB00481;
RX   PubMed=2083224;
RX   PubMed=17671176;
RX   PubMed=19154404;
RX   PubMed=20596667;
RX   PubMed=22246397;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 43 hours (PubMed=2083224); 75 hours (PubMed=25984343); ~25 hours (Note=Lot 03162009), ~36 hours (Note=Lot 02242017) (JCRB=IFO50320).
CC   HLA typing: A*02:07,33:03; B*15:18,46:01; C*01:02,03:03; DQA1*02:01,02:01; DQB1*03:02,03:02; DRB1*11:30,11:30 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala347Val (c.1040C>T); ClinVar=VCV000422725; Zygosity=Homozygous (DepMap=ACH-000701).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.94%; Native American=0.79%; East Asian, North=40.77%; East Asian, South=53.64%; South Asian=0%; European, North=0%; European, South=3.86% (PubMed=30894373).
CC   Misspelling: RUMG-S; CGH-DB=347-2; CGH-DB=350-3.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): JCRB=IFO50320; PubMed=20596667; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 12,14.2
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 13 (PubMed=20596667)
ST   D3S1358: 14 (PubMed=25877200)
ST   D5S818: 10,14
ST   D7S820: 12
ST   D8S1179: 11
ST   FGA: 19,24
ST   Penta D: 13
ST   Penta E: 5,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   RMZ
AC   CVCL_8422
DR   CLO; CLO_0008848
DR   CLDB; cl4165
DR   Cell_Model_Passport; SIDM01869
DR   Wikidata; Q54950736
RX   CelloPub=CLPUB00569;
RX   PubMed=3801282;
RX   PubMed=23882450;
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (PubMed=3801282).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   RMZ-RC2
AC   CVCL_L510
SY   RMZ clone RC2; RC2
DR   Cell_Model_Passport; SIDM01916
DR   Cosmic; 1082513
DR   DepMap; ACH-001743
DR   Wikidata; Q54950737
RX   PubMed=3801282;
RX   PubMed=8617485;
RX   PubMed=23882450;
WW   Provider; Metalab; -; https://web.archive.org/web/20170423034824/http://lollini.it/rmz.htm
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~38 hours (PubMed=3801282).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8422 ! RMZ
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   RMZ-RC5
AC   CVCL_L511
SY   RMZ clone RC5
DR   Cell_Model_Passport; SIDM01923
DR   Wikidata; Q54950739
RX   PubMed=3801282;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8422 ! RMZ
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   RN
AC   CVCL_WT23
DR   Wikidata; Q98129148
RX   PubMed=78764;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but is probably a B-lymphoblastoid cell line (PubMed=29533902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M628 ! RSp
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 6
//
ID   RN 22
AC   CVCL_4293
SY   RN-2
DR   CLO; CLO_0008849
DR   CLDB; cl4166
DR   ECACC; 93011414
DR   Wikidata; Q54950740
RX   PubMed=4342966;
CC   Doubling time: ~20 hours (PubMed=4342966).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, cervical spinal nerve root; UBERON=UBERON_0009632.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   Rn 5TES
AC   CVCL_6438
DR   CLO; CLO_0008852
DR   ATCC; CRL-6513
DR   Wikidata; Q54950741
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6513; true.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   RN-1-R
AC   CVCL_XH35
DR   CCLV; CCLV-RIE 0036
DR   Wikidata; Q98129151
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   RN-GA
AC   CVCL_9895
DR   Wikidata; Q54950742
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2703273;
CC   Doubling time: 21 hours (PubMed=2703273).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   RN-R
AC   CVCL_XH09
DR   CCLV; CCLV-RIE 0027
DR   Wikidata; Q98129152
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   Rn1T
AC   CVCL_3590
DR   CLO; CLO_0008853
DR   ATCC; CRL-6598
DR   Wikidata; Q54950743
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6598; true.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Rn2Nod
AC   CVCL_U278
DR   ATCC; CRL-6600
DR   Wikidata; Q54950744
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6600; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_3591 ! Rn2T
SX   Female
AG   2Y
CA   Undefined cell line type
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 6
//
ID   Rn2T
AC   CVCL_3591
DR   CLO; CLO_0008854
DR   ATCC; CRL-6599
DR   Wikidata; Q54950745
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_U278 ! Rn2Nod
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   RN33B
AC   CVCL_0E00
SY   Rn33B
DR   EFO; EFO_0022816
DR   ATCC; CRL-2825
DR   Wikidata; Q54950747
RX   PubMed=7905006;
RX   PubMed=8364724;
RX   PubMed=8699192;
RX   PubMed=12061867;
RX   PubMed=12112642;
RX   PubMed=15139013;
RX   PubMed=22863662;
RX   PubMed=31758567;
CC   Characteristics: Profiferates at the permissive temperature (33 Celsius). At the restrictive temperature (38.5 Celsius) ceases mitotic activity and differentiates with phase bright cell bodies and 'neuritic-like' processes.
CC   Doubling time: 48 hours (PubMed=8364724).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, medullary raphe nucleus; UBERON=UBERON_0002692.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   12-13FD
CA   Conditionally immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 17
//
ID   Rn33B-A68B2M
AC   CVCL_C1L0
DR   Wikidata; Q114312807
RX   PubMed=31758567;
CC   Virology: Susceptible to infection by equine herpesvirus type 1 (EHV-1) (PubMed=31758567).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; C9K796; Horse ELA A68.
CC   Genetic integration: Method=Transfection/transduction; Gene=VGNC; VGNC:15722; Horse B2M.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, medullary raphe nucleus; UBERON=UBERON_0002692.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0E00 ! RN33B
SX   Sex unspecified
AG   12-13FD
CA   Conditionally immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   RN33B.LV-AA2
AC   CVCL_XF90
DR   Wikidata; Q98129153
RX   PubMed=12112642;
RX   PubMed=15881422;
CC   Characteristics: Expresses eGFP under the control of the CMV promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, medullary raphe nucleus; UBERON=UBERON_0002692.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0E00 ! RN33B
SX   Sex unspecified
AG   12-13FD
CA   Conditionally immortalized cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   Rn3T
AC   CVCL_3592
SY   Rn 3T
DR   CLO; CLO_0008850
DR   ATCC; CRL-6511
DR   Wikidata; Q54950748
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: ATCC; CRL-6511; true.
DI   NCIt; C134942; Rat neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   RN46A
AC   CVCL_D261
SY   RN-46A
DR   BTO; BTO_0003779
DR   EFO; EFO_0022804
DR   ECACC; 12061302
DR   Wikidata; Q54950749
RX   PubMed=7601307;
RX   PubMed=7965075;
RX   PubMed=8690054;
RX   PubMed=22863662;
CC   Characteristics: At the restrictive temperature (39 Celsius) the cells are capable of differentiating.
CC   Doubling time: 9 hours (Note=At 33 Celsius) (PubMed=7965075); 19 hours (ECACC=12061302).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, medullary raphe nucleus; UBERON=UBERON_0002692.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 18
//
ID   RN46A-B14
AC   CVCL_U016
SY   46A-B14
DR   ECACC; 12061303
DR   Wikidata; Q54950750
RX   PubMed=8690054;
CC   Doubling time: 25 hours (ECACC=12061303).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2202; Bdnf.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, medullary raphe nucleus; UBERON=UBERON_0002692.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_D261 ! RN46A
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 15
//
ID   Rn4T
AC   CVCL_3593
SY   Rn 4T
DR   CLO; CLO_0008851
DR   ATCC; CRL-6512
DR   Wikidata; Q54950751
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: ATCC; CRL-6512; true.
DI   NCIt; C134942; Rat neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   RN5
AC   CVCL_4Z50
DR   Wikidata; Q54950753
RX   PubMed=25877069;
CC   Breed/subspecies: C57BL/6J Nf2+/-.
DI   NCIt; C21619; Mouse mesothelioma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 4
//
ID   Rn6T
AC   CVCL_3594
DR   CLO; CLO_0008855
DR   ATCC; CRL-6601
DR   Wikidata; Q54950755
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Discontinued: ATCC; CRL-6601; true.
DI   NCIt; C134942; Rat neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   RNA-iPSC #1
AC   CVCL_A8XX
SY   RNAiPS_1
DR   GEO; GSM4610407
DR   Wikidata; Q108821240
RX   PubMed=31178141;
CC   Group: Non-human primate cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
HI   CVCL_A8XW ! E01F
SX   Female
AG   95FD
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   RNB
AC   CVCL_D273
DR   JCRB; IFO50491
DR   Wikidata; Q54950756
CC   Doubling time: 20 hours (Note=Lot 09212010) (JCRB=IFO50491).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   RNCEC/HL-032
AC   CVCL_B6ZA
SY   Rabbit Normal Cornea Epithelial Cell/HL-032
DR   CCRID; 4201PAT-CCTCC00880
DR   Wikidata; Q112044499
RX   Patent=CN107058213A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201677.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   RNJ11
AC   CVCL_B906
DR   Wikidata; Q54950757
WW   Info; NIHhESC; -; https://acd.od.nih.gov/documents/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reprogenetics, LLC; Livingston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   RNJ12
AC   CVCL_B907
DR   Wikidata; Q54950758
WW   Info; NIHhESC; -; https://acd.od.nih.gov/documents/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reprogenetics, LLC; Livingston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   RNJ18
AC   CVCL_B908
DR   NIHhESC; NIHhESC-11-0128
DR   Wikidata; Q54950759
CC   From: Reprogenetics, LLC; Livingston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0128.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RNJ19
AC   CVCL_B909
DR   NIHhESC; NIHhESC-11-0126
DR   Wikidata; Q54950760
CC   From: Reprogenetics, LLC; Livingston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0126.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RNJ20
AC   CVCL_B910
DR   NIHhESC; NIHhESC-11-0127
DR   Wikidata; Q54950762
CC   From: Reprogenetics, LLC; Livingston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0127.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   RNJ7
AC   CVCL_B911
DR   Wikidata; Q54950763
WW   Info; NIHhESC; -; https://acd.od.nih.gov/documents/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
WW   Info; NIHhESC; -; https://grants.nih.gov/stem_cells/registry/not_approved.htm
CC   From: Reprogenetics, LLC; Livingston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; not approved.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   RNK-0
AC   CVCL_F854
SY   Rat Natural Killer-0
DR   Wikidata; Q54950764
RX   PubMed=6197459;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-1
AC   CVCL_F856
SY   Rat Natural Killer-1
DR   Wikidata; Q54950765
RX   PubMed=6197459;
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-10
AC   CVCL_F857
SY   Rat Natural Killer-10
DR   Wikidata; Q54950766
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-11
AC   CVCL_F852
SY   Rat Natural Killer-11
DR   Wikidata; Q54950767
RX   PubMed=6197459;
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-16
AC   CVCL_6849
SY   RNK16; CRNK-16; Rat Natural Killer-16
DR   BTO; BTO_0002031
DR   Wikidata; Q54950768
RX   PubMed=6197459;
RX   PubMed=6837719;
RX   PubMed=8133042;
RX   PubMed=16465528;
WW   Info; -; -; https://web.archive.org/web/20141104152235/http://www2.kumc.edu/soalab/LabLinks/cell%20lines/rnk16.htm
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   RNK-4
AC   CVCL_F859
SY   Rat Natural Killer-4
DR   Wikidata; Q54950769
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-5
AC   CVCL_F860
SY   Rat Natural Killer-5
DR   Wikidata; Q54950770
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-6
AC   CVCL_F858
SY   Rat Natural Killer-6
DR   Wikidata; Q54950771
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-7
AC   CVCL_F855
SY   Rat Natural Killer-7
DR   Wikidata; Q54950781
RX   PubMed=6197459;
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-8
AC   CVCL_F853
SY   Rat Natural Killer-8
DR   Wikidata; Q54950782
RX   PubMed=6197459;
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RNK-9
AC   CVCL_F861
SY   Rat Natural Killer-9
DR   Wikidata; Q54950783
RX   PubMed=6837719;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64066; Rat large granular lymphocyte leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RnKerTr-NYUSC-1
AC   CVCL_BS97
DR   GEO; GSM144733
DR   GEO; GSM144734
DR   GEO; GSM144735
DR   GEO; GSM144736
DR   GEO; GSM144737
DR   GEO; GSM144738
DR   Wikidata; Q54950784
RX   PubMed=17392591;
RX   PubMed=26107436;
CC   Transformant: NCIt; C129641; Iron-56 ion irradiation.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Cell line has been lost.
CC   Miscellaneous: Cell line name, transformant, sex of donor and loss of cell line, from personal communication of Burns, Fredric J.
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   RNL-1
AC   CVCL_WM66
SY   RNL1
DR   Wikidata; Q98129154
RX   PubMed=1845952;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13591; Human NCAM1/CD56.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   RNL-2
AC   CVCL_WM67
SY   RNL2
DR   Wikidata; Q98129155
RX   PubMed=1845952;
RX   PubMed=7685762;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16799; Human RTN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   RNL-3
AC   CVCL_WM68
SY   RNL3
DR   Wikidata; Q98129156
RX   PubMed=1845952;
RX   PubMed=7685762;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16799; Human RTN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   RNRMUi001-A
AC   CVCL_D0MQ
SY   RDEB-iPSC-d1
DR   BioSamples; SAMEA113934129
DR   hPSCreg; RNRMUi001-A
DR   Wikidata; Q123033361
CC   From: Pirogov Russian National Research Medical University; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RNRMUi002-A
AC   CVCL_D0MR
SY   RDEB-iPSC-d2
DR   BioSamples; SAMEA113966367
DR   hPSCreg; RNRMUi002-A
DR   Wikidata; Q123033362
CC   From: Pirogov Russian National Research Medical University; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RNRMUi003-A
AC   CVCL_D0MS
SY   RDEB-iPSC-d3A
DR   BioSamples; SAMEA113966806
DR   hPSCreg; RNRMUi003-A
DR   Wikidata; Q123033363
CC   From: Pirogov Russian National Research Medical University; Moscow; Russia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RNRMUi005-A
AC   CVCL_D0MT
SY   RDEB-iPSC-d4
DR   hPSCreg; RNRMUi005-A
DR   Wikidata; Q123033364
CC   From: Pirogov Russian National Research Medical University; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RNRMUi006-A
AC   CVCL_D0MU
SY   RDEB-iPSC-d10
DR   hPSCreg; RNRMUi006-A
DR   Wikidata; Q123033365
CC   From: Pirogov Russian National Research Medical University; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RNRMUi007-A
AC   CVCL_D0MV
SY   RDEB-iPSC-d12
DR   hPSCreg; RNRMUi007-A
DR   Wikidata; Q123033366
CC   From: Pirogov Russian National Research Medical University; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RO
AC   CVCL_1886
SY   Ro; Robert
DR   BioSample; SAMN03473551
DR   DSMZ; ACC-452
DR   DSMZCellDive; ACC-452
DR   Wikidata; Q54950785
RX   PubMed=3133120;
RX   PubMed=7744245;
RX   PubMed=20454443;
CC   Doubling time: ~50-60 hours (DSMZ=ACC-452).
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Arg294Ter (c.880C>T); ClinVar=VCV001431893; Zygosity=Homozygous (PubMed=7744245).
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Pro409Arg (c.1226C>G); ClinVar=VCV000292612; Zygosity=Homozygous (PubMed=7744245).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-452
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 28,29
ST   D2S1338: 20,21
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   Ro
AC   CVCL_U878
SY   Rossi
DR   cancercelllines; CVCL_U878
DR   Wikidata; Q54950786
RX   PubMed=11169959;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/Ro.html
CC   From: Scarpa, Aldo; Universita di Verona; Verona; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=11169959).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   Ro Bel
AC   CVCL_X713
SY   Robel
DR   ATCC; CRL-1187
DR   Wikidata; Q54950787
RX   PubMed=450131;
RX   PubMed=6458814;
RX   PubMed=6621576;
RX   PubMed=7301938;
RX   PubMed=22282976;
CC   Discontinued: ATCC; CRL-1187; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 8
//
ID   Ro Bon
AC   CVCL_3585
DR   CLO; CLO_0008856
DR   ATCC; CRL-1248
DR   Wikidata; Q54950789
RX   PubMed=1054840;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Ro cl 3-1
AC   CVCL_6G53
SY   Rocl3-1
DR   Wikidata; Q54950790
RX   PubMed=2656885;
RX   PubMed=6574462;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   Ro Das
AC   CVCL_Y127
SY   RoDas
DR   ATCC; CRL-1114
DR   Wikidata; Q54950791
CC   Discontinued: ATCC; CRL-1114; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 7
//
ID   Ro Dow
AC   CVCL_3586
DR   CLO; CLO_0008857
DR   ATCC; CRL-1337
DR   BioSample; SAMN03471354
DR   Wikidata; Q54950792
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1337
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C125697; Ehlers-Danlos syndrome, type II
DI   ORDO; Orphanet_287; Classical Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   Ro Hen
AC   CVCL_0F68
DR   ATCC; CRL-1118
DR   Wikidata; Q54950793
CC   Discontinued: ATCC; CRL-1118; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   Ro Shi
AC   CVCL_3587
DR   CLO; CLO_0008858
DR   ATCC; CRL-1310
DR   Wikidata; Q54950794
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85019; Porokeratosis
DI   ORDO; Orphanet_79358; Porokeratosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Ro Vid
AC   CVCL_3588
DR   CLO; CLO_0008859
DR   ATCC; CRL-1308
DR   Wikidata; Q54950796
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   RO-D81-1
AC   CVCL_M779
DR   BioSample; SAMN03151796
DR   cancercelllines; CVCL_M779
DR   Wikidata; Q54950797
RX   PubMed=2538133;
RX   PubMed=23472229;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=23472229). Originally thought to originate from a thyroid gland medullary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00482.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 26
//
ID   RO-H85-1
AC   CVCL_A666
SY   HRO 85-1
DR   BioSample; SAMN03151606
DR   Wikidata; Q54950798
RX   PubMed=2538133;
RX   PubMed=7736432;
RX   PubMed=23472229;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a 647V derivative (PubMed=23472229). Originally thought to originate from a thyroid gland medullary carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00481.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Gln993Ter (c.2977C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6974; MDM4; Simple; p.Ser161Ter (c.482C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile162Asn (c.485T>A); ClinVar=VCV001408611; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1049 ! 647V
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   ROB [Human mesothelioma]
AC   CVCL_N818
SY   Rob
DR   Cosmic; 1656046
DR   Wikidata; Q54950799
RX   PubMed=15274292;
RX   PubMed=22426987;
RX   PubMed=22552293;
RX   PubMed=22893632;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   ROB [Rat osteoblastic]
AC   CVCL_W165
DR   Wikidata; Q54950800
RX   PubMed=1657329;
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   ROB-C11
AC   CVCL_W176
SY   C11
DR   Wikidata; Q54950801
RX   PubMed=1657329;
WW   Info; KAKEN; 01870076; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-01870076/
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_W165 ! ROB [Rat osteoblastic]
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   ROB-C20
AC   CVCL_W178
SY   C20
DR   Wikidata; Q54950803
RX   PubMed=1657329;
RX   PubMed=1849907;
WW   Info; KAKEN; 01870076; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-01870076/
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_W165 ! ROB [Rat osteoblastic]
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   ROB-C23
AC   CVCL_W177
SY   C23
DR   Wikidata; Q54950804
RX   PubMed=1657329;
WW   Info; KAKEN; 01870076; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-01870076/
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_W165 ! ROB [Rat osteoblastic]
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   ROB-C26
AC   CVCL_0507
SY   C26
DR   MCCL; MCC:0000404
DR   Wikidata; Q54950805
RX   PubMed=1657329;
RX   PubMed=1849907;
RX   PubMed=16949358;
WW   Info; KAKEN; 01870076; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-01870076/
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_W165 ! ROB [Rat osteoblastic]
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   ROB-C8a
AC   CVCL_W164
SY   C8a
DR   Wikidata; Q54950806
RX   PubMed=1657329;
WW   Info; KAKEN; 01870076; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-01870076/
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_W165 ! ROB [Rat osteoblastic]
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   RoBE-4
AC   CVCL_IP71
SY   Rock Bream Embryo-4
DR   Wikidata; Q54950807
RX   PubMed=27688178;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by red seabream iridovirus (RSIV) (PubMed=27688178).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=163134; ! Oplegnathus fasciatus (Barred knifejaw)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   ROBINETTE
AC   CVCL_C8CY
DR   Wikidata; Q123033367
RX   PubMed=8205524;
CC   Donor information: No history of asbestos exposure (PubMed=8205524).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   ROC-1
AC   CVCL_5H93
DR   Wikidata; Q54950808
RX   PubMed=3456614;
RX   PubMed=8446011;
CC   Characteristics: Hybrid of C6TK- with rat oligodendroglia cells.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5H90 ! C6TK-
CA   Hybrid cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 4
//
ID   ROD1
AC   CVCL_F0J0
RX   PubMed=2606940;
RX   PubMed=7838181;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q381S5; Trypanosoma brucei brucei Tb11.01.6740 (5.20).
CC   Caution: The target of the mAB produced by this hybridoma is called 5.20 by PubMed=7838181 who sequenced a partial clone. However their translation was erroneous and a BlastX shows that it corresponds to Tb11.01.6740.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   ROE2
AC   CVCL_W851
SY   Rat Oral Epithelial 2
DR   GEO; GSM1086963
DR   GEO; GSM1086964
DR   GEO; GSM1086965
DR   GEO; GSM1086966
DR   Wikidata; Q54950809
RX   PubMed=24521861;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Embryonic oral cavity, tongue; UBERON=UBERON_0010056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Conditionally immortalized cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 13
//
ID   RoEnd/4
AC   CVCL_RX67
SY   RoEnd-4
DR   Wikidata; Q54950811
RX   CelloPub=CLPUB00422;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
SX   Female
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   ROF-NL
AC   CVCL_E819
DR   dbMHC; 49011
DR   ECACC; 94071435
DR   IHW; IHW09332
DR   IPD-IMGT/HLA; 11331
DR   Wikidata; Q54950812
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03,32; B*07,55; C*03,07; DQA1*01:02:01; DQB1*06:02; DRB1*15:01:01; DRB5*01:01:01 (IPD-IMGT/HLA=11331).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   ROG
AC   CVCL_6724
SY   Rat Ovarian Granulosa
DR   Wikidata; Q54950813
RX   PubMed=9202200;
RX   PubMed=15541573;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   14D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   ROHA-9
AC   CVCL_F846
SY   Roha-9; Roha 9; ROHA9
DR   Wikidata; Q54950814
RX   PubMed=2435800;
RX   PubMed=6327874;
CC   Characteristics: Secretes IL1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   ROHA-9MC3
AC   CVCL_DD93
SY   ROHA-9 MC3; Roha9-MC3
DR   Wikidata; Q54950815
RX   PubMed=2435800;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F846 ! ROHA-9
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Rok
AC   CVCL_R800
SY   ROK
DR   ATCC; CRL-1854
DR   Wikidata; Q54950816
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-1854; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Rolf B1.T
AC   CVCL_AR52
DR   ECACC; 03071601
DR   Wikidata; Q54950817
RX   PubMed=8833195;
CC   Derived from site: In situ; Nose, nasal cavity, olfactory nerve; UBERON=UBERON_0001579.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   >3M
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 7
//
ID   ROM1
AC   CVCL_E6Z5
DR   ABM; T0413
RX   PubMed=32433794;
RX   PubMed=37899851;
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (ABM=T0413).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Donor information: Established from a patient with recurrent otitis media normal hearing (PubMed=37899851).
CC   Caution: The same name is used for the primary culture described in PubMed=32433794 and the immortalized cell line described in PubMed=37899851.
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C34885; Otitis media
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ROM2
AC   CVCL_E6Z6
DR   ABM; T0414
RX   PubMed=32433794;
RX   PubMed=37899851;
CC   Population: Caucasian.
CC   Doubling time: 48-72 hours (ABM=T0414).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Donor information: Established from a patient with recurrent otitis media normal hearing (PubMed=37899851).
CC   Caution: The same name is used for the primary culture described in PubMed=32433794 and the immortalized cell line described in PubMed=37899851.
CC   Derived from site: In situ; Ear, middle ear; UBERON=UBERON_0001756.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C34885; Otitis media
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y1M
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   ROMCAT
AC   CVCL_VG37
SY   Romcat
DR   Wikidata; Q54950818
RX   CelloPub=CLPUB00429;
RX   PubMed=1726925;
RX   PubMed=10588824;
CC   Derived from site: In situ; Thyroid gland; Note=From a goiter; UBERON=UBERON_0002046.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   Ron Har
AC   CVCL_3159
DR   CLO; CLO_0008861
DR   ATCC; CRL-1131
DR   Wikidata; Q54950819
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   RON169
AC   CVCL_E9UV
SY   RON169A
RX   PubMed=17451356;
WW   Info; EuroMAbNet; -; https://www.euromabnet.com/monoclonal-antibodies/malt1/238.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UDY8; Human MALT1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RoNi/7
AC   CVCL_RX23
SY   RoNi-7
DR   Wikidata; Q54950820
RX   CelloPub=CLPUB00422;
RX   PubMed=23232719;
RX   PubMed=24023659;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   RoNi/7.1
AC   CVCL_RX24
DR   Wikidata; Q54950821
RX   PubMed=21987760;
RX   PubMed=26698106;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
HI   CVCL_RX23 ! RoNi/7
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   ROS 17/2
AC   CVCL_IR39
SY   Rat Osteogenic Sarcoma 17/2
DR   Wikidata; Q54950822
RX   PubMed=6968673;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E273 ! ROS 2/3
OI   CVCL_E231 ! ROS 25/1
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   ROS 17/2.8
AC   CVCL_0508
SY   ROS 17/28; Ros 17/2.8; ROS-17/2.8; ROS17/28; ROS17/2.8
DR   BTO; BTO_0002648
DR   EFO; EFO_0022809
DR   MCCL; MCC:0000405
DR   TOKU-E; 3659
DR   Wikidata; Q54950823
RX   DOI=10.1016/j.asr.2006.02.060;
RX   PubMed=2325669;
RX   PubMed=3855255;
RX   PubMed=7988420;
RX   PubMed=8456584;
RX   PubMed=9028534;
RX   PubMed=9344586;
RX   PubMed=11511518;
CC   Group: Space-flown cell line (cellonaut).
CC   Anecdotal: Have been flown in space on Cosmos-2229 (Bion-10), Foton-11 and Foton-12 to study growth and cytoskeletal changes in microgravity (PubMed=9028534; PubMed=11511518).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_IR39 ! ROS 17/2
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   ROS 17/2.8-5
AC   CVCL_U259
SY   ROS-17/2.8-5
DR   RCB; RCB0462
DR   Wikidata; Q54950830
RX   PubMed=2821716;
CC   Discontinued: RCB; RCB0462; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0508 ! ROS 17/2.8
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   ROS 184
AC   CVCL_VQ05
SY   ROS184
DR   Wikidata; Q98129157
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   ROS 2/3
AC   CVCL_E273
SY   Rat Osteogenic Sarcoma 2/3
DR   Wikidata; Q54950831
RX   PubMed=6968673;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_IR39 ! ROS 17/2
OI   CVCL_E231 ! ROS 25/1
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   ROS 25/1
AC   CVCL_E231
SY   Ros 25/1; ROS25/1; Rat Osteogenic Sarcoma 25/1
DR   Wikidata; Q54950832
RX   PubMed=2325669;
RX   PubMed=6968673;
RX   PubMed=7988420;
RX   PubMed=8456584;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_E273 ! ROS 2/3
OI   CVCL_IR39 ! ROS 17/2
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 9
//
ID   ROS-16
AC   CVCL_ZU68
SY   ROS16
DR   Wikidata; Q98129158
RX   PubMed=2470097;
RX   PubMed=12145705;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   ROS-17
AC   CVCL_QZ50
DR   Wikidata; Q54950824
RX   PubMed=8558920;
RX   PubMed=12145705;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 6
//
ID   ROS-50
AC   CVCL_1887
SY   Ros-50; ROS.50; ROS 50; Ros 50; ROS50; Ros50; Rotterdam Suspension cell line no. 50
DR   CLO; CLO_0037188
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1002
DR   BioSample; SAMN03473536
DR   cancercelllines; CVCL_1887
DR   Cell_Model_Passport; SIDM00415
DR   Cosmic; 2297010
DR   Cosmic-CLP; 1331025
DR   DepMap; ACH-001639
DR   DSMZ; ACC-557
DR   DSMZCellDive; ACC-557
DR   EGA; EGAS00001000978
DR   GDSC; 1331025
DR   GEO; GSM119485
DR   GEO; GSM1035323
DR   GEO; GSM1670385
DR   LINCS_LDP; LCL-1094
DR   PharmacoDB; ROS50_1323_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1887
DR   Wikidata; Q54950834
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8019967;
RX   PubMed=16960149;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-557).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0%; Native American=0.07%; East Asian, North=0.46%; East Asian, South=0%; South Asian=1.38%; European, North=66.51%; European, South=31.58% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1331025; DepMap=ACH-001639; DSMZ=ACC-557
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 8,12
ST   D18S51: 14,15
ST   D19S433: 15,16
ST   D21S11: 29,31
ST   D2S1338: 20,26
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 10,15
ST   FGA: 24,26
ST   Penta D: 10
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   ROSA KIT D816V
AC   CVCL_5G50
DR   Wikidata; Q54950836
RX   CelloPub=CLPUB00277;
RX   Patent=US10383955;
RX   PubMed=24677542;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4552.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=With del 417-419 insY).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G49 ! ROSA KIT WT
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   ROSA KIT Delta 417-419 insY
AC   CVCL_5G51
DR   Wikidata; Q54950837
RX   CelloPub=CLPUB00277;
RX   Patent=US10383955;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4553.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6342; KIT (Note=With del 417-419 insY).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G49 ! ROSA KIT WT
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   ROSA KIT WT
AC   CVCL_5G49
DR   Wikidata; Q54950835
RX   CelloPub=CLPUB00277;
RX   Patent=US10383955;
RX   PubMed=24677542;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4551.
CC   Characteristics: KITLG dependent.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Factor-dependent cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
ID   ROSE 199
AC   CVCL_B6GY
SY   Rat Ovarian Surface Epithelium 199
DR   Wikidata; Q112044500
RX   PubMed=4029476;
RX   PubMed=8069444;
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   ROSE 239
AC   CVCL_B6GZ
SY   Rat Ovarian Surface Epithelium 239
DR   Wikidata; Q112044502
RX   PubMed=4029476;
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   Rosi
AC   CVCL_A5AJ
SY   ROSI
DR   Wikidata; Q107116750
RX   PubMed=30674989;
CC   Miscellaneous: Age/sex of donor and cancer type from personal communication of van Baren, Nicolas.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5AU ! Rosi EBV-B
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   Rosi EBV-B
AC   CVCL_A5AU
SY   Rosi EBV
DR   Wikidata; Q107116751
RX   PubMed=17131342;
CC   HLA typing: A*24:02,32:01; B*35:03,44:031; C*04:01,04:01 (PubMed=17131342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5AJ ! Rosi
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ROT58/C3
AC   CVCL_HA29
DR   Wikidata; Q54950838
RX   PubMed=106957;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   ROT68/C1
AC   CVCL_HA30
DR   Wikidata; Q54950839
RX   PubMed=106957;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   ROT68/C1 Cis-Ptr
AC   CVCL_HA31
SY   Cis-Ptr
DR   Wikidata; Q54950840
RX   PubMed=2702997;
RX   PubMed=3169090;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C129858; Rat ovarian adenocarcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_HA30 ! ROT68/C1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 13
//
ID   ROV-S
AC   CVCL_3415
SY   ROV
DR   CLDB; cl7164
DR   ICLC; HTL05002
DR   Wikidata; Q54950841
RX   PubMed=2543775;
RX   PubMed=3465677;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C61235; Shwachman-Diamond syndrome
DI   ORDO; Orphanet_811; Shwachman-Diamond syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Rov9
AC   CVCL_U156
DR   Wikidata; Q54950842
RX   PubMed=11259656;
CC   Characteristics: After exposure to scrapie agent, cultures were repeatedly found to accumulate high levels of abnormal PrP (PrPres) (PubMed=11259656).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P23907; Sheep PRNP (Note=With p.Ala136Val and p.Arg171Gln = VRQ allele).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3155 ! RK 13
SX   Sex unspecified
AG   5W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   ROVA
AC   CVCL_5166
DR   BTO; BTO_0003113
DR   SKY/M-FISH/CGH; 2651
DR   Wikidata; Q54950843
RX   PubMed=12659655;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   ROVA001-4
AC   CVCL_E3PQ
SY   ROVA001; ROVA1-4; ROVA1; F_PDO_000108
DR   CancerTools; 160962
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA002-4
AC   CVCL_E3PR
SY   ROVA002; ROVA2-4; ROVA2; F_PDO_000006
DR   CancerTools; 160963
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA004-2
AC   CVCL_E3PS
SY   ROVA004; ROVA4-2; ROVA4; F_PDO_000129
DR   CancerTools; 160964
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA007-2
AC   CVCL_E3PT
SY   ROVA007; ROVA7-2; ROVA7; F_PDO_000137
DR   CancerTools; 160965
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA009-2
AC   CVCL_E3PU
SY   ROVA009; ROVA9-2; ROVA9; F_PDO_000045
DR   CancerTools; 160966
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA014-2
AC   CVCL_E3PV
SY   ROVA014; ROVA14-2; ROVA14; F_PDO_000049
DR   CancerTools; 160968
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA016-3
AC   CVCL_E3PW
SY   ROVA016; ROVA16-3; ROVA16; F_PDO_000180
DR   CancerTools; 160969
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA017
AC   CVCL_E3PX
SY   ROVA17; F_PDO_000118
DR   CancerTools; 160970
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA018
AC   CVCL_E3PY
SY   ROVA18; F_PDO_000119
DR   CancerTools; 160971
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ROVA023
AC   CVCL_E3PZ
SY   ROVA23; F_PDO_000168
DR   CancerTools; 160974
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   Royan B1
AC   CVCL_9281
SY   Royan-B1
DR   RSCB; RSCB0001
DR   Wikidata; Q54950844
RX   PubMed=15311967;
RX   PubMed=16973132;
CC   From: Royan Institute; Theran; Iran.
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   Royan B10
AC   CVCL_9282
DR   RSCB; RSCB0236
DR   Wikidata; Q54950846
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B11
AC   CVCL_9283
DR   RSCB; RSCB0237
DR   Wikidata; Q54950847
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B12
AC   CVCL_9284
DR   RSCB; RSCB0238
DR   Wikidata; Q54950848
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B13
AC   CVCL_9285
DR   RSCB; RSCB0239
DR   Wikidata; Q54950849
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B14
AC   CVCL_9286
DR   RSCB; RSCB0240
DR   Wikidata; Q54950850
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B15
AC   CVCL_9287
DR   RSCB; RSCB0241
DR   Wikidata; Q54950851
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B16
AC   CVCL_9288
DR   RSCB; RSCB0242
DR   Wikidata; Q54950852
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B2
AC   CVCL_9289
DR   RSCB; RSCB0002
DR   Wikidata; Q54950853
RX   PubMed=15311967;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B3
AC   CVCL_9290
DR   RSCB; RSCB0229
DR   Wikidata; Q54950855
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B4
AC   CVCL_9291
DR   RSCB; RSCB0230
DR   Wikidata; Q54950856
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B5
AC   CVCL_9496
DR   RSCB; RSCB0231
DR   Wikidata; Q54950857
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B6
AC   CVCL_9292
DR   RSCB; RSCB0232
DR   Wikidata; Q54950858
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B7
AC   CVCL_9293
DR   RSCB; RSCB0233
DR   Wikidata; Q54950859
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B8
AC   CVCL_9294
DR   RSCB; RSCB0234
DR   Wikidata; Q54950860
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan B9
AC   CVCL_9295
DR   RSCB; RSCB0235
DR   Wikidata; Q54950861
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C1
AC   CVCL_9296
DR   RSCB; RSCB0003
DR   Wikidata; Q54950862
RX   PubMed=15311967;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C10
AC   CVCL_9297
DR   RSCB; RSCB0289
DR   Wikidata; Q54950863
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C11
AC   CVCL_9298
DR   RSCB; RSCB0290
DR   Wikidata; Q54950864
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C12
AC   CVCL_9299
DR   RSCB; RSCB0291
DR   Wikidata; Q54950865
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C13
AC   CVCL_9300
DR   RSCB; RSCB0292
DR   Wikidata; Q54950866
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C14
AC   CVCL_9301
DR   RSCB; RSCB0293
DR   Wikidata; Q54950867
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C15
AC   CVCL_9302
DR   RSCB; RSCB0294
DR   Wikidata; Q54950868
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C16
AC   CVCL_9303
DR   RSCB; RSCB0295
DR   Wikidata; Q54950869
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C17
AC   CVCL_9304
DR   RSCB; RSCB0296
DR   Wikidata; Q54950870
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C18
AC   CVCL_9305
DR   RSCB; RSCB0297
DR   Wikidata; Q54950871
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C19
AC   CVCL_9306
DR   RSCB; RSCB0298
DR   Wikidata; Q54950872
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C2.3
AC   CVCL_9307
DR   RSCB; RSCB0004
DR   Wikidata; Q54950883
RX   PubMed=15311967;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C20
AC   CVCL_9308
DR   RSCB; RSCB0299
DR   Wikidata; Q54950884
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C21
AC   CVCL_9309
DR   RSCB; RSCB0300
DR   Wikidata; Q54950885
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C22
AC   CVCL_9310
DR   RSCB; RSCB0301
DR   Wikidata; Q54950886
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C23
AC   CVCL_9311
DR   RSCB; RSCB0302
DR   Wikidata; Q54950887
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C24
AC   CVCL_9312
DR   RSCB; RSCB0303
DR   Wikidata; Q54950888
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C25
AC   CVCL_9313
DR   RSCB; RSCB0304
DR   Wikidata; Q54950889
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C26
AC   CVCL_9314
DR   RSCB; RSCB0305
DR   Wikidata; Q54950890
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C27
AC   CVCL_9315
DR   RSCB; RSCB0306
DR   Wikidata; Q54950891
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C28
AC   CVCL_9316
DR   RSCB; RSCB0307
DR   Wikidata; Q54950893
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C29
AC   CVCL_9317
DR   RSCB; RSCB0308
DR   Wikidata; Q54950894
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C3.4
AC   CVCL_9318
SY   Royan C3
DR   RSCB; RSCB0005
DR   Wikidata; Q54950895
RX   PubMed=15311967;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C30
AC   CVCL_9319
DR   RSCB; RSCB0309
DR   Wikidata; Q54950896
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C31
AC   CVCL_9320
DR   RSCB; RSCB0310
DR   Wikidata; Q54950898
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C32
AC   CVCL_9321
DR   RSCB; RSCB0311
DR   Wikidata; Q54950899
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C33
AC   CVCL_9322
DR   RSCB; RSCB0312
DR   Wikidata; Q54950900
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C34
AC   CVCL_9323
DR   RSCB; RSCB0313
DR   Wikidata; Q54950901
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C35
AC   CVCL_9324
DR   RSCB; RSCB0314
DR   Wikidata; Q54950903
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C36
AC   CVCL_9325
DR   RSCB; RSCB0315
DR   Wikidata; Q54950904
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C37
AC   CVCL_9326
DR   RSCB; RSCB0316
DR   Wikidata; Q54950906
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C38
AC   CVCL_9327
DR   RSCB; RSCB0323
DR   Wikidata; Q54950907
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C39
AC   CVCL_9328
DR   RSCB; RSCB0324
DR   Wikidata; Q54950908
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C4
AC   CVCL_9329
DR   RSCB; RSCB0154
DR   Wikidata; Q54950909
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C40
AC   CVCL_9330
DR   RSCB; RSCB0325
DR   Wikidata; Q54950910
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C41
AC   CVCL_9331
DR   RSCB; RSCB0326
DR   Wikidata; Q54950911
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C42
AC   CVCL_9332
DR   RSCB; RSCB0327
DR   Wikidata; Q54950912
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C5
AC   CVCL_9333
DR   RSCB; RSCB0155
DR   Wikidata; Q54950913
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c x NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C6
AC   CVCL_9334
DR   RSCB; RSCB0156
DR   Wikidata; Q54950914
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c x NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C7
AC   CVCL_9335
DR   RSCB; RSCB0286
DR   Wikidata; Q54950915
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C8
AC   CVCL_9336
DR   RSCB; RSCB0287
DR   Wikidata; Q54950916
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan C9
AC   CVCL_9337
DR   RSCB; RSCB0288
DR   Wikidata; Q54950918
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D1
AC   CVCL_9338
DR   RSCB; RSCB0251
DR   Wikidata; Q54950920
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D10
AC   CVCL_9339
DR   RSCB; RSCB0260
DR   Wikidata; Q54950922
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D11
AC   CVCL_9340
DR   RSCB; RSCB0261
DR   Wikidata; Q54950923
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D12
AC   CVCL_9341
DR   RSCB; RSCB0262
DR   Wikidata; Q54950924
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D13
AC   CVCL_9342
DR   RSCB; RSCB0263
DR   Wikidata; Q54950925
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D14
AC   CVCL_9343
DR   RSCB; RSCB0264
DR   Wikidata; Q54950926
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D15
AC   CVCL_9344
DR   RSCB; RSCB0265
DR   Wikidata; Q54950927
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D16
AC   CVCL_9345
DR   RSCB; RSCB0266
DR   Wikidata; Q54950929
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D17
AC   CVCL_9346
DR   RSCB; RSCB0267
DR   Wikidata; Q54950930
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D18
AC   CVCL_9347
DR   RSCB; RSCB0268
DR   Wikidata; Q54950944
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D19
AC   CVCL_9348
DR   RSCB; RSCB0269
DR   Wikidata; Q54950946
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D2
AC   CVCL_9349
DR   RSCB; RSCB0252
DR   Wikidata; Q54950947
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D20
AC   CVCL_9350
DR   RSCB; RSCB0270
DR   Wikidata; Q54950948
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D21
AC   CVCL_9351
DR   RSCB; RSCB0271
DR   Wikidata; Q54950949
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D22
AC   CVCL_9352
DR   RSCB; RSCB0272
DR   Wikidata; Q54950950
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D23
AC   CVCL_9353
DR   RSCB; RSCB0273
DR   Wikidata; Q54950951
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D24
AC   CVCL_9354
DR   RSCB; RSCB0274
DR   Wikidata; Q54950952
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D25
AC   CVCL_9355
DR   RSCB; RSCB0275
DR   Wikidata; Q54950953
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D26
AC   CVCL_9356
DR   RSCB; RSCB0276
DR   Wikidata; Q54950954
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D27
AC   CVCL_9357
DR   RSCB; RSCB0277
DR   Wikidata; Q54950955
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D28
AC   CVCL_9358
DR   RSCB; RSCB0278
DR   Wikidata; Q54950956
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D29
AC   CVCL_9359
DR   RSCB; RSCB0279
DR   Wikidata; Q54950958
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D3
AC   CVCL_9360
DR   RSCB; RSCB0253
DR   Wikidata; Q54950959
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D30
AC   CVCL_9361
DR   RSCB; RSCB0280
DR   Wikidata; Q54950960
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D31
AC   CVCL_9362
DR   RSCB; RSCB0281
DR   Wikidata; Q54950961
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D32
AC   CVCL_9363
DR   RSCB; RSCB0282
DR   Wikidata; Q54950962
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D33
AC   CVCL_9364
DR   RSCB; RSCB0283
DR   Wikidata; Q54950963
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D34
AC   CVCL_9365
DR   RSCB; RSCB0284
DR   Wikidata; Q54950965
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D35
AC   CVCL_9366
DR   RSCB; RSCB0285
DR   Wikidata; Q54950966
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D4
AC   CVCL_9367
DR   RSCB; RSCB0254
DR   Wikidata; Q54950967
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D5
AC   CVCL_9368
DR   RSCB; RSCB0255
DR   Wikidata; Q54950968
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D6
AC   CVCL_9369
DR   RSCB; RSCB0256
DR   Wikidata; Q54950969
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D7
AC   CVCL_9370
DR   RSCB; RSCB0257
DR   Wikidata; Q54950970
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D8
AC   CVCL_9371
DR   RSCB; RSCB0258
DR   Wikidata; Q54950971
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan D9
AC   CVCL_9372
DR   RSCB; RSCB0259
DR   Wikidata; Q54950972
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F1
AC   CVCL_9373
DR   RSCB; RSCB0243
DR   Wikidata; Q54950973
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F2
AC   CVCL_9374
DR   RSCB; RSCB0244
DR   Wikidata; Q54950974
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F3
AC   CVCL_9375
DR   RSCB; RSCB0245
DR   Wikidata; Q54950975
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F4
AC   CVCL_9376
DR   RSCB; RSCB0246
DR   Wikidata; Q54950976
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F5
AC   CVCL_9377
DR   RSCB; RSCB0247
DR   Wikidata; Q54950977
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F6
AC   CVCL_9378
DR   RSCB; RSCB0248
DR   Wikidata; Q54950978
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F7
AC   CVCL_9379
DR   RSCB; RSCB0249
DR   Wikidata; Q54950979
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan F8
AC   CVCL_9380
DR   RSCB; RSCB0250
DR   Wikidata; Q54950981
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan H1
AC   CVCL_9381
SY   ROYANH1; RIe001-A
DR   hPSCreg; RIe001-A
DR   RSCB; RSCB0018
DR   SKIP; SKIP002007
DR   Wikidata; Q54950982
RX   PubMed=15270778;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   Royan H10
AC   CVCL_9382
SY   RIe010-A
DR   hPSCreg; RIe010-A
DR   RSCB; RSCB0027
DR   SKIP; SKIP002356
DR   Wikidata; Q54950983
RX   PubMed=20177993;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Royan H2
AC   CVCL_9383
SY   ROYANH2; RIe002-A
DR   hPSCreg; RIe002-A
DR   RSCB; RSCB0019
DR   SKIP; SKIP002008
DR   Wikidata; Q54950984
RX   PubMed=16512855;
CC   From: Royan Institute; Theran; Iran.
CC   Doubling time: 31.5 +- 0.8 hours (PubMed=16512855).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   Royan H3
AC   CVCL_9384
SY   RIe003-A
DR   hPSCreg; RIe003-A
DR   RSCB; RSCB0020
DR   SKIP; SKIP002009
DR   Wikidata; Q54950986
RX   PubMed=16512855;
CC   From: Royan Institute; Theran; Iran.
CC   Doubling time: 23.8 +- 0.7 hours (PubMed=16512855).
CC   Karyotypic information: 69,XXY (PubMed=16512855).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   Royan H4
AC   CVCL_9385
SY   RIe004-A
DR   hPSCreg; RIe004-A
DR   RSCB; RSCB0021
DR   SKIP; SKIP002010
DR   Wikidata; Q54950987
RX   PubMed=16512855;
CC   From: Royan Institute; Theran; Iran.
CC   Doubling time: 23.2 +- 0.4 hours (PubMed=16512855).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   Royan H5
AC   CVCL_9386
SY   ROYANH5; RIe005-A
DR   hPSCreg; RIe005-A
DR   RSCB; RSCB0022
DR   SKIP; SKIP002011
DR   Wikidata; Q54950988
RX   PubMed=16512855;
RX   PubMed=21198400;
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Doubling time: 32.9 +- 0.6 hours (PubMed=16512855).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   Royan H6
AC   CVCL_9387
SY   ROYANH6; RIe006-A
DR   hPSCreg; RIe006-A
DR   RSCB; RSCB0023
DR   SKIP; SKIP002012
DR   Wikidata; Q54950998
RX   PubMed=16512855;
RX   PubMed=21198400;
RX   PubMed=22145677;
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Doubling time: 32.1 +- 0.8 hours (PubMed=16512855).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   Royan H6-Lmx1
AC   CVCL_9462
DR   RSCB; RSCB0328
DR   Wikidata; Q54951000
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9387 ! Royan H6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Royan H6-Lmx2
AC   CVCL_9463
DR   RSCB; RSCB0329
DR   Wikidata; Q54951001
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9387 ! Royan H6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Royan H6-Lmx3
AC   CVCL_9468
DR   RSCB; RSCB0343
DR   Wikidata; Q54951002
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9387 ! Royan H6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Royan H6-Lmx4
AC   CVCL_9464
DR   RSCB; RSCB0330
DR   Wikidata; Q54951003
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9387 ! Royan H6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Royan H6-Wnt1
AC   CVCL_9465
DR   RSCB; RSCB0331
DR   Wikidata; Q54951004
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9387 ! Royan H6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Royan H6-Wnt2
AC   CVCL_9466
DR   RSCB; RSCB0332
DR   Wikidata; Q54951005
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9387 ! Royan H6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Royan H6-Wnt3
AC   CVCL_9467
DR   RSCB; RSCB0344
DR   Wikidata; Q54951006
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9387 ! Royan H6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   Royan H7
AC   CVCL_9388
SY   RIe007-A
DR   hPSCreg; RIe007-A
DR   RSCB; RSCB0024
DR   SKIP; SKIP002353
DR   Wikidata; Q54951007
RX   PubMed=20177993;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Royan H8
AC   CVCL_9389
SY   RIe008-A
DR   hPSCreg; RIe008-A
DR   RSCB; RSCB0025
DR   SKIP; SKIP002354
DR   Wikidata; Q54951008
RX   PubMed=20177993;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Royan H9
AC   CVCL_9390
SY   RIe009-A
DR   hPSCreg; RIe009-A
DR   RSCB; RSCB0026
DR   SKIP; SKIP002355
DR   Wikidata; Q54951010
RX   PubMed=20177993;
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   Royan N1
AC   CVCL_9391
DR   RSCB; RSCB0157
DR   Wikidata; Q54951011
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N10
AC   CVCL_9392
DR   RSCB; RSCB0166
DR   Wikidata; Q54951012
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N11
AC   CVCL_9393
DR   RSCB; RSCB0167
DR   Wikidata; Q54951013
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N12
AC   CVCL_9394
DR   RSCB; RSCB0168
DR   Wikidata; Q54951014
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N13
AC   CVCL_9395
DR   RSCB; RSCB0169
DR   Wikidata; Q54951015
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N14
AC   CVCL_9396
DR   RSCB; RSCB0170
DR   Wikidata; Q54951016
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N15
AC   CVCL_9397
DR   RSCB; RSCB0171
DR   Wikidata; Q54951017
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N16
AC   CVCL_9398
DR   RSCB; RSCB0172
DR   Wikidata; Q54951019
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N17
AC   CVCL_9399
DR   RSCB; RSCB0173
DR   Wikidata; Q54951020
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N18
AC   CVCL_9400
DR   RSCB; RSCB0174
DR   Wikidata; Q54951021
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N19
AC   CVCL_9401
DR   RSCB; RSCB0175
DR   RSCB; RSCB0191
DR   Wikidata; Q54951023
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N2
AC   CVCL_9402
DR   RSCB; RSCB0158
DR   Wikidata; Q54951024
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N20
AC   CVCL_9403
DR   RSCB; RSCB0176
DR   RSCB; RSCB0192
DR   Wikidata; Q54951025
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N21
AC   CVCL_9404
DR   RSCB; RSCB0193
DR   Wikidata; Q54951026
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N22
AC   CVCL_9405
DR   RSCB; RSCB0194
DR   Wikidata; Q54951027
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N23
AC   CVCL_9406
DR   RSCB; RSCB0195
DR   Wikidata; Q54951029
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N24
AC   CVCL_9407
DR   RSCB; RSCB0196
DR   Wikidata; Q54951030
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N25
AC   CVCL_9408
DR   RSCB; RSCB0197
DR   Wikidata; Q54951031
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N26
AC   CVCL_9409
DR   RSCB; RSCB0198
DR   Wikidata; Q54951032
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N27
AC   CVCL_9410
DR   RSCB; RSCB0199
DR   Wikidata; Q54951033
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N28
AC   CVCL_9411
DR   RSCB; RSCB0200
DR   Wikidata; Q54951034
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N29
AC   CVCL_9412
DR   RSCB; RSCB0201
DR   Wikidata; Q54951035
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N3
AC   CVCL_9413
DR   RSCB; RSCB0159
DR   Wikidata; Q54951036
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N30
AC   CVCL_9414
DR   RSCB; RSCB0202
DR   Wikidata; Q54951037
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N31
AC   CVCL_9415
DR   RSCB; RSCB0203
DR   Wikidata; Q54951038
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N32
AC   CVCL_9416
DR   RSCB; RSCB0204
DR   Wikidata; Q54951040
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N33
AC   CVCL_9417
DR   RSCB; RSCB0205
DR   Wikidata; Q54951041
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N34
AC   CVCL_9418
DR   RSCB; RSCB0206
DR   Wikidata; Q54951042
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N35
AC   CVCL_9419
DR   RSCB; RSCB0207
DR   Wikidata; Q54951043
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N36
AC   CVCL_9420
DR   RSCB; RSCB0208
DR   Wikidata; Q54951054
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N37
AC   CVCL_9421
DR   RSCB; RSCB0209
DR   Wikidata; Q54951055
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N38
AC   CVCL_9422
DR   RSCB; RSCB0210
DR   Wikidata; Q54951056
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N39
AC   CVCL_9423
DR   RSCB; RSCB0211
DR   Wikidata; Q54951057
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N4
AC   CVCL_9424
DR   RSCB; RSCB0160
DR   Wikidata; Q54951058
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N40
AC   CVCL_9425
DR   RSCB; RSCB0212
DR   Wikidata; Q54951059
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N41
AC   CVCL_9426
DR   RSCB; RSCB0213
DR   Wikidata; Q54951061
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N42
AC   CVCL_9427
DR   RSCB; RSCB0214
DR   Wikidata; Q54951062
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N43
AC   CVCL_9428
DR   RSCB; RSCB0215
DR   Wikidata; Q54951063
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N44
AC   CVCL_9429
DR   RSCB; RSCB0216
DR   Wikidata; Q54951064
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N45
AC   CVCL_9430
DR   RSCB; RSCB0217
DR   Wikidata; Q54951066
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N46
AC   CVCL_9431
DR   RSCB; RSCB0218
DR   Wikidata; Q54951067
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N47
AC   CVCL_9432
DR   RSCB; RSCB0219
DR   Wikidata; Q54951069
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N48
AC   CVCL_9433
DR   RSCB; RSCB0220
DR   Wikidata; Q54951071
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N49
AC   CVCL_9434
DR   RSCB; RSCB0221
DR   Wikidata; Q54951072
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N5
AC   CVCL_9435
DR   RSCB; RSCB0161
DR   Wikidata; Q54951074
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N50
AC   CVCL_9436
DR   RSCB; RSCB0222
DR   Wikidata; Q54951075
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N51
AC   CVCL_9437
DR   RSCB; RSCB0223
DR   Wikidata; Q54951076
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N52
AC   CVCL_9438
DR   RSCB; RSCB0224
DR   Wikidata; Q54951077
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N53
AC   CVCL_9439
DR   RSCB; RSCB0225
DR   Wikidata; Q54951081
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N54
AC   CVCL_9440
DR   RSCB; RSCB0226
DR   Wikidata; Q54951082
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N55
AC   CVCL_9441
DR   RSCB; RSCB0227
DR   Wikidata; Q54951083
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N56
AC   CVCL_9442
DR   RSCB; RSCB0228
DR   Wikidata; Q54951084
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N57
AC   CVCL_9443
DR   RSCB; RSCB0347
DR   Wikidata; Q54951085
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N58
AC   CVCL_9444
DR   RSCB; RSCB0348
DR   Wikidata; Q54951086
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N59
AC   CVCL_9445
DR   RSCB; RSCB0349
DR   Wikidata; Q54951087
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N6
AC   CVCL_9446
DR   RSCB; RSCB0162
DR   Wikidata; Q54951088
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N60
AC   CVCL_9447
DR   RSCB; RSCB0350
DR   Wikidata; Q54951089
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N61
AC   CVCL_9448
DR   RSCB; RSCB0351
DR   Wikidata; Q54951090
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N62
AC   CVCL_9449
DR   RSCB; RSCB0352
DR   Wikidata; Q54951091
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N63
AC   CVCL_9450
DR   RSCB; RSCB0353
DR   Wikidata; Q54951092
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N64
AC   CVCL_9451
DR   RSCB; RSCB0354
DR   Wikidata; Q54951093
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N65
AC   CVCL_9452
DR   RSCB; RSCB0355
DR   Wikidata; Q54951094
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N7
AC   CVCL_9453
DR   RSCB; RSCB0163
DR   Wikidata; Q54951095
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N8
AC   CVCL_9454
DR   RSCB; RSCB0164
DR   Wikidata; Q54951096
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan N9
AC   CVCL_9455
DR   RSCB; RSCB0165
DR   Wikidata; Q54951097
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan S1
AC   CVCL_9456
DR   RSCB; RSCB0317
DR   Wikidata; Q54951098
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: SW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan S2
AC   CVCL_9457
DR   RSCB; RSCB0318
DR   Wikidata; Q54951099
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: SW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan S3
AC   CVCL_9458
DR   RSCB; RSCB0319
DR   Wikidata; Q54951100
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: SW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan S4
AC   CVCL_9459
DR   RSCB; RSCB0320
DR   Wikidata; Q54951101
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: SW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan S5
AC   CVCL_9460
DR   RSCB; RSCB0321
DR   Wikidata; Q54951107
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: SW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   Royan S6
AC   CVCL_9461
DR   RSCB; RSCB0322
DR   Wikidata; Q54951108
CC   From: Royan Institute; Theran; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: SW.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   RP 215
AC   CVCL_C3TH
SY   RP215
DR   Wikidata; Q116050182
RX   Patent=US5650291;
RX   PubMed=1611619;
RX   PubMed=19407368;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10095.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human cancer cells expressed IgH carbohydrate-associated epitope CA215/COX-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   RP-1
AC   CVCL_G342
DR   JCRB; JCRB0195
DR   JCRB; NIHS0253
DR   TKG; TKG 0618
DR   Wikidata; Q54951109
RX   PubMed=2424975;
CC   Monoclonal antibody isotype: IgG1.
CC   Discontinued: JCRB; NIHS0253; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RP-2
AC   CVCL_DF06
DR   Wikidata; Q54951110
RX   PubMed=26663014;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1-2M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   RP-3
AC   CVCL_G343
DR   JCRB; JCRB0196
DR   JCRB; NIHS0254
DR   TKG; TKG 0617
DR   Wikidata; Q54951111
RX   PubMed=2746139;
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: JCRB; NIHS0254; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   RP-HzGUT-AW1
AC   CVCL_Z653
DR   ICLDB; rp-hzgut-aw1
DR   Wikidata; Q54951112
RX   PubMed=15311972;
RX   PubMed=33276037;
CC   Group: Insect cell line.
CC   Doubling time: 58.2 hours (PubMed=33276037).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   RP-HzOV-AW2
AC   CVCL_Z654
DR   ICLDB; rp-hzov-aw2
DR   Wikidata; Q54951113
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   RP-HzVNC-AW1
AC   CVCL_Z655
SY   RP-HzNU-AW1
DR   ICLDB; rp-hzvnc-aw1
DR   Wikidata; Q54951114
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   RP-HzVNC-AW1-Clone 14C4
AC   CVCL_C2TP
DR   ICLDB; rp-hzvnc-aw1-clone-14c4
DR   Wikidata; Q114312810
RX   PubMed=15311972;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ventral nerve cord; UBERON=UBERON_0000934.
OX   NCBI_TaxID=7113; ! Helicoverpa zea (Corn earworm moth)
HI   CVCL_Z655 ! RP-HzVNC-AW1
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   RP.0.03
AC   CVCL_B7EV
DR   Wikidata; Q114312811
RX   PubMed=2784769;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   RP.0.07
AC   CVCL_B7EW
DR   Wikidata; Q114312812
RX   PubMed=2784769;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   RP.0.10
AC   CVCL_B7EX
DR   Wikidata; Q114312813
RX   PubMed=2784769;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   RP.0.16
AC   CVCL_B7EY
DR   Wikidata; Q114312814
RX   PubMed=2784769;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   RP1-hiPSC1
AC   CVCL_C902
SY   RP.1.H.iPSC.1
DR   RSCB; RSCB0108
DR   Wikidata; Q54951115
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC10
AC   CVCL_C903
SY   RP.1.H.iPSC.10
DR   RSCB; RSCB0117
DR   Wikidata; Q54951116
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC11
AC   CVCL_C904
SY   RP.1.H.iPSC.11
DR   RSCB; RSCB0118
DR   Wikidata; Q54951117
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC12
AC   CVCL_C905
SY   RP.1.H.iPSC.12
DR   RSCB; RSCB0119
DR   Wikidata; Q54951118
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC2
AC   CVCL_C906
SY   RP.1.H.iPSC.2; RIi012-A
DR   hPSCreg; RIi012-A
DR   RSCB; RSCB0109
DR   SKIP; SKIP002407
DR   SKIP; SKIP005837
DR   Wikidata; Q54951119
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   RP1-hiPSC3
AC   CVCL_C907
SY   RP.1.H.iPSC.3
DR   RSCB; RSCB0110
DR   Wikidata; Q54951120
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC4
AC   CVCL_C908
SY   RP.1.H.iPSC.4
DR   RSCB; RSCB0111
DR   Wikidata; Q54951121
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC5
AC   CVCL_C909
SY   RP.1.H.iPSC.5
DR   RSCB; RSCB0112
DR   Wikidata; Q54951122
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC6
AC   CVCL_C910
SY   RP.1.H.iPSC.6
DR   RSCB; RSCB0113
DR   Wikidata; Q54951123
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC7
AC   CVCL_C911
SY   RP.1.H.iPSC.7
DR   RSCB; RSCB0114
DR   Wikidata; Q54951124
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   RP1-hiPSC8
AC   CVCL_C912
SY   RP.1.H.iPSC.8
DR   RSCB; RSCB0115
DR   Wikidata; Q54951125
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C913 ! RP1-hiPSC9
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP1-hiPSC9
AC   CVCL_C913
SY   RP.1.H.iPSC.9
DR   RSCB; RSCB0116
DR   Wikidata; Q54951127
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C902 ! RP1-hiPSC1
OI   CVCL_C906 ! RP1-hiPSC2
OI   CVCL_C907 ! RP1-hiPSC3
OI   CVCL_C908 ! RP1-hiPSC4
OI   CVCL_C909 ! RP1-hiPSC5
OI   CVCL_C910 ! RP1-hiPSC6
OI   CVCL_C911 ! RP1-hiPSC7
OI   CVCL_C912 ! RP1-hiPSC8
OI   CVCL_C903 ! RP1-hiPSC10
OI   CVCL_C904 ! RP1-hiPSC11
OI   CVCL_C905 ! RP1-hiPSC12
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP12-2
AC   CVCL_XB75
SY   HB RP12-2
DR   CCRID; 4201PAT-CCTCC00076
DR   Wikidata; Q98129159
RX   Patent=US6602687;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10532.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26441; Human CNTF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   RP12-9
AC   CVCL_XB76
DR   Wikidata; Q98129160
RX   Patent=US6602687;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26441; Human CNTF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   RP2-hiPSC1
AC   CVCL_C914
SY   RP2.H.iPSC.1
DR   RSCB; RSCB0093
DR   Wikidata; Q54951128
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C915 ! RP2-hiPSC2
OI   CVCL_C916 ! RP2-hiPSC3
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP2-hiPSC2
AC   CVCL_C915
SY   RP2.H.iPSC.2
DR   RSCB; RSCB0094
DR   Wikidata; Q54951129
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C914 ! RP2-hiPSC1
OI   CVCL_C916 ! RP2-hiPSC3
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   RP2-hiPSC3
AC   CVCL_C916
SY   RP2.H.iPSC.3; RIi009-A
DR   hPSCreg; RIi009-A
DR   RSCB; RSCB0095
DR   SKIP; SKIP002404
DR   SKIP; SKIP005836
DR   Wikidata; Q54951130
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C914 ! RP2-hiPSC1
OI   CVCL_C915 ! RP2-hiPSC2
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   RP3-12
AC   CVCL_XB73
SY   HB RP3-12
DR   CCRID; 4201PAT-CCTCC00075
DR   Wikidata; Q98129161
RX   Patent=US6602687;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10531.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P26441; Human CNTF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   RP3-17
AC   CVCL_XB74
SY   HB RP3-17
DR   CCRID; 4201PAT-CCTCC00087
DR   Wikidata; Q98129162
RX   Patent=US6602687;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P26441; Human CNTF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   RPAN001
AC   CVCL_E3Q0
SY   RPAN1; F_PDO_000185
DR   CancerTools; 160976
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RPAN002
AC   CVCL_E3Q1
SY   RPAN2; F_PDO_000194
DR   CancerTools; 160977
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RPC-5
AC   CVCL_R784
DR   Wikidata; Q54951131
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   RPC-9
AC   CVCL_B263
SY   RPC9
DR   cancercelllines; CVCL_B263
DR   Cosmic; 1083085
DR   Wikidata; Q54951132
RX   PubMed=17699786;
CC   Population: Chinese; Han and Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B260 ! PC-9
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   RPC-C2A
AC   CVCL_0E53
DR   Wikidata; Q54951133
RX   PubMed=1472061;
RX   PubMed=3256295;
CC   Doubling time: 13.7 hours (PubMed=3256295).
CC   Derived from site: In situ; Tooth, incisor, dental pulp; UBERON=UBERON_0015837.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   7W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   RPC5.4
AC   CVCL_8974
SY   RPC 5,4; RPC-5 clone 4
DR   CLO; CLO_0008865
DR   ATCC; TIB-12
DR   Wikidata; Q54951134
RX   PubMed=4099030;
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_R784 ! RPC-5
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   RPChiPS8023G1
AC   CVCL_E3R4
SY   StemRNA Human iPSC 802-3G; SYNTHEGO 802-30F; CIGLi001-A; iPSC TBX4 WT
DR   BioSamples; SAMEA114652059
DR   hPSCreg; CIGLi001-A
WW   Provider; REPROCELL; RCRP004N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-802-3g
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSBL003
AC   CVCL_E3R5
SY   StemRNA Human iPSC BL003
WW   Provider; REPROCELL; RCRP009N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-bl003
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3RA ! RPChiPSSK0032
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSSK006
AC   CVCL_E3R6
SY   StemRNA Human iPSC SK006.4
WW   Provider; REPROCELL; RCRP012N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-sk006
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSSK0011
AC   CVCL_E3R7
SY   StemRNA Human iPSC SK001.1
WW   Provider; REPROCELL; RCRP006N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-sk001-1
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSSK014
AC   CVCL_E3R8
SY   StemRNA Human iPSC SK014
WW   Provider; REPROCELL; RCRP031N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-sk014
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSSK0021
AC   CVCL_E3R9
SY   StemRNA Human iPSC SK002.1
WW   Provider; REPROCELL; RCRP008N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-sk002-1
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSSK0032
AC   CVCL_E3RA
SY   StemRNA Human iPSC SK003.2
WW   Provider; REPROCELL; RCRP011N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-sk003-2
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E3R5 ! RPChiPSBL003
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSSK0042
AC   CVCL_E3RB
SY   StemRNA Human iPSC SK004.2
WW   Provider; REPROCELL; RCRP007N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-sk004-2
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPChiPSSK0053
AC   CVCL_E3RC
SY   StemRNA Human iPSC SK005.3
WW   Provider; REPROCELL; RCRP010N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-sk005-3
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RPCI-WM1
AC   CVCL_M087
SY   Roswell Park Cancer Institute-Waldenstrom Macroglobulinemia 1
DR   cancercelllines; CVCL_M087
DR   Cosmic; 2645646
DR   Wikidata; Q54951135
RX   PubMed=22812491;
RX   PubMed=22950966;
RX   PubMed=25853860;
RX   PubMed=28548645;
RX   PubMed=40254718;
CC   Doubling time: ~34 hours (PubMed=22812491).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (PubMed=22812491).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 19
//
ID   RPCI-WM1/IR
AC   CVCL_VJ33
DR   cancercelllines; CVCL_VJ33
DR   Cosmic; 2645647
DR   Wikidata; Q98129163
RX   PubMed=28548645;
CC   Selected for resistance to: ChEBI; CHEBI_76612; Ibrutinib (Imbruvica).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M087 ! RPCI-WM1
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   RPCi001-A
AC   CVCL_UM17
SY   RPChiPS7713G1; StemRNA Human iPSC 771-3G; RPC hiPS 771; RPChiPS 771; RPChiPS771; PChiPS771
DR   hPSCreg; RPCi001-A
DR   Wikidata; Q98129164
WW   Provider; REPROCELL; RCRP005N; https://www.reprocell.com/product-catalog/induced-pluripotent-stem-cells/stemrna-human-ipsc-771-3g
CC   From: REPROCELL, Inc.; Yokohama; Japan.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Endothelial colony forming cell; CL=CL_0009090.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 5
//
ID   RPD 67.7
AC   CVCL_LN14
DR   Wikidata; Q54951136
RX   DOI=10.1007/978-3-642-85791-1_7;
CC   Group: Amphibian cell line.
CC   Doubling time: ~60 hours (DOI=10.1007/978-3-642-85791-1_7).
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPDS-1M19
AC   CVCL_B0LF
DR   Wikidata; Q108821241
RX   Patent=US8680246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-02.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RPDS-1M20
AC   CVCL_B0LE
SY   AB0030
DR   Wikidata; Q108821242
RX   Patent=US8680246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-04.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RPDS-1M21
AC   CVCL_B0LG
DR   Wikidata; Q108821243
RX   Patent=US8680246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-03.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RPDS-1M27
AC   CVCL_B0LH
DR   Wikidata; Q108821244
RX   Patent=US8680246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-01.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RPDS-1M31
AC   CVCL_B0LI
DR   Wikidata; Q108821245
RX   Patent=US8680246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 260310-01.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RPDS-2M2
AC   CVCL_B0LJ
DR   Wikidata; Q108821246
RX   Patent=US8680246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 260310-02.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RPDS-2M4
AC   CVCL_B0LK
DR   Wikidata; Q108821247
RX   Patent=US8680246;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, IDA of Canada (IDAC); 260310-03.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RPE-18
AC   CVCL_C8FC
SY   HE-18
DR   Wikidata; Q123033368
RX   PubMed=6193052;
CC   Derived from site: In situ; Fetal eye, retina, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3FM
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   RPE-18 SV2
AC   CVCL_0D87
SY   RPE-18 Sv2; RPE 18 SV2; AG06095; AG 6095
DR   CLO; CLO_0035281
DR   Coriell; AG06095
DR   Wikidata; Q54951137
RX   CelloPub=CLPUB00597;
RX   PubMed=3558490;
RX   PubMed=6193052;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain Rh911).
CC   Derived from site: In situ; Fetal eye, retina, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8FC ! RPE-18
SX   Male
AG   3FM
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   RPE-28
AC   CVCL_0D88
SY   HE-28; AG05337; AG05337A; AG 5337
DR   CLO; CLO_0035220
DR   Coriell; AG05337
DR   Wikidata; Q54951138
RX   CelloPub=CLPUB00597;
RX   PubMed=3558490;
CC   Derived from site: In situ; Fetal eye, retina, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3FM
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   RPE-28 SV4
AC   CVCL_0D89
SY   RPE-28 Sv4; RPE 28 SV4; AG06096; AG06096A
DR   CLO; CLO_0035278
DR   Coriell; AG06096
DR   Wikidata; Q54951139
RX   CelloPub=CLPUB00597;
RX   PubMed=6193052;
RX   PubMed=11095622;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain Rh911).
CC   Derived from site: In situ; Fetal eye, retina, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0D88 ! RPE-28
SX   Male
AG   3FM
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   RPE-30
AC   CVCL_0D94
SY   AG05338
DR   CLO; CLO_0035219
DR   Coriell; AG05338
DR   Wikidata; Q54951140
RX   CelloPub=CLPUB00597;
RX   PubMed=6193052;
CC   Derived from site: In situ; Fetal eye, retina, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3FM
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   RPE-340
AC   CVCL_B365
SY   RPE 340; RPE340; 340RPE
DR   Wikidata; Q54951141
RX   PubMed=9888444;
RX   PubMed=10617776;
RX   PubMed=25177495;
CC   Senescence: Senesces afer 50-60 PDL.
CC   Caution: Indicated as originating from a 1 year old male trauma victim (PubMed=10617776) but the TERT-immortalized derived cell line hTERT-RPE1 (Cellosaurus=CVCL_4388) is stated to originate from a female donor.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   RPE-J
AC   CVCL_3789
DR   CLO; CLO_0008866
DR   ATCC; CRL-2240
DR   Wikidata; Q54951142
RX   PubMed=8383696;
RX   PubMed=11825020;
RX   PubMed=27050416;
WW   Info; LRI; -; https://web.archive.org/web/20100714222258/http://www.lerner.ccf.org/eye/crabb/research/gel_rpe-j_cell.php
CC   Characteristics: At the restrictive temperature (40 Celsius) this cell line acquires a differentiated polarized RPE phenotype (PubMed=8383696).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   RPE/LULS53
AC   CVCL_C1YN
DR   Wikidata; Q114312815
RX   PubMed=36292854;
WW   Info; UKRI; -; https://gtr.ukri.org/resources/outcome.html#?type=researchmaterial&outcomeId=601e7f8a98fcd2.37066647&grantRef=BB%2FP024270%2F1
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Swansea University laboratory colony.
OX   NCBI_TaxID=13249; ! Rhodnius prolixus (Triatomid bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RPE/LULS57
AC   CVCL_E1IA
RX   PubMed=36292854;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Swansea University laboratory colony.
OX   NCBI_TaxID=13249; ! Rhodnius prolixus (Triatomid bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   RPE.40
AC   CVCL_U563
SY   RPE 40; RPE40; CHO-RPE40
DR   Wikidata; Q54951143
RX   PubMed=1850015;
RX   PubMed=6411625;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-375.html
CC   Characteristics: Deficient in furin.
CC   Selected for resistance to: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   RPE1_APC_836
AC   CVCL_C1AM
DR   Wikidata; Q114312816
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_APC_845
AC   CVCL_C1AN
DR   Wikidata; Q114312817
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_ARID1A_1.C7
AC   CVCL_C1AP
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312818
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_ARID1A_D5
AC   CVCL_C1AQ
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312819
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_ATM_303
AC   CVCL_C1AR
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312820
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_ATM_306
AC   CVCL_C1AS
DR   Wikidata; Q114312821
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_CDKN2A_7
AC   CVCL_C1AT
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312822
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_CDKN2C_241
AC   CVCL_C1AU
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312826
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1789; CDKN2C.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_CDKN2C_242
AC   CVCL_C1AV
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312827
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1789; CDKN2C.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_EZH2_2
AC   CVCL_C1AW
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312828
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_EZH2_A1
AC   CVCL_C1AX
DR   Wikidata; Q114312829
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_EZH2_A4
AC   CVCL_C1AY
DR   Wikidata; Q114312832
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_HPRT1_E10
AC   CVCL_C1CL
DR   Wikidata; Q114312833
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5157; HPRT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_MLL2_8
AC   CVCL_C1AZ
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312834
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MSH2_393
AC   CVCL_C1B0
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312835
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MSH2_394
AC   CVCL_C1B1
DR   Wikidata; Q114312836
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_MSH2_405
AC   CVCL_C1B2
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312837
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MSH6_266
AC   CVCL_C1B3
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312838
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MSH6_269
AC   CVCL_C1B4
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312839
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MSH6_271
AC   CVCL_C1B5
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312841
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MTAP_5
AC   CVCL_C1CG
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312842
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MTAP_6
AC   CVCL_C1CH
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312844
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_MTAP_7
AC   CVCL_C1CI
DR   Wikidata; Q114312845
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_NOTCH1_2
AC   CVCL_C1B6
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312846
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_NOTCH1_B6
AC   CVCL_C1B7
DR   Wikidata; Q114312847
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_NOTCH1_C2
AC   CVCL_C1B8
DR   Wikidata; Q114312849
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   RPE1_PTCH1_3
AC   CVCL_C1B9
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312852
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_PTCH1_6
AC   CVCL_C1BA
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312854
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_PTEN_2
AC   CVCL_C1BB
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312857
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_PTEN_8
AC   CVCL_C1BC
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312861
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_STAG2_2
AC   CVCL_C1BD
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312862
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_STAG2_5
AC   CVCL_C1BE
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312865
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_STAG2_8
AC   CVCL_C1BF
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312867
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_TET2_C9
AC   CVCL_C1BG
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312869
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_TET2_D2
AC   CVCL_C1BH
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312870
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_TET2_E7
AC   CVCL_C1BI
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312871
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_TP53_219
AC   CVCL_C1BJ
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312872
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_TP53_221
AC   CVCL_C1BK
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312875
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1_TP53_224
AC   CVCL_C1BL
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312877
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   RPE1-SS111
AC   CVCL_C8DM
SY   RPE1SS111
DR   DepMap; ACH-002466
DR   Wikidata; Q123033369
RX   PubMed=33505028;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: This cell line has a stable aneuploid karyotype, the parent cell line was transiently treated with the TTK inhibitor reversine to induce random chromosome gains and losses (PubMed=33505028).
CC   Karyotypic information: Contains extra Chr 8, Chr 9 and Chr 18 (PubMed=33505028).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   RPE1-SS119
AC   CVCL_C8DN
SY   RPE1SS119
DR   DepMap; ACH-002465
DR   Wikidata; Q123033370
RX   PubMed=33505028;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: This cell line has a stable aneuploid karyotype, the parent cell line was transiently treated with the TTK inhibitor reversine to induce random chromosome gains and losses (PubMed=33505028).
CC   Karyotypic information: Contains an extra Chr 8 (PubMed=33505028).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   RPE1-SS31
AC   CVCL_C8DP
DR   Wikidata; Q123033371
RX   PubMed=33505028;
CC   Characteristics: Control cell line for a set of aneuploid derivatives (PubMed=33505028).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   RPE1-SS48
AC   CVCL_C8DQ
SY   RPE1SS48
DR   DepMap; ACH-002462
DR   Wikidata; Q123033372
RX   PubMed=33505028;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Control cell line for a set of aneuploid derivatives (PubMed=33505028).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   RPE1-SS51
AC   CVCL_C8DR
SY   RPE1SS51
DR   DepMap; ACH-002467
DR   Wikidata; Q123033374
RX   PubMed=33505028;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: This cell line has a stable aneuploid karyotype, the parent cell line was transiently treated with the TTK inhibitor reversine to induce random chromosome gains and losses (PubMed=33505028).
CC   Karyotypic information: Contains extra Chr 7 and Chr 22 (PubMed=33505028).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   RPE1-SS6
AC   CVCL_C8DS
SY   RPE1SS6
DR   DepMap; ACH-002464
DR   Wikidata; Q123033375
RX   PubMed=33505028;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: This cell line has a stable aneuploid karyotype, the parent cell line was transiently treated with the TTK inhibitor reversine to induce random chromosome gains and losses (PubMed=33505028).
CC   Karyotypic information: Contains an extra Chr 7 (PubMed=33505028).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   RPE1-SS77
AC   CVCL_C8DT
SY   RPE1SS77
DR   DepMap; ACH-002463
DR   Wikidata; Q123033376
RX   PubMed=33505028;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Control cell line for a set of aneuploid derivatives (PubMed=33505028).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4388 ! hTERT-RPE1
SX   Female
AG   1Y
CA   Telomerase immortalized cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   RPEFC
AC   CVCL_JJ72
SY   Red Panda Ear Fibroblast Cell line
DR   Wikidata; Q54951144
RX   PubMed=19232145;
CC   Group: Endangered species/breed cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9649; ! Ailurus fulgens (Himalayan red panda)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   RPER001-3
AC   CVCL_E3QB
SY   RPER001; RPER1-3; RPER1; F_PDO_000054
DR   CancerTools; 160978
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Cancer organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   RPET
AC   CVCL_X028
DR   Wikidata; Q54951145
RX   PubMed=9078403;
RX   PubMed=11520047;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 12
//
ID   RPG1/SV40
AC   CVCL_S467
SY   RPG1; Rat Parotid salivary Gland 1
DR   Wikidata; Q54951146
RX   PubMed=9599299;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   RPH 67.194
AC   CVCL_LN06
DR   Wikidata; Q54951147
RX   DOI=10.1007/978-3-642-85791-1_7;
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPH 67.205
AC   CVCL_6725
DR   Wikidata; Q54951153
RX   PubMed=5263768;
CC   Group: Amphibian cell line.
CC   Group: Haploid karyotype cell line.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   RPK-1
AC   CVCL_0B31
SY   RPK1
DR   BTO; BTO_0005470
DR   cancercelllines; CVCL_0B31
DR   Cell_Model_Passport; SIDM01633
DR   GEO; GSM862565
DR   GEO; GSM862567
DR   Wikidata; Q54951154
RX   PubMed=22490663;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=22490663).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (PubMed=22490663).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4717 ! PK-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   RPK-59
AC   CVCL_0B32
SY   RPK59
DR   BTO; BTO_0005471
DR   cancercelllines; CVCL_0B32
DR   GEO; GSM862573
DR   GEO; GSM862575
DR   Wikidata; Q54951155
RX   PubMed=22490663;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=22490663).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4897 ! PK-59
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   RPK-9
AC   CVCL_0B33
SY   RPK9
DR   BTO; BTO_0005469
DR   cancercelllines; CVCL_0B33
DR   GEO; GSM862569
DR   GEO; GSM862571
DR   Wikidata; Q54951156
RX   PubMed=22490663;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=22490663).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=22490663).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D721 ! PK-9 [Human]
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   RPKID
AC   CVCL_T698
SY   Rana Pipiens KIDney
DR   Wikidata; Q54951157
RX   PubMed=1429360;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
AG   Premetamorphic tadpole
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   RPM
AC   CVCL_IX00
SY   Rat ProMegakaryoblasts; Clone 13
DR   Wikidata; Q54951158
RX   PubMed=2209761;
RX   PubMed=2387305;
RX   PubMed=6786390;
RX   PubMed=7430262;
CC   Doubling time: ~22 hours (PubMed=2387305).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Megakaryoblast; CL=CL_0000553.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   RPM-EP
AC   CVCL_M542
DR   Wikidata; Q54951159
RX   PubMed=1867326;
RX   PubMed=8429233;
RX   PubMed=9141475;
RX   PubMed=11606052;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   RPM-MC
AC   CVCL_M543
AS   CVCL_V644
SY   M2; MC
DR   ATCC; CRL-2499
DR   BioSample; SAMN03471596
DR   Wikidata; Q54951160
RX   PubMed=1549777;
RX   PubMed=1867326;
RX   PubMed=8429233;
RX   PubMed=9141475;
RX   PubMed=11606052;
CC   Discontinued: ATCC; CRL-2499; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-2499
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 7,10
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   RPMC 21
AC   CVCL_6B92
DR   Wikidata; Q54951161
RX   PubMed=20083474;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Peritoneal cavity; UBERON=UBERON_0001179.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RPMI-1120
AC   CVCL_JA32
SY   RPMI 1120; RPMI1120; Roswell Park Memorial Institute 1120
DR   Wikidata; Q54951162
RX   PubMed=62390;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   RPMI-1196
AC   CVCL_E9Z9
SY   RPMI 1196; RPMI1196; Roswell Park Memorial Institute 1196
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-131
AC   CVCL_C8CJ
SY   RPMI 131; RPMI131; R.P.M.I #131; Roswell Park Memorial Institute 131
DR   Wikidata; Q123033377
RX   PubMed=14082866;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   RPMI-1348
AC   CVCL_E9Z8
SY   RPMI 1348; RPMI1348; Roswell Park Memorial Institute 1348
RX   PubMed=5260617;
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-1358
AC   CVCL_UJ86
SY   RPMI 1358; RPMI1358; Roswell Park Memorial Institute 1358
DR   Wikidata; Q98129165
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   RPMI-1537
AC   CVCL_E9Z7
SY   RPMI 1537; RPMI1537; Roswell Park Memorial Institute 1537
RX   PubMed=5260617;
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-1608
AC   CVCL_E9ZA
SY   RPMI 1608; RPMI1608; Roswell Park Memorial Institute 1608
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   RPMI-1694
AC   CVCL_T297
SY   RPMI 1694; RPMI1694; Roswell Park Memorial Institute 1694
DR   Wikidata; Q54951163
RX   PubMed=5218782;
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T298 ! RPMI-1695
OI   CVCL_F530 ! RPMI-4265
OI   CVCL_T299 ! RPMI-7865
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   RPMI-1695
AC   CVCL_T298
SY   RPMI 1695; RPMI1695; Roswell Park Memorial Institute 1695
DR   Wikidata; Q54951164
RX   PubMed=5218782;
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T297 ! RPMI-1694
OI   CVCL_F530 ! RPMI-4265
OI   CVCL_T299 ! RPMI-7865
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   RPMI-1720
AC   CVCL_LK70
SY   RPMI 1720; RPMI1720; Roswell Park Memorial Institute 1720
DR   Wikidata; Q54951166
RX   PubMed=3518877;
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-1748
AC   CVCL_C9GC
SY   RPMI 1748; RPMI1748; Roswell Park Memorial Institute 1748
DR   Wikidata; Q123033378
RX   CelloPub=CLPUB00749;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RPMI-1788
AC   CVCL_2710
AS   CVCL_7352
SY   RPMI 1788; RPMI1788; Roswell Park Memorial Institute 1788; GM02131; GM2131; GM02131A; GM17219
DR   BTO; BTO_0005255
DR   CLO; CLO_0008867
DR   CLO; CLO_0013924
DR   CLO; CLO_0031846
DR   CLO; CLO_0051022
DR   CLDB; cl4169
DR   CLDB; cl4170
DR   CLDB; cl4171
DR   ATCC; CCL-156
DR   BioSample; SAMN00807500
DR   BioSample; SAMN03471459
DR   BioSample; SAMN03472770
DR   CLS; 300318
DR   Coriell; GM02131
DR   Coriell; GM17219
DR   ECACC; 85112106
DR   FANTOM5_SSTAR; 10427-106D4
DR   GEO; GSM569533
DR   GEO; GSM596283
DR   GEO; GSM596643
DR   GEO; GSM924821
DR   IZSLER; BS CL 75
DR   JCRB; IFO50037
DR   JCRB; JCRB0035
DR   KCLB; 10156
DR   RCB; RCB1878
DR   TKG; TKG 0464
DR   Wikidata; Q54951168
RX   CelloPub=CLPUB00447;
RX   PubMed=62390;
RX   PubMed=305004;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4366935;
RX   PubMed=6160588;
RX   PubMed=8139288;
RX   PubMed=9290701;
RX   PubMed=11173916;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29892436;
RX   PubMed=29959025;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=RPMI%201788
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,33:01:01; B*07:06:01,14:01:01; C*08:02:01,15:05:02; DPA1*01:03:01,02:01:01; DPB1*45:01,124:01:NEW; DQA1*02:01:01,03:03:01; DQB1*02:02:01,03:02:01; DRB1*04:05:01,07:01:01; DRB4*01:01:01,01:03:01 (PubMed=29959025).
CC   HLA typing: A*02:01:01,09:01:01; B*07:06:01,14:01:01; C*08:02:01,15:05:02; DPB1*03:01:01G,21:01; DQA1*02:01:01,03:03:01; DQB1*02:02:01,03:02:01; DRB1*04:05:01,07:01:01 (CLS=300318).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: KCLB; 10156; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-156; CLS=300318; ECACC=85112106; JCRB=IFO50037; JCRB=JCRB0035; RCB=RCB1878; TKG=TKG 0464
ST   Amelogenin: X (JCRB=IFO50037)
ST   Amelogenin: X,Y (ATCC=CCL-156; CLS=300318; ECACC=85112106; JCRB=JCRB0035; RCB=RCB1878; TKG=TKG 0464)
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 15,17
ST   D19S433: 13,14
ST   D21S11: 31,32.2
ST   D2S1338: 17
ST   D3S1358: 13,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 12,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   RPMI-1846
AC   CVCL_2711
SY   RPMI 1846; RPMI1846; RPMI No. 1846; RPMI #1846; Roswell Park Memorial Institute 1846; 3AA; Fortner's melanotic melanoma #3
DR   CLO; CLO_0008868
DR   CLDB; cl4172
DR   CLDB; cl4173
DR   CLDB; cl5169
DR   ATCC; CCL-49
DR   ECACC; 90102527
DR   ECACC; 93120834
DR   IZSLER; BS TCL 58
DR   JCRB; JCRB9087
DR   Wikidata; Q54951170
RX   DOI=10.1007/BF02618370;
RX   PubMed=1319723;
RX   PubMed=3734481;
RX   PubMed=4522794;
RX   PubMed=5556532;
RX   PubMed=5682441;
RX   PubMed=14071829;
RX   PubMed=14475649;
CC   Characteristics: Not pigmented (PubMed=5682441).
CC   Doubling time: ~36 hours (PubMed=14071829).
CC   Misspelling: RPMI No. 1856; PubMed=5682441; Note=In abstract.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   RPMI-191
AC   CVCL_C8CI
SY   RPMI 191; RPMI191; R.P.M.I #191; Roswell Park Memorial Institute 191
DR   Wikidata; Q123033379
RX   PubMed=14082866;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   RPMI-1922
AC   CVCL_RP63
SY   RPMI 1922; RPMI1922; R.P.M.I #1922; Roswell Park Memorial Institute 1922
DR   ATCC; HTB-84
DR   Wikidata; Q54951171
RX   CelloPub=CLPUB00417;
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=14082866;
CC   Discontinued: ATCC; HTB-84; true.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   RPMI-1938
AC   CVCL_C8CH
SY   RPMI 1938; RPMI1938; R.P.M.I #1938; Roswell Park Memorial Institute 1938
DR   Wikidata; Q123033380
RX   PubMed=14082866;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   RPMI-212
AC   CVCL_C8CK
SY   RPMI 212; RPMI212; R.P.M.I #212; Roswell Park Memorial Institute 212
DR   Wikidata; Q123033381
RX   PubMed=4207624;
RX   PubMed=14082866;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   RPMI-2298
AC   CVCL_5M14
SY   RPMI 2298; RPMI2298; RPMI No. 2298; RPMI #2298; Roswell Park Memorial Institute 2298; Adrenal carcinoma #5
DR   Wikidata; Q54951172
RX   PubMed=14071829;
DI   NCIt; C134990; Hamster adrenal carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   RPMI-2402
AC   CVCL_V741
SY   RPMI 2402; RPMI2402; RPMI No. 2402; RPMI #2402; Roswell Park Memorial Institute 2402; Small bowel carcinoma #1
DR   Wikidata; Q54951173
RX   PubMed=6060209;
RX   PubMed=14071829;
CC   Doubling time: 33 hours (PubMed=14071829).
DI   NCIt; C134994; Hamster small intestinal neoplasm
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   RPMI-2403
AC   CVCL_5M15
SY   RPMI 2403; RPMI2403; RPMI No. 2403; RPMI #2403; Roswell Park Memorial Institute 2403; Pancreatic carcinoma #1
DR   Wikidata; Q54951174
RX   PubMed=14071829;
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   RPMI-2567
AC   CVCL_E9ZB
SY   RPMI 2567; RPMI2567; Roswell Park Memorial Institute 2567
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-2650
AC   CVCL_1664
SY   RPMI 2650; RPMI2650; R.P.M.I. #2650; Roswell Park Memorial Institute 2650
DR   BTO; BTO_0004205
DR   CLO; CLO_0008869
DR   CLO; CLO_0008876
DR   EFO; EFO_0006478
DR   CLDB; cl4174
DR   CLDB; cl4175
DR   CLDB; cl4176
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-30
DR   BCRC; 60296
DR   BCRJ; 0412
DR   BioSample; SAMN01821660
DR   BioSample; SAMN01821717
DR   BioSample; SAMN03473151
DR   cancercelllines; CVCL_1664
DR   Cell_Model_Passport; SIDM00809
DR   ChEMBL-Cells; CHEMBL3308780
DR   ChEMBL-Targets; CHEMBL1075566
DR   CLS; 300323
DR   Cosmic; 686978
DR   Cosmic; 909700
DR   Cosmic; 1006465
DR   Cosmic; 1017789
DR   Cosmic; 1041670
DR   Cosmic; 1339925
DR   Cosmic; 2043886
DR   Cosmic-CLP; 909700
DR   DepMap; ACH-001385
DR   DSMZ; ACC-287
DR   DSMZCellDive; ACC-287
DR   ECACC; 88031602
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10805-111A4
DR   GDSC; 909700
DR   GEO; GSM960607
DR   GEO; GSM960608
DR   GEO; GSM960609
DR   GEO; GSM960610
DR   GEO; GSM960611
DR   GEO; GSM960612
DR   GEO; GSM960613
DR   GEO; GSM1374853
DR   GEO; GSM1374854
DR   GEO; GSM1670386
DR   IARC_TP53; 21290
DR   IGRhCellID; RPMI2650%20GSE9585
DR   IZSLER; BS TCL 59
DR   JCRB; JCRB9058
DR   KCLB; 10030
DR   LINCS_LDP; LCL-1881
DR   PharmacoDB; RPMI2650_1324_2019
DR   PubChem_Cell_line; CVCL_1664
DR   Wikidata; Q54951175
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=77569;
RX   PubMed=174085;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1260760;
RX   PubMed=3518877;
RX   PubMed=5831238;
RX   PubMed=6277475;
RX   PubMed=14082866;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29348827;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-287).
CC   HLA typing: A*02,03; B*07,w22; C*w03,w06 (PubMed=77569).
CC   HLA typing: A*02:01,03:01; B*07:02,35:08; C*03:03,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 15 fused to NUTM1 exon 2 (PubMed=25485619; PubMed=29348827).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.38%; Native American=0.9%; East Asian, North=1.71%; East Asian, South=0%; South Asian=0%; European, North=68.78%; European, South=28.23% (PubMed=30894373).
CC   Misspelling: CCL30; Note=Based on the ATCC catalog number.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CCL-30; CLS=300323; Cosmic-CLP=909700; DepMap=ACH-001385; DSMZ=ACC-287; ECACC=88031602; JCRB=JCRB9058; KCLB=10030; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 14,16
ST   D21S11: 28,33.2
ST   D2S1338: 20,25
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 9,13
ST   FGA: 23,25
ST   Penta D: 9,10
ST   Penta E: 11,19
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C34447; Head and neck squamous cell carcinoma
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   RPMI-2667
AC   CVCL_E9ZC
SY   RPMI 2667; RPMI2667; Roswell Park Memorial Institute 2667
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-2739
AC   CVCL_5M16
SY   RPMI 2739; RPMI2739; RPMI No. 2739; RPMI #2739; Roswell Park Memorial Institute 2739; Melanotic melanoma #1
DR   Wikidata; Q54951176
RX   PubMed=14071829;
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   RPMI-3026
AC   CVCL_C5YL
SY   RPMI 3026; RPMI3026; R.P.M.I. 3026; Roswell Park Memorial Institute 3026
DR   Wikidata; Q116050183
RX   PubMed=5232150;
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   RPMI-3157
AC   CVCL_UJ87
SY   RPMI 3157; RPMI3157; Roswell Park Memorial Institute 3157
DR   Wikidata; Q98129166
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=11515052;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   RPMI-3236
AC   CVCL_T295
SY   RPMI 3236; RPMI3236; RPMI No. 3236; Roswell Park Memorial Institute 3236
DR   Wikidata; Q54951178
RX   PubMed=1161259;
RX   PubMed=4952499;
CC   Characteristics: Highly pigmented.
CC   Doubling time: 44 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RPMI-3287
AC   CVCL_UJ88
SY   RPMI 3287; RPMI3287; Roswell Park Memorial Institute 3287
DR   Wikidata; Q98129167
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=11515052;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   RPMI-3460
AC   CVCL_5M13
SY   RPMI 3460; RPMI3460; RPMI No. 3460; Roswell Park Memorial Institute 3460; MM No. 2
DR   Wikidata; Q54951179
RX   PubMed=574751;
RX   PubMed=5682441;
RX   PubMed=7075692;
RX   PubMed=7388784;
RX   PubMed=14254224;
CC   Characteristics: Pigmented (PubMed=5682441).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 6
//
ID   RPMI-3460 clone 5
AC   CVCL_D5ZL
DR   Wikidata; Q127384064
RX   PubMed=7075692;
CC   Characteristics: Insensitive to growth inhibition by dexamethasone (PubMed=7075692).
CC   Characteristics: In contrast to the parent cell line is not pigmented (PubMed=7075692).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_5M13 ! RPMI-3460
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   RPMI-3460 clone 6
AC   CVCL_D5ZM
DR   Wikidata; Q127384066
RX   PubMed=7075692;
CC   Characteristics: Sensitive to growth inhibition by dexamethasone (PubMed=7075692).
CC   Characteristics: Pigmented (PubMed=7075692).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_5M13 ! RPMI-3460
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   RPMI-3460/CM1
AC   CVCL_H244
SY   RPM1 3460, CM1; CM-1; CM1; Cell Monolayer-1
DR   Wikidata; Q54951181
RX   PubMed=574751;
RX   PubMed=7068778;
CC   Characteristics: Pigmented (from parent cell line).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_5M13 ! RPMI-3460
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   RPMI-3460/CS1
AC   CVCL_H245
SY   RPM1 3460, CS1; CS-1; CS1; Cell Suspension-1
DR   Wikidata; Q54951182
RX   PubMed=574751;
RX   PubMed=7068778;
CC   Characteristics: Pigmented (from parent cell line).
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_5M13 ! RPMI-3460
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   RPMI-4098
AC   CVCL_UD73
SY   RPMI 4098; RPMI4098; Roswell Park Memorial Institute 4098
DR   Wikidata; Q98129168
RX   PubMed=6804081;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   RPMI-41
AC   CVCL_E5F9
SY   RPMI 41; RPMI41; RPMI No. 41; RPMI #41; RPMI#41; Roswell Park Memorial Institute 41
RX   PubMed=4207624;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   RPMI-4265
AC   CVCL_F530
SY   RPMI 4265; RPMI4265; Roswell Park Memorial Institute 4265
DR   Wikidata; Q54951183
RX   DOI=10.1007/978-1-4757-1647-4_11;
RX   PubMed=62390;
RX   PubMed=3518877;
RX   PubMed=5218782;
RX   PubMed=5229350;
RX   PubMed=5260617;
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T297 ! RPMI-1694
OI   CVCL_T298 ! RPMI-1695
OI   CVCL_T299 ! RPMI-7865
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   RPMI-4445
AC   CVCL_T296
SY   RPMI 4445; RPMI4445; RPMI No. 4445; Roswell Park Memorial Institute 4445; M-2
DR   Wikidata; Q54951185
RX   PubMed=833871;
RX   PubMed=944091;
RX   PubMed=1127734;
RX   PubMed=1161259;
RX   PubMed=3518877;
RX   PubMed=4329447;
RX   PubMed=6220172;
CC   Doubling time: 29 hours (PubMed=1127734); 50 hours (PubMed=1161259).
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   RPMI-4467
AC   CVCL_UJ89
SY   RPMI 4467; RPMI4467; RPMI #4467; Roswell Park Memorial Institute 4467
DR   Wikidata; Q98129169
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RPMI-4666
AC   CVCL_UJ65
SY   RPMI 4666; RPMI4666; RPMI #4666; RPMI no. 4666; Roswell Park Memorial Institute 4666
DR   Wikidata; Q98129170
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=4177524;
RX   PubMed=4189100;
CC   Characteristics: Produces IgA kappa.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   RPMI-4767
AC   CVCL_LH81
SY   RPMI 4767; RPMI4767; RPMI #4767; Roswell Park Memorial Institute 4767
DR   Wikidata; Q54951186
RX   PubMed=1161259;
CC   Doubling time: 72 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-4788
AC   CVCL_0U46
SY   RPMI 4788; RPMI4788; R.P.M.I. #4788; Roswell Park Memorial Institute 4788
DR   BioSample; SAMN03151753
DR   BioSample; SAMN03472398
DR   JCRB; JCRB1309
DR   JCRB; NIHS0553
DR   Wikidata; Q54951187
RX   PubMed=2504864;
RX   PubMed=14082866;
RX   PubMed=23136038;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=23136038). Was originally thought to originate from the pleural fluid of a 73 year old female patient with a colon adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00387.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: JCRB; JCRB1309; true.
CC   Discontinued: JCRB; NIHS0553; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=JCRB1309
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   RPMI-5106
AC   CVCL_E9ZL
SY   RPMI 5106; RPMI5106; Roswell Park Memorial Institute 5106
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26919; Lymphosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-5157
AC   CVCL_E9ZM
SY   RPMI 5157; RPMI5157; Roswell Park Memorial Institute 5157
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3167; Acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-5286
AC   CVCL_E9ZJ
SY   RPMI 5286; RPMI5286; Roswell Park Memorial Institute 5286
RX   PubMed=5260617;
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-5287
AC   CVCL_JA33
SY   RPMI 5287; RPMI5287; Roswell Park Memorial Institute 5287
DR   Wikidata; Q54951188
RX   PubMed=62390;
RX   PubMed=4366935;
RX   PubMed=11515052;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   RPMI-5307
AC   CVCL_E9ZD
SY   RPMI 5307; RPMI5307; Roswell Park Memorial Institute 5307
RX   PubMed=11515052;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3444; Granulomatosis with polyangiitis
DI   ORDO; Orphanet_900; Granulomatosis with polyangiitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-5328
AC   CVCL_C9GB
SY   RPMI 5328; RPMI5328; Roswell Park Memorial Institute 5328
DR   Wikidata; Q123033382
RX   CelloPub=CLPUB00749;
RX   PubMed=5260617;
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   RPMI-5567
AC   CVCL_E9ZE
SY   RPMI 5567; RPMI5567; Roswell Park Memorial Institute 5567
RX   PubMed=11515052;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-5615
AC   CVCL_LH82
SY   RPMI 5615; RPMI5615; Roswell Park Memorial Institute 5615
DR   Wikidata; Q54951190
RX   PubMed=1161259;
CC   Doubling time: 76 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-5866
AC   CVCL_UJ66
SY   RPMI 5866; RPMI5866; Roswell Park Memorial Institute 5866
DR   Wikidata; Q98129171
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
DI   NCIt; C3167; Acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   RPMI-5959
AC   CVCL_1E28
SY   RPMI 5959; RPMI5959; Roswell Park Memorial Institute 5959
DR   Wikidata; Q54951191
RX   PubMed=327080;
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 4
//
ID   RPMI-5966
AC   CVCL_T294
SY   RPMI 5966; RPMI5966; RPMI No. 5966; Roswell Park Memorial Institute 5966; M-1
DR   Wikidata; Q54951192
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=944091;
RX   PubMed=1127734;
RX   PubMed=1161259;
RX   PubMed=4329447;
RX   PubMed=4952499;
CC   Doubling time: 33 hours (PubMed=1127734); 48 hours (PubMed=1161259).
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 11
//
ID   RPMI-615
AC   CVCL_C8CL
SY   RPMI 615; RPMI615; R.P.M.I #615; Roswell Park Memorial Institute 615
DR   Wikidata; Q123033383
RX   PubMed=14082866;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   RPMI-6237
AC   CVCL_E9ZF
SY   RPMI 6237; RPMI6237; Roswell Park Memorial Institute 6237
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-6410
AC   CVCL_8074
SY   RPMI 6410; RPMI6410; Roswell Park Memorial Institute 6410; R6410; 64-10; FCCH6047
DR   ChEMBL-Cells; CHEMBL3307429
DR   ChEMBL-Targets; CHEMBL614881
DR   Cosmic; 1197929
DR   PubChem_Cell_line; CVCL_8074
DR   Wikidata; Q54951194
RX   CelloPub=CLPUB00102;
RX   DOI=10.1007/978-1-4757-1647-4_11;
RX   PubMed=62390;
RX   PubMed=170370;
RX   PubMed=4169031;
RX   PubMed=4321017;
RX   PubMed=4325933;
RX   PubMed=4366935;
RX   PubMed=5218782;
RX   PubMed=5229350;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   RPMI-6467
AC   CVCL_UJ90
SY   RPMI 6467; RPMI6467; Roswell Park Memorial Institute 6467
DR   Wikidata; Q98129172
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=11515052;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   RPMI-6642
AC   CVCL_LH83
SY   RPMI 6642; RPMI6642; Roswell Park Memorial Institute 6642
DR   Wikidata; Q54951195
RX   PubMed=1161259;
CC   Doubling time: 56 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-6666
AC   CVCL_1665
SY   RPMI 6666; RPMI6666; Roswell Park Memorial Institute 6666
DR   CLO; CLO_0008870
DR   EFO; EFO_0002321
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-113
DR   BioSample; SAMN03151630
DR   BioSample; SAMN03472694
DR   BioSample; SAMN10988187
DR   Cell_Model_Passport; SIDM00813
DR   ChEMBL-Cells; CHEMBL3308884
DR   ChEMBL-Targets; CHEMBL2366187
DR   Cosmic; 684228
DR   Cosmic; 909701
DR   Cosmic-CLP; 909701
DR   DepMap; ACH-001182
DR   ECACC; 87081807
DR   EGA; EGAS00001000978
DR   GDSC; 909701
DR   GEO; GSM887546
DR   GEO; GSM888629
DR   GEO; GSM1670387
DR   IARC_TP53; 21291
DR   IGRhCellID; RPMI6666
DR   KCLB; 10113
DR   LINCS_LDP; LCL-2013
DR   PharmacoDB; RPMI6666_1325_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1665
DR   Wikidata; Q54951196
RX   PubMed=11515052;
RX   PubMed=12133989;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=20143388; PubMed=29533902).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00263.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*07:02/15,18:01/05; C*07:02,07:01/06; DQB1*06:02/11; DRB1*15:01; DRB5*01 (PubMed=12133989).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.17%; East Asian, North=0.15%; East Asian, South=0%; South Asian=0.52%; European, North=71.83%; European, South=27.33% (PubMed=30894373).
ST   Source(s): ATCC=CCL-113; Cosmic-CLP=909701; ECACC=87081807
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 15.2,16
ST   D21S11: 28,30
ST   D2S1338: 18,26
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 12,13
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   RPMI-6738
AC   CVCL_LH84
SY   RPMI 6738; RPMI6738; RPMI No. 6738; Roswell Park Memorial Institute 6738
DR   Wikidata; Q54951197
RX   PubMed=1161259;
CC   Characteristics: Pigmented.
CC   Doubling time: 120 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-6867
AC   CVCL_E9ZG
SY   RPMI 6867; RPMI6867; Roswell Park Memorial Institute 6867
RX   PubMed=11515052;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-7022
AC   CVCL_ZY44
SY   RPMI 7022; RPMI7022; Roswell Park Memorial Institute 7022
DR   Wikidata; Q102114849
RX   DOI=10.1093/jnci/59.2.301;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_U115 ! RPMI-8342
OI   CVCL_X375 ! RPMI-8362
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7031
AC   CVCL_LH85
SY   RPMI 7031; RPMI7031; Roswell Park Memorial Institute 7031
DR   Wikidata; Q54951198
RX   PubMed=1161259;
CC   Doubling time: 64 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-7113
AC   CVCL_5M17
SY   RPMI 7113; RPMI7113; RPMI No. 7113; RPMI #7113; Roswell Park Memorial Institute 7113; Amelanotic melanoma #5
DR   Wikidata; Q54951200
RX   PubMed=14071829;
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   RPMI-7127
AC   CVCL_E9ZH
SY   RPMI 7127; RPMI7127; Roswell Park Memorial Institute 7127
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-7197
AC   CVCL_E9ZK
SY   RPMI 7197; RPMI7197; Roswell Park Memorial Institute 7197
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-7206
AC   CVCL_ZV64
SY   RPMI 7206; RPMI7206; Roswell Park Memorial Institute 7206
DR   Wikidata; Q98129173
RX   PubMed=4960081;
RX   PubMed=5640868;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZV63 ! RPMI-7216
OI   CVCL_2712 ! RPMI-7666
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 5
//
ID   RPMI-7216
AC   CVCL_ZV63
SY   RPMI 7216; RPMI7216; Roswell Park Memorial Institute 7216
DR   Wikidata; Q98129174
RX   PubMed=4960081;
RX   PubMed=5640868;
RX   PubMed=11515052;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZV64 ! RPMI-7206
OI   CVCL_2712 ! RPMI-7666
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   RPMI-7262
AC   CVCL_T313
SY   RPMI 7262; RPMI7262; Roswell Park Memorial Institute 7262
DR   Wikidata; Q54951201
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   Population: Caucasian.
CC   Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   RPMI-7272
AC   CVCL_T314
SY   RPMI 7272; RPMI7272; Roswell Park Memorial Institute 7272; B72; M-4
DR   Wikidata; Q54951208
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=944091;
RX   PubMed=1127734;
RX   PubMed=1369420;
CC   Population: Caucasian.
CC   Doubling time: 38 hours (PubMed=1127734).
CC   Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   RPMI-7281
AC   CVCL_LH96
SY   RPMI 7281; RPMI7281; Roswell Park Memorial Institute 7281
DR   Wikidata; Q54951209
RX   PubMed=4366935;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   RPMI-7402
AC   CVCL_A7SY
SY   RPMI 7402; RPMI7402; Roswell Park Memorial Institute 7402
DR   Wikidata; Q107116752
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21; 46,XY (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7422
AC   CVCL_A7SX
SY   RPMI 7422; RPMI7422; Roswell Park Memorial Institute 7422
DR   Wikidata; Q107116753
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7437
AC   CVCL_UJ83
SY   RPMI 7437; RPMI7437; Roswell Park Memorial Institute 7437
DR   Wikidata; Q98129175
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   RPMI-7449
AC   CVCL_LH86
SY   RPMI 7449; RPMI7449; Roswell Park Memorial Institute 7449
DR   Wikidata; Q54951211
RX   PubMed=1161259;
CC   Doubling time: 58 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-7451
AC   CVCL_X403
SY   RPMI 7451; RPMI7451; Roswell Park Memorial Institute 7451
DR   Wikidata; Q54951213
RX   CelloPub=CLPUB00275;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2176543;
RX   PubMed=3518877;
RX   PubMed=6277475;
RX   PubMed=35640676;
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 10
//
ID   RPMI-7462
AC   CVCL_A7SZ
SY   RPMI 7462; RPMI7462; Roswell Park Memorial Institute 7462
DR   Wikidata; Q107116754
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7466
AC   CVCL_XX47
SY   RPMI 7466; RPMI7466; Roswell Park Memorial Institute 7466; Daniels
DR   Wikidata; Q98129176
RX   PubMed=4169243;
RX   PubMed=4304349;
RX   PubMed=4866767;
RX   PubMed=4960081;
RX   PubMed=5640868;
RX   PubMed=5668122;
RX   PubMed=11515052;
CC   Population: African American.
CC   Doubling time: ~40 hours (PubMed=4960081).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: We are not certain this is an EBV-transformed cell line. This assignment is based on the description of this cell line in PubMed=4304349 and PubMed=4960081.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   RPMI-7481
AC   CVCL_LH92
SY   RPMI 7481; RPMI7481; Roswell Park Memorial Institute 7481
DR   Wikidata; Q54951214
RX   PubMed=4130585;
RX   PubMed=4366935;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH89 ! RPMI-M7041
OI   CVCL_LH93 ! RPMI-7491
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   RPMI-7491
AC   CVCL_LH93
SY   RPMI 7491; RPMI7491; Roswell Park Memorial Institute 7491
DR   Wikidata; Q54951216
RX   PubMed=4130585;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH89 ! RPMI-M7041
OI   CVCL_LH92 ! RPMI-7481
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-7492
AC   CVCL_A7TC
SY   RPMI 7492; RPMI7492; Roswell Park Memorial Institute 7492
DR   Wikidata; Q107116755
RX   PubMed=4266330;
CC   Karyotypic information: 47,XX,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7551
AC   CVCL_T315
SY   RPMI 7551; RPMI7551; Roswell Park Memorial Institute 7551
DR   Wikidata; Q54951217
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=4366935;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RPMI-7532
AC   CVCL_A7TF
SY   RPMI 7532; RPMI7532; Roswell Park Memorial Institute 7532
DR   Wikidata; Q107116756
RX   PubMed=4266330;
CC   Karyotypic information: 47,XX,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7542
AC   CVCL_A7TH
SY   RPMI 7542; RPMI7542; Roswell Park Memorial Institute 7542
DR   Wikidata; Q107116757
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7552
AC   CVCL_A7TA
SY   RPMI 7552; RPMI7552; Roswell Park Memorial Institute 7552
DR   Wikidata; Q107116758
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7572
AC   CVCL_A7TD
SY   RPMI 7572; RPMI7572; Roswell Park Memorial Institute 7572
DR   Wikidata; Q107116759
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21; 48,XY,+21+C (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7TE ! RPMI-7852
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7582
AC   CVCL_A7TI
SY   RPMI 7582; RPMI7582; Roswell Park Memorial Institute 7582
DR   Wikidata; Q107116760
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7592
AC   CVCL_A7TJ
SY   RPMI 7592; RPMI7592; Roswell Park Memorial Institute 7592
DR   Wikidata; Q107116762
RX   PubMed=4266330;
CC   Karyotypic information: 47,XX,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7662
AC   CVCL_A7TK
SY   RPMI 7662; RPMI7662; Roswell Park Memorial Institute 7662
DR   Wikidata; Q107116763
RX   PubMed=4266330;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7666
AC   CVCL_2712
SY   RPMI 7666; RPMI7666; Roswell Park Memorial Institute 7666; Gerner 7666
DR   CLO; CLO_0008871
DR   CLDB; cl4178
DR   CLDB; cl4179
DR   ATCC; CCL-114
DR   BioSample; SAMN03472695
DR   ECACC; 87012703
DR   KCLB; 10114
DR   Wikidata; Q54951218
RX   PubMed=1086134;
RX   PubMed=4960081;
RX   PubMed=5668122;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: KCLB; 10114; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CCL-114; ECACC=87012703
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 18,21
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 20,25
ST   Penta D: 9,12
ST   Penta E: 5,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZV64 ! RPMI-7206
OI   CVCL_ZV63 ! RPMI-7216
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   RPMI-7672
AC   CVCL_A7TP
SY   RPMI 7672; RPMI7672; Roswell Park Memorial Institute 7672
DR   Wikidata; Q107116764
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7711
AC   CVCL_LH91
SY   RPMI 7711; RPMI7711; Roswell Park Memorial Institute 7711
DR   Wikidata; Q54951219
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=4130585;
RX   PubMed=4366935;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_U115 ! RPMI-8342
OI   CVCL_X375 ! RPMI-8362
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   RPMI-7712
AC   CVCL_A7TL
SY   RPMI 7712; RPMI7712; Roswell Park Memorial Institute 7712
DR   Wikidata; Q107116765
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7722
AC   CVCL_A7TN
SY   RPMI 7722; RPMI7722; Roswell Park Memorial Institute 7722
DR   Wikidata; Q107116766
RX   PubMed=4266330;
CC   Karyotypic information: 47,XX,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7732
AC   CVCL_A7TG
SY   RPMI 7732; RPMI7732; Roswell Park Memorial Institute 7732
DR   Wikidata; Q107116767
RX   PubMed=4266330;
CC   Karyotypic information: 47,XX,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7762
AC   CVCL_A7TM
SY   RPMI 7762; RPMI7762; Roswell Park Memorial Institute 7762
DR   Wikidata; Q107116768
RX   PubMed=4266330;
CC   Karyotypic information: 47,XX,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7781
AC   CVCL_T316
SY   RPMI 7781; RPMI7781; Roswell Park Memorial Institute 7781
DR   Wikidata; Q54951220
RX   DOI=10.1093/jnci/59.2.301;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RPMI-7801
AC   CVCL_T317
SY   RPMI 7801; RPMI7801; Roswell Park Memorial Institute 7801
DR   Wikidata; Q54951221
RX   DOI=10.1093/jnci/59.2.301;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RPMI-7821
AC   CVCL_LH87
AS   CVCL_LH90
SY   RPMI 7821; RPMI7821; RPMI-M7821; RPMI M7821; M7821; Roswell Park Memorial Institute 7821
DR   Wikidata; Q54951222
RX   PubMed=1161259;
RX   PubMed=4130585;
CC   Doubling time: 42 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_U115 ! RPMI-8342
OI   CVCL_X375 ! RPMI-8362
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   RPMI-7822
AC   CVCL_A7TQ
SY   RPMI 7822; RPMI7822; Roswell Park Memorial Institute 7822
DR   Wikidata; Q107116769
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7841
AC   CVCL_LH98
SY   RPMI 7841; RPMI7841; Roswell Park Memorial Institute 7841
DR   Wikidata; Q54951223
RX   PubMed=4366935;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   RPMI-7851
AC   CVCL_LH95
SY   RPMI 7851; RPMI7851; Roswell Park Memorial Institute 7851
DR   Wikidata; Q54951224
RX   PubMed=4366935;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from melanoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   RPMI-7852
AC   CVCL_A7TE
SY   RPMI 7852; RPMI7852; Roswell Park Memorial Institute 7852
DR   Wikidata; Q107116770
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7TD ! RPMI-7572
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7865
AC   CVCL_T299
SY   RPMI 7865; RPMI7865; Roswell Park Memorial Institute 7865
DR   Wikidata; Q54951225
RX   PubMed=5218782;
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F530 ! RPMI-4265
OI   CVCL_T297 ! RPMI-1694
OI   CVCL_T298 ! RPMI-1695
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RPMI-7881
AC   CVCL_LH97
SY   RPMI 7881; RPMI7881; Roswell Park Memorial Institute 7881
DR   Wikidata; Q54951227
RX   PubMed=4366935;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from acute myelogenous leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   RPMI-7882
AC   CVCL_A7TS
SY   RPMI 7882; RPMI7882; Roswell Park Memorial Institute 7882
DR   Wikidata; Q107116771
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7912
AC   CVCL_A7TR
SY   RPMI 7912; RPMI7912; Roswell Park Memorial Institute 7912
DR   Wikidata; Q107116772
RX   PubMed=4266330;
CC   Karyotypic information: 47,XX,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-7921
AC   CVCL_LH94
SY   RPMI 7921; RPMI7921; Roswell Park Memorial Institute 7921
DR   Wikidata; Q54951228
RX   PubMed=4366935;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from melanoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   RPMI-7922
AC   CVCL_T318
SY   RPMI 7922; RPMI7922; Roswell Park Memorial Institute 7922
DR   Wikidata; Q54951229
RX   DOI=10.1093/jnci/59.2.301;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RPMI-7931
AC   CVCL_3951
SY   RPMI 7931; RPMI7931; Roswell Park Memorial Institute 7931
DR   BTO; BTO_0002140
DR   Wikidata; Q54951230
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1161259;
RX   PubMed=3518877;
CC   Doubling time: 46 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   RPMI-7932
AC   CVCL_2713
SY   RPMI 7932; RPMI7932; Roswell Park Memorial Institute 7932; ULF
DR   BTO; BTO_0004062
DR   CLO; CLO_0008872
DR   CLDB; cl4180
DR   CLDB; cl4181
DR   cancercelllines; CVCL_2713
DR   Cell_Model_Passport; SIDM00916
DR   Cosmic; 889039
DR   Cosmic; 928744
DR   ECACC; 94072246
DR   GEO; GSM226865
DR   ICLC; HTL96012
DR   Progenetix; CVCL_2713
DR   Wikidata; Q54951231
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=72600;
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3180053;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6277475;
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
RX   PubMed=22383533;
CC   Population: Caucasian.
CC   HLA typing: A*02,03; B*07,w40 (PubMed=77569).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; None_reported; -; Zygosity=- (PubMed=15048078; PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   RPMI-7932 COL-1
AC   CVCL_RW16
SY   COL-1; COL 1; BMCOL-1
DR   Wikidata; Q54951232
RX   PubMed=3180053;
RX   PubMed=7954423;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2713 ! RPMI-7932
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   RPMI-7932 VBL-4
AC   CVCL_RW17
SY   VBL-4; VBL 4
DR   Wikidata; Q54951233
RX   PubMed=3180053;
RX   PubMed=7954423;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2713 ! RPMI-7932
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   RPMI-7932 VCR-4.5/4
AC   CVCL_RW18
SY   VCR-4.5/4; VCR 4.5/4
DR   Wikidata; Q54951234
RX   PubMed=3180053;
RX   PubMed=7954423;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2713 ! RPMI-7932
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
ID   RPMI-7951
AC   CVCL_1666
SY   RPMI 7951; RPMI7951; Roswell Park Memorial Institute 7951
DR   BTO; BTO_0003508
DR   CLO; CLO_0008877
DR   EFO; EFO_0005712
DR   CLDB; cl4187
DR   4DN; 4DNSRQW8GWCI
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-66
DR   BCRC; 60274
DR   BioGRID_ORCS_Cell_line; 384
DR   BioSample; SAMN03471611
DR   BioSample; SAMN03473473
DR   BioSample; SAMN10987964
DR   cancercelllines; CVCL_1666
DR   Cell_Model_Passport; SIDM01087
DR   CGH-DB; 9320-4
DR   ChEMBL-Cells; CHEMBL3307962
DR   ChEMBL-Targets; CHEMBL612447
DR   Cosmic; 687439
DR   Cosmic; 905233
DR   Cosmic; 910903
DR   Cosmic; 933001
DR   Cosmic; 1022287
DR   Cosmic; 1303050
DR   Cosmic; 1507596
DR   Cosmic; 2233666
DR   Cosmic-CLP; 910903
DR   DepMap; ACH-000348
DR   DSMZ; ACC-66
DR   DSMZCellDive; ACC-66
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS262AAA
DR   ENCODE; ENCBS457YHI
DR   ENCODE; ENCBS493TPA
DR   GDSC; 910903
DR   GEO; GSM206540
DR   GEO; GSM274689
DR   GEO; GSM827474
DR   GEO; GSM887547
DR   GEO; GSM888630
DR   GEO; GSM1670388
DR   IARC_TP53; 13321
DR   IARC_TP53; 27231
DR   KCLB; 30066
DR   LiGeA; CCLE_303
DR   LINCS_LDP; LCL-1254
DR   NCI-DTP; RPMI-7951
DR   PharmacoDB; RPMI7951_1326_2019
DR   PRIDE; PXD022992
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1666
DR   PubChem_Cell_line; CVCL_1666
DR   Wikidata; Q54951235
RX   DOI=10.1007/BF00199208;
RX   PubMed=833871;
RX   PubMed=1161259;
RX   PubMed=3335022;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=15467732;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23285177;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/RPMI7951_Stam_protocol.pdf
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 50 hours (PubMed=1161259); ~60 hours (DSMZ=ACC-66).
CC   HLA typing: A*01:01,02:01; B*08:01,13:02; C*06:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (ATCC=HTB-66).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=15467732; ATCC=HTB-66; Cosmic-CLP=910903; DepMap=ACH-000348).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser166Ter (c.497C>A); Zygosity=Homozygous (Cosmic-CLP=910903; DepMap=ACH-000348).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.85%; East Asian, North=0.16%; East Asian, South=0%; South Asian=0%; European, North=64.75%; European, South=33.24% (PubMed=30894373).
CC   Discontinued: KCLB; 30066; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-66; Cosmic-CLP=910903; DSMZ=ACC-66; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12 (ATCC=HTB-66; PubMed=25877200)
ST   D16S539: 12 (Cosmic-CLP=910903; DSMZ=ACC-66)
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,31.2
ST   D2S1338: 17,23
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 27
ST   Penta D: 12,13
ST   Penta E: 7,18
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   RPMI-7962
AC   CVCL_T319
SY   RPMI 7962; RPMI7962; Roswell Park Memorial Institute 7962
DR   Wikidata; Q54951237
RX   DOI=10.1093/jnci/59.2.301;
CC   Population: Caucasian.
CC   Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   RPMI-7972
AC   CVCL_T320
SY   RPMI 7972; RPMI7972; Roswell Park Memorial Institute 7972
DR   Wikidata; Q54951238
RX   DOI=10.1093/jnci/59.2.301;
CC   Population: Caucasian.
CC   Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T321 ! RPMI-8002
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   RPMI-8002
AC   CVCL_T321
SY   RPMI 8002; RPMI8002; Roswell Park Memorial Institute 8002
DR   Wikidata; Q54951239
RX   DOI=10.1093/jnci/59.2.301;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T322 ! RPMI-8072
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   RPMI-8057
AC   CVCL_JA34
SY   RPMI 8057; RPMI8057; Roswell Park Memorial Institute 8057
DR   Wikidata; Q54951240
RX   PubMed=62390;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   RPMI-8072
AC   CVCL_T322
SY   RPMI 8072; RPMI8072; Roswell Park Memorial Institute 8072
DR   Wikidata; Q54951241
RX   DOI=10.1093/jnci/59.2.301;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3317 ! HMCB
OI   CVCL_T313 ! RPMI-7262
OI   CVCL_T314 ! RPMI-7272
OI   CVCL_2713 ! RPMI-7932
OI   CVCL_T315 ! RPMI-7551
OI   CVCL_T316 ! RPMI-7781
OI   CVCL_T317 ! RPMI-7801
OI   CVCL_T318 ! RPMI-7922
OI   CVCL_T319 ! RPMI-7962
OI   CVCL_T320 ! RPMI-7972
OI   CVCL_T321 ! RPMI-8002
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   RPMI-8092
AC   CVCL_A7TB
SY   RPMI 8092; RPMI8092; Roswell Park Memorial Institute 8092
DR   Wikidata; Q107116773
RX   PubMed=4266330;
CC   Karyotypic information: 47,XY,+21 (PubMed=4266330).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RPMI-8113
AC   CVCL_5M18
SY   RPMI 8113; RPMI8113; RPMI No. 8113; RPMI #8113; Roswell Park Memorial Institute 8113; Pituitary carcinoma #1
DR   Wikidata; Q54951242
RX   PubMed=14071829;
DI   NCIt; C134993; Hamster pituitary carcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   RPMI-8195
AC   CVCL_T301
SY   RPMI 8195; RPMI8195; Roswell Park Memorial Institute 8195
DR   Wikidata; Q54951243
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=5218782;
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T302 ! RPMI-8205
OI   CVCL_T303 ! RPMI-8235
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   RPMI-8205
AC   CVCL_T302
SY   RPMI 8205; RPMI8205; Roswell Park Memorial Institute 8205; R8205
DR   Wikidata; Q54951244
RX   PubMed=4169031;
RX   PubMed=5218782;
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T301 ! RPMI-8195
OI   CVCL_T303 ! RPMI-8235
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RPMI-8226
AC   CVCL_0014
AS   CVCL_7353
SY   RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson
DR   BTO; BTO_0000726
DR   CLO; CLO_0008873
DR   CLO; CLO_0031845
DR   EFO; EFO_0002322
DR   MCCL; MCC:0000406
DR   CLDB; cl4182
DR   CLDB; cl4183
DR   CLDB; cl4184
DR   CLDB; cl5252
DR   AddexBio; C0003002/62
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ArrayExpress; E-TABM-937
DR   ATCC; CCL-155
DR   ATCC; CRM-CCL-155
DR   BCRC; 60384
DR   BioGRID_ORCS_Cell_line; 1003
DR   BioSample; SAMN03471458
DR   BioSample; SAMN03472934
DR   BioSample; SAMN03473581
DR   BioSample; SAMN10988318
DR   cancercelllines; CVCL_0014
DR   CCRID; 1101HUM-PUMC000083
DR   CCRID; 3101HUMTCHu234
DR   Cell_Model_Passport; SIDM00087
DR   CGH-DB; 9162-4
DR   ChEMBL-Cells; CHEMBL3307732
DR   ChEMBL-Targets; CHEMBL614882
DR   CLS; 300431
DR   Coriell; GM02132
DR   Cosmic; 720773
DR   Cosmic; 724856
DR   Cosmic; 742952
DR   Cosmic; 759915
DR   Cosmic; 760397
DR   Cosmic; 875867
DR   Cosmic; 886084
DR   Cosmic; 888018
DR   Cosmic; 897452
DR   Cosmic; 905964
DR   Cosmic; 919145
DR   Cosmic; 974250
DR   Cosmic; 991554
DR   Cosmic; 999791
DR   Cosmic; 1044255
DR   Cosmic; 1092628
DR   Cosmic; 1139509
DR   Cosmic; 1139639
DR   Cosmic; 1175858
DR   Cosmic; 1305340
DR   Cosmic; 1312326
DR   Cosmic; 1762461
DR   Cosmic; 1998470
DR   Cosmic; 2081405
DR   Cosmic; 2159574
DR   Cosmic; 2367260
DR   Cosmic; 2391801
DR   Cosmic-CLP; 905964
DR   DepMap; ACH-000817
DR   DSMZ; ACC-402
DR   DSMZCellDive; ACC-402
DR   ECACC; 87012702
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS457ZNO
DR   ENCODE; ENCBS604KZU
DR   GDSC; 905964
DR   GEO; GSM2135
DR   GEO; GSM50198
DR   GEO; GSM50261
DR   GEO; GSM143340
DR   GEO; GSM290304
DR   GEO; GSM562819
DR   GEO; GSM621590
DR   GEO; GSM743461
DR   GEO; GSM750813
DR   GEO; GSM799349
DR   GEO; GSM799412
DR   GEO; GSM887548
DR   GEO; GSM888631
DR   GEO; GSM1153419
DR   GEO; GSM1181289
DR   GEO; GSM1181334
DR   GEO; GSM1199922
DR   GEO; GSM1199923
DR   GEO; GSM1199924
DR   GEO; GSM1199925
DR   GEO; GSM1199926
DR   GEO; GSM1199927
DR   GEO; GSM1374855
DR   GEO; GSM1666389
DR   GEO; GSM1670389
DR   GEO; GSM2124680
DR   GEO; GSM7701441
DR   GEO; GSM7701457
DR   IARC_TP53; 360
DR   IARC_TP53; 27232
DR   IGRhCellID; RPMI8226
DR   IZSLER; BS TCL 92
DR   JCRB; IFO50013
DR   JCRB; JCRB0034
DR   KCLB; 10155
DR   LiGeA; CCLE_817
DR   LINCS_LDP; LCL-2049
DR   Lonza; 61
DR   NCBI_Iran; C210
DR   NCI-DTP; RPMI-8226
DR   PharmacoDB; RPMI8226_1327_2019
DR   PRIDE; PXD001276
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD013859
DR   PRIDE; PXD030239
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0014
DR   PubChem_Cell_line; CVCL_0014
DR   RCB; RCB3010
DR   SKY/M-FISH/CGH; 2743
DR   TKG; TKG 0243
DR   Wikidata; Q54951245
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1007/978-1-4757-1647-4_11;
RX   DOI=10.1016/0385-6380(87)90139-7;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=1373872;
RX   PubMed=1720489;
RX   PubMed=2041050;
RX   PubMed=2140233;
RX   PubMed=2537114;
RX   PubMed=2563664;
RX   PubMed=2875788;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=3893568;
RX   PubMed=4177524;
RX   PubMed=4366935;
RX   PubMed=5243066;
RX   PubMed=5260617;
RX   PubMed=6042436;
RX   PubMed=6350451;
RX   PubMed=8943038;
RX   PubMed=9290701;
RX   PubMed=9331090;
RX   PubMed=9510473;
RX   PubMed=10087940;
RX   PubMed=10557056;
RX   PubMed=10583232;
RX   PubMed=10700174;
RX   PubMed=10936422;
RX   PubMed=11001907;
RX   PubMed=11154231;
RX   PubMed=11157491;
RX   PubMed=11515052;
RX   PubMed=12068308;
RX   PubMed=14555701;
RX   PubMed=15215163;
RX   PubMed=15748285;
RX   PubMed=16956823;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=17171682;
RX   PubMed=17692805;
RX   PubMed=18277095;
RX   PubMed=18605421;
RX   PubMed=18647998;
RX   PubMed=18700954;
RX   PubMed=19306352;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21173094;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23074853;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29718670;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31465861;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32123307;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=33
WW   Provider; BRICS; BRICS0113; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3918
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: NCI-7 clinical proteomics reference material cell line panel.
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (PubMed=6042436; ATCC=CCL-155).
CC   Doubling time: 26.7 hours (PubMed=2875788); 60 hours (PubMed=25984343); ~60-70 hours (DSMZ=ACC-402); 33.5 hours (NCI-DTP=RPMI-8226).
CC   HLA typing: A*30:01,68:02; B*15:03,15:10; C*02:02:04,03:04:02; DPB1*01:01:02,13:01; DQB1*02:01,02:02; DRB1*03:01:01,07:01 (PubMed=15748285).
CC   HLA typing: A*30:01,68:02; B*15:10,15:10; C*02:02,03:04 (PubMed=26589293).
CC   HLA typing: A*30,68:02; B*15,15; C*02:02,03:04 (Direct_author_submission).
CC   HLA typing: A*30:01:01,68:02:01; B*15:10:01,15:03:01; C*02:10:01,03:04:02; DPA1*02:01:01,02:01:01; DRA*01:01:01,01:01:01; DRB1*03:01:01,07:01:01 (DSMZCellDive=ACC-402).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (CelloPub=CLPUB00604).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=11157491; PubMed=12068308; PubMed=17088437; PubMed=21173094; CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous; Note=Temperature-sensitive (PubMed=1373872; PubMed=9331090; PubMed=17088437; PubMed=18277095; PubMed=21173094; CelloPub=CLPUB00604).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (PubMed=17692805).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=73.94%; Native American=0%; East Asian, North=1.06%; East Asian, South=0%; South Asian=0%; European, North=11.76%; European, South=13.24% (PubMed=30894373).
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Misspelling: RPMI-8266; Note=Occasionally.
CC   Misspelling: RPMI-8826; Cosmic=875867.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): AddexBio=C0003002/62; ATCC=CCL-155; CCRID; CLS=300431; Cosmic-CLP=905964; DSMZ=ACC-402; ECACC=87012702; JCRB=IFO50013; JCRB=JCRB0034; KCLB=10155; PubMed=19372543; PubMed=25877200; Technion Genomics Center; TKG=TKG 0243
ST   Amelogenin: X (PubMed=19372543; TKG=TKG 0243)
ST   Amelogenin: X,Y (AddexBio=C0003002/62; ATCC=CCL-155; CCRID; CLS=300431; Cosmic-CLP=905964; DSMZ=ACC-402; ECACC=87012702; JCRB=IFO50013; JCRB=JCRB0034; KCLB=10155; PubMed=25877200; Technion Genomics Center)
ST   CSF1PO: 12
ST   D10S1248: 12
ST   D12S391: 16,19
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 15,19
ST   D19S433: 13.2,14 (ATCC=CCL-155; CCRID; PubMed=19372543; Technion Genomics Center)
ST   D19S433: 14 (DSMZ=ACC-402)
ST   D1S1656: 13
ST   D21S11: 28,29
ST   D22S1045: 15,17
ST   D2S1338: 20
ST   D2S441: 12,14
ST   D3S1358: 16,17
ST   D5S818: 11,13 (AddexBio=C0003002/62; ATCC=CCL-155; CCRID; CLS=300431; Cosmic-CLP=905964; DSMZ=ACC-402; ECACC=87012702; JCRB=IFO50013; JCRB=JCRB0034; KCLB=10155; PubMed=19372543; Technion Genomics Center; TKG=TKG 0243)
ST   D5S818: 13 (PubMed=25877200)
ST   D7S820: 9,10
ST   D8S1179: 12,13 (ATCC=CCL-155; CCRID)
ST   D8S1179: 13 (CLS=300431; DSMZ=ACC-402; PubMed=25877200; Technion Genomics Center)
ST   DYS391: 11
ST   FGA: 19
ST   Penta D: 2.2,11 (ATCC=CCL-155; CLS=300431; PubMed=25877200; Technion Genomics Center)
ST   Penta D: 11 (DSMZ=ACC-402)
ST   Penta E: 16,17
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16 (DSMZ=ACC-402)
ST   vWA: 16,18 (AddexBio=C0003002/62; ATCC=CCL-155; CCRID; CLS=300431; Cosmic-CLP=905964; ECACC=87012702; JCRB=IFO50013; JCRB=JCRB0034; KCLB=10155; PubMed=19372543; PubMed=25877200; Technion Genomics Center; TKG=TKG 0243)
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   RPMI-8226-B25
AC   CVCL_E5J8
SY   8226/B25; 8226-B25
RX   DOI=10.1182/blood.V124.21.2084.2084;
CC   Population: African American.
CC   Characteristics: Resistant to 25 nM of bortezomib (DOI=10.1182/blood.V124.21.2084.2084).
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RPMI-8226-EGFP
AC   CVCL_A9CZ
DR   cancercelllines; CVCL_A9CZ
DR   CCRID; 1101HUM-PUMC000849
DR   Wikidata; Q108821248
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): CCRID=1101HUM-PUMC000849
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 15,19
ST   D19S433: 13.2,14
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   RPMI-8226-Fluc-EmGFP
AC   CVCL_D5KK
DR   Imanis; CL177
DR   Wikidata; Q127384068
CC   Population: African American.
CC   Characteristics: Reporter cell line, transduced with the LV-SFFV-Luc2-P2A-EmGFP vector encoding for luciferase linked via a P2A cleavage site to Emerald GFP (emGFP) and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL177).
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   RPMI-8226-Fluc-Puro
AC   CVCL_D5KL
DR   Imanis; CL174
DR   Wikidata; Q127384071
CC   Population: African American.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL174).
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   RPMI-8226-Luc2-tdT
AC   CVCL_A9DA
DR   cancercelllines; CVCL_A9DA
DR   CCRID; 1101HUM-PUMC000852
DR   Wikidata; Q108821249
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): CCRID=1101HUM-PUMC000852
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 15,19
ST   D19S433: 13.2,14
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   RPMI-8226-mCherry
AC   CVCL_A9DB
DR   cancercelllines; CVCL_A9DB
DR   CCRID; 1101HUM-PUMC000850
DR   Wikidata; Q108821250
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): CCRID=1101HUM-PUMC000850
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 15,19
ST   D19S433: 13.2,14
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   RPMI-8226-tdT
AC   CVCL_A9DC
DR   cancercelllines; CVCL_A9DC
DR   CCRID; 1101HUM-PUMC000851
DR   Wikidata; Q108821251
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): CCRID=1101HUM-PUMC000851
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 15,19
ST   D19S433: 13.2,14
ST   D21S11: 28,29
ST   D2S1338: 20
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   RPMI-8226-R
AC   CVCL_XK17
SY   RPMI 8226-R; RPMI 8226R
DR   cancercelllines; CVCL_XK17
DR   PRIDE; PXD013859
DR   Wikidata; Q98129177
RX   PubMed=31465861;
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   RPMI-8226/Dox
AC   CVCL_E5J7
SY   8226/Dox
RX   PubMed=2875788;
CC   Population: African American.
CC   Characteristics: Resistant to 1 x 10-7 M of doxorubicin (PubMed=2875788).
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Doubling time: 28.9 hours (PubMed=2875788).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RPMI-8226/Dox40
AC   CVCL_J431
SY   RPMI 8226/DOX40; RPMI-8226DOX40; 8226/DOX40; 8226/Dox40; 8226/Dox(40); 8226 Dox40; 8226Dox40; Dox40
DR   cancercelllines; CVCL_J431
DR   Wikidata; Q54951246
RX   PubMed=2563664;
RX   PubMed=2569359;
RX   PubMed=10095106;
RX   PubMed=10825126;
RX   PubMed=11309308;
CC   Population: African American.
CC   Characteristics: Resistant to 40 x 10-8 M of doxorubicin (PubMed=2563664).
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   RPMI-8226/Dox6
AC   CVCL_J432
SY   RPMI 8226/DOX6; 8226/DOX6; 8226/Dox6; 8226Dox6; DOX-6; Dox6
DR   cancercelllines; CVCL_J432
DR   Wikidata; Q54951247
RX   PubMed=2563664;
RX   PubMed=2569359;
RX   PubMed=10070958;
CC   Population: African American.
CC   Characteristics: Resistant to 6 x 10-8 M of doxorubicin (PubMed=2563664).
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 21
//
ID   RPMI-8226/LR-5
AC   CVCL_J434
SY   RPMI-8226 LR5; RPMI8226-LR5; RPMI 8226/LR5; 8226/LR-5; 8226/LR5
DR   cancercelllines; CVCL_J434
DR   GEO; GSM562820
DR   PRIDE; PXD001276
DR   Wikidata; Q54951248
RX   PubMed=1988143;
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   RPMI-8226/MDR10V
AC   CVCL_J433
SY   8226/MDR10V; 8226/MDR(10)V; DOX-10V
DR   cancercelllines; CVCL_J433
DR   Wikidata; Q54951249
RX   PubMed=8968098;
RX   PubMed=10095106;
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Selected for resistance to: ChEBI; CHEBI_9948; Verapamil (VPL).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J431 ! RPMI-8226/Dox40
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 20
//
ID   RPMI-8226/MR20
AC   CVCL_0509
SY   RPMI 8226/MR20; RPMI8226/MR20; 8226/MR20; 8226 MR20
DR   MCCL; MCC:0000407
DR   cancercelllines; CVCL_0509
DR   Wikidata; Q54951250
RX   PubMed=10070958;
RX   PubMed=10825126;
RX   PubMed=11309308;
RX   PubMed=12116365;
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V90 ! RPMI-8226/MR4
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   RPMI-8226/MR4
AC   CVCL_4V90
SY   RPMI 8226/MR4; 8226/MR4
DR   cancercelllines; CVCL_4V90
DR   Wikidata; Q54951251
RX   PubMed=10070958;
CC   Population: African American.
CC   Characteristics: Produces IgG lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   RPMI-8235
AC   CVCL_T303
SY   RPMI 8235; RPMI8235; RPMI no. 8235; Roswell Park Memorial Institute 8235; R8235
DR   Wikidata; Q54951253
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=168255;
RX   PubMed=4169031;
RX   PubMed=4177524;
RX   PubMed=4366935;
RX   PubMed=5218782;
CC   Characteristics: Produces IgG kappa.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T301 ! RPMI-8195
OI   CVCL_T302 ! RPMI-8205
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 11
//
ID   RPMI-8252
AC   CVCL_T323
SY   RPMI 8252; RPMI8252; Roswell Park Memorial Institute 8252
DR   Wikidata; Q54951266
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_U115 ! RPMI-8342
OI   CVCL_X375 ! RPMI-8362
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   RPMI-8265
AC   CVCL_UJ84
SY   RPMI 8265; RPMI8265; Roswell Park Memorial Institute 8265
DR   Wikidata; Q98129178
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 6
//
ID   RPMI-8312
AC   CVCL_LH88
SY   RPMI 8312; RPMI8312; Roswell Park Memorial Institute 8312
DR   Wikidata; Q54951268
RX   PubMed=1161259;
CC   Doubling time: 74 hours (PubMed=1161259).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-8322
AC   CVCL_C542
SY   RPMI 8322; RPMI8322; Roswell Park Memorial Institute 8322; M-5; M5
DR   BTO; BTO_0005710
DR   Cosmic; 1054846
DR   Cosmic; 1507607
DR   Cosmic; 2233667
DR   Wikidata; Q54951269
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=72600;
RX   PubMed=77569;
RX   PubMed=944091;
RX   PubMed=1127734;
RX   PubMed=1832891;
RX   PubMed=2423348;
RX   PubMed=8845476;
RX   PubMed=17308088;
CC   Doubling time: 38 hours (PubMed=1127734).
CC   HLA typing: A*02,09; B*07,w05 (PubMed=77569).
CC   Misspelling: RPMI8332; Cosmic=1054846; PubMed=17308088.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_U115 ! RPMI-8342
OI   CVCL_X375 ! RPMI-8362
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   RPMI-8337
AC   CVCL_UJ85
SY   RPMI 8337; RPMI8337; Roswell Park Memorial Institute 8337
DR   Wikidata; Q98129179
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   RPMI-8342
AC   CVCL_U115
SY   RPMI 8342; RPMI8342; Roswell Park Memorial Institute 8342; M-3
DR   Wikidata; Q54951270
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=944091;
RX   PubMed=1127734;
RX   PubMed=1161259;
CC   Doubling time: 38 hours (PubMed=1127734); 62 hours (PubMed=1161259).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_X375 ! RPMI-8362
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   RPMI-8352
AC   CVCL_E5HK
SY   RPMI 8352; RPMI8352; Roswell Park Memorial Institute 8352
RX   PubMed=4207624;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RPMI-8362
AC   CVCL_X375
SY   RPMI 8362; RPMI8362; Roswell Park Memorial Institute 8362
DR   Wikidata; Q54951271
RX   DOI=10.1093/jnci/59.2.301;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_U115 ! RPMI-8342
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 8
//
ID   RPMI-8372
AC   CVCL_X376
SY   RPMI 8372; RPMI8372; Roswell Park Memorial Institute 8372
DR   Wikidata; Q54951272
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=6277475;
RX   PubMed=6349783;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_U115 ! RPMI-8342
OI   CVCL_X375 ! RPMI-8362
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 7
//
ID   RPMI-8382
AC   CVCL_B7RD
SY   RPMI 8382; RPMI8382; Roswell Park Memorial Institute 8382
DR   Wikidata; Q114312881
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7RE ! RPMI-8392
OI   CVCL_1667 ! RPMI-8402
OI   CVCL_WV43 ! RPMI-8432
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   RPMI-8392
AC   CVCL_B7RE
SY   RPMI 8392; RPMI8392; Roswell Park Memorial Institute 8392
DR   Wikidata; Q114312882
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7RD ! RPMI-8382
OI   CVCL_1667 ! RPMI-8402
OI   CVCL_WV43 ! RPMI-8432
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   RPMI-8402
AC   CVCL_1667
SY   RPMI 8402; RPMI8402; Roswell Park Memorial Institute 8402; 8402
DR   BTO; BTO_0001880
DR   CLO; CLO_0008874
DR   CLO; CLO_0009857
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-1994
DR   BioSample; SAMN03471272
DR   BioSample; SAMN10988543
DR   cancercelllines; CVCL_1667
DR   Cell_Model_Passport; SIDM00403
DR   ChEMBL-Cells; CHEMBL3307964
DR   ChEMBL-Targets; CHEMBL612517
DR   Cosmic; 801732
DR   Cosmic; 909702
DR   Cosmic; 913427
DR   Cosmic; 932767
DR   Cosmic; 998726
DR   Cosmic; 999753
DR   Cosmic; 1012115
DR   Cosmic; 1037681
DR   Cosmic; 1115587
DR   Cosmic; 1151791
DR   Cosmic; 1175132
DR   Cosmic; 1191706
DR   Cosmic; 1224369
DR   Cosmic; 1281383
DR   Cosmic; 1330501
DR   Cosmic; 1524817
DR   Cosmic; 1641386
DR   Cosmic; 1664527
DR   Cosmic; 1760531
DR   Cosmic; 2458761
DR   Cosmic; 2462860
DR   Cosmic; 2602930
DR   Cosmic; 2733531
DR   Cosmic-CLP; 909702
DR   DepMap; ACH-000636
DR   DSMZ; ACC-290
DR   DSMZCellDive; ACC-290
DR   EGA; EGAS00001000978
DR   GDSC; 909702
DR   GEO; GSM887549
DR   GEO; GSM888632
DR   GEO; GSM1670390
DR   GEO; GSM5137742
DR   IARC_TP53; 2503
DR   LiGeA; CCLE_140
DR   LINCS_LDP; LCL-1022
DR   NCBI_Iran; C184
DR   PharmacoDB; RPMI8402_1328_2019
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1667
DR   PubChem_Cell_line; CVCL_1667
DR   Wikidata; Q54951273
RX   CelloPub=CLPUB00338;
RX   DOI=10.1007/978-1-4757-1647-4_11;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2255914;
RX   PubMed=2501659;
RX   PubMed=2985879;
RX   PubMed=3039492;
RX   PubMed=3159941;
RX   PubMed=3518877;
RX   PubMed=3874327;
RX   PubMed=4547172;
RX   PubMed=9933131;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=15472075;
RX   PubMed=16408098;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=26589293;
RX   PubMed=26870252;
RX   PubMed=27397505;
RX   PubMed=29496689;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35354797;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/rpmi-8402/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Genetically heterogenous.
CC   Doubling time: ~48 hours (DSMZ=ACC-290).
CC   HLA typing: A*01:01,29:01; B*07:05,38:01; C*12:03,15:05 (PubMed=26589293).
CC   HLA typing: A*01:01:01,29:01:01; B*07:05:01,38:01:01; C*12:03:01,15:05:02 (DSMZCellDive=ACC-290).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6641; LMO1 + HGNC; HGNC:12252; TRD; Name(s)=LMO1-TRD (PubMed=2501659; PubMed=29496689).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (PubMed=2255914; PubMed=29496689).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Homozygous (PubMed=22675565; PubMed=26870252; Cosmic-CLP=909702).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Glu1583_Gln1584insProValGluLeuMetProProGlu (c.4750_4751insCCGTGGAGCTGATGCCGCCGGAGC); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg159Ser (c.477G>T); ClinVar=VCV000375959; Zygosity=Heterozygous (PubMed=22675565; PubMed=26870252; Cosmic-CLP=909702).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (PubMed=22675565; PubMed=26870252; Cosmic-CLP=909702).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser121Ter (c.362C>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909702).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.88%; Native American=0%; East Asian, North=2.78%; East Asian, South=0%; South Asian=0%; European, North=60.56%; European, South=35.77% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-1994; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-1994; Cosmic-CLP=909702; DSMZ=ACC-290; PubMed=29496689
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12 (ATCC=CRL-1994; DSMZ=ACC-290)
ST   D13S317: 12 (Cosmic-CLP=909702; PubMed=29496689)
ST   D16S539: 10,11
ST   D18S51: 16,20
ST   D19S433: 12,13,14 (PubMed=29496689)
ST   D19S433: 12,14 (DSMZ=ACC-290)
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 8,13
ST   D8S1179: 11
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 7,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,20
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7RD ! RPMI-8382
OI   CVCL_B7RE ! RPMI-8392
OI   CVCL_WV43 ! RPMI-8432
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   RPMI-8432
AC   CVCL_WV43
SY   RPMI 8432; RPMI8432; Roswell Park Memorial Institute 8432
DR   Wikidata; Q98129180
RX   PubMed=2501659;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4547172;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7RD ! RPMI-8382
OI   CVCL_B7RE ! RPMI-8392
OI   CVCL_1667 ! RPMI-8402
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   RPMI-8746
AC   CVCL_5M19
SY   RPMI 8746; RPMI8746; RPMI No. 8746; RPMI #8746; Roswell Park Memorial Institute 8746; Klein fibrosarcoma
DR   Wikidata; Q54951274
RX   PubMed=14071829;
DI   NCIt; C134992; Hamster fibrosarcoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   RPMI-8767
AC   CVCL_UJ91
SY   RPMI 8767; RPMI8767; Roswell Park Memorial Institute 8767
DR   Wikidata; Q98129181
RX   DOI=10.1016/B978-0-12-427150-0.50135-2;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   RPMI-8866
AC   CVCL_1668
SY   RPMI 8866; RPMI8866; Roswell Park Memorial Institute 8866; R8866; 8866
DR   BTO; BTO_0004206
DR   CLO; CLO_0008875
DR   CLO; CLO_0009858
DR   CLDB; cl4186
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00482
DR   ChEMBL-Cells; CHEMBL3308323
DR   ChEMBL-Targets; CHEMBL2366341
DR   Cosmic; 910544
DR   Cosmic-CLP; 910544
DR   DepMap; ACH-002302
DR   ECACC; 95041316
DR   EGA; EGAS00001000978
DR   GDSC; 910544
DR   GEO; GSM1670391
DR   IARC_TP53; 21292
DR   LINCS_LDP; LCL-1113
DR   PharmacoDB; RPMI8866_1329_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1668
DR   Wikidata; Q54951275
RX   DOI=10.1007/978-1-4757-1647-4_11;
RX   PubMed=4169031;
RX   PubMed=6967232;
RX   PubMed=17254797;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*02,03; B*07 (PubMed=6967232).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.14%; East Asian, North=0%; East Asian, South=0%; South Asian=3.24%; European, North=67.29%; European, South=29.33% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=910544; ECACC=95041316; PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,14
ST   D16S539: 11
ST   D18S51: 12,15
ST   D21S11: 27,29
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   TH01: 9.3 (Cosmic-CLP=910544; ECACC=95041316)
ST   TH01: 10 (PubMed=17254797)
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   RPMI-9154
AC   CVCL_T300
SY   RPMI 9154; RPMI9154; Roswell Park Memorial Institute 9154; R9154
DR   Wikidata; Q54951276
RX   PubMed=4169031;
RX   PubMed=5218782;
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   RPMI-9767
AC   CVCL_E9ZI
SY   RPMI 9767; RPMI9767; Roswell Park Memorial Institute 9767
RX   PubMed=11515052;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RPMI-M7021
AC   CVCL_DD42
SY   RPMI M7021; M7021; Roswell Park Memorial Institute M7021
DR   Wikidata; Q54951277
RX   PubMed=4130569;
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   RPMI-M7041
AC   CVCL_LH89
SY   RPMI M7041; M7041; Roswell Park Memorial Institute M7041
DR   Wikidata; Q54951279
RX   PubMed=4130585;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH92 ! RPMI-7481
OI   CVCL_LH93 ! RPMI-7491
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   RPMI-SE
AC   CVCL_A0HT
DR   Wikidata; Q123033384
RX   PubMed=4057430;
RX   PubMed=7591954;
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=4057430).
CC   Karyotypic information: Hypertetraploid (PubMed=4057430).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RPMI8322/CDDP-300
AC   CVCL_C543
DR   Wikidata; Q54951281
RX   PubMed=8845476;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C542 ! RPMI-8322
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   RPS-R
AC   CVCL_A3AL
DR   CCLV; CCLV-RIE 0824
DR   Wikidata; Q105510769
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal rumen, mucosa; UBERON=UBERON_8480046.
OX   NCBI_TaxID=9858; ! Capreolus capreolus (European roe deer)
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   RPT-I8
AC   CVCL_HA72
SY   Renal Proximal Tubule-Immortalized 8
DR   Kerafast; EBU020
DR   Wikidata; Q54951282
RX   PubMed=12460651;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   RPTC-1
AC   CVCL_V277
DR   BioSample; SAMN03151973
DR   Wikidata; Q54951283
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a TPC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00422.
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 8,10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6298 ! TPC-1
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 23
//
ID   RPTEC/TERT1
AC   CVCL_K278
SY   RPTEC TERT1; RPTEC/TERT 1; RPTec; Renal Proximal Tubule Epithelial Cells/TERT-immortalized 1
DR   ATCC; CRL-4031
DR   BioSample; SAMN03471734
DR   Evercyte; CHT-003-0002
DR   GEO; GSM7701468
DR   GEO; GSM7701471
DR   MetaboLights; MTBLS9
DR   Wikidata; Q54951284
RX   PubMed=18715936;
RX   PubMed=21103459;
RX   PubMed=25536518;
RX   PubMed=31078587;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: ~96 hours (PubMed=18715936); 76.8 hours (PubMed=31078587); 72-96 hours (Evercyte=CHT-003-0002).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Metabolomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): ATCC=CRL-4031
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 11,20
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 5,17
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   RPTEC/TERT1 OAT1
AC   CVCL_RM67
SY   RPTEC/TERT1-OAT1
DR   ATCC; CRL-4031-OAT1
DR   Wikidata; Q54951285
RX   CelloPub=CLPUB00660;
CC   Doubling time: ~70 hours (ATCC=CRL-4031-OAT1).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10970; SLC22A6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): ATCC=CRL-4031-OAT1
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   RPTEC/TERT1 OAT3
AC   CVCL_VR68
SY   RPTEC/TERT1-OAT3
DR   ATCC; CRL-4031-OAT3
DR   Wikidata; Q98129184
RX   CelloPub=CLPUB00660;
CC   Doubling time: ~70 hours (ATCC=CRL-4031-OAT3).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10972; SLC22A8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): ATCC=CRL-4031-OAT3
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   RPTEC/TERT1 OCT2
AC   CVCL_RM66
SY   RPTEC/TERT1-OCT2
DR   ATCC; CRL-4031-OCT2
DR   Wikidata; Q54951286
RX   CelloPub=CLPUB00660;
CC   Doubling time: ~85 hours (ATCC=CRL-4031-OCT2).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10966; SLC22A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): ATCC=CRL-4031-OCT2
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   RPTEC_APC_488
AC   CVCL_C1BM
DR   Wikidata; Q114312886
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_ATM_451
AC   CVCL_C1BN
DR   Wikidata; Q114312887
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_ATM_535
AC   CVCL_C1BP
DR   Wikidata; Q114312890
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_ATRX_932
AC   CVCL_C1BQ
DR   Wikidata; Q114312893
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_CDKN2A_10
AC   CVCL_C1BR
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312895
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   RPTEC_CDKN2A_13
AC   CVCL_C1BS
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312897
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   RPTEC_CDKN2A_3
AC   CVCL_C1BT
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312900
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   RPTEC_EZH2_1
AC   CVCL_C1BU
DR   Wikidata; Q114312902
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_EZH2_3
AC   CVCL_C1BV
DR   Wikidata; Q114312905
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MLH1_905
AC   CVCL_C1BW
DR   Wikidata; Q114312906
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MSH2_495
AC   CVCL_C1BX
DR   Wikidata; Q114312907
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MSH2_525
AC   CVCL_C1BY
DR   Wikidata; Q114312908
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MSH6_540
AC   CVCL_C1BZ
DR   Wikidata; Q114312910
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MSH6_541
AC   CVCL_C1C0
DR   Wikidata; Q114312911
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MSH6_543
AC   CVCL_C1C1
DR   Wikidata; Q114312912
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MTAP_A3
AC   CVCL_C1CJ
DR   Wikidata; Q114312913
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_MTAP_C6
AC   CVCL_C1CK
DR   Wikidata; Q114312914
RX   PubMed=35692635;
CC   Characteristics: Control cell line for the cancer pathway knockout panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_NOTCH1_550
AC   CVCL_C1C2
DR   Wikidata; Q114312915
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_NOTCH1_552
AC   CVCL_C1C3
DR   Wikidata; Q114312916
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_NOTCH1_606
AC   CVCL_C1C4
DR   Wikidata; Q114312917
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_PTEN_3
AC   CVCL_C1C5
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312918
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   RPTEC_PTEN_4
AC   CVCL_C1C6
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312919
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   RPTEC_PTEN_5
AC   CVCL_C1C7
DR   EGA; EGAD00001008559
DR   Wikidata; Q114312920
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   RPTEC_STAG2_943
AC   CVCL_C1C8
DR   Wikidata; Q114312921
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_STAG2_944
AC   CVCL_C1C9
DR   Wikidata; Q114312922
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_STAG2_946
AC   CVCL_C1CA
DR   Wikidata; Q114312923
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_TP53_471
AC   CVCL_C1CB
DR   Wikidata; Q114312924
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_TP53_544
AC   CVCL_C1CC
DR   Wikidata; Q114312925
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPTEC_TP53_588
AC   CVCL_C1CD
DR   Wikidata; Q114312926
RX   PubMed=35692635;
CC   Part of: Cancer Pathway Knockout Panel.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K278 ! RPTEC/TERT1
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 7
//
ID   RPW-1
AC   CVCL_A2PS
SY   Red Palm Weevil-1
DR   ICLDB; rpw-1
DR   Wikidata; Q105510772
RX   PubMed=24197670;
RX   PubMed=25381034;
CC   Group: Insect cell line.
CC   Characteristics: Optimal growth temperature is 27 Celsius in Grace's and Schneider's media was, 24 Celsius in TNM-FH medium and 21 Celsius in Medium-199 (PubMed=24197670).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=354439; ! Rhynchophorus ferrugineus (Red palm weevil)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   RR
AC   CVCL_UI85
DR   Wikidata; Q98129186
RX   PubMed=2155676;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   RR-CHOKI
AC   CVCL_4294
SY   RR-CHOK1
DR   CLO; CLO_0008881
DR   CLDB; cl4188
DR   ECACC; 92052129
DR   Wikidata; Q54951287
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 8
//
ID   RR-H460
AC   CVCL_VQ68
SY   Radiation-Resistant-H460
DR   cancercelllines; CVCL_VQ68
DR   Wikidata; Q98129187
RX   PubMed=24558369;
CC   Population: Caucasian.
CC   Characteristics: The parent cell line was irradiated with 20 Gy.
CC   Selected for resistance to: NCIt; C17262; X-Ray.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu289_Lys292del; Zygosity=Unspecified; Note=Produces a truncated protein (PubMed=24558369).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   RR1/1
AC   CVCL_E8WB
SY   RR1/1.1.1
RX   Patent=US5475091;
RX   PubMed=3525675;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05362; Human ICAM1/CD54.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RR1022
AC   CVCL_3589
SY   RR 1022
DR   CLO; CLO_0008878
DR   CLDB; cl4189
DR   CLDB; cl4190
DR   ATCC; CCL-47
DR   ECACC; 90102526
DR   IZSLER; BS TCL 60
DR   KCLB; 10047
DR   Wikidata; Q54951289
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1111/j.1601-5223.1963.tb01894.x;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Breed/subspecies: Amsterdam.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   RRAm1
AC   CVCL_3416
DR   CLO; CLO_0008880
DR   CLDB; cl4953
DR   ICLC; AL99001
DR   Wikidata; Q54951290
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   rRCCd5
AC   CVCL_A6ZH
SY   rRCCd5Parent; d5; d5P
DR   RCB; RCB4664
DR   Wikidata; Q107116774
CC   Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   25W
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   RRBL1
AC   CVCL_A7NK
SY   Rituximab-Resistant B-cell Lymphoma 1
DR   Wikidata; Q107116776
RX   PubMed=17675267;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=17675267).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   RS
AC   CVCL_AQ48
DR   Evercyte; CLT-003-0014
DR   Wikidata; Q54951291
RX   PubMed=24553072;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: Evercyte; CLT-003-0014; true.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   RS-1 [Human leukemia]
AC   CVCL_8423
DR   BioSample; SAMN03151812
DR   Wikidata; Q54951292
RX   PubMed=9210910;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a 2 year old child with acute megakaryoblastic leukemia (AML-M7).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00264.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   RS-1 [Human primitive neuroectodermal tumor]
AC   CVCL_JL75
DR   JCRB; NIHS0610
DR   Wikidata; Q54951293
RX   PubMed=7894770;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=7894770).
CC   Discontinued: JCRB; NIHS0610; true.
CC   Derived from site: Metastatic; Perirectal space; UBERON=UBERON_8480019.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8424 ! RS-2
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   RS-1C9
AC   CVCL_B5T3
DR   Wikidata; Q112044503
RX   PubMed=24553072;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ48 ! RS
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   RS-2
AC   CVCL_8424
DR   JCRB; JCRB1340
DR   JCRB; NIHS0611
DR   Wikidata; Q54951294
RX   PubMed=7894770;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=7894770).
CC   Discontinued: JCRB; NIHS0611; true.
CC   Derived from site: Metastatic; Perianal space; UBERON=UBERON_8480010.
ST   Source(s): JCRB=JCRB1340
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D5S818: 9
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JL75 ! RS-1 [Human primitive neuroectodermal tumor]
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   RS-5
AC   CVCL_2182
SY   RS5
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473499
DR   BioSample; SAMN10988436
DR   cancercelllines; CVCL_2182
DR   Cell_Model_Passport; SIDM01772
DR   DepMap; ACH-000531
DR   DSMZ; ACC-604
DR   DSMZCellDive; ACC-604
DR   IARC_TP53; 30153
DR   LiGeA; CCLE_175
DR   PharmacoDB; RS5_1330_2019
DR   Wikidata; Q54951295
RX   DOI=10.1101/166199;
RX   PubMed=15372243;
RX   PubMed=26589293;
RX   PubMed=31068700;
CC   Problematic cell line: May be misclassified. While still annotated as a pleural sarcomatoid mesothelioma cell line, a variety of omics methods are classifying this cell line as a fibroblast (DOI=10.1101/166199; DepMap=ACH-000531).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~4 days (DSMZ=ACC-604).
CC   HLA typing: A*02:01,11:01; B*35:01,44:02; C*04:01,07:04; DQA1*01:02,05:02; DQB1*05:01,05:01; DRB1*11:02,14:46 (PubMed=26589293).
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Not directly described in the original publication, but indirectly mentioned ('Three others cell lines progressed in tissue culture') (PubMed=15372243).
ST   Source(s): DSMZ=ACC-604
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 19,22
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 12
ST   Penta E: 5,16
ST   TH01: 7,10
ST   TPOX: 9,10
ST   vWA: 17
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   RS-537
AC   CVCL_9499
SY   RS 537; RS537
DR   CLO; CLO_0008884
DR   CLDB; cl4191
DR   Wikidata; Q54951296
RX   PubMed=4357884;
RX   PubMed=4967397;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   RS-63
AC   CVCL_9715
DR   Wikidata; Q54951297
RX   PubMed=1320624;
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   RS-A
AC   CVCL_8425
SY   Rat Spleen-A
DR   JCRB; JCRB0423
DR   Wikidata; Q54951298
RX   PubMed=4270044;
CC   Doubling time: ~18 hours (PubMed=4270044).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Donryu; RS=RS_0000253.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   40D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   RS004
AC   CVCL_D6SP
RX   PubMed=38643711;
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   RS1
AC   CVCL_DR20
SY   Rat Skin 1
DR   CCRID; 5301RAT-KCB0705SZJ
DR   KCB; KCB 200705SZJ
DR   Wikidata; Q54951299
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 10
//
ID   RS1 fibroblast
AC   CVCL_A3YW
DR   GEO; GSM1057284
DR   Wikidata; Q105510778
RX   PubMed=23805272;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous; Note=De novo mutation (PubMed=23805272).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from monozygotic twin of RS2 fibroblast (Cellosaurus=CVCL_A3YX). The donor of RS1 suffers from typical Rett syndrome while the donor of RS2 suffers from an atypical form of Rett syndrome.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   RS1-52M
AC   CVCL_A3YS
DR   SKIP; SKIP005452
DR   Wikidata; Q105510784
RX   PubMed=26012557;
CC   Population: Japanese.
CC   Characteristics: Due to X chromosome inactivation does not express the mutated allele.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous; Note=De novo mutation (PubMed=26012557).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3YW ! RS1 fibroblast
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RS1-61P
AC   CVCL_A3YT
DR   SKIP; SKIP005453
DR   Wikidata; Q105510788
RX   PubMed=26012557;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous; Note=De novo mutation (PubMed=26012557).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3YW ! RS1 fibroblast
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RS11846
AC   CVCL_E048
SY   RS-11846
DR   CLO; CLO_0037214
DR   Cosmic; 1086344
DR   Wikidata; Q54951301
RX   PubMed=1339299;
RX   PubMed=8558920;
RX   PubMed=11021758;
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   RS182
AC   CVCL_6B94
DR   Wikidata; Q54951302
RX   PubMed=17306763;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, hypothalamus, suprachiasmatic nucleus; UBERON=UBERON_0006238+UBERON_0002034.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   19FD
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RS2 fibroblast
AC   CVCL_A3YX
DR   GEO; GSM1057285
DR   Wikidata; Q105510792
RX   PubMed=23805272;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous; Note=De novo mutation (PubMed=23805272).
CC   Omics: Genomics; DNA methylation analysis.
CC   Donor information: Established from monozygotic twin of RS1 fibroblast (Cellosaurus=CVCL_A3YW). The donor of RS1 suffers from typical Rett syndrome while the donor of RS2 suffers from an atypical form of Rett syndrome.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   RS2-62P
AC   CVCL_A3YU
DR   SKIP; SKIP005455
DR   Wikidata; Q105510797
RX   PubMed=26012557;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous; Note=De novo mutation (PubMed=26012557).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3YX ! RS2 fibroblast
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RS2-65M
AC   CVCL_A3YV
DR   SKIP; SKIP005454
DR   Wikidata; Q105510800
RX   PubMed=26012557;
CC   Population: Japanese.
CC   Characteristics: Due to X chromosome inactivation does not express the mutated allele.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly269Alafs*20 (c.806delG) (p.Gly281Alafs*20, c.842delG) (V288X); ClinVar=VCV000095202; Zygosity=Heterozygous; Note=De novo mutation (PubMed=26012557).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3YX ! RS2 fibroblast
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RS2A-2-H-7
AC   CVCL_A0EP
SY   dTCS1, isotype IgG2a
DR   Wikidata; Q108821252
RX   Patent=US6171799;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10110.
CC   Characteristics: Isotype switched derivative of deltaTCAR-3.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; B7Z8K6; Human TRDC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0EN ! deltaTCAR-3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   RS4;11
AC   CVCL_0093
SY   RS4-11; RS4:11; RS 4;11; RS(4;11); RS411
DR   BTO; BTO_0004505
DR   CLO; CLO_0008883
DR   AddexBio; C0003012/4671
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1873
DR   BioGRID_ORCS_Cell_line; 1762
DR   BioSample; SAMN03471039
DR   BioSample; SAMN03473511
DR   BioSample; SAMN10987766
DR   cancercelllines; CVCL_0093
DR   Cell_Model_Passport; SIDM01086
DR   ChEMBL-Cells; CHEMBL3308247
DR   ChEMBL-Targets; CHEMBL2366159
DR   CLS; 305360
DR   Cosmic; 683547
DR   Cosmic; 909703
DR   Cosmic; 1012116
DR   Cosmic; 1037737
DR   Cosmic; 1118469
DR   Cosmic; 1127267
DR   Cosmic; 1130250
DR   Cosmic; 1278782
DR   Cosmic; 1509199
DR   Cosmic; 1524818
DR   Cosmic; 1623639
DR   Cosmic; 2131570
DR   Cosmic; 2393009
DR   Cosmic; 2393010
DR   Cosmic; 2491091
DR   Cosmic; 2542840
DR   Cosmic-CLP; 909703
DR   DepMap; ACH-000874
DR   DSMZ; ACC-508
DR   DSMZCellDive; ACC-508
DR   EGA; EGAS00001000978
DR   GDSC; 909703
DR   GEO; GSM236803
DR   GEO; GSM236839
DR   GEO; GSM887550
DR   GEO; GSM888633
DR   GEO; GSM1374856
DR   GEO; GSM1670392
DR   IARC_TP53; 21293
DR   LiGeA; CCLE_681
DR   LINCS_LDP; LCL-1040
DR   Lonza; 714
DR   PharmacoDB; RS4_11_1331_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0093
DR   PubChem_Cell_line; CVCL_0093
DR   Wikidata; Q54951304
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1423625;
RX   PubMed=1465024;
RX   PubMed=1720549;
RX   PubMed=3917311;
RX   PubMed=8180386;
RX   PubMed=8353274;
RX   PubMed=8358709;
RX   PubMed=9067587;
RX   PubMed=9738977;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=16523483;
RX   PubMed=20164919;
RX   PubMed=20922763;
RX   PubMed=21552520;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29786757;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32721124;
RX   PubMed=35124168;
RX   PubMed=35839778;
WW   Provider; CCR; -; https://www.cccells.org/cellreqs-ncipptp.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=20922763); 60 hours (PubMed=25984343); ~50 hours (DSMZ=ACC-508).
CC   HLA typing: A*03:01,32:01; B*14:02,37:01; C*06:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4; Note=In frame (PubMed=1423625; PubMed=8358709; PubMed=32721124).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168; DepMap=ACH-000874).
CC   Sequence variation: Mutation; HGNC; HGNC:8977; PIK3CD; Simple; p.Gly971Arg (c.2911G>A); ClinVar=VCV001337907; Zygosity=Heterozygous (DepMap=ACH-000874).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.02%; East Asian, North=0%; East Asian, South=1.26%; South Asian=1.83%; European, North=65.49%; European, South=31.4% (PubMed=30894373).
CC   Misspelling: RS-E11; Cosmic=2131570.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): AddexBio=C0003012/4671; ATCC=CRL-1873; COG; Cosmic-CLP=909703; DSMZ=ACC-508; PubMed=20922763; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 20,25
ST   D3S1358: 15,17
ST   D5S818: 12 (DSMZ=ACC-508)
ST   D5S818: 12,13 (AddexBio=C0003012/4671; ATCC=CRL-1873; COG; Cosmic-CLP=909703; PubMed=20922763; PubMed=25877200)
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 23,24,25 (DSMZ=ACC-508)
ST   FGA: 24,25 (ATCC=CRL-1873; COG; PubMed=25877200)
ST   Penta D: 8.4,10
ST   Penta E: 5,7
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   RS4;11 BCL2-F104L
AC   CVCL_XZ61
SY   RS4;11-BCL2-F104L
DR   KYinno; KC-1367
DR   Wikidata; Q98129188
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4; Note=In frame (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8977; PIK3CD; Simple; p.Gly971Arg (c.2911G>A); ClinVar=VCV001337907; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Phe104Leu).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0093 ! RS4;11
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   RS4;11 BCL2-G101V
AC   CVCL_XZ62
SY   RS4;11-BCL2-G101V
DR   KYinno; KC-1345
DR   Wikidata; Q98129190
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4; Note=In frame (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8977; PIK3CD; Simple; p.Gly971Arg (c.2911G>A); ClinVar=VCV001337907; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Gly101Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0093 ! RS4;11
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   RS4;11 mouse MCL1
AC   CVCL_E8JJ
SY   RS4;11-mouse-MCL1
DR   KYinno; KC-1346
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4; Note=In frame (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8977; PIK3CD; Simple; p.Gly971Arg (c.2911G>A); ClinVar=VCV001337907; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:101769; Mcl1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0093 ! RS4;11
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RS53
AC   CVCL_JG59
DR   JCRB; JCRB1712
DR   Wikidata; Q54951305
RX   PubMed=10200052;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.68-1G>C; ClinVar=VCV000251005; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=10200052).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1712
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   RS773
AC   CVCL_WS98
SY   RS-773
DR   Wikidata; Q98129191
RX   PubMed=22167753;
RX   PubMed=27467923;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be a B-lymphoblastoid cell line (PubMed=29533902).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 6
//
ID   RSa
AC   CVCL_JM11
DR   Wikidata; Q54951307
RX   PubMed=186619;
RX   PubMed=2451128;
RX   PubMed=3185589;
RX   PubMed=7329429;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JM10 ! HuE 13
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   RSA-ND
AC   CVCL_E820
DR   dbMHC; 49012
DR   ECACC; 94022546
DR   IHW; IHW09224
DR   IPD-IMGT/HLA; 11339
DR   Wikidata; Q54951308
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Southeast Asian; Filipino.
CC   HLA typing: A*02:01,34:01; B*15:13,38:02:01; C*07,08; DPB1*01:01:01 (IPD-IMGT/HLA=11339).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   RSAR001
AC   CVCL_E2TL
SY   RSAR1; F_PDO_000001
DR   CancerTools; 160990
DR   EGA; EGAD00001008611
RX   PubMed=30194147;
RX   PubMed=36959380;
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: ~35 hours (PubMed=30194147).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=30194147).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=36959380
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12,13
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 14
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   RSAR003
AC   CVCL_E3NP
SY   RSAR3; F_PDO_000002
DR   CancerTools; 160991
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8973; Endometrioid stromal sarcoma
DI   ORDO; Orphanet_213711; Endometrial stromal sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RSAR004
AC   CVCL_E3NQ
SY   RSAR4; F_PDO_000003
DR   CancerTools; 160992
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RSAR005
AC   CVCL_E3NR
SY   RSAR5; F_PDO_000042
DR   CancerTools; 160993
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002397.
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RSAR006
AC   CVCL_E3NS
SY   RSAR6; F_PDO_000043
DR   CancerTools; 160994
WW   Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: While established by the F-PDO project, this is a cell line and not an organoid.
DI   NCIt; C3088; Angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RSB
AC   CVCL_S941
SY   Rohu Swim Bladder
DR   Wikidata; Q54951309
RX   CelloPub=CLPUB00463;
RX   PubMed=20730759;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=84645; ! Labeo rohita (Indian major carp)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   RSb
AC   CVCL_JM12
DR   Wikidata; Q54951310
RX   PubMed=186619;
CC   Doubling time: 40-48 hours (PubMed=186619).
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Whole fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JM10 ! HuE 13
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   RSBF [Pagrus fin]
AC   CVCL_R920
SY   Red Sea Bream Fin
DR   Wikidata; Q54951311
RX   DOI=10.1007/BF02847922;
RX   DOI=10.1016/S0044-8486(98)00329-9;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=143350; ! Pagrus major (Red sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   RSBF [Pagrus fry]
AC   CVCL_R983
SY   Red Sea Bream Fry
DR   Wikidata; Q54951322
RX   DOI=10.3147/jsfp.15.201;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=143350; ! Pagrus major (Red sea bream)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 10
//
ID   RSBS-14
AC   CVCL_C8X4
DR   Wikidata; Q123033385
RX   PubMed=29609538;
RX   PubMed=35692560;
CC   Population: Indian.
CC   Doubling time: ~48 hours (PubMed=29609538).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RSBS-23
AC   CVCL_C8X5
DR   Wikidata; Q123033386
RX   PubMed=29609538;
RX   PubMed=35692560;
CC   Population: Indian.
CC   Doubling time: ~48 hours (PubMed=29609538).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RSBS-43
AC   CVCL_C8X6
DR   Wikidata; Q123033387
RX   PubMed=29609538;
RX   PubMed=35692560;
CC   Population: Indian.
CC   Doubling time: ~48 hours (PubMed=29609538).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   RSBS-9
AC   CVCL_C8X3
DR   Wikidata; Q123033388
RX   PubMed=29609538;
RX   PubMed=35692560;
CC   Population: Indian.
CC   Doubling time: ~48 hours (PubMed=29609538).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   RSBF-2
AC   CVCL_R921
SY   Red Sea Bream Fin-2
DR   Wikidata; Q54951323
RX   PubMed=20102463;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=143350; ! Pagrus major (Red sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   RSC261
AC   CVCL_X900
DR   Wikidata; Q54951324
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C7732; Renal pelvis squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 5
//
ID   RSC3-E2
AC   CVCL_5U50
DR   Wikidata; Q54951325
RX   PubMed=11123419;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U51 ! RSC3-LM
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   RSC3-E2R
AC   CVCL_5U52
DR   Wikidata; Q54951326
RX   PubMed=11123419;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5U50 ! RSC3-E2
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   RSC3-LM
AC   CVCL_5U51
DR   Wikidata; Q54951327
RX   PubMed=11123419;
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U50 ! RSC3-E2
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   RSC96
AC   CVCL_4694
SY   Rsc96; RSC-96; RSC 96; Rat Schwann Cell 96
DR   BTO; BTO_0004777
DR   CLO; CLO_0008886
DR   ATCC; CRL-2765
DR   BCRC; 60507
DR   CCRID; 1101RAT-PUMC000664
DR   CCRID; 3101RATGNR6
DR   CLS; 305202
DR   GEO; GSE69866
DR   Wikidata; Q54951329
RX   PubMed=9766530;
RX   PubMed=12210843;
RX   PubMed=22519560;
RX   PubMed=29034641;
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   RSC96 L-periaxin KO
AC   CVCL_C3NA
DR   Wikidata; Q116050184
RX   PubMed=29034641;
CC   Knockout cell: Method=TALEN; RGD; 619960; Prx (Note=Isoform L-periaxin).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4694 ! RSC96
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 4
//
ID   RSCC-1
AC   CVCL_RN75
SY   Rabbit Squamous Cell Carcinoma-1
DR   Wikidata; Q54951330
RX   PubMed=18691699;
CC   Doubling time: 22.89 hours (PubMed=18691699).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
DI   NCIt; C133739; Rabbit oral cavity squamous cell carcinoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   RSE/PILS35
AC   CVCL_RN45
DR   Wikidata; Q54951331
RX   PubMed=27484910;
RX   PubMed=29886187;
RX   PubMed=32158404;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus (Brown dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   RSE13
AC   CVCL_Z162
SY   RSE 13
DR   Wikidata; Q54951332
RX   PubMed=6644089;
CC   Group: Tick cell line.
OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus (Brown dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   RSE8
AC   CVCL_Z163
SY   RSE 8; RU RSE 8
DR   Wikidata; Q54951333
RX   PubMed=6644089;
RX   PubMed=7131199;
RX   PubMed=17662657;
RX   PubMed=19242658;
RX   PubMed=22743047;
RX   PubMed=29886187;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_6086c77397
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Tick cell line.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus (Brown dog tick)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   RSF
AC   CVCL_R984
SY   Red Snapper Fin
DR   Wikidata; Q54951334
RX   CelloPub=CLPUB00103;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=211834; ! Lutjanus argentimaculatus (Mangrove red snapper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   RSH
AC   CVCL_E821
SY   RSHD; TER118; TER227
DR   dbMHC; 49013
DR   ECACC; 88052021
DR   IHW; IHW09021
DR   IPD-IMGT/HLA; 11340
DR   Wikidata; Q54951335
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: African; Zulu.
CC   HLA typing: A*68:02:01:01,30:01:01; B*42:01:01; C*17:01:01:02; DPA1*03:01,02:02:02; DPB1*01:01:01,105:01; DQA1*04:01; DQB1*04:02:01; DRA*01:02; DRB1*03:02:01; DRB3*01:01:02:01 (IPD-IMGT/HLA=11340).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   RSMG-1
AC   CVCL_5584
SY   Rat SubMandibular Gland-1
DR   JCRB; JCRB1146
DR   Wikidata; Q54951336
RX   PubMed=10476908;
CC   Doubling time: ~35 hours (PubMed=10476908).
CC   Derived from site: In situ; Salivary gland, submandibular gland, epithelium; UBERON=UBERON_0003359.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   10W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   RSMG-2
AC   CVCL_8311
SY   Rat SubMandibular Gland-2
DR   JCRB; JCRB1152
DR   Wikidata; Q54951337
RX   DOI=10.11418/jtca1981.19.4_199;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: ~33 hours (DOI=10.11418/jtca1981.19.4_199).
CC   Derived from site: In situ; Salivary gland, submandibular gland, epithelium; UBERON=UBERON_0003359.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   RSMT-A5
AC   CVCL_9Y70
SY   A5
DR   Wikidata; Q54951338
RX   PubMed=2541043;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Salivary gland, submandibular gland, epithelium; UBERON=UBERON_0003359.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E3KU ! RSMTx
SX   Male
AG   30D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   RSMTx
AC   CVCL_E3KU
RX   PubMed=2769593;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Salivary gland, submandibular gland, epithelium; UBERON=UBERON_0003359.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   30D
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   RSN
AC   CVCL_YB63
SY   Red SnakeHead
DR   Wikidata; Q98129192
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=64149; ! Channa micropeltes (Giant snakehead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   rSN-122
AC   CVCL_YQ11
DR   Wikidata; Q98129193
RX   Patent=US20080254440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10144.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P59595; Human SARS coronavirus (SARS-CoV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   rSN-150
AC   CVCL_YQ12
DR   Wikidata; Q98129194
RX   Patent=US20080254440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10145.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P59595; Human SARS coronavirus (SARS-CoV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   rSN-18
AC   CVCL_YQ10
DR   Wikidata; Q98129195
RX   Patent=US20080254440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10143.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P59595; Human SARS coronavirus (SARS-CoV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   RSN-2
AC   CVCL_YB64
SY   Red SnakeHead-2
DR   Wikidata; Q98129196
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
CC   Group: Fish cell line.
OX   NCBI_TaxID=64149; ! Channa micropeltes (Giant snakehead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   rSN-21-2
AC   CVCL_YQ13
DR   Wikidata; Q98129197
RX   Patent=US20080254440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10146.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P59595; Human SARS coronavirus (SARS-CoV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   rSN-29
AC   CVCL_YQ14
DR   Wikidata; Q98129198
RX   Patent=US20080254440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10147.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P59595; Human SARS coronavirus (SARS-CoV) nucleoprotein (N).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   RsNF
AC   CVCL_D4AA
DR   Wikidata; Q127384073
RX   PubMed=37938540;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg2258Ter (c.6772C>T) (p.Arg2237Ter, c.6709C>T) (R2237*); ClinVar=VCV000230389; Zygosity=Unspecified (PubMed=37938540).
CC   Sequence variation: Mutation; HGNC; HGNC:17101; SUZ12; Simple; p.Ser539fs (c.1616_1619del); Zygosity=Unspecified (PubMed=37938540).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Right thigh, skin; UBERON=UBERON_0004262.
ST   Source(s): PubMed=37938540
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,21
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 18,25
ST   D2S441: 11,14
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 12,14
ST   D7S820: 11,13
ST   D8S1179: 13,15
ST   FGA: 23,24
ST   Penta D: 14
ST   Penta E: 15,16
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   RSO4
AC   CVCL_A2CL
DR   cancercelllines; CVCL_A2CL
DR   Cosmic; 2765438
DR   Wikidata; Q105510805
RX   PubMed=10863977;
RX   PubMed=12207908;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11920; FAS; Simple; p.His60Arg (c.179A>G); ClinVar=VCV001439236; Zygosity=Heterozygous (PubMed=12207908).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223His (c.668C>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VN48 ! SO-4
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   RSOI
AC   CVCL_6439
DR   CLO; CLO_0008887
DR   ATCC; CRL-1419
DR   Wikidata; Q54951339
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   RSp
AC   CVCL_M628
SY   RSP
DR   Wikidata; Q54951340
RX   PubMed=78764;
RX   PubMed=12592342;
RX   PubMed=29533902;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT23 ! RN
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   RSP-2
AC   CVCL_WH73
SY   Rat Spleen Plasma-2
DR   Wikidata; Q98129199
RX   PubMed=6609780;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   5D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RSP-2.P3
AC   CVCL_WH74
DR   Wikidata; Q98129200
RX   DOI=10.1247/csf.5.315;
RX   PubMed=3877731;
RX   PubMed=6609780;
CC   Group: Serum/protein free medium cell line.
CC   Misspelling: RSP-2 X P3; Note=Occasionally, due to a transcription of the period '.' into a 'X'.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: JAR-1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WH73 ! RSP-2
SX   Female
AG   5D
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   RSPC-2T
AC   CVCL_6D61
SY   RSPC 2T
DR   Wikidata; Q54951342
RX   PubMed=7789311;
RX   PubMed=18462435;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RSS18
AC   CVCL_5G92
DR   Wikidata; Q54951343
RX   PubMed=8639471;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 6
//
ID   RST1
AC   CVCL_A2CM
DR   Wikidata; Q105510811
RX   PubMed=10863977;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0G05 ! ST-1 [Human leukemia]
AG   Adult
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   RST2
AC   CVCL_5I55
DR   cancercelllines; CVCL_5I55
DR   CancerTools; 156502
DR   Kerafast; EH0001
DR   Wikidata; Q54951344
RX   PubMed=19687011;
CC   Population: African; Kenyan.
CC   Characteristics: Resistant to the various effects of interferon-alpha (PubMed=19687011).
CC   Characteristics: Expresses a STAT2 mRNA with an alternative splice site between exon 19 and 20 that causes STAT2 translation termination at the beginning of the SH2 domain (PubMed=19687011).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 20
//
ID   RSV-M
AC   CVCL_4Y24
DR   JCRB; JCRB1574
DR   RCB; RCB4549
DR   Wikidata; Q54951345
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21600; Mouse neuroglia neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   RT [Human]
AC   CVCL_UI99
DR   Wikidata; Q98129201
RX   PubMed=2155676;
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   RT [Oncorhynchus]
AC   CVCL_WC95
SY   Rainbow Trout
DR   IBRC; C10226
DR   Wikidata; Q98129202
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   RT 1
AC   CVCL_3417
SY   RT-1; RT1
DR   CLO; CLO_0008888
DR   CLDB; cl4192
DR   CLDB; cl4193
DR   ECACC; 94011416
DR   ICLC; ATL96002
DR   Wikidata; Q54951346
RX   PubMed=1326448;
RX   PubMed=9570350;
CC   Characteristics: Moderately tumorigenic (PubMed=1326448; PubMed=9570350).
CC   Virology: Does not express the viral genome of Rous sarcoma virus (PubMed=1326448; PubMed=9570350).
CC   Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=RSV-33).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
DI   NCIt; C60403; Rat fibrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   RT B-LCL
AC   CVCL_C5VX
DR   Wikidata; Q116050185
RX   PubMed=10843661;
CC   HLA typing: A*02,24; B*27:05,35 (PubMed=10843661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   RT-112
AC   CVCL_1670
SY   RT 112; RT112
DR   BTO; BTO_0003724
DR   CLO; CLO_0008890
DR   EFO; EFO_0006479
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 383
DR   BioSample; SAMN03473091
DR   BioSample; SAMN03473589
DR   BioSample; SAMN10988358
DR   cancercelllines; CVCL_1670
DR   Cell_Model_Passport; SIDM00402
DR   ChEMBL-Cells; CHEMBL3307307
DR   ChEMBL-Targets; CHEMBL614145
DR   CLS; 300324
DR   Cosmic; 715739
DR   Cosmic; 760482
DR   Cosmic; 845559
DR   Cosmic; 867837
DR   Cosmic; 909704
DR   Cosmic; 925820
DR   Cosmic; 928823
DR   Cosmic; 1046682
DR   Cosmic; 1068092
DR   Cosmic; 1285124
DR   Cosmic; 1285984
DR   Cosmic; 1819324
DR   Cosmic; 1938478
DR   Cosmic; 1938697
DR   Cosmic; 2037954
DR   Cosmic; 2050459
DR   Cosmic; 2057454
DR   Cosmic; 2444244
DR   Cosmic; 2686111
DR   Cosmic-CLP; 909704
DR   DepMap; ACH-000473
DR   DSMZ; ACC-418
DR   DSMZCellDive; ACC-418
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909704
DR   GEO; GSM887552
DR   GEO; GSM888635
DR   GEO; GSM1374857
DR   GEO; GSM1374858
DR   GEO; GSM1574545
DR   GEO; GSM1574581
DR   GEO; GSM1670393
DR   IARC_TP53; 13322
DR   LiGeA; CCLE_846
DR   LINCS_LDP; LCL-1716
DR   PharmacoDB; RT112_1332_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1670
DR   PubChem_Cell_line; CVCL_1670
DR   Wikidata; Q54951347
RX   PubMed=571047;
RX   PubMed=864752;
RX   PubMed=870558;
RX   PubMed=2144165;
RX   PubMed=2903891;
RX   PubMed=3708594;
RX   PubMed=6823318;
RX   PubMed=7490993;
RX   PubMed=8873383;
RX   PubMed=11207054;
RX   PubMed=11416159;
RX   PubMed=11921286;
RX   PubMed=12127398;
RX   PubMed=15846775;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=25997541;
RX   PubMed=26055179;
RX   PubMed=26589293;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=28855393;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; -; -; http://faculty.washington.edu/trawets/archive/Human/bladder/rt112/index.html
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=3708594); 25 hours (PubMed=25984343); 25.7 hours (PubMed=26055179); 21.6 +- 0.1 hours (PubMed=2144165); ~35 hours (DSMZ=ACC-418).
CC   HLA typing: A*26:01,26:01; B*08:01,27:05; C*01:02,01:02; DRB1*03:17,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (PubMed=25485619; PubMed=28855393).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (Cosmic-CLP=909704; DepMap=ACH-000473).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=909704; DepMap=ACH-000473).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.6%; East Asian, South=0%; South Asian=0%; European, North=65.6%; European, South=32.8% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): CLS=300324; Cosmic-CLP=909704; DSMZ=ACC-418; PubMed=11416159; PubMed=25877200; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 10 (PubMed=25877200)
ST   CSF1PO: 10,11 (CLS=300324; Cosmic-CLP=909704; DSMZ=ACC-418; PubMed=27270441)
ST   D13S317: 13,14
ST   D16S539: 11,13
ST   D18S51: 15 (CLS=300324)
ST   D18S51: 15,17 (DSMZ=ACC-418; PubMed=25877200)
ST   D19S433: 13,15
ST   D21S11: 27,30
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 23 (CLS=300324)
ST   FGA: 23,25 (DSMZ=ACC-418; PubMed=25877200)
ST   Penta D: 10 (DSMZ=ACC-418; PubMed=25877200)
ST   Penta D: 10,11 (CLS=300324)
ST   Penta E: 12,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   RT-2
AC   CVCL_J295
SY   RT2
DR   BTO; BTO_0004506
DR   Wikidata; Q54951350
RX   PubMed=19381449;
CC   Transformant: NCBI_TaxID; 11876; Avian sarcoma virus (ASV).
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   RT-4
AC   CVCL_0036
SY   RT4; RT4P
DR   BTO; BTO_0002870
DR   CLO; CLO_0008892
DR   EFO; EFO_0006480
DR   CLDB; cl4197
DR   CLDB; cl4198
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7937
DR   ATCC; HTB-2
DR   BCRC; 60111
DR   BCRJ; 0214
DR   BioGRID_ORCS_Cell_line; 382
DR   BioSample; SAMN03473092
DR   BioSample; SAMN10988330
DR   cancercelllines; CVCL_0036
DR   CCRID; 3101HUMTCHu226
DR   CCRID; 5301HUM-KCB16045YJ
DR   Cell_Model_Passport; SIDM01085
DR   ChEMBL-Cells; CHEMBL3307430
DR   ChEMBL-Targets; CHEMBL614884
DR   CLS; 300326
DR   Cosmic; 687455
DR   Cosmic; 715805
DR   Cosmic; 755396
DR   Cosmic; 760479
DR   Cosmic; 845560
DR   Cosmic; 846283
DR   Cosmic; 867839
DR   Cosmic; 925819
DR   Cosmic; 928816
DR   Cosmic; 943749
DR   Cosmic; 1016881
DR   Cosmic; 1046681
DR   Cosmic; 1068091
DR   Cosmic; 1285125
DR   Cosmic; 1285983
DR   Cosmic; 1819325
DR   Cosmic; 1927301
DR   Cosmic; 2037955
DR   Cosmic; 2050460
DR   Cosmic; 2057455
DR   Cosmic; 2444250
DR   Cosmic; 2686112
DR   Cosmic; 2700996
DR   Cosmic-CLP; 687455
DR   DepMap; ACH-000242
DR   DSMZ; ACC-412
DR   DSMZCellDive; ACC-412
DR   ECACC; 91091914
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687455
DR   GEO; GSM136232
DR   GEO; GSM763024
DR   GEO; GSM827439
DR   GEO; GSM887553
DR   GEO; GSM888636
DR   GEO; GSM1374859
DR   GEO; GSM1574570
DR   GEO; GSM1670394
DR   GEO; GSM7701369
DR   GEO; GSM7701370
DR   IARC_TP53; 21088
DR   KCB; KCB 2016045YJ
DR   KCLB; 30002
DR   LiGeA; CCLE_210
DR   LINCS_LDP; LCL-1717
DR   PharmacoDB; RT4_1334_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0036
DR   PubChem_Cell_line; CVCL_0036
DR   SKY/M-FISH/CGH; 1462
DR   Wikidata; Q54951351
RX   PubMed=77569;
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=864752;
RX   PubMed=870558;
RX   PubMed=1114348;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=5503601;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6823318;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=7787250;
RX   PubMed=8873383;
RX   PubMed=9850064;
RX   PubMed=11207054;
RX   PubMed=11921286;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=16957166;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25997541;
RX   PubMed=26055179;
RX   PubMed=26589293;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=28855393;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Part of: TCGA-110-CL cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 37 hours (PubMed=3708594); 65.8 hours (PubMed=26055179); ~80 hours (DSMZ=ACC-412).
CC   HLA typing: A*01,03; B*12 (PubMed=77569).
CC   HLA typing: A*02:01,03:01; B*44:02,44:02; C*05:01,05:01; DQA1*03:02,03:02; DQB1*05:03,05:03 (PubMed=25960936).
CC   HLA typing: A*02:01,03:01; B*44:02,44:02; C*05:01,05:01; DQA1*01:02,03:02; DQB1*05:03,05:03; DRB1*04:01,14:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (PubMed=28855393).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=7787250).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Leu557Cysfs*72 (c.1669delC); ClinVar=VCV000048811; Zygosity=Homozygous (PubMed=23401075; Cosmic-CLP=687455; DepMap=ACH-000242).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.72%; East Asian, South=0%; South Asian=0.98%; European, North=64.69%; European, South=31.61% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7937; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=HTB-2; CCRID; CLS=300326; Cosmic-CLP=687455; DSMZ=ACC-412; ECACC=91091914; KCLB=30002; PubMed=25877200; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 30,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 22,24
ST   Penta D: 12 (ATCC=HTB-2; CLS=300326; DSMZ=ACC-412)
ST   Penta D: 12,13 (PubMed=25877200)
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   RT-milt5
AC   CVCL_AZ89
SY   RTmilt5; Rainbow Trout-milt 5
DR   Wikidata; Q54951352
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Seminal fluid; UBERON=UBERON_0006530.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   3Y
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   RT-ovf1
AC   CVCL_AZ90
SY   Rainbow Trout-ovarian fluid 1
DR   Wikidata; Q54951353
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovarian fluid; UBERON=UBERON_8480040.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   RT-testis
AC   CVCL_YB70
SY   Rainbow Trout-testis
DR   Wikidata; Q98129203
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   RT10
AC   CVCL_C3SU
SY   RT 10
DR   Wikidata; Q116050187
RX   PubMed=2983000;
RX   PubMed=6299508;
CC   Characteristics: Produced from a tumor induced by the inoculation of the parent cell line.
CC   Transformant: NCBI_TaxID; 10315; Human herpesvirus 2 (HHV-2) (strain HG52).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C3SN ! RE1
SX   Female
AG   20FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   RT101
AC   CVCL_6440
SY   JB6 RT101; RT 101; R6101
DR   CLO; CLO_0008889
DR   ATCC; CRL-2002
DR   Wikidata; Q54951355
RX   PubMed=2985973;
RX   PubMed=6947266;
RX   PubMed=7728951;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-597.html
CC   Transformant: ChEBI; CHEBI_37537; 12-O-tetradecanoylphorbol-13-acetate (TPA).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0362 ! JB6 Cl 41-5a
SX   Sex unspecified
AG   Newborn
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   RT112 CP1.5
AC   CVCL_C7JU
SY   CP1.5
DR   Wikidata; Q117704825
RX   PubMed=10422815;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1670 ! RT-112
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   RT112 CP1.5 K1
AC   CVCL_C7JY
SY   K1
DR   Wikidata; Q117704826
RX   PubMed=10422815;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7JU ! RT112 CP1.5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   RT112 CP1.5 K2
AC   CVCL_C7JZ
SY   K2
DR   Wikidata; Q117704827
RX   PubMed=10422815;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7JU ! RT112 CP1.5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   RT112 CP2
AC   CVCL_C7JV
SY   CP2
DR   Wikidata; Q117704828
RX   PubMed=10422815;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7JU ! RT112 CP1.5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   RT112 CP2.5
AC   CVCL_C7JW
SY   CP2.5
DR   Wikidata; Q117704829
RX   PubMed=10422815;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7JV ! RT112 CP2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   RT112 CP3
AC   CVCL_C7JX
SY   CP3
DR   Wikidata; Q117704830
RX   PubMed=10422815;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7JW ! RT112 CP2.5
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   RT112/84
AC   CVCL_2714
SY   RT112-84; RT-112/84; RT11284
DR   CLO; CLO_0008891
DR   CLDB; cl4196
DR   BioGRID_ORCS_Cell_line; 475
DR   BioSample; SAMN10988011
DR   cancercelllines; CVCL_2714
DR   CancerTools; 153250
DR   Cell_Model_Passport; SIDM01202
DR   DepMap; ACH-001183
DR   ECACC; 85061106
DR   GEO; GSM827438
DR   GEO; GSM887551
DR   GEO; GSM888634
DR   IARC_TP53; 28358
DR   LINCS_LDP; LCL-1705
DR   PharmacoDB; RT112_84_1333_2019
DR   Progenetix; CVCL_2714
DR   Wikidata; Q54951356
DR   Ximbio; 153250
RX   PubMed=7664249;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (DepMap=ACH-001183).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (DepMap=ACH-001183).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.22%; Native American=0%; East Asian, North=2.64%; East Asian, South=0%; South Asian=0%; European, North=59.02%; European, South=36.11% (PubMed=30894373).
CC   Discontinued: ECACC; 85061106; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ECACC=85061106
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13,14
ST   D16S539: 11,13
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1670 ! RT-112
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   RT112/D21
AC   CVCL_6215
SY   RT-112-D21
DR   cancercelllines; CVCL_6215
DR   CLS; 300325
DR   Wikidata; Q54951357
RX   PubMed=7740654;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): CLS=300325
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13,14
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 27,30
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 10,11
ST   Penta E: 12,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1670 ! RT-112
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   RT112-CP
AC   CVCL_B7BP
DR   cancercelllines; CVCL_B7BP
DR   Wikidata; Q114312927
RX   PubMed=2144165;
CC   Population: Caucasian.
CC   Doubling time: 21.5 +- 1.5 hours (PubMed=2144165).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1670 ! RT-112
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   RT112rCDDP1000
AC   CVCL_RR17
DR   cancercelllines; CVCL_RR17
DR   Wikidata; Q54951358
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 23.0 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1670 ! RT-112
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   RT112rGEMCI20
AC   CVCL_RR18
DR   cancercelllines; CVCL_RR18
DR   Wikidata; Q54951360
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 26.6 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1670 ! RT-112
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   RT4 NF2.17 #6
AC   CVCL_D3XZ
DR   EFO; EFO_0022786
DR   Wikidata; Q127384075
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4 NF2.17 #8
AC   CVCL_D3Y0
DR   Wikidata; Q127384077
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4 NF2.E106G #27
AC   CVCL_D3Y1
DR   Wikidata; Q127384079
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2 (Note=With p.Glu106Gly).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4 NF2.K413E #4
AC   CVCL_D3Y2
DR   Wikidata; Q127384083
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2 (Note=With p.Lys413Glu).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4 NF2.K413E #8
AC   CVCL_D3Y3
DR   Wikidata; Q127384085
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2 (Note=With p.Lys413Glu).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4 NF2.L64P #10
AC   CVCL_D3Y5
DR   Wikidata; Q127384087
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2 (Note=With p.Leu64Pro).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4 NF2.L64P #7
AC   CVCL_D3Y4
DR   Wikidata; Q127384092
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2 (Note=With p.Leu64Pro).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4 NF2.Q538P #8
AC   CVCL_D3Y6
DR   Wikidata; Q127384094
RX   PubMed=11448944;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11448944).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2 (Note=With p.Gln538Pro).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4-54
AC   CVCL_D3XY
SY   RT4-D6P2T clone 54
DR   Wikidata; Q127384097
RX   PubMed=11316791;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11316791).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   RT4-67
AC   CVCL_JK04
SY   RT4-D6P2T clone 67
DR   EFO; EFO_0022785
DR   Wikidata; Q54951361
RX   PubMed=11316791;
RX   PubMed=14580336;
RX   PubMed=21481793;
RX   PubMed=28469964;
CC   Characteristics: Expression of NF2 is doxycycline-inducible as the parent cell line was transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=11316791).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7773; NF2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4006 ! RT4-D6P2T
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   RT4-D6
AC   CVCL_6E50
DR   Wikidata; Q54951362
RX   PubMed=751847;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   RT4-D6P2T
AC   CVCL_4006
SY   RT4-D6-P2T; D6P2T
DR   BTO; BTO_0001205
DR   CLO; CLO_0008893
DR   EFO; EFO_0022778
DR   CLDB; cl4200
DR   ATCC; CRL-2768
DR   BCRC; 60508
DR   BCRJ; 0399
DR   ECACC; 93011415
DR   PRIDE; PRD000566
DR   Wikidata; Q54951363
RX   PubMed=2824698;
RX   PubMed=11316791;
RX   PubMed=12210843;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
DI   NCIt; C60465; Rat malignant schwannoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6E50 ! RT4-D6
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   RT4/31
AC   CVCL_2715
DR   cancercelllines; CVCL_2715
DR   ECACC; 86082102
DR   Wikidata; Q54951364
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Leu557Cysfs*72 (c.1669delC); ClinVar=VCV000048811; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0036 ! RT-4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   RT4rCDDP1000
AC   CVCL_RR19
DR   cancercelllines; CVCL_RR19
DR   Wikidata; Q54951365
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 39.6 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Leu557Cysfs*72 (c.1669delC); ClinVar=VCV000048811; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0036 ! RT-4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   RT4rGEMCI10
AC   CVCL_RR20
DR   cancercelllines; CVCL_RR20
DR   Wikidata; Q54951366
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 56.2 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Leu557Cysfs*72 (c.1669delC); ClinVar=VCV000048811; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0036 ! RT-4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   RT4v6
AC   CVCL_T027
SY   RT4V6; RT-4-v6
DR   cancercelllines; CVCL_T027
DR   Cosmic; 1938696
DR   Wikidata; Q54951368
RX   PubMed=23175184;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12362; TSC1; Simple; p.Leu557Cysfs*72 (c.1669delC); ClinVar=VCV000048811; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0036 ! RT-4
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   RT7
AC   CVCL_UI28
DR   Lonza; 1647
DR   Wikidata; Q98129204
RX   DOI=10.6014/jjomm1995.8.1;
RX   PubMed=19029086;
RX   PubMed=23278752;
RX   PubMed=25359319;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   RT97
AC   CVCL_F0QM
SY   RT 97
RX   PubMed=6178036;
RX   PubMed=7028152;
RX   PubMed=9306199;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16884; Rat Nefh (Note=Also reacts with human, mouse, pig and chicken).
CC   Monoclonal antibody target: UniProtKB; P15205; Rat Map1b (Note=Phosphorylated).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   RTAZ-1
AC   CVCL_T477
SY   LSCC-UA1
DR   Wikidata; Q54951374
RX   PubMed=189048;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11950; Avian rous-associated virus type 1 (RAV-1).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: White Leghorn; VBO=VBO_0000646.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Male
AG   10-11FD
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   RTBrain
AC   CVCL_KB55
SY   Rainbow Trout Brain
DR   Wikidata; Q54951375
RX   PubMed=24357037;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 7
//
ID   RTC-8C
AC   CVCL_6D62
SY   RTC 8C
DR   Wikidata; Q54951376
RX   PubMed=7789311;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   RTC-8T1
AC   CVCL_6D63
SY   RTC 8T1
DR   Wikidata; Q54951378
RX   PubMed=7789311;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   RTC-8T12
AC   CVCL_6D64
SY   RTC 8T12; RTC8T12
DR   Wikidata; Q54951379
RX   PubMed=7789311;
RX   PubMed=15716129;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   RTC-8T3
AC   CVCL_6D65
SY   RTC 8T3
DR   Wikidata; Q54951380
RX   PubMed=7789311;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   RTC-8T6
AC   CVCL_6D66
SY   RTC 8T6
DR   Wikidata; Q54951381
RX   PubMed=7789311;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   10D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   RTC274
AC   CVCL_X899
DR   Wikidata; Q54951382
RX   PubMed=10761702;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C7355; Renal pelvis urothelial carcinoma
DI   ORDO; Orphanet_598216; Upper tract urothelial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 6
//
ID   RTC3
AC   CVCL_F760
DR   Wikidata; Q54951383
RX   PubMed=17708338;
RX   PubMed=22863662;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T155c).
CC   Derived from site: In situ; Embryonic brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   RTC4
AC   CVCL_F761
DR   Wikidata; Q54951384
RX   PubMed=17708338;
RX   PubMed=22863662;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=With p.Leu156_Thr708del = T155g).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T155c).
CC   Derived from site: In situ; Embryonic brain, ventral mesencephalon; UBERON=UBERON_0001943.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   RTCC-1/KMC
AC   CVCL_M748
DR   Wikidata; Q54951385
RX   PubMed=8774112;
RX   PubMed=17587681;
CC   Population: Chinese.
CC   Doubling time: 36 hours (Note=At 3rd passage) (PubMed=8774112).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   RtCE-1
AC   CVCL_DQ97
SY   Rat Corneal Epithelial cell line-1
DR   Wikidata; Q54951386
RX   PubMed=11318303;
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   RTdi-MI
AC   CVCL_B5E4
SY   Rainbow Trout distal intestine-Milano Italy
DR   Wikidata; Q110433171
RX   PubMed=34205481;
CC   Group: Fish cell line.
CC   Doubling time: 4.4 days (PubMed=34205481).
CC   Derived from site: In situ; Intestine; Note=Distal part; UBERON=UBERON_0000160.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   RTE [Carp embryo]
AC   CVCL_R851
SY   Rainbow Trout Embryo
DR   Wikidata; Q54951387
RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   RTE [Carp eye]
AC   CVCL_A1LJ
SY   Rainbow Trout Eye
DR   Wikidata; Q102114850
RX   DOI=10.1016/j.aquaculture.2020.736027;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by striped jack nervous necrosis virus (SJNNV), Tilapia lake virus (TiLV). Resistant to infection by Cyprinid herpes virus 2 (CyHV-2) (DOI=10.1016/j.aquaculture.2020.736027).
CC   Doubling time: ~33 hours (Note=At 61th passage) (DOI=10.1016/j.aquaculture.2020.736027).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   RTE-2
AC   CVCL_R852
SY   Rainbow Trout Embryo-2
DR   Wikidata; Q54951388
RX   CelloPub=CLPUB00103;
RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   RTE2
AC   CVCL_5889
SY   RTE-2; RTE 2; Rat Tongue Epithelial line 2
DR   CLS; 500327
DR   Wikidata; Q54951391
RX   PubMed=6229413;
CC   Derived from site: In situ; Oral cavity, tongue, epithelium; UBERON=UBERON_0003357.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RTEC11
AC   CVCL_6B93
DR   Wikidata; Q54951392
RX   PubMed=18725308;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   27W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RTee
AC   CVCL_DE14
SY   Rteeb; Rainbow Trout early embryo
DR   Wikidata; Q54951393
RX   CelloPub=CLPUB00341;
RX   PubMed=20420918;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 27-11-25; Version: 7
//
ID   RTF
AC   CVCL_DE16
SY   Red-line Torpedo Fin
DR   Wikidata; Q54951394
RX   CelloPub=CLPUB00463;
RX   DOI=10.1111/j.1365-2109.2011.02854.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=2985178; ! Dawkinsia denisonii (Denison barb)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 9
//
ID   RTFK-1
AC   CVCL_QZ53
DR   cancercelllines; CVCL_QZ53
DR   Wikidata; Q54951396
RX   PubMed=22490663;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Homozygous (from parent cell line).
CC   Misspelling: RTFKK-1; PubMed=22490663; Note=In supplementary figure 2.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2214 ! TFK-1
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   RTG
AC   CVCL_A7NZ
SY   Rat Tooth Germs
DR   Wikidata; Q107116777
RX   PubMed=293368;
CC   Doubling time: ~19 hours (PubMed=293368).
CC   Derived from site: In situ; Embryonic tooth bud, dental papilla, incisor; UBERON=UBERON_0003317.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   RTG-2
AC   CVCL_1920
SY   RTG 2; RTG2; Rainbow Trout Gonad-2
DR   BTO; BTO_0005472
DR   CLO; CLO_0008895
DR   CLDB; cl4202
DR   CLDB; cl4203
DR   CLDB; cl4204
DR   ATCC; CCL-55
DR   BCRC; 60445
DR   CCLV; CCLV-RIE 0038
DR   CCLV; CCLV-RIE 0088
DR   CCTCC; GDC0169
DR   DSMZ; ACC-352
DR   DSMZCellDive; ACC-352
DR   ECACC; 90102529
DR   IZSLER; BS CL 76
DR   KCB; KCB 89021YJ
DR   Wikidata; Q54951397
RX   CelloPub=CLPUB00103;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1139/f78-164;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
RX   PubMed=235493;
RX   PubMed=1368400;
RX   PubMed=2591197;
RX   PubMed=3410806;
RX   PubMed=5167740;
RX   PubMed=8736390;
RX   PubMed=11501281;
RX   PubMed=14007940;
RX   PubMed=19002917;
RX   PubMed=20420918;
RX   PubMed=28374170;
RX   PubMed=33053677;
RX   PubMed=34382581;
CC   Group: Fish cell line.
CC   Doubling time: ~2 days (Note=At 20 Celsius) (PubMed=5167740; PubMed=3410806); ~3-7 days (DSMZ=ACC-352).
CC   Anecdotal: First fish cell line, established in 1962.
CC   Misspelling: RTG-22; Note=Occasionally.
CC   Misspelling: RTG22; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 30
//
ID   RTG-2/f
AC   CVCL_0I50
DR   CCLV; CCLV-RIE 0686
DR   Wikidata; Q54951400
RX   PubMed=19941903;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
HI   CVCL_1920 ! RTG-2
SX   Female
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   RTG-P1
AC   CVCL_1921
DR   BTO; BTO_0005473
DR   CLO; CLO_0008897
DR   ATCC; CRL-2829
DR   Wikidata; Q54951401
RX   PubMed=15043947;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Characteristics: Can be used as a reporter cell line to study interferon pathways.
CC   Characteristics: The expression of the luciferase reporter gene is under control of the trout Mx1 gene promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Fibroblast of ovary; CL=CL_2000063.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
HI   CVCL_1920 ! RTG-2
SX   Female
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   RTgill-W1
AC   CVCL_6441
SY   RTGill-W1; RT-gill-W1; RT-gill W1; RTgillW1; RTG-W1; Rainbow Trout gill-Waterloo 1
DR   CLO; CLO_0008896
DR   ATCC; CRL-2523
DR   BCRJ; 0362
DR   DSMZ; ACC-899
DR   DSMZCellDive; ACC-899
DR   FCS-free; 159-12-290-1-16-3
DR   Wikidata; Q54951402
RX   CelloPub=CLPUB00786;
RX   DOI=10.1016/j.hal.2011.01.002;
RX   DOI=10.1016/j.namjnl.2025.100008;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.1111/j.1365-2761.1994.tb00258.x;
RX   DOI=10.1787/c66d5190-en;
RX   DOI=10.3390/app11062534;
RX   DOI=10.5075/epfl-thesis-6698;
RX   PubMed=19002917;
RX   PubMed=19184248;
RX   PubMed=20420918;
RX   PubMed=22281180;
RX   PubMed=24357037;
RX   PubMed=28374170;
RX   PubMed=30825313;
RX   PubMed=33053677;
WW   Info; -; -; https://aquatox-solutions.ch/wp-content/uploads/2019/04/RTgill-W1-Cell-Line-Assay.pdf
CC   Group: Fish cell line.
CC   Biotechnology: Used in the ISO 21115:2019 assay for the determination of acute toxicity of water samples (CelloPub=CLPUB00786).
CC   Biotechnology: Used in the Organisation for Economic Co-operation and Development (OECD) fish cell line acute toxicity test method 249 (DOI=10.1787/c66d5190-en).
CC   Biotechnology: Used in an assay for ichthyotoxic assessment of red tide phytoplankton (DOI=10.1016/j.hal.2011.01.002).
CC   Characteristics: Used for acute toxicity tests on chemicals.
CC   Doubling time: ~10-12 days (DSMZ=ACC-899); 3.71 +- 0.56 days (DOI=10.1016/j.namjnl.2025.100008).
CC   Discontinued: BCRJ; 0362; true.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   RTgill-W1-pf
AC   CVCL_IW82
SY   RTgill-W1-protein free
DR   FCS-free; 30-12-32-1-4-4
DR   Wikidata; Q54951403
RX   DOI=10.5075/epfl-thesis-6698;
RX   PubMed=27030289;
CC   Group: Fish cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Developed to allow study of nanoparticle-cell interactions for extended time period.
CC   Doubling time: 6 days (PubMed=27030289).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
HI   CVCL_6441 ! RTgill-W1
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
ID   RTgill-W1-sf
AC   CVCL_E7CD
SY   RTgill-W1-serum free
RX   DOI=10.1016/j.namjnl.2025.100008;
CC   Group: Fish cell line.
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 6.81 +- 0.96 days (Note=With Accutase), 4.84 +- 0.62 days (Note=With TrypZean) (DOI=10.1016/j.namjnl.2025.100008).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
HI   CVCL_6441 ! RTgill-W1
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   RTgutF
AC   CVCL_YI84
SY   Rainbow Trout gut Fibroblastic
DR   Wikidata; Q98129205
RX   PubMed=31256301;
CC   Group: Fish cell line.
CC   Doubling time: 6.5 days (Note=In 5% FBS), 5 days (Note=In 10% FBS), 4.5 days (Note=In 20% FBS) (PubMed=31256301).
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   RTgutGC
AC   CVCL_DE13
SY   Rainbow Trout gut Germany Canada
DR   Wikidata; Q54951405
RX   CelloPub=CLPUB00666;
RX   DOI=10.1111/j.1365-2095.2010.00757.x;
RX   PubMed=20420918;
RX   PubMed=24357037;
RX   PubMed=28251411;
RX   PubMed=28374170;
RX   PubMed=31256301;
RX   PubMed=33053677;
RX   PubMed=34205481;
CC   Group: Fish cell line.
CC   Doubling time: 2.9 days (PubMed=34205481).
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 10
//
ID   RTH
AC   CVCL_AZ91
SY   Rainbow Trout Heart
DR   ABM; T0444
DR   Wikidata; Q54951406
RX   PubMed=24698994;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=24698994).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-09-24; Version: 10
//
ID   RTH-149
AC   CVCL_3467
SY   RTH 149; RTH149; Rainbow Trout Hepatoma-149
DR   BTO; BTO_0002602
DR   CLO; CLO_0008898
DR   ATCC; CRL-1710
DR   Wikidata; Q54951407
RX   CelloPub=CLPUB00103;
RX   CelloPub=CLPUB00703;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.3147/jsfp.15.193;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   PubMed=6542066;
RX   PubMed=8736390;
RX   PubMed=19002917;
RX   PubMed=20420918;
RX   PubMed=28374170;
RX   PubMed=32707879;
RX   PubMed=33053677;
RX   PubMed=34382581;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV) (CelloPub=CLPUB00703).
CC   Transformant: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C134573; Rainbow trout hepatoma
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   RTH1B1A
AC   CVCL_KB51
DR   Wikidata; Q54951408
RX   PubMed=15311963;
CC   Group: Fish cell line.
CC   Doubling time: 3.9 +- 0.3 days (Note=At 135th passage) (PubMed=15311963).
CC   Transformant: ChEBI; CHEBI_35861; Dibenzo[a,l]pyrene (DBP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Shasta.
DI   NCIt; C134573; Rainbow trout hepatoma
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
OI   CVCL_KB52 ! RTH1B1D
OI   CVCL_KB53 ! RTH1B2A
OI   CVCL_KB54 ! RTH1B2C
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   RTH1B1D
AC   CVCL_KB52
DR   Wikidata; Q54951409
RX   PubMed=15311963;
CC   Group: Fish cell line.
CC   Doubling time: 3.5 +- 0.2 days (Note=At 135th passage) (PubMed=15311963).
CC   Transformant: ChEBI; CHEBI_35861; Dibenzo[a,l]pyrene (DBP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Shasta.
DI   NCIt; C134573; Rainbow trout hepatoma
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
OI   CVCL_KB51 ! RTH1B1A
OI   CVCL_KB53 ! RTH1B2A
OI   CVCL_KB54 ! RTH1B2C
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   RTH1B2A
AC   CVCL_KB53
DR   Wikidata; Q54951410
RX   PubMed=15311963;
CC   Group: Fish cell line.
CC   Doubling time: 3.0 +- 0.2 days (Note=At 135th passage) (PubMed=15311963).
CC   Transformant: ChEBI; CHEBI_35861; Dibenzo[a,l]pyrene (DBP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Shasta.
DI   NCIt; C134573; Rainbow trout hepatoma
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
OI   CVCL_KB51 ! RTH1B1A
OI   CVCL_KB52 ! RTH1B1D
OI   CVCL_KB54 ! RTH1B2C
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   RTH1B2C
AC   CVCL_KB54
DR   Wikidata; Q54951411
RX   PubMed=15311963;
CC   Group: Fish cell line.
CC   Doubling time: 4.5 +- 0.4 days (Note=At 135th passage) (PubMed=15311963).
CC   Transformant: ChEBI; CHEBI_35861; Dibenzo[a,l]pyrene (DBP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Shasta.
DI   NCIt; C134573; Rainbow trout hepatoma
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
OI   CVCL_KB51 ! RTH1B1A
OI   CVCL_KB52 ! RTH1B1D
OI   CVCL_KB53 ! RTH1B2A
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   RTH33
AC   CVCL_8753
SY   RTH 33; Rat Transformed Hepatocytes 33
DR   CLO; CLO_0050625
DR   RCB; RCB1025
DR   Wikidata; Q54951412
RX   CelloPub=CLPUB00285;
WW   Info; KAKEN; 63480308; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-63480308/
CC   Doubling time: ~17 hours (CelloPub=CLPUB00285).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RTHDF
AC   CVCL_S147
SY   Rainbow Trout HypoDermal Fibroblasts
DR   Wikidata; Q54951414
RX   DOI=10.1111/j.1095-8649.2004.00378.x;
RX   PubMed=20420918;
RX   PubMed=28374170;
RX   PubMed=31254564;
RX   PubMed=31512261;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 16
//
ID   RTIBDi001-A
AC   CVCL_YC53
SY   MCND-TENS2
DR   BioSamples; SAMEA6049776
DR   hPSCreg; RTIBDi001-A
DR   Wikidata; Q98129206
CC   From: National Institutes of Health, Regenerative therapies for inherited blood disorder; Bethesda; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   RTiv3
AC   CVCL_WN46
SY   RTiV3
DR   Wikidata; Q98129207
RX   PubMed=20135361;
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RTK [Carp]
AC   CVCL_A1LK
SY   Rainbow Trout Kidney
DR   Wikidata; Q102114851
RX   DOI=10.1016/j.aquaculture.2020.736027;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by striped jack nervous necrosis virus (SJNNV), Tilapia lake virus (TiLV). Resistant to infection by Cyprinid herpes virus 2 (CyHV-2) (DOI=10.1016/j.aquaculture.2020.736027).
CC   Doubling time: ~39 hours (Note=At 57th passage) (DOI=10.1016/j.aquaculture.2020.736027).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   RTK [Human kidney tumor]
AC   CVCL_4W74
SY   Rhabdoid Tumor of Kidney
DR   Wikidata; Q54951415
RX   PubMed=1706306;
CC   Doubling time: ~4 days (PubMed=1706306).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1W
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   RTK(J)-4N
AC   CVCL_EJ24
SY   RTK-J-4N; RTKJ4N
DR   Cosmic; 2144789
DR   Wikidata; Q54951416
RX   PubMed=24418192;
CC   Population: Japanese.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 7
//
ID   RTL-4
AC   CVCL_6D95
SY   Rainbow Trout Liver-4
DR   Wikidata; Q54951417
RX   DOI=10.2331/suisan.53.537;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   RTL-W1
AC   CVCL_L011
SY   Rainbow Trout Liver-Waterloo 1
DR   Wikidata; Q54951418
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=7766144;
RX   PubMed=8299006;
RX   PubMed=11501281;
RX   PubMed=19002917;
RX   PubMed=20420918;
RX   PubMed=22281180;
RX   PubMed=23305652;
RX   PubMed=24357037;
RX   PubMed=28374170;
RX   PubMed=29268113;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Doubling time: 98.9 hours (PubMed=29268113).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Male
AG   4Y
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 17
//
ID   RTM
AC   CVCL_KB24
SY   Rainbow Trout Mesothelioma
DR   Wikidata; Q54951419
RX   DOI=10.1111/j.1365-2761.1985.tb00958.x;
RX   PubMed=8736390;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C136977; Rainbow trout mesothelioma
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 6
//
ID   RTO [Mouse hybridoma against human PF4]
AC   CVCL_E9UX
DR   ABCD; ABCD_AG954
RX   Patent=US7728115;
RX   PubMed=10688805;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P02776; Human PF4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RTO [O.mykiss]
AC   CVCL_4553
SY   Rainbow Trout Ovary
DR   CLO; CLO_0008899
DR   CLDB; cl4205
DR   IZSLER; BS CL 77
DR   Wikidata; Q54951420
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   RTO-2
AC   CVCL_YB69
SY   Rainbow Trout Ovary-2
DR   Wikidata; Q98129208
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   RTP-2
AC   CVCL_L012
SY   Rainbow Trout Pituitary-2
DR   Wikidata; Q54951421
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=7773333;
RX   PubMed=11223380;
RX   PubMed=19002917;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   RTP-91E
AC   CVCL_L013
SY   Rainbow Trout Pituitary-1991 Epithelial
DR   Wikidata; Q54951437
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=11223380;
RX   PubMed=19002917;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
OI   CVCL_L014 ! RTP-91F
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 12
//
ID   RTP-91F
AC   CVCL_L014
SY   Rainbow Trout Pituitary-1991 Fibroblastic
DR   Wikidata; Q54951439
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   PubMed=11223380;
RX   PubMed=19002917;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
OI   CVCL_L013 ! RTP-91E
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 12
//
ID   RTpi-MI
AC   CVCL_B5E5
SY   Rainbow Trout proximal intestine-Milano Italy
DR   Wikidata; Q110433172
RX   PubMed=34205481;
CC   Group: Fish cell line.
CC   Doubling time: 3.0 days (PubMed=34205481).
CC   Derived from site: In situ; Intestine; Note=Proximal part; UBERON=UBERON_0000160.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   RTS
AC   CVCL_A1LL
SY   Rainbow Trout Spleen
DR   Wikidata; Q102114852
RX   DOI=10.1016/j.aquaculture.2020.736027;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by striped jack nervous necrosis virus (SJNNV), Tilapia lake virus (TiLV). Resistant to infection by Cyprinid herpes virus 2 (CyHV-2) (DOI=10.1016/j.aquaculture.2020.736027).
CC   Doubling time: ~28 hours (Note=At 55th passage) (DOI=10.1016/j.aquaculture.2020.736027).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   RTS11
AC   CVCL_F835
SY   RTS-11; Rainbow Trout Spleen 11
DR   Wikidata; Q54951440
RX   DOI=10.1006/fsim.1998.0153;
RX   PubMed=19002917;
RX   PubMed=20420918;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   RTS11-GFP
AC   CVCL_KR31
DR   Wikidata; Q54951441
WW   Info; -; -; https://web.archive.org/web/20161020152739/http://naciworkshop.com/session/evaluating-phagocytic-ability-of-rts11-gfp-a-stably-transfected-sub-line-of-rts11-a-monocytemacrophage-cell-line-from-spleen-of-rainbow-trout/
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
HI   CVCL_F835 ! RTS11
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   RTS3-3
AC   CVCL_6C40
SY   RT3-3
DR   Wikidata; Q54951442
RX   PubMed=12655154;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   27W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   RTS34
AC   CVCL_L015
SY   Rainbow Trout Spleen 34
DR   Wikidata; Q54951444
RX   PubMed=10475261;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 11
//
ID   RTS34st
AC   CVCL_L016
SY   RTS-34st; RTS34ST; Rainbow Trout Spleen 34 stromal; Low 16; RTSp-W1; Rainbow Trout Spleen-Waterloo 1
DR   Wikidata; Q54951445
RX   PubMed=7766144;
RX   PubMed=10475261;
RX   PubMed=19002917;
RX   PubMed=20420918;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Miscellaneous: Equivalence of RTS34st with RTSp-W1 from personal communication of Lee, Lucy E.J.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
HI   CVCL_L015 ! RTS34
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 15
//
ID   RTS34st(neo)
AC   CVCL_6E23
SY   RTS34st (neo); RTS34st-neo
DR   Wikidata; Q54951448
RX   PubMed=15602876;
CC   Group: Fish cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
HI   CVCL_L016 ! RTS34st
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   RTS3b
AC   CVCL_2G64
SY   RTS3B; RTS 3b
DR   EFO; EFO_0006748
DR   Wikidata; Q54951450
RX   PubMed=8221669;
RX   PubMed=9261424;
CC   Derived from site: In situ; Ear, skin, epidermis; UBERON=UBERON_0001459+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 5
//
ID   RTS7c
AC   CVCL_B6LW
DR   Wikidata; Q112044505
RX   PubMed=8221669;
CC   Derived from site: In situ; Hand, skin, epidermis; UBERON=UBERON_0001519+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   RTSCC
AC   CVCL_JF06
SY   Rabbit Tongue Squamous Cell Carcinoma
DR   Wikidata; Q54951451
RX   Patent=CN100408676C;
RX   PubMed=21071263;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200504.
CC   Doubling time: 91 hours (Note=At 5th passage), 84 hours (Note=At 15th passage), 89 hours (Note=At 25th passage), 37 hours (Note=At 35th passage), 39 hours (Note=At 53th passage), 35 hours (Note=At 57th passage) (PubMed=21071263).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Miscellaneous: As no cell line name was provided in the patent and the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
DI   NCIt; C133739; Rabbit oral cavity squamous cell carcinoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   RTSG
AC   CVCL_1671
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03151924
DR   BioSample; SAMN03472783
DR   CGH-DB; 9361-4
DR   Cosmic; 909705
DR   IARC_TP53; 21294
DR   JCRB; IFO50318
DR   Wikidata; Q54951452
RX   PubMed=2083225;
RX   PubMed=11330945;
RX   PubMed=20164919;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Promega; -; http://promega.co.jp/pdf/Cell_Authentication.pdf
CC   Problematic cell line: Contaminated. Shown to be a SNG-II derivative (JCRB=IFO50318). Originally thougth to originate from the pleural effusion of a 66 year old female patient with metastatic ovarian epithelial carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00423.
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=2083225).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; IFO50318; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=IFO50318
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,9,12
ST   D16S539: 12,13,14
ST   D5S818: 6,12
ST   D7S820: 9,11,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,16,17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3170 ! SNG-II
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   RTT
AC   CVCL_R853
SY   Rainbow Trout Tail
DR   Wikidata; Q54951453
RX   CelloPub=CLPUB00103;
RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Tail, skeletal muscle; UBERON=UBERON_0003665.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   RTT-1155del32 C15
AC   CVCL_YL26
SY   iPSC-RTT clone 15
DR   GEO; GSM525409
DR   GEO; GSM525410
DR   GEO; GSM525411
DR   Wikidata; Q98129209
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Argfs*8 (c.1157_1188del32) (p.Leu398Argfs*8, c.1193_1224del32) (1155del32); ClinVar=VCV000143366; Zygosity=Unspecified (PubMed=21074045).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F14 ! GM11272
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   RTT-1155del32 C18
AC   CVCL_YL32
SY   iPSC-RTT clone 18
DR   GEO; GSM525412
DR   GEO; GSM525413
DR   GEO; GSM525414
DR   Wikidata; Q98129210
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Leu386Argfs*8 (c.1157_1188del32) (p.Leu398Argfs*8, c.1193_1224del32) (1155del32); ClinVar=VCV000143366; Zygosity=Unspecified (PubMed=21074045).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F14 ! GM11272
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   RTT-Q244X C3
AC   CVCL_YL33
DR   Wikidata; Q98129211
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gln244Ter (c.730C>T); ClinVar=VCV000095200; Zygosity=Heterozygous (PubMed=21074045).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F42 ! GM16548
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   RTT-Q244X C4
AC   CVCL_YL42
DR   Wikidata; Q98129212
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gln244Ter (c.730C>T); ClinVar=VCV000095200; Zygosity=Heterozygous (PubMed=21074045).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F42 ! GM16548
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   RTT-R306C C1
AC   CVCL_YL44
DR   Wikidata; Q98129213
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Heterozygous (PubMed=21074045).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F181 ! GM11270
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   RTT-T158M C3
AC   CVCL_YL45
DR   Wikidata; Q98129214
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Thr158Met (c.473C>T) (p.Thr170Met, c.509C>T); ClinVar=VCV000011811; Zygosity=Heterozygous (PubMed=21074045).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4F48 ! GM17880
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   RTTe1-hiPSC #27
AC   CVCL_A4QQ
SY   RTTe1 #27
DR   SKIP; SKIP001032
DR   Wikidata; Q105510816
RX   PubMed=25644311;
CC   From: The Hospital for Sick Children; Toronto; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly16Glufs*22 (c.47_57delGCGAGGAGGAG); ClinVar=VCV000189770; Zygosity=Heterozygous (PubMed=25644311).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QR ! RTTe1-hiPSC #39
OI   CVCL_A4QS ! RTTe1-hiPSC #48
OI   CVCL_A4QT ! RTTe1-hiPSC #96
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RTTe1-hiPSC #39
AC   CVCL_A4QR
SY   RTTe1 #39
DR   SKIP; SKIP001033
DR   Wikidata; Q105510819
RX   PubMed=25644311;
CC   From: The Hospital for Sick Children; Toronto; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly16Glufs*22 (c.47_57delGCGAGGAGGAG); ClinVar=VCV000189770; Zygosity=Heterozygous (PubMed=25644311).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QQ ! RTTe1-hiPSC #27
OI   CVCL_A4QS ! RTTe1-hiPSC #48
OI   CVCL_A4QT ! RTTe1-hiPSC #96
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RTTe1-hiPSC #48
AC   CVCL_A4QS
SY   RTTe1 #48
DR   SKIP; SKIP001034
DR   Wikidata; Q105510823
RX   PubMed=25644311;
CC   From: The Hospital for Sick Children; Toronto; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly16Glufs*22 (c.47_57delGCGAGGAGGAG); ClinVar=VCV000189770; Zygosity=Heterozygous (PubMed=25644311).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QQ ! RTTe1-hiPSC #27
OI   CVCL_A4QR ! RTTe1-hiPSC #39
OI   CVCL_A4QT ! RTTe1-hiPSC #96
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   RTTe1-hiPSC #96
AC   CVCL_A4QT
SY   RTTe1 #96
DR   SKIP; SKIP001035
DR   Wikidata; Q105510826
RX   PubMed=25644311;
CC   From: The Hospital for Sick Children; Toronto; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly16Glufs*22 (c.47_57delGCGAGGAGGAG); ClinVar=VCV000189770; Zygosity=Heterozygous (PubMed=25644311).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QQ ! RTTe1-hiPSC #27
OI   CVCL_A4QR ! RTTe1-hiPSC #39
OI   CVCL_A4QS ! RTTe1-hiPSC #48
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   Ru Ra
AC   CVCL_3790
DR   CLO; CLO_0008900
DR   ATCC; CRL-1315
DR   Wikidata; Q54951454
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   RU-ASE-2A
AC   CVCL_Z259
SY   Rutgers University-Anopheles Stephensi Embryo-2A
DR   Wikidata; Q54951455
RX   DOI=10.2307/3576172;
RX   PubMed=16593348;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=30069; ! Anopheles stephensi (Indo-Pakistan malaria mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 9
//
ID   RU-ASE-IV
AC   CVCL_WK40
SY   ASE-IV; Rutgers University-Anopheles Stephensi Embryo-IV
DR   Wikidata; Q98129215
RX   CelloPub=CLPUB00497;
RX   PubMed=15667661;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=30069; ! Anopheles stephensi (Indo-Pakistan malaria mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 6
//
ID   RU-TAE-12V
AC   CVCL_Z238
SY   RU-Tae-12V; RUE-TAE 12 V; RU TAE 12 V; TAE-12V; TAE 12V; TAE 12 V; Rutgers University-Toxorhynchites Amboinensis Embryo-12V
DR   Wikidata; Q54951456
RX   CelloPub=CLPUB00497;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   PubMed=6129294;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   RU-TAE-14
AC   CVCL_Z239
SY   Rutgers University-Toxorhynchites Amboinensis Embryo-14
DR   Wikidata; Q54951457
RX   DOI=10.2307/3576172;
RX   PubMed=16593348;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   RUBHU.02
AC   CVCL_A5YW
DR   Wikidata; Q107116778
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5YX ! RUBHU.03
OI   CVCL_A5YY ! RUBHU.08
OI   CVCL_A5YZ ! RUBHU.09
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RUBHU.03
AC   CVCL_A5YX
DR   Wikidata; Q107116779
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5YW ! RUBHU.02
OI   CVCL_A5YY ! RUBHU.08
OI   CVCL_A5YZ ! RUBHU.09
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RUBHU.08
AC   CVCL_A5YY
DR   Wikidata; Q107116780
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5YW ! RUBHU.02
OI   CVCL_A5YX ! RUBHU.03
OI   CVCL_A5YZ ! RUBHU.09
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RUBHU.09
AC   CVCL_A5YZ
DR   Wikidata; Q107116781
RX   PubMed=2989374;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5YW ! RUBHU.02
OI   CVCL_A5YX ! RUBHU.03
OI   CVCL_A5YY ! RUBHU.08
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   RUCA-I
AC   CVCL_Z943
SY   RUCA-1; Rat Uterus Carcinoma-I
DR   Wikidata; Q54951459
RX   PubMed=1459735;
RX   PubMed=8809192;
CC   Doubling time: 16.6 +- 0.7 hours (PubMed=1459735).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: DA/Han (DA/Ztm); RS=RS_0000242.
DI   NCIt; C63961; Adenocarcinoma of the rat uterus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   RUCA-II
AC   CVCL_Z944
SY   Rat Uterus Carcinoma-II
DR   Wikidata; Q54951461
RX   PubMed=1459735;
CC   Doubling time: 24.4 +- 7.9 hours (PubMed=1459735).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Breed/subspecies: BDII/Han (BDII/Ztm); RS=RS_0000087.
DI   NCIt; C63961; Adenocarcinoma of the rat uterus
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   RUCDRi002-A-1
AC   CVCL_A7LD
SY   UMGi147-A-1
DR   hPSCreg; RUCDRi002-A-1
DR   Wikidata; Q107116783
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=356
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-10
AC   CVCL_A7LL
SY   UMGi147-A-10
DR   hPSCreg; RUCDRi002-A-10
DR   Wikidata; Q107116784
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=412
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-11
AC   CVCL_A7LM
SY   UMGi147-A-11
DR   hPSCreg; RUCDRi002-A-11
DR   Wikidata; Q107116785
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=446
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-12
AC   CVCL_A7LN
SY   UMGi147-A-12
DR   hPSCreg; RUCDRi002-A-12
DR   Wikidata; Q107116786
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=448
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-13
AC   CVCL_A7LP
SY   UMGi147-A-13
DR   hPSCreg; RUCDRi002-A-13
DR   Wikidata; Q107116787
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=449
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-14
AC   CVCL_A7LQ
SY   UMGi147-A-14
DR   hPSCreg; RUCDRi002-A-14
DR   Wikidata; Q107116788
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=461
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-15
AC   CVCL_A7LR
SY   TC-1133-CRISPRa2; hiPSC-CRISPRa2; UMGi147-A-15
DR   hPSCreg; RUCDRi002-A-15
DR   Wikidata; Q107116790
RX   PubMed=34481190;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=478
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Characteristics: Using CRISPR/Cas9 a dCas9-VPR-2A-tdTomato-WPRE construct containing dCas9 fused to heterotrimeric VPR transactivator consisting of VP64, p65, and RTA domains along with a tdTomato and a woodchuck hepatitis post-transcriptional regulatory element (WPRE) was introduced in the AAVS1 safe harbor locus (PubMed=34481190).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   RUCDRi002-A-16
AC   CVCL_A7LS
SY   TC-1133-CRISPRi; UMGi147-A-16
DR   hPSCreg; RUCDRi002-A-16
DR   Wikidata; Q107116791
RX   PubMed=34343828;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=479
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Characteristics: Using CRISPR/Cas9 a CAG-dCas9-KRAB-T2A-tdTomato-EF1a-puroR construct was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   RUCDRi002-A-17
AC   CVCL_A7LT
SY   TC-1133-CRISPRi2; UMGi147-A-17
DR   hPSCreg; RUCDRi002-A-17
DR   Wikidata; Q107116792
RX   PubMed=34343828;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=480
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Characteristics: Using CRISPR/Cas9 a CAG-dCas9-KRAB-T2A-tdTomato-WPRE construct was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   RUCDRi002-A-18
AC   CVCL_A7LU
SY   UMGi147-A-18
DR   hPSCreg; RUCDRi002-A-18
DR   Wikidata; Q107116793
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=491
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-19
AC   CVCL_A7LV
SY   UMGi147-A-19
DR   hPSCreg; RUCDRi002-A-19
DR   Wikidata; Q107116794
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=413
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Characteristics: Using CRISPR/Cas9 TTN was tagged at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   RUCDRi002-A-2
AC   CVCL_A7LE
SY   UMGi147-A-2
DR   hPSCreg; RUCDRi002-A-2
DR   Wikidata; Q107116795
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=357
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-20
AC   CVCL_A7LW
SY   UMGi147-A-20
DR   hPSCreg; RUCDRi002-A-20
DR   Wikidata; Q107116796
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=505
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-21
AC   CVCL_A7LX
SY   UMGi147-A-21
DR   hPSCreg; RUCDRi002-A-21
DR   Wikidata; Q107116797
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=504
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-22
AC   CVCL_A7LY
SY   UMGi147-A-22
DR   hPSCreg; RUCDRi002-A-22
DR   Wikidata; Q107116798
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=501
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-23
AC   CVCL_A7LZ
SY   UMGi147-A-23
DR   hPSCreg; RUCDRi002-A-23
DR   Wikidata; Q107116799
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=502
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-24
AC   CVCL_A7MA
SY   UMGi147-A-24
DR   hPSCreg; RUCDRi002-A-24
DR   Wikidata; Q107116800
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=503
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-25
AC   CVCL_A7MB
SY   UMGi147-A-25
DR   hPSCreg; RUCDRi002-A-25
DR   Wikidata; Q107116801
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=511
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-3
AC   CVCL_A7LF
SY   UMGi147-A-3
DR   hPSCreg; RUCDRi002-A-3
DR   Wikidata; Q107116802
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=358
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-4
AC   CVCL_A7LG
SY   UMGi147-A-4
DR   hPSCreg; RUCDRi002-A-4
DR   Wikidata; Q107116803
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=360
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-5
AC   CVCL_A1PK
SY   TC-1133-CRISPRa; UMGi147-A-5
DR   hPSCreg; RUCDRi002-A-5
DR   Wikidata; Q102114853
RX   PubMed=33038615;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=390
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Characteristics: Using CRISPR/Cas9 two constructs one containing CAGpromoter-dCas9-VPR-2A-tdTomato-gGH and the other EF1a-promoter-PuroR-SV40polyA were introduced in the AAVS1 safe harbor locus (PubMed=33038615).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   RUCDRi002-A-6
AC   CVCL_A7LH
SY   UMGi147-A-6
DR   hPSCreg; RUCDRi002-A-6
DR   Wikidata; Q107116804
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=394
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-63
AC   CVCL_D6N0
SY   LVIP05-RB1-CS1; RB1-CS1; LVPEIi003-A-63
DR   BioSamples; SAMEA114430734
DR   hPSCreg; RUCDRi002-A-63
RX   PubMed=38452707;
CC   Population: Hispanic.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=Disrupted at exon 18).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   RUCDRi002-A-64
AC   CVCL_D6N1
SY   LVIP05-RB1-CS2; RB1-CS2; LVPEIi003-A-64
DR   BioSamples; SAMEA114572969
DR   hPSCreg; RUCDRi002-A-64
RX   PubMed=38452707;
CC   Population: Hispanic.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=Disrupted at exon 18).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   RUCDRi002-A-65
AC   CVCL_D6N2
SY   LVIP05-RB1-CS3; RB1-CS3; LVPEIi003-A-65
DR   BioSamples; SAMEA115170104
DR   hPSCreg; RUCDRi002-A-65
RX   PubMed=38452707;
CC   Population: Hispanic.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=Disrupted at exon 18).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   RUCDRi002-A-69
AC   CVCL_D6MC
SY   PLP1-C33Y
DR   hPSCreg; RUCDRi002-A-69
DR   Wikidata; Q127384099
RX   PubMed=38104430;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple_edited; p.Cys33Tyr (c.98G>A); ClinVar=VCV000420045; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=38104430).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   RUCDRi002-A-7
AC   CVCL_A7LI
SY   UMGi147-A-7
DR   hPSCreg; RUCDRi002-A-7
DR   Wikidata; Q107116805
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=403
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-70
AC   CVCL_D6MN
SY   fPLP1
DR   hPSCreg; RUCDRi002-A-70
DR   Wikidata; Q127384101
RX   PubMed=38219302;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Characteristics: Using CRISPR/Cas9 PLP1 was tagged on its unique allele at the C-terminus with Citrine (PubMed=38219302).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   RUCDRi002-A-8
AC   CVCL_A7LJ
SY   UMGi147-A-8
DR   hPSCreg; RUCDRi002-A-8
DR   Wikidata; Q107116806
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=411
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCDRi002-A-9
AC   CVCL_A7LK
SY   UMGi147-A-9
DR   hPSCreg; RUCDRi002-A-9
DR   Wikidata; Q107116807
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=gen_mod&line=422
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Hispanic.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RH35 ! ND50038
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   RUCH-2
AC   CVCL_C540
SY   Ruch-2; RUCH2; Ruch2; Rhabdomyosarcoma of University Children's Hospital-2
DR   cancercelllines; CVCL_C540
DR   Cosmic; 686754
DR   Cosmic; 1309333
DR   GEO; GSM219755
DR   PRIDE; PXD000589
DR   Wikidata; Q54951463
RX   DOI=10.3929/ethz-a-003884990;
RX   PubMed=10735512;
RX   PubMed=12068308;
RX   PubMed=12904596;
RX   PubMed=19235922;
RX   PubMed=23882450;
RX   PubMed=25894527;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=12068308).
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   RUCH-3
AC   CVCL_C541
SY   RUCH3; Ruch3; Rhabdomyosarcoma of University Children's Hospital-3
DR   Cosmic; 687963
DR   GEO; GSM219746
DR   PRIDE; PXD039480
DR   Wikidata; Q54951464
RX   DOI=10.3929/ethz-a-003884990;
RX   PubMed=12904596;
RX   PubMed=19235922;
RX   PubMed=23882450;
RX   PubMed=36768928;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   RUD
AC   CVCL_ZI13
SY   Raji(Brdu)
DR   cancercelllines; CVCL_ZI13
DR   Wikidata; Q98129216
RX   PubMed=4550511;
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   RUDPICAT-1
AC   CVCL_6218
SY   RUD-PICAT-1
DR   Wikidata; Q54951465
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI13 ! RUD
HI   CVCL_ZI14 ! PICAT
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   RUDPUT-2
AC   CVCL_6219
DR   Wikidata; Q54951466
RX   PubMed=6278187;
RX   PubMed=6278188;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI13 ! RUD
HI   CVCL_ZI12 ! PUT
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   RUES1
AC   CVCL_B809
SY   Rockefeller University Embryonic Stem cell line 1; RUESe001-A
DR   BioSamples; SAMEA104387754
DR   hPSCreg; RUESe001-A
DR   NIHhESC; NIHhESC-10-0012
DR   SKIP; SKIP002083
DR   WiCell; rues1
DR   Wikidata; Q54951467
RX   PubMed=28445466;
WW   Provider; Rockefeller University; -; https://rues.rockefeller.edu/
CC   From: Rockefeller University; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0012.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=rues1
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 29,33.2
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 5,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   RUES1-EGFP/SMAD7
AC   CVCL_IQ86
DR   Wikidata; Q54951468
RX   PubMed=23034881;
CC   Characteristics: Transfected with a Tet-inducible bi-cistronic expression cassette encoding EGFP and SMAD7.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6773; SMAD7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B809 ! RUES1
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   RUES2
AC   CVCL_B810
SY   Rockefeller University Embryonic Stem cell line 2; RUESe002-A
DR   EFO; EFO_0009320
DR   4DN; 4DNSR2VQCV9W
DR   BioSamples; SAMEA104387770
DR   ENCODE; ENCBS089ZVW
DR   hPSCreg; RUESe002-A
DR   NIHhESC; NIHhESC-10-0013
DR   WiCell; rues2
DR   Wikidata; Q54951469
RX   PubMed=28445466;
RX   PubMed=35805069;
WW   Provider; Rockefeller University; -; https://rues.rockefeller.edu/
CC   From: Rockefeller University; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0013.
CC   Registration: Swiss research registry; BAG-hES-IMP-0057.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=rues2
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,15
ST   D18S51: 16,18
ST   D21S11: 29
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 9,12
ST   Penta E: 13,14
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   RUES2 HOPX KO
AC   CVCL_VM28
DR   Wikidata; Q98129217
RX   PubMed=28813672;
RX   PubMed=30290179;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24961; HOPX.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   RUES2 HOPX-tdTomato
AC   CVCL_VM29
SY   RUES2 HOPX-td-Tomato
DR   Wikidata; Q98129218
RX   PubMed=28813672;
RX   PubMed=30290179;
CC   Characteristics: Using CRISPR/Cas9 a tdTomato-pA-loxP-PGKp-PuroR-pA-loxP was integrated at the HOPX translational start site.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   RUES2 SFTPC-tdTomato
AC   CVCL_WN79
SY   RUES2-ST
DR   Wikidata; Q98129219
RX   PubMed=28965766;
CC   Characteristics: Using TALEN a tdTomato-pA-loxP-PGKp-PuroR-pA-loxP was integrated at the SFTPC translational start site.
CC   Genetic integration: Method=TALEN; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   RUES2-EGFP/SMAD7
AC   CVCL_IQ87
DR   Wikidata; Q54951470
RX   PubMed=23034881;
CC   Characteristics: Transfected with a Tet-inducible bi-cistronic expression cassette encoding EGFP and SMAD7.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6773; SMAD7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   RUES3
AC   CVCL_B811
SY   Rockefeller University Embryonic Stem cell line 3
DR   NIHhESC; NIHhESC-10-0042
DR   WiCell; rues3
DR   Wikidata; Q54951472
WW   Provider; Rockefeller University; -; https://rues.rockefeller.edu/
CC   From: Rockefeller University; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0042.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=rues3
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 12,18,19
ST   D21S11: 30
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 20,24
ST   Penta D: 9,11
ST   Penta E: 12,15
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   RUESe002-A-1
AC   CVCL_C1W2
SY   RUES2(B-CAG:EGFP-NLS;P-TT:RFP-NLS); RUES2 2123; RPIe003-A-1
DR   hPSCreg; RUESe002-A-1
DR   Wikidata; Q114312929
RX   PubMed=35805069;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   RUESe002-A-2
AC   CVCL_C1W3
SY   RUES2 1811
DR   hPSCreg; RUESe002-A-2
DR   Wikidata; Q114312930
RX   PubMed=35805069;
CC   From: Rockefeller University; New York; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   RUESe002-A-4
AC   CVCL_C1W4
SY   RUES2-mCitrine-SMAD2
DR   BioSamples; SAMEA10794674
DR   hPSCreg; RUESe002-A-4
DR   Wikidata; Q114312931
CC   From: Rockefeller University; New York; USA.
CC   Characteristics: Using CRISPR/Cas9 a PuroR-P2A-mcitrine construct was introduced at the N-terminal end of SMAD2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; VR7EN; Citrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   RUESe002-A-5
AC   CVCL_C1W5
SY   RUES2-RFP-SMAD1
DR   BioSamples; SAMEA10794729
DR   hPSCreg; RUESe002-A-5
DR   Wikidata; Q114312932
CC   From: Rockefeller University; New York; USA.
CC   Characteristics: Using CRISPR/Cas9 a Bsd-P2A-tagRFP construct was introduced at the N-terminal end of SMAD1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   RUESe002-A-6
AC   CVCL_E9CV
SY   RUES2-GLR
DR   BioSamples; SAMEA112765832
DR   hPSCreg; RUESe002-A-6
RX   PubMed=29795348;
CC   Registration: Swiss research registry; BAG-hES-IMP-0058.
CC   Characteristics: Using CRISPR/Cas9 three independent fate reporters SOX2-mCitrine, SOX17-tdTomato and TBXT-mCerulean were produced. First a P2A-H2B-tdTomato construct was inserted at the C-terminus of SOX17, then a PA2-mCerulean was inserted at the C-terminus of TBXT (called BRA) and finally a mCitrine was fused to the C-terminus of SOX2 (PubMed=29795348).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; J2JWA; mCerulean (Note=Bright cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 3Q37R; mCitrine (Note=Yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B810 ! RUES2
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   RuGli
AC   CVCL_JZ16
SY   Rugli
DR   Wikidata; Q54951473
RX   PubMed=2526967;
RX   PubMed=2970671;
RX   PubMed=4065092;
CC   Problematic cell line: Misidentified. Originally thought to be established from a human glioblastoma but found to be from rat (PubMed=2526967).
CC   Miscellaneous: Possibly identical to the C6 (Cellosaurus=CVCL_0194) rat glioma cell line (personal communication of Goodman, Simon L.). Experimental confirmation of such a relationship would be very welcome.
DI   NCIt; C64069; Rat malignant glioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 5
//
ID   rUGM
AC   CVCL_LF79
SY   rat UroGenital sinus Mesenchyme cell line
DR   Wikidata; Q54951474
RX   PubMed=7508897;
RX   PubMed=18462435;
CC   Derived from site: In situ; Urogenital sinus mesenchyme; UBERON=UBERON_0009845.
CC   Breed/subspecies: Nb.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   rumi[26]-Ras[V12]-4
AC   CVCL_IY72
SY   Rumi[26]Ras[v12]-4; Rumi-4; Rumi line 4; R-4
DR   DGRC; 198
DR   FlyBase_Cell_line; FBtc0000198
DR   Wikidata; Q54951475
RX   PubMed=19077546;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Characteristics: Contains a null mutant of rumi, which encodes a glycosyltransferase required for Notch signaling in Drosophila.
CC   Doubling time: 28 hours (DGRC=198).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Female
AG   Embryonic stage
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   RV-C2
AC   CVCL_2183
DR   CLO; CLO_0008901
DR   DSMZ; ACC-289
DR   DSMZCellDive; ACC-289
DR   Wikidata; Q54951477
CC   Doubling time: ~32 hours (DSMZ=ACC-289).
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   RV202
AC   CVCL_WM73
SY   RV 202
DR   Wikidata; Q98129220
RX   PubMed=2436934;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48616; Bovine VIM (Note=Also reacts with human, mouse, rat, etc.).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   RVAb-1
AC   CVCL_XX11
DR   CCRID; 4201PAT-CCTCC01038
DR   Wikidata; Q98129221
RX   Patent=CN107287167B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201743.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Rotavirus group A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   RVAb-2
AC   CVCL_XX12
DR   CCRID; 4201PAT-CCTCC01039
DR   Wikidata; Q98129222
RX   Patent=CN107287167B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201744.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Rotavirus group A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   RVH-421
AC   CVCL_1672
SY   RVH 421; RVH421
DR   CLO; CLO_0008902
DR   CLDB; cl4207
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 473
DR   BioSample; SAMN03472885
DR   BioSample; SAMN03473412
DR   BioSample; SAMN10987605
DR   cancercelllines; CVCL_1672
DR   Cell_Model_Passport; SIDM00401
DR   ChEMBL-Cells; CHEMBL3308126
DR   ChEMBL-Targets; CHEMBL1075567
DR   Cosmic; 909706
DR   Cosmic-CLP; 909706
DR   DepMap; ACH-000614
DR   DSMZ; ACC-127
DR   DSMZCellDive; ACC-127
DR   EGA; EGAS00001000978
DR   GDSC; 909706
DR   GEO; GSM887554
DR   GEO; GSM888637
DR   GEO; GSM1670395
DR   IARC_TP53; 21295
DR   LINCS_HMS; 50475
DR   LINCS_LDP; LCL-1255
DR   PharmacoDB; RVH421_1335_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1672
DR   PubChem_Cell_line; CVCL_1672
DR   Wikidata; Q54951478
RX   PubMed=6838761;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~54 hours (PubMed=6838761); ~50-60 hours (DSMZ=ACC-127).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=909706; DepMap=ACH-000614).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln52fs*71 (c.154delC); Zygosity=Heterozygous (Cosmic-CLP=909706; DepMap=ACH-000614).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.31%; Native American=0%; East Asian, North=2.07%; East Asian, South=0%; South Asian=1.58%; European, North=67.75%; European, South=28.29% (PubMed=30894373).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=909706; DSMZ=ACC-127; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11 (PubMed=25877200)
ST   D13S317: 11,13 (Cosmic-CLP=909706; DSMZ=ACC-127)
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 14,16
ST   D21S11: 29,30 (DSMZ=ACC-127)
ST   D21S11: 30 (PubMed=25877200)
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 10,14
ST   D7S820: 7,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   RVH-421 Dab-R
AC   CVCL_A1VM
SY   RVH421_Dab; RVH421 SKIN FV1; RVH421SKINFV1
DR   cancercelllines; CVCL_A1VM
DR   DepMap; ACH-002461
DR   Wikidata; Q105510831
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-002461).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln52fs*71 (c.154delC); Zygosity=Heterozygous (DepMap=ACH-002461).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1672 ! RVH-421
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   RVH-421rPLX4720_10muM
AC   CVCL_RR54
SY   RVH-421rPLX4720(10muM)
DR   cancercelllines; CVCL_RR54
DR   Wikidata; Q54951479
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln52fs*71 (c.154delC); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1672 ! RVH-421
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   RVH-6849
AC   CVCL_W793
SY   RVH6849
DR   Cosmic; 2560235
DR   Wikidata; Q54951481
RX   PubMed=1354400;
RX   PubMed=9649128;
RX   PubMed=11369051;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   RVP
AC   CVCL_C3HV
DR   Wikidata; Q114312934
RX   PubMed=1711532;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pX8 ori-).
CC   Derived from site: In situ; Fetal vas deferens, epithelium; UBERON=UBERON_0004806.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3HU ! REP
SX   Male
AG   18-22FW
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   RVP3
AC   CVCL_L978
DR   CLO; CLO_0008903
DR   CLDB; cl4208
DR   Wikidata; Q54951482
RX   PubMed=194849;
RX   PubMed=212332;
CC   Transformant: NCBI_TaxID; 11888; Rous sarcoma virus (strain Prague C).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   RW-2982
AC   CVCL_D174
SY   RW2982
DR   cancercelllines; CVCL_D174
DR   ColonAtlas; RW2982
DR   Cosmic; 1479600
DR   Cosmic; 1676748
DR   Cosmic; 1803949
DR   Cosmic; 2302004
DR   GEO; GSM1346885
DR   Wikidata; Q54951483
RX   CelloPub=CLPUB00125;
RX   PubMed=2837323;
RX   PubMed=8422623;
RX   PubMed=20570890;
RX   PubMed=24755471;
RX   PubMed=25944804;
CC   Population: Caucasian.
CC   Doubling time: 58.41 hours (PubMed=25944804).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1309Ter (c.3925G>T); ClinVar=VCV000824390; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000045115; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Cys363Tyr (c.1088G>A); ClinVar=VCV000233663; Zygosity=Unspecified (PubMed=24755471).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   RW-2982-NS
AC   CVCL_C3I3
DR   cancercelllines; CVCL_C3I3
DR   Wikidata; Q114312935
RX   PubMed=2837323;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1309Ter (c.3925G>T); ClinVar=VCV000824390; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000045115; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Cys363Tyr (c.1088G>A); ClinVar=VCV000233663; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D174 ! RW-2982
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   RW-5928
AC   CVCL_D176
SY   RW5928
DR   Wikidata; Q54951484
RX   PubMed=8422623;
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   RW-7213
AC   CVCL_D175
SY   RW7213
DR   cancercelllines; CVCL_D175
DR   ColonAtlas; RW7213
DR   Cosmic; 1479570
DR   Cosmic; 1676734
DR   Cosmic; 2302005
DR   GEO; GSM1346886
DR   GEO; GSM1448156
DR   Wikidata; Q54951485
RX   PubMed=2837323;
RX   PubMed=8422623;
RX   PubMed=20570890;
RX   PubMed=24755471;
RX   PubMed=25926053;
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Val1320fs*12 (c.3957_3958insT); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 8,10
ST   D21S11: 30,31
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C7966; Colon mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   RW-972
AC   CVCL_WS77
SY   RW972
DR   Wikidata; Q98129223
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2846143;
RX   PubMed=18937276;
CC   Doubling time: ~24 hours (PubMed=2846143).
CC   Derived from site: In situ; Breast, stroma; UBERON=UBERON_0003584.
DI   NCIt; C4504; Malignant breast phyllodes tumor
DI   ORDO; Orphanet_180261; Phyllodes tumor of the breast
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   RW4
AC   CVCL_6442
SY   RW-4; RW.4
DR   CLO; CLO_0008904
DR   ATCC; SCRC-1018
DR   CCRID; 3101MOUSCSP224
DR   Wikidata; Q54951486
RX   PubMed=8649401;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-488.html
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   RW4-OPG#12
AC   CVCL_N780
DR   Wikidata; Q54951490
RX   Patent=US6087555;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12418.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:109587; Tnfrsf11b.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6442 ! RW4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   RWD3051
AC   CVCL_RT61
DR   Wikidata; Q54951491
RX   PubMed=22328974;
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   RWD5700-1
AC   CVCL_RT62
DR   Wikidata; Q54951492
RX   PubMed=22328974;
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   RWE01
AC   CVCL_VZ72
SY   Rat Wistar Ear 01
DR   IBRC; C10074
DR   Wikidata; Q98129224
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_VZ74 ! RWT01
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RWE02
AC   CVCL_VZ73
SY   Rat Wistar Ear 02
DR   IBRC; C10078
DR   Wikidata; Q98129225
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_VZ75 ! RWT02
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RWLeu-4
AC   CVCL_D591
SY   RWLEU-4; RWLeu 4; RWLeu4; Roger Williams Leukemia-4
DR   BTO; BTO_0005332
DR   ChEMBL-Cells; CHEMBL3307431
DR   ChEMBL-Targets; CHEMBL614885
DR   PubChem_Cell_line; CVCL_D591
DR   Wikidata; Q54951494
RX   CelloPub=CLPUB00106;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1372318;
RX   PubMed=2159372;
RX   PubMed=3332852;
RX   PubMed=7994044;
RX   PubMed=8635507;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Characteristics: Proliferation inhibited by vitamin D3 (PubMed=1372318; PubMed=7994044).
CC   Doubling time: 33 hours (CelloPub=CLPUB00106); 25-26 hours (PubMed=2159372).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 21
//
ID   RWMH09s01
AC   CVCL_C1DT
SY   RWMH 09s01
DR   Wikidata; Q114312936
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/RWMH09s01_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DV ! RWMH15s02
OI   CVCL_C1DW ! RWMH23s01
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RWMH15s01
AC   CVCL_C1DU
SY   RWMH 15s01
DR   Wikidata; Q114312937
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/RWMH15s01_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DV ! RWMH15s02
OI   CVCL_C1DW ! RWMH23s01
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RWMH15s02
AC   CVCL_C1DV
SY   RWMH 15s02
DR   Wikidata; Q114312938
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/RWMH15s02_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DW ! RWMH23s01
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RWMH23s01
AC   CVCL_C1DW
SY   RWMH 23s01
DR   Wikidata; Q114312939
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/RWMH23s01_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*33:03; B*44:03; DRB1*13:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DP ! Ff-MH09s01
OI   CVCL_C1DQ ! Ff-MH15s01
OI   CVCL_C1DR ! Ff-MH15s02
OI   CVCL_C1DS ! Ff-MH23s01
OI   CVCL_C1DT ! RWMH09s01
OI   CVCL_C1DU ! RWMH15s01
OI   CVCL_C1DV ! RWMH15s02
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   RWP-1
AC   CVCL_4373
SY   RWP 1; RWP1; Roger Williams Pancreatic-1
DR   EFO; EFO_0022417
DR   cancercelllines; CVCL_4373
DR   Cosmic; 710870
DR   Cosmic; 948739
DR   GEO; GSM244429
DR   Progenetix; CVCL_4373
DR   Wikidata; Q54951495
RX   PubMed=7083162;
RX   PubMed=8026879;
RX   PubMed=9665481;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12800145;
RX   PubMed=19077451;
RX   PubMed=22585861;
RX   PubMed=27067801;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/RWP-1.html
CC   Doubling time: 45 hours (PubMed=7083162; PubMed=8026879); 23.6 +- 0.54 hours (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8026879; PubMed=11169959; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=11169959; PubMed=11787853).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   RWP-2
AC   CVCL_4374
SY   RWP 2; RWP2; Roger Williams Pancreatic-2
DR   cancercelllines; CVCL_4374
DR   Cosmic; 948730
DR   IARC_TP53; 3384
DR   Wikidata; Q54951496
RX   PubMed=7083162;
RX   PubMed=8026879;
RX   PubMed=9665481;
CC   Doubling time: 46 hours (PubMed=7083162; PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=8026879).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   RWPE-1
AC   CVCL_3791
SY   RWPE1
DR   BTO; BTO_0003709
DR   CLO; CLO_0008905
DR   EFO; EFO_0002323
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3607
DR   ATCC; CRL-11609
DR   BCRJ; 0389
DR   BioSample; SAMN03470832
DR   BioSample; SAMN05292437
DR   BioSample; SAMN07709991
DR   BioSample; SAMN07709992
DR   BioSample; SAMN07709993
DR   BioSample; SAMN07709994
DR   BioSample; SAMN07709995
DR   BioSample; SAMN07709996
DR   BioSample; SAMN07709997
DR   cancercelllines; CVCL_3791
DR   CCRID; 3101HUMGNHu37
DR   CCRID; 3101HUMSCSP5025
DR   CCRID; 4201HUM-CCTCC00178
DR   CCTCC; GDC0178
DR   Cell_Model_Passport; SIDM00020
DR   ChEMBL-Cells; CHEMBL4295468
DR   ChEMBL-Targets; CHEMBL4296492
DR   CLS; 305217
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS124FCL
DR   ENCODE; ENCBS192LWI
DR   ENCODE; ENCBS263AAA
DR   ENCODE; ENCBS875FPF
DR   GEO; GSM827387
DR   GEO; GSM1008595
DR   GEO; GSM1374860
DR   GEO; GSM1670396
DR   IGRhCellID; RWPE1
DR   Lonza; 870
DR   PharmacoDB; RWPE1_1336_2019
DR   Progenetix; CVCL_3791
DR   PubChem_Cell_line; CVCL_3791
DR   Wikidata; Q54951497
RX   Patent=US6255058;
RX   PubMed=8977636;
RX   PubMed=9214605;
RX   PubMed=9214606;
RX   PubMed=20215515;
RX   PubMed=22275356;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30305041;
RX   PubMed=30787054;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/RWPE_Crawford_protocol.pdf
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544576
CC   Group: Patented cell line.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11609.
CC   Population: Caucasian.
CC   Doubling time: ~22 hours (PBCF).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-11609; true.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-3607; CLS=305217; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3814 ! WPMY-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   RWPE-2
AC   CVCL_3792
SY   RWPE2
DR   BTO; BTO_0005994
DR   CLO; CLO_0008906
DR   EFO; EFO_0007610
DR   ATCC; CRL-3608
DR   ATCC; CRL-11610
DR   cancercelllines; CVCL_3792
DR   CCRID; 4201HUM-CCTCC00179
DR   CCTCC; GDC0179
DR   Cell_Model_Passport; SIDM01234
DR   ENCODE; ENCBS796LYI
DR   ENCODE; ENCBS942OEI
DR   GEO; GSM827388
DR   KCB; KCB 2013044YJ
DR   Lonza; 1673
DR   Progenetix; CVCL_3792
DR   Wikidata; Q54951498
RX   Patent=US6255058;
RX   PubMed=9018337;
RX   PubMed=9214605;
RX   PubMed=9214606;
RX   PubMed=12725112;
RX   PubMed=20215515;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11610.
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-11610; true.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-3608
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   RWPE2-W99
AC   CVCL_3793
DR   CLO; CLO_0008907
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2853
DR   cancercelllines; CVCL_3793
DR   Cell_Model_Passport; SIDM01258
DR   GEO; GSM827390
DR   GEO; GSM1670397
DR   PharmacoDB; RWPE2W99_1337_2019
DR   Progenetix; CVCL_3793
DR   Wikidata; Q54951500
RX   PubMed=16351690;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01117; Kirsten murine sarcoma virus k-Ras (v-Ki-ras).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2853
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3792 ! RWPE-2
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   RWT01
AC   CVCL_VZ74
SY   Rat Wistar Tail 01
DR   IBRC; C10076
DR   Wikidata; Q98129226
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_VZ72 ! RWE01
SX   Female
AG   2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RWT02
AC   CVCL_VZ75
SY   Rat Wistar Tail 02
DR   IBRC; C10077
DR   Wikidata; Q98129227
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_VZ73 ! RWE02
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   RWV366T
AC   CVCL_AV57
SY   KIJ366T
DR   ABM; T8250
DR   Wikidata; Q54951501
RX   PubMed=23633458;
CC   Miscellaneous: STR profile from personal communication of Marlow, Laura A.
CC   Misspelling: KIJ3667; Note=Occasionally.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 7,8
ST   D8S1179: 14,15
ST   FGA: 20,25
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   Rx 54-3
AC   CVCL_LG30
SY   RX-54.3
DR   Wikidata; Q54951503
RX   PubMed=7430676;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   Rx-GFP K/I EB5
AC   CVCL_J650
DR   RCB; AES0145
DR   SKIP; SKIP003035
DR   Wikidata; Q54951505
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J648 ! EB5 [Mouse ESC]
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 13
//
ID   RXF 393L
AC   CVCL_1673
SY   RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL
DR   BTO; BTO_0004207
DR   CLO; CLO_0009982
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1673
DR   Cell_Model_Passport; SIDM00086
DR   ChEMBL-Cells; CHEMBL3307734
DR   ChEMBL-Targets; CHEMBL614886
DR   Cosmic; 875872
DR   Cosmic; 905978
DR   Cosmic; 974306
DR   Cosmic; 1175851
DR   Cosmic; 1305376
DR   Cosmic; 1312364
DR   Cosmic; 1998471
DR   Cosmic-CLP; 905978
DR   DepMap; ACH-002195
DR   EGA; EGAS00001000978
DR   GDSC; 905978
DR   GEO; GSM2100
DR   GEO; GSM743484
DR   GEO; GSM750839
DR   GEO; GSM799375
DR   GEO; GSM799438
DR   GEO; GSM844678
DR   GEO; GSM844679
DR   GEO; GSM847111
DR   GEO; GSM1153448
DR   GEO; GSM1178577
DR   GEO; GSM1178578
DR   GEO; GSM1178579
DR   GEO; GSM1181369
DR   GEO; GSM1181370
DR   GEO; GSM1670398
DR   GEO; GSM2124681
DR   IARC_TP53; 18073
DR   LINCS_LDP; LCL-1770
DR   NCI-DTP; RXF 393
DR   PharmacoDB; RXF393_1338_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1673
DR   PubChem_Cell_line; CVCL_1673
DR   SKY/M-FISH/CGH; 2800
DR   Wikidata; Q54951507
RX   PubMed=2041050;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=39
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/rxf393-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 62.9 hours (NCI-DTP=RXF 393).
CC   HLA typing: A*02,24; B*14:01,44; C*05,08:02; DPB1*01:01:01,04:01; DQB1*03:01:01,06:02; DRB1*11:01:01,15:01:01 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095; Cosmic-CLP=905978; DepMap=ACH-002195).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.51%; Native American=0.1%; East Asian, North=0%; East Asian, South=0.68%; South Asian=3.61%; European, North=57.95%; European, South=37.15% (PubMed=30894373).
CC   Misspelling: RXF393-RU; Cosmic=1175851.
ST   Source(s): Cosmic-CLP=905978; PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 28,33.2
ST   D2S1338: 18
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24,27
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 43
//
ID   RXF 486L
AC   CVCL_D126
SY   RXF486L
DR   Wikidata; Q54951508
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   RXF 631L
AC   CVCL_A780
SY   RXF-631L; RXF631L; RXF 631; RXF-631; RXF631
DR   ChEMBL-Cells; CHEMBL3307735
DR   ChEMBL-Targets; CHEMBL614888
DR   Cosmic; 1436044
DR   NCI-DTP; RXF 631
DR   PubChem_Cell_line; CVCL_A780
DR   Wikidata; Q54951509
RX   PubMed=2041050;
RX   PubMed=22336246;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Part of: JFCR39 cancer cell line panel.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   RXF 944L
AC   CVCL_D127
SY   RXF944L; RXF 944; RXF944
DR   ChEMBL-Cells; CHEMBL3307433
DR   ChEMBL-Targets; CHEMBL614889
DR   PubChem_Cell_line; CVCL_D127
DR   Wikidata; Q54951510
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   RXT
AC   CVCL_JC43
SY   RXT796387; TER352; TER-352; Ter 352; TER402; TER-402; Ter 402; TER477; TER-477; Ter 477
DR   Wikidata; Q54951511
RX   PubMed=9162096;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/330cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/368cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   RY
AC   CVCL_U964
DR   BioSample; SAMN03152027
DR   Wikidata; Q54951512
RX   PubMed=265539;
RX   PubMed=7005696;
RX   PubMed=7192801;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=29533902;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NYT; -; https://www.nytimes.com/1981/01/22/us/cells-in-disease-study-said-to-come-from-monkeys.html
CC   Problematic cell line: Misidentified. Originally thought to be a Hodgkin lymphoma cell line but shown not be the case although the origin of this cell line is still not known (PubMed=7192801; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00084.
CC   Anecdotal: Part of a set of 4 cell lines that were fraudulently stated to originate from Hodgkin lymphoma (PubMed=265539).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   RY(ham) Yoshida Sarcoma
AC   CVCL_1D05
DR   CLS; 500415
DR   Wikidata; Q54951516
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   RY-B-E3
AC   CVCL_1Q93
DR   RCB; RCB2727
DR   Wikidata; Q54951514
RX   PubMed=15144798;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60395; Rat endometrial stromal sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1Q92 ! RY-PB
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   RY-PB
AC   CVCL_1Q92
DR   Wikidata; Q54951515
RX   PubMed=15144798;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60395; Rat endometrial stromal sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   RYAS41
AC   CVCL_2A39
SY   Ryas 41
DR   Wikidata; Q54951517
RX   PubMed=19266046;
CC   Characteristics: Secretes insulin in response to glucose stimulation.
CC   Characteristics: Has been transduced with a recombinant lentivirus expressing the SV40 T antigen under the control of the insulin promoter.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryonic pancreas, islets of Langerhans; UBERON=UBERON_0003921+UBERON_0000006.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   13FD
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   RyuF-2
AC   CVCL_UC76
SY   Ryukin Fin-2
DR   Wikidata; Q98129228
RX   PubMed=26290507;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=26290507).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Breed/subspecies: Ryukin; VBO=VBO_0017500.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   RZ 328
AC   CVCL_IX01
DR   Wikidata; Q54951519
RX   PubMed=10783328;
CC   Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1-2Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 8
//
ID   RZJ/IBM
AC   CVCL_E7C0
RX   PubMed=39324137;
WW   Info; NARO; -; https://www.naro.go.jp/english/topics/laboratory/nias/166574.html
CC   From: Institute of Agrobiological Sciences, National Agriculture and Food Research; Tsukuba; Japan.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:93883; Pig TERT.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Macrophage; CL=CL_0000235.
OX   NCBI_TaxID=273791; ! Potamochoerus porcus (Red river hog)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   RzM6
AC   CVCL_D636
DR   cancercelllines; CVCL_D636
DR   Wikidata; Q54951520
RX   PubMed=19861417;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   RzM6-LC
AC   CVCL_D637
DR   BTO; BTO_0005181
DR   cancercelllines; CVCL_D637
DR   Wikidata; Q54951522
RX   PubMed=19861417;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D636 ! RzM6
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   RZPBi001
AC   CVCL_C1LB
DR   Wikidata; Q114312940
RX   DOI=10.21203/rs.3.rs-1582613/v1;
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   S PBiPS1199-Sv4F-2
AC   CVCL_E7TP
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_S+PBiPS1199-Sv4F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_S+PBiPS1199-Sv4F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Molecular Biology Institute of Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 12,14
ST   D19S433: 14,14.2
ST   D21S11: 29,33.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   S PBiPS1580-Sv4F-3
AC   CVCL_E7TQ
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_S+PBiPS+1580-Sv4F-3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_S+PBiPS1580-Sv4F-3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Molecular Biology Institute of Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 30,32.2
ST   D2S1338: 16,24
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   S PBiPS1785-Sv4F-8
AC   CVCL_E7TR
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_plantilla_S+PBiPS1785-Sv4F-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_S+PBiPS1785-Sv4F-8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Molecular Biology Institute of Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 23,24
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   S PBiPS1786-Sv4F-12
AC   CVCL_E7TS
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_S+PBiPS1786_Sv4F-12.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_S+PBiPS1786-Sv4F-12.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Molecular Biology Institute of Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 10,13
ST   D16S539: 11,12
ST   D18S51: 11,14
ST   D19S433: 12.2,13
ST   D21S11: 30,31.2
ST   D2S1338: 18
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   S PBiPS1792-Sv4F-1
AC   CVCL_E7TT
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_S+PBiPS1792-Sv4F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento+de+Dep%C3%B3sito+S+PBiPS1792-Sv4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Molecular Biology Institute of Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 16,22
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 22,23
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 20,25
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   S PBiPS1919-Sv4F-14
AC   CVCL_E7TU
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_S+PBiPS1919-Sv4F-14.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_S+PBiPS1919-Sv4F-14.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Molecular Biology Institute of Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16,18
ST   D19S433: 13
ST   D21S11: 30,33.2
ST   D2S1338: 21,24
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 26
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   S PBiPS654-Sv4F-8
AC   CVCL_E7TN
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_S+PBiPS654-Sv4F-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_S+PBiPS654-Sv4F-8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Molecular Biology Institute of Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 14,15.2
ST   D21S11: 28,30
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   S+L-CAT2
AC   CVCL_3418
DR   CLO; CLO_0008908
DR   CLDB; cl4212
DR   ICLC; ATL96011
DR   Wikidata; Q54951553
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   S-1
AC   CVCL_B374
AS   CVCL_Y130
SY   S 1; S1
DR   CLO; CLO_0050050
DR   BioSample; SAMN03472046
DR   CGH-DB; 9046-4
DR   CGH-DB; 97-1
DR   RCB; RCB1966
DR   TKG; TKG 0244
DR   Wikidata; Q54951523
RX   CelloPub=CLPUB00155;
RX   PubMed=12107105;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB1966; TKG=TKG 0244
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16 (TKG=TKG 0244)
ST   vWA: 16 (RCB=RCB1966)
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   S-10-4
AC   CVCL_XE90
DR   Wikidata; Q98129229
RX   Patent=CN101891814B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200933.
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   S-113-6
AC   CVCL_XE91
DR   Wikidata; Q98129230
RX   Patent=CN101891814B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200932.
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   S-115-8
AC   CVCL_YA17
DR   Wikidata; Q98129231
RX   Patent=CN101070345B;
RX   Patent=CN101210927B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200620.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   S-117
AC   CVCL_1674
AS   CVCL_B271
SY   S117; CLS-117
DR   CLO; CLO_0008911
DR   CLDB; cl4235
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470955
DR   BioSample; SAMN03473335
DR   BioSample; SAMN10988560
DR   cancercelllines; CVCL_1674
DR   Cell_Model_Passport; SIDM00035
DR   ChEMBL-Cells; CHEMBL3308464
DR   ChEMBL-Targets; CHEMBL1075568
DR   CLS; 300329
DR   Cosmic; 910946
DR   Cosmic; 1459656
DR   Cosmic-CLP; 910946
DR   DepMap; ACH-000037
DR   DSMZ; ACC-266
DR   DSMZCellDive; ACC-266
DR   EGA; EGAS00001000978
DR   GDSC; 910946
DR   GEO; GSM887555
DR   GEO; GSM888638
DR   GEO; GSM1670399
DR   IARC_TP53; 27234
DR   LiGeA; CCLE_642
DR   LINCS_LDP; LCL-1777
DR   PharmacoDB; S117_1339_2019
DR   Progenetix; CVCL_1674
DR   PubChem_Cell_line; CVCL_1674
DR   Wikidata; Q54951524
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Virology: Infected with a murine leukemia virus-related virus (PubMed=30629668).
CC   Doubling time: ~37 hours (DSMZ=ACC-266).
CC   HLA typing: A*01:01,01:01; B*37:01,37:01; C*06:02,06:02; DQA1*05:01,05:01; DRB1*11:30,14:76 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu326Ter (c.976G>T); ClinVar=VCV000231815; Zygosity=Homozygous (Cosmic-CLP=910946; DepMap=ACH-000037).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.26%; Native American=0%; East Asian, North=3.68%; East Asian, South=0%; South Asian=0%; European, North=51.13%; European, South=41.93% (PubMed=30894373).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): CLS=300329; Cosmic-CLP=910946; DSMZ=ACC-266; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 11 (CLS=300329; Cosmic-CLP=910946; PubMed=25877200)
ST   D16S539: 11,14 (DSMZ=ACC-266)
ST   D18S51: 11
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 18
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C6041; Thyroid gland sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   S-13-16
AC   CVCL_B5AR
DR   Wikidata; Q110433174
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-13-24
AC   CVCL_B5AS
DR   Wikidata; Q110433175
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-145-9
AC   CVCL_XJ68
DR   CCRID; 4201PAT-CCTCC00235
DR   Wikidata; Q98129232
RX   Patent=CN101580545B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200808.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9Q0U6; Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   S-157-6
AC   CVCL_XJ69
DR   Wikidata; Q98129233
RX   Patent=CN101580545B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200809.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9Q0U6; Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   S-163-6
AC   CVCL_YM10
DR   CCRID; 4201PAT-CCTCC00290
DR   Wikidata; Q98129234
RX   Patent=CN101891815B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200925.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08727; Human KRT19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 6
//
ID   S-17-52
AC   CVCL_B5AT
DR   Wikidata; Q110433176
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-171-9
AC   CVCL_XJ70
DR   CCRID; 4201PAT-CCTCC00237
DR   Wikidata; Q98129235
RX   Patent=CN101591390B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200811.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Q0U8; Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd) nucleoprotein (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   S-18-24
AC   CVCL_B5AU
DR   Wikidata; Q110433177
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-18-325
AC   CVCL_B5AV
DR   Wikidata; Q110433178
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-19-352
AC   CVCL_B5AW
DR   Wikidata; Q110433179
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen found in all cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-19-57
AC   CVCL_B5AX
DR   Wikidata; Q110433181
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-191-5
AC   CVCL_YA18
DR   Wikidata; Q98129236
RX   Patent=CN101070345B;
RX   Patent=CN101210927B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200621.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   S-195-5
AC   CVCL_XF77
DR   Wikidata; Q98129237
RX   Patent=CN101891814B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200934.
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   S-2
AC   CVCL_4719
AS   CVCL_Y131
SY   S 2; S2
DR   CLO; CLO_0050052
DR   BioSample; SAMN03472010
DR   CGH-DB; 88-1
DR   CGH-DB; 9047-4
DR   RCB; RCB2133
DR   TKG; TKG 0245
DR   Wikidata; Q54951525
RX   CelloPub=CLPUB00155;
RX   PubMed=12107105;
RX   PubMed=38639832;
CC   Population: Lao.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2133; TKG=TKG 0245
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 8,11
ST   D5S818: 12
ST   D7S820: 11,13 (RCB=RCB2133)
ST   D7S820: 13 (TKG=TKG 0245)
ST   TH01: 7,9
ST   TPOX: 8 (TKG=TKG 0245)
ST   TPOX: 8,11 (RCB=RCB2133)
ST   vWA: 17,18 (RCB=RCB2133)
ST   vWA: 18 (TKG=TKG 0245)
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 19
//
ID   S-200-23
AC   CVCL_XJ71
DR   CCRID; 4201PAT-CCTCC00238
DR   Wikidata; Q98129238
RX   Patent=CN101591390B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200812.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Q0U8; Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd) nucleoprotein (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   S-29-3
AC   CVCL_XB46
DR   CCRID; 4201PAT-CCTCC00169
DR   Wikidata; Q98129239
RX   Patent=CN100387709C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200516.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Hepatitis B virus E-antigen (HBeAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   S-290-3
AC   CVCL_XJ72
DR   CCRID; 4201PAT-CCTCC00236
DR   Wikidata; Q98129240
RX   Patent=CN101591390B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200810.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q9Q0U8; Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd) nucleoprotein (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   S-294-4
AC   CVCL_XE92
DR   Wikidata; Q98129241
RX   Patent=CN101891814B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200931.
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   S-44-10
AC   CVCL_YA19
DR   Wikidata; Q98129242
RX   Patent=CN101070345B;
RX   Patent=CN101210927B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200622.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
ID   S-496
AC   CVCL_DG18
SY   S496
DR   GEO; GSM114611
DR   Wikidata; Q54951527
RX   PubMed=16966431;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   S-66-5
AC   CVCL_YM11
DR   CCRID; 4201PAT-CCTCC00288
DR   Wikidata; Q98129243
RX   Patent=CN101891815B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200923.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08727; Human KRT19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 6
//
ID   S-71-9
AC   CVCL_YM12
DR   CCRID; 4201PAT-CCTCC00289
DR   Wikidata; Q98129244
RX   Patent=CN101891815B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200924.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08727; Human KRT19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 6
//
ID   S-72-3
AC   CVCL_WI06
DR   CCRID; 4201PAT-CCTCC00170
DR   Wikidata; Q98129245
RX   Patent=CN100387709C;
RX   Patent=CN100398559C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200517.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Hepatitis B virus E-antigen (HBeAg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 7
//
ID   S-7512
AC   CVCL_IW25
DR   Wikidata; Q54951528
RX   PubMed=598646;
RX   PubMed=6998824;
CC   Population: Japanese.
CC   Doubling time: ~57 hours (PubMed=598646).
CC   Derived from site: Metastatic; Perineus, hypodermis; UBERON=UBERON_0002356+UBERON_0002072.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61-62Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   S-77-1
AC   CVCL_XE93
DR   Wikidata; Q98129247
RX   Patent=CN101891814B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200935.
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P10451; Human SPP1/OPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   S-9-11
AC   CVCL_XA77
DR   CCRID; 4201PAT-CCTCC00168
DR   Wikidata; Q98129249
RX   Patent=CN100519583C;
RX   PubMed=18986662;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200515.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P59594; Human SARS coronavirus (SARS-CoV) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 7
//
ID   S-95-7
AC   CVCL_A0PM
DR   CCRID; 4201PAT-CCTCC00344
DR   Wikidata; Q108821253
RX   Patent=CN102241768B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201024.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A5P8NB39; Influenza A virus (strain A/California/7/2009 H1N1) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   S-98-10
AC   CVCL_XJ73
DR   CCRID; 4201PAT-CCTCC00234
DR   Wikidata; Q98129250
RX   Patent=CN101580545B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200807.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9Q0U6; Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd) hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   S-cl-57
AC   CVCL_B5AY
DR   Wikidata; Q110433182
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-cl-69
AC   CVCL_B5B0
DR   Wikidata; Q110433184
RX   PubMed=6555061;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen found in many types of cancer cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   S-GAT mAb
AC   CVCL_C5QJ
DR   ABCD; ABCD_AW948
DR   Wikidata; Q116050188
RX   PubMed=35492441;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_53562; (S)-gatifloxacin (S-GAT).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   S-Lk9d-SLM
AC   CVCL_WX09
SY   S-LK9d(L)-SLM; Spongel-induced Lk9d-Selected Lung Metastasis
DR   Wikidata; Q98129251
RX   PubMed=9914777;
RX   PubMed=11011112;
CC   Characteristics: Metastatic.
CC   Sequence variation: Mutation; RGD; 3908; Tsc2; Simple; p.Val1272fs; Zygosity=Heterozygous; Note=Insertion of a 5 kb retrotransposon (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Eker x Long-Evans; RS=RS_0000385+RS_0000347.
DI   NCIt; C64111; Carcinoma of the rat kidney
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WX07 ! Lk9dL
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   S-PS
AC   CVCL_4920
DR   CLO; CLO_0009124
DR   CLDB; cl4229
DR   Wikidata; Q54951530
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   S-S.1
AC   CVCL_F766
DR   CLO; CLO_0009133
DR   ATCC; TIB-111
DR   Wikidata; Q54951531
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   S-S.3
AC   CVCL_F767
DR   CLO; CLO_0009134
DR   ATCC; TIB-112
DR   Wikidata; Q54951532
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   S-TFE
AC   CVCL_R854
DR   RCB; RCB4699
DR   Wikidata; Q54951529
RX   PubMed=23760492;
CC   Population: Japanese.
CC   Doubling time: 98.2 hours (PubMed=23760492).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13825; ASPSCR1 + HGNC; HGNC:11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3; Note=In frame (PubMed=23760492).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB4699
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   S. F.
AC   CVCL_C8NV
DR   Wikidata; Q123033389
RX   PubMed=1374683;
CC   Doubling time: 40.0 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   S.CET.M8.1.1
AC   CVCL_J281
SY   CET-M8
DR   JCRB; JCRB0011
DR   Wikidata; Q54951533
RX   PubMed=3769092;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_28324; 11-deoxycortisol.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   S/AN
AC   CVCL_8754
SY   AN
DR   IARC_TP53; 23786
DR   Wikidata; Q54951535
RX   PubMed=2253215;
RX   PubMed=2917357;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=2253215).
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   S/BR
AC   CVCL_8755
DR   cancercelllines; CVCL_8755
DR   Wikidata; Q54951536
RX   PubMed=1428233;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=1428233).
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   S/RG
AC   CVCL_8756
SY   RG
DR   cancercelllines; CVCL_8756
DR   IARC_TP53; 203
DR   Wikidata; Q54951537
RX   PubMed=2253215;
RX   PubMed=2917357;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=2253215).
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   S/RG/C2
AC   CVCL_IQ11
DR   cancercelllines; CVCL_IQ11
DR   Wikidata; Q54951539
RX   PubMed=16465285;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (from parent cell line).
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8756 ! S/RG
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   S/RR
AC   CVCL_8757
DR   cancercelllines; CVCL_8757
DR   Wikidata; Q54951550
RX   PubMed=1428233;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=1428233).
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   S/RR/Cl
AC   CVCL_8758
DR   cancercelllines; CVCL_8758
DR   Wikidata; Q54951551
RX   PubMed=1428233;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C5673; Colorectal adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8757 ! S/RR
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   S_M6R1
AC   CVCL_HG09
DR   cancercelllines; CVCL_HG09
DR   CancerTools; 152839
DR   Wikidata; Q54951555
DR   Ximbio; 152839
RX   PubMed=27323823;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_134602; MI-63.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1697 ! SJSA-1
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   S_N40R2
AC   CVCL_HG10
DR   cancercelllines; CVCL_HG10
DR   CancerTools; 152838
DR   ECACC; 17011210
DR   Wikidata; Q54951556
DR   Ximbio; 152838
RX   PubMed=27323823;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 17011210; true.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): ECACC=17011210
ST   Amelogenin: X,Y
ST   CSF1PO: 7.3,10.1
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 15,17
ST   D21S11: 28,33.2
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 2.2,10
ST   Penta E: 11,14
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1697 ! SJSA-1
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 17
//
ID   S003487
AC   CVCL_V831
DR   CLO; CLO_0021344
DR   BioSamples; SAME42345
DR   Coriell; S003487
DR   Wikidata; Q54951558
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003487; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003489
AC   CVCL_V832
DR   CLO; CLO_0021343
DR   BioSamples; SAME42342
DR   Coriell; S003489
DR   Wikidata; Q54951560
RX   PubMed=23697280;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003489; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V888 ! S005192
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   S003610
AC   CVCL_V987
DR   Coriell; S003610
DR   GEO; GSM291941
DR   GEO; GSM291942
DR   GEO; GSM291943
DR   GEO; GSM291944
DR   GEO; GSM945675
DR   GEO; GSM1468860
DR   GEO; GSM1468868
DR   GEO; GSM1468876
DR   GEO; GSM1468884
DR   GEO; GSM1468892
DR   GEO; GSM1468900
DR   Wikidata; Q54951562
RX   PubMed=19043577;
RX   PubMed=22797897;
RX   PubMed=23697280;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S003610; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V833 ! S003611
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   S003611
AC   CVCL_V833
DR   CLO; CLO_0021247
DR   BioSamples; SAME42390
DR   Coriell; S003611
DR   Wikidata; Q54951563
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S003611; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V987 ! S003610
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S003612
AC   CVCL_V834
DR   CLO; CLO_0021251
DR   BioSamples; SAME42391
DR   Coriell; S003612
DR   GEO; GSM291945
DR   GEO; GSM291946
DR   GEO; GSM291947
DR   GEO; GSM291948
DR   Wikidata; Q54951564
RX   PubMed=19043577;
RX   PubMed=23697280;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; S003612; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   S003619
AC   CVCL_V835
DR   CLO; CLO_0021250
DR   BioSamples; SAME42392
DR   Coriell; S003619
DR   Wikidata; Q54951566
RX   PubMed=23697280;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003619; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003621
AC   CVCL_V836
DR   CLO; CLO_0021249
DR   BioSamples; SAME42406
DR   Coriell; S003621
DR   Wikidata; Q54951568
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003621; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003622
AC   CVCL_V837
DR   CLO; CLO_0021248
DR   ArrayExpress; E-MTAB-1511
DR   BioSamples; SAME42408
DR   Coriell; S003622
DR   GEO; GSM291949
DR   GEO; GSM291950
DR   GEO; GSM291951
DR   GEO; GSM291952
DR   Wikidata; Q54951569
RX   PubMed=19043577;
RX   PubMed=24380390;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; YY1.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; S003622; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   S003623
AC   CVCL_V838
DR   CLO; CLO_0021258
DR   BioSamples; SAME42407
DR   Coriell; S003623
DR   GEO; GSM291953
DR   GEO; GSM291954
DR   GEO; GSM291955
DR   GEO; GSM291956
DR   Wikidata; Q54951570
RX   PubMed=19043577;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003623; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V839 ! S003624
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   S003624
AC   CVCL_V839
DR   CLO; CLO_0021256
DR   BioSamples; SAME42409
DR   Coriell; S003624
DR   Wikidata; Q54951572
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S003624; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V838 ! S003623
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S003626
AC   CVCL_V840
DR   CLO; CLO_0021254
DR   BioSamples; SAME42410
DR   Coriell; S003626
DR   Wikidata; Q54951573
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S003626; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S003628
AC   CVCL_V988
DR   Coriell; S003628
DR   Wikidata; Q54951574
RX   PubMed=23697280;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S003628; probable.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   S003629
AC   CVCL_V841
DR   CLO; CLO_0021253
DR   BioSamples; SAME42411
DR   Coriell; S003629
DR   Wikidata; Q54951575
RX   PubMed=23697280;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003629; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V842 ! S003630
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   S003630
AC   CVCL_V842
DR   CLO; CLO_0021260
DR   BioSamples; SAME42433
DR   Coriell; S003630
DR   Wikidata; Q54951577
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S003630; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V841 ! S003629
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S003639
AC   CVCL_V843
DR   CLO; CLO_0021279
DR   BioSamples; SAME42432
DR   Coriell; S003639
DR   Wikidata; Q54951579
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003639; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003641
AC   CVCL_V844
DR   CLO; CLO_0021278
DR   BioSamples; SAME42458
DR   Coriell; S003641
DR   GEO; GSM945679
DR   GEO; GSM1468861
DR   GEO; GSM1468869
DR   GEO; GSM1468877
DR   GEO; GSM1468885
DR   GEO; GSM1468893
DR   GEO; GSM1468901
DR   Wikidata; Q54951583
RX   PubMed=21321133;
RX   PubMed=22797897;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S003641; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V845 ! S003642
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S003642
AC   CVCL_V845
DR   CLO; CLO_0021281
DR   BioSamples; SAME42457
DR   Coriell; S003642
DR   Wikidata; Q54951584
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S003642; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V844 ! S003641
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003646
AC   CVCL_V846
DR   CLO; CLO_0021280
DR   BioSamples; SAME42460
DR   Coriell; S003646
DR   Wikidata; Q54951585
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003646; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V847 ! S003647
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003647
AC   CVCL_V847
SY   C3647_FB
DR   CLO; CLO_0021283
DR   BioSamples; SAME42459
DR   Coriell; S003647
DR   GEO; GSM1495407
DR   GEO; GSM1502709
DR   Wikidata; Q54951587
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S003647; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V846 ! S003646
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S003648
AC   CVCL_V848
DR   CLO; CLO_0021282
DR   BioSamples; SAME42455
DR   Coriell; S003648
DR   Wikidata; Q54951588
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003648; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V849 ! S003649
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003649
AC   CVCL_V849
SY   C3649_FB
DR   CLO; CLO_0021286
DR   BioSamples; SAME42454
DR   Coriell; S003649
DR   GEO; GSM1495408
DR   GEO; GSM1502710
DR   Wikidata; Q54951589
RX   PubMed=22720000;
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S003649; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V848 ! S003648
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S003650
AC   CVCL_V850
DR   CLO; CLO_0021284
DR   BioSamples; SAME42332
DR   Coriell; S003650
DR   Wikidata; Q54951590
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003650; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V851 ! S003651
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003651
AC   CVCL_V851
SY   C3651_FB
DR   CLO; CLO_0021289
DR   BioSamples; SAME42333
DR   Coriell; S003651
DR   GEO; GSM1495409
DR   GEO; GSM1502711
DR   Wikidata; Q54951593
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S003651; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V850 ! S003650
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S003654
AC   CVCL_V852
DR   CLO; CLO_0021288
DR   BioSamples; SAME42334
DR   Coriell; S003654
DR   Wikidata; Q54951594
RX   PubMed=23697280;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003654; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
ID   S003656
AC   CVCL_V853
DR   CLO; CLO_0021412
DR   BioSamples; SAME42335
DR   Coriell; S003656
DR   Wikidata; Q54951595
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003656; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S003657
AC   CVCL_V854
DR   CLO; CLO_0021410
DR   BioSamples; SAME42336
DR   Coriell; S003657
DR   Wikidata; Q54951596
RX   PubMed=23697280;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003657; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 13
//
ID   S003659
AC   CVCL_V855
DR   CLO; CLO_0021411
DR   BioSamples; SAME42330
DR   Coriell; S003659
DR   GEO; GSM945677
DR   GEO; GSM1204868
DR   GEO; GSM1468862
DR   GEO; GSM1468870
DR   GEO; GSM1468878
DR   GEO; GSM1468886
DR   GEO; GSM1468894
DR   GEO; GSM1468902
DR   PRIDE; PXD000419
DR   Wikidata; Q54951598
RX   PubMed=22797897;
RX   PubMed=24136357;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S003659; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   S003660
AC   CVCL_V856
DR   CLO; CLO_0021408
DR   BioSamples; SAME42375
DR   Coriell; S003660
DR   Wikidata; Q54951599
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S003660; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S004920
AC   CVCL_V857
DR   CLO; CLO_0021409
DR   BioSamples; SAME42353
DR   Coriell; S004920
DR   Wikidata; Q54951602
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S004920; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   S004921
AC   CVCL_2Y30
DR   CLO; CLO_0021406
DR   BioSamples; SAME42352
DR   Coriell; S004921
DR   Wikidata; Q54951604
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S004921; probable.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 7
//
ID   S004923
AC   CVCL_V858
DR   CLO; CLO_0021407
DR   BioSamples; SAME42350
DR   Coriell; S004923
DR   Wikidata; Q54951605
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004923; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004924
AC   CVCL_V859
DR   CLO; CLO_0021403
DR   BioSamples; SAME42349
DR   Coriell; S004924
DR   Wikidata; Q54951607
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S004924; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V860 ! S004925
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   S004925
AC   CVCL_V860
DR   CLO; CLO_0021404
DR   BioSamples; SAME42348
DR   Coriell; S004925
DR   Wikidata; Q54951608
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004925; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V859 ! S004924
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004933
AC   CVCL_V861
DR   CLO; CLO_0021399
DR   BioSamples; SAME42364
DR   Coriell; S004933
DR   Wikidata; Q54951610
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S004933; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V862 ! S004934
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   S004934
AC   CVCL_V862
DR   CLO; CLO_0021438
DR   BioSamples; SAME42359
DR   Coriell; S004934
DR   Wikidata; Q54951612
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004934; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V861 ! S004933
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004954
AC   CVCL_V863
DR   CLO; CLO_0021439
DR   BioSamples; SAME42426
DR   Coriell; S004954
DR   Wikidata; Q54951627
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004954; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V864 ! S004955
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S004955
AC   CVCL_V864
SY   C4955_FB
DR   CLO; CLO_0021440
DR   BioSamples; SAME42427
DR   Coriell; S004955
DR   GEO; GSM1495410
DR   GEO; GSM1502712
DR   Wikidata; Q54951629
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S004955; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V863 ! S004954
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S004960
AC   CVCL_V865
DR   CLO; CLO_0021441
DR   BioSamples; SAME42405
DR   Coriell; S004960
DR   Wikidata; Q54951630
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004960; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004968
AC   CVCL_V866
DR   CLO; CLO_0021434
DR   BioSamples; SAME42403
DR   Coriell; S004968
DR   Wikidata; Q54951631
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004968; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004971
AC   CVCL_V867
DR   CLO; CLO_0021435
DR   BioSamples; SAME42430
DR   Coriell; S004971
DR   Wikidata; Q54951632
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004971; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004973
AC   CVCL_V868
DR   CLO; CLO_0021436
DR   BioSamples; SAME42431
DR   Coriell; S004973
DR   GEO; GSM945676
DR   GEO; GSM1204867
DR   GEO; GSM1468863
DR   GEO; GSM1468871
DR   GEO; GSM1468879
DR   GEO; GSM1468887
DR   GEO; GSM1468895
DR   GEO; GSM1468903
DR   PRIDE; PXD000419
DR   Wikidata; Q54951634
RX   PubMed=22797897;
RX   PubMed=24136357;
RX   PubMed=25468404;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S004973; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 15
//
ID   S004978
AC   CVCL_V869
DR   CLO; CLO_0021437
DR   BioSamples; SAME42428
DR   Coriell; S004978
DR   Wikidata; Q54951635
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004978; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V870 ! S004979
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004979
AC   CVCL_V870
DR   CLO; CLO_0021429
DR   BioSamples; SAME42429
DR   Coriell; S004979
DR   Wikidata; Q54951637
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S004979; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V869 ! S004978
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   S004988
AC   CVCL_V871
DR   CLO; CLO_0021432
DR   BioSamples; SAME42372
DR   Coriell; S004988
DR   Wikidata; Q54951638
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004988; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S004990
AC   CVCL_V872
DR   CLO; CLO_0019988
DR   BioSamples; SAME42379
DR   Coriell; S004990
DR   Wikidata; Q54951640
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S004990; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S005028
AC   CVCL_V873
DR   CLO; CLO_0019987
DR   BioSamples; SAME42400
DR   Coriell; S005028
DR   Wikidata; Q54951641
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005028; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S005030
AC   CVCL_V874
DR   CLO; CLO_0019984
DR   BioSamples; SAME42414
DR   Coriell; S005030
DR   Wikidata; Q54951642
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005030; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S005032
AC   CVCL_V875
DR   CLO; CLO_0019983
DR   BioSamples; SAME42413
DR   Coriell; S005032
DR   Wikidata; Q54951643
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005032; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S005034
AC   CVCL_V876
DR   CLO; CLO_0019986
DR   BioSamples; SAME42418
DR   Coriell; S005034
DR   Wikidata; Q54951645
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005034; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S005041
AC   CVCL_V877
DR   CLO; CLO_0019985
DR   BioSamples; SAME42444
DR   Coriell; S005041
DR   Wikidata; Q54951646
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005041; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005043
AC   CVCL_V878
DR   CLO; CLO_0019980
DR   BioSamples; SAME42443
DR   Coriell; S005043
DR   Wikidata; Q54951647
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005043; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005045
AC   CVCL_V879
DR   CLO; CLO_0019982
DR   BioSamples; SAME42442
DR   Coriell; S005045
DR   Wikidata; Q54951649
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005045; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S005049
AC   CVCL_V880
DR   CLO; CLO_0019978
DR   BioSamples; SAME42448
DR   Coriell; S005049
DR   Wikidata; Q54951650
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005049; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005051
AC   CVCL_V881
DR   CLO; CLO_0019979
DR   BioSamples; SAME42467
DR   Coriell; S005051
DR   Wikidata; Q54951651
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005051; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005052
AC   CVCL_V882
DR   CLO; CLO_0019973
DR   BioSamples; SAME42468
DR   Coriell; S005052
DR   Wikidata; Q54951652
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005052; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005058
AC   CVCL_V883
DR   CLO; CLO_0019972
DR   BioSamples; SAME42472
DR   Coriell; S005058
DR   Wikidata; Q54951654
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005058; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005060
AC   CVCL_V884
DR   CLO; CLO_0019971
DR   BioSamples; SAME42340
DR   Coriell; S005060
DR   Wikidata; Q54951655
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005060; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005062
AC   CVCL_V885
DR   CLO; CLO_0019970
DR   BioSamples; SAME42341
DR   Coriell; S005062
DR   Wikidata; Q54951656
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005062; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005082
AC   CVCL_V886
DR   CLO; CLO_0019969
DR   BioSamples; SAME42369
DR   Coriell; S005082
DR   Wikidata; Q54951657
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005082; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005083
AC   CVCL_V887
DR   CLO; CLO_0019968
DR   BioSamples; SAME42368
DR   Coriell; S005083
DR   Wikidata; Q54951659
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005083; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005192
AC   CVCL_V888
DR   CLO; CLO_0019967
DR   BioSamples; SAME42461
DR   Coriell; S005192
DR   Wikidata; Q54951660
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005192; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V832 ! S003489
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005200
AC   CVCL_V889
DR   CLO; CLO_0019891
DR   BioSamples; SAME42436
DR   Coriell; S005200
DR   Wikidata; Q54951661
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005200; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005201
AC   CVCL_V890
DR   CLO; CLO_0019890
DR   BioSamples; SAME42435
DR   Coriell; S005201
DR   Wikidata; Q54951662
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005201; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005202
AC   CVCL_V891
DR   CLO; CLO_0019895
DR   BioSamples; SAME42438
DR   Coriell; S005202
DR   Wikidata; Q54951663
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005202; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005203
AC   CVCL_V892
DR   CLO; CLO_0019880
DR   BioSamples; SAME42437
DR   Coriell; S005203
DR   Wikidata; Q54951665
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005203; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005214
AC   CVCL_V893
DR   CLO; CLO_0019881
DR   BioSamples; SAME42371
DR   Coriell; S005214
DR   Wikidata; Q54951666
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005214; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005216
AC   CVCL_V894
DR   CLO; CLO_0019882
DR   BioSamples; SAME42453
DR   Coriell; S005216
DR   Wikidata; Q54951668
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005216; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005224
AC   CVCL_V895
DR   CLO; CLO_0019883
DR   BioSamples; SAME42399
DR   Coriell; S005224
DR   Wikidata; Q54951670
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005224; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005226
AC   CVCL_2Y31
DR   CLO; CLO_0019885
DR   BioSamples; SAME42397
DR   Coriell; S005226
DR   Wikidata; Q54951672
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005226; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   S005228
AC   CVCL_V896
DR   CLO; CLO_0019886
DR   BioSamples; SAME42396
DR   Coriell; S005228
DR   Wikidata; Q54951673
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005228; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005231
AC   CVCL_V897
DR   CLO; CLO_0019887
DR   BioSamples; SAME42421
DR   Coriell; S005231
DR   Wikidata; Q54951674
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005231; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005233
AC   CVCL_V898
DR   CLO; CLO_0019888
DR   BioSamples; SAME42422
DR   Coriell; S005233
DR   Wikidata; Q54951675
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005233; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005235
AC   CVCL_V899
DR   CLO; CLO_0019873
DR   BioSamples; SAME42419
DR   Coriell; S005235
DR   Wikidata; Q54951678
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005235; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005237
AC   CVCL_V900
DR   CLO; CLO_0019871
DR   BioSamples; SAME42420
DR   Coriell; S005237
DR   Wikidata; Q54951679
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005237; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005239
AC   CVCL_V901
DR   CLO; CLO_0019859
DR   BioSamples; SAME42417
DR   Coriell; S005239
DR   Wikidata; Q54951680
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005239; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005241
AC   CVCL_V902
DR   CLO; CLO_0019862
DR   BioSamples; SAME42370
DR   Coriell; S005241
DR   Wikidata; Q54951691
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005241; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005293
AC   CVCL_V903
DR   CLO; CLO_0019863
DR   BioSamples; SAME42473
DR   Coriell; S005293
DR   Wikidata; Q54951692
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005293; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005295
AC   CVCL_V904
DR   CLO; CLO_0019860
DR   BioSamples; SAME42471
DR   Coriell; S005295
DR   Wikidata; Q54951693
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005295; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   57Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005297
AC   CVCL_V905
DR   CLO; CLO_0019861
DR   BioSamples; SAME42470
DR   Coriell; S005297
DR   Wikidata; Q54951694
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005297; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005299
AC   CVCL_V906
DR   CLO; CLO_0019866
DR   BioSamples; SAME42469
DR   Coriell; S005299
DR   Wikidata; Q54951695
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005299; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005301
AC   CVCL_V907
DR   CLO; CLO_0019867
DR   BioSamples; SAME42389
DR   Coriell; S005301
DR   Wikidata; Q54951697
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005301; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005416
AC   CVCL_V908
DR   CLO; CLO_0019864
DR   BioSamples; SAME42446
DR   Coriell; S005416
DR   Wikidata; Q54951698
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005416; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005417
AC   CVCL_V909
DR   CLO; CLO_0019865
DR   BioSamples; SAME42447
DR   Coriell; S005417
DR   Wikidata; Q54951699
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005417; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005424
AC   CVCL_V910
DR   CLO; CLO_0019941
DR   BioSamples; SAME42434
DR   Coriell; S005424
DR   Wikidata; Q54951700
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005424; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005435
AC   CVCL_V911
DR   CLO; CLO_0019923
DR   BioSamples; SAME42338
DR   Coriell; S005435
DR   Wikidata; Q54951701
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005435; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005436
AC   CVCL_V912
DR   CLO; CLO_0019924
DR   BioSamples; SAME42337
DR   Coriell; S005436
DR   Wikidata; Q54951702
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005436; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005438
AC   CVCL_V913
DR   CLO; CLO_0019929
DR   BioSamples; SAME42339
DR   Coriell; S005438
DR   Wikidata; Q54951703
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005438; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005440
AC   CVCL_V914
DR   CLO; CLO_0019930
DR   BioSamples; SAME42357
DR   Coriell; S005440
DR   Wikidata; Q54951704
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005440; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005549
AC   CVCL_V915
DR   CLO; CLO_0019933
DR   BioSamples; SAME42463
DR   Coriell; S005549
DR   Wikidata; Q54951705
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005549; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005551
AC   CVCL_V916
DR   CLO; CLO_0019935
DR   BioSamples; SAME42439
DR   Coriell; S005551
DR   Wikidata; Q54951706
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005551; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005579
AC   CVCL_V917
DR   CLO; CLO_0019925
DR   BioSamples; SAME42398
DR   Coriell; S005579
DR   Wikidata; Q54951707
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005579; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005581
AC   CVCL_V918
DR   CLO; CLO_0019926
DR   BioSamples; SAME42388
DR   Coriell; S005581
DR   Wikidata; Q54951709
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005581; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005583
AC   CVCL_V919
DR   CLO; CLO_0019927
DR   BioSamples; SAME42387
DR   Coriell; S005583
DR   Wikidata; Q54951710
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005583; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005794
AC   CVCL_V920
DR   CLO; CLO_0019928
DR   BioSamples; SAME42382
DR   Coriell; S005794
DR   Wikidata; Q54951712
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005794; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005795
AC   CVCL_V921
DR   CLO; CLO_0019904
DR   BioSamples; SAME42381
DR   Coriell; S005795
DR   Wikidata; Q54951713
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S005795; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V922 ! S005796
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S005796
AC   CVCL_V922
DR   CLO; CLO_0019902
DR   BioSamples; SAME42380
DR   Coriell; S005796
DR   Wikidata; Q54951714
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005796; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V921 ! S005795
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005801
AC   CVCL_V923
DR   CLO; CLO_0019903
DR   BioSamples; SAME42393
DR   Coriell; S005801
DR   Wikidata; Q54951715
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005801; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005802
AC   CVCL_V924
DR   CLO; CLO_0019912
DR   BioSamples; SAME42456
DR   Coriell; S005802
DR   Wikidata; Q54951716
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005802; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005803
AC   CVCL_V925
DR   CLO; CLO_0019913
DR   BioSamples; SAME42440
DR   Coriell; S005803
DR   Wikidata; Q54951717
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005803; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005804
AC   CVCL_V926
DR   CLO; CLO_0019909
DR   BioSamples; SAME42445
DR   Coriell; S005804
DR   Wikidata; Q54951718
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005804; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005807
AC   CVCL_V927
DR   CLO; CLO_0019910
DR   BioSamples; SAME42464
DR   Coriell; S005807
DR   Wikidata; Q54951719
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005807; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005808
AC   CVCL_2Y32
DR   CLO; CLO_0019906
DR   BioSamples; SAME42331
DR   Coriell; S005808
DR   Wikidata; Q54951720
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005808; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 10
//
ID   S005823
AC   CVCL_V928
DR   CLO; CLO_0019907
DR   BioSamples; SAME42347
DR   Coriell; S005823
DR   Wikidata; Q54951721
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005823; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005824
AC   CVCL_V929
DR   CLO; CLO_0019905
DR   BioSamples; SAME42344
DR   Coriell; S005824
DR   Wikidata; Q54951723
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005824; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005825
AC   CVCL_V930
DR   CLO; CLO_0020178
DR   BioSamples; SAME42343
DR   Coriell; S005825
DR   Wikidata; Q54951724
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005825; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S005837
AC   CVCL_V931
DR   CLO; CLO_0020177
DR   BioSamples; SAME42358
DR   Coriell; S005837
DR   Wikidata; Q54951725
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S005837; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S006003
AC   CVCL_V932
DR   CLO; CLO_0020176
DR   BioSamples; SAME42356
DR   Coriell; S006003
DR   Wikidata; Q54951726
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S006003; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S006006
AC   CVCL_V933
SY   Clint
DR   CLO; CLO_0020175
DR   BioSamples; SAME42383
DR   Coriell; S006006
DR   GEO; GSM291957
DR   GEO; GSM291958
DR   GEO; GSM291959
DR   Wikidata; Q54951728
RX   PubMed=19043577;
RX   PubMed=28360230;
WW   Info; New Scientist; -; https://www.newscientist.com/article/dn6843
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from Clint, the 'reference' genome chimpanzee.
CC   Discontinued: Coriell; S006006; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V934 ! S006007
OI   CVCL_V938 ! S008395
OI   CVCL_V940 ! S008397
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   S006007
AC   CVCL_V934
DR   CLO; CLO_0020174
DR   BioSamples; SAME42384
DR   Coriell; S006007
DR   Wikidata; Q54951729
RX   PubMed=22720000;
WW   Info; New Scientist; -; https://www.newscientist.com/article/dn6843
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Donor information: Established from Clint, the 'reference' genome chimpanzee.
CC   Discontinued: Coriell; S006007; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V933 ! S006006
OI   CVCL_V938 ! S008395
OI   CVCL_V940 ! S008397
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S006008
AC   CVCL_V935
DR   CLO; CLO_0020172
DR   BioSamples; SAME42378
DR   Coriell; S006008
DR   Wikidata; Q54951730
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S006008; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S006AA
AC   CVCL_4766
DR   Wikidata; Q38515095
RX   PubMed=15162380;
CC   Problematic cell line: Possibly misidentified. Was reported to originate from the same patient as E006AA (Cellosaurus=CVCL_4834) which has been shown to be a 786-O derivative (Cellosaurus=CVCL_1051). But as this cell line is non-tumorigenic it could well originate from the prostate carcinoma patient.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   S007602
AC   CVCL_V936
DR   CLO; CLO_0020171
DR   BioSamples; SAME42395
DR   Coriell; S007602
DR   Wikidata; Q54951731
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S007602; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V937 ! S007603
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S007603
AC   CVCL_V937
DR   CLO; CLO_0020170
DR   BioSamples; SAME42394
DR   Coriell; S007603
DR   Wikidata; Q54951733
RX   PubMed=22720000;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S007603; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V936 ! S007602
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008395
AC   CVCL_V938
DR   CLO; CLO_0020169
DR   BioSamples; SAME42423
DR   Coriell; S008395
DR   Wikidata; Q54951734
WW   Info; New Scientist; -; https://www.newscientist.com/article/dn6843
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Donor information: Established from Clint, the 'reference' genome chimpanzee.
CC   Discontinued: Coriell; S008395; probable.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V933 ! S006006
OI   CVCL_V934 ! S006007
OI   CVCL_V940 ! S008397
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S008396
AC   CVCL_V939
DR   CLO; CLO_0020168
DR   BioSamples; SAME42424
DR   Coriell; S008396
DR   Wikidata; Q54951735
RX   PubMed=24092797;
WW   Info; New Scientist; -; https://www.newscientist.com/article/dn6843
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Donor information: Established from Clint, the 'reference' genome chimpanzee.
CC   Discontinued: Coriell; S008396; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
HI   CVCL_V934 ! S006007
SX   Male
AG   22Y
CA   Somatic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S008397
AC   CVCL_V940
DR   CLO; CLO_0020198
DR   BioSamples; SAME42425
DR   Coriell; S008397
DR   Wikidata; Q54951737
WW   Info; New Scientist; -; https://www.newscientist.com/article/dn6843
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Donor information: Established from Clint, the 'reference' genome chimpanzee.
CC   Discontinued: Coriell; S008397; probable.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V933 ! S006006
OI   CVCL_V934 ! S006007
OI   CVCL_V938 ! S008395
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S008829
AC   CVCL_V941
DR   CLO; CLO_0020195
DR   BioSamples; SAME42385
DR   Coriell; S008829
DR   Wikidata; Q54951749
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008829; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008842
AC   CVCL_V942
DR   CLO; CLO_0020194
DR   BioSamples; SAME42346
DR   Coriell; S008842
DR   Wikidata; Q54951750
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008842; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008843
AC   CVCL_V943
DR   CLO; CLO_0020197
DR   BioSamples; SAME42415
DR   Coriell; S008843
DR   Wikidata; Q54951751
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008843; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008844
AC   CVCL_V944
DR   CLO; CLO_0020196
DR   BioSamples; SAME42416
DR   Coriell; S008844
DR   Wikidata; Q54951752
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008844; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   S008860
AC   CVCL_V945
DR   CLO; CLO_0020191
DR   BioSamples; SAME42465
DR   Coriell; S008860
DR   Wikidata; Q54951753
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008860; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V946 ! S008861
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008861
AC   CVCL_V946
SY   C8861_FB
DR   CLO; CLO_0020190
DR   BioSamples; SAME42466
DR   Coriell; S008861
DR   GEO; GSM1495411
DR   GEO; GSM1502713
DR   Wikidata; Q54951754
RX   PubMed=26102527;
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: Coriell; S008861; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V945 ! S008860
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   S008868
AC   CVCL_V947
DR   CLO; CLO_0020193
DR   BioSamples; SAME42462
DR   Coriell; S008868
DR   Wikidata; Q54951755
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008868; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V948 ! S008869
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008869
AC   CVCL_V948
DR   CLO; CLO_0020192
DR   BioSamples; SAME42386
DR   Coriell; S008869
DR   Wikidata; Q54951756
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008869; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V947 ! S008868
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008882
AC   CVCL_V949
DR   CLO; CLO_0020189
DR   BioSamples; SAME42363
DR   Coriell; S008882
DR   Wikidata; Q54951757
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008882; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V950 ! S008883
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008883
AC   CVCL_V950
DR   CLO; CLO_0020224
DR   BioSamples; SAME42377
DR   Coriell; S008883
DR   Wikidata; Q54951759
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008883; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V949 ! S008882
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008885
AC   CVCL_V951
DR   CLO; CLO_0020223
DR   BioSamples; SAME42360
DR   Coriell; S008885
DR   Wikidata; Q54951760
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008885; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V952 ! S008886
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008886
AC   CVCL_V952
DR   CLO; CLO_0020228
DR   BioSamples; SAME42361
DR   Coriell; S008886
DR   Wikidata; Q54951761
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008886; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V951 ! S008885
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008887
AC   CVCL_V953
DR   CLO; CLO_0020227
DR   BioSamples; SAME42362
DR   Coriell; S008887
DR   Wikidata; Q54951762
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008887; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008888
AC   CVCL_V954
DR   CLO; CLO_0020226
DR   BioSamples; SAME42366
DR   Coriell; S008888
DR   Wikidata; Q54951763
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008888; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   S008889
AC   CVCL_V955
DR   CLO; CLO_0020225
DR   BioSamples; SAME42367
DR   Coriell; S008889
DR   Wikidata; Q54951765
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008889; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V956 ! S008890
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008890
AC   CVCL_V956
DR   CLO; CLO_0020221
DR   BioSamples; SAME42412
DR   Coriell; S008890
DR   Wikidata; Q54951766
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008890; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V955 ! S008889
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008891
AC   CVCL_V957
DR   CLO; CLO_0020220
DR   BioSamples; SAME42474
DR   Coriell; S008891
DR   Wikidata; Q54951767
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008891; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V958 ! S008892
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008892
AC   CVCL_V958
DR   CLO; CLO_0020218
DR   BioSamples; SAME42351
DR   Coriell; S008892
DR   Wikidata; Q54951768
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008892; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V957 ! S008891
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008893
AC   CVCL_V959
DR   CLO; CLO_0020216
DR   BioSamples; SAME42404
DR   Coriell; S008893
DR   Wikidata; Q54951769
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008893; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V960 ! S008894
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008894
AC   CVCL_V960
DR   CLO; CLO_0020252
DR   BioSamples; SAME42441
DR   Coriell; S008894
DR   Wikidata; Q54951770
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008894; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V959 ! S008893
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008895
AC   CVCL_V961
DR   CLO; CLO_0020254
DR   BioSamples; SAME42402
DR   Coriell; S008895
DR   Wikidata; Q54951771
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008895; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008919
AC   CVCL_V962
DR   CLO; CLO_0020253
DR   BioSamples; SAME42401
DR   Coriell; S008919
DR   Wikidata; Q54951773
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008919; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008920
AC   CVCL_V963
DR   CLO; CLO_0020256
DR   BioSamples; SAME42365
DR   Coriell; S008920
DR   Wikidata; Q54951774
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008920; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008933
AC   CVCL_V964
DR   CLO; CLO_0020255
DR   BioSamples; SAME42376
DR   Coriell; S008933
DR   Wikidata; Q54951775
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008933; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008938
AC   CVCL_V965
DR   CLO; CLO_0020258
DR   BioSamples; SAME42373
DR   Coriell; S008938
DR   Wikidata; Q54951776
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008938; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V966 ! S008939
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008939
AC   CVCL_V966
DR   CLO; CLO_0020257
DR   BioSamples; SAME42374
DR   Coriell; S008939
DR   Wikidata; Q54951778
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008939; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V965 ! S008938
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008956
AC   CVCL_V967
DR   CLO; CLO_0020250
DR   BioSamples; SAME42354
DR   Coriell; S008956
DR   Wikidata; Q54951779
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008956; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008973
AC   CVCL_V968
DR   CLO; CLO_0020247
DR   BioSamples; SAME42452
DR   Coriell; S008973
DR   Wikidata; Q54951780
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008973; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008974
AC   CVCL_V969
DR   CLO; CLO_0020251
DR   BioSamples; SAME42449
DR   Coriell; S008974
DR   Wikidata; Q54951781
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008974; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S008975
AC   CVCL_V970
DR   CLO; CLO_0013434
DR   BioSamples; SAME42450
DR   Coriell; S008975
DR   Wikidata; Q54951782
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S008975; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V971 ! S008976
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   S008976
AC   CVCL_V971
DR   CLO; CLO_0013433
DR   BioSamples; SAME42451
DR   Coriell; S008976
DR   Wikidata; Q54951783
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; S008976; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
OI   CVCL_V970 ! S008975
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   S011081
AC   CVCL_V972
DR   CLO; CLO_0013436
DR   BioSamples; SAME42355
DR   Coriell; S011081
DR   Wikidata; Q54951784
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S011081; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   S033665
AC   CVCL_HJ48
DR   Coriell; S033665
DR   Wikidata; Q54951785
CC   Group: Non-human primate cell line.
CC   Part of: Yerkes National Primate Research Center cell line collection.
CC   Discontinued: Coriell; S033665; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 7
//
ID   S08
AC   CVCL_IL01
DR   Wikidata; Q54951786
RX   PubMed=27789412;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150596; Hepatic steatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   S1
AC   CVCL_0H88
DR   cancercelllines; CVCL_0H88
DR   ChEMBL-Cells; CHEMBL4630771
DR   ChEMBL-Targets; CHEMBL4630779
DR   PubChem_Cell_line; CVCL_0H88
DR   Wikidata; Q54951787
RX   PubMed=7865904;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   S1-1D7
AC   CVCL_A7YB
DR   BEI_Resources; MRA-475
DR   Wikidata; Q107116809
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=42 kDa fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   S1-1G3
AC   CVCL_A7YC
DR   BEI_Resources; MRA-477
DR   Wikidata; Q107116810
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=42 kDa fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   S1-3D6
AC   CVCL_A7YD
DR   BEI_Resources; MRA-476
DR   Wikidata; Q107116811
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=19 kDa fragment. Also reacts with isolate 3D7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   S1-4A4
AC   CVCL_A7YE
DR   BEI_Resources; MRA-474
DR   Wikidata; Q107116812
CC   Group: Malaria research cell line.
CC   From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=42 kDa fragment).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   S1-B1-20
AC   CVCL_0H85
SY   S1B1-20; S1B20
DR   cancercelllines; CVCL_0H85
DR   ChEMBL-Cells; CHEMBL3307291
DR   ChEMBL-Targets; CHEMBL614053
DR   PubChem_Cell_line; CVCL_0H85
DR   Wikidata; Q54951788
RX   PubMed=7865904;
RX   PubMed=9865745;
RX   PubMed=11406094;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_88337; Bisantrene.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H88 ! S1
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 16
//
ID   S1-iPSC
AC   CVCL_GP64
DR   Wikidata; Q54951791
RX   PubMed=27510999;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   S1-IR20
AC   CVCL_A9DE
DR   cancercelllines; CVCL_A9DE
DR   Wikidata; Q108821254
RX   PubMed=33692943;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H88 ! S1
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   S1-M1-3.2
AC   CVCL_0H86
DR   cancercelllines; CVCL_0H86
DR   Wikidata; Q54951789
RX   PubMed=9865745;
RX   PubMed=11406094;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H88 ! S1
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   S1-M1-80
AC   CVCL_0H87
SY   S1-MI-80; S1MI80
DR   cancercelllines; CVCL_0H87
DR   ChEMBL-Cells; CHEMBL4630712
DR   ChEMBL-Targets; CHEMBL4630718
DR   PubChem_Cell_line; CVCL_0H87
DR   Wikidata; Q54951790
RX   PubMed=9892175;
RX   PubMed=11406094;
RX   PubMed=11559526;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:74; ABCG2; Simple; p.Arg482Gly (c.1444A>G); Zygosity=Unspecified (PubMed=11559526).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0H86 ! S1-M1-3.2
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   S10
AC   CVCL_E225
DR   Wikidata; Q54951792
RX   PubMed=1694879;
RX   PubMed=3492541;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=S10%20cells
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   S100A12-C5D10
AC   CVCL_D4X0
DR   Wikidata; Q127384104
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P80310; Pig S100A12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A12-D10E2
AC   CVCL_D4X1
DR   Wikidata; Q127384106
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P80310; Pig S100A12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A12-D10F10
AC   CVCL_D4X2
DR   Wikidata; Q127384108
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P80310; Pig S100A12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A12-F5C6
AC   CVCL_D4X3
DR   Wikidata; Q127384110
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P80310; Pig S100A12.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A8-C6D2
AC   CVCL_D4X4
DR   Wikidata; Q127384112
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; C3S7K5; Pig S100A8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A8-C6F6
AC   CVCL_D4X5
DR   Wikidata; Q127384114
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; C3S7K5; Pig S100A8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A8-C6F7
AC   CVCL_D4X6
DR   Wikidata; Q127384116
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A8-E11H7
AC   CVCL_D4X7
DR   Wikidata; Q127384118
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A8-F3C4
AC   CVCL_D4X8
DR   Wikidata; Q127384120
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; C3S7K5; Pig S100A8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A8-F8E8
AC   CVCL_D4X9
DR   Wikidata; Q127384121
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; C3S7K5; Pig S100A8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A8-F8F9
AC   CVCL_D4XA
DR   Wikidata; Q127384122
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; C3S7K5; Pig S100A8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A9-18H
AC   CVCL_D4XB
DR   Wikidata; Q127384124
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; K7GME6; Pig S100A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A9-A912D
AC   CVCL_D4XC
DR   Wikidata; Q127384126
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; K7GME6; Pig S100A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A9-A912E
AC   CVCL_D4XD
DR   Wikidata; Q127384128
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; K7GME6; Pig S100A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A9-A97A
AC   CVCL_D4XE
DR   Wikidata; Q127384132
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; K7GME6; Pig S100A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A9-C92H
AC   CVCL_D4XF
DR   Wikidata; Q127384134
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; K7GME6; Pig S100A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S100A9-G67B
AC   CVCL_D4XG
DR   Wikidata; Q127384136
RX   PubMed=38256103;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; K7GME6; Pig S100A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   S10F03
AC   CVCL_J591
DR   Wikidata; Q54951801
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8596.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00543; Feline sarcoma virus (strain Snyder-Theilen) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   S110-iPSC
AC   CVCL_DD58
DR   Wikidata; Q54951802
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg42Pro (c.125G>C); ClinVar=VCV000644125; Zygosity=Heterozygous (PubMed=25843045).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 10
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD49 ! ND31618
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 14
//
ID   S1120-01 fibroblast
AC   CVCL_A2ZF
DR   Wikidata; Q105510834
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-01 iPS #2
AC   CVCL_A2ZH
SY   S1120-01#2
DR   Wikidata; Q105510839
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZF ! S1120-01 fibroblast
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-01 iPS #4
AC   CVCL_A2ZI
SY   S1120-01#4
DR   Wikidata; Q105510843
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZF ! S1120-01 fibroblast
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-01 iPS #6
AC   CVCL_A2ZJ
SY   S1120-01#6; i1120-01#6
DR   SKIP; SKIP001220
DR   Wikidata; Q105510846
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZF ! S1120-01 fibroblast
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-01 iPS #7
AC   CVCL_A4RC
SY   S1120-01#7; i1120-01#7
DR   SKIP; SKIP001221
DR   Wikidata; Q105510850
RX   PubMed=26186191;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZF ! S1120-01 fibroblast
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   S1120-01 iPS #9
AC   CVCL_A2ZK
SY   S1120-01#9
DR   Wikidata; Q105510856
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZF ! S1120-01 fibroblast
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-03 fibroblast
AC   CVCL_A2ZG
DR   Wikidata; Q105510864
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-03 iPS #1
AC   CVCL_A2ZL
SY   S1120-03#1; i1120-03#1
DR   SKIP; SKIP001211
DR   Wikidata; Q105510869
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZG ! S1120-03 fibroblast
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-03 iPS #2
AC   CVCL_A4RD
SY   S1120-03#2; i1120-03#2
DR   SKIP; SKIP001212
DR   Wikidata; Q105510875
RX   PubMed=26186191;
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZG ! S1120-03 fibroblast
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   S1120-03 iPS #3
AC   CVCL_A2ZM
SY   S1120-03#3
DR   Wikidata; Q105510879
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZG ! S1120-03 fibroblast
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1120-03 iPS #5
AC   CVCL_A2ZN
SY   S1120-03#5; i1120-03#5
DR   SKIP; SKIP001213
DR   Wikidata; Q105510883
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2ZG ! S1120-03 fibroblast
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-01 fibroblast
AC   CVCL_A2TG
SY   GM27879
DR   Coriell; GM27879
DR   Wikidata; Q105510887
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   S1123-01 iPS #1
AC   CVCL_A2TW
SY   S1123-01#1
DR   GEO; GSM1019334
DR   Wikidata; Q105510891
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TG ! S1123-01 fibroblast
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   S1123-01 iPS #2
AC   CVCL_A2TX
SY   S1123-01#2
DR   GEO; GSM1019336
DR   Wikidata; Q105510895
RX   PubMed=23160490;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TG ! S1123-01 fibroblast
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   S1123-01 iPS #3
AC   CVCL_A2TY
AS   CVCL_A2TA
SY   S1123-01#3; S1123-01-i3
DR   GEO; GSM1019337
DR   Wikidata; Q105507376
RX   PubMed=23160490;
RX   PubMed=28235832;
RX   PubMed=37071670;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TG ! S1123-01 fibroblast
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   S1123-01 iPS #4
AC   CVCL_A2TZ
SY   S1123-01#4
DR   GEO; GSM1019338
DR   Wikidata; Q105510903
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TG ! S1123-01 fibroblast
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   S1123-02 fibroblast
AC   CVCL_A2TH
DR   Wikidata; Q105510906
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-02 iPS #2
AC   CVCL_A2UA
SY   S1123-02#2
DR   GEO; GSM1019348
DR   Wikidata; Q105510909
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TH ! S1123-02 fibroblast
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-02 iPS #5
AC   CVCL_A2UB
SY   S1123-02#5
DR   GEO; GSM1019339
DR   Wikidata; Q105510912
RX   PubMed=23160490;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TH ! S1123-02 fibroblast
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-02 iPS #11
AC   CVCL_A2UC
SY   S1123-02#11
DR   GEO; GSM1019340
DR   Wikidata; Q105510914
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TH ! S1123-02 fibroblast
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-02 iPS #17
AC   CVCL_A2UD
SY   S1123-02#17
DR   GEO; GSM1019341
DR   Wikidata; Q105510918
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TH ! S1123-02 fibroblast
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-03 fibroblast
AC   CVCL_A2TI
DR   Wikidata; Q105510921
RX   PubMed=23160490;
RX   PubMed=26186191;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-03 iPS #1
AC   CVCL_A2UE
SY   S1123-03#1
DR   GEO; GSM1019342
DR   Wikidata; Q105510924
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TI ! S1123-03 fibroblast
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-03 iPS #2
AC   CVCL_A2UF
SY   S1123-03#2
DR   GEO; GSM1019343
DR   Wikidata; Q105510928
RX   PubMed=23160490;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TI ! S1123-03 fibroblast
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-03 iPS #8
AC   CVCL_A2UG
SY   S1123-03#8
DR   GEO; GSM1019344
DR   Wikidata; Q105510933
RX   PubMed=23160490;
RX   PubMed=28235832;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TI ! S1123-03 fibroblast
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S1123-03 iPS #9
AC   CVCL_A2UH
SY   S1123-03#9
DR   GEO; GSM1019349
DR   Wikidata; Q105510935
RX   PubMed=23160490;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2TI ! S1123-03 fibroblast
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   S12 [Human iPSC]
AC   CVCL_IL02
DR   Wikidata; Q54951803
RX   PubMed=27789406;
CC   From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C150596; Hepatic steatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   S12 [Human keratinocyte]
AC   CVCL_T291
DR   Wikidata; Q54951804
RX   PubMed=12525636;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a low-grade squamous intraepithelial lesion (LG-SIL) (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T290 ! W12 [Human keratinocyte]
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   S12-26I3
AC   CVCL_D5XU
DR   DGRC; 342
DR   FlyBase_Cell_line; FBtc0000342
DR   Wikidata; Q127384138
RX   PubMed=27557709;
CC   Group: Insect cell line.
CC   Characteristics: Established from embryos carrying Act5C-GAL4 and UAS-Ras[V12].
CC   Knockout cell: Method=Mutagenesis; FlyBase_Gene; FBgn0020887; Su(z)12 (Note=p.Gln219Ter mutation).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Su(z)12(4).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   S12-27IIb
AC   CVCL_D5XT
DR   DGRC; 339
DR   FlyBase_Cell_line; FBtc0000339
DR   Wikidata; Q127384141
RX   PubMed=27557709;
CC   Group: Insect cell line.
CC   Characteristics: Established from embryos carrying Act5C-GAL4 and UAS-Ras[V12].
CC   Knockout cell: Method=Mutagenesis; FlyBase_Gene; FBgn0020887; Su(z)12 (Note=p.Gln219Ter mutation).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003205; Ras85D (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Su(z)12(4).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   S13ba3
AC   CVCL_V132
DR   CLO; CLO_0008914
DR   CLDB; cl4239
DR   IHW; 11w 8030
DR   Wikidata; Q54951805
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   S14-1
AC   CVCL_A0BQ
DR   Wikidata; Q108821255
RX   PubMed=8214009;
CC   Characteristics: Expresses transferrin and SGP-2, lacks a FSH response, and is capable of forming epithelial tumors in nude mice (PubMed=8214009).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   20D
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   S148
AC   CVCL_CW61
DR   Wikidata; Q54951807
RX   Patent=RU2421514;
RX   PubMed=22316485;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75683; Human SURF6 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   S16
AC   CVCL_B072
SY   S-16
DR   BTO; BTO_0002937
DR   ATCC; CRL-2941
DR   Wikidata; Q54951808
RX   PubMed=1705958;
RX   PubMed=7523597;
RX   PubMed=12210843;
CC   Doubling time: ~40 hours (ATCC=CRL-2941).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-3D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   S16Y
AC   CVCL_B073
DR   ATCC; CRL-2943
DR   Wikidata; Q54951809
RX   PubMed=7523597;
CC   Doubling time: ~20 hours (ATCC=CRL-2943).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_B072 ! S16
SX   Sex unspecified
AG   2-3D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   S17
AC   CVCL_E226
DR   BCRJ; 0215
DR   Wikidata; Q54951810
RX   PubMed=1694879;
RX   PubMed=3492541;
RX   PubMed=8639765;
RX   PubMed=12244569;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=S17
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/cAn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   S18
AC   CVCL_B0U9
SY   CNE-2 Clone-18; Clone-18
DR   Wikidata; Q108821256
RX   Patent=CN109536452B;
RX   PubMed=17062557;
RX   PubMed=25028967;
CC   Group: Patented cell line.
CC   Problematic cell line: Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6889 ! CNE-2
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   S18-1C3
AC   CVCL_B0UA
DR   CCRID; 4201PAT-CCTCC01296
DR   Wikidata; Q108821257
RX   Patent=CN109536452B;
CC   Group: Patented cell line.
CC   Problematic cell line: Probably contaminated. Grand-parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018189.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0U9 ! S18
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   S180-Kumamoto-TC
AC   CVCL_7889
SY   S180-Kumamoto
DR   CLO; CLO_0050209
DR   RCB; RCB2899
DR   TKG; TKG 0335
DR   TKG; TKG 0637
DR   Wikidata; Q54951811
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   S180-Meiji-TC
AC   CVCL_7890
SY   S180-Meiji
DR   CLO; CLO_0050210
DR   RCB; RCB2900
DR   TKG; TKG 0334
DR   TKG; TKG 0672
DR   Wikidata; Q54951812
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   S180-NCC-TC
AC   CVCL_7891
SY   S180-NCC
DR   CLO; CLO_0050211
DR   RCB; RCB2901
DR   TKG; TKG 0336
DR   TKG; TKG 0638
DR   Wikidata; Q54951813
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   S180-S1B11
AC   CVCL_BS87
SY   S-180-S1B11; S1B11
DR   Wikidata; Q54951814
RX   CelloPub=CLPUB00332;
RX   PubMed=16334560;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   S180-S1E11
AC   CVCL_IM39
SY   S-180-S1E11; S1E11
DR   Wikidata; Q54951815
RX   CelloPub=CLPUB00332;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 4
//
ID   S180-S1F11
AC   CVCL_BS88
SY   S-180-S1F11; S1F11
DR   Wikidata; Q54951816
RX   CelloPub=CLPUB00332;
RX   PubMed=16334560;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   S180-S1H10
AC   CVCL_BS89
SY   S-180-S1H10; S1H10
DR   Wikidata; Q54951817
RX   CelloPub=CLPUB00332;
RX   PubMed=16334560;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   S180-S2D7
AC   CVCL_BS90
SY   S-180-S2D7; S2D7
DR   Wikidata; Q54951819
RX   CelloPub=CLPUB00332;
RX   PubMed=16334560;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   S180-S2D9
AC   CVCL_BS91
SY   S-180-S2D9; S2D9
DR   CCRID; 4201MOU-CCTCC00131
DR   CCTCC; GDC0131
DR   Wikidata; Q54951820
RX   CelloPub=CLPUB00332;
RX   PubMed=16334560;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 8
//
ID   S180-S2H7
AC   CVCL_IM38
SY   S-180-S2H7; S2H7
DR   Wikidata; Q54951821
RX   CelloPub=CLPUB00332;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 4
//
ID   S180-S3F5
AC   CVCL_IM37
SY   S-180-S3F5; S3F5
DR   Wikidata; Q54951823
RX   CelloPub=CLPUB00332;
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 4
//
ID   S1814.PB5
AC   CVCL_2716
DR   CLO; CLO_0008915
DR   CLDB; cl4240
DR   ECACC; 85011402
DR   Wikidata; Q54951824
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ECACC=85011402
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   S19.8
AC   CVCL_F0V0
DR   ABCD; ABCD_BF032
RX   PubMed=6242882;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01887; Mouse B2M.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   S194
AC   CVCL_VG98
DR   TKG; TKG 0734
DR   Wikidata; Q54951825
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_4697 ! S194/5.XXO-1
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 5
//
ID   S194/5.XXO-1
AC   CVCL_4697
SY   S194/5.XXO
DR   BTO; BTO_0002910
DR   CLO; CLO_0008918
DR   ATCC; TIB-19
DR   Wikidata; Q54951826
RX   PubMed=4119881;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VG98 ! S194
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   S194/5.XXO.BU.1
AC   CVCL_4696
SY   S194/5XXO.BU.1; S194; GM05657
DR   BTO; BTO_0002911
DR   CLO; CLO_0008917
DR   CLO; CLO_0024609
DR   ATCC; CRL-8837
DR   ATCC; TIB-20
DR   Coriell; GM05657
DR   Wikidata; Q54951827
RX   CelloPub=CLPUB00447;
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8837.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Discontinued: ATCC; CRL-8837; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4697 ! S194/5.XXO-1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   S19L
AC   CVCL_IM71
DR   cancercelllines; CVCL_IM71
DR   Cosmic; 1608988
DR   GEO; GSM623744
DR   Wikidata; Q54951828
RX   PubMed=22080063;
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Unspecified (PubMed=22080063).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8795; Recurrent undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   s1A
AC   CVCL_U609
SY   S1A
DR   Wikidata; Q54951829
RX   Patent=US4710377;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8404.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella sporozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   S1A
AC   CVCL_4Y48
DR   Wikidata; Q54951830
RX   PubMed=5439579;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 3
//
ID   S1A(Thy-1-b)
AC   CVCL_6332
SY   S1A (Thy-1-b)
DR   CLO; CLO_0008919
DR   ATCC; TIB-231
DR   Wikidata; Q54951831
RX   PubMed=667934;
RX   PubMed=4544550;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6333 ! S1A.TB.4.8.2
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   S1A.TB.4.8.2
AC   CVCL_6333
SY   S1A.T4.G8; S1A.T4.G8.2
DR   CLO; CLO_0008920
DR   ATCC; TIB-27
DR   Wikidata; Q54951832
RX   PubMed=4544550;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4Y48 ! S1A
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   S1C4
AC   CVCL_U608
SY   s1C4
DR   Wikidata; Q54951833
RX   Patent=US4710377;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8333.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella sporozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   S1D7_Spike
AC   CVCL_A7AG
SY   S1D7
DR   RCB; RCB5392
DR   Wikidata; Q107116813
RX   PubMed=33524396;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   S1E4
AC   CVCL_G141
SY   s1E4; 1E4
DR   CLO; CLO_0008921
DR   ATCC; HB-8332
DR   Wikidata; Q54951834
RX   Patent=US4710377;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8332.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Eimeria tenella sporozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   S1F12
AC   CVCL_C4BX
DR   ABCD; ABCD_AE324
DR   Wikidata; Q116050189
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   S1F2
AC   CVCL_C4BW
DR   Wikidata; Q116050190
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   S1T
AC   CVCL_B7P4
DR   Wikidata; Q114312941
RX   PubMed=1472476;
RX   PubMed=1719236;
RX   PubMed=9357968;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   S2
AC   CVCL_4698
DR   BTO; BTO_0003070
DR   ECACC; 99043002
DR   Wikidata; Q54951835
RX   PubMed=2423487;
RX   PubMed=6205884;
CC   Doubling time: ~36 hours (ECACC=99043002).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01911; Human HLA-DRB1 (Note=Recognizes allele DRB1*13).
CC   Discontinued: ECACC; 99043002; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   S2 DmECT2-EGFP+Tag-RFP-alpha-tubulin
AC   CVCL_UZ83
DR   Wikidata; Q98129252
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003041; pbl.
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   S2 DmMKLP1-EGFP+Tag-RFP-alpha-tubulin
AC   CVCL_UZ77
DR   Wikidata; Q98129253
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0011692; pav.
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   S2 EB1-DeltaC-RacGAP50C-EGFP+Tag-RFP-alpha-tubulin
AC   CVCL_UZ85
DR   Wikidata; Q98129254
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0027066; Eb1.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0086356; tum (Note=With p.Ile527_Lys625del).
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   S2 EB1-DeltaPTIV-RacGAP50C-EGFP and TagRFP-alpha-tubulin
AC   CVCL_UZ86
DR   Wikidata; Q98129255
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0027066; Eb1.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0086356; tum (Note=With p.Pro533_Val536del).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   S2 EB1-RacGAP50C-EGFP+Tag-RFP-alpha-tubulin
AC   CVCL_UZ84
DR   Wikidata; Q98129256
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0027066; Eb1.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0086356; tum.
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   S2 EGFP-Rhotekin+Tag-RFP-alpha-tubulin
AC   CVCL_UZ80
DR   Wikidata; Q98129257
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107371; Rtkn; (Note=With p.Met1_Arg6del and p.Arg90_Val551del = rGBD).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   S2 Polo Kinase-EGFP
AC   CVCL_UZ79
DR   Wikidata; Q98129258
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003124; polo.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   S2 PfRH5 variant 1
AC   CVCL_D1FT
SY   S2 PfRH5 v1.0
DR   Wikidata; Q127384143
RX   PubMed=27457156;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0001218; Hsc70-3 (Note=AA 1-18 = Signal sequence).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5) (Note=With p.Met1_Phe25del, p.Thr40Ala, p.Cys203Tyr, p.Thr216Ala, p.Thr286Ala, p.Thr299Ala and a C-terminal His6 tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_A8PY ! HighMan-S2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   S2 PfRH5 variant 2
AC   CVCL_D1FU
SY   S2 PfRH5 v2.0
DR   Wikidata; Q127384145
RX   PubMed=27457156;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0001218; Hsc70-3 (Note=AA 1-18 = Signal sequence).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5) (Note=With p.Met1_Phe25del, p.Thr40Ala, p.Thr216Ala, p.Thr286Ala, p.Thr299Ala and a C-terminal His6 tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_A8PY ! HighMan-S2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   S2 PfRH5 variant 3
AC   CVCL_D1FV
SY   S2 PfRH5 v3.0
DR   Wikidata; Q127384147
RX   PubMed=27457156;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0001218; Hsc70-3 (Note=AA 1-18 = Signal sequence).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5) (Note=With p.Met1_Phe25del, p.Asn38Gln, p.Asn214Gln, p.Asn284Gln, p.Asn297Gln and a C-terminal His6 tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_A8PY ! HighMan-S2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   S2 PfRH5 variant 4
AC   CVCL_D1FW
SY   S2 PfRH5 v4.0
DR   Wikidata; Q127384149
RX   PubMed=27457156;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0001218; Hsc70-3 (Note=AA 1-18 = Signal sequence).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5) (Note=With p.Met1_Phe25del, p.Asn38Gln, p.Asn214Gln and a C-terminal His6 tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_A8PY ! HighMan-S2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   S2 PfRH5 variant 5
AC   CVCL_D1FX
SY   S2 PfRH5 v2.5
DR   Wikidata; Q127384152
RX   PubMed=27457156;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0001218; Hsc70-3 (Note=AA 1-18 = Signal sequence).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q8IFM5; Plasmodium falciparum (isolate 3D7) reticulocyte-binding protein homolog 5 (RH5) (PfRH5) (Note=With p.Met1_Phe25del and a C-terminal His6 tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_A8PY ! HighMan-S2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   S2 RacGAP50C-EGFP+Tag-RFP-alpha-tubulin
AC   CVCL_UZ78
DR   Wikidata; Q98129259
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0086356; tum.
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   S2 RFP-Rhotekin+DmMKLP1-EGFP
AC   CVCL_UZ81
DR   Wikidata; Q98129261
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0011692; pav.
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107371; Rtkn; (Note=With p.Met1_Arg6del and p.Arg90_Val551del = rGBD).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   S2 RFP-Rhotekin+MRLC-EGFP
AC   CVCL_UZ82
DR   Wikidata; Q98129263
RX   PubMed=30758285;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0003514; sqh.
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:107371; Rtkn; (Note=With p.Met1_Arg6del and p.Arg90_Val551del = rGBD).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   S2-007
AC   CVCL_B279
SY   SUIT2-007; S2 007; Suit S2 007
DR   cancercelllines; CVCL_B279
DR   TKG; TKG 0708
DR   Wikidata; Q54951839
RX   PubMed=1319859;
RX   PubMed=1391733;
RX   PubMed=10027404;
RX   PubMed=11854916;
CC   Population: Japanese.
CC   Doubling time: 29.7 hours (PubMed=1391733); 41.8 hours (PubMed=10027404).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0708
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3172 ! SUIT-2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   S2-013
AC   CVCL_B280
SY   SUIT2-013; S2013
DR   cancercelllines; CVCL_B280
DR   TKG; TKG 0709
DR   TOKU-E; 4026
DR   Wikidata; Q54951840
RX   PubMed=1319859;
RX   PubMed=1391733;
RX   PubMed=11854916;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-555.html
CC   Population: Japanese.
CC   Doubling time: 26.4 hours (PubMed=1391733).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Misspelling: S2-O13; Note=Occasionally.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0709
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3172 ! SUIT-2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   S2-020
AC   CVCL_B281
SY   SUIT2-020
DR   cancercelllines; CVCL_B281
DR   TKG; TKG 0710
DR   Wikidata; Q54951841
RX   PubMed=1319859;
RX   PubMed=1391733;
RX   PubMed=10027404;
RX   PubMed=11854916;
CC   Population: Japanese.
CC   Doubling time: 24.8 hours (PubMed=1391733); 35.8 hours (PubMed=10027404).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0710
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3172 ! SUIT-2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   S2-028
AC   CVCL_B282
SY   S2.028; SUIT2-028
DR   BTO; BTO_0006099
DR   cancercelllines; CVCL_B282
DR   TKG; TKG 0711
DR   Wikidata; Q54951842
RX   PubMed=1319859;
RX   PubMed=1391733;
RX   PubMed=10027404;
RX   PubMed=11169957;
RX   PubMed=11854916;
CC   Population: Japanese.
CC   Doubling time: 24.5 hours (PubMed=1391733); 35.3 hours (PubMed=10027404).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0711
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3172 ! SUIT-2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   S2-act-GFP-alphaTub84B
AC   CVCL_Z864
DR   DGRC; 170
DR   FlyBase_Cell_line; FBtc0000170
DR   Wikidata; Q54951844
RX   PubMed=24434506;
CC   Group: Insect cell line.
CC   Doubling time: 49 hours (DGRC=170).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-B2
AC   CVCL_IZ08
SY   S2 clone B2
DR   FlyBase_Cell_line; FBtc9000005
DR   Wikidata; Q54951854
RX   PubMed=23669073;
CC   Group: Insect cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   S2-CP8
AC   CVCL_F971
DR   cancercelllines; CVCL_F971
DR   TKG; TKG 0706
DR   Wikidata; Q54951855
RX   PubMed=11688961;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0706
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3172 ! SUIT-2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   S2-DGRC
AC   CVCL_TZ72
DR   DGRC; 6
DR   FlyBase_Cell_line; FBtc0000006
DR   Wikidata; Q54951856
CC   Group: Insect cell line.
CC   Doubling time: 23 hours (DGRC=6).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   S2-DGRC-attP-25C6
AC   CVCL_A5UV
SY   S2-DGRC-attP-25C6-Clone 8
DR   DGRC; 316
DR   FlyBase_Cell_line; FBtc0000316
DR   Wikidata; Q107116814
RX   PubMed=33963853;
CC   Group: Insect cell line.
CC   Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 7
//
ID   S2-DRSC
AC   CVCL_Z992
DR   EFO; EFO_0005836
DR   DGRC; 181
DR   ENCODE; ENCBS006VJB
DR   ENCODE; ENCBS008LGB
DR   ENCODE; ENCBS010RAQ
DR   ENCODE; ENCBS013MSY
DR   ENCODE; ENCBS017DFN
DR   ENCODE; ENCBS058HTA
DR   ENCODE; ENCBS087VIH
DR   ENCODE; ENCBS088XIQ
DR   ENCODE; ENCBS090MOB
DR   ENCODE; ENCBS090TPA
DR   ENCODE; ENCBS106RHP
DR   ENCODE; ENCBS110KRE
DR   ENCODE; ENCBS124PNL
DR   ENCODE; ENCBS126OLI
DR   ENCODE; ENCBS139KWP
DR   ENCODE; ENCBS142TUN
DR   ENCODE; ENCBS145BAB
DR   ENCODE; ENCBS158WAB
DR   ENCODE; ENCBS161TOO
DR   ENCODE; ENCBS170GIK
DR   ENCODE; ENCBS176ZPG
DR   ENCODE; ENCBS177SMN
DR   ENCODE; ENCBS180ZDI
DR   ENCODE; ENCBS184TBN
DR   ENCODE; ENCBS187WVO
DR   ENCODE; ENCBS200MCV
DR   ENCODE; ENCBS205XZV
DR   ENCODE; ENCBS208XXF
DR   ENCODE; ENCBS225CEK
DR   ENCODE; ENCBS227VZL
DR   ENCODE; ENCBS234EHK
DR   ENCODE; ENCBS250GJJ
DR   ENCODE; ENCBS258UQR
DR   ENCODE; ENCBS259VXP
DR   ENCODE; ENCBS274XUE
DR   ENCODE; ENCBS281RDY
DR   ENCODE; ENCBS292QNX
DR   ENCODE; ENCBS303AAJ
DR   ENCODE; ENCBS316OUD
DR   ENCODE; ENCBS333RPQ
DR   ENCODE; ENCBS339BLC
DR   ENCODE; ENCBS344TKR
DR   ENCODE; ENCBS371VQC
DR   ENCODE; ENCBS371XQA
DR   ENCODE; ENCBS373IOH
DR   ENCODE; ENCBS373OUA
DR   ENCODE; ENCBS385KGQ
DR   ENCODE; ENCBS386UAO
DR   ENCODE; ENCBS389HVY
DR   ENCODE; ENCBS397PYN
DR   ENCODE; ENCBS402GGY
DR   ENCODE; ENCBS406UIP
DR   ENCODE; ENCBS409GTV
DR   ENCODE; ENCBS412DDI
DR   ENCODE; ENCBS415HED
DR   ENCODE; ENCBS427UIS
DR   ENCODE; ENCBS436LNI
DR   ENCODE; ENCBS437DVR
DR   ENCODE; ENCBS440KSW
DR   ENCODE; ENCBS443REI
DR   ENCODE; ENCBS445QYZ
DR   ENCODE; ENCBS461THK
DR   ENCODE; ENCBS469AHD
DR   ENCODE; ENCBS474HDY
DR   ENCODE; ENCBS476QCZ
DR   ENCODE; ENCBS480TZB
DR   ENCODE; ENCBS485BHZ
DR   ENCODE; ENCBS492UGM
DR   ENCODE; ENCBS519HNG
DR   ENCODE; ENCBS540ZNI
DR   ENCODE; ENCBS551HAB
DR   ENCODE; ENCBS556BVX
DR   ENCODE; ENCBS564FYN
DR   ENCODE; ENCBS565UYU
DR   ENCODE; ENCBS571EYR
DR   ENCODE; ENCBS573WFM
DR   ENCODE; ENCBS578GMQ
DR   ENCODE; ENCBS579TQV
DR   ENCODE; ENCBS585ORA
DR   ENCODE; ENCBS595IUO
DR   ENCODE; ENCBS608LKQ
DR   ENCODE; ENCBS612KBM
DR   ENCODE; ENCBS614AWC
DR   ENCODE; ENCBS623ZGX
DR   ENCODE; ENCBS625GGT
DR   ENCODE; ENCBS638GFX
DR   ENCODE; ENCBS638NWC
DR   ENCODE; ENCBS641FHG
DR   ENCODE; ENCBS644WYM
DR   ENCODE; ENCBS654UWV
DR   ENCODE; ENCBS662TMA
DR   ENCODE; ENCBS665VZI
DR   ENCODE; ENCBS674MBC
DR   ENCODE; ENCBS676DSJ
DR   ENCODE; ENCBS687SHC
DR   ENCODE; ENCBS690QTC
DR   ENCODE; ENCBS692NDI
DR   ENCODE; ENCBS692UCT
DR   ENCODE; ENCBS692ZBZ
DR   ENCODE; ENCBS700MRY
DR   ENCODE; ENCBS704DOA
DR   ENCODE; ENCBS723OJC
DR   ENCODE; ENCBS736EAE
DR   ENCODE; ENCBS745GQM
DR   ENCODE; ENCBS749SFJ
DR   ENCODE; ENCBS784DOA
DR   ENCODE; ENCBS791WMF
DR   ENCODE; ENCBS810MSU
DR   ENCODE; ENCBS813THC
DR   ENCODE; ENCBS821BLW
DR   ENCODE; ENCBS826KGJ
DR   ENCODE; ENCBS831NED
DR   ENCODE; ENCBS833FAO
DR   ENCODE; ENCBS849VAW
DR   ENCODE; ENCBS855QAW
DR   ENCODE; ENCBS856XJT
DR   ENCODE; ENCBS857WVL
DR   ENCODE; ENCBS858CTP
DR   ENCODE; ENCBS868IBJ
DR   ENCODE; ENCBS882RWS
DR   ENCODE; ENCBS883CIX
DR   ENCODE; ENCBS888JJD
DR   ENCODE; ENCBS889VWF
DR   ENCODE; ENCBS892PNV
DR   ENCODE; ENCBS897YJE
DR   ENCODE; ENCBS898KFS
DR   ENCODE; ENCBS899NHE
DR   ENCODE; ENCBS899OTC
DR   ENCODE; ENCBS910OTN
DR   ENCODE; ENCBS917MPG
DR   ENCODE; ENCBS920HLB
DR   ENCODE; ENCBS956ORA
DR   ENCODE; ENCBS961VIF
DR   ENCODE; ENCBS972VQU
DR   ENCODE; ENCBS973RDS
DR   ENCODE; ENCBS975URF
DR   ENCODE; ENCBS977SEG
DR   ENCODE; ENCBS988DGF
DR   ENCODE; ENCBS991CJS
DR   ENCODE; ENCBS993EFF
DR   FlyBase_Cell_line; FBtc0000181
DR   Wikidata; Q54951857
RX   DOI=10.4172/2472-1115.1000103;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 46-93 hours (Note=Depending on growth medium) (DGRC=181).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   S2-dTat-KO
AC   CVCL_C8XJ
SY   S2-Atat-KO
DR   DGRC; 344
DR   FlyBase_Cell_line; FBtc0000344
DR   Wikidata; Q123033390
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0035989; Atat.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 4
//
ID   S2-GFP-RFP-Atg8a
AC   CVCL_XF59
SY   S2-RFP-GFP-Atg8a
DR   DGRC; 290
DR   FlyBase_Cell_line; FBtc0000290
DR   Wikidata; Q98129264
RX   PubMed=24862573;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0052672; Atg8a.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   S2-GFP-SKL
AC   CVCL_Z860
DR   DGRC; 197
DR   FlyBase_Cell_line; FBtc0000197
DR   Wikidata; Q54951858
RX   PubMed=24434506;
CC   Group: Insect cell line.
CC   Characteristics: Expresses GFP tagged with a peroxisome-targeting signal under the control of an Actin5C promoter.
CC   Doubling time: 46 hours (DGRC=197).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-iPSC
AC   CVCL_GP65
DR   Wikidata; Q54951859
RX   PubMed=27510999;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   S2-LiveDropGFP-M4
AC   CVCL_E8G3
DR   DGRC; 352
DR   FlyBase_Cell_line; FBtc0000352
RX   PubMed=35274690;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with LiveDrop, a sensitive probe used to identify the earliest steps of lipid droplet formation. LiveDrop contains the membrane hairpin domain (AA 160-216) of Gpat4 fused to eGFP (PubMed=35274690).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0034971; Gpat4 (Note=With p.Met1_Arg159del and p.Leu217_Thr458del = 160-216).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   S2-Mt-Dl
AC   CVCL_Z993
SY   L49-6-7
DR   DGRC; 152
DR   FlyBase_Cell_line; FBtc0000152
DR   Wikidata; Q54951860
RX   PubMed=1657403;
CC   Group: Insect cell line.
CC   Characteristics: Expresses Delta (Dl) from a copper-inducible metallothionein promoter.
CC   Doubling time: 64 hours (DGRC=152).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000463; Dl.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-EB1-GFP
AC   CVCL_0B20
DR   DGRC; 171
DR   FlyBase_Cell_line; FBtc0000171
DR   Wikidata; Q54951861
CC   Group: Insect cell line.
CC   Doubling time: 25 hours (DGRC=171).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0027066; Eb1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-Fog-myc
AC   CVCL_0A35
DR   DGRC; 218
DR   FlyBase_Cell_line; FBtc0000218
DR   Wikidata; Q54951862
RX   PubMed=24222713;
CC   Group: Insect cell line.
CC   Doubling time: ~24 hours (DGRC=218).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000719; fog.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-GFP
AC   CVCL_Z854
DR   DGRC; 194
DR   FlyBase_Cell_line; FBtc0000194
DR   Wikidata; Q54951864
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-GFP-Act5C
AC   CVCL_Z855
DR   DGRC; 169
DR   FlyBase_Cell_line; FBtc0000169
DR   Wikidata; Q54951865
CC   Group: Insect cell line.
CC   Characteristics: Expresses a GFP-Act5C fusion under the control of a metallothionein promoter.
CC   Doubling time: 2 days (DGRC=169).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000042; Act5C.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-GFP-alphaTub84B
AC   CVCL_Z856
DR   DGRC; 168
DR   FlyBase_Cell_line; FBtc0000168
DR   Wikidata; Q54951866
CC   Group: Insect cell line.
CC   Characteristics: Expresses a GFP-alphaTub84B fusion under the control of a metallothionein promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-mCherry-alphaTub84B+Mt-GFP-Orbit
AC   CVCL_IY69
DR   DGRC; 195
DR   FlyBase_Cell_line; FBtc0000195
DR   Wikidata; Q54951867
CC   Group: Insect cell line.
CC   Doubling time: 35 hours (DGRC=195).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003884; alphaTub84B.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   S2-Mt-Msps-GFP
AC   CVCL_1B56
DR   DGRC; 206
DR   FlyBase_Cell_line; FBtc0000206
DR   Wikidata; Q54951868
RX   PubMed=21965297;
CC   Group: Insect cell line.
CC   Characteristics: Expresses a msps-GFP fusion under the control of a metallothionein promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0027948; msps.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-N
AC   CVCL_0A47
DR   DGRC; 154
DR   FlyBase_Cell_line; FBtc0000154
DR   Wikidata; Q54951869
CC   Group: Insect cell line.
CC   Doubling time: 99 hours (DGRC=154).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0004647; N.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-Mt-Slit
AC   CVCL_0A48
DR   DGRC; 192
DR   FlyBase_Cell_line; FBtc0000192
DR   Wikidata; Q54951870
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0264089; sli.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-SQH-GFP
AC   CVCL_0A56
DR   DGRC; 172
DR   FlyBase_Cell_line; FBtc0000172
DR   Wikidata; Q54951871
CC   Group: Insect cell line.
CC   Doubling time: 24 hours (DGRC=172).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003514; sqh.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2-SQH-GFP+Mt-mCherry-actin
AC   CVCL_0A57
DR   DGRC; 193
DR   FlyBase_Cell_line; FBtc0000193
DR   Wikidata; Q54951872
CC   Group: Insect cell line.
CC   Doubling time: 87 hours (DGRC=193).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000042; Act5C.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003514; sqh.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_TZ72 ! S2-DGRC
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 11
//
ID   S2-Tub-wg
AC   CVCL_1B57
DR   DGRC; 165
DR   FlyBase_Cell_line; FBtc0000165
DR   Wikidata; Q54951873
CC   Group: Insect cell line.
CC   Doubling time: 39 hours (DGRC=165).
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0004009; wg.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   S2-VP10
AC   CVCL_F972
DR   cancercelllines; CVCL_F972
DR   TKG; TKG 0707
DR   Wikidata; Q54951874
RX   PubMed=11688961;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0707
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3172 ! SUIT-2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   S2.1
AC   CVCL_G078
DR   ECACC; 92040116
DR   Wikidata; Q54951836
CC   Monoclonal antibody isotype: IgA.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_3830 ! L231
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   S2.13
AC   CVCL_LF75
DR   Wikidata; Q54951837
RX   PubMed=17244020;
RX   PubMed=18462435;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AS21 ! Pre2.8
SX   Male
AG   71Y
CA   Conditionally immortalized cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 7
//
ID   S2.2
AC   CVCL_G079
DR   ECACC; 92040117
DR   Wikidata; Q54951838
CC   Monoclonal antibody isotype: IgA.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_3830 ! L231
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   S2/TXT
AC   CVCL_B283
DR   cancercelllines; CVCL_B283
DR   Wikidata; Q54951876
RX   PubMed=11819752;
RX   PubMed=11854916;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3172 ! SUIT-2
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   S2:DER2f
AC   CVCL_A5UZ
SY   D2F; D2f; DER2-expressing S2 cells; D2R
DR   FlyBase_Cell_line; FBtc9000067
DR   Wikidata; Q107116816
RX   PubMed=7601354;
RX   PubMed=15329724;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000434; Der.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2:spi4
AC   CVCL_A5VA
DR   Wikidata; Q107116817
RX   PubMed=7601354;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0005672; Spi.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S21
AC   CVCL_K245
DR   Wikidata; Q54951878
RX   PubMed=11375395;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=S21
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   S22
AC   CVCL_N329
SY   URO7
DR   Wikidata; Q54951879
RX   Patent=US4935344;
RX   PubMed=3857626;
RX   PubMed=6946460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8542.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen URO7 on renal cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   S22C06
AC   CVCL_J592
DR   ATCC; HB-8595
DR   Wikidata; Q54951881
RX   Patent=US5015571;
RX   Patent=US5733738;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8595.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00543; Feline sarcoma virus (strain Snyder-Theilen) v-Fes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 9
//
ID   S23
AC   CVCL_N330
SY   S.sub.23
DR   Wikidata; Q54951882
RX   Patent=US4713352;
RX   Patent=US4935344;
RX   PubMed=3857626;
RX   PubMed=6946460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8540.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human adenosine deaminase binding protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   S26
AC   CVCL_B0UB
SY   CNE-2 Clone-26; Clone-26
DR   Wikidata; Q108821258
RX   PubMed=17062557;
RX   PubMed=25028967;
CC   Group: Patented cell line.
CC   Problematic cell line: Probably contaminated. Parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6889 ! CNE-2
CA   Hybrid cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   S27
AC   CVCL_N331
SY   S.sub.27; URO4
DR   Wikidata; Q54951883
RX   Patent=US4713352;
RX   Patent=US4935344;
RX   PubMed=3857626;
RX   PubMed=6149219;
RX   PubMed=6946460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8428.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human adenosine deaminase binding protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   S2c1
AC   CVCL_IZ06
SY   S2 clone 1
DR   FlyBase_Cell_line; FBtc9000007
DR   Wikidata; Q54951884
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   S2D2
AC   CVCL_C5DS
DR   Wikidata; Q116050191
RX   PubMed=6375980;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08168; Bovine SAG (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   S2D8
AC   CVCL_C4BY
DR   ABCD; ABCD_AE326
DR   Wikidata; Q116050192
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   S2E9
AC   CVCL_C4BZ
DR   ABCD; ABCD_AE325
DR   Wikidata; Q116050193
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   S2G3
AC   CVCL_E4R7
RX   PubMed=2351695;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
CC   Monoclonal antibody target: UniProtKB; P56199; Human ITGA1/CD49a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   S2G7
AC   CVCL_C4C0
DR   Wikidata; Q116050194
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   S2G8
AC   CVCL_U610
SY   s2G8
DR   Wikidata; Q54951885
RX   Patent=US4710377;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8405.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella sporozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   S2H5
AC   CVCL_C4C1
DR   ABCD; ABCD_AE327
DR   Wikidata; Q116050196
RX   PubMed=3873342;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   S2R+
AC   CVCL_Z831
DR   EFO; EFO_0005837
DR   BioGRID_ORCS_Cell_line; 795
DR   DGRC; 150
DR   ENCODE; ENCBS016VBB
DR   ENCODE; ENCBS029XZY
DR   ENCODE; ENCBS045RXQ
DR   ENCODE; ENCBS050FWY
DR   ENCODE; ENCBS058XTV
DR   ENCODE; ENCBS085GBT
DR   ENCODE; ENCBS109IMN
DR   ENCODE; ENCBS123YPM
DR   ENCODE; ENCBS147REE
DR   ENCODE; ENCBS160PDG
DR   ENCODE; ENCBS168YHL
DR   ENCODE; ENCBS175MAB
DR   ENCODE; ENCBS180YAR
DR   ENCODE; ENCBS183BXZ
DR   ENCODE; ENCBS198NAV
DR   ENCODE; ENCBS206XLR
DR   ENCODE; ENCBS216ZWI
DR   ENCODE; ENCBS222QPU
DR   ENCODE; ENCBS239ENL
DR   ENCODE; ENCBS258AUT
DR   ENCODE; ENCBS264KCT
DR   ENCODE; ENCBS282ENR
DR   ENCODE; ENCBS289LAN
DR   ENCODE; ENCBS291KVV
DR   ENCODE; ENCBS291YGW
DR   ENCODE; ENCBS307DLP
DR   ENCODE; ENCBS320ZJJ
DR   ENCODE; ENCBS343PSJ
DR   ENCODE; ENCBS355XFZ
DR   ENCODE; ENCBS356VJX
DR   ENCODE; ENCBS361LVA
DR   ENCODE; ENCBS382JGX
DR   ENCODE; ENCBS410HWM
DR   ENCODE; ENCBS427TQS
DR   ENCODE; ENCBS430DSP
DR   ENCODE; ENCBS437QNC
DR   ENCODE; ENCBS450TBB
DR   ENCODE; ENCBS475GAU
DR   ENCODE; ENCBS483AEE
DR   ENCODE; ENCBS485JLN
DR   ENCODE; ENCBS501DBP
DR   ENCODE; ENCBS510QWA
DR   ENCODE; ENCBS549VKG
DR   ENCODE; ENCBS550EXK
DR   ENCODE; ENCBS550RIA
DR   ENCODE; ENCBS552ENG
DR   ENCODE; ENCBS570HGS
DR   ENCODE; ENCBS599XAS
DR   ENCODE; ENCBS610HCG
DR   ENCODE; ENCBS612RWZ
DR   ENCODE; ENCBS618PRZ
DR   ENCODE; ENCBS628PBB
DR   ENCODE; ENCBS640HBS
DR   ENCODE; ENCBS645OJF
DR   ENCODE; ENCBS663YGH
DR   ENCODE; ENCBS666UDJ
DR   ENCODE; ENCBS678BAN
DR   ENCODE; ENCBS690VKC
DR   ENCODE; ENCBS693XWV
DR   ENCODE; ENCBS696XGH
DR   ENCODE; ENCBS727TWQ
DR   ENCODE; ENCBS731WMM
DR   ENCODE; ENCBS795QWY
DR   ENCODE; ENCBS805GFV
DR   ENCODE; ENCBS829XOI
DR   ENCODE; ENCBS856IMY
DR   ENCODE; ENCBS858WYB
DR   ENCODE; ENCBS866VOG
DR   ENCODE; ENCBS880CBQ
DR   ENCODE; ENCBS921AAA
DR   ENCODE; ENCBS934YGZ
DR   ENCODE; ENCBS937EMZ
DR   ENCODE; ENCBS937JLS
DR   ENCODE; ENCBS955EPE
DR   ENCODE; ENCBS980MVL
DR   ENCODE; ENCBS991BPZ
DR   ENCODE; ENCBS999YIX
DR   FlyBase_Cell_line; FBtc0000150
DR   Wikidata; Q54951886
RX   PubMed=9822716;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=33028628;
RX   PubMed=36156149;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 39 hours (DGRC=150).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   S2R+-(FEx-10%)
AC   CVCL_A5UN
SY   S2R+ (FEx 10%); S2R+ FEx10%
DR   DGRC; 311
DR   FlyBase_Cell_line; FBtc0000311
DR   Wikidata; Q107116818
RX   PubMed=33028628;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in M3 + 10% Fly Extract (FEx) medium.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   S2R+-(FEx-2.5%)
AC   CVCL_A5UM
SY   S2R+ (FEx 2.5%); S2R+ FEx2.5%
DR   DGRC; 310
DR   FlyBase_Cell_line; FBtc0000310
DR   Wikidata; Q107116819
RX   PubMed=33028628;
RX   PubMed=33537561;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in M3 + 2.5% Fly Extract (FEx) medium.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   S2R+-Apc2-KO
AC   CVCL_UD31
SY   Apc2-C11
DR   DGRC; 267
DR   FlyBase_Cell_line; FBtc0000267
DR   Wikidata; Q98129265
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0026598; Apc2.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Apc-KO-1G
AC   CVCL_XF46
DR   DGRC; 271
DR   FlyBase_Cell_line; FBtc0000271
DR   Wikidata; Q98129266
RX   PubMed=32958931;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0015589; Apc.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Apc-KO-3E
AC   CVCL_XF47
DR   DGRC; 272
DR   FlyBase_Cell_line; FBtc0000272
DR   Wikidata; Q98129267
RX   PubMed=32958931;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0015589; Apc.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Apc-KO-E5
AC   CVCL_A5UG
SY   S2R+-Apc KO-E5
DR   DGRC; 304
DR   FlyBase_Cell_line; FBtc0000304
DR   Wikidata; Q107116820
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0015589; Apc.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2R+-arl8-GFP-4
AC   CVCL_XF61
DR   DGRC; 291
DR   FlyBase_Cell_line; FBtc0000291
DR   Wikidata; Q98129268
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Arl8 locus (FlyBase_Gene=FBgn0037551).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   S2R+-attP-99F8
AC   CVCL_A5UU
SY   S2R+-attP-99F8-; S2R+-attP-99F8-Clone 141
DR   DGRC; 315
DR   FlyBase_Cell_line; FBtc0000315
DR   Wikidata; Q107116821
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   S2R+-CG8786-KO
AC   CVCL_UD32
SY   CG8786-6
DR   DGRC; 269
DR   Wikidata; Q98129269
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0036897; CG8786.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   S2R+-Cnx99a-GFP-4
AC   CVCL_XF62
DR   DGRC; 273
DR   FlyBase_Cell_line; FBtc0000273
DR   Wikidata; Q98129270
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Cnx99a locus (FlyBase_Gene=FBgn0015622).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Fib-GFP-11
AC   CVCL_XF63
DR   DGRC; 278
DR   FlyBase_Cell_line; FBtc0000278
DR   Wikidata; Q98129271
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Fib locus (FlyBase_Gene=FBgn0003062).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Fib-GFP-12
AC   CVCL_XF64
DR   DGRC; 279
DR   FlyBase_Cell_line; FBtc0000279
DR   Wikidata; Q98129272
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Fib locus (FlyBase_Gene=FBgn0003062).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Fucci
AC   CVCL_1B58
SY   S2R+-FUCCI; S2R+_FUCCI
DR   DGRC; 243
DR   FlyBase_Cell_line; FBtc0000243
DR   Wikidata; Q54951887
CC   Group: Insect cell line.
CC   Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct.
CC   Characteristics: Transfected with a Fucci like probe which consist of a nuclear eGFP fused to an E2F1 degron and unlocalized mRFP1 fused to a CycB degron.
CC   Doubling time: ~35 hours (DGRC=243).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 10
//
ID   S2R+-gig-KO
AC   CVCL_XF65
DR   DGRC; 297
DR   FlyBase_Cell_line; FBtc0000297
DR   Wikidata; Q98129273
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0005198; gig.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 6
//
ID   S2R+-Gmap-GFP-4
AC   CVCL_XF66
DR   DGRC; 276
DR   FlyBase_Cell_line; FBtc0000276
DR   Wikidata; Q98129274
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Gmap locus (FlyBase_Gene=FBgn0027287).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Gmap-GFP-7
AC   CVCL_XF67
DR   DGRC; 277
DR   FlyBase_Cell_line; FBtc0000277
DR   Wikidata; Q98129275
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Gmap locus (FlyBase_Gene=FBgn0027287).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Golgin245-GFP-1
AC   CVCL_XF68
DR   DGRC; 280
DR   FlyBase_Cell_line; FBtc0000280
DR   Wikidata; Q98129276
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Golgin245 locus (FlyBase_Gene=FBgn0034854).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-hairy-KO-BF3B
AC   CVCL_XF48
DR   DGRC; 298
DR   FlyBase_Cell_line; FBtc0000298
DR   Wikidata; Q98129277
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0001168; hairy.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   S2R+-His2Av-mNeonGreen B11
AC   CVCL_XF49
DR   DGRC; 295
DR   FlyBase_Cell_line; FBtc0000295
DR   Wikidata; Q98129278
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of neonGreen into the His2AV locus (FlyBase_Gene=FBgn0001197).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZRKRV; mNeonGreen (Note=Derivative of Branchiostoma lanceolatum LanYFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 9
//
ID   S2R+-IA2-KO
AC   CVCL_UD33
DR   DGRC; 266
DR   FlyBase_Cell_line; FBtc0000266
DR   Wikidata; Q98129279
RX   PubMed=29223976;
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0031294; IA-2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   S2R+-Lam-GFP-7
AC   CVCL_XF69
DR   DGRC; 292
DR   FlyBase_Cell_line; FBtc0000292
DR   Wikidata; Q98129280
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Lam locus (FlyBase_Gene=FBgn0002525).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Lamin-mNeonGreen D6
AC   CVCL_XF50
DR   DGRC; 296
DR   FlyBase_Cell_line; FBtc0000296
DR   Wikidata; Q98129281
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of neonGreen into the Lam locus (FlyBase_Gene=FBgn0002525).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZRKRV; mNeonGreen (Note=Derivative of Branchiostoma lanceolatum LanYFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 9
//
ID   S2R+-Moe-KO-21B4
AC   CVCL_A5UF
SY   S2R+-Moe KO-21B4
DR   DGRC; 303
DR   FlyBase_Cell_line; FBtc0000303
DR   Wikidata; Q107116822
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0011661; Moe.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2R+-msl2-KO
AC   CVCL_D5B3
DR   DGRC; 341
DR   FlyBase_Cell_line; FBtc0000341
DR   Wikidata; Q127384154
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0005616; msl-2.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   S2R+-MT-sfGFP-TurboID
AC   CVCL_E8FZ
DR   DGRC; 350
DR   FlyBase_Cell_line; FBtc0000350
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a MT-sfGFP-TurboID construct containing a fusion of sfGFP with TurboID, a modified biotin ligase used for proximity labeling to identify proteins interacting with a protein of interest. The expression of the fusion protein is driven by a copper-inducible metallothionein promoter (DGRC=350).
CC   Genetic integration: Method=Transfection; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06709; Escherichia coli birA (Note=With p.Gln65Pro, p.Ile87Val, p.Arg118Ser, p.Glu140Lys, p.Gln141Arg, p.Ala146del, p.Ser150Gly, p.Leu151Pro, p.Val160Ala, p.Thr192Ala, p.Lys194Ile, p.Met209Val, p.Met241Thr, p.Ser263Pro and p.Ile305Val = TurboID).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   S2R+-MT-sfGFP-TurboID-ER
AC   CVCL_E8G0
DR   DGRC; 351
DR   FlyBase_Cell_line; FBtc0000351
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a MT-sfGFP-TurboID-ER construct containing a fusion of sfGFP with TurboID-ER, a modified biotin ligase targeted to the ER and used for proximity labeling to identify proteins interacting with a protein of interest. The expression of the fusion protein is driven by a copper-inducible metallothionein promoter (DGRC=351).
CC   Genetic integration: Method=Transfection; Gene=FPbase; B4SOW; Superfolder GFP (Note=sfGFP, superfolding variant of GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06709; Escherichia coli birA (Note=With p.Gln65Pro, p.Ile87Val, p.Arg118Ser, p.Glu140Lys, p.Gln141Arg, p.Ala146del, p.Ser150Gly, p.Leu151Pro, p.Val160Ala, p.Thr192Ala, p.Lys194Ile, p.Met209Val, p.Met241Thr, p.Ser263Pro and p.Ile305Val and with a C-terminal KDEL tag = TurboID-ER).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   S2R+-MT::Cas9
AC   CVCL_UD30
DR   DGRC; 268
DR   FlyBase_Cell_line; FBtc0000268
DR   Wikidata; Q98129282
RX   PubMed=32958931;
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (DGRC=268).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_0Q79 ! S2R+-NPT005
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 9
//
ID   S2R+-NPT005
AC   CVCL_0Q79
SY   S2R NPT005; NPT005
DR   DGRC; 229
DR   FlyBase_Cell_line; FBtc0000229
DR   Wikidata; Q54951888
RX   PubMed=22174071;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   S2R+-NPT005deltaDsh7
AC   CVCL_D5B4
SY   S2R+-NPT005deltaDsh
DR   DGRC; 346
DR   FlyBase_Cell_line; FBtc0000346
DR   Wikidata; Q127384157
RX   PubMed=37995695;
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0000499; dsh.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_0Q79 ! S2R+-NPT005
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   S2R+-NPT005deltaDsh7deltaStbm8
AC   CVCL_D5XX
SY   S2R+-NPT005deltaDshdeltaStbm
DR   DGRC; 348
DR   FlyBase_Cell_line; FBtc0000348
DR   Wikidata; Q127384160
RX   PubMed=37995695;
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0000499; dsh.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0015838; Vang.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_D5B4 ! S2R+-NPT005deltaDsh7
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   S2R+-NPT005deltaDsh7deltaStbm8deltaFz16
AC   CVCL_D5B5
SY   S2R+-NPT005deltaDshdeltaStbmdeltaFz; S2R+-NPT005 TKO
DR   DGRC; 347
DR   FlyBase_Cell_line; FBtc0000347
DR   Wikidata; Q127384163
RX   PubMed=37995695;
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0000499; dsh.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0001085; fz.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0015838; Vang.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_D5XX ! S2R+-NPT005deltaDsh7deltaStbm8
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   S2R+-NPT017
AC   CVCL_0Q80
SY   NPT017
DR   DGRC; 230
DR   FlyBase_Cell_line; FBtc0000230
DR   Wikidata; Q54951890
RX   PubMed=22174071;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   S2R+-NPT050
AC   CVCL_0Q81
SY   NPT050
DR   DGRC; 231
DR   FlyBase_Cell_line; FBtc0000231
DR   Wikidata; Q54951891
RX   PubMed=22174071;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   S2R+-NPT101
AC   CVCL_0Q82
SY   NPT101
DR   DGRC; 232
DR   FlyBase_Cell_line; FBtc0000232
DR   Wikidata; Q54951893
RX   PubMed=22174071;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
ID   S2R+-PE2-P2A-EGFP
AC   CVCL_E8FV
DR   DGRC; 349
DR   FlyBase_Cell_line; FBtc0000349
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a PE2-P2A-EGFP construct containing the prime editor protein (PE2) which is a fusion between the S.pyogenes Cas9(H840A) and an engineered Moloney murine leukemia virus (MMLV) reverse transcriptase domain. PE2 enables gene editing at potentially any locus in the genome by transfecting a pegRNA specific for the desired target locus (DGRC=349).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.His840Ala).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_0Q79 ! S2R+-NPT005
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   S2R+-Pex19-KO-A1
AC   CVCL_A5UI
SY   S2R+ Pex19KO
DR   DGRC; 306
DR   FlyBase_Cell_line; FBtc0000306
DR   Wikidata; Q107116823
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0032407; Pex19.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2R+-polo-GFP-2
AC   CVCL_UZ54
SY   polo-GFP-2/Cas9
DR   DGRC; 275
DR   FlyBase_Cell_line; FBtc0000275
DR   Wikidata; Q98129283
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Polo locus (FlyBase_Gene=FBgn0003124).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   S2R+-Pten-KO-1A4
AC   CVCL_A5UJ
SY   S2R+-Pten KO-1A4
DR   DGRC; 307
DR   FlyBase_Cell_line; FBtc0000307
DR   Wikidata; Q107116825
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0026379; Pten.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2R+-Rab11-GFP-14
AC   CVCL_UW09
SY   Rab11-GFP-14/Cas9
DR   DGRC; 274
DR   FlyBase_Cell_line; FBtc0000274
DR   Wikidata; Q98129284
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Rab11 locus (FlyBase_Gene=FBgn0015790).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   S2R+-Sec23-GFP-6
AC   CVCL_XF70
DR   DGRC; 294
DR   FlyBase_Cell_line; FBtc0000294
DR   Wikidata; Q98129285
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Sec23 locus (FlyBase_Gene=FBgn0262125).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-Slik-KO-22C2
AC   CVCL_A5UK
DR   DGRC; 308
DR   FlyBase_Cell_line; FBtc0000308
DR   Wikidata; Q107116826
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0035001; Slik.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2R+-spin-GFP-2
AC   CVCL_XF71
DR   DGRC; 293
DR   FlyBase_Cell_line; FBtc0000293
DR   Wikidata; Q98129287
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the spin locus (FlyBase_Gene=FBgn0086676).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 8
//
ID   S2R+-SQH-GFP
AC   CVCL_0A58
DR   DGRC; 196
DR   FlyBase_Cell_line; FBtc0000196
DR   Wikidata; Q54951894
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0003514; sqh.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   S2R+-Tnks-KO
AC   CVCL_UD34
SY   Tnks-91
DR   DGRC; 270
DR   Wikidata; Q98129288
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0027508; Tnks.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   S2R+-Tnks-KO-10B
AC   CVCL_XF72
DR   DGRC; 300
DR   FlyBase_Cell_line; FBtc0000300
DR   Wikidata; Q98129290
RX   PubMed=32958931;
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: Using CRISPR/Cas9 Tnks alleles were replaced with an insertion cassette carrying PuroR.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0027508; Tnks.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   S2R+-Tnks-KO-12A
AC   CVCL_XF73
DR   DGRC; 299
DR   FlyBase_Cell_line; FBtc0000299
DR   Wikidata; Q98129291
RX   PubMed=32958931;
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: Using CRISPR/Cas9 Tnks alleles were replaced with an insertion cassette carrying PuroR.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0027508; Tnks.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   S2R+-Tnks-KO-3H
AC   CVCL_XF74
DR   DGRC; 301
DR   FlyBase_Cell_line; FBtc0000301
DR   Wikidata; Q98129292
RX   PubMed=32958931;
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: Using CRISPR/Cas9 Tnks alleles were replaced with an insertion cassette carrying PuroR.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0027508; Tnks.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   S2R+-Tom20-GFP-2
AC   CVCL_XF75
DR   DGRC; 302
DR   FlyBase_Cell_line; FBtc0000302
DR   Wikidata; Q98129293
CC   Group: Insect cell line.
CC   From: Drosophila RNAi Screening Center (DRSC), Harvard Medical School; Boston; USA.
CC   Characteristics: The constitutively Cas9-expressed parent cell line was modified with a knock-in of eGFP into the Tom20 locus (FlyBase_Gene=FBgn0036928).
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   S2R+-TSC1-KO-C5
AC   CVCL_A5UH
SY   S2R+-TSC1 KO-C5
DR   DGRC; 305
DR   FlyBase_Cell_line; FBtc0000305
DR   Wikidata; Q107116827
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0026317; Tsc1.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2R+-Ubi-pHMA
AC   CVCL_1B59
DR   DGRC; 217
DR   FlyBase_Cell_line; FBtc0000217
DR   Wikidata; Q54951897
RX   PubMed=20014104;
CC   Group: Insect cell line.
CC   Doubling time: 82 hours (DGRC=217).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 9
//
ID   S2R+-Yki-KO-G7
AC   CVCL_A5UL
DR   DGRC; 309
DR   FlyBase_Cell_line; FBtc0000309
DR   Wikidata; Q107116828
CC   Group: Insect cell line.
CC   Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0034970; yki.
CC   Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_UD30 ! S2R+-MT::Cas9
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   S2R+-Znt63C-KO
AC   CVCL_UD35
DR   DGRC; 265
DR   FlyBase_Cell_line; FBtc0000265
DR   Wikidata; Q98129295
RX   PubMed=29223976;
CC   Group: Insect cell line.
CC   Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0035432; Znt63C.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z831 ! S2R+
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 7
//
ID   S3-1
AC   CVCL_GY00
SY   S3
DR   Wikidata; Q54951898
RX   PubMed=10864949;
RX   PubMed=16612388;
WW   Info; CIL; 35617; https://www.cellimagelibrary.org/images/35617
WW   Info; Xenbase; -; https://wiki.xenbase.org/xenwiki/index.php?title=Tissue_culture_of_Xenopus_cell_lines_S3,_XTC_(Stukenberg_lab)
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   NF stage 18
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 6
//
ID   S3-iPS4
AC   CVCL_C6VH
DR   Wikidata; Q117704831
RX   PubMed=20535210;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   S3.13
AC   CVCL_C7WR
SY   S3-13
DR   Wikidata; Q123033391
RX   PubMed=6603905;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human acute myelogenous leukemia 29 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   S3(LD5G11F4)
AC   CVCL_B4N5
DR   Wikidata; Q110433185
RX   PubMed=3804361;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   S37P-hTERT
AC   CVCL_C0QI
DR   PRIDE; PXD001282
DR   Wikidata; Q114312943
RX   PubMed=25489052;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18704; NAA10; Simple; p.Ser37Pro (c.109T>C); ClinVar=VCV000029927; Zygosity=Hemizygous (PubMed=25489052).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Proteomics; PTM; Acetylation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188215; Ogden syndrome
DI   ORDO; Orphanet_276432; Ogden syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   S3D3
AC   CVCL_G142
SY   s3D3; 3D3b
DR   CLO; CLO_0008924
DR   ATCC; HB-8331
DR   Wikidata; Q54951899
RX   Patent=US4710377;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8331.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Eimeria tenella sporozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   S3D8_Spike
AC   CVCL_A7AH
SY   S3D8
DR   RCB; RCB5393
DR   Wikidata; Q107116829
RX   PubMed=33524396;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   S4 [Mouse hybridoma against human URO2]
AC   CVCL_N332
SY   S.sub.4; URO2; URO-2
DR   Wikidata; Q54951901
RX   Patent=US4713352;
RX   Patent=US4935344;
RX   PubMed=3857626;
RX   PubMed=6946460;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8541.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen URO2 on renal cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   S4 [Mouse spermatogonia]
AC   CVCL_Y571
DR   Wikidata; Q54951902
RX   PubMed=12077424;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1202709; Tert.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonium; CL=CL_0000020.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6D
CA   Telomerase immortalized cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 10
//
ID   S4-1-15-5
AC   CVCL_J605
DR   TKG; TKG 0397
DR   Wikidata; Q54951915
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-11-1
AC   CVCL_J606
DR   TKG; TKG 0398
DR   Wikidata; Q54951916
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-11-3
AC   CVCL_J607
DR   TKG; TKG 0396
DR   Wikidata; Q54951917
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-15-10
AC   CVCL_J608
DR   TKG; TKG 0393
DR   Wikidata; Q54951919
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-15-13
AC   CVCL_J609
DR   TKG; TKG 0394
DR   Wikidata; Q54951920
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-15-14
AC   CVCL_J610
DR   TKG; TKG 0395
DR   Wikidata; Q54951922
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-15-6
AC   CVCL_J611
DR   TKG; TKG 0391
DR   Wikidata; Q54951923
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-15-7
AC   CVCL_J612
DR   TKG; TKG 0392
DR   Wikidata; Q54951925
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S4-3-15-8
AC   CVCL_J613
DR   TKG; TKG 0399
DR   Wikidata; Q54951926
RX   PubMed=2847359;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Human unknown antigen.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S42
AC   CVCL_B074
SY   S-42
DR   ATCC; CRL-2942
DR   Wikidata; Q54951927
RX   PubMed=1705958;
RX   PubMed=7523597;
CC   Doubling time: ~48 hours (ATCC=CRL-2942).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-3D
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   S4374-M32
AC   CVCL_WX11
SY   S-4374-M-32; S4374-M-32B
DR   Wikidata; Q98129296
RX   Patent=US3073746;
RX   PubMed=13838089;
CC   Characteristics: Produces gonadotropin.
CC   Derived from site: In situ; Fetal pituitary gland; UBERON=UBERON_0034875.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   S462
AC   CVCL_1Y70
SY   Patient 6 cell line
DR   EFO; EFO_0006292
DR   cancercelllines; CVCL_1Y70
DR   Cosmic; 1132062
DR   Cosmic; 1801809
DR   DepMap; ACH-002693
DR   Millipore; SCC414
DR   Wikidata; Q54951928
RX   PubMed=15207265;
RX   PubMed=15735744;
RX   PubMed=18650488;
RX   PubMed=21084276;
RX   PubMed=21695156;
RX   PubMed=23437333;
RX   PubMed=28556483;
RX   PubMed=32642732;
RX   PubMed=34059954;
RX   PubMed=36818284;
RX   PubMed=37798904;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Tumorigenic (PubMed=37798904).
CC   Doubling time: ~16 hours (PubMed=21084276); 1.61 days (PubMed=37798904).
CC   Karyotypic information: Average ploidy of 3.85 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous; Note=By translocation (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (PubMed=15207265; PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=15207265).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Tyr2285Ter (c.6855C>A) (p.Tyr2264Ter, c.6792C>A); ClinVar=VCV000185082; Zygosity=Heterozygous; Note=Germline (PubMed=15207265; PubMed=36818284; DepMap=ACH-002693).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Pro (c.329G>C); ClinVar=VCV000233627; Zygosity=Heterozygous (PubMed=21084276; DepMap=ACH-002693).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): Millipore=SCC414; PubMed=28556483; PubMed=36818284
ST   Amelogenin: X
ST   CSF1PO: 12 (PubMed=36818284)
ST   CSF1PO: 12,13 (Millipore=SCC414; PubMed=28556483)
ST   D13S317: 12
ST   D16S539: 11,13 (PubMed=36818284)
ST   D16S539: 13 (Millipore=SCC414; PubMed=28556483)
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 29 (PubMed=36818284)
ST   D21S11: 29,31 (Millipore=SCC414; PubMed=28556483)
ST   D2S1338: 23
ST   D3S1358: 14,17
ST   D5S818: 12 (PubMed=36818284)
ST   D5S818: 12,13 (Millipore=SCC414; PubMed=28556483)
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 11
ST   TH01: 7,8 (PubMed=36818284)
ST   TH01: 8 (Millipore=SCC414; PubMed=28556483)
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 16
//
ID   S462.TY
AC   CVCL_JK02
SY   S462-TY; S462TY
DR   cancercelllines; CVCL_JK02
DR   Wikidata; Q54951929
RX   PubMed=18281493;
RX   PubMed=28469964;
CC   Characteristics: Was created by passage of S462 as xenografts.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous; Note=By translocation (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Tyr2285Ter (c.6855C>A) (p.Tyr2264Ter, c.6792C>A); ClinVar=VCV000185082; Zygosity=Heterozygous; Note=Germline (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Pro (c.329G>C); ClinVar=VCV000233627; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y70 ! S462
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   S467
AC   CVCL_B0UJ
DR   CCRID; 4201PAT-CCTCC00439
DR   Wikidata; Q108821259
RX   Patent=CN103756973B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013193.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; E7BY76; Grass carp reovirus (strain GCRV-HZ08) protein NS38 (S10).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   S49 (Thy-1-a)
AC   CVCL_6518
DR   CLO; CLO_0008925
DR   ATCC; TIB-36
DR   BCRC; 60227
DR   Wikidata; Q54951932
RX   PubMed=667934;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6523 ! S49.1TB.2
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   S49 Kin-
AC   CVCL_D198
SY   Kin-S49; Kin-; kin-
DR   EFO; EFO_0001197
DR   Wikidata; Q54951930
RX   PubMed=2303438;
RX   PubMed=6627398;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6519 ! S49.1
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   S49.1
AC   CVCL_6519
SY   S49
DR   BTO; BTO_0001341
DR   CLO; CLO_0008926
DR   EFO; EFO_0001234
DR   ATCC; TIB-28
DR   BCRC; 60226
DR   ChEMBL-Cells; CHEMBL3307434
DR   ChEMBL-Targets; CHEMBL614891
DR   Lonza; 836
DR   PubChem_Cell_line; CVCL_6519
DR   Wikidata; Q54951933
RX   PubMed=5439579;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-422.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   S49.13R
AC   CVCL_D191
SY   S49.13r; S49.1A.13R
DR   Wikidata; Q54951934
RX   PubMed=4372597;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D193 ! S49.1TB4.1A
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   S49.143R
AC   CVCL_D192
SY   S49.143r; S49 143R; S49 143r
DR   Wikidata; Q54951935
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D193 ! S49.1TB4.1A
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   S49.1G.3
AC   CVCL_6520
SY   S49.1G3
DR   CLO; CLO_0008927
DR   ATCC; TIB-34
DR   Wikidata; Q54951937
RX   PubMed=4358928;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6519 ! S49.1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   S49.1G.3 PHA.100/0
AC   CVCL_6521
SY   S49.1G3 PHA.12P; S49.1G3.PHA.12P
DR   CLO; CLO_0008928
DR   ATCC; TIB-35
DR   Wikidata; Q54951938
RX   PubMed=4358928;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6520 ! S49.1G.3
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   S49.1H.1AG.6/2
AC   CVCL_6522
DR   CLO; CLO_0008929
DR   ATCC; TIB-29
DR   Wikidata; Q54951940
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_17650; Cortisol.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6519 ! S49.1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   S49.1TB.2
AC   CVCL_6523
DR   CLO; CLO_0008930
DR   ATCC; TIB-30
DR   Wikidata; Q54951941
RX   PubMed=4358928;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6519 ! S49.1
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   S49.1TB.4
AC   CVCL_0J65
DR   Wikidata; Q54951942
RX   PubMed=4358928;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6519 ! S49.1
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 6
//
ID   S49.1TB.4 DEX R.63
AC   CVCL_6524
DR   CLO; CLO_0008931
DR   ATCC; TIB-33
DR   Wikidata; Q54951943
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_41879; Dexamethasone.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J65 ! S49.1TB.4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   S49.1TB4.1A
AC   CVCL_D193
SY   S49.1A
DR   Wikidata; Q54951944
RX   PubMed=4372597;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J65 ! S49.1TB.4
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   S49.22R
AC   CVCL_D194
SY   S49.22r; S49.1A.22R
DR   Wikidata; Q54951945
RX   PubMed=4372597;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D193 ! S49.1TB4.1A
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   S49.55R
AC   CVCL_D195
SY   S49.55r; S49 55R; S49.1A.55R
DR   Wikidata; Q54951946
RX   PubMed=4372597;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D193 ! S49.1TB4.1A
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   S49.75R
AC   CVCL_D196
SY   S49.75r; S49.1A.75R
DR   Wikidata; Q54951947
RX   PubMed=4372597;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D193 ! S49.1TB4.1A
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   S49.A2
AC   CVCL_D197
SY   S49A2
DR   BTO; BTO_0003211
DR   Wikidata; Q54951948
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D193 ! S49.1TB4.1A
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 8
//
ID   S4B6
AC   CVCL_U242
DR   Wikidata; Q54951949
RX   Patent=US4690893;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8794.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04351; Mouse Il2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   S4B6-1
AC   CVCL_9236
DR   CLO; CLO_0008932
DR   ATCC; HB-10968
DR   Wikidata; Q54951953
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10968.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04351; Mouse Il2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U242 ! S4B6
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   S4B634
AC   CVCL_2H36
DR   BCRJ; 0216
DR   Wikidata; Q54951952
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04351; Mouse Il2.
CC   Discontinued: BCRJ; 0216; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_U242 ! S4B6
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   S4T
AC   CVCL_0P66
DR   Wikidata; Q54951954
RX   PubMed=2969255;
CC   Transformant: ChEBI; CHEBI_28112; Nickel atom.
CC   Breed/subspecies: Wistar Albino Glaxo (WAG); RS=RS_0000967.
DI   NCIt; C60504; Rat rhabdomyosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_0P64 ! RMS/0
OI   CVCL_0P65 ! RMS/8
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   S5 [Mouse hybridoma against human astrocytoma 120 kd protein]
AC   CVCL_G143
DR   CLO; CLO_0008933
DR   ATCC; HB-9255
DR   Wikidata; Q54951955
RX   Patent=US5059523;
RX   PubMed=2877731;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9255.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human astrocytoma 120 kd protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   S5 [Mouse hybridoma against human DRw13/DR2]
AC   CVCL_HF34
DR   ECACC; 99061827
DR   Wikidata; Q54951956
RX   PubMed=2423487;
CC   Monoclonal antibody isotype: IgM.
CC   Discontinued: ECACC; 99061827; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 5
//
ID   S5.7
AC   CVCL_C7WS
DR   Wikidata; Q123033393
RX   PubMed=6236145;
RX   PubMed=6603905;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P60033; Human CD81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   S520
AC   CVCL_AX35
SY   Patient 2 cell line
DR   cancercelllines; CVCL_AX35
DR   Cosmic; 1801810
DR   Wikidata; Q54951957
RX   PubMed=15207265;
RX   PubMed=15735744;
RX   PubMed=32642732;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (PubMed=15207265).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=15207265).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg440Ter (c.1318C>T); ClinVar=VCV000230673; Zygosity=Heterozygous (PubMed=15207265).
CC   Derived from site: In situ; Shoulder; UBERON=UBERON_0001467.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   S58-SF
AC   CVCL_1Y18
SY   SUIT-58-Serum Free
DR   FCS-free; 166-2-308-1-3-3
DR   Wikidata; Q54951958
RX   PubMed=26141632;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 35.7 hours (PubMed=26141632).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y17 ! SUIT-58
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
ID   S5B9
AC   CVCL_U611
SY   s5B9
DR   ATCC; HB-8402
DR   Wikidata; Q54951959
RX   Patent=US4710377;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8402.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella sporozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   S5C1
AC   CVCL_C4LE
DR   Wikidata; Q116050197
RX   PubMed=9870527;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A 12S.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   S5C10
AC   CVCL_C4LJ
DR   Wikidata; Q116050198
RX   PubMed=9870527;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A 12S.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   S5C11
AC   CVCL_C4LK
DR   Wikidata; Q116050199
RX   PubMed=9870527;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A 12S.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   S5C3
AC   CVCL_C4LF
DR   Wikidata; Q116050200
RX   PubMed=9870527;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A 12S.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   S5C4
AC   CVCL_C4LG
DR   Wikidata; Q116050201
RX   PubMed=9870527;
RX   PubMed=12958429;
CC   Doubling time: ~40 hours (PubMed=9870527).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A 12S.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   S5C7
AC   CVCL_C4LH
DR   Wikidata; Q116050202
RX   PubMed=9870527;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A 12S.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   S5C8
AC   CVCL_C4LI
DR   Wikidata; Q116050203
RX   PubMed=9870527;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Ad2-Ad5 hybrid E1A 12S.
CC   Derived from site: In situ; Brain, endothelium; UBERON=UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   S5E5
AC   CVCL_U612
SY   s5E5
DR   ATCC; HB-8403
DR   Wikidata; Q54951960
RX   Patent=US4710377;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8403.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Eimeria tenella sporozoite antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   S635c15
AC   CVCL_U615
DR   Wikidata; Q54951972
RX   PubMed=3021915;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60436; Rat malignant astrocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   2-3M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   S68
AC   CVCL_5585
DR   Wikidata; Q54951974
CC   From: Catros-Quemener, Veronique; Cell Biology Department, University of Rennes; Rennes; France.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   S6B45
AC   CVCL_A1SE
DR   cancercelllines; CVCL_A1SE
DR   Wikidata; Q105510939
RX   PubMed=1720489;
RX   PubMed=8510328;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6018; IL6.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M538 ! MM-S1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   S6D8
AC   CVCL_C5DT
DR   Wikidata; Q116050204
RX   PubMed=6375980;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08168; Bovine SAG (Note=Also reacts with human, mouse, guinea-pig and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   S6F1
AC   CVCL_C551
DR   CLO; CLO_0008934
DR   ATCC; HB-9579
DR   CCRID; 4201PAT-CCTCC00030
DR   Wikidata; Q54951975
RX   Patent=US5002869;
RX   PubMed=2446140;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9579.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   S6H8
AC   CVCL_C5DU
DR   Wikidata; Q116050205
RX   PubMed=6375980;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08168; Bovine SAG (Note=Also reacts with human, mouse, guinea-pig and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   S79
AC   CVCL_CW62
DR   Wikidata; Q54951976
RX   PubMed=22316485;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O75683; Human SURF6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   S7D6
AC   CVCL_C5DV
DR   Wikidata; Q116050206
RX   PubMed=6375980;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08168; Bovine SAG (Note=Also reacts with human, mouse, guinea-pig and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   S8
AC   CVCL_CW33
DR   Wikidata; Q54951977
RX   Patent=US5168043;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9036.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   S805
AC   CVCL_AX36
DR   Cosmic; 1801812
DR   Wikidata; Q54951979
RX   PubMed=15735744;
RX   PubMed=32642732;
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   S87
AC   CVCL_JX94
DR   Wikidata; Q54951980
RX   PubMed=27436441;
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
CC   Breed/subspecies: European shorthair; VBO=VBO_0100063.
DI   NCIt; C135724; Feline large granular lymphocyte lymphoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 7
//
ID   S8D1
AC   CVCL_C5DW
DR   Wikidata; Q116050207
RX   PubMed=6375980;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08168; Bovine SAG (Note=Also reacts with human, mouse, guinea-pig and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   S9.6
AC   CVCL_G144
DR   CLO; CLO_0008936
DR   ATCC; HB-8730
DR   Wikidata; Q54951981
RX   PubMed=2422282;
RX   PubMed=16614443;
WW   Provider; NIH OTT; E-738-2013-0; https://web.archive.org/web/20210804015959/https://www.ott.nih.gov/tech/e-738-2013-0
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8730.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma is used for an antibody-based microarray assay for small RNA detection.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: DNA:RNA hybrids.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 8
//
ID   S91
AC   CVCL_J817
SY   NCTC 3960; NCTC-3960; Cloudman S91 melanoma
DR   ATCC; CCL-53
DR   ChEMBL-Cells; CHEMBL3308036
DR   ChEMBL-Targets; CHEMBL613525
DR   PubChem_Cell_line; CVCL_J817
DR   Wikidata; Q54951982
RX   DOI=10.1007/BF02618370;
CC   Discontinued: ATCC; CCL-53; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_UJ48 ! NCTC 3959
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   S91 6neo
AC   CVCL_J816
SY   S91-6neo; S91(6neo); 6neo
DR   Wikidata; Q54951983
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J817 ! S91
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   S9E2
AC   CVCL_C5DX
DR   Wikidata; Q116050208
RX   PubMed=6375980;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08168; Bovine SAG (Note=Specific to bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SA
AC   CVCL_E822
DR   dbMHC; 49014
DR   ECACC; 88052001
DR   IHW; IHW09001
DR   IPD-IMGT/HLA; 11356
DR   Wikidata; Q54951984
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02:01:01; B*07:02:01:01; C*07:02:01:03; DPB1*04:02:01; DQA1*01:01; DQB1*05:01:01; DRB1*01:01:01 (IPD-IMGT/HLA=11356).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   Sa Nar
AC   CVCL_4J62
DR   ATCC; CRL-1105
DR   Wikidata; Q54951985
CC   Discontinued: ATCC; CRL-1105; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 7
//
ID   SA-001-1D2
AC   CVCL_W540
DR   SKIP; SKIP000319
DR   Wikidata; Q54951986
RX   PubMed=24389010;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W537 ! SA-001-3B1
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   SA-001-3B1
AC   CVCL_W537
DR   SKIP; SKIP000276
DR   Wikidata; Q54951987
RX   PubMed=24389010;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2989; 22q11.2 deletion syndrome
DI   ORDO; Orphanet_567; 22q11.2 deletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W540 ! SA-001-1D2
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   SA-1077
AC   CVCL_C0NT
DR   Wikidata; Q114312945
RX   PubMed=2990594;
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   SA-1077-SV
AC   CVCL_C0NU
DR   Wikidata; Q114312946
RX   PubMed=2990594;
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Doubling time: ~20 hours (PubMed=2990594).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0NT ! SA-1077
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   SA-4
AC   CVCL_8910
SY   SA4; TxS-HuSa1; SA4TXS1
DR   ATCC; CRL-7938
DR   BioSample; SAMN03151754
DR   Cosmic; 2800528
DR   Wikidata; Q54951988
RX   PubMed=1246601;
RX   PubMed=4469665;
RX   PubMed=20143388;
RX   PubMed=22911243;
RX   PubMed=26643872;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4469665; PubMed=20143388). Originally thought to originate from a male patient suffering from a liposarcoma.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00085.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7938; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   SA001
AC   CVCL_B347
SY   SA01; Sahlgrenska 1; CEBe033-A
DR   GEO; GSM856727
DR   GEO; GSM862736
DR   hPSCreg; CEBe033-A
DR   NIHhESC; NIHhESC-10-0085
DR   SKIP; SKIP001961
DR   WiCell; sa01
DR   Wikidata; Q54951989
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=20177996;
RX   PubMed=23117585;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/32
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0085.
CC   Registration: Swiss research registry; BAG-hES-IMP-0031.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-14.
CC   HLA typing: A*01,02; B*07,35; C*04,07; DQB1*06; DRB1*13,15; DRB3*02; DRB5*01 (PubMed=16919167).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=sa01
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   SA002
AC   CVCL_B348
SY   SA02; Sahlgrenska 2; CEBe034-A
DR   GEO; GSM862737
DR   GEO; GSM1040247
DR   GEO; GSM1040317
DR   hPSCreg; CEBe034-A
DR   NIHhESC; NIHhESC-10-0086
DR   SKIP; SKIP001962
DR   WiCell; sa02
DR   Wikidata; Q54951990
RX   PubMed=15153613;
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=20177996;
RX   PubMed=23117585;
RX   PubMed=24259714;
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/34
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0086.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-14.
CC   HLA typing: A*01:23; B*07,51; C*07,15; DQB1*05; DRB1*14,14; DRB3*02 (PubMed=16919167).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=sa02
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11,14
ST   D16S539: 12,14
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   SA002.5
AC   CVCL_B290
SY   SA02.5; CEBe034-A-1
DR   hPSCreg; CEBe034-A-1
DR   SKIP; SKIP001759
DR   Wikidata; Q54951992
RX   PubMed=16919167;
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-14.
CC   HLA typing: A*01:23; B*07,51; C*07,15; DQB1*05; DRB1*14,14; DRB3*02 (PubMed=16919167).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 12,14
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B348 ! SA002
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 18
//
ID   SA003
AC   CVCL_B291
SY   SA03; Sahlgrenska 3; CEBe035-A
DR   hPSCreg; CEBe035-A
DR   SKIP; SKIP002076
DR   Wikidata; Q54951993
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 12
//
ID   SA046
AC   CVCL_B292
SY   SA46; CEBe007-A
DR   hPSCreg; CEBe007-A
DR   SKIP; SKIP001766
DR   Wikidata; Q54951994
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA085
AC   CVCL_B293
SY   CEBe009-A
DR   hPSCreg; CEBe009-A
DR   SKIP; SKIP001768
DR   Wikidata; Q54951995
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SA094
AC   CVCL_B294
SY   SA94; CEBe010-A
DR   hPSCreg; CEBe010-A
DR   SKIP; SKIP001769
DR   Wikidata; Q54951996
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA101
AC   CVCL_8908
SY   SA 101
DR   Wikidata; Q54951997
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=899730;
CC   Doubling time: 4 days (PubMed=899730).
CC   Derived from site: In situ; Brain, fronto-temporal lobe.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SA111
AC   CVCL_B295
SY   CEBe011-A
DR   hPSCreg; CEBe011-A
DR   SKIP; SKIP001770
DR   Wikidata; Q54951998
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA12
AC   CVCL_CW63
DR   Wikidata; Q54951999
RX   PubMed=7680508;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09428; Bovine IL1B (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   SA121
AC   CVCL_B296
SY   SA 121; CEBe012-A; CEBe036-A; ES Cell Line 121
DR   hPSCreg; CEBe012-A
DR   SKIP; SKIP001771
DR   Wikidata; Q54952000
RX   PubMed=15153613;
RX   PubMed=20177996;
RX   PubMed=26385115;
RX   PubMed=29026098;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-31.
CC   HLA typing: A*32,68; B*07,44; C*07;07; DQA1*01,01; DQB1*06,06; DRB1*13,15 (PubMed=29026098).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 17
//
ID   SA13
AC   CVCL_8975
DR   CLO; CLO_0008937
DR   ATCC; HB-8501
DR   BioSample; SAMN03471083
DR   Wikidata; Q54952001
RX   Patent=US4624921;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8501.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC   Discontinued: ATCC; HB-8501; true.
ST   Source(s): ATCC=HB-8501
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,10,12
ST   TH01: 8,9.3,10
ST   TPOX: 8,10,11
ST   vWA: 16,17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6416 ! LTR228
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 10
//
ID   SA134
AC   CVCL_A3BK
SY   SA 134
DR   Wikidata; Q105510942
RX   DOI=10.1007/0-306-46861-1_11;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SA137
AC   CVCL_A3BL
SY   SA 137
DR   Wikidata; Q105510945
RX   DOI=10.1007/0-306-46861-1_11;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SA142
AC   CVCL_B297
SY   CEBe013-A
DR   hPSCreg; CEBe013-A
DR   SKIP; SKIP001772
DR   Wikidata; Q54952002
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SA146 I
AC   CVCL_A3BM
SY   SA146; SA 146
DR   Wikidata; Q105510948
RX   PubMed=7684596;
RX   PubMed=9341940;
CC   Doubling time: 63 hours (Note=At 7th passage), 97 hours (Note=At 28th passage) (PubMed=9341940).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SA146 II
AC   CVCL_A3BN
DR   Wikidata; Q105510952
RX   PubMed=9341940;
CC   Characteristics: Established from a xenograft (SA146 XT) obtained from the parent cell line after subcutaneous injection into the thorax of nude mice.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A3BM ! SA146 I
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SA167
AC   CVCL_B298
SY   SA 167; CEBe014-A; ES Cell Line 167
DR   hPSCreg; CEBe014-A
DR   SKIP; SKIP001773
DR   Wikidata; Q54952003
RX   PubMed=20177996;
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: Swiss research registry; BAG-hES-IMP-0030.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-31.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA181
AC   CVCL_B299
SY   CEBe015-A; ES Cell Line 181
DR   hPSCreg; CEBe015-A
DR   SKIP; SKIP001774
DR   Wikidata; Q54952005
RX   PubMed=15153613;
RX   PubMed=20177996;
RX   PubMed=23856292;
RX   PubMed=26385115;
RX   PubMed=29026098;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-31.
CC   HLA typing: A*02,68; B*08,39; C*07,12; DQA1*02,05; DQB1*02,02; DRB1*03,07 (PubMed=29026098).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   SA191
AC   CVCL_B300
SY   CEBe016-A
DR   hPSCreg; CEBe016-A
DR   SKIP; SKIP001775
DR   Wikidata; Q54952006
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA196
AC   CVCL_B301
SY   CEBe017-A
DR   hPSCreg; CEBe017-A
DR   SKIP; SKIP001776
DR   Wikidata; Q54952007
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA2
AC   CVCL_JL50
SY   SA-2
DR   Wikidata; Q54952009
RX   PubMed=9885975;
RX   PubMed=15750630;
RX   PubMed=20638124;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Breed/subspecies: CBA/Ca.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 3
//
ID   SA202
AC   CVCL_B302
SY   CEBe018-A
DR   hPSCreg; CEBe018-A
DR   SKIP; SKIP001777
DR   Wikidata; Q54952010
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA203
AC   CVCL_B303
SY   CEBe019-A
DR   hPSCreg; CEBe019-A
DR   SKIP; SKIP001778
DR   Wikidata; Q54952011
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SA211
AC   CVCL_B304
SY   CEBe020-A
DR   hPSCreg; CEBe020-A
DR   SKIP; SKIP001779
DR   Wikidata; Q54952012
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SA218
AC   CVCL_B305
SY   CEBe021-A
DR   hPSCreg; CEBe021-A
DR   SKIP; SKIP001780
DR   Wikidata; Q54952013
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA22
AC   CVCL_G145
DR   CLO; CLO_0008938
DR   ATCC; CRL-2052
DR   Wikidata; Q54952014
RX   PubMed=7680508;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09428; Bovine IL1B (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SA240
AC   CVCL_B306
SY   CEBe022-A
DR   hPSCreg; CEBe022-A
DR   SKIP; SKIP001781
DR   Wikidata; Q54952017
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA279
AC   CVCL_B307
SY   CEBe024-A
DR   hPSCreg; CEBe024-A
DR   SKIP; SKIP001783
DR   Wikidata; Q54952026
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   Sa3
AC   CVCL_8063
SY   Sa-3
DR   BTO; BTO_0006553
DR   CLO; CLO_0050150
DR   BioSample; SAMN03472193
DR   cancercelllines; CVCL_8063
DR   GEO; GSM850386
DR   Progenetix; CVCL_8063
DR   RCB; RCB0980
DR   Wikidata; Q54952028
RX   DOI=10.5794/jjoms.39.965;
RX   PubMed=15756446;
CC   Population: Japanese.
CC   Doubling time: 55 hours (DOI=10.5794/jjoms.39.965).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): RCB=RCB0980
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 14
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8173; Upper gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Sa3R
AC   CVCL_C8QA
SY   Sa-3R
DR   Wikidata; Q123033395
RX   PubMed=15756446;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C8173; Upper gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8063 ! Sa3
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   SA348
AC   CVCL_B308
SY   CEBe023-A
DR   hPSCreg; CEBe023-A
DR   SKIP; SKIP001782
DR   Wikidata; Q54952029
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA352
AC   CVCL_B309
SY   CEBe025-A
DR   hPSCreg; CEBe025-A
DR   SKIP; SKIP001784
DR   Wikidata; Q54952030
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA39
AC   CVCL_8909
SY   SA 39
DR   Wikidata; Q54952032
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=899730;
RX   PubMed=7684596;
CC   Doubling time: 3 days (PubMed=899730).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SA399
AC   CVCL_B310
SY   CEBe026-A
DR   hPSCreg; CEBe026-A
DR   SKIP; SKIP001785
DR   Wikidata; Q54952033
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA4 [Human glioblastoma]
AC   CVCL_X210
SY   SA 4
DR   Wikidata; Q54952034
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=899730;
RX   PubMed=7684596;
CC   Doubling time: 1 day (PubMed=899730).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   SA4 [Human leukemia]
AC   CVCL_A1KY
DR   Wikidata; Q102114854
RX   PubMed=8652393;
CC   Karyotypic information: 46,XY (PubMed=8652393).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Leu).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1KZ ! SA4-2
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   SA4-2
AC   CVCL_A1KZ
SY   SA42
DR   Wikidata; Q102114855
RX   PubMed=8652393;
CC   Karyotypic information: 45,XY,-20 (PubMed=8652393).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7989; NRAS (Note=With p.Gln61Leu).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: SA4-3; PubMed=8652393; Note=In two instances in the text.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1KY ! SA4 [Human leukemia]
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   SA44
AC   CVCL_8911
SY   SA 44
DR   Wikidata; Q54952035
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=899730;
CC   Doubling time: 1 day (PubMed=899730).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SA45
AC   CVCL_8912
SY   SA 45
DR   Wikidata; Q54952037
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=899730;
RX   PubMed=7684596;
CC   Doubling time: 1 day (PubMed=899730).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SA461
AC   CVCL_B311
SY   CEBe027-A; ES Cell Line 461
DR   hPSCreg; CEBe027-A
DR   SKIP; SKIP001786
DR   Wikidata; Q54952038
RX   PubMed=20177996;
RX   PubMed=26385115;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-31.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   Sa5
AC   CVCL_M546
DR   Wikidata; Q54952039
RX   CelloPub=CLPUB00107;
RX   PubMed=10936422;
CC   Characteristics: Produces Ig kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   SA502
AC   CVCL_B312
SY   CEBe028-A
DR   hPSCreg; CEBe028-A
DR   SKIP; SKIP001787
DR   Wikidata; Q54952040
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA506
AC   CVCL_B313
SY   CEBe029-A
DR   hPSCreg; CEBe029-A
DR   SKIP; SKIP001788
DR   Wikidata; Q54952041
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA521
AC   CVCL_B314
SY   CEBe030-A
DR   hPSCreg; CEBe030-A
DR   SKIP; SKIP001789
DR   Wikidata; Q54952042
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA540
AC   CVCL_B315
SY   CEBe031-A
DR   hPSCreg; CEBe031-A
DR   SKIP; SKIP001790
DR   Wikidata; Q54952043
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC05-21.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA611
AC   CVCL_B316
SY   CEBe032-A
DR   hPSCreg; CEBe032-A
DR   SKIP; SKIP001791
DR   Wikidata; Q54952044
RX   PubMed=20177996;
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-15.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SA7K
AC   CVCL_B5ZP
SY   RPTEC SA7K control cell line; RPTC-HK016 Zen Bio
DR   Sigma-Aldrich; MTOX1030
DR   Wikidata; Q112044506
RX   PubMed=28401035;
CC   Population: African American.
CC   Characteristics: The cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (Sigma-Aldrich=MTOX1030).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8-9Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 6
//
ID   SA7K MATE1 KO
AC   CVCL_B6AV
SY   SA7K MATE1(-/-)
DR   Wikidata; Q112044507
RX   DOI=10.1016/j.dmpk.2020.04.247;
CC   Population: African American.
CC   Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:25588; SLC47A1.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZP ! SA7K
SX   Female
AG   8-9Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   SA7K MATE1/MATE2K KO
AC   CVCL_B6AW
SY   SA7K MATE1/2K(-/-,-/-)
DR   Wikidata; Q112044508
RX   DOI=10.1016/j.dmpk.2020.04.247;
CC   Population: African American.
CC   Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:25588; SLC47A1.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:26439; SLC47A2.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZP ! SA7K
SX   Female
AG   8-9Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   SA7K MATE2K KO
AC   CVCL_B6AX
SY   SA7K MATE2K(-/-)
DR   Wikidata; Q112044509
RX   DOI=10.1016/j.dmpk.2020.04.247;
CC   Population: African American.
CC   Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:26439; SLC47A2.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZP ! SA7K
SX   Female
AG   8-9Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   SA7K MDR1 KO
AC   CVCL_B5ZQ
SY   RPTEC MDR1 (P-gp) Knockout Cells; PTEC MDR1(-/-)
DR   Sigma-Aldrich; MTOX1071
DR   Wikidata; Q112044510
CC   Population: African American.
CC   Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZP ! SA7K
SX   Female
AG   8-9Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   SA7K OCT2 KO
AC   CVCL_B5ZR
SY   RPTEC OCT2 KO Cells
DR   Sigma-Aldrich; MTOX1080
DR   Wikidata; Q112044512
CC   Population: African American.
CC   Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line).
CC   Knockout cell: Method=ZFN; HGNC; HGNC:10966; SLC22A2.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5ZP ! SA7K
SX   Female
AG   8-9Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   SaA fibroblast
AC   CVCL_B7LT
DR   Wikidata; Q114312947
RX   PubMed=11466404;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (from autologous cell line SaA LCL).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LU ! SaA LCL
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SaA LCL
AC   CVCL_B7LU
DR   Wikidata; Q114312948
RX   PubMed=11466404;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (PubMed=11466404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LT ! SaA fibroblast
SX   Female
AG   11Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SAA1-iPSC
AC   CVCL_A4SI
SY   SAA1
DR   SKIP; SKIP003046
DR   Wikidata; Q107116830
RX   PubMed=29374141;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61229; Severe aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SAA2-iPSC
AC   CVCL_A4SJ
SY   SAA2
DR   SKIP; SKIP003047
DR   Wikidata; Q107116831
RX   PubMed=29374141;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61229; Severe aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SAA3-iPSC
AC   CVCL_A4SK
SY   SAA3
DR   SKIP; SKIP003048
DR   Wikidata; Q107116832
RX   PubMed=29374141;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61229; Severe aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SaB-1
AC   CVCL_A9H7
SY   Sparus aurata Brain-1
DR   ABM; T0849
DR   Wikidata; Q102114856
RX   PubMed=32771610;
CC   Group: Fish cell line.
CC   Characteristics: Neural stem cells, have a neuron-like morphology and show a rapid growth in culture (PubMed=32771610).
CC   Virology: Susceptible to infection by nervous necrosis virus (NNV), spring viremia carp virus (SVCV), infectious pancreatic necrosis virus (IPNV) and viral hemorrhagic septicemia virus (VHSV) (PubMed=32771610).
CC   Doubling time: 35.5 hours (PubMed=32771610).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 7
//
ID   SAB-113B
AC   CVCL_B891
DR   Wikidata; Q54952045
RX   PubMed=22039509;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B892 ! SAB-113D
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   SAB-113D
AC   CVCL_B892
DR   Wikidata; Q54952046
RX   PubMed=22039509;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B891 ! SAB-113B
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   SaBa
AC   CVCL_U956
DR   Wikidata; Q54952048
RX   PubMed=14490970;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   SaBE-1
AC   CVCL_Y567
SY   SaBE1; Sparus aurata Blastula Embryo-1
DR   Wikidata; Q54952049
RX   PubMed=10596751;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Blastula stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   SaBE-1c
AC   CVCL_Y568
SY   Sa BE-1c
DR   Wikidata; Q54952050
RX   PubMed=12113460;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
HI   CVCL_Y567 ! SaBE-1
SX   Sex unspecified
AG   Blastula stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   Sable 1194
AC   CVCL_A7UA
DR   Wikidata; Q107116833
RX   PubMed=9577776;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776).
CC   Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317.
OX   NCBI_TaxID=37189; ! Hippotragus niger (Sable antelope)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SAC-IIB2
AC   CVCL_XA37
SY   SAC-IIb2; SACIIB2
DR   Wikidata; Q98129297
RX   CelloPub=CLPUB00530;
RX   DOI=10.1007/BF02997220;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA35 ! SRS-82
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   SAC-IIC3
AC   CVCL_XA36
SY   SACIIC3
DR   Wikidata; Q98129298
RX   CelloPub=CLPUB00530;
RX   DOI=10.1007/BF02997220;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA35 ! SRS-82
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   SAC-IID9
AC   CVCL_XA39
SY   SACIID9
DR   Wikidata; Q98129299
RX   DOI=10.1007/BF02997220;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA35 ! SRS-82
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   SACC-83
AC   CVCL_H589
SY   SACC83
DR   EFO; EFO_0022679
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00034
DR   GEO; GSM1670400
DR   PharmacoDB; SACC83_1341_2019
DR   Wikidata; Q54952051
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=2163817;
RX   PubMed=18620900;
RX   PubMed=21441221;
RX   PubMed=23673996;
RX   PubMed=27397505;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Salivary gland, sublingual gland; UBERON=UBERON_0001832.
ST   Source(s): PubMed=23673996
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,16,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,16,17
ST   FGA: 18,21
ST   Penta D: 9,12
ST   vWA: 14,16
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   SACC-LM
AC   CVCL_H590
SY   SACCLM
DR   EFO; EFO_0022584
DR   ChEMBL-Cells; CHEMBL3307736
DR   ChEMBL-Targets; CHEMBL614893
DR   PubChem_Cell_line; CVCL_H590
DR   Wikidata; Q54952052
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=18620900;
RX   PubMed=21441221;
RX   PubMed=23673996;
CC   Population: Chinese.
CC   Characteristics: Highly metastatic to lung.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Salivary gland, sublingual gland; UBERON=UBERON_0001832.
ST   Source(s): PubMed=23673996
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,16,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,16,17
ST   FGA: 18,21
ST   Penta D: 9,12
ST   vWA: 14,16
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H589 ! SACC-83
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   SACC-LM-KRT19-KD
AC   CVCL_A5UD
DR   Wikidata; Q107116835
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6436; KRT19.
CC   Miscellaneous: Cell line information from personal communication of Kong, Lu.
CC   Derived from site: In situ; Salivary gland, sublingual gland; UBERON=UBERON_0001832.
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H590 ! SACC-LM
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SACHI
AC   CVCL_M501
DR   Cosmic; 2081406
DR   Wikidata; Q54952054
RX   PubMed=11429052;
RX   PubMed=12810253;
RX   PubMed=12886255;
RX   PubMed=17229644;
RX   PubMed=17692805;
RX   PubMed=18647998;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Population: Japanese.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   SACK-Xn 3C5
AC   CVCL_5L00
SY   3C5
DR   Kerafast; EJS001
DR   Wikidata; Q54952055
RX   Patent=US7655465;
RX   PubMed=22355691;
CC   Breed/subspecies: FVB/NTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Somatic stem cell
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   SACK-Xn 5B8
AC   CVCL_5L01
SY   5B8
DR   Wikidata; Q54952056
RX   Patent=US7655465;
RX   PubMed=22355691;
CC   Breed/subspecies: FVB/NTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Somatic stem cell
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 4
//
ID   SACK-Xs 12(3)
AC   CVCL_5K97
DR   Kerafast; EJS002
DR   Wikidata; Q54952057
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Somatic stem cell
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   SACK-Xs Lig-13
AC   CVCL_5K98
SY   Lig-13
DR   Kerafast; EJS004
DR   Wikidata; Q54952058
RX   Patent=US8404481;
CC   Group: Patented cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Somatic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   SACK-Xs Lig-8
AC   CVCL_5K99
SY   Lig-8
DR   Kerafast; EJS003
DR   Wikidata; Q54952060
RX   Patent=US8404481;
CC   Group: Patented cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Somatic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   SAD1
AC   CVCL_YE11
DR   Wikidata; Q98129300
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   SAE
AC   CVCL_6E24
SY   Squalus Acanthias Embryo
DR   Wikidata; Q38596705
RX   PubMed=16949345;
RX   PubMed=20471924;
RX   PubMed=22497417;
CC   Group: Fish cell line.
CC   Doubling time: ~1 week (PubMed=16949345).
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7797; ! Squalus acanthias (Spiny dogfish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   SaE fibroblast
AC   CVCL_B7LV
DR   Wikidata; Q114312949
RX   PubMed=11466404;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (from autologous cell line SaE LCL).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LW ! SaE LCL
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SaE LCL
AC   CVCL_B7LW
DR   Wikidata; Q114312950
RX   PubMed=11466404;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (PubMed=11466404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LV ! SaE fibroblast
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SAEC-A3
AC   CVCL_A7MV
DR   Wikidata; Q107116836
RX   PubMed=34044158;
CC   Group: Fish cell line.
CC   Doubling time: 1.7 days (PubMed=34044158).
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SAEC-C1
AC   CVCL_A7MW
DR   Wikidata; Q107116837
RX   CelloPub=CLPUB00629;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gastrula; UBERON=UBERON_0004734.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Gastrula stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SAEC-F1
AC   CVCL_A7MX
DR   Wikidata; Q107116838
RX   CelloPub=CLPUB00629;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gastrula; UBERON=UBERON_0004734.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Gastrula stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SAEC-H7
AC   CVCL_A7MU
DR   Wikidata; Q107116839
RX   CelloPub=CLPUB00628;
RX   PubMed=34044158;
CC   Group: Fish cell line.
CC   Doubling time: 1.7 days (PubMed=34044158).
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SAF-1
AC   CVCL_4295
SY   SAF1; Sparus Aurata Fin-1; Sparus Aurata Fibroblast-1
DR   BTO; BTO_0003506
DR   ECACC; 00122301
DR   Wikidata; Q54952061
RX   DOI=10.1016/S0044-8486(96)01469-X;
RX   DOI=10.3390/fishes7060354;
RX   PubMed=10092979;
RX   PubMed=15976938;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   Safi-1
AC   CVCL_1E92
DR   Wikidata; Q54952062
RX   DOI=10.1007/978-1-4757-1647-4_5;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 5
//
ID   SAG5-BC11
AC   CVCL_E7DU
RX   PubMed=28186433;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Fasciola hepatica 27 kDa excretory-secretory antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SAHGMUi001-A
AC   CVCL_A1WU
SY   NS-iPSC
DR   BioSamples; SAMEA7718792
DR   hPSCreg; SAHGMUi001-A
DR   Wikidata; Q105510956
RX   PubMed=33556917;
CC   From: The Second Affiliated Hospital of Guangzhou Medical University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:15464; SPINK5; Simple; p.Lys754Ter (c.2260A>T); ClinVar=VCV001379542; Zygosity=Heterozygous (PubMed=33556917).
CC   Sequence variation: Mutation; HGNC; HGNC:15464; SPINK5; Simple; p.Thr808Ile (c.2423C>T); ClinVar=VCV000848986; Zygosity=Heterozygous (PubMed=33556917).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84922; Netherton syndrome
DI   ORDO; Orphanet_634; Netherton syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   SaI
AC   CVCL_3595
SY   Sa1; Sa I; Sarcoma I
DR   CLO; CLO_0008944
DR   ATCC; CRL-2543
DR   Wikidata; Q54952064
RX   PubMed=14452904;
CC   Transformant: ChEBI; CHEBI_35299; Dibenz[a,h]anthracene (DBA).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6443 ! SaI/N
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 6
//
ID   SaI/N
AC   CVCL_6443
AS   CVCL_8137
SY   Sa1/N; SA1/N; Sa1N; SA1N
DR   CLO; CLO_0008945
DR   ATCC; CRL-2544
DR   Lonza; 65
DR   Wikidata; Q54952066
CC   Transformant: ChEBI; CHEBI_35299; Dibenz[a,h]anthracene (DBA).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3595 ! SaI
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 7
//
ID   Sai1
AC   CVCL_A5DS
SY   SAI1
DR   BTO; BTO_0006475
DR   Wikidata; Q107116841
RX   PubMed=23884946;
RX   PubMed=28041877;
CC   Characteristics: Neuroepithelial stem cell.
CC   Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5FW
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   Sai2
AC   CVCL_A5DT
SY   SAI2
DR   Wikidata; Q107116842
RX   PubMed=23884946;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Characteristics: Neuroepithelial stem cell.
CC   Miscellaneous: Sex of donor from personal communication of BioKryo (ISENET Biobanking).
CC   Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6FW
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   Sai3
AC   CVCL_A5DU
SY   SAI3
DR   Wikidata; Q107116843
RX   PubMed=23884946;
CC   Characteristics: Neuroepithelial stem cell.
CC   Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   5FW
CA   Somatic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SAIT-MET-AbF24
AC   CVCL_YK84
SY   AbF24
DR   Wikidata; Q98129301
RX   Patent=US8546544;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00219.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   SAIT-MET-Stan34
AC   CVCL_YK85
SY   Stan34
DR   Wikidata; Q98129302
RX   Patent=US8546544;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00223.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   SAJ008
AC   CVCL_F836
DR   IPD-IMGT/HLA; 11357
DR   Wikidata; Q54952067
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*47:01; DQA1*01:02,06:01; DQB1*03:01,06:02; DRB1*08:03:02,15:01 (IPD-IMGT/HLA=11357).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   SAJ022
AC   CVCL_F837
DR   IPD-IMGT/HLA; 11358
DR   Wikidata; Q54952069
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*26:05,33; DPB1*05:01,09:01; DQA1*01:02,01:03; DQB1*06:01,06:04; DRB1*13:02,15:02; DRB3*03:01 (IPD-IMGT/HLA=11358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   SAJ119
AC   CVCL_F838
DR   IPD-IMGT/HLA; 11359
DR   Wikidata; Q54952070
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*47:01 (IPD-IMGT/HLA=11359).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   Saka
AC   CVCL_4803
DR   Wikidata; Q54952072
RX   PubMed=7534699;
RX   PubMed=11864909;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=saka
CC   Doubling time: ~60 hours (PubMed=11864909).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Saka-tert
AC   CVCL_HA37
SY   SAKA-T
DR   Wikidata; Q54952073
RX   PubMed=11864909;
CC   Doubling time: 28.4 hours (PubMed=11864909).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4803 ! Saka
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   SAKRTLS 12.1
AC   CVCL_7699
SY   SAKRTLS12.1
DR   BTO; BTO_0002293
DR   Wikidata; Q54952074
RX   PubMed=1535337;
RX   PubMed=2530588;
CC   Breed/subspecies: AKR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 7
//
ID   Sal Mat
AC   CVCL_3596
DR   CLO; CLO_0008946
DR   ATCC; CRL-1110
DR   BioSample; SAMN03471328
DR   Wikidata; Q54952080
RX   PubMed=503099;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1110
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 13,19
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 18,19
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 11,14
ST   FGA: 22,28
ST   Penta D: 2.2,9
ST   Penta E: 7,10
ST   TH01: 7,9
ST   TPOX: 7,8
ST   vWA: 16,18
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   Sal-BL
AC   CVCL_7209
SY   Sal
DR   Wikidata; Q54952081
RX   PubMed=9882297;
RX   PubMed=12219084;
RX   PubMed=16051863;
RX   PubMed=28960205;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   SAL02
AC   CVCL_B4N6
SY   Sal-02
DR   ATCC; HB-11954
DR   Wikidata; Q110433186
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11954.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL03
AC   CVCL_B4N7
DR   Wikidata; Q110433187
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL04
AC   CVCL_B4N8
DR   Wikidata; Q110433188
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL05
AC   CVCL_B4N9
DR   Wikidata; Q110433189
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL06
AC   CVCL_B4NA
DR   Wikidata; Q110433191
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL07
AC   CVCL_B4NB
DR   Wikidata; Q110433192
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL08
AC   CVCL_B4NC
DR   Wikidata; Q110433193
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL09
AC   CVCL_B4ND
DR   Wikidata; Q110433194
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL1
AC   CVCL_S862
SY   SAL-1; SAL
DR   IARC_TP53; 23639
DR   Wikidata; Q54952083
RX   PubMed=2844401;
RX   PubMed=8378080;
RX   PubMed=9393981;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F122 ! SAL2
OI   CVCL_9681 ! STA-ET-1
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   SAL10
AC   CVCL_B4NE
DR   Wikidata; Q110433195
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL11
AC   CVCL_B4NF
DR   Wikidata; Q110433196
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL12
AC   CVCL_B4NG
DR   Wikidata; Q110433197
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL13
AC   CVCL_B4NH
DR   Wikidata; Q110433198
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL2
AC   CVCL_F122
SY   SAL-2
DR   IARC_TP53; 23640
DR   Wikidata; Q54952084
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=15192123;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S862 ! SAL1
OI   CVCL_9681 ! STA-ET-1
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 12
//
ID   SAL22
AC   CVCL_B4NI
DR   Wikidata; Q110433199
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL23
AC   CVCL_B4NJ
DR   Wikidata; Q110433201
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL24
AC   CVCL_B4NK
DR   Wikidata; Q110433202
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SAL25
AC   CVCL_B4NL
DR   Wikidata; Q110433203
RX   DOI=10.1021/jf00035a066;
RX   Patent=US5466784;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SALE
AC   CVCL_WS60
DR   BioSample; SAMN10988396
DR   DepMap; ACH-000064
DR   PharmacoDB; SALE_1342_2019
DR   Progenetix; CVCL_WS60
DR   Wikidata; Q98129304
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Caution: No information is available about this cell line except that it is a immortalized lung cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   Salim Mwalin
AC   CVCL_ZI21
DR   Wikidata; Q98129306
RX   PubMed=3026973;
RX   PubMed=24590883;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
ID   SALS-1
AC   CVCL_ZY84
DR   Wikidata; Q102114857
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY52 ! JaCALS LCL 001-0006
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-10
AC   CVCL_ZY93
DR   Wikidata; Q102114858
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY61 ! JaCALS LCL 001-0347
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-11
AC   CVCL_ZY94
DR   Wikidata; Q102114859
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY62 ! JaCALS LCL 001-0009
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-12
AC   CVCL_ZY95
DR   Wikidata; Q102114861
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY63 ! JaCALS LCL 001-0223
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-13
AC   CVCL_ZY96
DR   Wikidata; Q102114862
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY64 ! JaCALS LCL 001-0058
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-14
AC   CVCL_ZY97
DR   Wikidata; Q102114863
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY65 ! JaCALS LCL 023-0084
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-15
AC   CVCL_ZY98
DR   Wikidata; Q102114864
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY66 ! JaCALS LCL 023-0083
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-16
AC   CVCL_ZY99
DR   Wikidata; Q102114865
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY67 ! JaCALS LCL 023-0086
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-17
AC   CVCL_ZZ00
DR   Wikidata; Q102114867
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY68 ! JaCALS LCL 001-0459
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-18
AC   CVCL_ZZ01
DR   Wikidata; Q102114869
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY69 ! JaCALS LCL 001-0218
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-19
AC   CVCL_ZZ02
DR   Wikidata; Q102114870
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY70 ! JaCALS LCL 001-0431
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-2
AC   CVCL_ZY85
DR   Wikidata; Q102114871
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY53 ! JaCALS LCL 023-0052
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-20
AC   CVCL_ZZ03
DR   Wikidata; Q102114872
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY71 ! JaCALS LCL 001-0478
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-21
AC   CVCL_ZZ04
DR   Wikidata; Q102114873
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY72 ! JaCALS LCL 001-0126
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-22
AC   CVCL_ZZ05
DR   Wikidata; Q102114874
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY73 ! JaCALS LCL 001-0361
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-23
AC   CVCL_ZZ06
DR   Wikidata; Q102114875
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY74 ! JaCALS LCL 001-0481
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-24
AC   CVCL_ZZ07
DR   Wikidata; Q102114876
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY75 ! JaCALS LCL 001-0358
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-25
AC   CVCL_ZZ08
DR   Wikidata; Q102114878
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY76 ! JaCALS LCL 001-0460
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-26
AC   CVCL_ZZ09
DR   Wikidata; Q102114880
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY77 ! JaCALS LCL 023-0089
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-27
AC   CVCL_ZZ10
DR   Wikidata; Q102114882
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY78 ! JaCALS LCL 001-0482
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-28
AC   CVCL_ZZ11
DR   Wikidata; Q102114883
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY79 ! JaCALS LCL 023-0108
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-29
AC   CVCL_ZZ12
DR   Wikidata; Q102114884
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY80 ! JaCALS LCL 023-0009
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-3
AC   CVCL_ZY86
DR   Wikidata; Q102114885
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY54 ! JaCALS LCL 001-0040
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-30
AC   CVCL_ZZ13
DR   Wikidata; Q102114886
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY81 ! JaCALS LCL 001-0426
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-31
AC   CVCL_ZZ14
DR   Wikidata; Q102114887
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY82 ! JaCALS LCL 023-0100
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-32
AC   CVCL_ZZ15
DR   Wikidata; Q102114888
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY83 ! JaCALS LCL 023-0104
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-4
AC   CVCL_ZY87
DR   Wikidata; Q102114890
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY55 ! JaCALS LCL 001-0010
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-5
AC   CVCL_ZY88
DR   Wikidata; Q102114891
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY56 ! JaCALS LCL 001-0068
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-6
AC   CVCL_ZY89
DR   Wikidata; Q102114893
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY57 ! JaCALS LCL 001-0363
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-7
AC   CVCL_ZY90
DR   Wikidata; Q102114894
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY58 ! JaCALS LCL 001-0352
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-8
AC   CVCL_ZY91
DR   Wikidata; Q102114895
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY59 ! JaCALS LCL 001-0351
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SALS-9
AC   CVCL_ZY92
DR   Wikidata; Q102114896
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZY60 ! JaCALS LCL 023-0081
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   sALS2
AC   CVCL_UF88
DR   Wikidata; Q98129308
RX   PubMed=24379375;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   sALS5
AC   CVCL_UF89
DR   Wikidata; Q98129312
RX   PubMed=24379375;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   sALS9
AC   CVCL_UF90
DR   Wikidata; Q98129314
RX   PubMed=24379375;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   SALT-12
AC   CVCL_QZ48
DR   Wikidata; Q54952085
RX   PubMed=7768645;
CC   Population: Japanese.
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   SALT-3
AC   CVCL_A7NQ
DR   Wikidata; Q107116844
RX   PubMed=7474853;
RX   PubMed=8957066;
RX   PubMed=9116292;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   SALT-3/ADM cl-2
AC   CVCL_A7PZ
DR   Wikidata; Q107116846
RX   PubMed=9116292;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7NQ ! SALT-3
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   SaM fibroblast
AC   CVCL_B7LX
DR   Wikidata; Q114312951
RX   PubMed=11466404;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (from autologous cell line SaM LCL).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LY ! SaM LCL
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SAM iPSC clone 1
AC   CVCL_A4GX
DR   Wikidata; Q105510959
RX   PubMed=27934604;
CC   Characteristics: Stably expresses dCas9-VP64, a nuclease-deficient mutant of SpCas9 (dCas9) under the control of a promoter containing 4 copies of the activating domain of HSV-1 VP16 (termed VP64) and EF1a-MS2-P65-HSF1-2A-HygR where the coat protein of MS2 fused to the transactivation domain of p65(RELA) and of heat shock factor 1 (HSF1) (PubMed=27934604).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9955; RELA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03612; Escherichia phage MS2 capsid protein (Note=With p.Asn56Lys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GY ! SAM iPSC clone 2
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 12
//
ID   SAM iPSC clone 2
AC   CVCL_A4GY
DR   Wikidata; Q105510963
RX   PubMed=27934604;
CC   Characteristics: Stably expresses dCas9-VP64, a nuclease-deficient mutant of SpCas9 (dCas9) under the control of a promoter containing 4 copies of the activating domain of HSV-1 VP16 (termed VP64) and EF1a-MS2-P65-HSF1-2A-HygR where the coat protein of MS2 fused to the transactivation domain of p65(RELA) and of heat shock factor 1 (HSF1) (PubMed=27934604).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9955; RELA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03612; Escherichia phage MS2 capsid protein (Note=With p.Asn56Lys).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GX ! SAM iPSC clone 1
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 12
//
ID   SaM LCL
AC   CVCL_B7LY
DR   Wikidata; Q114312952
RX   PubMed=11466404;
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (PubMed=11466404).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LX ! SaM fibroblast
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SAM-1
AC   CVCL_8440
DR   BioSample; SAMN03151813
DR   Wikidata; Q54952086
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8562972;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=12412578;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=12412578; PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 22 year old male patient with chronic myelogenous leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00265.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SAM-19
AC   CVCL_WI55
DR   Lonza; 1248
DR   Wikidata; Q98129316
RX   PubMed=10544201;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WI54 ! PC60.21.14.4
CA   Hybrid cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   SAM-6
AC   CVCL_XI23
SY   SAM-6.10
DR   Wikidata; Q98129319
RX   Patent=US9273125;
RX   Patent=WO2009104100A2;
RX   PubMed=15173000;
RX   PubMed=17237291;
RX   PubMed=18268478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2903.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P11021; Human HSPA5/GRP78 (Note=Isoform SAM-6).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V19 ! HAB-1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   SAM-K
AC   CVCL_DF09
DR   Wikidata; Q54952087
RX   PubMed=12498315;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   SAML-1
AC   CVCL_9997
DR   ATCC; CRL-2776
DR   BioSample; SAMN03151985
DR   cancercelllines; CVCL_9997
DR   SKY/M-FISH/CGH; 1472
DR   Wikidata; Q54952088
RX   PubMed=12759925;
RX   PubMed=29533902;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/saml-1-atcc-crl-2776
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative. Originally thought to originate from a bone marrow aspirate from a 50 year old male patient suffering from a secondary acute myelogenous leukemia (AML) following Hodgkin's disease.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00424.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2776; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2776
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   SAML-2
AC   CVCL_9998
DR   ATCC; CRL-2840
DR   cancercelllines; CVCL_9998
DR   Cosmic; 975298
DR   SKY/M-FISH/CGH; 2854
DR   Wikidata; Q54952089
RX   PubMed=12759925;
RX   PubMed=14671638;
RX   PubMed=29533902;
CC   Characteristics: CSF2 dependent.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=12759925).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=12759925).
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Discontinued: ATCC; CRL-2840; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2840
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C8252; Therapy-related acute myeloid leukemia
DI   ORDO; Orphanet_86846; Therapy related acute myeloid leukemia and myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   SAN1
AC   CVCL_YE12
DR   Wikidata; Q98129321
RX   CelloPub=CLPUB00548;
RX   PubMed=4330463;
RX   PubMed=5287057;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   SANi001-A
AC   CVCL_QY82
SY   MIP 9 cl.25; MLL-7143-Cl1
DR   hPSCreg; SANi001-A
DR   Wikidata; Q54952091
RX   PubMed=29055227;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Megakaryoblast; CL=CL_0000553.
ST   Source(s): PubMed=29055227
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D21S11: 28,29
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   Penta D: 10,14
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   SANi002-A
AC   CVCL_QY83
SY   MIP 10 cl.9; MLL-10356-Cl2
DR   hPSCreg; SANi002-A
DR   Wikidata; Q54952092
RX   PubMed=29055227;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Megakaryoblast; CL=CL_0000553.
ST   Source(s): PubMed=29055227
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D21S11: 30
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 7,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   SANi003-A
AC   CVCL_QY86
SY   MEE630.cl5
DR   hPSCreg; SANi003-A
DR   Wikidata; Q54952093
RX   PubMed=29040913;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Caution: Indicated in PubMed=29040913 to originate from a female donor, but the karyotype is X,Y and the amelogenin STR locus is also X,Y.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): PubMed=29040913
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D21S11: 28,29
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 19,20
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY87 ! SANi003-B
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SANi003-B
AC   CVCL_QY87
SY   MEE630.cl4
DR   hPSCreg; SANi003-B
DR   Wikidata; Q54952094
RX   PubMed=29055227;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QY86 ! SANi003-A
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SANi004-A
AC   CVCL_VE28
SY   MEL 7; MEL1171.cl7
DR   hPSCreg; SANi004-A
DR   Wikidata; Q54952095
CC   From: Sanquin; Amsterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   SANi005-A
AC   CVCL_QY84
SY   BEL20 cl.8; BEL20.cl8
DR   hPSCreg; SANi005-A
DR   Wikidata; Q54952096
RX   PubMed=29055225;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:4238; GFI1B; Simple; p.Gln287Ter (c.859C>T); ClinVar=VCV000102428; Zygosity=Heterozygous (PubMed=29055225).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142084; Bleeding disorder, platelet-type 17
DI   ORDO; Orphanet_721; Gray platelet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   SANi006-A
AC   CVCL_A0JV
SY   PE2S.GPS38.cl6; GPS clone 6
DR   hPSCreg; SANi006-A
DR   Wikidata; Q108821260
RX   PubMed=34237592;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:31928; NBEAL2; Simple; p.Cys2190Alafs*23 (c.6568delT); ClinVar=VCV000982280; Zygosity=Heterozygous (PubMed=34237592).
CC   Sequence variation: Mutation; HGNC; HGNC:31928; NBEAL2; Simple; p.Leu2646Pro (c.7937T>C); ClinVar=VCV000982281; Zygosity=Heterozygous (PubMed=34237592).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84741; Gray platelet syndrome
DI   ORDO; Orphanet_721; Gray platelet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SANi007-A
AC   CVCL_A0JW
SY   PE2S.ELA239.cl9; ELA2 clone 9
DR   hPSCreg; SANi007-A
DR   Wikidata; Q108821261
RX   PubMed=34229202;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3309; ELANE; Simple; c.614delG; Zygosity=Heterozygous (PubMed=34229202).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SANi008-A
AC   CVCL_A0JX
SY   PE2S.LYST40.cl6; LYST clone 6
DR   hPSCreg; SANi008-A
DR   Wikidata; Q108821262
RX   PubMed=34224985;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Glu1441Valfs*11 (c.4322_4325delAGAG); ClinVar=VCV001173104; Zygosity=Heterozygous (PubMed=34224985).
CC   Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Asn3376Ser (c.10127A>G); ClinVar=VCV000065529; Zygosity=Heterozygous (PubMed=34224985).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2941; Chediak-Higashi syndrome
DI   ORDO; Orphanet_167; Chediak-Higashi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SANi009-A
AC   CVCL_A0JY
SY   PBL.HPS241.cl2; HPS2-90; HPS2 clone 2
DR   hPSCreg; SANi009-A
DR   Wikidata; Q108821263
RX   PubMed=34182253;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; p.Lys59Asnfs*5 (c.177delA); ClinVar=VCV000224763; Zygosity=Heterozygous (PubMed=34182253).
CC   Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; c.1839_1842delTAGA; ClinVar=VCV000224764; Zygosity=Heterozygous (PubMed=34182253).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150368; Hermansky-Pudlak syndrome 2
DI   ORDO; Orphanet_183678; Hermansky-Pudlak syndrome with neutropenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SANi010-A
AC   CVCL_A0JZ
SY   PBL.5486.cl3; WT-30 clone 3
DR   hPSCreg; SANi010-A
DR   Wikidata; Q108821264
RX   PubMed=34182253;
CC   From: Sanquin; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SaOS-1
AC   CVCL_1E51
SY   Sarcoma OSteogenic-1
DR   Wikidata; Q54952099
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=833871;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   SaOS-2
AC   CVCL_0548
SY   SAOS-2; Saos-2; SAOS 2; Saos 2; Saos2; SaOs2; SAOS2; Sarcoma OSteogenic-2; SaOS; SAOS
DR   BTO; BTO_0000971
DR   CLO; CLO_0008947
DR   CLO; CLO_0050140
DR   EFO; EFO_0022402
DR   MCCL; MCC:0000449
DR   CLDB; cl4250
DR   CLDB; cl4251
DR   CLDB; cl4252
DR   CLDB; cl5281
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7939
DR   ATCC; HTB-85
DR   BCRJ; 0217
DR   BioSample; SAMN01821594
DR   BioSample; SAMN01821661
DR   BioSample; SAMN03471126
DR   BioSample; SAMN10987923
DR   cancercelllines; CVCL_0548
DR   CancerTools; 161931
DR   CCRID; 1101HUM-PUMC000025
DR   CCRID; 3101HUMSCSP5057
DR   CCRID; 3101HUMTCHu114
DR   CCRID; 4201HUM-CCTCC00075
DR   CCTCC; GDC0075
DR   Cell_Model_Passport; SIDM01084
DR   ChEMBL-Cells; CHEMBL3307737
DR   ChEMBL-Targets; CHEMBL614894
DR   CLS; 300331
DR   Cosmic; 687930
DR   Cosmic; 755311
DR   Cosmic; 897500
DR   Cosmic; 909707
DR   Cosmic; 931039
DR   Cosmic; 931912
DR   Cosmic; 1044086
DR   Cosmic; 1044269
DR   Cosmic; 1070841
DR   Cosmic; 1074395
DR   Cosmic; 1082492
DR   Cosmic; 1529898
DR   Cosmic; 1733126
DR   Cosmic; 2301582
DR   Cosmic; 2816206
DR   Cosmic-CLP; 909707
DR   DepMap; ACH-000410
DR   DSMZ; ACC-243
DR   DSMZCellDive; ACC-243
DR   ECACC; 89050205
DR   EGA; EGAS00001000978
DR   GDSC; 909707
DR   GEO; GSM170249
DR   GEO; GSM185150
DR   GEO; GSM185151
DR   GEO; GSM320830
DR   GEO; GSM827588
DR   GEO; GSM879222
DR   GEO; GSM1639703
DR   GEO; GSM1639704
DR   GEO; GSM1670401
DR   GEO; GSM1676314
DR   GEO; GSM1701648
DR   GEO; GSM1915012
DR   GEO; GSM1915013
DR   IARC_TP53; 21653
DR   ICLC; HTL01001
DR   IZSLER; BS TCL 90
DR   KCB; KCB 200550YJ
DR   KCLB; 30085
DR   KCLB; 80023
DR   LiGeA; CCLE_519
DR   LINCS_LDP; LCL-1430
DR   Lonza; 747
DR   NCBI_Iran; C453
DR   PharmacoDB; Saos2_1343_2019
DR   PRIDE; PXD016398
DR   PRIDE; PXD017130
DR   PRIDE; PXD021564
DR   PRIDE; PXD025970
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0548
DR   PubChem_Cell_line; CVCL_0548
DR   RCB; RCB0428
DR   RCB; RCB3688
DR   TKG; TKG 0469
DR   TOKU-E; 3085
DR   Ubigene; YC-D017
DR   Wikidata; Q7420876
RX   PubMed=833871;
RX   PubMed=2233717;
RX   PubMed=2823272;
RX   PubMed=3040234;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=8617485;
RX   PubMed=10763916;
RX   PubMed=11416159;
RX   PubMed=12645653;
RX   PubMed=15150091;
RX   PubMed=15736406;
RX   PubMed=15939397;
RX   PubMed=16888811;
RX   PubMed=17354236;
RX   PubMed=17431109;
RX   PubMed=17981215;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21519327;
RX   PubMed=22075555;
RX   PubMed=23144859;
RX   PubMed=23671654;
RX   PubMed=24758355;
RX   PubMed=25031706;
RX   PubMed=26320182;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=29334376;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SaOS-2
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-20.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Saos-2_cells
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-osteosarcoma-cell-line-saos-2
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 771.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=16888811); 45.7 +- 3.3 hours (PubMed=10763916); ~48 hours (PubMed=21519327); 35-40 hours (CLS=300331); ~43 hours (DSMZ=ACC-243).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=2823272; PubMed=16888811; PubMed=19787792).
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.32%; Native American=0.17%; East Asian, North=0.46%; East Asian, South=0.55%; South Asian=6.66%; European, North=52.25%; European, South=38.6% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7939; true.
CC   Discontinued: KCLB; 80023; probable.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=HTB-85; CCRID; CLS=300331; Cosmic-CLP=909707; DSMZ=ACC-243; ECACC=89050205; PubMed=11416159; PubMed=19787792; RCB=RCB0428; TKG=TKG 0469
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 15 (CCRID; CLS=300331; DSMZ=ACC-243; PubMed=11416159)
ST   D18S51: 15,22 (ATCC=HTB-85; PubMed=19787792)
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 18
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,12
ST   FGA: 22,25
ST   Penta D: 11,12
ST   Penta E: 14,19
ST   SE33: 19,20
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   Saos-2 Tet-Off
AC   CVCL_KU47
DR   Wikidata; Q54952100
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630911.
CC   Discontinued: Takara/Clontech; Catalog number 631136.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 14
//
ID   Saos-2-EGFP
AC   CVCL_C8WB
DR   Ubigene; YC-D017-EGFP-P
DR   Wikidata; Q123033396
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Saos-2-Luc
AC   CVCL_C8WC
DR   Ubigene; YC-D017-Luc-P
DR   Wikidata; Q123033397
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SAOS-alpha2beta1
AC   CVCL_X642
SY   SAOS-a2b1
DR   BTO; BTO_0003778
DR   Wikidata; Q54952102
RX   PubMed=10525544;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6137; ITGA2.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   SaOS-LM1
AC   CVCL_9563
SY   SAOS-LM1
DR   Wikidata; Q54952103
RX   PubMed=10763916;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   SaOS-LM2
AC   CVCL_9564
SY   SAOS-LM2; SaOSLM2
DR   KCLB; 80024
DR   Wikidata; Q54952104
RX   PubMed=10763916;
CC   Population: Caucasian.
CC   Doubling time: 43.6 +- 4.2 hours (PubMed=10763916).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): KCLB=80024
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 8,10
ST   FGA: 22,25
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9563 ! SaOS-LM1
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   SaOS-LM3
AC   CVCL_9565
SY   SAOS-LM3
DR   Wikidata; Q54952105
RX   PubMed=10763916;
CC   Population: Caucasian.
CC   Doubling time: 44.1 +- 2.6 hours (PubMed=10763916).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9564 ! SaOS-LM2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   SaOS-LM4
AC   CVCL_9566
SY   SAOS-LM4
DR   Wikidata; Q54952107
RX   PubMed=10763916;
CC   Population: Caucasian.
CC   Doubling time: 44.1 +- 0.9 hours (PubMed=10763916).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9565 ! SaOS-LM3
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   SaOS-LM5
AC   CVCL_9567
SY   SAOS-LM5; LM5
DR   cancercelllines; CVCL_9567
DR   GEO; GSM1639705
DR   GEO; GSM1639706
DR   Progenetix; CVCL_9567
DR   Wikidata; Q54952108
RX   PubMed=10763916;
CC   Population: Caucasian.
CC   Doubling time: 37.2 +- 3.8 hours (PubMed=10763916).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9566 ! SaOS-LM4
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   SaOS-LM6
AC   CVCL_9568
SY   SAOS-LM6
DR   Wikidata; Q54952109
RX   PubMed=10763916;
CC   Population: Caucasian.
CC   Doubling time: 34.9 +- 1.4 hours (PubMed=10763916).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9567 ! SaOS-LM5
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   SaOS-LM7
AC   CVCL_0515
SY   SAOS-LM7; Saos-LM7; SaOs-lm7; SaOS/LM7; LM7
DR   MCCL; MCC:0000413
DR   GEO; GSM1914992
DR   GEO; GSM1914993
DR   GEO; GSM1914994
DR   GEO; GSM1914995
DR   Wikidata; Q54952110
RX   PubMed=22075555;
RX   PubMed=22186140;
RX   PubMed=24136885;
RX   PubMed=26320182;
RX   PubMed=29334376;
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Established by 7 cycling of parent cell line through the lungs of nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9568 ! SaOS-LM6
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Saos2-I
AC   CVCL_9U47
DR   Wikidata; Q54952112
RX   PubMed=25031706;
CC   Population: Caucasian.
CC   Characteristics: Increased developement of pulmonary metastases compared to the parent cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 16
//
ID   SAPi001-A
AC   CVCL_C0NK
SY   WT I
DR   hPSCreg; SAPi001-A
DR   Wikidata; Q114312953
CC   From: Sapienza University of Rome; Rome; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   SAPi002-A
AC   CVCL_YI87
SY   ALS I (FUSR514S/WT) clone#1; ALS I; ALS I-FUS-R514S/wt; FUS-R514S/wt
DR   BioSamples; SAMEA6358469
DR   hPSCreg; SAPi002-A
DR   Wikidata; Q98129323
RX   PubMed=26035390;
RX   PubMed=27318155;
CC   From: Sapienza University of Rome; Rome; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg514Ser (c.1542G>T); Zygosity=Heterozygous (PubMed=26035390; PubMed=27318155).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SAPi003-A
AC   CVCL_YI88
SY   ALS II (FUSR521C/WT) clone#34; ALS II, FUS-R521C/wt; ALS II-FUS-R521C/wt
DR   BioSamples; SAMEA6358471
DR   hPSCreg; SAPi003-A
DR   Wikidata; Q98129326
RX   PubMed=26035390;
RX   PubMed=27318155;
CC   From: Sapienza University of Rome; Rome; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521Cys (c.1561C>T); ClinVar=VCV000016224; Zygosity=Heterozygous (PubMed=26035390; PubMed=27318155).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SAPi004-A
AC   CVCL_YI89
SY   ALS III (TDP-43A382T/A382T) clone#2; ALS III; TDP43-A382T/A382T; ALS III-TDP43-A382T/A382T
DR   BioSamples; SAMEA6358473
DR   hPSCreg; SAPi004-A
DR   Wikidata; Q98129329
RX   PubMed=26035390;
RX   PubMed=27318155;
CC   From: Sapienza University of Rome; Rome; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Homozygous (PubMed=26035390; PubMed=27318155).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   Sar Nis
AC   CVCL_3597
DR   CLO; CLO_0008948
DR   ATCC; CRL-1231
DR   Wikidata; Q54952114
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118635; Pseudoachondroplasia
DI   ORDO; Orphanet_750; Pseudoachondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   SAR-HCV
AC   CVCL_HE81
DR   Wikidata; Q54952115
RX   PubMed=21273590;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 33.2 hours (PubMed=21273590).
CC   Karyotypic information: Near triploid karyotype.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   Sarc9371
AC   CVCL_5G89
SY   SARC9371
DR   cancercelllines; CVCL_5G89
DR   Cell_Model_Passport; SIDM00033
DR   Cosmic-CLP; 1303910
DR   DepMap; ACH-002396
DR   GDSC; 1303910
DR   PharmacoDB; Sarc9371_1344_2019
DR   Wikidata; Q54952116
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Phe (c.388C>T); ClinVar=VCV000216466; Zygosity=Heterozygous (Cosmic-CLP=1303910; DepMap=ACH-002396).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe134Leu (c.400T>C); ClinVar=VCV000080710; Zygosity=Heterozygous (Cosmic-CLP=1303910; DepMap=ACH-002396).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Genome ancestry: African=0.55%; Native American=0%; East Asian, North=3.77%; East Asian, South=0%; South Asian=23.42%; European, North=14.57%; European, South=57.68% (PubMed=30894373).
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 20
//
ID   SARCCR2
AC   CVCL_N852
SY   SARCCR 2
DR   Wikidata; Q54952117
RX   PubMed=8099901;
CC   Doubling time: 28 hours (PubMed=8099901).
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   Sarcoma 180
AC   CVCL_3598
SY   Sarcoma-180
DR   CLO; CLO_0008949
DR   AddexBio; C0035002/5002
DR   ATCC; TIB-66
DR   ChEMBL-Cells; CHEMBL3308362
DR   ChEMBL-Targets; CHEMBL614895
DR   CLS; 400330
DR   KCLB; 40066
DR   PubChem_Cell_line; CVCL_3598
DR   Wikidata; Q54952118
RX   PubMed=13431913;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Discontinued: CLS; 400330; true.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_2874 ! CCRF S-180 II
OI   CVCL_A9AY ! LLC-MS180
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SarmaEmb
AC   CVCL_C6JN
SY   Sarconesiopsis magellanica Embryonic
DR   Wikidata; Q116050209
RX   PubMed=24766352;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=1494667; ! Sarconesiopsis magellanica (Blowfly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SAS
AC   CVCL_1675
DR   BTO; BTO_0003981
DR   CLO; CLO_0051568
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1004
DR   BioSample; SAMN03471668
DR   BioSample; SAMN03472049
DR   cancercelllines; CVCL_1675
DR   Cell_Model_Passport; SIDM00351
DR   ChEMBL-Cells; CHEMBL3308781
DR   ChEMBL-Targets; CHEMBL1075569
DR   Cosmic; 909708
DR   Cosmic; 1042300
DR   Cosmic; 1118787
DR   Cosmic; 1120705
DR   Cosmic; 1571803
DR   Cosmic; 2546833
DR   Cosmic-CLP; 909708
DR   DepMap; ACH-002029
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10544-107H4
DR   GDSC; 909708
DR   GEO; GSM827230
DR   GEO; GSM850387
DR   GEO; GSM950309
DR   GEO; GSM950310
DR   GEO; GSM950311
DR   GEO; GSM950312
DR   GEO; GSM1670402
DR   IARC_TP53; 23803
DR   JCRB; JCRB0260
DR   LINCS_LDP; LCL-1221
DR   PharmacoDB; SAS_1345_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1675
DR   PubChem_Cell_line; CVCL_1675
DR   RCB; RCB1974
DR   TKG; TKG 0470
DR   Wikidata; Q54952119
RX   DOI=10.11277/stomatology1952.38.20;
RX   DOI=10.5843/jsot.13.Suppliment_301;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=17325662;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=24627082;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=32990596;
RX   PubMed=35839778;
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/sas-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 33 hours (PubMed=24627082); ~30 hours (Note=Lot 07312007), ~21 hours (Note=Lot 08022016) (JCRB=JCRB0260).
CC   HLA typing: A*24; B*52:01; C*12:02 (PubMed=9178645).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Homozygous (Cosmic-CLP=909708; DepMap=ACH-002029).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.4%; Native American=0%; East Asian, North=79.62%; East Asian, South=16.48%; South Asian=1.04%; European, North=0%; European, South=1.46% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Cosmic-CLP=909708; DepMap=ACH-002029; JCRB=JCRB0260; RCB=RCB1974; TKG=TKG 0470
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 16,17
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 24
ST   Penta D: 10,13
ST   Penta E: 5,20
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 10,14 (Cosmic-CLP=909708)
ST   vWA: 10,14,17 (JCRB=JCRB0260)
ST   vWA: 14,17 (DepMap=ACH-002029; RCB=RCB1974; TKG=TKG 0470)
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SAS-1
AC   CVCL_5890
DR   Wikidata; Q54952123
RX   PubMed=9220659;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SAS-1
CC   Population: Japanese.
CC   Characteristics: CSF2 and IL3 dependent.
CC   Doubling time: 72 hours (PubMed=9220659).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SAS-H1
AC   CVCL_R859
SY   SASH1
DR   Wikidata; Q54952124
RX   PubMed=8521415;
RX   PubMed=9379426;
CC   Population: Japanese.
CC   Doubling time: 30.4 +- 7.2 hours (PubMed=9379426).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1675 ! SAS
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   SAS-L1
AC   CVCL_R860
DR   Wikidata; Q54952125
RX   PubMed=8521415;
RX   PubMed=9379426;
CC   Population: Japanese.
CC   Doubling time: 31.4 +- 2.2 hours (PubMed=9379426).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1675 ! SAS
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   SAS-R
AC   CVCL_A8GP
SY   SAS-R1
DR   TKG; TKG 0800
DR   Wikidata; Q107116847
RX   PubMed=20410675;
RX   PubMed=21716292;
RX   PubMed=27681752;
CC   Population: Japanese.
CC   Characteristics: Radioresistant. Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=21716292).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): TKG=TKG 0800
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D5S818: 9
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1675 ! SAS
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 02-05-24; Version: 5
//
ID   SAS413
AC   CVCL_RM18
DR   Wikidata; Q54952120
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9920848;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM19 ! SAS527
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   SAS527
AC   CVCL_RM19
DR   Wikidata; Q54952122
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9920848;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM18 ! SAS413
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   SASY-1
AC   CVCL_C7S6
DR   Wikidata; Q117704832
RX   DOI=10.14930/jsma1939.53.537;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone, proximal femur; UBERON=UBERON_0004412.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SASY-4
AC   CVCL_C7S7
DR   Wikidata; Q117704833
RX   DOI=10.14930/jsma1939.53.537;
CC   Population: Japanese.
CC   Doubling time: 54 hours (DOI=10.14930/jsma1939.53.537).
CC   Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SAT [Human HNSCC]
AC   CVCL_3160
SY   Sat
DR   CLO; CLO_0009952
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472538
DR   cancercelllines; CVCL_3160
DR   Cell_Model_Passport; SIDM00350
DR   Cosmic-CLP; 1299050
DR   DepMap; ACH-001641
DR   EGA; EGAS00001000978
DR   GDSC; 1299050
DR   GEO; GSM827190
DR   GEO; GSM1670403
DR   JCRB; JCRB1027
DR   JCRB; NIHS0257
DR   LINCS_LDP; LCL-1210
DR   PharmacoDB; SAT_1346_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3160
DR   Wikidata; Q54952126
RX   PubMed=10601556;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: 72 hours (PubMed=10601556).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=1.29%; East Asian, North=77.72%; East Asian, South=18.87%; South Asian=0%; European, North=1.81%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0257; true.
ST   Source(s): Cosmic-CLP=1299050; DepMap=ACH-001641; JCRB=JCRB1027
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D18S51: 18
ST   D21S11: 29,32.1
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 8,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SAT [Mouse mammary carcinoma]
AC   CVCL_5891
SY   Stockholm Ascites Tumor
DR   CLS; 400332
DR   Wikidata; Q54952127
CC   Breed/subspecies: NMRI.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   SaTM-1
AC   CVCL_IW16
DR   Wikidata; Q54952128
RX   PubMed=19724886;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SaTM-1A
AC   CVCL_IW17
DR   Wikidata; Q54952136
RX   PubMed=19724886;
CC   Population: Japanese.
CC   Doubling time: 23.2 hours (PubMed=19724886).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW16 ! SaTM-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SaTM-1B
AC   CVCL_IW18
DR   Wikidata; Q54952137
RX   PubMed=19724886;
CC   Population: Japanese.
CC   Doubling time: 24.7 hours (PubMed=19724886).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW16 ! SaTM-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SaTM-1C
AC   CVCL_IW19
DR   Wikidata; Q54952138
RX   PubMed=19724886;
CC   Population: Japanese.
CC   Doubling time: 26.7 hours (PubMed=19724886).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW16 ! SaTM-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SaTM-1D
AC   CVCL_IW20
DR   Wikidata; Q54952139
RX   PubMed=19724886;
CC   Population: Japanese.
CC   Doubling time: 24.6 hours (PubMed=19724886).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW16 ! SaTM-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SaTM-1E
AC   CVCL_IW21
DR   Wikidata; Q54952141
RX   PubMed=19724886;
CC   Population: Japanese.
CC   Doubling time: 23.6 hours (PubMed=19724886).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW16 ! SaTM-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SaTM-1F
AC   CVCL_IW22
DR   Wikidata; Q54952143
RX   PubMed=19724886;
CC   Population: Japanese.
CC   Doubling time: 24.1 hours (PubMed=19724886).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9161; Anal squamous cell carcinoma
DI   ORDO; Orphanet_424019; Squamous cell carcinoma of the anal canal
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IW16 ! SaTM-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SAU
AC   CVCL_UD54
DR   Wikidata; Q98129331
RX   PubMed=1997098;
RX   PubMed=2789934;
RX   PubMed=3182331;
CC   Doubling time: 48 hours (PubMed=3182331).
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 3
//
ID   Sav-BL
AC   CVCL_7210
SY   Sav
DR   GEO; GSM1604065
DR   GEO; GSM1604066
DR   GEO; GSM1604067
DR   Wikidata; Q54952144
RX   PubMed=12219084;
RX   PubMed=16051863;
RX   PubMed=21088132;
RX   PubMed=28960205;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   SAVC
AC   CVCL_E823
SY   Savc
DR   EFO; EFO_0022640
DR   dbMHC; 49015
DR   ECACC; 95042723
DR   IHW; IHW09034
DR   IPD-IMGT/HLA; 11368
DR   Wikidata; Q54952145
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=7615790;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*02:01:01; DPB1*10:01:01; DQA1*03:01:01; DQB1*03:02:01; DRA*01:01; DRB1*04:01:01; DRB4*01:01 (IPD-IMGT/HLA=11368).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 17
//
ID   Sawano
AC   CVCL_4898
DR   CLO; CLO_0050872
DR   BioSample; SAMN03472162
DR   RCB; RCB1152
DR   Wikidata; Q54952146
RX   PubMed=8555123;
CC   Population: Japanese.
CC   Doubling time: 43.2 hours (Note=At 10th passage) (PubMed=8555123).
CC   Caution: Erroneously indicated as originating from a 67 year old patient in RCB=RCB1152.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1152
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 9,10
ST   D5S818: 9,12
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 19,20,21
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   SB
AC   CVCL_VK76
SY   Sea Bass
DR   Wikidata; Q98129334
RX   CelloPub=CLPUB00436;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 27-11-25; Version: 5
//
ID   SB Drug Discovery Inducible HEK-GluN1/2A
AC   CVCL_C9E4
DR   Wikidata; Q123033398
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4584; GRIN1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4585; GRIN2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Miscellaneous: Cell line information from personal communication of Dalrymple, David.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D585 ! T-REx-293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SB IV-6-2
AC   CVCL_JJ90
SY   SB-IV-6-2
DR   Wikidata; Q54952147
RX   Patent=US5646041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9316.
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; Q69467; Human herpesvirus 2 (HHV-2) glycoprotein D (gD).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JJ88 ! SPAZ-4
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 6
//
ID   SB-1
AC   CVCL_D5H2
SY   SB1
DR   Wikidata; Q127384165
RX   DOI=10.1016/S0176-1617(87)80007-x;
RX   DOI=10.1016/S0176-1617(87)80217-1;
RX   PubMed=2306122;
RX   PubMed=16657321;
RX   PubMed=24408461;
CC   Group: Plant cell line.
CC   Characteristics: Can be used to prepare protoplasts (PubMed=24408461).
CC   Derived from site: In situ; Root; PO=PO_0009005.
CC   Breed/subspecies: Cultivar Mandarin.
OX   NCBI_TaxID=3847; ! Glycine max (Soybean)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SB-1P
AC   CVCL_D5J9
SY   SB1-P
DR   Wikidata; Q127384168
RX   DOI=10.1007/BF02822702;
RX   DOI=10.1016/0168-9452(88)90187-2;
RX   PubMed=16667210;
RX   PubMed=16667897;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (DOI=10.1016/0168-9452(88)90187-2; PubMed=16667897).
CC   Characteristics: Capable of growth in vitamin-free medium (PubMed=16667897).
CC   Derived from site: In situ; Hypocotyl; PO=PO_0020100.
CC   Breed/subspecies: Cultivar PI-437833.
OX   NCBI_TaxID=3847; ! Glycine max (Soybean)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SB-2
AC   CVCL_0516
SY   SB2
DR   BTO; BTO_0003986
DR   MCCL; MCC:0000414
DR   Cosmic; 932708
DR   Cosmic; 1238105
DR   Cosmic; 1303051
DR   Wikidata; Q54952148
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   SB-28-Ohlfest
AC   CVCL_A5ED
SY   SB-28; SB28
DR   DSMZ; ACC-880
DR   DSMZCellDive; ACC-880
DR   Wikidata; Q107116848
RX   PubMed=24878890;
RX   PubMed=30524896;
CC   Characteristics: Glioma was induced by intraventricular transfection of pT2/C-Luc/PGKp-SB100 and Sleeping Beauty (SB)-flanked pT2/CAG-NRasV12 and pT2/shp53/mPDGF.
CC   Doubling time: ~30 hours (DSMZ=ACC-880).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   <1D
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   SB-3 [G.max]
AC   CVCL_D5H8
SY   SB3
DR   Wikidata; Q127384170
RX   DOI=10.1016/S0176-1617(87)80007-x;
RX   DOI=10.1016/S0176-1617(87)80217-1;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Root; PO=PO_0009005.
CC   Breed/subspecies: Cultivar Mandarin.
OX   NCBI_TaxID=3847; ! Glycine max (Soybean)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SB-3 [Human lung adenocarcinoma]
AC   CVCL_9U48
DR   Wikidata; Q54952149
RX   PubMed=1316092;
RX   PubMed=2201737;
RX   PubMed=2208054;
RX   PubMed=11414198;
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 7
//
ID   SB-CEV-1/A2
AC   CVCL_4Z54
SY   SB-CEV-1\A2
DR   Wikidata; Q54952150
RX   Patent=US5674484;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic gut; UBERON=UBERON_0007026.
CC   Breed/subspecies: White Leghorn SPAFAS.
DI   NCIt; C135005; Chicken neoplasm
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_4Z53 ! SB-CEV-1/P
SX   Sex unspecified
AG   20FD
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 10
//
ID   SB-CEV-1/F7
AC   CVCL_4Z55
SY   SB-CEV-1\F7; CEV-1/F7
DR   Wikidata; Q54952151
RX   Patent=US5674484;
RX   PubMed=7855124;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10495.
CC   Derived from site: In situ; Embryonic gut; UBERON=UBERON_0007026.
CC   Breed/subspecies: White Leghorn SPAFAS.
DI   NCIt; C135005; Chicken neoplasm
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_4Z53 ! SB-CEV-1/P
SX   Sex unspecified
AG   20FD
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   SB-CEV-1/G7
AC   CVCL_4Z56
SY   SB-CEV-1\G7; G7
DR   Wikidata; Q54952152
RX   Patent=US5674484;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10496.
CC   Derived from site: In situ; Embryonic gut; UBERON=UBERON_0007026.
CC   Breed/subspecies: White Leghorn SPAFAS.
DI   NCIt; C135005; Chicken neoplasm
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_4Z53 ! SB-CEV-1/P
SX   Sex unspecified
AG   20FD
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SB-CEV-1/P
AC   CVCL_4Z53
SY   SB-CEV1/p; SB-CEV-1
DR   Wikidata; Q54952153
RX   Patent=US5674484;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10497.
CC   Derived from site: In situ; Embryonic gut; UBERON=UBERON_0007026.
CC   Breed/subspecies: White Leghorn SPAFAS.
DI   NCIt; C135005; Chicken neoplasm
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   20FD
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   SB-HSA
AC   CVCL_0C95
SY   SB; SBHSA
DR   GEO; GSM1122229
DR   Wikidata; Q54952156
RX   PubMed=15064773;
RX   PubMed=15140399;
RX   PubMed=22594682;
RX   PubMed=24582862;
RX   PubMed=25190452;
RX   PubMed=26842912;
RX   PubMed=28029283;
RX   PubMed=30601866;
RX   PubMed=31175136;
CC   Characteristics: Established from a xenograft produced in bg/nu/XID nude mice (PubMed=15064773).
CC   Doubling time: ~20-24 hours (PubMed=15064773).
CC   Sequence variation: Mutation; VGNC; VGNC:84862; EP300; Simple; p.Asn1570fs (c.4704dupG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:44555; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Ala150fs (c.447delG); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Leu184Phe (c.550C>T); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 239
ST   Dog FHC2054: 156,164
ST   Dog FHC2079: 275
ST   Dog PEZ1: 115,119
ST   Dog PEZ3: 119,131
ST   Dog PEZ5: 103,107
ST   Dog PEZ6: 172,183
ST   Dog PEZ8: 228
ST   Dog PEZ12: 270,274
ST   Dog PEZ20: 176
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 20
//
ID   SB-iPS#3
AC   CVCL_A4FF
DR   SKIP; SKIP003053
DR   Wikidata; Q105510966
RX   PubMed=29279741;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C101201; Myelomeningocele
DI   ORDO; Orphanet_268369; Spina bifida aperta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SB-iPS#34
AC   CVCL_A4FE
DR   SKIP; SKIP003052
DR   Wikidata; Q105510969
RX   PubMed=29279741;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C101201; Myelomeningocele
DI   ORDO; Orphanet_268369; Spina bifida aperta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SB-iPS#8
AC   CVCL_A4FG
DR   SKIP; SKIP003054
DR   Wikidata; Q105510972
RX   PubMed=29279741;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C101201; Myelomeningocele
DI   ORDO; Orphanet_268369; Spina bifida aperta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SB-P
AC   CVCL_D5H3
DR   Wikidata; Q127384172
RX   DOI=10.1007/BF02822702;
RX   PubMed=1966489;
RX   PubMed=8251631;
RX   PubMed=16663019;
RX   PubMed=16665626;
RX   PubMed=16667210;
RX   PubMed=16667897;
RX   PubMed=24253991;
CC   Group: Plant cell line.
CC   Characteristics: Photoautotrophic growth (PubMed=16663019; PubMed=16665626; PubMed=16667210).
CC   Characteristics: Capable of photorespiration (PubMed=16667210).
CC   Characteristics: Can be used to prepare protoplasts (PubMed=24253991).
CC   Caution: PubMed=8251631 and PubMed=1966489 wrongly refer to this cell line as SB-1. Howerver, they provide as original reference for this cell line PubMed=16663019 and indicate that it originated from Widholm J.M.
CC   Derived from site: In situ; Cotyledon; PO=PO_0020030.
CC   Breed/subspecies: Cultivar Corsoy.
OX   NCBI_TaxID=3847; ! Glycine max (Soybean)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   SB.06
AC   CVCL_VJ93
SY   SB_06
DR   cancercelllines; CVCL_VJ93
DR   Cosmic; 2498852
DR   Wikidata; Q98129336
RX   PubMed=26962861;
CC   Doubling time: 45.9 hours (PubMed=26962861).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=26962861).
CC   Sequence variation: Mutation; HGNC; HGNC:9099; PLXNA1; Simple; p.Asp863Asn (c.2587G>A); dbSNP=rs367569800; Zygosity=Unspecified (PubMed=26962861).
CC   Omics: Genomics; Whole genome sequencing.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   SB.07
AC   CVCL_VJ94
SY   SB_07
DR   cancercelllines; CVCL_VJ94
DR   Cosmic; 2498853
DR   Wikidata; Q98129338
RX   PubMed=26962861;
CC   Doubling time: 50.3 hours (PubMed=26962861).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=26962861).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Ileal lymph node; UBERON=UBERON_0037522.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
ID   SB.12
AC   CVCL_VJ95
DR   Wikidata; Q98129340
RX   PubMed=26962861;
CC   Doubling time: 37.1 hours (PubMed=26962861).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   SB1
AC   CVCL_E7HE
RX   PubMed=29464042;
RX   PubMed=34495298;
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SB1-JP4
AC   CVCL_E7IV
RX   PubMed=34495298;
WW   Provider; Inserm Transfert; RT00735; https://technology-offers.inserm-transfert.com/offer/murine-cholangiocarcinoma-cell-line-sb1-jp4/
CC   Characteristics: Established from tumors obtained by subcutaneously injecting the parent cell line in the right flank of mice (PubMed=34495298).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E7HE ! SB1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SB1685CB
AC   CVCL_UI93
DR   cancercelllines; CVCL_UI93
DR   Wikidata; Q98129342
RX   PubMed=15645491;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.631+2T>G (IVS7+2T>G); ClinVar=VCV000009349; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=15645491).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (PubMed=15645491).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI92 ! AV036
OI   CVCL_UI94 ! SB1690CB
SX   Male
AG   2Y1M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   SB1690CB
AC   CVCL_UI94
DR   cancercelllines; CVCL_UI94
DR   Wikidata; Q98129344
RX   PubMed=15645491;
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.631+2T>G (IVS7+2T>G); ClinVar=VCV000009349; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=15645491).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Cys1200Terfs (c.3599_3600delGT) (3827delGT); Zygosity=Heterozygous (PubMed=15645491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   NCIt; C125705; Fanconi anemia, complementation group D1
DI   ORDO; Orphanet_519; Acute myeloid leukemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UI92 ! AV036
OI   CVCL_UI93 ! SB1685CB
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   SB2 [Mouse cholangiocarcinoma]
AC   CVCL_E7HF
RX   PubMed=29464042;
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SB2 [Mouse hybridoma against dog mammary carcinoma]
AC   CVCL_C1GE
DR   Wikidata; Q114312954
RX   PubMed=8578680;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Dog antigen on mammary carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   SB247
AC   CVCL_C394
SY   SB-247
DR   BTO; BTO_0004208
DR   Wikidata; Q54952158
RX   PubMed=18823010;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 9
//
ID   SB3 [Acipenser]
AC   CVCL_B7NI
SY   Sturgeon Brain 3
DR   Wikidata; Q114312955
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=41871; ! Acipenser fulvescens (Lake sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   SB3 [Mouse cholangiocarcinoma]
AC   CVCL_E7HG
RX   PubMed=29464042;
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SB4
AC   CVCL_E7HH
RX   PubMed=29464042;
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SB5
AC   CVCL_E7HI
RX   PubMed=29464042;
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Sb51
AC   CVCL_9Y75
DR   Wikidata; Q54952159
RX   Patent=EP0250128A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9127.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   SB6
AC   CVCL_E7HJ
RX   PubMed=29464042;
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SB7
AC   CVCL_E7HK
RX   PubMed=29464042;
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=HGNC; HGNC:16262; YAP1 (Note=With a FLAG tag).
CC   Genetic integration: Method=Sleeping Beauty transposition; Gene=MGI; MGI:87986; Akt1.
CC   Transformant: Akt1 and YAP1.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C38739; Mouse cholangiocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SBA-16
AC   CVCL_A2CN
DR   Cosmic; 2823110
DR   Wikidata; Q105510974
RX   PubMed=30352910;
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Tyr803His (c.2407T>C); Zygosity=Unspecified (PubMed=30352910).
DI   NCIt; C7888; Small intestinal adenocarcinoma
DI   ORDO; Orphanet_104075; Adenocarcinoma of the small instestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 4
//
ID   SBA-6
AC   CVCL_A2CP
DR   cancercelllines; CVCL_A2CP
DR   Cosmic; 2823113
DR   Wikidata; Q105510977
RX   PubMed=30352910;
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Val842Ile (c.2524G>A); ClinVar=VCV000375994; Zygosity=Unspecified (PubMed=30352910).
DI   NCIt; C7888; Small intestinal adenocarcinoma
DI   ORDO; Orphanet_104075; Adenocarcinoma of the small instestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   SBAC
AC   CVCL_3794
SY   Second passage Bovine Adrenocortical Cell line
DR   CLO; CLO_0008950
DR   CLDB; cl4256
DR   ATCC; CRL-1796
DR   BCRC; 60336
DR   ECACC; 91021201
DR   Wikidata; Q54952161
RX   PubMed=436716;
RX   PubMed=3032889;
RX   PubMed=7989438;
CC   Characteristics: Responsive to ACTH and other steroidogenic agents (ATCC=CRL-1796).
CC   Senescence: Capable of 60-70 PDL (ATCC=CRL-1796).
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   SBB-W1
AC   CVCL_S942
SY   Sea Bass Brain-Waterloo trial 1
DR   Wikidata; Q54952162
RX   PubMed=19026759;
CC   Group: Fish cell line.
CC   Doubling time: 6-7 days (PubMed=19026759).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=13489; ! Dicentrarchus labrax (European seabass)
SX   Sex unspecified
AG   Adult
CA   Somatic stem cell
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 10
//
ID   SBC-1
AC   CVCL_1676
AS   CVCL_D230
SY   SBC1; Lc817; LC817
DR   BTO; BTO_0005442
DR   CLO; CLO_0037041
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472514
DR   cancercelllines; CVCL_1676
DR   Cell_Model_Passport; SIDM00365
DR   ChEMBL-Cells; CHEMBL3308214
DR   ChEMBL-Targets; CHEMBL2366327
DR   Cosmic; 713885
DR   Cosmic; 1995623
DR   Cosmic-CLP; 713885
DR   DepMap; ACH-002196
DR   EGA; EGAS00001000978
DR   GDSC; 713885
DR   GEO; GSM986190
DR   GEO; GSM1670404
DR   IARC_TP53; 27235
DR   JCRB; JCRB0816
DR   JCRB; NIHS0676
DR   LINCS_LDP; LCL-1865
DR   PharmacoDB; SBC1_1347_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1676
DR   PubChem_Cell_line; CVCL_1676
DR   Wikidata; Q54902178
RX   CelloPub=CLPUB00132;
RX   DOI=10.2482/haigan.22.53;
RX   DOI=10.4044/joma1947.104.9-10_905;
RX   PubMed=2540905;
RX   PubMed=8286010;
RX   PubMed=9290701;
RX   PubMed=9413215;
RX   PubMed=12569360;
RX   PubMed=17270020;
RX   PubMed=18937546;
RX   PubMed=20164919;
RX   PubMed=22399608;
RX   PubMed=25120651;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Problematic cell line: Possibly misidentified/contaminated. Shown to be identical to SBC-2 (JCRB web site and STR profile).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 20.4 hours (PubMed=8286010); ~40 hours (Note=Lot 11012007) (JCRB=JCRB0816).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Gly48Ter (c.142G>T); Zygosity=Heterozygous (Cosmic-CLP=713885; DepMap=ACH-002196).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu112Ter (c.334G>T); ClinVar=VCV001730509; Zygosity=Homozygous (Cosmic-CLP=713885; DepMap=ACH-002196).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys120Ter (c.358A>T); ClinVar=VCV000012363; Zygosity=Homozygous (Cosmic-CLP=713885; DepMap=ACH-002196).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.47%; East Asian, North=73.66%; East Asian, South=25.87%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0676; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=713885; JCRB=JCRB0816
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W531 ! SBC-2 [Human SCLC]
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SBC-10
AC   CVCL_UW50
DR   Wikidata; Q98129347
RX   PubMed=10358721;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   SBC-2 [Human contaminated bladder carcinoma]
AC   CVCL_1677
SY   SBC2
DR   CLDB; cl4257
DR   BioSample; SAMN03151755
DR   BioSample; SAMN03473382
DR   DSMZ; ACC-228
DR   DSMZCellDive; ACC-228
DR   Wikidata; Q54952164
RX   PubMed=8230540;
RX   PubMed=10508494;
RX   PubMed=11668190;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an urinary bladder carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00156.
CC   Population: African American.
CC   Doubling time: ~40 hours (DSMZ=ACC-228).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: DSMZ; ACC-228; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DSMZ=ACC-228
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SBC-2 [Human SCLC]
AC   CVCL_W531
DR   CLO; CLO_0008951
DR   cancercelllines; CVCL_W531
DR   Cell_Model_Passport; SIDM00366
DR   GEO; GSM17312
DR   GEO; GSM827568
DR   JCRB; JCRB0817
DR   LINCS_LDP; LCL-1866
DR   Progenetix; CVCL_W531
DR   Wikidata; Q54952165
RX   CelloPub=CLPUB00132;
RX   DOI=10.4044/joma1947.104.9-10_905;
RX   PubMed=8286010;
RX   PubMed=9290701;
RX   PubMed=9413215;
RX   PubMed=10358721;
RX   PubMed=10628341;
RX   PubMed=15016488;
RX   PubMed=20215515;
RX   PubMed=22399608;
CC   Problematic cell line: Possibly misidentified/contaminated. Shown to be identical to SBC-1 (JCRB web site and STR profile).
CC   Population: Japanese.
CC   Doubling time: 33.8 hours (PubMed=8286010).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0817
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1676 ! SBC-1
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 23
//
ID   SBC-3
AC   CVCL_1678
SY   SBC3
DR   CLO; CLO_0037042
DR   EFO; EFO_0002854
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472515
DR   cancercelllines; CVCL_1678
DR   Cell_Model_Passport; SIDM00367
DR   CGH-DB; 103-1
DR   CGH-DB; 9049-4
DR   ChEMBL-Cells; CHEMBL3307308
DR   ChEMBL-Targets; CHEMBL614146
DR   Cosmic; 753610
DR   Cosmic; 889103
DR   Cosmic; 897745
DR   Cosmic; 1066171
DR   Cosmic; 1212200
DR   Cosmic; 1571746
DR   Cosmic-CLP; 753610
DR   DepMap; ACH-002197
DR   EGA; EGAS00001000978
DR   GDSC; 753610
DR   GEO; GSM17313
DR   GEO; GSM827567
DR   GEO; GSM1670405
DR   JCRB; JCRB0818
DR   LINCS_LDP; LCL-1879
DR   PharmacoDB; SBC3_1348_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1678
DR   PubChem_Cell_line; CVCL_1678
DR   Wikidata; Q54952168
RX   CelloPub=CLPUB00132;
RX   DOI=10.4044/joma1947.104.9-10_905;
RX   PubMed=2540905;
RX   PubMed=3012965;
RX   PubMed=3032107;
RX   PubMed=8286010;
RX   PubMed=9227790;
RX   PubMed=9290701;
RX   PubMed=9413215;
RX   PubMed=9615743;
RX   PubMed=9914787;
RX   PubMed=10358721;
RX   PubMed=10628341;
RX   PubMed=12107105;
RX   PubMed=15016488;
RX   PubMed=15185009;
RX   PubMed=20215515;
RX   PubMed=22399608;
RX   PubMed=23066953;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=3012965); 21.6 hours (PubMed=8286010; PubMed=9615743; PubMed=10628341); 14 hours (PubMed=9914787); ~30 hours (Note=Lots 012699 and 07262007), ~21 hours (Note=Lot 09082011) (JCRB=JCRB0818).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.39%; East Asian, North=77.93%; East Asian, South=21.68%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=753610; JCRB=JCRB0818
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 12,13
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SBC-3/ADM
AC   CVCL_M841
DR   Wikidata; Q54952169
RX   PubMed=3012965;
RX   PubMed=3012966;
RX   PubMed=3032107;
RX   PubMed=8104372;
RX   PubMed=10628341;
CC   Population: Japanese.
CC   Doubling time: 22 hours (PubMed=3012965); 45.9 hours (PubMed=10628341).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1678 ! SBC-3
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   SBC-3/ADM100
AC   CVCL_UW53
SY   SBC-3/ADM 100
DR   Wikidata; Q98129349
RX   PubMed=1442149;
RX   PubMed=8104372;
RX   PubMed=9227790;
CC   Population: Japanese.
CC   Doubling time: 46 hours (PubMed=8104372).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M841 ! SBC-3/ADM
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 8
//
ID   SBC-3/CDDP
AC   CVCL_M842
DR   Wikidata; Q54952171
RX   PubMed=9227790;
RX   PubMed=9615743;
RX   PubMed=10628341;
CC   Population: Japanese.
CC   Doubling time: 27.5 hours (PubMed=9615743; PubMed=10628341).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1678 ! SBC-3
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   SBC-3/DXCL1
AC   CVCL_M843
DR   Wikidata; Q54952173
RX   PubMed=9914787;
CC   Population: Japanese.
CC   Doubling time: 33.3 hours (PubMed=9914787).
CC   Selected for resistance to: ChEBI; CHEBI_31587; Exatecan mesilate hydrate (DX-8951f).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1678 ! SBC-3
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   SBC-3/ETP
AC   CVCL_W529
DR   Wikidata; Q54952174
RX   PubMed=1354408;
RX   PubMed=1442149;
RX   PubMed=9227790;
RX   PubMed=10628341;
CC   Population: Japanese.
CC   Doubling time: 38.0 hours (PubMed=10628341).
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1678 ! SBC-3
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   SBC-3/SN-38
AC   CVCL_W535
DR   Wikidata; Q54952176
RX   PubMed=15736431;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1678 ! SBC-3
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   SBC-4
AC   CVCL_A479
SY   SBC4
DR   cancercelllines; CVCL_A479
DR   Cosmic; 713886
DR   Cosmic; 929162
DR   GEO; GSM986191
DR   Progenetix; CVCL_A479
DR   Wikidata; Q54952177
RX   CelloPub=CLPUB00132;
RX   DOI=10.4044/joma1947.104.9-10_905;
RX   PubMed=8286010;
RX   PubMed=9413215;
RX   PubMed=10358721;
RX   PubMed=10628341;
RX   PubMed=22399608;
RX   PubMed=23066953;
CC   Population: Japanese.
CC   Doubling time: 52.6 hours (PubMed=8286010).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   SBC-5
AC   CVCL_1679
SY   SBC5
DR   CLO; CLO_0037043
DR   EFO; EFO_0002855
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472516
DR   BioSample; SAMN10988207
DR   cancercelllines; CVCL_1679
DR   Cell_Model_Passport; SIDM00368
DR   CGH-DB; 9050-4
DR   CGH-DB; 95-1
DR   ChEMBL-Cells; CHEMBL3308493
DR   ChEMBL-Targets; CHEMBL614896
DR   Cosmic; 713880
DR   Cosmic; 801614
DR   Cosmic; 844823
DR   Cosmic; 876155
DR   Cosmic; 918017
DR   Cosmic; 929153
DR   Cosmic; 932946
DR   Cosmic; 1212201
DR   Cosmic; 1571747
DR   Cosmic; 1995624
DR   Cosmic; 2125287
DR   Cosmic; 2668344
DR   Cosmic-CLP; 713880
DR   DepMap; ACH-000670
DR   EGA; EGAS00001000978
DR   GDSC; 713880
DR   GEO; GSM17314
DR   GEO; GSM827566
DR   GEO; GSM887556
DR   GEO; GSM888639
DR   GEO; GSM986192
DR   GEO; GSM1670406
DR   IARC_TP53; 2387
DR   JCRB; JCRB0819
DR   LiGeA; CCLE_781
DR   LINCS_LDP; LCL-1821
DR   PharmacoDB; SBC5_1349_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1679
DR   PubChem_Cell_line; CVCL_1679
DR   Wikidata; Q54952179
RX   CelloPub=CLPUB00132;
RX   DOI=10.4044/joma1947.104.9-10_905;
RX   PubMed=8263009;
RX   PubMed=8286010;
RX   PubMed=9290701;
RX   PubMed=9413215;
RX   PubMed=9673367;
RX   PubMed=10358721;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=12107105;
RX   PubMed=15016488;
RX   PubMed=15185009;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22399608;
RX   PubMed=22460905;
RX   PubMed=23066953;
RX   PubMed=23381221;
RX   PubMed=25120651;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38180245;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 24 hours (DOI=10.4044/joma1947.104.9-10_905); 31.6 hours (PubMed=8286010); ~40 hours (Note=Lot 111898), 21 hours (Note=Lot 08082007), ~21 hours (Note=Lot 09142018) (JCRB=JCRB0819).
CC   HLA typing: A*02:07,33:03; B*46:01,58:01; C*01:02,03:02; DQB1*06:07,06:07; DRB1*13:02,14:46 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Val82_Glu88del (c.245_265del); Zygosity=Homozygous (PubMed=9673367; DepMap=ACH-000670).
CC   Sequence variation: Mutation; HGNC; HGNC:2901; DLG2; Unexplicit; Ex7-9del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Ala1245Leufs*13 (c.3733_3734del); Zygosity=Homozygous (DepMap=ACH-000670).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=8263009; PubMed=10536175; Cosmic-CLP=713880; DepMap=ACH-000670).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.28%; Native American=0%; East Asian, North=78.17%; East Asian, South=20.72%; South Asian=0.15%; European, North=0.14%; European, South=0.54% (PubMed=30894373).
CC   Caution: Originally classified as originating from a lung small cell carcinoma, but is reclassified as a thoracic SMARCA4-deficient undifferentiated tumor based on a number of criteria (PubMed=38180245).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=713880; JCRB=JCRB0819
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 14,18
DI   NCIt; C183115; Thoracic SMARCA4-deficient undifferentiated tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SBC-6
AC   CVCL_DH97
DR   cancercelllines; CVCL_DH97
DR   GEO; GSM986188
DR   Progenetix; CVCL_DH97
DR   Wikidata; Q54952181
RX   PubMed=8286010;
RX   PubMed=9413215;
RX   PubMed=10358721;
RX   PubMed=22399608;
RX   PubMed=23066953;
CC   Population: Japanese.
CC   Doubling time: 26.2 hours (PubMed=8286010).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   SBC-7 [Human contaminated bladder carcinoma]
AC   CVCL_1680
SY   SBC7
DR   CLO; CLO_0008952
DR   CLDB; cl4258
DR   BioSample; SAMN03151756
DR   DSMZ; ACC-229
DR   DSMZCellDive; ACC-229
DR   Wikidata; Q54952183
RX   PubMed=8230540;
RX   PubMed=10508494;
RX   PubMed=11668190;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494; PubMed=20143388). Originally thought to originate from an urinary bladder carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00157.
CC   Population: African American.
CC   Doubling time: ~15-17 hours (DSMZ=ACC-229).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: DSMZ; ACC-229; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DSMZ=ACC-229
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SBC-7 [Human SCLC]
AC   CVCL_W530
SY   SBC7
DR   cancercelllines; CVCL_W530
DR   Cosmic; 1759307
DR   GEO; GSM986189
DR   Progenetix; CVCL_W530
DR   Wikidata; Q54952184
RX   PubMed=8286010;
RX   PubMed=9413215;
RX   PubMed=10358721;
RX   PubMed=10628341;
RX   PubMed=22399608;
RX   PubMed=23066953;
CC   Population: Japanese.
CC   Doubling time: 39.0 hours (PubMed=8286010).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   SBC-9A
AC   CVCL_DH98
SY   SBC-9
DR   cancercelllines; CVCL_DH98
DR   GEO; GSM986193
DR   Progenetix; CVCL_DH98
DR   Wikidata; Q54952186
RX   PubMed=8286010;
RX   PubMed=9413215;
RX   PubMed=22399608;
RX   PubMed=23066953;
CC   Population: Japanese.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UW49 ! SBC-9B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   SBC-9B
AC   CVCL_UW49
SY   SBC9B
DR   Wikidata; Q98129352
RX   PubMed=10358721;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH98 ! SBC-9A
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   SBC-H20
AC   CVCL_W179
SY   SBC/H20; SBCH20
DR   Wikidata; Q54952187
RX   DOI=10.1007/978-1-4684-4949-5_8;
RX   Patent=US4634666;
RX   PubMed=3084658;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8464.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Misspelling: SPC-H20; Note=Occasionally.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J171 ! Sp2/08A2
CA   Hybrid cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   SBC-H21
AC   CVCL_9V11
DR   Wikidata; Q54952188
RX   Patent=US4634666;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8463.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W179 ! SBC-H20
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   SBcl1
AC   CVCL_D731
SY   SBCL1; SbCl1; Sbcl1; SB cell line, clone-1; SB clone 1; SB1
DR   Wikidata; Q54952189
RX   PubMed=2064308;
RX   PubMed=21863025;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D732 ! SBcl2
OI   CVCL_VW99 ! SBcl3
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   SBcl2
AC   CVCL_D732
SY   SBCL2; SbCl2; Sbcl2; SB cell line, clone-2; SB clone 2; SB2; SBC2
DR   cancercelllines; CVCL_D732
DR   ChEMBL-Cells; CHEMBL4630603
DR   ChEMBL-Targets; CHEMBL4630702
DR   Cosmic; 686394
DR   Cosmic; 1507619
DR   Cosmic; 1665009
DR   Cosmic; 2647645
DR   GEO; GSM186455
DR   GEO; GSM186456
DR   Lonza; 831
DR   Progenetix; CVCL_D732
DR   PubChem_Cell_line; CVCL_D732
DR   Wikidata; Q54952190
RX   PubMed=2064308;
RX   PubMed=21424129;
RX   PubMed=21863025;
RX   PubMed=25645078;
RX   PubMed=28196595;
RX   PubMed=29492214;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (PubMed=25645078; PubMed=29492214).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Misspelling: SBc12; Cosmic=686394; Cosmic=1507619.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D731 ! SBcl1
OI   CVCL_VW99 ! SBcl3
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   SBcl3
AC   CVCL_VW99
SY   SB clone 3; SB3
DR   Wikidata; Q98129354
RX   PubMed=2064308;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D731 ! SBcl1
OI   CVCL_D732 ! SBcl2
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   SBCP2
AC   CVCL_6E25
SY   Sea Bass Caudal Peduncle 2
DR   Wikidata; Q54952200
RX   DOI=10.1111/are.12095;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   SBDS-iPS1
AC   CVCL_C736
SY   SBDS-IPS1
DR   Wikidata; Q54952201
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C61235; Shwachman-Diamond syndrome
DI   ORDO; Orphanet_811; Shwachman-Diamond syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C737 ! SBDS-iPS2
OI   CVCL_C738 ! SBDS-iPS3
OI   CVCL_C739 ! SBDS-iPS8
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   SBDS-iPS2
AC   CVCL_C737
SY   SBDS-IPS2
DR   Wikidata; Q54952202
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C61235; Shwachman-Diamond syndrome
DI   ORDO; Orphanet_811; Shwachman-Diamond syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C736 ! SBDS-iPS1
OI   CVCL_C738 ! SBDS-iPS3
OI   CVCL_C739 ! SBDS-iPS8
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 14
//
ID   SBDS-iPS3
AC   CVCL_C738
SY   SBDS-IPS3
DR   Wikidata; Q54952203
RX   Patent=US20110151447;
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C61235; Shwachman-Diamond syndrome
DI   ORDO; Orphanet_811; Shwachman-Diamond syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C736 ! SBDS-iPS1
OI   CVCL_C737 ! SBDS-iPS2
OI   CVCL_C739 ! SBDS-iPS8
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 15
//
ID   SBDS-iPS8
AC   CVCL_C739
SY   SBDS-IPS8
DR   Wikidata; Q54952204
RX   PubMed=18691744;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C61235; Shwachman-Diamond syndrome
DI   ORDO; Orphanet_811; Shwachman-Diamond syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C736 ! SBDS-iPS1
OI   CVCL_C737 ! SBDS-iPS2
OI   CVCL_C738 ! SBDS-iPS3
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   SBE-189
AC   CVCL_A7UF
SY   SBE 189; SBE189; Sheep Brain Endothelial-189
DR   Wikidata; Q107116849
RX   CelloPub=CLPUB00633;
RX   PubMed=8784483;
RX   PubMed=12234001;
CC   Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00633).
CC   Derived from site: In situ; Brain, microvascular endothelium; UBERON=UBERON_0000955+UBERON_0008339.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   SBES
AC   CVCL_S943
SY   Sea Bass Embryonic Stem-like
DR   Wikidata; Q54952205
RX   CelloPub=CLPUB00463;
RX   PubMed=17704967;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   SBES1
AC   CVCL_S944
SY   Sea Bream Embryonic Stem-like 1
DR   Wikidata; Q54952206
RX   DOI=10.1046/j.1095-8649.2003.00192.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=143350; ! Pagrus major (Red sea bream)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   SBF
AC   CVCL_WY68
SY   Sea Bass Fin
DR   Wikidata; Q98129357
RX   CelloPub=CLPUB00103;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   SBF-1
AC   CVCL_R985
SY   Striped Bass Fry-1
DR   Wikidata; Q54952208
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=34816; ! Morone saxatilis (Striped bass)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 8
//
ID   SBF59
AC   CVCL_D6DC
SY   Silkie Bantam Fibroblast 59
DR   Wikidata; Q127384174
RX   DOI=10.5713/ajas.2009.80480;
CC   Group: Bird cell line.
CC   Doubling time: 38.5 hours (DOI=10.5713/ajas.2009.80480).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Silkie bantam.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Female
AG   9FD
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SBG
AC   CVCL_E7AW
SY   SeaBass Gill
RX   PubMed=38780857;
CC   Group: Fish cell line.
CC   Characteristics: Can be used to detect of intracellular indium, mercury, and lutetium ions by specifc fuorescent probes (PubMed=38780857).
CC   Characteristics: Capable of growing from 22 to 32 Celsius, the optimal temperature is 28 Celsius (PubMed=38780857).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SBG1
AC   CVCL_C6UE
DR   Wikidata; Q117704834
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG1-iPSC
AC   CVCL_C6UF
SY   SBG1-(8993 T > G)-hiPSC
DR   Wikidata; Q117704835
RX   PubMed=34662843;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Heteroplasmic (PubMed=34662843).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6UE ! SBG1
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG10
AC   CVCL_C6UT
DR   Wikidata; Q117704836
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.10167_15568del; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG2
AC   CVCL_C6UG
DR   Wikidata; Q117704837
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG2-iPSC
AC   CVCL_C6UH
SY   SBG2-(8993 T > G)-hiPSC
DR   Wikidata; Q117704838
RX   PubMed=34662843;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Heteroplasmic (PubMed=34662843).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6UG ! SBG2
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG3
AC   CVCL_C6UI
DR   Wikidata; Q117704839
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG3-iPSC
AC   CVCL_C6UJ
SY   SBG3-(9185 T > C)-hiPSC
DR   Wikidata; Q117704840
RX   PubMed=34662843;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Heteroplasmic (PubMed=34662843).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6UI ! SBG3
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG4
AC   CVCL_C6UK
DR   Wikidata; Q117704841
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:7458; MT-ND3; Simple; m.10158T>C; ClinVar=VCV000009714; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG4-iPSC
AC   CVCL_C6UL
SY   SBG4-(10158 T > C)-hIPSC
DR   Wikidata; Q117704842
RX   PubMed=34662843;
CC   Sequence variation: Mutation; HGNC; HGNC:7458; MT-ND3; Simple; m.10158T>C; ClinVar=VCV000009714; Zygosity=Heteroplasmic (PubMed=34662843).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6UK ! SBG4
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG5
AC   CVCL_C6UM
DR   Wikidata; Q117704843
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:7461; MT-ND5; Simple; p.Phe124Leu (m.12706T>C); ClinVar=VCV000009698; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG5-iPSC
AC   CVCL_C6UN
SY   SBG5-(12706 T > C)-hiPSC
DR   Wikidata; Q117704844
RX   PubMed=34662843;
CC   Sequence variation: Mutation; HGNC; HGNC:7461; MT-ND5; Simple; p.Phe124Leu (m.12706T>C); ClinVar=VCV000009698; Zygosity=Heteroplasmic (PubMed=34662843).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6UM ! SBG5
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG6
AC   CVCL_C6UP
DR   Wikidata; Q117704845
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:7490; MT-TL1; Simple; m.3243A>G; ClinVar=VCV000009589; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG7
AC   CVCL_C6UQ
DR   Wikidata; Q117704846
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:7479; MT-TE; Simple; m.14739G>A; ClinVar=VCV000690211; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG8
AC   CVCL_C6UR
DR   Wikidata; Q117704847
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.10676_14868del; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBG9
AC   CVCL_C6US
DR   Wikidata; Q117704848
RX   PubMed=34200828;
CC   Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.7342_9916del; Zygosity=Heteroplasmic (PubMed=34200828).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   NCIt; C115326; Pearson syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
DI   ORDO; Orphanet_699; Pearson syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SBH-1
AC   CVCL_RL85
DR   Wikidata; Q54952209
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7742544;
RX   PubMed=29533902;
CC   Problematic cell line: Possibly misclassified. Originally thought to be a Hodgkin lymphoma cell line, but seems to be either a B-cell non-Hodgkin lymphoma or a diffuse large B-cell lymphoma (PubMed=29533902).
CC   Doubling time: 2-3 days (PubMed=7742544).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SBK [Lateolabrax]
AC   CVCL_R986
SY   Sea Bass Kidney
DR   Wikidata; Q54952210
RX   CelloPub=CLPUB00103;
RX   DOI=10.3147/jsfp.15.201;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   SBK [Pagrus]
AC   CVCL_WY72
SY   Sea Bream Kidney
DR   Wikidata; Q98129359
RX   DOI=10.3147/jsfp.30.23;
RX   PubMed=34382581;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=143350; ! Pagrus major (Red sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 7
//
ID   SBK-2
AC   CVCL_6F87
SY   Sea Bass Kidney-2
DR   Wikidata; Q54952211
RX   DOI=10.3147/jsfp.34.213;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   SBKMS-KS1
AC   CVCL_A8HX
SY   SBKMSKS1; SBSR-AKS
DR   Wikidata; Q107116850
RX   DOI=10.5282/edoc.27750;
RX   PubMed=19289832;
RX   PubMed=22080479;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=19289832).
CC   Derived from site: Metastatic; Groin; UBERON=UBERON_0008337.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SBL-H12578
AC   CVCL_6D40
SY   SBL-H-12578
DR   Wikidata; Q54952212
RX   CelloPub=CLPUB00300;
RX   PubMed=6310915;
CC   Doubling time: 8 hours (PubMed=6310915).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 5
//
ID   SBL-HSC-1000
AC   CVCL_W835
DR   Wikidata; Q54952214
RX   PubMed=3497992;
CC   Population: Japanese.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   SBL-HSC-1802
AC   CVCL_IS34
SY   SBLHSC1802
DR   Wikidata; Q54952215
RX   PubMed=3497992;
CC   Population: Japanese.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W835 ! SBL-HSC-1000
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SBN
AC   CVCL_HX10
SY   SBN-1
DR   ArrayExpress; E-TABM-1088
DR   IARC_TP53; 28501
DR   Wikidata; Q54952216
RX   PubMed=10100725;
RX   PubMed=10583232;
RX   PubMed=16956823;
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*02:01,32:01; B*14:02,57; C*06:02,08:02 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 12
//
ID   SBOT-3.1
AC   CVCL_E269
SY   SBOT 3.1; SBOT-3_1
DR   Cosmic; 1149705
DR   Wikidata; Q54952217
RX   PubMed=18217967;
RX   PubMed=18678400;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 4-6 days (PubMed=18217967).
CC   Karyotypic information: 51,XX,+8,+12,+14,+14,t(15;16)(q25;p11),+16,+18,+20 (PubMed=18217967).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C5226; Borderline ovarian serous tumor
DI   ORDO; Orphanet_398934; Malignant epithelial tumor of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   SBOT-4
AC   CVCL_C8DL
DR   Wikidata; Q123033399
RX   PubMed=18217967;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Senescence: Proliferates rapidly for 2-3 passages (approximately 10-12 PDLs) but then becomes stationary and eventually dies (PubMed=18217967).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=18217967).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5226; Borderline ovarian serous tumor
DI   ORDO; Orphanet_398934; Malignant epithelial tumor of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   SBRIi001-A
AC   CVCL_A8NB
DR   BioSamples; SAMEA111324949
DR   hPSCreg; SBRIi001-A
DR   Wikidata; Q108821265
CC   From: Stem Cell and Brain Research, U1208 INSERM; Bron; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 4
//
ID   SBRIi002-A
AC   CVCL_A8NC
DR   BioSamples; SAMEA8152177
DR   hPSCreg; SBRIi002-A
DR   Wikidata; Q108821266
CC   From: Stem Cell and Brain Research, U1208 INSERM; Bron; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SBRIi003-A
AC   CVCL_A8ND
DR   hPSCreg; SBRIi003-A
DR   Wikidata; Q108821267
CC   From: Stem Cell and Brain Research, U1208 INSERM; Bron; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SBRIi004-A
AC   CVCL_A8NE
DR   hPSCreg; SBRIi004-A
DR   Wikidata; Q108821268
CC   From: Stem Cell and Brain Research, U1208 INSERM; Bron; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SBSC
AC   CVCL_E7CE
SY   Sea Bass Spinal Cord
RX   PubMed=39103669;
CC   Group: Fish cell line.
CC   Virology: Highly susceptible to infection by striped jack nervous necrosis virus (SJNNV) (PubMed=39103669).
CC   Derived from site: In situ; Spinal cord; UBERON=UBERON_0002240.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SBT-E1
AC   CVCL_IZ45
SY   Southern Bluefin Tuna-E1
DR   Wikidata; Q54952218
RX   DOI=10.1016/j.aquaculture.2012.11.008;
RX   DOI=10.1016/j.aquaculture.2015.02.017;
RX   PubMed=24825740;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 25 Celsius (DOI=10.1016/j.aquaculture.2012.11.008).
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8240; ! Thunnus maccoyii (Southern bluefin tuna)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 6
//
ID   SBWCHi001-A
AC   CVCL_A2XU
SY   CTNNB1-C7
DR   BioSamples; SAMEA7655482
DR   hPSCreg; SBWCHi001-A
DR   Wikidata; Q105510980
RX   PubMed=33264726;
CC   From: Shenzhen Baoan Women's and Children's Hospital, Jinan University; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Tyr333Ter (c.999C>A); ClinVar=VCV000450550; Zygosity=Heterozygous (PubMed=33264726).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176897; Neurodevelopmental disorder with spastic diplegia and visual defects
DI   ORDO; Orphanet_404473; Severe intellectual disability-progressive spastic diplegia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   SC [Human contaminated U-937]
AC   CVCL_6444
SY   28SC
DR   CLO; CLO_0008954
DR   ATCC; CRL-3622
DR   ATCC; CRL-9855
DR   cancercelllines; CVCL_6444
DR   Wikidata; Q54952220
RX   Patent=US5447861;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. On the basis of the STR profile it seems to be a U-937 derivative.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00525.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9855.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-9855; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3622
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SC [Human Marfan syndrome]
AC   CVCL_B5M9
DR   CLDB; cl4260
DR   Wikidata; Q112044513
CC   From: Departement Scienze Biomediche e Biotecnologie, Universita degli Studi di Brescia; Brescia; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SC 11
AC   CVCL_4296
SY   SC11; SC11/K; Sc11/K
DR   CLO; CLO_0008955
DR   CLDB; cl4261
DR   ECACC; 90011892
DR   Wikidata; Q54952221
RX   PubMed=570703;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
SX   Male
AG   2Y4M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   SC 3T3/W
AC   CVCL_C5DH
DR   Wikidata; Q116050210
RX   PubMed=1709732;
CC   Doubling time: 19.5 hours (PubMed=1709732).
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 4
//
ID   SC B-LCL
AC   CVCL_C5VY
DR   Wikidata; Q116050211
RX   PubMed=10843661;
CC   HLA typing: A*02,02; B*27:05,27:05 (PubMed=10843661).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Sc-1
AC   CVCL_1888
AS   CVCL_2717
SY   SC-1; SC1; Scott; Sci-1; SCI-1; SCI1
DR   CLO; CLO_0037058
DR   EFO; EFO_0006481
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472729
DR   BioSample; SAMN03473537
DR   cancercelllines; CVCL_1888
DR   Cell_Model_Passport; SIDM00400
DR   ChEMBL-Cells; CHEMBL4523526
DR   ChEMBL-Targets; CHEMBL4523557
DR   Cosmic; 1086345
DR   Cosmic; 1945190
DR   Cosmic; 2297012
DR   Cosmic-CLP; 1331030
DR   DepMap; ACH-002303
DR   DepMap; ACH-002392
DR   DSMZ; ACC-558
DR   DSMZCellDive; ACC-558
DR   ECACC; 96090513
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1331031
DR   GEO; GSM119486
DR   GEO; GSM179648
DR   GEO; GSM274843
DR   GEO; GSM827440
DR   GEO; GSM907520
DR   GEO; GSM1035324
DR   GEO; GSM1374861
DR   GEO; GSM1670415
DR   LINCS_LDP; LCL-1951
DR   PharmacoDB; SC1_1350_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1888
DR   Progenetix; CVCL_2717
DR   PubChem_Cell_line; CVCL_1888
DR   Wikidata; Q54952223
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3098690;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=8558920;
RX   PubMed=16960149;
RX   PubMed=17495976;
RX   PubMed=20215515;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (DSMZ=ACC-558).
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*13:07,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.02%; Native American=0%; East Asian, North=1.9%; East Asian, South=0%; South Asian=0%; European, North=67.26%; European, South=29.81% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-002303; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1331030; DSMZ=ACC-558; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 15,16
ST   D21S11: 28,29
ST   D2S1338: 18,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 18,24
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 8,9.3 (DSMZ=ACC-558)
ST   TH01: 9.3 (Cosmic-CLP=1331030; PubMed=25877200)
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SC-1 [Chicken]
AC   CVCL_T436
DR   Wikidata; Q54952224
RX   PubMed=16206564;
RX   PubMed=16313905;
CC   Group: Bird cell line.
CC   Doubling time: ~44 hours (Note=At 95-135th passages) (PubMed=16313905).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   SC-1 [Human Cetus]
AC   CVCL_3435
SY   CTCC #0082
DR   CLO; CLO_0008956
DR   ATCC; CRL-8756
DR   BioSample; SAMN03471209
DR   LINCS_LDP; LCL-1944
DR   Wikidata; Q54952225
RX   Patent=US4683195;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8756.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (Patent=US4683195).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-8756; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8756
ST   Amelogenin: X,Y
ST   CSF1PO: 7.3,10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 6,9
ST   vWA: 14
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   SC-1 [Human/mouse hybridoma against human CD55]
AC   CVCL_XI15
DR   Wikidata; Q98129362
RX   PubMed=2706635;
RX   PubMed=10537313;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08174; Human CD55.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V21 ! SPM4-0
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   SC-1 [Mouse]
AC   CVCL_3436
SY   III6A
DR   CLO; CLO_0008957
DR   CLO; CLO_0008958
DR   CLO; CLO_0050606
DR   CLDB; cl4263
DR   CLDB; cl4264
DR   ATCC; CRL-1404
DR   ATCC; CRL-6450
DR   BCRC; 60294
DR   CCRID; 1102MOU-NIFDC00010
DR   ECACC; 86060301
DR   ICLC; ATL96009
DR   RCB; RCB1829
DR   Wikidata; Q54952226
RX   PubMed=167514;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6450; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SC-1/MuLV LP-BM5
AC   CVCL_X684
DR   BEI_Resources; ARP-1215
DR   Wikidata; Q54952227
RX   PubMed=2542949;
CC   Virology: Infected with Duplan murine leukemia virus strain LP-BM5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3436 ! SC-1 [Mouse]
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 10
//
ID   SC-115
AC   CVCL_F529
SY   SC 115; SC115; Shionogi Carcinoma-115
DR   Wikidata; Q54952229
RX   DOI=10.1016/0039-128X(64)90135-7;
RX   PubMed=5843266;
CC   Characteristics: This is not a cell line but an androgen-sensitive transplantable mouse tumor which was established from a spontaneously occuring hormone-independent mammary adenocarcinoma in a female mouse by successive transplantation for 18 generations in male mice (DOI=10.1016/0039-128X(64)90135-7; PubMed=5843266).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 6
//
ID   SC-2 [Chicken]
AC   CVCL_T434
DR   Wikidata; Q54952230
RX   PubMed=16813656;
CC   Group: Bird cell line.
CC   Doubling time: ~40 hours (Note=At 95th passage) (PubMed=16813656).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   SC-2 [Mouse]
AC   CVCL_T428
SY   II6C
DR   Wikidata; Q54952232
RX   PubMed=167514;
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   SC-3
AC   CVCL_D3L9
DR   Wikidata; Q127384176
RX   PubMed=3677094;
RX   PubMed=3791211;
RX   PubMed=7829396;
RX   PubMed=9605740;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F529 ! SC-115
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SC-3 A1
AC   CVCL_D3LA
SY   A1
DR   Wikidata; Q127384179
RX   PubMed=7829396;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:99604; Fgf8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3L9 ! SC-3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   SC-3 A1b
AC   CVCL_D3LB
SY   A1b
DR   Wikidata; Q127384181
RX   PubMed=7829396;
CC   Characteristics: Androgen independent (PubMed=7829396).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:99604; Fgf8.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3LA ! SC-3 A1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   SC-6-JCK
AC   CVCL_F953
DR   RCB; RCB2130
DR   TKG; TKG 0341
DR   Wikidata; Q54952233
RX   PubMed=7691144;
CC   Population: Japanese.
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Discontinued: RCB; RCB2130; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): TKG=TKG 0341
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 12
//
ID   SC-71
AC   CVCL_2184
DR   CLO; CLO_0008960
DR   CLDB; cl4266
DR   ABCD; ABCD_AW216
DR   ATCC; HB-277
DR   DSHB; SC-71
DR   DSMZ; ACC-217
DR   DSMZCellDive; ACC-217
DR   Wikidata; Q54952234
RX   DOI=10.1007/1-4020-3103-3_128;
CC   Doubling time: ~20 hours (DSMZ=ACC-217).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9BE41; Bovine MYH2 (Note=Also reacts with other mammalian species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   SC-75
AC   CVCL_2185
DR   CLO; CLO_0008961
DR   CLDB; cl4267
DR   DSMZ; ACC-232
DR   DSMZCellDive; ACC-232
DR   Wikidata; Q54952236
CC   Doubling time: ~23 hours (DSMZ=ACC-232).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   SC-KO1
AC   CVCL_E3ES
RX   PubMed=17204333;
CC   Knockout cell: Method=KO mouse; MGI; MGI:88077; Arsa.
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SC-M1
AC   CVCL_G299
SY   SCM-1; SCM1
DR   BTO; BTO_0003283
DR   Wikidata; Q54952238
RX   CelloPub=CLPUB00109;
RX   PubMed=1913609;
RX   PubMed=8083436;
RX   PubMed=8692540;
RX   PubMed=17022644;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 17 hours (PubMed=8083436).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   SC1 [Human ESC]
AC   CVCL_6F19
DR   Wikidata; Q54952240
RX   PubMed=19764648;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Doubling time: 47.0 +- 6.3 hours (PubMed=19764648).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 8
//
ID   SC1 [Silurus]
AC   CVCL_E7GN
RX   DOI=10.1016/j.aqrep.2024.102587;
CC   Group: Fish cell line.
CC   Characteristics: Capable of sperm production in vitro (DOI=10.1016/j.aqrep.2024.102587).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonial stem cell; CL=CL_0000016.
OX   NCBI_TaxID=175797; ! Silurus meridionalis (Southern catfish)
SX   Male
AG   4M
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Sc10/01
AC   CVCL_C5SZ
DR   Wikidata; Q116050213
RX   PubMed=570703;
CC   Group: Marsupial cell line.
CC   Miscellaneous: Cell line has been lost (PubMed=570703).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
SX   Female
AG   2Y3M
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SC10.111
AC   CVCL_C4GI
DR   ABCD; ABCD_AW100
DR   Wikidata; Q116050214
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.112
AC   CVCL_C4GJ
DR   ABCD; ABCD_AW101
DR   Wikidata; Q116050215
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.115
AC   CVCL_C4GK
DR   ABCD; ABCD_AW102
DR   Wikidata; Q116050216
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.118
AC   CVCL_C4GL
DR   ABCD; ABCD_AW103
DR   Wikidata; Q116050217
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.123
AC   CVCL_C4GM
DR   ABCD; ABCD_AW104
DR   Wikidata; Q116050218
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.124
AC   CVCL_C4GN
DR   ABCD; ABCD_AW105
DR   Wikidata; Q116050219
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.125
AC   CVCL_C4GP
DR   ABCD; ABCD_AW106
DR   Wikidata; Q116050220
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.126
AC   CVCL_C4GQ
DR   ABCD; ABCD_AW107
DR   Wikidata; Q116050221
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.127
AC   CVCL_C4GR
DR   ABCD; ABCD_AW108
DR   Wikidata; Q116050222
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.128
AC   CVCL_C4GS
DR   ABCD; ABCD_AW109
DR   Wikidata; Q116050223
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.129
AC   CVCL_C4GT
DR   ABCD; ABCD_AW110
DR   Wikidata; Q116050224
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.130
AC   CVCL_C4GU
DR   ABCD; ABCD_AW111
DR   Wikidata; Q116050225
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.132
AC   CVCL_C4GV
DR   ABCD; ABCD_AW112
DR   Wikidata; Q116050226
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.133
AC   CVCL_C4GW
DR   ABCD; ABCD_AW113
DR   Wikidata; Q116050227
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.134
AC   CVCL_C4GX
DR   ABCD; ABCD_AW114
DR   Wikidata; Q116050228
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.15
AC   CVCL_C4GB
DR   ABCD; ABCD_AW093
DR   Wikidata; Q116050229
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.163
AC   CVCL_C4GY
DR   ABCD; ABCD_AW115
DR   Wikidata; Q116050230
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.168
AC   CVCL_C4GZ
DR   ABCD; ABCD_AW116
DR   Wikidata; Q116050231
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.17
AC   CVCL_C4GC
DR   ABCD; ABCD_AW094
DR   Wikidata; Q116050232
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.178
AC   CVCL_C4H0
DR   ABCD; ABCD_AW117
DR   Wikidata; Q116050233
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.19
AC   CVCL_C4GD
DR   ABCD; ABCD_AW095
DR   Wikidata; Q116050234
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.35
AC   CVCL_C4GE
DR   ABCD; ABCD_AW096
DR   Wikidata; Q116050235
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.36
AC   CVCL_C4GF
DR   ABCD; ABCD_AW097
DR   Wikidata; Q116050236
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.38
AC   CVCL_C4GG
DR   ABCD; ABCD_AW098
DR   Wikidata; Q116050237
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.6
AC   CVCL_C4GA
DR   ABCD; ABCD_AW092
DR   Wikidata; Q116050238
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC10.75
AC   CVCL_C4GH
DR   ABCD; ABCD_AW099
DR   Wikidata; Q116050239
RX   Patent=US10087258;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC102A-1
AC   CVCL_IT66
SY   SC102-A1; SC102A1; SBIi006-A
DR   BioSamples; SAMEA103988351
DR   hPSCreg; SBIi006-A
DR   SKIP; SKIP002905
DR   Wikidata; Q54952241
RX   PubMed=25567319;
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Discontinued: Systems Biosciences; Catalog number SC102A-1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SC17.1
AC   CVCL_C4H1
DR   Wikidata; Q116050240
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.10
AC   CVCL_C4H7
DR   Wikidata; Q116050241
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.102
AC   CVCL_C4IQ
DR   Wikidata; Q116050242
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.11
AC   CVCL_C4H8
DR   Wikidata; Q116050243
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.114
AC   CVCL_C4IR
DR   Wikidata; Q116050244
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.115
AC   CVCL_C4IS
DR   Wikidata; Q116050245
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.120
AC   CVCL_C4IT
DR   Wikidata; Q116050246
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.121
AC   CVCL_C4IU
DR   Wikidata; Q116050247
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.122
AC   CVCL_C4IV
DR   Wikidata; Q116050248
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.14
AC   CVCL_C4H9
DR   Wikidata; Q116050249
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.140
AC   CVCL_C4IW
DR   Wikidata; Q116050250
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.15
AC   CVCL_C4HA
DR   Wikidata; Q116050251
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.151
AC   CVCL_C4IX
DR   Wikidata; Q116050252
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.156
AC   CVCL_C4IY
DR   Wikidata; Q116050253
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.16
AC   CVCL_C4HB
DR   Wikidata; Q116050254
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.161
AC   CVCL_C4IZ
DR   Wikidata; Q116050256
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.166
AC   CVCL_C4J0
DR   Wikidata; Q116050258
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.17
AC   CVCL_C4HC
DR   Wikidata; Q116050261
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.18
AC   CVCL_C4HD
DR   Wikidata; Q116050264
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.187
AC   CVCL_C4J1
DR   Wikidata; Q116050267
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.19
AC   CVCL_C4HE
DR   Wikidata; Q116050269
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.191
AC   CVCL_C4J2
DR   Wikidata; Q116050271
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.193
AC   CVCL_C4J3
DR   Wikidata; Q116050273
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.199
AC   CVCL_C4J4
DR   Wikidata; Q116050275
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.2
AC   CVCL_C4H2
DR   Wikidata; Q116050278
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.200
AC   CVCL_C4J5
DR   Wikidata; Q116050281
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.22
AC   CVCL_C4HF
DR   Wikidata; Q116050286
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.24
AC   CVCL_C4HG
DR   Wikidata; Q116050288
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.27
AC   CVCL_C4HH
DR   Wikidata; Q116050289
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.28
AC   CVCL_C4HI
DR   Wikidata; Q116050290
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.29
AC   CVCL_C4HJ
DR   Wikidata; Q116050291
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.3
AC   CVCL_C4H3
DR   Wikidata; Q116050292
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.30
AC   CVCL_C4HK
DR   Wikidata; Q116050293
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.32
AC   CVCL_C4HL
DR   Wikidata; Q116050294
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.34
AC   CVCL_C4HM
DR   Wikidata; Q116050297
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.35
AC   CVCL_C4HN
DR   Wikidata; Q116050300
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.36
AC   CVCL_C4HP
DR   Wikidata; Q116050303
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.38
AC   CVCL_C4HQ
DR   Wikidata; Q116050307
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.39
AC   CVCL_C4HR
DR   Wikidata; Q116050310
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.4
AC   CVCL_C4H4
DR   Wikidata; Q116050311
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.40
AC   CVCL_C4HS
DR   Wikidata; Q116050313
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.41
AC   CVCL_C4HT
DR   Wikidata; Q116050316
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.42
AC   CVCL_C4HU
DR   Wikidata; Q116050319
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.45
AC   CVCL_C4HV
DR   Wikidata; Q116050323
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.46
AC   CVCL_C4HW
DR   Wikidata; Q116050325
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.47
AC   CVCL_C4HX
DR   Wikidata; Q116050326
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.49
AC   CVCL_C4HY
DR   Wikidata; Q116050329
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.50
AC   CVCL_C4HZ
DR   Wikidata; Q116050331
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.53
AC   CVCL_C4I0
DR   Wikidata; Q116050333
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.54
AC   CVCL_C4I1
DR   Wikidata; Q116050334
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.56
AC   CVCL_C4I2
DR   Wikidata; Q116050337
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.57
AC   CVCL_C4I3
DR   Wikidata; Q116050339
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.59
AC   CVCL_C4I4
DR   Wikidata; Q116050341
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.61
AC   CVCL_C4I5
DR   Wikidata; Q116050343
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.63
AC   CVCL_C4I6
DR   Wikidata; Q116050345
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.71
AC   CVCL_C4I7
DR   Wikidata; Q116050348
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.72
AC   CVCL_C4I8
DR   Wikidata; Q116050351
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.74
AC   CVCL_C4I9
DR   Wikidata; Q116050353
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.76
AC   CVCL_C4IA
DR   Wikidata; Q116050355
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.77
AC   CVCL_C4IB
DR   Wikidata; Q116050356
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.79
AC   CVCL_C4IC
DR   Wikidata; Q116050357
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.8
AC   CVCL_C4H5
DR   Wikidata; Q116050358
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.81
AC   CVCL_C4ID
DR   Wikidata; Q116050359
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.82
AC   CVCL_C4IE
DR   Wikidata; Q116050360
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.84
AC   CVCL_C4IF
DR   Wikidata; Q116050361
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.85
AC   CVCL_C4IG
DR   Wikidata; Q116050362
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.87
AC   CVCL_C4IH
DR   Wikidata; Q116050363
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.89
AC   CVCL_C4II
DR   Wikidata; Q116050364
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.9
AC   CVCL_C4H6
DR   Wikidata; Q116050366
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.90
AC   CVCL_C4IJ
DR   Wikidata; Q116050368
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.91
AC   CVCL_C4IK
DR   Wikidata; Q116050369
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.93
AC   CVCL_C4IL
DR   Wikidata; Q116050370
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.95
AC   CVCL_C4IM
DR   Wikidata; Q116050372
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.97
AC   CVCL_C4IN
DR   Wikidata; Q116050373
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC17.99
AC   CVCL_C4IP
DR   Wikidata; Q116050374
RX   Patent=US10533051;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q53EL9; Human SEZ6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC2
AC   CVCL_6F20
DR   Wikidata; Q54952242
RX   PubMed=19764648;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Doubling time: 48.0 +- 6.9 hours (PubMed=19764648).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   SC201A-1
AC   CVCL_IT67
DR   Wikidata; Q54952244
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Discontinued: Systems Biosciences; Catalog number SC201A-1.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SC211A-1
AC   CVCL_IT76
SY   PhiC31 miPSC
DR   Wikidata; Q54952246
WW   Provider; SBI; SC211A-1; https://www.systembio.com/wp/wp-content/uploads/2020/10/phiC31_reprogramming_WEB-1.pdf
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9T221; Streptomyces phage phiC31 int.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   SC263 R10.2
AC   CVCL_LI56
DR   cancercelllines; CVCL_LI56
DR   Wikidata; Q54952247
RX   PubMed=26269754;
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.704_735del32; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (from parent cell line).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LI51 ! NKI-SC263
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   SC3
AC   CVCL_6F21
DR   Wikidata; Q54952248
RX   PubMed=19764648;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Doubling time: 28.5 +- 2.5 hours (PubMed=19764648).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   SC30
AC   CVCL_A0GC
DR   Wikidata; Q108821269
RX   Patent=US7915041;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10153.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SC3192
AC   CVCL_VB55
DR   ECACC; 15102982
DR   Wikidata; Q54952250
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3217
AC   CVCL_VB56
DR   ECACC; 15102983
DR   Wikidata; Q54952252
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3220
AC   CVCL_VB57
DR   ECACC; 15092918
DR   Wikidata; Q54952261
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3223
AC   CVCL_VB58
DR   ECACC; 15102984
DR   Wikidata; Q54952262
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3236
AC   CVCL_VB59
DR   ECACC; 15102985
DR   Wikidata; Q54952263
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3336
AC   CVCL_VB60
DR   ECACC; 15092919
DR   Wikidata; Q54952264
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3345
AC   CVCL_VB61
DR   ECACC; 15092920
DR   Wikidata; Q54952266
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC34.10
AC   CVCL_C3Y4
DR   Wikidata; Q116050375
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.11
AC   CVCL_C3Y5
DR   ABCD; ABCD_AP817
DR   Wikidata; Q116050376
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.13
AC   CVCL_C3Y6
DR   ABCD; ABCD_AP818
DR   Wikidata; Q116050377
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.14
AC   CVCL_C3Y7
DR   ABCD; ABCD_AP819
DR   Wikidata; Q116050378
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.15
AC   CVCL_C3Y8
DR   Wikidata; Q116050379
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.16
AC   CVCL_C3Y9
DR   ABCD; ABCD_AP820
DR   Wikidata; Q116050380
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.18
AC   CVCL_C3YA
DR   ABCD; ABCD_AP821
DR   Wikidata; Q116050381
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.19
AC   CVCL_C3YB
DR   ABCD; ABCD_AP822
DR   Wikidata; Q116050382
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.2
AC   CVCL_C3XW
DR   Wikidata; Q116050383
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.20
AC   CVCL_C3YC
DR   ABCD; ABCD_AP823
DR   Wikidata; Q116050385
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.22
AC   CVCL_C3YD
DR   Wikidata; Q116050387
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.24
AC   CVCL_C3YE
DR   ABCD; ABCD_AP825
DR   Wikidata; Q116050390
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.25
AC   CVCL_C3YF
DR   ABCD; ABCD_AP826
DR   Wikidata; Q116050393
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.26
AC   CVCL_C3YG
DR   ABCD; ABCD_AP827
DR   Wikidata; Q116050396
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.27
AC   CVCL_C3YH
DR   ABCD; ABCD_AP828
DR   Wikidata; Q116050398
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.28
AC   CVCL_C3YI
DR   ABCD; ABCD_AP829
DR   Wikidata; Q116050399
RX   Patent=US10189910;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized antibody tamrintamab (hSC34.28) which when conjugated to a pyrrolobenzodiazepine dimer is known as tamrintamab pamozirine (SC-003) and is used in clinical trials for the treatment of ovarian carcinoma.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.29
AC   CVCL_C3YJ
DR   Wikidata; Q116050402
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.3
AC   CVCL_C3XX
DR   Wikidata; Q116050404
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.32
AC   CVCL_C3YK
DR   Wikidata; Q116050405
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.33
AC   CVCL_C3YL
DR   ABCD; ABCD_AP830
DR   Wikidata; Q116050406
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.34
AC   CVCL_C3YM
DR   Wikidata; Q116050407
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.35
AC   CVCL_C3YN
DR   Wikidata; Q116050408
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.36
AC   CVCL_C3YP
DR   ABCD; ABCD_AP831
DR   Wikidata; Q116050410
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.37
AC   CVCL_C3YQ
DR   Wikidata; Q116050411
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.38
AC   CVCL_C3YR
DR   ABCD; ABCD_AP832
DR   Wikidata; Q116050412
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.39
AC   CVCL_C3YS
DR   ABCD; ABCD_AP833
DR   Wikidata; Q116050413
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.4
AC   CVCL_C3XY
DR   Wikidata; Q116050415
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3 (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.40
AC   CVCL_C3YT
DR   ABCD; ABCD_AP834
DR   Wikidata; Q116050416
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.41
AC   CVCL_C3YU
SY   SC34.61
DR   ABCD; ABCD_AP835
DR   Wikidata; Q116050417
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.43
AC   CVCL_C3YV
DR   Wikidata; Q116050418
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.44
AC   CVCL_C3YW
DR   Wikidata; Q116050420
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.45
AC   CVCL_C3YX
DR   Wikidata; Q116050421
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.46
AC   CVCL_C3YY
DR   ABCD; ABCD_AP836
DR   Wikidata; Q116050422
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.47
AC   CVCL_C3YZ
DR   Wikidata; Q116050423
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.48
AC   CVCL_C3Z0
DR   ABCD; ABCD_AP837
DR   Wikidata; Q116050424
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.49
AC   CVCL_C3Z1
DR   ABCD; ABCD_AP838
DR   Wikidata; Q116050426
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.5
AC   CVCL_C3XZ
DR   Wikidata; Q116050427
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.50
AC   CVCL_C3Z2
DR   ABCD; ABCD_AP839
DR   Wikidata; Q116050429
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.51
AC   CVCL_C3Z3
DR   Wikidata; Q116050430
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.52
AC   CVCL_C3Z4
DR   Wikidata; Q116050431
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.53
AC   CVCL_C3Z5
DR   ABCD; ABCD_AP840
DR   Wikidata; Q116050432
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.54
AC   CVCL_C3Z6
DR   Wikidata; Q116050433
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.55
AC   CVCL_C3Z7
DR   Wikidata; Q116050434
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.56
AC   CVCL_C3Z8
DR   Wikidata; Q116050435
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.58
AC   CVCL_C3Z9
DR   ABCD; ABCD_AP841
DR   Wikidata; Q116050436
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.59
AC   CVCL_C3ZA
DR   Wikidata; Q116050437
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.6
AC   CVCL_C3Y0
SY   SC34.21
DR   Wikidata; Q116050438
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.60
AC   CVCL_C3ZB
DR   Wikidata; Q116050439
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.62
AC   CVCL_C3ZC
DR   Wikidata; Q116050440
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.63
AC   CVCL_C3ZD
DR   ABCD; ABCD_AP842
DR   Wikidata; Q116050441
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.65
AC   CVCL_C3ZE
DR   Wikidata; Q116050442
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.66
AC   CVCL_C3ZF
DR   Wikidata; Q116050443
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.67
AC   CVCL_C3ZG
DR   ABCD; ABCD_AP843
DR   Wikidata; Q116050444
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.68
AC   CVCL_C3ZH
DR   Wikidata; Q116050446
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.69
AC   CVCL_C3ZI
DR   Wikidata; Q116050447
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.7
AC   CVCL_C3Y1
DR   Wikidata; Q116050448
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.70
AC   CVCL_C3ZJ
DR   Wikidata; Q116050449
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3 (Note=Also reacts with mouse and rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.71
AC   CVCL_C3ZK
DR   ABCD; ABCD_AP844
DR   Wikidata; Q116050450
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.72
AC   CVCL_C3ZL
DR   Wikidata; Q116050451
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.73
AC   CVCL_C3ZM
DR   Wikidata; Q116050452
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4A9; Human DPEP2.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.74
AC   CVCL_C3ZN
DR   Wikidata; Q116050453
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.75
AC   CVCL_C3ZP
DR   Wikidata; Q116050454
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.76
AC   CVCL_C3ZQ
DR   ABCD; ABCD_AP845
DR   Wikidata; Q116050455
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.77
AC   CVCL_C3ZR
DR   Wikidata; Q116050456
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.78
AC   CVCL_C3ZS
DR   ABCD; ABCD_AP846
DR   Wikidata; Q116050457
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.8
AC   CVCL_C3Y2
DR   Wikidata; Q116050458
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.80
AC   CVCL_C3ZT
DR   Wikidata; Q116050459
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.81
AC   CVCL_C3ZU
DR   Wikidata; Q116050460
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.83
AC   CVCL_C3ZV
DR   ABCD; ABCD_AP847
DR   Wikidata; Q116050461
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.84
AC   CVCL_C3ZW
DR   Wikidata; Q116050462
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.85
AC   CVCL_C3ZX
DR   Wikidata; Q116050463
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.86
AC   CVCL_C3ZY
DR   ABCD; ABCD_AP848
DR   Wikidata; Q116050464
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.87
AC   CVCL_C3ZZ
DR   ABCD; ABCD_AP849
DR   Wikidata; Q116050466
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.88
AC   CVCL_C4A0
DR   Wikidata; Q116050467
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.89
AC   CVCL_C4A1
DR   ABCD; ABCD_AP850
DR   Wikidata; Q116050468
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.9
AC   CVCL_C3Y3
DR   Wikidata; Q116050469
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.90
AC   CVCL_C4A2
DR   ABCD; ABCD_AP851
DR   Wikidata; Q116050470
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.91
AC   CVCL_C4A3
DR   ABCD; ABCD_AP852
DR   Wikidata; Q116050471
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.92
AC   CVCL_C4A4
DR   Wikidata; Q116050472
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.94
AC   CVCL_C4A5
DR   Wikidata; Q116050473
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.95
AC   CVCL_C4A6
DR   ABCD; ABCD_AP853
DR   Wikidata; Q116050474
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC34.96
AC   CVCL_C4A7
DR   Wikidata; Q116050475
RX   Patent=US10189910;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H4B8; Human DPEP3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SC3406
AC   CVCL_VB62
DR   ECACC; 15102986
DR   Wikidata; Q54952267
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3490
AC   CVCL_VB63
DR   ECACC; 15102987
DR   Wikidata; Q54952268
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3504
AC   CVCL_VB64
DR   ECACC; 15102988
DR   Wikidata; Q54952269
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3509
AC   CVCL_VB65
DR   ECACC; 15102989
DR   Wikidata; Q54952270
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3521
AC   CVCL_VB66
DR   ECACC; 15102990
DR   Wikidata; Q54952271
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3535
AC   CVCL_VB67
DR   ECACC; 15092921
DR   Wikidata; Q54952273
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3602
AC   CVCL_VB68
DR   ECACC; 15092922
DR   Wikidata; Q54952274
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3611
AC   CVCL_VB69
DR   ECACC; 15102992
DR   Wikidata; Q54952275
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3690
AC   CVCL_VB70
DR   ECACC; 15102993
DR   Wikidata; Q54952276
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3709
AC   CVCL_VB71
DR   ECACC; 15092923
DR   Wikidata; Q54952277
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3780
AC   CVCL_VB72
DR   ECACC; 15092924
DR   Wikidata; Q54952278
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3784
AC   CVCL_VB73
DR   ECACC; 15102994
DR   Wikidata; Q54952279
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SC3a
AC   CVCL_6F22
DR   Wikidata; Q54952280
RX   PubMed=21950051;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SC3a-MSC
AC   CVCL_6F61
DR   Wikidata; Q54952281
RX   PubMed=22567895;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Doubling time: 38.8 +- 1.0 hours (PubMed=22567895).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F22 ! SC3a
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   Sc3F
AC   CVCL_JZ55
DR   Wikidata; Q54952282
RX   DOI=10.1071/BI9770445;
RX   PubMed=569474;
RX   PubMed=805376;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   SC3VA4
AC   CVCL_F831
DR   Wikidata; Q54952283
RX   PubMed=8316630;
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 10
//
ID   SC4 [Human ESC]
AC   CVCL_6F23
DR   Wikidata; Q54952284
RX   PubMed=19764648;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Doubling time: 37.5 +- 4.2 hours (PubMed=19764648).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   SC4 [Mouse schwannoma]
AC   CVCL_JK03
DR   Wikidata; Q54952286
RX   PubMed=17234759;
RX   PubMed=28469964;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97307; Nf2 (Note=Conditional KO).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C21997; Mouse schwannoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 6
//
ID   SC5
AC   CVCL_6F24
DR   Wikidata; Q54952287
RX   PubMed=21950051;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SC5-MSC
AC   CVCL_6F62
DR   Wikidata; Q54952288
RX   PubMed=22567895;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Doubling time: 25.5 +- 0.1 hours (PubMed=22567895).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F24 ! SC5
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   SC6
AC   CVCL_6F25
DR   Wikidata; Q54952289
RX   PubMed=21950051;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SC600A-WT
AC   CVCL_IT68
DR   Wikidata; Q54952290
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Population: Caucasian.
CC   Discontinued: Systems Biosciences; Catalog number SC600A-WT.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SC601A/B-MLD
AC   CVCL_IT69
DR   Wikidata; Q54952291
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Discontinued: Systems Biosciences; Catalog number SC601A/B-MLD.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61251; Metachromatic leukodystrophy
DI   ORDO; Orphanet_512; Metachromatic leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   SC602A/B-DTI
AC   CVCL_IT70
DR   Wikidata; Q54952292
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Population: Hispanic.
CC   Discontinued: Systems Biosciences; Catalog number SC602A/B-DTI.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SC603A/B-ALS
AC   CVCL_IT71
DR   Wikidata; Q54952294
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Population: Latino.
CC   Discontinued: Systems Biosciences; Catalog number SC603A/B-ALS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   SC604A/B-MD
AC   CVCL_IT72
DR   Wikidata; Q54952295
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Population: Latino.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex3-6del; Zygosity=Hemizygous (SBI).
CC   Discontinued: Systems Biosciences; Catalog number SC604A/B-MD.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   SC605A/B-GBM
AC   CVCL_IT73
DR   Wikidata; Q54952296
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Population: Latino.
CC   Discontinued: Systems Biosciences; Catalog number SC605A/B-GBM.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   SC607A/B-PD
AC   CVCL_IT74
DR   Wikidata; Q54952297
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Population: Hispanic.
CC   Discontinued: Systems Biosciences; Catalog number SC607A/B-PD.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   SC608A/B-PD
AC   CVCL_IT75
DR   Wikidata; Q54952298
CC   From: Systems Biosciences (SBI), Inc.; Palo Alto; USA.
CC   Population: Hispanic.
CC   Discontinued: Systems Biosciences; Catalog number SC608A/B-PD.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   SC7
AC   CVCL_6F26
DR   Wikidata; Q54952300
RX   PubMed=21950051;
CC   From: Institute of Cytology, Russian Academy of Sciences; St. Petersburg; Russia.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SC78.H81.C81.A9
AC   CVCL_J315
SY   SC78.H81
DR   JCRB; JCRB1301
DR   Wikidata; Q54952301
RX   PubMed=1367787;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_16794; Scopolamine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   Sc9/01
AC   CVCL_JZ56
DR   Wikidata; Q54952303
RX   DOI=10.1071/BI9770445;
RX   DOI=10.1071/BI9770461;
RX   PubMed=570703;
CC   Group: Marsupial cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9301; ! Sminthopsis crassicaudata (Fat-tailed dunnart)
SX   Female
AG   1Y11M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   SCA-10
AC   CVCL_JY06
DR   Wikidata; Q54952304
RX   PubMed=6993784;
CC   Doubling time: 23.9 hours (Note=At 9th passage) (PubMed=6993784).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C134961; Mouse submandibular gland neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   SCA-5
AC   CVCL_JY07
DR   Wikidata; Q54952305
RX   PubMed=6993784;
CC   Doubling time: 21.2 hours (Note=At 9th passage) (PubMed=6993784).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C134961; Mouse submandibular gland neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   SCA-9
AC   CVCL_JY08
DR   Wikidata; Q54952306
RX   PubMed=6993784;
CC   Doubling time: 23.9 hours (Note=At 9th passage) (PubMed=6993784).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C134961; Mouse submandibular gland neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 7
//
ID   SCA-9 clone 15
AC   CVCL_6445
DR   CLO; CLO_0008964
DR   ATCC; CRL-1734
DR   Wikidata; Q54952314
RX   PubMed=15922327;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C134961; Mouse submandibular gland neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JY08 ! SCA-9
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   SCA-GFP-POS
AC   CVCL_C8Z2
DR   Wikidata; Q123033400
RX   PubMed=15922327;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C134961; Mouse submandibular gland neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6445 ! SCA-9 clone 15
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SCA3.A11
AC   CVCL_DQ98
DR   Wikidata; Q54952315
RX   PubMed=27346190;
RX   PubMed=27596958;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[83]; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=27596958).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE47 ! SCA3.A8
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   SCA3.A8
AC   CVCL_VE47
DR   Wikidata; Q54952316
RX   PubMed=27596958;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[83]; Zygosity=Heterozygous; Note=The other allele has 22 repeats (PubMed=27596958).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ98 ! SCA3.A11
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   SCA3.B1
AC   CVCL_VF01
DR   Wikidata; Q54952317
RX   PubMed=27596958;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[78]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=27596958).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ99 ! SCA3.B11
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   SCA3.B11
AC   CVCL_DQ99
DR   Wikidata; Q54952318
RX   PubMed=27346191;
RX   PubMed=27596958;
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[78]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=27596958).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF01 ! SCA3.B1
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   SCaBER
AC   CVCL_3599
SY   SCABER; Scaber
DR   BTO; BTO_0003777
DR   CLO; CLO_0008965
DR   EFO; EFO_0002325
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-3
DR   BioGRID_ORCS_Cell_line; 471
DR   BioSample; SAMN03472741
DR   BioSample; SAMN10988312
DR   cancercelllines; CVCL_3599
DR   CCRID; 3101HUMTCHu239
DR   Cell_Model_Passport; SIDM00032
DR   ChEMBL-Cells; CHEMBL3307437
DR   ChEMBL-Targets; CHEMBL614898
DR   CLS; 305111
DR   Cosmic; 687456
DR   Cosmic; 715717
DR   Cosmic; 760489
DR   Cosmic; 845570
DR   Cosmic; 923376
DR   Cosmic; 925835
DR   Cosmic; 928824
DR   Cosmic; 943743
DR   Cosmic; 1046689
DR   Cosmic; 1285126
DR   Cosmic; 1286000
DR   Cosmic; 1927304
DR   Cosmic; 1995625
DR   Cosmic; 2037956
DR   Cosmic; 2050461
DR   Cosmic; 2686113
DR   Cosmic-CLP; 1299051
DR   DepMap; ACH-000839
DR   EGA; EGAS00001000978
DR   GDSC; 1299051
DR   GEO; GSM136226
DR   GEO; GSM887557
DR   GEO; GSM888640
DR   GEO; GSM1374862
DR   GEO; GSM1374863
DR   GEO; GSM1574562
DR   GEO; GSM1670407
DR   IARC_TP53; 375
DR   IGRhCellID; SCaBER
DR   LiGeA; CCLE_439
DR   LINCS_LDP; LCL-1540
DR   PharmacoDB; SCaBER_1351_2019
DR   Progenetix; CVCL_3599
DR   PubChem_Cell_line; CVCL_3599
DR   Wikidata; Q54952320
RX   PubMed=571047;
RX   PubMed=947851;
RX   PubMed=2990217;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6823318;
RX   PubMed=6935474;
RX   PubMed=7656243;
RX   PubMed=8873383;
RX   PubMed=9850064;
RX   PubMed=11416159;
RX   PubMed=12127398;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=27270441;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (PubMed=9850064; Cosmic-CLP=1299051; DepMap=ACH-000839).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=86.54%; Native American=1.69%; East Asian, North=2.11%; East Asian, South=0%; South Asian=0%; European, North=6%; European, South=3.66% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=HTB-3; Cosmic-CLP=1299051; PubMed=11416159; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15 (PubMed=11416159)
ST   D18S51: 15,17 (ATCC=HTB-3)
ST   D19S433: 10,13
ST   D21S11: 29,32.2
ST   D2S1338: 19,21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   Penta D: 3.2,5
ST   Penta E: 7,9
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C4031; Bladder squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SCaBER/R
AC   CVCL_C8D5
DR   Wikidata; Q123033401
RX   PubMed=7656243;
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_195316; N-7-(2-(nitrophenyldithio)ethyl)mitomycin C (BMY-25067).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4031; Bladder squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3599 ! SCaBER
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   ScAP-23
AC   CVCL_RK65
DR   ABM; T0544
DR   Wikidata; Q54952321
RX   PubMed=17609412;
CC   Characteristics: This preadipocyte cell line can be onverted to adipocytes when treated with dexamethasone, 3-methylisobutylxanthine, insulin and indomethacin (PubMed=17609412).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   3W
CA   Telomerase immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   SCAUi001-A
AC   CVCL_D0KX
DR   BioSamples; SAMEA114396407
DR   hPSCreg; SCAUi001-A
DR   Wikidata; Q123033403
CC   From: South China Agricultural University; Guangzhou; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SCAUi001-A-1
AC   CVCL_D0KY
DR   BioSamples; SAMEA114401933
DR   hPSCreg; SCAUi001-A-1
DR   Wikidata; Q123033404
CC   From: South China Agricultural University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19977; RDH12.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0KX ! SCAUi001-A
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SCAUi001-A-2
AC   CVCL_D0KZ
DR   BioSamples; SAMEA114402034
DR   hPSCreg; SCAUi001-A-2
DR   Wikidata; Q123033405
CC   From: South China Agricultural University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12601; USH2A.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0KX ! SCAUi001-A
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SCC
AC   CVCL_C0WY
SY   Spinal Cord Chuatsi
DR   Wikidata; Q114312957
RX   PubMed=35748800;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 28 Celsius (PubMed=35748800).
CC   Virology: Susceptible to infection by infectious spleen and kidney necrosis virus (ISKNV), Siniperca chuatsi ranavirus (SCRaV) and Siniperca chuatsi rhabdovirus (SCRV) (PubMed=35748800).
CC   Derived from site: In situ; Spinal cord; UBERON=UBERON_0002240.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SCC 2/88
AC   CVCL_N510
SY   SCC2/88
DR   Wikidata; Q54952322
RX   PubMed=2063514;
RX   PubMed=8377475;
RX   PubMed=30268330;
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   SCC#10
AC   CVCL_C259
DR   ATCC; SCRC-1020
DR   Wikidata; Q54952371
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129X1/SvJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   SCC-1-Cet-R
AC   CVCL_4V02
SY   Cet-R
DR   Wikidata; Q54952324
RX   PubMed=19190133;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7707 ! UM-SCC-1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   SCC-1-Erl-R
AC   CVCL_4V03
SY   Erl-R
DR   Wikidata; Q54952325
RX   PubMed=19190133;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7707 ! UM-SCC-1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   SCC-1-Gef-R
AC   CVCL_4V04
SY   Gef-R
DR   Wikidata; Q54952326
RX   PubMed=19190133;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49668; Gefitinib (ZD1839; Iressa).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7707 ! UM-SCC-1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   SCC-12
AC   CVCL_4026
SY   SCC 12; SCC12
DR   cancercelllines; CVCL_4026
DR   Cosmic; 740989
DR   IGRhCellID; SCC12%20GSE9585
DR   Wikidata; Q54952327
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3360658;
RX   PubMed=7214336;
RX   PubMed=11992403;
RX   PubMed=17312569;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-322.html
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (PubMed=11992403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (PubMed=11992403).
CC   Donor information: Established from a kidney transplant recipient who had been treated with immunosuppressive drugs for the previous 7 years (PubMed=7214336).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 19
//
ID   SCC-12B
AC   CVCL_4027
SY   SCC-12b; SCC 12B; SCC12b; SCC12B; SCC-12 clone B
DR   BTO; BTO_0002192
DR   cancercelllines; CVCL_4027
DR   Cosmic; 1608862
DR   IARC_TP53; 1910
DR   Wikidata; Q54952328
RX   PubMed=1574572;
RX   PubMed=8390283;
RX   PubMed=22006338;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (PubMed=8390283).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4026 ! SCC-12
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   SCC-12B.2
AC   CVCL_M672
SY   SCC-12B2; SCC-12 B.2; SCC12B2
DR   cancercelllines; CVCL_M672
DR   Wikidata; Q54952329
RX   PubMed=3182330;
RX   PubMed=3360658;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4027 ! SCC-12B
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   SCC-12F
AC   CVCL_4028
SY   SCC 12F; SCC 12-F; SCC12F; SSC12f
DR   cancercelllines; CVCL_4028
DR   Cosmic; 1608863
DR   Wikidata; Q54952330
RX   PubMed=9204953;
RX   PubMed=22006338;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4026 ! SCC-12
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   SCC-12F.2
AC   CVCL_M673
SY   SCC-12F2; SCC-12 F.2; SCC12F2
DR   EFO; EFO_0022352
DR   cancercelllines; CVCL_M673
DR   Wikidata; Q54952331
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4028 ! SCC-12F
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   SCC-12F.2a
AC   CVCL_M674
SY   SCC-12 F.2a
DR   cancercelllines; CVCL_M674
DR   Wikidata; Q54952332
RX   PubMed=3360658;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M673 ! SCC-12F.2
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   SCC-12F.2b
AC   CVCL_M675
SY   SCC-12 F.2b
DR   cancercelllines; CVCL_M675
DR   Wikidata; Q54952333
RX   PubMed=3360658;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M673 ! SCC-12F.2
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   SCC-12V
AC   CVCL_M676
SY   SCC-12 V
DR   cancercelllines; CVCL_M676
DR   Wikidata; Q54952335
RX   PubMed=1574572;
RX   PubMed=3360658;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4026 ! SCC-12
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   SCC-13
AC   CVCL_4029
SY   SCC 13; SCC13
DR   BTO; BTO_0002193
DR   BioGRID_ORCS_Cell_line; 1574
DR   cancercelllines; CVCL_4029
DR   Cosmic; 740990
DR   IARC_TP53; 1911
DR   IGRhCellID; SCC13%20GSE9585
DR   PRIDE; PXD023701
DR   TOKU-E; 3610
DR   Wikidata; Q54952336
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=6722007;
RX   PubMed=7214336;
RX   PubMed=8390283;
RX   PubMed=11992403;
RX   PubMed=17312569;
RX   PubMed=22546478;
RX   PubMed=22564525;
RX   PubMed=34435183;
RX   PubMed=34593609;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Doubling time: 1 day (PubMed=34435183).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (PubMed=8390283; PubMed=11992403).
CC   Omics: Proteomics; Quantitative.
CC   Donor information: Established from a patient who had received a series of radiation treatments for the tumor for several years before its surgical removal (PubMed=7214336).
CC   Miscellaneous: STR profile from personal communication of Ramsey, Matthew Robert.
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14,19
ST   D19S433: 13,14
ST   D21S11: 31
ST   D2S1338: 24,26
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 10,18
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 24
//
ID   SCC-131
AC   CVCL_6726
SY   SCC131
DR   JCRB; JCRB0230
DR   Wikidata; Q54952337
RX   PubMed=19107611;
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 8
//
ID   SCC-15
AC   CVCL_1681
SY   SCC 15; SCC15
DR   BTO; BTO_0005102
DR   CLO; CLO_0008966
DR   EFO; EFO_0006482
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1623
DR   BCRJ; 0218
DR   BioSample; SAMN03473152
DR   BioSample; SAMN10988435
DR   cancercelllines; CVCL_1681
DR   Cell_Model_Passport; SIDM01083
DR   ChEMBL-Cells; CHEMBL3307438
DR   ChEMBL-Targets; CHEMBL614899
DR   Cosmic; 910911
DR   Cosmic; 921835
DR   Cosmic; 932150
DR   Cosmic; 1006468
DR   Cosmic; 1017794
DR   Cosmic; 1041675
DR   Cosmic; 1530752
DR   Cosmic; 1752765
DR   Cosmic; 2131855
DR   Cosmic; 2266793
DR   Cosmic; 2296301
DR   Cosmic-CLP; 910911
DR   DepMap; ACH-000254
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910911
DR   GEO; GSM422871
DR   GEO; GSM423674
DR   GEO; GSM887558
DR   GEO; GSM888641
DR   GEO; GSM950313
DR   GEO; GSM950314
DR   GEO; GSM950315
DR   GEO; GSM950316
DR   GEO; GSM1670408
DR   IGRhCellID; SCC15%20GSE9585
DR   LiGeA; CCLE_118
DR   LINCS_LDP; LCL-1222
DR   PharmacoDB; SCC15_1352_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1681
DR   PubChem_Cell_line; CVCL_1681
DR   TOKU-E; 3096
DR   Wikidata; Q54952338
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=3138611;
RX   PubMed=6186388;
RX   PubMed=6201865;
RX   PubMed=7214336;
RX   PubMed=8390283;
RX   PubMed=17312569;
RX   PubMed=20014447;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=22460905;
RX   PubMed=22546478;
RX   PubMed=25275298;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27664486;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-growth-and-morphology-atcc-crl-1623
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 1.5-1.7 days (PubMed=6201865); 1.93 +- 0.19 days (PubMed=27664486).
CC   HLA typing: A*01:01,01:01; B*08:01,51:01; C*07:01,14:02; DQA1*04:01,04:01; DQB1*04:02,04:02; DRB1*03:01,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.32%; East Asian, South=0%; South Asian=0%; European, North=67.04%; European, South=30.64% (PubMed=30894373).
CC   Discontinued: BCRJ; 0218; probable.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-1623; Cosmic-CLP=910911; PubMed=21868764; PubMed=25275298; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,14
ST   D16S539: 12,15
ST   D18S51: 16
ST   D19S433: 15
ST   D21S11: 30 (PubMed=25877200)
ST   D21S11: 30,31.2 (ATCC=CRL-1623; PubMed=25275298)
ST   D2S1338: 16,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 19,24
ST   Penta D: 9 (PubMed=25877200)
ST   Penta D: 9,13 (ATCC=CRL-1623; PubMed=25275298)
ST   Penta E: 7,13
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   SCC-158
AC   CVCL_6727
SY   SCC158
DR   JCRB; JCRB0231
DR   Wikidata; Q54952339
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 8
//
ID   SCC-1CB
AC   CVCL_M668
DR   Wikidata; Q54952340
RX   PubMed=2585777;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=2585777).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   SCC-25
AC   CVCL_1682
SY   SCC 25; SCC25; hSCC-25
DR   BTO; BTO_0003774
DR   CLO; CLO_0008967
DR   EFO; EFO_0006483
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1628
DR   BCRC; 60516
DR   BCRJ; 0194
DR   BioSample; SAMN01821595
DR   BioSample; SAMN01821662
DR   BioSample; SAMN03473153
DR   BioSample; SAMN10988425
DR   cancercelllines; CVCL_1682
DR   Cell_Model_Passport; SIDM01082
DR   ChEMBL-Cells; CHEMBL3307440
DR   ChEMBL-Targets; CHEMBL614901
DR   CLS; 300607
DR   Cosmic; 910701
DR   Cosmic; 921836
DR   Cosmic; 922091
DR   Cosmic; 927216
DR   Cosmic; 932151
DR   Cosmic; 1006470
DR   Cosmic; 1017795
DR   Cosmic; 1041676
DR   Cosmic; 1122672
DR   Cosmic; 1212701
DR   Cosmic; 1339916
DR   Cosmic; 1351515
DR   Cosmic; 1530753
DR   Cosmic; 1608864
DR   Cosmic; 1752766
DR   Cosmic; 2043888
DR   Cosmic; 2266782
DR   Cosmic; 2296302
DR   Cosmic; 2301591
DR   Cosmic; 2546842
DR   Cosmic; 2550367
DR   Cosmic-CLP; 910701
DR   DepMap; ACH-000188
DR   DSMZ; ACC-617
DR   DSMZCellDive; ACC-617
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910701
DR   GEO; GSM422872
DR   GEO; GSM423675
DR   GEO; GSM887559
DR   GEO; GSM888642
DR   GEO; GSM1374864
DR   GEO; GSM1519068
DR   GEO; GSM1519069
DR   GEO; GSM1519070
DR   GEO; GSM1670409
DR   IARC_TP53; 1914
DR   IGRhCellID; SCC25%20GSE9585
DR   LiGeA; CCLE_772
DR   LINCS_LDP; LCL-1223
DR   PharmacoDB; SCC25_1353_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1682
DR   PubChem_Cell_line; CVCL_1682
DR   TOKU-E; 3097
DR   Wikidata; Q54952341
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=1574572;
RX   PubMed=2380097;
RX   PubMed=2573646;
RX   PubMed=3138611;
RX   PubMed=3182330;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=3539321;
RX   PubMed=6722007;
RX   PubMed=7214336;
RX   PubMed=8339273;
RX   PubMed=8390283;
RX   PubMed=17312569;
RX   PubMed=17325662;
RX   PubMed=17848307;
RX   PubMed=20014447;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=22006338;
RX   PubMed=22460905;
RX   PubMed=22546478;
RX   PubMed=22564525;
RX   PubMed=24201445;
RX   PubMed=24825747;
RX   PubMed=25275298;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25888065;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27664486;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=29423072;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 2.4 +- 0.16 days (PubMed=27664486); 32.8 +- 2.4 hours (PubMed=29423072); ~50 hours (DSMZ=ACC-617).
CC   HLA typing: A*02:01,02:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (Cosmic-CLP=910701; DepMap=ACH-000188).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.72%; Native American=0.24%; East Asian, North=4.71%; East Asian, South=0%; South Asian=0%; European, North=56.41%; European, South=35.91% (PubMed=30894373).
CC   Misspelling: SCCS-25; GEO=GSM422872.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-1628; CLS=300607; Cosmic-CLP=910701; DSMZ=ACC-617; PubMed=21868764; PubMed=25275298; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,16
ST   D12S391: 17
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 15,16 (Technion Genomics Center)
ST   D18S51: 16 (ATCC=CRL-1628; CLS=300607; DSMZ=ACC-617; PubMed=25275298; PubMed=25877200)
ST   D19S433: 13,14
ST   D1S1656: 17,18.3
ST   D21S11: 30
ST   D22S1045: 11,15
ST   D2S1338: 17,19
ST   D2S441: 11.3
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 13,18
ST   D7S820: 12
ST   D8S1179: 12.3 (Technion Genomics Center)
ST   D8S1179: 13 (ATCC=CRL-1628; CLS=300607; DSMZ=ACC-617; PubMed=25275298; PubMed=25877200)
ST   FGA: 20,24
ST   Penta D: 13
ST   Penta E: 14,15
ST   TH01: 8
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   SCC-25/CP
AC   CVCL_A5BQ
SY   SCC25/CP
DR   BTO; BTO_0006418
DR   Wikidata; Q107116851
RX   PubMed=3539321;
RX   PubMed=8612713;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1682 ! SCC-25
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   SCC-3
AC   CVCL_1683
SY   SCC3
DR   CLO; CLO_0037057
DR   EFO; EFO_0006484
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470797
DR   BioSample; SAMN03472740
DR   cancercelllines; CVCL_1683
DR   Cell_Model_Passport; SIDM00384
DR   ChEMBL-Cells; CHEMBL3308215
DR   ChEMBL-Targets; CHEMBL2366081
DR   Cosmic; 910930
DR   Cosmic; 998750
DR   Cosmic; 1037667
DR   Cosmic; 1086352
DR   Cosmic-CLP; 910930
DR   DepMap; ACH-001642
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 910930
DR   GEO; GSM827237
DR   GEO; GSM1670410
DR   IARC_TP53; 27703
DR   JCRB; JCRB0115
DR   LINCS_LDP; LCL-1128
DR   PharmacoDB; SCC3_1354_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1683
DR   PubChem_Cell_line; CVCL_1683
DR   Wikidata; Q54952342
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3095281;
RX   PubMed=8558920;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: ~2 days (PubMed=3095281).
CC   HLA typing: A*02:01,26:02; B*35:01,40:06; C*03:03,08:01; DQB1*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.47%; Native American=0%; East Asian, North=76.44%; East Asian, South=12.26%; South Asian=0%; European, North=0%; European, South=6.83% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=910930; DepMap=ACH-001642; JCRB=JCRB0115; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12 (JCRB=JCRB0115)
ST   D16S539: 12 (Cosmic-CLP=910930; DepMap=ACH-001642; PubMed=25877200)
ST   D18S51: 13,18
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 11,12
ST   D8S1179: 11
ST   FGA: 19
ST   Penta D: 11,14
ST   Penta E: 17,19
ST   TH01: 8,9 (DepMap=ACH-001642)
ST   TH01: 9 (Cosmic-CLP=910930; JCRB=JCRB0115; PubMed=25877200)
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SCC-35
AC   CVCL_7115
SY   SCC 35; SCC35
DR   cancercelllines; CVCL_7115
DR   IARC_TP53; 1687
DR   Wikidata; Q54952343
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1423286;
RX   PubMed=1574572;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=6722007;
RX   PubMed=8339273;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=1423286).
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   SCC-4
AC   CVCL_1684
SY   SCC 4; SCC4
DR   BTO; BTO_0003775
DR   CLO; CLO_0008968
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1624
DR   BCRC; 60142
DR   BCRJ; 0195
DR   BioGRID_ORCS_Cell_line; 1005
DR   BioSample; SAMN01821596
DR   BioSample; SAMN01821663
DR   BioSample; SAMN03471408
DR   BioSample; SAMN10987944
DR   cancercelllines; CVCL_1684
DR   Cell_Model_Passport; SIDM01081
DR   ChEMBL-Cells; CHEMBL3308803
DR   ChEMBL-Targets; CHEMBL1075570
DR   CLS; 305384
DR   Cosmic; 910904
DR   Cosmic; 921833
DR   Cosmic; 1118794
DR   Cosmic; 1339920
DR   Cosmic; 1608861
DR   Cosmic; 1752767
DR   Cosmic; 2266792
DR   Cosmic; 2513910
DR   Cosmic; 2668291
DR   Cosmic-CLP; 910904
DR   DepMap; ACH-000238
DR   DSMZ; ACC-618
DR   DSMZCellDive; ACC-618
DR   ECACC; 89062002
DR   EGA; EGAS00001000978
DR   GDSC; 910904
DR   GEO; GSM422869
DR   GEO; GSM423672
DR   GEO; GSM827188
DR   GEO; GSM887560
DR   GEO; GSM888643
DR   GEO; GSM1374865
DR   GEO; GSM1670411
DR   IARC_TP53; 1913
DR   IGRhCellID; SCC4%20GSE9585
DR   JCRB; JCRB9118
DR   LiGeA; CCLE_541
DR   LINCS_LDP; LCL-1224
DR   PharmacoDB; SCC4_1355_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1684
DR   PubChem_Cell_line; CVCL_1684
DR   RCB; RCB0745
DR   Wikidata; Q54952345
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=6186388;
RX   PubMed=6722007;
RX   PubMed=7214336;
RX   PubMed=8390283;
RX   PubMed=17312569;
RX   PubMed=20014447;
RX   PubMed=20145189;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=22006338;
RX   PubMed=22460905;
RX   PubMed=24825747;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30135316;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~60-70 hours (DSMZ=ACC-618).
CC   HLA typing: A*02:01,02:01; B*07:02,44:03; C*04:01,07:02; DQA1*01:02,02:01; DQB1*02:02,06:02; DRB1*07:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified (PubMed=8390283).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.04%; East Asian, North=0%; East Asian, South=1.1%; South Asian=0.53%; European, North=69.79%; European, South=28.55% (PubMed=30894373).
CC   Discontinued: RCB; RCB0745; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-1624; Cosmic-CLP=910904; DSMZ=ACC-618; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 12,14
ST   D21S11: 32.2
ST   D2S1338: 16,24
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 12
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SCC-40
AC   CVCL_M666
SY   SCC40
DR   Cosmic; 921837
DR   Wikidata; Q54952346
RX   PubMed=6186388;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   SCC-49
AC   CVCL_7116
SY   SCC49
DR   Wikidata; Q54952347
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=6722007;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   SCC-50
AC   CVCL_7117
SY   SCC50
DR   Wikidata; Q54952348
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=17312569;
CC   Misspelling: SQ-50; PubMed=3458227; Note=In table 1.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   SCC-61
AC   CVCL_7118
SY   SCC 61; SCC61
DR   Cosmic; 1122673
DR   Cosmic; 1530756
DR   Millipore; SCC280
DR   Wikidata; Q54952349
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1574572;
RX   PubMed=2004949;
RX   PubMed=2380097;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3182330;
RX   PubMed=3458227;
RX   PubMed=6722007;
RX   PubMed=7938462;
RX   PubMed=8339273;
RX   PubMed=17312569;
RX   PubMed=17848307;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=79
CC   Part of: MD Anderson Cell Lines Project.
CC   Characteristics: Good model for studying radiation resistance in squamous cell carcinoma (Millipore=SCC280).
CC   Characteristics: Sensitive to radiation (PubMed=2004949).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=17848307).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
ST   Source(s): Millipore=SCC280; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 28,30
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 22,25
ST   Penta D: 10,12
ST   Penta E: 7,11
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SCC-61B
AC   CVCL_V282
DR   Wikidata; Q54952350
RX   PubMed=2004949;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7118 ! SCC-61
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   SCC-66
AC   CVCL_7119
SY   SCC 66; SCC66
DR   Cosmic; 921838
DR   Cosmic; 927217
DR   Cosmic; 932152
DR   Wikidata; Q54952351
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3458227;
RX   PubMed=6186388;
RX   PubMed=6722007;
RX   PubMed=17312569;
CC   Misspelling: SOC66; Cosmic=932152.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SCC-68
AC   CVCL_M667
DR   Cosmic; 927218
DR   Wikidata; Q54952353
RX   PubMed=17312569;
RX   PubMed=22546478;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   SCC-71
AC   CVCL_7120
SY   SCC71
DR   Cosmic; 927219
DR   Wikidata; Q54952354
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3458227;
RX   PubMed=6722007;
RX   PubMed=17312569;
RX   PubMed=22546478;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   SCC-73
AC   CVCL_7121
SY   SCC73
DR   Wikidata; Q54952355
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3458227;
RX   PubMed=6722007;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   SCC-76
AC   CVCL_7122
SY   SCC76
DR   Wikidata; Q54952357
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   SCC-9
AC   CVCL_1685
SY   SCC 9; SCC9; SFCI-SCC-09
DR   BTO; BTO_0005855
DR   CLO; CLO_0008969
DR   EFO; EFO_0006485
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1629
DR   BCRJ; 0196
DR   BioGRID_ORCS_Cell_line; 1006
DR   BioSample; SAMN03473154
DR   BioSample; SAMN10987925
DR   cancercelllines; CVCL_1685
DR   Cell_Model_Passport; SIDM01080
DR   ChEMBL-Cells; CHEMBL3308782
DR   ChEMBL-Targets; CHEMBL1075571
DR   CLS; 305390
DR   Cosmic; 909709
DR   Cosmic; 921834
DR   Cosmic; 1175847
DR   Cosmic; 1339929
DR   Cosmic; 1530757
DR   Cosmic; 2266781
DR   Cosmic; 2296303
DR   Cosmic; 2513911
DR   Cosmic; 2546841
DR   Cosmic-CLP; 909709
DR   DepMap; ACH-000181
DR   ECACC; 89062003
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909709
DR   GEO; GSM422870
DR   GEO; GSM423673
DR   GEO; GSM887561
DR   GEO; GSM888644
DR   GEO; GSM1374866
DR   GEO; GSM1670412
DR   GEO; GSM7695974
DR   GEO; GSM7695975
DR   IARC_TP53; 1688
DR   IGRhCellID; SCC9%20GSE9585
DR   LiGeA; CCLE_732
DR   LINCS_LDP; LCL-1225
DR   PharmacoDB; SCC9_1356_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1685
DR   PubChem_Cell_line; CVCL_1685
DR   RCB; RCB0718
DR   TOKU-E; 3099
DR   Wikidata; Q54952359
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1423286;
RX   PubMed=1574572;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3458227;
RX   PubMed=7214336;
RX   PubMed=8390283;
RX   PubMed=17312569;
RX   PubMed=17325662;
RX   PubMed=20014447;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21868764;
RX   PubMed=22460905;
RX   PubMed=25275298;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30135316;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=32990596;
RX   PubMed=35839778;
RX   PubMed=36912284;
RX   PubMed=37949965;
WW   Info; OHSU; -; https://apps.ohsu.edu/research/fanconi-anemia/uploads/material_datasheet/cell_line/download/sfci-scc-09-6222a9d4f3797875140876.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*35:03,44:03; C*04:01,16:02; DQA1*01:02,05:02; DRB1*01:16,13:14 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Glyfs*20 (c.822_853del); Zygosity=Homozygous (Cosmic-CLP=909709; DepMap=ACH-000181).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.25%; Native American=0.1%; East Asian, North=1.78%; East Asian, South=0.03%; South Asian=6.17%; European, North=30.07%; European, South=61.6% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at p.Val274_Glu285del (c.820_851del32) in PubMed=1423286 and PubMed=25275298.
CC   Discontinued: RCB; RCB0718; true.
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
ST   Source(s): ATCC=CRL-1629; Cosmic-CLP=909709; OHSU; PubMed=21868764; PubMed=25275298; PubMed=25877200; PubMed=36912284
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 10,11
ST   D18S51: 12,14
ST   D19S433: 12,14
ST   D21S11: 28
ST   D2S1338: 19,21
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 20,25
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   SCC-DF
AC   CVCL_B5DR
SY   Silver Crucian Carp-Dorsal Fin
DR   CCRID; 4201PAT-CCTCC00653
DR   Wikidata; Q110433204
RX   Patent=CN104774802B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201525.
CC   Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097.
OX   NCBI_TaxID=101364; ! Carassius gibelio (Prussian carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   SCC-S2
AC   CVCL_JA29
DR   Wikidata; Q54952362
RX   PubMed=590624;
RX   PubMed=1055416;
CC   Breed/subspecies: 129/Sv-SlJ-CP.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5T83 ! SIKR
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 3
//
ID   SCC-TC
AC   CVCL_1R13
SY   SCC
DR   RCB; RCB2291
DR   RCB; RCB3675
DR   TKG; TKG 0340
DR   TKG; TKG 0646
DR   Wikidata; Q54952370
CC   Discontinued: RCB; RCB2291; true.
ST   Source(s): TKG=TKG 0646
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,13
ST   D5S818: 9
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 19
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 02-05-24; Version: 6
//
ID   SCC084/R
AC   CVCL_WH59
DR   Wikidata; Q98129365
RX   PubMed=27045798;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220fs*27 (c.655delC) (p.P219Lfs); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C047 ! UPCI-SCC-084
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   SCC117
AC   CVCL_E7CL
RX   PubMed=39289983;
CC   Population: Chinese.
CC   Doubling time: 40.16 hours (PubMed=39289983).
CC   Karyotypic information: Hypotriploid karyotype (PubMed=39289983).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=39289983
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,16
ST   D21S11: 28,30.3
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 19,23
ST   Penta D: 11,13
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SCC12F-CR2
AC   CVCL_E2W8
RX   PubMed=1312681;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2336; CR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4028 ! SCC-12F
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   SCC12F-Neo
AC   CVCL_E2W9
RX   PubMed=1312681;
CC   Characteristics: Control cell line for SCCF12-CR2 (Cellosaurus=CVCL_E2W8) (PubMed=1312681).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Leu; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Gly (c.647T>G); ClinVar=VCV000376671; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4028 ! SCC-12F
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   SCC13-MET-KOc1-5
AC   CVCL_D2XN
DR   Wikidata; Q127384185
RX   PubMed=34593609;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4029 ! SCC-13
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SCC13-MET-KOc1-8
AC   CVCL_D2XP
DR   Wikidata; Q127384187
RX   PubMed=34593609;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4029 ! SCC-13
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SCC13-MET-KOc4-2
AC   CVCL_D2XQ
DR   Wikidata; Q127384189
RX   PubMed=34593609;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4029 ! SCC-13
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SCC13-MET-KOc4-3
AC   CVCL_D2XR
DR   Wikidata; Q127384191
RX   PubMed=34593609;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4029 ! SCC-13
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SCC131/R
AC   CVCL_WH60
DR   Wikidata; Q98129368
RX   PubMed=27045798;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2229 ! UPCI-SCC-131
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   SCC15/R1
AC   CVCL_B5MP
DR   Wikidata; Q112044515
RX   PubMed=6201865;
CC   Population: Caucasian.
CC   Doubling time: 1.5-1.7 days (PubMed=6201865).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1681 ! SCC-15
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   SCC15/R2
AC   CVCL_B5MQ
DR   Wikidata; Q112044516
RX   PubMed=6201865;
CC   Population: Caucasian.
CC   Doubling time: 1.5-1.7 days (PubMed=6201865).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1681 ! SCC-15
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   SCC15/R3
AC   CVCL_B5MR
DR   Wikidata; Q112044517
RX   PubMed=6201865;
CC   Population: Caucasian.
CC   Doubling time: 1.5-1.7 days (PubMed=6201865).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1681 ! SCC-15
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   SCC15/R4
AC   CVCL_B5MS
DR   Wikidata; Q112044518
RX   PubMed=6201865;
CC   Population: Caucasian.
CC   Doubling time: 1.5-1.7 days (PubMed=6201865).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1681 ! SCC-15
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   SCC210011
AC   CVCL_D072
DR   Wikidata; Q54952372
RX   PubMed=21971914;
CC   Population: Chinese.
CC   Doubling time: 42 hours (PubMed=21971914).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   SCC211441
AC   CVCL_D073
DR   Wikidata; Q54952373
RX   PubMed=21971914;
CC   Population: Chinese.
CC   Doubling time: 38 hours (PubMed=21971914).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   SCC60
AC   CVCL_9U49
DR   Wikidata; Q54952374
RX   PubMed=11314036;
RX   PubMed=24936210;
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   SCC7
AC   CVCL_V412
SY   SCC-7; SCCVII/St; SCCVII; SCC VII
DR   ChEMBL-Cells; CHEMBL3307309
DR   ChEMBL-Targets; CHEMBL614147
DR   PubChem_Cell_line; CVCL_V412
DR   Ubigene; YC-B033
DR   Wikidata; Q54952375
RX   PubMed=7201845;
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/21370/
CC   Derived from site: In situ; Abdominal wall; UBERON=UBERON_0003697.
CC   Breed/subspecies: C3H.
DI   NCIt; C21609; Mouse squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   SCC9 fat-1
AC   CVCL_E6ZH
DR   ABM; T6267
CC   From: Lim, Kyu; Department of Biochemistry, Chungnam National University Medical School; Daejeon; South Korea.
CC   Population: Caucasian.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6267).
CC   Doubling time: 18-26 hours (ABM=T6267).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Glyfs*20 (c.822_853del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1685 ! SCC-9
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SCCF1
AC   CVCL_L419
DR   ABM; T8294
DR   Wikidata; Q54952376
RX   DOI=10.4236/ojvm.2012.24045;
RX   PubMed=11776973;
RX   PubMed=19754818;
RX   PubMed=22265717;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   SCCF1-Luc-YFP
AC   CVCL_E6XS
SY   SCCF1Luc; SCCF110YFPLuc
DR   ABM; T6446
RX   PubMed=19754818;
RX   PubMed=22265717;
CC   Characteristics: Transfected with a luciferase-YFP fusion protein whose expression is under the control of a CMV promoter (PubMed=19754818).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_L419 ! SCCF1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SCCF2
AC   CVCL_C4UU
DR   ABM; T8295
DR   Wikidata; Q116050476
RX   PubMed=20959474;
RX   PubMed=22265717;
CC   Doubling time: 27 +- 3 hours (PubMed=22265717).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   SCCF2-Luc-YFP
AC   CVCL_E6XT
SY   SCCF2Luc
DR   ABM; T6447
RX   PubMed=20959474;
RX   PubMed=22265717;
CC   Characteristics: Transfected with a luciferase-YFP fusion protein whose expression is under the control of a CMV promoter (PubMed=20959474; PubMed=22265717).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_C4UU ! SCCF2
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SCCF3
AC   CVCL_C4UV
DR   ABM; T8296
DR   Wikidata; Q116050477
RX   PubMed=22265717;
CC   Doubling time: 30 +- 3 hours (PubMed=22265717).
CC   Karyotypic information: Half of the cells are diploid and the remaining are tetraploid (PubMed=22265717).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 4
//
ID   SCCF3-Luc-YFP
AC   CVCL_E6YR
SY   SCCF3Luc
DR   ABM; T6448
RX   PubMed=22265717;
CC   Characteristics: Transfected with a luciferase-YFP fusion protein whose expression is under the control of a CMV promoter (PubMed=22265717).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C132824; Feline oral squamous cell carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_C4UV ! SCCF3
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SCCH-196
AC   CVCL_3161
SY   SCCH196
DR   CLO; CLO_0037069
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00031
DR   Cosmic; 1078362
DR   Cosmic; 1085907
DR   GEO; GSM1670413
DR   IARC_TP53; 23592
DR   JCRB; JCRB0108
DR   LINCS_LDP; LCL-1403
DR   PharmacoDB; SCCH196_1358_2019
DR   TKG; TKG 0461
DR   Wikidata; Q54952377
RX   PubMed=2513302;
RX   PubMed=7591257;
RX   PubMed=8221663;
RX   PubMed=9738976;
RX   PubMed=12054564;
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=2513302); >5 days (Note=Lots 08032009 and 11302016) (JCRB=JCRB0108).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=7591257; PubMed=9738976).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): JCRB=JCRB0108; TKG=TKG 0461
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SCCH-26
AC   CVCL_1686
SY   SCCH26
DR   CLO; CLO_0050145
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN01821718
DR   BioSample; SAMN03470794
DR   ChEMBL-Cells; CHEMBL3308127
DR   ChEMBL-Targets; CHEMBL1075572
DR   Cosmic; 909710
DR   Cosmic; 2131597
DR   IARC_TP53; 23590
DR   JCRB; JCRB0106
DR   LINCS_LDP; LCL-1968
DR   PubChem_Cell_line; CVCL_1686
DR   RCB; RCB1952
DR   TKG; TKG 0460
DR   Wikidata; Q54952378
RX   PubMed=8221663;
RX   PubMed=12210830;
RX   PubMed=20164919;
CC   Population: Japanese.
CC   Doubling time: 3 days (Note=Lot 03082000) (JCRB=JCRB0106).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): JCRB=JCRB0106; RCB=RCB1952; TKG=TKG 0460
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SCCIC1
AC   CVCL_G300
SY   SCC-IC1; SCC IC1; IC1
DR   cancercelllines; CVCL_G300
DR   CancerTools; 153662
DR   Cosmic; 1608872
DR   Cosmic; 2688662
DR   GEO; GSM2611461
DR   GEO; GSM2611462
DR   GEO; GSM2611463
DR   Wikidata; Q54952379
DR   Ximbio; 153662
RX   PubMed=21602893;
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=29755650;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>A; ClinVar=VCV000635365; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Asp154Asn (c.460G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Cys456Ser (c.1366T>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Cys456Phe (c.1367G>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asn1809His; Zygosity=Unspecified (PubMed=22006338).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Pro1913Leu (c.5738C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Right temple, skin; UBERON=UBERON_8480028.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9,13
ST   D16S539: 9,13
ST   D18S51: 15,17
ST   D19S433: 15,16.2
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VJ58 ! SCCIC1Met
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 20
//
ID   SCCIC12
AC   CVCL_G301
SY   SCC IC12; IC12
DR   cancercelllines; CVCL_G301
DR   CancerTools; 153669
DR   Cosmic; 1608874
DR   Cosmic; 2688663
DR   GEO; GSM2611494
DR   GEO; GSM2611495
DR   GEO; GSM2611496
DR   Wikidata; Q54952380
DR   Ximbio; 153669
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Gly49Glu (c.146G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Pro (c.800G>C); ClinVar=VCV000428867; Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left calf, skin; UBERON=UBERON_8480050.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D19S433: 13.1,14
ST   D21S11: 28,31.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 11,12
ST   FGA: 22,24
ST   TH01: 6,10
ST   TPOX: 10,11
ST   vWA: 17,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   SCCIC15
AC   CVCL_VJ51
DR   cancercelllines; CVCL_VJ51
DR   Cosmic; 2688664
DR   Wikidata; Q98129370
RX   PubMed=24662767;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Ser106Pro (c.316T>C); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln1534Ter (c.4600C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln1864Arg (c.5591A>G); ClinVar=VCV002100138; Zygosity=Unspecified (PubMed=24662767).
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   SCCIC18
AC   CVCL_VJ52
SY   SCC IC18; IC18
DR   cancercelllines; CVCL_VJ52
DR   CancerTools; 153670
DR   Cosmic; 2688665
DR   GEO; GSM2611497
DR   GEO; GSM2611498
DR   GEO; GSM2611499
DR   Wikidata; Q98129372
DR   Ximbio; 153670
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly765Asp (c.2294G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Right ear, skin; UBERON=UBERON_0001459.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D18S51: 12
ST   D19S433: 13.1,15
ST   D21S11: 28,32.2
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 8,12
ST   FGA: 21
ST   TH01: 6,8
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   SCCIC19
AC   CVCL_VJ53
SY   SCC IC19; IC9
DR   cancercelllines; CVCL_VJ53
DR   CancerTools; 153671
DR   Cosmic; 2688666
DR   GEO; GSM2611500
DR   GEO; GSM2611501
DR   GEO; GSM2611502
DR   Wikidata; Q98129375
DR   Ximbio; 153671
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>A; ClinVar=VCV000635365; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Cys254Arg (c.760T>C); ClinVar=VCV002130225; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Trp1843Ter (c.5528G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Cys315Ter (c.945T>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro64Leu (c.191C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly199Glu (c.596G>A); ClinVar=VCV000582257; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 11,18
ST   D19S433: 13.1,15.2
ST   D21S11: 32.2
ST   D2S1338: 19,21
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   SCCIC1Met
AC   CVCL_VJ58
SY   SCCIC1MET; SCC IC1MET; IC1MET
DR   CancerTools; 153676
DR   GEO; GSM2611458
DR   GEO; GSM2611459
DR   GEO; GSM2611460
DR   Wikidata; Q98129377
DR   Ximbio; 153676
RX   PubMed=29755650;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9,13
ST   D16S539: 9,13
ST   D18S51: 15,17
ST   D19S433: 15,16.2
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G300 ! SCCIC1
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   SCCIC21
AC   CVCL_VJ54
DR   Cosmic; 2688667
DR   Wikidata; Q98129379
RX   PubMed=24662767;
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Val1867Ile (c.5599G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2405Pro (c.7214A>C); Zygosity=Unspecified (PubMed=24662767).
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   SCCIC4
AC   CVCL_VJ55
DR   Cosmic; 2688668
DR   Wikidata; Q98129382
RX   PubMed=24662767;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Leu159Ter (c.476T>A); Zygosity=Unspecified (PubMed=24662767).
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 5
//
ID   SCCIC8
AC   CVCL_G302
SY   IC8
DR   CancerTools; 153668
DR   Cosmic; 1608873
DR   Cosmic; 2688669
DR   GEO; GSM2611464
DR   GEO; GSM2611465
DR   GEO; GSM2611466
DR   Wikidata; Q54952382
DR   Ximbio; 153668
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln1687Ter (c.5059C>T); Zygosity=Unspecified (PubMed=22006338; PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Buttock, skin; UBERON=UBERON_8480014.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D19S433: 13.1,14
ST   D21S11: 29
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 16
ST   FGA: 19,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   SCCKN
AC   CVCL_5362
DR   CLO; CLO_0051566
DR   BioSample; SAMN03472315
DR   RCB; RCB0441
DR   Wikidata; Q54952384
RX   PubMed=1373668;
RX   PubMed=7536509;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SCCKN
CC   Population: Japanese.
CC   Doubling time: 24.4 hours (PubMed=1373668).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): RCB=RCB0441
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   SCCL-MT1
AC   CVCL_C4UX
SY   SCCLMT1
DR   Wikidata; Q116050478
RX   PubMed=21719345;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SCCMM
AC   CVCL_X162
DR   Wikidata; Q54952385
RX   PubMed=10889923;
CC   Population: Japanese.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   SCCNC1
AC   CVCL_X156
DR   cancercelllines; CVCL_X156
DR   Cosmic; 2614473
DR   GEO; GSM1377033
DR   Wikidata; Q54952386
RX   PubMed=24662767;
RX   PubMed=24816148;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=24816148).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C68611; Sinonasal squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   SCCNC2
AC   CVCL_X157
DR   Cosmic; 2614474
DR   GEO; GSM1377035
DR   Wikidata; Q54952387
RX   PubMed=24662767;
RX   PubMed=24816148;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C68611; Sinonasal squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   SCCNC4
AC   CVCL_X158
DR   Cosmic; 2614475
DR   GEO; GSM1377037
DR   Wikidata; Q54952388
RX   PubMed=24662767;
RX   PubMed=24816148;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C68611; Sinonasal squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   SCCNC5
AC   CVCL_X159
DR   cancercelllines; CVCL_X159
DR   Cosmic; 2614476
DR   GEO; GSM1377039
DR   Wikidata; Q54952389
RX   PubMed=24662767;
RX   PubMed=24816148;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Lys (c.511G>A); ClinVar=VCV000141566; Zygosity=Unspecified (PubMed=24816148).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C68611; Sinonasal squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   SCCNC6
AC   CVCL_X160
DR   Cosmic; 2614477
DR   GEO; GSM1377041
DR   Wikidata; Q54952390
RX   PubMed=24662767;
RX   PubMed=24816148;
CC   Doubling time: ~34 hours (PubMed=24816148).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C68611; Sinonasal squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   SCCNC7
AC   CVCL_X161
DR   cancercelllines; CVCL_X161
DR   Cosmic; 2614478
DR   GEO; GSM1377043
DR   Wikidata; Q54952391
RX   PubMed=24662767;
RX   PubMed=24816148;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=24816148).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C68611; Sinonasal squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 16
//
ID   SCCNij153
AC   CVCL_A7DR
DR   cancercelllines; CVCL_A7DR
DR   Wikidata; Q107116853
RX   PubMed=33802339;
CC   Characteristics: Established from a xenograft maintained in mouse.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Unspecified (PubMed=33802339).
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SCCNij167
AC   CVCL_A7DS
DR   cancercelllines; CVCL_A7DS
DR   Wikidata; Q107116854
RX   PubMed=33802339;
CC   Characteristics: Established from a xenograft maintained in mouse.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=33802339).
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SCCNij172
AC   CVCL_A7DT
DR   cancercelllines; CVCL_A7DT
DR   Wikidata; Q107116855
RX   PubMed=33802339;
CC   Characteristics: Established from a xenograft maintained in mouse.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=33802339).
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SCCNij185
AC   CVCL_A7DU
DR   cancercelllines; CVCL_A7DU
DR   Wikidata; Q107116856
RX   PubMed=33802339;
CC   Characteristics: Established from a xenograft maintained in mouse.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.His708Asn (c.2122C>A); Zygosity=Unspecified (PubMed=33802339).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=33802339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Serfs*13 (c.457_469del); Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339).
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SCCNij202
AC   CVCL_A7DV
DR   cancercelllines; CVCL_A7DV
DR   Wikidata; Q107116857
RX   PubMed=33802339;
CC   Characteristics: Established from a xenograft maintained in mouse.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783-1G>T; ClinVar=VCV000634661; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339).
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SCCOHT-1
AC   CVCL_VU69
SY   SCCOHT1; Small Cell Carcinoma of the Ovary, Hypercalcemic Type-1
DR   BTO; BTO_0005853
DR   cancercelllines; CVCL_VU69
DR   Cell_Model_Passport; SIDM01866
DR   DepMap; ACH-001279
DR   GEO; GSM1622408
DR   GEO; GSM2748144
DR   GEO; GSM2748145
DR   GEO; GSM2748146
DR   GEO; GSM2748147
DR   GEO; GSM2748148
DR   GEO; GSM2748149
DR   Millipore; SCC437
DR   Wikidata; Q98129384
RX   PubMed=22581215;
RX   PubMed=26356327;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 38.1 hours (PubMed=22581215).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Arg1077Ter (c.3229C>T); ClinVar=VCV001692588; Zygosity=Heterozygous (DepMap=ACH-001279).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Millipore=SCC437
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 13
ST   D21S11: 28,31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 16,25
ST   Penta D: 12,15
ST   Penta E: 10,13
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
DI   ORDO; Orphanet_370396; Small cell carcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 15
//
ID   SCCOHT-CH-1
AC   CVCL_D1GG
DR   Wikidata; Q127384193
RX   PubMed=37535222;
CC   Population: Chinese.
CC   Characteristics: Has extremely strong migratory and invasive abilities (PubMed=37535222).
CC   Doubling time: 33.02 hours (PubMed=37535222).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; c.939_940insT; Zygosity=Heterozygous (PubMed=37535222).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Tyr877Tyr (c.2631C>A); ClinVar=VCV000537876; Zygosity=Heterozygous (PubMed=37535222).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=37535222
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 11,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 19,24
ST   D3S1358: 14,15
ST   D5S818: 7,10
ST   D7S820: 9,10
ST   D8S1179: 16
ST   FGA: 24,26
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
DI   ORDO; Orphanet_370396; Small cell carcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SCCRDEB2
AC   CVCL_G303
SY   SCCRDEB 2
DR   cancercelllines; CVCL_G303
DR   Cosmic; 1608865
DR   Cosmic; 2688670
DR   Wikidata; Q54952392
RX   PubMed=21602893;
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=29755650;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Glu143Gly (c.428A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Thr1090Ser (c.3269C>G); ClinVar=VCV000544171; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   NCIt; C4819; Skin squamous cell carcinoma
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   SCCRDEB3
AC   CVCL_G304
SY   SCCRDEB 3
DR   cancercelllines; CVCL_G304
DR   Cosmic; 1608866
DR   Cosmic; 2688671
DR   Wikidata; Q54952393
RX   PubMed=21602893;
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=29755650;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Arg525Ter (c.1573C>T); ClinVar=VCV000279785; Zygosity=Heterozygous (PubMed=21602893).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Arg578Ter (c.1732C>T); ClinVar=VCV000372330; Zygosity=Heterozygous (PubMed=21602893).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Lys176Arg (c.527A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Arg353Cys (c.1057C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   NCIt; C4819; Skin squamous cell carcinoma
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   SCCRDEB4
AC   CVCL_G305
SY   SCCRDEB 4
DR   cancercelllines; CVCL_G305
DR   Cosmic; 1608867
DR   Cosmic; 2688672
DR   Wikidata; Q54952394
RX   PubMed=21602893;
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=29755650;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gly2749Argfs*41 (c.8244dupC) (c.8244insC); ClinVar=VCV001068914; Zygosity=Homozygous (PubMed=21602893).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp1517Asn (c.4549G>A); ClinVar=VCV000523598; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1797Pro (c.5390T>C); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Arg113Ter (c.337C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136Ter (c.406C>T); ClinVar=VCV001802458; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Leu (c.455C>T); ClinVar=VCV000142766; Zygosity=Unspecified (PubMed=21602893).
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   NCIt; C4819; Skin squamous cell carcinoma
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 19
//
ID   SCCRDEB5
AC   CVCL_G306
DR   Wikidata; Q54952395
RX   PubMed=21602893;
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   NCIt; C4819; Skin squamous cell carcinoma
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   SCCT1
AC   CVCL_G307
SY   SCC T1
DR   cancercelllines; CVCL_G307
DR   Cosmic; 1608868
DR   Cosmic; 2688673
DR   GEO; GSM2611479
DR   GEO; GSM2611480
DR   GEO; GSM2611481
DR   Wikidata; Q54952396
RX   PubMed=21602893;
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly95Glu (c.284G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly115Ser (c.343G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; c.1555+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Tyr577Ter (c.1731C>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly578Arg (c.1732G>C); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly578Ser (c.1732G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Cys861Tyr (c.2582G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Asp1515Glu (c.4545C>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Ser (c.701A>C); ClinVar=VCV000376690; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 30,32.2
ST   D2S1338: 18,20
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 9,9.3
ST   TPOX: 9,12
ST   vWA: 14,16
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   SCCT10
AC   CVCL_VJ56
SY   SCC T10; T10
DR   CancerTools; 153674
DR   Cosmic; 2688674
DR   GEO; GSM2611482
DR   GEO; GSM2611483
DR   GEO; GSM2611484
DR   Wikidata; Q98129386
DR   Ximbio; 153674
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Thr2295Ala (c.6883A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Left shin, skin; UBERON=UBERON_8480072.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 13,19
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 22,24
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: Not_detected
ST   D8S1179: 10,15
ST   FGA: 24,25
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   SCCT11
AC   CVCL_VJ57
SY   SCC T11; T11
DR   CancerTools; 153675
DR   Cosmic; 2688675
DR   GEO; GSM2611485
DR   GEO; GSM2611486
DR   GEO; GSM2611487
DR   Wikidata; Q98129389
DR   Ximbio; 153675
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Asp132Val (c.395A>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Lys170Arg (c.509A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Glu1117Val (c.3350A>T); Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 11,13
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 7,12
ST   D8S1179: 11,15
ST   FGA: 19,20
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   SCCT2
AC   CVCL_G308
SY   SCC T2; T2
DR   cancercelllines; CVCL_G308
DR   CancerTools; 153672
DR   Cosmic; 1608869
DR   Cosmic; 2688676
DR   GEO; GSM2611488
DR   GEO; GSM2611489
DR   GEO; GSM2611490
DR   Wikidata; Q54952397
DR   Ximbio; 153672
RX   PubMed=21602893;
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asn71Ile (c.212A>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Cys409Phe (c.1226G>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Glu415Asp (c.1245G>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp469Gly (c.1406A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; c.1108+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Cys433Tyr (c.1298G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Gly1751Asp (c.5252G>A); ClinVar=VCV001980813; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Arg2131Lys (c.6392G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Pro2343Ser (c.7027C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.375+1G>T; ClinVar=VCV000635393; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=21602893; PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Unspecified (PubMed=21602893; PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Hand, skin; UBERON=UBERON_0001519.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 10,11
ST   D18S51: 12,13
ST   D19S433: 14,16
ST   D21S11: 28,31
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: Not_detected
ST   D8S1179: 13,15
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   SCCT3
AC   CVCL_G309
SY   SCC T3
DR   cancercelllines; CVCL_G309
DR   Cosmic; 1608870
DR   Wikidata; Q54952399
RX   PubMed=21602893;
RX   PubMed=22006338;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Unspecified (PubMed=21602893).
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   SCCT8
AC   CVCL_G310
SY   SCC T8; T8
DR   cancercelllines; CVCL_G310
DR   CancerTools; 153673
DR   Cosmic; 1608871
DR   Cosmic; 2688677
DR   GEO; GSM2611491
DR   GEO; GSM2611492
DR   GEO; GSM2611493
DR   Wikidata; Q54952400
DR   Ximbio; 153673
RX   PubMed=21602893;
RX   PubMed=22006338;
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Cys616Phe (c.1847G>T); ClinVar=VCV000498790; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Cys616Ser (c.1847G>C); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Gly (c.271T>G); Zygosity=Unspecified (PubMed=21602893).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 14,15
ST   D21S11: 31.2,32.2
ST   D2S1338: 25
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   SCCT9
AC   CVCL_VJ50
SY   SCC T9; T9
DR   cancercelllines; CVCL_VJ50
DR   CancerTools; 153667
DR   Cosmic; 2688678
DR   Wikidata; Q98129392
DR   Ximbio; 153667
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro48Leu (c.143C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Asp107Gly (c.320A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; c.403+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Cys1089Tyr (c.3266G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Right hand, skin; UBERON=UBERON_0001519.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,21
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN09 ! MET-1
OI   CVCL_LN10 ! MET-2
OI   CVCL_LN11 ! MET-3
OI   CVCL_LN12 ! MET-4
OI   CVCL_LN13 ! PM-1 [Human oral dysplasia]
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 13
//
ID   SCCTF
AC   CVCL_0517
DR   MCCL; MCC:0000415
DR   BioSample; SAMN03151911
DR   RCB; RCB0442
DR   Wikidata; Q54952401
RX   PubMed=1373668;
RX   PubMed=7536509;
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SCCTF
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SCCKN derivative (PubMed=16643607; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00266.
CC   Population: Japanese.
CC   Doubling time: 22.2 hours (PubMed=1373668).
CC   Discontinued: RCB; RCB0442; true.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5362 ! SCCKN
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SCCTF TF-R
AC   CVCL_UZ94
SY   TF-R
DR   Wikidata; Q98129395
RX   PubMed=7536509;
CC   Problematic cell line: Contaminated. Parent cell line (SCCTF) has been shown to be a SCCKN derivative.
CC   Population: Japanese.
CC   Doubling time: 20.8 hours (PubMed=7536509).
CC   Selected for resistance to: ChEBI; CHEBI_22907; Bleomycin.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0517 ! SCCTF
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   SCCTF TF-S
AC   CVCL_UZ95
SY   TF-S
DR   Wikidata; Q98129397
RX   PubMed=7536509;
CC   Problematic cell line: Contaminated. Parent cell line (SCCTF) has been shown to be a SCCKN derivative.
CC   Population: Japanese.
CC   Doubling time: 24.0 hours (PubMed=7536509).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0517 ! SCCTF
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   SCD16-2E
AC   CVCL_RJ10
DR   GEO; GSM2265468
DR   GEO; GSM2265469
DR   SKIP; SKIP001271
DR   Wikidata; Q54952402
RX   PubMed=27806289;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[22] (c.6937CAG[22]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Heterozygous; Note=The non-expanded allele has p.Gln2313[12] (PubMed=27806289).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   SCD162-13-2
AC   CVCL_RJ05
DR   SKIP; SKIP001273
DR   Wikidata; Q54952404
RX   PubMed=27806289;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[23] (c.6937CAG[23]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Homozygous (PubMed=27806289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ04 ! SCD162-6-2
OI   CVCL_RJ06 ! SCD162-17-2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   SCD162-17-2
AC   CVCL_RJ06
DR   GEO; GSM2265466
DR   GEO; GSM2265467
DR   SKIP; SKIP001274
DR   Wikidata; Q54952405
RX   PubMed=27806289;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[23] (c.6937CAG[23]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Homozygous (PubMed=27806289).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ04 ! SCD162-6-2
OI   CVCL_RJ05 ! SCD162-13-2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   SCD162-6-2
AC   CVCL_RJ04
DR   SKIP; SKIP001272
DR   Wikidata; Q54952406
RX   PubMed=27806289;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[23] (c.6937CAG[23]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Homozygous (PubMed=27806289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ05 ! SCD162-13-2
OI   CVCL_RJ06 ! SCD162-17-2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   SCD166-2-14
AC   CVCL_RJ08
DR   GEO; GSM2265472
DR   GEO; GSM2265473
DR   SKIP; SKIP001269
DR   Wikidata; Q54952408
RX   PubMed=27806289;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[26] (c.6937CAG[26]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Heterozygous; Note=The non-expanded allele has p.Gln2313[14] (PubMed=27806289).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ07 ! SCD166-2-3
OI   CVCL_RJ09 ! SCD166-2-16
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   SCD166-2-16
AC   CVCL_RJ09
DR   SKIP; SKIP001270
DR   Wikidata; Q54952409
RX   PubMed=27806289;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[26] (c.6937CAG[26]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Heterozygous; Note=The non-expanded allele has p.Gln2313[14] (PubMed=27806289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ07 ! SCD166-2-3
OI   CVCL_RJ08 ! SCD166-2-14
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   SCD166-2-3
AC   CVCL_RJ07
DR   SKIP; SKIP001268
DR   Wikidata; Q54952411
RX   PubMed=27806289;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[26] (c.6937CAG[26]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Heterozygous; Note=The non-expanded allele has p.Gln2313[14] (PubMed=27806289).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ08 ! SCD166-2-14
OI   CVCL_RJ09 ! SCD166-2-16
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   SCD36-1
AC   CVCL_A3FH
SY   SCD4 E2; HPS1034
DR   RCB; HPS1034
DR   Wikidata; Q105510982
RX   PubMed=28918022;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:15911; NOP56; Simple; c.3+71_3+75[(16_?)] (IVS1 GGCCTG repeat expansion); ClinVar=VCV000031106; Zygosity=Unspecified (PubMed=28918022).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148316; Spinocerebellar ataxia type 36
DI   ORDO; Orphanet_276198; Spinocerebellar ataxia type 36
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   SCD36-2
AC   CVCL_A3FI
SY   SCD10 9E; HPS0422
DR   RCB; HPS0422
DR   Wikidata; Q105510986
RX   PubMed=28918022;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:15911; NOP56; Simple; c.3+71_3+75[(16_?)] (IVS1 GGCCTG repeat expansion); ClinVar=VCV000031106; Zygosity=Unspecified (PubMed=28918022).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148316; Spinocerebellar ataxia type 36
DI   ORDO; Orphanet_276198; Spinocerebellar ataxia type 36
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   SCD36-3
AC   CVCL_A3FJ
SY   SCD20 2E
DR   Wikidata; Q105510989
RX   PubMed=28918022;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:15911; NOP56; Simple; c.3+71_3+75[(16_?)] (IVS1 GGCCTG repeat expansion); ClinVar=VCV000031106; Zygosity=Unspecified (PubMed=28918022).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148316; Spinocerebellar ataxia type 36
DI   ORDO; Orphanet_276198; Spinocerebellar ataxia type 36
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   SCEACono2
AC   CVCL_D3YU
DR   GEO; GSM7695976
DR   GEO; GSM7695977
DR   GEO; GSM7695978
DR   RCB; RCB5515
DR   Wikidata; Q127384195
RX   PubMed=37949965;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=37949965).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Ala465Thr (c.1393G>A); ClinVar=VCV000390565; Zygosity=Unspecified (PubMed=37949965).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=37949965).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ear, auditory canal; UBERON=UBERON_0001352.
ST   Source(s): PubMed=37949965
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 13
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 12,16
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 18,19
DI   NCIt; C202594; External auditory canal squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   SCED 461
AC   CVCL_E920
DR   Wikidata; Q54952412
WW   Provider; Takara Bio Europe; -; https://web.archive.org/web/20121201062341/http://www.cellectis-stemcells.com/products-and-services/pluripotent-stem-cells/human-es-cells
CC   From: Takara Bio Europe AB (Cellartis); Gothenburg; Sweden.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   SCF
AC   CVCL_WY69
SY   Silver Carp Fin
DR   Wikidata; Q98129400
RX   CelloPub=CLPUB00103;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=13095; ! Hypophthalmichthys molitrix (Silver carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   SCF1-12
AC   CVCL_A1HN
SY   SCF1-12;Type 3
DR   ABM; T0809
DR   GEO; GSM2995293
DR   Wikidata; Q127384199
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF1-13
AC   CVCL_A1HP
SY   SCF1-13,Type 3
DR   ABM; T0810
DR   GEO; GSM2995294
DR   Wikidata; Q127384201
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF1-15
AC   CVCL_A1HQ
SY   SCF1-15,Type 3
DR   ABM; T0811
DR   GEO; GSM2995295
DR   Wikidata; Q127384203
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF1-18
AC   CVCL_A1HR
SY   SCF1-18,Other
DR   GEO; GSM2995296
DR   Wikidata; Q127384206
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF1-23
AC   CVCL_A1HS
SY   SCF1-23,Type 2
DR   ABM; T0805
DR   GEO; GSM2995297
DR   Wikidata; Q127384208
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF1-7
AC   CVCL_A1HT
SY   SCF1-7,Other
DR   GEO; GSM2995292
DR   Wikidata; Q127384210
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF3-1
AC   CVCL_A1HU
SY   SCF3-1,Type 2
DR   ABM; T0806
DR   GEO; GSM2995298
DR   Wikidata; Q127384212
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF3-11
AC   CVCL_A1HV
SY   SCF3-11,Type 2
DR   ABM; T0804
DR   GEO; GSM2995302
DR   Wikidata; Q127384215
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF3-16
AC   CVCL_A1HW
SY   SCF3-16,Other
DR   GEO; GSM2995303
DR   Wikidata; Q127384217
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF3-6
AC   CVCL_A1HX
SY   SCF3-6,Other
DR   GEO; GSM2995299
DR   Wikidata; Q127384219
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF3-8
AC   CVCL_A1HY
SY   SCF3-8,Type 2
DR   ABM; T0807
DR   GEO; GSM2995300
DR   Wikidata; Q127384222
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HZ ! SCF3-9
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF3-9
AC   CVCL_A1HZ
SY   SCF3-9,Type 3
DR   GEO; GSM2995301
DR   Wikidata; Q127384224
RX   PubMed=30530479;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190.
CC   Cell type: Subcutaneous preadipocyte; CL=CL_0002583.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_A1HC ! PGF2-2
OI   CVCL_A1HD ! PGF2-4
OI   CVCL_A1HE ! PGF2-5
OI   CVCL_A1HF ! PGF2-8
OI   CVCL_A1HI ! PGF3-2
OI   CVCL_A1HJ ! PGF3-3
OI   CVCL_A1HK ! PGF3-4
OI   CVCL_A1HL ! PGF3-5
OI   CVCL_A1HM ! PGF3-6
OI   CVCL_A1HG ! PGF3-11
OI   CVCL_A1HH ! PGF3-15
OI   CVCL_A1HT ! SCF1-7
OI   CVCL_A1HN ! SCF1-12
OI   CVCL_A1HP ! SCF1-13
OI   CVCL_A1HQ ! SCF1-15
OI   CVCL_A1HR ! SCF1-18
OI   CVCL_A1HS ! SCF1-23
OI   CVCL_A1HU ! SCF3-1
OI   CVCL_A1HX ! SCF3-6
OI   CVCL_A1HY ! SCF3-8
OI   CVCL_A1HV ! SCF3-11
OI   CVCL_A1HW ! SCF3-16
SX   Male
AG   6W
CA   Conditionally immortalized cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SCF36
AC   CVCL_F0BA
RX   DOI=10.36478/javaa.2013.823.830;
CC   Doubling time: ~72 hours (DOI=10.36478/javaa.2013.823.830).
CC   Donor information: It is not clear from the paper if this cell line is derived from a pool of ear tissue from 32 different goats or if it was established from one of these samples.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mongolian cashmere; VBO=VBO_0200804.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SCg6
AC   CVCL_E1IF
SY   SubClone grand 6
RX   CelloPub=CLPUB00773;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I1 ! CID 9
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCGN-F9
AC   CVCL_WI07
DR   CCRID; 4201PAT-CCTCC00217
DR   Wikidata; Q98129402
RX   Patent=CN101270162B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200729.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O76038; Human SCGN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 6
//
ID   SCGR-11
AC   CVCL_S168
SY   SCGR11
DR   Wikidata; Q54952413
RX   PubMed=1709732;
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Misspelling: SGGR11; Note=Occasionally.
CC   Misspelling: SGRII; Note=Occasionally.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C5DH ! SC 3T3/W
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   SCGR-8
AC   CVCL_S169
DR   Wikidata; Q54952414
RX   PubMed=1709732;
CC   Doubling time: 25.2 hours (PubMed=1709732).
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C5DH ! SC 3T3/W
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 9
//
ID   ScGT1
AC   CVCL_6267
SY   ScGT1-trk
DR   BTO; BTO_0004339
DR   Wikidata; Q54952415
CC   Characteristics: Infected with mouse scrapie prions.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: GnRH neuron; CL=CL_0011111.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 transgenic with rat Gnrh1 promoter-Tg(SV40).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6236 ! GT1-1
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SCH
AC   CVCL_1687
DR   BTO; BTO_0005929
DR   CLO; CLO_0037148
DR   EFO; EFO_0002856
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1008
DR   BioSample; SAMN03471666
DR   cancercelllines; CVCL_1687
DR   Cell_Model_Passport; SIDM00383
DR   ChEMBL-Cells; CHEMBL3308783
DR   ChEMBL-Targets; CHEMBL1075573
DR   Cosmic; 801343
DR   Cosmic; 909711
DR   Cosmic; 1187290
DR   Cosmic-CLP; 909711
DR   DepMap; ACH-002198
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10785-110H2
DR   GDSC; 909711
DR   GEO; GSM552371
DR   GEO; GSM562417
DR   GEO; GSM827269
DR   GEO; GSM1670414
DR   IARC_TP53; 4347
DR   JCRB; JCRB0251
DR   LINCS_LDP; LCL-1148
DR   PharmacoDB; SCH_1359_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1687
DR   PubChem_Cell_line; CVCL_1687
DR   Wikidata; Q54952424
RX   CelloPub=CLPUB00141;
RX   CelloPub=CLPUB00142;
RX   CelloPub=CLPUB00584;
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=1170940;
RX   PubMed=2878840;
RX   PubMed=6682628;
RX   PubMed=7819056;
RX   PubMed=9290701;
RX   PubMed=11014955;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25343454;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 54 hours (CelloPub=CLPUB00142); 36-37 hours (CelloPub=CLPUB00584); ~1.5 days (Note=Lot 07022010) (JCRB=JCRB0251).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249dup (c.745_747dupAGG) (p.Arg249_Pro250insArg) (c.747_748insAGG); Zygosity=Heterozygous (PubMed=7819056; Cosmic-CLP=909711; DepMap=ACH-002198).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=77.74%; East Asian, South=22.24%; South Asian=0.01%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): Cosmic-CLP=909711; JCRB=JCRB0251
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C95749; Gastric choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   SCHi002-A
AC   CVCL_E4EY
DR   BioSamples; SAMEA113462079
DR   hPSCreg; SCHi002-A
CC   From: Severance Children's Hospital, Yonsei University College of Medicine; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCHL
AC   CVCL_B7QI
SY   Siganus Canaliculatus Hepatocyte Line
DR   Wikidata; Q114312958
RX   PubMed=28691159;
CC   Group: Fish cell line.
CC   Doubling time: 32.2 hours (PubMed=28691159).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=75042; ! Siganus canaliculatus (White-spotted spinefoot)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCHM-1
AC   CVCL_S923
DR   Wikidata; Q54952425
RX   PubMed=8039117;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   Schneider 1
AC   CVCL_Z231
SY   S1; S-1; SL-1; SL1; Schneider S1; Schneider's Line 1; Schneider Line 1; Schneider line-1; Drosophila Line 1; WR69-DM-1; WR-DM-1; DM1; Dm1; DL1
DR   EFO; EFO_0002078
DR   DGRC; 9
DR   ECACC; 90070555
DR   ENCODE; ENCBS902SGJ
DR   FlyBase_Cell_line; FBtc0000009
DR   Wikidata; Q54952426
RX   CelloPub=CLPUB00466;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   DOI=10.2307/3576172;
RX   PubMed=4625067;
RX   PubMed=11669127;
RX   PubMed=16593348;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 32-35 hours (Note=Depending on growth medium) (DGRC=9).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 90070555; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 18
//
ID   Schneider 2
AC   CVCL_Z232
SY   S2; S-2; SC-2; SL-2; SL2; Line 2; Schneider's Line S2; Schneider's line 2; Schneider Line 2; Schneider L2; Schneider's Drosophila Line2; SCHNEIDER-2; SCHNEIDER S2; Schneider S2; Drosophila Line 2; D. mel. (2); D.Mel-2; D.mel-2; WR69-DM-2; WR-DM-2; Dm2; Drosophila line No. 2; DL2; S2-ATCC; S2-Invitrogen; S2-RIKEN; S2U
DR   BTO; BTO_0001677
DR   CLO; CLO_0008922
DR   CLO; CLO_0008971
DR   CLO; CLO_0050770
DR   EFO; EFO_0001233
DR   CLDB; cl4242
DR   CLDB; cl4270
DR   ATCC; CRL-1963
DR   BCRC; 60442
DR   CCRID; 1101INS-PUMC000516
DR   CCTCC; GDC0138
DR   ChEMBL-Cells; CHEMBL3308861
DR   DSMZ; ACC-130
DR   DSMZCellDive; ACC-130
DR   ECACC; 90070554
DR   FlyBase_Cell_line; FBtc0000999
DR   FlyBase_Cell_line; FBtc9000001
DR   FlyBase_Cell_line; FBtc9000006
DR   FlyBase_Cell_line; FBtc9000008
DR   FlyBase_Cell_line; FBtc9000009
DR   FlyBase_Cell_line; FBtc9000011
DR   FlyBase_Cell_line; FBtc9000068
DR   KCB; KCB 200559YJ
DR   Lonza; 957
DR   PRIDE; PXD001455
DR   PubChem_Cell_line; CVCL_Z232
DR   RCB; RCB1153
DR   TOKU-E; 4025
DR   Wikidata; Q7431879
RX   DOI=10.1016/0020-1790(83)90040-9;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   DOI=10.2307/3576172;
RX   PubMed=873048;
RX   PubMed=4625067;
RX   PubMed=8799737;
RX   PubMed=15038778;
RX   PubMed=16409117;
RX   PubMed=16593348;
RX   PubMed=17417030;
RX   PubMed=17890361;
RX   PubMed=23891577;
RX   PubMed=24434506;
RX   PubMed=33389257;
WW   Info; -; -; https://palivec.entu.cas.cz/zurovec/eng/research/cultures.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-68.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-9.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Schneider_2_cells
WW   Provider; Expression Systems; 94-005F/94-005S; https://expressionsystems.com/wp-content/uploads/2017/01/S2-Cells-IFU-Rev-1.pdf
WW   Provider; Thermo Fisher; R69007; https://tools.thermofisher.com/content/sfs/manuals/Drosophila_S2_Cells_UG.pdf
WW   Provider; Thermo Fisher; R69007; https://www.thermofisher.com/order/catalog/product/R69007
CC   Group: Insect cell line.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: ~30 hours (Note=At 25 Celsius) (PubMed=873048); ~40 hours (DSMZ=ACC-130).
CC   Discontinued: ECACC; 90070554; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 30
//
ID   Schneider 3
AC   CVCL_Z233
SY   S3; S-3; SL-3; SL3; Schneider's line 3; Schneider line 3; Schneider S3; Schneider SL3; Dm3; DM3; WR70-Dm-3
DR   EFO; EFO_0005838
DR   DGRC; 5
DR   ECACC; 90070548
DR   ENCODE; ENCBS004EYT
DR   FlyBase_Cell_line; FBtc0000005
DR   Wikidata; Q54952427
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=3141801;
RX   PubMed=4625067;
RX   PubMed=7615077;
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 19-21 hours (Note=Depending on growth medium) (DGRC=5).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 90070548; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 17
//
ID   SCHU
AC   CVCL_E824
DR   dbMHC; 49016
DR   ECACC; 88052013
DR   IHW; IHW09013
DR   IPD-IMGT/HLA; 11647
DR   Wikidata; Q54952428
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01; DPB1*04:02:01; DQA1*01:02:01; DQB1*06:02:01; DRA*01:02; DRB1*15:01:01; DRB5*01:01; DRB6*02:01 (IPD-IMGT/HLA=11647).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   SCI13D
AC   CVCL_B7IK
DR   Wikidata; Q114312959
RX   PubMed=34572381;
CC   Karyotypic information: 46,XY,+10 (PubMed=34572381).
CC   Derived from site: In situ; Lung, bronchoalveolar fluid; UBERON=UBERON_0006538.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=34572381
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,14
ST   D18S51: 13,16
ST   D21S11: 27,30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 19,22
ST   Penta D: 9,11
ST   Penta E: 7,17
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 16
DI   NCIt; C186787; Fibrotic hypersensitivity pneumonitis
DI   ORDO; Orphanet_31740; Hypersensitivity pneumonitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   sciCHO
AC   CVCL_A5TD
DR   CLS; 603481
DR   CLS; 613481
DR   Wikidata; Q107116858
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in suspension. Optimized for the generation of stable populations and clones for high-yield recombinant protein production (CLS=603481).
CC   Doubling time: 18-22 hours (CLS=603481).
CC   Discontinued: CLS; 603481; true.
CC   Discontinued: CLS; 613481; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   sciCHO:hACE2
AC   CVCL_A5TE
DR   CLS; 603482
DR   Wikidata; Q107116859
CC   Group: SARS-CoV-2 research cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Can be used for ACE2 binding assays, flow cytometry, screening of ACE2 antibodies (CLS=603482).
CC   Characteristics: Adapted to growth in suspension (CLS=603482).
CC   Doubling time: 18-22 hours (CLS=603482).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: CLS; 603482; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5TD ! sciCHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   sciCHO:hACE2:hTMPRSS2
AC   CVCL_A5TF
SY   sciCHO:hACE2:TMPRSS2
DR   CLS; 603483
DR   Wikidata; Q107116860
CC   Group: SARS-CoV-2 research cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in suspension (CLS=603483).
CC   Doubling time: 18-22 hours (CLS=603483).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: CLS; 603483; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A5TD ! sciCHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   SCID 5045-4
AC   CVCL_4899
DR   Wikidata; Q54952429
RX   PubMed=11836566;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4890 ! pRNS-1-1
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SCID-01
AC   CVCL_WB05
SY   SCID-1; Severe Combined ImmunoDeficiency-01
DR   IBRC; C10373
DR   Wikidata; Q98129405
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3472; Severe combined immunodeficiency
DI   ORDO; Orphanet_183660; Severe combined immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SCID-03
AC   CVCL_WB06
SY   Severe Combined ImmunoDeficiency-03
DR   IBRC; C10969
DR   Wikidata; Q98129407
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3472; Severe combined immunodeficiency
DI   ORDO; Orphanet_183660; Severe combined immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   Scid.adh
AC   CVCL_B7SC
SY   SCID.adh
DR   ABM; T8203
DR   Lonza; 69
DR   Wikidata; Q114312960
RX   PubMed=10452996;
RX   PubMed=15882585;
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl).
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 5
//
ID   Scid.adh.14B2
AC   CVCL_B7SF
SY   adh.14B2
DR   Wikidata; Q114312961
RX   PubMed=15882585;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl).
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7SC ! Scid.adh
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 5
//
ID   Scid.adh.2C2
AC   CVCL_B7SD
SY   adh.2C2
DR   Wikidata; Q112930348
RX   PubMed=15882585;
CC   Characteristics: Overexpresses PU.1 (Spi1).
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl).
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7SC ! Scid.adh
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 6
//
ID   Scid.adh.6D4
AC   CVCL_B7SE
SY   adh.6D4
DR   Wikidata; Q112930349
RX   PubMed=15882585;
CC   Characteristics: Overexpresses PU.1 (Spi1).
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl).
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B7SC ! Scid.adh
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 6
//
ID   SCID215
AC   CVCL_RK92
SY   SCID 215
DR   Wikidata; Q54952430
RX   DOI=10.2177/jsci.15.594;
RX   PubMed=8500535;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3472; Severe combined immunodeficiency
DI   ORDO; Orphanet_183660; Severe combined immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RK91 ! SCID86730
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   SCID221
AC   CVCL_RK93
SY   SCID 221
DR   Wikidata; Q54952431
RX   DOI=10.2177/jsci.15.594;
RX   PubMed=8500535;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3472; Severe combined immunodeficiency
DI   ORDO; Orphanet_183660; Severe combined immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RK91 ! SCID86730
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   SCID5038D
AC   CVCL_E4C3
RX   PubMed=12738999;
CC   Characteristics: The parent cell line was injected subcutaneously into SCID mice and this cell line was established from tumors at the sites of innoculation (PubMed=12738999).
CC   Karyotypic information: Hypotetraploid karyotype (PubMed=12738999).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4C2 ! RC-9/E6E7
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   SCID86730
AC   CVCL_RK91
SY   SCID 86730
DR   Wikidata; Q54952432
RX   DOI=10.2177/jsci.15.594;
RX   PubMed=8500535;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3472; Severe combined immunodeficiency
DI   ORDO; Orphanet_183660; Severe combined immunodeficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   SCIKFi001-A
AC   CVCL_C0J1
SY   D3-iR-2
DR   BioSamples; SAMEA13371561
DR   hPSCreg; SCIKFi001-A
DR   Wikidata; Q112930350
RX   PubMed=35462157;
CC   From: Stem Cell and Cancer Institute, PT Kalbe Farma Tbk; Jakarta; Indonesia.
CC   Population: Asian.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0L0 ! SCIKFi001-B
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   SCIKFi001-B
AC   CVCL_D0L0
SY   D3-iE
DR   BioSamples; SAMEA115090065
DR   hPSCreg; SCIKFi001-B
DR   Wikidata; Q123033406
RX   PubMed=39332133;
CC   From: Stem Cell and Cancer Institute, PT Kalbe Farma Tbk; Jakarta; Indonesia.
CC   Population: Asian.
CC   Karyotypic information: 46,XY,der(21)t(5;21)(q12;q22) (PubMed=39332133).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0J1 ! SCIKFi001-A
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SCIT-C8
AC   CVCL_F731
SY   Sertoli Cells from Immature Testis-Clone 8
DR   Wikidata; Q54952433
RX   PubMed=15716129;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   19D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   SCK [Human cholangiocarcinoma]
AC   CVCL_M271
DR   Wikidata; Q54952434
RX   CelloPub=CLPUB00275;
RX   PubMed=11107175;
RX   PubMed=35640676;
CC   Population: Korean.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   SCK [S.chuatsi]
AC   CVCL_D3X7
SY   Siniperca Chuatsi Kidney; MFK; Mandarin Fish Kidney
DR   BioSample; SAMN38845202
DR   Wikidata; Q123827409
RX   PubMed=38201223;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by mandarin fish ranavirus (MRV) (PubMed=38201223).
CC   Doubling time: ~48 hours (PubMed=38201223).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   SCK-f
AC   CVCL_D7ER
SY   Siniperca Chuatsi Kidney clone f; MFK-f; Mandarin Fish Kidney clone f
DR   BioSample; SAMN38845369
DR   Wikidata; Q123828643
RX   PubMed=38201223;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by mandarin fish ranavirus (MRV) (PubMed=38201223).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
HI   CVCL_D3X7 ! SCK [S.chuatsi]
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   SCKO-1
AC   CVCL_B462
SY   SCKO1; Scko1
DR   Cosmic; 1043825
DR   Cosmic; 2800570
DR   Wikidata; Q54952435
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   SCL 4.1/F7
AC   CVCL_4297
SY   SCL4.1/F7
DR   ECACC; 93031204
DR   Wikidata; Q54952437
RX   PubMed=7967716;
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   SCL-116A
AC   CVCL_E826
SY   TER459; TER-459; Ter 459; TER495; TER-495; Ter-495; Ter 495
DR   dbMHC; 49017
DR   IHW; IHW09465
DR   IPD-IMGT/HLA; 26058
DR   Wikidata; Q54952438
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/359cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/378cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,30:02; B*18:01,56:01; C*01:02,05; DQA1*01:02,01:03; DQB1*06:03,06:09; DRB1*03:07,13:01 (IPD-IMGT/HLA=26058).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   SCL-I
AC   CVCL_A789
SY   SCL I; SCL-1; SCL1
DR   ChEMBL-Cells; CHEMBL3307442
DR   ChEMBL-Targets; CHEMBL614903
DR   CLS; 300496
DR   Cosmic; 740987
DR   PubChem_Cell_line; CVCL_A789
DR   Wikidata; Q54952439
RX   PubMed=2293663;
RX   PubMed=6196111;
RX   PubMed=6950169;
RX   PubMed=11992403;
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (CLS=300496).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val197Ter; Zygosity=Unspecified (PubMed=11992403).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
ST   Source(s): CLS=300496
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 16,19
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 13,14
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   SCL-II
AC   CVCL_A790
SY   SCL II; SCL-2; SCL2
DR   cancercelllines; CVCL_A790
DR   CLS; 300497
DR   Cosmic; 740988
DR   Wikidata; Q54952440
RX   PubMed=6196111;
RX   PubMed=11992403;
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (CLS=300497).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Unspecified (PubMed=11992403).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
ST   Source(s): CLS=300497
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D18S51: 17
ST   D21S11: 29
ST   D3S1358: 14
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 26
ST   Penta D: 9,13
ST   Penta E: 13
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   SCL1-CD4 clone 6
AC   CVCL_A0CN
SY   SCL1 clone 6
DR   Wikidata; Q108821271
RX   PubMed=2293663;
RX   PubMed=8095307;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val197Ter; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A789 ! SCL-I
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   SCL215
AC   CVCL_VQ64
DR   Wikidata; Q98129410
RX   CelloPub=CLPUB00443;
RX   PubMed=23202794;
CC   Characteristics: Expresses a rat GNRHR fused to a catfish GNRHR C-terminal cytoplasmic domain. The fusion protein binds GNRH and analogs but this does not activate signaling.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 70513; Gnrhr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; O42329; Clarias gariepinus cfGnRH-R (Note=With p.Met1_Phe328del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   SCL60
AC   CVCL_VQ89
SY   HEK293[SCL60]; 293-A2
DR   Wikidata; Q98129413
RX   CelloPub=CLPUB00443;
RX   PubMed=7588262;
RX   PubMed=18676858;
RX   PubMed=23202794;
CC   Doubling time: 21.4 hours (PubMed=18676858).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 70513; Gnrhr.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   SCLC-16HC
AC   CVCL_X025
SY   SCLC-16H
DR   BioSample; SAMN03151912
DR   Wikidata; Q54952441
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2438285;
RX   PubMed=2473086;
RX   PubMed=10508494;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00158.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0024 ! SCLC-21H
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 18
//
ID   SCLC-16HV
AC   CVCL_X026
DR   Wikidata; Q54952442
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2438285;
RX   PubMed=2473086;
RX   PubMed=11414198;
CC   Problematic cell line: Contaminated. Parent cell line (SCLC-16HC) has been shown to be a SCLC-21H (or SCLC-22H) derivative.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X025 ! SCLC-16HC
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 14
//
ID   SCLC-203H
AC   CVCL_X023
DR   Wikidata; Q54952443
RX   PubMed=2438285;
RX   PubMed=3029138;
CC   Doubling time: >200 hours (PubMed=2438285; PubMed=3029138).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   SCLC-21H
AC   CVCL_0024
SY   SCLC21H
DR   CLO; CLO_0008972
DR   EFO; EFO_0006749
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473050
DR   BioSample; SAMN10988516
DR   cancercelllines; CVCL_0024
DR   Cell_Model_Passport; SIDM00029
DR   ChEMBL-Cells; CHEMBL3308465
DR   ChEMBL-Targets; CHEMBL1075574
DR   CLS; 300225
DR   Cosmic; 753611
DR   DepMap; ACH-000659
DR   DSMZ; ACC-372
DR   DSMZCellDive; ACC-372
DR   EGA; EGAS00001000610
DR   GDSC; 753611
DR   GEO; GSM784216
DR   GEO; GSM887562
DR   GEO; GSM888645
DR   GEO; GSM7701447
DR   GEO; GSM7701454
DR   IARC_TP53; 27236
DR   LiGeA; CCLE_035
DR   LINCS_LDP; LCL-1822
DR   PharmacoDB; SCLC21H_1361_2019
DR   PRIDE; PXD011896
DR   Progenetix; CVCL_0024
DR   PubChem_Cell_line; CVCL_0024
DR   Wikidata; Q54952444
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2438285;
RX   PubMed=2473086;
RX   PubMed=3029138;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=16957166;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Virology: Infected with a murine leukemia virus-related virus (PubMed=30629668).
CC   Doubling time: 45-85 hours (Note=Depending on growth medium) (PubMed=3029138); >45 hours (PubMed=2438285); ~2 days (DSMZ=ACC-372).
CC   HLA typing: A*01:01,32:01; B*07:02,07:02; C*02:02,02:02 (PubMed=25960936).
CC   HLA typing: A*01:01,32:03; B*39:04,44:02; C*02:02,08:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Arg (c.833C>G); ClinVar=VCV000376644; Zygosity=Homozygous (DepMap=ACH-000659).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.58%; Native American=1.19%; East Asian, North=1.82%; East Asian, South=0%; South Asian=0%; European, North=61.58%; European, South=34.82% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CLS=300225; DSMZ=ACC-372; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 22 (CLS=300225)
ST   FGA: 22,23 (DSMZ=ACC-372; PubMed=11416159; PubMed=25877200)
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2186 ! SCLC-22H
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 43
//
ID   SCLC-22H
AC   CVCL_2186
SY   SCLC22H
DR   CLO; CLO_0008973
DR   EFO; EFO_0006750
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_2186
DR   Cell_Model_Passport; SIDM00028
DR   CLS; 300445
DR   DepMap; ACH-001386
DR   DSMZ; ACC-373
DR   DSMZCellDive; ACC-373
DR   EGA; EGAS00001000610
DR   GEO; GSM784218
DR   PharmacoDB; SCLC22H_1362_2019
DR   Progenetix; CVCL_2186
DR   Wikidata; Q54952445
RX   PubMed=1320893;
RX   PubMed=1845952;
RX   PubMed=2438285;
RX   PubMed=2473086;
RX   PubMed=3029138;
RX   PubMed=11414198;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=26589293;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 75-85 hours (Note=Depending on growth medium) (PubMed=3029138); 75 hours (PubMed=2438285); ~48 hours (DSMZ=ACC-373).
CC   HLA typing: A*01:01,32:01; B*35:86,27:05; C*02:02,02:02 (PubMed=25960936).
CC   HLA typing: A*01:01,32:01; B*27:05,35:86; C*02:02,02:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Arg (c.833C>G); ClinVar=VCV000376644; Zygosity=Homozygous (DepMap=ACH-001386).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
ST   Source(s): CLS=300445; DepMap=ACH-001386; DSMZ=ACC-373
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 22 (CLS=300445)
ST   FGA: 22,23 (DepMap=ACH-001386; DSMZ=ACC-373)
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0024 ! SCLC-21H
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SCLC-24H
AC   CVCL_8262
SY   MAR-24H; MAR 24H; MAR24H; 24H
DR   BioSample; SAMN03151913
DR   CLS; 300177
DR   Cosmic; 2648018
DR   Wikidata; Q54952446
RX   PubMed=1845952;
RX   PubMed=2438285;
RX   PubMed=2473086;
RX   PubMed=3029138;
RX   PubMed=9744504;
RX   PubMed=10508494;
RX   PubMed=11414198;
RX   PubMed=12712436;
RX   PubMed=20143388;
RX   PubMed=24586258;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SCLC-21H (or SCLC-22H) derivative (PubMed=10508494; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00159.
CC   Population: Caucasian.
CC   Doubling time: 70-75 hours (Note=Depending on growth medium) (PubMed=3029138).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=24586258
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14,15
ST   D21S11: 29,31.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0024 ! SCLC-21H
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SCLC-86M1
AC   CVCL_8263
SY   MAR-86MI; MAR 86MI; MAR86M1; MAR86MI; MAR 86 MI; 86MI; 86M1
DR   Cosmic; 2648019
DR   Wikidata; Q54952447
RX   PubMed=1845952;
RX   PubMed=2438285;
RX   PubMed=2473086;
RX   PubMed=2574988;
RX   PubMed=3029138;
RX   PubMed=9744504;
RX   PubMed=12712436;
CC   Characteristics: Established from a first passage xenograft maintained in nude mice.
CC   Doubling time: 70 hours (PubMed=2438285).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X024 ! SCLC-86M2
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SCLC-86M2
AC   CVCL_X024
DR   Wikidata; Q54952448
RX   PubMed=2438285;
RX   PubMed=3029138;
CC   Characteristics: Established from a second passage xenograft maintained in nude mice.
CC   Doubling time: 70 hours (PubMed=2438285).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8263 ! SCLC-86M1
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   SCLC-J1
AC   CVCL_B7JK
DR   cancercelllines; CVCL_B7JK
DR   Wikidata; Q112930351
RX   PubMed=34381882;
CC   Population: Japanese.
CC   Doubling time: 64.5 hours (PubMed=34381882).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Gly1111Val (c.3332_3333delGGinsTT); Zygosity=Homozygous (PubMed=34381882).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Gly936Cys (c.2806G>T); Zygosity=Homozygous (PubMed=34381882).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu218Val (c.652T>G); ClinVar=VCV000572140; Zygosity=Homozygous (PubMed=34381882).
CC   Donor information: Established from a one pack per day smoker (PubMed=34381882).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SCLC-R1
AC   CVCL_WH07
DR   Wikidata; Q98129415
RX   PubMed=9713281;
RX   PubMed=10841287;
CC   Doubling time: ~62 hours (PubMed=9713281).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SCMC-ES1
AC   CVCL_7123
SY   SCMC-ES-1; Saitama Children's Medical Center-Ewing Sarcoma 1
DR   BTO; BTO_0004786
DR   cancercelllines; CVCL_7123
DR   Cosmic; 1078360
DR   Cosmic; 1381105
DR   GEO; GSM393026
DR   IARC_TP53; 1273
DR   IGRhCellID; SCMSES1%20GEO
DR   JCRB; NIHS0048
DR   Progenetix; CVCL_7123
DR   Wikidata; Q54952450
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=7591257;
RX   PubMed=8221663;
RX   PubMed=18082704;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=7591257).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141Tyr (c.422G>A); ClinVar=VCV000140801; Zygosity=Unspecified (PubMed=8221663).
CC   Misspelling: SCMS-ES1; Note=Occasionally.
CC   Discontinued: JCRB; NIHS0048; true.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   SCMC-ES2
AC   CVCL_7124
SY   SCMC-ES-2; Saitama Children's Medical Center-Ewing Sarcoma 2
DR   cancercelllines; CVCL_7124
DR   Cosmic; 1078361
DR   Cosmic; 1381108
DR   IARC_TP53; 1274
DR   JCRB; NIHS0049
DR   Wikidata; Q54952451
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=7591257;
RX   PubMed=8221663;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=7591257).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=8221663).
CC   Discontinued: JCRB; NIHS0049; true.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   SCMC-L1
AC   CVCL_7125
AS   CVCL_G317
SY   SCMC-L-1; SCMCL-L1; Saitama Children's Medical Center-Leukemia 1
DR   Cosmic; 998688
DR   Cosmic; 1037738
DR   Wikidata; Q54952452
RX   CelloPub=CLPUB00110;
RX   CelloPub=CLPUB00111;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7647001;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14671638;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   SCMC-L10
AC   CVCL_7126
SY   L10; Saitama Children's Medical Center-Leukemia 10
DR   BTO; BTO_0004949
DR   Cosmic; 710460
DR   Cosmic; 996294
DR   Cosmic; 998689
DR   Cosmic; 1037740
DR   IARC_TP53; 3950
DR   Wikidata; Q54952453
RX   CelloPub=CLPUB00111;
RX   PubMed=7727782;
RX   PubMed=8139288;
RX   PubMed=10233379;
RX   PubMed=14504097;
RX   PubMed=29786757;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.627_632AAACAC>CCCACACGCA; Zygosity=Unspecified (PubMed=7727782).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   SCMC-L11
AC   CVCL_7127
SY   Saitama Children's Medical Center-Leukemia 11
DR   Cosmic; 710461
DR   IARC_TP53; 3951
DR   Wikidata; Q54952454
RX   CelloPub=CLPUB00111;
RX   PubMed=7727782;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser240Cys (c.718A>T); Zygosity=Unspecified (PubMed=7727782).
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   SCMC-L2
AC   CVCL_7128
SY   SCMC-L-2; SCMCL2; L2; Saitama Children's Medical Center-Leukemia 2
DR   Cosmic; 1037739
DR   Wikidata; Q54952455
RX   CelloPub=CLPUB00110;
RX   CelloPub=CLPUB00111;
RX   PubMed=8139288;
RX   PubMed=10071072;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; c.2675+2T>C; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35124168).
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   SCMC-L20
AC   CVCL_7129
SY   Saitama Children's Medical Center-Leukemia 20
DR   Cosmic; 998687
DR   Cosmic; 1037741
DR   Wikidata; Q54952457
RX   PubMed=10233379;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   SCMC-L3
AC   CVCL_G318
SY   SCMC-L-3; SCMCL-L3; Saitama Children's Medical Center-Leukemia 3
DR   Cosmic; 919139
DR   Wikidata; Q54952467
RX   CelloPub=CLPUB00110;
RX   CelloPub=CLPUB00111;
RX   PubMed=9510473;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 14
//
ID   SCMC-L4
AC   CVCL_G319
SY   SCMC-L-4; SCMCL-L4; Saitama Children's Medical Center-Leukemia 4
DR   Cosmic; 919140
DR   Wikidata; Q54952476
RX   CelloPub=CLPUB00110;
RX   CelloPub=CLPUB00111;
RX   PubMed=9510473;
CC   Population: Japanese.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 14
//
ID   SCMC-L9
AC   CVCL_7130
SY   Saitama Children's Medical Center-Leukemia 9
DR   cancercelllines; CVCL_7130
DR   Cosmic; 710459
DR   IARC_TP53; 3952
DR   Wikidata; Q54952458
RX   PubMed=7727782;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Cys (c.523C>T); ClinVar=VCV000245851; Zygosity=Unspecified (PubMed=7727782).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=7727782).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu358Lys (c.1072G>A); ClinVar=VCV000142105; Zygosity=Unspecified (PubMed=7727782).
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   SCMC-MM-1
AC   CVCL_UF76
SY   MM-1
DR   JCRB; NIHS0045
DR   Wikidata; Q98129417
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=1313401;
RX   PubMed=23665679;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=1313401).
CC   Discontinued: JCRB; NIHS0045; true.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 6
//
ID   SCMC-MM-1-19P
AC   CVCL_UF77
SY   MM-1-19P
DR   Wikidata; Q98129420
RX   PubMed=1313401;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=1313401).
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF76 ! SCMC-MM-1
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   SCMC-MM-1-1T
AC   CVCL_UF78
SY   MM-1-1T
DR   Wikidata; Q98129422
RX   PubMed=1313401;
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=1313401).
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF76 ! SCMC-MM-1
SX   Female
AG   11M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   SCMC-N2
AC   CVCL_5921
SY   SCMC-N-2; SCMCN2; Saitama Children's Medical Center-Neuroblastoma 2
DR   cancercelllines; CVCL_5921
DR   Cosmic; 801750
DR   Cosmic; 920249
DR   Cosmic; 947699
DR   Cosmic; 1037346
DR   Cosmic; 1099143
DR   Cosmic; 1153789
DR   Cosmic; 2131581
DR   GEO; GSM314016
DR   IARC_TP53; 23587
DR   JCRB; NIHS0039
DR   Progenetix; CVCL_5921
DR   Wikidata; Q54952459
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=8221663;
RX   PubMed=9041193;
RX   PubMed=18923524;
CC   Population: Japanese.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0039; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SCMC-N3
AC   CVCL_5922
SY   SCMC-N-3; SCMCN3; Saitama Children's Medical Center-Neuroblastoma 3
DR   Cosmic; 801751
DR   Cosmic; 920250
DR   Cosmic; 947700
DR   Cosmic; 2131582
DR   IARC_TP53; 23588
DR   JCRB; NIHS0040
DR   Wikidata; Q54952460
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=8221663;
RX   PubMed=9041193;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0040; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   SCMC-N4
AC   CVCL_5923
SY   SCMC-N-4; SCMCN4; Saitama Children's Medical Center-Neuroblastoma 4
DR   cancercelllines; CVCL_5923
DR   Cosmic; 801752
DR   Cosmic; 920251
DR   Cosmic; 947697
DR   Cosmic; 1037347
DR   Cosmic; 1099144
DR   Cosmic; 1153790
DR   Cosmic; 2131572
DR   GEO; GSM314017
DR   GEO; GSM333804
DR   IARC_TP53; 23589
DR   JCRB; NIHS0041
DR   Progenetix; CVCL_5923
DR   Wikidata; Q54952461
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=8221663;
RX   PubMed=9041193;
RX   PubMed=18923524;
CC   Population: Japanese.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0041; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SCMC-N5
AC   CVCL_5924
SY   SCMC-N-5; SCMCN5; Saitama Children's Medical Center-Neuroblastoma 5
DR   cancercelllines; CVCL_5924
DR   Cosmic; 801753
DR   Cosmic; 920252
DR   Cosmic; 947698
DR   Cosmic; 1037348
DR   Cosmic; 1099145
DR   Cosmic; 1153791
DR   Cosmic; 2131583
DR   GEO; GSM314018
DR   GEO; GSM333805
DR   JCRB; NIHS0042
DR   Progenetix; CVCL_5924
DR   Wikidata; Q54952462
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=9041193;
RX   PubMed=18923524;
CC   Population: Japanese.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0042; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   SCMC-RM1
AC   CVCL_UF92
SY   SCMC-RM-1; SCMC-R-1; SCMCRM1; Saitama Children's Medical Center-RhabdoMyosarcoma 1
DR   JCRB; NIHS0043
DR   Wikidata; Q98129425
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0043; true.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   SCMC-RM2
AC   CVCL_A667
AS   CVCL_UF93
SY   SCMC-RM-2; SCMC-R-2; SCMCRM2; Saitama Children's Medical Center-RhabdoMyosarcoma 2
DR   cancercelllines; CVCL_A667
DR   Cell_Model_Passport; SIDM01346
DR   Cosmic; 687965
DR   Cosmic; 801761
DR   Cosmic; 1037300
DR   Cosmic; 1048113
DR   Cosmic; 1718359
DR   Cosmic; 2355929
DR   DepMap; ACH-001184
DR   GEO; GSM219592
DR   GEO; GSM1012754
DR   JCRB; NIHS0044
DR   Wikidata; Q54952464
RX   CelloPub=CLPUB00110;
RX   CelloPub=CLPUB00599;
RX   DOI=10.2198/sbk.34.289;
RX   PubMed=2323848;
RX   PubMed=18082704;
RX   PubMed=19235922;
RX   PubMed=22142829;
RX   PubMed=23578105;
RX   PubMed=23882450;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=2323848).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR; Note=Not found in original tumor (PubMed=23578105; CelloPub=CLPUB00599).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: SCMC-RMZ; PubMed=19235922.
CC   Discontinued: JCRB; NIHS0044; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DepMap=ACH-001184
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11,12
ST   D16S539: 10,11
ST   D18S51: 11,13
ST   D21S11: 30,33.2
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 19,27
ST   Penta D: 9
ST   Penta E: 11,20,22
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   SCMC-RM2-1
AC   CVCL_A668
DR   Cell_Model_Passport; SIDM01634
DR   Wikidata; Q54952465
RX   PubMed=2323848;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=2323848).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A667 ! SCMC-RM2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   SCMC-W1
AC   CVCL_UF79
SY   SCMC-W-1; Saitama Children's Medical Center-Wilms tumor 1
DR   JCRB; NIHS0046
DR   Wikidata; Q98129427
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0046; true.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 6
//
ID   SCMC-W2
AC   CVCL_UF80
SY   SCMC-W-2; Saitama Children's Medical Center-Wilms tumor 2
DR   JCRB; NIHS0047
DR   Wikidata; Q98129429
RX   CelloPub=CLPUB00110;
RX   DOI=10.2198/sbk.34.289;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0047; true.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 6
//
ID   SCMCi001-A
AC   CVCL_A8HD
DR   BioSamples; SAMEA8633347
DR   hPSCreg; SCMCi001-A
DR   Wikidata; Q107116861
RX   PubMed=34509918;
CC   From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SCMCi001-A-1
AC   CVCL_A8HE
SY   hiPSC-PTCH1_KO
DR   BioSamples; SAMEA8686789
DR   hPSCreg; SCMCi001-A-1
DR   Wikidata; Q107116862
RX   PubMed=34509918;
CC   From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese; Han.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HD ! SCMCi001-A
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCMCi002-A
AC   CVCL_B0PM
SY   T3 iPS
DR   hPSCreg; SCMCi002-A
DR   Wikidata; Q108821272
RX   PubMed=34298433;
CC   From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese.
CC   Karyotypic information: 47,XX,del(5)(q22q25),del(7)(q22),del(12)(p11.2),+13 (PubMed=34298433).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SCMCi003-A
AC   CVCL_B0PN
SY   M5 iPS
DR   hPSCreg; SCMCi003-A
DR   Wikidata; Q108821273
RX   PubMed=34298433;
CC   From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese.
CC   Karyotypic information: 52,XY,t(9,22)(q34:q11.2),+11,14,17,21,22,Y (PubMed=34298433).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SCMCi004-A
AC   CVCL_B0PP
SY   M7 iPS
DR   hPSCreg; SCMCi004-A
DR   Wikidata; Q108821274
RX   PubMed=34298433;
CC   From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese.
CC   Karyotypic information: 45,XY,19,add(21)(p13) (PubMed=34298433).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SCN1.4
AC   CVCL_D049
SY   SCN 1.4
DR   CancerTools; 160515
DR   Wikidata; Q54952477
RX   PubMed=10213449;
CC   Doubling time: 28 hours (PubMed=10213449).
CC   Transformant: Psi2 defective retrovirus adenovirus E1A.
CC   Derived from site: In situ; Embryonic brain, hypothalamus, suprachiasmatic nucleus; UBERON=UBERON_0006238+UBERON_0002034.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   15-16FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   SCN2.2
AC   CVCL_D050
SY   SCN 2.2
DR   EFO; EFO_0002708
DR   ABM; T0296
DR   CancerTools; 160400
DR   GEO; GSM28447
DR   GEO; GSM28448
DR   GEO; GSM28449
DR   GEO; GSM28450
DR   GEO; GSM28451
DR   GEO; GSM28452
DR   GEO; GSM28453
DR   GEO; GSM28454
DR   GEO; GSM28455
DR   GEO; GSM28456
DR   GEO; GSM28458
DR   GEO; GSM28459
DR   GEO; GSM28460
DR   GEO; GSM28461
DR   GEO; GSM28462
DR   GEO; GSM28463
DR   GEO; GSM28464
DR   GEO; GSM28465
DR   GEO; GSM28466
DR   GEO; GSM28467
DR   GEO; GSM28468
DR   GEO; GSM28469
DR   GEO; GSM28470
DR   GEO; GSM28471
DR   GEO; GSM28472
DR   GEO; GSM28473
DR   GEO; GSM28474
DR   Kerafast; EUT500
DR   Wikidata; Q54952478
RX   PubMed=10213449;
RX   PubMed=15769907;
RX   PubMed=17284666;
CC   Characteristics: Capable to differentiate into different phenotypes. Expresses the neuronal markers (NSE, PGP and MAP2), but absent of glial markers. Valuable tool for studies relating to the regulation of the central mammalian pacemaker function and the development of the suprachiasmatic nucleus (SCN) cell types (Kerafast=EUT500).
CC   Doubling time: 28 hours (PubMed=10213449).
CC   Transformant: Psi2 defective retrovirus adenovirus E1A.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Embryonic brain, hypothalamus, suprachiasmatic nucleus; UBERON=UBERON_0006238+UBERON_0002034.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   15-16FD
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   ScN2a
AC   CVCL_6268
DR   BTO; BTO_0003716
DR   ChEMBL-Cells; CHEMBL3308084
DR   ChEMBL-Targets; CHEMBL613872
DR   PubChem_Cell_line; CVCL_6268
DR   Wikidata; Q54952480
RX   PubMed=10756052;
RX   PubMed=17850126;
CC   Characteristics: Infected with mouse RML strain prions.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SCO1
AC   CVCL_9U52
SY   Southern Catfish Ovary 1
DR   Wikidata; Q54952481
RX   CelloPub=CLPUB00551;
RX   PubMed=24671650;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=175797; ! Silurus meridionalis (Southern catfish)
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   Scooter
AC   CVCL_0D16
SY   SCOOTER; SCO
DR   Wikidata; Q54952483
RX   PubMed=11467477;
RX   PubMed=12944992;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SCP
AC   CVCL_4298
SY   Sheep Choroid Plexus
DR   CLO; CLO_0008974
DR   CLDB; cl4272
DR   ATCC; CRL-1700
DR   CCLV; CCLV-RIE 0213
DR   ECACC; 89101302
DR   IZSLER; BS CL 120
DR   Wikidata; Q54952487
RX   PubMed=7989438;
RX   PubMed=25565633;
CC   Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Fetal brain, choroid plexus; UBERON=UBERON_0006238+UBERON_0001886.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   SCP-HS
AC   CVCL_C5SY
DR   Wikidata; Q116050479
RX   PubMed=34737324;
CC   Problematic cell line: Misidentified. Originally thought to be a derivative of the sheep SCP cell line (Cellosaurus=CVCL_4298) but shown to originate from bovine (PubMed=34737324).
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SCP-1
AC   CVCL_C3VP
DR   Wikidata; Q116050480
RX   PubMed=18318690;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3VS ! SCP-9
OI   CVCL_C3VQ ! SCP-11
OI   CVCL_C3VR ! SCP-12
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SCP-11
AC   CVCL_C3VQ
DR   Wikidata; Q116050481
RX   PubMed=18318690;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3VP ! SCP-1
OI   CVCL_C3VS ! SCP-9
OI   CVCL_C3VR ! SCP-12
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SCP-12
AC   CVCL_C3VR
DR   Wikidata; Q116050482
RX   PubMed=18318690;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3VP ! SCP-1
OI   CVCL_C3VS ! SCP-9
OI   CVCL_C3VQ ! SCP-11
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SCP-9
AC   CVCL_C3VS
DR   Wikidata; Q116050483
RX   PubMed=18318690;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3VP ! SCP-1
OI   CVCL_C3VQ ! SCP-11
OI   CVCL_C3VR ! SCP-12
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SCp2
AC   CVCL_E1I2
SY   scp2; SubClone petit 2
DR   Millipore; SCC458
RX   CelloPub=CLPUB00773;
RX   PubMed=7528920;
RX   PubMed=7760836;
RX   PubMed=9671467;
CC   Characteristics: When given lactogenic hormones and basement membrane ECM in serum-free medium, they arrest growth, form three-dimensional alveolar structures, and express beta-casein (CelloPub=CLPUB00773).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
ST   Source(s): Millipore=SCC458
ST   Mouse STR 1-1: 13,14
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 17,18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 24
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I1 ! CID 9
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   SCp2-antisense Id-1
AC   CVCL_E1I4
SY   SCp2-Id-AS
RX   PubMed=7760836;
RX   PubMed=9671467;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96396; Id1 (Note=In antisense orientation).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I2 ! SCp2
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SCp2-Id-1
AC   CVCL_E1I3
SY   SCp2-Id-S
RX   PubMed=7760836;
RX   PubMed=9671467;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96396; Id1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I2 ! SCp2
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SCp2-Id-1A
AC   CVCL_E1I5
RX   PubMed=9671467;
CC   Characteristics: Does not seem to express Id1. Can be used as a control cell line (PubMed=9671467).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96396; Id1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I3 ! SCp2-Id-1
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SCp2-Id-1B
AC   CVCL_E1I6
RX   PubMed=9671467;
CC   Characteristics: Expresses moderate levels of Id1 (PubMed=9671467).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96396; Id1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I3 ! SCp2-Id-1
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SCp2-Id-1C
AC   CVCL_E1I7
RX   PubMed=9671467;
CC   Characteristics: Expresses moderate levels of Id1 (PubMed=9671467).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96396; Id1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I3 ! SCp2-Id-1
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SCp2-Id-1D
AC   CVCL_E1I8
RX   PubMed=9671467;
CC   Characteristics: Expresses high levels of Id1 and undetectable levels of beta-casein (PubMed=9671467).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96396; Id1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I3 ! SCp2-Id-1
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SCp2-Id-1E
AC   CVCL_E1I9
RX   PubMed=9671467;
CC   Characteristics: Expresses high levels of Id1 and undetectable levels of beta-casein (PubMed=9671467).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96396; Id1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E1I3 ! SCp2-Id-1
SX   Female
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SCR5
AC   CVCL_4349
DR   ECACC; 95071120
DR   Wikidata; Q54952488
RX   PubMed=2073461;
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Discontinued: ECACC; 95071120; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_V322 ! CCR5
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SCRC-1
AC   CVCL_W962
SY   Small Cell Renal Carcinoma-1
DR   Wikidata; Q54952489
RX   PubMed=10688041;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 91.4 hours (PubMed=10688041).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C116317; Kidney small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   SCRP0104i
AC   CVCL_JV27
SY   KBET0104i
DR   SKIP; SKIP003288
DR   WiCell; scrp0104i
DR   Wikidata; Q54952490
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0202i
AC   CVCL_JV28
SY   KBET0202i
DR   SKIP; SKIP003289
DR   WiCell; scrp0202i
DR   Wikidata; Q54952492
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0203i
AC   CVCL_JV29
SY   C00096
DR   SKIP; SKIP003290
DR   WiCell; scrp0203i
DR   Wikidata; Q54952493
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0302i
AC   CVCL_JV30
SY   C00103
DR   SKIP; SKIP003291
DR   WiCell; scrp0302i
DR   Wikidata; Q54952495
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0307i
AC   CVCL_JV31
SY   KBET0307i
DR   SKIP; SKIP003293
DR   WiCell; scrp0307i
DR   Wikidata; Q54952496
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0402i
AC   CVCL_JV32
SY   KBET0402i
DR   SKIP; SKIP003301
DR   WiCell; scrp0402i
DR   Wikidata; Q54952497
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0404i
AC   CVCL_JV33
SY   C00125
DR   SKIP; SKIP003292
DR   WiCell; scrp0404i
DR   Wikidata; Q54952499
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0517i
AC   CVCL_JV34
SY   KBET0517i
DR   SKIP; SKIP003307
DR   WiCell; scrp0517i
DR   Wikidata; Q54952500
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0601i
AC   CVCL_JV35
SY   KBET0601i
DR   SKIP; SKIP003310
DR   WiCell; scrp0601i
DR   Wikidata; Q54952501
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0608i
AC   CVCL_JV36
SY   C00168
DR   SKIP; SKIP003294
DR   WiCell; scrp0608i
DR   Wikidata; Q54952502
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0709i
AC   CVCL_JV37
SY   KBET0709i
DR   SKIP; SKIP003314
DR   WiCell; scrp0709i
DR   Wikidata; Q54952504
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP0802i
AC   CVCL_JV38
SY   KBET0802i
DR   SKIP; SKIP003330
DR   WiCell; scrp0802i
DR   Wikidata; Q54952506
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1002i
AC   CVCL_JV39
SY   HE01070
DR   SKIP; SKIP004421
DR   WiCell; scrp1002i
DR   Wikidata; Q54952507
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1005i
AC   CVCL_JV40
SY   C00246
DR   SKIP; SKIP003295
DR   WiCell; scrp1005i
DR   Wikidata; Q54952508
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1021i
AC   CVCL_JV41
SY   HE01083
DR   SKIP; SKIP004422
DR   WiCell; scrp1021i
DR   Wikidata; Q54952510
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   91Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1031i
AC   CVCL_JV42
SY   HE01187
DR   SKIP; SKIP004423
DR   WiCell; scrp1031i
DR   Wikidata; Q54952511
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1041i
AC   CVCL_JV43
SY   HE01189
DR   SKIP; SKIP004424
DR   WiCell; scrp1041i
DR   Wikidata; Q54952512
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1103i
AC   CVCL_JV44
SY   C00251
DR   SKIP; SKIP003296
DR   WiCell; scrp1103i
DR   Wikidata; Q54952514
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1203i
AC   CVCL_JV45
SY   C00316
DR   SKIP; SKIP003297
DR   WiCell; scrp1203i
DR   Wikidata; Q54952516
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1307i
AC   CVCL_JV46
SY   C00350
DR   SKIP; SKIP003298
DR   WiCell; scrp1307i
DR   Wikidata; Q54952517
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1602i
AC   CVCL_JV47
SY   C00410
DR   SKIP; SKIP003299
DR   WiCell; scrp1602i
DR   Wikidata; Q54952518
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP1702i
AC   CVCL_JV48
SY   C00426
DR   SKIP; SKIP003300
DR   WiCell; scrp1702i
DR   Wikidata; Q54952520
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2001i
AC   CVCL_JV49
SY   C00490
DR   SKIP; SKIP003302
DR   WiCell; scrp2001i
DR   Wikidata; Q54952521
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2101i
AC   CVCL_JV50
SY   KBET2101i
DR   SKIP; SKIP004378
DR   WiCell; scrp2101i
DR   Wikidata; Q54952522
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2102i
AC   CVCL_JV51
SY   C00492
DR   SKIP; SKIP003303
DR   WiCell; scrp2102i
DR   Wikidata; Q54952524
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2106i
AC   CVCL_JV52
SY   KBET2106i
DR   SKIP; SKIP004380
DR   WiCell; scrp2106i
DR   Wikidata; Q54952526
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2115i
AC   CVCL_JV53
SY   KBET2115i
DR   SKIP; SKIP004379
DR   WiCell; scrp2115i
DR   Wikidata; Q54952527
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   94Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2201i
AC   CVCL_JV54
SY   C00496
DR   SKIP; SKIP003304
DR   WiCell; scrp2201i
DR   Wikidata; Q54952528
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2208i
AC   CVCL_JV55
SY   KBET2208i
DR   SKIP; SKIP004386
DR   WiCell; scrp2208i
DR   Wikidata; Q54952529
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2210i
AC   CVCL_JV56
SY   KBET2210i
DR   SKIP; SKIP004388
DR   WiCell; scrp2210i
DR   Wikidata; Q54952531
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2211i
AC   CVCL_JV57
SY   KBET2211i
DR   SKIP; SKIP004387
DR   WiCell; scrp2211i
DR   Wikidata; Q54952532
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   95Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2305i
AC   CVCL_JV58
SY   KBET2305i
DR   SKIP; SKIP004393
DR   WiCell; scrp2305i
DR   Wikidata; Q54952552
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2306i
AC   CVCL_JV59
SY   C00498
DR   SKIP; SKIP003305
DR   WiCell; scrp2306i
DR   Wikidata; Q54952553
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2307i
AC   CVCL_JV60
SY   KBET2307i
DR   SKIP; SKIP004394
DR   WiCell; scrp2307i
DR   Wikidata; Q54952555
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2310i
AC   CVCL_JV61
SY   KBET2310i
DR   SKIP; SKIP004395
DR   WiCell; scrp2310i
DR   Wikidata; Q54952556
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2407i
AC   CVCL_JV62
SY   KBET2407i
DR   SKIP; SKIP004397
DR   WiCell; scrp2407i
DR   Wikidata; Q54952557
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2409i
AC   CVCL_JV63
SY   KBET2409i
DR   SKIP; SKIP004398
DR   WiCell; scrp2409i
DR   Wikidata; Q54952558
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2411i
AC   CVCL_JV64
SY   KBET2411i
DR   SKIP; SKIP004399
DR   WiCell; scrp2411i
DR   Wikidata; Q54952559
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   100Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2501i
AC   CVCL_JV65
SY   C00510
DR   SKIP; SKIP003306
DR   WiCell; scrp2501i
DR   Wikidata; Q54952561
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2503i
AC   CVCL_JV66
SY   KBET2503i
DR   SKIP; SKIP004405
DR   WiCell; scrp2503i
DR   Wikidata; Q54952562
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2506i
AC   CVCL_JV67
SY   KBET2506i
DR   SKIP; SKIP004407
DR   WiCell; scrp2506i
DR   Wikidata; Q54952563
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2508i
AC   CVCL_JV68
SY   KBET2508i
DR   SKIP; SKIP004406
DR   WiCell; scrp2508i
DR   Wikidata; Q54952565
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2706i
AC   CVCL_JV69
SY   C00519
DR   SKIP; SKIP003308
DR   WiCell; scrp2706i
DR   Wikidata; Q54952567
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP2801i
AC   CVCL_JV70
SY   C00541
DR   SKIP; SKIP003309
DR   WiCell; scrp2801i
DR   Wikidata; Q54952568
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3202i
AC   CVCL_JV71
SY   C00599
DR   SKIP; SKIP003311
DR   WiCell; scrp3202i
DR   Wikidata; Q54952569
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3304i
AC   CVCL_JV72
SY   C00611
DR   SKIP; SKIP003312
DR   WiCell; scrp3304i
DR   Wikidata; Q54952570
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3401i
AC   CVCL_JV73
SY   C00651
DR   SKIP; SKIP003313
DR   WiCell; scrp3401i
DR   Wikidata; Q54952572
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3510i
AC   CVCL_JV74
SY   C00706
DR   SKIP; SKIP003315
DR   WiCell; scrp3510i
DR   Wikidata; Q54952573
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3601i
AC   CVCL_JV75
SY   C00709
DR   SKIP; SKIP003316
DR   WiCell; scrp3601i
DR   Wikidata; Q54952574
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3702i
AC   CVCL_JV76
SY   C00710
DR   SKIP; SKIP003317
DR   WiCell; scrp3702i
DR   Wikidata; Q54952576
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3803i
AC   CVCL_JV77
SY   C00711
DR   SKIP; SKIP003318
DR   WiCell; scrp3803i
DR   Wikidata; Q54952577
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP3901i
AC   CVCL_JV78
SY   C00717
DR   SKIP; SKIP003319
DR   WiCell; scrp3901i
DR   Wikidata; Q54952578
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4102i
AC   CVCL_JV79
SY   C00741
DR   SKIP; SKIP003320
DR   WiCell; scrp4102i
DR   Wikidata; Q54952580
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4201i
AC   CVCL_JV80
SY   C00747
DR   SKIP; SKIP003321
DR   WiCell; scrp4201i
DR   Wikidata; Q54952581
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4203i
AC   CVCL_JV81
SY   KBET4203i
DR   SKIP; SKIP004676
DR   WiCell; scrp4203i
DR   Wikidata; Q54952584
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4301i
AC   CVCL_JV82
SY   C00793
DR   SKIP; SKIP003322
DR   WiCell; scrp4301i
DR   Wikidata; Q54952585
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4305i
AC   CVCL_JV83
SY   KBET4305i
DR   SKIP; SKIP004677
DR   WiCell; scrp4305i
DR   Wikidata; Q54952587
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4403i
AC   CVCL_JV84
SY   KBET4403i
DR   SKIP; SKIP004678
DR   WiCell; scrp4403i
DR   Wikidata; Q54952589
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4406i
AC   CVCL_JV85
SY   C00805
DR   SKIP; SKIP003323
DR   WiCell; scrp4406i
DR   Wikidata; Q54952590
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4502i
AC   CVCL_JV86
SY   C00808
DR   SKIP; SKIP003324
DR   WiCell; scrp4502i
DR   Wikidata; Q54952591
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4505i
AC   CVCL_JV87
SY   KBET4505i
DR   SKIP; SKIP004679
DR   WiCell; scrp4505i
DR   Wikidata; Q54952593
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4602i
AC   CVCL_JV88
SY   KBET4602i
DR   SKIP; SKIP004680
DR   WiCell; scrp4602i
DR   Wikidata; Q54952594
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4603i
AC   CVCL_JV89
SY   C00815
DR   SKIP; SKIP003325
DR   WiCell; scrp4603i
DR   Wikidata; Q54952596
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4703i
AC   CVCL_JV90
SY   C00863
DR   SKIP; SKIP003326
DR   WiCell; scrp4703i
DR   Wikidata; Q54952597
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4803i
AC   CVCL_JV91
SY   C00880
DR   SKIP; SKIP003327
DR   WiCell; scrp4803i
DR   Wikidata; Q54952599
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP4903i
AC   CVCL_JV92
SY   C00890
DR   SKIP; SKIP003328
DR   WiCell; scrp4903i
DR   Wikidata; Q54952600
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP5003i
AC   CVCL_JV93
SY   C00892
DR   SKIP; SKIP003329
DR   WiCell; scrp5003i
DR   Wikidata; Q54952601
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26732; Coronary artery disease
DI   NCIt; C27996; Myocardial infarction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP5402i
AC   CVCL_JV94
SY   HE00003
DR   SKIP; SKIP004376
DR   WiCell; scrp5402i
DR   Wikidata; Q54952603
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP5508i
AC   CVCL_JV95
SY   HE00018
DR   SKIP; SKIP004377
DR   WiCell; scrp5508i
DR   Wikidata; Q54952604
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP5603i
AC   CVCL_JV96
SY   HE00020
DR   SKIP; SKIP004381
DR   WiCell; scrp5603i
DR   Wikidata; Q54952605
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP5707i
AC   CVCL_JV97
SY   HE00043
DR   SKIP; SKIP004382
DR   WiCell; scrp5707i
DR   Wikidata; Q54952607
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP5803i
AC   CVCL_JV98
SY   HE00045
DR   SKIP; SKIP004383
DR   WiCell; scrp5803i
DR   Wikidata; Q54952622
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP6007i
AC   CVCL_JV99
SY   HE00065
DR   SKIP; SKIP004384
DR   WiCell; scrp6007i
DR   Wikidata; Q54952623
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP6101i
AC   CVCL_JW00
SY   HE00083
DR   SKIP; SKIP004385
DR   WiCell; scrp6101i
DR   Wikidata; Q54952625
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP6301i
AC   CVCL_JW01
SY   HE00163
DR   SKIP; SKIP004389
DR   WiCell; scrp6301i
DR   Wikidata; Q54952626
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   95Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP6401i
AC   CVCL_JW02
SY   HE00168
DR   SKIP; SKIP004390
DR   WiCell; scrp6401i
DR   Wikidata; Q54952627
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   92Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP6504i
AC   CVCL_JW03
SY   HE00170
DR   SKIP; SKIP004391
DR   WiCell; scrp6504i
DR   Wikidata; Q54952628
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP6703i
AC   CVCL_JW04
SY   HE00215
DR   SKIP; SKIP004392
DR   WiCell; scrp6703i
DR   Wikidata; Q54952629
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP6904i
AC   CVCL_JW05
SY   HE00487
DR   SKIP; SKIP004396
DR   WiCell; scrp6904i
DR   Wikidata; Q54952631
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP7301i
AC   CVCL_JW06
SY   HE00569
DR   SKIP; SKIP004400
DR   WiCell; scrp7301i
DR   Wikidata; Q54952633
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP7602i
AC   CVCL_JW07
SY   HE00705
DR   SKIP; SKIP004401
DR   WiCell; scrp7602i
DR   Wikidata; Q54952634
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP7803i
AC   CVCL_JW08
SY   HE00750
DR   SKIP; SKIP004402
DR   WiCell; scrp7803i
DR   Wikidata; Q54952636
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP7903i
AC   CVCL_JW09
SY   HE00762
DR   SKIP; SKIP004403
DR   WiCell; scrp7903i
DR   Wikidata; Q54952637
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP8105i
AC   CVCL_JW10
SY   HE00777
DR   SKIP; SKIP004404
DR   WiCell; scrp8105i
DR   Wikidata; Q54952639
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP8305i
AC   CVCL_JW11
SY   HE00812
DR   SKIP; SKIP004408
DR   WiCell; scrp8305i
DR   Wikidata; Q54952640
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP8401i
AC   CVCL_JW12
SY   HE00813
DR   SKIP; SKIP004409
DR   WiCell; scrp8401i
DR   Wikidata; Q54952642
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP8503i
AC   CVCL_JW13
SY   HE00827
DR   SKIP; SKIP004410
DR   WiCell; scrp8503i
DR   Wikidata; Q54952643
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP8601i
AC   CVCL_JW14
SY   HE00832
DR   SKIP; SKIP004411
DR   WiCell; scrp8601i
DR   Wikidata; Q54952645
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP8717i
AC   CVCL_JW15
SY   HE00841
DR   SKIP; SKIP004412
DR   WiCell; scrp8717i
DR   Wikidata; Q54952646
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP8901i
AC   CVCL_JW16
SY   HE00861
DR   SKIP; SKIP004413
DR   WiCell; scrp8901i
DR   Wikidata; Q54952648
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP9001i
AC   CVCL_JW17
SY   HE00870
DR   SKIP; SKIP004414
DR   WiCell; scrp9001i
DR   Wikidata; Q54952649
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP9301i
AC   CVCL_JW18
SY   HE00890
DR   SKIP; SKIP004415
DR   WiCell; scrp9301i
DR   Wikidata; Q54952650
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP9403i
AC   CVCL_JW19
SY   HE00894
DR   SKIP; SKIP004416
DR   WiCell; scrp9403i
DR   Wikidata; Q54952653
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP9501i
AC   CVCL_JW20
SY   HE01020
DR   SKIP; SKIP004417
DR   WiCell; scrp9501i
DR   Wikidata; Q54952654
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP9602i
AC   CVCL_JW21
SY   HE01028
DR   SKIP; SKIP004418
DR   WiCell; scrp9602i
DR   Wikidata; Q54952655
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP9805i
AC   CVCL_JW22
SY   HE01051
DR   SKIP; SKIP004419
DR   WiCell; scrp9805i
DR   Wikidata; Q54952657
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRP9904i
AC   CVCL_JW23
SY   HE01053
DR   SKIP; SKIP004420
DR   WiCell; scrp9904i
DR   Wikidata; Q54952658
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Topol, Eric Jeffrey; The Scripps Research Institute; La Jolla; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   SCRV-G-1B2
AC   CVCL_XY08
DR   CCRID; 4201PAT-CCTCC00285
DR   Wikidata; Q98129432
RX   Patent=CN101503471B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200918.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q06Z36; Siniperca chuatsi rhabdovirus glycoprotein (G).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   SCS214
AC   CVCL_WU91
SY   SCS-214
DR   cancercelllines; CVCL_WU91
DR   Cell_Model_Passport; SIDM01345
DR   DepMap; ACH-001280
DR   Wikidata; Q98129434
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (DepMap=ACH-001280).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Tyr (c.94G>T); ClinVar=VCV000017581; Zygosity=Heterozygous (DepMap=ACH-001280).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   SCSC [Human gingival carcinoma]
AC   CVCL_GZ04
SY   Spindle Cell Squamous Carcinoma
DR   cancercelllines; CVCL_GZ04
DR   IARC_TP53; 24500
DR   Wikidata; Q54952660
RX   PubMed=16918599;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Unspecified (PubMed=16918599).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129289; Gingival spindle cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   SCSC [Siniperca chuatsi]
AC   CVCL_C1D3
SY   Siniperca Chuatsi Skin Cell
DR   Wikidata; Q114312962
RX   PubMed=35762824;
CC   Group: Fish cell line.
CC   Doubling time: ~3 days (PubMed=35762824).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=119488; ! Siniperca chuatsi (Mandarin fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SCSe001-A
AC   CVCL_B863
SY   MEL-1; Mel-1; Mel 1; Mel1; MEL1
DR   BioSamples; SAMEA7783168
DR   GEO; GSM1053949
DR   GEO; GSM1053950
DR   GEO; GSM1053951
DR   hPSCreg; SCSe001-A
DR   Millipore; SCC020
DR   NIHhESC; NIHhESC-11-0139
DR   SKIP; SKIP001931
DR   Wikidata; Q54952661
RX   PubMed=17572666;
RX   PubMed=23225669;
RX   PubMed=28445466;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/mel-1.aspx
CC   From: Monash University; Melbourne; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0139.
CC   Registration: Swiss research registry; BAG-hES-IMP-0003.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-001, Steering comm. appl. SCSC04-35.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Millipore; SCC020; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   SCSe001-A-1
AC   CVCL_VE95
SY   MEL-1 10.2; MCRIe002-A-1
DR   BioSamples; SAMEA4760676
DR   hPSCreg; SCSe001-A-1
DR   Wikidata; Q54952663
RX   PubMed=29499499;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16499; RAB39B.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B863 ! SCSe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 5
//
ID   SCSe001-A-2
AC   CVCL_VE96
SY   MEL-1 30.3; MCRIe002-A-2
DR   BioSamples; SAMEA7782418
DR   hPSCreg; SCSe001-A-2
DR   Wikidata; Q54952664
RX   PubMed=29499499;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16499; RAB39B.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B863 ! SCSe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 5
//
ID   SCSe001-A-3
AC   CVCL_A4WX
SY   Mel1 INS-GFP SST-RFP; CHOPe002-A-3
DR   hPSCreg; SCSe001-A-3
DR   Wikidata; Q107116863
RX   PubMed=33316598;
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in the INS locus and using CRISPR/Cas9 a tandem-dimer RFP was introduced in the SST gene (PubMed=33316598).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA16 ! MEL-1 INSGFP/w
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   SCSe001-A-4
AC   CVCL_C1W6
SY   Mel1 InsGFP/w ARX-/-; Mel1-INS-GFP ARX KO; CHOPe002-A-4
DR   hPSCreg; SCSe001-A-4
DR   Wikidata; Q114312963
CC   From: Children's Hospital of Philadelphia; Philadelphia; USA.
CC   Characteristics: Using homologous recombination an EGFP reporter gene was introduced in the INS locus.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18060; ARX.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XA16 ! MEL-1 INSGFP/w
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SCSe002-A
AC   CVCL_B864
SY   MEL-2; Mel-2; Mel2; MEL2
DR   hPSCreg; SCSe002-A
DR   Millipore; SCC021
DR   NIHhESC; NIHhESC-11-0140
DR   SKIP; SKIP001932
DR   Wikidata; Q54952665
RX   PubMed=17572666;
RX   PubMed=28445466;
CC   From: Monash University; Melbourne; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0140.
CC   Registration: Swiss research registry; BAG-hES-IMP-0002.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-003, Steering comm. appl. SCSC06-22.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: Millipore; SCC021; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   SCSe003-A
AC   CVCL_B865
SY   MEL-3; Mel-3
DR   hPSCreg; SCSe003-A
DR   NIHhESC; NIHhESC-11-0141
DR   SKIP; SKIP002002
DR   Wikidata; Q54952667
RX   PubMed=28445466;
CC   From: Monash University; Melbourne; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0141.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-21.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   SCSe004-A
AC   CVCL_B866
SY   MEL-4; Mel-4
DR   hPSCreg; SCSe004-A
DR   NIHhESC; NIHhESC-11-0142
DR   SKIP; SKIP002003
DR   Wikidata; Q54952668
RX   PubMed=28445466;
CC   From: Monash University; Melbourne; Australia.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0142.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-21.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   ScSFT-1
AC   CVCL_9U50
DR   Wikidata; Q54952671
RX   PubMed=23661087;
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Doubling time: 41.53 hours (PubMed=23661087).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=103600; ! Sousa chinensis (Indo-pacific humpbacked dolphin)
OI   CVCL_9U51 ! ScSFT-2
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   ScSFT-2
AC   CVCL_9U51
DR   Wikidata; Q54952673
RX   PubMed=23661087;
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=103600; ! Sousa chinensis (Indo-pacific humpbacked dolphin)
OI   CVCL_9U50 ! ScSFT-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   SCSV-9
AC   CVCL_C5DI
DR   Wikidata; Q116050484
RX   PubMed=1709732;
CC   Doubling time: 27.1 hours (PubMed=1709732).
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C5DH ! SC 3T3/W
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 4
//
ID   SCT1
AC   CVCL_YL76
SY   Southern Catfish Testis 1
DR   Wikidata; Q98129437
RX   CelloPub=CLPUB00551;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=175797; ! Silurus meridionalis (Southern catfish)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   SCTCi008-A
AC   CVCL_A2YI
SY   IPS17-00095; SCTCi001-A
DR   BioSamples; SAMEA7655096
DR   hPSCreg; SCTCi008-A
DR   Wikidata; Q105510994
RX   PubMed=35078129;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   SCTCi009-A
AC   CVCL_A2YD
SY   IPS17-00097; SCTCi002-A
DR   BioSamples; SAMEA7762097
DR   hPSCreg; SCTCi009-A
DR   Wikidata; Q105510997
RX   PubMed=35078129;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   SCTCi010-A
AC   CVCL_A2YE
SY   IPS17-00041; SCTCi003-A
DR   BioSamples; SAMEA7784069
DR   hPSCreg; SCTCi010-A
DR   Wikidata; Q105511000
RX   PubMed=35078129;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   SCTCi011-A
AC   CVCL_A2YF
SY   IPS18-00072; SCTCi004-A
DR   BioSamples; SAMEA7807651
DR   hPSCreg; SCTCi011-A
DR   Wikidata; Q105511004
RX   PubMed=35063911;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Lys204Thrfs*26 (c.607_610dupCCAA); ClinVar=VCV004291308; Zygosity=Heterozygous (PubMed=35063911).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 8
//
ID   SCTCi012-A
AC   CVCL_A2YG
SY   IPS19-00027; SCTCi005-A
DR   BioSamples; SAMEA7851600
DR   hPSCreg; SCTCi012-A
DR   Wikidata; Q105511005
RX   PubMed=35063911;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Ile184Leufs*33 (c.550delA); ClinVar=VCV004291295; Zygosity=Heterozygous (PubMed=35063911).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 8
//
ID   SCTCi013-A
AC   CVCL_A2YH
SY   IPS19-00053; SCTCi006-A
DR   BioSamples; SAMEA7851607
DR   hPSCreg; SCTCi013-A
DR   Wikidata; Q105511008
RX   PubMed=35063911;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Arg175Gln (c.524G>A); ClinVar=VCV004291293; Zygosity=Heterozygous (PubMed=35063911).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 8
//
ID   SCTCi014-A
AC   CVCL_B5TA
SY   IPS17-00056 clone 1
DR   BioSamples; SAMEA10457738
DR   hPSCreg; SCTCi014-A
DR   Wikidata; Q112044519
RX   PubMed=35526386;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5394; CFI; Simple; p.Gly119Arg (c.355G>A); ClinVar=VCV000066014; Zygosity=Heterozygous (PubMed=35526386).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187704; Age-related macular degeneration-13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCTCi014-A-1
AC   CVCL_C0FT
SY   IPS17-00056 clone O5; IPS17-00056 Crispr clone O5
DR   BioSamples; SAMEA11293804
DR   hPSCreg; SCTCi014-A-1
DR   Wikidata; Q112930352
RX   PubMed=35526386;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5394; CFI; Simple_corrected; p.Gly119Arg (c.355G>A); ClinVar=VCV000066014; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35526386).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187704; Age-related macular degeneration-13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5TA ! SCTCi014-A
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SCTCi015-A
AC   CVCL_B5T9
SY   IPS19-00051 clone 3
DR   BioSamples; SAMEA11357064
DR   hPSCreg; SCTCi015-A
DR   Wikidata; Q112044520
RX   PubMed=35526389;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5394; CFI; Simple; p.Gly119Arg (c.355G>A); ClinVar=VCV000066014; Zygosity=Heterozygous (PubMed=35526389).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187704; Age-related macular degeneration-13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCTCi015-A-1
AC   CVCL_C0FS
SY   IPS19-00051 clone H6; IPS19-00051 Crispr clone H6
DR   BioSamples; SAMEA11350641
DR   hPSCreg; SCTCi015-A-1
DR   Wikidata; Q112930353
RX   PubMed=35526389;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5394; CFI; Simple_corrected; p.Gly119Arg (c.355G>A); ClinVar=VCV000066014; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35526389).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187704; Age-related macular degeneration-13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5T9 ! SCTCi015-A
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SCTCi016-A
AC   CVCL_B5T7
SY   IPS18-00092 clone 1
DR   BioSamples; SAMEA11324664
DR   hPSCreg; SCTCi016-A
DR   Wikidata; Q112044521
RX   PubMed=35121194;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple; c.11+5G>A; ClinVar=VCV000098825; Zygosity=Homozygous (PubMed=35121194).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCTCi017-A
AC   CVCL_B5T6
SY   IPS15-00006
DR   BioSamples; SAMEA11422972
DR   hPSCreg; SCTCi017-A
DR   Wikidata; Q112044522
RX   PubMed=37441824;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Cys1488Arg (c.4462T>C); ClinVar=VCV000099284; Zygosity=Heterozygous (PubMed=37441824).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5196+1137G>A; ClinVar=VCV000438100; Zygosity=Heterozygous (PubMed=37441824).
CC   Derived from site: In situ; Finger, skin; UBERON=UBERON_0003533.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   SCTCi017-A-1
AC   CVCL_C9I3
SY   IPS21-00183; RMCGENi018-A-1
DR   BioSamples; SAMEA113690252
DR   hPSCreg; SCTCi017-A-1
DR   Wikidata; Q123033407
RX   PubMed=37480818;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple_corrected; p.Cys1488Arg (c.4462T>C); ClinVar=VCV000099284; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37480818).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple_corrected; c.5196+1137G>A; ClinVar=VCV000438100; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37480818).
CC   Derived from site: In situ; Finger, skin; UBERON=UBERON_0003533.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5T6 ! SCTCi017-A
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SCTCi018-A
AC   CVCL_B5T8
SY   IPS15-00007
DR   BioSamples; SAMEA11423530
DR   hPSCreg; SCTCi018-A
DR   Wikidata; Q112044523
RX   PubMed=37441824;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.4539+2001G>A; ClinVar=VCV00056042; Zygosity=Heterozygous (PubMed=37441824).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu1631Pro (c.4892T>C); ClinVar=VCV000099328; Zygosity=Heterozygous (PubMed=37441824).
CC   Derived from site: In situ; Finger, skin; UBERON=UBERON_0003533.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   SCTCi018-A-1
AC   CVCL_C9I2
SY   IPS21-00181; RMCGENi019-A-1
DR   BioSamples; SAMEA113716787
DR   hPSCreg; SCTCi018-A-1
DR   Wikidata; Q123033408
RX   PubMed=37480818;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple_corrected; c.4539+2001G>A; ClinVar=VCV00056042; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37480818).
CC   Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple_corrected; p.Leu1631Pro (c.4892T>C); ClinVar=VCV000099328; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37480818).
CC   Derived from site: In situ; Finger, skin; UBERON=UBERON_0003533.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5T8 ! SCTCi018-A
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SCTCi019-A
AC   CVCL_C6SE
SY   IPS21-00081
DR   BioSamples; SAMEA112124172
DR   hPSCreg; SCTCi019-A
DR   Wikidata; Q117704849
RX   PubMed=36947993;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4189; GCDH.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   SCTCi019-B
AC   CVCL_C6SF
SY   IPS21-00080
DR   hPSCreg; SCTCi019-B
DR   Wikidata; Q117704850
RX   PubMed=37540965;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:877; ALDH7A1.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   SCTCi020-A
AC   CVCL_C9I4
SY   IPS17-00028
DR   BioSamples; SAMEA113399616
DR   hPSCreg; SCTCi020-A
DR   Wikidata; Q123033409
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SCTCi021-A
AC   CVCL_C9I5
SY   IPS17-00027
DR   BioSamples; SAMEA113400376
DR   hPSCreg; SCTCi021-A
DR   Wikidata; Q123033410
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SCTCi022-A
AC   CVCL_C9I6
SY   IPS17-00042
DR   BioSamples; SAMEA113400489
DR   hPSCreg; SCTCi022-A
DR   Wikidata; Q123033411
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SCTCi023-A
AC   CVCL_C9I7
SY   IPS17-00063
DR   BioSamples; SAMEA113401290
DR   hPSCreg; SCTCi023-A
DR   Wikidata; Q123033412
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SCTCi024-A
AC   CVCL_C9I8
SY   IPS18-00047
DR   BioSamples; SAMEA113401301
DR   hPSCreg; SCTCi024-A
DR   Wikidata; Q123033413
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SCTCi025-A
AC   CVCL_C9I9
SY   IPS18-00095
DR   BioSamples; SAMEA113401519
DR   hPSCreg; SCTCi025-A
DR   Wikidata; Q123033414
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-4Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SCTCi026-A
AC   CVCL_D6S7
SY   IPS22-00005; LUMC0247iPDE04
DR   BioSamples; SAMEA115712954
DR   hPSCreg; SCTCi026-A
RX   PubMed=38936157;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:877; ALDH7A1; Simple; p.Glu427Gln (c.1279G>C); ClinVar=VCV000017994; Zygosity=Homozygous (PubMed=38936157).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C210888; Early-onset vitamin B6-dependent epilepsy-4
DI   ORDO; Orphanet_3006; Pyridoxine-dependent epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SCTCi027-A
AC   CVCL_E2U2
SY   IPS23-00126; LUMC0250iPDE01
DR   BioSamples; SAMEA115713121
DR   hPSCreg; SCTCi027-A
RX   PubMed=38936157;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:877; ALDH7A1; Simple; p.Glu427Gln (c.1279G>C); ClinVar=VCV000017994; Zygosity=Homozygous (PubMed=38936157).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C210888; Early-onset vitamin B6-dependent epilepsy-4
DI   ORDO; Orphanet_3006; Pyridoxine-dependent epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SCTCi028-A
AC   CVCL_E2U3
SY   IPS22-00007; LUMC0249iPDE02
DR   BioSamples; SAMEA115713635
DR   hPSCreg; SCTCi028-A
RX   PubMed=38936157;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:877; ALDH7A1; Simple; p.Glu427Gln (c.1279G>C); ClinVar=VCV000017994; Zygosity=Homozygous (PubMed=38936157).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C210888; Early-onset vitamin B6-dependent epilepsy-4
DI   ORDO; Orphanet_3006; Pyridoxine-dependent epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SCTCi029-A
AC   CVCL_E2U4
SY   IPS22-00008; LUMC0248iPDE02
DR   BioSamples; SAMEA115713655
DR   hPSCreg; SCTCi029-A
RX   PubMed=38936157;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:877; ALDH7A1; Simple; p.Glu427Gln (c.1279G>C); ClinVar=VCV000017994; Zygosity=Homozygous (PubMed=38936157).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C210888; Early-onset vitamin B6-dependent epilepsy-4
DI   ORDO; Orphanet_3006; Pyridoxine-dependent epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SCTCi030-A
AC   CVCL_E2U6
DR   BioSamples; SAMEA115713658
DR   hPSCreg; SCTCi030-A
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCTCi031-A
AC   CVCL_E2U7
DR   BioSamples; SAMEA115714051
DR   hPSCreg; SCTCi031-A
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCTCi032-A
AC   CVCL_E2U8
DR   BioSamples; SAMEA115714245
DR   hPSCreg; SCTCi032-A
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCTCi033-A
AC   CVCL_E2U9
DR   BioSamples; SAMEA115714247
DR   hPSCreg; SCTCi033-A
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99101; Glutaric acidemia type 1
DI   ORDO; Orphanet_25; Glutaryl-CoA dehydrogenase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCTCi034-A
AC   CVCL_D6S5
SY   iPS21-00085
DR   BioSamples; SAMEA114761061
DR   hPSCreg; SCTCi034-A
RX   PubMed=38739972;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:25412; SGIP1; Simple; c.764dupA; Zygosity=Homozygous (PubMed=38739972).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SCTCi035-A
AC   CVCL_D6S6
SY   iPS22-00044
DR   BioSamples; SAMEA114764214
DR   hPSCreg; SCTCi035-A
RX   PubMed=38739972;
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:25412; SGIP1; Simple; c.74+1G>A; dbSNP=rs1315026372; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=38739972).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SCTCi037-A
AC   CVCL_E2TZ
SY   IPS19-00015
DR   BioSamples; SAMEA115428385
DR   hPSCreg; SCTCi037-A
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCTCi038-A
AC   CVCL_E2U0
SY   IPS19-00085
DR   BioSamples; SAMEA115428387
DR   hPSCreg; SCTCi038-A
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCTCi039-A
AC   CVCL_E2U1
DR   BioSamples; SAMEA115428391
DR   hPSCreg; SCTCi039-A
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-4Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SCTi001-A
AC   CVCL_9S49
SY   STiPS-F016
DR   hPSCreg; SCTi001-A
DR   SKIP; SKIP002594
DR   Wikidata; Q54952674
RX   CelloPub=CLPUB00425;
CC   From: STEMCELL Technologies, Inc.; Vancouver; Canada.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   SCTi002-A
AC   CVCL_9S50
SY   STiPS-M001
DR   hPSCreg; SCTi002-A
DR   SKIP; SKIP002595
DR   Wikidata; Q54952676
RX   CelloPub=CLPUB00425;
CC   From: STEMCELL Technologies, Inc.; Vancouver; Canada.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   SCTi003-A
AC   CVCL_C1W7
DR   BioSamples; SAMEA11358265
DR   hPSCreg; SCTi003-A
DR   Wikidata; Q114312964
WW   Provider; STEMCELL; 200-0511; https://www.stemcell.com/products/healthy-control-human-ipsc-line-female-scti003-a.html
CC   From: STEMCELL Technologies, Inc.; Vancouver; Canada.
CC   Population: Caucasian and South Asian.
CC   HLA typing: A*24:02:01,26:01:01; B*07:02:01; C*07:02:01; DPB1*02:01:02,04:01:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (STEMCELL=200-0511).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): STEMCELL
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15,17
ST   D21S11: 27,29
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 26
ST   Penta D: 12,14
ST   Penta E: 8,17
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SCTi004-A
AC   CVCL_E2TY
DR   BioSamples; SAMEA115048409
DR   hPSCreg; SCTi004-A
WW   Provider; STEMCELL; 200-0769; https://www.stemcell.com/product-portfolios/human-pluripotent-stem-cell-research/maintenance/healthy-control-human-ipsc-line-male-scti004-a.html
CC   From: STEMCELL Technologies, Inc.; Vancouver; Canada.
CC   Population: African American.
CC   HLA typing: A*34:02:01; B*44:03:02,52:01:02; C*07:01:01,16:01:01; DPB1*01:01:01,04:02:01; DQB1*02:01:01,05:01:01; DRB1*13:01:01,13:03:01; DRB3*01:01:02,02:02:01 (STEMCELL=200-0769).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): STEMCELL
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 15
ST   D21S11: 28,30
ST   D5S818: 8,10
ST   D7S820: 11,13
ST   D8S1179: 14,15
ST   FGA: 19,24
ST   Penta D: 9,11
ST   Penta E: 8,14
ST   TPOX: 11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   SCVI-111
AC   CVCL_C6U9
SY   SCVI 111; SCVI111
DR   Wikidata; Q117704851
RX   PubMed=32619518;
RX   PubMed=33615277;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVI-112
AC   CVCL_A8QD
SY   SCVI 112; SCVI112; BIHi049-A
DR   BioSamples; SAMEA115121822
DR   hPSCreg; BIHi049-A
DR   Wikidata; Q108821275
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   SCVI-113
AC   CVCL_A8QC
SY   SCVI 113; SCVI113; BIHi050-A
DR   BioSample; SAMN09534211
DR   hPSCreg; BIHi050-A
DR   Wikidata; Q108821276
RX   PubMed=30241615;
RX   PubMed=32619518;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SCVI-114
AC   CVCL_A5FZ
SY   SCVI 114; SCVI114
DR   Wikidata; Q107116864
RX   PubMed=28246128;
RX   PubMed=33615277;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SCVI-116
AC   CVCL_C6U8
SY   SCVI 116; SCVI116
DR   Wikidata; Q117704852
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVI-15
AC   CVCL_A5GB
SY   SCVI 15; SCVI15
DR   Wikidata; Q107116865
RX   PubMed=28246128;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SCVI-19
AC   CVCL_A5GA
SY   SCVI 19; SCVI19
DR   Wikidata; Q107116866
RX   PubMed=28246128;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SCVI-202
AC   CVCL_C6UA
SY   SCVI 202; SCVI202
DR   Wikidata; Q117704853
RX   PubMed=32619518;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVI-273
AC   CVCL_A5GC
SY   SCVI 273; SCVI273
DR   Wikidata; Q107116867
RX   PubMed=32619518;
RX   PubMed=32981093;
RX   PubMed=33615277;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SCVI-34
AC   CVCL_C6UB
SY   SCVI 34; SCVI34
DR   Wikidata; Q117704854
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVIi001-A
AC   CVCL_A5FU
SY   SCVI-550; SCVI 550; SCVI550
DR   BioSamples; SAMEA7996634
DR   hPSCreg; SCVIi001-A
DR   Wikidata; Q107116869
RX   PubMed=33743363;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.3330+2T>G; ClinVar=VCV000008621; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33743363).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi002-A
AC   CVCL_A5FV
SY   SCVI-591; SCVI 591; SCVI591
DR   hPSCreg; SCVIi002-A
DR   Wikidata; Q107116870
RX   PubMed=33743363;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.3330+2T>G; ClinVar=VCV000008621; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33743363).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi003-A
AC   CVCL_A5FW
SY   SCVI-385; SCVI 385; SCVI385
DR   hPSCreg; SCVIi003-A
DR   Wikidata; Q107116871
RX   PubMed=33743362;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.His733Alafs*8 (c.2197_2202delinsG) (p.His689fs, c.2065_2070delinsG); ClinVar=VCV000045063; Zygosity=Heterozygous (PubMed=33743362).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi004-A
AC   CVCL_A5FX
SY   SCVI-410; SCVI 410; SCVI410
DR   hPSCreg; SCVIi004-A
DR   Wikidata; Q107116872
RX   PubMed=33743362;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Arg79Ter (c.235C>T); ClinVar=VCV000006754; Zygosity=Heterozygous (PubMed=33743362).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi005-A
AC   CVCL_A5FY
SY   SCVI-740; SCVI 740; SCVI740
DR   hPSCreg; SCVIi005-A
DR   Wikidata; Q107116873
RX   PubMed=33743362;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Arg577Aspfs*5 (c.1725_1728dupGATG); ClinVar=VCV000406551; Zygosity=Heterozygous (PubMed=33743362).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi006-A
AC   CVCL_A7KL
SY   SCVI-211; SCVI 211; SCVI211
DR   hPSCreg; SCVIi006-A
DR   Wikidata; Q107116874
RX   PubMed=34352619;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Glu1356Lys (c.4066G>A); ClinVar=VCV000164294; Zygosity=Heterozygous (PubMed=34352619).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi007-A
AC   CVCL_A7KM
SY   SCVI-216; SCVI 216; SCVI216
DR   hPSCreg; SCVIi007-A
DR   Wikidata; Q107116875
RX   PubMed=34352619;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg1712Gln (c.5135G>A); ClinVar=VCV000036642; Zygosity=Heterozygous (PubMed=34352619).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi008-A
AC   CVCL_A7KN
SY   SCVI-333; SCVI 333; SCVI333
DR   hPSCreg; SCVIi008-A
DR   Wikidata; Q107116876
RX   PubMed=34352619;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg723Cys (c.2167C>T); ClinVar=VCV000014095; Zygosity=Heterozygous (PubMed=34352619).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi009-A
AC   CVCL_A7KP
SY   SCVI-2177; SCVI 2177; SCVI2177
DR   hPSCreg; SCVIi009-A
DR   Wikidata; Q107116877
RX   PubMed=34051449;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Gly572Ser (c.1714G>A); ClinVar=VCV000067248; Zygosity=Heterozygous (PubMed=34051449).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi010-A
AC   CVCL_A7KQ
SY   SCVI-2182; SCVI 2182; SCVI2182
DR   hPSCreg; SCVIi010-A
DR   Wikidata; Q107116878
RX   PubMed=34051449;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Ser624Cys (c.1870A>T); ClinVar=VCV000644725; Zygosity=Heterozygous (PubMed=34051449).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi011-A
AC   CVCL_A7KR
SY   SCVI-2237; SCVI 2237; SCVI2237
DR   hPSCreg; SCVIi011-A
DR   Wikidata; Q107116879
RX   PubMed=34051449;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Leu987Argfs*70 (c.2960delT); ClinVar=VCV000943648; Zygosity=Heterozygous (PubMed=34051449).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi012-A
AC   CVCL_A8NF
SY   SCVI-815; SCVI 815; SCVI815
DR   hPSCreg; SCVIi012-A
DR   Wikidata; Q108821277
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SCVIi013-A
AC   CVCL_A8NG
SY   SCVI-394; SCVI 394; SCVI394
DR   hPSCreg; SCVIi013-A
DR   Wikidata; Q108821278
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SCVIi014-A
AC   CVCL_A9AI
SY   SCVI-253; SCVI 253; SCVI253
DR   BioSamples; SAMEA9082265
DR   hPSCreg; SCVIi014-A
DR   Wikidata; Q108821279
RX   PubMed=34411974;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg190Gln (c.569G>A) (p.Arg63Gln, c.188G>A); ClinVar=VCV000003117; Zygosity=Heterozygous (PubMed=34411974).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34411974
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D19S433: 13.2,15.2
ST   D21S11: 30.2,32
ST   D2S1338: 20,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,16
ST   FGA: 25,26
ST   TH01: 7,10
ST   TPOX: 7,8
ST   vWA: 15,17
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi015-A
AC   CVCL_A9AJ
SY   SCVI-255; SCVI 255; SCVI255
DR   hPSCreg; SCVIi015-A
DR   Wikidata; Q108821280
RX   PubMed=34411974;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Lys196Serfs*41 (c.585delG) (p.Lys69Serfs*41, c.204delG); ClinVar=VCV000053076; Zygosity=Heterozygous (PubMed=34411974).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34411974
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 15
ST   D21S11: 28,29
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi016-A
AC   CVCL_A9AK
SY   SCVI-750; SCVI 750; SCVI750
DR   hPSCreg; SCVIi016-A
DR   Wikidata; Q108821281
RX   PubMed=34411974;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg192Cysfs*91 (c.573_577delGCGCT) (p.Arg65Cysfs*91, c.192_196delGCGCT); ClinVar=VCV000053072; Zygosity=Heterozygous (PubMed=34411974).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34411974
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 12,14.2
ST   D19S433: 14,15
ST   D21S11: 29,33.2
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi017-A
AC   CVCL_B0PJ
SY   SCVI-239; SCVI 239; SCVI239
DR   hPSCreg; SCVIi017-A
DR   Wikidata; Q108821282
RX   PubMed=34798544;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11947; TNNI3; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000012426; Zygosity=Heterozygous (PubMed=34798544).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C184989; Familial hypertrophic cardiomyopathy type 7
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi018-A
AC   CVCL_B0PK
SY   SCVI-433; SCVI 433; SCVI433
DR   hPSCreg; SCVIi018-A
DR   Wikidata; Q108821283
RX   PubMed=34798544;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11947; TNNI3; Simple; p.Arg204Cys (c.610C>T); ClinVar=VCV000177631; Zygosity=Heterozygous (PubMed=34798544).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C184989; Familial hypertrophic cardiomyopathy type 7
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi019-A
AC   CVCL_B0PL
SY   SCVI-744; SCVI 744; SCVI744
DR   hPSCreg; SCVIi019-A
DR   Wikidata; Q108821284
RX   PubMed=34798544;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11947; TNNI3; Simple; p.Arg79Cys (c.235C>T); ClinVar=VCV000043367; Zygosity=Heterozygous (PubMed=34798544).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C184989; Familial hypertrophic cardiomyopathy type 7
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi020-A
AC   CVCL_B5FR
SY   SCVI-466; SCVI 466; SCVI466
DR   hPSCreg; SCVIi020-A
DR   Wikidata; Q110433205
RX   PubMed=34954454;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000048031; Zygosity=Heterozygous (PubMed=34954454).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi021-A
AC   CVCL_B5FS
SY   SCVI-741; SCVI 741; SCVI741
DR   hPSCreg; SCVIi021-A
DR   Wikidata; Q110433206
RX   PubMed=34954454;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000048031; Zygosity=Heterozygous (PubMed=34954454).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi022-A
AC   CVCL_B5FT
SY   SCVI-973; SCVI 973; SCVI973
DR   hPSCreg; SCVIi022-A
DR   Wikidata; Q110433207
RX   PubMed=34954454;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Native American.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000048031; Zygosity=Heterozygous (PubMed=34954454).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi023-A
AC   CVCL_B5FU
SY   SCVI-2352; SCVI 2352; SCVI2352
DR   hPSCreg; SCVIi023-A
DR   Wikidata; Q110433208
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SCVIi024-A
AC   CVCL_B5FQ
SY   SCVI-2370; SCVI 2370; SCVI2370
DR   hPSCreg; SCVIi024-A
DR   Wikidata; Q110433210
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SCVIi025-A
AC   CVCL_B5FP
SY   SCVI-2400; SCVI 2400; SCVI2400
DR   hPSCreg; SCVIi025-A
DR   Wikidata; Q110433211
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SCVIi026-A
AC   CVCL_B5FM
DR   hPSCreg; SCVIi026-A
DR   Wikidata; Q110433212
RX   PubMed=34856468;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Glu1784Lys (c.5350G>A) (p.Glu1783Lys, c.5347G>A); ClinVar=VCV000009377; Zygosity=Heterozygous (PubMed=34856468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34856468
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 14,17
ST   D19S433: 12,13
ST   D21S11: 28.2,29.2
ST   D2S1338: 18,25
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 19,21
ST   TH01: 8
ST   TPOX: 7,10
ST   vWA: 14,17
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi027-A
AC   CVCL_B5FN
DR   hPSCreg; SCVIi027-A
DR   Wikidata; Q110433213
RX   PubMed=34856468;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Pro701Leu (c.2102C>T); ClinVar=VCV000067713; Zygosity=Heterozygous (PubMed=34856468).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34856468
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 18,20
ST   D19S433: 12,13
ST   D21S11: 27,29.2
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 19,25
ST   TH01: 6
ST   TPOX: 10
ST   vWA: 16
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SCVIi028-A
AC   CVCL_C0EW
SY   SCVi-15S
DR   hPSCreg; SCVIi028-A
DR   Wikidata; Q112930354
RX   PubMed=34875545;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi028-A-1
AC   CVCL_C0EX
SY   SCVi-15S-PE2
DR   hPSCreg; SCVIi028-A-1
DR   Wikidata; Q112930355
RX   PubMed=34875545;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Characteristics: Dox-inducible expression of the prime editor protein (PE2) which is a fusion between the S.pyogenes Cas9(H840A) and an engineered Moloney murine leukemia virus (MMLV) reverse transcriptase domain. PE2 enables gene editing at potentially any locus in the genome by transfecting a pegRNA specific for the desired target locus (PubMed=34875545).
CC   Characteristics: Using CRISPR/Cas9 a T2A-Neo-CAG-rtTA-BFP-P2A-PE2-TRE3G construct has been inserted at the AAVS1 safe harbor locus (PubMed=34875545).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; SDS4K; BFP (Note=Blue fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.His840Ala).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0EW ! SCVIi028-A
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   SCVIi030-A
AC   CVCL_B7DZ
DR   BioSamples; SAMEA13252311
DR   hPSCreg; SCVIi030-A
DR   Wikidata; Q112930356
RX   PubMed=35700631;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35700631).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi031-A
AC   CVCL_B7DY
DR   BioSamples; SAMEA13252408
DR   hPSCreg; SCVIi031-A
DR   Wikidata; Q112930357
RX   PubMed=35700631;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35700631).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi032-A
AC   CVCL_B7A3
SY   SCVI-944; SCVI 944; SCVI944
DR   BioSamples; SAMEA10299209
DR   hPSCreg; SCVIi032-A
DR   Wikidata; Q112044524
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   SCVIi033-A
AC   CVCL_B7A2
SY   SCVI-962; SCVI 962; SCVI962
DR   BioSamples; SAMEA10299211
DR   hPSCreg; SCVIi033-A
DR   Wikidata; Q112044525
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   SCVIi034-A
AC   CVCL_B7A0
SY   SCVI-989; SCVI 989; SCVI989
DR   BioSamples; SAMEA10299213
DR   hPSCreg; SCVIi034-A
DR   Wikidata; Q112044526
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   SCVIi035-A
AC   CVCL_B6ZZ
SY   SCVI-991; SCVI 991; SCVI991
DR   BioSamples; SAMEA10299215
DR   hPSCreg; SCVIi035-A
DR   Wikidata; Q112044527
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   SCVIi036-A
AC   CVCL_B6ZY
SY   SCVI-248; SCVI 248; SCVI248
DR   BioSamples; SAMEA13128358
DR   hPSCreg; SCVIi036-A
DR   Wikidata; Q112044528
RX   PubMed=35413566;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Southeast Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Ile154Leufs*5 (c.459delC); ClinVar=VCV000042755; Zygosity=Heterozygous (PubMed=35413566).
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Thr568Met (c.1703C>T); ClinVar=VCV000181464; Zygosity=Heterozygous (PubMed=35413566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi037-A
AC   CVCL_B7A1
SY   SCVI-672; SCVI 672; SCVI672
DR   BioSamples; SAMEA13252309
DR   hPSCreg; SCVIi037-A
DR   Wikidata; Q112044529
RX   PubMed=35413566;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Southeast Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Ile154Leufs*5 (c.459delC); ClinVar=VCV000042755; Zygosity=Heterozygous (PubMed=35413566).
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Thr568Met (c.1703C>T); ClinVar=VCV000181464; Zygosity=Heterozygous (PubMed=35413566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi038-A
AC   CVCL_C0J0
SY   AICS-0052-003-iKRABdCas9; ipsc WTC-my17 KRAB-mcherry clone 1
DR   hPSCreg; SCVIi038-A
DR   Wikidata; Q112930358
RX   PubMed=35325819;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 a doxycycline-inducible dCas9-KRAB-mCherry cassette was introduced in both alleles of the AAVS1 safe harbor locus (PubMed=35325819).
CC   Characteristics: Using CRISPR/Cas9 MYL7 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UD15 ! WTC-mEGFP-MYL7-cl3
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   SCVIi039-A
AC   CVCL_B5Q1
SY   302
DR   hPSCreg; SCVIi039-A
DR   Wikidata; Q112044530
RX   PubMed=34999423;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Gln (c.398G>A); ClinVar=VCV000200934; Zygosity=Heterozygous (PubMed=34999423).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi040-A
AC   CVCL_B5Q2
DR   hPSCreg; SCVIi040-A
DR   Wikidata; Q112044532
RX   PubMed=34999423;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Gln (c.398G>A); ClinVar=VCV000200934; Zygosity=Heterozygous (PubMed=34999423).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi041-A
AC   CVCL_B5Q3
DR   hPSCreg; SCVIi041-A
DR   Wikidata; Q112044533
RX   PubMed=34999423;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Gln (c.398G>A); ClinVar=VCV000200934; Zygosity=Heterozygous (PubMed=34999423).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi042-A
AC   CVCL_B7SK
SY   SCVI-435; SCVI 435; SCVI435
DR   hPSCreg; SCVIi042-A
DR   Wikidata; Q112930359
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi043-A
AC   CVCL_B7SL
SY   SCVI-596; SCVI 596; SCVI596
DR   hPSCreg; SCVIi043-A
DR   Wikidata; Q112930360
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi044-A
AC   CVCL_B7SM
SY   SCVI-2012; SCVI 2012; SCVI2012
DR   hPSCreg; SCVIi044-A
DR   Wikidata; Q112930361
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi045-A
AC   CVCL_B7SN
SY   SCVI-503; SCVI 503; SCVI503
DR   hPSCreg; SCVIi045-A
DR   Wikidata; Q112930362
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi046-A
AC   CVCL_B7SP
SY   SCVI-2379; SCVI 2379; SCVI2379
DR   hPSCreg; SCVIi046-A
DR   Wikidata; Q112930363
RX   PubMed=36270069;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Pacific.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   SCVIi047-A
AC   CVCL_B7SQ
SY   SCVI-212; SCVI 212; SCVI212
DR   hPSCreg; SCVIi047-A
DR   Wikidata; Q112930364
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi048-A
AC   CVCL_B7SR
SY   SCVI-457; SCVI 457; SCVI457
DR   hPSCreg; SCVIi048-A
DR   Wikidata; Q112930365
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi049-A
AC   CVCL_B7SI
SY   SCVI-104; SCVI 104; SCVI104
DR   BioSamples; SAMEA14322389
DR   hPSCreg; SCVIi049-A
DR   Wikidata; Q112930366
RX   PubMed=35853412;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg9Cys (c.25C>T); ClinVar=VCV000013636; Zygosity=Heterozygous (PubMed=35853412).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi050-A
AC   CVCL_B7SJ
SY   SCVI-2486; SCVI 2486; SCVI2486
DR   BioSamples; SAMEA14322390
DR   hPSCreg; SCVIi050-A
DR   Wikidata; Q112930367
RX   PubMed=35853412;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35853412).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi051-A
AC   CVCL_C1RY
SY   477
DR   BioSamples; SAMEA114857235
DR   hPSCreg; SCVIi051-A
DR   Wikidata; Q114312965
RX   PubMed=38359472;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   SCVIi052-A
AC   CVCL_C1RZ
SY   480
DR   hPSCreg; SCVIi052-A
DR   Wikidata; Q114312966
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   SCVIi053-A
AC   CVCL_C1S0
SY   2021
DR   BioSamples; SAMEA114857237
DR   hPSCreg; SCVIi053-A
DR   Wikidata; Q114312967
RX   PubMed=38359472;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   SCVIi054-A
AC   CVCL_C1S1
SY   2028
DR   hPSCreg; SCVIi054-A
DR   Wikidata; Q114312968
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   SCVIi055-A
AC   CVCL_C1S2
SY   SCVI-868; SCVI 868; SCVI868
DR   BioSamples; SAMEA111533742
DR   hPSCreg; SCVIi055-A
DR   Wikidata; Q114312969
RX   PubMed=36427473;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi056-A
AC   CVCL_C1S3
SY   SCVI-956; SCVI 956; SCVI956
DR   BioSamples; SAMEA111533744
DR   hPSCreg; SCVIi056-A
DR   Wikidata; Q114312970
RX   PubMed=36427473;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi057-A
AC   CVCL_C1S4
SY   SCVI-975; SCVI 975; SCVI975
DR   BioSamples; SAMEA111533746
DR   hPSCreg; SCVIi057-A
DR   Wikidata; Q114312971
RX   PubMed=36427473;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi058-A
AC   CVCL_C1S5
SY   SCVI-2211; SCVI 2211; SCVI2211
DR   hPSCreg; SCVIi058-A
DR   Wikidata; Q114312972
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SCVIi059-A
AC   CVCL_C1S6
SY   SCVIi2413
DR   BioSamples; SAMEA110696402
DR   hPSCreg; SCVIi059-A
DR   Wikidata; Q114312973
RX   PubMed=36194907;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Arg2230His (c.6689G>A); ClinVar=VCV000567146; Zygosity=Heterozygous (PubMed=36194907).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SCVIi060-A
AC   CVCL_C1S7
SY   SCVi2506
DR   BioSamples; SAMEA110696403
DR   hPSCreg; SCVIi060-A
DR   Wikidata; Q114312974
RX   PubMed=36194907;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Asp1249Asn (c.3745G>A); ClinVar=VCV000539405; Zygosity=Heterozygous (PubMed=36194907).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SCVIi061-A
AC   CVCL_C1S8
SY   SCVI2149C1
DR   BioSamples; SAMEA110250528
DR   hPSCreg; SCVIi061-A
DR   Wikidata; Q114312975
RX   PubMed=36528013;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11167; SNTA1; Simple; p.Glu363Ala (c.1088A>C); ClinVar=VCV000190918; Zygosity=Heterozygous (PubMed=36528013).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192202; Long QT syndrome 12
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi062-A
AC   CVCL_C1S9
SY   SCVI2150c1
DR   BioSamples; SAMEA110266499
DR   hPSCreg; SCVIi062-A
DR   Wikidata; Q114312976
RX   PubMed=36528013;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11167; SNTA1; Simple; p.Glu363Ala (c.1088A>C); ClinVar=VCV000190918; Zygosity=Heterozygous (PubMed=36528013).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192202; Long QT syndrome 12
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi063-A
AC   CVCL_C1SA
SY   SCVI-2020; SCVI 2020; SCVI2020; SCVIi2020
DR   hPSCreg; SCVIi063-A
DR   Wikidata; Q114312977
RX   PubMed=36332467;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16882; HCN4; Simple; p.Ala863Ser (c.2587G>T); ClinVar=VCV000573236; Zygosity=Heterozygous (PubMed=36332467).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi064-A
AC   CVCL_C1SB
SY   SCVI-2234; SCVI 2234; SCVI2234; SCVIi2234
DR   hPSCreg; SCVIi064-A
DR   Wikidata; Q114312978
RX   PubMed=36332467;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16882; HCN4; Simple; p.Arg949Gln (c.2846G>A); ClinVar=VCV000933551; Zygosity=Heterozygous (PubMed=36332467).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SCVIi065-A
AC   CVCL_C1SC
DR   hPSCreg; SCVIi065-A
DR   Wikidata; Q114312979
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   SCVIi066-A
AC   CVCL_C1SD
SY   SCVI-2047; SCVI 2047; SCVI2047
DR   BioSamples; SAMEA110424193
DR   hPSCreg; SCVIi066-A
DR   Wikidata; Q114312980
RX   PubMed=37788558;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Val50Met (c.148G>A) (V30M); dbSNP=rs28933979; Zygosity=Heterozygous (PubMed=37788558).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SCVIi067-A
AC   CVCL_C1SE
SY   SCVI-2742; SCVI 2742; SCVI2742
DR   BioSamples; SAMEA110424195
DR   hPSCreg; SCVIi067-A
DR   Wikidata; Q114312981
RX   PubMed=37788558;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Val50Met (c.148G>A) (V30M); dbSNP=rs28933979; Zygosity=Heterozygous (PubMed=37788558).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_85447; ATTRV30M amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SCVIi068-A
AC   CVCL_C4N4
SY   SCVI-715; SCVI 715; SCVI715
DR   hPSCreg; SCVIi068-A
DR   Wikidata; Q116050486
RX   PubMed=36270069;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Arg31606Ter (c.94816C>T); ClinVar=VCV000404748; Zygosity=Heterozygous (PubMed=36270069).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   SCVIi069-A
AC   CVCL_C6SG
SY   SCVI-2445; SCVI 2445; SCVI2445
DR   BioSamples; SAMEA111500288
DR   hPSCreg; SCVIi069-A
DR   Wikidata; Q117704855
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVIi070-A
AC   CVCL_C6SH
SY   SCVI-2471; SCVI 2471; SCVI2471
DR   hPSCreg; SCVIi070-A
DR   Wikidata; Q117704856
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVIi071-A
AC   CVCL_C6SI
SY   SCVI-529; SCVI 529; SCVI529
DR   hPSCreg; SCVIi071-A
DR   Wikidata; Q117704857
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVIi072-A
AC   CVCL_C6SJ
SY   SCVI-824; SCVI 824; SCVI824
DR   hPSCreg; SCVIi072-A
DR   Wikidata; Q117704858
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SCVIi073-A
AC   CVCL_C6SK
SY   SCVIi574C2
DR   BioSamples; SAMEA112228227
DR   hPSCreg; SCVIi073-A
DR   Wikidata; Q117704859
RX   PubMed=36642055;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple; p.Tyr233Ter (c.699C>A); ClinVar=VCV000234982; Zygosity=Homozygous (PubMed=36642055).
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple; p.Ala262Thr (c.784G>A); ClinVar=VCV000234983; Zygosity=Heterozygous (PubMed=36642055).
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Leu3729Thrfs*9 (c.11183dupG) (p.Leu3557Thrfs*9, c.10670dupG); ClinVar=VCV000202507; Zygosity=Heterozygous (hPSCreg=SCVIi073-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192082; Dilated cardiomyopathy-1HH
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SCVIi074-A
AC   CVCL_C6SL
SY   SCVIi599C1
DR   BioSamples; SAMEA112228228
DR   hPSCreg; SCVIi074-A
DR   Wikidata; Q117704860
RX   PubMed=36642055;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple; p.Ser185Leu (c.554C>T); ClinVar=VCV000180282; Zygosity=Heterozygous (PubMed=36642055).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192082; Dilated cardiomyopathy-1HH
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   SCVIi075-A
AC   CVCL_C7YD
SY   SCVIi075A; SCVi075A
DR   BioSamples; SAMEA112288082
DR   hPSCreg; SCVIi075-A
DR   Wikidata; Q123033415
RX   PubMed=37087898;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7del; Zygosity=Homozygous (PubMed=37087898).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi076-A
AC   CVCL_C7YE
SY   SCVIi076A; SCVi076A
DR   BioSamples; SAMEA112288085
DR   hPSCreg; SCVIi076-A
DR   Wikidata; Q123033416
RX   PubMed=37087898;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7del; Zygosity=Homozygous (PubMed=37087898).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi077-A
AC   CVCL_C7YF
DR   BioSamples; SAMEA114260323
DR   hPSCreg; SCVIi077-A
DR   Wikidata; Q123033417
RX   PubMed=37210947;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Lys34Gln (c.100A>C); ClinVar=VCV000235050; Zygosity=Heterozygous (PubMed=37210947).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi078-A
AC   CVCL_C7YG
DR   BioSamples; SAMEA114260510
DR   hPSCreg; SCVIi078-A
DR   Wikidata; Q123033418
RX   PubMed=37210947;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Cys361Tyr (c.1082G>A); ClinVar=VCV000201208; Zygosity=Heterozygous (PubMed=37210947).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi079-A
AC   CVCL_C7YH
SY   SCVI-167; SCVI 167; SCVI167; PHBI-ST-036
DR   BioSamples; SAMEA114071410
DR   hPSCreg; SCVIi079-A
DR   Wikidata; Q123033419
RX   PubMed=37804546;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   SCVIi080-A
AC   CVCL_C7YI
SY   SCVI-171; SCVI 171; SCVI171; PHBI-ST-040
DR   BioSamples; SAMEA114071485
DR   hPSCreg; SCVIi080-A
DR   Wikidata; Q123033420
RX   PubMed=37804546;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   SCVIi081-A
AC   CVCL_D0L1
SY   SCVI-2535; SCVI 2535; SCVI2535
DR   BioSamples; SAMEA113429116
DR   hPSCreg; SCVIi081-A
DR   Wikidata; Q123033421
RX   PubMed=37816281;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asp2723His (c.8167G>C) (8395G>C); ClinVar=VCV000052515; Zygosity=Heterozygous (PubMed=37816281).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   SCVIi082-A
AC   CVCL_D0L2
SY   SCVI-2838; SCVI 2838; SCVI2838
DR   BioSamples; SAMEA113436892
DR   hPSCreg; SCVIi082-A
DR   Wikidata; Q123033423
RX   PubMed=37816281;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Asn528Thrfs*30 (c.1583delA) (1811delA); ClinVar=VCV001190132; Zygosity=Heterozygous (PubMed=37816281).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   SCVIi083-A
AC   CVCL_D0L3
SY   SCVI-2655; SCVI 2655; SCVI2655
DR   BioSamples; SAMEA113437166
DR   hPSCreg; SCVIi083-A
DR   Wikidata; Q123033424
RX   PubMed=37951143;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro1382Serfs*6 (c.4143dupT); ClinVar=VCV000181880; Zygosity=Heterozygous (PubMed=37951143).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206118; Non-BRCA hereditary breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   SCVIi084-A
AC   CVCL_D0L4
SY   SCVI-2591; SCVI 2591; SCVI2591
DR   BioSamples; SAMEA113437296
DR   hPSCreg; SCVIi084-A
DR   Wikidata; Q123033425
RX   PubMed=37951143;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Cys1899Ter (c.5697C>A); ClinVar=VCV000421488; Zygosity=Heterozygous (PubMed=37951143).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206118; Non-BRCA hereditary breast carcinoma
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   SCVIi085-A
AC   CVCL_D0L5
DR   BioSamples; SAMEA114242733
DR   hPSCreg; SCVIi085-A
DR   Wikidata; Q123033427
RX   PubMed=37734318;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: South Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SCVIi086-A
AC   CVCL_D0L6
DR   BioSamples; SAMEA114242735
DR   hPSCreg; SCVIi086-A
DR   Wikidata; Q123033428
RX   PubMed=37734318;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SCVIi087-A
AC   CVCL_D0L7
SY   SCVIi-087A
DR   BioSamples; SAMEA114260324
DR   hPSCreg; SCVIi087-A
DR   Wikidata; Q123033429
RX   PubMed=37740996;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex51del; Zygosity=Hemizygous (PubMed=37740996).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SCVIi088-A
AC   CVCL_D0L8
SY   SCVIi-088A
DR   BioSamples; SAMEA114260508
DR   hPSCreg; SCVIi088-A
DR   Wikidata; Q123033430
RX   PubMed=37740996;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Arg3391Ter (c.10171C>T); ClinVar=VCV000094428; Zygosity=Hemizygous (PubMed=37740996).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SCVIi089-A
AC   CVCL_D0L9
DR   hPSCreg; SCVIi089-A
DR   Wikidata; Q123033432
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SCVIi090-A
AC   CVCL_D0LA
DR   hPSCreg; SCVIi090-A
DR   Wikidata; Q123033433
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SCVIi091-A
AC   CVCL_D0LB
SY   SCVI-2617; SCVI 2617; SCVI2617
DR   BioSamples; SAMEA113567256
DR   hPSCreg; SCVIi091-A
DR   Wikidata; Q123033434
RX   PubMed=38100909;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Ala117Ser (c.349G>T); ClinVar=VCV000013468; Zygosity=Heterozygous (PubMed=38100909).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi092-A
AC   CVCL_D0LC
SY   SCVI-2628; SCVI 2628; SCVI2628
DR   BioSamples; SAMEA113567258
DR   hPSCreg; SCVIi092-A
DR   Wikidata; Q123033436
RX   PubMed=38100909;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12405; TTR; Simple; p.Phe84Leu (c.250T>C); ClinVar=VCV000013453; Zygosity=Heterozygous (PubMed=38100909).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165489; Hereditary transthyretin amyloid cardiomyopathy
DI   ORDO; Orphanet_271861; Hereditary ATTR amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi094-A
AC   CVCL_D0LD
SY   SCVI2189C1
DR   hPSCreg; SCVIi094-A
DR   Wikidata; Q123033437
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SCVIi095-A
AC   CVCL_D0LE
SY   SCVI2194C1
DR   hPSCreg; SCVIi095-A
DR   Wikidata; Q123033438
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SCVIi096-A
AC   CVCL_D0LF
SY   SCVI-675fs1
DR   BioSamples; SAMEA114192552
DR   hPSCreg; SCVIi096-A
DR   Wikidata; Q123033439
RX   PubMed=37944352;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:17574; ALPK3; Simple; p.Gln675Serfs (c.2023delC) (p.Gln473Serfs, c.1417del); ClinVar=VCV000427757; Zygosity=Heterozygous (PubMed=37944352).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179054; Familial hypertrophic cardiomyopathy type 27
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41-50Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi097-A
AC   CVCL_D0LG
SY   SCVI-675fs2
DR   BioSamples; SAMEA114210488
DR   hPSCreg; SCVIi097-A
DR   Wikidata; Q123033440
RX   PubMed=37944352;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:17574; ALPK3; Simple; p.Gln675Serfs (c.2023delC) (p.Gln473Serfs, c.1417del); ClinVar=VCV000427757; Zygosity=Heterozygous (PubMed=37944352).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179054; Familial hypertrophic cardiomyopathy type 27
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18-30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi098-A
AC   CVCL_D0LH
SY   SCVI-675fs3
DR   BioSamples; SAMEA114210538
DR   hPSCreg; SCVIi098-A
DR   Wikidata; Q123033441
RX   PubMed=37944352;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:17574; ALPK3; Simple; p.Gln675Serfs (c.2023delC) (p.Gln473Serfs, c.1417del); ClinVar=VCV000427757; Zygosity=Heterozygous (PubMed=37944352).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179054; Familial hypertrophic cardiomyopathy type 27
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51-60Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi099-A
AC   CVCL_D0LI
SY   SCVI-675fs4
DR   BioSamples; SAMEA114210564
DR   hPSCreg; SCVIi099-A
DR   Wikidata; Q123033442
RX   PubMed=37944352;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:17574; ALPK3; Simple; p.Gln675Serfs (c.2023delC) (p.Gln473Serfs, c.1417del); ClinVar=VCV000427757; Zygosity=Heterozygous (PubMed=37944352).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179054; Familial hypertrophic cardiomyopathy type 27
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18-30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi100-A
AC   CVCL_D0LJ
SY   SCVI-2009A; SCVI 2009A; SCVI2009A
DR   hPSCreg; SCVIi100-A
DR   Wikidata; Q123033443
RX   PubMed=38100915;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: South Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi101-A
AC   CVCL_D0LK
SY   SCVI-926A; SCVI 926A; SCVI926A
DR   hPSCreg; SCVIi101-A
DR   Wikidata; Q123033444
RX   PubMed=38100915;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: South Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SCVIi102-A
AC   CVCL_D6LJ
DR   hPSCreg; SCVIi102-A
DR   Wikidata; Q127384226
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SCVIi103-A
AC   CVCL_D6LK
DR   hPSCreg; SCVIi103-A
DR   Wikidata; Q127384228
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SCVIi104-A
AC   CVCL_D6LL
SY   SCVIi2996
DR   BioSamples; SAMEA115130031
DR   hPSCreg; SCVIi104-A
DR   Wikidata; Q127384231
RX   PubMed=39133963;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=39133963).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SCVIi105-A
AC   CVCL_D6LM
SY   SCVIi3001
DR   BioSamples; SAMEA115121764
DR   hPSCreg; SCVIi105-A
DR   Wikidata; Q127384233
RX   PubMed=39133963;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156His (c.467G>A); ClinVar=VCV000127811; Zygosity=Heterozygous (PubMed=39133963).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SCVIi106-A
AC   CVCL_D6LN
DR   BioSamples; SAMEA115358165
DR   hPSCreg; SCVIi106-A
DR   Wikidata; Q127384235
RX   PubMed=38861775;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   SCVIi107-A
AC   CVCL_D6LP
DR   BioSamples; SAMEA115358206
DR   hPSCreg; SCVIi107-A
DR   Wikidata; Q127384237
RX   PubMed=38861775;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   SCVIi108-A
AC   CVCL_D6LQ
SY   SCVI-2767; SCVI 2767; SCVI2767
DR   BioSamples; SAMEA115395164
DR   hPSCreg; SCVIi108-A
DR   Wikidata; Q127384239
RX   PubMed=38852422;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Native South American.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.His211Tyr (c.631C>T); ClinVar=VCV000251335; Zygosity=Heterozygous (PubMed=38852422).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SCVIi109-A
AC   CVCL_D6LR
SY   SCVI-3020; SCVI 3020; SCVI3020
DR   BioSamples; SAMEA115395166
DR   hPSCreg; SCVIi109-A
DR   Wikidata; Q127384241
RX   PubMed=38852422;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.313+1G>A; ClinVar=VCV000003736; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=38852422).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SCVIi110-A
AC   CVCL_D6LS
SY   SCVI-340; SCVI 340; SCVI340
DR   BioSamples; SAMEA115429266
DR   hPSCreg; SCVIi110-A
DR   Wikidata; Q127384244
RX   PubMed=38763038;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ala344Val (c.1031C>T); ClinVar=VCV000052936; Zygosity=Heterozygous (PubMed=38763038).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SCVIi111-A
AC   CVCL_D6LT
SY   SCVI-627; SCVI 627; SCVI627
DR   BioSamples; SAMEA115429405
DR   hPSCreg; SCVIi111-A
DR   Wikidata; Q127384246
RX   PubMed=38763038;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Leu374His (c.1121T>A); ClinVar=VCV000052961; Zygosity=Heterozygous (PubMed=38763038).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SCVIi112-A
AC   CVCL_D6LU
DR   hPSCreg; SCVIi112-A
DR   Wikidata; Q127384248
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SCVIi113-A
AC   CVCL_D6LV
DR   hPSCreg; SCVIi113-A
DR   Wikidata; Q127384250
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SCVIi114-A
AC   CVCL_D6LW
DR   BioSamples; SAMEA115468041
DR   hPSCreg; SCVIi114-A
DR   Wikidata; Q127384252
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SCVIi115-A
AC   CVCL_D6LX
DR   BioSamples; SAMEA115468069
DR   hPSCreg; SCVIi115-A
DR   Wikidata; Q127384254
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SCVIi116-A
AC   CVCL_E4EZ
SY   365
DR   hPSCreg; SCVIi116-A
RX   PubMed=40818271;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40818271
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,14
ST   D21S11: 27,30
ST   D5S818: 14,15
ST   D7S820: 10,12
ST   TH01: 9,10
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C222356; PHACE syndrome
DI   ORDO; Orphanet_42775; PHACE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   SCVIi117-A
AC   CVCL_E4F0
SY   2597
DR   hPSCreg; SCVIi117-A
RX   PubMed=40818271;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40818271
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9
ST   D21S11: 29,32.2
ST   D5S818: 15,16
ST   D7S820: 7,10
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C222356; PHACE syndrome
DI   ORDO; Orphanet_42775; PHACE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   SCVIi118-A
AC   CVCL_E4F1
SY   2702
DR   hPSCreg; SCVIi118-A
RX   PubMed=40818271;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40818271
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 12,13
ST   D21S11: 29,30.2
ST   D5S818: 13,16
ST   D7S820: 8,10
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C222356; PHACE syndrome
DI   ORDO; Orphanet_42775; PHACE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   SCVIi119-A
AC   CVCL_E4F2
DR   hPSCreg; SCVIi119-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi120-A
AC   CVCL_E4F3
DR   hPSCreg; SCVIi120-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi121-A
AC   CVCL_E4F4
SY   SCVI-488; SCVI 488; SCVI488
DR   BioSamples; SAMEA115580280
DR   hPSCreg; SCVIi121-A
RX   PubMed=39067410;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Arg814Trp (c.2440C>T); ClinVar=VCV000067731; Zygosity=Heterozygous (PubMed=39067410).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212862; Dilated cardiomyopathy-1E
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-40Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi123-A
AC   CVCL_E4F5
SY   SCVI-2176; SCVI 2176; SCVI2176
DR   BioSamples; SAMEA115580282
DR   hPSCreg; SCVIi123-A
RX   PubMed=39067410;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Arg222Gln (c.665G>A); ClinVar=VCV000039444; Zygosity=Heterozygous (PubMed=39067410).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C212862; Dilated cardiomyopathy-1E
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi124-A
AC   CVCL_E4K0
DR   BioSamples; SAMEA115880926
DR   hPSCreg; SCVIi124-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi125-A
AC   CVCL_E4FB
DR   hPSCreg; SCVIi125-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi126-A
AC   CVCL_E4FC
SY   SCVI126-A; SCVI-2899; SCVI 2899; SCVI2899
DR   hPSCreg; SCVIi126-A
RX   PubMed=40773824;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40773824
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D18S51: 14,16
ST   D19S433: 14,17
ST   D21S11: 31.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y11M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   SCVIi127-A
AC   CVCL_E4FD
SY   SCVI127-A; SCVI-2830; SCVI 2830; SCVI2830
DR   BioSamples; SAMEA118790350
DR   hPSCreg; SCVIi127-A
RX   PubMed=40773824;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Caution: The reported STR value for TH01 of 17 seems incorrect (out of the range of observed values).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=40773824
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 8,11
ST   D18S51: 13.2,14
ST   D19S433: 15,16.2
ST   D21S11: 28,32.2
ST   D2S1338: 18,20
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 7,10
ST   D8S1179: 10,15
ST   FGA: 18,19
ST   TH01: 17
ST   TPOX: 10,11
ST   vWA: 13,16
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y10M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 27-11-25; Version: 2
//
ID   SCVIi128-A
AC   CVCL_E4FE
SY   SCVI-766; SCVI 766; SCVI766
DR   BioSamples; SAMEA115829495
DR   hPSCreg; SCVIi128-A
RX   PubMed=39096853;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys1942Ter (c.5826C>A); ClinVar=VCV000547334; Zygosity=Heterozygous (PubMed=39096853).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi129-A
AC   CVCL_E4FF
SY   SCVI-2454; SCVI 2454; SCVI2454
DR   BioSamples; SAMEA115829496
DR   hPSCreg; SCVIi129-A
RX   PubMed=39096853;
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
CC   Population: South Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys652Arg (c.1954T>C); ClinVar=VCV000839687; Zygosity=Heterozygous (PubMed=39096853).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi130-A
AC   CVCL_E4FG
DR   hPSCreg; SCVIi130-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi131-A
AC   CVCL_E4FH
DR   hPSCreg; SCVIi131-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi132-A
AC   CVCL_E4FI
SY   SCVI-2235; SCVI 2235; SCVI2235
DR   BioSamples; SAMEA115928486
DR   hPSCreg; SCVIi132-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCVIi133-A
AC   CVCL_E4FJ
DR   hPSCreg; SCVIi133-A
CC   From: Stanford Cardiovascular Institute; Palo Alto; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SCZ#3-4 iPSC
AC   CVCL_WR36
DR   Wikidata; Q98129438
RX   PubMed=27934603;
CC   From: CIBIO, University of Trento; Trento; Italy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   SCZ#4-9 iPSC
AC   CVCL_WR37
DR   Wikidata; Q98129440
RX   PubMed=27934596;
CC   From: CIBIO, University of Trento; Trento; Italy.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   SD
AC   CVCL_W902
DR   Cosmic; 715783
DR   Cosmic; 760486
DR   Cosmic; 845566
DR   Cosmic; 1046683
DR   Cosmic; 1285127
DR   Cosmic; 1285986
DR   Cosmic; 2050462
DR   Cosmic; 2057456
DR   Cosmic; 2444242
DR   Cosmic; 2686114
DR   Wikidata; Q54952678
RX   PubMed=3518877;
RX   PubMed=6826254;
RX   PubMed=11921286;
RX   PubMed=15846775;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=29732388;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   SD-1
AC   CVCL_0094
SY   SD1
DR   CLO; CLO_0008975
DR   AddexBio; C0003015/4882
DR   BioSample; SAMN03473320
DR   Cosmic; 1019835
DR   Cosmic; 1026576
DR   Cosmic; 1498419
DR   Cosmic; 1524819
DR   DSMZ; ACC-366
DR   DSMZCellDive; ACC-366
DR   GEO; GSM236804
DR   GEO; GSM236840
DR   Wikidata; Q54952709
RX   PubMed=1847983;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15843827;
RX   PubMed=20454443;
CC   Doubling time: ~28-32 hours (DSMZ=ACC-366).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: AddexBio; C0003015/4882; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003015/4882; DSMZ=ACC-366
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 28,32
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 14,16
ST   FGA: 20,26
ST   Penta D: 9,12
ST   Penta E: 5,13
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   SD-4
AC   CVCL_0G04
DR   CGH-DB; 9030-4
DR   Wikidata; Q54952679
RX   PubMed=10570904;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Caution: It is uncertain if this is not a misspelling of the SO-4 (Cellosaurus=CVCL_VN48) cell line. The only mention we can find of SD-4 is in PubMed=10570904.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   SD-PJEC
AC   CVCL_ZZ35
SY   South Dakota-Porcine Jejunal Epithelium Cell line
DR   Wikidata; Q102114897
RX   PubMed=22739061;
RX   PubMed=29880757;
CC   Virology: Susceptible to infection by human and avian influenza viruses (PubMed=22739061).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 7
//
ID   SD-Tg.EC1
AC   CVCL_5F79
DR   Wikidata; Q54952680
RX   PubMed=22455749;
WW   Provider; RRRC; RRRC_00561; https://www.rrrc.us/Strain/?x=561
CC   Doubling time: ~24-48 hours (RRRC=561).
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Sprague Dawley SD-Tg(UBC-EGFP)2BalRrrc transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   SD-Tg.EC11
AC   CVCL_5F83
DR   Wikidata; Q54952703
RX   PubMed=22455749;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Sprague Dawley SD-Tg(UBC-EGFP)2BalRrrc transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   SD-Tg.EC12
AC   CVCL_5F84
DR   Wikidata; Q54952704
RX   PubMed=22455749;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Sprague Dawley SD-Tg(UBC-EGFP)2BalRrrc transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   SD-Tg.EC2
AC   CVCL_5F80
DR   Wikidata; Q54952705
RX   PubMed=22455749;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Sprague Dawley SD-Tg(UBC-EGFP)2BalRrrc transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   SD-Tg.EC7
AC   CVCL_5F81
DR   Wikidata; Q54952707
RX   PubMed=22455749;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Sprague Dawley SD-Tg(UBC-EGFP)2BalRrrc transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   SD-Tg.EC8
AC   CVCL_5F82
DR   Wikidata; Q54952708
RX   PubMed=22455749;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Sprague Dawley SD-Tg(UBC-EGFP)2BalRrrc transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 8
//
ID   SD0302
AC   CVCL_C8VP
DR   Wikidata; Q123033445
RX   PubMed=12839934;
CC   Characteristics: Amelanotic. Obtained from a tumor established from a tumor (0302) transplanted into a syngeneic SCID mouse (PubMed=12839934).
CC   Transformant: ChEBI; CHEBI_16236; Ethanol.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Dorsal, skin; UBERON=UBERON_3010006.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SDAR1
AC   CVCL_AV63
DR   ABM; T8257
DR   cancercelllines; CVCL_AV63
DR   Wikidata; Q54952711
RX   CelloPub=CLPUB00321;
RX   PubMed=25675381;
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val54fs (c.160delG); Zygosity=Homozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Pro (c.845G>C); ClinVar=VCV000376659; Zygosity=Heterozygous (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8 (PubMed=29846633)
ST   D13S317: 8,12 (PubMed=30737244)
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 27
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AV64 ! SDAR2
OI   CVCL_AV65 ! SDAR3
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   SDAR2
AC   CVCL_AV64
DR   ABM; T8258
DR   Wikidata; Q54952712
RX   CelloPub=CLPUB00321;
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Val54fs (c.160delG); Zygosity=Homozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val217fs (c.648delG); Zygosity=Homozygous (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8 (PubMed=29846633)
ST   D13S317: 8,12 (PubMed=30737244)
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 27
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AV63 ! SDAR1
OI   CVCL_AV65 ! SDAR3
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   SDAR3
AC   CVCL_AV65
DR   Wikidata; Q54952713
RX   CelloPub=CLPUB00321;
CC   Derived from site: Metastatic; Jugular vein; UBERON=UBERON_0004711.
ST   Source(s): CelloPub=CLPUB00321
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 27
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AV63 ! SDAR1
OI   CVCL_AV64 ! SDAR2
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   SDASi001-A
AC   CVCL_D0LL
DR   BioSamples; SAMEA114402110
DR   hPSCreg; SDASi001-A
DR   Wikidata; Q123033447
RX   PubMed=37788557;
CC   From: Qilu University of Technology, Shandong Academy of Sciences; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11102; SMARCAL1; Simple; p.Ala325Serfs*34 (c.971dupC); Zygosity=Heterozygous (PubMed=37788557).
CC   Sequence variation: Mutation; HGNC; HGNC:11102; SMARCAL1; Simple; c.1334+1G>A; ClinVar=VCV002734387; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=37788557).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C135087; Schimke immunoosseous dysplasia
DI   ORDO; Orphanet_1830; Schimke immuno-osseous dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 4
//
ID   SDCHi001-A
AC   CVCL_D6LE
DR   BioSamples; SAMEA114789073
DR   hPSCreg; SDCHi001-A
DR   Wikidata; Q127384256
RX   PubMed=38118205;
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SDCHi002-A
AC   CVCL_D6LF
SY   NPRL3-ZHW4; ZHW4-IPS
DR   BioSamples; SAMEA115080428
DR   hPSCreg; SDCHi002-A
DR   Wikidata; Q127384257
RX   PubMed=39426047;
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14124; NPRL3; Simple; p.Gln399Ter (c.1195C>T); ClinVar=VCV000620361; Zygosity=Heterozygous (PubMed=39426047).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217086; Familial focal epilepsy with variable foci 3
DI   ORDO; Orphanet_98820; Familial focal epilepsy with variable foci
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   SDCHi003-A
AC   CVCL_D6LG
SY   NPRL2-ZHW5; ZHW5-IPS
DR   BioSamples; SAMEA115080427
DR   hPSCreg; SDCHi003-A
DR   Wikidata; Q127384261
RX   PubMed=38430737;
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:24969; NPRL2; Unexplicit; Partial deletion; Zygosity=Heterozygous (PubMed=38430737).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206114; Familial focal epilepsy with variable foci 2
DI   ORDO; Orphanet_98820; Familial focal epilepsy with variable foci
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SDCHi004-A
AC   CVCL_D6LH
SY   NPRL2-RY8
DR   hPSCreg; SDCHi004-A
DR   Wikidata; Q127384263
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   SDCHi005-A
AC   CVCL_D6LI
SY   DEPDC5-ZHW
DR   BioSamples; SAMEA115797733
DR   hPSCreg; SDCHi005-A
DR   Wikidata; Q127384265
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C161005; Familial focal epilepsy with variable foci 1
DI   ORDO; Orphanet_98820; Familial focal epilepsy with variable foci
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   SDCHi006-A
AC   CVCL_E9US
SY   NPRL2-RY8
DR   hPSCreg; SDCHi006-A
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SDCHi007-A
AC   CVCL_E9CW
SY   RY5; RY-5
DR   BioSamples; SAMEA115797731
DR   hPSCreg; SDCHi007-A
RX   PubMed=39002250;
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:800; ATP1A2; Simple; p.Leu108Arg (c.323T>G); Zygosity=Heterozygous (PubMed=39002250).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217085; Developmental and epileptic encephalopathy 98
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SDCHi008-A
AC   CVCL_E9CY
SY   CX2
DR   BioSamples; SAMEA115716971
DR   hPSCreg; SDCHi008-A
RX   PubMed=39079397;
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6296; KCNQ2; Simple; p.Gly290Ser (c.868G>A); ClinVar=VCV000369768; Zygosity=Heterozygous (PubMed=39079397).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192087; Developmental and epileptic encephalopathy 7
DI   ORDO; Orphanet_439218; KCNQ2-related epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SDCHi009-A
AC   CVCL_E9CZ
SY   RY6
DR   BioSamples; SAMEA115807742
DR   hPSCreg; SDCHi009-A
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SDCHi010-A
AC   CVCL_E9D0
DR   hPSCreg; SDCHi010-A
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SDCHi011-A
AC   CVCL_E9D1
DR   BioSamples; SAMEA115651564
DR   hPSCreg; SDCHi011-A
RX   PubMed=39461115;
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Sdhb fl/fl
AC   CVCL_HG11
DR   CancerTools; 153294
DR   Wikidata; Q54952714
DR   Ximbio; 153294
RX   PubMed=26302408;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Ncr x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E222 ! G4 [Mouse ESC]
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   Sdhb-/- CL 5
AC   CVCL_HG12
SY   Sdhb -/- CL 5
DR   CancerTools; 153292
DR   Wikidata; Q54952715
DR   Ximbio; 153292
RX   PubMed=26302408;
CC   Knockout cell: Method=Cre/loxP; MGI; MGI:1914930; Sdhb.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Ncr x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG11 ! Sdhb fl/fl
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   Sdhb-/- CL 7
AC   CVCL_HG13
SY   Sdhb -/- CL 7
DR   CancerTools; 153293
DR   Wikidata; Q54952717
DR   Ximbio; 153293
RX   PubMed=26302408;
CC   Knockout cell: Method=Cre/loxP; MGI; MGI:1914930; Sdhb.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6Ncr x 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG11 ! Sdhb fl/fl
SX   Male
AG   Blastocyst stage
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   SDHCEC1
AC   CVCL_VF66
SY   Spontaneously Derived Human Corneal Epithelial Cell line 1
DR   Wikidata; Q54952718
RX   PubMed=17223104;
RX   PubMed=20700758;
CC   Doubling time: 19.6 hours (PubMed=17223104).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SDM-114
AC   CVCL_C8K5
DR   Wikidata; Q123033448
RX   PubMed=10691672;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_32161; Sulfadimethoxine (SDM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SDM-18
AC   CVCL_C8K1
DR   Wikidata; Q123033449
RX   PubMed=10691672;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_32161; Sulfadimethoxine (SDM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SDM-19
AC   CVCL_C8K2
DR   Wikidata; Q123033450
RX   PubMed=10691672;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_32161; Sulfadimethoxine (SDM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SDM-44
AC   CVCL_C8K3
DR   Wikidata; Q123033451
RX   PubMed=10691672;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_32161; Sulfadimethoxine (SDM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SDM-70
AC   CVCL_C8K4
DR   Wikidata; Q123033453
RX   PubMed=10691672;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_32161; Sulfadimethoxine (SDM).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SDM103T2
AC   CVCL_D313
DR   ECACC; 11120712
DR   Wikidata; Q54952719
RX   PubMed=21729925;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=11120712
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 15
//
ID   SDM104
AC   CVCL_IT34
DR   PRIDE; PXD000589
DR   Wikidata; Q54952720
RX   PubMed=21729925;
RX   PubMed=24207061;
RX   PubMed=25894527;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Miscellaneous: Age/sex of donor from personal communication of Felley-Bosco, Emanuela.
DI   NCIt; C26860; Pleuritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   SDM117
AC   CVCL_B7MS
DR   Wikidata; Q112930368
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Wipplinger, Martin.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   SDM161
AC   CVCL_B7MT
DR   Wikidata; Q112930369
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line information from personal communication of Wipplinger, Martin.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   SDM34
AC   CVCL_IT31
DR   PRIDE; PXD000589
DR   Wikidata; Q54952722
RX   PubMed=24207061;
RX   PubMed=25894527;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Miscellaneous: Age/sex of donor and exact cancer type from personal communication of Felley-Bosco, Emanuela.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   SDM4
AC   CVCL_IT32
DR   PRIDE; PXD000589
DR   Wikidata; Q54952723
RX   PubMed=24207061;
RX   PubMed=25894527;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Miscellaneous: Age/sex of donor, exact cancer type and sampling site from personal communication of Felley-Bosco, Emanuela.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   SDM5
AC   CVCL_IT33
DR   PRIDE; PXD000589
DR   Wikidata; Q54952725
RX   PubMed=24207061;
RX   PubMed=25894527;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Miscellaneous: Age/sex of donor, exact cancer type and sampling site from personal communication of Felley-Bosco, Emanuela.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   SDPHi001-A
AC   CVCL_B3MU
DR   BioSamples; SAMEA9797604
DR   hPSCreg; SDPHi001-A
DR   Wikidata; Q110433214
RX   PubMed=34547706;
CC   From: Shandong Provincial Hospital Affiliated to Shandong First Medical University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SDPHi002-A
AC   CVCL_C6SM
DR   BioSamples; SAMEA112763047
DR   hPSCreg; SDPHi002-A
DR   Wikidata; Q117704861
RX   PubMed=37104933;
CC   From: Shandong Provincial Hospital Affiliated to Shandong First Medical University; Jinan; China.
CC   Population: Chinese; Han.
CC   Donor information: Established from a patient suffering from a lung neuroendocrine carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   SDPHi003-A
AC   CVCL_C9JF
DR   BioSamples; SAMEA112735959
DR   hPSCreg; SDPHi003-A
DR   Wikidata; Q123033454
RX   PubMed=37429069;
CC   From: Shandong Provincial Hospital Affiliated to Shandong First Medical University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SDPHi004-A
AC   CVCL_C9JG
DR   BioSamples; SAMEA112815082
DR   hPSCreg; SDPHi004-A
DR   Wikidata; Q123033455
RX   PubMed=37385132;
CC   From: Shandong Provincial Hospital Affiliated to Shandong First Medical University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SDPHi005-A
AC   CVCL_D6QU
DR   BioSamples; SAMEA115410981
DR   hPSCreg; SDPHi005-A
RX   PubMed=38531229;
CC   From: Shandong Provincial Hospital Affiliated to Shandong First Medical University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHe001-A
AC   CVCL_D0QJ
DR   hPSCreg; SDQLCHe001-A
DR   Wikidata; Q123033456
RX   PubMed=37245339;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple_edited; p.Gln539Ter (c.1615C>T); ClinVar=VCV000488807; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37245339).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SDQLCHi001-A
AC   CVCL_XC37
DR   hPSCreg; SDQLCHi001-A
DR   Wikidata; Q98129443
RX   PubMed=31472451;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   SDQLCHi002-A
AC   CVCL_XC38
DR   hPSCreg; SDQLCHi002-A
DR   Wikidata; Q98129445
RX   PubMed=31472451;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   SDQLCHi003-A
AC   CVCL_XC39
DR   hPSCreg; SDQLCHi003-A
DR   SKIP; SKIP005553
DR   Wikidata; Q98129448
RX   PubMed=31415973;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2962; DYNC2H1; Simple; p.Trp314Arg (c.940T>C); Zygosity=Heterozygous (PubMed=31415973).
CC   Sequence variation: Mutation; HGNC; HGNC:2962; DYNC2H1; Simple; p.Pro3388Leu (c.10163C>T) (p.Pro3381Leu, c.10142C>T); ClinVar=VCV000439631; Zygosity=Heterozygous (PubMed=31415973).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C163755; Short-rib thoracic dysplasia 3 with or without polydactyly
DI   ORDO; Orphanet_93270; Short rib-polydactyly syndrome, Saldino-Noonan type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y3M
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   SDQLCHi004-A
AC   CVCL_XI74
DR   hPSCreg; SDQLCHi004-A
DR   Wikidata; Q98129450
RX   PubMed=31526942;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12011; TPM2; Simple; p.Arg133Trp (c.397C>T); ClinVar=VCV000012463; Zygosity=Heterozygous (PubMed=31526942).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C164225; Nemaline myopathy 4
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi005-A
AC   CVCL_XI48
DR   hPSCreg; SDQLCHi005-A
DR   Wikidata; Q98129452
RX   PubMed=31522012;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=31522012).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7137; Cutaneous mastocytosis
DI   ORDO; Orphanet_79457; Maculopapular cutaneous mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   SDQLCHi006-A
AC   CVCL_XJ78
DR   hPSCreg; SDQLCHi006-A
DR   Wikidata; Q98129456
RX   PubMed=31610500;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:987; BCKDHB; Simple; p.Arg168Cys (c.502C>T); ClinVar=VCV000096586; Zygosity=Heterozygous (PubMed=31610500).
CC   Sequence variation: Mutation; HGNC; HGNC:987; BCKDHB; Simple; p.Thr322Ile (c.965C>T); Zygosity=Heterozygous (PubMed=31610500).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi007-A
AC   CVCL_XJ79
DR   hPSCreg; SDQLCHi007-A
DR   SKIP; SKIP005646
DR   Wikidata; Q98129458
RX   PubMed=31812072;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex49-50del; Zygosity=Hemizygous (PubMed=31812072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y7M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi008-A
AC   CVCL_XI75
DR   hPSCreg; SDQLCHi008-A
DR   SKIP; SKIP005560
DR   Wikidata; Q98129462
RX   PubMed=31505389;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14262; AUTS2; Unexplicit; Ex1del; Zygosity=Heterozygous; Note=De novo mutation (PubMed=31505389).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   SDQLCHi009-A
AC   CVCL_YK73
DR   hPSCreg; SDQLCHi009-A
DR   SKIP; SKIP005641
DR   Wikidata; Q98129464
RX   PubMed=32014801;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; c.663+2T>G; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=32014801).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SDQLCHi010-A
AC   CVCL_YK74
DR   hPSCreg; SDQLCHi010-A
DR   Wikidata; Q98129467
RX   PubMed=31707209;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8620; PAX6; Simple; p.Ser74Gly (c.220A>G); Zygosity=Heterozygous (PubMed=31707209).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101268; Bilateral optic nerve hypoplasia
DI   ORDO; Orphanet_637061; Isolated optic nerve hypoplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi011-A
AC   CVCL_YK75
DR   hPSCreg; SDQLCHi011-A
DR   Wikidata; Q98129469
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi012-A
AC   CVCL_XV11
DR   hPSCreg; SDQLCHi012-A
DR   Wikidata; Q98129471
RX   PubMed=31648101;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:5964; IL10RA; Simple; c.188+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=31648101).
CC   Sequence variation: Mutation; HGNC; HGNC:5964; IL10RA; Simple; p.Arg101Trp (c.301C>T); ClinVar=VCV000039432; Zygosity=Heterozygous (PubMed=31648101).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C164676; Inflammatory bowel disease 28
DI   ORDO; Orphanet_238569; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi013-A
AC   CVCL_YJ23
DR   hPSCreg; SDQLCHi013-A
DR   Wikidata; Q98129474
RX   PubMed=31775088;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Thr211Met (c.632C>T); ClinVar=VCV000093365; Zygosity=Heterozygous (PubMed=31775088).
CC   Sequence variation: Mutation; HGNC; HGNC:986; BCKDHA; Simple; p.Leu427_Ala428delinsPro (c.1280_1282delTGG); ClinVar=VCV000557742; Zygosity=Heterozygous (PubMed=31775088).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31775088
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 17,18
ST   D13S317: 9,10
ST   D16S539: 9,11
ST   D18S51: 16,19
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D6S1043: 18,20
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi014-A
AC   CVCL_YI67
DR   hPSCreg; SDQLCHi014-A
DR   Wikidata; Q98129475
RX   PubMed=31707215;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4599; GRM7; Unexplicit; Ex3-7del; Zygosity=Heterozygous; Note=De novo mutation (PubMed=31707215).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi015-A
AC   CVCL_YK76
DR   hPSCreg; SDQLCHi015-A
DR   SKIP; SKIP005572
DR   Wikidata; Q98129477
RX   PubMed=31678776;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2555; CUL4B; Simple; p.Ile336Lysfs*2 (c.1007_1011delTTATA); ClinVar=VCV000426723; Zygosity=Hemizygous (PubMed=31678776).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C167216; Intellectual developmental disorder, X-linked syndromic, Cabezas type
DI   ORDO; Orphanet_85293; X-linked intellectual disability, Cabezas type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   SDQLCHi016-A
AC   CVCL_YK77
DR   hPSCreg; SDQLCHi016-A
DR   Wikidata; Q98129480
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi017-A
AC   CVCL_YK78
DR   hPSCreg; SDQLCHi017-A
DR   SKIP; SKIP005691
DR   Wikidata; Q98129481
RX   PubMed=32062132;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.6915+1G>T; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=32062132).
CC   Sequence variation: Mutation; HGNC; HGNC:7720; NEB; Simple; c.14910+3G>C; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=32062132).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118784; Nemaline myopathy 2
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi018-A
AC   CVCL_YK79
AS   CVCL_YK80
SY   SDQLCHi019-A
DR   hPSCreg; SDQLCHi018-A
DR   hPSCreg; SDQLCHi019-A
DR   Wikidata; Q98129482
RX   PubMed=33465529;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9863; RAPSN; Simple; p.Asn88Lys (c.264C>A); ClinVar=VCV000008046; Zygosity=Heterozygous (PubMed=33465529).
CC   Sequence variation: Mutation; HGNC; HGNC:9863; RAPSN; Simple; c.532-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33465529).
CC   Discontinued: hPSCreg; SDQLCHi019-A; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177546; Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency
DI   ORDO; Orphanet_590; Congenital myasthenic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14D
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SDQLCHi020-A
AC   CVCL_YK81
DR   hPSCreg; SDQLCHi020-A
DR   Wikidata; Q98129484
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi021-A
AC   CVCL_YK82
DR   hPSCreg; SDQLCHi021-A
DR   SKIP; SKIP005642
DR   Wikidata; Q98129485
RX   PubMed=32058304;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Ile150Pro (c.448_449delinsCC); Zygosity=Heterozygous (PubMed=32058304).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (PubMed=32058304).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SDQLCHi022-A
AC   CVCL_YK83
DR   hPSCreg; SDQLCHi022-A
DR   Wikidata; Q98129486
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi023-A
AC   CVCL_ZC34
DR   hPSCreg; SDQLCHi023-A
DR   Wikidata; Q98129487
RX   PubMed=33493992;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C177544; Xq25 microduplication syndrome
DI   ORDO; Orphanet_521258; Xq25 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   SDQLCHi024-A
AC   CVCL_ZC35
DR   hPSCreg; SDQLCHi024-A
DR   Wikidata; Q98129488
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi025-A
AC   CVCL_ZC33
DR   hPSCreg; SDQLCHi025-A
DR   SKIP; SKIP005787
DR   Wikidata; Q98129489
RX   PubMed=32272370;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Ser388Leu (c.1163C>T); ClinVar=VCV000579011; Zygosity=Heterozygous (PubMed=32272370).
CC   Sequence variation: Mutation; HGNC; HGNC:10483; RYR1; Simple; p.Phe4808Asn (c.14422_14423inv) (c.14422_14423delTTinsAA); ClinVar=VCV000478199; Zygosity=Heterozygous (PubMed=32272370).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C150608; Minicore myopathy with external ophthalmoplegia
DI   ORDO; Orphanet_98905; Congenital multicore myopathy with external ophthalmoplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   SDQLCHi026-A
AC   CVCL_ZC36
DR   hPSCreg; SDQLCHi026-A
DR   Wikidata; Q98129490
RX   PubMed=33882394;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Trp234Leu (c.701G>T); Zygosity=Heterozygous (PubMed=33882394).
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Pro261Leu (c.782C>T); ClinVar=VCV000021058; Zygosity=Heterozygous (PubMed=33882394).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35D
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   SDQLCHi027-A
AC   CVCL_A4XJ
DR   hPSCreg; SDQLCHi027-A
DR   Wikidata; Q107116881
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi028-A
AC   CVCL_A4XK
DR   hPSCreg; SDQLCHi028-A
DR   Wikidata; Q107116882
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi029-A
AC   CVCL_A4XL
DR   BioSamples; SAMEA115300562
DR   hPSCreg; SDQLCHi029-A
DR   Wikidata; Q107116883
RX   PubMed=38430736;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6930; MC2R; Simple; p.Arg137Trp (c.409C>T); ClinVar=VCV000003265; Zygosity=Heterozygous (PubMed=38430736).
CC   Sequence variation: Mutation; HGNC; HGNC:6930; MC2R; Simple; p.Thr143Ile (c.428C>T); Zygosity=Heterozygous (PubMed=38430736).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123727; Familial glucocorticoid deficiency type 1
DI   ORDO; Orphanet_361; Familial glucocorticoid deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SDQLCHi030-A
AC   CVCL_A4XM
DR   BioSamples; SAMEA115039271
DR   hPSCreg; SDQLCHi030-A
DR   Wikidata; Q107116885
RX   PubMed=38154384;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg170Ter (c.508C>T); ClinVar=VCV000010063; Zygosity=Hemizygous (PubMed=38154384).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y5M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi031-A
AC   CVCL_A4XN
DR   hPSCreg; SDQLCHi031-A
DR   Wikidata; Q107116886
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi032-A
AC   CVCL_A4XP
DR   hPSCreg; SDQLCHi032-A
DR   Wikidata; Q107116887
RX   PubMed=33550138;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:5154; HPGD; Simple; p.Leu104Alafs*3 (c.308_309CT[1]) (c.310_311delCT); ClinVar=VCV000156027; Zygosity=Homozygous (PubMed=33550138).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179057; Primary hypertrophic osteoarthropathy, autosomal recessive type 1
DI   ORDO; Orphanet_2796; Pachydermoperiostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y7M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi033-A
AC   CVCL_A3ZD
DR   hPSCreg; SDQLCHi033-A
DR   Wikidata; Q105511012
RX   PubMed=33388706;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:987; BCKDHB; Simple; p.Pro366Gln (c.1097C>A); Zygosity=Homozygous (PubMed=33388706).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34806; Maple syrup urine disease
DI   ORDO; Orphanet_511; Maple syrup urine disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi034-A
AC   CVCL_A4XQ
DR   hPSCreg; SDQLCHi034-A
DR   Wikidata; Q107116888
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi035-A
AC   CVCL_A4XR
DR   hPSCreg; SDQLCHi035-A
DR   Wikidata; Q107116889
RX   PubMed=33517119;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Heterozygous (PubMed=33517119).
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.His100Argfs*14 (c.299_300delAT); ClinVar=VCV000044736; Zygosity=Heterozygous (PubMed=33517119).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi036-A
AC   CVCL_A4XS
DR   hPSCreg; SDQLCHi036-A
DR   Wikidata; Q107116890
RX   PubMed=33550136;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Unexplicit; Ex3-9del; Zygosity=Heterozygous (PubMed=33550136).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
DI   ORDO; Orphanet_664; Ornithine transcarbamylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi037-A
AC   CVCL_A4XH
DR   hPSCreg; SDQLCHi037-A
DR   Wikidata; Q107116891
RX   PubMed=33465531;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Gln539Ter (c.1615C>T); ClinVar=VCV000488807; Zygosity=Heterozygous (PubMed=33465531).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi038-A
AC   CVCL_A4XT
DR   hPSCreg; SDQLCHi038-A
DR   Wikidata; Q107116892
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SDQLCHi039-A
AC   CVCL_A4XG
DR   hPSCreg; SDQLCHi039-A
DR   Wikidata; Q107116893
RX   PubMed=33453577;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple; p.Tyr510_Glu513delGluTyrLeuGluinsGlu (c.1530_1538delATACCTGGA); Zygosity=Hemizygous (PubMed=33453577).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3822; X-linked agammaglobulinemia
DI   ORDO; Orphanet_47; X-linked agammaglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y5M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi040-A
AC   CVCL_A4XU
DR   hPSCreg; SDQLCHi040-A
DR   Wikidata; Q107116894
RX   PubMed=34530396;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:5964; IL10RA; Simple; p.Arg101Trp (c.301C>T); ClinVar=VCV000039432; Zygosity=Homozygous (PubMed=34530396).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C164676; Inflammatory bowel disease 28
DI   ORDO; Orphanet_238569; Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi041-A
AC   CVCL_A4XV
DR   hPSCreg; SDQLCHi041-A
DR   Wikidata; Q107116895
RX   PubMed=33550137;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg203Gln (c.608G>A); ClinVar=VCV001029750; Zygosity=Heterozygous (PubMed=33550137).
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Glu446Lys (c.1336G>A); ClinVar=VCV000553423; Zygosity=Heterozygous (PubMed=33550137).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y9M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi042-A
AC   CVCL_A8NH
DR   hPSCreg; SDQLCHi042-A
DR   Wikidata; Q108821285
RX   PubMed=34087978;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6677; LPL; Simple; c.88+1G>C; ClinVar=VCV000001542; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34087978).
CC   Sequence variation: Mutation; HGNC; HGNC:6677; LPL; Simple; p.Leu279Arg (c.836T>G); ClinVar=VCV000851236; Zygosity=Heterozygous (PubMed=34087978).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84771; Hyperlipoproteinemia, type I
DI   ORDO; Orphanet_309015; Familial lipoprotein lipase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi043-A
AC   CVCL_A8NI
DR   hPSCreg; SDQLCHi043-A
DR   Wikidata; Q108821286
RX   PubMed=38394970;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000553380; Zygosity=Heterozygous (PubMed=38394970).
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; c.1498+2T>C; ClinVar=VCV000217895; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=38394970).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi044-A
AC   CVCL_C1WD
DR   hPSCreg; SDQLCHi044-A
DR   Wikidata; Q114312982
RX   PubMed=36183676;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11497; SYNGAP1; Simple; p.Arg687Ter (c.2059C>T); ClinVar=VCV000411584; Zygosity=Heterozygous (PubMed=36183676).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178414; Intellectual developmental disorder, autosomal dominant 5
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   SDQLCHi045-A
AC   CVCL_C1WE
DR   hPSCreg; SDQLCHi045-A
DR   Wikidata; Q114312983
RX   PubMed=36473251;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Gln642Ter (c.1924C>T); Zygosity=Heterozygous (PubMed=36473251).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35321; Coffin-Siris syndrome
DI   ORDO; Orphanet_1465; Coffin-Siris syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi046-A
AC   CVCL_C1WF
DR   hPSCreg; SDQLCHi046-A
DR   Wikidata; Q114312984
RX   PubMed=36481505;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:13315; HDAC8; Simple; p.Glu186Lys (c.556G>A); ClinVar=VCV000211142; Zygosity=Hemizygous (PubMed=36481505).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75016; Cornelia de Lange syndrome
DI   ORDO; Orphanet_199; Cornelia de Lange syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi048-A
AC   CVCL_C6SN
DR   hPSCreg; SDQLCHi048-A
DR   Wikidata; Q117704862
RX   PubMed=37229976;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SDQLCHi049-A
AC   CVCL_C6SP
DR   hPSCreg; SDQLCHi049-A
DR   Wikidata; Q117704863
RX   PubMed=37075622;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14D
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SDQLCHi050-A
AC   CVCL_C8DV
DR   BioSamples; SAMEA114277624
DR   hPSCreg; SDQLCHi050-A
DR   Wikidata; Q123033457
RX   PubMed=38128452;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 02-05-24; Version: 4
//
ID   SDQLCHi051-A
AC   CVCL_C8DW
DR   hPSCreg; SDQLCHi051-A
DR   Wikidata; Q123033458
RX   PubMed=37229974;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:20153; CHD8; Simple; p.Ile1292Met (c.3876T>G); Zygosity=Heterozygous (PubMed=37229974).
CC   Sequence variation: Mutation; HGNC; HGNC:20153; CHD8; Simple; p.Arg2243His (c.6728G>A); Zygosity=Heterozygous (PubMed=37229974).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   SDQLCHi052-A
AC   CVCL_C8DU
DR   hPSCreg; SDQLCHi052-A
DR   Wikidata; Q123033459
RX   PubMed=37320988;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20D
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SDQLCHi053-A
AC   CVCL_C8DX
DR   hPSCreg; SDQLCHi053-A
DR   Wikidata; Q123033460
RX   PubMed=37385133;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11497; SYNGAP1; Simple; p.Arg143Ter (c.427C>T); ClinVar=VCV000060716; Zygosity=Heterozygous (PubMed=37385133).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178414; Intellectual developmental disorder, autosomal dominant 5
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y10M
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 27-11-25; Version: 5
//
ID   SDQLCHi054-A
AC   CVCL_C8DY
DR   BioSamples; SAMEA114469191
DR   hPSCreg; SDQLCHi054-A
DR   Wikidata; Q123033461
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C178414; Intellectual developmental disorder, autosomal dominant 5
DI   ORDO; Orphanet_178469; Autosomal dominant non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 27-11-25; Version: 3
//
ID   SDQLCHi055-A
AC   CVCL_C8DZ
DR   hPSCreg; SDQLCHi055-A
DR   Wikidata; Q123033463
RX   PubMed=38364504;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Leu285Ter (c.854T>A); Zygosity=Heterozygous (PubMed=38364504).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176897; Neurodevelopmental disorder with spastic diplegia and visual defects
DI   ORDO; Orphanet_404473; Severe intellectual disability-progressive spastic diplegia syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   SDQLCHi056-A
AC   CVCL_C8E0
DR   hPSCreg; SDQLCHi056-A
DR   Wikidata; Q123033464
RX   PubMed=37995436;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11098; SMARCA2; Simple; p.Val1198Met (c.3592G>A); Zygosity=Heterozygous (PubMed=37995436).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C205644; Nicolaides-Baraitser syndrome
DI   ORDO; Orphanet_3051; Nicolaides-Baraitser syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi057-A
AC   CVCL_C9JH
DR   hPSCreg; SDQLCHi057-A
DR   Wikidata; Q123033466
RX   PubMed=38401345;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6186; IVD; Simple; p.Asn72Ser (c.215A>G); ClinVar=VCV002168221; Zygosity=Heterozygous (PubMed=38401345).
CC   Sequence variation: Mutation; HGNC; HGNC:6186; IVD; Simple; p.Met295Val (c.883A>G); Zygosity=Heterozygous (PubMed=38401345).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98964; Isovaleric acidemia
DI   ORDO; Orphanet_33; Isovaleric acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SDQLCHi058-A
AC   CVCL_C9JI
DR   hPSCreg; SDQLCHi058-A
DR   Wikidata; Q123033467
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SDQLCHi059-A
AC   CVCL_C9JJ
DR   BioSamples; SAMEA115076569
DR   hPSCreg; SDQLCHi059-A
DR   Wikidata; Q123033468
RX   PubMed=38493608;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:7216; MPI; Simple; p.Pro126_His128dupProGlnHis (c.376_384dupCCGCAGCAC); Zygosity=Heterozygous (PubMed=38493608).
CC   Sequence variation: Mutation; HGNC; HGNC:7216; MPI; Simple; p.Ile398Thr (c.1193T>C); ClinVar=VCV000860729; Zygosity=Heterozygous (PubMed=38493608).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206519; Congenital disorder of glycosylation type Ib
DI   ORDO; Orphanet_79319; MPI-CDG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi060-A
AC   CVCL_C9JK
DR   hPSCreg; SDQLCHi060-A
DR   Wikidata; Q123033469
RX   PubMed=37948839;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14262; AUTS2; Simple; p.Gln496Ter (c.1486C>T); Zygosity=Heterozygous (PubMed=37948839).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SDQLCHi061-A
AC   CVCL_C9JL
DR   BioSamples; SAMEA115084979
DR   hPSCreg; SDQLCHi061-A
DR   Wikidata; Q123033471
RX   PubMed=38394969;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2323; CPS1; Simple; p.Met792Val (c.2374A>G); Zygosity=Heterozygous (PubMed=38394969).
CC   Sequence variation: Mutation; HGNC; HGNC:2323; CPS1; Simple; p.Arg1317Trp (c.3949C>T); ClinVar=VCV002441763; Zygosity=Heterozygous (PubMed=38394969).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84612; Carbamoyl-phosphate synthetase I deficiency
DI   ORDO; Orphanet_147; Carbamoyl-phosphate synthetase 1 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SDQLCHi062-A
AC   CVCL_C9JM
DR   BioSamples; SAMEA114558317
DR   hPSCreg; SDQLCHi062-A
DR   Wikidata; Q123033472
RX   PubMed=38029557;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8616; PAX2; Simple; p.Gly76Ser (c.226G>A); ClinVar=VCV000013799; Zygosity=Heterozygous (PubMed=38029557).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C202604; Focal segmental glomerulosclerosis 7
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SDQLCHi063-A
AC   CVCL_C9JN
DR   BioSamples; SAMEA115300943
DR   hPSCreg; SDQLCHi063-A
DR   Wikidata; Q123033473
RX   PubMed=38507882;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4195; GCK; Unexplicit; Ex1del; Zygosity=Heterozygous (PubMed=38507882).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129741; Glucokinase-associated diabetes mellitus
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   SDQLCHi064-A
AC   CVCL_C9JP
DR   BioSamples; SAMEA115098521
DR   hPSCreg; SDQLCHi064-A
DR   Wikidata; Q123033474
RX   PubMed=38309148;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Leu187Argfs*5 (c.556_559dupGTTC); Zygosity=Heterozygous (PubMed=38309148).
CC   Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ser307Valfs*24 (c.919delA); Zygosity=Heterozygous (PubMed=38309148).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SDQLCHi065-A
AC   CVCL_D4ZN
DR   BioSamples; SAMEA115174033
DR   hPSCreg; SDQLCHi065-A
DR   Wikidata; Q127384267
RX   PubMed=38377649;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Karyotypic information: 47,XY,+21,inv(9)(p12;q21),16qh+ (PubMed=38377649).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8D
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SDQLCHi066-A
AC   CVCL_D4ZP
DR   BioSamples; SAMEA115174533
DR   hPSCreg; SDQLCHi066-A
DR   Wikidata; Q127384269
RX   PubMed=38492469;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Gly247Ser (c.739G>A) (p.Gly216Ser, c.646G>A); ClinVar=VCV000948892; Zygosity=Heterozygous (PubMed=38492469).
CC   Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Asp491His (c.1471G>C); Zygosity=Heterozygous (PubMed=38492469).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C157158; Tyrosine hydroxylase deficiency
DI   ORDO; Orphanet_101150; Autosomal recessive dopa-responsive dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SDQLCHi067-A
AC   CVCL_D4ZQ
DR   BioSamples; SAMEA115078188
DR   hPSCreg; SDQLCHi067-A
DR   Wikidata; Q127384271
RX   PubMed=38402847;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2714; DCX; Simple; p.Lys190Glu (c.568A>G); ClinVar=VCV000096552; Zygosity=Heterozygous (PubMed=38402847).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C205645; X-linked lissencephaly-1
DI   ORDO; Orphanet_2148; Lissencephaly type 1 due to doublecortin gene mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SDQLCHi068-A
AC   CVCL_D4ZR
DR   BioSamples; SAMEA115382132
DR   hPSCreg; SDQLCHi068-A
DR   Wikidata; Q127384273
RX   PubMed=38507881;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8977; PIK3CD; Simple; p.Glu1021Lys (c.3061G>A); ClinVar=VCV000088675; Zygosity=Heterozygous (PubMed=38507881).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C220694; Activated phosphatidylinositol-3-OH kinase delta syndrome, type 1
DI   ORDO; Orphanet_397596; Activated PI3K-delta syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 4
//
ID   SDQLCHi069-A
AC   CVCL_D4ZS
DR   hPSCreg; SDQLCHi069-A
DR   Wikidata; Q127384275
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SDQLCHi070-A
AC   CVCL_D4ZT
DR   hPSCreg; SDQLCHi070-A
DR   Wikidata; Q127384277
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SDQLCHi071-A
AC   CVCL_D4ZU
DR   hPSCreg; SDQLCHi071-A
DR   Wikidata; Q127384279
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SDQLCHi072-A
AC   CVCL_D4ZV
DR   BioSamples; SAMEA115879341
DR   hPSCreg; SDQLCHi072-A
DR   Wikidata; Q127384281
RX   PubMed=39276529;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:14262; AUTS2; Simple; p.Ala1020Val (c.3059C>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=39276529).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SDQLCHi073-A
AC   CVCL_D4ZW
DR   BioSamples; SAMEA115885858
DR   hPSCreg; SDQLCHi073-A
DR   Wikidata; Q127384283
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SDQLCHi074-A
AC   CVCL_D6QV
DR   hPSCreg; SDQLCHi074-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHi075-A
AC   CVCL_D6QW
DR   hPSCreg; SDQLCHi075-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHi076-A
AC   CVCL_D6QX
DR   hPSCreg; SDQLCHi076-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHi077-A
AC   CVCL_D6QY
DR   hPSCreg; SDQLCHi077-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHi078-A
AC   CVCL_D6QZ
DR   hPSCreg; SDQLCHi078-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHi079-A
AC   CVCL_D6R0
DR   BioSamples; SAMEA115664991
DR   hPSCreg; SDQLCHi079-A
RX   PubMed=39053320;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:16808; UBR1; Simple; c.1911+14C>G; Zygosity=Heterozygous (PubMed=39053320).
CC   Sequence variation: Mutation; HGNC; HGNC:16808; UBR1; Simple; p.Ser1056Ter (c.3167C>G); Zygosity=Heterozygous (PubMed=39053320).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C210826; Johanson-Blizzard syndrome
DI   ORDO; Orphanet_2315; Johanson-Blizzard syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SDQLCHi080-A
AC   CVCL_D6R1
DR   BioSamples; SAMEA115938033
DR   hPSCreg; SDQLCHi080-A
RX   PubMed=39213692;
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Gln175Ter (c.523C>T); ClinVar=VCV000551241; Zygosity=Heterozygous (PubMed=39213692).
CC   Sequence variation: Mutation; HGNC; HGNC:4298; GLB1; Simple; p.Tyr192His (c.574T>C); ClinVar=VCV000918052; Zygosity=Heterozygous (PubMed=39213692).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SDQLCHi081-A
AC   CVCL_E3CH
DR   hPSCreg; SDQLCHi081-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHi082-A
AC   CVCL_E3CI
DR   BioSamples; SAMEA115966492
DR   hPSCreg; SDQLCHi082-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDQLCHi083-A
AC   CVCL_E3CJ
DR   hPSCreg; SDQLCHi083-A
CC   From: Qilu Children's Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDR-P-1D5
AC   CVCL_A6JE
DR   RCB; RCB3600
DR   Wikidata; Q107116896
RX   PubMed=29949606;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Spontaneous dwarf rat (SDR); RS=RS_0002342.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   SDRL-1
AC   CVCL_W372
SY   Spontaneous Dwarf Rat Liver-1
DR   RCB; RCB3601
DR   Wikidata; Q54952726
RX   PubMed=21166888;
CC   Doubling time: ~96 hours (PubMed=21166888).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Spontaneous dwarf rat (SDR); RS=RS_0002342.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 9
//
ID   SDRL-2
AC   CVCL_A6JD
SY   Spontaneous Dwarf Rat Liver-2
DR   RCB; RCB3602
DR   Wikidata; Q107116897
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Spontaneous dwarf rat (SDR); RS=RS_0002342.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   SDT3
AC   CVCL_D2PN
DR   Wikidata; Q127384285
RX   PubMed=22002975;
CC   Breed/subspecies: English Bulldog; VBO=VBO_0200485.
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SDT3G
AC   CVCL_D2PS
SY   SDT-3G
DR   Wikidata; Q127384287
RX   PubMed=27251041;
RX   PubMed=28480569;
RX   PubMed=37254642;
RX   PubMed=37365849;
CC   Miscellaneous: STR profile carried out by CLS and provided by Schrock, Morgan S. The STR profile has 3 additional loci not in standard set: PEZ2:124,128, PEZ15:216 and PEZ17:210,214.
CC   Breed/subspecies: English Bulldog; VBO=VBO_0200485.
ST   Source(s): Direct_author_submission
ST   Dog FHC2010: 225,229
ST   Dog FHC2054: 154,178
ST   Dog FHC2079: 270
ST   Dog PEZ1: 110,114
ST   Dog PEZ6: 188,192
ST   Dog PEZ8: 231
ST   Dog PEZ12: 266
DI   NCIt; C129297; Canine glioma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_D2PN ! SDT3
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SDUBMSi001-A
AC   CVCL_YT38
DR   BioSamples; SAMEA6592711
DR   hPSCreg; SDUBMSi001-A
DR   SKIP; SKIP005690
DR   Wikidata; Q98129491
RX   PubMed=32045731;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Thr258Met (c.773C>T); ClinVar=VCV000464261; Zygosity=Heterozygous (PubMed=32045731).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C170435; Spastic paraplegia 30
DI   ORDO; Orphanet_101010; Autosomal spastic paraplegia type 30
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   SDUBMSi002-A
AC   CVCL_YT39
DR   hPSCreg; SDUBMSi002-A
DR   SKIP; SKIP005689
DR   Wikidata; Q98129492
RX   PubMed=32078988;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2555; CUL4B; Simple; p.Arg388Ter (c.1162C>T) (c.1564C>T); ClinVar=VCV000011339; Zygosity=Hemizygous (PubMed=32078988).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C167216; Intellectual developmental disorder, X-linked syndromic, Cabezas type
DI   ORDO; Orphanet_85293; X-linked intellectual disability, Cabezas type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 8
//
ID   SDUBMSi003-A
AC   CVCL_A7GH
DR   hPSCreg; SDUBMSi003-A
DR   Wikidata; Q107116899
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SDUBMSi004-A
AC   CVCL_A7GI
DR   hPSCreg; SDUBMSi004-A
DR   Wikidata; Q107116900
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SDUBMSi005-A
AC   CVCL_A7GG
SY   CDH1
DR   hPSCreg; SDUBMSi005-A
DR   Wikidata; Q107116901
RX   PubMed=33770698;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Thr560Arg (c.1679C>G); ClinVar=VCV000234554; Zygosity=Heterozygous (PubMed=33770698).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C43295; Hereditary gastric diffuse adenocarcinoma
DI   ORDO; Orphanet_26106; Hereditary diffuse gastric cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDUBMSi006-A
AC   CVCL_A7GD
SY   COL4A3-WB
DR   hPSCreg; SDUBMSi006-A
DR   Wikidata; Q107116902
RX   PubMed=33601099;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Gly1406Arg (c.4216G>A); Zygosity=Heterozygous (PubMed=33601099).
CC   Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Gly1415Arg (c.4243G>A); Zygosity=Heterozygous (PubMed=33601099).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDUBMSi007-A
AC   CVCL_A7GE
SY   COL4A5-WX
DR   hPSCreg; SDUBMSi007-A
DR   Wikidata; Q107116903
RX   PubMed=33878711;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Arg266Ter (c.796C>T); ClinVar=VCV000024325; Zygosity=Hemizygous (PubMed=33878711).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDUBMSi008-A
AC   CVCL_A7GF
SY   COL4A5-WRD
DR   hPSCreg; SDUBMSi008-A
DR   Wikidata; Q107116904
RX   PubMed=33878711;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Arg266Ter (c.796C>T); ClinVar=VCV000024325; Zygosity=Hemizygous (PubMed=33878711).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDUBMSi009-A
AC   CVCL_A4XW
DR   hPSCreg; SDUBMSi009-A
DR   Wikidata; Q107116905
RX   PubMed=33540283;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple; c.940-11G>A; ClinVar=VCV000279859; Zygosity=Hemizygous (PubMed=33540283).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84940; Oculocerebrorenal syndrome
DI   ORDO; Orphanet_534; Oculocerebrorenal syndrome of Lowe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDUBMSi010-A
AC   CVCL_A9AH
SY   LXL
DR   hPSCreg; SDUBMSi010-A
DR   Wikidata; Q108821287
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SDUBMSi011-A
AC   CVCL_A7JF
DR   hPSCreg; SDUBMSi011-A
DR   Wikidata; Q107116906
RX   PubMed=33892290;
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:20323; SMOC2; Simple; p.Leu359Arg (c.1076T>G); Zygosity=Heterozygous (PubMed=33892290).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   ORDO; Orphanet_251; Multiple epiphyseal dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SDUBMSi012-A
AC   CVCL_A9AF
DR   hPSCreg; SDUBMSi012-A
DR   Wikidata; Q108821288
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SDUBMSi013-A
AC   CVCL_A9AG
DR   hPSCreg; SDUBMSi013-A
DR   Wikidata; Q108821289
CC   From: School of Basic Medical Sciences, Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SDUCHi001-A
AC   CVCL_D6RF
DR   BioSamples; SAMEA115373599
DR   hPSCreg; SDUCHi001-A
RX   PubMed=38718593;
CC   From: Children's Hospital Affiliated to Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDUCTi001-A
AC   CVCL_C6U2
SY   IP-CT1-2EXP1C1; IP-CT1-2
DR   hPSCreg; SDUCTi001-A
DR   Wikidata; Q117704864
RX   PubMed=36402078;
CC   From: Department of Clinical Research, University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SDUCTi003-A
AC   CVCL_C6U3
SY   IP-CT3EXP25C2; IP-CT3
DR   hPSCreg; SDUCTi003-A
DR   Wikidata; Q117704865
CC   From: Department of Clinical Research, University of Southern Denmark; Odense; Denmark.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SDUCTi005-A
AC   CVCL_C6U4
SY   IP-CT5EXP27C2; IP-CT5
DR   hPSCreg; SDUCTi005-A
DR   Wikidata; Q117704866
CC   From: Department of Clinical Research, University of Southern Denmark; Odense; Denmark.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SDUCTi006-A
AC   CVCL_C6U5
SY   IP-CT6EXP27C1; IP-CT6
DR   hPSCreg; SDUCTi006-A
DR   Wikidata; Q117704867
CC   From: Department of Clinical Research, University of Southern Denmark; Odense; Denmark.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SDUe001-A
AC   CVCL_B019
SY   Odense-3; Odense3; OD3
DR   hPSCreg; SDUe001-A
DR   SKIP; SKIP001888
DR   Wikidata; Q54952728
RX   PubMed=18393673;
CC   From: University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SDUe002-A
AC   CVCL_A275
SY   KMEB1
DR   hPSCreg; SDUe002-A
DR   SKIP; SKIP001889
DR   Wikidata; Q54952729
RX   PubMed=18393673;
RX   PubMed=20198448;
CC   From: University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SDUe003-A
AC   CVCL_A277
SY   KMEB3
DR   hPSCreg; SDUe003-A
DR   SKIP; SKIP001890
DR   Wikidata; Q54952730
RX   PubMed=18393673;
RX   PubMed=20198448;
CC   From: University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SDUe004-A
AC   CVCL_A278
SY   KMEB4
DR   hPSCreg; SDUe004-A
DR   SKIP; SKIP001891
DR   Wikidata; Q54952732
RX   PubMed=18393673;
RX   PubMed=20198448;
CC   From: University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SDUe005-A
AC   CVCL_A279
SY   KMEB5
DR   hPSCreg; SDUe005-A
DR   SKIP; SKIP001892
DR   Wikidata; Q54952734
RX   PubMed=18393673;
RX   PubMed=20198448;
CC   From: University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SDUe006-A
AC   CVCL_B018
SY   Odense-4; Odense4
DR   hPSCreg; SDUe006-A
DR   SKIP; SKIP001893
DR   Wikidata; Q54952735
CC   From: University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SDUe007-A
AC   CVCL_A276
SY   KMEB2
DR   hPSCreg; SDUe007-A
DR   SKIP; SKIP001983
DR   Wikidata; Q54952736
RX   PubMed=18393673;
RX   PubMed=20198448;
CC   From: University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SDUKIi001-A
AC   CVCL_ZJ12
SY   IP-AP001; IP-AP1; IP-AP1EXP25C1
DR   hPSCreg; SDUKIi001-A
DR   Wikidata; Q98129495
CC   From: Institute of Clinical Research, University of Southern Denmark; Odense; Denmark.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   SDUKIi002-A
AC   CVCL_ZJ13
SY   IP-AP002; IP-AP2; IP-AP2EXP25C1
DR   hPSCreg; SDUKIi002-A
DR   Wikidata; Q98129496
RX   PubMed=32447258;
CC   From: Institute of Clinical Research, University of Southern Denmark; Odense; Denmark.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   SDUKIi003-A
AC   CVCL_A9XH
SY   IP-AP3; IP-AP3EXP25C1
DR   hPSCreg; SDUKIi003-A
DR   Wikidata; Q102114899
RX   PubMed=32916638;
CC   From: Institute of Clinical Research, University of Southern Denmark; Odense; Denmark.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   SDUKIi004-A
AC   CVCL_A1MK
SY   IP-AP4; IP-AP4EXP27C1
DR   hPSCreg; SDUKIi004-A
DR   Wikidata; Q102114901
RX   PubMed=33068890;
CC   From: Institute of Clinical Research, University of Southern Denmark; Odense; Denmark.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   SDUKIi005-A
AC   CVCL_A1ML
DR   hPSCreg; SDUKIi005-A
DR   Wikidata; Q102114902
CC   From: Institute of Clinical Research, University of Southern Denmark; Odense; Denmark.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   SDUKIi006-A
AC   CVCL_A1MM
SY   IP-AP6; IP-AP6EXP27C1
DR   hPSCreg; SDUKIi006-A
DR   Wikidata; Q102114903
RX   PubMed=33524673;
CC   From: Institute of Clinical Research, University of Southern Denmark; Odense; Denmark.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   SDW18.1.1
AC   CVCL_A0JJ
DR   ATCC; HB-9228
DR   Wikidata; Q108821290
RX   Patent=US5698419;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9228.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SDZ 11046-4591
AC   CVCL_E2X7
SY   San Diego Zoo 11046-4591
RX   PubMed=21518243;
CC   Senescence: Cells enter stasis at 5 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=70687; ! Tupaia tana (Large tree shrew)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 11247
AC   CVCL_E2X8
SY   San Diego Zoo 11247
RX   PubMed=21518243;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=340076; ! Chaetophractus vellerosus (Screaming hairy armadillo)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 12163
AC   CVCL_E2X9
SY   San Diego Zoo 12163
RX   PubMed=21518243;
CC   Senescence: Cells enter stasis at 6 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9368; ! Atelerix albiventris (Middle-African hedgehog)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updat